Citrus Sinensis ID: 019650

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------
Protein Sequence
MTLVRERRHQQALTLSLPATAANHQFRRRRHHFPTSNPTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNIEGLII
Secondary Structure (PSIPRED)
ccccccccccccccccccccccccccccccccccccccccccccccccHHHHccccccccEEEEEEEEcccccEEEEEEEEccccHHHHHHHHHHHHHHHHccccccEEEcEEEEccccEEEEEEEccccccHHHHHHHcccccHHHHHHHHHHHHHHHHHHHHccccccccccccEEEcccccEEEEccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHccccccccccccccHHHHHHHHcccccccccccccHHHHHHHHHHHcccccccccHHHHHccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
cccccccccccccccccccccccccccccccccccccccccccccccccEEEEEcccccHHHEEEEEEcccccEEEEEEEEcccccHHHHHHHHHHHHHHHcccccEEEEEEEEEccccEEEEEEEEcccHHHHHHHHHcccccHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEcccccEEEccccccEEccHccccccEEEEccccccccccccccccccccHHHHcccccccccccEEEHHHHHHHHHHHHccccccccccHHHHHHHHHHHccccccEEccccccHHHHHHHHHHHcccHHHcccHHHHHccHHHHcccccHccccccc
Coil and Loop (DISEMBL)
MTLVRERRHQQALTlslpataanhqfrrrrhhfptsnptspdvenisdlkkltvlghgnggIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLhgmqiihgdikpsnllingkgevkiadfGVSRIVEETrnnnnhnnnnnnnIGEAAIACMgtcaymspervdserwggdygfagdVWSLGVVVLECLvghypligfgekpdLMALICAICFgerlempetaspeFRRFVRSCLEKdwrkrgtveeLLAYPfvtkrssssnieglii
Flexible Loop (DISEMBL)
mtlvrerrhqqaltlslpataanhqfrrrrhhfptsnptspdvenISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEEtrnnnnhnnnnnnNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEmpetaspefrrFVRSCLekdwrkrgtveellaypfvtkrssssnieglii
Low Complexity Region (SEG)
MTLVRERRHQQALTLSLPATAANHQFRRRRHHFPTSNPTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRnnnnhnnnnnnnIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNIEGLII
Disordered region (IsUnstruct)
***********************************************DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIV********************AIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVT*************
Disordered Region (DISOPRED)
***********************************************DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICF*ERLE***TASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNIEGLII
Disordered Region (DISEMBL)
***********ALTLSLPATAANHQFRRRRHHFPTSNPTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKR***********
Disordered Region (DISPRO)
********************************************NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNIEGLII
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (MEMSAT)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
SSSSSSSSSSSSSSSSSSSSSoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MTLVRERRHQQALTLSLPATAANHQFRRRRHHFPTSNPTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNIEGLII
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	337	2.2.26 [Sep-21-2011]
O80397	366	Mitogen-activated protein	no	no	0.801	0.737	0.422	4e-57
Q8RXG3	348	Mitogen-activated protein	no	no	0.813	0.787	0.403	2e-55
Q5QN75	355	Mitogen-activated protein	no	no	0.863	0.819	0.370	3e-45
Q9FJV0	356	Mitogen-activated protein	no	no	0.765	0.724	0.378	2e-43
Q9S7U9	363	Mitogen-activated protein	no	no	0.813	0.754	0.363	6e-43
Q94A06	354	Mitogen-activated protein	no	no	0.759	0.723	0.385	1e-40
Q13163	448	Dual specificity mitogen-	yes	no	0.756	0.569	0.349	1e-39
Q62862	448	Dual specificity mitogen-	yes	no	0.756	0.569	0.349	2e-39
Q9WVS7	448	Dual specificity mitogen-	yes	no	0.756	0.569	0.349	2e-39
Q55CL6	660	Dual specificity mitogen-	yes	no	0.593	0.303	0.404	1e-38

>sp|O80397|M2K4_ARATH Mitogen-activated protein kinase kinase 4 OS=Arabidopsis thaliana GN=MKK4 PE=1 SV=1

 Score =  222 bits (565), Expect = 4e-57,   Method: Compositional matrix adjust.
 Identities = 123/291 (42%), Positives = 176/291 (60%), Gaps = 21/291 (7%)

Query: 42  DVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKR 101
           + +N SDL +   +G G GG VYKV H+ S+ +YALKV+       +R Q   E EIL+ 
Sbjct: 72  EAKNYSDLVRGNRIGSGAGGTVYKVIHRPSSRLYALKVIYGNHEETVRRQICREIEILRD 131

Query: 102 LDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQY 161
           ++   +VKCH +F    GEI  ++E M++GSL +   V K   E  ++ ++ ++L GL Y
Sbjct: 132 VNHPNVVKCHEMFDQ-NGEIQVLLEFMDKGSL-EGAHVWK---EQQLADLSRQILSGLAY 186

Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACM 221
           LH   I+H DIKPSNLLIN    VKIADFGVSRI+ +T +  N              + +
Sbjct: 187 LHSRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCN--------------SSV 232

Query: 222 GTCAYMSPERVDSERWGGDY-GFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAI 280
           GT AYMSPER++++   G Y G+AGD+WSLGV +LE  +G +P      + D  +L+CAI
Sbjct: 233 GTIAYMSPERINTDLNQGKYDGYAGDIWSLGVSILEFYLGRFPF-PVSRQGDWASLMCAI 291

Query: 281 CFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSN 331
           C  +  E P TASPEFR F+  CL+++  KR +  +LL +PF+ + S S N
Sbjct: 292 CMSQPPEAPATASPEFRHFISCCLQREPGKRRSAMQLLQHPFILRASPSQN 342

Involved in the second phase of hydrogen peroxide generation during hypersensitive response-like cell death. Involved in the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6) downstream of bacterial flagellin receptor FLS2. Activates by phosphorylation the downstream MPK3 and MPK6.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 2EC: .EC: 2

>sp|Q8RXG3|M2K5_ARATH Mitogen-activated protein kinase kinase 5 OS=Arabidopsis thaliana GN=MKK5 PE=1 SV=2

 Score =  216 bits (550), Expect = 2e-55,   Method: Compositional matrix adjust.
 Identities = 119/295 (40%), Positives = 175/295 (59%), Gaps = 21/295 (7%)

Query: 43  VENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRL 102
            +++S+L+++  +G G GG VYKV H  ++  +ALKV+       +R Q   E EIL+ +
Sbjct: 64  AKSLSELERVNRIGSGAGGTVYKVIHTPTSRPFALKVIYGNHEDTVRRQICREIEILRSV 123

Query: 103 DSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYL 162
           D   +VKCH +F    GEI  ++E M++GSL  +        E  ++ ++ ++L GL YL
Sbjct: 124 DHPNVVKCHDMF-DHNGEIQVLLEFMDQGSLEGA----HIWQEQELADLSRQILSGLAYL 178

Query: 163 HGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMG 222
           H   I+H DIKPSNLLIN    VKIADFGVSRI+ +T +  N              + +G
Sbjct: 179 HRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCN--------------SSVG 224

Query: 223 TCAYMSPERVDSERWGGDY-GFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAIC 281
           T AYMSPER++++   G Y G+AGDVWSLGV +LE  +G +P      + D  +L+CAIC
Sbjct: 225 TIAYMSPERINTDLNHGRYDGYAGDVWSLGVSILEFYLGRFPF-AVSRQGDWASLMCAIC 283

Query: 282 FGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNIEGLI 336
             +  E P TAS EFR FV  CL+ D  KR + ++LL +PF+ K +   N+  ++
Sbjct: 284 MSQPPEAPATASQEFRHFVSCCLQSDPPKRWSAQQLLQHPFILKATGGPNLRQML 338

Involved in the second phase of hydrogen peroxide generation during hypersensitive response-like cell death. Involved in the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6) downstream of bacterial flagellin receptor FLS2. Activates by phosphorylation the downstream MPK3 and MPK6.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 2

>sp|Q5QN75|M2K1_ORYSJ Mitogen-activated protein kinase kinase 1 OS=Oryza sativa subsp. japonica GN=MEK1 PE=1 SV=1

 Score =  182 bits (462), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 120/324 (37%), Positives = 174/324 (53%), Gaps = 33/324 (10%)

Query: 7   RRHQQALTLSLPATAANHQFRRRRHHFPTSNPTSPDVE-NISDLKKLTVLGHGNGGIVYK 65
           R +Q+ L L    TA   Q         ++N    DV+ ++ DL+ + V+G G+GGIV  
Sbjct: 37  RLNQRGLQLISEETADEPQ---------STNLKVEDVQLSMDDLEMIQVIGKGSGGIVQL 87

Query: 66  VRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVM 125
           VRH+   ++YALK +       +R Q   E +I +   +  IV CH  FY   G I  V+
Sbjct: 88  VRHKWVGTLYALKGIQMNIQEAVRKQIVQELKINQATQNAHIVLCHQSFYH-NGVIYLVL 146

Query: 126 EHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYL-HGMQIIHGDIKPSNLLINGKGE 184
           E+M+RGSL D ++  K + E  ++ +  +VL+GL YL H   +IH DIKPSNLL+N KGE
Sbjct: 147 EYMDRGSLADIIKQVKTILEPYLAVLCKQVLEGLLYLHHERHVIHRDIKPSNLLVNRKGE 206

Query: 185 VKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFA 244
           VKI DFGVS ++  +    +                +GT  YM+PER+     G  Y + 
Sbjct: 207 VKITDFGVSAVLASSMGQRD--------------TFVGTYNYMAPERIS----GSSYDYK 248

Query: 245 GDVWSLGVVVLECLVGHYPLI-GFGEK-PDLMALICAICFGERLEMP-ETASPEFRRFVR 301
            D+WSLG+V+LEC +G +P I   GE       L+ AI        P +  SPEF  F+ 
Sbjct: 249 SDIWSLGLVILECAIGRFPYIPSEGEGWLSFYELLEAIVDQPPPSAPADQFSPEFCAFIS 308

Query: 302 SCLEKDWRKRGTVEELLAYPFVTK 325
           SC++KD  +R +  ELL +PF+ K
Sbjct: 309 SCIQKDPAERMSASELLNHPFIKK 332

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 2

>sp|Q9FJV0|M2K6_ARATH Mitogen-activated protein kinase kinase 6 OS=Arabidopsis thaliana GN=MKK6 PE=1 SV=1

 Score =  176 bits (446), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 108/285 (37%), Positives = 157/285 (55%), Gaps = 27/285 (9%)

Query: 48  DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQ-- 105
           DL+ + V+G G+GG+V  VRH+     +A+KV+       IR Q   E +I  +  SQ  
Sbjct: 69  DLETVKVIGKGSGGVVQLVRHKWVGKFFAMKVIQMNIQEEIRKQIVQELKI-NQASSQCP 127

Query: 106 FIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGM 165
            +V C+  FY   G    V+E+M+RGSL D +R  K + E  ++ V  +VL GL YLH  
Sbjct: 128 HVVVCYHSFYH-NGAFSLVLEYMDRGSLADVIRQVKTILEPYLAVVCKQVLLGLVYLHNE 186

Query: 166 Q-IIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTC 224
           + +IH DIKPSNLL+N KGEVKI+DFGVS  +  +    +                +GT 
Sbjct: 187 RHVIHRDIKPSNLLVNHKGEVKISDFGVSASLASSMGQRD--------------TFVGTY 232

Query: 225 AYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEK---PDLMALICAIC 281
            YMSPER+     G  Y ++ D+WSLG+ VLEC +G +P +   ++   P    L+ AI 
Sbjct: 233 NYMSPERIS----GSTYDYSSDIWSLGMSVLECAIGRFPYLESEDQQNPPSFYELLAAIV 288

Query: 282 FGERLEMP-ETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTK 325
                  P +  SPEF  FV +C++KD   R +  +LL++PF+ K
Sbjct: 289 ENPPPTAPSDQFSPEFCSFVSACIQKDPPARASSLDLLSHPFIKK 333

Involved in the regulation of plant cytokinesis during meiosis and mitosis. Activates MPK13 in vitro.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 2

>sp|Q9S7U9|M2K2_ARATH Mitogen-activated protein kinase kinase 2 OS=Arabidopsis thaliana GN=MKK2 PE=1 SV=2

 Score =  174 bits (442), Expect = 6e-43,   Method: Compositional matrix adjust.
 Identities = 109/300 (36%), Positives = 158/300 (52%), Gaps = 26/300 (8%)

Query: 37  NPTSP--DVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH 94
           +P  P  D  ++SDL  + V+G G+ G+V  V+H+ +   +ALKV+       IR   A 
Sbjct: 56  SPIKPADDQLSLSDLDMVKVIGKGSSGVVQLVQHKWTGQFFALKVIQLNIDEAIRKAIAQ 115

Query: 95  EAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYR 154
           E +I +      +V  +  FY   G I  ++E+M+ GSL D L+  K + +  +S +  +
Sbjct: 116 ELKINQSSQCPNLVTSYQSFYD-NGAISLILEYMDGGSLADFLKSVKAIPDSYLSAIFRQ 174

Query: 155 VLKGLQYLH-GMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNI 213
           VL+GL YLH    IIH D+KPSNLLIN +GEVKI DFGVS ++  T    N         
Sbjct: 175 VLQGLIYLHHDRHIIHRDLKPSNLLINHRGEVKITDFGVSTVMTNTAGLAN--------- 225

Query: 214 GEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEK--- 270
                  +GT  YMSPER+     G  YG   D+WSLG+VVLEC  G +P     ++   
Sbjct: 226 -----TFVGTYNYMSPERI----VGNKYGNKSDIWSLGLVVLECATGKFPYAPPNQEETW 276

Query: 271 PDLMALICAICFGERLEMPE-TASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSS 329
             +  L+ AI       +P    SPE   F+ +CL+KD   R + +EL+ +PF+ K   S
Sbjct: 277 TSVFELMEAIVDQPPPALPSGNFSPELSSFISTCLQKDPNSRSSAKELMEHPFLNKYDYS 336

May be involved in the cold and salinity stress-mediated MAP kinase signaling cascade (MEKK1, MEK1/MKK2 and MPK4/MPK6). Activates by phosphorylation the downstream MPK4 and MPK6.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 2

>sp|Q94A06|M2K1_ARATH Mitogen-activated protein kinase kinase 1 OS=Arabidopsis thaliana GN=MKK1 PE=1 SV=2

 Score =  167 bits (422), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 111/288 (38%), Positives = 159/288 (55%), Gaps = 32/288 (11%)

Query: 45  NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKV--LNTTSSTIIRHQAAHEAEILKRL 102
           +++DL+ + V+G G+ G V  V+H+ +   +ALKV  LNT  ST      A   E+   L
Sbjct: 64  SLADLEVIKVIGKGSSGNVQLVKHKLTQQFFALKVIQLNTEESTC----RAISQELRINL 119

Query: 103 DSQ--FIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQ 160
            SQ  ++V C+  FY   G +  ++E M+ GSL D L+   K+ E+++S +  RVL+GL 
Sbjct: 120 SSQCPYLVSCYQSFYH-NGLVSIILEFMDGGSLADLLKKVGKVPENMLSAICKRVLRGLC 178

Query: 161 YLH-GMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIA 219
           Y+H   +IIH D+KPSNLLIN +GEVKI DFGVS+I+  T +  N              +
Sbjct: 179 YIHHERRIIHRDLKPSNLLINHRGEVKITDFGVSKILTSTSSLAN--------------S 224

Query: 220 CMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEK---PDLMAL 276
            +GT  YMSPER+     G  Y    D+WSLG+V+LEC  G +P      K     +  L
Sbjct: 225 FVGTYPYMSPERIS----GSLYSNKSDIWSLGLVLLECATGKFPYTPPEHKKGWSSVYEL 280

Query: 277 ICAICFGERLEMPETA-SPEFRRFVRSCLEKDWRKRGTVEELLAYPFV 323
           + AI        P    SPEF  F+  C++KD R R + +ELL + FV
Sbjct: 281 VDAIVENPPPCAPSNLFSPEFCSFISQCVQKDPRDRKSAKELLEHKFV 328

May be involved in the cold and salinity stress-mediated MAP kinase signaling cascade (MEKK1, MEK1/MKK2 and MPK4/MPK6). Phosphorylates MPK4 in vitro.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 2

>sp|Q13163|MP2K5_HUMAN Dual specificity mitogen-activated protein kinase kinase 5 OS=Homo sapiens GN=MAP2K5 PE=1 SV=2

 Score =  164 bits (414), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 100/286 (34%), Positives = 150/286 (52%), Gaps = 31/286 (10%)

Query: 45  NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDS 104
           N  D++    LGHGNGG VYK  H  S  I A+KV+    +  ++ Q   E EIL + DS
Sbjct: 162 NEQDIRYRDTLGHGNGGTVYKAYHVPSGKILAVKVILLDITLELQKQIMSELEILYKCDS 221

Query: 105 QFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG 164
            +I+  +  F+ +E  I    E M+ GSL     V +K+ E V+  +A  V+KGL YL  
Sbjct: 222 SYIIGFYGAFF-VENRISICTEFMDGGSL----DVYRKMPEHVLGRIAVAVVKGLTYLWS 276

Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTC 224
           ++I+H D+KPSN+L+N +G+VK+ DFGVS                   +   A   +GT 
Sbjct: 277 LKILHRDVKPSNMLVNTRGQVKLCDFGVS----------------TQLVNSIAKTYVGTN 320

Query: 225 AYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGE-KPDLMALICAICFG 283
           AYM+PER+  E+    YG   DVWSLG+  +E  +G +P     + +  LM L    C  
Sbjct: 321 AYMAPERISGEQ----YGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIV 376

Query: 284 ER----LEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTK 325
           +     L + E + P F  F+  C+ K  ++R   EEL+ +PF+ +
Sbjct: 377 DEDSPVLPVGEFSEP-FVHFITQCMRKQPKERPAPEELMGHPFIVQ 421

Acts as a scaffold for the formation of a ternary MAP3K2/MAP3K3-MAP3K5-MAPK7 signaling complex. Activation of this pathway appears to play a critical role in protecting cells from stress-induced apoptosis, neuronal survival and cardiac development and angiogenesis.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 2

>sp|Q62862|MP2K5_RAT Dual specificity mitogen-activated protein kinase kinase 5 OS=Rattus norvegicus GN=Map2k5 PE=1 SV=1

 Score =  163 bits (412), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 100/286 (34%), Positives = 149/286 (52%), Gaps = 31/286 (10%)

Query: 45  NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDS 104
           N  D++    LGHGNGG VYK  H  S  I A+KV+    +  ++ Q   E EIL + DS
Sbjct: 162 NEQDIRYRDTLGHGNGGTVYKAYHVPSGKILAVKVILLDITLELQKQIMSELEILYKCDS 221

Query: 105 QFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG 164
            +I+  +  F+ +E  I    E M+ GSL     V +K+ E V+  +A  V+KGL YL  
Sbjct: 222 SYIIGFYGAFF-VENRISICTEFMDGGSL----DVYRKIPEHVLGRIAVAVVKGLTYLWS 276

Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTC 224
           ++I+H D+KPSN+L+N  G+VK+ DFGVS                   +   A   +GT 
Sbjct: 277 LKILHRDVKPSNMLVNTSGQVKLCDFGVS----------------TQLVNSIAKTYVGTN 320

Query: 225 AYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGE-KPDLMALICAICFG 283
           AYM+PER+  E+    YG   DVWSLG+  +E  +G +P     + +  LM L    C  
Sbjct: 321 AYMAPERISGEQ----YGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIV 376

Query: 284 ER----LEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTK 325
           +     L + E + P F  F+  C+ K  ++R   EEL+ +PF+ +
Sbjct: 377 DEDSPVLPLGEFSEP-FVHFITQCMRKQPKERPAPEELMGHPFIVQ 421

Acts as a scaffold for the formation of a ternary MAP3K2/MAP3K3-MAP3K5-MAPK7 signaling complex. Activation of this pathway appears to play a critical role in protecting cells from stress-induced apoptosis, neuronal survival and cardiac development and angiogenesis.

Rattus norvegicus (taxid: 10116)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 2

>sp|Q9WVS7|MP2K5_MOUSE Dual specificity mitogen-activated protein kinase kinase 5 OS=Mus musculus GN=Map2k5 PE=1 SV=1

 Score =  162 bits (411), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 100/286 (34%), Positives = 149/286 (52%), Gaps = 31/286 (10%)

Query: 45  NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDS 104
           N  D++    LGHGNGG VYK  H  S  I A+KV+    +  ++ Q   E EIL + DS
Sbjct: 162 NEQDIRYRDTLGHGNGGTVYKAHHVPSGKILAVKVILLDITLELQKQIMSELEILYKCDS 221

Query: 105 QFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG 164
            +I+  +  F+ +E  I    E M+ GSL     V +K+ E V+  +A  V+KGL YL  
Sbjct: 222 SYIIGFYGAFF-VENRISICTEFMDGGSL----DVYRKIPEHVLGRIAVAVVKGLTYLWS 276

Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTC 224
           ++I+H D+KPSN+L+N  G+VK+ DFGVS                   +   A   +GT 
Sbjct: 277 LKILHRDVKPSNMLVNTGGQVKLCDFGVS----------------TQLVNSIAKTYVGTN 320

Query: 225 AYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGE-KPDLMALICAICFG 283
           AYM+PER+  E+    YG   DVWSLG+  +E  +G +P     + +  LM L    C  
Sbjct: 321 AYMAPERISGEQ----YGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIV 376

Query: 284 ER----LEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTK 325
           +     L + E + P F  F+  C+ K  ++R   EEL+ +PF+ +
Sbjct: 377 DEDSPVLPLGEFSEP-FVHFITQCMRKQPKERPAPEELMGHPFIVQ 421

Acts as a scaffold for the formation of a ternary MAP3K2/MAP3K3-MAP3K5-MAPK7 signaling complex. Activation of this pathway appears to play a critical role in protecting cells from stress-induced apoptosis, neuronal survival and cardiac development and angiogenesis.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 2

>sp|Q55CL6|MP2K1_DICDI Dual specificity mitogen-activated protein kinase kinase 1 OS=Dictyostelium discoideum GN=mekA PE=1 SV=1

 Score =  160 bits (406), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 89/220 (40%), Positives = 125/220 (56%), Gaps = 20/220 (9%)

Query: 45  NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDS 104
           ++ DLK + VLG G GG+V    H+ S +  ALKV+       IR Q   E + L +   
Sbjct: 288 DLKDLKIIRVLGRGAGGVVKLAYHETSGTYIALKVITLDIQENIRKQIILELKTLHKTSY 347

Query: 105 QFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLH- 163
            +IV  +  FYT EG I   +E ME GSL D ++    + E V+  +A++VL+GL YLH 
Sbjct: 348 PYIVSFYDAFYT-EGSIFIALEFMELGSLSDIMKKTSTIPEPVLGKIAFQVLQGLVYLHR 406

Query: 164 GMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGT 223
            + +IH DIKPSN+L+N KGE KIADFGVS  ++ T +               A+  +GT
Sbjct: 407 KLHLIHRDIKPSNILVNNKGEAKIADFGVSGQLQHTLS--------------KAVTWVGT 452

Query: 224 CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYP 263
             YMSPER+     G  Y F  ++WSLG+ +LEC +G +P
Sbjct: 453 VTYMSPERIS----GRSYSFDSEIWSLGLTILECAIGKFP 488

Required for cAMP-mediated activation of guanylyl cyclase activity and plays an essential role in aggregation, morphogenesis, and chemotaxis. Appears to act upstream of erk1 but not erk2.

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 2

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	337
224138184	332	predicted protein [Populus trichocarpa]	0.934	0.948	0.630	1e-111
356497649	337	PREDICTED: mitogen-activated protein kin	0.919	0.919	0.562	6e-96
378745366	335	MAP kinase kinase 10 [Lotus japonicus]	0.905	0.910	0.561	5e-95
297846200	309	ATMKK10 [Arabidopsis lyrata subsp. lyrat	0.910	0.993	0.567	8e-93
99083589	337	double MYC-tagged mitogen activated prot	0.899	0.899	0.539	3e-90
116830942	306	unknown [Arabidopsis thaliana]	0.899	0.990	0.539	5e-90
15223165	305	MAP kinase kinase 10 [Arabidopsis thalia	0.899	0.993	0.539	6e-90
255573443	302	mitogen activated protein kinase kinase,	0.833	0.930	0.511	2e-87
116790857	318	unknown [Picea sitchensis]	0.902	0.955	0.466	8e-74
147770515	314	hypothetical protein VITISV_038954 [Viti	0.922	0.990	0.460	2e-73

>gi|224138184|ref|XP_002326539.1| predicted protein [Populus trichocarpa] gi|222833861|gb|EEE72338.1| predicted protein [Populus trichocarpa]

 Score =  406 bits (1044), Expect = e-111,   Method: Compositional matrix adjust.
 Identities = 212/336 (63%), Positives = 247/336 (73%), Gaps = 21/336 (6%)

Query: 1   MTLVRERRHQQALTLSLPATAANHQFRRRRHHFPTS---NPTSPDVENISDLKKLTVLGH 57
           MTLVRERRHQQ L LSLP       FR + H    S   +P SP +E +SDL+KL VLGH
Sbjct: 1   MTLVRERRHQQPLRLSLPPPIPAADFRHQIHSPSLSLTISPDSPSIEKLSDLEKLAVLGH 60

Query: 58  GNGGIVYKVRHQKSNSIYALKVLN-TTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYT 116
           GN G VYKVRH++S+SI+ALK L    +STIIR QA  EAEIL+R+DS ++V+CHAVF +
Sbjct: 61  GNSGTVYKVRHKRSSSIFALKTLRFDRNSTIIRQQAGREAEILRRVDSPYVVQCHAVFDS 120

Query: 117 IEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSN 176
            E ++ F MEHMERGSL D L V + L EDVISGVA  +L GLQYLH  QI+HGDIKPSN
Sbjct: 121 -EDDLYFAMEHMERGSLHDVLLVHRILPEDVISGVARCILNGLQYLHEKQIVHGDIKPSN 179

Query: 177 LLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSER 236
           LLIN +G VKIADFGVSR+V        H++             MGTCAYMSPER+D ER
Sbjct: 180 LLINAEGVVKIADFGVSRVV-----VGKHDSYETY---------MGTCAYMSPERIDPER 225

Query: 237 W--GGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPETASP 294
           W   GD+GFAGDVWSLGVVVLECLVGHYPLIG GEKPD  AL+CAICFGERL+MP++AS 
Sbjct: 226 WDGNGDHGFAGDVWSLGVVVLECLVGHYPLIGCGEKPDWAALVCAICFGERLQMPKSASS 285

Query: 295 EFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSS 330
             + FVR CLEKDW+KRGTV ELL +PFVT+ S  S
Sbjct: 286 RIQSFVRRCLEKDWKKRGTVGELLDHPFVTQISFES 321

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356497649|ref|XP_003517672.1| PREDICTED: mitogen-activated protein kinase kinase 4-like [Glycine max]

 Score =  357 bits (915), Expect = 6e-96,   Method: Compositional matrix adjust.
 Identities = 194/345 (56%), Positives = 239/345 (69%), Gaps = 35/345 (10%)

Query: 1   MTLV-RERRHQQALTLSLPATAANHQFRRRRHHFPTSNPT-------SPDV-ENISDLKK 51
           MTLV RERRH+QAL LSLP   ++  F+    H P   P+       SP + +++SDL+K
Sbjct: 1   MTLVIRERRHKQALMLSLPKPHSDFPFQT---HIPAVLPSPFSHVDSSPGIIKDLSDLEK 57

Query: 52  LTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCH 111
           L VLGHGNGGIVYKV H K+ S YALKVL    + I       EAEILKR++S +IV+CH
Sbjct: 58  LAVLGHGNGGIVYKVYHTKNRSFYALKVLRLNENGI----GILEAEILKRVNSPYIVRCH 113

Query: 112 AVF---YTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQII 168
           AVF      EG+I FVME+ME GSL D L+   +L E+VIS +A RVL+GL YLHGM I+
Sbjct: 114 AVFDNDNCSEGDIGFVMEYMEGGSLHDVLQEHHRLPEEVISVLAKRVLEGLNYLHGMHIV 173

Query: 169 HGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMS 228
           H DIKPSNLL+N KGEVKIADFGVS +VE     ++ N               GTCAYMS
Sbjct: 174 HRDIKPSNLLVNDKGEVKIADFGVSHVVEGKFEVSDSN--------------AGTCAYMS 219

Query: 229 PERVDSERWGGDYG--FAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERL 286
           PER+D +RWGG+    FAGDVW+ GVV+LEC +G++PLIG G++PD   L+CAICFGE+L
Sbjct: 220 PERIDPDRWGGENADEFAGDVWATGVVMLECFLGYFPLIGPGQRPDWATLMCAICFGEKL 279

Query: 287 EMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSN 331
           EMPE ASPEF+ FVR CLEK+WRKR TV ELL +PFV +    S+
Sbjct: 280 EMPEKASPEFQNFVRRCLEKNWRKRATVLELLHHPFVGRNCCCSS 324

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|378745366|gb|AFC36319.1| MAP kinase kinase 10 [Lotus japonicus]

 Score =  353 bits (907), Expect = 5e-95,   Method: Compositional matrix adjust.
 Identities = 197/351 (56%), Positives = 238/351 (67%), Gaps = 46/351 (13%)

Query: 1   MTLV-RERRHQQALTLSLPATA-ANHQFRRRRHHFPT-SNPTS------PDVENISDLKK 51
           MTLV RERRH+QALTLSLP        F  + H  P  S+P+S        + NISDL+K
Sbjct: 1   MTLVIRERRHKQALTLSLPKPKIPPSDFPYQTHTPPLFSSPSSHLINSCSYIRNISDLEK 60

Query: 52  LTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCH 111
           + VLGHG GG VYKV H++++S YALKV         R     EAEILKR+DS +IVKCH
Sbjct: 61  VAVLGHGYGGTVYKVHHKENHSFYALKV---------RRFKTLEAEILKRVDSPYIVKCH 111

Query: 112 AVFYTIE---------GEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYL 162
           AVF             G++ FVME+MERGSL D LR   +L E+VIS +A RVL+GL+YL
Sbjct: 112 AVFDNGACSESDNNGGGDLSFVMEYMERGSLDDVLREHHRLPEEVISVMANRVLEGLKYL 171

Query: 163 HGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMG 222
           HGM+I+H DIKPSNLL+N KGEVKIADFGVS +VEE  ++N+                 G
Sbjct: 172 HGMKIVHRDIKPSNLLVNDKGEVKIADFGVSHVVEEEADSND-----------------G 214

Query: 223 TCAYMSPERVDSERWGGDY--GFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAI 280
           T AYMSPER D  RWGG+    FAGDVWSLGVV+LEC +GH+P I  G+KPDL+ L+CAI
Sbjct: 215 TYAYMSPERFDLSRWGGENVDEFAGDVWSLGVVMLECFLGHFPFIDPGQKPDLVTLVCAI 274

Query: 281 CFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSN 331
           CFGE+LEMPE ASPEF+ FV+ CLEKDWRKR TV ELL +PFV +    S+
Sbjct: 275 CFGEKLEMPEEASPEFQSFVKRCLEKDWRKRATVLELLHHPFVNRNCCCSS 325

Source: Lotus japonicus

Species: Lotus japonicus

Genus: Lotus

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297846200|ref|XP_002890981.1| ATMKK10 [Arabidopsis lyrata subsp. lyrata] gi|297336823|gb|EFH67240.1| ATMKK10 [Arabidopsis lyrata subsp. lyrata]

 Score =  346 bits (888), Expect = 8e-93,   Method: Compositional matrix adjust.
 Identities = 186/328 (56%), Positives = 230/328 (70%), Gaps = 21/328 (6%)

Query: 1   MTLVRERRHQQALTLSLPATAANHQFRRRRHHFPTSNPTSPDVENISDLKKLTVLGHGNG 60
           MTLVRERRHQ+ LTLS+P     H+         +S+P S  VE I+DL+KL VLG G+G
Sbjct: 1   MTLVRERRHQEPLTLSIPPLLY-HRTAFSVASSSSSSPDSSPVETINDLEKLAVLGQGSG 59

Query: 61  GIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGE 120
           G VYK RH+++ ++YALKVL +  +T      A E +ILKR+ S FIVKC+AVF     +
Sbjct: 60  GTVYKTRHRRTKTLYALKVLRSNLNTTTTTTTAVEVDILKRIKSSFIVKCYAVFLN-SSD 118

Query: 121 ICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLIN 180
           +CFVME ME+GSL D+L  ++  +E +IS +A R+L+GL+YL  M+I+HGDIKPSNLLIN
Sbjct: 119 LCFVMELMEKGSLHDALLAQQVFTEPMISTLANRILQGLRYLQEMRIVHGDIKPSNLLIN 178

Query: 181 GKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWG-- 238
            KGEVKIADFG SRIV       ++ +N             GTCAYMSPERVD E+WG  
Sbjct: 179 NKGEVKIADFGASRIVA----GGDYGSN-------------GTCAYMSPERVDPEKWGFG 221

Query: 239 GDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRR 298
           G+ GFAGDVWSLGVVVLEC +G YPL   G+KPD  ALICAIC  E++E+P + SPEFR 
Sbjct: 222 GEVGFAGDVWSLGVVVLECYIGRYPLTKVGDKPDWAALICAICCNEKVEIPVSGSPEFRD 281

Query: 299 FVRSCLEKDWRKRGTVEELLAYPFVTKR 326
           FV  CLEKDWRKRGTVEELL + FV  R
Sbjct: 282 FVGRCLEKDWRKRGTVEELLRHSFVKNR 309

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|99083589|gb|ABF55670.2| double MYC-tagged mitogen activated protein kinase kinase 10 [synthetic construct]

 Score =  337 bits (865), Expect = 3e-90,   Method: Compositional matrix adjust.
 Identities = 177/328 (53%), Positives = 228/328 (69%), Gaps = 25/328 (7%)

Query: 1   MTLVRERRHQQALTLSLPATAANHQFRRRRHHFPTSNPTSPDVENISDLKKLTVLGHGNG 60
           MTLVRERRHQ+ LTLS+P    +           +S  TSP ++ ++DL+KL+VLG G+G
Sbjct: 1   MTLVRERRHQEPLTLSIPPLIYHGTAFSVASSSSSSPETSP-IQTLNDLEKLSVLGQGSG 59

Query: 61  GIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGE 120
           G VYK RH+++ ++YALKVL    +T +      EA+ILKR++S FI+KC+AVF ++  +
Sbjct: 60  GTVYKTRHRRTKTLYALKVLRPNLNTTV----TVEADILKRIESSFIIKCYAVFVSLY-D 114

Query: 121 ICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLIN 180
           +CFVME ME+GSL D+L  ++  SE ++S +A R+L+GL+YL  M I+HGDIKPSNLLIN
Sbjct: 115 LCFVMELMEKGSLHDALLAQQVFSEPMVSSLANRILQGLRYLQKMGIVHGDIKPSNLLIN 174

Query: 181 GKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWG-- 238
            KGEVKIADFG SRIV       ++ +N             GTCAYMSPERVD E+WG  
Sbjct: 175 KKGEVKIADFGASRIVA----GGDYGSN-------------GTCAYMSPERVDLEKWGFG 217

Query: 239 GDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRR 298
           G+ GFAGDVWSLGVVVLEC +G YPL   G+KPD   L CAIC  E++++P + S EFR 
Sbjct: 218 GEVGFAGDVWSLGVVVLECYIGRYPLTKVGDKPDWATLFCAICCNEKVDIPVSCSLEFRD 277

Query: 299 FVRSCLEKDWRKRGTVEELLAYPFVTKR 326
           FV  CLEKDWRKR TVEELL + FV  R
Sbjct: 278 FVGRCLEKDWRKRDTVEELLRHSFVKNR 305

Source: synthetic construct

Species: synthetic construct

Genus: N/A

Family: N/A

Order: N/A

Class: N/A

Phylum: N/A

>gi|116830942|gb|ABK28427.1| unknown [Arabidopsis thaliana]

 Score =  337 bits (863), Expect = 5e-90,   Method: Compositional matrix adjust.
 Identities = 177/328 (53%), Positives = 228/328 (69%), Gaps = 25/328 (7%)

Query: 1   MTLVRERRHQQALTLSLPATAANHQFRRRRHHFPTSNPTSPDVENISDLKKLTVLGHGNG 60
           MTLVRERRHQ+ LTLS+P    +           +S  TSP ++ ++DL+KL+VLG G+G
Sbjct: 1   MTLVRERRHQEPLTLSIPPLIYHGTAFSVASSSSSSPETSP-IQTLNDLEKLSVLGQGSG 59

Query: 61  GIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGE 120
           G VYK RH+++ ++YALKVL    +T +      EA+ILKR++S FI+KC+AVF ++  +
Sbjct: 60  GTVYKTRHRRTKTLYALKVLRPNLNTTV----TVEADILKRIESSFIIKCYAVFVSLY-D 114

Query: 121 ICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLIN 180
           +CFVME ME+GSL D+L  ++  SE ++S +A R+L+GL+YL  M I+HGDIKPSNLLIN
Sbjct: 115 LCFVMELMEKGSLHDALLAQQVFSEPMVSSLANRILQGLRYLQKMGIVHGDIKPSNLLIN 174

Query: 181 GKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWG-- 238
            KGEVKIADFG SRIV       ++ +N             GTCAYMSPERVD E+WG  
Sbjct: 175 KKGEVKIADFGASRIVA----GGDYGSN-------------GTCAYMSPERVDLEKWGFG 217

Query: 239 GDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRR 298
           G+ GFAGDVWSLGVVVLEC +G YPL   G+KPD   L CAIC  E++++P + S EFR 
Sbjct: 218 GEVGFAGDVWSLGVVVLECYIGRYPLTKVGDKPDWATLFCAICCNEKVDIPVSCSLEFRD 277

Query: 299 FVRSCLEKDWRKRGTVEELLAYPFVTKR 326
           FV  CLEKDWRKR TVEELL + FV  R
Sbjct: 278 FVGRCLEKDWRKRDTVEELLRHSFVKNR 305

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|15223165|ref|NP_174510.1| MAP kinase kinase 10 [Arabidopsis thaliana] gi|8920605|gb|AAF81327.1|AC007767_7 Contains similarity to MAP kinase kinase 4 from Arabidopsis thaliana gb|AB015315. It contains a eukaryotic protein kinase domain PF|00069 [Arabidopsis thaliana] gi|12597861|gb|AAG60170.1|AC084110_3 MAP kinase, putative [Arabidopsis thaliana] gi|91805897|gb|ABE65677.1| mitogen-activated protein kinase kinase [Arabidopsis thaliana] gi|332193342|gb|AEE31463.1| MAP kinase kinase 10 [Arabidopsis thaliana]

 Score =  337 bits (863), Expect = 6e-90,   Method: Compositional matrix adjust.
 Identities = 177/328 (53%), Positives = 228/328 (69%), Gaps = 25/328 (7%)

Query: 1   MTLVRERRHQQALTLSLPATAANHQFRRRRHHFPTSNPTSPDVENISDLKKLTVLGHGNG 60
           MTLVRERRHQ+ LTLS+P    +           +S  TSP ++ ++DL+KL+VLG G+G
Sbjct: 1   MTLVRERRHQEPLTLSIPPLIYHGTAFSVASSSSSSPETSP-IQTLNDLEKLSVLGQGSG 59

Query: 61  GIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGE 120
           G VYK RH+++ ++YALKVL    +T +      EA+ILKR++S FI+KC+AVF ++  +
Sbjct: 60  GTVYKTRHRRTKTLYALKVLRPNLNTTV----TVEADILKRIESSFIIKCYAVFVSLY-D 114

Query: 121 ICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLIN 180
           +CFVME ME+GSL D+L  ++  SE ++S +A R+L+GL+YL  M I+HGDIKPSNLLIN
Sbjct: 115 LCFVMELMEKGSLHDALLAQQVFSEPMVSSLANRILQGLRYLQKMGIVHGDIKPSNLLIN 174

Query: 181 GKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWG-- 238
            KGEVKIADFG SRIV       ++ +N             GTCAYMSPERVD E+WG  
Sbjct: 175 KKGEVKIADFGASRIVA----GGDYGSN-------------GTCAYMSPERVDLEKWGFG 217

Query: 239 GDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRR 298
           G+ GFAGDVWSLGVVVLEC +G YPL   G+KPD   L CAIC  E++++P + S EFR 
Sbjct: 218 GEVGFAGDVWSLGVVVLECYIGRYPLTKVGDKPDWATLFCAICCNEKVDIPVSCSLEFRD 277

Query: 299 FVRSCLEKDWRKRGTVEELLAYPFVTKR 326
           FV  CLEKDWRKR TVEELL + FV  R
Sbjct: 278 FVGRCLEKDWRKRDTVEELLRHSFVKNR 305

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255573443|ref|XP_002527647.1| mitogen activated protein kinase kinase, putative [Ricinus communis] gi|223532952|gb|EEF34718.1| mitogen activated protein kinase kinase, putative [Ricinus communis]

 Score =  328 bits (842), Expect = 2e-87,   Method: Compositional matrix adjust.
 Identities = 180/352 (51%), Positives = 223/352 (63%), Gaps = 71/352 (20%)

Query: 1   MTLVRERRHQQALTLSLPATAANHQFRRRRHHFPT---------------SNPTSPDVEN 45
           MTLVRERRHQQ L +S+P  +    F    HH  T               ++P S  +++
Sbjct: 1   MTLVRERRHQQPLNISVPPPSPAALF----HHIHTHHLPLPPVPPSSPDITSPNSTAIDS 56

Query: 46  ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVL--NTTSSTIIRHQAAHEAEILKRLD 103
           +SDL++LT LG GNGGIVYKVRH+ + SI+ALKVL  +  ++TI R QAA EA+ILKR+D
Sbjct: 57  LSDLERLTTLGRGNGGIVYKVRHRPTGSIFALKVLRFDNDTATICR-QAAQEAQILKRVD 115

Query: 104 SQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLH 163
           S +IV+C+AVF + E  +CF MEHMERGSL D L   K+L E+VISGVA+RVL GLQYL 
Sbjct: 116 SPYIVRCYAVFNS-ESYLCFAMEHMERGSLNDVLIGIKRLPENVISGVAWRVLHGLQYLQ 174

Query: 164 GMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGT 223
            +QI+HGDIKPSNLL N +G+VKIADFG +                              
Sbjct: 175 RVQIVHGDIKPSNLLTNAEGDVKIADFGAN------------------------------ 204

Query: 224 CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFG 283
                             G++GDVWSLGVVVLECLVGHYPLIG GEKPD  AL+CAIC G
Sbjct: 205 ------------------GYSGDVWSLGVVVLECLVGHYPLIGSGEKPDWAALVCAICSG 246

Query: 284 ERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNIEGL 335
           +RL+ P  ASPE + F++ CLEKDW KRGTV+ELL +PFV K      + GL
Sbjct: 247 KRLDFPANASPELQSFLQRCLEKDWNKRGTVDELLDHPFVNKICCDQGLPGL 298

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|116790857|gb|ABK25765.1| unknown [Picea sitchensis]

 Score =  283 bits (724), Expect = 8e-74,   Method: Compositional matrix adjust.
 Identities = 151/324 (46%), Positives = 205/324 (63%), Gaps = 20/324 (6%)

Query: 8   RHQQALTLSLPATAANHQFRRRRHHFPTSNPTSPDVENISDLKKLTVLGHGNGGIVYKVR 67
           R    L + +PA      +R      P +   S DV ++SDL+++ +LGHG+GG VYKVR
Sbjct: 4   RRNPRLNIPIPARQQTQLYRLPLP--PQNTAVSKDVSDLSDLERIQILGHGSGGNVYKVR 61

Query: 68  HQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEH 127
           H+K++++YALKV++      +R Q   E EILK+ +S +IVKCH +F   E EI F +E 
Sbjct: 62  HRKTSALYALKVIHGNHDEAVRRQIIREMEILKKTESPYIVKCHGIFEKGE-EIHFALEF 120

Query: 128 MERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKI 187
           M+ GSL    R    +SE  ++ VA +VL+GL+YLH  +I+H DIKPSNLLIN K EVKI
Sbjct: 121 MDGGSL--EQRRSDMMSERFLAQVARQVLEGLKYLHRHKIVHRDIKPSNLLINKKQEVKI 178

Query: 188 ADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDY-GFAGD 246
           ADFGVSRI+ +T +  N                +GTCAYMSPER D E +GG Y G+AGD
Sbjct: 179 ADFGVSRILSQTLDPCN--------------TYVGTCAYMSPERFDPETYGGRYDGYAGD 224

Query: 247 VWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEK 306
           +WSLG+ +LEC +GH+P +  G+K D  AL+CAIC+G+    P TAS  FR F+  CL K
Sbjct: 225 IWSLGLSLLECYIGHFPFLAAGQKADWPALMCAICYGDPPSPPPTASAHFRSFITCCLHK 284

Query: 307 DWRKRGTVEELLAYPFVTKRSSSS 330
           D R R T  +LLA+PF+   S  +
Sbjct: 285 DARNRWTAAQLLAHPFLLSNSPQA 308

Source: Picea sitchensis

Species: Picea sitchensis

Genus: Picea

Family: Pinaceae

Order: Coniferales

Class: Coniferopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147770515|emb|CAN75681.1| hypothetical protein VITISV_038954 [Vitis vinifera]

 Score =  282 bits (721), Expect = 2e-73,   Method: Compositional matrix adjust.
 Identities = 151/328 (46%), Positives = 210/328 (64%), Gaps = 17/328 (5%)

Query: 1   MTLVRERRHQQALTLSLPATAANHQFRRRRHHFPTSNPTSPDVENISDLKKLTVLGHGNG 60
           M +VR+RR Q  L L LP  + + + R      PT+ P S      +DL+K+ V+GHGNG
Sbjct: 1   MAVVRDRR-QLNLRLPLPEIS-DRRPRFPLPLPPTNLPFSSGATTAADLEKIEVIGHGNG 58

Query: 61  GIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGE 120
           G VYKV+H+++ + YALKV++      +R Q   E EIL+  DS F+V+CH +F    G+
Sbjct: 59  GTVYKVQHKRTAANYALKVVHGDCDPTVRRQVLREMEILRFTDSPFVVQCHGIFQKPSGD 118

Query: 121 ICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLIN 180
           I  +ME+M+ G+L   L  +   SE  ++GVA +VL GL YLH  +IIH DIKP+NLL+N
Sbjct: 119 IAILMEYMDAGTLKTLLETQGTFSEVDLAGVAGQVLNGLSYLHSHKIIHRDIKPANLLVN 178

Query: 181 GKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGD 240
           G  EVKIADFGVS+I+    ++ N              + +GTCAYMSPER D +  G +
Sbjct: 179 GNMEVKIADFGVSKIMRRMLDSCN--------------SYVGTCAYMSPERFDPDSHGSN 224

Query: 241 Y-GFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRRF 299
           Y G++GD+WSLG+ +LE  VGH+PL+  G+KPD   L+CAICFGE   +PE  S EFR F
Sbjct: 225 YDGYSGDIWSLGLTLLELYVGHFPLLPAGQKPDWATLMCAICFGEEPALPEGVSEEFRNF 284

Query: 300 VRSCLEKDWRKRGTVEELLAYPFVTKRS 327
           +  CL+KD  KR T  +LL++PF+ K+S
Sbjct: 285 IECCLQKDSTKRWTAAQLLSHPFICKQS 312

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	337
TAIR|locus:2206885	310	MKK9 "MAP kinase kinase 9" [Ar	0.884	0.961	0.462	5.1e-67
TAIR|locus:2028301	305	MKK10 "MAP kinase kinase 10" [	0.635	0.701	0.581	1.1e-64
TAIR|locus:2014099	307	MKK7 "MAP kinase kinase 7" [Ar	0.816	0.895	0.428	3.6e-57
TAIR|locus:2017662	366	MKK4 "mitogen-activated protei	0.821	0.756	0.416	3e-53
TAIR|locus:2094761	348	MKK5 "MAP kinase kinase 5" [Ar	0.810	0.784	0.401	6.5e-51
TAIR|locus:2082390	293	MKK8 "MAP kinase kinase 8" [Ar	0.709	0.815	0.410	3.4e-45
UNIPROTKB|Q0VD16	393	MAP2K1 "MAP2K1 protein" [Bos t	0.620	0.531	0.346	4e-45
UNIPROTKB|Q02750	393	MAP2K1 "Dual specificity mitog	0.620	0.531	0.346	4e-45
RGD|70495	393	Map2k1 "mitogen activated prot	0.620	0.531	0.346	4e-45
MGI|MGI:1346866	393	Map2k1 "mitogen-activated prot	0.620	0.531	0.346	5.1e-45

TAIR|locus:2206885 MKK9 "MAP kinase kinase 9" [Arabidopsis thaliana (taxid:3702)]

 Score = 681 (244.8 bits), Expect = 5.1e-67, P = 5.1e-67
 Identities = 147/318 (46%), Positives = 201/318 (63%)

Query:     8 RHQQALTLSLPATAANHQFRRRRHHFPTSNPTSPDVENISDLKKLTVLGHGNGGIVYKVR 67
             R Q  L L LP  + + +F        T+     +  +  DL+KL VLG GNGGIVYKVR
Sbjct:     7 RRQLNLRLPLPPIS-DRRFSTSSSSATTTTVAGCNGISACDLEKLNVLGCGNGGIVYKVR 65

Query:    68 HQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYT-IEGEICFVME 126
             H+ ++ IYALK +N     I   Q   E EIL+R DS ++VKCH +F   + GE+  +ME
Sbjct:    66 HKTTSEIYALKTVNGDMDPIFTRQLMREMEILRRTDSPYVVKCHGIFEKPVVGEVSILME 125

Query:   127 HMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVK 186
             +M+ G+L +SLR    ++E  ++G A ++LKGL YLH ++I+H DIKP+NLL+N K EVK
Sbjct:   126 YMDGGTL-ESLR--GGVTEQKLAGFAKQILKGLSYLHALKIVHRDIKPANLLLNSKNEVK 182

Query:   187 IADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERVDSERWGGDYG-FAG 245
             IADFGVS+I+  +               ++  + +GTCAYMSPER DSE  GG    +AG
Sbjct:   183 IADFGVSKILVRSL--------------DSCNSYVGTCAYMSPERFDSESSGGSSDIYAG 228

Query:   246 DVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLE 305
             D+WS G+++LE LVGH+PL+  G++PD   L+CA+CFGE    PE  S EFR FV  CL 
Sbjct:   229 DIWSFGLMMLELLVGHFPLLPPGQRPDWATLMCAVCFGEPPRAPEGCSEEFRSFVECCLR 288

Query:   306 KDWRKRGTVEELLAYPFV 323
             KD  KR T  +LLA+PF+
Sbjct:   289 KDSSKRWTAPQLLAHPFL 306

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005739 "mitochondrion" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0008152 "metabolic process" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004708 "MAP kinase kinase activity" evidence=IDA;TAS

GO:0009611 "response to wounding" evidence=IEP

GO:0009873 "ethylene mediated signaling pathway" evidence=IMP

GO:0009651 "response to salt stress" evidence=IMP

GO:0009693 "ethylene biosynthetic process" evidence=RCA;IDA

GO:0010120 "camalexin biosynthetic process" evidence=IDA

GO:0030295 "protein kinase activator activity" evidence=IDA

GO:0045893 "positive regulation of transcription, DNA-dependent" evidence=IEP

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0006569 "tryptophan catabolic process" evidence=RCA

GO:0009684 "indoleacetic acid biosynthetic process" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0019344 "cysteine biosynthetic process" evidence=RCA

TAIR|locus:2028301 MKK10 "MAP kinase kinase 10" [Arabidopsis thaliana (taxid:3702)]

 Score = 659 (237.0 bits), Expect = 1.1e-64, P = 1.1e-64
 Identities = 136/234 (58%), Positives = 167/234 (71%)

Query:    95 EAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYR 154
             EA+ILKR++S FI+KC+AVF ++  ++CFVME ME+GSL D+L  ++  SE ++S +A R
Sbjct:    90 EADILKRIESSFIIKCYAVFVSLY-DLCFVMELMEKGSLHDALLAQQVFSEPMVSSLANR 148

Query:   155 VLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIG 214
             +L+GL+YL  M I+HGDIKPSNLLIN KGEVKIADFG SRIV                 G
Sbjct:   149 ILQGLRYLQKMGIVHGDIKPSNLLINKKGEVKIADFGASRIVAG---------------G 193

Query:   215 EAAIACMGTCAYMSPERVDSERWG--GDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPD 272
             +      GTCAYMSPERVD E+WG  G+ GFAGDVWSLGVVVLEC +G YPL   G+KPD
Sbjct:   194 D--YGSNGTCAYMSPERVDLEKWGFGGEVGFAGDVWSLGVVVLECYIGRYPLTKVGDKPD 251

Query:   273 LMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKR 326
                L CAIC  E++++P + S EFR FV  CLEKDWRKR TVEELL + FV  R
Sbjct:   252 WATLFCAICCNEKVDIPVSCSLEFRDFVGRCLEKDWRKRDTVEELLRHSFVKNR 305

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004708 "MAP kinase kinase activity" evidence=TAS

TAIR|locus:2014099 MKK7 "MAP kinase kinase 7" [Arabidopsis thaliana (taxid:3702)]

 Score = 588 (212.0 bits), Expect = 3.6e-57, P = 3.6e-57
 Identities = 126/294 (42%), Positives = 177/294 (60%)

Query:    33 FPTSNPTSPDVEN---ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIR 89
             F  ++ T+P + N    SD++KL VLG G+ GIVYKV H+ +  IYALK +N   S    
Sbjct:    26 FSFASSTAPVINNGISASDVEKLHVLGRGSSGIVYKVHHKTTGEIYALKSVNGDMSPAFT 85

Query:    90 HQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVIS 149
              Q A E EIL+R DS ++V+C  +F         ++     G   +SLR    ++E  ++
Sbjct:    86 RQLAREMEILRRTDSPYVVRCQGIFEKPIVGEVSILMEYMDGGNLESLR--GAVTEKQLA 143

Query:   150 GVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXX 209
             G + ++LKGL YLH ++I+H DIKP+NLL+N + EVKIADFGVS+I+  TR         
Sbjct:   144 GFSRQILKGLSYLHSLKIVHRDIKPANLLLNSRNEVKIADFGVSKII--TRSL------- 194

Query:   210 XXXIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGE 269
                  +   + +GTCAYMSPER DS        +AGD+WS GV++LE  VGH+PL+  G+
Sbjct:   195 -----DYCNSYVGTCAYMSPERFDSAAGENSDVYAGDIWSFGVMILELFVGHFPLLPQGQ 249

Query:   270 KPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV 323
             +PD   L+C +CFGE    PE  S EFR FV  CL K+  +R T  +LL +PF+
Sbjct:   250 RPDWATLMCVVCFGEPPRAPEGCSDEFRSFVDCCLRKESSERWTASQLLGHPFL 303

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004708 "MAP kinase kinase activity" evidence=TAS

GO:0009926 "auxin polar transport" evidence=IMP

GO:0002229 "defense response to oomycetes" evidence=IMP

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=IMP

GO:0042742 "defense response to bacterium" evidence=IMP

TAIR|locus:2017662 MKK4 "mitogen-activated protein kinase kinase 4" [Arabidopsis thaliana (taxid:3702)]

 Score = 551 (199.0 bits), Expect = 3.0e-53, P = 3.0e-53
 Identities = 124/298 (41%), Positives = 179/298 (60%)

Query:    35 TSNPTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH 94
             T+  +S + +N SDL +   +G G GG VYKV H+ S+ +YALKV+       +R Q   
Sbjct:    65 TNTNSSIEAKNYSDLVRGNRIGSGAGGTVYKVIHRPSSRLYALKVIYGNHEETVRRQICR 124

Query:    95 EAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYR 154
             E EIL+ ++   +VKCH +F    GEI  ++E M++GSL +   V K   E  ++ ++ +
Sbjct:   125 EIEILRDVNHPNVVKCHEMFDQ-NGEIQVLLEFMDKGSL-EGAHVWK---EQQLADLSRQ 179

Query:   155 VLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIG 214
             +L GL YLH   I+H DIKPSNLLIN    VKIADFGVSRI+ +T               
Sbjct:   180 ILSGLAYLHSRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM-------------- 225

Query:   215 EAAIACMGTCAYMSPERVDSERWGGDY-GFAGDVWSLGVVVLECLVGHYPLIGFGEKPDL 273
             +   + +GT AYMSPER++++   G Y G+AGD+WSLGV +LE  +G +P      + D 
Sbjct:   226 DPCNSSVGTIAYMSPERINTDLNQGKYDGYAGDIWSLGVSILEFYLGRFPF-PVSRQGDW 284

Query:   274 MALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSN 331
              +L+CAIC  +  E P TASPEFR F+  CL+++  KR +  +LL +PF+ + S S N
Sbjct:   285 ASLMCAICMSQPPEAPATASPEFRHFISCCLQREPGKRRSAMQLLQHPFILRASPSQN 342

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009814 "defense response, incompatible interaction" evidence=RCA;IMP

GO:0005737 "cytoplasm" evidence=IDA

GO:2000037 "regulation of stomatal complex patterning" evidence=IGI

GO:2000038 "regulation of stomatal complex development" evidence=IGI

GO:0010227 "floral organ abscission" evidence=IMP

GO:0000165 "MAPK cascade" evidence=IC;RCA

GO:0002679 "respiratory burst involved in defense response" evidence=RCA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0007154 "cell communication" evidence=RCA

GO:0009409 "response to cold" evidence=RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009617 "response to bacterium" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035304 "regulation of protein dephosphorylation" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0043900 "regulation of multi-organism process" evidence=RCA

GO:0045088 "regulation of innate immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

GO:0010229 "inflorescence development" evidence=IGI

GO:0004708 "MAP kinase kinase activity" evidence=ISS;IDA

TAIR|locus:2094761 MKK5 "MAP kinase kinase 5" [Arabidopsis thaliana (taxid:3702)]

 Score = 529 (191.3 bits), Expect = 6.5e-51, P = 6.5e-51
 Identities = 118/294 (40%), Positives = 176/294 (59%)

Query:    44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLD 103
             +++S+L+++  +G G GG VYKV H  ++  +ALKV+       +R Q   E EIL+ +D
Sbjct:    65 KSLSELERVNRIGSGAGGTVYKVIHTPTSRPFALKVIYGNHEDTVRRQICREIEILRSVD 124

Query:   104 SQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLH 163
                +VKCH +F    GEI  ++E M++GSL +   + +   E  ++ ++ ++L GL YLH
Sbjct:   125 HPNVVKCHDMF-DHNGEIQVLLEFMDQGSL-EGAHIWQ---EQELADLSRQILSGLAYLH 179

Query:   164 GMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGT 223
                I+H DIKPSNLLIN    VKIADFGVSRI+ +T               +   + +GT
Sbjct:   180 RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM--------------DPCNSSVGT 225

Query:   224 CAYMSPERVDSERWGGDY-GFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICF 282
              AYMSPER++++   G Y G+AGDVWSLGV +LE  +G +P      + D  +L+CAIC 
Sbjct:   226 IAYMSPERINTDLNHGRYDGYAGDVWSLGVSILEFYLGRFPF-AVSRQGDWASLMCAICM 284

Query:   283 GERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNIEGLI 336
              +  E P TAS EFR FV  CL+ D  KR + ++LL +PF+ K +   N+  ++
Sbjct:   285 SQPPEAPATASQEFRHFVSCCLQSDPPKRWSAQQLLQHPFILKATGGPNLRQML 338

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005739 "mitochondrion" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009814 "defense response, incompatible interaction" evidence=IMP

GO:2000037 "regulation of stomatal complex patterning" evidence=IGI

GO:0010227 "floral organ abscission" evidence=IMP

GO:0015824 "proline transport" evidence=RCA

GO:0010229 "inflorescence development" evidence=IGI

GO:0004708 "MAP kinase kinase activity" evidence=ISS

TAIR|locus:2082390 MKK8 "MAP kinase kinase 8" [Arabidopsis thaliana (taxid:3702)]

 Score = 475 (172.3 bits), Expect = 3.4e-45, P = 3.4e-45
 Identities = 112/273 (41%), Positives = 169/273 (61%)

Query:    45 NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALK-VLNTTSSTIIRHQAAHEAEILKRLD 103
             ++++L +++VLG GNGG V+KV+ + ++ IYALK V     ST +R     E EIL+ ++
Sbjct:    49 SVANLDRISVLGSGNGGTVFKVKDKTTSEIYALKKVKENWDSTSLR-----EIEILRMVN 103

Query:   104 SQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLH 163
             S ++ KCH +F    GE+  +M++M+ GSL +SLR    ++E  ++ ++ +VL+G  YLH
Sbjct:   104 SPYVAKCHDIFQNPSGEVSILMDYMDLGSL-ESLR---GVTEKQLALMSRQVLEGKNYLH 159

Query:   164 GMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGT 223
               +I+H DIKP+NLL + K EVKIADFGVS+IV  +                   + +GT
Sbjct:   160 EHKIVHRDIKPANLLRSSKEEVKIADFGVSKIVVRSL--------------NKCNSFVGT 205

Query:   224 CAYMSPERVDSERWG---GDYG--FAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALIC 278
              AYMSPER+DSE  G    D    +AGD+WS G+ +LE LVG+YP++     PD  A++C
Sbjct:   206 FAYMSPERLDSEADGVTEEDKSNVYAGDIWSFGLTMLEILVGYYPML-----PDQAAIVC 260

Query:   279 AICFGERLEMPETASPEFRRFVRSCLEKDWRKR 311
             A+CFGE  + PE  S + + F+  CL K   +R
Sbjct:   261 AVCFGEPPKAPEECSDDLKSFMDCCLRKKASER 293

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004708 "MAP kinase kinase activity" evidence=TAS

UNIPROTKB|Q0VD16 MAP2K1 "MAP2K1 protein" [Bos taurus (taxid:9913)]

 Score = 330 (121.2 bits), Expect = 4.0e-45, Sum P(3) = 4.0e-45
 Identities = 79/228 (34%), Positives = 125/228 (54%)

Query:    11 QALTLSLPATAANHQFRRRRHHFPTSNPTSPDVENISDLKKLTVLGHGNGGIVYKVRHQK 70
             +AL   L     + Q R+R   F T      ++++  D +K++ LG GNGG+V+KV H+ 
Sbjct:    31 EALQKKLEELELDEQQRKRLEAFLTQKQKVGELKD-DDFEKISELGAGNGGVVFKVSHKP 89

Query:    71 SNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMER 130
             S  + A K+++      IR+Q   E ++L   +S +IV  +  FY+ +GEI   MEHM+ 
Sbjct:    90 SGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-DGEISICMEHMDG 148

Query:   131 GSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGM-QIIHGDIKPSNLLINGKGEVKIAD 189
             GSL   L+   ++ E ++  V+  V+KGL YL    +I+H D+KPSN+L+N +GE+K+ D
Sbjct:   149 GSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCD 208

Query:   190 FGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERVDSERW 237
             FGVS                   I   A + +GT +YMSPER+    +
Sbjct:   209 FGVS----------------GQLIDSMANSFVGTRSYMSPERLQGTHY 240

GO:0090398 "cellular senescence" evidence=IEA

GO:0060711 "labyrinthine layer development" evidence=IEA

GO:0060674 "placenta blood vessel development" evidence=IEA

GO:0048870 "cell motility" evidence=IEA

GO:0045597 "positive regulation of cell differentiation" evidence=IEA

GO:0043539 "protein serine/threonine kinase activator activity" evidence=IEA

GO:0030216 "keratinocyte differentiation" evidence=IEA

GO:0030182 "neuron differentiation" evidence=IEA

GO:0008285 "negative regulation of cell proliferation" evidence=IEA

GO:0007050 "cell cycle arrest" evidence=IEA

GO:0005886 "plasma membrane" evidence=IEA

GO:0005737 "cytoplasm" evidence=IEA

GO:0004728 "receptor signaling protein tyrosine phosphatase activity" evidence=IEA

GO:0004708 "MAP kinase kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

UNIPROTKB|Q02750 MAP2K1 "Dual specificity mitogen-activated protein kinase kinase 1" [Homo sapiens (taxid:9606)]

 Score = 330 (121.2 bits), Expect = 4.0e-45, Sum P(3) = 4.0e-45
 Identities = 79/228 (34%), Positives = 125/228 (54%)

Query:    11 QALTLSLPATAANHQFRRRRHHFPTSNPTSPDVENISDLKKLTVLGHGNGGIVYKVRHQK 70
             +AL   L     + Q R+R   F T      ++++  D +K++ LG GNGG+V+KV H+ 
Sbjct:    31 EALQKKLEELELDEQQRKRLEAFLTQKQKVGELKD-DDFEKISELGAGNGGVVFKVSHKP 89

Query:    71 SNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMER 130
             S  + A K+++      IR+Q   E ++L   +S +IV  +  FY+ +GEI   MEHM+ 
Sbjct:    90 SGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-DGEISICMEHMDG 148

Query:   131 GSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGM-QIIHGDIKPSNLLINGKGEVKIAD 189
             GSL   L+   ++ E ++  V+  V+KGL YL    +I+H D+KPSN+L+N +GE+K+ D
Sbjct:   149 GSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCD 208

Query:   190 FGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERVDSERW 237
             FGVS                   I   A + +GT +YMSPER+    +
Sbjct:   209 FGVS----------------GQLIDSMANSFVGTRSYMSPERLQGTHY 240

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0003056 "regulation of vascular smooth muscle contraction" evidence=IEA

GO:0004728 "receptor signaling protein tyrosine phosphatase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005938 "cell cortex" evidence=IEA

GO:0006979 "response to oxidative stress" evidence=IEA

GO:0007067 "mitosis" evidence=IEA

GO:0008283 "cell proliferation" evidence=IEA

GO:0017016 "Ras GTPase binding" evidence=IEA

GO:0030216 "keratinocyte differentiation" evidence=IEA

GO:0030335 "positive regulation of cell migration" evidence=IEA

GO:0031435 "mitogen-activated protein kinase kinase kinase binding" evidence=IEA

GO:0032320 "positive regulation of Ras GTPase activity" evidence=IEA

GO:0032402 "melanosome transport" evidence=IEA

GO:0032839 "dendrite cytoplasm" evidence=IEA

GO:0032968 "positive regulation of transcription elongation from RNA polymerase II promoter" evidence=IEA

GO:0033267 "axon part" evidence=IEA

GO:0034111 "negative regulation of homotypic cell-cell adhesion" evidence=IEA

GO:0043204 "perikaryon" evidence=IEA

GO:0045597 "positive regulation of cell differentiation" evidence=IEA

GO:0046579 "positive regulation of Ras protein signal transduction" evidence=IEA

GO:0047496 "vesicle transport along microtubule" evidence=IEA

GO:0048313 "Golgi inheritance" evidence=IEA

GO:0048471 "perinuclear region of cytoplasm" evidence=IEA

GO:0048678 "response to axon injury" evidence=IEA

GO:0048870 "cell motility" evidence=IEA

GO:0051291 "protein heterooligomerization" evidence=IEA

GO:0051384 "response to glucocorticoid stimulus" evidence=IEA

GO:0060674 "placenta blood vessel development" evidence=IEA

GO:0060711 "labyrinthine layer development" evidence=IEA

GO:0005816 "spindle pole body" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0005829 "cytosol" evidence=TAS

GO:0005634 "nucleus" evidence=TAS

GO:0000187 "activation of MAPK activity" evidence=TAS

GO:0032872 "regulation of stress-activated MAPK cascade" evidence=TAS

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=TAS

GO:0005769 "early endosome" evidence=TAS

GO:0005770 "late endosome" evidence=TAS

GO:2000641 "regulation of early endosome to late endosome transport" evidence=TAS

GO:0005794 "Golgi apparatus" evidence=TAS

GO:0090170 "regulation of Golgi inheritance" evidence=TAS

GO:0005739 "mitochondrion" evidence=TAS

GO:0005925 "focal adhesion" evidence=TAS

GO:0071902 "positive regulation of protein serine/threonine kinase activity" evidence=IDA

GO:0004708 "MAP kinase kinase activity" evidence=IDA

GO:0043539 "protein serine/threonine kinase activator activity" evidence=IDA

GO:0004672 "protein kinase activity" evidence=TAS

GO:0006928 "cellular component movement" evidence=TAS

GO:0006935 "chemotaxis" evidence=TAS

GO:0007165 "signal transduction" evidence=TAS

GO:0000165 "MAPK cascade" evidence=TAS

GO:0000186 "activation of MAPKK activity" evidence=TAS

GO:0002224 "toll-like receptor signaling pathway" evidence=TAS

GO:0002755 "MyD88-dependent toll-like receptor signaling pathway" evidence=TAS

GO:0002756 "MyD88-independent toll-like receptor signaling pathway" evidence=TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=TAS

GO:0007173 "epidermal growth factor receptor signaling pathway" evidence=TAS

GO:0007264 "small GTPase mediated signal transduction" evidence=TAS

GO:0007265 "Ras protein signal transduction" evidence=TAS

GO:0007411 "axon guidance" evidence=TAS

GO:0008063 "Toll signaling pathway" evidence=TAS

GO:0008286 "insulin receptor signaling pathway" evidence=TAS

GO:0008543 "fibroblast growth factor receptor signaling pathway" evidence=TAS

GO:0034130 "toll-like receptor 1 signaling pathway" evidence=TAS

GO:0034134 "toll-like receptor 2 signaling pathway" evidence=TAS

GO:0034138 "toll-like receptor 3 signaling pathway" evidence=TAS

GO:0034142 "toll-like receptor 4 signaling pathway" evidence=TAS

GO:0035666 "TRIF-dependent toll-like receptor signaling pathway" evidence=TAS

GO:0045087 "innate immune response" evidence=TAS

GO:0048011 "neurotrophin TRK receptor signaling pathway" evidence=TAS

GO:0051403 "stress-activated MAPK cascade" evidence=TAS

GO:0007050 "cell cycle arrest" evidence=IMP

GO:0008285 "negative regulation of cell proliferation" evidence=IDA

GO:0090398 "cellular senescence" evidence=IMP

GO:0005737 "cytoplasm" evidence=IDA

GO:0005886 "plasma membrane" evidence=IDA

RGD|70495 Map2k1 "mitogen activated protein kinase kinase 1" [Rattus norvegicus (taxid:10116)]

 Score = 330 (121.2 bits), Expect = 4.0e-45, Sum P(3) = 4.0e-45
 Identities = 79/228 (34%), Positives = 125/228 (54%)

Query:    11 QALTLSLPATAANHQFRRRRHHFPTSNPTSPDVENISDLKKLTVLGHGNGGIVYKVRHQK 70
             +AL   L     + Q R+R   F T      ++++  D +K++ LG GNGG+V+KV H+ 
Sbjct:    31 EALQKKLEELELDEQQRKRLEAFLTQKQKVGELKD-DDFEKISELGAGNGGVVFKVSHKP 89

Query:    71 SNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMER 130
             S  + A K+++      IR+Q   E ++L   +S +IV  +  FY+ +GEI   MEHM+ 
Sbjct:    90 SGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-DGEISICMEHMDG 148

Query:   131 GSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGM-QIIHGDIKPSNLLINGKGEVKIAD 189
             GSL   L+   ++ E ++  V+  V+KGL YL    +I+H D+KPSN+L+N +GE+K+ D
Sbjct:   149 GSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCD 208

Query:   190 FGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERVDSERW 237
             FGVS                   I   A + +GT +YMSPER+    +
Sbjct:   209 FGVS----------------GQLIDSMANSFVGTRSYMSPERLQGTHY 240

GO:0000165 "MAPK cascade" evidence=IMP

GO:0000187 "activation of MAPK activity" evidence=ISO;IDA;TAS

GO:0003056 "regulation of vascular smooth muscle contraction" evidence=IMP

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004708 "MAP kinase kinase activity" evidence=ISO;IMP;IDA;TAS

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=TAS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0004728 "receptor signaling protein tyrosine phosphatase activity" evidence=IEA;ISO

GO:0005515 "protein binding" evidence=IPI

GO:0005524 "ATP binding" evidence=IDA

GO:0005634 "nucleus" evidence=TAS

GO:0005737 "cytoplasm" evidence=ISO

GO:0005739 "mitochondrion" evidence=TAS

GO:0005769 "early endosome" evidence=TAS

GO:0005770 "late endosome" evidence=TAS

GO:0005794 "Golgi apparatus" evidence=IDA;TAS

GO:0005816 "spindle pole body" evidence=IEA

GO:0005829 "cytosol" evidence=IDA;TAS

GO:0005886 "plasma membrane" evidence=ISO;IDA

GO:0005925 "focal adhesion" evidence=TAS

GO:0005938 "cell cortex" evidence=IDA

GO:0006468 "protein phosphorylation" evidence=ISO;IDA;TAS

GO:0006979 "response to oxidative stress" evidence=IDA

GO:0007050 "cell cycle arrest" evidence=IEA;ISO

GO:0007067 "mitosis" evidence=IDA

GO:0007243 "intracellular protein kinase cascade" evidence=TAS

GO:0008283 "cell proliferation" evidence=IDA

GO:0008285 "negative regulation of cell proliferation" evidence=IEA;ISO

GO:0017016 "Ras GTPase binding" evidence=IPI

GO:0019901 "protein kinase binding" evidence=IPI

GO:0030182 "neuron differentiation" evidence=ISO;IMP

GO:0030216 "keratinocyte differentiation" evidence=IEA;ISO

GO:0030335 "positive regulation of cell migration" evidence=IMP

GO:0030425 "dendrite" evidence=IDA

GO:0031435 "mitogen-activated protein kinase kinase kinase binding" evidence=IDA;IPI

GO:0032320 "positive regulation of Ras GTPase activity" evidence=IMP

GO:0032402 "melanosome transport" evidence=IDA

GO:0032839 "dendrite cytoplasm" evidence=IDA

GO:0032872 "regulation of stress-activated MAPK cascade" evidence=TAS

GO:0032968 "positive regulation of transcription elongation from RNA polymerase II promoter" evidence=IMP

GO:0033267 "axon part" evidence=IDA

GO:0034111 "negative regulation of homotypic cell-cell adhesion" evidence=IMP

GO:0043204 "perikaryon" evidence=IDA

GO:0043539 "protein serine/threonine kinase activator activity" evidence=IEA;ISO

GO:0045597 "positive regulation of cell differentiation" evidence=IEA;ISO

GO:0046579 "positive regulation of Ras protein signal transduction" evidence=IMP

GO:0047496 "vesicle transport along microtubule" evidence=IDA

GO:0048313 "Golgi inheritance" evidence=IMP

GO:0048471 "perinuclear region of cytoplasm" evidence=IDA

GO:0048678 "response to axon injury" evidence=IMP

GO:0048812 "neuron projection morphogenesis" evidence=IMP

GO:0048870 "cell motility" evidence=IEA;ISO

GO:0051291 "protein heterooligomerization" evidence=IPI

GO:0051384 "response to glucocorticoid stimulus" evidence=IDA

GO:0060674 "placenta blood vessel development" evidence=IEA;ISO

GO:0060711 "labyrinthine layer development" evidence=IEA;ISO

GO:0071902 "positive regulation of protein serine/threonine kinase activity" evidence=ISO

GO:0090170 "regulation of Golgi inheritance" evidence=TAS

GO:0090398 "cellular senescence" evidence=IEA;ISO

GO:2000641 "regulation of early endosome to late endosome transport" evidence=TAS

GO:0005874 "microtubule" evidence=IDA

MGI|MGI:1346866 Map2k1 "mitogen-activated protein kinase kinase 1" [Mus musculus (taxid:10090)]

 Score = 330 (121.2 bits), Expect = 5.1e-45, Sum P(3) = 5.1e-45
 Identities = 79/228 (34%), Positives = 125/228 (54%)

Query:    11 QALTLSLPATAANHQFRRRRHHFPTSNPTSPDVENISDLKKLTVLGHGNGGIVYKVRHQK 70
             +AL   L     + Q R+R   F T      ++++  D +K++ LG GNGG+V+KV H+ 
Sbjct:    31 EALQKKLEELELDEQQRKRLEAFLTQKQKVGELKD-DDFEKISELGAGNGGVVFKVSHKP 89

Query:    71 SNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMER 130
             S  + A K+++      IR+Q   E ++L   +S +IV  +  FY+ +GEI   MEHM+ 
Sbjct:    90 SGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-DGEISICMEHMDG 148

Query:   131 GSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGM-QIIHGDIKPSNLLINGKGEVKIAD 189
             GSL   L+   ++ E ++  V+  V+KGL YL    +I+H D+KPSN+L+N +GE+K+ D
Sbjct:   149 GSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCD 208

Query:   190 FGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERVDSERW 237
             FGVS                   I   A + +GT +YMSPER+    +
Sbjct:   209 FGVS----------------GQLIDSMANSFVGTRSYMSPERLQGTHY 240

GO:0000165 "MAPK cascade" evidence=ISO

GO:0000166 "nucleotide binding" evidence=IEA

GO:0000187 "activation of MAPK activity" evidence=ISO;IMP;TAS

GO:0003056 "regulation of vascular smooth muscle contraction" evidence=ISO

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004708 "MAP kinase kinase activity" evidence=ISO;IMP

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=TAS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0004728 "receptor signaling protein tyrosine phosphatase activity" evidence=IMP

GO:0005524 "ATP binding" evidence=ISO

GO:0005634 "nucleus" evidence=TAS

GO:0005737 "cytoplasm" evidence=IEA

GO:0005739 "mitochondrion" evidence=TAS

GO:0005769 "early endosome" evidence=TAS

GO:0005770 "late endosome" evidence=TAS

GO:0005794 "Golgi apparatus" evidence=ISO;TAS

GO:0005829 "cytosol" evidence=ISO;TAS

GO:0005856 "cytoskeleton" evidence=IEA

GO:0005874 "microtubule" evidence=ISO

GO:0005886 "plasma membrane" evidence=ISO

GO:0005925 "focal adhesion" evidence=TAS

GO:0005938 "cell cortex" evidence=ISO

GO:0006468 "protein phosphorylation" evidence=IEA;ISO;IMP

GO:0006979 "response to oxidative stress" evidence=ISO

GO:0007050 "cell cycle arrest" evidence=ISO

GO:0007067 "mitosis" evidence=ISO

GO:0008283 "cell proliferation" evidence=ISO

GO:0008285 "negative regulation of cell proliferation" evidence=ISO

GO:0016301 "kinase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016740 "transferase activity" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0017016 "Ras GTPase binding" evidence=ISO

GO:0019901 "protein kinase binding" evidence=ISO

GO:0030182 "neuron differentiation" evidence=ISO;IMP

GO:0030216 "keratinocyte differentiation" evidence=IMP

GO:0030335 "positive regulation of cell migration" evidence=ISO

GO:0030425 "dendrite" evidence=ISO

GO:0031435 "mitogen-activated protein kinase kinase kinase binding" evidence=ISO

GO:0032320 "positive regulation of Ras GTPase activity" evidence=ISO

GO:0032402 "melanosome transport" evidence=ISO

GO:0032839 "dendrite cytoplasm" evidence=ISO

GO:0032872 "regulation of stress-activated MAPK cascade" evidence=TAS

GO:0032968 "positive regulation of transcription elongation from RNA polymerase II promoter" evidence=ISO

GO:0033267 "axon part" evidence=ISO

GO:0034111 "negative regulation of homotypic cell-cell adhesion" evidence=ISO

GO:0043204 "perikaryon" evidence=ISO

GO:0043539 "protein serine/threonine kinase activator activity" evidence=ISO

GO:0045597 "positive regulation of cell differentiation" evidence=IDA

GO:0046579 "positive regulation of Ras protein signal transduction" evidence=ISO

GO:0047496 "vesicle transport along microtubule" evidence=ISO

GO:0048313 "Golgi inheritance" evidence=ISO

GO:0048471 "perinuclear region of cytoplasm" evidence=ISO

GO:0048678 "response to axon injury" evidence=ISO

GO:0048812 "neuron projection morphogenesis" evidence=ISO

GO:0048870 "cell motility" evidence=IMP

GO:0051291 "protein heterooligomerization" evidence=ISO

GO:0051384 "response to glucocorticoid stimulus" evidence=ISO

GO:0060674 "placenta blood vessel development" evidence=IMP

GO:0060711 "labyrinthine layer development" evidence=IMP

GO:0071902 "positive regulation of protein serine/threonine kinase activity" evidence=ISO

GO:0090170 "regulation of Golgi inheritance" evidence=TAS

GO:0090398 "cellular senescence" evidence=ISO

GO:2000641 "regulation of early endosome to late endosome transport" evidence=TAS

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
3rd Layer	2.7.12	0.766
4th Layer	2.7.11.1	0.737
3rd Layer	2.7.11	0.691

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	337
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	1e-114
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	3e-80
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	5e-78
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	3e-72
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	3e-67
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	5e-66
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	3e-63
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	4e-59
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-58
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	2e-57
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-56
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	3e-55
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	7e-54
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	2e-53
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	6e-53
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	1e-50
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	7e-49
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-48
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	6e-48
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	1e-44
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-44
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	2e-44
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	7e-44
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	1e-43
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	1e-43
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	1e-43
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	1e-42
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	3e-42
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	4e-42
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	2e-41
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	4e-41
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	9e-41
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	9e-41
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	1e-39
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	5e-39
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	6e-39
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	7e-37
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	9e-37
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	1e-36
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	2e-36
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	2e-36
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	7e-36
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	2e-35
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	2e-35
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	3e-34
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	8e-34
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	1e-33
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	1e-33
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	2e-33
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-33
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	3e-33
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	3e-33
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	7e-33
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	6e-32
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	9e-32
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	2e-31
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	4e-31
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	1e-30
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-30
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	3e-30
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	9e-30
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	9e-30
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-29
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	4e-29
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	5e-29
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	5e-29
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	6e-29
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	7e-29
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	3e-28
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	3e-28
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	4e-28
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	5e-28
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	9e-28
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	1e-27
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	1e-27
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	2e-27
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	2e-27
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	3e-27
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	3e-27
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	6e-27
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	7e-27
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	1e-26
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	1e-26
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	2e-26
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	3e-26
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	3e-26
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	3e-26
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	3e-26
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	3e-26
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	5e-26
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	5e-26
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	6e-26
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	2e-25
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	3e-25
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	6e-25
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	8e-25
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	8e-25
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	2e-24
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-24
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-24
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	3e-24
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	3e-24
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	6e-24
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	8e-24
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	8e-24
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	1e-23
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	1e-23
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	2e-23
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	3e-23
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	3e-23
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	3e-23
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	6e-23
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	1e-22
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	1e-22
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	2e-22
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	2e-22
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	3e-22
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	3e-22
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	3e-22
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	4e-22
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	4e-22
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	5e-22
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	6e-22
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	6e-22
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-21
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	3e-21
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	3e-21
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	4e-21
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	5e-21
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	5e-21
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	6e-21
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	6e-21
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	9e-21
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	1e-20
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	1e-20
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	1e-20
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	1e-20
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	1e-20
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	1e-20
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	2e-20
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	2e-20
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	2e-20
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	3e-20
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	3e-20
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	3e-20
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	3e-20
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	4e-20
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	4e-20
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	5e-20
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	5e-20
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	1e-19
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-19
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-19
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	2e-19
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	3e-19
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	3e-19
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	5e-19
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	5e-19
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	7e-19
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	9e-19
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	9e-19
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	1e-18
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	1e-18
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	1e-18
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-18
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	3e-18
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	3e-18
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	4e-18
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	4e-18
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	5e-18
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	5e-18
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	5e-18
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	7e-18
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	7e-18
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	1e-17
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	1e-17
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	1e-17
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	1e-17
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	2e-17
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-17
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	2e-17
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	2e-17
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	3e-17
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	3e-17
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	3e-17
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	5e-17
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	5e-17
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	6e-17
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	7e-17
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	7e-17
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	8e-17
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	8e-17
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	1e-16
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	1e-16
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	1e-16
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-16
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	2e-16
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	2e-16
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-16
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	4e-16
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	5e-16
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	5e-16
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	6e-16
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	6e-16
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	6e-16
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	8e-16
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	1e-15
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	1e-15
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	1e-15
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	1e-15
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	2e-15
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	3e-15
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	4e-15
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	4e-15
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	4e-15
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	6e-15
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	7e-15
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	1e-14
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	2e-14
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	2e-14
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	3e-14
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	3e-14
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	3e-14
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	3e-14
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	4e-14
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	5e-14
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	5e-14
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	7e-14
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	9e-14
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	9e-14
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	1e-13
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	1e-13
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	1e-13
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	1e-13
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	2e-13
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	4e-13
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	5e-13
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	6e-13
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	7e-13
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	1e-12
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	1e-12
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	1e-12
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	2e-12
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	2e-12
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	2e-12
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	2e-12
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	3e-12
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	5e-12
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	7e-12
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	8e-12
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	1e-11
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	1e-11
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-11
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	2e-11
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	3e-11
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	4e-11
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	4e-11
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	5e-11
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	5e-11
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	8e-11
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	8e-11
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	8e-11
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	9e-11
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	1e-10
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	2e-10
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	3e-10
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	4e-10
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	7e-10
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	8e-10
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-09
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	2e-09
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	4e-09
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	5e-09
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	5e-09
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	8e-09
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	1e-08
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	1e-08
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	2e-08
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	2e-08
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	2e-08
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-08
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	2e-08
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	3e-08
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	3e-08
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	3e-08
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	6e-08
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	1e-07
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	1e-07
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	3e-07
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	3e-07
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	4e-07
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	1e-06
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	2e-06
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	3e-06
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	4e-06
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	4e-06
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	5e-06
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-05
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	3e-05
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	7e-05
TIGR01982	437	TIGR01982, UbiB, 2-polyprenylphenol 6-hydroxylase	2e-04
COG3642	204	COG3642, COG3642, Mn2+-dependent serine/threonine	2e-04
PRK14879	211	PRK14879, PRK14879, serine/threonine protein kinas	2e-04
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	3e-04
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	8e-04
COG0661	517	COG0661, AarF, Predicted unusual protein kinase [G	0.001
TIGR03724	199	TIGR03724, arch_bud32, Kae1-associated kinase Bud3	0.002
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	0.003
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	0.003
PRK09605	535	PRK09605, PRK09605, bifunctional UGMP family prote	0.003
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	0.003

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  331 bits (850), Expect = e-114
 Identities = 125/284 (44%), Positives = 175/284 (61%), Gaps = 22/284 (7%)

Query: 47  SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQF 106
           SDL+++ VLG G+ G+VYKVRH+ +  IYALK ++       R Q   E + L+  +S +
Sbjct: 1   SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60

Query: 107 IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGM- 165
           +VKC+  FY  EGEI  V+E+M+ GSL D L+   K+ E V++ +A ++LKGL YLH   
Sbjct: 61  VVKCYGAFYK-EGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKR 119

Query: 166 QIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCA 225
            IIH DIKPSNLLIN KGEVKIADFG+S+++E T +  N                +GT  
Sbjct: 120 HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTF--------------VGTVT 165

Query: 226 YMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGER 285
           YMSPER+  E     Y +A D+WSLG+ +LEC +G +P +    +P    L+ AIC G  
Sbjct: 166 YMSPERIQGES----YSYAADIWSLGLTLLECALGKFPFL-PPGQPSFFELMQAICDGPP 220

Query: 286 LEMPET-ASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSS 328
             +P    SPEFR F+ +CL+KD +KR +  ELL +PF+ K  +
Sbjct: 221 PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKADN 264

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score =  247 bits (633), Expect = 3e-80
 Identities = 117/297 (39%), Positives = 173/297 (58%), Gaps = 21/297 (7%)

Query: 36  SNPTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHE 95
           S       +++S+L+++  +G G GG VYKV H+ +  +YALKV+       +R Q   E
Sbjct: 63  SGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICRE 122

Query: 96  AEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRV 155
            EIL+ ++   +VKCH   +   GEI  ++E M+ GSL +   +     E  ++ VA ++
Sbjct: 123 IEILRDVNHPNVVKCHD-MFDHNGEIQVLLEFMDGGSL-EGTHIAD---EQFLADVARQI 177

Query: 156 LKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGE 215
           L G+ YLH   I+H DIKPSNLLIN    VKIADFGVSRI+ +T +  N           
Sbjct: 178 LSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCN----------- 226

Query: 216 AAIACMGTCAYMSPERVDSERWGGDY-GFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLM 274
              + +GT AYMSPER++++   G Y G+AGD+WSLGV +LE  +G +P  G G + D  
Sbjct: 227 ---SSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPF-GVGRQGDWA 282

Query: 275 ALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSN 331
           +L+CAIC  +  E P TAS EFR F+  CL+++  KR +  +LL +PF+ +      
Sbjct: 283 SLMCAICMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQPGQG 339

Length = 353

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  238 bits (611), Expect = 5e-78
 Identities = 96/276 (34%), Positives = 138/276 (50%), Gaps = 25/276 (9%)

Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVK 109
           + L  LG G+ G VY  R +K+  + A+KV+        R +   E +ILK+L    IV+
Sbjct: 2   EILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVR 61

Query: 110 CHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIH 169
            + VF   E ++  VME+ E G LFD L+ R +LSED       ++L  L+YLH   I+H
Sbjct: 62  LYDVFED-EDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGIVH 120

Query: 170 GDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSP 229
            D+KP N+L++  G VK+ADFG++R ++                       +GT  YM+P
Sbjct: 121 RDLKPENILLDEDGHVKLADFGLARQLDPGEKLTT---------------FVGTPEYMAP 165

Query: 230 ERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMP 289
           E +  +     YG A D+WSLGV++ E L G  P   F     L+ L   I   +    P
Sbjct: 166 EVLLGKG----YGKAVDIWSLGVILYELLTGKPP---FPGDDQLLELFKKIGKPKPPFPP 218

Query: 290 E--TASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV 323
                SPE +  +R  L KD  KR T EE L +PF 
Sbjct: 219 PEWDISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  224 bits (573), Expect = 3e-72
 Identities = 103/283 (36%), Positives = 154/283 (54%), Gaps = 25/283 (8%)

Query: 47  SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQF 106
            DL+ L  LG GN G+V KV H+ +  I A+K +    +  I+ Q   E +IL + +S +
Sbjct: 1   DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPY 60

Query: 107 IVKCHAVFYTIEGEICFVMEHMERGSLFDSL-RVRKKLSEDVISGVAYRVLKGLQYLH-G 164
           IV  +  FY   G+I   ME+M+ GSL   L  V+ ++ E ++  +A  VLKGL YLH  
Sbjct: 61  IVGFYGAFYN-NGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEK 119

Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTC 224
            +IIH D+KPSN+L+N +G++K+ DFGVS                   +   A   +GT 
Sbjct: 120 HKIIHRDVKPSNILVNSRGQIKLCDFGVSG----------------QLVNSLAKTFVGTS 163

Query: 225 AYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPD-LMALICAICFG 283
           +YM+PER+     G DY    D+WSLG+ ++E   G +P     + PD +  L+  I   
Sbjct: 164 SYMAPERIQ----GNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNE 219

Query: 284 ERLEMP-ETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTK 325
               +P    SP+F+ FV  CL KD R+R + +ELL +PF+ K
Sbjct: 220 PPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKK 262

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  211 bits (539), Expect = 3e-67
 Identities = 90/279 (32%), Positives = 140/279 (50%), Gaps = 22/279 (7%)

Query: 48  DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQA-AHEAEILKRLDSQF 106
           +  +  +LG G+ G VY    + +  + A+K +  +  +    +A   E  IL  L    
Sbjct: 1   EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60

Query: 107 IVKCHAVFYTIEGE-ICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGM 165
           IV+ +      E   +   +E++  GSL   L+   KL E VI     ++L+GL YLH  
Sbjct: 61  IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSN 120

Query: 166 QIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCA 225
            I+H DIK +N+L++  G VK+ADFG ++ + +               GE   +  GT  
Sbjct: 121 GIVHRDIKGANILVDSDGVVKLADFGCAKRLGD------------IETGEGTGSVRGTPY 168

Query: 226 YMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAI-CFGE 284
           +M+PE +     G +YG A D+WSLG  V+E   G  P   + E  + MA +  I   GE
Sbjct: 169 WMAPEVIR----GEEYGRAADIWSLGCTVIEMATGKPP---WSELGNPMAALYKIGSSGE 221

Query: 285 RLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV 323
             E+PE  S E + F+R CL +D +KR T +ELL +PF+
Sbjct: 222 PPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  208 bits (531), Expect = 5e-66
 Identities = 102/280 (36%), Positives = 142/280 (50%), Gaps = 25/280 (8%)

Query: 49  LKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH-EAEILKRLDSQFI 107
            + L  LG G+ G VYK +H+ +  I A+K+L   S    + Q A  E  IL+RL    I
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60

Query: 108 VKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQI 167
           V+    F   +  +  VME+ E G LFD L     LSED    +A ++L+GL+YLH   I
Sbjct: 61  VRLIDAFED-KDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGI 119

Query: 168 IHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYM 227
           IH D+KP N+L++  G VKIADFG+++        ++ +               GT  YM
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKK----LLKSSSSLTTF---------V-GTPWYM 165

Query: 228 SPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLE 287
           +PE +     G  YG   DVWSLGV++ E L G  P  G     D + LI  I  G  LE
Sbjct: 166 APEVL---LGGNGYGPKVDVWSLGVILYELLTGKPPFSG-ENILDQLQLIRRI-LGPPLE 220

Query: 288 MPE----TASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV 323
             E    + S E +  ++ CL KD  KR T EE+L +P+ 
Sbjct: 221 FDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQHPWF 260

Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  201 bits (513), Expect = 3e-63
 Identities = 96/277 (34%), Positives = 144/277 (51%), Gaps = 26/277 (9%)

Query: 48  DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFI 107
             + L  +G G  G VYK RH+++    A+KV+   S    + +  +E +ILK+     I
Sbjct: 1   LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEK-KEKIINEIQILKKCKHPNI 59

Query: 108 VKCHAVFYTIEGEICFVMEHMERGSLFDSLRVR-KKLSEDVISGVAYRVLKGLQYLHGMQ 166
           VK +  +   + E+  VME    GSL D L+   + L+E  I+ V   +LKGL+YLH   
Sbjct: 60  VKYYGSYL-KKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG 118

Query: 167 IIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAY 226
           IIH DIK +N+L+   GEVK+ DFG+S  + +T+  N                 +GT  +
Sbjct: 119 IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTM---------------VGTPYW 163

Query: 227 MSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFG-ER 285
           M+PE ++    G  Y +  D+WSLG+  +E   G  P   + E P + AL      G   
Sbjct: 164 MAPEVIN----GKPYDYKADIWSLGITAIELAEGKPP---YSELPPMKALFKIATNGPPG 216

Query: 286 LEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPF 322
           L  PE  S EF+ F++ CL+K+  KR T E+LL +PF
Sbjct: 217 LRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  190 bits (485), Expect = 4e-59
 Identities = 84/279 (30%), Positives = 142/279 (50%), Gaps = 28/279 (10%)

Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH-EAEILKRLDSQFIV 108
           + +  +G G+ G VY VR +    +Y LK ++ ++ +    + A  E +ILK+L+   I+
Sbjct: 3   EIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNII 62

Query: 109 KCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKK----LSEDVISGVAYRVLKGLQYLHG 164
           K +  F   +G++C VME+ + G L   ++ +KK      E+ I     ++   L+YLH 
Sbjct: 63  KYYESFEE-KGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS 121

Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTC 224
            +I+H DIKP N+ +   G VK+ DFG+S+++  T               + A   +GT 
Sbjct: 122 RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST--------------VDLAKTVVGTP 167

Query: 225 AYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGE 284
            Y+SPE   ++     Y +  D+WSLG V+ E     +P   F E  +L+ L   I  G+
Sbjct: 168 YYLSPELCQNKP----YNYKSDIWSLGCVLYELCTLKHP---F-EGENLLELALKILKGQ 219

Query: 285 RLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV 323
              +P   S E R  V S L+KD  +R ++ ++L  PF+
Sbjct: 220 YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  187 bits (478), Expect = 1e-58
 Identities = 86/269 (31%), Positives = 130/269 (48%), Gaps = 56/269 (20%)

Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVF 114
           LG G  G VY  R +K+    A+K++    S+ +  +   E EILK+L+   IVK + VF
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 115 YTIEGEICFVMEHMERGSLFDSL-RVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIK 173
              E  +  VME+ E GSL D L     KLSED I  +  ++L+GL+YLH   IIH D+K
Sbjct: 61  ED-ENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLK 119

Query: 174 PSNLLI-NGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERV 232
           P N+L+ +  G+VK+ADFG+S+++   ++                   +GT AYM+PE +
Sbjct: 120 PENILLDSDNGKVKLADFGLSKLLTSDKSLLKT--------------IVGTPAYMAPEVL 165

Query: 233 DSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPETA 292
             +   G Y    D+WSLGV++ E                                    
Sbjct: 166 LGK---GYYSEKSDIWSLGVILYEL----------------------------------- 187

Query: 293 SPEFRRFVRSCLEKDWRKRGTVEELLAYP 321
            PE +  +R  L+KD  KR + +E+L + 
Sbjct: 188 -PELKDLIRKMLQKDPEKRPSAKEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  185 bits (473), Expect = 2e-57
 Identities = 99/285 (34%), Positives = 147/285 (51%), Gaps = 35/285 (12%)

Query: 44  ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVL--NTTSSTIIRHQAAHEAEILKR 101
           E + D+  L  LG G+ G VYK  H+++  + A+KV+        II+     E  ILK+
Sbjct: 2   EEVFDI--LEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIK-----EISILKQ 54

Query: 102 LDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKK-LSEDVISGVAYRVLKGLQ 160
            DS +IVK +  ++    ++  VME+   GS+ D +++  K L+E+ I+ + Y+ LKGL+
Sbjct: 55  CDSPYIVKYYGSYFK-NTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLE 113

Query: 161 YLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIAC 220
           YLH  + IH DIK  N+L+N +G+ K+ADFGVS  + +T    N                
Sbjct: 114 YLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRN--------------TV 159

Query: 221 MGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAI 280
           +GT  +M+PE V  E     Y    D+WSLG+  +E   G  P       P  M  I  I
Sbjct: 160 IGTPFWMAPE-VIQEI---GYNNKADIWSLGITAIEMAEGKPPYSDI--HP--MRAIFMI 211

Query: 281 CFG--ERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV 323
                  L  PE  SPEF  FV+ CL KD  +R +  +LL +PF+
Sbjct: 212 PNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  184 bits (470), Expect = 2e-56
 Identities = 106/289 (36%), Positives = 148/289 (51%), Gaps = 42/289 (14%)

Query: 52  LTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCH 111
           L+ LG G GG V K R + +  I+ALK + T  +  ++ Q   E EI K   S +IVK +
Sbjct: 6   LSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYY 65

Query: 112 AVFYT-IEGEICFVMEHMERGSLFDSL--RVRKK---LSEDVISGVAYRVLKGLQYLHGM 165
             F       I   ME+ E GSL DS+  +V+K+   + E V+  +A  VLKGL YLH  
Sbjct: 66  GAFLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR 124

Query: 166 QIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEA----AIACM 221
           +IIH DIKPSN+L+  KG+VK+ DFGVS                    GE     A    
Sbjct: 125 KIIHRDIKPSNILLTRKGQVKLCDFGVS--------------------GELVNSLAGTFT 164

Query: 222 GTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP----DLMALI 277
           GT  YM+PER+     G  Y    DVWSLG+ +LE     +P    GE P    +L++ I
Sbjct: 165 GTSFYMAPERIQ----GKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYI 220

Query: 278 CAICFGERLEMPETA---SPEFRRFVRSCLEKDWRKRGTVEELLAYPFV 323
             +   E  + P      S EF+ F++ CLEKD  +R T  ++L +P++
Sbjct: 221 VNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWI 269

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score =  182 bits (463), Expect = 3e-55
 Identities = 105/321 (32%), Positives = 164/321 (51%), Gaps = 56/321 (17%)

Query: 47  SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQF 106
            D +KL  LG GNGG+V KV H+ S  I A K+++      IR+Q   E ++L   +S +
Sbjct: 1   DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPY 60

Query: 107 IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG-M 165
           IV  +  FY+ +GEI   MEHM+ GSL   L+   ++ E+++  ++  VL+GL YL    
Sbjct: 61  IVGFYGAFYS-DGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKH 119

Query: 166 QIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCA 225
           +I+H D+KPSN+L+N +GE+K+ DFGVS  +                I   A + +GT +
Sbjct: 120 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----------------IDSMANSFVGTRS 163

Query: 226 YMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPL--------------------- 264
           YMSPER+     G  Y    D+WSLG+ ++E  +G YP+                     
Sbjct: 164 YMSPERLQ----GTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEA 219

Query: 265 --------IGFGEKPDLMA---LICAICFGERLEMPETA-SPEFRRFVRSCLEKDWRKRG 312
                       + P  MA   L+  I      ++P  A S EF+ FV  CL+K+ ++R 
Sbjct: 220 KESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERA 279

Query: 313 TVEELLAYPFVTKRSSSSNIE 333
            ++EL  +PF+ KR+    ++
Sbjct: 280 DLKELTKHPFI-KRAELEEVD 299

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score =  178 bits (452), Expect = 7e-54
 Identities = 97/294 (32%), Positives = 150/294 (51%), Gaps = 42/294 (14%)

Query: 47  SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVL-----NTTSSTIIRHQAAHEAEILKR 101
            +++ L  LG GN G VYKV H+ +    A+K +      +  + II      E +IL +
Sbjct: 1   DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIM-----ELDILHK 55

Query: 102 LDSQFIVKCHAVFYTIEGEICFVMEHMERGS---LFDSLRVRKKLSEDVISGVAYRVLKG 158
             S +IV  +  F+ IEG +   ME+M+ GS   L+      + + EDV+  + Y V+KG
Sbjct: 56  AVSPYIVDFYGAFF-IEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKG 114

Query: 159 LQYL-HGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAA 217
           L++L     IIH D+KP+N+L+NG G+VK+ DFGVS              N   ++ +  
Sbjct: 115 LKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVS-------------GNLVASLAKTN 161

Query: 218 IACMGTCAYMSPERVDSERWGGD--YGFAGDVWSLGVVVLECLVGHYPLIGFGEKPD--- 272
           I C    +YM+PER+ S     +  Y    DVWSLG+ +LE  +G YP       P+   
Sbjct: 162 IGCQ---SYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPY-----PPETYA 213

Query: 273 -LMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTK 325
            + A + AI  G+   +P   S + + FV  CL K   +R T  +LL +P++ K
Sbjct: 214 NIFAQLSAIVDGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVK 267

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score =  176 bits (449), Expect = 2e-53
 Identities = 99/304 (32%), Positives = 155/304 (50%), Gaps = 37/304 (12%)

Query: 42  DVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKR 101
           D+ N  DL+ ++ LG GNGG V KV+H  + ++ A KV++  + + +R Q   E +I+  
Sbjct: 1   DLRN-EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHE 59

Query: 102 LDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQY 161
             S +IV  +  F   E  IC  ME M+ GSL    +    +  +++  +A  V++GL Y
Sbjct: 60  CRSPYIVSFYGAFLN-ENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTY 118

Query: 162 LHGM-QIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIAC 220
           L+ + +I+H DIKPSN+L+N +G++K+ DFGVS  +                I   A   
Sbjct: 119 LYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGEL----------------INSIADTF 162

Query: 221 MGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDL------- 273
           +GT  YMSPER+     GG Y    DVWSLG+ ++E  +G +P   F             
Sbjct: 163 VGTSTYMSPERIQ----GGKYTVKSDVWSLGISIIELALGKFP---FAFSNIDDDGQDDP 215

Query: 274 ---MALICAICFGERLEMPETASPE-FRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSS 329
              + L+  I       +P +  PE  R FV +CL KD  +R T ++L A P   +   +
Sbjct: 216 MGILDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALRA 275

Query: 330 SNIE 333
           SN++
Sbjct: 276 SNVD 279

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  174 bits (443), Expect = 6e-53
 Identities = 93/275 (33%), Positives = 134/275 (48%), Gaps = 33/275 (12%)

Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAA----HEAEILKRLDSQFIVKC 110
           LG G+ G V  VR + +  +YA+KVL      II+ +       E  IL R++  FIVK 
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLK--KKKIIKRKEVEHTLTERNILSRINHPFIVKL 58

Query: 111 HAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHG 170
           H  F T E ++  V+E+   G LF  L    + SE+     A  ++  L+YLH + II+ 
Sbjct: 59  HYAFQT-EEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYR 117

Query: 171 DIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPE 230
           D+KP N+L++  G +K+ DFG+++ +    +  N               C GT  Y++PE
Sbjct: 118 DLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT-------------FC-GTPEYLAPE 163

Query: 231 RVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPE 290
            +     G  YG A D WSLGV++ E L G  P   F    D   +   I     L  PE
Sbjct: 164 VLL----GKGYGKAVDWWSLGVLLYEMLTGKPP---F-YAEDRKEIYEKILKDP-LRFPE 214

Query: 291 TASPEFRRFVRSCLEKDWRKR---GTVEELLAYPF 322
             SPE R  +   L+KD  KR   G  EE+ A+PF
Sbjct: 215 FLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPF 249

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score =  169 bits (430), Expect = 1e-50
 Identities = 98/291 (33%), Positives = 152/291 (52%), Gaps = 32/291 (10%)

Query: 48  DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFI 107
           D++   +LGHGNGG VYK  H  +  I A+KV+    +  ++ Q   E EIL + DS +I
Sbjct: 2   DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYI 61

Query: 108 VKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQI 167
           +  +  F+ +E  I    E M+ GSL     V +K+ E V+  +A  V+KGL YL  ++I
Sbjct: 62  IGFYGAFF-VENRISICTEFMDGGSL----DVYRKIPEHVLGRIAVAVVKGLTYLWSLKI 116

Query: 168 IHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYM 227
           +H D+KPSN+L+N +G+VK+ DFGVS  +                +   A   +GT AYM
Sbjct: 117 LHRDVKPSNMLVNTRGQVKLCDFGVSTQL----------------VNSIAKTYVGTNAYM 160

Query: 228 SPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGF-GEKPDLMALICAICFGE-- 284
           +PER+  E+    YG   DVWSLG+  +E  +G +P       +  LM L    C  +  
Sbjct: 161 APERISGEQ----YGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED 216

Query: 285 --RLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNIE 333
              L + +  S +F  F+  C+ K  ++R   E L+ +PF+ +  +  N E
Sbjct: 217 PPVLPVGQF-SEKFVHFITQCMRKQPKERPAPENLMDHPFIVQ-YNDGNAE 265

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  165 bits (419), Expect = 7e-49
 Identities = 97/296 (32%), Positives = 139/296 (46%), Gaps = 38/296 (12%)

Query: 49  LKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS---STIIRHQAAHEAEILKRLDSQ 105
            K L  +G G  G VYK   + +    A+K +         II      E  I+K     
Sbjct: 21  YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIIN-----EILIMKDCKHP 75

Query: 106 FIVK---CHAVFYTIEGEICFVMEHMERGSLFDSLRV-RKKLSEDVISGVAYRVLKGLQY 161
            IV         Y +  E+  VME+M+ GSL D +     +++E  I+ V   VL+GL+Y
Sbjct: 76  NIVDYYDS----YLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEY 131

Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACM 221
           LH   +IH DIK  N+L++  G VK+ADFG +   + T+  +  N            + +
Sbjct: 132 LHSQNVIHRDIKSDNILLSKDGSVKLADFGFA--AQLTKEKSKRN------------SVV 177

Query: 222 GTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAIC 281
           GT  +M+PE +       DYG   D+WSLG++ +E   G  P +     P L AL     
Sbjct: 178 GTPYWMAPEVIK----RKDYGPKVDIWSLGIMCIEMAEGEPPYLRE---PPLRALFLITT 230

Query: 282 FG-ERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNIEGLI 336
            G   L+ PE  SPEF+ F+  CL KD  KR + EELL +PF+ K         LI
Sbjct: 231 KGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKACPKEEFAPLI 286

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score =  164 bits (417), Expect = 2e-48
 Identities = 95/303 (31%), Positives = 147/303 (48%), Gaps = 49/303 (16%)

Query: 46  ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAE-------- 97
           ++DL+ L  +G G  G VYK+R +K+  + A+K        + R     E +        
Sbjct: 14  LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVK-------QMRRTGNKEENKRILMDLDV 66

Query: 98  ILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSL--RVRKKLSEDVISGVAYRV 155
           +LK  D  +IVKC+  F T + ++   ME M   +  D L  R++  + ED++  +   +
Sbjct: 67  VLKSHDCPYIVKCYGYFIT-DSDVFICMELM--STCLDKLLKRIQGPIPEDILGKMTVAI 123

Query: 156 LKGLQYL---HGMQIIHGDIKPSNLLINGKGEVKIADFGVS-RIVEETRNNNNHNNNNNN 211
           +K L YL   HG  +IH D+KPSN+L++  G VK+ DFG+S R+V+              
Sbjct: 124 VKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLVDS------------- 168

Query: 212 NIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP 271
              +A     G  AYM+PER+D       Y    DVWSLG+ ++E   G +P      + 
Sbjct: 169 ---KAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF 225

Query: 272 DLMALICAICFGE---RLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSS 328
           +++  I      E    L   E  SP+F  FV  CL KD RKR    ELL +PF+ +  +
Sbjct: 226 EVLTKI----LQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYET 281

Query: 329 SSN 331
           +  
Sbjct: 282 AEV 284

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  162 bits (412), Expect = 6e-48
 Identities = 90/298 (30%), Positives = 143/298 (47%), Gaps = 39/298 (13%)

Query: 47  SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSS-----TIIRHQAAHEAEILKR 101
                L  +G G+ G VYK   +++N + A+KV++   +      I +     E + L +
Sbjct: 1   ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQ-----EIQFLSQ 55

Query: 102 LDSQFIVKCHAVFYTIEG-EICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQ 160
             S +I K +  F  ++G ++  +ME+   GS  D L+  K L E  I+ +   VL GL+
Sbjct: 56  CRSPYITKYYGSF--LKGSKLWIIMEYCGGGSCLDLLKPGK-LDETYIAFILREVLLGLE 112

Query: 161 YLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIAC 220
           YLH    IH DIK +N+L++ +G+VK+ADFGVS  +  T +  N                
Sbjct: 113 YLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRN--------------TF 158

Query: 221 MGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAI 280
           +GT  +M+PE +        Y    D+WSLG+  +E   G  PL         M ++  I
Sbjct: 159 VGTPFWMAPEVIK----QSGYDEKADIWSLGITAIELAKGEPPLSDL----HPMRVLFLI 210

Query: 281 --CFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNIEGLI 336
                  LE  +  S  F+ FV  CL KD ++R + +ELL + F+ K   +S +  LI
Sbjct: 211 PKNNPPSLEGNKF-SKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAKKTSYLTLLI 267

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  156 bits (394), Expect = 1e-44
 Identities = 81/297 (27%), Positives = 130/297 (43%), Gaps = 28/297 (9%)

Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLN--TTSSTIIRHQAAHEAEILKRLDSQ-F 106
           + L  LG G+ G VY  R +K   + ALKVL     S +    +   E +IL  L+    
Sbjct: 3   RILRKLGEGSFGEVYLARDRK---LVALKVLAKKLESKSKEVERFLREIQILASLNHPPN 59

Query: 107 IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVR---KKLSEDVISGVAYRVLKGLQYLH 163
           IVK +  F   EG +  VME+++ GSL D L+       LSE     +  ++L  L+YLH
Sbjct: 60  IVKLYDFFQD-EGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118

Query: 164 GMQIIHGDIKPSNLLINGKG-EVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMG 222
              IIH DIKP N+L++  G  VK+ DFG+++++ +  + ++     + ++        G
Sbjct: 119 SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSV--------G 170

Query: 223 TCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICF 282
           T  YM+PE +           + D+WSLG+ + E L G  P  G          +  I  
Sbjct: 171 TPGYMAPEVLLGLS-LAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILE 229

Query: 283 GE--------RLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSN 331
                         PE  S      ++  L KD + R +    L++  +       +
Sbjct: 230 LPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKES 286

Length = 384

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  153 bits (389), Expect = 2e-44
 Identities = 76/286 (26%), Positives = 132/286 (46%), Gaps = 31/286 (10%)

Query: 54  VLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH----EAEILKRLD-SQFIV 108
           ++G G+   V   + +++N  YA+K+L+     +I+ +       E E+L RL+    I+
Sbjct: 8   IIGEGSFSTVVLAKEKETNKEYAIKILDK--RQLIKEKKVKYVKIEKEVLTRLNGHPGII 65

Query: 109 KCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQII 168
           K +  F   E  + FV+E+   G L   +R    L E      A  +L  L+YLH   II
Sbjct: 66  KLYYTFQD-EENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGII 124

Query: 169 HGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACM------- 221
           H D+KP N+L++    +KI DFG ++++    N++  +N  +    ++ I          
Sbjct: 125 HRDLKPENILLDKDMHIKITDFGTAKVL--DPNSSPESNKGDATNIDSQIEKNRRRFASF 182

Query: 222 -GTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAI 280
            GT  Y+SPE ++ +      G + D+W+LG ++ + L G  P  G  E       I  +
Sbjct: 183 VGTAEYVSPELLNEKPA----GKSSDLWALGCIIYQMLTGKPPFRGSNE-YLTFQKILKL 237

Query: 281 CFGERLEMPETASPEFRRFVRSCLEKDWRKRGTV----EELLAYPF 322
            +      P    P+ +  +   L  D + R  V    +EL A+PF
Sbjct: 238 EY----SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPF 279

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score =  154 bits (391), Expect = 2e-44
 Identities = 103/334 (30%), Positives = 163/334 (48%), Gaps = 76/334 (22%)

Query: 48  DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFI 107
           D +K++ LG GNGG+V+KV H+ S  I A K+++      IR+Q   E ++L   +S +I
Sbjct: 6   DFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 65

Query: 108 VKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYL-HGMQ 166
           V  +  FY+ +GEI   MEHM+ GSL   L+   ++ E ++  V+  V+KGL YL    +
Sbjct: 66  VGFYGAFYS-DGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 124

Query: 167 IIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAY 226
           I+H D+KPSN+L+N +GE+K+ DFGVS                   I   A + +GT +Y
Sbjct: 125 IMHRDVKPSNILVNSRGEIKLCDFGVS----------------GQLIDSMANSFVGTRSY 168

Query: 227 MSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERL 286
           MSPER+     G  Y    D+WS+G+ ++E  +G YP+      PD   L   + FG  +
Sbjct: 169 MSPERLQ----GTHYSVQSDIWSMGLSLVEMAIGRYPI----PPPDAKEL--ELMFGCPV 218

Query: 287 EM----------------------PETASP-------------------------EFRRF 299
           E                       P++  P                         EF+ F
Sbjct: 219 EGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDF 278

Query: 300 VRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNIE 333
           V  CL K+  +R  +++L+ + F+ KRS +  ++
Sbjct: 279 VNKCLIKNPAERADLKQLMVHAFI-KRSEAEEVD 311

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  151 bits (382), Expect = 7e-44
 Identities = 87/277 (31%), Positives = 144/277 (51%), Gaps = 26/277 (9%)

Query: 48  DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-STIIRHQAAHEAEILKRLDSQF 106
           D + L  +G G+ G+V+KV  +    +YA+K ++ +  +   R +A  EA +L +LDS +
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60

Query: 107 IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKK--LSEDVISGVAYRVLKGLQYLHG 164
           I++ +  F   +G++  VME+ E G L   L++++   L ED +     ++L GL +LH 
Sbjct: 61  IIRYYESFLD-KGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS 119

Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTC 224
            +I+H DIK  NL ++    VKI D GV++++       + N N  N I       +GT 
Sbjct: 120 KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLL-------SDNTNFANTI-------VGTP 165

Query: 225 AYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGE 284
            Y+SPE  + +     Y    DVW+LGVV+ EC  G +P     +  +  ALI  I  G 
Sbjct: 166 YYLSPELCEDK----PYNEKSDVWALGVVLYECCTGKHPF----DANNQGALILKIIRGV 217

Query: 285 RLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYP 321
              + +  S +  + +  CL KD+R+R    +LL  P
Sbjct: 218 FPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNP 254

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score =  152 bits (386), Expect = 1e-43
 Identities = 83/218 (38%), Positives = 128/218 (58%), Gaps = 22/218 (10%)

Query: 48  DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFI 107
           D ++++ LG GNGG+V KV+H+ S  I A K+++      IR+Q   E ++L   +S +I
Sbjct: 6   DFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 65

Query: 108 VKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYL-HGMQ 166
           V  +  FY+ +GEI   MEHM+ GSL   L+  K++ E+++  V+  VL+GL YL    Q
Sbjct: 66  VGFYGAFYS-DGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQ 124

Query: 167 IIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAY 226
           I+H D+KPSN+L+N +GE+K+ DFGVS                   I   A + +GT +Y
Sbjct: 125 IMHRDVKPSNILVNSRGEIKLCDFGVS----------------GQLIDSMANSFVGTRSY 168

Query: 227 MSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPL 264
           MSPER+     G  Y    D+WS+G+ ++E  +G YP+
Sbjct: 169 MSPERLQ----GTHYSVQSDIWSMGLSLVELAIGRYPI 202

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score =  150 bits (382), Expect = 1e-43
 Identities = 90/296 (30%), Positives = 139/296 (46%), Gaps = 35/296 (11%)

Query: 41  PDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILK 100
           PD   I +L +  V+G G  G VYK RH+K+  + A+K+++             E  IL+
Sbjct: 2   PDPTGIFELVE--VIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEE--IKEEYNILR 57

Query: 101 RLDSQ-FIVKCHAVFY-----TIEGEICFVMEHMERGSLFD----SLRVRKKLSEDVISG 150
           +  +   I   +  F        + ++  VME    GS+ D      +  K+L E+ I+ 
Sbjct: 58  KYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAY 117

Query: 151 VAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNN 210
           +    L+GL YLH  ++IH DIK  N+L+    EVK+ DFGVS  ++ T    N      
Sbjct: 118 ILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRN------ 171

Query: 211 NNIGEAAIACMGTCAYMSPERVD-SERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGE 269
                     +GT  +M+PE +   E+    Y    DVWSLG+  +E   G  PL    +
Sbjct: 172 --------TFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPL---CD 220

Query: 270 KPDLMALICAICFGE--RLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV 323
              + AL   I       L+ PE  S +F  F+  CL K++ +R  +EELL +PF+
Sbjct: 221 MHPMRAL-FKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  150 bits (380), Expect = 1e-43
 Identities = 80/273 (29%), Positives = 132/273 (48%), Gaps = 28/273 (10%)

Query: 54  VLGHGNGGIVYKVRHQKSNSIYALK---VLNTTSSTIIRHQAAHEAEILKRLDSQFIVKC 110
           ++G G  G+VYK  + ++    A+K   +       +       E ++LK L    IVK 
Sbjct: 7   LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQ--EIDLLKNLKHPNIVKY 64

Query: 111 HAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHG 170
                     +  ++E+ E GSL   ++      E +++   Y+VL+GL YLH   +IH 
Sbjct: 65  IG-SIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHR 123

Query: 171 DIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPE 230
           DIK +N+L    G VK+ADFGV+     T+ N+   ++ +          +GT  +M+PE
Sbjct: 124 DIKAANILTTKDGVVKLADFGVA-----TKLNDVSKDDAS---------VVGTPYWMAPE 169

Query: 231 RVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPE 290
            ++          A D+WSLG  V+E L G+ P   +   P  MA +  I   +   +PE
Sbjct: 170 VIE----MSGASTASDIWSLGCTVIELLTGNPPY--YDLNP--MAALFRIVQDDHPPLPE 221

Query: 291 TASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV 323
             SPE + F+  C +KD   R T ++LL +P++
Sbjct: 222 GISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  148 bits (375), Expect = 1e-42
 Identities = 82/275 (29%), Positives = 132/275 (48%), Gaps = 31/275 (11%)

Query: 61  GIVYKVRHQKSNSIYALKVLNTTSSTIIR----HQAAHEAEILKRLDSQFIVKCHAVFYT 116
           G V+  + + +  IYA+KV+      +IR     Q   E +IL +  S ++VK   ++Y+
Sbjct: 7   GRVFLAKKKSTGDIYAIKVIKKAD--MIRKNQVDQVLTERDILSQAQSPYVVK---LYYS 61

Query: 117 IEGE--ICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKP 174
            +G+  +  VME++  G L   L     L EDV       ++  L+YLH   IIH D+KP
Sbjct: 62  FQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKP 121

Query: 175 SNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDS 234
            N+LI+  G +K+ DFG+S++    R  N +++   +         +GT  Y++PE +  
Sbjct: 122 DNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDK------RIVGTPDYIAPEVILG 175

Query: 235 ERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPE--TA 292
           +     +    D WSLG ++ E LVG  P    GE P    +   I  G ++E PE    
Sbjct: 176 Q----GHSKTVDWWSLGCILYEFLVGIPPF--HGETP--EEIFQNILNG-KIEWPEDVEV 226

Query: 293 SPEFRRFVRSCLEKDWRKR---GTVEELLAYPFVT 324
           S E    +   L  D  KR    ++EE+  +PF  
Sbjct: 227 SDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFK 261

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  147 bits (372), Expect = 3e-42
 Identities = 86/272 (31%), Positives = 137/272 (50%), Gaps = 18/272 (6%)

Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH-EAEILKRLDSQFIVKCHAV 113
           +G G  G VY   +  +  + A+K +    +     +    E ++L+ L    +VK + V
Sbjct: 8   IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67

Query: 114 FYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIK 173
               E ++   ME+   G+L + L   + L E VI     ++L+GL YLH   I+H DIK
Sbjct: 68  EVHRE-KVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIK 126

Query: 174 PSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVD 233
           P+N+ ++  G +K+ DFG +  ++          NN   +GE   +  GT AYM+PE + 
Sbjct: 127 PANIFLDHNGVIKLGDFGCAVKLK----------NNTTTMGEEVQSLAGTPAYMAPEVIT 176

Query: 234 SERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPE--T 291
             +  G +G A D+WSLG VVLE   G  P   + E  +   ++  +  G +  +P+   
Sbjct: 177 GGKGKG-HGRAADIWSLGCVVLEMATGKRP---WSELDNEFQIMFHVGAGHKPPIPDSLQ 232

Query: 292 ASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV 323
            SPE + F+  CLE D +KR T  ELL +PFV
Sbjct: 233 LSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  146 bits (371), Expect = 4e-42
 Identities = 89/280 (31%), Positives = 128/280 (45%), Gaps = 24/280 (8%)

Query: 47  SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSS---TIIRHQAAHEAEILKRLD 103
            D + +  +G G  G VYK R   +  + A+KV+         II+     E  +LK   
Sbjct: 3   EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQ----EISMLKECR 58

Query: 104 SQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRV-RKKLSEDVISGVAYRVLKGLQYL 162
              IV      Y    ++  VME+   GSL D  +V R  LSE  I+ V    LKGL YL
Sbjct: 59  HPNIVAYFGS-YLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYL 117

Query: 163 HGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMG 222
           H    IH DIK +N+L+   G+VK+ADFGVS  +  T                   + +G
Sbjct: 118 HETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRK--------------SFIG 163

Query: 223 TCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICF 282
           T  +M+PE V +    G Y    D+W+LG+  +E      P+        L  +  +   
Sbjct: 164 TPYWMAPE-VAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFP 222

Query: 283 GERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPF 322
             +L+  E  SP F  F++ CL KD +KR T  +LL +PF
Sbjct: 223 PPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score =  145 bits (367), Expect = 2e-41
 Identities = 85/285 (29%), Positives = 143/285 (50%), Gaps = 27/285 (9%)

Query: 48  DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKR-LDSQF 106
           DL+ +  LG G  G+V K+RH  + +I A+K +  T ++  + +   + +I  R +D  +
Sbjct: 2   DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPY 61

Query: 107 IVKCHAVFYTIEGEICFVMEHMERGSLFD----SLRVRKKLSEDVISGVAYRVLKGLQYL 162
            V  +   +  EG++   ME M+  SL             + ED++  +A  ++K L+YL
Sbjct: 62  TVTFYGALFR-EGDVWICMEVMDT-SLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYL 119

Query: 163 HG-MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACM 221
           H  + +IH D+KPSN+LIN  G+VK+ DFG+S                 +++ +   A  
Sbjct: 120 HSKLSVIHRDVKPSNVLINRNGQVKLCDFGIS-------------GYLVDSVAKTIDA-- 164

Query: 222 GTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAIC 281
           G   YM+PER++ E     Y    DVWSLG+ ++E   G +P   +         +  + 
Sbjct: 165 GCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWK---TPFQQLKQVV 221

Query: 282 FGERLEMP-ETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTK 325
                ++P E  SPEF+ FV  CL+K++++R    ELL +PF   
Sbjct: 222 EEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFEL 266

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  144 bits (365), Expect = 4e-41
 Identities = 83/284 (29%), Positives = 128/284 (45%), Gaps = 26/284 (9%)

Query: 47  SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQF 106
            D + + V+G G   +VY      +N   A+K ++         +   E + + + +   
Sbjct: 1   DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPN 60

Query: 107 IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKK---LSEDVISGVAYRVLKGLQYLH 163
           +VK +  F  +  E+  VM ++  GSL D ++       L E +I+ V   VLKGL+YLH
Sbjct: 61  VVKYYTSF-VVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH 119

Query: 164 GMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGT 223
               IH DIK  N+L+   G VKIADFGVS  + +  +                   +GT
Sbjct: 120 SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKT----------FVGT 169

Query: 224 CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFG 283
             +M+PE V  +  G  Y F  D+WS G+  +E   G  P   +   P  M ++      
Sbjct: 170 PCWMAPE-VMEQVHG--YDFKADIWSFGITAIELATGAAPYSKY--PP--MKVLMLTLQN 222

Query: 284 ERLEMPETA-----SPEFRRFVRSCLEKDWRKRGTVEELLAYPF 322
           +   +   A     S  FR+ +  CL+KD  KR T EELL + F
Sbjct: 223 DPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKF 266

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  142 bits (361), Expect = 9e-41
 Identities = 81/281 (28%), Positives = 130/281 (46%), Gaps = 32/281 (11%)

Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAE----ILKRLDSQ 105
           +K  +LG G+ G VY+  +      +A+K ++         +A  + E    +L +L   
Sbjct: 3   RKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHP 62

Query: 106 FIVKCHAVFY---TIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYL 162
            IV+    +      E  +   +E +  GSL   L+      E VI     ++L GL+YL
Sbjct: 63  NIVQ----YLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYL 118

Query: 163 HGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMG 222
           H    +H DIK +N+L++  G VK+ADFG+++ V E                  A +  G
Sbjct: 119 HDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS---------------FAKSFKG 163

Query: 223 TCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICF 282
           +  +M+PE +  +   G YG A D+WSLG  VLE   G  P   + +   + A+      
Sbjct: 164 SPYWMAPEVIAQQ---GGYGLAADIWSLGCTVLEMATGKPP---WSQLEGVAAVFKIGRS 217

Query: 283 GERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV 323
            E   +P+  S E + F+  CL++D   R T  ELL +PFV
Sbjct: 218 KELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  143 bits (364), Expect = 9e-41
 Identities = 84/270 (31%), Positives = 132/270 (48%), Gaps = 35/270 (12%)

Query: 47  SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRH-QAAH---EAEILKRL 102
            D + +  LG G+ G V  VRH+ S   YALK+L+     I++  Q  H   E  IL+ +
Sbjct: 1   DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAK--IVKLKQVEHVLNEKRILQSI 58

Query: 103 DSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYL 162
              F+V  +  F   +  +  VME++  G LF  LR   +  E V    A +V+  L+YL
Sbjct: 59  RHPFLVNLYGSFQD-DSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYL 117

Query: 163 HGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMG 222
           H + I++ D+KP NLL++  G +KI DFG ++ V+                G     C G
Sbjct: 118 HSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVK----------------GRTYTLC-G 160

Query: 223 TCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLM-ALICAIC 281
           T  Y++PE + S+     YG A D W+LG+++ E L G+ P   F + P  +   I    
Sbjct: 161 TPEYLAPEIILSK----GYGKAVDWWALGILIYEMLAGYPPF--FDDNPIQIYEKILE-- 212

Query: 282 FGERLEMPETASPEFRRFVRSCLEKDWRKR 311
              ++  P   SP+ +  +R+ L+ D  KR
Sbjct: 213 --GKVRFPSFFSPDAKDLIRNLLQVDLTKR 240

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  140 bits (354), Expect = 1e-39
 Identities = 86/283 (30%), Positives = 134/283 (47%), Gaps = 34/283 (12%)

Query: 48  DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-STIIRHQAAHEAEILKRLDSQF 106
           D K L  LG G+ G VYKV+    N  YALK ++  S S   R  A +E  IL  ++   
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60

Query: 107 IVKCHAVFYTIEGEI-CFVMEHMERGSLFDSLRVRKK----LSEDVISGVAYRVLKGLQY 161
           I+     F  ++G   C VME+   G L  ++  RKK    + E  I  +  ++L+GLQ 
Sbjct: 61  IISYKEAF--LDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQA 118

Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACM 221
           LH  +I+H D+K +N+L+     VKI D G+S+++++                  A   +
Sbjct: 119 LHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN----------------MAKTQI 162

Query: 222 GTCAYMSPERVDSERWGGD-YGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAI 280
           GT  YM+P     E W G  Y +  D+WSLG ++ E      P     E   +  L   +
Sbjct: 163 GTPHYMAP-----EVWKGRPYSYKSDIWSLGCLLYEMATFAPPF----EARSMQDLRYKV 213

Query: 281 CFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV 323
             G+   +P   S + + F+RS L+   + R   +++LA P V
Sbjct: 214 QRGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV 256

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  139 bits (352), Expect = 5e-39
 Identities = 82/310 (26%), Positives = 133/310 (42%), Gaps = 62/310 (20%)

Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSS------TIIRHQAAHEAEILKRLD 103
           +K+  +G G  G VYK R++K+  + ALK +   +       T IR     E ++L++L 
Sbjct: 2   EKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIR-----EIKLLQKLR 56

Query: 104 SQFIVKCHA-VFYTIEGEICFVMEHME---RGSLFDSLRVRKKLSEDVISGVAYRVLKGL 159
              IV+    V    +G I  V E+M+    G L        K +E  I     ++L+GL
Sbjct: 57  HPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLL---DSPEVKFTESQIKCYMKQLLEGL 113

Query: 160 QYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIA 219
           QYLH   I+H DIK SN+LIN  G +K+ADFG++R   +  + +  N             
Sbjct: 114 QYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNR------------ 161

Query: 220 CMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICA 279
            + T  Y  PE +        YG   D+WS+G ++ E  +G     G  E  + +  I  
Sbjct: 162 -VITLWYRPPELLLGAT---RYGPEVDMWSVGCILAELFLGKPIFQGSTE-LEQLEKIFE 216

Query: 280 IC---------------FGERLEMPETASPEFRRFVRSC--------LEK----DWRKRG 312
           +C               + E L+  +      R F +          L+K    D +KR 
Sbjct: 217 LCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRI 276

Query: 313 TVEELLAYPF 322
           + ++ L + +
Sbjct: 277 SADQALQHEY 286

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score =  139 bits (351), Expect = 6e-39
 Identities = 89/305 (29%), Positives = 144/305 (47%), Gaps = 45/305 (14%)

Query: 47  SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRL-DSQ 105
            DLK L  +G G  G V K+ H+ S +I A+K + +T     + +   + +++ R  D  
Sbjct: 4   EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCP 63

Query: 106 FIVKCHAVFYTI---EGE--ICFVMEHMERGSLFDSL------RVRKKLSEDVISGVAYR 154
           +IVK    FY     EG+  IC  ME M+     D         ++  + E+++  +A  
Sbjct: 64  YIVK----FYGALFREGDCWIC--MELMD--ISLDKFYKYVYEVLKSVIPEEILGKIAVA 115

Query: 155 VLKGLQYL-HGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNI 213
            +K L YL   ++IIH D+KPSN+L++  G +K+ DFG+S  +              ++I
Sbjct: 116 TVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV-------------DSI 162

Query: 214 GEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDL 273
            +   A  G   YM+PER+D     G Y    DVWSLG+ + E   G +P   +     +
Sbjct: 163 AKTRDA--GCRPYMAPERIDPSARDG-YDVRSDVWSLGITLYEVATGKFPYPKWNS---V 216

Query: 274 MALICAICFGERLEMPETA----SPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSS 329
              +  +  G+   +  +     SP F  F+  CL KD  KR   +ELL +PF+ K    
Sbjct: 217 FDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFI-KDYEE 275

Query: 330 SNIEG 334
            N++ 
Sbjct: 276 RNVDV 280

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  132 bits (335), Expect = 7e-37
 Identities = 79/283 (27%), Positives = 120/283 (42%), Gaps = 41/283 (14%)

Query: 49  LKKLTVLGHGNGGIVYK--VRHQKSNSIY--ALKVLNTTSSTIIRHQAAHEAEILKRLDS 104
           L     LG G  G VYK  ++ +        A+K L   +S     +   EA I+++LD 
Sbjct: 1   LTLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDH 60

Query: 105 QFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKK--LSEDVISGVAYRVLKGLQYL 162
             IVK   V  T E  +  VME+M  G L D LR  +   LS   +   A ++ +G++YL
Sbjct: 61  PNIVKLLGVC-TEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYL 119

Query: 163 HGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMG 222
                IH D+   N L+     VKI+DFG+SR + +               G+  I    
Sbjct: 120 ESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKG-------GKLPI---- 168

Query: 223 TCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP-------DLMA 275
              +M+PE +      G +    DVWS GV++ E       +   GE+P       +++ 
Sbjct: 169 --RWMAPESLKE----GKFTSKSDVWSFGVLLWE-------IFTLGEEPYPGMSNAEVLE 215

Query: 276 LICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELL 318
            +     G RL  P    PE  + +  C  +D   R T  EL+
Sbjct: 216 YLKK---GYRLPKPPNCPPELYKLMLQCWAEDPEDRPTFSELV 255

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  132 bits (335), Expect = 9e-37
 Identities = 78/282 (27%), Positives = 117/282 (41%), Gaps = 40/282 (14%)

Query: 49  LKKLTVLGHGNGGIVYK--VRHQKSNSIY--ALKVLNTTSSTIIRHQAAHEAEILKRLDS 104
           L     LG G  G VYK  ++ +        A+K L   +S     +   EA I+++LD 
Sbjct: 1   LTLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDH 60

Query: 105 QFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLR-VRKKLSEDVISGVAYRVLKGLQYLH 163
             +VK   V  T E  +  VME+ME G L   LR  R KLS   +   A ++ +G++YL 
Sbjct: 61  PNVVKLLGVC-TEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE 119

Query: 164 GMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGT 223
               IH D+   N L+     VKI+DFG+SR + +                         
Sbjct: 120 SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY-------------RKRGGKLP 166

Query: 224 CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP-------DLMAL 276
             +M+PE +      G +    DVWS GV++ E       +   GE+P       +++  
Sbjct: 167 IRWMAPESLKE----GKFTSKSDVWSFGVLLWE-------IFTLGEQPYPGMSNEEVLEY 215

Query: 277 ICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELL 318
           +     G RL  P    PE    +  C  +D   R T  EL+
Sbjct: 216 LKN---GYRLPQPPNCPPELYDLMLQCWAEDPEDRPTFSELV 254

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  132 bits (334), Expect = 1e-36
 Identities = 77/289 (26%), Positives = 113/289 (39%), Gaps = 56/289 (19%)

Query: 54  VLGHGNGGIVYK-VRHQKSNSIY--ALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKC 110
            LG G  G VYK     K       A+K L   +S   R     EA ++K+L    +V+ 
Sbjct: 2   KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRL 61

Query: 111 HAVFYTIEGEICFVMEHMERGSLFDSLRVRKK---------LSEDVISGVAYRVLKGLQY 161
             V  T E  +  V+E+ME G L D LR  +          LS   +   A ++ KG++Y
Sbjct: 62  LGV-CTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACM 221
           L   + +H D+   N L+     VKI+DFG+SR V +                       
Sbjct: 121 LASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDY-----------------YRK 163

Query: 222 GTCA-----YMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP----- 271
            T       +M+PE +      G +    DVWS GV++ E           G  P     
Sbjct: 164 KTGGKLPIRWMAPESLKD----GIFTSKSDVWSFGVLLWEIFT-------LGATPYPGLS 212

Query: 272 --DLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELL 318
             +++  +     G RL  PE    E    + SC + D   R T  EL+
Sbjct: 213 NEEVLEYLRK---GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELV 258

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  131 bits (333), Expect = 2e-36
 Identities = 77/282 (27%), Positives = 116/282 (41%), Gaps = 39/282 (13%)

Query: 49  LKKLTVLGHGNGGIVYK----VRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDS 104
           L+    LG G  G VYK       + + +  A+K L   +S   R +   EA I+K+L  
Sbjct: 1   LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSH 60

Query: 105 QFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQYLH 163
             IV+   V  T    +  V E+M  G L D LR    KL+   +  +A ++ KG++YL 
Sbjct: 61  PNIVRLLGV-CTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE 119

Query: 164 GMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGT 223
               +H D+   N L+     VKI+DFG+SR + E                         
Sbjct: 120 SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGG------------GKLP 167

Query: 224 CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP-------DLMAL 276
             +M+PE +      G +    DVWS GV++ E       +   GE+P       +++ L
Sbjct: 168 IKWMAPESLK----DGKFTSKSDVWSFGVLLWE-------IFTLGEQPYPGMSNEEVLEL 216

Query: 277 ICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELL 318
           +     G RL  PE    E    +  C   D   R T  EL+
Sbjct: 217 LED---GYRLPRPENCPDELYELMLQCWAYDPEDRPTFSELV 255

Length = 258

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  131 bits (333), Expect = 2e-36
 Identities = 76/288 (26%), Positives = 121/288 (42%), Gaps = 35/288 (12%)

Query: 48  DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLN-TTSSTIIRHQAAHEAEILKRLDSQF 106
           D + L  +G G+ G V KVR +    I   K ++    +   + Q   E  IL+ L    
Sbjct: 1   DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPN 60

Query: 107 IVK-CHAVFYTIEGEICFVMEHMERGSLFDSL-----RVRKKLSEDVISGVAYRVLKGLQ 160
           IV+    +       +  VME+ E G L   L     + RK + E+ I  +  ++L  L 
Sbjct: 61  IVRYYDRIIDRSNQTLYIVMEYCEGGDL-AQLIQKCKKERKYIEEEFIWRILTQLLLALY 119

Query: 161 YLH-----GMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGE 215
             H     G  ++H D+KP+N+ ++    VK+ DFG+++I+                   
Sbjct: 120 ECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDS--------------S 165

Query: 216 AAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMA 275
            A   +GT  YMSPE+++       Y    D+WSLG ++ E      P     +      
Sbjct: 166 FAKTYVGTPYYMSPEQLNHMS----YDEKSDIWSLGCLIYELCALSPPFTARNQL----Q 217

Query: 276 LICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV 323
           L   I  G+   +P   S E    ++S L  D  KR + EELL  P +
Sbjct: 218 LASKIKEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  130 bits (328), Expect = 7e-36
 Identities = 77/277 (27%), Positives = 121/277 (43%), Gaps = 30/277 (10%)

Query: 52  LTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAA----HEAEILKRLDSQFI 107
           L V+G G  G V  V+ + +  ++A+K +N      +   +     +E  IL+ L+  F+
Sbjct: 5   LRVIGKGAFGKVCIVQKRDTKKMFAMKYMN--KQKCVEKGSVRNVLNERRILQELNHPFL 62

Query: 108 VKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQI 167
           V     F   E  +  V++ +  G L   L  + K SE+ +      ++  L+YLH   I
Sbjct: 63  VNLWYSFQDEE-NMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGI 121

Query: 168 IHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYM 227
           IH DIKP N+L++ +G V I DF ++  V       + +               GT  YM
Sbjct: 122 IHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTS---------------GTPGYM 166

Query: 228 SPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLE 287
           +PE +  +     Y  A D WSLGV   ECL G  P  G          I A      + 
Sbjct: 167 APEVLCRQ----GYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI--RDQIRAKQETADVL 220

Query: 288 MPETASPEFRRFVRSCLEKDWRKR--GTVEELLAYPF 322
            P T S E    +   LE+D +KR    +++L  +P+
Sbjct: 221 YPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPY 257

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score =  129 bits (327), Expect = 2e-35
 Identities = 87/291 (29%), Positives = 144/291 (49%), Gaps = 34/291 (11%)

Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVF 114
           LG G  G VYK +H+++    A K++   S   +      E +IL       IV  +  +
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMV-EIDILSECKHPNIVGLYEAY 71

Query: 115 YTIEGEICFVMEHMERGSLFDSLRVR--KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDI 172
           +  E ++  ++E  + G+L DS+ +   + L+E  I  V  ++L+ L +LH  ++IH D+
Sbjct: 72  F-YENKLWILIEFCDGGAL-DSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDL 129

Query: 173 KPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERV 232
           K  N+L+   G+VK+ADFGVS   + T    +                +GT  +M+PE V
Sbjct: 130 KAGNILLTLDGDVKLADFGVSAKNKSTLQKRD--------------TFIGTPYWMAPEVV 175

Query: 233 DSERWGGD-YGFAGDVWSLGVVVLECLVGHYPLIGFGEKP--DL--MALICAICFGE--R 285
             E +  + Y +  D+WSLG+ ++E        +   E P  +L  M ++  I   E   
Sbjct: 176 ACETFKDNPYDYKADIWSLGITLIE--------LAQMEPPHHELNPMRVLLKILKSEPPT 227

Query: 286 LEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNIEGLI 336
           L+ P   S  F  F++SCL KD   R T  ELL +PFV+ +S +  I+ L+
Sbjct: 228 LDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQSDNKAIKDLL 278

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score =  130 bits (329), Expect = 2e-35
 Identities = 76/240 (31%), Positives = 120/240 (50%), Gaps = 26/240 (10%)

Query: 47  SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIR---HQAAHEAEILKRLD 103
              KK+ +LG G+ G V+ VR + +  ++ALKVL+     I R    +   E EIL  LD
Sbjct: 1   KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDK-KEMIKRNKVKRVLTEQEILATLD 59

Query: 104 SQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVR--KKLSEDVISGVAYRVLKGLQY 161
             F+   +A F T E  +C VM++   G LF  L+ +  K LSE+V    A  VL  L+Y
Sbjct: 60  HPFLPTLYASFQT-ETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEY 118

Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVS-------RIVEETRNNNNHNNNNNNNIG 214
           LH + I++ D+KP N+L++  G + ++DF +S         V +     +  ++ N+   
Sbjct: 119 LHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPS 178

Query: 215 EAAIA--------CMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIG 266
           E             +GT  Y++PE +     G  +G A D W+LG+++ E L G  P  G
Sbjct: 179 ETFSEEPSFRSNSFVGTEEYIAPEVIS----GDGHGSAVDWWTLGILLYEMLYGTTPFKG 234

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  125 bits (317), Expect = 3e-34
 Identities = 76/257 (29%), Positives = 113/257 (43%), Gaps = 29/257 (11%)

Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH---EAEILKRLDSQFIVKCH 111
           LG G  G V  V+ +  N  +ALK +      +   Q  H   E EIL+  +  FIVK +
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKK-RHIVETGQQEHIFSEKEILEECNHPFIVKLY 59

Query: 112 AVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGD 171
             F   +  I  +ME+   G L+  LR R    E         V+   +YLH   II+ D
Sbjct: 60  RTFKD-KKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRD 118

Query: 172 IKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPER 231
           +KP NLL++  G VK+ DFG ++ ++                G+      GT  Y++PE 
Sbjct: 119 LKPENLLLDSNGYVKLVDFGFAKKLKS---------------GQKTWTFCGTPEYVAPEI 163

Query: 232 VDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGE-KPDLMALICAICFG-ERLEMP 289
           +        Y F+ D WSLG+++ E L G  P   FGE   D M +   I  G  +LE P
Sbjct: 164 IL----NKGYDFSVDYWSLGILLYELLTGRPP---FGEDDEDPMEIYNDILKGNGKLEFP 216

Query: 290 ETASPEFRRFVRSCLEK 306
                  +  ++  L +
Sbjct: 217 NYIDKAAKDLIKQLLRR 233

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  124 bits (314), Expect = 8e-34
 Identities = 85/274 (31%), Positives = 128/274 (46%), Gaps = 25/274 (9%)

Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNT--TSSTIIRHQAAHEAEI--LKRLDSQFIVKC 110
           LG G  G VY      +    A+K +     S    +   A E EI  LK L  + IV+ 
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69

Query: 111 HAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHG 170
           +      +  +   ME+M  GS+ D L+    L+E V      ++L+G++YLH   I+H 
Sbjct: 70  YGCL-RDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHR 128

Query: 171 DIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPE 230
           DIK +N+L +  G VK+ DFG S+ ++   ++           G    +  GT  +MSPE
Sbjct: 129 DIKGANILRDSAGNVKLGDFGASKRLQTICSS-----------GTGMKSVTGTPYWMSPE 177

Query: 231 RVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGE-RLEMP 289
            +  E     YG   DVWS+G  V+E L    P   F    + MA I  I       ++P
Sbjct: 178 VISGE----GYGRKADVWSVGCTVVEMLTEKPPWAEF----EAMAAIFKIATQPTNPQLP 229

Query: 290 ETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV 323
              SP+ R F+R    ++ +KR + EELL + FV
Sbjct: 230 SHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score =  125 bits (315), Expect = 1e-33
 Identities = 93/301 (30%), Positives = 145/301 (48%), Gaps = 32/301 (10%)

Query: 37  NPTSPDVENISD----LKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQA 92
           N +   +E++ D     + +  +G G  G VYKV ++K  S+ A+K+L+  S   +  + 
Sbjct: 8   NSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD--VDEEI 65

Query: 93  AHEAEILKRLDSQ-FIVKCHAVFYTIE----GEICFVMEHMERGSLFDS----LRVRKKL 143
             E  IL+ L +   +VK + +FY  +    G++  V+E    GS+ +     L   ++L
Sbjct: 66  EAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRL 125

Query: 144 SEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNN 203
            E +IS + Y  L GLQ+LH  +IIH D+K +N+L+  +G VK+ DFGVS  +  TR   
Sbjct: 126 DEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRR 185

Query: 204 NHNNNNNNNIGEAAIACMGTCAYMSPERVDSE-RWGGDYGFAGDVWSLGVVVLECLVGHY 262
           N                +GT  +M+PE +  E ++   Y    DVWSLG+  +E   G  
Sbjct: 186 N--------------TSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDP 231

Query: 263 PLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPF 322
           PL  F   P              L  PE     F  F+  CL KD+  R +V  LL +PF
Sbjct: 232 PL--FDMHPVKTLFKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPF 289

Query: 323 V 323
           +
Sbjct: 290 I 290

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score =  126 bits (318), Expect = 1e-33
 Identities = 91/297 (30%), Positives = 139/297 (46%), Gaps = 31/297 (10%)

Query: 47  SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH---EAEILKRLD 103
            D + + V+G G  G V+ VR + +  +YA+KVL   S  I R+Q AH   E +IL   D
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRK-SDMIKRNQIAHVRAERDILADAD 59

Query: 104 SQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLH 163
           S +IVK +  F   E  +  VME+M  G L + L  +    E+        ++  L  +H
Sbjct: 60  SPWIVKLYYSFQD-EEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVH 118

Query: 164 GMQIIHGDIKPSNLLINGKGEVKIADFGVS-RIVE----ETRNNNNHNNNNNNNIGEAA- 217
            +  IH DIKP N+LI+  G +K+ADFG+  ++ +    E   N++HN    +N+     
Sbjct: 119 KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRR 178

Query: 218 -------IAC--MGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFG 268
                   A   +GT  Y++PE +        YG   D WSLGV++ E L G  P   + 
Sbjct: 179 DHKQRRVRANSTVGTPDYIAPEVLRGTP----YGLECDWWSLGVILYEMLYGFPPF--YS 232

Query: 269 EKPDLMAL-ICAICFGERLEMPETA--SPEFRRFVRSCLEKDWRKRGTVEELLAYPF 322
           +        I  I + E L  P     SPE    +   L     + G+ EE+ ++PF
Sbjct: 233 DTLQETYNKI--INWKESLRFPPDPPVSPEAIDLICRLLCDPEDRLGSFEEIKSHPF 287

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  124 bits (313), Expect = 2e-33
 Identities = 78/282 (27%), Positives = 136/282 (48%), Gaps = 27/282 (9%)

Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLN--TTSSTI--IRHQAAHEAEILKRLDSQ 105
           ++L ++G G  G VY+ +H  +  + ALK++N  T    +  I+ + A  ++ L++    
Sbjct: 4   QRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQ-LRQSQPP 62

Query: 106 FIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGM 165
            I K +   Y     +  +ME+ E GS+   ++    ++E  IS +   VL  L+Y+H +
Sbjct: 63  NITKYYGS-YLKGPRLWIIMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKV 120

Query: 166 QIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCA 225
            +IH DIK +N+L+   G VK+ DFGV+ ++ +  +                   +GT  
Sbjct: 121 GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKR--------------STFVGTPY 166

Query: 226 YMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGER 285
           +M+PE +     G  Y    D+WSLG+ + E   G+ P     +    M LI       R
Sbjct: 167 WMAPEVI---TEGKYYDTKADIWSLGITIYEMATGNPPYSDV-DAFRAMMLI-PKSKPPR 221

Query: 286 LEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRS 327
           LE     S   R FV +CL+++ ++R + EELL   ++   S
Sbjct: 222 LED-NGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHS 262

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  124 bits (314), Expect = 2e-33
 Identities = 89/305 (29%), Positives = 131/305 (42%), Gaps = 55/305 (18%)

Query: 52  LTVLGHGNGGIVYKVRHQKSNSIYALK-VLNTTSSTIIRHQAAHEAEILKRLDSQFIVKC 110
           L  +G G  GIV+K + +++    ALK V        I +QA  E + L+     ++VK 
Sbjct: 5   LGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKL 64

Query: 111 HAVFYTIEGEICFVMEHMERGSLFDSLR-VRKKLSEDVISGVAYRVLKGLQYLHGMQIIH 169
             VF    G    VME+M    L + LR   + L E  +      +LKG+ Y+H   I+H
Sbjct: 65  LDVFPHGSG-FVLVMEYMPS-DLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMH 122

Query: 170 GDIKPSNLLINGKGEVKIADFGVSRIV-EETRNNNNHNNNNNNNIGEAAIACMGTCAYMS 228
            D+KP+NLLI+  G +KIADFG++R+  EE     +H               + T  Y +
Sbjct: 123 RDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ--------------VATRWYRA 168

Query: 229 PERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALIC---------- 278
           PE +   R    Y    D+W++G +  E L G  PL  F  + D+  L            
Sbjct: 169 PELLYGAR---KYDPGVDLWAVGCIFAELLNGS-PL--FPGENDIEQLAIVFRTLGTPNE 222

Query: 279 -------------AICF----GERLE--MPETASPEFRRFVRSCLEKDWRKRGTVEELLA 319
                         I F       LE   P+ ASPE    ++  L  D  KR +  E L 
Sbjct: 223 ETWPGLTSLPDYNKITFPESKPIPLEEIFPD-ASPEALDLLKGLLVYDPSKRLSAAEALR 281

Query: 320 YPFVT 324
           +P+ T
Sbjct: 282 HPYFT 286

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  123 bits (312), Expect = 3e-33
 Identities = 71/223 (31%), Positives = 105/223 (47%), Gaps = 34/223 (15%)

Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVL------NTTSSTIIRHQAAHEAEILKRLD 103
           +KL  LG G  G+VYK R +K+  I ALK +          ST +R     E  +LK L 
Sbjct: 2   EKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALR-----EISLLKELK 56

Query: 104 SQFIVKCHAVFYTIEGEICFVMEHMER--GSLFDSLRVRKKLSEDVISGVAYRVLKGLQY 161
              IVK   V +T E ++  V E+ +       D       LS ++I  + Y++L+GL Y
Sbjct: 57  HPNIVKLLDVIHT-ERKLYLVFEYCDMDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAY 113

Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACM 221
            H  +I+H D+KP N+LIN  G +K+ADFG++R          H            +   
Sbjct: 114 CHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHE-----------VV-- 160

Query: 222 GTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPL 264
            T  Y +PE +   +    Y  A D+WS+G +  E + G  PL
Sbjct: 161 -TLWYRAPEILLGSK---HYSTAVDIWSVGCIFAEMITGK-PL 198

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score =  123 bits (310), Expect = 3e-33
 Identities = 93/276 (33%), Positives = 126/276 (45%), Gaps = 28/276 (10%)

Query: 54  VLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEIL--KRLDSQFIVKCH 111
           VLG G  GIVY  R   +    A+K +    S  +  Q  HE EI     L  + IV+  
Sbjct: 15  VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYV--QPLHE-EIALHSYLKHRNIVQYL 71

Query: 112 AVFYTIEGEICFVMEHMERGSLFDSLRVR---KKLSEDVISGVAYRVLKGLQYLHGMQII 168
               +  G     ME +  GSL   LR +    K +E  I     ++L+GL+YLH  QI+
Sbjct: 72  GSD-SENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIV 130

Query: 169 HGDIKPSNLLING-KGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYM 227
           H DIK  N+L+N   G VKI+DFG S+ +                I        GT  YM
Sbjct: 131 HRDIKGDNVLVNTYSGVVKISDFGTSKRLA--------------GINPCTETFTGTLQYM 176

Query: 228 SPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLE 287
           +PE +D    G  YG   D+WSLG  ++E   G  P I  GE    M  +    F    E
Sbjct: 177 APEVIDKGPRG--YGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGM--FKIHPE 232

Query: 288 MPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV 323
           +PE+ S E + F+  C E D  KR +  +LL  PF+
Sbjct: 233 IPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  122 bits (308), Expect = 7e-33
 Identities = 80/282 (28%), Positives = 132/282 (46%), Gaps = 31/282 (10%)

Query: 54  VLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH---------EAEILKRLDS 104
           ++G G  G VY   +  +  + A+K +   ++   RH +           E E LK LD 
Sbjct: 8   LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67

Query: 105 QFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG 164
             IV+    F T E  +   +E++  GS+   LR   +  E ++     +VL+GL YLH 
Sbjct: 68  LNIVQYLG-FETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHS 126

Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTC 224
             I+H D+K  NLL++  G  KI+DFG+S+     ++++ ++N+ N ++        G+ 
Sbjct: 127 KGILHRDLKADNLLVDADGICKISDFGISK-----KSDDIYDNDQNMSM-------QGSV 174

Query: 225 AYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGE 284
            +M+PE + S   G  Y    D+WSLG VVLE   G  P   + ++  + A+        
Sbjct: 175 FWMAPEVIHSYSQG--YSAKVDIWSLGCVVLEMFAGRRP---WSDEEAIAAMFKLGNKRS 229

Query: 285 RLEMPE----TASPEFRRFVRSCLEKDWRKRGTVEELLAYPF 322
              +P       SP    F+ +C   +   R T  ELL +PF
Sbjct: 230 APPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPF 271

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score =  120 bits (303), Expect = 6e-32
 Identities = 88/288 (30%), Positives = 146/288 (50%), Gaps = 28/288 (9%)

Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVF 114
           LG G  G VYK +++++ ++ A KV+ T S   +      E EIL   +  +IVK    F
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMV-EIEILATCNHPYIVKLLGAF 78

Query: 115 YTIEGEICFVMEHMERGSLFDS--LRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDI 172
           Y  +G++  ++E    G++ D+  L + + L+E  I  +  ++L+ LQYLH M+IIH D+
Sbjct: 79  Y-WDGKLWIMIEFCPGGAV-DAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDL 136

Query: 173 KPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERV 232
           K  N+L+   G++K+ADFGVS    +T    +              + +GT  +M+PE V
Sbjct: 137 KAGNVLLTLDGDIKLADFGVSAKNVKTLQRRD--------------SFIGTPYWMAPEVV 182

Query: 233 DSERW-GGDYGFAGDVWSLGVVVLECLV---GHYPLIGFGEKPDLMALICAICFGERLEM 288
             E      Y +  D+WSLG+ ++E       H+ L      P  + L  A      L  
Sbjct: 183 MCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL-----NPMRVLLKIAKSEPPTLSQ 237

Query: 289 PETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNIEGLI 336
           P   S EFR F+++ L+K    R +  +LL +PFV+  +S+  +  L+
Sbjct: 238 PSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSNRPLRELV 285

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score =  119 bits (300), Expect = 9e-32
 Identities = 84/283 (29%), Positives = 139/283 (49%), Gaps = 28/283 (9%)

Query: 51  KLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKC 110
           KL  +G G+ G VYK    ++  + A+K+++   +         E  +L + DS +I + 
Sbjct: 8   KLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRY 67

Query: 111 HAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHG 170
           +   Y    ++  +ME++  GS  D L+    L E  I+ +   +LKGL YLH  + IH 
Sbjct: 68  YGS-YLKGTKLWIIMEYLGGGSALDLLK-PGPLEETYIATILREILKGLDYLHSERKIHR 125

Query: 171 DIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPE 230
           DIK +N+L++ +G+VK+ADFGV+  + +T+   N                +GT  +M+PE
Sbjct: 126 DIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRN--------------TFVGTPFWMAPE 171

Query: 231 RVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDL--MALICAICFGERLEM 288
            +        Y F  D+WSLG+  +E   G  P        DL  M ++  I       +
Sbjct: 172 VIKQSA----YDFKADIWSLGITAIELAKGEPP------NSDLHPMRVLFLIPKNSPPTL 221

Query: 289 PETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSN 331
               S  F+ FV +CL KD R R T +ELL + F+T+ +  ++
Sbjct: 222 EGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRYTKKTS 264

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score =  119 bits (301), Expect = 2e-31
 Identities = 83/283 (29%), Positives = 142/283 (50%), Gaps = 33/283 (11%)

Query: 52  LTVLGHGNGGIVY---KVRHQKSNSIYALKVLNTTSSTII-RHQAAHEAEILKRLDSQFI 107
           L VLG G+ G V+   K+    +  +YA+KVL   +  +  R +   E +IL  ++  FI
Sbjct: 1   LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFI 60

Query: 108 VKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQI 167
           VK H  F T EG++  +++ +  G LF  L      +E+ +      +   L +LH + I
Sbjct: 61  VKLHYAFQT-EGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGI 119

Query: 168 IHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYM 227
           I+ D+KP N+L++ +G +K+ DFG+S+   E+ ++              A +  GT  YM
Sbjct: 120 IYRDLKPENILLDEEGHIKLTDFGLSK---ESIDHEKK-----------AYSFCGTVEYM 165

Query: 228 SPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLE 287
           +PE V+  R G  +  + D WS GV++ E L G  P  G  ++ + M +I       +L 
Sbjct: 166 APEVVN--RRG--HTQSADWWSFGVLMFEMLTGSLPFQG-KDRKETMTMI----LKAKLG 216

Query: 288 MPETASPEFRRFVRSCLEKDWRKR-----GTVEELLAYPFVTK 325
           MP+  SPE +  +R+  +++   R       VEE+  +PF + 
Sbjct: 217 MPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFST 259

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score =  118 bits (297), Expect = 4e-31
 Identities = 83/285 (29%), Positives = 134/285 (47%), Gaps = 27/285 (9%)

Query: 48  DLKKLTVLGHGNGGIVYKVRH---QKSNSIYALKVLNTTSSTIIRHQAAH---EAEILKR 101
           + + L VLG G  G V+ VR      +  +YA+KVL   +       A H   E ++L+ 
Sbjct: 1   NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60

Query: 102 L-DSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQ 160
           +    F+V  H  F T + ++  +++++  G LF  L  R+  +E  +      ++  L 
Sbjct: 61  VRRCPFLVTLHYAFQT-DTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALD 119

Query: 161 YLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIAC 220
           +LH + II+ DIK  N+L++ +G V + DFG+S+                    E A + 
Sbjct: 120 HLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLA-------------EEEERAYSF 166

Query: 221 MGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAI 280
            GT  YM+PE +     G  +  A D WSLGV+  E L G  P    GE+ +  + I   
Sbjct: 167 CGTIEYMAPEVIRGGSGG--HDKAVDWWSLGVLTFELLTGASPFTVDGEQ-NSQSEISRR 223

Query: 281 CFGERLEMPETASPEFRRFVRSCLEKDWRKR---GTVEELLAYPF 322
               +   P+T S E R F++  LEKD +KR      +E+  +PF
Sbjct: 224 ILKSKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPF 268

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score =  117 bits (295), Expect = 1e-30
 Identities = 94/299 (31%), Positives = 142/299 (47%), Gaps = 49/299 (16%)

Query: 52  LTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHE-AEILKRLDSQFIVKC 110
           L  +GHG+ G VY  R  ++N + A+K ++ +       Q+  +  +I+K +  +F+ + 
Sbjct: 20  LREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGK-----QSNEKWQDIIKEV--RFLQQL 72

Query: 111 -HAVFYTIEGEICFVMEH-----MER--GSLFDSLRVRKK-LSEDVISGVAYRVLKGLQY 161
            H    TIE + C++ EH     ME   GS  D L V KK L E  I+ + +  L+GL Y
Sbjct: 73  RHP--NTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAY 130

Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACM 221
           LH  + IH DIK  N+L+   G VK+ADFG + +V                    A + +
Sbjct: 131 LHSHERIHRDIKAGNILLTEPGTVKLADFGSASLV------------------SPANSFV 172

Query: 222 GTCAYMSPERV---DSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALIC 278
           GT  +M+PE +   D     G Y    DVWSLG+  +E      PL       + M+ + 
Sbjct: 173 GTPYWMAPEVILAMDE----GQYDGKVDVWSLGITCIELAERKPPLFNM----NAMSALY 224

Query: 279 AICFGERLEMPETA-SPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNIEGLI 336
            I   +   +     S  FR FV SCL+K  + R + EELL + FV +    + I  LI
Sbjct: 225 HIAQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRERPPTVIIDLI 283

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score =  116 bits (292), Expect = 2e-30
 Identities = 92/283 (32%), Positives = 140/283 (49%), Gaps = 36/283 (12%)

Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRL-DSQFIVKCHAV 113
           +G G  G V+KV ++K+ S  A+K+L+      I  +   E  ILK L D   +VK + +
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVKILDPIHD--IDEEIEAEYNILKALSDHPNVVKFYGM 83

Query: 114 FYTIE----GEICFVMEHMERGSLFD----SLRVRKKLSEDVISGVAYRVLKGLQYLHGM 165
           +Y  +     ++  V+E    GS+ D     L+  +++ E +I+ + +  L GLQ+LH  
Sbjct: 84  YYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN 143

Query: 166 QIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCA 225
           + IH D+K +N+L+  +G VK+ DFGVS  +  TR   N                +GT  
Sbjct: 144 KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRN--------------TSVGTPF 189

Query: 226 YMSPERVDSE-RWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDL--MALICAICF 282
           +M+PE +  E +    Y    DVWSLG+  +E   G  PL       DL  M  +  I  
Sbjct: 190 WMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPL------ADLHPMRALFKIPR 243

Query: 283 G--ERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV 323
                L  PE  S EF  F+R CL KD+ KR TV +LL + F+
Sbjct: 244 NPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  115 bits (290), Expect = 3e-30
 Identities = 85/283 (30%), Positives = 131/283 (46%), Gaps = 29/283 (10%)

Query: 51  KLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTI---IRHQA-----AHEAEILKRL 102
           K  ++G G+ G VY   +  S  + A+K +   S +     R ++     A E  +LK L
Sbjct: 4   KGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL 63

Query: 103 DSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYL 162
             + IV+ +         +   +E++  GS+   L       E ++     ++LKGL YL
Sbjct: 64  QHENIVQ-YLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYL 122

Query: 163 HGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMG 222
           H   IIH DIK +N+L++ KG +KI+DFG+S+ +E         N+ +     A  +  G
Sbjct: 123 HNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEA--------NSLSTKTNGARPSLQG 174

Query: 223 TCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICF 282
           +  +M+PE V        Y    D+WSLG +V+E L G +P       PD   L      
Sbjct: 175 SVFWMAPEVVKQTS----YTRKADIWSLGCLVVEMLTGKHPF------PDCTQLQAIFKI 224

Query: 283 GE--RLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV 323
           GE    E+P   S E   F+    E D  KR T  ELL +PF+
Sbjct: 225 GENASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  114 bits (286), Expect = 9e-30
 Identities = 75/276 (27%), Positives = 122/276 (44%), Gaps = 28/276 (10%)

Query: 51  KLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-STIIRHQAAHEAEILKRLDSQFIVK 109
            + VLG G  G     R  + +S+   K +N T  S   R  A +E  IL  L    I+ 
Sbjct: 4   PIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIA 63

Query: 110 CHAVFYTIEGEICFV-MEHMERGSLFDSLRVRKK--LSEDVISGVAYRVLKGLQYLHGMQ 166
            +  F  ++     + ME+   G+L+D +  +K     E+++    ++++  + Y+H   
Sbjct: 64  YYNHF--MDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG 121

Query: 167 IIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAY 226
           I+H DIK  N+ +   G +K+ DFG+S+I+               +    A   +GT  Y
Sbjct: 122 ILHRDIKTLNIFLTKAGLIKLGDFGISKIL--------------GSEYSMAETVVGTPYY 167

Query: 227 MSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERL 286
           MSPE       G  Y F  D+W+LG V+ E L     L    +  + + L+  I  G   
Sbjct: 168 MSPELCQ----GVKYNFKSDIWALGCVLYELLT----LKRTFDATNPLNLVVKIVQGNYT 219

Query: 287 EMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPF 322
            +    S E    V S L++D  KR T +E+L  P 
Sbjct: 220 PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPL 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score =  114 bits (287), Expect = 9e-30
 Identities = 90/279 (32%), Positives = 138/279 (49%), Gaps = 26/279 (9%)

Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVF 114
           LG G  G VYK +++++  + A KV++T S   +      E +IL   D   IVK    F
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMV-EIDILASCDHPNIVKLLDAF 71

Query: 115 YTIEGEICFVMEHMERGSLFDS--LRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDI 172
           Y  E  +  ++E    G++ D+  L + + L+E  I  V  + L+ L YLH  +IIH D+
Sbjct: 72  Y-YENNLWILIEFCAGGAV-DAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDL 129

Query: 173 KPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERV 232
           K  N+L    G++K+ADFGVS   + TR     +            + +GT  +M+PE V
Sbjct: 130 KAGNILFTLDGDIKLADFGVS--AKNTRTIQRRD------------SFIGTPYWMAPEVV 175

Query: 233 DSERWGG-DYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGE--RLEMP 289
             E      Y +  DVWSLG+ ++E      P      + + M ++  I   E   L  P
Sbjct: 176 MCETSKDRPYDYKADVWSLGITLIEMAQIEPP----HHELNPMRVLLKIAKSEPPTLAQP 231

Query: 290 ETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSS 328
              S EF+ F++ CLEK+   R T  +LL +PFVT  S+
Sbjct: 232 SRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNSN 270

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  113 bits (285), Expect = 2e-29
 Identities = 85/304 (27%), Positives = 136/304 (44%), Gaps = 54/304 (17%)

Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALK-VLNTTSSTIIRHQAAHEAEILKRLDSQFIV 108
           +KL  +G G  G+VYK R + +  I A+K +     S  I   A  E ++LK L+   I+
Sbjct: 2   QKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNII 61

Query: 109 KCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKK-LSEDVISGVAYRVLKGLQYLHGMQI 167
           K   VF   +G++  V E M+   L+  ++ R++ L E +I    Y++L+GL + H   I
Sbjct: 62  KLLDVFRH-KGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGI 119

Query: 168 IHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYM 227
           +H D+KP NLLIN +G +K+ADFG++R          H               + T  Y 
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHY--------------VVTRWYR 165

Query: 228 SPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAIC------ 281
           +PE +  ++    Y    D+WS+G +  E L+   PL  F  K ++  L   I       
Sbjct: 166 APELLLGDKG---YSTPVDIWSVGCIFAE-LLSRRPL--FPGKSEIDQL-FKIFRTLGTP 218

Query: 282 --------------------FGERLEMPE---TASPEFRRFVRSCLEKDWRKRGTVEELL 318
                                   + +P+    ASP+    +   L  D  KR T E+ L
Sbjct: 219 DPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQAL 278

Query: 319 AYPF 322
           A+P+
Sbjct: 279 AHPY 282

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score =  113 bits (283), Expect = 4e-29
 Identities = 85/284 (29%), Positives = 133/284 (46%), Gaps = 25/284 (8%)

Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVF 114
           +G G  G V+      +    A+K +N       +    +E  ++K L +  IV      
Sbjct: 27  IGQGASGTVFTAIDVATGQEVAIKQINLQKQPK-KELIINEILVMKELKNPNIVN-FLDS 84

Query: 115 YTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKP 174
           + +  E+  VME++  GSL D +     + E  I+ V    L+ L++LH  Q+IH DIK 
Sbjct: 85  FLVGDELFVVMEYLAGGSLTDVV-TETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKS 143

Query: 175 SNLLINGKGEVKIADFG-VSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVD 233
            N+L+   G VK+ DFG  ++I  E    +                 +GT  +M+PE V 
Sbjct: 144 DNVLLGMDGSVKLTDFGFCAQITPEQSKRS---------------TMVGTPYWMAPEVVT 188

Query: 234 SERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPETAS 293
            +     YG   D+WSLG++ +E + G  P +   E P     + A      L+ PE  S
Sbjct: 189 RKA----YGPKVDIWSLGIMAIEMVEGEPPYL--NENPLRALYLIATNGTPELQNPEKLS 242

Query: 294 PEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNIEGLII 337
           P FR F+  CLE D  KRG+ +ELL +PF+      S++  LI+
Sbjct: 243 PIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAKPLSSLTPLIL 286

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score =  113 bits (283), Expect = 5e-29
 Identities = 89/297 (29%), Positives = 133/297 (44%), Gaps = 43/297 (14%)

Query: 51  KLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--------STIIRHQAAHEAEILKRL 102
           +   +G G  G VY      +    A+K +N           + I+  +      I+  L
Sbjct: 23  RFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYL 82

Query: 103 DSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYL 162
           DS          Y +  E+  VME++  GSL D +     + E  I+ V    L+ L++L
Sbjct: 83  DS----------YLVGDELWVVMEYLAGGSLTDVV-TETCMDEGQIAAVCRECLQALEFL 131

Query: 163 HGMQIIHGDIKPSNLLINGKGEVKIADFG-VSRIVEETRNNNNHNNNNNNNIGEAAIACM 221
           H  Q+IH DIK  N+L+   G VK+ DFG  ++I  E    +                 +
Sbjct: 132 HSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS---------------TMV 176

Query: 222 GTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAIC 281
           GT  +M+PE V  +     YG   D+WSLG++ +E + G  P +   E P L AL     
Sbjct: 177 GTPYWMAPEVVTRKA----YGPKVDIWSLGIMAIEMVEGEPPYL--NENP-LRALYLIAT 229

Query: 282 FGE-RLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNIEGLII 337
            G   L+ PE  S  FR F+  CLE D  KRG+ +ELL +PF+      S++  LI 
Sbjct: 230 NGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAKPLSSLTPLIA 286

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score =  112 bits (282), Expect = 5e-29
 Identities = 86/295 (29%), Positives = 137/295 (46%), Gaps = 33/295 (11%)

Query: 47  SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQF 106
           S L     +G G+ GIV     + +    A+K ++       R    +E  I++      
Sbjct: 19  SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQR-RELLFNEVVIMRDYQHPN 77

Query: 107 IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQ 166
           IV+ ++  Y +  E+  VME +E G+L D +    +++E+ I+ V   VLK L +LH   
Sbjct: 78  IVEMYSS-YLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLAVLKALSFLHAQG 135

Query: 167 IIHGDIKPSNLLINGKGEVKIADFG----VSRIVEETRNNNNHNNNNNNNIGEAAIACMG 222
           +IH DIK  ++L+   G VK++DFG    VS+ V   +                  + +G
Sbjct: 136 VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRK------------------SLVG 177

Query: 223 TCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP-DLMALICAIC 281
           T  +M+PE +        YG   D+WSLG++V+E + G  P   F E P   M  I    
Sbjct: 178 TPYWMAPEVISRL----PYGTEVDIWSLGIMVIEMVDGEPPY--FNEPPLQAMKRIRDN- 230

Query: 282 FGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNIEGLI 336
              +L+     SP  R F+   L +D  +R T  ELL +PF+ K    S+I  L+
Sbjct: 231 LPPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGPPSSIVPLM 285

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score =  113 bits (284), Expect = 6e-29
 Identities = 80/277 (28%), Positives = 124/277 (44%), Gaps = 33/277 (11%)

Query: 54  VLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH---EAEILKRLDSQFIVKC 110
           +LG G  G V  VR + +   YA+K+L      I + + AH   E+ +L+     F+   
Sbjct: 2   LLGKGTFGKVILVREKATGKYYAMKILKK-EVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60

Query: 111 HAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHG 170
              F T    +CFVME+   G LF  L   +  SED        ++  L YLH   +++ 
Sbjct: 61  KYSFQT-HDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYR 119

Query: 171 DIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPE 230
           D+K  NL+++  G +KI DFG+ +  E   +            G       GT  Y++PE
Sbjct: 120 DLKLENLMLDKDGHIKITDFGLCK--EGISD------------GATMKTFCGTPEYLAPE 165

Query: 231 RVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPE 290
            ++      DYG A D W LGVV+ E + G  P     +   L  LI      E +  P 
Sbjct: 166 VLEDN----DYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILM----EEIRFPR 216

Query: 291 TASPEFRRFVRSCLEKDWRKR-----GTVEELLAYPF 322
           T SPE +  +   L+KD ++R        +E++ + F
Sbjct: 217 TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRF 253

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score =  113 bits (284), Expect = 7e-29
 Identities = 85/283 (30%), Positives = 128/283 (45%), Gaps = 36/283 (12%)

Query: 39  TSPDVEN--ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIR-HQAAH- 94
           T PD  +  +SD +    LG G+ G V   +H+ +   YA+K L      I++  Q  H 
Sbjct: 8   TKPDTSSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLK--KREILKMKQVQHV 65

Query: 95  --EAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVA 152
             E  IL  L   FIV     F   E  + F++E +  G LF  LR   +   DV     
Sbjct: 66  AQEKSILMELSHPFIVNMMCSFQD-ENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYH 124

Query: 153 YRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNN 212
             ++   +YLH   II+ D+KP NLL++ KG VK+ DFG ++ V +              
Sbjct: 125 AELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR------------- 171

Query: 213 IGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPD 272
                    GT  Y++PE + S+     +G A D W++GV++ E + G+ P   F + P 
Sbjct: 172 ----TFTLCGTPEYLAPEVIQSK----GHGKAVDWWTMGVLLYEFIAGYPPF--FDDTP- 220

Query: 273 LMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKR-GTV 314
              +   I  G RL+ P       R  V+  L+ D  KR GT+
Sbjct: 221 -FRIYEKILAG-RLKFPNWFDGRARDLVKGLLQTDHTKRLGTL 261

Length = 329

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score =  112 bits (282), Expect = 3e-28
 Identities = 84/287 (29%), Positives = 135/287 (47%), Gaps = 30/287 (10%)

Query: 45  NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAA---HEAEILKR 101
              D   + V+G G  G V  VRH+ S  +YA+K+L+     I R  +A    E +I+  
Sbjct: 41  KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSK-FEMIKRSDSAFFWEERDIMAH 99

Query: 102 LDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQY 161
            +S++IV+ H  F   +  +  VME+M  G L  +L     + E         V+  L  
Sbjct: 100 ANSEWIVQLHYAFQD-DKYLYMVMEYMPGGDLV-NLMSNYDIPEKWARFYTAEVVLALDA 157

Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACM 221
           +H M  IH D+KP N+L++  G +K+ADFG    ++   N     +             +
Sbjct: 158 IHSMGFIHRDVKPDNMLLDKSGHLKLADFGTC--MKMDANGMVRCDT-----------AV 204

Query: 222 GTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYP-----LIGFGEKPDLMAL 276
           GT  Y+SPE + S+   G YG   D WS+GV + E LVG  P     L+G   K  +M  
Sbjct: 205 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSK--IMDH 262

Query: 277 ICAICFGERLEMPETASPEFRRFVRSCLEKDWR-KRGTVEELLAYPF 322
             ++ F + +E+ + A      F+     ++ R  R  V+E+ ++PF
Sbjct: 263 KNSLTFPDDIEISKQAKDLICAFLTD---REVRLGRNGVDEIKSHPF 306

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  109 bits (275), Expect = 3e-28
 Identities = 78/275 (28%), Positives = 123/275 (44%), Gaps = 38/275 (13%)

Query: 58  GNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQA----AHEAEILKRLDSQFIVKCHAV 113
           G  G VY  + + +   +A+KVL   S  I ++Q     A  A ++ + +S ++ K   +
Sbjct: 7   GAFGSVYLAKKRSTGDYFAIKVLKK-SDMIAKNQVTNVKAERAIMMIQGESPYVAK---L 62

Query: 114 FYTIEGE--ICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGD 171
           +Y+ + +  +  VME++  G     ++    L ED        V+ G++ LH   IIH D
Sbjct: 63  YYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRD 122

Query: 172 IKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPER 231
           IKP NLLI+  G +K+ DFG+SR   E +                    +GT  Y++PE 
Sbjct: 123 IKPENLLIDQTGHLKLTDFGLSRNGLENKK------------------FVGTPDYLAPET 164

Query: 232 VDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPD-LMALICAICFGERLEMPE 290
           +     G       D WSLG V+ E L G+ P     E PD +   I +       E+ E
Sbjct: 165 IL----GVGDDKMSDWWSLGCVIFEFLFGYPPF--HAETPDAVFDNILSRRINWPEEVKE 218

Query: 291 TASPEFRRFVRSCLEKDWRKR---GTVEELLAYPF 322
             SPE    +   L  D  KR      +E+ ++PF
Sbjct: 219 FCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPF 253

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score =  110 bits (275), Expect = 4e-28
 Identities = 80/285 (28%), Positives = 136/285 (47%), Gaps = 32/285 (11%)

Query: 51  KLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKC 110
           KL  +G G+ G V+K    ++  + A+K+++   +         E  +L + DS ++ K 
Sbjct: 8   KLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKY 67

Query: 111 HAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHG 170
           +   Y    ++  +ME++  GS  D LR      E  I+ +   +LKGL YLH  + IH 
Sbjct: 68  YGS-YLKGTKLWIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHR 125

Query: 171 DIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPE 230
           DIK +N+L++ +G+VK+ADFGV+  + +T+   N                +GT  +M+PE
Sbjct: 126 DIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRN--------------TFVGTPFWMAPE 171

Query: 231 RVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPE 290
            +        Y    D+WSLG+  +E        +  GE P+       + F      P 
Sbjct: 172 VIQQSA----YDSKADIWSLGITAIE--------LAKGEPPNSDMHPMRVLFLIPKNNPP 219

Query: 291 TASPEFRR----FVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSN 331
           T + EF +    F+ +CL KD   R T +ELL + F+ K +  ++
Sbjct: 220 TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNAKKTS 264

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score =  109 bits (274), Expect = 5e-28
 Identities = 83/279 (29%), Positives = 135/279 (48%), Gaps = 28/279 (10%)

Query: 54  VLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDS-QFIVKCHA 112
           ++G+G  G VYK RH K+  + A+KV++ T       +   E  +LK+    + I   + 
Sbjct: 13  LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE--EEEIKQEINMLKKYSHHRNIATYYG 70

Query: 113 VFYT-----IEGEICFVMEHMERGSLFDSLRVRK--KLSEDVISGVAYRVLKGLQYLHGM 165
            F       ++ ++  VME    GS+ D ++  K   L E+ I+ +   +L+GL +LH  
Sbjct: 71  AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH 130

Query: 166 QIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCA 225
           ++IH DIK  N+L+    EVK+ DFGVS  ++ T    N                +GT  
Sbjct: 131 KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRN--------------TFIGTPY 176

Query: 226 YMSPERVD-SERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGE 284
           +M+PE +   E     Y F  D+WSLG+  +E   G  PL      P     +       
Sbjct: 177 WMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM--HPMRALFLIPRNPAP 234

Query: 285 RLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV 323
           RL+  +  S +F+ F+ SCL K+  +R T E+L+ +PF+
Sbjct: 235 RLK-SKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score =  109 bits (273), Expect = 9e-28
 Identities = 84/286 (29%), Positives = 133/286 (46%), Gaps = 42/286 (14%)

Query: 54  VLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAV 113
           V+G+G  G VYK RH K+  + A+KV++ T       +   E  +LK+      +   A 
Sbjct: 23  VVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDE--EEEIKLEINMLKKYSHHRNI---AT 77

Query: 114 FYTI---------EGEICFVMEHMERGSLFDSLRVRK--KLSEDVISGVAYRVLKGLQYL 162
           +Y           + ++  VME    GS+ D ++  K   L ED I+ +   +L+GL +L
Sbjct: 78  YYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHL 137

Query: 163 HGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMG 222
           H  ++IH DIK  N+L+    EVK+ DFGVS  ++ T    N                +G
Sbjct: 138 HAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRN--------------TFIG 183

Query: 223 TCAYMSPERVD-SERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAIC 281
           T  +M+PE +   E     Y +  D+WSLG+  +E   G  PL         M  + A+ 
Sbjct: 184 TPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCD-------MHPMRALF 236

Query: 282 FGERLEMPETA----SPEFRRFVRSCLEKDWRKRGTVEELLAYPFV 323
              R   P+      S +F  F+  CL K++  R + E+LL +PF+
Sbjct: 237 LIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score =  109 bits (273), Expect = 1e-27
 Identities = 86/292 (29%), Positives = 130/292 (44%), Gaps = 41/292 (14%)

Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTS--------STIIRHQAAHEAEILKRLDSQF 106
           +G G  G VY      +    A+K +N           + I+  +      I+  LDS  
Sbjct: 27  IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS-- 84

Query: 107 IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQ 166
                   Y +  E+  VME++  GSL D +     + E  I+ V    L+ L +LH  Q
Sbjct: 85  --------YLVGDELWVVMEYLAGGSLTDVV-TETCMDEGQIAAVCRECLQALDFLHSNQ 135

Query: 167 IIHGDIKPSNLLINGKGEVKIADFG-VSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCA 225
           +IH DIK  N+L+   G VK+ DFG  ++I  E    +                 +GT  
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS---------------TMVGTPY 180

Query: 226 YMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGER 285
           +M+PE V  +     YG   D+WSLG++ +E + G  P +   E P     + A      
Sbjct: 181 WMAPEVVTRKA----YGPKVDIWSLGIMAIEMVEGEPPYL--NENPLRALYLIATNGTPE 234

Query: 286 LEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNIEGLII 337
           L+ PE  S  FR F+  CLE D  +RG+ +ELL +PF+      S++  LII
Sbjct: 235 LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKPLSSLTPLII 286

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score =  109 bits (274), Expect = 1e-27
 Identities = 86/279 (30%), Positives = 133/279 (47%), Gaps = 35/279 (12%)

Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH---EAEILKR---LDSQFIV 108
           +G G  G VY+VR + +  IYA+KVL +    + + + AH   E  IL R    +S FIV
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVL-SKKEIVAKKEVAHTIGERNILVRTLLDESPFIV 59

Query: 109 KCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQII 168
                F T + ++  V ++M  G LF  L+   + SED        ++  L++LH   I+
Sbjct: 60  GLKFSFQT-DSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIV 118

Query: 169 HGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMS 228
           + D+KP N+L++  G + + DFG+S+        N  +N   N        C GT  Y++
Sbjct: 119 YRDLKPENILLDATGHIALCDFGLSK-------ANLTDNKTTNTF------C-GTTEYLA 164

Query: 229 PERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEM 288
           PE +  E+    Y    D WSLGV+V E   G  P        D   +   I FG ++  
Sbjct: 165 PEVLLDEK---GYTKHVDFWSLGVLVFEMCCGWSPFYA----EDTQQMYRNIAFG-KVRF 216

Query: 289 PE-TASPEFRRFVRSCLEKDWRKR-GTV---EELLAYPF 322
           P+   S E R+FV+  L ++ + R G      EL  +PF
Sbjct: 217 PKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPF 255

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score =  109 bits (273), Expect = 2e-27
 Identities = 85/287 (29%), Positives = 135/287 (47%), Gaps = 45/287 (15%)

Query: 52  LTVLGHGNGGIVYKVRH---QKSNSIYALKVLNTTSSTIIRHQ--AAH---EAEILKRLD 103
           L VLG G  G V++VR      +  I+A+KVL    +TI+R+Q   AH   E  IL+ + 
Sbjct: 1   LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLK--KATIVRNQKDTAHTKAERNILEAVK 58

Query: 104 SQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLH 163
             FIV     F T  G++  ++E++  G LF  L       ED        +   L++LH
Sbjct: 59  HPFIVDLIYAFQT-GGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLH 117

Query: 164 GMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIA---C 220
              II+ D+KP N+L++ +G VK+ DFG+ +                 +I E  +    C
Sbjct: 118 QQGIIYRDLKPENILLDAQGHVKLTDFGLCK----------------ESIHEGTVTHTFC 161

Query: 221 MGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAI 280
            GT  YM+PE +   R G  +G A D WSLG ++ + L G  P      K  +  ++   
Sbjct: 162 -GTIEYMAPEIL--MRSG--HGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKG- 215

Query: 281 CFGERLEMPETASPEFRRFVRSCLEKDWRKR-----GTVEELLAYPF 322
               +L +P   +PE R  ++  L+++   R     G   E+ ++PF
Sbjct: 216 ----KLNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPF 258

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score =  108 bits (271), Expect = 2e-27
 Identities = 77/272 (28%), Positives = 131/272 (48%), Gaps = 39/272 (14%)

Query: 47  SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIR-HQAAH---EAEILKRL 102
            DL+++  +G G  G V+ VR + S   YALKV+      +IR  Q  H   E  +LK +
Sbjct: 1   DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPE--VIRLKQEQHVHNEKRVLKEV 58

Query: 103 DSQFIVKCHAVFYTIEGE--ICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQ 160
              FI++   +F+T   +  +  +ME++  G LF  LR   + S       A  ++  L+
Sbjct: 59  SHPFIIR---LFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALE 115

Query: 161 YLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSR-IVEETRNNNNHNNNNNNNIGEAAIA 219
           YLH  +I++ D+KP N+L++ +G +K+ DFG ++ + + T                    
Sbjct: 116 YLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWT-----------------L 158

Query: 220 CMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICA 279
           C GT  Y++PE + S+     +  A D W+LG+++ E LVG+ P   F + P    +   
Sbjct: 159 C-GTPEYLAPEVIQSK----GHNKAVDWWALGILIYEMLVGYPPF--FDDNPF--GIYEK 209

Query: 280 ICFGERLEMPETASPEFRRFVRSCLEKDWRKR 311
           I  G +LE P       +  ++  L  D  +R
Sbjct: 210 ILAG-KLEFPRHLDLYAKDLIKKLLVVDRTRR 240

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score =  107 bits (268), Expect = 3e-27
 Identities = 78/278 (28%), Positives = 127/278 (45%), Gaps = 28/278 (10%)

Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAA-HEAEILKRLDSQFIV 108
           +K+ V+G G  GIV+  R +    +  +K +     T     AA +E ++LK L    I+
Sbjct: 3   EKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNII 62

Query: 109 KCHAVFYTIEGEICFVMEHMERGSLFDSL--RVRKKLSEDVISGVAYRVLKGLQYLHGMQ 166
           + +  F   +  +  VME+   G+L + +  R    L ED I     ++L  L ++H   
Sbjct: 63  EYYENFLE-DKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL 121

Query: 167 IIHGDIKPSNLLING-KGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCA 225
           I+H D+K  N+L++  K  VKI DFG+S+I+                    A   +GT  
Sbjct: 122 ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK---------------SKAYTVVGTPC 166

Query: 226 YMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGER 285
           Y+SPE  +    G  Y    D+W+LG V+ E       L    E  +L AL+  I  G  
Sbjct: 167 YISPELCE----GKPYNQKSDIWALGCVLYELA----SLKRAFEAANLPALVLKIMSGTF 218

Query: 286 LEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV 323
             + +  SP+ R+ + S L  D  KR  + +++A P  
Sbjct: 219 APISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score =  106 bits (267), Expect = 3e-27
 Identities = 81/275 (29%), Positives = 129/275 (46%), Gaps = 25/275 (9%)

Query: 52  LTVLGHGNGGIVYKVRHQKSNSIYALKVLN-TTSSTIIRHQAAHEAEILKRLDSQFIVKC 110
           + V+G G+ G V  VRH+     Y +K LN   +S   R  A  EA++L +L    IV  
Sbjct: 5   VRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY 64

Query: 111 HAVFYTIEGEICFVMEHMERGSLFDSLRVRKK--LSEDVISGVAYRVLKGLQYLHGMQII 168
              +   +G +  VM   E G L+  L+ +K   L E+ +     ++   LQYLH   I+
Sbjct: 65  RESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHIL 124

Query: 169 HGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMS 228
           H D+K  N+ +     +K+ D G++R++E      N          + A   +GT  YMS
Sbjct: 125 HRDLKTQNVFLTRTNIIKVGDLGIARVLE------NQC--------DMASTLIGTPYYMS 170

Query: 229 PERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEM 288
           PE   ++     Y +  DVW+LG  V E     +    F  K D+ +L+  I  G+   M
Sbjct: 171 PELFSNK----PYNYKSDVWALGCCVYEMATLKH---AFNAK-DMNSLVYRIIEGKLPPM 222

Query: 289 PETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV 323
           P+  SPE    + + L K   KR +V+ +L  P++
Sbjct: 223 PKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  107 bits (268), Expect = 6e-27
 Identities = 77/304 (25%), Positives = 129/304 (42%), Gaps = 51/304 (16%)

Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTT-SSTIIRHQAAHEAEILKRLDSQFIV 108
           + L V+G G  G+V K R++ +  I A+K    +     ++  A  E ++L++L  + IV
Sbjct: 4   EVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIV 63

Query: 109 KCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQII 168
                F   +G +  V E++ER  L         L  D +    +++L+ + Y H   II
Sbjct: 64  NLKEAFRR-KGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNII 122

Query: 169 HGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMS 228
           H DIKP N+L++  G +K+ DFG +R +              + + +     + T  Y +
Sbjct: 123 HRDIKPENILVSESGVLKLCDFGFARALRA---------RPASPLTDY----VATRWYRA 169

Query: 229 PERV--DSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAIC----- 281
           PE +  D+      YG   DVW++G ++ E L G  PL       D + LI         
Sbjct: 170 PELLVGDTN-----YGKPVDVWAIGCIMAELLDGE-PLFPGDSDIDQLYLIQKCLGPLPP 223

Query: 282 ------------FGERLEMPETASPEFRR-----------FVRSCLEKDWRKRGTVEELL 318
                        G     P       RR           F+++CL  D ++R T +ELL
Sbjct: 224 SHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELL 283

Query: 319 AYPF 322
            +P+
Sbjct: 284 QHPY 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score =  106 bits (266), Expect = 7e-27
 Identities = 77/281 (27%), Positives = 133/281 (47%), Gaps = 24/281 (8%)

Query: 51  KLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKC 110
           KL  +G G+ G V+K    ++  + A+K+++   +         E  +L + DS ++ K 
Sbjct: 8   KLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKY 67

Query: 111 HAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHG 170
           +   Y  + ++  +ME++  GS  D L     L E  I+ +   +LKGL YLH  + IH 
Sbjct: 68  YGS-YLKDTKLWIIMEYLGGGSALDLLE-PGPLDETQIATILREILKGLDYLHSEKKIHR 125

Query: 171 DIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPE 230
           DIK +N+L++  GEVK+ADFGV+  + +T+   N                +GT  +M+PE
Sbjct: 126 DIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN--------------TFVGTPFWMAPE 171

Query: 231 RVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPE 290
            +        Y    D+WSLG+  +E   G  P      +   M ++  I       +  
Sbjct: 172 VIKQSA----YDSKADIWSLGITAIELAKGEPP----HSELHPMKVLFLIPKNNPPTLEG 223

Query: 291 TASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSN 331
             S   + FV +CL K+   R T +ELL + F+ + +  ++
Sbjct: 224 NYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRFAKKTS 264

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  106 bits (268), Expect = 1e-26
 Identities = 74/320 (23%), Positives = 122/320 (38%), Gaps = 82/320 (25%)

Query: 52  LTVLGHGNGGIVYKVRHQKSNSIYALK-VLNTTSSTIIRHQAAHEAEILKRLDSQFIVKC 110
           L  +G G  G+V     +++    A+K + N     I   +   E ++L+ L  + I+  
Sbjct: 5   LKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGL 64

Query: 111 HAVFYTIE----GEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQ 166
             +          ++  V E ME   L   ++  + L++D I    Y++L+GL+YLH   
Sbjct: 65  LDILRPPSPEDFNDVYIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSAN 123

Query: 167 IIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAY 226
           +IH D+KPSN+L+N   ++KI DFG++R V+   +                         
Sbjct: 124 VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGF--------------------- 162

Query: 227 MSPERVDSERW---------GGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP------ 271
           ++   V   RW            Y  A D+WS+G +  E L           KP      
Sbjct: 163 LTEYVV--TRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTR---------KPLFPGRD 211

Query: 272 --DLMALICAIC---------FGERLEMPE------------------TASPEFRRFVRS 302
             D + LI  +          F    +                      ASPE    +  
Sbjct: 212 YIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEK 271

Query: 303 CLEKDWRKRGTVEELLAYPF 322
            L  D +KR T +E LA+P+
Sbjct: 272 MLVFDPKKRITADEALAHPY 291

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score =  107 bits (267), Expect = 1e-26
 Identities = 81/263 (30%), Positives = 120/263 (45%), Gaps = 32/263 (12%)

Query: 54  VLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH---EAEILKRLDSQFIVKC 110
           +LG G  G V  VR + S   YA+K+L      I + + AH   E+ +LK     F+   
Sbjct: 2   LLGKGTFGKVILVREKASGKYYAMKILKK-EVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60

Query: 111 HAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHG 170
              F T +  +CFVME++  G LF  L   +  SED        ++  L YLH  +I++ 
Sbjct: 61  KYSFQT-KDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYR 119

Query: 171 DIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAI--ACMGTCAYMS 228
           D+K  NL+++  G +KI DFG+ +                  I +AA      GT  Y++
Sbjct: 120 DLKLENLMLDKDGHIKITDFGLCK----------------EGITDAATMKTFCGTPEYLA 163

Query: 229 PERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEM 288
           PE ++      DYG A D W LGVV+ E + G  P     +   L  LI      E ++ 
Sbjct: 164 PEVLEDN----DYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILM----EDIKF 214

Query: 289 PETASPEFRRFVRSCLEKDWRKR 311
           P T S + +  +   L KD  KR
Sbjct: 215 PRTLSADAKSLLSGLLIKDPNKR 237

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score =  106 bits (266), Expect = 2e-26
 Identities = 95/304 (31%), Positives = 141/304 (46%), Gaps = 52/304 (17%)

Query: 47  SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTT--SSTIIRHQAAHEAEILKRLDS 104
           +DL+++   GHG+ G VY  R  ++N + A+K ++ +   S         E + L+R+  
Sbjct: 28  TDLREI---GHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKH 84

Query: 105 QFIVKCHAVFYTIEGEICFVMEH-----MER--GSLFDSLRVRKK-LSEDVISGVAYRVL 156
                      +IE + C++ EH     ME   GS  D L V KK L E  I+ + +  L
Sbjct: 85  P---------NSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGAL 135

Query: 157 KGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEA 216
           +GL YLH   +IH DIK  N+L+   G+VK+ADFG + I                     
Sbjct: 136 QGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIA------------------SP 177

Query: 217 AIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMAL 276
           A + +GT  +M+PE + +    G Y    DVWSLG+  +E      PL         M  
Sbjct: 178 ANSFVGTPYWMAPEVILAMD-EGQYDGKVDVWSLGITCIELAERKPPLFN-------MNA 229

Query: 277 ICAICFGERLEMPETASPE----FRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNI 332
           + A+    + E P   S E    FR FV SCL+K  + R T EELL + FV +    + +
Sbjct: 230 MSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERPETVL 289

Query: 333 EGLI 336
             LI
Sbjct: 290 IDLI 293

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  105 bits (263), Expect = 3e-26
 Identities = 76/288 (26%), Positives = 127/288 (44%), Gaps = 36/288 (12%)

Query: 49  LKKLTVLGHGNGGIVYKVRHQ----KSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDS 104
           LK +  LG G+ G V   R+      +    A+K LN +     R     E EIL+ LD 
Sbjct: 6   LKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDH 65

Query: 105 QFIVKCHAVFYTIEG-EICFVMEHMERGSLFDSLR-VRKKLSEDVISGVAYRVLKGLQYL 162
           + IVK   V     G  +  +ME++  GSL D L+  R +++   +   + ++ KG+ YL
Sbjct: 66  ENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYL 125

Query: 163 HGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMG 222
              + IH D+   N+L+  +  VKI+DFG+++++ E     + +       GE+ I    
Sbjct: 126 GSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPE-----DKDYYYVKEPGESPI---- 176

Query: 223 TCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHY----------PLIGFGEKPD 272
              + +PE + + +    +  A DVWS GV + E     Y           L   G    
Sbjct: 177 --FWYAPECLRTSK----FSSASDVWSFGVTLYELFT--YGDPSQSPPAEFLRMIGIAQG 228

Query: 273 LMA---LICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEEL 317
            M    L+  +  GERL  P +   E    ++ C E + + R +  +L
Sbjct: 229 QMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADL 276

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score =  105 bits (263), Expect = 3e-26
 Identities = 80/302 (26%), Positives = 137/302 (45%), Gaps = 51/302 (16%)

Query: 51  KLTVLGHGNGGIVYKVRHQKSNSIYALK-VLNTTSSTIIRHQAAHEAEILKRLDSQFIVK 109
           KL+ +G G+ G+V+K R++++  I A+K  + +    +I+  A  E  +LK+L    +V 
Sbjct: 5   KLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVN 64

Query: 110 CHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIH 169
              VF   + ++  V E+ +   L +  +  + + E +I  + ++ L+ + + H    IH
Sbjct: 65  LIEVFRR-KRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIH 123

Query: 170 GDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSP 229
            D+KP N+LI  +G++K+ DFG +RI+                 G+     + T  Y +P
Sbjct: 124 RDVKPENILITKQGQIKLCDFGFARIL--------------TGPGDDYTDYVATRWYRAP 169

Query: 230 ERVDSERWGGD--YGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAIC------ 281
           E +      GD  YG   DVW++G V  E L G  PL       D + LI          
Sbjct: 170 ELL-----VGDTQYGPPVDVWAIGCVFAELLTGQ-PLWPGKSDVDQLYLIRKTLGDLIPR 223

Query: 282 -----------FGERLEMPETASP---EFRR-------FVRSCLEKDWRKRGTVEELLAY 320
                       G  +  PET  P   +F         F++ CL+ D  +R + EELL +
Sbjct: 224 HQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283

Query: 321 PF 322
           P+
Sbjct: 284 PY 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score =  104 bits (261), Expect = 3e-26
 Identities = 85/280 (30%), Positives = 131/280 (46%), Gaps = 38/280 (13%)

Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRH----QAAHEAEILKRLDSQFIVKC 110
           LG G+ G VY V+ +K+ +   LKVL       +      QA  EA++L +LD   IVK 
Sbjct: 8   LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKF 67

Query: 111 HAVFYTIEGEICFVMEHMERGSLFDSLR----VRKKLSEDVISGVAYRVLKGLQYLHGMQ 166
           HA F   +   C + E+ E   L   L       K LSE+ +     ++L G+ Y+H  +
Sbjct: 68  HASFLERDA-FCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR 126

Query: 167 IIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACM--GTC 224
           I+H D+K  N+ +     +KI DFGVSR++                +G   +A    GT 
Sbjct: 127 ILHRDLKAKNIFLK-NNLLKIGDFGVSRLL----------------MGSCDLATTFTGTP 169

Query: 225 AYMSPERVDSERWGGDYGFAGDVWSLGVVVLE-CLVGHYPLIGFGEKPDLMALICAICFG 283
            YMSPE +  +     Y    D+WSLG ++ E C + H    G     + ++++  I  G
Sbjct: 170 YYMSPEALKHQ----GYDSKSDIWSLGCILYEMCCLAH-AFEGQ----NFLSVVLRIVEG 220

Query: 284 ERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV 323
               +PET S +    ++S L KD   R +  E+L  PF+
Sbjct: 221 PTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score =  105 bits (264), Expect = 3e-26
 Identities = 83/293 (28%), Positives = 139/293 (47%), Gaps = 31/293 (10%)

Query: 47  SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIR---HQAAHEAEILKRLD 103
            D + + ++ +G  G VY VRH+++   +A+K +N   + I+R    Q   E +IL   +
Sbjct: 1   EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINK-QNLILRNQIQQVFVERDILTFAE 59

Query: 104 SQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLH 163
           + F+V     F T +  +C VME++E G     L+    L  D+        +  L+YLH
Sbjct: 60  NPFVVSMFCSFET-KRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLH 118

Query: 164 GMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGE--AAIACM 221
              I+H D+KP NLLI   G +K+ DFG+S+I   +   N +  +   +  E      C 
Sbjct: 119 NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVC- 177

Query: 222 GTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAIC 281
           GT  Y++PE +   R G  YG   D W++G+++ E LVG  P   FG+ P+ +       
Sbjct: 178 GTPEYIAPEVI--LRQG--YGKPVDWWAMGIILYEFLVGCVPF--FGDTPEEL------- 224

Query: 282 FG----ERLEMP---ETASPEFRRFVRSCLEKDWRKR---GTVEELLAYPFVT 324
           FG    + +E P   E    + +  +   L ++  +R   G   E+  + F  
Sbjct: 225 FGQVISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFL 277

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score =  105 bits (264), Expect = 3e-26
 Identities = 78/264 (29%), Positives = 120/264 (45%), Gaps = 34/264 (12%)

Query: 54  VLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH---EAEILKRLDSQFIVKC 110
           +LG G  G V  VR + +   YA+K+L      I + + AH   E+ +L+     F+   
Sbjct: 2   LLGKGTFGKVILVREKATGRYYAMKILRK-EVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60

Query: 111 HAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHG 170
              F T    +CFVME+   G LF  L   +  +E+        ++  L+YLH   +++ 
Sbjct: 61  KYAFQT-HDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYR 119

Query: 171 DIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIA---CMGTCAYM 227
           DIK  NL+++  G +KI DFG+ +                  I + A     C GT  Y+
Sbjct: 120 DIKLENLMLDKDGHIKITDFGLCK----------------EGISDGATMKTFC-GTPEYL 162

Query: 228 SPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLE 287
           +PE ++      DYG A D W LGVV+ E + G  P     +   L  LI      E + 
Sbjct: 163 APEVLEDN----DYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELILM----EEIR 213

Query: 288 MPETASPEFRRFVRSCLEKDWRKR 311
            P T SPE +  +   L+KD ++R
Sbjct: 214 FPRTLSPEAKSLLAGLLKKDPKQR 237

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  104 bits (262), Expect = 5e-26
 Identities = 83/310 (26%), Positives = 129/310 (41%), Gaps = 70/310 (22%)

Query: 52  LTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDS-QFIVKC 110
           +  LG G  G VY  R++++  + A+K +     +        E + L++L+    IVK 
Sbjct: 4   IKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKL 63

Query: 111 HAVFYTIEGEICFVMEHMERGSLFD--SLRVRKKLSEDVISGVAYRVLKGLQYLHGMQII 168
             VF     E+ FV E+ME G+L+     R  K  SE VI  + Y++L+GL ++H     
Sbjct: 64  KEVFR-ENDELYFVFEYME-GNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFF 121

Query: 169 HGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMS 228
           H D+KP NLL++G   VKIADFG++R   E R+   +                    Y+ 
Sbjct: 122 HRDLKPENLLVSGPEVVKIADFGLAR---EIRSRPPYT------------------DYV- 159

Query: 229 PERVDSERW---------GGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICA 279
                S RW            Y    D+W+LG ++ E L    PL     + D +  IC+
Sbjct: 160 -----STRWYRAPEILLRSTSYSSPVDIWALGCIMAE-LYTLRPLFPGSSEIDQLYKICS 213

Query: 280 I-------------------------CFGERLE--MPETASPEFRRFVRSCLEKDWRKRG 312
           +                              L   +P  ASPE    ++  L  D +KR 
Sbjct: 214 VLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIP-NASPEAIDLIKDMLRWDPKKRP 272

Query: 313 TVEELLAYPF 322
           T  + L +P+
Sbjct: 273 TASQALQHPY 282

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  104 bits (260), Expect = 5e-26
 Identities = 79/273 (28%), Positives = 122/273 (44%), Gaps = 32/273 (11%)

Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNT--TSSTIIRHQAAHEAEILKRLDSQFIVKCHA 112
           +G G   +VYK        + ALK +          R     E ++LK+LD   ++K  A
Sbjct: 10  IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLA 69

Query: 113 VFYTIE-GEICFVMEHMERGSLFDSLRVRKK----LSEDVISGVAYRVLKGLQYLHGMQI 167
            F  IE  E+  V+E  + G L   ++  KK    + E  I     ++   L+++H  +I
Sbjct: 70  SF--IENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRI 127

Query: 168 IHGDIKPSNLLINGKGEVKIADFGVSRIV-EETRNNNNHNNNNNNNIGEAAIACMGTCAY 226
           +H DIKP+N+ I   G VK+ D G+ R    +T                AA + +GT  Y
Sbjct: 128 MHRDIKPANVFITATGVVKLGDLGLGRFFSSKT---------------TAAHSLVGTPYY 172

Query: 227 MSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERL 286
           MSPER+        Y F  D+WSLG ++ E      P   +G+K +L +L   I   +  
Sbjct: 173 MSPERIH----ENGYNFKSDIWSLGCLLYEMAALQSPF--YGDKMNLYSLCKKIEKCDYP 226

Query: 287 EMP-ETASPEFRRFVRSCLEKDWRKRGTVEELL 318
            +P +  S E R  V  C+  D  KR  +  +L
Sbjct: 227 PLPADHYSEELRDLVSRCINPDPEKRPDISYVL 259

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score =  104 bits (261), Expect = 6e-26
 Identities = 83/291 (28%), Positives = 129/291 (44%), Gaps = 41/291 (14%)

Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTS--------STIIRHQAAHEAEILKRLDSQF 106
           +G G  G VY      +    A++ +N           + I+  +      I+  LDS  
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS-- 85

Query: 107 IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQ 166
                   Y +  E+  VME++  GSL D +     + E  I+ V    L+ L++LH  Q
Sbjct: 86  --------YLVGDELWVVMEYLAGGSLTDVV-TETCMDEGQIAAVCRECLQALEFLHSNQ 136

Query: 167 IIHGDIKPSNLLINGKGEVKIADFG-VSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCA 225
           +IH DIK  N+L+   G VK+ DFG  ++I  E    +                 +GT  
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST---------------MVGTPY 181

Query: 226 YMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGER 285
           +M+PE V  +     YG   D+WSLG++ +E + G  P +   E P     + A      
Sbjct: 182 WMAPEVVTRKA----YGPKVDIWSLGIMAIEMIEGEPPYL--NENPLRALYLIATNGTPE 235

Query: 286 LEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNIEGLI 336
           L+ PE  S  FR F+  CL+ D  KRG+ +ELL + F+      S++  LI
Sbjct: 236 LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLTPLI 286

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  102 bits (256), Expect = 2e-25
 Identities = 86/283 (30%), Positives = 124/283 (43%), Gaps = 25/283 (8%)

Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALK----VLNTTSSTIIRHQA-AHEAEILKRLDS 104
            K   LG G     Y+ R  K+ ++ A+K    V NT+S      +A   E  ++ RL+ 
Sbjct: 3   LKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNH 62

Query: 105 QFIVKCHAVFYTIE-GEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLH 163
             I++      T E       +E M  GS+   L       E VI     ++L+GL YLH
Sbjct: 63  PHIIRMLGA--TCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLH 120

Query: 164 GMQIIHGDIKPSNLLINGKGE-VKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMG 222
             QIIH D+K +NLLI+  G+ ++IADFG +  +                 GE     +G
Sbjct: 121 ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARL----------AAKGTGAGEFQGQLLG 170

Query: 223 TCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAI-C 281
           T A+M+PE +  E     YG + DVWS+G V++E      P     +  + +ALI  I  
Sbjct: 171 TIAFMAPEVLRGE----QYGRSCDVWSVGCVIIEMATAKPPW-NAEKHSNHLALIFKIAS 225

Query: 282 FGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVT 324
                 +PE  SP  R     CLE     R    ELL +P   
Sbjct: 226 ATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score =  103 bits (260), Expect = 3e-25
 Identities = 83/315 (26%), Positives = 137/315 (43%), Gaps = 54/315 (17%)

Query: 47  SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH---EAEILKRLD 103
            D + + V+G G  G V  V+ + +  IYA+K L   S  + + Q AH   E +IL   D
Sbjct: 1   DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRK-SEMLEKEQVAHVRAERDILAEAD 59

Query: 104 SQFIVKCHAVFYTIEGE--ICFVMEHMERGSLFDSLRVRKKLSEDVIS-GVAYRVLKGLQ 160
           + ++VK   ++Y+ + E  +  +ME++  G +   L  +   +E+     +A  +L  + 
Sbjct: 60  NPWVVK---LYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETIL-AID 115

Query: 161 YLHGMQIIHGDIKPSNLLINGKGEVKIADFGVS------------RIVEETRNNNN---- 204
            +H +  IH DIKP NLL++ KG +K++DFG+             RI+     +N     
Sbjct: 116 SIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFI 175

Query: 205 ----------HNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVV 254
                          N      A + +GT  Y++PE          Y    D WSLGV++
Sbjct: 176 SKPMSSKRKAETWKRNRRA--LAYSTVGTPDYIAPEVFLQT----GYNKECDWWSLGVIM 229

Query: 255 LECLVGHYPLIGFGEKPDLMALICAICFGERLEMPETA--SPE----FRRFVRSCLEKDW 308
            E LVG+ P     + P        I + E L+ P+    SPE     +R    C  +  
Sbjct: 230 YEMLVGYPPF--CSDNPQETYRK-IINWKETLQFPDEVPLSPEAKDLIKRLC--CEAERR 284

Query: 309 RKRGTVEELLAYPFV 323
                V E+ ++PF 
Sbjct: 285 LGNNGVNEIKSHPFF 299

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score =  101 bits (252), Expect = 6e-25
 Identities = 71/229 (31%), Positives = 108/229 (47%), Gaps = 20/229 (8%)

Query: 95  EAEILKRLDSQFIVKCHAVFYT-IEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAY 153
           E ++LK L  + IV+ +       E  +   ME+M  GS+ D L+    L+E V      
Sbjct: 54  EIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTR 113

Query: 154 RVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNI 213
           ++L+G+ YLH   I+H DIK +N+L +  G VK+ DFG S+ ++    +           
Sbjct: 114 QILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMS----------- 162

Query: 214 GEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDL 273
           G    +  GT  +MSPE +  E     YG   DVWSLG  V+E L    P   + E   +
Sbjct: 163 GTGIRSVTGTPYWMSPEVISGE----GYGRKADVWSLGCTVVEMLTEKPP---WAEYEAM 215

Query: 274 MALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPF 322
            A+          ++P   S   R F+  C+  + R R + EELL +PF
Sbjct: 216 AAIFKIATQPTNPQLPSHISEHARDFLG-CIFVEARHRPSAEELLRHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score =  102 bits (256), Expect = 8e-25
 Identities = 84/285 (29%), Positives = 133/285 (46%), Gaps = 32/285 (11%)

Query: 48  DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAA---HEAEILKRLDS 104
           D   + V+G G  G V  VRH+ S  +YA+K+L +    I R  +A    E +I+   +S
Sbjct: 44  DYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLL-SKFEMIKRSDSAFFWEERDIMAFANS 102

Query: 105 QFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG 164
            ++V+    F   +  +  VME+M  G L + L     + E         V+  L  +H 
Sbjct: 103 PWVVQLFCAFQD-DKYLYMVMEYMPGGDLVN-LMSNYDVPEKWAKFYTAEVVLALDAIHS 160

Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIAC---M 221
           M +IH D+KP N+L++  G +K+ADFG    ++ET                  + C   +
Sbjct: 161 MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDET----------------GMVRCDTAV 204

Query: 222 GTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIG---FGEKPDLMALIC 278
           GT  Y+SPE + S+   G YG   D WS+GV + E LVG  P       G    +M    
Sbjct: 205 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKN 264

Query: 279 AICFGERLEMPETASPEFRRFVRSCLEKDWR-KRGTVEELLAYPF 322
           ++ F E +E+ + A      F+    +++ R  R  VEE+  +PF
Sbjct: 265 SLNFPEDVEISKHAKNLICAFLT---DREVRLGRNGVEEIKQHPF 306

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score =  102 bits (255), Expect = 8e-25
 Identities = 65/221 (29%), Positives = 105/221 (47%), Gaps = 26/221 (11%)

Query: 54  VLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQ-----FIV 108
           VLG G+ G V     + ++ +YA+KVL      I++          KR+ +      F+ 
Sbjct: 2   VLGKGSFGKVLLAELKGTDELYAVKVLK--KDVILQDDDVECTMTEKRVLALAGKHPFLT 59

Query: 109 KCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQII 168
           + H+ F T +  + FVME++  G L   ++   +  E      A  ++ GLQ+LH   II
Sbjct: 60  QLHSCFQTKD-RLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGII 118

Query: 169 HGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMS 228
           + D+K  N+L++ +G +KIADFG+ +  E        +             C GT  Y++
Sbjct: 119 YRDLKLDNVLLDSEGHIKIADFGMCK--EGILGGVTTST-----------FC-GTPDYIA 164

Query: 229 PERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGE 269
           PE +  +     YG A D W+LGV++ E L G  P  G  E
Sbjct: 165 PEILSYQ----PYGPAVDWWALGVLLYEMLAGQSPFEGDDE 201

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score =  100 bits (250), Expect = 2e-24
 Identities = 85/288 (29%), Positives = 133/288 (46%), Gaps = 33/288 (11%)

Query: 52  LTVLGHGNGGIVYKVRH---QKSNSIYALKVLNTTSSTIIRHQAAH---EAEILKRL-DS 104
           L VLG G  G V+ VR      S  +YA+KVL   +         H   E ++L+ +  S
Sbjct: 5   LKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQS 64

Query: 105 QFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG 164
            F+V  H  F T + ++  +++++  G LF  L  R++  E  +   +  ++  L++LH 
Sbjct: 65  PFLVTLHYAFQT-DTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHK 123

Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTC 224
           + II+ DIK  N+L++  G V + DFG+S+   E                E A +  GT 
Sbjct: 124 LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV-------------ERAYSFCGTI 170

Query: 225 AYMSPERVDSERWGGDYGF--AGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICF 282
            YM+P+ V     GGD G   A D WS+GV++ E L G  P    GEK +  A I     
Sbjct: 171 EYMAPDIVR----GGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK-NSQAEISRRIL 225

Query: 283 GERLEMPETASPEFRRFVRSCLEKDWRKR-----GTVEELLAYPFVTK 325
                 P+  S   +  ++  L KD +KR        +E+  +PF  K
Sbjct: 226 KSEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQK 273

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score =  101 bits (252), Expect = 2e-24
 Identities = 79/288 (27%), Positives = 133/288 (46%), Gaps = 32/288 (11%)

Query: 48  DLKKLTVLGHGNGGIVYKVRH---QKSNSIYALKVLNTTSSTIIRHQAAH---EAEILKR 101
           + + L VLG G  G V+ VR      +  +YA+KVL   +         H   E  +L+ 
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60

Query: 102 L-DSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQ 160
           +  S F+V  H  F T E ++  +++++  G +F  L  R   SED +   +  ++  L+
Sbjct: 61  VRQSPFLVTLHYAFQT-EAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALE 119

Query: 161 YLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSR-IVEETRNNNNHNNNNNNNIGEAAIA 219
           +LH + I++ DIK  N+L++ +G V + DFG+S+  + E +              E   +
Sbjct: 120 HLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEK--------------ERTYS 165

Query: 220 CMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICA 279
             GT  YM+PE +  +   G +G A D WSLG+++ E L G  P    GE+ +  + +  
Sbjct: 166 FCGTIEYMAPEIIRGK---GGHGKAVDWWSLGILIFELLTGASPFTLEGER-NTQSEVSR 221

Query: 280 ICFGERLEMPETASPEFRRFVRSCLEKDWRKR-----GTVEELLAYPF 322
                    P    PE +  +   L KD +KR         E+  +PF
Sbjct: 222 RILKCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPF 269

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  100 bits (250), Expect = 2e-24
 Identities = 59/219 (26%), Positives = 99/219 (45%), Gaps = 38/219 (17%)

Query: 52  LTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSS------TIIRHQAAHEAEILKRLDSQ 105
           L  +G G  G VYK R   +    ALK +    S      + +R     E  +LK+L+S 
Sbjct: 4   LAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLR-----EIALLKQLESF 58

Query: 106 ---FIVKCHAVFYTIEGE----ICFVMEHMERG-SLFDSLRVRKKLSEDVISGVAYRVLK 157
               IV+   V +    +    +  V EH+++  + + S   +  L  + I  +  ++L+
Sbjct: 59  EHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLR 118

Query: 158 GLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAA 217
           G+ +LH  +I+H D+KP N+L+   G+VKIADFG++RI                    A 
Sbjct: 119 GVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEM---------------AL 163

Query: 218 IACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLE 256
            + + T  Y +PE +        Y    D+WS+G +  E
Sbjct: 164 TSVVVTLWYRAPEVL----LQSSYATPVDMWSVGCIFAE 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 99.9 bits (249), Expect = 3e-24
 Identities = 74/279 (26%), Positives = 130/279 (46%), Gaps = 34/279 (12%)

Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQ----AAHEAEILKRLDSQFIVKC 110
           LG G  G V   + + +  +YA K L+     + + +    A +E +IL+++ S+FIV  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLD--KKRLKKRKGEQMALNEKKILEKVSSRFIV-S 57

Query: 111 HAVFYTIEGEICFVMEHMERGSL-FDSLRVRKK-LSEDVISGVAYRVLKGLQYLHGMQII 168
            A  +  + ++C VM  M  G L +    V +    E      A +++ GL++LH  +I+
Sbjct: 58  LAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIV 117

Query: 169 HGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMS 228
           + D+KP N+L++  G V+I+D G++  ++                G+      GT  YM+
Sbjct: 118 YRDLKPENVLLDDHGNVRISDLGLAVELKG---------------GKKIKGRAGTPGYMA 162

Query: 229 PERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEM 288
           PE +  E     Y F+ D ++LG  + E + G  P     EK +   L         +E 
Sbjct: 163 PEVLQGEV----YDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRT-LEMAVEY 217

Query: 289 PETASPEFRRFVRSCLEKDWRKR-----GTVEELLAYPF 322
           P+  SPE +    + L+KD  KR     G+ +E+  +P 
Sbjct: 218 PDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPL 256

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score =  100 bits (250), Expect = 3e-24
 Identities = 85/319 (26%), Positives = 122/319 (38%), Gaps = 55/319 (17%)

Query: 45  NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALK-VLNTTSSTIIRHQAAHEAEILKRLD 103
            + D + L  LG G  G VYK R  K+  + ALK +L           A  E +ILK+L 
Sbjct: 6   KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLK 65

Query: 104 SQFIVKC--------------HAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVIS 149
              +V                    Y +       M+H   G L ++  V  KL+E  I 
Sbjct: 66  HPNVVPLIDMAVERPDKSKRKRGSVYMVT----PYMDHDLSG-LLENPSV--KLTESQIK 118

Query: 150 GVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNN 209
               ++L+G+ YLH   I+H DIK +N+LI+ +G +KIADFG++R  +    N       
Sbjct: 119 CYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGG 178

Query: 210 NNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGE 269
                      + T  Y  PE +  ER    Y  A D+W +G V  E       L G  +
Sbjct: 179 G---TRKYTNLVVTRWYRPPELLLGER---RYTTAVDIWGIGCVFAEMFTRRPILQGKSD 232

Query: 270 KPDLMALICAIC----------------------FGE---RLEMP-ETASPEFRRFVRSC 303
             D + LI  +C                      F      LE       PE    +   
Sbjct: 233 I-DQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKL 291

Query: 304 LEKDWRKRGTVEELLAYPF 322
           L  D  KR T  + L +P+
Sbjct: 292 LSLDPYKRLTASDALEHPY 310

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 98.9 bits (246), Expect = 6e-24
 Identities = 80/286 (27%), Positives = 134/286 (46%), Gaps = 31/286 (10%)

Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVF 114
           +G G+ GIV     + S  + A+K ++       R    +E  I++    + +V+ +   
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQR-RELLFNEVVIMRDYQHENVVEMYNS- 85

Query: 115 YTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKP 174
           Y +  E+  VME +E G+L D +    +++E+ I+ V   VLK L  LH   +IH DIK 
Sbjct: 86  YLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKS 144

Query: 175 SNLLINGKGEVKIADFG----VSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPE 230
            ++L+   G VK++DFG    VS+ V   +                  + +GT  +M+PE
Sbjct: 145 DSILLTHDGRVKLSDFGFCAQVSKEVPRRK------------------SLVGTPYWMAPE 186

Query: 231 RVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPE 290
            +    +G +     D+WSLG++V+E + G  P   F E P     +       +L+   
Sbjct: 187 LISRLPYGPEV----DIWSLGIMVIEMVDGEPPY--FNEPPLKAMKMIRDNLPPKLKNLH 240

Query: 291 TASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNIEGLI 336
             SP  + F+   L +D  +R T  ELL +PF+ K    S I  L+
Sbjct: 241 KVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPSCIVPLM 286

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 98.7 bits (246), Expect = 8e-24
 Identities = 75/241 (31%), Positives = 119/241 (49%), Gaps = 37/241 (15%)

Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNT-----TSSTIIRHQAAHEAEILKRLDS 104
           K+L  LG G    VYK R++ +  I ALK ++      T ST IR     E  ++K L  
Sbjct: 3   KQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIR-----EISLMKELKH 57

Query: 105 QFIVKCHAVFYTIEGEICFVMEHMERG--SLFDSLRVRKKLSEDVISGVAYRVLKGLQYL 162
           + IV+ H V +T E ++  V E+M++      D+  VR  L  + +    Y++LKG+ + 
Sbjct: 58  ENIVRLHDVIHT-ENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFC 116

Query: 163 HGMQIIHGDIKPSNLLINGKGEVKIADFGVSR---IVEETRNNNNHNNNNNNNIGEAAIA 219
           H  +++H D+KP NLLIN +GE+K+ADFG++R   I   T +N                 
Sbjct: 117 HENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNE---------------- 160

Query: 220 CMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICA 279
            + T  Y +P+ +   R    Y  + D+WS+G ++ E + G  PL       D +  I  
Sbjct: 161 -VVTLWYRAPDVLLGSR---TYSTSIDIWSVGCIMAEMITG-RPLFPGTNNEDQLLKIFR 215

Query: 280 I 280
           I
Sbjct: 216 I 216

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 98.0 bits (244), Expect = 8e-24
 Identities = 70/277 (25%), Positives = 127/277 (45%), Gaps = 28/277 (10%)

Query: 51  KLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-STIIRHQAAHEAEILKRLDSQFIVK 109
           K+  +G G+ G    V+ ++    Y +K +N +  S   R ++  E  +L  +    IV+
Sbjct: 4   KVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQ 63

Query: 110 CHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKL--SEDVISGVAYRVLKGLQYLHGMQI 167
               F    G +  VM++ E G L+  +  ++ +   ED I     ++   L+++H  +I
Sbjct: 64  YQESFEEN-GNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKI 122

Query: 168 IHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYM 227
           +H DIK  N+ +   G +K+ DFG++R++              N+  E A  C+GT  Y+
Sbjct: 123 LHRDIKSQNIFLTKDGTIKLGDFGIARVL--------------NSTVELARTCIGTPYYL 168

Query: 228 SPERVDSERWGGDYGFAGDVWSLGVVVLE-CLVGHYPLIGFGEKPDLMALICAICFGERL 286
           SPE  ++      Y    D+W+LG V+ E C + H     F E  ++  L+  I  G   
Sbjct: 169 SPEICENR----PYNNKSDIWALGCVLYEMCTLKH----AF-EAGNMKNLVLKIIRGSYP 219

Query: 287 EMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV 323
            +    S + R  V    +++ R R +V  +L   F+
Sbjct: 220 PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 99.0 bits (247), Expect = 1e-23
 Identities = 73/252 (28%), Positives = 117/252 (46%), Gaps = 40/252 (15%)

Query: 41  PDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSS------TIIRHQAAH 94
               ++++ +KL  +G G  GIVY+ R   S  I ALK +   +       + +R     
Sbjct: 1   GRCRSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLR----- 55

Query: 95  EAEILKRLDSQFIVKCHAVFYTIEGE----ICFVMEHMER--GSLFDSLRVRKKLSEDVI 148
           E  +L  L    IV+   V   + G+    I  VME+ E+   SL D+  +    SE  +
Sbjct: 56  EITLLLNLRHPNIVELKEV---VVGKHLDSIFLVMEYCEQDLASLLDN--MPTPFSESQV 110

Query: 149 SGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNN 208
             +  ++L+GLQYLH   IIH D+K SNLL+  KG +KIADFG++R              
Sbjct: 111 KCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYG----------- 159

Query: 209 NNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFG 268
                 +     + T  Y +PE +        Y  A D+W++G ++ E L+ H PL+   
Sbjct: 160 ---LPAKPMTPKVVTLWYRAPELLLGCT---TYTTAIDMWAVGCILAE-LLAHKPLLPGK 212

Query: 269 EKPDLMALICAI 280
            + + + LI  +
Sbjct: 213 SEIEQLDLIIQL 224

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 97.8 bits (243), Expect = 1e-23
 Identities = 81/283 (28%), Positives = 122/283 (43%), Gaps = 33/283 (11%)

Query: 48  DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVL--------NTTSSTIIRHQAAHEAEIL 99
           D + +  +G G  G VYK R+  +  + A+KV+              II  +    + I+
Sbjct: 10  DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIV 69

Query: 100 KRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGL 159
               S          Y    ++   ME    GSL D   V   LSE  I+ V+   L+GL
Sbjct: 70  AYFGS----------YLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGL 119

Query: 160 QYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIA 219
            YLH    +H DIK +N+L+   G VK+ADFGVS  +  T                   +
Sbjct: 120 YYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRK--------------S 165

Query: 220 CMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICA 279
            +GT  +M+PE    ER GG Y    D+W++G+  +E      P+        L  +  +
Sbjct: 166 FIGTPYWMAPEVAAVERKGG-YNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKS 224

Query: 280 ICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPF 322
                +L+     S  F  FV+  L K+ +KR T E+LL +PF
Sbjct: 225 NFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 98.6 bits (245), Expect = 2e-23
 Identities = 76/262 (29%), Positives = 118/262 (45%), Gaps = 29/262 (11%)

Query: 54  VLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH---EAEILKRLDSQFIVKC 110
           +LG G  G V  V+ + +   YA+K+L      + + + AH   E  +L+     F+   
Sbjct: 2   LLGKGTFGKVILVKEKATGRYYAMKILKK-EVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60

Query: 111 HAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG-MQIIH 169
              F T    +CFVME+   G LF  L   +  SED        ++  L YLH    +++
Sbjct: 61  KYSFQT-HDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVY 119

Query: 170 GDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSP 229
            D+K  NL+++  G +KI DFG+ +  E  ++            G       GT  Y++P
Sbjct: 120 RDLKLENLMLDKDGHIKITDFGLCK--EGIKD------------GATMKTFCGTPEYLAP 165

Query: 230 ERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMP 289
           E ++      DYG A D W LGVV+ E + G  P     +   L  LI      E +  P
Sbjct: 166 EVLEDN----DYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILM----EEIRFP 216

Query: 290 ETASPEFRRFVRSCLEKDWRKR 311
            T SPE +  +   L+KD ++R
Sbjct: 217 RTLSPEAKSLLSGLLKKDPKQR 238

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 97.4 bits (242), Expect = 3e-23
 Identities = 92/299 (30%), Positives = 140/299 (46%), Gaps = 42/299 (14%)

Query: 47  SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQF 106
           SDL+++   GHG+ G VY  R  +++ + A+K ++ +     +       +I+K +  +F
Sbjct: 18  SDLREI---GHGSFGAVYFARDVRNSEVVAIKKMSYSG----KQSNEKWQDIIKEV--RF 68

Query: 107 IVKCHAVFYTIEGEICFVMEH-----MER--GSLFDSLRVRKK-LSEDVISGVAYRVLKG 158
           + K      TI+   C++ EH     ME   GS  D L V KK L E  I+ V +  L+G
Sbjct: 69  LQKLRHP-NTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQG 127

Query: 159 LQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAI 218
           L YLH   +IH D+K  N+L++  G VK+ DFG + I+                    A 
Sbjct: 128 LAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM------------------APAN 169

Query: 219 ACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALIC 278
             +GT  +M+PE + +    G Y    DVWSLG+  +E      PL       + M+ + 
Sbjct: 170 XFVGTPYWMAPEVILAMD-EGQYDGKVDVWSLGITCIELAERKPPLFNM----NAMSALY 224

Query: 279 AICFGERLEMPETA-SPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNIEGLI 336
            I   E   +     S  FR FV SCL+K  + R T E LL + FV +    + I  LI
Sbjct: 225 HIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLI 283

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 97.6 bits (243), Expect = 3e-23
 Identities = 73/263 (27%), Positives = 119/263 (45%), Gaps = 29/263 (11%)

Query: 53  TVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH-EAE---ILKRLDSQFIV 108
            V+G G+ G V   +H+     YA+KVL    + + + +  H  AE   +LK +   F+V
Sbjct: 1   KVIGKGSFGKVLLAKHKADGKFYAVKVLQK-KAILKKKEQKHIMAERNVLLKNVKHPFLV 59

Query: 109 KCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQII 168
             H  F T + ++ FV++++  G LF  L+  +   E      A  +   L YLH + II
Sbjct: 60  GLHYSFQTAD-KLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNII 118

Query: 169 HGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMS 228
           + D+KP N+L++ +G V + DFG+ +  E   ++              +  C GT  Y++
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGLCK--EGIEHS-----------KTTSTFC-GTPEYLA 164

Query: 229 PERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEM 288
           PE +  +     Y    D W LG V+ E L G  P   F  + D   +   I   + L +
Sbjct: 165 PEVLRKQ----PYDRTVDWWCLGAVLYEMLYGLPP---FYSR-DTAEMYDNI-LNKPLRL 215

Query: 289 PETASPEFRRFVRSCLEKDWRKR 311
               S   R  +   L+KD  KR
Sbjct: 216 KPNISVSARHLLEGLLQKDRTKR 238

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 98.2 bits (244), Expect = 3e-23
 Identities = 87/307 (28%), Positives = 139/307 (45%), Gaps = 45/307 (14%)

Query: 48  DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH---EAEILKRLDS 104
           D + L V+G G  G V  V+ + +  IYA+K+L   +  + + Q AH   E +IL   D 
Sbjct: 2   DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRK-ADMLEKEQVAHIRAERDILVEADG 60

Query: 105 QFIVKCHAVFYTIEGE--ICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYL 162
            ++VK   +FY+ + +  +  +ME +  G +   L  +  LSE+         +  +  +
Sbjct: 61  AWVVK---MFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAI 117

Query: 163 HGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVE-----ETRNNNNHN--------NNN 209
           H +  IH DIKP NLL++ KG VK++DFG+   ++     E   N  HN        N N
Sbjct: 118 HQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMN 177

Query: 210 NNNIGEA--------AIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGH 261
           +    E         A + +GT  Y++PE          Y    D WSLGV++ E L+G+
Sbjct: 178 SKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQT----GYNKLCDWWSLGVIMYEMLIGY 233

Query: 262 YPLIGFGEKPD-----LMALICAICFGERLEMPETASPEFRRFVRSCLEKDWR-KRGTVE 315
            P     E P      +M     + F   + + E A     RF   C + + R     VE
Sbjct: 234 PPFC--SETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRF---CTDSENRIGSNGVE 288

Query: 316 ELLAYPF 322
           E+ ++PF
Sbjct: 289 EIKSHPF 295

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 96.6 bits (240), Expect = 6e-23
 Identities = 85/285 (29%), Positives = 127/285 (44%), Gaps = 49/285 (17%)

Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIR--HQAAHEAEILKRLDSQFIVKCHA 112
           +GHG+ G VY   +  +N + A+K ++ +             E + L++L          
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHP------- 81

Query: 113 VFYTIEGEICFVMEH-----MER--GSLFDSLRVRKK-LSEDVISGVAYRVLKGLQYLHG 164
              TIE + C++ EH     ME   GS  D L V KK L E  I+ + +  L+GL YLH 
Sbjct: 82  --NTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS 139

Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTC 224
             +IH DIK  N+L+   G+VK+ADFG +                       A + +GT 
Sbjct: 140 HNMIHRDIKAGNILLTEPGQVKLADFGSASKS------------------SPANSFVGTP 181

Query: 225 AYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGE 284
            +M+PE + +    G Y    DVWSLG+  +E      PL         M  + A+    
Sbjct: 182 YWMAPEVILAMD-EGQYDGKVDVWSLGITCIELAERKPPLFN-------MNAMSALYHIA 233

Query: 285 RLEMPETASPE----FRRFVRSCLEKDWRKRGTVEELLAYPFVTK 325
           + + P   S E    FR FV  CL+K  ++R    ELL + FV +
Sbjct: 234 QNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRR 278

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 96.3 bits (239), Expect = 1e-22
 Identities = 74/267 (27%), Positives = 130/267 (48%), Gaps = 30/267 (11%)

Query: 54  VLGHGNGGIVYKVRHQKSNSIYALKVL-----NTTSSTIIRHQAAHEAEILKRLDSQFIV 108
           V+G G+   V  VR +K+  IYA+KV+     N            H  E  +  +  F+V
Sbjct: 2   VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFE--QASNHPFLV 59

Query: 109 KCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQII 168
             H+ F T E  + FV+E++  G L   ++ ++KL E+     +  +   L YLH   II
Sbjct: 60  GLHSCFQT-ESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGII 118

Query: 169 HGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMS 228
           + D+K  N+L++ +G +K+ D+G+ +  E  R             G+      GT  Y++
Sbjct: 119 YRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRP------------GDTTSTFCGTPNYIA 164

Query: 229 PERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYP--LIGFGEKPDLMA--LICAICFGE 284
           PE +  E    DYGF+ D W+LGV++ E + G  P  ++G  + PD      +  +   +
Sbjct: 165 PEILRGE----DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK 220

Query: 285 RLEMPETASPEFRRFVRSCLEKDWRKR 311
           ++ +P + S +    ++S L KD ++R
Sbjct: 221 QIRIPRSLSVKAASVLKSFLNKDPKER 247

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 95.5 bits (237), Expect = 1e-22
 Identities = 82/300 (27%), Positives = 143/300 (47%), Gaps = 47/300 (15%)

Query: 49  LKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIV 108
           L+    +G G+ GIV   R + S    A+K+++       R    +E  I++    Q +V
Sbjct: 23  LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQR-RELLFNEVVIMRDYQHQNVV 81

Query: 109 KCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQII 168
           + +   Y +  E+  +ME ++ G+L D +  + +L+E+ I+ V   VL+ L YLH   +I
Sbjct: 82  EMYKS-YLVGEELWVLMEFLQGGALTDIVS-QTRLNEEQIATVCESVLQALCYLHSQGVI 139

Query: 169 HGDIKPSNLLINGKGEVKIADFG----VSRIVEETRNNNNHNNNNNNNIGEAAIACMGTC 224
           H DIK  ++L+   G VK++DFG    +S+ V + +                  + +GT 
Sbjct: 140 HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK------------------SLVGTP 181

Query: 225 AYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGE 284
            +M+PE +        YG   D+WSLG++V+E + G  P   F + P     + A+   +
Sbjct: 182 YWMAPEVISRT----PYGTEVDIWSLGIMVIEMVDGEPPY--FSDSP-----VQAM---K 227

Query: 285 RL--EMPETA------SPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNIEGLI 336
           RL    P         SP  R F+   L ++ ++R T +ELL +PF+ +      +  LI
Sbjct: 228 RLRDSPPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTGLPECLVPLI 287

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 95.5 bits (238), Expect = 2e-22
 Identities = 74/228 (32%), Positives = 102/228 (44%), Gaps = 41/228 (17%)

Query: 52  LTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILK----------R 101
           L VLG G+ G V    ++K+  +YA+K L      II   A  E E L            
Sbjct: 4   LAVLGRGHFGKVLLAEYKKTGELYAIKALK--KGDII---ARDEVESLMCEKRIFETANS 58

Query: 102 LDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQY 161
               F+V   A F T E  +CFVME+   G L   +      SE      A  V+ GLQY
Sbjct: 59  ERHPFLVNLFACFQT-EDHVCFVMEYAAGGDLMMHIH-TDVFSEPRAVFYAACVVLGLQY 116

Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIG---EAAI 218
           LH  +I++ D+K  NLL++ +G VKIADFG+ +                  +G     + 
Sbjct: 117 LHENKIVYRDLKLDNLLLDTEGFVKIADFGLCK----------------EGMGFGDRTST 160

Query: 219 ACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIG 266
            C GT  +++PE +        Y  A D W LGV++ E LVG  P  G
Sbjct: 161 FC-GTPEFLAPEVLTETS----YTRAVDWWGLGVLIYEMLVGESPFPG 203

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 95.6 bits (238), Expect = 2e-22
 Identities = 78/280 (27%), Positives = 127/280 (45%), Gaps = 42/280 (15%)

Query: 54  VLGHGNGGIVYKVRHQKSNSIYALKVL--------NTTSSTIIRHQAAHEAEILKRLDSQ 105
           VLG G+ G V     + +N  +A+K L        +    T++      E  +L  L  +
Sbjct: 2   VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMV------ERRVLA-LAWE 54

Query: 106 FIVKCHAVFYTIEGE--ICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLH 163
                H +F T + +  + FVME++  G L   ++   +  E      A  ++ GLQ+LH
Sbjct: 55  HPFLTH-LFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLH 113

Query: 164 GMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGT 223
              II+ D+K  N+L++  G +KIADFG+ +              N N  G+A+  C GT
Sbjct: 114 KKGIIYRDLKLDNVLLDKDGHIKIADFGMCK-------------ENMNGEGKASTFC-GT 159

Query: 224 CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFG 283
             Y++PE +  ++    Y  + D WS GV++ E L+G  P  G  E  +L   I      
Sbjct: 160 PDYIAPEILKGQK----YNESVDWWSFGVLLYEMLIGQSPFHGEDED-ELFDSILN---- 210

Query: 284 ERLEMPETASPEFRRFVRSCLEKDWRKR-GTVEELLAYPF 322
           +R   P   S E +  +    E+D  KR G   ++  +PF
Sbjct: 211 DRPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPF 250

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 93.9 bits (233), Expect = 3e-22
 Identities = 72/270 (26%), Positives = 118/270 (43%), Gaps = 34/270 (12%)

Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHA 112
           +G G    VY+          ALK +          R     E ++LK+L+   ++K +A
Sbjct: 10  IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 69

Query: 113 VFYTIEGEICFVMEHMERGSLFDSLRVRKK----LSEDVISGVAYRVLKGLQYLHGMQII 168
            F   + E+  V+E  + G L   ++  KK    + E  +     ++   L+++H  +++
Sbjct: 70  SFIE-DNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVM 128

Query: 169 HGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMS 228
           H DIKP+N+ I   G VK+ D G+ R                     AA + +GT  YMS
Sbjct: 129 HRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--------------AAHSLVGTPYYMS 174

Query: 229 PERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEM 288
           PER+        Y F  D+WSLG ++ E      P   +G+K +L +L   I   E+ + 
Sbjct: 175 PERIHEN----GYNFKSDIWSLGCLLYEMAALQSPF--YGDKMNLYSLCKKI---EQCDY 225

Query: 289 P----ETASPEFRRFVRSCLEKDWRKRGTV 314
           P    +  S E R+ V  C+  D  KR  +
Sbjct: 226 PPLPSDHYSEELRQLVNMCINPDPEKRPDI 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 93.9 bits (233), Expect = 3e-22
 Identities = 82/276 (29%), Positives = 125/276 (45%), Gaps = 26/276 (9%)

Query: 54  VLGHGNGGIVYKVRHQKSNSIYALKVL--NTTSSTIIRHQAAHEAEI--LKRLDSQFIVK 109
           +LG G  G VY      +    A+K +  +  S    +   A E EI  LK L  + IV+
Sbjct: 9   LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68

Query: 110 CHAVFY-TIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQII 168
            +      +E  +   MEHM  GS+ D L+    L+E+V      ++L+G+ YLH   I+
Sbjct: 69  YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIV 128

Query: 169 HGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMS 228
           H DIK +N+L +  G VK+ DFG S+ ++    +           G    +  GT  +MS
Sbjct: 129 HRDIKGANILRDSVGNVKLGDFGASKRLQTICLS-----------GTGMKSVTGTPYWMS 177

Query: 229 PERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFG-ERLE 287
           PE +  E     YG   D+WS+G  V+E L    P   F    + MA I  I        
Sbjct: 178 PEVISGE----GYGRKADIWSVGCTVVEMLTEKPPWAEF----EAMAAIFKIATQPTNPV 229

Query: 288 MPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV 323
           +P   S   R F++     + + R + +ELL + FV
Sbjct: 230 LPPHVSDHCRDFLKRIF-VEAKLRPSADELLRHTFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 93.9 bits (233), Expect = 3e-22
 Identities = 69/231 (29%), Positives = 111/231 (48%), Gaps = 22/231 (9%)

Query: 95  EAEILKRLDSQFIVKCHAVFYT-IEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAY 153
           E ++LK L    IV+ +       E ++   +E+M  GS+ D L+    L+E+V      
Sbjct: 54  EIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTR 113

Query: 154 RVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNI 213
           ++L+G+ YLH   I+H DIK +N+L +  G VK+ DFG S+ ++    +           
Sbjct: 114 QILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMS----------- 162

Query: 214 GEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDL 273
           G    +  GT  +MSPE +  E     YG   DVWS+   V+E L    P   +    + 
Sbjct: 163 GTGIKSVTGTPYWMSPEVISGE----GYGRKADVWSVACTVVEMLTEKPPWAEY----EA 214

Query: 274 MALICAICFG-ERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV 323
           MA I  I     +  +P+  S   R F++    ++ ++R T E LL +PFV
Sbjct: 215 MAAIFKIATQPTKPMLPDGVSDACRDFLKQIFVEE-KRRPTAEFLLRHPFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 94.0 bits (234), Expect = 4e-22
 Identities = 82/312 (26%), Positives = 132/312 (42%), Gaps = 73/312 (23%)

Query: 52  LTVLGHGNGGIVYKVRHQKSNSIYALKV-LNTTSSTIIRHQAAHEAEILKRLDSQFIV-- 108
           L ++G G+ G+V K +H+++  I A+K  L +    +++  A  E  +LK+L  + +V  
Sbjct: 6   LGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNL 65

Query: 109 --------KCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQ 160
                   + + VF  ++  +   +E    G   D  RVRK L         +++L+G++
Sbjct: 66  IEVFRRKKRLYLVFEFVDHTVLDDLEKYPNG--LDESRVRKYL---------FQILRGIE 114

Query: 161 YLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIAC 220
           + H   IIH DIKP N+L++  G VK+ DFG +R +                 GE     
Sbjct: 115 FCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTL--------------AAPGEVYTDY 160

Query: 221 MGTCAYMSPERVDSERWGGD--YGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALIC 278
           + T  Y +PE +      GD  YG A D+W++G +V E L G  PL       D +  I 
Sbjct: 161 VATRWYRAPELL-----VGDTKYGRAVDIWAVGCLVTEMLTGE-PLFPGDSDIDQLYHI- 213

Query: 279 AICFGE------------------RLEMPETASPEFRRF----------VRSCLEKDWRK 310
             C G                   RL   +   P  +RF           + CL  D   
Sbjct: 214 IKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDD 273

Query: 311 RGTVEELLAYPF 322
           R +  +LL + F
Sbjct: 274 RPSSSQLLHHEF 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 95.3 bits (237), Expect = 4e-22
 Identities = 84/320 (26%), Positives = 136/320 (42%), Gaps = 55/320 (17%)

Query: 48  DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH---EAEILKRLDS 104
           D   + V+G G  G V  V+ + +  IYA+K L   S    + Q AH   E ++L   DS
Sbjct: 2   DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTL-LKSEMFKKDQLAHVKAERDVLAESDS 60

Query: 105 QFIVKCHAVFYTIEGE--ICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYL 162
            ++V    ++Y+ +    +  +ME +  G L   L      SEDV        +  ++ +
Sbjct: 61  PWVVS---LYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAV 117

Query: 163 HGMQIIHGDIKPSNLLINGKGEVKIADFGVS-------------RIVEETRNNNNHNNNN 209
           H +  IH DIKP N+LI+  G +K++DFG+S             ++++   N N  +N N
Sbjct: 118 HKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRN 177

Query: 210 NNNIGE--------------------AAIACMGTCAYMSPERVDSERWGGDYGFAGDVWS 249
           +  +                       A + +GT  Y++PE          YG   D WS
Sbjct: 178 SVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIF----LQQGYGQECDWWS 233

Query: 250 LGVVVLECLVGHYPLIGFGEKP-DLMALICAICFGERLEMPE--TASPEFRRFVRSCL-E 305
           LG ++ ECL+G  P     E   +    I  I + E L  P+    S E    +R  +  
Sbjct: 234 LGAIMFECLIGWPPFC--SENSHETYRKI--INWRETLYFPDDIHLSVEAEDLIRRLITN 289

Query: 306 KDWR-KRGTVEELLAYPFVT 324
            + R  RG   E+ ++PF  
Sbjct: 290 AENRLGRGGAHEIKSHPFFR 309

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 93.2 bits (232), Expect = 5e-22
 Identities = 68/292 (23%), Positives = 122/292 (41%), Gaps = 41/292 (14%)

Query: 47  SDLKKLTVLGHGNGGIVYK-----VRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKR 101
             +  +  LG G+ G+VY+     V   +  +  A+K +N  +S   R +  +EA ++K 
Sbjct: 6   EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKE 65

Query: 102 LDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGV---------- 151
            +   +V+   V  T       VME M +G L   LR R+   E   +            
Sbjct: 66  FNCHHVVRLLGVVST-GQPTLVVMELMAKGDLKSYLRSRR--PEAENNPGLGPPTLQKFI 122

Query: 152 --AYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNN 209
             A  +  G+ YL   + +H D+   N ++     VKI DFG++R + ET        + 
Sbjct: 123 QMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYET--------DY 174

Query: 210 NNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLE-CLVGHYPLIGFG 268
               G+  +       +M+PE +      G +    DVWS GVV+ E   +   P  G  
Sbjct: 175 YRKGGKGLLPVR----WMAPESLKD----GVFTTKSDVWSFGVVLWEMATLAEQPYQGLS 226

Query: 269 EKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY 320
            + +++  +     G  L++PE    +    +R C + + + R T  E+++ 
Sbjct: 227 NE-EVLKFVID---GGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSS 274

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 93.1 bits (231), Expect = 6e-22
 Identities = 71/276 (25%), Positives = 125/276 (45%), Gaps = 27/276 (9%)

Query: 52  LTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAA-HEAEILKRLDSQFIVKC 110
           +  +G G+ G +Y  + +  +    +K ++ T   +   +A+  E  +L ++    IV  
Sbjct: 5   IKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTF 64

Query: 111 HAVFYTIEGEICFVMEHMERGSLFDSLRVRKKL--SEDVISGVAYRVLKGLQYLHGMQII 168
            A F    G +  VME+ + G L   +  ++ +  SED I     ++  GL+++H  +I+
Sbjct: 65  FASFQE-NGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKIL 123

Query: 169 HGDIKPSNLLINGKGEV-KIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYM 227
           H DIK  N+ ++  G V K+ DFG++R +              N+  E A  C+GT  Y+
Sbjct: 124 HRDIKSQNIFLSKNGMVAKLGDFGIARQL--------------NDSMELAYTCVGTPYYL 169

Query: 228 SPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLE 287
           SPE   +      Y    D+WSLG V+ E     +P     E  +L  L+  IC G    
Sbjct: 170 SPEICQNR----PYNNKTDIWSLGCVLYELCTLKHPF----EGNNLHQLVLKICQGYFAP 221

Query: 288 MPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV 323
           +    S + R  +    +   R R ++  +L  PF+
Sbjct: 222 ISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 93.4 bits (232), Expect = 6e-22
 Identities = 84/295 (28%), Positives = 128/295 (43%), Gaps = 64/295 (21%)

Query: 54  VLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQ----AAHEAEILKRLDSQFIVK 109
           VLG G  G V   + + +  +YA K L      I + +    A +E +IL++++S+F+V 
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKKLE--KKRIKKRKGEAMALNEKQILEKVNSRFVVS 64

Query: 110 CHAVFYTIEGEICFVMEHMERGSL-----------FDSLRVRKKLSEDVISGVAYRVLKG 158
             A  Y  +  +C V+  M  G L           FD  R     +E         +  G
Sbjct: 65  L-AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAE---------ITCG 114

Query: 159 LQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAI 218
           L+ LH  +I++ D+KP N+L++  G ++I+D G++  + E               GE   
Sbjct: 115 LEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPE---------------GETIR 159

Query: 219 ACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALIC 278
             +GT  YM+PE V +ER    Y F+ D W LG ++ E + G  P     EK     +  
Sbjct: 160 GRVGTVGYMAPEVVKNER----YTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEV-- 213

Query: 279 AICFGERL--EMPETASPEFRRFVRS-C---LEKDWRKR-----GTVEELLAYPF 322
                ER   E  E  S +F    RS C   L KD   R        EE+ A+PF
Sbjct: 214 -----ERRVKEDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPF 263

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 92.0 bits (228), Expect = 2e-21
 Identities = 78/278 (28%), Positives = 126/278 (45%), Gaps = 23/278 (8%)

Query: 48  DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSS---TIIRHQAAHEAEILKRLDS 104
           D + +  +G G  G VYK R+  +  + A+K++        ++I+     E  ++K    
Sbjct: 10  DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQ----EIFMVKECKH 65

Query: 105 QFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG 164
             IV     + + E ++   ME+   GSL D   V   LSE  I+ V    L+GL YLH 
Sbjct: 66  CNIVAYFGSYLSRE-KLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHS 124

Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTC 224
              +H DIK +N+L+   G+VK+ADFGV+  +  T                   + +GT 
Sbjct: 125 KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRK--------------SFIGTP 170

Query: 225 AYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGE 284
            +M+PE    E+ GG Y    D+W++G+  +E      P+        L  +  +     
Sbjct: 171 YWMAPEVAAVEKNGG-YNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPP 229

Query: 285 RLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPF 322
           +L+     S  F  FV+  L K+ +KR T E LL + F
Sbjct: 230 KLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 91.2 bits (227), Expect = 3e-21
 Identities = 73/284 (25%), Positives = 122/284 (42%), Gaps = 38/284 (13%)

Query: 47  SDLKKLTVLGHGNGGIVYKVRHQKSNSIY---ALKVLNTTSSTIIRHQAAHEAEILKRLD 103
           S +    V+G G  G V + R +         A+K L   SS   R     EA I+ + D
Sbjct: 4   SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFD 63

Query: 104 SQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQYL 162
              I++   V  T    +  + E+ME GSL   LR    K +   + G+   +  G++YL
Sbjct: 64  HPNIIRLEGVV-TKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYL 122

Query: 163 HGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMG 222
             M  +H D+   N+L+N     K++DFG+SR +E++               EA     G
Sbjct: 123 SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS---------------EATYTTKG 167

Query: 223 ---TCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP----DLMA 275
                 + +PE +   +    +  A DVWS G+V+ E       ++ +GE+P        
Sbjct: 168 GKIPIRWTAPEAIAYRK----FTSASDVWSFGIVMWE-------VMSYGERPYWDMSNQD 216

Query: 276 LICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA 319
           +I A+  G RL  P        + +  C +KD  +R T  ++++
Sbjct: 217 VIKAVEDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVS 260

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 92.1 bits (229), Expect = 3e-21
 Identities = 69/239 (28%), Positives = 111/239 (46%), Gaps = 36/239 (15%)

Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVF 114
           LG G+ G+V+       +   A+K +  T    ++H A  E +I++RLD   IVK + V 
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKH-ALREIKIIRRLDHDNIVKVYEVL 71

Query: 115 Y-------------TIEGEICFVMEHMERGSLFDSLRV--RKKLSEDVISGVAYRVLKGL 159
                         T    +  V E+ME     D   V  +  LSE+      Y++L+GL
Sbjct: 72  GPSGSDLTEDVGSLTELNSVYIVQEYMET----DLANVLEQGPLSEEHARLFMYQLLRGL 127

Query: 160 QYLHGMQIIHGDIKPSNLLINGKGEV-KIADFGVSRIVEETRNNNNHNNNNNNNIGEAAI 218
           +Y+H   ++H D+KP+N+ IN +  V KI DFG++RIV+   ++  + +           
Sbjct: 128 KYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEG--------- 178

Query: 219 ACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALI 277
             + T  Y SP  + S     +Y  A D+W+ G +  E L G  PL     + + M LI
Sbjct: 179 --LVTKWYRSPRLLLSPN---NYTKAIDMWAAGCIFAEMLTGK-PLFAGAHELEQMQLI 231

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 91.2 bits (226), Expect = 4e-21
 Identities = 71/267 (26%), Positives = 127/267 (47%), Gaps = 35/267 (13%)

Query: 54  VLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQ--AAHEAEILKRL---DSQFIV 108
           ++G G  G VY  R   +  +YA+K L+     + + +  A +E  +L  +   D  FIV
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 109 KCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQII 168
                F+T + ++CF+++ M  G L   L      SE  +   A  ++ GL+++H   ++
Sbjct: 61  CMTYAFHTPD-KLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVV 119

Query: 169 HGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMS 228
           + D+KP+N+L++  G V+I+D G++    + + +                A +GT  YM+
Sbjct: 120 YRDLKPANILLDEHGHVRISDLGLACDFSKKKPH----------------ASVGTHGYMA 163

Query: 229 PERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP----DLMALICAICFGE 284
           PE +     G  Y  + D +SLG ++ + L GH P      K     D M L   +    
Sbjct: 164 PEVLQK---GTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNV---- 216

Query: 285 RLEMPETASPEFRRFVRSCLEKDWRKR 311
             E+P++ SPE +  +   L++D  KR
Sbjct: 217 --ELPDSFSPELKSLLEGLLQRDVSKR 241

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 90.8 bits (226), Expect = 5e-21
 Identities = 65/223 (29%), Positives = 104/223 (46%), Gaps = 33/223 (14%)

Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS------STIIRHQAAHEAEILKRLD 103
           +K+  +G G  G+VYK R + +  I ALK +   +      ST IR     E  +LK L+
Sbjct: 2   QKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIR-----EISLLKELN 56

Query: 104 SQFIVKCHAVFYTIEGEICFVMEH--MERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQY 161
              IV+   V ++ E ++  V E   ++     DS      L   +I    Y++L+G+ Y
Sbjct: 57  HPNIVRLLDVVHS-ENKLYLVFEFLDLDLKKYMDSSP-LTGLDPPLIKSYLYQLLQGIAY 114

Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACM 221
            H  +++H D+KP NLLI+ +G +K+ADFG++R          H               +
Sbjct: 115 CHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHE--------------V 160

Query: 222 GTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPL 264
            T  Y +PE +   R    Y    D+WS+G +  E +V   PL
Sbjct: 161 VTLWYRAPEILLGSRQ---YSTPVDIWSIGCIFAE-MVNRRPL 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 90.7 bits (225), Expect = 5e-21
 Identities = 77/279 (27%), Positives = 130/279 (46%), Gaps = 31/279 (11%)

Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIR-HQAAH-EAEILKRLDSQFIVKCHA 112
           LG G  G V   + + +  +YA K LN       + ++ A  E  IL ++ S+FIV    
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 113 VFYTIEGEICFVMEHMERGSL-FDSLRVRKK---LSEDVISGVAYRVLKGLQYLHGMQII 168
            F T + ++C VM  M  G L +    V ++     E        +++ GL++LH  +II
Sbjct: 61  AFQT-KTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRII 119

Query: 169 HGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMS 228
           + D+KP N+L++  G V+I+D G++  +++ ++            G A     GT  +M+
Sbjct: 120 YRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTK---------GYA-----GTPGFMA 165

Query: 229 PERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEM 288
           PE +  E    +Y F+ D ++LGV + E +    P    GEK +   L   I   + +  
Sbjct: 166 PELLQGE----EYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRI-LNDSVTY 220

Query: 289 PETASPEFRRFVRSCLEKDWRKR-----GTVEELLAYPF 322
           P+  SP  + F  + L KD  KR     G  + L  +P 
Sbjct: 221 PDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPL 259

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 91.2 bits (226), Expect = 6e-21
 Identities = 75/263 (28%), Positives = 116/263 (44%), Gaps = 31/263 (11%)

Query: 54  VLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIR-----HQAAHEAEILKRLDSQFIV 108
           V+G G+ G V   + +   S YA+KVL     TI++     H  A    +LK L   F+V
Sbjct: 2   VIGKGSFGKVLLAKRKSDGSFYAVKVLQ--KKTILKKKEQNHIMAERNVLLKNLKHPFLV 59

Query: 109 KCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQII 168
             H  F T E ++ FV++++  G LF  L+  +   E      A  V   + YLH + II
Sbjct: 60  GLHYSFQTAE-KLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNII 118

Query: 169 HGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMS 228
           + D+KP N+L++ +G V + DFG+ +   E                  +  C GT  Y++
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-------------ETTSTFC-GTPEYLA 164

Query: 229 PERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEM 288
           PE +  E     Y    D W LG V+ E L G  P        D+  +   I   + L++
Sbjct: 165 PEVLRKE----PYDRTVDWWCLGAVLYEMLYGLPPFY----SRDVSQMYDNI-LHKPLQL 215

Query: 289 PETASPEFRRFVRSCLEKDWRKR 311
           P   +      +   L KD R+R
Sbjct: 216 PGGKTVAACDLLVGLLHKDQRRR 238

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 91.4 bits (227), Expect = 6e-21
 Identities = 79/285 (27%), Positives = 124/285 (43%), Gaps = 25/285 (8%)

Query: 48  DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAE--ILKRLDSQ 105
           D    +++G G+ G V  VR + +  IYA+KV+  +        +  E E  IL   +S 
Sbjct: 2   DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSP 61

Query: 106 FIVKCHAVFYTIEGEICFVMEHMERGSLFDSL-RVRKKLSEDVISGVAYRVLKGLQYLHG 164
           +I +    F   +  +  VME+   G L   L R   +  ED+       ++  +  +H 
Sbjct: 62  WIPQLQYAFQDKD-NLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQ 120

Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTC 224
           M  +H DIKP N+LI+  G +K+ADFG +  +      N   N         +   +GT 
Sbjct: 121 MGYVHRDIKPENVLIDRTGHIKLADFGSAARL----TANKMVN---------SKLPVGTP 167

Query: 225 AYMSPE--RVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICF 282
            Y++PE     +    G YG   D WSLGV+  E + G  P   F E          + F
Sbjct: 168 DYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP---FHEGTSAKTYNNIMNF 224

Query: 283 GERLEMPE--TASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTK 325
              L+ PE    S +F   ++S L    ++R   E L  +PF +K
Sbjct: 225 QRFLKFPEDPKVSSDFLDLIQSLLCGQ-KERLGYEGLCCHPFFSK 268

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 89.8 bits (223), Expect = 9e-21
 Identities = 77/274 (28%), Positives = 115/274 (41%), Gaps = 34/274 (12%)

Query: 54  VLGHGNGGIVYKVRHQKSNSI---YALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKC 110
            +G G  G VY+  +    +     A+K     +S  +R +   EA I+++ D   IVK 
Sbjct: 13  CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72

Query: 111 HAVFYTIEGEICFVMEHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQYLHGMQIIH 169
             V    E  +  VME    G L   L+V K  L    +   +Y++   L YL   + +H
Sbjct: 73  IGV--ITENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVH 130

Query: 170 GDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSP 229
            DI   N+L++    VK+ DFG+SR +E+        +    + G+  I       +M+P
Sbjct: 131 RDIAARNVLVSSPDCVKLGDFGLSRYLED-------ESYYKASKGKLPI------KWMAP 177

Query: 230 ERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP----DLMALICAICFGER 285
           E ++  R    +  A DVW  GV + E L+        G KP        +I  I  GER
Sbjct: 178 ESINFRR----FTSASDVWMFGVCMWEILM-------LGVKPFQGVKNNDVIGRIENGER 226

Query: 286 LEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA 319
           L MP    P     +  C   D  KR    EL A
Sbjct: 227 LPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKA 260

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 91.3 bits (226), Expect = 1e-20
 Identities = 86/307 (28%), Positives = 138/307 (44%), Gaps = 45/307 (14%)

Query: 48  DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH---EAEILKRLDS 104
           D + L V+G G  G V  V+ + +  +YA+K+L   +  + + Q  H   E +IL   DS
Sbjct: 2   DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRK-ADMLEKEQVGHIRAERDILVEADS 60

Query: 105 QFIVKCHAVFYTIEGE--ICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYL 162
            ++VK   +FY+ + +  +  +ME +  G +   L  +  L+E+         +  +  +
Sbjct: 61  LWVVK---MFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSI 117

Query: 163 HGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVE-----ETRNNNNHN--------NNN 209
           H +  IH DIKP NLL++ KG VK++DFG+   ++     E   N NH+        N N
Sbjct: 118 HQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMN 177

Query: 210 NNNIGEA--------AIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGH 261
           +    E         A + +GT  Y++PE          Y    D WSLGV++ E L+G+
Sbjct: 178 SKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQT----GYNKLCDWWSLGVIMYEMLIGY 233

Query: 262 YPLIGFGEKPD-----LMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGT-VE 315
            P     E P      +M     + F   + + E A     RF   C E + R     VE
Sbjct: 234 PPFC--SETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRF---CCEWEHRIGAPGVE 288

Query: 316 ELLAYPF 322
           E+   PF
Sbjct: 289 EIKTNPF 295

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 91.2 bits (226), Expect = 1e-20
 Identities = 69/225 (30%), Positives = 109/225 (48%), Gaps = 29/225 (12%)

Query: 48  DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAA---HEAEILKRLDS 104
           D + + V+G G  G V  VRH+ +  +YA+K+L +    I R  +A    E +I+   +S
Sbjct: 44  DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLL-SKFEMIKRSDSAFFWEERDIMAFANS 102

Query: 105 QFIVKCHAVFYTIEGE--ICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYL 162
            ++V+   +FY  + +  +  VME+M  G L + L     + E         V+  L  +
Sbjct: 103 PWVVQ---LFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLALDAI 158

Query: 163 HGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIAC-- 220
           H M  IH D+KP N+L++  G +K+ADFG    + +                E  + C  
Sbjct: 159 HSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK----------------EGMVRCDT 202

Query: 221 -MGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPL 264
            +GT  Y+SPE + S+   G YG   D WS+GV + E LVG  P 
Sbjct: 203 AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 90.5 bits (224), Expect = 1e-20
 Identities = 67/271 (24%), Positives = 126/271 (46%), Gaps = 40/271 (14%)

Query: 54  VLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQ-------- 105
           V+G G+   V  VR +K++ IYA+KV        ++ +  H+ E +  + ++        
Sbjct: 2   VIGRGSYAKVLLVRLKKNDQIYAMKV--------VKKELVHDDEDIDWVQTEKHVFEQAS 53

Query: 106 ---FIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYL 162
              F+V  H+ F T    +  V+E++  G L   ++ ++KL E+     A  +   L +L
Sbjct: 54  SNPFLVGLHSCFQT-TSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFL 112

Query: 163 HGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMG 222
           H   II+ D+K  N+L++  G +K+ D+G+ +  E                G+      G
Sbjct: 113 HERGIIYRDLKLDNVLLDADGHIKLTDYGMCK--EGLGP------------GDTTSTFCG 158

Query: 223 TCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMA--LICAI 280
           T  Y++PE +  E    +YGF+ D W+LGV++ E + G  P     + PD+     +  +
Sbjct: 159 TPNYIAPEILRGE----EYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQV 214

Query: 281 CFGERLEMPETASPEFRRFVRSCLEKDWRKR 311
              + + +P   S +    ++  L KD ++R
Sbjct: 215 ILEKPIRIPRFLSVKASHVLKGFLNKDPKER 245

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 89.8 bits (223), Expect = 1e-20
 Identities = 51/155 (32%), Positives = 82/155 (52%), Gaps = 14/155 (9%)

Query: 48  DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS------STIIRHQAAHEAEILKR 101
           D  K+  +G G  G+VYK R++K+  I A+K +   S      ST IR     E  +LK 
Sbjct: 1   DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIR-----EISLLKE 55

Query: 102 LDSQFIVKCHAVFYTIEGEICFVMEH--MERGSLFDSLRVRKKLSEDVISGVAYRVLKGL 159
           L    IV    V    E  +  + E   M+     DSL   + +  +++    Y++L+G+
Sbjct: 56  LQHPNIVCLQDVLMQ-ESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGI 114

Query: 160 QYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSR 194
            + H  +++H D+KP NLLI+ KG +K+ADFG++R
Sbjct: 115 LFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLAR 149

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 89.7 bits (222), Expect = 1e-20
 Identities = 74/273 (27%), Positives = 127/273 (46%), Gaps = 31/273 (11%)

Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVF 114
           +G G+ GIV     + +    A+K ++       R    +E  I++    + +V  +   
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQR-RELLFNEVVIMRDYHHENVVDMYNS- 87

Query: 115 YTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKP 174
           Y +  E+  VME +E G+L D +    +++E+ I+ V   VL+ L YLH   +IH DIK 
Sbjct: 88  YLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKS 146

Query: 175 SNLLINGKGEVKIADFG----VSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPE 230
            ++L+   G +K++DFG    VS+ V + +                  + +GT  +M+PE
Sbjct: 147 DSILLTSDGRIKLSDFGFCAQVSKEVPKRK------------------SLVGTPYWMAPE 188

Query: 231 RVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPE 290
            +        YG   D+WSLG++V+E + G  P   F E P             R++   
Sbjct: 189 VISRL----PYGTEVDIWSLGIMVIEMIDGEPPY--FNEPPLQAMRRIRDNLPPRVKDSH 242

Query: 291 TASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV 323
             S   R F+   L ++  +R T +ELL +PF+
Sbjct: 243 KVSSVLRGFLDLMLVREPSQRATAQELLQHPFL 275

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 91.0 bits (226), Expect = 1e-20
 Identities = 71/252 (28%), Positives = 119/252 (47%), Gaps = 44/252 (17%)

Query: 47  SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH---EAEILKRLD 103
           S   K+  +G G  G V  VR   +N++YA+K L   +  ++R+QAAH   E +IL   D
Sbjct: 1   SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRK-ADVLMRNQAAHVKAERDILAEAD 59

Query: 104 SQFIVKCHAVFYTIEGEIC--FVMEHMERGSLFDSLRVRKKL-SEDVISGVAYRVLKGLQ 160
           ++++VK   ++Y+ + +    FVM+++  G +  SL +R  +  ED+       +   ++
Sbjct: 60  NEWVVK---LYYSFQDKDNLYFVMDYIPGGDMM-SLLIRLGIFEEDLARFYIAELTCAIE 115

Query: 161 YLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNN-----NNHNNNNNNNIGE 215
            +H M  IH DIKP N+LI+  G +K+ DFG+      T ++      +H+  ++    E
Sbjct: 116 SVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSE 175

Query: 216 AAIACM------------------------GTCAYMSPERVDSERWGGDYGFAGDVWSLG 251
                                         GT  Y++PE +   R G  Y    D WS+G
Sbjct: 176 EWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVL--LRTG--YTQLCDWWSVG 231

Query: 252 VVVLECLVGHYP 263
           V++ E LVG  P
Sbjct: 232 VILYEMLVGQPP 243

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 89.4 bits (222), Expect = 2e-20
 Identities = 46/147 (31%), Positives = 83/147 (56%), Gaps = 6/147 (4%)

Query: 51  KLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTI-IRHQAAHEAEILKRLDSQFIVK 109
           KL  +G G  G V+K ++++++ I ALK +        +   A  E  +LK L  + IV+
Sbjct: 4   KLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVR 63

Query: 110 CHAVFYTIEGEICFVMEHMERG--SLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQI 167
            + V ++ + ++  V E+ ++     FDS      +  +++    +++LKGL + H   +
Sbjct: 64  LYDVLHS-DKKLTLVFEYCDQDLKKYFDSCN--GDIDPEIVKSFMFQLLKGLAFCHSHNV 120

Query: 168 IHGDIKPSNLLINGKGEVKIADFGVSR 194
           +H D+KP NLLIN  GE+K+ADFG++R
Sbjct: 121 LHRDLKPQNLLINKNGELKLADFGLAR 147

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 88.9 bits (220), Expect = 2e-20
 Identities = 69/276 (25%), Positives = 118/276 (42%), Gaps = 34/276 (12%)

Query: 46  ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNT--TSSTIIRHQAAHEAEILKRLD 103
           +++ +    +G G    VY+          ALK +          R     E ++LK+L+
Sbjct: 1   LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN 60

Query: 104 SQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKK----LSEDVISGVAYRVLKGL 159
              ++K    F   + E+  V+E  + G L   ++  KK    + E  +     ++   +
Sbjct: 61  HPNVIKYLDSFIE-DNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAV 119

Query: 160 QYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIA 219
           +++H  +++H DIKP+N+ I   G VK+ D G+ R                     AA +
Sbjct: 120 EHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--------------AAHS 165

Query: 220 CMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICA 279
            +GT  YMSPER+        Y F  D+WSLG ++ E      P   +G+K +L +L   
Sbjct: 166 LVGTPYYMSPERIHEN----GYNFKSDIWSLGCLLYEMAALQSPF--YGDKMNLFSLCQK 219

Query: 280 ICFGERLEMP----ETASPEFRRFVRSCLEKDWRKR 311
           I   E+ + P    E  S + R  V  C+  D  +R
Sbjct: 220 I---EQCDYPPLPTEHYSEKLRELVSMCIYPDPDQR 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 89.4 bits (222), Expect = 2e-20
 Identities = 70/228 (30%), Positives = 106/228 (46%), Gaps = 29/228 (12%)

Query: 41  PDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALK---VLNTTSSTIIRHQAAHEAE 97
           P  + +S  +KL  +G G  G V+K RH+K+  I ALK   + N      I   A  E +
Sbjct: 6   PFCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPI--TALREIK 63

Query: 98  ILKRLDSQFIVKCHAVFYT-------IEGEICFVMEHMER--GSLFDSLRVRKKLSEDVI 148
           IL+ L  + +V    +  T        +G    V E  E     L  +  V+  LSE  I
Sbjct: 64  ILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSE--I 121

Query: 149 SGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNN 208
             V   +L GL Y+H  +I+H D+K +N+LI   G +K+ADFG++R    ++N+  +   
Sbjct: 122 KKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYT 181

Query: 209 NNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLE 256
           N           + T  Y  PE +  ER   DYG   D+W  G ++ E
Sbjct: 182 NR----------VVTLWYRPPELLLGER---DYGPPIDMWGAGCIMAE 216

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 88.8 bits (220), Expect = 3e-20
 Identities = 77/286 (26%), Positives = 119/286 (41%), Gaps = 32/286 (11%)

Query: 49  LKKLTVLGHGNGGIVYKVRHQKSN----SIYALKVLNTTSSTIIRHQAAHEAEILKRLDS 104
           LKK+ VLG G+ G V    +  +N     + A+K L              E  ILK L  
Sbjct: 6   LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYH 65

Query: 105 QFIVKCHAVFYTIEGEIC-FVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLH 163
           + IVK         G+    +ME++  GSL D L  + KL+   +   A ++ +G+ YLH
Sbjct: 66  ENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLP-KHKLNLAQLLLFAQQICEGMAYLH 124

Query: 164 GMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGT 223
               IH D+   N+L++    VKI DFG+++ V E         + ++ +   A+ C+  
Sbjct: 125 SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKE 184

Query: 224 CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLE----CLVGHYPLIGF----GEKPDLMA 275
             +                +A DVWS GV + E    C     P   F    G K   M 
Sbjct: 185 NKFS---------------YASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMT 229

Query: 276 ---LICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELL 318
              LI  +  G RL  P+    E    +++C E + + R T   L+
Sbjct: 230 VVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLI 275

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 89.5 bits (222), Expect = 3e-20
 Identities = 78/298 (26%), Positives = 127/298 (42%), Gaps = 55/298 (18%)

Query: 55  LGHGNGGIVYKVRHQKSNSIYALK-VLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAV 113
           +G G  G+V   R Q +    A+K ++   S+ ++  +   E ++LK L  + I+    +
Sbjct: 18  VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDI 77

Query: 114 FYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIK 173
           F +   +I FV E +  G+    L   + L +  I    Y++L+GL+Y+H   ++H D+K
Sbjct: 78  FISPLEDIYFVTELL--GTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLK 135

Query: 174 PSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVD 233
           PSN+LIN   ++KI DFG++RI +                       + T  Y +PE + 
Sbjct: 136 PSNILINENCDLKICDFGLARIQDPQMT-----------------GYVSTRYYRAPEIML 178

Query: 234 SERWGGDYGFAGDVWSLGVVVLECLVGHYPLIG--------------FGEKPDLMALICA 279
           + +    Y    D+WS G +  E L G  PL                 G  PD   +I  
Sbjct: 179 TWQ---KYDVEVDIWSAGCIFAEMLEGK-PLFPGKDHVNQFSIITDLLGTPPD--DVINT 232

Query: 280 IC------FGERLEMPE---------TASPEFRRFVRSCLEKDWRKRGTVEELLAYPF 322
           IC      F + L   E          A P     +   L  D +KR +  E LA+P+
Sbjct: 233 ICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPY 290

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 88.1 bits (218), Expect = 3e-20
 Identities = 70/270 (25%), Positives = 123/270 (45%), Gaps = 25/270 (9%)

Query: 52  LTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCH 111
           L V+G G+ G    V+H  S+  YA+K +    S+     +  EA +L ++    IV   
Sbjct: 5   LRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFK 64

Query: 112 AVFYTIEGEICFVMEHMERGSLFDSLRVR--KKLSEDVISGVAYRVLKGLQYLHGMQIIH 169
             F   +G +  VME+ + G L   ++++  K   ED I     ++  G+Q++H  +++H
Sbjct: 65  ESFEA-DGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLH 123

Query: 170 GDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSP 229
            DIK  N+ +   G+VK+ DFG +R++               + G  A   +GT  Y+ P
Sbjct: 124 RDIKSKNIFLTQNGKVKLGDFGSARLL--------------TSPGAYACTYVGTPYYVPP 169

Query: 230 ERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMP 289
           E  ++      Y    D+WSLG ++ E     +P      K     LI  +C G    +P
Sbjct: 170 EIWENM----PYNNKSDIWSLGCILYELCTLKHPFQANSWK----NLILKVCQGSYKPLP 221

Query: 290 ETASPEFRRFVRSCLEKDWRKRGTVEELLA 319
              S E R  ++   +++ R R +   +L+
Sbjct: 222 SHYSYELRSLIKQMFKRNPRSRPSATTILS 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 88.8 bits (221), Expect = 3e-20
 Identities = 62/215 (28%), Positives = 91/215 (42%), Gaps = 26/215 (12%)

Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALK--VLNTTSSTI--IRHQAAHEAEILKRLDSQ 105
           +K   LG G   +VYK R +++  I A+K   L         I   A  E ++L+ L   
Sbjct: 3   EKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHP 62

Query: 106 FIVKCHAVFYTIEGEICFVMEHMERG--SLFDSLRVRKKLSEDVISGVAYRVLKGLQYLH 163
            I+    VF   +  I  V E ME     +     +   L+   I       L+GL+YLH
Sbjct: 63  NIIGLLDVF-GHKSNINLVFEFMETDLEKVIKDKSIV--LTPADIKSYMLMTLRGLEYLH 119

Query: 164 GMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGT 223
              I+H D+KP+NLLI   G +K+ADFG++R          H            +     
Sbjct: 120 SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQ----------VVTRW-- 167

Query: 224 CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECL 258
             Y +PE +   R    YG   D+WS+G +  E L
Sbjct: 168 --YRAPELLFGAR---HYGVGVDMWSVGCIFAELL 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 87.8 bits (218), Expect = 4e-20
 Identities = 71/274 (25%), Positives = 117/274 (42%), Gaps = 39/274 (14%)

Query: 55  LGHGNGGIV----YKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKC 110
           LGHGN G V    Y ++  K   + A+K L        + +   EA ++ +LD   IV+ 
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEV-AVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRL 61

Query: 111 HAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHG 170
             V       +  VME    G L   L+ R+++    +  +A++V  G+ YL     +H 
Sbjct: 62  IGV--CKGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHR 119

Query: 171 DIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPE 230
           D+   N+L+  + + KI+DFG+SR +              ++   A  A      + +PE
Sbjct: 120 DLAARNVLLVNRHQAKISDFGMSRAL-----------GAGSDYYRATTAGRWPLKWYAPE 168

Query: 231 RVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP-------DLMALICAICFG 283
            ++     G +    DVWS GV + E          +G KP       +++A++ +   G
Sbjct: 169 CINY----GKFSSKSDVWSYGVTLWEAF-------SYGAKPYGEMKGAEVIAMLES---G 214

Query: 284 ERLEMPETASPEFRRFVRSCLEKDWRKRGTVEEL 317
           ERL  PE    E    + SC +     R T  EL
Sbjct: 215 ERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSEL 248

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 88.3 bits (219), Expect = 4e-20
 Identities = 65/215 (30%), Positives = 106/215 (49%), Gaps = 32/215 (14%)

Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKV--LNTTS----STIIRHQAAHEAEILKRLD 103
           +K+  +G G  G+VYK R++ +  + ALK   L+T +    ST IR     E  +LK L+
Sbjct: 3   QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-----EISLLKELN 57

Query: 104 SQFIVKCHAVFYTIEGEICFVME--HMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQY 161
              IVK   V +T E ++  V E  H +     D+  +   +   +I    +++L+GL +
Sbjct: 58  HPNIVKLLDVIHT-ENKLYLVFEFLHQDLKKFMDASPL-SGIPLPLIKSYLFQLLQGLAF 115

Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACM 221
            H  +++H D+KP NLLIN +G +K+ADFG++R          H               +
Sbjct: 116 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHE--------------V 161

Query: 222 GTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLE 256
            T  Y +PE +   ++   Y  A D+WSLG +  E
Sbjct: 162 VTLWYRAPEILLGCKY---YSTAVDIWSLGCIFAE 193

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 88.7 bits (220), Expect = 5e-20
 Identities = 64/233 (27%), Positives = 113/233 (48%), Gaps = 40/233 (17%)

Query: 53  TVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQ------- 105
            V+G G+   V  V  +K+  IYA+KV        I+ +  ++ E +  + ++       
Sbjct: 1   RVIGRGSYAKVLLVELKKTRRIYAMKV--------IKKELVNDDEDIDWVQTEKHVFETA 52

Query: 106 ----FIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQY 161
               F+V  H+ F T E  + FV+E +  G L   ++ ++KL E+     +  +   L +
Sbjct: 53  SNHPFLVGLHSCFQT-ESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNF 111

Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACM 221
           LH   II+ D+K  N+L++ +G +K+ D+G+ +  E  R             G+      
Sbjct: 112 LHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCK--EGIRP------------GDTTSTFC 157

Query: 222 GTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYP--LIGFGEKPD 272
           GT  Y++PE +  E    DYGF+ D W+LGV++ E + G  P  ++G  + PD
Sbjct: 158 GTPNYIAPEILRGE----DYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPD 206

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 88.7 bits (220), Expect = 5e-20
 Identities = 64/229 (27%), Positives = 104/229 (45%), Gaps = 30/229 (13%)

Query: 48  DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRL----- 102
           D   L VLG G+ G V     + ++ +YA+K+L      II+        + KR+     
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILK--KDVIIQDDDVECTMVEKRVLALPG 58

Query: 103 DSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYL 162
              F+ + H+ F T++  + FVME++  G L   ++   K  E      A  +  GL +L
Sbjct: 59  KPPFLTQLHSCFQTMD-RLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFL 117

Query: 163 HGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACM- 221
           H   II+ D+K  N++++ +G +KIADFG+ +                 NI         
Sbjct: 118 HSKGIIYRDLKLDNVMLDAEGHIKIADFGMCK----------------ENIFGGKTTRTF 161

Query: 222 -GTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGE 269
            GT  Y++PE +  +     YG + D W+ GV++ E L G  P  G  E
Sbjct: 162 CGTPDYIAPEIIAYQ----PYGKSVDWWAFGVLLYEMLAGQPPFDGEDE 206

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 87.8 bits (218), Expect = 1e-19
 Identities = 76/287 (26%), Positives = 121/287 (42%), Gaps = 39/287 (13%)

Query: 47  SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTI-----IRHQAAHEAEILKR 101
            D + LT +G G  G V+  + + +  I ALK +    S +     +RH    E +IL  
Sbjct: 1   KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMK--KSLLFKLNEVRH-VLTERDILTT 57

Query: 102 LDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQY 161
             S+++VK    F   E  +   ME++  G     L     LSED        + + +  
Sbjct: 58  TKSEWLVKLLYAFQDDE-YLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDA 116

Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACM 221
           LH +  IH D+KP N LI+  G +K+ DFG+S+                  I   A + +
Sbjct: 117 LHELGYIHRDLKPENFLIDASGHIKLTDFGLSK-----------------GIVTYANSVV 159

Query: 222 GTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAIC 281
           G+  YM+PE +  +     Y F  D WSLG ++ E L G  P    G  P+         
Sbjct: 160 GSPDYMAPEVLRGKG----YDFTVDYWSLGCMLYEFLCGFPPFS--GSTPN-ETWENLKY 212

Query: 282 FGERLEMPETASPEFR------RFVRSCLEKDWRKRGTVEELLAYPF 322
           + E L+ P    P F         +   +    R+ G++E++  +PF
Sbjct: 213 WKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPF 259

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 87.4 bits (216), Expect = 2e-19
 Identities = 66/222 (29%), Positives = 107/222 (48%), Gaps = 20/222 (9%)

Query: 48  DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAA---HEAEILKRLDS 104
           D + + V+G G  G V  V+ + +  IYA+K+LN     + R + A    E  +L   D 
Sbjct: 2   DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWE-MLKRAETACFREERNVLVNGDC 60

Query: 105 QFIVKCHAVFYTIEGEICFVMEHMERGSLFDSL-RVRKKLSEDVISGVAYRVLKGLQYLH 163
           Q+I   H  F   E  +  VM++   G L   L +   +L ED+       ++  +  +H
Sbjct: 61  QWITTLHYAFQD-ENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIH 119

Query: 164 GMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGT 223
            +  +H DIKP N+L++  G +++ADFG    +            N +   ++++A +GT
Sbjct: 120 QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKM------------NQDGTVQSSVA-VGT 166

Query: 224 CAYMSPERVDSERWG-GDYGFAGDVWSLGVVVLECLVGHYPL 264
             Y+SPE + +   G G YG   D WSLGV + E L G  P 
Sbjct: 167 PDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 208

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 86.1 bits (213), Expect = 2e-19
 Identities = 76/276 (27%), Positives = 121/276 (43%), Gaps = 23/276 (8%)

Query: 54  VLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTII---RHQAAHE-AEILKRLDSQFIVK 109
           VLG G  G VY     +   I   +V   TS+ +     ++   E  ++LK L    IV+
Sbjct: 7   VLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66

Query: 110 CHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIH 169
                   +  I   ME +  GS+   L     L E V      ++L G+ YLH   ++H
Sbjct: 67  YLGTCLD-DNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVH 125

Query: 170 GDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSP 229
            DIK +N+++   G +K+ DFG +R +     +  H+N           +  GT  +M+P
Sbjct: 126 RDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSN--------MLKSMHGTPYWMAP 177

Query: 230 ERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERL--E 287
           E ++       YG   D+WS+G  V E   G  PL       D +A +  I     L   
Sbjct: 178 EVINES----GYGRKSDIWSIGCTVFEMATGKPPLASM----DRLAAMFYIGAHRGLMPR 229

Query: 288 MPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV 323
           +P++ S     FV SCL +D  +R +  +LL + F+
Sbjct: 230 LPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 85.7 bits (213), Expect = 2e-19
 Identities = 60/224 (26%), Positives = 105/224 (46%), Gaps = 30/224 (13%)

Query: 103 DSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYL 162
           D+   +K +    T++G +  +M++++ G LFD L+   KLSE  +  +  ++++ L  L
Sbjct: 67  DNPNFIKLYYSVTTLKGHV-LIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDL 125

Query: 163 HGMQIIHGDIKPSNLLING-KGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACM 221
           H   IIH DIK  N+L +  K  + + D+G+ +I+                      +C 
Sbjct: 126 HKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKII-------------------GTPSCY 166

Query: 222 -GTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPL-IGFGEKPDLMALICA 279
            GT  Y SPE++    +  D  F  D W++GV+  E L G +P      E+ DL +L   
Sbjct: 167 DGTLDYFSPEKIKGHNY--DVSF--DWWAVGVLTYELLTGKHPFKEDEDEELDLESL--L 220

Query: 280 ICFGERLEMPETASPEFRRFVRSCLEKDWRKR-GTVEELLAYPF 322
               ++L   +  S     FV+S L+ +   R     E++ +PF
Sbjct: 221 KRQQKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPF 264

Length = 267

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 86.9 bits (216), Expect = 3e-19
 Identities = 86/307 (28%), Positives = 132/307 (42%), Gaps = 57/307 (18%)

Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVL-----NTTSSTIIRHQAAHEAEILKRL-DSQFIV 108
           LG G  GIV+K   +++  + ALK +     N T +     +   E   L+ L D   IV
Sbjct: 15  LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDA----QRTFREIMFLQELGDHPNIV 70

Query: 109 KCHAVFYTIEG-EICFVMEHMERGSLFDSLRV-RKKLSEDV-ISGVAYRVLKGLQYLHGM 165
           K   V       +I  V E+ME     D   V R  + EDV    + Y++LK L+Y+H  
Sbjct: 71  KLLNVIKAENDKDIYLVFEYMET----DLHAVIRANILEDVHKRYIMYQLLKALKYIHSG 126

Query: 166 QIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCA 225
            +IH D+KPSN+L+N    VK+ADFG++R +      +    N  N +    +A   T  
Sbjct: 127 NVIHRDLKPSNILLNSDCRVKLADFGLARSL------SELEENPENPVLTDYVA---TRW 177

Query: 226 YMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPL----------------IGFGE 269
           Y +PE +        Y    D+WS+G ++ E L+G  PL                IG   
Sbjct: 178 YRAPEILLGSTR---YTKGVDMWSVGCILGEMLLGK-PLFPGTSTLNQLEKIIEVIGPPS 233

Query: 270 KPDLMALI--CAICFGERLEMPE---------TASPEFRRFVRSCLEKDWRKRGTVEELL 318
             D+ ++    A    + L              AS +    ++  L  +  KR T EE L
Sbjct: 234 AEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEAL 293

Query: 319 AYPFVTK 325
            +P+V +
Sbjct: 294 EHPYVAQ 300

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 85.8 bits (212), Expect = 3e-19
 Identities = 63/226 (27%), Positives = 108/226 (47%), Gaps = 24/226 (10%)

Query: 49  LKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQ--AAHEAEILKRLDSQF 106
            ++  VLG G  G V   + + +  +YA K L        + +  A +E +IL++++SQF
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61

Query: 107 IVKCHAVFYTIEGEICFVMEHMERGSL-FDSLRV-RKKLSEDVISGVAYRVLKGLQYLHG 164
           +V   A  Y  +  +C V+  M  G L F    +      E+     A  +L GL+ LH 
Sbjct: 62  VVNL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHR 120

Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTC 224
              ++ D+KP N+L++  G ++I+D G++  + E               GE+    +GT 
Sbjct: 121 ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPE---------------GESIRGRVGTV 165

Query: 225 AYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEK 270
            YM+PE ++++R    Y  + D W LG ++ E + G  P  G  EK
Sbjct: 166 GYMAPEVLNNQR----YTLSPDYWGLGCLIYEMIEGQSPFRGRKEK 207

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 85.8 bits (212), Expect = 5e-19
 Identities = 61/223 (27%), Positives = 103/223 (46%), Gaps = 28/223 (12%)

Query: 54  VLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRL-----DSQFIV 108
           +LG G+ G V+    + +N  +A+K L      ++         + KR+     +  F+ 
Sbjct: 2   MLGKGSFGKVFLAELKGTNQFFAIKALK--KDVVLMDDDVECTMVEKRVLSLAWEHPFLT 59

Query: 109 KCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQII 168
             +  F T E  + FVME++  G L   ++   K      +  A  ++ GLQ+LH   I+
Sbjct: 60  HLYCTFQTKE-NLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIV 118

Query: 169 HGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACM-GTCAYM 227
           + D+K  N+L++  G +KIADFG+ +                N +G+A      GT  Y+
Sbjct: 119 YRDLKLDNILLDTDGHIKIADFGMCK---------------ENMLGDAKTCTFCGTPDYI 163

Query: 228 SPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEK 270
           +PE +     G  Y  + D WS GV++ E L+G  P  G  E+
Sbjct: 164 APEIL----LGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE 202

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 85.0 bits (211), Expect = 5e-19
 Identities = 57/208 (27%), Positives = 93/208 (44%), Gaps = 41/208 (19%)

Query: 63  VYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEI--LKRLDSQ-FIVKCHAVFYTIE- 118
           V K + +K+   YA+K +     ++   Q  +  EI  L+RL     I++   V +  + 
Sbjct: 15  VLKAQSRKTGKYYAIKCMKKHFKSL--EQVNNLREIQALRRLSPHPNILRLIEVLFDRKT 72

Query: 119 GEICFVMEHMERGSLFDSLRVRKK-LSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNL 177
           G +  V E M+  +L++ ++ RK+ L E  +    Y++LK L ++H   I H DIKP N+
Sbjct: 73  GRLALVFELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENI 131

Query: 178 LINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIAC-------MGTCAYMSPE 230
           LI     +K+ADFG  R                       I         + T  Y +PE
Sbjct: 132 LIK-DDILKLADFGSCR----------------------GIYSKPPYTEYISTRWYRAPE 168

Query: 231 RVDSERWGGDYGFAGDVWSLGVVVLECL 258
            + +    G YG   D+W++G V  E L
Sbjct: 169 CLLT---DGYYGPKMDIWAVGCVFFEIL 193

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 84.4 bits (209), Expect = 7e-19
 Identities = 70/282 (24%), Positives = 120/282 (42%), Gaps = 43/282 (15%)

Query: 45  NISDLKKLTVLGHGNGGIVYK--VRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRL 102
           N  +LK    +G G  G V     R QK     A+K L   S+         EA ++  L
Sbjct: 4   NSKELKLGATIGKGEFGDVMLGDYRGQK----VAVKCLKDDSTAA--QAFLAEASVMTTL 57

Query: 103 DSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKK--LSEDVISGVAYRVLKGLQ 160
               +V+   V       +  V E+M +GSL D LR R +  ++     G A  V +G++
Sbjct: 58  RHPNLVQLLGVVLQ-GNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGME 116

Query: 161 YLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIAC 220
           YL     +H D+   N+L++     K++DFG+++   +             + G+  +  
Sbjct: 117 YLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQ-----------GQDSGKLPV-- 163

Query: 221 MGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP----DLMAL 276
                + +PE +  ++    +    DVWS G+++ E       +  FG  P     L  +
Sbjct: 164 ----KWTAPEALREKK----FSTKSDVWSFGILLWE-------IYSFGRVPYPRIPLKDV 208

Query: 277 ICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELL 318
           +  +  G R+E PE   PE  + ++ C E D  KR T ++L 
Sbjct: 209 VPHVEKGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLR 250

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 85.2 bits (211), Expect = 9e-19
 Identities = 60/225 (26%), Positives = 93/225 (41%), Gaps = 30/225 (13%)

Query: 55  LGHGNGGIVYKVRHQKSNSIYALK-VLNTTSSTI------------IRHQAAHEAEILKR 101
           LG G  G V K     +  I A+K V     S              I      E +I+  
Sbjct: 17  LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76

Query: 102 LDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQY 161
           +  + I+    V Y     I  VM+ M    L   +  + +L+E  +  +  ++L GL  
Sbjct: 77  IKHENIMGLVDV-YVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNV 134

Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSR-----IVEETRNNNNHNNNNNNNIGEA 216
           LH    +H D+ P+N+ IN KG  KIADFG++R        +T + +           + 
Sbjct: 135 LHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKV 194

Query: 217 AIACMGTCAYMSPERV-DSERWGGDYGFAGDVWSLGVVVLECLVG 260
                 T  Y +PE +  +E+    Y FA D+WS+G +  E L G
Sbjct: 195 V-----TLWYRAPELLMGAEK----YHFAVDMWSVGCIFAELLTG 230

Length = 335

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 85.0 bits (210), Expect = 9e-19
 Identities = 70/280 (25%), Positives = 127/280 (45%), Gaps = 33/280 (11%)

Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH---EAEILKRLDSQFIVKCH 111
           +G G+ G V +VR + +  IYALK +   +  + R +  H   E  +L +++  FIV   
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRK-AHIVSRSEVTHTLAERTVLAQVNCPFIVPLK 59

Query: 112 AVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGD 171
             F +   ++  V+  +  G LF  L+   +            +L  L+ LH   +I+ D
Sbjct: 60  FSFQS-PEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRD 118

Query: 172 IKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPER 231
           +KP N+L++ +G + + DFG+ ++       N  +++  N        C GT  Y++PE 
Sbjct: 119 LKPENILLDYQGHIALCDFGLCKL-------NMKDDDKTNTF------C-GTPEYLAPEL 164

Query: 232 VDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEK-PDLMALICAICFGERLEMPE 290
           +     G  Y  A D W+LGV++ E L G  P   + E   ++   I      E L  P+
Sbjct: 165 L----LGHGYTKAVDWWTLGVLLYEMLTGLPPF--YDENVNEMYRKI----LQEPLRFPD 214

Query: 291 TASPEFRRFVRSCLEKDWRKR---GTVEELLAYPFVTKRS 327
               + +  +   L +D  +R      +E+  +PF ++ S
Sbjct: 215 GFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLS 254

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 84.0 bits (208), Expect = 1e-18
 Identities = 71/274 (25%), Positives = 119/274 (43%), Gaps = 32/274 (11%)

Query: 49  LKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIV 108
           ++ L  LG G  G V++     +  + A+K L     T+       EA+I+K+L    ++
Sbjct: 8   IQLLRKLGAGQFGEVWEGLWNNTTPV-AVKTLK--PGTMDPKDFLAEAQIMKKLRHPKLI 64

Query: 109 KCHAVFYTIEGEICFVMEHMERGSLFDSLRVRK----KLSEDVISGVAYRVLKGLQYLHG 164
           + +AV  T+E  I  V E M+ GSL + L+       KL + +   +A +V  G+ YL  
Sbjct: 65  QLYAVC-TLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLI--DMAAQVASGMAYLEA 121

Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTC 224
              IH D+   N+L+      K+ADFG++R+++E             +I EA        
Sbjct: 122 QNYIHRDLAARNVLVGENNICKVADFGLARVIKE-------------DIYEAREGAKFPI 168

Query: 225 AYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICAICFG 283
            + +PE     R    +    DVWS G+++ E +  G  P  G         ++  +  G
Sbjct: 169 KWTAPEAALYNR----FSIKSDVWSFGILLTEIVTYGRMPYPGMTNA----EVLQQVDQG 220

Query: 284 ERLEMPETASPEFRRFVRSCLEKDWRKRGTVEEL 317
            R+  P     E    +  C ++D   R T E L
Sbjct: 221 YRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETL 254

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 84.2 bits (208), Expect = 1e-18
 Identities = 73/286 (25%), Positives = 131/286 (45%), Gaps = 46/286 (16%)

Query: 54  VLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRL--------DSQ 105
           ++G G  G VY  R   +  +YA+K L+      I+ +      + +R+        D  
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKR---IKMKQGETLALNERIMLSLVSTGDCP 57

Query: 106 FIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGM 165
           FIV     F+T + ++ F+++ M  G L   L      SE  +   A  ++ GL+++H  
Sbjct: 58  FIVCMSYAFHTPD-KLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNR 116

Query: 166 QIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCA 225
            +++ D+KP+N+L++  G V+I+D G++    + + +                A +GT  
Sbjct: 117 FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH----------------ASVGTHG 160

Query: 226 YMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP----DLMALICAIC 281
           YM+PE +     G  Y  + D +SLG ++ + L GH P      K     D M L  A+ 
Sbjct: 161 YMAPEVLQK---GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV- 216

Query: 282 FGERLEMPETASPEFRRFVRSCLEKDWRKR-----GTVEELLAYPF 322
                E+P++ SPE R  +   L++D  +R        +E+  +PF
Sbjct: 217 -----ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPF 257

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 84.7 bits (209), Expect = 1e-18
 Identities = 62/214 (28%), Positives = 100/214 (46%), Gaps = 22/214 (10%)

Query: 54  VLGHGNGGIVYKVRHQKSNSIYALKVLNTTS---STIIRHQAAHEAEILKRLDSQFIVKC 110
           V+G G+ G V   RH+     YA+KVL   +       +H  +    +LK +   F+V  
Sbjct: 2   VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61

Query: 111 HAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHG 170
           H  F T + ++ FV++++  G LF  L+  +   E      A  +   L YLH + I++ 
Sbjct: 62  HFSFQTAD-KLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYR 120

Query: 171 DIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPE 230
           D+KP N+L++ +G + + DFG+       + N  HN       G  +  C GT  Y++PE
Sbjct: 121 DLKPENILLDSQGHIVLTDFGL------CKENIEHN-------GTTSTFC-GTPEYLAPE 166

Query: 231 RVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPL 264
            +  +     Y    D W LG V+ E L G  P 
Sbjct: 167 VLHKQ----PYDRTVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 83.6 bits (207), Expect = 2e-18
 Identities = 52/159 (32%), Positives = 79/159 (49%), Gaps = 29/159 (18%)

Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNT-----TSSTIIRHQAAHEAEILKRLDS 104
           KKL  LG G+   VYK R + +  + ALK +          T IR     EA +LK L  
Sbjct: 8   KKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR-----EASLLKDLKH 62

Query: 105 QFIVKCHAVFYTIEGEICFVMEHMER---------GSLFDSLRVRKKLSEDVISGVAYRV 155
             IV  H + +T +  +  V E+++          G       VR  L         +++
Sbjct: 63  ANIVTLHDIIHT-KKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFL---------FQL 112

Query: 156 LKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSR 194
           L+GL Y H  +++H D+KP NLLI+ +GE+K+ADFG++R
Sbjct: 113 LRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 83.8 bits (207), Expect = 3e-18
 Identities = 75/282 (26%), Positives = 123/282 (43%), Gaps = 37/282 (13%)

Query: 54  VLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDS-----QFIV 108
           VLG G+ G V   R ++S  +YA+KVL      I++          KR+ S      F+ 
Sbjct: 2   VLGKGSFGKVMLARLKESGRLYAVKVLK--KDVILQDDDVECTMTEKRILSLARNHPFLT 59

Query: 109 KCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQII 168
           + +  F T +  + FVME +  G L   ++  ++  E      A  +   L +LH   II
Sbjct: 60  QLYCCFQTPD-RLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGII 118

Query: 169 HGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMS 228
           + D+K  N+L++ +G  K+ADFG+ +  E   N            G+      GT  Y++
Sbjct: 119 YRDLKLDNVLLDHEGHCKLADFGMCK--EGIFN------------GKTTSTFCGTPDYIA 164

Query: 229 PERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEM 288
           PE +        YG + D W++GV++ E L GH P     E  DL   I      + +  
Sbjct: 165 PEILQEML----YGPSVDWWAMGVLLYEMLCGHAPFEAENED-DLFEAI----LNDEVVY 215

Query: 289 PETASPEFRRFVRSCLEKDWRKR------GTVEELLAYPFVT 324
           P   S +    +++ + K+   R      G  E +L +PF  
Sbjct: 216 PTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFK 257

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 83.1 bits (205), Expect = 3e-18
 Identities = 59/206 (28%), Positives = 102/206 (49%), Gaps = 19/206 (9%)

Query: 52  LTVLGHGNGGIVYKVRHQKSNSIYALKVL-NTTSSTIIRHQAAHEAEILKRLDSQFIVKC 110
           L V+G G  G+V K RH+++  I A+K   ++  +  ++     E ++L+ L  + IV+ 
Sbjct: 6   LGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVEL 65

Query: 111 HAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHG 170
              F    G++  V E++E+  L     +   +  + +    Y+++K + + H   I+H 
Sbjct: 66  KEAFRR-RGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHR 124

Query: 171 DIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPE 230
           DIKP NLLI+    +K+ DFG +R         N +  +N N  E     + T  Y SPE
Sbjct: 125 DIKPENLLISHNDVLKLCDFGFAR---------NLSEGSNANYTEY----VATRWYRSPE 171

Query: 231 RVDSERWGGDYGFAGDVWSLGVVVLE 256
            +     G  YG A D+WS+G ++ E
Sbjct: 172 LL----LGAPYGKAVDMWSVGCILGE 193

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 82.2 bits (203), Expect = 4e-18
 Identities = 79/281 (28%), Positives = 124/281 (44%), Gaps = 37/281 (13%)

Query: 45  NISDLKKLTVLGHGNGGIVY--KVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRL 102
           N S+L  +  LG G  G+V+  K R Q   +I A+     +    I      EA+++ +L
Sbjct: 2   NPSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIE-----EAKVMMKL 56

Query: 103 DSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQY 161
               +V+ + V  T +  +  V E ME G L + LR R+ KLS+D++  +   V +G++Y
Sbjct: 57  SHPKLVQLYGVC-TQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEY 115

Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACM 221
           L     IH D+   N L++  G VK++DFG++R V                + +   +  
Sbjct: 116 LERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYV----------------LDDEYTSSS 159

Query: 222 GT---CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALI 277
           G      +  PE  +  +    Y    DVWS GV++ E    G  P     EK     ++
Sbjct: 160 GAKFPVKWSPPEVFNFSK----YSSKSDVWSFGVLMWEVFTEGKMPF----EKKSNYEVV 211

Query: 278 CAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELL 318
             I  G RL  P+ AS      + SC  +    R T  ELL
Sbjct: 212 EMISRGFRLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELL 252

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 82.9 bits (205), Expect = 4e-18
 Identities = 90/317 (28%), Positives = 139/317 (43%), Gaps = 71/317 (22%)

Query: 52  LTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSS------TIIRHQAAHEAEILKRLDSQ 105
           +  +G G  G VYK R + +  + ALK +   +       T IR     E +IL++L+ +
Sbjct: 12  IGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIR-----EIKILRQLNHR 66

Query: 106 FIVKCHAV---------FYTIEGEICFVMEHMERG--SLFDSLRVRKKLSEDVISGVAYR 154
            IV    +         F   +G    V E+M+     L +S  V    SED I     +
Sbjct: 67  NIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLV--HFSEDHIKSFMKQ 124

Query: 155 VLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRI--VEETRNNNNHNNNNNNN 212
           +L+GL Y H    +H DIK SN+L+N KG++K+ADFG++R+   EE+R   N        
Sbjct: 125 LLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNK------- 177

Query: 213 IGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPD 272
                   + T  Y  PE +  E     YG A DVWS G ++ E L    P+    ++  
Sbjct: 178 --------VITLWYRPPELLLGEE---RYGPAIDVWSCGCILGE-LFTKKPIFQANQELA 225

Query: 273 LMALICAIC-------FGERLEMP--ETASPE--FRRFVRS---------------CLEK 306
            + LI  +C       + + +++P   T  P+  +RR +R                 L  
Sbjct: 226 QLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTL 285

Query: 307 DWRKRGTVEELLAYPFV 323
           D  KR T EE L  P++
Sbjct: 286 DPSKRCTAEEALNSPWL 302

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 83.2 bits (205), Expect = 5e-18
 Identities = 80/290 (27%), Positives = 134/290 (46%), Gaps = 34/290 (11%)

Query: 48  DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAA---HEAEILKRLDS 104
           D + L V+G G  G V  V+ + ++ ++A+K+LN     + R + A    E ++L   D+
Sbjct: 2   DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWE-MLKRAETACFREERDVLVNGDN 60

Query: 105 QFIVKCHAVFYTIEGEICFVMEHMERGSLFDSL-RVRKKLSEDVISGVAYRVLKGLQYLH 163
           Q+I   H  F   E  +  VM++   G L   L +   +L ED+       ++  +  +H
Sbjct: 61  QWITTLHYAFQD-ENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVH 119

Query: 164 GMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGT 223
            +  +H DIKP N+L++  G +++ADFG    + E            +   ++++A +GT
Sbjct: 120 QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLME------------DGTVQSSVA-VGT 166

Query: 224 CAYMSPERVDS-ERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAIC- 281
             Y+SPE + + E   G YG   D WSLGV + E L G  P   + E   L+     I  
Sbjct: 167 PDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPF--YAES--LVETYGKIMN 222

Query: 282 FGERLEMP-------ETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVT 324
             ER + P       E A    RR +  C  +    +  +E+   +PF T
Sbjct: 223 HKERFQFPAQVTDVSEDAKDLIRRLI--CSREHRLGQNGIEDFKQHPFFT 270

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 82.7 bits (205), Expect = 5e-18
 Identities = 63/223 (28%), Positives = 103/223 (46%), Gaps = 33/223 (14%)

Query: 45  NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSS------TIIRHQAAHEAEI 98
           ++ + +KL  +  G  G+VY+ R +K+  I ALK L           T +R     E  I
Sbjct: 3   SVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLR-----EINI 57

Query: 99  LKRLDSQFIVKC-HAVFYTIEGEICFVMEHMERG--SLFDSLRVRKKLSEDVISGVAYRV 155
           L +L    IV     V  +   +I  VME++E    SL ++++     SE  +  +  ++
Sbjct: 58  LLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSE--VKCLMLQL 115

Query: 156 LKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGE 215
           L G+ +LH   I+H D+K SNLL+N +G +KI DFG++R                     
Sbjct: 116 LSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQL--------- 166

Query: 216 AAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECL 258
                + T  Y +PE +   +   +Y  A D+WS+G +  E L
Sbjct: 167 -----VVTLWYRAPELLLGAK---EYSTAIDMWSVGCIFAELL 201

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 81.7 bits (202), Expect = 5e-18
 Identities = 60/230 (26%), Positives = 98/230 (42%), Gaps = 30/230 (13%)

Query: 94  HEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRK-KLSEDVISGVA 152
            EA+++ +L    +V+ + V  T +  I  V E+M  G L + LR RK KL  + +  + 
Sbjct: 48  EEAKVMMKLSHPNLVQLYGVC-TKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMC 106

Query: 153 YRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNN 212
             V + ++YL     IH D+   N L+     VK++DFG++R V                
Sbjct: 107 SDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYV---------------- 150

Query: 213 IGEAAIACMGT---CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFG 268
           + +   +  GT     +  PE  D  R    +    DVWS GV++ E    G  P   F 
Sbjct: 151 LDDQYTSSQGTKFPVKWAPPEVFDYSR----FSSKSDVWSFGVLMWEVFSEGKMPYERFS 206

Query: 269 EKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELL 318
                  ++ ++  G RL  P+ A  E    + SC  +    R   ++LL
Sbjct: 207 N----SEVVESVSAGYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLL 252

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 82.3 bits (203), Expect = 7e-18
 Identities = 67/229 (29%), Positives = 105/229 (45%), Gaps = 24/229 (10%)

Query: 52  LTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCH 111
           L  LG G+   VYK   + +  + ALKV++  +   +   A  EA +LK L    IV  H
Sbjct: 10  LEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLH 69

Query: 112 AVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGD 171
            + +T E  + FV E+M        ++    L    +    +++L+GL Y+HG  I+H D
Sbjct: 70  DIIHTKE-TLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRD 128

Query: 172 IKPSNLLINGKGEVKIADFGVSR---IVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMS 228
           +KP NLLI+  GE+K+ADFG++R   I  +T ++                  + T  Y  
Sbjct: 129 LKPQNLLISYLGELKLADFGLARAKSIPSQTYSSE-----------------VVTLWYRP 171

Query: 229 PERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALI 277
           P   D      DY  A D+W  G + +E L G     G  +  + +  I
Sbjct: 172 P---DVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKI 217

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 82.8 bits (205), Expect = 7e-18
 Identities = 42/149 (28%), Positives = 72/149 (48%), Gaps = 5/149 (3%)

Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH-EAEILKRLDSQFIV 108
           K +  +G G  G+V      +S    A+K +          +    E +IL+      I+
Sbjct: 8   KPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNII 67

Query: 109 KCHAVFYTIEGE---ICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGM 165
               +      +   +  VM+ ME   L   +   + L+E+ I    Y++L+GL+Y+H  
Sbjct: 68  AIRDILRPPGADFKDVYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSA 126

Query: 166 QIIHGDIKPSNLLINGKGEVKIADFGVSR 194
            +IH D+KPSNLL+N   E++I DFG++R
Sbjct: 127 NVIHRDLKPSNLLVNEDCELRIGDFGMAR 155

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 80.9 bits (200), Expect = 1e-17
 Identities = 66/278 (23%), Positives = 110/278 (39%), Gaps = 38/278 (13%)

Query: 55  LGHGNGGIVYKVRHQKSNSIY---ALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCH 111
           LG G+ G+V +     S       A+K L +   + I      EA I+  LD + +++ +
Sbjct: 3   LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62

Query: 112 AVFYTIEGEICFVMEHMERGSLFDSLRVRKK--LSEDVISGVAYRVLKGLQYLHGMQIIH 169
            V  T    +  V E    GSL D LR           +   A ++  G++YL   + IH
Sbjct: 63  GVVLT--HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIH 120

Query: 170 GDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSP 229
            D+   N+L+    +VKI DFG+ R + +  ++     +                A+ +P
Sbjct: 121 RDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPF-----------AWCAP 169

Query: 230 ERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP-------DLMALICAICF 282
           E + +      +  A DVW  GV + E       +  +GE+P        ++  I     
Sbjct: 170 ESLRTRT----FSHASDVWMFGVTLWE-------MFTYGEEPWAGLSGSQILKKIDKE-- 216

Query: 283 GERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY 320
           GERLE PE    +    +  C   +   R T   L  +
Sbjct: 217 GERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREF 254

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 82.3 bits (203), Expect = 1e-17
 Identities = 67/256 (26%), Positives = 113/256 (44%), Gaps = 29/256 (11%)

Query: 23  NHQFRRRRHHFPTSNPTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNT 82
           N Q  +++    T  P   +     D   +  LG G+ G V    ++  +    + +   
Sbjct: 6   NLQLHKKKDSDSTKEPKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNED-FPPVAIKRF 64

Query: 83  TSSTIIRH-QAAH---EAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLR 138
             S II+  Q  H   E +IL  ++  F V  +  F   E  +  V+E +  G  F  LR
Sbjct: 65  EKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKD-ESYLYLVLEFVIGGEFFTFLR 123

Query: 139 VRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEE 198
             K+   DV    A +++   +YL  + I++ D+KP NLL++  G +K+ DFG +++V +
Sbjct: 124 RNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV-D 182

Query: 199 TRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECL 258
           TR                     GT  Y++PE +        +G A D W+LG+ + E L
Sbjct: 183 TR----------------TYTLCGTPEYIAPEIL----LNVGHGKAADWWTLGIFIYEIL 222

Query: 259 VGHYPLIGFGEKPDLM 274
           VG  P   +  +P L+
Sbjct: 223 VGCPPF--YANEPLLI 236

Length = 340

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 82.0 bits (203), Expect = 1e-17
 Identities = 82/303 (27%), Positives = 136/303 (44%), Gaps = 51/303 (16%)

Query: 55  LGHGNGGIVYKVRHQKSNSIYALK-VLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAV 113
           +G G  GIV   ++ ++N   A+K + N   + I   +   E ++L+ LD + ++    +
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDI 72

Query: 114 FYTIEGE----ICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIH 169
                 E    +  V E M+   L   +R  + LS+D      Y++L+GL+Y+H   ++H
Sbjct: 73  MPPPHREAFNDVYIVYELMDT-DLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLH 131

Query: 170 GDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSP 229
            D+KPSNLL+N   ++KI DFG++R   E               G+     + T  Y +P
Sbjct: 132 RDLKPSNLLLNANCDLKICDFGLARTTSEK--------------GDFMTEYVVTRWYRAP 177

Query: 230 ERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLE-M 288
           E + +     +Y  A DVWS+G +  E L+G  PL    +    + LI  +      E +
Sbjct: 178 ELLLN---CSEYTTAIDVWSVGCIFAE-LLGRKPLFPGKDYVHQLKLITELLGSPSEEDL 233

Query: 289 PETASPEFRRFVRS----------------------CLEK----DWRKRGTVEELLAYPF 322
               + + RR++RS                       LEK    D  KR TVEE LA+P+
Sbjct: 234 GFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPY 293

Query: 323 VTK 325
           +  
Sbjct: 294 LAS 296

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 82.0 bits (203), Expect = 1e-17
 Identities = 46/155 (29%), Positives = 79/155 (50%), Gaps = 10/155 (6%)

Query: 47  SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQF 106
              + L+ +G G  G+V    H+ +    A+K ++         +   E +IL+R   + 
Sbjct: 5   PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHEN 64

Query: 107 IVKCHAVFY--TIEG--EICFVMEHMERGSLFDSLRVRK--KLSEDVISGVAYRVLKGLQ 160
           I+    +    + E   ++  V E ME     D  ++ K   LS D I    Y++L+GL+
Sbjct: 65  IIGILDIIRPPSFESFNDVYIVQELMET----DLYKLIKTQHLSNDHIQYFLYQILRGLK 120

Query: 161 YLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRI 195
           Y+H   ++H D+KPSNLL+N   ++KI DFG++RI
Sbjct: 121 YIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARI 155

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 82.0 bits (202), Expect = 2e-17
 Identities = 85/323 (26%), Positives = 144/323 (44%), Gaps = 51/323 (15%)

Query: 51  KLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH---EAEILKRLDSQFI 107
           K+  LG G  G V       ++++YA+K L      + R+Q AH   E +IL   D++++
Sbjct: 5   KIKTLGIGAFGEVCLACKVDTHALYAMKTLRK-KDVLNRNQVAHVKAERDILAEADNEWV 63

Query: 108 VKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLK-GLQYLHGMQ 166
           VK +  F   +  + FVM+++  G +  SL +R ++  +V++      L   ++ +H M 
Sbjct: 64  VKLYYSFQDKD-NLYFVMDYIPGGDMM-SLLIRMEVFPEVLARFYIAELTLAIESVHKMG 121

Query: 167 IIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNN----------------- 209
            IH DIKP N+LI+  G +K+ DFG+      T N+  +   +                 
Sbjct: 122 FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVS 181

Query: 210 NNNIGEA----------------AIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVV 253
           N   G+                 A + +GT  Y++PE +   R G  Y    D WS+GV+
Sbjct: 182 NCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVL--LRKG--YTQLCDWWSVGVI 237

Query: 254 VLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPETA--SPEFRRFVRS--CLEKDWR 309
           + E LVG  P +     P    L   I +   L +P     SPE    +    C  ++  
Sbjct: 238 LFEMLVGQPPFL--APTPTETQLK-VINWENTLHIPPQVKLSPEAVDLITKLCCSAEERL 294

Query: 310 KRGTVEELLAYPFVTKRSSSSNI 332
            R   +++ A+PF ++   SS+I
Sbjct: 295 GRNGADDIKAHPFFSEVDFSSDI 317

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 80.8 bits (199), Expect = 2e-17
 Identities = 61/220 (27%), Positives = 106/220 (48%), Gaps = 24/220 (10%)

Query: 49  LKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQ--AAHEAEILKRLDSQF 106
            ++  VLG G  G V   + + +  +YA K L        + +  A +E +IL++++S+F
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61

Query: 107 IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAY--RVLKGLQYLHG 164
           +V   A  Y  +  +C V+  M  G L   +    +   +    V Y   +  GL+ LH 
Sbjct: 62  VVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQ 120

Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTC 224
            +I++ D+KP N+L++  G ++I+D G++  V E               G+     +GT 
Sbjct: 121 ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE---------------GQTIKGRVGTV 165

Query: 225 AYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPL 264
            YM+PE V +ER    Y F+ D W+LG ++ E + G  P 
Sbjct: 166 GYMAPEVVKNER----YTFSPDWWALGCLLYEMIAGQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 82.0 bits (202), Expect = 2e-17
 Identities = 84/324 (25%), Positives = 146/324 (45%), Gaps = 51/324 (15%)

Query: 51  KLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH---EAEILKRLDSQFI 107
           K+  LG G  G V   R   + ++YA+K L      ++R+Q AH   E +IL   D++++
Sbjct: 5   KIKTLGIGAFGEVCLARKVDTKALYAMKTLRK-KDVLLRNQVAHVKAERDILAEADNEWV 63

Query: 108 VKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKL-SEDVISGVAYRVLKGLQYLHGMQ 166
           V+ +  F   +  + FVM+++  G +  SL +R  +  ED+       +   ++ +H M 
Sbjct: 64  VRLYYSFQD-KDNLYFVMDYIPGGDMM-SLLIRMGIFPEDLARFYIAELTCAVESVHKMG 121

Query: 167 IIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNN---------NNNIGEA- 216
            IH DIKP N+LI+  G +K+ DFG+      T ++  + + +         +N  G+  
Sbjct: 122 FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPA 181

Query: 217 -----------------------AIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVV 253
                                  A + +GT  Y++PE +   R G  Y    D WS+GV+
Sbjct: 182 NCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVL--LRTG--YTQLCDWWSVGVI 237

Query: 254 VLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPETA--SPEFRRF-VRSCLEKDWR- 309
           + E LVG  P +    +  L   +  I +   L +P  A  SPE     ++ C   + R 
Sbjct: 238 LYEMLVGQPPFLA---QTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCRGPEDRL 294

Query: 310 KRGTVEELLAYPFVTKRSSSSNIE 333
            +   +E+ A+PF      SS++ 
Sbjct: 295 GKNGADEIKAHPFFKTIDFSSDLR 318

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 80.8 bits (199), Expect = 2e-17
 Identities = 74/285 (25%), Positives = 123/285 (43%), Gaps = 52/285 (18%)

Query: 54  VLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRL-----DSQFIV 108
           VLG G+ G V     +     +A+K L      ++         + KR+     ++ F+ 
Sbjct: 2   VLGKGSFGKVLLAELKGKGEYFAVKALK--KDVVLIDDDVECTMVEKRVLALAWENPFLT 59

Query: 109 KCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQII 168
             +  F T E  + FVME +  G L   ++ + +      +  A  ++ GLQ+LH   II
Sbjct: 60  HLYCTFQTKE-HLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGII 118

Query: 169 HGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGE--AAIACMGTCAY 226
           + D+K  N++++  G +KIADFG+ +                N  G+  A+  C GT  Y
Sbjct: 119 YRDLKLDNVMLDRDGHIKIADFGMCK---------------ENVFGDNRASTFC-GTPDY 162

Query: 227 MSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERL 286
           ++PE +     G  Y F+ D WS GV++ E L+G  P  G  E              E  
Sbjct: 163 IAPEILQ----GLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED-------------ELF 205

Query: 287 EMPETASPEFRRFV----RSCLEKDW-----RKRGTVEELLAYPF 322
           E     +P + R++    +  LEK +     R+ G V  +  +PF
Sbjct: 206 ESIRVDTPHYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPF 250

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 81.0 bits (200), Expect = 3e-17
 Identities = 65/222 (29%), Positives = 107/222 (48%), Gaps = 22/222 (9%)

Query: 48  DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAA---HEAEILKRLDS 104
           D + L V+G G  G V  V+ + +  +YA+K+LN     + R + A    E ++L   D 
Sbjct: 2   DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWE-MLKRAETACFREERDVLVNGDR 60

Query: 105 QFIVKCHAVFYTIEGEICFVMEHMERGSLFDSL-RVRKKLSEDVISGVAYRVLKGLQYLH 163
           ++I   H  F   E  +  VM++   G L   L +   +L ED+       ++  +  +H
Sbjct: 61  RWITNLHYAFQD-ENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVH 119

Query: 164 GMQIIHGDIKPSNLLINGKGEVKIADFGVS-RIVEETRNNNNHNNNNNNNIGEAAIACMG 222
            +  +H DIKP N+L++  G +++ADFG   R+               +   ++ +A +G
Sbjct: 120 QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRL-------------LADGTVQSNVA-VG 165

Query: 223 TCAYMSPERVDSERWG-GDYGFAGDVWSLGVVVLECLVGHYP 263
           T  Y+SPE + +   G G YG   D WSLGV + E L G  P
Sbjct: 166 TPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 80.2 bits (198), Expect = 3e-17
 Identities = 78/287 (27%), Positives = 125/287 (43%), Gaps = 34/287 (11%)

Query: 49  LKKLTVLGHGNGGIVYKVRHQ----KSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDS 104
           LK +  LG GN G V   R+      +  + A+K L  +++  +R     E EILK L  
Sbjct: 6   LKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLR-DFEREIEILKSLQH 64

Query: 105 QFIVKCHAVFYTI-EGEICFVMEHMERGSLFDSL-RVRKKLSEDVISGVAYRVLKGLQYL 162
             IVK   V Y+     +  VME++  GSL D L + R++L    +   A ++ KG++YL
Sbjct: 65  DNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYL 124

Query: 163 HGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMG 222
              + +H D+   N+L+  +  VKI DFG+++++ +     +         GE+ I    
Sbjct: 125 GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ-----DKEYYKVREPGESPI---- 175

Query: 223 TCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLE----CLVGHYPLIGF-----GEKPDL 273
              + +PE +   +    +  A DVWS GVV+ E          P   F      +K   
Sbjct: 176 --FWYAPESLTESK----FSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQ 229

Query: 274 MA---LICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEEL 317
           M    LI  +    RL  P     E    ++ C   D  +R +  EL
Sbjct: 230 MIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSEL 276

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 80.0 bits (197), Expect = 3e-17
 Identities = 69/260 (26%), Positives = 118/260 (45%), Gaps = 39/260 (15%)

Query: 55  LGHGNGGIVYKVRHQ--KSNSIYALKVL-NTTSSTIIRHQAAHEAEILKRLDSQFIVKCH 111
           LG GN G V K  ++  KS    A+K+L N  +   ++ +   EA ++++LD+ +IV+  
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 112 AVFYTIEGE-ICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHG 170
            +    E E    VME  E G L   L+  K ++E  I+ + ++V  G++YL     +H 
Sbjct: 63  GI---CEAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHR 119

Query: 171 DIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPE 230
           D+   N+L+  +   KI+DFG+S+ +    N      +    +   A  CM    + S  
Sbjct: 120 DLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSS-- 177

Query: 231 RVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP-------DLMALICAICFG 283
                          DVWS GV++ E          +G+KP       ++  +I +   G
Sbjct: 178 -------------KSDVWSFGVLMWEAF-------SYGQKPYKGMKGNEVTQMIES---G 214

Query: 284 ERLEMPETASPEFRRFVRSC 303
           ER+E P+   PE    ++ C
Sbjct: 215 ERMECPQRCPPEMYDLMKLC 234

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 79.4 bits (196), Expect = 5e-17
 Identities = 72/288 (25%), Positives = 115/288 (39%), Gaps = 47/288 (16%)

Query: 54  VLGHGNGGIVYK-----VRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIV 108
            LG G  G V+      +  +    + A+K L  T+S   R     EAE+L     + IV
Sbjct: 12  ELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIV 71

Query: 109 KCHAVFYTIEGEICFVMEHMERGSLFDSLRVR--------------KKLSEDVISGVAYR 154
           K + V  T       V E+ME G L   LR                 +L+   +  +A +
Sbjct: 72  KFYGVC-TEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130

Query: 155 VLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIG 214
           +  G+ YL     +H D+   N L+     VKI DFG+SR V  T         +   +G
Sbjct: 131 IASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTT---------DYYRVG 181

Query: 215 EAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP--- 271
                 M    +M PE +   +    +    DVWS GVV+ E       +  +G++P   
Sbjct: 182 GHT---MLPIRWMPPESIMYRK----FTTESDVWSFGVVLWE-------IFTYGKQPWYG 227

Query: 272 -DLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELL 318
                +I  I  G  L+ P T   E    +  C ++D ++R  ++++ 
Sbjct: 228 LSNEEVIECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIH 275

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 79.7 bits (196), Expect = 5e-17
 Identities = 66/262 (25%), Positives = 119/262 (45%), Gaps = 25/262 (9%)

Query: 54  VLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQ--AAHEAEILKRLDSQFIVKCH 111
           VLG G  G V   + + +  +YA K L        + +  A +E  IL++++S+F+V   
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL- 65

Query: 112 AVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAY--RVLKGLQYLHGMQIIH 169
           A  Y  +  +C V+  M  G L   +        D    + Y   +  GL+ L   +I++
Sbjct: 66  AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVY 125

Query: 170 GDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSP 229
            D+KP N+L++ +G ++I+D G++  + E               GE     +GT  YM+P
Sbjct: 126 RDLKPENILLDDRGHIRISDLGLAVQIPE---------------GETVRGRVGTVGYMAP 170

Query: 230 ERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMP 289
           E +++E+    Y F+ D W LG ++ E + G  P     E+     +   +   +  E  
Sbjct: 171 EVINNEK----YTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQE-EYS 225

Query: 290 ETASPEFRRFVRSCLEKDWRKR 311
           E  S + +   R  L K+ ++R
Sbjct: 226 EKFSEDAKSICRMLLTKNPKER 247

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 79.9 bits (197), Expect = 6e-17
 Identities = 60/215 (27%), Positives = 97/215 (45%), Gaps = 26/215 (12%)

Query: 54  VLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRL-----DSQFIV 108
           VLG G+ G V     + ++ +YA+KVL      I++          KR+        F+ 
Sbjct: 2   VLGKGSFGKVMLAELKGTDEVYAIKVLK--KDVILQDDDVDCTMTEKRILALAAKHPFLT 59

Query: 109 KCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQII 168
             H  F T +  + FVME++  G L   ++  +K  E      A  V   L +LH   +I
Sbjct: 60  ALHCCFQTKD-RLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVI 118

Query: 169 HGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMS 228
           + D+K  N+L++ +G  K+ADFG+ +   E   N                 C GT  Y++
Sbjct: 119 YRDLKLDNILLDAEGHCKLADFGMCK---EGILNGVTTTT----------FC-GTPDYIA 164

Query: 229 PERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYP 263
           PE +       +YG + D W+LGV++ E + G  P
Sbjct: 165 PEILQEL----EYGPSVDWWALGVLMYEMMAGQPP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 78.8 bits (194), Expect = 7e-17
 Identities = 56/216 (25%), Positives = 97/216 (44%), Gaps = 28/216 (12%)

Query: 45  NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDS 104
           + S+L  +  +G G  G+V+     +   + A+K +   + +        EA+++ +L  
Sbjct: 2   HPSELTLVQEIGSGQFGLVWLGYWLEKRKV-AIKTIREGAMS--EEDFIEEAQVMMKLSH 58

Query: 105 QFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQYLH 163
             +V+ + V       IC V E ME G L D LR ++ K S++ + G+   V +G+ YL 
Sbjct: 59  PKLVQLYGVCTE-RSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE 117

Query: 164 GMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGT 223
              +IH D+   N L+     VK++DFG++R V + +  ++                 GT
Sbjct: 118 SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST----------------GT 161

Query: 224 ---CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLE 256
                + SPE          Y    DVWS GV++ E
Sbjct: 162 KFPVKWSSPEVFSF----SKYSSKSDVWSFGVLMWE 193

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 79.4 bits (195), Expect = 7e-17
 Identities = 64/229 (27%), Positives = 104/229 (45%), Gaps = 20/229 (8%)

Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVK 109
           +KL  LG G+   VYK + + +  + ALKV+           A  EA +LK L    IV 
Sbjct: 8   EKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVL 67

Query: 110 CHAVFYTIEG-EICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQII 168
            H + +T E   + F   H +     D  +    L  + +    +++L+GL Y+H   I+
Sbjct: 68  LHDIIHTKETLTLVFEYVHTDLCQYMD--KHPGGLHPENVKLFLFQLLRGLSYIHQRYIL 125

Query: 169 HGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMS 228
           H D+KP NLLI+  GE+K+ADFG++R     ++  +H  +N           + T  Y  
Sbjct: 126 HRDLKPQNLLISDTGELKLADFGLAR----AKSVPSHTYSNE----------VVTLWYRP 171

Query: 229 PERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALI 277
           P   D      +Y    D+W +G + +E + G     G  +  D +  I
Sbjct: 172 P---DVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERI 217

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 79.7 bits (196), Expect = 8e-17
 Identities = 62/227 (27%), Positives = 105/227 (46%), Gaps = 26/227 (11%)

Query: 48  DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQ-- 105
           D   L VLG G+ G V     + ++ +YA+K+L      +I+        + KR+ +   
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILK--KDVVIQDDDVECTMVEKRVLALQD 58

Query: 106 ---FIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYL 162
              F+ + H+ F T++  + FVME++  G L   ++   K  E      A  +  GL +L
Sbjct: 59  KPPFLTQLHSCFQTVD-RLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFL 117

Query: 163 HGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMG 222
           H   II+ D+K  N++++ +G +KIADFG+ +               +   G       G
Sbjct: 118 HRRGIIYRDLKLDNVMLDSEGHIKIADFGMCK--------------EHMVDGVTTRTFCG 163

Query: 223 TCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGE 269
           T  Y++PE +  +     YG + D W+ GV++ E L G  P  G  E
Sbjct: 164 TPDYIAPEIIAYQ----PYGKSVDWWAYGVLLYEMLAGQPPFDGEDE 206

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 78.5 bits (194), Expect = 8e-17
 Identities = 75/284 (26%), Positives = 124/284 (43%), Gaps = 45/284 (15%)

Query: 44  ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLD 103
           E++   +KL   G G  G V+      +  + A+K L     T+       EA+I+K+L 
Sbjct: 6   ESLKLERKL---GAGQFGEVWMGTWNGTTKV-AVKTLK--PGTMSPEAFLQEAQIMKKLR 59

Query: 104 SQFIVKCHAVFYTIEGE-ICFVMEHMERGSLFDSLRVR--KKLSEDVISGVAYRVLKGLQ 160
              +V+ +AV    E E I  V E+M +GSL D L+    KKL    +  +A ++ +G+ 
Sbjct: 60  HDKLVQLYAV--CSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMA 117

Query: 161 YLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIAC 220
           YL     IH D+   N+L+      KIADFG++R++E+                +   A 
Sbjct: 118 YLESRNYIHRDLAARNILVGENLVCKIADFGLARLIED----------------DEYTAR 161

Query: 221 MGT---CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP-DLMA- 275
            G      + +PE  +     G +    DVWS G+++ E       ++ +G  P   M  
Sbjct: 162 EGAKFPIKWTAPEAANY----GRFTIKSDVWSFGILLTE-------IVTYGRVPYPGMTN 210

Query: 276 --LICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEEL 317
             ++  +  G R+  P     E    +  C +KD  +R T E L
Sbjct: 211 REVLEQVERGYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYL 254

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 79.6 bits (196), Expect = 1e-16
 Identities = 82/306 (26%), Positives = 130/306 (42%), Gaps = 56/306 (18%)

Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTT-SSTIIRHQAAHEAEILKRLDSQFIV 108
           + L  +G G  G V     +++ +  A+K L     S +   +A  E  +LK +  + ++
Sbjct: 18  RDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVI 77

Query: 109 KCHAVFYTIEG-----EICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLH 163
               VF          +   VM  M  G+    L   +KLSED I  + Y++LKGL+Y+H
Sbjct: 78  GLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIH 135

Query: 164 GMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGT 223
              IIH D+KP NL +N   E+KI DFG++R              ++   G        T
Sbjct: 136 AAGIIHRDLKPGNLAVNEDCELKILDFGLAR------------QTDSEMTGYVV-----T 178

Query: 224 CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAIC-- 281
             Y +PE + +  W   Y    D+WS+G ++ E L G  PL    +  D +  I  +   
Sbjct: 179 RWYRAPEVILN--W-MHYTQTVDIWSVGCIMAEMLTGK-PLFKGHDHLDQLMEIMKVTGT 234

Query: 282 ----FGERLE----------MPETASPEFRRFVRSC-------LEK----DWRKRGTVEE 316
               F ++L+          +P     +FR  + +        LEK    D   R T  E
Sbjct: 235 PSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAE 294

Query: 317 LLAYPF 322
            LA+P+
Sbjct: 295 ALAHPY 300

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 78.6 bits (194), Expect = 1e-16
 Identities = 68/283 (24%), Positives = 119/283 (42%), Gaps = 40/283 (14%)

Query: 47  SDLKKLTVLGHGNGGIVYK---VRHQKSNSI-YALKVLNTTSSTIIRHQAAHEAEILKRL 102
           ++L+K+ VLG G  G VYK   +   +   I  A+KVL   +S     +   EA ++  +
Sbjct: 7   TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASV 66

Query: 103 DSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRV-RKKLSEDVISGVAYRVLKGLQY 161
           D   +V+   +  +   ++  + + M  G L D +R  +  +    +     ++ KG+ Y
Sbjct: 67  DHPHVVRLLGICLS--SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSY 124

Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACM 221
           L   +++H D+   N+L+     VKI DFG++++++      +            A    
Sbjct: 125 LEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYH------------AEGGK 172

Query: 222 GTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP-------DLM 274
               +M+ E +        Y    DVWS GV V E       L+ FG KP       ++ 
Sbjct: 173 VPIKWMALESILH----RIYTHKSDVWSYGVTVWE-------LMTFGAKPYEGIPAVEIP 221

Query: 275 ALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEEL 317
            L+     GERL  P   + +    +  C   D   R T +EL
Sbjct: 222 DLLEK---GERLPQPPICTIDVYMVLVKCWMIDAESRPTFKEL 261

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 78.9 bits (194), Expect = 1e-16
 Identities = 62/227 (27%), Positives = 104/227 (45%), Gaps = 26/227 (11%)

Query: 48  DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRL----- 102
           D   L VLG G+ G V     + ++ +YA+K+L      +I+        + KR+     
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILK--KDVVIQDDDVECTMVEKRVLALSG 58

Query: 103 DSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYL 162
              F+ + H+ F T++  + FVME++  G L   ++   +  E      A  +  GL +L
Sbjct: 59  KPPFLTQLHSCFQTMD-RLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFL 117

Query: 163 HGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMG 222
           H   II+ D+K  N++++ +G +KIADFG+ +               N   G       G
Sbjct: 118 HSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK--------------ENMWDGVTTKTFCG 163

Query: 223 TCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGE 269
           T  Y++PE +  +     YG + D W+ GV++ E L G  P  G  E
Sbjct: 164 TPDYIAPEIIAYQ----PYGKSVDWWAFGVLLYEMLAGQAPFEGEDE 206

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 78.9 bits (194), Expect = 1e-16
 Identities = 59/214 (27%), Positives = 93/214 (43%), Gaps = 22/214 (10%)

Query: 54  VLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAE---ILKRLDSQFIVKC 110
           V+G G+ G V   + +     YA+KVL        + Q    AE   +LK +   F+V  
Sbjct: 2   VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61

Query: 111 HAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHG 170
           H  F T E ++ FV++ +  G LF  L+  +   E      A  +   L YLH + I++ 
Sbjct: 62  HYSFQTTE-KLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYR 120

Query: 171 DIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPE 230
           D+KP N+L++ +G V + DFG+ +                    +      GT  Y++PE
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCK--------------EGIAQSDTTTTFCGTPEYLAPE 166

Query: 231 RVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPL 264
            +  +     Y    D W LG V+ E L G  P 
Sbjct: 167 VIRKQ----PYDNTVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 78.5 bits (194), Expect = 2e-16
 Identities = 68/334 (20%), Positives = 129/334 (38%), Gaps = 73/334 (21%)

Query: 52  LTVLGHG--NGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH-EAEILKRLDSQFIV 108
           LT++G    +  IV+  +H+ +N++ A+K +N  S +    +    E    ++L    I+
Sbjct: 3   LTLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNIL 62

Query: 109 KCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKK--LSEDVISGVAYRVLKGLQYLHGMQ 166
                F  ++ E+  V   M  GS  D L+      L E  I+ +   VL  L Y+H   
Sbjct: 63  PYVTSF-IVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG 121

Query: 167 IIHGDIKPSNLLINGKGEVKIADFGVSR-----------IVEETRNNNNHNNNNNNNIGE 215
            IH  +K S++L++G G+V ++    S            + +  +++  +          
Sbjct: 122 FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLP-------- 173

Query: 216 AAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMA 275
                     ++SPE +     G  Y    D++S+G+   E   GH P   F + P    
Sbjct: 174 ----------WLSPEVLQQNLQG--YNEKSDIYSVGITACELANGHVP---FKDMPATQM 218

Query: 276 LI------------CAICFGERLEMPE--------------------TASPEFRRFVRSC 303
           L+             +        M +                    T S  F +FV  C
Sbjct: 219 LLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELC 278

Query: 304 LEKDWRKRGTVEELLAYPFVTK-RSSSSNIEGLI 336
           L++D   R +  +LL + F  + +  ++++  L+
Sbjct: 279 LQRDPESRPSASQLLNHSFFKQCKRRNTSLLDLL 312

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 77.3 bits (190), Expect = 2e-16
 Identities = 74/276 (26%), Positives = 125/276 (45%), Gaps = 42/276 (15%)

Query: 55  LGHGNGGIVYK-VRHQKSNSI-YALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHA 112
           LG GN G V K V   +   I  A+KVL   +   +R +   EAEI+ +LD+ +IV+   
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62

Query: 113 VFYTIEGE-ICFVMEHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQYLHGMQIIHG 170
           V    E E +  VME    G L   L  +K +++   +  + ++V  G++YL G   +H 
Sbjct: 63  V---CEAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHR 119

Query: 171 DIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPE 230
           D+   N+L+  +   KI+DFG+S+ +             +++  +A  A      + +PE
Sbjct: 120 DLAARNVLLVNQHYAKISDFGLSKAL-----------GADDSYYKARSAGKWPLKWYAPE 168

Query: 231 RVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP-------DLMALICAICFG 283
            ++  ++        DVWS G+ + E          +G+KP       ++M+ I     G
Sbjct: 169 CINFRKFSS----RSDVWSYGITMWEAF-------SYGQKPYKKMKGPEVMSFIEQ---G 214

Query: 284 ERLEMPETASPEFRRFVRSCLEKDWRKR---GTVEE 316
           +RL+ P    PE    ++ C    W  R     VEE
Sbjct: 215 KRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEE 250

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 77.2 bits (190), Expect = 2e-16
 Identities = 72/272 (26%), Positives = 130/272 (47%), Gaps = 29/272 (10%)

Query: 49  LKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIV 108
           LK +  LG G  G V+ + +   ++  A+K L   S +     A  EA ++K+L    +V
Sbjct: 8   LKLVKKLGAGQFGEVW-MGYYNGHTKVAIKSLKQGSMSPEAFLA--EANLMKQLQHPRLV 64

Query: 109 KCHAVFYTIEGEICFVMEHMERGSLFDSLRVR--KKLSEDVISGVAYRVLKGLQYLHGMQ 166
           + +AV    +  I  + E+ME GSL D L+     KL+ + +  +A ++ +G+ ++    
Sbjct: 65  RLYAV--VTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN 122

Query: 167 IIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAY 226
            IH D++ +N+L++     KIADFG++R++E          +N     E A   +    +
Sbjct: 123 YIHRDLRAANILVSETLCCKIADFGLARLIE----------DNEYTAREGAKFPI---KW 169

Query: 227 MSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICAICFGER 285
            +PE ++     G +    DVWS G+++ E +  G  P  G    P+   +I  +  G R
Sbjct: 170 TAPEAINY----GTFTIKSDVWSFGILLTEIVTYGRIPYPGM-TNPE---VIQNLERGYR 221

Query: 286 LEMPETASPEFRRFVRSCLEKDWRKRGTVEEL 317
           +  P+    E    +R C ++   +R T E L
Sbjct: 222 MPRPDNCPEELYELMRLCWKEKPEERPTFEYL 253

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 77.4 bits (190), Expect = 4e-16
 Identities = 49/153 (32%), Positives = 79/153 (51%), Gaps = 19/153 (12%)

Query: 51  KLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKC 110
           KL  LG G    VYK R + ++++ ALK +           A  E  +LK L    IV  
Sbjct: 10  KLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTL 69

Query: 111 HAVFYTIEGEICFVMEHMER---------GSLFDSLRVRKKLSEDVISGVAYRVLKGLQY 161
           H + +T E  +  V E++++         G+  +   V+  L         +++L+GL Y
Sbjct: 70  HDIIHT-EKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFL---------FQLLRGLNY 119

Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSR 194
            H  +++H D+KP NLLIN +GE+K+ADFG++R
Sbjct: 120 CHRRKVLHRDLKPQNLLINERGELKLADFGLAR 152

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 77.0 bits (189), Expect = 5e-16
 Identities = 76/281 (27%), Positives = 123/281 (43%), Gaps = 32/281 (11%)

Query: 47  SDLKKLTVLGHGNGGIVYK---VRHQKSNSI-YALKVLNTTSSTIIRHQAAHEAEILKRL 102
           ++LK++ VLG G  G VYK   V   ++  I  A+K+LN T+      +   EA I+  +
Sbjct: 7   TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASM 66

Query: 103 DSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQY 161
           D   +V+   V   +   I  V + M  G L D +   K  +   ++     ++ KG+ Y
Sbjct: 67  DHPHLVRLLGV--CLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMY 124

Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACM 221
           L   +++H D+   N+L+     VKI DFG++R++E      N +       G+  I   
Sbjct: 125 LEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADG------GKMPI--- 175

Query: 222 GTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFG--EKPDLMALIC 278
               +M+ E +   +    +    DVWS GV + E +  G  P  G    E PDL+    
Sbjct: 176 ---KWMALECIHYRK----FTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEK-- 226

Query: 279 AICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA 319
               GERL  P   + +    +  C   D   R   +EL A
Sbjct: 227 ----GERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAA 263

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 77.3 bits (191), Expect = 5e-16
 Identities = 74/311 (23%), Positives = 128/311 (41%), Gaps = 64/311 (20%)

Query: 52  LTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH-EAEILKRLDSQFIVKC 110
           L+ +G G  G V      K+    A+K L+    + I  +  + E  +LK +D + ++  
Sbjct: 20  LSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGL 79

Query: 111 HAVFYTIEG-----EICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGM 165
             VF          ++  V   M    L + ++  +KLS+D I  + Y++L+GL+Y+H  
Sbjct: 80  LDVFTPASSLEDFQDVYLVTHLMGA-DLNNIVK-CQKLSDDHIQFLVYQILRGLKYIHSA 137

Query: 166 QIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACM---- 221
            IIH D+KPSN+ +N   E+KI DFG++R  ++                      M    
Sbjct: 138 GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE---------------------MTGYV 176

Query: 222 GTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAIC 281
            T  Y +PE +        Y    D+WS+G ++ E L G   L    +  D +  I  + 
Sbjct: 177 ATRWYRAPEIM---LNWMHYNQTVDIWSVGCIMAELLTGK-TLFPGSDHIDQLKRIMNLV 232

Query: 282 ------FGERLE----------MPET-----------ASPEFRRFVRSCLEKDWRKRGTV 314
                   +++           +P+            A+P     +   L  D  KR T 
Sbjct: 233 GTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITA 292

Query: 315 EELLAYPFVTK 325
            E LA+P++ +
Sbjct: 293 AEALAHPYLAE 303

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 76.2 bits (187), Expect = 6e-16
 Identities = 74/278 (26%), Positives = 133/278 (47%), Gaps = 33/278 (11%)

Query: 44  ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQA-AHEAEILKRL 102
           E+I  +KKL   G G  G V+   +  S  + A+K L   + ++   QA   EA ++K L
Sbjct: 6   ESIKLVKKL---GAGQFGEVWMGYYNNSTKV-AVKTLKPGTMSV---QAFLEEANLMKTL 58

Query: 103 DSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRK--KLSEDVISGVAYRVLKGLQ 160
               +V+ +AV  T E  I  + E+M +GSL D L+  +  K+    +   + ++ +G+ 
Sbjct: 59  QHDKLVRLYAVV-TKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMA 117

Query: 161 YLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIAC 220
           Y+     IH D++ +N+L++     KIADFG++R++E+          N     E A   
Sbjct: 118 YIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIED----------NEYTAREGAKFP 167

Query: 221 MGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICA 279
           +    + +PE ++     G +    DVWS G+++ E +  G  P  G     D+M+   A
Sbjct: 168 I---KWTAPEAINF----GSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS-DVMS---A 216

Query: 280 ICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEEL 317
           +  G R+   E    E    +++C ++   +R T + L
Sbjct: 217 LQRGYRMPRMENCPDELYDIMKTCWKEKAEERPTFDYL 254

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 76.0 bits (187), Expect = 6e-16
 Identities = 78/273 (28%), Positives = 113/273 (41%), Gaps = 38/273 (13%)

Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVF 114
           +G GN G VYK    K N+  A+K   +T    ++ +   EAEILK+ D   IVK   V 
Sbjct: 3   IGKGNFGDVYKGVL-KGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61

Query: 115 YTIEGEICFVMEHMERGSLFDSLRVRK------KLSEDVISGVAYRVLKGLQYLHGMQII 168
              +  I  VME +  GSL   LR +K      KL +  +   A     G++YL     I
Sbjct: 62  VQKQ-PIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAA-----GMEYLESKNCI 115

Query: 169 HGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMS 228
           H D+   N L+     +KI+DFG+SR  EE             + G   I    T    +
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSR--EE------EGGIYTVSDGLKQIPIKWT----A 163

Query: 229 PERVDSERWGGDYGFAGDVWSLGVVVLECL---VGHYPLIGFGEKPDLMALICAICFGER 285
           PE ++     G Y    DVWS G+++ E        YP +   +  +       I  G R
Sbjct: 164 PEALNY----GRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRER------IESGYR 213

Query: 286 LEMPETASPEFRRFVRSCLEKDWRKRGTVEELL 318
           +  P+    E  R +  C   D   R +  E+ 
Sbjct: 214 MPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIY 246

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 76.6 bits (188), Expect = 6e-16
 Identities = 77/283 (27%), Positives = 128/283 (45%), Gaps = 38/283 (13%)

Query: 47  SDLKKLTVLGHGNGGIVYK---VRHQKSNSI-YALKVLNTTSSTIIRHQAAHEAEILKRL 102
           ++LKK+ VLG G  G VYK   +   ++  I  A+KVL   +S     +   EA ++  +
Sbjct: 7   TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGV 66

Query: 103 DSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKL--SEDVISGVAYRVLKGLQ 160
            S ++  C  +   +   +  V + M  G L D +R  K    S+D+++    ++ KG+ 
Sbjct: 67  GSPYV--CRLLGICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCV-QIAKGMS 123

Query: 161 YLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRI--VEETRNNNNHNNNNNNNIGEAAI 218
           YL  ++++H D+   N+L+     VKI DFG++R+  ++ET  + +         G+  I
Sbjct: 124 YLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADG--------GKVPI 175

Query: 219 ACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFG--EKPDLMA 275
                  +M+ E +   R    +    DVWS GV V E +  G  P  G    E PDL+ 
Sbjct: 176 ------KWMALESILHRR----FTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLE 225

Query: 276 LICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELL 318
                  GERL  P   + +    +  C   D   R    EL+
Sbjct: 226 K------GERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELV 262

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 75.8 bits (186), Expect = 8e-16
 Identities = 73/275 (26%), Positives = 122/275 (44%), Gaps = 29/275 (10%)

Query: 49  LKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIV 108
           L+ +  LG+G  G V+ +     N+  A+K L     T+       EA+I+K+L    +V
Sbjct: 8   LQLIKKLGNGQFGEVW-MGTWNGNTKVAVKTLK--PGTMSPESFLEEAQIMKKLRHDKLV 64

Query: 109 KCHAVFYTIEGEICFVMEHMERGSLFDSLR--VRKKLSEDVISGVAYRVLKGLQYLHGMQ 166
           + +AV    E  I  V E+M +GSL D L+    + L    +  +A +V  G+ Y+  M 
Sbjct: 65  QLYAV--VSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN 122

Query: 167 IIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAY 226
            IH D++ +N+L+      KIADFG++R++E+             N   A         +
Sbjct: 123 YIHRDLRSANILVGDGLVCKIADFGLARLIED-------------NEYTARQGAKFPIKW 169

Query: 227 MSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICAICFGER 285
            +PE        G +    DVWS G+++ E +  G  P  G   +  L      +  G R
Sbjct: 170 TAPEAA----LYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLE----QVERGYR 221

Query: 286 LEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY 320
           +  P+         +  C +KD  +R T E L ++
Sbjct: 222 MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSF 256

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 76.2 bits (187), Expect = 1e-15
 Identities = 48/153 (31%), Positives = 78/153 (50%), Gaps = 19/153 (12%)

Query: 51  KLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKC 110
           KL  LG G    V+K R + + ++ ALK +           A  E  +LK L    IV  
Sbjct: 10  KLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTL 69

Query: 111 HAVFYTIEGEICFVMEHMER---------GSLFDSLRVRKKLSEDVISGVAYRVLKGLQY 161
           H + +T +  +  V E++++         G++     V+  L         Y++L+GL Y
Sbjct: 70  HDIVHT-DKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFL---------YQILRGLAY 119

Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSR 194
            H  +++H D+KP NLLIN +GE+K+ADFG++R
Sbjct: 120 CHRRKVLHRDLKPQNLLINERGELKLADFGLAR 152

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 75.7 bits (186), Expect = 1e-15
 Identities = 75/288 (26%), Positives = 119/288 (41%), Gaps = 32/288 (11%)

Query: 49  LKKLTVLGHGNGGIV----YKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDS 104
           LK++  LG G+ G V    Y      +    A+K L   S          E EIL+ L  
Sbjct: 6   LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYH 65

Query: 105 QFIVKCHAVFYTIEGE-ICFVMEHMERGSLFDSL-RVRKKLSEDVISGVAYRVLKGLQYL 162
           + IVK   +     G  I  +ME +  GSL + L R + K++       A ++ KG+ YL
Sbjct: 66  ENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYL 125

Query: 163 HGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMG 222
              Q +H D+   N+L+  + +VKI DFG+++ +E  +      ++ ++ +   A  C+ 
Sbjct: 126 GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLI 185

Query: 223 TCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLE----CLVGHYPLIGF----GEKPDLM 274
              +                 A DVWS GV + E    C     P+  F    G     M
Sbjct: 186 QSKFY---------------IASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQM 230

Query: 275 A---LICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA 319
               L+  +  G+RL  P     E  + +R C E    KR T + L+ 
Sbjct: 231 TVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIE 278

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 77.2 bits (190), Expect = 1e-15
 Identities = 75/284 (26%), Positives = 125/284 (44%), Gaps = 38/284 (13%)

Query: 53  TVLGHGNGGIVYKVRHQKSNSIYALKVLNT---TSSTIIRHQAAHEAEILKRLDSQFIVK 109
            VLG G  G V   +       +A+KV++    + +   R QA  E   L   D   IVK
Sbjct: 38  RVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQA--EVCCLLNCDFFSIVK 95

Query: 110 CHAVF-YTIEGE------ICFVMEHMERGSLFDSLRVRKKLSEDVI---SGVAY-RVLKG 158
           CH  F             I  V+++   G L   ++ R K +       +G+ + +VL  
Sbjct: 96  CHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLA 155

Query: 159 LQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAI 218
           + ++H   +IH DIK +N+L+   G VK+ DFG S++         +    ++++G    
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKM---------YAATVSDDVGRT-- 204

Query: 219 ACMGTCAYMSPERVDSERW-GGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALI 277
            C GT  Y++P     E W    Y    D++SLGV++ E L    P  G     ++  ++
Sbjct: 205 FC-GTPYYVAP-----EIWRRKPYSKKADMFSLGVLLYELLTLKRPFDG----ENMEEVM 254

Query: 278 CAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYP 321
                G    +P + SPE +  V + L  D ++R +  +LL  P
Sbjct: 255 HKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMP 298

Length = 496

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 76.3 bits (188), Expect = 1e-15
 Identities = 79/303 (26%), Positives = 125/303 (41%), Gaps = 49/303 (16%)

Query: 55  LGHGNGGIVYKVRHQKSNS---IYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKC- 110
           LG G  GIV   R+ +++    +   K+ N  S  I+  +A  E ++L+       + C 
Sbjct: 8   LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCL 67

Query: 111 ---HAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQI 167
                VF     E+    E ME   L   +R  + L++       Y++L GL+Y+H   +
Sbjct: 68  YDMDIVFPGNFNELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANV 126

Query: 168 IHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYM 227
           +H D+KP NLL+N   E+KI DFG++R   E     N   N        A     T  Y 
Sbjct: 127 LHRDLKPGNLLVNADCELKICDFGLARGFSE-----NPGENAGFMTEYVA-----TRWYR 176

Query: 228 SPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAIC------ 281
           +PE + S +    Y  A DVWS+G ++ E L+G  P+    +  D +  I  +       
Sbjct: 177 APEIMLSFQ---SYTKAIDVWSVGCILAE-LLGRKPVFKGKDYVDQLNQILQVLGTPDEE 232

Query: 282 ------------FGERLEMPE---------TASPEFRRFVRSCLEKDWRKRGTVEELLAY 320
                       +   L              A+P     +   L  D  KR +VEE L +
Sbjct: 233 TLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292

Query: 321 PFV 323
           P++
Sbjct: 293 PYL 295

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 74.8 bits (184), Expect = 2e-15
 Identities = 49/161 (30%), Positives = 77/161 (47%), Gaps = 21/161 (13%)

Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS------STIIRHQAAHEAEILKRL- 102
           +KL  +G G  G VYK R + +  + ALK             T +R     E  +L+ L 
Sbjct: 4   EKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALR-----EISLLQMLS 58

Query: 103 DSQFIVKCHAVFYTIE--GEICF--VMEHMERG--SLFDSLR--VRKKLSEDVISGVAYR 154
           +S +IV+   V +  E  G+     V E+++       DS      + L    I    Y+
Sbjct: 59  ESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQ 118

Query: 155 VLKGLQYLHGMQIIHGDIKPSNLLIN-GKGEVKIADFGVSR 194
           +LKG+ + H   ++H D+KP NLL++  KG +KIAD G+ R
Sbjct: 119 LLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR 159

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 74.5 bits (183), Expect = 3e-15
 Identities = 62/230 (26%), Positives = 104/230 (45%), Gaps = 46/230 (20%)

Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNT------TSSTIIRHQAAHEAEILKRLD 103
           +K+  +G G  G+VYK R + +N   ALK +          ST IR     E  +LK + 
Sbjct: 5   EKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIR-----EISLLKEMQ 59

Query: 104 SQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKL--------SEDVISGVAYRV 155
              IV+   V ++ E  +  V E+++       L ++K +        +  +I    Y++
Sbjct: 60  HGNIVRLQDVVHS-EKRLYLVFEYLD-------LDLKKHMDSSPDFAKNPRLIKTYLYQI 111

Query: 156 LKGLQYLHGMQIIHGDIKPSNLLINGK-GEVKIADFGVSRIVEETRNNNNHNNNNNNNIG 214
           L+G+ Y H  +++H D+KP NLLI+ +   +K+ADFG++R          H         
Sbjct: 112 LRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHE-------- 163

Query: 215 EAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPL 264
                 + T  Y +PE +   R    Y    D+WS+G +  E +V   PL
Sbjct: 164 ------VVTLWYRAPEILLGSR---HYSTPVDIWSVGCIFAE-MVNQKPL 203

Length = 294

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 74.3 bits (182), Expect = 4e-15
 Identities = 50/153 (32%), Positives = 77/153 (50%), Gaps = 19/153 (12%)

Query: 51  KLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKC 110
           KL  LG G    V+K R + + ++ ALK +           A  E  +LK L    IV  
Sbjct: 9   KLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTL 68

Query: 111 HAVFYTIEGEICFVMEHMER---------GSLFDSLRVRKKLSEDVISGVAYRVLKGLQY 161
           H + +T E  +  V E+++          G+L     V+  +         +++L+GL Y
Sbjct: 69  HDIIHT-ERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFM---------FQLLRGLSY 118

Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSR 194
            H  +I+H D+KP NLLIN KGE+K+ADFG++R
Sbjct: 119 CHKRKILHRDLKPQNLLINEKGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 73.8 bits (181), Expect = 4e-15
 Identities = 68/275 (24%), Positives = 121/275 (44%), Gaps = 29/275 (10%)

Query: 45  NISDLKKLTVLGHGNGGIVYKVRHQ---KSNSIYALKVLNTTSSTIIRHQAAHEAEILKR 101
           ++S +K   V+G G  G V + R +   K     A+K L +  +   R     EA I+ +
Sbjct: 2   DVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQ 61

Query: 102 LDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQ 160
            D   I+    V  T    +  + E ME G+L   LR    + +   + G+   +  G++
Sbjct: 62  FDHPNIIHLEGVV-TKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMK 120

Query: 161 YLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIAC 220
           YL  M  +H D+   N+L+N     K++DFG+SR +E+  ++  +          +++  
Sbjct: 121 YLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYT---------SSLGG 171

Query: 221 MGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP--DL--MAL 276
                + +PE +   +    +  A DVWS G+V+ E       ++ +GE+P  D+    +
Sbjct: 172 KIPIRWTAPEAIAYRK----FTSASDVWSYGIVMWE-------VMSYGERPYWDMSNQDV 220

Query: 277 ICAICFGERLEMPETASPEFRRFVRSCLEKDWRKR 311
           I AI    RL  P        + +  C +KD   R
Sbjct: 221 INAIEQDYRLPPPMDCPTALHQLMLDCWQKDRNAR 255

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 73.9 bits (181), Expect = 4e-15
 Identities = 68/273 (24%), Positives = 121/273 (44%), Gaps = 31/273 (11%)

Query: 47  SDLKKLTVLGHGNGGIVYKVRHQ---KSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLD 103
           S + K  V+G G  G V++   +   +     A+K L    +   R     EA I+ +  
Sbjct: 5   SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFS 64

Query: 104 SQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQYL 162
              I++   V    +     + E+ME G+L   LR    + S   + G+   +  G++YL
Sbjct: 65  HHNIIRLEGVVTKFK-PAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYL 123

Query: 163 HGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMG 222
             M  +H D+   N+L+N   E K++DFG+SR++E+     +       + G+  I    
Sbjct: 124 SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLED-----DPEGTYTTSGGKIPI---- 174

Query: 223 TCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP--DL--MALIC 278
              + +PE +   ++      A DVWS G+V+ E       ++ FGE+P  D+    ++ 
Sbjct: 175 --RWTAPEAIAYRKFTS----ASDVWSFGIVMWE-------VMSFGERPYWDMSNHEVMK 221

Query: 279 AICFGERLEMPETASPEFRRFVRSCLEKDWRKR 311
           AI  G RL  P        + +  C ++D  +R
Sbjct: 222 AINDGFRLPAPMDCPSAVYQLMLQCWQQDRARR 254

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 75.3 bits (185), Expect = 6e-15
 Identities = 50/170 (29%), Positives = 84/170 (49%), Gaps = 32/170 (18%)

Query: 41  PDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIR----HQAAHEA 96
           P +E    +K ++    G  G VY  R + ++ +YA+KV+    + +I     HQ   E 
Sbjct: 1   PSIEEFVIVKPIS---RGAFGKVYLGRKKNNSKLYAVKVVK--KADMINKNMVHQVQAER 55

Query: 97  EILKRLDSQFIVKCHAVFYTIEG--EICFVMEHMERGSL---------FDSLRVRKKLSE 145
           + L    S FIV    ++Y+++    +  VME++  G +         FD     K +SE
Sbjct: 56  DALALSKSPFIVH---LYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISE 112

Query: 146 DVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRI 195
             ++         L YLH   IIH D+KP N+LI+ +G +K+ DFG+S++
Sbjct: 113 VALA---------LDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 73.5 bits (180), Expect = 7e-15
 Identities = 76/289 (26%), Positives = 125/289 (43%), Gaps = 53/289 (18%)

Query: 55  LGHGNGGIVY-----KVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVK 109
           LG G  G V+      +  ++   + A+K L   S +  R     EAE+L  L  Q IV+
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESA-RQDFQREAELLTVLQHQHIVR 71

Query: 110 CHAVFYTIEGE-ICFVMEHMERGSLFDSLRVR---KKL---SEDVISG---------VAY 153
            + V    EG  +  V E+M  G L   LR      K+    EDV  G         +A 
Sbjct: 72  FYGV--CTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIAS 129

Query: 154 RVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNI 213
           ++  G+ YL  +  +H D+   N L+     VKI DFG+SR +  T         +   +
Sbjct: 130 QIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYST---------DYYRV 180

Query: 214 GEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP-- 271
           G      M    +M PE +   ++  +     D+WS GVV+ E       +  +G++P  
Sbjct: 181 GGRT---MLPIRWMPPESILYRKFTTE----SDIWSFGVVLWE-------IFTYGKQPWY 226

Query: 272 ---DLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEEL 317
              +  A+ C I  G  LE P T  PE    ++ C +++ ++R  ++++
Sbjct: 227 QLSNTEAIEC-ITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDI 274

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 73.9 bits (181), Expect = 1e-14
 Identities = 53/176 (30%), Positives = 81/176 (46%), Gaps = 19/176 (10%)

Query: 89  RHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVI 148
           R   A EA IL+ ++   I++    F T     C ++    +  L+  L  ++ ++   I
Sbjct: 127 RGGTATEAHILRAINHPSIIQLKGTF-TYNKFTCLILPRY-KTDLYCYLAAKRNIAICDI 184

Query: 149 SGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNN 208
             +   VL+ +QYLH  +IIH DIK  N+ IN  G+V + DFG +    +         N
Sbjct: 185 LAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDI--------N 236

Query: 209 NNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPL 264
            N   G A     GT A  +PE +  +     YG A D+WS G+V+ E    H  L
Sbjct: 237 ANKYYGWA-----GTIATNAPELLARD----PYGPAVDIWSAGIVLFEMATCHDSL 283

Length = 391

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 73.0 bits (179), Expect = 2e-14
 Identities = 57/222 (25%), Positives = 94/222 (42%), Gaps = 33/222 (14%)

Query: 52  LTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCH 111
           +  L  G+ G V+            LK+     +T+I      EA +L+ ++   +++  
Sbjct: 71  IKTLTPGSEGRVFVATKPGQPDPVVLKI-GQKGTTLI------EAMLLQNVNHPSVIRMK 123

Query: 112 AVFYTIEGEI-CFVMEHMERGSLFDSLRVR-KKLSEDVISGVAYRVLKGLQYLHGMQIIH 169
               +  G I C V+ H     L+  L  R + L  D    +  ++L+GL+YLH  +IIH
Sbjct: 124 DTLVS--GAITCMVLPHY-SSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIH 180

Query: 170 GDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSP 229
            D+K  N+ IN   +V I D G ++                  +G A     GT    +P
Sbjct: 181 RDVKTENIFINDVDQVCIGDLGAAQF----------PVVAPAFLGLA-----GTVETNAP 225

Query: 230 ERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP 271
           E +  ++    Y    D+WS G+V+ E L   YP   F + P
Sbjct: 226 EVLARDK----YNSKADIWSAGIVLFEMLA--YPSTIFEDPP 261

Length = 357

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 71.9 bits (176), Expect = 2e-14
 Identities = 57/222 (25%), Positives = 102/222 (45%), Gaps = 24/222 (10%)

Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTT--SSTIIRHQAAHEAEILKRLDSQFIVKCHA 112
           LG G  G V  V+ + +  +YA K L+            A  E EIL++++S FIV   A
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNL-A 59

Query: 113 VFYTIEGEICFVMEHMERGSL-FDSLRV-RKKLSEDVISGVAYRVLKGLQYLHGMQIIHG 170
             +  +  +C VM  M  G L +    V  + L  + +   + ++  G+ +LH M I++ 
Sbjct: 60  YAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYR 119

Query: 171 DIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPE 230
           D+KP N+L++ +G  +++D G++  +++               G+      GT  YM+PE
Sbjct: 120 DMKPENVLLDDQGNCRLSDLGLAVELKD---------------GKTITQRAGTNGYMAPE 164

Query: 231 RVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPD 272
            +  E     Y +  D +++G  + E + G  P     EK  
Sbjct: 165 ILKEE----PYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA 202

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 71.4 bits (175), Expect = 3e-14
 Identities = 57/219 (26%), Positives = 99/219 (45%), Gaps = 38/219 (17%)

Query: 55  LGHGNGGIVYKVR-HQKSNSIYALKVLNTT----------SSTIIRHQAAHEAEILKRLD 103
           LG G  G VYKVR      ++ ALK +N                I    +    I ++L 
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 104 SQFIVKCHAVFYTIEGE-ICFVMEHMERGSL---FDSLRVRK-KLSEDVISGVAYRVLKG 158
              IV+ +  F  +E + +  VM+ +E   L   F+SL+ +K + +E+ I  +  +++  
Sbjct: 68  HPNIVRYYKTF--LENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLA 125

Query: 159 LQYLHG-MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAA 217
           L+YLH   +I+H D+ P+N+++    +V I DFG+++                + +    
Sbjct: 126 LRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAK-----------QKQPESKLTSVV 174

Query: 218 IACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLE 256
               GT  Y  PE V +E     YG   DVW+ G ++ +
Sbjct: 175 ----GTILYSCPEIVKNE----PYGEKADVWAFGCILYQ 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 71.2 bits (174), Expect = 3e-14
 Identities = 69/269 (25%), Positives = 118/269 (43%), Gaps = 29/269 (10%)

Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVF 114
           LG G  G V+      +  + A+K L     T++      EA+I+K+L    +V  +AV 
Sbjct: 14  LGQGCFGEVWMGTWNGTTKV-AIKTLK--PGTMMPEAFLQEAQIMKKLRHDKLVPLYAV- 69

Query: 115 YTIEGEICFVMEHMERGSLFDSLRVR--KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDI 172
              E  I  V E M +GSL D L+    K L    +  +A ++  G+ Y+  M  IH D+
Sbjct: 70  -VSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDL 128

Query: 173 KPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERV 232
           + +N+L+      KIADFG++R++E+             N   A         + +PE  
Sbjct: 129 RAANILVGDNLVCKIADFGLARLIED-------------NEYTARQGAKFPIKWTAPEAA 175

Query: 233 DSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICAICFGERLEMPET 291
                 G +    DVWS G+++ E +  G  P  G   +     ++  +  G R+  P+ 
Sbjct: 176 ----LYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR----EVLEQVERGYRMPCPQG 227

Query: 292 ASPEFRRFVRSCLEKDWRKRGTVEELLAY 320
                   ++ C +KD  +R T E + ++
Sbjct: 228 CPESLHELMKLCWKKDPDERPTFEYIQSF 256

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 71.1 bits (174), Expect = 3e-14
 Identities = 72/279 (25%), Positives = 124/279 (44%), Gaps = 37/279 (13%)

Query: 48  DLKKLTVLGHGNGGIVY--KVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQ 105
           DL  L  LG G  G+V   K R Q   +I  +K  + +    I      EA+++ +L  +
Sbjct: 5   DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIE-----EAKVMMKLSHE 59

Query: 106 FIVKCHAVFYTIEGEICFVMEHMERGSLFDSLR-VRKKLSEDVISGVAYRVLKGLQYLHG 164
            +V+ + V  T +  I  V E+M  G L + LR   K+     +  +   V +G+ YL  
Sbjct: 60  KLVQLYGVC-TKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLES 118

Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGT- 223
            Q IH D+   N L++ +G VK++DFG+SR V                + +   + +G+ 
Sbjct: 119 KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYV----------------LDDEYTSSVGSK 162

Query: 224 --CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECL-VGHYPLIGFGEKPDLMALICAI 280
               +  PE +   +    +    DVW+ GV++ E   +G  P     E+ +    +  +
Sbjct: 163 FPVRWSPPEVLLYSK----FSSKSDVWAFGVLMWEVYSLGKMPY----ERFNNSETVEKV 214

Query: 281 CFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA 319
             G RL  P  AS +    + SC  +   +R T ++LL+
Sbjct: 215 SQGLRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLS 253

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 72.0 bits (176), Expect = 3e-14
 Identities = 58/216 (26%), Positives = 104/216 (48%), Gaps = 26/216 (12%)

Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH-EAEILKRLDSQFIV 108
           + L+ +G G  G V      K+    A+K L+    +II  +  + E  +LK +  + ++
Sbjct: 20  QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI 79

Query: 109 KCHAVFYTI----EGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG 164
               VF       E    +++ H+    L + ++  +KL++D +  + Y++L+GL+Y+H 
Sbjct: 80  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHS 138

Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTC 224
             IIH D+KPSNL +N   E+KI DFG++R                 +  +     + T 
Sbjct: 139 ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----------------HTDDEMTGYVATR 181

Query: 225 AYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVG 260
            Y +PE + +  W   Y    D+WS+G ++ E L G
Sbjct: 182 WYRAPEIMLN--W-MHYNQTVDIWSVGCIMAELLTG 214

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 70.8 bits (173), Expect = 4e-14
 Identities = 67/266 (25%), Positives = 119/266 (44%), Gaps = 29/266 (10%)

Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVF 114
           LG G  G V+   + K   + A+K +   S ++       EA ++K L    +VK HAV 
Sbjct: 14  LGAGQFGEVWMATYNKHTKV-AVKTMKPGSMSV--EAFLAEANVMKTLQHDKLVKLHAV- 69

Query: 115 YTIEGEICFVMEHMERGSLFDSLRVRK--KLSEDVISGVAYRVLKGLQYLHGMQIIHGDI 172
              +  I  + E M +GSL D L+  +  K     +   + ++ +G+ ++     IH D+
Sbjct: 70  -VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDL 128

Query: 173 KPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERV 232
           + +N+L++     KIADFG++R++E+          N     E A   +    + +PE +
Sbjct: 129 RAANILVSASLVCKIADFGLARVIED----------NEYTAREGAKFPI---KWTAPEAI 175

Query: 233 DSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICAICFGERLEMPET 291
           +     G +    DVWS G++++E +  G  P  G         +I A+  G R+  PE 
Sbjct: 176 NF----GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP----EVIRALERGYRMPRPEN 227

Query: 292 ASPEFRRFVRSCLEKDWRKRGTVEEL 317
              E    +  C +    +R T E +
Sbjct: 228 CPEELYNIMMRCWKNRPEERPTFEYI 253

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 70.7 bits (173), Expect = 5e-14
 Identities = 74/277 (26%), Positives = 120/277 (43%), Gaps = 39/277 (14%)

Query: 54  VLGHGNGGIVYKVRHQ---KSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKC 110
           V+G G  G V   R +   K     A+K L    +   R     EA I+ + D   I+  
Sbjct: 11  VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 111 HAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVIS--GVAYRVLKGLQYLHGMQII 168
             V  T    +  V E+ME GSL D+   +      VI   G+   +  G++YL  M  +
Sbjct: 71  EGVV-TKSKPVMIVTEYMENGSL-DAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYV 128

Query: 169 HGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMG---TCA 225
           H D+   N+L+N     K++DFG+SR++E+                EAA    G      
Sbjct: 129 HRDLAARNILVNSNLVCKVSDFGLSRVLEDDP--------------EAAYTTRGGKIPIR 174

Query: 226 YMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP--DL--MALICAIC 281
           + +PE +   ++      A DVWS G+V+ E       ++ +GE+P  ++    +I AI 
Sbjct: 175 WTAPEAIAYRKFTS----ASDVWSYGIVMWE-------VMSYGERPYWEMSNQDVIKAIE 223

Query: 282 FGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELL 318
            G RL  P        + +  C +KD  +R   E+++
Sbjct: 224 EGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIV 260

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 71.1 bits (174), Expect = 5e-14
 Identities = 71/296 (23%), Positives = 132/296 (44%), Gaps = 53/296 (17%)

Query: 53  TVLGHGNGGIVYK-----VRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFI 107
             LG G  G V K     ++ +   +  A+K+L   +S+        E  +LK+++   +
Sbjct: 6   KTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHV 65

Query: 108 VKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLS----------------------- 144
           +K +    + +G +  ++E+ + GSL   LR  +K+                        
Sbjct: 66  IKLYGAC-SQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERAL 124

Query: 145 --EDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNN 202
              D+IS  A+++ +G+QYL  M+++H D+   N+L+    ++KI+DFG+SR V E    
Sbjct: 125 TMGDLIS-FAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYE---E 180

Query: 203 NNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECL-VGH 261
           +++   +   I            +M+ E +        Y    DVWS GV++ E + +G 
Sbjct: 181 DSYVKRSKGRI---------PVKWMAIESLFDHI----YTTQSDVWSFGVLLWEIVTLGG 227

Query: 262 YPLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEEL 317
            P  G   +  L  L+     G R+E PE  S E    + +C +++  KR T  ++
Sbjct: 228 NPYPGIAPE-RLFNLLKT---GYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADI 279

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 71.1 bits (174), Expect = 7e-14
 Identities = 81/310 (26%), Positives = 126/310 (40%), Gaps = 67/310 (21%)

Query: 51  KLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTT-SSTIIRHQAAHEAEILKRLDSQFIVK 109
            L  +G G  G V     +++    A+K L+    S I   +A  E  +LK +  + ++ 
Sbjct: 19  SLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIG 78

Query: 110 CHAVFYTIEG-----EICFVMEHMERGSLFDSLRVR-KKLSEDVISGVAYRVLKGLQYLH 163
              VF +        +   VM +M+     D  ++    LSED +  + Y++L GL+Y+H
Sbjct: 79  LLDVFTSAVSGDEFQDFYLVMPYMQT----DLQKIMGHPLSEDKVQYLVYQMLCGLKYIH 134

Query: 164 GMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMG- 222
              IIH D+KP NL +N   E+KI DFG++R                      A A M  
Sbjct: 135 SAGIIHRDLKPGNLAVNEDCELKILDFGLAR---------------------HADAEMTG 173

Query: 223 ---TCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICA 279
              T  Y +PE + +  W   Y    D+WS+G ++ E L G     G  +  D +  I  
Sbjct: 174 YVVTRWYRAPEVILN--W-MHYNQTVDIWSVGCIMAEMLTGKTLFKG-KDYLDQLTQILK 229

Query: 280 IC------FGERLE-------------MPE--------TASPEFRRFVRSCLEKDWRKRG 312
           +       F ++LE              P          ASP+    +   LE D  KR 
Sbjct: 230 VTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRL 289

Query: 313 TVEELLAYPF 322
           T  E L +P+
Sbjct: 290 TATEALEHPY 299

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 70.9 bits (174), Expect = 9e-14
 Identities = 42/116 (36%), Positives = 60/116 (51%), Gaps = 16/116 (13%)

Query: 143 LSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNN 202
           LS D +    Y++L+GL+YLH   I+H DIKP NLL+N    +KI DFG++R VEE   +
Sbjct: 100 LSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLAR-VEEPDES 158

Query: 203 NNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECL 258
            +                + T  Y +PE +   R    Y  A D+WS+G +  E L
Sbjct: 159 KHMTQE------------VVTQYYRAPEILMGSR---HYTSAVDIWSVGCIFAELL 199

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 69.7 bits (170), Expect = 9e-14
 Identities = 74/274 (27%), Positives = 110/274 (40%), Gaps = 36/274 (13%)

Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVF 114
           +G GN G V+  R +  N+  A+K    T    ++ +   EA ILK+     IV+   V 
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62

Query: 115 YTIEGEICFVMEHMERGSLFDSLRVR-KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIK 173
            T +  I  VME ++ G     LR    +L    +  +      G++YL     IH D+ 
Sbjct: 63  -TQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLA 121

Query: 174 PSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMG-----TCAYMS 228
             N L+  K  +KI+DFG+SR  EE                +   A  G        + +
Sbjct: 122 ARNCLVTEKNVLKISDFGMSR--EEE---------------DGVYASTGGMKQIPVKWTA 164

Query: 229 PERVDSERWGGDYGFAGDVWSLGVVVLECL-VGHYPLIGFGEKPDLMALICAICFGERLE 287
           PE ++     G Y    DVWS G+++ E   +G  P      +    A    I  G RL 
Sbjct: 165 PEALNY----GRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREA----IEQGVRLP 216

Query: 288 MPETASPEFRRFVRSCLEKDWRKR---GTVEELL 318
            PE       R +  C E D  +R    TV + L
Sbjct: 217 CPELCPDAVYRLMERCWEYDPGQRPSFSTVHQEL 250

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 70.4 bits (172), Expect = 1e-13
 Identities = 52/155 (33%), Positives = 75/155 (48%), Gaps = 19/155 (12%)

Query: 55  LGHGNGGIVYKVRHQKSNSIYALK-VLNTTSSTIIRHQAAHEAEILKRL---DSQFIVKC 110
           +G G  G VYK R   S    ALK V   T+   +      E  +LKRL   D   IV+ 
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 111 HAVFYTI----EGEICFVMEHMERGSLFDSLRVRKK------LSEDVISGVAYRVLKGLQ 160
             V  T     E ++  V EH+++      LR          L  + I  +  + L+GL 
Sbjct: 68  MDVCATSRTDRETKVTLVFEHVDQ-----DLRTYLDKVPPPGLPAETIKDLMRQFLRGLD 122

Query: 161 YLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRI 195
           +LH   I+H D+KP N+L+   G+VK+ADFG++RI
Sbjct: 123 FLHANCIVHRDLKPENILVTSGGQVKLADFGLARI 157

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 69.7 bits (170), Expect = 1e-13
 Identities = 58/230 (25%), Positives = 103/230 (44%), Gaps = 26/230 (11%)

Query: 94  HEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLR--VRKKLSEDVISGV 151
            EA+++K+L  + +V+ +AV    E  I  V E+M +GSL D L+  + K L    +  +
Sbjct: 50  QEAQVMKKLRHEKLVQLYAV--VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDM 107

Query: 152 AYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNN 211
           A ++  G+ Y+  M  +H D++ +N+L+      K+ADFG++R++E+             
Sbjct: 108 AAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED------------- 154

Query: 212 NIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEK 270
           N   A         + +PE        G +    DVWS G+++ E    G  P  G   +
Sbjct: 155 NEYTARQGAKFPIKWTAPEAA----LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR 210

Query: 271 PDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY 320
                ++  +  G R+  P          +  C  K+  +R T E L A+
Sbjct: 211 ----EVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAF 256

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 69.8 bits (171), Expect = 1e-13
 Identities = 59/224 (26%), Positives = 96/224 (42%), Gaps = 41/224 (18%)

Query: 116 TIEGEICFVMEHMERGSLFDSLRVR----------------KKLSEDVISGVAYRVLKGL 159
           T EG +  V+E+   G+L D LR R                + L++  +   AY+V +G+
Sbjct: 86  TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGM 145

Query: 160 QYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIA 219
           ++L   + IH D+   N+L+     +KIADFG++R +          N      G   + 
Sbjct: 146 EFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTN------GRLPV- 198

Query: 220 CMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLE--CLVGH-YPLIGFGEKPDLMAL 276
                 +M+PE +        Y    DVWS GV++ E   L G  YP I   E   L+  
Sbjct: 199 -----KWMAPEALFDRV----YTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKE 249

Query: 277 ICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY 320
                 G R+E P+  + E    +R C  +   +R T ++L+  
Sbjct: 250 ------GYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 70.0 bits (172), Expect = 1e-13
 Identities = 40/154 (25%), Positives = 70/154 (45%), Gaps = 13/154 (8%)

Query: 56  GHGNGGIVYKVR--HQKSNSIYALKVLNTTSSTI--IRHQAAHEAEILKRLDSQFIVKCH 111
           G G  G VYK +  + K    YA+K           I   A  E  +L+ L  + +V   
Sbjct: 9   GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLV 68

Query: 112 AVFYT-IEGEICFVMEHMERGSL----FDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQ 166
            VF    +  +  + ++ E        F     R  +   ++  + +++L G+ YLH   
Sbjct: 69  EVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW 128

Query: 167 IIHGDIKPSNLLINGKGE----VKIADFGVSRIV 196
           ++H D+KP+N+L+ G+G     VKI D G++R+ 
Sbjct: 129 VLHRDLKPANILVMGEGPERGVVKIGDLGLARLF 162

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 68.7 bits (168), Expect = 2e-13
 Identities = 67/268 (25%), Positives = 116/268 (43%), Gaps = 31/268 (11%)

Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVF 114
           LG G  G VY+   +K +   A+K L     T+   +   EA ++K +    +V+   V 
Sbjct: 14  LGGGQYGEVYEGVWKKYSLTVAVKTLK--EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 71

Query: 115 YTIEGEICFVMEHMERGSLFDSLRV--RKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDI 172
            T E     + E M  G+L D LR   R++++  V+  +A ++   ++YL     IH D+
Sbjct: 72  -TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDL 130

Query: 173 KPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERV 232
              N L+     VK+ADFG+SR++               +   A         + +PE +
Sbjct: 131 AARNCLVGENHLVKVADFGLSRLMTG-------------DTYTAHAGAKFPIKWTAPESL 177

Query: 233 DSERWGGDYGFAGDVWSLGVVVLECL---VGHYPLIGFGEKPDLMALICAICFGERLEMP 289
              +    +    DVW+ GV++ E     +  YP I      DL  +   +  G R+E P
Sbjct: 178 AYNK----FSIKSDVWAFGVLLWEIATYGMSPYPGI------DLSQVYELLEKGYRMERP 227

Query: 290 ETASPEFRRFVRSCLEKDWRKRGTVEEL 317
           E   P+    +R+C + +   R +  E+
Sbjct: 228 EGCPPKVYELMRACWQWNPSDRPSFAEI 255

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 68.1 bits (166), Expect = 4e-13
 Identities = 61/280 (21%), Positives = 119/280 (42%), Gaps = 41/280 (14%)

Query: 45  NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQA-AHEAEILKRLD 103
           N+ +LK L  +G G  G V    ++ +    A+K +   ++     QA   EA ++ +L 
Sbjct: 4   NMKELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDATA----QAFLAEASVMTQLR 57

Query: 104 SQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKK--LSEDVISGVAYRVLKGLQY 161
              +V+   V    +G +  V E+M +GSL D LR R +  L  D +   +  V + ++Y
Sbjct: 58  HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 117

Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACM 221
           L     +H D+   N+L++     K++DFG+++    T++                    
Sbjct: 118 LEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL---------------- 161

Query: 222 GTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP----DLMALI 277
               + +PE +  ++    +    DVWS G+++ E       +  FG  P     L  ++
Sbjct: 162 -PVKWTAPEALREKK----FSTKSDVWSFGILLWE-------IYSFGRVPYPRIPLKDVV 209

Query: 278 CAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEEL 317
             +  G +++ P+   P     ++ C   D   R +  +L
Sbjct: 210 PRVEKGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQL 249

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 67.9 bits (166), Expect = 5e-13
 Identities = 62/255 (24%), Positives = 108/255 (42%), Gaps = 42/255 (16%)

Query: 46  ISDLKKLTVLGHGNGGIVYK-----VRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILK 100
           +S ++ L  LG G  G VYK        + S +  A+K L   +   ++ +   EAE++ 
Sbjct: 4   LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMS 63

Query: 101 RLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISG---------- 150
            L    IV C     T E   C + E++  G L + L VR     DV +           
Sbjct: 64  DLQHPNIV-CLLGVCTKEQPTCMLFEYLAHGDLHEFL-VRNSPHSDVGAESGDETVKSSL 121

Query: 151 -------VAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNN 203
                  +A ++  G++YL     +H D+   N L+     VKI+DFG+SR +       
Sbjct: 122 DCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDI------- 174

Query: 204 NHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECL-VGHY 262
            ++ +      ++ +       +M PE +   ++  +     D+WS GVV+ E    G  
Sbjct: 175 -YSADYYRVQSKSLLPVR----WMPPEAILYGKFTTE----SDIWSFGVVLWEIFSYGLQ 225

Query: 263 PLIGFGEKPDLMALI 277
           P  GF  + +++ +I
Sbjct: 226 PYYGFSNQ-EVIEMI 239

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 68.5 bits (167), Expect = 6e-13
 Identities = 58/218 (26%), Positives = 105/218 (48%), Gaps = 28/218 (12%)

Query: 49  LKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH-EAEILKRLDSQFI 107
            + LT +G G  G V      +     A+K L+    ++I  +  + E  +LK +  + +
Sbjct: 17  YQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENV 76

Query: 108 VKCHAVFY---TIE--GEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYL 162
           +    VF    +IE   E+  V   M  G+  +++   +KLS++ +  + Y++L+GL+Y+
Sbjct: 77  IGLLDVFTPATSIENFNEVYLVTNLM--GADLNNIVKCQKLSDEHVQFLIYQLLRGLKYI 134

Query: 163 HGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMG 222
           H   IIH D+KPSN+ +N   E++I DFG++R  ++                      + 
Sbjct: 135 HSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMT-----------------GYVA 177

Query: 223 TCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVG 260
           T  Y +PE + +  W   Y    D+WS+G ++ E L G
Sbjct: 178 TRWYRAPEIMLN--W-MHYNQTVDIWSVGCIMAELLKG 212

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 67.5 bits (165), Expect = 7e-13
 Identities = 72/295 (24%), Positives = 116/295 (39%), Gaps = 57/295 (19%)

Query: 55  LGHGNGGIVYKVRH-----QKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVK 109
           +G G  G V++ R       +  ++ A+K+L   +S  ++     EA ++   D   IVK
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72

Query: 110 CHAVFYTIEGE-ICFVMEHMERGSLFDSLRVRK----------------------KLSED 146
              V     G+ +C + E+M  G L + LR R                        LS  
Sbjct: 73  LLGV--CAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCT 130

Query: 147 VISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHN 206
               +A +V  G+ YL   + +H D+   N L+     VKIADFG+SR +      + + 
Sbjct: 131 EQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA---DYYK 187

Query: 207 NNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIG 266
            + N+ I            +M PE +   R    Y    DVW+ GVV+ E       +  
Sbjct: 188 ASENDAI---------PIRWMPPESIFYNR----YTTESDVWAYGVVLWE-------IFS 227

Query: 267 FGEKPDL-MA---LICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEEL 317
           +G +P   MA   +I  +  G  L  P+    E    +R C  K    R +   +
Sbjct: 228 YGMQPYYGMAHEEVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASI 282

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 66.8 bits (163), Expect = 1e-12
 Identities = 63/233 (27%), Positives = 100/233 (42%), Gaps = 36/233 (15%)

Query: 95  EAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKK-------LSEDV 147
           EA ++   +   IVK   V    E     +ME ME G L   LR  +        L+   
Sbjct: 49  EAHLMSNFNHPNIVKLLGVCLLNE-PQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKE 107

Query: 148 ISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGE-----VKIADFGVSRIVEETRNN 202
           +  +   V KG  YL  M  IH D+   N L++ KG      VKI DFG++R +      
Sbjct: 108 LLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDI------ 161

Query: 203 NNHNNNNNNNIGEAAIACMGTCAYMSPER-VDSERWGGDYGFAGDVWSLGVVVLECL-VG 260
             + ++     GE  +       +M+PE  +D     G +    DVWS GV++ E L +G
Sbjct: 162 --YKSDYYRKEGEGLL----PVRWMAPESLLD-----GKFTTQSDVWSFGVLMWEILTLG 210

Query: 261 HYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGT 313
             P      + +++  + A   G RL+ PE    +  + + +C  +D  +R T
Sbjct: 211 QQPYPALNNQ-EVLQHVTA---GGRLQKPENCPDKIYQLMTNCWAQDPSERPT 259

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 67.3 bits (164), Expect = 1e-12
 Identities = 64/247 (25%), Positives = 109/247 (44%), Gaps = 51/247 (20%)

Query: 95  EAEILKRLDS-QFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRK-----------K 142
           E E++K +   + I+    V  T EG +  ++E+  +G+L + LR R+           K
Sbjct: 67  EMELMKLIGKHKNIINLLGVC-TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITK 125

Query: 143 LSEDVIS-----GVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVE 197
           + E+ +S       AY+V +G++YL   + IH D+   N+L+     +KIADFG++R V 
Sbjct: 126 VPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVH 185

Query: 198 ETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPE----RVDSERWGGDYGFAGDVWSLGVV 253
           +    + +   +N  +            +M+PE    RV        Y    DVWS G++
Sbjct: 186 DI---DYYKKTSNGRL---------PVKWMAPEALFDRV--------YTHQSDVWSFGIL 225

Query: 254 VLECLV---GHYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRK 310
           + E        YP I   E   L  L+     G R++ P   + E    +R C      +
Sbjct: 226 MWEIFTLGGSPYPGIPVEE---LFKLLRE---GHRMDKPSNCTHELYMLMRECWHAVPTQ 279

Query: 311 RGTVEEL 317
           R T ++L
Sbjct: 280 RPTFKQL 286

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 67.6 bits (165), Expect = 1e-12
 Identities = 50/175 (28%), Positives = 83/175 (47%), Gaps = 21/175 (12%)

Query: 145 EDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNN 204
           ED++S  +Y+V KG+ +L     IH D+   N+L+      KI DFG++R   + RN++N
Sbjct: 214 EDLLS-FSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLAR---DIRNDSN 269

Query: 205 HNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECL-VGHYP 263
           +    N  +            +M+PE +    +   Y F  DVWS G+++ E   +G  P
Sbjct: 270 YVVKGNARL---------PVKWMAPESI----FNCVYTFESDVWSYGILLWEIFSLGSSP 316

Query: 264 LIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELL 318
             G         +I     G R+  PE A  E    ++SC + D  KR T ++++
Sbjct: 317 YPGMPVDSKFYKMIKE---GYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIV 368

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 67.0 bits (163), Expect = 2e-12
 Identities = 55/219 (25%), Positives = 97/219 (44%), Gaps = 32/219 (14%)

Query: 55  LGHGNGGIVYKVRHQ--KSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHA 112
           +G G  G VYK + +  K    YALK +  T    I   A  E  +L+ L    ++    
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG---ISMSACREIALLRELKHPNVIALQK 65

Query: 113 VFYTIEGEICFVMEHMERGSLFDSLRVRK---------KLSEDVISGVAYRVLKGLQYLH 163
           VF +      +++       L+  ++  +         +L   ++  + Y++L G+ YLH
Sbjct: 66  VFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH 125

Query: 164 GMQIIHGDIKPSNLLING----KGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIA 219
              ++H D+KP+N+L+ G    +G VKIAD G +R+           N+    + +    
Sbjct: 126 ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF----------NSPLKPLADLDPV 175

Query: 220 CMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECL 258
            + T  Y +PE +   R    Y  A D+W++G +  E L
Sbjct: 176 VV-TFWYRAPELLLGAR---HYTKAIDIWAIGCIFAELL 210

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 66.9 bits (163), Expect = 2e-12
 Identities = 67/282 (23%), Positives = 113/282 (40%), Gaps = 34/282 (12%)

Query: 47  SDLKKLTVLGHGNGGIVYK----VRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRL 102
           ++ KK+ VLG G  G VYK       +K     A+K L   +S     +   EA ++  +
Sbjct: 7   TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 66

Query: 103 DSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQY 161
           D+  +  C  +   +   +  + + M  G L D +R  K  +    +     ++ KG+ Y
Sbjct: 67  DNPHV--CRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 124

Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACM 221
           L   +++H D+   N+L+     VKI DFG+++++             +   G+  I   
Sbjct: 125 LEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLL------GADEKEYHAEGGKVPI--- 175

Query: 222 GTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP----DLMALI 277
               +M+ E +        Y    DVWS GV V E       L+ FG KP        + 
Sbjct: 176 ---KWMALESI--LHR--IYTHQSDVWSYGVTVWE-------LMTFGSKPYDGIPASEIS 221

Query: 278 CAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA 319
             +  GERL  P   + +    +  C   D   R    EL+ 
Sbjct: 222 SILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELII 263

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 66.2 bits (161), Expect = 2e-12
 Identities = 73/284 (25%), Positives = 118/284 (41%), Gaps = 49/284 (17%)

Query: 55  LGHGNGGIV-----YKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVK 109
           LG G  G V     Y +  ++   + A+K L   S    R     EAE+L  L  + IVK
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNA-RKDFHREAELLTNLQHEHIVK 71

Query: 110 CHAVFYTIEGE-ICFVMEHMERGSLFDSLRVR-------------KKLSEDVISGVAYRV 155
            + V   +EG+ +  V E+M+ G L   LR                +L++  +  +A ++
Sbjct: 72  FYGV--CVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQI 129

Query: 156 LKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGE 215
             G+ YL     +H D+   N L+     VKI DFG+SR V  T         +   +G 
Sbjct: 130 AAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYST---------DYYRVGG 180

Query: 216 AAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLM- 274
                M    +M PE +   ++  +     DVWSLGVV+ E       +  +G++P    
Sbjct: 181 HT---MLPIRWMPPESIMYRKFTTE----SDVWSLGVVLWE-------IFTYGKQPWYQL 226

Query: 275 ---ALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVE 315
               +I  I  G  L+ P T   E    +  C +++   R  ++
Sbjct: 227 SNNEVIECITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIK 270

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 66.4 bits (162), Expect = 2e-12
 Identities = 72/275 (26%), Positives = 120/275 (43%), Gaps = 33/275 (12%)

Query: 54  VLGHGNGGIV-----YKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQF-I 107
            LG G  G V     Y +    +    A+K+L  T+ +  R     E +I+  L +   I
Sbjct: 42  TLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENI 101

Query: 108 VKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKK--LSEDVISGVAYRVLKGLQYLHGM 165
           V       TI G I  + E+   G L + LR +++  L+ + +   +Y+V KG+ +L   
Sbjct: 102 VNLLGAC-TIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK 160

Query: 166 QIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCA 225
             IH D+   N+L+     VKI DFG++R   +  N++N+    N  +            
Sbjct: 161 NCIHRDLAARNVLLTHGKIVKICDFGLAR---DIMNDSNYVVKGNARL---------PVK 208

Query: 226 YMSPERVDSERWGGDYGFAGDVWSLGVVVLECL---VGHYPLIGFGEKPDLMALICAICF 282
           +M+PE +    +   Y F  DVWS G+++ E        YP +    K         I  
Sbjct: 209 WMAPESI----FNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK-----FYKLIKE 259

Query: 283 GERLEMPETASPEFRRFVRSCLEKDWRKRGTVEEL 317
           G R+  PE A  E    +++C + D  KR T +++
Sbjct: 260 GYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQI 294

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 66.8 bits (163), Expect = 3e-12
 Identities = 50/169 (29%), Positives = 79/169 (46%), Gaps = 19/169 (11%)

Query: 92  AAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVR-KKLSEDVISG 150
           + HEA +L+RL    ++    V   + G  C V+    R  L+  L  R + L    ++ 
Sbjct: 207 SVHEARLLRRLSHPAVLALLDV-RVVGGLTCLVLPKY-RSDLYTYLGARLRPLGLAQVTA 264

Query: 151 VAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNN 210
           VA ++L  + Y+HG  IIH DIK  N+L+NG  ++ + DFG +     + +   H     
Sbjct: 265 VARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFH----- 319

Query: 211 NNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV 259
                  IA  GT    +PE +     G  Y  + D+WS G+V+ E  V
Sbjct: 320 -----YGIA--GTVDTNAPEVLA----GDPYTPSVDIWSAGLVIFEAAV 357

Length = 461

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 65.5 bits (159), Expect = 5e-12
 Identities = 55/219 (25%), Positives = 98/219 (44%), Gaps = 32/219 (14%)

Query: 55  LGHGNGGIVYKVRHQ--KSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHA 112
           +G G  G VYK + +  K +  YALK +  T    I   A  E  +L+ L    ++    
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG---ISMSACREIALLRELKHPNVISLQK 65

Query: 113 VFYTIEGEICFVMEHMERGSLFDSLRVRK---------KLSEDVISGVAYRVLKGLQYLH 163
           VF +      +++       L+  ++  +         +L   ++  + Y++L G+ YLH
Sbjct: 66  VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 125

Query: 164 GMQIIHGDIKPSNLLING----KGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIA 219
              ++H D+KP+N+L+ G    +G VKIAD G +R+           N+    + +    
Sbjct: 126 ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF----------NSPLKPLADLDPV 175

Query: 220 CMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECL 258
            + T  Y +PE +   R    Y  A D+W++G +  E L
Sbjct: 176 VV-TFWYRAPELLLGAR---HYTKAIDIWAIGCIFAELL 210

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 64.6 bits (157), Expect = 7e-12
 Identities = 54/216 (25%), Positives = 96/216 (44%), Gaps = 37/216 (17%)

Query: 55  LGHGNGGIVYKVRHQKSNSIY-ALK-VLNTTSSTIIRHQAAHEAEILKRLDS-------Q 105
           +G G  G V+K R  K+   + ALK V   T    +      E  +L+ L++       +
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68

Query: 106 FIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSE-----DVISGVAYRVLKGLQ 160
               C       E ++  V EH+++    D      K+ E     + I  + +++L+GL 
Sbjct: 69  LFDVCTVSRTDRETKLTLVFEHVDQ----DLTTYLDKVPEPGVPTETIKDMMFQLLRGLD 124

Query: 161 YLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIAC 220
           +LH  +++H D+KP N+L+   G++K+ADFG++RI                +   A  + 
Sbjct: 125 FLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY---------------SFQMALTSV 169

Query: 221 MGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLE 256
           + T  Y +PE +        Y    D+WS+G +  E
Sbjct: 170 VVTLWYRAPEVL----LQSSYATPVDLWSVGCIFAE 201

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 65.0 bits (158), Expect = 8e-12
 Identities = 56/222 (25%), Positives = 98/222 (44%), Gaps = 41/222 (18%)

Query: 116 TIEGEICFVMEHMERGSLFDSLRVRK-----------KLSEDVIS-----GVAYRVLKGL 159
           T +G +  ++E+  +G+L + LR R+           KL E+ ++       AY+V +G+
Sbjct: 88  TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGM 147

Query: 160 QYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIA 219
           +YL   + IH D+   N+L+     +KIADFG++R   +  N + +    N  +      
Sbjct: 148 EYLASQKCIHRDLAARNVLVTEDNVMKIADFGLAR---DVHNIDYYKKTTNGRL------ 198

Query: 220 CMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV---GHYPLIGFGEKPDLMAL 276
                 +M+PE +    +   Y    DVWS GV++ E        YP I   E   L+  
Sbjct: 199 ---PVKWMAPEAL----FDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKE 251

Query: 277 ICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELL 318
                 G R++ P   + E    +R C      +R T ++L+
Sbjct: 252 ------GHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLV 287

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 63.9 bits (155), Expect = 1e-11
 Identities = 68/282 (24%), Positives = 123/282 (43%), Gaps = 39/282 (13%)

Query: 55  LGHGNGGIVYK-----VRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVK 109
           LG G+ G+VY+     V   +  +  A+K +N  +S   R +  +EA ++K  +   +V+
Sbjct: 14  LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 110 CHAVFYTIEGEICFV-MEHMERGSLFDSLR-VRKKLSEDVISG---------VAYRVLKG 158
              V    +G+   V ME M RG L   LR +R ++  + +           +A  +  G
Sbjct: 74  LLGV--VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADG 131

Query: 159 LQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAI 218
           + YL+  + +H D+   N ++     VKI DFG++R + ET        +     G+  +
Sbjct: 132 MAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET--------DYYRKGGKGLL 183

Query: 219 ACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLE-CLVGHYPLIGFGEKPDLMALI 277
                  +MSPE +      G +    DVWS GVV+ E   +   P  G   +  L  ++
Sbjct: 184 PVR----WMSPESLKD----GVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVM 235

Query: 278 CAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA 319
                G  L+ P+         +R C + + + R +  E+++
Sbjct: 236 ----EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 273

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 63.4 bits (154), Expect = 1e-11
 Identities = 49/200 (24%), Positives = 89/200 (44%), Gaps = 34/200 (17%)

Query: 124 VMEHMERGSLFDSLRVRKKLSEDVISGVAYR--VLKGLQYLHGMQIIHGDIKPSNLLING 181
           VME M +G+L + LR R +    VI  + +   V +G++YL   +++H D+   N+L++ 
Sbjct: 76  VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSE 135

Query: 182 KGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDY 241
            G  K++DFG++R+     +N+                      + +PE +        +
Sbjct: 136 DGVAKVSDFGLARVGSMGVDNS-----------------KLPVKWTAPEALKH----KKF 174

Query: 242 GFAGDVWSLGVVVLECLVGHYPLIGFGEKP----DLMALICAICFGERLEMPETASPEFR 297
               DVWS GV++ E       +  +G  P     L  +   +  G R+E PE    +  
Sbjct: 175 SSKSDVWSYGVLLWE-------VFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVY 227

Query: 298 RFVRSCLEKDWRKRGTVEEL 317
             + SC E + +KR +  +L
Sbjct: 228 VLMTSCWETEPKKRPSFHKL 247

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 63.6 bits (155), Expect = 1e-11
 Identities = 66/264 (25%), Positives = 112/264 (42%), Gaps = 36/264 (13%)

Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVF 114
           LG G  G V++    K+    A+K+L +    + +     E + LKRL  + ++   AV 
Sbjct: 14  LGSGYFGEVWEGL-WKNRVRVAIKILKS-DDLLKQQDFQKEVQALKRLRHKHLISLFAV- 70

Query: 115 YTIEGE-ICFVMEHMERGSLFDSLRVRKKLSEDVIS--GVAYRVLKGLQYLHGMQIIHGD 171
               GE +  + E ME+GSL   LR  +     V S   +A +V +G+ YL     IH D
Sbjct: 71  -CSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRD 129

Query: 172 IKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPER 231
           +   N+L+      K+ADFG++R+++E     +   +++  I            + +PE 
Sbjct: 130 LAARNILVGEDLVCKVADFGLARLIKE-----DVYLSSDKKI---------PYKWTAPEA 175

Query: 232 VDSERWGGDYGFAGDVWSLGVVVLECLVGH----YPLIGFGEKPDLMALICAICFGERLE 287
                  G +    DVWS G+++ E +  +    YP +   E  D       I  G R+ 
Sbjct: 176 ASH----GTFSTKSDVWSFGILLYE-MFTYGQVPYPGMNNHEVYDQ------ITAGYRMP 224

Query: 288 MPETASPEFRRFVRSCLEKDWRKR 311
            P     E  + +  C   +   R
Sbjct: 225 CPAKCPQEIYKIMLECWAAEPEDR 248

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 64.7 bits (157), Expect = 2e-11
 Identities = 61/240 (25%), Positives = 110/240 (45%), Gaps = 28/240 (11%)

Query: 91  QAAH---EAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKK----L 143
           QAA+   E   L   D   IVK H   +  + ++  +ME+   G L   ++ R K     
Sbjct: 108 QAAYARSELHCLAACDHFGIVK-HFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPF 166

Query: 144 SEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNN 203
            E  +  + Y+++  L  +H  +++H D+K +N+ +   G +K+ DFG S+         
Sbjct: 167 QEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSK--------- 217

Query: 204 NHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYP 263
               +++ ++  A+  C GT  Y++PE  + +R    Y    D+WSLGV++ E L  H P
Sbjct: 218 --QYSDSVSLDVASSFC-GTPYYLAPELWERKR----YSKKADMWSLGVILYELLTLHRP 270

Query: 264 LIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV 323
             G    P    ++  + +G+    P   S   +  +   L K+   R T ++LL   F+
Sbjct: 271 FKG----PSQREIMQQVLYGKYDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFL 326

Length = 478

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 62.7 bits (152), Expect = 3e-11
 Identities = 57/223 (25%), Positives = 97/223 (43%), Gaps = 43/223 (19%)

Query: 116 TIEGEICFVMEHMERGSLFDSLRVRKKLS-----------------EDVISGVAYRVLKG 158
           T +G +  ++E+  +G+L + LR R+                    +D++S   Y+V +G
Sbjct: 91  TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVS-CTYQVARG 149

Query: 159 LQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAI 218
           ++YL   + IH D+   N+L+     +KIADFG++R V    NN ++     N  G   +
Sbjct: 150 MEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDV----NNIDYYKKTTN--GRLPV 203

Query: 219 ACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV---GHYPLIGFGEKPDLMA 275
                  +M+PE +    +   Y    DVWS GV++ E        YP I   E   L+ 
Sbjct: 204 ------KWMAPEAL----FDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK 253

Query: 276 LICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELL 318
                  G R++ P   + E    +R C       R T ++L+
Sbjct: 254 E------GHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLV 290

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 60.9 bits (148), Expect = 4e-11
 Identities = 43/214 (20%), Positives = 67/214 (31%), Gaps = 57/214 (26%)

Query: 131 GSLFDSLRVRKK-LSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIAD 189
            SL D L VR + L+E+ I  V  + L  L+ LH        +   + L+   G V    
Sbjct: 1   VSLADILEVRGRPLNEEEIWAVCLQCLGALRELHRQAKSGNILLTWDGLLKLDGSVAFK- 59

Query: 190 FGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWS 249
                    T   +                      +M+PE V   +    Y    D++S
Sbjct: 60  ---------TPEQSR-----------------PDPYFMAPE-VIQGQ---SYTEKADIYS 89

Query: 250 LGVVVLECLVGHYPLIGFGE---KPDLMALICAICFGERLEMPET------------ASP 294
           LG+ + E L    P     E      L  L+          MP              A+ 
Sbjct: 90  LGITLYEALDYELP--YNEERELSAILEILL--------NGMPADDPRDRSNLEGVSAAR 139

Query: 295 EFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSS 328
            F  F+R C  +  ++R      LA+       +
Sbjct: 140 SFEDFMRLCASRLPQRREAANHYLAHCRALFAET 173

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 62.3 bits (151), Expect = 4e-11
 Identities = 69/279 (24%), Positives = 116/279 (41%), Gaps = 32/279 (11%)

Query: 47  SDLKKLTVLGHGNGGIVYK-VRHQKSNSI---YALKVLNTTSSTIIRHQAAHEAEILKRL 102
           ++L+KL +LG G  G V+K +   + +SI    A+K +   S      +       +  L
Sbjct: 7   TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSL 66

Query: 103 DSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQY 161
           D  +IV+   +       +  V +    GSL D +R  +  L    +     ++ KG+ Y
Sbjct: 67  DHAYIVRLLGI--CPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYY 124

Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACM 221
           L   +++H ++   N+L+     V+IADFGV+ ++        ++ +             
Sbjct: 125 LEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKT----------- 173

Query: 222 GTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGF--GEKPDLMALIC 278
               +M+ E +      G Y    DVWS GV V E +  G  P  G    E PDL+    
Sbjct: 174 -PIKWMALESILF----GRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEK-- 226

Query: 279 AICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEEL 317
               GERL  P+  + +    +  C   D   R T +EL
Sbjct: 227 ----GERLAQPQICTIDVYMVMVKCWMIDENVRPTFKEL 261

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 62.3 bits (151), Expect = 5e-11
 Identities = 54/220 (24%), Positives = 98/220 (44%), Gaps = 37/220 (16%)

Query: 116 TIEGEICFVMEHMERGSLFDSLRVRK----------------KLSEDVISGVAYRVLKGL 159
           T +G +  ++E+  +G+L + LR R+                +LS   +   AY+V +G+
Sbjct: 94  TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGM 153

Query: 160 QYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIA 219
           +YL   + IH D+   N+L+     +KIADFG++R +      + +    N  +      
Sbjct: 154 EYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI---DYYKKTTNGRL------ 204

Query: 220 CMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECL-VGHYPLIGFGEKPDLMALIC 278
                 +M+PE +    +   Y    DVWS GV++ E   +G  P  G   + +L  L+ 
Sbjct: 205 ---PVKWMAPEAL----FDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE-ELFKLLK 256

Query: 279 AICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELL 318
               G R++ P   + E    +R C      +R T ++L+
Sbjct: 257 E---GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLV 293

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 62.3 bits (151), Expect = 5e-11
 Identities = 71/286 (24%), Positives = 113/286 (39%), Gaps = 46/286 (16%)

Query: 55  LGHGNGGIV-----YKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVK 109
           LG G  G V     Y +   K   + A+K L   +    R     EAE+L  L  + IVK
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAA-RKDFQREAELLTNLQHEHIVK 71

Query: 110 CHAVFYTIEGE-ICFVMEHMERGSLFDSLRVRKKLSEDVISG----------------VA 152
            + V    +G+ +  V E+M+ G L   LR     +  ++ G                +A
Sbjct: 72  FYGV--CGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 129

Query: 153 YRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNN 212
            ++  G+ YL     +H D+   N L+     VKI DFG+SR V  T         +   
Sbjct: 130 SQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYST---------DYYR 180

Query: 213 IGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKP 271
           +G      M    +M PE +   ++  +     DVWS GV++ E    G  P        
Sbjct: 181 VGGHT---MLPIRWMPPESIMYRKFTTE----SDVWSFGVILWEIFTYGKQPWFQLSNT- 232

Query: 272 DLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEEL 317
               +I  I  G  LE P     E    +  C +++ ++R  ++E+
Sbjct: 233 ---EVIECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEI 275

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 61.9 bits (150), Expect = 8e-11
 Identities = 69/312 (22%), Positives = 119/312 (38%), Gaps = 55/312 (17%)

Query: 56  GHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFY 115
           G  N   VY  RH  + ++  +++ +  + T    +A     +L        +      +
Sbjct: 9   GFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVF 68

Query: 116 TIEGEICFVMEHMERGSLFDSLRVR--KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIK 173
           T    +  +   M  GS    L+    + +SE +I  + +  L+GL YLH    IH +IK
Sbjct: 69  TTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIK 128

Query: 174 PSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVD 233
            S++LI+G G V ++  G+S +    RN        +      ++       ++SPE + 
Sbjct: 129 ASHILISGDGLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSVL-----PWLSPELLR 181

Query: 234 SERWGGDYGFAGDVWSLGVVVLECLVGHYPLI---------------------------- 265
            + +G  Y    D++S+G+   E   G  P                              
Sbjct: 182 QDLYG--YNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCE 239

Query: 266 -------------GFGEKPDLMALICAICFGERLEMP--ETASPEFRRFVRSCLEKDWRK 310
                        G GE   + A +      ERL  P  +T SP F+  V  CL++D  K
Sbjct: 240 ESRMKNSQSGVDSGIGESV-VAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEK 298

Query: 311 RGTVEELLAYPF 322
           R +   LL++ F
Sbjct: 299 RPSASSLLSHAF 310

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 61.9 bits (150), Expect = 8e-11
 Identities = 48/178 (26%), Positives = 85/178 (47%), Gaps = 27/178 (15%)

Query: 145 EDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNN 204
           ED+I   +++V +G+++L   + IH D+   N+L++    VKI DFG++R +        
Sbjct: 174 EDLIC-YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDI-------- 224

Query: 205 HNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECL---VGH 261
           + + +    G A +       +M+PE +    +   Y    DVWS GV++ E        
Sbjct: 225 YKDPDYVRKGSARLP----LKWMAPESI----FDKVYTTQSDVWSFGVLLWEIFSLGASP 276

Query: 262 YPLIGFGEKPDLMALICA-ICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELL 318
           YP +   E+       C  +  G R+  PE A+PE  R + +C + D ++R T   L+
Sbjct: 277 YPGVQINEE------FCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALV 328

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 61.6 bits (149), Expect = 8e-11
 Identities = 74/293 (25%), Positives = 111/293 (37%), Gaps = 64/293 (21%)

Query: 47  SDLKKLTVLGHGNGGIVYKVRHQKSN--SIYALKVLNTTSSTIIRHQAAHEAEILKRLDS 104
           +D+K   V+G GN G V K R +K       A+K +   +S       A E E+L +L  
Sbjct: 7   NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 66

Query: 105 Q-----FIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYR----- 154
                  +  C        G +   +E+   G+L D LR  + L  D    +A       
Sbjct: 67  HPNIINLLGACEH-----RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 121

Query: 155 -----------VLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNN 203
                      V +G+ YL   Q IH D+   N+L+      KIADFG+SR  E      
Sbjct: 122 SSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV--- 178

Query: 204 NHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYP 263
                    +G   +       +M+ E ++       Y    DVWS GV++ E       
Sbjct: 179 ------KKTMGRLPV------RWMAIESLNYSV----YTTNSDVWSYGVLLWE------- 215

Query: 264 LIGFGEKPDLMALICAICF-----GERLEMPETASPEFRRFVRSCLEKDWRKR 311
           ++  G  P    + CA  +     G RLE P     E    +R C    WR++
Sbjct: 216 IVSLGGTP-YCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQC----WREK 263

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 62.2 bits (151), Expect = 9e-11
 Identities = 61/264 (23%), Positives = 101/264 (38%), Gaps = 52/264 (19%)

Query: 95  EAEILKRLDSQFIVKC-HAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAY 153
           E +ILK +  + I+   HA  Y  +  +C VM    +  LF  +     L  +    +  
Sbjct: 136 EIDILKTISHRAIINLIHA--YRWKSTVCMVMPKY-KCDLFTYVDRSGPLPLEQAITIQR 192

Query: 154 RVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNI 213
           R+L+ L YLHG  IIH D+K  N+ ++      + DFG +  ++        + +     
Sbjct: 193 RLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDA-------HPDTPQCY 245

Query: 214 GEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGF---GEK 270
           G +     GT    SPE +  +     Y    D+WS G+V+ E  V +  L G       
Sbjct: 246 GWS-----GTLETNSPELLALD----PYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSS 296

Query: 271 PDLMALI---------------CAIC-----FGERLEMPETASPEFRRFVRS-------- 302
             L ++I                 +C     +   L  P T  P  R++           
Sbjct: 297 SQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIA 356

Query: 303 -CLEKDWRKRGTVEELLAYPFVTK 325
             L  D   R + +++L+ P  TK
Sbjct: 357 KMLTFDQEFRPSAQDILSLPLFTK 380

Length = 392

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 61.2 bits (148), Expect = 1e-10
 Identities = 45/177 (25%), Positives = 82/177 (46%), Gaps = 25/177 (14%)

Query: 145 EDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNN 204
           ED+I   +++V KG+++L   + IH D+   N+L++    VKI DFG++R +        
Sbjct: 179 EDLIC-YSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDI-------- 229

Query: 205 HNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECL---VGH 261
           + + +    G+A +       +M+PE +    +   Y    DVWS GV++ E        
Sbjct: 230 YKDPDYVRKGDARLP----LKWMAPETI----FDRVYTIQSDVWSFGVLLWEIFSLGASP 281

Query: 262 YPLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELL 318
           YP +   E+         +  G R+  P+  +PE  + +  C   +  +R T  EL+
Sbjct: 282 YPGVKIDEE-----FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELV 333

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 60.4 bits (146), Expect = 2e-10
 Identities = 67/291 (23%), Positives = 127/291 (43%), Gaps = 40/291 (13%)

Query: 44  ENISDLKKLTVLGHGNGGIVYK-----VRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEI 98
           E I+ L++L   G G+ G+VY+     +   ++ +  A+K +N ++S   R +  +EA +
Sbjct: 6   EKITLLREL---GQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASV 62

Query: 99  LKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSED----------VI 148
           +K      +V+   V    +  +  VME M  G L   LR  +  +E+           +
Sbjct: 63  MKGFTCHHVVRLLGVVSKGQPTLV-VMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 121

Query: 149 SGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNN 208
             +A  +  G+ YL+  + +H D+   N ++     VKI DFG++R + ET        +
Sbjct: 122 IQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYET--------D 173

Query: 209 NNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLE-CLVGHYPLIGF 267
                G+  +       +M+PE +      G +  + D+WS GVV+ E   +   P  G 
Sbjct: 174 YYRKGGKGLLPV----RWMAPESLKD----GVFTTSSDMWSFGVVLWEITSLAEQPYQGL 225

Query: 268 GEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELL 318
             +  L  ++     G  L+ P+         +R C + + + R T  E++
Sbjct: 226 SNEQVLKFVMD----GGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIV 272

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 61.3 bits (148), Expect = 3e-10
 Identities = 68/299 (22%), Positives = 125/299 (41%), Gaps = 51/299 (17%)

Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTS-STIIRHQAAHEAEILKRLDSQFIVKCHAV 113
           +G+G  G V+ V+H+++   +  K ++        + Q   E  +++ L  + IV+    
Sbjct: 21  IGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDR 80

Query: 114 FYTIEGEICFV-MEHMERGSLFDSL----RVRKKLSEDVISGVAYRVLKGLQYLH----- 163
           F     +  ++ ME  + G L  ++    ++  K+ E  I  +  ++L  L Y H     
Sbjct: 81  FLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDG 140

Query: 164 --GMQIIHGDIKPSNLL-----------------INGKGEVKIADFGVSRIVEETRNNNN 204
             G +++H D+KP N+                  +NG+   KI DFG+S+          
Sbjct: 141 PNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSK---------- 190

Query: 205 HNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPL 264
                N  I   A +C+GT  Y SPE +  E     Y    D+W+LG ++ E   G  P 
Sbjct: 191 -----NIGIESMAHSCVGTPYYWSPELLLHET--KSYDDKSDMWALGCIIYELCSGKTP- 242

Query: 265 IGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV 323
             F +  +   LI  +  G  L + +  S E    +++ L    ++R +  + L Y  +
Sbjct: 243 --FHKANNFSQLISELKRGPDLPI-KGKSKELNILIKNLLNLSAKERPSALQCLGYQII 298

Length = 1021

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 58.9 bits (142), Expect = 4e-10
 Identities = 66/266 (24%), Positives = 108/266 (40%), Gaps = 25/266 (9%)

Query: 54  VLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAV 113
           +LG GN G V+K   +    + A+K         ++ +   EA ILK+ D   IVK   V
Sbjct: 2   LLGKGNFGEVFKGTLKDKTPV-AVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGV 60

Query: 114 FYTIEGEICFVMEHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQYLHGMQIIHGDI 172
             T    I  VME +  G     LR +K +L    +   A     G+ YL     IH D+
Sbjct: 61  C-TQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDL 119

Query: 173 KPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERV 232
              N L+     +KI+DFG+SR         +    +++ + +  I       + +PE +
Sbjct: 120 AARNCLVGENNVLKISDFGMSR-------QEDDGIYSSSGLKQIPI------KWTAPEAL 166

Query: 233 DSERWGGDYGFAGDVWSLGVVVLECL-VGHYPLIGFGEKPDLMALICAICFGERLEMPET 291
           +     G Y    DVWS G+++ E   +G  P  G   +         +  G R+  P+ 
Sbjct: 167 NY----GRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQARE----QVEKGYRMSCPQK 218

Query: 292 ASPEFRRFVRSCLEKDWRKRGTVEEL 317
              +  + ++ C +     R    EL
Sbjct: 219 CPDDVYKVMQRCWDYKPENRPKFSEL 244

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 58.6 bits (142), Expect = 7e-10
 Identities = 49/239 (20%), Positives = 99/239 (41%), Gaps = 43/239 (17%)

Query: 32  HFPTSNPTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNS-----IYALKVLNTTSST 86
            FP SN           L+++T LG G  G V+  + +         +  +K L  T   
Sbjct: 1   AFPRSN-----------LQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDE 49

Query: 87  IIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSED 146
            ++ +   E ++ ++L  + +V+   +    E     ++E+ + G L   LR  K   E 
Sbjct: 50  NLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH-YMILEYTDLGDLKQFLRATKSKDEK 108

Query: 147 VIS---------GVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVE 197
           +            +  ++  G+ +L   + +H D+   N L++ + EVK++   +S+   
Sbjct: 109 LKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSK--- 165

Query: 198 ETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLE 256
           +  N+  +   N       A+  +    +++PE V       D+    DVWS GV++ E
Sbjct: 166 DVYNSEYYKLRN-------ALIPL---RWLAPEAVQE----DDFSTKSDVWSFGVLMWE 210

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 58.8 bits (142), Expect = 8e-10
 Identities = 50/194 (25%), Positives = 86/194 (44%), Gaps = 28/194 (14%)

Query: 76  ALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSL-- 133
           A+K+L   ++   R+    E +I+ RL    I++  AV  T +  +C + E+ME G L  
Sbjct: 50  AVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSD-PLCMITEYMENGDLNQ 108

Query: 134 -FDSLRVRKKLSEDVISGVAYRVLK--------GLQYLHGMQIIHGDIKPSNLLINGKGE 184
                  ++   +  +  ++Y  L         G++YL  +  +H D+   N L+     
Sbjct: 109 FLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYT 168

Query: 185 VKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFA 244
           +KIADFG+SR        N ++ +     G A +       +MS E +      G +  A
Sbjct: 169 IKIADFGMSR--------NLYSGDYYRIQGRAVLPIR----WMSWESI----LLGKFTTA 212

Query: 245 GDVWSLGVVVLECL 258
            DVW+ GV + E L
Sbjct: 213 SDVWAFGVTLWEIL 226

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 57.3 bits (138), Expect = 2e-09
 Identities = 76/296 (25%), Positives = 110/296 (37%), Gaps = 72/296 (24%)

Query: 48  DLKKLTVLGHGNGGIVYKVRHQKSNSIY--ALKVLNTTSSTIIRHQAAHEAEILKRLDSQ 105
           D+K   V+G GN G V +   +K       A+K+L   +S       A E E+L +L   
Sbjct: 3   DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHH 62

Query: 106 -----FIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSED--------VISGVA 152
                 +  C        G +   +E+   G+L D LR  + L  D          S + 
Sbjct: 63  PNIINLLGACEN-----RGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLT 117

Query: 153 YRVL--------KGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNN 204
            + L         G+QYL   Q IH D+   N+L+      KIADFG+SR          
Sbjct: 118 SQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR---------- 167

Query: 205 HNNNNNNNIGEAAIA--CMGTCA--YMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVG 260
                    GE       MG     +M+ E ++       Y    DVWS GV++ E    
Sbjct: 168 ---------GEEVYVKKTMGRLPVRWMAIESLNYSV----YTTKSDVWSFGVLLWE---- 210

Query: 261 HYPLIGFGEKPDLMALICAICF-----GERLEMPETASPEFRRFVRSCLEKDWRKR 311
              ++  G  P    + CA  +     G R+E P     E    +R C    WR R
Sbjct: 211 ---IVSLGGTP-YCGMTCAELYEKLPQGYRMEKPRNCDDEVYELMRQC----WRDR 258

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 56.8 bits (137), Expect = 2e-09
 Identities = 58/248 (23%), Positives = 100/248 (40%), Gaps = 60/248 (24%)

Query: 86  TIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSE 145
           TII H   +   + K     +IV   +VF         V++H E G L+  +     + E
Sbjct: 38  TIIPHCVPNMVCLHK-----YIVSEDSVF--------LVLQHAEGGKLWSHISKFLNIPE 84

Query: 146 DVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNH 205
           + +   A  ++  L  LH   I+  D+ P+N+L++ +G +++  F     VE++ +    
Sbjct: 85  ECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGE-- 142

Query: 206 NNNNNNNIGEAAIACMGTCAYMSPERVDSERWGG--DYGFAGDVWSLGVVVLECLVGHYP 263
                      A+  M    Y +PE       GG  +   A D WSLG ++ E L G   
Sbjct: 143 -----------AVENM----YCAPEV------GGISEETEACDWWSLGAILFELLTG--- 178

Query: 264 LIGFGEKPDLMALI----CAICFGERLEMPETASPEFRRFVRSCLEKDWRKR-----GTV 314
                       L+      I     L +PE  S E R  ++  L+ +  +R       V
Sbjct: 179 ----------KTLVECHPSGINTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGV 228

Query: 315 EELLAYPF 322
           E++ ++PF
Sbjct: 229 EDIKSHPF 236

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 57.4 bits (138), Expect = 4e-09
 Identities = 30/68 (44%), Positives = 39/68 (57%)

Query: 126 EHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEV 185
           E M  G        + K   +VI GV  +VL GL+ LH + I+H DIKP NLL+   G+V
Sbjct: 289 EFMMAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQV 348

Query: 186 KIADFGVS 193
           KI DFG +
Sbjct: 349 KIIDFGAA 356

Length = 507

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 57.0 bits (137), Expect = 5e-09
 Identities = 49/199 (24%), Positives = 80/199 (40%), Gaps = 47/199 (23%)

Query: 154 RVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNI 213
           ++L  ++Y+H  ++IH DIK  N+ +N  G++ + DFG +   E+ R   ++        
Sbjct: 275 QLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDY-------- 326

Query: 214 GEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHY-PLIGFGEKP- 271
                  +GT A  SPE +     G  Y    D+WS G+++L+ L   + P+   G KP 
Sbjct: 327 -----GWVGTVATNSPEILA----GDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPG 377

Query: 272 -DLMALI--CAIC----------------FGERLEMPETASPEFRRF---------VRSC 303
             L+ +I   ++C                  E      +  P  R           +   
Sbjct: 378 KQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKM 437

Query: 304 LEKDWRKRGTVEELLAYPF 322
           L  DW  R    ELLA P 
Sbjct: 438 LTFDWHLRPGAAELLALPL 456

Length = 501

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 56.6 bits (136), Expect = 5e-09
 Identities = 47/177 (26%), Positives = 79/177 (44%), Gaps = 20/177 (11%)

Query: 143 LSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNN 202
           LS   + G +Y+V  G+++L     +H D+   N+LI     VKI DFG++R +      
Sbjct: 236 LSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIM----- 290

Query: 203 NNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECL-VGH 261
                 ++N I + +        +M+PE +    +   Y    DVWS G+++ E   +G 
Sbjct: 291 -----RDSNYISKGSTFL--PLKWMAPESI----FNNLYTTLSDVWSFGILLWEIFTLGG 339

Query: 262 YPLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELL 318
            P   + E P       AI  G R+  P  AS E    ++ C E+ +  R    +L+
Sbjct: 340 TP---YPELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLV 393

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 55.7 bits (134), Expect = 8e-09
 Identities = 53/205 (25%), Positives = 81/205 (39%), Gaps = 42/205 (20%)

Query: 76  ALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFD 135
           A+K+L   ++   R+    E +IL RL    I++   V    E  +C + E+ME G L  
Sbjct: 50  AVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVD-EDPLCMITEYMENGDLNQ 108

Query: 136 SLRVRK-------------------KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSN 176
            L                        +S   +  VA ++  G++YL  +  +H D+   N
Sbjct: 109 FLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRN 168

Query: 177 LLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAA--IACMG-TCAYMSPERVD 233
            L+     +KIADFG+SR        N +  +     G A   I  M   C  M      
Sbjct: 169 CLVGENLTIKIADFGMSR--------NLYAGDYYRIQGRAVLPIRWMAWECILM------ 214

Query: 234 SERWGGDYGFAGDVWSLGVVVLECL 258
                G +  A DVW+ GV + E L
Sbjct: 215 -----GKFTTASDVWAFGVTLWEIL 234

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 55.2 bits (133), Expect = 1e-08
 Identities = 44/148 (29%), Positives = 68/148 (45%), Gaps = 21/148 (14%)

Query: 120 EICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLI 179
           +I  V E ME   L   ++    L+ +      Y++L+ L+Y+H   + H D+KP N+L 
Sbjct: 78  DIYVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILA 136

Query: 180 NGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAI---ACMGTCAYMSPERVDSER 236
           N   ++KI DFG++R+                N    AI     + T  Y +PE   S  
Sbjct: 137 NADCKLKICDFGLARVA--------------FNDTPTAIFWTDYVATRWYRAPELCGS-- 180

Query: 237 WGGDYGFAGDVWSLGVVVLECLVGHYPL 264
           +   Y  A D+WS+G +  E L G  PL
Sbjct: 181 FFSKYTPAIDIWSIGCIFAEVLTGK-PL 207

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 54.7 bits (132), Expect = 1e-08
 Identities = 44/175 (25%), Positives = 74/175 (42%), Gaps = 31/175 (17%)

Query: 152 AYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNH--NNNN 209
           A ++  G+ YLH   +IH DI   N +I+ + +VKI D  +SR   +    + H   +N 
Sbjct: 123 AIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSR---DLFPMDYHCLGDNE 179

Query: 210 NNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGE 269
           N  +            +M+ E + ++    +Y  A DVWS GV++ E       L+  G+
Sbjct: 180 NRPV-----------KWMALESLVNK----EYSSASDVWSFGVLLWE-------LMTLGQ 217

Query: 270 KP----DLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY 320
            P    D   +   +  G RL  P     E    +  C   D  +R +  +L+  
Sbjct: 218 TPYVEIDPFEMAAYLKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQC 272

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 54.6 bits (131), Expect = 2e-08
 Identities = 62/288 (21%), Positives = 116/288 (40%), Gaps = 43/288 (14%)

Query: 46  ISDLKKLTVLGHGNGGIVYK----VRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKR 101
           +S ++ +  LG    G +YK    +       + A+K L   ++     +   EA ++  
Sbjct: 4   LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAE 63

Query: 102 LDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISG----------- 150
           L    IV C     T E  +C + E++ +G L + L +R   S+   S            
Sbjct: 64  LHHPNIV-CLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLD 122

Query: 151 ------VAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNN 204
                 +A ++  G++YL     +H D+   N+LI  +  VKI+D G+SR   E  + + 
Sbjct: 123 HGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSR---EIYSADY 179

Query: 205 HNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECL-VGHYP 263
           +     +         +    +M PE +   ++  D     D+WS GVV+ E    G  P
Sbjct: 180 YRVQPKS---------LLPIRWMPPEAIMYGKFSSD----SDIWSFGVVLWEIFSFGLQP 226

Query: 264 LIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKR 311
             GF  + +++ ++      + L   E   P     +  C ++   +R
Sbjct: 227 YYGFSNQ-EVIEMVRK---RQLLPCSEDCPPRMYSLMTECWQEGPSRR 270

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 54.4 bits (131), Expect = 2e-08
 Identities = 76/281 (27%), Positives = 116/281 (41%), Gaps = 50/281 (17%)

Query: 44  ENISDLKKLTVLGHGNGGIVYK--VRHQKSNSI---YALKVLNTTSSTIIRHQAAHEAEI 98
           ++I+ L+    LGHG  G VY+   R +  +++    A+K L  + S         EA I
Sbjct: 6   DSITLLR---ALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALI 62

Query: 99  LKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLR-VRKKLSE-------DVISG 150
           + + + Q IV+   V +        ++E M  G L   LR  R +          D++  
Sbjct: 63  MSKFNHQNIVRLIGVSFERLPRF-ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLF- 120

Query: 151 VAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGE---VKIADFGVSRIVEET---RNNNN 204
            A  V KG +YL     IH DI   N L+  KG     KIADFG++R +      R    
Sbjct: 121 CARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKG-- 178

Query: 205 HNNNNNNNIGEAAIACMGTCAYMSPER-VDSERWGGDYGFAGDVWSLGVVVLECL-VGHY 262
                    G A    M    +M PE  +D     G +    DVWS GV++ E   +G+ 
Sbjct: 179 ---------GRA----MLPIKWMPPEAFLD-----GIFTSKTDVWSFGVLLWEIFSLGYM 220

Query: 263 PLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSC 303
           P  G   + ++M  +     G RL+ P+       R +  C
Sbjct: 221 PYPGRTNQ-EVMEFVTG---GGRLDPPKGCPGPVYRIMTDC 257

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 54.2 bits (130), Expect = 2e-08
 Identities = 48/193 (24%), Positives = 85/193 (44%), Gaps = 29/193 (15%)

Query: 76  ALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFD 135
           A+K+L    +   R+    E +I+ RL +  I++   V  + +  +C + E+ME G L  
Sbjct: 48  AVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVS-DDPLCMITEYMENGDLNQ 106

Query: 136 SLRVRKKLSEDVISG------------VAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKG 183
            L  R+  S    +             +A ++  G++YL  +  +H D+   N L+    
Sbjct: 107 FLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHY 166

Query: 184 EVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGF 243
            +KIADFG+SR        N ++ +     G A +       +M+ E +      G +  
Sbjct: 167 TIKIADFGMSR--------NLYSGDYYRIQGRAVLPIR----WMAWESI----LLGKFTT 210

Query: 244 AGDVWSLGVVVLE 256
           A DVW+ GV + E
Sbjct: 211 ASDVWAFGVTLWE 223

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 53.9 bits (129), Expect = 2e-08
 Identities = 73/290 (25%), Positives = 109/290 (37%), Gaps = 72/290 (24%)

Query: 54  VLGHGNGGIVYKVRHQKSNSIY--ALKVLNTTSSTIIRHQAAHEAEILKRLDSQ-----F 106
           V+G GN G V K R +K       A+K +   +S       A E E+L +L         
Sbjct: 2   VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61

Query: 107 IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSED--------VISGVAYRVL-- 156
           +  C        G +   +E+   G+L D LR  + L  D          S ++ + L  
Sbjct: 62  LGACEH-----RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 116

Query: 157 ------KGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNN 210
                 +G+ YL   Q IH D+   N+L+      KIADFG+SR                
Sbjct: 117 FAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR---------------- 160

Query: 211 NNIGEAAIA--CMGTCA--YMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIG 266
              G+       MG     +M+ E ++       Y    DVWS GV++ E       ++ 
Sbjct: 161 ---GQEVYVKKTMGRLPVRWMAIESLNYSV----YTTNSDVWSYGVLLWE-------IVS 206

Query: 267 FGEKPDLMALICAICF-----GERLEMPETASPEFRRFVRSCLEKDWRKR 311
            G  P    + CA  +     G RLE P     E    +R C    WR++
Sbjct: 207 LGGTP-YCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQC----WREK 251

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 54.5 bits (131), Expect = 2e-08
 Identities = 48/175 (27%), Positives = 82/175 (46%), Gaps = 23/175 (13%)

Query: 145 EDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNN 204
           ED+IS  +++V +G+++L   + IH D+   N+L++    VKI DFG++R +        
Sbjct: 173 EDLIS-YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDI-------- 223

Query: 205 HNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECL-VGHYP 263
           + + +    G+A +       +M+PE +    +   Y    DVWS GV++ E   +G  P
Sbjct: 224 YKDPDYVRKGDARLP----LKWMAPESI----FDKVYTTQSDVWSFGVLLWEIFSLGASP 275

Query: 264 LIGFGEKPDLMALICA-ICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEEL 317
             G     +     C  +  G R+  PE A+PE    +  C   +   R T  EL
Sbjct: 276 YPGVQIDEEF----CRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSEL 326

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 53.9 bits (129), Expect = 3e-08
 Identities = 60/255 (23%), Positives = 99/255 (38%), Gaps = 40/255 (15%)

Query: 45  NISDLKKLTVLGHGNGGIVYK-----VRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEIL 99
           N+S ++ +  LG    G VYK         +     A+K L   +   +R +  HEA + 
Sbjct: 3   NLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMR 62

Query: 100 KRLDSQFIVKCHAVFYTIEGEICFVME----------------HMERGSLFDSLRVRKKL 143
            RL    IV C     T E  +  +                  H + GS  D   V+  L
Sbjct: 63  SRLQHPNIV-CLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTL 121

Query: 144 SEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNN 203
                  +  ++  G+++L    ++H D+   N+L+  K  VKI+D G+ R V       
Sbjct: 122 EPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYK 181

Query: 204 NHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECL-VGHY 262
              N+            +    +MSPE +      G +    D+WS GVV+ E    G  
Sbjct: 182 LMGNS------------LLPIRWMSPEAIMY----GKFSIDSDIWSYGVVLWEVFSYGLQ 225

Query: 263 PLIGFGEKPDLMALI 277
           P  G+  + D++ +I
Sbjct: 226 PYCGYSNQ-DVIEMI 239

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 53.4 bits (128), Expect = 3e-08
 Identities = 59/244 (24%), Positives = 97/244 (39%), Gaps = 36/244 (14%)

Query: 76  ALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFD 135
           A+  L    S   R     EA  L + D   IV+   V  T    +  V E+M  G+L  
Sbjct: 37  AIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVI-TRGNTMMIVTEYMSNGALDS 95

Query: 136 SLRVRK-KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSR 194
            LR  + +L    + G+   +  G++YL  M  +H  +    +L+N     KI+ F   R
Sbjct: 96  FLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFR--R 153

Query: 195 IVEETRNNNNHNNNNNNNIGEAAIACMG---TCAYMSPERVDSERWGGDYGFAGDVWSLG 251
           + E+                EA    M       + +PE +        +  A DVWS G
Sbjct: 154 LQEDKS--------------EAIYTTMSGKSPVLWAAPEAIQYHH----FSSASDVWSFG 195

Query: 252 VVVLECLVGHYPLIGFGEKP--DL--MALICAICFGERLEMPETASPEFRRFVRSCLEKD 307
           +V+ E       ++ +GE+P  D+    +I A+  G RL  P        + +  C +K+
Sbjct: 196 IVMWE-------VMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLLHQLMLDCWQKE 248

Query: 308 WRKR 311
             +R
Sbjct: 249 RGER 252

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 53.2 bits (128), Expect = 3e-08
 Identities = 66/274 (24%), Positives = 115/274 (41%), Gaps = 29/274 (10%)

Query: 54  VLGHGNGGIVYKVRHQKSNSIY---ALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKC 110
           V+G G+ G VY      S+      A+K LN  +      Q   E  I+K      ++  
Sbjct: 2   VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSL 61

Query: 111 HAVFYTIEGEICFVMEHMERGSLFDSLR--VRKKLSEDVISGVAYRVLKGLQYLHGMQII 168
             +    EG    V+ +M+ G L + +R        +D+I G   +V KG++YL   + +
Sbjct: 62  LGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLI-GFGLQVAKGMEYLASKKFV 120

Query: 169 HGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMS 228
           H D+   N +++    VK+ADFG++R + +    + HN+           A +    +M+
Sbjct: 121 HRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTG---------AKL-PVKWMA 170

Query: 229 PERVDSERWGGDYGFAGDVWSLGVVVLECL---VGHYPLIGFGEKPDLMALICAICFGER 285
            E + +++    +    DVWS GV++ E +      YP +      D   +   +  G R
Sbjct: 171 LESLQTQK----FTTKSDVWSFGVLLWELMTRGAPPYPDV------DSFDITVYLLQGRR 220

Query: 286 LEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA 319
           L  PE         + SC       R T  EL++
Sbjct: 221 LLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVS 254

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 53.2 bits (128), Expect = 6e-08
 Identities = 26/76 (34%), Positives = 47/76 (61%), Gaps = 3/76 (3%)

Query: 120 EICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLI 179
           ++  VME M+  +L     ++  L  + +S + Y++L G+++LH   IIH D+KPSN+++
Sbjct: 95  DVYLVMELMD-ANLCQV--IQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 151

Query: 180 NGKGEVKIADFGVSRI 195
                +KI DFG++R 
Sbjct: 152 KSDCTLKILDFGLART 167

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 52.0 bits (125), Expect = 1e-07
 Identities = 60/231 (25%), Positives = 95/231 (41%), Gaps = 44/231 (19%)

Query: 55  LGHGNGGIV----------YKVRHQKSNS------IYALKVLNTTSSTIIRHQAAHEAEI 98
           LG G  G V          +  +    N       + A+KVL   +S   R     E +I
Sbjct: 13  LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKI 72

Query: 99  LKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVR-----------KKLSEDV 147
           L RL    I +   V  T++  +C +ME+ME G L   L+             K LS   
Sbjct: 73  LSRLSDPNIARLLGV-CTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFST 131

Query: 148 ISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNN 207
           +  +A ++  G++YL  +  +H D+   N L+     +KIADFG+SR         N  +
Sbjct: 132 LLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSR---------NLYS 182

Query: 208 NNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECL 258
           ++   +   A   +    +M+ E V      G +    DVW+ GV + E L
Sbjct: 183 SDYYRVQGRAPLPI---RWMAWESV----LLGKFTTKSDVWAFGVTLWEIL 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 52.9 bits (127), Expect = 1e-07
 Identities = 45/191 (23%), Positives = 77/191 (40%), Gaps = 16/191 (8%)

Query: 76  ALKVLNTTSSTIIRHQAAHEAEI--LKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSL 133
           A+K+L T +      +A    E     RL    IV          G +  V E++   +L
Sbjct: 7   AIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTL 66

Query: 134 FDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKG---EVKIADF 190
            + L     L       +  +VL  L   H   I+H D+KP N++++  G     K+ DF
Sbjct: 67  REVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDF 126

Query: 191 GVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSL 250
           G+  ++   R+ +                 +GT  Y +PE++  E          D+++ 
Sbjct: 127 GIGTLLPGVRDADVATLT-------RTTEVLGTPTYCAPEQLRGEPVTP----NSDLYAW 175

Query: 251 GVVVLECLVGH 261
           G++ LECL G 
Sbjct: 176 GLIFLECLTGQ 186

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 51.2 bits (122), Expect = 3e-07
 Identities = 34/128 (26%), Positives = 58/128 (45%), Gaps = 31/128 (24%)

Query: 139 VRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEE 198
           ++ +L  + +S + Y++L G+++LH   IIH D+KPSN+++     +KI DFG++R    
Sbjct: 119 IQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-- 176

Query: 199 TRNNNNHNNNNNNNIGEAAIACMGTCAYMSPE------RVDSERWGGDYGFAGDVWSLGV 252
                                  GT   M+P       R      G  Y    D+WS+G 
Sbjct: 177 -----------------------GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGC 213

Query: 253 VVLECLVG 260
           ++ E + G
Sbjct: 214 IMGEMIKG 221

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 50.9 bits (121), Expect = 3e-07
 Identities = 42/151 (27%), Positives = 80/151 (52%), Gaps = 9/151 (5%)

Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH-EAEILKRLDSQFIV 108
           + L  +G G  GIV        +   A+K L+         + A+ E  ++K ++ + I+
Sbjct: 20  QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 79

Query: 109 KCHAVFY---TIE--GEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLH 163
               VF    ++E   ++  VME M+  +L   +++  +L  + +S + Y++L G+++LH
Sbjct: 80  SLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQM--ELDHERMSYLLYQMLCGIKHLH 136

Query: 164 GMQIIHGDIKPSNLLINGKGEVKIADFGVSR 194
              IIH D+KPSN+++     +KI DFG++R
Sbjct: 137 SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 167

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 50.8 bits (121), Expect = 4e-07
 Identities = 47/175 (26%), Positives = 86/175 (49%), Gaps = 27/175 (15%)

Query: 91  QAAHEAEILKRLDSQFIVKCHAVFY---TIE--GEICFVMEHMERGSLFDSLRVRKKLSE 145
           +A  E  +LK ++ + I+    VF    ++E   ++  VME M+  +L   + +  +L  
Sbjct: 66  RAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIHM--ELDH 122

Query: 146 DVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNH 205
           + +S + Y++L G+++LH   IIH D+KPSN+++     +KI DFG++R           
Sbjct: 123 ERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--------- 173

Query: 206 NNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVG 260
                N +    +    T  Y +PE +     G  Y    D+WS+G ++ E + G
Sbjct: 174 ---CTNFMMTPYVV---TRYYRAPEVI----LGMGYKENVDIWSVGCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 49.0 bits (117), Expect = 1e-06
 Identities = 62/285 (21%), Positives = 111/285 (38%), Gaps = 35/285 (12%)

Query: 42  DVENISDLKKLTVLGHGNGGIVYK-VRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILK 100
           + ++I D     ++   +   +YK + + K   I   K  +     +I     +E + L+
Sbjct: 16  ESDDI-DKYTSVLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLID-ITENEIKNLR 73

Query: 101 RLDSQFIVKCHAVFYTIEGEICFV---MEHMERGSLFDSLRVRKKLSEDVISGVAYRVLK 157
           R+DS  I+K +     I  ++  +   +E+  RG L + L   K LS      +A    K
Sbjct: 74  RIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCK 133

Query: 158 GLQYLHG-MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEA 216
           GL  L+      + ++   + L+    ++KI   G+    E+  ++    N N       
Sbjct: 134 GLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGL----EKILSSPPFKNVN------- 182

Query: 217 AIACMGTCAYMSPE---RVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDL 273
                    Y S +    + SE     Y    D++SLGVV+ E   G  P      K   
Sbjct: 183 ------FMVYFSYKMLNDIFSE-----YTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIY 231

Query: 274 MALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELL 318
             +I        L++P     E +  V +C   D  KR  ++E+L
Sbjct: 232 DLIINKN---NSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEIL 273

Length = 283

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 48.7 bits (116), Expect = 2e-06
 Identities = 41/169 (24%), Positives = 74/169 (43%), Gaps = 24/169 (14%)

Query: 152 AYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNN 211
           + +V +G+ +L     IH D+   N+L+      KI DFG++R +    N++N+    N 
Sbjct: 218 SSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIM---NDSNYVVKGNA 274

Query: 212 NIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECL-VGH--YPLIGFG 268
            +            +M+PE +    +   Y    DVWS G+++ E   +G   YP I   
Sbjct: 275 RL---------PVKWMAPESI----FDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVN 321

Query: 269 EKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEEL 317
            K   M     +  G ++  P+ A PE    ++ C   +  +R T  ++
Sbjct: 322 SKFYKM-----VKRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQI 365

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 48.0 bits (114), Expect = 3e-06
 Identities = 66/292 (22%), Positives = 107/292 (36%), Gaps = 65/292 (22%)

Query: 95  EAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSL--RVRKKLSEDVISGVA 152
           E  + K  +   IV   A F   + E+  V   M  GS  D +       +SE  I+ + 
Sbjct: 49  ELHVSKLFNHPNIVPYRATFIA-DNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYIL 107

Query: 153 YRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADF--GVSRIVEETRNNNNHNNNNN 210
             VLK L Y+H M  +H  +K S++LI+  G+V ++     +S I    R    H+    
Sbjct: 108 QGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKY 167

Query: 211 NNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEK 270
           +         +    ++SPE +     G  Y    D++S+G+   E   GH P   F + 
Sbjct: 168 S---------VKVLPWLSPEVLQQNLQG--YDAKSDIYSVGITACELANGHVP---FKDM 213

Query: 271 PDLMALICAI-----CFGERLEMP------------------------------------ 289
           P    L+  +     C  +   +P                                    
Sbjct: 214 PATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSH 273

Query: 290 ---ETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVT--KRSSSSNIEGLI 336
               T SP F  FV  CL+++   R +   LL + F    KR +S  +  L+
Sbjct: 274 PYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKRRASEALPELL 325

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 48.2 bits (115), Expect = 4e-06
 Identities = 41/167 (24%), Positives = 79/167 (47%), Gaps = 27/167 (16%)

Query: 112 AVFYT---IEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVA--------YRVLKGLQ 160
            V+YT   IEG            SL  S+  ++ LS+++    +        +++   ++
Sbjct: 76  PVYYTMPYIEGYTL--------KSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIE 127

Query: 161 YLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIAC 220
           Y+H   ++H D+KP N+L+   GEV I D+G +   +    +    + +  NI  +++  
Sbjct: 128 YVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTI 187

Query: 221 M----GTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYP 263
                GT  YM+PER+     G     + D+++LGV++ + L   +P
Sbjct: 188 PGKIVGTPDYMAPERLL----GVPASESTDIYALGVILYQMLTLSFP 230

Length = 932

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 47.7 bits (113), Expect = 4e-06
 Identities = 43/182 (23%), Positives = 79/182 (43%), Gaps = 28/182 (15%)

Query: 139 VRKKLSEDVISGVA--------YRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADF 190
           V+  LS+D   G+         Y+V +G+++L     +H D+   N+L+     VKI DF
Sbjct: 222 VKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDF 281

Query: 191 GVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSL 250
           G++R   +  +++N+ +  +  +            +M+PE +    +   Y    DVWS 
Sbjct: 282 GLAR---DIMHDSNYVSKGSTFL---------PVKWMAPESI----FDNLYTTLSDVWSY 325

Query: 251 GVVVLECL-VGHYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWR 309
           G+++ E   +G  P  G          I +   G R+  P+ A+ E    +  C   +  
Sbjct: 326 GILLWEIFSLGGTPYPGMIVDSTFYNKIKS---GYRMAKPDHATQEVYDIMVKCWNSEPE 382

Query: 310 KR 311
           KR
Sbjct: 383 KR 384

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 47.3 bits (112), Expect = 5e-06
 Identities = 32/114 (28%), Positives = 58/114 (50%), Gaps = 20/114 (17%)

Query: 152 AYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGE-VKIADFGVSRIVEETRNNNNHNNNNN 210
           +Y++ + L Y+H   I H D+KP NLLI+     +K+ DFG ++               N
Sbjct: 176 SYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAK---------------N 220

Query: 211 NNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPL 264
              G+ +++ + +  Y +PE +       +Y    D+WSLG ++ E ++G YP+
Sbjct: 221 LLAGQRSVSYICSRFYRAPELMLGAT---NYTTHIDLWSLGCIIAEMILG-YPI 270

Length = 440

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 45.6 bits (108), Expect = 2e-05
 Identities = 63/284 (22%), Positives = 109/284 (38%), Gaps = 44/284 (15%)

Query: 54  VLGHGNGGIVYKVRHQKSN------SIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFI 107
           +LG G  G V + +  + +      ++  +K+   T S I   +   EA  +K  D   +
Sbjct: 6   ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEI--EEFLSEAACMKDFDHPNV 63

Query: 108 VKCHAVFYTIEGEICF-----VMEHMERGSLFDSL-RVR-----KKLSEDVISGVAYRVL 156
           +K   V +             ++  M+ G L   L   R     +KL    +      + 
Sbjct: 64  MKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIA 123

Query: 157 KGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEA 216
            G++YL     IH D+   N ++     V +ADFG+S+ +            + +   + 
Sbjct: 124 LGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIY-----------SGDYYRQG 172

Query: 217 AIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV---GHYPLIGFGEKPDL 273
            IA M    +++ E + ++R    Y    DVW+ GV + E        YP +   E  D 
Sbjct: 173 RIAKM-PVKWIAIESL-ADRV---YTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDY 227

Query: 274 MALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEEL 317
           +        G RL+ PE    E    + SC   D + R T  +L
Sbjct: 228 LR------HGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKL 265

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 43.2 bits (102), Expect = 3e-05
 Identities = 33/149 (22%), Positives = 61/149 (40%), Gaps = 20/149 (13%)

Query: 48  DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFI 107
              KL   G  N   +   + +     Y LK+  +      R +   E  IL+ L  + +
Sbjct: 1   SSIKLLKGGLTNRVYLLGTKDED----YVLKINPSREKGADRER---EVAILQLLARKGL 53

Query: 108 VKCHAVFYTIEGEICF--VMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGM 165
                V  + E +     +ME +E G   D      ++SE+    +A ++ + L  LH +
Sbjct: 54  -PVPKVLASGESDGWSYLLMEWIE-GETLD------EVSEEEKEDIAEQLAELLAKLHQL 105

Query: 166 QI---IHGDIKPSNLLINGKGEVKIADFG 191
            +    HGD+ P N+L++    + I D+ 
Sbjct: 106 PLLVLCHGDLHPGNILVDDGKILGIIDWE 134

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 43.4 bits (102), Expect = 7e-05
 Identities = 50/204 (24%), Positives = 81/204 (39%), Gaps = 30/204 (14%)

Query: 77  LKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSL--- 133
           +K L  ++S   + +   EA+  + L    +++C      +   +  VME    G L   
Sbjct: 27  VKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYL-LVMEFCPLGDLKGY 85

Query: 134 FDSLRVRKKLSED--VISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFG 191
             S R  + ++ D   +  +A  +  GL +LH    IH D+   N L+     VKI D+G
Sbjct: 86  LRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYG 145

Query: 192 VSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGG----DYGFAGDV 247
           +S           HN    +         +    +++PE VD E  G     D     +V
Sbjct: 146 LS-----------HNKYKEDYYVTPDQLWV-PLRWIAPELVD-EVHGNLLVVDQTKESNV 192

Query: 248 WSLGVVVLECLVGHYPLIGFGEKP 271
           WSLGV + E       L   G +P
Sbjct: 193 WSLGVTIWE-------LFELGSQP 209

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|233667 TIGR01982, UbiB, 2-polyprenylphenol 6-hydroxylase

 Score = 42.7 bits (101), Expect = 2e-04
 Identities = 32/121 (26%), Positives = 54/121 (44%), Gaps = 18/121 (14%)

Query: 89  RHQAAHEAEILK--RLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRV------R 140
           R +AA+ +E+ +  + D    V    V++    E    ME ++   L D   +      R
Sbjct: 201 RREAANASELGENFKNDPGVYVP--EVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLDR 258

Query: 141 KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFG-VSRIVEET 199
           K L+E++      +VL+      G    H D+ P N+ +   G++   DFG V R+ EE 
Sbjct: 259 KALAENLARSFLNQVLR-----DGF--FHADLHPGNIFVLKDGKIIALDFGIVGRLSEED 311

Query: 200 R 200
           R
Sbjct: 312 R 312

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol -> 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species [Biosynthesis of cofactors, prosthetic groups, and carriers, Menaquinone and ubiquinone]. Length = 437

>gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

 Score = 41.5 bits (98), Expect = 2e-04
 Identities = 35/133 (26%), Positives = 53/133 (39%), Gaps = 15/133 (11%)

Query: 63  VYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEIC 122
           V K R  K    Y    L+     + R +   EA IL +      V    V+        
Sbjct: 23  VVKERIPKR---YRHPELD---EKLRRERTRREARILAKARE-AGVPVPIVYDVDPDNGL 75

Query: 123 FVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGK 182
            VME++E G L       K   E+    +   V + +  LH   I+HGD+  SN++++G 
Sbjct: 76  IVMEYIE-GELL------KDALEEARPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGG 128

Query: 183 GEVKIADFGVSRI 195
               I DFG+   
Sbjct: 129 RIYFI-DFGLGEF 140

Length = 204

>gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional

 Score = 41.8 bits (99), Expect = 2e-04
 Identities = 37/134 (27%), Positives = 59/134 (44%), Gaps = 12/134 (8%)

Query: 62  IVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEI 121
            V K R  K    Y    L+     I R +   EA I+ R   +  V   AV++      
Sbjct: 22  AVIKWRIPKR---YRHPELD---ERIRRERTRREARIMSRA-RKAGVNVPAVYFVDPENF 74

Query: 122 CFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLING 181
             VME++E   L D +        ++   +   V K    LH   IIHGD+  SN++++G
Sbjct: 75  IIVMEYIEGEPLKDLINSNGMEELELSREIGRLVGK----LHSAGIIHGDLTTSNMILSG 130

Query: 182 KGEVKIADFGVSRI 195
            G++ + DFG++  
Sbjct: 131 -GKIYLIDFGLAEF 143

Length = 211

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 41.5 bits (97), Expect = 3e-04
 Identities = 17/46 (36%), Positives = 28/46 (60%)

Query: 147 VISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGV 192
           +I  +   +L  L+Y+H   I HGDIKP N++++G     I D+G+
Sbjct: 127 LIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGI 172

Length = 294

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 40.1 bits (94), Expect = 8e-04
 Identities = 58/285 (20%), Positives = 94/285 (32%), Gaps = 67/285 (23%)

Query: 55  LGHGNGGIVYK-VRHQKSNSIYALKVLNTTSSTIIRHQAAHEAE-------ILKRLDSQF 106
           LG G    +YK V   +S+          +    +      ++        ++ +L  + 
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 107 IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKK-LSEDVISGVAYRVLKGLQYLHGM 165
           +VK + V   +  E   V E+++ G L   L   K  +S      VA ++   L YL   
Sbjct: 63  LVKLYGV--CVRDENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDK 120

Query: 166 QIIHGDIKPSNLLINGKGE-------VKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAI 218
           +++HG++   N+L+   G        +K++D G+                          
Sbjct: 121 KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI------------------------ 156

Query: 219 ACMGTCAYMSPERVDSERW------GGDYGF---AGDVWSLGVVVLE-CLVGHYPL--IG 266
                      ERV+   W               A D WS G  +LE C  G  PL  + 
Sbjct: 157 -----TVLSREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLS 211

Query: 267 FGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKR 311
             EK              RL MP+    E    +  C   D  KR
Sbjct: 212 SSEKERFYQD------QHRLPMPD--CAELANLINQCWTYDPTKR 248

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|223733 COG0661, AarF, Predicted unusual protein kinase [General function prediction only]

 Score = 40.0 bits (94), Expect = 0.001
 Identities = 32/124 (25%), Positives = 54/124 (43%), Gaps = 20/124 (16%)

Query: 89  RHQAAHEAEILKRL---DSQFIVKCHAVFYTIEGEICFVMEHME--RGSLFDSLRV---- 139
           R +AA+ AE  +     D    V    V++         ME ++  + S   +L+     
Sbjct: 209 RREAAN-AERFRENFKDDPDVYVPK--VYWEYTTRRVLTMEWIDGIKISDIAALKSAGID 265

Query: 140 RKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFG-VSRIVEE 198
           RK+L+E ++   A+  L+ L    G    H D  P N+L+   G + + DFG V R+  +
Sbjct: 266 RKELAELLV--RAF--LRQL-LRDG--FFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318

Query: 199 TRNN 202
            R  
Sbjct: 319 FRRY 322

Length = 517

>gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32

 Score = 38.7 bits (91), Expect = 0.002
 Identities = 20/72 (27%), Positives = 35/72 (48%), Gaps = 8/72 (11%)

Query: 124 VMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKG 183
           VME++E   L D +       ++++  +   V K    LH   I+HGD+  SN+++    
Sbjct: 75  VMEYIEGKPLKDVIEEGN---DELLREIGRLVGK----LHKAGIVHGDLTTSNIIVRDDK 127

Query: 184 EVKIADFGVSRI 195
              I DFG+ + 
Sbjct: 128 LYLI-DFGLGKY 138

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 38.3 bits (89), Expect = 0.003
 Identities = 34/141 (24%), Positives = 54/141 (38%), Gaps = 20/141 (14%)

Query: 124 VMEHMERGSLFDSLR-----VRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLL 178
           V+E    G L + LR     V +   +DV+  +A  V  GL +LH    IH D+   N  
Sbjct: 73  VLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQ 132

Query: 179 INGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWG 238
           +     VKI D+G++                 +              +++PE V+     
Sbjct: 133 LTADLSVKIGDYGLA-----------LEQYPEDYY-ITKDCHAVPLRWLAPELVEIRGQD 180

Query: 239 ---GDYGFAGDVWSLGVVVLE 256
               D     ++WSLGV + E
Sbjct: 181 LLPKDQTKKSNIWSLGVTMWE 201

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 38.5 bits (89), Expect = 0.003
 Identities = 42/166 (25%), Positives = 68/166 (40%), Gaps = 25/166 (15%)

Query: 155 VLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIG 214
           +  G++YL     IH D+   N ++N    V +ADFG+S+ +            N +   
Sbjct: 121 IASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIY-----------NGDYYR 169

Query: 215 EAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GH--YPLIGFGEKP 271
           +  IA M    +++ E + ++R    Y    DVWS GV + E    G   YP +   E  
Sbjct: 170 QGRIAKM-PVKWIAIESL-ADRV---YTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIY 224

Query: 272 DLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEEL 317
           D +        G RL+ P          + SC   + + R + E L
Sbjct: 225 DYLRQ------GNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETL 264

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated

 Score = 38.7 bits (91), Expect = 0.003
 Identities = 34/142 (23%), Positives = 52/142 (36%), Gaps = 22/142 (15%)

Query: 60  GGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTI-- 117
              V K R  K    Y    L+     +   +   EA +L       +     V Y +  
Sbjct: 357 RDAVIKERVPKG---YRHPELD---ERLRTERTRAEARLLSEARRAGV--PTPVIYDVDP 408

Query: 118 -EGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSN 176
            E  I  VME++    L D L    +L   V   VA         LH   I+HGD+  SN
Sbjct: 409 EEKTI--VMEYIGGKDLKDVLEGNPELVRKVGEIVAK--------LHKAGIVHGDLTTSN 458

Query: 177 LLINGKGEVKIADFGVSRIVEE 198
            ++     + + DFG+ +  + 
Sbjct: 459 FIVRD-DRLYLIDFGLGKYSDL 479

Length = 535

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 38.6 bits (90), Expect = 0.003
 Identities = 17/46 (36%), Positives = 26/46 (56%), Gaps = 1/46 (2%)

Query: 147 VISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLIN-GKGEVKIADFG 191
           +I  +  ++L  L  LH   I+H D+KP N++ + G G  KI D G
Sbjct: 256 IIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLG 301

Length = 566

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	337
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0576	829	consensus Mitogen-activated protein kinase kinase	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG1167	418	consensus Serine/threonine protein kinase of the C	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	100.0
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	100.0
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
PLN00181	793	protein SPA1-RELATED; Provisional	99.97
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.96
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.95
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.95
PRK09188	365	serine/threonine protein kinase; Provisional	99.94
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.93
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.93
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.93
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.92
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.92
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.91
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.91
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.91
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.9
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.89
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.89
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.86
PRK12274	218	serine/threonine protein kinase; Provisional	99.86
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.86
smart00090	237	RIO RIO-like kinase.	99.85
PRK10345	210	hypothetical protein; Provisional	99.83
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.82
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.81
PRK14879	211	serine/threonine protein kinase; Provisional	99.8
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.79
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.78
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.78
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.75
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.72
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.71
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.67
KOG1243	690	consensus Protein kinase [General function predict	99.64
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.63
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.59
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.59
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.55
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.55
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.51
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.5
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.49
KOG3087	229	consensus Serine/threonine protein kinase [General	99.47
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.42
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.32
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.32
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.31
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.3
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.24
COG4248	637	Uncharacterized protein with protein kinase and he	99.23
COG0478	304	RIO-like serine/threonine protein kinase fused to	99.18
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	99.13
PRK09902	216	hypothetical protein; Provisional	99.06
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.93
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.88
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.76
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.72
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.68
PF01636	239	APH: Phosphotransferase enzyme family This family	98.65
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.62
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.6
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.44
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.28
PLN02876	822	acyl-CoA dehydrogenase	98.28
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.25
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.22
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	98.16
KOG2268	465	consensus Serine/threonine protein kinase [Signal	98.15
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.12
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	98.08
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.07
KOG2270	520	consensus Serine/threonine protein kinase involved	98.03
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.95
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.9
PRK05231	319	homoserine kinase; Provisional	97.81
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.81
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.75
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.53
KOG1093	725	consensus Predicted protein kinase (contains TBC a	97.44
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	97.33
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.33
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	97.3
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	97.28
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.19
PLN02236	344	choline kinase	97.16
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	97.09
PRK12396	409	5-methylribose kinase; Reviewed	97.04
PRK10593	297	hypothetical protein; Provisional	96.99
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.79
PLN02756	418	S-methyl-5-thioribose kinase	96.73
PRK11768	325	serine/threonine protein kinase; Provisional	96.69
PRK06148	1013	hypothetical protein; Provisional	96.55
PTZ00384	383	choline kinase; Provisional	96.52
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	96.37
PTZ00296	442	choline kinase; Provisional	96.28
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.25
COG2334	331	Putative homoserine kinase type II (protein kinase	96.13
KOG2269	531	consensus Serine/threonine protein kinase [Signal	95.63
KOG1236	565	consensus Predicted unusual protein kinase [Genera	95.61

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-58  Score=388.71  Aligned_cols=264  Identities=46%  Similarity=0.739  Sum_probs=242.6

Q ss_pred             CccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 019650           45 NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFV  124 (337)
Q Consensus        45 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv  124 (337)
                      ..++.+.++.||+|..|+||++.++.|++.+|+|++.........+++.+|++++++++||+||.+++.|+.....++++
T Consensus        77 ~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~  156 (364)
T KOG0581|consen   77 SLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISIC  156 (364)
T ss_pred             CHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEee
Confidence            34589999999999999999999999999999999988888888999999999999999999999999998843359999


Q ss_pred             EeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCC
Q 019650          125 MEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG-MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNN  203 (337)
Q Consensus       125 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~-~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~  203 (337)
                      |||+++|+|++++...+.+++.....++.++++||.|||+ ++||||||||+|+|++..|.+||+|||.+..+...    
T Consensus       157 mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS----  232 (364)
T KOG0581|consen  157 MEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS----  232 (364)
T ss_pred             hhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh----
Confidence            9999999999999988999999999999999999999995 99999999999999999999999999999887653    


Q ss_pred             CCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCC-CCchhHHHHHHHhhc
Q 019650          204 NHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGF-GEKPDLMALICAICF  282 (337)
Q Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~-~~~~~~~~~~~~~~~  282 (337)
                                  ...+++||..|||||.+.    +..|+.++||||||+.++|+++|+.||... .......+++..+..
T Consensus       233 ------------~a~tfvGT~~YMsPERi~----g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~  296 (364)
T KOG0581|consen  233 ------------IANTFVGTSAYMSPERIS----GESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVD  296 (364)
T ss_pred             ------------hcccccccccccChhhhc----CCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhc
Confidence                        233558999999999999    568999999999999999999999999765 345678888899999


Q ss_pred             cCCCCCCCC-CCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCC
Q 019650          283 GERLEMPET-ASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSS  328 (337)
Q Consensus       283 ~~~~~~~~~-~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~  328 (337)
                      +.++..|.. +++++++||..||++||.+|+|+.|++.|||+++...
T Consensus       297 ~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~  343 (364)
T KOG0581|consen  297 EPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFED  343 (364)
T ss_pred             CCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhccc
Confidence            999999997 9999999999999999999999999999999997764

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.1e-58  Score=392.69  Aligned_cols=269  Identities=30%  Similarity=0.392  Sum_probs=235.3

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchH------hHHHHHHHHHHHHhcCCCCceeeeeeEEee
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTI------IRHQAAHEAEILKRLDSQFIVKCHAVFYTI  117 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~------~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~  117 (337)
                      ..-+.|.+.+.||+|+||.|-+|....+++.||||+++......      ......+|+++|+++.||+|+++++.+.. 
T Consensus       169 s~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~-  247 (475)
T KOG0615|consen  169 SFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEV-  247 (475)
T ss_pred             hhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeec-
Confidence            45678899999999999999999999999999999998765222      23345699999999999999999998766 


Q ss_pred             CCeEEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCC---CcEEEeeccCcc
Q 019650          118 EGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGK---GEVKIADFGVSR  194 (337)
Q Consensus       118 ~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~---~~~~l~Dfg~~~  194 (337)
                      ..+.|+||||++||+|.+.+-.++.+.+...+.+++||+.|+.|||++||+||||||+|||++.+   ..+||+|||++.
T Consensus       248 ~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK  327 (475)
T KOG0615|consen  248 PDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAK  327 (475)
T ss_pred             CCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhh
Confidence            67789999999999999999999999999999999999999999999999999999999999876   679999999998


Q ss_pred             chhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCC-CccccHHHHHHHHHHHHhCCCCCCCCCCchhH
Q 019650          195 IVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDY-GFAGDVWSLGVVVLECLVGHYPLIGFGEKPDL  273 (337)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~-~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~  273 (337)
                      ..+..               .....++||+.|.|||++.+.  |..+ ..++|+|||||++|-+++|.+||........+
T Consensus       328 ~~g~~---------------sfm~TlCGTpsYvAPEVl~~k--g~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl  390 (475)
T KOG0615|consen  328 VSGEG---------------SFMKTLCGTPSYVAPEVLASK--GVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSL  390 (475)
T ss_pred             ccccc---------------eehhhhcCCccccChhheecC--CeecccchheeeeccceEEEEeccCCCcccccCCccH
Confidence            87643               455567899999999999876  3333 34899999999999999999999887666666


Q ss_pred             HHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCCc
Q 019650          274 MALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSS  330 (337)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~~  330 (337)
                      .+.+.+......+..+..+++...+||.+||..||++|||+.|+|+||||+-..+.+
T Consensus       391 ~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~~~s  447 (475)
T KOG0615|consen  391 KEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAPCLS  447 (475)
T ss_pred             HHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcccccc
Confidence            777767666667777788999999999999999999999999999999999665443

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.1e-56  Score=397.08  Aligned_cols=266  Identities=29%  Similarity=0.454  Sum_probs=234.3

Q ss_pred             CccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCC
Q 019650           42 DVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEG  119 (337)
Q Consensus        42 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~  119 (337)
                      +... .+|+..++||+|+|+++|++.+..+|..||+|++.+..  .....+.+.+|+++.++|+|||||++++.|.+ ..
T Consensus        14 D~~~-~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FED-s~   91 (592)
T KOG0575|consen   14 DPRS-KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFED-SN   91 (592)
T ss_pred             cCCc-ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeec-CC
Confidence            3344 78999999999999999999999999999999997642  34456788899999999999999999998877 79


Q ss_pred             eEEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhcc
Q 019650          120 EICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEET  199 (337)
Q Consensus       120 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~  199 (337)
                      ++|+|+|+|..++|-.+++..++++|.+++.+++||+.||.|||+++|+|||||..|+|++.+.++||+|||++..+..+
T Consensus        92 nVYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~  171 (592)
T KOG0575|consen   92 NVYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD  171 (592)
T ss_pred             ceEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999998765


Q ss_pred             ccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHH
Q 019650          200 RNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICA  279 (337)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~  279 (337)
                      .              +.....+|||.|.|||++.    ....+..+||||+||++|.|+.|++||...    ...+...+
T Consensus       172 ~--------------Erk~TlCGTPNYIAPEVl~----k~gHsfEvDiWSlGcvmYtLL~G~PPFetk----~vkety~~  229 (592)
T KOG0575|consen  172 G--------------ERKKTLCGTPNYIAPEVLN----KSGHSFEVDIWSLGCVMYTLLVGRPPFETK----TVKETYNK  229 (592)
T ss_pred             c--------------cccceecCCCcccChhHhc----cCCCCCchhhhhhhhHHHhhhhCCCCcccc----hHHHHHHH
Confidence            4              5556678999999999999    457899999999999999999999999653    33333333


Q ss_pred             hhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCCccc
Q 019650          280 ICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNI  332 (337)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~~~~  332 (337)
                      +... ...+|..++.++++||.+||+.||.+|||+++||.|+||++...+..+
T Consensus       230 Ik~~-~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g~~p~~l  281 (592)
T KOG0575|consen  230 IKLN-EYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSGFTPARL  281 (592)
T ss_pred             HHhc-CcccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCCCcCCCC
Confidence            3333 566778899999999999999999999999999999999766655444

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-55  Score=385.68  Aligned_cols=277  Identities=27%  Similarity=0.428  Sum_probs=238.5

Q ss_pred             ccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHHhc-CCCCceeeeeeEEeeCC
Q 019650           43 VENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRL-DSQFIVKCHAVFYTIEG  119 (337)
Q Consensus        43 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~  119 (337)
                      .....+|+.++.||.|+|++|++|.+.++++.||||++.+..  .+...+....|-..|.+| .||+|++++..|.+ +.
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD-~~  147 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQD-EE  147 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeec-cc
Confidence            456789999999999999999999999999999999986643  222234455688888888 99999999999988 78


Q ss_pred             eEEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhcc
Q 019650          120 EICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEET  199 (337)
Q Consensus       120 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~  199 (337)
                      .+|+|+||+++|+|.++|...+.|++..++.++.+|+.||.|||++|||||||||+|||++.+|+++|+|||.+..+.+.
T Consensus       148 sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~  227 (604)
T KOG0592|consen  148 SLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPS  227 (604)
T ss_pred             ceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChh
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999988765


Q ss_pred             ccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHH
Q 019650          200 RNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICA  279 (337)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~  279 (337)
                      ...... ............+++||-.|.+||++.    +...++.+|+|+|||++|+|+.|.+||.+..+--.+.+++..
T Consensus       228 ~~~~~~-~~~~~~a~s~~~SFVGTAeYVSPElL~----~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l  302 (604)
T KOG0592|consen  228 QKSQEN-PVDPNQASSRRSSFVGTAEYVSPELLN----DSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQAL  302 (604)
T ss_pred             hccccC-ccCcccccCcccceeeeecccCHHHhc----CCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHh
Confidence            433221 111111112246789999999999999    668899999999999999999999999887665555555544


Q ss_pred             hhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCCc
Q 019650          280 ICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSS  330 (337)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~~  330 (337)
                           ...++++.++.+.+||+++|..||++|+|+.+|..||||.+.+|..
T Consensus       303 -----~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~n  348 (604)
T KOG0592|consen  303 -----DYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWEN  348 (604)
T ss_pred             -----cccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhh
Confidence                 6788899999999999999999999999999999999999988753

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=8.4e-55  Score=367.54  Aligned_cols=268  Identities=31%  Similarity=0.463  Sum_probs=235.3

Q ss_pred             ccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCe
Q 019650           43 VENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGE  120 (337)
Q Consensus        43 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~  120 (337)
                      ....++|+++++||.|+||+|+.+...++++.+|+|++++..  .....+....|..++.+++||.|+.++..|.+ ...
T Consensus        21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt-~~k   99 (357)
T KOG0598|consen   21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQT-EEK   99 (357)
T ss_pred             cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEeccc-CCe
Confidence            355789999999999999999999999999999999997764  23346778889999999999999999999988 789


Q ss_pred             EEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccc
Q 019650          121 ICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETR  200 (337)
Q Consensus       121 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~  200 (337)
                      +|+|+||+.||.|+..|++.+.+++..++.++.+|+.||.|||++|||||||||+|||++.+|+++|+|||++.......
T Consensus       100 LylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~  179 (357)
T KOG0598|consen  100 LYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG  179 (357)
T ss_pred             EEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999998654432


Q ss_pred             cCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHh
Q 019650          201 NNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAI  280 (337)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~  280 (337)
                                    ..+..++||+.|||||++.    +..|+..+|+||||+++|+|++|.+||.+.+    .......+
T Consensus       180 --------------~~t~tfcGT~eYmAPEil~----~~gy~~~vDWWsLGillYeML~G~pPF~~~~----~~~~~~~I  237 (357)
T KOG0598|consen  180 --------------DATRTFCGTPEYMAPEILL----GKGYDKAVDWWSLGILLYEMLTGKPPFYAED----VKKMYDKI  237 (357)
T ss_pred             --------------CccccccCCccccChHHHh----cCCCCcccchHhHHHHHHHHhhCCCCCcCcc----HHHHHHHH
Confidence                          4445578999999999999    5689999999999999999999999997643    23334444


Q ss_pred             hccCCCCCCCCCCHHHHHHHHHHhhcCcCCCC----CHHHHhcCccccccCCCcccc
Q 019650          281 CFGERLEMPETASPEFRRFVRSCLEKDWRKRG----TVEELLAYPFVTKRSSSSNIE  333 (337)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~----s~~eil~hp~f~~~~~~~~~~  333 (337)
                      ..+.....+...+...++++.++|..||++|.    ++++|-+||||....|..-+.
T Consensus       238 ~~~k~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l~~  294 (357)
T KOG0598|consen  238 LKGKLPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEKLLA  294 (357)
T ss_pred             hcCcCCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHHHHHh
Confidence            44444566666899999999999999999995    799999999999998865443

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-53  Score=348.06  Aligned_cols=263  Identities=30%  Similarity=0.472  Sum_probs=234.1

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeE
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEI  121 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~  121 (337)
                      ...++|.+++.||.|+||.|.++.++.+|..+|+|++++..  .-...+...+|..+++.+.||.++++++.+.+ ...+
T Consensus        41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d-~~~l  119 (355)
T KOG0616|consen   41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKD-NSNL  119 (355)
T ss_pred             cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeecc-CCeE
Confidence            67899999999999999999999999999999999997754  22234566789999999999999999999988 7899


Q ss_pred             EEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhcccc
Q 019650          122 CFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRN  201 (337)
Q Consensus       122 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~  201 (337)
                      |+||||++||.|+.++++.+++++..++.++.||+.||.|||+++|++|||||+|||+|.+|.+||+|||.+..+..   
T Consensus       120 ymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~---  196 (355)
T KOG0616|consen  120 YMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG---  196 (355)
T ss_pred             EEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecC---
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999988753   


Q ss_pred             CCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhh
Q 019650          202 NNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAIC  281 (337)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~  281 (337)
                                    .++..+|||.|+|||.+.    ..+|+.++|+|+||+++|||+.|.+||.+.......    +++.
T Consensus       197 --------------rT~TlCGTPeYLAPEii~----sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY----~KI~  254 (355)
T KOG0616|consen  197 --------------RTWTLCGTPEYLAPEIIQ----SKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIY----EKIL  254 (355)
T ss_pred             --------------cEEEecCCccccChHHhh----cCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHH----HHHH
Confidence                          356678999999999999    568899999999999999999999999876553333    3333


Q ss_pred             ccCCCCCCCCCCHHHHHHHHHHhhcCcCCCC-----CHHHHhcCccccccCCCcccc
Q 019650          282 FGERLEMPETASPEFRRFVRSCLEKDWRKRG-----TVEELLAYPFVTKRSSSSNIE  333 (337)
Q Consensus       282 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~-----s~~eil~hp~f~~~~~~~~~~  333 (337)
                      .+ ...+|...+..+++|+.++|+.|-.+|.     -.++|..||||++..|..-+.
T Consensus       255 ~~-~v~fP~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~i~~  310 (355)
T KOG0616|consen  255 EG-KVKFPSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEAILQ  310 (355)
T ss_pred             hC-cccCCcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccHHHHhh
Confidence            33 7888999999999999999999999993     578999999999988765443

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-51  Score=351.44  Aligned_cols=263  Identities=29%  Similarity=0.445  Sum_probs=225.0

Q ss_pred             ccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCC-chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeE
Q 019650           43 VENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEI  121 (337)
Q Consensus        43 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~  121 (337)
                      ...+++|.+.+.||+|+|++||+|.+.+++..||||.+.... .....+.+..|+.+++.++|+|||.+++.... .+.+
T Consensus         6 ~~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~-~~~i   84 (429)
T KOG0595|consen    6 MRVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIED-DDFI   84 (429)
T ss_pred             ccccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEec-CCeE
Confidence            456789999999999999999999999999999999997765 55567778899999999999999999998776 7899


Q ss_pred             EEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCC------CcEEEeeccCccc
Q 019650          122 CFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGK------GEVKIADFGVSRI  195 (337)
Q Consensus       122 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~------~~~~l~Dfg~~~~  195 (337)
                      |+|||||+||+|.++++..+.+++.+++.++.||+.||++||+++||||||||+|||++..      -.+||+|||+++.
T Consensus        85 ~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~  164 (429)
T KOG0595|consen   85 YLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF  164 (429)
T ss_pred             EEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence            9999999999999999999999999999999999999999999999999999999999875      4699999999998


Q ss_pred             hhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHH
Q 019650          196 VEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMA  275 (337)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~  275 (337)
                      +.+.               ......+|++-|||||++..    ..|+-++|+||+|+++|++++|+.||......+.+. 
T Consensus       165 L~~~---------------~~a~tlcGSplYMAPEV~~~----~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~-  224 (429)
T KOG0595|consen  165 LQPG---------------SMAETLCGSPLYMAPEVIMS----QQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLL-  224 (429)
T ss_pred             CCch---------------hHHHHhhCCccccCHHHHHh----ccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHH-
Confidence            8754               33345579999999999985    478899999999999999999999997644333222 


Q ss_pred             HHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccC
Q 019650          276 LICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRS  327 (337)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~  327 (337)
                      ..++ .....+.++...+....+++...+..+|..|.++.+-+.|+++...-
T Consensus       225 ~~~k-~~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p  275 (429)
T KOG0595|consen  225 YIKK-GNEIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAANP  275 (429)
T ss_pred             HHhc-cccccCchhhhccCchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence            1111 12223334455677888999999999999999999999999887543

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=1.9e-52  Score=343.40  Aligned_cols=261  Identities=26%  Similarity=0.444  Sum_probs=223.8

Q ss_pred             ccccccccccccCcceEEEEEEEccCCceEEEEEeecCCc-hHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 019650           46 ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSS-TIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFV  124 (337)
Q Consensus        46 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv  124 (337)
                      ++.|+.+.++|+|++|+||+|.++.||+.||||.+..+.+ ....+-..+|++++++++|+|+|.++++|-. ...+++|
T Consensus         1 MekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrr-krklhLV   79 (396)
T KOG0593|consen    1 MEKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRR-KRKLHLV   79 (396)
T ss_pred             CcHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHh-cceeEEE
Confidence            3679999999999999999999999999999999987664 5556667899999999999999999999866 6889999


Q ss_pred             EeccCCCCchHHhhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCC
Q 019650          125 MEHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNN  203 (337)
Q Consensus       125 ~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~  203 (337)
                      +|||+. ++.+-++..+ .++.+.+.++++|++.|+.|+|+++++||||||+|||++.+|.+||||||+++.+..++...
T Consensus        80 FE~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~Y  158 (396)
T KOG0593|consen   80 FEYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNY  158 (396)
T ss_pred             eeecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcchh
Confidence            999987 7777776654 58999999999999999999999999999999999999999999999999999887544333


Q ss_pred             CCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhcc
Q 019650          204 NHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFG  283 (337)
Q Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~  283 (337)
                      .              ..+.|.+|.|||.+.+   +.+|+..+|||++||++.||++|++.|++..+-+.+..+...+...
T Consensus       159 T--------------DYVATRWYRaPELLvG---DtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L  221 (396)
T KOG0593|consen  159 T--------------DYVATRWYRAPELLVG---DTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNL  221 (396)
T ss_pred             h--------------hhhhhhhccChhhhcc---cCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHccc
Confidence            2              2367899999999996   3689999999999999999999999999888777777666553322


Q ss_pred             CCC--------------CCC------------CCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccc
Q 019650          284 ERL--------------EMP------------ETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTK  325 (337)
Q Consensus       284 ~~~--------------~~~------------~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~  325 (337)
                      .+.              .+|            +.++..+.+|+++||..||++|++.+++|.||||.+
T Consensus       222 ~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~  289 (396)
T KOG0593|consen  222 IPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDG  289 (396)
T ss_pred             CHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHH
Confidence            111              011            245668999999999999999999999999999954

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=5.4e-51  Score=358.34  Aligned_cols=280  Identities=28%  Similarity=0.390  Sum_probs=231.2

Q ss_pred             CccccccccccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEE
Q 019650           45 NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEIC  122 (337)
Q Consensus        45 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~  122 (337)
                      ..++|.++..||+|+||.||+|..+.||..+|+|++++..  .....+....|-.+|....++.||+++..|.+ ..++|
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD-~~~LY  217 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQD-KEYLY  217 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecC-CCeeE
Confidence            7899999999999999999999999999999999998764  33345566778889999999999999999987 78999


Q ss_pred             EEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccC
Q 019650          123 FVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNN  202 (337)
Q Consensus       123 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~  202 (337)
                      |||||++||++..+|...+.++++.++.++.+++.|+..||+.|+|||||||+|+|||..|++||+|||++.-+......
T Consensus       218 LiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~  297 (550)
T KOG0605|consen  218 LIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRI  297 (550)
T ss_pred             EEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhhh
Confidence            99999999999999999999999999999999999999999999999999999999999999999999998544321100


Q ss_pred             C----------C----CCCCCC-------------------CccccccccccCCCCCcCCcccccccCCCCCCccccHHH
Q 019650          203 N----------N----HNNNNN-------------------NNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWS  249 (337)
Q Consensus       203 ~----------~----~~~~~~-------------------~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Diws  249 (337)
                      .          .    ......                   .+....-.+.+|||.|+|||++.    +..|+...|+||
T Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll----~kgY~~~cDwWS  373 (550)
T KOG0605|consen  298 ESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLL----GKGYGKECDWWS  373 (550)
T ss_pred             hhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHh----cCCCCccccHHH
Confidence            0          0    000000                   00001223568999999999999    567899999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCC---CHHHHhcCcccccc
Q 019650          250 LGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRG---TVEELLAYPFVTKR  326 (337)
Q Consensus       250 lG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~---s~~eil~hp~f~~~  326 (337)
                      ||||+|||+.|-+||.+....+....++........+. ...+++++++||.+||. ||.+|.   .++||.+||||++.
T Consensus       374 LG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~-~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v  451 (550)
T KOG0605|consen  374 LGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPE-EVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGV  451 (550)
T ss_pred             HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCC-cCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccC
Confidence            99999999999999988777776666664432222222 23457999999999998 999996   69999999999999


Q ss_pred             CCCcc
Q 019650          327 SSSSN  331 (337)
Q Consensus       327 ~~~~~  331 (337)
                      +|..-
T Consensus       452 ~W~~l  456 (550)
T KOG0605|consen  452 DWDHL  456 (550)
T ss_pred             Ccchh
Confidence            98754

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.8e-53  Score=341.91  Aligned_cols=251  Identities=29%  Similarity=0.481  Sum_probs=221.8

Q ss_pred             CccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCC-chHhHHHHHHHHHHHHhcCCCCceeeee-eEEeeCC
Q 019650           42 DVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-STIIRHQAAHEAEILKRLDSQFIVKCHA-VFYTIEG  119 (337)
Q Consensus        42 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~-~~~~~~~  119 (337)
                      +..+..+|.++++||+|.||+||++.+..+|..+|.|.++-.. +....+.+..|+.++++|+||||+++++ .+.+...
T Consensus        14 ~~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~e   93 (375)
T KOG0591|consen   14 PQKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNE   93 (375)
T ss_pred             CcccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccch
Confidence            5667889999999999999999999999999999999887543 4556677889999999999999999999 5555333


Q ss_pred             eEEEEEeccCCCCchHHhhh----cCCCCHHHHHHHHHHHHHHHHHHHh--CC--ceeccCCCCCeEEcCCCcEEEeecc
Q 019650          120 EICFVMEHMERGSLFDSLRV----RKKLSEDVISGVAYRVLKGLQYLHG--MQ--IIHGDIKPSNLLINGKGEVKIADFG  191 (337)
Q Consensus       120 ~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~--~~--ivH~dl~~~Nili~~~~~~~l~Dfg  191 (337)
                      -+++|||+|++|+|.+.++.    .+.+++.++|+++.|++.||..+|+  ..  +.||||||.||+++.+|.+||+|||
T Consensus        94 vlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfG  173 (375)
T KOG0591|consen   94 VLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFG  173 (375)
T ss_pred             hhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccch
Confidence            48999999999999999963    4569999999999999999999998  44  8999999999999999999999999


Q ss_pred             CccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCch
Q 019650          192 VSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP  271 (337)
Q Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~  271 (337)
                      +++.+....              ....+.+|||.||+||.+.    +..|+.+|||||+||++|||+.-+.||.+.    
T Consensus       174 L~r~l~s~~--------------tfA~S~VGTPyYMSPE~i~----~~~Y~~kSDiWslGCllyEMcaL~~PF~g~----  231 (375)
T KOG0591|consen  174 LGRFLSSKT--------------TFAHSLVGTPYYMSPERIH----ESGYNFKSDIWSLGCLLYEMCALQSPFYGD----  231 (375)
T ss_pred             hHhHhcchh--------------HHHHhhcCCCcccCHHHHh----cCCCCcchhHHHHHHHHHHHHhcCCCcccc----
Confidence            999887665              5556779999999999999    568999999999999999999999999764    


Q ss_pred             hHHHHHHHhhccCCCCCC-CCCCHHHHHHHHHHhhcCcCCCCCH
Q 019650          272 DLMALICAICFGERLEMP-ETASPEFRRFVRSCLEKDWRKRGTV  314 (337)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~p~~R~s~  314 (337)
                      .+..+..++..+..+..| ...|..+.+||..|+..||..||+.
T Consensus       232 n~~~L~~KI~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t  275 (375)
T KOG0591|consen  232 NLLSLCKKIEQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDT  275 (375)
T ss_pred             cHHHHHHHHHcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCc
Confidence            667777778888777777 6779999999999999999999985

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-51  Score=350.15  Aligned_cols=272  Identities=31%  Similarity=0.459  Sum_probs=231.7

Q ss_pred             CCccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCe
Q 019650           41 PDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGE  120 (337)
Q Consensus        41 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~  120 (337)
                      .+....++|++...||.|..++||+|++..++..||||+++.+.-....+.+.+|+..++.++||||++++..|.. +..
T Consensus        20 ~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv-~~~   98 (516)
T KOG0582|consen   20 EFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVV-DSE   98 (516)
T ss_pred             cCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEe-cce
Confidence            3456789999999999999999999999999999999999988766668999999999999999999999999987 799


Q ss_pred             EEEEEeccCCCCchHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhc
Q 019650          121 ICFVMEHMERGSLFDSLRVR--KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEE  198 (337)
Q Consensus       121 ~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~  198 (337)
                      +++||.++.+|++.+++...  ..+++..+..|++++++||.|||.+|.||||||+.|||++.+|.++|+|||.+..+..
T Consensus        99 LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~  178 (516)
T KOG0582|consen   99 LWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFD  178 (516)
T ss_pred             eEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecc
Confidence            99999999999999999864  3599999999999999999999999999999999999999999999999998887766


Q ss_pred             cccCCCCCCCCCCcccccc-ccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHH
Q 019650          199 TRNNNNHNNNNNNNIGEAA-IACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALI  277 (337)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~  277 (337)
                      .+...           ... ..++|+++|||||++..+  ...|+.++||||||++..||.+|..||.......   -++
T Consensus       179 ~G~R~-----------~~rf~tfvgtp~wmAPEvl~q~--~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmk---vLl  242 (516)
T KOG0582|consen  179 SGDRQ-----------VTRFNTFVGTPCWMAPEVLMQQ--LHGYDFKADIWSFGITACELAHGHAPFSKYPPMK---VLL  242 (516)
T ss_pred             cCcee-----------eEeeccccCcccccChHHhhhc--ccCccchhhhhhhhHHHHHHhcCCCCcccCChHH---HHH
Confidence            54211           112 566899999999997655  5689999999999999999999999997654432   222


Q ss_pred             HHhhccCCC--------CCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCC
Q 019650          278 CAICFGERL--------EMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSS  329 (337)
Q Consensus       278 ~~~~~~~~~--------~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~  329 (337)
                      .++....+.        +.....+..++++|..||..||++|||++++|+|+||++....
T Consensus       243 ~tLqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~  302 (516)
T KOG0582|consen  243 LTLQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSK  302 (516)
T ss_pred             HHhcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccch
Confidence            232222211        1112346789999999999999999999999999999988754

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-51  Score=349.30  Aligned_cols=266  Identities=34%  Similarity=0.528  Sum_probs=222.9

Q ss_pred             ccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCC-eEEEE
Q 019650           46 ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEG-EICFV  124 (337)
Q Consensus        46 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~-~~~lv  124 (337)
                      ..+|+.++.||+|+||+||++.+.++|...|+|......... .+.+.+|+.++++++||+||+++|....... .++++
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~   94 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIF   94 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEee
Confidence            678999999999999999999999999999999987764332 6778899999999999999999997444334 68999


Q ss_pred             EeccCCCCchHHhhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcC-CCcEEEeeccCccchhccccC
Q 019650          125 MEHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLING-KGEVKIADFGVSRIVEETRNN  202 (337)
Q Consensus       125 ~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~-~~~~~l~Dfg~~~~~~~~~~~  202 (337)
                      |||+++|+|.+++...+ .+++..++.+..|++++|+|||++||+|+||||+|||++. ++.+||+|||.+.........
T Consensus        95 mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~  174 (313)
T KOG0198|consen   95 MEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTK  174 (313)
T ss_pred             eeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccccc
Confidence            99999999999999876 7999999999999999999999999999999999999999 799999999998876641111


Q ss_pred             CCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhc
Q 019650          203 NNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICF  282 (337)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~  282 (337)
                      .           .......||+.|||||++..   +.....++|||||||++.||+||+.||...  .............
T Consensus       175 ~-----------~~~~~~~Gtp~~maPEvi~~---g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~--~~~~~~~~~ig~~  238 (313)
T KOG0198|consen  175 S-----------DSELSVQGTPNYMAPEVIRN---GEVARRESDIWSLGCTVVEMLTGKPPWSEF--FEEAEALLLIGRE  238 (313)
T ss_pred             c-----------cccccccCCccccCchhhcC---CCcCCccchhhhcCCEEEeccCCCCcchhh--cchHHHHHHHhcc
Confidence            0           22334579999999999984   123346999999999999999999999763  1122222222333


Q ss_pred             cCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCC
Q 019650          283 GERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSS  328 (337)
Q Consensus       283 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~  328 (337)
                      ...+.+|..++..+++|+.+|+..||.+|||++++|+|||.++...
T Consensus       239 ~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~  284 (313)
T KOG0198|consen  239 DSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI  284 (313)
T ss_pred             CCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence            3456888899999999999999999999999999999999988664

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-50  Score=360.85  Aligned_cols=260  Identities=30%  Similarity=0.461  Sum_probs=224.1

Q ss_pred             ccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCC----chHhHHHHHHHHHHHHhcC-CCCceeeeeeEEee
Q 019650           43 VENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS----STIIRHQAAHEAEILKRLD-SQFIVKCHAVFYTI  117 (337)
Q Consensus        43 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~  117 (337)
                      ....+.|.+.+.||.|+||+|+.|.+..++..||+|++....    .....+.+.+|+.++++++ ||||+++++++.. 
T Consensus        13 ~~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t-   91 (370)
T KOG0583|consen   13 QLSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFAT-   91 (370)
T ss_pred             ccccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEec-
Confidence            456789999999999999999999999999999999876641    1134556678999999999 9999999999877 


Q ss_pred             CCeEEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCC-CcEEEeeccCccch
Q 019650          118 EGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGK-GEVKIADFGVSRIV  196 (337)
Q Consensus       118 ~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~-~~~~l~Dfg~~~~~  196 (337)
                      ...+++||||+.||+|.+++.+.+++++.+++.++.||+.|++|||++||+||||||+|++++.+ +++||+|||++...
T Consensus        92 ~~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~  171 (370)
T KOG0583|consen   92 PTKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAIS  171 (370)
T ss_pred             CCeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEecccccccc
Confidence            56799999999999999999999999999999999999999999999999999999999999999 99999999999877


Q ss_pred             hccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCC-CccccHHHHHHHHHHHHhCCCCCCCCCCchhHHH
Q 019650          197 EETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDY-GFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMA  275 (337)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~-~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~  275 (337)
                      ....              .....++|++.|+|||++....   .| ..++||||+|++||.|++|..||.....    ..
T Consensus       172 ~~~~--------------~~l~t~cGsp~Y~aPEvl~~~~---~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~----~~  230 (370)
T KOG0583|consen  172 PGED--------------GLLKTFCGSPAYAAPEVLSGKG---TYSGKAADVWSLGVILYVLLCGRLPFDDSNV----PN  230 (370)
T ss_pred             CCCC--------------CcccCCCCCcccCCHHHhCCCC---CcCCchhhhhhhHHHHHHHHhCCCCCCCccH----HH
Confidence            3111              3445568999999999999542   14 5799999999999999999999976322    22


Q ss_pred             HHHHhhccCCCCCCCCC-CHHHHHHHHHHhhcCcCCCCCHHHHhcCccccc
Q 019650          276 LICAICFGERLEMPETA-SPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTK  325 (337)
Q Consensus       276 ~~~~~~~~~~~~~~~~~-~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~  325 (337)
                      +... .......+|..+ +..++.++.+||..||.+|+|+.+|+.||||+.
T Consensus       231 l~~k-i~~~~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  231 LYRK-IRKGEFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             HHHH-HhcCCccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence            2222 333466777777 999999999999999999999999999999997

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-51  Score=356.01  Aligned_cols=268  Identities=26%  Similarity=0.386  Sum_probs=229.4

Q ss_pred             ccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcC-CCCceeeeeeEEeeCCeE
Q 019650           43 VENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLD-SQFIVKCHAVFYTIEGEI  121 (337)
Q Consensus        43 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~  121 (337)
                      ....++|+++++||.|.||.||+|....++..||||.++.....-....-.+|+.-+++|+ ||||+++.+++.+.++.+
T Consensus         6 ~~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L   85 (538)
T KOG0661|consen    6 VIFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRIL   85 (538)
T ss_pred             hhHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceE
Confidence            4557899999999999999999999999999999999987654433334468999999998 999999999999866699


Q ss_pred             EEEEeccCCCCchHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccc
Q 019650          122 CFVMEHMERGSLFDSLRVR-KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETR  200 (337)
Q Consensus       122 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~  200 (337)
                      ++||||++. +|.+++... +.+++..++.|+.||+++|+|+|.+|+.|||+||+|||+.....+||+|||+++.+....
T Consensus        86 ~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Skp  164 (538)
T KOG0661|consen   86 YFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSKP  164 (538)
T ss_pred             eeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccCC
Confidence            999999965 999999754 579999999999999999999999999999999999999988899999999999886543


Q ss_pred             cCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHh
Q 019650          201 NNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAI  280 (337)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~  280 (337)
                      .               -...+.|.+|.|||++..   ++.|+.+.|+|++|||++|+++-++.|++..+.+...++++-+
T Consensus       165 P---------------YTeYVSTRWYRAPEvLLr---s~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VL  226 (538)
T KOG0661|consen  165 P---------------YTEYVSTRWYRAPEVLLR---SGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVL  226 (538)
T ss_pred             C---------------cchhhhcccccchHHhhh---ccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHh
Confidence            2               223468999999999986   4689999999999999999999999999988877777766543


Q ss_pred             hccCCCC-------------------------CCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCC
Q 019650          281 CFGERLE-------------------------MPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSS  329 (337)
Q Consensus       281 ~~~~~~~-------------------------~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~  329 (337)
                      .......                         ..+..+.++.++|.+||++||.+|||+.|+|+||||+.....
T Consensus       227 GtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~~  300 (538)
T KOG0661|consen  227 GTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRAS  300 (538)
T ss_pred             CCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccccc
Confidence            3222111                         113467899999999999999999999999999999976644

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9e-51  Score=364.22  Aligned_cols=263  Identities=29%  Similarity=0.469  Sum_probs=232.7

Q ss_pred             ccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCe
Q 019650           43 VENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGE  120 (337)
Q Consensus        43 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~  120 (337)
                      ...++-|++++.||.|+.|.|-+|++..||+.+|||++....  .......+.+|+.+|+.+.|||++.+++++.. ..+
T Consensus         8 ~~tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~-~~~   86 (786)
T KOG0588|consen    8 KNTIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWEN-KQH   86 (786)
T ss_pred             cccccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeecc-Cce
Confidence            456788999999999999999999999999999999997652  33445667899999999999999999999866 789


Q ss_pred             EEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccc
Q 019650          121 ICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETR  200 (337)
Q Consensus       121 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~  200 (337)
                      +|+|.||++||.|++++-..+++++.++.+++.||+.|+.|+|..+|+|||+||+|+|++..+++||+|||++.....+ 
T Consensus        87 lylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g-  165 (786)
T KOG0588|consen   87 LYLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPG-  165 (786)
T ss_pred             EEEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCC-
Confidence            9999999999999999999999999999999999999999999999999999999999999999999999999876554 


Q ss_pred             cCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHh
Q 019650          201 NNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAI  280 (337)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~  280 (337)
                                    ......+|.|.|.+||++.+.+|+   +.++||||.|+|||.|+||++||.    ++....++.+.
T Consensus       166 --------------klLeTSCGSPHYA~PEIV~G~pYd---G~~sDVWSCGVILfALLtG~LPFd----DdNir~LLlKV  224 (786)
T KOG0588|consen  166 --------------KLLETSCGSPHYAAPEIVSGRPYD---GRPSDVWSCGVILFALLTGKLPFD----DDNIRVLLLKV  224 (786)
T ss_pred             --------------ccccccCCCcccCCchhhcCCCCC---CCccccchhHHHHHHHHhCCCCCC----CccHHHHHHHH
Confidence                          334445799999999999976554   448999999999999999999995    33455555555


Q ss_pred             hccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCC
Q 019650          281 CFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSS  329 (337)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~  329 (337)
                      +.+ ..++|..++.++++||.+||..||.+|+|.++|++|||+++-...
T Consensus       225 ~~G-~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~  272 (786)
T KOG0588|consen  225 QRG-VFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSL  272 (786)
T ss_pred             HcC-cccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCC
Confidence            555 577789999999999999999999999999999999999986543

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=7.8e-50  Score=340.80  Aligned_cols=281  Identities=30%  Similarity=0.440  Sum_probs=237.1

Q ss_pred             CCCCccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHHhcCCCCceeeeeeEEe
Q 019650           39 TSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHAVFYT  116 (337)
Q Consensus        39 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~  116 (337)
                      ........+.|++++.||.|..|+||++....++..+|+|++.+..  ......+.+.|.++|+.++||.++.++..+.+
T Consensus        69 ~~~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet  148 (459)
T KOG0610|consen   69 SKDGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFET  148 (459)
T ss_pred             cCCCccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeec
Confidence            3445567899999999999999999999999999999999997764  33445667789999999999999999999876


Q ss_pred             eCCeEEEEEeccCCCCchHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCcc
Q 019650          117 IEGEICFVMEHMERGSLFDSLRVR--KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSR  194 (337)
Q Consensus       117 ~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~  194 (337)
                       +...|++||||+||+|..+++.+  +.++++.++.++.+++.||.|||-.|||.|||||+|||+.++|+++|+||.++.
T Consensus       149 -~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~  227 (459)
T KOG0610|consen  149 -DKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSL  227 (459)
T ss_pred             -cceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccc
Confidence             78999999999999999999765  469999999999999999999999999999999999999999999999999876


Q ss_pred             chhccccCCCC----------------------CC--C-C-----------------CCccccccccccCCCCCcCCccc
Q 019650          195 IVEETRNNNNH----------------------NN--N-N-----------------NNNIGEAAIACMGTCAYMSPERV  232 (337)
Q Consensus       195 ~~~~~~~~~~~----------------------~~--~-~-----------------~~~~~~~~~~~~~~~~y~aPE~~  232 (337)
                      ...........                      ..  . .                 ...-+..+.+++||-+|+|||++
T Consensus       228 ~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI  307 (459)
T KOG0610|consen  228 RCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVI  307 (459)
T ss_pred             cCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceee
Confidence            55321100000                      00  0 0                 01122456688999999999999


Q ss_pred             ccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhccCCCCCCC--CCCHHHHHHHHHHhhcCcCC
Q 019650          233 DSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPE--TASPEFRRFVRSCLEKDWRK  310 (337)
Q Consensus       233 ~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~~p~~  310 (337)
                      .    |...+.++|+|+||+++|||+.|..||.+.++.+.+..++.+     ...+|.  .++..+++||+++|.+||.+
T Consensus       308 ~----G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~-----~l~Fp~~~~vs~~akDLIr~LLvKdP~k  378 (459)
T KOG0610|consen  308 R----GEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQ-----PLKFPEEPEVSSAAKDLIRKLLVKDPSK  378 (459)
T ss_pred             e----cCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcC-----CCcCCCCCcchhHHHHHHHHHhccChhh
Confidence            9    557888999999999999999999999998888888877654     444433  56799999999999999999


Q ss_pred             CCC----HHHHhcCccccccCCC
Q 019650          311 RGT----VEELLAYPFVTKRSSS  329 (337)
Q Consensus       311 R~s----~~eil~hp~f~~~~~~  329 (337)
                      |.-    ++||..||||++.+|.
T Consensus       379 Rlg~~rGA~eIK~HpFF~gVnWa  401 (459)
T KOG0610|consen  379 RLGSKRGAAEIKRHPFFEGVNWA  401 (459)
T ss_pred             hhccccchHHhhcCccccCCChh
Confidence            987    9999999999999986

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-52  Score=357.57  Aligned_cols=268  Identities=30%  Similarity=0.469  Sum_probs=240.5

Q ss_pred             ccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 019650           46 ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVM  125 (337)
Q Consensus        46 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~  125 (337)
                      -..|+..+.||+|.||.||+|.+..+++.||+|++..+......+.+++|+.++.+++++||..+++.+.. +..++++|
T Consensus        12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~-g~~LwiiM   90 (467)
T KOG0201|consen   12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLK-GTKLWIIM   90 (467)
T ss_pred             ccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheee-cccHHHHH
Confidence            45688889999999999999999999999999999998888888999999999999999999999999887 78899999


Q ss_pred             eccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCCC
Q 019650          126 EHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNH  205 (337)
Q Consensus       126 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~  205 (337)
                      ||+.||++.+.++....+++..+..++++++.||.|||.++.+|+|||+.||++..+|.++|+|||.+..+.....    
T Consensus        91 ey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~----  166 (467)
T KOG0201|consen   91 EYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK----  166 (467)
T ss_pred             HHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhh----
Confidence            9999999999999888889999999999999999999999999999999999999999999999999988876552    


Q ss_pred             CCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhccCC
Q 019650          206 NNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGER  285 (337)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~  285 (337)
                                ....++||+.|||||++.    +..|+.++||||||++.+||++|.+|+...+...    .+-.+....+
T Consensus       167 ----------rr~tfvGTPfwMAPEVI~----~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmr----vlflIpk~~P  228 (467)
T KOG0201|consen  167 ----------RRKTFVGTPFWMAPEVIK----QSGYDTKADIWSLGITAIELAKGEPPHSKLHPMR----VLFLIPKSAP  228 (467)
T ss_pred             ----------ccccccccccccchhhhc----cccccchhhhhhhhHHHHHHhcCCCCCcccCcce----EEEeccCCCC
Confidence                      234668999999999999    5589999999999999999999999998776632    2223334455


Q ss_pred             CCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCCccccCcC
Q 019650          286 LEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNIEGLI  336 (337)
Q Consensus       286 ~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~~~~~~~~  336 (337)
                      +......+..+++|+..||++||+.|||+.++|+|+|++.....+.|.++|
T Consensus       229 P~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a~k~s~L~~~i  279 (467)
T KOG0201|consen  229 PRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKRAKKTSELKELI  279 (467)
T ss_pred             CccccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHhcCCchHHHHHH
Confidence            666667889999999999999999999999999999999988888887765

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-50  Score=358.06  Aligned_cols=269  Identities=30%  Similarity=0.497  Sum_probs=232.7

Q ss_pred             CccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 019650           45 NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFV  124 (337)
Q Consensus        45 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv  124 (337)
                      ....|....+||+|+.|.||.+....+++.||||.+..... ...+-+.+|+.+++..+|+||+.+++.|.. +..+++|
T Consensus       271 P~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q-~~keLilnEi~Vm~~~~H~NiVnfl~Sylv-~deLWVV  348 (550)
T KOG0578|consen  271 PRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQ-PKKELLLNEILVMRDLHHPNIVNFLDSYLV-GDELWVV  348 (550)
T ss_pred             hhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccC-CchhhhHHHHHHHHhccchHHHHHHHHhcc-cceeEEE
Confidence            34688899999999999999999999999999999987643 245667899999999999999999999887 6889999


Q ss_pred             EeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCC
Q 019650          125 MEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNN  204 (337)
Q Consensus       125 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~  204 (337)
                      |||++||+|.|.+... .+++.++..|+.+++.||+|||.+||+|||||.+|||++.+|.+||+|||++..+....    
T Consensus       349 MEym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~----  423 (550)
T KOG0578|consen  349 MEYMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ----  423 (550)
T ss_pred             EeecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeecccccc----
Confidence            9999999999999743 49999999999999999999999999999999999999999999999999998876654    


Q ss_pred             CCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhccC
Q 019650          205 HNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGE  284 (337)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~  284 (337)
                                ......+|||.|||||+..    ...|+++.||||||++++||.-|++||....  ......+.......
T Consensus       424 ----------~KR~TmVGTPYWMAPEVvt----rk~YG~KVDIWSLGIMaIEMveGEPPYlnE~--PlrAlyLIa~ng~P  487 (550)
T KOG0578|consen  424 ----------SKRSTMVGTPYWMAPEVVT----RKPYGPKVDIWSLGIMAIEMVEGEPPYLNEN--PLRALYLIATNGTP  487 (550)
T ss_pred             ----------CccccccCCCCccchhhhh----hcccCccccchhhhhHHHHHhcCCCCccCCC--hHHHHHHHhhcCCC
Confidence                      2344568999999999999    5689999999999999999999999997522  22222222233333


Q ss_pred             CCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCCccccCcC
Q 019650          285 RLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNIEGLI  336 (337)
Q Consensus       285 ~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~~~~~~~~  336 (337)
                      ....++.++..+++|+.+||..|+.+|+|+.|+|+||||+.....++|+.||
T Consensus       488 ~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~a~p~ssL~pLi  539 (550)
T KOG0578|consen  488 KLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKMAKPESSLNPLI  539 (550)
T ss_pred             CcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhhcCCHHHhHHHH
Confidence            4456788999999999999999999999999999999999999888887765

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.1e-50  Score=359.84  Aligned_cols=266  Identities=30%  Similarity=0.410  Sum_probs=230.0

Q ss_pred             ccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHHhc-CCCCceeeeeeEEeeCC
Q 019650           43 VENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRL-DSQFIVKCHAVFYTIEG  119 (337)
Q Consensus        43 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~  119 (337)
                      ....++|.++++||+|.||+|+++..+.+++.+|||+++++.  .....+....|.+++... +||.++.++..|.+ ..
T Consensus       364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT-~~  442 (694)
T KOG0694|consen  364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQT-KE  442 (694)
T ss_pred             cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccccc-CC
Confidence            456789999999999999999999999999999999998875  344456666787777766 59999999999887 79


Q ss_pred             eEEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhcc
Q 019650          120 EICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEET  199 (337)
Q Consensus       120 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~  199 (337)
                      ++|+||||+.||++..+ +..+.+++..++.++..++.||.|||++|||+||||.+|||+|.+|++||+|||++....-.
T Consensus       443 ~l~fvmey~~Ggdm~~~-~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~  521 (694)
T KOG0694|consen  443 HLFFVMEYVAGGDLMHH-IHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ  521 (694)
T ss_pred             eEEEEEEecCCCcEEEE-EecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCC
Confidence            99999999999994433 33578999999999999999999999999999999999999999999999999999765322


Q ss_pred             ccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHH
Q 019650          200 RNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICA  279 (337)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~  279 (337)
                      +              ..+..++|||.|+|||++.    +..|+.++|+|+|||+||||+.|+.||.+.++++....++  
T Consensus       522 g--------------~~TsTfCGTpey~aPEil~----e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~--  581 (694)
T KOG0694|consen  522 G--------------DRTSTFCGTPEFLAPEVLT----EQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIV--  581 (694)
T ss_pred             C--------------CccccccCChhhcChhhhc----cCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHh--
Confidence            2              5566789999999999999    6689999999999999999999999998866665555443  


Q ss_pred             hhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCC-----HHHHhcCccccccCCCcccc
Q 019650          280 ICFGERLEMPETASPEFRRFVRSCLEKDWRKRGT-----VEELLAYPFVTKRSSSSNIE  333 (337)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s-----~~eil~hp~f~~~~~~~~~~  333 (337)
                         ...+.+|..++.++.++++++|.++|.+|.-     +++|..||||++..|..-.+
T Consensus       582 ---~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~  637 (694)
T KOG0694|consen  582 ---NDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLN  637 (694)
T ss_pred             ---cCCCCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHHHhh
Confidence               3367778889999999999999999999963     78999999999998865443

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=2.3e-50  Score=355.56  Aligned_cols=258  Identities=30%  Similarity=0.497  Sum_probs=229.6

Q ss_pred             ccccccccccccCcceEEEEEEEccCCceEEEEEeecCC-chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 019650           46 ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFV  124 (337)
Q Consensus        46 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv  124 (337)
                      +++|.+.+.||+|+||.||+|+.+.+.+.||+|.+.+.. .+...+.+.+|+++++.++||||+..++.|.+ ..++++|
T Consensus         1 me~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt-~~~~~vV   79 (808)
T KOG0597|consen    1 MEQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFET-SAHLWVV   79 (808)
T ss_pred             CcchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcc-cceEEEE
Confidence            368999999999999999999999999999999997654 55577888999999999999999999998866 7999999


Q ss_pred             EeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCC
Q 019650          125 MEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNN  204 (337)
Q Consensus       125 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~  204 (337)
                      +||+.| +|..+++..+.++++.++.++.+++.||.|||+.+|+|+|+||.||++..+|.+|++|||+++.+...+    
T Consensus        80 te~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t----  154 (808)
T KOG0597|consen   80 TEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT----  154 (808)
T ss_pred             ehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCc----
Confidence            999977 999999999999999999999999999999999999999999999999999999999999999887644    


Q ss_pred             CCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhccC
Q 019650          205 HNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGE  284 (337)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~  284 (337)
                                ....+.-|||.|||||.+.    +.+|+..+|+|||||++||+++|++||...    ...++.+. ....
T Consensus       155 ----------~vltsikGtPlYmAPElv~----e~pyd~~sDlWslGcilYE~~~G~PPF~a~----si~~Lv~~-I~~d  215 (808)
T KOG0597|consen  155 ----------SVLTSIKGTPLYMAPELVE----EQPYDHTSDLWSLGCILYELYVGQPPFYAR----SITQLVKS-ILKD  215 (808)
T ss_pred             ----------eeeeeccCcccccCHHHHc----CCCccchhhHHHHHHHHHHHhcCCCCchHH----HHHHHHHH-HhcC
Confidence                      3344556999999999999    568999999999999999999999999652    23333333 3344


Q ss_pred             CCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCC
Q 019650          285 RLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSS  328 (337)
Q Consensus       285 ~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~  328 (337)
                      +..+|...+..+.++++.+|.+||..|.|..+++.|||.++...
T Consensus       216 ~v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~~  259 (808)
T KOG0597|consen  216 PVKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKIN  259 (808)
T ss_pred             CCCCcccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhhhh
Confidence            67777889999999999999999999999999999999988754

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=3e-49  Score=319.08  Aligned_cols=265  Identities=27%  Similarity=0.373  Sum_probs=223.4

Q ss_pred             cccccccccccCcceEEEEEEEccCCceEEEEEeecCCch-HhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 019650           47 SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSST-IIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVM  125 (337)
Q Consensus        47 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~  125 (337)
                      ++|..++.||+|.||.||+|.+..+|+.||||.++..... .......+|+..++.++|+||+.++++|.. ...+.+|+
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~-~~~l~lVf   80 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPH-KSNLSLVF   80 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccC-CCceEEEE
Confidence            6899999999999999999999999999999999877532 334556799999999999999999999987 68899999


Q ss_pred             eccCCCCchHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCC
Q 019650          126 EHMERGSLFDSLRVR-KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNN  204 (337)
Q Consensus       126 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~  204 (337)
                      ||++. +|...++.. -.++..++..++.+++++|+|||++.|+||||||+|+|++.+|.+||+|||+++..+.....  
T Consensus        81 Efm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~--  157 (318)
T KOG0659|consen   81 EFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI--  157 (318)
T ss_pred             Eeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcc--
Confidence            99986 999999854 46899999999999999999999999999999999999999999999999999988765422  


Q ss_pred             CCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhccC
Q 019650          205 HNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGE  284 (337)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~  284 (337)
                                  ....+.|..|.|||.+.+.   ..|+...|+||.|||+.||+-+.+-|++..+-+.+..+...+....
T Consensus       158 ------------~~~~V~TRWYRAPELLfGs---r~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~  222 (318)
T KOG0659|consen  158 ------------QTHQVVTRWYRAPELLFGS---RQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPT  222 (318)
T ss_pred             ------------cccceeeeeccChHHhccc---hhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCC
Confidence                        2222689999999999974   4789999999999999999999988877666555555544433222


Q ss_pred             CCCC-----------------------CCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCCc
Q 019650          285 RLEM-----------------------PETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSS  330 (337)
Q Consensus       285 ~~~~-----------------------~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~~  330 (337)
                      ...+                       .+..+..+.+|+.+||..||.+|+|+.|+|+|+||++.--.+
T Consensus       223 ~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~pt  291 (318)
T KOG0659|consen  223 PDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLPT  291 (318)
T ss_pred             cccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCCC
Confidence            2111                       123567889999999999999999999999999999754333

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.1e-49  Score=343.25  Aligned_cols=265  Identities=29%  Similarity=0.414  Sum_probs=225.8

Q ss_pred             CccccccccccccCcceEEEEEEEccCCceEEEEEeecCC-chHhHHHHHHHHHHHHhcCCCCceeeeeeEEee-CCeEE
Q 019650           45 NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTI-EGEIC  122 (337)
Q Consensus        45 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-~~~~~  122 (337)
                      ..+.|+.+++||+|.||.||+|.+..+|+.||+|.+..+. .+.....+.+|+.+|++|+||||+++.+...+. ...+|
T Consensus       115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY  194 (560)
T KOG0600|consen  115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY  194 (560)
T ss_pred             chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence            4579999999999999999999999999999999997765 344556678999999999999999999998885 46899


Q ss_pred             EEEeccCCCCchHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhcccc
Q 019650          123 FVMEHMERGSLFDSLRVR-KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRN  201 (337)
Q Consensus       123 lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~  201 (337)
                      +|+||++. +|.-++... -.|++.++..+++||+.+|.|+|++||+|||||.+|||||.+|.+||+|||+++.......
T Consensus       195 lVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~  273 (560)
T KOG0600|consen  195 LVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGS  273 (560)
T ss_pred             EEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCCC
Confidence            99999987 888888764 3799999999999999999999999999999999999999999999999999997765443


Q ss_pred             CCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhh
Q 019650          202 NNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAIC  281 (337)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~  281 (337)
                      ..             ....+.|.+|.|||.+.+.   ..|+...|+||.||||.||++|++.|++..+.+.+..+... +
T Consensus       274 ~~-------------~T~rVvTLWYRpPELLLG~---t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfkl-c  336 (560)
T KOG0600|consen  274 AP-------------YTSRVVTLWYRPPELLLGA---TSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKL-C  336 (560)
T ss_pred             cc-------------cccceEEeeccChHHhcCC---cccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHH-h
Confidence            22             2344789999999999974   58999999999999999999999999988777666655543 3


Q ss_pred             ccCCCCCC-------------------------CCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccC
Q 019650          282 FGERLEMP-------------------------ETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRS  327 (337)
Q Consensus       282 ~~~~~~~~-------------------------~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~  327 (337)
                      .......+                         ...+....+|+..||..||++|.|+.++|.|+||...-
T Consensus       337 GSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~p  407 (560)
T KOG0600|consen  337 GSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTEP  407 (560)
T ss_pred             CCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccccCC
Confidence            22222111                         23567899999999999999999999999999995443

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=8.4e-49  Score=349.43  Aligned_cols=260  Identities=30%  Similarity=0.468  Sum_probs=220.8

Q ss_pred             ccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCe
Q 019650           43 VENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGE  120 (337)
Q Consensus        43 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~  120 (337)
                      ....++|++.+.||.|+||.||+|.+..+++.||+|++....  .....+.+.+|+.++++++|+||+++++.+.. +..
T Consensus        14 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~   92 (329)
T PTZ00263         14 SWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQD-ENR   92 (329)
T ss_pred             CCCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEc-CCE
Confidence            345789999999999999999999999999999999987542  12234567889999999999999999998876 688


Q ss_pred             EEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccc
Q 019650          121 ICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETR  200 (337)
Q Consensus       121 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~  200 (337)
                      .++||||+.|++|.+++...+.+++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||++.......
T Consensus        93 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  172 (329)
T PTZ00263         93 VYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT  172 (329)
T ss_pred             EEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc
Confidence            99999999999999999988889999999999999999999999999999999999999999999999999987653221


Q ss_pred             cCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHh
Q 019650          201 NNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAI  280 (337)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~  280 (337)
                                       ....|++.|+|||.+.    +..++.++||||||+++|+|++|..||.+....    ......
T Consensus       173 -----------------~~~~gt~~y~aPE~~~----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~----~~~~~i  227 (329)
T PTZ00263        173 -----------------FTLCGTPEYLAPEVIQ----SKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF----RIYEKI  227 (329)
T ss_pred             -----------------ceecCChhhcCHHHHc----CCCCCCcceeechHHHHHHHHcCCCCCCCCCHH----HHHHHH
Confidence                             1235899999999998    456789999999999999999999999654322    222222


Q ss_pred             hccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCC-----HHHHhcCccccccCCC
Q 019650          281 CFGERLEMPETASPEFRRFVRSCLEKDWRKRGT-----VEELLAYPFVTKRSSS  329 (337)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s-----~~eil~hp~f~~~~~~  329 (337)
                      ..+ ...++..++..+.++|.+||+.||.+|++     ++++++||||++..+.
T Consensus       228 ~~~-~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~~  280 (329)
T PTZ00263        228 LAG-RLKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANWD  280 (329)
T ss_pred             hcC-CcCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCCHH
Confidence            222 45566778999999999999999999986     7999999999986544

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.1e-49  Score=343.50  Aligned_cols=256  Identities=25%  Similarity=0.395  Sum_probs=217.2

Q ss_pred             cccccccccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 019650           47 SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFV  124 (337)
Q Consensus        47 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv  124 (337)
                      ++|++.+.||.|+||+||+|.+..+++.||+|++....  .....+.+.+|+.++++++|+||+++++.+.+ +..+++|
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv   79 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHD-QRFLYML   79 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhcc-CCeEEEE
Confidence            47999999999999999999999999999999986542  12234567789999999999999999998766 6889999


Q ss_pred             EeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCC
Q 019650          125 MEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNN  204 (337)
Q Consensus       125 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~  204 (337)
                      |||+++++|.+++...+.+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++.......    
T Consensus        80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~----  155 (291)
T cd05612          80 MEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT----  155 (291)
T ss_pred             EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCCc----
Confidence            9999999999999988899999999999999999999999999999999999999999999999999987653211    


Q ss_pred             CCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhccC
Q 019650          205 HNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGE  284 (337)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~  284 (337)
                                   ....|++.|+|||.+.    +..++.++||||||+++|+|++|..||............    .. .
T Consensus       156 -------------~~~~gt~~y~aPE~~~----~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i----~~-~  213 (291)
T cd05612         156 -------------WTLCGTPEYLAPEVIQ----SKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKI----LA-G  213 (291)
T ss_pred             -------------ccccCChhhcCHHHHc----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH----Hh-C
Confidence                         1235899999999998    456789999999999999999999999764332222222    12 2


Q ss_pred             CCCCCCCCCHHHHHHHHHHhhcCcCCCCC-----HHHHhcCccccccCCC
Q 019650          285 RLEMPETASPEFRRFVRSCLEKDWRKRGT-----VEELLAYPFVTKRSSS  329 (337)
Q Consensus       285 ~~~~~~~~~~~~~~li~~~l~~~p~~R~s-----~~eil~hp~f~~~~~~  329 (337)
                      ...++...+..++++|.+||+.||.+|++     ++++++||||+...+.
T Consensus       214 ~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~  263 (291)
T cd05612         214 KLEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWD  263 (291)
T ss_pred             CcCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCCHH
Confidence            44566777999999999999999999995     9999999999875543

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.6e-48  Score=324.30  Aligned_cols=277  Identities=26%  Similarity=0.323  Sum_probs=232.2

Q ss_pred             CCCCCCCCCCCccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchH-hHHHHHHHHHHHHhcCCCCceee
Q 019650           32 HFPTSNPTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTI-IRHQAAHEAEILKRLDSQFIVKC  110 (337)
Q Consensus        32 ~~~~~~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~  110 (337)
                      ..|..+.......++++|+++..|++|.||.||+|.++.|+..||+|.++-+.... ..--..+|+.++.+++|+|||.+
T Consensus        61 ~~p~~~~~l~gCrsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~v  140 (419)
T KOG0663|consen   61 PIPLKQELLGGCRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEV  140 (419)
T ss_pred             CCccccccccCcccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeee
Confidence            34444444566788999999999999999999999999999999999997665332 22234689999999999999999


Q ss_pred             eeeEEeeC-CeEEEEEeccCCCCchHHhhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEe
Q 019650          111 HAVFYTIE-GEICFVMEHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIA  188 (337)
Q Consensus       111 ~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~  188 (337)
                      .++..... ..+|+||||++. +|..++.+-+ ++...+++.++.|++.|++|||++.|+|||||++|+|++..|.+||+
T Consensus       141 kEVVvG~~~d~iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKia  219 (419)
T KOG0663|consen  141 KEVVVGSNMDKIYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIA  219 (419)
T ss_pred             EEEEeccccceeeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEec
Confidence            99877533 468999999987 9998887654 89999999999999999999999999999999999999999999999


Q ss_pred             eccCccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Q 019650          189 DFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFG  268 (337)
Q Consensus       189 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~  268 (337)
                      |||+++.++.+.              ......+.|.+|.|||.+.+.   ..|+.+.|+||+|||+.|++++++.|++..
T Consensus       220 DFGLAR~ygsp~--------------k~~T~lVVTLWYRaPELLLG~---~tyst~iDMWSvGCI~aE~l~~kPlf~G~s  282 (419)
T KOG0663|consen  220 DFGLAREYGSPL--------------KPYTPLVVTLWYRAPELLLGA---KTYSTAVDMWSVGCIFAELLTQKPLFPGKS  282 (419)
T ss_pred             ccchhhhhcCCc--------------ccCcceEEEeeecCHHHhcCC---cccCcchhhhhHHHHHHHHHhcCCCCCCCc
Confidence            999999988764              333445789999999999964   579999999999999999999999999888


Q ss_pred             CchhHHHHHHHhhccCCCC--------------------------CCCC-CCHHHHHHHHHHhhcCcCCCCCHHHHhcCc
Q 019650          269 EKPDLMALICAICFGERLE--------------------------MPET-ASPEFRRFVRSCLEKDWRKRGTVEELLAYP  321 (337)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~--------------------------~~~~-~~~~~~~li~~~l~~~p~~R~s~~eil~hp  321 (337)
                      +.+.+..+...+.......                          ++.. +++...+|+..+|..||.+|.|+++.|+|.
T Consensus       283 E~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~  362 (419)
T KOG0663|consen  283 EIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHE  362 (419)
T ss_pred             hHHHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhccc
Confidence            7777776665433222111                          1111 458899999999999999999999999999


Q ss_pred             ccccc
Q 019650          322 FVTKR  326 (337)
Q Consensus       322 ~f~~~  326 (337)
                      ||...
T Consensus       363 ~F~e~  367 (419)
T KOG0663|consen  363 YFRET  367 (419)
T ss_pred             ccccC
Confidence            99874

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-48  Score=337.55  Aligned_cols=273  Identities=30%  Similarity=0.440  Sum_probs=220.9

Q ss_pred             CCCccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCC-------------chHhHHHHHHHHHHHHhcCCCC
Q 019650           40 SPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-------------STIIRHQAAHEAEILKRLDSQF  106 (337)
Q Consensus        40 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-------------~~~~~~~~~~e~~~~~~l~~~~  106 (337)
                      ..+...+++|+++..||+|.||.|-+|++..+++.||||++.+..             .-...+...+|+.+++++.|+|
T Consensus        90 ~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~n  169 (576)
T KOG0585|consen   90 DQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPN  169 (576)
T ss_pred             cccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcC
Confidence            344567899999999999999999999999999999999995532             1123467889999999999999


Q ss_pred             ceeeeeeEEeeC-CeEEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcE
Q 019650          107 IVKCHAVFYTIE-GEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEV  185 (337)
Q Consensus       107 i~~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~  185 (337)
                      ||+++++.-+.. ..+|+|+|||..|.+...-.....+++.+++.++.+++.+|.|||.+|||||||||+|+|++.+|++
T Consensus       170 VV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~V  249 (576)
T KOG0585|consen  170 VVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTV  249 (576)
T ss_pred             eeEEEEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcE
Confidence            999999875543 5789999999988775444433349999999999999999999999999999999999999999999


Q ss_pred             EEeeccCccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCC
Q 019650          186 KIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLI  265 (337)
Q Consensus       186 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~  265 (337)
                      ||+|||.+...........         .......+|||.|+|||....+......+.+.||||+|++||.|+.|+.||.
T Consensus       250 KIsDFGVs~~~~~~~~~~~---------d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~  320 (576)
T KOG0585|consen  250 KISDFGVSNEFPQGSDEGS---------DDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFF  320 (576)
T ss_pred             EeeccceeeecccCCcccc---------HHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcc
Confidence            9999999886643311111         1334446899999999999864322234779999999999999999999997


Q ss_pred             CCCCchhHHHHHHHhhccCCCCCCCC--CCHHHHHHHHHHhhcCcCCCCCHHHHhcCcccccc
Q 019650          266 GFGEKPDLMALICAICFGERLEMPET--ASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKR  326 (337)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~  326 (337)
                      +....+...++    .. .+..+|..  +...+++||.+||.+||..|+++.+|..|||....
T Consensus       321 ~~~~~~l~~KI----vn-~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~  378 (576)
T KOG0585|consen  321 DDFELELFDKI----VN-DPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD  378 (576)
T ss_pred             cchHHHHHHHH----hc-CcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence            64333333333    22 24555543  68999999999999999999999999999999876

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=2.1e-47  Score=343.83  Aligned_cols=266  Identities=42%  Similarity=0.746  Sum_probs=219.4

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEE
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICF  123 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~l  123 (337)
                      ...++|+.++.||.|+||+||+|.+..+++.||+|++...........+.+|+.+++.++|+||+++++.+.. ...+++
T Consensus        71 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~l  149 (353)
T PLN00034         71 KSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDH-NGEIQV  149 (353)
T ss_pred             CCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEecc-CCeEEE
Confidence            3467899999999999999999999999999999999766555566778899999999999999999998766 788999


Q ss_pred             EEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCC
Q 019650          124 VMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNN  203 (337)
Q Consensus       124 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~  203 (337)
                      ||||+++++|.+..    ..++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++.......   
T Consensus       150 v~e~~~~~~L~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~---  222 (353)
T PLN00034        150 LLEFMDGGSLEGTH----IADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM---  222 (353)
T ss_pred             EEecCCCCcccccc----cCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccccc---
Confidence            99999999886543    45778889999999999999999999999999999999999999999999987654321   


Q ss_pred             CCCCCCCCccccccccccCCCCCcCCcccccccC-CCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhc
Q 019650          204 NHNNNNNNNIGEAAIACMGTCAYMSPERVDSERW-GGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICF  282 (337)
Q Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~  282 (337)
                                 ......+|+..|+|||.+..... +...+.++||||||+++|+|++|+.||.... ..+..........
T Consensus       223 -----------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~-~~~~~~~~~~~~~  290 (353)
T PLN00034        223 -----------DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGR-QGDWASLMCAICM  290 (353)
T ss_pred             -----------ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCC-CccHHHHHHHHhc
Confidence                       11122358999999999853211 2234568999999999999999999997432 2333344444444


Q ss_pred             cCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCC
Q 019650          283 GERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSS  329 (337)
Q Consensus       283 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~  329 (337)
                      ......+...+..+.+||.+||..||++|||+.|+|+||||.+....
T Consensus       291 ~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~~~  337 (353)
T PLN00034        291 SQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQPG  337 (353)
T ss_pred             cCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCCcc
Confidence            45556667789999999999999999999999999999999987644

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-50  Score=322.21  Aligned_cols=265  Identities=29%  Similarity=0.422  Sum_probs=226.1

Q ss_pred             ccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCC-chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeE
Q 019650           43 VENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEI  121 (337)
Q Consensus        43 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~  121 (337)
                      ....++|.+-+.||.|+|+.|+++.+..+|+.+++|+++... .....+.+.+|+++.+.|+||||+.++..+.+ ....
T Consensus         7 ~~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~-~~~~   85 (355)
T KOG0033|consen    7 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE-ESFH   85 (355)
T ss_pred             cccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcc-ccee
Confidence            345689999999999999999999999999999999986543 22356778899999999999999999998766 7889


Q ss_pred             EEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCC---CcEEEeeccCccchhc
Q 019650          122 CFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGK---GEVKIADFGVSRIVEE  198 (337)
Q Consensus       122 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~---~~~~l~Dfg~~~~~~~  198 (337)
                      |+|+|+++|++|..-+-...-+++..+...+.||+.||.|+|.+||||||+||.|+++-..   .-+||+|||.+..+..
T Consensus        86 ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~  165 (355)
T KOG0033|consen   86 YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVND  165 (355)
T ss_pred             EEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCC
Confidence            9999999999998777666778999999999999999999999999999999999999543   3599999999988873


Q ss_pred             cccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHH
Q 019650          199 TRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALIC  278 (337)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~  278 (337)
                      .               .....++|||.|||||++..+    +|+-.+|||+-|++||-|+.|.+||.+.+.. .+.+.+.
T Consensus       166 g---------------~~~~G~~GtP~fmaPEvvrkd----py~kpvDiW~cGViLfiLL~G~~PF~~~~~~-rlye~I~  225 (355)
T KOG0033|consen  166 G---------------EAWHGFAGTPGYLSPEVLKKD----PYSKPVDIWACGVILYILLVGYPPFWDEDQH-RLYEQIK  225 (355)
T ss_pred             c---------------cccccccCCCcccCHHHhhcC----CCCCcchhhhhhHHHHHHHhCCCCCCCccHH-HHHHHHh
Confidence            2               444566899999999999954    7788899999999999999999999774443 3333333


Q ss_pred             HhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCC
Q 019650          279 AICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSS  328 (337)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~  328 (337)
                      ......+...++.+++.+++|+++||..||.+|+|+.|+|+|||++++.+
T Consensus       226 ~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r~~  275 (355)
T KOG0033|consen  226 AGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNRER  275 (355)
T ss_pred             ccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcchHH
Confidence            43344445556788999999999999999999999999999999998864

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=2.5e-48  Score=347.29  Aligned_cols=264  Identities=24%  Similarity=0.365  Sum_probs=221.2

Q ss_pred             CCccCccccccccccccCcceEEEEEEEccCC-ceEEEEEeecCC--chHhHHHHHHHHHHHHhcCCCCceeeeeeEEee
Q 019650           41 PDVENISDLKKLTVLGHGNGGIVYKVRHQKSN-SIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTI  117 (337)
Q Consensus        41 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~-~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~  117 (337)
                      ......++|++.+.||.|+||.||+|.+..++ ..||+|.+....  .....+.+.+|+.+++.++||||+++++.+.+ 
T Consensus        24 ~~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~-  102 (340)
T PTZ00426         24 KNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKD-  102 (340)
T ss_pred             CCCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEe-
Confidence            34567889999999999999999999876554 689999986532  22344567789999999999999999998876 


Q ss_pred             CCeEEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchh
Q 019650          118 EGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVE  197 (337)
Q Consensus       118 ~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~  197 (337)
                      +...++||||+.+|+|.+++.....+++..+..++.||+.||.|||+.|++||||||+||+++.+++++|+|||++....
T Consensus       103 ~~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~  182 (340)
T PTZ00426        103 ESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD  182 (340)
T ss_pred             CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence            68899999999999999999988899999999999999999999999999999999999999999999999999987653


Q ss_pred             ccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHH
Q 019650          198 ETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALI  277 (337)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~  277 (337)
                      ..                 .....|++.|+|||++.    +..++.++|+||||+++|+|++|..||............ 
T Consensus       183 ~~-----------------~~~~~gt~~y~aPE~~~----~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i-  240 (340)
T PTZ00426        183 TR-----------------TYTLCGTPEYIAPEILL----NVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKI-  240 (340)
T ss_pred             CC-----------------cceecCChhhcCHHHHh----CCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHH-
Confidence            21                 11235899999999998    456788999999999999999999999764332222221 


Q ss_pred             HHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCC-----CHHHHhcCccccccCCCcc
Q 019650          278 CAICFGERLEMPETASPEFRRFVRSCLEKDWRKRG-----TVEELLAYPFVTKRSSSSN  331 (337)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~-----s~~eil~hp~f~~~~~~~~  331 (337)
                         . .....++...+..+.++|++||+.||.+|+     +++++++||||.+..+.+.
T Consensus       241 ---~-~~~~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~~~  295 (340)
T PTZ00426        241 ---L-EGIIYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVSL  295 (340)
T ss_pred             ---h-cCCCCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHHHH
Confidence               1 223456677899999999999999999995     8999999999998765543

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=2e-48  Score=346.15  Aligned_cols=255  Identities=29%  Similarity=0.475  Sum_probs=214.0

Q ss_pred             cccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEeccCC
Q 019650           53 TVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMER  130 (337)
Q Consensus        53 ~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~  130 (337)
                      +.||+|+||.||+|.+..+++.||+|++....  .......+.+|+.++++++|+||+++++.+.. ...+|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-~~~~~lv~e~~~~   79 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQT-HDRLCFVMEYANG   79 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEc-CCEEEEEEeCCCC
Confidence            46899999999999999999999999997542  22334566789999999999999999998766 6889999999999


Q ss_pred             CCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCCCCCCCC
Q 019650          131 GSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNN  210 (337)
Q Consensus       131 ~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~  210 (337)
                      ++|.+++...+.+++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||++.......          
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~----------  149 (323)
T cd05571          80 GELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG----------  149 (323)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC----------
Confidence            9999999988899999999999999999999999999999999999999999999999999886432211          


Q ss_pred             CccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhccCCCCCCC
Q 019650          211 NNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPE  290 (337)
Q Consensus       211 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (337)
                          ......+|++.|+|||++.    +..++.++||||||+++|+|++|..||.......    ..... ......++.
T Consensus       150 ----~~~~~~~gt~~y~aPE~~~----~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~----~~~~~-~~~~~~~p~  216 (323)
T cd05571         150 ----ATMKTFCGTPEYLAPEVLE----DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK----LFELI-LMEEIRFPR  216 (323)
T ss_pred             ----CcccceecCccccChhhhc----CCCCCccccCcccchhhhhhhcCCCCCCCCCHHH----HHHHH-HcCCCCCCC
Confidence                1122346899999999998    4578899999999999999999999996533221    11211 223456677


Q ss_pred             CCCHHHHHHHHHHhhcCcCCCC-----CHHHHhcCccccccCCCcc
Q 019650          291 TASPEFRRFVRSCLEKDWRKRG-----TVEELLAYPFVTKRSSSSN  331 (337)
Q Consensus       291 ~~~~~~~~li~~~l~~~p~~R~-----s~~eil~hp~f~~~~~~~~  331 (337)
                      .++..+.++|.+||..||++||     ++.++++||||++..+...
T Consensus       217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~~~~~~  262 (323)
T cd05571         217 TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINWQDV  262 (323)
T ss_pred             CCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCCCHHHH
Confidence            8899999999999999999999     8999999999998655433

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.6e-49  Score=312.32  Aligned_cols=257  Identities=32%  Similarity=0.432  Sum_probs=227.6

Q ss_pred             ccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCe
Q 019650           43 VENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGE  120 (337)
Q Consensus        43 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~  120 (337)
                      .-.+++|++++.||.|-||.||.|..++++..||+|++.+..  ......++.+|+++...|+||||+++++.|.+ +..
T Consensus        18 ~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd-~~r   96 (281)
T KOG0580|consen   18 TWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHD-SKR   96 (281)
T ss_pred             ccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheec-cce
Confidence            467899999999999999999999999999999999987654  23345677889999999999999999999988 789


Q ss_pred             EEEEEeccCCCCchHHhh--hcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhc
Q 019650          121 ICFVMEHMERGSLFDSLR--VRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEE  198 (337)
Q Consensus       121 ~~lv~e~~~~~~L~~~l~--~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~  198 (337)
                      .|+++||.++|+|...|+  ....+++...+.++.|++.||.|+|..+++||||||+|+|++..+.++++|||.+.....
T Consensus        97 iyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~  176 (281)
T KOG0580|consen   97 IYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS  176 (281)
T ss_pred             eEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecCC
Confidence            999999999999999998  556899999999999999999999999999999999999999999999999999987642


Q ss_pred             cccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHH
Q 019650          199 TRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALIC  278 (337)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~  278 (337)
                                      ......+||..|.+||...    +..++..+|+|++|++.||++.|.+||......+....+..
T Consensus       177 ----------------~kR~tlcgt~dyl~pEmv~----~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k  236 (281)
T KOG0580|consen  177 ----------------NKRKTLCGTLDYLPPEMVE----GRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRK  236 (281)
T ss_pred             ----------------CCceeeecccccCCHhhcC----CCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHH
Confidence                            2334457999999999999    56889999999999999999999999977654444443333


Q ss_pred             HhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccc
Q 019650          279 AICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTK  325 (337)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~  325 (337)
                      .     ...+|..++..+.++|.+||..+|.+|.+..|+++|||+..
T Consensus       237 ~-----~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a  278 (281)
T KOG0580|consen  237 V-----DLKFPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIVA  278 (281)
T ss_pred             c-----cccCCcccChhHHHHHHHHhccCccccccHHHHhhhHHHHh
Confidence            2     56677889999999999999999999999999999999875

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=1.4e-47  Score=335.59  Aligned_cols=260  Identities=26%  Similarity=0.354  Sum_probs=210.2

Q ss_pred             CccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 019650           45 NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFV  124 (337)
Q Consensus        45 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv  124 (337)
                      ..++|++.+.||.|+||+||+|.+..++..||+|.++..........+.+|+.++++++|+||+++++++.. +...++|
T Consensus         3 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv   81 (288)
T cd07871           3 KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHT-ERCLTLV   81 (288)
T ss_pred             ccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcC-CCeEEEE
Confidence            467899999999999999999999999999999998765433344567789999999999999999998766 6789999


Q ss_pred             EeccCCCCchHHhhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCC
Q 019650          125 MEHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNN  203 (337)
Q Consensus       125 ~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~  203 (337)
                      |||+++ +|.+++...+ .+++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||++.......   
T Consensus        82 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~---  157 (288)
T cd07871          82 FEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPT---  157 (288)
T ss_pred             EeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCC---
Confidence            999975 9999887544 57899999999999999999999999999999999999999999999999987543221   


Q ss_pred             CCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhcc
Q 019650          204 NHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFG  283 (337)
Q Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~  283 (337)
                                 .......+++.|+|||.+..   +..++.++|+||||+++|+|++|+.||.+....+............
T Consensus       158 -----------~~~~~~~~~~~y~aPE~~~~---~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  223 (288)
T cd07871         158 -----------KTYSNEVVTLWYRPPDVLLG---STEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTP  223 (288)
T ss_pred             -----------ccccCceecccccChHHhcC---CcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence                       11112247889999999863   2467889999999999999999999997654433332222111000


Q ss_pred             C-----------------C--------CCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccc
Q 019650          284 E-----------------R--------LEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV  323 (337)
Q Consensus       284 ~-----------------~--------~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f  323 (337)
                      .                 .        ....+..+..++++|.+||..||.+|||++|+|+||||
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         224 TEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             ChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence            0                 0        00113457889999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-48  Score=326.93  Aligned_cols=269  Identities=25%  Similarity=0.394  Sum_probs=223.7

Q ss_pred             ccccccccccccCcceEEEEEEEccCCceEEEEEeecC-CchHhHHHHHHHHHHHHhcCCCCceeeeeeEEe----eCCe
Q 019650           46 ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTT-SSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYT----IEGE  120 (337)
Q Consensus        46 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~----~~~~  120 (337)
                      ...|...+.||.|++|.|..+.+..+|..||||.+... ......++..+|+.+++.++|+||+.+.+++..    .-+.
T Consensus        21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D  100 (359)
T KOG0660|consen   21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND  100 (359)
T ss_pred             cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence            35666689999999999999999999999999988643 356678889999999999999999999998865    1246


Q ss_pred             EEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccc
Q 019650          121 ICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETR  200 (337)
Q Consensus       121 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~  200 (337)
                      +|+|+|+++ .+|.+.++.+..++++.+..+++||+.||+|+|+.|++||||||+|++++.++.+||+|||+++..... 
T Consensus       101 vYiV~elMe-tDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~-  178 (359)
T KOG0660|consen  101 VYLVFELME-TDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKF-  178 (359)
T ss_pred             eEEehhHHh-hHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeecccc-
Confidence            899999995 499999998888999999999999999999999999999999999999999999999999999988653 


Q ss_pred             cCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHh
Q 019650          201 NNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAI  280 (337)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~  280 (337)
                      ..           .......+.|.+|.|||.+..   ...|+.+.||||+|||+.||++|++.|.+.+....+..++...
T Consensus       179 ~~-----------~~~mTeYVaTRWYRAPElll~---~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~l  244 (359)
T KOG0660|consen  179 FE-----------DGFMTEYVATRWYRAPELLLN---SSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELL  244 (359)
T ss_pred             Cc-----------ccchhcceeeeeecCHHHHhc---cccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhc
Confidence            10           133445578999999999975   4689999999999999999999999998865443333222211


Q ss_pred             hccC------------------CC--------CCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCCc
Q 019650          281 CFGE------------------RL--------EMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSS  330 (337)
Q Consensus       281 ~~~~------------------~~--------~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~~  330 (337)
                      ....                  .+        ...+..++.+.+|+.+||..||.+|+|++|+|.||||...+..+
T Consensus       245 GtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~  320 (359)
T KOG0660|consen  245 GTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPE  320 (359)
T ss_pred             CCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCc
Confidence            1000                  00        01246788999999999999999999999999999999887654

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=3e-47  Score=336.31  Aligned_cols=259  Identities=30%  Similarity=0.461  Sum_probs=218.0

Q ss_pred             CCCccCccccccccccccCcceEEEEEEEccCCce-EEEEEeecCC-chHhHHHHHHHHHHHHhcCCCCceeeeeeEEee
Q 019650           40 SPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSI-YALKVLNTTS-STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTI  117 (337)
Q Consensus        40 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~-vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~  117 (337)
                      ..+....++..+.+.||.|+||+||+|.+.  |.. ||+|++.... .....+.+.+|+.++.+++||||++++|++.+.
T Consensus        34 ~~~~i~~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~  111 (362)
T KOG0192|consen   34 PEEEIDPDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSP  111 (362)
T ss_pred             cceecChHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence            345566788888999999999999999986  444 9999997654 222367899999999999999999999998763


Q ss_pred             CCeEEEEEeccCCCCchHHhhh--cCCCCHHHHHHHHHHHHHHHHHHHhCC-ceeccCCCCCeEEcCCC-cEEEeeccCc
Q 019650          118 EGEICFVMEHMERGSLFDSLRV--RKKLSEDVISGVAYRVLKGLQYLHGMQ-IIHGDIKPSNLLINGKG-EVKIADFGVS  193 (337)
Q Consensus       118 ~~~~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~i~~~l~~~l~~LH~~~-ivH~dl~~~Nili~~~~-~~~l~Dfg~~  193 (337)
                      ....++||||+++|+|.+++..  ...++...+..++.||+.|+.|||+++ |||||||++|+|++.++ ++||+|||++
T Consensus       112 ~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGls  191 (362)
T KOG0192|consen  112 PGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLS  191 (362)
T ss_pred             CCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccc
Confidence            3379999999999999999987  578999999999999999999999999 99999999999999997 9999999999


Q ss_pred             cchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhH
Q 019650          194 RIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDL  273 (337)
Q Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~  273 (337)
                      +......              .......||+.|||||++...  ...|+.++||||||+++|||+||+.||......   
T Consensus       192 r~~~~~~--------------~~~~~~~GT~~wMAPEv~~~~--~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~---  252 (362)
T KOG0192|consen  192 REKVISK--------------TSMTSVAGTYRWMAPEVLRGE--KSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV---  252 (362)
T ss_pred             eeecccc--------------ccccCCCCCccccChhhhcCC--CCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH---
Confidence            8776432              011113599999999999954  347999999999999999999999999775542   


Q ss_pred             HHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhc
Q 019650          274 MALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA  319 (337)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~  319 (337)
                      .........+.++.++..+++.+..++..||..||..||++.+++.
T Consensus       253 ~~~~~v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~  298 (362)
T KOG0192|consen  253 QVASAVVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVS  298 (362)
T ss_pred             HHHHHHHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence            1222223356677778889999999999999999999999999876

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=3.1e-47  Score=335.83  Aligned_cols=264  Identities=24%  Similarity=0.357  Sum_probs=210.0

Q ss_pred             CccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 019650           45 NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFV  124 (337)
Q Consensus        45 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv  124 (337)
                      ..++|.+.+.||.|+||+||+|.+..+++.||+|++...........+.+|+.+++.++|+||+++++++.+ ....++|
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv   81 (303)
T cd07869           3 KADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHT-KETLTLV   81 (303)
T ss_pred             ccccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEec-CCeEEEE
Confidence            468999999999999999999999999999999998765433334456789999999999999999998876 6789999


Q ss_pred             EeccCCCCchHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCC
Q 019650          125 MEHMERGSLFDSLRVR-KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNN  203 (337)
Q Consensus       125 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~  203 (337)
                      |||+. ++|.+++... ..+++..+..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++.......   
T Consensus        82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~---  157 (303)
T cd07869          82 FEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS---  157 (303)
T ss_pred             EECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC---
Confidence            99996 4888877654 568999999999999999999999999999999999999999999999999986543221   


Q ss_pred             CCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhcc
Q 019650          204 NHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFG  283 (337)
Q Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~  283 (337)
                                 .......+++.|+|||.+...   ..++.++|+||||+++|+|++|..||.+..+.......+......
T Consensus       158 -----------~~~~~~~~~~~y~aPE~~~~~---~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  223 (303)
T cd07869         158 -----------HTYSNEVVTLWYRPPDVLLGS---TEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGT  223 (303)
T ss_pred             -----------ccCCCCcccCCCCChHHHcCC---CCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCC
Confidence                       111123578999999998632   357889999999999999999999997654432222211111000


Q ss_pred             CC---------------CC----CC---------CCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccC
Q 019650          284 ER---------------LE----MP---------ETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRS  327 (337)
Q Consensus       284 ~~---------------~~----~~---------~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~  327 (337)
                      ..               ..    .+         ...+..+.+++.+||+.||++|||++++++||||++..
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~  295 (303)
T cd07869         224 PNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP  295 (303)
T ss_pred             CChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence            00               00    00         12346789999999999999999999999999998754

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=2.8e-47  Score=333.09  Aligned_cols=262  Identities=24%  Similarity=0.371  Sum_probs=216.5

Q ss_pred             cccccccccCcceEEEEEEEccCCceEEEEEeecCCc--hHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEe
Q 019650           49 LKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSS--TIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVME  126 (337)
Q Consensus        49 y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~e  126 (337)
                      |++.+.||+|+||+||+|.+..+++.||+|.+.....  ......+.+|+.++++++|++++++++.+.+ +...+++||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~-~~~~~lv~e   80 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYET-KDALCLVLT   80 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEcc-CCeEEEEEE
Confidence            7888999999999999999999999999999865431  2223456789999999999999999998766 678999999


Q ss_pred             ccCCCCchHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCC
Q 019650          127 HMERGSLFDSLRVR--KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNN  204 (337)
Q Consensus       127 ~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~  204 (337)
                      |+++|+|.+++...  ..+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++.......    
T Consensus        81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~----  156 (285)
T cd05631          81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE----  156 (285)
T ss_pred             ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC----
Confidence            99999998887543  468999999999999999999999999999999999999999999999999987653221    


Q ss_pred             CCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhccC
Q 019650          205 HNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGE  284 (337)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~  284 (337)
                                 ......|+..|+|||++.    +..++.++||||||+++|+|++|+.||............... ....
T Consensus       157 -----------~~~~~~g~~~y~aPE~~~----~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~-~~~~  220 (285)
T cd05631         157 -----------TVRGRVGTVGYMAPEVIN----NEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRR-VKED  220 (285)
T ss_pred             -----------eecCCCCCCCccCHhhhc----CCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHH-hhcc
Confidence                       112235899999999998    457889999999999999999999999765443222222222 2233


Q ss_pred             CCCCCCCCCHHHHHHHHHHhhcCcCCCCC-----HHHHhcCccccccCCCcc
Q 019650          285 RLEMPETASPEFRRFVRSCLEKDWRKRGT-----VEELLAYPFVTKRSSSSN  331 (337)
Q Consensus       285 ~~~~~~~~~~~~~~li~~~l~~~p~~R~s-----~~eil~hp~f~~~~~~~~  331 (337)
                      ...++...+..+.+|+.+||+.||.+||+     ++++++||||.+..+..-
T Consensus       221 ~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~~~  272 (285)
T cd05631         221 QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKRL  272 (285)
T ss_pred             cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHHHH
Confidence            44556678999999999999999999997     899999999999876543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=9.3e-47  Score=336.63  Aligned_cols=263  Identities=37%  Similarity=0.658  Sum_probs=218.6

Q ss_pred             CccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 019650           45 NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFV  124 (337)
Q Consensus        45 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv  124 (337)
                      ..++|++.+.||.|++|.||++.+..++..+|+|++.........+.+.+|+.++++++|+||+++++++.. +...++|
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv   81 (331)
T cd06649           3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-DGEISIC   81 (331)
T ss_pred             CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE-CCEEEEE
Confidence            357999999999999999999999999999999999876555556778899999999999999999998876 6889999


Q ss_pred             EeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCCeEEcCCCcEEEeeccCccchhccccCC
Q 019650          125 MEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGM-QIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNN  203 (337)
Q Consensus       125 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~-~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~  203 (337)
                      |||+++++|.+++.....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.......   
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---  158 (331)
T cd06649          82 MEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---  158 (331)
T ss_pred             eecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccccc---
Confidence            99999999999999888899999999999999999999986 69999999999999999999999999987553321   


Q ss_pred             CCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHH-------
Q 019650          204 NHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMAL-------  276 (337)
Q Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~-------  276 (337)
                                   .....++..|+|||++.    +..++.++|+||||+++|+|++|+.||...... .....       
T Consensus       159 -------------~~~~~g~~~y~aPE~~~----~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~-~~~~~~~~~~~~  220 (331)
T cd06649         159 -------------ANSFVGTRSYMSPERLQ----GTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAK-ELEAIFGRPVVD  220 (331)
T ss_pred             -------------cccCCCCcCcCCHhHhc----CCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHhcccccc
Confidence                         12235899999999998    457889999999999999999999999653221 11111       


Q ss_pred             ------------------------------------HHHhhccCCCCC-CCCCCHHHHHHHHHHhhcCcCCCCCHHHHhc
Q 019650          277 ------------------------------------ICAICFGERLEM-PETASPEFRRFVRSCLEKDWRKRGTVEELLA  319 (337)
Q Consensus       277 ------------------------------------~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~R~s~~eil~  319 (337)
                                                          .........+.. ....+..+.+||.+||..||++|||++++++
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~  300 (331)
T cd06649         221 GEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMN  300 (331)
T ss_pred             cccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhc
Confidence                                                111111111221 1245789999999999999999999999999


Q ss_pred             CccccccCCC
Q 019650          320 YPFVTKRSSS  329 (337)
Q Consensus       320 hp~f~~~~~~  329 (337)
                      ||||+.....
T Consensus       301 h~~~~~~~~~  310 (331)
T cd06649         301 HTFIKRSEVE  310 (331)
T ss_pred             ChHHhhcccc
Confidence            9999876543

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-47  Score=341.04  Aligned_cols=260  Identities=27%  Similarity=0.391  Sum_probs=216.0

Q ss_pred             cccccccccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 019650           47 SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFV  124 (337)
Q Consensus        47 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv  124 (337)
                      ++|++.+.||.|+||.||+|.+..+++.||+|++....  .......+.+|+.++..++|+||+++++.+.. ....|+|
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~-~~~~~lv   79 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQD-DEYLYLA   79 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEc-CCEEEEE
Confidence            47999999999999999999999999999999997542  12234567789999999999999999998766 7889999


Q ss_pred             EeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCC
Q 019650          125 MEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNN  204 (337)
Q Consensus       125 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~  204 (337)
                      |||++|++|.+++...+.+++..++.++.||+.||.|||+.|++||||||+||+++.++.++|+|||++......     
T Consensus        80 ~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~~-----  154 (333)
T cd05600          80 MEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTY-----  154 (333)
T ss_pred             EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCcccccc-----
Confidence            999999999999988888999999999999999999999999999999999999999999999999998755331     


Q ss_pred             CCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhccC
Q 019650          205 HNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGE  284 (337)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~  284 (337)
                                  .....|++.|+|||.+.    +..++.++||||||+++|+|++|..||......+.............
T Consensus       155 ------------~~~~~gt~~y~aPE~~~----~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  218 (333)
T cd05600         155 ------------ANSVVGSPDYMAPEVLR----GKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQ  218 (333)
T ss_pred             ------------cCCcccCccccChhHhc----CCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcccccc
Confidence                        11235899999999998    45788999999999999999999999976443332222221111111


Q ss_pred             CCCCC---CCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCC
Q 019650          285 RLEMP---ETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSS  328 (337)
Q Consensus       285 ~~~~~---~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~  328 (337)
                      .+...   ..++..+.+++.+||..+|.+||+++++++||||.+..+
T Consensus       219 ~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~~~  265 (333)
T cd05600         219 RPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVDW  265 (333)
T ss_pred             CCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCCCH
Confidence            11111   245889999999999999999999999999999997643

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=2.2e-47  Score=339.47  Aligned_cols=253  Identities=28%  Similarity=0.470  Sum_probs=212.2

Q ss_pred             cccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEeccCC
Q 019650           53 TVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMER  130 (337)
Q Consensus        53 ~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~  130 (337)
                      +.||+|+||.||++.+..++..||+|++....  .......+.+|+.+++.++|+||+++++.+.. ....|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~-~~~~~lv~E~~~~   79 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT-HDRLCFVMEYANG   79 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEec-CCEEEEEEeCCCC
Confidence            46899999999999999999999999997542  22334566789999999999999999998876 6789999999999


Q ss_pred             CCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCCCCCCCC
Q 019650          131 GSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNN  210 (337)
Q Consensus       131 ~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~  210 (337)
                      ++|.+++.....+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||++.......          
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~----------  149 (323)
T cd05595          80 GELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG----------  149 (323)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC----------
Confidence            9999999888889999999999999999999999999999999999999999999999999876432211          


Q ss_pred             CccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhccCCCCCCC
Q 019650          211 NNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPE  290 (337)
Q Consensus       211 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (337)
                          .......|++.|+|||.+.    +..++.++|+||||+++|+|++|..||............     ......++.
T Consensus       150 ----~~~~~~~gt~~y~aPE~~~----~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~-----~~~~~~~p~  216 (323)
T cd05595         150 ----ATMKTFCGTPEYLAPEVLE----DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI-----LMEEIRFPR  216 (323)
T ss_pred             ----CccccccCCcCcCCccccc----CCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH-----hcCCCCCCC
Confidence                1112335899999999997    457889999999999999999999999654332222211     122345667


Q ss_pred             CCCHHHHHHHHHHhhcCcCCCC-----CHHHHhcCccccccCCC
Q 019650          291 TASPEFRRFVRSCLEKDWRKRG-----TVEELLAYPFVTKRSSS  329 (337)
Q Consensus       291 ~~~~~~~~li~~~l~~~p~~R~-----s~~eil~hp~f~~~~~~  329 (337)
                      .+++.+.++|.+||+.||++|+     ++.++++||||.+..+.
T Consensus       217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~~~  260 (323)
T cd05595         217 TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQ  260 (323)
T ss_pred             CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCCHH
Confidence            7899999999999999999998     89999999999986644

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-46  Score=333.91  Aligned_cols=267  Identities=31%  Similarity=0.477  Sum_probs=229.6

Q ss_pred             ccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCch--HhHHHHHHHHHHHHhcC-CCCceeeeeeEEeeCC
Q 019650           43 VENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSST--IIRHQAAHEAEILKRLD-SQFIVKCHAVFYTIEG  119 (337)
Q Consensus        43 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~  119 (337)
                      ......|++.+.||.|.||.||+|.+..+|+.+|+|++.+....  .......+|+.+++++. ||||+.+++++.+ ..
T Consensus        31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~-~~  109 (382)
T KOG0032|consen   31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFED-PD  109 (382)
T ss_pred             ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEc-CC
Confidence            44567899999999999999999999999999999999776532  23467889999999998 9999999999877 67


Q ss_pred             eEEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCC----CcEEEeeccCccc
Q 019650          120 EICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGK----GEVKIADFGVSRI  195 (337)
Q Consensus       120 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~----~~~~l~Dfg~~~~  195 (337)
                      .+++|||++.||.|.+.+... .+++..+..++.|++.+++|||+.|++|+||||+|+|+...    +.++++|||++..
T Consensus       110 ~~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~  188 (382)
T KOG0032|consen  110 SVYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKF  188 (382)
T ss_pred             eEEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceE
Confidence            999999999999999999866 49999999999999999999999999999999999999543    4799999999998


Q ss_pred             hhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHH
Q 019650          196 VEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMA  275 (337)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~  275 (337)
                      ....               ......+||+.|+|||++.    +..|+..+|+||+|+++|.|++|..||.+..+......
T Consensus       189 ~~~~---------------~~~~~~~Gtp~y~APEvl~----~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~  249 (382)
T KOG0032|consen  189 IKPG---------------ERLHTIVGTPEYVAPEVLG----GRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLA  249 (382)
T ss_pred             ccCC---------------ceEeeecCCccccCchhhc----CCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHH
Confidence            7662               4445668999999999998    45899999999999999999999999988665555554


Q ss_pred             HHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCCcc
Q 019650          276 LICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSN  331 (337)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~~~  331 (337)
                      +... ........++.++..++++|.+||..||..|+|+.++|+|||+++....++
T Consensus       250 i~~~-~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~~~~~  304 (382)
T KOG0032|consen  250 ILRG-DFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIGEATN  304 (382)
T ss_pred             HHcC-CCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCCccccc
Confidence            3332 222344456778999999999999999999999999999999998754543

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-47  Score=336.66  Aligned_cols=249  Identities=26%  Similarity=0.446  Sum_probs=210.1

Q ss_pred             cccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEeccCCCC
Q 019650           55 LGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGS  132 (337)
Q Consensus        55 lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~  132 (337)
                      ||+|+||+||+|.+..+++.||+|++....  .......+..|+.++.+++|+||+++++.+.. ....++||||+++++
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~g~   79 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQS-PEKLYLVLAFINGGE   79 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEec-CCeEEEEEcCCCCCc
Confidence            799999999999999999999999987532  23344567789999999999999999998766 688999999999999


Q ss_pred             chHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCCCCCCCCCc
Q 019650          133 LFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNN  212 (337)
Q Consensus       133 L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~  212 (337)
                      |.+++...+.+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++.......            
T Consensus        80 L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~------------  147 (312)
T cd05585          80 LFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD------------  147 (312)
T ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC------------
Confidence            99999888889999999999999999999999999999999999999999999999999987532221            


Q ss_pred             cccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhccCCCCCCCCC
Q 019650          213 IGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPETA  292 (337)
Q Consensus       213 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (337)
                        .......|++.|+|||++.    +..++.++||||||+++|+|++|..||.......    ..... ......++..+
T Consensus       148 --~~~~~~~gt~~y~aPE~~~----~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~----~~~~~-~~~~~~~~~~~  216 (312)
T cd05585         148 --DKTNTFCGTPEYLAPELLL----GHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNE----MYRKI-LQEPLRFPDGF  216 (312)
T ss_pred             --CccccccCCcccCCHHHHc----CCCCCCccceechhHHHHHHHhCCCCcCCCCHHH----HHHHH-HcCCCCCCCcC
Confidence              1112335899999999998    4578899999999999999999999997543222    22222 22355667788


Q ss_pred             CHHHHHHHHHHhhcCcCCCC---CHHHHhcCccccccC
Q 019650          293 SPEFRRFVRSCLEKDWRKRG---TVEELLAYPFVTKRS  327 (337)
Q Consensus       293 ~~~~~~li~~~l~~~p~~R~---s~~eil~hp~f~~~~  327 (337)
                      +..+.+++.+||..||.+||   ++.++++||||.+..
T Consensus       217 ~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~~  254 (312)
T cd05585         217 DRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLS  254 (312)
T ss_pred             CHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCCC
Confidence            99999999999999999997   579999999999864

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=3.8e-47  Score=338.55  Aligned_cols=253  Identities=30%  Similarity=0.477  Sum_probs=212.6

Q ss_pred             cccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEeccCC
Q 019650           53 TVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMER  130 (337)
Q Consensus        53 ~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~  130 (337)
                      +.||.|+||.||++.+..++..||+|++....  .......+.+|+.+++.++|+||+++++.+.. ....++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~Ey~~~   79 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQT-KDRLCFVMEYVNG   79 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc-CCEEEEEEeCCCC
Confidence            36899999999999999999999999997542  22344567789999999999999999998766 6889999999999


Q ss_pred             CCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCCCCCCCC
Q 019650          131 GSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNN  210 (337)
Q Consensus       131 ~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~  210 (337)
                      ++|.+++.....+++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||++.......          
T Consensus        80 g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~----------  149 (328)
T cd05593          80 GELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA----------  149 (328)
T ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc----------
Confidence            9999999888889999999999999999999999999999999999999999999999999886532211          


Q ss_pred             CccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhccCCCCCCC
Q 019650          211 NNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPE  290 (337)
Q Consensus       211 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (337)
                          .......|++.|+|||.+.    +..++.++||||||+++|+|++|..||.......    ..... ......++.
T Consensus       150 ----~~~~~~~gt~~y~aPE~~~----~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~----~~~~~-~~~~~~~p~  216 (328)
T cd05593         150 ----ATMKTFCGTPEYLAPEVLE----DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK----LFELI-LMEDIKFPR  216 (328)
T ss_pred             ----cccccccCCcCccChhhhc----CCCCCccCCccccchHHHHHhhCCCCCCCCCHHH----HHHHh-ccCCccCCC
Confidence                1112335899999999998    4578899999999999999999999996543222    12221 223456677


Q ss_pred             CCCHHHHHHHHHHhhcCcCCCC-----CHHHHhcCccccccCCC
Q 019650          291 TASPEFRRFVRSCLEKDWRKRG-----TVEELLAYPFVTKRSSS  329 (337)
Q Consensus       291 ~~~~~~~~li~~~l~~~p~~R~-----s~~eil~hp~f~~~~~~  329 (337)
                      .++..+.++|.+||..||++|+     +++++++||||.+..+.
T Consensus       217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~  260 (328)
T cd05593         217 TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNWQ  260 (328)
T ss_pred             CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCCCHH
Confidence            8899999999999999999997     89999999999886554

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=6.9e-47  Score=331.01  Aligned_cols=259  Identities=26%  Similarity=0.384  Sum_probs=208.7

Q ss_pred             cccccccccccCcceEEEEEEEccCCceEEEEEeecCC-chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 019650           47 SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVM  125 (337)
Q Consensus        47 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~  125 (337)
                      ++|++.+.||+|+||+||+|.+..++..||+|++.... .....+.+.+|+.+++.++|+||+++++++.. +...++||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~   79 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRR-RGKLYLVF   79 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEec-CCEEEEEE
Confidence            47999999999999999999999999999999987643 22344567789999999999999999998766 68899999


Q ss_pred             eccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCCC
Q 019650          126 EHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNH  205 (337)
Q Consensus       126 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~  205 (337)
                      ||++++.+..+......+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||.+........    
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~----  155 (287)
T cd07848          80 EYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN----  155 (287)
T ss_pred             ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccc----
Confidence            9999876665555556799999999999999999999999999999999999999999999999999876543211    


Q ss_pred             CCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhc---
Q 019650          206 NNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICF---  282 (337)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~---  282 (337)
                               .......+++.|+|||++.    +..++.++|+||||+++|+|++|+.||..................   
T Consensus       156 ---------~~~~~~~~~~~y~aPE~~~----~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  222 (287)
T cd07848         156 ---------ANYTEYVATRWYRSPELLL----GAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPA  222 (287)
T ss_pred             ---------ccccccccccccCCcHHHc----CCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCH
Confidence                     1111235789999999997    456888999999999999999999999765443322222111000   


Q ss_pred             --------------cCCC----------CCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccc
Q 019650          283 --------------GERL----------EMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV  323 (337)
Q Consensus       283 --------------~~~~----------~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f  323 (337)
                                    ...+          .....++..+.+++.+||+.||++|||++++|+||||
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         223 EQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             HHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence                          0000          0112357789999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-47  Score=334.68  Aligned_cols=256  Identities=29%  Similarity=0.426  Sum_probs=222.3

Q ss_pred             CCCCccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeC
Q 019650           39 TSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIE  118 (337)
Q Consensus        39 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~  118 (337)
                      ..++....+.++.++.||+|-||.||.|....+ .+||+|.++...  ...+.+.+|+++|++|+|++|+++++++.. +
T Consensus       198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~-~~vavk~ik~~~--m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~-~  273 (468)
T KOG0197|consen  198 RDPWEIPREELKLIRELGSGQFGEVWLGKWNGS-TKVAVKTIKEGS--MSPEAFLREAQIMKKLRHEKLVKLYGVCTK-Q  273 (468)
T ss_pred             cCCeeecHHHHHHHHHhcCCccceEEEEEEcCC-CcccceEEeccc--cChhHHHHHHHHHHhCcccCeEEEEEEEec-C
Confidence            556778888999999999999999999999643 469999998753  345677899999999999999999999876 4


Q ss_pred             CeEEEEEeccCCCCchHHhhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccch
Q 019650          119 GEICFVMEHMERGSLFDSLRV--RKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIV  196 (337)
Q Consensus       119 ~~~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~  196 (337)
                      ..+||||||++.|+|.++|+.  ...+...+...++.|||+|++||+++++|||||.++|||++.+..+||+|||+++..
T Consensus       274 ~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~  353 (468)
T KOG0197|consen  274 EPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLI  353 (468)
T ss_pred             CceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEccccccccc
Confidence            579999999999999999986  467999999999999999999999999999999999999999999999999999965


Q ss_pred             hccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCchhHHH
Q 019650          197 EETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMA  275 (337)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~~~~~~~~~~  275 (337)
                      .++.....             ...-.+..|.|||.+..    ..++.+|||||||++|||++| |+.||.++.+    ..
T Consensus       354 ~d~~Y~~~-------------~~~kfPIkWtAPEa~~~----~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn----~e  412 (468)
T KOG0197|consen  354 GDDEYTAS-------------EGGKFPIKWTAPEALNY----GKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN----EE  412 (468)
T ss_pred             CCCceeec-------------CCCCCCceecCHHHHhh----CCcccccceeehhhhHHHHhccCCCCCCCCCH----HH
Confidence            54432221             12225778999999995    478999999999999999999 9999976644    45


Q ss_pred             HHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhc
Q 019650          276 LICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA  319 (337)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~  319 (337)
                      ++..+..+.+.+.|+.+++.+.+++..||+.+|++|||++.+..
T Consensus       413 v~~~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~  456 (468)
T KOG0197|consen  413 VLELLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLRE  456 (468)
T ss_pred             HHHHHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHH
Confidence            66677788999999999999999999999999999999997654

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=1.4e-46  Score=334.62  Aligned_cols=257  Identities=26%  Similarity=0.371  Sum_probs=212.5

Q ss_pred             ccccccccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHHhcCCCC-ceeeeeeEEeeCCeEEEE
Q 019650           48 DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQF-IVKCHAVFYTIEGEICFV  124 (337)
Q Consensus        48 ~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~~~~-i~~~~~~~~~~~~~~~lv  124 (337)
                      +|++.+.||.|+||.||+|.+..+++.||+|++....  .....+.+..|..++..+.|++ ++.+++.+.+ ...+|+|
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-~~~~~lv   79 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT-MDRLYFV   79 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEc-CCEEEEE
Confidence            5889999999999999999999999999999987542  2233456677888999998765 6677776655 6889999


Q ss_pred             EeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCC
Q 019650          125 MEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNN  204 (337)
Q Consensus       125 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~  204 (337)
                      |||+++++|.+++.....+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++.......    
T Consensus        80 ~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~----  155 (324)
T cd05587          80 MEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG----  155 (324)
T ss_pred             EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC----
Confidence            9999999999999888889999999999999999999999999999999999999999999999999876432111    


Q ss_pred             CCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhccC
Q 019650          205 HNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGE  284 (337)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~  284 (337)
                                .......|++.|+|||++.    +..++.++|+||||+++|+|++|+.||............    . ..
T Consensus       156 ----------~~~~~~~gt~~y~aPE~~~----~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i----~-~~  216 (324)
T cd05587         156 ----------KTTRTFCGTPDYIAPEIIA----YQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSI----M-EH  216 (324)
T ss_pred             ----------CceeeecCCccccChhhhc----CCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH----H-cC
Confidence                      1122345899999999998    457889999999999999999999999764332222222    1 23


Q ss_pred             CCCCCCCCCHHHHHHHHHHhhcCcCCCCCH-----HHHhcCccccccCC
Q 019650          285 RLEMPETASPEFRRFVRSCLEKDWRKRGTV-----EELLAYPFVTKRSS  328 (337)
Q Consensus       285 ~~~~~~~~~~~~~~li~~~l~~~p~~R~s~-----~eil~hp~f~~~~~  328 (337)
                      ...++..++..+.+++.+||..||.+|++.     +++++||||....+
T Consensus       217 ~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~  265 (324)
T cd05587         217 NVSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDW  265 (324)
T ss_pred             CCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence            455667789999999999999999999976     89999999987654

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=1.5e-46  Score=339.39  Aligned_cols=275  Identities=27%  Similarity=0.418  Sum_probs=214.5

Q ss_pred             cccccccccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 019650           47 SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFV  124 (337)
Q Consensus        47 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv  124 (337)
                      ++|++.+.||.|+||+||+|.+..+++.||+|++....  .......+..|+.++.+++|++|+++++.+.+ ...+|+|
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~-~~~~~lv   79 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQD-KLNLYLI   79 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEec-CCeEEEE
Confidence            47999999999999999999999999999999997532  22334567789999999999999999998876 6889999


Q ss_pred             EeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCC
Q 019650          125 MEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNN  204 (337)
Q Consensus       125 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~  204 (337)
                      |||++||+|.+++...+.+++..+..++.|++.||.|||++||+||||||+||+++.+++++|+|||++...........
T Consensus        80 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~  159 (363)
T cd05628          80 MEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEF  159 (363)
T ss_pred             EcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccccccccc
Confidence            99999999999999888999999999999999999999999999999999999999999999999999876532110000


Q ss_pred             C--------------CCCC-------CCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCC
Q 019650          205 H--------------NNNN-------NNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYP  263 (337)
Q Consensus       205 ~--------------~~~~-------~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~p  263 (337)
                      .              ....       ...........+||+.|+|||++.    +..++.++|+|||||++|+|++|..|
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~----~~~~~~~~DvwSlGvil~ell~G~~P  235 (363)
T cd05628         160 YRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFM----QTGYNKLCDWWSLGVIMYEMLIGYPP  235 (363)
T ss_pred             cccccccccccccccccccccccchhhhccccccccccCCccccCHHHHc----CCCCCCchhhhhhHHHHHHHHhCCCC
Confidence            0              0000       000001123457999999999998    45788899999999999999999999


Q ss_pred             CCCCCCchhHHHHHHHhhccCCCCCC--CCCCHHHHHHHHHHhhcCcC---CCCCHHHHhcCccccccCCCc
Q 019650          264 LIGFGEKPDLMALICAICFGERLEMP--ETASPEFRRFVRSCLEKDWR---KRGTVEELLAYPFVTKRSSSS  330 (337)
Q Consensus       264 f~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~---~R~s~~eil~hp~f~~~~~~~  330 (337)
                      |...........+...   .....++  ..+++.++++|.+|+. +|.   .||++++|++||||++..+..
T Consensus       236 f~~~~~~~~~~~i~~~---~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~~~~~  303 (363)
T cd05628         236 FCSETPQETYKKVMNW---KETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGVDWEH  303 (363)
T ss_pred             CCCCCHHHHHHHHHcC---cCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCCCHHH
Confidence            9764433322222211   1122222  2468899999999765 444   458999999999999876543

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=2e-46  Score=334.20  Aligned_cols=257  Identities=26%  Similarity=0.454  Sum_probs=211.2

Q ss_pred             cccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHHhc-CCCCceeeeeeEEeeCCeEEEEEeccC
Q 019650           53 TVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRL-DSQFIVKCHAVFYTIEGEICFVMEHME  129 (337)
Q Consensus        53 ~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~~lv~e~~~  129 (337)
                      +.||+|+||.||+|.+..+++.||+|+++...  .....+.+..|..++..+ +|+||+++++.+.+ ...+|+||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~-~~~~~lv~e~~~   79 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQT-ESRLFFVIEFVS   79 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEc-CCEEEEEEeCCC
Confidence            46899999999999999999999999997642  223445677889998888 79999999998766 688999999999


Q ss_pred             CCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCCCCCCC
Q 019650          130 RGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNN  209 (337)
Q Consensus       130 ~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~  209 (337)
                      |++|.+++...+.+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||++.......         
T Consensus        80 ~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~---------  150 (329)
T cd05588          80 GGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG---------  150 (329)
T ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCC---------
Confidence            99999999888899999999999999999999999999999999999999999999999999886422111         


Q ss_pred             CCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCc----hhHHHHHHHhhccCC
Q 019650          210 NNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEK----PDLMALICAICFGER  285 (337)
Q Consensus       210 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~----~~~~~~~~~~~~~~~  285 (337)
                           .......|++.|+|||++.    +..++.++|+||||+++|+|++|+.||......    ...............
T Consensus       151 -----~~~~~~~gt~~y~aPE~~~----~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  221 (329)
T cd05588         151 -----DTTSTFCGTPNYIAPEILR----GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ  221 (329)
T ss_pred             -----CccccccCCccccCHHHHc----CCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC
Confidence                 1122346899999999998    457888999999999999999999999532211    111112222223334


Q ss_pred             CCCCCCCCHHHHHHHHHHhhcCcCCCCC------HHHHhcCccccccCC
Q 019650          286 LEMPETASPEFRRFVRSCLEKDWRKRGT------VEELLAYPFVTKRSS  328 (337)
Q Consensus       286 ~~~~~~~~~~~~~li~~~l~~~p~~R~s------~~eil~hp~f~~~~~  328 (337)
                      ...+..++..+.+++.+||+.||.+|++      ++++++||||.+..+
T Consensus       222 ~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~  270 (329)
T cd05588         222 IRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDW  270 (329)
T ss_pred             CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence            5667778999999999999999999987      799999999987543

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.6e-47  Score=323.70  Aligned_cols=257  Identities=27%  Similarity=0.386  Sum_probs=227.1

Q ss_pred             ccccccccccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEE
Q 019650           46 ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICF  123 (337)
Q Consensus        46 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~l  123 (337)
                      -.+|++.+.||.|.||.|-++.+...|+.||||.++++.  ++...-.+.+|++++..|+||||+.++++|.. ...+.+
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFEN-kdKIvi  130 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFEN-KDKIVI  130 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcC-CceEEE
Confidence            369999999999999999999999999999999998764  45566778899999999999999999999866 678999


Q ss_pred             EEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCC
Q 019650          124 VMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNN  203 (337)
Q Consensus       124 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~  203 (337)
                      ||||..+|.|.||+.+.+.+++.+++.++.||++|+.|+|.++++|||||.+|||+|.++++||+|||++..+...    
T Consensus       131 vMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~----  206 (668)
T KOG0611|consen  131 VMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADK----  206 (668)
T ss_pred             EEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccc----
Confidence            9999999999999999999999999999999999999999999999999999999999999999999999877654    


Q ss_pred             CCCCCCCCccccccccccCCCCCcCCcccccccCCCCC-CccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhc
Q 019650          204 NHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDY-GFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICF  282 (337)
Q Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~-~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~  282 (337)
                                 .....++|.+-|.+||..++    .+| ++.+|.||||++||.|..|.+||.+.    +...+..++..
T Consensus       207 -----------kfLqTFCGSPLYASPEIvNG----~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~----Dhk~lvrQIs~  267 (668)
T KOG0611|consen  207 -----------KFLQTFCGSPLYASPEIVNG----TPYKGPEVDSWSLGVLLYTLVYGTMPFDGR----DHKRLVRQISR  267 (668)
T ss_pred             -----------cHHHHhcCCcccCCccccCC----CCCCCCccchhhHHHHHHHHhhcccccCCc----hHHHHHHHhhc
Confidence                       55667789999999999994    444 67999999999999999999999653    44555556666


Q ss_pred             cCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCC
Q 019650          283 GERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSS  328 (337)
Q Consensus       283 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~  328 (337)
                      +...+.  ..+..+.-||+.||..||++|.|+++|-+|=|+.=..+
T Consensus       268 GaYrEP--~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvNwgy~  311 (668)
T KOG0611|consen  268 GAYREP--ETPSDASGLIRWMLMVNPERRATIEDIASHWWVNWGYN  311 (668)
T ss_pred             ccccCC--CCCchHHHHHHHHHhcCcccchhHHHHhhhheeecccc
Confidence            655553  33778999999999999999999999999988764443

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=2.3e-46  Score=316.13  Aligned_cols=267  Identities=28%  Similarity=0.421  Sum_probs=223.1

Q ss_pred             ccccccccccccCcceEEEEEEEccCCceEEEEEeecCCc-hHhHHHHHHHHHHHHhcCCCC-ceeeeeeEEeeCC----
Q 019650           46 ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSS-TIIRHQAAHEAEILKRLDSQF-IVKCHAVFYTIEG----  119 (337)
Q Consensus        46 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~~~~-i~~~~~~~~~~~~----  119 (337)
                      ...|..+++||+|++|+||+|....+|+.||+|.++.+.. +.......+|+.+++.++|+| |+.+++++...+.    
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~   89 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI   89 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence            6789999999999999999999999999999999988754 345556688999999999999 9999999988553    


Q ss_pred             -eEEEEEeccCCCCchHHhhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCcc
Q 019650          120 -EICFVMEHMERGSLFDSLRVRK----KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSR  194 (337)
Q Consensus       120 -~~~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~  194 (337)
                       .+++|+||.+. +|..++...+    .++...++.++.||+.||+|||+++|+||||||+||+++++|.+||+|||+++
T Consensus        90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAr  168 (323)
T KOG0594|consen   90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLAR  168 (323)
T ss_pred             ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHH
Confidence             78999999976 9999998655    57889999999999999999999999999999999999999999999999998


Q ss_pred             chhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHH
Q 019650          195 IVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLM  274 (337)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~  274 (337)
                      ...-+..              .-..-++|..|.|||++.+.   ..|+...||||+|||+.||++++..|.+..+.+.+.
T Consensus       169 a~~ip~~--------------~yt~evvTlWYRaPEvLlGs---~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~  231 (323)
T KOG0594|consen  169 AFSIPMR--------------TYTPEVVTLWYRAPEVLLGS---TSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLF  231 (323)
T ss_pred             HhcCCcc--------------cccccEEEeeccCHHHhcCC---CcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHH
Confidence            6653321              12233689999999999964   369999999999999999999999998877766555


Q ss_pred             HHHHHhhccCCCCCC-------------------------CCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCC
Q 019650          275 ALICAICFGERLEMP-------------------------ETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSS  329 (337)
Q Consensus       275 ~~~~~~~~~~~~~~~-------------------------~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~  329 (337)
                      .+...+.......+|                         +..+....+++.+||..+|.+|.|++.+|.||||+.....
T Consensus       232 ~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~  311 (323)
T KOG0594|consen  232 RIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPEK  311 (323)
T ss_pred             HHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccccc
Confidence            555443322111111                         1223589999999999999999999999999999987543


Q ss_pred             c
Q 019650          330 S  330 (337)
Q Consensus       330 ~  330 (337)
                      .
T Consensus       312 ~  312 (323)
T KOG0594|consen  312 S  312 (323)
T ss_pred             h
Confidence            3

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-46  Score=340.76  Aligned_cols=273  Identities=26%  Similarity=0.416  Sum_probs=216.1

Q ss_pred             cccccccccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 019650           47 SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFV  124 (337)
Q Consensus        47 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv  124 (337)
                      ++|++.+.||.|+||+||+|.+..+++.||+|++....  .......+.+|+.++..++|+||+++++.+.+ +..+|+|
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~-~~~~~lv   79 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQD-ENYLYLI   79 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc-CCeEEEE
Confidence            47999999999999999999999999999999997542  22344567789999999999999999998876 7889999


Q ss_pred             EeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCC
Q 019650          125 MEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNN  204 (337)
Q Consensus       125 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~  204 (337)
                      |||++||+|.+++...+.+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++...........
T Consensus        80 ~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~  159 (364)
T cd05599          80 MEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEF  159 (364)
T ss_pred             ECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceeccccccccc
Confidence            99999999999998888899999999999999999999999999999999999999999999999999876532211000


Q ss_pred             CCCCCC------------------------CccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhC
Q 019650          205 HNNNNN------------------------NNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVG  260 (337)
Q Consensus       205 ~~~~~~------------------------~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg  260 (337)
                      ......                        ..........+||+.|+|||++.    +..++.++|||||||++|+|++|
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~DiwSlG~il~el~~G  235 (364)
T cd05599         160 YRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFL----QTGYNKECDWWSLGVIMYEMLVG  235 (364)
T ss_pred             cccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHc----CCCCCCeeeeecchhHHHHhhcC
Confidence            000000                        00000112346899999999997    45788999999999999999999


Q ss_pred             CCCCCCCCCchhHHHHHHHhhccCCCCCC--CCCCHHHHHHHHHHhhcCcCCCCC---HHHHhcCccccccCC
Q 019650          261 HYPLIGFGEKPDLMALICAICFGERLEMP--ETASPEFRRFVRSCLEKDWRKRGT---VEELLAYPFVTKRSS  328 (337)
Q Consensus       261 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~s---~~eil~hp~f~~~~~  328 (337)
                      ..||..............   ......++  ..+++.+.++|.+|+. +|.+|++   +++++.||||++..+
T Consensus       236 ~~Pf~~~~~~~~~~~i~~---~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~~~  304 (364)
T cd05599         236 YPPFCSDNPQETYRKIIN---WKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGVDW  304 (364)
T ss_pred             CCCCCCCCHHHHHHHHHc---CCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCCCH
Confidence            999976443222222211   11122222  2468899999999996 9999997   999999999988654

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=8.3e-46  Score=330.60  Aligned_cols=262  Identities=36%  Similarity=0.653  Sum_probs=216.4

Q ss_pred             CccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 019650           45 NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFV  124 (337)
Q Consensus        45 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv  124 (337)
                      ..++|++.+.||.|+||+||++.+..++..+|+|++...........+.+|+.++++++|+||+++++.+.+ +...++|
T Consensus         3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv   81 (333)
T cd06650           3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-DGEISIC   81 (333)
T ss_pred             chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEE-CCEEEEE
Confidence            357999999999999999999999999999999998776555556778899999999999999999999877 7899999


Q ss_pred             EeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCCeEEcCCCcEEEeeccCccchhccccCC
Q 019650          125 MEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGM-QIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNN  203 (337)
Q Consensus       125 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~-~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~  203 (337)
                      |||+++++|.+++...+.+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.......   
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~---  158 (333)
T cd06650          82 MEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---  158 (333)
T ss_pred             EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc---
Confidence            99999999999998888899999999999999999999975 79999999999999999999999999987553321   


Q ss_pred             CCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHH---------
Q 019650          204 NHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLM---------  274 (337)
Q Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~---------  274 (337)
                                   .....++..|+|||++.    +..++.++|+||||+++|+|++|+.||..........         
T Consensus       159 -------------~~~~~~~~~y~aPE~~~----~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  221 (333)
T cd06650         159 -------------ANSFVGTRSYMSPERLQ----GTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGD  221 (333)
T ss_pred             -------------cccCCCCccccCHHHhc----CCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCC
Confidence                         11235889999999997    4578889999999999999999999996532211100         


Q ss_pred             -------------------------------HHHHHhhccCCCCCC-CCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCcc
Q 019650          275 -------------------------------ALICAICFGERLEMP-ETASPEFRRFVRSCLEKDWRKRGTVEELLAYPF  322 (337)
Q Consensus       275 -------------------------------~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~  322 (337)
                                                     ...........+..+ ...+..+++|+.+||+.||++|||+++++.|||
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~  301 (333)
T cd06650         222 PAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAF  301 (333)
T ss_pred             ccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHH
Confidence                                           001111111111121 135678999999999999999999999999999


Q ss_pred             ccccC
Q 019650          323 VTKRS  327 (337)
Q Consensus       323 f~~~~  327 (337)
                      |+...
T Consensus       302 ~~~~~  306 (333)
T cd06650         302 IKRSE  306 (333)
T ss_pred             HhcCc
Confidence            98875

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=2.4e-46  Score=340.17  Aligned_cols=277  Identities=26%  Similarity=0.385  Sum_probs=216.0

Q ss_pred             cccccccccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 019650           47 SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFV  124 (337)
Q Consensus        47 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv  124 (337)
                      +.|++++.||+|+||+||+|.+..++..||+|++....  .......+.+|+.++++++|+||+++++.+.+ ...+++|
T Consensus         1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~-~~~~~lv   79 (381)
T cd05626           1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQD-KDNLYFV   79 (381)
T ss_pred             CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEec-CCEEEEE
Confidence            36899999999999999999999999999999997542  23345667889999999999999999998876 6889999


Q ss_pred             EeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCC
Q 019650          125 MEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNN  204 (337)
Q Consensus       125 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~  204 (337)
                      |||++||+|.+++...+.+++..++.++.||+.||.|||+.||+||||||+||+++.+++++|+|||++...........
T Consensus        80 ~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~  159 (381)
T cd05626          80 MDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKY  159 (381)
T ss_pred             EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccc
Confidence            99999999999998888899999999999999999999999999999999999999999999999998754321100000


Q ss_pred             C--------C-------------------------CCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHH
Q 019650          205 H--------N-------------------------NNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLG  251 (337)
Q Consensus       205 ~--------~-------------------------~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG  251 (337)
                      .        .                         ..............+||+.|+|||.+.    +..++.++||||||
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~----~~~~~~~~DiwSlG  235 (381)
T cd05626         160 YQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLL----RKGYTQLCDWWSVG  235 (381)
T ss_pred             ccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHc----CCCCCCccceeehh
Confidence            0        0                         000000001112457999999999998    45788999999999


Q ss_pred             HHHHHHHhCCCCCCCCCCchhHHHHHHHhhccCCCCCC--CCCCHHHHHHHHHHhh--cCcCCCCCHHHHhcCccccccC
Q 019650          252 VVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMP--ETASPEFRRFVRSCLE--KDWRKRGTVEELLAYPFVTKRS  327 (337)
Q Consensus       252 ~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~--~~p~~R~s~~eil~hp~f~~~~  327 (337)
                      |++|+|++|..||..............   .......+  ..++..+.++|.+|+.  .+|..|++++++++||||++..
T Consensus       236 ~il~elltG~~Pf~~~~~~~~~~~i~~---~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~~  312 (381)
T cd05626         236 VILFEMLVGQPPFLAPTPTETQLKVIN---WENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVD  312 (381)
T ss_pred             hHHHHHHhCCCCCcCCCHHHHHHHHHc---cccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCCC
Confidence            999999999999976543332222221   11122222  3568999999999654  4555699999999999999876


Q ss_pred             CCcc
Q 019650          328 SSSN  331 (337)
Q Consensus       328 ~~~~  331 (337)
                      +.+.
T Consensus       313 ~~~~  316 (381)
T cd05626         313 FSSD  316 (381)
T ss_pred             hhHH
Confidence            6543

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=1.3e-46  Score=334.10  Aligned_cols=252  Identities=27%  Similarity=0.386  Sum_probs=208.9

Q ss_pred             cccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHHhc-CCCCceeeeeeEEeeCCeEEEEEeccC
Q 019650           53 TVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRL-DSQFIVKCHAVFYTIEGEICFVMEHME  129 (337)
Q Consensus        53 ~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~~lv~e~~~  129 (337)
                      +.||+|+||+||+|.+..+++.||+|++....  .......+..|..++..+ .|+||+++++.+.. ...+|+||||++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~-~~~~~iv~Ey~~   79 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQT-PDRLFFVMEFVN   79 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEc-CCEEEEEEcCCC
Confidence            46899999999999999999999999987532  222344556777777766 79999999998766 688999999999


Q ss_pred             CCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCCCCCCC
Q 019650          130 RGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNN  209 (337)
Q Consensus       130 ~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~  209 (337)
                      +++|.+++.....+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++.......         
T Consensus        80 ~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~---------  150 (320)
T cd05590          80 GGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG---------  150 (320)
T ss_pred             CchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC---------
Confidence            99999999888899999999999999999999999999999999999999999999999999876532211         


Q ss_pred             CCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhccCCCCCC
Q 019650          210 NNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMP  289 (337)
Q Consensus       210 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  289 (337)
                           .......|++.|+|||.+.    +..++.++|+||||+++|+|++|..||........    ..... ......+
T Consensus       151 -----~~~~~~~gt~~y~aPE~~~----~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~----~~~i~-~~~~~~~  216 (320)
T cd05590         151 -----KTTSTFCGTPDYIAPEILQ----EMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDL----FEAIL-NDEVVYP  216 (320)
T ss_pred             -----CcccccccCccccCHHHHc----CCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH----HHHHh-cCCCCCC
Confidence                 1122345899999999998    45788899999999999999999999976433222    22222 2334556


Q ss_pred             CCCCHHHHHHHHHHhhcCcCCCCCH------HHHhcCccccccCC
Q 019650          290 ETASPEFRRFVRSCLEKDWRKRGTV------EELLAYPFVTKRSS  328 (337)
Q Consensus       290 ~~~~~~~~~li~~~l~~~p~~R~s~------~eil~hp~f~~~~~  328 (337)
                      ..++..+.+++.+||+.||.+|+++      +++++||||++..+
T Consensus       217 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~  261 (320)
T cd05590         217 TWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDW  261 (320)
T ss_pred             CCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCCH
Confidence            6789999999999999999999998      99999999987654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.1e-47  Score=340.20  Aligned_cols=275  Identities=29%  Similarity=0.432  Sum_probs=218.1

Q ss_pred             cccccccccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 019650           47 SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFV  124 (337)
Q Consensus        47 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv  124 (337)
                      ++|++.+.||.|+||+||+|.+..+++.||+|++....  .......+..|+.++..++|+||+++++.+.+ +...++|
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv   79 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQD-EEHLYLV   79 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheec-CCeEEEE
Confidence            47999999999999999999999999999999987542  11334567789999999999999999998776 6889999


Q ss_pred             EeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCC
Q 019650          125 MEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNN  204 (337)
Q Consensus       125 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~  204 (337)
                      |||+++++|.+++.....+++..++.++.||+.||+|||+.|++||||||+||+++.++.++|+|||++...........
T Consensus        80 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~  159 (350)
T cd05573          80 MEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREY  159 (350)
T ss_pred             EcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcccc
Confidence            99999999999998888899999999999999999999999999999999999999999999999999876654320000


Q ss_pred             CCCC---------------CCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCC
Q 019650          205 HNNN---------------NNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGE  269 (337)
Q Consensus       205 ~~~~---------------~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~  269 (337)
                      ....               .............|++.|+|||.+.    +..++.++|||||||++|+|++|..||.....
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~  235 (350)
T cd05573         160 YLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLR----GTPYGLECDWWSLGVILYEMLYGFPPFYSDTL  235 (350)
T ss_pred             cccccccccccccccccccccccccccccccccCccccCHHHHc----CCCCCCceeeEecchhhhhhccCCCCCCCCCH
Confidence            0000               0000001223346899999999998    45789999999999999999999999976543


Q ss_pred             chhHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCC-HHHHhcCccccccCC
Q 019650          270 KPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGT-VEELLAYPFVTKRSS  328 (337)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s-~~eil~hp~f~~~~~  328 (337)
                      ......+.... ..........+++.+.++|.+||. ||.+|++ ++++++||||++..+
T Consensus       236 ~~~~~~i~~~~-~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~~~  293 (350)
T cd05573         236 QETYNKIINWK-ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGIDW  293 (350)
T ss_pred             HHHHHHHhccC-CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCCCH
Confidence            33222222110 111112223358999999999997 9999999 999999999987654

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-47  Score=316.09  Aligned_cols=266  Identities=30%  Similarity=0.488  Sum_probs=234.0

Q ss_pred             ccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCe
Q 019650           43 VENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGE  120 (337)
Q Consensus        43 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~  120 (337)
                      -...++|..+++||.|.||.|.+|..+.+++.+|+|+++++.  ..........|-++++..+||.+..+...|.. ..+
T Consensus       164 kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt-~dr  242 (516)
T KOG0690|consen  164 KVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQT-QDR  242 (516)
T ss_pred             eeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhcc-Cce
Confidence            346789999999999999999999999999999999998764  34445666789999999999999999988877 789


Q ss_pred             EEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccc
Q 019650          121 ICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETR  200 (337)
Q Consensus       121 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~  200 (337)
                      +|+||||..||.|+-.+.....+++..++.+...|+.||.|||+++||.||||.+|++++++|++||+|||++......+
T Consensus       243 lCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g  322 (516)
T KOG0690|consen  243 LCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYG  322 (516)
T ss_pred             EEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhccccc
Confidence            99999999999999999988899999999999999999999999999999999999999999999999999987544332


Q ss_pred             cCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHh
Q 019650          201 NNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAI  280 (337)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~  280 (337)
                                    .....++|||.|+|||++.    +..|+.++|+|.+|+++|||++|+.||.+.+. +.+..++   
T Consensus       323 --------------~t~kTFCGTPEYLAPEVle----DnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh-~kLFeLI---  380 (516)
T KOG0690|consen  323 --------------DTTKTFCGTPEYLAPEVLE----DNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH-EKLFELI---  380 (516)
T ss_pred             --------------ceeccccCChhhcCchhhc----cccccceeehhhhhHHHHHHHhccCcccccch-hHHHHHH---
Confidence                          5666789999999999999    67899999999999999999999999986433 2332222   


Q ss_pred             hccCCCCCCCCCCHHHHHHHHHHhhcCcCCCC-----CHHHHhcCccccccCCCccc
Q 019650          281 CFGERLEMPETASPEFRRFVRSCLEKDWRKRG-----TVEELLAYPFVTKRSSSSNI  332 (337)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~-----s~~eil~hp~f~~~~~~~~~  332 (337)
                       ......+|..++++++.|+..+|.+||.+|.     .+.||..|+||.+..|..-+
T Consensus       381 -l~ed~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~  436 (516)
T KOG0690|consen  381 -LMEDLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATY  436 (516)
T ss_pred             -HhhhccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHH
Confidence             2346788899999999999999999999995     59999999999999886544

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=8.3e-47  Score=336.20  Aligned_cols=254  Identities=28%  Similarity=0.467  Sum_probs=211.6

Q ss_pred             cccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEeccCC
Q 019650           53 TVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMER  130 (337)
Q Consensus        53 ~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~  130 (337)
                      +.||+|+||+||++.+..++..||+|++....  .......+.+|+.++..++|+||+++++.+.. ....|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~-~~~~~lv~E~~~~   79 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT-HDRLCFVMEYANG   79 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEc-CCEEEEEEeCCCC
Confidence            46899999999999999999999999997542  22234556779999999999999999998766 6889999999999


Q ss_pred             CCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCCCCCCC
Q 019650          131 GSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG-MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNN  209 (337)
Q Consensus       131 ~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~-~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~  209 (337)
                      ++|.+++.....+++..+..++.||+.||+|||+ .|++||||||+||+++.++.++|+|||++.......         
T Consensus        80 ~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~---------  150 (325)
T cd05594          80 GELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG---------  150 (325)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC---------
Confidence            9999999888889999999999999999999997 799999999999999999999999999886432211         


Q ss_pred             CCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhccCCCCCC
Q 019650          210 NNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMP  289 (337)
Q Consensus       210 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  289 (337)
                           .......|++.|+|||++.    +..++.++||||||+++|+|++|..||....... .   ... .......++
T Consensus       151 -----~~~~~~~gt~~y~aPE~~~----~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~-~---~~~-i~~~~~~~p  216 (325)
T cd05594         151 -----ATMKTFCGTPEYLAPEVLE----DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK-L---FEL-ILMEEIRFP  216 (325)
T ss_pred             -----cccccccCCcccCCHHHHc----cCCCCCccccccccceeeeeccCCCCCCCCCHHH-H---HHH-HhcCCCCCC
Confidence                 1112235899999999997    4578899999999999999999999996543221 1   111 122345567


Q ss_pred             CCCCHHHHHHHHHHhhcCcCCCC-----CHHHHhcCccccccCCCc
Q 019650          290 ETASPEFRRFVRSCLEKDWRKRG-----TVEELLAYPFVTKRSSSS  330 (337)
Q Consensus       290 ~~~~~~~~~li~~~l~~~p~~R~-----s~~eil~hp~f~~~~~~~  330 (337)
                      ..++..+.+++.+||+.||++|+     ++.++++||||.+..+..
T Consensus       217 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~~  262 (325)
T cd05594         217 RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQD  262 (325)
T ss_pred             CCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCCCHHH
Confidence            77899999999999999999997     999999999999866543

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=4.3e-46  Score=331.92  Aligned_cols=257  Identities=27%  Similarity=0.467  Sum_probs=210.7

Q ss_pred             cccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHHhc-CCCCceeeeeeEEeeCCeEEEEEeccC
Q 019650           53 TVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRL-DSQFIVKCHAVFYTIEGEICFVMEHME  129 (337)
Q Consensus        53 ~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~~lv~e~~~  129 (337)
                      +.||+|+||+||+|.+..+++.+|+|++....  .....+.+..|..++.++ +|+||+++++.+.+ ....++||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~-~~~~~lv~E~~~   79 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT-ESRLFFVIEYVN   79 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEe-CCEEEEEEeCCC
Confidence            46999999999999999999999999997642  223445567788887776 89999999998776 789999999999


Q ss_pred             CCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCCCCCCC
Q 019650          130 RGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNN  209 (337)
Q Consensus       130 ~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~  209 (337)
                      +++|..++.....+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||++.......         
T Consensus        80 ~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~---------  150 (329)
T cd05618          80 GGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG---------  150 (329)
T ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC---------
Confidence            99999999888889999999999999999999999999999999999999999999999999886432211         


Q ss_pred             CCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCc----hhHHHHHHHhhccCC
Q 019650          210 NNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEK----PDLMALICAICFGER  285 (337)
Q Consensus       210 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~----~~~~~~~~~~~~~~~  285 (337)
                           .......|++.|+|||++.    +..++.++|+||||+++|+|++|..||......    ...............
T Consensus       151 -----~~~~~~~gt~~y~aPE~~~----~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~  221 (329)
T cd05618         151 -----DTTSTFCGTPNYIAPEILR----GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ  221 (329)
T ss_pred             -----CccccccCCccccCHHHHc----CCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC
Confidence                 1122346899999999998    457888999999999999999999999532111    111112222223345


Q ss_pred             CCCCCCCCHHHHHHHHHHhhcCcCCCCC------HHHHhcCccccccCC
Q 019650          286 LEMPETASPEFRRFVRSCLEKDWRKRGT------VEELLAYPFVTKRSS  328 (337)
Q Consensus       286 ~~~~~~~~~~~~~li~~~l~~~p~~R~s------~~eil~hp~f~~~~~  328 (337)
                      ..+|...+..+.+++.+||+.||++|++      ++++++||||++..+
T Consensus       222 ~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~  270 (329)
T cd05618         222 IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW  270 (329)
T ss_pred             CCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence            5677788999999999999999999998      589999999988654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=3e-46  Score=337.84  Aligned_cols=270  Identities=27%  Similarity=0.413  Sum_probs=218.5

Q ss_pred             CCccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeC
Q 019650           41 PDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIE  118 (337)
Q Consensus        41 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~  118 (337)
                      ......++|++.+.||.|+||+||++.+..++..||+|++....  .......+.+|+.+++.++|+||+++++.+.+ +
T Consensus        37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~-~  115 (370)
T cd05596          37 KLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQD-D  115 (370)
T ss_pred             cCCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEec-C
Confidence            33456789999999999999999999999999999999986432  12233456789999999999999999998766 7


Q ss_pred             CeEEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhc
Q 019650          119 GEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEE  198 (337)
Q Consensus       119 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~  198 (337)
                      ...++||||++||+|.+++.. ..+++..+..++.||+.||+|||+.||+||||||+||+++.++.++|+|||.+.....
T Consensus       116 ~~~~lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~  194 (370)
T cd05596         116 KYLYMVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA  194 (370)
T ss_pred             CEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence            889999999999999999865 4589999999999999999999999999999999999999999999999999876543


Q ss_pred             cccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHH
Q 019650          199 TRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALIC  278 (337)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~  278 (337)
                      ...             .......|++.|+|||.+.....+..++.++|+||||+++|+|++|..||..............
T Consensus       195 ~~~-------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~  261 (370)
T cd05596         195 NGM-------------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMD  261 (370)
T ss_pred             CCc-------------ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHc
Confidence            211             1112335899999999987543234578999999999999999999999976433222222211


Q ss_pred             HhhccCCCCCCC--CCCHHHHHHHHHHhhcCcCC--CCCHHHHhcCccccccCC
Q 019650          279 AICFGERLEMPE--TASPEFRRFVRSCLEKDWRK--RGTVEELLAYPFVTKRSS  328 (337)
Q Consensus       279 ~~~~~~~~~~~~--~~~~~~~~li~~~l~~~p~~--R~s~~eil~hp~f~~~~~  328 (337)
                         ......++.  .++..+.++|.+||+.+|.+  |+|++++++||||++..+
T Consensus       262 ---~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~~  312 (370)
T cd05596         262 ---HKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQW  312 (370)
T ss_pred             ---CCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCCh
Confidence               111223333  56899999999999999988  999999999999998654

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=2.3e-46  Score=332.75  Aligned_cols=252  Identities=27%  Similarity=0.376  Sum_probs=209.1

Q ss_pred             cccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHHhc-CCCCceeeeeeEEeeCCeEEEEEeccC
Q 019650           53 TVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRL-DSQFIVKCHAVFYTIEGEICFVMEHME  129 (337)
Q Consensus        53 ~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~~lv~e~~~  129 (337)
                      +.||.|+||.||+|.+..+++.||+|++....  .......+..|..++..+ +|++|+++++.+.. ....|+||||++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~-~~~~~lv~E~~~   79 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQT-KDRLFFVMEYVN   79 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc-CCeEEEEEeCCC
Confidence            46999999999999999999999999987542  223344566788888765 89999999998876 688999999999


Q ss_pred             CCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCCCCCCC
Q 019650          130 RGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNN  209 (337)
Q Consensus       130 ~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~  209 (337)
                      +++|.+++.....+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++.......         
T Consensus        80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~---------  150 (321)
T cd05591          80 GGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG---------  150 (321)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCC---------
Confidence            99999999888889999999999999999999999999999999999999999999999999886532211         


Q ss_pred             CCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhccCCCCCC
Q 019650          210 NNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMP  289 (337)
Q Consensus       210 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  289 (337)
                           .......|++.|+|||++.    +..++.++|+||||+++|+|++|+.||...........    ... ....++
T Consensus       151 -----~~~~~~~gt~~y~aPE~~~----~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~----i~~-~~~~~p  216 (321)
T cd05591         151 -----VTTTTFCGTPDYIAPEILQ----ELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFES----ILH-DDVLYP  216 (321)
T ss_pred             -----ccccccccCccccCHHHHc----CCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHH----HHc-CCCCCC
Confidence                 1122335899999999998    45788899999999999999999999976443322222    222 234456


Q ss_pred             CCCCHHHHHHHHHHhhcCcCCCC-------CHHHHhcCccccccCC
Q 019650          290 ETASPEFRRFVRSCLEKDWRKRG-------TVEELLAYPFVTKRSS  328 (337)
Q Consensus       290 ~~~~~~~~~li~~~l~~~p~~R~-------s~~eil~hp~f~~~~~  328 (337)
                      ..++..+.+++.+||..||++|+       +++++++||||.+..+
T Consensus       217 ~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~  262 (321)
T cd05591         217 VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDW  262 (321)
T ss_pred             CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCCCH
Confidence            66789999999999999999999       8999999999987644

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=3.9e-46  Score=332.94  Aligned_cols=263  Identities=30%  Similarity=0.481  Sum_probs=214.9

Q ss_pred             ccccccccccCcceEEEEEEEc---cCCceEEEEEeecCC---chHhHHHHHHHHHHHHhc-CCCCceeeeeeEEeeCCe
Q 019650           48 DLKKLTVLGHGNGGIVYKVRHQ---KSNSIYALKVLNTTS---STIIRHQAAHEAEILKRL-DSQFIVKCHAVFYTIEGE  120 (337)
Q Consensus        48 ~y~~~~~lg~g~~~~v~~~~~~---~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~  120 (337)
                      +|++++.||+|+||+||++.+.   .+++.||+|++....   .....+.+..|+.++.++ .|++|+++++.+.. +..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~-~~~   79 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQT-EAK   79 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEec-CCE
Confidence            5889999999999999998874   478899999986532   223345677899999999 58999999988765 688


Q ss_pred             EEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccc
Q 019650          121 ICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETR  200 (337)
Q Consensus       121 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~  200 (337)
                      .++||||+++|+|.+++.....+++..+..++.||+.||.|||++|++||||||+|||++.++.++|+|||++.......
T Consensus        80 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~  159 (332)
T cd05614          80 LHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE  159 (332)
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccC
Confidence            99999999999999999888889999999999999999999999999999999999999999999999999987543221


Q ss_pred             cCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHh
Q 019650          201 NNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAI  280 (337)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~  280 (337)
                      .             .......|++.|+|||.+...   ..++.++||||||+++|+|++|..||................
T Consensus       160 ~-------------~~~~~~~gt~~y~aPE~~~~~---~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~  223 (332)
T cd05614         160 K-------------ERTYSFCGTIEYMAPEIIRGK---GGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRI  223 (332)
T ss_pred             C-------------CccccccCCccccCHHHhcCC---CCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHH
Confidence            1             112234689999999999732   246789999999999999999999996543333222222222


Q ss_pred             hccCCCCCCCCCCHHHHHHHHHHhhcCcCCCC-----CHHHHhcCccccccCC
Q 019650          281 CFGERLEMPETASPEFRRFVRSCLEKDWRKRG-----TVEELLAYPFVTKRSS  328 (337)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~-----s~~eil~hp~f~~~~~  328 (337)
                       ....+.++..++..+.+++.+||+.||++||     +++++++||||++..+
T Consensus       224 -~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~  275 (332)
T cd05614         224 -LKCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDW  275 (332)
T ss_pred             -hcCCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence             2334556677899999999999999999999     8899999999987543

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=7.3e-46  Score=323.38  Aligned_cols=256  Identities=29%  Similarity=0.440  Sum_probs=209.9

Q ss_pred             cccCcceEEEEEEEccCCceEEEEEeecCCc--hHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEeccCCCC
Q 019650           55 LGHGNGGIVYKVRHQKSNSIYALKVLNTTSS--TIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGS  132 (337)
Q Consensus        55 lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~  132 (337)
                      ||.|+||+||++.+..+++.+|+|.+.....  ....+.+..|+.+++.++|++++++.+.+.. +...++||||+++++
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~-~~~~~lv~e~~~~g~   79 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQT-KTDLCLVMTIMNGGD   79 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcC-CCeEEEEEeCCCCCC
Confidence            6999999999999999999999999865432  1223556789999999999999999998766 678999999999999


Q ss_pred             chHHhh----hcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCCCCCC
Q 019650          133 LFDSLR----VRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNN  208 (337)
Q Consensus       133 L~~~l~----~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~  208 (337)
                      |.+++.    ....+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||.+.......        
T Consensus        80 L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~--------  151 (280)
T cd05608          80 LRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ--------  151 (280)
T ss_pred             HHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCC--------
Confidence            988774    33568999999999999999999999999999999999999999999999999987654322        


Q ss_pred             CCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhccCCCCC
Q 019650          209 NNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEM  288 (337)
Q Consensus       209 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  288 (337)
                            .......+++.|+|||.+.    +..++.++|+||||+++|+|++|+.||................ .......
T Consensus       152 ------~~~~~~~g~~~y~aPE~~~----~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~  220 (280)
T cd05608         152 ------SKTKGYAGTPGFMAPELLQ----GEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRI-LNDSVTY  220 (280)
T ss_pred             ------ccccccCCCcCccCHHHhc----CCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhh-cccCCCC
Confidence                  1112235889999999998    4578889999999999999999999997654433222222222 2234455


Q ss_pred             CCCCCHHHHHHHHHHhhcCcCCCC-----CHHHHhcCccccccCCCc
Q 019650          289 PETASPEFRRFVRSCLEKDWRKRG-----TVEELLAYPFVTKRSSSS  330 (337)
Q Consensus       289 ~~~~~~~~~~li~~~l~~~p~~R~-----s~~eil~hp~f~~~~~~~  330 (337)
                      +..++..+.+++.+||+.||++||     +++++++||||++..+..
T Consensus       221 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~~  267 (280)
T cd05608         221 PDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQ  267 (280)
T ss_pred             cccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCHhH
Confidence            667899999999999999999999     789999999999866554

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=4.2e-46  Score=333.57  Aligned_cols=267  Identities=25%  Similarity=0.347  Sum_probs=210.3

Q ss_pred             ccccccccccCcceEEEEEEEccCCceEEEEEeecCC-chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeC----CeEE
Q 019650           48 DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIE----GEIC  122 (337)
Q Consensus        48 ~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~----~~~~  122 (337)
                      +|++.+.||+|+||.||+|.+..++..||+|.+.... .......+.+|+.++++++|+||+++++++....    ..+|
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            5899999999999999999999999999999986432 2223456788999999999999999999876432    3589


Q ss_pred             EEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccC
Q 019650          123 FVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNN  202 (337)
Q Consensus       123 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~  202 (337)
                      +||||+. ++|.+++.....+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++.........
T Consensus        81 lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~  159 (338)
T cd07859          81 VVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT  159 (338)
T ss_pred             EEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccCc
Confidence            9999995 599999988888999999999999999999999999999999999999999999999999998754322111


Q ss_pred             CCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHH-----
Q 019650          203 NNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALI-----  277 (337)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~-----  277 (337)
                      .           ......++++.|+|||++...  ...++.++||||||+++|+|++|+.||.+...........     
T Consensus       160 ~-----------~~~~~~~~t~~y~aPE~~~~~--~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~  226 (338)
T cd07859         160 A-----------IFWTDYVATRWYRAPELCGSF--FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGT  226 (338)
T ss_pred             c-----------ccccCCCCCCCcCCHHHHhcc--ccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCC
Confidence            0           111234689999999998642  2467889999999999999999999996543221111000     


Q ss_pred             ------------------HHhhccCCC---CCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCC
Q 019650          278 ------------------CAICFGERL---EMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSS  328 (337)
Q Consensus       278 ------------------~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~  328 (337)
                                        .........   ...+..+..+.+++.+||+.||++|||++++++||||++...
T Consensus       227 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~  298 (338)
T cd07859         227 PSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK  298 (338)
T ss_pred             CCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence                              000000000   011345778999999999999999999999999999987654

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=4.8e-46  Score=330.91  Aligned_cols=253  Identities=30%  Similarity=0.456  Sum_probs=210.1

Q ss_pred             ccccccCcceEEEEEEEc---cCCceEEEEEeecCC---chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 019650           52 LTVLGHGNGGIVYKVRHQ---KSNSIYALKVLNTTS---STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVM  125 (337)
Q Consensus        52 ~~~lg~g~~~~v~~~~~~---~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~  125 (337)
                      ++.||+|+||.||++.+.   .+++.||+|++....   .......+.+|+.+++.++|+||+++++.+.. +...|+||
T Consensus         1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~-~~~~~lv~   79 (323)
T cd05584           1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQT-GGKLYLIL   79 (323)
T ss_pred             CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEec-CCeEEEEE
Confidence            368999999999999874   578899999987532   22234556789999999999999999998876 68899999


Q ss_pred             eccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCCC
Q 019650          126 EHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNH  205 (337)
Q Consensus       126 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~  205 (337)
                      ||+++++|.+++...+.+.+..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++.......     
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-----  154 (323)
T cd05584          80 EYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG-----  154 (323)
T ss_pred             eCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC-----
Confidence            999999999999888889999999999999999999999999999999999999999999999999876432211     


Q ss_pred             CCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhccCC
Q 019650          206 NNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGER  285 (337)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~  285 (337)
                               .......|++.|+|||++.    +..++.++||||||+++|+|++|..||........    ...... ..
T Consensus       155 ---------~~~~~~~gt~~y~aPE~~~----~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~----~~~~~~-~~  216 (323)
T cd05584         155 ---------TVTHTFCGTIEYMAPEILM----RSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKT----IDKILK-GK  216 (323)
T ss_pred             ---------CcccccCCCccccChhhcc----CCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHH----HHHHHc-CC
Confidence                     1112335899999999998    45678899999999999999999999976433222    222222 24


Q ss_pred             CCCCCCCCHHHHHHHHHHhhcCcCCCC-----CHHHHhcCccccccCC
Q 019650          286 LEMPETASPEFRRFVRSCLEKDWRKRG-----TVEELLAYPFVTKRSS  328 (337)
Q Consensus       286 ~~~~~~~~~~~~~li~~~l~~~p~~R~-----s~~eil~hp~f~~~~~  328 (337)
                      ...+..++..+.++|.+||+.+|++||     +++++++||||+...+
T Consensus       217 ~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~~  264 (323)
T cd05584         217 LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNW  264 (323)
T ss_pred             CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCCCH
Confidence            456677899999999999999999999     8999999999987644

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=4.3e-46  Score=331.48  Aligned_cols=255  Identities=31%  Similarity=0.436  Sum_probs=208.4

Q ss_pred             cccccccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHH---HhcCCCCceeeeeeEEeeCCeEEE
Q 019650           49 LKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEIL---KRLDSQFIVKCHAVFYTIEGEICF  123 (337)
Q Consensus        49 y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~---~~l~~~~i~~~~~~~~~~~~~~~l  123 (337)
                      |++++.||+|++|.||+|.+..+++.||+|+++...  .....+.+..|..++   +.++|+||+++++.+.. ....|+
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~-~~~~~l   79 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQT-EDHVCF   79 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEc-CCEEEE
Confidence            678999999999999999999999999999997542  122334455565544   56789999999998766 688999


Q ss_pred             EEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCC
Q 019650          124 VMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNN  203 (337)
Q Consensus       124 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~  203 (337)
                      ||||++|++|..++.. ..+++..+..++.||+.||.|||+.|++||||||+||+++.++.++|+|||++.......   
T Consensus        80 v~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~---  155 (324)
T cd05589          80 VMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG---  155 (324)
T ss_pred             EEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC---
Confidence            9999999999988864 569999999999999999999999999999999999999999999999999876432211   


Q ss_pred             CCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhcc
Q 019650          204 NHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFG  283 (337)
Q Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~  283 (337)
                                 .......|++.|+|||.+.    +..++.++|+||||+++|+|++|..||.+........    .... 
T Consensus       156 -----------~~~~~~~g~~~y~aPE~~~----~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~----~i~~-  215 (324)
T cd05589         156 -----------DRTSTFCGTPEFLAPEVLT----ETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFD----SIVN-  215 (324)
T ss_pred             -----------CcccccccCccccCHhHhc----CCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHH----HHHh-
Confidence                       1122346899999999998    4578889999999999999999999997643322222    2222 


Q ss_pred             CCCCCCCCCCHHHHHHHHHHhhcCcCCCC-----CHHHHhcCccccccCC
Q 019650          284 ERLEMPETASPEFRRFVRSCLEKDWRKRG-----TVEELLAYPFVTKRSS  328 (337)
Q Consensus       284 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~-----s~~eil~hp~f~~~~~  328 (337)
                      ....++..++..+.++|.+||..||++||     ++.++++||||++..+
T Consensus       216 ~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~  265 (324)
T cd05589         216 DEVRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINW  265 (324)
T ss_pred             CCCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCCH
Confidence            23446677899999999999999999999     7999999999988653

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.4e-47  Score=309.38  Aligned_cols=265  Identities=26%  Similarity=0.449  Sum_probs=222.4

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCceEEEEEeecCC-------chHhHHHHHHHHHHHHhc-CCCCceeeeeeEE
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-------STIIRHQAAHEAEILKRL-DSQFIVKCHAVFY  115 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~  115 (337)
                      .....|.-.+.||.|..++|-++.++.++..+|+|++....       .....+...+|+.+++++ .||+|+.+.+++.
T Consensus        14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye   93 (411)
T KOG0599|consen   14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE   93 (411)
T ss_pred             hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence            44678888999999999999999999999999999985532       223344456799999997 8999999999876


Q ss_pred             eeCCeEEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccc
Q 019650          116 TIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRI  195 (337)
Q Consensus       116 ~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~  195 (337)
                      + ...+++|+|.++.|.|+|++.+.-.++++..+.++.|++.+++|||..+||||||||+|||++++.+++|+|||+++.
T Consensus        94 s-~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~  172 (411)
T KOG0599|consen   94 S-DAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQ  172 (411)
T ss_pred             C-cchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeec
Confidence            5 788999999999999999999888999999999999999999999999999999999999999999999999999998


Q ss_pred             hhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccC--CCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhH
Q 019650          196 VEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERW--GGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDL  273 (337)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~  273 (337)
                      +.+.               +.....+|||+|+|||.+.=+-+  ...|+...|+|++|+|+|.|+.|.+||...... ..
T Consensus       173 l~~G---------------ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQm-lM  236 (411)
T KOG0599|consen  173 LEPG---------------EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQM-LM  236 (411)
T ss_pred             cCCc---------------hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHH-HH
Confidence            8765               55556689999999998743211  346888999999999999999999999653222 22


Q ss_pred             HHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccc
Q 019650          274 MALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTK  325 (337)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~  325 (337)
                      ...+.........+-+.++++..++||.+||..||.+|.|++|+|.||||.+
T Consensus       237 LR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q  288 (411)
T KOG0599|consen  237 LRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQ  288 (411)
T ss_pred             HHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHH
Confidence            2222233333344456788999999999999999999999999999999943

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=6e-46  Score=329.24  Aligned_cols=252  Identities=27%  Similarity=0.400  Sum_probs=206.9

Q ss_pred             cccccCcceEEEEEEEccCCceEEEEEeecCCc--hHhHHHHHHHHHHHHh-cCCCCceeeeeeEEeeCCeEEEEEeccC
Q 019650           53 TVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSS--TIIRHQAAHEAEILKR-LDSQFIVKCHAVFYTIEGEICFVMEHME  129 (337)
Q Consensus        53 ~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~-l~~~~i~~~~~~~~~~~~~~~lv~e~~~  129 (337)
                      +.||.|+||.||+|.+..++..||+|+++....  .........|..++.. .+|++|+++++.+.+ ...+|+||||+.
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-~~~~~lv~E~~~   79 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQT-KEHLFFVMEFLN   79 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEe-CCEEEEEECCCC
Confidence            469999999999999999999999999975421  1223445567777765 489999999998876 689999999999


Q ss_pred             CCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCCCCCCC
Q 019650          130 RGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNN  209 (337)
Q Consensus       130 ~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~  209 (337)
                      +++|.+++.....+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++.......         
T Consensus        80 ~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---------  150 (316)
T cd05620          80 GGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD---------  150 (316)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC---------
Confidence            99999999888889999999999999999999999999999999999999999999999999876432111         


Q ss_pred             CCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhccCCCCCC
Q 019650          210 NNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMP  289 (337)
Q Consensus       210 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  289 (337)
                           .......|++.|+|||++.    +..++.++|+||||+++|+|++|..||.......    ...... ...+.++
T Consensus       151 -----~~~~~~~gt~~y~aPE~~~----~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~----~~~~~~-~~~~~~~  216 (316)
T cd05620         151 -----NRASTFCGTPDYIAPEILQ----GLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE----LFESIR-VDTPHYP  216 (316)
T ss_pred             -----CceeccCCCcCccCHHHHc----CCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH----HHHHHH-hCCCCCC
Confidence                 1122345899999999998    4578899999999999999999999996543222    222222 2244556


Q ss_pred             CCCCHHHHHHHHHHhhcCcCCCCCH-HHHhcCccccccCC
Q 019650          290 ETASPEFRRFVRSCLEKDWRKRGTV-EELLAYPFVTKRSS  328 (337)
Q Consensus       290 ~~~~~~~~~li~~~l~~~p~~R~s~-~eil~hp~f~~~~~  328 (337)
                      ..++..+.+++.+||..||++|+++ +++++||||++..+
T Consensus       217 ~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~~~  256 (316)
T cd05620         217 RWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTINW  256 (316)
T ss_pred             CCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCCCH
Confidence            6789999999999999999999997 58999999988654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=4.5e-46  Score=338.65  Aligned_cols=275  Identities=26%  Similarity=0.375  Sum_probs=215.7

Q ss_pred             cccccccccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 019650           47 SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFV  124 (337)
Q Consensus        47 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv  124 (337)
                      +.|++++.||+|+||+||+|.+..+++.||+|++....  .......+.+|+.++++++|++|+++++.+.+ ...+|+|
T Consensus         1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~-~~~~~lv   79 (382)
T cd05625           1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQD-KDNLYFV   79 (382)
T ss_pred             CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEe-CCEEEEE
Confidence            36899999999999999999999999999999987532  22344567789999999999999999999876 6889999


Q ss_pred             EeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCC
Q 019650          125 MEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNN  204 (337)
Q Consensus       125 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~  204 (337)
                      |||+++|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+++++|+|||++...........
T Consensus        80 ~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~  159 (382)
T cd05625          80 MDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY  159 (382)
T ss_pred             EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccccc
Confidence            99999999999998888899999999999999999999999999999999999999999999999998753321000000


Q ss_pred             ------------CCC---------------------CCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHH
Q 019650          205 ------------HNN---------------------NNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLG  251 (337)
Q Consensus       205 ------------~~~---------------------~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG  251 (337)
                                  ...                     .............+||+.|+|||++.    +..++.++||||||
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~----~~~~~~~~DiwSlG  235 (382)
T cd05625         160 YQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLL----RTGYTQLCDWWSVG  235 (382)
T ss_pred             cccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhc----CCCCCCeeeEEech
Confidence                        000                     00000001122457899999999998    45788999999999


Q ss_pred             HHHHHHHhCCCCCCCCCCchhHHHHHHHhhccCCCCC--CCCCCHHHHHHHHHHhhcCcCCCCC---HHHHhcCcccccc
Q 019650          252 VVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEM--PETASPEFRRFVRSCLEKDWRKRGT---VEELLAYPFVTKR  326 (337)
Q Consensus       252 ~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~R~s---~~eil~hp~f~~~  326 (337)
                      |++|+|++|+.||.............   ........  ...+++.+.++|.+|+ .+|.+|++   ++++++||||++.
T Consensus       236 vil~elltG~~Pf~~~~~~~~~~~i~---~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~  311 (382)
T cd05625         236 VILYEMLVGQPPFLAQTPLETQMKVI---NWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTI  311 (382)
T ss_pred             HHHHHHHhCCCCCCCCCHHHHHHHHH---ccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCc
Confidence            99999999999997644332222221   11112222  2457899999999986 59999987   9999999999987


Q ss_pred             CCCc
Q 019650          327 SSSS  330 (337)
Q Consensus       327 ~~~~  330 (337)
                      .+.+
T Consensus       312 ~~~~  315 (382)
T cd05625         312 DFSS  315 (382)
T ss_pred             ChHH
Confidence            6554

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=7.1e-46  Score=329.90  Aligned_cols=257  Identities=26%  Similarity=0.380  Sum_probs=211.5

Q ss_pred             ccccccccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHHhc-CCCCceeeeeeEEeeCCeEEEE
Q 019650           48 DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRL-DSQFIVKCHAVFYTIEGEICFV  124 (337)
Q Consensus        48 ~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~~lv  124 (337)
                      +|.+.+.||+|+||.||+|.+..++..||+|++....  ..........|..++..+ .|++++.+++.+.+ ...+++|
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-~~~~~lv   79 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQT-MDRLYFV   79 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEec-CCEEEEE
Confidence            5889999999999999999999999999999987643  122334455677777777 46778888887765 6889999


Q ss_pred             EeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCC
Q 019650          125 MEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNN  204 (337)
Q Consensus       125 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~  204 (337)
                      |||+++|+|.+++...+.+++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||++.......    
T Consensus        80 ~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~----  155 (323)
T cd05616          80 MEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG----  155 (323)
T ss_pred             EcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC----
Confidence            9999999999999888889999999999999999999999999999999999999999999999999886432211    


Q ss_pred             CCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhccC
Q 019650          205 HNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGE  284 (337)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~  284 (337)
                                .......|++.|+|||++.    +..++.++|+||||+++|+|++|+.||.............     ..
T Consensus       156 ----------~~~~~~~gt~~y~aPE~~~----~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~-----~~  216 (323)
T cd05616         156 ----------VTTKTFCGTPDYIAPEIIA----YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM-----EH  216 (323)
T ss_pred             ----------CccccCCCChhhcCHHHhc----CCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHH-----hC
Confidence                      1122345899999999998    4578899999999999999999999997644332222221     22


Q ss_pred             CCCCCCCCCHHHHHHHHHHhhcCcCCCCC-----HHHHhcCccccccCC
Q 019650          285 RLEMPETASPEFRRFVRSCLEKDWRKRGT-----VEELLAYPFVTKRSS  328 (337)
Q Consensus       285 ~~~~~~~~~~~~~~li~~~l~~~p~~R~s-----~~eil~hp~f~~~~~  328 (337)
                      ...++...+..+.+++.+||+.+|.+|++     .+++++||||+...+
T Consensus       217 ~~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~  265 (323)
T cd05616         217 NVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDW  265 (323)
T ss_pred             CCCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCH
Confidence            44566778999999999999999999997     489999999987654

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=6.3e-46  Score=329.44  Aligned_cols=252  Identities=29%  Similarity=0.422  Sum_probs=209.6

Q ss_pred             cccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHHhc-CCCCceeeeeeEEeeCCeEEEEEeccC
Q 019650           53 TVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRL-DSQFIVKCHAVFYTIEGEICFVMEHME  129 (337)
Q Consensus        53 ~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~~lv~e~~~  129 (337)
                      +.||.|+||+||+|.+..++..||+|++....  .....+.+..|..++..+ +|+||+++++.+.. ...+|+||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~-~~~~~lv~e~~~   79 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQT-KDRLFFVMEYVN   79 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc-CCEEEEEEcCCC
Confidence            46999999999999999999999999997542  222345566788888877 79999999998766 678999999999


Q ss_pred             CCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCCCCCCC
Q 019650          130 RGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNN  209 (337)
Q Consensus       130 ~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~  209 (337)
                      |++|.+++.....+++..+..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++.......         
T Consensus        80 ~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~---------  150 (318)
T cd05570          80 GGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG---------  150 (318)
T ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCC---------
Confidence            99999999888889999999999999999999999999999999999999999999999999886422111         


Q ss_pred             CCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhccCCCCCC
Q 019650          210 NNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMP  289 (337)
Q Consensus       210 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  289 (337)
                           .......+++.|+|||.+.    +..++.++|+||||+++|+|++|+.||........    .... ......++
T Consensus       151 -----~~~~~~~g~~~y~aPE~~~----~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~----~~~i-~~~~~~~~  216 (318)
T cd05570         151 -----VTTSTFCGTPDYIAPEILS----YQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDEL----FQSI-LEDEVRYP  216 (318)
T ss_pred             -----CcccceecCccccCHHHhc----CCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHH----HHHH-HcCCCCCC
Confidence                 1112235899999999998    55788999999999999999999999965432221    1111 22344566


Q ss_pred             CCCCHHHHHHHHHHhhcCcCCCCCH-----HHHhcCccccccCC
Q 019650          290 ETASPEFRRFVRSCLEKDWRKRGTV-----EELLAYPFVTKRSS  328 (337)
Q Consensus       290 ~~~~~~~~~li~~~l~~~p~~R~s~-----~eil~hp~f~~~~~  328 (337)
                      ..++..+.++|.+||..||++|||+     .++++||||++..+
T Consensus       217 ~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~~  260 (318)
T cd05570         217 RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDW  260 (318)
T ss_pred             CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence            7789999999999999999999999     99999999988654

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=5.8e-46  Score=330.46  Aligned_cols=252  Identities=28%  Similarity=0.432  Sum_probs=205.6

Q ss_pred             cccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHH-HHHhcCCCCceeeeeeEEeeCCeEEEEEeccC
Q 019650           53 TVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAE-ILKRLDSQFIVKCHAVFYTIEGEICFVMEHME  129 (337)
Q Consensus        53 ~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~-~~~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~  129 (337)
                      +.||.|+||+||+|.+..+++.||+|++....  .......+..|.. +++.++|+||+++++.+.. ....++||||++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~-~~~~~lv~e~~~   79 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT-ADKLYFVLDYVN   79 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEe-CCEEEEEEcCCC
Confidence            46899999999999999999999999987542  1112233444444 5678999999999998766 688999999999


Q ss_pred             CCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCCCCCCC
Q 019650          130 RGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNN  209 (337)
Q Consensus       130 ~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~  209 (337)
                      +++|.+++.....+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++.......         
T Consensus        80 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~---------  150 (323)
T cd05575          80 GGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS---------  150 (323)
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC---------
Confidence            99999999888889999999999999999999999999999999999999999999999999886432211         


Q ss_pred             CCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhccCCCCCC
Q 019650          210 NNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMP  289 (337)
Q Consensus       210 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  289 (337)
                           .......|++.|+|||++.    +..++.++||||||+++|+|++|..||.......    ...... ......+
T Consensus       151 -----~~~~~~~gt~~y~aPE~~~----~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~----~~~~i~-~~~~~~~  216 (323)
T cd05575         151 -----KTTSTFCGTPEYLAPEVLR----KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE----MYDNIL-NKPLRLK  216 (323)
T ss_pred             -----CccccccCChhhcChhhhc----CCCCCccccccccchhhhhhhcCCCCCCCCCHHH----HHHHHH-cCCCCCC
Confidence                 1122335899999999998    4578899999999999999999999997543222    222222 2234556


Q ss_pred             CCCCHHHHHHHHHHhhcCcCCCCCH----HHHhcCccccccCC
Q 019650          290 ETASPEFRRFVRSCLEKDWRKRGTV----EELLAYPFVTKRSS  328 (337)
Q Consensus       290 ~~~~~~~~~li~~~l~~~p~~R~s~----~eil~hp~f~~~~~  328 (337)
                      +..+..+.++|.+||+.||.+||++    .++++||||.+..+
T Consensus       217 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~~  259 (323)
T cd05575         217 PNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINW  259 (323)
T ss_pred             CCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCCH
Confidence            6779999999999999999999987    69999999987554

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=8.4e-46  Score=328.29  Aligned_cols=252  Identities=29%  Similarity=0.433  Sum_probs=206.1

Q ss_pred             cccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHHh-cCCCCceeeeeeEEeeCCeEEEEEeccC
Q 019650           53 TVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKR-LDSQFIVKCHAVFYTIEGEICFVMEHME  129 (337)
Q Consensus        53 ~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~-l~~~~i~~~~~~~~~~~~~~~lv~e~~~  129 (337)
                      +.||.|+||.||+|.+..+++.||+|+++...  .....+....|..++.. ..|+||+++++.+.. +...++||||++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~-~~~~~lv~e~~~   79 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQT-KEHLFFVMEYLN   79 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEc-CCEEEEEEcCCC
Confidence            46999999999999999999999999987542  11223344456666654 489999999998766 688999999999


Q ss_pred             CCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCCCCCCC
Q 019650          130 RGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNN  209 (337)
Q Consensus       130 ~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~  209 (337)
                      |++|.+++.....+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++.......         
T Consensus        80 gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~---------  150 (316)
T cd05592          80 GGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE---------  150 (316)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC---------
Confidence            99999999888889999999999999999999999999999999999999999999999999987543211         


Q ss_pred             CCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhccCCCCCC
Q 019650          210 NNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMP  289 (337)
Q Consensus       210 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  289 (337)
                           .......|++.|+|||.+.    +..++.++|+||||+++|+|++|..||.+.....    ..... ....+.++
T Consensus       151 -----~~~~~~~gt~~y~aPE~~~----~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~----~~~~i-~~~~~~~~  216 (316)
T cd05592         151 -----GKASTFCGTPDYIAPEILK----GQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE----LFDSI-LNDRPHFP  216 (316)
T ss_pred             -----CccccccCCccccCHHHHc----CCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH----HHHHH-HcCCCCCC
Confidence                 1112335899999999998    4578899999999999999999999997643322    22222 22345566


Q ss_pred             CCCCHHHHHHHHHHhhcCcCCCCCH-HHHhcCccccccCC
Q 019650          290 ETASPEFRRFVRSCLEKDWRKRGTV-EELLAYPFVTKRSS  328 (337)
Q Consensus       290 ~~~~~~~~~li~~~l~~~p~~R~s~-~eil~hp~f~~~~~  328 (337)
                      ..++..+.+++.+||..||++||++ .++++||||.+..+
T Consensus       217 ~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~~~  256 (316)
T cd05592         217 RWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGIDW  256 (316)
T ss_pred             CCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCCCH
Confidence            7789999999999999999999986 58889999987653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=4.2e-46  Score=338.21  Aligned_cols=275  Identities=25%  Similarity=0.348  Sum_probs=214.1

Q ss_pred             cccccccccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 019650           47 SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFV  124 (337)
Q Consensus        47 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv  124 (337)
                      ++|++++.||.|+||+||+|.+..+++.||+|++....  .......+.+|+.++++++|++|+++++.+.+ +..+|+|
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~-~~~~~lv   79 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQD-KDNLYFV   79 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEc-CCEEEEE
Confidence            47999999999999999999999999999999986532  12234557789999999999999999998876 7899999


Q ss_pred             EeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCC-
Q 019650          125 MEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNN-  203 (337)
Q Consensus       125 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~-  203 (337)
                      |||+++|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++.......... 
T Consensus        80 ~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~  159 (376)
T cd05598          80 MDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY  159 (376)
T ss_pred             EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccccc
Confidence            9999999999999888889999999999999999999999999999999999999999999999999875321100000 


Q ss_pred             -------CC----CC-----------------CCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHH
Q 019650          204 -------NH----NN-----------------NNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVL  255 (337)
Q Consensus       204 -------~~----~~-----------------~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~  255 (337)
                             ..    ..                 .............+|++.|+|||++.    +..++.++|||||||++|
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~DiwSlGvily  235 (376)
T cd05598         160 YQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLL----RTGYTQLCDWWSVGVILY  235 (376)
T ss_pred             cccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHc----CCCCCcceeeeeccceee
Confidence                   00    00                 00000001112457999999999998    457889999999999999


Q ss_pred             HHHhCCCCCCCCCCchhHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCC---CHHHHhcCccccccCC
Q 019650          256 ECLVGHYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRG---TVEELLAYPFVTKRSS  328 (337)
Q Consensus       256 ~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~---s~~eil~hp~f~~~~~  328 (337)
                      +|++|+.||............. .............++..+.++|.+|+ .+|.+|+   ++.++++||||++...
T Consensus       236 ell~G~~Pf~~~~~~~~~~~i~-~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~~~  309 (376)
T cd05598         236 EMLVGQPPFLADTPAETQLKVI-NWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGIDF  309 (376)
T ss_pred             ehhhCCCCCCCCCHHHHHHHHh-ccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCCCH
Confidence            9999999997654332222221 11111112223457899999999976 5999999   9999999999998654

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1.3e-45  Score=326.28  Aligned_cols=267  Identities=24%  Similarity=0.354  Sum_probs=214.5

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEE
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICF  123 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~l  123 (337)
                      ...++|.+.+.||.|+||+||+|.+..++..+|+|.++..........+.+|+.++++++|+|++++++.+.. +...++
T Consensus         3 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~l   81 (309)
T cd07872           3 GKMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHT-DKSLTL   81 (309)
T ss_pred             CCCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEee-CCeEEE
Confidence            4568899999999999999999999999999999998765544444566789999999999999999998776 688999


Q ss_pred             EEeccCCCCchHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccC
Q 019650          124 VMEHMERGSLFDSLRVR-KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNN  202 (337)
Q Consensus       124 v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~  202 (337)
                      ||||+++ +|.+++... ..++...+..++.||+.||+|||+.|++||||||+||+++.++.++|+|||.+........ 
T Consensus        82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-  159 (309)
T cd07872          82 VFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK-  159 (309)
T ss_pred             EEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCcc-
Confidence            9999975 888888654 4589999999999999999999999999999999999999999999999999875432211 


Q ss_pred             CCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhc
Q 019650          203 NNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICF  282 (337)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~  282 (337)
                                   ......+++.|+|||.+..   ...++.++|+||||+++|+|++|+.||.+....+...........
T Consensus       160 -------------~~~~~~~~~~y~aPE~~~~---~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~  223 (309)
T cd07872         160 -------------TYSNEVVTLWYRPPDVLLG---SSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGT  223 (309)
T ss_pred             -------------ccccccccccccCCHHHhC---CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence                         1112247889999999863   235788999999999999999999999765443333322221100


Q ss_pred             c-----------------CCC--------CCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCC
Q 019650          283 G-----------------ERL--------EMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSS  329 (337)
Q Consensus       283 ~-----------------~~~--------~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~  329 (337)
                      .                 ..+        .....++..+.++|.+||..||.+|||++|+++||||++...+
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~  295 (309)
T cd07872         224 PTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLGTR  295 (309)
T ss_pred             CCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcccc
Confidence            0                 000        0113467889999999999999999999999999999986644

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.4e-46  Score=336.65  Aligned_cols=272  Identities=28%  Similarity=0.455  Sum_probs=212.5

Q ss_pred             cccccccccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 019650           47 SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFV  124 (337)
Q Consensus        47 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv  124 (337)
                      ++|++++.||.|+||+||++.+..+++.||+|++....  .....+.+.+|+.++++++|+||+++++.+.+ ....|+|
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~-~~~~~lv   79 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQD-AQYLYLI   79 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEc-CCeeEEE
Confidence            47999999999999999999999999999999986532  22344667789999999999999999998876 6789999


Q ss_pred             EeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCC-
Q 019650          125 MEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNN-  203 (337)
Q Consensus       125 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~-  203 (337)
                      |||++||+|.+++...+.+++..++.++.|++.||+|||+.||+||||||+||+++.++.++|+|||++.......... 
T Consensus        80 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  159 (377)
T cd05629          80 MEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAY  159 (377)
T ss_pred             EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccccccccccc
Confidence            9999999999999888889999999999999999999999999999999999999999999999999986432211000 


Q ss_pred             ------CCCCCC--------------------------CCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHH
Q 019650          204 ------NHNNNN--------------------------NNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLG  251 (337)
Q Consensus       204 ------~~~~~~--------------------------~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG  251 (337)
                            ......                          ...........+||+.|+|||++.    +..++.++||||||
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~DiwSlG  235 (377)
T cd05629         160 YQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFL----QQGYGQECDWWSLG  235 (377)
T ss_pred             ccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHc----cCCCCCceeeEecc
Confidence                  000000                          000000011346999999999997    45788999999999


Q ss_pred             HHHHHHHhCCCCCCCCCCchhHHHHHHHhhccCCCCCCC--CCCHHHHHHHHHHhhcCcCCC---CCHHHHhcCcccccc
Q 019650          252 VVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPE--TASPEFRRFVRSCLEKDWRKR---GTVEELLAYPFVTKR  326 (337)
Q Consensus       252 ~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~~p~~R---~s~~eil~hp~f~~~  326 (337)
                      |++|+|++|..||..............   ......++.  .++..+.++|.+||. +|.+|   +|+.+++.||||++.
T Consensus       236 vil~elltG~~Pf~~~~~~~~~~~i~~---~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~  311 (377)
T cd05629         236 AIMFECLIGWPPFCSENSHETYRKIIN---WRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGV  311 (377)
T ss_pred             hhhhhhhcCCCCCCCCCHHHHHHHHHc---cCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence            999999999999966433222222211   111222232  468899999999997 67665   599999999999875


Q ss_pred             C
Q 019650          327 S  327 (337)
Q Consensus       327 ~  327 (337)
                      .
T Consensus       312 ~  312 (377)
T cd05629         312 D  312 (377)
T ss_pred             C
Confidence            4

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-45  Score=320.61  Aligned_cols=260  Identities=28%  Similarity=0.397  Sum_probs=214.4

Q ss_pred             ccccccccccCcceEEEEEEEccCCceEEEEEeecCCc--hHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 019650           48 DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSS--TIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVM  125 (337)
Q Consensus        48 ~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~  125 (337)
                      .|++.+.||.|+||+||++.+..++..||+|++.....  ......+.+|+.+++.++|++|+++++.+.. +..+++||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~   79 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET-KDALCLVL   79 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecC-CCeEEEEE
Confidence            37889999999999999999998999999999875431  2223456689999999999999999998766 67899999


Q ss_pred             eccCCCCchHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCC
Q 019650          126 EHMERGSLFDSLRVR--KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNN  203 (337)
Q Consensus       126 e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~  203 (337)
                      ||+.+++|.+++...  ..+++..+..++.|++.||.|||+.|++|+||+|+||++++++.++|+|||++.......   
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~---  156 (285)
T cd05605          80 TLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE---  156 (285)
T ss_pred             eccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC---
Confidence            999999999888643  468999999999999999999999999999999999999999999999999987653221   


Q ss_pred             CCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhcc
Q 019650          204 NHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFG  283 (337)
Q Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~  283 (337)
                                  ......++..|+|||++.    +..++.++|+||+|+++|++++|..||.+............. ...
T Consensus       157 ------------~~~~~~~~~~y~aPE~~~----~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~-~~~  219 (285)
T cd05605         157 ------------TIRGRVGTVGYMAPEVVK----NERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERR-VKE  219 (285)
T ss_pred             ------------ccccccCCCCccCcHHhc----CCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHH-hhh
Confidence                        111235889999999997    457888999999999999999999999765433322222222 223


Q ss_pred             CCCCCCCCCCHHHHHHHHHHhhcCcCCCC-----CHHHHhcCccccccCC
Q 019650          284 ERLEMPETASPEFRRFVRSCLEKDWRKRG-----TVEELLAYPFVTKRSS  328 (337)
Q Consensus       284 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~-----s~~eil~hp~f~~~~~  328 (337)
                      ....++..++..+.+++.+||..||.+||     +++++++||||.+..+
T Consensus       220 ~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~  269 (285)
T cd05605         220 DQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANF  269 (285)
T ss_pred             cccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCH
Confidence            34455667899999999999999999999     8999999999998544

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-46  Score=326.03  Aligned_cols=265  Identities=25%  Similarity=0.417  Sum_probs=233.7

Q ss_pred             CccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCC-chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCe
Q 019650           42 DVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGE  120 (337)
Q Consensus        42 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~  120 (337)
                      +....+=|.+.+.||+|-|..|-++.+.-+|.+||+|++.+.. +......+.+|++.|+.+.||||++++++.-+ ...
T Consensus        13 DgkIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDT-QTK   91 (864)
T KOG4717|consen   13 DGKIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDT-QTK   91 (864)
T ss_pred             ccceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcc-cce
Confidence            3455678999999999999999999999999999999998765 45566778899999999999999999998655 789


Q ss_pred             EEEEEeccCCCCchHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCC-CcEEEeeccCccchhc
Q 019650          121 ICFVMEHMERGSLFDSLRVR-KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGK-GEVKIADFGVSRIVEE  198 (337)
Q Consensus       121 ~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~-~~~~l~Dfg~~~~~~~  198 (337)
                      +|+|+|+-++|+|++|+.++ ..+.++.+.+++.||+.|+.|+|+..+|||||||+|+++.+. |-+||+|||++....+
T Consensus        92 lyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P  171 (864)
T KOG4717|consen   92 LYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP  171 (864)
T ss_pred             EEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence            99999999999999999866 469999999999999999999999999999999999987554 8999999999876655


Q ss_pred             cccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHH
Q 019650          199 TRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALIC  278 (337)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~  278 (337)
                      .               ......+|...|.|||.+.++.|+   .+++||||||+|||.|.+|++||+..++.+.+.-++.
T Consensus       172 G---------------~kL~TsCGSLAYSAPEILLGDsYD---APAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImD  233 (864)
T KOG4717|consen  172 G---------------KKLTTSCGSLAYSAPEILLGDSYD---APAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMD  233 (864)
T ss_pred             c---------------chhhcccchhhccCchhhhcCccC---CcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhc
Confidence            4               455566899999999999976544   4589999999999999999999998877776666654


Q ss_pred             HhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCCc
Q 019650          279 AICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSS  330 (337)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~~  330 (337)
                      .     ....|..++.++++||..||..||.+|.|.++|.+|+|++..+.+.
T Consensus       234 C-----KYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~~  280 (864)
T KOG4717|consen  234 C-----KYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRGL  280 (864)
T ss_pred             c-----cccCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCCCc
Confidence            4     6778889999999999999999999999999999999999988654

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=2.1e-45  Score=327.28  Aligned_cols=258  Identities=25%  Similarity=0.436  Sum_probs=212.1

Q ss_pred             cccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHHhc-CCCCceeeeeeEEeeCCeEEEEEeccC
Q 019650           53 TVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRL-DSQFIVKCHAVFYTIEGEICFVMEHME  129 (337)
Q Consensus        53 ~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~~lv~e~~~  129 (337)
                      +.||+|+||+||+|.+..+++.||+|++....  .....+.+.+|..++.++ .|++|+.+++.+.. ...+|+||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~   79 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQT-TSRLFLVIEYVN   79 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEe-CCEEEEEEeCCC
Confidence            46999999999999999999999999997643  223445677888888888 68999999998766 688999999999


Q ss_pred             CCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCCCCCCC
Q 019650          130 RGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNN  209 (337)
Q Consensus       130 ~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~  209 (337)
                      +++|.+++...+.+++..++.++.||+.||+|||++|++||||||+||+++.++.++|+|||++.......         
T Consensus        80 ~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~---------  150 (327)
T cd05617          80 GGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG---------  150 (327)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCC---------
Confidence            99999999888889999999999999999999999999999999999999999999999999886432211         


Q ss_pred             CCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCch--hHHHHHHHhhccCCCC
Q 019650          210 NNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP--DLMALICAICFGERLE  287 (337)
Q Consensus       210 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~--~~~~~~~~~~~~~~~~  287 (337)
                           ......+|++.|+|||.+.    +..++.++|+||||+++|+|++|..||.......  ................
T Consensus       151 -----~~~~~~~gt~~y~aPE~~~----~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  221 (327)
T cd05617         151 -----DTTSTFCGTPNYIAPEILR----GEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIR  221 (327)
T ss_pred             -----CceecccCCcccCCHHHHC----CCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCC
Confidence                 1122346899999999998    4578899999999999999999999996432211  1112222222334556


Q ss_pred             CCCCCCHHHHHHHHHHhhcCcCCCCC------HHHHhcCccccccCCC
Q 019650          288 MPETASPEFRRFVRSCLEKDWRKRGT------VEELLAYPFVTKRSSS  329 (337)
Q Consensus       288 ~~~~~~~~~~~li~~~l~~~p~~R~s------~~eil~hp~f~~~~~~  329 (337)
                      .+...+..+.+++.+||+.||++|++      ++++++||||++..+.
T Consensus       222 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~~  269 (327)
T cd05617         222 IPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWD  269 (327)
T ss_pred             CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCHH
Confidence            67778999999999999999999987      5799999999987643

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=1.8e-45  Score=326.03  Aligned_cols=253  Identities=26%  Similarity=0.402  Sum_probs=207.4

Q ss_pred             cccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHHh-cCCCCceeeeeeEEeeCCeEEEEEeccC
Q 019650           53 TVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKR-LDSQFIVKCHAVFYTIEGEICFVMEHME  129 (337)
Q Consensus        53 ~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~-l~~~~i~~~~~~~~~~~~~~~lv~e~~~  129 (337)
                      +.||+|+||+||+|.+..++..||+|+++...  ..........|..++.. ++||||+++++.+.+ ...+++||||++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~-~~~~~lv~ey~~   79 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQT-KENLFFVMEYLN   79 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEe-CCEEEEEEeCCC
Confidence            46999999999999999999999999987642  11223445567777765 599999999998876 678999999999


Q ss_pred             CCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCCCCCCC
Q 019650          130 RGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNN  209 (337)
Q Consensus       130 ~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~  209 (337)
                      +|+|.+++.....+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++.......         
T Consensus        80 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~---------  150 (316)
T cd05619          80 GGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD---------  150 (316)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC---------
Confidence            99999999887889999999999999999999999999999999999999999999999999886432211         


Q ss_pred             CCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhccCCCCCC
Q 019650          210 NNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMP  289 (337)
Q Consensus       210 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  289 (337)
                           .......|++.|+|||++.    +..++.++|+||||+++|+|++|..||.......    ........ .+.++
T Consensus       151 -----~~~~~~~gt~~y~aPE~~~----~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~----~~~~i~~~-~~~~~  216 (316)
T cd05619         151 -----AKTCTFCGTPDYIAPEILL----GQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE----LFQSIRMD-NPCYP  216 (316)
T ss_pred             -----CceeeecCCccccCHHHHc----CCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH----HHHHHHhC-CCCCC
Confidence                 1112335899999999998    4578899999999999999999999997643222    22222222 34455


Q ss_pred             CCCCHHHHHHHHHHhhcCcCCCCCHH-HHhcCccccccCCC
Q 019650          290 ETASPEFRRFVRSCLEKDWRKRGTVE-ELLAYPFVTKRSSS  329 (337)
Q Consensus       290 ~~~~~~~~~li~~~l~~~p~~R~s~~-eil~hp~f~~~~~~  329 (337)
                      ...+..+.+++.+||..||++|+++. +++.||||+...+.
T Consensus       217 ~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~~~~  257 (316)
T cd05619         217 RWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREIDWS  257 (316)
T ss_pred             ccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCCCHH
Confidence            66789999999999999999999996 89999999987654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.4e-45  Score=333.21  Aligned_cols=266  Identities=29%  Similarity=0.428  Sum_probs=214.7

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeE
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEI  121 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~  121 (337)
                      ...++|++.+.||.|+||.||++.+..+++.+|+|++....  .......+.+|+.+++.++||||+++++.+.+ +...
T Consensus        40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~-~~~~  118 (370)
T cd05621          40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQD-DKYL  118 (370)
T ss_pred             CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc-CCEE
Confidence            45689999999999999999999999999999999986432  22234456789999999999999999998766 7889


Q ss_pred             EEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhcccc
Q 019650          122 CFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRN  201 (337)
Q Consensus       122 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~  201 (337)
                      |+||||++||+|.+++... .+++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||++........
T Consensus       119 ~lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~  197 (370)
T cd05621         119 YMVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGM  197 (370)
T ss_pred             EEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCCc
Confidence            9999999999999999754 589999999999999999999999999999999999999999999999999876543211


Q ss_pred             CCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhh
Q 019650          202 NNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAIC  281 (337)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~  281 (337)
                                   .......||+.|+|||++.....+..++.++|+||||+++|+|++|..||...........+..   
T Consensus       198 -------------~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~---  261 (370)
T cd05621         198 -------------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMD---  261 (370)
T ss_pred             -------------eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHh---
Confidence                         1112346899999999997543233478899999999999999999999976543333222221   


Q ss_pred             ccCCCCCCC--CCCHHHHHHHHHHhhcCcCC--CCCHHHHhcCccccccC
Q 019650          282 FGERLEMPE--TASPEFRRFVRSCLEKDWRK--RGTVEELLAYPFVTKRS  327 (337)
Q Consensus       282 ~~~~~~~~~--~~~~~~~~li~~~l~~~p~~--R~s~~eil~hp~f~~~~  327 (337)
                      ......++.  .++..+++++.+||..++.+  |++++++++||||++..
T Consensus       262 ~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~  311 (370)
T cd05621         262 HKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQ  311 (370)
T ss_pred             CCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCCC
Confidence            111223333  46889999999999855544  89999999999999754

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=4.2e-46  Score=332.43  Aligned_cols=265  Identities=26%  Similarity=0.400  Sum_probs=215.5

Q ss_pred             cccccccccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 019650           47 SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFV  124 (337)
Q Consensus        47 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv  124 (337)
                      ++|.+.+.||.|+||+||++.+..+++.||+|+++...  .....+.+..|+.+++.++|++|+++++.+.+ ....++|
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~-~~~~~lv   79 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQD-KDNLYLV   79 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEec-CCeEEEE
Confidence            47999999999999999999999999999999997643  22344567789999999999999999998766 6789999


Q ss_pred             EeccCCCCchHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCC
Q 019650          125 MEHMERGSLFDSLRVR-KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNN  203 (337)
Q Consensus       125 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~  203 (337)
                      |||+++++|.+++... ..+++..+..++.|++.||.|||+.|++||||||+||+++.+++++|+|||++......... 
T Consensus        80 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~-  158 (330)
T cd05601          80 MEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV-  158 (330)
T ss_pred             ECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCce-
Confidence            9999999999999876 67999999999999999999999999999999999999999999999999998765432211 


Q ss_pred             CCCCCCCCccccccccccCCCCCcCCcccccccC--CCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhh
Q 019650          204 NHNNNNNNNIGEAAIACMGTCAYMSPERVDSERW--GGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAIC  281 (337)
Q Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~  281 (337)
                                  ......+++.|+|||++.....  +..++.++||||||+++|+|++|..||...........+...  
T Consensus       159 ------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~--  224 (330)
T cd05601         159 ------------NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNF--  224 (330)
T ss_pred             ------------eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcC--
Confidence                        1112358999999999863211  235778999999999999999999999654333322222211  


Q ss_pred             ccCCCCC--CCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCC
Q 019650          282 FGERLEM--PETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSS  329 (337)
Q Consensus       282 ~~~~~~~--~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~  329 (337)
                       .....+  ...++..+.+++.+||. +|.+|||+++++.||||++..+.
T Consensus       225 -~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~~~  272 (330)
T cd05601         225 -QRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKIDWN  272 (330)
T ss_pred             -CCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCCHH
Confidence             111222  23568999999999997 99999999999999999986544

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=3.2e-45  Score=320.94  Aligned_cols=257  Identities=24%  Similarity=0.398  Sum_probs=201.7

Q ss_pred             cccccccccccCcceEEEEEEEcc-CCceEEEEEeecCCch-HhHHHHHHHHHHHHhc---CCCCceeeeeeEEe----e
Q 019650           47 SDLKKLTVLGHGNGGIVYKVRHQK-SNSIYALKVLNTTSST-IIRHQAAHEAEILKRL---DSQFIVKCHAVFYT----I  117 (337)
Q Consensus        47 ~~y~~~~~lg~g~~~~v~~~~~~~-~~~~vaiK~~~~~~~~-~~~~~~~~e~~~~~~l---~~~~i~~~~~~~~~----~  117 (337)
                      ++|++.+.||+|+||+||+|.+.. ++..||+|.+...... .....+.+|+.+++.+   +||||+++++++..    .
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            479999999999999999999854 5688999998754322 1223445566666655   79999999998753    2


Q ss_pred             CCeEEEEEeccCCCCchHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccc
Q 019650          118 EGEICFVMEHMERGSLFDSLRVR--KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRI  195 (337)
Q Consensus       118 ~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~  195 (337)
                      ...+++|||++++ +|.+++...  ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||.+..
T Consensus        81 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~  159 (290)
T cd07862          81 ETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI  159 (290)
T ss_pred             CCcEEEEEccCCC-CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEe
Confidence            3568999999974 999998753  4589999999999999999999999999999999999999999999999999876


Q ss_pred             hhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHH
Q 019650          196 VEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMA  275 (337)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~  275 (337)
                      .....               ......+++.|+|||.+.    +..++.++|+||||+++|+|++|..||.+.........
T Consensus       160 ~~~~~---------------~~~~~~~~~~y~aPE~~~----~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~  220 (290)
T cd07862         160 YSFQM---------------ALTSVVVTLWYRAPEVLL----QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGK  220 (290)
T ss_pred             ccCCc---------------ccccccccccccChHHHh----CCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHH
Confidence            53321               112235899999999997    45788899999999999999999999977554444333


Q ss_pred             HHHHhhccCCC----------------------CCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccc
Q 019650          276 LICAICFGERL----------------------EMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV  323 (337)
Q Consensus       276 ~~~~~~~~~~~----------------------~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f  323 (337)
                      ...........                      ...+..+..+.+++.+||+.||++|||+.++|+||||
T Consensus       221 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         221 ILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             HHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence            33221100000                      0123467889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.1e-46  Score=328.39  Aligned_cols=259  Identities=28%  Similarity=0.433  Sum_probs=227.7

Q ss_pred             CccccccccccccCcceEEEEEEEccCCceEEEEEeecCC-chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEE
Q 019650           45 NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICF  123 (337)
Q Consensus        45 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~l  123 (337)
                      ..++|..++.+|.|+||.++++.++..++.+|+|.+.... .........+|..+++++.||||+.+.+.|.+.+..++|
T Consensus         2 ~m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~I   81 (426)
T KOG0589|consen    2 EMDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCI   81 (426)
T ss_pred             ccchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEE
Confidence            3678999999999999999999999999999999997764 333445678899999999999999999999986556999


Q ss_pred             EEeccCCCCchHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhcccc
Q 019650          124 VMEHMERGSLFDSLRVR--KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRN  201 (337)
Q Consensus       124 v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~  201 (337)
                      ||+||+||+|.+.+...  ..++++.+..|+.|++.|+.|||+..|+|||||++|||+++++.++|+|||++..+.... 
T Consensus        82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~-  160 (426)
T KOG0589|consen   82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED-  160 (426)
T ss_pred             EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCch-
Confidence            99999999999999754  468999999999999999999999999999999999999999999999999999987654 


Q ss_pred             CCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhh
Q 019650          202 NNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAIC  281 (337)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~  281 (337)
                                   ......+||+.|+.||.+.    +.+|+.++|||||||++|||++-+++|.+.    +...+..++.
T Consensus       161 -------------~~a~tvvGTp~YmcPEil~----d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~----~m~~Li~ki~  219 (426)
T KOG0589|consen  161 -------------SLASTVVGTPYYMCPEILS----DIPYNEKSDIWSLGCCLYEMCTLKPAFKAS----NMSELILKIN  219 (426)
T ss_pred             -------------hhhheecCCCcccCHHHhC----CCCCCccCcchhhcchHHHHHhcccccCcc----chHHHHHHHh
Confidence                         1333557999999999999    779999999999999999999999999654    3444455555


Q ss_pred             ccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccc
Q 019650          282 FGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTK  325 (337)
Q Consensus       282 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~  325 (337)
                      .......+...+..++.+|..||..+|..||++.++|.+|....
T Consensus       220 ~~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~  263 (426)
T KOG0589|consen  220 RGLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLLR  263 (426)
T ss_pred             hccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhhh
Confidence            55566778889999999999999999999999999999987763

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=7.3e-46  Score=334.65  Aligned_cols=274  Identities=27%  Similarity=0.423  Sum_probs=216.0

Q ss_pred             cccccccccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 019650           47 SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFV  124 (337)
Q Consensus        47 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv  124 (337)
                      ++|++.+.||.|+||+||++.+..+++.||+|++....  .......+..|..++.+++|++++++++.+.+ ...+|+|
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~-~~~~~lv   79 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQD-KRNLYLI   79 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc-CCEEEEE
Confidence            47899999999999999999999999999999987532  22344567789999999999999999998766 6889999


Q ss_pred             EeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCC
Q 019650          125 MEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNN  204 (337)
Q Consensus       125 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~  204 (337)
                      |||++||+|.+++...+.+++..++.++.|++.||.|||+.|++||||||+||+++.+++++|+|||++...........
T Consensus        80 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~  159 (360)
T cd05627          80 MEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEF  159 (360)
T ss_pred             EeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccccccccccc
Confidence            99999999999998888899999999999999999999999999999999999999999999999999875532111000


Q ss_pred             C--------------CCC-------CCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCC
Q 019650          205 H--------------NNN-------NNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYP  263 (337)
Q Consensus       205 ~--------------~~~-------~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~p  263 (337)
                      .              ...       ............+||+.|+|||++.    +..++.++|+|||||++|+|++|..|
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~----~~~~~~~~DiwSlGvilyel~tG~~P  235 (360)
T cd05627         160 YRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFM----QTGYNKLCDWWSLGVIMYEMLIGYPP  235 (360)
T ss_pred             ccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHc----CCCCCCcceeccccceeeecccCCCC
Confidence            0              000       0000001122457999999999998    45788999999999999999999999


Q ss_pred             CCCCCCchhHHHHHHHhhccCCCCCCC--CCCHHHHHHHHHHhhcCcCCCC---CHHHHhcCccccccCCC
Q 019650          264 LIGFGEKPDLMALICAICFGERLEMPE--TASPEFRRFVRSCLEKDWRKRG---TVEELLAYPFVTKRSSS  329 (337)
Q Consensus       264 f~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~~p~~R~---s~~eil~hp~f~~~~~~  329 (337)
                      |...........+..   ......++.  .++..++++|.+|+ .||.+|+   +++++++||||++..+.
T Consensus       236 f~~~~~~~~~~~i~~---~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~~~~  302 (360)
T cd05627         236 FCSETPQETYRKVMN---WKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPFFEGVDWG  302 (360)
T ss_pred             CCCCCHHHHHHHHHc---CCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCCCCCCCCHH
Confidence            976543332222221   111222222  36889999999987 5999998   58999999999987654

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=2e-45  Score=326.84  Aligned_cols=257  Identities=26%  Similarity=0.384  Sum_probs=210.8

Q ss_pred             ccccccccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHHhcCC-CCceeeeeeEEeeCCeEEEE
Q 019650           48 DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDS-QFIVKCHAVFYTIEGEICFV  124 (337)
Q Consensus        48 ~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~~-~~i~~~~~~~~~~~~~~~lv  124 (337)
                      +|...+.||.|+||+||+|.+..+++.||+|++....  .....+.+..|..++..+.| ++++++++.+.+ ...+|+|
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-~~~~~lv   79 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQT-VDRLYFV   79 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEec-CCEEEEE
Confidence            4778899999999999999999999999999987542  22234456678888888865 566677776655 6789999


Q ss_pred             EeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCC
Q 019650          125 MEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNN  204 (337)
Q Consensus       125 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~  204 (337)
                      |||++|++|.+++...+.+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.......    
T Consensus        80 ~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~----  155 (323)
T cd05615          80 MEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG----  155 (323)
T ss_pred             EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCC----
Confidence            9999999999999888889999999999999999999999999999999999999999999999999886532211    


Q ss_pred             CCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhccC
Q 019650          205 HNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGE  284 (337)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~  284 (337)
                                .......|++.|+|||++.    +..++.++|+||||+++|+|++|..||............    . ..
T Consensus       156 ----------~~~~~~~gt~~y~aPE~~~----~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i----~-~~  216 (323)
T cd05615         156 ----------VTTRTFCGTPDYIAPEIIA----YQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSI----M-EH  216 (323)
T ss_pred             ----------ccccCccCCccccCHHHHc----CCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH----H-hC
Confidence                      1112335899999999998    456889999999999999999999999764332222222    1 12


Q ss_pred             CCCCCCCCCHHHHHHHHHHhhcCcCCCCC-----HHHHhcCccccccCC
Q 019650          285 RLEMPETASPEFRRFVRSCLEKDWRKRGT-----VEELLAYPFVTKRSS  328 (337)
Q Consensus       285 ~~~~~~~~~~~~~~li~~~l~~~p~~R~s-----~~eil~hp~f~~~~~  328 (337)
                      ...++...+..+.+++.+||..+|.+|++     .+++++||||++..+
T Consensus       217 ~~~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~  265 (323)
T cd05615         217 NVSYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDW  265 (323)
T ss_pred             CCCCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCCH
Confidence            34566778999999999999999999997     579999999998764

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.3e-45  Score=331.17  Aligned_cols=256  Identities=24%  Similarity=0.341  Sum_probs=205.0

Q ss_pred             ccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 019650           46 ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVM  125 (337)
Q Consensus        46 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~  125 (337)
                      .++|++++.||.|+||.||+|.+..+++.||+|...       ...+.+|+.++++++|+||+++++.+.. ....++++
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-------~~~~~~E~~il~~l~HpnIv~~~~~~~~-~~~~~lv~  162 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-------RGGTATEAHILRAINHPSIIQLKGTFTY-NKFTCLIL  162 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-------hhhhHHHHHHHHhCCCCCCCCEeEEEEE-CCeeEEEE
Confidence            468999999999999999999999999999999643       2345789999999999999999998866 68899999


Q ss_pred             eccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCCC
Q 019650          126 EHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNH  205 (337)
Q Consensus       126 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~  205 (337)
                      |++. ++|..++.....+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++........    
T Consensus       163 e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~----  237 (391)
T PHA03212        163 PRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA----  237 (391)
T ss_pred             ecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccc----
Confidence            9995 58999998888899999999999999999999999999999999999999999999999999865432111    


Q ss_pred             CCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCc------hhHHHHHHH
Q 019650          206 NNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEK------PDLMALICA  279 (337)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~------~~~~~~~~~  279 (337)
                               .......||+.|+|||++.    +..++.++||||||+++|+|++|..||......      ......+..
T Consensus       238 ---------~~~~~~~gt~~y~aPE~~~----~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~  304 (391)
T PHA03212        238 ---------NKYYGWAGTIATNAPELLA----RDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIR  304 (391)
T ss_pred             ---------cccccccCccCCCChhhhc----CCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHH
Confidence                     1112346899999999998    457889999999999999999999887542210      000000000


Q ss_pred             hhc-----------------------cCC--C-CC-----CCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccC
Q 019650          280 ICF-----------------------GER--L-EM-----PETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRS  327 (337)
Q Consensus       280 ~~~-----------------------~~~--~-~~-----~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~  327 (337)
                      ...                       ...  + ..     ....+..+.++|.+||..||.+|||++|+|+||||+...
T Consensus       305 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~  383 (391)
T PHA03212        305 RSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIP  383 (391)
T ss_pred             HhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCC
Confidence            000                       000  0 00     012456799999999999999999999999999998854

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=5e-45  Score=326.59  Aligned_cols=258  Identities=25%  Similarity=0.388  Sum_probs=209.3

Q ss_pred             ccCccccccccccccCcceEEEEEEEc-----cCCceEEEEEeecCCchHhHHHHHHHHHHHHhc-CCCCceeeeeeEEe
Q 019650           43 VENISDLKKLTVLGHGNGGIVYKVRHQ-----KSNSIYALKVLNTTSSTIIRHQAAHEAEILKRL-DSQFIVKCHAVFYT  116 (337)
Q Consensus        43 ~~~~~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~  116 (337)
                      ....++|.+.+.||.|+||.||+|.+.     .++..||+|++...........+.+|+.++.++ +|+||+++++.+..
T Consensus         3 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~   82 (338)
T cd05102           3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTK   82 (338)
T ss_pred             ccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecC
Confidence            445689999999999999999999752     345679999987654444556788999999999 89999999998876


Q ss_pred             eCCeEEEEEeccCCCCchHHhhhc--------------------------------------------------------
Q 019650          117 IEGEICFVMEHMERGSLFDSLRVR--------------------------------------------------------  140 (337)
Q Consensus       117 ~~~~~~lv~e~~~~~~L~~~l~~~--------------------------------------------------------  140 (337)
                      .+..++++|||+++|+|.+++...                                                        
T Consensus        83 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (338)
T cd05102          83 PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQE  162 (338)
T ss_pred             CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchh
Confidence            566789999999999999998642                                                        


Q ss_pred             ------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCCCCCCCCCccc
Q 019650          141 ------KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIG  214 (337)
Q Consensus       141 ------~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~  214 (337)
                            ..+++..+..++.||+.||+|||+.||+||||||+||+++.++.++|+|||++.........            
T Consensus       163 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~------------  230 (338)
T cd05102         163 TDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY------------  230 (338)
T ss_pred             ccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcch------------
Confidence                  23778889999999999999999999999999999999999999999999998765332111            


Q ss_pred             cccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHhhccCCCCCCCCCC
Q 019650          215 EAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICAICFGERLEMPETAS  293 (337)
Q Consensus       215 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (337)
                      .......++..|+|||++.    +..++.++||||||+++|+|++ |..||...........   ....+.....+...+
T Consensus       231 ~~~~~~~~~~~y~aPE~~~----~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~---~~~~~~~~~~~~~~~  303 (338)
T cd05102         231 VRKGSARLPLKWMAPESIF----DKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQ---RLKDGTRMRAPENAT  303 (338)
T ss_pred             hcccCCCCCccccCcHHhh----cCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHH---HHhcCCCCCCCCCCC
Confidence            0111223567899999997    4578899999999999999997 9999976544333222   223344455567788


Q ss_pred             HHHHHHHHHHhhcCcCCCCCHHHHhc
Q 019650          294 PEFRRFVRSCLEKDWRKRGTVEELLA  319 (337)
Q Consensus       294 ~~~~~li~~~l~~~p~~R~s~~eil~  319 (337)
                      ..+.+++.+||+.||.+|||+.++++
T Consensus       304 ~~l~~li~~cl~~dp~~RPs~~el~~  329 (338)
T cd05102         304 PEIYRIMLACWQGDPKERPTFSALVE  329 (338)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHH
Confidence            99999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=7.1e-45  Score=328.16  Aligned_cols=262  Identities=26%  Similarity=0.359  Sum_probs=207.9

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCceEEEEEeecCC-chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeC----
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIE----  118 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~----  118 (337)
                      ...++|++.+.||.|+||.||++.+..++..||+|.+.... .......+.+|+.+++.++|+||+++++++....    
T Consensus        18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   97 (359)
T cd07876          18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE   97 (359)
T ss_pred             hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence            45789999999999999999999999999999999986543 3334566778999999999999999999876432    


Q ss_pred             -CeEEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchh
Q 019650          119 -GEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVE  197 (337)
Q Consensus       119 -~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~  197 (337)
                       ..+|+||||+++ +|.+.+.  ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++....
T Consensus        98 ~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~  174 (359)
T cd07876          98 FQDVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAC  174 (359)
T ss_pred             cceeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccccc
Confidence             357999999976 6777664  458899999999999999999999999999999999999999999999999986543


Q ss_pred             ccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHH
Q 019650          198 ETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALI  277 (337)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~  277 (337)
                      ...               ......+++.|+|||.+.    +..++.++||||||+++|+|++|..||.+.+.........
T Consensus       175 ~~~---------------~~~~~~~t~~y~aPE~~~----~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~  235 (359)
T cd07876         175 TNF---------------MMTPYVVTRYYRAPEVIL----GMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVI  235 (359)
T ss_pred             cCc---------------cCCCCcccCCCCCchhcc----CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            221               112235789999999998    5578889999999999999999999997654322221111


Q ss_pred             HHhh-----------------ccCCC--------------------CCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          278 CAIC-----------------FGERL--------------------EMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       278 ~~~~-----------------~~~~~--------------------~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                      ....                 ....+                    ......++.+++||.+||..||++|||+.|+|.|
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  315 (359)
T cd07876         236 EQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH  315 (359)
T ss_pred             HhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence            1100                 00000                    0111235789999999999999999999999999


Q ss_pred             ccccccC
Q 019650          321 PFVTKRS  327 (337)
Q Consensus       321 p~f~~~~  327 (337)
                      |||+...
T Consensus       316 p~~~~~~  322 (359)
T cd07876         316 PYITVWY  322 (359)
T ss_pred             chhhhhc
Confidence            9998644

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=6.8e-46  Score=329.37  Aligned_cols=253  Identities=32%  Similarity=0.532  Sum_probs=209.2

Q ss_pred             ccccccCcceEEEEEEEc---cCCceEEEEEeecCCc-hHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEec
Q 019650           52 LTVLGHGNGGIVYKVRHQ---KSNSIYALKVLNTTSS-TIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEH  127 (337)
Q Consensus        52 ~~~lg~g~~~~v~~~~~~---~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~e~  127 (337)
                      ++.||+|+||.||++.+.   .+++.+|+|++..... ......+.+|+.++++++|+||+++++.+.+ ....|+||||
T Consensus         1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~   79 (318)
T cd05582           1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQT-EGKLYLILDF   79 (318)
T ss_pred             CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEc-CCEEEEEEcC
Confidence            367999999999998863   5789999999975431 1233456679999999999999999998876 6889999999


Q ss_pred             cCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCCCCC
Q 019650          128 MERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNN  207 (337)
Q Consensus       128 ~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~  207 (337)
                      +++++|.+++.....+++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||++.......       
T Consensus        80 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-------  152 (318)
T cd05582          80 LRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-------  152 (318)
T ss_pred             CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-------
Confidence            9999999999888889999999999999999999999999999999999999999999999999887543221       


Q ss_pred             CCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhccCCCC
Q 019650          208 NNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLE  287 (337)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~  287 (337)
                             .......|++.|+|||.+.    +..++.++|+||||+++|+|++|+.||............    . .....
T Consensus       153 -------~~~~~~~g~~~y~aPE~~~----~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i----~-~~~~~  216 (318)
T cd05582         153 -------KKAYSFCGTVEYMAPEVVN----RRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMI----L-KAKLG  216 (318)
T ss_pred             -------CceecccCChhhcCHHHHc----CCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHH----H-cCCCC
Confidence                   1122345899999999998    456788999999999999999999999754332222211    1 22345


Q ss_pred             CCCCCCHHHHHHHHHHhhcCcCCCCC-----HHHHhcCccccccCC
Q 019650          288 MPETASPEFRRFVRSCLEKDWRKRGT-----VEELLAYPFVTKRSS  328 (337)
Q Consensus       288 ~~~~~~~~~~~li~~~l~~~p~~R~s-----~~eil~hp~f~~~~~  328 (337)
                      ++..++..+.+++.+||+.||.+||+     ++++++||||++..+
T Consensus       217 ~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~~  262 (318)
T cd05582         217 MPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDW  262 (318)
T ss_pred             CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCCCH
Confidence            66778999999999999999999999     788999999987543

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=1.2e-44  Score=315.17  Aligned_cols=254  Identities=24%  Similarity=0.348  Sum_probs=204.0

Q ss_pred             cccCcceEEEEEEEccCCceEEEEEeecCCc--hHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEeccCCCC
Q 019650           55 LGHGNGGIVYKVRHQKSNSIYALKVLNTTSS--TIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGS  132 (337)
Q Consensus        55 lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~  132 (337)
                      ||.|+||+||++.+..+++.||+|.+.....  .........|+.++++++|+||+++++.+.. +...++||||++|++
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~-~~~~~lv~e~~~g~~   79 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFES-KTHLCLVMSLMNGGD   79 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEec-CCeEEEEEecCCCCC
Confidence            7999999999999999999999999864321  1123344569999999999999999998765 688999999999999


Q ss_pred             chHHhhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCCCCCCCC
Q 019650          133 LFDSLRVRK--KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNN  210 (337)
Q Consensus       133 L~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~  210 (337)
                      |.+++....  .+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++.......          
T Consensus        80 L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~----------  149 (277)
T cd05607          80 LKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK----------  149 (277)
T ss_pred             HHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc----------
Confidence            998886443  58899999999999999999999999999999999999999999999999987654321          


Q ss_pred             CccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhccCCCCCCC
Q 019650          211 NNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPE  290 (337)
Q Consensus       211 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (337)
                           ......++..|+|||++.    +..++.++|+||||+++|+|++|..||..........................
T Consensus       150 -----~~~~~~~~~~y~aPE~~~----~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  220 (277)
T cd05607         150 -----TITQRAGTNGYMAPEILK----EEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQ  220 (277)
T ss_pred             -----eeeccCCCCCccCHHHHc----cCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccc
Confidence                 111224889999999998    45688999999999999999999999976443322222222222222111224


Q ss_pred             CCCHHHHHHHHHHhhcCcCCCCCH----HHHhcCccccccCC
Q 019650          291 TASPEFRRFVRSCLEKDWRKRGTV----EELLAYPFVTKRSS  328 (337)
Q Consensus       291 ~~~~~~~~li~~~l~~~p~~R~s~----~eil~hp~f~~~~~  328 (337)
                      .++..+.+++.+||+.||.+||++    ++++.||||++..+
T Consensus       221 ~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~~  262 (277)
T cd05607         221 NFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINF  262 (277)
T ss_pred             cCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCCCH
Confidence            578999999999999999999999    67889999988653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-44  Score=311.09  Aligned_cols=258  Identities=29%  Similarity=0.460  Sum_probs=215.0

Q ss_pred             cccccccccccCcceEEEEEEEccCCceEEEEEeecCCc----hHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEE
Q 019650           47 SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSS----TIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEIC  122 (337)
Q Consensus        47 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~  122 (337)
                      +.|.+.+.||.|++|.||.|.+..++..+++|.+.....    ....+.+.+|+.++++++|+||+++++.+.+ +...+
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~   80 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRD-DETLS   80 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEcc-CCeEE
Confidence            569999999999999999999999999999999865432    1233567889999999999999999998876 67999


Q ss_pred             EEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccC
Q 019650          123 FVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNN  202 (337)
Q Consensus       123 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~  202 (337)
                      +++||+++++|.+++...+.+++..+..++.|++.||.+||+.|++|+||+|+||+++.+++++|+|||.+.........
T Consensus        81 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~  160 (263)
T cd06625          81 IFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSS  160 (263)
T ss_pred             EEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccccccc
Confidence            99999999999999988888999999999999999999999999999999999999999999999999998765332111


Q ss_pred             CCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhc
Q 019650          203 NNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICF  282 (337)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~  282 (337)
                      .           .......++..|+|||.+.    +..++.++|+||||+++|++++|+.||.........   ......
T Consensus       161 ~-----------~~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~---~~~~~~  222 (263)
T cd06625         161 G-----------TGMKSVTGTPYWMSPEVIS----GEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAI---FKIATQ  222 (263)
T ss_pred             c-----------ccccCCCcCccccCcceec----cCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHH---HHHhcc
Confidence            0           0001234778999999998    456889999999999999999999999654332222   222223


Q ss_pred             cCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccc
Q 019650          283 GERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV  323 (337)
Q Consensus       283 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f  323 (337)
                      ......+...+..+.+++.+||..+|.+|||++++++||||
T Consensus       223 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         223 PTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             CCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence            33455667789999999999999999999999999999998

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=3.1e-45  Score=331.16  Aligned_cols=269  Identities=26%  Similarity=0.372  Sum_probs=215.0

Q ss_pred             CccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCC
Q 019650           42 DVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEG  119 (337)
Q Consensus        42 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~  119 (337)
                      .....++|++.+.||.|+||.||+|.+..+++.+|+|++....  .......+.+|..+++.++|+||+++++.+.+ +.
T Consensus        38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~-~~  116 (371)
T cd05622          38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD-DR  116 (371)
T ss_pred             cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc-CC
Confidence            3455689999999999999999999999999999999986432  22234456789999999999999999998866 78


Q ss_pred             eEEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhcc
Q 019650          120 EICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEET  199 (337)
Q Consensus       120 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~  199 (337)
                      ..++||||++||+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||+++.+++++|+|||++......
T Consensus       117 ~~~lv~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~  195 (371)
T cd05622         117 YLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE  195 (371)
T ss_pred             EEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcC
Confidence            89999999999999999875 45899999999999999999999999999999999999999999999999998765432


Q ss_pred             ccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHH
Q 019650          200 RNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICA  279 (337)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~  279 (337)
                      ..             ......+||+.|+|||++.....+..++.++||||||+++|+|++|..||...........+.. 
T Consensus       196 ~~-------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~-  261 (371)
T cd05622         196 GM-------------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMN-  261 (371)
T ss_pred             Cc-------------ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHc-
Confidence            11             1112346899999999997543233478899999999999999999999976433222222221 


Q ss_pred             hhccCCCCC--CCCCCHHHHHHHHHHhhcCcCC--CCCHHHHhcCccccccCC
Q 019650          280 ICFGERLEM--PETASPEFRRFVRSCLEKDWRK--RGTVEELLAYPFVTKRSS  328 (337)
Q Consensus       280 ~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~--R~s~~eil~hp~f~~~~~  328 (337)
                        ......+  ...++..++++|.+||..++.+  |++++++++||||++..+
T Consensus       262 --~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~~  312 (371)
T cd05622         262 --HKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQW  312 (371)
T ss_pred             --CCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCCh
Confidence              1111222  2357899999999999844433  789999999999988543

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.9e-45  Score=325.49  Aligned_cols=268  Identities=25%  Similarity=0.362  Sum_probs=210.8

Q ss_pred             cccccccccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 019650           47 SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFV  124 (337)
Q Consensus        47 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv  124 (337)
                      ++|++.+.||+|+||+||++.+..+++.||+|++....  .....+.+.+|..++..++|++|+++++.+.+ +..+|+|
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv   79 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQD-ENNLYLV   79 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEec-CCeEEEE
Confidence            57999999999999999999999999999999987522  22234557789999999999999999998876 6889999


Q ss_pred             EeccCCCCchHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCC
Q 019650          125 MEHMERGSLFDSLRV-RKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNN  203 (337)
Q Consensus       125 ~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~  203 (337)
                      |||++|++|.+++.. ...+++..+..++.||+.||+|||++|++||||||+||+++.+++++|+|||++........  
T Consensus        80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--  157 (331)
T cd05597          80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT--  157 (331)
T ss_pred             EecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC--
Confidence            999999999999976 45799999999999999999999999999999999999999999999999999876543221  


Q ss_pred             CCCCCCCCccccccccccCCCCCcCCcccccccC-CCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhc
Q 019650          204 NHNNNNNNNIGEAAIACMGTCAYMSPERVDSERW-GGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICF  282 (337)
Q Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~  282 (337)
                                 .......|++.|+|||++..... ...++.++|+||||+++|+|++|+.||......+...........
T Consensus       158 -----------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~  226 (331)
T cd05597         158 -----------VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEH  226 (331)
T ss_pred             -----------ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCc
Confidence                       11112358999999999863210 135678999999999999999999999654333222222211111


Q ss_pred             cCCCCCCCCCCHHHHHHHHHHhhcCcCC--CCCHHHHhcCccccccCC
Q 019650          283 GERLEMPETASPEFRRFVRSCLEKDWRK--RGTVEELLAYPFVTKRSS  328 (337)
Q Consensus       283 ~~~~~~~~~~~~~~~~li~~~l~~~p~~--R~s~~eil~hp~f~~~~~  328 (337)
                      ...+.....++..+++++.+||..++.+  |++++++++||||.+..+
T Consensus       227 ~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~~  274 (331)
T cd05597         227 FQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDW  274 (331)
T ss_pred             ccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCCH
Confidence            1111222347899999999998654443  789999999999987543

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=2.7e-45  Score=326.46  Aligned_cols=251  Identities=27%  Similarity=0.415  Sum_probs=204.6

Q ss_pred             cccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHH-HHHhcCCCCceeeeeeEEeeCCeEEEEEeccC
Q 019650           53 TVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAE-ILKRLDSQFIVKCHAVFYTIEGEICFVMEHME  129 (337)
Q Consensus        53 ~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~-~~~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~  129 (337)
                      +.||.|+||+||+|.+..+++.+|+|++....  .......+..|.. +++.++|+||+++++.+.. ....++||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~-~~~~~lv~e~~~   79 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT-TEKLYFVLDFVN   79 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEec-CCEEEEEEcCCC
Confidence            46899999999999999999999999986542  1222334444544 4677999999999998766 688999999999


Q ss_pred             CCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCCCCCCC
Q 019650          130 RGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNN  209 (337)
Q Consensus       130 ~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~  209 (337)
                      +++|..++.....+++..+..++.||+.||.|||+.|++||||||+||+++.++.++|+|||++.......         
T Consensus        80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~---------  150 (325)
T cd05604          80 GGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS---------  150 (325)
T ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC---------
Confidence            99999999888899999999999999999999999999999999999999999999999999886432211         


Q ss_pred             CCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhccCCCCCC
Q 019650          210 NNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMP  289 (337)
Q Consensus       210 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  289 (337)
                           .......|++.|+|||.+.    +..++.++||||||+++|+|++|..||.........    ..... .....+
T Consensus       151 -----~~~~~~~gt~~y~aPE~~~----~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~----~~~~~-~~~~~~  216 (325)
T cd05604         151 -----DTTTTFCGTPEYLAPEVIR----KQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMY----DNILH-KPLVLR  216 (325)
T ss_pred             -----CCcccccCChhhCCHHHHc----CCCCCCcCccccccceehhhhcCCCCCCCCCHHHHH----HHHHc-CCccCC
Confidence                 1122345899999999998    457788999999999999999999999764332222    22222 234445


Q ss_pred             CCCCHHHHHHHHHHhhcCcCCCCCH----HHHhcCccccccC
Q 019650          290 ETASPEFRRFVRSCLEKDWRKRGTV----EELLAYPFVTKRS  327 (337)
Q Consensus       290 ~~~~~~~~~li~~~l~~~p~~R~s~----~eil~hp~f~~~~  327 (337)
                      +..+..+.+++.+||..+|.+||++    .++++||||.+..
T Consensus       217 ~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~~  258 (325)
T cd05604         217 PGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLS  258 (325)
T ss_pred             CCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCCC
Confidence            6678999999999999999999876    5999999998754

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=1.1e-44  Score=319.29  Aligned_cols=265  Identities=25%  Similarity=0.363  Sum_probs=212.5

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEE
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICF  123 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~l  123 (337)
                      ...++|++.+.||.|++|.||+|.+..++..||+|.+...........+.+|+.+++.++|+||+++++.+.. ....++
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~-~~~~~l   81 (301)
T cd07873           3 GKLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHT-EKSLTL   81 (301)
T ss_pred             ccccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEec-CCeEEE
Confidence            4678999999999999999999999999999999998765444344566789999999999999999998876 688999


Q ss_pred             EEeccCCCCchHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccC
Q 019650          124 VMEHMERGSLFDSLRVR-KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNN  202 (337)
Q Consensus       124 v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~  202 (337)
                      ||||+++ +|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+........ 
T Consensus        82 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-  159 (301)
T cd07873          82 VFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-  159 (301)
T ss_pred             EEecccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC-
Confidence            9999975 898888653 5689999999999999999999999999999999999999999999999998865432211 


Q ss_pred             CCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhc
Q 019650          203 NNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICF  282 (337)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~  282 (337)
                                   ......+++.|+|||.+...   ..++.++|+||||+++|+|++|+.||..................
T Consensus       160 -------------~~~~~~~~~~y~~PE~~~~~---~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~  223 (301)
T cd07873         160 -------------TYSNEVVTLWYRPPDILLGS---TDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGT  223 (301)
T ss_pred             -------------cccccceeecccCcHHHhCC---CCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCC
Confidence                         11122468899999998642   35788999999999999999999999765432222211111000


Q ss_pred             c-----------------CCC--------CCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccC
Q 019650          283 G-----------------ERL--------EMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRS  327 (337)
Q Consensus       283 ~-----------------~~~--------~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~  327 (337)
                      .                 ..+        .....+++.+.++|.+||..||.+|||+++++.||||+.-.
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~  293 (301)
T cd07873         224 PTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG  293 (301)
T ss_pred             CChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence            0                 000        01134678899999999999999999999999999998765

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=3.5e-45  Score=325.72  Aligned_cols=252  Identities=27%  Similarity=0.427  Sum_probs=205.0

Q ss_pred             cccccCcceEEEEEEEccCCceEEEEEeecCCc--hHhHHHHHHH-HHHHHhcCCCCceeeeeeEEeeCCeEEEEEeccC
Q 019650           53 TVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSS--TIIRHQAAHE-AEILKRLDSQFIVKCHAVFYTIEGEICFVMEHME  129 (337)
Q Consensus        53 ~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e-~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~  129 (337)
                      +.||.|+||+||+|.+..+++.||+|++.....  ......+..| ..+++.++|+||+++++.+.+ ....++||||++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~-~~~~~lv~e~~~   79 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT-ADKLYFVLDYIN   79 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEc-CCeEEEEEeCCC
Confidence            469999999999999999999999999875321  1122233333 345678899999999998766 688999999999


Q ss_pred             CCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCCCCCCC
Q 019650          130 RGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNN  209 (337)
Q Consensus       130 ~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~  209 (337)
                      +++|.+++.....+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++.......         
T Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~---------  150 (325)
T cd05602          80 GGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN---------  150 (325)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCC---------
Confidence            99999999888889999999999999999999999999999999999999999999999999986532211         


Q ss_pred             CCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhccCCCCCC
Q 019650          210 NNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMP  289 (337)
Q Consensus       210 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  289 (337)
                           .......|++.|+|||++.    +..++.++||||||+++|+|++|..||.............     ......+
T Consensus       151 -----~~~~~~~gt~~y~aPE~~~----~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~-----~~~~~~~  216 (325)
T cd05602         151 -----GTTSTFCGTPEYLAPEVLH----KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL-----NKPLQLK  216 (325)
T ss_pred             -----CCcccccCCccccCHHHHc----CCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHH-----hCCcCCC
Confidence                 1122346899999999998    4578889999999999999999999997643332222221     1234455


Q ss_pred             CCCCHHHHHHHHHHhhcCcCCCCCHH----HHhcCccccccCC
Q 019650          290 ETASPEFRRFVRSCLEKDWRKRGTVE----ELLAYPFVTKRSS  328 (337)
Q Consensus       290 ~~~~~~~~~li~~~l~~~p~~R~s~~----eil~hp~f~~~~~  328 (337)
                      +.++..+.+++.+||+.||.+|+++.    ++++|+||....+
T Consensus       217 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~~~  259 (325)
T cd05602         217 PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINW  259 (325)
T ss_pred             CCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCCCH
Confidence            67899999999999999999999765    8999999987654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-44  Score=316.11  Aligned_cols=272  Identities=30%  Similarity=0.456  Sum_probs=224.1

Q ss_pred             CccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 019650           45 NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFV  124 (337)
Q Consensus        45 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv  124 (337)
                      ..++|++.+.||.|++|+||++.+..++..+++|.+.... ....+.+..|+.++++++|+|++++++.+.. +...++|
T Consensus         3 ~~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv   80 (280)
T cd06611           3 PNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES-EEELEDFMVEIDILSECKHPNIVGLYEAYFY-ENKLWIL   80 (280)
T ss_pred             chhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCC-HHHHHHHHHHHHHHHhCCCCceeEEEEEEec-CCeEEEE
Confidence            3578999999999999999999998899999999987653 3345677889999999999999999998876 6889999


Q ss_pred             EeccCCCCchHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCC
Q 019650          125 MEHMERGSLFDSLRVR-KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNN  203 (337)
Q Consensus       125 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~  203 (337)
                      |||+++++|.+++... ..+++..+..++.|++.+|.|||+.|++|+||+|+||+++.++.++|+|||.+.......   
T Consensus        81 ~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~---  157 (280)
T cd06611          81 IEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL---  157 (280)
T ss_pred             eeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccc---
Confidence            9999999999998764 579999999999999999999999999999999999999999999999999876653321   


Q ss_pred             CCCCCCCCccccccccccCCCCCcCCcccccccC-CCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhc
Q 019650          204 NHNNNNNNNIGEAAIACMGTCAYMSPERVDSERW-GGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICF  282 (337)
Q Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~  282 (337)
                                 .......++..|+|||.+..+.+ +..++.++|+||||+++|+|++|..||........    ......
T Consensus       158 -----------~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~----~~~~~~  222 (280)
T cd06611         158 -----------QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRV----LLKILK  222 (280)
T ss_pred             -----------cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHH----HHHHhc
Confidence                       11122357889999999863321 34578899999999999999999999965433222    222222


Q ss_pred             cCC--CCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCCccccCcC
Q 019650          283 GER--LEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNIEGLI  336 (337)
Q Consensus       283 ~~~--~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~~~~~~~~  336 (337)
                      ...  ...+..++..+.+++.+||..+|++||+++++++||||.+......++++|
T Consensus       223 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~~~~~~~  278 (280)
T cd06611         223 SEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQSDNKAIKDLL  278 (280)
T ss_pred             CCCCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhcccchhHHHHHHh
Confidence            222  223456788999999999999999999999999999999988777777765

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-46  Score=353.43  Aligned_cols=272  Identities=31%  Similarity=0.448  Sum_probs=232.6

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeE
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEI  121 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~  121 (337)
                      ...++|.++++||+|+||.|..+.++.+++.||+|++++-.  .......|..|-.++..-+.+-|+.++..|.+ +.++
T Consensus        72 l~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD-~~~L  150 (1317)
T KOG0612|consen   72 LKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD-ERYL  150 (1317)
T ss_pred             CCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC-ccce
Confidence            34589999999999999999999999999999999987622  22344567778888888889999999999988 7999


Q ss_pred             EEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhcccc
Q 019650          122 CFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRN  201 (337)
Q Consensus       122 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~  201 (337)
                      |+||||++||+|..+|.+.++++++.++.++..|+.||..||+.|+|||||||+|||++..|+++|+|||.+-.+..++.
T Consensus       151 YlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~  230 (1317)
T KOG0612|consen  151 YLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGT  230 (1317)
T ss_pred             EEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCCc
Confidence            99999999999999999888999999999999999999999999999999999999999999999999999988875543


Q ss_pred             CCCCCCCCCCccccccccccCCCCCcCCcccccccCC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHh
Q 019650          202 NNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWG-GDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAI  280 (337)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~  280 (337)
                                   ..+...+|||.|.+||++.....+ +.|+...|+||+|+++|||+.|..||+...-.+.+.+++.- 
T Consensus       231 -------------V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~h-  296 (1317)
T KOG0612|consen  231 -------------VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNH-  296 (1317)
T ss_pred             -------------EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhch-
Confidence                         344566899999999999876545 67999999999999999999999999765444444444422 


Q ss_pred             hccCCCCCC--CCCCHHHHHHHHHHhhcCcCCCCC---HHHHhcCccccccCCCccccC
Q 019650          281 CFGERLEMP--ETASPEFRRFVRSCLEKDWRKRGT---VEELLAYPFVTKRSSSSNIEG  334 (337)
Q Consensus       281 ~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~s---~~eil~hp~f~~~~~~~~~~~  334 (337)
                        .....+|  ..+|.++++||.+.+ .+|+.|..   ++++..||||.+..| .+|.+
T Consensus       297 --k~~l~FP~~~~VSeeakdLI~~ll-~~~e~RLgrngiedik~HpFF~g~~W-~~iR~  351 (1317)
T KOG0612|consen  297 --KESLSFPDETDVSEEAKDLIEALL-CDREVRLGRNGIEDIKNHPFFEGIDW-DNIRE  351 (1317)
T ss_pred             --hhhcCCCcccccCHHHHHHHHHHh-cChhhhcccccHHHHHhCccccCCCh-hhhhh
Confidence              2233444  558999999999887 67888887   999999999999999 55543

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1.3e-44  Score=326.02  Aligned_cols=262  Identities=24%  Similarity=0.341  Sum_probs=208.7

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCceEEEEEeecCC-chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeC----
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIE----  118 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~----  118 (337)
                      ...++|.+.+.||.|+||.||++.+..+++.+|+|.+.... .......+.+|+.+++.++|+||+++++++....    
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   93 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE   93 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence            45689999999999999999999999999999999987543 2334566778999999999999999999875422    


Q ss_pred             -CeEEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchh
Q 019650          119 -GEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVE  197 (337)
Q Consensus       119 -~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~  197 (337)
                       ...+++|||+++ +|.+.+.  ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++....
T Consensus        94 ~~~~~lv~e~~~~-~l~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~  170 (355)
T cd07874          94 FQDVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  170 (355)
T ss_pred             cceeEEEhhhhcc-cHHHHHh--hcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCC
Confidence             357999999976 7777775  358899999999999999999999999999999999999999999999999987653


Q ss_pred             ccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHH
Q 019650          198 ETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALI  277 (337)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~  277 (337)
                      ...               ......+++.|+|||.+.    +..++.++|+||||+++|+|++|+.||.+...........
T Consensus       171 ~~~---------------~~~~~~~t~~y~aPE~~~----~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~  231 (355)
T cd07874         171 TSF---------------MMTPYVVTRYYRAPEVIL----GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI  231 (355)
T ss_pred             Ccc---------------ccCCccccCCccCHHHHc----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            321               112235899999999997    5578899999999999999999999997644322222221


Q ss_pred             HHhhcc-------------------------------------CCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          278 CAICFG-------------------------------------ERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       278 ~~~~~~-------------------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                      ......                                     .....+...+..++++|.+||+.||++|||+.|+|+|
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         232 EQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             HHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence            111000                                     0001112235678999999999999999999999999


Q ss_pred             ccccccC
Q 019650          321 PFVTKRS  327 (337)
Q Consensus       321 p~f~~~~  327 (337)
                      |||+...
T Consensus       312 p~~~~~~  318 (355)
T cd07874         312 PYINVWY  318 (355)
T ss_pred             cchhccc
Confidence            9998654

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.7e-44  Score=315.94  Aligned_cols=256  Identities=27%  Similarity=0.388  Sum_probs=200.9

Q ss_pred             ccccccccccCcceEEEEEEEccCCceEEEEEeecCCch-HhHHHHHHHHHHHHhc---CCCCceeeeeeEEee----CC
Q 019650           48 DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSST-IIRHQAAHEAEILKRL---DSQFIVKCHAVFYTI----EG  119 (337)
Q Consensus        48 ~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~~~~l---~~~~i~~~~~~~~~~----~~  119 (337)
                      +|++.+.||.|++|+||+|.+..+++.||+|.+...... .......+|+.+++.+   +|+||+++++++...    ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            588999999999999999999999999999998754311 1222344566665554   799999999987642    24


Q ss_pred             eEEEEEeccCCCCchHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchh
Q 019650          120 EICFVMEHMERGSLFDSLRVR--KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVE  197 (337)
Q Consensus       120 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~  197 (337)
                      ..+++||++++ +|.+++...  ..+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++....
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~  159 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYS  159 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCcccccc
Confidence            57999999975 898888753  358999999999999999999999999999999999999999999999999987654


Q ss_pred             ccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHH
Q 019650          198 ETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALI  277 (337)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~  277 (337)
                      ....               .....++..|+|||++.    +..++.++||||||+++|+|++|.+||.............
T Consensus       160 ~~~~---------------~~~~~~~~~y~aPE~~~----~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~  220 (288)
T cd07863         160 CQMA---------------LTPVVVTLWYRAPEVLL----QSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIF  220 (288)
T ss_pred             Cccc---------------CCCccccccccCchHhh----CCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHH
Confidence            3211               11235788999999997    4578899999999999999999999996654433333332


Q ss_pred             HHhhccCC----------------------CCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccc
Q 019650          278 CAICFGER----------------------LEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV  323 (337)
Q Consensus       278 ~~~~~~~~----------------------~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f  323 (337)
                      ........                      ....+.++..+.+++.+||+.||++|||+.+++.||||
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         221 DLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             HHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            21110000                      01123467889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=6.4e-45  Score=323.57  Aligned_cols=252  Identities=28%  Similarity=0.419  Sum_probs=205.4

Q ss_pred             cccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHH-HHHHhcCCCCceeeeeeEEeeCCeEEEEEeccC
Q 019650           53 TVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEA-EILKRLDSQFIVKCHAVFYTIEGEICFVMEHME  129 (337)
Q Consensus        53 ~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~-~~~~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~  129 (337)
                      +.||.|+||+||+|.+..++..||+|++....  .......+..|. .+++.++|+||+++++.+.+ ....++||||++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~-~~~~~lv~e~~~   79 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQT-AEKLYFVLDYVN   79 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEc-CCEEEEEEcCCC
Confidence            46999999999999999999999999987542  112233344444 45788999999999998766 678999999999


Q ss_pred             CCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCCCCCCC
Q 019650          130 RGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNN  209 (337)
Q Consensus       130 ~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~  209 (337)
                      +++|.+.+.....+++..+..++.||+.||.|||+.|++||||||+||+++.++.++|+|||++.......         
T Consensus        80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~---------  150 (321)
T cd05603          80 GGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE---------  150 (321)
T ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC---------
Confidence            99999999888889999999999999999999999999999999999999999999999999876432211         


Q ss_pred             CCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhccCCCCCC
Q 019650          210 NNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMP  289 (337)
Q Consensus       210 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  289 (337)
                           .......|++.|+|||.+.    +..++.++|+||||+++|+|++|..||...+...    ...... ......+
T Consensus       151 -----~~~~~~~gt~~y~aPE~~~----~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~----~~~~i~-~~~~~~~  216 (321)
T cd05603         151 -----ETTSTFCGTPEYLAPEVLR----KEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQ----MYDNIL-HKPLQLP  216 (321)
T ss_pred             -----CccccccCCcccCCHHHhc----CCCCCCcCcccccchhhhhhhcCCCCCCCCCHHH----HHHHHh-cCCCCCC
Confidence                 1122345899999999997    4578889999999999999999999997643221    222222 2345666


Q ss_pred             CCCCHHHHHHHHHHhhcCcCCCCCH----HHHhcCccccccCC
Q 019650          290 ETASPEFRRFVRSCLEKDWRKRGTV----EELLAYPFVTKRSS  328 (337)
Q Consensus       290 ~~~~~~~~~li~~~l~~~p~~R~s~----~eil~hp~f~~~~~  328 (337)
                      ...+..+.+++.+||+.||.+|+++    .++++||||....+
T Consensus       217 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~~~  259 (321)
T cd05603         217 GGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPINW  259 (321)
T ss_pred             CCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCCCH
Confidence            7789999999999999999999865    59999999986554

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=6.6e-46  Score=313.09  Aligned_cols=261  Identities=26%  Similarity=0.408  Sum_probs=216.0

Q ss_pred             CccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCC----e
Q 019650           45 NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEG----E  120 (337)
Q Consensus        45 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~----~  120 (337)
                      ..=.|...+++|.|+||.||.|....++..||||..-.+..     .-.+|+++|+.++||||+.+...|.....    +
T Consensus        22 ~~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~   96 (364)
T KOG0658|consen   22 VEISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVY   96 (364)
T ss_pred             eEEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhH
Confidence            34578889999999999999999999999999998755432     22359999999999999999888876433    3


Q ss_pred             EEEEEeccCCCCchHHhhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCC-CcEEEeeccCccc
Q 019650          121 ICFVMEHMERGSLFDSLRV----RKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGK-GEVKIADFGVSRI  195 (337)
Q Consensus       121 ~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~-~~~~l~Dfg~~~~  195 (337)
                      +.+||||++. +|.++++.    +..++...++-+.+||+.||+|||+.||+||||||+|+|+|.+ |.+||+|||.+..
T Consensus        97 lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~  175 (364)
T KOG0658|consen   97 LNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKV  175 (364)
T ss_pred             HHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCccee
Confidence            4689999987 99998874    5789999999999999999999999999999999999999988 8999999999999


Q ss_pred             hhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHH
Q 019650          196 VEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMA  275 (337)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~  275 (337)
                      +..+..+               .+...+..|.|||.+.+.   ..|+.+.||||.||++.||+-|++.|.+.+....+..
T Consensus       176 L~~~epn---------------iSYicSRyYRaPELifga---~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~e  237 (364)
T KOG0658|consen  176 LVKGEPN---------------ISYICSRYYRAPELIFGA---TEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVE  237 (364)
T ss_pred             eccCCCc---------------eeEEEeccccCHHHHcCc---cccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHH
Confidence            8766433               334578899999999963   5899999999999999999999999988655555544


Q ss_pred             HHHHhhccCCC-----------------------C-CCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCC
Q 019650          276 LICAICFGERL-----------------------E-MPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSS  329 (337)
Q Consensus       276 ~~~~~~~~~~~-----------------------~-~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~  329 (337)
                      +..-+......                       . +....++++.+|+.++|..+|.+|.++.|++.||||......
T Consensus       238 Iik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~  315 (364)
T KOG0658|consen  238 IIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP  315 (364)
T ss_pred             HHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence            44332211100                       0 224567899999999999999999999999999999876544

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=2.1e-44  Score=325.71  Aligned_cols=262  Identities=25%  Similarity=0.361  Sum_probs=208.9

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCceEEEEEeecCC-chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeC----
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIE----  118 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~----  118 (337)
                      ...++|.+.+.||+|+||.||++.+..+++.||+|++.... .......+.+|+.+++.++|+||+++++++....    
T Consensus        21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~  100 (364)
T cd07875          21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE  100 (364)
T ss_pred             chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence            34689999999999999999999999999999999987543 2334566778999999999999999998775422    


Q ss_pred             -CeEEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchh
Q 019650          119 -GEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVE  197 (337)
Q Consensus       119 -~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~  197 (337)
                       ...|+||||+++ +|.+.+.  ..+++..+..++.|++.||+|||++||+||||||+||+++.++.++|+|||++....
T Consensus       101 ~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~  177 (364)
T cd07875         101 FQDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  177 (364)
T ss_pred             cCeEEEEEeCCCC-CHHHHHH--hcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccC
Confidence             357999999975 7877775  358899999999999999999999999999999999999999999999999997653


Q ss_pred             ccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHH
Q 019650          198 ETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALI  277 (337)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~  277 (337)
                      ...               ......++..|+|||++.    +..++.++||||||+++|+|++|+.||.+...........
T Consensus       178 ~~~---------------~~~~~~~t~~y~aPE~~~----~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~  238 (364)
T cd07875         178 TSF---------------MMTPYVVTRYYRAPEVIL----GMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVI  238 (364)
T ss_pred             CCC---------------cccCCcccCCcCCHHHHh----CCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            321               112235899999999998    5578899999999999999999999997654433332222


Q ss_pred             HHhhc-----------------cCCC--------------------CCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          278 CAICF-----------------GERL--------------------EMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       278 ~~~~~-----------------~~~~--------------------~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                      .....                 ...+                    ......+..++++|.+||..||.+|||++++|+|
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         239 EQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             HhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            11000                 0000                    0111235678999999999999999999999999


Q ss_pred             ccccccC
Q 019650          321 PFVTKRS  327 (337)
Q Consensus       321 p~f~~~~  327 (337)
                      |||....
T Consensus       319 p~~~~~~  325 (364)
T cd07875         319 PYINVWY  325 (364)
T ss_pred             ccccccc
Confidence            9998643

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=3.9e-44  Score=316.73  Aligned_cols=261  Identities=38%  Similarity=0.666  Sum_probs=214.5

Q ss_pred             cccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEe
Q 019650           47 SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVME  126 (337)
Q Consensus        47 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~e  126 (337)
                      ++|.+.+.||.|+||.||++.+..++..+++|.+...........+.+|++++++++|+||+++++.+.+ +..++++||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e   79 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYS-DGEISICME   79 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee-CCEEEEEee
Confidence            4799999999999999999999999999999998765445556678889999999999999999998876 789999999


Q ss_pred             ccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCCC
Q 019650          127 HMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG-MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNH  205 (337)
Q Consensus       127 ~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~-~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~  205 (337)
                      |+++++|.+++...+.+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||.+.......     
T Consensus        80 y~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-----  154 (308)
T cd06615          80 HMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-----  154 (308)
T ss_pred             ccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccccc-----
Confidence            99999999999888889999999999999999999997 699999999999999999999999999876543211     


Q ss_pred             CCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHH--------
Q 019650          206 NNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALI--------  277 (337)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~--------  277 (337)
                                 .....++..|+|||.+.    +..++.++|+||||+++|+|++|..||..... .......        
T Consensus       155 -----------~~~~~~~~~~~aPE~~~----~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~  218 (308)
T cd06615         155 -----------ANSFVGTRSYMSPERLQ----GTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDA-KELEAMFGRPVSEGE  218 (308)
T ss_pred             -----------cccCCCCcCccChhHhc----CCCCCccchHHHHHHHHHHHHhCCCCCCCcch-hhHHHhhcCcccccc
Confidence                       11235788999999987    45688899999999999999999999854321 1111111        


Q ss_pred             -------------------------HHhhccCCCCCC-CCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCC
Q 019650          278 -------------------------CAICFGERLEMP-ETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSS  329 (337)
Q Consensus       278 -------------------------~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~  329 (337)
                                               ........+..+ ...+..+.+++.+||..+|++|||+++++.||||.+...+
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~  296 (308)
T cd06615         219 AKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAELE  296 (308)
T ss_pred             ccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhcccc
Confidence                                     011111111111 2357789999999999999999999999999999886544

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=8.7e-45  Score=334.73  Aligned_cols=259  Identities=23%  Similarity=0.349  Sum_probs=205.2

Q ss_pred             CccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEee-------
Q 019650           45 NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTI-------  117 (337)
Q Consensus        45 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-------  117 (337)
                      ...+|++++.||+|+||+||+|.+..+++.||+|.+....     ....+|+.+++.++|+||+++++.+...       
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~  138 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK  138 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCC
Confidence            3468999999999999999999999999999999886442     2234699999999999999998876542       


Q ss_pred             CCeEEEEEeccCCCCchHHhh----hcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCC-cEEEeeccC
Q 019650          118 EGEICFVMEHMERGSLFDSLR----VRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKG-EVKIADFGV  192 (337)
Q Consensus       118 ~~~~~lv~e~~~~~~L~~~l~----~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~-~~~l~Dfg~  192 (337)
                      ...+++||||+++ +|.+++.    ....+++..++.++.||+.||+|||+.||+||||||+||+++.++ .++|+|||+
T Consensus       139 ~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGl  217 (440)
T PTZ00036        139 NIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGS  217 (440)
T ss_pred             ceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeecccc
Confidence            1246799999975 7777664    346799999999999999999999999999999999999998765 799999999


Q ss_pred             ccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchh
Q 019650          193 SRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPD  272 (337)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~  272 (337)
                      +.......               ......+++.|+|||++.+   ...++.++|||||||++|+|++|.+||.+......
T Consensus       218 a~~~~~~~---------------~~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~  279 (440)
T PTZ00036        218 AKNLLAGQ---------------RSVSYICSRFYRAPELMLG---ATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQ  279 (440)
T ss_pred             chhccCCC---------------CcccCCCCcCccCHHHhcC---CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence            97654321               1122357899999999863   23688999999999999999999999976544333


Q ss_pred             HHHHHHHhhcc------------C------------CCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccC
Q 019650          273 LMALICAICFG------------E------------RLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRS  327 (337)
Q Consensus       273 ~~~~~~~~~~~------------~------------~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~  327 (337)
                      ...........            .            ...++...+..+.+||.+||..||.+|||+.++|.||||....
T Consensus       280 ~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~  358 (440)
T PTZ00036        280 LVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLR  358 (440)
T ss_pred             HHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhh
Confidence            33332211000            0            0012345678999999999999999999999999999998754

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.3e-44  Score=327.91  Aligned_cols=262  Identities=25%  Similarity=0.349  Sum_probs=210.0

Q ss_pred             ccccccccccCcceEEEEEEEccCCceEEEEEeecCC-chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeC----CeEE
Q 019650           48 DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIE----GEIC  122 (337)
Q Consensus        48 ~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~----~~~~  122 (337)
                      +|++.+.||.|+||+||++.+..+++.||+|.+.... .....+.+.+|+.+++.++|+||+++++++....    ...|
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            5788999999999999999999999999999986542 2334567788999999999999999999876632    2789


Q ss_pred             EEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccC
Q 019650          123 FVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNN  202 (337)
Q Consensus       123 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~  202 (337)
                      +||||+. ++|.+++.....+++..++.++.||+.||.|||+.|++||||||+||+++.++.++|+|||++........ 
T Consensus        81 lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~-  158 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES-  158 (372)
T ss_pred             EEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCcc-
Confidence            9999996 58999888778899999999999999999999999999999999999999999999999999876532211 


Q ss_pred             CCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHh--
Q 019650          203 NNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAI--  280 (337)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~--  280 (337)
                                  .......+++.|+|||.+.+.   ..++.++||||||+++|+|++|+.||.+.........+....  
T Consensus       159 ------------~~~~~~~~~~~y~aPE~~~~~---~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~  223 (372)
T cd07853         159 ------------KHMTQEVVTQYYRAPEILMGS---RHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGT  223 (372)
T ss_pred             ------------ccCCCCCcCCCcCCHHHHcCC---CCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCC
Confidence                        111123578899999998742   357889999999999999999999997654332222111100  


Q ss_pred             ------------------hccCCC-------CCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCcccccc
Q 019650          281 ------------------CFGERL-------EMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKR  326 (337)
Q Consensus       281 ------------------~~~~~~-------~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~  326 (337)
                                        .....+       ......+..+.++|.+||+.||.+|||+.++|.||||++.
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~  294 (372)
T cd07853         224 PSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG  294 (372)
T ss_pred             CCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence                              000000       1223457889999999999999999999999999999884

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1e-44  Score=323.62  Aligned_cols=268  Identities=25%  Similarity=0.375  Sum_probs=211.4

Q ss_pred             cccccccccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 019650           47 SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFV  124 (337)
Q Consensus        47 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv  124 (337)
                      ++|++.+.||+|+||+||++.+..+++.+|+|++....  .......+..|..++..++|++|+++++.+.+ ...+++|
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv   79 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQD-ENNLYLV   79 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEec-CCEEEEE
Confidence            47999999999999999999999999999999986432  22233456778899999999999999998766 6889999


Q ss_pred             EeccCCCCchHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCC
Q 019650          125 MEHMERGSLFDSLRV-RKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNN  203 (337)
Q Consensus       125 ~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~  203 (337)
                      |||+++|+|.+++.. ...+++..++.++.||+.||.|||+.|++||||||+||+++.++.++|+|||++........  
T Consensus        80 ~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~--  157 (332)
T cd05623          80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT--  157 (332)
T ss_pred             EeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCc--
Confidence            999999999999976 46789999999999999999999999999999999999999999999999999865432211  


Q ss_pred             CCCCCCCCccccccccccCCCCCcCCccccccc-CCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhc
Q 019650          204 NHNNNNNNNIGEAAIACMGTCAYMSPERVDSER-WGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICF  282 (337)
Q Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~  282 (337)
                                 ......+|++.|+|||++.... ....++.++|+||||+++|+|++|+.||..................
T Consensus       158 -----------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~  226 (332)
T cd05623         158 -----------VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKER  226 (332)
T ss_pred             -----------ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCcc
Confidence                       1112235899999999986321 0235788999999999999999999999764333322222211111


Q ss_pred             cCCCCCCCCCCHHHHHHHHHHhhcCcCC--CCCHHHHhcCccccccCC
Q 019650          283 GERLEMPETASPEFRRFVRSCLEKDWRK--RGTVEELLAYPFVTKRSS  328 (337)
Q Consensus       283 ~~~~~~~~~~~~~~~~li~~~l~~~p~~--R~s~~eil~hp~f~~~~~  328 (337)
                      ...+.....++..+.+++.+||..++.+  |++++++++||||++..+
T Consensus       227 ~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~~  274 (332)
T cd05623         227 FQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDW  274 (332)
T ss_pred             ccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCCH
Confidence            1112223457899999999999765544  689999999999998654

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.9e-44  Score=310.87  Aligned_cols=259  Identities=31%  Similarity=0.481  Sum_probs=218.7

Q ss_pred             cccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEe
Q 019650           47 SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVME  126 (337)
Q Consensus        47 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~e  126 (337)
                      ++|++.+.||.|++|.||+|.+..++..+++|.+...........+.+|+.+++.++|+|++++++.+.+ +...++|+|
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e   79 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLK-GSKLWIIME   79 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEE-CCeEEEEEE
Confidence            4799999999999999999999999999999999766544455677889999999999999999998776 688999999


Q ss_pred             ccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCCCC
Q 019650          127 HMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHN  206 (337)
Q Consensus       127 ~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~  206 (337)
                      |+++++|.+++... .+++..+..++.|++.||.+||+.+++|+||+|+||+++.++.++|+|||.+........     
T Consensus        80 ~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-----  153 (274)
T cd06609          80 YCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS-----  153 (274)
T ss_pred             eeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccccc-----
Confidence            99999999999865 789999999999999999999999999999999999999999999999999877754321     


Q ss_pred             CCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhccCCC
Q 019650          207 NNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERL  286 (337)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~  286 (337)
                               ......++..|+|||.+.    +..++.++|+||||+++|+|++|..||.......    ..........+
T Consensus       154 ---------~~~~~~~~~~y~~PE~~~----~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~----~~~~~~~~~~~  216 (274)
T cd06609         154 ---------KRNTFVGTPFWMAPEVIK----QSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR----VLFLIPKNNPP  216 (274)
T ss_pred             ---------ccccccCCccccChhhhc----cCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH----HHHHhhhcCCC
Confidence                     111234788899999998    4468999999999999999999999996543221    12222223333


Q ss_pred             CCCCC-CCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCC
Q 019650          287 EMPET-ASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSS  329 (337)
Q Consensus       287 ~~~~~-~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~  329 (337)
                      ..+.. ++..+.+++.+||..+|++|||++++++||||++....
T Consensus       217 ~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~~~~  260 (274)
T cd06609         217 SLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAKKT  260 (274)
T ss_pred             CCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCCCcc
Confidence            33333 78899999999999999999999999999999987755

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=6.7e-45  Score=313.61  Aligned_cols=257  Identities=34%  Similarity=0.526  Sum_probs=210.0

Q ss_pred             cccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHH-HHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEec
Q 019650           49 LKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRH-QAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEH  127 (337)
Q Consensus        49 y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~-~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~e~  127 (337)
                      |++.+.||+|+||+||++.+..++..+|+|++.......... ...+|+.++++++|+||+++++.+.. +...+++||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-~~~~~~v~~~   79 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD-DNYLYIVMEY   79 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE-SSEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc-cccccccccc
Confidence            788999999999999999999999999999998876443322 33569999999999999999998877 7889999999


Q ss_pred             cCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCCCCC
Q 019650          128 MERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNN  207 (337)
Q Consensus       128 ~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~  207 (337)
                      +.+++|.+++.....+++..+..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.+.......       
T Consensus        80 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~-------  152 (260)
T PF00069_consen   80 CPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENN-------  152 (260)
T ss_dssp             ETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTT-------
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-------
Confidence            9999999999988899999999999999999999999999999999999999999999999999987641111       


Q ss_pred             CCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhccC--C
Q 019650          208 NNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGE--R  285 (337)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~--~  285 (337)
                             .......++..|+|||.+..   +..++.++|+||||+++|+|++|..||....................  .
T Consensus       153 -------~~~~~~~~~~~y~aPE~~~~---~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~  222 (260)
T PF00069_consen  153 -------ENFNPFVGTPEYMAPEVLQQ---GKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSS  222 (260)
T ss_dssp             -------SEBSSSSSSGGGSCHHHHTT---TSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHH
T ss_pred             -------cccccccccccccccccccc---cccccccccccccccccccccccccccccccchhhhhhhhhccccccccc
Confidence                   22233458899999999872   34778899999999999999999999976522222222221111111  1


Q ss_pred             CCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccc
Q 019650          286 LEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV  323 (337)
Q Consensus       286 ~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f  323 (337)
                      .......+..+.+++.+||+.||++|||++++++||||
T Consensus       223 ~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  223 SQQSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             TTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred             ccccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence            11112224899999999999999999999999999998

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=2.4e-44  Score=335.68  Aligned_cols=262  Identities=27%  Similarity=0.406  Sum_probs=217.6

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCceEEEEEeecCC-chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCC---
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEG---  119 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~---  119 (337)
                      ...++|.+.+.||.|+||+||+|.+..+++.||+|++.... .......+.+|+.++..++|+++++++..+.....   
T Consensus        29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~  108 (496)
T PTZ00283         29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP  108 (496)
T ss_pred             ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence            44579999999999999999999999999999999987653 33445667889999999999999999887654322   


Q ss_pred             ----eEEEEEeccCCCCchHHhhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeecc
Q 019650          120 ----EICFVMEHMERGSLFDSLRVR----KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFG  191 (337)
Q Consensus       120 ----~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg  191 (337)
                          .+++||||+++|+|.+++...    ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||
T Consensus       109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFG  188 (496)
T PTZ00283        109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFG  188 (496)
T ss_pred             ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecc
Confidence                368999999999999998642    468999999999999999999999999999999999999999999999999


Q ss_pred             CccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCch
Q 019650          192 VSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP  271 (337)
Q Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~  271 (337)
                      ++.........            .......|++.|+|||++.    +..++.++||||||+++|+|++|+.||....   
T Consensus       189 ls~~~~~~~~~------------~~~~~~~Gt~~Y~aPE~~~----~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~---  249 (496)
T PTZ00283        189 FSKMYAATVSD------------DVGRTFCGTPYYVAPEIWR----RKPYSKKADMFSLGVLLYELLTLKRPFDGEN---  249 (496)
T ss_pred             cCeeccccccc------------cccccccCCcceeCHHHhC----CCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC---
Confidence            98765432111            1112345899999999998    4578999999999999999999999996532   


Q ss_pred             hHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccc
Q 019650          272 DLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTK  325 (337)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~  325 (337)
                       ..........+.....+..+++.+.+++.+||+.||.+||++.++++|||++.
T Consensus       250 -~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~  302 (496)
T PTZ00283        250 -MEEVMHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL  302 (496)
T ss_pred             -HHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence             22333333444445567788999999999999999999999999999999875

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=4e-44  Score=333.64  Aligned_cols=258  Identities=22%  Similarity=0.337  Sum_probs=201.6

Q ss_pred             ccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCC------CceeeeeeEEeeCC
Q 019650           46 ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQ------FIVKCHAVFYTIEG  119 (337)
Q Consensus        46 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~------~i~~~~~~~~~~~~  119 (337)
                      .++|++++.||.|+||+||+|.+..++..||+|+++...  ........|+.+++.+.|.      +++.+++++.....
T Consensus       128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~  205 (467)
T PTZ00284        128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP--KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETG  205 (467)
T ss_pred             CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch--hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCc
Confidence            468999999999999999999999999999999986432  2233445677777776554      47888887776567


Q ss_pred             eEEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCeEEcCCC---------------
Q 019650          120 EICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG-MQIIHGDIKPSNLLINGKG---------------  183 (337)
Q Consensus       120 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~-~~ivH~dl~~~Nili~~~~---------------  183 (337)
                      ++|+||+++ |++|.+++...+.+++..+..++.||+.||.|||+ .||+||||||+|||++.++               
T Consensus       206 ~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~  284 (467)
T PTZ00284        206 HMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDP  284 (467)
T ss_pred             eEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCC
Confidence            899999998 66999999888889999999999999999999997 5999999999999998765               


Q ss_pred             -cEEEeeccCccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCC
Q 019650          184 -EVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHY  262 (337)
Q Consensus       184 -~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~  262 (337)
                       .+||+|||.+.....                 .....+||+.|+|||++.    +..++.++|||||||++|||++|+.
T Consensus       285 ~~vkl~DfG~~~~~~~-----------------~~~~~~gt~~Y~APE~~~----~~~~~~~~DiwSlGvil~elltG~~  343 (467)
T PTZ00284        285 CRVRICDLGGCCDERH-----------------SRTAIVSTRHYRSPEVVL----GLGWMYSTDMWSMGCIIYELYTGKL  343 (467)
T ss_pred             ceEEECCCCccccCcc-----------------ccccccCCccccCcHHhh----cCCCCcHHHHHHHHHHHHHHHhCCC
Confidence             499999997753221                 112346899999999998    5578999999999999999999999


Q ss_pred             CCCCCCCchhHHHHHHHhhccCC-----------------------CC--------------C-CCCCCHHHHHHHHHHh
Q 019650          263 PLIGFGEKPDLMALICAICFGER-----------------------LE--------------M-PETASPEFRRFVRSCL  304 (337)
Q Consensus       263 pf~~~~~~~~~~~~~~~~~~~~~-----------------------~~--------------~-~~~~~~~~~~li~~~l  304 (337)
                      ||......+....+ .......+                       +.              . ....+..+.+||.+||
T Consensus       344 pf~~~~~~~~~~~i-~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL  422 (467)
T PTZ00284        344 LYDTHDNLEHLHLM-EKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLL  422 (467)
T ss_pred             CCCCCChHHHHHHH-HHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhC
Confidence            99765443222211 11100000                       00              0 0012456789999999


Q ss_pred             hcCcCCCCCHHHHhcCccccccCC
Q 019650          305 EKDWRKRGTVEELLAYPFVTKRSS  328 (337)
Q Consensus       305 ~~~p~~R~s~~eil~hp~f~~~~~  328 (337)
                      .+||.+|||++|+|+||||++...
T Consensus       423 ~~dP~~R~ta~e~L~Hp~~~~~~~  446 (467)
T PTZ00284        423 HYDRQKRLNARQMTTHPYVLKYYP  446 (467)
T ss_pred             CcChhhCCCHHHHhcCccccccCC
Confidence            999999999999999999998653

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=3.8e-44  Score=310.39  Aligned_cols=260  Identities=30%  Similarity=0.432  Sum_probs=212.2

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEE
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICF  123 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~l  123 (337)
                      ...++|++.+.||.|++|.||+|.+..+++.||+|+++.... .....+.+|+.+++.++|+|++++++.+.. ....++
T Consensus         6 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~-~~~~~l   83 (267)
T cd06645           6 NPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG-EDFAVVQQEIIMMKDCKHSNIVAYFGSYLR-RDKLWI   83 (267)
T ss_pred             CcHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhCCCCCeeeEEEEEEe-CCEEEE
Confidence            446799999999999999999999999999999999876532 234557789999999999999999998766 688999


Q ss_pred             EEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCC
Q 019650          124 VMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNN  203 (337)
Q Consensus       124 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~  203 (337)
                      +|||+++++|.+++...+.+++..+..++.|++.+|.|||+.|++|+||+|+||+++.++.++|+|||.+.......   
T Consensus        84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~---  160 (267)
T cd06645          84 CMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI---  160 (267)
T ss_pred             EEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc---
Confidence            99999999999999888899999999999999999999999999999999999999999999999999987654321   


Q ss_pred             CCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhcc
Q 019650          204 NHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFG  283 (337)
Q Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~  283 (337)
                                 .......++..|+|||.+.... ...++.++|+||||+++|+|++|..||...............  ..
T Consensus       161 -----------~~~~~~~~~~~y~aPE~~~~~~-~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~--~~  226 (267)
T cd06645         161 -----------AKRKSFIGTPYWMAPEVAAVER-KGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKS--NF  226 (267)
T ss_pred             -----------cccccccCcccccChhhhcccc-CCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhcc--CC
Confidence                       1112235889999999975221 345788999999999999999999998654432222211111  11


Q ss_pred             CCCCC--CCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCcc
Q 019650          284 ERLEM--PETASPEFRRFVRSCLEKDWRKRGTVEELLAYPF  322 (337)
Q Consensus       284 ~~~~~--~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~  322 (337)
                      .....  ...++..+.+++.+||..+|++|||++++++|||
T Consensus       227 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         227 QPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             CCCcccccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence            11111  1245788999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=7.6e-44  Score=306.67  Aligned_cols=254  Identities=30%  Similarity=0.479  Sum_probs=211.9

Q ss_pred             ccccccccccCcceEEEEEEEccCCceEEEEEeecCC-chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEe
Q 019650           48 DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVME  126 (337)
Q Consensus        48 ~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~e  126 (337)
                      +|++.+.||.|++|.||++.+..+++.+++|.+.... .....+.+.+|+.++++++|+|++++++.+...+..++++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            5899999999999999999999899999999987543 233456678899999999999999999877654567899999


Q ss_pred             ccCCCCchHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCC
Q 019650          127 HMERGSLFDSLRVR--KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNN  204 (337)
Q Consensus       127 ~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~  204 (337)
                      |+++++|.+++...  ..+++.++..++.+++.+|++||+.|++|+||+|+||+++.++.++|+|||.+.......    
T Consensus        81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~----  156 (257)
T cd08223          81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC----  156 (257)
T ss_pred             ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccC----
Confidence            99999999999753  458999999999999999999999999999999999999999999999999987653321    


Q ss_pred             CCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhccC
Q 019650          205 HNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGE  284 (337)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~  284 (337)
                                .......+++.|+|||.+.    +..++.++|+||||+++|+|++|+.||......    ........+.
T Consensus       157 ----------~~~~~~~~~~~y~aPE~~~----~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~----~~~~~~~~~~  218 (257)
T cd08223         157 ----------DMASTLIGTPYYMSPELFS----NKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN----SLVYRIIEGK  218 (257)
T ss_pred             ----------CccccccCCcCccChhHhc----CCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH----HHHHHHHhcC
Confidence                      1112234788999999987    457788999999999999999999998643322    2222233333


Q ss_pred             CCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccc
Q 019650          285 RLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV  323 (337)
Q Consensus       285 ~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f  323 (337)
                      .+..+...++.+.+++.+||+.+|++|||+.+++.||||
T Consensus       219 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         219 LPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI  257 (257)
T ss_pred             CCCCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            445566788999999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1e-43  Score=309.65  Aligned_cols=257  Identities=36%  Similarity=0.631  Sum_probs=210.8

Q ss_pred             cccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEe
Q 019650           47 SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVME  126 (337)
Q Consensus        47 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~e  126 (337)
                      ++|.+.++||.|++|.||+|.+..++..||+|.+...........+.+|+.++++++|+|++++++.+.. ....+++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e   79 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFV-ENRISICTE   79 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEE-CCEEEEEEe
Confidence            4688999999999999999999999999999998766444455678889999999999999999998876 688999999


Q ss_pred             ccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCCCC
Q 019650          127 HMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHN  206 (337)
Q Consensus       127 ~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~  206 (337)
                      |+++++|..+    ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.......      
T Consensus        80 ~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~------  149 (279)
T cd06619          80 FMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI------  149 (279)
T ss_pred             cCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc------
Confidence            9999988655    357889999999999999999999999999999999999999999999999987653321      


Q ss_pred             CCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchh---HHHHHHHhhcc
Q 019650          207 NNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPD---LMALICAICFG  283 (337)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~---~~~~~~~~~~~  283 (337)
                                .....++..|+|||.+.    +..++.++|+||||+++|+|++|..||........   ...........
T Consensus       150 ----------~~~~~~~~~y~aPE~~~----~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  215 (279)
T cd06619         150 ----------AKTYVGTNAYMAPERIS----GEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDE  215 (279)
T ss_pred             ----------ccCCCCChhhcCceeec----CCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhcc
Confidence                      11235889999999998    45688999999999999999999999965322211   11111111112


Q ss_pred             CCCCC-CCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCC
Q 019650          284 ERLEM-PETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSS  328 (337)
Q Consensus       284 ~~~~~-~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~  328 (337)
                      ..... ....+..+.+++.+||..+|.+||+++++++||||+....
T Consensus       216 ~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~~  261 (279)
T cd06619         216 DPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYND  261 (279)
T ss_pred             CCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccccC
Confidence            22222 2346789999999999999999999999999999988753

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=3.6e-44  Score=313.45  Aligned_cols=258  Identities=27%  Similarity=0.408  Sum_probs=210.9

Q ss_pred             ccccccccccCcceEEEEEEEccCCceEEEEEeecCCc--hHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 019650           48 DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSS--TIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVM  125 (337)
Q Consensus        48 ~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~  125 (337)
                      .|++.+.||.|+||+||++.+..+++.||+|.+.....  ....+.+.+|+.++++++|++++++++.+.+ +...++||
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~-~~~~~lv~   79 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYET-KDALCLVL   79 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEec-CCEEEEEE
Confidence            37788999999999999999999999999999865431  2223456789999999999999999998876 67899999


Q ss_pred             eccCCCCchHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCC
Q 019650          126 EHMERGSLFDSLRVR--KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNN  203 (337)
Q Consensus       126 e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~  203 (337)
                      ||+.|++|.+++...  ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++........  
T Consensus        80 e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~--  157 (285)
T cd05630          80 TLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--  157 (285)
T ss_pred             EecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc--
Confidence            999999999988543  3589999999999999999999999999999999999999999999999998865432211  


Q ss_pred             CCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhcc
Q 019650          204 NHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFG  283 (337)
Q Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~  283 (337)
                                   .....|+..|+|||.+.    +..++.++|+||+|+++|+|++|..||.......... ........
T Consensus       158 -------------~~~~~g~~~y~aPE~~~----~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~-~~~~~~~~  219 (285)
T cd05630         158 -------------IKGRVGTVGYMAPEVVK----NERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE-EVERLVKE  219 (285)
T ss_pred             -------------ccCCCCCccccChHHHc----CCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHH-HHHhhhhh
Confidence                         11235899999999998    4578889999999999999999999997643322111 11111112


Q ss_pred             CCCCCCCCCCHHHHHHHHHHhhcCcCCCCC-----HHHHhcCcccccc
Q 019650          284 ERLEMPETASPEFRRFVRSCLEKDWRKRGT-----VEELLAYPFVTKR  326 (337)
Q Consensus       284 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~s-----~~eil~hp~f~~~  326 (337)
                      .....+...+..+.+++.+||+.||.+|||     ++++++||||++.
T Consensus       220 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~  267 (285)
T cd05630         220 VQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQI  267 (285)
T ss_pred             hhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhcc
Confidence            223445667899999999999999999999     8999999999864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.2e-44  Score=322.90  Aligned_cols=268  Identities=25%  Similarity=0.355  Sum_probs=211.4

Q ss_pred             cccccccccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 019650           47 SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFV  124 (337)
Q Consensus        47 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv  124 (337)
                      ++|.+.+.||+|+||+||++.+..+++.||+|++....  .......+.+|..++..++|++|+.+++.+.+ ....|+|
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~-~~~~~lv   79 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQD-ENYLYLV   79 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc-CCEEEEE
Confidence            57999999999999999999999999999999986532  22234456778999999999999999998766 6889999


Q ss_pred             EeccCCCCchHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCC
Q 019650          125 MEHMERGSLFDSLRV-RKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNN  203 (337)
Q Consensus       125 ~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~  203 (337)
                      |||++||+|.+++.. ...+++..+..++.|++.||.|||++||+|+||||+||+++.++.++|+|||++........  
T Consensus        80 ~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~--  157 (331)
T cd05624          80 MDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT--  157 (331)
T ss_pred             EeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc--
Confidence            999999999999986 46789999999999999999999999999999999999999999999999999876543211  


Q ss_pred             CCCCCCCCccccccccccCCCCCcCCcccccccC-CCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhc
Q 019650          204 NHNNNNNNNIGEAAIACMGTCAYMSPERVDSERW-GGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICF  282 (337)
Q Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~  282 (337)
                                 .......|++.|+|||++..... ...++.++|+||||+++|+|++|+.||..................
T Consensus       158 -----------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~  226 (331)
T cd05624         158 -----------VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEER  226 (331)
T ss_pred             -----------eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCc
Confidence                       01112358999999999863210 135688999999999999999999999754332222222111000


Q ss_pred             cCCCCCCCCCCHHHHHHHHHHhhcCcCC--CCCHHHHhcCccccccCC
Q 019650          283 GERLEMPETASPEFRRFVRSCLEKDWRK--RGTVEELLAYPFVTKRSS  328 (337)
Q Consensus       283 ~~~~~~~~~~~~~~~~li~~~l~~~p~~--R~s~~eil~hp~f~~~~~  328 (337)
                      ...+.....++..+.+++.+||..++++  |++++++++||||++..+
T Consensus       227 ~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~~  274 (331)
T cd05624         227 FQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDW  274 (331)
T ss_pred             ccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCCH
Confidence            1111222346899999999999876654  469999999999988654

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=6.6e-44  Score=313.44  Aligned_cols=269  Identities=30%  Similarity=0.485  Sum_probs=222.5

Q ss_pred             CccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 019650           45 NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFV  124 (337)
Q Consensus        45 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv  124 (337)
                      ...+|++.+.||.|++|+||+|.+..+++.|++|.+...... ..+.+.+|+.+++.++|+|++++++.+.. ....++|
T Consensus        17 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv   94 (296)
T cd06655          17 PKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQP-KKELIINEILVMKELKNPNIVNFLDSFLV-GDELFVV   94 (296)
T ss_pred             CcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCc-hHHHHHHHHHHHHhcCCCceeeeeeeEec-CceEEEE
Confidence            346799999999999999999999999999999998754332 34667889999999999999999998866 6889999


Q ss_pred             EeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCC
Q 019650          125 MEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNN  204 (337)
Q Consensus       125 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~  204 (337)
                      +||+++++|.+++.. ..+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+.........  
T Consensus        95 ~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~--  171 (296)
T cd06655          95 MEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK--  171 (296)
T ss_pred             EEecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhccccccc--
Confidence            999999999998864 46899999999999999999999999999999999999999999999999988765432211  


Q ss_pred             CCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhccC
Q 019650          205 HNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGE  284 (337)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~  284 (337)
                                  .....++..|+|||.+.    +..++.++|+||||+++|+|++|..||..............  ....
T Consensus       172 ------------~~~~~~~~~y~aPE~~~----~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~--~~~~  233 (296)
T cd06655         172 ------------RSTMVGTPYWMAPEVVT----RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT--NGTP  233 (296)
T ss_pred             ------------CCCcCCCccccCcchhc----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--cCCc
Confidence                        11224788999999987    44678899999999999999999999976543332222211  1112


Q ss_pred             CCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCCccccCcC
Q 019650          285 RLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNIEGLI  336 (337)
Q Consensus       285 ~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~~~~~~~~  336 (337)
                      ....+..++..+.++|.+||..+|.+|||+.+++.||||+.....+.++..|
T Consensus       234 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~~~~~~~~~~  285 (296)
T cd06655         234 ELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAKPLSSLTPLI  285 (296)
T ss_pred             ccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhccccccCCccc
Confidence            2234556788999999999999999999999999999999888777777665

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=8.4e-44  Score=311.33  Aligned_cols=265  Identities=35%  Similarity=0.562  Sum_probs=220.1

Q ss_pred             cccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEe
Q 019650           47 SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVME  126 (337)
Q Consensus        47 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~e  126 (337)
                      ++|++++.||.|++|.||++.+..++..+|+|.+...........+.+|+.++++++|+|++++++.+.. .+..++|||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv~e   79 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFI-EGAVYMCME   79 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheec-CCeEEEEEe
Confidence            4799999999999999999999999999999998765444455678899999999999999999998776 788999999


Q ss_pred             ccCCCCchHHhhhc---CCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCeEEcCCCcEEEeeccCccchhccccC
Q 019650          127 HMERGSLFDSLRVR---KKLSEDVISGVAYRVLKGLQYLHG-MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNN  202 (337)
Q Consensus       127 ~~~~~~L~~~l~~~---~~l~~~~~~~i~~~l~~~l~~LH~-~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~  202 (337)
                      |+++++|..++...   ..+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||.+.......  
T Consensus        80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--  157 (286)
T cd06622          80 YMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL--  157 (286)
T ss_pred             ecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc--
Confidence            99999999988753   378999999999999999999996 599999999999999999999999999887653221  


Q ss_pred             CCCCCCCCCccccccccccCCCCCcCCcccccccC--CCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHh
Q 019650          203 NNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERW--GGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAI  280 (337)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~  280 (337)
                                    .....++..|+|||.+.....  ...++.++|+||||+++|+|++|..||...... .........
T Consensus       158 --------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~~~~~  222 (286)
T cd06622         158 --------------AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA-NIFAQLSAI  222 (286)
T ss_pred             --------------cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh-hHHHHHHHH
Confidence                          111247789999999864311  124578999999999999999999999654332 222333334


Q ss_pred             hccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCC
Q 019650          281 CFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSS  329 (337)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~  329 (337)
                      ........+..++..+.+++.+||..+|++||++++++.||||......
T Consensus       223 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~~  271 (286)
T cd06622         223 VDGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNA  271 (286)
T ss_pred             hhcCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccCC
Confidence            4455566677789999999999999999999999999999999887644

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=4.6e-44  Score=309.83  Aligned_cols=262  Identities=29%  Similarity=0.401  Sum_probs=211.2

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEE
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICF  123 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~l  123 (337)
                      ...++|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+.+|+.++++++|+|++++++.+.. +...++
T Consensus         6 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~-~~~~~i   83 (267)
T cd06646           6 NPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG-DDFSLIQQEIFMVKECKHCNIVAYFGSYLS-REKLWI   83 (267)
T ss_pred             CchhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc-chHHHHHHHHHHHHhcCCCCeeeeeEEEEe-CCEEEE
Confidence            446789999999999999999999999999999999875432 234567789999999999999999998876 688999


Q ss_pred             EEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCC
Q 019650          124 VMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNN  203 (337)
Q Consensus       124 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~  203 (337)
                      ||||+++++|.+++.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......   
T Consensus        84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~---  160 (267)
T cd06646          84 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI---  160 (267)
T ss_pred             EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccc---
Confidence            99999999999999888889999999999999999999999999999999999999999999999999987664321   


Q ss_pred             CCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhcc
Q 019650          204 NHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFG  283 (337)
Q Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~  283 (337)
                                 .......++..|+|||.+.... ...++.++|+||+|+++|+|++|..||...................
T Consensus       161 -----------~~~~~~~~~~~y~~PE~~~~~~-~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~  228 (267)
T cd06646         161 -----------AKRKSFIGTPYWMAPEVAAVEK-NGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQP  228 (267)
T ss_pred             -----------cccCccccCccccCHhHccccc-CCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCC
Confidence                       1111234788999999885321 3456789999999999999999999986543222111111110011


Q ss_pred             CCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCcc
Q 019650          284 ERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPF  322 (337)
Q Consensus       284 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~  322 (337)
                      ........++..+.+++.+||..+|++|||++++++|+|
T Consensus       229 ~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         229 PKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             CCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence            111122346789999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7e-45  Score=324.52  Aligned_cols=251  Identities=31%  Similarity=0.468  Sum_probs=201.3

Q ss_pred             cccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHHhc---CCCCceeeeeeEEeeCCeEEEEEeccC
Q 019650           55 LGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRL---DSQFIVKCHAVFYTIEGEICFVMEHME  129 (337)
Q Consensus        55 lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l---~~~~i~~~~~~~~~~~~~~~lv~e~~~  129 (337)
                      ||+|+||+||+|.+..+++.||+|++....  ..........|..++...   .|++|+.++..+.+ ....++||||++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~-~~~~~lv~e~~~   79 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQT-DSDLYLVTDYMS   79 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEec-CCeEEEEEcCCC
Confidence            799999999999999999999999986532  111223344555666554   79999999998766 688999999999


Q ss_pred             CCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCCCCCCC
Q 019650          130 RGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNN  209 (337)
Q Consensus       130 ~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~  209 (337)
                      +++|.+++...+.+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++.......         
T Consensus        80 ~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~---------  150 (330)
T cd05586          80 GGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN---------  150 (330)
T ss_pred             CChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC---------
Confidence            99999999888899999999999999999999999999999999999999999999999999986532221         


Q ss_pred             CCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhccCCCCCC
Q 019650          210 NNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMP  289 (337)
Q Consensus       210 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  289 (337)
                           .......|++.|+|||.+...   ..++.++||||||+++|+|++|..||......    ........+......
T Consensus       151 -----~~~~~~~gt~~y~aPE~~~~~---~~~~~~~DvwslGvil~elltG~~Pf~~~~~~----~~~~~i~~~~~~~~~  218 (330)
T cd05586         151 -----KTTNTFCGTTEYLAPEVLLDE---KGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ----QMYRNIAFGKVRFPK  218 (330)
T ss_pred             -----CCccCccCCccccCHHHHcCC---CCCCCccceeccccEEEEeccCCCCCCCCCHH----HHHHHHHcCCCCCCC
Confidence                 112233589999999998742   35788999999999999999999999654322    222222222222222


Q ss_pred             CCCCHHHHHHHHHHhhcCcCCCC----CHHHHhcCccccccC
Q 019650          290 ETASPEFRRFVRSCLEKDWRKRG----TVEELLAYPFVTKRS  327 (337)
Q Consensus       290 ~~~~~~~~~li~~~l~~~p~~R~----s~~eil~hp~f~~~~  327 (337)
                      ..+++.+.+++.+||+.||.+||    +++++++||||.+..
T Consensus       219 ~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~  260 (330)
T cd05586         219 NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADID  260 (330)
T ss_pred             ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCCC
Confidence            34689999999999999999998    799999999998754

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=9.4e-45  Score=326.94  Aligned_cols=255  Identities=31%  Similarity=0.463  Sum_probs=211.5

Q ss_pred             cccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcC-C-----CCceeeeeeEEeeCCe
Q 019650           47 SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLD-S-----QFIVKCHAVFYTIEGE  120 (337)
Q Consensus        47 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-~-----~~i~~~~~~~~~~~~~  120 (337)
                      .+|++++.||.|+||.|-+|.+.+|++.||||+++..  .....+...|+.+|..++ |     -|++++++.|.. +++
T Consensus       186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~--k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~f-r~H  262 (586)
T KOG0667|consen  186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK--KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYF-RNH  262 (586)
T ss_pred             EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC--hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccc-ccc
Confidence            4889999999999999999999999999999999754  345566677999999996 3     589999999888 899


Q ss_pred             EEEEEeccCCCCchHHhhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCC--CcEEEeeccCccch
Q 019650          121 ICFVMEHMERGSLFDSLRVRK--KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGK--GEVKIADFGVSRIV  196 (337)
Q Consensus       121 ~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~--~~~~l~Dfg~~~~~  196 (337)
                      +|||+|.+.. +|.+++..+.  .++...++.++.||+.||..||+.||||+||||+|||+...  ..+||+|||+++..
T Consensus       263 lciVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~  341 (586)
T KOG0667|consen  263 LCIVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE  341 (586)
T ss_pred             eeeeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence            9999999965 9999998764  68999999999999999999999999999999999999655  37999999999887


Q ss_pred             hccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHH
Q 019650          197 EETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMAL  276 (337)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~  276 (337)
                      .....                 ..+.+..|.|||++.    |.+|+.+.||||||||+.||++|.+.|++..+.+.+..+
T Consensus       342 ~q~vy-----------------tYiQSRfYRAPEVIL----GlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I  400 (586)
T KOG0667|consen  342 SQRVY-----------------TYIQSRFYRAPEVIL----GLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARI  400 (586)
T ss_pred             CCcce-----------------eeeeccccccchhhc----cCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHH
Confidence            65432                 234678899999999    779999999999999999999999989886665544444


Q ss_pred             HHHhhccCC-----------------------------------------------CCCC-----------CCCCHHHHH
Q 019650          277 ICAICFGER-----------------------------------------------LEMP-----------ETASPEFRR  298 (337)
Q Consensus       277 ~~~~~~~~~-----------------------------------------------~~~~-----------~~~~~~~~~  298 (337)
                      ++.+.....                                               ...|           ......+.+
T Consensus       401 ~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~d  480 (586)
T KOG0667|consen  401 IEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFID  480 (586)
T ss_pred             HHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHH
Confidence            332210000                                               0011           012346899


Q ss_pred             HHHHHhhcCcCCCCCHHHHhcCcccccc
Q 019650          299 FVRSCLEKDWRKRGTVEELLAYPFVTKR  326 (337)
Q Consensus       299 li~~~l~~~p~~R~s~~eil~hp~f~~~  326 (337)
                      ++.+||.+||.+|+|+.++|+||||.+.
T Consensus       481 flk~~L~~dP~~R~tp~qal~Hpfl~~~  508 (586)
T KOG0667|consen  481 FLKRCLEWDPAERITPAQALNHPFLTGT  508 (586)
T ss_pred             HHHHHhccCchhcCCHHHHhcCcccccc
Confidence            9999999999999999999999999943

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=5.7e-44  Score=308.83  Aligned_cols=260  Identities=38%  Similarity=0.663  Sum_probs=220.2

Q ss_pred             cccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEe
Q 019650           47 SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVME  126 (337)
Q Consensus        47 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~e  126 (337)
                      ++|++.+.||.|++|.||++.+..+++.+++|.+...........+.+|+.+++++.|+|++++++.+.. ....++++|
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv~e   79 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYN-NGDISICME   79 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeec-CCEEEEEEE
Confidence            4789999999999999999999999999999999876555556778899999999999999999998877 688999999


Q ss_pred             ccCCCCchHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCC
Q 019650          127 HMERGSLFDSLRVR-KKLSEDVISGVAYRVLKGLQYLHG-MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNN  204 (337)
Q Consensus       127 ~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~-~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~  204 (337)
                      ++++++|.+++... ..+++..+..++.|++.+|+|||+ .|++|+||+|+||+++.++.++|+|||.+.........  
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~--  157 (265)
T cd06605          80 YMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK--  157 (265)
T ss_pred             ecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh--
Confidence            99989999999876 789999999999999999999999 99999999999999999999999999988766432211  


Q ss_pred             CCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCC-chhHHHHHHHhhcc
Q 019650          205 HNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGE-KPDLMALICAICFG  283 (337)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~-~~~~~~~~~~~~~~  283 (337)
                                    ...++..|+|||.+.    +..++.++|+||||+++|+|++|..||..... ..............
T Consensus       158 --------------~~~~~~~y~~PE~~~----~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  219 (265)
T cd06605         158 --------------TFVGTSSYMAPERIQ----GNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNE  219 (265)
T ss_pred             --------------cccCChhccCHHHHc----CCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcC
Confidence                          134788999999998    45788999999999999999999999965421 12233333333344


Q ss_pred             CCCCCCCC-CCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccC
Q 019650          284 ERLEMPET-ASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRS  327 (337)
Q Consensus       284 ~~~~~~~~-~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~  327 (337)
                      ..+..+.. ++..+.++|.+||..+|++|||+.+++.||||++..
T Consensus       220 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~~  264 (265)
T cd06605         220 PPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKYE  264 (265)
T ss_pred             CCCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhccc
Confidence            44444444 788999999999999999999999999999998754

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.4e-43  Score=330.19  Aligned_cols=258  Identities=22%  Similarity=0.334  Sum_probs=214.8

Q ss_pred             ccccccccccccCcceEEEEEEEccC-CceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 019650           46 ISDLKKLTVLGHGNGGIVYKVRHQKS-NSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFV  124 (337)
Q Consensus        46 ~~~y~~~~~lg~g~~~~v~~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv  124 (337)
                      ...|.+.+.||+|++|.||+|....+ +..||+|.+.... ......+..|+.+++.++|+||+++++.+.. ...+|+|
T Consensus        66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~-~~~~~lv  143 (478)
T PTZ00267         66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND-ERQAAYARSELHCLAACDHFGIVKHFDDFKS-DDKLLLI  143 (478)
T ss_pred             ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEE-CCEEEEE
Confidence            45699999999999999999998876 7888998775443 3344567789999999999999999998876 6899999


Q ss_pred             EeccCCCCchHHhhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccc
Q 019650          125 MEHMERGSLFDSLRV----RKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETR  200 (337)
Q Consensus       125 ~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~  200 (337)
                      |||++||+|.+++..    ..++++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++.......
T Consensus       144 ~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~  223 (478)
T PTZ00267        144 MEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV  223 (478)
T ss_pred             EECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence            999999999988753    3468999999999999999999999999999999999999999999999999987654321


Q ss_pred             cCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHh
Q 019650          201 NNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAI  280 (337)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~  280 (337)
                      ..            ......+||+.|+|||++.    +..++.++||||||+++|+|++|..||......    ......
T Consensus       224 ~~------------~~~~~~~gt~~y~aPE~~~----~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~----~~~~~~  283 (478)
T PTZ00267        224 SL------------DVASSFCGTPYYLAPELWE----RKRYSKKADMWSLGVILYELLTLHRPFKGPSQR----EIMQQV  283 (478)
T ss_pred             cc------------ccccccCCCccccCHhHhC----CCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHH
Confidence            10            1123346899999999998    457889999999999999999999999654332    233333


Q ss_pred             hccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccc
Q 019650          281 CFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTK  325 (337)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~  325 (337)
                      ..+.....+..++..+.++|.+||..||++||++++++.|||++.
T Consensus       284 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~  328 (478)
T PTZ00267        284 LYGKYDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKY  328 (478)
T ss_pred             HhCCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence            334444556678899999999999999999999999999999864

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-46  Score=331.38  Aligned_cols=270  Identities=31%  Similarity=0.477  Sum_probs=226.9

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEE
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICF  123 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~l  123 (337)
                      ...+-|.|++.||.|+||.||++..+.++...|.|++...+ ....+.+.-|+.++..++||+|+++++.|+. ++.+++
T Consensus        29 nP~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetks-eEELEDylVEIeILa~CdHP~ivkLl~ayy~-enkLwi  106 (1187)
T KOG0579|consen   29 NPRDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKS-EEELEDYLVEIEILAECDHPVIVKLLSAYYF-ENKLWI  106 (1187)
T ss_pred             CHHHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccc-hhHHhhhhhhhhhhhcCCChHHHHHHHHHhc-cCceEE
Confidence            44578999999999999999999999999888999987654 4466777889999999999999999999888 789999


Q ss_pred             EEeccCCCCchHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccC
Q 019650          124 VMEHMERGSLFDSLRV-RKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNN  202 (337)
Q Consensus       124 v~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~  202 (337)
                      +.|||.||-++..+-. ...+.+.++..+++|++.||.|||+++|||||||..|||++-+|.++|+|||.+.......  
T Consensus       107 liEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~--  184 (1187)
T KOG0579|consen  107 LIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTR--  184 (1187)
T ss_pred             EEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHH--
Confidence            9999999998887754 4679999999999999999999999999999999999999999999999999886654432  


Q ss_pred             CCCCCCCCCccccccccccCCCCCcCCcccccccC-CCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhh
Q 019650          203 NNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERW-GGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAIC  281 (337)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~  281 (337)
                                  ...-+++|||.|||||+..-+.. +.+|++++||||||++|.||..+.+|.......    .++.++.
T Consensus       185 ------------qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM----RVllKia  248 (1187)
T KOG0579|consen  185 ------------QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM----RVLLKIA  248 (1187)
T ss_pred             ------------hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH----HHHHHHh
Confidence                        33446789999999998853311 568999999999999999999999997544332    3333334


Q ss_pred             ccCCCCC--CCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCCcccc
Q 019650          282 FGERLEM--PETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNIE  333 (337)
Q Consensus       282 ~~~~~~~--~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~~~~~  333 (337)
                      ...++.+  |...+..+.+|+.+||.+||+.||++.++|+||||++...-..+.
T Consensus       249 KSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~SnK~ir  302 (1187)
T KOG0579|consen  249 KSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAPSNKMIR  302 (1187)
T ss_pred             hcCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccCCcchHHH
Confidence            4444443  567788999999999999999999999999999999876444433

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=9.6e-44  Score=307.61  Aligned_cols=259  Identities=31%  Similarity=0.499  Sum_probs=214.8

Q ss_pred             cccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEe
Q 019650           47 SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVME  126 (337)
Q Consensus        47 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~e  126 (337)
                      ++|++.+.||.|++|+||+|.+..++..+++|++.........+.+.+|+..++.++|+|++++++.+.. ....+++||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~iv~e   79 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVV-GDELWLVMP   79 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEee-CCEEEEEEe
Confidence            5799999999999999999999889999999999765544466788899999999999999999998766 688999999


Q ss_pred             ccCCCCchHHhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCC
Q 019650          127 HMERGSLFDSLRVR---KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNN  203 (337)
Q Consensus       127 ~~~~~~L~~~l~~~---~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~  203 (337)
                      ++++++|.+++...   ..+++..+..++.|++.||++||+.|++|+||+|+||++++++.++|+|||.+..........
T Consensus        80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~  159 (267)
T cd06610          80 YLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRT  159 (267)
T ss_pred             ccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcccc
Confidence            99999999999764   458999999999999999999999999999999999999999999999999987775543211


Q ss_pred             CCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhcc
Q 019650          204 NHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFG  283 (337)
Q Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~  283 (337)
                      .          .......++..|+|||.+...   ..++.++|+||||+++|+|++|+.||...............    
T Consensus       160 ~----------~~~~~~~~~~~y~~Pe~~~~~---~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~----  222 (267)
T cd06610         160 R----------KVRKTFVGTPCWMAPEVMEQV---HGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN----  222 (267)
T ss_pred             c----------cccccccCChhhcChHHHccc---cCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcC----
Confidence            0          112333578899999998742   26788999999999999999999999665443322222221    


Q ss_pred             CCCCCC-----CCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccc
Q 019650          284 ERLEMP-----ETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV  323 (337)
Q Consensus       284 ~~~~~~-----~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f  323 (337)
                      ......     ..++..+.+++.+||..||++|||+++++.||||
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         223 DPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             CCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence            121111     2567899999999999999999999999999998

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=1.4e-43  Score=310.84  Aligned_cols=273  Identities=31%  Similarity=0.468  Sum_probs=219.8

Q ss_pred             ccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEE
Q 019650           43 VENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEIC  122 (337)
Q Consensus        43 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~  122 (337)
                      ...-+.|++++.||.|++|.||+|.+..++..+++|.+.... ......+.+|+.+++.++|+|++++++.+.. +...+
T Consensus         8 ~~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   85 (292)
T cd06644           8 LDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS-EEELEDYMVEIEILATCNHPYIVKLLGAFYW-DGKLW   85 (292)
T ss_pred             cCcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEe-CCeEE
Confidence            344578999999999999999999999999999999987653 3345677889999999999999999998776 67899


Q ss_pred             EEEeccCCCCchHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhcccc
Q 019650          123 FVMEHMERGSLFDSLRV-RKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRN  201 (337)
Q Consensus       123 lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~  201 (337)
                      +||||+++++|..++.+ ...+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+....... 
T Consensus        86 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-  164 (292)
T cd06644          86 IMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-  164 (292)
T ss_pred             EEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccccc-
Confidence            99999999999888754 4578999999999999999999999999999999999999999999999999876543221 


Q ss_pred             CCCCCCCCCCccccccccccCCCCCcCCcccccccC-CCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHh
Q 019650          202 NNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERW-GGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAI  280 (337)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~  280 (337)
                                   .......++..|+|||.+..... ...++.++|+||||+++|+|++|..||.........    ...
T Consensus       165 -------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~----~~~  227 (292)
T cd06644         165 -------------QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL----LKI  227 (292)
T ss_pred             -------------cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHH----HHH
Confidence                         11112347889999999853211 345788999999999999999999998654322211    111


Q ss_pred             hccCC--CCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCCccccCc
Q 019650          281 CFGER--LEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNIEGL  335 (337)
Q Consensus       281 ~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~~~~~~~  335 (337)
                      .....  ...+..++..+.+++.+||..+|++||+++++++||||....+.....++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~~~~~~  284 (292)
T cd06644         228 AKSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSNRPLREL  284 (292)
T ss_pred             hcCCCccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccccchhHHHH
Confidence            11211  12345567899999999999999999999999999999987766654443

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1e-43  Score=323.92  Aligned_cols=259  Identities=23%  Similarity=0.363  Sum_probs=206.2

Q ss_pred             CccccccccccccCcceEEEEEEEc--cCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEE
Q 019650           45 NISDLKKLTVLGHGNGGIVYKVRHQ--KSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEIC  122 (337)
Q Consensus        45 ~~~~y~~~~~lg~g~~~~v~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~  122 (337)
                      ...+|.+++.||.|+||.||+|...  .++..|++|.+...      ....+|+.++++++|+||+++++.+.. ....|
T Consensus        90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~------~~~~~E~~il~~l~h~~iv~~~~~~~~-~~~~~  162 (392)
T PHA03207         90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG------KTPGREIDILKTISHRAIINLIHAYRW-KSTVC  162 (392)
T ss_pred             ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc------ccHHHHHHHHHhcCCCCccceeeeEee-CCEEE
Confidence            3457999999999999999999764  45678999987643      234579999999999999999998765 68899


Q ss_pred             EEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccC
Q 019650          123 FVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNN  202 (337)
Q Consensus       123 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~  202 (337)
                      ++||++. ++|.+++.....+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++.........
T Consensus       163 lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~  241 (392)
T PHA03207        163 MVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDT  241 (392)
T ss_pred             EEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCccccc
Confidence            9999996 589999977788999999999999999999999999999999999999999999999999998765432211


Q ss_pred             CCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCch---hHHHHHHH
Q 019650          203 NNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP---DLMALICA  279 (337)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~---~~~~~~~~  279 (337)
                                  .......|++.|+|||++.    +..++.++||||||+++|+|++|+.||.+.....   .+..+...
T Consensus       242 ------------~~~~~~~gt~~y~aPE~~~----~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~  305 (392)
T PHA03207        242 ------------PQCYGWSGTLETNSPELLA----LDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRC  305 (392)
T ss_pred             ------------ccccccccccCccCHhHhc----CCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHH
Confidence                        1122346899999999998    4578899999999999999999999997643321   11111111


Q ss_pred             hh----------------------ccCCCCC--C-----CCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccC
Q 019650          280 IC----------------------FGERLEM--P-----ETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRS  327 (337)
Q Consensus       280 ~~----------------------~~~~~~~--~-----~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~  327 (337)
                      ..                      ......+  +     ...+..+.++|.+||..||++|||+.++|.||||++..
T Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~  382 (392)
T PHA03207        306 MQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEP  382 (392)
T ss_pred             hccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccc
Confidence            00                      0000000  1     12456789999999999999999999999999998754

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=8.1e-44  Score=312.10  Aligned_cols=257  Identities=30%  Similarity=0.497  Sum_probs=218.1

Q ss_pred             cccccccccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 019650           47 SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFV  124 (337)
Q Consensus        47 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv  124 (337)
                      ++|++.+.||.|++|.||++.+..+++.+|+|++....  .....+.+.+|+.+++++.|+||+++++.+.. +...+++
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v   79 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQD-DSNLYLV   79 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEc-CCeEEEE
Confidence            47999999999999999999999999999999986542  22345667889999999999999999998876 6889999


Q ss_pred             EeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCC
Q 019650          125 MEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNN  204 (337)
Q Consensus       125 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~  204 (337)
                      |||+++++|.+++.....+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++......     
T Consensus        80 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-----  154 (290)
T cd05580          80 MEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-----  154 (290)
T ss_pred             EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-----
Confidence            999999999999988889999999999999999999999999999999999999999999999999988765432     


Q ss_pred             CCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhccC
Q 019650          205 HNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGE  284 (337)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~  284 (337)
                                  .....+++.|+|||.+.    +..++.++|+||||+++|+|++|..||......    ....... ..
T Consensus       155 ------------~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~-~~  213 (290)
T cd05580         155 ------------TYTLCGTPEYLAPEIIL----SKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI----QIYEKIL-EG  213 (290)
T ss_pred             ------------CCCCCCCccccChhhhc----CCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHh-cC
Confidence                        11224788999999987    446788999999999999999999999654321    1122222 23


Q ss_pred             CCCCCCCCCHHHHHHHHHHhhcCcCCCC-----CHHHHhcCccccccCCCc
Q 019650          285 RLEMPETASPEFRRFVRSCLEKDWRKRG-----TVEELLAYPFVTKRSSSS  330 (337)
Q Consensus       285 ~~~~~~~~~~~~~~li~~~l~~~p~~R~-----s~~eil~hp~f~~~~~~~  330 (337)
                      ...++...+..+++++.+||..||.+|+     +++++++||||+...+..
T Consensus       214 ~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~  264 (290)
T cd05580         214 KVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWIA  264 (290)
T ss_pred             CccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCCHHH
Confidence            4556677799999999999999999999     999999999998776543

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.4e-43  Score=306.72  Aligned_cols=259  Identities=31%  Similarity=0.458  Sum_probs=214.1

Q ss_pred             ccccccccccCcceEEEEEEEccCCceEEEEEeecCCch--------HhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCC
Q 019650           48 DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSST--------IIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEG  119 (337)
Q Consensus        48 ~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~  119 (337)
                      +|.+...||.|++|.||+|.+..++..+++|.+......        ...+.+.+|+.++++++|+||+++++.+.. ..
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~   79 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLD-AD   79 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe-CC
Confidence            478889999999999999999888999999988654321        233567789999999999999999998776 67


Q ss_pred             eEEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhcc
Q 019650          120 EICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEET  199 (337)
Q Consensus       120 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~  199 (337)
                      ..+++|||+++++|.+++...+.+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd06628          80 HLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEAN  159 (267)
T ss_pred             ccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCcccccc
Confidence            89999999999999999988888999999999999999999999999999999999999999999999999998776532


Q ss_pred             ccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHH
Q 019650          200 RNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICA  279 (337)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~  279 (337)
                      ......        ........++..|+|||.+.    +..++.++|+||||+++|+|++|+.||........    ...
T Consensus       160 ~~~~~~--------~~~~~~~~~~~~y~~pe~~~----~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~----~~~  223 (267)
T cd06628         160 SLSTKT--------NGARPSLQGSVFWMAPEVVK----QTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQA----IFK  223 (267)
T ss_pred             cccCCc--------cccccccCCCcCccChhHhc----cCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHH----HHH
Confidence            111100        01122334788999999997    45678899999999999999999999975433222    222


Q ss_pred             hhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccc
Q 019650          280 ICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV  323 (337)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f  323 (337)
                      ......+..+...+..+.+++.+||+.||.+||++.++++||||
T Consensus       224 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         224 IGENASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             HhccCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence            22234455667789999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.2e-43  Score=307.32  Aligned_cols=262  Identities=29%  Similarity=0.435  Sum_probs=215.3

Q ss_pred             ccccccccccCcceEEEEEEEccCCceEEEEEeecCCc-----hHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEE
Q 019650           48 DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSS-----TIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEIC  122 (337)
Q Consensus        48 ~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~  122 (337)
                      +|+..+.||.|++|.||++.+..++..+|+|++.....     ....+.+.+|+.++++++|+|++++++.+.+ .+..+
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~   79 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCE-DSHFN   79 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceecc-CCeEE
Confidence            47888999999999999999999999999999875431     2245677889999999999999999998876 67899


Q ss_pred             EEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCC-cEEEeeccCccchhcccc
Q 019650          123 FVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKG-EVKIADFGVSRIVEETRN  201 (337)
Q Consensus       123 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~-~~~l~Dfg~~~~~~~~~~  201 (337)
                      +|+||+++++|.+++...+++++..+..++.|++.||.+||++|++|+||+|+||+++.++ .++|+|||.+........
T Consensus        80 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~  159 (268)
T cd06630          80 LFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGT  159 (268)
T ss_pred             EEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccccccc
Confidence            9999999999999998888899999999999999999999999999999999999998776 599999999877654321


Q ss_pred             CCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhh
Q 019650          202 NNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAIC  281 (337)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~  281 (337)
                      ...          .......++..|+|||.+.    +..++.++|+||||+++|+|++|..||.................
T Consensus       160 ~~~----------~~~~~~~~~~~~~~PE~~~----~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~  225 (268)
T cd06630         160 GAG----------EFQGQLLGTIAFMAPEVLR----GEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIAS  225 (268)
T ss_pred             cCC----------ccccccccccceeCHhHhc----cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhc
Confidence            110          1112234788999999987    45678899999999999999999999965433222222222222


Q ss_pred             ccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCcccc
Q 019650          282 FGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVT  324 (337)
Q Consensus       282 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~  324 (337)
                      .......+...+..+.+++.+||..+|++|||+.++++||||+
T Consensus       226 ~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~  268 (268)
T cd06630         226 ATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR  268 (268)
T ss_pred             cCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence            3334556667789999999999999999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=2.4e-43  Score=303.30  Aligned_cols=253  Identities=34%  Similarity=0.576  Sum_probs=213.4

Q ss_pred             ccccccccccCcceEEEEEEEccCCceEEEEEeecCC-chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEe
Q 019650           48 DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVME  126 (337)
Q Consensus        48 ~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~e  126 (337)
                      +|++.+.||.|++|.||+|.+..++..|++|.+.... .....+.+.+|+.++++++|+|++++++.+.+ ....+++||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e   79 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLD-KGKLNIVME   79 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeecc-CCEEEEEEE
Confidence            5888999999999999999999999999999986542 34456778889999999999999999998876 688999999


Q ss_pred             ccCCCCchHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCC
Q 019650          127 HMERGSLFDSLRVR--KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNN  204 (337)
Q Consensus       127 ~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~  204 (337)
                      |+++++|.+++...  ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+........   
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~---  156 (256)
T cd08529          80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN---  156 (256)
T ss_pred             eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccc---
Confidence            99999999999764  5789999999999999999999999999999999999999999999999998876643221   


Q ss_pred             CCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhccC
Q 019650          205 HNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGE  284 (337)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~  284 (337)
                                 ......+++.|+|||++.    +..++.++|+||||+++|+|++|..||......    ........+.
T Consensus       157 -----------~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~  217 (256)
T cd08529         157 -----------FANTIVGTPYYLSPELCE----DKPYNEKSDVWALGVVLYECCTGKHPFDANNQG----ALILKIIRGV  217 (256)
T ss_pred             -----------hhhccccCccccCHHHhc----CCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHcCC
Confidence                       111234788999999998    456788999999999999999999999654322    2222233344


Q ss_pred             CCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccc
Q 019650          285 RLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV  323 (337)
Q Consensus       285 ~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f  323 (337)
                      ....+..++..+.+++.+||+.+|++||++.+++.|||+
T Consensus       218 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         218 FPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL  256 (256)
T ss_pred             CCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence            445555778999999999999999999999999999995

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-43  Score=305.64  Aligned_cols=260  Identities=33%  Similarity=0.466  Sum_probs=212.2

Q ss_pred             ccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 019650           46 ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVM  125 (337)
Q Consensus        46 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~  125 (337)
                      .++|++.+.||.|++|.||+|.+..++..+++|++...... ..+.+.+|+.++++++|+|++++++.+.. +..++++|
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~l~~   79 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD-DFEIIQQEISMLKECRHPNIVAYFGSYLR-RDKLWIVM   79 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh-hHHHHHHHHHHHHhCCCCChhceEEEEEe-CCEEEEEE
Confidence            36899999999999999999999988999999999765433 45778889999999999999999998766 78899999


Q ss_pred             eccCCCCchHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCC
Q 019650          126 EHMERGSLFDSLRVR-KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNN  204 (337)
Q Consensus       126 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~  204 (337)
                      ||+++++|.+++... ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+.......    
T Consensus        80 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~----  155 (262)
T cd06613          80 EYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI----  155 (262)
T ss_pred             eCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhh----
Confidence            999999999999876 789999999999999999999999999999999999999999999999999987654321    


Q ss_pred             CCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhccC
Q 019650          205 HNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGE  284 (337)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~  284 (337)
                                .......++..|+|||.+.... ...++.++|+||||+++|+|++|..||....................
T Consensus       156 ----------~~~~~~~~~~~y~~Pe~~~~~~-~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~  224 (262)
T cd06613         156 ----------AKRKSFIGTPYWMAPEVAAVER-KGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPP  224 (262)
T ss_pred             ----------hccccccCCccccCchhhcccc-cCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCc
Confidence                      1111235788899999987321 12678899999999999999999999976543332222211100111


Q ss_pred             CCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCcc
Q 019650          285 RLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPF  322 (337)
Q Consensus       285 ~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~  322 (337)
                      ........+..+.+++.+||..+|.+|||+.+++.|||
T Consensus       225 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         225 KLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             cccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence            11223345678999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-43  Score=314.45  Aligned_cols=275  Identities=30%  Similarity=0.458  Sum_probs=219.6

Q ss_pred             cccccccccccCcceEEEEEEEccCCceEEEEEeecCCch--HhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 019650           47 SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSST--IIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFV  124 (337)
Q Consensus        47 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv  124 (337)
                      ++|.+.+.||.|++|+||+|.+..+++.+|+|.+......  ...+.+.+|+.+++.++|++|+++++.+.. +...+++
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv   79 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQT-ETYLCLV   79 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeec-CCEEEEE
Confidence            4789999999999999999999999999999999765422  245667889999999999999999998766 6889999


Q ss_pred             EeccCCCCchHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccC
Q 019650          125 MEHMERGSLFDSLRVR--KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNN  202 (337)
Q Consensus       125 ~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~  202 (337)
                      |||+.|++|.+++...  ..+++..+..++.|++.+|+|||+.|++|+||||+||+++.++.++|+|||.+.........
T Consensus        80 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~  159 (316)
T cd05574          80 MDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPP  159 (316)
T ss_pred             EEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhcccccccc
Confidence            9999999999998754  56899999999999999999999999999999999999999999999999988765432211


Q ss_pred             CCCCCCCC---------------CccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Q 019650          203 NNHNNNNN---------------NNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGF  267 (337)
Q Consensus       203 ~~~~~~~~---------------~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~  267 (337)
                      ........               ..........+|+..|+|||.+.    +..++.++||||||+++|+|++|..||...
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~----~~~~~~~~Di~slG~ll~~l~~g~~pf~~~  235 (316)
T cd05574         160 VSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVIS----GDGHGSAVDWWTLGILLYEMLYGTTPFKGS  235 (316)
T ss_pred             cccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHc----CCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence            10000000               00001122346888999999997    456788999999999999999999999765


Q ss_pred             CCchhHHHHHHHhhccCCCCCCC--CCCHHHHHHHHHHhhcCcCCCCC----HHHHhcCccccccCCCcc
Q 019650          268 GEKPDLMALICAICFGERLEMPE--TASPEFRRFVRSCLEKDWRKRGT----VEELLAYPFVTKRSSSSN  331 (337)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~~p~~R~s----~~eil~hp~f~~~~~~~~  331 (337)
                      ...........     ....++.  ..+..+.+++.+||..+|++|||    +++++.||||++..++..
T Consensus       236 ~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~~~~~  300 (316)
T cd05574         236 NRDETFSNILK-----KEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWALI  300 (316)
T ss_pred             chHHHHHHHhc-----CCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCChhhc
Confidence            44433332221     1222222  36899999999999999999999    999999999999876643

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.3e-43  Score=308.32  Aligned_cols=265  Identities=35%  Similarity=0.590  Sum_probs=220.1

Q ss_pred             CccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 019650           45 NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFV  124 (337)
Q Consensus        45 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv  124 (337)
                      ..++|++.+.||+|++|+||++.+..++..+|+|++.........+.+.+|+++++.++|+|++++++.+.. ...+++|
T Consensus         3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv   81 (284)
T cd06620           3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLN-ENNICMC   81 (284)
T ss_pred             cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEec-CCEEEEE
Confidence            357899999999999999999999999999999998766555566788899999999999999999998877 5889999


Q ss_pred             EeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCC
Q 019650          125 MEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG-MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNN  203 (337)
Q Consensus       125 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~-~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~  203 (337)
                      |||+++++|.+++...+.+++..+..++.+++.+|.|||+ .+++|+||+|+||+++.++.++|+|||++.......   
T Consensus        82 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~---  158 (284)
T cd06620          82 MEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI---  158 (284)
T ss_pred             EecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc---
Confidence            9999999999999888889999999999999999999997 699999999999999999999999999876542211   


Q ss_pred             CCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCc-------hhHHHH
Q 019650          204 NHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEK-------PDLMAL  276 (337)
Q Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~-------~~~~~~  276 (337)
                                   .....++..|+|||++.    +..++.++|+||||+++|++++|..||......       ......
T Consensus       159 -------------~~~~~~~~~~~aPE~~~----~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~  221 (284)
T cd06620         159 -------------ADTFVGTSTYMSPERIQ----GGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDL  221 (284)
T ss_pred             -------------cCccccCcccCCHHHHc----cCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHH
Confidence                         11235889999999987    457888999999999999999999999754332       111122


Q ss_pred             HHHhhccCCCCCCC-CCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCCc
Q 019650          277 ICAICFGERLEMPE-TASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSS  330 (337)
Q Consensus       277 ~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~~  330 (337)
                      ...........++. ..+..+.+++.+||+.||++|||+.++++||||.+....+
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~~~~  276 (284)
T cd06620         222 LQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALRAS  276 (284)
T ss_pred             HHHHhhccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccccc
Confidence            22222232333333 3678899999999999999999999999999998776544

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=2e-43  Score=308.80  Aligned_cols=259  Identities=26%  Similarity=0.405  Sum_probs=212.9

Q ss_pred             ccccccccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 019650           48 DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVM  125 (337)
Q Consensus        48 ~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~  125 (337)
                      .|+..+.||.|+||+||++.+..+++.+|+|.+....  .......+.+|+.++++++|++++++.+.+.. +...+++|
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~-~~~~~lv~   79 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYET-KDALCLVL   79 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEec-CCEEEEEE
Confidence            3778889999999999999999999999999986543  12223456789999999999999999998766 68899999


Q ss_pred             eccCCCCchHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCC
Q 019650          126 EHMERGSLFDSLRVR--KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNN  203 (337)
Q Consensus       126 e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~  203 (337)
                      ||+.+++|.+++...  ..+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++.......   
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~---  156 (285)
T cd05632          80 TIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE---  156 (285)
T ss_pred             EeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC---
Confidence            999999999888643  469999999999999999999999999999999999999999999999999886543211   


Q ss_pred             CCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhcc
Q 019650          204 NHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFG  283 (337)
Q Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~  283 (337)
                                  ......++..|+|||.+.    +..++.++|+||||+++|+|++|..||....+........... ..
T Consensus       157 ------------~~~~~~g~~~~~aPE~~~----~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~-~~  219 (285)
T cd05632         157 ------------SIRGRVGTVGYMAPEVLN----NQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRV-LE  219 (285)
T ss_pred             ------------cccCCCCCcCccChHHhc----CCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhh-hc
Confidence                        111235899999999997    4578889999999999999999999997654332222222222 22


Q ss_pred             CCCCCCCCCCHHHHHHHHHHhhcCcCCCCC-----HHHHhcCccccccC
Q 019650          284 ERLEMPETASPEFRRFVRSCLEKDWRKRGT-----VEELLAYPFVTKRS  327 (337)
Q Consensus       284 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~s-----~~eil~hp~f~~~~  327 (337)
                      ....++...+..+.+|+.+||+.||.+||+     +.+++.||||+...
T Consensus       220 ~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~  268 (285)
T cd05632         220 TEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMN  268 (285)
T ss_pred             cccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCC
Confidence            234455677899999999999999999999     88999999998863

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=2.3e-43  Score=304.69  Aligned_cols=261  Identities=48%  Similarity=0.860  Sum_probs=222.5

Q ss_pred             cccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEe
Q 019650           47 SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVME  126 (337)
Q Consensus        47 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~e  126 (337)
                      ++|++.+.||.|++|.||+|.+..+++.+++|.+...........+.+|+..+.+++|+|++++++.+.. ....+++||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~e   79 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYK-EGEISIVLE   79 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcc-CCeEEEEEE
Confidence            4688999999999999999999999999999998776544556778899999999999999999998876 688999999


Q ss_pred             ccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCCC
Q 019650          127 HMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG-MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNH  205 (337)
Q Consensus       127 ~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~-~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~  205 (337)
                      |+++++|.+++.....+++..+..++.|++.+|++||+ .|++|+||+|+||+++.++.++|+|||.+.........   
T Consensus        80 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~---  156 (264)
T cd06623          80 YMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ---  156 (264)
T ss_pred             ecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc---
Confidence            99999999999888889999999999999999999999 99999999999999999999999999988766432211   


Q ss_pred             CCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhccCC
Q 019650          206 NNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGER  285 (337)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~  285 (337)
                                 .....++..|+|||.+.    +..++.++|+||||+++|+|++|..||..... ...............
T Consensus       157 -----------~~~~~~~~~y~~pE~~~----~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~-~~~~~~~~~~~~~~~  220 (264)
T cd06623         157 -----------CNTFVGTVTYMSPERIQ----GESYSYAADIWSLGLTLLECALGKFPFLPPGQ-PSFFELMQAICDGPP  220 (264)
T ss_pred             -----------ccceeecccccCHhhhC----CCCCCchhhHHHHHHHHHHHHhCCCCCccccc-cCHHHHHHHHhcCCC
Confidence                       11224788999999987    45788899999999999999999999976542 123333344444444


Q ss_pred             CCCCCC-CCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccC
Q 019650          286 LEMPET-ASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRS  327 (337)
Q Consensus       286 ~~~~~~-~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~  327 (337)
                      ...+.. ++..+.++|.+||..+|++|||++++++||||++.+
T Consensus       221 ~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~~  263 (264)
T cd06623         221 PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKAD  263 (264)
T ss_pred             CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhcc
Confidence            555555 789999999999999999999999999999998754

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=3.3e-43  Score=304.16  Aligned_cols=260  Identities=28%  Similarity=0.432  Sum_probs=212.0

Q ss_pred             ccccccccccCcceEEEEEEEccCCceEEEEEeecCCc-----hHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEE
Q 019650           48 DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSS-----TIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEIC  122 (337)
Q Consensus        48 ~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~  122 (337)
                      +|++.+.||.|+||+||+|.+ .++..+|+|.+.....     ......+.+|+.++++++|+|++++++.+.+ ....+
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~   78 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLD-DNTIS   78 (265)
T ss_pred             CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeec-CCeEE
Confidence            588999999999999999986 4778899998865421     2233567789999999999999999998876 68899


Q ss_pred             EEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccC
Q 019650          123 FVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNN  202 (337)
Q Consensus       123 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~  202 (337)
                      +++||+++++|.+++.....+++..+..++.|++.+|+|||+.|++|+||+|+||+++.++.++|+|||.+.........
T Consensus        79 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~  158 (265)
T cd06631          79 IFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLH  158 (265)
T ss_pred             EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcccc
Confidence            99999999999999988788999999999999999999999999999999999999999999999999988765432111


Q ss_pred             CCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhc
Q 019650          203 NNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICF  282 (337)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~  282 (337)
                      ....        .......++..|+|||.+.    +..++.++|+||||+++|+|++|..||............  ....
T Consensus       159 ~~~~--------~~~~~~~~~~~~~~pe~~~----~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~--~~~~  224 (265)
T cd06631         159 GTHS--------NMLKSMHGTPYWMAPEVIN----ESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYI--GAHR  224 (265)
T ss_pred             cccc--------ccccccCCCccccChhhhc----CCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHh--hhcc
Confidence            1000        1112235788999999998    456788999999999999999999999654332222111  1111


Q ss_pred             cCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccc
Q 019650          283 GERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV  323 (337)
Q Consensus       283 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f  323 (337)
                      ...+..+...+..+.++|.+||..+|++||++.++++||||
T Consensus       225 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         225 GLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             CCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            23345566788999999999999999999999999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=2.5e-43  Score=309.77  Aligned_cols=266  Identities=28%  Similarity=0.461  Sum_probs=217.9

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEE
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICF  123 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~l  123 (337)
                      ....+|++.+.||.|++|.||+|.+..++..+++|.+...... ..+.+.+|+.+++.++|+|++++++.+.. +...++
T Consensus        17 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~-~~~~~~~e~~~l~~~~h~~v~~~~~~~~~-~~~~~l   94 (296)
T cd06654          17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLV-GDELWV   94 (296)
T ss_pred             CcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc-hHHHHHHHHHHHHhCCCCCEeeEEEEEEe-CCEEEE
Confidence            4457999999999999999999999999999999998765433 34667789999999999999999998776 688999


Q ss_pred             EEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCC
Q 019650          124 VMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNN  203 (337)
Q Consensus       124 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~  203 (337)
                      ||||+++++|.+++.. ..+++.++..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+........  
T Consensus        95 v~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~--  171 (296)
T cd06654          95 VMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--  171 (296)
T ss_pred             eecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhcccccc--
Confidence            9999999999999864 4589999999999999999999999999999999999999999999999998876533211  


Q ss_pred             CCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhcc
Q 019650          204 NHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFG  283 (337)
Q Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~  283 (337)
                                  ......+++.|+|||.+.    +..++.++|+||||+++|+|++|+.||.............  ....
T Consensus       172 ------------~~~~~~~~~~y~aPE~~~----~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~--~~~~  233 (296)
T cd06654         172 ------------KRSTMVGTPYWMAPEVVT----RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA--TNGT  233 (296)
T ss_pred             ------------ccCcccCCccccCHHHHc----CCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHh--cCCC
Confidence                        111224788999999987    4567889999999999999999999996543322221111  1111


Q ss_pred             CCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCCccc
Q 019650          284 ERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNI  332 (337)
Q Consensus       284 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~~~~  332 (337)
                      .....+..++..+.+++.+||..+|.+|||+++++.||||......+.+
T Consensus       234 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~~~~~  282 (296)
T cd06654         234 PELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSL  282 (296)
T ss_pred             CCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhccCCcccc
Confidence            1223345678899999999999999999999999999999877654443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=3.8e-43  Score=304.01  Aligned_cols=259  Identities=29%  Similarity=0.446  Sum_probs=211.4

Q ss_pred             cccccccccccCcceEEEEEEEccCCceEEEEEeecCC----chHhHHHHHHHHHHHHhcCCCCceeeeeeEEee-CCeE
Q 019650           47 SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS----STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTI-EGEI  121 (337)
Q Consensus        47 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-~~~~  121 (337)
                      .+|++.+.||.|++|.||++.+..++..|++|.+....    .......+.+|+.++++++|+|++++++.+.+. +...
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            46899999999999999999999999999999886432    222345677899999999999999999987653 3578


Q ss_pred             EEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhcccc
Q 019650          122 CFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRN  201 (337)
Q Consensus       122 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~  201 (337)
                      ++++||+++++|.+++.....+++...+.++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~  161 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICM  161 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccc
Confidence            89999999999999998878899999999999999999999999999999999999999999999999999876532111


Q ss_pred             CCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhh
Q 019650          202 NNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAIC  281 (337)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~  281 (337)
                      ..           .......++..|+|||.+.    +..++.++|+||+|+++|+|++|+.||........   ......
T Consensus       162 ~~-----------~~~~~~~~~~~y~aPE~~~----~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~---~~~~~~  223 (266)
T cd06651         162 SG-----------TGIRSVTGTPYWMSPEVIS----GEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAA---IFKIAT  223 (266)
T ss_pred             cC-----------CccccCCccccccCHHHhC----CCCCCchhhhHHHHHHHHHHHHCCCCccccchHHH---HHHHhc
Confidence            00           1111234788999999997    45678899999999999999999999975433222   222222


Q ss_pred             ccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCcccc
Q 019650          282 FGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVT  324 (337)
Q Consensus       282 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~  324 (337)
                      ....+.++...+..+.+++ .||..+|++||+++++++||||+
T Consensus       224 ~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~  265 (266)
T cd06651         224 QPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ  265 (266)
T ss_pred             CCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence            3334555666788999999 67789999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.2e-43  Score=318.39  Aligned_cols=262  Identities=26%  Similarity=0.367  Sum_probs=207.7

Q ss_pred             CccccccccccccCcceEEEEEEEccCCceEEEEEeecCCc-hHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeC-----
Q 019650           45 NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSS-TIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIE-----  118 (337)
Q Consensus        45 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~-----  118 (337)
                      ..++|.+++.||.|+||+||+|.+..++..||+|.+..... ......+.+|+.++++++|+||+++++++....     
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07878          13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF   92 (343)
T ss_pred             hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence            35789999999999999999999999999999999875432 233455678999999999999999998775321     


Q ss_pred             CeEEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhc
Q 019650          119 GEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEE  198 (337)
Q Consensus       119 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~  198 (337)
                      ...|++++++ +++|.+++. ...+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++.....
T Consensus        93 ~~~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~  170 (343)
T cd07878          93 NEVYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADD  170 (343)
T ss_pred             CcEEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCC
Confidence            3478999998 668988775 45699999999999999999999999999999999999999999999999999876532


Q ss_pred             cccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHH
Q 019650          199 TRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALIC  278 (337)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~  278 (337)
                      ..                 ...++++.|+|||++..   ...++.++||||||+++|+|++|..||..............
T Consensus       171 ~~-----------------~~~~~t~~y~aPE~~~~---~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~  230 (343)
T cd07878         171 EM-----------------TGYVATRWYRAPEIMLN---WMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIME  230 (343)
T ss_pred             Cc-----------------CCccccccccCchHhcC---CccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHH
Confidence            11                 12358899999999873   24678899999999999999999999976433222222211


Q ss_pred             Hhhcc------------------CCCC--------CCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCC
Q 019650          279 AICFG------------------ERLE--------MPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSS  328 (337)
Q Consensus       279 ~~~~~------------------~~~~--------~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~  328 (337)
                      .....                  ....        .....++.+.+++.+||..||.+|||+.++|.||||.+...
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~  306 (343)
T cd07878         231 VVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHD  306 (343)
T ss_pred             HhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCC
Confidence            10000                  0000        11234667899999999999999999999999999987654

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=2e-43  Score=308.78  Aligned_cols=257  Identities=26%  Similarity=0.394  Sum_probs=205.0

Q ss_pred             ccccccccccCcceEEEEEEEccCCceEEEEEeecCC-chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEe
Q 019650           48 DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVME  126 (337)
Q Consensus        48 ~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~e  126 (337)
                      +|++.+.||.|++|.||+|.+..++..||+|.+.... .......+.+|+.++++++|+|++++++.+.. +...++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e   79 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQ-ESRLYLIFE   79 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEee-CCeEEEEEe
Confidence            5889999999999999999999899999999986543 22234567789999999999999999998876 788999999


Q ss_pred             ccCCCCchHHhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCC
Q 019650          127 HMERGSLFDSLRVR---KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNN  203 (337)
Q Consensus       127 ~~~~~~L~~~l~~~---~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~  203 (337)
                      |+. ++|.+++...   ..+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++........  
T Consensus        80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~--  156 (285)
T cd07861          80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR--  156 (285)
T ss_pred             cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc--
Confidence            997 4888888643   4689999999999999999999999999999999999999999999999999875432211  


Q ss_pred             CCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhc-
Q 019650          204 NHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICF-  282 (337)
Q Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~-  282 (337)
                                  ......+++.|+|||.+...   ..++.++|+||||+++|+|++|+.||....+............. 
T Consensus       157 ------------~~~~~~~~~~y~aPE~~~~~---~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~  221 (285)
T cd07861         157 ------------VYTHEVVTLWYRAPEVLLGS---PRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTP  221 (285)
T ss_pred             ------------cccCCcccccccChHHhcCC---CCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCC
Confidence                        11112468899999998642   34688999999999999999999999754332222221111000 


Q ss_pred             -----------------------cCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccc
Q 019650          283 -----------------------GERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV  323 (337)
Q Consensus       283 -----------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f  323 (337)
                                             .........++..+.++|.+||..||++|||++++++||||
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         222 TEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             ChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence                                   00001123468899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.9e-43  Score=339.69  Aligned_cols=267  Identities=22%  Similarity=0.412  Sum_probs=216.0

Q ss_pred             CCccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCC-chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeC-
Q 019650           41 PDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIE-  118 (337)
Q Consensus        41 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~-  118 (337)
                      +.....++|++++.||.|+||+||+|.+..++..+|+|++.... .......+..|+.++.+++|+||+++++.+.... 
T Consensus         7 ~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~   86 (1021)
T PTZ00266          7 DGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKAN   86 (1021)
T ss_pred             CCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCC
Confidence            34566789999999999999999999999999999999987543 3334567888999999999999999999886543 


Q ss_pred             CeEEEEEeccCCCCchHHhhh----cCCCCHHHHHHHHHHHHHHHHHHHhC-------CceeccCCCCCeEEcCC-----
Q 019650          119 GEICFVMEHMERGSLFDSLRV----RKKLSEDVISGVAYRVLKGLQYLHGM-------QIIHGDIKPSNLLINGK-----  182 (337)
Q Consensus       119 ~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~~-------~ivH~dl~~~Nili~~~-----  182 (337)
                      ..+|+||||+++++|.++|..    ...+++..++.|+.||+.||+|||+.       +|+|+||||+|||++.+     
T Consensus        87 ~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg  166 (1021)
T PTZ00266         87 QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG  166 (1021)
T ss_pred             CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence            568999999999999999875    25799999999999999999999984       49999999999999642     


Q ss_pred             ------------CcEEEeeccCccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHH
Q 019650          183 ------------GEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSL  250 (337)
Q Consensus       183 ------------~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Diwsl  250 (337)
                                  +.++|+|||++.......               ......+++.|+|||++...  ...++.++|||||
T Consensus       167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s---------------~~~s~vGTp~YmAPEvL~ge--~~~~s~KSDVWSL  229 (1021)
T PTZ00266        167 KITAQANNLNGRPIAKIGDFGLSKNIGIES---------------MAHSCVGTPYYWSPELLLHE--TKSYDDKSDMWAL  229 (1021)
T ss_pred             cccccccccCCCCceEEccCCccccccccc---------------cccccCCCccccCHHHHhcc--CCCCCchhHHHHH
Confidence                        348999999987653321               11234689999999998643  2457889999999


Q ss_pred             HHHHHHHHhCCCCCCCCCCchhHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCC
Q 019650          251 GVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSS  328 (337)
Q Consensus       251 G~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~  328 (337)
                      ||++|+|++|..||...........   ...... .......+..+.+||..||..+|.+||++.++|.||||++...
T Consensus       230 G~ILYELLTGk~PF~~~~~~~qli~---~lk~~p-~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~~  303 (1021)
T PTZ00266        230 GCIIYELCSGKTPFHKANNFSQLIS---ELKRGP-DLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVGP  303 (1021)
T ss_pred             HHHHHHHHHCCCCCCcCCcHHHHHH---HHhcCC-CCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcCC
Confidence            9999999999999975443332222   222222 2222456889999999999999999999999999999986654

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.3e-43  Score=309.84  Aligned_cols=257  Identities=25%  Similarity=0.376  Sum_probs=203.6

Q ss_pred             ccccccccccCcceEEEEEEEccCCceEEEEEeecCC-chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEe
Q 019650           48 DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVME  126 (337)
Q Consensus        48 ~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~e  126 (337)
                      +|++.+.||.|++|.||+|.+..+|..+++|.+.... .......+.+|+.++++++|+|++++++.+.+ ....++++|
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e   79 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHS-DKKLTLVFE   79 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhcc-CCceEEEEe
Confidence            5889999999999999999999999999999987543 22233456779999999999999999998876 678999999


Q ss_pred             ccCCCCchHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCCC
Q 019650          127 HMERGSLFDSLRV-RKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNH  205 (337)
Q Consensus       127 ~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~  205 (337)
                      |+++ +|.+++.. ...+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||.+........    
T Consensus        80 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~----  154 (284)
T cd07839          80 YCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR----  154 (284)
T ss_pred             cCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC----
Confidence            9975 88888764 46799999999999999999999999999999999999999999999999999876533211    


Q ss_pred             CCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhcc--
Q 019650          206 NNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFG--  283 (337)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~--  283 (337)
                                ......++..|+|||.+...   ..++.++|+||||+++|+|++|..|+....+..............  
T Consensus       155 ----------~~~~~~~~~~y~aPE~~~~~---~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~  221 (284)
T cd07839         155 ----------CYSAEVVTLWYRPPDVLFGA---KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPT  221 (284)
T ss_pred             ----------CcCCCccccCCcChHHHhCC---cccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCC
Confidence                      11122468899999998742   356889999999999999999988865433322221111111000  


Q ss_pred             --------------CCC---------CCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccc
Q 019650          284 --------------ERL---------EMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV  323 (337)
Q Consensus       284 --------------~~~---------~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f  323 (337)
                                    ...         ...+.++..+.++|.+||+.||.+|||++++++||||
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         222 EESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             hHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence                          000         1113467889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=6.8e-43  Score=305.01  Aligned_cols=263  Identities=32%  Similarity=0.452  Sum_probs=213.1

Q ss_pred             cccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEe
Q 019650           47 SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVME  126 (337)
Q Consensus        47 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~e  126 (337)
                      +-|++.+.||.|++|.||++.+..++..+++|.+.... ....+.+.+|+.+++.++|+|++++++.+.. ....++|+|
T Consensus         5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~-~~~~~~v~e   82 (282)
T cd06643           5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS-EEELEDYMVEIDILASCDHPNIVKLLDAFYY-ENNLWILIE   82 (282)
T ss_pred             HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC-HHHHHHHHHHHHHHHHCCCCCeeeEEEEEee-CCEEEEEEE
Confidence            34789999999999999999999999999999986543 3345667889999999999999999998876 688999999


Q ss_pred             ccCCCCchHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCCC
Q 019650          127 HMERGSLFDSLRV-RKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNH  205 (337)
Q Consensus       127 ~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~  205 (337)
                      |+++++|..++.. ..++++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......     
T Consensus        83 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-----  157 (282)
T cd06643          83 FCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-----  157 (282)
T ss_pred             ecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccc-----
Confidence            9999999888764 4579999999999999999999999999999999999999999999999999987653321     


Q ss_pred             CCCCCCccccccccccCCCCCcCCccccccc-CCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhccC
Q 019650          206 NNNNNNNIGEAAIACMGTCAYMSPERVDSER-WGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGE  284 (337)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~  284 (337)
                               .......++..|+|||.+.... .+..++.++|+||||+++|+|++|..||...............  ...
T Consensus       158 ---------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~--~~~  226 (282)
T cd06643         158 ---------QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS--EPP  226 (282)
T ss_pred             ---------cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhc--CCC
Confidence                     1112235788999999985321 1345788999999999999999999999654332222222111  111


Q ss_pred             CCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccC
Q 019650          285 RLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRS  327 (337)
Q Consensus       285 ~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~  327 (337)
                      ....+..++..+.++|.+||+.+|.+||++++++.||||+...
T Consensus       227 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  269 (282)
T cd06643         227 TLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNS  269 (282)
T ss_pred             CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEeccC
Confidence            2233456788999999999999999999999999999999764

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=4.2e-43  Score=301.77  Aligned_cols=254  Identities=35%  Similarity=0.567  Sum_probs=211.5

Q ss_pred             ccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 019650           46 ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVM  125 (337)
Q Consensus        46 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~  125 (337)
                      .++|++.+.||.|++|.||+|.+..++..+++|.+.....   .+.+.+|+.++++++|+|++++++.+.+ ....|+++
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~e~~~~~~l~~~~i~~~~~~~~~-~~~~~l~~   77 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED---LQEIIKEISILKQCDSPYIVKYYGSYFK-NTDLWIVM   77 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH---HHHHHHHHHHHHhCCCCcEeeeeeeeec-CCcEEEEE
Confidence            4789999999999999999999998889999999865422   6778899999999999999999998877 68899999


Q ss_pred             eccCCCCchHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCC
Q 019650          126 EHMERGSLFDSLRV-RKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNN  204 (337)
Q Consensus       126 e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~  204 (337)
                      |++++++|.+++.. ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+........   
T Consensus        78 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~---  154 (256)
T cd06612          78 EYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA---  154 (256)
T ss_pred             ecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc---
Confidence            99999999999975 45789999999999999999999999999999999999999999999999999887643321   


Q ss_pred             CCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhccC
Q 019650          205 HNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGE  284 (337)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~  284 (337)
                                 ......++..|+|||.+.    +..++.++|+||||+++|+|++|..||............  ......
T Consensus       155 -----------~~~~~~~~~~y~~PE~~~----~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~--~~~~~~  217 (256)
T cd06612         155 -----------KRNTVIGTPFWMAPEVIQ----EIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMI--PNKPPP  217 (256)
T ss_pred             -----------ccccccCCccccCHHHHh----cCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhh--ccCCCC
Confidence                       111234788999999987    457888999999999999999999999654332221111  111111


Q ss_pred             CCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccc
Q 019650          285 RLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV  323 (337)
Q Consensus       285 ~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f  323 (337)
                      ....+..++..+.+++.+||+.+|++|||++++|.||||
T Consensus       218 ~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~  256 (256)
T cd06612         218 TLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI  256 (256)
T ss_pred             CCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence            222344567899999999999999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=4.2e-43  Score=306.78  Aligned_cols=259  Identities=27%  Similarity=0.444  Sum_probs=209.5

Q ss_pred             cccccccccccCcceEEEEEEEccCCceEEEEEeecCCc-hHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 019650           47 SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSS-TIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVM  125 (337)
Q Consensus        47 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~  125 (337)
                      ++|++.+.||.|++|.||+|.+..+++.||+|.+..... ....+.+.+|+.++++++|+|++++++.+.. ....+++|
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~~v~   79 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRR-KRKLHLVF   79 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEee-CCEEEEEE
Confidence            479999999999999999999998999999999865432 2234557789999999999999999998876 68899999


Q ss_pred             eccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCCC
Q 019650          126 EHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNH  205 (337)
Q Consensus       126 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~  205 (337)
                      ||+++++|..++.....+++..+..++.|++.+|+|||+.|++|+||+|+||+++.++.++|+|||.+........    
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~----  155 (286)
T cd07847          80 EYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD----  155 (286)
T ss_pred             eccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcc----
Confidence            9999988888877777899999999999999999999999999999999999999999999999999887644321    


Q ss_pred             CCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhcc--
Q 019650          206 NNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFG--  283 (337)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~--  283 (337)
                                ......++..|+|||.+...   ..++.++|+||||+++|+|++|..||.+....+............  
T Consensus       156 ----------~~~~~~~~~~~~aPE~~~~~---~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  222 (286)
T cd07847         156 ----------DYTDYVATRWYRAPELLVGD---TQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIP  222 (286)
T ss_pred             ----------cccCcccccccCCHHHHhCC---CCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence                      11122467889999998632   357889999999999999999999997654433322222111000  


Q ss_pred             -----------------CCC-------CCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccc
Q 019650          284 -----------------ERL-------EMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV  323 (337)
Q Consensus       284 -----------------~~~-------~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f  323 (337)
                                       ...       ......+..+.+++.+||+.+|++|||+.+++.||||
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         223 RHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             HHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence                             000       0012457889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=4.9e-43  Score=305.10  Aligned_cols=260  Identities=29%  Similarity=0.466  Sum_probs=218.0

Q ss_pred             ccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 019650           46 ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVM  125 (337)
Q Consensus        46 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~  125 (337)
                      ...|+..+.||.|++|.||+|.+..++..+|+|.+...........+.+|+.+++++.|++++++++.+.+ +...++||
T Consensus         3 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~   81 (277)
T cd06640           3 EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-GTKLWIIM   81 (277)
T ss_pred             HHhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-CCEEEEEE
Confidence            35688999999999999999999989999999998766545556788899999999999999999998876 78899999


Q ss_pred             eccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCCC
Q 019650          126 EHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNH  205 (337)
Q Consensus       126 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~  205 (337)
                      ||++|++|.+++.. .++++..+..++.|++.||.+||+.+++|+||+|+||+++.++.++++|||.+........    
T Consensus        82 e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~----  156 (277)
T cd06640          82 EYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI----  156 (277)
T ss_pred             ecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc----
Confidence            99999999999874 5689999999999999999999999999999999999999999999999999876543221    


Q ss_pred             CCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhccCC
Q 019650          206 NNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGER  285 (337)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~  285 (337)
                                ......++..|+|||.+.    +..++.++|+||||+++|+|++|..||.......    ..........
T Consensus       157 ----------~~~~~~~~~~y~apE~~~----~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~----~~~~~~~~~~  218 (277)
T cd06640         157 ----------KRNTFVGTPFWMAPEVIQ----QSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR----VLFLIPKNNP  218 (277)
T ss_pred             ----------ccccccCcccccCHhHhc----cCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh----HhhhhhcCCC
Confidence                      111224788899999987    4567899999999999999999999996543221    1122223334


Q ss_pred             CCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCC
Q 019650          286 LEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSS  329 (337)
Q Consensus       286 ~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~  329 (337)
                      +..+...+..+.+++.+||+.+|++||++++++.||||.+....
T Consensus       219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~  262 (277)
T cd06640         219 PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNAKK  262 (277)
T ss_pred             CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhcchh
Confidence            44555678899999999999999999999999999999887643

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=7e-43  Score=301.62  Aligned_cols=253  Identities=28%  Similarity=0.413  Sum_probs=212.6

Q ss_pred             cccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEeccCCCC
Q 019650           55 LGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGS  132 (337)
Q Consensus        55 lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~  132 (337)
                      ||.|++|.||+|.+..++..+++|++....  .....+.+.+|+.+++.++|+|++++++.+.+ +...++++||+++++
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~   79 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKD-KKYIYMLMEYCLGGE   79 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEc-CCccEEEEecCCCCc
Confidence            689999999999999999999999987543  22345678899999999999999999998765 688999999999999


Q ss_pred             chHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCCCCCCCCCc
Q 019650          133 LFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNN  212 (337)
Q Consensus       133 L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~  212 (337)
                      |.+++.....+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||.+.......            
T Consensus        80 L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~------------  147 (262)
T cd05572          80 LWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ------------  147 (262)
T ss_pred             HHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc------------
Confidence            99999888889999999999999999999999999999999999999999999999999987764331            


Q ss_pred             cccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhh-ccCCCCCCCC
Q 019650          213 IGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAIC-FGERLEMPET  291 (337)
Q Consensus       213 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~  291 (337)
                         ......++..|++||.+.    +..++.++|+||||+++|++++|..||.......  ........ ......++..
T Consensus       148 ---~~~~~~~~~~~~~PE~~~----~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~  218 (262)
T cd05572         148 ---KTWTFCGTPEYVAPEIIL----NKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP--MEIYNDILKGNGKLEFPNY  218 (262)
T ss_pred             ---ccccccCCcCccChhHhc----CCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH--HHHHHHHhccCCCCCCCcc
Confidence               111224788999999987    4567889999999999999999999997654211  22222222 2345556666


Q ss_pred             CCHHHHHHHHHHhhcCcCCCCC-----HHHHhcCccccccCCC
Q 019650          292 ASPEFRRFVRSCLEKDWRKRGT-----VEELLAYPFVTKRSSS  329 (337)
Q Consensus       292 ~~~~~~~li~~~l~~~p~~R~s-----~~eil~hp~f~~~~~~  329 (337)
                      .+..+.+++.+||..+|++||+     ++|+++||||++..|.
T Consensus       219 ~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~  261 (262)
T cd05572         219 IDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFDWE  261 (262)
T ss_pred             cCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCCCCC
Confidence            7899999999999999999999     9999999999987653

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=6.4e-43  Score=300.80  Aligned_cols=253  Identities=26%  Similarity=0.452  Sum_probs=212.7

Q ss_pred             ccccccccccCcceEEEEEEEccCCceEEEEEeecCC-chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEe
Q 019650           48 DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVME  126 (337)
Q Consensus        48 ~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~e  126 (337)
                      +|++.+.||.|++|.+|.+.+..+++.+++|.+.... .......+.+|+.++++++|+|++++++.+.. ....++|+|
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~e   79 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEE-NGNLYIVMD   79 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecC-CCeEEEEEe
Confidence            5899999999999999999999999999999987542 23345678889999999999999999998765 688999999


Q ss_pred             ccCCCCchHHhhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCC
Q 019650          127 HMERGSLFDSLRVRK--KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNN  204 (337)
Q Consensus       127 ~~~~~~L~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~  204 (337)
                      |+++++|.+++....  .+++..+..++.|++.+|.+||++|++|+||+|+||+++.++.++++|||.+........   
T Consensus        80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~---  156 (256)
T cd08218          80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE---  156 (256)
T ss_pred             cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh---
Confidence            999999999987543  578999999999999999999999999999999999999999999999999876543221   


Q ss_pred             CCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhccC
Q 019650          205 HNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGE  284 (337)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~  284 (337)
                                 ......+++.|+|||++.    +..++.++|+||||+++|+|++|..||.....    .........+.
T Consensus       157 -----------~~~~~~~~~~~~~pe~~~----~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~----~~~~~~~~~~~  217 (256)
T cd08218         157 -----------LARTCIGTPYYLSPEICE----NRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM----KNLVLKIIRGS  217 (256)
T ss_pred             -----------hhhhccCCccccCHHHhC----CCCCCCccchhHHHHHHHHHHcCCCCccCCCH----HHHHHHHhcCC
Confidence                       111234788899999987    45678899999999999999999999864322    22233333444


Q ss_pred             CCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccc
Q 019650          285 RLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV  323 (337)
Q Consensus       285 ~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f  323 (337)
                      ....+...+..+.++|.+||+.+|++||++.++++||||
T Consensus       218 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         218 YPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI  256 (256)
T ss_pred             CCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence            555667788999999999999999999999999999998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=2.8e-43  Score=303.43  Aligned_cols=254  Identities=30%  Similarity=0.436  Sum_probs=215.1

Q ss_pred             ccccccccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 019650           48 DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVM  125 (337)
Q Consensus        48 ~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~  125 (337)
                      +|.+.+.||.|++|.||+|.+..++..+++|++....  .....+.+.+|+.++++++|+|++++++.+.+ ....++|+
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~   79 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQD-EENMYLVV   79 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcC-CCeEEEEE
Confidence            4889999999999999999999999999999997543  22345678889999999999999999998765 68899999


Q ss_pred             eccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCCC
Q 019650          126 EHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNH  205 (337)
Q Consensus       126 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~  205 (337)
                      ||+.|++|.+++.....+++..+..++.|++.+|.|||++|++|+||+|+||+++.++.++|+|||.+........    
T Consensus        80 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~----  155 (258)
T cd05578          80 DLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL----  155 (258)
T ss_pred             eCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCcc----
Confidence            9999999999998777899999999999999999999999999999999999999999999999998877644321    


Q ss_pred             CCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhccCC
Q 019650          206 NNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGER  285 (337)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~  285 (337)
                                 .....++..|+|||.+..    ..++.++|+||||+++|+|++|..||...... ...... .......
T Consensus       156 -----------~~~~~~~~~y~~PE~~~~----~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~-~~~~~~~  218 (258)
T cd05578         156 -----------TTSTSGTPGYMAPEVLCR----QGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT-IRDQIR-AKQETAD  218 (258)
T ss_pred             -----------ccccCCChhhcCHHHHcc----cCCCCcccchhhHHHHHHHHhCCCCCCCCCcc-HHHHHH-HHhcccc
Confidence                       112247889999999984    45788999999999999999999999765432 111222 2222245


Q ss_pred             CCCCCCCCHHHHHHHHHHhhcCcCCCCCH--HHHhcCccc
Q 019650          286 LEMPETASPEFRRFVRSCLEKDWRKRGTV--EELLAYPFV  323 (337)
Q Consensus       286 ~~~~~~~~~~~~~li~~~l~~~p~~R~s~--~eil~hp~f  323 (337)
                      ...+...+..+.++|.+||+.||.+||++  .++++||||
T Consensus       219 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         219 VLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             ccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence            56667788999999999999999999999  999999998

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=5.9e-43  Score=307.80  Aligned_cols=267  Identities=27%  Similarity=0.374  Sum_probs=213.3

Q ss_pred             ccccccccccCcceEEEEEEEccCCceEEEEEeecCCc----hHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEE
Q 019650           48 DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSS----TIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICF  123 (337)
Q Consensus        48 ~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~l  123 (337)
                      +|++.+.||.|++|.||+|.+..+++.|++|.+.....    ......+..|+.++++++|+|++++++.+.+ ....++
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~l   79 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH-KSNINL   79 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec-CCEEEE
Confidence            48888999999999999999998899999999976532    2233456679999999999999999998877 788999


Q ss_pred             EEeccCCCCchHHhhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccC
Q 019650          124 VMEHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNN  202 (337)
Q Consensus       124 v~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~  202 (337)
                      ||||+ +++|.+++.... .+++..+..++.||++||+|||++|++|+||+|+||+++.++.++|+|||.+.........
T Consensus        80 v~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~  158 (298)
T cd07841          80 VFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK  158 (298)
T ss_pred             EEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCcc
Confidence            99999 889999998766 7999999999999999999999999999999999999999999999999998776443211


Q ss_pred             CCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhc
Q 019650          203 NNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICF  282 (337)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~  282 (337)
                                    .....++..|+|||.+..   ...++.++|+||||+++|+|++|.++|....+.............
T Consensus       159 --------------~~~~~~~~~y~aPE~~~~---~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~  221 (298)
T cd07841         159 --------------MTHQVVTRWYRAPELLFG---ARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGT  221 (298)
T ss_pred             --------------ccccccceeeeCHHHHhC---CCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCC
Confidence                          111236778999998853   245788999999999999999998777654433222222211100


Q ss_pred             cCC------------------C-----CCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCCcccc
Q 019650          283 GER------------------L-----EMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNIE  333 (337)
Q Consensus       283 ~~~------------------~-----~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~~~~~  333 (337)
                      ...                  .     ......+..+.++|.+||+.+|++|||+++++.||||++..-..+.+
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~~~~  295 (298)
T cd07841         222 PTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPTPPS  295 (298)
T ss_pred             CchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCCCCC
Confidence            000                  0     01134467899999999999999999999999999999987665544

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=6.5e-43  Score=316.63  Aligned_cols=259  Identities=25%  Similarity=0.364  Sum_probs=208.4

Q ss_pred             CccCccccccccccccCcceEEEEEEE-----ccCCceEEEEEeecCCchHhHHHHHHHHHHHHhc-CCCCceeeeeeEE
Q 019650           42 DVENISDLKKLTVLGHGNGGIVYKVRH-----QKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRL-DSQFIVKCHAVFY  115 (337)
Q Consensus        42 ~~~~~~~y~~~~~lg~g~~~~v~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~  115 (337)
                      +....++|++.+.||.|+||+||+|.+     ..++..||+|+++........+.+.+|+.++..+ +||||+++++.+.
T Consensus        30 ~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~  109 (375)
T cd05104          30 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACT  109 (375)
T ss_pred             cccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeec
Confidence            345567999999999999999999974     3466789999997654444556788899999999 8999999999886


Q ss_pred             eeCCeEEEEEeccCCCCchHHhhhcC------------------------------------------------------
Q 019650          116 TIEGEICFVMEHMERGSLFDSLRVRK------------------------------------------------------  141 (337)
Q Consensus       116 ~~~~~~~lv~e~~~~~~L~~~l~~~~------------------------------------------------------  141 (337)
                      + ....++||||+++|+|.+++....                                                      
T Consensus       110 ~-~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  188 (375)
T cd05104         110 V-GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS  188 (375)
T ss_pred             c-CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence            6 678999999999999999886421                                                      


Q ss_pred             ---------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccc
Q 019650          142 ---------------------KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETR  200 (337)
Q Consensus       142 ---------------------~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~  200 (337)
                                           .+++..+..++.||+.||+|||+.|++||||||+||+++.++.++|+|||++.......
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~  268 (375)
T cd05104         189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDS  268 (375)
T ss_pred             cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcc
Confidence                                 46788899999999999999999999999999999999999999999999987654322


Q ss_pred             cCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHH
Q 019650          201 NNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICA  279 (337)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~  279 (337)
                      ...            ......++..|+|||.+.    +..++.++||||||+++|+|++ |..||.............  
T Consensus       269 ~~~------------~~~~~~~~~~y~aPE~~~----~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~--  330 (375)
T cd05104         269 NYV------------VKGNARLPVKWMAPESIF----NCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMI--  330 (375)
T ss_pred             ccc------------ccCCCCCCcceeChhHhc----CCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHH--
Confidence            110            011122466899999998    4578899999999999999998 889987654433333332  


Q ss_pred             hhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          280 ICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                       ..+.....+...+..+.+++.+||+.||++|||+.++++.
T Consensus       331 -~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  370 (375)
T cd05104         331 -KEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL  370 (375)
T ss_pred             -HhCccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence             2233334455668899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=3.7e-43  Score=308.89  Aligned_cols=267  Identities=29%  Similarity=0.467  Sum_probs=217.8

Q ss_pred             ccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEE
Q 019650           43 VENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEIC  122 (337)
Q Consensus        43 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~  122 (337)
                      ....++|++.+.||.|++|.||++.+..++..||+|.+...... ..+.+.+|+.+++.++|+|++++++.+.. +...+
T Consensus        15 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~   92 (297)
T cd06656          15 GDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLV-GDELW   92 (297)
T ss_pred             CChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc-hHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEE
Confidence            34568999999999999999999999889999999998764332 34567789999999999999999998876 68899


Q ss_pred             EEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccC
Q 019650          123 FVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNN  202 (337)
Q Consensus       123 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~  202 (337)
                      +||||+++++|.+++.+ ..+++..+..++.|++.+|.|||+.|++|+||+|+||+++.++.++|+|||.+........ 
T Consensus        93 lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~-  170 (297)
T cd06656          93 VVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-  170 (297)
T ss_pred             EeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc-
Confidence            99999999999999864 4589999999999999999999999999999999999999999999999998876533221 


Q ss_pred             CCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhc
Q 019650          203 NNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICF  282 (337)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~  282 (337)
                                   ......+++.|+|||.+.    +..++.++|+||||+++|++++|..||............  ....
T Consensus       171 -------------~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~--~~~~  231 (297)
T cd06656         171 -------------KRSTMVGTPYWMAPEVVT----RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI--ATNG  231 (297)
T ss_pred             -------------CcCcccCCccccCHHHHc----CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeee--ccCC
Confidence                         111224788999999998    456788999999999999999999999654332211111  1111


Q ss_pred             cCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCCccc
Q 019650          283 GERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNI  332 (337)
Q Consensus       283 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~~~~  332 (337)
                      ......+...+..+.+++.+||..+|++||+++++++||||+.....+.+
T Consensus       232 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~~~  281 (297)
T cd06656         232 TPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKPLSSL  281 (297)
T ss_pred             CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhccccccccc
Confidence            11223345678899999999999999999999999999999876655443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=8e-43  Score=310.90  Aligned_cols=267  Identities=23%  Similarity=0.326  Sum_probs=204.9

Q ss_pred             cccccccC--cceEEEEEEEccCCceEEEEEeecCCc-hHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEec
Q 019650           51 KLTVLGHG--NGGIVYKVRHQKSNSIYALKVLNTTSS-TIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEH  127 (337)
Q Consensus        51 ~~~~lg~g--~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~e~  127 (337)
                      ++++||+|  ++++||++.+..+++.||+|.+..... ......+.+|+.+++.++||||+++++.+.. +...++||||
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~-~~~~~lv~e~   80 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIA-DNELWVVTSF   80 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEE-CCEEEEEEec
Confidence            57889999  789999999999999999999976532 3344567789999999999999999998876 6889999999


Q ss_pred             cCCCCchHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCCC
Q 019650          128 MERGSLFDSLRVR--KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNH  205 (337)
Q Consensus       128 ~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~  205 (337)
                      +++++|.+++..+  ..+++..++.++.|++.||+|||++|++|+||||+||+++.++.++++||+..............
T Consensus        81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~  160 (327)
T cd08227          81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRV  160 (327)
T ss_pred             cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccccc
Confidence            9999999999653  45899999999999999999999999999999999999999999999999865544322111000


Q ss_pred             CCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhc---
Q 019650          206 NNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICF---  282 (337)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~---  282 (337)
                      .       ........++..|+|||++...  ...++.++||||||+++|+|++|..||..................   
T Consensus       161 ~-------~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  231 (327)
T cd08227         161 V-------HDFPKYSVKVLPWLSPEVLQQN--LQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLL  231 (327)
T ss_pred             c-------ccccccccceecccChHHhhcc--cCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccc
Confidence            0       0011122467789999999742  135788999999999999999999999654322211111100000   


Q ss_pred             -----------------cC---------------------CCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCcccc
Q 019650          283 -----------------GE---------------------RLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVT  324 (337)
Q Consensus       283 -----------------~~---------------------~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~  324 (337)
                                       ..                     ........+..+.+++.+||+.||++|||++++++||||+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~  311 (327)
T cd08227         232 DTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFK  311 (327)
T ss_pred             cccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhh
Confidence                             00                     0001123467899999999999999999999999999998


Q ss_pred             ccC
Q 019650          325 KRS  327 (337)
Q Consensus       325 ~~~  327 (337)
                      +.+
T Consensus       312 ~~~  314 (327)
T cd08227         312 QIK  314 (327)
T ss_pred             hcc
Confidence            754

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.9e-43  Score=315.07  Aligned_cols=250  Identities=24%  Similarity=0.377  Sum_probs=196.7

Q ss_pred             cccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEe
Q 019650           47 SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVME  126 (337)
Q Consensus        47 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~e  126 (337)
                      .+|++++.||.|+||.||+|.+..++..||+|+....       ....|+.++++++|+||+++++.+.. ....++|||
T Consensus        66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-------~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e  137 (357)
T PHA03209         66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-------TTLIEAMLLQNVNHPSVIRMKDTLVS-GAITCMVLP  137 (357)
T ss_pred             cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-------ccHHHHHHHHhCCCCCCcChhheEEe-CCeeEEEEE
Confidence            4699999999999999999999999999999975432       22458999999999999999998876 678899999


Q ss_pred             ccCCCCchHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCCC
Q 019650          127 HMERGSLFDSLRV-RKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNH  205 (337)
Q Consensus       127 ~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~  205 (337)
                      ++.+ +|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||.+......      
T Consensus       138 ~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~------  210 (357)
T PHA03209        138 HYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA------  210 (357)
T ss_pred             ccCC-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccC------
Confidence            9964 88888864 467999999999999999999999999999999999999999999999999998643221      


Q ss_pred             CCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCC-CCCCCc---------hhHHH
Q 019650          206 NNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPL-IGFGEK---------PDLMA  275 (337)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf-~~~~~~---------~~~~~  275 (337)
                               .......|+..|+|||++.    +..++.++||||||+++|+|+++..++ ......         ..+..
T Consensus       211 ---------~~~~~~~gt~~y~aPE~~~----~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~  277 (357)
T PHA03209        211 ---------PAFLGLAGTVETNAPEVLA----RDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLK  277 (357)
T ss_pred             ---------cccccccccccccCCeecC----CCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHH
Confidence                     1112235899999999998    457889999999999999999854444 322111         01111


Q ss_pred             HHHHhhccCCCCCC------------------------------CCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccc
Q 019650          276 LICAICFGERLEMP------------------------------ETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTK  325 (337)
Q Consensus       276 ~~~~~~~~~~~~~~------------------------------~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~  325 (337)
                      ...... ..+..++                              ...+..+.++|.+||+.||.+|||++|+|+||||++
T Consensus       278 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~  356 (357)
T PHA03209        278 IISTLK-VHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ  356 (357)
T ss_pred             HHHHhc-cChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence            111100 0000111                              134567788999999999999999999999999986

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.6e-43  Score=303.51  Aligned_cols=258  Identities=28%  Similarity=0.473  Sum_probs=213.4

Q ss_pred             ccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcC---CCCceeeeeeEEeeCCeEEEE
Q 019650           48 DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLD---SQFIVKCHAVFYTIEGEICFV  124 (337)
Q Consensus        48 ~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~---~~~i~~~~~~~~~~~~~~~lv  124 (337)
                      .|++.+.||.|++|.||+|.+..++..+++|.+...........+.+|+.+++++.   |+|++++++.+.. +...+++
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~-~~~~~lv   80 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLK-GPRLWII   80 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeee-CCEEEEE
Confidence            58889999999999999999999999999999876555555667888999999986   9999999998766 7889999


Q ss_pred             EeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCC
Q 019650          125 MEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNN  204 (337)
Q Consensus       125 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~  204 (337)
                      |||+++++|.+++.. ..+++..+..++.|++.+|.|||+.|++|+||+|+||+++.++.++|+|||.+........   
T Consensus        81 ~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~---  156 (277)
T cd06917          81 MEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS---  156 (277)
T ss_pred             EecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc---
Confidence            999999999999875 4789999999999999999999999999999999999999999999999999877654321   


Q ss_pred             CCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhccC
Q 019650          205 HNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGE  284 (337)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~  284 (337)
                                 ......++..|+|||.+..   +..++.++|+||||+++|+|++|..||.......    .........
T Consensus       157 -----------~~~~~~~~~~y~aPE~~~~---~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~----~~~~~~~~~  218 (277)
T cd06917         157 -----------KRSTFVGTPYWMAPEVITE---GKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR----AMMLIPKSK  218 (277)
T ss_pred             -----------ccccccCCcceeCHHHhcc---CCccccchhHHHHHHHHHHHHhCCCCCCCCChhh----hhhccccCC
Confidence                       1112347889999999864   2456889999999999999999999996543221    111111222


Q ss_pred             CCCCCC-CCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCC
Q 019650          285 RLEMPE-TASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSS  328 (337)
Q Consensus       285 ~~~~~~-~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~  328 (337)
                      .+..+. ..+..+.+++.+||+.||++||++.+++.||||++...
T Consensus       219 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~~  263 (277)
T cd06917         219 PPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHSK  263 (277)
T ss_pred             CCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhcccc
Confidence            233333 36789999999999999999999999999999988664

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-44  Score=294.41  Aligned_cols=258  Identities=28%  Similarity=0.412  Sum_probs=209.1

Q ss_pred             Ccccccc-ccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHH-hcCCCCceeeeeeEEee---CC
Q 019650           45 NISDLKK-LTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILK-RLDSQFIVKCHAVFYTI---EG  119 (337)
Q Consensus        45 ~~~~y~~-~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~-~l~~~~i~~~~~~~~~~---~~  119 (337)
                      ..++|++ -++||-|-.|.|..|.++.|++++|+|++...      ....+|+++.- .-.|+|||.+++++...   ..
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rk  132 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS------PKARREVELHWMASGHPHIVSIIDVYENSYQGRK  132 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCce
Confidence            4577877 46899999999999999999999999998643      33445666533 34899999999987532   34


Q ss_pred             eEEEEEeccCCCCchHHhhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCC---CcEEEeeccCcc
Q 019650          120 EICFVMEHMERGSLFDSLRVRK--KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGK---GEVKIADFGVSR  194 (337)
Q Consensus       120 ~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~---~~~~l~Dfg~~~  194 (337)
                      .+.+|||.++||.|+..+++++  ++++.++..|++||+.|+.|||+.+|.||||||+|+|+...   ..+||+|||++.
T Consensus       133 cLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK  212 (400)
T KOG0604|consen  133 CLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAK  212 (400)
T ss_pred             eeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccccccc
Confidence            6789999999999999998775  49999999999999999999999999999999999999654   479999999998


Q ss_pred             chhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHH
Q 019650          195 IVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLM  274 (337)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~  274 (337)
                      ........               ..-+.|+.|.|||++-.+    .|+-.-|+||+|+++|-|++|.+||...+......
T Consensus       213 ~t~~~~~L---------------~TPc~TPyYvaPevlg~e----KydkscdmwSlgVimYIlLCGyPPFYS~hg~aisp  273 (400)
T KOG0604|consen  213 ETQEPGDL---------------MTPCFTPYYVAPEVLGPE----KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP  273 (400)
T ss_pred             ccCCCccc---------------cCCcccccccCHHHhCch----hcCCCCCccchhHHHHHhhcCCCcccccCCccCCh
Confidence            77653322               223579999999999866    46677899999999999999999998876543222


Q ss_pred             HHHHHhhccCCCCCC----CCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCC
Q 019650          275 ALICAICFGERLEMP----ETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSS  328 (337)
Q Consensus       275 ~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~  328 (337)
                      ....++.. ....||    ..+|+..+++|+++|+.+|.+|.|++++++|||+.+...
T Consensus       274 gMk~rI~~-gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~  330 (400)
T KOG0604|consen  274 GMKRRIRT-GQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEA  330 (400)
T ss_pred             hHHhHhhc-cCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccccc
Confidence            22222222 234444    456889999999999999999999999999999987653

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=2.7e-43  Score=306.69  Aligned_cols=259  Identities=31%  Similarity=0.492  Sum_probs=215.6

Q ss_pred             ccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 019650           46 ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVM  125 (337)
Q Consensus        46 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~  125 (337)
                      .+.|+..+.||.|++|.||+|.+..++..||+|.+.........+.+.+|+.++++++|+|++++++.+.. +...++||
T Consensus         3 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~   81 (277)
T cd06642           3 EELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLK-GTKLWIIM   81 (277)
T ss_pred             HHHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhccccc-CCceEEEE
Confidence            45688999999999999999999988999999998765544556778899999999999999999998876 67899999


Q ss_pred             eccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCCC
Q 019650          126 EHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNH  205 (337)
Q Consensus       126 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~  205 (337)
                      ||+++++|.+++.. ..+++..+..++.|++.|+.|||+.|++|+||+|+||+++.++.++++|||++.......     
T Consensus        82 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-----  155 (277)
T cd06642          82 EYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-----  155 (277)
T ss_pred             EccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcc-----
Confidence            99999999998864 568999999999999999999999999999999999999999999999999987654321     


Q ss_pred             CCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhccCC
Q 019650          206 NNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGER  285 (337)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~  285 (337)
                               .......++..|+|||++.    +..++.++|+||||+++|+|++|..||.........    ........
T Consensus       156 ---------~~~~~~~~~~~y~aPE~~~----~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~----~~~~~~~~  218 (277)
T cd06642         156 ---------IKRNTFVGTPFWMAPEVIK----QSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVL----FLIPKNSP  218 (277)
T ss_pred             ---------hhhhcccCcccccCHHHhC----cCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHH----hhhhcCCC
Confidence                     1111234788999999998    456788999999999999999999998654322211    11222233


Q ss_pred             CCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCC
Q 019650          286 LEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSS  328 (337)
Q Consensus       286 ~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~  328 (337)
                      .......+..+.+++.+||+.+|++|||+.+++.||||.+..+
T Consensus       219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  261 (277)
T cd06642         219 PTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRYTK  261 (277)
T ss_pred             CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHHHhh
Confidence            3444567889999999999999999999999999999986553

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-44  Score=320.56  Aligned_cols=265  Identities=32%  Similarity=0.446  Sum_probs=223.9

Q ss_pred             ccccccccccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEE
Q 019650           46 ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICF  123 (337)
Q Consensus        46 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~l  123 (337)
                      ...|.-++.||.|+||-||.+.+..+...||||.+....  +......+..|+.++++++|||++.+.+.|.. +...++
T Consensus        25 Eklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLr-e~TaWL  103 (948)
T KOG0577|consen   25 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLR-EHTAWL  103 (948)
T ss_pred             HHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeec-cchHHH
Confidence            357888999999999999999999999999999986543  33455678889999999999999999998766 677899


Q ss_pred             EEeccCCCCchHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccC
Q 019650          124 VMEHMERGSLFDSLRVR-KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNN  202 (337)
Q Consensus       124 v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~  202 (337)
                      |||||-| +..|++.-+ +++.+.++..|+++.+.||+|||+++.||||||..|||+++.|.|||+|||.+....+.   
T Consensus       104 VMEYClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA---  179 (948)
T KOG0577|consen  104 VMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA---  179 (948)
T ss_pred             HHHHHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCch---
Confidence            9999965 888888643 68999999999999999999999999999999999999999999999999999877543   


Q ss_pred             CCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhc
Q 019650          203 NNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICF  282 (337)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~  282 (337)
                                     .+++|||.|||||++..-. .+.|+-++||||||++..||.-.++|+.+++-...+..+.    .
T Consensus       180 ---------------nsFvGTPywMAPEVILAMD-EGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIA----Q  239 (948)
T KOG0577|consen  180 ---------------NSFVGTPYWMAPEVILAMD-EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA----Q  239 (948)
T ss_pred             ---------------hcccCCccccchhHheecc-ccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHH----h
Confidence                           3568999999999986432 3689999999999999999999999988765544444433    2


Q ss_pred             cCCCCC-CCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCCccccCc
Q 019650          283 GERLEM-PETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNIEGL  335 (337)
Q Consensus       283 ~~~~~~-~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~~~~~~~  335 (337)
                      +..+.. .+..++.+++|+..||++-|.+|||.+++|+|+|+.-...+..+-.|
T Consensus       240 NesPtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~Rp~tvi~dL  293 (948)
T KOG0577|consen  240 NESPTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRERPPTVIMDL  293 (948)
T ss_pred             cCCCCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccCCCchHHHHH
Confidence            233333 45678899999999999999999999999999999877666555444

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=1.4e-42  Score=301.34  Aligned_cols=260  Identities=30%  Similarity=0.488  Sum_probs=209.3

Q ss_pred             CccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhc-CCCCceeeeeeEEeeC-----
Q 019650           45 NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRL-DSQFIVKCHAVFYTIE-----  118 (337)
Q Consensus        45 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~-----  118 (337)
                      ..+.|++.+.||.|++|.||+|.+..++..+|+|++.....  ....+.+|+.+++++ +|+|++++++.+....     
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD--EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc--cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            35679999999999999999999999999999999875432  235677899999988 7999999999887532     


Q ss_pred             CeEEEEEeccCCCCchHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccch
Q 019650          119 GEICFVMEHMERGSLFDSLRVR--KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIV  196 (337)
Q Consensus       119 ~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~  196 (337)
                      ...+++|||+.+++|.+++...  ..+++..+..++.|++.||+|||+++++|+||+|+||+++.++.++|+|||++...
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~  161 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL  161 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceec
Confidence            4589999999999999999864  46899999999999999999999999999999999999999999999999998765


Q ss_pred             hccccCCCCCCCCCCccccccccccCCCCCcCCccccccc-CCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHH
Q 019650          197 EETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSER-WGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMA  275 (337)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~  275 (337)
                      ....              .......++..|+|||++.... .+..++.++|+||+|+++|+|++|..||...........
T Consensus       162 ~~~~--------------~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~  227 (272)
T cd06637         162 DRTV--------------GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL  227 (272)
T ss_pred             cccc--------------ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHH
Confidence            3321              1112235788999999986321 124678899999999999999999999965432222211


Q ss_pred             HHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccc
Q 019650          276 LICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV  323 (337)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f  323 (337)
                      .   .............+..+.+++.+||..+|.+|||+.++++||||
T Consensus       228 ~---~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         228 I---PRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             H---hcCCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence            1   11122222334568899999999999999999999999999998

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=2.1e-42  Score=299.19  Aligned_cols=259  Identities=28%  Similarity=0.429  Sum_probs=210.4

Q ss_pred             cccccccccccCcceEEEEEEEccCCceEEEEEeecCC----chHhHHHHHHHHHHHHhcCCCCceeeeeeEEee-CCeE
Q 019650           47 SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS----STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTI-EGEI  121 (337)
Q Consensus        47 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-~~~~  121 (337)
                      .+|++.+.||.|++|.||.+.+..++..|++|.+....    .....+.+.+|+.+++++.|+|++++++.+.+. ...+
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            57999999999999999999999999999999886432    223456778899999999999999999987653 2467


Q ss_pred             EEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhcccc
Q 019650          122 CFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRN  201 (337)
Q Consensus       122 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~  201 (337)
                      +++|||+++++|.+++.....+++..+..++.|++.+|.+||++|++|+||+|+||+++.++.++|+|||.+........
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~  161 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL  161 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence            89999999999999998778899999999999999999999999999999999999999999999999998876532111


Q ss_pred             CCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhh
Q 019650          202 NNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAIC  281 (337)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~  281 (337)
                      ..           .......++..|+|||.+.    +..++.++|+||||+++|+|++|+.||........   ......
T Consensus       162 ~~-----------~~~~~~~~~~~y~aPE~~~----~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~---~~~~~~  223 (265)
T cd06652         162 SG-----------TGMKSVTGTPYWMSPEVIS----GEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA---IFKIAT  223 (265)
T ss_pred             cc-----------cccccCCCCccccChhhhc----CCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH---HHHHhc
Confidence            00           0111234788999999997    45678899999999999999999999965432222   222222


Q ss_pred             ccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCcccc
Q 019650          282 FGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVT  324 (337)
Q Consensus       282 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~  324 (337)
                      ....+..+...+..+.+++.+|+ .+|++||++++++.|||+.
T Consensus       224 ~~~~~~~~~~~~~~~~~~i~~~l-~~p~~Rp~~~~il~~~~~~  265 (265)
T cd06652         224 QPTNPVLPPHVSDHCRDFLKRIF-VEAKLRPSADELLRHTFVH  265 (265)
T ss_pred             CCCCCCCchhhCHHHHHHHHHHh-cChhhCCCHHHHhcCcccC
Confidence            22234456667889999999999 4999999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-46  Score=304.95  Aligned_cols=262  Identities=32%  Similarity=0.483  Sum_probs=225.3

Q ss_pred             ccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 019650           46 ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVM  125 (337)
Q Consensus        46 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~  125 (337)
                      ..-|.++++||+|++|.||+++++.+|..+|||.+..+   ....++..|+.++++++.++++++++.+.. ...+++||
T Consensus        32 EEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~---sDLQEIIKEISIMQQC~S~yVVKYYGSYFK-~sDLWIVM  107 (502)
T KOG0574|consen   32 EEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD---TDLQEIIKEISIMQQCKSKYVVKYYGSYFK-HSDLWIVM  107 (502)
T ss_pred             HHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc---chHHHHHHHHHHHHHcCCchhhhhhhhhcc-CCceEeeh
Confidence            35688999999999999999999999999999988654   356788899999999999999999999876 68899999


Q ss_pred             eccCCCCchHHhh-hcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCC
Q 019650          126 EHMERGSLFDSLR-VRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNN  204 (337)
Q Consensus       126 e~~~~~~L~~~l~-~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~  204 (337)
                      |||..|++.+.++ .+++++++++..++..-+++|.|||...-+|||||..|||++.+|+.||+|||.+-.+.+.-    
T Consensus       108 EYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM----  183 (502)
T KOG0574|consen  108 EYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM----  183 (502)
T ss_pred             hhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhH----
Confidence            9999999999997 45789999999999999999999999999999999999999999999999999998887653    


Q ss_pred             CCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhccC
Q 019650          205 HNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGE  284 (337)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~  284 (337)
                                ......+||+.|||||++.    .-.|+-++||||||++..||.-|++||.+.+......    .+....
T Consensus       184 ----------AKRNTVIGTPFWMAPEVI~----EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF----MIPT~P  245 (502)
T KOG0574|consen  184 ----------AKRNTVIGTPFWMAPEVIE----EIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF----MIPTKP  245 (502)
T ss_pred             ----------HhhCccccCcccccHHHHH----HhccchhhhHhhhcchhhhhhcCCCCcccccccceeE----eccCCC
Confidence                      2333457999999999998    4578889999999999999999999998765543211    111122


Q ss_pred             CCC--CCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCCcccc
Q 019650          285 RLE--MPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNIE  333 (337)
Q Consensus       285 ~~~--~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~~~~~  333 (337)
                      ++.  .|...++++.+++++||-++|++|-|+.++++|||+++...-+.+.
T Consensus       246 PPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~g~~I~~  296 (502)
T KOG0574|consen  246 PPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNAPGCDIMQ  296 (502)
T ss_pred             CCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCCcccHHH
Confidence            222  2456789999999999999999999999999999999988655443

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=8.7e-43  Score=320.68  Aligned_cols=256  Identities=25%  Similarity=0.389  Sum_probs=201.8

Q ss_pred             ccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 019650           46 ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVM  125 (337)
Q Consensus        46 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~  125 (337)
                      ...|.+.+.||.|+||.||+|.+..+++.||+|....       ..+.+|+.++++++|+||+++++++.. +...+++|
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-------~~~~~E~~iL~~L~HpnIv~l~~~~~~-~~~~~lv~  239 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY-------ASSVHEARLLRRLSHPAVLALLDVRVV-GGLTCLVL  239 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc-------cCHHHHHHHHHHCCCCCCCcEEEEEEE-CCEEEEEE
Confidence            4579999999999999999999999999999996432       234679999999999999999998766 68899999


Q ss_pred             eccCCCCchHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCC
Q 019650          126 EHMERGSLFDSLRVR-KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNN  204 (337)
Q Consensus       126 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~  204 (337)
                      +++. ++|.+++... ..+++..++.++.|++.||.|||++||+|+||||+|||++.++.++|+|||++.........  
T Consensus       240 e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~--  316 (461)
T PHA03211        240 PKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST--  316 (461)
T ss_pred             EccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccccc--
Confidence            9995 5888888654 46999999999999999999999999999999999999999999999999998765322110  


Q ss_pred             CCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCc-------hhHHHHH
Q 019650          205 HNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEK-------PDLMALI  277 (337)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~-------~~~~~~~  277 (337)
                                .......||..|+|||++.    +..++.++|||||||++|||++|..++......       ......+
T Consensus       317 ----------~~~~~~~GT~~Y~APE~~~----~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i  382 (461)
T PHA03211        317 ----------PFHYGIAGTVDTNAPEVLA----GDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRII  382 (461)
T ss_pred             ----------ccccccCCCcCCcCHHHHc----CCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHH
Confidence                      1112346899999999998    557889999999999999999987665432211       1122222


Q ss_pred             HHhhcc--C---------------------CCCCC-------CCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCcccccc
Q 019650          278 CAICFG--E---------------------RLEMP-------ETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKR  326 (337)
Q Consensus       278 ~~~~~~--~---------------------~~~~~-------~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~  326 (337)
                      ......  .                     .....       ...+..+.+||.+||..||.+|||+.|+|+||||+++
T Consensus       383 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~~  461 (461)
T PHA03211        383 RQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQSK  461 (461)
T ss_pred             HhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCCC
Confidence            111100  0                     00000       1235678999999999999999999999999999864

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1.7e-42  Score=300.05  Aligned_cols=250  Identities=24%  Similarity=0.392  Sum_probs=202.9

Q ss_pred             cccccccccc--ccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHh-cCCCCceeeeeeEEeeCCeEE
Q 019650           46 ISDLKKLTVL--GHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKR-LDSQFIVKCHAVFYTIEGEIC  122 (337)
Q Consensus        46 ~~~y~~~~~l--g~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~-l~~~~i~~~~~~~~~~~~~~~  122 (337)
                      .+.|++.+.+  |.|+||.||++.+..++..+++|.+.......    .  |...... .+|+|++++++.+.. ....+
T Consensus        13 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~----~--e~~~~~~~~~h~~iv~~~~~~~~-~~~~~   85 (267)
T PHA03390         13 LKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA----I--EPMVHQLMKDNPNFIKLYYSVTT-LKGHV   85 (267)
T ss_pred             HHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch----h--hHHHHHHhhcCCCEEEEEEEEec-CCeeE
Confidence            4677777776  99999999999999999999999986542111    1  2222221 279999999998877 67899


Q ss_pred             EEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCC-cEEEeeccCccchhcccc
Q 019650          123 FVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKG-EVKIADFGVSRIVEETRN  201 (337)
Q Consensus       123 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~-~~~l~Dfg~~~~~~~~~~  201 (337)
                      +||||+++++|.+++.....+++..+..++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||.+....... 
T Consensus        86 iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~-  164 (267)
T PHA03390         86 LIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS-  164 (267)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCCc-
Confidence            9999999999999998877899999999999999999999999999999999999999998 99999999887653221 


Q ss_pred             CCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhh
Q 019650          202 NNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAIC  281 (337)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~  281 (337)
                                       ...++..|+|||++.    +..++.++|+||+|+++|+|++|..||.................
T Consensus       165 -----------------~~~~~~~y~aPE~~~----~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~  223 (267)
T PHA03390        165 -----------------CYDGTLDYFSPEKIK----GHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ  223 (267)
T ss_pred             -----------------cCCCCCcccChhhhc----CCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh
Confidence                             123788999999998    45678899999999999999999999975433221112222222


Q ss_pred             ccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCC-HHHHhcCccccc
Q 019650          282 FGERLEMPETASPEFRRFVRSCLEKDWRKRGT-VEELLAYPFVTK  325 (337)
Q Consensus       282 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s-~~eil~hp~f~~  325 (337)
                       ......+...+..+.++|.+||+.+|.+|++ ++++|+||||++
T Consensus       224 -~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~  267 (267)
T PHA03390        224 -QKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI  267 (267)
T ss_pred             -cccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence             3344555678999999999999999999995 699999999975

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.2e-42  Score=303.62  Aligned_cols=255  Identities=25%  Similarity=0.398  Sum_probs=210.9

Q ss_pred             CccccccccccccCcceEEEEEEEccCC-----ceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCC
Q 019650           45 NISDLKKLTVLGHGNGGIVYKVRHQKSN-----SIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEG  119 (337)
Q Consensus        45 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~  119 (337)
                      ..++|++++.||.|++|.||+|.+...+     ..+++|.+...........+.+|+.++.+++|+||+++++.+.. ..
T Consensus         3 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~-~~   81 (283)
T cd05048           3 PLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTK-EQ   81 (283)
T ss_pred             ChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcC-CC
Confidence            4678999999999999999999876544     67999998766555566778899999999999999999998765 57


Q ss_pred             eEEEEEeccCCCCchHHhhhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCC
Q 019650          120 EICFVMEHMERGSLFDSLRVR----------------KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKG  183 (337)
Q Consensus       120 ~~~lv~e~~~~~~L~~~l~~~----------------~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~  183 (337)
                      ..+++|||+++++|.+++...                ..+++..++.++.|++.||.|||+.|++|+||||+||+++.++
T Consensus        82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGL  161 (283)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCC
Confidence            789999999999999999754                4578899999999999999999999999999999999999999


Q ss_pred             cEEEeeccCccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCC
Q 019650          184 EVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHY  262 (337)
Q Consensus       184 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~  262 (337)
                      .++|+|||++.........            .......+++.|+|||.+.    +..++.++|+||||+++|+|++ |..
T Consensus       162 ~~~L~dfg~~~~~~~~~~~------------~~~~~~~~~~~y~aPE~~~----~~~~~~~sDv~slG~il~el~~~g~~  225 (283)
T cd05048         162 TVKISDFGLSRDIYSADYY------------RVQSKSLLPVRWMPPEAIL----YGKFTTESDIWSFGVVLWEIFSYGLQ  225 (283)
T ss_pred             cEEECCCcceeeccccccc------------cccCCCcccccccCHHHhc----cCcCchhhhHHHHHHHHHHHHcCCCC
Confidence            9999999998755332110            1111224678899999987    4578899999999999999998 999


Q ss_pred             CCCCCCCchhHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          263 PLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       263 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                      ||.+....+    .............+..++..+.+++.+||+.||.+||++.+++++
T Consensus       226 p~~~~~~~~----~~~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~  279 (283)
T cd05048         226 PYYGFSNQE----VIEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR  279 (283)
T ss_pred             CCCCCCHHH----HHHHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            997654322    233333444455667789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=2.4e-42  Score=302.13  Aligned_cols=269  Identities=32%  Similarity=0.493  Sum_probs=222.3

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEE
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICF  123 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~l  123 (337)
                      ...+.|++...||.|++|.||++.+..++..+++|++.....  ....+.+|+..+++++|+|++++++.+.. ....++
T Consensus        16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~l   92 (286)
T cd06614          16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ--NKELIINEILIMKDCKHPNIVDYYDSYLV-GDELWV   92 (286)
T ss_pred             CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch--hHHHHHHHHHHHHHCCCCCeeEEEEEEEE-CCEEEE
Confidence            456779999999999999999999998899999999976543  45667889999999999999999998877 688999


Q ss_pred             EEeccCCCCchHHhhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccC
Q 019650          124 VMEHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNN  202 (337)
Q Consensus       124 v~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~  202 (337)
                      ++||+++++|.+++...+ .++...+..++.|++.+|++||+.|++|+||+|+||+++.++.++|+|||.+........ 
T Consensus        93 v~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-  171 (286)
T cd06614          93 VMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS-  171 (286)
T ss_pred             EEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh-
Confidence            999999999999999876 899999999999999999999999999999999999999999999999998765543221 


Q ss_pred             CCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhc
Q 019650          203 NNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICF  282 (337)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~  282 (337)
                                   ......++..|+|||.+.    +..++.++|+||||+++|+|++|..||.............  ...
T Consensus       172 -------------~~~~~~~~~~y~~PE~~~----~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~--~~~  232 (286)
T cd06614         172 -------------KRNSVVGTPYWMAPEVIK----RKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLIT--TKG  232 (286)
T ss_pred             -------------hhccccCCcccCCHhHhc----CCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--hcC
Confidence                         111224678999999987    4567889999999999999999999996543322222111  111


Q ss_pred             cCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCCccccCc
Q 019650          283 GERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNIEGL  335 (337)
Q Consensus       283 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~~~~~~~  335 (337)
                      ......+..++..+.++|.+||+.+|.+|||+.+++.||||++.++.+.+..+
T Consensus       233 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~~~~~~~  285 (286)
T cd06614         233 IPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKACPKEEFAPL  285 (286)
T ss_pred             CCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhccCchHhhhhc
Confidence            11112223378899999999999999999999999999999998888776654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1.5e-42  Score=302.32  Aligned_cols=256  Identities=27%  Similarity=0.454  Sum_probs=204.1

Q ss_pred             ccccCcceEEEEEEEccCCceEEEEEeecCCch--HhHHHHHHHHHH---HHhcCCCCceeeeeeEEeeCCeEEEEEecc
Q 019650           54 VLGHGNGGIVYKVRHQKSNSIYALKVLNTTSST--IIRHQAAHEAEI---LKRLDSQFIVKCHAVFYTIEGEICFVMEHM  128 (337)
Q Consensus        54 ~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~---~~~l~~~~i~~~~~~~~~~~~~~~lv~e~~  128 (337)
                      .||+|+||.||++.+..++..+|+|.+......  .......++..+   +....|++++.+++.+.. ++..++||||+
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~-~~~~~lv~e~~   79 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHT-PDKLCFILDLM   79 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEec-CCeEEEEEecC
Confidence            489999999999999999999999998654311  112223334333   333478999999988766 67899999999


Q ss_pred             CCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCCCCCC
Q 019650          129 ERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNN  208 (337)
Q Consensus       129 ~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~  208 (337)
                      ++++|.+++...+.+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||.+........       
T Consensus        80 ~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~-------  152 (279)
T cd05633          80 NGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-------  152 (279)
T ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc-------
Confidence            9999999998888899999999999999999999999999999999999999999999999998865432211       


Q ss_pred             CCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhccCCCCC
Q 019650          209 NNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEM  288 (337)
Q Consensus       209 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  288 (337)
                               ....++..|+|||.+..   +..++.++|+||+|+++|+|++|..||........ . .............
T Consensus       153 ---------~~~~~~~~y~aPE~~~~---~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~-~~~~~~~~~~~~~  218 (279)
T cd05633         153 ---------HASVGTHGYMAPEVLQK---GTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-H-EIDRMTLTVNVEL  218 (279)
T ss_pred             ---------cCcCCCcCccCHHHhcC---CCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH-H-HHHHHhhcCCcCC
Confidence                     11248899999999863   24578899999999999999999999965432221 1 1222222334456


Q ss_pred             CCCCCHHHHHHHHHHhhcCcCCCC-----CHHHHhcCccccccCCCcc
Q 019650          289 PETASPEFRRFVRSCLEKDWRKRG-----TVEELLAYPFVTKRSSSSN  331 (337)
Q Consensus       289 ~~~~~~~~~~li~~~l~~~p~~R~-----s~~eil~hp~f~~~~~~~~  331 (337)
                      +...+..+.++|.+||+.||++|+     |++++++||||++..+...
T Consensus       219 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~~~~  266 (279)
T cd05633         219 PDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQV  266 (279)
T ss_pred             ccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCCHhHH
Confidence            677899999999999999999999     6999999999999776543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=1.4e-42  Score=303.05  Aligned_cols=263  Identities=32%  Similarity=0.574  Sum_probs=207.8

Q ss_pred             cccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHH-HHhcCCCCceeeeeeEEeeCCeEEEEE
Q 019650           47 SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEI-LKRLDSQFIVKCHAVFYTIEGEICFVM  125 (337)
Q Consensus        47 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~-~~~l~~~~i~~~~~~~~~~~~~~~lv~  125 (337)
                      ++|++.+.||.|+||.||++.+..++..||+|.+...........+..|... ++.+.|+|++++++.+.. ....+++|
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~-~~~~~lv~   79 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFR-EGDVWICM   79 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEec-CCcEEEEh
Confidence            4799999999999999999999999999999998765433333445555554 666799999999998866 67899999


Q ss_pred             eccCCCCchHHhhh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCCeEEcCCCcEEEeeccCccchhccc
Q 019650          126 EHMERGSLFDSLRV----RKKLSEDVISGVAYRVLKGLQYLHGM-QIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETR  200 (337)
Q Consensus       126 e~~~~~~L~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~~-~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~  200 (337)
                      ||++ ++|.+++..    ...+++..++.++.|++.||+|||++ +++|+||+|+||+++.++.++|+|||.+.......
T Consensus        80 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  158 (283)
T cd06617          80 EVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV  158 (283)
T ss_pred             hhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccccccc
Confidence            9997 488777753    24689999999999999999999997 99999999999999999999999999987653221


Q ss_pred             cCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHh
Q 019650          201 NNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAI  280 (337)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~  280 (337)
                      .               .....++..|+|||.+........++.++|+||||+++|+|++|..||.......  ..... .
T Consensus       159 ~---------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~~~~-~  220 (283)
T cd06617         159 A---------------KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF--QQLKQ-V  220 (283)
T ss_pred             c---------------cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCH--HHHHH-H
Confidence            1               1112478889999998743212456889999999999999999999996433221  11111 1


Q ss_pred             hccCCCCCC-CCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCC
Q 019650          281 CFGERLEMP-ETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSS  329 (337)
Q Consensus       281 ~~~~~~~~~-~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~  329 (337)
                      ........+ ..++..+.++|.+||..+|++||++.++++||||++...+
T Consensus       221 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~  270 (283)
T cd06617         221 VEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHLSK  270 (283)
T ss_pred             HhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcccc
Confidence            222233332 3468899999999999999999999999999999997754

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=2.8e-42  Score=302.45  Aligned_cols=263  Identities=33%  Similarity=0.536  Sum_probs=209.7

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhc-CCCCceeeeeeEEeeC----
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRL-DSQFIVKCHAVFYTIE----  118 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~----  118 (337)
                      ...++|.+.+.||.|++|.||++.+..+++.+|+|++....  .....+.+|+.++.++ +|+|++++++.+...+    
T Consensus        19 ~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~   96 (291)
T cd06639          19 DPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS--DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVG   96 (291)
T ss_pred             CCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc--cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCC
Confidence            34688999999999999999999999999999999986542  2245567788889888 8999999999887543    


Q ss_pred             CeEEEEEeccCCCCchHHhhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCcc
Q 019650          119 GEICFVMEHMERGSLFDSLRV----RKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSR  194 (337)
Q Consensus       119 ~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~  194 (337)
                      ...++||||+++++|.+++..    ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.
T Consensus        97 ~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~  176 (291)
T cd06639          97 GQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSA  176 (291)
T ss_pred             CeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccch
Confidence            368999999999999998853    4578999999999999999999999999999999999999999999999999987


Q ss_pred             chhccccCCCCCCCCCCccccccccccCCCCCcCCccccccc-CCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhH
Q 019650          195 IVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSER-WGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDL  273 (337)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~  273 (337)
                      ........              .....++..|+|||.+.... .+..++.++|+||||+++|+|++|+.||.........
T Consensus       177 ~~~~~~~~--------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~  242 (291)
T cd06639         177 QLTSTRLR--------------RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTL  242 (291)
T ss_pred             hccccccc--------------ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHH
Confidence            65432211              11224788999999986431 1224688999999999999999999999754332222


Q ss_pred             HHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCcccc
Q 019650          274 MALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVT  324 (337)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~  324 (337)
                      ......  .......+...+..+.++|.+||+.+|++||++.+++.||||+
T Consensus       243 ~~~~~~--~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  291 (291)
T cd06639         243 FKIPRN--PPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK  291 (291)
T ss_pred             HHHhcC--CCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence            221110  1111122345677899999999999999999999999999995

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=3.4e-42  Score=301.03  Aligned_cols=264  Identities=29%  Similarity=0.439  Sum_probs=215.2

Q ss_pred             ccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 019650           46 ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVM  125 (337)
Q Consensus        46 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~  125 (337)
                      ...|.....||.|++|.||++.+..++..+++|.+..... ...+.+.+|+.+++.++|+|++++++.+.. ....++++
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~-~~~~~~v~   95 (285)
T cd06648          18 RSYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQ-QRRELLFNEVVIMRDYQHPNIVEMYSSYLV-GDELWVVM   95 (285)
T ss_pred             hHhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccch-hHHHHHHHHHHHHHHcCCCChheEEEEEEc-CCeEEEEE
Confidence            3566777899999999999999988999999999865432 234567789999999999999999998766 68899999


Q ss_pred             eccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCCC
Q 019650          126 EHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNH  205 (337)
Q Consensus       126 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~  205 (337)
                      ||+++++|.+++.. ..+++..+..++.|++.||++||++|++||||+|+||+++.++.++|+|||.+.......     
T Consensus        96 e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~-----  169 (285)
T cd06648          96 EFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV-----  169 (285)
T ss_pred             eccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCC-----
Confidence            99999999999986 679999999999999999999999999999999999999999999999999876543221     


Q ss_pred             CCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhccCC
Q 019650          206 NNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGER  285 (337)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~  285 (337)
                               .......++..|+|||.+.    +..++.++|+||||+++|+|++|..||........    .........
T Consensus       170 ---------~~~~~~~~~~~y~aPE~~~----~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~----~~~~~~~~~  232 (285)
T cd06648         170 ---------PRRKSLVGTPYWMAPEVIS----RLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQA----MKRIRDNLP  232 (285)
T ss_pred             ---------cccccccCCccccCHHHhc----CCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHH----HHHHHhcCC
Confidence                     1111234788999999987    45678899999999999999999999965332222    122222222


Q ss_pred             CC--CCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCCccccC
Q 019650          286 LE--MPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNIEG  334 (337)
Q Consensus       286 ~~--~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~~~~~~  334 (337)
                      ..  .+..++..+.+++.+||..+|++|||++++++||||++...++.+..
T Consensus       233 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~~~~~~  283 (285)
T cd06648         233 PKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGPPSSIVP  283 (285)
T ss_pred             CCCcccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCCCcchhcc
Confidence            22  22336889999999999999999999999999999998776555443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=2.8e-42  Score=297.93  Aligned_cols=254  Identities=30%  Similarity=0.458  Sum_probs=213.6

Q ss_pred             ccccccccccCcceEEEEEEEccCCceEEEEEeecCC-chHhHHHHHHHHHHHHhcCCCCceeeeeeEEee-CCeEEEEE
Q 019650           48 DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTI-EGEICFVM  125 (337)
Q Consensus        48 ~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-~~~~~lv~  125 (337)
                      +|++.+.||.|++|.||++.+..++..+++|.+.... .....+.+.+|+.++++++|+|++++++.+... +...+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            5889999999999999999999999999999987543 344556788899999999999999999877643 35689999


Q ss_pred             eccCCCCchHHhhh----cCCCCHHHHHHHHHHHHHHHHHHH-----hCCceeccCCCCCeEEcCCCcEEEeeccCccch
Q 019650          126 EHMERGSLFDSLRV----RKKLSEDVISGVAYRVLKGLQYLH-----GMQIIHGDIKPSNLLINGKGEVKIADFGVSRIV  196 (337)
Q Consensus       126 e~~~~~~L~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH-----~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~  196 (337)
                      ||+++++|.+++..    ...+++..++.++.||+.||.+||     +.+++|+||+|+||+++.++.++|+|||.+...
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~  160 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL  160 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence            99999999999975    357899999999999999999999     999999999999999999999999999998876


Q ss_pred             hccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHH
Q 019650          197 EETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMAL  276 (337)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~  276 (337)
                      .....              ......++..|+|||.+.    +..++.++|+||||+++|+|++|..||....    ....
T Consensus       161 ~~~~~--------------~~~~~~~~~~~~~pE~~~----~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~----~~~~  218 (265)
T cd08217         161 GHDSS--------------FAKTYVGTPYYMSPEQLN----HMSYDEKSDIWSLGCLIYELCALSPPFTARN----QLQL  218 (265)
T ss_pred             cCCcc--------------cccccccCCCccChhhhc----CCCCCchhHHHHHHHHHHHHHHCCCcccCcC----HHHH
Confidence            54321              011234788999999998    4567889999999999999999999997543    2223


Q ss_pred             HHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccc
Q 019650          277 ICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV  323 (337)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f  323 (337)
                      ............+...+..+.+++.+||+.+|++||++++|++|||+
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         219 ASKIKEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             HHHHhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence            33334444555667788999999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.7e-42  Score=297.07  Aligned_cols=254  Identities=31%  Similarity=0.471  Sum_probs=212.6

Q ss_pred             ccccccccccCcceEEEEEEEccCCceEEEEEeecCC----chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEE
Q 019650           48 DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS----STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICF  123 (337)
Q Consensus        48 ~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~l  123 (337)
                      +|+..+.||+|++|+||+|.+..++..|++|.+....    .....+.+.+|+.+++.++|+|++++++.+.. ....++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~l   79 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTERE-EDNLYI   79 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEec-CCeEEE
Confidence            4778899999999999999998889999999986543    12345678889999999999999999998765 678999


Q ss_pred             EEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCC
Q 019650          124 VMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNN  203 (337)
Q Consensus       124 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~  203 (337)
                      ++||+++++|.+++...+.+++..+..++.|++.+|++||+.|++|+||+|+||+++.++.++|+|||.+.......   
T Consensus        80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~---  156 (258)
T cd06632          80 FLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS---  156 (258)
T ss_pred             EEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc---
Confidence            99999999999999888889999999999999999999999999999999999999999999999999887654322   


Q ss_pred             CCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhcc
Q 019650          204 NHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFG  283 (337)
Q Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~  283 (337)
                                  ......++..|+|||.+...   ..++.++|+||||+++|+|++|..||.........   .......
T Consensus       157 ------------~~~~~~~~~~y~~pe~~~~~---~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~---~~~~~~~  218 (258)
T cd06632         157 ------------FAKSFKGSPYWMAPEVIAQQ---GGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAV---FKIGRSK  218 (258)
T ss_pred             ------------cccccCCCcceeCHHHhcCC---CCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHH---HHHHhcc
Confidence                        11123478899999998742   13788999999999999999999999654322222   2222223


Q ss_pred             CCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccc
Q 019650          284 ERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV  323 (337)
Q Consensus       284 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f  323 (337)
                      .....+..++..+.+++.+||..+|++||++.+++.|||+
T Consensus       219 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         219 ELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             cCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence            3445666788999999999999999999999999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=8.1e-43  Score=305.92  Aligned_cols=271  Identities=27%  Similarity=0.429  Sum_probs=219.6

Q ss_pred             ccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEE
Q 019650           43 VENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEIC  122 (337)
Q Consensus        43 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~  122 (337)
                      ....+.|.....||.|++|.||++.+..++..||+|.+.... ....+.+.+|+.+++.++|+|++++++.+.. ....+
T Consensus        18 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~-~~~~~   95 (292)
T cd06658          18 GDPREYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK-QQRRELLFNEVVIMRDYHHENVVDMYNSYLV-GDELW   95 (292)
T ss_pred             CchHHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch-HHHHHHHHHHHHHHHhCCCCcHHHHHHheec-CCeEE
Confidence            344577777889999999999999999899999999986543 3345667889999999999999999998766 68899


Q ss_pred             EEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccC
Q 019650          123 FVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNN  202 (337)
Q Consensus       123 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~  202 (337)
                      ++|||+++++|.+++.. +.+++..+..++.||+.+|.|||++|++|+||+|+||+++.++.++|+|||++.......  
T Consensus        96 lv~e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~--  172 (292)
T cd06658          96 VVMEFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV--  172 (292)
T ss_pred             EEEeCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhccccc--
Confidence            99999999999998854 568999999999999999999999999999999999999999999999999886543221  


Q ss_pred             CCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhc
Q 019650          203 NNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICF  282 (337)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~  282 (337)
                                  .......++..|+|||.+.    +..++.++|+||||+++|+|++|..||........... ... ..
T Consensus       173 ------------~~~~~~~~~~~y~aPE~~~----~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~-~~~-~~  234 (292)
T cd06658         173 ------------PKRKSLVGTPYWMAPEVIS----RLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRR-IRD-NL  234 (292)
T ss_pred             ------------ccCceeecCccccCHHHHc----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHh-cC
Confidence                        1111235788999999997    45678899999999999999999999965433222111 111 11


Q ss_pred             cCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCCccccCcC
Q 019650          283 GERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNIEGLI  336 (337)
Q Consensus       283 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~~~~~~~~  336 (337)
                      ..........+..+.+++.+||..||.+|||++++++||||+....++++..++
T Consensus       235 ~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~~~~~~~~  288 (292)
T cd06658         235 PPRVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGPPSCIVPLM  288 (292)
T ss_pred             CCccccccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccCCccccchhh
Confidence            111222335688999999999999999999999999999999888888766543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.6e-42  Score=302.11  Aligned_cols=264  Identities=37%  Similarity=0.566  Sum_probs=212.6

Q ss_pred             cccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEee-CCeEEEEE
Q 019650           47 SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTI-EGEICFVM  125 (337)
Q Consensus        47 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-~~~~~lv~  125 (337)
                      ++|+..+.||.|++|.||+|.+..++..+|+|.+...........+.+|++++++++|+||+++++.+... ...+++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            47899999999999999999999999999999998665555667788999999999999999999987653 34689999


Q ss_pred             eccCCCCchHHhhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhcccc
Q 019650          126 EHMERGSLFDSLRV----RKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRN  201 (337)
Q Consensus       126 e~~~~~~L~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~  201 (337)
                      ||+++++|.+++..    ...+++..+..++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~  160 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA  160 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccccccc
Confidence            99999999888753    34589999999999999999999999999999999999999999999999998765432211


Q ss_pred             CCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCc-hhHHHHHHHh
Q 019650          202 NNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEK-PDLMALICAI  280 (337)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~-~~~~~~~~~~  280 (337)
                                      ....++..|+|||.+.    +..++.++|+||||+++|+|++|..||...... ..........
T Consensus       161 ----------------~~~~~~~~y~~pE~~~----~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~  220 (287)
T cd06621         161 ----------------GTFTGTSFYMAPERIQ----GKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYI  220 (287)
T ss_pred             ----------------ccccCCccccCHHHhc----CCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHH
Confidence                            1224678899999987    457888999999999999999999999754210 1111222222


Q ss_pred             hccCCCCCC------CCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCCc
Q 019650          281 CFGERLEMP------ETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSS  330 (337)
Q Consensus       281 ~~~~~~~~~------~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~~  330 (337)
                      .....+..+      ...++.+.+++.+||..+|++|||+.|++.||||++...+.
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~~~  276 (287)
T cd06621         221 VNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKKK  276 (287)
T ss_pred             hcCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccccch
Confidence            221112111      12357899999999999999999999999999997776543

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-42  Score=303.92  Aligned_cols=260  Identities=26%  Similarity=0.375  Sum_probs=204.8

Q ss_pred             CccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 019650           45 NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFV  124 (337)
Q Consensus        45 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv  124 (337)
                      ..++|++.+.||.|++|+||+|.+..++..||+|.+...........+.+|+.++++++|+||+++++++.+ ....++|
T Consensus         3 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv   81 (291)
T cd07844           3 KLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHT-KKTLTLV   81 (291)
T ss_pred             CccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEec-CCeEEEE
Confidence            468999999999999999999999889999999998765433333456689999999999999999998766 6889999


Q ss_pred             EeccCCCCchHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCC
Q 019650          125 MEHMERGSLFDSLRVR-KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNN  203 (337)
Q Consensus       125 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~  203 (337)
                      |||+.+ +|.+++... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+........  
T Consensus        82 ~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~--  158 (291)
T cd07844          82 FEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK--  158 (291)
T ss_pred             EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCc--
Confidence            999975 999988754 4689999999999999999999999999999999999999999999999998865432110  


Q ss_pred             CCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhcc
Q 019650          204 NHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFG  283 (337)
Q Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~  283 (337)
                                  ......++..|+|||.+..   ...++.++|+||+|+++|+|++|..||...................
T Consensus       159 ------------~~~~~~~~~~~~aPE~~~~---~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~  223 (291)
T cd07844         159 ------------TYSNEVVTLWYRPPDVLLG---STEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGT  223 (291)
T ss_pred             ------------cccccccccccCCcHHhhc---CcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCC
Confidence                        0011135788999999863   2357889999999999999999999996544222211111110000


Q ss_pred             CC-----------------------C---CCCCCCC--HHHHHHHHHHhhcCcCCCCCHHHHhcCccc
Q 019650          284 ER-----------------------L---EMPETAS--PEFRRFVRSCLEKDWRKRGTVEELLAYPFV  323 (337)
Q Consensus       284 ~~-----------------------~---~~~~~~~--~~~~~li~~~l~~~p~~R~s~~eil~hp~f  323 (337)
                      ..                       .   ......+  ..+.+++.+||+.+|.+|||+.+++.||||
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         224 PTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             CChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            00                       0   0001233  788999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.9e-42  Score=299.59  Aligned_cols=253  Identities=23%  Similarity=0.329  Sum_probs=207.9

Q ss_pred             CccccccccccccCcceEEEEEEEc---cCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeE
Q 019650           45 NISDLKKLTVLGHGNGGIVYKVRHQ---KSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEI  121 (337)
Q Consensus        45 ~~~~y~~~~~lg~g~~~~v~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~  121 (337)
                      ..++|++.+.||+|+||.||+|.+.   ..+..||+|.++..........+.+|+..+.+++|+|++++++.+.. +...
T Consensus         3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~   81 (266)
T cd05064           3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITR-GNTM   81 (266)
T ss_pred             chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEec-CCCc
Confidence            3568999999999999999999875   45678999998876555556678899999999999999999998766 6889


Q ss_pred             EEEEeccCCCCchHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccc
Q 019650          122 CFVMEHMERGSLFDSLRVR-KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETR  200 (337)
Q Consensus       122 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~  200 (337)
                      ++||||+++++|.+++... ..+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.++++|||.+.......
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~  161 (266)
T cd05064          82 MIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA  161 (266)
T ss_pred             EEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccccc
Confidence            9999999999999999764 578999999999999999999999999999999999999999999999999765532211


Q ss_pred             cCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHH
Q 019650          201 NNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICA  279 (337)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~  279 (337)
                      ..             ......++..|+|||.+.    +..++.++||||||+++|++++ |..||.......    ....
T Consensus       162 ~~-------------~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~----~~~~  220 (266)
T cd05064         162 IY-------------TTMSGKSPVLWAAPEAIQ----YHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD----VIKA  220 (266)
T ss_pred             hh-------------cccCCCCceeecCHHHHh----hCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH----HHHH
Confidence            00             011122467899999997    4578899999999999999876 999997653322    2223


Q ss_pred             hhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhc
Q 019650          280 ICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA  319 (337)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~  319 (337)
                      ...+.....+..++..+.+++.+||+.+|++|||+++|++
T Consensus       221 ~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~  260 (266)
T cd05064         221 VEDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHS  260 (266)
T ss_pred             HHCCCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence            3334445566778999999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=1.2e-42  Score=307.50  Aligned_cols=268  Identities=30%  Similarity=0.378  Sum_probs=211.7

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCch-HhHHHHHHHHHHHHhcCCCCceeeeeeEEeeC-CeE
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSST-IIRHQAAHEAEILKRLDSQFIVKCHAVFYTIE-GEI  121 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~-~~~  121 (337)
                      ...++|++.+.||.|++|.||+|.+..++..||+|.+...... .......+|+.++++++|+|++++++.+.... ...
T Consensus         4 ~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (309)
T cd07845           4 RSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSI   83 (309)
T ss_pred             ccccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeE
Confidence            4678999999999999999999999999999999998754322 22234567999999999999999999876533 568


Q ss_pred             EEEEeccCCCCchHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccc
Q 019650          122 CFVMEHMERGSLFDSLRV-RKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETR  200 (337)
Q Consensus       122 ~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~  200 (337)
                      ++||||+.+ +|.+++.. ...+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        84 ~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~  162 (309)
T cd07845          84 FLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA  162 (309)
T ss_pred             EEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCcc
Confidence            999999965 88888875 3678999999999999999999999999999999999999999999999999987764332


Q ss_pred             cCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHh
Q 019650          201 NNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAI  280 (337)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~  280 (337)
                      ..              .....++..|+|||.+...   ..++.++|+||||+++|+|++|..||.+..............
T Consensus       163 ~~--------------~~~~~~~~~y~aPE~~~~~---~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~  225 (309)
T cd07845         163 KP--------------MTPKVVTLWYRAPELLLGC---TTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLL  225 (309)
T ss_pred             CC--------------CCcccccccccChhhhcCC---CCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence            11              1112357789999998732   357889999999999999999999997654443333332211


Q ss_pred             hccC--------------CCCC-----------CCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCC
Q 019650          281 CFGE--------------RLEM-----------PETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSS  329 (337)
Q Consensus       281 ~~~~--------------~~~~-----------~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~  329 (337)
                      ....              ....           ....+..+.++|.+||..||++|||+++++.||||++..-.
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~  299 (309)
T cd07845         226 GTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLP  299 (309)
T ss_pred             CCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCC
Confidence            1000              0000           01247789999999999999999999999999999876543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=9.4e-43  Score=315.30  Aligned_cols=258  Identities=24%  Similarity=0.320  Sum_probs=208.0

Q ss_pred             CccCccccccccccccCcceEEEEEEEcc-----CCceEEEEEeecCCchHhHHHHHHHHHHHHhc-CCCCceeeeeeEE
Q 019650           42 DVENISDLKKLTVLGHGNGGIVYKVRHQK-----SNSIYALKVLNTTSSTIIRHQAAHEAEILKRL-DSQFIVKCHAVFY  115 (337)
Q Consensus        42 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~  115 (337)
                      +....++|.+.+.||+|+||.||+|.+..     ++..||+|.+...........+.+|+.+++.+ +|+||+++++.+.
T Consensus        33 ~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~  112 (374)
T cd05106          33 WEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACT  112 (374)
T ss_pred             ccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEec
Confidence            44567899999999999999999998643     34579999997665555566788899999999 8999999999887


Q ss_pred             eeCCeEEEEEeccCCCCchHHhhhc-------------------------------------------------------
Q 019650          116 TIEGEICFVMEHMERGSLFDSLRVR-------------------------------------------------------  140 (337)
Q Consensus       116 ~~~~~~~lv~e~~~~~~L~~~l~~~-------------------------------------------------------  140 (337)
                      . ....++||||+++|+|.+++...                                                       
T Consensus       113 ~-~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (374)
T cd05106         113 H-GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS  191 (374)
T ss_pred             C-CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence            6 67899999999999999988532                                                       


Q ss_pred             ---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCCC
Q 019650          141 ---------------KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNH  205 (337)
Q Consensus       141 ---------------~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~  205 (337)
                                     .++++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||++.........   
T Consensus       192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~---  268 (374)
T cd05106         192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY---  268 (374)
T ss_pred             cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcce---
Confidence                           13678889999999999999999999999999999999999999999999998765322110   


Q ss_pred             CCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHhhccC
Q 019650          206 NNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICAICFGE  284 (337)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~  284 (337)
                               .......++..|+|||++.    +..++.++||||||+++|+|++ |+.||.............   ....
T Consensus       269 ---------~~~~~~~~~~~y~aPE~~~----~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~---~~~~  332 (374)
T cd05106         269 ---------VVKGNARLPVKWMAPESIF----DCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMV---KRGY  332 (374)
T ss_pred             ---------eeccCCCCccceeCHHHhc----CCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHH---Hccc
Confidence                     0111122466899999997    4578999999999999999997 999997654433333322   2233


Q ss_pred             CCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhc
Q 019650          285 RLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA  319 (337)
Q Consensus       285 ~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~  319 (337)
                      ....+...+..+.+++.+||+.||.+|||+.++++
T Consensus       333 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~  367 (374)
T cd05106         333 QMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ  367 (374)
T ss_pred             CccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            34445567899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=4.6e-42  Score=295.45  Aligned_cols=253  Identities=29%  Similarity=0.446  Sum_probs=213.0

Q ss_pred             ccccccccccCcceEEEEEEEccCCceEEEEEeecCC-chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEe
Q 019650           48 DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVME  126 (337)
Q Consensus        48 ~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~e  126 (337)
                      +|+..+.||.|++|.||.+.+..++..+++|.+.... .......+.+|+.++++++|+|++++++.+.+ ....+++||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~~~~e   79 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMD-DNTLLIEME   79 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEec-CCeEEEEEE
Confidence            5889999999999999999999999999999987543 33445667889999999999999999999877 688999999


Q ss_pred             ccCCCCchHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCC
Q 019650          127 HMERGSLFDSLRVR--KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNN  204 (337)
Q Consensus       127 ~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~  204 (337)
                      |+++++|.+++...  ..+++..+..++.|++.+|+|||+.|++|+||+|+||+++.++.++|+|||.+........   
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~---  156 (256)
T cd08221          80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS---  156 (256)
T ss_pred             ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc---
Confidence            99999999999764  4689999999999999999999999999999999999999999999999999876643321   


Q ss_pred             CCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhccC
Q 019650          205 HNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGE  284 (337)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~  284 (337)
                                 ......+++.|+|||.+.    +..++.++|+||||+++|+|++|..||......    ........+.
T Consensus       157 -----------~~~~~~~~~~y~ape~~~----~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~----~~~~~~~~~~  217 (256)
T cd08221         157 -----------MAETVVGTPYYMSPELCQ----GVKYNFKSDIWALGCVLYELLTLKRTFDATNPL----NLVVKIVQGN  217 (256)
T ss_pred             -----------cccccCCCccccCHhhcC----CCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH----HHHHHHHcCC
Confidence                       111235789999999987    446788999999999999999999998653322    2222223333


Q ss_pred             CCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccc
Q 019650          285 RLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV  323 (337)
Q Consensus       285 ~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f  323 (337)
                      ....+...+..+.+++.+||..+|++|||++++++|||+
T Consensus       218 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l  256 (256)
T cd08221         218 YTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL  256 (256)
T ss_pred             CCCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence            444456678999999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=1.6e-42  Score=309.81  Aligned_cols=260  Identities=24%  Similarity=0.339  Sum_probs=210.7

Q ss_pred             CccCccccccccccccCcceEEEEEEEc-----cCCceEEEEEeecCCchHhHHHHHHHHHHHHhc-CCCCceeeeeeEE
Q 019650           42 DVENISDLKKLTVLGHGNGGIVYKVRHQ-----KSNSIYALKVLNTTSSTIIRHQAAHEAEILKRL-DSQFIVKCHAVFY  115 (337)
Q Consensus        42 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~  115 (337)
                      |....++|++.+.||.|+||.||+|.+.     .+++.||+|++.........+.+..|+.++.++ .|+||+++++.+.
T Consensus         2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~   81 (337)
T cd05054           2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACT   81 (337)
T ss_pred             cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEe
Confidence            4555679999999999999999999753     345789999987654444456677899999999 8999999999887


Q ss_pred             eeCCeEEEEEeccCCCCchHHhhhc-------------------------------------------------------
Q 019650          116 TIEGEICFVMEHMERGSLFDSLRVR-------------------------------------------------------  140 (337)
Q Consensus       116 ~~~~~~~lv~e~~~~~~L~~~l~~~-------------------------------------------------------  140 (337)
                      ..+..++++|||+++++|.+++...                                                       
T Consensus        82 ~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (337)
T cd05054          82 KPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE  161 (337)
T ss_pred             cCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence            7677899999999999999988532                                                       


Q ss_pred             ------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCCCCCCCCCccc
Q 019650          141 ------KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIG  214 (337)
Q Consensus       141 ------~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~  214 (337)
                            ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++..+......            
T Consensus       162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~------------  229 (337)
T cd05054         162 GDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY------------  229 (337)
T ss_pred             hhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcch------------
Confidence                  25788999999999999999999999999999999999999999999999998765332111            


Q ss_pred             cccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHhhccCCCCCCCCCC
Q 019650          215 EAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICAICFGERLEMPETAS  293 (337)
Q Consensus       215 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (337)
                      .......++..|+|||++.    +..++.++|||||||++|+|++ |..||......+.....+   ..+.....+...+
T Consensus       230 ~~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~  302 (337)
T cd05054         230 VRKGDARLPLKWMAPESIF----DKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRL---KEGTRMRAPEYAT  302 (337)
T ss_pred             hhccCCCCCccccCcHHhc----CCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHH---hccCCCCCCccCC
Confidence            0111223567899999998    5678999999999999999998 999997654433332222   2333444556678


Q ss_pred             HHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          294 PEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       294 ~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                      ..+.+++.+||+.+|++||+++++++|
T Consensus       303 ~~~~~l~~~cl~~~p~~RPs~~ell~~  329 (337)
T cd05054         303 PEIYSIMLDCWHNNPEDRPTFSELVEI  329 (337)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            899999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=1.6e-42  Score=307.67  Aligned_cols=254  Identities=24%  Similarity=0.393  Sum_probs=192.1

Q ss_pred             ccccccCcceEEEEEEEc--cCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEee-CCeEEEEEecc
Q 019650           52 LTVLGHGNGGIVYKVRHQ--KSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTI-EGEICFVMEHM  128 (337)
Q Consensus        52 ~~~lg~g~~~~v~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-~~~~~lv~e~~  128 (337)
                      ..+||+|+||+||+|.+.  .+++.+|+|.+.....   .....+|+.++++++|+||+++++.+... +...+++|||+
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~   82 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI---SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA   82 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC---cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc
Confidence            468999999999999965  4678899999865432   23467899999999999999999987643 35688999999


Q ss_pred             CCCCchHHhhhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEE----cCCCcEEEeeccCccc
Q 019650          129 ERGSLFDSLRVR---------KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLI----NGKGEVKIADFGVSRI  195 (337)
Q Consensus       129 ~~~~L~~~l~~~---------~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili----~~~~~~~l~Dfg~~~~  195 (337)
                      .+ +|.+++...         ..+++..++.++.||+.||.|||+.|++|+||||+||++    +.++.++|+|||++..
T Consensus        83 ~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~  161 (317)
T cd07868          83 EH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL  161 (317)
T ss_pred             CC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceec
Confidence            65 888887532         258899999999999999999999999999999999999    4557899999999976


Q ss_pred             hhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCch----
Q 019650          196 VEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP----  271 (337)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~----  271 (337)
                      ........           .......+++.|+|||++...   ..++.++|+||+|+++|+|++|+.||....+..    
T Consensus       162 ~~~~~~~~-----------~~~~~~~~t~~y~aPE~~~~~---~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~  227 (317)
T cd07868         162 FNSPLKPL-----------ADLDPVVVTFWYRAPELLLGA---RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSN  227 (317)
T ss_pred             cCCCCccc-----------cccCCccccccccCCHHHcCC---CCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccc
Confidence            54321110           112234689999999998742   357889999999999999999999996543211    


Q ss_pred             -----hHHHHHHHhh------------------------ccCCC---------CCCCCCCHHHHHHHHHHhhcCcCCCCC
Q 019650          272 -----DLMALICAIC------------------------FGERL---------EMPETASPEFRRFVRSCLEKDWRKRGT  313 (337)
Q Consensus       272 -----~~~~~~~~~~------------------------~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~R~s  313 (337)
                           ..........                        .....         ......+..+.++|.+||..||.+|||
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t  307 (317)
T cd07868         228 PYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRIT  307 (317)
T ss_pred             cccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCC
Confidence                 0111100000                        00000         000122457899999999999999999


Q ss_pred             HHHHhcCccc
Q 019650          314 VEELLAYPFV  323 (337)
Q Consensus       314 ~~eil~hp~f  323 (337)
                      ++|+|+||||
T Consensus       308 ~~e~l~hp~f  317 (317)
T cd07868         308 SEQAMQDPYF  317 (317)
T ss_pred             HHHHhcCCCC
Confidence            9999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=4.2e-42  Score=303.36  Aligned_cols=275  Identities=27%  Similarity=0.391  Sum_probs=214.0

Q ss_pred             cccccccccccCcceEEEEEEEccCCceEEEEEeecCCc--hHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 019650           47 SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSS--TIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFV  124 (337)
Q Consensus        47 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv  124 (337)
                      ++|.+.+.||.|++|.||++.+..+++.|++|.+.....  ....+.+.+|+.+++.++|+||+++++.+.. +..++++
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv   79 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFET-KRHLCMV   79 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEec-CCEEEEE
Confidence            478999999999999999999999999999999876532  2234567789999999999999999998765 6789999


Q ss_pred             EeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCC
Q 019650          125 MEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNN  204 (337)
Q Consensus       125 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~  204 (337)
                      |||++|++|.+++...+.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+...........
T Consensus        80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~  159 (305)
T cd05609          80 MEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNL  159 (305)
T ss_pred             EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCccccc
Confidence            99999999999998888899999999999999999999999999999999999999999999999998764211100000


Q ss_pred             CC-CCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhcc
Q 019650          205 HN-NNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFG  283 (337)
Q Consensus       205 ~~-~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~  283 (337)
                      .. ...............++..|+|||.+.    +..++.++|+||||+++|++++|..||.+.....    ........
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~----~~~~~~~~  231 (305)
T cd05609         160 YEGHIEKDTREFLDKQVCGTPEYIAPEVIL----RQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE----LFGQVISD  231 (305)
T ss_pred             cccccccchhhccccCCccCccccCchhcc----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHhc
Confidence            00 000000000111234678899999987    4567899999999999999999999997543222    12221111


Q ss_pred             --CCCCCCCCCCHHHHHHHHHHhhcCcCCCCC---HHHHhcCccccccCCCc
Q 019650          284 --ERLEMPETASPEFRRFVRSCLEKDWRKRGT---VEELLAYPFVTKRSSSS  330 (337)
Q Consensus       284 --~~~~~~~~~~~~~~~li~~~l~~~p~~R~s---~~eil~hp~f~~~~~~~  330 (337)
                        ..+......+..+.+++.+||+.+|++||+   +.++|+||||.+..+..
T Consensus       232 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~~~  283 (305)
T cd05609         232 DIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWNG  283 (305)
T ss_pred             ccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCHHH
Confidence              112222356889999999999999999997   79999999998766543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=2.4e-42  Score=297.05  Aligned_cols=250  Identities=27%  Similarity=0.457  Sum_probs=210.2

Q ss_pred             ccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEec
Q 019650           48 DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEH  127 (337)
Q Consensus        48 ~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~e~  127 (337)
                      +|.+.+.||.|++|.||++.+..++..+++|.++........+.+.+|+.+++.++|+|++++++.+.+ +..++++|||
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~   79 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEA-DGHLYIVMEY   79 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEE-CCEEEEEEee
Confidence            588999999999999999999999999999998765544556778889999999999999999998766 7899999999


Q ss_pred             cCCCCchHHhhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCCC
Q 019650          128 MERGSLFDSLRV--RKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNH  205 (337)
Q Consensus       128 ~~~~~L~~~l~~--~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~  205 (337)
                      +++++|.+++..  ...+++..+..++.|++.||.+||++|++|+||+|+||+++.++.++++|||.+........    
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~----  155 (255)
T cd08219          80 CDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA----  155 (255)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccccc----
Confidence            999999998864  34589999999999999999999999999999999999999999999999998876543221    


Q ss_pred             CCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhccCC
Q 019650          206 NNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGER  285 (337)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~  285 (337)
                                ......+++.|+|||++.    +..++.++|+||||+++|+|++|..||.....    .........+..
T Consensus       156 ----------~~~~~~~~~~~~aPE~~~----~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~----~~~~~~~~~~~~  217 (255)
T cd08219         156 ----------YACTYVGTPYYVPPEIWE----NMPYNNKSDIWSLGCILYELCTLKHPFQANSW----KNLILKVCQGSY  217 (255)
T ss_pred             ----------ccccccCCccccCHHHHc----cCCcCchhhhhhhchhheehhhccCCCCCCCH----HHHHHHHhcCCC
Confidence                      112235788999999997    45688899999999999999999999965322    222233334444


Q ss_pred             CCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          286 LEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       286 ~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                      ...+..++..+.+++.+||+.||++|||+.++++-
T Consensus       218 ~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         218 KPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             CCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            45566788999999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=1.8e-42  Score=302.79  Aligned_cols=259  Identities=30%  Similarity=0.421  Sum_probs=209.1

Q ss_pred             ccccccccccCcceEEEEEEEccCCceEEEEEeecCCc-hHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEe
Q 019650           48 DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSS-TIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVME  126 (337)
Q Consensus        48 ~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~e  126 (337)
                      +|++.+.||.|++|.||+|.+..++..|++|++..... ......+.+|+.++++++|+|++++++.+.. +...++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~~v~e   79 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPH-GSGFVLVME   79 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEec-CCeeEEEec
Confidence            58999999999999999999998999999999876542 3345678889999999999999999998876 788999999


Q ss_pred             ccCCCCchHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCCC
Q 019650          127 HMERGSLFDSLRV-RKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNH  205 (337)
Q Consensus       127 ~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~  205 (337)
                      |+ +++|.+++.. ...+++..++.++.|++.+|+|||+.|++|+||+|+||+++.++.++|+|||.+.........   
T Consensus        80 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~---  155 (286)
T cd07832          80 YM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPR---  155 (286)
T ss_pred             cc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCC---
Confidence            99 8899999864 457899999999999999999999999999999999999999999999999998766433210   


Q ss_pred             CCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhccCC
Q 019650          206 NNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGER  285 (337)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~  285 (337)
                                ......++..|+|||.+...   ..++.++||||+|+++|+|++|.++|....+................
T Consensus       156 ----------~~~~~~~~~~y~aPE~~~~~---~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~  222 (286)
T cd07832         156 ----------LYSHQVATRWYRAPELLYGA---RKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNE  222 (286)
T ss_pred             ----------ccccccCcccccCceeeecc---ccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCCh
Confidence                      01122478899999998642   35688999999999999999998888654433322222221110000


Q ss_pred             -------------------------CCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCcccc
Q 019650          286 -------------------------LEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVT  324 (337)
Q Consensus       286 -------------------------~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~  324 (337)
                                               ....+..+..+.++|.+||..+|.+|||+++++.||||.
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~  286 (286)
T cd07832         223 ETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT  286 (286)
T ss_pred             HHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence                                     001134578999999999999999999999999999984

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=2.1e-42  Score=301.83  Aligned_cols=243  Identities=21%  Similarity=0.305  Sum_probs=201.0

Q ss_pred             cccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHHhcCCCCceeeeeeEEe--e-CCeEEEEEec
Q 019650           53 TVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHAVFYT--I-EGEICFVMEH  127 (337)
Q Consensus        53 ~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~-~~~~~lv~e~  127 (337)
                      ..|++|+++.||+|..  +++.||+|.++...  .....+.+.+|+.++++++|+||+++++.+.+  . ....++||||
T Consensus        26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey  103 (283)
T PHA02988         26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY  103 (283)
T ss_pred             eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence            6799999999999987  58899999987643  22235677899999999999999999998765  2 2468999999


Q ss_pred             cCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCCCC
Q 019650          128 MERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG-MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHN  206 (337)
Q Consensus       128 ~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~-~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~  206 (337)
                      +++|+|.+++...+.+++.....++.+++.+|.|||+ .+++||||+|+||+++.++.++|+|||++.......      
T Consensus       104 ~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~------  177 (283)
T PHA02988        104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP------  177 (283)
T ss_pred             CCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc------
Confidence            9999999999988889999999999999999999998 499999999999999999999999999987653321      


Q ss_pred             CCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhccCCC
Q 019650          207 NNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERL  286 (337)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~  286 (337)
                                 ....++..|+|||.+...  ...++.++||||||+++|+|++|+.||............   .......
T Consensus       178 -----------~~~~~~~~y~aPE~~~~~--~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i---~~~~~~~  241 (283)
T PHA02988        178 -----------FKNVNFMVYFSYKMLNDI--FSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLI---INKNNSL  241 (283)
T ss_pred             -----------ccccCcccccCHHHhhhc--cccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHH---HhcCCCC
Confidence                       112478899999999732  247899999999999999999999999765332222211   1223344


Q ss_pred             CCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhc
Q 019650          287 EMPETASPEFRRFVRSCLEKDWRKRGTVEELLA  319 (337)
Q Consensus       287 ~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~  319 (337)
                      ..+...+..+.+++.+||+.||++|||++++++
T Consensus       242 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  274 (283)
T PHA02988        242 KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILY  274 (283)
T ss_pred             CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence            555578999999999999999999999999986

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=3.9e-42  Score=301.09  Aligned_cols=266  Identities=24%  Similarity=0.358  Sum_probs=212.9

Q ss_pred             CccCccccccccccccCcceEEEEEEEcc-----CCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEe
Q 019650           42 DVENISDLKKLTVLGHGNGGIVYKVRHQK-----SNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYT  116 (337)
Q Consensus        42 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~  116 (337)
                      |....++|++.+.||.|+||.||+|.+..     .+..||+|.+...........+.+|+.+++.++|+|++++++.+.+
T Consensus         1 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   80 (288)
T cd05061           1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSK   80 (288)
T ss_pred             CcccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence            34567899999999999999999997642     3457999988755433344567789999999999999999998766


Q ss_pred             eCCeEEEEEeccCCCCchHHhhhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEE
Q 019650          117 IEGEICFVMEHMERGSLFDSLRVR----------KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVK  186 (337)
Q Consensus       117 ~~~~~~lv~e~~~~~~L~~~l~~~----------~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~  186 (337)
                       ....+++|||+++|+|.+++...          ...+...+..++.|++.||.|||++|++|+||||+||+++.++.++
T Consensus        81 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~  159 (288)
T cd05061          81 -GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVK  159 (288)
T ss_pred             -CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEE
Confidence             57889999999999999999642          2346778899999999999999999999999999999999999999


Q ss_pred             EeeccCccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCC
Q 019650          187 IADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLI  265 (337)
Q Consensus       187 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~  265 (337)
                      |+|||++.........            .......++..|+|||.+.    +..++.++|+||||+++|++++ |..||.
T Consensus       160 L~Dfg~~~~~~~~~~~------------~~~~~~~~~~~y~~pE~~~----~~~~~~~~DvwslG~~l~el~~~~~~p~~  223 (288)
T cd05061         160 IGDFGMTRDIYETDYY------------RKGGKGLLPVRWMAPESLK----DGVFTTSSDMWSFGVVLWEITSLAEQPYQ  223 (288)
T ss_pred             ECcCCccccccccccc------------cccCCCcccccccCHHHhc----cCCCChHhHHHHHHHHHHHHHhCCCCCCC
Confidence            9999988755332211            0111123567899999987    4578889999999999999999 788986


Q ss_pred             CCCCchhHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhc------CccccccCC
Q 019650          266 GFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA------YPFVTKRSS  328 (337)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~------hp~f~~~~~  328 (337)
                      .....    ........+.....+...+..+.+++.+||+.+|++|||+.++++      ||||++..|
T Consensus       224 ~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~~  288 (288)
T cd05061         224 GLSNE----QVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVSF  288 (288)
T ss_pred             CCCHH----HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCCCC
Confidence            54322    222333334444556677899999999999999999999999987      999988654

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=5.7e-42  Score=296.11  Aligned_cols=261  Identities=31%  Similarity=0.512  Sum_probs=214.6

Q ss_pred             ccccccccccCcceEEEEEEEccCCceEEEEEeecCCc-hHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEe
Q 019650           48 DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSS-TIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVME  126 (337)
Q Consensus        48 ~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~e  126 (337)
                      +|.+.+.||.|++|.||++.+..+++.+++|.+..... ....+.+..|+.++++++|+||+++++.... ....++|+|
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-~~~~~lv~e   79 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVH-REKVYIFME   79 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEec-CCEEEEEEe
Confidence            58899999999999999999988999999999876543 2456778899999999999999999998765 678999999


Q ss_pred             ccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCCCC
Q 019650          127 HMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHN  206 (337)
Q Consensus       127 ~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~  206 (337)
                      |+++++|.+++.....+++..+..++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||.+...........  
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~--  157 (264)
T cd06626          80 YCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMG--  157 (264)
T ss_pred             cCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccc--
Confidence            999999999998877899999999999999999999999999999999999999999999999999887654332111  


Q ss_pred             CCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhccCCC
Q 019650          207 NNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERL  286 (337)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~  286 (337)
                              .......++..|+|||.+.... ...++.++|+||||+++|++++|..||....+...   ..........+
T Consensus       158 --------~~~~~~~~~~~~~~PE~~~~~~-~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~  225 (264)
T cd06626         158 --------EEVQSLAGTPAYMAPEVITGGK-GKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ---IMFHVGAGHKP  225 (264)
T ss_pred             --------ccccCCcCCcCccChhhccCCC-CCCCCcccchHHHHHHHHHHHhCCCCccCCcchHH---HHHHHhcCCCC
Confidence                    0011234788999999998431 12478899999999999999999999965432221   11122223344


Q ss_pred             CCCCC--CCHHHHHHHHHHhhcCcCCCCCHHHHhcCccc
Q 019650          287 EMPET--ASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV  323 (337)
Q Consensus       287 ~~~~~--~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f  323 (337)
                      ..+..  ++..+.+++.+||+.+|++|||+++++.|||+
T Consensus       226 ~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         226 PIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             CCCcccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            44443  38899999999999999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=2.2e-42  Score=300.97  Aligned_cols=254  Identities=28%  Similarity=0.424  Sum_probs=208.9

Q ss_pred             cccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEeccCCCC
Q 019650           55 LGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGS  132 (337)
Q Consensus        55 lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~  132 (337)
                      ||.|+||+||+|.+..+++.+++|.+....  .......+..|+.++++++|++++++++.+.. ....|+||||+++++
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~e~~~~~~   79 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFET-KDDLCLVMTLMNGGD   79 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEec-CCeEEEEEecCCCCc
Confidence            689999999999999999999999986532  12233455679999999999999999998766 678999999999999


Q ss_pred             chHHhhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCCCCCCCC
Q 019650          133 LFDSLRVRK--KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNN  210 (337)
Q Consensus       133 L~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~  210 (337)
                      |.+++....  .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.......          
T Consensus        80 L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~----------  149 (277)
T cd05577          80 LKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK----------  149 (277)
T ss_pred             HHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC----------
Confidence            999997655  79999999999999999999999999999999999999999999999999887653311          


Q ss_pred             CccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhccCCCCCCC
Q 019650          211 NNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPE  290 (337)
Q Consensus       211 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (337)
                           ......++..|+|||.+.    +..++.++|+||||+++|+|++|+.||............. ..........+.
T Consensus       150 -----~~~~~~~~~~y~~PE~~~----~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~  219 (277)
T cd05577         150 -----KIKGRAGTPGYMAPEVLQ----GEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELK-RRTLEMAVEYPD  219 (277)
T ss_pred             -----ccccccCCCCcCCHHHhc----CCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHH-hccccccccCCc
Confidence                 111224778999999987    4468889999999999999999999997654322222222 222233455666


Q ss_pred             CCCHHHHHHHHHHhhcCcCCCC-----CHHHHhcCccccccCCC
Q 019650          291 TASPEFRRFVRSCLEKDWRKRG-----TVEELLAYPFVTKRSSS  329 (337)
Q Consensus       291 ~~~~~~~~li~~~l~~~p~~R~-----s~~eil~hp~f~~~~~~  329 (337)
                      ..++.+.++|.+||+.+|.+||     ++.+++.||||....+.
T Consensus       220 ~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~~  263 (277)
T cd05577         220 KFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWR  263 (277)
T ss_pred             cCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCChh
Confidence            7799999999999999999999     88889999999877664

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=4e-42  Score=295.68  Aligned_cols=252  Identities=29%  Similarity=0.446  Sum_probs=210.9

Q ss_pred             ccccccccccCcceEEEEEEEccCCceEEEEEeecCC-chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEe
Q 019650           48 DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVME  126 (337)
Q Consensus        48 ~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~e  126 (337)
                      +|.+.+.||.|++|.||++.+..++..+++|.+.... .......+.+|+.+++.++|+|++++++.+.. ++..++|||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv~e   79 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLE-DKALMIVME   79 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEec-CCEEEEEEe
Confidence            5889999999999999999999999999999987643 33345678889999999999999999998765 688999999


Q ss_pred             ccCCCCchHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCC-cEEEeeccCccchhccccCC
Q 019650          127 HMERGSLFDSLRVR--KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKG-EVKIADFGVSRIVEETRNNN  203 (337)
Q Consensus       127 ~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~-~~~l~Dfg~~~~~~~~~~~~  203 (337)
                      |+++++|.+++...  ..+++..+..++.+++.+|.|||++|++|+||+|+||+++.++ .++|+|||.+.......   
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~---  156 (256)
T cd08220          80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS---  156 (256)
T ss_pred             cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc---
Confidence            99999999999763  3589999999999999999999999999999999999998654 68999999988764321   


Q ss_pred             CCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhcc
Q 019650          204 NHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFG  283 (337)
Q Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~  283 (337)
                                  ......++..|+|||.+.    +..++.++|+||||+++|+|++|..||.......    ........
T Consensus       157 ------------~~~~~~~~~~y~aPE~~~----~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~----~~~~~~~~  216 (256)
T cd08220         157 ------------KAYTVVGTPCYISPELCE----GKPYNQKSDIWALGCVLYELASLKRAFEAANLPA----LVLKIMSG  216 (256)
T ss_pred             ------------cccccccCCcccCchhcc----CCCCCcccchHHHHHHHHHHHhCCCCcccCchHH----HHHHHHhc
Confidence                        111234788999999998    4467889999999999999999999996543322    22222333


Q ss_pred             CCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccc
Q 019650          284 ERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV  323 (337)
Q Consensus       284 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f  323 (337)
                      .....+...+..+.+++.+||..+|++|||+++++.||||
T Consensus       217 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         217 TFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             CCCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence            3445566788999999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=3e-42  Score=299.32  Aligned_cols=258  Identities=29%  Similarity=0.439  Sum_probs=207.9

Q ss_pred             ccccccccccCcceEEEEEEEccCCceEEEEEeecCCc---------hHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeC
Q 019650           48 DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSS---------TIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIE  118 (337)
Q Consensus        48 ~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~---------~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~  118 (337)
                      +|.+.+.||.|++|.||+|.+..+++.+|+|.+.....         ....+.+..|+.+++.++|+|++++++.+.. .
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~   80 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETT-E   80 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEecc-C
Confidence            57889999999999999999988999999998864321         1123456789999999999999999998765 6


Q ss_pred             CeEEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhc
Q 019650          119 GEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEE  198 (337)
Q Consensus       119 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~  198 (337)
                      ...++||||+++++|.+++...+.+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++++|||.+.....
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~  160 (272)
T cd06629          81 EYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDD  160 (272)
T ss_pred             CceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeeccccccccc
Confidence            88999999999999999998888899999999999999999999999999999999999999999999999999875432


Q ss_pred             cccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHH
Q 019650          199 TRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALIC  278 (337)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~  278 (337)
                      ....            .......++..|+|||.+...  ...++.++|+||||+++|++++|..||............. 
T Consensus       161 ~~~~------------~~~~~~~~~~~y~~PE~~~~~--~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~-  225 (272)
T cd06629         161 IYDN------------DQNMSMQGSVFWMAPEVIHSY--SQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLG-  225 (272)
T ss_pred             cccc------------cccccccCCccccCHHHhccc--cCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhh-
Confidence            1100            111223478899999998743  1247889999999999999999999996433322222211 


Q ss_pred             HhhccCCCC----CCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccc
Q 019650          279 AICFGERLE----MPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV  323 (337)
Q Consensus       279 ~~~~~~~~~----~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f  323 (337)
                        .......    ....++..+.+++.+||..+|++|||++++|+||||
T Consensus       226 --~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         226 --NKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             --ccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence              1111222    223458899999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=3e-42  Score=302.31  Aligned_cols=259  Identities=27%  Similarity=0.394  Sum_probs=202.6

Q ss_pred             ccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 019650           46 ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVM  125 (337)
Q Consensus        46 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~  125 (337)
                      .++|.+.+.||.|++|.||+|.+..++..|++|.+...........+.+|+.+++.++|+||+++++.+.. +...++||
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~-~~~~~lv~   82 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHT-KETLTFVF   82 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEec-CCeEEEEE
Confidence            47899999999999999999999999999999998765433333456789999999999999999998766 67899999


Q ss_pred             eccCCCCchHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCC
Q 019650          126 EHMERGSLFDSLRV-RKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNN  204 (337)
Q Consensus       126 e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~  204 (337)
                      ||+. ++|.+++.. ...+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+........   
T Consensus        83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~---  158 (291)
T cd07870          83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ---  158 (291)
T ss_pred             eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCC---
Confidence            9996 577777654 35678889999999999999999999999999999999999999999999998875432211   


Q ss_pred             CCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhccC
Q 019650          205 HNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGE  284 (337)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~  284 (337)
                                 ......++..|+|||.+...   ..++.++|+||||+++|+|++|..||....................
T Consensus       159 -----------~~~~~~~~~~y~aPE~~~~~---~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~  224 (291)
T cd07870         159 -----------TYSSEVVTLWYRPPDVLLGA---TDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVP  224 (291)
T ss_pred             -----------CCCCccccccccCCceeecC---CCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCC
Confidence                       11122468899999998732   3467899999999999999999999975433211111111000000


Q ss_pred             --------------CCC-----CC---------CCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccc
Q 019650          285 --------------RLE-----MP---------ETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV  323 (337)
Q Consensus       285 --------------~~~-----~~---------~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f  323 (337)
                                    ...     .+         ...+..+.+++.+|+..||++|||+.+++.||||
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         225 TEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             ChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence                          000     00         1125689999999999999999999999999998

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=3e-42  Score=304.14  Aligned_cols=257  Identities=24%  Similarity=0.328  Sum_probs=202.8

Q ss_pred             ccccccccccccCcceEEEEEEEcc----------------CCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCcee
Q 019650           46 ISDLKKLTVLGHGNGGIVYKVRHQK----------------SNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVK  109 (337)
Q Consensus        46 ~~~y~~~~~lg~g~~~~v~~~~~~~----------------~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~  109 (337)
                      .++|.+.+.||+|+||.||+|.+..                ++..||+|++...........+.+|+.++.+++|+||++
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~   83 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR   83 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence            5789999999999999999998642                344799999877655555677889999999999999999


Q ss_pred             eeeeEEeeCCeEEEEEeccCCCCchHHhhhcC-------------------CCCHHHHHHHHHHHHHHHHHHHhCCceec
Q 019650          110 CHAVFYTIEGEICFVMEHMERGSLFDSLRVRK-------------------KLSEDVISGVAYRVLKGLQYLHGMQIIHG  170 (337)
Q Consensus       110 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-------------------~l~~~~~~~i~~~l~~~l~~LH~~~ivH~  170 (337)
                      +++.+.+ ....+++|||+++++|.+++....                   .+++..+..++.||+.||+|||+.|++|+
T Consensus        84 ~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~  162 (304)
T cd05096          84 LLGVCVD-EDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHR  162 (304)
T ss_pred             EEEEEec-CCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence            9998876 578999999999999999986431                   36778899999999999999999999999


Q ss_pred             cCCCCCeEEcCCCcEEEeeccCccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHH
Q 019650          171 DIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSL  250 (337)
Q Consensus       171 dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Diwsl  250 (337)
                      ||||+||+++.++.++|+|||++.........            .......++..|+|||.+.    +..++.++|||||
T Consensus       163 dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~------------~~~~~~~~~~~y~aPE~~~----~~~~~~~~Dv~sl  226 (304)
T cd05096         163 DLATRNCLVGENLTIKIADFGMSRNLYAGDYY------------RIQGRAVLPIRWMAWECIL----MGKFTTASDVWAF  226 (304)
T ss_pred             CcchhheEEcCCccEEECCCccceecccCcee------------EecCcCCCCccccCHHHHh----cCCCCchhhhHHH
Confidence            99999999999999999999998765332110            1111223578899999987    4568899999999


Q ss_pred             HHHHHHHHh--CCCCCCCCCCchhHHHHHHHhhc---cCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhc
Q 019650          251 GVVVLECLV--GHYPLIGFGEKPDLMALICAICF---GERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA  319 (337)
Q Consensus       251 G~il~~l~t--g~~pf~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~  319 (337)
                      |+++|+|++  +..||..................   ......++.++..+.+++.+||..+|.+|||+.+|.+
T Consensus       227 G~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~  300 (304)
T cd05096         227 GVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA  300 (304)
T ss_pred             HHHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence            999999987  56777654433222222111111   1112234567899999999999999999999999954

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.3e-43  Score=308.39  Aligned_cols=263  Identities=25%  Similarity=0.383  Sum_probs=207.5

Q ss_pred             CccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhc-CCCCceeeeeeEEeeCCeEEE
Q 019650           45 NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRL-DSQFIVKCHAVFYTIEGEICF  123 (337)
Q Consensus        45 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~~l  123 (337)
                      .-..|++++.||.||.+.||++...+.+..++.|+.....+....+.+.+|+.+|.++ .|..|+.++++-.. ++.+|+
T Consensus       359 kg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~-d~~lYm  437 (677)
T KOG0596|consen  359 KGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVT-DGYLYM  437 (677)
T ss_pred             CcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeecc-CceEEE
Confidence            3468999999999999999999886665544445444445667888999999999999 56899999997666 799999


Q ss_pred             EEeccCCCCchHHhhhcCCC-CHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccC
Q 019650          124 VMEHMERGSLFDSLRVRKKL-SEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNN  202 (337)
Q Consensus       124 v~e~~~~~~L~~~l~~~~~l-~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~  202 (337)
                      |||+-+ .+|..+|++.... ....++.+..|++.|+.++|++||||.||||.|+|+- .|.+||+|||.+..+..++..
T Consensus       438 vmE~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DTTs  515 (677)
T KOG0596|consen  438 VMECGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDTTS  515 (677)
T ss_pred             Eeeccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechhcccCccccc
Confidence            999985 4999999876543 3358899999999999999999999999999999987 679999999999988776654


Q ss_pred             CCCCCCCCCccccccccccCCCCCcCCcccccccCC-------CCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHH
Q 019650          203 NNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWG-------GDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMA  275 (337)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-------~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~  275 (337)
                      ...            .+-+||+.||+||.+..-.++       -..+.++||||||||||+|+.|+.||....   ....
T Consensus       516 I~k------------dsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~---n~~a  580 (677)
T KOG0596|consen  516 IVK------------DSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII---NQIA  580 (677)
T ss_pred             eee------------ccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH---HHHH
Confidence            332            233799999999998643211       125789999999999999999999995432   2233


Q ss_pred             HHHHhhcc-CCCCCCCCCCH-HHHHHHHHHhhcCcCCCCCHHHHhcCccccc
Q 019650          276 LICAICFG-ERLEMPETASP-EFRRFVRSCLEKDWRKRGTVEELLAYPFVTK  325 (337)
Q Consensus       276 ~~~~~~~~-~~~~~~~~~~~-~~~~li~~~l~~~p~~R~s~~eil~hp~f~~  325 (337)
                      .+..+... -..++|..-+. ++.++++.||.+||++|||+.++|+|||++.
T Consensus       581 Kl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~  632 (677)
T KOG0596|consen  581 KLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQI  632 (677)
T ss_pred             HHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence            33333222 11234333233 3999999999999999999999999999987

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=9e-43  Score=304.76  Aligned_cols=259  Identities=26%  Similarity=0.429  Sum_probs=208.1

Q ss_pred             cccccccccccCcceEEEEEEEccCCceEEEEEeecCCc-hHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 019650           47 SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSS-TIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVM  125 (337)
Q Consensus        47 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~  125 (337)
                      ++|++.+.||.|++|.||+|.+..+++.||+|.+..... ....+.+.+|+.+++.++|+|++++++.+.. ....++||
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~   79 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRR-KKRLYLVF   79 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhccc-CCeEEEEE
Confidence            478999999999999999999998999999999865432 2244567789999999999999999998865 78899999


Q ss_pred             eccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCCC
Q 019650          126 EHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNH  205 (337)
Q Consensus       126 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~  205 (337)
                      ||+++++|..+......+++..+..++.|++.+|+|||+.|++|+||+|+||+++.++.++|+|||++.........   
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~---  156 (286)
T cd07846          80 EFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV---  156 (286)
T ss_pred             ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccc---
Confidence            99999888888776667999999999999999999999999999999999999999999999999998765432211   


Q ss_pred             CCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhc---
Q 019650          206 NNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICF---  282 (337)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~---  282 (337)
                                 .....++..|+|||.+...   ..++.++|+||||+++|+|++|..||......+...........   
T Consensus       157 -----------~~~~~~~~~y~aPE~~~~~---~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~  222 (286)
T cd07846         157 -----------YTDYVATRWYRAPELLVGD---TKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIP  222 (286)
T ss_pred             -----------cCcccceeeccCcHHhccc---cccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCch
Confidence                       1122478899999998742   35678999999999999999999998654332222221110000   


Q ss_pred             --------------cCCC---------CCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccc
Q 019650          283 --------------GERL---------EMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV  323 (337)
Q Consensus       283 --------------~~~~---------~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f  323 (337)
                                    ...+         ...+.++..+.+++.+||..+|++||++.+++.||||
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         223 RHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             hhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence                          0000         0123567889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1.7e-42  Score=302.73  Aligned_cols=257  Identities=27%  Similarity=0.409  Sum_probs=205.2

Q ss_pred             ccccccccccCcceEEEEEEEccCCceEEEEEeecCC-chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEe
Q 019650           48 DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVME  126 (337)
Q Consensus        48 ~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~e  126 (337)
                      +|++.+.||.|++|.||+|.+..++..|++|.+.... .......+.+|+.++++++|+|++++++.+.+ +...+++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e   79 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT-ENKLYLVFE   79 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhccc-CCcEEEEee
Confidence            4889999999999999999999999999999987543 22233567889999999999999999998765 678999999


Q ss_pred             ccCCCCchHHhhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCC
Q 019650          127 HMERGSLFDSLRV--RKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNN  204 (337)
Q Consensus       127 ~~~~~~L~~~l~~--~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~  204 (337)
                      |+. ++|.+++..  ...+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+.........  
T Consensus        80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~--  156 (284)
T cd07860          80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--  156 (284)
T ss_pred             ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccc--
Confidence            996 589888864  356899999999999999999999999999999999999999999999999988755332110  


Q ss_pred             CCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhccC
Q 019650          205 HNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGE  284 (337)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~  284 (337)
                                  .....++..|+|||.+...   ..++.++|+||||+++|+|+||+.||....+...............
T Consensus       157 ------------~~~~~~~~~y~aPE~~~~~---~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~  221 (284)
T cd07860         157 ------------YTHEVVTLWYRAPEILLGC---KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD  221 (284)
T ss_pred             ------------cccccccccccCCeEEecC---CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence                        1111367889999988732   3467899999999999999999999976543333322222111000


Q ss_pred             ------------------------CCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccc
Q 019650          285 ------------------------RLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV  323 (337)
Q Consensus       285 ------------------------~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f  323 (337)
                                              .....+.++..++++|.+||+.||++|||++++++||||
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         222 EVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             hhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence                                    001123467889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-44  Score=316.29  Aligned_cols=246  Identities=26%  Similarity=0.452  Sum_probs=211.7

Q ss_pred             CccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeE
Q 019650           42 DVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEI  121 (337)
Q Consensus        42 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~  121 (337)
                      |+...+....++-||.|+.|-||+|...  ++.||||.++...        ..+++=|++|+|+||+.+.+++.. .+.+
T Consensus       119 WeiPFe~IsELeWlGSGaQGAVF~Grl~--netVAVKKV~elk--------ETdIKHLRkLkH~NII~FkGVCtq-sPcy  187 (904)
T KOG4721|consen  119 WEIPFEEISELEWLGSGAQGAVFLGRLH--NETVAVKKVRELK--------ETDIKHLRKLKHPNIITFKGVCTQ-SPCY  187 (904)
T ss_pred             ccCCHHHhhhhhhhccCcccceeeeecc--CceehhHHHhhhh--------hhhHHHHHhccCcceeeEeeeecC-Ccee
Confidence            4455566777888999999999999875  5679999775432        347888999999999999999866 7999


Q ss_pred             EEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhcccc
Q 019650          122 CFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRN  201 (337)
Q Consensus       122 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~  201 (337)
                      |||||||..|.|.+.|+...++.......|.++|+.++.|||.+.|||||||.-||||+.+..+||+|||.+....+.  
T Consensus       188 CIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--  265 (904)
T KOG4721|consen  188 CIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK--  265 (904)
T ss_pred             EEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhh--
Confidence            999999999999999999999999999999999999999999999999999999999999999999999999877654  


Q ss_pred             CCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHH-h
Q 019650          202 NNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICA-I  280 (337)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~-~  280 (337)
                                   ....+++||..|||||++.+    .+.+.++|||||||+||||+||..||.+.+...    ++.. .
T Consensus       266 -------------STkMSFaGTVaWMAPEvIrn----ePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA----IIwGVG  324 (904)
T KOG4721|consen  266 -------------STKMSFAGTVAWMAPEVIRN----EPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA----IIWGVG  324 (904)
T ss_pred             -------------hhhhhhhhhHhhhCHHHhhc----CCcccccceehhHHHHHHHHhcCCCccccchhe----eEEecc
Confidence                         44556789999999999994    489999999999999999999999996543322    2221 1


Q ss_pred             hccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCc
Q 019650          281 CFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYP  321 (337)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp  321 (337)
                      ........|..+++.++=|++.||+-.|.+||||.+||.|-
T Consensus       325 sNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hl  365 (904)
T KOG4721|consen  325 SNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHL  365 (904)
T ss_pred             CCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHH
Confidence            22334566788999999999999999999999999999983

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=3.8e-42  Score=300.80  Aligned_cols=263  Identities=33%  Similarity=0.502  Sum_probs=208.4

Q ss_pred             ccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhc-CCCCceeeeeeEEe----e
Q 019650           43 VENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRL-DSQFIVKCHAVFYT----I  117 (337)
Q Consensus        43 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~----~  117 (337)
                      ....++|++.+.||+|++|.||++.+..+++.+++|++.....  ....+.+|+.+++.+ +|+|++++++.+..    .
T Consensus        14 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~--~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~   91 (286)
T cd06638          14 PDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD--IDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKN   91 (286)
T ss_pred             CCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc--hHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCC
Confidence            3456899999999999999999999999999999998765322  235567789999998 79999999998753    2


Q ss_pred             CCeEEEEEeccCCCCchHHhhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCc
Q 019650          118 EGEICFVMEHMERGSLFDSLRV----RKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVS  193 (337)
Q Consensus       118 ~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~  193 (337)
                      +...+++|||+++++|.+++..    ...+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++
T Consensus        92 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~  171 (286)
T cd06638          92 GDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVS  171 (286)
T ss_pred             CCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCce
Confidence            3568999999999999988752    356889999999999999999999999999999999999999999999999998


Q ss_pred             cchhccccCCCCCCCCCCccccccccccCCCCCcCCccccccc-CCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchh
Q 019650          194 RIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSER-WGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPD  272 (337)
Q Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~  272 (337)
                      .......              .......++..|+|||.+.... .+..++.++|+||||+++|+|++|+.||........
T Consensus       172 ~~~~~~~--------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~  237 (286)
T cd06638         172 AQLTSTR--------------LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA  237 (286)
T ss_pred             eecccCC--------------CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH
Confidence            7654321              1111224889999999985321 134578899999999999999999999965433222


Q ss_pred             HHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccc
Q 019650          273 LMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV  323 (337)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f  323 (337)
                      .......  .......+...+..+.+++.+||+.||++|||+.++++||||
T Consensus       238 ~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         238 LFKIPRN--PPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             Hhhcccc--CCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence            2111100  011112234457889999999999999999999999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=2.1e-42  Score=311.39  Aligned_cols=266  Identities=24%  Similarity=0.366  Sum_probs=210.1

Q ss_pred             CccccccccccccCcceEEEEEEEccCCceEEEEEeecCC-chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeC-----
Q 019650           45 NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIE-----  118 (337)
Q Consensus        45 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~-----  118 (337)
                      ..++|++.+.||.|++|.||+|.+..++..||+|.+.... .......+.+|+.++++++|+|++++++.+....     
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            4688999999999999999999999999999999986532 2334456778999999999999999999875422     


Q ss_pred             CeEEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhc
Q 019650          119 GEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEE  198 (337)
Q Consensus       119 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~  198 (337)
                      ...|+||||+.+ +|.+.+...  +++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||.+.....
T Consensus        94 ~~~~lv~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~  170 (353)
T cd07850          94 QDVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  170 (353)
T ss_pred             CcEEEEEeccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCC
Confidence            357999999965 888888643  89999999999999999999999999999999999999999999999999876543


Q ss_pred             cccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHH
Q 019650          199 TRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALIC  278 (337)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~  278 (337)
                      ...               .....++..|+|||.+.    +..++.++|+||||+++|+|++|+.||...+..........
T Consensus       171 ~~~---------------~~~~~~~~~y~aPE~~~----~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~  231 (353)
T cd07850         171 SFM---------------MTPYVVTRYYRAPEVIL----GMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIE  231 (353)
T ss_pred             CCC---------------CCCCcccccccCHHHHh----CCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHH
Confidence            211               11224788999999997    55788999999999999999999999975433222211111


Q ss_pred             Hhhc-----------------cCCC--------------CC-------CCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          279 AICF-----------------GERL--------------EM-------PETASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       279 ~~~~-----------------~~~~--------------~~-------~~~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                      ....                 ....              .+       +...++.+.++|.+||+.||++|||+.++|.|
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~  311 (353)
T cd07850         232 QLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH  311 (353)
T ss_pred             hcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            0000                 0000              00       11345678999999999999999999999999


Q ss_pred             ccccccCCCccc
Q 019650          321 PFVTKRSSSSNI  332 (337)
Q Consensus       321 p~f~~~~~~~~~  332 (337)
                      |||+.++..+..
T Consensus       312 ~~~~~~~~~~~~  323 (353)
T cd07850         312 PYINVWYDPSEV  323 (353)
T ss_pred             hhHhhccCCccC
Confidence            999977765443

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=3.2e-42  Score=300.72  Aligned_cols=261  Identities=30%  Similarity=0.475  Sum_probs=209.2

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhc-CCCCceeeeeeEEee-----
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRL-DSQFIVKCHAVFYTI-----  117 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~-----  117 (337)
                      ...+.|++.+.||.|+||+||+|.+..++..+++|++....  .....+..|+.+++++ +|+|++++++.+...     
T Consensus        13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~   90 (282)
T cd06636          13 DPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE--DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGH   90 (282)
T ss_pred             ChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh--HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCC
Confidence            45689999999999999999999999999999999986543  2345677888888888 799999999987532     


Q ss_pred             CCeEEEEEeccCCCCchHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccc
Q 019650          118 EGEICFVMEHMERGSLFDSLRVR--KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRI  195 (337)
Q Consensus       118 ~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~  195 (337)
                      ....+++|||+++++|.+++...  ..+++..+..++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||.+..
T Consensus        91 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~  170 (282)
T cd06636          91 DDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ  170 (282)
T ss_pred             CCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhh
Confidence            35789999999999999999753  4588999999999999999999999999999999999999999999999998876


Q ss_pred             hhccccCCCCCCCCCCccccccccccCCCCCcCCccccccc-CCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHH
Q 019650          196 VEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSER-WGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLM  274 (337)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~  274 (337)
                      .....              .......++..|+|||.+.... .+..++.++|+||||+++|+|++|..||..........
T Consensus       171 ~~~~~--------------~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~  236 (282)
T cd06636         171 LDRTV--------------GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF  236 (282)
T ss_pred             hhccc--------------cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh
Confidence            53221              1112235788999999986321 12467889999999999999999999996543322221


Q ss_pred             HHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccc
Q 019650          275 ALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV  323 (337)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f  323 (337)
                      .   .............++..+.++|.+||..||.+|||+.++++||||
T Consensus       237 ~---~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         237 L---IPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             h---HhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence            1   111111122234578899999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-42  Score=299.02  Aligned_cols=259  Identities=31%  Similarity=0.517  Sum_probs=209.7

Q ss_pred             CccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhc-CCCCceeeeeeEEeeC-----
Q 019650           45 NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRL-DSQFIVKCHAVFYTIE-----  118 (337)
Q Consensus        45 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~-----  118 (337)
                      ..++|++.+.||.|++|+||+|.+..+++.+++|++.....  ..+.+.+|+.+++++ .|+|++++++.+....     
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED--EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND   81 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch--hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence            35899999999999999999999998899999999876543  346788899999998 7999999999886532     


Q ss_pred             CeEEEEEeccCCCCchHHhhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCcc
Q 019650          119 GEICFVMEHMERGSLFDSLRV----RKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSR  194 (337)
Q Consensus       119 ~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~  194 (337)
                      ..++++|||+++++|.+++..    ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~  161 (275)
T cd06608          82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSA  161 (275)
T ss_pred             eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccce
Confidence            348999999999999998864    3578999999999999999999999999999999999999999999999999887


Q ss_pred             chhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccC-CCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhH
Q 019650          195 IVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERW-GGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDL  273 (337)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~  273 (337)
                      ......              .......++..|+|||.+..... ...++.++|+||||+++|+|++|..||.........
T Consensus       162 ~~~~~~--------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~  227 (275)
T cd06608         162 QLDSTL--------------GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRAL  227 (275)
T ss_pred             ecccch--------------hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHH
Confidence            654322              11122357889999999864311 245788999999999999999999999654332222


Q ss_pred             HHHHHHhhccCCC--CCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccc
Q 019650          274 MALICAICFGERL--EMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV  323 (337)
Q Consensus       274 ~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f  323 (337)
                      ...    ......  ..+...+..+.+++.+||..||++|||++++++|||+
T Consensus       228 ~~~----~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         228 FKI----PRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             HHh----hccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence            221    111111  2223367899999999999999999999999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=3.1e-42  Score=301.06  Aligned_cols=257  Identities=27%  Similarity=0.434  Sum_probs=207.0

Q ss_pred             ccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEec
Q 019650           48 DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEH  127 (337)
Q Consensus        48 ~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~e~  127 (337)
                      +|++.+.||.|++|.||+|.+..++..||+|.+.........+.+.+|+.++++++|+|++++++.+.+ ....++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~   79 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHT-ENKLMLVFEY   79 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEee-CCcEEEEEec
Confidence            588999999999999999999999999999999776544445667789999999999999999998877 6788999999


Q ss_pred             cCCCCchHHhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCC
Q 019650          128 MERGSLFDSLRVR---KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNN  204 (337)
Q Consensus       128 ~~~~~L~~~l~~~---~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~  204 (337)
                      +++ +|.+++...   ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.........  
T Consensus        80 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~--  156 (284)
T cd07836          80 MDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT--  156 (284)
T ss_pred             CCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccc--
Confidence            985 888888654   35899999999999999999999999999999999999999999999999998755332110  


Q ss_pred             CCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhcc-
Q 019650          205 HNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFG-  283 (337)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~-  283 (337)
                                  .....++..|++||.+...   ..++.++|+||||+++|+|++|..||.+................. 
T Consensus       157 ------------~~~~~~~~~y~~PE~~~~~---~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~  221 (284)
T cd07836         157 ------------FSNEVVTLWYRAPDVLLGS---RTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPT  221 (284)
T ss_pred             ------------cccccccccccChHHhcCC---CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC
Confidence                        1112467889999998642   356889999999999999999999997654433322222110000 


Q ss_pred             ----------C--CC-----------CCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccc
Q 019650          284 ----------E--RL-----------EMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV  323 (337)
Q Consensus       284 ----------~--~~-----------~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f  323 (337)
                                .  ..           ...+..+..+.+++.+||+.||.+||++.++++||||
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         222 ESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             hhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence                      0  00           0112457789999999999999999999999999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-42  Score=310.35  Aligned_cols=268  Identities=26%  Similarity=0.413  Sum_probs=209.9

Q ss_pred             ccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeC----CeE
Q 019650           46 ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIE----GEI  121 (337)
Q Consensus        46 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~----~~~  121 (337)
                      .++|++.+.||.|++|.||+|.+..++..||+|.+...........+.+|+.++++++|+|++++++++....    ...
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            4789999999999999999999999999999999875444445566778999999999999999998765422    357


Q ss_pred             EEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhcccc
Q 019650          122 CFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRN  201 (337)
Q Consensus       122 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~  201 (337)
                      ++++||+.+ +|.+++. ...+++..++.++.|++.||++||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus        84 ~lv~e~~~~-~l~~~~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~  161 (336)
T cd07849          84 YIVQELMET-DLYKLIK-TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHD  161 (336)
T ss_pred             EEEehhccc-CHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecccccc
Confidence            999999965 8887775 45699999999999999999999999999999999999999999999999999876543221


Q ss_pred             CCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhh
Q 019650          202 NNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAIC  281 (337)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~  281 (337)
                      ..           .......++..|+|||.+..   ...++.++|+||||+++|+|++|+.||.................
T Consensus       162 ~~-----------~~~~~~~~~~~y~aPE~~~~---~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~  227 (336)
T cd07849         162 HT-----------GFLTEYVATRWYRAPEIMLN---SKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLG  227 (336)
T ss_pred             cc-----------CCcCCcCcCCCccChHHhhC---CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcC
Confidence            11           11122357889999998753   23578899999999999999999999965432111111100000


Q ss_pred             -------------------c-c-CCC-----CCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCC
Q 019650          282 -------------------F-G-ERL-----EMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSS  329 (337)
Q Consensus       282 -------------------~-~-~~~-----~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~  329 (337)
                                         . . ...     ...+..+..+.+++.+||+.+|.+|||+.++++||||......
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~  301 (336)
T cd07849         228 TPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDP  301 (336)
T ss_pred             CCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCC
Confidence                               0 0 000     0113457889999999999999999999999999999988754

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=7.2e-42  Score=296.31  Aligned_cols=258  Identities=33%  Similarity=0.502  Sum_probs=208.1

Q ss_pred             ccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 019650           46 ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVM  125 (337)
Q Consensus        46 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~  125 (337)
                      .+.+.....||+|+||.||+|.+..++..|++|.+..... .....+.+|+.++++++|+||+++++.+.. +...++++
T Consensus         7 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~   84 (268)
T cd06624           7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDS-RYVQPLHEEIALHSYLKHRNIVQYLGSDSE-NGFFKIFM   84 (268)
T ss_pred             cccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCH-HHHHHHHHHHHHHHhcCCCCeeeeeeeecc-CCEEEEEE
Confidence            4445555689999999999999998999999998876543 345678899999999999999999998766 68899999


Q ss_pred             eccCCCCchHHhhhc-CCC--CHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcC-CCcEEEeeccCccchhcccc
Q 019650          126 EHMERGSLFDSLRVR-KKL--SEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLING-KGEVKIADFGVSRIVEETRN  201 (337)
Q Consensus       126 e~~~~~~L~~~l~~~-~~l--~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~-~~~~~l~Dfg~~~~~~~~~~  201 (337)
                      ||+++++|.+++... ..+  ++..+..++.|++.||+|||+.|++|+||+|+||+++. ++.++|+|||.+........
T Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~  164 (268)
T cd06624          85 EQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP  164 (268)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC
Confidence            999999999999754 455  88889999999999999999999999999999999976 57999999998876532211


Q ss_pred             CCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhh
Q 019650          202 NNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAIC  281 (337)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~  281 (337)
                                    ......+++.|+|||.+...  ...++.++|+||||+++|+|++|..||.........  ......
T Consensus       165 --------------~~~~~~~~~~~~aPE~~~~~--~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~--~~~~~~  226 (268)
T cd06624         165 --------------CTETFTGTLQYMAPEVIDKG--PRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA--MFKVGM  226 (268)
T ss_pred             --------------ccccCCCCccccChhhhccc--cccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh--Hhhhhh
Confidence                          11122478899999998643  234788999999999999999999999654322111  111112


Q ss_pred             ccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccc
Q 019650          282 FGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV  323 (337)
Q Consensus       282 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f  323 (337)
                      ....+.++...++.+.+++.+||+.+|++|||+.+++.||||
T Consensus       227 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         227 FKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             hccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence            233445667788999999999999999999999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=4.8e-42  Score=301.31  Aligned_cols=261  Identities=28%  Similarity=0.371  Sum_probs=207.7

Q ss_pred             CccccccccccccCcceEEEEEEEccCCceEEEEEeecCCc-hHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeC-CeEE
Q 019650           45 NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSS-TIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIE-GEIC  122 (337)
Q Consensus        45 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~-~~~~  122 (337)
                      ..++|++.+.||.|++|.||+|.+..+++.+++|.++.... ......+.+|+.++.+++|+|++++++.+.... ...|
T Consensus         3 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~   82 (293)
T cd07843           3 SVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIY   82 (293)
T ss_pred             chhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEE
Confidence            46789999999999999999999998999999999875432 222334567999999999999999999876532 7899


Q ss_pred             EEEeccCCCCchHHhhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhcccc
Q 019650          123 FVMEHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRN  201 (337)
Q Consensus       123 lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~  201 (337)
                      ++|||+.+ +|.+++.... .+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus        83 lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~  161 (293)
T cd07843          83 MVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK  161 (293)
T ss_pred             EEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCcc
Confidence            99999975 9999887643 589999999999999999999999999999999999999999999999998876654311


Q ss_pred             CCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhh
Q 019650          202 NNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAIC  281 (337)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~  281 (337)
                                    ......+++.|+|||.+...   ..++.++|+||||+++|+|++|..||.................
T Consensus       162 --------------~~~~~~~~~~~~aPE~~~~~---~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~  224 (293)
T cd07843         162 --------------PYTQLVVTLWYRAPELLLGA---KEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLG  224 (293)
T ss_pred             --------------ccccccccccccCchhhcCC---ccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence                          11112467889999998742   2467899999999999999999999976543332222221110


Q ss_pred             c--------------------------cCCCCCCCC-CCHHHHHHHHHHhhcCcCCCCCHHHHhcCccc
Q 019650          282 F--------------------------GERLEMPET-ASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV  323 (337)
Q Consensus       282 ~--------------------------~~~~~~~~~-~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f  323 (337)
                      .                          .....++.. +++.+.++|.+||+.+|++|||++|+|.||||
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         225 TPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             CCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence            0                          000112222 58889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=5.6e-42  Score=298.47  Aligned_cols=257  Identities=29%  Similarity=0.470  Sum_probs=214.1

Q ss_pred             cccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEe
Q 019650           47 SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVME  126 (337)
Q Consensus        47 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~e  126 (337)
                      +-|++.+.||.|+||.||+|.+..++..+|+|.+.........+.+.+|+.++.+++|+|++++++.+.. +...++|||
T Consensus         4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e   82 (277)
T cd06641           4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-DTKLWIIME   82 (277)
T ss_pred             HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEe-CCeEEEEEE
Confidence            4578889999999999999999889999999998765544455678889999999999999999998876 688999999


Q ss_pred             ccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCCCC
Q 019650          127 HMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHN  206 (337)
Q Consensus       127 ~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~  206 (337)
                      |+++++|.+++.. ..+++..+..++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+........     
T Consensus        83 ~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~-----  156 (277)
T cd06641          83 YLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-----  156 (277)
T ss_pred             eCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchh-----
Confidence            9999999999864 4689999999999999999999999999999999999999999999999998866533211     


Q ss_pred             CCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhccCCC
Q 019650          207 NNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERL  286 (337)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~  286 (337)
                               ......++..|+|||.+.    +...+.++|+||||+++|+|++|..||.......    ...........
T Consensus       157 ---------~~~~~~~~~~y~~PE~~~----~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~~~~  219 (277)
T cd06641         157 ---------KRNTFVGTPFWMAPEVIK----QSAYDSKADIWSLGITAIELAKGEPPHSELHPMK----VLFLIPKNNPP  219 (277)
T ss_pred             ---------hhccccCCccccChhhhc----cCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH----HHHHHhcCCCC
Confidence                     111234788899999987    4467889999999999999999999996533221    11222233344


Q ss_pred             CCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccC
Q 019650          287 EMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRS  327 (337)
Q Consensus       287 ~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~  327 (337)
                      ..+..++..+.+++.+||..+|.+||++.+++.||||.+..
T Consensus       220 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~~  260 (277)
T cd06641         220 TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRFA  260 (277)
T ss_pred             CCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhhh
Confidence            45566788999999999999999999999999999998754

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=2.3e-42  Score=303.23  Aligned_cols=270  Identities=29%  Similarity=0.458  Sum_probs=218.2

Q ss_pred             ccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEE
Q 019650           43 VENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEIC  122 (337)
Q Consensus        43 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~  122 (337)
                      ....++|.+.+.||.|++|.||++.+..++..+++|.+.... ....+.+.+|+.+++.++|+|++++++.+.. ....+
T Consensus        15 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-~~~~~   92 (293)
T cd06647          15 GDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ-QPKKELIINEILVMRENKHPNIVNYLDSYLV-GDELW   92 (293)
T ss_pred             cCchhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc-chHHHHHHHHHHHHhhcCCCCeeehhheeee-CCcEE
Confidence            344689999999999999999999998889999999986543 2234667889999999999999999998766 67899


Q ss_pred             EEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccC
Q 019650          123 FVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNN  202 (337)
Q Consensus       123 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~  202 (337)
                      +|+||+++++|.+++.. ..+++..+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||.+........ 
T Consensus        93 lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~-  170 (293)
T cd06647          93 VVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-  170 (293)
T ss_pred             EEEecCCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc-
Confidence            99999999999999875 3588999999999999999999999999999999999999999999999998765543221 


Q ss_pred             CCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhc
Q 019650          203 NNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICF  282 (337)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~  282 (337)
                                   ......+++.|+|||.+.    +..++.++|+||||+++|++++|..||..............  ..
T Consensus       171 -------------~~~~~~~~~~y~~PE~~~----~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~--~~  231 (293)
T cd06647         171 -------------KRSTMVGTPYWMAPEVVT----RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT--NG  231 (293)
T ss_pred             -------------ccccccCChhhcCchhhc----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhc--CC
Confidence                         111224788899999987    44678899999999999999999999965433222111110  01


Q ss_pred             cCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCCccccCc
Q 019650          283 GERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNIEGL  335 (337)
Q Consensus       283 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~~~~~~~  335 (337)
                      ......+..++..+.+++.+||..+|.+||++++++.||||++..-.+.+.-+
T Consensus       232 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~~~~~~~~~  284 (293)
T cd06647         232 TPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAKPLSSLTPL  284 (293)
T ss_pred             CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCcccccccch
Confidence            11112234467889999999999999999999999999999988765555443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-43  Score=285.33  Aligned_cols=264  Identities=31%  Similarity=0.599  Sum_probs=220.9

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhc-CCCCceeeeeeEEeeCCeEE
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRL-DSQFIVKCHAVFYTIEGEIC  122 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~~  122 (337)
                      .++++.+.++.||.|.-|+|+++....++..+|+|.+....+....+++...+.++... .+|+|++++|.|.. +..++
T Consensus        89 ~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~-n~dV~  167 (391)
T KOG0983|consen   89 ADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFIT-NTDVF  167 (391)
T ss_pred             cChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEee-CchHH
Confidence            34567888899999999999999999999999999999888888888888888887666 48999999999988 78889


Q ss_pred             EEEeccCCCCchHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCeEEcCCCcEEEeeccCccchhccc
Q 019650          123 FVMEHMERGSLFDSLRV-RKKLSEDVISGVAYRVLKGLQYLHG-MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETR  200 (337)
Q Consensus       123 lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~-~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~  200 (337)
                      +.||.+.. .++.++.. .+++++..+-++...+++||.||-+ +||+|||+||+|||+|..|++|++|||.+-++.+..
T Consensus       168 IcMelMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk  246 (391)
T KOG0983|consen  168 ICMELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK  246 (391)
T ss_pred             HHHHHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeeccc
Confidence            99999854 56666653 3679999999999999999999984 699999999999999999999999999998887664


Q ss_pred             cCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHh
Q 019650          201 NNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAI  280 (337)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~  280 (337)
                      .+               ....|-+.|||||.+.... ...|+..+||||||+.++||.||+.||.+...+-+.   +...
T Consensus       247 Ah---------------trsAGC~~YMaPERidp~~-~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~---ltkv  307 (391)
T KOG0983|consen  247 AH---------------TRSAGCAAYMAPERIDPPD-KPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEV---LTKV  307 (391)
T ss_pred             cc---------------ccccCCccccCccccCCCC-CCccchhhhhhhhccchhhhhcccCCCCCCCccHHH---HHHH
Confidence            32               2335889999999998653 357899999999999999999999999875443332   3333


Q ss_pred             hccCCCCCC--CCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCC
Q 019650          281 CFGERLEMP--ETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSS  328 (337)
Q Consensus       281 ~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~  328 (337)
                      ...+++..+  ...++.+++++..||.+|+.+||...++|+|||+.-.+.
T Consensus       308 ln~ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye~  357 (391)
T KOG0983|consen  308 LNEEPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYET  357 (391)
T ss_pred             HhcCCCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecch
Confidence            334444443  347999999999999999999999999999999986653

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.6e-42  Score=295.62  Aligned_cols=252  Identities=29%  Similarity=0.372  Sum_probs=201.4

Q ss_pred             cccccCcceEEEEEEEccCCceEEEEEeecCCc--hHhHHHHHHHHHH-HHhcCCCCceeeeeeEEeeCCeEEEEEeccC
Q 019650           53 TVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSS--TIIRHQAAHEAEI-LKRLDSQFIVKCHAVFYTIEGEICFVMEHME  129 (337)
Q Consensus        53 ~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~-~~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~  129 (337)
                      +.||.|++|.||+|.+..+++.||+|.+.....  ......+..|... ....+|+|++++++.+.. +...++++||++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~   80 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQS-KDYLYLVMEYLN   80 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEc-CCeEEEEEeccC
Confidence            579999999999999998999999999865421  1122233344433 445689999999998866 688999999999


Q ss_pred             CCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCCCCCCC
Q 019650          130 RGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNN  209 (337)
Q Consensus       130 ~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~  209 (337)
                      +++|.+++...+.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+......          
T Consensus        81 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~----------  150 (260)
T cd05611          81 GGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN----------  150 (260)
T ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceecccc----------
Confidence            9999999988888999999999999999999999999999999999999999999999999987654321          


Q ss_pred             CCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhccCCCCCC
Q 019650          210 NNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMP  289 (337)
Q Consensus       210 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  289 (337)
                              ....++..|+|||.+.    +..++.++|+||||+++|+|++|..||......... ...............
T Consensus       151 --------~~~~~~~~y~~pe~~~----~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~  217 (260)
T cd05611         151 --------KKFVGTPDYLAPETIL----GVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVF-DNILSRRINWPEEVK  217 (260)
T ss_pred             --------ccCCCCcCccChhhhc----CCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHH-HHHHhcccCCCCccc
Confidence                    1224788999999988    345788999999999999999999999654332221 111111111222333


Q ss_pred             CCCCHHHHHHHHHHhhcCcCCCC---CHHHHhcCccccccCC
Q 019650          290 ETASPEFRRFVRSCLEKDWRKRG---TVEELLAYPFVTKRSS  328 (337)
Q Consensus       290 ~~~~~~~~~li~~~l~~~p~~R~---s~~eil~hp~f~~~~~  328 (337)
                      ..+++.+.+++.+||..+|++||   +++|+++||||++.+|
T Consensus       218 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~~  259 (260)
T cd05611         218 EFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSINW  259 (260)
T ss_pred             ccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcCCC
Confidence            45789999999999999999999   5589999999998775

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=4e-42  Score=302.28  Aligned_cols=267  Identities=28%  Similarity=0.439  Sum_probs=216.1

Q ss_pred             CccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 019650           45 NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFV  124 (337)
Q Consensus        45 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv  124 (337)
                      ....|.....||.|+||.||++.+..++..||+|.+..... ...+.+.+|+.++..+.|+|++++++.+.. +...+++
T Consensus        19 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-~~~~~iv   96 (297)
T cd06659          19 PRSLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ-QRRELLFNEVVIMRDYQHQNVVEMYKSYLV-GEELWVL   96 (297)
T ss_pred             chhhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc-chHHHHHHHHHHHHhCCCCchhhhhhheee-CCeEEEE
Confidence            34566677789999999999999998999999999865432 234567789999999999999999998766 7889999


Q ss_pred             EeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCC
Q 019650          125 MEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNN  204 (337)
Q Consensus       125 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~  204 (337)
                      |||+++++|.+++.. ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.......    
T Consensus        97 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~----  171 (297)
T cd06659          97 MEFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV----  171 (297)
T ss_pred             EecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccc----
Confidence            999999999887754 568999999999999999999999999999999999999999999999999886543221    


Q ss_pred             CCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhccC
Q 019650          205 HNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGE  284 (337)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~  284 (337)
                                .......++..|+|||.+.    +..++.++|+||||+++|+|++|..||............ .. ....
T Consensus       172 ----------~~~~~~~~~~~y~aPE~~~----~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~-~~-~~~~  235 (297)
T cd06659         172 ----------PKRKSLVGTPYWMAPEVIS----RTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL-RD-SPPP  235 (297)
T ss_pred             ----------ccccceecCccccCHHHHc----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-hc-cCCC
Confidence                      1112235788999999997    456788999999999999999999999754332222111 11 1111


Q ss_pred             CCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCCccccC
Q 019650          285 RLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNIEG  334 (337)
Q Consensus       285 ~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~~~~~~  334 (337)
                      ....+...+..+.+++.+||+.+|.+||+++++++||||.+..-.+++-.
T Consensus       236 ~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~~~~~~~~  285 (297)
T cd06659         236 KLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTGLPECLVP  285 (297)
T ss_pred             CccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCCCcccccc
Confidence            12233456889999999999999999999999999999998876666543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=5.2e-42  Score=301.29  Aligned_cols=260  Identities=27%  Similarity=0.358  Sum_probs=204.2

Q ss_pred             cccccccccccCcceEEEEEEEccCCceEEEEEeecCCch-HhHHHHHHHHHHHHhcC-CCCceeeeeeEEeeCC----e
Q 019650           47 SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSST-IIRHQAAHEAEILKRLD-SQFIVKCHAVFYTIEG----E  120 (337)
Q Consensus        47 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~----~  120 (337)
                      ++|++.+.||.|++|.||+|.+..+++.||+|.+...... .....+.+|+.+++.+. |+|++++++.+.....    .
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            4799999999999999999999999999999998665322 23456778999999995 5999999998766332    3


Q ss_pred             EEEEEeccCCCCchHHhhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcC-CCcEEEeeccCcc
Q 019650          121 ICFVMEHMERGSLFDSLRVR-----KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLING-KGEVKIADFGVSR  194 (337)
Q Consensus       121 ~~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~-~~~~~l~Dfg~~~  194 (337)
                      .|++|||+++ +|.+++...     ..+++..++.++.||+.||.|||+.|++|+||+|+||+++. ++.++|+|||.+.
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~  159 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR  159 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccce
Confidence            7999999986 888887642     35799999999999999999999999999999999999998 7899999999887


Q ss_pred             chhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHH
Q 019650          195 IVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLM  274 (337)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~  274 (337)
                      ........              .....+++.|+|||.+..   ...++.++|+||||+++|+|++|..||....+.....
T Consensus       160 ~~~~~~~~--------------~~~~~~~~~~~aPE~~~~---~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~  222 (295)
T cd07837         160 AFSIPVKS--------------YTHEIVTLWYRAPEVLLG---STHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLL  222 (295)
T ss_pred             ecCCCccc--------------cCCcccccCCCChHHhhC---CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence            55322110              011136788999998863   2357889999999999999999999997654433333


Q ss_pred             HHHHHhhccCC---------------C--------CCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCcccc
Q 019650          275 ALICAICFGER---------------L--------EMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVT  324 (337)
Q Consensus       275 ~~~~~~~~~~~---------------~--------~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~  324 (337)
                      ...........               +        ...+.++..+.++|.+||..||.+||++.+++.||||+
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         223 HIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             HHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence            32221110000               0        01134688899999999999999999999999999985

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-42  Score=300.73  Aligned_cols=260  Identities=27%  Similarity=0.450  Sum_probs=209.7

Q ss_pred             cccccccccccCcceEEEEEEEccCCceEEEEEeecCC-chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 019650           47 SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVM  125 (337)
Q Consensus        47 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~  125 (337)
                      ++|++.+.||.|++|.||+|.+..+++.|++|.++... .....+.+.+|+.++++++|+|++++++.+.. +...+++|
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~iv~   79 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR-KGRLYLVF   79 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE-CCEEEEEE
Confidence            47999999999999999999999999999999987543 23345678889999999999999999998876 78899999


Q ss_pred             eccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCCC
Q 019650          126 EHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNH  205 (337)
Q Consensus       126 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~  205 (337)
                      ||++++.+..+......+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.........   
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~---  156 (288)
T cd07833          80 EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPAS---  156 (288)
T ss_pred             ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccc---
Confidence            99998777666666677999999999999999999999999999999999999999999999999998776543210   


Q ss_pred             CCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhccC-
Q 019650          206 NNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGE-  284 (337)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~-  284 (337)
                                ......++..|+|||.+...   ..++.++|+||||+++|+|++|..||.................... 
T Consensus       157 ----------~~~~~~~~~~~~~PE~~~~~---~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~  223 (288)
T cd07833         157 ----------PLTDYVATRWYRAPELLVGD---TNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPP  223 (288)
T ss_pred             ----------cccCcccccCCcCCchhcCC---CCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence                      11123468889999999842   2678899999999999999999999975443322222211100000 


Q ss_pred             --------------------------CCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccc
Q 019650          285 --------------------------RLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV  323 (337)
Q Consensus       285 --------------------------~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f  323 (337)
                                                ...++..++..+.++|.+||..+|++|||++++++||||
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         224 SHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             HHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence                                      001223347889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=7e-42  Score=298.19  Aligned_cols=253  Identities=28%  Similarity=0.391  Sum_probs=209.0

Q ss_pred             ccccccccccccCcceEEEEEEEcc-----CCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCe
Q 019650           46 ISDLKKLTVLGHGNGGIVYKVRHQK-----SNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGE  120 (337)
Q Consensus        46 ~~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~  120 (337)
                      .++|.+.+.||.|++|.||+|.+..     ++..||+|.++........+.+.+|+.+++.++|+|++++++.+.. ...
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~   82 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTE-GDP   82 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEec-CCC
Confidence            5689999999999999999998743     3578999999876555456788899999999999999999998877 688


Q ss_pred             EEEEEeccCCCCchHHhhhcC--------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEE
Q 019650          121 ICFVMEHMERGSLFDSLRVRK--------------KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVK  186 (337)
Q Consensus       121 ~~lv~e~~~~~~L~~~l~~~~--------------~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~  186 (337)
                      .+++|||+++++|.+++...+              .+++..+..++.|++.+|.+||++|++|+||+|+||+++.++.++
T Consensus        83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~k  162 (280)
T cd05049          83 PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVK  162 (280)
T ss_pred             eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeEE
Confidence            999999999999999997542              478889999999999999999999999999999999999999999


Q ss_pred             EeeccCccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCC
Q 019650          187 IADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLI  265 (337)
Q Consensus       187 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~  265 (337)
                      |+|||.+.........            .......+++.|+|||.+.    +..++.++||||||+++|+|++ |..||.
T Consensus       163 l~d~g~~~~~~~~~~~------------~~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~il~e~~~~g~~p~~  226 (280)
T cd05049         163 IGDFGMSRDVYTTDYY------------RVGGHTMLPIRWMPPESIM----YRKFTTESDVWSFGVVLWEIFTYGKQPWY  226 (280)
T ss_pred             ECCcccceecccCcce------------ecCCCCcccceecChhhhc----cCCcchhhhHHHHHHHHHHHHhcCCCCCC
Confidence            9999998754322111            0111223578899999998    4578899999999999999999 999996


Q ss_pred             CCCCchhHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhc
Q 019650          266 GFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA  319 (337)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~  319 (337)
                      ......    .......+.....+...+..+.+++.+||+.||++||+++|+++
T Consensus       227 ~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  276 (280)
T cd05049         227 GLSNEE----VIECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE  276 (280)
T ss_pred             CCCHHH----HHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            654332    22222334444555678899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-43  Score=311.92  Aligned_cols=263  Identities=22%  Similarity=0.388  Sum_probs=212.8

Q ss_pred             CCCCCCCCccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCC-chHhHHHHHHHHHHHHhcCCCCceeeeee
Q 019650           35 TSNPTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-STIIRHQAAHEAEILKRLDSQFIVKCHAV  113 (337)
Q Consensus        35 ~~~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~  113 (337)
                      .+.+...|+...++..++..||+|.||+||+|.+..   .||||+++.+. .....+.|.+|+.++++-+|.||+-+.|+
T Consensus       380 ~s~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~  456 (678)
T KOG0193|consen  380 ASDSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGA  456 (678)
T ss_pred             CCccccccccCHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehh
Confidence            334446678888999999999999999999999963   49999998765 45577889999999999999999999997


Q ss_pred             EEeeCCeEEEEEeccCCCCchHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccC
Q 019650          114 FYTIEGEICFVMEHMERGSLFDSLRVR-KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGV  192 (337)
Q Consensus       114 ~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~  192 (337)
                      +-  ++.+.||+.+|.|-+|..+++-. ..|+....+.|+.|+++|+.|||.++|||+|||..|||+.++++|+|+|||+
T Consensus       457 ~~--~p~~AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGL  534 (678)
T KOG0193|consen  457 CM--NPPLAIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGL  534 (678)
T ss_pred             hc--CCceeeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccc
Confidence            75  45569999999999999999743 5689999999999999999999999999999999999999999999999999


Q ss_pred             ccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchh
Q 019650          193 SRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPD  272 (337)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~  272 (337)
                      +.....-...            .....--|...|||||++.-+. ..+|++++||||||+++|||+||..||. ..+.+.
T Consensus       535 atvk~~w~g~------------~q~~qp~gsilwmAPEvIRmqd-~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~dq  600 (678)
T KOG0193|consen  535 ATVKTRWSGE------------QQLEQPHGSLLWMAPEVIRMQD-DNPFSFQSDVYAFGIVWYELLTGELPYS-IQNRDQ  600 (678)
T ss_pred             eeeeeeeccc------------cccCCCccchhhhcHHHHhhcc-cCCCCcccchhhhhHHHHHHHhCcCCcC-CCChhh
Confidence            8765432100            0001112677899999997554 6789999999999999999999999997 333322


Q ss_pred             HHHHHHHhhcc----CCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhc
Q 019650          273 LMALICAICFG----ERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA  319 (337)
Q Consensus       273 ~~~~~~~~~~~----~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~  319 (337)
                         ++.....+    ........+++++++|+..||++++++||.+.+||.
T Consensus       601 ---IifmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  601 ---IIFMVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS  648 (678)
T ss_pred             ---eEEEecccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence               22111222    122334566789999999999999999999999987

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=6.2e-42  Score=299.05  Aligned_cols=256  Identities=25%  Similarity=0.390  Sum_probs=205.6

Q ss_pred             cccccccccCcceEEEEEEEccCCceEEEEEeecCCc-hHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEec
Q 019650           49 LKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSS-TIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEH  127 (337)
Q Consensus        49 y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~e~  127 (337)
                      |++.+.||.|++|.||+|.+..++..|++|++..... ......+.+|+.++++++|++++++++.+.+ ....+++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~-~~~~~iv~e~   79 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHS-ENKLYLVFEF   79 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheecc-CCeEEEEEec
Confidence            6788999999999999999999999999999875432 2233567789999999999999999998876 6889999999


Q ss_pred             cCCCCchHHhhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCCC
Q 019650          128 MERGSLFDSLRVRK--KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNH  205 (337)
Q Consensus       128 ~~~~~L~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~  205 (337)
                      ++ ++|.+++....  .+++..+..++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||.+.........   
T Consensus        80 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~---  155 (283)
T cd07835          80 LD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT---  155 (283)
T ss_pred             cC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc---
Confidence            95 59999997665  7899999999999999999999999999999999999999999999999998755322110   


Q ss_pred             CCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhh----
Q 019650          206 NNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAIC----  281 (337)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~----  281 (337)
                                 .....++..|+|||++..   +..++.++|+||||+++|+|++|+.||.................    
T Consensus       156 -----------~~~~~~~~~~~aPE~~~~---~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  221 (283)
T cd07835         156 -----------YTHEVVTLWYRAPEILLG---SRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDE  221 (283)
T ss_pred             -----------cCccccccCCCCCceeec---CcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence                       011135788999998863   23568899999999999999999999976443322222211100    


Q ss_pred             --------------------ccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccc
Q 019650          282 --------------------FGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV  323 (337)
Q Consensus       282 --------------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f  323 (337)
                                          ..........++..+.++|.+||+.+|.+|||+++++.||||
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         222 DVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             HHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence                                000111234567899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=1.4e-41  Score=292.30  Aligned_cols=253  Identities=33%  Similarity=0.568  Sum_probs=214.9

Q ss_pred             ccccccccccCcceEEEEEEEccCCceEEEEEeecCCc-hHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEe
Q 019650           48 DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSS-TIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVME  126 (337)
Q Consensus        48 ~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~e  126 (337)
                      +|.+.+.||.|++|.||++.+..++..+++|.+..... ......+.+|+++++.++|+|++++.+.+.. ....++++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~-~~~~~lv~e   79 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEE-KGKLCIVME   79 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEec-CCEEEEEEE
Confidence            58899999999999999999998999999999876542 3455677889999999999999999998876 588999999


Q ss_pred             ccCCCCchHHhhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccC
Q 019650          127 HMERGSLFDSLRVR----KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNN  202 (337)
Q Consensus       127 ~~~~~~L~~~l~~~----~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~  202 (337)
                      ++++++|.+++...    ..+++..+..++.+++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.......  
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--  157 (258)
T cd08215          80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV--  157 (258)
T ss_pred             ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc--
Confidence            99999999999763    679999999999999999999999999999999999999999999999999987664432  


Q ss_pred             CCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhc
Q 019650          203 NNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICF  282 (337)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~  282 (337)
                                  .......+++.|+|||.+.    +..++.++|+||+|+++|+|++|..||....    ..........
T Consensus       158 ------------~~~~~~~~~~~y~~pe~~~----~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~----~~~~~~~~~~  217 (258)
T cd08215         158 ------------DLAKTVVGTPYYLSPELCQ----NKPYNYKSDIWSLGCVLYELCTLKHPFEGEN----LLELALKILK  217 (258)
T ss_pred             ------------ceecceeeeecccChhHhc----cCCCCccccHHHHHHHHHHHHcCCCCCCCCc----HHHHHHHHhc
Confidence                        1112235788999999987    4467889999999999999999999985543    2223333333


Q ss_pred             cCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccc
Q 019650          283 GERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV  323 (337)
Q Consensus       283 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f  323 (337)
                      ......+...+..+.+++.+||..+|++|||+.++|+||||
T Consensus       218 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         218 GQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence            44555566788999999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=9.5e-42  Score=301.65  Aligned_cols=267  Identities=29%  Similarity=0.402  Sum_probs=206.7

Q ss_pred             CccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCc-hHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeC--
Q 019650           42 DVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSS-TIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIE--  118 (337)
Q Consensus        42 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~--  118 (337)
                      ....+++|++.+.||.|++|.||+|.+..++..||+|.+..... ......+.+|+.++++++|+||+++++++....  
T Consensus         7 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   86 (310)
T cd07865           7 FCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATP   86 (310)
T ss_pred             ccchhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEeccccc
Confidence            45678899999999999999999999999999999999865432 222334567999999999999999999876532  


Q ss_pred             -----CeEEEEEeccCCCCchHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccC
Q 019650          119 -----GEICFVMEHMERGSLFDSLRVR-KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGV  192 (337)
Q Consensus       119 -----~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~  192 (337)
                           ...++||||+.+ +|.+++... ..+++.+++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.
T Consensus        87 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~  165 (310)
T cd07865          87 YNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGL  165 (310)
T ss_pred             ccCCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCC
Confidence                 346999999965 888887654 3689999999999999999999999999999999999999999999999999


Q ss_pred             ccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchh
Q 019650          193 SRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPD  272 (337)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~  272 (337)
                      +...........          .......++..|+|||.+...   ..++.++|+||||+++|+|++|..||........
T Consensus       166 ~~~~~~~~~~~~----------~~~~~~~~~~~y~aPE~~~~~---~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~  232 (310)
T cd07865         166 ARAFSLSKNSKP----------NRYTNRVVTLWYRPPELLLGE---RDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQ  232 (310)
T ss_pred             cccccCCcccCC----------CCccCcccCccccCcHHhcCC---cccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            876643321110          111223467889999998632   3467899999999999999999999865433222


Q ss_pred             HHHHHHHhhccCCCC---------------C-------------CCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccc
Q 019650          273 LMALICAICFGERLE---------------M-------------PETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV  323 (337)
Q Consensus       273 ~~~~~~~~~~~~~~~---------------~-------------~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f  323 (337)
                       ..............               .             +...+..+.++|.+||..||.+|||++++|+||||
T Consensus       233 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         233 -LTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             -HHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence             11222211110000               0             11235678899999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=1.8e-41  Score=295.39  Aligned_cols=254  Identities=28%  Similarity=0.465  Sum_probs=203.0

Q ss_pred             ccccCcceEEEEEEEccCCceEEEEEeecCCch--HhHHHHHHH---HHHHHhcCCCCceeeeeeEEeeCCeEEEEEecc
Q 019650           54 VLGHGNGGIVYKVRHQKSNSIYALKVLNTTSST--IIRHQAAHE---AEILKRLDSQFIVKCHAVFYTIEGEICFVMEHM  128 (337)
Q Consensus        54 ~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e---~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~e~~  128 (337)
                      .||+|++|.||++.+..+++.||+|.+......  ........|   ...++...|++++.+++.+.. ....++||||+
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~-~~~~~~v~e~~   79 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT-PDKLSFILDLM   79 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeec-CCEEEEEEecC
Confidence            489999999999999999999999998654311  111122233   334455689999999998766 67899999999


Q ss_pred             CCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCCCCCC
Q 019650          129 ERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNN  208 (337)
Q Consensus       129 ~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~  208 (337)
                      .|++|.+++...+.+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||.+.......        
T Consensus        80 ~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--------  151 (278)
T cd05606          80 NGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--------  151 (278)
T ss_pred             CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC--------
Confidence            999999999888889999999999999999999999999999999999999999999999999886543211        


Q ss_pred             CCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhccCCCCC
Q 019650          209 NNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEM  288 (337)
Q Consensus       209 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  288 (337)
                              .....++..|+|||.+..   +..++.++|+||+|+++|+|++|..||........ .. ............
T Consensus       152 --------~~~~~~~~~y~aPE~~~~---~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~-~~-~~~~~~~~~~~~  218 (278)
T cd05606         152 --------PHASVGTHGYMAPEVLQK---GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HE-IDRMTLTMAVEL  218 (278)
T ss_pred             --------CcCcCCCcCCcCcHHhcC---CCCCCcccchHhHHHHHHHHHhCCCCCCCCCccch-HH-HHHHhhccCCCC
Confidence                    112248899999999874   23578899999999999999999999976422211 11 112222334556


Q ss_pred             CCCCCHHHHHHHHHHhhcCcCCCC-----CHHHHhcCccccccCCC
Q 019650          289 PETASPEFRRFVRSCLEKDWRKRG-----TVEELLAYPFVTKRSSS  329 (337)
Q Consensus       289 ~~~~~~~~~~li~~~l~~~p~~R~-----s~~eil~hp~f~~~~~~  329 (337)
                      +...+..+.+++.+||..+|.+|+     +++++++||||+...+.
T Consensus       219 ~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~~  264 (278)
T cd05606         219 PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQ  264 (278)
T ss_pred             CCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCCch
Confidence            667799999999999999999999     99999999999887643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-43  Score=304.08  Aligned_cols=265  Identities=27%  Similarity=0.397  Sum_probs=226.9

Q ss_pred             CccccccccccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEE
Q 019650           45 NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEIC  122 (337)
Q Consensus        45 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~  122 (337)
                      ..+.|+..++||.|+||.|+-+....||+-||+|.+.+..  .........+|-.++.++..+.||.+-..|.+ ...+|
T Consensus       183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeT-kd~LC  261 (591)
T KOG0986|consen  183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFET-KDALC  261 (591)
T ss_pred             cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecC-CCceE
Confidence            4578899999999999999999999999999999875432  12223445789999999999999988887766 78999


Q ss_pred             EEEeccCCCCchHHhhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccc
Q 019650          123 FVMEHMERGSLFDSLRVRK--KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETR  200 (337)
Q Consensus       123 lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~  200 (337)
                      +||..+.||+|.-.|-+.+  .++++.+..++.+|+.+|.+||..+||.||+||+|||+|+.|++.|+|+|++..+....
T Consensus       262 lVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~  341 (591)
T KOG0986|consen  262 LVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGK  341 (591)
T ss_pred             EEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCCC
Confidence            9999999999998887655  79999999999999999999999999999999999999999999999999999887653


Q ss_pred             cCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHh
Q 019650          201 NNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAI  280 (337)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~  280 (337)
                                     .....+||.+|||||++.+    ..|+...|+|+|||++|+|+.|+-||....+..... .+...
T Consensus       342 ---------------~~~~rvGT~GYMAPEvl~n----e~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~e-Evdrr  401 (591)
T KOG0986|consen  342 ---------------PIRGRVGTVGYMAPEVLQN----EVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKRE-EVDRR  401 (591)
T ss_pred             ---------------ccccccCcccccCHHHHcC----CcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHH-HHHHH
Confidence                           3334489999999999995    469999999999999999999999997765544333 33344


Q ss_pred             hccCCCCCCCCCCHHHHHHHHHHhhcCcCCCC-----CHHHHhcCccccccCCCc
Q 019650          281 CFGERLEMPETASPEFRRFVRSCLEKDWRKRG-----TVEELLAYPFVTKRSSSS  330 (337)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~-----s~~eil~hp~f~~~~~~~  330 (337)
                      ......+++...++++++|.+.+|.+||.+|.     .++++.+||||+..+|..
T Consensus       402 ~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~r  456 (591)
T KOG0986|consen  402 TLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRR  456 (591)
T ss_pred             HhcchhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhH
Confidence            44556778889999999999999999999996     578999999999987754

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=7.1e-42  Score=298.42  Aligned_cols=255  Identities=27%  Similarity=0.400  Sum_probs=200.1

Q ss_pred             cccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcC-CCCceeeeeeEEeeC-CeEEEEEe
Q 019650           49 LKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLD-SQFIVKCHAVFYTIE-GEICFVME  126 (337)
Q Consensus        49 y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~-~~~~lv~e  126 (337)
                      |++.+.||.|++|.||+|.+..++..+|+|.++............+|+..+.++. |+|++++++.+.+.. ..+++|||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            6788999999999999999999999999999876432222233456888888885 999999999887631 67899999


Q ss_pred             ccCCCCchHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCCC
Q 019650          127 HMERGSLFDSLRVR-KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNH  205 (337)
Q Consensus       127 ~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~  205 (337)
                      |+.+ +|.+.+... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++. +.++|+|||.+.........   
T Consensus        81 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~---  155 (282)
T cd07831          81 LMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPY---  155 (282)
T ss_pred             cCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCCc---
Confidence            9975 888888653 57899999999999999999999999999999999999999 99999999998766432211   


Q ss_pred             CCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhh----
Q 019650          206 NNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAIC----  281 (337)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~----  281 (337)
                                  ....++..|+|||.+..   +..++.++|+||||+++|+|++|..||...+..+..........    
T Consensus       156 ------------~~~~~~~~y~aPE~~~~---~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~  220 (282)
T cd07831         156 ------------TEYISTRWYRAPECLLT---DGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDA  220 (282)
T ss_pred             ------------CCCCCCcccCChhHhhc---CCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCH
Confidence                        11247889999998753   23568899999999999999999999976433222211111000    


Q ss_pred             -------cc--CCCCC-----------CCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccc
Q 019650          282 -------FG--ERLEM-----------PETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV  323 (337)
Q Consensus       282 -------~~--~~~~~-----------~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f  323 (337)
                             ..  ....+           ....+..+.++|.+||..+|++||++++++.||||
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         221 EVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             HHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence                   00  00011           13457899999999999999999999999999998

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=2.1e-41  Score=291.24  Aligned_cols=257  Identities=34%  Similarity=0.526  Sum_probs=216.2

Q ss_pred             ccccccccccCcceEEEEEEEccCCceEEEEEeecCCc-hHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeC--CeEEEE
Q 019650           48 DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSS-TIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIE--GEICFV  124 (337)
Q Consensus        48 ~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~--~~~~lv  124 (337)
                      +|.+.+.||.|++|.||+|.+..+++.+++|++..... ....+.+.+|+.++++++|+|++++++.+.. .  ...+++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~~lv   79 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERD-EEKNTLNIF   79 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEec-CCCCeEEEE
Confidence            47888999999999999999998999999999876542 2456778899999999999999999998876 4  688999


Q ss_pred             EeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCC
Q 019650          125 MEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNN  204 (337)
Q Consensus       125 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~  204 (337)
                      +|++++++|.+++.....+++..+..++.|++.+|+|||+.|++|+||+|+||+++.++.++|+|||.+.........  
T Consensus        80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~--  157 (260)
T cd06606          80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG--  157 (260)
T ss_pred             EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccc--
Confidence            999999999999988889999999999999999999999999999999999999999999999999998877554321  


Q ss_pred             CCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhccC
Q 019650          205 HNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGE  284 (337)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~  284 (337)
                                .......++..|+|||.+.    +...+.++|+||||+++|+|++|..||....+  .............
T Consensus       158 ----------~~~~~~~~~~~y~~pE~~~----~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~~~  221 (260)
T cd06606         158 ----------EGTGSVRGTPYWMAPEVIR----GEEYGRAADIWSLGCTVIEMATGKPPWSELGN--PMAALYKIGSSGE  221 (260)
T ss_pred             ----------ccccCCCCCccccCHhhhc----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--hHHHHHhccccCC
Confidence                      0112234788999999998    44588999999999999999999999976541  1112222222234


Q ss_pred             CCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccc
Q 019650          285 RLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV  323 (337)
Q Consensus       285 ~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f  323 (337)
                      ....+...+..+.+++.+||..+|++||++.+++.||||
T Consensus       222 ~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         222 PPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             CcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence            455667779999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=1e-41  Score=298.43  Aligned_cols=263  Identities=30%  Similarity=0.545  Sum_probs=209.4

Q ss_pred             ccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcC-CCCceeeeeeEEeeCCeEEEE
Q 019650           46 ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLD-SQFIVKCHAVFYTIEGEICFV  124 (337)
Q Consensus        46 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~~lv  124 (337)
                      .++|...+.||.|++|.||++.+..++..+|+|.+...........+.+|+.++.++. |+||+++++.+.. ....+++
T Consensus         3 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~-~~~~~~~   81 (288)
T cd06616           3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFR-EGDCWIC   81 (288)
T ss_pred             HHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEec-CCcEEEE
Confidence            5688899999999999999999999999999999876554455667788999999996 9999999998766 6788899


Q ss_pred             EeccCCCCchHHhh-----hcCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCCeEEcCCCcEEEeeccCccchhc
Q 019650          125 MEHMERGSLFDSLR-----VRKKLSEDVISGVAYRVLKGLQYLHGM-QIIHGDIKPSNLLINGKGEVKIADFGVSRIVEE  198 (337)
Q Consensus       125 ~e~~~~~~L~~~l~-----~~~~l~~~~~~~i~~~l~~~l~~LH~~-~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~  198 (337)
                      ||++.+ ++.++..     ....+++..+..++.|++.||+|||+. |++||||+|+||+++.++.++|+|||++.....
T Consensus        82 ~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  160 (288)
T cd06616          82 MELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD  160 (288)
T ss_pred             EecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence            999864 6655432     236799999999999999999999974 999999999999999999999999999876543


Q ss_pred             cccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHH
Q 019650          199 TRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALIC  278 (337)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~  278 (337)
                      ....               ....++..|+|||.+.... ...++.++|+||||+++|+|++|+.||....   .......
T Consensus       161 ~~~~---------------~~~~~~~~y~aPE~~~~~~-~~~~~~~~Di~slG~il~el~~g~~p~~~~~---~~~~~~~  221 (288)
T cd06616         161 SIAK---------------TRDAGCRPYMAPERIDPSA-RDGYDVRSDVWSLGITLYEVATGKFPYPKWN---SVFDQLT  221 (288)
T ss_pred             CCcc---------------ccccCccCccCHHHhcccc-ccCCcchhhhhHHHHHHHHHHhCCCCchhcc---hHHHHHh
Confidence            2111               1224788999999987431 1367889999999999999999999996533   1112222


Q ss_pred             HhhccCCCCC----CCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCC
Q 019650          279 AICFGERLEM----PETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSS  329 (337)
Q Consensus       279 ~~~~~~~~~~----~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~  329 (337)
                      .......+..    +..++..+.+|+.+||..+|++|||+++++.||||+.....
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~~~  276 (288)
T cd06616         222 QVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYEER  276 (288)
T ss_pred             hhcCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchhhc
Confidence            2222222222    23468899999999999999999999999999999886644

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=1.2e-41  Score=296.29  Aligned_cols=257  Identities=25%  Similarity=0.374  Sum_probs=206.1

Q ss_pred             ccCccccccccccccCcceEEEEEEEc-----cCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEee
Q 019650           43 VENISDLKKLTVLGHGNGGIVYKVRHQ-----KSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTI  117 (337)
Q Consensus        43 ~~~~~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~  117 (337)
                      ....++|++.+.||+|++|+||+|.+.     .++..||+|.+...........+.+|+.+++.++|+||+++++.+.+ 
T Consensus         2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~-   80 (277)
T cd05062           2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ-   80 (277)
T ss_pred             cccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC-
Confidence            345688999999999999999999864     24567999998654444445667889999999999999999998765 


Q ss_pred             CCeEEEEEeccCCCCchHHhhhcC----------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEE
Q 019650          118 EGEICFVMEHMERGSLFDSLRVRK----------KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKI  187 (337)
Q Consensus       118 ~~~~~lv~e~~~~~~L~~~l~~~~----------~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l  187 (337)
                      +...++||||+++++|.+++....          .++...+..++.|++.||.|||+.|++|+||||+||+++.++.++|
T Consensus        81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          81 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEE
Confidence            678999999999999999986532          3577889999999999999999999999999999999999999999


Q ss_pred             eeccCccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCC
Q 019650          188 ADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIG  266 (337)
Q Consensus       188 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~  266 (337)
                      +|||++..........            ......+++.|+|||.+.    +..++.++|+||||+++|+|++ |..||..
T Consensus       161 ~dfg~~~~~~~~~~~~------------~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~~l~el~~~~~~p~~~  224 (277)
T cd05062         161 GDFGMTRDIYETDYYR------------KGGKGLLPVRWMSPESLK----DGVFTTYSDVWSFGVVLWEIATLAEQPYQG  224 (277)
T ss_pred             CCCCCccccCCcceee------------cCCCCccCHhhcChhHhh----cCCcCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence            9999887553321110            011123577899999997    4578899999999999999999 7888865


Q ss_pred             CCCchhHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          267 FGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                      ....    ..............+...+..+.+++.+||+.+|++|||+.+++++
T Consensus       225 ~~~~----~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  274 (277)
T cd05062         225 MSNE----QVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  274 (277)
T ss_pred             CCHH----HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            4332    2222222333445567788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=2e-41  Score=292.77  Aligned_cols=253  Identities=25%  Similarity=0.378  Sum_probs=209.3

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEE
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICF  123 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~l  123 (337)
                      ....+|.+.+.||.|++|.||+|.+..++..+++|.+....  ...+.+.+|+.++++++|++++++++.+.. +...++
T Consensus         3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~l   79 (263)
T cd05052           3 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-EPPFYI   79 (263)
T ss_pred             CchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc--hHHHHHHHHHHHHHhCCCCChhheEEEEcC-CCCcEE
Confidence            44567999999999999999999999999999999987543  335678889999999999999999998766 678899


Q ss_pred             EEeccCCCCchHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhcccc
Q 019650          124 VMEHMERGSLFDSLRVR--KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRN  201 (337)
Q Consensus       124 v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~  201 (337)
                      +|||+++++|.+++...  ..+++..++.++.|++.+|+|||+.|++|+||+|+||++++++.++|+|||.+........
T Consensus        80 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~  159 (263)
T cd05052          80 ITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY  159 (263)
T ss_pred             EEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence            99999999999999653  3589999999999999999999999999999999999999999999999999876543221


Q ss_pred             CCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHh
Q 019650          202 NNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICAI  280 (337)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~  280 (337)
                      ..             .....++..|+|||.+.    +..++.++|+||||+++|+|++ |..||.+... .   ......
T Consensus       160 ~~-------------~~~~~~~~~y~aPE~~~----~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~-~---~~~~~~  218 (263)
T cd05052         160 TA-------------HAGAKFPIKWTAPESLA----YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-S---QVYELL  218 (263)
T ss_pred             ec-------------cCCCCCccccCCHHHhc----cCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH-H---HHHHHH
Confidence            10             01112456899999987    4577889999999999999998 8999865322 2   222333


Q ss_pred             hccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          281 CFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                      ........+...+..+.+++.+||+.+|++|||+.++++.
T Consensus       219 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~  258 (263)
T cd05052         219 EKGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQA  258 (263)
T ss_pred             HCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHH
Confidence            3344556677789999999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=1.9e-41  Score=293.40  Aligned_cols=254  Identities=25%  Similarity=0.420  Sum_probs=206.4

Q ss_pred             ccccccccccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEE
Q 019650           46 ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICF  123 (337)
Q Consensus        46 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~l  123 (337)
                      .++|++.+.||.|+||.||+|.+..++..||+|.+....  .......+.+|+.+++.++|+|++++++.+.+ ....++
T Consensus         1 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~   79 (267)
T cd08228           1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIE-DNELNI   79 (267)
T ss_pred             CcceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEE-CCeEEE
Confidence            368999999999999999999999999999999876432  33345567889999999999999999998776 678999


Q ss_pred             EEeccCCCCchHHhhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhcc
Q 019650          124 VMEHMERGSLFDSLRV----RKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEET  199 (337)
Q Consensus       124 v~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~  199 (337)
                      ++||+++++|.+++..    ...+++..+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||.+......
T Consensus        80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~  159 (267)
T cd08228          80 VLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK  159 (267)
T ss_pred             EEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccch
Confidence            9999999999988853    345899999999999999999999999999999999999999999999999988765432


Q ss_pred             ccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHH
Q 019650          200 RNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICA  279 (337)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~  279 (337)
                      ..              ......+++.|+|||.+.    +..++.++|+||+|+++|+|++|..||......  .......
T Consensus       160 ~~--------------~~~~~~~~~~~~aPE~~~----~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~--~~~~~~~  219 (267)
T cd08228         160 TT--------------AAHSLVGTPYYMSPERIH----ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN--LFSLCQK  219 (267)
T ss_pred             hH--------------HHhcCCCCccccChhhhc----cCCCCchhhHHHHHHHHHHHhcCCCCCcccccc--HHHHHHH
Confidence            21              111224788999999998    456788999999999999999999998653222  1222222


Q ss_pred             hhccCCCC-CCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          280 ICFGERLE-MPETASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       280 ~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                      ......+. .....+..+.+++.+||..+|++|||++++++.
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~  261 (267)
T cd08228         220 IEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQI  261 (267)
T ss_pred             HhcCCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHH
Confidence            22222222 233567899999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=1e-41  Score=293.35  Aligned_cols=253  Identities=26%  Similarity=0.465  Sum_probs=209.5

Q ss_pred             ccccccccccCcceEEEEEEEccCCceEEEEEeecCC-chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEe
Q 019650           48 DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVME  126 (337)
Q Consensus        48 ~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~e  126 (337)
                      +|++.+.||.|++|.||++.+..++..+|+|.+.... .....+.+.+|+.++++++|+|++++++.+.. ....++++|
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~-~~~~~lv~e   79 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQE-NGRLFIVME   79 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheecc-CCeEEEEEe
Confidence            5889999999999999999999999999999986542 12234567789999999999999999998766 688999999


Q ss_pred             ccCCCCchHHhhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCC-cEEEeeccCccchhccccCC
Q 019650          127 HMERGSLFDSLRVRK--KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKG-EVKIADFGVSRIVEETRNNN  203 (337)
Q Consensus       127 ~~~~~~L~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~-~~~l~Dfg~~~~~~~~~~~~  203 (337)
                      |+++++|.+++....  .+++..+..++.|++.||.|||+.+++|+||+|+||+++.++ .++++|||.+........  
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~--  157 (257)
T cd08225          80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME--  157 (257)
T ss_pred             cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc--
Confidence            999999999997543  479999999999999999999999999999999999998886 469999998876643221  


Q ss_pred             CCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhcc
Q 019650          204 NHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFG  283 (337)
Q Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~  283 (337)
                                  ......+++.|+|||.+.    +..++.++|+||||+++|++++|..||.......    ........
T Consensus       158 ------------~~~~~~~~~~~~ape~~~----~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~----~~~~~~~~  217 (257)
T cd08225         158 ------------LAYTCVGTPYYLSPEICQ----NRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ----LVLKICQG  217 (257)
T ss_pred             ------------cccccCCCccccCHHHHc----CCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH----HHHHHhcc
Confidence                        111234788999999987    4568889999999999999999999996543222    22222333


Q ss_pred             CCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccc
Q 019650          284 ERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV  323 (337)
Q Consensus       284 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f  323 (337)
                      ......+..+..+.+++.+||..+|++|||+.++++||||
T Consensus       218 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         218 YFAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL  257 (257)
T ss_pred             cCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence            3344556678899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=2.2e-41  Score=299.10  Aligned_cols=262  Identities=31%  Similarity=0.458  Sum_probs=211.7

Q ss_pred             CccccccccccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEE
Q 019650           45 NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEIC  122 (337)
Q Consensus        45 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~  122 (337)
                      ....|.+.+.||.|++|+||+|.+..+++.|++|.+....  .......+.+|+.+++.++|+|++++++.+.. ....+
T Consensus        13 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~-~~~~~   91 (307)
T cd06607          13 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLR-EHTAW   91 (307)
T ss_pred             cchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEe-CCeEE
Confidence            3467999999999999999999999899999999986432  23344567889999999999999999998876 67889


Q ss_pred             EEEeccCCCCchHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhcccc
Q 019650          123 FVMEHMERGSLFDSLRV-RKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRN  201 (337)
Q Consensus       123 lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~  201 (337)
                      +||||+.| ++.+++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+....... 
T Consensus        92 lv~e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~~-  169 (307)
T cd06607          92 LVMEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPAN-  169 (307)
T ss_pred             EEHHhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCCC-
Confidence            99999975 77777753 4579999999999999999999999999999999999999999999999999886543221 


Q ss_pred             CCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhh
Q 019650          202 NNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAIC  281 (337)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~  281 (337)
                                       ...++..|+|||.+.... ...++.++|+||||+++|+|++|..||..........    ...
T Consensus       170 -----------------~~~~~~~y~aPE~~~~~~-~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~----~~~  227 (307)
T cd06607         170 -----------------SFVGTPYWMAPEVILAMD-EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY----HIA  227 (307)
T ss_pred             -----------------CccCCccccCceeeeccC-CCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHH----HHh
Confidence                             124778999999885321 2467889999999999999999999996543222111    111


Q ss_pred             ccCCCCC-CCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCCcc
Q 019650          282 FGERLEM-PETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSN  331 (337)
Q Consensus       282 ~~~~~~~-~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~~~  331 (337)
                      ....+.. +...+..+.+++.+||..+|++||++.+++.||||........
T Consensus       228 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~~  278 (307)
T cd06607         228 QNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRERPPTV  278 (307)
T ss_pred             cCCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcccCCcHH
Confidence            1222222 3346788999999999999999999999999999998775443

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=2e-42  Score=298.28  Aligned_cols=249  Identities=31%  Similarity=0.536  Sum_probs=201.5

Q ss_pred             ccccccccCcceEEEEEEEc----cCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 019650           50 KKLTVLGHGNGGIVYKVRHQ----KSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVM  125 (337)
Q Consensus        50 ~~~~~lg~g~~~~v~~~~~~----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~  125 (337)
                      ++.+.||.|.||.||+|...    ..+..|++|.++........+.+.+|+..+++++|+||+++++.+.. ....++|+
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~-~~~~~lv~   80 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIE-NEPLFLVM   80 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEES-SSSEEEEE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccc-cccccccc
Confidence            46789999999999999987    45678999999766555567889999999999999999999999885 56799999


Q ss_pred             eccCCCCchHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCC
Q 019650          126 EHMERGSLFDSLRVR--KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNN  203 (337)
Q Consensus       126 e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~  203 (337)
                      ||+++|+|.+++...  ..+++..+..++.|++.||+|||+.+++|++|+++||+++.++.+||+|||++......... 
T Consensus        81 e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~-  159 (259)
T PF07714_consen   81 EYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY-  159 (259)
T ss_dssp             E--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE-
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-
Confidence            999999999999876  67999999999999999999999999999999999999999999999999998776221110 


Q ss_pred             CCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHhhc
Q 019650          204 NHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICAICF  282 (337)
Q Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~  282 (337)
                                 ...........|+|||.+..    ..++.++||||||+++||+++ |+.||.....    .........
T Consensus       160 -----------~~~~~~~~~~~~~aPE~~~~----~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~----~~~~~~~~~  220 (259)
T PF07714_consen  160 -----------KNDSSQQLPLRYLAPEVLKD----GEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN----EEIIEKLKQ  220 (259)
T ss_dssp             -----------EESTTSESGGGGS-HHHHHH----SEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH----HHHHHHHHT
T ss_pred             -----------cccccccccccccccccccc----cccccccccccccccccccccccccccccccc----ccccccccc
Confidence                       11112236778999999984    468999999999999999999 7889865422    233344445


Q ss_pred             cCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhc
Q 019650          283 GERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA  319 (337)
Q Consensus       283 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~  319 (337)
                      +.....+..++..+.+++..||+.+|.+|||+.++++
T Consensus       221 ~~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  221 GQRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ  257 (259)
T ss_dssp             TEETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred             cccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence            5566677788999999999999999999999999975

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-41  Score=289.08  Aligned_cols=253  Identities=30%  Similarity=0.511  Sum_probs=215.7

Q ss_pred             ccccccccccCcceEEEEEEEccCCceEEEEEeecCCc-hHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEe
Q 019650           48 DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSS-TIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVME  126 (337)
Q Consensus        48 ~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~e  126 (337)
                      +|++.+.||.|++|.||++.+..+++.+++|.+..... ....+.+.+|++++.+++|++++++++.+.. ....+++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~v~e   79 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIET-SDSLYIILE   79 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEe-CCEEEEEEe
Confidence            58899999999999999999998999999999876542 2355678899999999999999999998766 688999999


Q ss_pred             ccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCCCC
Q 019650          127 HMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHN  206 (337)
Q Consensus       127 ~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~  206 (337)
                      ++++++|.+++.....+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+.........    
T Consensus        80 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~----  155 (254)
T cd06627          80 YAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD----  155 (254)
T ss_pred             cCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc----
Confidence            9999999999988888999999999999999999999999999999999999999999999999998876543211    


Q ss_pred             CCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhccCCC
Q 019650          207 NNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERL  286 (337)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~  286 (337)
                                .....++..|+|||...    +..++.++|+|+||+++|+|++|..||..........    ........
T Consensus       156 ----------~~~~~~~~~y~~pe~~~----~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~----~~~~~~~~  217 (254)
T cd06627         156 ----------DASVVGTPYWMAPEVIE----MSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALF----RIVQDDHP  217 (254)
T ss_pred             ----------ccccccchhhcCHhhhc----CCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHH----HHhccCCC
Confidence                      11224788999999987    3457889999999999999999999996544322222    22233445


Q ss_pred             CCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccc
Q 019650          287 EMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV  323 (337)
Q Consensus       287 ~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f  323 (337)
                      ..+...+..+.+++.+||..+|++|||+.++++||||
T Consensus       218 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~  254 (254)
T cd06627         218 PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI  254 (254)
T ss_pred             CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence            5667789999999999999999999999999999997

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.2e-43  Score=313.92  Aligned_cols=258  Identities=28%  Similarity=0.466  Sum_probs=216.3

Q ss_pred             cCcccc-ccccccccCcceEEEEEEEccCCceEEEEEe---ecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCC
Q 019650           44 ENISDL-KKLTVLGHGNGGIVYKVRHQKSNSIYALKVL---NTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEG  119 (337)
Q Consensus        44 ~~~~~y-~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~---~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~  119 (337)
                      ...++| +....||+|+|.+||+|.|..+|..||=-.+   +........+++..|+.+++.|+|+||++++.++.+..+
T Consensus        36 ~p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n  115 (632)
T KOG0584|consen   36 DPTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDN  115 (632)
T ss_pred             CCCCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCC
Confidence            333444 3467899999999999999999988774322   223355567889999999999999999999999887543


Q ss_pred             -eEEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhC--CceeccCCCCCeEEcCC-CcEEEeeccCccc
Q 019650          120 -EICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGM--QIIHGDIKPSNLLINGK-GEVKIADFGVSRI  195 (337)
Q Consensus       120 -~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~--~ivH~dl~~~Nili~~~-~~~~l~Dfg~~~~  195 (337)
                       .+.+|+|.+..|+|+.|+.+++..+.+.++.|+.||+++|.|||++  .|+|||||.+||||+.+ |.|||+|+|++..
T Consensus       116 ~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl  195 (632)
T KOG0584|consen  116 KTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATL  195 (632)
T ss_pred             ceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHH
Confidence             4788999999999999999999999999999999999999999988  59999999999999877 8999999999988


Q ss_pred             hhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHH
Q 019650          196 VEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMA  275 (337)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~  275 (337)
                      .....                -.+.+|||.|||||.+.     ..|+..+||||||+++.||.|+.+||....+.....+
T Consensus       196 ~r~s~----------------aksvIGTPEFMAPEmYE-----E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYK  254 (632)
T KOG0584|consen  196 LRKSH----------------AKSVIGTPEFMAPEMYE-----ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYK  254 (632)
T ss_pred             hhccc----------------cceeccCccccChHHHh-----hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHH
Confidence            75432                22368999999999997     4799999999999999999999999987766554444


Q ss_pred             HHHHhhccCCCC-CCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCcccccc
Q 019650          276 LICAICFGERLE-MPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKR  326 (337)
Q Consensus       276 ~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~  326 (337)
                      .   ...+..+. +...-.+++++||.+||.. .++|+|+.|+|.||||...
T Consensus       255 K---V~SGiKP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d  302 (632)
T KOG0584|consen  255 K---VTSGIKPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED  302 (632)
T ss_pred             H---HHcCCCHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence            4   34444443 2233478999999999999 8999999999999999986

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.4e-42  Score=310.03  Aligned_cols=263  Identities=26%  Similarity=0.391  Sum_probs=228.0

Q ss_pred             CCccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCC-chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCC
Q 019650           41 PDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEG  119 (337)
Q Consensus        41 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~  119 (337)
                      .....+.-|.+...||.|.|+.|.++.+..++..||||++++.. +......+.+|+.+++.++||||++++++... ..
T Consensus        50 ~~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t-~~  128 (596)
T KOG0586|consen   50 DDSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIET-EA  128 (596)
T ss_pred             cccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeee-cc
Confidence            44566789999999999999999999999999999999998775 33344568899999999999999999998876 78


Q ss_pred             eEEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhcc
Q 019650          120 EICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEET  199 (337)
Q Consensus       120 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~  199 (337)
                      .+|+||||+.+|.+++++..++...+..++.++.|++.|++|||+++|||||||++|++++.+.+++|+|||++......
T Consensus       129 ~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~  208 (596)
T KOG0586|consen  129 TLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYG  208 (596)
T ss_pred             eeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeeccc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999877643


Q ss_pred             ccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHH
Q 019650          200 RNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICA  279 (337)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~  279 (337)
                                     .....++|++.|.|||++.+.+   ..+++.|+||+|+++|.|..|.+||.+..-.+.....+  
T Consensus       209 ---------------~~lqt~cgsppyAaPEl~~g~~---y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl--  268 (596)
T KOG0586|consen  209 ---------------LMLQTFCGSPPYAAPELFNGKK---YDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVL--  268 (596)
T ss_pred             ---------------ccccccCCCCCccChHhhcCcc---cCCcceehhhhhhhheeeeecccccCCcccccccchhe--
Confidence                           4455668999999999999654   34679999999999999999999997644333222222  


Q ss_pred             hhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccC
Q 019650          280 ICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRS  327 (337)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~  327 (337)
                         .....++-.++..+.++|.++|-.+|.+|++.+++++|.|..-..
T Consensus       269 ---~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~  313 (596)
T KOG0586|consen  269 ---RGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLL  313 (596)
T ss_pred             ---eeeecccceeechhHHHHHHhhccCccccCCHHHhhhhcccchhh
Confidence               123445667789999999999999999999999999999986544

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=8.9e-42  Score=294.79  Aligned_cols=258  Identities=31%  Similarity=0.431  Sum_probs=207.9

Q ss_pred             cccCcceEEEEEEEccCCceEEEEEeecCCc--hHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEeccCCCC
Q 019650           55 LGHGNGGIVYKVRHQKSNSIYALKVLNTTSS--TIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGS  132 (337)
Q Consensus        55 lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~  132 (337)
                      ||.|++|.||++.+..+++.+++|.+.....  ......+.+|+.++++++|+|++++++.+.. +...|++|||+++++
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~   79 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQG-KKNLYLVMEYLPGGD   79 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheec-CcEEEEEEecCCCCc
Confidence            6899999999999998999999999865432  2345667889999999999999999998765 788999999999999


Q ss_pred             chHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCCCCCCCCCc
Q 019650          133 LFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNN  212 (337)
Q Consensus       133 L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~  212 (337)
                      |.+++...+.+++..+..++.|++.+|++||+.|++|+||+|+||+++.++.++|+|||++...........      ..
T Consensus        80 L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~------~~  153 (265)
T cd05579          80 LASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINL------ND  153 (265)
T ss_pred             HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccc------cc
Confidence            999998877899999999999999999999999999999999999999999999999998775533211000      00


Q ss_pred             cccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhccCCCCCCCC-
Q 019650          213 IGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPET-  291 (337)
Q Consensus       213 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-  291 (337)
                      .........++..|+|||....    ...+.++|+||||+++|++++|..||...........    ...+ ....+.. 
T Consensus       154 ~~~~~~~~~~~~~~~~Pe~~~~----~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~----~~~~-~~~~~~~~  224 (265)
T cd05579         154 DEKEDKRIVGTPDYIAPEVILG----QGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQN----ILNG-KIEWPEDV  224 (265)
T ss_pred             ccccccCcccCccccCHHHhcC----CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH----HhcC-CcCCCccc
Confidence            0012223357889999999983    4578899999999999999999999965443222211    1111 2233333 


Q ss_pred             -CCHHHHHHHHHHhhcCcCCCCCH---HHHhcCccccccCC
Q 019650          292 -ASPEFRRFVRSCLEKDWRKRGTV---EELLAYPFVTKRSS  328 (337)
Q Consensus       292 -~~~~~~~li~~~l~~~p~~R~s~---~eil~hp~f~~~~~  328 (337)
                       .+..+.+++.+||+.+|++|||+   .++|+||||++..|
T Consensus       225 ~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~~  265 (265)
T cd05579         225 EVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGIDW  265 (265)
T ss_pred             cCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCCCC
Confidence             38999999999999999999999   99999999987654

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=1.6e-41  Score=295.59  Aligned_cols=255  Identities=27%  Similarity=0.353  Sum_probs=208.4

Q ss_pred             CccccccccccccCcceEEEEEEEcc-----CCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCC
Q 019650           45 NISDLKKLTVLGHGNGGIVYKVRHQK-----SNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEG  119 (337)
Q Consensus        45 ~~~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~  119 (337)
                      ..++|.+.+.||.|++|.||+|.+..     ++..|++|.+...........+.+|+.++++++|+||+++++.+.+ ..
T Consensus         4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~   82 (277)
T cd05036           4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFE-RL   82 (277)
T ss_pred             CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc-CC
Confidence            45789999999999999999999976     7788999988765545555678889999999999999999998776 56


Q ss_pred             eEEEEEeccCCCCchHHhhhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCC---cEEEee
Q 019650          120 EICFVMEHMERGSLFDSLRVRK-------KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKG---EVKIAD  189 (337)
Q Consensus       120 ~~~lv~e~~~~~~L~~~l~~~~-------~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~---~~~l~D  189 (337)
                      ..+++|||++|++|.+++....       .+++..+..++.||+.+|+|||+.+++|+||+|+||+++.++   .++|+|
T Consensus        83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~d  162 (277)
T cd05036          83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIAD  162 (277)
T ss_pred             CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEecc
Confidence            7899999999999999997543       488999999999999999999999999999999999998764   599999


Q ss_pred             ccCccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCC
Q 019650          190 FGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFG  268 (337)
Q Consensus       190 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~~~  268 (337)
                      ||++..........            .......+..|+|||++.    +..++.++||||||+++|+|++ |..||....
T Consensus       163 fg~~~~~~~~~~~~------------~~~~~~~~~~y~aPE~~~----~~~~~~~~DiwslG~il~el~~~g~~pf~~~~  226 (277)
T cd05036         163 FGMARDIYRASYYR------------KGGRAMLPIKWMPPEAFL----DGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRT  226 (277)
T ss_pred             CccccccCCcccee------------cCCCCCccHhhCCHHHHh----cCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC
Confidence            99988763221100            011112456899999997    4578999999999999999997 999996543


Q ss_pred             CchhHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          269 EKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                      ..    ..............+..++..+.+++.+||+.+|++|||+.++++|
T Consensus       227 ~~----~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~  274 (277)
T cd05036         227 NQ----EVMEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER  274 (277)
T ss_pred             HH----HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            32    2222333334455667789999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=2.4e-41  Score=290.37  Aligned_cols=246  Identities=27%  Similarity=0.395  Sum_probs=201.3

Q ss_pred             cccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEeccCCCC
Q 019650           53 TVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGS  132 (337)
Q Consensus        53 ~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~  132 (337)
                      +.||.|++|.||+|.+..++..+|+|.+...........+.+|+.++++++|+||+++++.+.. ....++||||+++++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~   79 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ-KQPIYIVMELVQGGD   79 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCeEEEEeeccCCc
Confidence            4799999999999999989999999998765555566778899999999999999999998766 678999999999999


Q ss_pred             chHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCCCCCCCCC
Q 019650          133 LFDSLRVR-KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNN  211 (337)
Q Consensus       133 L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~  211 (337)
                      |.+++... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.........         
T Consensus        80 L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~---------  150 (252)
T cd05084          80 FLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYA---------  150 (252)
T ss_pred             HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCccccccccc---------
Confidence            99999754 46899999999999999999999999999999999999999999999999998754321100         


Q ss_pred             ccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHhhccCCCCCCC
Q 019650          212 NIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICAICFGERLEMPE  290 (337)
Q Consensus       212 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (337)
                         ........+..|+|||.+.    +..++.++|+||||+++|++++ |..||.......    .............+.
T Consensus       151 ---~~~~~~~~~~~y~aPE~~~----~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~----~~~~~~~~~~~~~~~  219 (252)
T cd05084         151 ---STGGMKQIPVKWTAPEALN----YGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ----TREAIEQGVRLPCPE  219 (252)
T ss_pred             ---ccCCCCCCceeecCchhhc----CCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH----HHHHHHcCCCCCCcc
Confidence               0000112346799999997    4568889999999999999998 888886543221    222222333445566


Q ss_pred             CCCHHHHHHHHHHhhcCcCCCCCHHHHhc
Q 019650          291 TASPEFRRFVRSCLEKDWRKRGTVEELLA  319 (337)
Q Consensus       291 ~~~~~~~~li~~~l~~~p~~R~s~~eil~  319 (337)
                      ..+..+.+++.+||..+|++|||+.++++
T Consensus       220 ~~~~~~~~li~~~l~~~p~~Rps~~~~~~  248 (252)
T cd05084         220 LCPDAVYRLMERCWEYDPGQRPSFSTVHQ  248 (252)
T ss_pred             cCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            77899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=1e-41  Score=296.99  Aligned_cols=267  Identities=27%  Similarity=0.454  Sum_probs=216.4

Q ss_pred             cccccccccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHHhcC-CCCceeeeeeEEeeCCeEEE
Q 019650           47 SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLD-SQFIVKCHAVFYTIEGEICF  123 (337)
Q Consensus        47 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~~l  123 (337)
                      ++|.+.+.||.|++|.||++.+..++..+++|++....  .....+.+.+|..+++++. |+||+++++.+.. ....++
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~-~~~~~l   79 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQD-EENLYF   79 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcC-CceEEE
Confidence            47999999999999999999999999999999986532  2233466778999999998 9999999998766 678999


Q ss_pred             EEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCC
Q 019650          124 VMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNN  203 (337)
Q Consensus       124 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~  203 (337)
                      +||++.+++|.+++...+.+++..++.++.|++.||.+||+.|++|+||+|+||+++.+++++++|||.+..........
T Consensus        80 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~  159 (280)
T cd05581          80 VLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPE  159 (280)
T ss_pred             EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCccccc
Confidence            99999999999999988889999999999999999999999999999999999999999999999999987665432211


Q ss_pred             CCCC------CCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHH
Q 019650          204 NHNN------NNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALI  277 (337)
Q Consensus       204 ~~~~------~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~  277 (337)
                      ....      ..............++..|+|||.+.    +..++.++|+||||++++++++|..||.............
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~----~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~  235 (280)
T cd05581         160 SNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLN----EKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKIL  235 (280)
T ss_pred             cCCCCCccccccccccccccccccCCccccCHHHhC----CCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH
Confidence            0000      00000002223445788999999987    4468889999999999999999999997654322222211


Q ss_pred             HHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCH----HHHhcCccc
Q 019650          278 CAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTV----EELLAYPFV  323 (337)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~----~eil~hp~f  323 (337)
                           .....++..+++.+.+++.+||+.+|++|||+    +++++||||
T Consensus       236 -----~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~  280 (280)
T cd05581         236 -----KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF  280 (280)
T ss_pred             -----hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence                 23445666779999999999999999999999    999999998

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=5.2e-42  Score=306.54  Aligned_cols=270  Identities=27%  Similarity=0.402  Sum_probs=213.5

Q ss_pred             cccccccccccCcceEEEEEEEccCCceEEEEEeecCCc-hHhHHHHHHHHHHHHhcCCCCceeeeeeEEee---CCeEE
Q 019650           47 SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSS-TIIRHQAAHEAEILKRLDSQFIVKCHAVFYTI---EGEIC  122 (337)
Q Consensus        47 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~---~~~~~  122 (337)
                      ++|++.+.||.|++|.||+|.+..++..|++|.+..... ......+.+|+.++++++|+||+++++++...   ...++
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY   84 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence            789999999999999999999999999999999876432 23455677899999999999999999876532   35689


Q ss_pred             EEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccC
Q 019650          123 FVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNN  202 (337)
Q Consensus       123 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~  202 (337)
                      +||||+. ++|.+++.....+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.........
T Consensus        85 lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~  163 (334)
T cd07855          85 VVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTE  163 (334)
T ss_pred             EEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCcC
Confidence            9999996 599999987788999999999999999999999999999999999999999999999999998765433211


Q ss_pred             CCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHH---
Q 019650          203 NNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICA---  279 (337)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~---  279 (337)
                      ..          .......++..|+|||.+...   ..++.++|+||||+++|+|++|+.||...............   
T Consensus       164 ~~----------~~~~~~~~~~~y~~PE~~~~~---~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~  230 (334)
T cd07855         164 HK----------YFMTEYVATRWYRAPELLLSL---PEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGS  230 (334)
T ss_pred             CC----------cccccccccccccChHHhcCC---cccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCC
Confidence            10          111223578899999998642   35788999999999999999999999654322111111100   


Q ss_pred             -----------------h-hccCCCC-----CCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCCc
Q 019650          280 -----------------I-CFGERLE-----MPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSS  330 (337)
Q Consensus       280 -----------------~-~~~~~~~-----~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~~  330 (337)
                                       . .......     ..+..+..+.++|.+||+.+|++|||+++++.||||.+.....
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~  304 (334)
T cd07855         231 PSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPD  304 (334)
T ss_pred             ChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCc
Confidence                             0 0000111     1234688999999999999999999999999999998877554

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.5e-41  Score=290.68  Aligned_cols=258  Identities=28%  Similarity=0.428  Sum_probs=212.2

Q ss_pred             cccccccccccCcceEEEEEEEccCCceEEEEEeecCC----chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeC-CeE
Q 019650           47 SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS----STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIE-GEI  121 (337)
Q Consensus        47 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~-~~~  121 (337)
                      .+|.+.+.||.|++|.||+|.+..++..+++|.+....    .......+.+|+.++++++|+|++++++.+.+.. ..+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            47899999999999999999999999999999875421    2334567788999999999999999999876532 468


Q ss_pred             EEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhcccc
Q 019650          122 CFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRN  201 (337)
Q Consensus       122 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~  201 (337)
                      ++++||+++++|.+++.....+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  161 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM  161 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccc
Confidence            89999999999999998777899999999999999999999999999999999999999999999999999876532111


Q ss_pred             CCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhh
Q 019650          202 NNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAIC  281 (337)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~  281 (337)
                      ..           .......++..|+|||.+.    +..++.++|+||||+++|+|++|+.||......   ........
T Consensus       162 ~~-----------~~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~  223 (264)
T cd06653         162 SG-----------TGIKSVTGTPYWMSPEVIS----GEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM---AAIFKIAT  223 (264)
T ss_pred             cC-----------ccccccCCcccccCHhhhc----CCCCCccccHHHHHHHHHHHHhCCCCCCccCHH---HHHHHHHc
Confidence            00           1111235788999999998    446788999999999999999999999654322   22222233


Q ss_pred             ccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccc
Q 019650          282 FGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV  323 (337)
Q Consensus       282 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f  323 (337)
                      ......++...++.+.+++.+||. +|..||++.+++.|||+
T Consensus       224 ~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~  264 (264)
T cd06653         224 QPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV  264 (264)
T ss_pred             CCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence            334456678889999999999998 57999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1.7e-41  Score=297.92  Aligned_cols=262  Identities=24%  Similarity=0.362  Sum_probs=206.5

Q ss_pred             ccccccccccccCcceEEEEEEEccCCceEEEEEeecCCc-hHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 019650           46 ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSS-TIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFV  124 (337)
Q Consensus        46 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv  124 (337)
                      +++|++.+.||.|++|+||+|.+..+++.|++|.+..... ....+.+.+|+.++++++|+|++++++.+.. ....++|
T Consensus         1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv   79 (294)
T PLN00009          1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS-EKRLYLV   79 (294)
T ss_pred             CCceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEec-CCeEEEE
Confidence            3689999999999999999999998999999999865432 2234567789999999999999999998876 6889999


Q ss_pred             EeccCCCCchHHhhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcC-CCcEEEeeccCccchhcccc
Q 019650          125 MEHMERGSLFDSLRVRK--KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLING-KGEVKIADFGVSRIVEETRN  201 (337)
Q Consensus       125 ~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~-~~~~~l~Dfg~~~~~~~~~~  201 (337)
                      |||+++ +|.+++....  .+++..+..++.||+.||.|||++|++|+||+|+||+++. ++.++|+|||.+........
T Consensus        80 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~  158 (294)
T PLN00009         80 FEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR  158 (294)
T ss_pred             Eecccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcc
Confidence            999964 8888876543  3578899999999999999999999999999999999985 45799999999876543211


Q ss_pred             CCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhh
Q 019650          202 NNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAIC  281 (337)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~  281 (337)
                      .              .....+++.|+|||.+..   +..++.++|+||||+++|+|++|..||.................
T Consensus       159 ~--------------~~~~~~~~~y~~PE~~~~---~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~  221 (294)
T PLN00009        159 T--------------FTHEVVTLWYRAPEILLG---SRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILG  221 (294)
T ss_pred             c--------------cccCceeecccCHHHHhC---CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence            0              011246789999999863   23578899999999999999999999976544333332221111


Q ss_pred             ccC----------------CC--------CCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCcccccc
Q 019650          282 FGE----------------RL--------EMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKR  326 (337)
Q Consensus       282 ~~~----------------~~--------~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~  326 (337)
                      ...                ..        ...+..+..+.+++.+||+.+|++||++++++.||||++.
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~  290 (294)
T PLN00009        222 TPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL  290 (294)
T ss_pred             CCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHH
Confidence            000                00        0123567889999999999999999999999999999875

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=3e-41  Score=295.93  Aligned_cols=266  Identities=29%  Similarity=0.455  Sum_probs=214.9

Q ss_pred             cccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEe
Q 019650           47 SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVME  126 (337)
Q Consensus        47 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~e  126 (337)
                      ..|.....||.|++|.||++....++..+|+|.+.... ......+.+|+.+++.++|+|++++++.+.. ....+++||
T Consensus        20 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e   97 (292)
T cd06657          20 TYLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK-QQRRELLFNEVVIMRDYQHENVVEMYNSYLV-GDELWVVME   97 (292)
T ss_pred             HHhhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc-hhHHHHHHHHHHHHHhcCCcchhheeeEEEe-CCEEEEEEe
Confidence            44555678999999999999999999999999986543 3345668889999999999999999998876 688999999


Q ss_pred             ccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCCCC
Q 019650          127 HMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHN  206 (337)
Q Consensus       127 ~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~  206 (337)
                      |+++++|.+++. ...+++..+..++.|++.+|+|||+.|++|+||+|+||+++.++.++|+|||.+.......      
T Consensus        98 ~~~~~~L~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~------  170 (292)
T cd06657          98 FLEGGALTDIVT-HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV------  170 (292)
T ss_pred             cCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccc------
Confidence            999999998875 3468999999999999999999999999999999999999999999999999876553321      


Q ss_pred             CCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhccCCC
Q 019650          207 NNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERL  286 (337)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~  286 (337)
                              .......++..|+|||.+.    +..++.++|+||+|+++|+|++|..||.......... .... ......
T Consensus       171 --------~~~~~~~~~~~y~~pE~~~----~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~-~~~~-~~~~~~  236 (292)
T cd06657         171 --------PRRKSLVGTPYWMAPELIS----RLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMK-MIRD-NLPPKL  236 (292)
T ss_pred             --------ccccccccCccccCHHHhc----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHh-hCCccc
Confidence                    1112234788999999987    3467889999999999999999999996543222211 1111 111122


Q ss_pred             CCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCCccccCc
Q 019650          287 EMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNIEGL  335 (337)
Q Consensus       287 ~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~~~~~~~  335 (337)
                      .....++..+.+++.+||..+|.+||++++++.||||.....+++..-+
T Consensus       237 ~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~~~~~~~~~  285 (292)
T cd06657         237 KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPSCIVPL  285 (292)
T ss_pred             CCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccCCCcccccH
Confidence            2234568899999999999999999999999999999999877765443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.4e-41  Score=301.45  Aligned_cols=254  Identities=24%  Similarity=0.395  Sum_probs=207.0

Q ss_pred             CccccccccccccCcceEEEEEEEccCCc----eEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCe
Q 019650           45 NISDLKKLTVLGHGNGGIVYKVRHQKSNS----IYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGE  120 (337)
Q Consensus        45 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~  120 (337)
                      ...+|++.+.||+|+||+||+|.+..++.    .||+|.++..........+.+|+.+++.++|+||+++++.+..  ..
T Consensus         5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~--~~   82 (316)
T cd05108           5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT--ST   82 (316)
T ss_pred             chhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC--CC
Confidence            45789999999999999999998765554    4899998765555566778899999999999999999998765  45


Q ss_pred             EEEEEeccCCCCchHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhcc
Q 019650          121 ICFVMEHMERGSLFDSLRVR-KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEET  199 (337)
Q Consensus       121 ~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~  199 (337)
                      .+++++|+++|+|.+++... ..+++..+..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++......
T Consensus        83 ~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~  162 (316)
T cd05108          83 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD  162 (316)
T ss_pred             ceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccCC
Confidence            78999999999999999864 46889999999999999999999999999999999999999999999999999876432


Q ss_pred             ccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHH
Q 019650          200 RNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALIC  278 (337)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~  278 (337)
                      ....            ......++..|+|||.+.    +..++.++||||||+++|+|++ |..||.+... .....   
T Consensus       163 ~~~~------------~~~~~~~~~~y~apE~~~----~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~-~~~~~---  222 (316)
T cd05108         163 EKEY------------HAEGGKVPIKWMALESIL----HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEISS---  222 (316)
T ss_pred             Ccce------------eccCCccceeecChHHhc----cCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH-HHHHH---
Confidence            2111            001112467899999997    4578899999999999999998 9999865322 22222   


Q ss_pred             HhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          279 AICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                      ..........+..++..+.+++.+||..+|.+|||+.+++.+
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~  264 (316)
T cd05108         223 ILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  264 (316)
T ss_pred             HHhCCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            222333444556678899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1e-41  Score=305.00  Aligned_cols=266  Identities=27%  Similarity=0.406  Sum_probs=210.1

Q ss_pred             ccccccccccccCcceEEEEEEEccCCceEEEEEeecCC-chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeC----Ce
Q 019650           46 ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIE----GE  120 (337)
Q Consensus        46 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~----~~  120 (337)
                      .++|.+.+.||.|++|+||++.+..++..||+|.+.... .......+.+|+.+++.++|+|++++++.+....    ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            468999999999999999999999999999999986532 2223456678999999999999999999775432    35


Q ss_pred             EEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccc
Q 019650          121 ICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETR  200 (337)
Q Consensus       121 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~  200 (337)
                      .|+++||+. ++|.+++...+.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~  162 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG  162 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCCc
Confidence            899999996 5999999888889999999999999999999999999999999999999999999999999987654321


Q ss_pred             cCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHH--
Q 019650          201 NNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALIC--  278 (337)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~--  278 (337)
                      .              ......++..|+|||.+...   ..++.++|+||||+++|+|++|..||.+............  
T Consensus       163 ~--------------~~~~~~~~~~y~aPE~~~~~---~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  225 (337)
T cd07858         163 D--------------FMTEYVVTRWYRAPELLLNC---SEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELL  225 (337)
T ss_pred             c--------------cccccccccCccChHHHhcC---CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHh
Confidence            1              11122468899999988642   3578899999999999999999999965422111111100  


Q ss_pred             ---------------------HhhccCC---CCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCC
Q 019650          279 ---------------------AICFGER---LEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSS  329 (337)
Q Consensus       279 ---------------------~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~  329 (337)
                                           .......   ....+.++..+.++|.+||+.+|++|||++++++||||....-.
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~  300 (337)
T cd07858         226 GSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDP  300 (337)
T ss_pred             CCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCc
Confidence                                 0000000   01124568889999999999999999999999999999875433

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=3.6e-41  Score=291.64  Aligned_cols=254  Identities=27%  Similarity=0.400  Sum_probs=208.3

Q ss_pred             ccccccccccccCcceEEEEEEEccC---CceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEE
Q 019650           46 ISDLKKLTVLGHGNGGIVYKVRHQKS---NSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEIC  122 (337)
Q Consensus        46 ~~~y~~~~~lg~g~~~~v~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~  122 (337)
                      .++|++.+.||.|+||+||+|.+..+   ...|++|.+...........+.+|+.++++++|+||+++++.+.. ....+
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   81 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTK-SRPVM   81 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEec-CCceE
Confidence            56899999999999999999998643   457999998766555556678889999999999999999998765 67899


Q ss_pred             EEEeccCCCCchHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhcccc
Q 019650          123 FVMEHMERGSLFDSLRVR-KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRN  201 (337)
Q Consensus       123 lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~  201 (337)
                      ++|||+++++|.+++... +.+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus        82 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~  161 (266)
T cd05033          82 IITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEA  161 (266)
T ss_pred             EEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccccccc
Confidence            999999999999999754 4689999999999999999999999999999999999999999999999999987742111


Q ss_pred             CCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHh
Q 019650          202 NNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICAI  280 (337)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~  280 (337)
                      ..            ......++..|+|||.+.    +..++.++|+||||+++|+|++ |..||.......    .....
T Consensus       162 ~~------------~~~~~~~~~~y~~Pe~~~----~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~----~~~~~  221 (266)
T cd05033         162 TY------------TTKGGKIPIRWTAPEAIA----YRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD----VIKAV  221 (266)
T ss_pred             ce------------eccCCCCCccccChhhhc----cCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH----HHHHH
Confidence            00            011112467899999998    4578889999999999999998 999986543222    22223


Q ss_pred             hccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          281 CFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                      ........+...+..+.+++.+||+.+|++||++++++++
T Consensus       222 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~  261 (266)
T cd05033         222 EDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVST  261 (266)
T ss_pred             HcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            3333444556778999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=1.9e-41  Score=308.17  Aligned_cols=258  Identities=24%  Similarity=0.310  Sum_probs=208.2

Q ss_pred             CccCccccccccccccCcceEEEEEEEcc-----CCceEEEEEeecCCchHhHHHHHHHHHHHHhcC-CCCceeeeeeEE
Q 019650           42 DVENISDLKKLTVLGHGNGGIVYKVRHQK-----SNSIYALKVLNTTSSTIIRHQAAHEAEILKRLD-SQFIVKCHAVFY  115 (337)
Q Consensus        42 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~  115 (337)
                      +....++|.+++.||.|+||.||+|.+..     ++..||+|++.........+.+.+|+.+++++. ||||+++++.+.
T Consensus        32 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~  111 (400)
T cd05105          32 WEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACT  111 (400)
T ss_pred             eeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc
Confidence            34557899999999999999999998743     234699999976655555677889999999996 999999999886


Q ss_pred             eeCCeEEEEEeccCCCCchHHhhhc-------------------------------------------------------
Q 019650          116 TIEGEICFVMEHMERGSLFDSLRVR-------------------------------------------------------  140 (337)
Q Consensus       116 ~~~~~~~lv~e~~~~~~L~~~l~~~-------------------------------------------------------  140 (337)
                      + ....|+||||+++|+|.+++...                                                       
T Consensus       112 ~-~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (400)
T cd05105         112 K-SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP  190 (400)
T ss_pred             c-CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence            6 68899999999999999988542                                                       


Q ss_pred             -----------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEE
Q 019650          141 -----------------------------------------KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLI  179 (337)
Q Consensus       141 -----------------------------------------~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili  179 (337)
                                                               ..+++..+..++.|++.||.|||+.|++|+||||+||++
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill  270 (400)
T cd05105         191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLL  270 (400)
T ss_pred             hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEE
Confidence                                                     136778889999999999999999999999999999999


Q ss_pred             cCCCcEEEeeccCccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh
Q 019650          180 NGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV  259 (337)
Q Consensus       180 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t  259 (337)
                      +.++.++|+|||++.........            .......++..|+|||.+.    +..++.++||||||+++|+|++
T Consensus       271 ~~~~~~kL~DfGla~~~~~~~~~------------~~~~~~~~~~~y~aPE~~~----~~~~~~~~DiwSlGvil~ellt  334 (400)
T cd05105         271 AQGKIVKICDFGLARDIMHDSNY------------VSKGSTFLPVKWMAPESIF----DNLYTTLSDVWSYGILLWEIFS  334 (400)
T ss_pred             eCCCEEEEEeCCcceeccccccc------------cccCCcCCCcceEChhhhc----CCCCCchhhHHHHHHHHHHHHH
Confidence            99999999999998765332111            1111224678899999997    4578899999999999999997


Q ss_pred             -CCCCCCCCCCchhHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhc
Q 019650          260 -GHYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA  319 (337)
Q Consensus       260 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~  319 (337)
                       |..||...........   ....+.....+..++..+.+++.+||+.+|++|||+.++.+
T Consensus       335 ~g~~P~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  392 (400)
T cd05105         335 LGGTPYPGMIVDSTFYN---KIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD  392 (400)
T ss_pred             CCCCCCcccchhHHHHH---HHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence             9999876433332222   22233344556678899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=2.2e-41  Score=300.39  Aligned_cols=254  Identities=25%  Similarity=0.404  Sum_probs=191.3

Q ss_pred             ccccccCcceEEEEEEEc--cCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEee-CCeEEEEEecc
Q 019650           52 LTVLGHGNGGIVYKVRHQ--KSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTI-EGEICFVMEHM  128 (337)
Q Consensus        52 ~~~lg~g~~~~v~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-~~~~~lv~e~~  128 (337)
                      ...||.|+||+||+|.+.  .++..||+|.+....   ....+.+|+.++++++|+|++++++.+... +...+++|||+
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~   82 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG---ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYA   82 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC---CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeee
Confidence            357999999999999965  366889999886543   223567899999999999999999987643 45789999999


Q ss_pred             CCCCchHHhhhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEE----cCCCcEEEeeccCccc
Q 019650          129 ERGSLFDSLRVR---------KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLI----NGKGEVKIADFGVSRI  195 (337)
Q Consensus       129 ~~~~L~~~l~~~---------~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili----~~~~~~~l~Dfg~~~~  195 (337)
                      .+ +|.+++...         ..+++..++.++.||+.||.|||+.|++|+||||+||++    +.++.++|+|||++..
T Consensus        83 ~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~  161 (317)
T cd07867          83 EH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL  161 (317)
T ss_pred             CC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceec
Confidence            65 888877522         247899999999999999999999999999999999999    4567899999999976


Q ss_pred             hhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCch----
Q 019650          196 VEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP----  271 (337)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~----  271 (337)
                      ........           .......+++.|+|||.+...   ..++.++||||||+++|+|+||+.||....+..    
T Consensus       162 ~~~~~~~~-----------~~~~~~~~t~~y~aPE~~~~~---~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~  227 (317)
T cd07867         162 FNSPLKPL-----------ADLDPVVVTFWYRAPELLLGA---RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSN  227 (317)
T ss_pred             cCCCcccc-----------cccCcceecccccCcHHhcCC---CccCcHHHHHhHHHHHHHHHhCCCCcccccccccccc
Confidence            64322110           111234578999999998732   357889999999999999999999996533211    


Q ss_pred             -----hHHHHHHHhh------------------------ccC---------CCCCCCCCCHHHHHHHHHHhhcCcCCCCC
Q 019650          272 -----DLMALICAIC------------------------FGE---------RLEMPETASPEFRRFVRSCLEKDWRKRGT  313 (337)
Q Consensus       272 -----~~~~~~~~~~------------------------~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~R~s  313 (337)
                           ..........                        ...         ........+..+.+++.+||..||.+|||
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t  307 (317)
T cd07867         228 PFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRIT  307 (317)
T ss_pred             cccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccC
Confidence                 0000000000                        000         00001123567889999999999999999


Q ss_pred             HHHHhcCccc
Q 019650          314 VEELLAYPFV  323 (337)
Q Consensus       314 ~~eil~hp~f  323 (337)
                      ++|+|+||||
T Consensus       308 ~~e~l~hp~f  317 (317)
T cd07867         308 SEQALQDPYF  317 (317)
T ss_pred             HHHHhcCCCC
Confidence            9999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=2.5e-41  Score=295.30  Aligned_cols=255  Identities=24%  Similarity=0.395  Sum_probs=208.0

Q ss_pred             CccccccccccccCcceEEEEEEEc----cCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCe
Q 019650           45 NISDLKKLTVLGHGNGGIVYKVRHQ----KSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGE  120 (337)
Q Consensus        45 ~~~~y~~~~~lg~g~~~~v~~~~~~----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~  120 (337)
                      ..++|++.+.||+|+||+||+|...    .++..+++|.+...........+.+|+.++++++|+|++++++.+.. ...
T Consensus         3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~   81 (283)
T cd05090           3 PLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQ-EQP   81 (283)
T ss_pred             ChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEec-CCc
Confidence            4578999999999999999999853    45678999999765555555678889999999999999999998766 678


Q ss_pred             EEEEEeccCCCCchHHhhhc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCC
Q 019650          121 ICFVMEHMERGSLFDSLRVR-----------------KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKG  183 (337)
Q Consensus       121 ~~lv~e~~~~~~L~~~l~~~-----------------~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~  183 (337)
                      .|++|||+++++|.+++...                 ..+++..+..++.|++.||+|||++|++|+||+|+||+++.++
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~  161 (283)
T cd05090          82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQL  161 (283)
T ss_pred             eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCC
Confidence            99999999999999998532                 2478889999999999999999999999999999999999999


Q ss_pred             cEEEeeccCccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCC
Q 019650          184 EVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHY  262 (337)
Q Consensus       184 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~  262 (337)
                      .++|+|||++.........            .......++..|+|||.+.    +..++.++|+||||+++|+|++ |..
T Consensus       162 ~~kl~dfg~~~~~~~~~~~------------~~~~~~~~~~~y~aPE~~~----~~~~~~~~Dv~slG~il~el~~~g~~  225 (283)
T cd05090         162 HVKISDLGLSREIYSADYY------------RVQPKSLLPIRWMPPEAIM----YGKFSSDSDIWSFGVVLWEIFSFGLQ  225 (283)
T ss_pred             cEEeccccccccccCCcce------------ecccCCCccceecChHHhc----cCCCCchhhhHHHHHHHHHHHcCCCC
Confidence            9999999998765432110            1112223567899999997    4568899999999999999998 999


Q ss_pred             CCCCCCCchhHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          263 PLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       263 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                      ||.+...    ...............+..++..+.+++.+||+.||.+||++.+++++
T Consensus       226 p~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~  279 (283)
T cd05090         226 PYYGFSN----QEVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR  279 (283)
T ss_pred             CCCCCCH----HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            9865432    22233333344445567789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=2.8e-41  Score=302.00  Aligned_cols=278  Identities=24%  Similarity=0.307  Sum_probs=211.6

Q ss_pred             cccccc-ccccccCcceEEEEEEEccCCceEEEEEeecCCchH-------------hHHHHHHHHHHHHhcCCCCceeee
Q 019650           46 ISDLKK-LTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTI-------------IRHQAAHEAEILKRLDSQFIVKCH  111 (337)
Q Consensus        46 ~~~y~~-~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-------------~~~~~~~e~~~~~~l~~~~i~~~~  111 (337)
                      .++|.. .+.||.|++|+||+|.+..+++.||+|.+.......             ....+.+|+.++++++|+|+++++
T Consensus         7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~   86 (335)
T PTZ00024          7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV   86 (335)
T ss_pred             ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence            456764 577999999999999999999999999986543221             012466899999999999999999


Q ss_pred             eeEEeeCCeEEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeecc
Q 019650          112 AVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFG  191 (337)
Q Consensus       112 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg  191 (337)
                      +++.. +...+++|||+. ++|.+++.....+++..+..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||
T Consensus        87 ~~~~~-~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg  164 (335)
T PTZ00024         87 DVYVE-GDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFG  164 (335)
T ss_pred             EEEec-CCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCcc
Confidence            98766 688999999997 4999999887889999999999999999999999999999999999999999999999999


Q ss_pred             CccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCch
Q 019650          192 VSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP  271 (337)
Q Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~  271 (337)
                      .+............................++..|+|||.+...   ..++.++|+||||+++|+|++|..||....+..
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~  241 (335)
T PTZ00024        165 LARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGA---EKYHFAVDMWSVGCIFAELLTGKPLFPGENEID  241 (335)
T ss_pred             ceeecccccccccccccccccccccccccccccCCCCChhcccC---CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            98766522111000000000000111223467889999998732   346889999999999999999999997655433


Q ss_pred             hHHHHHHHhhccCCC-----------------------CCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCC
Q 019650          272 DLMALICAICFGERL-----------------------EMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSS  328 (337)
Q Consensus       272 ~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~  328 (337)
                      ...............                       ......+..+.++|.+||+.+|++|||++++|.||||++...
T Consensus       242 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~~  321 (335)
T PTZ00024        242 QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDPL  321 (335)
T ss_pred             HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCCC
Confidence            333332221111100                       011234778999999999999999999999999999987653

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8.3e-42  Score=304.81  Aligned_cols=267  Identities=27%  Similarity=0.400  Sum_probs=214.6

Q ss_pred             ccccccccccCcceEEEEEEEccCCceEEEEEeecCCc-hHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeC----CeEE
Q 019650           48 DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSS-TIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIE----GEIC  122 (337)
Q Consensus        48 ~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~----~~~~  122 (337)
                      +|.+.+.||.|++|.||+|.+..++..+++|.+..... ....+.+.+|+.+++.++|+|++++.+++....    ...|
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            58899999999999999999998899999999876432 344567888999999999999999999877643    3789


Q ss_pred             EEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccC
Q 019650          123 FVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNN  202 (337)
Q Consensus       123 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~  202 (337)
                      ++|+|+.+ +|.+++.....+++..++.++.||+.||++||+.|++|+||+|.||+++.++.++|+|||.+.........
T Consensus        81 lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~  159 (330)
T cd07834          81 IVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDE  159 (330)
T ss_pred             EEecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeecccccc
Confidence            99999974 89999987778999999999999999999999999999999999999999999999999999876543211


Q ss_pred             CCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhc
Q 019650          203 NNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICF  282 (337)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~  282 (337)
                      .           .......++..|+|||.+...   ..++.++|+||||+++|+|++|..||..................
T Consensus       160 ~-----------~~~~~~~~~~~y~aPE~~~~~---~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~  225 (330)
T cd07834         160 K-----------GFLTEYVVTRWYRAPELLLSS---SRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGT  225 (330)
T ss_pred             c-----------ccccccccccCcCCceeeecc---cCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCC
Confidence            0           111223478899999999842   26788999999999999999999999765433222222211100


Q ss_pred             cC-----------------------C---CCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCC
Q 019650          283 GE-----------------------R---LEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSS  329 (337)
Q Consensus       283 ~~-----------------------~---~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~  329 (337)
                      ..                       .   ....+..+..+.++|.+||+.+|++|||+++++.||||++....
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~  298 (330)
T cd07834         226 PSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDP  298 (330)
T ss_pred             CChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccc
Confidence            00                       0   00123467889999999999999999999999999999876654

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=6.1e-41  Score=290.13  Aligned_cols=252  Identities=29%  Similarity=0.471  Sum_probs=207.5

Q ss_pred             cccccccccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 019650           47 SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFV  124 (337)
Q Consensus        47 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv  124 (337)
                      ++|++.+.||.|++|.||+|.+..+++.+++|.++...  .....+.+.+|+.++++++|++++++++.+.. .+..+++
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~-~~~~~lv   80 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIE-NNELNIV   80 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeec-CCeEEEE
Confidence            68999999999999999999999899999999886432  23345678899999999999999999998876 6889999


Q ss_pred             EeccCCCCchHHhhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccc
Q 019650          125 MEHMERGSLFDSLRV----RKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETR  200 (337)
Q Consensus       125 ~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~  200 (337)
                      |||+++++|.+++..    ...+++..+..++.+++.+|+|||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~  160 (267)
T cd08224          81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT  160 (267)
T ss_pred             EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCC
Confidence            999999999998864    2458999999999999999999999999999999999999999999999999887553321


Q ss_pred             cCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHh
Q 019650          201 NNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAI  280 (337)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~  280 (337)
                      .              ......++..|+|||.+.    +..++.++|+||||+++|+|++|..||....  ..........
T Consensus       161 ~--------------~~~~~~~~~~y~apE~~~----~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~  220 (267)
T cd08224         161 T--------------AAHSLVGTPYYMSPERIH----ENGYNFKSDIWSLGCLLYEMAALQSPFYGDK--MNLYSLCKKI  220 (267)
T ss_pred             c--------------ccceecCCccccCHHHhc----cCCCCchhcHHHHHHHHHHHHHCCCCcccCC--ccHHHHHhhh
Confidence            1              111224788899999987    4578889999999999999999999995432  2222333333


Q ss_pred             hccCCCCCCC-CCCHHHHHHHHHHhhcCcCCCCCHHHHhc
Q 019650          281 CFGERLEMPE-TASPEFRRFVRSCLEKDWRKRGTVEELLA  319 (337)
Q Consensus       281 ~~~~~~~~~~-~~~~~~~~li~~~l~~~p~~R~s~~eil~  319 (337)
                      ..+.....+. ..+..+.++|.+||..+|++|||+.+|++
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         221 EKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             hcCCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            3333334443 67889999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=3.1e-41  Score=294.67  Aligned_cols=255  Identities=24%  Similarity=0.359  Sum_probs=208.1

Q ss_pred             CccccccccccccCcceEEEEEEEcc-----CCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCC
Q 019650           45 NISDLKKLTVLGHGNGGIVYKVRHQK-----SNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEG  119 (337)
Q Consensus        45 ~~~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~  119 (337)
                      ...+|.+.+.||.|+||.||+|.+..     .+..||+|+++........+.+.+|..++..++|+||+++++.+.+ ..
T Consensus         3 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~-~~   81 (283)
T cd05091           3 NLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTK-EQ   81 (283)
T ss_pred             CHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-CC
Confidence            45789999999999999999998754     3578999999866555455678889999999999999999998766 57


Q ss_pred             eEEEEEeccCCCCchHHhhhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCC
Q 019650          120 EICFVMEHMERGSLFDSLRVR----------------KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKG  183 (337)
Q Consensus       120 ~~~lv~e~~~~~~L~~~l~~~----------------~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~  183 (337)
                      ..++++||+.+++|.+++...                ..+++..+..++.|++.||.|||++|++||||||+||+++.++
T Consensus        82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~  161 (283)
T cd05091          82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKL  161 (283)
T ss_pred             ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCC
Confidence            789999999999999998532                2478889999999999999999999999999999999999999


Q ss_pred             cEEEeeccCccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCC
Q 019650          184 EVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHY  262 (337)
Q Consensus       184 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~  262 (337)
                      .++|+|||++.........            .......+++.|+|||.+.    +..++.++|+||||+++|||++ |..
T Consensus       162 ~~kl~Dfg~~~~~~~~~~~------------~~~~~~~~~~~y~aPE~~~----~~~~~~~~Dv~slG~~l~el~~~g~~  225 (283)
T cd05091         162 NVKISDLGLFREVYAADYY------------KLMGNSLLPIRWMSPEAIM----YGKFSIDSDIWSYGVVLWEVFSYGLQ  225 (283)
T ss_pred             ceEecccccccccccchhe------------eeccCccCCccccCHHHHh----cCCCCcchhHHHHHHHHHHHHcCCCC
Confidence            9999999988765432211            1111223567899999997    4568889999999999999998 888


Q ss_pred             CCCCCCCchhHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          263 PLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       263 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                      ||.+....    ..............+...+..+.+++.+||+.+|.+||++++|+..
T Consensus       226 p~~~~~~~----~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~  279 (283)
T cd05091         226 PYCGYSNQ----DVIEMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR  279 (283)
T ss_pred             CCCCCCHH----HHHHHHHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence            88654332    2333344444455677889999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.7e-41  Score=293.16  Aligned_cols=256  Identities=25%  Similarity=0.397  Sum_probs=209.3

Q ss_pred             cCccccccccccccCcceEEEEEEEccC-----CceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeC
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKS-----NSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIE  118 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~  118 (337)
                      ...++|.+.+.||.|++|.||+|.+...     +..+++|.+...........+.+|+.+++.++|+|++++++.+.. .
T Consensus         3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~   81 (277)
T cd05032           3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVST-G   81 (277)
T ss_pred             cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC-C
Confidence            4568999999999999999999998643     378999998765544455677889999999999999999998766 6


Q ss_pred             CeEEEEEeccCCCCchHHhhhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEe
Q 019650          119 GEICFVMEHMERGSLFDSLRVR----------KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIA  188 (337)
Q Consensus       119 ~~~~lv~e~~~~~~L~~~l~~~----------~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~  188 (337)
                      ...+++|||+++++|.+++...          ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+
T Consensus        82 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~  161 (277)
T cd05032          82 QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIG  161 (277)
T ss_pred             CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEEC
Confidence            7899999999999999998643          236788999999999999999999999999999999999999999999


Q ss_pred             eccCccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCC
Q 019650          189 DFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGF  267 (337)
Q Consensus       189 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~~  267 (337)
                      |||++.........            .......++..|+|||.+.    +..++.++|+||||+++|++++ |..||...
T Consensus       162 dfg~~~~~~~~~~~------------~~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~il~el~t~g~~p~~~~  225 (277)
T cd05032         162 DFGMTRDIYETDYY------------RKGGKGLLPVRWMAPESLK----DGVFTTKSDVWSFGVVLWEMATLAEQPYQGL  225 (277)
T ss_pred             CcccchhhccCccc------------ccCCCCCccccccCHHHHh----cCCCCcccchHHHHHHHHHhhccCCCCCccC
Confidence            99998765432211            0111223678899999987    4568889999999999999998 99998654


Q ss_pred             CCchhHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          268 GEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                      ....    .............+...+..+.+++.+||+.+|++|||+.++++.
T Consensus       226 ~~~~----~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~  274 (277)
T cd05032         226 SNEE----VLKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSS  274 (277)
T ss_pred             CHHH----HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            3322    222233444556677789999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=2e-41  Score=298.76  Aligned_cols=253  Identities=29%  Similarity=0.368  Sum_probs=204.1

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCce--EEEEEeecCCchHhHHHHHHHHHHHHhc-CCCCceeeeeeEEeeCCe
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSI--YALKVLNTTSSTIIRHQAAHEAEILKRL-DSQFIVKCHAVFYTIEGE  120 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~--vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~  120 (337)
                      ...++|++.+.||.|+||.||+|.+..++..  +++|.+...........+.+|+.++.++ +|+|++++++.+.+ +..
T Consensus         4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~-~~~   82 (303)
T cd05088           4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-RGY   82 (303)
T ss_pred             cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECC-CCC
Confidence            4578999999999999999999998776654  5777766544444556788899999999 89999999998766 678


Q ss_pred             EEEEEeccCCCCchHHhhhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCc
Q 019650          121 ICFVMEHMERGSLFDSLRVRK----------------KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGE  184 (337)
Q Consensus       121 ~~lv~e~~~~~~L~~~l~~~~----------------~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~  184 (337)
                      .+++|||+++++|.+++....                .+++..++.++.|++.||+|||+.|++||||||+||+++.++.
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~  162 (303)
T cd05088          83 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV  162 (303)
T ss_pred             ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCc
Confidence            999999999999999996432                5789999999999999999999999999999999999999999


Q ss_pred             EEEeeccCccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCC
Q 019650          185 VKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYP  263 (337)
Q Consensus       185 ~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~p  263 (337)
                      ++|+|||++.......               .......+..|+|||.+.    +..++.++||||||+++|+|+| |..|
T Consensus       163 ~kl~dfg~~~~~~~~~---------------~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~il~ellt~g~~p  223 (303)
T cd05088         163 AKIADFGLSRGQEVYV---------------KKTMGRLPVRWMAIESLN----YSVYTTNSDVWSYGVLLWEIVSLGGTP  223 (303)
T ss_pred             EEeCccccCcccchhh---------------hcccCCCcccccCHHHHh----ccCCcccccchhhhhHHHHHHhcCCCC
Confidence            9999999885322110               011112466899999887    4467889999999999999998 9999


Q ss_pred             CCCCCCchhHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          264 LIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       264 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                      |.......    .............+...+..+.+++.+||+.+|++||++++++.+
T Consensus       224 ~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  276 (303)
T cd05088         224 YCGMTCAE----LYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  276 (303)
T ss_pred             cccCChHH----HHHHHhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            96543322    222222333344455678899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=2e-42  Score=321.14  Aligned_cols=259  Identities=25%  Similarity=0.341  Sum_probs=208.1

Q ss_pred             ccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcC-CCCceeeeeeEEeeC------
Q 019650           46 ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLD-SQFIVKCHAVFYTIE------  118 (337)
Q Consensus        46 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~------  118 (337)
                      -.+++|.+.|.+|||+.||+|.+...+..||+|++-.. ++.....+.+|+.+|++|+ |+|||.+++......      
T Consensus        36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~-de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~  114 (738)
T KOG1989|consen   36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN-DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV  114 (738)
T ss_pred             CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC-CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence            35788899999999999999999988899999998766 6677888999999999996 999999999433211      


Q ss_pred             CeEEEEEeccCCCCchHHhhh--cCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCCeEEcCCCcEEEeeccCcc
Q 019650          119 GEICFVMEHMERGSLFDSLRV--RKKLSEDVISGVAYRVLKGLQYLHGMQ--IIHGDIKPSNLLINGKGEVKIADFGVSR  194 (337)
Q Consensus       119 ~~~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~i~~~l~~~l~~LH~~~--ivH~dl~~~Nili~~~~~~~l~Dfg~~~  194 (337)
                      ..++|+||||.||.|-|+|..  ...|++.++++|+.++|+|+++||..+  |||||||.+|||++.+|+.||||||.+.
T Consensus       115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSat  194 (738)
T KOG1989|consen  115 WEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSAT  194 (738)
T ss_pred             eEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence            357899999999999999974  345999999999999999999999997  9999999999999999999999999886


Q ss_pred             chhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHH
Q 019650          195 IVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLM  274 (337)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~  274 (337)
                      -.........     ....-+..-....|+.|.|||.+.--. +..++.++|||+|||+||.||....||...+.-..+ 
T Consensus       195 t~~~~~~~~~-----e~~~ve~eI~k~TTp~YRsPEMIDlys-g~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIl-  267 (738)
T KOG1989|consen  195 TKILSPTSAQ-----EVNYVEEEIEKYTTPQYRSPEMIDLYS-GLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAIL-  267 (738)
T ss_pred             cccCCCccHH-----HHHHHHHHHHhhCCccccChHHHhhhc-CCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEE-
Confidence            5433221000     000001111224689999999986544 678899999999999999999999999664332211 


Q ss_pred             HHHHHhhccCCCCCC--CCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          275 ALICAICFGERLEMP--ETASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       275 ~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                              .....+|  +.+++.+++||..||+.||++||++-+++.+
T Consensus       268 --------ng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~  307 (738)
T KOG1989|consen  268 --------NGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEE  307 (738)
T ss_pred             --------eccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence                    1122332  4679999999999999999999999998875

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-42  Score=327.12  Aligned_cols=255  Identities=27%  Similarity=0.385  Sum_probs=219.8

Q ss_pred             cCccccccccccccCcceEEEEEEEccCC-----ceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeC
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSN-----SIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIE  118 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~  118 (337)
                      ...+..+..+.||+|+||.||.|......     ..||+|.+....+.....+|.+|..+|++++||||++++|++.+ .
T Consensus       689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~-~  767 (1025)
T KOG1095|consen  689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD-S  767 (1025)
T ss_pred             CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC-C
Confidence            44677888999999999999999986322     34999999888888888999999999999999999999999998 7


Q ss_pred             CeEEEEEeccCCCCchHHhhhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeecc
Q 019650          119 GEICFVMEHMERGSLFDSLRVR-------KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFG  191 (337)
Q Consensus       119 ~~~~lv~e~~~~~~L~~~l~~~-------~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg  191 (337)
                      ...++++||+.||+|..+|++.       ..++..+...++.|+++++.||+++++|||||..+|+|++....+||+|||
T Consensus       768 ~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFG  847 (1025)
T KOG1095|consen  768 GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFG  847 (1025)
T ss_pred             CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccc
Confidence            7889999999999999999865       358999999999999999999999999999999999999999999999999


Q ss_pred             CccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCc
Q 019650          192 VSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEK  270 (337)
Q Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~~~~~  270 (337)
                      +++.+-.......            ......+..|||||.+.    +..++.++||||||+++||++| |..||.+..+.
T Consensus       848 lArDiy~~~yyr~------------~~~a~lPvkWm~PEsl~----d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~  911 (1025)
T KOG1095|consen  848 LARDIYDKDYYRK------------HGEAMLPVKWMPPESLK----DGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNF  911 (1025)
T ss_pred             hhHhhhhchheec------------cCccccceecCCHHHHh----hcccccccchhhhHHHHHHHHhCCCCCCCCcchH
Confidence            9995544332211            11124578999999999    6789999999999999999999 99999776554


Q ss_pred             hhHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhc
Q 019650          271 PDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA  319 (337)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~  319 (337)
                      +    ++.....+.+...|..+++.+.+++..||+.+|++||++..|++
T Consensus       912 ~----v~~~~~~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  912 E----VLLDVLEGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             H----HHHHHHhCCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence            3    33322333488889999999999999999999999999999998

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=3.9e-41  Score=301.79  Aligned_cols=260  Identities=24%  Similarity=0.340  Sum_probs=208.2

Q ss_pred             CccCccccccccccccCcceEEEEEEEc-----cCCceEEEEEeecCCchHhHHHHHHHHHHHHhc-CCCCceeeeeeEE
Q 019650           42 DVENISDLKKLTVLGHGNGGIVYKVRHQ-----KSNSIYALKVLNTTSSTIIRHQAAHEAEILKRL-DSQFIVKCHAVFY  115 (337)
Q Consensus        42 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~  115 (337)
                      |....++|++.+.||.|+||+||+|.+.     .+++.||+|+++..........+.+|+.++.++ .|+|++++++.+.
T Consensus         2 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~   81 (343)
T cd05103           2 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT   81 (343)
T ss_pred             cccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceee
Confidence            4456789999999999999999999853     467889999997655444556778899999999 6799999999887


Q ss_pred             eeCCeEEEEEeccCCCCchHHhhhc-------------------------------------------------------
Q 019650          116 TIEGEICFVMEHMERGSLFDSLRVR-------------------------------------------------------  140 (337)
Q Consensus       116 ~~~~~~~lv~e~~~~~~L~~~l~~~-------------------------------------------------------  140 (337)
                      ..+...+++|||+++|+|.+++...                                                       
T Consensus        82 ~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (343)
T cd05103          82 KPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV  161 (343)
T ss_pred             cCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence            7667789999999999999998642                                                       


Q ss_pred             ------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCCCCCC
Q 019650          141 ------------KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNN  208 (337)
Q Consensus       141 ------------~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~  208 (337)
                                  ..++...+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||++.........      
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~------  235 (343)
T cd05103         162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY------  235 (343)
T ss_pred             hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcch------
Confidence                        13677888999999999999999999999999999999999999999999998765322110      


Q ss_pred             CCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHhhccCCCC
Q 019650          209 NNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICAICFGERLE  287 (337)
Q Consensus       209 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  287 (337)
                            .......++..|+|||.+.    +..++.++|+||||+++|++++ |..||...........   ....+....
T Consensus       236 ------~~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~---~~~~~~~~~  302 (343)
T cd05103         236 ------VRKGDARLPLKWMAPETIF----DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR---RLKEGTRMR  302 (343)
T ss_pred             ------hhcCCCCCCcceECcHHhc----CCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHH---HHhccCCCC
Confidence                  0011122567899999987    4578889999999999999997 9999976543333222   222333444


Q ss_pred             CCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          288 MPETASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       288 ~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                      .+...++.+.+++..||+.+|.+|||+.++++|
T Consensus       303 ~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~  335 (343)
T cd05103         303 APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  335 (343)
T ss_pred             CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            455568899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=8e-41  Score=286.49  Aligned_cols=250  Identities=35%  Similarity=0.569  Sum_probs=209.3

Q ss_pred             ccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEec
Q 019650           48 DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEH  127 (337)
Q Consensus        48 ~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~e~  127 (337)
                      +|.+.+.||.|++|.||++.+..++..+++|.+..... .....+.+|+.++++++|++++++++.+.. ....++++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~l~~e~   78 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK-EKKEKIINEIQILKKCKHPNIVKYYGSYLK-KDELWIVMEF   78 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch-hHHHHHHHHHHHHHhCCCCCEeEEEEEEec-CCeEEEEEec
Confidence            58889999999999999999998999999999976543 345678889999999999999999998766 6889999999


Q ss_pred             cCCCCchHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCCCC
Q 019650          128 MERGSLFDSLRVR-KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHN  206 (337)
Q Consensus       128 ~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~  206 (337)
                      +++++|.+++... ..+++..+..++.|++.+|.+||+.|++||||+|+||+++.++.++|+|||.+........     
T Consensus        79 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-----  153 (253)
T cd05122          79 CSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-----  153 (253)
T ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc-----
Confidence            9999999999876 6799999999999999999999999999999999999999999999999998877654321     


Q ss_pred             CCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhccCCC
Q 019650          207 NNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERL  286 (337)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~  286 (337)
                                .....++..|+|||.+.    +..++.++|+||||+++|+|++|..||.............    .....
T Consensus       154 ----------~~~~~~~~~~~~PE~~~----~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~----~~~~~  215 (253)
T cd05122         154 ----------RNTMVGTPYWMAPEVIN----GKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIA----TNGPP  215 (253)
T ss_pred             ----------ccceecCCcccCHHHHc----CCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHH----hcCCC
Confidence                      11234788999999998    3457889999999999999999999996543322222111    12222


Q ss_pred             CCCCC--CCHHHHHHHHHHhhcCcCCCCCHHHHhcCcc
Q 019650          287 EMPET--ASPEFRRFVRSCLEKDWRKRGTVEELLAYPF  322 (337)
Q Consensus       287 ~~~~~--~~~~~~~li~~~l~~~p~~R~s~~eil~hp~  322 (337)
                      ..+..  ++..+.+++.+||..||++|||+.++++|||
T Consensus       216 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         216 GLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             CcCcccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence            22222  3789999999999999999999999999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=5.6e-41  Score=288.77  Aligned_cols=249  Identities=29%  Similarity=0.429  Sum_probs=203.4

Q ss_pred             ccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 019650           46 ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVM  125 (337)
Q Consensus        46 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~  125 (337)
                      .++|++.+.||+|+||.||++... ++..+|+|.+....  ...+.+.+|+.++++++|+||+++++.+.. ....+++|
T Consensus         3 ~~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~iv~   78 (256)
T cd05114           3 PSELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGA--MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ-QKPLYIVT   78 (256)
T ss_pred             HHHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCC--ccHHHHHHHHHHHHHCCCCCceeEEEEEcc-CCCEEEEE
Confidence            578999999999999999999875 45579999876432  234567889999999999999999998765 67899999


Q ss_pred             eccCCCCchHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCC
Q 019650          126 EHMERGSLFDSLRVR-KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNN  204 (337)
Q Consensus       126 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~  204 (337)
                      ||+++++|.+++... +.+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+.........  
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~--  156 (256)
T cd05114          79 EFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT--  156 (256)
T ss_pred             EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCcee--
Confidence            999999999999753 46899999999999999999999999999999999999999999999999988765332111  


Q ss_pred             CCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHhhcc
Q 019650          205 HNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICAICFG  283 (337)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~  283 (337)
                                 ......++..|+|||.+.    +..++.++|+||||+++|+|++ |+.||......    ........+
T Consensus       157 -----------~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~----~~~~~i~~~  217 (256)
T cd05114         157 -----------SSSGAKFPVKWSPPEVFN----FSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY----EVVEMISRG  217 (256)
T ss_pred             -----------ccCCCCCchhhCChhhcc----cCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH----HHHHHHHCC
Confidence                       111223566899999997    4467889999999999999999 89999654332    222233334


Q ss_pred             CCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhc
Q 019650          284 ERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA  319 (337)
Q Consensus       284 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~  319 (337)
                      .....+...+..+.+++.+||+.+|++|||+++++.
T Consensus       218 ~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~  253 (256)
T cd05114         218 FRLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLR  253 (256)
T ss_pred             CCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            444455667889999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=6.1e-41  Score=293.83  Aligned_cols=265  Identities=30%  Similarity=0.479  Sum_probs=214.2

Q ss_pred             ccccccccccCcceEEEEEEEc---cCCceEEEEEeecCC---chHhHHHHHHHHHHHHhc-CCCCceeeeeeEEeeCCe
Q 019650           48 DLKKLTVLGHGNGGIVYKVRHQ---KSNSIYALKVLNTTS---STIIRHQAAHEAEILKRL-DSQFIVKCHAVFYTIEGE  120 (337)
Q Consensus        48 ~y~~~~~lg~g~~~~v~~~~~~---~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~  120 (337)
                      .|++.+.||.|++|.||++.+.   .++..||+|++....   .....+.+.+|+.++.++ .|++|+++++.+.. +..
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~-~~~   79 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT-DTK   79 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeec-CCe
Confidence            4788999999999999999874   478899999987532   122345677899999999 58999999987765 678


Q ss_pred             EEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccc
Q 019650          121 ICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETR  200 (337)
Q Consensus       121 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~  200 (337)
                      .++||||+++++|.+++.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus        80 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~  159 (290)
T cd05613          80 LHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDE  159 (290)
T ss_pred             EEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceeccccc
Confidence            89999999999999999888889999999999999999999999999999999999999999999999999887653321


Q ss_pred             cCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHh
Q 019650          201 NNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAI  280 (337)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~  280 (337)
                      .             .......++..|+|||.+...  ...++.++|+||||+++|+|++|..||................
T Consensus       160 ~-------------~~~~~~~~~~~y~aPE~~~~~--~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~  224 (290)
T cd05613         160 V-------------ERAYSFCGTIEYMAPDIVRGG--DGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRI  224 (290)
T ss_pred             c-------------cccccccCCcccCChhhccCC--CCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHh
Confidence            1             111223578899999998743  2346789999999999999999999996533332223332222


Q ss_pred             hccCCCCCCCCCCHHHHHHHHHHhhcCcCCCC-----CHHHHhcCccccccCCC
Q 019650          281 CFGERLEMPETASPEFRRFVRSCLEKDWRKRG-----TVEELLAYPFVTKRSSS  329 (337)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~-----s~~eil~hp~f~~~~~~  329 (337)
                       .......+..++..+.+++.+||..+|++|+     +++++++||||+...+.
T Consensus       225 -~~~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~  277 (290)
T cd05613         225 -LKSEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWD  277 (290)
T ss_pred             -hccCCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCHH
Confidence             2223445667889999999999999999997     89999999999988753

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=5.2e-41  Score=295.27  Aligned_cols=250  Identities=28%  Similarity=0.362  Sum_probs=202.8

Q ss_pred             cccccccccccCcceEEEEEEEccCCc--eEEEEEeecCCchHhHHHHHHHHHHHHhc-CCCCceeeeeeEEeeCCeEEE
Q 019650           47 SDLKKLTVLGHGNGGIVYKVRHQKSNS--IYALKVLNTTSSTIIRHQAAHEAEILKRL-DSQFIVKCHAVFYTIEGEICF  123 (337)
Q Consensus        47 ~~y~~~~~lg~g~~~~v~~~~~~~~~~--~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~~l  123 (337)
                      ++|++.+.||.|+||.||+|.+..++.  .+++|.++........+.+.+|+.++.++ +|+||+++++.+.. ....++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-~~~~~l   80 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACEN-RGYLYI   80 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEcc-CCcceE
Confidence            689999999999999999999876654  46888877544444556788899999999 79999999998766 678999


Q ss_pred             EEeccCCCCchHHhhhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEE
Q 019650          124 VMEHMERGSLFDSLRVRK----------------KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKI  187 (337)
Q Consensus       124 v~e~~~~~~L~~~l~~~~----------------~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l  187 (337)
                      +|||+++++|.+++....                .+++..++.++.|++.||+|||+.|++|+||||+||+++.++.++|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl  160 (297)
T cd05089          81 AIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKI  160 (297)
T ss_pred             EEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEEE
Confidence            999999999999996532                4788999999999999999999999999999999999999999999


Q ss_pred             eeccCccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCC
Q 019650          188 ADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIG  266 (337)
Q Consensus       188 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~  266 (337)
                      +|||++........               ......+..|+|||.+.    +..++.++||||||+++|+|++ |..||..
T Consensus       161 ~dfg~~~~~~~~~~---------------~~~~~~~~~y~aPE~~~----~~~~~~~~DvwSlG~il~el~t~g~~pf~~  221 (297)
T cd05089         161 ADFGLSRGEEVYVK---------------KTMGRLPVRWMAIESLN----YSVYTTKSDVWSFGVLLWEIVSLGGTPYCG  221 (297)
T ss_pred             CCcCCCccccceec---------------cCCCCcCccccCchhhc----cCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Confidence            99998753321100               00112355799999987    4568889999999999999998 9999965


Q ss_pred             CCCchhHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          267 FGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                      .....    .............+..++..+.+++.+||+.+|.+|||+++++..
T Consensus       222 ~~~~~----~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  271 (297)
T cd05089         222 MTCAE----LYEKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ  271 (297)
T ss_pred             CCHHH----HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            43322    223333344445566788999999999999999999999999765

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.4e-43  Score=313.88  Aligned_cols=253  Identities=31%  Similarity=0.498  Sum_probs=218.8

Q ss_pred             ccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEeccCCCCc
Q 019650           54 VLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSL  133 (337)
Q Consensus        54 ~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L  133 (337)
                      +||.|.+|+||.|.+..+...+|||-+....+. ...-+..|+.+.++++|.|||+++|.+.+ ++.+-+.||-++||+|
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr-~~QPLhEEIaLH~~LrHkNIVrYLGs~se-nGf~kIFMEqVPGGSL  659 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSR-EVQPLHEEIALHSTLRHKNIVRYLGSVSE-NGFFKIFMEQVPGGSL  659 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccch-hhccHHHHHHHHHHHhhHhHHHHhhccCC-CCeEEEEeecCCCCcH
Confidence            799999999999999999999999988655433 34456679999999999999999998765 6788899999999999


Q ss_pred             hHHhhhc-CCC--CHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcC-CCcEEEeeccCccchhccccCCCCCCCC
Q 019650          134 FDSLRVR-KKL--SEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLING-KGEVKIADFGVSRIVEETRNNNNHNNNN  209 (337)
Q Consensus       134 ~~~l~~~-~~l--~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~  209 (337)
                      .++++.. +++  .+.++..+.+||+++|.|||++.|||||||-.|+|++. .|.+||+|||.+.++..-          
T Consensus       660 SsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi----------  729 (1226)
T KOG4279|consen  660 SSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI----------  729 (1226)
T ss_pred             HHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccC----------
Confidence            9999753 677  78899999999999999999999999999999999965 589999999999887432          


Q ss_pred             CCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhccCCCCCC
Q 019650          210 NNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMP  289 (337)
Q Consensus       210 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  289 (337)
                          +..+..+-||..|||||++..+  ...|+.++|||||||++.||.||++||...+...  .....-......+++|
T Consensus       730 ----nP~TETFTGTLQYMAPEvIDqG--~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq--AAMFkVGmyKvHP~iP  801 (1226)
T KOG4279|consen  730 ----NPCTETFTGTLQYMAPEVIDQG--PRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ--AAMFKVGMYKVHPPIP  801 (1226)
T ss_pred             ----CccccccccchhhhChHhhccC--CcCCCchhhhhhccceeEeeccCCCCeeecCChh--HhhhhhcceecCCCCc
Confidence                2566677899999999999876  3578999999999999999999999997665433  2233334455577888


Q ss_pred             CCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCcccccc
Q 019650          290 ETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKR  326 (337)
Q Consensus       290 ~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~  326 (337)
                      ..++.+++++|.+|+.++|..||++.++|..||++..
T Consensus       802 eelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~  838 (1226)
T KOG4279|consen  802 EELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN  838 (1226)
T ss_pred             HHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence            9999999999999999999999999999999999876

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=2.6e-42  Score=319.18  Aligned_cols=255  Identities=28%  Similarity=0.447  Sum_probs=221.1

Q ss_pred             cCccccccccccccCcceEEEEEEEc-----cCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeC
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQ-----KSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIE  118 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~  118 (337)
                      ....+.+..+.||+|+||.||+|+..     +...-||||.++...+.....+|.+|++++..++|+|||+++|++.+ +
T Consensus       483 i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~-~  561 (774)
T KOG1026|consen  483 IPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCRE-G  561 (774)
T ss_pred             echhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc-C
Confidence            44578888999999999999999874     34567999999988777788999999999999999999999999988 7


Q ss_pred             CeEEEEEeccCCCCchHHhhhcC--------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCc
Q 019650          119 GEICFVMEHMERGSLFDSLRVRK--------------KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGE  184 (337)
Q Consensus       119 ~~~~lv~e~~~~~~L~~~l~~~~--------------~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~  184 (337)
                      ..+|+|+||+..|+|.++|....              +++..+.+.|+.||+.++.||-++.+|||||.++|+||.++..
T Consensus       562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~  641 (774)
T KOG1026|consen  562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLV  641 (774)
T ss_pred             CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceE
Confidence            88999999999999999996432              2888999999999999999999999999999999999999999


Q ss_pred             EEEeeccCccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCC
Q 019650          185 VKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYP  263 (337)
Q Consensus       185 ~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~p  263 (337)
                      |||+|||+++..-...+....            .....+.+|||||.+.+    +.++.+|||||+||+|||+++ |+.|
T Consensus       642 VKIsDfGLsRdiYssDYYk~~------------~~t~lPIRWMppEsIly----~kFTteSDVWs~GVvLWEIFsyG~QP  705 (774)
T KOG1026|consen  642 VKISDFGLSRDIYSSDYYKVR------------GNTLLPIRWMPPESILY----GKFTTESDVWSFGVVLWEIFSYGKQP  705 (774)
T ss_pred             EEecccccchhhhhhhhhccc------------CCceeeeecCCHHHhhc----CcccchhhhhhhhhhhhhhhccccCc
Confidence            999999999877554432211            11135789999999995    478999999999999999999 9999


Q ss_pred             CCCCCCchhHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhc
Q 019650          264 LIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA  319 (337)
Q Consensus       264 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~  319 (337)
                      |.+..+.    ++++.+..+.....|.+++.++.+|+..||+.+|.+||++.||-+
T Consensus       706 y~glSn~----EVIe~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~  757 (774)
T KOG1026|consen  706 YYGLSNQ----EVIECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHS  757 (774)
T ss_pred             ccccchH----HHHHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence            9877554    455666677778889999999999999999999999999999854

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=7.2e-41  Score=293.13  Aligned_cols=253  Identities=28%  Similarity=0.400  Sum_probs=205.5

Q ss_pred             ccccccccccccCcceEEEEEEEc-----cCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCe
Q 019650           46 ISDLKKLTVLGHGNGGIVYKVRHQ-----KSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGE  120 (337)
Q Consensus        46 ~~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~  120 (337)
                      -++|.+.+.||.|+||+||++.+.     .++..+++|.+.... ....+.+.+|+.+++++.|++++++++.+.. ...
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~   81 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNLQHEHIVKFYGVCVE-GDP   81 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CCc
Confidence            468999999999999999999862     345668999886543 3345678889999999999999999998876 688


Q ss_pred             EEEEEeccCCCCchHHhhhcC-------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEE
Q 019650          121 ICFVMEHMERGSLFDSLRVRK-------------KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKI  187 (337)
Q Consensus       121 ~~lv~e~~~~~~L~~~l~~~~-------------~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l  187 (337)
                      .+++|||+++++|.+++...+             .+++..++.++.|++.||+|||++|++||||||+||+++.++.++|
T Consensus        82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl  161 (288)
T cd05093          82 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKI  161 (288)
T ss_pred             cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEe
Confidence            999999999999999997543             4899999999999999999999999999999999999999999999


Q ss_pred             eeccCccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCC
Q 019650          188 ADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIG  266 (337)
Q Consensus       188 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~  266 (337)
                      +|||.+.........            .......++..|+|||.+.    +..++.++|+||||+++|+|++ |..||..
T Consensus       162 ~dfg~~~~~~~~~~~------------~~~~~~~~~~~y~aPE~~~----~~~~~~~sDiwslG~il~~l~t~g~~p~~~  225 (288)
T cd05093         162 GDFGMSRDVYSTDYY------------RVGGHTMLPIRWMPPESIM----YRKFTTESDVWSLGVVLWEIFTYGKQPWYQ  225 (288)
T ss_pred             ccCCccccccCCcee------------ecCCCCCccccccCHHHhc----cCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            999998755332110            1111223577899999997    4578889999999999999998 8999865


Q ss_pred             CCCchhHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          267 FGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                      .....    .......+.....+...+..+.+++.+||+.||.+|||++++++.
T Consensus       226 ~~~~~----~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~  275 (288)
T cd05093         226 LSNNE----VIECITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSL  275 (288)
T ss_pred             CCHHH----HHHHHHcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence            43322    222333344444556678999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=6e-41  Score=290.30  Aligned_cols=253  Identities=26%  Similarity=0.438  Sum_probs=206.0

Q ss_pred             ccccccccccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEE
Q 019650           46 ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICF  123 (337)
Q Consensus        46 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~l  123 (337)
                      +++|++.+.||.|++|.||++.+..++..+++|.+....  .......+.+|+.+++.+.|+|++++++.+.+ +...++
T Consensus         1 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~~   79 (267)
T cd08229           1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE-DNELNI   79 (267)
T ss_pred             CchhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEe-CCeEEE
Confidence            368999999999999999999998899999999876532  23344677889999999999999999998876 678999


Q ss_pred             EEeccCCCCchHHhhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhcc
Q 019650          124 VMEHMERGSLFDSLRV----RKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEET  199 (337)
Q Consensus       124 v~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~  199 (337)
                      +|||+++++|.+++..    ...+++..++.++.|++.+|.|||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus        80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd08229          80 VLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK  159 (267)
T ss_pred             EEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence            9999999999998863    346899999999999999999999999999999999999999999999999988765432


Q ss_pred             ccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHH
Q 019650          200 RNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICA  279 (337)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~  279 (337)
                      ..              ......++..|+|||.+.    +..++.++|+||||+++|+|++|..||.....  ........
T Consensus       160 ~~--------------~~~~~~~~~~~~ape~~~----~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~~~~  219 (267)
T cd08229         160 TT--------------AAHSLVGTPYYMSPERIH----ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM--NLYSLCKK  219 (267)
T ss_pred             Cc--------------ccccccCCcCccCHHHhc----CCCccchhhHHHHHHHHHHHHhCCCCcccccc--hHHHHhhh
Confidence            21              111234788999999997    45678899999999999999999999965332  22222222


Q ss_pred             hhccCCCC-CCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhc
Q 019650          280 ICFGERLE-MPETASPEFRRFVRSCLEKDWRKRGTVEELLA  319 (337)
Q Consensus       280 ~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~  319 (337)
                      ......+. .+...+..+.+++.+||+.+|++|||+++|++
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~  260 (267)
T cd08229         220 IEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYD  260 (267)
T ss_pred             hhcCCCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence            22222222 23456889999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-43  Score=308.10  Aligned_cols=258  Identities=29%  Similarity=0.463  Sum_probs=221.2

Q ss_pred             ccccccCcceEEEEEEEccCCceEEEEEeecCC-chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEeccCC
Q 019650           52 LTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMER  130 (337)
Q Consensus        52 ~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~  130 (337)
                      .++||+|-||+||-|++.++|+.||||++.+.. .....+.+.+|..+++.+.||+|+.+..-+.+ ...+++|||-+.|
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET-~ervFVVMEKl~G  647 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFET-PERVFVVMEKLHG  647 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecC-CceEEEEehhhcc
Confidence            578999999999999999999999999997654 34445778899999999999999999887766 6789999999976


Q ss_pred             CCchHHh-h-hcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCC---CcEEEeeccCccchhccccCCCC
Q 019650          131 GSLFDSL-R-VRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGK---GEVKIADFGVSRIVEETRNNNNH  205 (337)
Q Consensus       131 ~~L~~~l-~-~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~---~~~~l~Dfg~~~~~~~~~~~~~~  205 (337)
                       ++.+.+ . +.+.+++.....++.||+.||.|||.+||+|+||||+|||+...   ..+||+|||+++.++..      
T Consensus       648 -DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk------  720 (888)
T KOG4236|consen  648 -DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK------  720 (888)
T ss_pred             -hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchh------
Confidence             555554 3 34789999999999999999999999999999999999999643   48999999999998765      


Q ss_pred             CCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhccCC
Q 019650          206 NNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGER  285 (337)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~  285 (337)
                               ....+.+|||.|+|||++.    ...|+...|+||+|+|+|--++|..||.   ++++....+.....-.+
T Consensus       721 ---------sFRrsVVGTPAYLaPEVLr----nkGyNrSLDMWSVGVIiYVsLSGTFPFN---EdEdIndQIQNAaFMyP  784 (888)
T KOG4236|consen  721 ---------SFRRSVVGTPAYLAPEVLR----NKGYNRSLDMWSVGVIIYVSLSGTFPFN---EDEDINDQIQNAAFMYP  784 (888)
T ss_pred             ---------hhhhhhcCCccccCHHHHh----hccccccccceeeeEEEEEEecccccCC---CccchhHHhhccccccC
Confidence                     3344568999999999999    5689999999999999999999999994   44555555555555566


Q ss_pred             CCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCCcccc
Q 019650          286 LEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNIE  333 (337)
Q Consensus       286 ~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~~~~~  333 (337)
                      +..+..++..+.+||..+|+..-++|.|.++.|+|||+++...-..+.
T Consensus       785 p~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~yq~w~DLR  832 (888)
T KOG4236|consen  785 PNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDYQTWLDLR  832 (888)
T ss_pred             CCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcchHHHHHH
Confidence            777788999999999999999999999999999999999987655443

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=8.4e-41  Score=288.09  Aligned_cols=247  Identities=30%  Similarity=0.436  Sum_probs=209.0

Q ss_pred             cccccCcceEEEEEEEccC---CceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEeccC
Q 019650           53 TVLGHGNGGIVYKVRHQKS---NSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHME  129 (337)
Q Consensus        53 ~~lg~g~~~~v~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~  129 (337)
                      +.||.|+||.||+|.+...   +..+++|.+.........+.+.+|+..+..++|++++++++++.. +...+++|||++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~   79 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTE-EEPLYLVLEYME   79 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecC-CCceEEEEEecc
Confidence            4799999999999999865   889999999876554456788899999999999999999998876 788999999999


Q ss_pred             CCCchHHhhhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccc
Q 019650          130 RGSLFDSLRVR---------KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETR  200 (337)
Q Consensus       130 ~~~L~~~l~~~---------~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~  200 (337)
                      +++|.+++...         ..+++..++.++.|++.||++||++|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~  159 (262)
T cd00192          80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDD  159 (262)
T ss_pred             CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEccccccccccccc
Confidence            99999999875         779999999999999999999999999999999999999999999999999998765432


Q ss_pred             cCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHH
Q 019650          201 NNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICA  279 (337)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~  279 (337)
                      ..            .......++..|+|||.+.    +..++.++|+||||+++|+|++ |..||.....    ......
T Consensus       160 ~~------------~~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~----~~~~~~  219 (262)
T cd00192         160 YY------------RKKTGGKLPIRWMAPESLK----DGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN----EEVLEY  219 (262)
T ss_pred             cc------------ccccCCCcCccccCHHHhc----cCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH----HHHHHH
Confidence            10            1112234688999999988    4478899999999999999999 6999976532    223333


Q ss_pred             hhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          280 ICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                      ...+.....+..++..+.+++.+||+.+|++|||+++++++
T Consensus       220 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  260 (262)
T cd00192         220 LRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER  260 (262)
T ss_pred             HHcCCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            33355566677789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=8.5e-41  Score=287.82  Aligned_cols=245  Identities=27%  Similarity=0.427  Sum_probs=200.8

Q ss_pred             ccccCcceEEEEEEE--ccCCceEEEEEeecCC-chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEeccCC
Q 019650           54 VLGHGNGGIVYKVRH--QKSNSIYALKVLNTTS-STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMER  130 (337)
Q Consensus        54 ~lg~g~~~~v~~~~~--~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~  130 (337)
                      .||+|+||.||+|.+  ..++..+|+|+++... .....+.+.+|+.+++.+.|+||+++++.+.  ....++||||+++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~lv~e~~~~   79 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE--AESWMLVMELAEL   79 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc--CCCcEEEEecCCC
Confidence            689999999999965  4677889999986543 2335567888999999999999999998763  4577899999999


Q ss_pred             CCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCCCCCCCC
Q 019650          131 GSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNN  210 (337)
Q Consensus       131 ~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~  210 (337)
                      ++|.+++.....+++..+..++.|++.||.+||++|++|+||||.||+++.++.++|+|||.+..........       
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~-------  152 (257)
T cd05116          80 GPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYY-------  152 (257)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCee-------
Confidence            9999999887889999999999999999999999999999999999999999999999999987664332110       


Q ss_pred             CccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHhhccCCCCCC
Q 019650          211 NNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICAICFGERLEMP  289 (337)
Q Consensus       211 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  289 (337)
                          .......++..|+|||.+.    ...++.++|+||||+++|||++ |..||......    ........+.....+
T Consensus       153 ----~~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~----~~~~~i~~~~~~~~~  220 (257)
T cd05116         153 ----KAKTHGKWPVKWYAPECMN----YYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN----EVTQMIESGERMECP  220 (257)
T ss_pred             ----eecCCCCCCccccCHhHhc----cCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH----HHHHHHHCCCCCCCC
Confidence                0011123467899999987    4467889999999999999998 99999654332    223333444556677


Q ss_pred             CCCCHHHHHHHHHHhhcCcCCCCCHHHHhc
Q 019650          290 ETASPEFRRFVRSCLEKDWRKRGTVEELLA  319 (337)
Q Consensus       290 ~~~~~~~~~li~~~l~~~p~~R~s~~eil~  319 (337)
                      ..++..+.++|.+||+.||++||++.+|..
T Consensus       221 ~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~  250 (257)
T cd05116         221 QRCPPEMYDLMKLCWTYGVDERPGFAVVEL  250 (257)
T ss_pred             CCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence            788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=8e-41  Score=287.79  Aligned_cols=246  Identities=23%  Similarity=0.396  Sum_probs=204.0

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEE
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICF  123 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~l  123 (337)
                      ...++|.+.+.||+|++|.||++...  +..+++|.+....   ..+.+.+|+.++++++|++++++++.+...+...++
T Consensus         3 ~~~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~l   77 (256)
T cd05082           3 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI   77 (256)
T ss_pred             ccHHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc---hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEE
Confidence            45679999999999999999999764  6779999886443   345678899999999999999999987665678999


Q ss_pred             EEeccCCCCchHHhhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhcccc
Q 019650          124 VMEHMERGSLFDSLRVRK--KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRN  201 (337)
Q Consensus       124 v~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~  201 (337)
                      +|||+++++|.+++....  .+++..+..++.|++.+|+|||++|++|+||+|+||+++.++.++|+|||.+........
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~  157 (256)
T cd05082          78 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD  157 (256)
T ss_pred             EEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccCC
Confidence            999999999999997543  488999999999999999999999999999999999999999999999998875432211


Q ss_pred             CCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHh
Q 019650          202 NNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICAI  280 (337)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~  280 (337)
                                       ....+..|+|||++.    +..++.++|+||||+++|+|++ |+.||.....    .......
T Consensus       158 -----------------~~~~~~~y~aPE~~~----~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~----~~~~~~~  212 (256)
T cd05082         158 -----------------TGKLPVKWTAPEALR----EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL----KDVVPRV  212 (256)
T ss_pred             -----------------CCccceeecCHHHHc----cCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHH
Confidence                             112456899999987    4578889999999999999998 9999865322    2233333


Q ss_pred             hccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhc
Q 019650          281 CFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA  319 (337)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~  319 (337)
                      ........+..++..+.+++.+||+.+|++|||+.++++
T Consensus       213 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  251 (256)
T cd05082         213 EKGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE  251 (256)
T ss_pred             hcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            334455566778999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=6.7e-41  Score=294.44  Aligned_cols=266  Identities=32%  Similarity=0.598  Sum_probs=209.7

Q ss_pred             ccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhc-CCCCceeeeeeEEeeCCeE
Q 019650           43 VENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRL-DSQFIVKCHAVFYTIEGEI  121 (337)
Q Consensus        43 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~  121 (337)
                      ....++|++.+.||.|++|.||+|.+..++..||+|.++..........+..|+.++.+. .|+||+++++.+.+ ....
T Consensus        11 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-~~~~   89 (296)
T cd06618          11 PADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFIT-DSDV   89 (296)
T ss_pred             cCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeec-CCeE
Confidence            456789999999999999999999999889999999997654444445566677666666 59999999998876 6889


Q ss_pred             EEEEeccCCCCchHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCeEEcCCCcEEEeeccCccchhcc
Q 019650          122 CFVMEHMERGSLFDSLRV-RKKLSEDVISGVAYRVLKGLQYLHG-MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEET  199 (337)
Q Consensus       122 ~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~-~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~  199 (337)
                      +++|||+.+ +|.+++.. ...+++..+..++.|++.+|+|||+ .|++|+||+|+||+++.++.++|+|||.+......
T Consensus        90 ~~v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~  168 (296)
T cd06618          90 FICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS  168 (296)
T ss_pred             EEEeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence            999999854 77777754 4578999999999999999999997 59999999999999999999999999998765432


Q ss_pred             ccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHH
Q 019650          200 RNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICA  279 (337)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~  279 (337)
                      ...               ....++..|+|||.+........++.++|+||||+++|+|++|+.||.......   .....
T Consensus       169 ~~~---------------~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---~~~~~  230 (296)
T cd06618         169 KAK---------------TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF---EVLTK  230 (296)
T ss_pred             Ccc---------------cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH---HHHHH
Confidence            111               112367889999999754222457889999999999999999999996532211   12222


Q ss_pred             hhccCCCCCC--CCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCC
Q 019650          280 ICFGERLEMP--ETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSS  328 (337)
Q Consensus       280 ~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~  328 (337)
                      .........+  ..++..+.+++.+||..||.+||++++++.||||+....
T Consensus       231 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  281 (296)
T cd06618         231 ILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYET  281 (296)
T ss_pred             HhcCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccch
Confidence            2222222222  246889999999999999999999999999999997654

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=6.7e-41  Score=289.07  Aligned_cols=252  Identities=25%  Similarity=0.414  Sum_probs=205.4

Q ss_pred             ccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEE
Q 019650           43 VENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEIC  122 (337)
Q Consensus        43 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~  122 (337)
                      ....++|++.++||+|++|.||+|... ++..|++|.+....  ...+.+.+|+.++++++|+|++++++.+.. ....+
T Consensus         2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   77 (261)
T cd05072           2 EIPRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGT--MSVQAFLEEANLMKTLQHDKLVRLYAVVTK-EEPIY   77 (261)
T ss_pred             cCchHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCc--hhHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCCcE
Confidence            456789999999999999999999865 55679999876533  235678889999999999999999998765 67889


Q ss_pred             EEEeccCCCCchHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccc
Q 019650          123 FVMEHMERGSLFDSLRVR--KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETR  200 (337)
Q Consensus       123 lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~  200 (337)
                      ++|||+++++|.+++...  ..++...+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        78 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~  157 (261)
T cd05072          78 IITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE  157 (261)
T ss_pred             EEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCc
Confidence            999999999999999653  568899999999999999999999999999999999999999999999999997754321


Q ss_pred             cCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHH
Q 019650          201 NNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICA  279 (337)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~  279 (337)
                      .             .......++..|+|||.+.    +..++.++|+||||+++|+|++ |..||.......    ....
T Consensus       158 ~-------------~~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~----~~~~  216 (261)
T cd05072         158 Y-------------TAREGAKFPIKWTAPEAIN----FGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD----VMSA  216 (261)
T ss_pred             e-------------eccCCCccceecCCHHHhc----cCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH----HHHH
Confidence            1             0111123567899999987    4567889999999999999998 999996543322    2222


Q ss_pred             hhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhc
Q 019650          280 ICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA  319 (337)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~  319 (337)
                      ............++..+.+++.+||+.+|++|||++++++
T Consensus       217 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  256 (261)
T cd05072         217 LQRGYRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQS  256 (261)
T ss_pred             HHcCCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            2233344445567899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-42  Score=283.63  Aligned_cols=275  Identities=25%  Similarity=0.370  Sum_probs=222.3

Q ss_pred             Ccccccc-ccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhc-CCCCceeeeeeEEeeCCeEE
Q 019650           45 NISDLKK-LTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRL-DSQFIVKCHAVFYTIEGEIC  122 (337)
Q Consensus        45 ~~~~y~~-~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~~  122 (337)
                      ..+-|++ .+.||+|+++.|..+....++..||+|++.+. ......+..+|++++.++ .|+||+++++.|.+ +...|
T Consensus        75 F~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq-~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEd-d~~FY  152 (463)
T KOG0607|consen   75 FEDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ-PGHSRSRVFREVETFYQCQGHKNILQLIEFFED-DTRFY  152 (463)
T ss_pred             HHHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcC-CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcc-cceEE
Confidence            3455666 56899999999999999999999999999876 555678888999999998 78999999998766 78999


Q ss_pred             EEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCc---EEEeeccCccchhcc
Q 019650          123 FVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGE---VKIADFGVSRIVEET  199 (337)
Q Consensus       123 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~---~~l~Dfg~~~~~~~~  199 (337)
                      +|||-+.||+|...++++..+++.++..+.++|+.||.+||++||.|||+||+|||.....+   +||+||.+..-....
T Consensus       153 LVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~  232 (463)
T KOG0607|consen  153 LVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLN  232 (463)
T ss_pred             EEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccC
Confidence            99999999999999999999999999999999999999999999999999999999976654   899999987654433


Q ss_pred             ccCCCCCCCCCCccccccccccCCCCCcCCcccccccC-CCCCCccccHHHHHHHHHHHHhCCCCCCCCCCc--------
Q 019650          200 RNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERW-GGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEK--------  270 (337)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~--------  270 (337)
                      .......     .  .....-+|+-.|||||+..-... ...|+.+-|.||||+|+|-|++|.+||.+.=..        
T Consensus       233 ~~~spas-----t--P~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe  305 (463)
T KOG0607|consen  233 NDCSPAS-----T--PELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGE  305 (463)
T ss_pred             CCCCCCC-----C--ccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCC
Confidence            2222110     0  23334468889999998743211 346788999999999999999999999774221        


Q ss_pred             ---hhHHHHHHHhhccCCCCCC----CCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCC
Q 019650          271 ---PDLMALICAICFGERLEMP----ETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSS  329 (337)
Q Consensus       271 ---~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~  329 (337)
                         .....+.+.+..+ ..++|    ..+++..+++|..+|..++.+|.++.+++.|||++.....
T Consensus       306 ~Cr~CQ~~LFesIQEG-kYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~e  370 (463)
T KOG0607|consen  306 VCRVCQNKLFESIQEG-KYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPE  370 (463)
T ss_pred             ccHHHHHHHHHHHhcc-CCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchh
Confidence               1233334444444 34444    4678999999999999999999999999999999876543

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-40  Score=286.80  Aligned_cols=246  Identities=28%  Similarity=0.401  Sum_probs=201.4

Q ss_pred             cccccCcceEEEEEEEccCC---ceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEeccC
Q 019650           53 TVLGHGNGGIVYKVRHQKSN---SIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHME  129 (337)
Q Consensus        53 ~~lg~g~~~~v~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~  129 (337)
                      +.||+|++|.||+|....++   ..+|+|.+.........+.+.+|+.+++.++|+|++++++.+.  ....+++|||++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~v~e~~~   78 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK--GEPLMLVMELAP   78 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc--CCceEEEEEeCC
Confidence            47999999999999875444   7899999886655445677889999999999999999999754  467899999999


Q ss_pred             CCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCCCCCCC
Q 019650          130 RGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNN  209 (337)
Q Consensus       130 ~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~  209 (337)
                      +++|.+++...+.+++..+..++.|++.+|++||+.|++|+||+|+||+++.++.++|+|||.+...........     
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~-----  153 (257)
T cd05060          79 LGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR-----  153 (257)
T ss_pred             CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccc-----
Confidence            999999998888899999999999999999999999999999999999999999999999999876643221110     


Q ss_pred             CCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHhhccCCCCC
Q 019650          210 NNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICAICFGERLEM  288 (337)
Q Consensus       210 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  288 (337)
                            ......++..|+|||.+.    +..++.++|+||||+++|++++ |..||......    ..............
T Consensus       154 ------~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~----~~~~~~~~~~~~~~  219 (257)
T cd05060         154 ------ATTAGRWPLKWYAPECIN----YGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA----EVIAMLESGERLPR  219 (257)
T ss_pred             ------cccCccccccccCHHHhc----CCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH----HHHHHHHcCCcCCC
Confidence                  001112346799999997    4578889999999999999998 99999654332    22223333444556


Q ss_pred             CCCCCHHHHHHHHHHhhcCcCCCCCHHHHhc
Q 019650          289 PETASPEFRRFVRSCLEKDWRKRGTVEELLA  319 (337)
Q Consensus       289 ~~~~~~~~~~li~~~l~~~p~~R~s~~eil~  319 (337)
                      +..++..+.+++.+||..+|++|||+.++++
T Consensus       220 ~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~  250 (257)
T cd05060         220 PEECPQEIYSIMLSCWKYRPEDRPTFSELES  250 (257)
T ss_pred             CCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            6778899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=7.5e-41  Score=295.64  Aligned_cols=257  Identities=25%  Similarity=0.368  Sum_probs=207.2

Q ss_pred             ccCccccccccccccCcceEEEEEEEcc-------CCceEEEEEeecCCchHhHHHHHHHHHHHHhc-CCCCceeeeeeE
Q 019650           43 VENISDLKKLTVLGHGNGGIVYKVRHQK-------SNSIYALKVLNTTSSTIIRHQAAHEAEILKRL-DSQFIVKCHAVF  114 (337)
Q Consensus        43 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~  114 (337)
                      ....++|.+.+.||+|+||.||++.+..       +...+|+|.+...........+.+|+.+++.+ +|+|++++++.+
T Consensus        14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   93 (307)
T cd05098          14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC   93 (307)
T ss_pred             eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence            4446899999999999999999998643       23469999998654444556788899999999 799999999988


Q ss_pred             EeeCCeEEEEEeccCCCCchHHhhhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeE
Q 019650          115 YTIEGEICFVMEHMERGSLFDSLRVRK----------------KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLL  178 (337)
Q Consensus       115 ~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nil  178 (337)
                      .. ....++||||+++++|.+++....                .++..++..++.|++.||+|||+.|++|+||+|+||+
T Consensus        94 ~~-~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nil  172 (307)
T cd05098          94 TQ-DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL  172 (307)
T ss_pred             ec-CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheE
Confidence            66 678999999999999999997542                4788999999999999999999999999999999999


Q ss_pred             EcCCCcEEEeeccCccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHH
Q 019650          179 INGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECL  258 (337)
Q Consensus       179 i~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~  258 (337)
                      ++.++.++|+|||.+..........            ......++..|+|||.+.    +..++.++|+||||+++|+|+
T Consensus       173 l~~~~~~kL~dfg~a~~~~~~~~~~------------~~~~~~~~~~y~aPE~~~----~~~~~~~~DvwslG~~l~el~  236 (307)
T cd05098         173 VTEDNVMKIADFGLARDIHHIDYYK------------KTTNGRLPVKWMAPEALF----DRIYTHQSDVWSFGVLLWEIF  236 (307)
T ss_pred             EcCCCcEEECCCcccccccccchhh------------ccccCCCccceeChHHhc----cCCCCcHHHHHHHHHHHHHHH
Confidence            9999999999999887553211100            001112456899999997    457889999999999999999


Q ss_pred             h-CCCCCCCCCCchhHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          259 V-GHYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       259 t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                      + |..||.... .   ...............+...+..+.+++.+||..+|++|||+.+++++
T Consensus       237 ~~g~~p~~~~~-~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~  295 (307)
T cd05098         237 TLGGSPYPGVP-V---EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  295 (307)
T ss_pred             cCCCCCCCcCC-H---HHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            8 888885432 2   22233333444556667789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=5.2e-41  Score=297.07  Aligned_cols=273  Identities=28%  Similarity=0.352  Sum_probs=206.5

Q ss_pred             ccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCc-hHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeC---
Q 019650           43 VENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSS-TIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIE---  118 (337)
Q Consensus        43 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~---  118 (337)
                      ....++|++.+.||.|++|.||+|.+..++..+++|.+..... ........+|+.+++.++|+||+++++.+.+..   
T Consensus         4 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (311)
T cd07866           4 CSKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKS   83 (311)
T ss_pred             CcccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccc
Confidence            4458999999999999999999999999999999999865432 112334567999999999999999998876533   


Q ss_pred             ----CeEEEEEeccCCCCchHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCc
Q 019650          119 ----GEICFVMEHMERGSLFDSLRV-RKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVS  193 (337)
Q Consensus       119 ----~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~  193 (337)
                          ..++++|+|+.+ +|...+.. ...+++..+..++.|+++||+|||++|++|+||+|+||+++.++.++|+|||++
T Consensus        84 ~~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~  162 (311)
T cd07866          84 KRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLA  162 (311)
T ss_pred             cccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccc
Confidence                247999999965 77777654 457999999999999999999999999999999999999999999999999998


Q ss_pred             cchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhH
Q 019650          194 RIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDL  273 (337)
Q Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~  273 (337)
                      ..............   ...........+++.|+|||.+..   +..++.++|+||||+++|+|++|.+||.+.......
T Consensus       163 ~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~  236 (311)
T cd07866         163 RPYDGPPPNPKGGG---GGGTRKYTNLVVTRWYRPPELLLG---ERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQL  236 (311)
T ss_pred             hhccCCCcccccCC---cccccccccceeccCcCChHHhhC---CCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            76643322111000   000011123356888999998863   235788999999999999999999999654433322


Q ss_pred             HHHHHHhhccCC-------------------CCC-------CCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccc
Q 019650          274 MALICAICFGER-------------------LEM-------PETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV  323 (337)
Q Consensus       274 ~~~~~~~~~~~~-------------------~~~-------~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f  323 (337)
                      ...... .....                   ...       ....+..+.+++.+||..||.+|||+.+++.||||
T Consensus       237 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         237 HLIFKL-CGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             HHHHHH-hCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence            222211 11000                   000       01234678999999999999999999999999998

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=6e-41  Score=300.08  Aligned_cols=273  Identities=29%  Similarity=0.393  Sum_probs=213.2

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCceEEEEEeecCC-chHhHHHHHHHHHHHHhc-CCCCceeeeeeEEee-CCe
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-STIIRHQAAHEAEILKRL-DSQFIVKCHAVFYTI-EGE  120 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~-~~~  120 (337)
                      ...++|++.+.||.|++|.||+|.+..++..+|+|.+.... .......+.+|+.+++++ +|+||+++++.+... ...
T Consensus         4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~   83 (337)
T cd07852           4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKD   83 (337)
T ss_pred             hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCce
Confidence            45689999999999999999999998889999999885432 222344566799999999 999999999987653 346


Q ss_pred             EEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccc
Q 019650          121 ICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETR  200 (337)
Q Consensus       121 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~  200 (337)
                      .++||||+.+ +|.+++... .+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        84 ~~lv~e~~~~-~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~  161 (337)
T cd07852          84 IYLVFEYMET-DLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELE  161 (337)
T ss_pred             EEEEeccccc-CHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcccccc
Confidence            8999999975 999988765 78999999999999999999999999999999999999999999999999887664332


Q ss_pred             cCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHh
Q 019650          201 NNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAI  280 (337)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~  280 (337)
                      ....         ........++..|+|||.+..   ...++.++|+||||+++|+|++|+.||................
T Consensus       162 ~~~~---------~~~~~~~~~~~~y~aPE~~~~---~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~  229 (337)
T cd07852         162 ENPE---------NPVLTDYVATRWYRAPEILLG---STRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVI  229 (337)
T ss_pred             cccc---------CcchhcccccccccCceeeec---cccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence            1100         011223357889999998863   2457889999999999999999999996544332222111110


Q ss_pred             h-----------------------ccC---CCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCCc
Q 019650          281 C-----------------------FGE---RLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSS  330 (337)
Q Consensus       281 ~-----------------------~~~---~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~~  330 (337)
                      .                       ...   .....+..+..+.++|.+||+.+|++|||+.+++.||||++....+
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~~  305 (337)
T cd07852         230 GPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNPS  305 (337)
T ss_pred             CCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccCC
Confidence            0                       000   0111233688999999999999999999999999999998876554

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1e-40  Score=290.75  Aligned_cols=255  Identities=25%  Similarity=0.405  Sum_probs=207.0

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCc----eEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCC
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNS----IYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEG  119 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~  119 (337)
                      ...++|++.+.||.|+||+||+|.+..++.    .||+|++...........+.+|..+++.+.|+|++++++.+..  .
T Consensus         4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~   81 (279)
T cd05109           4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT--S   81 (279)
T ss_pred             cchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC--C
Confidence            346789999999999999999999876665    4899998766555556778889999999999999999998754  5


Q ss_pred             eEEEEEeccCCCCchHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhc
Q 019650          120 EICFVMEHMERGSLFDSLRVR-KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEE  198 (337)
Q Consensus       120 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~  198 (337)
                      ..+++++++++|+|.+++... +.+++..+..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++.....
T Consensus        82 ~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~  161 (279)
T cd05109          82 TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI  161 (279)
T ss_pred             CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence            678999999999999999764 5689999999999999999999999999999999999999999999999999876643


Q ss_pred             cccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCchhHHHHH
Q 019650          199 TRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALI  277 (337)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~  277 (337)
                      ......            .....++..|+|||...    +..++.++||||||+++|||++ |..||...... ..   .
T Consensus       162 ~~~~~~------------~~~~~~~~~y~~PE~~~----~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-~~---~  221 (279)
T cd05109         162 DETEYH------------ADGGKVPIKWMALESIL----HRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR-EI---P  221 (279)
T ss_pred             ccceee------------cCCCccchhhCCHHHhc----cCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-HH---H
Confidence            221100            00112467899999997    4568889999999999999998 89998653322 22   2


Q ss_pred             HHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          278 CAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                      ...........+...+..+.+++.+||+.||++||++.++++.
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~  264 (279)
T cd05109         222 DLLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDE  264 (279)
T ss_pred             HHHHCCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            2222334445566778999999999999999999999999954

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=6.4e-41  Score=294.12  Aligned_cols=258  Identities=26%  Similarity=0.379  Sum_probs=209.1

Q ss_pred             CccCccccccccccccCcceEEEEEEEccC-----CceEEEEEeecCCchHhHHHHHHHHHHHHhc-CCCCceeeeeeEE
Q 019650           42 DVENISDLKKLTVLGHGNGGIVYKVRHQKS-----NSIYALKVLNTTSSTIIRHQAAHEAEILKRL-DSQFIVKCHAVFY  115 (337)
Q Consensus        42 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~  115 (337)
                      +....++|++.+.||+|++|.||++.....     ...+++|.+...........+.+|+.+++++ +|+||+++++++.
T Consensus         7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   86 (293)
T cd05053           7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT   86 (293)
T ss_pred             cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence            455668999999999999999999987643     3679999987654444456688899999999 8999999999876


Q ss_pred             eeCCeEEEEEeccCCCCchHHhhh----------------cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEE
Q 019650          116 TIEGEICFVMEHMERGSLFDSLRV----------------RKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLI  179 (337)
Q Consensus       116 ~~~~~~~lv~e~~~~~~L~~~l~~----------------~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili  179 (337)
                      . +...+++|||+++++|.+++..                ...+++..+..++.|++.||+|||+.|++|+||+|+||++
T Consensus        87 ~-~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~  165 (293)
T cd05053          87 Q-EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLV  165 (293)
T ss_pred             C-CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEE
Confidence            6 6789999999999999999854                2468899999999999999999999999999999999999


Q ss_pred             cCCCcEEEeeccCccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh
Q 019650          180 NGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV  259 (337)
Q Consensus       180 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t  259 (337)
                      +.++.++|+|||.+..........            ......++..|+|||.+.    +..++.++||||||+++|++++
T Consensus       166 ~~~~~~kL~Dfg~~~~~~~~~~~~------------~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~il~el~~  229 (293)
T cd05053         166 TEDHVMKIADFGLARDIHHIDYYR------------KTTNGRLPVKWMAPEALF----DRVYTHQSDVWSFGVLLWEIFT  229 (293)
T ss_pred             cCCCeEEeCcccccccccccccee------------ccCCCCCCccccCHHHhc----cCCcCcccceeehhhHHHHHhc
Confidence            999999999999988654322110            001112456899999987    4578889999999999999998


Q ss_pred             -CCCCCCCCCCchhHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          260 -GHYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       260 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                       |..||......    ..............+...+..+.+++.+||..+|++|||+.+++++
T Consensus       230 ~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~  287 (293)
T cd05053         230 LGGSPYPGIPVE----ELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED  287 (293)
T ss_pred             CCCCCCCCCCHH----HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence             99998654322    2222333344445666778999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=1e-40  Score=286.82  Aligned_cols=251  Identities=32%  Similarity=0.514  Sum_probs=212.0

Q ss_pred             ccccccccccCcceEEEEEEEccCCceEEEEEeecCC-chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEe
Q 019650           48 DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVME  126 (337)
Q Consensus        48 ~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~e  126 (337)
                      +|++.+.||.|++|.||++.+..++..+++|.+.... .......+.+|+.+++.++|+|++++++.+.+ ....++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~v~e   79 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLD-GNKLCIVME   79 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhcc-CCEEEEEeh
Confidence            5889999999999999999999999999999987643 33445667789999999999999999998877 688999999


Q ss_pred             ccCCCCchHHhhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccC
Q 019650          127 HMERGSLFDSLRV----RKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNN  202 (337)
Q Consensus       127 ~~~~~~L~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~  202 (337)
                      |+++++|.+++..    ...+++..++.++.|++.||++||+.|++|+||+|.||+++.++.++|+|||.+........ 
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~~-  158 (256)
T cd08530          80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMA-  158 (256)
T ss_pred             hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccCCc-
Confidence            9999999999875    35689999999999999999999999999999999999999999999999999877654311 


Q ss_pred             CCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhc
Q 019650          203 NNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICF  282 (337)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~  282 (337)
                                     ....++..|+|||.+.    +..++.++|+||||+++|+|++|+.||......    ........
T Consensus       159 ---------------~~~~~~~~~~~Pe~~~----~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~----~~~~~~~~  215 (256)
T cd08530         159 ---------------KTQIGTPHYMAPEVWK----GRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ----DLRYKVQR  215 (256)
T ss_pred             ---------------ccccCCccccCHHHHC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHhc
Confidence                           1124788999999997    457788999999999999999999999654322    22223333


Q ss_pred             cCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccc
Q 019650          283 GERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV  323 (337)
Q Consensus       283 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f  323 (337)
                      ......+...+..+.+++.+||..+|++|||+.+++.||++
T Consensus       216 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         216 GKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV  256 (256)
T ss_pred             CCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence            44445556778999999999999999999999999999985

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1.6e-40  Score=292.75  Aligned_cols=258  Identities=27%  Similarity=0.376  Sum_probs=209.5

Q ss_pred             CccCccccccccccccCcceEEEEEEEc-----cCCceEEEEEeecCCchHhHHHHHHHHHHHHhc-CCCCceeeeeeEE
Q 019650           42 DVENISDLKKLTVLGHGNGGIVYKVRHQ-----KSNSIYALKVLNTTSSTIIRHQAAHEAEILKRL-DSQFIVKCHAVFY  115 (337)
Q Consensus        42 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~  115 (337)
                      +....++|.+.+.||.|+||.||++.+.     .++..+|+|.++........+.+.+|+.+++++ +|+||+++++.+.
T Consensus        30 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~  109 (302)
T cd05055          30 WEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACT  109 (302)
T ss_pred             ccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEe
Confidence            4466789999999999999999999863     345679999987655444566788999999999 7999999999876


Q ss_pred             eeCCeEEEEEeccCCCCchHHhhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCc
Q 019650          116 TIEGEICFVMEHMERGSLFDSLRVRK--KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVS  193 (337)
Q Consensus       116 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~  193 (337)
                      . .+..+++|||+++++|.+++....  .+++.++..++.|++.||.|||+.|++|+||+|+||+++.++.++++|||.+
T Consensus       110 ~-~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~  188 (302)
T cd05055         110 I-GGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLA  188 (302)
T ss_pred             c-CCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCccc
Confidence            6 678999999999999999997543  3899999999999999999999999999999999999999999999999998


Q ss_pred             cchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCchh
Q 019650          194 RIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPD  272 (337)
Q Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~~~~~~~  272 (337)
                      .........            .......++..|+|||.+.    +..++.++||||+|+++|++++ |..||........
T Consensus       189 ~~~~~~~~~------------~~~~~~~~~~~y~aPE~~~----~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~  252 (302)
T cd05055         189 RDIMNDSNY------------VVKGNARLPVKWMAPESIF----NCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK  252 (302)
T ss_pred             ccccCCCce------------eecCCCCcccccCCHhhhc----cCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH
Confidence            765432110            0111123567899999997    4578889999999999999998 9999976554433


Q ss_pred             HHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhc
Q 019650          273 LMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA  319 (337)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~  319 (337)
                      .....   ..+.....+...+..+.+++.+||+.+|++|||+.+++.
T Consensus       253 ~~~~~---~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~  296 (302)
T cd05055         253 FYKLI---KEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ  296 (302)
T ss_pred             HHHHH---HcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            33322   223333445567899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-40  Score=286.41  Aligned_cols=250  Identities=26%  Similarity=0.400  Sum_probs=203.6

Q ss_pred             ccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 019650           46 ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVM  125 (337)
Q Consensus        46 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~  125 (337)
                      ..+|++.+.||.|++|.||++.+. ++..+++|++....  ...+.+.+|+.+++.++|+|++++++.+.. ....+++|
T Consensus         3 ~~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~   78 (256)
T cd05059           3 PSELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGA--MSEDDFIEEAKVMMKLSHPNLVQLYGVCTK-QRPIFIVT   78 (256)
T ss_pred             hHHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCC--CCHHHHHHHHHHHHhCCCCCEEEEEEEEcC-CCceEEEE
Confidence            467999999999999999999875 46679999986432  233567789999999999999999998765 67889999


Q ss_pred             eccCCCCchHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCC
Q 019650          126 EHMERGSLFDSLRVR-KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNN  204 (337)
Q Consensus       126 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~  204 (337)
                      ||+++++|.+++... ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+.......... 
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~-  157 (256)
T cd05059          79 EYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS-  157 (256)
T ss_pred             ecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccccc-
Confidence            999999999999753 468999999999999999999999999999999999999999999999999887654321110 


Q ss_pred             CCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHhhcc
Q 019650          205 HNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICAICFG  283 (337)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~  283 (337)
                                  .....++..|+|||.+.    +..++.++|+||||+++|++++ |..||......+.    .......
T Consensus       158 ------------~~~~~~~~~y~~Pe~~~----~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~----~~~~~~~  217 (256)
T cd05059         158 ------------SQGTKFPVKWAPPEVFD----YSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEV----VESVSAG  217 (256)
T ss_pred             ------------cCCCCCCccccCHHHhc----cCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHH----HHHHHcC
Confidence                        01112356799999998    4578889999999999999999 8999865433222    2223333


Q ss_pred             CCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          284 ERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       284 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                      .....+...+..+.+++.+||+.+|++|||+.++++.
T Consensus       218 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~  254 (256)
T cd05059         218 YRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ  254 (256)
T ss_pred             CcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence            3445566789999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.3e-40  Score=290.71  Aligned_cols=257  Identities=27%  Similarity=0.357  Sum_probs=201.2

Q ss_pred             ccc-ccccccccCcceEEEEEE----EccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeC-Ce
Q 019650           47 SDL-KKLTVLGHGNGGIVYKVR----HQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIE-GE  120 (337)
Q Consensus        47 ~~y-~~~~~lg~g~~~~v~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~-~~  120 (337)
                      ++| ++.+.||.|+||+||++.    ...++..||+|.+...........+.+|+.++++++|+|++++++.+.... ..
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (283)
T cd05080           3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG   82 (283)
T ss_pred             hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence            455 899999999999998865    335778899999876544445567788999999999999999999776533 45


Q ss_pred             EEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccc
Q 019650          121 ICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETR  200 (337)
Q Consensus       121 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~  200 (337)
                      .+++|||+++++|.+++... .+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.......
T Consensus        83 ~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~  161 (283)
T cd05080          83 LQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH  161 (283)
T ss_pred             EEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCcc
Confidence            88999999999999999754 59999999999999999999999999999999999999999999999999987654321


Q ss_pred             cCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCch---------
Q 019650          201 NNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP---------  271 (337)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~---------  271 (337)
                      ....           ......++..|+|||.+.    +..++.++||||||+++|+|++|..||.......         
T Consensus       162 ~~~~-----------~~~~~~~~~~~~~PE~~~----~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~  226 (283)
T cd05080         162 EYYR-----------VREDGDSPVFWYAVECLK----ENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQG  226 (283)
T ss_pred             hhhc-----------cCCCCCCCceeeCHhHhc----ccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhccccc
Confidence            1100           001112456799999987    4567889999999999999999999985432210         


Q ss_pred             --hHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhc
Q 019650          272 --DLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA  319 (337)
Q Consensus       272 --~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~  319 (337)
                        .................+...+..+.+++.+||+.+|++|||+++++.
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~  276 (283)
T cd05080         227 QMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP  276 (283)
T ss_pred             ccchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence              001111111122233345667899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=7.5e-41  Score=288.74  Aligned_cols=250  Identities=24%  Similarity=0.400  Sum_probs=207.5

Q ss_pred             CccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 019650           45 NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFV  124 (337)
Q Consensus        45 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv  124 (337)
                      ...+|++.+.||.|++|.||+|.+.. +..+++|.+..... .....+.+|+.+++.++|+|++++++.+.. ....+++
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv   80 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDL-LKQQDFQKEVQALKRLRHKHLISLFAVCSV-GEPVYII   80 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccch-hhHHHHHHHHHHHhcCCCcchhheeeeEec-CCCeEEE
Confidence            45789999999999999999999977 78899999876532 235567889999999999999999998766 6788999


Q ss_pred             EeccCCCCchHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccC
Q 019650          125 MEHMERGSLFDSLRVR--KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNN  202 (337)
Q Consensus       125 ~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~  202 (337)
                      |||+++++|.+++...  ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.........
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~  160 (261)
T cd05148          81 TELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL  160 (261)
T ss_pred             EeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCcccc
Confidence            9999999999999753  46899999999999999999999999999999999999999999999999998766432111


Q ss_pred             CCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHhh
Q 019650          203 NNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICAIC  281 (337)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~  281 (337)
                                    .....++..|+|||.+.    +..++.++|+||||+++|+|++ |+.||......+..    ....
T Consensus       161 --------------~~~~~~~~~~~~PE~~~----~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~----~~~~  218 (261)
T cd05148         161 --------------SSDKKIPYKWTAPEAAS----HGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVY----DQIT  218 (261)
T ss_pred             --------------ccCCCCceEecCHHHHc----cCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHH----HHHH
Confidence                          01223567899999987    4577889999999999999998 89999654432222    2222


Q ss_pred             ccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhc
Q 019650          282 FGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA  319 (337)
Q Consensus       282 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~  319 (337)
                      .......+...++.+.+++.+||+.||++|||+.++++
T Consensus       219 ~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~  256 (261)
T cd05148         219 AGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALRE  256 (261)
T ss_pred             hCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            34445556778999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.6e-40  Score=289.66  Aligned_cols=254  Identities=25%  Similarity=0.369  Sum_probs=204.3

Q ss_pred             CccccccccccccCcceEEEEEEEccCCc----eEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCe
Q 019650           45 NISDLKKLTVLGHGNGGIVYKVRHQKSNS----IYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGE  120 (337)
Q Consensus        45 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~  120 (337)
                      ..++|++.+.||.|+||+||+|.+..++.    ++++|.+...........+..|+..+.+++|+||+++++.+.  ...
T Consensus         5 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~--~~~   82 (279)
T cd05111           5 KETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP--GAS   82 (279)
T ss_pred             CHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC--CCc
Confidence            45789999999999999999999876665    477787765444445567778888899999999999999764  456


Q ss_pred             EEEEEeccCCCCchHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhcc
Q 019650          121 ICFVMEHMERGSLFDSLRVR-KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEET  199 (337)
Q Consensus       121 ~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~  199 (337)
                      .++++||+++|+|.+++... +.+++..+..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||.+......
T Consensus        83 ~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~  162 (279)
T cd05111          83 LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPD  162 (279)
T ss_pred             cEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence            78999999999999999754 57899999999999999999999999999999999999999999999999998765432


Q ss_pred             ccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHH
Q 019650          200 RNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALIC  278 (337)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~  278 (337)
                      ....            ......++..|+|||.+.    +..++.++|+||||+++||+++ |..||.+.... .....  
T Consensus       163 ~~~~------------~~~~~~~~~~y~~pE~~~----~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~-~~~~~--  223 (279)
T cd05111         163 DKKY------------FYSEHKTPIKWMALESIL----FGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH-EVPDL--  223 (279)
T ss_pred             Cccc------------ccCCCCCcccccCHHHhc----cCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH-HHHHH--
Confidence            1110            011123667899999997    4578899999999999999998 99999654322 12222  


Q ss_pred             HhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          279 AICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                       ...+.....+...+..+.+++.+||..||.+|||+.++++.
T Consensus       224 -~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~  264 (279)
T cd05111         224 -LEKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANE  264 (279)
T ss_pred             -HHCCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence             23334444555678899999999999999999999999873

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-41  Score=259.81  Aligned_cols=262  Identities=25%  Similarity=0.385  Sum_probs=219.0

Q ss_pred             cccccccccccCcceEEEEEEEccCCceEEEEEeecCC-chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 019650           47 SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVM  125 (337)
Q Consensus        47 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~  125 (337)
                      ..|..+++||+|.+|+||++....++..||+|.++.+. ++.......+|+-+++.++|.||++++++... ++.+.+|+
T Consensus         2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhs-dkkltlvf   80 (292)
T KOG0662|consen    2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS-DKKLTLVF   80 (292)
T ss_pred             cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhcc-CceeEEeH
Confidence            46888999999999999999999999999999998765 33455667899999999999999999998655 78999999


Q ss_pred             eccCCCCchHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCC
Q 019650          126 EHMERGSLFDSLRV-RKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNN  204 (337)
Q Consensus       126 e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~  204 (337)
                      |+|+. +|..+... ++.++.+.++.++.|++.+|.++|++++.|||+||.|.+|+.+|.+|++|||+++..+-+.    
T Consensus        81 e~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipv----  155 (292)
T KOG0662|consen   81 EFCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV----  155 (292)
T ss_pred             HHhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCce----
Confidence            99976 88888754 5789999999999999999999999999999999999999999999999999998776443    


Q ss_pred             CCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHhhcc
Q 019650          205 HNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICAICFG  283 (337)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~  283 (337)
                                ..-..-+.|..|.+|.++.+.   .-|+.+.|+||.|||+.|+.. |.+.|++.+-.+.+..+...+...
T Consensus       156 ----------rcysaevvtlwyrppdvlfga---kly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p  222 (292)
T KOG0662|consen  156 ----------RCYSAEVVTLWYRPPDVLFGA---KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTP  222 (292)
T ss_pred             ----------EeeeceeeeeeccCcceeeee---ehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCC
Confidence                      222334679999999999963   468999999999999999998 888888766666666655543322


Q ss_pred             CCCCCC------------------------CCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccC
Q 019650          284 ERLEMP------------------------ETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRS  327 (337)
Q Consensus       284 ~~~~~~------------------------~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~  327 (337)
                      ....+|                        +......+++++++|.-+|..|++++++++||||....
T Consensus       223 ~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~s  290 (292)
T KOG0662|consen  223 TEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDFS  290 (292)
T ss_pred             ccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccccC
Confidence            211111                        23456789999999999999999999999999998643

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.2e-40  Score=291.03  Aligned_cols=259  Identities=27%  Similarity=0.345  Sum_probs=205.6

Q ss_pred             cccccccccccCcceEEEEEEE----ccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEee-CCeE
Q 019650           47 SDLKKLTVLGHGNGGIVYKVRH----QKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTI-EGEI  121 (337)
Q Consensus        47 ~~y~~~~~lg~g~~~~v~~~~~----~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-~~~~  121 (337)
                      .-|++++.||+|+||.||++..    ..++..|++|.++..........+.+|+.+++.+.|+|++++++.+... ....
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            3478999999999999999974    3567889999987665555667788999999999999999999987664 2568


Q ss_pred             EEEEeccCCCCchHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccc
Q 019650          122 CFVMEHMERGSLFDSLRVR-KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETR  200 (337)
Q Consensus       122 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~  200 (337)
                      +++|||++|++|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~  163 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK  163 (284)
T ss_pred             EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccCc
Confidence            9999999999999999754 368999999999999999999999999999999999999999999999999987664322


Q ss_pred             cCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCC-----------C
Q 019650          201 NNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFG-----------E  269 (337)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~-----------~  269 (337)
                      ...           .......++..|+|||.+.    +..++.++|+||||+++|+|+++..|+....           .
T Consensus       164 ~~~-----------~~~~~~~~~~~y~apE~~~----~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~  228 (284)
T cd05079         164 EYY-----------TVKDDLDSPVFWYAPECLI----QSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHG  228 (284)
T ss_pred             cce-----------eecCCCCCCccccCHHHhc----cCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccc
Confidence            110           1111234667899999987    4578889999999999999999776542211           0


Q ss_pred             chhHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          270 KPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                      .............+.....+..++..+.+|+.+||+.+|++|||+.++++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  279 (284)
T cd05079         229 QMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG  279 (284)
T ss_pred             cccHHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            111112222222333444566788999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.6e-40  Score=285.44  Aligned_cols=251  Identities=25%  Similarity=0.385  Sum_probs=204.5

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEE
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICF  123 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~l  123 (337)
                      ...++|++.+.||.|++|.||+|.+. ++..||+|.++...  ...+.+.+|+.++++++|+|++++++.+.. .+..++
T Consensus         3 ~~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~l   78 (261)
T cd05068           3 IDRTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGT--MDPKDFLAEAQIMKKLRHPKLIQLYAVCTL-EEPIYI   78 (261)
T ss_pred             cchhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCc--ccHHHHHHHHHHHHHCCCCCccceeEEEec-CCCeee
Confidence            45678999999999999999999875 45679999987543  234567889999999999999999998765 678999


Q ss_pred             EEeccCCCCchHHhhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhcccc
Q 019650          124 VMEHMERGSLFDSLRVRK--KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRN  201 (337)
Q Consensus       124 v~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~  201 (337)
                      +||++++++|.+++....  .+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus        79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  158 (261)
T cd05068          79 VTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY  158 (261)
T ss_pred             eeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence            999999999999997644  689999999999999999999999999999999999999999999999999887653211


Q ss_pred             CCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHh
Q 019650          202 NNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICAI  280 (337)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~  280 (337)
                      ..             ......+..|+|||.+.    +..++.++|+||||+++|+|++ |+.||.+.....    .....
T Consensus       159 ~~-------------~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~----~~~~~  217 (261)
T cd05068         159 EA-------------REGAKFPIKWTAPEAAL----YNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE----VLQQV  217 (261)
T ss_pred             cc-------------cCCCcCceeccCccccc----cCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH----HHHHH
Confidence            10             01112346899999987    4578889999999999999999 999996543322    22222


Q ss_pred             hccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhc
Q 019650          281 CFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA  319 (337)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~  319 (337)
                      ........+...+..+.+++.+||+.+|.+||++.++++
T Consensus       218 ~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~  256 (261)
T cd05068         218 DQGYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQW  256 (261)
T ss_pred             HcCCCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence            223334455677899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1.3e-40  Score=286.59  Aligned_cols=251  Identities=27%  Similarity=0.419  Sum_probs=203.8

Q ss_pred             CccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 019650           45 NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFV  124 (337)
Q Consensus        45 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv  124 (337)
                      ..++|++.+.||.|++|+||.+.... +..+|+|.+....  ...+.+.+|+.++++++|+||+++++.+.+ ....+++
T Consensus         2 ~~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv   77 (256)
T cd05113           2 DPKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGS--MSEDEFIEEAKVMMKLSHEKLVQLYGVCTK-QRPIYIV   77 (256)
T ss_pred             ChHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCc--ccHHHHHHHHHHHhcCCCCCeeeEEEEEcc-CCCcEEE
Confidence            35689999999999999999998753 4469999886543  234567889999999999999999998765 5778999


Q ss_pred             EeccCCCCchHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCC
Q 019650          125 MEHMERGSLFDSLRVR-KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNN  203 (337)
Q Consensus       125 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~  203 (337)
                      |||+.+++|.+++... ..+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+......... 
T Consensus        78 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~-  156 (256)
T cd05113          78 TEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT-  156 (256)
T ss_pred             EEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCcee-
Confidence            9999999999999764 46899999999999999999999999999999999999999999999999988765432111 


Q ss_pred             CCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHhhc
Q 019650          204 NHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICAICF  282 (337)
Q Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~  282 (337)
                                  ......++..|+|||.+.    +..++.++|+||||+++|+|++ |..||.......    .......
T Consensus       157 ------------~~~~~~~~~~y~~pe~~~----~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~----~~~~~~~  216 (256)
T cd05113         157 ------------SSVGSKFPVRWSPPEVLL----YSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE----TVEKVSQ  216 (256)
T ss_pred             ------------ecCCCccChhhCCHHHHh----cCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH----HHHHHhc
Confidence                        001112567899999997    4568889999999999999999 999986543322    2222233


Q ss_pred             cCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          283 GERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       283 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                      ......+...+..+.+++.+||+.+|.+||++.+++++
T Consensus       217 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~  254 (256)
T cd05113         217 GLRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS  254 (256)
T ss_pred             CCCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence            33444455678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-41  Score=304.42  Aligned_cols=258  Identities=28%  Similarity=0.391  Sum_probs=218.9

Q ss_pred             CCCCccCccccccccccccCcceEEEEEEEccCC----ceEEEEEeec--CCchHhHHHHHHHHHHHHhcCCCCceeeee
Q 019650           39 TSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSN----SIYALKVLNT--TSSTIIRHQAAHEAEILKRLDSQFIVKCHA  112 (337)
Q Consensus        39 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~----~~vaiK~~~~--~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~  112 (337)
                      -.+|+..-++..+.++||+|+||.||+|.....+    ..||+|..+.  ........++.+|++++++++|+||++++|
T Consensus       149 r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yG  228 (474)
T KOG0194|consen  149 RQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYG  228 (474)
T ss_pred             ccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence            3467888889999999999999999999987432    2389999875  245667888999999999999999999999


Q ss_pred             eEEeeCCeEEEEEeccCCCCchHHhhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeecc
Q 019650          113 VFYTIEGEICFVMEHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFG  191 (337)
Q Consensus       113 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg  191 (337)
                      +... +..+++|||+|.||+|.++|+..+ .++..+...++.+.+.||+|||+++++||||-.+|+|++.++.+||+|||
T Consensus       229 Va~~-~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFG  307 (474)
T KOG0194|consen  229 VAVL-EEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFG  307 (474)
T ss_pred             EEcC-CCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccc
Confidence            9877 677899999999999999999887 49999999999999999999999999999999999999999999999999


Q ss_pred             CccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCc
Q 019650          192 VSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEK  270 (337)
Q Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~~~~~  270 (337)
                      ++.....-...              ....-.+.+|+|||.+.    ...++.++||||||+++||+++ |..||.+....
T Consensus       308 Ls~~~~~~~~~--------------~~~~klPirWLAPEtl~----~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~  369 (474)
T KOG0194|consen  308 LSRAGSQYVMK--------------KFLKKLPIRWLAPETLN----TGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY  369 (474)
T ss_pred             cccCCcceeec--------------cccccCcceecChhhhc----cCccccccchhheeeeEEeeeccCCCCCCCCCHH
Confidence            98765411111              10112578999999999    4589999999999999999999 88899775443


Q ss_pred             hhHHHHHHHh-hccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhc
Q 019650          271 PDLMALICAI-CFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA  319 (337)
Q Consensus       271 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~  319 (337)
                          .+.... ..+.+...+...+..+..++.+||..+|+.|||+.++.+
T Consensus       370 ----~v~~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~  415 (474)
T KOG0194|consen  370 ----EVKAKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK  415 (474)
T ss_pred             ----HHHHHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence                344444 567777888888999999999999999999999998765

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=1.4e-40  Score=319.92  Aligned_cols=266  Identities=21%  Similarity=0.250  Sum_probs=203.2

Q ss_pred             ccccccccccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEE
Q 019650           46 ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICF  123 (337)
Q Consensus        46 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~l  123 (337)
                      +++|.+.+.||.|+||.||+|.+..+++.||+|++....  .....+++.+|+.++++++|||++++++.+.+ +...++
T Consensus         1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d-~~~lyL   79 (932)
T PRK13184          1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSD-GDPVYY   79 (932)
T ss_pred             CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEee-CCEEEE
Confidence            468999999999999999999999999999999987542  23445678899999999999999999998766 678999


Q ss_pred             EEeccCCCCchHHhhhc-----------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccC
Q 019650          124 VMEHMERGSLFDSLRVR-----------KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGV  192 (337)
Q Consensus       124 v~e~~~~~~L~~~l~~~-----------~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~  192 (337)
                      +|||++|++|.+++...           ...+...+..++.||+.||+|||+.|++||||||+||+++.++.++|+|||+
T Consensus        80 VMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGL  159 (932)
T PRK13184         80 TMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGA  159 (932)
T ss_pred             EEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCc
Confidence            99999999999988631           2355677889999999999999999999999999999999999999999999


Q ss_pred             ccchhccccCCCCCC----CCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Q 019650          193 SRIVEETRNNNNHNN----NNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFG  268 (337)
Q Consensus       193 ~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~  268 (337)
                      +..............    .............+||+.|+|||++.    +..++.++||||||+++|+|+||..||....
T Consensus       160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~----g~~~S~kSDIWSLGVILyELLTG~~PF~~~~  235 (932)
T PRK13184        160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLL----GVPASESTDIYALGVILYQMLTLSFPYRRKK  235 (932)
T ss_pred             ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhc----CCCCCcHhHHHHHHHHHHHHHHCCCCCCCcc
Confidence            987622111000000    00000012223457999999999998    5578999999999999999999999996532


Q ss_pred             CchhHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHh
Q 019650          269 EKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELL  318 (337)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil  318 (337)
                      .......  ..............++..+.+++.+||+.||++|++..+.+
T Consensus       236 ~~ki~~~--~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeL  283 (932)
T PRK13184        236 GRKISYR--DVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQEL  283 (932)
T ss_pred             hhhhhhh--hhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence            2211111  11111111111235788999999999999999998655544

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-40  Score=292.33  Aligned_cols=258  Identities=22%  Similarity=0.316  Sum_probs=203.1

Q ss_pred             CccccccccccccCcceEEEEEEEccCC--------------ceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceee
Q 019650           45 NISDLKKLTVLGHGNGGIVYKVRHQKSN--------------SIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKC  110 (337)
Q Consensus        45 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~--------------~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~  110 (337)
                      ..++|++.+.||+|+||.||+|.+..++              ..||+|.++..........+.+|++++++++|+|++++
T Consensus         3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~   82 (295)
T cd05097           3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRL   82 (295)
T ss_pred             chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence            3468999999999999999999875432              34899998766555556678899999999999999999


Q ss_pred             eeeEEeeCCeEEEEEeccCCCCchHHhhhcC------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeE
Q 019650          111 HAVFYTIEGEICFVMEHMERGSLFDSLRVRK------------KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLL  178 (337)
Q Consensus       111 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nil  178 (337)
                      ++.+.. ....++||||+++++|.+++....            .+++..+..++.|++.||+|||+.|++|+||+|+||+
T Consensus        83 ~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil  161 (295)
T cd05097          83 LGVCVS-DDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL  161 (295)
T ss_pred             EEEEcC-CCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEE
Confidence            998866 678999999999999999986432            3688899999999999999999999999999999999


Q ss_pred             EcCCCcEEEeeccCccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHH
Q 019650          179 INGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECL  258 (337)
Q Consensus       179 i~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~  258 (337)
                      ++.++.++|+|||++.........            .......++..|+|||.+.    +..++.++|+||||+++|+|+
T Consensus       162 l~~~~~~kl~dfg~~~~~~~~~~~------------~~~~~~~~~~~y~aPE~~~----~~~~~~~~DvwSlG~~l~el~  225 (295)
T cd05097         162 VGNHYTIKIADFGMSRNLYSGDYY------------RIQGRAVLPIRWMAWESIL----LGKFTTASDVWAFGVTLWEMF  225 (295)
T ss_pred             EcCCCcEEecccccccccccCcce------------eccCcCcCceeecChhhhc----cCCcCchhhHHHHHHHHHHHH
Confidence            999999999999998765322110            1111223567899999987    456889999999999999999


Q ss_pred             h--CCCCCCCCCCchhHHHHHHHhh---ccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhc
Q 019650          259 V--GHYPLIGFGEKPDLMALICAIC---FGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA  319 (337)
Q Consensus       259 t--g~~pf~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~  319 (337)
                      +  +..||.................   .......++..+..+.+|+.+||..+|++|||++++++
T Consensus       226 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~  291 (295)
T cd05097         226 TLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH  291 (295)
T ss_pred             HcCCCCCCcccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            8  6678765443332222211111   11112334557899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=1.6e-40  Score=287.96  Aligned_cols=257  Identities=25%  Similarity=0.411  Sum_probs=207.1

Q ss_pred             CccccccccccccCcceEEEEEEEccCCc---eEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeE
Q 019650           45 NISDLKKLTVLGHGNGGIVYKVRHQKSNS---IYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEI  121 (337)
Q Consensus        45 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~  121 (337)
                      ..++|++.+.||.|+||.||+|.+..+++   .|++|.+...........+..|+.++++++|+|++++++.+.. +...
T Consensus         2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~-~~~~   80 (269)
T cd05065           2 DVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK-SRPV   80 (269)
T ss_pred             ChHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECC-CCce
Confidence            35679999999999999999999876654   5999998765555556788899999999999999999998765 6788


Q ss_pred             EEEEeccCCCCchHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccc
Q 019650          122 CFVMEHMERGSLFDSLRVR-KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETR  200 (337)
Q Consensus       122 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~  200 (337)
                      +++|||+++++|.+++... +.+++..++.++.|++.||+|||++|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~  160 (269)
T cd05065          81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT  160 (269)
T ss_pred             EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence            9999999999999999753 568999999999999999999999999999999999999999999999999887654322


Q ss_pred             cCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHH
Q 019650          201 NNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICA  279 (337)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~  279 (337)
                      .....         ........+..|+|||.+.    +..++.++|+||||+++||+++ |..||.......    ....
T Consensus       161 ~~~~~---------~~~~~~~~~~~y~~PE~~~----~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~----~~~~  223 (269)
T cd05065         161 SDPTY---------TSSLGGKIPIRWTAPEAIA----YRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD----VINA  223 (269)
T ss_pred             ccccc---------ccccCCCcceeecCHhHhc----cCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH----HHHH
Confidence            11110         0001111245799999998    4577889999999999999887 999996543322    2222


Q ss_pred             hhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhc
Q 019650          280 ICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA  319 (337)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~  319 (337)
                      .........+..++..+.+++.+||..+|++||++++++.
T Consensus       224 i~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  263 (269)
T cd05065         224 IEQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVS  263 (269)
T ss_pred             HHcCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            2233344455677899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1.8e-40  Score=291.65  Aligned_cols=258  Identities=25%  Similarity=0.324  Sum_probs=206.0

Q ss_pred             CccccccccccccCcceEEEEEEEccCC----------------ceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCce
Q 019650           45 NISDLKKLTVLGHGNGGIVYKVRHQKSN----------------SIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIV  108 (337)
Q Consensus        45 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~----------------~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~  108 (337)
                      ..++|++++.||+|+||.||+|.+..++                ..||+|.+.........+.+.+|+.++.+++|+|++
T Consensus         3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~   82 (296)
T cd05051           3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIA   82 (296)
T ss_pred             chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEe
Confidence            3568999999999999999999876533                558999988765555667788999999999999999


Q ss_pred             eeeeeEEeeCCeEEEEEeccCCCCchHHhhhcC-----------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCe
Q 019650          109 KCHAVFYTIEGEICFVMEHMERGSLFDSLRVRK-----------KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNL  177 (337)
Q Consensus       109 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----------~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Ni  177 (337)
                      ++++.+.. +...+++||++++++|.+++....           .+++..++.++.|++.||+|||++|++|+||||+||
T Consensus        83 ~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Ni  161 (296)
T cd05051          83 RLLGVCTV-DPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNC  161 (296)
T ss_pred             EEEEEEec-CCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhce
Confidence            99998766 688999999999999999997655           689999999999999999999999999999999999


Q ss_pred             EEcCCCcEEEeeccCccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHH
Q 019650          178 LINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLEC  257 (337)
Q Consensus       178 li~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l  257 (337)
                      +++.++.++|+|||.+.........            .......++..|+|||.+.    +..++.++||||||+++|+|
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~------------~~~~~~~~~~~y~aPE~~~----~~~~~~~~Dv~slG~~l~el  225 (296)
T cd05051         162 LVGKNYTIKIADFGMSRNLYSSDYY------------RVQGRAPLPIRWMAWESVL----LGKFTTKSDVWAFGVTLWEI  225 (296)
T ss_pred             eecCCCceEEccccceeecccCcce------------eecCcCCCCceecCHHHhh----cCCCCccchhhhhHHHHHHH
Confidence            9999999999999998765332111            1112234677899999987    44688999999999999999


Q ss_pred             Hh--CCCCCCCCCCchhHHHHHHHh---hccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhc
Q 019650          258 LV--GHYPLIGFGEKPDLMALICAI---CFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA  319 (337)
Q Consensus       258 ~t--g~~pf~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~  319 (337)
                      ++  +..||................   ........+...+..+.+++.+||+.||.+|||+.++++
T Consensus       226 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~  292 (296)
T cd05051         226 LTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL  292 (296)
T ss_pred             HhcCCCCCCCCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence            98  677876543332222221110   011112234456789999999999999999999999965

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=2.1e-40  Score=301.21  Aligned_cols=259  Identities=26%  Similarity=0.358  Sum_probs=209.5

Q ss_pred             CccCccccccccccccCcceEEEEEEEc-----cCCceEEEEEeecCCchHhHHHHHHHHHHHHhcC-CCCceeeeeeEE
Q 019650           42 DVENISDLKKLTVLGHGNGGIVYKVRHQ-----KSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLD-SQFIVKCHAVFY  115 (337)
Q Consensus        42 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~  115 (337)
                      +....++|.+.+.||.|+||.||+|.+.     .++..||+|+++........+.+.+|+.++.++. |+||+++++.+.
T Consensus        32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~  111 (401)
T cd05107          32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT  111 (401)
T ss_pred             ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence            5667789999999999999999999863     3556899999986654444567888999999997 999999999886


Q ss_pred             eeCCeEEEEEeccCCCCchHHhhhcC------------------------------------------------------
Q 019650          116 TIEGEICFVMEHMERGSLFDSLRVRK------------------------------------------------------  141 (337)
Q Consensus       116 ~~~~~~~lv~e~~~~~~L~~~l~~~~------------------------------------------------------  141 (337)
                      . ....++||||+++|+|.+++...+                                                      
T Consensus       112 ~-~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (401)
T cd05107         112 K-GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV  190 (401)
T ss_pred             c-CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence            6 678999999999999999986431                                                      


Q ss_pred             --------------------------------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCe
Q 019650          142 --------------------------------------------KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNL  177 (337)
Q Consensus       142 --------------------------------------------~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Ni  177 (337)
                                                                  .+++..+..++.||+.||.|||+.|++|+||||+||
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~Ni  270 (401)
T cd05107         191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNV  270 (401)
T ss_pred             chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceE
Confidence                                                        256677889999999999999999999999999999


Q ss_pred             EEcCCCcEEEeeccCccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHH
Q 019650          178 LINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLEC  257 (337)
Q Consensus       178 li~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l  257 (337)
                      +++.++.++|+|||++..........            ......++..|+|||.+.    +..++.++|+||||+++|||
T Consensus       271 Ll~~~~~~kL~DfGla~~~~~~~~~~------------~~~~~~~~~~y~aPE~~~----~~~~~~~~DvwslGvil~e~  334 (401)
T cd05107         271 LICEGKLVKICDFGLARDIMRDSNYI------------SKGSTFLPLKWMAPESIF----NNLYTTLSDVWSFGILLWEI  334 (401)
T ss_pred             EEeCCCEEEEEecCcceecccccccc------------cCCCcCCCCceeChHHhc----CCCCCcHhHHHHHHHHHHHH
Confidence            99999999999999987653321110            011224678899999997    45678899999999999999


Q ss_pred             Hh-CCCCCCCCCCchhHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          258 LV-GHYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       258 ~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                      ++ |..||......+.....   ...+.....+..++..+.+++.+||..+|.+||++++|++.
T Consensus       335 l~~g~~P~~~~~~~~~~~~~---~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~  395 (401)
T cd05107         335 FTLGGTPYPELPMNEQFYNA---IKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL  395 (401)
T ss_pred             HHcCCCCCCCCCchHHHHHH---HHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            98 88998665433332222   22333445566778999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=5.7e-41  Score=300.68  Aligned_cols=267  Identities=29%  Similarity=0.395  Sum_probs=207.2

Q ss_pred             ccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeC-------
Q 019650           46 ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIE-------  118 (337)
Q Consensus        46 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~-------  118 (337)
                      .++|.+.+.||.|++|.||+|.+..++..||+|.+..... ...+.+.+|+.++++++|+|++++++.+....       
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~-~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP-QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDV   82 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC-chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccc
Confidence            4789999999999999999999999999999999876543 34466778999999999999999998765422       


Q ss_pred             ------CeEEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcC-CCcEEEeecc
Q 019650          119 ------GEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLING-KGEVKIADFG  191 (337)
Q Consensus       119 ------~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~-~~~~~l~Dfg  191 (337)
                            ...+++|||+++ +|.+++.. ..+++..++.++.||+.||.|||+.|++|+||+|+||+++. ++.++++|||
T Consensus        83 ~~~~~~~~~~lv~e~~~~-~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg  160 (342)
T cd07854          83 GSLTELNSVYIVQEYMET-DLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFG  160 (342)
T ss_pred             ccccccceEEEEeecccc-cHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCcc
Confidence                  357899999974 88888864 46899999999999999999999999999999999999975 4578999999


Q ss_pred             CccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCch
Q 019650          192 VSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP  271 (337)
Q Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~  271 (337)
                      .+..........           .......++..|+|||.+..   +..++.++|+||||+++|+|++|+.||.......
T Consensus       161 ~~~~~~~~~~~~-----------~~~~~~~~~~~y~aPE~~~~---~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~  226 (342)
T cd07854         161 LARIVDPHYSHK-----------GYLSEGLVTKWYRSPRLLLS---PNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELE  226 (342)
T ss_pred             cceecCCccccc-----------cccccccccccccCHHHHhC---ccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            987653321111           11112246888999998753   2457889999999999999999999997654332


Q ss_pred             hHHHHHHHhh--------------------ccCCC-----CCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCcccccc
Q 019650          272 DLMALICAIC--------------------FGERL-----EMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKR  326 (337)
Q Consensus       272 ~~~~~~~~~~--------------------~~~~~-----~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~  326 (337)
                      ..........                    .....     ...+..+..+.+++.+||..||.+|||+.+++.||||+..
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~  306 (342)
T cd07854         227 QMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY  306 (342)
T ss_pred             HHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccc
Confidence            2222211100                    00000     1123567889999999999999999999999999999865


Q ss_pred             CCC
Q 019650          327 SSS  329 (337)
Q Consensus       327 ~~~  329 (337)
                      .+.
T Consensus       307 ~~~  309 (342)
T cd07854         307 SCP  309 (342)
T ss_pred             cCC
Confidence            443

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=2.6e-40  Score=293.07  Aligned_cols=257  Identities=26%  Similarity=0.380  Sum_probs=206.8

Q ss_pred             CccCccccccccccccCcceEEEEEEEc-------cCCceEEEEEeecCCchHhHHHHHHHHHHHHhc-CCCCceeeeee
Q 019650           42 DVENISDLKKLTVLGHGNGGIVYKVRHQ-------KSNSIYALKVLNTTSSTIIRHQAAHEAEILKRL-DSQFIVKCHAV  113 (337)
Q Consensus        42 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~  113 (337)
                      +....++|++.+.||.|++|.||+|.+.       .....+|+|.++..........+.+|+.+++++ .|+||++++++
T Consensus         7 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~   86 (314)
T cd05099           7 WEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGV   86 (314)
T ss_pred             ccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEE
Confidence            3455689999999999999999999863       234568999987655445566788899999999 69999999998


Q ss_pred             EEeeCCeEEEEEeccCCCCchHHhhhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCe
Q 019650          114 FYTIEGEICFVMEHMERGSLFDSLRVR----------------KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNL  177 (337)
Q Consensus       114 ~~~~~~~~~lv~e~~~~~~L~~~l~~~----------------~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Ni  177 (337)
                      +.. +...+++|||+++++|.+++...                ..+++..+..++.|++.||.|||++|++|+||||+||
T Consensus        87 ~~~-~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Ni  165 (314)
T cd05099          87 CTQ-EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNV  165 (314)
T ss_pred             Ecc-CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeE
Confidence            766 67899999999999999999653                3478899999999999999999999999999999999


Q ss_pred             EEcCCCcEEEeeccCccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHH
Q 019650          178 LINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLEC  257 (337)
Q Consensus       178 li~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l  257 (337)
                      +++.++.++|+|||.+..........            ......++..|+|||.+.    +..++.++|+||||+++|+|
T Consensus       166 ll~~~~~~kL~Dfg~~~~~~~~~~~~------------~~~~~~~~~~y~aPE~~~----~~~~~~~~DiwslG~~l~el  229 (314)
T cd05099         166 LVTEDNVMKIADFGLARGVHDIDYYK------------KTSNGRLPVKWMAPEALF----DRVYTHQSDVWSFGILMWEI  229 (314)
T ss_pred             EEcCCCcEEEcccccccccccccccc------------ccccCCCCccccCHHHHc----cCCcCccchhhHHHHHHHHH
Confidence            99999999999999997654321110            001112446799999997    45788899999999999999


Q ss_pred             Hh-CCCCCCCCCCchhHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhc
Q 019650          258 LV-GHYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA  319 (337)
Q Consensus       258 ~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~  319 (337)
                      ++ |..||......    ..............+..++..+.+++.+||+.+|++|||+.++++
T Consensus       230 ~~~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~  288 (314)
T cd05099         230 FTLGGSPYPGIPVE----ELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE  288 (314)
T ss_pred             HhCCCCCCCCCCHH----HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            99 88998654322    222223334445566778899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-40  Score=284.46  Aligned_cols=245  Identities=35%  Similarity=0.546  Sum_probs=207.0

Q ss_pred             cccCcceEEEEEEEccCCceEEEEEeecCCc--hHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEeccCCCC
Q 019650           55 LGHGNGGIVYKVRHQKSNSIYALKVLNTTSS--TIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGS  132 (337)
Q Consensus        55 lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~  132 (337)
                      ||.|++|.||++.+..++..+++|++.....  ....+.+..|+.++++++|+|++++++.+.. +...+++||++++++
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e~~~~~~   79 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQT-EEKLYLVLEYAPGGE   79 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeec-CCeeEEEEecCCCCc
Confidence            6899999999999988899999999876532  2245677889999999999999999998765 788999999999999


Q ss_pred             chHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCCCCCCCCCc
Q 019650          133 LFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNN  212 (337)
Q Consensus       133 L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~  212 (337)
                      |.+++.....+++..+..++.|++.+|.+||+.+++|+||+|+||+++.++.++|+|||.+........           
T Consensus        80 L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~-----------  148 (250)
T cd05123          80 LFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS-----------  148 (250)
T ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCC-----------
Confidence            999998888899999999999999999999999999999999999999999999999999877644321           


Q ss_pred             cccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhccCCCCCCCCC
Q 019650          213 IGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPETA  292 (337)
Q Consensus       213 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (337)
                         ......++..|+|||...    +...+.++|+||||+++|++++|..||.....    ......... ....++...
T Consensus       149 ---~~~~~~~~~~~~~Pe~~~----~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~----~~~~~~~~~-~~~~~~~~~  216 (250)
T cd05123         149 ---RTNTFCGTPEYLAPEVLL----GKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR----KEIYEKILK-DPLRFPEFL  216 (250)
T ss_pred             ---cccCCcCCccccChHHhC----CCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH----HHHHHHHhc-CCCCCCCCC
Confidence               112234788999999997    34578899999999999999999999965432    112222222 345667777


Q ss_pred             CHHHHHHHHHHhhcCcCCCCCH---HHHhcCccc
Q 019650          293 SPEFRRFVRSCLEKDWRKRGTV---EELLAYPFV  323 (337)
Q Consensus       293 ~~~~~~li~~~l~~~p~~R~s~---~eil~hp~f  323 (337)
                      +..+.+++.+||..||++||++   +++++||||
T Consensus       217 ~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f  250 (250)
T cd05123         217 SPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF  250 (250)
T ss_pred             CHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence            9999999999999999999999   999999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=2.6e-40  Score=284.80  Aligned_cols=246  Identities=26%  Similarity=0.431  Sum_probs=200.1

Q ss_pred             ccccCcceEEEEEEEc--cCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEeccCCC
Q 019650           54 VLGHGNGGIVYKVRHQ--KSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERG  131 (337)
Q Consensus        54 ~lg~g~~~~v~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~  131 (337)
                      .||.|+||.||+|.+.  .++..||+|++.........+.+.+|+.++++++|+||+++++.+.  ....++||||++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~--~~~~~lv~e~~~~~   79 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE--AEALMLVMEMASGG   79 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc--CCCeEEEEEeCCCC
Confidence            4899999999999775  4456799999877655555677889999999999999999999764  46789999999999


Q ss_pred             CchHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCCCCCCCC
Q 019650          132 SLFDSLRV-RKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNN  210 (337)
Q Consensus       132 ~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~  210 (337)
                      +|.+++.. ...+++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||.+...........      
T Consensus        80 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~------  153 (257)
T cd05115          80 PLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK------  153 (257)
T ss_pred             CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCcccee------
Confidence            99999974 45789999999999999999999999999999999999999999999999999875543221110      


Q ss_pred             CccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHhhccCCCCCC
Q 019650          211 NNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICAICFGERLEMP  289 (337)
Q Consensus       211 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  289 (337)
                           ......++..|+|||.+.    +..++.++|+||||+++|++++ |..||......    ........+.....+
T Consensus       154 -----~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~----~~~~~~~~~~~~~~~  220 (257)
T cd05115         154 -----ARSAGKWPLKWYAPECIN----FRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP----EVMSFIEQGKRLDCP  220 (257)
T ss_pred             -----ccCCCCCCcccCCHHHHc----cCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH----HHHHHHHCCCCCCCC
Confidence                 001112357899999987    3467889999999999999997 99999664332    223333444556667


Q ss_pred             CCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          290 ETASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       290 ~~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                      ...+..+.+++.+||..+|++||++.++.+.
T Consensus       221 ~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~  251 (257)
T cd05115         221 AECPPEMYALMKDCWIYKWEDRPNFAKVEER  251 (257)
T ss_pred             CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            7789999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=1.2e-40  Score=293.59  Aligned_cols=262  Identities=29%  Similarity=0.389  Sum_probs=207.1

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCc-hHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeC----
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSS-TIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIE----  118 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~----  118 (337)
                      ...++|++.+.||.|++|+||+|.+..+++.|++|.++.... ......+.+|+.++++++|+|++++++.+.+..    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            346899999999999999999999998999999999876432 223345678999999999999999999876532    


Q ss_pred             -----CeEEEEEeccCCCCchHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccC
Q 019650          119 -----GEICFVMEHMERGSLFDSLRVR-KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGV  192 (337)
Q Consensus       119 -----~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~  192 (337)
                           ..+++++||+++ ++.+.+... ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~  162 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGL  162 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcccc
Confidence                 378999999976 777777653 4689999999999999999999999999999999999999999999999999


Q ss_pred             ccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchh
Q 019650          193 SRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPD  272 (337)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~  272 (337)
                      +..........             .....++..|+|||.+...   ..++.++|+||||+++|+|++|+.||........
T Consensus       163 ~~~~~~~~~~~-------------~~~~~~~~~y~~PE~~~~~---~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~  226 (302)
T cd07864         163 ARLYNSEESRP-------------YTNKVITLWYRPPELLLGE---ERYGPAIDVWSCGCILGELFTKKPIFQANQELAQ  226 (302)
T ss_pred             cccccCCcccc-------------cccceeccCccChHHhcCC---CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence            87664432110             0111357789999988632   3467899999999999999999999975443333


Q ss_pred             HHHHHHHhhccCCC--------------------------CCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccc
Q 019650          273 LMALICAICFGERL--------------------------EMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV  323 (337)
Q Consensus       273 ~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f  323 (337)
                      ...+... ......                          .....++..+.+++.+||+.+|++|||+++++.||||
T Consensus       227 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         227 LELISRL-CGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             HHHHHHH-hCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence            3222221 111100                          0112457899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=7.1e-41  Score=313.19  Aligned_cols=264  Identities=23%  Similarity=0.362  Sum_probs=192.0

Q ss_pred             CccccccccccccCcceEEEEEEEccCC-ceEEEEE--------------eec--CCchHhHHHHHHHHHHHHhcCCCCc
Q 019650           45 NISDLKKLTVLGHGNGGIVYKVRHQKSN-SIYALKV--------------LNT--TSSTIIRHQAAHEAEILKRLDSQFI  107 (337)
Q Consensus        45 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~-~~vaiK~--------------~~~--~~~~~~~~~~~~e~~~~~~l~~~~i  107 (337)
                      ..++|++++.||+|+||+||+|...... ...+.|.              +..  .........+.+|+.++++++|+||
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI  225 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI  225 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence            3578999999999999999998764322 1111110              100  1122234567889999999999999


Q ss_pred             eeeeeeEEeeCCeEEEEEeccCCCCchHHhhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCC
Q 019650          108 VKCHAVFYTIEGEICFVMEHMERGSLFDSLRVR-----KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGK  182 (337)
Q Consensus       108 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~  182 (337)
                      +++++++.. ....|++++++.+ +|.+++...     .......++.++.||+.||.|||++||+||||||+|||++.+
T Consensus       226 v~l~~~~~~-~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~  303 (501)
T PHA03210        226 LKIEEILRS-EANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCD  303 (501)
T ss_pred             CcEeEEEEE-CCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC
Confidence            999998766 6788999999954 787776532     234467788999999999999999999999999999999999


Q ss_pred             CcEEEeeccCccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCC
Q 019650          183 GEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHY  262 (337)
Q Consensus       183 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~  262 (337)
                      +.++|+|||++........             ......+|+..|+|||++.    +..++.++|||||||++|||++|..
T Consensus       304 ~~vkL~DFGla~~~~~~~~-------------~~~~~~~gt~~y~aPE~~~----~~~~~~~~DiwSlGvil~ell~~~~  366 (501)
T PHA03210        304 GKIVLGDFGTAMPFEKERE-------------AFDYGWVGTVATNSPEILA----GDGYCEITDIWSCGLILLDMLSHDF  366 (501)
T ss_pred             CCEEEEeCCCceecCcccc-------------cccccccCCcCCCCchhhc----CCCCCcHHHHHHHHHHHHHHHHCCC
Confidence            9999999999976643211             1122346899999999998    4578899999999999999999875


Q ss_pred             CCCCCCCch---hHHHHHHHhh--ccC-------------------C-CCC-----CCCCCHHHHHHHHHHhhcCcCCCC
Q 019650          263 PLIGFGEKP---DLMALICAIC--FGE-------------------R-LEM-----PETASPEFRRFVRSCLEKDWRKRG  312 (337)
Q Consensus       263 pf~~~~~~~---~~~~~~~~~~--~~~-------------------~-~~~-----~~~~~~~~~~li~~~l~~~p~~R~  312 (337)
                      ++.......   .....+....  ...                   . ..+     ....+..+.++|.+||+.||.+||
T Consensus       367 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rp  446 (501)
T PHA03210        367 CPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRP  446 (501)
T ss_pred             CCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCc
Confidence            443222111   1111111100  000                   0 000     013456788889999999999999


Q ss_pred             CHHHHhcCccccccC
Q 019650          313 TVEELLAYPFVTKRS  327 (337)
Q Consensus       313 s~~eil~hp~f~~~~  327 (337)
                      |+.|+|.||||.+..
T Consensus       447 sa~elL~hp~f~~~~  461 (501)
T PHA03210        447 GAAELLALPLFSAEE  461 (501)
T ss_pred             CHHHHhhChhhhcCC
Confidence            999999999998743

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=7.8e-41  Score=298.20  Aligned_cols=268  Identities=22%  Similarity=0.346  Sum_probs=203.7

Q ss_pred             cccccC--cceEEEEEEEccCCceEEEEEeecCC-chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEeccC
Q 019650           53 TVLGHG--NGGIVYKVRHQKSNSIYALKVLNTTS-STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHME  129 (337)
Q Consensus        53 ~~lg~g--~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~  129 (337)
                      ..||.|  ++|+||++.+..+++.||+|++.... .....+.+.+|+.+++.++|+||+++++++.. +...++||||+.
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~-~~~~~~v~e~~~   82 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTT-GSWLWVISPFMA   82 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEec-CCceEEEEeccc
Confidence            456666  99999999999999999999987643 33345678889999999999999999999876 678999999999


Q ss_pred             CCCchHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCCCCC
Q 019650          130 RGSLFDSLRVR--KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNN  207 (337)
Q Consensus       130 ~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~  207 (337)
                      +++|.+++...  ..+++..+..++.|++.||+|||+.|++|+||||+||+++.++.++++||+................
T Consensus        83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (328)
T cd08226          83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVY  162 (328)
T ss_pred             CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccc
Confidence            99999999764  3589999999999999999999999999999999999999999999999986544322111100000


Q ss_pred             CCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhc-----
Q 019650          208 NNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICF-----  282 (337)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~-----  282 (337)
                             .......++..|+|||++...  ...++.++|+||||+++|+|++|..||..................     
T Consensus       163 -------~~~~~~~~~~~y~aPE~~~~~--~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  233 (328)
T cd08226         163 -------DFPQFSTSVLPWLSPELLRQD--LYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDI  233 (328)
T ss_pred             -------cccccccCccCccChhhhcCC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccc
Confidence                   000111245679999999743  135788999999999999999999999764332222111110000     


Q ss_pred             -------------------------------------cCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccc
Q 019650          283 -------------------------------------GERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTK  325 (337)
Q Consensus       283 -------------------------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~  325 (337)
                                                           ..........+..+.+++.+||..||++|||++++|+||||++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~  313 (328)
T cd08226         234 TTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQ  313 (328)
T ss_pred             cccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHH
Confidence                                                 0000011234667999999999999999999999999999998


Q ss_pred             cCCCc
Q 019650          326 RSSSS  330 (337)
Q Consensus       326 ~~~~~  330 (337)
                      ...+.
T Consensus       314 ~~~~~  318 (328)
T cd08226         314 VKEQT  318 (328)
T ss_pred             HHHhc
Confidence            87654

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=2e-40  Score=289.15  Aligned_cols=255  Identities=22%  Similarity=0.255  Sum_probs=208.2

Q ss_pred             CccccccccccccCcceEEEEEEEcc----CCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCe
Q 019650           45 NISDLKKLTVLGHGNGGIVYKVRHQK----SNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGE  120 (337)
Q Consensus        45 ~~~~y~~~~~lg~g~~~~v~~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~  120 (337)
                      ..++|.+.+.||+|+||.||+|.+..    ++..|++|.+...........+.+|+.++++++|+|++++++.+......
T Consensus         4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   83 (280)
T cd05043           4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP   83 (280)
T ss_pred             chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            46789999999999999999999875    35789999987665556677788999999999999999999987765677


Q ss_pred             EEEEEeccCCCCchHHhhhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccC
Q 019650          121 ICFVMEHMERGSLFDSLRVR--------KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGV  192 (337)
Q Consensus       121 ~~lv~e~~~~~~L~~~l~~~--------~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~  192 (337)
                      .+++++|+++++|.+++...        ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||+
T Consensus        84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g~  163 (280)
T cd05043          84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNAL  163 (280)
T ss_pred             CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCCC
Confidence            89999999999999998653        3588999999999999999999999999999999999999999999999999


Q ss_pred             ccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCch
Q 019650          193 SRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKP  271 (337)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~~~~~~  271 (337)
                      +..+........            .....++..|+|||++.    +..++.++||||||+++|++++ |+.||..... .
T Consensus       164 ~~~~~~~~~~~~------------~~~~~~~~~y~apE~~~----~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-~  226 (280)
T cd05043         164 SRDLFPMDYHCL------------GDNENRPVKWMALESLV----NKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP-F  226 (280)
T ss_pred             cccccCCceEEe------------CCCCCcchhccCHHHHh----cCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH-H
Confidence            876543221100            00112567899999997    4578899999999999999999 9999965422 2


Q ss_pred             hHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhc
Q 019650          272 DLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA  319 (337)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~  319 (337)
                         ..............+..+++.+.+++.+||..+|++|||+.++++
T Consensus       227 ---~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  271 (280)
T cd05043         227 ---EMAAYLKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQ  271 (280)
T ss_pred             ---HHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence               222222333344445567899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.6e-40  Score=283.72  Aligned_cols=245  Identities=27%  Similarity=0.415  Sum_probs=205.5

Q ss_pred             CccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 019650           45 NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFV  124 (337)
Q Consensus        45 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv  124 (337)
                      ..++|++.+.||.|++|.||+|...  ++.|++|.+.....  ..+.+.+|+.+++.++|+|++++++.+.. ....++|
T Consensus         4 ~~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~v   78 (256)
T cd05039           4 NSKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST--AAQAFLAEASVMTTLRHPNLVQLLGVVLQ-GNPLYIV   78 (256)
T ss_pred             ChhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh--HHHHHHHHHHHHHhcCCcceeeeEEEEcC-CCCeEEE
Confidence            4678999999999999999999875  77899999976543  46778889999999999999999998776 6889999


Q ss_pred             EeccCCCCchHHhhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccC
Q 019650          125 MEHMERGSLFDSLRVRK--KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNN  202 (337)
Q Consensus       125 ~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~  202 (337)
                      |||+++++|.+++....  .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+........ 
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-  157 (256)
T cd05039          79 TEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-  157 (256)
T ss_pred             EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence            99999999999997655  689999999999999999999999999999999999999999999999999876632211 


Q ss_pred             CCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHhh
Q 019650          203 NNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICAIC  281 (337)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~  281 (337)
                                      ....+..|+|||.+.    +..++.++|+||||+++|++++ |..||...... .   ......
T Consensus       158 ----------------~~~~~~~~~ape~~~----~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-~---~~~~~~  213 (256)
T cd05039         158 ----------------SGKLPVKWTAPEALR----EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-D---VVPHVE  213 (256)
T ss_pred             ----------------cCCCcccccCchhhc----CCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH-H---HHHHHh
Confidence                            112466899999987    4567889999999999999998 99998654322 2   222222


Q ss_pred             ccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhc
Q 019650          282 FGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA  319 (337)
Q Consensus       282 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~  319 (337)
                      .......+...++.+.+++.+||..+|++|||++++++
T Consensus       214 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  251 (256)
T cd05039         214 KGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE  251 (256)
T ss_pred             cCCCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence            23344556667899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-40  Score=290.00  Aligned_cols=258  Identities=28%  Similarity=0.395  Sum_probs=205.7

Q ss_pred             cccccccccCcceEEEEEEEccCCceEEEEEeecCC-chHhHHHHHHHHHHHHhcCCCCceeeeeeEEee-CCeEEEEEe
Q 019650           49 LKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTI-EGEICFVME  126 (337)
Q Consensus        49 y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-~~~~~lv~e  126 (337)
                      |++.+.||.|++|.||+|.+..+++.+++|.+.... .......+.+|+.++++++|+|++++++.+... ....++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            678899999999999999999999999999998764 233345677899999999999999999988763 278999999


Q ss_pred             ccCCCCchHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCCC
Q 019650          127 HMERGSLFDSLRVR-KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNH  205 (337)
Q Consensus       127 ~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~  205 (337)
                      |+++ +|.+++... ..+++..++.++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.+.........   
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~---  156 (287)
T cd07840          81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA---  156 (287)
T ss_pred             cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc---
Confidence            9975 898888755 57999999999999999999999999999999999999999999999999998776543210   


Q ss_pred             CCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhccCC
Q 019650          206 NNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGER  285 (337)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~  285 (337)
                                ......++..|+|||.+...   ..++.++|+||||+++|+|++|+.||.....................
T Consensus       157 ----------~~~~~~~~~~y~~PE~~~~~---~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~  223 (287)
T cd07840         157 ----------DYTNRVITLWYRPPELLLGA---TRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTD  223 (287)
T ss_pred             ----------cccccccccccCCceeeEcc---ccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCch
Confidence                      01112467889999987632   35788999999999999999999999765433222222211100000


Q ss_pred             C--------------------------CCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccc
Q 019650          286 L--------------------------EMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV  323 (337)
Q Consensus       286 ~--------------------------~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f  323 (337)
                      .                          .+....+..+.+++.+||..+|.+||++++++.||||
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         224 ENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             hhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence            0                          0011137889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=1e-40  Score=291.20  Aligned_cols=256  Identities=30%  Similarity=0.476  Sum_probs=206.7

Q ss_pred             cccccccccCcceEEEEEEEccCCceEEEEEeecCCch-HhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEec
Q 019650           49 LKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSST-IIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEH  127 (337)
Q Consensus        49 y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~e~  127 (337)
                      |++.+.||.|++|.||+|.+..+++.+++|.+...... .....+.+|+.++++++|++++++++.+.. +...++++||
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~v~e~   79 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRH-KGDLYLVFEF   79 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhcc-CCCEEEEEec
Confidence            67889999999999999999989999999998765422 345677789999999999999999998776 6889999999


Q ss_pred             cCCCCchHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCCCC
Q 019650          128 MERGSLFDSLRV-RKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHN  206 (337)
Q Consensus       128 ~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~  206 (337)
                      +++ +|.+++.. ...+++..+..++.|++.+|.|||+.|++|+||+|+||+++.++.++|+|||.+.........    
T Consensus        80 ~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~----  154 (283)
T cd05118          80 MDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRP----  154 (283)
T ss_pred             cCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCccc----
Confidence            976 88888875 357999999999999999999999999999999999999999999999999988776543210    


Q ss_pred             CCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhccCC-
Q 019650          207 NNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGER-  285 (337)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~-  285 (337)
                                .....++..|+|||.+...   ..++.++|+||||+++|+|++|+.||......+.............. 
T Consensus       155 ----------~~~~~~~~~~~~PE~~~~~---~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~  221 (283)
T cd05118         155 ----------YTHYVVTRWYRAPELLLGD---KGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPE  221 (283)
T ss_pred             ----------ccCccCcccccCcHHHhcC---CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchH
Confidence                      1112467889999998742   26788999999999999999999999765443322222211111000 


Q ss_pred             ------------------------CCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccc
Q 019650          286 ------------------------LEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV  323 (337)
Q Consensus       286 ------------------------~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f  323 (337)
                                              ....+..+..+.++|.+||+.||.+||++++++.||||
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         222 VWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             hcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence                                    01123457889999999999999999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=2.2e-40  Score=290.52  Aligned_cols=254  Identities=27%  Similarity=0.398  Sum_probs=205.5

Q ss_pred             CccccccccccccCcceEEEEEEEc-----cCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCC
Q 019650           45 NISDLKKLTVLGHGNGGIVYKVRHQ-----KSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEG  119 (337)
Q Consensus        45 ~~~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~  119 (337)
                      ...+|.+.+.||.|++|.||+|.+.     .++..+++|.+.... ....+.+.+|+.++++++|+|++++++.+.. ..
T Consensus         3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~   80 (291)
T cd05094           3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT-LAARKDFQREAELLTNLQHEHIVKFYGVCGD-GD   80 (291)
T ss_pred             chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc-HHHHHHHHHHHHHHhcCCCCCcceEEEEEcc-CC
Confidence            3567999999999999999999863     345668888876543 2334567889999999999999999998866 67


Q ss_pred             eEEEEEeccCCCCchHHhhhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCC
Q 019650          120 EICFVMEHMERGSLFDSLRVRK----------------KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKG  183 (337)
Q Consensus       120 ~~~lv~e~~~~~~L~~~l~~~~----------------~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~  183 (337)
                      ..++||||+++++|.+++..+.                .+++..++.++.||+.||+|||++|++|+||+|+||+++.++
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~  160 (291)
T cd05094          81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANL  160 (291)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC
Confidence            8999999999999999997542                378999999999999999999999999999999999999999


Q ss_pred             cEEEeeccCccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCC
Q 019650          184 EVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHY  262 (337)
Q Consensus       184 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~  262 (337)
                      .++|+|||.+.........            .......++..|+|||.+.    +..++.++|+||||+++|+|++ |..
T Consensus       161 ~~~l~dfg~a~~~~~~~~~------------~~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~il~el~t~g~~  224 (291)
T cd05094         161 LVKIGDFGMSRDVYSTDYY------------RVGGHTMLPIRWMPPESIM----YRKFTTESDVWSFGVILWEIFTYGKQ  224 (291)
T ss_pred             cEEECCCCcccccCCCcee------------ecCCCCCcceeecChHHhc----cCCCCchhhHHHHHHHHHHHHhCCCC
Confidence            9999999998765432211            1111224678899999988    4578889999999999999999 999


Q ss_pred             CCCCCCCchhHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          263 PLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       263 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                      ||.......    .......+.....+...+..+.+++.+||+.+|++|||+.++++.
T Consensus       225 p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~  278 (291)
T cd05094         225 PWFQLSNTE----VIECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKI  278 (291)
T ss_pred             CCCCCCHHH----HHHHHhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            986543322    222333344445556678999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=3.8e-40  Score=291.84  Aligned_cols=261  Identities=29%  Similarity=0.418  Sum_probs=209.2

Q ss_pred             cccccccccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 019650           47 SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFV  124 (337)
Q Consensus        47 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv  124 (337)
                      +.|...+.||.|++|+||+|.+..++..+++|.+....  .......+.+|+.+++.++|+|++++++.+.+ ....+++
T Consensus        21 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv   99 (313)
T cd06633          21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLK-EHTAWLV   99 (313)
T ss_pred             HHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEe-CCEEEEE
Confidence            44777888999999999999999999999999986542  22334567789999999999999999998876 6889999


Q ss_pred             EeccCCCCchHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCC
Q 019650          125 MEHMERGSLFDSLRV-RKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNN  203 (337)
Q Consensus       125 ~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~  203 (337)
                      |||+.+ +|.+++.. ...+++..+..++.|++.+|.|||+.|++|+||+|+||+++.++.++|+|||.+......    
T Consensus       100 ~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~----  174 (313)
T cd06633         100 MEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA----  174 (313)
T ss_pred             EecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCCC----
Confidence            999965 78777754 457899999999999999999999999999999999999999999999999987543211    


Q ss_pred             CCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhcc
Q 019650          204 NHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFG  283 (337)
Q Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~  283 (337)
                                    ....++..|+|||.+.... +..++.++|+||||+++|+|++|..||............   ....
T Consensus       175 --------------~~~~~~~~y~aPE~~~~~~-~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~---~~~~  236 (313)
T cd06633         175 --------------NSFVGTPYWMAPEVILAMD-EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI---AQND  236 (313)
T ss_pred             --------------CCccccccccChhhccccC-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH---HhcC
Confidence                          1224788999999985321 245788999999999999999999998654332222222   1112


Q ss_pred             CCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCCcc
Q 019650          284 ERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSN  331 (337)
Q Consensus       284 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~~~  331 (337)
                      .+.......+..+.+++.+||+.+|.+||++.+++.||||+.......
T Consensus       237 ~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~~~~~  284 (313)
T cd06633         237 SPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRDRPARV  284 (313)
T ss_pred             CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCchhHH
Confidence            222223456788999999999999999999999999999997664443

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=2.7e-40  Score=286.27  Aligned_cols=254  Identities=27%  Similarity=0.396  Sum_probs=205.6

Q ss_pred             ccccccccccccCcceEEEEEEEccCC---ceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEE
Q 019650           46 ISDLKKLTVLGHGNGGIVYKVRHQKSN---SIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEIC  122 (337)
Q Consensus        46 ~~~y~~~~~lg~g~~~~v~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~  122 (337)
                      ..+|++.+.||.|+||.||+|.+..++   ..+++|.++........+.+.+|+.++++++|+||+++++.+.. +...+
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   81 (267)
T cd05066           3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK-SKPVM   81 (267)
T ss_pred             HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CCccE
Confidence            568999999999999999999886443   36999998765544456678889999999999999999998765 67899


Q ss_pred             EEEeccCCCCchHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhcccc
Q 019650          123 FVMEHMERGSLFDSLRVR-KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRN  201 (337)
Q Consensus       123 lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~  201 (337)
                      ++|||+++++|.+++... ..++..++..++.|++.||++||+.|++|+||+|+||+++.++.++++|||.+........
T Consensus        82 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~  161 (267)
T cd05066          82 IVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE  161 (267)
T ss_pred             EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccccccc
Confidence            999999999999999764 4689999999999999999999999999999999999999999999999999877643221


Q ss_pred             CCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHh
Q 019650          202 NNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICAI  280 (337)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~  280 (337)
                      ...           ......++..|+|||.+.    +..++.++|+||||+++|++++ |..||........    ....
T Consensus       162 ~~~-----------~~~~~~~~~~y~~pe~~~----~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~----~~~~  222 (267)
T cd05066         162 AAY-----------TTRGGKIPIRWTAPEAIA----YRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDV----IKAI  222 (267)
T ss_pred             eee-----------ecCCCccceeecCHhHhc----cCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHH----HHHH
Confidence            110           001112356899999998    4578889999999999999887 9999965433222    2222


Q ss_pred             hccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhc
Q 019650          281 CFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA  319 (337)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~  319 (337)
                      ........+..++..+.+++.+||+.+|.+||++.++++
T Consensus       223 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  261 (267)
T cd05066         223 EEGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVS  261 (267)
T ss_pred             hCCCcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence            233334445567899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-40  Score=290.43  Aligned_cols=255  Identities=30%  Similarity=0.455  Sum_probs=204.0

Q ss_pred             cccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcC-CCCceeeeeeEEeeCCeEEEEEec
Q 019650           49 LKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLD-SQFIVKCHAVFYTIEGEICFVMEH  127 (337)
Q Consensus        49 y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~~lv~e~  127 (337)
                      |.+.+.||.|++|+||+|....+++.+++|.+.............+|+..+.+++ |+|++++++.+.. +...++||||
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~-~~~~~lv~e~   79 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRE-NDELYFVFEY   79 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhc-CCcEEEEEec
Confidence            6788999999999999999988899999999876543323334457889999999 9999999998877 7889999999


Q ss_pred             cCCCCchHHhhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCCC
Q 019650          128 MERGSLFDSLRVRK--KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNH  205 (337)
Q Consensus       128 ~~~~~L~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~  205 (337)
                      + +++|.+++....  .+++..+..++.|++.+|.|||++|++|+||+|+||+++.++.++|+|||.+........    
T Consensus        80 ~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~----  154 (283)
T cd07830          80 M-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP----  154 (283)
T ss_pred             C-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC----
Confidence            9 679999887654  789999999999999999999999999999999999999999999999998876543211    


Q ss_pred             CCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhcc--
Q 019650          206 NNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFG--  283 (337)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~--  283 (337)
                                 .....++..|+|||.+..   +..++.++|+||||+++++|++|+.||...................  
T Consensus       155 -----------~~~~~~~~~~~aPE~~~~---~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~  220 (283)
T cd07830         155 -----------YTDYVSTRWYRAPEILLR---STSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTK  220 (283)
T ss_pred             -----------cCCCCCcccccCceeeec---CcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCCh
Confidence                       112347889999998864   2457889999999999999999999996654333222221110000  


Q ss_pred             ------------C-----------CCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccc
Q 019650          284 ------------E-----------RLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV  323 (337)
Q Consensus       284 ------------~-----------~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f  323 (337)
                                  .           .....+..+..+.+++.+||..+|++|||++|++.||||
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         221 QDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             hhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence                        0           000112336789999999999999999999999999997

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=3.5e-40  Score=284.44  Aligned_cols=251  Identities=28%  Similarity=0.431  Sum_probs=203.6

Q ss_pred             ccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEE
Q 019650           43 VENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEIC  122 (337)
Q Consensus        43 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~  122 (337)
                      ....++|++.+.||.|++|.||+|.+. ++..+++|.+.....  ..+.+.+|+.++++++|++++++++.+.  ....+
T Consensus         2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~~~~--~~~~~   76 (260)
T cd05070           2 EIPRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM--SPESFLEEAQIMKKLRHDKLVQLYAVVS--EEPIY   76 (260)
T ss_pred             CCchHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC--CHHHHHHHHHHHHhcCCCceEEEEeEEC--CCCcE
Confidence            345678999999999999999999875 556699999875432  2356788999999999999999998763  45688


Q ss_pred             EEEeccCCCCchHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccc
Q 019650          123 FVMEHMERGSLFDSLRVR--KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETR  200 (337)
Q Consensus       123 lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~  200 (337)
                      ++|||+++++|.+++...  ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05070          77 IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE  156 (260)
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence            999999999999999753  458999999999999999999999999999999999999999999999999987654321


Q ss_pred             cCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHH
Q 019650          201 NNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICA  279 (337)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~  279 (337)
                      ..             ......++..|+|||.+.    +..++.++|+||||+++|+|++ |..||......+    ....
T Consensus       157 ~~-------------~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~----~~~~  215 (260)
T cd05070         157 YT-------------ARQGAKFPIKWTAPEAAL----YGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE----VLEQ  215 (260)
T ss_pred             cc-------------cccCCCCCccccChHHHh----cCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH----HHHH
Confidence            10             011123566899999987    4568889999999999999999 899996543222    2223


Q ss_pred             hhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhc
Q 019650          280 ICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA  319 (337)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~  319 (337)
                      .........+...+..+.+++.+||..+|++|||++++++
T Consensus       216 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  255 (260)
T cd05070         216 VERGYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQS  255 (260)
T ss_pred             HHcCCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence            3334445556677899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=2.2e-40  Score=290.02  Aligned_cols=264  Identities=31%  Similarity=0.485  Sum_probs=211.7

Q ss_pred             ccccccccccCcceEEEEEEEc---cCCceEEEEEeecCC---chHhHHHHHHHHHHHHhc-CCCCceeeeeeEEeeCCe
Q 019650           48 DLKKLTVLGHGNGGIVYKVRHQ---KSNSIYALKVLNTTS---STIIRHQAAHEAEILKRL-DSQFIVKCHAVFYTIEGE  120 (337)
Q Consensus        48 ~y~~~~~lg~g~~~~v~~~~~~---~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~  120 (337)
                      +|++.+.||.|++|.||++.+.   .++..+|+|++....   .....+.+.+|+.++.++ .|++++++++.+.. +..
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~-~~~   79 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQT-DTK   79 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeec-CCE
Confidence            4788999999999999999864   467889999987532   122345677899999999 58999999988765 678


Q ss_pred             EEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccc
Q 019650          121 ICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETR  200 (337)
Q Consensus       121 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~  200 (337)
                      .++||||+++++|.+++.....+++..+..++.|++.+|.|||+.|++|+||+|.||+++.++.++|+|||++.......
T Consensus        80 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  159 (288)
T cd05583          80 LHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEE  159 (288)
T ss_pred             EEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccccccc
Confidence            99999999999999999877789999999999999999999999999999999999999999999999999876643321


Q ss_pred             cCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHh
Q 019650          201 NNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAI  280 (337)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~  280 (337)
                      .             .......++..|+|||.+...  ....+.++|+||||+++|+|++|..||................
T Consensus       160 ~-------------~~~~~~~~~~~y~aPE~~~~~--~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~  224 (288)
T cd05583         160 E-------------ERAYSFCGTIEYMAPEVIRGG--SGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRI  224 (288)
T ss_pred             c-------------cccccccCCccccCHHHhcCC--CCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHH
Confidence            1             111123478899999998743  1236789999999999999999999996433222222222222


Q ss_pred             hccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCC---HHHHhcCccccccCC
Q 019650          281 CFGERLEMPETASPEFRRFVRSCLEKDWRKRGT---VEELLAYPFVTKRSS  328 (337)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s---~~eil~hp~f~~~~~  328 (337)
                      . ......+...+..+.+++.+||+.+|++|||   +.++|+||||++..+
T Consensus       225 ~-~~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~  274 (288)
T cd05583         225 L-KSKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDW  274 (288)
T ss_pred             H-ccCCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCH
Confidence            2 2234556667899999999999999999998   567899999999876

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=3.9e-40  Score=290.71  Aligned_cols=258  Identities=24%  Similarity=0.364  Sum_probs=208.0

Q ss_pred             CccCccccccccccccCcceEEEEEEEc-------cCCceEEEEEeecCCchHhHHHHHHHHHHHHhc-CCCCceeeeee
Q 019650           42 DVENISDLKKLTVLGHGNGGIVYKVRHQ-------KSNSIYALKVLNTTSSTIIRHQAAHEAEILKRL-DSQFIVKCHAV  113 (337)
Q Consensus        42 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~  113 (337)
                      +....++|.+.+.||.|+||.||+|.+.       ..+..+++|.+...........+.+|+.+++.+ +|+||+++++.
T Consensus        10 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~   89 (304)
T cd05101          10 WEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGA   89 (304)
T ss_pred             ccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEE
Confidence            3466789999999999999999999752       234579999987654444567788999999999 89999999998


Q ss_pred             EEeeCCeEEEEEeccCCCCchHHhhhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCe
Q 019650          114 FYTIEGEICFVMEHMERGSLFDSLRVR----------------KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNL  177 (337)
Q Consensus       114 ~~~~~~~~~lv~e~~~~~~L~~~l~~~----------------~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Ni  177 (337)
                      +.. ....+++|||+++++|.+++...                ..++...+..++.|++.||.|||++|++|+||||+||
T Consensus        90 ~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Ni  168 (304)
T cd05101          90 CTQ-DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNV  168 (304)
T ss_pred             Eec-CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceE
Confidence            766 67889999999999999999753                2467788999999999999999999999999999999


Q ss_pred             EEcCCCcEEEeeccCccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHH
Q 019650          178 LINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLEC  257 (337)
Q Consensus       178 li~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l  257 (337)
                      +++.++.++|+|||.+..........            ......++..|+|||++.    +..++.++||||||+++|++
T Consensus       169 li~~~~~~kl~D~g~~~~~~~~~~~~------------~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~~l~el  232 (304)
T cd05101         169 LVTENNVMKIADFGLARDVNNIDYYK------------KTTNGRLPVKWMAPEALF----DRVYTHQSDVWSFGVLMWEI  232 (304)
T ss_pred             EEcCCCcEEECCCccceecccccccc------------cccCCCCCceeeCchhhc----cCCCCchhhHHHHHHHHHHH
Confidence            99999999999999987664322111            011123567899999997    45788899999999999999


Q ss_pred             Hh-CCCCCCCCCCchhHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          258 LV-GHYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       258 ~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                      ++ |..||.....    ...............+...+..+.+++.+||..+|++|||+.++++.
T Consensus       233 ~~~g~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~  292 (304)
T cd05101         233 FTLGGSPYPGIPV----EELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED  292 (304)
T ss_pred             HcCCCCCcccCCH----HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence            98 7888855422    22333333444445566788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=4e-40  Score=285.33  Aligned_cols=255  Identities=25%  Similarity=0.404  Sum_probs=206.1

Q ss_pred             CccccccccccccCcceEEEEEEEccCCc---eEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeE
Q 019650           45 NISDLKKLTVLGHGNGGIVYKVRHQKSNS---IYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEI  121 (337)
Q Consensus        45 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~  121 (337)
                      ..++|+..+.||.|++|.||+|.+..++.   .+++|.+.........+.+.+|+.++++++|+|++++.+.+.. ....
T Consensus         3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~   81 (268)
T cd05063           3 HPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTK-FKPA   81 (268)
T ss_pred             ChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEcc-CCCc
Confidence            35688999999999999999999875554   6999998765444456678899999999999999999998766 6788


Q ss_pred             EEEEeccCCCCchHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccc
Q 019650          122 CFVMEHMERGSLFDSLRVR-KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETR  200 (337)
Q Consensus       122 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~  200 (337)
                      +++|||+++++|.+++... +.+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++++|||.+.......
T Consensus        82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~  161 (268)
T cd05063          82 MIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDP  161 (268)
T ss_pred             EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceeccccc
Confidence            9999999999999999754 578999999999999999999999999999999999999999999999999987654322


Q ss_pred             cCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHH
Q 019650          201 NNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICA  279 (337)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~  279 (337)
                      ....           .......+..|+|||.+.    +..++.++|+||||+++|++++ |..||.......    ....
T Consensus       162 ~~~~-----------~~~~~~~~~~y~~PE~~~----~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~----~~~~  222 (268)
T cd05063         162 EGTY-----------TTSGGKIPIRWTAPEAIA----YRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE----VMKA  222 (268)
T ss_pred             ccce-----------eccCCCcCceecCHHHhh----cCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH----HHHH
Confidence            1110           001112345799999997    4467889999999999999998 999996543322    2222


Q ss_pred             hhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhc
Q 019650          280 ICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA  319 (337)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~  319 (337)
                      .........+...+..+.+++.+||+.+|++||++.++++
T Consensus       223 i~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~  262 (268)
T cd05063         223 INDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVN  262 (268)
T ss_pred             HhcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            2223344445567899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=3.9e-40  Score=284.56  Aligned_cols=250  Identities=26%  Similarity=0.404  Sum_probs=202.4

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEE
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICF  123 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~l  123 (337)
                      ...++|++.+.||.|++|+||+|.+..+ ..|++|.+.....  ..+.+.+|+.++++++|+|++++++.+.  ....++
T Consensus         3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~~~~--~~~~~l   77 (262)
T cd05071           3 IPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVS--EEPIYI   77 (262)
T ss_pred             CChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc--CHHHHHHHHHHHHhCCCCCcceEEEEEC--CCCcEE
Confidence            4467899999999999999999988655 4599999875332  2356788999999999999999998763  466899


Q ss_pred             EEeccCCCCchHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhcccc
Q 019650          124 VMEHMERGSLFDSLRVR--KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRN  201 (337)
Q Consensus       124 v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~  201 (337)
                      +|||+++++|.+++...  ..+++..+..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~  157 (262)
T cd05071          78 VTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  157 (262)
T ss_pred             EEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence            99999999999999753  3578999999999999999999999999999999999999999999999999876543221


Q ss_pred             CCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHh
Q 019650          202 NNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICAI  280 (337)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~  280 (337)
                      ..             .....++..|+|||...    +..++.++|+||||+++|++++ |..||.......    .....
T Consensus       158 ~~-------------~~~~~~~~~y~~PE~~~----~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~----~~~~~  216 (262)
T cd05071         158 TA-------------RQGAKFPIKWTAPEAAL----YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----VLDQV  216 (262)
T ss_pred             cc-------------ccCCcccceecCHhHhc----cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH----HHHHH
Confidence            10             01123567899999987    4578899999999999999999 888886543322    22222


Q ss_pred             hccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhc
Q 019650          281 CFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA  319 (337)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~  319 (337)
                      ........+...+..+.+++.+||+.+|++|||+.++++
T Consensus       217 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~  255 (262)
T cd05071         217 ERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQA  255 (262)
T ss_pred             hcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            233334445667899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=1.8e-40  Score=294.15  Aligned_cols=267  Identities=22%  Similarity=0.306  Sum_probs=201.1

Q ss_pred             cccccccccCcceEEEEEEEccCCceEEEEEeecC-CchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEec
Q 019650           49 LKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTT-SSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEH  127 (337)
Q Consensus        49 y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~e~  127 (337)
                      +.+++.+|.|  +.||.+.+..+++.||+|++... ......+.+.+|+.+++.++|+||+++++++.. ....+++|||
T Consensus         4 ~~i~~~~~~~--~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~-~~~~~~~~e~   80 (314)
T cd08216           4 TLIGKCFEDL--MIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIV-DSELYVVSPL   80 (314)
T ss_pred             hhhhHhhcCC--ceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeec-CCeEEEEEec
Confidence            3455555555  44555555668999999999765 344566788899999999999999999998876 6788999999


Q ss_pred             cCCCCchHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCCC
Q 019650          128 MERGSLFDSLRVR--KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNH  205 (337)
Q Consensus       128 ~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~  205 (337)
                      +++++|.+++...  ..+++..+..++.|++.||.|||++||+|+||+|+||+++.++.++++||+.+............
T Consensus        81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~  160 (314)
T cd08216          81 MAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV  160 (314)
T ss_pred             cCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence            9999999999753  46899999999999999999999999999999999999999999999999988766432211000


Q ss_pred             CCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhc---
Q 019650          206 NNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICF---  282 (337)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~---  282 (337)
                             .........++..|+|||.+...  ...++.++|+||+|+++|+|++|..||..................   
T Consensus       161 -------~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  231 (314)
T cd08216         161 -------VHDFPKSSVKNLPWLSPEVLQQN--LQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLL  231 (314)
T ss_pred             -------cccccccccccccccCHHHhcCC--CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCcccc
Confidence                   00112233467889999998743  135788999999999999999999999764433222111110000   


Q ss_pred             --c------------------------CCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccC
Q 019650          283 --G------------------------ERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRS  327 (337)
Q Consensus       283 --~------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~  327 (337)
                        .                        .........+..+.+++.+||..||++|||++++|+||||++..
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~  302 (314)
T cd08216         232 DKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK  302 (314)
T ss_pred             ccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence              0                        00001112246788999999999999999999999999998764

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=2e-40  Score=294.05  Aligned_cols=261  Identities=25%  Similarity=0.396  Sum_probs=202.2

Q ss_pred             ccccccccccCcceEEEEEEEcc--CCceEEEEEeecCC--chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeC-CeEE
Q 019650           48 DLKKLTVLGHGNGGIVYKVRHQK--SNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIE-GEIC  122 (337)
Q Consensus        48 ~y~~~~~lg~g~~~~v~~~~~~~--~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~-~~~~  122 (337)
                      +|.+.+.||+|++|.||+|.+..  ++..||+|.+....  .......+.+|+.++++++|+|++++++.+.... ..++
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            48899999999999999999987  88999999987632  1223455678999999999999999999887631 6789


Q ss_pred             EEEeccCCCCchHHhhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcC----CCcEEEeeccCc
Q 019650          123 FVMEHMERGSLFDSLRVR-----KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLING----KGEVKIADFGVS  193 (337)
Q Consensus       123 lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~----~~~~~l~Dfg~~  193 (337)
                      +||||+++ +|.+++...     ..+++..++.++.|++.||+|||+.|++|+||+|+||+++.    ++.++|+|||++
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~  159 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA  159 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence            99999975 777776432     36899999999999999999999999999999999999999    889999999998


Q ss_pred             cchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCch--
Q 019650          194 RIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP--  271 (337)
Q Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~--  271 (337)
                      ..........           .......++..|+|||.+...   ..++.++|+||||+++|+|++|..||.......  
T Consensus       160 ~~~~~~~~~~-----------~~~~~~~~~~~y~aPE~~~~~---~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~  225 (316)
T cd07842         160 RLFNAPLKPL-----------ADLDPVVVTIWYRAPELLLGA---RHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKK  225 (316)
T ss_pred             cccCCCcccc-----------cccCCccccccccCHHHHhCC---CCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccc
Confidence            7654332110           111223578899999988642   357889999999999999999999997543322  


Q ss_pred             -------hHHHHHHHhh---------------------ccCCCCCC-----------CCCCHHHHHHHHHHhhcCcCCCC
Q 019650          272 -------DLMALICAIC---------------------FGERLEMP-----------ETASPEFRRFVRSCLEKDWRKRG  312 (337)
Q Consensus       272 -------~~~~~~~~~~---------------------~~~~~~~~-----------~~~~~~~~~li~~~l~~~p~~R~  312 (337)
                             ..........                     ......++           ...+..+.+++.+||..||++||
T Consensus       226 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp  305 (316)
T cd07842         226 SNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRI  305 (316)
T ss_pred             cchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCc
Confidence                   0111110000                     00001111           14567899999999999999999


Q ss_pred             CHHHHhcCccc
Q 019650          313 TVEELLAYPFV  323 (337)
Q Consensus       313 s~~eil~hp~f  323 (337)
                      |+.+++.||||
T Consensus       306 s~~eil~~~~f  316 (316)
T cd07842         306 TAEEALEHPYF  316 (316)
T ss_pred             CHHHHhcCCCC
Confidence            99999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-40  Score=287.84  Aligned_cols=255  Identities=27%  Similarity=0.389  Sum_probs=200.5

Q ss_pred             cccccccccCcceEEEEEEEccCCceEEEEEeecCCc-hHhHHHHHHHHHHHHhc---CCCCceeeeeeEEeeCC----e
Q 019650           49 LKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSS-TIIRHQAAHEAEILKRL---DSQFIVKCHAVFYTIEG----E  120 (337)
Q Consensus        49 y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l---~~~~i~~~~~~~~~~~~----~  120 (337)
                      |++.+.||.|++|.||+|.+..++..+|+|.+..... ......+.+|+.+++++   +|+|++++++.+.....    .
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            6788999999999999999988899999999975432 22233455677766665   69999999999877432    3


Q ss_pred             EEEEEeccCCCCchHHhhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhc
Q 019650          121 ICFVMEHMERGSLFDSLRVRK--KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEE  198 (337)
Q Consensus       121 ~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~  198 (337)
                      .+++||++++ +|.+++....  .+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~  159 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSF  159 (287)
T ss_pred             eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccC
Confidence            8999999975 8988887643  589999999999999999999999999999999999999999999999998876533


Q ss_pred             cccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHH
Q 019650          199 TRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALIC  278 (337)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~  278 (337)
                      ...               .....++..|+|||.+.    +..++.++|+||||+++|+|++|..||......+.......
T Consensus       160 ~~~---------------~~~~~~~~~~~~PE~~~----~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~  220 (287)
T cd07838         160 EMA---------------LTSVVVTLWYRAPEVLL----QSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFD  220 (287)
T ss_pred             Ccc---------------cccccccccccChHHhc----cCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHH
Confidence            211               11224688899999997    45678899999999999999999999976544443333332


Q ss_pred             HhhccCCC----------------------CCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccc
Q 019650          279 AICFGERL----------------------EMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV  323 (337)
Q Consensus       279 ~~~~~~~~----------------------~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f  323 (337)
                      ........                      ...+..+..+.+++.+||+.||++||++++++.||||
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         221 VIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             HcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence            21110000                      0012345778999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=7.8e-40  Score=290.38  Aligned_cols=262  Identities=31%  Similarity=0.442  Sum_probs=211.0

Q ss_pred             ccccccccccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEE
Q 019650           46 ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICF  123 (337)
Q Consensus        46 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~l  123 (337)
                      ...|+..+.||+|+||.||++.+..++..+++|.+....  .......+.+|+.++++++|+|++++++.+.. +...++
T Consensus        24 ~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~l  102 (317)
T cd06635          24 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLR-EHTAWL  102 (317)
T ss_pred             hhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-CCeEEE
Confidence            355899999999999999999999899999999986542  22344567889999999999999999998776 678899


Q ss_pred             EEeccCCCCchHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccC
Q 019650          124 VMEHMERGSLFDSLRV-RKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNN  202 (337)
Q Consensus       124 v~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~  202 (337)
                      ||||+.| +|.+.+.. ...+++..+..++.|++.+|.|||+.|++|+||+|+||+++.++.++|+|||.+......   
T Consensus       103 v~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~---  178 (317)
T cd06635         103 VMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA---  178 (317)
T ss_pred             EEeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCCc---
Confidence            9999975 77777754 456899999999999999999999999999999999999999999999999987654321   


Q ss_pred             CCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhc
Q 019650          203 NNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICF  282 (337)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~  282 (337)
                                     ....++..|+|||.+.... ...++.++|+||||+++|+|++|..||.............   ..
T Consensus       179 ---------------~~~~~~~~y~aPE~~~~~~-~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~---~~  239 (317)
T cd06635         179 ---------------NSFVGTPYWMAPEVILAMD-EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA---QN  239 (317)
T ss_pred             ---------------ccccCCccccChhhhhcCC-CCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH---hc
Confidence                           1124788999999985321 3467889999999999999999999986643322222221   11


Q ss_pred             cCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCCcc
Q 019650          283 GERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSN  331 (337)
Q Consensus       283 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~~~  331 (337)
                      ..........+..+.+++.+||+.+|.+||++.++++|+|+........
T Consensus       240 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~~~  288 (317)
T cd06635         240 ESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERPETV  288 (317)
T ss_pred             cCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCcccc
Confidence            2222233456788999999999999999999999999999977665443

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=4.1e-40  Score=285.83  Aligned_cols=252  Identities=21%  Similarity=0.305  Sum_probs=200.9

Q ss_pred             cccccccccCcceEEEEEEEccCCc--eEEEEEeecCC-chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeC-----Ce
Q 019650           49 LKKLTVLGHGNGGIVYKVRHQKSNS--IYALKVLNTTS-STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIE-----GE  120 (337)
Q Consensus        49 y~~~~~lg~g~~~~v~~~~~~~~~~--~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~-----~~  120 (337)
                      |.+.+.||+|+||.||+|.+..++.  .+|+|.++... .....+.+..|+.+++.++|+||+++++.+....     ..
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            4578899999999999999876664  68999886542 3344567788999999999999999998764321     24


Q ss_pred             EEEEEeccCCCCchHHhhh------cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCcc
Q 019650          121 ICFVMEHMERGSLFDSLRV------RKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSR  194 (337)
Q Consensus       121 ~~lv~e~~~~~~L~~~l~~------~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~  194 (337)
                      .+++|||+.+++|.+++..      ...+++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||.+.
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  160 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK  160 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCccc
Confidence            6899999999999988742      2347899999999999999999999999999999999999999999999999987


Q ss_pred             chhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCchhH
Q 019650          195 IVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDL  273 (337)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~~~~~~~~  273 (337)
                      .........            ......+++.|+|||.+.    +..++.++|+||||+++|+|++ |..||......   
T Consensus       161 ~~~~~~~~~------------~~~~~~~~~~~~~pe~~~----~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---  221 (272)
T cd05075         161 KIYNGDYYR------------QGRIAKMPVKWIAIESLA----DRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS---  221 (272)
T ss_pred             ccCccccee------------cCCcccCCcccCCHHHcc----CCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH---
Confidence            764322100            011123567899999998    4578899999999999999999 88999654322   


Q ss_pred             HHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          274 MALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                       ........+.....+...+..+.+++.+||+.+|++|||+++++++
T Consensus       222 -~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  267 (272)
T cd05075         222 -EIYDYLRQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE  267 (272)
T ss_pred             -HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence             2233333444445566788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.2e-40  Score=285.24  Aligned_cols=252  Identities=23%  Similarity=0.331  Sum_probs=203.3

Q ss_pred             cccccccccCcceEEEEEEEcc---CCceEEEEEeecCC-chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCC-----
Q 019650           49 LKKLTVLGHGNGGIVYKVRHQK---SNSIYALKVLNTTS-STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEG-----  119 (337)
Q Consensus        49 y~~~~~lg~g~~~~v~~~~~~~---~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~-----  119 (337)
                      |.+++.||+|+||.||+|....   ++..||+|.++... .....+.+.+|+..++.++|+|++++++.+.+...     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            6788999999999999998764   34789999987643 33345678889999999999999999998765322     


Q ss_pred             eEEEEEeccCCCCchHHhhhc------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCc
Q 019650          120 EICFVMEHMERGSLFDSLRVR------KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVS  193 (337)
Q Consensus       120 ~~~lv~e~~~~~~L~~~l~~~------~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~  193 (337)
                      ..+++|||+++++|..++...      ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||.+
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~  160 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS  160 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccce
Confidence            378999999999999888432      35899999999999999999999999999999999999999999999999998


Q ss_pred             cchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCchh
Q 019650          194 RIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPD  272 (337)
Q Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~~~~~~~  272 (337)
                      ...........            ......+..|+|||.+.    +..++.++|+||||+++|||++ |..||......  
T Consensus       161 ~~~~~~~~~~~------------~~~~~~~~~~~~pe~~~----~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~--  222 (273)
T cd05035         161 KKIYSGDYYRQ------------GRIAKMPVKWIAIESLA----DRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH--  222 (273)
T ss_pred             eeccccccccc------------cccccCCccccCHhhcc----cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH--
Confidence            76643321110            01112466899999987    4578899999999999999999 88998654332  


Q ss_pred             HHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          273 LMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                        ........+.....+...+..+.+++.+||+.||++|||+.+++++
T Consensus       223 --~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~  268 (273)
T cd05035         223 --EIYDYLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV  268 (273)
T ss_pred             --HHHHHHHcCCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence              2333334445556677889999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.6e-40  Score=296.46  Aligned_cols=262  Identities=28%  Similarity=0.373  Sum_probs=208.5

Q ss_pred             CccccccccccccCcceEEEEEEEccCCceEEEEEeecCC-chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeC-----
Q 019650           45 NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIE-----  118 (337)
Q Consensus        45 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~-----  118 (337)
                      ..++|++.+.||.|++|.||++.+..++..||+|.+.... .......+.+|+.++++++|+||+++++++....     
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF   92 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence            4678999999999999999999999999999999986533 2334456778999999999999999999876532     


Q ss_pred             CeEEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhc
Q 019650          119 GEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEE  198 (337)
Q Consensus       119 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~  198 (337)
                      ...++||+++ +++|.+++.. ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus        93 ~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~  170 (343)
T cd07880          93 HDFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDS  170 (343)
T ss_pred             ceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccccccc
Confidence            2458999999 6688888764 5799999999999999999999999999999999999999999999999999875532


Q ss_pred             cccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHH
Q 019650          199 TRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALIC  278 (337)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~  278 (337)
                      ..                 ....+++.|+|||.+...   ..++.++|+||||+++|+|++|..||............+.
T Consensus       171 ~~-----------------~~~~~~~~y~aPE~~~~~---~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~  230 (343)
T cd07880         171 EM-----------------TGYVVTRWYRAPEVILNW---MHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMK  230 (343)
T ss_pred             Cc-----------------cccccCCcccCHHHHhCC---CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            21                 112468899999998732   3578899999999999999999999975433222221111


Q ss_pred             Hhhc-----------------------cC---CCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCC
Q 019650          279 AICF-----------------------GE---RLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSS  328 (337)
Q Consensus       279 ~~~~-----------------------~~---~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~  328 (337)
                      ....                       ..   ........+..+.++|.+||..||++|||+.+++.||||+....
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~  306 (343)
T cd07880         231 VTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHD  306 (343)
T ss_pred             hcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcC
Confidence            0000                       00   00112456788999999999999999999999999999998643

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=1.8e-40  Score=286.22  Aligned_cols=252  Identities=33%  Similarity=0.483  Sum_probs=204.9

Q ss_pred             ccccccccccCcceEEEEEEEccCCceEEEEEeecCC----chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEE
Q 019650           48 DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS----STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICF  123 (337)
Q Consensus        48 ~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~l  123 (337)
                      +|.+.+.||.|++|+||++.+..++..+++|+++...    .......+..|+.++++++|+|++++++.+.+ ....++
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~l   79 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLE-RDAFCI   79 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhc-CCceEE
Confidence            5889999999999999999998777777777765421    22233456678999999999999999998766 677899


Q ss_pred             EEeccCCCCchHHhhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhcc
Q 019650          124 VMEHMERGSLFDSLRV----RKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEET  199 (337)
Q Consensus       124 v~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~  199 (337)
                      ++||+++++|.+++..    ...+++..++.++.|++.||.|||+.|++|+||+|+||+++. +.++|+|||.+......
T Consensus        80 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~  158 (260)
T cd08222          80 ITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGS  158 (260)
T ss_pred             EEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCC
Confidence            9999999999988853    356899999999999999999999999999999999999974 57999999988765332


Q ss_pred             ccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHH
Q 019650          200 RNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICA  279 (337)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~  279 (337)
                      ..              ......++..|+|||.+.    +..++.++|+||||+++|+|++|..||....    .......
T Consensus       159 ~~--------------~~~~~~~~~~~~~pe~~~----~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~----~~~~~~~  216 (260)
T cd08222         159 CD--------------LATTFTGTPYYMSPEALK----HQGYDSKSDIWSLGCILYEMCCLAHAFEGQN----FLSVVLR  216 (260)
T ss_pred             cc--------------cccCCCCCcCccCHHHHc----cCCCCchhhHHHHHHHHHHHHhCCCCCCCcc----HHHHHHH
Confidence            11              111224678899999987    4567889999999999999999999985432    2233333


Q ss_pred             hhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccc
Q 019650          280 ICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV  323 (337)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f  323 (337)
                      ...+..+..+...+..+.++|.+||..+|++||++.+++.||||
T Consensus       217 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         217 IVEGPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             HHcCCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence            44455556667788999999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=5.5e-40  Score=283.23  Aligned_cols=250  Identities=27%  Similarity=0.426  Sum_probs=204.0

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEE
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICF  123 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~l  123 (337)
                      ...++|.+.++||.|+||.||+|... +++.+|+|.+.....  ....+.+|+.++++++|+|++++++.+.  ....++
T Consensus         3 ~~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~   77 (260)
T cd05067           3 VPRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSM--SPEAFLAEANLMKQLQHPRLVRLYAVVT--QEPIYI   77 (260)
T ss_pred             cchHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCC--cHHHHHHHHHHHHhcCCcCeeeEEEEEc--cCCcEE
Confidence            44678999999999999999999864 567899999875442  3457788999999999999999998753  467899


Q ss_pred             EEeccCCCCchHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhcccc
Q 019650          124 VMEHMERGSLFDSLRVR--KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRN  201 (337)
Q Consensus       124 v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~  201 (337)
                      +||++.+++|.+++...  ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  157 (260)
T cd05067          78 ITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY  157 (260)
T ss_pred             EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence            99999999999998653  4689999999999999999999999999999999999999999999999999876542111


Q ss_pred             CCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHh
Q 019650          202 NNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICAI  280 (337)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~  280 (337)
                                   .......++..|+|||.+.    +..++.++|+||||+++|++++ |+.||.+.....    .....
T Consensus       158 -------------~~~~~~~~~~~y~~pe~~~----~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~----~~~~~  216 (260)
T cd05067         158 -------------TAREGAKFPIKWTAPEAIN----YGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE----VIQNL  216 (260)
T ss_pred             -------------ccccCCcccccccCHHHhc----cCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH----HHHHH
Confidence                         1111223567899999997    4567889999999999999999 999997543322    22222


Q ss_pred             hccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhc
Q 019650          281 CFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA  319 (337)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~  319 (337)
                      ........+...+..+.+++.+||+.+|++|||++++++
T Consensus       217 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05067         217 ERGYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRS  255 (260)
T ss_pred             HcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            333344556667899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2e-40  Score=289.15  Aligned_cols=256  Identities=31%  Similarity=0.439  Sum_probs=205.4

Q ss_pred             cccccccccCcceEEEEEEEccCCceEEEEEeecCC-chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEec
Q 019650           49 LKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEH  127 (337)
Q Consensus        49 y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~e~  127 (337)
                      |++.+.||.|++|.||+|....+++.+++|.+.... .....+.+..|+.++++++|++++++++.+.+ ....++|||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~~v~e~   79 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHT-ERKLYLVFEY   79 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhc-CCceEEEecC
Confidence            667889999999999999999999999999997653 23334566789999999999999999998876 5889999999


Q ss_pred             cCCCCchHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCCCC
Q 019650          128 MERGSLFDSLRVR-KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHN  206 (337)
Q Consensus       128 ~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~  206 (337)
                      +++ +|.+++... ..+++..+..++.|++.+|++||+.|++|+||+|+||+++.++.++|+|||.+.........    
T Consensus        80 ~~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~----  154 (282)
T cd07829          80 CDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT----  154 (282)
T ss_pred             cCc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccc----
Confidence            975 999999876 57999999999999999999999999999999999999999999999999988765432211    


Q ss_pred             CCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhccC--
Q 019650          207 NNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGE--  284 (337)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~--  284 (337)
                                .....++..|+|||.+...   ..++.++|+||||+++|++++|..||....................  
T Consensus       155 ----------~~~~~~~~~~~aPE~~~~~---~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  221 (282)
T cd07829         155 ----------YTHEVVTLWYRAPEILLGS---KHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEE  221 (282)
T ss_pred             ----------cCccccCcCcCChHHhcCC---cCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHH
Confidence                      1112356789999998732   3678899999999999999999999966433322222221110000  


Q ss_pred             --------------CC--------CCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccc
Q 019650          285 --------------RL--------EMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV  323 (337)
Q Consensus       285 --------------~~--------~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f  323 (337)
                                    ..        ...+..+..+.+++.+||..+|++||++++++.||||
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         222 SWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             HHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence                          00        1112347789999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.8e-40  Score=295.65  Aligned_cols=263  Identities=26%  Similarity=0.378  Sum_probs=206.9

Q ss_pred             CccccccccccccCcceEEEEEEEccCCceEEEEEeecCC-chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeC-----
Q 019650           45 NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIE-----  118 (337)
Q Consensus        45 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~-----  118 (337)
                      ..++|.+.+.||+|++|.||+|.+..++..||+|++.... .....+.+.+|+.++++++|+||+++++++....     
T Consensus        15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (345)
T cd07877          15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF   94 (345)
T ss_pred             ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccc
Confidence            4588999999999999999999999999999999987543 2233456778999999999999999999875422     


Q ss_pred             CeEEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhc
Q 019650          119 GEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEE  198 (337)
Q Consensus       119 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~  198 (337)
                      ...+++++++ +++|.+++.. ..+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus        95 ~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~  172 (345)
T cd07877          95 NDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD  172 (345)
T ss_pred             ccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccccccc
Confidence            3468888887 6799888764 4699999999999999999999999999999999999999999999999998875432


Q ss_pred             cccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHH
Q 019650          199 TRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALIC  278 (337)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~  278 (337)
                      ..                 ....++..|+|||.+...   ..++.++|+||||+++|+|++|..||..............
T Consensus       173 ~~-----------------~~~~~~~~y~aPE~~~~~---~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~  232 (345)
T cd07877         173 EM-----------------TGYVATRWYRAPEIMLNW---MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR  232 (345)
T ss_pred             cc-----------------cccccCCCccCHHHHhCc---cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            11                 122478899999988631   3578899999999999999999999965443222222111


Q ss_pred             Hhh-----------------------ccCCC---CCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCC
Q 019650          279 AIC-----------------------FGERL---EMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSS  329 (337)
Q Consensus       279 ~~~-----------------------~~~~~---~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~  329 (337)
                      ...                       .....   ......+..+.++|.+||+.||.+||++.+++.||||++....
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~  309 (345)
T cd07877         233 LVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP  309 (345)
T ss_pred             HhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCC
Confidence            100                       00000   0112357789999999999999999999999999999976543

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=4.9e-40  Score=292.80  Aligned_cols=264  Identities=27%  Similarity=0.403  Sum_probs=209.1

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCceEEEEEeecCC-chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEE
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEIC  122 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~  122 (337)
                      ...++|.+.+.||.|++|.||++.+..++..||+|.+.... .....+.+.+|+.++++++|||++++.+.+...+...+
T Consensus         7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   86 (328)
T cd07856           7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY   86 (328)
T ss_pred             ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence            45678999999999999999999999999999999886532 22334667789999999999999999998876567889


Q ss_pred             EEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccC
Q 019650          123 FVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNN  202 (337)
Q Consensus       123 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~  202 (337)
                      +++||+ +++|.+++.. ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+......   
T Consensus        87 lv~e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~---  161 (328)
T cd07856          87 FVTELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ---  161 (328)
T ss_pred             EEeehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCCC---
Confidence            999999 4588888764 46888999999999999999999999999999999999999999999999988643211   


Q ss_pred             CCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHH---
Q 019650          203 NNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICA---  279 (337)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~---  279 (337)
                                    .....++..|+|||.+..   +..++.++|+||||+++|+|++|..||...............   
T Consensus       162 --------------~~~~~~~~~y~aPE~~~~---~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~  224 (328)
T cd07856         162 --------------MTGYVSTRYYRAPEIMLT---WQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGT  224 (328)
T ss_pred             --------------cCCCcccccccCceeeec---cCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence                          112246788999998863   246788999999999999999999999654321111110000   


Q ss_pred             --------------------hhccCCC---CCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCC
Q 019650          280 --------------------ICFGERL---EMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSS  329 (337)
Q Consensus       280 --------------------~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~  329 (337)
                                          .......   ...+..+..+.++|.+||+.+|++|||+++++.||||+..+..
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~  297 (328)
T cd07856         225 PPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDP  297 (328)
T ss_pred             CCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCC
Confidence                                0000000   1123467899999999999999999999999999999876644

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.2e-40  Score=298.73  Aligned_cols=265  Identities=28%  Similarity=0.405  Sum_probs=210.1

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCceEEEEEeecCC-chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCC---
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEG---  119 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~---  119 (337)
                      ...++|++.+.||.|++|.||+|.+..++..||+|++.... .......+.+|+.++++++|+|++++.+.+...+.   
T Consensus        12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07851          12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED   91 (343)
T ss_pred             cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence            34678999999999999999999999999999999986542 22334566789999999999999999887655322   


Q ss_pred             --eEEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchh
Q 019650          120 --EICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVE  197 (337)
Q Consensus       120 --~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~  197 (337)
                        ..++|+|++ +++|.+++.. ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+....
T Consensus        92 ~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~  169 (343)
T cd07851          92 FQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTD  169 (343)
T ss_pred             cccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccccc
Confidence              489999999 5699998875 569999999999999999999999999999999999999999999999999987653


Q ss_pred             ccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHH
Q 019650          198 ETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALI  277 (337)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~  277 (337)
                      ...                 ....++..|+|||.+...   ..++.++|+||||+++|++++|+.||.............
T Consensus       170 ~~~-----------------~~~~~~~~y~aPE~~~~~---~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~  229 (343)
T cd07851         170 DEM-----------------TGYVATRWYRAPEIMLNW---MHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIM  229 (343)
T ss_pred             ccc-----------------cCCcccccccCHHHHhCC---CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence            221                 122468889999998632   357889999999999999999999997543332222221


Q ss_pred             HHhhcc-----------------------CCC---CCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCCc
Q 019650          278 CAICFG-----------------------ERL---EMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSS  330 (337)
Q Consensus       278 ~~~~~~-----------------------~~~---~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~~  330 (337)
                      ......                       ...   ......+..+.+++.+||+.+|++|||+.+++.||||++....+
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~~  308 (343)
T cd07851         230 NLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPE  308 (343)
T ss_pred             HhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCCc
Confidence            110000                       000   01123588999999999999999999999999999999876543

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=4.2e-40  Score=293.97  Aligned_cols=268  Identities=26%  Similarity=0.363  Sum_probs=207.8

Q ss_pred             ccccccccccCcceEEEEEEEccC--CceEEEEEeecCC-chHhHHHHHHHHHHHHhc-CCCCceeeeeeEEee---CCe
Q 019650           48 DLKKLTVLGHGNGGIVYKVRHQKS--NSIYALKVLNTTS-STIIRHQAAHEAEILKRL-DSQFIVKCHAVFYTI---EGE  120 (337)
Q Consensus        48 ~y~~~~~lg~g~~~~v~~~~~~~~--~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~---~~~  120 (337)
                      +|++.+.||.|+||.||++.+..+  +..||+|.+.... .......+.+|+.+++++ .|+||+++++.....   ...
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            488999999999999999999877  8899999986532 222345667899999998 599999999864331   245


Q ss_pred             EEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccc
Q 019650          121 ICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETR  200 (337)
Q Consensus       121 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~  200 (337)
                      .+++++++. ++|.+++.....+++..++.++.||+.||.|||+.|++|+||||+||+++.++.++|+|||.+.......
T Consensus        81 ~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~  159 (332)
T cd07857          81 LYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENP  159 (332)
T ss_pred             EEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceeccccc
Confidence            788999985 5999999888889999999999999999999999999999999999999999999999999997664332


Q ss_pred             cCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHh
Q 019650          201 NNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAI  280 (337)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~  280 (337)
                      ....          .......++..|+|||.+..   ...++.++|+||+|+++|++++|..||............+...
T Consensus       160 ~~~~----------~~~~~~~g~~~y~aPE~~~~---~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~  226 (332)
T cd07857         160 GENA----------GFMTEYVATRWYRAPEIMLS---FQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVL  226 (332)
T ss_pred             cccc----------ccccCcccCccccCcHHHhC---CCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHh
Confidence            1110          11223468899999998863   2367889999999999999999999996543221111111100


Q ss_pred             -----------------------hccCC---CCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCC
Q 019650          281 -----------------------CFGER---LEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSS  329 (337)
Q Consensus       281 -----------------------~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~  329 (337)
                                             .....   ....+..+..+.+++.+||+.||.+|||+.+++.||||++....
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~~  301 (332)
T cd07857         227 GTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDP  301 (332)
T ss_pred             CCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcCc
Confidence                                   00000   01123457899999999999999999999999999999877654

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=1.2e-39  Score=279.45  Aligned_cols=245  Identities=26%  Similarity=0.385  Sum_probs=200.2

Q ss_pred             cccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEeccCCCC
Q 019650           53 TVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGS  132 (337)
Q Consensus        53 ~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~  132 (337)
                      +.||.|++|.||+|... ++..+|+|.++..........+.+|+.++++++|+|++++++.+.. ....++||||+++++
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~   78 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQ-RQPIYIVMELVPGGD   78 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEec-CCccEEEEECCCCCc
Confidence            47899999999999864 6788999998776555555678889999999999999999998766 678999999999999


Q ss_pred             chHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCCCCCCCCC
Q 019650          133 LFDSLRVR-KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNN  211 (337)
Q Consensus       133 L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~  211 (337)
                      |.+++... ..+++..+..++.|++.+|.|||+.|++|+||+|+||+++.++.++|+|||++..........        
T Consensus        79 L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~--------  150 (250)
T cd05085          79 FLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSS--------  150 (250)
T ss_pred             HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceecccccccc--------
Confidence            99998753 468999999999999999999999999999999999999999999999999886543221100        


Q ss_pred             ccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHhhccCCCCCCC
Q 019650          212 NIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICAICFGERLEMPE  290 (337)
Q Consensus       212 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (337)
                           .....++..|+|||++.    +..++.++|+||||+++|++++ |..||.......    .............+.
T Consensus       151 -----~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~----~~~~~~~~~~~~~~~  217 (250)
T cd05085         151 -----SGLKQIPIKWTAPEALN----YGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ----AREQVEKGYRMSCPQ  217 (250)
T ss_pred             -----CCCCCCcccccCHHHhc----cCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH----HHHHHHcCCCCCCCC
Confidence                 01112456799999997    4567889999999999999998 999996543322    222233344455566


Q ss_pred             CCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          291 TASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       291 ~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                      .++..+.+++.+||+.+|++|||+.++++.
T Consensus       218 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~  247 (250)
T cd05085         218 KCPDDVYKVMQRCWDYKPENRPKFSELQKE  247 (250)
T ss_pred             CCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence            788999999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.9e-40  Score=282.35  Aligned_cols=251  Identities=29%  Similarity=0.428  Sum_probs=205.5

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEE
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICF  123 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~l  123 (337)
                      ...++|++.+.||.|++|+||++.+. ++..+++|.+.....  ..+.+.+|+.++++++|++++++++.+.. +...++
T Consensus         3 ~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~   78 (261)
T cd05034           3 IPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTM--SPEAFLQEAQIMKKLRHDKLVQLYAVCSE-EEPIYI   78 (261)
T ss_pred             cchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCcc--CHHHHHHHHHHHhhCCCCCEeeeeeeeec-CCceEE
Confidence            45689999999999999999999975 457799999875432  34668889999999999999999998765 678999


Q ss_pred             EEeccCCCCchHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhcccc
Q 019650          124 VMEHMERGSLFDSLRVR--KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRN  201 (337)
Q Consensus       124 v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~  201 (337)
                      +||++++++|.+++...  ..++...+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+........
T Consensus        79 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~  158 (261)
T cd05034          79 VTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY  158 (261)
T ss_pred             EEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence            99999999999999764  3689999999999999999999999999999999999999999999999999876543211


Q ss_pred             CCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHh
Q 019650          202 NNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICAI  280 (337)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~  280 (337)
                      .             .......+..|+|||.+.    +..++.++|+||||+++|++++ |+.||.+.....    .....
T Consensus       159 ~-------------~~~~~~~~~~y~~PE~~~----~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~----~~~~~  217 (261)
T cd05034         159 T-------------AREGAKFPIKWTAPEAAN----YGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE----VLEQV  217 (261)
T ss_pred             h-------------hhhccCCCccccCHHHhc----cCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH----HHHHH
Confidence            0             011112456899999998    4578889999999999999999 999996543322    22222


Q ss_pred             hccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhc
Q 019650          281 CFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA  319 (337)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~  319 (337)
                      ........+...+..+.+++.+||..+|++||+++++++
T Consensus       218 ~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~  256 (261)
T cd05034         218 ERGYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQS  256 (261)
T ss_pred             HcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            333344455667899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=5.8e-40  Score=286.20  Aligned_cols=252  Identities=27%  Similarity=0.415  Sum_probs=204.2

Q ss_pred             ccccccccccccCcceEEEEEEEc-----cCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCe
Q 019650           46 ISDLKKLTVLGHGNGGIVYKVRHQ-----KSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGE  120 (337)
Q Consensus        46 ~~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~  120 (337)
                      .++|...+.||.|+||.||++...     .++..+++|.+.... ......+.+|+.+++.+.|+||+++++.+.. ...
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~   81 (280)
T cd05092           4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTVLQHQHIVRFYGVCTE-GRP   81 (280)
T ss_pred             hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC-HHHHHHHHHHHHHHhcCCCCCCceEEEEEec-CCc
Confidence            468889999999999999999753     346678889876543 3445678899999999999999999998766 677


Q ss_pred             EEEEEeccCCCCchHHhhhcC---------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcE
Q 019650          121 ICFVMEHMERGSLFDSLRVRK---------------KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEV  185 (337)
Q Consensus       121 ~~lv~e~~~~~~L~~~l~~~~---------------~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~  185 (337)
                      .+++|||+++++|.+++...+               .+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.+
T Consensus        82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~~  161 (280)
T cd05092          82 LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVV  161 (280)
T ss_pred             eEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCCE
Confidence            899999999999999997543               47899999999999999999999999999999999999999999


Q ss_pred             EEeeccCccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCC
Q 019650          186 KIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPL  264 (337)
Q Consensus       186 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf  264 (337)
                      +|+|||++.........            .......+++.|+|||.+.    +..++.++|+||||+++|+|++ |..||
T Consensus       162 kL~dfg~~~~~~~~~~~------------~~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~il~el~~~g~~p~  225 (280)
T cd05092         162 KIGDFGMSRDIYSTDYY------------RVGGRTMLPIRWMPPESIL----YRKFTTESDIWSFGVVLWEIFTYGKQPW  225 (280)
T ss_pred             EECCCCceeEcCCCcee------------ecCCCccccccccCHHHhc----cCCcCchhhHHHHHHHHHHHHcCCCCCC
Confidence            99999988654322100            0111223567899999998    4578899999999999999998 89998


Q ss_pred             CCCCCchhHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhc
Q 019650          265 IGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA  319 (337)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~  319 (337)
                      ........    ......+.....+..++..+.+++.+||+.||.+||+++++++
T Consensus       226 ~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~  276 (280)
T cd05092         226 YQLSNTEA----IECITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS  276 (280)
T ss_pred             ccCCHHHH----HHHHHcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            65433222    2222333344556678899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=5.5e-40  Score=287.51  Aligned_cols=254  Identities=27%  Similarity=0.392  Sum_probs=205.5

Q ss_pred             CccccccccccccCcceEEEEEEEc-----cCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCC
Q 019650           45 NISDLKKLTVLGHGNGGIVYKVRHQ-----KSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEG  119 (337)
Q Consensus        45 ~~~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~  119 (337)
                      ..++|++.+.||.|+||.||+|.+.     .++..+++|.+...........+.+|+.+++++.|+|++++++.+.. +.
T Consensus         3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~-~~   81 (288)
T cd05050           3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAV-GK   81 (288)
T ss_pred             ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcC-CC
Confidence            4678999999999999999999874     36778999998765544456678889999999999999999998765 67


Q ss_pred             eEEEEEeccCCCCchHHhhhcC----------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCe
Q 019650          120 EICFVMEHMERGSLFDSLRVRK----------------------KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNL  177 (337)
Q Consensus       120 ~~~lv~e~~~~~~L~~~l~~~~----------------------~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Ni  177 (337)
                      ..+++|||+++++|.+++....                      .+++..++.++.|++.||.|||+.|++|+||+|+||
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~ni  161 (288)
T cd05050          82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNC  161 (288)
T ss_pred             ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhhe
Confidence            8899999999999999997432                      367888999999999999999999999999999999


Q ss_pred             EEcCCCcEEEeeccCccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHH
Q 019650          178 LINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLEC  257 (337)
Q Consensus       178 li~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l  257 (337)
                      +++.++.++|+|||.+..........            .......+..|+|||.+.    +..++.++|+||||+++|+|
T Consensus       162 l~~~~~~~~l~dfg~~~~~~~~~~~~------------~~~~~~~~~~y~aPE~~~----~~~~~~~~Dv~slG~il~el  225 (288)
T cd05050         162 LVGENMVVKIADFGLSRNIYSADYYK------------ASENDAIPIRWMPPESIF----YNRYTTESDVWAYGVVLWEI  225 (288)
T ss_pred             EecCCCceEECccccceecccCcccc------------ccCCCccChhhcCHHHHh----cCCCCchhHHHHHHHHHHHH
Confidence            99999999999999887553322110            011112456799999987    45788999999999999999


Q ss_pred             Hh-CCCCCCCCCCchhHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhc
Q 019650          258 LV-GHYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA  319 (337)
Q Consensus       258 ~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~  319 (337)
                      ++ |..||.+....    ........+.....+...+..+.+++.+||+.+|++|||++|+++
T Consensus       226 ~~~~~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~  284 (288)
T cd05050         226 FSYGMQPYYGMAHE----EVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR  284 (288)
T ss_pred             HhCCCCCCCCCCHH----HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            98 88888654322    222233334344445667899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-39  Score=284.38  Aligned_cols=254  Identities=25%  Similarity=0.405  Sum_probs=208.2

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCc----eEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCC
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNS----IYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEG  119 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~  119 (337)
                      ...++|.+.+.||+|+||+||+|.+..++.    .+++|.+...........+.+|+.++++++|+|++++++.+..  .
T Consensus         4 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~   81 (279)
T cd05057           4 LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS--S   81 (279)
T ss_pred             cCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec--C
Confidence            456889999999999999999999876554    5899988766555566778899999999999999999998765  6


Q ss_pred             eEEEEEeccCCCCchHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhc
Q 019650          120 EICFVMEHMERGSLFDSLRVR-KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEE  198 (337)
Q Consensus       120 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~  198 (337)
                      ..+++|||+++++|.+++... ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus        82 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~  161 (279)
T cd05057          82 QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV  161 (279)
T ss_pred             ceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence            889999999999999999764 4689999999999999999999999999999999999999999999999999877643


Q ss_pred             cccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCchhHHHHH
Q 019650          199 TRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALI  277 (337)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~  277 (337)
                      ......            .....++..|+|||.+.    +..++.++|+||||+++|++++ |..||...... .   ..
T Consensus       162 ~~~~~~------------~~~~~~~~~y~~PE~~~----~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-~---~~  221 (279)
T cd05057         162 DEKEYH------------AEGGKVPIKWMALESIL----HRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV-E---IP  221 (279)
T ss_pred             ccccee------------cCCCcccccccCHHHhh----cCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH-H---HH
Confidence            221100            01112356899999987    4577889999999999999999 99999654322 2   22


Q ss_pred             HHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhc
Q 019650          278 CAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA  319 (337)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~  319 (337)
                      .....+.....+...+..+.+++.+||..+|.+||++.++++
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~  263 (279)
T cd05057         222 DLLEKGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELIN  263 (279)
T ss_pred             HHHhCCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            233344445556667899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=6.6e-40  Score=292.99  Aligned_cols=260  Identities=25%  Similarity=0.355  Sum_probs=208.3

Q ss_pred             CCccCccccccccccccCcceEEEEEEEccC-------CceEEEEEeecCCchHhHHHHHHHHHHHHhc-CCCCceeeee
Q 019650           41 PDVENISDLKKLTVLGHGNGGIVYKVRHQKS-------NSIYALKVLNTTSSTIIRHQAAHEAEILKRL-DSQFIVKCHA  112 (337)
Q Consensus        41 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~  112 (337)
                      .++....+|++++.||.|+||.||+|.+...       ...+|+|.+.........+.+.+|+.+++++ +|+||+++++
T Consensus         6 ~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~   85 (334)
T cd05100           6 KWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLG   85 (334)
T ss_pred             ccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeE
Confidence            3455667899999999999999999986422       2368999887655555567788999999999 8999999999


Q ss_pred             eEEeeCCeEEEEEeccCCCCchHHhhhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCC
Q 019650          113 VFYTIEGEICFVMEHMERGSLFDSLRVRK----------------KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSN  176 (337)
Q Consensus       113 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~N  176 (337)
                      .+.. ....+++|||+++++|.+++....                .++...+..++.|++.||+|||++|++|+||+|+|
T Consensus        86 ~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~N  164 (334)
T cd05100          86 ACTQ-DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARN  164 (334)
T ss_pred             EEcc-CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccce
Confidence            8876 678999999999999999997532                47788899999999999999999999999999999


Q ss_pred             eEEcCCCcEEEeeccCccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHH
Q 019650          177 LLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLE  256 (337)
Q Consensus       177 ili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~  256 (337)
                      |+++.++.++|+|||.+..........            ......++..|+|||.+.    +..++.++|+||||+++|+
T Consensus       165 ill~~~~~~kL~Dfg~~~~~~~~~~~~------------~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~il~e  228 (334)
T cd05100         165 VLVTEDNVMKIADFGLARDVHNIDYYK------------KTTNGRLPVKWMAPEALF----DRVYTHQSDVWSFGVLLWE  228 (334)
T ss_pred             EEEcCCCcEEECCcccceecccccccc------------cccCCCcCceEcCHHHhc----cCCcCchhhhHHHHHHHHH
Confidence            999999999999999987654321110            011112456799999997    4578889999999999999


Q ss_pred             HHh-CCCCCCCCCCchhHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCc
Q 019650          257 CLV-GHYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYP  321 (337)
Q Consensus       257 l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp  321 (337)
                      |++ |..||.....    ...............+...+..+.+++.+||+.+|.+|||+.+++++-
T Consensus       229 l~~~g~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l  290 (334)
T cd05100         229 IFTLGGSPYPGIPV----EELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDL  290 (334)
T ss_pred             HHhcCCCCCCCCCH----HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence            998 8889865432    222223333344455667789999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-41  Score=289.02  Aligned_cols=265  Identities=28%  Similarity=0.399  Sum_probs=226.0

Q ss_pred             CccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHHhc-CCCCceeeeeeEEeeC
Q 019650           42 DVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRL-DSQFIVKCHAVFYTIE  118 (337)
Q Consensus        42 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~  118 (337)
                      +.....+|..+.+||.|+||.|.++..+.+..-+|||+++++.  .+...+-...|-+++... +-|.+++++..|.+ -
T Consensus       344 d~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQT-m  422 (683)
T KOG0696|consen  344 DRIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQT-M  422 (683)
T ss_pred             cceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhh-h
Confidence            4567789999999999999999999999999999999997764  222233344566666655 45677888887766 6


Q ss_pred             CeEEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhc
Q 019650          119 GEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEE  198 (337)
Q Consensus       119 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~  198 (337)
                      ..+|+||||+.||+|--.+++-+.+.+..+..++..|+-+|-+||++||+.||||..||+++.+|++||+|||++..---
T Consensus       423 DRLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~  502 (683)
T KOG0696|consen  423 DRLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIF  502 (683)
T ss_pred             hheeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeeccccccccc
Confidence            88999999999999999999999999999999999999999999999999999999999999999999999999865432


Q ss_pred             cccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHH
Q 019650          199 TRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALIC  278 (337)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~  278 (337)
                      ..              ..+..++|||.|+|||.+.++    +|+.++|+||+|++||||+.|++||.+.++.+....+++
T Consensus       503 ~~--------------~TTkTFCGTPdYiAPEIi~Yq----PYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~e  564 (683)
T KOG0696|consen  503 DG--------------VTTKTFCGTPDYIAPEIIAYQ----PYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIME  564 (683)
T ss_pred             CC--------------cceeeecCCCcccccceEEec----ccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence            22              556678999999999999976    678889999999999999999999988776666655554


Q ss_pred             HhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCC-----HHHHhcCccccccCCCc
Q 019650          279 AICFGERLEMPETASPEFRRFVRSCLEKDWRKRGT-----VEELLAYPFVTKRSSSS  330 (337)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s-----~~eil~hp~f~~~~~~~  330 (337)
                      .     ...+|...+.++.+++...|.+.|.+|.-     -++|-.||||+..+|..
T Consensus       565 h-----nvsyPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek  616 (683)
T KOG0696|consen  565 H-----NVSYPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEK  616 (683)
T ss_pred             c-----cCcCcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHHH
Confidence            4     56778889999999999999999999952     46788999999988753

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=1.4e-41  Score=280.49  Aligned_cols=272  Identities=26%  Similarity=0.434  Sum_probs=214.4

Q ss_pred             ccCccccccccccccCcceEEEEEEEccCC----ceEEEEEeecCCch-HhHHHHHHHHHHHHhcCCCCceeeeeeEEee
Q 019650           43 VENISDLKKLTVLGHGNGGIVYKVRHQKSN----SIYALKVLNTTSST-IIRHQAAHEAEILKRLDSQFIVKCHAVFYTI  117 (337)
Q Consensus        43 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~----~~vaiK~~~~~~~~-~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~  117 (337)
                      ++....|++.+.||+|.+|.||+|...++.    +.+|+|.++.+... ......-+|+.+++.++|+|++.+..++...
T Consensus        20 ve~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~   99 (438)
T KOG0666|consen   20 VEDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSH   99 (438)
T ss_pred             HHHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc
Confidence            456789999999999999999999665433    37899999766422 2334456899999999999999999999987


Q ss_pred             CCeEEEEEeccCCCCchHHhhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCC----CcEEEe
Q 019650          118 EGEICFVMEHMERGSLFDSLRVR-----KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGK----GEVKIA  188 (337)
Q Consensus       118 ~~~~~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~----~~~~l~  188 (337)
                      +..+++++||.+. +|++.+..+     ..++...++.++.||+.++.|||++-++||||||+||++..+    |.+||+
T Consensus       100 d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIa  178 (438)
T KOG0666|consen  100 DKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIA  178 (438)
T ss_pred             CceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEee
Confidence            8899999999987 999999744     368999999999999999999999999999999999999877    899999


Q ss_pred             eccCccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Q 019650          189 DFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFG  268 (337)
Q Consensus       189 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~  268 (337)
                      |+|+++....+-.-.           ......+.|..|.|||.+.+.   ..|+.+.|+|++|||+.||+|-++.|.+..
T Consensus       179 DlGlaR~~~~plkpl-----------~s~d~VVVTiWYRAPELLLGa---~hYT~AiDvWAiGCIfaElLtl~PlF~g~E  244 (438)
T KOG0666|consen  179 DLGLARLFNNPLKPL-----------ASLDPVVVTIWYRAPELLLGA---RHYTKAIDVWAIGCIFAELLTLEPLFKGRE  244 (438)
T ss_pred             cccHHHHhhcccccc-----------ccCCceEEEEEecChHHhccc---ccccchhhhHHHHHHHHHHHccCccccchh
Confidence            999999886543211           112244679999999999964   589999999999999999999998886532


Q ss_pred             Cc---------hhHHHHHHHhhccCCCC------CC--------------------------CCCCHHHHHHHHHHhhcC
Q 019650          269 EK---------PDLMALICAICFGERLE------MP--------------------------ETASPEFRRFVRSCLEKD  307 (337)
Q Consensus       269 ~~---------~~~~~~~~~~~~~~~~~------~~--------------------------~~~~~~~~~li~~~l~~~  307 (337)
                      .+         +.+..+++-+.....-.      +|                          ..-++...+|+.+||..|
T Consensus       245 ~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yD  324 (438)
T KOG0666|consen  245 EKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYD  324 (438)
T ss_pred             hhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccC
Confidence            21         11112221111110000      00                          113455899999999999


Q ss_pred             cCCCCCHHHHhcCccccccCCC
Q 019650          308 WRKRGTVEELLAYPFVTKRSSS  329 (337)
Q Consensus       308 p~~R~s~~eil~hp~f~~~~~~  329 (337)
                      |.+|+|++++|+|+||+.....
T Consensus       325 P~kRIta~qAleh~yF~~d~lp  346 (438)
T KOG0666|consen  325 PIKRITAEQALEHPYFTEDPLP  346 (438)
T ss_pred             chhhccHHHHhcccccccCCCC
Confidence            9999999999999999988644

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=7e-40  Score=282.01  Aligned_cols=247  Identities=26%  Similarity=0.411  Sum_probs=200.9

Q ss_pred             cccccCcceEEEEEEEcc-CC--ceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEeccC
Q 019650           53 TVLGHGNGGIVYKVRHQK-SN--SIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHME  129 (337)
Q Consensus        53 ~~lg~g~~~~v~~~~~~~-~~--~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~  129 (337)
                      +.||+|++|.||+|.+.. ++  ..+|+|.+.........+.+.+|+.++++++|+|++++++.+..  ...+++|||++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~v~e~~~   78 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT--HPLMMVTELAP   78 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC--CeEEEEEEecC
Confidence            468999999999999864 33  36899999876654566788899999999999999999998765  78899999999


Q ss_pred             CCCchHHhhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCCCCC
Q 019650          130 RGSLFDSLRVRK--KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNN  207 (337)
Q Consensus       130 ~~~L~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~  207 (337)
                      +++|.+++....  .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+..........    
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~----  154 (257)
T cd05040          79 LGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY----  154 (257)
T ss_pred             CCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccce----
Confidence            999999997654  68999999999999999999999999999999999999999999999999988765432111    


Q ss_pred             CCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHhhccCCC
Q 019650          208 NNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICAICFGERL  286 (337)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~  286 (337)
                             .......++..|+|||.+.    +..++.++|+||||+++|+|++ |..||......+..... ..  .....
T Consensus       155 -------~~~~~~~~~~~y~~pE~~~----~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~-~~--~~~~~  220 (257)
T cd05040         155 -------VMEEHLKVPFAWCAPESLR----TRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI-DK--EGERL  220 (257)
T ss_pred             -------ecccCCCCCceecCHHHhc----ccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-Hh--cCCcC
Confidence                   0111224677899999988    4578889999999999999999 99999654332222221 11  23333


Q ss_pred             CCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhc
Q 019650          287 EMPETASPEFRRFVRSCLEKDWRKRGTVEELLA  319 (337)
Q Consensus       287 ~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~  319 (337)
                      ..+...+..+.+++.+||+.+|++|||+.++++
T Consensus       221 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  253 (257)
T cd05040         221 ERPEACPQDIYNVMLQCWAHNPADRPTFAALRE  253 (257)
T ss_pred             CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence            445567899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=6.3e-40  Score=288.28  Aligned_cols=257  Identities=24%  Similarity=0.336  Sum_probs=201.7

Q ss_pred             ccccccccccccCcceEEEEEEEcc----------------CCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCcee
Q 019650           46 ISDLKKLTVLGHGNGGIVYKVRHQK----------------SNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVK  109 (337)
Q Consensus        46 ~~~y~~~~~lg~g~~~~v~~~~~~~----------------~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~  109 (337)
                      -++|++.+.||.|+||+||++.+..                +...+|+|.+...........+.+|+.+++.++|+|+++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~   83 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR   83 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence            4679999999999999999986532                345689999876555555677889999999999999999


Q ss_pred             eeeeEEeeCCeEEEEEeccCCCCchHHhhhcC-----------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeE
Q 019650          110 CHAVFYTIEGEICFVMEHMERGSLFDSLRVRK-----------KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLL  178 (337)
Q Consensus       110 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----------~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nil  178 (337)
                      +++.+.. ....+++|||+++++|.+++....           .+++..+..++.|++.||+|||+.|++|+||||+||+
T Consensus        84 ~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nil  162 (296)
T cd05095          84 LLAVCIT-SDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCL  162 (296)
T ss_pred             EEEEEec-CCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEE
Confidence            9998766 677899999999999999997543           3667789999999999999999999999999999999


Q ss_pred             EcCCCcEEEeeccCccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHH
Q 019650          179 INGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECL  258 (337)
Q Consensus       179 i~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~  258 (337)
                      ++.++.++|+|||.+.........            .......++..|++||...    +..++.++|+||||+++|+|+
T Consensus       163 i~~~~~~~l~dfg~~~~~~~~~~~------------~~~~~~~~~~~~~~pe~~~----~~~~~~~~DiwSlG~~l~el~  226 (296)
T cd05095         163 VGKNYTIKIADFGMSRNLYSGDYY------------RIQGRAVLPIRWMSWESIL----LGKFTTASDVWAFGVTLWEIL  226 (296)
T ss_pred             EcCCCCEEeccCcccccccCCcce------------eccCcCcCccccCCHHHHh----cCCccchhhhhHHHHHHHHHH
Confidence            999999999999998765332111            0111123467899999887    457889999999999999999


Q ss_pred             h--CCCCCCCCCCchhHHHHHHHhh---ccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhc
Q 019650          259 V--GHYPLIGFGEKPDLMALICAIC---FGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA  319 (337)
Q Consensus       259 t--g~~pf~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~  319 (337)
                      +  |..||.................   .......+..++..+.+++.+||+.||.+|||+.++++
T Consensus       227 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~  292 (296)
T cd05095         227 TLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA  292 (296)
T ss_pred             HhCCCCCccccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            8  7788865433332221111111   11122334567899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=7.7e-40  Score=286.90  Aligned_cols=251  Identities=27%  Similarity=0.401  Sum_probs=202.0

Q ss_pred             ccccccccccCcceEEEEEEEcc-----CCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEE
Q 019650           48 DLKKLTVLGHGNGGIVYKVRHQK-----SNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEIC  122 (337)
Q Consensus        48 ~y~~~~~lg~g~~~~v~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~  122 (337)
                      +|.+.+.||.|+||.||+|.+..     ....+++|.+...........+.+|+.+++.+.|+||+++++.+.. +...+
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~   79 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQ-DGPLL   79 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEec-CCCcE
Confidence            47889999999999999998753     2356888888765554456778899999999999999999998765 67789


Q ss_pred             EEEeccCCCCchHHhhhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeE
Q 019650          123 FVMEHMERGSLFDSLRVR------------------------KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLL  178 (337)
Q Consensus       123 lv~e~~~~~~L~~~l~~~------------------------~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nil  178 (337)
                      +++||+.+++|.+++...                        ..+++..+..++.|++.||.|||+.|++||||+|+||+
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nil  159 (290)
T cd05045          80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVL  159 (290)
T ss_pred             EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEE
Confidence            999999999999988642                        24788999999999999999999999999999999999


Q ss_pred             EcCCCcEEEeeccCccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHH
Q 019650          179 INGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECL  258 (337)
Q Consensus       179 i~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~  258 (337)
                      ++.++.++|+|||.+..........            ......++..|+|||.+.    +..++.++||||||+++|+|+
T Consensus       160 l~~~~~~kl~dfg~~~~~~~~~~~~------------~~~~~~~~~~y~apE~~~----~~~~~~~~Di~slG~~l~el~  223 (290)
T cd05045         160 VAEGRKMKISDFGLSRDVYEEDSYV------------KRSKGRIPVKWMAIESLF----DHIYTTQSDVWSFGVLLWEIV  223 (290)
T ss_pred             EcCCCcEEeccccccccccCccchh------------cccCCCCCccccCHHHHc----cCCcchHhHHHHHHHHHHHHH
Confidence            9999999999999987653322110            011123567899999987    457889999999999999999


Q ss_pred             h-CCCCCCCCCCchhHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhc
Q 019650          259 V-GHYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA  319 (337)
Q Consensus       259 t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~  319 (337)
                      + |..||.+... ...   ............+...+..+.+++.+||+.+|++||++.++++
T Consensus       224 t~g~~p~~~~~~-~~~---~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~  281 (290)
T cd05045         224 TLGGNPYPGIAP-ERL---FNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK  281 (290)
T ss_pred             hcCCCCCCCCCH-HHH---HHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            9 9999965432 222   2222233344556677899999999999999999999999976

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=7.5e-40  Score=289.36  Aligned_cols=260  Identities=31%  Similarity=0.437  Sum_probs=208.9

Q ss_pred             CccccccccccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEE
Q 019650           45 NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEIC  122 (337)
Q Consensus        45 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~  122 (337)
                      ....|...+.||.|++|+||+|.+..++..+++|.+....  .......+.+|+.+++.++|+|++++.+.+.. ....+
T Consensus        13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   91 (308)
T cd06634          13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-EHTAW   91 (308)
T ss_pred             cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEc-CCeeE
Confidence            3456899999999999999999999899999999986432  23344567789999999999999999998776 67889


Q ss_pred             EEEeccCCCCchHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhcccc
Q 019650          123 FVMEHMERGSLFDSLRV-RKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRN  201 (337)
Q Consensus       123 lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~  201 (337)
                      +||||+. ++|.+++.. ...+++..+..++.|++.+|.|||+.|++|+||+|+||+++.++.++|+|||.+....... 
T Consensus        92 lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~-  169 (308)
T cd06634          92 LVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN-  169 (308)
T ss_pred             EEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCcc-
Confidence            9999996 488777753 4568999999999999999999999999999999999999999999999999886643221 


Q ss_pred             CCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhh
Q 019650          202 NNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAIC  281 (337)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~  281 (337)
                                       ...++..|+|||.+.... ...++.++||||||+++|+|++|..||.............   .
T Consensus       170 -----------------~~~~~~~y~aPE~~~~~~-~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~---~  228 (308)
T cd06634         170 -----------------XFVGTPYWMAPEVILAMD-EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA---Q  228 (308)
T ss_pred             -----------------cccCCccccCHHHHhhcc-cCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHh---h
Confidence                             124788999999975211 2357889999999999999999999986543222222111   1


Q ss_pred             ccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCC
Q 019650          282 FGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSS  328 (337)
Q Consensus       282 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~  328 (337)
                      ...........+..+.++|.+||..+|++||++++++.|||+.+...
T Consensus       229 ~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~~  275 (308)
T cd06634         229 NESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERP  275 (308)
T ss_pred             cCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccccCC
Confidence            11122223457889999999999999999999999999999988654

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=9.3e-40  Score=282.07  Aligned_cols=250  Identities=24%  Similarity=0.352  Sum_probs=196.1

Q ss_pred             cccccCcceEEEEEEEcc---CCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEeccC
Q 019650           53 TVLGHGNGGIVYKVRHQK---SNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHME  129 (337)
Q Consensus        53 ~~lg~g~~~~v~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~  129 (337)
                      +.||+|+||.||+|.+..   .+..+|+|.+.........+.+.+|+.+++.++|+|++++++.+...++..+++|||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            468999999999998643   34579999886544444556778899999999999999999977665667899999999


Q ss_pred             CCCchHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCCCCCC
Q 019650          130 RGSLFDSLRVR-KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNN  208 (337)
Q Consensus       130 ~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~  208 (337)
                      +++|.+++... ...++..+..++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||++...........    
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~----  156 (262)
T cd05058          81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV----  156 (262)
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceee----
Confidence            99999999754 4567888899999999999999999999999999999999999999999999875543211100    


Q ss_pred             CCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHhhccCCCC
Q 019650          209 NNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICAICFGERLE  287 (337)
Q Consensus       209 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  287 (337)
                            .......++..|+|||.+.    +..++.++||||||+++|+|++ |.+||.....    .........+....
T Consensus       157 ------~~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~----~~~~~~~~~~~~~~  222 (262)
T cd05058         157 ------HNHTGAKLPVKWMALESLQ----TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS----FDITVYLLQGRRLL  222 (262)
T ss_pred             ------cccccCcCCccccChhHhc----cCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH----HHHHHHHhcCCCCC
Confidence                  0011123567899999987    4568889999999999999999 5566654322    22222333344444


Q ss_pred             CCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          288 MPETASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       288 ~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                      .+...+..+.+++.+||..+|++||++.++++.
T Consensus       223 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~  255 (262)
T cd05058         223 QPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSR  255 (262)
T ss_pred             CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            556678999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1e-39  Score=283.21  Aligned_cols=243  Identities=29%  Similarity=0.381  Sum_probs=195.5

Q ss_pred             cccccCcceEEEEEEEccCCc--eEEEEEeecCCchHhHHHHHHHHHHHHhc-CCCCceeeeeeEEeeCCeEEEEEeccC
Q 019650           53 TVLGHGNGGIVYKVRHQKSNS--IYALKVLNTTSSTIIRHQAAHEAEILKRL-DSQFIVKCHAVFYTIEGEICFVMEHME  129 (337)
Q Consensus        53 ~~lg~g~~~~v~~~~~~~~~~--~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~~lv~e~~~  129 (337)
                      +.||.|++|.||+|.+..++.  .+++|.+...........+.+|+.++.++ .|+|++++++.+.. ....+++|||++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-~~~~~lv~e~~~   79 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-RGYLYLAIEYAP   79 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEec-CCCceEEEEeCC
Confidence            468999999999999987765  46888877544444556788899999999 89999999998866 677899999999


Q ss_pred             CCCchHHhhhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCc
Q 019650          130 RGSLFDSLRVRK----------------KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVS  193 (337)
Q Consensus       130 ~~~L~~~l~~~~----------------~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~  193 (337)
                      +++|.+++....                .+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++++|||++
T Consensus        80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~  159 (270)
T cd05047          80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS  159 (270)
T ss_pred             CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCc
Confidence            999999997532                4788999999999999999999999999999999999999999999999987


Q ss_pred             cchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCchh
Q 019650          194 RIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPD  272 (337)
Q Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~~~~~~~  272 (337)
                      .......               .......+..|+|||++.    +..++.++|+||||+++|+|++ |..||......  
T Consensus       160 ~~~~~~~---------------~~~~~~~~~~y~apE~~~----~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~--  218 (270)
T cd05047         160 RGQEVYV---------------KKTMGRLPVRWMAIESLN----YSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--  218 (270)
T ss_pred             cccchhh---------------hccCCCCccccCChHHHc----cCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH--
Confidence            5322110               001112356799999987    4568889999999999999997 99999654322  


Q ss_pred             HHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhc
Q 019650          273 LMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA  319 (337)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~  319 (337)
                        ..............+...+..+.+++.+||+.+|.+|||+.+++.
T Consensus       219 --~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (270)
T cd05047         219 --ELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV  263 (270)
T ss_pred             --HHHHHHhCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence              222223333344555667889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.3e-39  Score=280.31  Aligned_cols=249  Identities=31%  Similarity=0.448  Sum_probs=207.0

Q ss_pred             cccccccccCcceEEEEEEEccCC----ceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 019650           49 LKKLTVLGHGNGGIVYKVRHQKSN----SIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFV  124 (337)
Q Consensus        49 y~~~~~lg~g~~~~v~~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv  124 (337)
                      +++.+.||.|+||.||++.+..++    ..+|+|.+.........+.+..|+.+++.++|+|++++++.+.+ ....+++
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~i   79 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTE-EEPLMIV   79 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcC-CCeeEEE
Confidence            467889999999999999998766    88999999766554456788899999999999999999998877 5789999


Q ss_pred             EeccCCCCchHHhhhcCC--CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccC
Q 019650          125 MEHMERGSLFDSLRVRKK--LSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNN  202 (337)
Q Consensus       125 ~e~~~~~~L~~~l~~~~~--l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~  202 (337)
                      ||++++++|.+++.....  +++..+..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.+.........
T Consensus        80 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~  159 (258)
T smart00219       80 MEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY  159 (258)
T ss_pred             EeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceeccccccc
Confidence            999999999999976544  999999999999999999999999999999999999999999999999998776543111


Q ss_pred             CCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHhh
Q 019650          203 NNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICAIC  281 (337)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~  281 (337)
                      ..             ....+++.|+|||.+.    +..++.++|+||||+++|+|++ |..||.....    ........
T Consensus       160 ~~-------------~~~~~~~~y~~Pe~~~----~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~----~~~~~~~~  218 (258)
T smart00219      160 KK-------------KGGKLPIRWMAPESLK----DGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN----EEVLEYLK  218 (258)
T ss_pred             cc-------------ccCCCcccccChHHhc----cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHHh
Confidence            10             0112678999999986    4578899999999999999998 7888865322    22223333


Q ss_pred             ccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhc
Q 019650          282 FGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA  319 (337)
Q Consensus       282 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~  319 (337)
                      .......+...+..+.+++.+||+.+|++|||+.++++
T Consensus       219 ~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  256 (258)
T smart00219      219 KGYRLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE  256 (258)
T ss_pred             cCCCCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence            34455556668999999999999999999999999986

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.3e-39  Score=280.93  Aligned_cols=250  Identities=28%  Similarity=0.427  Sum_probs=201.3

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEE
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICF  123 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~l  123 (337)
                      ...++|.+.+.||.|++|.||+|.+..+ ..+++|.+....  ...+.+.+|+.++++++|++++++++.+.  ....++
T Consensus         3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~   77 (260)
T cd05069           3 IPRESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGT--MMPEAFLQEAQIMKKLRHDKLVPLYAVVS--EEPIYI   77 (260)
T ss_pred             CChHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCC--ccHHHHHHHHHHHHhCCCCCeeeEEEEEc--CCCcEE
Confidence            3457899999999999999999987655 458999876543  23456788999999999999999998763  456889


Q ss_pred             EEeccCCCCchHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhcccc
Q 019650          124 VMEHMERGSLFDSLRVR--KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRN  201 (337)
Q Consensus       124 v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~  201 (337)
                      +|||+.+++|.+++...  ..+++..+..++.|++.||.|||+.|++|+||+|+||++++++.++|+|||.+........
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~  157 (260)
T cd05069          78 VTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY  157 (260)
T ss_pred             EEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCcc
Confidence            99999999999999754  3478999999999999999999999999999999999999999999999999876533211


Q ss_pred             CCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHh
Q 019650          202 NNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICAI  280 (337)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~  280 (337)
                      .             ......++..|+|||...    +..++.++|+||||+++|+|++ |..||.........    ...
T Consensus       158 ~-------------~~~~~~~~~~y~~Pe~~~----~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~----~~~  216 (260)
T cd05069         158 T-------------ARQGAKFPIKWTAPEAAL----YGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVL----EQV  216 (260)
T ss_pred             c-------------ccCCCccchhhCCHHHhc----cCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH----HHH
Confidence            0             001113567899999887    4568889999999999999999 89999764332222    222


Q ss_pred             hccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhc
Q 019650          281 CFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA  319 (337)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~  319 (337)
                      ........+...+..+.+++.+||+.||++||+++++++
T Consensus       217 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  255 (260)
T cd05069         217 ERGYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQS  255 (260)
T ss_pred             HcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            223334455677899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.5e-40  Score=295.58  Aligned_cols=261  Identities=28%  Similarity=0.388  Sum_probs=205.1

Q ss_pred             ccccccccccccCcceEEEEEEEccCCceEEEEEeecCC-chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeC-----C
Q 019650           46 ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIE-----G  119 (337)
Q Consensus        46 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~-----~  119 (337)
                      .++|.+.+.||.|++|.||+|.+..++..||+|.+.... .......+.+|+.+++.++|+||+++++++....     .
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            468999999999999999999998899999999986542 2233456778999999999999999999876532     2


Q ss_pred             eEEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhcc
Q 019650          120 EICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEET  199 (337)
Q Consensus       120 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~  199 (337)
                      ..++++||+.. +|..++.  ..+++..+..++.|++.||+|||+.|++||||+|+||+++.++.++|+|||++......
T Consensus        94 ~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~  170 (342)
T cd07879          94 DFYLVMPYMQT-DLQKIMG--HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE  170 (342)
T ss_pred             eEEEEeccccc-CHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC
Confidence            46899999964 7776653  46899999999999999999999999999999999999999999999999998654221


Q ss_pred             ccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHH
Q 019650          200 RNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICA  279 (337)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~  279 (337)
                      .                 ....++..|+|||.+..   +..++.++|+||||+++|+|++|+.||.+.............
T Consensus       171 ~-----------------~~~~~~~~y~aPE~~~~---~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~  230 (342)
T cd07879         171 M-----------------TGYVVTRWYRAPEVILN---WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKV  230 (342)
T ss_pred             C-----------------CCceeeecccChhhhcC---ccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence            1                 12246788999999863   235788999999999999999999999764322222221110


Q ss_pred             hh------------------ccCCCC--------CCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCC
Q 019650          280 IC------------------FGERLE--------MPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSS  329 (337)
Q Consensus       280 ~~------------------~~~~~~--------~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~  329 (337)
                      ..                  ....+.        ..+..+..+.++|.+||+.||.+||++++++.||||+.....
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~  306 (342)
T cd07879         231 TGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDA  306 (342)
T ss_pred             cCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccc
Confidence            00                  000000        112457789999999999999999999999999999987654

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.2e-39  Score=284.82  Aligned_cols=259  Identities=27%  Similarity=0.389  Sum_probs=202.1

Q ss_pred             ccccccccccccCcceEEEEEEE----ccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEee-CCe
Q 019650           46 ISDLKKLTVLGHGNGGIVYKVRH----QKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTI-EGE  120 (337)
Q Consensus        46 ~~~y~~~~~lg~g~~~~v~~~~~----~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-~~~  120 (337)
                      ..+|++.+.||+|+||+||++..    ..++..|++|.+.... ....+.+.+|+.++++++|+|++++++.+... ...
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   81 (284)
T cd05081           3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST-AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN   81 (284)
T ss_pred             cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCc
Confidence            45899999999999999999973    4578899999987553 33456778899999999999999999976543 346


Q ss_pred             EEEEEeccCCCCchHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhcc
Q 019650          121 ICFVMEHMERGSLFDSLRVR-KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEET  199 (337)
Q Consensus       121 ~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~  199 (337)
                      +++||||+++++|.+++... ..+++..+..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++......
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~  161 (284)
T cd05081          82 LRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQD  161 (284)
T ss_pred             eEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccCC
Confidence            89999999999999999754 46899999999999999999999999999999999999999999999999998876432


Q ss_pred             ccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCc---------
Q 019650          200 RNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEK---------  270 (337)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~---------  270 (337)
                      ....           .......++..|+|||.+.    +..++.++|+||||+++|+|++|..++......         
T Consensus       162 ~~~~-----------~~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~  226 (284)
T cd05081         162 KEYY-----------KVREPGESPIFWYAPESLT----ESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDK  226 (284)
T ss_pred             Ccce-----------eecCCCCCceEeeCHHHhc----cCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhccccc
Confidence            2110           0001112345699999997    457888999999999999999987665332110         


Q ss_pred             ---hhHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          271 ---PDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       271 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                         ..................+..++..+.+++.+||+.+|++|||+.++++.
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  279 (284)
T cd05081         227 QGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQ  279 (284)
T ss_pred             ccccchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence               00011111222233334456678999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-41  Score=272.72  Aligned_cols=267  Identities=22%  Similarity=0.303  Sum_probs=207.9

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEee----CC
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTI----EG  119 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~----~~  119 (337)
                      ..-++|.+.+.||.|+|+-||++....++..||+|.+...+ ....+...+|+...++++|||++++++.....    ..
T Consensus        18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~-~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~   96 (302)
T KOG2345|consen   18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS-QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH   96 (302)
T ss_pred             EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc-hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence            44579999999999999999999998999999999998765 44567788999999999999999987755432    23


Q ss_pred             eEEEEEeccCCCCchHHhhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCCeEEcCCCcEEEeeccCc
Q 019650          120 EICFVMEHMERGSLFDSLRV----RKKLSEDVISGVAYRVLKGLQYLHGMQ--IIHGDIKPSNLLINGKGEVKIADFGVS  193 (337)
Q Consensus       120 ~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~~~--ivH~dl~~~Nili~~~~~~~l~Dfg~~  193 (337)
                      ..|++++|+..|+|.+.++.    +..+++.++..|+.++++||.+||+..  ++|+||||.||+++.++..++.|||.+
T Consensus        97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~  176 (302)
T KOG2345|consen   97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSA  176 (302)
T ss_pred             eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCc
Confidence            58999999999999999974    336899999999999999999999998  999999999999999999999999998


Q ss_pred             cchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhH
Q 019650          194 RIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDL  273 (337)
Q Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~  273 (337)
                      ....-.-........   .  -....--.|..|.|||.+.-.. +...+.++|||||||++|+|+.|..||...-+....
T Consensus       177 ~~a~i~i~~~~~a~~---l--Qe~a~e~Ct~pyRAPELf~vk~-~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgS  250 (302)
T KOG2345|consen  177 TQAPIQIEGSRQALR---L--QEWAEERCTIPYRAPELFNVKS-HCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGS  250 (302)
T ss_pred             cccceEeechHHHHH---H--HHHHHHhCCCcccCchheeccc-CcccccccchhhhhHHHHHHHHcCCcchHHhhcCCe
Confidence            765432211110000   0  0011112578999999997543 567799999999999999999999999432221111


Q ss_pred             HHHHHHhhccCCCCCC--CCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          274 MALICAICFGERLEMP--ETASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       274 ~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                      ..+..   .+....+|  ...++.+.++|+.||+.||.+||++.+++.+
T Consensus       251 laLAv---~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~  296 (302)
T KOG2345|consen  251 LALAV---QNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK  296 (302)
T ss_pred             EEEee---eccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            11110   11112222  3378999999999999999999999999874

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=1.4e-39  Score=282.36  Aligned_cols=253  Identities=30%  Similarity=0.416  Sum_probs=206.4

Q ss_pred             CccccccccccccCcceEEEEEEEccC---CceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeE
Q 019650           45 NISDLKKLTVLGHGNGGIVYKVRHQKS---NSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEI  121 (337)
Q Consensus        45 ~~~~y~~~~~lg~g~~~~v~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~  121 (337)
                      ..++|.+.+.||.|++|.||+|.+...   ...+++|...........+.+.+|+.+++++.|+|++++++.+..  ...
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~   81 (270)
T cd05056           4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE--NPV   81 (270)
T ss_pred             chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC--CCc
Confidence            356799999999999999999987543   456899988766545556788899999999999999999997654  567


Q ss_pred             EEEEeccCCCCchHHhhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccc
Q 019650          122 CFVMEHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETR  200 (337)
Q Consensus       122 ~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~  200 (337)
                      +++|||+++++|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~  161 (270)
T cd05056          82 WIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES  161 (270)
T ss_pred             EEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeeccccc
Confidence            89999999999999997643 58999999999999999999999999999999999999999999999999887654321


Q ss_pred             cCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHH
Q 019650          201 NNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICA  279 (337)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~  279 (337)
                      ...             .....++..|+|||.+.    +..++.++|+||||+++|++++ |..||........    ...
T Consensus       162 ~~~-------------~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~----~~~  220 (270)
T cd05056         162 YYK-------------ASKGKLPIKWMAPESIN----FRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV----IGR  220 (270)
T ss_pred             cee-------------cCCCCccccccChhhhc----cCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH----HHH
Confidence            100             00112456899999987    4567889999999999999986 9999966543322    222


Q ss_pred             hhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          280 ICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                      ...+.....+..++..+.+++.+|+..+|++|||+.++++.
T Consensus       221 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~  261 (270)
T cd05056         221 IENGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQ  261 (270)
T ss_pred             HHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            33444556677889999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-42  Score=329.45  Aligned_cols=265  Identities=30%  Similarity=0.446  Sum_probs=232.4

Q ss_pred             ccccccccccCcceEEEEEEEccCCceEEEEEeecCC-chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEe
Q 019650           48 DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVME  126 (337)
Q Consensus        48 ~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~e  126 (337)
                      ++....+||.|.||.||.|.+..+|.-.|+|-+.... .....+...+|..++..++|||++.++|+-.+ +...+|.||
T Consensus      1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvH-Rekv~IFME 1314 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVH-REKVYIFME 1314 (1509)
T ss_pred             eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeec-HHHHHHHHH
Confidence            6667789999999999999999999999999886654 23455667889999999999999999999877 678899999


Q ss_pred             ccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCCCC
Q 019650          127 HMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHN  206 (337)
Q Consensus       127 ~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~  206 (337)
                      ||.||+|.+.++..+..++.....+..|++.|++|||++|||||||||+||+++.+|.+|++|||.+..+........  
T Consensus      1315 yC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~-- 1392 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMP-- 1392 (1509)
T ss_pred             HhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCC--
Confidence            999999999999888888999999999999999999999999999999999999999999999999998876531111  


Q ss_pred             CCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhccCCC
Q 019650          207 NNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERL  286 (337)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~  286 (337)
                              ......+||+-|||||++.+-+ +.....+.|||||||++.||+||+.||...+   ..++++.....+..+
T Consensus      1393 --------~el~~~~GT~~YMAPEvit~t~-~kG~~~A~DiWslGCVVlEM~tGkrPW~~~d---ne~aIMy~V~~gh~P 1460 (1509)
T KOG4645|consen 1393 --------GELQSMMGTPMYMAPEVITGTK-GKGHGGAADIWSLGCVVLEMATGKRPWAELD---NEWAIMYHVAAGHKP 1460 (1509)
T ss_pred             --------HHHHhhcCCchhcCchhhcccc-cCCCCcchhhhcccceEEEeecCCCchhhcc---chhHHHhHHhccCCC
Confidence                    3344668999999999998765 3456779999999999999999999997543   457788888899999


Q ss_pred             CCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccC
Q 019650          287 EMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRS  327 (337)
Q Consensus       287 ~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~  327 (337)
                      .+|..+++..+++|..||..||++|+++.|+++|-|-+...
T Consensus      1461 q~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~~ 1501 (1509)
T KOG4645|consen 1461 QIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSCT 1501 (1509)
T ss_pred             CCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhcccccc
Confidence            99999999999999999999999999999999998866543

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-42  Score=298.83  Aligned_cols=266  Identities=24%  Similarity=0.380  Sum_probs=234.6

Q ss_pred             ccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCe
Q 019650           43 VENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGE  120 (337)
Q Consensus        43 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~  120 (337)
                      .....+++++..||-|+||.|=++..+.....+|+|++++..  .....++...|-.++..+..+.|++++-.|-+ +.+
T Consensus       416 ~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd-~ky  494 (732)
T KOG0614|consen  416 QVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRD-SKY  494 (732)
T ss_pred             ccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhcc-chh
Confidence            345788999999999999999999887655568899887654  34455677789999999999999999998877 789


Q ss_pred             EEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccc
Q 019650          121 ICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETR  200 (337)
Q Consensus       121 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~  200 (337)
                      +|++||-|-||.|+..|+..+.+++.+++.++..+++|+.|||.+|||.|||||+|++++.+|=+||.|||++..+... 
T Consensus       495 vYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g-  573 (732)
T KOG0614|consen  495 VYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG-  573 (732)
T ss_pred             hhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccC-
Confidence            9999999999999999999999999999999999999999999999999999999999999999999999999988764 


Q ss_pred             cCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHh
Q 019650          201 NNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAI  280 (337)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~  280 (337)
                                    ..++.++|||.|.|||.+.    +...+.++|.|+||+++|||++|.+||.+.+.......++.. 
T Consensus       574 --------------~KTwTFcGTpEYVAPEIIL----nKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkG-  634 (732)
T KOG0614|consen  574 --------------RKTWTFCGTPEYVAPEIIL----NKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKG-  634 (732)
T ss_pred             --------------CceeeecCCcccccchhhh----ccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhh-
Confidence                          6788899999999999998    557788999999999999999999999987666555544433 


Q ss_pred             hccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCC-----HHHHhcCccccccCCCcc
Q 019650          281 CFGERLEMPETASPEFRRFVRSCLEKDWRKRGT-----VEELLAYPFVTKRSSSSN  331 (337)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s-----~~eil~hp~f~~~~~~~~  331 (337)
                        .....+|..++....++|+++++.+|.+|.-     +.+|.+|.||.+-+|..-
T Consensus       635 --id~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdwegl  688 (732)
T KOG0614|consen  635 --IDKIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGL  688 (732)
T ss_pred             --hhhhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhh
Confidence              3445677888999999999999999999974     999999999999988653

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=3e-39  Score=277.14  Aligned_cols=245  Identities=29%  Similarity=0.405  Sum_probs=200.1

Q ss_pred             cccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEeccCCCC
Q 019650           53 TVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGS  132 (337)
Q Consensus        53 ~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~  132 (337)
                      ++||.|++|.||++.+.. ++.|++|.+...........+.+|+.++++++|++|+++++.+.. ....+++|||+++++
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~v~e~~~~~~   78 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQ-KQPIYIVMELVPGGS   78 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEec-CCCeEEEEEcCCCCc
Confidence            479999999999999877 899999998776544456778899999999999999999998776 678999999999999


Q ss_pred             chHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCCCCCCCCC
Q 019650          133 LFDSLRV-RKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNN  211 (337)
Q Consensus       133 L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~  211 (337)
                      |.+++.. ...++...+..++.+++.+|.|||++|++|+||+|+||+++.++.++|+|||.+...........       
T Consensus        79 l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~-------  151 (251)
T cd05041          79 LLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVS-------  151 (251)
T ss_pred             HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceec-------
Confidence            9999965 35689999999999999999999999999999999999999999999999999876542111000       


Q ss_pred             ccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHhhccCCCCCCC
Q 019650          212 NIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICAICFGERLEMPE  290 (337)
Q Consensus       212 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (337)
                           ......+..|+|||.+.    +..++.++|+||||+++|+|++ |..||.......    .............+.
T Consensus       152 -----~~~~~~~~~y~~PE~~~----~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~----~~~~~~~~~~~~~~~  218 (251)
T cd05041         152 -----DGLKQIPIKWTAPEALN----YGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ----TRERIESGYRMPAPQ  218 (251)
T ss_pred             -----cccCcceeccCChHhhc----cCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH----HHHHHhcCCCCCCCc
Confidence                 00112356799999987    4578899999999999999999 888886543322    122222233444566


Q ss_pred             CCCHHHHHHHHHHhhcCcCCCCCHHHHhc
Q 019650          291 TASPEFRRFVRSCLEKDWRKRGTVEELLA  319 (337)
Q Consensus       291 ~~~~~~~~li~~~l~~~p~~R~s~~eil~  319 (337)
                      ..+..+.+++.+||..+|++|||+.++++
T Consensus       219 ~~~~~~~~li~~~l~~~p~~Rp~~~ell~  247 (251)
T cd05041         219 LCPEEIYRLMLQCWAYDPENRPSFSEIYN  247 (251)
T ss_pred             cCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence            77899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7e-40  Score=291.44  Aligned_cols=255  Identities=28%  Similarity=0.382  Sum_probs=198.1

Q ss_pred             ccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 019650           46 ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVM  125 (337)
Q Consensus        46 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~  125 (337)
                      .+.|.-...||.|+||+||+|....+ ..||||.+....... ..+|.+|+.++.+++|+|+++++|++.+.+...++|+
T Consensus        74 T~~Fs~~~~ig~Ggfg~VYkG~l~~~-~~vAVK~~~~~~~~~-~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVY  151 (361)
T KOG1187|consen   74 TNNFSESNLIGEGGFGTVYKGVLSDG-TVVAVKRLSSNSGQG-EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVY  151 (361)
T ss_pred             HhCCchhcceecCCCeEEEEEEECCC-CEEEEEEecCCCCcc-hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEE
Confidence            36888889999999999999998644 889999887654432 4569999999999999999999999987433599999


Q ss_pred             eccCCCCchHHhhhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCCCCeEEcCCCcEEEeeccCccchhccc
Q 019650          126 EHMERGSLFDSLRVRK--KLSEDVISGVAYRVLKGLQYLHGM---QIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETR  200 (337)
Q Consensus       126 e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~---~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~  200 (337)
                      ||++.|+|.+.+....  +++|..+.+|+.+++.||+|||+.   .|+|||||++|||+|.+.+.||+|||++.......
T Consensus       152 Eym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~~  231 (361)
T KOG1187|consen  152 EYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEGD  231 (361)
T ss_pred             EccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCccc
Confidence            9999999999998654  899999999999999999999975   39999999999999999999999999995443211


Q ss_pred             cCCCCCCCCCCccccccccc-cCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCC--CchhHHHHH
Q 019650          201 NNNNHNNNNNNNIGEAAIAC-MGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFG--EKPDLMALI  277 (337)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~-~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~--~~~~~~~~~  277 (337)
                                    ...... .||.+|+|||+..    .+..+.++||||||+++.||+||+.+.....  ....+....
T Consensus       232 --------------~~~~~~~~gt~gY~~PEy~~----~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~  293 (361)
T KOG1187|consen  232 --------------TSVSTTVMGTFGYLAPEYAS----TGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWA  293 (361)
T ss_pred             --------------cceeeecCCCCccCChhhhc----cCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHH
Confidence                          111111 5899999999998    4578999999999999999999998775432  111112211


Q ss_pred             -HHhhcc-----CCCCCC-CCCC-----HHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          278 -CAICFG-----ERLEMP-ETAS-----PEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       278 -~~~~~~-----~~~~~~-~~~~-----~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                       .....+     ..+.+. ...+     ..+..+...|++.+|.+||++.++++.
T Consensus       294 ~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~  348 (361)
T KOG1187|consen  294 KPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKE  348 (361)
T ss_pred             HHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHH
Confidence             111111     111221 1222     236677889999999999999997653

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-40  Score=296.96  Aligned_cols=248  Identities=25%  Similarity=0.359  Sum_probs=208.5

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhc-CCCCceeeeeeEEeeCCeEE
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRL-DSQFIVKCHAVFYTIEGEIC  122 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~~  122 (337)
                      ...++|++...+|.|+|+.|-.+.+..+++..++|++....     ....+|+.++... .|+|++++++++.+ ..+.|
T Consensus       319 ~~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~-----~~~~~e~~~~~~~~~h~niv~~~~v~~~-~~~~~  392 (612)
T KOG0603|consen  319 PFTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA-----DDNQDEIPISLLVRDHPNIVKSHDVYED-GKEIY  392 (612)
T ss_pred             CcchhhccccccCCCCccceeeeeccccccchhheeccccc-----cccccccchhhhhcCCCcceeecceecC-Cceee
Confidence            45689999999999999999999999999999999997762     2233466555444 89999999999866 78999


Q ss_pred             EEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEE-cCCCcEEEeeccCccchhcccc
Q 019650          123 FVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLI-NGKGEVKIADFGVSRIVEETRN  201 (337)
Q Consensus       123 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili-~~~~~~~l~Dfg~~~~~~~~~~  201 (337)
                      +|||.+.|+-+.+.+...+.+. ..+..|+.+|+.|+.|||++|+|||||||+|||+ +..++++|+|||.+........
T Consensus       393 ~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~~~  471 (612)
T KOG0603|consen  393 LVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERSCD  471 (612)
T ss_pred             eeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchhhc
Confidence            9999999998888887666566 8888999999999999999999999999999999 5889999999999987765411


Q ss_pred             CCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhh
Q 019650          202 NNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAIC  281 (337)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~  281 (337)
                                       .-+.|..|.|||++.    ...|+++.||||||++||+|++|+.||......   ..+..++.
T Consensus       472 -----------------tp~~t~~y~APEvl~----~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~---~ei~~~i~  527 (612)
T KOG0603|consen  472 -----------------TPALTLQYVAPEVLA----IQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG---IEIHTRIQ  527 (612)
T ss_pred             -----------------ccchhhcccChhhhc----cCCCCcchhhHHHHHHHHHHHhCCCccccCCch---HHHHHhhc
Confidence                             113688999999999    458999999999999999999999999876544   23333322


Q ss_pred             ccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccc
Q 019650          282 FGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTK  325 (337)
Q Consensus       282 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~  325 (337)
                         ..++...+|..+++|+.+||..||.+|+++.+++.||||.+
T Consensus       528 ---~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~~~  568 (612)
T KOG0603|consen  528 ---MPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWFLS  568 (612)
T ss_pred             ---CCccccccCHHHHHHHHHhccCChhhCcChhhhccCcchhc
Confidence               33344778999999999999999999999999999999933

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=1.3e-39  Score=283.12  Aligned_cols=253  Identities=21%  Similarity=0.391  Sum_probs=204.5

Q ss_pred             ccccccccccccCcceEEEEEEEcc-----CCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCe
Q 019650           46 ISDLKKLTVLGHGNGGIVYKVRHQK-----SNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGE  120 (337)
Q Consensus        46 ~~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~  120 (337)
                      .++|++...||.|+||+||+|....     +.+.+++|.+.........+.+.+|+.++++++|+|++++++.+.+ ...
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~   82 (275)
T cd05046           4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCRE-AEP   82 (275)
T ss_pred             hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECC-CCc
Confidence            4689999999999999999999753     4567999988765555466788899999999999999999997755 578


Q ss_pred             EEEEEeccCCCCchHHhhhcC---------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeecc
Q 019650          121 ICFVMEHMERGSLFDSLRVRK---------KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFG  191 (337)
Q Consensus       121 ~~lv~e~~~~~~L~~~l~~~~---------~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg  191 (337)
                      .++||||+++++|.+++....         .+++..+..++.|++.+|+|||+.|++|+||+|+||+++.++.++++|||
T Consensus        83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~  162 (275)
T cd05046          83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLS  162 (275)
T ss_pred             ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcccc
Confidence            899999999999999997655         68999999999999999999999999999999999999999999999999


Q ss_pred             CccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCc
Q 019650          192 VSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEK  270 (337)
Q Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~~~~~  270 (337)
                      .+........             .......++..|+|||.+.    +...+.++|+||||+++|++++ |..||......
T Consensus       163 ~~~~~~~~~~-------------~~~~~~~~~~~y~~PE~~~----~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~  225 (275)
T cd05046         163 LSKDVYNSEY-------------YKLRNALIPLRWLAPEAVQ----EDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE  225 (275)
T ss_pred             cccccCcccc-------------cccCCceeEEeecChhhhc----cCCCCchhhHHHHHHHHHHHHhCCCCCccccchH
Confidence            8764432211             0111123567799999987    4467889999999999999999 88898654332


Q ss_pred             hhHHHHHHHhhc-cCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          271 PDLMALICAICF-GERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       271 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                      ..    ...... ......+...+..+.+++.+||+.+|.+|||+.++++.
T Consensus       226 ~~----~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~  272 (275)
T cd05046         226 EV----LNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA  272 (275)
T ss_pred             HH----HHHHHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence            21    111111 11223345678999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=4.2e-39  Score=277.76  Aligned_cols=251  Identities=26%  Similarity=0.429  Sum_probs=202.9

Q ss_pred             ccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEE
Q 019650           43 VENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEIC  122 (337)
Q Consensus        43 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~  122 (337)
                      +...++|.+.+.||+|++|.||++.+. .+..+++|.+....  ...+.+.+|+.++++++|+|++++++.+.+  ...+
T Consensus         2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~   76 (260)
T cd05073           2 EIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS--MSVEAFLAEANVMKTLQHDKLVKLHAVVTK--EPIY   76 (260)
T ss_pred             cccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCCh--hHHHHHHHHHHHHHhcCCCCcceEEEEEcC--CCeE
Confidence            455789999999999999999999865 44569999876542  335678889999999999999999998765  6789


Q ss_pred             EEEeccCCCCchHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccc
Q 019650          123 FVMEHMERGSLFDSLRVR--KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETR  200 (337)
Q Consensus       123 lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~  200 (337)
                      ++|||+++++|.+++...  ..++...+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  156 (260)
T cd05073          77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE  156 (260)
T ss_pred             EEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence            999999999999999753  457888999999999999999999999999999999999999999999999887654321


Q ss_pred             cCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHH
Q 019650          201 NNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICA  279 (337)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~  279 (337)
                      ..             ......++..|+|||.+.    +..++.++|+||||+++|++++ |..||......    .....
T Consensus       157 ~~-------------~~~~~~~~~~y~~PE~~~----~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~----~~~~~  215 (260)
T cd05073         157 YT-------------AREGAKFPIKWTAPEAIN----FGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP----EVIRA  215 (260)
T ss_pred             cc-------------cccCCcccccccCHhHhc----cCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH----HHHHH
Confidence            10             011123567799999997    4568889999999999999999 99999654322    22222


Q ss_pred             hhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhc
Q 019650          280 ICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA  319 (337)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~  319 (337)
                      .........+...+..+.+++.+||+.+|++||++.++++
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05073         216 LERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQS  255 (260)
T ss_pred             HhCCCCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence            2333344455677899999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=1e-39  Score=277.67  Aligned_cols=229  Identities=24%  Similarity=0.322  Sum_probs=189.2

Q ss_pred             CcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEeccCCCCchHHh
Q 019650           58 GNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSL  137 (337)
Q Consensus        58 g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l  137 (337)
                      |.++.||++.+..+++.+|+|.+....      ...+|...+....|+|++++++.+.. ....+++|||++|++|.+++
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~------~~~~~~~~~~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l   76 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS------EYSRERLTIIPHCVPNMVCLHKYIVS-EDSVFLVLQHAEGGKLWSHI   76 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh------hhhhHHHHHHhcCCCceeehhhheec-CCeEEEEEecCCCCCHHHHH
Confidence            889999999999999999999987642      22334555556679999999998876 67899999999999999999


Q ss_pred             hhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCCCCCCCCCcccccc
Q 019650          138 RVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAA  217 (337)
Q Consensus       138 ~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~  217 (337)
                      .....+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++++|||.+........                
T Consensus        77 ~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~~----------------  140 (237)
T cd05576          77 SKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCD----------------  140 (237)
T ss_pred             HHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccccc----------------
Confidence            8878899999999999999999999999999999999999999999999999998765433211                


Q ss_pred             ccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhccCCCCCCCCCCHHHH
Q 019650          218 IACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPETASPEFR  297 (337)
Q Consensus       218 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (337)
                       ...++..|+|||.+.    +..++.++|+||+|+++|++++|..|+......         .........+..++..+.
T Consensus       141 -~~~~~~~y~aPE~~~----~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~  206 (237)
T cd05576         141 -GEAVENMYCAPEVGG----ISEETEACDWWSLGAILFELLTGKTLVECHPSG---------INTHTTLNIPEWVSEEAR  206 (237)
T ss_pred             -cCCcCccccCCcccC----CCCCCchhhHHHHHHHHHHHHHCcchhhcCchh---------cccccccCCcccCCHHHH
Confidence             112566799999987    446788999999999999999999887432111         001112345566789999


Q ss_pred             HHHHHHhhcCcCCCCCH-----HHHhcCccc
Q 019650          298 RFVRSCLEKDWRKRGTV-----EELLAYPFV  323 (337)
Q Consensus       298 ~li~~~l~~~p~~R~s~-----~eil~hp~f  323 (337)
                      ++|.+||+.||++|+++     +++++||||
T Consensus       207 ~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~  237 (237)
T cd05576         207 SLLQQLLQFNPTERLGAGVAGVEDIKSHPFF  237 (237)
T ss_pred             HHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence            99999999999999985     999999998

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=3.7e-39  Score=277.33  Aligned_cols=250  Identities=27%  Similarity=0.433  Sum_probs=202.6

Q ss_pred             ccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 019650           46 ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVM  125 (337)
Q Consensus        46 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~  125 (337)
                      .++|++.+.||.|++|.||++.+. ++..+++|.+....  .....+.+|+.+++++.|++++++++.+.. ....+++|
T Consensus         3 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~v~   78 (256)
T cd05112           3 PSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGA--MSEEDFIEEAQVMMKLSHPKLVQLYGVCTE-RSPICLVF   78 (256)
T ss_pred             hhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCC--CCHHHHHHHHHHHHhCCCCCeeeEEEEEcc-CCceEEEE
Confidence            468999999999999999999875 46689999886543  224567889999999999999999998765 67889999


Q ss_pred             eccCCCCchHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCC
Q 019650          126 EHMERGSLFDSLRVR-KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNN  204 (337)
Q Consensus       126 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~  204 (337)
                      ||+++++|.+++... ..++++.++.++.|++.+|++||+.|++|+||+|+||+++.++.++|+|||.+.........  
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~--  156 (256)
T cd05112          79 EFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT--  156 (256)
T ss_pred             EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCccc--
Confidence            999999999999754 46899999999999999999999999999999999999999999999999988765332110  


Q ss_pred             CCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHhhcc
Q 019650          205 HNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICAICFG  283 (337)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~  283 (337)
                                 ......++..|+|||.+.    +..++.++|+||||+++|+|++ |..||......    ........+
T Consensus       157 -----------~~~~~~~~~~~~aPe~~~----~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~----~~~~~~~~~  217 (256)
T cd05112         157 -----------SSTGTKFPVKWSSPEVFS----FSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS----EVVETINAG  217 (256)
T ss_pred             -----------ccCCCccchhhcCHhHhc----cCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH----HHHHHHhCC
Confidence                       011123567899999997    4568889999999999999998 99998653322    222222333


Q ss_pred             CCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          284 ERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       284 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                      .....+...+..+.+++.+||+.+|++|||+.++++.
T Consensus       218 ~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~  254 (256)
T cd05112         218 FRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ  254 (256)
T ss_pred             CCCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence            3334455678999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=2.6e-39  Score=278.03  Aligned_cols=244  Identities=24%  Similarity=0.408  Sum_probs=200.6

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEE
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICF  123 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~l  123 (337)
                      ...++|++.+.||.|+||.||++..  ++..+++|.+....   ....+.+|+.++++++|+|++++++.+..  ...++
T Consensus         3 ~~~~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~---~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~   75 (254)
T cd05083           3 LNLQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV---TAQAFLEETAVMTKLHHKNLVRLLGVILH--NGLYI   75 (254)
T ss_pred             ccHHHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc---hHHHHHHHHHHHHhCCCCCcCeEEEEEcC--CCcEE
Confidence            4568899999999999999999864  67789999986543   34567889999999999999999998754  45799


Q ss_pred             EEeccCCCCchHHhhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhcccc
Q 019650          124 VMEHMERGSLFDSLRVRK--KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRN  201 (337)
Q Consensus       124 v~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~  201 (337)
                      +|||+++++|.+++....  .+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||.+........
T Consensus        76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~~  155 (254)
T cd05083          76 VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVD  155 (254)
T ss_pred             EEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceeccccCC
Confidence            999999999999997543  578999999999999999999999999999999999999999999999998865432110


Q ss_pred             CCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHh
Q 019650          202 NNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICAI  280 (337)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~  280 (337)
                                       ....+..|+|||.+.    +..++.++|+||||+++|+|++ |..||.......    .....
T Consensus       156 -----------------~~~~~~~y~~pe~~~----~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~----~~~~~  210 (254)
T cd05083         156 -----------------NSKLPVKWTAPEALK----HKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE----VKECV  210 (254)
T ss_pred             -----------------CCCCCceecCHHHhc----cCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH----HHHHH
Confidence                             112456799999987    4578889999999999999998 999996543322    22222


Q ss_pred             hccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhc
Q 019650          281 CFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA  319 (337)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~  319 (337)
                      ..+.....+..++..+.+++.+||+.+|.+||++.+++.
T Consensus       211 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  249 (254)
T cd05083         211 EKGYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLRE  249 (254)
T ss_pred             hCCCCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            333444555677899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=2.9e-39  Score=285.00  Aligned_cols=254  Identities=27%  Similarity=0.420  Sum_probs=205.0

Q ss_pred             CccccccccccccCcceEEEEEEEccCCc----eEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCe
Q 019650           45 NISDLKKLTVLGHGNGGIVYKVRHQKSNS----IYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGE  120 (337)
Q Consensus        45 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~  120 (337)
                      ..++|++.+.||+|++|.||+|.+..++.    .+|+|.+...........+.+|+.+++.+.|+||+++++.+..  ..
T Consensus         5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~--~~   82 (303)
T cd05110           5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS--PT   82 (303)
T ss_pred             chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC--CC
Confidence            45789999999999999999999876665    5788988765554445567889999999999999999998754  45


Q ss_pred             EEEEEeccCCCCchHHhhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhcc
Q 019650          121 ICFVMEHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEET  199 (337)
Q Consensus       121 ~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~  199 (337)
                      .+++++|+++|+|.+++.... .+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++......
T Consensus        83 ~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~  162 (303)
T cd05110          83 IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGD  162 (303)
T ss_pred             ceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccCc
Confidence            779999999999999997654 6899999999999999999999999999999999999999999999999999765432


Q ss_pred             ccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHH
Q 019650          200 RNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALIC  278 (337)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~  278 (337)
                      ....            ......++..|+|||.+.    +..++.++||||||+++|++++ |..||.+... ......  
T Consensus       163 ~~~~------------~~~~~~~~~~y~~PE~~~----~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~-~~~~~~--  223 (303)
T cd05110         163 EKEY------------NADGGKMPIKWMALECIH----YRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT-REIPDL--  223 (303)
T ss_pred             cccc------------ccCCCccccccCCHHHhc----cCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHH--
Confidence            2110            011123567899999987    4578899999999999999998 8899865322 222222  


Q ss_pred             HhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          279 AICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                       ...+.....+...+..+.+++.+||..+|++||+++++++.
T Consensus       224 -~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~  264 (303)
T cd05110         224 -LEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAE  264 (303)
T ss_pred             -HHCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence             22333444456678899999999999999999999998875

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=1.8e-39  Score=281.33  Aligned_cols=246  Identities=27%  Similarity=0.426  Sum_probs=198.2

Q ss_pred             cccccCcceEEEEEEEccCC------ceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEe
Q 019650           53 TVLGHGNGGIVYKVRHQKSN------SIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVME  126 (337)
Q Consensus        53 ~~lg~g~~~~v~~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~e  126 (337)
                      +.||.|++|.||+|.+....      ..+++|.+...........+.+|+.+++.++|+||+++++.+.. ....+++||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e   79 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLL-NEPQYIIME   79 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecC-CCCeEEEEe
Confidence            36899999999999986433      67999988665434456678889999999999999999998766 678999999


Q ss_pred             ccCCCCchHHhhhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCC-----cEEEeeccCcc
Q 019650          127 HMERGSLFDSLRVR-------KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKG-----EVKIADFGVSR  194 (337)
Q Consensus       127 ~~~~~~L~~~l~~~-------~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~-----~~~l~Dfg~~~  194 (337)
                      |+++++|.+++...       ..+++..+..++.|++.||+|||+.+++|+||+|+||+++.++     .++++|||++.
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~  159 (269)
T cd05044          80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR  159 (269)
T ss_pred             ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccccc
Confidence            99999999999642       3478899999999999999999999999999999999999877     89999999987


Q ss_pred             chhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCchhH
Q 019650          195 IVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDL  273 (337)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~~~~~~~~  273 (337)
                      ........            .......++..|+|||.+.    +..++.++|+||||+++|+|++ |..||......   
T Consensus       160 ~~~~~~~~------------~~~~~~~~~~~y~aPE~~~----~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~---  220 (269)
T cd05044         160 DIYKSDYY------------RKEGEGLLPVRWMAPESLL----DGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ---  220 (269)
T ss_pred             cccccccc------------ccCcccCCCccccCHHHHc----cCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH---
Confidence            65432111            0111223567899999997    4578899999999999999998 99998643322   


Q ss_pred             HHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhc
Q 019650          274 MALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA  319 (337)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~  319 (337)
                       ..............+...+..+.+++.+||..+|.+||++.++++
T Consensus       221 -~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  265 (269)
T cd05044         221 -EVLQHVTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE  265 (269)
T ss_pred             -HHHHHHhcCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence             222222333444556677899999999999999999999999875

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=2.8e-40  Score=313.93  Aligned_cols=274  Identities=27%  Similarity=0.398  Sum_probs=215.3

Q ss_pred             CccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeC------
Q 019650           45 NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIE------  118 (337)
Q Consensus        45 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~------  118 (337)
                      -..+|+.++.||+||||.||++..+-+|+.||||.+....+......+.+|+.++.+|+|||+++++..+.+..      
T Consensus       477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~  556 (1351)
T KOG1035|consen  477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL  556 (1351)
T ss_pred             HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence            46799999999999999999999999999999999988766677788899999999999999999987765420      


Q ss_pred             --------------------------------------------------------------------------------
Q 019650          119 --------------------------------------------------------------------------------  118 (337)
Q Consensus       119 --------------------------------------------------------------------------------  118 (337)
                                                                                                      
T Consensus       557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~  636 (1351)
T KOG1035|consen  557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS  636 (1351)
T ss_pred             cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence                                                                                            


Q ss_pred             --------------------------------CeEEEEEeccCCCCchHHhhhcCCC-CHHHHHHHHHHHHHHHHHHHhC
Q 019650          119 --------------------------------GEICFVMEHMERGSLFDSLRVRKKL-SEDVISGVAYRVLKGLQYLHGM  165 (337)
Q Consensus       119 --------------------------------~~~~lv~e~~~~~~L~~~l~~~~~l-~~~~~~~i~~~l~~~l~~LH~~  165 (337)
                                                      ..+||=||||+..++.+++..+... .....+.++.+|++||+|+|++
T Consensus       637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~  716 (1351)
T KOG1035|consen  637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQ  716 (1351)
T ss_pred             CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhC
Confidence                                            0146778888876666666655444 5789999999999999999999


Q ss_pred             CceeccCCCCCeEEcCCCcEEEeeccCccchh---ccccCCCCCCCCCCccc-cccccccCCCCCcCCcccccccCCCCC
Q 019650          166 QIIHGDIKPSNLLINGKGEVKIADFGVSRIVE---ETRNNNNHNNNNNNNIG-EAAIACMGTCAYMSPERVDSERWGGDY  241 (337)
Q Consensus       166 ~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~---~~~~~~~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~  241 (337)
                      |+|||||||.|||++.++.|||+|||++....   .........+......+ ....+.+||.-|+|||++.... ...|
T Consensus       717 giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~-~~~Y  795 (1351)
T KOG1035|consen  717 GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS-SNKY  795 (1351)
T ss_pred             ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc-cccc
Confidence            99999999999999999999999999998833   11111111122222222 3667789999999999998542 2369


Q ss_pred             CccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhccCCCCC---CCCCCHHHHHHHHHHhhcCcCCCCCHHHHh
Q 019650          242 GFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEM---PETASPEFRRFVRSCLEKDWRKRGTVEELL  318 (337)
Q Consensus       242 ~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~R~s~~eil  318 (337)
                      +.++|+||||++++||+.   ||.   ...+....+..++.+..+..   ....-+.-..+|+.|++.||++|||+.|+|
T Consensus       796 n~KiDmYSLGIVlFEM~y---PF~---TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL  869 (1351)
T KOG1035|consen  796 NSKIDMYSLGIVLFEMLY---PFG---TSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELL  869 (1351)
T ss_pred             cchhhhHHHHHHHHHHhc---cCC---chHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHh
Confidence            999999999999999986   453   34444555555554444433   333345677899999999999999999999


Q ss_pred             cCccccc
Q 019650          319 AYPFVTK  325 (337)
Q Consensus       319 ~hp~f~~  325 (337)
                      ++-||--
T Consensus       870 ~s~llpp  876 (1351)
T KOG1035|consen  870 NSELLPP  876 (1351)
T ss_pred             hccCCCc
Confidence            9999874

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.6e-39  Score=280.00  Aligned_cols=239  Identities=21%  Similarity=0.329  Sum_probs=190.4

Q ss_pred             cccccCcceEEEEEEEccCCc-------eEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 019650           53 TVLGHGNGGIVYKVRHQKSNS-------IYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVM  125 (337)
Q Consensus        53 ~~lg~g~~~~v~~~~~~~~~~-------~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~  125 (337)
                      +.||.|+||+||+|.+...+.       ++++|.+.... ....+.+..|..+++.+.|+|++++++.+.. ....++||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~-~~~~~lv~   78 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH-RNYSESFFEAASMMSQLSHKHLVLNYGVCVC-GDESIMVQ   78 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchh-HHHHHHHHHHHHHHHhCCCCChhheeeEEEe-CCCcEEEE
Confidence            479999999999998865443       48888875432 3345567789999999999999999998876 57789999


Q ss_pred             eccCCCCchHHhhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCc--------EEEeeccCccch
Q 019650          126 EHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGE--------VKIADFGVSRIV  196 (337)
Q Consensus       126 e~~~~~~L~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~--------~~l~Dfg~~~~~  196 (337)
                      ||+++|+|.+++...+ .+++..+..++.||+.||+|||+.|++|+||||+||+++.++.        ++++|||.+...
T Consensus        79 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~  158 (258)
T cd05078          79 EYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITV  158 (258)
T ss_pred             ecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccccc
Confidence            9999999999997644 5899999999999999999999999999999999999987764        699999987654


Q ss_pred             hccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCC-CCCCCCCCchhHHH
Q 019650          197 EETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGH-YPLIGFGEKPDLMA  275 (337)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~-~pf~~~~~~~~~~~  275 (337)
                      ....                  ...++..|+|||++...   ..++.++|+||||+++|+|++|. .||..... .....
T Consensus       159 ~~~~------------------~~~~~~~y~aPE~~~~~---~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~-~~~~~  216 (258)
T cd05078         159 LPKE------------------ILLERIPWVPPECIENP---QNLSLAADKWSFGTTLWEIFSGGDKPLSALDS-QKKLQ  216 (258)
T ss_pred             CCch------------------hccccCCccCchhccCC---CCCCchhhHHHHHHHHHHHHcCCCCChhhccH-HHHHH
Confidence            3221                  12467889999999742   35788999999999999999984 56543322 11111


Q ss_pred             HHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          276 LICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                      ..     .....++...+..+.+++.+||+.+|++|||++++++.
T Consensus       217 ~~-----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  256 (258)
T cd05078         217 FY-----EDRHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRD  256 (258)
T ss_pred             HH-----HccccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence            11     12345566667899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=4.6e-39  Score=278.90  Aligned_cols=254  Identities=20%  Similarity=0.254  Sum_probs=192.6

Q ss_pred             cccccCcceEEEEEEEc--cCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEeccCC
Q 019650           53 TVLGHGNGGIVYKVRHQ--KSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMER  130 (337)
Q Consensus        53 ~~lg~g~~~~v~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~  130 (337)
                      +.||+|+||.||+|...  .....+++|.+...........+.+|+..++.++|+||+++++.+.+ ....++||||+++
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~-~~~~~lv~e~~~~   79 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIE-SIPYLLVLEFCPL   79 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECC-CCceEEEEEeCCC
Confidence            36899999999999653  24457888887655555556677889999999999999999998876 6789999999999


Q ss_pred             CCchHHhhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCCC
Q 019650          131 GSLFDSLRVRK-----KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNH  205 (337)
Q Consensus       131 ~~L~~~l~~~~-----~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~  205 (337)
                      ++|.+++....     ..++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||.+..........  
T Consensus        80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~--  157 (269)
T cd05042          80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI--  157 (269)
T ss_pred             CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchhee--
Confidence            99999997543     24678889999999999999999999999999999999999999999999886543221100  


Q ss_pred             CCCCCCccccccccccCCCCCcCCccccccc---CCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHhh
Q 019650          206 NNNNNNNIGEAAIACMGTCAYMSPERVDSER---WGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICAIC  281 (337)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~~~~~DiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~  281 (337)
                                ......++..|+|||++....   ....++.++|+||||+++|+|++ |..||....+............
T Consensus       158 ----------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~  227 (269)
T cd05042         158 ----------TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQD  227 (269)
T ss_pred             ----------ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccC
Confidence                      011223567899999975321   12456889999999999999999 7888865433332222221111


Q ss_pred             -ccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          282 -FGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       282 -~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                       ....+..+...+..+.+++..|+ .||++|||++++++-
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~  266 (269)
T cd05042         228 IKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHEL  266 (269)
T ss_pred             ccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHH
Confidence             11122234467888999999998 599999999999863

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=9.8e-39  Score=276.85  Aligned_cols=253  Identities=21%  Similarity=0.231  Sum_probs=192.0

Q ss_pred             cccccCcceEEEEEEEc--cCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEeccCC
Q 019650           53 TVLGHGNGGIVYKVRHQ--KSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMER  130 (337)
Q Consensus        53 ~~lg~g~~~~v~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~  130 (337)
                      +.||+|+||.||+|...  .++..+++|.++..........+.+|+.++++++|+|++++++.+.+ ....++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~   79 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTE-VTPYLLVMEFCPL   79 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CCCcEEEEECCCC
Confidence            36899999999999864  35567999988766544445678889999999999999999998766 5778999999999


Q ss_pred             CCchHHhhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCCC
Q 019650          131 GSLFDSLRVRK-----KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNH  205 (337)
Q Consensus       131 ~~L~~~l~~~~-----~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~  205 (337)
                      ++|.+++....     ..++..+..++.|++.||.|||+.|++|+||||+||+++.+++++|+|||.+.........   
T Consensus        80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~---  156 (269)
T cd05087          80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY---  156 (269)
T ss_pred             CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCccee---
Confidence            99999997432     4567788899999999999999999999999999999999999999999988654322110   


Q ss_pred             CCCCCCccccccccccCCCCCcCCcccccccC---CCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHH-h
Q 019650          206 NNNNNNNIGEAAIACMGTCAYMSPERVDSERW---GGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICA-I  280 (337)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~~~~~DiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~-~  280 (337)
                               .......++..|+|||.+.....   ...++.++|+||||+++|+|++ |..||............... .
T Consensus       157 ---------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~  227 (269)
T cd05087         157 ---------VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQ  227 (269)
T ss_pred             ---------ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhccc
Confidence                     11112346788999999863210   1245789999999999999997 99999765433322111111 0


Q ss_pred             hccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhc
Q 019650          281 CFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA  319 (337)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~  319 (337)
                      .....+......+..+.+++..|+ .+|++|||+++|+.
T Consensus       228 ~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~  265 (269)
T cd05087         228 LKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL  265 (269)
T ss_pred             CCCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence            111112222346788999999998 68999999999985

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.7e-41  Score=282.53  Aligned_cols=255  Identities=27%  Similarity=0.421  Sum_probs=204.2

Q ss_pred             ccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCC--C-C---ceeeeeeEEeeCC
Q 019650           46 ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDS--Q-F---IVKCHAVFYTIEG  119 (337)
Q Consensus        46 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~--~-~---i~~~~~~~~~~~~  119 (337)
                      .++|+++..+|+|.||.|-.+.+..++..||+|+++.-  ....+...-|+.++.++.+  | +   ++++.+.| +..+
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V--~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF-dyrg  164 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV--DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWF-DYRG  164 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH--HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh-hccC
Confidence            47999999999999999999999999999999998643  2334445568999999833  2 2   34444434 4479


Q ss_pred             eEEEEEeccCCCCchHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEc-----------------
Q 019650          120 EICFVMEHMERGSLFDSLRVR--KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLIN-----------------  180 (337)
Q Consensus       120 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~-----------------  180 (337)
                      +.|+|+|.+ |.++.++|..+  .+++...++.+..||+.++++||+.+++|.||||+||++.                 
T Consensus       165 hiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~  243 (415)
T KOG0671|consen  165 HICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFI  243 (415)
T ss_pred             ceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCcccee
Confidence            999999999 56999999865  3689999999999999999999999999999999999993                 


Q ss_pred             ---CCCcEEEeeccCccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHH
Q 019650          181 ---GKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLEC  257 (337)
Q Consensus       181 ---~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l  257 (337)
                         ++..++++|||.+.....                 .....+.|..|.|||++.    +..++...||||+||||+||
T Consensus       244 r~~ks~~I~vIDFGsAtf~~e-----------------~hs~iVsTRHYRAPEViL----gLGwS~pCDvWSiGCIL~El  302 (415)
T KOG0671|consen  244 RPLKSTAIKVIDFGSATFDHE-----------------HHSTIVSTRHYRAPEVIL----GLGWSQPCDVWSIGCILVEL  302 (415)
T ss_pred             ccCCCcceEEEecCCcceecc-----------------CcceeeeccccCCchhee----ccCcCCccCceeeeeEEEEe
Confidence               133589999999876542                 334557899999999999    67999999999999999999


Q ss_pred             HhCCCCCCCCCCchhHHHHHHHhhccCCCCC-----------------CC-------------------------CCCHH
Q 019650          258 LVGHYPLIGFGEKPDLMALICAICFGERLEM-----------------PE-------------------------TASPE  295 (337)
Q Consensus       258 ~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~-------------------------~~~~~  295 (337)
                      +||...|+..++.+.+ ..++.+....+..+                 +.                         .....
T Consensus       303 ytG~~LFqtHen~EHL-aMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~  381 (415)
T KOG0671|consen  303 YTGETLFQTHENLEHL-AMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQ  381 (415)
T ss_pred             eccceecccCCcHHHH-HHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhH
Confidence            9999999887655443 45554443322211                 00                         11235


Q ss_pred             HHHHHHHHhhcCcCCCCCHHHHhcCcccccc
Q 019650          296 FRRFVRSCLEKDWRKRGTVEELLAYPFVTKR  326 (337)
Q Consensus       296 ~~~li~~~l~~~p~~R~s~~eil~hp~f~~~  326 (337)
                      +.+|+++||..||.+|+|+.|+|.||||...
T Consensus       382 LfDLl~~mL~fDP~~RiTl~EAL~HpFF~~~  412 (415)
T KOG0671|consen  382 LFDLLRRMLEFDPARRITLREALSHPFFARL  412 (415)
T ss_pred             HHHHHHHHHccCccccccHHHHhcCHHhhcC
Confidence            8999999999999999999999999999764

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=9.3e-40  Score=291.45  Aligned_cols=249  Identities=27%  Similarity=0.401  Sum_probs=215.7

Q ss_pred             ccccccccccCcceEEEEEEEcc----CCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEE
Q 019650           48 DLKKLTVLGHGNGGIVYKVRHQK----SNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICF  123 (337)
Q Consensus        48 ~y~~~~~lg~g~~~~v~~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~l  123 (337)
                      ..+..+.||.|-||.||.|....    ..-.||||.++.+......+.|..|..+++.++||||++++|++.+  ...++
T Consensus       390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e--~P~Wi  467 (974)
T KOG4257|consen  390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE--QPMWI  467 (974)
T ss_pred             hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec--cceeE
Confidence            44556789999999999998742    2345899999887777778899999999999999999999999865  67889


Q ss_pred             EEeccCCCCchHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccC
Q 019650          124 VMEHMERGSLFDSLRVR-KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNN  202 (337)
Q Consensus       124 v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~  202 (337)
                      |||.++.|.|..|++.+ ..++......++.||+.||+|||+..+|||||..+|||+....-+||+|||+++.+.+....
T Consensus       468 vmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yY  547 (974)
T KOG4257|consen  468 VMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYY  547 (974)
T ss_pred             EEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccchh
Confidence            99999999999999866 46999999999999999999999999999999999999999999999999999999876543


Q ss_pred             CCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHhh
Q 019650          203 NNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICAIC  281 (337)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~  281 (337)
                      ...             ..-.+..|||||.++..    .++.++|||.||+++||++. |..||++..+.+    ++..+.
T Consensus       548 kaS-------------~~kLPIKWmaPESINfR----rFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD----VI~~iE  606 (974)
T KOG4257|consen  548 KAS-------------RGKLPIKWMAPESINFR----RFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD----VIGHIE  606 (974)
T ss_pred             hcc-------------ccccceeecCccccchh----cccchhhHHHHHHHHHHHHHhcCCccccccccc----eEEEec
Confidence            221             12257789999999954    68899999999999999998 999998876654    344566


Q ss_pred             ccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhc
Q 019650          282 FGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA  319 (337)
Q Consensus       282 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~  319 (337)
                      .+.+.+.|+.+++.+..|+.+||+.+|.+||.+.+|..
T Consensus       607 nGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~  644 (974)
T KOG4257|consen  607 NGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKA  644 (974)
T ss_pred             CCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHH
Confidence            78899999999999999999999999999999988754

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=6.1e-39  Score=309.06  Aligned_cols=149  Identities=30%  Similarity=0.481  Sum_probs=135.8

Q ss_pred             CccccccccccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEE
Q 019650           45 NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEIC  122 (337)
Q Consensus        45 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~  122 (337)
                      .+++|.+++.||.|+||+||+|.+..+++.||+|++....  .......+..|+.++..++|++|++++..+.. ...+|
T Consensus         2 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~-~~~~~   80 (669)
T cd05610           2 SIEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQS-ANNVY   80 (669)
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEE-CCEEE
Confidence            4689999999999999999999999999999999987542  23344677889999999999999999988766 68899


Q ss_pred             EEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCcc
Q 019650          123 FVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSR  194 (337)
Q Consensus       123 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~  194 (337)
                      +||||+.|++|.+++...+.+++..++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||++.
T Consensus        81 lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          81 LVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            999999999999999887889999999999999999999999999999999999999999999999999876

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.9e-40  Score=291.33  Aligned_cols=258  Identities=25%  Similarity=0.371  Sum_probs=226.9

Q ss_pred             CCCCCccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEee
Q 019650           38 PTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTI  117 (337)
Q Consensus        38 ~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~  117 (337)
                      -...|+....+.+.-++||.|-+|.||.|.+++-.--||+|.++.+  .+..++|+.|+.+|+.++|||++++++++.. 
T Consensus       258 n~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED--tMeveEFLkEAAvMKeikHpNLVqLLGVCT~-  334 (1157)
T KOG4278|consen  258 NADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTH-  334 (1157)
T ss_pred             CcchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc--chhHHHHHHHHHHHHhhcCccHHHHhhhhcc-
Confidence            3356777778888899999999999999999988888999998765  4567899999999999999999999999876 


Q ss_pred             CCeEEEEEeccCCCCchHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccc
Q 019650          118 EGEICFVMEHMERGSLFDSLRVR--KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRI  195 (337)
Q Consensus       118 ~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~  195 (337)
                      +...|||+||+..|+|.+||++.  ..++.-....++.||..|+.||..+++|||||...|+|+.++..+|++|||+++.
T Consensus       335 EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRl  414 (1157)
T KOG4278|consen  335 EPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRL  414 (1157)
T ss_pred             CCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhh
Confidence            78899999999999999999854  3577788899999999999999999999999999999999999999999999998


Q ss_pred             hhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCchhHH
Q 019650          196 VEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLM  274 (337)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~~~~~~~~~  274 (337)
                      +..+..             +.....-.++.|.|||.+.+    ..++.++|||+||++|||+.| |--||.+.    ++.
T Consensus       415 MtgDTY-------------TAHAGAKFPIKWTAPEsLAy----NtFSiKSDVWAFGVLLWEIATYGMsPYPGi----dlS  473 (1157)
T KOG4278|consen  415 MTGDTY-------------TAHAGAKFPIKWTAPESLAY----NTFSIKSDVWAFGVLLWEIATYGMSPYPGI----DLS  473 (1157)
T ss_pred             hcCCce-------------ecccCccCcccccCcccccc----cccccchhhHHHHHHHHHHHhcCCCCCCCc----cHH
Confidence            865543             33444446889999999985    478899999999999999999 88888654    556


Q ss_pred             HHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhc
Q 019650          275 ALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA  319 (337)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~  319 (337)
                      ++...+..+.+++-|.++++.+.+|+..||+++|..||+++|+-.
T Consensus       474 qVY~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHq  518 (1157)
T KOG4278|consen  474 QVYGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQ  518 (1157)
T ss_pred             HHHHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHH
Confidence            666777788999999999999999999999999999999999843

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=8.7e-39  Score=279.14  Aligned_cols=259  Identities=26%  Similarity=0.379  Sum_probs=205.9

Q ss_pred             ccccccccccccCcceEEEEEEEc----cCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEee-CCe
Q 019650           46 ISDLKKLTVLGHGNGGIVYKVRHQ----KSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTI-EGE  120 (337)
Q Consensus        46 ~~~y~~~~~lg~g~~~~v~~~~~~----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-~~~  120 (337)
                      .++|++.+.||.|+||.||++...    .++..+|+|.+...........+.+|+.+++.+.|+|++++++.+... +..
T Consensus         3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~   82 (284)
T cd05038           3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS   82 (284)
T ss_pred             hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence            457889999999999999999864    357889999997665433567788999999999999999999876542 346


Q ss_pred             EEEEEeccCCCCchHHhhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhcc
Q 019650          121 ICFVMEHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEET  199 (337)
Q Consensus       121 ~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~  199 (337)
                      .+++|||+++++|.+++.... .+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus        83 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  162 (284)
T cd05038          83 LRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPED  162 (284)
T ss_pred             eEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccccC
Confidence            899999999999999997654 6899999999999999999999999999999999999999999999999999876532


Q ss_pred             ccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCch--------
Q 019650          200 RNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP--------  271 (337)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~--------  271 (337)
                      ....           .......++..|+|||.+.    +..++.++|+||||+++|+|++|..|+.......        
T Consensus       163 ~~~~-----------~~~~~~~~~~~~~~Pe~~~----~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~  227 (284)
T cd05038         163 KDYY-----------YVKEPGESPIFWYAPECLR----TSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQ  227 (284)
T ss_pred             Ccce-----------eccCCCCCcccccCcHHHc----cCCCCcccchHHHhhhhheeeccCCCcccccchhcccccccc
Confidence            1110           0011123456799999987    4578889999999999999999999885432211        


Q ss_pred             ---hHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhc
Q 019650          272 ---DLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA  319 (337)
Q Consensus       272 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~  319 (337)
                         .................+..++..+.+++.+||+.+|++|||+.++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05038         228 GQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL  278 (284)
T ss_pred             ccccHHHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence               112222222333344445667889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=8.1e-39  Score=275.62  Aligned_cols=237  Identities=23%  Similarity=0.321  Sum_probs=190.5

Q ss_pred             cccccCcceEEEEEEEccCC----------ceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEE
Q 019650           53 TVLGHGNGGIVYKVRHQKSN----------SIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEIC  122 (337)
Q Consensus        53 ~~lg~g~~~~v~~~~~~~~~----------~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~  122 (337)
                      +.||.|+||.||+|.+..++          ..+++|.+......  ...+.+|+.++++++|+|++++++.+..  ...+
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~   76 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD--SLAFFETASLMSQLSHKHLVKLYGVCVR--DENI   76 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh--HHHHHHHHHHHHcCCCcchhheeeEEec--CCcE
Confidence            47899999999999998666          35788877654322  5677889999999999999999998766  5678


Q ss_pred             EEEeccCCCCchHHhhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCC-------cEEEeeccCcc
Q 019650          123 FVMEHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKG-------EVKIADFGVSR  194 (337)
Q Consensus       123 lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~-------~~~l~Dfg~~~  194 (337)
                      +||||+++++|.+++...+ .++...+..++.||+.||+|||++|++|+||||+||+++.++       .++|+|||.+.
T Consensus        77 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~  156 (259)
T cd05037          77 MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI  156 (259)
T ss_pred             EEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCccc
Confidence            9999999999999998766 789999999999999999999999999999999999999887       79999999987


Q ss_pred             chhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCchhH
Q 019650          195 IVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDL  273 (337)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~~~~~~~~  273 (337)
                      ......                  ...++..|+|||++...  ...++.++|+||||+++|+|++ |..||....... .
T Consensus       157 ~~~~~~------------------~~~~~~~y~aPE~~~~~--~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~-~  215 (259)
T cd05037         157 TVLSRE------------------ERVERIPWIAPECIRNG--QASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE-K  215 (259)
T ss_pred             cccccc------------------ccccCCCccChhhhcCC--CCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh-H
Confidence            654311                  12356789999999743  1367889999999999999999 677876543221 1


Q ss_pred             HHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhc
Q 019650          274 MALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA  319 (337)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~  319 (337)
                      .....   .  ....+......+.+++.+||..+|.+|||+.++++
T Consensus       216 ~~~~~---~--~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  256 (259)
T cd05037         216 ERFYQ---D--QHRLPMPDCAELANLINQCWTYDPTKRPSFRAILR  256 (259)
T ss_pred             HHHHh---c--CCCCCCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence            11111   1  11222223489999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.2e-38  Score=276.98  Aligned_cols=238  Identities=24%  Similarity=0.352  Sum_probs=187.2

Q ss_pred             ccccCcceEEEEEEEcc------------------------CCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCcee
Q 019650           54 VLGHGNGGIVYKVRHQK------------------------SNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVK  109 (337)
Q Consensus        54 ~lg~g~~~~v~~~~~~~------------------------~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~  109 (337)
                      .||+|+||.||+|....                        ....|++|++..... .....+.+|+.+++.++|+||++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~-~~~~~~~~~~~~~~~l~h~niv~   80 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHR-DIALAFFETASLMSQVSHIHLAF   80 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHH-HHHHHHHHHHHHHhcCCCCCeee
Confidence            69999999999997532                        124588888865432 33456777899999999999999


Q ss_pred             eeeeEEeeCCeEEEEEeccCCCCchHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCC-----
Q 019650          110 CHAVFYTIEGEICFVMEHMERGSLFDSLRV-RKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKG-----  183 (337)
Q Consensus       110 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~-----  183 (337)
                      +++++.+ ....++||||+++++|..++.. .+.+++..+..++.|++.||+|||+.|++|+||||+||+++..+     
T Consensus        81 ~~~~~~~-~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~  159 (274)
T cd05076          81 VHGVCVR-GSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGT  159 (274)
T ss_pred             EEEEEEe-CCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCc
Confidence            9998876 6788999999999999999865 46789999999999999999999999999999999999997643     


Q ss_pred             --cEEEeeccCccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHH-hC
Q 019650          184 --EVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECL-VG  260 (337)
Q Consensus       184 --~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~-tg  260 (337)
                        .++++|||.+.......                  ...++..|+|||.+..   +..++.++|+||||+++|+++ +|
T Consensus       160 ~~~~kl~d~g~~~~~~~~~------------------~~~~~~~~~aPe~~~~---~~~~~~~~Dv~slG~~l~el~~~g  218 (274)
T cd05076         160 SPFIKLSDPGVSFTALSRE------------------ERVERIPWIAPECVPG---GNSLSTAADKWSFGTTLLEICFDG  218 (274)
T ss_pred             cceeeecCCcccccccccc------------------ccccCCcccCchhhcC---CCCCCcHHHHHHHHHHHHHHHhCC
Confidence              38999999875432211                  1136778999998864   246788999999999999985 69


Q ss_pred             CCCCCCCCCchhHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          261 HYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       261 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                      ..||........ .....     .....+......+.+++.+||+.+|++|||+++++++
T Consensus       219 ~~p~~~~~~~~~-~~~~~-----~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~  272 (274)
T cd05076         219 EVPLKERTPSEK-ERFYE-----KKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRD  272 (274)
T ss_pred             CCCccccChHHH-HHHHH-----hccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence            999865433221 11111     1223334456789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-39  Score=287.89  Aligned_cols=257  Identities=23%  Similarity=0.329  Sum_probs=217.9

Q ss_pred             ccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 019650           46 ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVM  125 (337)
Q Consensus        46 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~  125 (337)
                      .+...+.++||+|-||.|.+|+.. ...+||+|.++..........|..|+++|.+++||||+.+++++.. +..+|+++
T Consensus       537 Rs~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~-DePicmI~  614 (807)
T KOG1094|consen  537 RSRLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQ-DDPLCMIT  614 (807)
T ss_pred             hhheehhhhhcCcccceeEEEEec-CceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeec-CCchHHHH
Confidence            367889999999999999999875 3688999999988777778899999999999999999999999987 68899999


Q ss_pred             eccCCCCchHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCC
Q 019650          126 EHMERGSLFDSLRVR--KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNN  203 (337)
Q Consensus       126 e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~  203 (337)
                      ||++.|+|.+++..+  +.........++.||+.+++||.+.++|||||.+.|+|++.++++||+|||+++.+-..... 
T Consensus       615 EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy-  693 (807)
T KOG1094|consen  615 EYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY-  693 (807)
T ss_pred             HHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCce-
Confidence            999999999999877  44566777889999999999999999999999999999999999999999999866543322 


Q ss_pred             CCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh--CCCCCCCCCCchhHHHHHHHhh
Q 019650          204 NHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV--GHYPLIGFGEKPDLMALICAIC  281 (337)
Q Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t--g~~pf~~~~~~~~~~~~~~~~~  281 (337)
                                 .....++.+++|||||.+.    .+.++.++|+|+||+++||+++  .+.||....++...........
T Consensus       694 -----------~vqgr~vlpiRwmawEsil----lgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~  758 (807)
T KOG1094|consen  694 -----------RVQGRAVLPIRWMAWESIL----LGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFR  758 (807)
T ss_pred             -----------eeecceeeeeeehhHHHHH----hccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcC
Confidence                       3344567889999999998    4578999999999999999776  7889987766554444444333


Q ss_pred             ccCCC---CCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          282 FGERL---EMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       282 ~~~~~---~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                      .+...   ..|..++..+.+++..||+.+-.+|||++++..|
T Consensus       759 ~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~  800 (807)
T KOG1094|consen  759 DQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLF  800 (807)
T ss_pred             CCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHH
Confidence            33222   3567789999999999999999999999998643

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.6e-38  Score=273.10  Aligned_cols=239  Identities=22%  Similarity=0.317  Sum_probs=187.0

Q ss_pred             cccccCcceEEEEEEEcc------------CCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCe
Q 019650           53 TVLGHGNGGIVYKVRHQK------------SNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGE  120 (337)
Q Consensus        53 ~~lg~g~~~~v~~~~~~~------------~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~  120 (337)
                      +.||.|++|.||+|+...            ....+++|.+.... ......+..|+.++..++||||+++++++.. ...
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~-~~~   78 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH-RDISLAFFETASMMRQVSHKHIVLLYGVCVR-DVE   78 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh-hhHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCC
Confidence            468999999999998532            23358888876543 3344567788999999999999999998776 677


Q ss_pred             EEEEEeccCCCCchHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCc-------EEEeeccC
Q 019650          121 ICFVMEHMERGSLFDSLRV-RKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGE-------VKIADFGV  192 (337)
Q Consensus       121 ~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~-------~~l~Dfg~  192 (337)
                      .+++|||+++++|..++.. ...+++..+..++.||+.||+|||+.|++|+||+|+||+++.++.       ++++|||.
T Consensus        79 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~  158 (262)
T cd05077          79 NIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI  158 (262)
T ss_pred             CEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCC
Confidence            8999999999999988875 356899999999999999999999999999999999999986654       89999998


Q ss_pred             ccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCch
Q 019650          193 SRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKP  271 (337)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~~~~~~  271 (337)
                      +......                  ....++..|+|||.+..   +..++.++||||||+++|+|++ |..||...... 
T Consensus       159 ~~~~~~~------------------~~~~~~~~y~aPE~~~~---~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~-  216 (262)
T cd05077         159 PITVLSR------------------QECVERIPWIAPECVED---SKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLA-  216 (262)
T ss_pred             CccccCc------------------ccccccccccChhhhcC---CCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchh-
Confidence            7654321                  11247788999998863   2467889999999999999984 88887543211 


Q ss_pred             hHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          272 DLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                      .....    ... ........+..+.+++.+||+.||.+||++.+|+.+
T Consensus       217 ~~~~~----~~~-~~~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~  260 (262)
T cd05077         217 EKERF----YEG-QCMLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD  260 (262)
T ss_pred             HHHHH----Hhc-CccCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence            11111    111 122223346789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=3.9e-38  Score=273.02  Aligned_cols=249  Identities=25%  Similarity=0.423  Sum_probs=199.5

Q ss_pred             ccccccccccCcceEEEEEEEcc-CCceEEEEEeecCC---------chHhHHHHHHHHHHHHh-cCCCCceeeeeeEEe
Q 019650           48 DLKKLTVLGHGNGGIVYKVRHQK-SNSIYALKVLNTTS---------STIIRHQAAHEAEILKR-LDSQFIVKCHAVFYT  116 (337)
Q Consensus        48 ~y~~~~~lg~g~~~~v~~~~~~~-~~~~vaiK~~~~~~---------~~~~~~~~~~e~~~~~~-l~~~~i~~~~~~~~~  116 (337)
                      .|++.+.||.|++|.||+|.+.. +++.+++|.+....         .......+.+|+.++.+ ++|+|++++++.+.+
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            48899999999999999999987 77889999875421         22344556678887765 799999999998876


Q ss_pred             eCCeEEEEEeccCCCCchHHhhh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCeEEcCCCcEEEeecc
Q 019650          117 IEGEICFVMEHMERGSLFDSLRV----RKKLSEDVISGVAYRVLKGLQYLHG-MQIIHGDIKPSNLLINGKGEVKIADFG  191 (337)
Q Consensus       117 ~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~-~~ivH~dl~~~Nili~~~~~~~l~Dfg  191 (337)
                       +...+++|||+++++|.+++..    ...+++..++.++.|++.+|.+||+ .|++|+||+|+||+++.++.++|+|||
T Consensus        81 -~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg  159 (269)
T cd08528          81 -NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFG  159 (269)
T ss_pred             -CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEeccc
Confidence             7889999999999999988743    3468999999999999999999996 789999999999999999999999999


Q ss_pred             CccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCch
Q 019650          192 VSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP  271 (337)
Q Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~  271 (337)
                      .+.......               ......++..|+|||.+.    +..++.++|+||||+++|+|++|..||.......
T Consensus       160 ~~~~~~~~~---------------~~~~~~~~~~~~~Pe~~~----~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~  220 (269)
T cd08528         160 LAKQKQPES---------------KLTSVVGTILYSCPEIVK----NEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLS  220 (269)
T ss_pred             ceeeccccc---------------ccccccCcccCcChhhhc----CCCCchHHHHHHHHHHHHHHHhCCCcccccCHHH
Confidence            987654432               111234788999999998    4567889999999999999999999996533222


Q ss_pred             hHHHHHHHhhccCCCCC-CCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          272 DLMALICAICFGERLEM-PETASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       272 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                          ............. ....+..+.+++.+||+.||++||++.|+..+
T Consensus       221 ----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~  266 (269)
T cd08528         221 ----LATKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM  266 (269)
T ss_pred             ----HHHHHhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence                2222222222222 22568899999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=6.4e-38  Score=271.58  Aligned_cols=253  Identities=18%  Similarity=0.212  Sum_probs=191.1

Q ss_pred             cccccCcceEEEEEEEcc--CCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEeccCC
Q 019650           53 TVLGHGNGGIVYKVRHQK--SNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMER  130 (337)
Q Consensus        53 ~~lg~g~~~~v~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~  130 (337)
                      +.||+|+||+||++....  ....+++|.+.........+.+.+|+.+++.++|+|++++++.+.. ....++||||+++
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~   79 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVE-AIPYLLVFEYCEL   79 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecC-CCccEEEEecCCC
Confidence            369999999999997543  2345677777655444456788899999999999999999998876 6788999999999


Q ss_pred             CCchHHhhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCCCC
Q 019650          131 GSLFDSLRVR----KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHN  206 (337)
Q Consensus       131 ~~L~~~l~~~----~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~  206 (337)
                      ++|.+++...    ...+...+..++.|++.||+|||+.+++|+||||+||+++.++.++|+|||.+.........    
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~----  155 (268)
T cd05086          80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYI----  155 (268)
T ss_pred             CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhh----
Confidence            9999999753    34567788899999999999999999999999999999999999999999987543211100    


Q ss_pred             CCCCCccccccccccCCCCCcCCcccccccC---CCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHhh-
Q 019650          207 NNNNNNIGEAAIACMGTCAYMSPERVDSERW---GGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICAIC-  281 (337)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~~~~~DiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~-  281 (337)
                              .......++..|+|||++.....   ...++.++||||||+++|+|++ +..||....+............ 
T Consensus       156 --------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~  227 (268)
T cd05086         156 --------ETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQV  227 (268)
T ss_pred             --------hcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhccc
Confidence                    01112347889999999853211   2245789999999999999997 5778865443333332222111 


Q ss_pred             ccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhc
Q 019650          282 FGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA  319 (337)
Q Consensus       282 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~  319 (337)
                      ....+..+...++.+.+++..|| .+|++||+++++++
T Consensus       228 ~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~  264 (268)
T cd05086         228 KLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR  264 (268)
T ss_pred             ccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence            11223344557889999999999 68999999999975

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-39  Score=280.63  Aligned_cols=279  Identities=28%  Similarity=0.381  Sum_probs=226.2

Q ss_pred             cccccccccccCcceEEEEEEEccCCceEEEEEeecCCc------hHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCe
Q 019650           47 SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSS------TIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGE  120 (337)
Q Consensus        47 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~  120 (337)
                      ++|-++++||+|+|+.||++.+....+.||+|+-....+      ...-+..-+|..+.+.|+||-||++++.+.-....
T Consensus       463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds  542 (775)
T KOG1151|consen  463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS  542 (775)
T ss_pred             HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence            689999999999999999999988889999999755432      22334456799999999999999999998877778


Q ss_pred             EEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhC--CceeccCCCCCeEEcCC---CcEEEeeccCccc
Q 019650          121 ICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGM--QIIHGDIKPSNLLINGK---GEVKIADFGVSRI  195 (337)
Q Consensus       121 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~--~ivH~dl~~~Nili~~~---~~~~l~Dfg~~~~  195 (337)
                      .|-|+|||+|.+|+-||..++-+++++++.|+.||+.||.||.+.  .|||-||||.|||+-.+   |.+||+|||++..
T Consensus       543 FCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKI  622 (775)
T KOG1151|consen  543 FCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKI  622 (775)
T ss_pred             ceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhhh
Confidence            999999999999999999999999999999999999999999976  69999999999999543   6899999999998


Q ss_pred             hhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHH
Q 019650          196 VEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMA  275 (337)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~  275 (337)
                      +.+...+.-.       .-+.+.-+.||.+|++||++.-.+.....+.++||||+|+|+|.++.|+.||.......+...
T Consensus       623 MdddSy~~vd-------GmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILq  695 (775)
T KOG1151|consen  623 MDDDSYNSVD-------GMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQ  695 (775)
T ss_pred             ccCCccCccc-------ceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHh
Confidence            8765433111       114455667999999999998654445678999999999999999999999976433333322


Q ss_pred             HHHHhhccC-CCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCCccc
Q 019650          276 LICAICFGE-RLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNI  332 (337)
Q Consensus       276 ~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~~~~  332 (337)
                      ...-+...+ ..+.-+.++++++++|++||+.--+.|.+.-++-.||||...-+.+..
T Consensus       696 eNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh~rrs~s  753 (775)
T KOG1151|consen  696 ENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPHIRRSVS  753 (775)
T ss_pred             hhchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccchhhhccc
Confidence            222111111 112235679999999999999999999999999999999876555443

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=3.4e-38  Score=273.95  Aligned_cols=252  Identities=21%  Similarity=0.315  Sum_probs=198.7

Q ss_pred             cccccccccCcceEEEEEEEc---cCCceEEEEEeecCC-chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCC-----
Q 019650           49 LKKLTVLGHGNGGIVYKVRHQ---KSNSIYALKVLNTTS-STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEG-----  119 (337)
Q Consensus        49 y~~~~~lg~g~~~~v~~~~~~---~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~-----  119 (337)
                      |++.+.||+|++|+||+|.+.   .++..+|+|++.... .....+.+.+|+.++++++|+|++++++.+.....     
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            678899999999999999864   457889999987643 33446678889999999999999999998765321     


Q ss_pred             eEEEEEeccCCCCchHHhhhc------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCc
Q 019650          120 EICFVMEHMERGSLFDSLRVR------KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVS  193 (337)
Q Consensus       120 ~~~lv~e~~~~~~L~~~l~~~------~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~  193 (337)
                      ..+++++|+.+++|.+++...      ..++...+..++.|++.||+|||+.|++|+||+|+||+++.++.++++|||.+
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~  160 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS  160 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccc
Confidence            247899999999998887422      24788999999999999999999999999999999999999999999999998


Q ss_pred             cchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCchh
Q 019650          194 RIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPD  272 (337)
Q Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~~~~~~~  272 (337)
                      ..........            ......++..|++||.+.    +..++.++|+||||+++|+|++ |..||......  
T Consensus       161 ~~~~~~~~~~------------~~~~~~~~~~~~~pe~~~----~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~--  222 (273)
T cd05074         161 KKIYSGDYYR------------QGCASKLPVKWLALESLA----DNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS--  222 (273)
T ss_pred             ccccCCccee------------cCCCccCchhhcCHhHHh----cCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH--
Confidence            8654321110            011123567899999987    4567889999999999999999 88888654322  


Q ss_pred             HHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          273 LMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                        ..............+...+..+.+++.+||+.+|++|||+.+++.+
T Consensus       223 --~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~  268 (273)
T cd05074         223 --EIYNYLIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ  268 (273)
T ss_pred             --HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence              2222222333344456678999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-39  Score=270.49  Aligned_cols=268  Identities=25%  Similarity=0.441  Sum_probs=223.9

Q ss_pred             ccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHHhc-CCCCceeeeeeEEeeCC
Q 019650           43 VENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRL-DSQFIVKCHAVFYTIEG  119 (337)
Q Consensus        43 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~  119 (337)
                      ....++|.++++||+|++..|..+.++++.+.||+|+++++.  .+...+-.+.|-.+..+- +||.++-++..|.+ ++
T Consensus       246 ~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqt-es  324 (593)
T KOG0695|consen  246 GLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQT-ES  324 (593)
T ss_pred             ccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcc-cc
Confidence            445689999999999999999999999999999999997753  333444555666665554 78999999998877 78


Q ss_pred             eEEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhcc
Q 019650          120 EICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEET  199 (337)
Q Consensus       120 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~  199 (337)
                      .+++|.||++||+|--.++...+++++.++.+...|+.||.|||++||+.||||..|+|++..|++||+|+|++..-..+
T Consensus       325 rlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~~  404 (593)
T KOG0695|consen  325 RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGP  404 (593)
T ss_pred             eEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCCC
Confidence            99999999999999999998999999999999999999999999999999999999999999999999999998654333


Q ss_pred             ccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCC--C-CchhHHHH
Q 019650          200 RNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGF--G-EKPDLMAL  276 (337)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~--~-~~~~~~~~  276 (337)
                                    +..+..++|||.|.|||.+.    |..|..++|+|+||++++||+.|+.||.-.  + .+......
T Consensus       405 --------------gd~tstfcgtpnyiapeilr----geeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedy  466 (593)
T KOG0695|consen  405 --------------GDTTSTFCGTPNYIAPEILR----GEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDY  466 (593)
T ss_pred             --------------CcccccccCCCcccchhhhc----ccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHH
Confidence                          25566778999999999999    668999999999999999999999999432  1 11222222


Q ss_pred             HHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCC------CHHHHhcCccccccCCC
Q 019650          277 ICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRG------TVEELLAYPFVTKRSSS  329 (337)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~------s~~eil~hp~f~~~~~~  329 (337)
                      +-+........+|...+-.+..+++..|++||.+|.      -+.++..|+||++.+|.
T Consensus       467 lfqvilekqiriprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd  525 (593)
T KOG0695|consen  467 LFQVILEKQIRIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWD  525 (593)
T ss_pred             HHHHHhhhcccccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHH
Confidence            333334445666777788889999999999999994      58999999999988774

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=7.1e-38  Score=274.89  Aligned_cols=261  Identities=20%  Similarity=0.264  Sum_probs=192.6

Q ss_pred             CccccccccccccCcceEEEEEEEccC---CceEEEEEeecCCchHhHH----------HHHHHHHHHHhcCCCCceeee
Q 019650           45 NISDLKKLTVLGHGNGGIVYKVRHQKS---NSIYALKVLNTTSSTIIRH----------QAAHEAEILKRLDSQFIVKCH  111 (337)
Q Consensus        45 ~~~~y~~~~~lg~g~~~~v~~~~~~~~---~~~vaiK~~~~~~~~~~~~----------~~~~e~~~~~~l~~~~i~~~~  111 (337)
                      .-++|++.+.||+|+||+||+|.+..+   +..+++|+..........+          ....+...+..+.|++++.++
T Consensus        10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~   89 (294)
T PHA02882         10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY   89 (294)
T ss_pred             CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence            346999999999999999999998776   6677888654333221111          112233445667999999999


Q ss_pred             eeEEeeCC---eEEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEe
Q 019650          112 AVFYTIEG---EICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIA  188 (337)
Q Consensus       112 ~~~~~~~~---~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~  188 (337)
                      +.......   ..+++++++.. ++.+.+......++..+..++.|++.||+|||+.+++||||||+||+++.++.++|+
T Consensus        90 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~  168 (294)
T PHA02882         90 GCGSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYII  168 (294)
T ss_pred             EeeeEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEE
Confidence            87655332   34678888743 777777665667889999999999999999999999999999999999999999999


Q ss_pred             eccCccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Q 019650          189 DFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFG  268 (337)
Q Consensus       189 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~  268 (337)
                      |||++..............       .......||+.|+|||++.    +..++.++||||||+++|+|++|..||....
T Consensus       169 DFGla~~~~~~~~~~~~~~-------~~~~~~~gt~~y~ape~~~----~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~  237 (294)
T PHA02882        169 DYGIASHFIIHGKHIEYSK-------EQKDLHRGTLYYAGLDAHN----GACVTRRGDLESLGYCMLKWAGIKLPWKGFG  237 (294)
T ss_pred             EcCCceeeccCCccccccc-------ccccccCCCccccCHHHhC----CCCCCcHHHHHHHHHHHHHHHhCCCCCCccc
Confidence            9999977643221111000       1122335899999999998    5678999999999999999999999997763


Q ss_pred             CchhHHHHH-----HHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhc
Q 019650          269 EKPDLMALI-----CAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA  319 (337)
Q Consensus       269 ~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~  319 (337)
                      .........     .....+ .. .....+..+.+++..|++.+|++||+++++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~  291 (294)
T PHA02882        238 HNGNLIHAAKCDFIKRLHEG-KI-KIKNANKFIYDFIECVTKLSYEEKPDYDALIK  291 (294)
T ss_pred             cchHHHHHhHHHHHHHhhhh-hh-ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            333222111     111111 11 23455789999999999999999999999875

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-40  Score=299.59  Aligned_cols=263  Identities=25%  Similarity=0.400  Sum_probs=226.5

Q ss_pred             cCccccccccccccCcceEEEEEEEccCC---ceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCe
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSN---SIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGE  120 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~  120 (337)
                      .+.+..+|.++||.|.||.|++|..+..+   ..||||.++....+.....|+.|+.+|-+..||||+.+.|+... ...
T Consensus       626 Id~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTk-s~P  704 (996)
T KOG0196|consen  626 IDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTK-SKP  704 (996)
T ss_pred             cChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEec-Cce
Confidence            44578899999999999999999997554   56999999998888888999999999999999999999998654 678


Q ss_pred             EEEEEeccCCCCchHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhcc
Q 019650          121 ICFVMEHMERGSLFDSLRVR-KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEET  199 (337)
Q Consensus       121 ~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~  199 (337)
                      ++||+||+++|+|+.+|+.+ +.++..+...++..|+.+++||-++|+|||||...|||++.+-.+|++|||+++.+.++
T Consensus       705 vMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd  784 (996)
T KOG0196|consen  705 VMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  784 (996)
T ss_pred             eEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccC
Confidence            89999999999999999865 67999999999999999999999999999999999999999999999999999988665


Q ss_pred             ccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHH
Q 019650          200 RNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALIC  278 (337)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~  278 (337)
                      ......           +...--+.+|.|||.+.+.    .++.+|||||+|+++||.++ |+.||.++.+.+    ++.
T Consensus       785 ~~~~yt-----------t~GGKIPiRWTAPEAIa~R----KFTsASDVWSyGIVmWEVmSyGERPYWdmSNQd----VIk  845 (996)
T KOG0196|consen  785 PEAAYT-----------TLGGKIPIRWTAPEAIAYR----KFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD----VIK  845 (996)
T ss_pred             CCcccc-----------ccCCccceeecChhHhhhc----ccCchhhccccceEEEEecccCCCcccccchHH----HHH
Confidence            422211           1111236799999999954    68999999999999999999 999998776543    455


Q ss_pred             HhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC--cccccc
Q 019650          279 AICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY--PFVTKR  326 (337)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~h--p~f~~~  326 (337)
                      .+..+.+.+.|.+++..+.+|+..||++|..+||.+.+|+++  ..+++.
T Consensus       846 aIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP  895 (996)
T KOG0196|consen  846 AIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNP  895 (996)
T ss_pred             HHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence            556677888888999999999999999999999999999884  455543

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.9e-39  Score=287.91  Aligned_cols=278  Identities=25%  Similarity=0.346  Sum_probs=219.3

Q ss_pred             ccccccccccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEE
Q 019650           46 ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICF  123 (337)
Q Consensus        46 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~l  123 (337)
                      -+-|..++.||-|+||.|.++...+|...||+|.+.+..  ..........|-.+|..-+.+-||+++..|.+ ..++|+
T Consensus       628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQD-kdnLYF  706 (1034)
T KOG0608|consen  628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQD-KDNLYF  706 (1034)
T ss_pred             ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEecc-CCceEE
Confidence            456889999999999999999999999999999986542  11223344568888999999999999999988 789999


Q ss_pred             EEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchh---c--
Q 019650          124 VMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVE---E--  198 (337)
Q Consensus       124 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~---~--  198 (337)
                      ||+|++||++-.+|-.-+-|.++.++.++.++..|+.+.|..|+|||||||+|||||.+|++||+|||++.=..   +  
T Consensus       707 VMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdsk  786 (1034)
T KOG0608|consen  707 VMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK  786 (1034)
T ss_pred             EEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceeccccc
Confidence            99999999999999888899999999999999999999999999999999999999999999999999974321   1  


Q ss_pred             ---c----ccCCCCCCCCCCcccc----------------ccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHH
Q 019650          199 ---T----RNNNNHNNNNNNNIGE----------------AAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVL  255 (337)
Q Consensus       199 ---~----~~~~~~~~~~~~~~~~----------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~  255 (337)
                         .    ..+....+++|...+.                .-...+||+.|+|||++.    ...|+...|+||.|+|||
T Consensus       787 YYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~----r~g~~q~cdwws~gvil~  862 (1034)
T KOG0608|consen  787 YYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLA----RTGYTQLCDWWSVGVILY  862 (1034)
T ss_pred             cccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhc----ccCccccchhhHhhHHHH
Confidence               0    1111112222222222                223458999999999998    568899999999999999


Q ss_pred             HHHhCCCCCCCCCCchhHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCC---CHHHHhcCccccccCCCc
Q 019650          256 ECLVGHYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRG---TVEELLAYPFVTKRSSSS  330 (337)
Q Consensus       256 ~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~---s~~eil~hp~f~~~~~~~  330 (337)
                      ||+.|++||.+....+...+++... ..........++.++.++|.+++ -+++.|.   -.+++..||||++++.++
T Consensus       863 em~~g~~pf~~~tp~~tq~kv~nw~-~~l~~~~~~~ls~e~~~li~kLc-~sad~RLGkng~d~vKaHpfFkgIDfss  938 (1034)
T KOG0608|consen  863 EMLVGQPPFLADTPGETQYKVINWR-NFLHIPYQGNLSKEALDLIQKLC-CSADSRLGKNGADQVKAHPFFKGIDFSS  938 (1034)
T ss_pred             HHhhCCCCccCCCCCcceeeeeehh-hccccccccccCHHHHHHHHHHh-cChhhhhcccchhhhhcCccccccchHh
Confidence            9999999997765544433332211 11233444677999999999875 5667775   477899999999999876

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.3e-40  Score=266.01  Aligned_cols=282  Identities=26%  Similarity=0.347  Sum_probs=222.7

Q ss_pred             CCCCCCccCccccccccccccCcceEEEEEEEccCCceEEEEEeec-CCchHhHHHHHHHHHHHHhcCCCCceeeeeeEE
Q 019650           37 NPTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNT-TSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFY  115 (337)
Q Consensus        37 ~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~  115 (337)
                      +...|.....+.|+.+.+||+|.||.||+|....++++||+|+.-- ...+..-....+|+.++..++|+|++.+++++.
T Consensus         7 s~~~P~~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~   86 (376)
T KOG0669|consen    7 SMYEPFCDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICR   86 (376)
T ss_pred             cccCCceecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHh
Confidence            3455778889999999999999999999999999999999876422 223334445678999999999999999888765


Q ss_pred             ee-------CCeEEEEEeccCCCCchHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEE
Q 019650          116 TI-------EGEICFVMEHMERGSLFDSLRVR-KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKI  187 (337)
Q Consensus       116 ~~-------~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l  187 (337)
                      ..       +..+|+|+++|+. +|.-++.+. -.++..++..++.++..+|.|+|...|+|||+|++|+||+.+|.++|
T Consensus        87 tk~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilkl  165 (376)
T KOG0669|consen   87 TKATPTNRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKL  165 (376)
T ss_pred             hccCCcccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEe
Confidence            42       2348999999976 888888765 57999999999999999999999999999999999999999999999


Q ss_pred             eeccCccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Q 019650          188 ADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGF  267 (337)
Q Consensus       188 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~  267 (337)
                      +|||+++...........          .-.-.+.|..|.+||.+.+.   ..|+++.|+|..||++.+|+|+.+.+++.
T Consensus       166 ADFGlar~fs~~~n~~kp----------rytnrvvTLwYrppEllLG~---r~yg~~iDiWgAgCimaeMwtrspimqgn  232 (376)
T KOG0669|consen  166 ADFGLARAFSTSKNVVKP----------RYTNRVVTLWYRPPELLLGD---REYGPPIDIWGAGCIMAEMWTRSPIMQGN  232 (376)
T ss_pred             eccccccceecccccCCC----------CcccceeeeecCCHHHhhcc---cccCCcchhHhHHHHHHHHHccCccccCC
Confidence            999999765443222111          01123579999999999975   58999999999999999999999988775


Q ss_pred             CCchhHHHHHHHhhccCCCCCCC-------------------------------CCCHHHHHHHHHHhhcCcCCCCCHHH
Q 019650          268 GEKPDLMALICAICFGERLEMPE-------------------------------TASPEFRRFVRSCLEKDWRKRGTVEE  316 (337)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~~li~~~l~~~p~~R~s~~e  316 (337)
                      .+.. ....+..++.....+.++                               .-++...+|+.++|..||.+|+++.+
T Consensus       233 teqq-ql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~  311 (376)
T KOG0669|consen  233 TEQQ-QLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQ  311 (376)
T ss_pred             hHHH-HHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHh
Confidence            4433 333344444433332221                               11347889999999999999999999


Q ss_pred             HhcCccccccCCC-cccc
Q 019650          317 LLAYPFVTKRSSS-SNIE  333 (337)
Q Consensus       317 il~hp~f~~~~~~-~~~~  333 (337)
                      +|+|.||.+.-.. +++.
T Consensus       312 alnh~~F~kdp~pqanl~  329 (376)
T KOG0669|consen  312 ALNHDFFWKDPMPQANLQ  329 (376)
T ss_pred             hhchhhhhcCCcchhhHH
Confidence            9999999887655 4443

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-39  Score=290.84  Aligned_cols=248  Identities=30%  Similarity=0.429  Sum_probs=200.7

Q ss_pred             cccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeC-----CeE
Q 019650           47 SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIE-----GEI  121 (337)
Q Consensus        47 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~-----~~~  121 (337)
                      .-|..-+.||.|+||.||++.++.+|+.||||.++........+..-+|++++++++|+|||+++++-.+..     ...
T Consensus        13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~   92 (732)
T KOG4250|consen   13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP   92 (732)
T ss_pred             cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence            567778899999999999999999999999999988766666777788999999999999999999755432     235


Q ss_pred             EEEEeccCCCCchHHhhh---cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCC--C--cEEEeeccCcc
Q 019650          122 CFVMEHMERGSLFDSLRV---RKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGK--G--EVKIADFGVSR  194 (337)
Q Consensus       122 ~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~--~--~~~l~Dfg~~~  194 (337)
                      .++||||.||+|+..|++   ...+++.+++.++.+++.||.|||++||+||||||.||++-.+  |  ..||+|||+++
T Consensus        93 vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Ar  172 (732)
T KOG4250|consen   93 VLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAR  172 (732)
T ss_pred             eEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccc
Confidence            799999999999999974   4579999999999999999999999999999999999998433  3  58999999999


Q ss_pred             chhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHH
Q 019650          195 IVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLM  274 (337)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~  274 (337)
                      .+.++               ....+.+||..|++||.+..+   ..|+...|.|||||++|+++||..||..........
T Consensus       173 el~d~---------------s~~~S~vGT~~YLhPel~E~q---~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~  234 (732)
T KOG4250|consen  173 ELDDN---------------SLFTSLVGTEEYLHPELYERQ---KKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNK  234 (732)
T ss_pred             cCCCC---------------CeeeeecCchhhcChHHHhhc---cCcCceeehhhhhhHHHHHhccCCCCCcCCCccccc
Confidence            88765               445567899999999999853   478889999999999999999999997654443222


Q ss_pred             HHHHHhhccC--------------------CCCCCCCCC----HHHHHHHHHHhhcCcCCCC
Q 019650          275 ALICAICFGE--------------------RLEMPETAS----PEFRRFVRSCLEKDWRKRG  312 (337)
Q Consensus       275 ~~~~~~~~~~--------------------~~~~~~~~~----~~~~~li~~~l~~~p~~R~  312 (337)
                      ..+.......                    ..+++...+    ..+..++..+|..+|.+|.
T Consensus       235 ~~~~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~  296 (732)
T KOG4250|consen  235 EIMWHIITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG  296 (732)
T ss_pred             hhhhhhhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence            2222221111                    111222222    3466788899999999998

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-39  Score=262.03  Aligned_cols=263  Identities=28%  Similarity=0.528  Sum_probs=213.7

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHH-HhcCCCCceeeeeeEEeeCCeEE
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEIL-KRLDSQFIVKCHAVFYTIEGEIC  122 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~-~~l~~~~i~~~~~~~~~~~~~~~  122 (337)
                      ...++..-++.||.|+||+|++..++.+|+.+|+|.++.........++..|.... +.-+.|+|++++|.... ++.-+
T Consensus        61 F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~-EGdcW  139 (361)
T KOG1006|consen   61 FTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFS-EGDCW  139 (361)
T ss_pred             cccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhc-CCcee
Confidence            44467778889999999999999999999999999998877666677777777764 44578999999999887 67788


Q ss_pred             EEEeccCCCCchHHhh-----hcCCCCHHHHHHHHHHHHHHHHHHH-hCCceeccCCCCCeEEcCCCcEEEeeccCccch
Q 019650          123 FVMEHMERGSLFDSLR-----VRKKLSEDVISGVAYRVLKGLQYLH-GMQIIHGDIKPSNLLINGKGEVKIADFGVSRIV  196 (337)
Q Consensus       123 lv~e~~~~~~L~~~l~-----~~~~l~~~~~~~i~~~l~~~l~~LH-~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~  196 (337)
                      +.||.++- +|+.+-.     ....+++..+-.|....+.||.||- +..|+|||+||+|||++..|.+||+|||.+-.+
T Consensus       140 iCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqL  218 (361)
T KOG1006|consen  140 ICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQL  218 (361)
T ss_pred             eeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhH
Confidence            99999964 7765443     3457999999999999999999998 469999999999999999999999999998877


Q ss_pred             hccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHH
Q 019650          197 EETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMAL  276 (337)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~  276 (337)
                      ..+-               .....+|-..|||||.+...  +..|+.+||+||||++|||+.||+.|+..-.   .....
T Consensus       219 v~Si---------------AkT~daGCrpYmAPERi~p~--~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~---svfeq  278 (361)
T KOG1006|consen  219 VDSI---------------AKTVDAGCRPYMAPERIDPS--DKGYDIRSDVWSLGITLYEVATGNFPYRKWD---SVFEQ  278 (361)
T ss_pred             HHHH---------------HhhhccCCccccChhccCCc--cCCcchhhhhhhhcceEeeeecCCCCcchHH---HHHHH
Confidence            6542               22333578899999999877  5579999999999999999999999986432   23333


Q ss_pred             HHHhhccCCCCCC--C---CCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCC
Q 019650          277 ICAICFGERLEMP--E---TASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSS  328 (337)
Q Consensus       277 ~~~~~~~~~~~~~--~---~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~  328 (337)
                      +.....+.++.+.  .   ..+..+..+|..||.+|.+.||++.+++++||++-...
T Consensus       279 l~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~~  335 (361)
T KOG1006|consen  279 LCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYAV  335 (361)
T ss_pred             HHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhhh
Confidence            3333344443322  2   35788999999999999999999999999999876543

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=1e-36  Score=259.31  Aligned_cols=242  Identities=39%  Similarity=0.558  Sum_probs=201.5

Q ss_pred             cceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEeccCCCCchHHhh
Q 019650           59 NGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLR  138 (337)
Q Consensus        59 ~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~  138 (337)
                      ++|.||+|.+..++..+++|++.........+.+.+|++.+++++|++++++++.+.. ....++++|++.+++|.+++.
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-~~~~~l~~e~~~~~~L~~~~~   79 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFED-EDKLYLVMEYCDGGDLFDLLK   79 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheee-CCEEEEEEeCCCCCCHHHHHH
Confidence            5899999999988999999999766543336788899999999999999999998776 688999999999999999998


Q ss_pred             hcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCCCCCCCCCccccccc
Q 019650          139 VRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAI  218 (337)
Q Consensus       139 ~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~  218 (337)
                      ....++...+..++.+++.++.+||+.|++|+||+|+||+++.++.++++|||.+.......               ...
T Consensus        80 ~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---------------~~~  144 (244)
T smart00220       80 KRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---------------LLT  144 (244)
T ss_pred             hccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc---------------ccc
Confidence            76669999999999999999999999999999999999999999999999999988765432               111


Q ss_pred             cccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhccCCCCCCCC--CCHHH
Q 019650          219 ACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPET--ASPEF  296 (337)
Q Consensus       219 ~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~  296 (337)
                      ...++..|++||.+.    +..++.++|+|+||++++++++|..||....+........   ...........  ++..+
T Consensus       145 ~~~~~~~~~~pE~~~----~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~  217 (244)
T smart00220      145 TFVGTPEYMAPEVLL----GKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKI---GKPKPPFPPPEWKISPEA  217 (244)
T ss_pred             cccCCcCCCCHHHHc----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH---hccCCCCccccccCCHHH
Confidence            234788999999998    4567889999999999999999999996533333322222   22222222221  78899


Q ss_pred             HHHHHHHhhcCcCCCCCHHHHhcCccc
Q 019650          297 RRFVRSCLEKDWRKRGTVEELLAYPFV  323 (337)
Q Consensus       297 ~~li~~~l~~~p~~R~s~~eil~hp~f  323 (337)
                      .+++.+||..+|++||++.++++||||
T Consensus       218 ~~~i~~~l~~~p~~Rp~~~~~~~~~~~  244 (244)
T smart00220      218 KDLIRKLLVKDPEKRLTAEEALQHPFF  244 (244)
T ss_pred             HHHHHHHccCCchhccCHHHHhhCCCC
Confidence            999999999999999999999999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.5e-38  Score=281.76  Aligned_cols=260  Identities=25%  Similarity=0.375  Sum_probs=222.3

Q ss_pred             ccCccccccccccccCcceEEEEEEEcc---CCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCC
Q 019650           43 VENISDLKKLTVLGHGNGGIVYKVRHQK---SNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEG  119 (337)
Q Consensus        43 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~  119 (337)
                      ....++.++.++||+|+||.|++|.+..   +...||||++..+......+.|.+|+..|.+|+|+|++++||+..+  .
T Consensus       106 lIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~--q  183 (1039)
T KOG0199|consen  106 LIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD--Q  183 (1039)
T ss_pred             eccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc--c
Confidence            3445788999999999999999999973   3345899999888766688999999999999999999999999875  6


Q ss_pred             eEEEEEeccCCCCchHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchh
Q 019650          120 EICFVMEHMERGSLFDSLRVR--KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVE  197 (337)
Q Consensus       120 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~  197 (337)
                      .+.+|||+++.|+|.+.|...  ..|-....-.++.||+.|+.||..+++|||||...|+++-....+||+|||+.+.++
T Consensus       184 p~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg  263 (1039)
T KOG0199|consen  184 PAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALG  263 (1039)
T ss_pred             hhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccC
Confidence            678999999999999999863  457888999999999999999999999999999999999988899999999999887


Q ss_pred             ccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCchhHHHH
Q 019650          198 ETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMAL  276 (337)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~~~~~~~~~~~  276 (337)
                      .....+...           ...-.+..|+|||.+.    ...++.++|+|++|+++|||+| |+.||.+..    -..+
T Consensus       264 ~ned~Yvm~-----------p~rkvPfAWCaPEsLr----h~kFShaSDvWmyGVTiWEMFtyGEePW~G~~----g~qI  324 (1039)
T KOG0199|consen  264 ENEDMYVMA-----------PQRKVPFAWCAPESLR----HRKFSHASDVWMYGVTIWEMFTYGEEPWVGCR----GIQI  324 (1039)
T ss_pred             CCCcceEec-----------CCCcCcccccCHhHhc----cccccccchhhhhhhhHHhhhccCCCCCCCCC----HHHH
Confidence            654433211           1112567899999999    4578999999999999999999 999997653    3455


Q ss_pred             HHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccc
Q 019650          277 ICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV  323 (337)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f  323 (337)
                      ++.+..+++..-|..+++.+.++++.||..+|.+||||..|.+.-+.
T Consensus       325 L~~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l  371 (1039)
T KOG0199|consen  325 LKNIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVL  371 (1039)
T ss_pred             HHhccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHH
Confidence            66666888889999999999999999999999999999998754433

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=2.5e-37  Score=291.10  Aligned_cols=267  Identities=19%  Similarity=0.187  Sum_probs=179.1

Q ss_pred             ccCccccccccccccCcceEEEEEEEccC----CceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeE----
Q 019650           43 VENISDLKKLTVLGHGNGGIVYKVRHQKS----NSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVF----  114 (337)
Q Consensus        43 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~----~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~----  114 (337)
                      ....++|.+.+.||+|+||.||+|.+..+    +..||+|.+......   +....+  .+....+.++..+...+    
T Consensus       128 ~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~---e~~~~e--~l~~~~~~~~~~~~~~~~~~~  202 (566)
T PLN03225        128 SFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV---EIWMNE--RVRRACPNSCADFVYGFLEPV  202 (566)
T ss_pred             CCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh---HHHHHH--HHHhhchhhHHHHHHhhhccc
Confidence            34678999999999999999999999888    899999987643211   111111  11111112222111111    


Q ss_pred             -EeeCCeEEEEEeccCCCCchHHhhhcCC--------------------CCHHHHHHHHHHHHHHHHHHHhCCceeccCC
Q 019650          115 -YTIEGEICFVMEHMERGSLFDSLRVRKK--------------------LSEDVISGVAYRVLKGLQYLHGMQIIHGDIK  173 (337)
Q Consensus       115 -~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------------------l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~  173 (337)
                       ...+...++|+||+.+++|.+++.....                    .....+..++.||+.||.|||+.||+|||||
T Consensus       203 ~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLK  282 (566)
T PLN03225        203 SSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVK  282 (566)
T ss_pred             ccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCC
Confidence             1235678999999999999999874321                    1234567899999999999999999999999


Q ss_pred             CCCeEEcC-CCcEEEeeccCccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCC--------------
Q 019650          174 PSNLLING-KGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWG--------------  238 (337)
Q Consensus       174 ~~Nili~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~--------------  238 (337)
                      |+|||++. ++.++|+|||++........             .......+++.|+|||.+......              
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~-------------~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp  349 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVGIN-------------YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSP  349 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCccccccccc-------------cCCcccccCCCccChHHhhccCCCCCCccccccccccc
Confidence            99999986 57999999999976533211             112234689999999976432110              


Q ss_pred             ----CCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhh----------cc-C------CCCCCCCCCHHHH
Q 019650          239 ----GDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAIC----------FG-E------RLEMPETASPEFR  297 (337)
Q Consensus       239 ----~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~----------~~-~------~~~~~~~~~~~~~  297 (337)
                          ..+..++|||||||++|||+++..++..  +.......+....          .. .      ........+....
T Consensus       350 ~l~~~~~~~k~DVwSlGviL~el~~~~~~~~~--~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  427 (566)
T PLN03225        350 VLWQLNLPDRFDIYSAGLIFLQMAFPNLRSDS--NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGW  427 (566)
T ss_pred             hhccccCCCCcccHHHHHHHHHHHhCcCCCch--HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHH
Confidence                1234467999999999999997665421  1111111111000          00 0      0011112234567


Q ss_pred             HHHHHHhhcCcCCCCCHHHHhcCccccccCCC
Q 019650          298 RFVRSCLEKDWRKRGTVEELLAYPFVTKRSSS  329 (337)
Q Consensus       298 ~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~  329 (337)
                      +||.+||..||.+|||++++|+||||++....
T Consensus       428 dLi~~mL~~dP~kR~ta~e~L~Hpff~~~~~~  459 (566)
T PLN03225        428 ELLKSMMRFKGRQRISAKAALAHPYFDREGLL  459 (566)
T ss_pred             HHHHHHccCCcccCCCHHHHhCCcCcCCCCcc
Confidence            99999999999999999999999999987653

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=3.8e-37  Score=244.18  Aligned_cols=262  Identities=21%  Similarity=0.344  Sum_probs=210.2

Q ss_pred             CCccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcC-CCCceeeeeeEEeeC-
Q 019650           41 PDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLD-SQFIVKCHAVFYTIE-  118 (337)
Q Consensus        41 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~-  118 (337)
                      ..-...++|++.+++|+|.++.||.|....+..+++||+++..    ..+.+.+|+.++..+. |+||++++++..+.. 
T Consensus        32 i~wg~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV----kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~S  107 (338)
T KOG0668|consen   32 IDWGNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV----KKKKIKREIKILQNLRGGPNIIKLLDIVKDPES  107 (338)
T ss_pred             eeccccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH----HHHHHHHHHHHHHhccCCCCeeehhhhhcCccc
Confidence            4446789999999999999999999999999999999999754    4677889999999996 899999999987754 


Q ss_pred             CeEEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCC-CcEEEeeccCccchh
Q 019650          119 GEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGK-GEVKIADFGVSRIVE  197 (337)
Q Consensus       119 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~-~~~~l~Dfg~~~~~~  197 (337)
                      ....+++|++...+...+.   +.++..+++.++.++++||.|+|++||.|||+||.|++|+.. ..++|+|+|++....
T Consensus       108 ktpaLiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH  184 (338)
T KOG0668|consen  108 KTPSLIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  184 (338)
T ss_pred             cCchhHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcC
Confidence            3467999999886655554   578999999999999999999999999999999999999876 579999999998887


Q ss_pred             ccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCc-hhHHHH
Q 019650          198 ETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEK-PDLMAL  276 (337)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~-~~~~~~  276 (337)
                      +...-+               ..+.+..|.-||.+..-   ..|+++.|+|||||++..|+..+-||....+. +.+..+
T Consensus       185 p~~eYn---------------VRVASRyfKGPELLVdy---~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkI  246 (338)
T KOG0668|consen  185 PGKEYN---------------VRVASRYFKGPELLVDY---QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKI  246 (338)
T ss_pred             CCceee---------------eeeehhhcCCchheeec---hhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHH
Confidence            654322               23456778899999753   47899999999999999999988888654433 222222


Q ss_pred             HHHhh------------ccCCCC--------------------CCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCcccc
Q 019650          277 ICAIC------------FGERLE--------------------MPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVT  324 (337)
Q Consensus       277 ~~~~~------------~~~~~~--------------------~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~  324 (337)
                      ..-+.            ...++.                    -....++++.+++.++|..|-.+|+|+.|++.||||.
T Consensus       247 akVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~  326 (338)
T KOG0668|consen  247 AKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFA  326 (338)
T ss_pred             HHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHH
Confidence            21111            000110                    0123468899999999999999999999999999997


Q ss_pred             ccC
Q 019650          325 KRS  327 (337)
Q Consensus       325 ~~~  327 (337)
                      ...
T Consensus       327 ~~~  329 (338)
T KOG0668|consen  327 PVR  329 (338)
T ss_pred             HHH
Confidence            654

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-37  Score=282.48  Aligned_cols=263  Identities=30%  Similarity=0.520  Sum_probs=220.9

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhc-CCCCceeeeeeEEeeC----
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRL-DSQFIVKCHAVFYTIE----  118 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~----  118 (337)
                      ...+.|++.++||.|.+|.||++...++++.+|+|+.....+.  .++++-|+.+++.. .|||++..++++.-..    
T Consensus        16 dp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~--deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~   93 (953)
T KOG0587|consen   16 DPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE--EEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNG   93 (953)
T ss_pred             CCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc--cHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCC
Confidence            4467899999999999999999999999999999998776533  34556688888776 7899999999988754    


Q ss_pred             CeEEEEEeccCCCCchHHhhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccch
Q 019650          119 GEICFVMEHMERGSLFDSLRV--RKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIV  196 (337)
Q Consensus       119 ~~~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~  196 (337)
                      ..++||||||.||+.-|++..  ...+++..+..|++.++.+|.+||...++|||+|-.|||++.++.+||+|||.+..+
T Consensus        94 DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQl  173 (953)
T KOG0587|consen   94 DQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL  173 (953)
T ss_pred             CeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeee
Confidence            468999999999999999974  457899999999999999999999999999999999999999999999999999888


Q ss_pred             hccccCCCCCCCCCCccccccccccCCCCCcCCcccccc-cCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHH
Q 019650          197 EETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSE-RWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMA  275 (337)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~  275 (337)
                      ....              .....++|||.|||||++.-+ .++..|+..+|+||||++..||..|.+|+.+++....+..
T Consensus       174 dsT~--------------grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~  239 (953)
T KOG0587|consen  174 DSTV--------------GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFL  239 (953)
T ss_pred             eccc--------------ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhcc
Confidence            7654              333456899999999998533 3356789999999999999999999999987766543332


Q ss_pred             HHHHhhccCCCCC--CCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCcccccc
Q 019650          276 LICAICFGERLEM--PETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKR  326 (337)
Q Consensus       276 ~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~  326 (337)
                      +    ..+.+++.  |...++.+-++|..||.+|..+||+..++|+|||++..
T Consensus       240 I----pRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~  288 (953)
T KOG0587|consen  240 I----PRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQ  288 (953)
T ss_pred             C----CCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCccccc
Confidence            2    22223322  45667889999999999999999999999999999843

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5e-36  Score=260.86  Aligned_cols=131  Identities=25%  Similarity=0.429  Sum_probs=114.5

Q ss_pred             cccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcC--------CCCceeeeeeEEeeC
Q 019650           47 SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLD--------SQFIVKCHAVFYTIE  118 (337)
Q Consensus        47 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~--------~~~i~~~~~~~~~~~  118 (337)
                      .+|.+.++||+|-|+|||+|.|..+.+.||+|+.+.  .+...+....|+.++++++        ...||++++.|...+
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS--AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG  155 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS--AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG  155 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh--hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence            689999999999999999999999999999999874  3455666778999999982        246999999988754


Q ss_pred             ---CeEEEEEeccCCCCchHHhhh--cCCCCHHHHHHHHHHHHHHHHHHH-hCCceeccCCCCCeEEc
Q 019650          119 ---GEICFVMEHMERGSLFDSLRV--RKKLSEDVISGVAYRVLKGLQYLH-GMQIIHGDIKPSNLLIN  180 (337)
Q Consensus       119 ---~~~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~i~~~l~~~l~~LH-~~~ivH~dl~~~Nili~  180 (337)
                         .++|+|+|++ |.+|..+|..  .+.++...++.|+.||+.+|.||| +.||||.||||+|||+.
T Consensus       156 pNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~  222 (590)
T KOG1290|consen  156 PNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC  222 (590)
T ss_pred             CCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence               4799999999 6699999974  357999999999999999999999 56999999999999994

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.3e-35  Score=273.11  Aligned_cols=270  Identities=23%  Similarity=0.233  Sum_probs=187.5

Q ss_pred             cCccccccccccccCcceEEEEEEEc----------------cCCceEEEEEeecCCchHh-------------HHHHHH
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQ----------------KSNSIYALKVLNTTSSTII-------------RHQAAH   94 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~----------------~~~~~vaiK~~~~~~~~~~-------------~~~~~~   94 (337)
                      ...++|++.++||+|+||+||+|.+.                ..++.||+|.+........             .+....
T Consensus       142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v  221 (507)
T PLN03224        142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV  221 (507)
T ss_pred             ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence            45789999999999999999999752                3456799999865432211             112234


Q ss_pred             HHHHHHhcCCCCc-----eeeeeeEEe-------eCCeEEEEEeccCCCCchHHhhhc----------------------
Q 019650           95 EAEILKRLDSQFI-----VKCHAVFYT-------IEGEICFVMEHMERGSLFDSLRVR----------------------  140 (337)
Q Consensus        95 e~~~~~~l~~~~i-----~~~~~~~~~-------~~~~~~lv~e~~~~~~L~~~l~~~----------------------  140 (337)
                      |+.++.+++|.++     +.+++.+..       .....++||||+++++|.+++...                      
T Consensus       222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~  301 (507)
T PLN03224        222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM  301 (507)
T ss_pred             HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence            6666777766554     444444332       135689999999999999988632                      


Q ss_pred             --CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCCCCCCCCCccccccc
Q 019650          141 --KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAI  218 (337)
Q Consensus       141 --~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~  218 (337)
                        ..+++..++.++.|++.+|.|||+.+++|+||||+||+++.++.++|+|||++........             ....
T Consensus       302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-------------~~~~  368 (507)
T PLN03224        302 PQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-------------FNPL  368 (507)
T ss_pred             ccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCc-------------cCcc
Confidence              1235678899999999999999999999999999999999999999999999865432211             0111


Q ss_pred             cccCCCCCcCCcccccccCCC------------------CCCccccHHHHHHHHHHHHhCCC-CCCCCCCchhH------
Q 019650          219 ACMGTCAYMSPERVDSERWGG------------------DYGFAGDVWSLGVVVLECLVGHY-PLIGFGEKPDL------  273 (337)
Q Consensus       219 ~~~~~~~y~aPE~~~~~~~~~------------------~~~~~~DiwslG~il~~l~tg~~-pf~~~~~~~~~------  273 (337)
                      ...+++.|+|||.+.......                  ......|+||+||++|+|+++.. ||.........      
T Consensus       369 ~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~  448 (507)
T PLN03224        369 YGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDN  448 (507)
T ss_pred             ccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccc
Confidence            123578999999986321000                  11234799999999999999875 66432111100      


Q ss_pred             --HHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCc---CCCCCHHHHhcCcccccc
Q 019650          274 --MALICAICFGERLEMPETASPEFRRFVRSCLEKDW---RKRGTVEELLAYPFVTKR  326 (337)
Q Consensus       274 --~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p---~~R~s~~eil~hp~f~~~  326 (337)
                        ................+..++..++++.+||..+|   .+|+|++|+|+||||...
T Consensus       449 ~~~~~r~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~~  506 (507)
T PLN03224        449 DLNRWRMYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLPE  506 (507)
T ss_pred             hHHHHHhhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCCC
Confidence              00000011111223345678999999999999866   689999999999999764

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=1.9e-37  Score=271.47  Aligned_cols=255  Identities=24%  Similarity=0.386  Sum_probs=205.6

Q ss_pred             cccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCC------CCceeeeeeEEeeCCe
Q 019650           47 SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDS------QFIVKCHAVFYTIEGE  120 (337)
Q Consensus        47 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~------~~i~~~~~~~~~~~~~  120 (337)
                      ++|.+....|.|-||+|.+|.+...+..||||++...  +.--+.=+.|+++|++|..      -|.+.++..|.. .++
T Consensus       432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN--E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~h-knH  508 (752)
T KOG0670|consen  432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN--EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKH-KNH  508 (752)
T ss_pred             ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc--hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhh-cce
Confidence            6888999999999999999999999999999999643  2233344579999999943      478888888877 799


Q ss_pred             EEEEEeccCCCCchHHhhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCC-CcEEEeeccCccch
Q 019650          121 ICFVMEHMERGSLFDSLRVRK---KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGK-GEVKIADFGVSRIV  196 (337)
Q Consensus       121 ~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~-~~~~l~Dfg~~~~~  196 (337)
                      +|+|+|.+.- +|.++|...+   .+....++.++.||+.||..|-.+||+|.||||.|||++++ ..+||||||.+...
T Consensus       509 LClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~  587 (752)
T KOG0670|consen  509 LCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSASFA  587 (752)
T ss_pred             eEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCcccccc
Confidence            9999999954 9999998655   58899999999999999999999999999999999999987 57999999999887


Q ss_pred             hccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHH
Q 019650          197 EETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMAL  276 (337)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~  276 (337)
                      ..+..-                ....+..|.|||++.    |..|++..|+||+||+||||+||+..|++..+..-+...
T Consensus       588 ~eneit----------------PYLVSRFYRaPEIiL----G~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~  647 (752)
T KOG0670|consen  588 SENEIT----------------PYLVSRFYRAPEIIL----GLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLF  647 (752)
T ss_pred             cccccc----------------HHHHHHhccCcceee----cCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHH
Confidence            654311                113456799999999    678999999999999999999999999887665433322


Q ss_pred             HHHhhccCCCC-----------------------------------------------------CCCC---CCHHHHHHH
Q 019650          277 ICAICFGERLE-----------------------------------------------------MPET---ASPEFRRFV  300 (337)
Q Consensus       277 ~~~~~~~~~~~-----------------------------------------------------~~~~---~~~~~~~li  300 (337)
                      + .+....+-.                                                     ++..   +-.++.+|+
T Consensus       648 m-e~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLL  726 (752)
T KOG0670|consen  648 M-ELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLL  726 (752)
T ss_pred             H-HhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHH
Confidence            2 211111110                                                     0000   114689999


Q ss_pred             HHHhhcCcCCCCCHHHHhcCcccccc
Q 019650          301 RSCLEKDWRKRGTVEELLAYPFVTKR  326 (337)
Q Consensus       301 ~~~l~~~p~~R~s~~eil~hp~f~~~  326 (337)
                      .+||..||.+|.|..++|.||||+++
T Consensus       727 dkml~LdP~KRit~nqAL~HpFi~~k  752 (752)
T KOG0670|consen  727 DKMLILDPEKRITVNQALKHPFITEK  752 (752)
T ss_pred             HHHhccChhhcCCHHHHhcCCcccCC
Confidence            99999999999999999999999863

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-35  Score=279.54  Aligned_cols=260  Identities=27%  Similarity=0.400  Sum_probs=219.1

Q ss_pred             CCccCccccccccccccCcceEEEEEEEc---c----CCceEEEEEeecCCchHhHHHHHHHHHHHHhc-CCCCceeeee
Q 019650           41 PDVENISDLKKLTVLGHGNGGIVYKVRHQ---K----SNSIYALKVLNTTSSTIIRHQAAHEAEILKRL-DSQFIVKCHA  112 (337)
Q Consensus        41 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~---~----~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~  112 (337)
                      .++...++.++.+.||.|+||.|++|...   .    ....||+|.++........+.+..|+.+++.+ +|+|++.+.+
T Consensus       290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG  369 (609)
T KOG0200|consen  290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG  369 (609)
T ss_pred             ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence            45666677788889999999999999854   1    25679999998776667778889999999998 5999999999


Q ss_pred             eEEeeCCeEEEEEeccCCCCchHHhhhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCC
Q 019650          113 VFYTIEGEICFVMEHMERGSLFDSLRVRK----------------KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSN  176 (337)
Q Consensus       113 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~N  176 (337)
                      .+.. +..+++|+||+..|+|.++++..+                .++..+...++.||+.+++||++.+++||||..+|
T Consensus       370 ~~t~-~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRN  448 (609)
T KOG0200|consen  370 ACTQ-DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARN  448 (609)
T ss_pred             eecc-CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhh
Confidence            8877 788999999999999999998665                48899999999999999999999999999999999


Q ss_pred             eEEcCCCcEEEeeccCccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHH
Q 019650          177 LLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLE  256 (337)
Q Consensus       177 ili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~  256 (337)
                      ||+..+..+||+|||+++...........          ..... .+..|||||.+.    +..++.++||||+|++|||
T Consensus       449 VLi~~~~~~kIaDFGlar~~~~~~~y~~~----------~~~~~-LP~kWmApEsl~----~~~ft~kSDVWSfGI~L~E  513 (609)
T KOG0200|consen  449 VLITKNKVIKIADFGLARDHYNKDYYRTK----------SSAGT-LPVKWMAPESLF----DRVFTSKSDVWSFGILLWE  513 (609)
T ss_pred             EEecCCCEEEEccccceeccCCCCceEec----------CCCCc-cceeecCHHHhc----cCcccccchhhHHHHHHHH
Confidence            99999999999999999865443221100          00111 356799999999    5689999999999999999


Q ss_pred             HHh-CCCCCCCCCCchhHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhc
Q 019650          257 CLV-GHYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA  319 (337)
Q Consensus       257 l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~  319 (337)
                      ++| |..||.+.....++   .+.+..+.+...|..++.++.++++.||+.+|.+||++.++.+
T Consensus       514 ifsLG~~PYp~~~~~~~l---~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~  574 (609)
T KOG0200|consen  514 IFTLGGTPYPGIPPTEEL---LEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE  574 (609)
T ss_pred             HhhCCCCCCCCCCcHHHH---HHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence            999 99999764333333   4467788899999999999999999999999999999999875

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-36  Score=249.64  Aligned_cols=259  Identities=26%  Similarity=0.363  Sum_probs=208.5

Q ss_pred             ccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCC-chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeC---
Q 019650           43 VENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIE---  118 (337)
Q Consensus        43 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~---  118 (337)
                      .....+|.-+..+|.|+- .|..+.|.-.++.||+|...... ...-.++..+|..++..+.|+|+++++.++...+   
T Consensus        13 ftv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~   91 (369)
T KOG0665|consen   13 FTVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLE   91 (369)
T ss_pred             eeeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHH
Confidence            355679999999999999 88889999999999999875543 3334567788999999999999999999875432   


Q ss_pred             --CeEEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccch
Q 019650          119 --GEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIV  196 (337)
Q Consensus       119 --~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~  196 (337)
                        ...|+|||+++. +|.+.+.  -.++-+++..++.|++.|+++||+.||+||||||+||++..++.+||.|||++...
T Consensus        92 ~~~e~y~v~e~m~~-nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e  168 (369)
T KOG0665|consen   92 EFQEVYLVMELMDA-NLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTE  168 (369)
T ss_pred             HHHhHHHHHHhhhh-HHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhccc
Confidence              247999999975 8988887  46788999999999999999999999999999999999999999999999999876


Q ss_pred             hccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHH
Q 019650          197 EETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMAL  276 (337)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~  276 (337)
                      ...-               .....+.+..|.|||++.    +..|...+||||+||++.||++|...|.+...-+.+.+.
T Consensus       169 ~~~~---------------~mtpyVvtRyyrapevil----~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki  229 (369)
T KOG0665|consen  169 DTDF---------------MMTPYVVTRYYRAPEVIL----GMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKI  229 (369)
T ss_pred             Cccc---------------ccCchhheeeccCchhee----ccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHH
Confidence            5441               122346888999999999    667999999999999999999999999764333333332


Q ss_pred             HHHhhccC-------------------------------CCCCC------CCCCHHHHHHHHHHhhcCcCCCCCHHHHhc
Q 019650          277 ICAICFGE-------------------------------RLEMP------ETASPEFRRFVRSCLEKDWRKRGTVEELLA  319 (337)
Q Consensus       277 ~~~~~~~~-------------------------------~~~~~------~~~~~~~~~li~~~l~~~p~~R~s~~eil~  319 (337)
                      ...+....                               ...++      +.-...+++++.+||..||++|.|++++|.
T Consensus       230 ~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~  309 (369)
T KOG0665|consen  230 IEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR  309 (369)
T ss_pred             HHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence            22211100                               00011      122457999999999999999999999999


Q ss_pred             Ccccc
Q 019650          320 YPFVT  324 (337)
Q Consensus       320 hp~f~  324 (337)
                      ||||+
T Consensus       310 HPY~~  314 (369)
T KOG0665|consen  310 HPYIK  314 (369)
T ss_pred             CCeee
Confidence            99998

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-36  Score=274.81  Aligned_cols=253  Identities=26%  Similarity=0.383  Sum_probs=216.5

Q ss_pred             CccccccccccccCcceEEEEEEEccCC----ceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCe
Q 019650           45 NISDLKKLTVLGHGNGGIVYKVRHQKSN----SIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGE  120 (337)
Q Consensus        45 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~  120 (337)
                      .....+..++||+|+||+||+|.+...+    -+||+|++..........++..|+.++.+++|+|++++++++..  +.
T Consensus       694 kEtelkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~--s~  771 (1177)
T KOG1025|consen  694 KETELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCML--ST  771 (1177)
T ss_pred             hhhhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhccc--ch
Confidence            3456777889999999999999986433    46899998877777778889999999999999999999999876  34


Q ss_pred             EEEEEeccCCCCchHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhcc
Q 019650          121 ICFVMEHMERGSLFDSLRVR-KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEET  199 (337)
Q Consensus       121 ~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~  199 (337)
                      +.||++|+++|+|.++++.+ +++-.+..+.|+.||++|+.|||++++|||||-++|||+.+..++|+.|||++..+...
T Consensus       772 ~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d  851 (1177)
T KOG1025|consen  772 LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD  851 (1177)
T ss_pred             HHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence            88999999999999999865 57999999999999999999999999999999999999999999999999999998776


Q ss_pred             ccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHH
Q 019650          200 RNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALIC  278 (337)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~  278 (337)
                      .......            ..-..+.|+|-|.+.    ...++.++||||+||++||++| |..|+.+..-    .++-.
T Consensus       852 ~~ey~~~------------~gK~pikwmale~i~----~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~----~eI~d  911 (1177)
T KOG1025|consen  852 EKEYSAP------------GGKVPIKWMALESIR----IRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPA----EEIPD  911 (1177)
T ss_pred             ccccccc------------ccccCcHHHHHHHhh----ccCCCchhhhhhhhhhHHHHHhcCCCccCCCCH----HHhhH
Confidence            5544321            112467899999998    4588999999999999999999 9999876533    33444


Q ss_pred             HhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhc
Q 019650          279 AICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA  319 (337)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~  319 (337)
                      .+..+.+...|+.++..+..++.+||..|++.||+++++..
T Consensus       912 lle~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~  952 (1177)
T KOG1025|consen  912 LLEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAE  952 (1177)
T ss_pred             HHhccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence            45567778888999999999999999999999999888754

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=9.6e-36  Score=273.90  Aligned_cols=251  Identities=22%  Similarity=0.310  Sum_probs=191.5

Q ss_pred             cccccccccCcce-EEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhc-CCCCceeeeeeEEeeCCeEEEEEe
Q 019650           49 LKKLTVLGHGNGG-IVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRL-DSQFIVKCHAVFYTIEGEICFVME  126 (337)
Q Consensus        49 y~~~~~lg~g~~~-~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~~lv~e  126 (337)
                      |.--+.+|.|+.| .||+|...  ++.||||.+-.+    ..+...+|+..+..- +|+||+++++.-.+ +..+|+..|
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~e----~~~~A~rEi~lL~eSD~H~NviRyyc~E~d-~qF~YIalE  583 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVYE--GREVAVKRLLEE----FFDFAQREIQLLQESDEHPNVIRYYCSEQD-RQFLYIALE  583 (903)
T ss_pred             eccHHHcccCCCCcEEEEEeeC--CceehHHHHhhH----hHHHHHHHHHHHHhccCCCceEEEEeeccC-CceEEEEeh
Confidence            3335578899887 57889775  779999987543    345667899988876 89999999997655 688999999


Q ss_pred             ccCCCCchHHhhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcC---CC--cEEEeeccCccchh
Q 019650          127 HMERGSLFDSLRVRK----KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLING---KG--EVKIADFGVSRIVE  197 (337)
Q Consensus       127 ~~~~~~L~~~l~~~~----~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~---~~--~~~l~Dfg~~~~~~  197 (337)
                      .|.. +|.++++...    .......+.++.|+++||++||+.+||||||||.||||+.   ++  +++|+|||++.++.
T Consensus       584 LC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~  662 (903)
T KOG1027|consen  584 LCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA  662 (903)
T ss_pred             Hhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence            9965 9999998641    1222556888999999999999999999999999999976   33  79999999999987


Q ss_pred             ccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCchhHHHH
Q 019650          198 ETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMAL  276 (337)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~~~~~~~~~~~  276 (337)
                      .......           ......||-+|+|||++..+    ..+.++|||||||++|+.++ |.+||......+.  .+
T Consensus       663 ~~~sS~~-----------r~s~~sGt~GW~APE~L~~~----~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~--NI  725 (903)
T KOG1027|consen  663 GGKSSFS-----------RLSGGSGTSGWQAPEQLRED----RKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA--NI  725 (903)
T ss_pred             CCcchhh-----------cccCCCCcccccCHHHHhcc----ccCcccchhhcCceEEEEecCCccCCCchHHhhh--hh
Confidence            6543332           23455699999999999954    45669999999999999999 5999965433221  11


Q ss_pred             HHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCcccccc
Q 019650          277 ICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKR  326 (337)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~  326 (337)
                      .......  ....+.....+.+||.+|++.+|..||++.++|.||+|=..
T Consensus       726 l~~~~~L--~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~  773 (903)
T KOG1027|consen  726 LTGNYTL--VHLEPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDS  773 (903)
T ss_pred             hcCccce--eeeccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCCh
Confidence            1111111  11112222389999999999999999999999999998544

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=2.2e-34  Score=290.64  Aligned_cols=243  Identities=22%  Similarity=0.347  Sum_probs=185.7

Q ss_pred             ccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 019650           46 ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVM  125 (337)
Q Consensus        46 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~  125 (337)
                      ...+.....||+|+||.||+|.+..++..||+|.+......     ...|+..+++++||||+++++++.+ ....++||
T Consensus       689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~l~~l~HpnIv~~~~~~~~-~~~~~lv~  762 (968)
T PLN00113        689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI-----PSSEIADMGKLQHPNIVKLIGLCRS-EKGAYLIH  762 (968)
T ss_pred             HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc-----cHHHHHHHhhCCCCCcceEEEEEEc-CCCCEEEE
Confidence            35677788999999999999999889999999998654321     1235788999999999999999876 57789999


Q ss_pred             eccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccC
Q 019650          126 EHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLH---GMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNN  202 (337)
Q Consensus       126 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH---~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~  202 (337)
                      ||+++|+|.+++.   .+++..+..++.|++.||+|||   +.+++||||||+||+++.++..++. |+........   
T Consensus       763 Ey~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~---  835 (968)
T PLN00113        763 EYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD---  835 (968)
T ss_pred             eCCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC---
Confidence            9999999999996   4899999999999999999999   6699999999999999988877665 4443322111   


Q ss_pred             CCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCC-chhHHHHHHHhh
Q 019650          203 NNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGE-KPDLMALICAIC  281 (337)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~-~~~~~~~~~~~~  281 (337)
                                     ....+++.|+|||++.    +..++.++||||||+++|||+||+.||..... ............
T Consensus       836 ---------------~~~~~t~~y~aPE~~~----~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~  896 (968)
T PLN00113        836 ---------------TKCFISSAYVAPETRE----TKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCY  896 (968)
T ss_pred             ---------------CCccccccccCccccc----CCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhc
Confidence                           1124788999999998    45789999999999999999999999843211 111111111100


Q ss_pred             cc------CCCCC------CCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          282 FG------ERLEM------PETASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       282 ~~------~~~~~------~~~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                      ..      ..+..      .......+.+++.+||+.||++|||++++++.
T Consensus       897 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  947 (968)
T PLN00113        897 SDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT  947 (968)
T ss_pred             CccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence            00      00111      11112357789999999999999999999876

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-36  Score=270.56  Aligned_cols=265  Identities=32%  Similarity=0.429  Sum_probs=223.7

Q ss_pred             CccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 019650           45 NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFV  124 (337)
Q Consensus        45 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv  124 (337)
                      ..++|+.+..+|+|.+|.||++++..+++..|+|+++..- .....-.++|+.+++.++|+||+.+++.+.. +..+++.
T Consensus        13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep-~dd~~~iqqei~~~~dc~h~nivay~gsylr-~dklwic   90 (829)
T KOG0576|consen   13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEP-GDDFSGIQQEIGMLRDCRHPNIVAYFGSYLR-RDKLWIC   90 (829)
T ss_pred             CccchhheeeecCCcccchhhhcccccCchhhheeeeccC-CccccccccceeeeecCCCcChHHHHhhhhh-hcCcEEE
Confidence            3679999999999999999999999999999999998764 3456677889999999999999999999876 6789999


Q ss_pred             EeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCC
Q 019650          125 MEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNN  204 (337)
Q Consensus       125 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~  204 (337)
                      ||||.||+|.+.-.-.+++++.++..+++..+++|+|||+.|-+|||||-.||++++.|.+++.|||.+-.+...-    
T Consensus        91 MEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati----  166 (829)
T KOG0576|consen   91 MEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATI----  166 (829)
T ss_pred             EEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhh----
Confidence            9999999999999888899999999999999999999999999999999999999999999999999987776543    


Q ss_pred             CCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhccC
Q 019650          205 HNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGE  284 (337)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~  284 (337)
                                .+..++.||+.|||||+..-++ .+.|+...|+|++|+...|+---++|.........+.-.-.......
T Consensus       167 ----------~KrksfiGtpywmapEvaaver-kggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp  235 (829)
T KOG0576|consen  167 ----------AKRKSFIGTPYWMAPEVAAVER-KGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPP  235 (829)
T ss_pred             ----------hhhhcccCCccccchhHHHHHh-cccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCC
Confidence                      4455678999999999986655 46889999999999999999888888655443322221111111111


Q ss_pred             CCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCcccccc
Q 019650          285 RLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKR  326 (337)
Q Consensus       285 ~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~  326 (337)
                      ..+-....++.+.+|++.+|.++|++||+++.+|.|||+...
T Consensus       236 ~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~  277 (829)
T KOG0576|consen  236 TLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT  277 (829)
T ss_pred             cccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence            112234567899999999999999999999999999999875

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-34  Score=224.17  Aligned_cols=209  Identities=33%  Similarity=0.554  Sum_probs=179.0

Q ss_pred             CccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhc-CCCCceeeeeeEEeeCCe
Q 019650           42 DVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRL-DSQFIVKCHAVFYTIEGE  120 (337)
Q Consensus        42 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~  120 (337)
                      .+...++...+..||+|++|.|=+..+..+|...|+|.+.........++...|+.+..+. .+|.++.+++.+.. +..
T Consensus        41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~r-egd  119 (282)
T KOG0984|consen   41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFR-EGD  119 (282)
T ss_pred             cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhc-ccc
Confidence            4556788889999999999999999999999999999998877666677778888876554 78999999998877 688


Q ss_pred             EEEEEeccCCCCchHHh----hhcCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCCeEEcCCCcEEEeeccCccc
Q 019650          121 ICFVMEHMERGSLFDSL----RVRKKLSEDVISGVAYRVLKGLQYLHGM-QIIHGDIKPSNLLINGKGEVKIADFGVSRI  195 (337)
Q Consensus       121 ~~lv~e~~~~~~L~~~l----~~~~~l~~~~~~~i~~~l~~~l~~LH~~-~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~  195 (337)
                      +++.||.++. +|..+-    ..++.+++..+-+++..++.||.|||++ .++|||+||+|||++.+|++|+||||.+-.
T Consensus       120 vwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~  198 (282)
T KOG0984|consen  120 VWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGY  198 (282)
T ss_pred             EEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEccccccee
Confidence            9999999965 776544    4567899999999999999999999975 899999999999999999999999999988


Q ss_pred             hhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Q 019650          196 VEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGF  267 (337)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~  267 (337)
                      +.++-               ......|-..|+|||.+..+--...|+.++||||||+.+.||.+++.||..-
T Consensus       199 L~dSi---------------Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w  255 (282)
T KOG0984|consen  199 LVDSI---------------AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW  255 (282)
T ss_pred             ehhhh---------------HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence            76542               2222347788999999987754558999999999999999999999999653

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-36  Score=243.02  Aligned_cols=262  Identities=26%  Similarity=0.393  Sum_probs=205.1

Q ss_pred             ccccccccccCcceEEEEEEEccCCceEEEEEeecCC-chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeC----CeEE
Q 019650           48 DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIE----GEIC  122 (337)
Q Consensus        48 ~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~----~~~~  122 (337)
                      +.+--+.||.|+||.||.+++..+|+.|++|.+..-. .-...+++.+|+.++.-.+|.|++..+++.....    ..+|
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY  133 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY  133 (449)
T ss_pred             cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence            3444569999999999999999999999998874332 3345577889999999999999999988764322    1357


Q ss_pred             EEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccC
Q 019650          123 FVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNN  202 (337)
Q Consensus       123 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~  202 (337)
                      +++|.+. .+|...+-.-..++.+.+.-+++||+.+|+|||+.||.||||||.|.+++.+..+||+|||+++........
T Consensus       134 V~TELmQ-SDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~  212 (449)
T KOG0664|consen  134 VLTELMQ-SDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRL  212 (449)
T ss_pred             HHHHHHH-hhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhhh
Confidence            7888885 489888888889999999999999999999999999999999999999999999999999999876554322


Q ss_pred             CCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHH---
Q 019650          203 NNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICA---  279 (337)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~---  279 (337)
                      .             ...-+.|..|.|||.+.+.   ..|+.+.||||+|||+.||+..+..|+..+..+.+.-+...   
T Consensus       213 h-------------MTqEVVTQYYRAPEiLMGa---RhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGT  276 (449)
T KOG0664|consen  213 N-------------MTHEVVTQYYRAPELLMGA---RRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGT  276 (449)
T ss_pred             h-------------hHHHHHHHHhccHHHhhcc---hhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCC
Confidence            1             1222568899999999974   58999999999999999999999999876554433222211   


Q ss_pred             --------hhccCC----------CCC--------CCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCcccccc
Q 019650          280 --------ICFGER----------LEM--------PETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKR  326 (337)
Q Consensus       280 --------~~~~~~----------~~~--------~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~  326 (337)
                              .+.+..          +.+        +....-....++.+++.+||+.|.+.++.+.|+|....
T Consensus       277 Ps~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~  349 (449)
T KOG0664|consen  277 PSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEG  349 (449)
T ss_pred             CcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccccc
Confidence                    111110          011        11223457788899999999999999999999997653

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-33  Score=242.98  Aligned_cols=259  Identities=21%  Similarity=0.287  Sum_probs=195.8

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHh--cCCCCceeeeeeEEeeCC--
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKR--LDSQFIVKCHAVFYTIEG--  119 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~--l~~~~i~~~~~~~~~~~~--  119 (337)
                      ....+..+.+.||+|.||.||+|.+.  |..||||+|......    ...+|.++.+.  |+|+||+.++..-...++  
T Consensus       208 TiarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srdE~----SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~  281 (513)
T KOG2052|consen  208 TIARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRDER----SWFRETEIYQTVMLRHENILGFIAADNKDNGSW  281 (513)
T ss_pred             hhhheeEEEEEecCccccceeecccc--CCceEEEEecccchh----hhhhHHHHHHHHHhccchhhhhhhccccCCCce
Confidence            44578999999999999999999987  778999999866433    33455555554  699999999987654332  


Q ss_pred             -eEEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CceeccCCCCCeEEcCCCcEEEeec
Q 019650          120 -EICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGM--------QIIHGDIKPSNLLINGKGEVKIADF  190 (337)
Q Consensus       120 -~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~--------~ivH~dl~~~Nili~~~~~~~l~Df  190 (337)
                       .+++|++|++.|+|.|+|.. .+++.+...+++..++.+|++||-.        .|.|||||..|||+.+++.+-|+|+
T Consensus       282 TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADL  360 (513)
T KOG2052|consen  282 TQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL  360 (513)
T ss_pred             EEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeec
Confidence             47999999999999999986 6799999999999999999999942        4999999999999999999999999


Q ss_pred             cCccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCC--CCCccccHHHHHHHHHHHHhC--------
Q 019650          191 GVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGG--DYGFAGDVWSLGVVVLECLVG--------  260 (337)
Q Consensus       191 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~--~~~~~~DiwslG~il~~l~tg--------  260 (337)
                      |++..........-          ......+||.+|||||++...-...  ..-..+||||||.++||++..        
T Consensus       361 GLAv~h~~~t~~id----------i~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~e  430 (513)
T KOG2052|consen  361 GLAVRHDSDTDTID----------IPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVE  430 (513)
T ss_pred             eeeEEecccCCccc----------CCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEeh
Confidence            99998876542222          3334458999999999997431001  112368999999999998763        


Q ss_pred             --CCCCCCCCCchhHHHHHHHhhc--cCCCCCCCCCC-----HHHHHHHHHHhhcCcCCCCCHHHHhc
Q 019650          261 --HYPLIGFGEKPDLMALICAICF--GERLEMPETAS-----PEFRRFVRSCLEKDWRKRGTVEELLA  319 (337)
Q Consensus       261 --~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~-----~~~~~li~~~l~~~p~~R~s~~eil~  319 (337)
                        ++||.+.-+.+...+.+.....  ..++.+|....     ..+..+++-||..||.-|.|+-.|.+
T Consensus       431 ey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKK  498 (513)
T KOG2052|consen  431 EYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKK  498 (513)
T ss_pred             hhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence              6788766444433344433221  22333333322     34677899999999999998766543

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=100.00  E-value=4.5e-34  Score=245.15  Aligned_cols=273  Identities=28%  Similarity=0.365  Sum_probs=206.8

Q ss_pred             CccccccccccccCcceEEEEEEEcc---CCceEEEEEeecCCchHhHHHHHHHHHHHHhc-CCCCceeeeeeEEeeCCe
Q 019650           45 NISDLKKLTVLGHGNGGIVYKVRHQK---SNSIYALKVLNTTSSTIIRHQAAHEAEILKRL-DSQFIVKCHAVFYTIEGE  120 (337)
Q Consensus        45 ~~~~y~~~~~lg~g~~~~v~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~  120 (337)
                      ..+.|..+.+||.|.|++||++.+..   .+..||+|.+...+..   .++.+|++++..+ .+.||+++.+.+- .+..
T Consensus        34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p---~ri~~El~~L~~~gG~~ni~~~~~~~r-nnd~  109 (418)
T KOG1167|consen   34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP---SRILNELEMLYRLGGSDNIIKLNGCFR-NNDQ  109 (418)
T ss_pred             hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc---hHHHHHHHHHHHhccchhhhcchhhhc-cCCe
Confidence            34789999999999999999999976   7889999999876544   5678899999999 4578888888654 4788


Q ss_pred             EEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCC-CcEEEeeccCccchhcc
Q 019650          121 ICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGK-GEVKIADFGVSRIVEET  199 (337)
Q Consensus       121 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~-~~~~l~Dfg~~~~~~~~  199 (337)
                      .++|+||++..+..++..   .++...++.+++.++.||+++|..|||||||||+|++++.. ++-.|+|||++......
T Consensus       110 v~ivlp~~~H~~f~~l~~---~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~  186 (418)
T KOG1167|consen  110 VAIVLPYFEHDRFRDLYR---SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGY  186 (418)
T ss_pred             eEEEecccCccCHHHHHh---cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhh
Confidence            999999999988888875   67899999999999999999999999999999999999876 78999999999832211


Q ss_pred             c-cC---------CC------CCCC---C-----------CCccccccccccCCCCCcCCcccccccCCCCCCccccHHH
Q 019650          200 R-NN---------NN------HNNN---N-----------NNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWS  249 (337)
Q Consensus       200 ~-~~---------~~------~~~~---~-----------~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Diws  249 (337)
                      . ..         ..      ..+.   .           .-..........||++|.|||++..-   ...+.+.||||
T Consensus       187 ~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~---~~QttaiDiws  263 (418)
T KOG1167|consen  187 QQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRC---PRQTTAIDIWS  263 (418)
T ss_pred             hhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhc---cCcCCccceee
Confidence            0 00         00      0000   0           01111234456799999999999864   35688999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCCchhHHHHHHHhh-----------ccC----------------------------------
Q 019650          250 LGVVVLECLVGHYPLIGFGEKPDLMALICAIC-----------FGE----------------------------------  284 (337)
Q Consensus       250 lG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~-----------~~~----------------------------------  284 (337)
                      .|+|+..+++++.||....++.+....+..+.           .+.                                  
T Consensus       264 ~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n  343 (418)
T KOG1167|consen  264 AGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPN  343 (418)
T ss_pred             ccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccc
Confidence            99999999999999976444321111110000           000                                  


Q ss_pred             --CCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccC
Q 019650          285 --RLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRS  327 (337)
Q Consensus       285 --~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~  327 (337)
                        .....+..+..+.+++.+||..||.+|.|++++|+||||...+
T Consensus       344 ~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~  388 (418)
T KOG1167|consen  344 TEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEAD  388 (418)
T ss_pred             eeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchh
Confidence              0001122355899999999999999999999999999998543

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-33  Score=237.41  Aligned_cols=253  Identities=20%  Similarity=0.250  Sum_probs=214.9

Q ss_pred             cccccccccccCcceEEEEEEEcc-----CCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeE
Q 019650           47 SDLKKLTVLGHGNGGIVYKVRHQK-----SNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEI  121 (337)
Q Consensus        47 ~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~  121 (337)
                      .++...-.+-+|.||.||.|++.+     +.+.|.+|.++..-++.....+.+|.-.+..+.|+|+.++.++..+.....
T Consensus       284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P  363 (563)
T KOG1024|consen  284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATP  363 (563)
T ss_pred             hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcc
Confidence            466777788999999999997752     234577788877777888888999999999999999999999999877888


Q ss_pred             EEEEeccCCCCchHHhhh--------cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCc
Q 019650          122 CFVMEHMERGSLFDSLRV--------RKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVS  193 (337)
Q Consensus       122 ~lv~e~~~~~~L~~~l~~--------~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~  193 (337)
                      ++++.+..-|+|..++..        ...++..+...++.|++.|++|||++|+||.||..+|++|++.-++||+|=.++
T Consensus       364 ~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDsaLS  443 (563)
T KOG1024|consen  364 FVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDSALS  443 (563)
T ss_pred             eEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEeccchhc
Confidence            999999988899999972        135778888999999999999999999999999999999999999999999999


Q ss_pred             cchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCchh
Q 019650          194 RIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPD  272 (337)
Q Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~~~~~~~  272 (337)
                      +.+.+...+--+..+            -.+..||+||.+.    ...|+..+|+||||+++|||+| |+.|+...+.   
T Consensus       444 RDLFP~DYhcLGDnE------------nRPvkWMslEal~----n~~yssasDvWsfGVllWELmtlg~~PyaeIDP---  504 (563)
T KOG1024|consen  444 RDLFPGDYHCLGDNE------------NRPVKWMSLEALQ----NSHYSSASDVWSFGVLLWELMTLGKLPYAEIDP---  504 (563)
T ss_pred             cccCcccccccCCCC------------CCcccccCHHHHh----hhhhcchhhhHHHHHHHHHHHhcCCCCccccCH---
Confidence            988776544322211            1567899999999    5589999999999999999999 9999865433   


Q ss_pred             HHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhc
Q 019650          273 LMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA  319 (337)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~  319 (337)
                       .+....+..+.+...|.++++++..++.-||+..|++||+++|+..
T Consensus       505 -fEm~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~  550 (563)
T KOG1024|consen  505 -FEMEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVI  550 (563)
T ss_pred             -HHHHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence             3445556778888889999999999999999999999999999875

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-34  Score=252.97  Aligned_cols=203  Identities=26%  Similarity=0.410  Sum_probs=174.3

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCceEEEEEeecCC--chHhH-----HHHHHHHHHHHhcC---CCCceeeeee
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIR-----HQAAHEAEILKRLD---SQFIVKCHAV  113 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~-----~~~~~e~~~~~~l~---~~~i~~~~~~  113 (337)
                      ....+|+.+..+|.|+||.|++|+++.+...|++|.+.++.  .+.+.     -..--|+++|..++   |+||+++++.
T Consensus       558 ~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdf  637 (772)
T KOG1152|consen  558 KKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDF  637 (772)
T ss_pred             cccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhe
Confidence            44568999999999999999999999999999999987653  11111     11234999999997   9999999998


Q ss_pred             EEeeCCeEEEEEecc-CCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccC
Q 019650          114 FYTIEGEICFVMEHM-ERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGV  192 (337)
Q Consensus       114 ~~~~~~~~~lv~e~~-~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~  192 (337)
                      |.+ +.++|++||-. +|.+|+++++..+.+++.++..|++|++.++++||+.||||||||-+|+.++.+|-++|+|||.
T Consensus       638 FEd-dd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgs  716 (772)
T KOG1152|consen  638 FED-DDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGS  716 (772)
T ss_pred             eec-CCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccc
Confidence            866 78999999986 4569999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCC
Q 019650          193 SRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIG  266 (337)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~  266 (337)
                      +.......                --.++||..|.|||++.+++|   .+..-|||+||++||.+...+.||.+
T Consensus       717 aa~~ksgp----------------fd~f~gtv~~aapevl~g~~y---~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  717 AAYTKSGP----------------FDVFVGTVDYAAPEVLGGEKY---LGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             hhhhcCCC----------------cceeeeeccccchhhhCCCcc---CCCcchhhhhhheeeEEEeccCCCcC
Confidence            98765432                234579999999999997654   24578999999999999999999864

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-32  Score=239.36  Aligned_cols=251  Identities=24%  Similarity=0.346  Sum_probs=187.5

Q ss_pred             CccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHh--cCCCCceeeeeeEEeeCC---
Q 019650           45 NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKR--LDSQFIVKCHAVFYTIEG---  119 (337)
Q Consensus        45 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~--l~~~~i~~~~~~~~~~~~---  119 (337)
                      ..+.....+.||+|.||.||+|...  ++.||||++...    ..+.+.+|-.+.+.  ++|+||+++++.-.. ..   
T Consensus       208 ~l~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~~----~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr-~t~~~  280 (534)
T KOG3653|consen  208 ELDPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPEQ----EKQSFQNEKNIYSLPGMKHENILQFIGAEKR-GTADR  280 (534)
T ss_pred             cCCchhhHHHhhcCccceeehhhcc--CceeEEEecCHH----HHHHHHhHHHHHhccCccchhHHHhhchhcc-CCccc
Confidence            3677888999999999999999775  589999999754    34566777777665  599999999986543 33   


Q ss_pred             -eEEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhC---------CceeccCCCCCeEEcCCCcEEEee
Q 019650          120 -EICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGM---------QIIHGDIKPSNLLINGKGEVKIAD  189 (337)
Q Consensus       120 -~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~---------~ivH~dl~~~Nili~~~~~~~l~D  189 (337)
                       .+++|++|.+.|+|.+||.. ..+++....+++..++.+|+|||+.         .|+|||||.+|||+..|+.+-|+|
T Consensus       281 ~eywLVt~fh~kGsL~dyL~~-ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaD  359 (534)
T KOG3653|consen  281 MEYWLVTEFHPKGSLCDYLKA-NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIAD  359 (534)
T ss_pred             cceeEEeeeccCCcHHHHHHh-ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeec
Confidence             68999999999999999984 4599999999999999999999962         599999999999999999999999


Q ss_pred             ccCccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccC--CCCCCccccHHHHHHHHHHHHhCCCC----
Q 019650          190 FGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERW--GGDYGFAGDVWSLGVVVLECLVGHYP----  263 (337)
Q Consensus       190 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~~~~~DiwslG~il~~l~tg~~p----  263 (337)
                      ||++..+......            .....-+||.+|||||++.+--.  +...-.+.||||+|.++||+++...-    
T Consensus       360 FGLAl~~~p~~~~------------~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~  427 (534)
T KOG3653|consen  360 FGLALRLEPGKPQ------------GDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPG  427 (534)
T ss_pred             cceeEEecCCCCC------------cchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCC
Confidence            9999988754322            22233479999999999974200  01112369999999999999985332    


Q ss_pred             --------CCC-CCCchhHHHHHHH-hhccCCCCCCCC-----CCHHHHHHHHHHhhcCcCCCCCHH
Q 019650          264 --------LIG-FGEKPDLMALICA-ICFGERLEMPET-----ASPEFRRFVRSCLEKDWRKRGTVE  315 (337)
Q Consensus       264 --------f~~-~~~~~~~~~~~~~-~~~~~~~~~~~~-----~~~~~~~li~~~l~~~p~~R~s~~  315 (337)
                              |.. .++...+.+.... ...-.++.++..     -...+++.+..||+.||+.|.|+.
T Consensus       428 ~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~  494 (534)
T KOG3653|consen  428 PVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAG  494 (534)
T ss_pred             CCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhH
Confidence                    221 1111222222211 112223444332     235699999999999999999854

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=100.00  E-value=1.9e-31  Score=221.61  Aligned_cols=213  Identities=40%  Similarity=0.649  Sum_probs=185.4

Q ss_pred             cccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEeccCCCCch
Q 019650           55 LGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLF  134 (337)
Q Consensus        55 lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~  134 (337)
                      ||.|++|.||++.+..++..+++|++.........+.+.+|+..++.+.|++++++++.+.. ....++++|+++|++|.
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-~~~~~~~~e~~~~~~l~   79 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFED-ENHLYLVMEYCEGGSLK   79 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeec-CCeEEEEEecCCCCcHH
Confidence            68999999999999888999999999876543245678899999999999999999998876 57899999999989999


Q ss_pred             HHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcC-CCcEEEeeccCccchhccccCCCCCCCCCCc
Q 019650          135 DSLRVR-KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLING-KGEVKIADFGVSRIVEETRNNNNHNNNNNNN  212 (337)
Q Consensus       135 ~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~  212 (337)
                      +++... ..++...+..++.+++.++.+||+.|++|+||+|.||+++. ++.++|+|||.+........           
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-----------  148 (215)
T cd00180          80 DLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-----------  148 (215)
T ss_pred             HHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-----------
Confidence            999865 57899999999999999999999999999999999999999 89999999999876644321           


Q ss_pred             cccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhccCCCCCCCCC
Q 019650          213 IGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPETA  292 (337)
Q Consensus       213 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (337)
                         ......+...|++||.+...   ..++.++|+|++|++++++                                   
T Consensus       149 ---~~~~~~~~~~~~~pe~~~~~---~~~~~~~D~~~lg~~~~~l-----------------------------------  187 (215)
T cd00180         149 ---LLKTIVGTPAYMAPEVLLGK---GYYSEKSDIWSLGVILYEL-----------------------------------  187 (215)
T ss_pred             ---hhhcccCCCCccChhHhccc---CCCCchhhhHHHHHHHHHH-----------------------------------
Confidence               01122477889999999732   2678899999999999998                                   


Q ss_pred             CHHHHHHHHHHhhcCcCCCCCHHHHhcCc
Q 019650          293 SPEFRRFVRSCLEKDWRKRGTVEELLAYP  321 (337)
Q Consensus       293 ~~~~~~li~~~l~~~p~~R~s~~eil~hp  321 (337)
                       ..+.+++.+|++.+|++||+++++++|+
T Consensus       188 -~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 -PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             -HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence             6899999999999999999999999885

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-33  Score=226.21  Aligned_cols=261  Identities=21%  Similarity=0.262  Sum_probs=201.5

Q ss_pred             ccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhc-CCCCceeeeeeEEeeCCeE
Q 019650           43 VENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRL-DSQFIVKCHAVFYTIEGEI  121 (337)
Q Consensus        43 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~  121 (337)
                      ..-.+.|.|.+.||+|.||.+.++.+..+...+|+|.+...  ....++|.+|...--.| .|.||+.-+++.....+.+
T Consensus        20 v~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p--~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Y   97 (378)
T KOG1345|consen   20 VDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP--QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAY   97 (378)
T ss_pred             cchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc--hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceE
Confidence            45568999999999999999999999999999999998765  34578888898876666 5789999888887777888


Q ss_pred             EEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcC-C-CcEEEeeccCccchhcc
Q 019650          122 CFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLING-K-GEVKIADFGVSRIVEET  199 (337)
Q Consensus       122 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~-~-~~~~l~Dfg~~~~~~~~  199 (337)
                      ++++||++.|+|..-+... .+-+.....++.|+++|+.|||+.++||||||.+||||-. + -++||||||.....+..
T Consensus        98 vF~qE~aP~gdL~snv~~~-GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t  176 (378)
T KOG1345|consen   98 VFVQEFAPRGDLRSNVEAA-GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT  176 (378)
T ss_pred             EEeeccCccchhhhhcCcc-cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCce
Confidence            9999999999999988754 4888899999999999999999999999999999999943 3 48999999998876543


Q ss_pred             ccCCCCCCCCCCccccccccccCCCCCcCCcccccccC-CCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHH
Q 019650          200 RNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERW-GGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALIC  278 (337)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~  278 (337)
                      ..                 ..-.+..|.+||....-+. .-...+.+|+|+||+++|.++||+.||+...-.........
T Consensus       177 V~-----------------~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~  239 (378)
T KOG1345|consen  177 VK-----------------YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWE  239 (378)
T ss_pred             eh-----------------hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHH
Confidence            21                 1224667889987653321 12458899999999999999999999986543332222222


Q ss_pred             HhhccC---CCCCCCCCCHHHHHHHHHHhhcCcCCC---CCHHHHhcCccc
Q 019650          279 AICFGE---RLEMPETASPEFRRFVRSCLEKDWRKR---GTVEELLAYPFV  323 (337)
Q Consensus       279 ~~~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~R---~s~~eil~hp~f  323 (337)
                      .-....   .+......++.+..+.++-|..++.+|   .++......-|.
T Consensus       240 ~w~~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~  290 (378)
T KOG1345|consen  240 QWLKRKNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWK  290 (378)
T ss_pred             HHhcccCccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHH
Confidence            222222   222234568899999999999999999   444444444444

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=1.4e-29  Score=213.07  Aligned_cols=201  Identities=37%  Similarity=0.559  Sum_probs=172.7

Q ss_pred             cccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEecc
Q 019650           49 LKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHM  128 (337)
Q Consensus        49 y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~e~~  128 (337)
                      |.+.+.||.|++++||++.+.++++.+++|.+.........+.+.+|+..+++++|++++++++.+.. ....++++|++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~-~~~~~~v~e~~   79 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFED-PEPLYLVMEYC   79 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeec-CCceEEEEecc
Confidence            56788999999999999999988899999999765433246778889999999999999999998765 67899999999


Q ss_pred             CCCCchHHhhhcCC-CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCCCCC
Q 019650          129 ERGSLFDSLRVRKK-LSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNN  207 (337)
Q Consensus       129 ~~~~L~~~l~~~~~-l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~  207 (337)
                      ++++|.+++..... +++..+..++.+++.++.+||+.+++|+|++|.||+++.++.++|+|||.+........      
T Consensus        80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~------  153 (225)
T smart00221       80 EGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA------  153 (225)
T ss_pred             CCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc------
Confidence            99999999987666 89999999999999999999999999999999999999999999999998887654320      


Q ss_pred             CCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCC
Q 019650          208 NNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIG  266 (337)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~  266 (337)
                             .......+...|++||.+. .  ...++.++|+|+||+++++|++|+.||..
T Consensus       154 -------~~~~~~~~~~~~~~pe~~~-~--~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      154 -------ALLKTVKGTPFYLAPEVLL-G--GKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             -------ccccceeccCCcCCHhHhc-C--CCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence                   0112234678899999984 1  45677799999999999999999999954

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.97  E-value=3.4e-30  Score=254.11  Aligned_cols=197  Identities=17%  Similarity=0.153  Sum_probs=137.1

Q ss_pred             CeEEEEEeccCCCCchHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchh
Q 019650          119 GEICFVMEHMERGSLFDSLRV-RKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVE  197 (337)
Q Consensus       119 ~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~  197 (337)
                      ..+++++|++ +++|.+++.. ...+++.+++.++.||+.||+|||++||+||||||+|||++..+.++++|||.+....
T Consensus        53 ~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~  131 (793)
T PLN00181         53 DSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCFVMSSFNHVSFIESASCSDSG  131 (793)
T ss_pred             chhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhEEEcccCcEEEeeccccCccc
Confidence            3567788888 4599999975 3569999999999999999999999999999999999999776666666666553322


Q ss_pred             ccccCCCCCCCC---------------------CCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHH
Q 019650          198 ETRNNNNHNNNN---------------------NNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLE  256 (337)
Q Consensus       198 ~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~  256 (337)
                      ............                     ...........++|+.|+|||++.    +..++.++|||||||++||
T Consensus       132 ~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~----~~~~~~~sDVwSlGviL~E  207 (793)
T PLN00181        132 SDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDN----GSSSNCASDVYRLGVLLFE  207 (793)
T ss_pred             ccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhc----cCCCCchhhhhhHHHHHHH
Confidence            110000000000                     000001112246889999999998    4578999999999999999


Q ss_pred             HHhCCCCCCCCCCchhHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCcccccc
Q 019650          257 CLVGHYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKR  326 (337)
Q Consensus       257 l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~  326 (337)
                      |+++..|+....  ........    ...+...........+++.+||..+|.+||++.|+++||||.+.
T Consensus       208 Ll~~~~~~~~~~--~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~~  271 (793)
T PLN00181        208 LFCPVSSREEKS--RTMSSLRH----RVLPPQILLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINEP  271 (793)
T ss_pred             HhhCCCchhhHH--HHHHHHHH----hhcChhhhhcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhhh
Confidence            999888764211  11111111    11111111224567789999999999999999999999999874

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.96  E-value=4.9e-29  Score=202.13  Aligned_cols=165  Identities=25%  Similarity=0.328  Sum_probs=127.6

Q ss_pred             CCchHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCCCCCCC
Q 019650          131 GSLFDSLRVR-KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNN  209 (337)
Q Consensus       131 ~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~  209 (337)
                      |+|.+++... ..+++..++.++.|++.||.|||+.+      ||+||+++.++.+++  ||.+.......         
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~---------   63 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ---------   63 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecccc---------
Confidence            5899999864 56999999999999999999999998      999999999999999  99887653321         


Q ss_pred             CCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhccCCC---
Q 019650          210 NNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERL---  286 (337)
Q Consensus       210 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~---  286 (337)
                                ..|++.|+|||++.    +..++.++||||||+++|+|++|+.||......................   
T Consensus        64 ----------~~g~~~y~aPE~~~----~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  129 (176)
T smart00750       64 ----------SRVDPYFMAPEVIQ----GQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDR  129 (176)
T ss_pred             ----------CCCcccccChHHhc----CCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCcccc
Confidence                      13789999999998    4578899999999999999999999996543322222222111111100   


Q ss_pred             CCCCCCCH--HHHHHHHHHhhcCcCCCCCHHHHhcCcccccc
Q 019650          287 EMPETASP--EFRRFVRSCLEKDWRKRGTVEELLAYPFVTKR  326 (337)
Q Consensus       287 ~~~~~~~~--~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~  326 (337)
                      ..+...+.  .+.+++.+||..+|.+||++.++++|+|+...
T Consensus       130 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~  171 (176)
T smart00750      130 SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA  171 (176)
T ss_pred             ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence            11122233  69999999999999999999999999998643

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=8.4e-26  Score=200.26  Aligned_cols=259  Identities=22%  Similarity=0.221  Sum_probs=193.7

Q ss_pred             ccccccccccCcceEEEEEEEccCC-ceEEEEEeecCCchHhHHHHHHHHHHHHhcC----CCCceeeeeeEEeeCCeEE
Q 019650           48 DLKKLTVLGHGNGGIVYKVRHQKSN-SIYALKVLNTTSSTIIRHQAAHEAEILKRLD----SQFIVKCHAVFYTIEGEIC  122 (337)
Q Consensus        48 ~y~~~~~lg~g~~~~v~~~~~~~~~-~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~----~~~i~~~~~~~~~~~~~~~  122 (337)
                      +|++.+.||.|+||.||.|.+..++ ..+|+|........... .+..|..++..+.    ..++..++..+.......+
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~-~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~   97 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS-VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNF   97 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc-cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeE
Confidence            8999999999999999999987664 67888887654322222 4566788877776    3678888887643356789


Q ss_pred             EEEeccCCCCchHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCC-----CcEEEeeccCccc
Q 019650          123 FVMEHMERGSLFDSLRVR--KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGK-----GEVKIADFGVSRI  195 (337)
Q Consensus       123 lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~-----~~~~l~Dfg~~~~  195 (337)
                      +||+.+ |.+|.++....  +.++..++..++.|++.+|.+||+.|++||||||+|+++...     ..+.|.|||+++.
T Consensus        98 iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~  176 (322)
T KOG1164|consen   98 IVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARR  176 (322)
T ss_pred             EEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCcc
Confidence            999999 67999988654  579999999999999999999999999999999999999765     3699999999983


Q ss_pred             hh--ccccCC-CCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchh
Q 019650          196 VE--ETRNNN-NHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPD  272 (337)
Q Consensus       196 ~~--~~~~~~-~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~  272 (337)
                      ..  ...... ...       ......+.||.+|.++....    +...+.+.|+||++.++.++..|..||........
T Consensus       177 ~~~~~~~~~~~~~~-------r~~~~~~rGT~ry~S~~~H~----~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~  245 (322)
T KOG1164|consen  177 FKYVGDSGGNLRPP-------RPQKGLFRGTLRYASINVHL----GIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL  245 (322)
T ss_pred             ccccCCCCcccccC-------CCCccCCCCccccccHHHhC----CCccCCchhhhhHHHHHHHHhcCCCCCccccccch
Confidence            32  222111 000       01123456999999999988    66889999999999999999999999976554333


Q ss_pred             HHHHHHHhhccCCCC-CCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          273 LMALICAICFGERLE-MPETASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       273 ~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                      ....... ....... .....+..+.++...+-..+...+|....+...
T Consensus       246 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~  293 (322)
T KOG1164|consen  246 KSKFEKD-PRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL  293 (322)
T ss_pred             HHHHHHH-hhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence            2222221 1111111 334456788888887777899999988777554

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=4.1e-28  Score=228.25  Aligned_cols=266  Identities=23%  Similarity=0.313  Sum_probs=197.8

Q ss_pred             ccccccccCcceEEEEEEEccCCceEEEEEee----cCC-chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 019650           50 KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLN----TTS-STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFV  124 (337)
Q Consensus        50 ~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~----~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv  124 (337)
                      ...+.+|.|++|.|+.+.........+.|.+.    ... .......+..|+-+-..+.|++++.......+...... .
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~-~  399 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQ-S  399 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchh-h
Confidence            56778999999988887775444445555443    111 22222224456666777899999887777666433333 4


Q ss_pred             EeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCC
Q 019650          125 MEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNN  204 (337)
Q Consensus       125 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~  204 (337)
                      ||||++ +|+..+...+.+...++..+++||+.+|.|+|+.|+.|+|+|++|++++.+|.+||+|||.+....-..... 
T Consensus       400 mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~-  477 (601)
T KOG0590|consen  400 MEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKN-  477 (601)
T ss_pred             hhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchh-
Confidence            999999 999999988889999999999999999999999999999999999999999999999999887654332211 


Q ss_pred             CCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHH----Hh
Q 019650          205 HNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALIC----AI  280 (337)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~----~~  280 (337)
                               ......++|...|+|||.+....|+   ....||||.|++++.|.+|+.||..............    ..
T Consensus       478 ---------~~~~~g~~gS~pY~apE~~~~~~yd---pr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~  545 (601)
T KOG0590|consen  478 ---------IHESSGIVGSDPYLAPEVLTGKEYD---PRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRN  545 (601)
T ss_pred             ---------hhhhcCcccCCcCcCcccccccccC---cchhhhhhccceEEEEecCCCccccccccccchhhhccccccc
Confidence                     1334456789999999999954332   3379999999999999999999976544433211110    00


Q ss_pred             hccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCCc
Q 019650          281 CFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSS  330 (337)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~~  330 (337)
                      ....+..+...++...+.+|.+||+.||.+|.|+++|++.+||+...+-.
T Consensus       546 ~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~c~  595 (601)
T KOG0590|consen  546 IFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIECCH  595 (601)
T ss_pred             cccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcceEE
Confidence            01111123345678899999999999999999999999999999987543

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.94  E-value=9.9e-26  Score=199.58  Aligned_cols=176  Identities=19%  Similarity=0.153  Sum_probs=133.5

Q ss_pred             ccCccccccccccccCcceEEEEEEEcc-CCceEEEEEeecCC----chHhHHHHHHHHHHHHhcCCCCceeeeeeEEee
Q 019650           43 VENISDLKKLTVLGHGNGGIVYKVRHQK-SNSIYALKVLNTTS----STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTI  117 (337)
Q Consensus        43 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~-~~~~vaiK~~~~~~----~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~  117 (337)
                      ..-.++|.+.+.||+|+||+||+|.+.. ++..+|+|+.....    .......+.+|+.++++++|+++++.+..    
T Consensus        14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~----   89 (365)
T PRK09188         14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA----   89 (365)
T ss_pred             ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE----
Confidence            3456789999999999999999999875 67778999865331    23345668899999999999999864432    


Q ss_pred             CCeEEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccC-CCCCeEEcCCCcEEEeeccCccch
Q 019650          118 EGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDI-KPSNLLINGKGEVKIADFGVSRIV  196 (337)
Q Consensus       118 ~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl-~~~Nili~~~~~~~l~Dfg~~~~~  196 (337)
                      ....|+||||++|++|.. +.   ...   ...++.+++.+|.|||+.||+|||| ||+||+++.+++++|+|||++...
T Consensus        90 ~~~~~LVmE~~~G~~L~~-~~---~~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~  162 (365)
T PRK09188         90 TGKDGLVRGWTEGVPLHL-AR---PHG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVF  162 (365)
T ss_pred             cCCcEEEEEccCCCCHHH-hC---ccc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceec
Confidence            245799999999988863 21   111   1467899999999999999999999 999999998999999999999877


Q ss_pred             hccccCCCCCCCCCCccccccccccCCCCCcCCcccccc
Q 019650          197 EETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSE  235 (337)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  235 (337)
                      ..........      .-+......+++.|+|||.+..+
T Consensus       163 ~~~~~~~~~~------~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        163 RRRGALYRIA------AYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             ccCcchhhhh------hhhhhhhhhccCccCCcccCChh
Confidence            5533211100      00111244678889999998754

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.93  E-value=1.5e-23  Score=186.15  Aligned_cols=266  Identities=29%  Similarity=0.406  Sum_probs=204.4

Q ss_pred             cccccccccCcceEEEEEEEccCCceEEEEEeecCCchH--hHHHHHHHHHHHHhcCCC-CceeeeeeEEeeCCeEEEEE
Q 019650           49 LKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTI--IRHQAAHEAEILKRLDSQ-FIVKCHAVFYTIEGEICFVM  125 (337)
Q Consensus        49 y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~~~~l~~~-~i~~~~~~~~~~~~~~~lv~  125 (337)
                      |.+...||.|+|+.||.+.+.   ..+++|.+.......  ....+.+|...+..+.|+ +++.+.+.+.. ....++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-~~~~~~~~   77 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQD-EGSLYLVM   77 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEec-CCEEEEEE
Confidence            788899999999999999987   678999987665333  467788899999999998 69999998844 56679999


Q ss_pred             eccCCCCchHHhhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCC-cEEEeeccCccchhcccc
Q 019650          126 EHMERGSLFDSLRVRK---KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKG-EVKIADFGVSRIVEETRN  201 (337)
Q Consensus       126 e~~~~~~L~~~l~~~~---~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~-~~~l~Dfg~~~~~~~~~~  201 (337)
                      +++.++++.+++....   .+.......++.|++.++.++|+.+++|+|+||+||+++..+ .++++|||.+........
T Consensus        78 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~  157 (384)
T COG0515          78 EYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGS  157 (384)
T ss_pred             ecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCc
Confidence            9999999998877665   799999999999999999999999999999999999999988 799999999875443321


Q ss_pred             CCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCC---chhHHHHHH
Q 019650          202 NNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGE---KPDLMALIC  278 (337)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~---~~~~~~~~~  278 (337)
                      .....        .......++..|++||.+.... ...+....|+|++|++++++++|..||.....   .........
T Consensus       158 ~~~~~--------~~~~~~~~t~~~~~pe~~~~~~-~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~  228 (384)
T COG0515         158 TSSIP--------ALPSTSVGTPGYMAPEVLLGLS-LAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIIL  228 (384)
T ss_pred             ccccc--------ccccccccccccCCHHHhcCCC-CCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHH
Confidence            11000        0223446899999999998420 04678899999999999999999999765543   122222222


Q ss_pred             Hhhcc-CCCCCCCCC----CHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccC
Q 019650          279 AICFG-ERLEMPETA----SPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRS  327 (337)
Q Consensus       279 ~~~~~-~~~~~~~~~----~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~  327 (337)
                      ..... .........    ...+.+++..++..+|..|.+..+...+++.....
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~  282 (384)
T COG0515         229 ELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLK  282 (384)
T ss_pred             hcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCcc
Confidence            21111 111111211    25799999999999999999999988886665544

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.93  E-value=7.1e-25  Score=175.81  Aligned_cols=257  Identities=19%  Similarity=0.215  Sum_probs=190.1

Q ss_pred             CCccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCC-CCceeeeeeEEeeCC
Q 019650           41 PDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDS-QFIVKCHAVFYTIEG  119 (337)
Q Consensus        41 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~-~~i~~~~~~~~~~~~  119 (337)
                      +.....+.|.++++||+|+||.+|.|....+|..||||+-+..   ..-.++..|..+...+.+ .+|..+.....+ +.
T Consensus         9 ~~~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~---a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e-~~   84 (341)
T KOG1163|consen    9 EELIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK---AKHPQLLYESKVYRILQGGVGIPHIRHYGTE-KD   84 (341)
T ss_pred             hhheeccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc---CCCcchhHHHHHHHHhccCCCCchhhhhccc-cc
Confidence            3456678999999999999999999999999999999985433   233455668888888866 566666665444 67


Q ss_pred             eEEEEEeccCCCCchHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCC---CcEEEeeccCccc
Q 019650          120 EICFVMEHMERGSLFDSLRV-RKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGK---GEVKIADFGVSRI  195 (337)
Q Consensus       120 ~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~---~~~~l~Dfg~~~~  195 (337)
                      +-.+||+.+ |.+|++++.- ...++.++++-++-|++.-+.|+|.++++||||||+|+|+.-+   .++.++|||++..
T Consensus        85 ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKk  163 (341)
T KOG1163|consen   85 YNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKK  163 (341)
T ss_pred             cceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhh
Confidence            889999999 7799998874 3579999999999999999999999999999999999999654   3699999999998


Q ss_pred             hhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchh---
Q 019650          196 VEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPD---  272 (337)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~---  272 (337)
                      ..+.....-..-       .......||.+|.+--...    +...+...|+-|+|.++.++-.|..||++......   
T Consensus       164 y~d~~t~~HIpy-------re~r~ltGTaRYASinAh~----g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QK  232 (341)
T KOG1163|consen  164 YRDIRTRQHIPY-------REDRNLTGTARYASINAHL----GIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQK  232 (341)
T ss_pred             hccccccccCcc-------ccCCccceeeeehhhhhhh----hhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHH
Confidence            865432211100       1112235888998876665    45678899999999999999999999988644332   


Q ss_pred             HHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCC
Q 019650          273 LMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGT  313 (337)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s  313 (337)
                      ...+.+............+.|.++.-.+.-|=..--.+-|+
T Consensus       233 yEkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pd  273 (341)
T KOG1163|consen  233 YEKISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPD  273 (341)
T ss_pred             HHHHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCc
Confidence            22222222222222234566777777777775555555554

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.93  E-value=1.5e-25  Score=182.86  Aligned_cols=247  Identities=19%  Similarity=0.297  Sum_probs=198.4

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCceEEEEEeecCC-chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEE
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEIC  122 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~  122 (337)
                      .++++..+..+|.....|..|+|.++++  .+++|+++... .......|..|.-.++-..||||+++++.+.. -+++.
T Consensus       187 id~~~lnl~tkl~e~hsgelwrgrwqgn--divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacns-ppnlv  263 (448)
T KOG0195|consen  187 IDVSSLNLITKLAESHSGELWRGRWQGN--DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNS-PPNLV  263 (448)
T ss_pred             cchhhhhhhhhhccCCCcccccccccCc--chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccC-CCCce
Confidence            4567888889999999999999999744  57888886654 22344567788888898999999999999877 58899


Q ss_pred             EEEeccCCCCchHHhhhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCCeEEcCCCcEE--EeeccCccch
Q 019650          123 FVMEHMERGSLFDSLRVRK--KLSEDVISGVAYRVLKGLQYLHGMQ--IIHGDIKPSNLLINGKGEVK--IADFGVSRIV  196 (337)
Q Consensus       123 lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~~--ivH~dl~~~Nili~~~~~~~--l~Dfg~~~~~  196 (337)
                      ++..|++.|+|...+.+..  ..+..++.+++.+++.+++|||+..  |.--.|+...++++++...+  ++|--++.. 
T Consensus       264 ~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfq-  342 (448)
T KOG0195|consen  264 IISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ-  342 (448)
T ss_pred             EeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeee-
Confidence            9999999999999998654  3678899999999999999999874  44557889999999886544  444333321 


Q ss_pred             hccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHH
Q 019650          197 EETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMAL  276 (337)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~  276 (337)
                                          .......|.|++||.+...+ ....-.+.|+|||++++|||.|.+.||....+.+...++
T Consensus       343 --------------------e~gr~y~pawmspealqrkp-ed~n~raadmwsfaillwel~trevpfadlspmecgmki  401 (448)
T KOG0195|consen  343 --------------------EVGRAYSPAWMSPEALQRKP-EDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKI  401 (448)
T ss_pred             --------------------ccccccCcccCCHHHHhcCc-hhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhh
Confidence                                11224688999999998654 233466899999999999999999999887776655444


Q ss_pred             HHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHh
Q 019650          277 ICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELL  318 (337)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil  318 (337)
                         ...+.+..+|++++.+...++.-|++.||.+||.+..++
T Consensus       402 ---aleglrv~ippgis~hm~klm~icmnedpgkrpkfdmiv  440 (448)
T KOG0195|consen  402 ---ALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIV  440 (448)
T ss_pred             ---hhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence               344678889999999999999999999999999988765

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.92  E-value=6.8e-25  Score=186.33  Aligned_cols=239  Identities=20%  Similarity=0.266  Sum_probs=154.0

Q ss_pred             ccccccccccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHHhcCC----------CCceeeeee
Q 019650           46 ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDS----------QFIVKCHAV  113 (337)
Q Consensus        46 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~~----------~~i~~~~~~  113 (337)
                      ...+...+.||.|+++.||.+++..+++.+++|++....  .....+.+.+|......+.+          -.++..++.
T Consensus        11 ~r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~   90 (288)
T PF14531_consen   11 PRTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDL   90 (288)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEE
T ss_pred             ceEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEE
Confidence            346778899999999999999999999999999986544  23344555555544443221          122222222


Q ss_pred             EEee--------C--------CeEEEEEeccCCCCchHHhhh---cCC----CCHHHHHHHHHHHHHHHHHHHhCCceec
Q 019650          114 FYTI--------E--------GEICFVMEHMERGSLFDSLRV---RKK----LSEDVISGVAYRVLKGLQYLHGMQIIHG  170 (337)
Q Consensus       114 ~~~~--------~--------~~~~lv~e~~~~~~L~~~l~~---~~~----l~~~~~~~i~~~l~~~l~~LH~~~ivH~  170 (337)
                      ..-.        .        .+.+++|+...+ +|.+++..   ...    +.......+..|+++.+++||..|++|+
T Consensus        91 ~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~-dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHg  169 (288)
T PF14531_consen   91 LRIPGKPPFFERGPGQSIYWVLNRFLLMPRAQG-DLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHG  169 (288)
T ss_dssp             EEETTS-SEEEECETTEEEEEESEEEEEE--SE-EHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEES
T ss_pred             EEEcCCCcceecCCCCccceeehhhhccchhhh-cHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEec
Confidence            2211        1        134678888854 88877642   222    2233445556899999999999999999


Q ss_pred             cCCCCCeEEcCCCcEEEeeccCccchhccccCCCCCCCCCCccccccccccCCCCCcCCccccccc----CCCCCCcccc
Q 019650          171 DIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSER----WGGDYGFAGD  246 (337)
Q Consensus       171 dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~~~~~D  246 (337)
                      ||+|+|++++.+|.++|+||+.....+.....                 ...+..|.+||......    ....++.+.|
T Consensus       170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----------------~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~D  232 (288)
T PF14531_consen  170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-----------------SEFPVAFTPPELESCAGQFGQNNAPYTFATD  232 (288)
T ss_dssp             T-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-----------------GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHH
T ss_pred             ccceeeEEEcCCCCEEEcChHHHeecCceeec-----------------cCCCcccCChhhhhhhcccCcccceeeeccC
Confidence            99999999999999999999988877654321                 12567899999774310    1235788999


Q ss_pred             HHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCC
Q 019650          247 VWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKR  311 (337)
Q Consensus       247 iwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R  311 (337)
                      .|+||+++|.|+|+..||...........         .......+++.++.||..+|+.||.+|
T Consensus       233 aW~LG~~ly~lWC~~lPf~~~~~~~~~~~---------~f~~C~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  233 AWQLGITLYSLWCGRLPFGLSSPEADPEW---------DFSRCRDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HHHHHHHHHHHHHSS-STCCCGGGSTSGG---------GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred             HHHHHHHHHHHHHccCCCCCCCccccccc---------cchhcCCcCHHHHHHHHHHccCCcccC
Confidence            99999999999999999965422211110         122223779999999999999999987

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.92  E-value=5.5e-26  Score=205.03  Aligned_cols=242  Identities=29%  Similarity=0.469  Sum_probs=199.6

Q ss_pred             ccccCcceEEEEEEE---ccCCceEEEEEeecCCchH-hHHHHHHHHHHHHhcC-CCCceeeeeeEEeeCCeEEEEEecc
Q 019650           54 VLGHGNGGIVYKVRH---QKSNSIYALKVLNTTSSTI-IRHQAAHEAEILKRLD-SQFIVKCHAVFYTIEGEICFVMEHM  128 (337)
Q Consensus        54 ~lg~g~~~~v~~~~~---~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~~lv~e~~  128 (337)
                      ++|.|++|.|+++..   .+.+.-+++|+.++..... .......|-.++..+. |+.++.++..+.. +..+++++++.
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt-~~kl~l~ld~~   79 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQT-DGKLYLILDFL   79 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeecc-ccchhHhhhhc
Confidence            478999999988654   3566778888876543111 1114445777777776 8999999998876 78899999999


Q ss_pred             CCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCCCCCC
Q 019650          129 ERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNN  208 (337)
Q Consensus       129 ~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~  208 (337)
                      .||.|...+.....+.+.....+...++.++.++|+.+++|+|+|++||+++.+|++++.|||.++..-....       
T Consensus        80 rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~-------  152 (612)
T KOG0603|consen   80 RGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI-------  152 (612)
T ss_pred             ccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhh-------
Confidence            9999999999888999999999999999999999999999999999999999999999999999987654321       


Q ss_pred             CCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhccCCCCC
Q 019650          209 NNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEM  288 (337)
Q Consensus       209 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  288 (337)
                                 .+|+..|||||+..      ....++|+||+|+++++|+||..||..    +....+.     .....+
T Consensus       153 -----------~cgt~eymApEI~~------gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il-----~~~~~~  206 (612)
T KOG0603|consen  153 -----------ACGTYEYRAPEIIN------GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRIL-----KAELEM  206 (612)
T ss_pred             -----------cccchhhhhhHhhh------ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHh-----hhccCC
Confidence                       16899999999998      456789999999999999999999965    2222222     224566


Q ss_pred             CCCCCHHHHHHHHHHhhcCcCCCC-----CHHHHhcCccccccCCC
Q 019650          289 PETASPEFRRFVRSCLEKDWRKRG-----TVEELLAYPFVTKRSSS  329 (337)
Q Consensus       289 ~~~~~~~~~~li~~~l~~~p~~R~-----s~~eil~hp~f~~~~~~  329 (337)
                      |...+..+++++..++..+|.+|.     -..++++|+||++..|.
T Consensus       207 p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~  252 (612)
T KOG0603|consen  207 PRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWN  252 (612)
T ss_pred             chhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHh
Confidence            777889999999999999999995     46899999999998876

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.91  E-value=1.7e-25  Score=212.03  Aligned_cols=252  Identities=21%  Similarity=0.243  Sum_probs=185.5

Q ss_pred             ccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHH--HHhcCCCCceeeeeeEEeeCCeEEEEE
Q 019650           48 DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEI--LKRLDSQFIVKCHAVFYTIEGEICFVM  125 (337)
Q Consensus        48 ~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~--~~~l~~~~i~~~~~~~~~~~~~~~lv~  125 (337)
                      ++...+.||++.|=.|.+|.+.+ |. |++|++-+.......+.+.+.++-  ...+++||.+++.-+... +...|+|-
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t-~kAAylvR  100 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVT-DKAAYLVR  100 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHh-hHHHHHHH
Confidence            78889999999999999998753 33 899999777655555554443322  455699999998887544 67788999


Q ss_pred             eccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccC---
Q 019650          126 EHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNN---  202 (337)
Q Consensus       126 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~---  202 (337)
                      +|... +|.|.+...+-+...+.+.|+.||+.||..+|..||+|||||.+||||+.=+=+.|+||..-.-.--+..+   
T Consensus       101 qyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPad  179 (1431)
T KOG1240|consen  101 QYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPAD  179 (1431)
T ss_pred             HHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCccc
Confidence            99976 99999999888999999999999999999999999999999999999998888999999876433211111   


Q ss_pred             CCCCCCCCCccccccccccCCCCCcCCccccccc------CCCC-CCccccHHHHHHHHHHHHh-CCCCCCCCCCchhHH
Q 019650          203 NNHNNNNNNNIGEAAIACMGTCAYMSPERVDSER------WGGD-YGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLM  274 (337)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~------~~~~-~~~~~DiwslG~il~~l~t-g~~pf~~~~~~~~~~  274 (337)
                      ....+++.          -.-.+|.|||.+....      .+.. .+++.||||+||++.||++ |+++|.       +.
T Consensus       180 f~fFFDTS----------rRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~-------LS  242 (1431)
T KOG1240|consen  180 FTFFFDTS----------RRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT-------LS  242 (1431)
T ss_pred             ceEEEecC----------CceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc-------HH
Confidence            11111100          1235799999886521      1122 6789999999999999999 888882       22


Q ss_pred             HHHHHhhccC-CC--CCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          275 ALICAICFGE-RL--EMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       275 ~~~~~~~~~~-~~--~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                      ++..-...+. .+  .+..-.+..++++|..|++.||++|.|+++.|+-
T Consensus       243 QL~aYr~~~~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  243 QLLAYRSGNADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             HHHhHhccCccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence            2222211110 00  0011124589999999999999999999999975

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.91  E-value=2.5e-23  Score=174.20  Aligned_cols=252  Identities=21%  Similarity=0.250  Sum_probs=186.0

Q ss_pred             ccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCC-CCceeeeeeEEeeCCeEEEE
Q 019650           46 ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDS-QFIVKCHAVFYTIEGEICFV  124 (337)
Q Consensus        46 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~-~~i~~~~~~~~~~~~~~~lv  124 (337)
                      --.|.++++||.|+||.++.|+..-++..||||.-...+   ...++..|.+..+.|.+ ++|..++....+ +.+-.+|
T Consensus        27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS---~APQLrdEYr~YKlL~g~~GIP~vYYFGqe-G~~NiLV  102 (449)
T KOG1165|consen   27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS---EAPQLRDEYRTYKLLGGTEGIPQVYYFGQE-GKYNILV  102 (449)
T ss_pred             cccceeccccccCcceeeecccccccCceEEEEeccccC---CcchHHHHHHHHHHHcCCCCCCceeeeccc-cchhhhh
Confidence            358999999999999999999999999999999754432   23456668888888754 777777765444 6777899


Q ss_pred             EeccCCCCchHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCC-----cEEEeeccCccchhc
Q 019650          125 MEHMERGSLFDSLRVR-KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKG-----EVKIADFGVSRIVEE  198 (337)
Q Consensus       125 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~-----~~~l~Dfg~~~~~~~  198 (337)
                      +|++ |.+|+|+..-. ..|+.+++.-++.|++.-+.++|++.+|.|||||+|+||...+     .+.++|||++....+
T Consensus       103 idLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD  181 (449)
T KOG1165|consen  103 IDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD  181 (449)
T ss_pred             hhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence            9999 77999888754 5799999999999999999999999999999999999996443     599999999998876


Q ss_pred             cccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHH
Q 019650          199 TRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALIC  278 (337)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~  278 (337)
                      +....-..-       ....+..||-+||+--...    |...+...|+-+||=++++.+.|.+||++..-.. ..+..+
T Consensus       182 p~TkqHIPY-------rE~KSLsGTARYMSINTHl----GrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~t-nK~kYe  249 (449)
T KOG1165|consen  182 PKTKQHIPY-------REHKSLSGTARYMSINTHL----GREQSRRDDLEALGHVFMYFLRGSLPWQGLKADT-NKEKYE  249 (449)
T ss_pred             ccccccCcc-------ccccccccceeeeEeeccc----cchhhhhhhHHHhhhhhhhhccCCCccccccCcc-hHHHHH
Confidence            553322211       2333456999999987777    6688999999999999999999999998864322 111222


Q ss_pred             HhhccCCC----CCCCCCCHHHHHHHHHHhhcCcCCCCCH
Q 019650          279 AICFGERL----EMPETASPEFRRFVRSCLEKDWRKRGTV  314 (337)
Q Consensus       279 ~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~R~s~  314 (337)
                      ++......    .+..+.+.++..-+.-.=+.+-.+-|+.
T Consensus       250 KIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDY  289 (449)
T KOG1165|consen  250 KIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDY  289 (449)
T ss_pred             HhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCH
Confidence            22111111    1223445555555554444444555543

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.91  E-value=6.7e-24  Score=181.61  Aligned_cols=199  Identities=20%  Similarity=0.233  Sum_probs=148.1

Q ss_pred             CCCCceeeeeeEEee--------------------------CCeEEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHH
Q 019650          103 DSQFIVKCHAVFYTI--------------------------EGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVL  156 (337)
Q Consensus       103 ~~~~i~~~~~~~~~~--------------------------~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~  156 (337)
                      +||||+.+.+.|.++                          ...+|+||..++. +|.+++-.+ ..+.....-++.|++
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~-~~s~r~~~~~laQlL  351 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR-HRSYRTGRVILAQLL  351 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC-CCchHHHHHHHHHHH
Confidence            699999998887753                          1247999999976 999999643 467788889999999


Q ss_pred             HHHHHHHhCCceeccCCCCCeEEc--CCC--cEEEeeccCccchhccccCCCCCCCCCCccccccccccCCCCCcCCccc
Q 019650          157 KGLQYLHGMQIIHGDIKPSNLLIN--GKG--EVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERV  232 (337)
Q Consensus       157 ~~l~~LH~~~ivH~dl~~~Nili~--~~~--~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  232 (337)
                      +|+.|||.+|+.|||+|.+|||+.  +|+  .+.++|||++-.-...+......        ......-|.-.-||||+.
T Consensus       352 Eav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~--------S~~Vd~GGNa~lmAPEi~  423 (598)
T KOG4158|consen  352 EAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYE--------SDEVDLGGNAKLMAPEIA  423 (598)
T ss_pred             HHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccc--------cccccCCCcceecchhhh
Confidence            999999999999999999999994  333  58999999875443322111111        111122367789999998


Q ss_pred             ccccC--CCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCC
Q 019650          233 DSERW--GGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRK  310 (337)
Q Consensus       233 ~~~~~--~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~  310 (337)
                      ..-+.  .-....++|.|+.|.+.||+++...||...++.....   ........+.++..++..+++++..+|+.||++
T Consensus       424 ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~---r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~psk  500 (598)
T KOG4158|consen  424 TAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDT---RTYQESQLPALPSRVPPVARQLVFDLLKRDPSK  500 (598)
T ss_pred             hcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheech---hhhhhhhCCCCcccCChHHHHHHHHHhcCCccc
Confidence            74321  1123458999999999999999999998744322111   113344567788899999999999999999999


Q ss_pred             CCCH
Q 019650          311 RGTV  314 (337)
Q Consensus       311 R~s~  314 (337)
                      |+|+
T Consensus       501 Rvsp  504 (598)
T KOG4158|consen  501 RVSP  504 (598)
T ss_pred             cCCc
Confidence            9984

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.90  E-value=2.3e-23  Score=169.92  Aligned_cols=140  Identities=22%  Similarity=0.254  Sum_probs=111.0

Q ss_pred             ccccccCcceEEEEEEEccCCceEEEEEeecCCchH-------------------------hHHHHHHHHHHHHhcCCCC
Q 019650           52 LTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTI-------------------------IRHQAAHEAEILKRLDSQF  106 (337)
Q Consensus        52 ~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-------------------------~~~~~~~e~~~~~~l~~~~  106 (337)
                      .+.||.|++|.||+|.+. +|+.||+|+++......                         .......|+..+.++.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            568999999999999986 89999999997642110                         0122345999999998877


Q ss_pred             ceeeeeeEEeeCCeEEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHH-HhCCceeccCCCCCeEEcCCCcE
Q 019650          107 IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYL-HGMQIIHGDIKPSNLLINGKGEV  185 (337)
Q Consensus       107 i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~L-H~~~ivH~dl~~~Nili~~~~~~  185 (337)
                      +...... .. . ..++||||++|+++...+.....++...+..++.|++.+|.++ |+.|++||||||+||+++ ++.+
T Consensus        81 v~~p~~~-~~-~-~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v  156 (190)
T cd05147          81 IPCPEPI-LL-K-SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKL  156 (190)
T ss_pred             CCCCcEE-Ee-c-CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcE
Confidence            6443322 22 2 2379999999877766544457899999999999999999999 799999999999999998 5789


Q ss_pred             EEeeccCccch
Q 019650          186 KIADFGVSRIV  196 (337)
Q Consensus       186 ~l~Dfg~~~~~  196 (337)
                      +|+|||++...
T Consensus       157 ~LiDFG~a~~~  167 (190)
T cd05147         157 YIIDVSQSVEH  167 (190)
T ss_pred             EEEEccccccC
Confidence            99999998754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.89  E-value=3e-23  Score=171.30  Aligned_cols=172  Identities=18%  Similarity=0.245  Sum_probs=130.7

Q ss_pred             ccccccccccccCcceEEEEEEEccCCceEEEEEeecCCch--HhHHH------HHHHHHHHHhcCCCCceeeeeeEEee
Q 019650           46 ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSST--IIRHQ------AAHEAEILKRLDSQFIVKCHAVFYTI  117 (337)
Q Consensus        46 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~------~~~e~~~~~~l~~~~i~~~~~~~~~~  117 (337)
                      .++|.+.+++|.|+||.||++.+  ++..+|+|++......  .....      +.+|+..+.++.|+++..+...+...
T Consensus        30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~  107 (232)
T PRK10359         30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA  107 (232)
T ss_pred             hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence            47999999999999999999765  3667999999755322  22222      57899999999999999988876543


Q ss_pred             C-------CeEEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeec
Q 019650          118 E-------GEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADF  190 (337)
Q Consensus       118 ~-------~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Df  190 (337)
                      .       +..+++|||++|.+|.++..    +++    ....+++.+|..+|+.|++|||++|+||+++++| ++|+||
T Consensus       108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDf  178 (232)
T PRK10359        108 ERKTLRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDL  178 (232)
T ss_pred             ccccccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEEC
Confidence            2       35789999999999988742    333    2456999999999999999999999999999988 999999


Q ss_pred             cCccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHH
Q 019650          191 GVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECL  258 (337)
Q Consensus       191 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~  258 (337)
                      |..........                    .      ...+.    ...++.++|+|+||+++..+.
T Consensus       179 g~~~~~~e~~a--------------------~------d~~vl----er~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        179 SGKRCTAQRKA--------------------K------DRIDL----ERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             CCcccccchhh--------------------H------HHHHH----HhHhcccccccceeEeehHHH
Confidence            98765422110                    0      00222    124556899999999987653

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.89  E-value=2.2e-22  Score=164.76  Aligned_cols=142  Identities=20%  Similarity=0.239  Sum_probs=113.3

Q ss_pred             cccccccCcceEEEEEEEccCCceEEEEEeecCCch-------------------------HhHHHHHHHHHHHHhcCCC
Q 019650           51 KLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSST-------------------------IIRHQAAHEAEILKRLDSQ  105 (337)
Q Consensus        51 ~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~-------------------------~~~~~~~~e~~~~~~l~~~  105 (337)
                      +.+.||+|++|+||+|.+. +|+.||+|+++.....                         ........|...+.++.++
T Consensus         1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~   79 (190)
T cd05145           1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA   79 (190)
T ss_pred             CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence            4678999999999999987 8999999999765311                         0122235788999999998


Q ss_pred             CceeeeeeEEeeCCeEEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCeEEcCCCc
Q 019650          106 FIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG-MQIIHGDIKPSNLLINGKGE  184 (337)
Q Consensus       106 ~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~-~~ivH~dl~~~Nili~~~~~  184 (337)
                      ++.........   ..++||||++|+++.........++......++.|++.++.++|+ .|++|+||||+||+++ ++.
T Consensus        80 ~i~~p~~~~~~---~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~  155 (190)
T cd05145          80 GVPVPEPILLK---KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGK  155 (190)
T ss_pred             CCCCceEEEec---CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCC
Confidence            87544443322   247999999987655443344568889999999999999999999 9999999999999999 889


Q ss_pred             EEEeeccCccchh
Q 019650          185 VKIADFGVSRIVE  197 (337)
Q Consensus       185 ~~l~Dfg~~~~~~  197 (337)
                      ++|+|||++....
T Consensus       156 ~~liDFG~a~~~~  168 (190)
T cd05145         156 PYIIDVSQAVELD  168 (190)
T ss_pred             EEEEEcccceecC
Confidence            9999999997654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.86  E-value=1e-21  Score=186.21  Aligned_cols=243  Identities=28%  Similarity=0.426  Sum_probs=169.1

Q ss_pred             ccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEE
Q 019650           43 VENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEIC  122 (337)
Q Consensus        43 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~  122 (337)
                      ....++|..++.|..|++|-||.+.++.+.+.+|+| ++++.            .+++.     |    ..+.   ...+
T Consensus        79 ~p~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~------------lilRn-----i----lt~a---~npf  133 (1205)
T KOG0606|consen   79 APSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQN------------LILRN-----I----LTFA---GNPF  133 (1205)
T ss_pred             CCCccccceeEeeccCCCCceeeeeccccccchhhc-ccccc------------hhhhc-----c----cccc---CCcc
Confidence            345679999999999999999999999999999995 33321            01110     1    1111   1222


Q ss_pred             EEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccC
Q 019650          123 FVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNN  202 (337)
Q Consensus       123 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~  202 (337)
                      .|      |+=...+...++++.+.        +.++.|||+.||+|+|+||+|.+|+.=|++|++|||++........-
T Consensus       134 vv------gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at  199 (1205)
T KOG0606|consen  134 VV------GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT  199 (1205)
T ss_pred             ee------chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence            22      34344454445555433        88999999999999999999999999999999999998765432111


Q ss_pred             C-CCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhh
Q 019650          203 N-NHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAIC  281 (337)
Q Consensus       203 ~-~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~  281 (337)
                      . ...-.....+.=.-...+||+.|.|||++..+    .|...+|+|++|+|+|+.+-|..||.+....+.+-.++....
T Consensus       200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrq----gygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i  275 (1205)
T KOG0606|consen  200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQ----GYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDI  275 (1205)
T ss_pred             hhhhcchHHHHHHhhhccccCCccccChhhhhhh----ccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhc
Confidence            0 00000000000011234799999999999954    567779999999999999999999987655444444443211


Q ss_pred             ccCCCCCCCCCCHHHHHHHHHHhhcCcCCC---CCHHHHhcCccccccCCCc
Q 019650          282 FGERLEMPETASPEFRRFVRSCLEKDWRKR---GTVEELLAYPFVTKRSSSS  330 (337)
Q Consensus       282 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~R---~s~~eil~hp~f~~~~~~~  330 (337)
                      .  .++-....+.+++++|.++|+.+|..|   ..+-++..|+||+.-+|.+
T Consensus       276 ~--wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~~  325 (1205)
T KOG0606|consen  276 E--WPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWKS  325 (1205)
T ss_pred             c--ccccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccch
Confidence            1  122244568899999999999999999   4688899999999988764

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.86  E-value=8.8e-21  Score=153.39  Aligned_cols=199  Identities=14%  Similarity=0.048  Sum_probs=138.0

Q ss_pred             ccccccccCcceEEEEEEEccCCceEEEEEeecCCc---hHhHHHHHHHHHHHHhcCC-CCceeeeeeEEeeCCeEEEEE
Q 019650           50 KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSS---TIIRHQAAHEAEILKRLDS-QFIVKCHAVFYTIEGEICFVM  125 (337)
Q Consensus        50 ~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~~~~l~~-~~i~~~~~~~~~~~~~~~lv~  125 (337)
                      -+...|++|+||+|+.+..  .+.+++.+.+.....   ......+.+|+++++++.| ++++.+++.     ...+++|
T Consensus         5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~-----~~~~lvm   77 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW-----DGRHLDR   77 (218)
T ss_pred             ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE-----cCEEEEE
Confidence            3567899999999998755  577788777765432   1122357789999999965 678888774     3468999


Q ss_pred             eccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccC-CCCCeEEcCCCcEEEeeccCccchhccccCCC
Q 019650          126 EHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDI-KPSNLLINGKGEVKIADFGVSRIVEETRNNNN  204 (337)
Q Consensus       126 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl-~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~  204 (337)
                      +|+.|.+|.+.+..       ....++.|++.+|.++|++|++|+|| ||+||+++.++.++|+|||++...........
T Consensus        78 eyI~G~~L~~~~~~-------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r  150 (218)
T PRK12274         78 SYLAGAAMYQRPPR-------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMR  150 (218)
T ss_pred             eeecCccHHhhhhh-------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHH
Confidence            99999888654421       12457889999999999999999999 79999999999999999999985443221000


Q ss_pred             CCCCCCCccc-cccccccCCCCCcCCcccccccCCCCCC-ccccHHHHHHHHHHHHhCCCCCCCC
Q 019650          205 HNNNNNNNIG-EAAIACMGTCAYMSPERVDSERWGGDYG-FAGDVWSLGVVVLECLVGHYPLIGF  267 (337)
Q Consensus       205 ~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~DiwslG~il~~l~tg~~pf~~~  267 (337)
                      ....  .+.. -...-...++.+++|+...-.   ...+ ...++++.|.-+|.++|+..++...
T Consensus       151 ~L~~--rDl~~llk~~~~y~~~~l~~~~~~~l---~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~  210 (218)
T PRK12274        151 LLAR--EDLRHLLKHKRMYCPAALTPVERRVL---KRTSWIRELWFATGKPVYRFVTRRVLHWED  210 (218)
T ss_pred             HHHH--HHHHHHHHHHHhcCCCCCCHHHHhhh---ccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence            0000  0000 000011256778888765422   1223 5678899999999999988876543

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.86  E-value=1.8e-21  Score=187.36  Aligned_cols=209  Identities=24%  Similarity=0.310  Sum_probs=162.8

Q ss_pred             CCCCCCCCCCCccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcC---CCCce
Q 019650           32 HFPTSNPTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLD---SQFIV  108 (337)
Q Consensus        32 ~~~~~~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~---~~~i~  108 (337)
                      +.|..++..-....-..|.|-+.||.|++|+||+|.+.+ ++.||+|+-+......    ++=-.+++.+|+   -+.|+
T Consensus       683 ~~~~l~~~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WE----fYI~~q~~~RLk~~~~~~~~  757 (974)
T KOG1166|consen  683 RVPKLNPNTEFEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWE----FYICLQVMERLKPQMLPSIM  757 (974)
T ss_pred             cccccCccceeeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCcee----eeehHHHHHhhchhhhcchH
Confidence            444445545555566799999999999999999999877 9999999987665331    111334445555   13344


Q ss_pred             eeeeeEEeeCCeEEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcC-------
Q 019650          109 KCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLING-------  181 (337)
Q Consensus       109 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~-------  181 (337)
                      .+...+.- .+.-++|+||.+.|+|.+++...+.+++..+..+..|++..|..||.++||||||||+|+++..       
T Consensus       758 ~~~~a~~~-~~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~  836 (974)
T KOG1166|consen  758 HISSAHVF-QNASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSD  836 (974)
T ss_pred             HHHHHHcc-CCcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCc
Confidence            44444333 3455789999999999999998899999999999999999999999999999999999999942       


Q ss_pred             CCcEEEeeccCccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCC
Q 019650          182 KGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGH  261 (337)
Q Consensus       182 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~  261 (337)
                      .--++|+|||.+..+......            ..-.+..+|..+-.+|...    |..++++.|.|.|+.++|-|+.|+
T Consensus       837 ~~~l~lIDfG~siDm~lfp~~------------~~F~~~~~td~f~C~EM~~----grpWtYq~DyfGlAa~~h~mLFG~  900 (974)
T KOG1166|consen  837 SKGLYLIDFGRSIDMKLFPDG------------TKFKAVWHTDLFDCIEMRE----GRPWTYQIDYFGLAATVHVMLFGK  900 (974)
T ss_pred             ccceEEEecccceeeeEcCCC------------cEEeeeeccccchhHHHhc----CCCCchhhhhHHHHHHHHHHHHHH
Confidence            225999999998776543322            2233445788999999999    679999999999999999999997


Q ss_pred             C
Q 019650          262 Y  262 (337)
Q Consensus       262 ~  262 (337)
                      +
T Consensus       901 y  901 (974)
T KOG1166|consen  901 Y  901 (974)
T ss_pred             H
Confidence            4

>smart00090 RIO RIO-like kinase

Probab=99.85  E-value=2.1e-20  Score=157.71  Aligned_cols=144  Identities=22%  Similarity=0.201  Sum_probs=114.7

Q ss_pred             ccccccccccCcceEEEEEE-EccCCceEEEEEeecCCch-----------------------HhHHHHHHHHHHHHhcC
Q 019650           48 DLKKLTVLGHGNGGIVYKVR-HQKSNSIYALKVLNTTSST-----------------------IIRHQAAHEAEILKRLD  103 (337)
Q Consensus        48 ~y~~~~~lg~g~~~~v~~~~-~~~~~~~vaiK~~~~~~~~-----------------------~~~~~~~~e~~~~~~l~  103 (337)
                      -|.+.+.||.|++|.||+|. +..+|..||+|+++.....                       .....+..|+.++.++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            57889999999999999998 6678999999998754210                       01123567999999997


Q ss_pred             CCC--ceeeeeeEEeeCCeEEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC-ceeccCCCCCeEEc
Q 019650          104 SQF--IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQ-IIHGDIKPSNLLIN  180 (337)
Q Consensus       104 ~~~--i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~-ivH~dl~~~Nili~  180 (337)
                      +.+  +..++.   .  ...++||||++|.+|.........+....+..++.|++.++++||+.| ++|+||||+||+++
T Consensus       109 ~~~i~~p~~~~---~--~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~  183 (237)
T smart00090      109 EAGVPVPKPIA---W--RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH  183 (237)
T ss_pred             hcCCCCCeeeE---e--cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE
Confidence            533  333333   2  234799999999888776654556777788999999999999999999 99999999999999


Q ss_pred             CCCcEEEeeccCccchh
Q 019650          181 GKGEVKIADFGVSRIVE  197 (337)
Q Consensus       181 ~~~~~~l~Dfg~~~~~~  197 (337)
                       +++++|+|||.+....
T Consensus       184 -~~~i~LiDFg~a~~~~  199 (237)
T smart00090      184 -DGKVVIIDVSQSVELD  199 (237)
T ss_pred             -CCCEEEEEChhhhccC
Confidence             8899999999887543

>PRK10345 hypothetical protein; Provisional

Probab=99.83  E-value=7.7e-20  Score=150.59  Aligned_cols=138  Identities=20%  Similarity=0.194  Sum_probs=107.7

Q ss_pred             cccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhc-----CCCCceeeeeeEEeeC--CeE
Q 019650           49 LKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRL-----DSQFIVKCHAVFYTIE--GEI  121 (337)
Q Consensus        49 y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-----~~~~i~~~~~~~~~~~--~~~  121 (337)
                      +.-...||+|+++.||.  +..+... +||++..... ...+.+.+|+.+++.+     .|+||+++++++.+..  +.+
T Consensus         4 L~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~-~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v   79 (210)
T PRK10345          4 LSEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD-GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV   79 (210)
T ss_pred             cCCcceecCCCceEEEE--CCCCcCe-EEEEEecccc-chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence            44567899999999996  6666655 6898866432 2346788999999999     6799999999988743  243


Q ss_pred             E-EEEec--cCCCCchHHhhhcCCCCHHHHHHHHHHHHHHH-HHHHhCCceeccCCCCCeEEcCC----CcEEEeeccCc
Q 019650          122 C-FVMEH--MERGSLFDSLRVRKKLSEDVISGVAYRVLKGL-QYLHGMQIIHGDIKPSNLLINGK----GEVKIADFGVS  193 (337)
Q Consensus       122 ~-lv~e~--~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l-~~LH~~~ivH~dl~~~Nili~~~----~~~~l~Dfg~~  193 (337)
                      + +|+||  +.+++|.+++.+. .+++.  ..++.+++.++ +|||+++|+|+||||+||+++..    ++++|+|++.+
T Consensus        80 ~~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~  156 (210)
T PRK10345         80 YDVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE  156 (210)
T ss_pred             EEEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence            4 78999  5578999999763 46655  35678888777 89999999999999999999743    37999995444

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.82  E-value=9.3e-20  Score=164.68  Aligned_cols=207  Identities=28%  Similarity=0.362  Sum_probs=159.7

Q ss_pred             HhcCCCCceeeeeeEEeeCCeEEEEEeccCCCCchHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCc-eeccCCCCCe
Q 019650          100 KRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRV-RKKLSEDVISGVAYRVLKGLQYLHGMQI-IHGDIKPSNL  177 (337)
Q Consensus       100 ~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~~i-vH~dl~~~Ni  177 (337)
                      +.+.|.|+.++++.+.. ++..+.|.+||.-|+|.|.+.. .-.++..-...++++++.+|.|||...| .||.++..|+
T Consensus         2 ~~l~h~n~~~f~g~~~~-~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC   80 (484)
T KOG1023|consen    2 RQLDHDNLNKFIGASVD-GPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC   80 (484)
T ss_pred             cccchhhhhhheeeEec-CCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence            56889999999999988 5899999999999999999986 3468888899999999999999998866 9999999999


Q ss_pred             EEcCCCcEEEeeccCccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCC---CCccccHHHHHHHH
Q 019650          178 LINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGD---YGFAGDVWSLGVVV  254 (337)
Q Consensus       178 li~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~---~~~~~DiwslG~il  254 (337)
                      +++..-.+|++|||+..........            ..........-|.|||.+........   .+.+.|+||+|+++
T Consensus        81 lvd~~w~lklt~~Gl~~~~~~~~~~------------~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~  148 (484)
T KOG1023|consen   81 LVDSRWVLKLTDFGLNSLLEETAEP------------EAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIM  148 (484)
T ss_pred             eeeeeEEEEechhhhcccccccccc------------cccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHH
Confidence            9999999999999998877541100            00111113456999999986432222   57789999999999


Q ss_pred             HHHHhCCCCCCCCCCchhHHHHHHHhhc-cC---CCCCC--CCCCHHHHHHHHHHhhcCcCCCCCHHHHhc
Q 019650          255 LECLVGHYPLIGFGEKPDLMALICAICF-GE---RLEMP--ETASPEFRRFVRSCLEKDWRKRGTVEELLA  319 (337)
Q Consensus       255 ~~l~tg~~pf~~~~~~~~~~~~~~~~~~-~~---~~~~~--~~~~~~~~~li~~~l~~~p~~R~s~~eil~  319 (337)
                      +|+++...||..........+++..... +.   ++...  ....+.+..++..||..+|.+||+++++-.
T Consensus       149 ~ei~~r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~  219 (484)
T KOG1023|consen  149 YEILFRSGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS  219 (484)
T ss_pred             HHHHhccCccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence            9999999999775444443444444333 22   12221  133457999999999999999999998755

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.81  E-value=2.8e-20  Score=165.23  Aligned_cols=181  Identities=25%  Similarity=0.386  Sum_probs=138.5

Q ss_pred             eEEEEEeccCCCCchHHhhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccch
Q 019650          120 EICFVMEHMERGSLFDSLRVRK---KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIV  196 (337)
Q Consensus       120 ~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~  196 (337)
                      ++|+.|++|.-.+|.+|+...+   ..+......+++|++.++.|   +|.+|+|+||.||++..+..++|.|||+....
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~  406 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQ  406 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheeec
Confidence            5789999999999999997443   46788999999999999999   99999999999999999999999999998876


Q ss_pred             hccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCchhHHH
Q 019650          197 EETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMA  275 (337)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~~~~~~~~~~  275 (337)
                      .......        .........+||..||+||++.    +..|+.++|||+||++++||+. -...+       ....
T Consensus       407 ~~~~~~~--------~~~a~~t~~~gt~~YmsPEQi~----g~~y~~kvdIyaLGlil~EL~~~f~T~~-------er~~  467 (516)
T KOG1033|consen  407 DKDETVA--------PAAASHTQQVGTLLYMSPEQIR----GQQYSEKVDIYALGLILAELLIQFSTQF-------ERIA  467 (516)
T ss_pred             ccCCccc--------chhhhhhhcccccccCCHHHHh----hhhhhhhcchhhHHHHHHHHHHHhccHH-------HHHH
Confidence            5443110        0012334457999999999999    5689999999999999999998 22222       2333


Q ss_pred             HHHHhhccCCC-CCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccc
Q 019650          276 LICAICFGERL-EMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV  323 (337)
Q Consensus       276 ~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f  323 (337)
                      .+..+..+..+ .+... -+.-..|+.+|+...|.+||++.+.--|+|.
T Consensus       468 t~~d~r~g~ip~~~~~d-~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~  515 (516)
T KOG1033|consen  468 TLTDIRDGIIPPEFLQD-YPEEYTLLQQLLSPSPEERPSAIEVALHEFL  515 (516)
T ss_pred             hhhhhhcCCCChHHhhc-CcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence            33333444333 22222 3455689999999999999987777777765

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.80  E-value=8.4e-19  Score=146.33  Aligned_cols=136  Identities=21%  Similarity=0.286  Sum_probs=111.4

Q ss_pred             ccccccCcceEEEEEEEccCCceEEEEEeecCCc-------hHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 019650           52 LTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSS-------TIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFV  124 (337)
Q Consensus        52 ~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv  124 (337)
                      ++.||+|++|.||+|..  ++..+++|+......       ......+.+|+.++..+.++++......+.. ....+++
T Consensus         1 ~~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~-~~~~~lv   77 (211)
T PRK14879          1 MKLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVD-PENFIIV   77 (211)
T ss_pred             CcccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEe-CCCCEEE
Confidence            36799999999999987  567799998654321       1123456789999999999888766665554 4677899


Q ss_pred             EeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccc
Q 019650          125 MEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRI  195 (337)
Q Consensus       125 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~  195 (337)
                      |||++|++|.+++.....    ....++.+++.+|.++|+.|++|+|++|.||+++ ++.++++|||.+..
T Consensus        78 ~e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         78 MEYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             EEEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            999999999999864332    8889999999999999999999999999999999 78999999998764

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.79  E-value=2.1e-18  Score=142.55  Aligned_cols=131  Identities=21%  Similarity=0.289  Sum_probs=104.6

Q ss_pred             ccccCcceEEEEEEEccCCceEEEEEeecCC-------chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEe
Q 019650           54 VLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-------STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVME  126 (337)
Q Consensus        54 ~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~e  126 (337)
                      .||+|++|.||+|..  ++..+++|......       ......++.+|+.++..+.++++......+.. ....+++||
T Consensus         1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~-~~~~~lv~e   77 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVD-PDNKTIVME   77 (199)
T ss_pred             CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEE-CCCCEEEEE
Confidence            489999999999984  56789999865432       11123566789999999988775544443333 456789999


Q ss_pred             ccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccc
Q 019650          127 HMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRI  195 (337)
Q Consensus       127 ~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~  195 (337)
                      |++|++|.+++.....       .++.+++.+|.+||+.|++|+|++|.||+++ ++.++++|||++..
T Consensus        78 ~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        78 YIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             EECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            9999999988764321       8899999999999999999999999999999 88999999998765

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.78  E-value=2.1e-20  Score=176.31  Aligned_cols=265  Identities=23%  Similarity=0.247  Sum_probs=209.6

Q ss_pred             CccccccccccccCcceEEEEEEEc-cCCceEEEEEeecCC-chHhHHHHHHHHHHHHhcC-CCCceeeeeeEEeeCCeE
Q 019650           45 NISDLKKLTVLGHGNGGIVYKVRHQ-KSNSIYALKVLNTTS-STIIRHQAAHEAEILKRLD-SQFIVKCHAVFYTIEGEI  121 (337)
Q Consensus        45 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~  121 (337)
                      ....|.+.+.||.|+++.+-..... .+...++.|.+.... ..........|..+-+.+. |.|++..++.... ....
T Consensus        18 ~~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~-~~~~   96 (601)
T KOG0590|consen   18 PNSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSS-PRSY   96 (601)
T ss_pred             ccccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCC-Cccc
Confidence            4667888888999999999888764 445556667665543 3334455556777777776 9999999997655 5678


Q ss_pred             EEEEeccCCCCchHHh-hhcC-CCCHHHHHHHHHHHHHHHHHHH-hCCceeccCCCCCeEEcCCC-cEEEeeccCccchh
Q 019650          122 CFVMEHMERGSLFDSL-RVRK-KLSEDVISGVAYRVLKGLQYLH-GMQIIHGDIKPSNLLINGKG-EVKIADFGVSRIVE  197 (337)
Q Consensus       122 ~lv~e~~~~~~L~~~l-~~~~-~l~~~~~~~i~~~l~~~l~~LH-~~~ivH~dl~~~Nili~~~~-~~~l~Dfg~~~~~~  197 (337)
                      ++++++..|+++.+-+ .... ..+...+..++.|+..++.|+| ..++.|+|++|+|.+++..+ .+++.|||++....
T Consensus        97 ~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~  176 (601)
T KOG0590|consen   97 LLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYR  176 (601)
T ss_pred             ccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhcccc
Confidence            8999999999999998 5554 6788899999999999999999 99999999999999999999 99999999998876


Q ss_pred             c-cccCCCCCCCCCCccccccccccC-CCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHH
Q 019650          198 E-TRNNNNHNNNNNNNIGEAAIACMG-TCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMA  275 (337)
Q Consensus       198 ~-~~~~~~~~~~~~~~~~~~~~~~~~-~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~  275 (337)
                      . .+..            ......+| ++.|+|||...+.   ....+..|+||.|+++.-+++|..|+...........
T Consensus       177 ~~~g~~------------~~~~~~~g~s~~y~a~E~~~~~---~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~  241 (601)
T KOG0590|consen  177 NKNGAE------------RSLKDRCGSSPPYGAPEHLSGK---AYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYS  241 (601)
T ss_pred             ccCCcc------------eeeecccCCCCCCCCcccccch---hhcCCCcccccccccccccccCCCCccccccccccce
Confidence            5 2211            33344467 9999999999853   2446789999999999999999999976554443322


Q ss_pred             HHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccc
Q 019650          276 LICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTK  325 (337)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~  325 (337)
                      .............+..++....+++.+++..+|.+|.+.+++..+||+..
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  242 SWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             eecccccccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence            22222222234556678899999999999999999999999999999998

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.78  E-value=3.1e-18  Score=141.35  Aligned_cols=137  Identities=21%  Similarity=0.197  Sum_probs=107.2

Q ss_pred             cccccccccCcceEEEEEEEccCCceEEEEEeecCCch---------------------HhHHHHHHHHHHHHhcCCCC-
Q 019650           49 LKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSST---------------------IIRHQAAHEAEILKRLDSQF-  106 (337)
Q Consensus        49 y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~---------------------~~~~~~~~e~~~~~~l~~~~-  106 (337)
                      |.+.+.||.|++|.||++... +++.+|+|++......                     ........|+.++..+.+.+ 
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   95 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF   95 (198)
T ss_pred             hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence            778899999999999999874 7899999987653210                     01123567888888887764 


Q ss_pred             -ceeeeeeEEeeCCeEEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcE
Q 019650          107 -IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEV  185 (337)
Q Consensus       107 -i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~  185 (337)
                       +...+.     ....+++|||++|++|......      .....++.+++.++.++|+.|++|+||+|+||+++.++.+
T Consensus        96 ~v~~~~~-----~~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~  164 (198)
T cd05144          96 PVPKPID-----WNRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKI  164 (198)
T ss_pred             CCCceee-----cCCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcE
Confidence             333332     2345899999999888765431      3456788999999999999999999999999999999999


Q ss_pred             EEeeccCccchh
Q 019650          186 KIADFGVSRIVE  197 (337)
Q Consensus       186 ~l~Dfg~~~~~~  197 (337)
                      +|+|||.+....
T Consensus       165 ~liDfg~~~~~~  176 (198)
T cd05144         165 YIIDWPQMVSTD  176 (198)
T ss_pred             EEEECCccccCC
Confidence            999999986543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.75  E-value=2.4e-17  Score=155.93  Aligned_cols=138  Identities=19%  Similarity=0.180  Sum_probs=109.3

Q ss_pred             cccccccccccCcceEEEEEEEccCCceEEEEEeecCC-------chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCC
Q 019650           47 SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-------STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEG  119 (337)
Q Consensus        47 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~  119 (337)
                      ..|...+.||+|+||+||++.....  .+++|+.....       .....+.+.+|+.+++.++|++++........ ..
T Consensus       333 ~~~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~-~~  409 (535)
T PRK09605        333 RRKIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVD-PE  409 (535)
T ss_pred             cccCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEe-CC
Confidence            4456788999999999999987543  34444322111       11234567889999999999998876665554 45


Q ss_pred             eEEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccch
Q 019650          120 EICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIV  196 (337)
Q Consensus       120 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~  196 (337)
                      ..++||||++|++|.+++.        ....++.+++.+|.+||+.|++|||+||+||++ .++.++|+|||++...
T Consensus       410 ~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~  477 (535)
T PRK09605        410 EKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS  477 (535)
T ss_pred             CCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence            6789999999999999885        457789999999999999999999999999999 5789999999998653

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.72  E-value=7.1e-17  Score=132.04  Aligned_cols=138  Identities=22%  Similarity=0.274  Sum_probs=98.7

Q ss_pred             cccccccCcceEEEEEEEccCCceEEEEEeecCCchH-hHHH----------------------HHHHHHHHHhcCCCC-
Q 019650           51 KLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTI-IRHQ----------------------AAHEAEILKRLDSQF-  106 (337)
Q Consensus        51 ~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~----------------------~~~e~~~~~~l~~~~-  106 (337)
                      +.+.||+|++|+||+|.+. ++..||+|++....... ....                      ...|...+.++.+.+ 
T Consensus         1 ~~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~   79 (187)
T cd05119           1 VGGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGV   79 (187)
T ss_pred             CCcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCC
Confidence            3568999999999999886 78899999987543111 0111                      134555566654433 


Q ss_pred             -ceeeeeeEEeeCCeEEEEEeccCCCCchH-HhhhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCeEEcCCC
Q 019650          107 -IVKCHAVFYTIEGEICFVMEHMERGSLFD-SLRVRKKLSEDVISGVAYRVLKGLQYLHG-MQIIHGDIKPSNLLINGKG  183 (337)
Q Consensus       107 -i~~~~~~~~~~~~~~~lv~e~~~~~~L~~-~l~~~~~l~~~~~~~i~~~l~~~l~~LH~-~~ivH~dl~~~Nili~~~~  183 (337)
                       +.+.++.     ...+++|||++++++.. .+... ... ..+..++.+++.++.++|. .|++|+||+|+||+++ ++
T Consensus        80 ~~~~~~~~-----~~~~lv~e~~~g~~~~~~~l~~~-~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~  151 (187)
T cd05119          80 PVPKPIDL-----NRHVLVMEFIGGDGIPAPRLKDV-RLL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DG  151 (187)
T ss_pred             CCCceEec-----CCCEEEEEEeCCCCccChhhhhh-hhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CC
Confidence             3333332     23589999999854322 22111 111 6788999999999999999 9999999999999999 88


Q ss_pred             cEEEeeccCccchh
Q 019650          184 EVKIADFGVSRIVE  197 (337)
Q Consensus       184 ~~~l~Dfg~~~~~~  197 (337)
                      .++++|||.+....
T Consensus       152 ~~~liDfg~a~~~~  165 (187)
T cd05119         152 KVYIIDVPQAVEID  165 (187)
T ss_pred             cEEEEECccccccc
Confidence            99999999986553

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.71  E-value=2.1e-16  Score=133.58  Aligned_cols=142  Identities=19%  Similarity=0.251  Sum_probs=105.9

Q ss_pred             ccccc-ccccc-cCcceEEEEEEEccCCceEEEEEeecCC------------chHhHHHHHHHHHHHHhcCCCCc--eee
Q 019650           47 SDLKK-LTVLG-HGNGGIVYKVRHQKSNSIYALKVLNTTS------------STIIRHQAAHEAEILKRLDSQFI--VKC  110 (337)
Q Consensus        47 ~~y~~-~~~lg-~g~~~~v~~~~~~~~~~~vaiK~~~~~~------------~~~~~~~~~~e~~~~~~l~~~~i--~~~  110 (337)
                      +.+.. ...|| .|+.|+||.+...  +..+++|.+....            .......+.+|+.++.++.|+++  +..
T Consensus        30 ~~~~~~~~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~p  107 (239)
T PRK01723         30 DFWQQQARVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRP  107 (239)
T ss_pred             HHHhhcCceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCcee
Confidence            44433 34576 8888899998764  6678999885421            11233567789999999988775  555


Q ss_pred             eeeEEeeCCe---EEEEEeccCC-CCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEE
Q 019650          111 HAVFYTIEGE---ICFVMEHMER-GSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVK  186 (337)
Q Consensus       111 ~~~~~~~~~~---~~lv~e~~~~-~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~  186 (337)
                      ++........   .++|||+++| .+|.+++.. ..+++..    +.+++.+|.+||+.||+|+||||.|||++.++.++
T Consensus       108 l~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~  182 (239)
T PRK01723        108 IAARVVRHGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFW  182 (239)
T ss_pred             EeeeeeecCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEE
Confidence            5543332222   3599999997 588888864 3455543    56899999999999999999999999999989999


Q ss_pred             EeeccCccc
Q 019650          187 IADFGVSRI  195 (337)
Q Consensus       187 l~Dfg~~~~  195 (337)
                      |+|||.+..
T Consensus       183 LIDfg~~~~  191 (239)
T PRK01723        183 LIDFDRGEL  191 (239)
T ss_pred             EEECCCccc
Confidence            999998764

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.67  E-value=9.3e-16  Score=120.61  Aligned_cols=132  Identities=24%  Similarity=0.322  Sum_probs=109.0

Q ss_pred             cccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCC--CCceeeeeeEEeeCCeEEEEEecc
Q 019650           51 KLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDS--QFIVKCHAVFYTIEGEICFVMEHM  128 (337)
Q Consensus        51 ~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~--~~i~~~~~~~~~~~~~~~lv~e~~  128 (337)
                      +++.|+.|.++.||++....  ..+++|.......   ...+.+|...+..+.+  ..+++++..... .+..+++|||+
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~---~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~-~~~~~~v~e~~   75 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK---GADREREVAILQLLARKGLPVPKVLASGES-DGWSYLLMEWI   75 (155)
T ss_pred             cceecccccccceEEEEecC--CeEEEEecCCCCc---hhHHHHHHHHHHHHHHcCCCCCeEEEEcCC-CCccEEEEEec
Confidence            56789999999999999854  6799999865533   4567789999999976  477777775543 46789999999


Q ss_pred             CCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCCCCeEEcCCCcEEEeeccCccc
Q 019650          129 ERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGM---QIIHGDIKPSNLLINGKGEVKIADFGVSRI  195 (337)
Q Consensus       129 ~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~---~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~  195 (337)
                      .|+.+..+       +......++.+++.+++.||..   +++|+|++|.||++++.+.++++||+.+..
T Consensus        76 ~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          76 EGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             CCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            88777554       5567788899999999999985   799999999999999989999999998764

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.64  E-value=8.6e-15  Score=134.23  Aligned_cols=170  Identities=19%  Similarity=0.320  Sum_probs=132.2

Q ss_pred             EEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEeccCCCCchHHhhhcCCCC
Q 019650           65 KVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLS  144 (337)
Q Consensus        65 ~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~  144 (337)
                      .|..+.++.+|.+..++.... .......+.++.++.++||+|++++..+.+ ++..|+|+|.+.  .|..++.+   +.
T Consensus        30 ~~t~k~~~~~vsVF~~~~~~~-~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~-~~~~ylvTErV~--Pl~~~lk~---l~  102 (690)
T KOG1243|consen   30 DGTRKADGGPVSVFVYKRSNG-EVTELAKRAVKRLKTLRHPNILSYLDTTEE-EGTLYLVTERVR--PLETVLKE---LG  102 (690)
T ss_pred             ccceeccCCceEEEEEeCCCc-hhhHHHHHHHHHhhhccCchhhhhhhhhcc-cCceEEEeeccc--cHHHHHHH---hH
Confidence            455667888999998887655 455667788999999999999999998766 689999999993  78888864   33


Q ss_pred             HHHHHHHHHHHHHHHHHHH-hCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCCCCCCCCCccccccccccCC
Q 019650          145 EDVISGVAYRVLKGLQYLH-GMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGT  223 (337)
Q Consensus       145 ~~~~~~i~~~l~~~l~~LH-~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  223 (337)
                      ...+..-++||+.||.+|| +.+++|++|+...|+++..|+.+|++|..+........              .......-
T Consensus       103 ~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--------------~~~~~~~~  168 (690)
T KOG1243|consen  103 KEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--------------PAKSLYLI  168 (690)
T ss_pred             HHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--------------ccccchhh
Confidence            6777778899999999997 67999999999999999999999999998865432211              00001123


Q ss_pred             CCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCC
Q 019650          224 CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGH  261 (337)
Q Consensus       224 ~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~  261 (337)
                      ..|..|+.....      .-..|.|.||+++++++.|.
T Consensus       169 ~s~~~P~~~~~s------~~s~D~~~Lg~li~el~ng~  200 (690)
T KOG1243|consen  169 ESFDDPEEIDPS------EWSIDSWGLGCLIEELFNGS  200 (690)
T ss_pred             hcccChhhcCcc------ccchhhhhHHHHHHHHhCcc
Confidence            356677666522      13579999999999999993

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.63  E-value=4.8e-16  Score=140.90  Aligned_cols=262  Identities=23%  Similarity=0.267  Sum_probs=197.3

Q ss_pred             Ccccccccccccc--CcceEEEEEEE--ccCCceEEEEEeecCCc-hHhHHHHHHHHHHHHhc-CCCCceeeeeeEEeeC
Q 019650           45 NISDLKKLTVLGH--GNGGIVYKVRH--QKSNSIYALKVLNTTSS-TIIRHQAAHEAEILKRL-DSQFIVKCHAVFYTIE  118 (337)
Q Consensus        45 ~~~~y~~~~~lg~--g~~~~v~~~~~--~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~  118 (337)
                      ....+-+.+.+|.  |.+|.+|.+.+  ..++..+|+|.-+.... ......-.+++...+.+ .|++.++.+..+.+ +
T Consensus       112 ~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~-~  190 (524)
T KOG0601|consen  112 FDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEG-S  190 (524)
T ss_pred             hhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccccc-C
Confidence            3456777888999  99999999998  78888899987443321 12222334566665655 57888887776554 7


Q ss_pred             CeEEEEEeccCCCCchHHhhhcCC-CCHHHHHHHHHHHHH----HHHHHHhCCceeccCCCCCeEEcCC-CcEEEeeccC
Q 019650          119 GEICFVMEHMERGSLFDSLRVRKK-LSEDVISGVAYRVLK----GLQYLHGMQIIHGDIKPSNLLINGK-GEVKIADFGV  192 (337)
Q Consensus       119 ~~~~lv~e~~~~~~L~~~l~~~~~-l~~~~~~~i~~~l~~----~l~~LH~~~ivH~dl~~~Nili~~~-~~~~l~Dfg~  192 (337)
                      +..++-+|++. .+|..+...... ++...++..+.+...    ||.++|..+++|-|++|.||+...+ ..++++|||.
T Consensus       191 ~~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~  269 (524)
T KOG0601|consen  191 GILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGL  269 (524)
T ss_pred             Ccceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcce
Confidence            88899999995 588888887665 888899999999999    9999999999999999999999999 8999999999


Q ss_pred             ccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchh
Q 019650          193 SRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPD  272 (337)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~  272 (337)
                      ...+.+.......         .......+...|++||.+.     +-++...|+|+||.++.+..++..++..... ..
T Consensus       270 v~~i~~~~~~~~~---------~~~~r~~~~~~Y~~ke~~~-----~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~-~~  334 (524)
T KOG0601|consen  270 VSKISDGNFSSVF---------KVSKRPEGDCIYAAKELLN-----GLATFASDIFSLGEVILEAILGSHLPSVGKN-SS  334 (524)
T ss_pred             eEEccCCccccce---------eeeecCCCCceEeChhhhc-----cccchHhhhcchhhhhHhhHhhcccccCCCC-CC
Confidence            9988776533332         1122335788999999998     4678899999999999999998766533211 11


Q ss_pred             HHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCcccccc
Q 019650          273 LMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKR  326 (337)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~  326 (337)
                      +...- .  ...+.++....+..+...+..|++.+|..|++++.++.|+++...
T Consensus       335 W~~~r-~--~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~  385 (524)
T KOG0601|consen  335 WSQLR-Q--GYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK  385 (524)
T ss_pred             ccccc-c--ccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccch
Confidence            11110 0  012233444557777889999999999999999999999998754

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.59  E-value=1.1e-15  Score=145.76  Aligned_cols=281  Identities=21%  Similarity=0.215  Sum_probs=196.2

Q ss_pred             CccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCc--hHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCC
Q 019650           42 DVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSS--TIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEG  119 (337)
Q Consensus        42 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~  119 (337)
                      .....+++.+.+.+.+|+++.++.+.-..++...++|+......  ....+....+-.+.....+|-++.....+ ....
T Consensus       799 yrsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~-~~rs  877 (1205)
T KOG0606|consen  799 YRSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSF-PCRS  877 (1205)
T ss_pred             ccCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCC-CCCC
Confidence            45678899999999999999999988777775555555432210  00001111111111112233344333322 2356


Q ss_pred             eEEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhcc
Q 019650          120 EICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEET  199 (337)
Q Consensus       120 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~  199 (337)
                      ..+++++|+.+++|...++..+..+.+-++..+..++.++.+||...+.|+|++|.|.++..+++..+.||+.....+..
T Consensus       878 P~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~  957 (1205)
T KOG0606|consen  878 PLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLI  957 (1205)
T ss_pred             CcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccc
Confidence            78999999999999999998888999999999999999999999999999999999999999999999999844333211


Q ss_pred             --ccCC-----------CCCCCCCCc----cccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCC
Q 019650          200 --RNNN-----------NHNNNNNNN----IGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHY  262 (337)
Q Consensus       200 --~~~~-----------~~~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~  262 (337)
                        ....           .........    .........+|+.|.+||.+.    +......+|+|++|+++++.++|..
T Consensus       958 ~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~l----g~~hgs~ad~~~~g~~l~e~l~g~p 1033 (1205)
T KOG0606|consen  958 PPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILL----GRRHGSAADWWSSGVCLFEVLTGIP 1033 (1205)
T ss_pred             cCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccc----cccCCCcchhhhhhhhhhhhhcCCC
Confidence              0000           000000111    112356678999999999999    5677889999999999999999999


Q ss_pred             CCCCCCCchhHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHH---HHhcCccccccCCC
Q 019650          263 PLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVE---ELLAYPFVTKRSSS  329 (337)
Q Consensus       263 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~---eil~hp~f~~~~~~  329 (337)
                      ||...........+...  ....+.-+...+...++++...+..+|.+|..+.   ++-.||||+...|.
T Consensus      1034 p~na~tpq~~f~ni~~~--~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~ 1101 (1205)
T KOG0606|consen 1034 PFNAETPQQIFENILNR--DIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDWE 1101 (1205)
T ss_pred             CCCCcchhhhhhccccC--CCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCcc
Confidence            99664333322222111  1112223445688999999999999999998877   89999999998865

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.59  E-value=1.6e-14  Score=132.55  Aligned_cols=143  Identities=21%  Similarity=0.226  Sum_probs=101.7

Q ss_pred             ccccccCcceEEEEEEEccCCceEEEEEeecCCchHhH-----------------------------H----------HH
Q 019650           52 LTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIR-----------------------------H----------QA   92 (337)
Q Consensus        52 ~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~-----------------------------~----------~~   92 (337)
                      .+.||+|++|+||+|... +|+.||||+.+........                             +          .+
T Consensus       122 ~~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf  200 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL  200 (437)
T ss_pred             CcceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence            368999999999999874 7889999998654211100                             0          12


Q ss_pred             HHHHHHHHhc----CCCCceeeeeeEEeeCCeEEEEEeccCCCCchHHhhhc-CCCCHHHHHHHHHHHHH-HHHHHHhCC
Q 019650           93 AHEAEILKRL----DSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVR-KKLSEDVISGVAYRVLK-GLQYLHGMQ  166 (337)
Q Consensus        93 ~~e~~~~~~l----~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~-~l~~LH~~~  166 (337)
                      .+|+..+.++    ++.+-+.+..++.+.....++||||++|++|.++.... ...   ....++..++. .+..+|..|
T Consensus       201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~~g  277 (437)
T TIGR01982       201 RREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLRDG  277 (437)
T ss_pred             HHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHhCC
Confidence            3344444444    33444444445544455678999999999998877532 122   23445555655 477899999


Q ss_pred             ceeccCCCCCeEEcCCCcEEEeeccCccchhc
Q 019650          167 IIHGDIKPSNLLINGKGEVKIADFGVSRIVEE  198 (337)
Q Consensus       167 ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~  198 (337)
                      ++|+|++|.||+++.+++++++|||++..+..
T Consensus       278 ~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       278 FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence            99999999999999999999999999987754

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.55  E-value=2e-14  Score=133.49  Aligned_cols=147  Identities=20%  Similarity=0.227  Sum_probs=103.5

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchH---------------------------------hHH
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTI---------------------------------IRH   90 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~---------------------------------~~~   90 (337)
                      ....+|.. +.||+|++|+||+|....+|+.||||+.+......                                 ..+
T Consensus       117 ~~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~  195 (537)
T PRK04750        117 EWFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEK  195 (537)
T ss_pred             HHHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHH
Confidence            33456777 89999999999999998889999999997542110                                 011


Q ss_pred             H------HHHHHHHHHhc----CCCCceeeeeeEEeeCCeEEEEEeccCCCCchHHh--hhcC----CCCHHHHHHHHHH
Q 019650           91 Q------AAHEAEILKRL----DSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSL--RVRK----KLSEDVISGVAYR  154 (337)
Q Consensus        91 ~------~~~e~~~~~~l----~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l--~~~~----~l~~~~~~~i~~~  154 (337)
                      .      +.+|+..+.++    .+...+.+..++.+.....++||||++|+.+.+.-  ...+    .+.+..+..++.|
T Consensus       196 ~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q  275 (537)
T PRK04750        196 TLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ  275 (537)
T ss_pred             HHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH
Confidence            1      23344444444    34455566666666567788999999999997743  2222    2333444444444


Q ss_pred             HHHHHHHHHhCCceeccCCCCCeEEcCCC----cEEEeeccCccchhc
Q 019650          155 VLKGLQYLHGMQIIHGDIKPSNLLINGKG----EVKIADFGVSRIVEE  198 (337)
Q Consensus       155 l~~~l~~LH~~~ivH~dl~~~Nili~~~~----~~~l~Dfg~~~~~~~  198 (337)
                      +       ...|++|+|++|.||+++.++    +++++|||++..+..
T Consensus       276 i-------f~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        276 V-------FRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             H-------HhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            4       469999999999999999888    999999999987754

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.55  E-value=9.7e-14  Score=112.39  Aligned_cols=140  Identities=20%  Similarity=0.234  Sum_probs=100.5

Q ss_pred             cccccccCcceEEEEEEEcc------CCceEEEEEeecCC------------c---------hHhHHHH----HHHHHHH
Q 019650           51 KLTVLGHGNGGIVYKVRHQK------SNSIYALKVLNTTS------------S---------TIIRHQA----AHEAEIL   99 (337)
Q Consensus        51 ~~~~lg~g~~~~v~~~~~~~------~~~~vaiK~~~~~~------------~---------~~~~~~~----~~e~~~~   99 (337)
                      +...||.|-.+.||.|....      .+..+|+|+++...            .         ......+    .+|+..|
T Consensus         1 ~~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L   80 (197)
T cd05146           1 INGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNL   80 (197)
T ss_pred             CCCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHH
Confidence            35689999999999998653      35789999984321            0         0112222    3789999


Q ss_pred             HhcCCC--CceeeeeeEEeeCCeEEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHH-HhCCceeccCCCCC
Q 019650          100 KRLDSQ--FIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYL-HGMQIIHGDIKPSN  176 (337)
Q Consensus       100 ~~l~~~--~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~L-H~~~ivH~dl~~~N  176 (337)
                      +++...  +++..+..     ..-++||||+.+..+..-.-....++.+....++.+++.+|..| |+.|++||||++.|
T Consensus        81 ~rl~~~Gv~vP~pi~~-----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~N  155 (197)
T cd05146          81 KRMQKAGIPCPEVVVL-----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYN  155 (197)
T ss_pred             HHHHHcCCCCCeEEEe-----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence            988554  44455542     34578999997643322111223456667788889999999998 89999999999999


Q ss_pred             eEEcCCCcEEEeeccCccch
Q 019650          177 LLINGKGEVKIADFGVSRIV  196 (337)
Q Consensus       177 ili~~~~~~~l~Dfg~~~~~  196 (337)
                      |++. ++.++++|||.+...
T Consensus       156 IL~~-~~~v~iIDF~qav~~  174 (197)
T cd05146         156 MLWH-DGKVWFIDVSQSVEP  174 (197)
T ss_pred             EEEE-CCcEEEEECCCceeC
Confidence            9997 578999999988755

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.51  E-value=1.4e-13  Score=110.56  Aligned_cols=129  Identities=20%  Similarity=0.234  Sum_probs=95.4

Q ss_pred             ccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEeccCCC
Q 019650           52 LTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERG  131 (337)
Q Consensus        52 ~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~  131 (337)
                      .+.|+.|.++.||++...  +..+++|+......  ....+..|+.+++.+.+.++++..-.+.  ...-++|||+++|.
T Consensus         3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~--~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~   76 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE--LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGS   76 (170)
T ss_pred             eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc--cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCC
Confidence            457899999999999864  67899999765432  1223567888888886655554332222  23347999999998


Q ss_pred             CchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCc-----eeccCCCCCeEEcCCCcEEEeeccCccc
Q 019650          132 SLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQI-----IHGDIKPSNLLINGKGEVKIADFGVSRI  195 (337)
Q Consensus       132 ~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~i-----vH~dl~~~Nili~~~~~~~l~Dfg~~~~  195 (337)
                      ++.+..        .....++.+++.+|+.||..++     +|||++|.||+++ ++.++++||+.+..
T Consensus        77 ~l~~~~--------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          77 ELLTED--------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             cccccc--------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            876531        1123456789999999999885     9999999999999 67899999998753

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.50  E-value=8.6e-14  Score=117.34  Aligned_cols=211  Identities=21%  Similarity=0.267  Sum_probs=143.2

Q ss_pred             HHHHHhcCCCCceeeeeeEEee----CCeEEEEEeccCCCCchHHhhh----cCCCCHHHHHHHHHHHHHHHHHHHhC--
Q 019650           96 AEILKRLDSQFIVKCHAVFYTI----EGEICFVMEHMERGSLFDSLRV----RKKLSEDVISGVAYRVLKGLQYLHGM--  165 (337)
Q Consensus        96 ~~~~~~l~~~~i~~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~~--  165 (337)
                      +..+.++-|.|+++.+.++.+.    .+...++.||+..|+|.++|++    ...+....-.+|+.||++||.|||+.  
T Consensus       118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~P  197 (458)
T KOG1266|consen  118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDP  197 (458)
T ss_pred             HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCC
Confidence            3345566788999988876543    2457899999999999999974    34688899999999999999999987  


Q ss_pred             CceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccc
Q 019650          166 QIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAG  245 (337)
Q Consensus       166 ~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~  245 (337)
                      -|+|+++..+.|++..+|-+++.--... ...........         .....--+-++|.+||.=.    ....+-.+
T Consensus       198 piihgnlTc~tifiq~ngLIkig~~ap~-s~h~s~~~~~~---------~Ek~~~~~~~g~~a~~sg~----~tn~~~a~  263 (458)
T KOG1266|consen  198 PIIHGNLTCDTIFIQHNGLIKIGSVAPD-STHPSVNSTRE---------AEKSVNTSLPGFSAPESGT----TTNTTGAS  263 (458)
T ss_pred             ccccCCcchhheeecCCceEEecccCcc-ccchhhhhhhH---------hhhhccccCCccccCCcCc----ccccccch
Confidence            5999999999999998887777532211 11111000000         0111112567899998765    34567789


Q ss_pred             cHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccc
Q 019650          246 DVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTK  325 (337)
Q Consensus       246 DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~  325 (337)
                      |||++|++..+|..+...-..............      ... .......-+.++.+|++..|..||++++++.||-.-+
T Consensus       264 dIy~fgmcAlemailEiq~tnseS~~~~ee~ia------~~i-~~len~lqr~~i~kcl~~eP~~rp~ar~llfHpllfe  336 (458)
T KOG1266|consen  264 DIYKFGMCALEMAILEIQSTNSESKVEVEENIA------NVI-IGLENGLQRGSITKCLEGEPNGRPDARLLLFHPLLFE  336 (458)
T ss_pred             hhhhhhHHHHHHHHheeccCCCcceeehhhhhh------hhe-eeccCccccCcCcccccCCCCCCcchhhhhcCceeee
Confidence            999999999999988754211111111111100      011 1111234456899999999999999999999997766


Q ss_pred             cC
Q 019650          326 RS  327 (337)
Q Consensus       326 ~~  327 (337)
                      -+
T Consensus       337 Vh  338 (458)
T KOG1266|consen  337 VH  338 (458)
T ss_pred             cc
Confidence            54

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.49  E-value=6.4e-13  Score=104.09  Aligned_cols=132  Identities=22%  Similarity=0.270  Sum_probs=99.6

Q ss_pred             cccccCcceEEEEEEEccCCceEEEEEeecCC-------chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 019650           53 TVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-------STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVM  125 (337)
Q Consensus        53 ~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~  125 (337)
                      ..+.+|+.+.++.+...  +..+++|.-....       ......+..+|+.++.+++..++....-...+ .....++|
T Consensus         2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD-~~~~~I~m   78 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVD-PDNGLIVM   78 (204)
T ss_pred             chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEc-CCCCEEEE
Confidence            46889999999999664  3346677632221       23445567789999999876655544333344 45567999


Q ss_pred             eccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccc
Q 019650          126 EHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRI  195 (337)
Q Consensus       126 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~  195 (337)
                      ||++|..|.+.+...       ...++..+-..+.-||..||+||||.++||++..+ ++.++|||++..
T Consensus        79 e~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~-~i~~IDfGLg~~  140 (204)
T COG3642          79 EYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGG-RIYFIDFGLGEF  140 (204)
T ss_pred             EEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCC-cEEEEECCcccc
Confidence            999998899898755       25677778888899999999999999999999855 499999999864

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.47  E-value=8.2e-13  Score=103.02  Aligned_cols=142  Identities=21%  Similarity=0.299  Sum_probs=108.4

Q ss_pred             cccccccCcceEEEEEEEccCCceEEEEEeecC-------CchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEE
Q 019650           51 KLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTT-------SSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICF  123 (337)
Q Consensus        51 ~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~-------~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~l  123 (337)
                      .+..+.+|+.+.|+++...  |+.++||.-...       .......+..+|++.+.++.-.+|.-..-.+.+ ...-++
T Consensus        11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D-~~~~~i   87 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFID-TYGGQI   87 (229)
T ss_pred             cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEe-cCCCeE
Confidence            6789999999999999774  777777753221       134566778899999999876666554444444 355679


Q ss_pred             EEeccCC-CCchHHhhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCC---cEEEeeccCccc
Q 019650          124 VMEHMER-GSLFDSLRVRK--KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKG---EVKIADFGVSRI  195 (337)
Q Consensus       124 v~e~~~~-~~L~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~---~~~l~Dfg~~~~  195 (337)
                      +|||++| .++.+++....  .....-...++.+|-..+.-||..+++||||..+||++.+++   .+.++|||++..
T Consensus        88 ~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   88 YMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence            9999987 37888886543  333344478999999999999999999999999999998776   358999998864

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.42  E-value=1.2e-11  Score=110.60  Aligned_cols=215  Identities=19%  Similarity=0.275  Sum_probs=155.3

Q ss_pred             cceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEee---CCeEEEEEeccCCC-Cch
Q 019650           59 NGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTI---EGEICFVMEHMERG-SLF  134 (337)
Q Consensus        59 ~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~---~~~~~lv~e~~~~~-~L~  134 (337)
                      ...+.|++....+|..|++|+++....... ...-.-.+.++++.|.|++++.+++.+.   +..+++|++|+++. +|.
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~-nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~  366 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQST-NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLY  366 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCc-ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHH
Confidence            457999999999999999999944332211 1122357788999999999999998742   35689999999864 666


Q ss_pred             HHhh---------------hcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhcc
Q 019650          135 DSLR---------------VRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEET  199 (337)
Q Consensus       135 ~~l~---------------~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~  199 (337)
                      ++--               ++...++..+|.++.||..||.++|+.|+...-|.|.+|+++.+.+++|...|....+..+
T Consensus       367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d  446 (655)
T KOG3741|consen  367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQED  446 (655)
T ss_pred             HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence            5432               2235778999999999999999999999999999999999999999999988876655332


Q ss_pred             ccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHH
Q 019650          200 RNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICA  279 (337)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~  279 (337)
                      .                          .  |-+.       -..+-|.=.||.++..|.||.---..  ...........
T Consensus       447 ~--------------------------~--~~le-------~~Qq~D~~~lG~ll~aLAt~~~ns~~--~d~~~~s~~~~  489 (655)
T KOG3741|consen  447 P--------------------------T--EPLE-------SQQQNDLRDLGLLLLALATGTENSNR--TDSTQSSHLTR  489 (655)
T ss_pred             C--------------------------C--cchh-------HHhhhhHHHHHHHHHHHhhccccccc--ccchHHHHHHH
Confidence            1                          1  1122       12367999999999999998532100  11111110111


Q ss_pred             hhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          280 ICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                              +-...+.+++++|.-+...++++ -++.+++.+
T Consensus       490 --------I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~  521 (655)
T KOG3741|consen  490 --------ITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM  521 (655)
T ss_pred             --------hhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence                    12345788999999999888877 778887764

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.32  E-value=1.5e-12  Score=118.42  Aligned_cols=251  Identities=20%  Similarity=0.167  Sum_probs=178.9

Q ss_pred             ccccccccccccCcceEEEEEEEc-cCCceEEEEEeecCCchHhHHHH-HHHHHHHHhc-CCCCceeeeeeEEeeCCeEE
Q 019650           46 ISDLKKLTVLGHGNGGIVYKVRHQ-KSNSIYALKVLNTTSSTIIRHQA-AHEAEILKRL-DSQFIVKCHAVFYTIEGEIC  122 (337)
Q Consensus        46 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~-~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~~  122 (337)
                      ..+|..+..||.|.|+.++.+.-. .++..|++|-..........+.+ ..|..+...+ -|.+++.+...+.. ....|
T Consensus       264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~-~r~~~  342 (524)
T KOG0601|consen  264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQ-LRQGY  342 (524)
T ss_pred             cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccc-ccccc
Confidence            468889999999999999997755 67778888876544322222222 2344444443 56777777776655 56677


Q ss_pred             EEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCC-CcEEEeeccCccchhcccc
Q 019650          123 FVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGK-GEVKIADFGVSRIVEETRN  201 (337)
Q Consensus       123 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~-~~~~l~Dfg~~~~~~~~~~  201 (337)
                      +=.|||.++++...+.....+++...+.+..|++.++.++|+..++|+|++|+||++..+ +..++.||++...+.... 
T Consensus       343 ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~-  421 (524)
T KOG0601|consen  343 IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSS-  421 (524)
T ss_pred             CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccceec-
Confidence            888999998877766555678999999999999999999999999999999999999876 788999999887532211 


Q ss_pred             CCCCCCCCCCccccccccccCCCCCc-CCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHh
Q 019650          202 NNNHNNNNNNNIGEAAIACMGTCAYM-SPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAI  280 (337)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~y~-aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~  280 (337)
                                      ..+....++. ..|.+..   ...+..+.|+++||.-+.+.+++...-..   ......+    
T Consensus       422 ----------------~~~~~~~r~~p~~~~~~e---~~~~~~~~~~~sl~~~~~e~~~~~~ls~~---~~~~~~i----  475 (524)
T KOG0601|consen  422 ----------------GVFHHIDRLYPIAEILLE---DYPHLSKADIFSLGLSVDEAITGSPLSES---GVQSLTI----  475 (524)
T ss_pred             ----------------ccccccccccccchhhcc---ccccccccccccccccccccccCcccCcc---cccceee----
Confidence                            1112334444 2555554   34678899999999999999998643221   1111111    


Q ss_pred             hccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccc
Q 019650          281 CFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTK  325 (337)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~  325 (337)
                       ........+.....+..+.+.+...++..|+++.++..|+=|-.
T Consensus       476 -~~~~~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~  519 (524)
T KOG0601|consen  476 -RSGDTPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR  519 (524)
T ss_pred             -ecccccCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence             11122333444588899999999999999999999998875543

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.32  E-value=9.6e-13  Score=121.42  Aligned_cols=162  Identities=22%  Similarity=0.359  Sum_probs=118.4

Q ss_pred             HHHHHHHHHh-CCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccc
Q 019650          155 VLKGLQYLHG-MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVD  233 (337)
Q Consensus       155 l~~~l~~LH~-~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  233 (337)
                      .+.|+.++|. .++||++|.|++|+++.++.+||++|+.+................     +...-..-...|.|||++.
T Consensus       108 v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~-----~lp~~~~~~~~f~apE~~~  182 (700)
T KOG2137|consen  108 VADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDP-----PLPLLLQPHLNFLAPEYLL  182 (700)
T ss_pred             ccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCC-----CCChhhccCcccccchhhc
Confidence            4499999995 589999999999999999999999999887765533311111100     1222223467899999999


Q ss_pred             cccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCC
Q 019650          234 SERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRG  312 (337)
Q Consensus       234 ~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~  312 (337)
                          +...+.++|+||+|+++|.+.. |+..+...+. .....................+++++++=+.+++..++.-||
T Consensus       183 ----~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~-~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp  257 (700)
T KOG2137|consen  183 ----GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGG-LLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRP  257 (700)
T ss_pred             ----cccccccccceeeeeEEEEEecCCcchhhccCC-cchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCc
Confidence                5678899999999999999995 6555544322 222222222222223345577899999999999999999999


Q ss_pred             CHHHHhcCcccccc
Q 019650          313 TVEELLAYPFVTKR  326 (337)
Q Consensus       313 s~~eil~hp~f~~~  326 (337)
                      ++..++..|||+..
T Consensus       258 ~~~~l~~~~ff~D~  271 (700)
T KOG2137|consen  258 TLDLLLSIPFFSDP  271 (700)
T ss_pred             chhhhhcccccCCc
Confidence            99999999999864

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.31  E-value=2.6e-11  Score=101.75  Aligned_cols=142  Identities=22%  Similarity=0.283  Sum_probs=104.9

Q ss_pred             ccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCC--ceeeeeeEEeeC--CeEEEEEec
Q 019650           52 LTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQF--IVKCHAVFYTIE--GEICFVMEH  127 (337)
Q Consensus        52 ~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~--i~~~~~~~~~~~--~~~~lv~e~  127 (337)
                      .+.|+.|.++.+|++...+ |..+++|+............+.+|..+++.+.+.+  +.+++.......  +..++|||+
T Consensus         3 ~~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~   81 (223)
T cd05154           3 VRQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMER   81 (223)
T ss_pred             ceecCCCccceEEEEEecC-CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEE
Confidence            3678999999999998743 57899999765432223456788999999987644  455555433211  256899999


Q ss_pred             cCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHh-------------------------------------------
Q 019650          128 MERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG-------------------------------------------  164 (337)
Q Consensus       128 ~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~-------------------------------------------  164 (337)
                      ++|.++.+.+.. ..++......++.+++.+|+.||+                                           
T Consensus        82 i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (223)
T cd05154          82 VDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL  160 (223)
T ss_pred             eCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence            999888776532 456777777788888888888873                                           


Q ss_pred             -------------CCceeccCCCCCeEEcC--CCcEEEeeccCccc
Q 019650          165 -------------MQIIHGDIKPSNLLING--KGEVKIADFGVSRI  195 (337)
Q Consensus       165 -------------~~ivH~dl~~~Nili~~--~~~~~l~Dfg~~~~  195 (337)
                                   ..++|||+++.||+++.  ++.+.++||+.+..
T Consensus       161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                         23689999999999998  56789999998754

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.30  E-value=8.6e-11  Score=100.57  Aligned_cols=140  Identities=18%  Similarity=0.087  Sum_probs=98.4

Q ss_pred             ccccCcceEEEEEEEccCCceEEEEEeecCCchHhHH----------HHHHHHHHHHhcCCCCce--eeeeeEEee----
Q 019650           54 VLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRH----------QAAHEAEILKRLDSQFIV--KCHAVFYTI----  117 (337)
Q Consensus        54 ~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~----------~~~~e~~~~~~l~~~~i~--~~~~~~~~~----  117 (337)
                      .+.......|.++..  .|+.+.+|...........+          .+.+|...+.++...+|.  ..+......    
T Consensus        29 ~v~~~~~rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~  106 (268)
T PRK15123         29 VFRELEGRRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA  106 (268)
T ss_pred             EEecCCCceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence            344444445666644  46789999774433111111          366888888888444433  333333221    


Q ss_pred             CCeEEEEEeccCCC-CchHHhhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcC-------CCcEEE
Q 019650          118 EGEICFVMEHMERG-SLFDSLRV--RKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLING-------KGEVKI  187 (337)
Q Consensus       118 ~~~~~lv~e~~~~~-~L~~~l~~--~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~-------~~~~~l  187 (337)
                      ...-++|||++++. +|.+++..  ..+.+......++.+++..++.||+.|++|+|++++|||++.       +..+.+
T Consensus       107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~L  186 (268)
T PRK15123        107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSV  186 (268)
T ss_pred             cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEE
Confidence            12468999999876 79888863  345667788899999999999999999999999999999975       358999


Q ss_pred             eeccCccc
Q 019650          188 ADFGVSRI  195 (337)
Q Consensus       188 ~Dfg~~~~  195 (337)
                      +||+.+..
T Consensus       187 IDl~r~~~  194 (268)
T PRK15123        187 IDLHRAQI  194 (268)
T ss_pred             EECCcccc
Confidence            99998753

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.24  E-value=1.2e-10  Score=94.06  Aligned_cols=126  Identities=28%  Similarity=0.282  Sum_probs=81.5

Q ss_pred             EEEEEEEccCCceEEEEEeecCC-------------------------chHhHHHHHHHHHHHHhcCCCC--ceeeeeeE
Q 019650           62 IVYKVRHQKSNSIYALKVLNTTS-------------------------STIIRHQAAHEAEILKRLDSQF--IVKCHAVF  114 (337)
Q Consensus        62 ~v~~~~~~~~~~~vaiK~~~~~~-------------------------~~~~~~~~~~e~~~~~~l~~~~--i~~~~~~~  114 (337)
                      .||.|.. .++..+|+|+.+...                         .........+|.+.|.++...+  ++..+.. 
T Consensus         1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-   78 (188)
T PF01163_consen    1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-   78 (188)
T ss_dssp             EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE-
T ss_pred             CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE-
Confidence            3788877 456789999984321                         1122344568999999998765  4444432 


Q ss_pred             EeeCCeEEEEEeccC--CCCchHHhhhcCCCCHHHHHHHHHHHHHHHHH-HHhCCceeccCCCCCeEEcCCCcEEEeecc
Q 019650          115 YTIEGEICFVMEHME--RGSLFDSLRVRKKLSEDVISGVAYRVLKGLQY-LHGMQIIHGDIKPSNLLINGKGEVKIADFG  191 (337)
Q Consensus       115 ~~~~~~~~lv~e~~~--~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~-LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg  191 (337)
                       .   .-++||||++  |..+..+...  .++.+....++.+++..+.. +|..|++|||+++.||+++++ .+.++|||
T Consensus        79 -~---~~~ivME~I~~~G~~~~~l~~~--~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~  151 (188)
T PF01163_consen   79 -N---RNVIVMEYIGEDGVPLPRLKDV--DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFG  151 (188)
T ss_dssp             -E---TTEEEEE--EETTEEGGCHHHC--GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GT
T ss_pred             -e---CCEEEEEecCCCccchhhHHhc--cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecC
Confidence             1   2359999998  5455443321  12245567777788885554 689999999999999999977 99999999


Q ss_pred             Cccch
Q 019650          192 VSRIV  196 (337)
Q Consensus       192 ~~~~~  196 (337)
                      .+...
T Consensus       152 qav~~  156 (188)
T PF01163_consen  152 QAVDS  156 (188)
T ss_dssp             TEEET
T ss_pred             cceec
Confidence            88654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.23  E-value=5.3e-10  Score=98.02  Aligned_cols=242  Identities=16%  Similarity=0.183  Sum_probs=155.6

Q ss_pred             cccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhc-CCCCcee--------eeeeEEeeCCeE
Q 019650           51 KLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRL-DSQFIVK--------CHAVFYTIEGEI  121 (337)
Q Consensus        51 ~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~--------~~~~~~~~~~~~  121 (337)
                      ..+.||+|+.+.+|..-..   ...+.|++.........    +....+... .||-+-.        ++|-  ..+..+
T Consensus        15 ~gr~LgqGgea~ly~l~e~---~d~VAKIYh~Pppa~~a----qk~a~la~~p~~p~~~~rvaWPqa~L~G~--~~~~~i   85 (637)
T COG4248          15 PGRPLGQGGEADLYTLGEV---RDQVAKIYHAPPPAAQA----QKVAELAATPDAPLLNYRVAWPQATLHGG--RRGKVI   85 (637)
T ss_pred             CCccccCCccceeeecchh---hchhheeecCCCchHHH----HHHHHhccCCCCcchhhhhcccHHHhhCC--Ccccee
Confidence            4568999999999986443   23467888765432211    122223322 3332211        1221  112237


Q ss_pred             EEEEeccCCC-CchHHhh------hcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCcc
Q 019650          122 CFVMEHMERG-SLFDSLR------VRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSR  194 (337)
Q Consensus       122 ~lv~e~~~~~-~L~~~l~------~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~  194 (337)
                      .++|+.++|. .+.++..      ..+...+.....+...|+.+.+.||..|.+-||++++|+|+++++.+.|+|=+...
T Consensus        86 GflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq  165 (637)
T COG4248          86 GFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQ  165 (637)
T ss_pred             EEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEccccee
Confidence            7899998775 3333332      22457899999999999999999999999999999999999999999999866544


Q ss_pred             chhccccCCCCCCCCCCccccccccccCCCCCcCCcccc-cccCCCCCCccccHHHHHHHHHHHHhC-CCCCCCCCCch-
Q 019650          195 IVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVD-SERWGGDYGFAGDVWSLGVVVLECLVG-HYPLIGFGEKP-  271 (337)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~~~~~DiwslG~il~~l~tg-~~pf~~~~~~~-  271 (337)
                      .....               .....-+|...|.+||.-. ..-.+..-+..+|.|.||+++++|+.| ++||.+..... 
T Consensus       166 i~~ng---------------~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~  230 (637)
T COG4248         166 INANG---------------TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISD  230 (637)
T ss_pred             eccCC---------------ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCC
Confidence            33211               3334447899999999776 222245567899999999999999985 99997643221 


Q ss_pred             ---hHHHHHHHh--------hccCCC---C-CCCCCCHHHHHHHHHHhhc--CcCCCCCHHH
Q 019650          272 ---DLMALICAI--------CFGERL---E-MPETASPEFRRFVRSCLEK--DWRKRGTVEE  316 (337)
Q Consensus       272 ---~~~~~~~~~--------~~~~~~---~-~~~~~~~~~~~li~~~l~~--~p~~R~s~~e  316 (337)
                         .....+...        ..+..+   . ...-+++.+..+..+|+..  ++.-|||++.
T Consensus       231 ap~p~E~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a  292 (637)
T COG4248         231 APNPLETDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA  292 (637)
T ss_pred             CCCcchhhhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence               111011000        000000   0 1123567899999999875  4567998764

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=99.18  E-value=4.1e-10  Score=93.70  Aligned_cols=137  Identities=23%  Similarity=0.255  Sum_probs=103.5

Q ss_pred             cccccccccCcceEEEEEEEccCCceEEEEEeecCC-------------------c--hHhHHHHHHHHHHHHhcCCC--
Q 019650           49 LKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-------------------S--TIIRHQAAHEAEILKRLDSQ--  105 (337)
Q Consensus        49 y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-------------------~--~~~~~~~~~e~~~~~~l~~~--  105 (337)
                      ..++..||.|-.|.||.|.+. .|.++|+|+-+...                   +  ........+|.+.|.++...  
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~  171 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV  171 (304)
T ss_pred             HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence            456678999999999999885 67889999863321                   1  12233456799999998655  


Q ss_pred             CceeeeeeEEeeCCeEEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcE
Q 019650          106 FIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEV  185 (337)
Q Consensus       106 ~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~  185 (337)
                      .+...++.     +.-++|||+++|..|...-     ++.+....++..|+.-+..+-..|+||||+++-||+++++|.+
T Consensus       172 ~VP~P~~~-----nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~  241 (304)
T COG0478         172 KVPKPIAW-----NRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDI  241 (304)
T ss_pred             CCCCcccc-----ccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCE
Confidence            55555553     4456999999986654432     2566667777778888887779999999999999999999999


Q ss_pred             EEeeccCccch
Q 019650          186 KIADFGVSRIV  196 (337)
Q Consensus       186 ~l~Dfg~~~~~  196 (337)
                      .++||--+...
T Consensus       242 ~vIDwPQ~v~~  252 (304)
T COG0478         242 VVIDWPQAVPI  252 (304)
T ss_pred             EEEeCcccccC
Confidence            99999766543

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.13  E-value=6.8e-10  Score=91.93  Aligned_cols=108  Identities=22%  Similarity=0.233  Sum_probs=84.8

Q ss_pred             HHHHHHHHHHHHhcCCCC--ceeeeeeEEeeC---CeEEEEEeccCCC-CchHHhhhcCCCCHHHHHHHHHHHHHHHHHH
Q 019650           89 RHQAAHEAEILKRLDSQF--IVKCHAVFYTIE---GEICFVMEHMERG-SLFDSLRVRKKLSEDVISGVAYRVLKGLQYL  162 (337)
Q Consensus        89 ~~~~~~e~~~~~~l~~~~--i~~~~~~~~~~~---~~~~lv~e~~~~~-~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~L  162 (337)
                      .....+|...+..+...+  .+..+.......   ...++|+|++++. +|.+++......+......++.+++..++-|
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~l  134 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKL  134 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHH
Confidence            345667888777774433  444455443321   2358999999875 8999998766688888999999999999999


Q ss_pred             HhCCceeccCCCCCeEEcCCC---cEEEeeccCccch
Q 019650          163 HGMQIIHGDIKPSNLLINGKG---EVKIADFGVSRIV  196 (337)
Q Consensus       163 H~~~ivH~dl~~~Nili~~~~---~~~l~Dfg~~~~~  196 (337)
                      |+.|++|+|+++.|||++.++   .+.++||+.+...
T Consensus       135 H~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  135 HDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            999999999999999999887   8999999977643

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PRK09902 hypothetical protein; Provisional

Probab=99.06  E-value=4.6e-09  Score=85.42  Aligned_cols=139  Identities=17%  Similarity=0.124  Sum_probs=100.1

Q ss_pred             ccCcceEEEEEEEccCCceEEEEEeecCC-----chHhHHHHHHHHHHHHhcCCCCce--eeeeeEEee---CCeEEEEE
Q 019650           56 GHGNGGIVYKVRHQKSNSIYALKVLNTTS-----STIIRHQAAHEAEILKRLDSQFIV--KCHAVFYTI---EGEICFVM  125 (337)
Q Consensus        56 g~g~~~~v~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~~e~~~~~~l~~~~i~--~~~~~~~~~---~~~~~lv~  125 (337)
                      |+|+.|.|++....  |..+-+|......     ......-+.+|+..+.++...++.  +........   ....+||+
T Consensus        27 ~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT  104 (216)
T PRK09902         27 RRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT  104 (216)
T ss_pred             CCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence            56899999997654  3358888764111     022345678888888888544333  333111111   12357999


Q ss_pred             eccCC-CCchHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCc--EEEeeccCccch
Q 019650          126 EHMER-GSLFDSLRVR--KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGE--VKIADFGVSRIV  196 (337)
Q Consensus       126 e~~~~-~~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~--~~l~Dfg~~~~~  196 (337)
                      |-++| .+|.+++.+.  .+.+......++.+++.+++-||+.|+.|+|+-+.||+++.++.  +.++||.-++..
T Consensus       105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~~  180 (216)
T PRK09902        105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRRR  180 (216)
T ss_pred             EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccchh
Confidence            98864 3899988653  35678888999999999999999999999999999999986776  999999977654

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.93  E-value=3.1e-08  Score=80.94  Aligned_cols=137  Identities=18%  Similarity=0.230  Sum_probs=88.6

Q ss_pred             cccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHH---------HHHHHHHHHhcCCC---CceeeeeeE
Q 019650           47 SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQ---------AAHEAEILKRLDSQ---FIVKCHAVF  114 (337)
Q Consensus        47 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~---------~~~e~~~~~~l~~~---~i~~~~~~~  114 (337)
                      ++|++.+.+.......|.+..-  ++..+++|..+..... ....         ..+.+..+.++...   ....++.+.
T Consensus        31 ~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r-~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~  107 (229)
T PF06176_consen   31 NNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRR-PERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA  107 (229)
T ss_pred             CCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhh-HHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence            5777778888877777777754  4678999988654311 1111         22334444444322   222222222


Q ss_pred             Eee----CCeEEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeec
Q 019650          115 YTI----EGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADF  190 (337)
Q Consensus       115 ~~~----~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Df  190 (337)
                      .-.    ....+++|||++|..|.+...    +++    .+.-.+.+++..||+.|++|||.+|.|++++++ .++++||
T Consensus       108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~i~iID~  178 (229)
T PF06176_consen  108 EKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-GIRIIDT  178 (229)
T ss_pred             eeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-cEEEEEC
Confidence            111    123568999999988876642    333    244567788999999999999999999999955 5999999


Q ss_pred             cCccc
Q 019650          191 GVSRI  195 (337)
Q Consensus       191 g~~~~  195 (337)
                      +....
T Consensus       179 ~~k~~  183 (229)
T PF06176_consen  179 QGKRM  183 (229)
T ss_pred             ccccc
Confidence            87653

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.88  E-value=3e-08  Score=91.99  Aligned_cols=141  Identities=17%  Similarity=0.242  Sum_probs=97.2

Q ss_pred             cccccCcceEEEEEEEccCCceEEEEEeecCCchH-----------------------------hHHH----------HH
Q 019650           53 TVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTI-----------------------------IRHQ----------AA   93 (337)
Q Consensus        53 ~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-----------------------------~~~~----------~~   93 (337)
                      ..|+.++-|+||+|... +|+.||||+.+..-.+.                             ..++          +.
T Consensus       131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            68999999999999985 58999999984432110                             0011          22


Q ss_pred             HHHHHHHhc----CCCCceeeeeeEEeeCCeEEEEEeccCCCCchHHh--hhcCCCCHHHHHHHHHHHHHH-HHHHHhCC
Q 019650           94 HEAEILKRL----DSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSL--RVRKKLSEDVISGVAYRVLKG-LQYLHGMQ  166 (337)
Q Consensus        94 ~e~~~~~~l----~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l--~~~~~l~~~~~~~i~~~l~~~-l~~LH~~~  166 (337)
                      +|...+.++    +...-+.+-.++++..+...++|||++|..+.+..  .. ...+.+.+..   .++.+ +..+-..|
T Consensus       210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~---~~~~~f~~q~~~dg  285 (517)
T COG0661         210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAE---LLVRAFLRQLLRDG  285 (517)
T ss_pred             HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHH---HHHHHHHHHHHhcC
Confidence            344443333    34445556666666567788999999999888884  33 3355333333   23322 33344589


Q ss_pred             ceeccCCCCCeEEcCCCcEEEeeccCccchhc
Q 019650          167 IIHGDIKPSNLLINGKGEVKIADFGVSRIVEE  198 (337)
Q Consensus       167 ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~  198 (337)
                      ++|+|.+|.||+++.+|++.+.|||+...+.+
T Consensus       286 ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         286 FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            99999999999999999999999999887764

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.76  E-value=1.4e-07  Score=77.99  Aligned_cols=137  Identities=23%  Similarity=0.278  Sum_probs=92.4

Q ss_pred             cccccCcceEEEEEEEccCCceEEEEEeecCCchH------------------hHHH-----HHHHHHHHHhcCCCC--c
Q 019650           53 TVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTI------------------IRHQ-----AAHEAEILKRLDSQF--I  107 (337)
Q Consensus        53 ~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~------------------~~~~-----~~~e~~~~~~l~~~~--i  107 (337)
                      ..|+.|-.+.||+|.. .++..+|+|+++......                  ...+     ...|+..|+++...+  +
T Consensus        54 g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv  132 (268)
T COG1718          54 GCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV  132 (268)
T ss_pred             eeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence            3778888899999975 567889999985432110                  0111     234677777775444  3


Q ss_pred             eeeeeeEEeeCCeEEEEEeccCCCC-chHHhhhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCeEEcCCCcE
Q 019650          108 VKCHAVFYTIEGEICFVMEHMERGS-LFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG-MQIIHGDIKPSNLLINGKGEV  185 (337)
Q Consensus       108 ~~~~~~~~~~~~~~~lv~e~~~~~~-L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~-~~ivH~dl~~~Nili~~~~~~  185 (337)
                      .+.+..     ..-.+|||++...- -.=.|.. -++..+++..+..++++.+.-|-. .++|||||+.=|||+. ++.+
T Consensus       133 P~Pi~~-----~~nVLvMEfIg~~g~pAP~LkD-v~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p  205 (268)
T COG1718         133 PEPIAF-----RNNVLVMEFIGDDGLPAPRLKD-VPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEP  205 (268)
T ss_pred             CCceee-----cCCeEEEEeccCCCCCCCCccc-CCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeE
Confidence            333332     23458999995421 0001111 123444788888999999988887 8999999999999999 8899


Q ss_pred             EEeeccCccchh
Q 019650          186 KIADFGVSRIVE  197 (337)
Q Consensus       186 ~l~Dfg~~~~~~  197 (337)
                      .++|++-+....
T Consensus       206 ~iID~~QaV~~~  217 (268)
T COG1718         206 YIIDVSQAVTID  217 (268)
T ss_pred             EEEECccccccC
Confidence            999999887553

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.72  E-value=2.9e-07  Score=77.21  Aligned_cols=134  Identities=17%  Similarity=0.213  Sum_probs=80.9

Q ss_pred             ccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCc--eeeeeeEEeeCCeEEEEEeccC
Q 019650           52 LTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFI--VKCHAVFYTIEGEICFVMEHME  129 (337)
Q Consensus        52 ~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i--~~~~~~~~~~~~~~~lv~e~~~  129 (337)
                      ...|+.|..+.||+..    +..+++|......   ......+|.++++.+...++  .+.+.+... .....+||++++
T Consensus         6 ~~~i~~G~t~~~y~~~----~~~~VlR~~~~~~---~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~-~~~~glv~e~i~   77 (226)
T TIGR02172         6 WTQTGEGGNGESYTHK----TGKWMLKLYNPGF---DKETIKREFDASRKVFSLGIPTPHPFDLVED-GGRLGLIYELIV   77 (226)
T ss_pred             heeecCCCCcceeEec----CCCEEEEeCCCCC---CHHHHHHHHHHHHHHHHcCCCCCceEEEEec-CCeeeeeeeecC
Confidence            4688999999999842    4457889876533   23446789999988865544  445554433 566788999999


Q ss_pred             CCC-chHHhh---------------------hc--CCCCHHH-HHHHHH----------HHHHH-HHHHH----hCCcee
Q 019650          130 RGS-LFDSLR---------------------VR--KKLSEDV-ISGVAY----------RVLKG-LQYLH----GMQIIH  169 (337)
Q Consensus       130 ~~~-L~~~l~---------------------~~--~~l~~~~-~~~i~~----------~l~~~-l~~LH----~~~ivH  169 (337)
                      |.+ +...+.                     ..  ....... ...+-.          .+... ..+|.    ...++|
T Consensus        78 G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~H  157 (226)
T TIGR02172        78 GKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLH  157 (226)
T ss_pred             CccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEe
Confidence            863 211111                     00  0001000 000000          01111 11222    124789


Q ss_pred             ccCCCCCeEEcCCCcEEEeeccCcc
Q 019650          170 GDIKPSNLLINGKGEVKIADFGVSR  194 (337)
Q Consensus       170 ~dl~~~Nili~~~~~~~l~Dfg~~~  194 (337)
                      ||++|.||++++++ +.++||+.+.
T Consensus       158 gD~~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       158 GDFQIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             cCCCCCcEEEcCCC-cEEEechhcC
Confidence            99999999999888 9999999875

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.68  E-value=2.8e-07  Score=72.19  Aligned_cols=133  Identities=24%  Similarity=0.237  Sum_probs=97.8

Q ss_pred             cccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEe
Q 019650           47 SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVME  126 (337)
Q Consensus        47 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~e  126 (337)
                      ....+.+.|+.|.+|.||+|.+.  +..+|+|+-+.+.   ....+..|++++..+...++.+-+-.+.    ..++.||
T Consensus        22 ~~~~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~ds---~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me   92 (201)
T COG2112          22 YELRVEKELAKGTTSVVYLGEWR--GGEVALKVRRRDS---PRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRME   92 (201)
T ss_pred             hhhhhhhhhhcccccEEEEeecc--CceEEEEEecCCc---chhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhh
Confidence            34556788999999999999875  5589999876654   3466778999999998888777544332    2346699


Q ss_pred             ccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCC-CCCeEEcCCCcEEEeeccCccc
Q 019650          127 HMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIK-PSNLLINGKGEVKIADFGVSRI  195 (337)
Q Consensus       127 ~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~-~~Nili~~~~~~~l~Dfg~~~~  195 (337)
                      |+.|-.|.++-...   +    ++-+..++....-|...||-|+.|+ |...++..++.+.|+||..+..
T Consensus        93 ~i~G~~L~~~~~~~---~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112          93 YIDGRPLGKLEIGG---D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             hhcCcchhhhhhcc---c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            99987776665421   2    3344456677667888999999996 5555565566999999998873

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.65  E-value=3.4e-07  Score=77.29  Aligned_cols=139  Identities=24%  Similarity=0.306  Sum_probs=80.4

Q ss_pred             ccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCc--eeeeeeEE--eeCCeEEEEEec
Q 019650           52 LTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFI--VKCHAVFY--TIEGEICFVMEH  127 (337)
Q Consensus        52 ~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i--~~~~~~~~--~~~~~~~lv~e~  127 (337)
                      ++.++.|..+.||++....  ..+++|+....   .....+.+|..+++.+...++  ..++....  ......+++|++
T Consensus         2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~---~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~   76 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP---DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEY   76 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT--SEEEEEEESSH---HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEE
T ss_pred             CccCCCCCeeeEEEEEECC--cEEEEEEeCCC---CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEE
Confidence            4678999999999998765  47899987543   345667778888888754443  34444221  123457899999


Q ss_pred             cCCCCchH----------------Hhh---hc----CCCCHHH---------HH-----HH-------HHHHHH-HHHHH
Q 019650          128 MERGSLFD----------------SLR---VR----KKLSEDV---------IS-----GV-------AYRVLK-GLQYL  162 (337)
Q Consensus       128 ~~~~~L~~----------------~l~---~~----~~l~~~~---------~~-----~i-------~~~l~~-~l~~L  162 (337)
                      ++|.++..                .+.   ..    ..+....         ..     ..       ...+.. .+..+
T Consensus        77 i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (239)
T PF01636_consen   77 IPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQEL  156 (239)
T ss_dssp             ESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHH
T ss_pred             eccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHH
Confidence            99877766                111   11    0001000         00     00       111222 23333


Q ss_pred             H-------hCCceeccCCCCCeEEc-CCCcEEEeeccCccc
Q 019650          163 H-------GMQIIHGDIKPSNLLIN-GKGEVKIADFGVSRI  195 (337)
Q Consensus       163 H-------~~~ivH~dl~~~Nili~-~~~~~~l~Dfg~~~~  195 (337)
                      +       ...++|||+.+.||+++ .++.+.|+||+.+..
T Consensus       157 ~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~  197 (239)
T PF01636_consen  157 EALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW  197 (239)
T ss_dssp             HHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred             HhhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence            3       24699999999999999 556678999998753

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.62  E-value=5.8e-07  Score=83.32  Aligned_cols=143  Identities=16%  Similarity=0.232  Sum_probs=94.3

Q ss_pred             cccccccCcceEEEEEEEccCCceEEEEEeecCCchH------------------------------hHHH------HHH
Q 019650           51 KLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTI------------------------------IRHQ------AAH   94 (337)
Q Consensus        51 ~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~------------------------------~~~~------~~~   94 (337)
                      --+.|+..+.++||+|.... |..||+|+-+..-...                              ..+.      |.+
T Consensus       165 ~~~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~  243 (538)
T KOG1235|consen  165 DEEPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTK  243 (538)
T ss_pred             CcchhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHH
Confidence            34689999999999999865 9999999975532111                              0011      122


Q ss_pred             HHHHHH----hcCCCC---ceeeeeeEEeeCCeEEEEEeccCCCCchHHh--hhcCCCCHHHHHHHHHHHHHHHH-HHHh
Q 019650           95 EAEILK----RLDSQF---IVKCHAVFYTIEGEICFVMEHMERGSLFDSL--RVRKKLSEDVISGVAYRVLKGLQ-YLHG  164 (337)
Q Consensus        95 e~~~~~----~l~~~~---i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l--~~~~~l~~~~~~~i~~~l~~~l~-~LH~  164 (337)
                      |++...    .++|-+   -+.+-.++++......++|||++|..+.|.-  .+. .++..   .++..+.++.. .|=.
T Consensus       244 EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~-gi~~~---~i~~~l~~~~~~qIf~  319 (538)
T KOG1235|consen  244 EAKNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKR-GISPH---DILNKLVEAYLEQIFK  319 (538)
T ss_pred             HHHhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHc-CCCHH---HHHHHHHHHHHHHHHh
Confidence            332222    234444   2334555555566788999999998776654  333 35555   44444555433 3346


Q ss_pred             CCceeccCCCCCeEEcC----CCcEEEeeccCccchhc
Q 019650          165 MQIIHGDIKPSNLLING----KGEVKIADFGVSRIVEE  198 (337)
Q Consensus       165 ~~ivH~dl~~~Nili~~----~~~~~l~Dfg~~~~~~~  198 (337)
                      .|++|+|-+|.||++++    ++.+.+.|||+...+..
T Consensus       320 ~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  320 TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             cCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            78999999999999984    56899999999877654

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.60  E-value=2.6e-07  Score=90.82  Aligned_cols=241  Identities=18%  Similarity=0.232  Sum_probs=161.0

Q ss_pred             cccCcceEEEEEEEcc----CCceEEEEE--eecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCC---eEEEEE
Q 019650           55 LGHGNGGIVYKVRHQK----SNSIYALKV--LNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEG---EICFVM  125 (337)
Q Consensus        55 lg~g~~~~v~~~~~~~----~~~~vaiK~--~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~---~~~lv~  125 (337)
                      +..-.+|+++...+..    ....+-++.  +..............|+..+.++.|+|+..++.+..+...   ...+..
T Consensus       186 ls~~~~~~l~l~k~~~~~qs~~~~~~~s~~~~~~~~~k~~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~  265 (1351)
T KOG1035|consen  186 LSHLTQGTLLLVKWVEQAQSLSEPIEISHDYESTPCGKKEIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQ  265 (1351)
T ss_pred             eccccCceEEEEehhhhHHhhcCcccccCcccCccchHHHHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHH
Confidence            6666677777766531    111111111  1111122233444567788889999999999887665321   123456


Q ss_pred             eccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCC---CeEEcCCCcEEEe--eccCccchhccc
Q 019650          126 EHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPS---NLLINGKGEVKIA--DFGVSRIVEETR  200 (337)
Q Consensus       126 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~---Nili~~~~~~~l~--Dfg~~~~~~~~~  200 (337)
                      +++...++...++.-...+....+.+..++.++|+++|+....|.-+..+   +.-.+..+.+.++  ||+.+.......
T Consensus       266 ~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~  345 (1351)
T KOG1035|consen  266 EICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNE  345 (1351)
T ss_pred             hhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhccceeEEecccccccccCccceeecchhhhcccccCCCcc
Confidence            78888899999998889999999999999999999999997666666655   4444555666666  888877665442


Q ss_pred             cCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHh
Q 019650          201 NNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAI  280 (337)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~  280 (337)
                      .               ......+..+.++|.....  ........|+|++|.+...+..+..+-..   ..    .    
T Consensus       346 ~---------------~~~~~~~~~~~~~e~~~~~--~~~~~r~~dL~~lgll~~~~~~~~~i~~~---~~----~----  397 (1351)
T KOG1035|consen  346 K---------------SFSDLLAEIRNADEDLKEN--TAKKSRLTDLWCLGLLLLQLSQGEDISEK---SA----V----  397 (1351)
T ss_pred             c---------------chhhcCccccccccccccc--cchhhhhhHHHHHHHHHhhhhhcCccccc---cc----c----
Confidence            2               2222456678888888754  23445567999999999999887644211   00    0    


Q ss_pred             hccCCCCCCC-CCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccC
Q 019650          281 CFGERLEMPE-TASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRS  327 (337)
Q Consensus       281 ~~~~~~~~~~-~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~  327 (337)
                          ...+.+ .......+...+|+..++++|+++.+++.|||.+-..
T Consensus       398 ----~~~~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~~  441 (1351)
T KOG1035|consen  398 ----PVSLLDVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFPT  441 (1351)
T ss_pred             ----hhhhhccccchhhhhhhhhhcchhhhhccchhhhhhchhccccc
Confidence                111111 1222788899999999999999999999999987554

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.44  E-value=3.2e-06  Score=72.00  Aligned_cols=135  Identities=15%  Similarity=0.121  Sum_probs=79.3

Q ss_pred             cccccCcc-eEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCC-CCceeeeeeEEeeCCeEEEEEeccCC
Q 019650           53 TVLGHGNG-GIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDS-QFIVKCHAVFYTIEGEICFVMEHMER  130 (337)
Q Consensus        53 ~~lg~g~~-~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~-~~i~~~~~~~~~~~~~~~lv~e~~~~  130 (337)
                      ..|..|.. ..||++...  +..+++|+.....    .....+|+.+++.+.. ..+.+++..... .+..++||++++|
T Consensus         4 ~~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~-~~~~~lv~e~i~G   76 (244)
T cd05150           4 ERVTEGQSGATVYRLDGK--NPGLYLKIAPSGP----TYELEREAERLRWLAGKLPVPEVIDYGSD-DGRAWLLTSAVPG   76 (244)
T ss_pred             eecCCCCCcCeEEEEcCC--CCcEEEEecCCCc----ccchHHHHHHHHHHHhcCCCCeEEEEEec-CCccEEEEEeeCC
Confidence            34555655 788998653  3578888875432    2345668888887743 334455554433 3567899999998


Q ss_pred             CCchHHhh-------------------hcC----CCCHH--HHHHHHH--------------------HHHHHHHHHH--
Q 019650          131 GSLFDSLR-------------------VRK----KLSED--VISGVAY--------------------RVLKGLQYLH--  163 (337)
Q Consensus       131 ~~L~~~l~-------------------~~~----~l~~~--~~~~i~~--------------------~l~~~l~~LH--  163 (337)
                      .+|.....                   ..+    ++...  .......                    .+...+..|-  
T Consensus        77 ~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  156 (244)
T cd05150          77 VPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEAT  156 (244)
T ss_pred             ccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhh
Confidence            77654320                   000    11100  0000000                    0111122221  


Q ss_pred             -----hCCceeccCCCCCeEEcCCCcEEEeeccCcc
Q 019650          164 -----GMQIIHGDIKPSNLLINGKGEVKIADFGVSR  194 (337)
Q Consensus       164 -----~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~  194 (337)
                           ...++|||+.|.||+++.++.+.|+||+.+.
T Consensus       157 ~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         157 RPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             CCCcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence                 2348999999999999987778899999774

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.28  E-value=4e-06  Score=68.09  Aligned_cols=100  Identities=21%  Similarity=0.253  Sum_probs=80.6

Q ss_pred             HHHHHHHhcCC-CCceeeeeeEEeeCCeEEEEEeccCCCCchH---HhhhcCCCCHHHHHHHHHHHHHHHHHHHh---CC
Q 019650           94 HEAEILKRLDS-QFIVKCHAVFYTIEGEICFVMEHMERGSLFD---SLRVRKKLSEDVISGVAYRVLKGLQYLHG---MQ  166 (337)
Q Consensus        94 ~e~~~~~~l~~-~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~---~l~~~~~l~~~~~~~i~~~l~~~l~~LH~---~~  166 (337)
                      .|..+++.+.+ +++++++|.+..     +++.|+...+++..   .+......++..+.+++.+++..+.+|+.   ..
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~CG~-----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSCGR-----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeECCC-----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            47888888876 689999998743     47999997665542   12222357899999999999999999997   45


Q ss_pred             ceeccCCCCCeEEcCCCcEEEeeccCccchhc
Q 019650          167 IIHGDIKPSNLLINGKGEVKIADFGVSRIVEE  198 (337)
Q Consensus       167 ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~  198 (337)
                      +...|++++|+-++.+++++++|.+.+.....
T Consensus        83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~~~  114 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVEDK  114 (188)
T ss_pred             EEEeecchHHeEEeCCCcEEEEechhcchhHH
Confidence            88899999999999999999999998776654

Proteins in this uncharacterised family are described as transmembrane proteins.

>PLN02876 acyl-CoA dehydrogenase

Probab=98.28  E-value=1.5e-05  Score=79.68  Aligned_cols=82  Identities=17%  Similarity=0.265  Sum_probs=54.0

Q ss_pred             ccccccCcceEEEEEEEccCC--ceEEEEEeecCCchHhHHHHHHHHHHHHhcC-CCCc--eeeeeeEEee--CCeEEEE
Q 019650           52 LTVLGHGNGGIVYKVRHQKSN--SIYALKVLNTTSSTIIRHQAAHEAEILKRLD-SQFI--VKCHAVFYTI--EGEICFV  124 (337)
Q Consensus        52 ~~~lg~g~~~~v~~~~~~~~~--~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-~~~i--~~~~~~~~~~--~~~~~lv  124 (337)
                      ++.++.|.+..+|+......+  ..+++|+............+.+|+.+++.+. |.++  .+++..+.+.  .+..|+|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            567899999999998765432  4677777543321122346778999999985 5554  5555544331  1457899


Q ss_pred             EeccCCCCc
Q 019650          125 MEHMERGSL  133 (337)
Q Consensus       125 ~e~~~~~~L  133 (337)
                      ||+++|..+
T Consensus       123 ME~v~G~~~  131 (822)
T PLN02876        123 MEYLEGRIF  131 (822)
T ss_pred             EEecCCccc
Confidence            999988643

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.25  E-value=4.8e-05  Score=62.15  Aligned_cols=130  Identities=18%  Similarity=0.252  Sum_probs=90.1

Q ss_pred             cccccccCcceEEEEEEEccCCceEEEEEeecCC---------------chHhHHHHHHHHHHHHhcC------CCCcee
Q 019650           51 KLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS---------------STIIRHQAAHEAEILKRLD------SQFIVK  109 (337)
Q Consensus        51 ~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~---------------~~~~~~~~~~e~~~~~~l~------~~~i~~  109 (337)
                      -...||.|+.-.||.--   .....+||+.....               .....++..+|+.....+.      +.+|.+
T Consensus         5 ~~~~i~~G~~R~cy~HP---~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r   81 (199)
T PF10707_consen    5 ESDLIAQGGERDCYQHP---DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPR   81 (199)
T ss_pred             CCcccccCCCceEEECC---CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCccccccc
Confidence            34689999999999843   33446789987654               1122455566666666665      788999


Q ss_pred             eeeeEEeeCCeEEEEEeccCC------CCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCC
Q 019650          110 CHAVFYTIEGEICFVMEHMER------GSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKG  183 (337)
Q Consensus       110 ~~~~~~~~~~~~~lv~e~~~~------~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~  183 (337)
                      ++|...+ +-.+.+|+|.+.+      .+|.+++.+ +.++. .   +...+-.-..+|-+.+|+.+|++|.||++....
T Consensus        82 ~~G~veT-~~G~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~-~---~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~  155 (199)
T PF10707_consen   82 FYGFVET-NLGLGLVVELIRDADGNISPTLEDYLKE-GGLTE-E---LRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRD  155 (199)
T ss_pred             EeEEEec-CCceEEEEEEEECCCCCcCccHHHHHHc-CCccH-H---HHHHHHHHHHHHHHcCCeecCCCcccEEEEecC
Confidence            9998766 6777888887532      367788753 34555 3   333344555678899999999999999995432


Q ss_pred             ----cEEEee
Q 019650          184 ----EVKIAD  189 (337)
Q Consensus       184 ----~~~l~D  189 (337)
                          .+.|+|
T Consensus       156 ~~~~~lvlID  165 (199)
T PF10707_consen  156 SGEFRLVLID  165 (199)
T ss_pred             CCceEEEEEe
Confidence                577776

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.22  E-value=1.3e-05  Score=67.94  Aligned_cols=74  Identities=12%  Similarity=0.048  Sum_probs=44.7

Q ss_pred             cccccCcce-EEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCC---CceeeeeeEEeeC--CeEEEEEe
Q 019650           53 TVLGHGNGG-IVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQ---FIVKCHAVFYTIE--GEICFVME  126 (337)
Q Consensus        53 ~~lg~g~~~-~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~---~i~~~~~~~~~~~--~~~~lv~e  126 (337)
                      +.|+.|+.. .||+..     ..+++|+.....   ....+.+|.+++..+...   .+..++......+  ...+++|+
T Consensus         3 ~~~~~gG~~n~vy~~~-----~~~VlR~~~~~~---~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~   74 (235)
T cd05155           3 EPVDSGGTDNATFRLG-----DDMSVRLPSAAG---YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYR   74 (235)
T ss_pred             eeccCCCcccceEEcC-----CceEEEcCCccc---hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEE
Confidence            467766665 588862     247788765422   234677899888887542   2333333221111  23478999


Q ss_pred             ccCCCCch
Q 019650          127 HMERGSLF  134 (337)
Q Consensus       127 ~~~~~~L~  134 (337)
                      +++|.++.
T Consensus        75 ~i~G~~l~   82 (235)
T cd05155          75 WLEGETAT   82 (235)
T ss_pred             eecCCCCC
Confidence            99987764

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=98.16  E-value=2.9e-05  Score=65.73  Aligned_cols=77  Identities=14%  Similarity=0.165  Sum_probs=49.2

Q ss_pred             ccccccCcceEEEEEEEcc-CCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEeccCC
Q 019650           52 LTVLGHGNGGIVYKVRHQK-SNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMER  130 (337)
Q Consensus        52 ~~~lg~g~~~~v~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~  130 (337)
                      ++.|..|-...+|++.... .+..+++|+....... . -...+|..+++.+...++.+-+-...  .+  .++|||++|
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~-~d~~~E~~~~~~l~~~gl~P~v~~~~--~~--~~l~e~i~G   76 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-I-IDRERELRIHKLLSKHGLAPKLYATF--QN--GLIYEFIPG   76 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-e-ecHHHHHHHHHHHHhCCCCCeEEEEe--CC--cEEEEeeCC
Confidence            4567889999999997543 3567889987643211 1 22346888888886555554332221  12  379999998


Q ss_pred             CCch
Q 019650          131 GSLF  134 (337)
Q Consensus       131 ~~L~  134 (337)
                      .++.
T Consensus        77 ~~l~   80 (235)
T cd05157          77 RTLE   80 (235)
T ss_pred             CcCC
Confidence            7763

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=98.15  E-value=3.4e-06  Score=72.47  Aligned_cols=138  Identities=18%  Similarity=0.189  Sum_probs=96.7

Q ss_pred             ccccccccccCcceEEEEEEEccCCceEEEEEeecCC-------------------chHhHHH--HHHHHHHHHhcCCCC
Q 019650           48 DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-------------------STIIRHQ--AAHEAEILKRLDSQF  106 (337)
Q Consensus        48 ~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-------------------~~~~~~~--~~~e~~~~~~l~~~~  106 (337)
                      -+.++..||-|-.+.||.+-+. .|...++|+-+...                   +.....+  ..+|+..++.+....
T Consensus        93 v~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g  171 (465)
T KOG2268|consen   93 VESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG  171 (465)
T ss_pred             hhhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence            4667889999999999999774 56778888753211                   1222222  246888888885433


Q ss_pred             --ceeeeeeEEeeCCeEEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCc
Q 019650          107 --IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGE  184 (337)
Q Consensus       107 --i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~  184 (337)
                        +.+.++     -+.-|+|||++.|..|.+.-+      ......+...+...+--|..+|+||||+.--||+++.++.
T Consensus       172 fpVPkpiD-----~~RH~Vvmelv~g~Pl~~v~~------v~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~  240 (465)
T KOG2268|consen  172 FPVPKPID-----HNRHCVVMELVDGYPLRQVRH------VEDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDK  240 (465)
T ss_pred             CCCCCccc-----ccceeeHHHhhcccceeeeee------cCChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCC
Confidence              333444     245679999999888766542      1223444555666666788899999999999999999999


Q ss_pred             EEEeeccCccchh
Q 019650          185 VKIADFGVSRIVE  197 (337)
Q Consensus       185 ~~l~Dfg~~~~~~  197 (337)
                      ++++||--.....
T Consensus       241 i~vIDFPQmvS~s  253 (465)
T KOG2268|consen  241 IVVIDFPQMVSTS  253 (465)
T ss_pred             EEEeechHhhccC
Confidence            9999998655443

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.12  E-value=0.00016  Score=58.78  Aligned_cols=127  Identities=31%  Similarity=0.445  Sum_probs=87.4

Q ss_pred             cccccccccccCcc-eEEEEEEEccCCceEEEEEeec---CCc-----------h------HhHHHHHHHHHHHHh---c
Q 019650           47 SDLKKLTVLGHGNG-GIVYKVRHQKSNSIYALKVLNT---TSS-----------T------IIRHQAAHEAEILKR---L  102 (337)
Q Consensus        47 ~~y~~~~~lg~g~~-~~v~~~~~~~~~~~vaiK~~~~---~~~-----------~------~~~~~~~~e~~~~~~---l  102 (337)
                      .+++.++.||.|.. |.||++...  |+.+|+|++..   ...           .      ...+-|..|.+..-+   +
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~  114 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA  114 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence            89999999999999 999999774  77999999321   110           0      222335556555444   4


Q ss_pred             CCCCc--eeeeeeEEeeC-----------------CeEEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHH
Q 019650          103 DSQFI--VKCHAVFYTIE-----------------GEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLH  163 (337)
Q Consensus       103 ~~~~i--~~~~~~~~~~~-----------------~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH  163 (337)
                      .+.++  ++++|...-..                 ....||.||.+...         .++.+.    +.+|..-+..+|
T Consensus       115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~~----~~~~~~dl~~~~  181 (207)
T PF13095_consen  115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIRD----IPQMLRDLKILH  181 (207)
T ss_pred             cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccchhH----HHHHHHHHHHHH
Confidence            55566  89998775431                 12356777665532         233333    455777778899


Q ss_pred             hCCceeccCCCCCeEEcCCCcEEEeeccCc
Q 019650          164 GMQIIHGDIKPSNLLINGKGEVKIADFGVS  193 (337)
Q Consensus       164 ~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~  193 (337)
                      ..||+-+|+++.|..     .=+|+|||.+
T Consensus       182 k~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  182 KLGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HCCeeeccCcccccc-----CCEEEecccC
Confidence            999999999999987     3488999864

>TIGR02721 ycfN_thiK thiamine kinase

Probab=98.08  E-value=3e-05  Score=66.55  Aligned_cols=133  Identities=17%  Similarity=0.227  Sum_probs=77.6

Q ss_pred             ccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCcee-eeeeEEeeCCeEEEEEeccCCCC
Q 019650           54 VLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVK-CHAVFYTIEGEICFVMEHMERGS  132 (337)
Q Consensus        54 ~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~-~~~~~~~~~~~~~lv~e~~~~~~  132 (337)
                      .+..|-...+|++.  .++..+++|........... ...+|..+++.+...++.+ ++..  . .  -++||+|++|.+
T Consensus         3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~~~-~r~~E~~~l~~l~~~g~~P~~i~~--~-~--~~~v~e~i~G~~   74 (256)
T TIGR02721         3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCKALGV-DRQREYQILQALSALGLAPKPILV--N-E--HWLLVEWLEGEV   74 (256)
T ss_pred             cCCCcCcCCeEEEE--eCCccEEEeeCCcccccccC-cHHHHHHHHHHHHhcCCCCceEEE--e-C--CEEEEEeccCcc
Confidence            46678888999986  34667888876543222111 2466888888886655543 3322  1 2  258999999866


Q ss_pred             chHH-------h----------hhcC----CCCHH-HHHHHHHHH---------HHHHHHHHh--------CCceeccCC
Q 019650          133 LFDS-------L----------RVRK----KLSED-VISGVAYRV---------LKGLQYLHG--------MQIIHGDIK  173 (337)
Q Consensus       133 L~~~-------l----------~~~~----~l~~~-~~~~i~~~l---------~~~l~~LH~--------~~ivH~dl~  173 (337)
                      +...       +          +..+    +++.. .+..+..++         ...+..+-.        ..++|+|+.
T Consensus        75 ~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~  154 (256)
T TIGR02721        75 ITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVH  154 (256)
T ss_pred             cccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCC
Confidence            5321       1          1111    11211 111211111         111222221        248999999


Q ss_pred             CCCeEEcCCCcEEEeeccCccc
Q 019650          174 PSNLLINGKGEVKIADFGVSRI  195 (337)
Q Consensus       174 ~~Nili~~~~~~~l~Dfg~~~~  195 (337)
                      |.||++++++ +.++||+.+..
T Consensus       155 ~~Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       155 AYNLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             cCcEEEeCCC-CEEEeccccCc
Confidence            9999999876 78999998754

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.07  E-value=1.1e-06  Score=81.44  Aligned_cols=241  Identities=18%  Similarity=0.128  Sum_probs=158.8

Q ss_pred             CccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCC-ceeeeeeEEeeCCeEEE
Q 019650           45 NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQF-IVKCHAVFYTIEGEICF  123 (337)
Q Consensus        45 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~-i~~~~~~~~~~~~~~~l  123 (337)
                      ...-+...+-.+.|+.+.+++.....++.-+ .+++...      ....-+++++.+++||| .+..++.+ +.+.+..+
T Consensus       240 k~kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~------l~~rl~~eLLdK~n~P~~~v~~~~d~-~~E~~~~i  311 (829)
T KOG0576|consen  240 KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT------LSRRLAIELLDKVNNPNPVVRYLEDY-DGEDYLWI  311 (829)
T ss_pred             CccchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc------hhhHHHHHHHHHccCCCCcccccccC-Ccccccch
Confidence            3445666778899999999998776554433 5555433      22234888999999999 55555544 33677889


Q ss_pred             EEeccCCC-CchHHh-hhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhcccc
Q 019650          124 VMEHMERG-SLFDSL-RVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRN  201 (337)
Q Consensus       124 v~e~~~~~-~L~~~l-~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~  201 (337)
                      .++++.++ +....+ .....+..-....++..-...++++|+..-+|+|    ||+-. .+..+..||+....+.+.. 
T Consensus       312 ~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s-~~~~~~~~~~v~~~L~~~~-  385 (829)
T KOG0576|consen  312 PMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGS-EEEVKLLDFAVPPQLTRTM-  385 (829)
T ss_pred             hhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----ccccc-ccccccccccCCcccCccc-
Confidence            99999887 322222 2223455556666777778899999998878888    66655 3678999999887765542 


Q ss_pred             CCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhh
Q 019650          202 NNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAIC  281 (337)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~  281 (337)
                                    ....+.+++.++|||+..    .+.+...-|.|++|.-..++.-|.+|-.......        ..
T Consensus       386 --------------~~~t~~~~~~~~~pev~~----~~~~~~~p~~~~~~~~~~~~ap~~pPr~~P~~~~--------~~  439 (829)
T KOG0576|consen  386 --------------KPRTAIGTPEPLAPEVIQ----ENTIDGCPDSGSLAVSAIQMAPGLPPRSSPPAVL--------PM  439 (829)
T ss_pred             --------------ccccCCCCCCCCCchhhc----ccccccCCCccCCCcchhhcCCCCCCCCCCcccc--------CC
Confidence                          122346899999999888    4577888999999987777766766642210000        00


Q ss_pred             ccCCCCCCC-----CCCHHHH-HHHHHHhhcCcCCCCCHHHHhcCccccc
Q 019650          282 FGERLEMPE-----TASPEFR-RFVRSCLEKDWRKRGTVEELLAYPFVTK  325 (337)
Q Consensus       282 ~~~~~~~~~-----~~~~~~~-~li~~~l~~~p~~R~s~~eil~hp~f~~  325 (337)
                      .+..+..+.     ..+.... ++...|+...|..|+..-.++.|.+|.+
T Consensus       440 ~g~~p~s~~L~~~~aw~~~~~~~~~~~~~~g~P~~pkv~mgacfsKvfng  489 (829)
T KOG0576|consen  440 IGNGPNSPMLTDKSAWSPVFHRDFPAPCLNGLPPTPKVHMGACFSKVFNG  489 (829)
T ss_pred             CCCCCCccccchhhhcCcccccCCcccccCCCCCCCcchhhHHHHHHhcc
Confidence            000000000     0111122 3667888889999999999998888864

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=98.03  E-value=9.5e-05  Score=64.90  Aligned_cols=140  Identities=21%  Similarity=0.264  Sum_probs=95.9

Q ss_pred             cccccccCcceEEEEEEEccCCceEEEEEeecCC-------------------------chHhHHHHHHHHHHHHhcCCC
Q 019650           51 KLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-------------------------STIIRHQAAHEAEILKRLDSQ  105 (337)
Q Consensus        51 ~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-------------------------~~~~~~~~~~e~~~~~~l~~~  105 (337)
                      +-++|+.|-.+.||.+.. .+|..+|||+++..-                         ..+..-=...|++.++++...
T Consensus       148 inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a  226 (520)
T KOG2270|consen  148 INGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA  226 (520)
T ss_pred             cccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence            345678888899999876 466779999983210                         111111234688889999887


Q ss_pred             CceeeeeeEEeeCCeEEEEEeccCCCCchHHh-hhcCCCCHHHHHHHHHHHHHHHHHHH-hCCceeccCCCCCeEEcCCC
Q 019650          106 FIVKCHAVFYTIEGEICFVMEHMERGSLFDSL-RVRKKLSEDVISGVAYRVLKGLQYLH-GMQIIHGDIKPSNLLINGKG  183 (337)
Q Consensus       106 ~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l-~~~~~l~~~~~~~i~~~l~~~l~~LH-~~~ivH~dl~~~Nili~~~~  183 (337)
                      +|.-.-- ..-  ..-.|||+++.. +=+-.- -..-.++...+..+-.+++..+.-|. .+++||.||+--|+|+. +|
T Consensus       227 GIP~PeP-IlL--k~hVLVM~FlGr-dgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyh-dG  301 (520)
T KOG2270|consen  227 GIPCPEP-ILL--KNHVLVMEFLGR-DGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYH-DG  301 (520)
T ss_pred             CCCCCCc-eee--ecceEeeeeccC-CCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEE-CC
Confidence            7443333 222  234589999943 221111 12235777788888888888888765 67999999999999987 67


Q ss_pred             cEEEeeccCccch
Q 019650          184 EVKIADFGVSRIV  196 (337)
Q Consensus       184 ~~~l~Dfg~~~~~  196 (337)
                      .++++|.+-+...
T Consensus       302 ~lyiIDVSQSVE~  314 (520)
T KOG2270|consen  302 KLYIIDVSQSVEH  314 (520)
T ss_pred             EEEEEEccccccC
Confidence            9999999877654

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.95  E-value=0.00015  Score=63.59  Aligned_cols=141  Identities=16%  Similarity=0.168  Sum_probs=82.9

Q ss_pred             cccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCC--ceeeeee-----EEeeCCeE
Q 019650           49 LKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQF--IVKCHAV-----FYTIEGEI  121 (337)
Q Consensus        49 y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~--i~~~~~~-----~~~~~~~~  121 (337)
                      ..-.+.|..|....+|++...  +..+++|++...    ..+.+..|+.++..+.+.+  +.+++..     +....+..
T Consensus        16 ~~~i~~i~~G~~n~~y~v~~~--~~~~vLr~~~~~----~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~   89 (296)
T cd05153          16 LLSFEGISAGIENTNYFVTTD--SGRYVLTLFEKV----SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKP   89 (296)
T ss_pred             hhheecccCccccceEEEEeC--CCcEEEEEcCCC----ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCce
Confidence            344667888988999998653  346888987642    2345566777777774433  3333221     11223456


Q ss_pred             EEEEeccCCCCchH----Hhh----------hc-CCC----------CHHHH----------HHHHHHHHHHHHHHHh--
Q 019650          122 CFVMEHMERGSLFD----SLR----------VR-KKL----------SEDVI----------SGVAYRVLKGLQYLHG--  164 (337)
Q Consensus       122 ~lv~e~~~~~~L~~----~l~----------~~-~~l----------~~~~~----------~~i~~~l~~~l~~LH~--  164 (337)
                      ++|+++++|..+..    ...          .. ..+          .+...          ......+..++.++..  
T Consensus        90 ~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~  169 (296)
T cd05153          90 AALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFD  169 (296)
T ss_pred             EEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhh
Confidence            89999999876532    000          00 000          00000          0011112233444443  


Q ss_pred             -----CCceeccCCCCCeEEcCCCcEEEeeccCccc
Q 019650          165 -----MQIIHGDIKPSNLLINGKGEVKIADFGVSRI  195 (337)
Q Consensus       165 -----~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~  195 (337)
                           .+++|||+.|.|++++.++.+.|+||+.+..
T Consensus       170 ~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         170 PSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             hhcCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence                 4799999999999999877778999998754

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.90  E-value=0.0003  Score=62.08  Aligned_cols=142  Identities=18%  Similarity=0.228  Sum_probs=80.7

Q ss_pred             cccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCC--ceeeeee-----EEeeCCeE
Q 019650           49 LKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQF--IVKCHAV-----FYTIEGEI  121 (337)
Q Consensus        49 y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~--i~~~~~~-----~~~~~~~~  121 (337)
                      ......++.|....+|++... ++ .+++|+.......   +.+..+..++..|...+  +.+++..     +....+..
T Consensus        24 ~~~i~~~~~G~~n~~y~v~t~-~~-~~vLK~~~~~~~~---~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~   98 (307)
T TIGR00938        24 LLSLKGIAEGVENSNYLLTTD-VG-RYILTLYEKRVKA---EELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKP   98 (307)
T ss_pred             ceeccccCCccccceEEEEeC-CC-cEEEEEecCCCCH---HHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeE
Confidence            334667788888899998643 34 5778987653222   33445666666664333  2233221     11123557


Q ss_pred             EEEEeccCCCCchH-----------Hh---hhc-CCCC-------HHHHH----------------HHHHHHHHHHHHHH
Q 019650          122 CFVMEHMERGSLFD-----------SL---RVR-KKLS-------EDVIS----------------GVAYRVLKGLQYLH  163 (337)
Q Consensus       122 ~lv~e~~~~~~L~~-----------~l---~~~-~~l~-------~~~~~----------------~i~~~l~~~l~~LH  163 (337)
                      +++++|++|..+..           .+   +.. ..++       ....+                .....+...+.++.
T Consensus        99 ~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~  178 (307)
T TIGR00938        99 ACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLD  178 (307)
T ss_pred             EEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHH
Confidence            89999998855421           00   000 0000       00000                00112233444443


Q ss_pred             -------hCCceeccCCCCCeEEcCCCcEEEeeccCccc
Q 019650          164 -------GMQIIHGDIKPSNLLINGKGEVKIADFGVSRI  195 (337)
Q Consensus       164 -------~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~  195 (337)
                             ..+++|||+++.|++++.++...++||+.+..
T Consensus       179 ~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~  217 (307)
T TIGR00938       179 KFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT  217 (307)
T ss_pred             hhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence                   26899999999999999887778999998743

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PRK05231 homoserine kinase; Provisional

Probab=97.81  E-value=0.00066  Score=60.25  Aligned_cols=138  Identities=14%  Similarity=0.171  Sum_probs=74.2

Q ss_pred             ccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCC--ceeeeee-----EEeeCCeEEEE
Q 019650           52 LTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQF--IVKCHAV-----FYTIEGEICFV  124 (337)
Q Consensus        52 ~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~--i~~~~~~-----~~~~~~~~~lv  124 (337)
                      .+.++.|...++|++... ++ .+++|++. ....   +.+..+..++..|...+  +.+.+..     +....+..+++
T Consensus        27 ~~~l~~G~~n~~y~v~t~-~g-~~vLK~~~-~~~~---~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l  100 (319)
T PRK05231         27 LKGIAEGIENSNFFLTTT-QG-EYVLTLFE-RLTA---EDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAI  100 (319)
T ss_pred             cchhccccccceEEEEeC-CC-cEEEEEec-cCCh---HHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEE
Confidence            456778888899998754 33 58889876 2222   23334555555553222  2222211     11224567899


Q ss_pred             EeccCCCCchH-----------Hhh---hc-CCC--------C--H-HHH------------HHHHHH-HHHHHHHHH--
Q 019650          125 MEHMERGSLFD-----------SLR---VR-KKL--------S--E-DVI------------SGVAYR-VLKGLQYLH--  163 (337)
Q Consensus       125 ~e~~~~~~L~~-----------~l~---~~-~~l--------~--~-~~~------------~~i~~~-l~~~l~~LH--  163 (337)
                      +++++|..+..           .+.   .. ..+        .  . ...            ...+.+ +...+..+.  
T Consensus       101 ~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  180 (319)
T PRK05231        101 VTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASA  180 (319)
T ss_pred             EEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcc
Confidence            99999864421           110   00 000        0  0 000            011111 111222222  


Q ss_pred             -----hCCceeccCCCCCeEEcCCCcEEEeeccCccc
Q 019650          164 -----GMQIIHGDIKPSNLLINGKGEVKIADFGVSRI  195 (337)
Q Consensus       164 -----~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~  195 (337)
                           ..|+||||+++.||+++.+...-++||+.+..
T Consensus       181 ~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        181 AWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             ccccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence                 24899999999999998665568999998753

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.81  E-value=0.0002  Score=63.05  Aligned_cols=76  Identities=17%  Similarity=0.221  Sum_probs=48.9

Q ss_pred             ccccccCcceEEEEEEEcc------CCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCcee-eeeeEEeeCCeEEEE
Q 019650           52 LTVLGHGNGGIVYKVRHQK------SNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVK-CHAVFYTIEGEICFV  124 (337)
Q Consensus        52 ~~~lg~g~~~~v~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~-~~~~~~~~~~~~~lv  124 (337)
                      ++.+..|-...+|++....      .++.+++|+......  ......+|..+++.+...++.+ ++..+ . +   .+|
T Consensus         3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~--~~~~r~~E~~~~~~l~~~g~~P~~~~~~-~-~---~~v   75 (302)
T cd05156           3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE--LLIDRERELVVFARLSERNLGPKLYGIF-P-N---GRI   75 (302)
T ss_pred             EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc--ceechHHHHHHHHHHHhCCCCCceEEEe-C-C---Cch
Confidence            3466778888999987643      257899999765432  2234566888888886555543 34432 2 2   258


Q ss_pred             EeccCCCCch
Q 019650          125 MEHMERGSLF  134 (337)
Q Consensus       125 ~e~~~~~~L~  134 (337)
                      ++|++|.++.
T Consensus        76 ~e~i~G~~l~   85 (302)
T cd05156          76 EEFIPSRTLT   85 (302)
T ss_pred             hheeCCCcCC
Confidence            9999887664

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.75  E-value=0.00087  Score=60.79  Aligned_cols=78  Identities=23%  Similarity=0.241  Sum_probs=51.7

Q ss_pred             ccccccCcceEEEEEEEccCCceEEEEEeecC-----Cc-hHhHHHHHHHHHHHHhcC---CCCceeeeeeEEeeCCeEE
Q 019650           52 LTVLGHGNGGIVYKVRHQKSNSIYALKVLNTT-----SS-TIIRHQAAHEAEILKRLD---SQFIVKCHAVFYTIEGEIC  122 (337)
Q Consensus        52 ~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~-----~~-~~~~~~~~~e~~~~~~l~---~~~i~~~~~~~~~~~~~~~  122 (337)
                      .+.||.|....||++...++++.+++|.-...     .. ....++...|.+.+..+.   ...+++++.+  + ....+
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D-~~~~~  107 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--D-EELAV  107 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--C-CCCCE
Confidence            35799999999999998654467999984311     11 234556667777777763   2345555554  2 34567


Q ss_pred             EEEeccCCCC
Q 019650          123 FVMEHMERGS  132 (337)
Q Consensus       123 lv~e~~~~~~  132 (337)
                      +|||++++..
T Consensus       108 lVME~L~~~~  117 (401)
T PRK09550        108 TVMEDLSDHK  117 (401)
T ss_pred             EEEecCCCcc
Confidence            9999997643

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.53  E-value=0.0015  Score=57.29  Aligned_cols=144  Identities=18%  Similarity=0.240  Sum_probs=85.1

Q ss_pred             ccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCC--CceeeeeeEEeeC-CeEEEE
Q 019650           48 DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQ--FIVKCHAVFYTIE-GEICFV  124 (337)
Q Consensus        48 ~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~--~i~~~~~~~~~~~-~~~~lv  124 (337)
                      ...+++.+..|....+|...+.  ++++++................+|+.+++.+..-  .+...++.+.+.. +..+.|
T Consensus        26 ~~~~v~~~~~G~sn~t~~~~~~--~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v  103 (321)
T COG3173          26 GLLIVEEISGGWSNDTFRLGDT--GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYV  103 (321)
T ss_pred             CCceeeeccCCcccceEEEecC--CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEE
Confidence            3444555555655566666543  6778888221122333455666788888887542  2333444444322 356899


Q ss_pred             EeccCCCCchHHhhhcCCCCHHHHHHHH-HHHHHHHHHHHh---------------------------------------
Q 019650          125 MEHMERGSLFDSLRVRKKLSEDVISGVA-YRVLKGLQYLHG---------------------------------------  164 (337)
Q Consensus       125 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~-~~l~~~l~~LH~---------------------------------------  164 (337)
                      |+++.|..+.+.+..   .+..  ..++ -.+...|+.||+                                       
T Consensus       104 ~~~veGe~~~~~~~~---~~~~--~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p  178 (321)
T COG3173         104 MEWVEGEVVWSALPP---ESLG--RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIP  178 (321)
T ss_pred             EEEecceeccCcCCc---ccch--HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCc
Confidence            999988543322210   0000  1111 244444444443                                       


Q ss_pred             -------------------CCceeccCCCCCeEEcCCCcEEEeeccCccchhc
Q 019650          165 -------------------MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEE  198 (337)
Q Consensus       165 -------------------~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~  198 (337)
                                         -.++|||+++.|+++++++-+-++||+.+..-.+
T Consensus       179 ~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP  231 (321)
T COG3173         179 LADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDP  231 (321)
T ss_pred             hHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence                               2489999999999999998899999999875443

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=97.44  E-value=0.00034  Score=64.02  Aligned_cols=167  Identities=23%  Similarity=0.232  Sum_probs=102.5

Q ss_pred             HHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 019650           89 RHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQII  168 (337)
Q Consensus        89 ~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~iv  168 (337)
                      ...+..-..+++.+.|++...++......-....+|||++. .+|.+.+..+. +......              .+|+.
T Consensus        26 s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~-~Sled~~~~~~-l~~~s~~--------------~~~~~   89 (725)
T KOG1093|consen   26 SIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYT-MSLEDILKTGN-LKDESLL--------------AHGVL   89 (725)
T ss_pred             HHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhc-cchHHHHHhcc-cchhhhc--------------ccccc
Confidence            34566778899999999999998876554445788999995 49999987554 2221111              22222


Q ss_pred             eccCCCCCeEEcCCCcEEEeeccCccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHH
Q 019650          169 HGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVW  248 (337)
Q Consensus       169 H~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Diw  248 (337)
                      |-+            .++.+| .+..                              .|  |         ....+++|||
T Consensus        90 ~~~------------~~~~td-~~~t------------------------------~~--~---------~~~~pKsdVw  115 (725)
T KOG1093|consen   90 HLN------------IIYITD-HFLT------------------------------KY--P---------SPIGPKSDVW  115 (725)
T ss_pred             eeh------------hhhccc-cccc------------------------------cC--C---------CCCCcchhhh
Confidence            221            222333 0000                              00  0         1222589999


Q ss_pred             HHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhccCCC-------CCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCc
Q 019650          249 SLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERL-------EMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYP  321 (337)
Q Consensus       249 slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp  321 (337)
                      ++|.++.++.-|...+....+.+....+..........       .+.-..+..+.++..+|+...|..||.+.++.+++
T Consensus       116 sl~~i~~el~L~~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~  195 (725)
T KOG1093|consen  116 SLGFIILELYLGISLEAELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRC  195 (725)
T ss_pred             hHHHHHHHHHHhhHHHHHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCc
Confidence            99999999999876664433333222222111111000       01123466788899999999999999999999998


Q ss_pred             cccc
Q 019650          322 FVTK  325 (337)
Q Consensus       322 ~f~~  325 (337)
                      -|..
T Consensus       196 i~~e  199 (725)
T KOG1093|consen  196 SFTE  199 (725)
T ss_pred             cHHH
Confidence            7764

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=97.33  E-value=0.0024  Score=57.00  Aligned_cols=138  Identities=14%  Similarity=0.211  Sum_probs=79.3

Q ss_pred             cccccccCcceEEEEEEEccC---CceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCcee-eeeeEEeeCCeEEEEEe
Q 019650           51 KLTVLGHGNGGIVYKVRHQKS---NSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVK-CHAVFYTIEGEICFVME  126 (337)
Q Consensus        51 ~~~~lg~g~~~~v~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~-~~~~~~~~~~~~~lv~e  126 (337)
                      ..+.|..|-+..+|++.....   +..|++|+....... .. ...+|..+++.+...++-+ +++.+ . ++   +|.+
T Consensus        18 ~i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~-~I-dR~~E~~il~~l~~~gl~P~~l~~~-~-~G---~i~~   90 (330)
T PLN02421         18 SVERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY-VI-DRERELQAIKYLSAAGFGAKLLGVF-G-NG---MIQS   90 (330)
T ss_pred             EEEEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCe-Ee-chHHHHHHHHHHHhcCCCCceeEEe-C-Cc---Eeeh
Confidence            345566688889999875432   347999988654321 22 2246888888887766654 44433 2 22   5888


Q ss_pred             ccCCCCchH-------Hh----------hhcC-C----CC-HHHHHHHHHHH----------------------HHHHHH
Q 019650          127 HMERGSLFD-------SL----------RVRK-K----LS-EDVISGVAYRV----------------------LKGLQY  161 (337)
Q Consensus       127 ~~~~~~L~~-------~l----------~~~~-~----l~-~~~~~~i~~~l----------------------~~~l~~  161 (337)
                      |++|.+|..       .+          +..+ +    .+ ...+..++.++                      ..-+..
T Consensus        91 fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  170 (330)
T PLN02421         91 FINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVE  170 (330)
T ss_pred             hhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHH
Confidence            887766531       01          1101 0    11 12222222221                      111222


Q ss_pred             ---HH-hC----CceeccCCCCCeEEcC-CCcEEEeeccCccc
Q 019650          162 ---LH-GM----QIIHGDIKPSNLLING-KGEVKIADFGVSRI  195 (337)
Q Consensus       162 ---LH-~~----~ivH~dl~~~Nili~~-~~~~~l~Dfg~~~~  195 (337)
                         +. ..    -++|+|+.+.||++++ ++.++++||+.+..
T Consensus       171 l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        171 LKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             HHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence               21 11    2789999999999975 47899999998753

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.33  E-value=0.0047  Score=53.55  Aligned_cols=30  Identities=23%  Similarity=0.678  Sum_probs=25.3

Q ss_pred             CceeccCCCCCeEEcCCCc-EEEeeccCccc
Q 019650          166 QIIHGDIKPSNLLINGKGE-VKIADFGVSRI  195 (337)
Q Consensus       166 ~ivH~dl~~~Nili~~~~~-~~l~Dfg~~~~  195 (337)
                      .++|||+++.||+++++++ .-|+||+.+..
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            3899999999999997555 57999998864

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=97.30  E-value=0.0048  Score=54.98  Aligned_cols=81  Identities=21%  Similarity=0.217  Sum_probs=50.1

Q ss_pred             ccccCcceEEEEEEEccCCceEEEEEee----c--CCchHhHHHHHHHHHHHHhcCC--CCce-eeeeeEEeeCCeEEEE
Q 019650           54 VLGHGNGGIVYKVRHQKSNSIYALKVLN----T--TSSTIIRHQAAHEAEILKRLDS--QFIV-KCHAVFYTIEGEICFV  124 (337)
Q Consensus        54 ~lg~g~~~~v~~~~~~~~~~~vaiK~~~----~--~~~~~~~~~~~~e~~~~~~l~~--~~i~-~~~~~~~~~~~~~~lv  124 (337)
                      .||.|....||++.+..+++.++||.-.    .  ..-....++...|...++....  |..+ +++..  + .....++
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D-~e~~~~v   78 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--D-TEMAVTV   78 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--c-cccceeh
Confidence            5799999999999986444679999842    1  1224455566667777766532  4333 34442  2 3455689


Q ss_pred             EeccCCC-CchHHh
Q 019650          125 MEHMERG-SLFDSL  137 (337)
Q Consensus       125 ~e~~~~~-~L~~~l  137 (337)
                      ||+++.. .|++.+
T Consensus        79 MEdL~~~~ilR~~L   92 (370)
T TIGR01767        79 MEDLSHHKIARKGL   92 (370)
T ss_pred             HhhCccchHHHHHH
Confidence            9998543 344444

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=97.28  E-value=0.0017  Score=57.20  Aligned_cols=75  Identities=17%  Similarity=0.211  Sum_probs=59.3

Q ss_pred             CCeEEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCCeEEcCCCcEEEeeccCccch
Q 019650          118 EGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGM-QIIHGDIKPSNLLINGKGEVKIADFGVSRIV  196 (337)
Q Consensus       118 ~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~-~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~  196 (337)
                      ..+.|++|++. |+++.-.    ..-..+++..++.+.+..++-+... .+-|+|+...||+|+ .|++.|+||.+++.-
T Consensus       298 ~~y~yl~~kdh-gt~is~i----k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl~  371 (488)
T COG5072         298 TLYLYLHFKDH-GTPISII----KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRLS  371 (488)
T ss_pred             ceEEEEEEecC-Cceeeee----ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeecc
Confidence            45677888887 4444322    3456788899999999988888854 789999999999999 999999999999854


Q ss_pred             hc
Q 019650          197 EE  198 (337)
Q Consensus       197 ~~  198 (337)
                      .+
T Consensus       372 ~~  373 (488)
T COG5072         372 YS  373 (488)
T ss_pred             cC
Confidence            33

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.19  E-value=3.8e-05  Score=78.09  Aligned_cols=206  Identities=11%  Similarity=-0.028  Sum_probs=132.6

Q ss_pred             HHHHHHhcCCCCceeeeeeEEee-CCeEEEEEeccCCCCchHHhhhc----CCCCHHHHHHHHHHHHHHHHHHHhC----
Q 019650           95 EAEILKRLDSQFIVKCHAVFYTI-EGEICFVMEHMERGSLFDSLRVR----KKLSEDVISGVAYRVLKGLQYLHGM----  165 (337)
Q Consensus        95 e~~~~~~l~~~~i~~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~~l~~~l~~LH~~----  165 (337)
                      |....++..|+++.......... ....+..++++.+|.+.+.+-++    +.++..-+.....+.+.+..-+|..    
T Consensus      1279 e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg 1358 (2724)
T KOG1826|consen 1279 ERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLG 1358 (2724)
T ss_pred             hhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCC
Confidence            33344455787777766554432 23467899999999999988643    3445555555555546666666643    


Q ss_pred             -CceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCcc
Q 019650          166 -QIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFA  244 (337)
Q Consensus       166 -~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~  244 (337)
                       --+|.++++.|.+|..+-+++++++|+.+...+..              ...+..++++.|++|+..+.    -.++.+
T Consensus      1359 ~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~--------------sf~Gl~l~sp~~v~qli~N~----ik~t~r 1420 (2724)
T KOG1826|consen 1359 NTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVL--------------SFFGLELCSPIYVLQLIKNE----IKFTKR 1420 (2724)
T ss_pred             ccchhhhhhhhccceecCCcccccccccccccCchH--------------hhhhhhhCCHHHHHHHHHHH----HhhhhH
Confidence             26799999999999999999999999988333222              22223457888999998883    456667


Q ss_pred             ccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHh-hccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccc
Q 019650          245 GDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAI-CFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV  323 (337)
Q Consensus       245 ~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f  323 (337)
                      +|+|..|+.+|.+..|..+|-.     .....+... ........+...+...-.....+|-+...+||.-...++-+.|
T Consensus      1421 sdilr~s~~ly~rs~~n~~fi~-----flq~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~ 1495 (2724)
T KOG1826|consen 1421 SDILRRSLSLYLRSDGNAYFIF-----FLQPALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHF 1495 (2724)
T ss_pred             HHHHHHHHHHHHHhcccHHHHH-----HHHHHHcCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhhcccccc
Confidence            9999999999999888877621     122222221 1122222223334444445555666667788887777776554

>PLN02236 choline kinase

Probab=97.16  E-value=0.0048  Score=55.32  Aligned_cols=138  Identities=12%  Similarity=0.160  Sum_probs=81.8

Q ss_pred             cccccccCcceEEEEEEEcc----CCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCcee-eeeeEEeeCCeEEEEE
Q 019650           51 KLTVLGHGNGGIVYKVRHQK----SNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVK-CHAVFYTIEGEICFVM  125 (337)
Q Consensus        51 ~~~~lg~g~~~~v~~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~-~~~~~~~~~~~~~lv~  125 (337)
                      -...+..|-+..+|++....    +++.+++|+..... ....++ .+|..+++.+...++.+ +++.+ . +.   .|.
T Consensus        40 ~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t-~~~idR-~~E~~~~~~l~~~gl~P~~~~~~-~-~g---~v~  112 (344)
T PLN02236         40 QVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV-ELFFDR-DDEIRTFECMSRHGQGPRLLGRF-P-NG---RVE  112 (344)
T ss_pred             EEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC-Ceeech-HHHHHHHHHHHHcCCCCceEEEE-C-Cc---eEE
Confidence            34466778899999987532    34679999886543 222333 56888888887666654 44433 2 22   578


Q ss_pred             eccCCCCchHH-------h----------hhcC-C----CC-HHHHHHHHHHH-----------------HHHHHHH---
Q 019650          126 EHMERGSLFDS-------L----------RVRK-K----LS-EDVISGVAYRV-----------------LKGLQYL---  162 (337)
Q Consensus       126 e~~~~~~L~~~-------l----------~~~~-~----l~-~~~~~~i~~~l-----------------~~~l~~L---  162 (337)
                      +|+++.+|...       +          +... +    .+ .+.+..++.++                 ...+..|   
T Consensus       113 efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~  192 (344)
T PLN02236        113 EFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKE  192 (344)
T ss_pred             EeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHH
Confidence            88877666421       1          0000 0    11 22222332111                 1112122   


Q ss_pred             -H----hCCceeccCCCCCeEEcCC-CcEEEeeccCccc
Q 019650          163 -H----GMQIIHGDIKPSNLLINGK-GEVKIADFGVSRI  195 (337)
Q Consensus       163 -H----~~~ivH~dl~~~Nili~~~-~~~~l~Dfg~~~~  195 (337)
                       .    ...++|+|+++.||+++++ +.+.++||+.+..
T Consensus       193 ~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        193 LSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             hcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence             1    2358999999999999864 6899999998753

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=97.09  E-value=0.012  Score=51.95  Aligned_cols=29  Identities=28%  Similarity=0.403  Sum_probs=25.5

Q ss_pred             CCceeccCCCCCeEEcCCCcEEEeeccCcc
Q 019650          165 MQIIHGDIKPSNLLINGKGEVKIADFGVSR  194 (337)
Q Consensus       165 ~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~  194 (337)
                      .+++|||+.+.||+++. +.+.++||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            57899999999999987 678999999664

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PRK12396 5-methylribose kinase; Reviewed

Probab=97.04  E-value=0.0047  Score=55.71  Aligned_cols=83  Identities=19%  Similarity=0.238  Sum_probs=52.1

Q ss_pred             ccccccCcceEEEEEEEccCCceEEEEEe----ecC-CchHhHHHHHHHHHHHHhcCC--CCcee-eeeeEEeeCCeEEE
Q 019650           52 LTVLGHGNGGIVYKVRHQKSNSIYALKVL----NTT-SSTIIRHQAAHEAEILKRLDS--QFIVK-CHAVFYTIEGEICF  123 (337)
Q Consensus        52 ~~~lg~g~~~~v~~~~~~~~~~~vaiK~~----~~~-~~~~~~~~~~~e~~~~~~l~~--~~i~~-~~~~~~~~~~~~~l  123 (337)
                      .+.||.|.-..||++.+..+++.++||.-    +.. .-....++...|.+.++....  |..+| ++..  + .....+
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D-~e~~~~  110 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--D-SVMNCC  110 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--C-cHHhhH
Confidence            56789999999999998533567888874    211 224456666778777776632  44444 4442  2 344568


Q ss_pred             EEeccCCC-CchHHh
Q 019650          124 VMEHMERG-SLFDSL  137 (337)
Q Consensus       124 v~e~~~~~-~L~~~l  137 (337)
                      |||+++.. .|++.|
T Consensus       111 vMEdL~~~~ilR~~L  125 (409)
T PRK12396        111 VMEDLSDHTILRTAL  125 (409)
T ss_pred             HHHhCcccHHHHHHH
Confidence            99988543 344433

>PRK10593 hypothetical protein; Provisional

Probab=96.99  E-value=0.012  Score=51.59  Aligned_cols=106  Identities=12%  Similarity=0.093  Sum_probs=73.3

Q ss_pred             ccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCC---CCceeeeeeEEe--eCCeEEEE
Q 019650           50 KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDS---QFIVKCHAVFYT--IEGEICFV  124 (337)
Q Consensus        50 ~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~---~~i~~~~~~~~~--~~~~~~lv  124 (337)
                      .-.+.||.|..+.||.....+ + .+++|..+...   ....+..|...++.+..   ..+.++++.+..  ..+..++|
T Consensus        17 ~~~~~i~~G~~~~vy~~~~~~-~-~~~~k~~~~~~---~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LV   91 (297)
T PRK10593         17 SRVECISEQPYAALWALYDSQ-G-NPMPLMARSFS---TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLL   91 (297)
T ss_pred             heeeecCCccceeEEEEEcCC-C-CEEEEEecccc---cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEE
Confidence            345689999999999986543 2 46778754311   23467788888888854   346666665432  13568999


Q ss_pred             EeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 019650          125 MEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGM  165 (337)
Q Consensus       125 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~  165 (337)
                      ||+++|.++.+.     ..+......+..+++.+|+.||..
T Consensus        92 mE~i~G~~~~~~-----~~~~~~~~~l~~~l~~~La~LH~~  127 (297)
T PRK10593         92 LERLRGVSVEAP-----ARTPERWEQLKDQIVEGLLAWHRI  127 (297)
T ss_pred             EeccCCEecCCC-----CCCHHHHHHHHHHHHHHHHHHhCC
Confidence            999999887762     134455667778888999999974

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.79  E-value=0.023  Score=50.22  Aligned_cols=30  Identities=17%  Similarity=0.334  Sum_probs=27.6

Q ss_pred             CceeccCCCCCeEEcCCCcEEEeeccCccc
Q 019650          166 QIIHGDIKPSNLLINGKGEVKIADFGVSRI  195 (337)
Q Consensus       166 ~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~  195 (337)
                      +++|||+.+.|++++.++.+.++||..+..
T Consensus       197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            799999999999999999999999998754

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.73  E-value=0.047  Score=49.68  Aligned_cols=75  Identities=19%  Similarity=0.210  Sum_probs=47.5

Q ss_pred             cccccccCcceEEEEEEEccCCceEEEEEeecCC---c---hHhHHHHHHHHHHHHhcC---CCCceeeeeeEEeeCCeE
Q 019650           51 KLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS---S---TIIRHQAAHEAEILKRLD---SQFIVKCHAVFYTIEGEI  121 (337)
Q Consensus        51 ~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~---~---~~~~~~~~~e~~~~~~l~---~~~i~~~~~~~~~~~~~~  121 (337)
                      ..+.||.|....||++.+.  +..++||.-....   .   .....+...|...|+.+.   ...+++++.+.   ...-
T Consensus        36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~d---ed~~  110 (418)
T PLN02756         36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFD---RTMA  110 (418)
T ss_pred             eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEEC---CCCC
Confidence            3668899999999999873  3458899854111   0   113344444666666553   24566666654   2445


Q ss_pred             EEEEeccCC
Q 019650          122 CFVMEHMER  130 (337)
Q Consensus       122 ~lv~e~~~~  130 (337)
                      +++||++++
T Consensus       111 vlvME~L~~  119 (418)
T PLN02756        111 LIGMRYLEP  119 (418)
T ss_pred             EEEEeecCC
Confidence            788999977

>PRK11768 serine/threonine protein kinase; Provisional

Probab=96.69  E-value=0.078  Score=47.20  Aligned_cols=28  Identities=29%  Similarity=0.534  Sum_probs=24.0

Q ss_pred             CCceeccCCCCCeEEcCCCcEEEeeccCcc
Q 019650          165 MQIIHGDIKPSNLLINGKGEVKIADFGVSR  194 (337)
Q Consensus       165 ~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~  194 (337)
                      .+++|+|+.+.||+++ + .+.++||+.+.
T Consensus       196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~  223 (325)
T PRK11768        196 LLRLHGDCHPGNILWR-D-GPHFVDLDDAR  223 (325)
T ss_pred             ccceecCCCchhcccc-C-CcEEEeCCCCC
Confidence            4789999999999995 4 57899999775

>PRK06148 hypothetical protein; Provisional

Probab=96.55  E-value=0.076  Score=54.63  Aligned_cols=32  Identities=28%  Similarity=0.549  Sum_probs=26.7

Q ss_pred             CCceeccCCCCCeEEcCCC--cEE-EeeccCccch
Q 019650          165 MQIIHGDIKPSNLLINGKG--EVK-IADFGVSRIV  196 (337)
Q Consensus       165 ~~ivH~dl~~~Nili~~~~--~~~-l~Dfg~~~~~  196 (337)
                      .++||+|+++.||+++.++  ++. |+|||.+...
T Consensus       203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~~  237 (1013)
T PRK06148        203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVHA  237 (1013)
T ss_pred             cceECCCCCcccEEEcCCCCcceEEEEECcccccc
Confidence            5799999999999999875  555 9999987543

>PTZ00384 choline kinase; Provisional

Probab=96.52  E-value=0.046  Score=49.66  Aligned_cols=78  Identities=13%  Similarity=0.092  Sum_probs=46.1

Q ss_pred             cccccccCcceEEEEEEEccC-Cce-----EEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 019650           51 KLTVLGHGNGGIVYKVRHQKS-NSI-----YALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFV  124 (337)
Q Consensus        51 ~~~~lg~g~~~~v~~~~~~~~-~~~-----vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv  124 (337)
                      ..+.|..|-+..+|++..... +..     |+++.... ......+ -.+|+.+++.+...++-+.+.....    -+++
T Consensus        54 ~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~-~~~l~Id-R~~E~~i~~~Ls~~glgP~l~~~f~----~g~l  127 (383)
T PTZ00384         54 EIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSST-YNSLVID-NDLQYNIAKLLGDNNFGPKIIGRFG----DFTI  127 (383)
T ss_pred             EEEEeCCcccceEEEEEecCCCCCccccceEEEEeccC-CCceEec-cHHHHHHHHHHHhCCCCCeEEEecC----CEEE
Confidence            445677799999999975432 122     44444321 1111222 2458888998877666654443322    2589


Q ss_pred             EeccCCCCch
Q 019650          125 MEHMERGSLF  134 (337)
Q Consensus       125 ~e~~~~~~L~  134 (337)
                      .||++|-+|.
T Consensus       128 ~efIeGr~l~  137 (383)
T PTZ00384        128 QEWVEGNTMG  137 (383)
T ss_pred             EEEeccccCC
Confidence            9999887664

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=96.37  E-value=0.021  Score=46.99  Aligned_cols=116  Identities=16%  Similarity=0.169  Sum_probs=73.4

Q ss_pred             CcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEeccCCCCchHHh
Q 019650           58 GNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSL  137 (337)
Q Consensus        58 g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l  137 (337)
                      |+.++.-.+..+- | +..+|.+....-......+.++.+++.++.  +|+++..-   ..-.+.++.|+|--..     
T Consensus        73 ~gNsTl~~~kt~i-G-~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND---n~~~yGvIlE~Cy~~~-----  140 (308)
T PF07387_consen   73 NGNSTLLIGKTKI-G-PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND---NNYKYGVILERCYKIK-----  140 (308)
T ss_pred             CCceEEEEecccc-c-hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC---CCceeEEEEeeccCcc-----
Confidence            4455555554433 3 344555543333334456678888888765  57777753   2445778999884321     


Q ss_pred             hhcCCCCHHHHHHHHHHHHHHHHHHHh--CCceeccCCCCCeEEcCCCcEEEeeccCc
Q 019650          138 RVRKKLSEDVISGVAYRVLKGLQYLHG--MQIIHGDIKPSNLLINGKGEVKIADFGVS  193 (337)
Q Consensus       138 ~~~~~l~~~~~~~i~~~l~~~l~~LH~--~~ivH~dl~~~Nili~~~~~~~l~Dfg~~  193 (337)
                             ... .-++..=+++|.-.|+  .+.+|||-.|+||+.++.|.+||.|=++.
T Consensus       141 -------i~~-~N~i~agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~L  190 (308)
T PF07387_consen  141 -------INF-SNFITAGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVCL  190 (308)
T ss_pred             -------cch-hHHHHHhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhhh
Confidence                   111 1111222566777883  47999999999999999999999997653

The function of this family is unknown.

>PTZ00296 choline kinase; Provisional

Probab=96.28  E-value=0.065  Score=49.69  Aligned_cols=76  Identities=12%  Similarity=0.170  Sum_probs=48.0

Q ss_pred             cccccccCcceEEEEEEEccC--------CceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCcee-eeeeEEeeCCeE
Q 019650           51 KLTVLGHGNGGIVYKVRHQKS--------NSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVK-CHAVFYTIEGEI  121 (337)
Q Consensus        51 ~~~~lg~g~~~~v~~~~~~~~--------~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~-~~~~~~~~~~~~  121 (337)
                      -++.|..|-+-.+|++.....        ++.|++++.-...... . ...+|..+++.+...++-+ +++.+ . +   
T Consensus       109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~l-I-dR~~E~~v~~~ls~~gi~P~l~~~f-~-g---  181 (442)
T PTZ00296        109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDEL-Y-NPISEFEVYKTMSKYRIAPQLLNTF-S-G---  181 (442)
T ss_pred             EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccce-e-CHHHHHHHHHHHHHCCCCCceEEEe-C-C---
Confidence            566778888889999876422        4679999875543222 2 2345777777776656554 44432 1 2   


Q ss_pred             EEEEeccCCCCc
Q 019650          122 CFVMEHMERGSL  133 (337)
Q Consensus       122 ~lv~e~~~~~~L  133 (337)
                      +.|.+|++|-+|
T Consensus       182 g~I~efi~g~~l  193 (442)
T PTZ00296        182 GRIEEWLYGDPL  193 (442)
T ss_pred             CEEEEeeCCccC
Confidence            357888887644

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.25  E-value=0.054  Score=47.17  Aligned_cols=75  Identities=23%  Similarity=0.234  Sum_probs=44.8

Q ss_pred             ccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhc---CCCCceeeeeeEEeeCCeEEEEEe
Q 019650           50 KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRL---DSQFIVKCHAVFYTIEGEICFVME  126 (337)
Q Consensus        50 ~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l---~~~~i~~~~~~~~~~~~~~~lv~e  126 (337)
                      +-.+.++.|....+|+..  .++..+.+|+-..    .....+..|..-++.|   ....+++++..... ....++|||
T Consensus        20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~----~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~-~~~~fLlle   92 (288)
T PF03881_consen   20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNSE----SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEY-DDDAFLLLE   92 (288)
T ss_dssp             -EEEEE--SSSSEEEEEE--TTS-EEEEEEEEG----GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE--SSCCEEEEE
T ss_pred             eeeEecCCCChhheEEEE--CCCccEEEEecCh----hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEee-cCCceEEEE
Confidence            445678999999999987  5677899998662    2335566777777777   23446667776544 456689999


Q ss_pred             ccCCC
Q 019650          127 HMERG  131 (337)
Q Consensus       127 ~~~~~  131 (337)
                      |++.+
T Consensus        93 ~l~~~   97 (288)
T PF03881_consen   93 FLEMG   97 (288)
T ss_dssp             -----
T ss_pred             eecCC
Confidence            99765

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=96.13  E-value=0.14  Score=45.55  Aligned_cols=136  Identities=22%  Similarity=0.331  Sum_probs=75.9

Q ss_pred             ccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCc---ee---eeeeEEe-eCC--eEEEE
Q 019650           54 VLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFI---VK---CHAVFYT-IEG--EICFV  124 (337)
Q Consensus        54 ~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i---~~---~~~~~~~-~~~--~~~lv  124 (337)
                      .|.+ ....+|+....+.+  +++|+.....   ...++..|...+..+...++   ++   .-|.... ...  +.+-+
T Consensus        33 ~l~s-~eN~~f~~~~~~g~--~iLki~~~~~---~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~l  106 (331)
T COG2334          33 GLNS-EENSNFRVQTEDGR--YILKIYRPGW---TRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAAL  106 (331)
T ss_pred             cccc-ccCceEEEEecCCC--eEEEEecCCC---CHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEE
Confidence            4444 55678888765333  4899987752   23455567777777632221   11   1111110 123  67789


Q ss_pred             EeccCCCCchH-H----hh--------------h----cC----CCCHH-------------HHHHHHHHHHHHHHHHHh
Q 019650          125 MEHMERGSLFD-S----LR--------------V----RK----KLSED-------------VISGVAYRVLKGLQYLHG  164 (337)
Q Consensus       125 ~e~~~~~~L~~-~----l~--------------~----~~----~l~~~-------------~~~~i~~~l~~~l~~LH~  164 (337)
                      .+|++|..+.. .    +.              .    ++    ...+.             .-.....++...+..+.+
T Consensus       107 f~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~  186 (331)
T COG2334         107 FEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLA  186 (331)
T ss_pred             EEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHh
Confidence            99999877662 1    00              0    00    01111             001122333333444332


Q ss_pred             --------CC--ceeccCCCCCeEEcCCCc-EEEeeccCccc
Q 019650          165 --------MQ--IIHGDIKPSNLLINGKGE-VKIADFGVSRI  195 (337)
Q Consensus       165 --------~~--ivH~dl~~~Nili~~~~~-~~l~Dfg~~~~  195 (337)
                              .+  +||+|+.|.||+++.+.. +.++||+.+..
T Consensus       187 ~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~  228 (331)
T COG2334         187 RLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGY  228 (331)
T ss_pred             hchhhCCcccceeeecCCCccceeEcCCCCeeeEEEcccccc
Confidence                    23  999999999999998875 89999998753

>KOG2269 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=95.63  E-value=0.055  Score=47.31  Aligned_cols=72  Identities=22%  Similarity=0.204  Sum_probs=54.1

Q ss_pred             EEEEeccCCCCch-HHhhhcCCCCHHHHHHHHHHHHHHHHHHH-hCCceeccCCCCCeEEcCCCcEEEeeccCccc
Q 019650          122 CFVMEHMERGSLF-DSLRVRKKLSEDVISGVAYRVLKGLQYLH-GMQIIHGDIKPSNLLINGKGEVKIADFGVSRI  195 (337)
Q Consensus       122 ~lv~e~~~~~~L~-~~l~~~~~l~~~~~~~i~~~l~~~l~~LH-~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~  195 (337)
                      .+||.++...-+- -.| .+-.++..+....-.|+..+++.|. ++-+||-|++--|+|+..+ .+.++|..-+..
T Consensus       359 vLVMsFiGd~~~aAPkL-K~v~l~d~E~~~aY~q~~~~M~~lY~Ec~LVHADlSEyN~Lw~~g-Kvw~IDVsQsve  432 (531)
T KOG2269|consen  359 VLVMSFIGDQGLAAPKL-KNVELTDDERRNAYDQVQSIMCRLYKECLLVHADLSEYNLLWTPG-KVWVIDVSQSVE  432 (531)
T ss_pred             eEEEEeecCCCCCCccc-cccccChHHHHHHHHHHHHHHHHHHHhhheeecchhhhhheecCC-ceEEEechhccC
Confidence            4899888432111 111 1234888898999999999988765 7789999999999999966 999999876653

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=95.61  E-value=0.056  Score=48.71  Aligned_cols=61  Identities=21%  Similarity=0.243  Sum_probs=45.0

Q ss_pred             EEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHH-hCCceeccCCCCCeEEcCC
Q 019650          121 ICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLH-GMQIIHGDIKPSNLLINGK  182 (337)
Q Consensus       121 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH-~~~ivH~dl~~~Nili~~~  182 (337)
                      ..++-+|..|.++..++.. ...+++....++.-.++|+-.+- -.+++|.|++|.||++..+
T Consensus       320 ~vl~E~~~~Gl~v~~~v~~-~~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~  381 (565)
T KOG1236|consen  320 LVLVETYERGLSVLRFVKW-KSQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFN  381 (565)
T ss_pred             ceeeeeccccccHHhhhhc-ccChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEec
Confidence            3456667778888888863 33556677788877788876554 5689999999999999533

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	337
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		2e-41
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		1e-40
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-40
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		3e-38
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-38
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-37
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-37
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		7e-37
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		7e-37
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-36
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		9e-30
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		9e-29
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		3e-28
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		1e-27
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		2e-27
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		8e-26
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		1e-25
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		1e-25
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-25
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		2e-25
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		2e-25
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		2e-25
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-25
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		2e-25
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		3e-25
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		3e-25
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		4e-25
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		5e-25
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		5e-25
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		5e-25
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		6e-25
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		6e-25
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		6e-25
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		6e-25
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		6e-25
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		7e-25
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		7e-25
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		7e-25
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		9e-25
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		9e-25
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		9e-25
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-24
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		1e-24
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		1e-24
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		1e-24
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		1e-24
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		1e-24
3g51_A	325	Structural Diversity Of The Active Conformation Of		1e-24
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		2e-24
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		2e-24
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-24
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		2e-24
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		2e-24
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		2e-24
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		2e-24
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-24
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-24
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		3e-24
3a7f_A	303	Human Mst3 Kinase Length = 303		3e-24
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		4e-24
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		4e-24
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		5e-24
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		5e-24
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		5e-24
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		1e-23
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		1e-23
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		1e-23
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		1e-23
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		2e-23
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		2e-23
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-23
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		2e-23
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		2e-23
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		2e-23
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-23
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		3e-23
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		3e-23
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		3e-23
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		3e-23
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		3e-23
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-23
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		3e-23
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		3e-23
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		4e-23
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		4e-23
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		4e-23
4ae6_A	343	Structure And Function Of The Human Sperm-specific		4e-23
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		4e-23
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		4e-23
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-23
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		4e-23
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-23
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		4e-23
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		5e-23
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		5e-23
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		5e-23
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		5e-23
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		5e-23
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		5e-23
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		6e-23
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		6e-23
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		6e-23
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		6e-23
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		6e-23
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		7e-23
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		8e-23
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		8e-23
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		8e-23
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		1e-22
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		1e-22
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		1e-22
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		1e-22
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		1e-22
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-22
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-22
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		1e-22
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		1e-22
4ae9_A	343	Structure And Function Of The Human Sperm-specific		1e-22
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		1e-22
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		1e-22
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-22
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		2e-22
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-22
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		2e-22
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-22
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		2e-22
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-22
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		2e-22
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		2e-22
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		3e-22
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		3e-22
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		4e-22
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		4e-22
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		4e-22
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		4e-22
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		4e-22
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		5e-22
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		6e-22
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		6e-22
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		7e-22
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		7e-22
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		7e-22
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		7e-22
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		8e-22
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		8e-22
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		8e-22
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		8e-22
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		8e-22
4fie_A	423	Full-Length Human Pak4 Length = 423		8e-22
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		8e-22
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		8e-22
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		9e-22
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		9e-22
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		9e-22
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		9e-22
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		9e-22
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		1e-21
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		1e-21
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		1e-21
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		1e-21
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		1e-21
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		1e-21
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		1e-21
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		1e-21
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		1e-21
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		1e-21
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-21
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		1e-21
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		1e-21
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		1e-21
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		2e-21
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-21
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		2e-21
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-21
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		2e-21
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-21
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		3e-21
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		3e-21
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		3e-21
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		3e-21
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		4e-21
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		4e-21
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		7e-21
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		9e-21
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		9e-21
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		1e-20
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		1e-20
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		1e-20
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		2e-20
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		2e-20
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		2e-20
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		3e-20
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		4e-20
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		5e-20
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		6e-20
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		6e-20
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		7e-20
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		7e-20
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		7e-20
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		8e-20
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		9e-20
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		1e-19
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		1e-19
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		1e-19
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		1e-19
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		1e-19
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		1e-19
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-19
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		2e-19
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		2e-19
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		2e-19
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-19
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-19
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		2e-19
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-19
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		2e-19
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		3e-19
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		3e-19
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		3e-19
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		3e-19
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		4e-19
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		4e-19
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		4e-19
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		4e-19
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		5e-19
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		6e-19
3kk9_A	282	Camkii Substrate Complex B Length = 282		6e-19
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		6e-19
3kk8_A	284	Camkii Substrate Complex A Length = 284		6e-19
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		7e-19
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		9e-19
3soa_A	444	Full-Length Human Camkii Length = 444		1e-18
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		1e-18
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		1e-18
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		1e-18
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		1e-18
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		1e-18
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		1e-18
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-18
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		2e-18
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-18
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-18
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		2e-18
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		2e-18
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		3e-18
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		3e-18
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-18
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		3e-18
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		4e-18
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		4e-18
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		4e-18
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		5e-18
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		5e-18
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		6e-18
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		6e-18
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-18
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		7e-18
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		7e-18
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		7e-18
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		7e-18
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		8e-18
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		8e-18
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		8e-18
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		9e-18
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		9e-18
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		9e-18
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		9e-18
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		1e-17
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-17
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		1e-17
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		1e-17
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		1e-17
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-17
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		1e-17
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		1e-17
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		2e-17
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		2e-17
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-17
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		2e-17
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-17
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		2e-17
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		2e-17
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		3e-17
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		3e-17
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		3e-17
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-17
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		3e-17
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		3e-17
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		4e-17
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		4e-17
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		4e-17
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		4e-17
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		4e-17
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		4e-17
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		4e-17
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		5e-17
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		5e-17
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		5e-17
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		5e-17
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		5e-17
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		6e-17
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		6e-17
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		6e-17
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		6e-17
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		6e-17
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-17
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		6e-17
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		6e-17
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		6e-17
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		6e-17
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		6e-17
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		6e-17
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		6e-17
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		7e-17
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		7e-17
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		7e-17
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		7e-17
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		7e-17
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		7e-17
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		7e-17
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		7e-17
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		7e-17
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		7e-17
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		7e-17
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		7e-17
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		7e-17
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		7e-17
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		7e-17
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		7e-17
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		8e-17
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		8e-17
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		8e-17
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		8e-17
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		8e-17
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		9e-17
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		9e-17
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		9e-17
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-16
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		1e-16
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		1e-16
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		1e-16
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		1e-16
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-16
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		1e-16
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-16
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		1e-16
2pl0_A	289	Lck Bound To Imatinib Length = 289		2e-16
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		2e-16
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		2e-16
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-16
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-16
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		4e-16
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		4e-16
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		5e-16
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		5e-16
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		5e-16
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-16
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		6e-16
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		6e-16
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		7e-16
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		7e-16
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		7e-16
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		7e-16
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		7e-16
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		7e-16
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		7e-16
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		8e-16
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		8e-16
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		9e-16
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		9e-16
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		1e-15
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		1e-15
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-15
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		1e-15
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		1e-15
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		1e-15
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		1e-15
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		1e-15
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-15
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-15
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-15
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		1e-15
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-15
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		1e-15
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		2e-15
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		2e-15
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		2e-15
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-15
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		2e-15
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		2e-15
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		2e-15
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-15
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-15
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		2e-15
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		2e-15
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		2e-15
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		2e-15
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		2e-15
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		2e-15
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-15
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		2e-15
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-15
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		3e-15
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		3e-15
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		3e-15
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		3e-15
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		4e-15
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		4e-15
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		4e-15
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		5e-15
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		5e-15
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		6e-15
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		6e-15
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		6e-15
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		6e-15
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		6e-15
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		6e-15
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		7e-15
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		7e-15
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		7e-15
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		8e-15
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		9e-15
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		9e-15
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		9e-15
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		9e-15
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		9e-15
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		1e-14
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-14
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		1e-14
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		1e-14
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		1e-14
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		1e-14
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		1e-14
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-14
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		1e-14
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		1e-14
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		1e-14
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		1e-14
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		1e-14
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		1e-14
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		1e-14
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		1e-14
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		1e-14
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		1e-14
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		1e-14
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		1e-14
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		1e-14
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		1e-14
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		1e-14
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		1e-14
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		1e-14
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		1e-14
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		2e-14
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-14
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-14
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		2e-14
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		2e-14
4h58_A	275	Braf In Complex With Compound 3 Length = 275		2e-14
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-14
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-14
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-14
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		2e-14
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		2e-14
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		2e-14
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-14
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		2e-14
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-14
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		2e-14
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		2e-14
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		2e-14
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		2e-14
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-14
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		2e-14
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		2e-14
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		2e-14
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		2e-14
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		3e-14
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		3e-14
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		3e-14
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		3e-14
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		3e-14
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		3e-14
2oza_A	356	Structure Of P38alpha Complex Length = 356		3e-14
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		3e-14
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-14
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		3e-14
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		3e-14
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		3e-14
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		3e-14
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		3e-14
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		3e-14
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		3e-14
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		3e-14
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		4e-14
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		4e-14
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		4e-14
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		4e-14
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		4e-14
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		4e-14
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		4e-14
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		4e-14
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		4e-14
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		4e-14
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		4e-14
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		4e-14
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		4e-14
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		4e-14
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		4e-14
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		4e-14
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		4e-14
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		4e-14
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		4e-14
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		4e-14
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		4e-14
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		4e-14
2oza_B	366	Structure Of P38alpha Complex Length = 366		4e-14
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		4e-14
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		4e-14
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		4e-14
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		4e-14
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		4e-14
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		4e-14
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		4e-14
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		4e-14
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		4e-14
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		4e-14
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		5e-14
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		5e-14
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		5e-14
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		5e-14
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		5e-14
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		5e-14
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		5e-14
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		5e-14
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		5e-14
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		5e-14
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		5e-14
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		5e-14
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		5e-14
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		5e-14
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		5e-14
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		5e-14
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		5e-14
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		5e-14
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		5e-14
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		5e-14
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		6e-14
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		6e-14
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		6e-14
3hec_A	348	P38 In Complex With Imatinib Length = 348		6e-14
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		6e-14
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		6e-14
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		6e-14
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		6e-14
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		6e-14
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		6e-14
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		6e-14
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		6e-14
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		6e-14
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		6e-14
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		6e-14
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		6e-14
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		6e-14
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		6e-14
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		6e-14
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		6e-14
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		6e-14
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		6e-14
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		6e-14
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		6e-14
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		6e-14
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		6e-14
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		6e-14
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		6e-14
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		6e-14
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		7e-14
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		7e-14
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		7e-14
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		7e-14
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		7e-14
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		7e-14
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		7e-14
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		7e-14
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		8e-14
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		8e-14
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		9e-14
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		9e-14
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		9e-14
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		1e-13
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		1e-13
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		1e-13
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		1e-13
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		1e-13
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		1e-13
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-13
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		1e-13
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		1e-13
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		2e-13
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		2e-13
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		2e-13
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		2e-13
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		2e-13
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		2e-13
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		2e-13
3a4o_X	286	Lyn Kinase Domain Length = 286		2e-13
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		2e-13
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-13
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		2e-13
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		2e-13
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		2e-13
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		2e-13
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		2e-13
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		2e-13
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		2e-13
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		2e-13
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		2e-13
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		2e-13
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		3e-13
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-13
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		3e-13
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		3e-13
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		3e-13
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		3e-13
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		3e-13
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		3e-13
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		3e-13
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		3e-13
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		3e-13
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		3e-13
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		3e-13
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		3e-13
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		3e-13
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		3e-13
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		3e-13
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		3e-13
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		3e-13
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		3e-13
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		3e-13
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		3e-13
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		3e-13
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		3e-13
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		3e-13
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		3e-13
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		3e-13
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		3e-13
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		3e-13
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		4e-13
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		4e-13
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		4e-13
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		4e-13
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		4e-13
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		4e-13
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		4e-13
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		4e-13
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		4e-13
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		4e-13
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		4e-13
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		4e-13
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		5e-13
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		5e-13
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		5e-13
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		5e-13
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		6e-13
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		6e-13
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		6e-13
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		6e-13
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		6e-13
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		6e-13
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		7e-13
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		7e-13
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		7e-13
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		7e-13
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		7e-13
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		7e-13
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		8e-13
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		8e-13
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		8e-13
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		8e-13
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		9e-13
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		9e-13
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		9e-13
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		9e-13
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		9e-13
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		9e-13
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		9e-13
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		1e-12
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-12
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		1e-12
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		1e-12
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		1e-12
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-12
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		1e-12
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		1e-12
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		1e-12
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-12
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		1e-12
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-12
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		1e-12
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-12
4exu_A	371	Mapk13, Inactive Form Length = 371		2e-12
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		2e-12
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		2e-12
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		2e-12
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		2e-12
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		2e-12
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		2e-12
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		2e-12
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-12
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		2e-12
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		2e-12
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		3e-12
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		3e-12
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-12
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		3e-12
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		3e-12
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		3e-12
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		3e-12
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		3e-12
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		3e-12
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		3e-12
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		3e-12
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		3e-12
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		3e-12
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		3e-12
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		3e-12
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		3e-12
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		4e-12
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		4e-12
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		4e-12
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		4e-12
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		5e-12
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		5e-12
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		5e-12
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		5e-12
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		5e-12
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		5e-12
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		5e-12
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		6e-12
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		6e-12
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		6e-12
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		6e-12
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		6e-12
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		6e-12
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		7e-12
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		7e-12
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		7e-12
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		7e-12
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		7e-12
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		7e-12
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		7e-12
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		7e-12
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		8e-12
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		8e-12
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		8e-12
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		8e-12
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		9e-12
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		9e-12
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		1e-11
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		1e-11
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		1e-11
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		1e-11
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		1e-11
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		1e-11
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		1e-11
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		1e-11
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		1e-11
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		1e-11
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		1e-11
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-11
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		1e-11
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-11
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		1e-11
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		1e-11
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		1e-11
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		1e-11
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		1e-11
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		1e-11
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		1e-11
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		2e-11
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		2e-11
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		2e-11
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		2e-11
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		2e-11
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		2e-11
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-11
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		2e-11
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		2e-11
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		2e-11
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		3e-11
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		3e-11
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		3e-11
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-11
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-11
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		3e-11
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		3e-11
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		3e-11
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		3e-11
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		3e-11
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		3e-11
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		3e-11
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		3e-11
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-11
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-11
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		4e-11
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		4e-11
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		4e-11
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		4e-11
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		4e-11
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		4e-11
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		4e-11
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		4e-11
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		4e-11
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		4e-11
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		4e-11
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		4e-11
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		4e-11
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		4e-11
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		4e-11
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		4e-11
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		4e-11
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		4e-11
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		4e-11
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		4e-11
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		4e-11
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		5e-11
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		5e-11
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		5e-11
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		5e-11
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		5e-11
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-11
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		5e-11
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		5e-11
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		6e-11
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		6e-11
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		6e-11
4fl2_A	636	Structural And Biophysical Characterization Of The		8e-11
4fl3_A	635	Structural And Biophysical Characterization Of The		8e-11
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		9e-11
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		9e-11
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		1e-10
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		1e-10
1fvr_A	327	Tie2 Kinase Domain Length = 327		1e-10
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		1e-10
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-10
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		1e-10
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		1e-10
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		1e-10
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		2e-10
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-10
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-10
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		2e-10
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-10
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		2e-10
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-10
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		3e-10
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		3e-10
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		3e-10
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		3e-10
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		4e-10
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		6e-10
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		6e-10
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		6e-10
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		6e-10
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		7e-10
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		7e-10
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		7e-10
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		7e-10
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		7e-10
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		7e-10
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		8e-10
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		8e-10
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		9e-10
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		9e-10
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		9e-10
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		9e-10
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		1e-09
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		1e-09
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		1e-09
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		1e-09
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		1e-09
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-09
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-09
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-09
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		1e-09
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		1e-09
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		2e-09
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		2e-09
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		2e-09
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		2e-09
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		2e-09
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		2e-09
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-09
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-09
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-09
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		2e-09
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		2e-09
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		2e-09
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		3e-09
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		3e-09
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		3e-09
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		3e-09
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		3e-09
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		3e-09
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		4e-09
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		4e-09
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		4e-09
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		5e-09
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-09
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		6e-09
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-09
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		7e-09
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		7e-09
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-09
3b2t_A	311	Structure Of Phosphotransferase Length = 311		7e-09
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		7e-09
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		7e-09
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		8e-09
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-09
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		8e-09
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-09
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-09
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-08
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		1e-08
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-08
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-08
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		1e-08
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		1e-08
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		1e-08
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-08
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		1e-08
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-08
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-08
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-08
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-08
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		2e-08
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		2e-08
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		2e-08
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		3e-08
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		3e-08
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-08
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-08
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		4e-08
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		4e-08
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		5e-08
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-08
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		6e-08
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		8e-08
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		9e-08
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		9e-08
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		9e-08
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		9e-08
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		1e-07
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		1e-07
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		1e-07
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		1e-07
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-07
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		1e-07
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-07
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		1e-07
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		1e-07
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		1e-07
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		2e-07
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		2e-07
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		2e-07
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-07
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-07
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		3e-07
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		3e-07
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		3e-07
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		3e-07
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		3e-07
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-07
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		3e-07
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		4e-07
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		4e-07
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		4e-07
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		5e-07
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		5e-07
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		5e-07
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		5e-07
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		5e-07
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		5e-07
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		5e-07
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		5e-07
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		5e-07
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		5e-07
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		6e-07
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		6e-07
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		6e-07
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		7e-07
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		7e-07
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		7e-07
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		7e-07
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		8e-07
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		8e-07
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		9e-07
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		9e-07
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		9e-07
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		9e-07
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		1e-06

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score =  166 bits (420), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 104/311 (33%), Positives = 169/311 (54%), Gaps = 25/311 (8%)
Query: 25  QFRRRRHHFPTSNPTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS 84
           Q R+R   F T      ++++  D +K++ LG GNGG+V+KV H+ S  + A K+++   
Sbjct: 4   QQRKRLEAFLTQKQKVGELKD-DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI 62
Query: 85  STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLS 144
              IR+Q   E ++L   +S +IV  +  FY+ +GEI   MEHM+ GSL   L+   ++ 
Sbjct: 63  KPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-DGEISICMEHMDGGSLDQVLKKAGRIP 121
Query: 145 EDVISGVAYRVLKGLQYL-HGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXX 203
           E ++  V+  V+KGL YL    +I+H D+KPSN+L+N +GE+K+ DFGVS          
Sbjct: 122 EQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVS---------- 171
Query: 204 XXXXXXXXXIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYP 263
                    I   A + +GT +YMSPER+     G  Y    D+WS+G+ ++E  VG YP
Sbjct: 172 ------GQLIDSMANSFVGTRSYMSPERLQ----GTHYSVQSDIWSMGLSLVEMAVGRYP 221
Query: 264 LIGFGEKPDLMALICAICFGERLEMPETA-SPEFRRFVRSCLEKDWRKRGTVEELLAYPF 322
           +        +  L+  I      ++P    S EF+ FV  CL K+  +R  +++L+ + F
Sbjct: 222 IGSGSGSMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF 281
Query: 323 VTKRSSSSNIE 333
           + KRS +  ++
Sbjct: 282 I-KRSDAEEVD 291

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score =  163 bits (413), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 101/295 (34%), Positives = 161/295 (54%), Gaps = 30/295 (10%)
Query: 47  SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQF 106
            D +K++ LG GNGG+V+KV H+ S  + A K+++      IR+Q   E ++L   +S +
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 107 IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYL-HGM 165
           IV  +  FY+ +GEI   MEHM+ GSL   L+   ++ E ++  V+  V+KGL YL    
Sbjct: 66  IVGFYGAFYS-DGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH 124
Query: 166 QIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCA 225
           +I+H D+KPSN+L+N +GE+K+ DFGVS                   I   A + +GT +
Sbjct: 125 KIMHRDVKPSNILVNSRGEIKLCDFGVS----------------GQLIDSMANSFVGTRS 168
Query: 226 YMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPD------LMALICA 279
           YMSPER+     G  Y    D+WS+G+ ++E  VG YP+     K D      +  L+  
Sbjct: 169 YMSPERLQ----GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEDSRPPMAIFELLDY 224
Query: 280 ICFGERLEMPETA-SPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNIE 333
           I      ++P    S EF+ FV  CL K+  +R  +++L+ + F+ KRS +  ++
Sbjct: 225 IVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI-KRSDAEEVD 278

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score =  162 bits (411), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 101/291 (34%), Positives = 160/291 (54%), Gaps = 32/291 (10%)
Query: 47  SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQF 106
            D +K++ LG GNGG+V+KV H+ S  + A K+++      IR+Q   E ++L   +S +
Sbjct: 9   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 68
Query: 107 IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYL-HGM 165
           IV  +  FY+ +GEI   MEHM+ GSL   L+   ++ E ++  V+  V+KGL YL    
Sbjct: 69  IVGFYGAFYS-DGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH 127
Query: 166 QIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCA 225
           +I+H D+KPSN+L+N +GE+K+ DFGVS                   I E A   +GT +
Sbjct: 128 KIMHRDVKPSNILVNSRGEIKLCDFGVS----------------GQLIDEMANEFVGTRS 171
Query: 226 YMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDL--MALICAICFG 283
           YMSPER+     G  Y    D+WS+G+ ++E  VG YP      +P +    L+  I   
Sbjct: 172 YMSPERLQ----GTHYSVQSDIWSMGLSLVEMAVGRYP------RPPMAIFELLDYIVNE 221
Query: 284 ERLEMPETA-SPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNIE 333
              ++P    S EF+ FV  CL K+  +R  +++L+ + F+ KRS +  ++
Sbjct: 222 PPPKLPSAVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI-KRSDAEEVD 271

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score =  155 bits (392), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 106/351 (30%), Positives = 173/351 (49%), Gaps = 63/351 (17%)
Query: 23  NHQFRRRRHHFPTSNPTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNT 82
           + Q R+R   F T      ++++  D +K++ LG GNGG+V+KV H+ S  + A K+++ 
Sbjct: 45  DEQQRKRLEAFLTQKQKVGELKD-DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL 103
Query: 83  TSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKK 142
                IR+Q   E ++L   +S +IV  +  FY+ +GEI   MEHM+ GSL   L+   +
Sbjct: 104 EIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-DGEISICMEHMDGGSLDQVLKKAGR 162
Query: 143 LSEDVISGVAYRVLKGLQYL-HGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRX 201
           + E ++  V+  V+KGL YL    +I+H D+KPSN+L+N +GE+K+ DFGVS        
Sbjct: 163 IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVS-------- 214
Query: 202 XXXXXXXXXXXIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGH 261
                      I   A + +GT +YMSPER+     G  Y    D+WS+G+ ++E  VG 
Sbjct: 215 --------GQLIDSMANSFVGTRSYMSPERLQ----GTHYSVQSDIWSMGLSLVEMAVGR 262
Query: 262 YPL------------------------------------IGFGEKPDL--MALICAICFG 283
           YP+                                     G   +P +    L+  I   
Sbjct: 263 YPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNE 322
Query: 284 ERLEMPETA-SPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNIE 333
              ++P    S EF+ FV  CL K+  +R  +++L+ + F+ KRS +  ++
Sbjct: 323 PPPKLPSAVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI-KRSDAEEVD 372

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score =  155 bits (391), Expect = 4e-38,   Method: Compositional matrix adjust.
 Identities = 106/351 (30%), Positives = 173/351 (49%), Gaps = 63/351 (17%)
Query: 23  NHQFRRRRHHFPTSNPTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNT 82
           + Q R+R   F T      ++++  D +K++ LG GNGG+V+KV H+ S  + A K+++ 
Sbjct: 10  DEQQRKRLEAFLTQKQKVGELKD-DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL 68
Query: 83  TSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKK 142
                IR+Q   E ++L   +S +IV  +  FY+ +GEI   MEHM+ GSL   L+   +
Sbjct: 69  EIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-DGEISICMEHMDGGSLDQVLKKAGR 127
Query: 143 LSEDVISGVAYRVLKGLQYL-HGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRX 201
           + E ++  V+  V+KGL YL    +I+H D+KPSN+L+N +GE+K+ DFGVS        
Sbjct: 128 IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVS-------- 179
Query: 202 XXXXXXXXXXXIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGH 261
                      I   A + +GT +YMSPER+     G  Y    D+WS+G+ ++E  VG 
Sbjct: 180 --------GQLIDSMANSFVGTRSYMSPERLQ----GTHYSVQSDIWSMGLSLVEMAVGR 227
Query: 262 YPL------------------------------------IGFGEKPDL--MALICAICFG 283
           YP+                                     G   +P +    L+  I   
Sbjct: 228 YPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNE 287
Query: 284 ERLEMPETA-SPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNIE 333
              ++P    S EF+ FV  CL K+  +R  +++L+ + F+ KRS +  ++
Sbjct: 288 PPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI-KRSDAEEVD 337

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score =  151 bits (381), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 101/326 (30%), Positives = 162/326 (49%), Gaps = 62/326 (19%)
Query: 48  DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFI 107
           D +K++ LG GNGG+V+KV H+ S  + A K+++      IR+Q   E ++L   +S +I
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 108 VKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYL-HGMQ 166
           V  +  FY+ +GEI   MEHM+ GSL   L+   ++ E ++  V+  V+KGL YL    +
Sbjct: 67  VGFYGAFYS-DGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 125
Query: 167 IIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAY 226
           I+H D+KPSN+L+N +GE+K+ DFGVS                   I   A + +GT +Y
Sbjct: 126 IMHRDVKPSNILVNSRGEIKLCDFGVS----------------GQLIDSMANSFVGTRSY 169
Query: 227 MSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPL---------------------- 264
           MSPER+     G  Y    D+WS+G+ ++E  VG YP+                      
Sbjct: 170 MSPERLQ----GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAE 225
Query: 265 --------------IGFGEKPDL--MALICAICFGERLEMPETA-SPEFRRFVRSCLEKD 307
                          G   +P +    L+  I      ++P    S EF+ FV  CL K+
Sbjct: 226 TPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKN 285
Query: 308 WRKRGTVEELLAYPFVTKRSSSSNIE 333
             +R  +++L+ + F+ KRS +  ++
Sbjct: 286 PAERADLKQLMVHAFI-KRSDAEEVD 310

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score =  151 bits (381), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 101/326 (30%), Positives = 162/326 (49%), Gaps = 62/326 (19%)
Query: 48  DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFI 107
           D +K++ LG GNGG+V+KV H+ S  + A K+++      IR+Q   E ++L   +S +I
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 108 VKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYL-HGMQ 166
           V  +  FY+ +GEI   MEHM+ GSL   L+   ++ E ++  V+  V+KGL YL    +
Sbjct: 67  VGFYGAFYS-DGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 125
Query: 167 IIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAY 226
           I+H D+KPSN+L+N +GE+K+ DFGVS                   I   A + +GT +Y
Sbjct: 126 IMHRDVKPSNILVNSRGEIKLCDFGVS----------------GQLIDSMANSFVGTRSY 169
Query: 227 MSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPL---------------------- 264
           MSPER+     G  Y    D+WS+G+ ++E  VG YP+                      
Sbjct: 170 MSPERLQ----GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAE 225
Query: 265 --------------IGFGEKPDL--MALICAICFGERLEMPETA-SPEFRRFVRSCLEKD 307
                          G   +P +    L+  I      ++P    S EF+ FV  CL K+
Sbjct: 226 TPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKN 285
Query: 308 WRKRGTVEELLAYPFVTKRSSSSNIE 333
             +R  +++L+ + F+ KRS +  ++
Sbjct: 286 PAERADLKQLMVHAFI-KRSDAEEVD 310

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score =  150 bits (380), Expect = 7e-37,   Method: Compositional matrix adjust.
 Identities = 101/327 (30%), Positives = 162/327 (49%), Gaps = 62/327 (18%)
Query: 47  SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQF 106
            D +K++ LG GNGG+V+KV H+ S  + A K+++      IR+Q   E ++L   +S +
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 107 IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYL-HGM 165
           IV  +  FY+ +GEI   MEHM+ GSL   L+   ++ E ++  V+  V+KGL YL    
Sbjct: 66  IVGFYGAFYS-DGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH 124
Query: 166 QIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCA 225
           +I+H D+KPSN+L+N +GE+K+ DFGVS                   I   A + +GT +
Sbjct: 125 KIMHRDVKPSNILVNSRGEIKLCDFGVS----------------GQLIDSMANSFVGTRS 168
Query: 226 YMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPL--------------------- 264
           YMSPER+     G  Y    D+WS+G+ ++E  VG YP+                     
Sbjct: 169 YMSPERLQ----GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAA 224
Query: 265 ---------------IGFGEKPDL--MALICAICFGERLEMPETA-SPEFRRFVRSCLEK 306
                           G   +P +    L+  I      ++P    S EF+ FV  CL K
Sbjct: 225 ETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIK 284
Query: 307 DWRKRGTVEELLAYPFVTKRSSSSNIE 333
           +  +R  +++L+ + F+ KRS +  ++
Sbjct: 285 NPAERADLKQLMVHAFI-KRSDAEEVD 310

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score =  150 bits (380), Expect = 7e-37,   Method: Compositional matrix adjust.
 Identities = 101/327 (30%), Positives = 162/327 (49%), Gaps = 62/327 (18%)
Query: 47  SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQF 106
            D +K++ LG GNGG+V+KV H+ S  + A K+++      IR+Q   E ++L   +S +
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 107 IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYL-HGM 165
           IV  +  FY+ +GEI   MEHM+ GSL   L+   ++ E ++  V+  V+KGL YL    
Sbjct: 66  IVGFYGAFYS-DGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH 124
Query: 166 QIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCA 225
           +I+H D+KPSN+L+N +GE+K+ DFGVS                   I   A + +GT +
Sbjct: 125 KIMHRDVKPSNILVNSRGEIKLCDFGVS----------------GQLIDSMANSFVGTRS 168
Query: 226 YMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPL--------------------- 264
           YMSPER+     G  Y    D+WS+G+ ++E  VG YP+                     
Sbjct: 169 YMSPERLQ----GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAA 224
Query: 265 ---------------IGFGEKPDL--MALICAICFGERLEMPETA-SPEFRRFVRSCLEK 306
                           G   +P +    L+  I      ++P    S EF+ FV  CL K
Sbjct: 225 ETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIK 284
Query: 307 DWRKRGTVEELLAYPFVTKRSSSSNIE 333
           +  +R  +++L+ + F+ KRS +  ++
Sbjct: 285 NPAERADLKQLMVHAFI-KRSDAEEVD 310

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score =  149 bits (377), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 101/331 (30%), Positives = 162/331 (48%), Gaps = 66/331 (19%)
Query: 47  SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQF 106
            D ++++ LG GNGG+V KV+H+ S  I A K+++      IR+Q   E ++L   +S +
Sbjct: 16  DDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 75
Query: 107 IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYL-HGM 165
           IV  +  FY+ +GEI   MEHM+ GSL   L+  K++ E+++  V+  VL+GL YL    
Sbjct: 76  IVGFYGAFYS-DGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKH 134
Query: 166 QIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCA 225
           QI+H D+KPSN+L+N +GE+K+ DFGVS                   I   A + +GT +
Sbjct: 135 QIMHRDVKPSNILVNSRGEIKLCDFGVS----------------GQLIDSMANSFVGTRS 178
Query: 226 YMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLI-------------------- 265
           YM+PER+     G  Y    D+WS+G+ ++E  VG YP+                     
Sbjct: 179 YMAPERLQ----GTHYSVQSDIWSMGLSLVELAVGRYPIPPPDAKELEAIFGRPVVDGEE 234
Query: 266 --------------------GFGEKPDL--MALICAICFGERLEMPETA-SPEFRRFVRS 302
                               G   +P +    L+  I      ++P    +P+F+ FV  
Sbjct: 235 GEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNK 294
Query: 303 CLEKDWRKRGTVEELLAYPFVTKRSSSSNIE 333
           CL K+  +R  ++ L  + F+ KRS    ++
Sbjct: 295 CLIKNPAERADLKMLTNHTFI-KRSEVEEVD 324

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score =  127 bits (319), Expect = 9e-30,   Method: Compositional matrix adjust.
 Identities = 89/286 (31%), Positives = 134/286 (46%), Gaps = 25/286 (8%)
Query: 52  LTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCH 111
           L  LG G+ G VYK  H+++  I A+K +   S      +   E  I+++ DS  +VK +
Sbjct: 34  LEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDL---QEIIKEISIMQQCDSPHVVKYY 90
Query: 112 AVFYTIEGEICFVMEHMERGSLFDSLRVRKK-LSEDVISGVAYRVLKGLQYLHGMQIIHG 170
             ++    ++  VME+   GS+ D +R+R K L+ED I+ +    LKGL+YLH M+ IH 
Sbjct: 91  GSYFK-NTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHR 149
Query: 171 DIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPE 230
           DIK  N+L+N +G  K+ADFGV+  + +                      +GT  +M+PE
Sbjct: 150 DIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRN--------------XVIGTPFWMAPE 195
Query: 231 RVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPE 290
            +        Y    D+WSLG+  +E   G  P       P     +           PE
Sbjct: 196 VIQE----IGYNCVADIWSLGITAIEMAEGKPPYADI--HPMRAIFMIPTNPPPTFRKPE 249
Query: 291 TASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNIEGLI 336
             S  F  FV+ CL K   +R T  +LL +PFV      S +  LI
Sbjct: 250 LWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKGVSILRDLI 295

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score =  124 bits (310), Expect = 9e-29,   Method: Compositional matrix adjust.
 Identities = 82/284 (28%), Positives = 142/284 (50%), Gaps = 25/284 (8%)
Query: 47  SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEI-LKRLDSQ 105
            DL+ +  LG G  G+V K+RH  S  I A+K +  T ++  + +   + +I ++ +D  
Sbjct: 51  DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 110
Query: 106 FIVKCHAVFYTIEGEICFVMEHMERG-SLFDSLRVRK--KLSEDVISGVAYRVLKGLQYL 162
           F V  +   +  EG++   ME M+     F    + K   + ED++  +A  ++K L++L
Sbjct: 111 FTVTFYGALFR-EGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHL 169
Query: 163 HG-MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACM 221
           H  + +IH D+KPSN+LIN  G+VK+ DFG+S  + ++                A     
Sbjct: 170 HSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDSV---------------AKTIDA 214
Query: 222 GTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAIC 281
           G   YM+PER++ E     Y    D+WSLG+ ++E  +  +P   +G        +  + 
Sbjct: 215 GCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP---FQQLKQVV 271
Query: 282 FGERLEMP-ETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVT 324
                ++P +  S EF  F   CL+K+ ++R T  EL+ +PF T
Sbjct: 272 EEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFT 315

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score =  122 bits (306), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 84/289 (29%), Positives = 144/289 (49%), Gaps = 27/289 (9%)
Query: 47  SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEI-LKRLDSQ 105
            DL+ +  LG G  G+V K+RH  S  I A+K +  T ++  + +   + +I ++ +D  
Sbjct: 7   DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66
Query: 106 FIVKCHAVFYTIEGEICFVMEHMERG-SLFDSLRVRK--KLSEDVISGVAYRVLKGLQYL 162
           F V  +   +  EG++   ME M+     F    + K   + ED++  +A  ++K L++L
Sbjct: 67  FTVTFYGALFR-EGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHL 125
Query: 163 HG-MQIIHGDIKPSNLLINGKGEVKIADFGVS-RIVEETRXXXXXXXXXXXXIGEAAIAC 220
           H  + +IH D+KPSN+LIN  G+VK+ DFG+S  +V++                 A    
Sbjct: 126 HSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDV----------------AKDID 169
Query: 221 MGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAI 280
            G   YM+PER++ E     Y    D+WSLG+ ++E  +  +P   +G        +  +
Sbjct: 170 AGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP---FQQLKQV 226
Query: 281 CFGERLEMP-ETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSS 328
                 ++P +  S EF  F   CL+K+ ++R T  EL+ +PF T   S
Sbjct: 227 VEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHES 275

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score =  120 bits (300), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 89/290 (30%), Positives = 149/290 (51%), Gaps = 34/290 (11%)
Query: 46  ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEI-LKRLDS 104
           I+DL+ L  +G G  G V+K+R +K+  + A+K +  + +     +   + ++ LK  D 
Sbjct: 24  INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDC 83
Query: 105 QFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKK--LSEDVISGVAYRVLKGLQYL 162
            +IV+C   F T   ++   ME M  G+  + L+ R +  + E ++  +   ++K L YL
Sbjct: 84  PYIVQCFGTFIT-NTDVFIAMELM--GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYL 140
Query: 163 ---HGMQIIHGDIKPSNLLINGKGEVKIADFGVS-RIVEETRXXXXXXXXXXXXIGEAAI 218
              HG  +IH D+KPSN+L++ +G++K+ DFG+S R+V++                +A  
Sbjct: 141 KEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLVDD----------------KAKD 182
Query: 219 ACMGTCAYMSPERVD-SERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALI 277
              G  AYM+PER+D  +    DY    DVWSLG+ ++E   G +P      K D   L 
Sbjct: 183 RSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNC--KTDFEVLT 240
Query: 278 CAICFGERLEMPETA--SPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTK 325
             +   E   +P     S +F+ FV+ CL KD RKR    +LL + F+ +
Sbjct: 241 -KVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKR 289

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 83/284 (29%), Positives = 136/284 (47%), Gaps = 28/284 (9%)
Query: 51  KLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKC 110
           KL  +G G+ G VYK     +  + A+K+++   +         E  +L + DS +I + 
Sbjct: 23  KLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRY 82
Query: 111 HAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHG 170
               Y    ++  +ME++  GS  D L+    L E  I+ +   +LKGL YLH  + IH 
Sbjct: 83  FGS-YLKSTKLWIIMEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHR 140
Query: 171 DIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPE 230
           DIK +N+L++ +G+VK+ADFGV+  + +T+                    +GT  +M+PE
Sbjct: 141 DIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRN--------------XFVGTPFWMAPE 186
Query: 231 RVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDL--MALICAICFGERLEM 288
            +        Y F  D+WSLG+  +E   G  P        DL  M ++  I       +
Sbjct: 187 VIKQSA----YDFKADIWSLGITAIELAKGEPP------NSDLHPMRVLFLIPKNSPPTL 236
Query: 289 PETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNI 332
               S  F+ FV +CL KD R R T +ELL + F+T+ +  ++ 
Sbjct: 237 EGQHSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRYTKKTSF 280

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score =  114 bits (285), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 81/293 (27%), Positives = 138/293 (47%), Gaps = 32/293 (10%)
Query: 45  NISD----LKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILK 100
           NI+D      KL  +G G+ G V+K    ++  + A+K+++   +         E  +L 
Sbjct: 17  NIADPEELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLS 76
Query: 101 RLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQ 160
           + DS ++ K +   Y    ++  +ME++  GS  D LR      E  I+ +   +LKGL 
Sbjct: 77  QCDSSYVTKYYGS-YLKGSKLWIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLD 134
Query: 161 YLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIAC 220
           YLH  + IH DIK +N+L++ +G+VK+ADFGV+  + +T+                    
Sbjct: 135 YLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRN--------------TF 180
Query: 221 MGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDL--MALIC 278
           +GT  +M+PE +        Y    D+WSLG+  +E   G  P        D+  M ++ 
Sbjct: 181 VGTPFWMAPEVIQQSA----YDSKADIWSLGITAIELAKGEPP------NSDMHPMRVLF 230
Query: 279 AICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSN 331
            I       +    +  F+ F+ +CL KD   R T +ELL + F+ K S  ++
Sbjct: 231 LIPKNNPPTLVGDFTKSFKEFIDACLNKDPSFRPTAKELLKHKFIVKNSKKTS 283

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 84/299 (28%), Positives = 138/299 (46%), Gaps = 39/299 (13%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTSST-----IIRHQAAHEAEILKRLDSQFIVK 109
           LG G   IV K R + +   YA K +    S      + R +   E  IL+++    I+ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 110 CHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIH 169
            H V Y    ++  ++E +  G LFD L  ++ LSE+  +    ++L G+ YLH  +I H
Sbjct: 80  LHDV-YENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAH 138
Query: 170 GDIKPSNLLINGKG----EVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCA 225
            D+KP N+++  K      +K+ DFG++  +E+               G       GT  
Sbjct: 139 FDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED---------------GVEFKNIFGTPE 183
Query: 226 YMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGER 285
           +++PE V+ E      G   D+WS+GV+    L G  P +G   K + +A I A+ +   
Sbjct: 184 FVAPEIVNYE----PLGLEADMWSIGVITYILLSGASPFLG-DTKQETLANITAVSYDFD 238
Query: 286 LEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVT---------KRSSSSNIEGL 335
            E     S   + F+R  L K+ RKR T++E L +P++T         +R S  N+E  
Sbjct: 239 EEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMVRRESVVNLENF 297

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score =  113 bits (283), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 83/299 (27%), Positives = 138/299 (46%), Gaps = 39/299 (13%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTSST-----IIRHQAAHEAEILKRLDSQFIVK 109
           LG G   IV K R + +   YA K +    S      + R +   E  IL+++    ++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 110 CHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIH 169
            H V Y    ++  ++E +  G LFD L  ++ LSE+  +    ++L G+ YLH  +I H
Sbjct: 80  LHDV-YENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAH 138
Query: 170 GDIKPSNLLINGKG----EVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCA 225
            D+KP N+++  K      +K+ DFG++  +E+               G       GT  
Sbjct: 139 FDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED---------------GVEFKNIFGTPE 183
Query: 226 YMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGER 285
           +++PE V+ E      G   D+WS+GV+    L G  P +G   K + +A I A+ +   
Sbjct: 184 FVAPEIVNYE----PLGLEADMWSIGVITYILLSGASPFLG-DTKQETLANITAVSYDFD 238
Query: 286 LEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVT---------KRSSSSNIEGL 335
            E     S   + F+R  L K+ RKR T++E L +P++T         +R S  N+E  
Sbjct: 239 EEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRESVVNLENF 297

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  113 bits (283), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 83/299 (27%), Positives = 138/299 (46%), Gaps = 39/299 (13%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTSST-----IIRHQAAHEAEILKRLDSQFIVK 109
           LG G   IV K R + +   YA K +    S      + R +   E  IL+++    ++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 110 CHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIH 169
            H V Y    ++  ++E +  G LFD L  ++ LSE+  +    ++L G+ YLH  +I H
Sbjct: 80  LHDV-YENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAH 138
Query: 170 GDIKPSNLLINGKG----EVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCA 225
            D+KP N+++  K      +K+ DFG++  +E+               G       GT  
Sbjct: 139 FDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED---------------GVEFKNIFGTPE 183
Query: 226 YMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGER 285
           +++PE V+ E      G   D+WS+GV+    L G  P +G   K + +A I A+ +   
Sbjct: 184 FVAPEIVNYE----PLGLEADMWSIGVITYILLSGASPFLG-DTKQETLANITAVSYDFD 238
Query: 286 LEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVT---------KRSSSSNIEGL 335
            E     S   + F+R  L K+ RKR T++E L +P++T         +R S  N+E  
Sbjct: 239 EEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRESVVNLENF 297

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 82/297 (27%), Positives = 142/297 (47%), Gaps = 39/297 (13%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLN---TTSST--IIRHQAAHEAEILKRLDSQFIVK 109
           LG G   +V K R + +   YA K +    T SS   + R     E  ILK +    ++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 110 CHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIH 169
            H V Y  + ++  ++E +  G LFD L  ++ L+E+  +    ++L G+ YLH +QI H
Sbjct: 79  LHEV-YENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAH 137
Query: 170 GDIKPSNLLING----KGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCA 225
            D+KP N+++      K  +KI DFG++  ++                G       GT A
Sbjct: 138 FDLKPENIMLLDRNVPKPRIKIIDFGLAHKID---------------FGNEFKNIFGTPA 182
Query: 226 YMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGER 285
           +++PE V+ E      G   D+WS+GV+    L G  P +G   K + +A + A+ +   
Sbjct: 183 FVAPEIVNYE----PLGLEADMWSIGVITYILLSGASPFLG-DTKQETLANVSAVNYEFE 237
Query: 286 LEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV---------TKRSSSSNIE 333
            E     S   + F+R  L KD +KR T+++ L +P++         ++++S+ N+E
Sbjct: 238 DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSRKASAVNME 294

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 84/289 (29%), Positives = 135/289 (46%), Gaps = 35/289 (12%)
Query: 48  DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRL-DSQF 106
           DLK L  +G G  G V K+ H+ S  I A+K + +T     + Q   + +++ R  D  +
Sbjct: 23  DLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPY 82
Query: 107 IVKCHAVFYTIEGEICFVMEHMERGSLFDSLR------VRKKLSEDVISGVAYRVLKGLQ 160
           IV+ +   +  EG+    ME M   + FD         +   + E+++  +    +K L 
Sbjct: 83  IVQFYGALFR-EGDCWICMELM--STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALN 139
Query: 161 YL-HGMQIIHGDIKPSNLLINGKGEVKIADFGVS-RIVEETRXXXXXXXXXXXXIGEAAI 218
           +L   ++IIH DIKPSN+L++  G +K+ DFG+S ++V+                  A  
Sbjct: 140 HLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSI----------------AKT 183
Query: 219 ACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALIC 278
              G   YM+PER+D       Y    DVWSLG+ + E   G +P   +    D +  + 
Sbjct: 184 RDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVV 243
Query: 279 AICFGERLEMPETA----SPEFRRFVRSCLEKDWRKRGTVEELLAYPFV 323
               G+  ++  +     SP F  FV  CL KD  KR   +ELL +PF+
Sbjct: 244 K---GDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFI 289

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 80/289 (27%), Positives = 136/289 (47%), Gaps = 27/289 (9%)
Query: 47  SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKR-LDSQ 105
            DL+ +  LG G  G+V K RH  S  I A+K +  T ++  + +   + +I  R +D  
Sbjct: 34  DDLEPIXELGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQKRLLXDLDISXRTVDCP 93
Query: 106 FIVKCHAVFYTIEGE--ICFVMEHMERGSLFDSLRVR-KKLSEDVISGVAYRVLKGLQYL 162
           F V  +   +  EG+  IC  +        +  +  + + + ED++  +A  ++K L++L
Sbjct: 94  FTVTFYGALFR-EGDVWICXELXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHL 152
Query: 163 HG-MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACM 221
           H  + +IH D+KPSN+LIN  G+VK  DFG+S  +                + + A    
Sbjct: 153 HSKLSVIHRDVKPSNVLINALGQVKXCDFGISGYL----------------VDDVAKDID 196
Query: 222 GTC-AYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAI 280
             C  Y +PER++ E     Y    D+WSLG+  +E  +  +P   +G        +  +
Sbjct: 197 AGCKPYXAPERINPELNQKGYSVKSDIWSLGITXIELAILRFPYDSWGTP---FQQLKQV 253
Query: 281 CFGERLEMP-ETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSS 328
                 ++P +  S EF  F   CL+K+ ++R T  EL  +PF T   S
Sbjct: 254 VEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELXQHPFFTLHES 302

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  112 bits (281), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 89/277 (32%), Positives = 133/277 (48%), Gaps = 22/277 (7%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVF 114
           LG G  G VYK ++++++ + A KV++T S   +      E +IL   D   IVK    F
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMV-EIDILASCDHPNIVKLLDAF 103
Query: 115 YTIEGEICFVMEHMERGSLFDS--LRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDI 172
           Y  E  +  ++E    G++ D+  L + + L+E  I  V  + L  L YLH  +IIH D+
Sbjct: 104 Y-YENNLWILIEFCAGGAV-DAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDL 161
Query: 173 KPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERV 232
           K  N+L    G++K+ADFGVS   + TR                  + +GT  +M+PE V
Sbjct: 162 KAGNILFTLDGDIKLADFGVS--AKNTRTIQRRD------------SFIGTPYWMAPEVV 207
Query: 233 DSERWGG-DYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPET 291
             E      Y +  DVWSLG+ ++E      P       P  + L  A      L  P  
Sbjct: 208 MCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELN--PMRVLLKIAKSEPPTLAQPSR 265
Query: 292 ASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSS 328
            S  F+ F++ CLEK+   R T  +LL +PFVT  S+
Sbjct: 266 WSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSN 302

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score =  112 bits (281), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 95/285 (33%), Positives = 127/285 (44%), Gaps = 26/285 (9%)
Query: 54  VLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEIL-KRLDSQFIVKCHA 112
           VLG G  GIVY  R   +    A+K +    S     Q  HE   L K L  + IV+   
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRY--SQPLHEEIALHKHLKHKNIVQYLG 86
Query: 113 VFYTIEGEICFVMEHMERGSLFDSLRVR---KKLSEDVISGVAYRVLKGLQYLHGMQIIH 169
            F +  G I   ME +  GSL   LR +    K +E  I     ++L+GL+YLH  QI+H
Sbjct: 87  SF-SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVH 145
Query: 170 GDIKPSNLLING-KGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMS 228
            DIK  N+LIN   G +KI+DFG S+ +                I        GT  YM+
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRL--------------AGINPCTETFTGTLQYMA 191
Query: 229 PERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEM 288
           PE +D    G  YG A D+WSLG  ++E   G  P    GE     A+     F    E+
Sbjct: 192 PEIIDKGPRG--YGKAADIWSLGCTIIEMATGKPPFYELGEP--QAAMFKVGMFKVHPEI 247
Query: 289 PETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNIE 333
           PE+ S E + F+  C E D  KR    +LL   F+   S     +
Sbjct: 248 PESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKKKKTQ 292

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score =  112 bits (280), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 90/277 (32%), Positives = 134/277 (48%), Gaps = 22/277 (7%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVF 114
           LG G  G VYK ++++++ + A KV++T S   +      E +IL   D   IVK    F
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMV-EIDILASCDHPNIVKLLDAF 103
Query: 115 YTIEGEICFVMEHMERGSLFDS--LRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDI 172
           Y  E  +  ++E    G++ D+  L + + L+E  I  V  + L  L YLH  +IIH D+
Sbjct: 104 Y-YENNLWILIEFCAGGAV-DAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDL 161
Query: 173 KPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERV 232
           K  N+L    G++K+ADFGVS   + TR                  + +GT  +M+PE V
Sbjct: 162 KAGNILFTLDGDIKLADFGVS--AKNTRXIQRRD------------SFIGTPYWMAPEVV 207
Query: 233 DSERWGG-DYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPET 291
             E      Y +  DVWSLG+ ++E      P       P  + L  A      L  P  
Sbjct: 208 MCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELN--PMRVLLKIAKSEPPTLAQPSR 265
Query: 292 ASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSS 328
            S  F+ F++ CLEK+   R T  +LL +PFVT  S+
Sbjct: 266 WSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSN 302

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score =  112 bits (280), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 94/275 (34%), Positives = 125/275 (45%), Gaps = 26/275 (9%)
Query: 54  VLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEIL-KRLDSQFIVKCHA 112
           VLG G  GIVY  R   +    A+K +    S     Q  HE   L K L  + IV+   
Sbjct: 15  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRY--SQPLHEEIALHKHLKHKNIVQYLG 72
Query: 113 VFYTIEGEICFVMEHMERGSLFDSLRVR---KKLSEDVISGVAYRVLKGLQYLHGMQIIH 169
            F +  G I   ME +  GSL   LR +    K +E  I     ++L+GL+YLH  QI+H
Sbjct: 73  SF-SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVH 131
Query: 170 GDIKPSNLLING-KGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMS 228
            DIK  N+LIN   G +KI+DFG S+ +                I        GT  YM+
Sbjct: 132 RDIKGDNVLINTYSGVLKISDFGTSKRL--------------AGINPCTETFTGTLQYMA 177
Query: 229 PERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEM 288
           PE +D    G  YG A D+WSLG  ++E   G  P    GE     A+     F    E+
Sbjct: 178 PEIIDKGPRG--YGKAADIWSLGCTIIEMATGKPPFYELGEPQ--AAMFKVGMFKVHPEI 233
Query: 289 PETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV 323
           PE+ S E + F+  C E D  KR    +LL   F+
Sbjct: 234 PESMSAEAKAFILKCFEPDPDKRACANDLLVDEFL 268

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  112 bits (279), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 90/277 (32%), Positives = 133/277 (48%), Gaps = 22/277 (7%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVF 114
           LG G  G VYK ++++++ + A KV++T S   +      E +IL   D   IVK    F
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMV-EIDILASCDHPNIVKLLDAF 103
Query: 115 YTIEGEICFVMEHMERGSLFDS--LRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDI 172
           Y  E  +  ++E    G++ D+  L + + L+E  I  V  + L  L YLH  +IIH D+
Sbjct: 104 Y-YENNLWILIEFCAGGAV-DAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDL 161
Query: 173 KPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERV 232
           K  N+L    G++K+ADFGVS   + TR                    +GT  +M+PE V
Sbjct: 162 KAGNILFTLDGDIKLADFGVS--AKNTRXIQRRD------------XFIGTPYWMAPEVV 207
Query: 233 DSERWGG-DYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPET 291
             E      Y +  DVWSLG+ ++E      P       P  + L  A      L  P  
Sbjct: 208 MCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELN--PMRVLLKIAKSEPPTLAQPSR 265
Query: 292 ASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSS 328
            S  F+ F++ CLEK+   R T  +LL +PFVT  S+
Sbjct: 266 WSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSN 302

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  111 bits (278), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 82/299 (27%), Positives = 138/299 (46%), Gaps = 39/299 (13%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTSST-----IIRHQAAHEAEILKRLDSQFIVK 109
           LG G   IV K R + +   YA K +    S      + R +   E  IL+++    ++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 110 CHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIH 169
            H V Y    ++  ++E +  G LFD L  ++ LSE+  +    ++L G+ YLH  +I H
Sbjct: 80  LHDV-YENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAH 138
Query: 170 GDIKPSNLLINGKG----EVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCA 225
            D+KP N+++  K      +K+ DFG++  +E+               G       GT  
Sbjct: 139 FDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED---------------GVEFKNIFGTPE 183
Query: 226 YMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGER 285
           +++PE V+ E      G   D+WS+GV+    L G  P +G   K + +A I ++ +   
Sbjct: 184 FVAPEIVNYE----PLGLEADMWSIGVITYILLSGASPFLG-DTKQETLANITSVSYDFD 238
Query: 286 LEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVT---------KRSSSSNIEGL 335
            E     S   + F+R  L K+ RKR T++E L +P++T         +R S  N+E  
Sbjct: 239 EEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRESVVNLENF 297

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score =  111 bits (278), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 82/299 (27%), Positives = 138/299 (46%), Gaps = 39/299 (13%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTSST-----IIRHQAAHEAEILKRLDSQFIVK 109
           LG G   IV K R + +   YA K +    S      + R +   E  IL+++    ++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 110 CHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIH 169
            H V Y    ++  ++E +  G LFD L  ++ LSE+  +    ++L G+ YLH  +I H
Sbjct: 80  LHDV-YENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAH 138
Query: 170 GDIKPSNLLINGKG----EVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCA 225
            D+KP N+++  K      +K+ DFG++  +E+               G       GT  
Sbjct: 139 FDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED---------------GVEFKNIFGTPE 183
Query: 226 YMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGER 285
           +++PE V+ E      G   D+WS+GV+    L G  P +G   K + +A I ++ +   
Sbjct: 184 FVAPEIVNYE----PLGLEADMWSIGVITYILLSGASPFLG-DTKQETLANITSVSYDFD 238
Query: 286 LEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVT---------KRSSSSNIEGL 335
            E     S   + F+R  L K+ RKR T++E L +P++T         +R S  N+E  
Sbjct: 239 EEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRESVVNLENF 297

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score =  111 bits (278), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 81/297 (27%), Positives = 141/297 (47%), Gaps = 39/297 (13%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLN---TTSST--IIRHQAAHEAEILKRLDSQFIVK 109
           LG G   +V K R + +   YA K +    T SS   + R     E  ILK +    ++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 110 CHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIH 169
            H V Y  + ++  ++E +  G LFD L  ++ L+E+  +    ++L G+ YLH +QI H
Sbjct: 79  LHEV-YENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAH 137
Query: 170 GDIKPSNLLING----KGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCA 225
            D+KP N+++      K  +KI DFG++  ++                G       GT  
Sbjct: 138 FDLKPENIMLLDRNVPKPRIKIIDFGLAHKID---------------FGNEFKNIFGTPE 182
Query: 226 YMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGER 285
           +++PE V+ E      G   D+WS+GV+    L G  P +G   K + +A + A+ +   
Sbjct: 183 FVAPEIVNYE----PLGLEADMWSIGVITYILLSGASPFLG-DTKQETLANVSAVNYEFE 237
Query: 286 LEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV---------TKRSSSSNIE 333
            E     S   + F+R  L KD +KR T+++ L +P++         ++++S+ N+E
Sbjct: 238 DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSRKASAVNME 294

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score =  111 bits (277), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 78/283 (27%), Positives = 134/283 (47%), Gaps = 30/283 (10%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLN---TTSST--IIRHQAAHEAEILKRLDSQFIVK 109
           LG G   +V K R + +   YA K +    T SS   + R     E  ILK +    ++ 
Sbjct: 18  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 77
Query: 110 CHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIH 169
            H V Y  + ++  ++E +  G LFD L  ++ L+E+  +    ++L G+ YLH +QI H
Sbjct: 78  LHEV-YENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAH 136
Query: 170 GDIKPSNLLING----KGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCA 225
            D+KP N+++      K  +KI DFG++  ++                G       GT  
Sbjct: 137 FDLKPENIMLLDRNVPKPRIKIIDFGLAHKID---------------FGNEFKNIFGTPE 181
Query: 226 YMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGER 285
           +++PE V+ E      G   D+WS+GV+    L G  P +G   K + +A + A+ +   
Sbjct: 182 FVAPEIVNYE----PLGLEADMWSIGVITYILLSGASPFLG-DTKQETLANVSAVNYEFE 236
Query: 286 LEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSS 328
            E     S   + F+R  L KD +KR T+++ L +P++  + +
Sbjct: 237 DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDT 279

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score =  111 bits (277), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 78/285 (27%), Positives = 134/285 (47%), Gaps = 30/285 (10%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLN---TTSST--IIRHQAAHEAEILKRLDSQFIVK 109
           LG G   +V K R + +   YA K +    T SS   + R     E  ILK +    ++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 110 CHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIH 169
            H V Y  + ++  ++E +  G LFD L  ++ L+E+  +    ++L G+ YLH +QI H
Sbjct: 79  LHEV-YENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAH 137
Query: 170 GDIKPSNLLING----KGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCA 225
            D+KP N+++      K  +KI DFG++  ++                G       GT  
Sbjct: 138 FDLKPENIMLLDRNVPKPRIKIIDFGLAHKID---------------FGNEFKNIFGTPE 182
Query: 226 YMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGER 285
           +++PE V+ E      G   D+WS+GV+    L G  P +G   K + +A + A+ +   
Sbjct: 183 FVAPEIVNYE----PLGLEADMWSIGVITYILLSGASPFLG-DTKQETLANVSAVNYEFE 237
Query: 286 LEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSS 330
            E     S   + F+R  L KD +KR T+++ L +P++  + +  
Sbjct: 238 DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQ 282

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score =  111 bits (277), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 78/285 (27%), Positives = 134/285 (47%), Gaps = 30/285 (10%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLN---TTSST--IIRHQAAHEAEILKRLDSQFIVK 109
           LG G   +V K R + +   YA K +    T SS   + R     E  ILK +    ++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 110 CHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIH 169
            H V Y  + ++  ++E +  G LFD L  ++ L+E+  +    ++L G+ YLH +QI H
Sbjct: 79  LHEV-YENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAH 137
Query: 170 GDIKPSNLLING----KGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCA 225
            D+KP N+++      K  +KI DFG++  ++                G       GT  
Sbjct: 138 FDLKPENIMLLDRNVPKPRIKIIDFGLAHKID---------------FGNEFKNIFGTPE 182
Query: 226 YMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGER 285
           +++PE V+ E      G   D+WS+GV+    L G  P +G   K + +A + A+ +   
Sbjct: 183 FVAPEIVNYE----PLGLEADMWSIGVITYILLSGASPFLG-DTKQETLANVSAVNYEFE 237
Query: 286 LEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSS 330
            E     S   + F+R  L KD +KR T+++ L +P++  + +  
Sbjct: 238 DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQ 282

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score =  111 bits (277), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 78/285 (27%), Positives = 134/285 (47%), Gaps = 30/285 (10%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLN---TTSST--IIRHQAAHEAEILKRLDSQFIVK 109
           LG G   +V K R + +   YA K +    T SS   + R     E  ILK +    ++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 110 CHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIH 169
            H V Y  + ++  ++E +  G LFD L  ++ L+E+  +    ++L G+ YLH +QI H
Sbjct: 79  LHEV-YENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAH 137
Query: 170 GDIKPSNLLING----KGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCA 225
            D+KP N+++      K  +KI DFG++  ++                G       GT  
Sbjct: 138 FDLKPENIMLLDRNVPKPRIKIIDFGLAHKID---------------FGNEFKNIFGTPE 182
Query: 226 YMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGER 285
           +++PE V+ E      G   D+WS+GV+    L G  P +G   K + +A + A+ +   
Sbjct: 183 FVAPEIVNYE----PLGLEADMWSIGVITYILLSGASPFLG-DTKQETLANVSAVNYEFE 237
Query: 286 LEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSS 330
            E     S   + F+R  L KD +KR T+++ L +P++  + +  
Sbjct: 238 DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQ 282

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score =  111 bits (277), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 78/283 (27%), Positives = 134/283 (47%), Gaps = 30/283 (10%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLN---TTSST--IIRHQAAHEAEILKRLDSQFIVK 109
           LG G   +V K R + +   YA K +    T SS   + R     E  ILK +    ++ 
Sbjct: 18  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 77
Query: 110 CHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIH 169
            H V Y  + ++  ++E +  G LFD L  ++ L+E+  +    ++L G+ YLH +QI H
Sbjct: 78  LHEV-YENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAH 136
Query: 170 GDIKPSNLLING----KGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCA 225
            D+KP N+++      K  +KI DFG++  ++                G       GT  
Sbjct: 137 FDLKPENIMLLDRNVPKPRIKIIDFGLAHKID---------------FGNEFKNIFGTPE 181
Query: 226 YMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGER 285
           +++PE V+ E      G   D+WS+GV+    L G  P +G   K + +A + A+ +   
Sbjct: 182 FVAPEIVNYE----PLGLEADMWSIGVITYILLSGASPFLG-DTKQETLANVSAVNYEFE 236
Query: 286 LEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSS 328
            E     S   + F+R  L KD +KR T+++ L +P++  + +
Sbjct: 237 DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDT 279

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score =  111 bits (277), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 80/271 (29%), Positives = 133/271 (49%), Gaps = 32/271 (11%)
Query: 47  SDLKKLTVLGHGNGGIVY---KVRHQKSNSIYALKVLNTTSSTI-IRHQAAHEAEILKRL 102
           S  + L VLG G+ G V+   KV    S  +YA+KVL   +  +  R +   E +IL  +
Sbjct: 28  SHFELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADV 87
Query: 103 DSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYL 162
           +  F+VK H  F T EG++  +++ +  G LF  L      +E+ +      +  GL +L
Sbjct: 88  NHPFVVKLHYAFQT-EGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALGLDHL 146
Query: 163 HGMQIIHGDIKPSNLLINGKGEVKIADFGVSR--IVEETRXXXXXXXXXXXXIGEAAIAC 220
           H + II+ D+KP N+L++ +G +K+ DFG+S+  I  E +                A + 
Sbjct: 147 HSLGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKK----------------AYSF 190
Query: 221 MGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAI 280
            GT  YM+PE V+ +     +  + D WS GV++ E L G  P  G  ++ + M LI   
Sbjct: 191 CGTVEYMAPEVVNRQ----GHSHSADWWSYGVLMFEMLTGSLPFQG-KDRKETMTLILKA 245
Query: 281 CFGERLEMPETASPEFRRFVRSCLEKDWRKR 311
             G    MP+  S E +  +R+  +++   R
Sbjct: 246 KLG----MPQFLSTEAQSLLRALFKRNPANR 272

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score =  111 bits (277), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 78/283 (27%), Positives = 134/283 (47%), Gaps = 30/283 (10%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLN---TTSST--IIRHQAAHEAEILKRLDSQFIVK 109
           LG G   +V K R + +   YA K +    T SS   + R     E  ILK +    ++ 
Sbjct: 19  LGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 110 CHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIH 169
            H V Y  + ++  ++E +  G LFD L  ++ L+E+  +    ++L G+ YLH +QI H
Sbjct: 79  LHEV-YENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAH 137
Query: 170 GDIKPSNLLING----KGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCA 225
            D+KP N+++      K  +KI DFG++  ++                G       GT  
Sbjct: 138 FDLKPENIMLLDRNVPKPRIKIIDFGLAHKID---------------FGNEFKNIFGTPE 182
Query: 226 YMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGER 285
           +++PE V+ E      G   D+WS+GV+    L G  P +G   K + +A + A+ +   
Sbjct: 183 FVAPEIVNYE----PLGLEADMWSIGVITYILLSGASPFLG-DTKQETLANVSAVNYEFE 237
Query: 286 LEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSS 328
            E     S   + F+R  L KD +KR T+++ L +P++  + +
Sbjct: 238 DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDT 280

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score =  111 bits (277), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 78/283 (27%), Positives = 134/283 (47%), Gaps = 30/283 (10%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLN---TTSST--IIRHQAAHEAEILKRLDSQFIVK 109
           LG G   +V K R + +   YA K +    T SS   + R     E  ILK +    ++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 110 CHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIH 169
            H V Y  + ++  ++E +  G LFD L  ++ L+E+  +    ++L G+ YLH +QI H
Sbjct: 79  LHEV-YENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAH 137
Query: 170 GDIKPSNLLING----KGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCA 225
            D+KP N+++      K  +KI DFG++  ++                G       GT  
Sbjct: 138 FDLKPENIMLLDRNVPKPRIKIIDFGLAHKID---------------FGNEFKNIFGTPE 182
Query: 226 YMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGER 285
           +++PE V+ E      G   D+WS+GV+    L G  P +G   K + +A + A+ +   
Sbjct: 183 FVAPEIVNYE----PLGLEADMWSIGVITYILLSGASPFLG-DTKQETLANVSAVNYEFE 237
Query: 286 LEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSS 328
            E     S   + F+R  L KD +KR T+++ L +P++  + +
Sbjct: 238 DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDT 280

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score =  110 bits (276), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 78/279 (27%), Positives = 132/279 (47%), Gaps = 30/279 (10%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTSST-----IIRHQAAHEAEILKRLDSQFIVK 109
           LG G   IV K R + +   YA K +    S      + R +   E  IL+++    ++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 110 CHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIH 169
            H V Y    ++  ++E +  G LFD L  ++ LSE+  +    ++L G+ YLH  +I H
Sbjct: 80  LHDV-YENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAH 138
Query: 170 GDIKPSNLLINGKG----EVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCA 225
            D+KP N+++  K      +K+ DFG++  +E+               G       GT  
Sbjct: 139 FDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED---------------GVEFKNIFGTPE 183
Query: 226 YMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGER 285
           +++PE V+ E      G   D+WS+GV+    L G  P +G   K + +A I ++ +   
Sbjct: 184 FVAPEIVNYE----PLGLEADMWSIGVITYILLSGASPFLG-DTKQETLANITSVSYDFD 238
Query: 286 LEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVT 324
            E     S   + F+R  L K+ RKR T++E L +P++T
Sbjct: 239 EEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWIT 277

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score =  110 bits (276), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 78/283 (27%), Positives = 134/283 (47%), Gaps = 30/283 (10%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLN---TTSST--IIRHQAAHEAEILKRLDSQFIVK 109
           LG G   +V K R + +   YA K +    T SS   + R     E  ILK +    ++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 110 CHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIH 169
            H V Y  + ++  ++E +  G LFD L  ++ L+E+  +    ++L G+ YLH +QI H
Sbjct: 79  LHEV-YENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAH 137
Query: 170 GDIKPSNLLING----KGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCA 225
            D+KP N+++      K  +KI DFG++  ++                G       GT  
Sbjct: 138 FDLKPENIMLLDRNVPKPRIKIIDFGLAHKID---------------FGNEFKNIFGTPE 182
Query: 226 YMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGER 285
           +++PE V+ E      G   D+WS+GV+    L G  P +G   K + +A + A+ +   
Sbjct: 183 FVAPEIVNYE----PLGLEADMWSIGVITYILLSGASPFLG-DTKQETLANVSAVNYEFE 237
Query: 286 LEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSS 328
            E     S   + F+R  L KD +KR T+++ L +P++  + +
Sbjct: 238 DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDT 280

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score =  110 bits (276), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 83/294 (28%), Positives = 140/294 (47%), Gaps = 36/294 (12%)
Query: 52  LTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDS-QFIVKC 110
           + ++G+G  G VYK RH K+  + A+KV++ T       +   E  +LK+    + I   
Sbjct: 29  VELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE--EEEIKQEINMLKKYSHHRNIATY 86
Query: 111 HAVFYT-----IEGEICFVMEHMERGSLFDSLRVRK--KLSEDVISGVAYRVLKGLQYLH 163
           +  F       ++ ++  VME    GS+ D ++  K   L E+ I+ +   +L+GL +LH
Sbjct: 87  YGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH 146
Query: 164 GMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGT 223
             ++IH DIK  N+L+    EVK+ DFGVS  ++ T             +G      +GT
Sbjct: 147 QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT-------------VGRRN-TFIGT 192
Query: 224 CAYMSPERVD-SERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICF 282
             +M+PE +   E     Y F  D+WSLG+  +E   G  PL         M  + A+  
Sbjct: 193 PYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD-------MHPMRALFL 245
Query: 283 GERLEMP----ETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNI 332
             R   P    +  S +F+ F+ SCL K+  +R   E+L+ +PF+  + +   +
Sbjct: 246 IPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNERQV 299

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 78/270 (28%), Positives = 121/270 (44%), Gaps = 28/270 (10%)
Query: 45  NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH---EAEILKR 101
            ++D   L +LG G  G V  VR + +   YA+K+L      I + + AH   E+ +L+ 
Sbjct: 3   TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRK-EVIIAKDEVAHTVTESRVLQN 61
Query: 102 LDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQY 161
               F+      F T    +CFVME+   G LF  L   +  +E+        ++  L+Y
Sbjct: 62  TRHPFLTALKYAFQT-HDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 120
Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACM 221
           LH   +++ DIK  NL+++  G +KI DFG+ +                   G       
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCK--------------EGISDGATMKTFC 166
Query: 222 GTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAIC 281
           GT  Y++PE ++      DYG A D W LGVV+ E + G  P     +   L  LI    
Sbjct: 167 GTPEYLAPEVLED----NDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELILM-- 219
Query: 282 FGERLEMPETASPEFRRFVRSCLEKDWRKR 311
             E +  P T SPE +  +   L+KD ++R
Sbjct: 220 --EEIRFPRTLSPEAKSLLAGLLKKDPKQR 247

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 133/281 (47%), Gaps = 30/281 (10%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLN---TTSST--IIRHQAAHEAEILKRLDSQFIVK 109
           LG G   +V K R + +   YA K +    T SS   + R     E  ILK +    ++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 110 CHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIH 169
            H V Y  + ++  ++E +  G LFD L  ++ L+E+  +    ++L G+ YLH +QI H
Sbjct: 79  LHEV-YENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAH 137
Query: 170 GDIKPSNLLING----KGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCA 225
            D+KP N+++      K  +KI DFG++  ++                G       GT  
Sbjct: 138 FDLKPENIMLLDRNVPKPRIKIIDFGLAHKID---------------FGNEFKNIFGTPE 182
Query: 226 YMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGER 285
           +++PE V+ E      G   D+WS+GV+    L G  P +G   K + +A + A+ +   
Sbjct: 183 FVAPEIVNYE----PLGLEADMWSIGVITYILLSGASPFLG-DTKQETLANVSAVNYEFE 237
Query: 286 LEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKR 326
            E     S   + F+R  L KD +KR T+++ L +P++  +
Sbjct: 238 DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 278

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 78/270 (28%), Positives = 121/270 (44%), Gaps = 28/270 (10%)
Query: 45  NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH---EAEILKR 101
            ++D   L +LG G  G V  VR + +   YA+K+L      I + + AH   E+ +L+ 
Sbjct: 6   TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRK-EVIIAKDEVAHTVTESRVLQN 64
Query: 102 LDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQY 161
               F+      F T    +CFVME+   G LF  L   +  +E+        ++  L+Y
Sbjct: 65  TRHPFLTALKYAFQT-HDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 123
Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACM 221
           LH   +++ DIK  NL+++  G +KI DFG+ +                   G       
Sbjct: 124 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCK--------------EGISDGATMKTFC 169
Query: 222 GTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAIC 281
           GT  Y++PE ++      DYG A D W LGVV+ E + G  P     +   L  LI    
Sbjct: 170 GTPEYLAPEVLED----NDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELILM-- 222
Query: 282 FGERLEMPETASPEFRRFVRSCLEKDWRKR 311
             E +  P T SPE +  +   L+KD ++R
Sbjct: 223 --EEIRFPRTLSPEAKSLLAGLLKKDPKQR 250

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score =  110 bits (274), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 78/278 (28%), Positives = 132/278 (47%), Gaps = 30/278 (10%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLN---TTSST--IIRHQAAHEAEILKRLDSQFIVK 109
           LG G   +V K R + +   YA K +    T SS   + R     E  ILK +    ++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 110 CHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIH 169
            H V Y  + ++  ++E +  G LFD L  ++ L+E+  +    ++L G+ YLH +QI H
Sbjct: 79  LHEV-YENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAH 137
Query: 170 GDIKPSNLLING----KGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCA 225
            D+KP N+++      K  +KI DFG++  ++                G       GT  
Sbjct: 138 FDLKPENIMLLDRNVPKPRIKIIDFGLAHKID---------------FGNEFKNIFGTPE 182
Query: 226 YMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGER 285
           +++PE V+ E      G   D+WS+GV+    L G  P +G   K + +A + A+ +   
Sbjct: 183 FVAPEIVNYE----PLGLEADMWSIGVITYILLSGASPFLG-DTKQETLANVSAVNYEFE 237
Query: 286 LEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV 323
            E     S   + F+R  L KD +KR T+++ L +P++
Sbjct: 238 DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score =  110 bits (274), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 78/283 (27%), Positives = 134/283 (47%), Gaps = 30/283 (10%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLN---TTSST--IIRHQAAHEAEILKRLDSQFIVK 109
           LG G   +V K R + +   YA K +    T SS   + R     E  ILK +    ++ 
Sbjct: 19  LGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 110 CHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIH 169
            H V Y  + ++  ++E +  G LFD L  ++ L+E+  +    ++L G+ YLH +QI H
Sbjct: 79  LHEV-YENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAH 137
Query: 170 GDIKPSNLLING----KGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCA 225
            D+KP N+++      K  +KI DFG++  ++                G       GT  
Sbjct: 138 FDLKPENIMLLDRNVPKPRIKIIDFGLAHKID---------------FGNEFKNIFGTPE 182
Query: 226 YMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGER 285
           +++PE V+ E      G   D+WS+GV+    L G  P +G   K + +A + A+ +   
Sbjct: 183 FVAPEIVNYE----PLGLEADMWSIGVITYILLSGASPFLG-DTKQETLANVSAVNYEFE 237
Query: 286 LEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSS 328
            E     S   + F+R  L KD +KR T+++ L +P++  + +
Sbjct: 238 DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDT 280

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score =  110 bits (274), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 79/267 (29%), Positives = 132/267 (49%), Gaps = 32/267 (11%)
Query: 47  SDLKKLTVLGHGNGGIVY---KVRHQKSNSIYALKVLNTTSSTI-IRHQAAHEAEILKRL 102
           S  + L VLG G+ G V+   K+    +  +YA+KVL   +  +  R +   E +IL  +
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 83
Query: 103 DSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYL 162
           +  FIVK H  F T EG++  +++ +  G LF  L      +E+ +      +   L +L
Sbjct: 84  NHPFIVKLHYAFQT-EGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHL 142
Query: 163 HGMQIIHGDIKPSNLLINGKGEVKIADFGVSR--IVEETRXXXXXXXXXXXXIGEAAIAC 220
           H + II+ D+KP N+L++ +G +K+ DFG+S+  I  E +                A + 
Sbjct: 143 HSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK----------------AYSF 186
Query: 221 MGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAI 280
            GT  YM+PE V+  R G  +  + D WS GV++ E L G  P  G   K  +  ++ A 
Sbjct: 187 CGTVEYMAPEVVN--RRG--HTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKA- 241
Query: 281 CFGERLEMPETASPEFRRFVRSCLEKD 307
               +L MP+  SPE +  +R   +++
Sbjct: 242 ----KLGMPQFLSPEAQSLLRMLFKRN 264

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 78/270 (28%), Positives = 121/270 (44%), Gaps = 28/270 (10%)
Query: 45  NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH---EAEILKR 101
            ++D   L +LG G  G V  VR + +   YA+K+L      I + + AH   E+ +L+ 
Sbjct: 3   TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRK-EVIIAKDEVAHTVTESRVLQN 61
Query: 102 LDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQY 161
               F+      F T    +CFVME+   G LF  L   +  +E+        ++  L+Y
Sbjct: 62  TRHPFLTALKYAFQT-HDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 120
Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACM 221
           LH   +++ DIK  NL+++  G +KI DFG+ +                   G       
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCK--------------EGISDGATMKXFC 166
Query: 222 GTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAIC 281
           GT  Y++PE ++      DYG A D W LGVV+ E + G  P     +   L  LI    
Sbjct: 167 GTPEYLAPEVLED----NDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELILM-- 219
Query: 282 FGERLEMPETASPEFRRFVRSCLEKDWRKR 311
             E +  P T SPE +  +   L+KD ++R
Sbjct: 220 --EEIRFPRTLSPEAKSLLAGLLKKDPKQR 247

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 78/270 (28%), Positives = 121/270 (44%), Gaps = 28/270 (10%)
Query: 45  NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH---EAEILKR 101
            ++D   L +LG G  G V  VR + +   YA+K+L      I + + AH   E+ +L+ 
Sbjct: 3   TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRK-EVIIAKDEVAHTVTESRVLQN 61
Query: 102 LDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQY 161
               F+      F T    +CFVME+   G LF  L   +  +E+        ++  L+Y
Sbjct: 62  TRHPFLTALKYAFQT-HDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 120
Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACM 221
           LH   +++ DIK  NL+++  G +KI DFG+ +                   G       
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCK--------------EGISDGATMKXFC 166
Query: 222 GTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAIC 281
           GT  Y++PE ++      DYG A D W LGVV+ E + G  P     +   L  LI    
Sbjct: 167 GTPEYLAPEVLED----NDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELILM-- 219
Query: 282 FGERLEMPETASPEFRRFVRSCLEKDWRKR 311
             E +  P T SPE +  +   L+KD ++R
Sbjct: 220 --EEIRFPRTLSPEAKSLLAGLLKKDPKQR 247

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 78/270 (28%), Positives = 121/270 (44%), Gaps = 28/270 (10%)
Query: 45  NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH---EAEILKR 101
            ++D   L +LG G  G V  VR + +   YA+K+L      I + + AH   E+ +L+ 
Sbjct: 3   TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRK-EVIIAKDEVAHTVTESRVLQN 61
Query: 102 LDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQY 161
               F+      F T    +CFVME+   G LF  L   +  +E+        ++  L+Y
Sbjct: 62  TRHPFLTALKYAFQT-HDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 120
Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACM 221
           LH   +++ DIK  NL+++  G +KI DFG+ +                   G       
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCK--------------EGISDGATMKTFC 166
Query: 222 GTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAIC 281
           GT  Y++PE ++      DYG A D W LGVV+ E + G  P     +   L  LI    
Sbjct: 167 GTPEYLAPEVLED----NDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELILM-- 219
Query: 282 FGERLEMPETASPEFRRFVRSCLEKDWRKR 311
             E +  P T SPE +  +   L+KD ++R
Sbjct: 220 --EEIRFPRTLSPEAKSLLAGLLKKDPKQR 247

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 78/270 (28%), Positives = 121/270 (44%), Gaps = 28/270 (10%)
Query: 45  NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH---EAEILKR 101
            ++D   L +LG G  G V  VR + +   YA+K+L      I + + AH   E+ +L+ 
Sbjct: 3   TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRK-EVIIAKDEVAHTVTESRVLQN 61
Query: 102 LDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQY 161
               F+      F T    +CFVME+   G LF  L   +  +E+        ++  L+Y
Sbjct: 62  TRHPFLTALKYAFQT-HDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 120
Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACM 221
           LH   +++ DIK  NL+++  G +KI DFG+ +                   G       
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCK--------------EGISDGATMKXFC 166
Query: 222 GTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAIC 281
           GT  Y++PE ++      DYG A D W LGVV+ E + G  P     +   L  LI    
Sbjct: 167 GTPEYLAPEVLED----NDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELILM-- 219
Query: 282 FGERLEMPETASPEFRRFVRSCLEKDWRKR 311
             E +  P T SPE +  +   L+KD ++R
Sbjct: 220 --EEIRFPRTLSPEAKSLLAGLLKKDPKQR 247

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 78/270 (28%), Positives = 121/270 (44%), Gaps = 28/270 (10%)
Query: 45  NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH---EAEILKR 101
            ++D   L +LG G  G V  VR + +   YA+K+L      I + + AH   E+ +L+ 
Sbjct: 8   TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRK-EVIIAKDEVAHTVTESRVLQN 66
Query: 102 LDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQY 161
               F+      F T    +CFVME+   G LF  L   +  +E+        ++  L+Y
Sbjct: 67  TRHPFLTALKYAFQT-HDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 125
Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACM 221
           LH   +++ DIK  NL+++  G +KI DFG+ +                   G       
Sbjct: 126 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCK--------------EGISDGATMKXFC 171
Query: 222 GTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAIC 281
           GT  Y++PE ++      DYG A D W LGVV+ E + G  P     +   L  LI    
Sbjct: 172 GTPEYLAPEVLED----NDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELILM-- 224
Query: 282 FGERLEMPETASPEFRRFVRSCLEKDWRKR 311
             E +  P T SPE +  +   L+KD ++R
Sbjct: 225 --EEIRFPRTLSPEAKSLLAGLLKKDPKQR 252

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 84/289 (29%), Positives = 140/289 (48%), Gaps = 37/289 (12%)
Query: 47  SDLKKLTVLGHGNGGIVY---KVRHQKSNSIYALKVLNTTSSTI-IRHQAAHEAEILKRL 102
           S  + L VLG G+ G V+   K+    +  +YA+KVL   +  +  R +   E +IL  +
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 83
Query: 103 DSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYL 162
           +  FIVK H  F T EG++  +++ +  G LF  L      +E+ +      +   L +L
Sbjct: 84  NHPFIVKLHYAFQT-EGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHL 142
Query: 163 HGMQIIHGDIKPSNLLINGKGEVKIADFGVSR--IVEETRXXXXXXXXXXXXIGEAAIAC 220
           H + II+ D+KP N+L++ +G +K+ DFG+S+  I  E +                A + 
Sbjct: 143 HSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK----------------AYSF 186
Query: 221 MGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAI 280
            GT  YM+PE V+  R G  +  + D WS GV++ E L G  P  G   K  +  ++ A 
Sbjct: 187 CGTVEYMAPEVVN--RRG--HTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKA- 241
Query: 281 CFGERLEMPETASPEFRRFVRSCLEKDWRKR-----GTVEELLAYPFVT 324
               +L MP+  SPE +  +R   +++   R       VEE+  + F +
Sbjct: 242 ----KLGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFS 286

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score =  109 bits (272), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 84/289 (29%), Positives = 140/289 (48%), Gaps = 37/289 (12%)
Query: 47  SDLKKLTVLGHGNGGIVY---KVRHQKSNSIYALKVLNTTSSTI-IRHQAAHEAEILKRL 102
           S  + L VLG G+ G V+   K+    +  +YA+KVL   +  +  R +   E +IL  +
Sbjct: 25  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 84
Query: 103 DSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYL 162
           +  FIVK H  F T EG++  +++ +  G LF  L      +E+ +      +   L +L
Sbjct: 85  NHPFIVKLHYAFQT-EGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHL 143
Query: 163 HGMQIIHGDIKPSNLLINGKGEVKIADFGVSR--IVEETRXXXXXXXXXXXXIGEAAIAC 220
           H + II+ D+KP N+L++ +G +K+ DFG+S+  I  E +                A + 
Sbjct: 144 HSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK----------------AYSF 187
Query: 221 MGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAI 280
            GT  YM+PE V+  R G  +  + D WS GV++ E L G  P  G   K  +  ++ A 
Sbjct: 188 CGTVEYMAPEVVN--RRG--HTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKA- 242
Query: 281 CFGERLEMPETASPEFRRFVRSCLEKDWRKR-----GTVEELLAYPFVT 324
               +L MP+  SPE +  +R   +++   R       VEE+  + F +
Sbjct: 243 ----KLGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFS 287

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score =  109 bits (272), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 137/277 (49%), Gaps = 30/277 (10%)
Query: 37  NPTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRH--QAAH 94
           NP   +  ++   +++  +G G+ G V  V+H ++ + YA+K+L+      ++      +
Sbjct: 32  NPAQ-NTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN 90
Query: 95  EAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYR 154
           E  IL+ ++  F+VK    F      +  VME+M  G +F  LR   + SE      A +
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKD-NSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQ 149
Query: 155 VLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIG 214
           ++   +YLH + +I+ D+KP NLLI+ +G +K+ADFG ++ V+                G
Sbjct: 150 IVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVK----------------G 193
Query: 215 EAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLM 274
                C GT  Y++PE + S+     Y  A D W+LGV++ E   G+ P   F ++P  +
Sbjct: 194 RTWXLC-GTPEYLAPEIILSK----GYNKAVDWWALGVLIYEMAAGYPPF--FADQP--I 244
Query: 275 ALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKR 311
            +   I  G ++  P   S + +  +R+ L+ D  KR
Sbjct: 245 QIYEKIVSG-KVRFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 137/277 (49%), Gaps = 30/277 (10%)
Query: 37  NPTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRH--QAAH 94
           NP   +  ++   +++  +G G+ G V  V+H ++ + YA+K+L+      ++      +
Sbjct: 32  NPAQ-NTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN 90
Query: 95  EAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYR 154
           E  IL+ ++  F+VK    F      +  VME+M  G +F  LR   + SE      A +
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKD-NSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQ 149
Query: 155 VLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIG 214
           ++   +YLH + +I+ D+KP NLLI+ +G +K+ADFG ++ V+                G
Sbjct: 150 IVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVK----------------G 193
Query: 215 EAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLM 274
                C GT  Y++PE + S+     Y  A D W+LGV++ E   G+ P   F ++P  +
Sbjct: 194 RTWXLC-GTPEYLAPEIILSK----GYNKAVDWWALGVLIYEMAAGYPPF--FADQP--I 244
Query: 275 ALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKR 311
            +   I  G ++  P   S + +  +R+ L+ D  KR
Sbjct: 245 QIYEKIVSG-KVRFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score =  108 bits (271), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 78/283 (27%), Positives = 133/283 (46%), Gaps = 30/283 (10%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLN---TTSST--IIRHQAAHEAEILKRLDSQFIVK 109
           LG G   +V K R + +   YA K +    T SS   + R     E  ILK +    ++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 110 CHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIH 169
            H V Y  + ++  + E +  G LFD L  ++ L+E+  +    ++L G+ YLH +QI H
Sbjct: 79  LHEV-YENKTDVILIGELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAH 137
Query: 170 GDIKPSNLLING----KGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCA 225
            D+KP N+++      K  +KI DFG++  ++                G       GT  
Sbjct: 138 FDLKPENIMLLDRNVPKPRIKIIDFGLAHKID---------------FGNEFKNIFGTPE 182
Query: 226 YMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGER 285
           +++PE V+ E      G   D+WS+GV+    L G  P +G   K + +A + A+ +   
Sbjct: 183 FVAPEIVNYE----PLGLEADMWSIGVITYILLSGASPFLG-DTKQETLANVSAVNYEFE 237
Query: 286 LEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSS 328
            E     S   + F+R  L KD +KR T+++ L +P++  + +
Sbjct: 238 DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDT 280

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score =  108 bits (271), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 131/281 (46%), Gaps = 24/281 (8%)
Query: 51  KLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKC 110
           KL  +G G+ G V+K    ++  + A+K+++   +         E  +L + DS ++ K 
Sbjct: 26  KLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKY 85
Query: 111 HAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHG 170
           +   Y  + ++  +ME++  GS  D L     L E  I+ +   +LKGL YLH  + IH 
Sbjct: 86  YGS-YLKDTKLWIIMEYLGGGSALDLLE-PGPLDETQIATILREILKGLDYLHSEKKIHR 143
Query: 171 DIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPE 230
           DIK +N+L++  GEVK+ADFGV+  + +T+                    +GT  +M+PE
Sbjct: 144 DIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN--------------XFVGTPFWMAPE 189
Query: 231 RVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPE 290
            +        Y    D+WSLG+  +E   G  P          M ++  I       +  
Sbjct: 190 VIKQSA----YDSKADIWSLGITAIELARGEPPHSELHP----MKVLFLIPKNNPPTLEG 241
Query: 291 TASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSN 331
             S   + FV +CL K+   R T +ELL + F+ + +  ++
Sbjct: 242 NYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTS 282

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score =  108 bits (270), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 132/281 (46%), Gaps = 24/281 (8%)
Query: 51  KLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKC 110
           KL  +G G+ G V+K    ++  + A+K+++   +         E  +L + DS ++ K 
Sbjct: 31  KLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKY 90
Query: 111 HAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHG 170
           +   Y  + ++  +ME++  GS  D L     L E  I+ +   +LKGL YLH  + IH 
Sbjct: 91  YGS-YLKDTKLWIIMEYLGGGSALDLLE-PGPLDETQIATILREILKGLDYLHSEKKIHR 148
Query: 171 DIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPE 230
           DIK +N+L++  GEVK+ADFGV+  + +T+                    +GT  +M+PE
Sbjct: 149 DIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN--------------TFVGTPFWMAPE 194
Query: 231 RVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPE 290
            +        Y    D+WSLG+  +E   G  P      +   M ++  I       +  
Sbjct: 195 VIKQSA----YDSKADIWSLGITAIELARGEPP----HSELHPMKVLFLIPKNNPPTLEG 246
Query: 291 TASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSN 331
             S   + FV +CL K+   R T +ELL + F+ + +  ++
Sbjct: 247 NYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTS 287

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score =  108 bits (270), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 131/281 (46%), Gaps = 24/281 (8%)
Query: 51  KLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKC 110
           KL  +G G+ G V+K    ++  + A+K+++   +         E  +L + DS ++ K 
Sbjct: 11  KLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKY 70
Query: 111 HAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHG 170
           +   Y  + ++  +ME++  GS  D L     L E  I+ +   +LKGL YLH  + IH 
Sbjct: 71  YGS-YLKDTKLWIIMEYLGGGSALDLLE-PGPLDETQIATILREILKGLDYLHSEKKIHR 128
Query: 171 DIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPE 230
           DIK +N+L++  GEVK+ADFGV+  + +T+                    +GT  +M+PE
Sbjct: 129 DIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN--------------TFVGTPFWMAPE 174
Query: 231 RVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPE 290
            +        Y    D+WSLG+  +E   G  P          M ++  I       +  
Sbjct: 175 VIKQSA----YDSKADIWSLGITAIELARGEPPHSELHP----MKVLFLIPKNNPPTLEG 226
Query: 291 TASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSN 331
             S   + FV +CL K+   R T +ELL + F+ + +  ++
Sbjct: 227 NYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTS 267

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score =  108 bits (270), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 84/285 (29%), Positives = 142/285 (49%), Gaps = 22/285 (7%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVF 114
           LG G  G VYK +++++ ++ A KV+ T S   +      E EIL   D  +IVK    +
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIV-EIEILATCDHPYIVKLLGAY 85
Query: 115 YTIEGEICFVMEHMERGSLFDS--LRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDI 172
           Y  +G++  ++E    G++ D+  L + + L+E  I  V  ++L+ L +LH  +IIH D+
Sbjct: 86  YH-DGKLWIMIEFCPGGAV-DAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDL 143
Query: 173 KPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERV 232
           K  N+L+  +G++++ADFGVS    +T                   + +GT  +M+PE V
Sbjct: 144 KAGNVLMTLEGDIRLADFGVSAKNLKTLQKRD--------------SFIGTPYWMAPEVV 189
Query: 233 DSERWGG-DYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPET 291
             E      Y +  D+WSLG+ ++E      P       P  + L  A      L  P  
Sbjct: 190 MCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN--PMRVLLKIAKSDPPTLLTPSK 247
Query: 292 ASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNIEGLI 336
            S EFR F++  L+K+   R +  +LL +PFV+  +S+  +  L+
Sbjct: 248 WSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNKALRELV 292

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score =  108 bits (270), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 84/285 (29%), Positives = 142/285 (49%), Gaps = 22/285 (7%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVF 114
           LG G  G VYK +++++ ++ A KV+ T S   +      E EIL   D  +IVK    +
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIV-EIEILATCDHPYIVKLLGAY 77
Query: 115 YTIEGEICFVMEHMERGSLFDS--LRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDI 172
           Y  +G++  ++E    G++ D+  L + + L+E  I  V  ++L+ L +LH  +IIH D+
Sbjct: 78  YH-DGKLWIMIEFCPGGAV-DAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDL 135
Query: 173 KPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERV 232
           K  N+L+  +G++++ADFGVS    +T                   + +GT  +M+PE V
Sbjct: 136 KAGNVLMTLEGDIRLADFGVSAKNLKTLQKRD--------------SFIGTPYWMAPEVV 181
Query: 233 DSERWGG-DYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPET 291
             E      Y +  D+WSLG+ ++E      P       P  + L  A      L  P  
Sbjct: 182 MCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN--PMRVLLKIAKSDPPTLLTPSK 239
Query: 292 ASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNIEGLI 336
            S EFR F++  L+K+   R +  +LL +PFV+  +S+  +  L+
Sbjct: 240 WSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNKALRELV 284

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score =  108 bits (270), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 131/281 (46%), Gaps = 24/281 (8%)
Query: 51  KLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKC 110
           KL  +G G+ G V+K    ++  + A+K+++   +         E  +L + DS ++ K 
Sbjct: 11  KLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKY 70
Query: 111 HAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHG 170
           +   Y  + ++  +ME++  GS  D L     L E  I+ +   +LKGL YLH  + IH 
Sbjct: 71  YGS-YLKDTKLWIIMEYLGGGSALDLLE-PGPLDETQIATILREILKGLDYLHSEKKIHR 128
Query: 171 DIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPE 230
           DIK +N+L++  GEVK+ADFGV+  + +T+                    +GT  +M+PE
Sbjct: 129 DIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN--------------XFVGTPFWMAPE 174
Query: 231 RVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPE 290
            +        Y    D+WSLG+  +E   G  P          M ++  I       +  
Sbjct: 175 VIKQSA----YDSKADIWSLGITAIELARGEPPHSELHP----MKVLFLIPKNNPPTLEG 226
Query: 291 TASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSN 331
             S   + FV +CL K+   R T +ELL + F+ + +  ++
Sbjct: 227 NYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTS 267

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 76/277 (27%), Positives = 137/277 (49%), Gaps = 30/277 (10%)
Query: 37  NPTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRH--QAAH 94
           NP   +  ++   +++  +G G+ G V  V+H ++ + YA+K+L+      ++      +
Sbjct: 32  NPAQ-NTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN 90
Query: 95  EAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYR 154
           E  IL+ ++  F+VK    F      +  VME++  G +F  LR   + SE      A +
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKD-NSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQ 149
Query: 155 VLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIG 214
           ++   +YLH + +I+ D+KP NLLI+ +G +K+ADFG ++ V+                G
Sbjct: 150 IVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVK----------------G 193
Query: 215 EAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLM 274
                C GT  Y++PE + S+     Y  A D W+LGV++ E   G+ P   F ++P  +
Sbjct: 194 RTWXLC-GTPEYLAPEIILSK----GYNKAVDWWALGVLIYEMAAGYPPF--FADQP--I 244
Query: 275 ALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKR 311
            +   I  G ++  P   S + +  +R+ L+ D  KR
Sbjct: 245 QIYEKIVSG-KVRFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 84/291 (28%), Positives = 128/291 (43%), Gaps = 41/291 (14%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTS--------STIIRHQAAHEAEILKRLDSQF 106
           +G G  G VY      +    A++ +N           + I+  +      I+  LDS  
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS-- 85
Query: 107 IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQ 166
                   Y +  E+  VME++  GSL D +     + E  I+ V    L+ L++LH  Q
Sbjct: 86  --------YLVGDELWVVMEYLAGGSLTDVV-TETCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 167 IIHGDIKPSNLLINGKGEVKIADFGV-SRIVEETRXXXXXXXXXXXXIGEAAIACMGTCA 225
           +IH DIK  N+L+   G VK+ DFG  ++I  E                      +GT  
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS---------------XMVGTPY 181
Query: 226 YMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGER 285
           +M+PE V  +     YG   D+WSLG++ +E + G  P +   E P     + A      
Sbjct: 182 WMAPEVVTRKA----YGPKVDIWSLGIMAIEMIEGEPPYL--NENPLRALYLIATNGTPE 235
Query: 286 LEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNIEGLI 336
           L+ PE  S  FR F+  CLE D  KRG+ +ELL + F+      S++  LI
Sbjct: 236 LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAKPLSSLTPLI 286

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 75/274 (27%), Positives = 134/274 (48%), Gaps = 29/274 (10%)
Query: 40  SPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRH--QAAHEAE 97
           S +   +    ++  LG G+ G V  V+H++S + YA+K+L+      ++      +E  
Sbjct: 34  SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 98  ILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLK 157
           IL+ ++  F+VK    F      +  VME++  G +F  LR   + SE      A +++ 
Sbjct: 94  ILQAVNFPFLVKLEFSFKD-NSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 158 GLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAA 217
             +YLH + +I+ D+KP NLLI+ +G +++ DFG ++ V+                G   
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----------------GRTW 196
Query: 218 IACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALI 277
             C GT  Y++PE + S+     Y  A D W+LGV++ E   G+ P   F ++P  + + 
Sbjct: 197 XLC-GTPEYLAPEIILSK----GYNKAVDWWALGVLIYEMAAGYPPF--FADQP--IQIY 247
Query: 278 CAICFGERLEMPETASPEFRRFVRSCLEKDWRKR 311
             I  G ++  P   S + +  +R+ L+ D  KR
Sbjct: 248 EKIVSG-KVRFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score =  106 bits (265), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 75/274 (27%), Positives = 134/274 (48%), Gaps = 29/274 (10%)
Query: 40  SPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRH--QAAHEAE 97
           S +   +    ++  LG G+ G V  V+H++S + YA+K+L+      ++      +E  
Sbjct: 55  SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR 114
Query: 98  ILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLK 157
           IL+ ++  F+VK    F      +  VME++  G +F  LR   + SE      A +++ 
Sbjct: 115 ILQAVNFPFLVKLEFSFKD-NSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL 173
Query: 158 GLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAA 217
             +YLH + +I+ D+KP NLLI+ +G +++ DFG ++ V+                G   
Sbjct: 174 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----------------GATW 217
Query: 218 IACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALI 277
             C GT  Y++PE + S+     Y  A D W+LGV++ E   G+ P   F ++P  + + 
Sbjct: 218 TLC-GTPEYLAPEIILSK----GYNKAVDWWALGVLIYEMAAGYPPF--FADQP--IQIY 268
Query: 278 CAICFGERLEMPETASPEFRRFVRSCLEKDWRKR 311
             I  G ++  P   S + +  +R+ L+ D  KR
Sbjct: 269 EKIVSG-KVRFPSHFSSDLKDLLRNLLQVDLTKR 301

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 75/274 (27%), Positives = 134/274 (48%), Gaps = 29/274 (10%)
Query: 40  SPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRH--QAAHEAE 97
           S +   +    ++  LG G+ G V  V+H++S + YA+K+L+      ++      +E  
Sbjct: 35  SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR 94
Query: 98  ILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLK 157
           IL+ ++  F+VK    F      +  VME++  G +F  LR   + SE      A +++ 
Sbjct: 95  ILQAVNFPFLVKLEFSFKD-NSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL 153
Query: 158 GLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAA 217
             +YLH + +I+ D+KP NLLI+ +G +++ DFG ++ V+                G   
Sbjct: 154 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----------------GRTW 197
Query: 218 IACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALI 277
             C GT  Y++PE + S+     Y  A D W+LGV++ E   G+ P   F ++P  + + 
Sbjct: 198 XLC-GTPEYLAPEIILSK----GYNKAVDWWALGVLIYEMAAGYPPF--FADQP--IQIY 248
Query: 278 CAICFGERLEMPETASPEFRRFVRSCLEKDWRKR 311
             I  G ++  P   S + +  +R+ L+ D  KR
Sbjct: 249 EKIVSG-KVRFPSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 75/274 (27%), Positives = 134/274 (48%), Gaps = 29/274 (10%)
Query: 40  SPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRH--QAAHEAE 97
           S +   +    ++  LG G+ G V  V+H++S + YA+K+L+      ++      +E  
Sbjct: 34  SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 98  ILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLK 157
           IL+ ++  F+VK    F      +  VME++  G +F  LR   + SE      A +++ 
Sbjct: 94  ILQAVNFPFLVKLEFSFKD-NSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 158 GLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAA 217
             +YLH + +I+ D+KP NLLI+ +G +++ DFG ++ V+                G   
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----------------GRTW 196
Query: 218 IACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALI 277
             C GT  Y++PE + S+     Y  A D W+LGV++ E   G+ P   F ++P  + + 
Sbjct: 197 XLC-GTPEYLAPEIILSK----GYNKAVDWWALGVLIYEMAAGYPPF--FADQP--IQIY 247
Query: 278 CAICFGERLEMPETASPEFRRFVRSCLEKDWRKR 311
             I  G ++  P   S + +  +R+ L+ D  KR
Sbjct: 248 EKIVSG-KVRFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 75/274 (27%), Positives = 134/274 (48%), Gaps = 29/274 (10%)
Query: 40  SPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRH--QAAHEAE 97
           S +   +    ++  LG G+ G V  V+H++S + YA+K+L+      ++      +E  
Sbjct: 34  SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 98  ILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLK 157
           IL+ ++  F+VK    F      +  VME++  G +F  LR   + SE      A +++ 
Sbjct: 94  ILQAVNFPFLVKLEFSFKD-NSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 158 GLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAA 217
             +YLH + +I+ D+KP NLLI+ +G +++ DFG ++ V+                G   
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----------------GRTW 196
Query: 218 IACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALI 277
             C GT  Y++PE + S+     Y  A D W+LGV++ E   G+ P   F ++P  + + 
Sbjct: 197 XLC-GTPEYLAPEIILSK----GYNKAVDWWALGVLIYEMAAGYPPF--FADQP--IQIY 247
Query: 278 CAICFGERLEMPETASPEFRRFVRSCLEKDWRKR 311
             I  G ++  P   S + +  +R+ L+ D  KR
Sbjct: 248 EKIVSG-KVRFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 75/274 (27%), Positives = 134/274 (48%), Gaps = 29/274 (10%)
Query: 40  SPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRH--QAAHEAE 97
           S +   +    ++  LG G+ G V  V+H++S + YA+K+L+      ++      +E  
Sbjct: 21  SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR 80
Query: 98  ILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLK 157
           IL+ ++  F+VK    F      +  VME++  G +F  LR   + SE      A +++ 
Sbjct: 81  ILQAVNFPFLVKLEFSFKD-NSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL 139
Query: 158 GLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAA 217
             +YLH + +I+ D+KP NLLI+ +G +++ DFG ++ V+                G   
Sbjct: 140 TFEYLHSLDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVK----------------GRTW 183
Query: 218 IACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALI 277
             C GT  Y++PE + S+     Y  A D W+LGV++ E   G+ P   F ++P  + + 
Sbjct: 184 XLC-GTPEYLAPEIILSK----GYNKAVDWWALGVLIYEMAAGYPPF--FADQP--IQIY 234
Query: 278 CAICFGERLEMPETASPEFRRFVRSCLEKDWRKR 311
             I  G ++  P   S + +  +R+ L+ D  KR
Sbjct: 235 EKIVSG-KVRFPSHFSSDLKDLLRNLLQVDLTKR 267

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 75/274 (27%), Positives = 134/274 (48%), Gaps = 29/274 (10%)
Query: 40  SPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRH--QAAHEAE 97
           S +   +    ++  LG G+ G V  V+H++S + YA+K+L+      ++      +E  
Sbjct: 34  SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 98  ILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLK 157
           IL+ ++  F+VK    F      +  VME++  G +F  LR   + SE      A +++ 
Sbjct: 94  ILQAVNFPFLVKLEFSFKD-NSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 158 GLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAA 217
             +YLH + +I+ D+KP NLLI+ +G +++ DFG ++ V+                G   
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----------------GRTW 196
Query: 218 IACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALI 277
             C GT  Y++PE + S+     Y  A D W+LGV++ E   G+ P   F ++P  + + 
Sbjct: 197 XLC-GTPEYLAPEIILSK----GYNKAVDWWALGVLIYEMAAGYPPF--FADEP--IQIY 247
Query: 278 CAICFGERLEMPETASPEFRRFVRSCLEKDWRKR 311
             I  G ++  P   S + +  +R+ L+ D  KR
Sbjct: 248 EKIVSG-KVRFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 83/291 (28%), Positives = 128/291 (43%), Gaps = 41/291 (14%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTS--------STIIRHQAAHEAEILKRLDSQF 106
           +G G  G VY      +    A++ +N           + I+  +      I+  LDS  
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS-- 85
Query: 107 IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQ 166
                   Y +  E+  VME++  GSL D +     + E  I+ V    L+ L++LH  Q
Sbjct: 86  --------YLVGDELWVVMEYLAGGSLTDVV-TETCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 167 IIHGDIKPSNLLINGKGEVKIADFGV-SRIVEETRXXXXXXXXXXXXIGEAAIACMGTCA 225
           +IH DIK  N+L+   G VK+ DFG  ++I  E                      +GT  
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS---------------TMVGTPY 181
Query: 226 YMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGER 285
           +M+PE V  +     YG   D+WSLG++ +E + G  P +   E P     + A      
Sbjct: 182 WMAPEVVTRKA----YGPKVDIWSLGIMAIEMIEGEPPYL--NENPLRALYLIATNGTPE 235
Query: 286 LEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNIEGLI 336
           L+ PE  S  FR F+  CL+ D  KRG+ +ELL + F+      S++  LI
Sbjct: 236 LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLTPLI 286

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 83/291 (28%), Positives = 128/291 (43%), Gaps = 41/291 (14%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTS--------STIIRHQAAHEAEILKRLDSQF 106
           +G G  G VY      +    A++ +N           + I+  +      I+  LDS  
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS-- 86
Query: 107 IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQ 166
                   Y +  E+  VME++  GSL D +     + E  I+ V    L+ L++LH  Q
Sbjct: 87  --------YLVGDELWVVMEYLAGGSLTDVV-TETCMDEGQIAAVCRECLQALEFLHSNQ 137
Query: 167 IIHGDIKPSNLLINGKGEVKIADFGV-SRIVEETRXXXXXXXXXXXXIGEAAIACMGTCA 225
           +IH DIK  N+L+   G VK+ DFG  ++I  E                      +GT  
Sbjct: 138 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS---------------XMVGTPY 182
Query: 226 YMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGER 285
           +M+PE V  +     YG   D+WSLG++ +E + G  P +   E P     + A      
Sbjct: 183 WMAPEVVTRKA----YGPKVDIWSLGIMAIEMIEGEPPYL--NENPLRALYLIATNGTPE 236
Query: 286 LEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNIEGLI 336
           L+ PE  S  FR F+  CLE D  KRG+ +EL+ + F+      S++  LI
Sbjct: 237 LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELIQHQFLKIAKPLSSLTPLI 287

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 74/274 (27%), Positives = 134/274 (48%), Gaps = 29/274 (10%)
Query: 40  SPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRH--QAAHEAE 97
           S +   +    ++  LG G+ G V  V+H++S + YA+K+L+      ++      +E  
Sbjct: 34  SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 98  ILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLK 157
           IL+ ++  F+VK    F      +  VME++  G +F  LR   + SE      A +++ 
Sbjct: 94  ILQAVNFPFLVKLEFSFKD-NSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 158 GLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAA 217
             +YLH + +I+ D+KP NL+I+ +G +++ DFG ++ V+                G   
Sbjct: 153 TFEYLHSLDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVK----------------GRTW 196
Query: 218 IACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALI 277
             C GT  Y++PE + S+     Y  A D W+LGV++ E   G+ P   F ++P  + + 
Sbjct: 197 XLC-GTPEYLAPEIIISK----GYNKAVDWWALGVLIYEMAAGYPPF--FADQP--IQIY 247
Query: 278 CAICFGERLEMPETASPEFRRFVRSCLEKDWRKR 311
             I  G ++  P   S + +  +R+ L+ D  KR
Sbjct: 248 EKIVSG-KVRFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 83/291 (28%), Positives = 128/291 (43%), Gaps = 41/291 (14%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTS--------STIIRHQAAHEAEILKRLDSQF 106
           +G G  G VY      +    A++ +N           + I+  +      I+  LDS  
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS-- 85
Query: 107 IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQ 166
                   Y +  E+  VME++  GSL D +     + E  I+ V    L+ L++LH  Q
Sbjct: 86  --------YLVGDELWVVMEYLAGGSLTDVV-TETCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 167 IIHGDIKPSNLLINGKGEVKIADFGV-SRIVEETRXXXXXXXXXXXXIGEAAIACMGTCA 225
           +IH DIK  N+L+   G VK+ DFG  ++I  E                      +GT  
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEM---------------VGTPY 181
Query: 226 YMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGER 285
           +M+PE V  +     YG   D+WSLG++ +E + G  P +   E P     + A      
Sbjct: 182 WMAPEVVTRKA----YGPKVDIWSLGIMAIEMIEGEPPYL--NENPLRALYLIATNGTPE 235
Query: 286 LEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNIEGLI 336
           L+ PE  S  FR F+  CL+ D  KRG+ +ELL + F+      S++  LI
Sbjct: 236 LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLTPLI 286

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score =  105 bits (262), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 75/277 (27%), Positives = 136/277 (49%), Gaps = 30/277 (10%)
Query: 37  NPTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRH--QAAH 94
           NP   +  ++   +++  LG G+ G V  V+H ++ + YA+K+L+      ++      +
Sbjct: 18  NPAQ-NTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN 76
Query: 95  EAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYR 154
           E  IL+ ++  F+VK    F      +  VME++  G +F  LR   + SE      A +
Sbjct: 77  EKRILQAVNFPFLVKLEFSFKD-NSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQ 135
Query: 155 VLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIG 214
           ++   +YLH + +I+ D+KP NLLI+ +G +++ DFG ++ V+                G
Sbjct: 136 IVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----------------G 179
Query: 215 EAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLM 274
                C GT  Y++PE + S+     Y  A D W+LGV++ E   G+ P   F ++P  +
Sbjct: 180 RTWTLC-GTPEYLAPEIILSK----GYNKAVDWWALGVLIYEMAAGYPPF--FADQP--I 230
Query: 275 ALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKR 311
            +   I  G ++  P   S + +  +R+ L+ D  KR
Sbjct: 231 QIYEKIVSG-KVRFPSHFSSDLKDLLRNLLQVDLTKR 266

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score =  105 bits (262), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 75/277 (27%), Positives = 136/277 (49%), Gaps = 30/277 (10%)
Query: 37  NPTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRH--QAAH 94
           NP   +  ++   +++  LG G+ G V  V+H ++ + YA+K+L+      ++      +
Sbjct: 33  NPAQ-NTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN 91
Query: 95  EAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYR 154
           E  IL+ ++  F+VK    F      +  VME++  G +F  LR   + SE      A +
Sbjct: 92  EKRILQAVNFPFLVKLEFSFKD-NSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQ 150
Query: 155 VLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIG 214
           ++   +YLH + +I+ D+KP NLLI+ +G +++ DFG ++ V+                G
Sbjct: 151 IVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----------------G 194
Query: 215 EAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLM 274
                C GT  Y++PE + S+     Y  A D W+LGV++ E   G+ P   F ++P  +
Sbjct: 195 RTWTLC-GTPEYLAPEIILSK----GYNKAVDWWALGVLIYEMAAGYPPF--FADQP--I 245
Query: 275 ALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKR 311
            +   I  G ++  P   S + +  +R+ L+ D  KR
Sbjct: 246 QIYEKIVSG-KVRFPSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score =  105 bits (262), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 75/277 (27%), Positives = 136/277 (49%), Gaps = 30/277 (10%)
Query: 37  NPTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRH--QAAH 94
           NP   +  ++   +++  LG G+ G V  V+H ++ + YA+K+L+      ++      +
Sbjct: 32  NPAQ-NTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN 90
Query: 95  EAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYR 154
           E  IL+ ++  F+VK    F      +  VME++  G +F  LR   + SE      A +
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKD-NSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQ 149
Query: 155 VLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIG 214
           ++   +YLH + +I+ D+KP NLLI+ +G +++ DFG ++ V+                G
Sbjct: 150 IVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----------------G 193
Query: 215 EAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLM 274
                C GT  Y++PE + S+     Y  A D W+LGV++ E   G+ P   F ++P  +
Sbjct: 194 RTWXLC-GTPEYLAPEIILSK----GYNKAVDWWALGVLIYEMAAGYPPF--FADQP--I 244
Query: 275 ALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKR 311
            +   I  G ++  P   S + +  +R+ L+ D  KR
Sbjct: 245 QIYEKIVSG-KVRFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score =  105 bits (262), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 75/277 (27%), Positives = 136/277 (49%), Gaps = 30/277 (10%)
Query: 37  NPTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRH--QAAH 94
           NP   +  ++   +++  LG G+ G V  V+H ++ + YA+K+L+      ++      +
Sbjct: 33  NPAQ-NTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN 91
Query: 95  EAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYR 154
           E  IL+ ++  F+VK    F      +  VME++  G +F  LR   + SE      A +
Sbjct: 92  EKRILQAVNFPFLVKLEFSFKD-NSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQ 150
Query: 155 VLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIG 214
           ++   +YLH + +I+ D+KP NLLI+ +G +++ DFG ++ V+                G
Sbjct: 151 IVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----------------G 194
Query: 215 EAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLM 274
                C GT  Y++PE + S+     Y  A D W+LGV++ E   G+ P   F ++P  +
Sbjct: 195 RTWXLC-GTPEYLAPEIILSK----GYNKAVDWWALGVLIYEMAAGYPPF--FADQP--I 245
Query: 275 ALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKR 311
            +   I  G ++  P   S + +  +R+ L+ D  KR
Sbjct: 246 QIYEKIVSG-KVRFPSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score =  105 bits (262), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 74/274 (27%), Positives = 134/274 (48%), Gaps = 29/274 (10%)
Query: 40  SPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRH--QAAHEAE 97
           S +   +    ++  LG G+ G V  V+H++S + YA+K+L+      ++      +E  
Sbjct: 34  SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 98  ILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLK 157
           IL+ ++  F+VK    F      +  VME++  G +F  LR   + SE      A +++ 
Sbjct: 94  ILQAVNFPFLVKLEFSFKD-NSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 158 GLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAA 217
             +YLH + +I+ D+KP NLLI+ +G +++ DFG ++ V+                G   
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----------------GRTW 196
Query: 218 IACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALI 277
             C GT  Y++PE + S+     Y  A D W+LGV++ +   G+ P   F ++P  + + 
Sbjct: 197 XLC-GTPEYLAPEIILSK----GYNKAVDWWALGVLIYQMAAGYPPF--FADQP--IQIY 247
Query: 278 CAICFGERLEMPETASPEFRRFVRSCLEKDWRKR 311
             I  G ++  P   S + +  +R+ L+ D  KR
Sbjct: 248 EKIVSG-KVRFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score =  105 bits (262), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 74/274 (27%), Positives = 134/274 (48%), Gaps = 29/274 (10%)
Query: 40  SPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRH--QAAHEAE 97
           S +   +    ++  LG G+ G V  V+H++S + YA+K+L+      ++      +E  
Sbjct: 34  SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 98  ILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLK 157
           IL+ ++  F+VK    F      +  VME++  G +F  LR   + +E      A +++ 
Sbjct: 94  ILQAVNFPFLVKLEFSFKD-NSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARFYAAQIVL 152
Query: 158 GLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAA 217
             +YLH + +I+ D+KP NLLI+ +G +++ DFG ++ V+                G   
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----------------GRTW 196
Query: 218 IACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALI 277
             C GT  Y++PE + S+     Y  A D W+LGV++ E   G+ P   F ++P  + + 
Sbjct: 197 XLC-GTPEYLAPEIILSK----GYNKAVDWWALGVLIYEMAAGYPPF--FADQP--IQIY 247
Query: 278 CAICFGERLEMPETASPEFRRFVRSCLEKDWRKR 311
             I  G ++  P   S + +  +R+ L+ D  KR
Sbjct: 248 EKIVSG-KVRFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 75/277 (27%), Positives = 136/277 (49%), Gaps = 30/277 (10%)
Query: 37  NPTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRH--QAAH 94
           NP   +  ++   +++  LG G+ G V  V+H ++ + YA+K+L+      ++      +
Sbjct: 32  NPAQ-NTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN 90
Query: 95  EAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYR 154
           E  IL+ ++  F+VK    F      +  VME++  G +F  LR   + SE      A +
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKD-NSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQ 149
Query: 155 VLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIG 214
           ++   +YLH + +I+ D+KP NLLI+ +G +++ DFG ++ V+                G
Sbjct: 150 IVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----------------G 193
Query: 215 EAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLM 274
                C GT  Y++PE + S+     Y  A D W+LGV++ E   G+ P   F ++P  +
Sbjct: 194 RTWXLC-GTPEYLAPEIILSK----GYNKAVDWWALGVLIYEMAAGYPPF--FADQP--I 244
Query: 275 ALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKR 311
            +   I  G ++  P   S + +  +R+ L+ D  KR
Sbjct: 245 QIYEKIVSG-KVRFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 75/277 (27%), Positives = 136/277 (49%), Gaps = 30/277 (10%)
Query: 37  NPTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRH--QAAH 94
           NP   +  ++   +++  LG G+ G V  V+H ++ + YA+K+L+      ++      +
Sbjct: 32  NPAQ-NTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN 90
Query: 95  EAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYR 154
           E  IL+ ++  F+VK    F      +  VME++  G +F  LR   + SE      A +
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKD-NSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQ 149
Query: 155 VLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIG 214
           ++   +YLH + +I+ D+KP NLLI+ +G +++ DFG ++ V+                G
Sbjct: 150 IVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----------------G 193
Query: 215 EAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLM 274
                C GT  Y++PE + S+     Y  A D W+LGV++ E   G+ P   F ++P  +
Sbjct: 194 RTWXLC-GTPEYLAPEIILSK----GYNKAVDWWALGVLIYEMAAGYPPF--FADQP--I 244
Query: 275 ALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKR 311
            +   I  G ++  P   S + +  +R+ L+ D  KR
Sbjct: 245 QIYEKIVSG-KVRFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 75/277 (27%), Positives = 136/277 (49%), Gaps = 30/277 (10%)
Query: 37  NPTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRH--QAAH 94
           NP   +  ++   +++  LG G+ G V  V+H ++ + YA+K+L+      ++      +
Sbjct: 32  NPAQ-NTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN 90
Query: 95  EAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYR 154
           E  IL+ ++  F+VK    F      +  VME++  G +F  LR   + SE      A +
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKD-NSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQ 149
Query: 155 VLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIG 214
           ++   +YLH + +I+ D+KP NLLI+ +G +++ DFG ++ V+                G
Sbjct: 150 IVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----------------G 193
Query: 215 EAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLM 274
                C GT  Y++PE + S+     Y  A D W+LGV++ E   G+ P   F ++P  +
Sbjct: 194 RTWXLC-GTPEYLAPEIILSK----GYNKAVDWWALGVLIYEMAAGYPPF--FADQP--I 244
Query: 275 ALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKR 311
            +   I  G ++  P   S + +  +R+ L+ D  KR
Sbjct: 245 QIYEKIVSG-KVRFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 73/272 (26%), Positives = 135/272 (49%), Gaps = 29/272 (10%)
Query: 42  DVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRH--QAAHEAEIL 99
           +  ++   +++  LG G+ G V  V+H+++ + YA+K+L+      ++      +E  IL
Sbjct: 29  NTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIL 88
Query: 100 KRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGL 159
           + ++  F+VK    F      +  VME++  G +F  LR   + SE      A +++   
Sbjct: 89  QAVNFPFLVKLEFSFKD-NSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 147
Query: 160 QYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIA 219
           +YLH + +I+ D+KP NLLI+ +G +++ DFG ++ V+                G     
Sbjct: 148 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----------------GRTWXL 191
Query: 220 CMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICA 279
           C GT  Y++PE + S+     Y  A D W+LGV++ E   G+ P   F ++P  + +   
Sbjct: 192 C-GTPEYLAPEIILSK----GYNKAVDWWALGVLIYEMAAGYPPF--FADQP--IQIYEK 242
Query: 280 ICFGERLEMPETASPEFRRFVRSCLEKDWRKR 311
           I  G ++  P   S + +  +R+ L+ D  KR
Sbjct: 243 IVSG-KVRFPSHFSSDLKDLLRNLLQVDLTKR 273

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 73/272 (26%), Positives = 135/272 (49%), Gaps = 29/272 (10%)
Query: 42  DVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRH--QAAHEAEIL 99
           +  ++   +++  LG G+ G V  V+H+++ + YA+K+L+      ++      +E  IL
Sbjct: 37  NTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIL 96
Query: 100 KRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGL 159
           + ++  F+VK    F      +  VME++  G +F  LR   + SE      A +++   
Sbjct: 97  QAVNFPFLVKLEFSFKD-NSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 155
Query: 160 QYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIA 219
           +YLH + +I+ D+KP NLLI+ +G +++ DFG ++ V+                G     
Sbjct: 156 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----------------GRTWXL 199
Query: 220 CMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICA 279
           C GT  Y++PE + S+     Y  A D W+LGV++ E   G+ P   F ++P  + +   
Sbjct: 200 C-GTPEYLAPEIILSK----GYNKAVDWWALGVLIYEMAAGYPPF--FADQP--IQIYEK 250
Query: 280 ICFGERLEMPETASPEFRRFVRSCLEKDWRKR 311
           I  G ++  P   S + +  +R+ L+ D  KR
Sbjct: 251 IVSG-KVRFPSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 75/277 (27%), Positives = 136/277 (49%), Gaps = 30/277 (10%)
Query: 37  NPTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRH--QAAH 94
           NP   +  ++   +++  LG G+ G V  V+H ++ + YA+K+L+      ++      +
Sbjct: 32  NPAQ-NTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLN 90
Query: 95  EAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYR 154
           E  IL+ ++  F+VK    F      +  VME+   G +F  LR   + SE      A +
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKD-NSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQ 149
Query: 155 VLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIG 214
           ++   +YLH + +I+ D+KP NL+I+ +G +K+ DFG+++ V+                G
Sbjct: 150 IVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVK----------------G 193
Query: 215 EAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLM 274
                C GT  Y++PE + S+     Y  A D W+LGV++ E   G+ P   F ++P  +
Sbjct: 194 RTWXLC-GTPEYLAPEIILSK----GYNKAVDWWALGVLIYEMAAGYPPF--FADQP--I 244
Query: 275 ALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKR 311
            +   I  G ++  P   S + +  +R+ L+ D  KR
Sbjct: 245 QIYEKIVSG-KVRFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score =  105 bits (261), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 73/272 (26%), Positives = 135/272 (49%), Gaps = 29/272 (10%)
Query: 42  DVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRH--QAAHEAEIL 99
           +  ++   +++  LG G+ G V  V+H+++ + YA+K+L+      ++      +E  IL
Sbjct: 37  NTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIL 96
Query: 100 KRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGL 159
           + ++  F+VK    F      +  VME++  G +F  LR   + SE      A +++   
Sbjct: 97  QAVNFPFLVKLEFSFKD-NSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 155
Query: 160 QYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIA 219
           +YLH + +I+ D+KP NLLI+ +G +++ DFG ++ V+                G     
Sbjct: 156 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----------------GRTWXL 199
Query: 220 CMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICA 279
           C GT  Y++PE + S+     Y  A D W+LGV++ E   G+ P   F ++P  + +   
Sbjct: 200 C-GTPEYLAPEIILSK----GYNKAVDWWALGVLIYEMAAGYPPF--FADQP--IQIYEK 250
Query: 280 ICFGERLEMPETASPEFRRFVRSCLEKDWRKR 311
           I  G ++  P   S + +  +R+ L+ D  KR
Sbjct: 251 IVSG-KVRFPSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score =  105 bits (261), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 73/272 (26%), Positives = 135/272 (49%), Gaps = 29/272 (10%)
Query: 42  DVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRH--QAAHEAEIL 99
           +  ++   +++  LG G+ G V  V+H+++ + YA+K+L+      ++      +E  IL
Sbjct: 57  NTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIL 116
Query: 100 KRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGL 159
           + ++  F+VK    F      +  VME++  G +F  LR   + SE      A +++   
Sbjct: 117 QAVNFPFLVKLEFSFKD-NSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 175
Query: 160 QYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIA 219
           +YLH + +I+ D+KP NLLI+ +G +++ DFG ++ V+                G     
Sbjct: 176 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----------------GRTWXL 219
Query: 220 CMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICA 279
           C GT  Y++PE + S+     Y  A D W+LGV++ E   G+ P   F ++P  + +   
Sbjct: 220 C-GTPEYLAPEIILSK----GYNKAVDWWALGVLIYEMAAGYPPF--FADQP--IQIYEK 270
Query: 280 ICFGERLEMPETASPEFRRFVRSCLEKDWRKR 311
           I  G ++  P   S + +  +R+ L+ D  KR
Sbjct: 271 IVSG-KVRFPSHFSSDLKDLLRNLLQVDLTKR 301

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score =  105 bits (261), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 73/272 (26%), Positives = 135/272 (49%), Gaps = 29/272 (10%)
Query: 42  DVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRH--QAAHEAEIL 99
           +  ++   +++  LG G+ G V  V+H+++ + YA+K+L+      ++      +E  IL
Sbjct: 37  NTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIL 96
Query: 100 KRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGL 159
           + ++  F+VK    F      +  VME++  G +F  LR   + SE      A +++   
Sbjct: 97  QAVNFPFLVKLEFSFKD-NSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 155
Query: 160 QYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIA 219
           +YLH + +I+ D+KP NLLI+ +G +++ DFG ++ V+                G     
Sbjct: 156 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----------------GRTWXL 199
Query: 220 CMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICA 279
           C GT  Y++PE + S+     Y  A D W+LGV++ E   G+ P   F ++P  + +   
Sbjct: 200 C-GTPEYLAPEIILSK----GYNKAVDWWALGVLIYEMAAGYPPF--FADQP--IQIYEK 250
Query: 280 ICFGERLEMPETASPEFRRFVRSCLEKDWRKR 311
           I  G ++  P   S + +  +R+ L+ D  KR
Sbjct: 251 IVSG-KVRFPSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score =  105 bits (261), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 75/277 (27%), Positives = 135/277 (48%), Gaps = 30/277 (10%)
Query: 37  NPTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRH--QAAH 94
           NP   +  ++   +++  LG G+ G V  V+H ++ + YA+K+L+      ++      +
Sbjct: 32  NPAQ-NTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN 90
Query: 95  EAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYR 154
           E  IL+ ++  F+VK    F      +  VME+   G +F  LR   + SE      A +
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKD-NSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQ 149
Query: 155 VLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIG 214
           ++   +YLH + +I+ D+KP NL+I+ +G +K+ DFG ++ V+                G
Sbjct: 150 IVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK----------------G 193
Query: 215 EAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLM 274
                C GT  Y++PE + S+     Y  A D W+LGV++ E   G+ P   F ++P  +
Sbjct: 194 RTWXLC-GTPEYLAPEIILSK----GYNKAVDWWALGVLIYEMAAGYPPF--FADQP--I 244
Query: 275 ALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKR 311
            +   I  G ++  P   S + +  +R+ L+ D  KR
Sbjct: 245 QIYEKIVSG-KVRFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score =  105 bits (261), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 73/272 (26%), Positives = 134/272 (49%), Gaps = 29/272 (10%)
Query: 42  DVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRH--QAAHEAEIL 99
           +  ++   +++  LG G+ G V  V+H+++ + YA+K+L+      ++      +E  IL
Sbjct: 37  NTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIL 96
Query: 100 KRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGL 159
           + ++  F+VK    F      +  VME+   G +F  LR   + SE      A +++   
Sbjct: 97  QAVNFPFLVKLEFSFKD-NSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 155
Query: 160 QYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIA 219
           +YLH + +I+ D+KP NL+I+ +G +K+ DFG ++ V+                G     
Sbjct: 156 EYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK----------------GRTWXL 199
Query: 220 CMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICA 279
           C GT  Y++PE + S+     Y  A D W+LGV++ E   G+ P   F ++P  + +   
Sbjct: 200 C-GTPEYLAPEIILSK----GYNKAVDWWALGVLIYEMAAGYPPF--FADQP--IQIYEK 250
Query: 280 ICFGERLEMPETASPEFRRFVRSCLEKDWRKR 311
           I  G ++  P   S + +  +R+ L+ D  KR
Sbjct: 251 IVSG-KVRFPSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  105 bits (261), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 74/274 (27%), Positives = 133/274 (48%), Gaps = 29/274 (10%)
Query: 40  SPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRH--QAAHEAE 97
           S +   +    ++  LG G+ G V  V+H++S + YA+K+L+      ++      +E  
Sbjct: 34  SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 98  ILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLK 157
           IL+ ++  F+VK    F      +  VME++  G +F  LR   +  E      A +++ 
Sbjct: 94  ILQAVNFPFLVKLEFSFKD-NSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVL 152
Query: 158 GLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAA 217
             +YLH + +I+ D+KP NLLI+ +G +++ DFG ++ V+                G   
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----------------GRTW 196
Query: 218 IACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALI 277
             C GT  Y++PE + S+     Y  A D W+LGV++ E   G+ P   F ++P  + + 
Sbjct: 197 XLC-GTPEYLAPEIILSK----GYNKAVDWWALGVLIYEMAAGYPPF--FADQP--IQIY 247
Query: 278 CAICFGERLEMPETASPEFRRFVRSCLEKDWRKR 311
             I  G ++  P   S + +  +R+ L+ D  KR
Sbjct: 248 EKIVSG-KVRFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score =  105 bits (261), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 74/274 (27%), Positives = 133/274 (48%), Gaps = 29/274 (10%)
Query: 40  SPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRH--QAAHEAE 97
           S +   +    ++  LG G+ G V  V+H++S + YA+K+L+      ++      +E  
Sbjct: 29  SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR 88
Query: 98  ILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLK 157
           IL+ ++  F+VK    F      +  VME++  G +F  LR   +  E      A +++ 
Sbjct: 89  ILQAVNFPFLVKLEFSFKD-NSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVL 147
Query: 158 GLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAA 217
             +YLH + +I+ D+KP NLLI+ +G +++ DFG ++ V+                G   
Sbjct: 148 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----------------GRTW 191
Query: 218 IACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALI 277
             C GT  Y++PE + S+     Y  A D W+LGV++ E   G+ P   F ++P  + + 
Sbjct: 192 XLC-GTPEYLAPEIILSK----GYNKAVDWWALGVLIYEMAAGYPPF--FADQP--IQIY 242
Query: 278 CAICFGERLEMPETASPEFRRFVRSCLEKDWRKR 311
             I  G ++  P   S + +  +R+ L+ D  KR
Sbjct: 243 EKIVSG-KVRFPSHFSSDLKDLLRNLLQVDLTKR 275

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score =  105 bits (261), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 74/274 (27%), Positives = 133/274 (48%), Gaps = 29/274 (10%)
Query: 40  SPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRH--QAAHEAE 97
           S +   +    ++  LG G+ G V  V+H++S + YA+K+L+      ++      +E  
Sbjct: 55  SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR 114
Query: 98  ILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLK 157
           IL+ ++  F+VK    F      +  VME++  G +F  LR   +  E      A +++ 
Sbjct: 115 ILQAVNFPFLVKLEFSFKD-NSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVL 173
Query: 158 GLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAA 217
             +YLH + +I+ D+KP NLLI+ +G +++ DFG ++ V+                G   
Sbjct: 174 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----------------GRTW 217
Query: 218 IACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALI 277
             C GT  Y++PE + S+     Y  A D W+LGV++ E   G+ P   F ++P  + + 
Sbjct: 218 XLC-GTPEYLAPEIILSK----GYNKAVDWWALGVLIYEMAAGYPPF--FADQP--IQIY 268
Query: 278 CAICFGERLEMPETASPEFRRFVRSCLEKDWRKR 311
             I  G ++  P   S + +  +R+ L+ D  KR
Sbjct: 269 EKIVSG-KVRFPSHFSSDLKDLLRNLLQVDLTKR 301

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score =  104 bits (260), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 74/274 (27%), Positives = 133/274 (48%), Gaps = 29/274 (10%)
Query: 40  SPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRH--QAAHEAE 97
           S +   +    ++  LG G+ G V  V+H++S + YA+K+L+      ++      +E  
Sbjct: 34  SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 98  ILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLK 157
           IL+ ++  F+VK    F      +  VME++  G +F  LR   +  E      A +++ 
Sbjct: 94  ILQAVNFPFLVKLEFSFKD-NSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVL 152
Query: 158 GLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAA 217
             +YLH + +I+ D+KP NLLI+ +G +++ DFG ++ V+                G   
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----------------GRTW 196
Query: 218 IACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALI 277
             C GT  Y++PE + S+     Y  A D W+LGV++ E   G+ P   F ++P  + + 
Sbjct: 197 XLC-GTPEYLAPEIILSK----GYNKAVDWWALGVLIYEMAAGYPPF--FADQP--IQIY 247
Query: 278 CAICFGERLEMPETASPEFRRFVRSCLEKDWRKR 311
             I  G ++  P   S + +  +R+ L+ D  KR
Sbjct: 248 EKIVSG-KVRFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score =  104 bits (260), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 74/277 (26%), Positives = 137/277 (49%), Gaps = 30/277 (10%)
Query: 37  NPTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRH--QAAH 94
           NP   +  ++   +++  LG G+ G V  V+H+++ + +A+K+L+      ++      +
Sbjct: 32  NPAQ-NTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLN 90
Query: 95  EAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYR 154
           E  IL+ ++  F+VK    F      +  VME++  G +F  LR   + SE      A +
Sbjct: 91  EKRILQAVNFPFLVKLEYSFKD-NSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQ 149
Query: 155 VLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIG 214
           ++   +YLH + +I+ D+KP NLLI+ +G +++ DFG ++ V+                G
Sbjct: 150 IVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----------------G 193
Query: 215 EAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLM 274
                C GT  Y++PE + S+     Y  A D W+LGV++ E   G+ P   F ++P  +
Sbjct: 194 RTWXLC-GTPEYLAPEIILSK----GYNKAVDWWALGVLIYEMAAGYPPF--FADQP--I 244
Query: 275 ALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKR 311
            +   I  G ++  P   S + +  +R+ L+ D  KR
Sbjct: 245 QIYEKIVSG-KVRFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score =  104 bits (260), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 74/277 (26%), Positives = 137/277 (49%), Gaps = 30/277 (10%)
Query: 37  NPTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRH--QAAH 94
           NP   +  ++   +++  LG G+ G V  V+H+++ + +A+K+L+      ++      +
Sbjct: 32  NPAQ-NTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLN 90
Query: 95  EAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYR 154
           E  IL+ ++  F+VK    F      +  VME++  G +F  LR   + SE      A +
Sbjct: 91  EKRILQAVNFPFLVKLEYSFKD-NSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQ 149
Query: 155 VLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIG 214
           ++   +YLH + +I+ D+KP NLLI+ +G +++ DFG ++ V+                G
Sbjct: 150 IVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----------------G 193
Query: 215 EAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLM 274
                C GT  Y++PE + S+     Y  A D W+LGV++ E   G+ P   F ++P  +
Sbjct: 194 RTWXLC-GTPEYLAPEIILSK----GYNKAVDWWALGVLIYEMAAGYPPF--FADQP--I 244
Query: 275 ALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKR 311
            +   I  G ++  P   S + +  +R+ L+ D  KR
Sbjct: 245 QIYEKIVSG-KVRFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score =  104 bits (260), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 74/277 (26%), Positives = 137/277 (49%), Gaps = 30/277 (10%)
Query: 37  NPTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRH--QAAH 94
           NP   +  ++   +++  LG G+ G V  V+H+++ + +A+K+L+      ++      +
Sbjct: 32  NPAQ-NTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLN 90
Query: 95  EAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYR 154
           E  IL+ ++  F+VK    F      +  VME++  G +F  LR   + SE      A +
Sbjct: 91  EKRILQAVNFPFLVKLEYSFKD-NSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQ 149
Query: 155 VLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIG 214
           ++   +YLH + +I+ D+KP NLLI+ +G +++ DFG ++ V+                G
Sbjct: 150 IVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----------------G 193
Query: 215 EAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLM 274
                C GT  Y++PE + S+     Y  A D W+LGV++ E   G+ P   F ++P  +
Sbjct: 194 RTWXLC-GTPEYLAPEIILSK----GYNKAVDWWALGVLIYEMAAGYPPF--FADQP--I 244
Query: 275 ALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKR 311
            +   I  G ++  P   S + +  +R+ L+ D  KR
Sbjct: 245 QIYEKIVSG-KVRFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  104 bits (260), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 82/291 (28%), Positives = 128/291 (43%), Gaps = 41/291 (14%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTS--------STIIRHQAAHEAEILKRLDSQF 106
           +G G  G VY      +    A++ +N           + I+  +      I+  LDS  
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS-- 86
Query: 107 IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQ 166
                   Y +  E+  VME++  GSL D +     + E  I+ V    L+ L++LH  Q
Sbjct: 87  --------YLVGDELWVVMEYLAGGSLTDVV-TETCMDEGQIAAVCRECLQALEFLHSNQ 137
Query: 167 IIHGDIKPSNLLINGKGEVKIADFGV-SRIVEETRXXXXXXXXXXXXIGEAAIACMGTCA 225
           +IH +IK  N+L+   G VK+ DFG  ++I  E                      +GT  
Sbjct: 138 VIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS---------------TMVGTPY 182
Query: 226 YMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGER 285
           +M+PE V  +     YG   D+WSLG++ +E + G  P +   E P     + A      
Sbjct: 183 WMAPEVVTRKA----YGPKVDIWSLGIMAIEMIEGEPPYL--NENPLRALYLIATNGTPE 236
Query: 286 LEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNIEGLI 336
           L+ PE  S  FR F+  CLE D  KRG+ +EL+ + F+      S++  LI
Sbjct: 237 LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELIQHQFLKIAKPLSSLTPLI 287

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score =  104 bits (260), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 74/278 (26%), Positives = 129/278 (46%), Gaps = 30/278 (10%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKV-----LNTTSSTIIRHQAAHEAEILKRLDSQFIVK 109
           LG G   IV K R + +   YA K      L+++   + R +   E  IL+ +    I+ 
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 110 CHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIH 169
            H +F   + ++  ++E +  G LFD L  ++ L+ED  +    ++L G+ YLH  +I H
Sbjct: 73  LHDIFEN-KTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAH 131
Query: 170 GDIKPSNLLINGKG----EVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCA 225
            D+KP N+++  K      +K+ DFG++  +E                G       GT  
Sbjct: 132 FDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE---------------AGNEFKNIFGTPE 176
Query: 226 YMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGER 285
           +++PE V+ E      G   D+WS+GV+    L G  P +G   K + +  I A+ +   
Sbjct: 177 FVAPEIVNYE----PLGLEADMWSIGVITYILLSGASPFLG-ETKQETLTNISAVNYDFD 231
Query: 286 LEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV 323
            E     S   + F+R  L KD ++R T+ + L + ++
Sbjct: 232 EEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWI 269

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score =  104 bits (260), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 74/274 (27%), Positives = 133/274 (48%), Gaps = 29/274 (10%)
Query: 40  SPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRH--QAAHEAE 97
           S +   +    ++  LG G+ G V  V+H++S + YA+K+L+      ++      +E  
Sbjct: 34  SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 98  ILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLK 157
           IL+ ++  F+VK    F      +  VME++  G +F  LR   +  E      A +++ 
Sbjct: 94  ILQAVNFPFLVKLEFSFKD-NSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVL 152
Query: 158 GLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAA 217
             +YLH + +I+ D+KP NLLI+ +G +++ DFG ++ V+                G   
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----------------GRTW 196
Query: 218 IACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALI 277
             C GT  Y++PE + S+     Y  A D W+LGV++ E   G+ P   F ++P  + + 
Sbjct: 197 XLC-GTPEYLAPEIILSK----GYNKAVDWWALGVLIYEMAAGYPPF--FADQP--IQIY 247
Query: 278 CAICFGERLEMPETASPEFRRFVRSCLEKDWRKR 311
             I  G ++  P   S + +  +R+ L+ D  KR
Sbjct: 248 EKIVSG-KVRFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  104 bits (259), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 74/273 (27%), Positives = 133/273 (48%), Gaps = 29/273 (10%)
Query: 40  SPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRH--QAAHEAE 97
           S +   +    ++  LG G+ G V  V+H++S + YA+K+L+      ++      +E  
Sbjct: 34  SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 98  ILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLK 157
           IL+ ++  F+VK    F      +  VME++  G +F  LR   + SE      A +++ 
Sbjct: 94  ILQAVNFPFLVKLEFSFKD-NSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 158 GLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAA 217
             +YLH + +I+ D+KP NLLI+ +G +++ DFG ++ V+                G   
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----------------GRTW 196
Query: 218 IACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALI 277
             C GT  Y++PE + S+     Y  A D W+LGV++ E   G+ P   F ++P  + + 
Sbjct: 197 XLC-GTPEYLAPEIILSK----GYNKAVDWWALGVLIYEMAAGYPPF--FADQP--IQIY 247
Query: 278 CAICFGERLEMPETASPEFRRFVRSCLEKDWRK 310
             I  G ++  P   S + +  +R+ L+ D  K
Sbjct: 248 EKIVSG-KVRFPSHFSSDLKDLLRNLLQVDLTK 279

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score =  104 bits (259), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 73/274 (26%), Positives = 132/274 (48%), Gaps = 29/274 (10%)
Query: 40  SPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRH--QAAHEAE 97
           S +   +    ++  LG G+ G V  V+H++S + YA+K+L+      ++      +E  
Sbjct: 34  SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 98  ILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLK 157
           IL+ ++  F+VK    F      +  VME++  G +F  LR   + SE      A +++ 
Sbjct: 94  ILQAVNFPFLVKLEFSFKD-NSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 158 GLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAA 217
             +YLH + +I+ D+KP NLLI+ +G +++ DFG ++ V+                    
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----------------T 195
Query: 218 IACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALI 277
               GT  Y++PE + S+     Y  A D W+LGV++ E   G+ P   F ++P  + + 
Sbjct: 196 WXLAGTPEYLAPEIILSK----GYNKAVDWWALGVLIYEMAAGYPPF--FADQP--IQIY 247
Query: 278 CAICFGERLEMPETASPEFRRFVRSCLEKDWRKR 311
             I  G ++  P   S + +  +R+ L+ D  KR
Sbjct: 248 EKIVSG-KVRFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  104 bits (259), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 74/274 (27%), Positives = 133/274 (48%), Gaps = 29/274 (10%)
Query: 40  SPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRH--QAAHEAE 97
           S +   +    ++  LG G+ G V  V+H++S + YA+K+L+      ++      +E  
Sbjct: 34  SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 98  ILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLK 157
           IL+ ++  F+VK    F      +  VME++  G +F  LR   + SE      A +++ 
Sbjct: 94  ILQAVNFPFLVKLEFSFKD-NSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 158 GLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAA 217
             +YLH + +I+ D+KP NLLI+ +G +++ DFG ++ V+                G   
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----------------GRTW 196
Query: 218 IACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALI 277
             C GT  Y++P  + S+     Y  A D W+LGV++ E   G+ P   F ++P  + + 
Sbjct: 197 XLC-GTPEYLAPAIILSK----GYNKAVDWWALGVLIYEMAAGYPPF--FADQP--IQIY 247
Query: 278 CAICFGERLEMPETASPEFRRFVRSCLEKDWRKR 311
             I  G ++  P   S + +  +R+ L+ D  KR
Sbjct: 248 EKIVSG-KVRFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score =  104 bits (259), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 73/274 (26%), Positives = 132/274 (48%), Gaps = 29/274 (10%)
Query: 40  SPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRH--QAAHEAE 97
           S +   +    ++  LG G+ G V  V+H++S + YA+K+L+      ++      +E  
Sbjct: 34  SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 98  ILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLK 157
           IL+ ++  F+VK    F      +  VME++  G +F  LR   + SE      A +++ 
Sbjct: 94  ILQAVNFPFLVKLEFSFKD-NSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 158 GLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAA 217
             +YLH + +I+ D+KP NLLI+ +G +++ DFG ++ V+                    
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----------------T 195
Query: 218 IACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALI 277
               GT  Y++PE + S+     Y  A D W+LGV++ E   G+ P   F ++P  + + 
Sbjct: 196 WXLXGTPEYLAPEIILSK----GYNKAVDWWALGVLIYEMAAGYPPF--FADQP--IQIY 247
Query: 278 CAICFGERLEMPETASPEFRRFVRSCLEKDWRKR 311
             I  G ++  P   S + +  +R+ L+ D  KR
Sbjct: 248 EKIVSG-KVRFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 74/277 (26%), Positives = 136/277 (49%), Gaps = 30/277 (10%)
Query: 37  NPTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRH--QAAH 94
           NP   +  ++   +++  LG G+ G V  V+H ++ + YA+K+L+      ++      +
Sbjct: 32  NPAQ-NTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLN 90
Query: 95  EAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYR 154
           E  IL+ ++  F+VK    F      +  VME+   G +F  LR   + SE      A +
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKD-NSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQ 149
Query: 155 VLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIG 214
           ++   +YLH + +I+ D+KP NL+I+ +G +++ DFG+++ V+                G
Sbjct: 150 IVLTFEYLHSLDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVK----------------G 193
Query: 215 EAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLM 274
                C GT  Y++PE + S+     Y  A D W+LGV++ E   G+ P   F ++P  +
Sbjct: 194 RTWXLC-GTPEYLAPEIILSK----GYNKAVDWWALGVLIYEMAAGYPPF--FADQP--I 244
Query: 275 ALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKR 311
            +   I  G ++  P   S + +  +R+ L+ D  KR
Sbjct: 245 QIYEKIVSG-KVRFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 74/277 (26%), Positives = 135/277 (48%), Gaps = 30/277 (10%)
Query: 37  NPTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRH--QAAH 94
           NP   +  ++   +++  LG G+ G V  V+H ++ + YA+K+L+      ++      +
Sbjct: 32  NPAQ-NTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN 90
Query: 95  EAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYR 154
           E  IL+ ++  F+VK    F      +  VME+   G +F  LR   + SE      A +
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKD-NSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQ 149
Query: 155 VLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIG 214
           ++   +YLH + +I+ D+KP NL+I+ +G +++ DFG ++ V+                G
Sbjct: 150 IVLTFEYLHSLDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVK----------------G 193
Query: 215 EAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLM 274
                C GT  Y++PE + S+     Y  A D W+LGV++ E   G+ P   F ++P  +
Sbjct: 194 RTWXLC-GTPEYLAPEIILSK----GYNKAVDWWALGVLIYEMAAGYPPF--FADQP--I 244
Query: 275 ALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKR 311
            +   I  G ++  P   S + +  +R+ L+ D  KR
Sbjct: 245 QIYEKIVSG-KVRFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 74/277 (26%), Positives = 134/277 (48%), Gaps = 30/277 (10%)
Query: 37  NPTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRH--QAAH 94
           NP   +  ++   +++  LG G+ G V  V+H ++ + YA+K+L+      ++      +
Sbjct: 33  NPAQ-NTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN 91
Query: 95  EAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYR 154
           E  IL+ ++  F+ K    F      +  VME+   G +F  LR   + SE      A +
Sbjct: 92  EKRILQAVNFPFLTKLEFSFKD-NSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQ 150
Query: 155 VLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIG 214
           ++   +YLH + +I+ D+KP NL+I+ +G +K+ DFG ++ V+                G
Sbjct: 151 IVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK----------------G 194
Query: 215 EAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLM 274
                C GT  Y++PE + S+     Y  A D W+LGV++ E   G+ P   F ++P  +
Sbjct: 195 RTWXLC-GTPEYLAPEIILSK----GYNKAVDWWALGVLIYEMAAGYPPF--FADQP--I 245
Query: 275 ALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKR 311
            +   I  G ++  P   S + +  +R+ L+ D  KR
Sbjct: 246 QIYEKIVSG-KVRFPSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 74/277 (26%), Positives = 134/277 (48%), Gaps = 30/277 (10%)
Query: 37  NPTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRH--QAAH 94
           NP   +  ++   +++  LG G+ G V  V+H ++ + YA+K+L+      ++      +
Sbjct: 33  NPAQ-NTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN 91
Query: 95  EAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYR 154
           E  IL+ ++  F+ K    F      +  VME+   G +F  LR   + SE      A +
Sbjct: 92  EKRILQAVNFPFLTKLEFSFKD-NSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQ 150
Query: 155 VLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIG 214
           ++   +YLH + +I+ D+KP NL+I+ +G +K+ DFG ++ V+                G
Sbjct: 151 IVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK----------------G 194
Query: 215 EAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLM 274
                C GT  Y++PE + S+     Y  A D W+LGV++ E   G+ P   F ++P  +
Sbjct: 195 RTWXLC-GTPEYLAPEIILSK----GYNKAVDWWALGVLIYEMAAGYPPF--FADQP--I 245
Query: 275 ALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKR 311
            +   I  G ++  P   S + +  +R+ L+ D  KR
Sbjct: 246 QIYEKIVSG-KVRFPSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 82/284 (28%), Positives = 123/284 (43%), Gaps = 38/284 (13%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHA 112
           LG G  G VY  R ++S  I ALKVL         + HQ   E EI   L    I++ + 
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 113 VFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDI 172
            F+     +  ++E+  RG ++  L+   K  E   +     +   L Y H  ++IH DI
Sbjct: 81  YFHDA-TRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDI 139
Query: 173 KPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERV 232
           KP NLL+   GE+KIADFG S     +R                     GT  Y+ PE +
Sbjct: 140 KPENLLLGSAGELKIADFGWSVHAPSSRR----------------XXLXGTLDYLPPEMI 183
Query: 233 DSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPETA 292
           +    G  +    D+WSLGV+  E LVG         KP   A      + +R+   E  
Sbjct: 184 E----GRMHDEKVDLWSLGVLCYEFLVG---------KPPFEANTYQETY-KRISRVEFT 229
Query: 293 SPEF-----RRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSN 331
            P+F     R  +   L+ +  +R  + E+L +P++T  SS  +
Sbjct: 230 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPS 273

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 74/277 (26%), Positives = 135/277 (48%), Gaps = 30/277 (10%)
Query: 37  NPTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRH--QAAH 94
           NP   +  ++   +++  LG G+ G V  V+H ++ + YA+K+L+      ++      +
Sbjct: 33  NPAQ-NTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN 91
Query: 95  EAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYR 154
           E  IL+ ++  F+VK    F      +  VME++  G +F  LR   +  E      A +
Sbjct: 92  EKRILQAVNFPFLVKLEFSFKD-NSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQ 150
Query: 155 VLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIG 214
           ++   +YLH + +I+ D+KP NLLI+ +G +++ DFG ++ V+                G
Sbjct: 151 IVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----------------G 194
Query: 215 EAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLM 274
                C GT  Y++PE + S+     Y  A D W+LGV++ E   G+ P   F ++P  +
Sbjct: 195 RTWXLC-GTPEYLAPEIILSK----GYNKAVDWWALGVLIYEMAAGYPPF--FADQP--I 245
Query: 275 ALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKR 311
            +   I  G ++  P   S + +  +R+ L+ D  KR
Sbjct: 246 QIYEKIVSG-KVRFPSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  103 bits (257), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 74/277 (26%), Positives = 135/277 (48%), Gaps = 30/277 (10%)
Query: 37  NPTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRH--QAAH 94
           NP   +  ++   +++  LG G+ G V  V+H ++ + YA+K+L+      ++      +
Sbjct: 32  NPAQ-NTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN 90
Query: 95  EAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYR 154
           E  IL+ ++  F+VK    F      +  VME++  G +F  LR   +  E      A +
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKD-NSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQ 149
Query: 155 VLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIG 214
           ++   +YLH + +I+ D+KP NLLI+ +G +++ DFG ++ V+                G
Sbjct: 150 IVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----------------G 193
Query: 215 EAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLM 274
                C GT  Y++PE + S+     Y  A D W+LGV++ E   G+ P   F ++P  +
Sbjct: 194 RTWXLC-GTPEYLAPEIILSK----GYNKAVDWWALGVLIYEMAAGYPPF--FADQP--I 244
Query: 275 ALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKR 311
            +   I  G ++  P   S + +  +R+ L+ D  KR
Sbjct: 245 QIYEKIVSG-KVRFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score =  103 bits (257), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 82/284 (28%), Positives = 123/284 (43%), Gaps = 38/284 (13%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHA 112
           LG G  G VY  R ++S  I ALKVL         + HQ   E EI   L    I++ + 
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 113 VFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDI 172
            F+     +  ++E+  RG ++  L+   K  E   +     +   L Y H  ++IH DI
Sbjct: 81  YFHDA-TRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDI 139
Query: 173 KPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERV 232
           KP NLL+   GE+KIADFG S     +R                     GT  Y+ PE +
Sbjct: 140 KPENLLLGSAGELKIADFGWSVHAPSSRR----------------TTLCGTLDYLPPEMI 183
Query: 233 DSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPETA 292
           +    G  +    D+WSLGV+  E LVG         KP   A      + +R+   E  
Sbjct: 184 E----GRMHDEKVDLWSLGVLCYEFLVG---------KPPFEANTYQETY-KRISRVEFT 229
Query: 293 SPEF-----RRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSN 331
            P+F     R  +   L+ +  +R  + E+L +P++T  SS  +
Sbjct: 230 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPS 273

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score =  103 bits (257), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 74/277 (26%), Positives = 135/277 (48%), Gaps = 30/277 (10%)
Query: 37  NPTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRH--QAAH 94
           NP   +  ++   +++  LG G+ G V  V+H ++ + YA+K+L+      ++      +
Sbjct: 32  NPAQ-NTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN 90
Query: 95  EAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYR 154
           E  IL+ ++  F+VK    F      +  VME++  G +F  LR   +  E      A +
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKD-NSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQ 149
Query: 155 VLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIG 214
           ++   +YLH + +I+ D+KP NLLI+ +G +++ DFG ++ V+                G
Sbjct: 150 IVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----------------G 193
Query: 215 EAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLM 274
                C GT  Y++PE + S+     Y  A D W+LGV++ E   G+ P   F ++P  +
Sbjct: 194 RTWXLC-GTPEYLAPEIILSK----GYNKAVDWWALGVLIYEMAAGYPPF--FADQP--I 244
Query: 275 ALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKR 311
            +   I  G ++  P   S + +  +R+ L+ D  KR
Sbjct: 245 QIYEKIVSG-KVRFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score =  103 bits (257), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 72/272 (26%), Positives = 134/272 (49%), Gaps = 29/272 (10%)
Query: 42  DVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRH--QAAHEAEIL 99
           +  ++   +++  LG G+ G V  V+H+++ + YA+K+L+      ++      +E  IL
Sbjct: 29  NTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIL 88
Query: 100 KRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGL 159
           + ++  F+VK    F      +  VME++  G +F  LR   +  E      A +++   
Sbjct: 89  QAVNFPFLVKLEFSFKD-NSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTF 147
Query: 160 QYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIA 219
           +YLH + +I+ D+KP NLLI+ +G +++ DFG ++ V+                G     
Sbjct: 148 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----------------GRTWXL 191
Query: 220 CMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICA 279
           C GT  Y++PE + S+     Y  A D W+LGV++ E   G+ P   F ++P  + +   
Sbjct: 192 C-GTPEYLAPEIILSK----GYNKAVDWWALGVLIYEMAAGYPPF--FADQP--IQIYEK 242
Query: 280 ICFGERLEMPETASPEFRRFVRSCLEKDWRKR 311
           I  G ++  P   S + +  +R+ L+ D  KR
Sbjct: 243 IVSG-KVRFPSHFSSDLKDLLRNLLQVDLTKR 273

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score =  103 bits (257), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 74/277 (26%), Positives = 134/277 (48%), Gaps = 30/277 (10%)
Query: 37  NPTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRH--QAAH 94
           NP   +  ++   +++  LG G+ G V  V+H ++ + YA+K+L+      ++      +
Sbjct: 32  NPAQ-NTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN 90
Query: 95  EAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYR 154
           E  IL+ ++  F+VK    F      +  VME+   G +F  LR   +  E      A +
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKD-NSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQ 149
Query: 155 VLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIG 214
           ++   +YLH + +I+ D+KP NL+I+ +G +K+ DFG ++ V+                G
Sbjct: 150 IVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK----------------G 193
Query: 215 EAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLM 274
                C GT  Y++PE + S+     Y  A D W+LGV++ E   G+ P   F ++P  +
Sbjct: 194 RTWXLC-GTPEYLAPEIILSK----GYNKAVDWWALGVLIYEMAAGYPPF--FADQP--I 244
Query: 275 ALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKR 311
            +   I  G ++  P   S + +  +R+ L+ D  KR
Sbjct: 245 QIYEKIVSG-KVRFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score =  103 bits (257), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 92/296 (31%), Positives = 135/296 (45%), Gaps = 34/296 (11%)
Query: 54  VLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH-------EAEILKRLDSQF 106
            LG G  G V     +K+    A+K+++     I   + A        E EILK+L+   
Sbjct: 17  TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76
Query: 107 IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQ 166
           I+K    F   +  I  V+E ME G LFD +   K+L E       Y++L  +QYLH   
Sbjct: 77  IIKIKNFFDAEDYYI--VLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG 134
Query: 167 IIHGDIKPSNLLINGKGE---VKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGT 223
           IIH D+KP N+L++ + E   +KI DFG S+I+ ET                      GT
Sbjct: 135 IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR---------------TLCGT 179
Query: 224 CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFG 283
             Y++PE + S    G Y  A D WSLGV++  CL G+ P   F E    ++L   I  G
Sbjct: 180 PTYLAPEVLVSVGTAG-YNRAVDCWSLGVILFICLSGYPP---FSEHRTQVSLKDQITSG 235
Query: 284 ERLEMPET---ASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNIEGLI 336
           +   +PE     S +    V+  L  D + R T EE L +P++         + L+
Sbjct: 236 KYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLL 291

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score =  103 bits (257), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 92/296 (31%), Positives = 135/296 (45%), Gaps = 34/296 (11%)
Query: 54  VLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH-------EAEILKRLDSQF 106
            LG G  G V     +K+    A+K+++     I   + A        E EILK+L+   
Sbjct: 17  TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76
Query: 107 IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQ 166
           I+K    F   +  I  V+E ME G LFD +   K+L E       Y++L  +QYLH   
Sbjct: 77  IIKIKNFFDAEDYYI--VLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG 134
Query: 167 IIHGDIKPSNLLINGKGE---VKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGT 223
           IIH D+KP N+L++ + E   +KI DFG S+I+ ET                      GT
Sbjct: 135 IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR---------------TLCGT 179
Query: 224 CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFG 283
             Y++PE + S    G Y  A D WSLGV++  CL G+ P   F E    ++L   I  G
Sbjct: 180 PTYLAPEVLVSVGTAG-YNRAVDCWSLGVILFICLSGYPP---FSEHRTQVSLKDQITSG 235
Query: 284 ERLEMPET---ASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNIEGLI 336
           +   +PE     S +    V+  L  D + R T EE L +P++         + L+
Sbjct: 236 KYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLL 291

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 92/296 (31%), Positives = 135/296 (45%), Gaps = 34/296 (11%)
Query: 54  VLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH-------EAEILKRLDSQF 106
            LG G  G V     +K+    A+K+++     I   + A        E EILK+L+   
Sbjct: 16  TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 75
Query: 107 IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQ 166
           I+K    F   +  I  V+E ME G LFD +   K+L E       Y++L  +QYLH   
Sbjct: 76  IIKIKNFFDAEDYYI--VLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG 133
Query: 167 IIHGDIKPSNLLINGKGE---VKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGT 223
           IIH D+KP N+L++ + E   +KI DFG S+I+ ET                      GT
Sbjct: 134 IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR---------------TLCGT 178
Query: 224 CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFG 283
             Y++PE + S    G Y  A D WSLGV++  CL G+ P   F E    ++L   I  G
Sbjct: 179 PTYLAPEVLVSVGTAG-YNRAVDCWSLGVILFICLSGYPP---FSEHRTQVSLKDQITSG 234
Query: 284 ERLEMPET---ASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNIEGLI 336
           +   +PE     S +    V+  L  D + R T EE L +P++         + L+
Sbjct: 235 KYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLL 290

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 80/279 (28%), Positives = 120/279 (43%), Gaps = 28/279 (10%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHA 112
           LG G  G VY  R + S  I ALKVL         + HQ   E EI   L    I++ + 
Sbjct: 16  LGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 113 VFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDI 172
            F+     +  ++E+   G+++  L+   K  E   +     +   L Y H  ++IH DI
Sbjct: 76  YFHD-STRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKKVIHRDI 134
Query: 173 KPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERV 232
           KP NLL+   GE+KIADFG S     +R                  A  GT  Y+ PE +
Sbjct: 135 KPENLLLGSAGELKIADFGWSVHAPSSRRA----------------ALCGTLDYLPPEMI 178
Query: 233 DSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPETA 292
           +    G  +    D+WSLGV+  E LVG  P        D    I  + F      P+  
Sbjct: 179 E----GRMHDEKVDLWSLGVLCYEFLVGKPPFEA-NTYQDTYKRISRVEFT----FPDFV 229
Query: 293 SPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSN 331
           +   R  +   L+ +  +R  + E+L +P++T  SS  +
Sbjct: 230 TEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPS 268

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 92/296 (31%), Positives = 135/296 (45%), Gaps = 34/296 (11%)
Query: 54  VLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH-------EAEILKRLDSQF 106
            LG G  G V     +K+    A+K+++     I   + A        E EILK+L+   
Sbjct: 23  TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 82
Query: 107 IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQ 166
           I+K    F   +  I  V+E ME G LFD +   K+L E       Y++L  +QYLH   
Sbjct: 83  IIKIKNFFDAEDYYI--VLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG 140
Query: 167 IIHGDIKPSNLLINGKGE---VKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGT 223
           IIH D+KP N+L++ + E   +KI DFG S+I+ ET                      GT
Sbjct: 141 IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR---------------TLCGT 185
Query: 224 CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFG 283
             Y++PE + S    G Y  A D WSLGV++  CL G+ P   F E    ++L   I  G
Sbjct: 186 PTYLAPEVLVSVGTAG-YNRAVDCWSLGVILFICLSGYPP---FSEHRTQVSLKDQITSG 241
Query: 284 ERLEMPET---ASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNIEGLI 336
           +   +PE     S +    V+  L  D + R T EE L +P++         + L+
Sbjct: 242 KYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLL 297

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 92/296 (31%), Positives = 135/296 (45%), Gaps = 34/296 (11%)
Query: 54  VLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH-------EAEILKRLDSQF 106
            LG G  G V     +K+    A+K+++     I   + A        E EILK+L+   
Sbjct: 17  TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76
Query: 107 IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQ 166
           I+K    F   +  I  V+E ME G LFD +   K+L E       Y++L  +QYLH   
Sbjct: 77  IIKIKNFFDAEDYYI--VLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG 134
Query: 167 IIHGDIKPSNLLINGKGE---VKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGT 223
           IIH D+KP N+L++ + E   +KI DFG S+I+ ET                      GT
Sbjct: 135 IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR---------------TLCGT 179
Query: 224 CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFG 283
             Y++PE + S    G Y  A D WSLGV++  CL G+ P   F E    ++L   I  G
Sbjct: 180 PTYLAPEVLVSVGTAG-YNRAVDCWSLGVILFICLSGYPP---FSEHRTQVSLKDQITSG 235
Query: 284 ERLEMPET---ASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNIEGLI 336
           +   +PE     S +    V+  L  D + R T EE L +P++         + L+
Sbjct: 236 KYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLL 291

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 74/274 (27%), Positives = 133/274 (48%), Gaps = 29/274 (10%)
Query: 40  SPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRH--QAAHEAE 97
           S +   +    ++  LG G+ G V  V+H++S + YA+K+L+      ++      +E  
Sbjct: 34  SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 98  ILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLK 157
           IL+ ++  F+VK    F      +  VME++  G +F  LR   + SE      A +++ 
Sbjct: 94  ILQAVNFPFLVKLEFSFKD-NSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 158 GLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAA 217
             +YLH + +I+ D+KP NLLI+ +G +++ DFG ++ V+                G   
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----------------GRTW 196
Query: 218 IACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALI 277
             C GT   ++PE + S+     Y  A D W+LGV++ E   G+ P   F ++P  + + 
Sbjct: 197 XLC-GTPEALAPEIILSK----GYNKAVDWWALGVLIYEMAAGYPPF--FADQP--IQIY 247
Query: 278 CAICFGERLEMPETASPEFRRFVRSCLEKDWRKR 311
             I  G ++  P   S + +  +R+ L+ D  KR
Sbjct: 248 EKIVSG-KVRFPSHFSSDLKDLLRNLLQVDLTKR 280

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 73/272 (26%), Positives = 134/272 (49%), Gaps = 29/272 (10%)
Query: 42  DVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRH--QAAHEAEIL 99
           +  ++   +++  LG G+ G V  V+H+++ + YA+K+L+      ++      +E  I 
Sbjct: 37  NTAHLDQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQ 96
Query: 100 KRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGL 159
           + ++  F+VK    F      +  V+E+   G +F  LR   + SE      A +++   
Sbjct: 97  QAVNFPFLVKLEFSFKD-NSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 155
Query: 160 QYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIA 219
           +YLH + +I+ D+KP NLLI+ +G +K+ADFG ++ V+                G     
Sbjct: 156 EYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVK----------------GRTWXL 199
Query: 220 CMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICA 279
           C GT  Y++PE + S+     Y  A D W+LGV++ E   G+ P   F ++P  + +   
Sbjct: 200 C-GTPEYLAPEIILSK----GYNKAVDWWALGVLIYEMAAGYPPF--FADQP--IQIYEK 250
Query: 280 ICFGERLEMPETASPEFRRFVRSCLEKDWRKR 311
           I  G ++  P   S + +  +R+ L+ D  KR
Sbjct: 251 IVSG-KVRFPSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score =  102 bits (255), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 89/299 (29%), Positives = 139/299 (46%), Gaps = 33/299 (11%)
Query: 25  QFRRRRHHFPTSNPTS-PDVENISDLKKLTVLGHGNGGIVYKVRH---QKSNSIYALKVL 80
           Q    +H   T+N T   +   I + + L VLG G  G V+ VR      +  +YA+KVL
Sbjct: 31  QLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVL 90
Query: 81  NTTSSTIIRHQAAH---EAEILKRL-DSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDS 136
              +         H   E ++L+ +  S F+V  H  F T E ++  +++++  G LF  
Sbjct: 91  KKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT-ETKLHLILDYINGGELFTH 149
Query: 137 LRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSR-- 194
           L  R++ +E  +      ++  L++LH + II+ DIK  N+L++  G V + DFG+S+  
Sbjct: 150 LSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 209
Query: 195 IVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERVDSERWGGDYGF--AGDVWSLGV 252
           + +ET               E A    GT  YM+P+ V     GGD G   A D WSLGV
Sbjct: 210 VADET---------------ERAYDFCGTIEYMAPDIVR----GGDSGHDKAVDWWSLGV 250
Query: 253 VVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKR 311
           ++ E L G  P    GEK +  A I           P+  S   +  ++  L KD +KR
Sbjct: 251 LMYELLTGASPFTVDGEK-NSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKR 308

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score =  102 bits (255), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 82/284 (28%), Positives = 124/284 (43%), Gaps = 38/284 (13%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHA 112
           LG G  G VY  R ++S  I ALKVL         + HQ   E EI   L    I++ + 
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 113 VFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDI 172
            F+     +  ++E+   G+++  L+   K  E   +     +   L Y H  ++IH DI
Sbjct: 76  YFHDA-TRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDI 134
Query: 173 KPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERV 232
           KP NLL+   GE+KIADFG S     +R                  A  GT  Y+ PE +
Sbjct: 135 KPENLLLGSAGELKIADFGWSVHAPSSRRA----------------ALCGTLDYLPPEMI 178
Query: 233 DSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPETA 292
           +    G  +    D+WSLGV+  E LVG         KP   A      + +R+   E  
Sbjct: 179 E----GRMHDEKVDLWSLGVLCYEFLVG---------KPPFEANTYQETY-KRISRVEFT 224
Query: 293 SPEF-----RRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSN 331
            P+F     R  +   L+ +  +R  + E+L +P++T  SS  +
Sbjct: 225 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPS 268

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 73/278 (26%), Positives = 128/278 (46%), Gaps = 30/278 (10%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKV-----LNTTSSTIIRHQAAHEAEILKRLDSQFIVK 109
           LG G   IV K R + +   YA K      L+++   + R +   E  IL+ +    I+ 
Sbjct: 20  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 79
Query: 110 CHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIH 169
            H +F   + ++  ++E +  G LFD L  ++ L+ED  +    ++L G+ YLH  +I H
Sbjct: 80  LHDIFEN-KTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAH 138
Query: 170 GDIKPSNLLINGKG----EVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCA 225
            D+KP N+++  K      +K+ DFG++  +E                G       GT  
Sbjct: 139 FDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE---------------AGNEFKNIFGTPE 183
Query: 226 YMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGER 285
           +++PE V+ E      G   D+WS+GV+    L G  P +G   K + +  I A+ +   
Sbjct: 184 FVAPEIVNYE----PLGLEADMWSIGVITYILLSGASPFLG-ETKQETLTNISAVNYDFD 238
Query: 286 LEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV 323
            E     S   + F+R  L KD ++R  + + L + ++
Sbjct: 239 EEYFSNTSELAKDFIRRLLVKDPKRRMXIAQSLEHSWI 276

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 85/285 (29%), Positives = 133/285 (46%), Gaps = 32/285 (11%)
Query: 48  DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAA---HEAEILKRLDS 104
           D   + V+G G  G V  VRH+ S  +YA+K+L +    I R  +A    E +I+   +S
Sbjct: 76  DYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLL-SKFEMIKRSDSAFFWEERDIMAFANS 134
Query: 105 QFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG 164
            ++V+    F   +  +  VME+M  G L  +L     + E         V+  L  +H 
Sbjct: 135 PWVVQLFCAFQD-DKYLYMVMEYMPGGDLV-NLMSNYDVPEKWAKFYTAEVVLALDAIHS 192
Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIAC---M 221
           M +IH D+KP N+L++  G +K+ADFG    ++ET                  + C   +
Sbjct: 193 MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDET----------------GMVHCDTAV 236
Query: 222 GTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIG---FGEKPDLMALIC 278
           GT  Y+SPE + S+   G YG   D WS+GV + E LVG  P       G    +M    
Sbjct: 237 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKN 296
Query: 279 AICFGERLEMPETASPEFRRFVRSCLEKDWR-KRGTVEELLAYPF 322
           ++CF E  E+ + A      F+    +++ R  R  VEE+  +PF
Sbjct: 297 SLCFPEDAEISKHAKNLICAFLT---DREVRLGRNGVEEIKQHPF 338

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score =  102 bits (253), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 82/284 (28%), Positives = 124/284 (43%), Gaps = 38/284 (13%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHA 112
           LG G  G VY  R ++S  I ALKVL         + HQ   E EI   L    I++ + 
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 113 VFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDI 172
            F+     +  ++E+   G+++  L+   K  E   +     +   L Y H  ++IH DI
Sbjct: 79  YFHDA-TRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDI 137
Query: 173 KPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERV 232
           KP NLL+   GE+KIADFG S     +R                  A  GT  Y+ PE +
Sbjct: 138 KPENLLLGSAGELKIADFGWSVHAPSSRRA----------------ALCGTLDYLPPEMI 181
Query: 233 DSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPETA 292
           +    G  +    D+WSLGV+  E LVG         KP   A      + +R+   E  
Sbjct: 182 E----GRMHDEKVDLWSLGVLCYEFLVG---------KPPFEANTYQETY-KRISRVEFT 227
Query: 293 SPEF-----RRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSN 331
            P+F     R  +   L+ +  +R  + E+L +P++T  SS  +
Sbjct: 228 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPS 271

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score =  102 bits (253), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 91/296 (30%), Positives = 135/296 (45%), Gaps = 34/296 (11%)
Query: 54  VLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH-------EAEILKRLDSQF 106
            LG G  G V     +K+    A+++++     I   + A        E EILK+L+   
Sbjct: 156 TLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 215
Query: 107 IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQ 166
           I+K    F   +  I  V+E ME G LFD +   K+L E       Y++L  +QYLH   
Sbjct: 216 IIKIKNFFDAEDYYI--VLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG 273
Query: 167 IIHGDIKPSNLLINGKGE---VKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGT 223
           IIH D+KP N+L++ + E   +KI DFG S+I+ ET                      GT
Sbjct: 274 IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR---------------TLCGT 318
Query: 224 CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFG 283
             Y++PE + S    G Y  A D WSLGV++  CL G+ P   F E    ++L   I  G
Sbjct: 319 PTYLAPEVLVSVGTAG-YNRAVDCWSLGVILFICLSGYPP---FSEHRTQVSLKDQITSG 374
Query: 284 ERLEMPET---ASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNIEGLI 336
           +   +PE     S +    V+  L  D + R T EE L +P++         + L+
Sbjct: 375 KYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLL 430

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score =  102 bits (253), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 81/281 (28%), Positives = 122/281 (43%), Gaps = 38/281 (13%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHA 112
           LG G  G VY  R ++S  I ALKVL         + HQ   E EI   L    I++ + 
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 113 VFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDI 172
            F+     +  ++E+   G+++  L+   K  E   +     +   L Y H  ++IH DI
Sbjct: 81  YFHDA-TRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDI 139
Query: 173 KPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERV 232
           KP NLL+   GE+KIADFG S     +R                     GT  Y+ PE +
Sbjct: 140 KPENLLLGSAGELKIADFGWSVHAPSSRR----------------TTLCGTLDYLPPEXI 183
Query: 233 DSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPETA 292
           +    G  +    D+WSLGV+  E LVG         KP   A      + +R+   E  
Sbjct: 184 E----GRXHDEKVDLWSLGVLCYEFLVG---------KPPFEANTYQETY-KRISRVEFT 229
Query: 293 SPEF-----RRFVRSCLEKDWRKRGTVEELLAYPFVTKRSS 328
            P+F     R  +   L+ +  +R  + E+L +P++T  SS
Sbjct: 230 FPDFVTEGARDLISRLLKHNPSQRPXLREVLEHPWITANSS 270

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score =  102 bits (253), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 73/277 (26%), Positives = 133/277 (48%), Gaps = 30/277 (10%)
Query: 37  NPTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRH--QAAH 94
           NP   +  ++   +++  LG G+ G V  V+H ++ + YA+K+L+      ++      +
Sbjct: 33  NPAQ-NTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN 91
Query: 95  EAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYR 154
           E  IL+ ++  F+ K    F      +  VME+   G +F  LR   +  E      A +
Sbjct: 92  EKRILQAVNFPFLTKLEFSFKD-NSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQ 150
Query: 155 VLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIG 214
           ++   +YLH + +I+ D+KP NL+I+ +G +K+ DFG ++ V+                G
Sbjct: 151 IVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK----------------G 194
Query: 215 EAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLM 274
                C GT  Y++PE + S+     Y  A D W+LGV++ E   G+ P   F ++P  +
Sbjct: 195 RTWXLC-GTPEYLAPEIILSK----GYNKAVDWWALGVLIYEMAAGYPPF--FADQP--I 245
Query: 275 ALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKR 311
            +   I  G ++  P   S + +  +R+ L+ D  KR
Sbjct: 246 QIYEKIVSG-KVRFPSHFSSDLKDLLRNLLQVDLTKR 281

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score =  102 bits (253), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 91/296 (30%), Positives = 135/296 (45%), Gaps = 34/296 (11%)
Query: 54  VLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH-------EAEILKRLDSQF 106
            LG G  G V     +K+    A+++++     I   + A        E EILK+L+   
Sbjct: 142 TLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 201
Query: 107 IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQ 166
           I+K    F   +  I  V+E ME G LFD +   K+L E       Y++L  +QYLH   
Sbjct: 202 IIKIKNFFDAEDYYI--VLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG 259
Query: 167 IIHGDIKPSNLLINGKGE---VKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGT 223
           IIH D+KP N+L++ + E   +KI DFG S+I+ ET                      GT
Sbjct: 260 IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR---------------TLCGT 304
Query: 224 CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFG 283
             Y++PE + S    G Y  A D WSLGV++  CL G+ P   F E    ++L   I  G
Sbjct: 305 PTYLAPEVLVSVGTAG-YNRAVDCWSLGVILFICLSGYPP---FSEHRTQVSLKDQITSG 360
Query: 284 ERLEMPET---ASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNIEGLI 336
           +   +PE     S +    V+  L  D + R T EE L +P++         + L+
Sbjct: 361 KYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLL 416

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score =  101 bits (252), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 73/278 (26%), Positives = 127/278 (45%), Gaps = 30/278 (10%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKV-----LNTTSSTIIRHQAAHEAEILKRLDSQFIVK 109
           LG G   IV K R + +   YA K      L ++   + R +   E  IL+ +    I+ 
Sbjct: 34  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREIRHPNIIT 93
Query: 110 CHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIH 169
            H +F   + ++  ++E +  G LFD L  ++ L+ED  +    ++L G+ YLH  +I H
Sbjct: 94  LHDIFEN-KTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAH 152
Query: 170 GDIKPSNLLINGKG----EVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCA 225
            D+KP N+++  K      +K+ DFG++  +E                G       GT  
Sbjct: 153 FDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE---------------AGNEFKNIFGTPE 197
Query: 226 YMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGER 285
           +++PE V+ E      G   D+WS+GV+    L G  P +G   K + +  I A+ +   
Sbjct: 198 FVAPEIVNYE----PLGLEADMWSIGVITYILLSGASPFLG-ETKQETLTNISAVNYDFD 252
Query: 286 LEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV 323
            E     S   + F+R  L KD ++R  + + L + ++
Sbjct: 253 EEYFSNTSELAKDFIRRLLVKDPKRRMXIAQSLEHSWI 290

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 86/288 (29%), Positives = 133/288 (46%), Gaps = 40/288 (13%)
Query: 54  VLGHGNGGIVYKVRHQKSNSIYALKVLNTTS------STIIRHQAAHEAEILKRLDSQFI 107
           +LG G+ G V K + + +   YA+KV+N  S      STI+R     E E+LK+LD   I
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILR-----EVELLKKLDHPNI 83
Query: 108 VKCHAVFYTIEGEICF--VMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGM 165
           +K   +F  +E    F  V E    G LFD +  RK+ SE   + +  +V  G+ Y+H  
Sbjct: 84  MK---LFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH 140
Query: 166 QIIHGDIKPSNLLINGKG---EVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMG 222
            I+H D+KP N+L+  K    ++KI DFG+S   ++                      +G
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR---------------IG 185
Query: 223 TCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICF 282
           T  Y++PE +      G Y    DVWS GV++   L G  P  G  E  D++  +    +
Sbjct: 186 TAYYIAPEVL-----RGTYDEKCDVWSAGVILYILLSGTPPFYGKNEY-DILKRVETGKY 239
Query: 283 GERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSS 330
              L    T S + +  +R  L      R T  + L +P++ K SS +
Sbjct: 240 AFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSET 287

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score =  101 bits (251), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 81/281 (28%), Positives = 122/281 (43%), Gaps = 38/281 (13%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHA 112
           LG G  G VY  R ++S  I ALKVL         + HQ   E EI   L    I++ + 
Sbjct: 42  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 101
Query: 113 VFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDI 172
            F+     +  ++E+   G+++  L+   K  E   +     +   L Y H  ++IH DI
Sbjct: 102 YFHDA-TRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDI 160
Query: 173 KPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERV 232
           KP NLL+   GE+KIADFG S     +R                     GT  Y+ PE +
Sbjct: 161 KPENLLLGSAGELKIADFGWSVHAPSSRR----------------TTLCGTLDYLPPEMI 204
Query: 233 DSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPETA 292
           +    G  +    D+WSLGV+  E LVG         KP   A      + +R+   E  
Sbjct: 205 E----GRMHDEKVDLWSLGVLCYEFLVG---------KPPFEANTYQETY-KRISRVEFT 250
Query: 293 SPEF-----RRFVRSCLEKDWRKRGTVEELLAYPFVTKRSS 328
            P+F     R  +   L+ +  +R  + E+L +P++T  SS
Sbjct: 251 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSS 291

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score =  101 bits (251), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 81/294 (27%), Positives = 136/294 (46%), Gaps = 31/294 (10%)
Query: 47  SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQF 106
           S L     +G G+ GIV     + S  + A+K ++       R    +E  I++    + 
Sbjct: 74  SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR-RELLFNEVVIMRDYQHEN 132
Query: 107 IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQ 166
           +V+ +   Y +  E+  VME +E G+L D +    +++E+ I+ V   VL+ L  LH   
Sbjct: 133 VVEMYNS-YLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQG 190
Query: 167 IIHGDIKPSNLLINGKGEVKIADFG----VSRIVEETRXXXXXXXXXXXXIGEAAIACMG 222
           +IH DIK  ++L+   G VK++DFG    VS+ V   +                    +G
Sbjct: 191 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK------------------XLVG 232
Query: 223 TCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICF 282
           T  +M+PE +    +G +     D+WSLG++V+E + G  P   F E P     +     
Sbjct: 233 TPYWMAPELISRLPYGPEV----DIWSLGIMVIEMVDGEPPY--FNEPPLKAMKMIRDNL 286
Query: 283 GERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNIEGLI 336
             RL+     SP  + F+   L +D  +R T  ELL +PF+ K    ++I  L+
Sbjct: 287 PPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPASIVPLM 340

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score =  101 bits (251), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 86/286 (30%), Positives = 132/286 (46%), Gaps = 40/286 (13%)
Query: 54  VLGHGNGGIVYKVRHQKSNSIYALKVLNTTS------STIIRHQAAHEAEILKRLDSQFI 107
           +LG G+ G V K + + +   YA+KV+N  S      STI+R     E E+LK+LD   I
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILR-----EVELLKKLDHPNI 83
Query: 108 VKCHAVFYTIEGEICF--VMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGM 165
           +K   +F  +E    F  V E    G LFD +  RK+ SE   + +  +V  G+ Y+H  
Sbjct: 84  MK---LFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH 140
Query: 166 QIIHGDIKPSNLLINGKG---EVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMG 222
            I+H D+KP N+L+  K    ++KI DFG+S   ++                      +G
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR---------------IG 185
Query: 223 TCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICF 282
           T  Y++PE +      G Y    DVWS GV++   L G  P  G  E  D++  +    +
Sbjct: 186 TAYYIAPEVL-----RGTYDEKCDVWSAGVILYILLSGTPPFYGKNEY-DILKRVETGKY 239
Query: 283 GERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSS 328
              L    T S + +  +R  L      R T  + L +P++ K SS
Sbjct: 240 AFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS 285

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score =  101 bits (251), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 81/284 (28%), Positives = 123/284 (43%), Gaps = 38/284 (13%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHA 112
           LG G  G VY  R ++S  I ALKVL         + HQ   E EI   L    I++ + 
Sbjct: 15  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 74
Query: 113 VFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDI 172
            F+     +  ++E+   G+++  L+   K  E   +     +   L Y H  ++IH DI
Sbjct: 75  YFHDA-TRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDI 133
Query: 173 KPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERV 232
           KP NLL+   GE+KIADFG S     +R                     GT  Y+ PE +
Sbjct: 134 KPENLLLGSAGELKIADFGWSVHAPSSRR----------------TTLCGTLDYLPPEMI 177
Query: 233 DSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPETA 292
           +    G  +    D+WSLGV+  E LVG         KP   A      + +R+   E  
Sbjct: 178 E----GRMHDEKVDLWSLGVLCYEFLVG---------KPPFEANTYQETY-KRISRVEFT 223
Query: 293 SPEF-----RRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSN 331
            P+F     R  +   L+ +  +R  + E+L +P++T  SS  +
Sbjct: 224 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPS 267

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score =  101 bits (251), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 86/286 (30%), Positives = 132/286 (46%), Gaps = 40/286 (13%)
Query: 54  VLGHGNGGIVYKVRHQKSNSIYALKVLNTTS------STIIRHQAAHEAEILKRLDSQFI 107
           +LG G+ G V K + + +   YA+KV+N  S      STI+R     E E+LK+LD   I
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILR-----EVELLKKLDHPNI 83
Query: 108 VKCHAVFYTIEGEICF--VMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGM 165
           +K   +F  +E    F  V E    G LFD +  RK+ SE   + +  +V  G+ Y+H  
Sbjct: 84  MK---LFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH 140
Query: 166 QIIHGDIKPSNLLINGKG---EVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMG 222
            I+H D+KP N+L+  K    ++KI DFG+S   ++                      +G
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR---------------IG 185
Query: 223 TCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICF 282
           T  Y++PE +      G Y    DVWS GV++   L G  P  G  E  D++  +    +
Sbjct: 186 TAYYIAPEVL-----RGTYDEKCDVWSAGVILYILLSGTPPFYGKNEY-DILKRVETGKY 239
Query: 283 GERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSS 328
              L    T S + +  +R  L      R T  + L +P++ K SS
Sbjct: 240 AFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS 285

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score =  101 bits (251), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 81/294 (27%), Positives = 136/294 (46%), Gaps = 31/294 (10%)
Query: 47  SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQF 106
           S L     +G G+ GIV     + S  + A+K ++       R    +E  I++    + 
Sbjct: 20  SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR-RELLFNEVVIMRDYQHEN 78
Query: 107 IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQ 166
           +V+ +   Y +  E+  VME +E G+L D +    +++E+ I+ V   VL+ L  LH   
Sbjct: 79  VVEMYNS-YLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQG 136
Query: 167 IIHGDIKPSNLLINGKGEVKIADFG----VSRIVEETRXXXXXXXXXXXXIGEAAIACMG 222
           +IH DIK  ++L+   G VK++DFG    VS+ V   +                    +G
Sbjct: 137 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK------------------XLVG 178
Query: 223 TCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICF 282
           T  +M+PE +    +G +     D+WSLG++V+E + G  P   F E P     +     
Sbjct: 179 TPYWMAPELISRLPYGPEV----DIWSLGIMVIEMVDGEPPY--FNEPPLKAMKMIRDNL 232
Query: 283 GERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNIEGLI 336
             RL+     SP  + F+   L +D  +R T  ELL +PF+ K    ++I  L+
Sbjct: 233 PPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPASIVPLM 286

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score =  101 bits (251), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 81/294 (27%), Positives = 136/294 (46%), Gaps = 31/294 (10%)
Query: 47  SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQF 106
           S L     +G G+ GIV     + S  + A+K ++       R    +E  I++    + 
Sbjct: 29  SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR-RELLFNEVVIMRDYQHEN 87
Query: 107 IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQ 166
           +V+ +   Y +  E+  VME +E G+L D +    +++E+ I+ V   VL+ L  LH   
Sbjct: 88  VVEMYNS-YLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQG 145
Query: 167 IIHGDIKPSNLLINGKGEVKIADFG----VSRIVEETRXXXXXXXXXXXXIGEAAIACMG 222
           +IH DIK  ++L+   G VK++DFG    VS+ V   +                    +G
Sbjct: 146 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK------------------XLVG 187
Query: 223 TCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICF 282
           T  +M+PE +    +G +     D+WSLG++V+E + G  P   F E P     +     
Sbjct: 188 TPYWMAPELISRLPYGPEV----DIWSLGIMVIEMVDGEPPY--FNEPPLKAMKMIRDNL 241
Query: 283 GERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNIEGLI 336
             RL+     SP  + F+   L +D  +R T  ELL +PF+ K    ++I  L+
Sbjct: 242 PPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPASIVPLM 295

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score =  101 bits (251), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 81/281 (28%), Positives = 122/281 (43%), Gaps = 38/281 (13%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHA 112
           LG G  G VY  R ++S  I ALKVL         + HQ   E EI   L    I++ + 
Sbjct: 33  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 92
Query: 113 VFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDI 172
            F+     +  ++E+   G+++  L+   K  E   +     +   L Y H  ++IH DI
Sbjct: 93  YFHDA-TRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDI 151
Query: 173 KPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERV 232
           KP NLL+   GE+KIADFG S     +R                     GT  Y+ PE +
Sbjct: 152 KPENLLLGSAGELKIADFGWSVHAPSSRR----------------TTLCGTLDYLPPEMI 195
Query: 233 DSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPETA 292
           +    G  +    D+WSLGV+  E LVG         KP   A      + +R+   E  
Sbjct: 196 E----GRMHDEKVDLWSLGVLCYEFLVG---------KPPFEANTYQETY-KRISRVEFT 241
Query: 293 SPEF-----RRFVRSCLEKDWRKRGTVEELLAYPFVTKRSS 328
            P+F     R  +   L+ +  +R  + E+L +P++T  SS
Sbjct: 242 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSS 282

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score =  101 bits (251), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 75/271 (27%), Positives = 120/271 (44%), Gaps = 29/271 (10%)
Query: 45  NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH---EAEILKR 101
            +++ + L +LG G  G V  V+ + +   YA+K+L      + + + AH   E  +L+ 
Sbjct: 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKK-EVIVAKDEVAHTLTENRVLQN 204
Query: 102 LDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQY 161
               F+      F T    +CFVME+   G LF  L   +  SED        ++  L Y
Sbjct: 205 SRHPFLTALKYSFQT-HDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDY 263
Query: 162 LHGMQ-IIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIAC 220
           LH  + +++ D+K  NL+++  G +KI DFG+ +                   G      
Sbjct: 264 LHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--------------EGIKDGATMKTF 309
Query: 221 MGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAI 280
            GT  Y++PE ++      DYG A D W LGVV+ E + G  P     +   L  LI   
Sbjct: 310 CGTPEYLAPEVLED----NDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILM- 363
Query: 281 CFGERLEMPETASPEFRRFVRSCLEKDWRKR 311
              E +  P T  PE +  +   L+KD ++R
Sbjct: 364 ---EEIRFPRTLGPEAKSLLSGLLKKDPKQR 391

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score =  100 bits (250), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 81/294 (27%), Positives = 136/294 (46%), Gaps = 31/294 (10%)
Query: 47  SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQF 106
           S L     +G G+ GIV     + S  + A+K ++       R    +E  I++    + 
Sbjct: 31  SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR-RELLFNEVVIMRDYQHEN 89
Query: 107 IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQ 166
           +V+ +   Y +  E+  VME +E G+L D +    +++E+ I+ V   VL+ L  LH   
Sbjct: 90  VVEMYNS-YLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQG 147
Query: 167 IIHGDIKPSNLLINGKGEVKIADFG----VSRIVEETRXXXXXXXXXXXXIGEAAIACMG 222
           +IH DIK  ++L+   G VK++DFG    VS+ V   +                    +G
Sbjct: 148 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK------------------XLVG 189
Query: 223 TCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICF 282
           T  +M+PE +    +G +     D+WSLG++V+E + G  P   F E P     +     
Sbjct: 190 TPYWMAPELISRLPYGPEV----DIWSLGIMVIEMVDGEPPY--FNEPPLKAMKMIRDNL 243
Query: 283 GERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNIEGLI 336
             RL+     SP  + F+   L +D  +R T  ELL +PF+ K    ++I  L+
Sbjct: 244 PPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPASIVPLM 297

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score =  100 bits (250), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 81/294 (27%), Positives = 136/294 (46%), Gaps = 31/294 (10%)
Query: 47  SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQF 106
           S L     +G G+ GIV     + S  + A+K ++       R    +E  I++    + 
Sbjct: 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR-RELLFNEVVIMRDYQHEN 209
Query: 107 IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQ 166
           +V+ +   Y +  E+  VME +E G+L D +    +++E+ I+ V   VL+ L  LH   
Sbjct: 210 VVEMYNS-YLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQG 267
Query: 167 IIHGDIKPSNLLINGKGEVKIADFG----VSRIVEETRXXXXXXXXXXXXIGEAAIACMG 222
           +IH DIK  ++L+   G VK++DFG    VS+ V   +                    +G
Sbjct: 268 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK------------------XLVG 309
Query: 223 TCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICF 282
           T  +M+PE +    +G +     D+WSLG++V+E + G  P   F E P     +     
Sbjct: 310 TPYWMAPELISRLPYGPEV----DIWSLGIMVIEMVDGEPPY--FNEPPLKAMKMIRDNL 363
Query: 283 GERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNIEGLI 336
             RL+     SP  + F+   L +D  +R T  ELL +PF+ K    ++I  L+
Sbjct: 364 PPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPASIVPLM 417

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score =  100 bits (250), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 75/271 (27%), Positives = 120/271 (44%), Gaps = 29/271 (10%)
Query: 45  NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH---EAEILKR 101
            +++ + L +LG G  G V  V+ + +   YA+K+L      + + + AH   E  +L+ 
Sbjct: 149 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKK-EVIVAKDEVAHTLTENRVLQN 207
Query: 102 LDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQY 161
               F+      F T    +CFVME+   G LF  L   +  SED        ++  L Y
Sbjct: 208 SRHPFLTALKYSFQT-HDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDY 266
Query: 162 LHGMQ-IIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIAC 220
           LH  + +++ D+K  NL+++  G +KI DFG+ +                   G      
Sbjct: 267 LHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--------------EGIKDGATMKTF 312
Query: 221 MGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAI 280
            GT  Y++PE ++      DYG A D W LGVV+ E + G  P     +   L  LI   
Sbjct: 313 CGTPEYLAPEVLED----NDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILM- 366
Query: 281 CFGERLEMPETASPEFRRFVRSCLEKDWRKR 311
              E +  P T  PE +  +   L+KD ++R
Sbjct: 367 ---EEIRFPRTLGPEAKSLLSGLLKKDPKQR 394

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score =  100 bits (250), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 81/284 (28%), Positives = 123/284 (43%), Gaps = 38/284 (13%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHA 112
           LG G  G VY  R ++S  I ALKVL         + HQ   E EI   L    I++ + 
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 113 VFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDI 172
            F+     +  ++E+   G+++  L+   K  E   +     +   L Y H  ++IH DI
Sbjct: 76  YFHDA-TRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDI 134
Query: 173 KPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERV 232
           KP NLL+   GE+KIADFG S     +R                     GT  Y+ PE +
Sbjct: 135 KPENLLLGSAGELKIADFGWSVHAPSSRR----------------TTLCGTLDYLPPEMI 178
Query: 233 DSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPETA 292
           +    G  +    D+WSLGV+  E LVG         KP   A      + +R+   E  
Sbjct: 179 E----GRMHDEKVDLWSLGVLCYEFLVG---------KPPFEANTYQETY-KRISRVEFT 224
Query: 293 SPEF-----RRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSN 331
            P+F     R  +   L+ +  +R  + E+L +P++T  SS  +
Sbjct: 225 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPS 268

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score =  100 bits (250), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 81/284 (28%), Positives = 123/284 (43%), Gaps = 38/284 (13%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHA 112
           LG G  G VY  R ++S  I ALKVL         + HQ   E EI   L    I++ + 
Sbjct: 20  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 113 VFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDI 172
            F+     +  ++E+   G+++  L+   K  E   +     +   L Y H  ++IH DI
Sbjct: 80  YFHDAT-RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDI 138
Query: 173 KPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERV 232
           KP NLL+   GE+KIADFG S     +R                     GT  Y+ PE +
Sbjct: 139 KPENLLLGSAGELKIADFGWSVHAPSSRR----------------TTLCGTLDYLPPEMI 182
Query: 233 DSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPETA 292
           +    G  +    D+WSLGV+  E LVG         KP   A      + +R+   E  
Sbjct: 183 E----GRMHDEKVDLWSLGVLCYEFLVG---------KPPFEANTYQETY-KRISRVEFT 228
Query: 293 SPEF-----RRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSN 331
            P+F     R  +   L+ +  +R  + E+L +P++T  SS  +
Sbjct: 229 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPS 272

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score =  100 bits (250), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 81/284 (28%), Positives = 123/284 (43%), Gaps = 38/284 (13%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHA 112
           LG G  G VY  R ++S  I ALKVL         + HQ   E EI   L    I++ + 
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 113 VFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDI 172
            F+     +  ++E+   G+++  L+   K  E   +     +   L Y H  ++IH DI
Sbjct: 79  YFHDA-TRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDI 137
Query: 173 KPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERV 232
           KP NLL+   GE+KIADFG S     +R                     GT  Y+ PE +
Sbjct: 138 KPENLLLGSAGELKIADFGWSVHAPSSRR----------------TTLCGTLDYLPPEMI 181
Query: 233 DSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPETA 292
           +    G  +    D+WSLGV+  E LVG         KP   A      + +R+   E  
Sbjct: 182 E----GRMHDEKVDLWSLGVLCYEFLVG---------KPPFEANTYQETY-KRISRVEFT 227
Query: 293 SPEF-----RRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSN 331
            P+F     R  +   L+ +  +R  + E+L +P++T  SS  +
Sbjct: 228 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPS 271

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score =  100 bits (250), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 81/294 (27%), Positives = 136/294 (46%), Gaps = 31/294 (10%)
Query: 47  SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQF 106
           S L     +G G+ GIV     + S  + A+K ++       R    +E  I++    + 
Sbjct: 24  SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR-RELLFNEVVIMRDYQHEN 82
Query: 107 IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQ 166
           +V+ +   Y +  E+  VME +E G+L D +    +++E+ I+ V   VL+ L  LH   
Sbjct: 83  VVEMYNS-YLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQG 140
Query: 167 IIHGDIKPSNLLINGKGEVKIADFG----VSRIVEETRXXXXXXXXXXXXIGEAAIACMG 222
           +IH DIK  ++L+   G VK++DFG    VS+ V   +                    +G
Sbjct: 141 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK------------------XLVG 182
Query: 223 TCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICF 282
           T  +M+PE +    +G +     D+WSLG++V+E + G  P   F E P     +     
Sbjct: 183 TPYWMAPELISRLPYGPEV----DIWSLGIMVIEMVDGEPPY--FNEPPLKAMKMIRDNL 236
Query: 283 GERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNIEGLI 336
             RL+     SP  + F+   L +D  +R T  ELL +PF+ K    ++I  L+
Sbjct: 237 PPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPASIVPLM 290

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score =  100 bits (250), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 81/281 (28%), Positives = 122/281 (43%), Gaps = 38/281 (13%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHA 112
           LG G  G VY  R ++S  I ALKVL         + HQ   E EI   L    I++ + 
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 113 VFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDI 172
            F+     +  ++E+   G+++  L+   K  E   +     +   L Y H  ++IH DI
Sbjct: 81  YFHDA-TRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDI 139
Query: 173 KPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERV 232
           KP NLL+   GE+KIADFG S     +R                     GT  Y+ PE +
Sbjct: 140 KPENLLLGSAGELKIADFGWSVHAPSSRR----------------TTLCGTLDYLPPEMI 183
Query: 233 DSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPETA 292
           +    G  +    D+WSLGV+  E LVG         KP   A      + +R+   E  
Sbjct: 184 E----GRMHDEKVDLWSLGVLCYEFLVG---------KPPFEANTYQETY-KRISRVEFT 229
Query: 293 SPEF-----RRFVRSCLEKDWRKRGTVEELLAYPFVTKRSS 328
            P+F     R  +   L+ +  +R  + E+L +P++T  SS
Sbjct: 230 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSS 270

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score =  100 bits (250), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 81/284 (28%), Positives = 123/284 (43%), Gaps = 38/284 (13%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHA 112
           LG G  G VY  R ++S  I ALKVL         + HQ   E EI   L    I++ + 
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 113 VFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDI 172
            F+     +  ++E+   G+++  L+   K  E   +     +   L Y H  ++IH DI
Sbjct: 76  YFHDA-TRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDI 134
Query: 173 KPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERV 232
           KP NLL+   GE+KIADFG S     +R                     GT  Y+ PE +
Sbjct: 135 KPENLLLGSAGELKIADFGWSVHAPSSRR----------------TXLCGTLDYLPPEMI 178
Query: 233 DSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPETA 292
           +    G  +    D+WSLGV+  E LVG         KP   A      + +R+   E  
Sbjct: 179 E----GRMHDEKVDLWSLGVLCYEFLVG---------KPPFEANTYQETY-KRISRVEFT 224
Query: 293 SPEF-----RRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSN 331
            P+F     R  +   L+ +  +R  + E+L +P++T  SS  +
Sbjct: 225 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPS 268

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 81/281 (28%), Positives = 122/281 (43%), Gaps = 38/281 (13%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHA 112
           LG G  G VY  R ++S  I ALKVL         + HQ   E EI   L    I++ + 
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 113 VFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDI 172
            F+     +  ++E+   G+++  L+   K  E   +     +   L Y H  ++IH DI
Sbjct: 77  YFHDA-TRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDI 135
Query: 173 KPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERV 232
           KP NLL+   GE+KIADFG S     +R                     GT  Y+ PE +
Sbjct: 136 KPENLLLGSAGELKIADFGWSCHAPSSRR----------------TTLSGTLDYLPPEMI 179
Query: 233 DSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPETA 292
           +    G  +    D+WSLGV+  E LVG         KP   A      + +R+   E  
Sbjct: 180 E----GRMHDEKVDLWSLGVLCYEFLVG---------KPPFEANTYQETY-KRISRVEFT 225
Query: 293 SPEF-----RRFVRSCLEKDWRKRGTVEELLAYPFVTKRSS 328
            P+F     R  +   L+ +  +R  + E+L +P++T  SS
Sbjct: 226 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSS 266

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 81/281 (28%), Positives = 122/281 (43%), Gaps = 38/281 (13%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHA 112
           LG G  G VY  R ++S  I ALKVL         + HQ   E EI   L    I++ + 
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 113 VFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDI 172
            F+     +  ++E+   G+++  L+   K  E   +     +   L Y H  ++IH DI
Sbjct: 79  YFHDA-TRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDI 137
Query: 173 KPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERV 232
           KP NLL+   GE+KIADFG S     +R                     GT  Y+ PE +
Sbjct: 138 KPENLLLGSAGELKIADFGWSVHAPSSRR----------------TTLCGTLDYLPPEMI 181
Query: 233 DSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPETA 292
           +    G  +    D+WSLGV+  E LVG         KP   A      + +R+   E  
Sbjct: 182 E----GRMHDEKVDLWSLGVLCYEFLVG---------KPPFEANTYQETY-KRISRVEFT 227
Query: 293 SPEF-----RRFVRSCLEKDWRKRGTVEELLAYPFVTKRSS 328
            P+F     R  +   L+ +  +R  + E+L +P++T  SS
Sbjct: 228 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSS 268

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 81/284 (28%), Positives = 123/284 (43%), Gaps = 38/284 (13%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHA 112
           LG G  G VY  R ++S  I ALKVL         + HQ   E EI   L    I++ + 
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 113 VFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDI 172
            F+     +  ++E+   G+++  L+   K  E   +     +   L Y H  ++IH DI
Sbjct: 76  YFHDA-TRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDI 134
Query: 173 KPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERV 232
           KP NLL+   GE+KIADFG S     +R                     GT  Y+ PE +
Sbjct: 135 KPENLLLGSAGELKIADFGWSVHAPSSRR----------------TELCGTLDYLPPEMI 178
Query: 233 DSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPETA 292
           +    G  +    D+WSLGV+  E LVG         KP   A      + +R+   E  
Sbjct: 179 E----GRMHDEKVDLWSLGVLCYEFLVG---------KPPFEANTYQETY-KRISRVEFT 224
Query: 293 SPEF-----RRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSN 331
            P+F     R  +   L+ +  +R  + E+L +P++T  SS  +
Sbjct: 225 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPS 268

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 81/284 (28%), Positives = 123/284 (43%), Gaps = 38/284 (13%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHA 112
           LG G  G VY  R ++S  I ALKVL         + HQ   E EI   L    I++ + 
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 113 VFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDI 172
            F+     +  ++E+   G+++  L+   K  E   +     +   L Y H  ++IH DI
Sbjct: 77  YFHDA-TRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDI 135
Query: 173 KPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERV 232
           KP NLL+   GE+KIADFG S     +R                     GT  Y+ PE +
Sbjct: 136 KPENLLLGSAGELKIADFGWSVHAPSSRRD----------------TLCGTLDYLPPEMI 179
Query: 233 DSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPETA 292
           +    G  +    D+WSLGV+  E LVG         KP   A      + +R+   E  
Sbjct: 180 E----GRMHDEKVDLWSLGVLCYEFLVG---------KPPFEANTYQETY-KRISRVEFT 225
Query: 293 SPEF-----RRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSN 331
            P+F     R  +   L+ +  +R  + E+L +P++T  SS  +
Sbjct: 226 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPS 269

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 75/271 (27%), Positives = 120/271 (44%), Gaps = 29/271 (10%)
Query: 45  NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH---EAEILKR 101
            +++ + L +LG G  G V  V+ + +   YA+K+L      + + + AH   E  +L+ 
Sbjct: 6   TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKK-EVIVAKDEVAHTLTENRVLQN 64
Query: 102 LDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQY 161
               F+      F T    +CFVME+   G LF  L   +  SED        ++  L Y
Sbjct: 65  SRHPFLTALKYSFQT-HDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDY 123
Query: 162 LHGMQ-IIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIAC 220
           LH  + +++ D+K  NL+++  G +KI DFG+ +                   G      
Sbjct: 124 LHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--------------EGIKDGATMKXF 169
Query: 221 MGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAI 280
            GT  Y++PE ++      DYG A D W LGVV+ E + G  P     +   L  LI   
Sbjct: 170 CGTPEYLAPEVLED----NDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILM- 223
Query: 281 CFGERLEMPETASPEFRRFVRSCLEKDWRKR 311
              E +  P T  PE +  +   L+KD ++R
Sbjct: 224 ---EEIRFPRTLGPEAKSLLSGLLKKDPKQR 251

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 75/271 (27%), Positives = 120/271 (44%), Gaps = 29/271 (10%)
Query: 45  NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH---EAEILKR 101
            +++ + L +LG G  G V  V+ + +   YA+K+L      + + + AH   E  +L+ 
Sbjct: 7   TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKK-EVIVAKDEVAHTLTENRVLQN 65
Query: 102 LDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQY 161
               F+      F T    +CFVME+   G LF  L   +  SED        ++  L Y
Sbjct: 66  SRHPFLTALKYSFQT-HDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDY 124
Query: 162 LHGMQ-IIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIAC 220
           LH  + +++ D+K  NL+++  G +KI DFG+ +                   G      
Sbjct: 125 LHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--------------EGIKDGATMKXF 170
Query: 221 MGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAI 280
            GT  Y++PE ++      DYG A D W LGVV+ E + G  P     +   L  LI   
Sbjct: 171 CGTPEYLAPEVLED----NDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILM- 224
Query: 281 CFGERLEMPETASPEFRRFVRSCLEKDWRKR 311
              E +  P T  PE +  +   L+KD ++R
Sbjct: 225 ---EEIRFPRTLGPEAKSLLSGLLKKDPKQR 252

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 81/284 (28%), Positives = 123/284 (43%), Gaps = 38/284 (13%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHA 112
           LG G  G VY  R ++S  I ALKVL         + HQ   E EI   L    I++ + 
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 113 VFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDI 172
            F+     +  ++E+   G+++  L+   K  E   +     +   L Y H  ++IH DI
Sbjct: 76  YFHDA-TRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDI 134
Query: 173 KPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERV 232
           KP NLL+   GE+KIADFG S     +R                     GT  Y+ PE +
Sbjct: 135 KPENLLLGSAGELKIADFGWSVHAPSSRR----------------XXLCGTLDYLPPEMI 178
Query: 233 DSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPETA 292
           +    G  +    D+WSLGV+  E LVG         KP   A      + +R+   E  
Sbjct: 179 E----GRMHDEKVDLWSLGVLCYEFLVG---------KPPFEANTYQETY-KRISRVEFT 224
Query: 293 SPEF-----RRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSN 331
            P+F     R  +   L+ +  +R  + E+L +P++T  SS  +
Sbjct: 225 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPS 268

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 81/281 (28%), Positives = 122/281 (43%), Gaps = 38/281 (13%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHA 112
           LG G  G VY  R ++S  I ALKVL         + HQ   E EI   L    I++ + 
Sbjct: 42  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 101
Query: 113 VFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDI 172
            F+     +  ++E+   G+++  L+   K  E   +     +   L Y H  ++IH DI
Sbjct: 102 YFHDA-TRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDI 160
Query: 173 KPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERV 232
           KP NLL+   GE+KIADFG S     +R                     GT  Y+ PE +
Sbjct: 161 KPENLLLGSAGELKIADFGWSVHAPSSRRDD----------------LCGTLDYLPPEMI 204
Query: 233 DSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPETA 292
           +    G  +    D+WSLGV+  E LVG         KP   A      + +R+   E  
Sbjct: 205 E----GRMHDEKVDLWSLGVLCYEFLVG---------KPPFEANTYQETY-KRISRVEFT 250
Query: 293 SPEF-----RRFVRSCLEKDWRKRGTVEELLAYPFVTKRSS 328
            P+F     R  +   L+ +  +R  + E+L +P++T  SS
Sbjct: 251 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSS 291

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  100 bits (248), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 81/281 (28%), Positives = 122/281 (43%), Gaps = 38/281 (13%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHA 112
           LG G  G VY  R ++S  I ALKVL         + HQ   E EI   L    I++ + 
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 113 VFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDI 172
            F+     +  ++E+   G+++  L+   K  E   +     +   L Y H  ++IH DI
Sbjct: 79  YFHDA-TRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDI 137
Query: 173 KPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERV 232
           KP NLL+   GE+KIADFG S     +R                     GT  Y+ PE +
Sbjct: 138 KPENLLLGSAGELKIADFGWSVHAPSSRR----------------XXLCGTLDYLPPEMI 181
Query: 233 DSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPETA 292
           +    G  +    D+WSLGV+  E LVG         KP   A      + +R+   E  
Sbjct: 182 E----GRMHDEKVDLWSLGVLCYEFLVG---------KPPFEANTYQETY-KRISRVEFT 227
Query: 293 SPEF-----RRFVRSCLEKDWRKRGTVEELLAYPFVTKRSS 328
            P+F     R  +   L+ +  +R  + E+L +P++T  SS
Sbjct: 228 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSS 268

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score =  100 bits (248), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 75/271 (27%), Positives = 120/271 (44%), Gaps = 29/271 (10%)
Query: 45  NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH---EAEILKR 101
            +++ + L +LG G  G V  V+ + +   YA+K+L      + + + AH   E  +L+ 
Sbjct: 8   TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKK-EVIVAKDEVAHTLTENRVLQN 66
Query: 102 LDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQY 161
               F+      F T    +CFVME+   G LF  L   +  SED        ++  L Y
Sbjct: 67  SRHPFLTALKYSFQT-HDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDY 125
Query: 162 LHGMQ-IIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIAC 220
           LH  + +++ D+K  NL+++  G +KI DFG+ +                   G      
Sbjct: 126 LHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--------------EGIKDGATMKXF 171
Query: 221 MGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAI 280
            GT  Y++PE ++      DYG A D W LGVV+ E + G  P     +   L  LI   
Sbjct: 172 CGTPEYLAPEVLED----NDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILM- 225
Query: 281 CFGERLEMPETASPEFRRFVRSCLEKDWRKR 311
              E +  P T  PE +  +   L+KD ++R
Sbjct: 226 ---EEIRFPRTLGPEAKSLLSGLLKKDPKQR 253

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score =  100 bits (248), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 81/284 (28%), Positives = 123/284 (43%), Gaps = 38/284 (13%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHA 112
           LG G  G VY  R ++S  I ALKVL         + HQ   E EI   L    I++ + 
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 113 VFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDI 172
            F+     +  ++E+   G+++  L+   K  E   +     +   L Y H  ++IH DI
Sbjct: 76  YFHDA-TRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDI 134
Query: 173 KPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERV 232
           KP NLL+   GE+KIADFG S     +R                     GT  Y+ PE +
Sbjct: 135 KPENLLLGSAGELKIADFGWSVHAPSSRR----------------TDLCGTLDYLPPEMI 178
Query: 233 DSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPETA 292
           +    G  +    D+WSLGV+  E LVG         KP   A      + +R+   E  
Sbjct: 179 E----GRMHDEKVDLWSLGVLCYEFLVG---------KPPFEANTYQETY-KRISRVEFT 224
Query: 293 SPEF-----RRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSN 331
            P+F     R  +   L+ +  +R  + E+L +P++T  SS  +
Sbjct: 225 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPS 268

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score =  100 bits (248), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 81/284 (28%), Positives = 123/284 (43%), Gaps = 38/284 (13%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHA 112
           LG G  G VY  R ++S  I ALKVL         + HQ   E EI   L    I++ + 
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 113 VFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDI 172
            F+     +  ++E+   G+++  L+   K  E   +     +   L Y H  ++IH DI
Sbjct: 77  YFHDA-TRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDI 135
Query: 173 KPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERV 232
           KP NLL+   GE+KIADFG S     +R                     GT  Y+ PE +
Sbjct: 136 KPENLLLGSAGELKIADFGWSVHAPSSRRTD----------------LCGTLDYLPPEMI 179
Query: 233 DSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPETA 292
           +    G  +    D+WSLGV+  E LVG         KP   A      + +R+   E  
Sbjct: 180 E----GRMHDEKVDLWSLGVLCYEFLVG---------KPPFEANTYQETY-KRISRVEFT 225
Query: 293 SPEF-----RRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSN 331
            P+F     R  +   L+ +  +R  + E+L +P++T  SS  +
Sbjct: 226 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPS 269

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score =  100 bits (248), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 81/284 (28%), Positives = 123/284 (43%), Gaps = 38/284 (13%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHA 112
           LG G  G VY  R ++S  I ALKVL         + HQ   E EI   L    I++ + 
Sbjct: 18  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 77
Query: 113 VFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDI 172
            F+     +  ++E+   G+++  L+   K  E   +     +   L Y H  ++IH DI
Sbjct: 78  YFHDA-TRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDI 136
Query: 173 KPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERV 232
           KP NLL+   GE+KIADFG S     +R                     GT  Y+ PE +
Sbjct: 137 KPENLLLGSAGELKIADFGWSVHAPSSRR----------------XXLCGTLDYLPPEMI 180
Query: 233 DSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPETA 292
           +    G  +    D+WSLGV+  E LVG         KP   A      + +R+   E  
Sbjct: 181 E----GRMHDEKVDLWSLGVLCYEFLVG---------KPPFEANTYQETY-KRISRVEFT 226
Query: 293 SPEF-----RRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSN 331
            P+F     R  +   L+ +  +R  + E+L +P++T  SS  +
Sbjct: 227 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPS 270

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score =  100 bits (248), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 81/284 (28%), Positives = 123/284 (43%), Gaps = 38/284 (13%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHA 112
           LG G  G VY  R ++S  I ALKVL         + HQ   E EI   L    I++ + 
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 113 VFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDI 172
            F+     +  ++E+   G+++  L+   K  E   +     +   L Y H  ++IH DI
Sbjct: 76  YFHDA-TRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDI 134
Query: 173 KPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERV 232
           KP NLL+   GE+KIADFG S     +R                     GT  Y+ PE +
Sbjct: 135 KPENLLLGSAGELKIADFGWSVHAPSSRRTD----------------LCGTLDYLPPEMI 178
Query: 233 DSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPETA 292
           +    G  +    D+WSLGV+  E LVG         KP   A      + +R+   E  
Sbjct: 179 E----GRMHDEKVDLWSLGVLCYEFLVG---------KPPFEANTYQETY-KRISRVEFT 224
Query: 293 SPEF-----RRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSN 331
            P+F     R  +   L+ +  +R  + E+L +P++T  SS  +
Sbjct: 225 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPS 268

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 76/275 (27%), Positives = 134/275 (48%), Gaps = 30/275 (10%)
Query: 46  ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVL-----NTTSSTIIRHQAAHEAEILK 100
           + D   L V+G G+   V  VR +K++ IYA+KV+     N            H  E  +
Sbjct: 4   LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFE--Q 61
Query: 101 RLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQ 160
             +  F+V  H+ F T E  + FV+E++  G L   ++ ++KL E+     +  +   L 
Sbjct: 62  ASNHPFLVGLHSCFQT-ESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALN 120
Query: 161 YLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIAC 220
           YLH   II+ D+K  N+L++ +G +K+ D+G+ +  E  R             G+     
Sbjct: 121 YLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRP------------GDTTSXF 166
Query: 221 MGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYP--LIGFGEKPDLMA--L 276
            GT  Y++PE +  E    DYGF+ D W+LGV++ E + G  P  ++G  + PD      
Sbjct: 167 CGTPNYIAPEILRGE----DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDY 222
Query: 277 ICAICFGERLEMPETASPEFRRFVRSCLEKDWRKR 311
           +  +   +++ +P + S +    ++S L KD ++R
Sbjct: 223 LFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKER 257

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 81/284 (28%), Positives = 123/284 (43%), Gaps = 38/284 (13%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHA 112
           LG G  G VY  R ++S  I ALKVL         + HQ   E EI   L    I++ + 
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 113 VFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDI 172
            F+     +  ++E+   G+++  L+   K  E   +     +   L Y H  ++IH DI
Sbjct: 81  YFHDA-TRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDI 139
Query: 173 KPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERV 232
           KP NLL+   GE+KIADFG S     +R                     GT  Y+ PE +
Sbjct: 140 KPENLLLGSAGELKIADFGWSVHAPSSRRTD----------------LCGTLDYLPPEMI 183
Query: 233 DSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPETA 292
           +    G  +    D+WSLGV+  E LVG         KP   A      + +R+   E  
Sbjct: 184 E----GRMHDEKVDLWSLGVLCYEFLVG---------KPPFEANTYQETY-KRISRVEFT 229
Query: 293 SPEF-----RRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSN 331
            P+F     R  +   L+ +  +R  + E+L +P++T  SS  +
Sbjct: 230 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPS 273

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 76/275 (27%), Positives = 134/275 (48%), Gaps = 30/275 (10%)
Query: 46  ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVL-----NTTSSTIIRHQAAHEAEILK 100
           + D   L V+G G+   V  VR +K++ IYA+KV+     N            H  E  +
Sbjct: 8   LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFE--Q 65
Query: 101 RLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQ 160
             +  F+V  H+ F T E  + FV+E++  G L   ++ ++KL E+     +  +   L 
Sbjct: 66  ASNHPFLVGLHSCFQT-ESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALN 124
Query: 161 YLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIAC 220
           YLH   II+ D+K  N+L++ +G +K+ D+G+ +  E  R             G+     
Sbjct: 125 YLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRP------------GDTTSXF 170
Query: 221 MGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYP--LIGFGEKPDLMA--L 276
            GT  Y++PE +  E    DYGF+ D W+LGV++ E + G  P  ++G  + PD      
Sbjct: 171 CGTPNYIAPEILRGE----DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDY 226
Query: 277 ICAICFGERLEMPETASPEFRRFVRSCLEKDWRKR 311
           +  +   +++ +P + S +    ++S L KD ++R
Sbjct: 227 LFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKER 261

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 74/273 (27%), Positives = 133/273 (48%), Gaps = 26/273 (9%)
Query: 46  ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLN---TTSSTIIRHQAAHEAEILKRL 102
           + D   L V+G G+   V  VR +K++ IYA+KV+          I      +    +  
Sbjct: 19  LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS 78
Query: 103 DSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYL 162
           +  F+V  H+ F T E  + FV+E++  G L   ++ ++KL E+     +  +   L YL
Sbjct: 79  NHPFLVGLHSCFQT-ESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYL 137
Query: 163 HGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMG 222
           H   II+ D+K  N+L++ +G +K+ D+G+ +  E  R             G+      G
Sbjct: 138 HERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRP------------GDTTSXFCG 183
Query: 223 TCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYP--LIGFGEKPDLMA--LIC 278
           T  Y++PE +  E    DYGF+ D W+LGV++ E + G  P  ++G  + PD      + 
Sbjct: 184 TPNYIAPEILRGE----DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLF 239
Query: 279 AICFGERLEMPETASPEFRRFVRSCLEKDWRKR 311
            +   +++ +P + S +    ++S L KD ++R
Sbjct: 240 QVILEKQIRIPRSMSVKAASVLKSFLNKDPKER 272

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 81/284 (28%), Positives = 123/284 (43%), Gaps = 38/284 (13%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHA 112
           LG G  G VY  R ++S  I ALKVL         + HQ   E EI   L    I++ + 
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 113 VFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDI 172
            F+     +  ++E+   G+++  L+   K  E   +     +   L Y H  ++IH DI
Sbjct: 79  YFHDAT-RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDI 137
Query: 173 KPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERV 232
           KP NLL+   GE+KIADFG S     +R                     GT  Y+ PE +
Sbjct: 138 KPENLLLGSAGELKIADFGWSVHAPSSRRDD----------------LCGTLDYLPPEMI 181
Query: 233 DSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPETA 292
           +    G  +    D+WSLGV+  E LVG         KP   A      + +R+   E  
Sbjct: 182 E----GRMHDEKVDLWSLGVLCYEFLVG---------KPPFEANTYQETY-KRISRVEFT 227
Query: 293 SPEF-----RRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSN 331
            P+F     R  +   L+ +  +R  + E+L +P++T  SS  +
Sbjct: 228 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPS 271

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 78/279 (27%), Positives = 122/279 (43%), Gaps = 28/279 (10%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHA 112
           LG G  G VY  R ++S  I ALKVL  T      + HQ   E EI   L    I++ + 
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 113 VFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDI 172
            F+     +  ++E+   G+++  L+   +  E   +     +   L Y H  ++IH DI
Sbjct: 80  YFHDAT-RVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHSKRVIHRDI 138
Query: 173 KPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERV 232
           KP NLL+   GE+KIADFG S     +R                     GT  Y+ PE +
Sbjct: 139 KPENLLLGSNGELKIADFGWSVHAPSSRR----------------TTLCGTLDYLPPEMI 182
Query: 233 DSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPETA 292
           +    G  +    D+WSLGV+  E LVG  P      + +    I  + F      P+  
Sbjct: 183 E----GRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQ-ETYRRISRVEF----TFPDFV 233
Query: 293 SPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSN 331
           +   R  +   L+ +  +R T+ E+L +P++   SS  +
Sbjct: 234 TEGARDLISRLLKHNASQRLTLAEVLEHPWIKANSSKPS 272

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 78/279 (27%), Positives = 122/279 (43%), Gaps = 28/279 (10%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHA 112
           LG G  G VY  R ++S  I ALKVL  T      + HQ   E EI   L    I++ + 
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 113 VFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDI 172
            F+     +  ++E+   G+++  L+   +  E   +     +   L Y H  ++IH DI
Sbjct: 80  YFHDAT-RVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHSKRVIHRDI 138
Query: 173 KPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERV 232
           KP NLL+   GE+KIADFG S     +R                     GT  Y+ PE +
Sbjct: 139 KPENLLLGSNGELKIADFGWSVHAPSSRRD----------------TLCGTLDYLPPEMI 182
Query: 233 DSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPETA 292
           +    G  +    D+WSLGV+  E LVG  P      + +    I  + F      P+  
Sbjct: 183 E----GRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQ-ETYRRISRVEF----TFPDFV 233
Query: 293 SPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSN 331
           +   R  +   L+ +  +R T+ E+L +P++   SS  +
Sbjct: 234 TEGARDLISRLLKHNASQRLTLAEVLEHPWIKANSSKPS 272

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 80/281 (28%), Positives = 122/281 (43%), Gaps = 38/281 (13%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHA 112
           LG G  G VY  R ++S  I ALKVL         + HQ   E EI   L    I++ + 
Sbjct: 18  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 77
Query: 113 VFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDI 172
            F+     +  ++E+   G+++  L+   K  E   +     +   L Y H  ++IH DI
Sbjct: 78  YFHDA-TRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDI 136
Query: 173 KPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERV 232
           KP NLL+   GE+KIA+FG S     +R                     GT  Y+ PE +
Sbjct: 137 KPENLLLGSAGELKIANFGWSVHAPSSRR----------------TTLCGTLDYLPPEMI 180
Query: 233 DSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPETA 292
           +    G  +    D+WSLGV+  E LVG         KP   A      + +R+   E  
Sbjct: 181 E----GRMHDEKVDLWSLGVLCYEFLVG---------KPPFEANTYQETY-KRISRVEFT 226
Query: 293 SPEF-----RRFVRSCLEKDWRKRGTVEELLAYPFVTKRSS 328
            P+F     R  +   L+ +  +R  + E+L +P++T  SS
Sbjct: 227 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSS 267

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 99.0 bits (245), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 80/284 (28%), Positives = 123/284 (43%), Gaps = 38/284 (13%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHA 112
           LG G  G VY  R ++S  I ALKVL         + HQ   E EI   L    I++ + 
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 113 VFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDI 172
            F+     +  ++E+   G+++  L+   K  E   +     +   L Y H  ++IH DI
Sbjct: 79  YFHDA-TRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDI 137
Query: 173 KPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERV 232
           KP NLL+   GE+KIA+FG S     +R                     GT  Y+ PE +
Sbjct: 138 KPENLLLGSAGELKIANFGWSVHAPSSRR----------------TTLCGTLDYLPPEMI 181
Query: 233 DSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPETA 292
           +    G  +    D+WSLGV+  E LVG         KP   A      + +R+   E  
Sbjct: 182 E----GRMHDEKVDLWSLGVLCYEFLVG---------KPPFEANTYQETY-KRISRVEFT 227
Query: 293 SPEF-----RRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSN 331
            P+F     R  +   L+ +  +R  + E+L +P++T  SS  +
Sbjct: 228 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPS 271

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 99.0 bits (245), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 73/273 (26%), Positives = 133/273 (48%), Gaps = 26/273 (9%)
Query: 46  ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLN---TTSSTIIRHQAAHEAEILKRL 102
           + D   L V+G G+   V  VR +K++ IYA++V+          I      +    +  
Sbjct: 51  LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQAS 110
Query: 103 DSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYL 162
           +  F+V  H+ F T E  + FV+E++  G L   ++ ++KL E+     +  +   L YL
Sbjct: 111 NHPFLVGLHSCFQT-ESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYL 169
Query: 163 HGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMG 222
           H   II+ D+K  N+L++ +G +K+ D+G+ +  E  R             G+      G
Sbjct: 170 HERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRP------------GDTTSTFCG 215
Query: 223 TCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYP--LIGFGEKPDLMA--LIC 278
           T  Y++PE +  E    DYGF+ D W+LGV++ E + G  P  ++G  + PD      + 
Sbjct: 216 TPNYIAPEILRGE----DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLF 271
Query: 279 AICFGERLEMPETASPEFRRFVRSCLEKDWRKR 311
            +   +++ +P + S +    ++S L KD ++R
Sbjct: 272 QVILEKQIRIPRSLSVKAASVLKSFLNKDPKER 304

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 80/281 (28%), Positives = 121/281 (43%), Gaps = 38/281 (13%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHA 112
           LG G  G VY  R ++   I ALKVL         + HQ   E EI   L    I++ + 
Sbjct: 13  LGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 72
Query: 113 VFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDI 172
            F+     +  ++E+   G+++  L+   K  E   +     +   L Y H  ++IH DI
Sbjct: 73  YFHDA-TRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDI 131
Query: 173 KPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERV 232
           KP NLL+   GE+KIADFG S     +R                     GT  Y+ PE +
Sbjct: 132 KPENLLLGSAGELKIADFGWSVHAPSSRR----------------TTLCGTLDYLPPEMI 175
Query: 233 DSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPETA 292
           +    G  +    D+WSLGV+  E LVG         KP   A      + +R+   E  
Sbjct: 176 E----GRMHDEKVDLWSLGVLCYEFLVG---------KPPFEANTYQETY-KRISRVEFT 221
Query: 293 SPEF-----RRFVRSCLEKDWRKRGTVEELLAYPFVTKRSS 328
            P+F     R  +   L+ +  +R  + E+L +P++T  SS
Sbjct: 222 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSS 262

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 98.6 bits (244), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 80/290 (27%), Positives = 135/290 (46%), Gaps = 24/290 (8%)
Query: 47  SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQA-AHEAEILKRLDSQ 105
            D +    LG G   +V +   +     YA K++NT   +   HQ    EA I + L   
Sbjct: 31  DDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLLKHP 90
Query: 106 FIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGM 165
            IV+ H    + EG    V + +  G LF+ +  R+  SE   S   +++L+ + ++H  
Sbjct: 91  NIVRLHDSI-SEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIHQILESVNHIHQH 149
Query: 166 QIIHGDIKPSNLLINGK---GEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMG 222
            I+H D+KP NLL+  K     VK+ADFG++  V+  +              +A     G
Sbjct: 150 DIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQ--------------QAWFGFAG 195
Query: 223 TCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICF 282
           T  Y+SPE +  +     YG   D+W+ GV++   LVG YP     ++  L   I A  +
Sbjct: 196 TPGYLSPEVLRKD----PYGKPVDIWACGVILYILLVG-YPPFWDEDQHKLYQQIKAGAY 250
Query: 283 GERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNI 332
                  +T +PE +  +   L  +  KR T ++ L +P+V +RS+ +++
Sbjct: 251 DFPSPEWDTVTPEAKNLINQMLTINPAKRITADQALKHPWVCQRSTVASM 300

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 97.8 bits (242), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 107/224 (47%), Gaps = 28/224 (12%)
Query: 45  NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIR-HQAAH---EAEILK 100
           ++ D + L  LG G+ G V+ +R + +   YA+KVL      ++R  Q  H   E  +L 
Sbjct: 4   SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLK--KEIVVRLKQVEHTNDERLMLS 61
Query: 101 RLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQ 160
            +   FI++    F   + +I  +M+++E G LF  LR  ++    V    A  V   L+
Sbjct: 62  IVTHPFIIRMWGTFQDAQ-QIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALE 120
Query: 161 YLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIAC 220
           YLH   II+ D+KP N+L++  G +KI DFG ++ V                  +     
Sbjct: 121 YLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP-----------------DVTYXL 163
Query: 221 MGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPL 264
            GT  Y++PE V ++     Y  + D WS G+++ E L G+ P 
Sbjct: 164 CGTPDYIAPEVVSTK----PYNKSIDWWSFGILIYEMLAGYTPF 203

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 97.4 bits (241), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 84/291 (28%), Positives = 135/291 (46%), Gaps = 31/291 (10%)
Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAA--HEAEILKRLDSQFI 107
           +++  LG G  G V   + + + +  A+K++  +S T   +  A   E  +LK+LD   I
Sbjct: 7   QRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNI 66
Query: 108 VKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQI 167
           +K +  F+  +     VME    G LFD + +R+K SE   + +  +VL G  YLH   I
Sbjct: 67  MKLYE-FFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHKHNI 125
Query: 168 IHGDIKPSNLLINGKGE---VKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTC 224
           +H D+KP NLL+  K     +KI DFG+S   E               +G      +GT 
Sbjct: 126 VHRDLKPENLLLESKSRDALIKIVDFGLSAHFE---------------VGGKMKERLGTA 170
Query: 225 AYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGE 284
            Y++PE +  +     Y    DVWS GV++   L G+ P   FG + D   L        
Sbjct: 171 YYIAPEVLRKK-----YDEKCDVWSCGVILYILLCGYPP---FGGQTDQEILKRVEKGKF 222
Query: 285 RLEMPE--TASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNIE 333
             + P+    S E ++ V+  L  +  KR + EE L +P++ K  S  + +
Sbjct: 223 SFDPPDWTQVSDEAKQLVKLMLTYEPSKRISAEEALNHPWIVKFCSQKHTD 273

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 97.4 bits (241), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 86/294 (29%), Positives = 137/294 (46%), Gaps = 32/294 (10%)
Query: 44  ENISD-LKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAA--HEAEILK 100
           + +SD  +++  LG G  G V   + + + +  A+K++  +S T   +  A   E  +LK
Sbjct: 17  QGLSDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLK 76
Query: 101 RLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQ 160
           +LD   I+K +  F+  +     VME    G LFD + +R+K SE   + +  +VL G  
Sbjct: 77  QLDHPNIMKLYE-FFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTT 135
Query: 161 YLHGMQIIHGDIKPSNLLINGKGE---VKIADFGVSRIVEETRXXXXXXXXXXXXIGEAA 217
           YLH   I+H D+KP NLL+  K     +KI DFG+S   E               +G   
Sbjct: 136 YLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFE---------------VGGKM 180
Query: 218 IACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALI 277
              +GT  Y++PE +  +     Y    DVWS GV++   L G+ P   FG + D   L 
Sbjct: 181 KERLGTAYYIAPEVLRKK-----YDEKCDVWSCGVILYILLCGYPP---FGGQTDQEILK 232
Query: 278 CAICFGERLEMPE--TASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSS 329
                    + P+    S E ++ V+  L  +  KR + EE L +P++ K  S 
Sbjct: 233 RVEKGKFSFDPPDWTQVSDEAKQLVKLMLTYEPSKRISAEEALNHPWIVKFCSQ 286

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 92/300 (30%), Positives = 140/300 (46%), Gaps = 42/300 (14%)
Query: 46  ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQ 105
            SDL+++   GHG+ G VY  R  +++ + A+K ++ +     +       +I+K +  +
Sbjct: 56  FSDLREI---GHGSFGAVYFARDVRNSEVVAIKKMSYSG----KQSNEKWQDIIKEV--R 106
Query: 106 FIVKCHAVFYTIEGEICFVMEH-----MER--GSLFDSLRVRKK-LSEDVISGVAYRVLK 157
           F+ K      TI+   C++ EH     ME   GS  D L V KK L E  I+ V +  L+
Sbjct: 107 FLQKLRHP-NTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQ 165
Query: 158 GLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAA 217
           GL YLH   +IH D+K  N+L++  G VK+ DFG + I+                    A
Sbjct: 166 GLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM------------------APA 207
Query: 218 IACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALI 277
              +GT  +M+PE + +    G Y    DVWSLG+  +E      PL       + M+ +
Sbjct: 208 NXFVGTPYWMAPEVILAMD-EGQYDGKVDVWSLGITCIELAERKPPLFNM----NAMSAL 262
Query: 278 CAICFGERLEMPETASPE-FRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNIEGLI 336
             I   E   +      E FR FV SCL+K  + R T E LL + FV +    + I  LI
Sbjct: 263 YHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLI 322

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 86/283 (30%), Positives = 127/283 (44%), Gaps = 36/283 (12%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLN-TTSSTIIRHQAAHEAEILKRLDSQFIVKCHAV 113
           LG G   IVY+ + + +   YALKVL  T    I+R     E  +L RL    I+K   +
Sbjct: 61  LGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRT----EIGVLLRLSHPNIIKLKEI 116
Query: 114 FYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIK 173
           F T   EI  V+E +  G LFD +  +   SE   +    ++L+ + YLH   I+H D+K
Sbjct: 117 FET-PTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLK 175
Query: 174 PSNLLING---KGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPE 230
           P NLL         +KIADFG+S+IVE                        GT  Y +PE
Sbjct: 176 PENLLYATPAPDAPLKIADFGLSKIVEHQVLMK---------------TVCGTPGYCAPE 220
Query: 231 RVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMA----LICAICFGERL 286
            +     G  YG   D+WS+G++    L G  P   + E+ D       L C   F    
Sbjct: 221 ILR----GCAYGPEVDMWSVGIITYILLCGFEPF--YDERGDQFMFRRILNCEYYFIS-- 272
Query: 287 EMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSS 329
              +  S   +  VR  +  D +KR T  + L +P+VT ++++
Sbjct: 273 PWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAAN 315

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 92/300 (30%), Positives = 140/300 (46%), Gaps = 42/300 (14%)
Query: 46  ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQ 105
            SDL+++   GHG+ G VY  R  +++ + A+K ++ +     +       +I+K +  +
Sbjct: 17  FSDLREI---GHGSFGAVYFARDVRNSEVVAIKKMSYSG----KQSNEKWQDIIKEV--R 67
Query: 106 FIVKCHAVFYTIEGEICFVMEH-----MER--GSLFDSLRVRKK-LSEDVISGVAYRVLK 157
           F+ K      TI+   C++ EH     ME   GS  D L V KK L E  I+ V +  L+
Sbjct: 68  FLQKLRHP-NTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQ 126
Query: 158 GLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAA 217
           GL YLH   +IH D+K  N+L++  G VK+ DFG + I+                    A
Sbjct: 127 GLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM------------------APA 168
Query: 218 IACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALI 277
              +GT  +M+PE + +    G Y    DVWSLG+  +E      PL       + M+ +
Sbjct: 169 NXFVGTPYWMAPEVILAMD-EGQYDGKVDVWSLGITCIELAERKPPLFNM----NAMSAL 223
Query: 278 CAICFGERLEMPETASPE-FRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNIEGLI 336
             I   E   +      E FR FV SCL+K  + R T E LL + FV +    + I  LI
Sbjct: 224 YHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLI 283

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 91/306 (29%), Positives = 138/306 (45%), Gaps = 63/306 (20%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRH------------------------ 90
           +G G+ G+V    ++  N+ YA+KVL  +   +IR                         
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVL--SKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRG 78
Query: 91  ---QAAHEAEILKRLDSQFIVKCHAVFYTI-EGEICFVMEHMERGSLFDSLRVRKKLSED 146
              Q   E  ILK+LD   +VK   V     E  +  V E + +G + + +   K LSED
Sbjct: 79  PIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME-VPTLKPLSED 137
Query: 147 VISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXX 206
                   ++KG++YLH  +IIH DIKPSNLL+   G +KIADFGVS   +         
Sbjct: 138 QARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFK--------- 188
Query: 207 XXXXXXIGEAAI--ACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPL 264
                  G  A+    +GT A+M+PE + SE      G A DVW++G V L C V     
Sbjct: 189 -------GSDALLSNTVGTPAFMAPESL-SETRKIFSGKALDVWAMG-VTLYCFV----- 234
Query: 265 IGFGEKPDLMALICAI---CFGERLEMPETA--SPEFRRFVRSCLEKDWRKRGTVEELLA 319
             FG+ P +   I  +      + LE P+    + + +  +   L+K+   R  V E+  
Sbjct: 235 --FGQCPFMDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292
Query: 320 YPFVTK 325
           +P+VT+
Sbjct: 293 HPWVTR 298

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 77/289 (26%), Positives = 134/289 (46%), Gaps = 29/289 (10%)
Query: 52  LTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCH 111
           L  LG G  G+V++   + +  ++  K +NT    + ++   +E  I+ +L    ++  H
Sbjct: 56  LEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP-LDKYTVKNEISIMNQLHHPKLINLH 114
Query: 112 AVFYTIEGEICFVMEHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQYLHGMQIIHG 170
             F   + E+  ++E +  G LFD +     K+SE  +     +  +GL+++H   I+H 
Sbjct: 115 DAFED-KYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHL 173
Query: 171 DIKPSNLLINGK--GEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMS 228
           DIKP N++   K    VKI DFG++  +                  E       T  + +
Sbjct: 174 DIKPENIMCETKKASSVKIIDFGLATKLNP---------------DEIVKVTTATAEFAA 218
Query: 229 PERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALI-CAICFGERLE 287
           PE VD E      GF  D+W++GV+    L G  P  G  +   L  +  C   F E  +
Sbjct: 219 PEIVDRE----PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDE--D 272
Query: 288 MPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNIEGLI 336
              + SPE + F+++ L+K+ RKR TV + L +P++  +   SN+   I
Sbjct: 273 AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWL--KGDHSNLTSRI 319

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 76/287 (26%), Positives = 121/287 (42%), Gaps = 28/287 (9%)
Query: 38  PTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQ----AA 93
           P  P  +   D K   +LG G+   V   R   ++  YA+K+L      II+        
Sbjct: 1   PPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILE--KRHIIKENKVPYVT 58
Query: 94  HEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAY 153
            E +++ RLD  F VK +  F   E ++ F + + + G L   +R      E        
Sbjct: 59  RERDVMSRLDHPFFVKLYFTFQDDE-KLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA 117
Query: 154 RVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXI 213
            ++  L+YLHG  IIH D+KP N+L+N    ++I DFG ++++                 
Sbjct: 118 EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR--------- 168
Query: 214 GEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDL 273
              A   +GT  Y+SPE + +E+       + D+W+LG ++ + + G  P     E    
Sbjct: 169 ---ANXFVGTAQYVSPELL-TEKSACK---SSDLWALGCIIYQLVAGLPPFRAGNE---- 217
Query: 274 MALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY 320
             LI         + PE   P+ R  V   L  D  KR   EE+  Y
Sbjct: 218 -YLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 263

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 75/277 (27%), Positives = 119/277 (42%), Gaps = 28/277 (10%)
Query: 48  DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQ----AAHEAEILKRLD 103
           D K   +LG G+   V   R   ++  YA+K+L      II+         E +++ RLD
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILE--KRHIIKENKVPYVTRERDVMSRLD 90
Query: 104 SQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLH 163
             F VK +  F   E ++ F + + + G L   +R      E         ++  L+YLH
Sbjct: 91  HPFFVKLYFTFQDDE-KLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLH 149
Query: 164 GMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGT 223
           G  IIH D+KP N+L+N    ++I DFG ++++                    A   +GT
Sbjct: 150 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR------------ANXFVGT 197
Query: 224 CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFG 283
             Y+SPE + +E+       + D+W+LG ++ + + G  P     E      LI A    
Sbjct: 198 AQYVSPELL-TEKSAXK---SSDLWALGCIIYQLVAGLPPFRAGNE-----GLIFAKIIK 248
Query: 284 ERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY 320
              + PE   P+ R  V   L  D  KR   EE+  Y
Sbjct: 249 LEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 285

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 95.1 bits (235), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 74/277 (26%), Positives = 117/277 (42%), Gaps = 28/277 (10%)
Query: 48  DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQ----AAHEAEILKRLD 103
           D K   +LG G+   V   R   ++  YA+K+L      II+         E +++ RLD
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILE--KRHIIKENKVPYVTRERDVMSRLD 90
Query: 104 SQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLH 163
             F VK +  F   E ++ F + + + G L   +R      E         ++  L+YLH
Sbjct: 91  HPFFVKLYFTFQDDE-KLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLH 149
Query: 164 GMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGT 223
           G  IIH D+KP N+L+N    ++I DFG ++++                    A   +GT
Sbjct: 150 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR------------ANXFVGT 197
Query: 224 CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFG 283
             Y+SPE +  +        + D+W+LG ++ + + G  P     E      LI A    
Sbjct: 198 AQYVSPELLTEKSACK----SSDLWALGCIIYQLVAGLPPFRAGNE-----GLIFAKIIK 248
Query: 284 ERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY 320
              + PE   P+ R  V   L  D  KR   EE+  Y
Sbjct: 249 LEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 285

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 134/285 (47%), Gaps = 30/285 (10%)
Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-STIIRHQAAHEAEILKRLDSQFIV 108
           +++  LG G  G V   R + ++   A+K++  TS ST    +   E  +LK LD   I+
Sbjct: 40  QRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIM 99
Query: 109 KCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQII 168
           K +  F+  +     VME  + G LFD +  R K +E   + +  +VL G+ YLH   I+
Sbjct: 100 KLYD-FFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIV 158
Query: 169 HGDIKPSNLLINGKGE---VKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCA 225
           H D+KP NLL+  K +   +KI DFG+S + E  +                    +GT  
Sbjct: 159 HRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKER---------------LGTAY 203
Query: 226 YMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGER 285
           Y++PE +  +     Y    DVWS+GV++   L G+ P   FG + D   L         
Sbjct: 204 YIAPEVLRKK-----YDEKCDVWSIGVILFILLAGYPP---FGGQTDQEILRKVEKGKYT 255
Query: 286 LEMPE--TASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSS 328
            + PE    S   +  ++  L+ D ++R + ++ L +P++ +  S
Sbjct: 256 FDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCS 300

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 94.7 bits (234), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 80/282 (28%), Positives = 131/282 (46%), Gaps = 24/282 (8%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQA-AHEAEILKRLDSQFIVKCHAV 113
           +G G   +V +     +   YA K++NT   +   HQ    EA I + L    IV+ H  
Sbjct: 12  IGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKHSNIVRLHDS 71
Query: 114 FYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIK 173
             + EG    V + +  G LF+ +  R+  SE   S    ++L+ + + H M ++H D+K
Sbjct: 72  I-SEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRDLK 130
Query: 174 PSNLLINGK---GEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPE 230
           P NLL+  K     VK+ADFG++  V+  +              +A     GT  Y+SPE
Sbjct: 131 PENLLLASKCKGAAVKLADFGLAIEVQGDQ--------------QAWFGFAGTPGYLSPE 176
Query: 231 RVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPE 290
            +  E     YG   D+W+ GV++   LVG YP     ++  L   I A  +       +
Sbjct: 177 VLRKEA----YGKPVDIWACGVILYILLVG-YPPFWDEDQHKLYQQIKAGAYDFPSPEWD 231
Query: 291 TASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNI 332
           T +PE +  +   L  +  KR T  E L +P+V +RS+ +++
Sbjct: 232 TVTPEAKNLINQMLTINPAKRITAHEALKHPWVCQRSTVASM 273

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 94.7 bits (234), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 78/275 (28%), Positives = 130/275 (47%), Gaps = 37/275 (13%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH-----EAEILKRLDSQFIVK 109
           LG G+ G V    H K+    ALK +   S  +++    H     E   LK L    I+K
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFI---SRQLLKKSDMHMRVEREISYLKLLRHPHIIK 73
Query: 110 CHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIH 169
            + V  T   +I  V+E+   G LFD +  +K+++ED       +++  ++Y H  +I+H
Sbjct: 74  LYDVI-TTPTDIVMVIEYAG-GELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVH 131
Query: 170 GDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSP 229
            D+KP NLL++    VKIADFG+S I+ +               G       G+  Y +P
Sbjct: 132 RDLKPENLLLDDNLNVKIADFGLSNIMTD---------------GNFLKTSCGSPNYAAP 176
Query: 230 ERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEK--PDLMALICAICFGERLE 287
           E ++ + + G      DVWS G+V+   LVG  P   F ++  P+L   + +  +     
Sbjct: 177 EVINGKLYAGP---EVDVWSCGIVLYVMLVGRLP---FDDEFIPNLFKKVNSCVYV---- 226
Query: 288 MPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPF 322
           MP+  SP  +  +R  +  D  +R T++E+   P+
Sbjct: 227 MPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPW 261

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 81/301 (26%), Positives = 129/301 (42%), Gaps = 40/301 (13%)
Query: 45  NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDS 104
           N  D +   V+G G   +V            A+K +N         +   E + + +   
Sbjct: 8   NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHH 67
Query: 105 QFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLR--VRKK------LSEDVISGVAYRVL 156
             IV  +  F  ++ E+  VM+ +  GS+ D ++  V K       L E  I+ +   VL
Sbjct: 68  PNIVSYYTSF-VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 126
Query: 157 KGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIV----EETRXXXXXXXXXXXX 212
           +GL+YLH    IH D+K  N+L+   G V+IADFGVS  +    + TR            
Sbjct: 127 EGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITR------------ 174
Query: 213 IGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPD 272
             +     +GT  +M+PE ++  R    Y F  D+WS G+  +E   G  P   + + P 
Sbjct: 175 -NKVRKTFVGTPCWMAPEVMEQVR---GYDFKADIWSFGITAIELATGAAP---YHKYPP 227
Query: 273 LMALICAICFG--------ERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVT 324
           +  L+  +           +  EM +     FR+ +  CL+KD  KR T  ELL + F  
Sbjct: 228 MKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQ 287
Query: 325 K 325
           K
Sbjct: 288 K 288

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 75/277 (27%), Positives = 119/277 (42%), Gaps = 28/277 (10%)
Query: 48  DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQ----AAHEAEILKRLD 103
           D K   +LG G+   V   R   ++  YA+K+L      II+         E +++ RLD
Sbjct: 31  DFKFGKILGEGSFSTVVLARELATSREYAIKILE--KRHIIKENKVPYVTRERDVMSRLD 88
Query: 104 SQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLH 163
             F VK +  F   E ++ F + + + G L   +R      E         ++  L+YLH
Sbjct: 89  HPFFVKLYFTFQDDE-KLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLH 147
Query: 164 GMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGT 223
           G  IIH D+KP N+L+N    ++I DFG ++++                    A A +GT
Sbjct: 148 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR------------ANAFVGT 195
Query: 224 CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFG 283
             Y+SPE + +E+       + D+W+LG ++ + + G  P     E      LI      
Sbjct: 196 AQYVSPELL-TEKSACK---SSDLWALGCIIYQLVAGLPPFRAGNE-----YLIFQKIIK 246
Query: 284 ERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY 320
              + PE   P+ R  V   L  D  KR   EE+  Y
Sbjct: 247 LEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 283

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 81/301 (26%), Positives = 129/301 (42%), Gaps = 40/301 (13%)
Query: 45  NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDS 104
           N  D +   V+G G   +V            A+K +N         +   E + + +   
Sbjct: 13  NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHH 72
Query: 105 QFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLR--VRKK------LSEDVISGVAYRVL 156
             IV  +  F  ++ E+  VM+ +  GS+ D ++  V K       L E  I+ +   VL
Sbjct: 73  PNIVSYYTSF-VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 131
Query: 157 KGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIV----EETRXXXXXXXXXXXX 212
           +GL+YLH    IH D+K  N+L+   G V+IADFGVS  +    + TR            
Sbjct: 132 EGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITR------------ 179
Query: 213 IGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPD 272
             +     +GT  +M+PE ++  R    Y F  D+WS G+  +E   G  P   + + P 
Sbjct: 180 -NKVRKTFVGTPCWMAPEVMEQVR---GYDFKADIWSFGITAIELATGAAP---YHKYPP 232
Query: 273 LMALICAICFG--------ERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVT 324
           +  L+  +           +  EM +     FR+ +  CL+KD  KR T  ELL + F  
Sbjct: 233 MKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQ 292
Query: 325 K 325
           K
Sbjct: 293 K 293

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 94.4 bits (233), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 75/280 (26%), Positives = 129/280 (46%), Gaps = 28/280 (10%)
Query: 51  KLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-STIIRHQAAHEAEILKRLDSQFIVK 109
           +L  +G G+ G    V+  +    Y +K +N +  S+  R ++  E  +L  +    IV+
Sbjct: 28  RLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQ 87
Query: 110 CHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKL--SEDVISGVAYRVLKGLQYLHGMQI 167
               F    G +  VM++ E G LF  +  +K +   ED I     ++   L+++H  +I
Sbjct: 88  YRESFEE-NGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKI 146
Query: 168 IHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYM 227
           +H DIK  N+ +   G V++ DFG++R++  T               E A AC+GT  Y+
Sbjct: 147 LHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV--------------ELARACIGTPYYL 192
Query: 228 SPERVDSERWGGDYGFAGDVWSLGVVVLE-CLVGHYPLIGFGEKPDLMALICAICFGERL 286
           SPE  +++     Y    D+W+LG V+ E C + H     F E   +  L+  I  G   
Sbjct: 193 SPEICENK----PYNNKSDIWALGCVLYELCTLKH----AF-EAGSMKNLVLKIISGSFP 243
Query: 287 EMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKR 326
            +    S + R  V    +++ R R +V  +L   F+ KR
Sbjct: 244 PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKR 283

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 94.4 bits (233), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 74/277 (26%), Positives = 119/277 (42%), Gaps = 28/277 (10%)
Query: 48  DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQ----AAHEAEILKRLD 103
           D K   +LG G+   V   R   ++  YA+K+L      II+         E +++ RLD
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILE--KRHIIKENKVPYVTRERDVMSRLD 90
Query: 104 SQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLH 163
             F VK +  F   E ++ F + + + G L   +R      E         ++  L+YLH
Sbjct: 91  HPFFVKLYFTFQDDE-KLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAEIVSALEYLH 149
Query: 164 GMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGT 223
           G  IIH D+KP N+L+N    ++I DFG ++++                    A + +GT
Sbjct: 150 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR------------ANSFVGT 197
Query: 224 CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFG 283
             Y+SPE + +E+       + D+W+LG ++ + + G  P     E      LI      
Sbjct: 198 AQYVSPELL-TEKSASK---SSDLWALGCIIYQLVAGLPPFRAGNE-----YLIFQKIIK 248
Query: 284 ERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY 320
              + PE   P+ R  V   L  D  KR   EE+  Y
Sbjct: 249 LEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 285

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 130/281 (46%), Gaps = 24/281 (8%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQA-AHEAEILKRLDSQFIVKCHAV 113
           LG G   +V +     +   YA K++NT   +   HQ    EA I + L    IV+ H  
Sbjct: 30  LGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 89
Query: 114 FYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIK 173
             + EG    + + +  G LF+ +  R+  SE   S    ++L+ + + H M ++H D+K
Sbjct: 90  I-SEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRDLK 148
Query: 174 PSNLLINGK---GEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPE 230
           P NLL+  K     VK+ADFG++  VE  +              +A     GT  Y+SPE
Sbjct: 149 PENLLLASKLKGAAVKLADFGLAIEVEGEQ--------------QAWFGFAGTPGYLSPE 194
Query: 231 RVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPE 290
            +  +     YG   D+W+ GV++   LVG YP     ++  L   I A  +       +
Sbjct: 195 VLRKD----PYGKPVDLWACGVILYILLVG-YPPFWDEDQHRLYQQIKAGAYDFPSPEWD 249
Query: 291 TASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSN 331
           T +PE +  +   L  +  KR T  E L +P+++ RS+ ++
Sbjct: 250 TVTPEAKDLINKMLTINPSKRITAAEALKHPWISHRSTVAS 290

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 74/275 (26%), Positives = 129/275 (46%), Gaps = 31/275 (11%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVF 114
           +G G+ GIV   R + S    A+K+++       R +      ++ R    F V      
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ--RRELLFNEVVIMRDYQHFNVVEMYKS 110
Query: 115 YTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKP 174
           Y +  E+  +ME ++ G+L D +  + +L+E+ I+ V   VL+ L YLH   +IH DIK 
Sbjct: 111 YLVGEELWVLMEFLQGGALTDIVS-QVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKS 169
Query: 175 SNLLINGKGEVKIADFG----VSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPE 230
            ++L+   G VK++DFG    +S+ V + +                    +GT  +M+PE
Sbjct: 170 DSILLTLDGRVKLSDFGFCAQISKDVPKRK------------------XLVGTPYWMAPE 211
Query: 231 RVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPE 290
            +    +  +     D+WSLG++V+E + G  P   F + P             +L+   
Sbjct: 212 VISRSLYATEV----DIWSLGIMVIEMVDGEPPY--FSDSPVQAMKRLRDSPPPKLKNSH 265
Query: 291 TASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTK 325
             SP  R F+   L +D ++R T +ELL +PF+ +
Sbjct: 266 KVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQ 300

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 69/225 (30%), Positives = 109/225 (48%), Gaps = 29/225 (12%)
Query: 48  DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAA---HEAEILKRLDS 104
           D + + V+G G  G V  VRH+ +  +YA+K+L +    I R  +A    E +I+   +S
Sbjct: 75  DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLL-SKFEMIKRSDSAFFWEERDIMAFANS 133
Query: 105 QFIVKCHAVFYTIEGE--ICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYL 162
            ++V+   +FY  + +  +  VME+M  G L  +L     + E         V+  L  +
Sbjct: 134 PWVVQ---LFYAFQDDRYLYMVMEYMPGGDLV-NLMSNYDVPEKWARFYTAEVVLALDAI 189
Query: 163 HGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIAC-- 220
           H M  IH D+KP N+L++  G +K+ADFG    + +                E  + C  
Sbjct: 190 HSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK----------------EGMVRCDT 233
Query: 221 -MGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPL 264
            +GT  Y+SPE + S+   G YG   D WS+GV + E LVG  P 
Sbjct: 234 AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 278

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 69/225 (30%), Positives = 109/225 (48%), Gaps = 29/225 (12%)
Query: 48  DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAA---HEAEILKRLDS 104
           D + + V+G G  G V  VRH+ +  +YA+K+L +    I R  +A    E +I+   +S
Sbjct: 70  DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLL-SKFEMIKRSDSAFFWEERDIMAFANS 128
Query: 105 QFIVKCHAVFYTIEGE--ICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYL 162
            ++V+   +FY  + +  +  VME+M  G L  +L     + E         V+  L  +
Sbjct: 129 PWVVQ---LFYAFQDDRYLYMVMEYMPGGDLV-NLMSNYDVPEKWARFYTAEVVLALDAI 184
Query: 163 HGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIAC-- 220
           H M  IH D+KP N+L++  G +K+ADFG    + +                E  + C  
Sbjct: 185 HSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK----------------EGMVRCDT 228
Query: 221 -MGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPL 264
            +GT  Y+SPE + S+   G YG   D WS+GV + E LVG  P 
Sbjct: 229 AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 273

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 69/225 (30%), Positives = 109/225 (48%), Gaps = 29/225 (12%)
Query: 48  DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAA---HEAEILKRLDS 104
           D + + V+G G  G V  VRH+ +  +YA+K+L +    I R  +A    E +I+   +S
Sbjct: 75  DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLL-SKFEMIKRSDSAFFWEERDIMAFANS 133
Query: 105 QFIVKCHAVFYTIEGE--ICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYL 162
            ++V+   +FY  + +  +  VME+M  G L  +L     + E         V+  L  +
Sbjct: 134 PWVVQ---LFYAFQDDRYLYMVMEYMPGGDLV-NLMSNYDVPEKWARFYTAEVVLALDAI 189
Query: 163 HGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIAC-- 220
           H M  IH D+KP N+L++  G +K+ADFG    + +                E  + C  
Sbjct: 190 HSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK----------------EGMVRCDT 233
Query: 221 -MGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPL 264
            +GT  Y+SPE + S+   G YG   D WS+GV + E LVG  P 
Sbjct: 234 AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 278

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 74/277 (26%), Positives = 119/277 (42%), Gaps = 28/277 (10%)
Query: 48  DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQ----AAHEAEILKRLD 103
           D K   +LG G+   V   R   ++  YA+K+L      II+         E +++ RLD
Sbjct: 34  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRH--IIKENKVPYVTRERDVMSRLD 91
Query: 104 SQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLH 163
             F VK +  F   E ++ F + + + G L   +R      E         ++  L+YLH
Sbjct: 92  HPFFVKLYFTFQDDE-KLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLH 150
Query: 164 GMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGT 223
           G  IIH D+KP N+L+N    ++I DFG ++++                    A + +GT
Sbjct: 151 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR------------ANSFVGT 198
Query: 224 CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFG 283
             Y+SPE + +E+       + D+W+LG ++ + + G  P     E      LI      
Sbjct: 199 AQYVSPELL-TEKSACK---SSDLWALGCIIYQLVAGLPPFRAGNE-----YLIFQKIIK 249
Query: 284 ERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY 320
              + PE   P+ R  V   L  D  KR   EE+  Y
Sbjct: 250 LEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 286

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 75/285 (26%), Positives = 120/285 (42%), Gaps = 28/285 (9%)
Query: 40  SPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQ----AAHE 95
            P  +   D K   +LG G+   V   R   ++  YA+K+L      II+         E
Sbjct: 2   QPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILE--KRHIIKENKVPYVTRE 59
Query: 96  AEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRV 155
            +++ RLD  F VK +  F   E ++ F + + + G L   +R      E         +
Sbjct: 60  RDVMSRLDHPFFVKLYFTFQDDE-KLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 118
Query: 156 LKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGE 215
           +  L+YLHG  IIH D+KP N+L+N    ++I DFG ++++                   
Sbjct: 119 VSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR----------- 167
Query: 216 AAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMA 275
            A   +GT  Y+SPE + +E+       + D+W+LG ++ + + G  P     E      
Sbjct: 168 -ANXFVGTAQYVSPELL-TEKSACK---SSDLWALGCIIYQLVAGLPPFRAGNE-----Y 217
Query: 276 LICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY 320
           LI         + PE   P+ R  V   L  D  KR   EE+  Y
Sbjct: 218 LIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 262

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 74/277 (26%), Positives = 119/277 (42%), Gaps = 28/277 (10%)
Query: 48  DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQ----AAHEAEILKRLD 103
           D K   +LG G+   V   R   ++  YA+K+L      II+         E +++ RLD
Sbjct: 30  DFKFGKILGEGSFSTVVLARELATSREYAIKILE--KRHIIKENKVPYVTRERDVMSRLD 87
Query: 104 SQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLH 163
             F VK +  F   E ++ F + + + G L   +R      E         ++  L+YLH
Sbjct: 88  HPFFVKLYFTFQDDE-KLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLH 146
Query: 164 GMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGT 223
           G  IIH D+KP N+L+N    ++I DFG ++++                    A + +GT
Sbjct: 147 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR------------ANSFVGT 194
Query: 224 CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFG 283
             Y+SPE + +E+       + D+W+LG ++ + + G  P     E      LI      
Sbjct: 195 AQYVSPELL-TEKSACK---SSDLWALGCIIYQLVAGLPPFRAGNE-----YLIFQKIIK 245
Query: 284 ERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY 320
              + PE   P+ R  V   L  D  KR   EE+  Y
Sbjct: 246 LEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 282

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 75/284 (26%), Positives = 120/284 (42%), Gaps = 28/284 (9%)
Query: 41  PDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQ----AAHEA 96
           P  +   D K   +LG G+   V   R   ++  YA+K+L      II+         E 
Sbjct: 1   PRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILE--KRHIIKENKVPYVTRER 58
Query: 97  EILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVL 156
           +++ RLD  F VK +  F   E ++ F + + + G L   +R      E         ++
Sbjct: 59  DVMSRLDHPFFVKLYFTFQDDE-KLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV 117
Query: 157 KGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEA 216
             L+YLHG  IIH D+KP N+L+N    ++I DFG ++++                    
Sbjct: 118 SALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR------------ 165
Query: 217 AIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMAL 276
           A   +GT  Y+SPE + +E+       + D+W+LG ++ + + G  P     E      L
Sbjct: 166 ANXFVGTAQYVSPELL-TEKSACK---SSDLWALGCIIYQLVAGLPPFRAGNE-----YL 216
Query: 277 ICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY 320
           I         + PE   P+ R  V   L  D  KR   EE+  Y
Sbjct: 217 IFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 260

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 75/285 (26%), Positives = 120/285 (42%), Gaps = 28/285 (9%)
Query: 40  SPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQ----AAHE 95
            P  +   D K   +LG G+   V   R   ++  YA+K+L      II+         E
Sbjct: 1   QPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILE--KRHIIKENKVPYVTRE 58
Query: 96  AEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRV 155
            +++ RLD  F VK +  F   E ++ F + + + G L   +R      E         +
Sbjct: 59  RDVMSRLDHPFFVKLYFTFQDDE-KLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 117
Query: 156 LKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGE 215
           +  L+YLHG  IIH D+KP N+L+N    ++I DFG ++++                   
Sbjct: 118 VSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR----------- 166
Query: 216 AAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMA 275
            A   +GT  Y+SPE + +E+       + D+W+LG ++ + + G  P     E      
Sbjct: 167 -ANXFVGTAQYVSPELL-TEKSACK---SSDLWALGCIIYQLVAGLPPFRAGNE-----Y 216
Query: 276 LICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY 320
           LI         + PE   P+ R  V   L  D  KR   EE+  Y
Sbjct: 217 LIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 261

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 74/277 (26%), Positives = 118/277 (42%), Gaps = 28/277 (10%)
Query: 48  DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQ----AAHEAEILKRLD 103
           D K   +LG G+   V   R   ++  YA+K+L      II+         E +++ RLD
Sbjct: 31  DFKFGKILGEGSFSTVVLARELATSREYAIKILE--KRHIIKENKVPYVTRERDVMSRLD 88
Query: 104 SQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLH 163
             F VK +  F   E ++ F + + + G L   +R      E         ++  L+YLH
Sbjct: 89  HPFFVKLYFTFQDDE-KLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLH 147
Query: 164 GMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGT 223
           G  IIH D+KP N+L+N    ++I DFG ++++                    A   +GT
Sbjct: 148 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR------------ANXFVGT 195
Query: 224 CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFG 283
             Y+SPE + +E+       + D+W+LG ++ + + G  P     E      LI      
Sbjct: 196 AQYVSPELL-TEKSACK---SSDLWALGCIIYQLVAGLPPFRAGNE-----YLIFQKIIK 246
Query: 284 ERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY 320
              + PE   P+ R  V   L  D  KR   EE+  Y
Sbjct: 247 LEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 283

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 74/277 (26%), Positives = 118/277 (42%), Gaps = 28/277 (10%)
Query: 48  DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQ----AAHEAEILKRLD 103
           D K   +LG G+   V   R   ++  YA+K+L      II+         E +++ RLD
Sbjct: 31  DFKFGKILGEGSFSTVVLARELATSREYAIKILE--KRHIIKENKVPYVTRERDVMSRLD 88
Query: 104 SQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLH 163
             F VK +  F   E ++ F + + + G L   +R      E         ++  L+YLH
Sbjct: 89  HPFFVKLYFTFQDDE-KLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLH 147
Query: 164 GMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGT 223
           G  IIH D+KP N+L+N    ++I DFG ++++                    A   +GT
Sbjct: 148 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR------------ANXFVGT 195
Query: 224 CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFG 283
             Y+SPE + +E+       + D+W+LG ++ + + G  P     E      LI      
Sbjct: 196 AQYVSPELL-TEKSACK---SSDLWALGCIIYQLVAGLPPFRAGNE-----YLIFQKIIK 246
Query: 284 ERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY 320
              + PE   P+ R  V   L  D  KR   EE+  Y
Sbjct: 247 LEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 283

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 74/277 (26%), Positives = 118/277 (42%), Gaps = 28/277 (10%)
Query: 48  DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQ----AAHEAEILKRLD 103
           D K   +LG G+   V   R   ++  YA+K+L      II+         E +++ RLD
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILE--KRHIIKENKVPYVTRERDVMSRLD 90
Query: 104 SQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLH 163
             F VK +  F   E ++ F + + + G L   +R      E         ++  L+YLH
Sbjct: 91  HPFFVKLYFTFQDDE-KLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLH 149
Query: 164 GMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGT 223
           G  IIH D+KP N+L+N    ++I DFG ++++                    A   +GT
Sbjct: 150 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR------------ANXFVGT 197
Query: 224 CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFG 283
             Y+SPE + +E+       + D+W+LG ++ + + G  P     E      LI      
Sbjct: 198 AQYVSPELL-TEKSACK---SSDLWALGCIIYQLVAGLPPFRAGNE-----YLIFQKIIK 248
Query: 284 ERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY 320
              + PE   P+ R  V   L  D  KR   EE+  Y
Sbjct: 249 LEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 285

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 74/277 (26%), Positives = 118/277 (42%), Gaps = 28/277 (10%)
Query: 48  DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQ----AAHEAEILKRLD 103
           D K   +LG G+   V   R   ++  YA+K+L      II+         E +++ RLD
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILE--KRHIIKENKVPYVTRERDVMSRLD 90
Query: 104 SQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLH 163
             F VK +  F   E ++ F + + + G L   +R      E         ++  L+YLH
Sbjct: 91  HPFFVKLYFTFQDDE-KLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLH 149
Query: 164 GMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGT 223
           G  IIH D+KP N+L+N    ++I DFG ++++                    A   +GT
Sbjct: 150 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR------------ANXFVGT 197
Query: 224 CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFG 283
             Y+SPE + +E+       + D+W+LG ++ + + G  P     E      LI      
Sbjct: 198 AQYVSPELL-TEKSACK---SSDLWALGCIIYQLVAGLPPFRAGNE-----YLIFQKIIK 248
Query: 284 ERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY 320
              + PE   P+ R  V   L  D  KR   EE+  Y
Sbjct: 249 LEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 285

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 74/277 (26%), Positives = 118/277 (42%), Gaps = 28/277 (10%)
Query: 48  DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQ----AAHEAEILKRLD 103
           D K   +LG G+   V   R   ++  YA+K+L      II+         E +++ RLD
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILE--KRHIIKENKVPYVTRERDVMSRLD 90
Query: 104 SQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLH 163
             F VK +  F   E ++ F + + + G L   +R      E         ++  L+YLH
Sbjct: 91  HPFFVKLYFTFQDDE-KLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLH 149
Query: 164 GMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGT 223
           G  IIH D+KP N+L+N    ++I DFG ++++                    A   +GT
Sbjct: 150 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR------------ANXFVGT 197
Query: 224 CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFG 283
             Y+SPE + +E+       + D+W+LG ++ + + G  P     E      LI      
Sbjct: 198 AQYVSPELL-TEKSACK---SSDLWALGCIIYQLVAGLPPFRAGNE-----YLIFQKIIK 248
Query: 284 ERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY 320
              + PE   P+ R  V   L  D  KR   EE+  Y
Sbjct: 249 LEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 285

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 74/277 (26%), Positives = 118/277 (42%), Gaps = 28/277 (10%)
Query: 48  DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQ----AAHEAEILKRLD 103
           D K   +LG G+   V   R   ++  YA+K+L      II+         E +++ RLD
Sbjct: 34  DFKFGKILGEGSFSTVVLARELATSREYAIKILE--KRHIIKENKVPYVTRERDVMSRLD 91
Query: 104 SQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLH 163
             F VK +  F   E ++ F + + + G L   +R      E         ++  L+YLH
Sbjct: 92  HPFFVKLYFTFQDDE-KLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLH 150
Query: 164 GMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGT 223
           G  IIH D+KP N+L+N    ++I DFG ++++                    A   +GT
Sbjct: 151 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR------------ANXFVGT 198
Query: 224 CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFG 283
             Y+SPE + +E+       + D+W+LG ++ + + G  P     E      LI      
Sbjct: 199 AQYVSPELL-TEKSACK---SSDLWALGCIIYQLVAGLPPFRAGNE-----YLIFQKIIK 249
Query: 284 ERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY 320
              + PE   P+ R  V   L  D  KR   EE+  Y
Sbjct: 250 LEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 286

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 74/277 (26%), Positives = 118/277 (42%), Gaps = 28/277 (10%)
Query: 48  DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQ----AAHEAEILKRLD 103
           D K   +LG G+   V   R   ++  YA+K+L      II+         E +++ RLD
Sbjct: 30  DFKFGKILGEGSFSTVVLARELATSREYAIKILE--KRHIIKENKVPYVTRERDVMSRLD 87
Query: 104 SQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLH 163
             F VK +  F   E ++ F + + + G L   +R      E         ++  L+YLH
Sbjct: 88  HPFFVKLYFTFQDDE-KLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLH 146
Query: 164 GMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGT 223
           G  IIH D+KP N+L+N    ++I DFG ++++                    A   +GT
Sbjct: 147 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR------------ANXFVGT 194
Query: 224 CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFG 283
             Y+SPE + +E+       + D+W+LG ++ + + G  P     E      LI      
Sbjct: 195 AQYVSPELL-TEKSACK---SSDLWALGCIIYQLVAGLPPFRAGNE-----YLIFQKIIK 245
Query: 284 ERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY 320
              + PE   P+ R  V   L  D  KR   EE+  Y
Sbjct: 246 LEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 282

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 74/277 (26%), Positives = 118/277 (42%), Gaps = 28/277 (10%)
Query: 48  DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQ----AAHEAEILKRLD 103
           D K   +LG G+   V   R   ++  YA+K+L      II+         E +++ RLD
Sbjct: 15  DFKFGKILGEGSFSTVVLARELATSREYAIKILE--KRHIIKENKVPYVTRERDVMSRLD 72
Query: 104 SQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLH 163
             F VK +  F   E ++ F + + + G L   +R      E         ++  L+YLH
Sbjct: 73  HPFFVKLYFTFQDDE-KLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLH 131
Query: 164 GMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGT 223
           G  IIH D+KP N+L+N    ++I DFG ++++                    A   +GT
Sbjct: 132 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR------------ANXFVGT 179
Query: 224 CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFG 283
             Y+SPE + +E+       + D+W+LG ++ + + G  P     E      LI      
Sbjct: 180 AQYVSPELL-TEKSACK---SSDLWALGCIIYQLVAGLPPFRAGNE-----YLIFQKIIK 230
Query: 284 ERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY 320
              + PE   P+ R  V   L  D  KR   EE+  Y
Sbjct: 231 LEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 267

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 73/277 (26%), Positives = 116/277 (41%), Gaps = 28/277 (10%)
Query: 48  DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQ----AAHEAEILKRLD 103
           D K   +LG G+   V   R   ++  YA+K+L      II+         E +++ RLD
Sbjct: 38  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRH--IIKENKVPYVTRERDVMSRLD 95
Query: 104 SQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLH 163
             F VK +  F   E ++ F + + + G L   +R      E         ++  L+YLH
Sbjct: 96  HPFFVKLYFCFQDDE-KLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLH 154
Query: 164 GMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGT 223
           G  IIH D+KP N+L+N    ++I DFG ++++                    A   +GT
Sbjct: 155 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR------------ANXFVGT 202
Query: 224 CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFG 283
             Y+SPE +  +        + D+W+LG ++ + + G  P     E      LI      
Sbjct: 203 AQYVSPELLTEKSACK----SSDLWALGCIIYQLVAGLPPFRAGNE-----YLIFQKIIK 253
Query: 284 ERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY 320
              + PE   P+ R  V   L  D  KR   EE+  Y
Sbjct: 254 LEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 290

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 79/282 (28%), Positives = 131/282 (46%), Gaps = 24/282 (8%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQA-AHEAEILKRLDSQFIVKCHAV 113
           LG G   +V +     +   YA K++NT   +   HQ    EA I + L    IV+ H  
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 71
Query: 114 FYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIK 173
             + EG    V + +  G LF+ +  R+  SE   S    ++L+ + + H   I+H D+K
Sbjct: 72  I-SEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLNGIVHRDLK 130
Query: 174 PSNLLINGKGE---VKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPE 230
           P NLL+  K +   VK+ADFG++  V+  +              +A     GT  Y+SPE
Sbjct: 131 PENLLLASKSKGAAVKLADFGLAIEVQGDQ--------------QAWFGFAGTPGYLSPE 176
Query: 231 RVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPE 290
            +  +     YG   D+W+ GV++   LVG YP     ++  L   I A  +       +
Sbjct: 177 VLRKD----PYGKPVDMWACGVILYILLVG-YPPFWDEDQHRLYQQIKAGAYDFPSPEWD 231
Query: 291 TASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNI 332
           T +PE +  +   L  +  KR T  E L +P++ +RS+ +++
Sbjct: 232 TVTPEAKDLINKMLTINPAKRITASEALKHPWICQRSTVASM 273

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 79/282 (28%), Positives = 131/282 (46%), Gaps = 24/282 (8%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQA-AHEAEILKRLDSQFIVKCHAV 113
           LG G   +V +     +   YA K++NT   +   HQ    EA I + L    IV+ H  
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 71
Query: 114 FYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIK 173
             + EG    V + +  G LF+ +  R+  SE   S    ++L+ + + H   I+H D+K
Sbjct: 72  I-SEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLNGIVHRDLK 130
Query: 174 PSNLLINGKGE---VKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPE 230
           P NLL+  K +   VK+ADFG++  V+  +              +A     GT  Y+SPE
Sbjct: 131 PENLLLASKSKGAAVKLADFGLAIEVQGDQ--------------QAWFGFAGTPGYLSPE 176
Query: 231 RVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPE 290
            +  +     YG   D+W+ GV++   LVG YP     ++  L   I A  +       +
Sbjct: 177 VLRKD----PYGKPVDMWACGVILYILLVG-YPPFWDEDQHRLYQQIKAGAYDFPSPEWD 231
Query: 291 TASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNI 332
           T +PE +  +   L  +  KR T  E L +P++ +RS+ +++
Sbjct: 232 TVTPEAKDLINKMLTINPAKRITASEALKHPWICQRSTVASM 273

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 68/222 (30%), Positives = 95/222 (42%), Gaps = 23/222 (10%)
Query: 45  NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVL--NTTSSTIIRHQAAHEAEILKRL 102
            I D   +  LG G  G VY  R +++  I ALKVL  +      + HQ   E EI   L
Sbjct: 12  TIDDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL 71
Query: 103 DSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYL 162
               I++ +  F+     I  ++E   RG L+  L+   +  E   +     +   L Y 
Sbjct: 72  RHPNILRMYNYFHD-RKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYC 130
Query: 163 HGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMG 222
           H  ++IH DIKP NLL+  KGE+KIADFG S      R                     G
Sbjct: 131 HERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR----------------XMCG 174
Query: 223 TCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPL 264
           T  Y+ PE ++    G  +    D+W  GV+  E LVG  P 
Sbjct: 175 TLDYLPPEMIE----GKTHDEKVDLWCAGVLCYEFLVGMPPF 212

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 127/276 (46%), Gaps = 25/276 (9%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQA-AHEAEILKRLDSQFIVKCHAV 113
           LG G   +V +  H+ +   +A K++NT   +    Q    EA I ++L    IV+ H  
Sbjct: 37  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 96
Query: 114 FYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIK 173
               E     V + +  G LF+ +  R+  SE   S    ++L+ + Y H   I+H ++K
Sbjct: 97  IQE-ESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLK 155
Query: 174 PSNLLINGKGE---VKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPE 230
           P NLL+  K +   VK+ADFG++  V ++               EA     GT  Y+SPE
Sbjct: 156 PENLLLASKAKGAAVKLADFGLAIEVNDS---------------EAWHGFAGTPGYLSPE 200
Query: 231 RVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPE 290
            +  +     Y    D+W+ GV++   LVG YP     ++  L A I A  +       +
Sbjct: 201 VLKKD----PYSKPVDIWACGVILYILLVG-YPPFWDEDQHRLYAQIKAGAYDYPSPEWD 255
Query: 291 TASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKR 326
           T +PE +  + S L  + +KR T ++ L  P++  R
Sbjct: 256 TVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR 291

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 73/277 (26%), Positives = 117/277 (42%), Gaps = 28/277 (10%)
Query: 48  DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQ----AAHEAEILKRLD 103
           D K   +LG G+       R   ++  YA+K+L      II+         E +++ RLD
Sbjct: 31  DFKFGKILGEGSFSTTVLARELATSREYAIKILE--KRHIIKENKVPYVTRERDVMSRLD 88
Query: 104 SQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLH 163
             F VK +  F   E ++ F + + + G L   +R      E         ++  L+YLH
Sbjct: 89  HPFFVKLYFTFQDDE-KLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLH 147
Query: 164 GMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGT 223
           G  IIH D+KP N+L+N    ++I DFG ++++                    A   +GT
Sbjct: 148 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR------------ANXFVGT 195
Query: 224 CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFG 283
             Y+SPE + +E+       + D+W+LG ++ + + G  P     E      LI      
Sbjct: 196 AQYVSPELL-TEKSACK---SSDLWALGCIIYQLVAGLPPFRAGNE-----YLIFQKIIK 246
Query: 284 ERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY 320
              + PE   P+ R  V   L  D  KR   EE+  Y
Sbjct: 247 LEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 283

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 127/276 (46%), Gaps = 25/276 (9%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQA-AHEAEILKRLDSQFIVKCHAV 113
           LG G   +V +  H+ +   +A K++NT   +    Q    EA I ++L    IV+ H  
Sbjct: 13  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 72
Query: 114 FYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIK 173
               E     V + +  G LF+ +  R+  SE   S    ++L+ + Y H   I+H ++K
Sbjct: 73  IQE-ESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLK 131
Query: 174 PSNLLINGKGE---VKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPE 230
           P NLL+  K +   VK+ADFG++  V ++               EA     GT  Y+SPE
Sbjct: 132 PENLLLASKAKGAAVKLADFGLAIEVNDS---------------EAWHGFAGTPGYLSPE 176
Query: 231 RVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPE 290
            +  +     Y    D+W+ GV++   LVG YP     ++  L A I A  +       +
Sbjct: 177 VLKKD----PYSKPVDIWACGVILYILLVG-YPPFWDEDQHRLYAQIKAGAYDYPSPEWD 231
Query: 291 TASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKR 326
           T +PE +  + S L  + +KR T ++ L  P++  R
Sbjct: 232 TVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR 267

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 91.3 bits (225), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 78/292 (26%), Positives = 131/292 (44%), Gaps = 31/292 (10%)
Query: 49  LKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIV 108
           L     +G G+ GIV     + +    A+K ++       R    +E  I++      +V
Sbjct: 47  LANFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQR-RELLFNEVVIMRDYHHDNVV 105
Query: 109 KCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQII 168
             ++  Y +  E+  VME +E G+L D +    +++E+ I+ V   VL+ L YLH   +I
Sbjct: 106 DMYSS-YLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLSVLRALSYLHNQGVI 163
Query: 169 HGDIKPSNLLINGKGEVKIADFG----VSRIVEETRXXXXXXXXXXXXIGEAAIACMGTC 224
           H DIK  ++L+   G +K++DFG    VS+ V + +                    +GT 
Sbjct: 164 HRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRK------------------XLVGTP 205
Query: 225 AYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGE 284
            +M+PE +        YG   D+WSLG++V+E + G  P   F E P             
Sbjct: 206 YWMAPEVISRL----PYGTEVDIWSLGIMVIEMIDGEPPY--FNEPPLQAMRRIRDSLPP 259
Query: 285 RLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNIEGLI 336
           R++     S   R F+   L ++  +R T +ELL +PF+      S I  L+
Sbjct: 260 RVKDLHKVSSVLRGFLDLMLVREPSQRATAQELLGHPFLKLAGPPSCIVPLM 311

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 91.3 bits (225), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 127/276 (46%), Gaps = 25/276 (9%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQA-AHEAEILKRLDSQFIVKCHAV 113
           LG G   +V +  H+ +   +A K++NT   +    Q    EA I ++L    IV+ H  
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73
Query: 114 FYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIK 173
               E     V + +  G LF+ +  R+  SE   S    ++L+ + Y H   I+H ++K
Sbjct: 74  IQE-ESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLK 132
Query: 174 PSNLLINGKGE---VKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPE 230
           P NLL+  K +   VK+ADFG++  V ++               EA     GT  Y+SPE
Sbjct: 133 PENLLLASKAKGAAVKLADFGLAIEVNDS---------------EAWHGFAGTPGYLSPE 177
Query: 231 RVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPE 290
            +  +     Y    D+W+ GV++   LVG YP     ++  L A I A  +       +
Sbjct: 178 VLKKD----PYSKPVDIWACGVILYILLVG-YPPFWDEDQHRLYAQIKAGAYDYPSPEWD 232
Query: 291 TASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKR 326
           T +PE +  + S L  + +KR T ++ L  P++  R
Sbjct: 233 TVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR 268

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 91.3 bits (225), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 127/276 (46%), Gaps = 25/276 (9%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQA-AHEAEILKRLDSQFIVKCHAV 113
           LG G   +V +  H+ +   +A K++NT   +    Q    EA I ++L    IV+ H  
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73
Query: 114 FYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIK 173
               E     V + +  G LF+ +  R+  SE   S    ++L+ + Y H   I+H ++K
Sbjct: 74  IQE-ESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLK 132
Query: 174 PSNLLINGKGE---VKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPE 230
           P NLL+  K +   VK+ADFG++  V ++               EA     GT  Y+SPE
Sbjct: 133 PENLLLASKAKGAAVKLADFGLAIEVNDS---------------EAWHGFAGTPGYLSPE 177
Query: 231 RVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPE 290
            +  +     Y    D+W+ GV++   LVG YP     ++  L A I A  +       +
Sbjct: 178 VLKKD----PYSKPVDIWACGVILYILLVG-YPPFWDEDQHRLYAQIKAGAYDYPSPEWD 232
Query: 291 TASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKR 326
           T +PE +  + S L  + +KR T ++ L  P++  R
Sbjct: 233 TVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR 268

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 90.9 bits (224), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 73/277 (26%), Positives = 117/277 (42%), Gaps = 28/277 (10%)
Query: 48  DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQ----AAHEAEILKRLD 103
           D K   +LG G+   V   R   ++  YA+K+L      II+         E +++ RLD
Sbjct: 36  DFKFGKILGEGSFSTVVLARELATSREYAIKILE--KRHIIKENKVPYVTRERDVMSRLD 93
Query: 104 SQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLH 163
             F VK +  F   E ++ F + + + G L   +R      E         ++  L+YLH
Sbjct: 94  HPFFVKLYFTFQDDE-KLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLH 152
Query: 164 GMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGT 223
           G  IIH D+KP N+L+N    ++I DFG ++++                    A   +GT
Sbjct: 153 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR------------ANXFVGT 200
Query: 224 CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFG 283
             Y+SPE + +E+       + D+W+LG ++ + + G  P     E      LI      
Sbjct: 201 AQYVSPELL-TEKSACK---SSDLWALGCIIYQLVAGLPPFRAGNE-----YLIFQKIIK 251
Query: 284 ERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY 320
              + P    P+ R  V   L  D  KR   EE+  Y
Sbjct: 252 LEYDFPAAFFPKARDLVEKLLVLDATKRLGCEEMEGY 288

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 77/281 (27%), Positives = 129/281 (45%), Gaps = 24/281 (8%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQA-AHEAEILKRLDSQFIVKCHAV 113
           LG G   +V +     +   YA  ++NT   +   HQ    EA I + L    IV+ H  
Sbjct: 19  LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78
Query: 114 FYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIK 173
             + EG    + + +  G LF+ +  R+  SE   S    ++L+ + + H M ++H ++K
Sbjct: 79  I-SEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLK 137
Query: 174 PSNLLINGK---GEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPE 230
           P NLL+  K     VK+ADFG++  VE  +              +A     GT  Y+SPE
Sbjct: 138 PENLLLASKLKGAAVKLADFGLAIEVEGEQ--------------QAWFGFAGTPGYLSPE 183
Query: 231 RVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPE 290
            +  +     YG   D+W+ GV++   LVG YP     ++  L   I A  +       +
Sbjct: 184 VLRKD----PYGKPVDLWACGVILYILLVG-YPPFWDEDQHRLYQQIKAGAYDFPSPEWD 238
Query: 291 TASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSN 331
           T +PE +  +   L  +  KR T  E L +P+++ RS+ ++
Sbjct: 239 TVTPEAKDLINKMLTINPSKRITAAEALKHPWISHRSTVAS 279

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 72/276 (26%), Positives = 129/276 (46%), Gaps = 35/276 (12%)
Query: 45  NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQ--AAHEAEILKRL 102
            ++D     ++G G  G VY  R   +  +YA+K L+     + + +  A +E  +L  +
Sbjct: 186 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV 245
Query: 103 ---DSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGL 159
              D  FIV     F+T + ++ F+++ M  G L   L      SE  +   A  ++ GL
Sbjct: 246 STGDCPFIVCMSYAFHTPD-KLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGL 304
Query: 160 QYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIA 219
           +++H   +++ D+KP+N+L++  G V+I+D G++    + +                  A
Sbjct: 305 EHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH----------------A 348
Query: 220 CMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP----DLMA 275
            +GT  YM+PE +     G  Y  + D +SLG ++ + L GH P      K     D M 
Sbjct: 349 SVGTHGYMAPEVLQK---GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT 405
Query: 276 LICAICFGERLEMPETASPEFRRFVRSCLEKDWRKR 311
           L  A+      E+P++ SPE R  +   L++D  +R
Sbjct: 406 LTMAV------ELPDSFSPELRSLLEGLLQRDVNRR 435

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 72/276 (26%), Positives = 129/276 (46%), Gaps = 35/276 (12%)
Query: 45  NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQ--AAHEAEILKRL 102
            ++D     ++G G  G VY  R   +  +YA+K L+     + + +  A +E  +L  +
Sbjct: 187 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV 246
Query: 103 ---DSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGL 159
              D  FIV     F+T + ++ F+++ M  G L   L      SE  +   A  ++ GL
Sbjct: 247 STGDCPFIVCMSYAFHTPD-KLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGL 305
Query: 160 QYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIA 219
           +++H   +++ D+KP+N+L++  G V+I+D G++    + +                  A
Sbjct: 306 EHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH----------------A 349
Query: 220 CMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP----DLMA 275
            +GT  YM+PE +     G  Y  + D +SLG ++ + L GH P      K     D M 
Sbjct: 350 SVGTHGYMAPEVLQK---GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT 406
Query: 276 LICAICFGERLEMPETASPEFRRFVRSCLEKDWRKR 311
           L  A+      E+P++ SPE R  +   L++D  +R
Sbjct: 407 LTMAV------ELPDSFSPELRSLLEGLLQRDVNRR 436

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 81/284 (28%), Positives = 127/284 (44%), Gaps = 39/284 (13%)
Query: 52  LTVLGHGNGGIVYKVRH---QKSNSIYALKVLNTTSSTIIRH--QAAH---EAEILKRLD 103
           L VLG G  G V++VR      +  I+A+KVL    + I+R+    AH   E  IL+ + 
Sbjct: 22  LRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLK--KAMIVRNAKDTAHTKAERNILEEVK 79
Query: 104 SQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLH 163
             FIV     F T  G++  ++E++  G LF  L       ED        +   L +LH
Sbjct: 80  HPFIVDLIYAFQT-GGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLH 138
Query: 164 GMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGT 223
              II+ D+KP N+++N +G VK+ DFG+ +                   G       GT
Sbjct: 139 QKGIIYRDLKPENIMLNHQGHVKLTDFGLCK--------------ESIHDGTVTHTFCGT 184
Query: 224 CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFG 283
             YM+PE +   R G  +  A D WSLG ++ + L G  P  G   K  +  ++      
Sbjct: 185 IEYMAPEIL--MRSG--HNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKC---- 236
Query: 284 ERLEMPETASPEFRRFVRSCLEKDWRKR-----GTVEELLAYPF 322
            +L +P   + E R  ++  L+++   R     G   E+ A+PF
Sbjct: 237 -KLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPF 279

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 72/276 (26%), Positives = 129/276 (46%), Gaps = 35/276 (12%)
Query: 45  NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQ--AAHEAEILKRL 102
            ++D     ++G G  G VY  R   +  +YA+K L+     + + +  A +E  +L  +
Sbjct: 187 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV 246
Query: 103 ---DSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGL 159
              D  FIV     F+T + ++ F+++ M  G L   L      SE  +   A  ++ GL
Sbjct: 247 STGDCPFIVCMSYAFHTPD-KLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGL 305
Query: 160 QYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIA 219
           +++H   +++ D+KP+N+L++  G V+I+D G++    + +                  A
Sbjct: 306 EHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH----------------A 349
Query: 220 CMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP----DLMA 275
            +GT  YM+PE +     G  Y  + D +SLG ++ + L GH P      K     D M 
Sbjct: 350 SVGTHGYMAPEVLQK---GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT 406
Query: 276 LICAICFGERLEMPETASPEFRRFVRSCLEKDWRKR 311
           L  A+      E+P++ SPE R  +   L++D  +R
Sbjct: 407 LTMAV------ELPDSFSPELRSLLEGLLQRDVNRR 436

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 72/276 (26%), Positives = 129/276 (46%), Gaps = 35/276 (12%)
Query: 45  NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQ--AAHEAEILKRL 102
            ++D     ++G G  G VY  R   +  +YA+K L+     + + +  A +E  +L  +
Sbjct: 187 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV 246
Query: 103 ---DSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGL 159
              D  FIV     F+T + ++ F+++ M  G L   L      SE  +   A  ++ GL
Sbjct: 247 STGDCPFIVCMSYAFHTPD-KLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGL 305
Query: 160 QYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIA 219
           +++H   +++ D+KP+N+L++  G V+I+D G++    + +                  A
Sbjct: 306 EHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH----------------A 349
Query: 220 CMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP----DLMA 275
            +GT  YM+PE +     G  Y  + D +SLG ++ + L GH P      K     D M 
Sbjct: 350 SVGTHGYMAPEVLQK---GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT 406
Query: 276 LICAICFGERLEMPETASPEFRRFVRSCLEKDWRKR 311
           L  A+      E+P++ SPE R  +   L++D  +R
Sbjct: 407 LTMAV------ELPDSFSPELRSLLEGLLQRDVNRR 436

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 72/266 (27%), Positives = 117/266 (43%), Gaps = 26/266 (9%)
Query: 54  VLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCH 111
            LG G  G V   +H+ +    A+K+LN     S  +  +   E + LK      I+K +
Sbjct: 23  TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82
Query: 112 AVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGD 171
            V  T   +I  VME++  G LFD +    +L E     +  ++L G+ Y H   ++H D
Sbjct: 83  QVIST-PSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRD 141
Query: 172 IKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPER 231
           +KP N+L++     KIADFG+S ++ +               GE      G+  Y +PE 
Sbjct: 142 LKPENVLLDAHMNAKIADFGLSNMMSD---------------GEFLRXSCGSPNYAAPEV 186
Query: 232 VDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPET 291
           +    + G      D+WS GV++   L G  P       P L   IC   F      P+ 
Sbjct: 187 ISGRLYAGP---EVDIWSSGVILYALLCGTLPFDD-DHVPTLFKKICDGIF----YTPQY 238
Query: 292 ASPEFRRFVRSCLEKDWRKRGTVEEL 317
            +P     ++  L+ D  KR T++++
Sbjct: 239 LNPSVISLLKHMLQVDPMKRATIKDI 264

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 79/287 (27%), Positives = 129/287 (44%), Gaps = 30/287 (10%)
Query: 36  SNPTSPDVE-NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTT---SSTIIRHQ 91
           ++ TS D + +I + + L  +G GN   V   RH  +    A+K+++ T   SS++   +
Sbjct: 2   NSATSADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSL--QK 59
Query: 92  AAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGV 151
              E  I+K L+   IVK   V  T E  +  VME+   G +FD L    ++ E      
Sbjct: 60  LFREVRIMKVLNHPNIVKLFEVIET-EKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAK 118
Query: 152 AYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXX 211
             +++  +QY H   I+H D+K  NLL++    +KIADFG S                  
Sbjct: 119 FRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSN---------------EF 163
Query: 212 XIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP 271
             G    A  G   Y +PE    +++ G      DVWSLGV++   + G  P  G     
Sbjct: 164 TFGNKLDAFCGAPPYAAPELFQGKKYDGP---EVDVWSLGVILYTLVSGSLPFDG----Q 216
Query: 272 DLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELL 318
           +L  L   +  G +  +P   S +    ++  L  +  KRGT+E+++
Sbjct: 217 NLKELRERVLRG-KYRIPFYMSTDCENLLKKFLILNPSKRGTLEQIM 262

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 74/281 (26%), Positives = 121/281 (43%), Gaps = 31/281 (11%)
Query: 34  PTSNPTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS---STIIRH 90
           P+SNP +      SD   L V+G G+ G V   RH+     YA+KVL   +       +H
Sbjct: 29  PSSNPHA----KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKH 84
Query: 91  QAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISG 150
             +    +LK +   F+V  H  F T + ++ FV++++  G LF  L+  +   E     
Sbjct: 85  IMSERNVLLKNVKHPFLVGLHFSFQTAD-KLYFVLDYINGGELFYHLQRERCFLEPRARF 143
Query: 151 VAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXX 210
            A  +   L YLH + I++ D+KP N+L++ +G + + DFG+ +   E            
Sbjct: 144 YAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN---------- 193
Query: 211 XXIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEK 270
                 +  C GT  Y++PE +  +     Y    D W LG V+ E L G  P       
Sbjct: 194 ---STTSTFC-GTPEYLAPEVLHKQ----PYDRTVDWWCLGAVLYEMLYGLPPFYSRN-- 243
Query: 271 PDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKR 311
               A +      + L++    +   R  +   L+KD  KR
Sbjct: 244 ---TAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTKR 281

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 81/284 (28%), Positives = 127/284 (44%), Gaps = 39/284 (13%)
Query: 52  LTVLGHGNGGIVYKVRH---QKSNSIYALKVLNTTSSTIIRH--QAAH---EAEILKRLD 103
           L VLG G  G V++VR      +  I+A+KVL    + I+R+    AH   E  IL+ + 
Sbjct: 22  LRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLK--KAMIVRNAKDTAHTKAERNILEEVK 79
Query: 104 SQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLH 163
             FIV     F T  G++  ++E++  G LF  L       ED        +   L +LH
Sbjct: 80  HPFIVDLIYAFQT-GGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLH 138
Query: 164 GMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGT 223
              II+ D+KP N+++N +G VK+ DFG+ +                   G       GT
Sbjct: 139 QKGIIYRDLKPENIMLNHQGHVKLTDFGLCK--------------ESIHDGTVTHXFCGT 184
Query: 224 CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFG 283
             YM+PE +   R G  +  A D WSLG ++ + L G  P  G   K  +  ++      
Sbjct: 185 IEYMAPEIL--MRSG--HNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKC---- 236
Query: 284 ERLEMPETASPEFRRFVRSCLEKDWRKR-----GTVEELLAYPF 322
            +L +P   + E R  ++  L+++   R     G   E+ A+PF
Sbjct: 237 -KLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPF 279

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 68/222 (30%), Positives = 94/222 (42%), Gaps = 23/222 (10%)
Query: 45  NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVL--NTTSSTIIRHQAAHEAEILKRL 102
            I D      LG G  G VY  R +++  I ALKVL  +      + HQ   E EI   L
Sbjct: 13  TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL 72
Query: 103 DSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYL 162
               I++ +  F+     I  ++E   RG L+  L+   +  E   +     +   L Y 
Sbjct: 73  RHPNILRMYNYFHD-RKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYC 131
Query: 163 HGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMG 222
           H  ++IH DIKP NLL+  KGE+KIADFG S      R                     G
Sbjct: 132 HERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR----------------XMCG 175
Query: 223 TCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPL 264
           T  Y+ PE ++    G  +    D+W  GV+  E LVG  P 
Sbjct: 176 TLDYLPPEMIE----GKTHDEKVDLWCAGVLCYEFLVGMPPF 213

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 107/224 (47%), Gaps = 18/224 (8%)
Query: 43  VENIS-DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKR 101
           V NIS D +  ++LG G  G+V    H+ +  I A+K +      +   +   E +ILK 
Sbjct: 6   VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKH 65
Query: 102 LDSQFIVKCHAV----FYTIEGEICFVMEHMERGSLFDSLRV--RKKLSEDVISGVAYRV 155
              + I+    +     +    E+  + E M+     D  RV   + LS+D I    Y+ 
Sbjct: 66  FKHENIITIFNIQRPDSFENFNEVYIIQELMQT----DLHRVISTQMLSDDHIQYFIYQT 121
Query: 156 LKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGE 215
           L+ ++ LHG  +IH D+KPSNLLIN   ++K+ DFG++RI++E+             + E
Sbjct: 122 LRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTE 181
Query: 216 AAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV 259
                + T  Y +PE + +      Y  A DVWS G ++ E  +
Sbjct: 182 X----VATRWYRAPEVMLT---SAKYSRAMDVWSCGCILAELFL 218

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 107/231 (46%), Gaps = 26/231 (11%)
Query: 89  RHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKK----LS 144
           R     E ++LK+L+   ++K +A F   + E+  V+E  + G L   ++  KK    + 
Sbjct: 76  RADCIKEIDLLKQLNHPNVIKYYASFIE-DNELNIVLELADAGDLSRMIKHFKKQKRLIP 134
Query: 145 EDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXX 204
           E  +     ++   L+++H  +++H DIKP+N+ I   G VK+ D G+ R          
Sbjct: 135 ERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--- 191
Query: 205 XXXXXXXXIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPL 264
                      AA + +GT  YMSPER+        Y F  D+WSLG ++ E      P 
Sbjct: 192 -----------AAHSLVGTPYYMSPERIHE----NGYNFKSDIWSLGCLLYEMAALQSPF 236
Query: 265 IGFGEKPDLMALICAICFGERLEMP-ETASPEFRRFVRSCLEKDWRKRGTV 314
             +G+K +L +L   I   +   +P +  S E R+ V  C+  D  KR  V
Sbjct: 237 --YGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDV 285

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 107/224 (47%), Gaps = 18/224 (8%)
Query: 43  VENIS-DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKR 101
           V NIS D +  ++LG G  G+V    H+ +  I A+K +      +   +   E +ILK 
Sbjct: 6   VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKH 65
Query: 102 LDSQFIVKCHAV----FYTIEGEICFVMEHMERGSLFDSLRV--RKKLSEDVISGVAYRV 155
              + I+    +     +    E+  + E M+     D  RV   + LS+D I    Y+ 
Sbjct: 66  FKHENIITIFNIQRPDSFENFNEVYIIQELMQT----DLHRVISTQMLSDDHIQYFIYQT 121
Query: 156 LKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGE 215
           L+ ++ LHG  +IH D+KPSNLLIN   ++K+ DFG++RI++E+             + E
Sbjct: 122 LRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTE 181
Query: 216 AAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV 259
                + T  Y +PE + +      Y  A DVWS G ++ E  +
Sbjct: 182 Y----VATRWYRAPEVMLT---SAKYSRAMDVWSCGCILAELFL 218

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 78/287 (27%), Positives = 129/287 (44%), Gaps = 30/287 (10%)
Query: 36  SNPTSPDVE-NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTT---SSTIIRHQ 91
           ++ TS D + +I + + L  +G GN   V   RH  +    A+K+++ T   SS++   +
Sbjct: 2   NSATSADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSL--QK 59
Query: 92  AAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGV 151
              E  I+K L+   IVK   V  T E  +  VME+   G +FD L    ++ E      
Sbjct: 60  LFREVRIMKVLNHPNIVKLFEVIET-EKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAK 118
Query: 152 AYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXX 211
             +++  +QY H   I+H D+K  NLL++    +KIADFG S                  
Sbjct: 119 FRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSN---------------EF 163
Query: 212 XIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP 271
             G       G+  Y +PE    +++ G      DVWSLGV++   + G  P  G     
Sbjct: 164 TFGNKLDTFCGSPPYAAPELFQGKKYDGP---EVDVWSLGVILYTLVSGSLPFDG----Q 216
Query: 272 DLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELL 318
           +L  L   +  G +  +P   S +    ++  L  +  KRGT+E+++
Sbjct: 217 NLKELRERVLRG-KYRIPFYMSTDCENLLKKFLILNPSKRGTLEQIM 262

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 78/287 (27%), Positives = 129/287 (44%), Gaps = 30/287 (10%)
Query: 36  SNPTSPDVE-NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTT---SSTIIRHQ 91
           ++ TS D + +I + + L  +G GN   V   RH  +    A+K+++ T   SS++   +
Sbjct: 2   NSATSADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSL--QK 59
Query: 92  AAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGV 151
              E  I+K L+   IVK   V  T E  +  VME+   G +FD L    ++ E      
Sbjct: 60  LFREVRIMKVLNHPNIVKLFEVIET-EKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAK 118
Query: 152 AYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXX 211
             +++  +QY H   I+H D+K  NLL++    +KIADFG S                  
Sbjct: 119 FRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSN---------------EF 163
Query: 212 XIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP 271
             G       G+  Y +PE    +++ G      DVWSLGV++   + G  P  G     
Sbjct: 164 TFGNKLDTFCGSPPYAAPELFQGKKYDGP---EVDVWSLGVILYTLVSGSLPFDG----Q 216
Query: 272 DLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELL 318
           +L  L   +  G +  +P   S +    ++  L  +  KRGT+E+++
Sbjct: 217 NLKELRERVLRG-KYRIPFYMSTDCENLLKKFLILNPSKRGTLEQIM 262

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 67/283 (23%), Positives = 122/283 (43%), Gaps = 29/283 (10%)
Query: 54  VLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTI-------IRHQAAHEAEILKRLDSQF 106
           V+G G   +V +  H+ +   +A+K++  T+  +       +R     E  IL+++    
Sbjct: 101 VIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHP 160
Query: 107 IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQ 166
            +      Y     +  V + M +G LFD L  +  LSE     +   +L+ + +LH   
Sbjct: 161 HIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANN 220
Query: 167 IIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAY 226
           I+H D+KP N+L++   +++++DFG S  +E                GE      GT  Y
Sbjct: 221 IVHRDLKPENILLDDNMQIRLSDFGFSCHLEP---------------GEKLRELCGTPGY 265
Query: 227 MSPE--RVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGE 284
           ++PE  +   +     YG   D+W+ GV++   L G  P   F  +  ++ L   +    
Sbjct: 266 LAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP---FWHRRQILMLRMIMEGQY 322
Query: 285 RLEMPE--TASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTK 325
           +   PE    S   +  +   L+ D   R T E+ L +PF  +
Sbjct: 323 QFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 107/224 (47%), Gaps = 18/224 (8%)
Query: 43  VENIS-DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKR 101
           V NIS D +  ++LG G  G+V    H+ +  I A+K +      +   +   E +ILK 
Sbjct: 6   VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKH 65
Query: 102 LDSQFIVKCHAV----FYTIEGEICFVMEHMERGSLFDSLRV--RKKLSEDVISGVAYRV 155
              + I+    +     +    E+  + E M+     D  RV   + LS+D I    Y+ 
Sbjct: 66  FKHENIITIFNIQRPDSFENFNEVYIIQELMQT----DLHRVISTQMLSDDHIQYFIYQT 121
Query: 156 LKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGE 215
           L+ ++ LHG  +IH D+KPSNLLIN   ++K+ DFG++RI++E+             + E
Sbjct: 122 LRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVE 181
Query: 216 AAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV 259
                + T  Y +PE + +      Y  A DVWS G ++ E  +
Sbjct: 182 ----FVATRWYRAPEVMLT---SAKYSRAMDVWSCGCILAELFL 218

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 79/296 (26%), Positives = 126/296 (42%), Gaps = 37/296 (12%)
Query: 51  KLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRH------------QAAHEAEI 98
           K+  LG G  G V   + +  +S  A+KV+  +     R+            +  +E  +
Sbjct: 40  KVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISL 99
Query: 99  LKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKG 158
           LK LD   I+K   VF   +     V E  E G LF+ +  R K  E   + +  ++L G
Sbjct: 100 LKSLDHPNIIKLFDVFED-KKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSG 158
Query: 159 LQYLHGMQIIHGDIKPSNLLINGKG---EVKIADFGVSRIVEETRXXXXXXXXXXXXIGE 215
           + YLH   I+H DIKP N+L+  K     +KI DFG+S    +                 
Sbjct: 159 ICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDR---------- 208
Query: 216 AAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMA 275
                +GT  Y++PE +  +     Y    DVWS GV++   L G YP  G     D++ 
Sbjct: 209 -----LGTAYYIAPEVLKKK-----YNEKCDVWSCGVIMYILLCG-YPPFGGQNDQDIIK 257
Query: 276 LICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSN 331
            +    +       +  S E +  ++  L  D+ KR T EE L   ++ K +++ N
Sbjct: 258 KVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNIN 313

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 88.2 bits (217), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 88/318 (27%), Positives = 134/318 (42%), Gaps = 34/318 (10%)
Query: 16  SLPATAANHQFRRRRHHFPTSNPTS--PDV----ENISDLKKLTVLGHGNGGIVYKVRHQ 69
           S+ A  A    +   H  P S P    PDV      +    +   LG G     Y++   
Sbjct: 5   SMSAAIAKPSAKPSAHVDPKSAPLKEIPDVLVDPRTMKRYMRGRFLGKGGFAKCYEITDM 64
Query: 70  KSNSIYALKVLNTTSSTIIRHQA---AHEAEILKRLDSQFIVKCHAVFYTIEGEICFVME 126
            +  ++A KV+   S  +  HQ    + E  I K LD+  +V  H  F+  +  +  V+E
Sbjct: 65  DTKEVFAGKVV-PKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG-FFEDDDFVYVVLE 122
Query: 127 HMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVK 186
              R SL +  + RK ++E        + ++G+QYLH  ++IH D+K  NL +N   +VK
Sbjct: 123 ICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVK 182
Query: 187 IADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGD 246
           I DFG++  +E                GE      GT  Y++PE +  +     + F  D
Sbjct: 183 IGDFGLATKIEFD--------------GERKKTLCGTPNYIAPEVLCKK----GHSFEVD 224
Query: 247 VWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEK 306
           +WSLG ++   LVG  P     E   L      I   E   +P   +P     +R  L  
Sbjct: 225 IWSLGCILYTLLVGKPPF----ETSCLKETYIRIKKNE-YSVPRHINPVASALIRRMLHA 279
Query: 307 DWRKRGTVEELLAYPFVT 324
           D   R +V ELL   F T
Sbjct: 280 DPTLRPSVAELLTDEFFT 297

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 88.2 bits (217), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 73/285 (25%), Positives = 126/285 (44%), Gaps = 32/285 (11%)
Query: 54  VLGHGNGGIVYKVRHQKSNSIYALKVLNTTSS--------TIIRHQAAHEAEILKRLDSQ 105
           +LG G   +V +  H+ +   YA+K+++ T            +R     E +IL+++   
Sbjct: 24  ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 83
Query: 106 FIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGM 165
             +      Y        V + M++G LFD L  +  LSE     +   +L+ +  LH +
Sbjct: 84  PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL 143
Query: 166 QIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCA 225
            I+H D+KP N+L++    +K+ DFG S  ++                GE   +  GT +
Sbjct: 144 NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP---------------GEKLRSVCGTPS 188
Query: 226 YMSPERVD---SERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICF 282
           Y++PE ++   ++   G YG   D+WS GV++   L G  P   F  +  ++ L   +  
Sbjct: 189 YLAPEIIECSMNDNHPG-YGKEVDMWSTGVIMYTLLAGSPP---FWHRKQMLMLRMIMSG 244
Query: 283 GERLEMPE--TASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTK 325
             +   PE    S   +  V   L    +KR T EE LA+PF  +
Sbjct: 245 NYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 289

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 88/318 (27%), Positives = 134/318 (42%), Gaps = 34/318 (10%)
Query: 16  SLPATAANHQFRRRRHHFPTSNPTS--PDV----ENISDLKKLTVLGHGNGGIVYKVRHQ 69
           S+ A  A    +   H  P S P    PDV      +    +   LG G     Y++   
Sbjct: 5   SMSAAIAKPSAKPSAHVDPKSAPLKEIPDVLVDPRTMKRYMRGRFLGKGGFAKCYEITDM 64
Query: 70  KSNSIYALKVLNTTSSTIIRHQA---AHEAEILKRLDSQFIVKCHAVFYTIEGEICFVME 126
            +  ++A KV+   S  +  HQ    + E  I K LD+  +V  H  F+  +  +  V+E
Sbjct: 65  DTKEVFAGKVV-PKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG-FFEDDDFVYVVLE 122
Query: 127 HMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVK 186
              R SL +  + RK ++E        + ++G+QYLH  ++IH D+K  NL +N   +VK
Sbjct: 123 ICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVK 182
Query: 187 IADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGD 246
           I DFG++  +E                GE      GT  Y++PE +  +     + F  D
Sbjct: 183 IGDFGLATKIEFD--------------GERKKXLCGTPNYIAPEVLCKK----GHSFEVD 224
Query: 247 VWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEK 306
           +WSLG ++   LVG  P     E   L      I   E   +P   +P     +R  L  
Sbjct: 225 IWSLGCILYTLLVGKPPF----ETSCLKETYIRIKKNE-YSVPRHINPVASALIRRMLHA 279
Query: 307 DWRKRGTVEELLAYPFVT 324
           D   R +V ELL   F T
Sbjct: 280 DPTLRPSVAELLTDEFFT 297

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 74/275 (26%), Positives = 121/275 (44%), Gaps = 25/275 (9%)
Query: 45  NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAA-HEAEILKRLD 103
           +I + + L  +G GN   V   RH  +    A+K+++ T       Q    E  I+K L+
Sbjct: 13  HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILN 72
Query: 104 SQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLH 163
              IVK   V  T E  +  +ME+   G +FD L    ++ E        +++  +QY H
Sbjct: 73  HPNIVKLFEVIET-EKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCH 131
Query: 164 GMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGT 223
             +I+H D+K  NLL++    +KIADFG S                   +G    A  G 
Sbjct: 132 QKRIVHRDLKAENLLLDADMNIKIADFGFSN---------------EFTVGGKLDAFCGA 176
Query: 224 CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFG 283
             Y +PE    +++ G      DVWSLGV++   + G  P  G     +L  L   +  G
Sbjct: 177 PPYAAPELFQGKKYDGP---EVDVWSLGVILYTLVSGSLPFDG----QNLKELRERVLRG 229
Query: 284 ERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELL 318
            +  +P   S +    ++  L  +  KRGT+E+++
Sbjct: 230 -KYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIM 263

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 77/287 (26%), Positives = 129/287 (44%), Gaps = 30/287 (10%)
Query: 36  SNPTSPDVE-NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTT---SSTIIRHQ 91
           ++ TS D + +I + + L  +G GN   V   RH  +    A+++++ T   SS++   +
Sbjct: 2   NSATSADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSL--QK 59
Query: 92  AAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGV 151
              E  I+K L+   IVK   V  T E  +  VME+   G +FD L    ++ E      
Sbjct: 60  LFREVRIMKVLNHPNIVKLFEVIET-EKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAK 118
Query: 152 AYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXX 211
             +++  +QY H   I+H D+K  NLL++    +KIADFG S                  
Sbjct: 119 FRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSN---------------EF 163
Query: 212 XIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP 271
             G       G+  Y +PE    +++ G      DVWSLGV++   + G  P  G     
Sbjct: 164 TFGNKLDTFCGSPPYAAPELFQGKKYDGP---EVDVWSLGVILYTLVSGSLPFDG----Q 216
Query: 272 DLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELL 318
           +L  L   +  G +  +P   S +    ++  L  +  KRGT+E+++
Sbjct: 217 NLKELRERVLRG-KYRIPFYMSTDCENLLKKFLILNPSKRGTLEQIM 262

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 96/219 (43%), Gaps = 28/219 (12%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVF 114
           LG G  G V+ V  + S     +K +N   S +   Q   E E+LK LD   I+K   VF
Sbjct: 30  LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 115 YTIEGEICFVMEHMERGSLFD---SLRVR-KKLSEDVISGVAYRVLKGLQYLHGMQIIHG 170
                 +  VME  E G L +   S + R K LSE  ++ +  +++  L Y H   ++H 
Sbjct: 90  EDYHN-MYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHK 148
Query: 171 DIKPSNLLINGK---GEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYM 227
           D+KP N+L         +KI DFG++ + +                 E +    GT  YM
Sbjct: 149 DLKPENILFQDTSPHSPIKIIDFGLAELFKS---------------DEHSTNAAGTALYM 193
Query: 228 SPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIG 266
           +P     E +  D  F  D+WS GVV+   L G  P  G
Sbjct: 194 AP-----EVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTG 227

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 77/304 (25%), Positives = 131/304 (43%), Gaps = 44/304 (14%)
Query: 45  NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTI-IRHQAAHEAEILKRLD 103
           ++ + +K+  +G G  G+VYK R++ +  + ALK +   + T  +   A  E  +LK L+
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 104 SQFIVKCHAVFYTIEGEICFVMEHMERG-SLFDSLRVRKKLSEDVISGVAYRVLKGLQYL 162
              IVK   V +T E ++  V EH+++    F        +   +I    +++L+GL + 
Sbjct: 64  HPNIVKLLDVIHT-ENKLYLVFEHVDQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 163 HGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMG 222
           H  +++H D+KP NLLIN +G +K+ADFG++R                            
Sbjct: 123 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-------------- 168
Query: 223 TCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICF 282
           T  Y +PE +   ++   Y  A D+WSLG +  E +       G  E   L  +   +  
Sbjct: 169 TLWYRAPEILLGCKY---YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT 225
Query: 283 GERLEMPETAS-----PEFRRFVRSCLEK-------------------DWRKRGTVEELL 318
            + +  P   S     P F ++ R    K                   D  KR + +  L
Sbjct: 226 PDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAAL 285
Query: 319 AYPF 322
           A+PF
Sbjct: 286 AHPF 289

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 87.8 bits (216), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 88/318 (27%), Positives = 134/318 (42%), Gaps = 34/318 (10%)
Query: 16  SLPATAANHQFRRRRHHFPTSNPTS--PDV----ENISDLKKLTVLGHGNGGIVYKVRHQ 69
           S+ A  A    +   H  P S P    PDV      +    +   LG G     Y++   
Sbjct: 5   SMSAAIAKPSAKPSAHVDPKSAPLKEIPDVLVDPRTMKRYMRGRFLGKGGFAKCYEITDM 64
Query: 70  KSNSIYALKVLNTTSSTIIRHQA---AHEAEILKRLDSQFIVKCHAVFYTIEGEICFVME 126
            +  ++A KV+   S  +  HQ    + E  I K LD+  +V  H  F+  +  +  V+E
Sbjct: 65  DTKEVFAGKVV-PKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG-FFEDDDFVYVVLE 122
Query: 127 HMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVK 186
              R SL +  + RK ++E        + ++G+QYLH  ++IH D+K  NL +N   +VK
Sbjct: 123 ICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVK 182
Query: 187 IADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGD 246
           I DFG++  +E                GE      GT  Y++PE +  +     + F  D
Sbjct: 183 IGDFGLATKIEFD--------------GERKKDLCGTPNYIAPEVLCKK----GHSFEVD 224
Query: 247 VWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEK 306
           +WSLG ++   LVG  P     E   L      I   E   +P   +P     +R  L  
Sbjct: 225 IWSLGCILYTLLVGKPPF----ETSCLKETYIRIKKNE-YSVPRHINPVASALIRRMLHA 279
Query: 307 DWRKRGTVEELLAYPFVT 324
           D   R +V ELL   F T
Sbjct: 280 DPTLRPSVAELLTDEFFT 297

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 87.8 bits (216), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 107/222 (48%), Gaps = 20/222 (9%)
Query: 48  DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAA---HEAEILKRLDS 104
           D + + V+G G  G V  V+ + +  IYA+K+LN     + R + A    E ++L   D 
Sbjct: 75  DFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWE-MLKRAETACFREERDVLVNGDC 133
Query: 105 QFIVKCHAVFYTIEGEICFVMEHMERGSLFDSL-RVRKKLSEDVISGVAYRVLKGLQYLH 163
           Q+I   H  F   E  +  VM++   G L   L +   KL ED+       ++  +  +H
Sbjct: 134 QWITALHYAFQD-ENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIH 192
Query: 164 GMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGT 223
            +  +H DIKP N+L++  G +++ADFG    + +                ++++A +GT
Sbjct: 193 QLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTV------------QSSVA-VGT 239
Query: 224 CAYMSPERVDSERWG-GDYGFAGDVWSLGVVVLECLVGHYPL 264
             Y+SPE + +   G G YG   D WSLGV + E L G  P 
Sbjct: 240 PDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 281

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 77/287 (26%), Positives = 129/287 (44%), Gaps = 30/287 (10%)
Query: 36  SNPTSPDVE-NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTT---SSTIIRHQ 91
           ++ TS D + +I + + L  +G GN   V   RH  +    A+++++ T   SS++   +
Sbjct: 2   NSATSADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSL--QK 59
Query: 92  AAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGV 151
              E  I+K L+   IVK   V  T E  +  VME+   G +FD L    ++ E      
Sbjct: 60  LFREVRIMKVLNHPNIVKLFEVIET-EKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAK 118
Query: 152 AYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXX 211
             +++  +QY H   I+H D+K  NLL++    +KIADFG S                  
Sbjct: 119 FRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSN---------------EF 163
Query: 212 XIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP 271
             G       G+  Y +PE    +++ G      DVWSLGV++   + G  P  G     
Sbjct: 164 TFGNKLDEFCGSPPYAAPELFQGKKYDGP---EVDVWSLGVILYTLVSGSLPFDG----Q 216
Query: 272 DLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELL 318
           +L  L   +  G +  +P   S +    ++  L  +  KRGT+E+++
Sbjct: 217 NLKELRERVLRG-KYRIPFYMSTDCENLLKKFLILNPSKRGTLEQIM 262

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 107/222 (48%), Gaps = 20/222 (9%)
Query: 48  DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAA---HEAEILKRLDS 104
           D + + V+G G  G V  V+ + +  IYA+K+LN     + R + A    E ++L   D 
Sbjct: 91  DFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWE-MLKRAETACFREERDVLVNGDC 149
Query: 105 QFIVKCHAVFYTIEGEICFVMEHMERGSLFDSL-RVRKKLSEDVISGVAYRVLKGLQYLH 163
           Q+I   H  F   E  +  VM++   G L   L +   KL ED+       ++  +  +H
Sbjct: 150 QWITALHYAFQD-ENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIH 208
Query: 164 GMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGT 223
            +  +H DIKP N+L++  G +++ADFG    + +                ++++A +GT
Sbjct: 209 QLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTV------------QSSVA-VGT 255
Query: 224 CAYMSPERVDSERWG-GDYGFAGDVWSLGVVVLECLVGHYPL 264
             Y+SPE + +   G G YG   D WSLGV + E L G  P 
Sbjct: 256 PDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 297

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 76/303 (25%), Positives = 128/303 (42%), Gaps = 44/303 (14%)
Query: 46  ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTI-IRHQAAHEAEILKRLDS 104
           + + +K+  +G G  G+VYK R++ +  + ALK +   + T  +   A  E  +LK L+ 
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 105 QFIVKCHAVFYTIEGEICFVMEHMERG-SLFDSLRVRKKLSEDVISGVAYRVLKGLQYLH 163
             IVK   V +T E ++  V EH+ +    F        +   +I    +++L+GL + H
Sbjct: 61  PNIVKLLDVIHT-ENKLYLVFEHVHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 164 GMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGT 223
             +++H D+KP NLLIN +G +K+ADFG++R                            T
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--------------T 165
Query: 224 CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFG 283
             Y +PE +   ++   Y  A D+WSLG +  E +       G  E   L  +   +   
Sbjct: 166 LWYRAPEILLGCKY---YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTP 222
Query: 284 ERLEMPETAS-----PEFRRFVRSCLEK-------------------DWRKRGTVEELLA 319
           + +  P   S     P F ++ R    K                   D  KR + +  LA
Sbjct: 223 DEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282
Query: 320 YPF 322
           +PF
Sbjct: 283 HPF 285

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 73/285 (25%), Positives = 125/285 (43%), Gaps = 32/285 (11%)
Query: 54  VLGHGNGGIVYKVRHQKSNSIYALKVLNTTSS--------TIIRHQAAHEAEILKRLDSQ 105
           +LG G   +V +  H+ +   YA+K+++ T            +R     E +IL+++   
Sbjct: 24  ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 83
Query: 106 FIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGM 165
             +      Y        V + M++G LFD L  +  LSE     +   +L+ +  LH +
Sbjct: 84  PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL 143
Query: 166 QIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCA 225
            I+H D+KP N+L++    +K+ DFG S  ++                GE      GT +
Sbjct: 144 NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP---------------GEKLREVCGTPS 188
Query: 226 YMSPERVD---SERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICF 282
           Y++PE ++   ++   G YG   D+WS GV++   L G  P   F  +  ++ L   +  
Sbjct: 189 YLAPEIIECSMNDNHPG-YGKEVDMWSTGVIMYTLLAGSPP---FWHRKQMLMLRMIMSG 244
Query: 283 GERLEMPE--TASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTK 325
             +   PE    S   +  V   L    +KR T EE LA+PF  +
Sbjct: 245 NYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 289

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 102/223 (45%), Gaps = 23/223 (10%)
Query: 45  NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH---EAEILKR 101
           N    + L  +G G+ G V  V+   +  +YA+K +N     + R++  +   E +I++ 
Sbjct: 13  NFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNK-QKCVERNEVRNVFKELQIMQG 71
Query: 102 LDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQY 161
           L+  F+V     F   E ++  V++ +  G L   L+      E+ +      ++  L Y
Sbjct: 72  LEHPFLVNLWYSFQD-EEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDY 130
Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACM 221
           L   +IIH D+KP N+L++  G V I DF ++ ++                  E  I  M
Sbjct: 131 LQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR----------------ETQITTM 174
Query: 222 -GTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYP 263
            GT  YM+PE   S R G  Y FA D WSLGV   E L G  P
Sbjct: 175 AGTKPYMAPEMF-SSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 87.4 bits (215), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 74/280 (26%), Positives = 123/280 (43%), Gaps = 25/280 (8%)
Query: 40  SPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAA-HEAEI 98
           S +  +I + + L  +G GN   V   RH  +    A+K+++ T       Q    E  I
Sbjct: 5   SDEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRI 64
Query: 99  LKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKG 158
           +K L+   IVK   V  T E  +  +ME+   G +FD L    ++ E        +++  
Sbjct: 65  MKILNHPNIVKLFEVIET-EKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSA 123
Query: 159 LQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAI 218
           +QY H  +I+H D+K  NLL++    +KIADFG S                   +G    
Sbjct: 124 VQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSN---------------EFTVGGKLD 168
Query: 219 ACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALIC 278
              G+  Y +PE    +++ G      DVWSLGV++   + G  P  G     +L  L  
Sbjct: 169 TFCGSPPYAAPELFQGKKYDGP---EVDVWSLGVILYTLVSGSLPFDG----QNLKELRE 221
Query: 279 AICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELL 318
            +  G +  +P   S +    ++  L  +  KRGT+E+++
Sbjct: 222 RVLRG-KYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIM 260

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 87.4 bits (215), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 72/288 (25%), Positives = 130/288 (45%), Gaps = 30/288 (10%)
Query: 42  DVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKR 101
           D+ +I D +   VLG G    V     +++  + A+K +   +         +E  +L +
Sbjct: 15  DIRDIYDFR--DVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHK 72
Query: 102 LDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQY 161
           +    IV    + Y   G +  +M+ +  G LFD +  +   +E   S + ++VL  ++Y
Sbjct: 73  IKHPNIVALDDI-YESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKY 131
Query: 162 LHGMQIIHGDIKPSNLL---INGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAI 218
           LH + I+H D+KP NLL   ++   ++ I+DFG+S++ +                G    
Sbjct: 132 LHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP---------------GSVLS 176
Query: 219 ACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALIC 278
              GT  Y++PE +  +     Y  A D WS+GV+    L G+ P   F ++ D      
Sbjct: 177 TACGTPGYVAPEVLAQKP----YSKAVDCWSIGVIAYILLCGYPP---FYDENDAKLFEQ 229
Query: 279 AICFGERLEMP--ETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVT 324
            +      + P  +  S   + F+R  +EKD  KR T E+ L +P++ 
Sbjct: 230 ILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIA 277

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 72/284 (25%), Positives = 122/284 (42%), Gaps = 30/284 (10%)
Query: 54  VLGHGNGGIVYKVRHQKSNSIYALKVLNTTSS--------TIIRHQAAHEAEILKRLDSQ 105
           +LG G   +V +  H+ +   YA+K+++ T            +R     E +IL+++   
Sbjct: 11  ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 70
Query: 106 FIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGM 165
             +      Y        V + M++G LFD L  +  LSE     +   +L+ +  LH +
Sbjct: 71  PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL 130
Query: 166 QIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCA 225
            I+H D+KP N+L++    +K+ DFG S  ++                GE      GT +
Sbjct: 131 NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP---------------GEKLREVCGTPS 175
Query: 226 YMSPERVDSERWGGD--YGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFG 283
           Y++PE ++         YG   D+WS GV++   L G  P   F  +  ++ L   +   
Sbjct: 176 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP---FWHRKQMLMLRMIMSGN 232
Query: 284 ERLEMPE--TASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTK 325
            +   PE    S   +  V   L    +KR T EE LA+PF  +
Sbjct: 233 YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 276

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 74/296 (25%), Positives = 132/296 (44%), Gaps = 43/296 (14%)
Query: 47  SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS---STIIRHQAAHEAEILKRLD 103
           SD +++ VLG G  G V K R+   +  YA+K +  T    STI+      E  +L  L+
Sbjct: 6   SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILS-----EVMLLASLN 60
Query: 104 SQFIVKCHAVFY------------TIEGEICFVMEHMERGSLFDSLRVRK-KLSEDVISG 150
            Q++V+ +A +               +  +   ME+ E G+L+D +         D    
Sbjct: 61  HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWR 120
Query: 151 VAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXX 210
           +  ++L+ L Y+H   IIH D+KP N+ I+    VKI DFG+++ V  +           
Sbjct: 121 LFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180
Query: 211 XXIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEK 270
               +   + +GT  Y++ E +D     G Y    D++SLG++  E +   YP     E+
Sbjct: 181 PGSSDNLTSAIGTAMYVATEVLDG---TGHYNEKIDMYSLGIIFFEMI---YPFSTGMER 234
Query: 271 PDLMALICAICFGERLEMPETASPEF--------RRFVRSCLEKDWRKRGTVEELL 318
            +++  + ++     +E P    P+F        ++ +R  ++ D  KR     LL
Sbjct: 235 VNILKKLRSVS----IEFP----PDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLL 282

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 72/288 (25%), Positives = 130/288 (45%), Gaps = 30/288 (10%)
Query: 42  DVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKR 101
           D+ +I D +   VLG G    V     +++  + A+K +   +         +E  +L +
Sbjct: 15  DIRDIYDFR--DVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHK 72
Query: 102 LDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQY 161
           +    IV    + Y   G +  +M+ +  G LFD +  +   +E   S + ++VL  ++Y
Sbjct: 73  IKHPNIVALDDI-YESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKY 131
Query: 162 LHGMQIIHGDIKPSNLL---INGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAI 218
           LH + I+H D+KP NLL   ++   ++ I+DFG+S++ +                G    
Sbjct: 132 LHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP---------------GSVLS 176
Query: 219 ACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALIC 278
              GT  Y++PE +  +     Y  A D WS+GV+    L G+ P   F ++ D      
Sbjct: 177 TACGTPGYVAPEVLAQKP----YSKAVDCWSIGVIAYILLCGYPP---FYDENDAKLFEQ 229
Query: 279 AICFGERLEMP--ETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVT 324
            +      + P  +  S   + F+R  +EKD  KR T E+ L +P++ 
Sbjct: 230 ILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIA 277

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 72/288 (25%), Positives = 130/288 (45%), Gaps = 30/288 (10%)
Query: 42  DVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKR 101
           D+ +I D +   VLG G    V     +++  + A+K +   +         +E  +L +
Sbjct: 15  DIRDIYDFR--DVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHK 72
Query: 102 LDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQY 161
           +    IV    + Y   G +  +M+ +  G LFD +  +   +E   S + ++VL  ++Y
Sbjct: 73  IKHPNIVALDDI-YESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKY 131
Query: 162 LHGMQIIHGDIKPSNLL---INGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAI 218
           LH + I+H D+KP NLL   ++   ++ I+DFG+S++ +                G    
Sbjct: 132 LHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP---------------GSVLS 176
Query: 219 ACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALIC 278
              GT  Y++PE +  +     Y  A D WS+GV+    L G+ P   F ++ D      
Sbjct: 177 TACGTPGYVAPEVLAQKP----YSKAVDCWSIGVIAYILLCGYPP---FYDENDAKLFEQ 229
Query: 279 AICFGERLEMP--ETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVT 324
            +      + P  +  S   + F+R  +EKD  KR T E+ L +P++ 
Sbjct: 230 ILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIA 277

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/246 (26%), Positives = 110/246 (44%), Gaps = 31/246 (12%)
Query: 34  PTSNPTSPDVE---NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRH 90
           P  N   P ++    I D +   +LG G+ G V+    +K+N  +A+K L      ++  
Sbjct: 2   PELNKERPSLQIKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKAL--KKDVVLMD 59
Query: 91  QAAHEAEILKRL-----DSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSE 145
                  + KR+     +  F+      F T E  + FVME++  G L   ++   K   
Sbjct: 60  DDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN-LFFVMEYLNGGDLMYHIQSCHKFDL 118
Query: 146 DVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXX 205
              +  A  ++ GLQ+LH   I++ D+K  N+L++  G +KIADFG+ +           
Sbjct: 119 SRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCK----------- 167
Query: 206 XXXXXXXIGEAAIACM-GTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPL 264
                  +G+A      GT  Y++PE +     G  Y  + D WS GV++ E L+G  P 
Sbjct: 168 ----ENMLGDAKTNEFCGTPDYIAPEIL----LGQKYNHSVDWWSFGVLLYEMLIGQSPF 219
Query: 265 IGFGEK 270
            G  E+
Sbjct: 220 HGQDEE 225

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 78/273 (28%), Positives = 120/273 (43%), Gaps = 28/273 (10%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQA---AHEAEILKRLDSQFIVKCH 111
           LG G     Y++    +  ++A KV+   S  +  HQ    + E  I K LD+  +V  H
Sbjct: 34  LGKGGFAKCYEITDMDTKEVFAGKVV-PKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFH 92
Query: 112 AVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGD 171
             F+  +  +  V+E   R SL +  + RK ++E        + ++G+QYLH  ++IH D
Sbjct: 93  G-FFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRD 151
Query: 172 IKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPER 231
           +K  NL +N   +VKI DFG++  +E                GE      GT  Y++PE 
Sbjct: 152 LKLGNLFLNDDMDVKIGDFGLATKIEFD--------------GERKKDLCGTPNYIAPEV 197
Query: 232 VDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPET 291
           +  +     + F  D+WSLG ++   LVG  P     E   L      I   E   +P  
Sbjct: 198 LCKK----GHSFEVDIWSLGCILYTLLVGKPPF----ETSCLKETYIRIKKNE-YSVPRH 248
Query: 292 ASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVT 324
            +P     +R  L  D   R +V ELL   F T
Sbjct: 249 INPVASALIRRMLHADPTLRPSVAELLTDEFFT 281

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 72/268 (26%), Positives = 125/268 (46%), Gaps = 38/268 (14%)
Query: 3   LVRERRHQQALTLSLPATAANHQFRRRRHHFPTSNPTSPDVENISDLKKLTVLGHGNGGI 62
           L RE+   + L  + P T+   Q R  R                 D + L V+G G  G 
Sbjct: 46  LRREKNILEYLEWAKPFTSKVKQMRLHRE----------------DFEILKVIGRGAFGE 89
Query: 63  VYKVRHQKSNSIYALKVLNTTSSTIIRHQAA---HEAEILKRLDSQFIVKCHAVFYTIEG 119
           V  V+ + ++ ++A+K+LN     + R + A    E ++L   DS++I   H  F   + 
Sbjct: 90  VAVVKLKNADKVFAMKILNKWE-MLKRAETACFREERDVLVNGDSKWITTLHYAFQD-DN 147
Query: 120 EICFVMEHMERGSLFDSL-RVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLL 178
            +  VM++   G L   L +   +L E++       ++  +  +H +  +H DIKP N+L
Sbjct: 148 NLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNIL 207
Query: 179 INGKGEVKIADFGVS-RIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERVDSERW 237
           ++  G +++ADFG   +++E+                ++++A +GT  Y+SPE + +   
Sbjct: 208 MDMNGHIRLADFGSCLKLMEDGTV-------------QSSVA-VGTPDYISPEILQAMEG 253
Query: 238 G-GDYGFAGDVWSLGVVVLECLVGHYPL 264
           G G YG   D WSLGV + E L G  P 
Sbjct: 254 GKGRYGPECDWWSLGVCMYEMLYGETPF 281

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 77/306 (25%), Positives = 129/306 (42%), Gaps = 46/306 (15%)
Query: 44  ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTI-IRHQAAHEAEILKRL 102
           E + + +K+  +G G  G+VYK R++ +  + ALK +   + T  +   A  E  +LK L
Sbjct: 7   EFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 66
Query: 103 DSQFIVKCHAVFYTIEGEICFVME--HMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQ 160
           +   IVK   V +T E ++  V E  H +     D+      +   +I    +++L+GL 
Sbjct: 67  NHPNIVKLLDVIHT-ENKLYLVFEFLHQDLKKFMDA-SALTGIPLPLIKSYLFQLLQGLA 124
Query: 161 YLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIAC 220
           + H  +++H D+KP NLLIN +G +K+ADFG++R                          
Sbjct: 125 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV------------ 172
Query: 221 MGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAI 280
             T  Y +PE +   ++   Y  A D+WSLG +  E +       G  E   L  +   +
Sbjct: 173 --TLWYRAPEILLGXKY---YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL 227
Query: 281 CFGERLEMPETAS-----PEFRRFVRSCLEK-------------------DWRKRGTVEE 316
              + +  P   S     P F ++ R    K                   D  KR + + 
Sbjct: 228 GTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKA 287
Query: 317 LLAYPF 322
            LA+PF
Sbjct: 288 ALAHPF 293

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 72/288 (25%), Positives = 130/288 (45%), Gaps = 30/288 (10%)
Query: 42  DVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKR 101
           D+ +I D +   VLG G    V     +++  + A+K +   +         +E  +L +
Sbjct: 15  DIRDIYDFR--DVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHK 72
Query: 102 LDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQY 161
           +    IV    + Y   G +  +M+ +  G LFD +  +   +E   S + ++VL  ++Y
Sbjct: 73  IKHPNIVALDDI-YESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKY 131
Query: 162 LHGMQIIHGDIKPSNLL---INGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAI 218
           LH + I+H D+KP NLL   ++   ++ I+DFG+S++ +                G    
Sbjct: 132 LHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP---------------GSVLS 176
Query: 219 ACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALIC 278
              GT  Y++PE +  +     Y  A D WS+GV+    L G+ P   F ++ D      
Sbjct: 177 TACGTPGYVAPEVLAQKP----YSKAVDCWSIGVIAYILLCGYPP---FYDENDAKLFEQ 229
Query: 279 AICFGERLEMP--ETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVT 324
            +      + P  +  S   + F+R  +EKD  KR T E+ L +P++ 
Sbjct: 230 ILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIA 277

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 72/222 (32%), Positives = 100/222 (45%), Gaps = 23/222 (10%)
Query: 45  NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVL--NTTSSTIIRHQAAHEAEILKRL 102
            I D +    LG G  G VY  R +KS+ I ALKVL  +      + HQ   E EI   L
Sbjct: 21  TIDDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHL 80
Query: 103 DSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYL 162
               I++ +  FY     I  ++E+  RG L+  L+      E   + +   +   L Y 
Sbjct: 81  HHPNILRLYNYFYD-RRRIYLILEYAPRGELYKELQKSCTFDEQRTATIMEELADALMYC 139
Query: 163 HGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMG 222
           HG ++IH DIKP NLL+  KGE+KIADFG S      R                     G
Sbjct: 140 HGKKVIHRDIKPENLLLGLKGELKIADFGWSVHAPSLRRK----------------TMCG 183
Query: 223 TCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPL 264
           T  Y+ PE ++    G  +    D+W +GV+  E LVG+ P 
Sbjct: 184 TLDYLPPEMIE----GRMHNEKVDLWCIGVLCYELLVGNPPF 221

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 78/311 (25%), Positives = 134/311 (43%), Gaps = 58/311 (18%)
Query: 45  NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTI-IRHQAAHEAEILKRLD 103
           ++ + +K+  +G G  G+VYK R++ +  + ALK +   + T  +   A  E  +LK L+
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 104 SQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVA--------YRV 155
              IVK   V +T E ++  V E       F S+ ++K +    ++G+         +++
Sbjct: 62  HPNIVKLLDVIHT-ENKLYLVFE-------FLSMDLKKFMDASALTGIPLPLIKSYLFQL 113
Query: 156 LKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGE 215
           L+GL + H  +++H D+KP NLLIN +G +K+ADFG++R                     
Sbjct: 114 LQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV------- 166
Query: 216 AAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMA 275
                  T  Y +PE +   ++   Y  A D+WSLG +  E +       G  E   L  
Sbjct: 167 -------TLWYRAPEILLGCKY---YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR 216
Query: 276 LICAICFGERLEMPETAS-----PEFRRFVRSCLEK-------------------DWRKR 311
           +   +   + +  P   S     P F ++ R    K                   D  KR
Sbjct: 217 IFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKR 276
Query: 312 GTVEELLAYPF 322
            + +  LA+PF
Sbjct: 277 ISAKAALAHPF 287

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 77/287 (26%), Positives = 123/287 (42%), Gaps = 33/287 (11%)
Query: 48  DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQA-AHEAEILKRLDSQF 106
           D + L  +G G+ G   K+R +    I   K L+  S T    Q    E  +L+ L    
Sbjct: 7   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 66
Query: 107 IVKCHA-VFYTIEGEICFVMEHMERGSLFDSL----RVRKKLSEDVISGVAYRVLKGLQY 161
           IV+ +  +       +  VME+ E G L   +    + R+ L E+ +  V  ++   L+ 
Sbjct: 67  IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 126
Query: 162 LH-----GMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEA 216
            H     G  ++H D+KP+N+ ++GK  VK+ DFG++RI+                    
Sbjct: 127 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF-------------- 172
Query: 217 AIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMAL 276
           A A +GT  YMSPE+++       Y    D+WSLG ++ E      P   F +K     L
Sbjct: 173 AKAFVGTPYYMSPEQMNR----MSYNEKSDIWSLGCLLYELCALMPPFTAFSQK----EL 224
Query: 277 ICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV 323
              I  G+   +P   S E    +   L      R +VEE+L  P +
Sbjct: 225 AGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 78/311 (25%), Positives = 134/311 (43%), Gaps = 58/311 (18%)
Query: 45  NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTI-IRHQAAHEAEILKRLD 103
           ++ + +K+  +G G  G+VYK R++ +  + ALK +   + T  +   A  E  +LK L+
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 104 SQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVA--------YRV 155
              IVK   V +T E ++  V E       F S+ ++K +    ++G+         +++
Sbjct: 64  HPNIVKLLDVIHT-ENKLYLVFE-------FLSMDLKKFMDASALTGIPLPLIKSYLFQL 115
Query: 156 LKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGE 215
           L+GL + H  +++H D+KP NLLIN +G +K+ADFG++R                     
Sbjct: 116 LQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV------- 168
Query: 216 AAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMA 275
                  T  Y +PE +   ++   Y  A D+WSLG +  E +       G  E   L  
Sbjct: 169 -------TLWYRAPEILLGCKY---YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR 218
Query: 276 LICAICFGERLEMPETAS-----PEFRRFVRSCLEK-------------------DWRKR 311
           +   +   + +  P   S     P F ++ R    K                   D  KR
Sbjct: 219 IFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKR 278
Query: 312 GTVEELLAYPF 322
            + +  LA+PF
Sbjct: 279 ISAKAALAHPF 289

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 79/271 (29%), Positives = 119/271 (43%), Gaps = 30/271 (11%)
Query: 55  LGHGNGGIVYK---VRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCH 111
           +G G  G V++   +  +      A+K     +S  +R +   EA  +++ D   IVK  
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 112 AVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGV--AYRVLKGLQYLHGMQIIH 169
            V    E  +  +ME    G L   L+VRK  S D+ S +  AY++   L YL   + +H
Sbjct: 78  GVI--TENPVWIIMELCTLGELRSFLQVRK-FSLDLASLILYAYQLSTALAYLESKRFVH 134
Query: 170 GDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSP 229
            DI   N+L++    VK+ DFG+SR +E++              G+  I       +M+P
Sbjct: 135 RDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASK-------GKLPI------KWMAP 181
Query: 230 ERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICAICFGERLEM 288
           E ++  R    +  A DVW  GV + E L+ G  P  G         +I  I  GERL M
Sbjct: 182 ESINFRR----FTSASDVWMFGVCMWEILMHGVKPFQGVKNN----DVIGRIENGERLPM 233
Query: 289 PETASPEFRRFVRSCLEKDWRKRGTVEELLA 319
           P    P     +  C   D  +R    EL A
Sbjct: 234 PPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 264

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/246 (26%), Positives = 109/246 (44%), Gaps = 31/246 (12%)
Query: 34  PTSNPTSPDVE---NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRH 90
           P  N   P ++    I D     +LG G+ G V+    +K+N  +A+K L      ++  
Sbjct: 1   PELNKERPSLQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKAL--KKDVVLMD 58
Query: 91  QAAHEAEILKRL-----DSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSE 145
                  + KR+     +  F+      F T E  + FVME++  G L   ++   K   
Sbjct: 59  DDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN-LFFVMEYLNGGDLMYHIQSCHKFDL 117
Query: 146 DVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXX 205
              +  A  ++ GLQ+LH   I++ D+K  N+L++  G +KIADFG+ +           
Sbjct: 118 SRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCK----------- 166
Query: 206 XXXXXXXIGEAAIACM-GTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPL 264
                  +G+A      GT  Y++PE +     G  Y  + D WS GV++ E L+G  P 
Sbjct: 167 ----ENMLGDAKTNXFCGTPDYIAPEIL----LGQKYNHSVDWWSFGVLLYEMLIGQSPF 218
Query: 265 IGFGEK 270
            G  E+
Sbjct: 219 HGQDEE 224

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 79/308 (25%), Positives = 130/308 (42%), Gaps = 49/308 (15%)
Query: 42  DVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTI-IRHQAAHEAEILK 100
           D+EN   ++K+   G G  G+VYK R++ +  + ALK +   + T  +   A  E  +LK
Sbjct: 5   DMENFQKVEKI---GEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 61
Query: 101 RLDSQFIVKCHAVFYTIEGEICFVME--HMERGSLFDSLRVRKKLSEDVISGVAYRVLKG 158
            L+   IVK   V +T E ++  V E  H +     D+      +   +I    +++L+G
Sbjct: 62  ELNHPNIVKLLDVIHT-ENKLYLVFEFLHQDLKKFMDA-SALTGIPLPLIKSYLFQLLQG 119
Query: 159 LQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAI 218
           L + H  +++H D+KP NLLIN +G +K+ADFG++R                        
Sbjct: 120 LAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV---------- 169
Query: 219 ACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALIC 278
               T  Y +PE +   ++   Y  A D+WSLG +  E +       G  E   L  +  
Sbjct: 170 ----TLWYRAPEILLGCKY---YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFR 222
Query: 279 AICFGERLEMPETAS-----PEFRRFVRSCLEK-------------------DWRKRGTV 314
            +   + +  P   S     P F ++ R    K                   D  KR + 
Sbjct: 223 TLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 282
Query: 315 EELLAYPF 322
           +  LA+PF
Sbjct: 283 KAALAHPF 290

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 76/304 (25%), Positives = 128/304 (42%), Gaps = 46/304 (15%)
Query: 46  ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTI-IRHQAAHEAEILKRLDS 104
           + + +K+  +G G  G+VYK R++ +  + ALK +   + T  +   A  E  +LK L+ 
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 105 QFIVKCHAVFYTIEGEICFVME--HMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYL 162
             IVK   V +T E ++  V E  H +     D+      +   +I    +++L+GL + 
Sbjct: 62  PNIVKLLDVIHT-ENKLYLVFEFLHQDLKKFMDA-SALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 163 HGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMG 222
           H  +++H D+KP NLLIN +G +K+ADFG++R                            
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-------------- 165
Query: 223 TCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICF 282
           T  Y +PE +   ++   Y  A D+WSLG +  E +       G  E   L  +   +  
Sbjct: 166 TLWYRAPEILLGXKY---YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT 222
Query: 283 GERLEMPETAS-----PEFRRFVRSCLEK-------------------DWRKRGTVEELL 318
            + +  P   S     P F ++ R    K                   D  KR + +  L
Sbjct: 223 PDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAAL 282
Query: 319 AYPF 322
           A+PF
Sbjct: 283 AHPF 286

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 75/277 (27%), Positives = 122/277 (44%), Gaps = 29/277 (10%)
Query: 45  NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTT---SSTIIRHQAAHEAEILKR 101
           +I + + L  +G GN   V   RH  +    A+K+++ T   SS++   +   E  I+K 
Sbjct: 5   HIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSL--QKLFREVRIMKV 62
Query: 102 LDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQY 161
           L+   IVK   V  T E  +  VME+   G +FD L     + E        +++  +QY
Sbjct: 63  LNHPNIVKLFEVIET-EKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQY 121
Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACM 221
            H   I+H D+K  NLL++    +KIADFG S                    G       
Sbjct: 122 CHQKFIVHRDLKAENLLLDADMNIKIADFGFSN---------------EFTFGNKLDTFC 166
Query: 222 GTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAIC 281
           G+  Y +PE    +++ G      DVWSLGV++   + G  P  G     +L  L   + 
Sbjct: 167 GSPPYAAPELFQGKKYDGP---EVDVWSLGVILYTLVSGSLPFDG----QNLKELRERVL 219
Query: 282 FGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELL 318
            G +  +P   S +    ++  L  +  KRGT+E+++
Sbjct: 220 RG-KYRIPFYMSTDCENLLKKFLILNPSKRGTLEQIM 255

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 77/271 (28%), Positives = 117/271 (43%), Gaps = 30/271 (11%)
Query: 55  LGHGNGGIVYK---VRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCH 111
           +G G  G V++   +  +      A+K     +S  +R +   EA  +++ D   IVK  
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 112 AVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGV--AYRVLKGLQYLHGMQIIH 169
            V    E  +  +ME    G L   L+VRK  S D+ S +  AY++   L YL   + +H
Sbjct: 78  GVI--TENPVWIIMELCTLGELRSFLQVRK-FSLDLASLILYAYQLSTALAYLESKRFVH 134
Query: 170 GDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSP 229
            DI   N+L++    VK+ DFG+SR +E++              G+  I       +M+P
Sbjct: 135 RDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASK-------GKLPI------KWMAP 181
Query: 230 ERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICAICFGERLEM 288
           E ++  R    +  A DVW  GV + E L+ G  P  G         +I  I  GERL M
Sbjct: 182 ESINFRR----FTSASDVWMFGVCMWEILMHGVKPFQGVKNN----DVIGRIENGERLPM 233
Query: 289 PETASPEFRRFVRSCLEKDWRKRGTVEELLA 319
           P    P     +  C   D  +R    EL A
Sbjct: 234 PPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 264

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 72/296 (24%), Positives = 128/296 (43%), Gaps = 41/296 (13%)
Query: 44  ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLD 103
           E I D K   +LG G+   VY+     +    A+K+++         +A ++A +++R+ 
Sbjct: 8   EKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDK--------KAMYKAGMVQRVQ 59
Query: 104 SQFIVKCHAV---------FYTIEGEICFVMEHMERGSLFDSLRVR-KKLSEDVISGVAY 153
           ++  + C            ++     +  V+E    G +   L+ R K  SE+      +
Sbjct: 60  NEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMH 119
Query: 154 RVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXI 213
           +++ G+ YLH   I+H D+  SNLL+     +KIADFG++  ++                
Sbjct: 120 QIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH------------- 166
Query: 214 GEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDL 273
            E      GT  Y+SPE          +G   DVWSLG +    L+G  P      K  L
Sbjct: 167 -EKHYTLCGTPNYISPEIATRSA----HGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL 221
Query: 274 MALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSS 329
             ++ A       EMP   S E +  +   L ++   R ++  +L +PF+++ SS+
Sbjct: 222 NKVVLA-----DYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNSST 272

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 76/287 (26%), Positives = 123/287 (42%), Gaps = 33/287 (11%)
Query: 48  DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQA-AHEAEILKRLDSQF 106
           D + L  +G G+ G   K+R +    I   K L+  S T    Q    E  +L+ L    
Sbjct: 7   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 66
Query: 107 IVKCHA-VFYTIEGEICFVMEHMERGSLFDSL----RVRKKLSEDVISGVAYRVLKGLQY 161
           IV+ +  +       +  VME+ E G L   +    + R+ L E+ +  V  ++   L+ 
Sbjct: 67  IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 126
Query: 162 LH-----GMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEA 216
            H     G  ++H D+KP+N+ ++GK  VK+ DFG++RI+                  + 
Sbjct: 127 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDE--------------DF 172
Query: 217 AIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMAL 276
           A   +GT  YMSPE+++       Y    D+WSLG ++ E      P   F +K     L
Sbjct: 173 AKEFVGTPYYMSPEQMNR----MSYNEKSDIWSLGCLLYELCALMPPFTAFSQK----EL 224
Query: 277 ICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV 323
              I  G+   +P   S E    +   L      R +VEE+L  P +
Sbjct: 225 AGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 77/305 (25%), Positives = 131/305 (42%), Gaps = 46/305 (15%)
Query: 45  NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTI-IRHQAAHEAEILKRLD 103
           ++ + +K+  +G G  G+VYK R++ +  + ALK +   + T  +   A  E  +LK L+
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 104 SQFIVKCHAVFYTIEGEICFVME--HMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQY 161
              IVK   V +T E ++  V E  H +  +  D+      +   +I    +++L+GL +
Sbjct: 64  HPNIVKLLDVIHT-ENKLYLVFEFLHQDLKTFMDA-SALTGIPLPLIKSYLFQLLQGLAF 121
Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACM 221
            H  +++H D+KP NLLIN +G +K+ADFG++R                           
Sbjct: 122 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV------------- 168
Query: 222 GTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAIC 281
            T  Y +PE +   ++   Y  A D+WSLG +  E +       G  E   L  +   + 
Sbjct: 169 -TLWYRAPEILLGCKY---YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 224
Query: 282 FGERLEMPETAS-----PEFRRFVRSCLEK-------------------DWRKRGTVEEL 317
             + +  P   S     P F ++ R    K                   D  KR + +  
Sbjct: 225 TPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 284
Query: 318 LAYPF 322
           LA+PF
Sbjct: 285 LAHPF 289

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 77/285 (27%), Positives = 126/285 (44%), Gaps = 45/285 (15%)
Query: 54  VLGHGNGGIVYKVRHQKSNSIYALKVLN--TTSSTIIRHQAAHEAEILKRLDSQFIVKCH 111
           VLG G+ G V   + + +    A+KV++         +     E ++LK+LD   I+K +
Sbjct: 33  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 92
Query: 112 AVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGD 171
             F+  +G    V E    G LFD +  RK+ SE   + +  +VL G+ Y+H  +I+H D
Sbjct: 93  E-FFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRD 151
Query: 172 IKPSNLLINGKGE---VKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMS 228
           +KP NLL+  K +   ++I DFG+S   E ++                    +GT  Y++
Sbjct: 152 LKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK---------------IGTAYYIA 196
Query: 229 PERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEM 288
           PE +      G Y    DVWS GV++   L G  P  G  E  D++  +    +    E+
Sbjct: 197 PEVL-----HGTYDEKCDVWSTGVILYILLSGCPPFNGANE-YDILKKVEKGKY--TFEL 248
Query: 289 PE----------------TASPEFRRFVRSCLEKDWRKRGTVEEL 317
           P+                T  P  R   R  L+ +W +  T E++
Sbjct: 249 PQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQI 293

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 77/306 (25%), Positives = 129/306 (42%), Gaps = 46/306 (15%)
Query: 44  ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTI-IRHQAAHEAEILKRL 102
           E + + +K+  +G G  G+VYK R++ +  + ALK +   + T  +   A  E  +LK L
Sbjct: 7   EFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 66
Query: 103 DSQFIVKCHAVFYTIEGEICFVME--HMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQ 160
           +   IVK   V +T E ++  V E  H +     D+      +   +I    +++L+GL 
Sbjct: 67  NHPNIVKLLDVIHT-ENKLYLVFEFLHQDLKKFMDA-SALTGIPLPLIKSYLFQLLQGLA 124
Query: 161 YLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIAC 220
           + H  +++H D+KP NLLIN +G +K+ADFG++R                          
Sbjct: 125 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV------------ 172
Query: 221 MGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAI 280
             T  Y +PE +   ++   Y  A D+WSLG +  E +       G  E   L  +   +
Sbjct: 173 --TLWYRAPEILLGCKY---YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL 227
Query: 281 CFGERLEMPETAS-----PEFRRFVRSCLEK-------------------DWRKRGTVEE 316
              + +  P   S     P F ++ R    K                   D  KR + + 
Sbjct: 228 GTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKA 287
Query: 317 LLAYPF 322
            LA+PF
Sbjct: 288 ALAHPF 293

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 71/274 (25%), Positives = 116/274 (42%), Gaps = 40/274 (14%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLN-------TTSSTIIRHQAAHEAEILKRLDSQFI 107
           +G GN G+   +R +++N + A+K +             II H++     I+ R     +
Sbjct: 27  IGAGNFGVARLMRDKQANELVAVKYIERGEKIDENVKREIINHRSLRHPNIV-RFKEVIL 85
Query: 108 VKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQI 167
              H         +  VME+   G LF+ +    + SED       +++ G+ Y H MQ+
Sbjct: 86  TPTH---------LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYAHAMQV 136
Query: 168 IHGDIKPSNLLINGK--GEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCA 225
            H D+K  N L++G     +KIADFG S+                  +     + +GT A
Sbjct: 137 AHRDLKLENTLLDGSPAPRLKIADFGYSK---------------ASVLHSQPKSAVGTPA 181
Query: 226 YMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGER 285
           Y++PE +  + + G      DVWS GV +   LVG YP     E  +    I  I    +
Sbjct: 182 YIAPEVLLKKEYDGK---VADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI-LNVQ 237
Query: 286 LEMPETA--SPEFRRFVRSCLEKDWRKRGTVEEL 317
             +P+    SPE R  +      D  KR ++ E+
Sbjct: 238 YAIPDYVHISPECRHLISRIFVADPAKRISIPEI 271

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 79/290 (27%), Positives = 130/290 (44%), Gaps = 55/290 (18%)
Query: 54  VLGHGNGGIVYKVRHQKSNSIYALKVLN-------TTSSTIIRHQAAHEAEILKRLDSQF 106
           VLG G+ G V   + + +    A+KV++       T   +++R     E ++LK+LD   
Sbjct: 56  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLR-----EVQLLKQLDHPN 110
Query: 107 IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQ 166
           I+K +  F+  +G    V E    G LFD +  RK+ SE   + +  +VL G+ Y+H  +
Sbjct: 111 IMKLYE-FFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK 169
Query: 167 IIHGDIKPSNLLINGKGE---VKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGT 223
           I+H D+KP NLL+  K +   ++I DFG+S   E ++                    +GT
Sbjct: 170 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK---------------IGT 214
Query: 224 CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFG 283
             Y++PE +      G Y    DVWS GV++   L G  P  G  E  D++  +    + 
Sbjct: 215 AYYIAPEVLH-----GTYDEKCDVWSTGVILYILLSGCPPFNGANEY-DILKKVEKGKY- 267
Query: 284 ERLEMPE----------------TASPEFRRFVRSCLEKDWRKRGTVEEL 317
              E+P+                T  P  R   R  L+ +W +  T E++
Sbjct: 268 -TFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQI 316

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 77/271 (28%), Positives = 117/271 (43%), Gaps = 30/271 (11%)
Query: 55  LGHGNGGIVYK---VRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCH 111
           +G G  G V++   +  +      A+K     +S  +R +   EA  +++ D   IVK  
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 112 AVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGV--AYRVLKGLQYLHGMQIIH 169
            V    E  +  +ME    G L   L+VRK  S D+ S +  AY++   L YL   + +H
Sbjct: 458 GVI--TENPVWIIMELCTLGELRSFLQVRK-FSLDLASLILYAYQLSTALAYLESKRFVH 514
Query: 170 GDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSP 229
            DI   N+L++    VK+ DFG+SR +E++              G+  I       +M+P
Sbjct: 515 RDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK-------GKLPI------KWMAP 561
Query: 230 ERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICAICFGERLEM 288
           E ++  R+      A DVW  GV + E L+ G  P  G         +I  I  GERL M
Sbjct: 562 ESINFRRFTS----ASDVWMFGVCMWEILMHGVKPFQGVKNN----DVIGRIENGERLPM 613
Query: 289 PETASPEFRRFVRSCLEKDWRKRGTVEELLA 319
           P    P     +  C   D  +R    EL A
Sbjct: 614 PPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 644

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 85.1 bits (209), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 79/290 (27%), Positives = 130/290 (44%), Gaps = 55/290 (18%)
Query: 54  VLGHGNGGIVYKVRHQKSNSIYALKVLN-------TTSSTIIRHQAAHEAEILKRLDSQF 106
           VLG G+ G V   + + +    A+KV++       T   +++R     E ++LK+LD   
Sbjct: 57  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLR-----EVQLLKQLDHPN 111
Query: 107 IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQ 166
           I+K +  F+  +G    V E    G LFD +  RK+ SE   + +  +VL G+ Y+H  +
Sbjct: 112 IMKLYE-FFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK 170
Query: 167 IIHGDIKPSNLLINGKGE---VKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGT 223
           I+H D+KP NLL+  K +   ++I DFG+S   E ++                    +GT
Sbjct: 171 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK---------------IGT 215
Query: 224 CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFG 283
             Y++PE +      G Y    DVWS GV++   L G  P  G  E  D++  +    + 
Sbjct: 216 AYYIAPEVLH-----GTYDEKCDVWSTGVILYILLSGCPPFNGANEY-DILKKVEKGKY- 268
Query: 284 ERLEMPE----------------TASPEFRRFVRSCLEKDWRKRGTVEEL 317
              E+P+                T  P  R   R  L+ +W +  T E++
Sbjct: 269 -TFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQI 317

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 77/271 (28%), Positives = 117/271 (43%), Gaps = 30/271 (11%)
Query: 55  LGHGNGGIVYK---VRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCH 111
           +G G  G V++   +  +      A+K     +S  +R +   EA  +++ D   IVK  
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 112 AVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGV--AYRVLKGLQYLHGMQIIH 169
            V    E  +  +ME    G L   L+VRK  S D+ S +  AY++   L YL   + +H
Sbjct: 78  GVI--TENPVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKRFVH 134
Query: 170 GDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSP 229
            DI   N+L++    VK+ DFG+SR +E++              G+  I       +M+P
Sbjct: 135 RDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK-------GKLPI------KWMAP 181
Query: 230 ERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICAICFGERLEM 288
           E ++  R    +  A DVW  GV + E L+ G  P  G         +I  I  GERL M
Sbjct: 182 ESINFRR----FTSASDVWMFGVCMWEILMHGVKPFQGVKNN----DVIGRIENGERLPM 233
Query: 289 PETASPEFRRFVRSCLEKDWRKRGTVEELLA 319
           P    P     +  C   D  +R    EL A
Sbjct: 234 PPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 264

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 76/275 (27%), Positives = 123/275 (44%), Gaps = 26/275 (9%)
Query: 52  LTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCH 111
           + VLG G    V+ V+ + +  ++ALK +   S         +E  +LK++  + IV   
Sbjct: 14  MEVLGSGAFSEVFLVKQRLTGKLFALKCIKK-SPAFRDSSLENEIAVLKKIKHENIVTLE 72
Query: 112 AVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGD 171
            + Y        VM+ +  G LFD +  R   +E   S V  +VL  ++YLH   I+H D
Sbjct: 73  DI-YESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRD 131
Query: 172 IKPSNLLI---NGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMS 228
           +KP NLL        ++ I DFG+S++ +                G  + AC GT  Y++
Sbjct: 132 LKPENLLYLTPEENSKIMITDFGLSKMEQN---------------GIMSTAC-GTPGYVA 175
Query: 229 PERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEM 288
           PE +  +     Y  A D WS+GV+    L G+ P     E   L   I    +      
Sbjct: 176 PEVLAQK----PYSKAVDCWSIGVITYILLCGYPPFYEETES-KLFEKIKEGYYEFESPF 230
Query: 289 PETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV 323
            +  S   + F+   LEKD  +R T E+ L++P++
Sbjct: 231 WDDISESAKDFICHLLEKDPNERYTCEKALSHPWI 265

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 77/271 (28%), Positives = 117/271 (43%), Gaps = 30/271 (11%)
Query: 55  LGHGNGGIVYK---VRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCH 111
           +G G  G V++   +  +      A+K     +S  +R +   EA  +++ D   IVK  
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 112 AVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGV--AYRVLKGLQYLHGMQIIH 169
            V    E  +  +ME    G L   L+VRK  S D+ S +  AY++   L YL   + +H
Sbjct: 458 GVI--TENPVWIIMELCTLGELRSFLQVRK-FSLDLASLILYAYQLSTALAYLESKRFVH 514
Query: 170 GDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSP 229
            DI   N+L++    VK+ DFG+SR +E++              G+  I       +M+P
Sbjct: 515 RDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASK-------GKLPI------KWMAP 561
Query: 230 ERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICAICFGERLEM 288
           E ++  R+      A DVW  GV + E L+ G  P  G         +I  I  GERL M
Sbjct: 562 ESINFRRFTS----ASDVWMFGVCMWEILMHGVKPFQGVKNN----DVIGRIENGERLPM 613
Query: 289 PETASPEFRRFVRSCLEKDWRKRGTVEELLA 319
           P    P     +  C   D  +R    EL A
Sbjct: 614 PPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 644

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 76/305 (24%), Positives = 129/305 (42%), Gaps = 46/305 (15%)
Query: 45  NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTI-IRHQAAHEAEILKRLD 103
           ++ + +K+  +G G  G+VYK R++ +  + ALK +   + T  +   A  E  +LK L+
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 104 SQFIVKCHAVFYTIEGEICFVME--HMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQY 161
              IVK   V +T E ++  V E  H +     D+      +   +I    +++L+GL +
Sbjct: 62  HPNIVKLLDVIHT-ENKLYLVFEFLHQDLKKFMDA-SALTGIPLPLIKSYLFQLLQGLAF 119
Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACM 221
            H  +++H D+KP NLLIN +G +K+ADFG++R                           
Sbjct: 120 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV------------- 166
Query: 222 GTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAIC 281
            T  Y +PE +   ++   Y  A D+WSLG +  E +       G  E   L  +   + 
Sbjct: 167 -TLWYRAPEILLGCKY---YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 222
Query: 282 FGERLEMPETAS-----PEFRRFVRSCLEK-------------------DWRKRGTVEEL 317
             + +  P   S     P F ++ R    K                   D  KR + +  
Sbjct: 223 TPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 282
Query: 318 LAYPF 322
           LA+PF
Sbjct: 283 LAHPF 287

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 77/271 (28%), Positives = 117/271 (43%), Gaps = 30/271 (11%)
Query: 55  LGHGNGGIVYK---VRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCH 111
           +G G  G V++   +  +      A+K     +S  +R +   EA  +++ D   IVK  
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 112 AVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGV--AYRVLKGLQYLHGMQIIH 169
            V    E  +  +ME    G L   L+VRK  S D+ S +  AY++   L YL   + +H
Sbjct: 106 GVI--TENPVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKRFVH 162
Query: 170 GDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSP 229
            DI   N+L++    VK+ DFG+SR +E++              G+  I       +M+P
Sbjct: 163 RDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK-------GKLPI------KWMAP 209
Query: 230 ERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICAICFGERLEM 288
           E ++  R    +  A DVW  GV + E L+ G  P  G         +I  I  GERL M
Sbjct: 210 ESINFRR----FTSASDVWMFGVCMWEILMHGVKPFQGVKNN----DVIGRIENGERLPM 261
Query: 289 PETASPEFRRFVRSCLEKDWRKRGTVEELLA 319
           P    P     +  C   D  +R    EL A
Sbjct: 262 PPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 292

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 77/271 (28%), Positives = 117/271 (43%), Gaps = 30/271 (11%)
Query: 55  LGHGNGGIVYK---VRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCH 111
           +G G  G V++   +  +      A+K     +S  +R +   EA  +++ D   IVK  
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 112 AVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGV--AYRVLKGLQYLHGMQIIH 169
            V    E  +  +ME    G L   L+VRK  S D+ S +  AY++   L YL   + +H
Sbjct: 78  GVI--TENPVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKRFVH 134
Query: 170 GDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSP 229
            DI   N+L++    VK+ DFG+SR +E++              G+  I       +M+P
Sbjct: 135 RDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK-------GKLPI------KWMAP 181
Query: 230 ERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICAICFGERLEM 288
           E ++  R    +  A DVW  GV + E L+ G  P  G         +I  I  GERL M
Sbjct: 182 ESINFRR----FTSASDVWMFGVCMWEILMHGVKPFQGVKNN----DVIGRIENGERLPM 233
Query: 289 PETASPEFRRFVRSCLEKDWRKRGTVEELLA 319
           P    P     +  C   D  +R    EL A
Sbjct: 234 PPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 264

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 84.7 bits (208), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 77/284 (27%), Positives = 125/284 (44%), Gaps = 45/284 (15%)
Query: 54  VLGHGNGGIVYKVRHQKSNSIYALKVLN--TTSSTIIRHQAAHEAEILKRLDSQFIVKCH 111
           VLG G+ G V   + + +    A+KV++         +     E ++LK+LD   I+K +
Sbjct: 39  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 98
Query: 112 AVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGD 171
             F+  +G    V E    G LFD +  RK+ SE   + +  +VL G+ Y+H  +I+H D
Sbjct: 99  E-FFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRD 157
Query: 172 IKPSNLLINGKGE---VKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMS 228
           +KP NLL+  K +   ++I DFG+S   E ++                    +GT  Y++
Sbjct: 158 LKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK---------------IGTAYYIA 202
Query: 229 PERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEM 288
           PE +      G Y    DVWS GV++   L G  P  G  E  D++  +    +    E+
Sbjct: 203 PEVLH-----GTYDEKCDVWSTGVILYILLSGCPPFNGANEY-DILKKVEKGKY--TFEL 254
Query: 289 PE----------------TASPEFRRFVRSCLEKDWRKRGTVEE 316
           P+                T  P  R   R  L+ +W +  T E+
Sbjct: 255 PQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQ 298

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 84.7 bits (208), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 96/222 (43%), Gaps = 20/222 (9%)
Query: 46  ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAA-HEAEILKRLDS 104
           I + +    +G GN   V   RH  +    A+K+++ T       Q    E  I+K L+ 
Sbjct: 14  IGNYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNH 73
Query: 105 QFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG 164
             IVK   V  T E  +  VME+   G +FD L    ++ E        +++  +QY H 
Sbjct: 74  PNIVKLFEVIET-EKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQ 132
Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTC 224
             I+H D+K  NLL++G   +KIADFG S                   +G       G+ 
Sbjct: 133 KYIVHRDLKAENLLLDGDMNIKIADFGFSN---------------EFTVGNKLDTFCGSP 177
Query: 225 AYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIG 266
            Y +PE    +++ G      DVWSLGV++   + G  P  G
Sbjct: 178 PYAAPELFQGKKYDGP---EVDVWSLGVILYTLVSGSLPFDG 216

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 84.7 bits (208), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 77/305 (25%), Positives = 130/305 (42%), Gaps = 46/305 (15%)
Query: 45  NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTI-IRHQAAHEAEILKRLD 103
           ++ + +K+  +G G  G+VYK R++ +  + ALK +   + T  +   A  E  +LK L+
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 104 SQFIVKCHAVFYTIEGEICFVME--HMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQY 161
              IVK   V +T E ++  V E  H +     D+      +   +I    +++L+GL +
Sbjct: 61  HPNIVKLLDVIHT-ENKLYLVFEFLHQDLKKFMDA-SALTGIPLPLIKSYLFQLLQGLAF 118
Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACM 221
            H  +++H D+KP NLLIN +G +K+ADFG++R                           
Sbjct: 119 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV------------- 165
Query: 222 GTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAIC 281
            T  Y +PE +   ++   Y  A D+WSLG +  E +       G  E   L  +   + 
Sbjct: 166 -TLWYRAPEILLGCKY---YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 221
Query: 282 FGERLEMPETAS-----PEFRRFVRSCLEK-------------------DWRKRGTVEEL 317
             + +  P   S     P F ++ R    K                   D  KR + +  
Sbjct: 222 TPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 281
Query: 318 LAYPF 322
           LA+PF
Sbjct: 282 LAHPF 286

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 84.7 bits (208), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 76/287 (26%), Positives = 122/287 (42%), Gaps = 33/287 (11%)
Query: 48  DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQA-AHEAEILKRLDSQF 106
           D + L  +G G+ G   K+R +    I   K L+  S T    Q    E  +L+ L    
Sbjct: 7   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 66
Query: 107 IVKCHA-VFYTIEGEICFVMEHMERGSLFDSL----RVRKKLSEDVISGVAYRVLKGLQY 161
           IV+ +  +       +  VME+ E G L   +    + R+ L E+ +  V  ++   L+ 
Sbjct: 67  IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 126
Query: 162 LH-----GMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEA 216
            H     G  ++H D+KP+N+ ++GK  VK+ DFG++RI+                    
Sbjct: 127 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF-------------- 172
Query: 217 AIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMAL 276
           A   +GT  YMSPE+++       Y    D+WSLG ++ E      P   F +K     L
Sbjct: 173 AKTFVGTPYYMSPEQMNR----MSYNEKSDIWSLGCLLYELCALMPPFTAFSQK----EL 224
Query: 277 ICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV 323
              I  G+   +P   S E    +   L      R +VEE+L  P +
Sbjct: 225 AGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 84.7 bits (208), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 78/286 (27%), Positives = 125/286 (43%), Gaps = 30/286 (10%)
Query: 36  SNPTSPDVE-NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTT---SSTIIRHQ 91
           ++ TS D + +I + + L  +G GN   V   RH  +    A+K+++ T   SS++   +
Sbjct: 2   NSATSADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSL--QK 59
Query: 92  AAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGV 151
              E  I K L+   IVK   V  T E  +  V E+   G +FD L    +  E      
Sbjct: 60  LFREVRIXKVLNHPNIVKLFEVIET-EKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAK 118
Query: 152 AYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXX 211
             +++  +QY H   I+H D+K  NLL++    +KIADFG S                  
Sbjct: 119 FRQIVSAVQYCHQKFIVHRDLKAENLLLDADXNIKIADFGFSN---------------EF 163
Query: 212 XIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP 271
             G    A  G   Y +PE    +++ G      DVWSLGV++   + G  P  G     
Sbjct: 164 TFGNKLDAFCGAPPYAAPELFQGKKYDGP---EVDVWSLGVILYTLVSGSLPFDG----Q 216
Query: 272 DLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEEL 317
           +L  L   +  G +  +P   S +    ++  L  +  KRGT+E++
Sbjct: 217 NLKELRERVLRG-KYRIPFYXSTDCENLLKKFLILNPSKRGTLEQI 261

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 84.7 bits (208), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 76/304 (25%), Positives = 128/304 (42%), Gaps = 46/304 (15%)
Query: 46  ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTI-IRHQAAHEAEILKRLDS 104
           + + +K+  +G G  G+VYK R++ +  + ALK +   + T  +   A  E  +LK L+ 
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 105 QFIVKCHAVFYTIEGEICFVME--HMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYL 162
             IVK   V +T E ++  V E  H +     D+      +   +I    +++L+GL + 
Sbjct: 62  PNIVKLLDVIHT-ENKLYLVFEFLHQDLKKFMDA-SALTGIPLPLIKSYLFQLLQGLSFC 119
Query: 163 HGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMG 222
           H  +++H D+KP NLLIN +G +K+ADFG++R                            
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-------------- 165
Query: 223 TCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICF 282
           T  Y +PE +   ++   Y  A D+WSLG +  E +       G  E   L  +   +  
Sbjct: 166 TLWYRAPEILLGCKY---YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT 222
Query: 283 GERLEMPETAS-----PEFRRFVRSCLEK-------------------DWRKRGTVEELL 318
            + +  P   S     P F ++ R    K                   D  KR + +  L
Sbjct: 223 PDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAAL 282
Query: 319 AYPF 322
           A+PF
Sbjct: 283 AHPF 286

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 84.7 bits (208), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 77/305 (25%), Positives = 130/305 (42%), Gaps = 46/305 (15%)
Query: 45  NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTI-IRHQAAHEAEILKRLD 103
           ++ + +K+  +G G  G+VYK R++ +  + ALK +   + T  +   A  E  +LK L+
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 104 SQFIVKCHAVFYTIEGEICFVME--HMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQY 161
              IVK   V +T E ++  V E  H +     D+      +   +I    +++L+GL +
Sbjct: 61  HPNIVKLLDVIHT-ENKLYLVFEFLHQDLKKFMDA-SALTGIPLPLIKSYLFQLLQGLAF 118
Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACM 221
            H  +++H D+KP NLLIN +G +K+ADFG++R                    E      
Sbjct: 119 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR---------AFGVPVRTYXHEVV---- 165
Query: 222 GTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAIC 281
            T  Y +PE +   ++   Y  A D+WSLG +  E +       G  E   L  +   + 
Sbjct: 166 -TLWYRAPEILLGCKY---YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 221
Query: 282 FGERLEMPETAS-----PEFRRFVRSCLEK-------------------DWRKRGTVEEL 317
             + +  P   S     P F ++ R    K                   D  KR + +  
Sbjct: 222 TPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 281
Query: 318 LAYPF 322
           LA+PF
Sbjct: 282 LAHPF 286

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 84.7 bits (208), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 77/305 (25%), Positives = 130/305 (42%), Gaps = 46/305 (15%)
Query: 45  NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTI-IRHQAAHEAEILKRLD 103
           ++ + +K+  +G G  G+VYK R++ +  + ALK +   + T  +   A  E  +LK L+
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 104 SQFIVKCHAVFYTIEGEICFVME--HMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQY 161
              IVK   V +T E ++  V E  H +     D+      +   +I    +++L+GL +
Sbjct: 64  HPNIVKLLDVIHT-ENKLYLVFEFLHQDLKKFMDA-SALTGIPLPLIKSYLFQLLQGLAF 121
Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACM 221
            H  +++H D+KP NLLIN +G +K+ADFG++R                           
Sbjct: 122 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV------------- 168
Query: 222 GTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAIC 281
            T  Y +PE +   ++   Y  A D+WSLG +  E +       G  E   L  +   + 
Sbjct: 169 -TLWYRAPEILLGCKY---YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 224
Query: 282 FGERLEMPETAS-----PEFRRFVRSCLEK-------------------DWRKRGTVEEL 317
             + +  P   S     P F ++ R    K                   D  KR + +  
Sbjct: 225 TPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 284
Query: 318 LAYPF 322
           LA+PF
Sbjct: 285 LAHPF 289

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 84.7 bits (208), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 77/305 (25%), Positives = 130/305 (42%), Gaps = 46/305 (15%)
Query: 45  NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTI-IRHQAAHEAEILKRLD 103
           ++ + +K+  +G G  G+VYK R++ +  + ALK +   + T  +   A  E  +LK L+
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 104 SQFIVKCHAVFYTIEGEICFVME--HMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQY 161
              IVK   V +T E ++  V E  H +     D+      +   +I    +++L+GL +
Sbjct: 63  HPNIVKLLDVIHT-ENKLYLVFEFLHQDLKKFMDA-SALTGIPLPLIKSYLFQLLQGLAF 120
Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACM 221
            H  +++H D+KP NLLIN +G +K+ADFG++R                           
Sbjct: 121 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV------------- 167
Query: 222 GTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAIC 281
            T  Y +PE +   ++   Y  A D+WSLG +  E +       G  E   L  +   + 
Sbjct: 168 -TLWYRAPEILLGCKY---YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 223
Query: 282 FGERLEMPETAS-----PEFRRFVRSCLEK-------------------DWRKRGTVEEL 317
             + +  P   S     P F ++ R    K                   D  KR + +  
Sbjct: 224 TPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 283
Query: 318 LAYPF 322
           LA+PF
Sbjct: 284 LAHPF 288

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 84.7 bits (208), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 77/305 (25%), Positives = 130/305 (42%), Gaps = 46/305 (15%)
Query: 45  NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTI-IRHQAAHEAEILKRLD 103
           ++ + +K+  +G G  G+VYK R++ +  + ALK +   + T  +   A  E  +LK L+
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 104 SQFIVKCHAVFYTIEGEICFVME--HMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQY 161
              IVK   V +T E ++  V E  H +     D+      +   +I    +++L+GL +
Sbjct: 61  HPNIVKLLDVIHT-ENKLYLVFEFLHQDLKKFMDA-SALTGIPLPLIKSYLFQLLQGLAF 118
Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACM 221
            H  +++H D+KP NLLIN +G +K+ADFG++R                    E      
Sbjct: 119 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR---------AFGVPVRTYXHEVV---- 165
Query: 222 GTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAIC 281
            T  Y +PE +   ++   Y  A D+WSLG +  E +       G  E   L  +   + 
Sbjct: 166 -TLWYRAPEILLGCKY---YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 221
Query: 282 FGERLEMPETAS-----PEFRRFVRSCLEK-------------------DWRKRGTVEEL 317
             + +  P   S     P F ++ R    K                   D  KR + +  
Sbjct: 222 TPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 281
Query: 318 LAYPF 322
           LA+PF
Sbjct: 282 LAHPF 286

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 84.7 bits (208), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 77/271 (28%), Positives = 117/271 (43%), Gaps = 30/271 (11%)
Query: 55  LGHGNGGIVYK---VRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCH 111
           +G G  G V++   +  +      A+K     +S  +R +   EA  +++ D   IVK  
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 79
Query: 112 AVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGV--AYRVLKGLQYLHGMQIIH 169
            V    E  +  +ME    G L   L+VRK  S D+ S +  AY++   L YL   + +H
Sbjct: 80  GVI--TENPVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKRFVH 136
Query: 170 GDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSP 229
            DI   N+L++    VK+ DFG+SR +E++              G+  I       +M+P
Sbjct: 137 RDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK-------GKLPI------KWMAP 183
Query: 230 ERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICAICFGERLEM 288
           E ++  R    +  A DVW  GV + E L+ G  P  G         +I  I  GERL M
Sbjct: 184 ESINFRR----FTSASDVWMFGVCMWEILMHGVKPFQGVKNN----DVIGRIENGERLPM 235
Query: 289 PETASPEFRRFVRSCLEKDWRKRGTVEELLA 319
           P    P     +  C   D  +R    EL A
Sbjct: 236 PPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 266

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 84.7 bits (208), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 108/247 (43%), Gaps = 27/247 (10%)
Query: 76  ALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFD 135
           A+K     +S  +R +   EA  +++ D   IVK   V    E  +  +ME    G L  
Sbjct: 47  AIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI--TENPVWIIMELCTLGELRS 104
Query: 136 SLRVRKKLSEDVISGV--AYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVS 193
            L+VRK  S D+ S +  AY++   L YL   + +H DI   N+L++    VK+ DFG+S
Sbjct: 105 FLQVRK-YSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS 163
Query: 194 RIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVV 253
           R +E++              G+  I       +M+PE ++  R    +  A DVW  GV 
Sbjct: 164 RYMEDSTYYKASK-------GKLPI------KWMAPESINFRR----FTSASDVWMFGVC 206
Query: 254 VLECLV-GHYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRG 312
           + E L+ G  P  G         +I  I  GERL MP    P     +  C   D  +R 
Sbjct: 207 MWEILMHGVKPFQGVKNN----DVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRP 262
Query: 313 TVEELLA 319
              EL A
Sbjct: 263 RFTELKA 269

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 77/305 (25%), Positives = 130/305 (42%), Gaps = 46/305 (15%)
Query: 45  NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTI-IRHQAAHEAEILKRLD 103
           ++ + +K+  +G G  G+VYK R++ +  + ALK +   + T  +   A  E  +LK L+
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 104 SQFIVKCHAVFYTIEGEICFVME--HMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQY 161
              IVK   V +T E ++  V E  H +     D+      +   +I    +++L+GL +
Sbjct: 64  HPNIVKLLDVIHT-ENKLYLVFEFLHQDLKKFMDA-SALTGIPLPLIKSYLFQLLQGLAF 121
Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACM 221
            H  +++H D+KP NLLIN +G +K+ADFG++R                           
Sbjct: 122 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV------------- 168
Query: 222 GTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAIC 281
            T  Y +PE +   ++   Y  A D+WSLG +  E +       G  E   L  +   + 
Sbjct: 169 -TLWYRAPEILLGCKY---YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 224
Query: 282 FGERLEMPETAS-----PEFRRFVRSCLEK-------------------DWRKRGTVEEL 317
             + +  P   S     P F ++ R    K                   D  KR + +  
Sbjct: 225 TPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 284
Query: 318 LAYPF 322
           LA+PF
Sbjct: 285 LAHPF 289

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 77/305 (25%), Positives = 130/305 (42%), Gaps = 46/305 (15%)
Query: 45  NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTI-IRHQAAHEAEILKRLD 103
           ++ + +K+  +G G  G+VYK R++ +  + ALK +   + T  +   A  E  +LK L+
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 104 SQFIVKCHAVFYTIEGEICFVME--HMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQY 161
              IVK   V +T E ++  V E  H +     D+      +   +I    +++L+GL +
Sbjct: 63  HPNIVKLLDVIHT-ENKLYLVFEFLHQDLKKFMDA-SALTGIPLPLIKSYLFQLLQGLAF 120
Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACM 221
            H  +++H D+KP NLLIN +G +K+ADFG++R                           
Sbjct: 121 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV------------- 167
Query: 222 GTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAIC 281
            T  Y +PE +   ++   Y  A D+WSLG +  E +       G  E   L  +   + 
Sbjct: 168 -TLWYRAPEILLGCKY---YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 223
Query: 282 FGERLEMPETAS-----PEFRRFVRSCLEK-------------------DWRKRGTVEEL 317
             + +  P   S     P F ++ R    K                   D  KR + +  
Sbjct: 224 TPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 283
Query: 318 LAYPF 322
           LA+PF
Sbjct: 284 LAHPF 288

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 77/305 (25%), Positives = 130/305 (42%), Gaps = 46/305 (15%)
Query: 45  NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTI-IRHQAAHEAEILKRLD 103
           ++ + +K+  +G G  G+VYK R++ +  + ALK +   + T  +   A  E  +LK L+
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 64
Query: 104 SQFIVKCHAVFYTIEGEICFVME--HMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQY 161
              IVK   V +T E ++  V E  H +     D+      +   +I    +++L+GL +
Sbjct: 65  HPNIVKLLDVIHT-ENKLYLVFEFLHQDLKKFMDA-SALTGIPLPLIKSYLFQLLQGLAF 122
Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACM 221
            H  +++H D+KP NLLIN +G +K+ADFG++R                           
Sbjct: 123 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV------------- 169
Query: 222 GTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAIC 281
            T  Y +PE +   ++   Y  A D+WSLG +  E +       G  E   L  +   + 
Sbjct: 170 -TLWYRAPEILLGCKY---YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 225
Query: 282 FGERLEMPETAS-----PEFRRFVRSCLEK-------------------DWRKRGTVEEL 317
             + +  P   S     P F ++ R    K                   D  KR + +  
Sbjct: 226 TPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 285
Query: 318 LAYPF 322
           LA+PF
Sbjct: 286 LAHPF 290

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 77/305 (25%), Positives = 130/305 (42%), Gaps = 46/305 (15%)
Query: 45  NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTI-IRHQAAHEAEILKRLD 103
           ++ + +K+  +G G  G+VYK R++ +  + ALK +   + T  +   A  E  +LK L+
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 104 SQFIVKCHAVFYTIEGEICFVME--HMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQY 161
              IVK   V +T E ++  V E  H +     D+      +   +I    +++L+GL +
Sbjct: 61  HPNIVKLLDVIHT-ENKLYLVFEFLHQDLKDFMDA-SALTGIPLPLIKSYLFQLLQGLAF 118
Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACM 221
            H  +++H D+KP NLLIN +G +K+ADFG++R                    E      
Sbjct: 119 CHSHRVLHRDLKPENLLINTEGAIKLADFGLAR---------AFGVPVRTYXHEVV---- 165
Query: 222 GTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAIC 281
            T  Y +PE +   ++   Y  A D+WSLG +  E +       G  E   L  +   + 
Sbjct: 166 -TLWYRAPEILLGCKY---YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 221
Query: 282 FGERLEMPETAS-----PEFRRFVRSCLEK-------------------DWRKRGTVEEL 317
             + +  P   S     P F ++ R    K                   D  KR + +  
Sbjct: 222 TPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 281
Query: 318 LAYPF 322
           LA+PF
Sbjct: 282 LAHPF 286

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 76/304 (25%), Positives = 128/304 (42%), Gaps = 46/304 (15%)
Query: 46  ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTI-IRHQAAHEAEILKRLDS 104
           + + +K+  +G G  G+VYK R++ +  + ALK +   + T  +   A  E  +LK L+ 
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 105 QFIVKCHAVFYTIEGEICFVME--HMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYL 162
             IVK   V +T E ++  V E  H +     D+      +   +I    +++L+GL + 
Sbjct: 62  PNIVKLLDVIHT-ENKLYLVFEFLHQDLKKFMDA-SALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 163 HGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMG 222
           H  +++H D+KP NLLIN +G +K+ADFG++R                            
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-------------- 165
Query: 223 TCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICF 282
           T  Y +PE +   ++   Y  A D+WSLG +  E +       G  E   L  +   +  
Sbjct: 166 TLWYRAPEILLGCKY---YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT 222
Query: 283 GERLEMPETAS-----PEFRRFVRSCLEK-------------------DWRKRGTVEELL 318
            + +  P   S     P F ++ R    K                   D  KR + +  L
Sbjct: 223 PDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAAL 282
Query: 319 AYPF 322
           A+PF
Sbjct: 283 AHPF 286

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 76/304 (25%), Positives = 128/304 (42%), Gaps = 46/304 (15%)
Query: 46  ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTI-IRHQAAHEAEILKRLDS 104
           + + +K+  +G G  G+VYK R++ +  + ALK +   + T  +   A  E  +LK L+ 
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 105 QFIVKCHAVFYTIEGEICFVME--HMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYL 162
             IVK   V +T E ++  V E  H +     D+      +   +I    +++L+GL + 
Sbjct: 61  PNIVKLLDVIHT-ENKLYLVFEFLHQDLKKFMDA-SALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 163 HGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMG 222
           H  +++H D+KP NLLIN +G +K+ADFG++R                            
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-------------- 164
Query: 223 TCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICF 282
           T  Y +PE +   ++   Y  A D+WSLG +  E +       G  E   L  +   +  
Sbjct: 165 TLWYRAPEILLGCKY---YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT 221
Query: 283 GERLEMPETAS-----PEFRRFVRSCLEK-------------------DWRKRGTVEELL 318
            + +  P   S     P F ++ R    K                   D  KR + +  L
Sbjct: 222 PDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAAL 281
Query: 319 AYPF 322
           A+PF
Sbjct: 282 AHPF 285

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 77/305 (25%), Positives = 130/305 (42%), Gaps = 46/305 (15%)
Query: 45  NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTI-IRHQAAHEAEILKRLD 103
           ++ + +K+  +G G  G+VYK R++ +  + ALK +   + T  +   A  E  +LK L+
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 104 SQFIVKCHAVFYTIEGEICFVME--HMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQY 161
              IVK   V +T E ++  V E  H +     D+      +   +I    +++L+GL +
Sbjct: 62  HPNIVKLLDVIHT-ENKLYLVFEFLHQDLKKFMDA-SALTGIPLPLIKSYLFQLLQGLAF 119
Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACM 221
            H  +++H D+KP NLLIN +G +K+ADFG++R                           
Sbjct: 120 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV------------- 166
Query: 222 GTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAIC 281
            T  Y +PE +   ++   Y  A D+WSLG +  E +       G  E   L  +   + 
Sbjct: 167 -TLWYRAPEILLGCKY---YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 222
Query: 282 FGERLEMPETAS-----PEFRRFVRSCLEK-------------------DWRKRGTVEEL 317
             + +  P   S     P F ++ R    K                   D  KR + +  
Sbjct: 223 TPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 282
Query: 318 LAYPF 322
           LA+PF
Sbjct: 283 LAHPF 287

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 77/305 (25%), Positives = 130/305 (42%), Gaps = 46/305 (15%)
Query: 45  NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTI-IRHQAAHEAEILKRLD 103
           ++ + +K+  +G G  G+VYK R++ +  + ALK +   + T  +   A  E  +LK L+
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 104 SQFIVKCHAVFYTIEGEICFVME--HMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQY 161
              IVK   V +T E ++  V E  H +     D+      +   +I    +++L+GL +
Sbjct: 63  HPNIVKLLDVIHT-ENKLYLVFEFLHQDLKKFMDA-SALTGIPLPLIKSYLFQLLQGLAF 120
Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACM 221
            H  +++H D+KP NLLIN +G +K+ADFG++R                           
Sbjct: 121 CHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV------------- 167
Query: 222 GTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAIC 281
            T  Y +PE +   ++   Y  A D+WSLG +  E +       G  E   L  +   + 
Sbjct: 168 -TLWYRAPEILLGCKY---YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 223
Query: 282 FGERLEMPETAS-----PEFRRFVRSCLEK-------------------DWRKRGTVEEL 317
             + +  P   S     P F ++ R    K                   D  KR + +  
Sbjct: 224 TPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 283
Query: 318 LAYPF 322
           LA+PF
Sbjct: 284 LAHPF 288

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 77/305 (25%), Positives = 130/305 (42%), Gaps = 46/305 (15%)
Query: 45  NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTI-IRHQAAHEAEILKRLD 103
           ++ + +K+  +G G  G+VYK R++ +  + ALK +   + T  +   A  E  +LK L+
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 104 SQFIVKCHAVFYTIEGEICFVME--HMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQY 161
              IVK   V +T E ++  V E  H +     D+      +   +I    +++L+GL +
Sbjct: 62  HPNIVKLLDVIHT-ENKLYLVFEFLHQDLKKFMDA-SALTGIPLPLIKSYLFQLLQGLAF 119
Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACM 221
            H  +++H D+KP NLLIN +G +K+ADFG++R                           
Sbjct: 120 CHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV------------- 166
Query: 222 GTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAIC 281
            T  Y +PE +   ++   Y  A D+WSLG +  E +       G  E   L  +   + 
Sbjct: 167 -TLWYRAPEILLGCKY---YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 222
Query: 282 FGERLEMPETAS-----PEFRRFVRSCLEK-------------------DWRKRGTVEEL 317
             + +  P   S     P F ++ R    K                   D  KR + +  
Sbjct: 223 TPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 282
Query: 318 LAYPF 322
           LA+PF
Sbjct: 283 LAHPF 287

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 77/271 (28%), Positives = 117/271 (43%), Gaps = 30/271 (11%)
Query: 55  LGHGNGGIVYK---VRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCH 111
           +G G  G V++   +  +      A+K     +S  +R +   EA  +++ D   IVK  
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 112 AVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGV--AYRVLKGLQYLHGMQIIH 169
            V    E  +  +ME    G L   L+VRK  S D+ S +  AY++   L YL   + +H
Sbjct: 75  GVI--TENPVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKRFVH 131
Query: 170 GDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSP 229
            DI   N+L++    VK+ DFG+SR +E++              G+  I       +M+P
Sbjct: 132 RDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK-------GKLPI------KWMAP 178
Query: 230 ERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICAICFGERLEM 288
           E ++  R    +  A DVW  GV + E L+ G  P  G         +I  I  GERL M
Sbjct: 179 ESINFRR----FTSASDVWMFGVCMWEILMHGVKPFQGVKNN----DVIGRIENGERLPM 230
Query: 289 PETASPEFRRFVRSCLEKDWRKRGTVEELLA 319
           P    P     +  C   D  +R    EL A
Sbjct: 231 PPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 261

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 76/304 (25%), Positives = 128/304 (42%), Gaps = 46/304 (15%)
Query: 46  ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTI-IRHQAAHEAEILKRLDS 104
           + + +K+  +G G  G+VYK R++ +  + ALK +   + T  +   A  E  +LK L+ 
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 105 QFIVKCHAVFYTIEGEICFVME--HMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYL 162
             IVK   V +T E ++  V E  H +     D+      +   +I    +++L+GL + 
Sbjct: 62  PNIVKLLDVIHT-ENKLYLVFEFLHQDLKKFMDA-SALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 163 HGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMG 222
           H  +++H D+KP NLLIN +G +K+ADFG++R                            
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-------------- 165
Query: 223 TCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICF 282
           T  Y +PE +   ++   Y  A D+WSLG +  E +       G  E   L  +   +  
Sbjct: 166 TLWYRAPEILLGCKY---YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT 222
Query: 283 GERLEMPETAS-----PEFRRFVRSCLEK-------------------DWRKRGTVEELL 318
            + +  P   S     P F ++ R    K                   D  KR + +  L
Sbjct: 223 PDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAAL 282
Query: 319 AYPF 322
           A+PF
Sbjct: 283 AHPF 286

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 77/271 (28%), Positives = 117/271 (43%), Gaps = 30/271 (11%)
Query: 55  LGHGNGGIVYK---VRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCH 111
           +G G  G V++   +  +      A+K     +S  +R +   EA  +++ D   IVK  
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 80
Query: 112 AVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGV--AYRVLKGLQYLHGMQIIH 169
            V    E  +  +ME    G L   L+VRK  S D+ S +  AY++   L YL   + +H
Sbjct: 81  GVI--TENPVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKRFVH 137
Query: 170 GDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSP 229
            DI   N+L++    VK+ DFG+SR +E++              G+  I       +M+P
Sbjct: 138 RDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK-------GKLPI------KWMAP 184
Query: 230 ERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICAICFGERLEM 288
           E ++  R    +  A DVW  GV + E L+ G  P  G         +I  I  GERL M
Sbjct: 185 ESINFRR----FTSASDVWMFGVCMWEILMHGVKPFQGVKNN----DVIGRIENGERLPM 236
Query: 289 PETASPEFRRFVRSCLEKDWRKRGTVEELLA 319
           P    P     +  C   D  +R    EL A
Sbjct: 237 PPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 267

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 77/311 (24%), Positives = 133/311 (42%), Gaps = 58/311 (18%)
Query: 45  NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTI-IRHQAAHEAEILKRLD 103
           ++ + +K+  +G G  G+VYK R++ +  + ALK +   + T  +   A  E  +LK L+
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 104 SQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVA--------YRV 155
              IVK   V +T E ++  V E       F S+ ++  +    ++G+         +++
Sbjct: 63  HPNIVKLLDVIHT-ENKLYLVFE-------FLSMDLKDFMDASALTGIPLPLIKSYLFQL 114
Query: 156 LKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGE 215
           L+GL + H  +++H D+KP NLLIN +G +K+ADFG++R                     
Sbjct: 115 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV------- 167
Query: 216 AAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMA 275
                  T  Y +PE +   ++   Y  A D+WSLG +  E +       G  E   L  
Sbjct: 168 -------TLWYRAPEILLGCKY---YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR 217
Query: 276 LICAICFGERLEMPETAS-----PEFRRFVRSCLEK-------------------DWRKR 311
           +   +   + +  P   S     P F ++ R    K                   D  KR
Sbjct: 218 IFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKR 277
Query: 312 GTVEELLAYPF 322
            + +  LA+PF
Sbjct: 278 ISAKAALAHPF 288

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 77/304 (25%), Positives = 129/304 (42%), Gaps = 46/304 (15%)
Query: 46  ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTI-IRHQAAHEAEILKRLDS 104
           + + +K+  +G G  G+VYK R++ +  + ALK +   + T  +   A  E  +LK L+ 
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 105 QFIVKCHAVFYTIEGEICFVME--HMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYL 162
             IVK   V +T E ++  V E  H +     D+      +   +I    +++L+GL + 
Sbjct: 61  PNIVKLLDVIHT-ENKLYLVFEFLHQDLKKFMDA-SALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 163 HGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMG 222
           H  +++H D+KP NLLIN +G +K+ADFG++R                    E       
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFGLAR---------AFGVPVRTYXHEVV----- 164
Query: 223 TCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICF 282
           T  Y +PE +   ++   Y  A D+WSLG +  E +       G  E   L  +   +  
Sbjct: 165 TLWYRAPEILLGCKY---YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT 221
Query: 283 GERLEMPETAS-----PEFRRFVRSCLEK-------------------DWRKRGTVEELL 318
            + +  P   S     P F ++ R    K                   D  KR + +  L
Sbjct: 222 PDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAAL 281
Query: 319 AYPF 322
           A+PF
Sbjct: 282 AHPF 285

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 77/305 (25%), Positives = 130/305 (42%), Gaps = 46/305 (15%)
Query: 45  NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTI-IRHQAAHEAEILKRLD 103
           ++ + +K+  +G G  G+VYK R++ +  + ALK +   + T  +   A  E  +LK L+
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 104 SQFIVKCHAVFYTIEGEICFVME--HMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQY 161
              IVK   V +T E ++  V E  H +     D+      +   +I    +++L+GL +
Sbjct: 61  HPNIVKLLDVIHT-ENKLYLVFEFLHQDLKKFMDA-SALTGIPLPLIKSYLFQLLQGLAF 118
Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACM 221
            H  +++H D+KP NLLIN +G +K+ADFG++R                           
Sbjct: 119 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV------------- 165
Query: 222 GTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAIC 281
            T  Y +PE +   ++   Y  A D+WSLG +  E +       G  E   L  +   + 
Sbjct: 166 -TLWYRAPEILLGCKY---YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 221
Query: 282 FGERLEMPETAS-----PEFRRFVRSCLEK-------------------DWRKRGTVEEL 317
             + +  P   S     P F ++ R    K                   D  KR + +  
Sbjct: 222 TPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 281
Query: 318 LAYPF 322
           LA+PF
Sbjct: 282 LAHPF 286

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 77/311 (24%), Positives = 133/311 (42%), Gaps = 58/311 (18%)
Query: 45  NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTI-IRHQAAHEAEILKRLD 103
           ++ + +K+  +G G  G+VYK R++ +  + ALK +   + T  +   A  E  +LK L+
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 104 SQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVA--------YRV 155
              IVK   V +T E ++  V E       F S+ ++  +    ++G+         +++
Sbjct: 64  HPNIVKLLDVIHT-ENKLYLVFE-------FLSMDLKDFMDASALTGIPLPLIKSYLFQL 115
Query: 156 LKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGE 215
           L+GL + H  +++H D+KP NLLIN +G +K+ADFG++R                     
Sbjct: 116 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV------- 168
Query: 216 AAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMA 275
                  T  Y +PE +   ++   Y  A D+WSLG +  E +       G  E   L  
Sbjct: 169 -------TLWYRAPEILLGCKY---YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR 218
Query: 276 LICAICFGERLEMPETAS-----PEFRRFVRSCLEK-------------------DWRKR 311
           +   +   + +  P   S     P F ++ R    K                   D  KR
Sbjct: 219 IFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKR 278
Query: 312 GTVEELLAYPF 322
            + +  LA+PF
Sbjct: 279 ISAKAALAHPF 289

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 84.3 bits (207), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 77/305 (25%), Positives = 130/305 (42%), Gaps = 46/305 (15%)
Query: 45  NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTI-IRHQAAHEAEILKRLD 103
           ++ + +K+  +G G  G+VYK R++ +  + ALK +   + T  +   A  E  +LK L+
Sbjct: 2   HMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 104 SQFIVKCHAVFYTIEGEICFVME--HMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQY 161
              IVK   V +T E ++  V E  H +     D+      +   +I    +++L+GL +
Sbjct: 62  HPNIVKLLDVIHT-ENKLYLVFEFLHQDLKKFMDA-SALTGIPLPLIKSYLFQLLQGLAF 119
Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACM 221
            H  +++H D+KP NLLIN +G +K+ADFG++R                           
Sbjct: 120 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV------------- 166
Query: 222 GTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAIC 281
            T  Y +PE +   ++   Y  A D+WSLG +  E +       G  E   L  +   + 
Sbjct: 167 -TLWYRAPEILLGCKY---YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 222
Query: 282 FGERLEMPETAS-----PEFRRFVRSCLEK-------------------DWRKRGTVEEL 317
             + +  P   S     P F ++ R    K                   D  KR + +  
Sbjct: 223 TPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 282
Query: 318 LAYPF 322
           LA+PF
Sbjct: 283 LAHPF 287

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 84.3 bits (207), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 76/274 (27%), Positives = 120/274 (43%), Gaps = 30/274 (10%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTII----RHQAAHEAEILKRLDSQFIVKC 110
           LG G     +++    +  ++A K++    S ++    R + + E  I + L  Q +V  
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIV--PKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 82
Query: 111 HAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHG 170
           H  F+     +  V+E   R SL +  + RK L+E        +++ G QYLH  ++IH 
Sbjct: 83  HG-FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHR 141
Query: 171 DIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPE 230
           D+K  NL +N   EVKI DFG++  VE                GE      GT  Y++PE
Sbjct: 142 DLKLGNLFLNEDLEVKIGDFGLATKVEYD--------------GERKKTLCGTPNYIAPE 187
Query: 231 RVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPE 290
            +  +     + F  DVWS+G ++   LVG  P     E   L      I   E   +P+
Sbjct: 188 VLSKK----GHSFEVDVWSIGCIMYTLLVGKPPF----ETSCLKETYLRIKKNE-YSIPK 238
Query: 291 TASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVT 324
             +P     ++  L+ D   R T+ ELL   F T
Sbjct: 239 HINPVAASLIQKMLQTDPTARPTINELLNDEFFT 272

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 84.3 bits (207), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 76/274 (27%), Positives = 120/274 (43%), Gaps = 30/274 (10%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTII----RHQAAHEAEILKRLDSQFIVKC 110
           LG G     +++    +  ++A K++    S ++    R + + E  I + L  Q +V  
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIV--PKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 86
Query: 111 HAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHG 170
           H  F+     +  V+E   R SL +  + RK L+E        +++ G QYLH  ++IH 
Sbjct: 87  HG-FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHR 145
Query: 171 DIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPE 230
           D+K  NL +N   EVKI DFG++  VE                GE      GT  Y++PE
Sbjct: 146 DLKLGNLFLNEDLEVKIGDFGLATKVEYD--------------GERKKTLCGTPNYIAPE 191
Query: 231 RVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPE 290
            +  +     + F  DVWS+G ++   LVG  P     E   L      I   E   +P+
Sbjct: 192 VLSKK----GHSFEVDVWSIGCIMYTLLVGKPPF----ETSCLKETYLRIKKNE-YSIPK 242
Query: 291 TASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVT 324
             +P     ++  L+ D   R T+ ELL   F T
Sbjct: 243 HINPVAASLIQKMLQTDPTARPTINELLNDEFFT 276

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 84.3 bits (207), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 77/304 (25%), Positives = 129/304 (42%), Gaps = 46/304 (15%)
Query: 46  ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTI-IRHQAAHEAEILKRLDS 104
           + + +K+  +G G  G+VYK R++ +  + ALK +   + T  +   A  E  +LK L+ 
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 105 QFIVKCHAVFYTIEGEICFVME--HMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYL 162
             IVK   V +T E ++  V E  H +     D+      +   +I    +++L+GL + 
Sbjct: 61  PNIVKLLDVIHT-ENKLYLVFEFLHQDLKKFMDA-SALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 163 HGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMG 222
           H  +++H D+KP NLLIN +G +K+ADFG++R                    E       
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFGLAR---------AFGVPVRTYXHEVV----- 164
Query: 223 TCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICF 282
           T  Y +PE +   ++   Y  A D+WSLG +  E +       G  E   L  +   +  
Sbjct: 165 TLWYRAPEILLGCKY---YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT 221
Query: 283 GERLEMPETAS-----PEFRRFVRSCLEK-------------------DWRKRGTVEELL 318
            + +  P   S     P F ++ R    K                   D  KR + +  L
Sbjct: 222 PDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAAL 281
Query: 319 AYPF 322
           A+PF
Sbjct: 282 AHPF 285

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 84.3 bits (207), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 76/302 (25%), Positives = 127/302 (42%), Gaps = 46/302 (15%)
Query: 48  DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTI-IRHQAAHEAEILKRLDSQF 106
           + +K+  +G G  G+VYK R++ +  + ALK +   + T  +   A  E  +LK L+   
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 107 IVKCHAVFYTIEGEICFVME--HMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG 164
           IVK   V +T E ++  V E  H +     D+      +   +I    +++L+GL + H 
Sbjct: 63  IVKLLDVIHT-ENKLYLVFEFLHQDLKKFMDA-SALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTC 224
            +++H D+KP NLLIN +G +K+ADFG++R                            T 
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--------------TL 166
Query: 225 AYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGE 284
            Y +PE +   ++   Y  A D+WSLG +  E +       G  E   L  +   +   +
Sbjct: 167 WYRAPEILLGCKY---YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD 223
Query: 285 RLEMPETAS-----PEFRRFVRSCLEK-------------------DWRKRGTVEELLAY 320
            +  P   S     P F ++ R    K                   D  KR + +  LA+
Sbjct: 224 EVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283
Query: 321 PF 322
           PF
Sbjct: 284 PF 285

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 76/274 (27%), Positives = 120/274 (43%), Gaps = 30/274 (10%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTII----RHQAAHEAEILKRLDSQFIVKC 110
           LG G     +++    +  ++A K++    S ++    R + + E  I + L  Q +V  
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIV--PKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 104
Query: 111 HAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHG 170
           H  F+     +  V+E   R SL +  + RK L+E        +++ G QYLH  ++IH 
Sbjct: 105 HG-FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHR 163
Query: 171 DIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPE 230
           D+K  NL +N   EVKI DFG++  VE                GE      GT  Y++PE
Sbjct: 164 DLKLGNLFLNEDLEVKIGDFGLATKVEYD--------------GERKKVLCGTPNYIAPE 209
Query: 231 RVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPE 290
            +  +     + F  DVWS+G ++   LVG  P     E   L      I   E   +P+
Sbjct: 210 VLSKK----GHSFEVDVWSIGCIMYTLLVGKPPF----ETSCLKETYLRIKKNE-YSIPK 260
Query: 291 TASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVT 324
             +P     ++  L+ D   R T+ ELL   F T
Sbjct: 261 HINPVAASLIQKMLQTDPTARPTINELLNDEFFT 294

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 71/274 (25%), Positives = 115/274 (41%), Gaps = 40/274 (14%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLN-------TTSSTIIRHQAAHEAEILKRLDSQFI 107
           +G GN G+   +R ++SN + A+K +             II H++     I+ R     +
Sbjct: 26  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIV-RFKEVIL 84
Query: 108 VKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQI 167
              H         +  VME+   G LF+ +    + SED       +++ G+ Y H MQ+
Sbjct: 85  TPTH---------LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 135
Query: 168 IHGDIKPSNLLINGK--GEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCA 225
            H D+K  N L++G     +KI DFG S+                  +     + +GT A
Sbjct: 136 CHRDLKLENTLLDGSPAPRLKICDFGYSK---------------SSVLHSQPKSTVGTPA 180
Query: 226 YMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGER 285
           Y++PE +  + + G      DVWS GV +   LVG YP     E  +    I  I    +
Sbjct: 181 YIAPEVLLKKEYDGK---VADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI-LNVQ 236
Query: 286 LEMPETA--SPEFRRFVRSCLEKDWRKRGTVEEL 317
             +P+    SPE R  +      D  KR ++ E+
Sbjct: 237 YAIPDYVHISPECRHLISRIFVADPAKRISIPEI 270

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 76/274 (27%), Positives = 120/274 (43%), Gaps = 30/274 (10%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTII----RHQAAHEAEILKRLDSQFIVKC 110
           LG G     +++    +  ++A K++    S ++    R + + E  I + L  Q +V  
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIV--PKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 82
Query: 111 HAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHG 170
           H  F+     +  V+E   R SL +  + RK L+E        +++ G QYLH  ++IH 
Sbjct: 83  HG-FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHR 141
Query: 171 DIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPE 230
           D+K  NL +N   EVKI DFG++  VE                GE      GT  Y++PE
Sbjct: 142 DLKLGNLFLNEDLEVKIGDFGLATKVEYD--------------GERKKTLCGTPNYIAPE 187
Query: 231 RVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPE 290
            +  +     + F  DVWS+G ++   LVG  P     E   L      I   E   +P+
Sbjct: 188 VLSKK----GHSFEVDVWSIGCIMYTLLVGKPPF----ETSCLKETYLRIKKNE-YSIPK 238
Query: 291 TASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVT 324
             +P     ++  L+ D   R T+ ELL   F T
Sbjct: 239 HINPVAASLIQKMLQTDPTARPTINELLNDEFFT 272

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 73/296 (24%), Positives = 131/296 (44%), Gaps = 43/296 (14%)
Query: 47  SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS---STIIRHQAAHEAEILKRLD 103
           SD +++ VLG G  G V K R+   +  YA+K +  T    STI+      E  +L  L+
Sbjct: 6   SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILS-----EVMLLASLN 60
Query: 104 SQFIVKCHAVFY------------TIEGEICFVMEHMERGSLFDSLRVRK-KLSEDVISG 150
            Q++V+ +A +               +  +   ME+ E  +L+D +         D    
Sbjct: 61  HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWR 120
Query: 151 VAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXX 210
           +  ++L+ L Y+H   IIH D+KP N+ I+    VKI DFG+++ V  +           
Sbjct: 121 LFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180
Query: 211 XXIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEK 270
               +   + +GT  Y++ E +D     G Y    D++SLG++  E +   YP     E+
Sbjct: 181 PGSSDNLTSAIGTAMYVATEVLDG---TGHYNEKIDMYSLGIIFFEMI---YPFSTGMER 234
Query: 271 PDLMALICAICFGERLEMPETASPEF--------RRFVRSCLEKDWRKRGTVEELL 318
            +++  + ++     +E P    P+F        ++ +R  ++ D  KR     LL
Sbjct: 235 VNILKKLRSVS----IEFP----PDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLL 282

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 76/274 (27%), Positives = 120/274 (43%), Gaps = 30/274 (10%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTII----RHQAAHEAEILKRLDSQFIVKC 110
           LG G     +++    +  ++A K++    S ++    R + + E  I + L  Q +V  
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIV--PKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 106
Query: 111 HAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHG 170
           H  F+     +  V+E   R SL +  + RK L+E        +++ G QYLH  ++IH 
Sbjct: 107 HG-FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHR 165
Query: 171 DIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPE 230
           D+K  NL +N   EVKI DFG++  VE                GE      GT  Y++PE
Sbjct: 166 DLKLGNLFLNEDLEVKIGDFGLATKVEYD--------------GERKKVLCGTPNYIAPE 211
Query: 231 RVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPE 290
            +  +     + F  DVWS+G ++   LVG  P     E   L      I   E   +P+
Sbjct: 212 VLSKK----GHSFEVDVWSIGCIMYTLLVGKPPF----ETSCLKETYLRIKKNE-YSIPK 262
Query: 291 TASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVT 324
             +P     ++  L+ D   R T+ ELL   F T
Sbjct: 263 HINPVAASLIQKMLQTDPTARPTINELLNDEFFT 296

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 74/301 (24%), Positives = 128/301 (42%), Gaps = 47/301 (15%)
Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALK-VLNTTSSTIIRHQAAHEAEILKRLDSQFIV 108
           +K+  +G G+ G+V+K R++ +  I A+K  L +    +I+  A  E  +LK+L    +V
Sbjct: 6   EKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLV 65
Query: 109 KCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQII 168
               VF   +  +  V E+ +   L +  R ++ + E ++  + ++ L+ + + H    I
Sbjct: 66  NLLEVFRR-KRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCI 124
Query: 169 HGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMS 228
           H D+KP N+LI     +K+ DFG +R++                        + T  Y S
Sbjct: 125 HRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDE--------------VATRWYRS 170
Query: 229 PERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALI----------- 277
           PE +  +     YG   DVW++G V  E L G  PL       D + LI           
Sbjct: 171 PELLVGD---TQYGPPVDVWAIGCVFAELLSG-VPLWPGKSDVDQLYLIRKTLGDLIPRH 226
Query: 278 ------CAICFGERLEMPETASPEFRRF----------VRSCLEKDWRKRGTVEELLAYP 321
                      G ++  PE   P   +F          ++ CL  D  +R T E+LL +P
Sbjct: 227 QQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHP 286
Query: 322 F 322
           +
Sbjct: 287 Y 287

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 71/274 (25%), Positives = 115/274 (41%), Gaps = 40/274 (14%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLN-------TTSSTIIRHQAAHEAEILKRLDSQFI 107
           +G GN G+   +R ++SN + A+K +             II H++     I+ R     +
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIAANVKREIINHRSLRHPNIV-RFKEVIL 85
Query: 108 VKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQI 167
              H         +  VME+   G LF+ +    + SED       +++ G+ Y H MQ+
Sbjct: 86  TPTH---------LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 136
Query: 168 IHGDIKPSNLLINGK--GEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCA 225
            H D+K  N L++G     +KI DFG S+                  +     + +GT A
Sbjct: 137 CHRDLKLENTLLDGSPAPRLKICDFGYSK---------------SSVLHSQPKSTVGTPA 181
Query: 226 YMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGER 285
           Y++PE +  + + G      DVWS GV +   LVG YP     E  +    I  I    +
Sbjct: 182 YIAPEVLLKKEYDGK---VADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI-LNVQ 237
Query: 286 LEMPETA--SPEFRRFVRSCLEKDWRKRGTVEEL 317
             +P+    SPE R  +      D  KR ++ E+
Sbjct: 238 YAIPDYVHISPECRHLISRIFVADPAKRISIPEI 271

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 76/274 (27%), Positives = 120/274 (43%), Gaps = 30/274 (10%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTII----RHQAAHEAEILKRLDSQFIVKC 110
           LG G     +++    +  ++A K++    S ++    R + + E  I + L  Q +V  
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIV--PKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 80
Query: 111 HAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHG 170
           H  F+     +  V+E   R SL +  + RK L+E        +++ G QYLH  ++IH 
Sbjct: 81  HG-FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHR 139
Query: 171 DIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPE 230
           D+K  NL +N   EVKI DFG++  VE                GE      GT  Y++PE
Sbjct: 140 DLKLGNLFLNEDLEVKIGDFGLATKVEYD--------------GERKKVLCGTPNYIAPE 185
Query: 231 RVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPE 290
            +  +     + F  DVWS+G ++   LVG  P     E   L      I   E   +P+
Sbjct: 186 VLSKK----GHSFEVDVWSIGCIMYTLLVGKPPF----ETSCLKETYLRIKKNE-YSIPK 236
Query: 291 TASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVT 324
             +P     ++  L+ D   R T+ ELL   F T
Sbjct: 237 HINPVAASLIQKMLQTDPTARPTINELLNDEFFT 270

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 76/304 (25%), Positives = 128/304 (42%), Gaps = 46/304 (15%)
Query: 46  ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYAL-KVLNTTSSTIIRHQAAHEAEILKRLDS 104
           + + +K+  +G G  G+VYK R++ +  + AL K+   T +  +   A  E  +LK L+ 
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 105 QFIVKCHAVFYTIEGEICFVME--HMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYL 162
             IVK   V +T E ++  V E  H +     D+      +   +I    +++L+GL + 
Sbjct: 62  PNIVKLLDVIHT-ENKLYLVFEFLHQDLKKFMDA-SALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 163 HGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMG 222
           H  +++H D+KP NLLIN +G +K+ADFG++R                            
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-------------- 165
Query: 223 TCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICF 282
           T  Y +PE +   ++   Y  A D+WSLG +  E +       G  E   L  +   +  
Sbjct: 166 TLWYRAPEILLGCKY---YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT 222
Query: 283 GERLEMPETAS-----PEFRRFVRSCLEK-------------------DWRKRGTVEELL 318
            + +  P   S     P F ++ R    K                   D  KR + +  L
Sbjct: 223 PDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAAL 282
Query: 319 AYPF 322
           A+PF
Sbjct: 283 AHPF 286

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 76/304 (25%), Positives = 128/304 (42%), Gaps = 46/304 (15%)
Query: 46  ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYAL-KVLNTTSSTIIRHQAAHEAEILKRLDS 104
           + + +K+  +G G  G+VYK R++ +  + AL K+   T +  +   A  E  +LK L+ 
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 105 QFIVKCHAVFYTIEGEICFVME--HMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYL 162
             IVK   V +T E ++  V E  H +     D+      +   +I    +++L+GL + 
Sbjct: 61  PNIVKLLDVIHT-ENKLYLVFEFLHQDLKKFMDA-SALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 163 HGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMG 222
           H  +++H D+KP NLLIN +G +K+ADFG++R                            
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-------------- 164
Query: 223 TCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICF 282
           T  Y +PE +   ++   Y  A D+WSLG +  E +       G  E   L  +   +  
Sbjct: 165 TLWYRAPEILLGCKY---YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT 221
Query: 283 GERLEMPETAS-----PEFRRFVRSCLEK-------------------DWRKRGTVEELL 318
            + +  P   S     P F ++ R    K                   D  KR + +  L
Sbjct: 222 PDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAAL 281
Query: 319 AYPF 322
           A+PF
Sbjct: 282 AHPF 285

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 72/288 (25%), Positives = 129/288 (44%), Gaps = 30/288 (10%)
Query: 42  DVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKR 101
           D++ I + K+   LG G    V     + +  ++A+K +   +         +E  +L++
Sbjct: 19  DIKKIFEFKE--TLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRK 76
Query: 102 LDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQY 161
           +  + IV    + Y     +  VM+ +  G LFD +  +   +E   S +  +VL  + Y
Sbjct: 77  IKHENIVALEDI-YESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLDAVYY 135
Query: 162 LHGMQIIHGDIKPSNLLINGKGE---VKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAI 218
           LH M I+H D+KP NLL   + E   + I+DFG+S++  +               G+   
Sbjct: 136 LHRMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGK---------------GDVMS 180
Query: 219 ACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALIC 278
              GT  Y++PE +  +     Y  A D WS+GV+    L G+ P   F ++ D      
Sbjct: 181 TACGTPGYVAPEVLAQK----PYSKAVDCWSIGVIAYILLCGYPP---FYDENDSKLFEQ 233
Query: 279 AICFGERLEMP--ETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVT 324
            +      + P  +  S   + F+R+ +EKD  KR T E+   +P++ 
Sbjct: 234 ILKAEYEFDSPYWDDISDSAKDFIRNLMEKDPNKRYTCEQAARHPWIA 281

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 80/326 (24%), Positives = 147/326 (45%), Gaps = 37/326 (11%)
Query: 4   VRERRHQQALTLSLPATAANHQFRRRRHHFPTSNPTSPDVENISDLKKLTVLGHGNGGIV 63
           V+ +R   AL + +PA  A        H   T+   +  V +   + K  +LG G  G V
Sbjct: 54  VKSKR-TSALAVDIPAPPAPFD-----HRIVTAKQGA--VNSFYTVSKTEILGGGRFGQV 105
Query: 64  YKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICF 123
           +K     +    A K++ T      + +  +E  ++ +LD   +++ +  F + + +I  
Sbjct: 106 HKCEETATGLKLAAKIIKTRGMKD-KEEVKNEISVMNQLDHANLIQLYDAFES-KNDIVL 163
Query: 124 VMEHMERGSLFDSL-RVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGK 182
           VME+++ G LFD +      L+E        ++ +G++++H M I+H D+KP N+L   +
Sbjct: 164 VMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNR 223
Query: 183 G--EVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERVDSERWGGD 240
              ++KI DFG++R  +                 E      GT  +++PE V+ +     
Sbjct: 224 DAKQIKIIDFGLARRYKPR---------------EKLKVNFGTPEFLAPEVVNYDF---- 264
Query: 241 YGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFV 300
             F  D+WS+GV+    L G  P +G  +   L  ++      E  E  +  S E + F+
Sbjct: 265 VSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDI-SEEAKEFI 323
Query: 301 RSCL--EKDWRKRGTVEELLAYPFVT 324
              L  EK WR   +  E L +P+++
Sbjct: 324 SKLLIKEKSWRISAS--EALKHPWLS 347

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 73/294 (24%), Positives = 134/294 (45%), Gaps = 34/294 (11%)
Query: 32  HFPTSNPTSPDVENISDLKKLTV-----LGHGNGGIVYKVRHQKSNSIYALKVLNTTSST 86
           H  T  P  P  E+  ++ + T+     LG G  G V+ + +   ++  A+K L   S +
Sbjct: 3   HMQTQKPQKPWWEDEWEVPRETLKLVERLGAGQFGEVW-MGYYNGHTKVAVKSLKQGSMS 61
Query: 87  IIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRK--KLS 144
                A  EA ++K+L  Q +V+ +AV    +  I  + E+ME GSL D L+     KL+
Sbjct: 62  PDAFLA--EANLMKQLQHQRLVRLYAV--VTQEPIYIITEYMENGSLVDFLKTPSGIKLT 117
Query: 145 EDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXX 204
            + +  +A ++ +G+ ++     IH D++ +N+L++     KIADFG++R++E+      
Sbjct: 118 INKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT-- 175
Query: 205 XXXXXXXXIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYP 263
                      A         + +PE ++     G +    DVWS G+++ E +  G  P
Sbjct: 176 -----------AREGAKFPIKWTAPEAINY----GTFTIKSDVWSFGILLTEIVTHGRIP 220
Query: 264 LIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEEL 317
             G         +I  +  G R+  P+    E  + +R C ++    R T + L
Sbjct: 221 YPGMTNP----EVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYL 270

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 102/216 (47%), Gaps = 31/216 (14%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEI--LKRLDSQ-FIVKCH 111
           LG G+  I  K  H+KSN  +A+K+++       R +A  + EI  LK  +    IVK H
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKIISK------RMEANTQKEITALKLCEGHPNIVKLH 72
Query: 112 AVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGD 171
            VF+  +     VME +  G LF+ ++ +K  SE   S +  +++  + ++H + ++H D
Sbjct: 73  EVFHD-QLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRD 131
Query: 172 IKPSNLLI---NGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMS 228
           +KP NLL    N   E+KI DFG +R+                        C  T  Y +
Sbjct: 132 LKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ-------------PLKTPCF-TLHYAA 177
Query: 229 PERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPL 264
           PE ++       Y  + D+WSLGV++   L G  P 
Sbjct: 178 PELLNQ----NGYDESCDLWSLGVILYTMLSGQVPF 209

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/233 (27%), Positives = 106/233 (45%), Gaps = 26/233 (11%)
Query: 42  DVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH----EAE 97
           D   ++D   L VLG G+ G V     + +  +YA+K+L      +I+         E  
Sbjct: 14  DRVKLTDFNFLMVLGKGSFGKVMLADRKGTEELYAIKILK--KDVVIQDDDVECTMVEKR 71
Query: 98  ILKRLDSQ-FIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVL 156
           +L  LD   F+ + H+ F T++  + FVME++  G L   ++   K  E      A  + 
Sbjct: 72  VLALLDKPPFLTQLHSCFQTVD-RLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEIS 130
Query: 157 KGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEA 216
            GL +LH   II+ D+K  N++++ +G +KIADFG+ +                   G  
Sbjct: 131 IGLFFLHKRGIIYRDLKLDNVMLDSEGHIKIADFGMCK--------------EHMMDGVT 176
Query: 217 AIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGE 269
                GT  Y++PE +  +     YG + D W+ GV++ E L G  P  G  E
Sbjct: 177 TREFCGTPDYIAPEIIAYQP----YGKSVDWWAYGVLLYEMLAGQPPFDGEDE 225

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 80/290 (27%), Positives = 129/290 (44%), Gaps = 55/290 (18%)
Query: 54  VLGHGNGGIVYKVRHQKSNSIYALKVLN-------TTSSTIIRHQAAHEAEILKRLDSQF 106
           VLG G+ G V   + + +    A+KV++       T   +++R     E ++LK+LD   
Sbjct: 33  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLR-----EVQLLKQLDHPN 87
Query: 107 IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQ 166
           I K +  F+  +G    V E    G LFD +  RK+ SE   + +  +VL G+ Y H  +
Sbjct: 88  IXKLYE-FFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYXHKNK 146
Query: 167 IIHGDIKPSNLLINGKGE---VKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGT 223
           I+H D+KP NLL+  K +   ++I DFG+S   E ++                    +GT
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDK---------------IGT 191
Query: 224 CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFG 283
             Y++PE +      G Y    DVWS GV++   L G  P  G  E  D++  +    + 
Sbjct: 192 AYYIAPEVL-----HGTYDEKCDVWSTGVILYILLSGCPPFNGANE-YDILKKVEKGKY- 244
Query: 284 ERLEMPE----------------TASPEFRRFVRSCLEKDWRKRGTVEEL 317
              E+P+                T  P  R   R  L+ +W +  T E++
Sbjct: 245 -TFELPQWKKVSESAKDLIRKXLTYVPSXRISARDALDHEWIQTYTKEQI 293

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 82/291 (28%), Positives = 127/291 (43%), Gaps = 44/291 (15%)
Query: 42  DVENISDLKKLTVLGHGNGGIV----YKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAE 97
           D  NIS  K   V+G G  G V     K+  +K  S+ A+K L    +   R     EA 
Sbjct: 43  DATNISIDK---VVGAGEFGEVCSGRLKLPSKKEISV-AIKTLKVGYTEKQRRDFLGEAS 98
Query: 98  ILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVIS--GVAYRV 155
           I+ + D   I++   V  T    +  V E+ME GSL DS   +      VI   G+   +
Sbjct: 99  IMGQFDHPNIIRLEGVV-TKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGI 156
Query: 156 LKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGE 215
             G++YL  M  +H D+   N+LIN     K++DFG+SR++E+                E
Sbjct: 157 ASGMKYLSDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDD--------------PE 202
Query: 216 AAIACMG---TCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP- 271
           AA    G      + SPE +   +    +  A DVWS G+V+ E       ++ +GE+P 
Sbjct: 203 AAYTTRGGKIPIRWTSPEAIAYRK----FTSASDVWSYGIVLWE-------VMSYGERPY 251
Query: 272 ---DLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA 319
                  +I A+  G RL  P        + +  C +KD   R   E++++
Sbjct: 252 WEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 49/148 (33%), Positives = 83/148 (56%), Gaps = 6/148 (4%)
Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALK-VLNTTSSTIIRHQAAHEAEILKRLDSQFIV 108
           +KL  +G G  G V+K ++++++ I ALK V        +   A  E  +LK L  + IV
Sbjct: 5   EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIV 64
Query: 109 KCHAVFYTIEGEICFVMEHMERG--SLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQ 166
           + H V ++ + ++  V E  ++     FDS      L  +++    +++LKGL + H   
Sbjct: 65  RLHDVLHS-DKKLTLVFEFCDQDLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCHSRN 121
Query: 167 IIHGDIKPSNLLINGKGEVKIADFGVSR 194
           ++H D+KP NLLIN  GE+K+ADFG++R
Sbjct: 122 VLHRDLKPQNLLINRNGELKLADFGLAR 149

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 124/281 (44%), Gaps = 35/281 (12%)
Query: 48  DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIR-HQAAHEAEILKRLDSQF 106
           DL     +G G+ G V++     S+   A+K+L        R ++   E  I+KRL    
Sbjct: 38  DLNIKEKIGAGSFGTVHRAEWHGSD--VAVKILMEQDFHAERVNEFLREVAIMKRLRHPN 95
Query: 107 IVKCHAVFYTIEGEICFVMEHMERGSLFDSLR---VRKKLSEDVISGVAYRVLKGLQYLH 163
           IV       T    +  V E++ RGSL+  L     R++L E     +AY V KG+ YLH
Sbjct: 96  IVLFMGAV-TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH 154
Query: 164 GMQ--IIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACM 221
                I+H ++K  NLL++ K  VK+ DFG+SR+   T                ++ +  
Sbjct: 155 NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFL--------------SSKSAA 200
Query: 222 GTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAIC 281
           GT  +M+PE +  E          DV+S GV++ E      P            ++ A+ 
Sbjct: 201 GTPEWMAPEVLRDE----PSNEKSDVYSFGVILWELATLQQPWGNLNPA----QVVAAVG 252
Query: 282 FG-ERLEMPETASPEFRRFVRSCLEKDWRKR---GTVEELL 318
           F  +RLE+P   +P+    +  C   +  KR    T+ +LL
Sbjct: 253 FKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLL 293

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 82/291 (28%), Positives = 127/291 (43%), Gaps = 44/291 (15%)
Query: 42  DVENISDLKKLTVLGHGNGGIV----YKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAE 97
           D  NIS  K   V+G G  G V     K+  +K  S+ A+K L    +   R     EA 
Sbjct: 41  DATNISIDK---VVGAGEFGEVCSGRLKLPSKKEISV-AIKTLKVGYTEKQRRDFLGEAS 96
Query: 98  ILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVIS--GVAYRV 155
           I+ + D   I++   V  T    +  V E+ME GSL DS   +      VI   G+   +
Sbjct: 97  IMGQFDHPNIIRLEGVV-TKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGI 154
Query: 156 LKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGE 215
             G++YL  M  +H D+   N+LIN     K++DFG+SR++E+                E
Sbjct: 155 ASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD--------------PE 200
Query: 216 AAIACMG---TCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP- 271
           AA    G      + SPE +   +    +  A DVWS G+V+ E       ++ +GE+P 
Sbjct: 201 AAYTTRGGKIPIRWTSPEAIAYRK----FTSASDVWSYGIVLWE-------VMSYGERPY 249
Query: 272 ---DLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA 319
                  +I A+  G RL  P        + +  C +KD   R   E++++
Sbjct: 250 WEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 300

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 71/271 (26%), Positives = 121/271 (44%), Gaps = 26/271 (9%)
Query: 47  SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQF 106
           S  K+L  LG+G    VYK  ++ +    ALK +   S       A  E  ++K L  + 
Sbjct: 5   SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHEN 64
Query: 107 IVKCHAVFYTIEGEICFVMEHMERG--SLFDSLRV---RKKLSEDVISGVAYRVLKGLQY 161
           IV+ + V +T E ++  V E M+       DS  V    + L  +++    +++L+GL +
Sbjct: 65  IVRLYDVIHT-ENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAF 123
Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACM 221
            H  +I+H D+KP NLLIN +G++K+ DFG++R                       +   
Sbjct: 124 CHENKILHRDLKPQNLLINKRGQLKLGDFGLARAF----------GIPVNTFSSEVV--- 170
Query: 222 GTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAI- 280
            T  Y +P+ +   R    Y  + D+WS G ++ E + G  PL       + + LI  I 
Sbjct: 171 -TLWYRAPDVLMGSR---TYSTSIDIWSCGCILAEMITGK-PLFPGTNDEEQLKLIFDIM 225
Query: 281 -CFGERLEMPETASPEFRRFVRSCLEKDWRK 310
               E L    T  P++   ++    +D R+
Sbjct: 226 GTPNESLWPSVTKLPKYNPNIQQRPPRDLRQ 256

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 82/291 (28%), Positives = 127/291 (43%), Gaps = 44/291 (15%)
Query: 42  DVENISDLKKLTVLGHGNGGIV----YKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAE 97
           D  NIS  K   V+G G  G V     K+  +K  S+ A+K L    +   R     EA 
Sbjct: 43  DATNISIDK---VVGAGEFGEVCSGRLKLPSKKEISV-AIKTLKVGYTEKQRRDFLGEAS 98
Query: 98  ILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVIS--GVAYRV 155
           I+ + D   I++   V  T    +  V E+ME GSL DS   +      VI   G+   +
Sbjct: 99  IMGQFDHPNIIRLEGVV-TKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGI 156
Query: 156 LKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGE 215
             G++YL  M  +H D+   N+LIN     K++DFG+SR++E+                E
Sbjct: 157 ASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD--------------PE 202
Query: 216 AAIACMG---TCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP- 271
           AA    G      + SPE +   +    +  A DVWS G+V+ E       ++ +GE+P 
Sbjct: 203 AAYTTRGGKIPIRWTSPEAIAYRK----FTSASDVWSYGIVLWE-------VMSYGERPY 251
Query: 272 ---DLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA 319
                  +I A+  G RL  P        + +  C +KD   R   E++++
Sbjct: 252 WEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 82/291 (28%), Positives = 127/291 (43%), Gaps = 44/291 (15%)
Query: 42  DVENISDLKKLTVLGHGNGGIV----YKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAE 97
           D  NIS  K   V+G G  G V     K+  +K  S+ A+K L    +   R     EA 
Sbjct: 43  DATNISIDK---VVGAGEFGEVCSGRLKLPSKKEISV-AIKTLKVGYTEKQRRDFLGEAS 98
Query: 98  ILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVIS--GVAYRV 155
           I+ + D   I++   V  T    +  V E+ME GSL DS   +      VI   G+   +
Sbjct: 99  IMGQFDHPNIIRLEGVV-TKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGI 156
Query: 156 LKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGE 215
             G++YL  M  +H D+   N+LIN     K++DFG+SR++E+                E
Sbjct: 157 ASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD--------------PE 202
Query: 216 AAIACMG---TCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP- 271
           AA    G      + SPE +   +    +  A DVWS G+V+ E       ++ +GE+P 
Sbjct: 203 AAYTTRGGKIPIRWTSPEAIAYRK----FTSASDVWSYGIVLWE-------VMSYGERPY 251
Query: 272 ---DLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA 319
                  +I A+  G RL  P        + +  C +KD   R   E++++
Sbjct: 252 WEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 82/291 (28%), Positives = 127/291 (43%), Gaps = 44/291 (15%)
Query: 42  DVENISDLKKLTVLGHGNGGIV----YKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAE 97
           D  NIS  K   V+G G  G V     K+  +K  S+ A+K L    +   R     EA 
Sbjct: 43  DATNISIDK---VVGAGEFGEVCSGRLKLPSKKEISV-AIKTLKVGYTEKQRRDFLGEAS 98
Query: 98  ILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVIS--GVAYRV 155
           I+ + D   I++   V  T    +  V E+ME GSL DS   +      VI   G+   +
Sbjct: 99  IMGQFDHPNIIRLEGVV-TKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGI 156
Query: 156 LKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGE 215
             G++YL  M  +H D+   N+LIN     K++DFG+SR++E+                E
Sbjct: 157 ASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD--------------PE 202
Query: 216 AAIACMG---TCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP- 271
           AA    G      + SPE +   +    +  A DVWS G+V+ E       ++ +GE+P 
Sbjct: 203 AAYTTRGGKIPIRWTSPEAIAYRK----FTSASDVWSYGIVLWE-------VMSYGERPY 251
Query: 272 ---DLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA 319
                  +I A+  G RL  P        + +  C +KD   R   E++++
Sbjct: 252 WEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 82/291 (28%), Positives = 127/291 (43%), Gaps = 44/291 (15%)
Query: 42  DVENISDLKKLTVLGHGNGGIV----YKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAE 97
           D  NIS  K   V+G G  G V     K+  +K  S+ A+K L    +   R     EA 
Sbjct: 43  DATNISIDK---VVGAGEFGEVCSGRLKLPSKKEISV-AIKTLKVGYTEKQRRDFLGEAS 98
Query: 98  ILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVIS--GVAYRV 155
           I+ + D   I++   V  T    +  V E+ME GSL DS   +      VI   G+   +
Sbjct: 99  IMGQFDHPNIIRLEGVV-TKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGI 156
Query: 156 LKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGE 215
             G++YL  M  +H D+   N+LIN     K++DFG+SR++E+                E
Sbjct: 157 ASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD--------------PE 202
Query: 216 AAIACMG---TCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP- 271
           AA    G      + SPE +   +    +  A DVWS G+V+ E       ++ +GE+P 
Sbjct: 203 AAYTTRGGKIPIRWTSPEAIAYRK----FTSASDVWSYGIVLWE-------VMSYGERPY 251
Query: 272 ---DLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA 319
                  +I A+  G RL  P        + +  C +KD   R   E++++
Sbjct: 252 WEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 73/291 (25%), Positives = 135/291 (46%), Gaps = 34/291 (11%)
Query: 35  TSNPTSPDVENISDLKKLTV-----LGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIR 89
           T  P  P  E+  ++ + T+     LG G  G V+ + +   ++  A+K L   S +   
Sbjct: 2   TQKPQKPWWEDEWEVPRETLKLVERLGAGQFGEVW-MGYYNGHTKVAVKSLKQGSMSPDA 60
Query: 90  HQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRK--KLSEDV 147
             A  EA ++K+L  Q +V+ +AV    +  I  + E+ME GSL D L+     KL+ + 
Sbjct: 61  FLA--EANLMKQLQHQRLVRLYAV--VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINK 116
Query: 148 ISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXX 207
           +  +A ++ +G+ ++     IH D++ +N+L++     KIADFG++R++E+         
Sbjct: 117 LLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT----- 171
Query: 208 XXXXXIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIG 266
                   A         + +PE ++     G +    DVWS G+++ E +  G  P  G
Sbjct: 172 --------AREGAKFPIKWTAPEAINY----GTFTIKSDVWSFGILLTEIVTHGRIPYPG 219
Query: 267 FGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEEL 317
               P+   +I  +  G R+  P+    E  + +R C ++    R T + L
Sbjct: 220 MT-NPE---VIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYL 266

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 73/291 (25%), Positives = 134/291 (46%), Gaps = 34/291 (11%)
Query: 35  TSNPTSPDVENISDLKKLTV-----LGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIR 89
           T  P  P  E+  ++ + T+     LG G  G V+ + +   ++  A+K L   S +   
Sbjct: 2   TQKPQKPWWEDEWEVPRETLKLVERLGAGQFGEVW-MGYYNGHTKVAVKSLKQGSMSPDA 60
Query: 90  HQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRK--KLSEDV 147
             A  EA ++K+L  Q +V+ +AV    +  I  + E+ME GSL D L+     KL+ + 
Sbjct: 61  FLA--EANLMKQLQHQRLVRLYAV--VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINK 116
Query: 148 ISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXX 207
           +  +A ++ +G+ ++     IH D++ +N+L++     KIADFG++R++E+         
Sbjct: 117 LLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXT----- 171
Query: 208 XXXXXIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIG 266
                   A         + +PE ++     G +    DVWS G+++ E +  G  P  G
Sbjct: 172 --------AREGAKFPIKWTAPEAINY----GTFTIKSDVWSFGILLTEIVTHGRIPYPG 219
Query: 267 FGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEEL 317
                    +I  +  G R+  P+    E  + +R C ++    R T + L
Sbjct: 220 MTNP----EVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYL 266

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 71/272 (26%), Positives = 129/272 (47%), Gaps = 29/272 (10%)
Query: 49  LKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIV 108
           LK +  LG G  G V+ + +   ++  A+K L   S +     A  EA ++K+L  Q +V
Sbjct: 15  LKLVERLGAGQAGEVW-MGYYNGHTKVAVKSLKQGSMSPDAFLA--EANLMKQLQHQRLV 71
Query: 109 KCHAVFYTIEGEICFVMEHMERGSLFDSLRVRK--KLSEDVISGVAYRVLKGLQYLHGMQ 166
           + +AV    +  I  + E+ME GSL D L+     KL+ + +  +A ++ +G+ ++    
Sbjct: 72  RLYAV--VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 129
Query: 167 IIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAY 226
            IH D++ +N+L++     KIADFG++R++E+                 A         +
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXT-------------AREGAKFPIKW 176
Query: 227 MSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICAICFGER 285
            +PE ++     G +    DVWS G+++ E +  G  P  G    P+   +I  +  G R
Sbjct: 177 TAPEAINY----GTFTIKSDVWSFGILLTEIVTHGRIPYPGMT-NPE---VIQNLERGYR 228
Query: 286 LEMPETASPEFRRFVRSCLEKDWRKRGTVEEL 317
           +  P+    E  + +R C ++    R T + L
Sbjct: 229 MVRPDNCPEELYQLMRLCWKERPEDRPTFDYL 260

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 73/291 (25%), Positives = 135/291 (46%), Gaps = 34/291 (11%)
Query: 35  TSNPTSPDVENISDLKKLTV-----LGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIR 89
           T  P  P  E+  ++ + T+     LG G  G V+ + +   ++  A+K L   S +   
Sbjct: 1   TQKPQKPWWEDEWEVPRETLKLVERLGAGQFGEVW-MGYYNGHTKVAVKSLKQGSMSPDA 59
Query: 90  HQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRK--KLSEDV 147
             A  EA ++K+L  Q +V+ +AV    +  I  + E+ME GSL D L+     KL+ + 
Sbjct: 60  FLA--EANLMKQLQHQRLVRLYAV--VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINK 115
Query: 148 ISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXX 207
           +  +A ++ +G+ ++     IH D++ +N+L++     KIADFG++R++E+         
Sbjct: 116 LLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT----- 170
Query: 208 XXXXXIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIG 266
                   A         + +PE ++     G +    DVWS G+++ E +  G  P  G
Sbjct: 171 --------AREGAKFPIKWTAPEAINY----GTFTIKSDVWSFGILLTEIVTHGRIPYPG 218
Query: 267 FGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEEL 317
               P+   +I  +  G R+  P+    E  + +R C ++    R T + L
Sbjct: 219 MT-NPE---VIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYL 265

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 68/288 (23%), Positives = 126/288 (43%), Gaps = 27/288 (9%)
Query: 47  SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS---STIIRHQAAHEAEILKRLD 103
           SD +++ VLG G  G V K R+   +  YA+K +  T    STI+      E  +L  L+
Sbjct: 6   SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILS-----EVXLLASLN 60
Query: 104 SQFIVKCHAVFY-----------TIEGEICFVM-EHMERGSLFDSLRVRK-KLSEDVISG 150
            Q++V+ +A +              +    F+  E+ E  +L+D +         D    
Sbjct: 61  HQYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWR 120
Query: 151 VAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXX 210
           +  ++L+ L Y+H   IIH ++KP N+ I+    VKI DFG+++ V  +           
Sbjct: 121 LFRQILEALSYIHSQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180
Query: 211 XXIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEK 270
               +   + +GT  Y++ E +D     G Y    D +SLG++  E +   YP     E+
Sbjct: 181 PGSSDNLTSAIGTAXYVATEVLDG---TGHYNEKIDXYSLGIIFFEXI---YPFSTGXER 234
Query: 271 PDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELL 318
            +++  + ++      +  +      ++ +R  ++ D  KR     LL
Sbjct: 235 VNILKKLRSVSIEFPPDFDDNKXKVEKKIIRLLIDHDPNKRPGARTLL 282

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 82/291 (28%), Positives = 127/291 (43%), Gaps = 44/291 (15%)
Query: 42  DVENISDLKKLTVLGHGNGGIV----YKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAE 97
           D  NIS  K   V+G G  G V     K+  +K  S+ A+K L    +   R     EA 
Sbjct: 31  DATNISIDK---VVGAGEFGEVCSGRLKLPSKKEISV-AIKTLKVGYTEKQRRDFLGEAS 86
Query: 98  ILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVIS--GVAYRV 155
           I+ + D   I++   V  T    +  V E+ME GSL DS   +      VI   G+   +
Sbjct: 87  IMGQFDHPNIIRLEGVV-TKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGI 144
Query: 156 LKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGE 215
             G++YL  M  +H D+   N+LIN     K++DFG+SR++E+                E
Sbjct: 145 ASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDP--------------E 190
Query: 216 AAIACMG---TCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP- 271
           AA    G      + SPE +   +    +  A DVWS G+V+ E       ++ +GE+P 
Sbjct: 191 AAYTTRGGKIPIRWTSPEAIAYRK----FTSASDVWSYGIVLWE-------VMSYGERPY 239
Query: 272 ---DLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA 319
                  +I A+  G RL  P        + +  C +KD   R   E++++
Sbjct: 240 WEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 290

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 65/268 (24%), Positives = 124/268 (46%), Gaps = 21/268 (7%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQA-AHEAEILKRLDSQFIVKCHAV 113
           +G G+ G VYK    K +   A+K+LN T+ T  + QA  +E  +L++  ++ +     +
Sbjct: 32  IGSGSFGTVYK---GKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRK--TRHVNILLFM 86
Query: 114 FYTIEGEICFVMEHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQYLHGMQIIHGDI 172
            Y+ + ++  V +  E  SL+  L   + K     +  +A +  +G+ YLH   IIH D+
Sbjct: 87  GYSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDL 146
Query: 173 KPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERV 232
           K +N+ ++    VKI DFG++   E++R                     G+  +M+PE +
Sbjct: 147 KSNNIFLHEDNTVKIGDFGLA--TEKSRWSGSHQFEQLS----------GSILWMAPEVI 194
Query: 233 DSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPETA 292
             +     Y F  DV++ G+V+ E + G  P      +  ++ ++        L    + 
Sbjct: 195 RMQD-SNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSN 253
Query: 293 SPE-FRRFVRSCLEKDWRKRGTVEELLA 319
            P+  +R +  CL+K   +R +   +LA
Sbjct: 254 CPKRMKRLMAECLKKKRDERPSFPRILA 281

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 73/291 (25%), Positives = 134/291 (46%), Gaps = 34/291 (11%)
Query: 35  TSNPTSPDVENISDLKKLTV-----LGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIR 89
           T  P  P  E+  ++ + T+     LG G  G V+ + +   ++  A+K L   S +   
Sbjct: 4   TQKPQKPWWEDEWEVPRETLKLVERLGAGQFGEVW-MGYYNGHTKVAVKSLKQGSMSPDA 62
Query: 90  HQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRK--KLSEDV 147
             A  EA ++K+L  Q +V+ +AV    +  I  + E+ME GSL D L+     KL+ + 
Sbjct: 63  FLA--EANLMKQLQHQRLVRLYAV--VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINK 118
Query: 148 ISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXX 207
           +  +A ++ +G+ ++     IH D++ +N+L++     KIADFG++R++E+         
Sbjct: 119 LLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXT----- 173
Query: 208 XXXXXIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIG 266
                   A         + +PE ++     G +    DVWS G+++ E +  G  P  G
Sbjct: 174 --------AREGAKFPIKWTAPEAINY----GTFTIKSDVWSFGILLTEIVTHGRIPYPG 221
Query: 267 FGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEEL 317
                    +I  +  G R+  P+    E  + +R C ++    R T + L
Sbjct: 222 MTNP----EVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYL 268

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 82/291 (28%), Positives = 127/291 (43%), Gaps = 44/291 (15%)
Query: 42  DVENISDLKKLTVLGHGNGGIV----YKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAE 97
           D  NIS  K   V+G G  G V     K+  +K  S+ A+K L    +   R     EA 
Sbjct: 14  DATNISIDK---VVGAGEFGEVCSGRLKLPSKKEISV-AIKTLKVGYTEKQRRDFLGEAS 69
Query: 98  ILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVIS--GVAYRV 155
           I+ + D   I++   V  T    +  V E+ME GSL DS   +      VI   G+   +
Sbjct: 70  IMGQFDHPNIIRLEGVV-TKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGI 127
Query: 156 LKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGE 215
             G++YL  M  +H D+   N+LIN     K++DFG+SR++E+                E
Sbjct: 128 ASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD--------------PE 173
Query: 216 AAIACMG---TCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP- 271
           AA    G      + SPE +   +    +  A DVWS G+V+ E       ++ +GE+P 
Sbjct: 174 AAYTTRGGKIPIRWTSPEAIAYRK----FTSASDVWSYGIVLWE-------VMSYGERPY 222
Query: 272 ---DLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA 319
                  +I A+  G RL  P        + +  C +KD   R   E++++
Sbjct: 223 WEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 273

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 70/274 (25%), Positives = 114/274 (41%), Gaps = 40/274 (14%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLN-------TTSSTIIRHQAAHEAEILKRLDSQFI 107
           +G GN G+   +R ++SN + A+K +             II H++     I+ R     +
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIV-RFKEVIL 85
Query: 108 VKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQI 167
              H         +  VME+   G LF+ +    + SED       +++ G+ Y H MQ+
Sbjct: 86  TPTH---------LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 136
Query: 168 IHGDIKPSNLLINGK--GEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCA 225
            H D+K  N L++G     +KI  FG S+                  +     + +GT A
Sbjct: 137 CHRDLKLENTLLDGSPAPRLKICAFGYSK---------------SSVLHSQPKSTVGTPA 181
Query: 226 YMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGER 285
           Y++PE +  + + G      DVWS GV +   LVG YP     E  +    I  I    +
Sbjct: 182 YIAPEVLLKKEYDGK---VADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI-LNVQ 237
Query: 286 LEMPETA--SPEFRRFVRSCLEKDWRKRGTVEEL 317
             +P+    SPE R  +      D  KR ++ E+
Sbjct: 238 YAIPDYVHISPECRHLISRIFVADPAKRISIPEI 271

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 68/270 (25%), Positives = 121/270 (44%), Gaps = 29/270 (10%)
Query: 49  LKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIV 108
           LK    LG G  G V+   + K   + A+K +   S ++    A  EA ++K L    +V
Sbjct: 17  LKLEKKLGAGQFGEVWMATYNKHTKV-AVKTMKPGSMSVEAFLA--EANVMKTLQHDKLV 73
Query: 109 KCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAY--RVLKGLQYLHGMQ 166
           K HAV    +  I  + E M +GSL D L+  +   + +   + +  ++ +G+ ++    
Sbjct: 74  KLHAV--VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN 131
Query: 167 IIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAY 226
            IH D++ +N+L++     KIADFG++R++E+                 A         +
Sbjct: 132 YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT-------------AREGAKFPIKW 178
Query: 227 MSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICAICFGER 285
            +PE ++     G +    DVWS G++++E +  G  P  G    P+   +I A+  G R
Sbjct: 179 TAPEAINF----GSFTIKSDVWSFGILLMEIVTYGRIPYPGMS-NPE---VIRALERGYR 230
Query: 286 LEMPETASPEFRRFVRSCLEKDWRKRGTVE 315
           +  PE    E    +  C +    +R T E
Sbjct: 231 MPRPENCPEELYNIMMRCWKNRPEERPTFE 260

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 80/292 (27%), Positives = 132/292 (45%), Gaps = 42/292 (14%)
Query: 49  LKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAA--HEAEILKRLDSQF 106
            ++  VLG G  G V   + + +  +YA K L        + +A   +E +IL++++S+F
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 245
Query: 107 IVKCHAVFYTIEGEICFVMEHMERGSL-FDSLRV-RKKLSEDVISGVAYRVLKGLQYLHG 164
           +V   A  Y  +  +C V+  M  G L F    + +    E      A  +  GL+ LH 
Sbjct: 246 VVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHR 304
Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTC 224
            +I++ D+KP N+L++  G ++I+D G++  V E               G+     +GT 
Sbjct: 305 ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE---------------GQTIKGRVGTV 349
Query: 225 AYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGE 284
            YM+PE V +ER    Y F+ D W+LG ++ E + G  P     +K     +       E
Sbjct: 350 GYMAPEVVKNER----YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV-------E 398
Query: 285 RL--EMPETA----SPEFRRFVRSCLEKDWRKR-----GTVEELLAYPFVTK 325
           RL  E+PE      SP+ R      L KD  +R     G+  E+  +P   K
Sbjct: 399 RLVKEVPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKK 450

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 73/289 (25%), Positives = 127/289 (43%), Gaps = 34/289 (11%)
Query: 35  TSNPTSP---DVENI--SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIR 89
           +S P  P   D   I    LK    LG G  G V+   + K   + A+K +   S ++  
Sbjct: 171 SSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKV-AVKTMKPGSMSVEA 229
Query: 90  HQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVIS 149
             A  EA ++K L    +VK HAV    +  I  + E M +GSL D L+  +   + +  
Sbjct: 230 FLA--EANVMKTLQHDKLVKLHAV--VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPK 285
Query: 150 GVAY--RVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXX 207
            + +  ++ +G+ ++     IH D++ +N+L++     KIADFG++R++E+         
Sbjct: 286 LIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT----- 340
Query: 208 XXXXXIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIG 266
                   A         + +PE ++     G +    DVWS G++++E +  G  P  G
Sbjct: 341 --------AREGAKFPIKWTAPEAINF----GSFTIKSDVWSFGILLMEIVTYGRIPYPG 388
Query: 267 FGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVE 315
               P+   +I A+  G R+  PE    E    +  C +    +R T E
Sbjct: 389 MS-NPE---VIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFE 433

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 81/291 (27%), Positives = 127/291 (43%), Gaps = 44/291 (15%)
Query: 42  DVENISDLKKLTVLGHGNGGIV----YKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAE 97
           D  NIS  K   V+G G  G V     K+  +K  S+ A+K L    +   R     EA 
Sbjct: 43  DATNISIDK---VVGAGEFGEVCSGRLKLPSKKEISV-AIKTLKVGYTEKQRRDFLGEAS 98
Query: 98  ILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVIS--GVAYRV 155
           I+ + D   I++   V  T    +  V E+ME GSL DS   +      VI   G+   +
Sbjct: 99  IMGQFDHPNIIRLEGVV-TKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGI 156
Query: 156 LKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGE 215
             G++YL  M  +H D+   N+LIN     K++DFG++R++E+                E
Sbjct: 157 ASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDD--------------PE 202
Query: 216 AAIACMG---TCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP- 271
           AA    G      + SPE +   +    +  A DVWS G+V+ E       ++ +GE+P 
Sbjct: 203 AAYTTRGGKIPIRWTSPEAIAYRK----FTSASDVWSYGIVLWE-------VMSYGERPY 251
Query: 272 ---DLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA 319
                  +I A+  G RL  P        + +  C +KD   R   E++++
Sbjct: 252 WEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 80/292 (27%), Positives = 132/292 (45%), Gaps = 42/292 (14%)
Query: 49  LKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAA--HEAEILKRLDSQF 106
            ++  VLG G  G V   + + +  +YA K L        + +A   +E +IL++++S+F
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 245
Query: 107 IVKCHAVFYTIEGEICFVMEHMERGSL-FDSLRV-RKKLSEDVISGVAYRVLKGLQYLHG 164
           +V   A  Y  +  +C V+  M  G L F    + +    E      A  +  GL+ LH 
Sbjct: 246 VVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHR 304
Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTC 224
            +I++ D+KP N+L++  G ++I+D G++  V E               G+     +GT 
Sbjct: 305 ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE---------------GQTIKGRVGTV 349
Query: 225 AYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGE 284
            YM+PE V +ER    Y F+ D W+LG ++ E + G  P     +K     +       E
Sbjct: 350 GYMAPEVVKNER----YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV-------E 398
Query: 285 RL--EMPETA----SPEFRRFVRSCLEKDWRKR-----GTVEELLAYPFVTK 325
           RL  E+PE      SP+ R      L KD  +R     G+  E+  +P   K
Sbjct: 399 RLVKEVPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKK 450

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 82/291 (28%), Positives = 126/291 (43%), Gaps = 44/291 (15%)
Query: 42  DVENISDLKKLTVLGHGNGGIV----YKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAE 97
           D  NIS  K   V+G G  G V     K+  +K  S+ A+K L    +   R     EA 
Sbjct: 43  DATNISIDK---VVGAGEFGEVCSGRLKLPSKKEISV-AIKTLKVGYTEKQRRDFLGEAS 98
Query: 98  ILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVIS--GVAYRV 155
           I+ + D   I++   V  T    +  V E ME GSL DS   +      VI   G+   +
Sbjct: 99  IMGQFDHPNIIRLEGVV-TKSKPVMIVTEXMENGSL-DSFLRKHDAQFTVIQLVGMLRGI 156
Query: 156 LKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGE 215
             G++YL  M  +H D+   N+LIN     K++DFG+SR++E+                E
Sbjct: 157 ASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD--------------PE 202
Query: 216 AAIACMG---TCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP- 271
           AA    G      + SPE +   +    +  A DVWS G+V+ E       ++ +GE+P 
Sbjct: 203 AAYTTRGGKIPIRWTSPEAIAYRK----FTSASDVWSYGIVLWE-------VMSYGERPY 251
Query: 272 ---DLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA 319
                  +I A+  G RL  P        + +  C +KD   R   E++++
Sbjct: 252 WEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 74/279 (26%), Positives = 128/279 (45%), Gaps = 31/279 (11%)
Query: 54  VLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIR-HQAAH-EAEILKRLDSQFIVKCH 111
           VLG G  G V+  + + +  +YA K LN       + +Q A  E +IL ++ S+FIV   
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA 251
Query: 112 AVFYTIEGEICFVMEHMERGSL----FDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQI 167
             F T + ++C VM  M  G +    ++         E        +++ GL++LH   I
Sbjct: 252 YAFET-KTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNI 310
Query: 168 IHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYM 227
           I+ D+KP N+L++  G V+I+D G++  ++  +                     GT  +M
Sbjct: 311 IYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTK--------------GYAGTPGFM 356
Query: 228 SPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLE 287
           +PE +     G +Y F+ D ++LGV + E +    P    GEK +   L   +   + + 
Sbjct: 357 APELL----LGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRV-LEQAVT 411
Query: 288 MPETASPEFRRFVRSCLEKDWRKR-----GTVEELLAYP 321
            P+  SP  + F  + L+KD  KR     G+ + L  +P
Sbjct: 412 YPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHP 450

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 70/272 (25%), Positives = 127/272 (46%), Gaps = 29/272 (10%)
Query: 49  LKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIV 108
           LK +  LG G  G V+ + +   ++  A+K L   S +     A  EA ++K+L  Q +V
Sbjct: 24  LKLVERLGAGQFGEVW-MGYYNGHTKVAVKSLKQGSMSPDAFLA--EANLMKQLQHQRLV 80
Query: 109 KCHAVFYTIEGEICFVMEHMERGSLFDSLRVRK--KLSEDVISGVAYRVLKGLQYLHGMQ 166
           + +AV    +  I  + E+ME GSL D L+     KL+ + +  +A ++ +G+ ++    
Sbjct: 81  RLYAV--VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 138
Query: 167 IIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAY 226
            IH D++ +N+L++     KIADFG++R++E+                 A         +
Sbjct: 139 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXT-------------AREGAKFPIKW 185
Query: 227 MSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICAICFGER 285
            +PE ++     G +    DVWS G+++ E +  G  P  G         +I  +  G R
Sbjct: 186 TAPEAINY----GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP----EVIQNLERGYR 237
Query: 286 LEMPETASPEFRRFVRSCLEKDWRKRGTVEEL 317
           +  P+    E  + +R C ++    R T + L
Sbjct: 238 MVRPDNCPEELYQLMRLCWKERPEDRPTFDYL 269

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 126/288 (43%), Gaps = 38/288 (13%)
Query: 54  VLGHGNGGIVYKVRHQKSNSIYALKVLN----TTSSTIIRHQAAHEAEILKRLDSQFIVK 109
           V+G G   +V +  ++++   +A+K+++    T+S  +       EA I   L    IV+
Sbjct: 31  VIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 110 CHAVFYTIEGEICFVMEHMERGSLFDSLRVRKK----LSEDVISGVAYRVLKGLQYLHGM 165
                Y+ +G +  V E M+   L   +  R       SE V S    ++L+ L+Y H  
Sbjct: 91  LLET-YSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN 149
Query: 166 QIIHGDIKPSNLLINGK---GEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMG 222
            IIH D+KP N+L+  K     VK+ DFGV+  + E+              G  A   +G
Sbjct: 150 NIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGES--------------GLVAGGRVG 195
Query: 223 TCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICF 282
           T  +M+PE V  E     YG   DVW  GV++   L G  P  G  E+     L   I  
Sbjct: 196 TPHFMAPEVVKRE----PYGKPVDVWGCGVILFILLSGCLPFYGTKER-----LFEGIIK 246
Query: 283 GERLEMPET---ASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRS 327
           G+    P      S   +  VR  L  D  +R TV E L +P++ +R 
Sbjct: 247 GKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERD 294

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/268 (24%), Positives = 123/268 (45%), Gaps = 21/268 (7%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQA-AHEAEILKRLDSQFIVKCHAV 113
           +G G+ G VYK    K +   A+K+LN T+ T  + QA  +E  +L++  ++ +     +
Sbjct: 32  IGSGSFGTVYK---GKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRK--TRHVNILLFM 86
Query: 114 FYTIEGEICFVMEHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQYLHGMQIIHGDI 172
            Y+   ++  V +  E  SL+  L   + K     +  +A +  +G+ YLH   IIH D+
Sbjct: 87  GYSTAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDL 146
Query: 173 KPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERV 232
           K +N+ ++    VKI DFG++   E++R                     G+  +M+PE +
Sbjct: 147 KSNNIFLHEDNTVKIGDFGLA--TEKSRWSGSHQFEQLS----------GSILWMAPEVI 194
Query: 233 DSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPETA 292
             +     Y F  DV++ G+V+ E + G  P      +  ++ ++        L    + 
Sbjct: 195 RMQD-SNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSN 253
Query: 293 SPE-FRRFVRSCLEKDWRKRGTVEELLA 319
            P+  +R +  CL+K   +R +   +LA
Sbjct: 254 CPKRMKRLMAECLKKKRDERPSFPRILA 281

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 71/264 (26%), Positives = 122/264 (46%), Gaps = 26/264 (9%)
Query: 54  VLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIR-HQAAH-EAEILKRLDSQFIVKCH 111
           VLG G  G V+  + + +  +YA K LN       + +Q A  E +IL ++ S+FIV   
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA 251
Query: 112 AVFYTIEGEICFVMEHMERGSL----FDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQI 167
             F T + ++C VM  M  G +    ++         E        +++ GL++LH   I
Sbjct: 252 YAFET-KTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNI 310
Query: 168 IHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYM 227
           I+ D+KP N+L++  G V+I+D G++  ++  +                     GT  +M
Sbjct: 311 IYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTK--------------GYAGTPGFM 356
Query: 228 SPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLE 287
           +PE +     G +Y F+ D ++LGV + E +    P    GEK +   L   +   + + 
Sbjct: 357 APELL----LGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRV-LEQAVT 411
Query: 288 MPETASPEFRRFVRSCLEKDWRKR 311
            P+  SP  + F  + L+KD  KR
Sbjct: 412 YPDKFSPASKDFCEALLQKDPEKR 435

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 82/291 (28%), Positives = 126/291 (43%), Gaps = 44/291 (15%)
Query: 42  DVENISDLKKLTVLGHGNGGIV----YKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAE 97
           D  NIS  K   V+G G  G V     K+  +K  S+ A+K L    +   R     EA 
Sbjct: 43  DATNISIDK---VVGAGEFGEVCSGRLKLPSKKEISV-AIKTLKVGYTEKQRRDFLGEAS 98
Query: 98  ILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVIS--GVAYRV 155
           I+ + D   I++   V  T    +  V E ME GSL DS   +      VI   G+   +
Sbjct: 99  IMGQFDHPNIIRLEGVV-TKSKPVMIVTEXMENGSL-DSFLRKHDAQFTVIQLVGMLRGI 156
Query: 156 LKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGE 215
             G++YL  M  +H D+   N+LIN     K++DFG+SR++E+                E
Sbjct: 157 ASGMKYLSDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDD--------------PE 202
Query: 216 AAIACMG---TCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP- 271
           AA    G      + SPE +   +    +  A DVWS G+V+ E       ++ +GE+P 
Sbjct: 203 AAYTTRGGKIPIRWTSPEAIAYRK----FTSASDVWSYGIVLWE-------VMSYGERPY 251
Query: 272 ---DLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA 319
                  +I A+  G RL  P        + +  C +KD   R   E++++
Sbjct: 252 WEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 74/279 (26%), Positives = 128/279 (45%), Gaps = 31/279 (11%)
Query: 54  VLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIR-HQAAH-EAEILKRLDSQFIVKCH 111
           VLG G  G V+  + + +  +YA K LN       + +Q A  E +IL ++ S+FIV   
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA 251
Query: 112 AVFYTIEGEICFVMEHMERGSL----FDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQI 167
             F T + ++C VM  M  G +    ++         E        +++ GL++LH   I
Sbjct: 252 YAFET-KTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNI 310
Query: 168 IHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYM 227
           I+ D+KP N+L++  G V+I+D G++  ++  +                     GT  +M
Sbjct: 311 IYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTK--------------GYAGTPGFM 356
Query: 228 SPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLE 287
           +PE +     G +Y F+ D ++LGV + E +    P    GEK +   L   +   + + 
Sbjct: 357 APELL----LGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRV-LEQAVT 411
Query: 288 MPETASPEFRRFVRSCLEKDWRKR-----GTVEELLAYP 321
            P+  SP  + F  + L+KD  KR     G+ + L  +P
Sbjct: 412 YPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHP 450

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 71/264 (26%), Positives = 122/264 (46%), Gaps = 26/264 (9%)
Query: 54  VLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIR-HQAAH-EAEILKRLDSQFIVKCH 111
           VLG G  G V+  + + +  +YA K LN       + +Q A  E +IL ++ S+FIV   
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA 251
Query: 112 AVFYTIEGEICFVMEHMERGSL----FDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQI 167
             F T + ++C VM  M  G +    ++         E        +++ GL++LH   I
Sbjct: 252 YAFET-KTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNI 310
Query: 168 IHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYM 227
           I+ D+KP N+L++  G V+I+D G++  ++  +                     GT  +M
Sbjct: 311 IYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTK--------------GYAGTPGFM 356
Query: 228 SPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLE 287
           +PE +     G +Y F+ D ++LGV + E +    P    GEK +   L   +   + + 
Sbjct: 357 APELL----LGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRV-LEQAVT 411
Query: 288 MPETASPEFRRFVRSCLEKDWRKR 311
            P+  SP  + F  + L+KD  KR
Sbjct: 412 YPDKFSPASKDFCEALLQKDPEKR 435

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 121/281 (43%), Gaps = 35/281 (12%)
Query: 48  DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIR-HQAAHEAEILKRLDSQF 106
           DL     +G G+ G V++     S+   A+K+L        R ++   E  I+KRL    
Sbjct: 38  DLNIKEKIGAGSFGTVHRAEWHGSD--VAVKILMEQDFHAERVNEFLREVAIMKRLRHPN 95
Query: 107 IVKCHAVFYTIEGEICFVMEHMERGSLFDSLR---VRKKLSEDVISGVAYRVLKGLQYLH 163
           IV       T    +  V E++ RGSL+  L     R++L E     +AY V KG+ YLH
Sbjct: 96  IVLFMGAV-TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH 154
Query: 164 GMQ--IIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACM 221
                I+H D+K  NLL++ K  VK+ DFG+SR+                     +    
Sbjct: 155 NRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFL--------------XSKXAA 200
Query: 222 GTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAIC 281
           GT  +M+PE +  E          DV+S GV++ E      P            ++ A+ 
Sbjct: 201 GTPEWMAPEVLRDE----PSNEKSDVYSFGVILWELATLQQPWGNLNPA----QVVAAVG 252
Query: 282 FG-ERLEMPETASPEFRRFVRSCLEKDWRKR---GTVEELL 318
           F  +RLE+P   +P+    +  C   +  KR    T+ +LL
Sbjct: 253 FKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLL 293

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 47/151 (31%), Positives = 75/151 (49%), Gaps = 19/151 (12%)
Query: 118 EGEICF--VMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPS 175
           E + C+  VME++E  +L + +     LS D       ++L G+++ H M+I+H DIKP 
Sbjct: 81  EEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQ 140
Query: 176 NLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERVDSE 235
           N+LI+    +KI DFG+++ + ET                     +GT  Y SPE+   E
Sbjct: 141 NILIDSNKTLKIFDFGIAKALSETSLTQTNH-------------VLGTVQYFSPEQAKGE 187
Query: 236 RWGGDYGFAGDVWSLGVVVLECLVGHYPLIG 266
                     D++S+G+V+ E LVG  P  G
Sbjct: 188 ATDE----CTDIYSIGIVLYEMLVGEPPFNG 214

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 48/148 (32%), Positives = 83/148 (56%), Gaps = 6/148 (4%)
Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALK-VLNTTSSTIIRHQAAHEAEILKRLDSQFIV 108
           +KL  +G G  G V+K ++++++ I ALK V        +   A  E  +LK L  + IV
Sbjct: 5   EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIV 64
Query: 109 KCHAVFYTIEGEICFVMEHMERG--SLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQ 166
           + H V ++ + ++  V E  ++     FDS      L  +++    +++LKGL + H   
Sbjct: 65  RLHDVLHS-DKKLTLVFEFCDQDLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCHSRN 121
Query: 167 IIHGDIKPSNLLINGKGEVKIADFGVSR 194
           ++H D+KP NLLIN  GE+K+A+FG++R
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLAR 149

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 105/232 (45%), Gaps = 24/232 (10%)
Query: 37  NPTS--PDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH 94
           NP S   D  +I + + +  LG G+ G V    H  +    ALK++N         Q   
Sbjct: 1   NPKSSLADGAHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRI 60
Query: 95  EAEI--LKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVA 152
           E EI  L+ L    I+K + V  + + EI  V+E+     LFD +  R K+SE       
Sbjct: 61  EREISYLRLLRHPHIIKLYDVIKS-KDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFF 118
Query: 153 YRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXX 212
            +++  ++Y H  +I+H D+KP NLL++    VKIADFG+S I+ +              
Sbjct: 119 QQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD-------------- 164
Query: 213 IGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPL 264
            G       G+  Y +PE +  + + G      DVWS GV++   L    P 
Sbjct: 165 -GNFLKTSCGSPNYAAPEVISGKLYAGP---EVDVWSCGVILYVMLCRRLPF 212

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 105/232 (45%), Gaps = 24/232 (10%)
Query: 37  NPTS--PDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH 94
           NP S   D  +I + + +  LG G+ G V    H  +    ALK++N         Q   
Sbjct: 2   NPKSSLADGAHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRI 61
Query: 95  EAEI--LKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVA 152
           E EI  L+ L    I+K + V  + + EI  V+E+     LFD +  R K+SE       
Sbjct: 62  EREISYLRLLRHPHIIKLYDVIKS-KDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFF 119
Query: 153 YRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXX 212
            +++  ++Y H  +I+H D+KP NLL++    VKIADFG+S I+ +              
Sbjct: 120 QQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD-------------- 165
Query: 213 IGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPL 264
            G       G+  Y +PE +  + + G      DVWS GV++   L    P 
Sbjct: 166 -GNFLKTSCGSPNYAAPEVISGKLYAGP---EVDVWSCGVILYVMLCRRLPF 213

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 71/272 (26%), Positives = 129/272 (47%), Gaps = 29/272 (10%)
Query: 49  LKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIV 108
           LK +  LG G  G V+ + +   ++  A+K L   S +     A  EA ++K+L  Q +V
Sbjct: 15  LKLVERLGAGQFGEVW-MGYYNGHTKVAVKSLKQGSMSPDAFLA--EANLMKQLQHQRLV 71
Query: 109 KCHAVFYTIEGEICFVMEHMERGSLFDSLRVRK--KLSEDVISGVAYRVLKGLQYLHGMQ 166
           + +AV    +  I  + E+ME GSL D L+     KL+ + +  +A ++ +G+ ++    
Sbjct: 72  RLYAV--VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 129
Query: 167 IIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAY 226
            IH D++ +N+L++     KIADFG++R++E+                 A         +
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXT-------------AREGAKFPIKW 176
Query: 227 MSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICAICFGER 285
            +PE ++     G +    DVWS G+++ E +  G  P  G    P+   +I  +  G R
Sbjct: 177 TAPEAINY----GTFTIKSDVWSFGILLTEIVTHGRIPYPGMT-NPE---VIQNLERGYR 228
Query: 286 LEMPETASPEFRRFVRSCLEKDWRKRGTVEEL 317
           +  P+    E  + +R C ++    R T + L
Sbjct: 229 MVRPDNCPEELYQLMRLCWKERPEDRPTFDYL 260

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 87/321 (27%), Positives = 131/321 (40%), Gaps = 53/321 (16%)
Query: 24  HQFRRRRHHF----------PTSNPTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNS 73
           HQ + RR  F          P  +P+ P+       ++L+ LGHG+ G V+KVR ++   
Sbjct: 24  HQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGR 83
Query: 74  IYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIE-----GEICFVMEHM 128
           +YA+K     S +  R      A  L  + S   V  H     +E     G I ++   +
Sbjct: 84  LYAVK----RSMSPFRG-PKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTEL 138
Query: 129 ERGSLFDSLRV-RKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKI 187
              SL          L E  + G     L  L +LH   ++H D+KP+N+ +  +G  K+
Sbjct: 139 CGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKL 198
Query: 188 ADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACM--GTCAYMSPERVDSERWGGDYGFAG 245
            DFG+  +VE               +G A    +  G   YM+PE +      G YG A 
Sbjct: 199 GDFGL--LVE---------------LGTAGAGEVQEGDPRYMAPELLQ-----GSYGTAA 236
Query: 246 DVWSLGVVVLECLVG-HYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCL 304
           DV+SLG+ +LE       P  G G +      +         E     S E R  +   L
Sbjct: 237 DVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPP-------EFTAGLSSELRSVLVMML 289
Query: 305 EKDWRKRGTVEELLAYPFVTK 325
           E D + R T E LLA P + +
Sbjct: 290 EPDPKLRATAEALLALPVLRQ 310

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 71/272 (26%), Positives = 129/272 (47%), Gaps = 29/272 (10%)
Query: 49  LKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIV 108
           LK +  LG G  G V+ + +   ++  A+K L   S +     A  EA ++K+L  Q +V
Sbjct: 17  LKLVERLGAGQFGEVW-MGYYNGHTKVAVKSLKQGSMSPDAFLA--EANLMKQLQHQRLV 73
Query: 109 KCHAVFYTIEGEICFVMEHMERGSLFDSLRVRK--KLSEDVISGVAYRVLKGLQYLHGMQ 166
           + +AV    +  I  + E+ME GSL D L+     KL+ + +  +A ++ +G+ ++    
Sbjct: 74  RLYAV--VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 131
Query: 167 IIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAY 226
            IH D++ +N+L++     KIADFG++R++E+                 A         +
Sbjct: 132 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXT-------------AREGAKFPIKW 178
Query: 227 MSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICAICFGER 285
            +PE ++     G +    DVWS G+++ E +  G  P  G    P+   +I  +  G R
Sbjct: 179 TAPEAINY----GTFTIKSDVWSFGILLTEIVTHGRIPYPGMT-NPE---VIQNLERGYR 230
Query: 286 LEMPETASPEFRRFVRSCLEKDWRKRGTVEEL 317
           +  P+    E  + +R C ++    R T + L
Sbjct: 231 MVRPDNCPEELYQLMRLCWKERPEDRPTFDYL 262

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/268 (23%), Positives = 124/268 (46%), Gaps = 21/268 (7%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQA-AHEAEILKRLDSQFIVKCHAV 113
           +G G+ G VYK    K +   A+K+LN T+ T  + QA  +E  +L++  ++ +     +
Sbjct: 20  IGSGSFGTVYK---GKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRK--TRHVNILLFM 74
Query: 114 FYTIEGEICFVMEHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQYLHGMQIIHGDI 172
            Y+ + ++  V +  E  SL+  L   + K     +  +A +  +G+ YLH   IIH D+
Sbjct: 75  GYSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDL 134
Query: 173 KPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERV 232
           K +N+ ++    VKI DFG++ +  ++R                     G+  +M+PE +
Sbjct: 135 KSNNIFLHEDNTVKIGDFGLATV--KSRWSGSHQFEQLS----------GSILWMAPEVI 182
Query: 233 DSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPETA 292
             +     Y F  DV++ G+V+ E + G  P      +  ++ ++        L    + 
Sbjct: 183 RMQD-SNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSN 241
Query: 293 SPE-FRRFVRSCLEKDWRKRGTVEELLA 319
            P+  +R +  CL+K   +R +   +LA
Sbjct: 242 CPKRMKRLMAECLKKKRDERPSFPRILA 269

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 81/291 (27%), Positives = 126/291 (43%), Gaps = 44/291 (15%)
Query: 42  DVENISDLKKLTVLGHGNGGIV----YKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAE 97
           D  NIS  K   V+G G  G V     K+  +K  S+ A+K L    +   R     EA 
Sbjct: 43  DATNISIDK---VVGAGEFGEVCSGRLKLPSKKEISV-AIKTLKVGYTEKQRRDFLGEAS 98
Query: 98  ILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVIS--GVAYRV 155
           I+ + D   I++   V  T    +  V E+ME GSL DS   +      VI   G+   +
Sbjct: 99  IMGQFDHPNIIRLEGVV-TKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGI 156
Query: 156 LKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGE 215
             G++YL  M  +H D+   N+LIN     K++DFG+ R++E+                E
Sbjct: 157 ASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP--------------E 202
Query: 216 AAIACMG---TCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP- 271
           AA    G      + SPE +   +    +  A DVWS G+V+ E       ++ +GE+P 
Sbjct: 203 AAYTTRGGKIPIRWTSPEAIAYRK----FTSASDVWSYGIVLWE-------VMSYGERPY 251
Query: 272 ---DLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA 319
                  +I A+  G RL  P        + +  C +KD   R   E++++
Sbjct: 252 WEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 71/272 (26%), Positives = 129/272 (47%), Gaps = 29/272 (10%)
Query: 49  LKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIV 108
           LK +  LG G  G V+ + +   ++  A+K L   S +     A  EA ++K+L  Q +V
Sbjct: 16  LKLVERLGAGQFGEVW-MGYYNGHTKVAVKSLKQGSMSPDAFLA--EANLMKQLQHQRLV 72
Query: 109 KCHAVFYTIEGEICFVMEHMERGSLFDSLRVRK--KLSEDVISGVAYRVLKGLQYLHGMQ 166
           + +AV    +  I  + E+ME GSL D L+     KL+ + +  +A ++ +G+ ++    
Sbjct: 73  RLYAV--VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 130
Query: 167 IIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAY 226
            IH D++ +N+L++     KIADFG++R++E+                 A         +
Sbjct: 131 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXT-------------AREGAKFPIKW 177
Query: 227 MSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICAICFGER 285
            +PE ++     G +    DVWS G+++ E +  G  P  G    P+   +I  +  G R
Sbjct: 178 TAPEAINY----GTFTIKSDVWSFGILLTEIVTHGRIPYPGMT-NPE---VIQNLERGYR 229
Query: 286 LEMPETASPEFRRFVRSCLEKDWRKRGTVEEL 317
           +  P+    E  + +R C ++    R T + L
Sbjct: 230 MVRPDNCPEELYQLMRLCWKERPEDRPTFDYL 261

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/272 (25%), Positives = 128/272 (47%), Gaps = 29/272 (10%)
Query: 49  LKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIV 108
           LK +  LG G  G V+ + +   ++  A+K L   S +     A  EA ++K+L  Q +V
Sbjct: 15  LKLVERLGAGQFGEVW-MGYYNGHTKVAVKSLKQGSMSPDAFLA--EANLMKQLQHQRLV 71
Query: 109 KCHAVFYTIEGEICFVMEHMERGSLFDSLRVRK--KLSEDVISGVAYRVLKGLQYLHGMQ 166
           + +AV    +  I  + E+ME GSL D L+     KL+ + +  +A ++ +G+ ++    
Sbjct: 72  RLYAV--VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 129
Query: 167 IIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAY 226
            IH D++ +N+L++     KIADFG++R++E+                 A         +
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT-------------AREGAKFPIKW 176
Query: 227 MSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICAICFGER 285
            +PE ++     G +    DVWS G+++ E +  G  P  G    P+   +I  +  G R
Sbjct: 177 TAPEAINY----GTFTIKSDVWSFGILLTEIVTHGRIPYPGMT-NPE---VIQNLERGYR 228
Query: 286 LEMPETASPEFRRFVRSCLEKDWRKRGTVEEL 317
           +  P+    E  + +R C ++    R T + L
Sbjct: 229 MVRPDNCPEELYQLMRLCWKERPEDRPTFDYL 260

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 72/275 (26%), Positives = 123/275 (44%), Gaps = 29/275 (10%)
Query: 49  LKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIV 108
           L+ +  LG+G  G V+ +     N+  A+K L     T+       EA+I+K+L    +V
Sbjct: 11  LQLIKRLGNGQFGEVW-MGTWNGNTKVAIKTLK--PGTMSPESFLEEAQIMKKLKHDKLV 67
Query: 109 KCHAVFYTIEGEICFVMEHMERGSLFDSLR--VRKKLSEDVISGVAYRVLKGLQYLHGMQ 166
           + +AV    E  I  V E+M +GSL D L+    + L    +  +A +V  G+ Y+  M 
Sbjct: 68  QLYAV--VSEEPIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN 125
Query: 167 IIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAY 226
            IH D++ +N+L+      KIADFG++R++E+                 A         +
Sbjct: 126 YIHRDLRSANILVGNGLICKIADFGLARLIEDNEXT-------------ARQGAKFPIKW 172
Query: 227 MSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICAICFGER 285
            +PE        G +    DVWS G+++ E +  G  P  G   +     ++  +  G R
Sbjct: 173 TAPEAALY----GRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR----EVLEQVERGYR 224
Query: 286 LEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY 320
           +  P+         +  C +KD  +R T E L ++
Sbjct: 225 MPCPQDCPISLHELMIHCWKKDPEERPTFEYLQSF 259

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 71/272 (26%), Positives = 129/272 (47%), Gaps = 29/272 (10%)
Query: 49  LKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIV 108
           LK +  LG G  G V+ + +   ++  A+K L   S +     A  EA ++K+L  Q +V
Sbjct: 15  LKLVERLGAGQFGEVW-MGYYNGHTKVAVKSLKQGSMSPDAFLA--EANLMKQLQHQRLV 71
Query: 109 KCHAVFYTIEGEICFVMEHMERGSLFDSLRVRK--KLSEDVISGVAYRVLKGLQYLHGMQ 166
           + +AV    +  I  + E+ME GSL D L+     KL+ + +  +A ++ +G+ ++    
Sbjct: 72  RLYAV--VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 129
Query: 167 IIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAY 226
            IH D++ +N+L++     KIADFG++R++E+                 A         +
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXT-------------AREGAKFPIKW 176
Query: 227 MSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICAICFGER 285
            +PE ++     G +    DVWS G+++ E +  G  P  G    P+   +I  +  G R
Sbjct: 177 TAPEAINY----GTFTIKSDVWSFGILLTEIVTHGRIPYPGMT-NPE---VIQNLERGYR 228
Query: 286 LEMPETASPEFRRFVRSCLEKDWRKRGTVEEL 317
           +  P+    E  + +R C ++    R T + L
Sbjct: 229 MVRPDNCPEELYQLMRLCWKERPEDRPTFDYL 260

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/274 (25%), Positives = 113/274 (41%), Gaps = 40/274 (14%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLN-------TTSSTIIRHQAAHEAEILKRLDSQFI 107
           +G GN G+   +R ++SN + A+K +             II H++     I+ R     +
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIV-RFKEVIL 85
Query: 108 VKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQI 167
              H         +  VME+   G LF+ +    + SED       +++ G+ Y H MQ+
Sbjct: 86  TPTH---------LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 136
Query: 168 IHGDIKPSNLLINGK--GEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCA 225
            H D+K  N L++G     +KI  FG S+                  +       +GT A
Sbjct: 137 CHRDLKLENTLLDGSPAPRLKICAFGYSK---------------SSVLHSQPKDTVGTPA 181
Query: 226 YMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGER 285
           Y++PE +  + + G      DVWS GV +   LVG YP     E  +    I  I    +
Sbjct: 182 YIAPEVLLKKEYDGK---VADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI-LNVQ 237
Query: 286 LEMPETA--SPEFRRFVRSCLEKDWRKRGTVEEL 317
             +P+    SPE R  +      D  KR ++ E+
Sbjct: 238 YAIPDYVHISPECRHLISRIFVADPAKRISIPEI 271

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 73/251 (29%), Positives = 112/251 (44%), Gaps = 26/251 (10%)
Query: 41  PDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALK-VLNTTSSTIIRHQAAHEAEIL 99
           P  + +S  +KL  +G G  G V+K RH+K+    ALK VL           A  E +IL
Sbjct: 12  PFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKIL 71
Query: 100 KRLDSQFIVKCHAVFYT-------IEGEICFVMEHMER--GSLFDSLRVRKKLSEDVISG 150
           + L  + +V    +  T        +G I  V +  E     L  ++ V+  LSE  I  
Sbjct: 72  QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSE--IKR 129
Query: 151 VAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXX 210
           V   +L GL Y+H  +I+H D+K +N+LI   G +K+ADFG++R     +          
Sbjct: 130 VMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNR 189
Query: 211 XXIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEK 270
                       T  Y  PE +  ER   DYG   D+W  G ++ E +    P++    +
Sbjct: 190 VV----------TLWYRPPELLLGER---DYGPPIDLWGAGCIMAE-MWTRSPIMQGNTE 235
Query: 271 PDLMALICAIC 281
              +ALI  +C
Sbjct: 236 QHQLALISQLC 246

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 82/291 (28%), Positives = 126/291 (43%), Gaps = 44/291 (15%)
Query: 42  DVENISDLKKLTVLGHGNGGIV----YKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAE 97
           D  NIS  K   V+G G  G V     K+  +K  S+ A+K L    +   R     EA 
Sbjct: 14  DATNISIDK---VVGAGEFGEVCSGRLKLPSKKEISV-AIKTLKVGYTEKQRRDFLGEAS 69
Query: 98  ILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVIS--GVAYRV 155
           I+ + D   I++   V  T    +  V E ME GSL DS   +      VI   G+   +
Sbjct: 70  IMGQFDHPNIIRLEGVV-TKSKPVMIVTEXMENGSL-DSFLRKHDAQFTVIQLVGMLRGI 127
Query: 156 LKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGE 215
             G++YL  M  +H D+   N+LIN     K++DFG+SR++E+                E
Sbjct: 128 ASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD--------------PE 173
Query: 216 AAIACMG---TCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP- 271
           AA    G      + SPE +   +    +  A DVWS G+V+ E       ++ +GE+P 
Sbjct: 174 AAYTTRGGKIPIRWTSPEAIAYRK----FTSASDVWSYGIVLWE-------VMSYGERPY 222
Query: 272 ---DLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA 319
                  +I A+  G RL  P        + +  C +KD   R   E++++
Sbjct: 223 WEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 273

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/272 (25%), Positives = 128/272 (47%), Gaps = 29/272 (10%)
Query: 49  LKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIV 108
           LK +  LG G  G V+ + +   ++  A+K L   S +     A  EA ++K+L  Q +V
Sbjct: 10  LKLVERLGAGQFGEVW-MGYYNGHTKVAVKSLKQGSMSPDAFLA--EANLMKQLQHQRLV 66
Query: 109 KCHAVFYTIEGEICFVMEHMERGSLFDSLRVRK--KLSEDVISGVAYRVLKGLQYLHGMQ 166
           + +AV    +  I  + E+ME GSL D L+     KL+ + +  +A ++ +G+ ++    
Sbjct: 67  RLYAV--VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 124
Query: 167 IIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAY 226
            IH D++ +N+L++     KIADFG++R++E+                 A         +
Sbjct: 125 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT-------------AREGAKFPIKW 171
Query: 227 MSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICAICFGER 285
            +PE ++     G +    DVWS G+++ E +  G  P  G    P+   +I  +  G R
Sbjct: 172 TAPEAINY----GTFTIKSDVWSFGILLTEIVTHGRIPYPGMT-NPE---VIQNLERGYR 223
Query: 286 LEMPETASPEFRRFVRSCLEKDWRKRGTVEEL 317
           +  P+    E  + +R C ++    R T + L
Sbjct: 224 MVRPDNCPEELYQLMRLCWKERPEDRPTFDYL 255

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 73/251 (29%), Positives = 112/251 (44%), Gaps = 26/251 (10%)
Query: 41  PDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALK-VLNTTSSTIIRHQAAHEAEIL 99
           P  + +S  +KL  +G G  G V+K RH+K+    ALK VL           A  E +IL
Sbjct: 11  PFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKIL 70
Query: 100 KRLDSQFIVKCHAVFYT-------IEGEICFVMEHMER--GSLFDSLRVRKKLSEDVISG 150
           + L  + +V    +  T        +G I  V +  E     L  ++ V+  LSE  I  
Sbjct: 71  QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSE--IKR 128
Query: 151 VAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXX 210
           V   +L GL Y+H  +I+H D+K +N+LI   G +K+ADFG++R     +          
Sbjct: 129 VMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNR 188
Query: 211 XXIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEK 270
                       T  Y  PE +  ER   DYG   D+W  G ++ E +    P++    +
Sbjct: 189 VV----------TLWYRPPELLLGER---DYGPPIDLWGAGCIMAE-MWTRSPIMQGNTE 234
Query: 271 PDLMALICAIC 281
              +ALI  +C
Sbjct: 235 QHQLALISQLC 245

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/236 (25%), Positives = 106/236 (44%), Gaps = 26/236 (11%)
Query: 36  SNPTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHE 95
            N  + D   ++D   L VLG G+ G V     + ++ +YA+K+L      +I+      
Sbjct: 9   DNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILK--KDVVIQDDDVEC 66
Query: 96  AEILKRL-----DSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISG 150
             + KR+        F+ + H+ F T++  + FVME++  G L   ++   +  E     
Sbjct: 67  TMVEKRVLALPGKPPFLTQLHSCFQTMD-RLYFVMEYVNGGDLMYHIQQVGRFKEPHAVF 125
Query: 151 VAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXX 210
            A  +  GL +L    II+ D+K  N++++ +G +KIADFG+ +                
Sbjct: 126 YAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK--------------EN 171
Query: 211 XXIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIG 266
              G       GT  Y++PE +  +     YG + D W+ GV++ E L G  P  G
Sbjct: 172 IWDGVTTKXFCGTPDYIAPEIIAYQ----PYGKSVDWWAFGVLLYEMLAGQAPFEG 223

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 105/233 (45%), Gaps = 26/233 (11%)
Query: 42  DVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKR 101
           D   ++D   L VLG G+ G V     + ++ +YA+K+L      +I+        + KR
Sbjct: 336 DRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILK--KDVVIQDDDVECTMVEKR 393
Query: 102 L-----DSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVL 156
           +        F+ + H+ F T++  + FVME++  G L   ++   +  E      A  + 
Sbjct: 394 VLALPGKPPFLTQLHSCFQTMD-RLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIA 452
Query: 157 KGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEA 216
            GL +L    II+ D+K  N++++ +G +KIADFG+ +                   G  
Sbjct: 453 IGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK--------------ENIWDGVT 498
Query: 217 AIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGE 269
                GT  Y++PE +  +     YG + D W+ GV++ E L G  P  G  E
Sbjct: 499 TKXFCGTPDYIAPEIIAYQ----PYGKSVDWWAFGVLLYEMLAGQAPFEGEDE 547

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 78/299 (26%), Positives = 122/299 (40%), Gaps = 32/299 (10%)
Query: 36  SNPTSPDVENISDLKKLTVLGHGNGGIV----YKVRHQKSNSIYALKVLNTTSSTIIRHQ 91
             P  P V +   LKK+  LG G+ G V    Y   +  +  + A+K L   +    R  
Sbjct: 20  QGPGDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSG 79
Query: 92  AAHEAEILKRLDSQFIVKCHAVFYTI-EGEICFVMEHMERGSLFDSLRVRKKLSEDVISG 150
              E +IL+ L  + I+K            +  VME++  GSL D L  R  +    +  
Sbjct: 80  WKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLP-RHSIGLAQLLL 138
Query: 151 VAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXX 210
            A ++ +G+ YLH    IH D+   N+L++    VKI DFG+++ V E            
Sbjct: 139 FAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGD 198
Query: 211 XXIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLE----CLVGHYP--- 263
             +   A  C+    +                +A DVWS GV + E    C     P   
Sbjct: 199 SPVFWYAPECLKEYKFY---------------YASDVWSFGVTLYELLTHCDSSQSPPTK 243
Query: 264 ---LIGFGE-KPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELL 318
              LIG  + +  ++ L   +  GERL  P+    E    +++C E +   R T E L+
Sbjct: 244 FLELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLI 302

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 73/251 (29%), Positives = 112/251 (44%), Gaps = 26/251 (10%)
Query: 41  PDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALK-VLNTTSSTIIRHQAAHEAEIL 99
           P  + +S  +KL  +G G  G V+K RH+K+    ALK VL           A  E +IL
Sbjct: 12  PFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKIL 71
Query: 100 KRLDSQFIVKCHAVFYT-------IEGEICFVMEHMER--GSLFDSLRVRKKLSEDVISG 150
           + L  + +V    +  T        +G I  V +  E     L  ++ V+  LSE  I  
Sbjct: 72  QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSE--IKR 129
Query: 151 VAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXX 210
           V   +L GL Y+H  +I+H D+K +N+LI   G +K+ADFG++R     +          
Sbjct: 130 VMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNR 189
Query: 211 XXIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEK 270
                       T  Y  PE +  ER   DYG   D+W  G ++ E +    P++    +
Sbjct: 190 VV----------TLWYRPPELLLGER---DYGPPIDLWGAGCIMAE-MWTRSPIMQGNTE 235
Query: 271 PDLMALICAIC 281
              +ALI  +C
Sbjct: 236 QHQLALISQLC 246

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 72/265 (27%), Positives = 122/265 (46%), Gaps = 29/265 (10%)
Query: 68  HQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEH 127
           H+ +N  YA+KV++ +     +   + E EIL R      +      Y     +  V E 
Sbjct: 48  HKATNMEYAVKVIDKS-----KRDPSEEIEILLRYGQHPNIITLKDVYDDGKHVYLVTEL 102
Query: 128 MERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLI---NGKGE 184
           M  G L D +  +K  SE   S V + + K ++YLH   ++H D+KPSN+L    +G  E
Sbjct: 103 MRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQGVVHRDLKPSNILYVDESGNPE 162
Query: 185 -VKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERVDSERWGGDYGF 243
            ++I DFG ++ +                 G     C  T  +++PE +  +R G D G 
Sbjct: 163 CLRICDFGFAKQLRAEN-------------GLLMTPCY-TANFVAPEVL--KRQGYDEGC 206
Query: 244 AGDVWSLGVVVLECLVGHYPLI-GFGEKP-DLMALICAICFGERLEMPETASPEFRRFVR 301
             D+WSLG+++   L G+ P   G  + P +++  I +  F        T S   +  V 
Sbjct: 207 --DIWSLGILLYTMLAGYTPFANGPSDTPEEILTRIGSGKFTLSGGNWNTVSETAKDLVS 264
Query: 302 SCLEKDWRKRGTVEELLAYPFVTKR 326
             L  D  +R T +++L +P+VT++
Sbjct: 265 KMLHVDPHQRLTAKQVLQHPWVTQK 289

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 73/278 (26%), Positives = 123/278 (44%), Gaps = 35/278 (12%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVF 114
           +G G+  +  +  H+ +N  +A+K+++ +     +     E EIL R      +      
Sbjct: 30  IGVGSYSVCKRCIHKATNMEFAVKIIDKS-----KRDPTEEIEILLRYGQHPNIITLKDV 84
Query: 115 YTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKP 174
           Y     +  V E M+ G L D +  +K  SE   S V + + K ++YLH   ++H D+KP
Sbjct: 85  YDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKP 144
Query: 175 SNLLI---NGKGE-VKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPE 230
           SN+L    +G  E ++I DFG ++ +                 G     C  T  +++PE
Sbjct: 145 SNILYVDESGNPESIRICDFGFAKQLRAEN-------------GLLMTPCY-TANFVAPE 190
Query: 231 RVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPD-----LMALICAICFGER 285
            +  ER G  Y  A D+WSLGV++   L G+ P   F   PD     ++A I +  F   
Sbjct: 191 VL--ERQG--YDAACDIWSLGVLLYTMLTGYTP---FANGPDDTPEEILARIGSGKFSLS 243
Query: 286 LEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV 323
                + S   +  V   L  D  +R T   +L +P++
Sbjct: 244 GGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWI 281

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 102/225 (45%), Gaps = 22/225 (9%)
Query: 42  DVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEI--L 99
           D  +I + + +  LG G+ G V    H  +    ALK++N         Q   E EI  L
Sbjct: 3   DGAHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYL 62
Query: 100 KRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGL 159
           + L    I+K + V  + + EI  V+E+     LFD +  R K+SE        +++  +
Sbjct: 63  RLLRHPHIIKLYDVIKS-KDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAV 120
Query: 160 QYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIA 219
           +Y H  +I+H D+KP NLL++    VKIADFG+S I+ +               G     
Sbjct: 121 EYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD---------------GNFLKT 165
Query: 220 CMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPL 264
             G+  Y +PE +  + + G      DVWS GV++   L    P 
Sbjct: 166 SCGSPNYAAPEVISGKLYAGP---EVDVWSCGVILYVMLCRRLPF 207

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 101/222 (45%), Gaps = 22/222 (9%)
Query: 45  NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEI--LKRL 102
           +I + + +  LG G+ G V    H  +    ALK++N         Q   E EI  L+ L
Sbjct: 2   HIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLL 61
Query: 103 DSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYL 162
               I+K + V  + + EI  V+E+     LFD +  R K+SE        +++  ++Y 
Sbjct: 62  RHPHIIKLYDVIKS-KDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAVEYC 119
Query: 163 HGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMG 222
           H  +I+H D+KP NLL++    VKIADFG+S I+ +               G       G
Sbjct: 120 HRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD---------------GNFLKTSCG 164
Query: 223 TCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPL 264
           +  Y +PE +  + + G      DVWS GV++   L    P 
Sbjct: 165 SPNYAAPEVISGKLYAGP---EVDVWSCGVILYVMLCRRLPF 203

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 72/265 (27%), Positives = 122/265 (46%), Gaps = 29/265 (10%)
Query: 68  HQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEH 127
           H+ +N  YA+KV++ +     +   + E EIL R      +      Y     +  V E 
Sbjct: 48  HKATNMEYAVKVIDKS-----KRDPSEEIEILLRYGQHPNIITLKDVYDDGKHVYLVTEL 102
Query: 128 MERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLI---NGKGE 184
           M  G L D +  +K  SE   S V + + K ++YLH   ++H D+KPSN+L    +G  E
Sbjct: 103 MRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQGVVHRDLKPSNILYVDESGNPE 162
Query: 185 -VKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERVDSERWGGDYGF 243
            ++I DFG ++ +                 G     C  T  +++PE +  +R G D G 
Sbjct: 163 CLRICDFGFAKQLRAEN-------------GLLMTPCY-TANFVAPEVL--KRQGYDEGC 206
Query: 244 AGDVWSLGVVVLECLVGHYPLI-GFGEKP-DLMALICAICFGERLEMPETASPEFRRFVR 301
             D+WSLG+++   L G+ P   G  + P +++  I +  F        T S   +  V 
Sbjct: 207 --DIWSLGILLYTMLAGYTPFANGPSDTPEEILTRIGSGKFTLSGGNWNTVSETAKDLVS 264
Query: 302 SCLEKDWRKRGTVEELLAYPFVTKR 326
             L  D  +R T +++L +P+VT++
Sbjct: 265 KMLHVDPHQRLTAKQVLQHPWVTQK 289

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 77/296 (26%), Positives = 120/296 (40%), Gaps = 32/296 (10%)
Query: 39  TSPDVENISDLKKLTVLGHGNGGIV----YKVRHQKSNSIYALKVLNTTSSTIIRHQAAH 94
           + P V +   LKK+  LG G+ G V    Y   +  +  + A+K L       +R     
Sbjct: 1   SDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQR 60
Query: 95  EAEILKRLDSQFIVKCHAVFYTI-EGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAY 153
           E EIL+ L  + IVK         E  +  VME++  GSL D L  R  +    +   A 
Sbjct: 61  EIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYL-PRHCVGLAQLLLFAQ 119
Query: 154 RVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXI 213
           ++ +G+ YLH    IH  +   N+L++    VKI DFG+++ V E              +
Sbjct: 120 QICEGMAYLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPV 179
Query: 214 GEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLE----CLVGHYPLIGFGE 269
              A  C+  C +                +A DVWS GV + E    C     P   F E
Sbjct: 180 FWYAPECLKECKFY---------------YASDVWSFGVTLYELLTYCDSNQSPHTKFTE 224
Query: 270 -------KPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELL 318
                  +  ++ L   +  GERL  P+    E    +++C E +   R T + L+
Sbjct: 225 LIGHTQGQMTVLRLTELLERGERLPRPDRCPCEIYHLMKNCWETEASFRPTFQNLV 280

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 69/272 (25%), Positives = 128/272 (47%), Gaps = 29/272 (10%)
Query: 49  LKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIV 108
           LK +  LG G  G V+ + +   ++  A+K L   S +     A  EA ++K+L  Q +V
Sbjct: 11  LKLVERLGAGQFGEVW-MGYYNGHTKVAVKSLKQGSMSPDAFLA--EANLMKQLQHQRLV 67
Query: 109 KCHAVFYTIEGEICFVMEHMERGSLFDSLRVRK--KLSEDVISGVAYRVLKGLQYLHGMQ 166
           + +AV    +  I  + E+ME GSL D L+     KL+ + +  +A ++ +G+ ++    
Sbjct: 68  RLYAV--VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 125
Query: 167 IIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAY 226
            IH +++ +N+L++     KIADFG++R++E+                 A         +
Sbjct: 126 YIHRNLRAANILVSDTLSCKIADFGLARLIEDNEYT-------------AREGAKFPIKW 172
Query: 227 MSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICAICFGER 285
            +PE ++     G +    DVWS G+++ E +  G  P  G    P+   +I  +  G R
Sbjct: 173 TAPEAINY----GTFTIKSDVWSFGILLTEIVTHGRIPYPGM-TNPE---VIQNLERGYR 224
Query: 286 LEMPETASPEFRRFVRSCLEKDWRKRGTVEEL 317
           +  P+    E  + +R C ++    R T + L
Sbjct: 225 MVRPDNCPEELYQLMRLCWKERPEDRPTFDYL 256

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 80/310 (25%), Positives = 131/310 (42%), Gaps = 53/310 (17%)
Query: 44  ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALK-VLNTTSSTIIRHQAAHEAEILKRL 102
           +++   + L ++G G+ G+V K R++ +  I A+K  L +    +++  A  E ++LK+L
Sbjct: 22  QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQL 81
Query: 103 DSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYL 162
             + +V    V    +     V E ++   L D       L   V+    ++++ G+ + 
Sbjct: 82  RHENLVNLLEVCKK-KKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFC 140
Query: 163 HGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMG 222
           H   IIH DIKP N+L++  G VK+ DFG +R +                 GE     + 
Sbjct: 141 HSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP--------------GEVYDDEVA 186
Query: 223 TCAYMSPERVDSERWGGD--YGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAI 280
           T  Y +PE +      GD  YG A DVW++G +V E  +G  PL       D +  I  +
Sbjct: 187 TRWYRAPELL-----VGDVKYGKAVDVWAIGCLVTEMFMGE-PLFPGDSDIDQLYHI-MM 239
Query: 281 CFGERL----------------EMPETA--SPEFRRF----------VRSCLEKDWRKRG 312
           C G  +                 +PE     P  RR+           + CL  D  KR 
Sbjct: 240 CLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRP 299
Query: 313 TVEELLAYPF 322
              ELL + F
Sbjct: 300 FCAELLHHDF 309

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 74/256 (28%), Positives = 114/256 (44%), Gaps = 36/256 (14%)
Query: 41  PDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALK-VLNTTSSTIIRHQAAHEAEIL 99
           P  + +S  +KL  +G G  G V+K RH+K+    ALK VL           A  E +IL
Sbjct: 12  PFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKIL 71
Query: 100 KRLDSQFIV--------------KCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSE 145
           + L  + +V              +C A  Y +  + C   EH +   L  ++ V+  LSE
Sbjct: 72  QLLKHENVVNLIEICRTKASPYNRCKASIYLV-FDFC---EH-DLAGLLSNVLVKFTLSE 126
Query: 146 DVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXX 205
             I  V   +L GL Y+H  +I+H D+K +N+LI   G +K+ADFG++R     +     
Sbjct: 127 --IKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPN 184
Query: 206 XXXXXXXIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLI 265
                            T  Y  PE +  ER   DYG   D+W  G ++ E +    P++
Sbjct: 185 RYXNRVV----------TLWYRPPELLLGER---DYGPPIDLWGAGCIMAE-MWTRSPIM 230
Query: 266 GFGEKPDLMALICAIC 281
               +   +ALI  +C
Sbjct: 231 QGNTEQHQLALISQLC 246

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 77/302 (25%), Positives = 134/302 (44%), Gaps = 34/302 (11%)
Query: 35  TSNPTSPDVENISDLKKLTV--LGHGNGGIVYKVRHQKSNSIYALKVLNTTS-STIIRHQ 91
           T N     +EN ++   LT   LG G   +V +   + +   YA K L         R +
Sbjct: 15  TENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAE 74
Query: 92  AAHEAEILKRLDS-QFIVKCHAVFYTIEGEICFVMEHMERGSLFDSL--RVRKKLSEDVI 148
             HE  +L+   S   ++  H V Y    EI  ++E+   G +F      + + +SE+ +
Sbjct: 75  ILHEIAVLELAKSCPRVINLHEV-YENTSEIILILEYAAGGEIFSLCLPELAEMVSENDV 133
Query: 149 SGVAYRVLKGLQYLHGMQIIHGDIKPSNLLING---KGEVKIADFGVSRIVEETRXXXXX 205
             +  ++L+G+ YLH   I+H D+KP N+L++     G++KI DFG+SR           
Sbjct: 134 IRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSR----------- 182
Query: 206 XXXXXXXIGEAAI--ACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYP 263
                  IG A      MGT  Y++PE ++ +        A D+W++G++    L    P
Sbjct: 183 ------KIGHACELREIMGTPEYLAPEILNYDPITT----ATDMWNIGIIAYMLLTHTSP 232
Query: 264 LIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV 323
            +G   +   +  I  +      E   + S     F++S L K+  KR T E  L++ ++
Sbjct: 233 FVGEDNQETYLN-ISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWL 291
Query: 324 TK 325
            +
Sbjct: 292 QQ 293

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 65/268 (24%), Positives = 126/268 (47%), Gaps = 21/268 (7%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQA-AHEAEILKRLDSQFIVKCHAV 113
           +G G+ G VYK    K +   A+K+LN T+ T  + QA  +E  +L++  ++ +     +
Sbjct: 36  IGSGSFGTVYK---GKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRK--TRHVNILLFM 90
Query: 114 FYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDV-ISGVAYRVLKGLQYLHGMQIIHGDI 172
            Y+ + ++  V +  E  SL+  L + +   E + +  +A +  +G+ YLH   IIH D+
Sbjct: 91  GYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDL 150
Query: 173 KPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERV 232
           K +N+ ++    VKI DFG++   E++R                     G+  +M+PE +
Sbjct: 151 KSNNIFLHEDLTVKIGDFGLA--TEKSRWSGSHQFEQLS----------GSILWMAPEVI 198
Query: 233 DSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPETA 292
             +     Y F  DV++ G+V+ E + G  P      +  ++ ++        L    + 
Sbjct: 199 RMQD-KNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSN 257
Query: 293 SPE-FRRFVRSCLEKDWRKRGTVEELLA 319
            P+  +R +  CL+K   +R    ++LA
Sbjct: 258 CPKAMKRLMAECLKKKRDERPLFPQILA 285

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 70/277 (25%), Positives = 121/277 (43%), Gaps = 33/277 (11%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVF 114
           LG G  G+V++V  + + + +A K + T   +  +     E + +  L    +V  H  F
Sbjct: 59  LGTGAFGVVHRVTERATGNNFAAKFVMTPHESD-KETVRKEIQTMSVLRHPTLVNLHDAF 117
Query: 115 YTIEGEICFVMEHMERGSLFDSL-RVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIK 173
              + E+  + E M  G LF+ +     K+SED       +V KGL ++H    +H D+K
Sbjct: 118 ED-DNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLK 176
Query: 174 PSNLLINGK--GEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPER 231
           P N++   K   E+K+ DFG++  ++                 ++     GT  + +PE 
Sbjct: 177 PENIMFTTKRSNELKLIDFGLTAHLDPK---------------QSVKVTTGTAEFAAPEV 221
Query: 232 VDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPET 291
            +    G   G+  D+WS+GV+    L G  P    GE  D        C      M ++
Sbjct: 222 AE----GKPVGYYTDMWSVGVLSYILLSGLSPF--GGENDDETLRNVKSC---DWNMDDS 272
Query: 292 A----SPEFRRFVRSCLEKDWRKRGTVEELLAYPFVT 324
           A    S + + F+R  L  D   R T+ + L +P++T
Sbjct: 273 AFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLT 309

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 77.8 bits (190), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 66/268 (24%), Positives = 124/268 (46%), Gaps = 21/268 (7%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQA-AHEAEILKRLDSQFIVKCHAV 113
           +G G+ G VYK    K +   A+K+LN T+ T  + QA  +E  +L++     I+     
Sbjct: 16  IGSGSFGTVYK---GKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG- 71
Query: 114 FYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDV-ISGVAYRVLKGLQYLHGMQIIHGDI 172
            Y+ + ++  V +  E  SL+  L + +   E + +  +A +  +G+ YLH   IIH D+
Sbjct: 72  -YSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDL 130
Query: 173 KPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERV 232
           K +N+ ++    VKI DFG++   E++R                     G+  +M+PE +
Sbjct: 131 KSNNIFLHEDLTVKIGDFGLA--TEKSRWSGSHQFEQLS----------GSILWMAPEVI 178
Query: 233 DSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPETA 292
             +     Y F  DV++ G+V+ E + G  P      +  ++ ++        L    + 
Sbjct: 179 RMQD-KNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSN 237
Query: 293 SPE-FRRFVRSCLEKDWRKRGTVEELLA 319
            P+  +R +  CL+K   +R    ++LA
Sbjct: 238 CPKAMKRLMAECLKKKRDERPLFPQILA 265

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 77.8 bits (190), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 65/268 (24%), Positives = 124/268 (46%), Gaps = 21/268 (7%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQA-AHEAEILKRLDSQFIVKCHAV 113
           +G G+ G VYK    K +   A+K+LN T+ T  + QA  +E  +L++  ++ +     +
Sbjct: 44  IGSGSFGTVYK---GKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRK--TRHVNILLFM 98
Query: 114 FYTIEGEICFVMEHMERGSLFDSLRV-RKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDI 172
            Y+ + ++  V +  E  SL+  L +   K     +  +A +  +G+ YLH   IIH D+
Sbjct: 99  GYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDL 158
Query: 173 KPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERV 232
           K +N+ ++    VKI DFG++   E++R                     G+  +M+PE +
Sbjct: 159 KSNNIFLHEDLTVKIGDFGLA--TEKSRWSGSHQFEQLS----------GSILWMAPEVI 206
Query: 233 DSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPETA 292
             +     Y F  DV++ G+V+ E + G  P      +  ++ ++        L    + 
Sbjct: 207 RMQD-KNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSN 265
Query: 293 SPE-FRRFVRSCLEKDWRKRGTVEELLA 319
            P+  +R +  CL+K   +R    ++LA
Sbjct: 266 CPKAMKRLMAECLKKKRDERPLFPQILA 293

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 77/295 (26%), Positives = 119/295 (40%), Gaps = 32/295 (10%)
Query: 40  SPDVENISDLKKLTVLGHGNGGIV----YKVRHQKSNSIYALKVLNTTSSTIIRHQAAHE 95
            P V +   LKK+  LG G+ G V    Y   +  +  + A+K L       +R     E
Sbjct: 1   DPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQRE 60
Query: 96  AEILKRLDSQFIVKCHAVFYTI-EGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYR 154
            EIL+ L  + IVK         E  +  VME++  GSL D L  R  +    +   A +
Sbjct: 61  IEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYL-PRHCVGLAQLLLFAQQ 119
Query: 155 VLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIG 214
           + +G+ YLH    IH  +   N+L++    VKI DFG+++ V E              + 
Sbjct: 120 ICEGMAYLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF 179
Query: 215 EAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLE----CLVGHYPLIGFGE- 269
             A  C+  C +                +A DVWS GV + E    C     P   F E 
Sbjct: 180 WYAPECLKECKFY---------------YASDVWSFGVTLYELLTYCDSNQSPHTKFTEL 224
Query: 270 ------KPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELL 318
                 +  ++ L   +  GERL  P+    E    +++C E +   R T + L+
Sbjct: 225 IGHTQGQMTVLRLTELLERGERLPRPDRCPCEIYHLMKNCWETEASFRPTFQNLV 279

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 77/297 (25%), Positives = 123/297 (41%), Gaps = 33/297 (11%)
Query: 38  PTSPDVENISDLKKLTVLGHGNGGIVYKVRHQ----KSNSIYALKVLNTTSSTIIRHQAA 93
           P  P +     LK ++ LG GN G V   R+      + ++ A+K L  +     R    
Sbjct: 2   PQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQR-DFQ 60
Query: 94  HEAEILKRLDSQFIVKCHAVFYTI-EGEICFVMEHMERGSLFDSL-RVRKKLSEDVISGV 151
            E +ILK L S FIVK   V Y      +  VME++  G L D L R R +L    +   
Sbjct: 61  REIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLY 120
Query: 152 AYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXX 211
           + ++ KG++YL   + +H D+   N+L+  +  VKIADFG+++++   +           
Sbjct: 121 SSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREP--- 177
Query: 212 XIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLE----CLVGHYPLIGF 267
             G++ I       + +PE +        +    DVWS GVV+ E    C     P   F
Sbjct: 178 --GQSPI------FWYAPESLSD----NIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEF 225
Query: 268 GEKPDLMALICAIC-------FGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEEL 317
                    + A+C        G+RL  P     E    ++ C     + R +   L
Sbjct: 226 LRMMGCERDVPALCRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSAL 282

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 70/277 (25%), Positives = 121/277 (43%), Gaps = 33/277 (11%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVF 114
           LG G  G+V++V  + + + +A K + T   +  +     E + +  L    +V  H  F
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESD-KETVRKEIQTMSVLRHPTLVNLHDAF 223
Query: 115 YTIEGEICFVMEHMERGSLFDSL-RVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIK 173
              + E+  + E M  G LF+ +     K+SED       +V KGL ++H    +H D+K
Sbjct: 224 ED-DNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLK 282
Query: 174 PSNLLINGK--GEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPER 231
           P N++   K   E+K+ DFG++  ++                 ++     GT  + +PE 
Sbjct: 283 PENIMFTTKRSNELKLIDFGLTAHLDPK---------------QSVKVTTGTAEFAAPEV 327
Query: 232 VDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPET 291
            +    G   G+  D+WS+GV+    L G  P    GE  D        C      M ++
Sbjct: 328 AE----GKPVGYYTDMWSVGVLSYILLSGLSPF--GGENDDETLRNVKSC---DWNMDDS 378
Query: 292 A----SPEFRRFVRSCLEKDWRKRGTVEELLAYPFVT 324
           A    S + + F+R  L  D   R T+ + L +P++T
Sbjct: 379 AFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLT 415

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 101/224 (45%), Gaps = 26/224 (11%)
Query: 46  ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRL--- 102
           I + + + VLG G+ G V   R +++  +YA+KVL      I++          KR+   
Sbjct: 22  IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLK--KDVILQDDDVECTMTEKRILSL 79
Query: 103 --DSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQ 160
             +  F+ +    F T +  + FVME +  G L   ++  ++  E      A  ++  L 
Sbjct: 80  ARNHPFLTQLFCCFQTPD-RLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALM 138
Query: 161 YLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIAC 220
           +LH   II+ D+K  N+L++ +G  K+ADFG+ +                   G      
Sbjct: 139 FLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCK--------------EGICNGVTTATF 184
Query: 221 MGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPL 264
            GT  Y++PE +        YG A D W++GV++ E L GH P 
Sbjct: 185 CGTPDYIAPEILQEML----YGPAVDWWAMGVLLYEMLCGHAPF 224

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 77.4 bits (189), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 74/310 (23%), Positives = 132/310 (42%), Gaps = 44/310 (14%)
Query: 51  KLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKC 110
            L+ +G G  G+V       +    A+K ++         +   E +IL R   + I+  
Sbjct: 47  NLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI 106
Query: 111 HAVFY--TIEG-EICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQI 167
           + +    TIE  +  +++ H+    L+  L+  + LS D I    Y++L+GL+Y+H   +
Sbjct: 107 NDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANV 165
Query: 168 IHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYM 227
           +H D+KPSNLL+N   ++KI DFG++R+ +                       + T  Y 
Sbjct: 166 LHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEY-----------VATRWYR 214
Query: 228 SPERVDSERWGGDYGFAGDVWSLGVVVLECLVG-------HY-----PLIGFGEKPDLMA 275
           +PE + + +    Y  + D+WS+G ++ E L         HY      ++G    P    
Sbjct: 215 APEIMLNSK---GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 271
Query: 276 LICAICFGER---LEMPETASPEFRRFVRSCLEK-----------DWRKRGTVEELLAYP 321
           L C I    R   L +P      + R   +   K           +  KR  VE+ LA+P
Sbjct: 272 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP 331
Query: 322 FVTKRSSSSN 331
           ++ +    S+
Sbjct: 332 YLEQYYDPSD 341

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 77.4 bits (189), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 73/294 (24%), Positives = 137/294 (46%), Gaps = 36/294 (12%)
Query: 52  LTVLGHGNGGIVYKVRHQKSNSIYALKVLN---TTSSTI--IRHQAAHEAEILKRLDSQF 106
           L  +G G    V++V ++K   IYA+K +N     + T+   R++ A+  ++ +  D   
Sbjct: 17  LKQIGSGGSSKVFQVLNEKK-QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK-- 73
Query: 107 IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAY--RVLKGLQYLHG 164
           I++ +   Y I  +  +++  ME G++  +  ++KK S D     +Y   +L+ +  +H 
Sbjct: 74  IIRLYD--YEITDQYIYMV--MECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 129
Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTC 224
             I+H D+KP+N LI   G +K+ DFG++  ++                     + +GT 
Sbjct: 130 HGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKD------------SQVGTV 176
Query: 225 AYMSPERV---DSERWGGDYGFAG----DVWSLGVVVLECLVGHYPLIGFGEKPDLMALI 277
            YM PE +    S R  G          DVWSLG ++     G  P      +  +  L 
Sbjct: 177 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ--ISKLH 234
Query: 278 CAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSN 331
             I     +E P+    + +  ++ CL++D ++R ++ ELLA+P+V  ++   N
Sbjct: 235 AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVN 288

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 73/294 (24%), Positives = 137/294 (46%), Gaps = 36/294 (12%)
Query: 52  LTVLGHGNGGIVYKVRHQKSNSIYALKVLN---TTSSTI--IRHQAAHEAEILKRLDSQF 106
           L  +G G    V++V ++K   IYA+K +N     + T+   R++ A+  ++ +  D   
Sbjct: 33  LKQIGSGGSSKVFQVLNEKK-QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK-- 89
Query: 107 IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAY--RVLKGLQYLHG 164
           I++ +   Y I  +  +++  ME G++  +  ++KK S D     +Y   +L+ +  +H 
Sbjct: 90  IIRLYD--YEITDQYIYMV--MECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 145
Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTC 224
             I+H D+KP+N LI   G +K+ DFG++  ++                     + +GT 
Sbjct: 146 HGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKD------------SQVGTV 192
Query: 225 AYMSPERV---DSERWGGDYGFAG----DVWSLGVVVLECLVGHYPLIGFGEKPDLMALI 277
            YM PE +    S R  G          DVWSLG ++     G  P      +  +  L 
Sbjct: 193 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ--ISKLH 250
Query: 278 CAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSN 331
             I     +E P+    + +  ++ CL++D ++R ++ ELLA+P+V  ++   N
Sbjct: 251 AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVN 304

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 73/294 (24%), Positives = 137/294 (46%), Gaps = 36/294 (12%)
Query: 52  LTVLGHGNGGIVYKVRHQKSNSIYALKVLN---TTSSTI--IRHQAAHEAEILKRLDSQF 106
           L  +G G    V++V ++K   IYA+K +N     + T+   R++ A+  ++ +  D   
Sbjct: 61  LKQIGSGGSSKVFQVLNEKK-QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK-- 117
Query: 107 IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAY--RVLKGLQYLHG 164
           I++ +   Y I  +  +++  ME G++  +  ++KK S D     +Y   +L+ +  +H 
Sbjct: 118 IIRLYD--YEITDQYIYMV--MECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 173
Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTC 224
             I+H D+KP+N LI   G +K+ DFG++  ++                     + +GT 
Sbjct: 174 HGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKD------------SQVGTV 220
Query: 225 AYMSPERV---DSERWGGDYGFAG----DVWSLGVVVLECLVGHYPLIGFGEKPDLMALI 277
            YM PE +    S R  G          DVWSLG ++     G  P      +  +  L 
Sbjct: 221 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ--ISKLH 278
Query: 278 CAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSN 331
             I     +E P+    + +  ++ CL++D ++R ++ ELLA+P+V  ++   N
Sbjct: 279 AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVN 332

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 70/267 (26%), Positives = 115/267 (43%), Gaps = 30/267 (11%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHA 112
           LG G  G V    HQ +    A+K+LN     S  +  +   E + LK      I+K + 
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 113 VFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDI 172
           V  T   +   VME++  G LFD +    ++ E     +  ++L  + Y H   ++H D+
Sbjct: 79  VIST-PTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDL 137
Query: 173 KPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERV 232
           KP N+L++     KIADFG+S ++ +               GE      G+  Y +PE +
Sbjct: 138 KPENVLLDAHMNAKIADFGLSNMMSD---------------GEFLRTSCGSPNYAAPEVI 182
Query: 233 DSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEK--PDLMALICAICFGERLEMPE 290
               + G      D+WS GV++   L G  P   F ++  P L   I    F     +PE
Sbjct: 183 SGRLYAGP---EVDIWSCGVILYALLCGTLP---FDDEHVPTLFKKIRGGVF----YIPE 232
Query: 291 TASPEFRRFVRSCLEKDWRKRGTVEEL 317
             +      +   L+ D  KR T++++
Sbjct: 233 YLNRSVATLLMHMLQVDPLKRATIKDI 259

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 104/218 (47%), Gaps = 24/218 (11%)
Query: 49  LKKLTVLGHGNGGIV----YKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDS 104
           LK L  LG GN G V    Y      +  + A+K L  ++   +R     E EILK L  
Sbjct: 11  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQH 69
Query: 105 QFIVKCHAVFYTI-EGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAY--RVLKGLQY 161
             IVK   V Y+     +  +ME++  GSL D L+  K+   D I  + Y  ++ KG++Y
Sbjct: 70  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI-DHIKLLQYTSQICKGMEY 128
Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACM 221
           L   + IH D+   N+L+  +  VKI DFG+++++ + +             GE+ I   
Sbjct: 129 LGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEP-----GESPI--- 180
Query: 222 GTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV 259
               + +PE +   +    +  A DVWS GVV+ E   
Sbjct: 181 ---FWYAPESLTESK----FSVASDVWSFGVVLYELFT 211

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 104/218 (47%), Gaps = 24/218 (11%)
Query: 49  LKKLTVLGHGNGGIV----YKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDS 104
           LK L  LG GN G V    Y      +  + A+K L  ++   +R     E EILK L  
Sbjct: 16  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQH 74
Query: 105 QFIVKCHAVFYTI-EGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAY--RVLKGLQY 161
             IVK   V Y+     +  +ME++  GSL D L+  K+   D I  + Y  ++ KG++Y
Sbjct: 75  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI-DHIKLLQYTSQICKGMEY 133
Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACM 221
           L   + IH D+   N+L+  +  VKI DFG+++++ + +             GE+ I   
Sbjct: 134 LGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEP-----GESPI--- 185
Query: 222 GTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV 259
               + +PE +   +    +  A DVWS GVV+ E   
Sbjct: 186 ---FWYAPESLTESK----FSVASDVWSFGVVLYELFT 216

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 104/218 (47%), Gaps = 24/218 (11%)
Query: 49  LKKLTVLGHGNGGIV----YKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDS 104
           LK L  LG GN G V    Y      +  + A+K L  ++   +R     E EILK L  
Sbjct: 15  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQH 73
Query: 105 QFIVKCHAVFYTI-EGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAY--RVLKGLQY 161
             IVK   V Y+     +  +ME++  GSL D L+  K+   D I  + Y  ++ KG++Y
Sbjct: 74  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI-DHIKLLQYTSQICKGMEY 132
Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACM 221
           L   + IH D+   N+L+  +  VKI DFG+++++ + +             GE+ I   
Sbjct: 133 LGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEP-----GESPI--- 184
Query: 222 GTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV 259
               + +PE +   +    +  A DVWS GVV+ E   
Sbjct: 185 ---FWYAPESLTESK----FSVASDVWSFGVVLYELFT 215

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 104/218 (47%), Gaps = 24/218 (11%)
Query: 49  LKKLTVLGHGNGGIV----YKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDS 104
           LK L  LG GN G V    Y      +  + A+K L  ++   +R     E EILK L  
Sbjct: 10  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQH 68
Query: 105 QFIVKCHAVFYTI-EGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAY--RVLKGLQY 161
             IVK   V Y+     +  +ME++  GSL D L+ + K   D I  + Y  ++ KG++Y
Sbjct: 69  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYTSQICKGMEY 127
Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACM 221
           L   + IH D+   N+L+  +  VKI DFG+++++ + +             GE+ I   
Sbjct: 128 LGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEP-----GESPI--- 179
Query: 222 GTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV 259
               + +PE +   +    +  A DVWS GVV+ E   
Sbjct: 180 ---FWYAPESLTESK----FSVASDVWSFGVVLYELFT 210

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 73/294 (24%), Positives = 137/294 (46%), Gaps = 36/294 (12%)
Query: 52  LTVLGHGNGGIVYKVRHQKSNSIYALKVLN---TTSSTI--IRHQAAHEAEILKRLDSQF 106
           L  +G G    V++V ++K   IYA+K +N     + T+   R++ A+  ++ +  D   
Sbjct: 13  LKQIGSGGSSKVFQVLNEKK-QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK-- 69
Query: 107 IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAY--RVLKGLQYLHG 164
           I++ +   Y I  +  +++  ME G++  +  ++KK S D     +Y   +L+ +  +H 
Sbjct: 70  IIRLYD--YEITDQYIYMV--MECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 125
Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTC 224
             I+H D+KP+N LI   G +K+ DFG++  ++                     + +GT 
Sbjct: 126 HGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKD------------SQVGTV 172
Query: 225 AYMSPERV---DSERWGGDYGFAG----DVWSLGVVVLECLVGHYPLIGFGEKPDLMALI 277
            YM PE +    S R  G          DVWSLG ++     G  P      +  +  L 
Sbjct: 173 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ--ISKLH 230
Query: 278 CAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSN 331
             I     +E P+    + +  ++ CL++D ++R ++ ELLA+P+V  ++   N
Sbjct: 231 AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVN 284

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 78/286 (27%), Positives = 123/286 (43%), Gaps = 33/286 (11%)
Query: 49  LKKLTVLGHGNGGIVYKVRHQ----KSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDS 104
           LK ++ LG GN G V   R+      + ++ A+K L  +     R     E +ILK L S
Sbjct: 9   LKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQR-DFQREIQILKALHS 67
Query: 105 QFIVKCHAVFYTI-EGEICFVMEHMERGSLFDSL-RVRKKLSEDVISGVAYRVLKGLQYL 162
            FIVK   V Y     E+  VME++  G L D L R R +L    +   + ++ KG++YL
Sbjct: 68  DFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYL 127
Query: 163 HGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMG 222
              + +H D+   N+L+  +  VKIADFG+++++   +             G++ I    
Sbjct: 128 GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREP-----GQSPI---- 178
Query: 223 TCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLE----CLVGHYPLIGFGEKPDLMALIC 278
              + +PE +        +    DVWS GVV+ E    C     P   F         + 
Sbjct: 179 --FWYAPESLSD----NIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVP 232
Query: 279 AIC-------FGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEEL 317
           A+C        G+RL  P     E    ++ C     + R +   L
Sbjct: 233 ALCRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSAL 278

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 104/218 (47%), Gaps = 24/218 (11%)
Query: 49  LKKLTVLGHGNGGIV----YKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDS 104
           LK L  LG GN G V    Y      +  + A+K L  ++   +R     E EILK L  
Sbjct: 17  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQH 75
Query: 105 QFIVKCHAVFYTI-EGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAY--RVLKGLQY 161
             IVK   V Y+     +  +ME++  GSL D L+  K+   D I  + Y  ++ KG++Y
Sbjct: 76  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI-DHIKLLQYTSQICKGMEY 134
Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACM 221
           L   + IH D+   N+L+  +  VKI DFG+++++ + +             GE+ I   
Sbjct: 135 LGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEP-----GESPI--- 186
Query: 222 GTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV 259
               + +PE +   +    +  A DVWS GVV+ E   
Sbjct: 187 ---FWYAPESLTESK----FSVASDVWSFGVVLYELFT 217

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 75/294 (25%), Positives = 139/294 (47%), Gaps = 36/294 (12%)
Query: 52  LTVLGHGNGGIVYKVRHQKSNSIYALKVLN---TTSSTI--IRHQAAHEAEILKRLDSQF 106
           L  +G G    V++V ++K   IYA+K +N     + T+   R++ A+  ++ +  D   
Sbjct: 33  LKQIGSGGSSKVFQVLNEKK-QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK-- 89
Query: 107 IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAY--RVLKGLQYLHG 164
           I++ +   Y I  +  +++  ME G++  +  ++KK S D     +Y   +L+ +  +H 
Sbjct: 90  IIRLYD--YEITDQYIYMV--MECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 145
Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTC 224
             I+H D+KP+N LI   G +K+ DFG++  ++                     + +GT 
Sbjct: 146 HGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDXXXVVKD------------SQVGTV 192
Query: 225 AYMSPERV---DSERWGGDYGFAG----DVWSLGVVVLECLVGHYPLIGFGEKPDLMALI 277
            YM PE +    S R  G          DVWSLG ++     G  P      +  +  L 
Sbjct: 193 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ--ISKLH 250
Query: 278 CAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSN 331
             I     +E P+    + +  ++ CL++D ++R ++ ELLA+P+V  ++   N
Sbjct: 251 AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVN 304

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 104/218 (47%), Gaps = 24/218 (11%)
Query: 49  LKKLTVLGHGNGGIV----YKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDS 104
           LK L  LG GN G V    Y      +  + A+K L  ++   +R     E EILK L  
Sbjct: 12  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQH 70
Query: 105 QFIVKCHAVFYTI-EGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAY--RVLKGLQY 161
             IVK   V Y+     +  +ME++  GSL D L+  K+   D I  + Y  ++ KG++Y
Sbjct: 71  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI-DHIKLLQYTSQICKGMEY 129
Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACM 221
           L   + IH D+   N+L+  +  VKI DFG+++++ + +             GE+ I   
Sbjct: 130 LGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEP-----GESPI--- 181
Query: 222 GTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV 259
               + +PE +   +    +  A DVWS GVV+ E   
Sbjct: 182 ---FWYAPESLTESK----FSVASDVWSFGVVLYELFT 212

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 73/310 (23%), Positives = 132/310 (42%), Gaps = 44/310 (14%)
Query: 51  KLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKC 110
            L+ +G G  G+V       +    A+K ++         +   E +IL R   + I+  
Sbjct: 31  NLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENIIGI 90
Query: 111 HAVFY--TIEG-EICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQI 167
           + +    TIE  +  ++++ +    L+  L+  + LS D I    Y++L+GL+Y+H   +
Sbjct: 91  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANV 149
Query: 168 IHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYM 227
           +H D+KPSNLL+N   ++KI DFG++R+ +                       + T  Y 
Sbjct: 150 LHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEY-----------VATRWYR 198
Query: 228 SPERVDSERWGGDYGFAGDVWSLGVVVLECLVG-------HY-----PLIGFGEKPDLMA 275
           +PE + + +    Y  + D+WS+G ++ E L         HY      ++G    P    
Sbjct: 199 APEIMLNSK---GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 255
Query: 276 LICAICFGER---LEMPETASPEFRRFVRSCLEK-----------DWRKRGTVEELLAYP 321
           L C I    R   L +P      + R   +   K           +  KR  VE+ LA+P
Sbjct: 256 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP 315
Query: 322 FVTKRSSSSN 331
           ++ +    S+
Sbjct: 316 YLEQYYDPSD 325

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 73/294 (24%), Positives = 137/294 (46%), Gaps = 36/294 (12%)
Query: 52  LTVLGHGNGGIVYKVRHQKSNSIYALKVLN---TTSSTI--IRHQAAHEAEILKRLDSQF 106
           L  +G G    V++V ++K   IYA+K +N     + T+   R++ A+  ++ +  D   
Sbjct: 14  LKQIGSGGSSKVFQVLNEKK-QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK-- 70
Query: 107 IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAY--RVLKGLQYLHG 164
           I++ +   Y I  +  +++  ME G++  +  ++KK S D     +Y   +L+ +  +H 
Sbjct: 71  IIRLYD--YEITDQYIYMV--MECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 126
Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTC 224
             I+H D+KP+N LI   G +K+ DFG++  ++                     + +GT 
Sbjct: 127 HGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKD------------SQVGTV 173
Query: 225 AYMSPERV---DSERWGGDYGFAG----DVWSLGVVVLECLVGHYPLIGFGEKPDLMALI 277
            YM PE +    S R  G          DVWSLG ++     G  P      +  +  L 
Sbjct: 174 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ--ISKLH 231
Query: 278 CAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSN 331
             I     +E P+    + +  ++ CL++D ++R ++ ELLA+P+V  ++   N
Sbjct: 232 AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVN 285

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 104/218 (47%), Gaps = 24/218 (11%)
Query: 49  LKKLTVLGHGNGGIV----YKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDS 104
           LK L  LG GN G V    Y      +  + A+K L  ++   +R     E EILK L  
Sbjct: 43  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQH 101
Query: 105 QFIVKCHAVFYTI-EGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAY--RVLKGLQY 161
             IVK   V Y+     +  +ME++  GSL D L+  K+   D I  + Y  ++ KG++Y
Sbjct: 102 DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI-DHIKLLQYTSQICKGMEY 160
Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACM 221
           L   + IH D+   N+L+  +  VKI DFG+++++ + +             GE+ I   
Sbjct: 161 LGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEP-----GESPI--- 212
Query: 222 GTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV 259
               + +PE +   +    +  A DVWS GVV+ E   
Sbjct: 213 ---FWYAPESLTESK----FSVASDVWSFGVVLYELFT 243

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 104/218 (47%), Gaps = 24/218 (11%)
Query: 49  LKKLTVLGHGNGGIV----YKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDS 104
           LK L  LG GN G V    Y      +  + A+K L  ++   +R     E EILK L  
Sbjct: 18  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQH 76
Query: 105 QFIVKCHAVFYTI-EGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAY--RVLKGLQY 161
             IVK   V Y+     +  +ME++  GSL D L+  K+   D I  + Y  ++ KG++Y
Sbjct: 77  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI-DHIKLLQYTSQICKGMEY 135
Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACM 221
           L   + IH D+   N+L+  +  VKI DFG+++++ + +             GE+ I   
Sbjct: 136 LGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEP-----GESPI--- 187
Query: 222 GTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV 259
               + +PE +   +    +  A DVWS GVV+ E   
Sbjct: 188 ---FWYAPESLTESK----FSVASDVWSFGVVLYELFT 218

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 79/301 (26%), Positives = 124/301 (41%), Gaps = 35/301 (11%)
Query: 34  PTSNPTSPDVENISDLKKLTVLGHGNGGIV----YKVRHQKSNSIYALKVLNTTSSTIIR 89
           P S+PT   V +   LKK+  LG G+ G V    Y   +  +  + A+K L        R
Sbjct: 4   PASDPT---VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHR 60
Query: 90  HQAAHEAEILKRLDSQFIVKCHAVFYTI-EGEICFVMEHMERGSLFDSLRVRKKLSEDVI 148
                E +IL+ L  + I+K         E  +  VME++  GSL D L  R  +    +
Sbjct: 61  SGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYL-PRHSIGLAQL 119
Query: 149 SGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXX 208
              A ++ +G+ YLH    IH ++   N+L++    VKI DFG+++ V E          
Sbjct: 120 LLFAQQICEGMAYLHAQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVRED 179
Query: 209 XXXXIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLE----CLVGHYP- 263
               +   A  C+    +                +A DVWS GV + E    C     P 
Sbjct: 180 GDSPVFWYAPECLKEYKFY---------------YASDVWSFGVTLYELLTHCDSSQSPP 224
Query: 264 -----LIGFGE-KPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEEL 317
                LIG  + +  ++ L   +  GERL  P+    E    +++C E +   R T E L
Sbjct: 225 TKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPCEVYHLMKNCWETEASFRPTFENL 284
Query: 318 L 318
           +
Sbjct: 285 I 285

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 101/220 (45%), Gaps = 20/220 (9%)
Query: 46  ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQ 105
           + D   +  LG G  G V    ++ +    A+K+++   +         E  I K L+ +
Sbjct: 5   VEDWDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 106 FIVKCHAVFYTIEGEICFV-MEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG 164
            +VK +   +  EG I ++ +E+   G LFD +     + E       ++++ G+ YLHG
Sbjct: 65  NVVKFYG--HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACM-GT 223
           + I H DIKP NLL++ +  +KI+DFG++ +                   E  +  M GT
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR-------------ERLLNKMCGT 169
Query: 224 CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYP 263
             Y++PE +    +  +     DVWS G+V+   L G  P
Sbjct: 170 LPYVAPELLKRREFHAE---PVDVWSCGIVLTAMLAGELP 206

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 98/219 (44%), Gaps = 18/219 (8%)
Query: 46  ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQ 105
           + D   +  LG G  G V    ++ +    A+K+++   +         E  I K L+ +
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE 65
Query: 106 FIVKCHAVFYTIEGEICFV-MEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG 164
            +VK +   +  EG I ++ +E+   G LFD +     + E       ++++ G+ YLHG
Sbjct: 66  NVVKFYG--HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTC 224
           + I H DIKP NLL++ +  +KI+DFG++ +                          GT 
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN------------KMXGTL 171
Query: 225 AYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYP 263
            Y++PE +    +  +     DVWS G+V+   L G  P
Sbjct: 172 PYVAPELLKRREFHAE---PVDVWSCGIVLTAMLAGELP 207

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 104/218 (47%), Gaps = 24/218 (11%)
Query: 49  LKKLTVLGHGNGGIV----YKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDS 104
           LK L  LG GN G V    Y      +  + A+K L  ++   +R     E EILK L  
Sbjct: 19  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQH 77
Query: 105 QFIVKCHAVFYTI-EGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAY--RVLKGLQY 161
             IVK   V Y+     +  +ME++  GSL D L+  K+   D I  + Y  ++ KG++Y
Sbjct: 78  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI-DHIKLLQYTSQICKGMEY 136
Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACM 221
           L   + IH D+   N+L+  +  VKI DFG+++++ + +             GE+ I   
Sbjct: 137 LGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEP-----GESPI--- 188
Query: 222 GTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV 259
               + +PE +   +    +  A DVWS GVV+ E   
Sbjct: 189 ---FWYAPESLTESK----FSVASDVWSFGVVLYELFT 219

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 105/216 (48%), Gaps = 26/216 (12%)
Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH-EAEILKRLDSQFIV 108
           + L+ +G G  G V      KS    A+K L+    +II  +  + E  +LK +  + ++
Sbjct: 54  QTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI 113
Query: 109 KCHAVFYTI----EGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG 164
               VF       E    +++ H+  G+  +++   +KL++D +  + Y++L+GL+Y+H 
Sbjct: 114 GLLDVFTPATSLEEFNDVYLVTHL-MGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 172
Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTC 224
             IIH D+KPSNL +N   E+KI DFG++R  +                 +     + T 
Sbjct: 173 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-----------------DEMTGYVATR 215
Query: 225 AYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVG 260
            Y +PE + +  W   Y    D+WS+G ++ E L G
Sbjct: 216 WYRAPEIMLN--WMH-YNMTVDIWSVGCIMAELLTG 248

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/268 (24%), Positives = 124/268 (46%), Gaps = 21/268 (7%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQA-AHEAEILKRLDSQFIVKCHAV 113
           +G G+ G VYK    K +   A+K+LN T+ T  + QA  +E  +L++     I+     
Sbjct: 18  IGSGSFGTVYK---GKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG- 73
Query: 114 FYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDV-ISGVAYRVLKGLQYLHGMQIIHGDI 172
            Y+ + ++  V +  E  SL+  L + +   E + +  +A +  +G+ YLH   IIH D+
Sbjct: 74  -YSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDL 132
Query: 173 KPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERV 232
           K +N+ ++    VKI DFG++ +  ++R                     G+  +M+PE +
Sbjct: 133 KSNNIFLHEDLTVKIGDFGLATV--KSRWSGSHQFEQLS----------GSILWMAPEVI 180
Query: 233 DSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPETA 292
             +     Y F  DV++ G+V+ E + G  P      +  ++ ++        L    + 
Sbjct: 181 RMQD-KNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSN 239
Query: 293 SPE-FRRFVRSCLEKDWRKRGTVEELLA 319
            P+  +R +  CL+K   +R    ++LA
Sbjct: 240 CPKAMKRLMAECLKKKRDERPLFPQILA 267

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 101/220 (45%), Gaps = 20/220 (9%)
Query: 46  ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQ 105
           + D   +  LG G  G V    ++ +    A+K+++   +         E  I K L+ +
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE 64
Query: 106 FIVKCHAVFYTIEGEICFV-MEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG 164
            +VK +   +  EG I ++ +E+   G LFD +     + E       ++++ G+ YLHG
Sbjct: 65  NVVKFYG--HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACM-GT 223
           + I H DIKP NLL++ +  +KI+DFG++ +                   E  +  M GT
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR-------------ERLLNKMCGT 169
Query: 224 CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYP 263
             Y++PE +    +  +     DVWS G+V+   L G  P
Sbjct: 170 LPYVAPELLKRREFHAE---PVDVWSCGIVLTAMLAGELP 206

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 101/220 (45%), Gaps = 20/220 (9%)
Query: 46  ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQ 105
           + D   +  LG G  G V    ++ +    A+K+++   +         E  I K L+ +
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE 64
Query: 106 FIVKCHAVFYTIEGEICFV-MEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG 164
            +VK +   +  EG I ++ +E+   G LFD +     + E       ++++ G+ YLHG
Sbjct: 65  NVVKFYG--HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACM-GT 223
           + I H DIKP NLL++ +  +KI+DFG++ +                   E  +  M GT
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR-------------ERLLNKMXGT 169
Query: 224 CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYP 263
             Y++PE +    +  +     DVWS G+V+   L G  P
Sbjct: 170 LPYVAPELLKRREFHAE---PVDVWSCGIVLTAMLAGELP 206

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 104/218 (47%), Gaps = 24/218 (11%)
Query: 49  LKKLTVLGHGNGGIV----YKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDS 104
           LK L  LG GN G V    Y      +  + A+K L  ++   +R     E EILK L  
Sbjct: 12  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQH 70
Query: 105 QFIVKCHAVFYTI-EGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAY--RVLKGLQY 161
             IVK   V Y+     +  +ME++  GSL D L+  K+   D I  + Y  ++ KG++Y
Sbjct: 71  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI-DHIKLLQYTSQICKGMEY 129
Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACM 221
           L   + IH D+   N+L+  +  VKI DFG+++++ + +             GE+ I   
Sbjct: 130 LGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEP-----GESPI--- 181
Query: 222 GTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV 259
               + +PE +   +    +  A DVWS GVV+ E   
Sbjct: 182 ---FWYAPESLTESK----FSVASDVWSFGVVLYELFT 212

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 72/278 (25%), Positives = 122/278 (43%), Gaps = 35/278 (12%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVF 114
           +G G+  +  +  H+ +N  +A+K+++ +     +     E EIL R      +      
Sbjct: 30  IGVGSYSVCKRCIHKATNXEFAVKIIDKS-----KRDPTEEIEILLRYGQHPNIITLKDV 84
Query: 115 YTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKP 174
           Y     +  V E  + G L D +  +K  SE   S V + + K ++YLH   ++H D+KP
Sbjct: 85  YDDGKYVYVVTELXKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKP 144
Query: 175 SNLLI---NGKGE-VKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPE 230
           SN+L    +G  E ++I DFG ++ +                 G     C  T  +++PE
Sbjct: 145 SNILYVDESGNPESIRICDFGFAKQLRAEN-------------GLLXTPCY-TANFVAPE 190
Query: 231 RVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPD-----LMALICAICFGER 285
            +  ER G  Y  A D+WSLGV++   L G+ P   F   PD     ++A I +  F   
Sbjct: 191 VL--ERQG--YDAACDIWSLGVLLYTXLTGYTP---FANGPDDTPEEILARIGSGKFSLS 243
Query: 286 LEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV 323
                + S   +  V   L  D  +R T   +L +P++
Sbjct: 244 GGYWNSVSDTAKDLVSKXLHVDPHQRLTAALVLRHPWI 281

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 73/286 (25%), Positives = 133/286 (46%), Gaps = 36/286 (12%)
Query: 52  LTVLGHGNGGIVYKVRHQKSNSIYALKVLN---TTSSTIIRHQAAHEAEILKRLD--SQF 106
           L  +G G    V++V ++K   IYA+K +N     + T+  ++  +E   L +L   S  
Sbjct: 61  LKQIGSGGSSKVFQVLNEKK-QIYAIKYVNLEEADNQTLDSYR--NEIAYLNKLQQHSDK 117
Query: 107 IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAY--RVLKGLQYLHG 164
           I++ +   Y I  +  +++  ME G++  +  ++KK S D     +Y   +L+ +  +H 
Sbjct: 118 IIRLYD--YEITDQYIYMV--MECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 173
Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTC 224
             I+H D+KP+N LI   G +K+ DFG++  ++                     + +GT 
Sbjct: 174 HGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKD------------SQVGTV 220
Query: 225 AYMSPERV---DSERWGGDYGFAG----DVWSLGVVVLECLVGHYPLIGFGEKPDLMALI 277
            YM PE +    S R  G          DVWSLG ++     G  P      +  +  L 
Sbjct: 221 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ--ISKLH 278
Query: 278 CAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV 323
             I     +E P+    + +  ++ CL++D ++R ++ ELLA+P+V
Sbjct: 279 AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 324

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 77/298 (25%), Positives = 119/298 (39%), Gaps = 64/298 (21%)
Query: 48  DLKKLT---VLGHGNGGIVYKV------------RHQKSNSIYALKVLNTTSSTIIRHQA 92
           D  +LT   ++G G  G VY+             RH     I         S TI     
Sbjct: 5   DFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDI---------SQTI--ENV 53
Query: 93  AHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVA 152
             EA++   L    I+    V    E  +C VME   RG   + +   K++  D++   A
Sbjct: 54  RQEAKLFAMLKHPNIIALRGVCLK-EPNLCLVME-FARGGPLNRVLSGKRIPPDILVNWA 111
Query: 153 YRVLKGLQYLHG---MQIIHGDIKPSNLLINGKGE--------VKIADFGVSRIVEETRX 201
            ++ +G+ YLH    + IIH D+K SN+LI  K E        +KI DFG++R    T  
Sbjct: 112 VQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRT-- 169
Query: 202 XXXXXXXXXXXIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGH 261
                           ++  G  A+M+PE + +      +    DVWS GV++ E L G 
Sbjct: 170 --------------TKMSAAGAYAWMAPEVIRASM----FSKGSDVWSYGVLLWELLTGE 211
Query: 262 YPLIGFGEKPDLMALICAICFGE-RLEMPETASPEFRRFVRSCLEKDWRKRGTVEELL 318
            P  G     D +A+   +   +  L +P T    F + +  C   D   R +   +L
Sbjct: 212 VPFRGI----DGLAVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNIL 265

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 79/301 (26%), Positives = 124/301 (41%), Gaps = 35/301 (11%)
Query: 34  PTSNPTSPDVENISDLKKLTVLGHGNGGIV----YKVRHQKSNSIYALKVLNTTSSTIIR 89
           P S+PT   V +   LKK+  LG G+ G V    Y   +  +  + A+K L        R
Sbjct: 4   PASDPT---VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHR 60
Query: 90  HQAAHEAEILKRLDSQFIVKCHAVFYTI-EGEICFVMEHMERGSLFDSLRVRKKLSEDVI 148
                E +IL+ L  + I+K         E  +  VME++  GSL D L  R  +    +
Sbjct: 61  SGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYL-PRHSIGLAQL 119
Query: 149 SGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXX 208
              A ++ +G+ YLH    IH ++   N+L++    VKI DFG+++ V E          
Sbjct: 120 LLFAQQICEGMAYLHSQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVRED 179
Query: 209 XXXXIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLE----CLVGHYP- 263
               +   A  C+    +                +A DVWS GV + E    C     P 
Sbjct: 180 GDSPVFWYAPECLKEYKFY---------------YASDVWSFGVTLYELLTHCDSSQSPP 224
Query: 264 -----LIGFGE-KPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEEL 317
                LIG  + +  ++ L   +  GERL  P+    E    +++C E +   R T E L
Sbjct: 225 TKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPCEVYHLMKNCWETEASFRPTFENL 284
Query: 318 L 318
           +
Sbjct: 285 I 285

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 104/218 (47%), Gaps = 24/218 (11%)
Query: 49  LKKLTVLGHGNGGIV----YKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDS 104
           LK L  LG GN G V    Y      +  + A+K L  ++   +R     E EILK L  
Sbjct: 30  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQH 88
Query: 105 QFIVKCHAVFYTI-EGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAY--RVLKGLQY 161
             IVK   V Y+     +  +ME++  GSL D L+ + K   D I  + Y  ++ KG++Y
Sbjct: 89  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYTSQICKGMEY 147
Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACM 221
           L   + IH D+   N+L+  +  VKI DFG+++++ + +             GE+ I   
Sbjct: 148 LGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEP-----GESPI--- 199
Query: 222 GTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV 259
               + +PE +   +    +  A DVWS GVV+ E   
Sbjct: 200 ---FWYAPESLTESK----FSVASDVWSFGVVLYELFT 230

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 102/218 (46%), Gaps = 24/218 (11%)
Query: 49  LKKLTVLGHGNGGIV----YKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDS 104
           LK L  LG GN G V    Y      +  + A+K L  ++   +R     E EILK L  
Sbjct: 12  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQH 70
Query: 105 QFIVKCHAVFYTI-EGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAY--RVLKGLQY 161
             IVK   V Y+     +  +ME++  GSL D L+  K+   D I  + Y  ++ KG++Y
Sbjct: 71  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI-DHIKLLQYTSQICKGMEY 129
Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACM 221
           L   + IH D+   N+L+  +  VKI DFG+++++ + +             GE+ I   
Sbjct: 130 LGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEP-----GESPI--- 181
Query: 222 GTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV 259
               + +PE +   +    +  A DVWS GVV+ E   
Sbjct: 182 ---FWYAPESLTESK----FSVASDVWSFGVVLYELFT 212

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/268 (24%), Positives = 124/268 (46%), Gaps = 21/268 (7%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQA-AHEAEILKRLDSQFIVKCHAV 113
           +G G+ G VYK    K +   A+K+LN T+ T  + QA  +E  +L++     I+     
Sbjct: 16  IGSGSFGTVYK---GKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG- 71
Query: 114 FYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDV-ISGVAYRVLKGLQYLHGMQIIHGDI 172
            Y+ + ++  V +  E  SL+  L + +   E + +  +A +  +G+ YLH   IIH D+
Sbjct: 72  -YSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDL 130
Query: 173 KPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERV 232
           K +N+ ++    VKI DFG++ +  ++R                     G+  +M+PE +
Sbjct: 131 KSNNIFLHEDLTVKIGDFGLATV--KSRWSGSHQFEQLS----------GSILWMAPEVI 178
Query: 233 DSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPETA 292
             +     Y F  DV++ G+V+ E + G  P      +  ++ ++        L    + 
Sbjct: 179 RMQD-KNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSN 237
Query: 293 SPE-FRRFVRSCLEKDWRKRGTVEELLA 319
            P+  +R +  CL+K   +R    ++LA
Sbjct: 238 CPKAMKRLMAECLKKKRDERPLFPQILA 265

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 70/267 (26%), Positives = 115/267 (43%), Gaps = 30/267 (11%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHA 112
           LG G  G V    HQ +    A+K+LN     S  +  +   E + LK      I+K + 
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 113 VFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDI 172
           V  T   +   VME++  G LFD +    ++ E     +  ++L  + Y H   ++H D+
Sbjct: 79  VIST-PTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDL 137
Query: 173 KPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERV 232
           KP N+L++     KIADFG+S ++ +               GE      G+  Y +PE +
Sbjct: 138 KPENVLLDAHMNAKIADFGLSNMMSD---------------GEFLRDSCGSPNYAAPEVI 182
Query: 233 DSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEK--PDLMALICAICFGERLEMPE 290
               + G      D+WS GV++   L G  P   F ++  P L   I    F     +PE
Sbjct: 183 SGRLYAGP---EVDIWSCGVILYALLCGTLP---FDDEHVPTLFKKIRGGVF----YIPE 232
Query: 291 TASPEFRRFVRSCLEKDWRKRGTVEEL 317
             +      +   L+ D  KR T++++
Sbjct: 233 YLNRSVATLLMHMLQVDPLKRATIKDI 259

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 104/216 (48%), Gaps = 26/216 (12%)
Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH-EAEILKRLDSQFIV 108
           + L+ +G G  G V      K+    A+K L+    +II  +  + E  +LK +  + ++
Sbjct: 25  QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI 84
Query: 109 KCHAVFYTI----EGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG 164
               VF       E    +++ H+  G+  +++   +KL++D +  + Y++L+GL+Y+H 
Sbjct: 85  GLLDVFTPARSLEEFNDVYLVTHL-MGADLNNIVKXQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTC 224
             IIH D+KPSNL +N   E+KI DFG++R  +                 +     + T 
Sbjct: 144 ADIIHRDLKPSNLAVNEDXELKILDFGLARHTD-----------------DEMTGYVATR 186
Query: 225 AYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVG 260
            Y +PE +    W   Y    D+WS+G ++ E L G
Sbjct: 187 WYRAPEIM--LNWMH-YNQTVDIWSVGCIMAELLTG 219

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/268 (23%), Positives = 124/268 (46%), Gaps = 21/268 (7%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQA-AHEAEILKRLDSQFIVKCHAV 113
           +G G+ G VYK    K +   A+K+LN T+ T  + QA  +E  +L++  ++ +     +
Sbjct: 43  IGSGSFGTVYK---GKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRK--TRHVNILLFM 97
Query: 114 FYTIEGEICFVMEHMERGSLFDSLRV-RKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDI 172
            Y+ + ++  V +  E  SL+  L +   K     +  +A +  +G+ YLH   IIH D+
Sbjct: 98  GYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDL 157
Query: 173 KPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERV 232
           K +N+ ++    VKI DFG++ +  ++R                     G+  +M+PE +
Sbjct: 158 KSNNIFLHEDLTVKIGDFGLATV--KSRWSGSHQFEQLS----------GSILWMAPEVI 205
Query: 233 DSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPETA 292
             +     Y F  DV++ G+V+ E + G  P      +  ++ ++        L    + 
Sbjct: 206 RMQD-KNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSN 264
Query: 293 SPE-FRRFVRSCLEKDWRKRGTVEELLA 319
            P+  +R +  CL+K   +R    ++LA
Sbjct: 265 CPKAMKRLMAECLKKKRDERPLFPQILA 292

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 77/302 (25%), Positives = 133/302 (44%), Gaps = 51/302 (16%)
Query: 46  ISDLKKLT--VLGHGNGGIVYKVRHQKSNSIYALKVLNTTSST---IIRHQAAHEAEILK 100
           I D  K+T  VLG G  G V ++ ++++   +ALK+L         +  H  A +   + 
Sbjct: 20  IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIV 79
Query: 101 RLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVR--KKLSEDVISGVAYRVLKG 158
           R     IV  +   Y     +  VME ++ G LF  ++ R  +  +E   S +   + + 
Sbjct: 80  R-----IVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 134
Query: 159 LQYLHGMQIIHGDIKPSNLLINGK---GEVKIADFGVSRIVEETRXXXXXXXXXXXXIGE 215
           +QYLH + I H D+KP NLL   K     +K+ DFG ++   ET                
Sbjct: 135 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSH-----------NS 180
Query: 216 AAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLI---GFGEKPD 272
               C  T  Y++PE +  E+    Y  + D+WSLGV++   L G+ P     G    P 
Sbjct: 181 LTTPCY-TPYYVAPEVLGPEK----YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG 235
Query: 273 LMALICAICFGERLEMPETASPEF-------RRFVRSCLEKDWRKRGTVEELLAYPFVTK 325
           +   I       R+   E  +PE+       +  +R+ L+ +  +R T+ E + +P++ +
Sbjct: 236 MKTRI-------RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 288
Query: 326 RS 327
            +
Sbjct: 289 ST 290

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 77/302 (25%), Positives = 133/302 (44%), Gaps = 51/302 (16%)
Query: 46  ISDLKKLT--VLGHGNGGIVYKVRHQKSNSIYALKVLNTTSST---IIRHQAAHEAEILK 100
           I D  K+T  VLG G  G V ++ ++++   +ALK+L         +  H  A +   + 
Sbjct: 19  IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIV 78
Query: 101 RLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVR--KKLSEDVISGVAYRVLKG 158
           R     IV  +   Y     +  VME ++ G LF  ++ R  +  +E   S +   + + 
Sbjct: 79  R-----IVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 133
Query: 159 LQYLHGMQIIHGDIKPSNLLINGK---GEVKIADFGVSRIVEETRXXXXXXXXXXXXIGE 215
           +QYLH + I H D+KP NLL   K     +K+ DFG ++   ET                
Sbjct: 134 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSH-----------NS 179
Query: 216 AAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLI---GFGEKPD 272
               C  T  Y++PE +  E+    Y  + D+WSLGV++   L G+ P     G    P 
Sbjct: 180 LTTPCY-TPYYVAPEVLGPEK----YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG 234
Query: 273 LMALICAICFGERLEMPETASPEF-------RRFVRSCLEKDWRKRGTVEELLAYPFVTK 325
           +   I       R+   E  +PE+       +  +R+ L+ +  +R T+ E + +P++ +
Sbjct: 235 MKTRI-------RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 287
Query: 326 RS 327
            +
Sbjct: 288 ST 289

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/268 (23%), Positives = 126/268 (47%), Gaps = 21/268 (7%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQA-AHEAEILKRLDSQFIVKCHAV 113
           +G G+ G VYK    K +   A+K+LN T+ T  + QA  +E  +L++  ++ +     +
Sbjct: 21  IGSGSFGTVYK---GKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRK--TRHVNILLFM 75
Query: 114 FYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDV-ISGVAYRVLKGLQYLHGMQIIHGDI 172
            Y+ + ++  V +  E  SL+  L + +   E + +  +A +  +G+ YLH   IIH D+
Sbjct: 76  GYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDL 135
Query: 173 KPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERV 232
           K +N+ ++    VKI DFG++ +  ++R                     G+  +M+PE +
Sbjct: 136 KSNNIFLHEDLTVKIGDFGLATV--KSRWSGSHQFEQLS----------GSILWMAPEVI 183
Query: 233 DSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPETA 292
             +     Y F  DV++ G+V+ E + G  P      +  ++ ++        L    + 
Sbjct: 184 RMQD-KNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSN 242
Query: 293 SPE-FRRFVRSCLEKDWRKRGTVEELLA 319
            P+  +R +  CL+K   +R    ++LA
Sbjct: 243 CPKAMKRLMAECLKKKRDERPLFPQILA 270

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 104/218 (47%), Gaps = 24/218 (11%)
Query: 49  LKKLTVLGHGNGGIV----YKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDS 104
           LK L  LG GN G V    Y      +  + A+K L  ++   +R     E EILK L  
Sbjct: 30  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQH 88
Query: 105 QFIVKCHAVFYTI-EGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAY--RVLKGLQY 161
             IVK   V Y+     +  +ME++  GSL D L+ + K   D I  + Y  ++ KG++Y
Sbjct: 89  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYTSQICKGMEY 147
Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACM 221
           L   + IH D+   N+L+  +  VKI DFG+++++ + +             GE+ I   
Sbjct: 148 LGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEP-----GESPI--- 199
Query: 222 GTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV 259
               + +PE +   +    +  A DVWS GVV+ E   
Sbjct: 200 ---FWYAPESLTESK----FSVASDVWSFGVVLYELFT 230

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 72/310 (23%), Positives = 133/310 (42%), Gaps = 44/310 (14%)
Query: 51  KLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKC 110
            L+ +G G  G+V       +    A+K ++         +   E +IL R   + I+  
Sbjct: 25  NLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI 84
Query: 111 HAVFY--TIEG-EICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQI 167
           + +    TIE  +  ++++ +    L+  L+  + LS D I    Y++L+GL+Y+H   +
Sbjct: 85  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANV 143
Query: 168 IHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYM 227
           +H D+KPSNLL+N   ++KI DFG++R+ +                       + T  Y 
Sbjct: 144 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY-----------VATRWYR 192
Query: 228 SPERVDSERWGGDYGFAGDVWSLGVVVLECLVG-------HY--------PLIGFGEKPD 272
           +PE + + +    Y  + D+WS+G ++ E L         HY         ++G  E+ D
Sbjct: 193 APEIMLNSK---GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPEQED 249
Query: 273 LMALICAICFGERLEMPETASPEFRRFVRSCLEK-----------DWRKRGTVEELLAYP 321
           L  +I        L +P      + R   +   K           +  KR  VE+ LA+P
Sbjct: 250 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP 309
Query: 322 FVTKRSSSSN 331
           ++ +    S+
Sbjct: 310 YLEQYYDPSD 319

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/268 (23%), Positives = 124/268 (46%), Gaps = 21/268 (7%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQA-AHEAEILKRLDSQFIVKCHAV 113
           +G G+ G VYK    K +   A+K+LN T+ T  + QA  +E  +L++  ++ +     +
Sbjct: 44  IGSGSFGTVYK---GKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRK--TRHVNILLFM 98
Query: 114 FYTIEGEICFVMEHMERGSLFDSLRV-RKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDI 172
            Y+ + ++  V +  E  SL+  L +   K     +  +A +  +G+ YLH   IIH D+
Sbjct: 99  GYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDL 158
Query: 173 KPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERV 232
           K +N+ ++    VKI DFG++ +  ++R                     G+  +M+PE +
Sbjct: 159 KSNNIFLHEDLTVKIGDFGLATV--KSRWSGSHQFEQLS----------GSILWMAPEVI 206
Query: 233 DSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPETA 292
             +     Y F  DV++ G+V+ E + G  P      +  ++ ++        L    + 
Sbjct: 207 RMQD-KNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSN 265
Query: 293 SPE-FRRFVRSCLEKDWRKRGTVEELLA 319
            P+  +R +  CL+K   +R    ++LA
Sbjct: 266 CPKAMKRLMAECLKKKRDERPLFPQILA 293

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 77/302 (25%), Positives = 133/302 (44%), Gaps = 51/302 (16%)
Query: 46  ISDLKKLT--VLGHGNGGIVYKVRHQKSNSIYALKVLNTTSST---IIRHQAAHEAEILK 100
           I D  K+T  VLG G  G V ++ ++++   +ALK+L         +  H  A +   + 
Sbjct: 21  IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIV 80
Query: 101 RLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVR--KKLSEDVISGVAYRVLKG 158
           R     IV  +   Y     +  VME ++ G LF  ++ R  +  +E   S +   + + 
Sbjct: 81  R-----IVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 135
Query: 159 LQYLHGMQIIHGDIKPSNLLINGK---GEVKIADFGVSRIVEETRXXXXXXXXXXXXIGE 215
           +QYLH + I H D+KP NLL   K     +K+ DFG ++   ET                
Sbjct: 136 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSH-----------NS 181
Query: 216 AAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLI---GFGEKPD 272
               C  T  Y++PE +  E+    Y  + D+WSLGV++   L G+ P     G    P 
Sbjct: 182 LTTPCY-TPYYVAPEVLGPEK----YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG 236
Query: 273 LMALICAICFGERLEMPETASPEF-------RRFVRSCLEKDWRKRGTVEELLAYPFVTK 325
           +   I       R+   E  +PE+       +  +R+ L+ +  +R T+ E + +P++ +
Sbjct: 237 MKTRI-------RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 289
Query: 326 RS 327
            +
Sbjct: 290 ST 291

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/268 (24%), Positives = 124/268 (46%), Gaps = 21/268 (7%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQA-AHEAEILKRLDSQFIVKCHAV 113
           +G G+ G VYK    K +   A+K+LN T+ T  + QA  +E  +L++     I+     
Sbjct: 21  IGSGSFGTVYK---GKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG- 76
Query: 114 FYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDV-ISGVAYRVLKGLQYLHGMQIIHGDI 172
            Y+ + ++  V +  E  SL+  L + +   E + +  +A +  +G+ YLH   IIH D+
Sbjct: 77  -YSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDL 135
Query: 173 KPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERV 232
           K +N+ ++    VKI DFG++ +  ++R                     G+  +M+PE +
Sbjct: 136 KSNNIFLHEDLTVKIGDFGLATV--KSRWSGSHQFEQLS----------GSILWMAPEVI 183
Query: 233 DSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPETA 292
             +     Y F  DV++ G+V+ E + G  P      +  ++ ++        L    + 
Sbjct: 184 RMQD-KNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSN 242
Query: 293 SPE-FRRFVRSCLEKDWRKRGTVEELLA 319
            P+  +R +  CL+K   +R    ++LA
Sbjct: 243 CPKAMKRLMAECLKKKRDERPLFPQILA 270

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 73/292 (25%), Positives = 128/292 (43%), Gaps = 49/292 (16%)
Query: 54  VLGHGNGGIVYKVRHQKSNSIYALKVLNTTSST---IIRHQAAHEAEILKRLDSQFIVKC 110
           VLG G  G V ++ ++++   +ALK+L         +  H  A +   + R     IV  
Sbjct: 24  VLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVR-----IVDV 78
Query: 111 HAVFYTIEGEICFVMEHMERGSLFDSLRVR--KKLSEDVISGVAYRVLKGLQYLHGMQII 168
           +   Y     +  VME ++ G LF  ++ R  +  +E   S +   + + +QYLH + I 
Sbjct: 79  YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIA 138
Query: 169 HGDIKPSNLLINGK---GEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCA 225
           H D+KP NLL   K     +K+ DFG ++   ET                    C  T  
Sbjct: 139 HRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSH-----------NSLTTPCY-TPY 183
Query: 226 YMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLI---GFGEKPDLMALICAICF 282
           Y++PE +  E+    Y  + D+WSLGV++   L G+ P     G    P +   I     
Sbjct: 184 YVAPEVLGPEK----YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI----- 234
Query: 283 GERLEMPETASPEF-------RRFVRSCLEKDWRKRGTVEELLAYPFVTKRS 327
             R+   E  +PE+       +  +R+ L+ +  +R T+ E + +P++ + +
Sbjct: 235 --RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 284

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 103/216 (47%), Gaps = 26/216 (12%)
Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH-EAEILKRLDSQFIV 108
           + L+ +G G  G V      K+    A+K L+    +II  +  + E  +LK +  + ++
Sbjct: 25  QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI 84
Query: 109 KCHAVFYTI----EGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG 164
               VF       E    +++ H+  G+  +++   +KL++D +  + Y++L+GL+Y+H 
Sbjct: 85  GLLDVFTPARSLEEFNDVYLVTHL-MGADLNNIVKSQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTC 224
             IIH D+KPSNL +N   E+KI DFG+ R  +                 +     + T 
Sbjct: 144 ADIIHRDLKPSNLAVNEDSELKILDFGLCRHTD-----------------DEMTGYVATR 186
Query: 225 AYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVG 260
            Y +PE +    W   Y    D+WS+G ++ E L G
Sbjct: 187 WYRAPEIM--LNWMH-YNQTVDIWSVGCIMAELLTG 219

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 104/216 (48%), Gaps = 26/216 (12%)
Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH-EAEILKRLDSQFIV 108
           + L+ +G G  G V      K+    A+K L+    +II  +  + E  +LK +  + ++
Sbjct: 25  QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI 84
Query: 109 KCHAVFYTI----EGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG 164
               VF       E    +++ H+  G+  +++   +KL++D +  + Y++L+GL+Y+H 
Sbjct: 85  GLLDVFTPARSLEEFNDVYLVTHL-MGADLNNIVKXQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTC 224
             IIH D+KPSNL +N   E+KI DFG++R  +                 +     + T 
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-----------------DEMTGYVATR 186
Query: 225 AYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVG 260
            Y +PE +    W   Y    D+WS+G ++ E L G
Sbjct: 187 WYRAPEIM--LNWMH-YNQTVDIWSVGCIMAELLTG 219

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 73/292 (25%), Positives = 128/292 (43%), Gaps = 49/292 (16%)
Query: 54  VLGHGNGGIVYKVRHQKSNSIYALKVLNTTSST---IIRHQAAHEAEILKRLDSQFIVKC 110
           VLG G  G V ++ ++++   +ALK+L         +  H  A +   + R     IV  
Sbjct: 23  VLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVR-----IVDV 77
Query: 111 HAVFYTIEGEICFVMEHMERGSLFDSLRVR--KKLSEDVISGVAYRVLKGLQYLHGMQII 168
           +   Y     +  VME ++ G LF  ++ R  +  +E   S +   + + +QYLH + I 
Sbjct: 78  YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIA 137
Query: 169 HGDIKPSNLLINGK---GEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCA 225
           H D+KP NLL   K     +K+ DFG ++   ET                    C  T  
Sbjct: 138 HRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSH-----------NSLTTPCY-TPY 182
Query: 226 YMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLI---GFGEKPDLMALICAICF 282
           Y++PE +  E+    Y  + D+WSLGV++   L G+ P     G    P +   I     
Sbjct: 183 YVAPEVLGPEK----YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI----- 233
Query: 283 GERLEMPETASPEF-------RRFVRSCLEKDWRKRGTVEELLAYPFVTKRS 327
             R+   E  +PE+       +  +R+ L+ +  +R T+ E + +P++ + +
Sbjct: 234 --RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 283

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 77/302 (25%), Positives = 133/302 (44%), Gaps = 51/302 (16%)
Query: 46  ISDLKKLT--VLGHGNGGIVYKVRHQKSNSIYALKVLNTTSST---IIRHQAAHEAEILK 100
           I D  K+T  VLG G  G V ++ ++++   +ALK+L         +  H  A +   + 
Sbjct: 15  IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIV 74
Query: 101 RLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVR--KKLSEDVISGVAYRVLKG 158
           R     IV  +   Y     +  VME ++ G LF  ++ R  +  +E   S +   + + 
Sbjct: 75  R-----IVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 129
Query: 159 LQYLHGMQIIHGDIKPSNLLINGK---GEVKIADFGVSRIVEETRXXXXXXXXXXXXIGE 215
           +QYLH + I H D+KP NLL   K     +K+ DFG ++   ET                
Sbjct: 130 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSH-----------NS 175
Query: 216 AAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLI---GFGEKPD 272
               C  T  Y++PE +  E+    Y  + D+WSLGV++   L G+ P     G    P 
Sbjct: 176 LTTPCY-TPYYVAPEVLGPEK----YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG 230
Query: 273 LMALICAICFGERLEMPETASPEF-------RRFVRSCLEKDWRKRGTVEELLAYPFVTK 325
           +   I       R+   E  +PE+       +  +R+ L+ +  +R T+ E + +P++ +
Sbjct: 231 MKTRI-------RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 283
Query: 326 RS 327
            +
Sbjct: 284 ST 285

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 100/229 (43%), Gaps = 33/229 (14%)
Query: 54  VLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAV 113
           +LG G    V++ RH+K+  ++A+KV N  S          E E+LK+L+ + IVK  A+
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 114 -FYTIEGEICFVMEHMERGSLFDSLRVRKK---LSEDVISGVAYRVLKGLQYLHGMQIIH 169
              T       +ME    GSL+  L        L E     V   V+ G+ +L    I+H
Sbjct: 76  EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVH 135
Query: 170 GDIKPSNLL----INGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCA 225
            +IKP N++     +G+   K+ DFG +R +E+                E  ++  GT  
Sbjct: 136 RNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD---------------EQFVSLYGTEE 180
Query: 226 YMSPE-------RVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGF 267
           Y+ P+       R D ++    YG   D+WS+GV       G  P   F
Sbjct: 181 YLHPDMYERAVLRKDHQK---KYGATVDLWSIGVTFYHAATGSLPFRPF 226

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 76/301 (25%), Positives = 132/301 (43%), Gaps = 50/301 (16%)
Query: 46  ISDLKKLT-VLGHGNGGIVYKVRHQKSNSIYALKVLNTTSST---IIRHQAAHEAEILKR 101
           I D K  + VLG G  G V ++ ++++   +ALK+L         +  H  A +   + R
Sbjct: 30  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVR 89
Query: 102 LDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVR--KKLSEDVISGVAYRVLKGL 159
                IV  +   Y     +  VME ++ G LF  ++ R  +  +E   S +   + + +
Sbjct: 90  -----IVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI 144
Query: 160 QYLHGMQIIHGDIKPSNLLINGK---GEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEA 216
           QYLH + I H D+KP NLL   K     +K+ DFG ++   ET                 
Sbjct: 145 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSH-----------NSL 190
Query: 217 AIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLI---GFGEKPDL 273
              C  T  Y++PE +  E+    Y  + D+WSLGV++   L G+ P     G    P +
Sbjct: 191 TTPCY-TPYYVAPEVLGPEK----YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM 245
Query: 274 MALICAICFGERLEMPETASPEF-------RRFVRSCLEKDWRKRGTVEELLAYPFVTKR 326
              I       R+   E  +PE+       +  +R+ L+ +  +R T+ E + +P++ + 
Sbjct: 246 KTRI-------RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 298
Query: 327 S 327
           +
Sbjct: 299 T 299

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 76/293 (25%), Positives = 131/293 (44%), Gaps = 51/293 (17%)
Query: 54  VLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDS-QFIVKCHA 112
           VLG G  G V ++ ++++   +ALK+L          +A  E E+  R      IV+   
Sbjct: 69  VLGLGINGKVLQIFNKRTQEKFALKMLQDCP------KARREVELHWRASQCPHIVRIVD 122
Query: 113 VFYTI-EGEICF--VMEHMERGSLFDSLRVR--KKLSEDVISGVAYRVLKGLQYLHGMQI 167
           V+  +  G  C   VME ++ G LF  ++ R  +  +E   S +   + + +QYLH + I
Sbjct: 123 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINI 182
Query: 168 IHGDIKPSNLLINGK---GEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTC 224
            H D+KP NLL   K     +K+ DFG ++   ET                    C  T 
Sbjct: 183 AHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSH-----------NSLTTPCY-TP 227
Query: 225 AYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLI---GFGEKPDLMALICAIC 281
            Y++PE +  E+    Y  + D+WSLGV++   L G+ P     G    P +   I    
Sbjct: 228 YYVAPEVLGPEK----YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI---- 279
Query: 282 FGERLEMPETASPEF-------RRFVRSCLEKDWRKRGTVEELLAYPFVTKRS 327
              R+   E  +PE+       +  +R+ L+ +  +R T+ E + +P++ + +
Sbjct: 280 ---RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 329

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/268 (24%), Positives = 123/268 (45%), Gaps = 21/268 (7%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQA-AHEAEILKRLDSQFIVKCHAV 113
           +G G+ G VYK    K +   A+K+LN T+ T  + QA  +E  +L++     I+     
Sbjct: 16  IGSGSFGTVYK---GKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG- 71
Query: 114 FYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDV-ISGVAYRVLKGLQYLHGMQIIHGDI 172
            Y+   ++  V +  E  SL+  L + +   E + +  +A +  +G+ YLH   IIH D+
Sbjct: 72  -YSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDL 130
Query: 173 KPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERV 232
           K +N+ ++    VKI DFG++ +  ++R                     G+  +M+PE +
Sbjct: 131 KSNNIFLHEDLTVKIGDFGLATV--KSRWSGSHQFEQLS----------GSILWMAPEVI 178
Query: 233 DSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPETA 292
             +     Y F  DV++ G+V+ E + G  P      +  ++ ++        L    + 
Sbjct: 179 RMQD-KNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSN 237
Query: 293 SPE-FRRFVRSCLEKDWRKRGTVEELLA 319
            P+  +R +  CL+K   +R    ++LA
Sbjct: 238 CPKAMKRLMAECLKKKRDERPLFPQILA 265

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 73/310 (23%), Positives = 132/310 (42%), Gaps = 44/310 (14%)
Query: 51  KLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKC 110
            L+ +G G  G+V       +    A+K ++         +   E +IL R   + I+  
Sbjct: 27  NLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI 86
Query: 111 HAVFY--TIEG-EICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQI 167
           + +    TIE  +  ++++ +    L+  L+  + LS D I    Y++L+GL+Y+H   +
Sbjct: 87  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANV 145
Query: 168 IHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYM 227
           +H D+KPSNLL+N   ++KI DFG++R+ +                       + T  Y 
Sbjct: 146 LHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEY-----------VATRWYR 194
Query: 228 SPERVDSERWGGDYGFAGDVWSLGVVVLECLVG-------HY-----PLIGFGEKPDLMA 275
           +PE + + +    Y  + D+WS+G ++ E L         HY      ++G    P    
Sbjct: 195 APEIMLNSK---GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 251
Query: 276 LICAICFGER---LEMPETASPEFRRFVRSCLEK-----------DWRKRGTVEELLAYP 321
           L C I    R   L +P      + R   +   K           +  KR  VE+ LA+P
Sbjct: 252 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP 311
Query: 322 FVTKRSSSSN 331
           ++ +    S+
Sbjct: 312 YLEQYYDPSD 321

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 104/216 (48%), Gaps = 26/216 (12%)
Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH-EAEILKRLDSQFIV 108
           + L+ +G G  G V      K+    A+K L+    +II  +  + E  +LK +  + ++
Sbjct: 27  QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI 86
Query: 109 KCHAVFYTI----EGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG 164
               VF       E    +++ H+  G+  +++   +KL++D +  + Y++L+GL+Y+H 
Sbjct: 87  GLLDVFTPARSLEEFNDVYLVTHL-MGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 145
Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTC 224
             IIH D+KPSNL +N   E+KI DFG++R  +                 +     + T 
Sbjct: 146 ADIIHRDLKPSNLAVNEDSELKILDFGLARHTD-----------------DEMTGYVATR 188
Query: 225 AYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVG 260
            Y +PE +    W   Y    D+WS+G ++ E L G
Sbjct: 189 WYRAPEIM--LNWMH-YNQTVDIWSVGCIMAELLTG 221

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 73/310 (23%), Positives = 132/310 (42%), Gaps = 44/310 (14%)
Query: 51  KLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKC 110
            L+ +G G  G+V       +    A+K ++         +   E +IL R   + I+  
Sbjct: 31  NLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI 90
Query: 111 HAVFY--TIEG-EICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQI 167
           + +    TIE  +  ++++ +    L+  L+  + LS D I    Y++L+GL+Y+H   +
Sbjct: 91  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANV 149
Query: 168 IHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYM 227
           +H D+KPSNLL+N   ++KI DFG++R+ +                       + T  Y 
Sbjct: 150 LHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEY-----------VATRWYR 198
Query: 228 SPERVDSERWGGDYGFAGDVWSLGVVVLECLVG-------HY-----PLIGFGEKPDLMA 275
           +PE + + +    Y  + D+WS+G ++ E L         HY      ++G    P    
Sbjct: 199 APEIMLNSK---GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 255
Query: 276 LICAICFGER---LEMPETASPEFRRFVRSCLEK-----------DWRKRGTVEELLAYP 321
           L C I    R   L +P      + R   +   K           +  KR  VE+ LA+P
Sbjct: 256 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP 315
Query: 322 FVTKRSSSSN 331
           ++ +    S+
Sbjct: 316 YLEQYYDPSD 325

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 104/216 (48%), Gaps = 26/216 (12%)
Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH-EAEILKRLDSQFIV 108
           + L+ +G G  G V      K+    A+K L+    +II  +  + E  +LK +  + ++
Sbjct: 31  QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI 90
Query: 109 KCHAVFYTI----EGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG 164
               VF       E    +++ H+  G+  +++   +KL++D +  + Y++L+GL+Y+H 
Sbjct: 91  GLLDVFTPARSLEEFNDVYLVTHL-MGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 149
Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTC 224
             IIH D+KPSNL +N   E+KI DFG++R  +                 +     + T 
Sbjct: 150 ADIIHRDLKPSNLAVNEDSELKILDFGLARHTD-----------------DEMTGYVATR 192
Query: 225 AYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVG 260
            Y +PE +    W   Y    D+WS+G ++ E L G
Sbjct: 193 WYRAPEIM--LNWMH-YNQTVDIWSVGCIMAELLTG 225

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 73/292 (25%), Positives = 128/292 (43%), Gaps = 49/292 (16%)
Query: 54  VLGHGNGGIVYKVRHQKSNSIYALKVLNTTSST---IIRHQAAHEAEILKRLDSQFIVKC 110
           VLG G  G V ++ ++++   +ALK+L         +  H  A +   + R     IV  
Sbjct: 25  VLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVR-----IVDV 79
Query: 111 HAVFYTIEGEICFVMEHMERGSLFDSLRVR--KKLSEDVISGVAYRVLKGLQYLHGMQII 168
           +   Y     +  VME ++ G LF  ++ R  +  +E   S +   + + +QYLH + I 
Sbjct: 80  YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIA 139
Query: 169 HGDIKPSNLLINGK---GEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCA 225
           H D+KP NLL   K     +K+ DFG ++   ET                    C  T  
Sbjct: 140 HRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSH-----------NSLTTPCY-TPY 184
Query: 226 YMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLI---GFGEKPDLMALICAICF 282
           Y++PE +  E+    Y  + D+WSLGV++   L G+ P     G    P +   I     
Sbjct: 185 YVAPEVLGPEK----YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI----- 235
Query: 283 GERLEMPETASPEF-------RRFVRSCLEKDWRKRGTVEELLAYPFVTKRS 327
             R+   E  +PE+       +  +R+ L+ +  +R T+ E + +P++ + +
Sbjct: 236 --RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 285

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 77/286 (26%), Positives = 124/286 (43%), Gaps = 33/286 (11%)
Query: 49  LKKLTVLGHGNGGIVYKVRHQ----KSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDS 104
           LK ++ LG GN G V   R+      + ++ A+K L  +     R     E +ILK L S
Sbjct: 12  LKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQR-DFQREIQILKALHS 70
Query: 105 QFIVKCHAVFYTI-EGEICFVMEHMERGSLFDSL-RVRKKLSEDVISGVAYRVLKGLQYL 162
            FIVK   V Y      +  VME++  G L D L R R +L    +   + ++ KG++YL
Sbjct: 71  DFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYL 130
Query: 163 HGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMG 222
              + +H D+   N+L+  +  VKIADFG+++++   +             G++ I    
Sbjct: 131 GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREP-----GQSPI---- 181
Query: 223 TCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLE----CLVGHYPLIGF----GEKPDLM 274
              + +PE +        +    DVWS GVV+ E    C     P   F    G + D+ 
Sbjct: 182 --FWYAPESLSD----NIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGSERDVP 235
Query: 275 AL---ICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEEL 317
           AL   +  +  G+RL  P     E    ++ C     + R +   L
Sbjct: 236 ALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSAL 281

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 73/310 (23%), Positives = 132/310 (42%), Gaps = 44/310 (14%)
Query: 51  KLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKC 110
            L+ +G G  G+V       +    A+K ++         +   E +IL R   + I+  
Sbjct: 29  NLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI 88
Query: 111 HAVFY--TIEG-EICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQI 167
           + +    TIE  +  ++++ +    L+  L+  + LS D I    Y++L+GL+Y+H   +
Sbjct: 89  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANV 147
Query: 168 IHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYM 227
           +H D+KPSNLL+N   ++KI DFG++R+ +                       + T  Y 
Sbjct: 148 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY-----------VATRWYR 196
Query: 228 SPERVDSERWGGDYGFAGDVWSLGVVVLECLVG-------HY-----PLIGFGEKPDLMA 275
           +PE + + +    Y  + D+WS+G ++ E L         HY      ++G    P    
Sbjct: 197 APEIMLNSK---GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 253
Query: 276 LICAICFGER---LEMPETASPEFRRFVRSCLEK-----------DWRKRGTVEELLAYP 321
           L C I    R   L +P      + R   +   K           +  KR  VE+ LA+P
Sbjct: 254 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP 313
Query: 322 FVTKRSSSSN 331
           ++ +    S+
Sbjct: 314 YLEQYYDPSD 323

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 77/289 (26%), Positives = 131/289 (45%), Gaps = 43/289 (14%)
Query: 54  VLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDS-QFIVKCHA 112
           VLG G  G V ++ ++++   +ALK+L          +A  E E+  R      IV+   
Sbjct: 75  VLGLGINGKVLQIFNKRTQEKFALKMLQDCP------KARREVELHWRASQCPHIVRIVD 128
Query: 113 VFYTI-EGEICF--VMEHMERGSLFDSLRVR--KKLSEDVISGVAYRVLKGLQYLHGMQI 167
           V+  +  G  C   VME ++ G LF  ++ R  +  +E   S +   + + +QYLH + I
Sbjct: 129 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINI 188
Query: 168 IHGDIKPSNLLINGK---GEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTC 224
            H D+KP NLL   K     +K+ DFG ++   ET                    C  T 
Sbjct: 189 AHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSH-----------NSLTTPCY-TP 233
Query: 225 AYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLI---GFGEKPDLMALICAIC 281
            Y++PE +  E+    Y  + D+WSLGV++   L G+ P     G    P    +   I 
Sbjct: 234 YYVAPEVLGPEK----YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP---GMKTRIR 286
Query: 282 FGE-RLEMPETA--SPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRS 327
            G+     PE +  S E +  +R+ L+ +  +R T+ E + +P++ + +
Sbjct: 287 MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 335

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 73/310 (23%), Positives = 132/310 (42%), Gaps = 44/310 (14%)
Query: 51  KLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKC 110
            L+ +G G  G+V       +    A+K ++         +   E +IL R   + I+  
Sbjct: 47  NLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI 106
Query: 111 HAVFY--TIEG-EICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQI 167
           + +    TIE  +  ++++ +    L+  L+  + LS D I    Y++L+GL+Y+H   +
Sbjct: 107 NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANV 165
Query: 168 IHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYM 227
           +H D+KPSNLL+N   ++KI DFG++R+ +                       + T  Y 
Sbjct: 166 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY-----------VATRWYR 214
Query: 228 SPERVDSERWGGDYGFAGDVWSLGVVVLECLVG-------HY-----PLIGFGEKPDLMA 275
           +PE + + +    Y  + D+WS+G ++ E L         HY      ++G    P    
Sbjct: 215 APEIMLNSK---GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 271
Query: 276 LICAICFGER---LEMPETASPEFRRFVRSCLEK-----------DWRKRGTVEELLAYP 321
           L C I    R   L +P      + R   +   K           +  KR  VE+ LA+P
Sbjct: 272 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP 331
Query: 322 FVTKRSSSSN 331
           ++ +    S+
Sbjct: 332 YLEQYYDPSD 341

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 101/220 (45%), Gaps = 20/220 (9%)
Query: 46  ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQ 105
           + D   +  LG G  G V    ++ +    A+K+++   +         E  I K L+ +
Sbjct: 4   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 63
Query: 106 FIVKCHAVFYTIEGEICFV-MEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG 164
            +VK +   +  EG I ++ +E+   G LFD +     + E       ++++ G+ YLHG
Sbjct: 64  NVVKFYG--HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACM-GT 223
           + I H DIKP NLL++ +  +KI+DFG++ +                   E  +  M GT
Sbjct: 122 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR-------------ERLLNKMCGT 168
Query: 224 CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYP 263
             Y++PE +    +  +     DVWS G+V+   L G  P
Sbjct: 169 LPYVAPELLKRREFHAE---PVDVWSCGIVLTAMLAGELP 205

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 103/218 (47%), Gaps = 24/218 (11%)
Query: 49  LKKLTVLGHGNGGIV----YKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDS 104
           LK L  LG GN G V    Y      +  + A+K L  ++   +R     E EILK L  
Sbjct: 15  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQH 73
Query: 105 QFIVKCHAVFYTI-EGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAY--RVLKGLQY 161
             IVK   V Y+     +  +ME++  GSL D L+   +   D I  + Y  ++ KG++Y
Sbjct: 74  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERI-DHIKLLQYTSQICKGMEY 132
Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACM 221
           L   + IH D+   N+L+  +  VKI DFG+++++ + +             GE+ I   
Sbjct: 133 LGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEP-----GESPI--- 184
Query: 222 GTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV 259
               + +PE +   +    +  A DVWS GVV+ E   
Sbjct: 185 ---FWYAPESLTESK----FSVASDVWSFGVVLYELFT 215

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 101/220 (45%), Gaps = 20/220 (9%)
Query: 46  ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQ 105
           + D   +  LG G  G V    ++ +    A+K+++   +         E  I K L+ +
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 106 FIVKCHAVFYTIEGEICFV-MEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG 164
            +VK +   +  EG I ++ +E+   G LFD +     + E       ++++ G+ YLHG
Sbjct: 66  NVVKFYG--HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACM-GT 223
           + I H DIKP NLL++ +  +KI+DFG++ +                   E  +  M GT
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR-------------ERLLNKMCGT 170
Query: 224 CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYP 263
             Y++PE +    +  +     DVWS G+V+   L G  P
Sbjct: 171 LPYVAPELLKRREFHAE---PVDVWSCGIVLTAMLAGELP 207

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 104/216 (48%), Gaps = 26/216 (12%)
Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH-EAEILKRLDSQFIV 108
           + L+ +G G  G V      K+    A+K L+    +II  +  + E  +LK +  + ++
Sbjct: 30  QNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI 89
Query: 109 KCHAVFYTI----EGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG 164
               VF       E    +++ H+  G+  +++   +KL++D +  + Y++L+GL+Y+H 
Sbjct: 90  GLLDVFTPARSLEEFNDVYLVTHL-MGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 148
Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTC 224
             IIH D+KPSNL +N   E+KI DFG++R  +                 +     + T 
Sbjct: 149 ADIIHRDLKPSNLAVNEDXELKILDFGLARHTD-----------------DEMTGYVATR 191
Query: 225 AYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVG 260
            Y +PE +    W   Y    D+WS+G ++ E L G
Sbjct: 192 WYRAPEIM--LNWMH-YNQTVDIWSVGCIMAELLTG 224

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 101/220 (45%), Gaps = 20/220 (9%)
Query: 46  ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQ 105
           + D   +  LG G  G V    ++ +    A+K+++   +         E  I K L+ +
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 106 FIVKCHAVFYTIEGEICFV-MEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG 164
            +VK +   +  EG I ++ +E+   G LFD +     + E       ++++ G+ YLHG
Sbjct: 65  NVVKFYG--HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACM-GT 223
           + I H DIKP NLL++ +  +KI+DFG++ +                   E  +  M GT
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR-------------ERLLNKMXGT 169
Query: 224 CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYP 263
             Y++PE +    +  +     DVWS G+V+   L G  P
Sbjct: 170 LPYVAPELLKRREFHAE---PVDVWSCGIVLTAMLAGELP 206

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 101/220 (45%), Gaps = 20/220 (9%)
Query: 46  ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQ 105
           + D   +  LG G  G V    ++ +    A+K+++   +         E  I K L+ +
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 106 FIVKCHAVFYTIEGEICFV-MEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG 164
            +VK +   +  EG I ++ +E+   G LFD +     + E       ++++ G+ YLHG
Sbjct: 66  NVVKFYG--HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACM-GT 223
           + I H DIKP NLL++ +  +KI+DFG++ +                   E  +  M GT
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR-------------ERLLNKMCGT 170
Query: 224 CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYP 263
             Y++PE +    +  +     DVWS G+V+   L G  P
Sbjct: 171 LPYVAPELLKRREFHAE---PVDVWSCGIVLTAMLAGELP 207

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 73/310 (23%), Positives = 132/310 (42%), Gaps = 44/310 (14%)
Query: 51  KLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKC 110
            L+ +G G  G+V       +    A+K ++         +   E +IL R   + I+  
Sbjct: 35  NLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI 94
Query: 111 HAVFY--TIEG-EICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQI 167
           + +    TIE  +  ++++ +    L+  L+  + LS D I    Y++L+GL+Y+H   +
Sbjct: 95  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANV 153
Query: 168 IHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYM 227
           +H D+KPSNLL+N   ++KI DFG++R+ +                       + T  Y 
Sbjct: 154 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY-----------VATRWYR 202
Query: 228 SPERVDSERWGGDYGFAGDVWSLGVVVLECLVG-------HY-----PLIGFGEKPDLMA 275
           +PE + + +    Y  + D+WS+G ++ E L         HY      ++G    P    
Sbjct: 203 APEIMLNSK---GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 259
Query: 276 LICAICFGER---LEMPETASPEFRRFVRSCLEK-----------DWRKRGTVEELLAYP 321
           L C I    R   L +P      + R   +   K           +  KR  VE+ LA+P
Sbjct: 260 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP 319
Query: 322 FVTKRSSSSN 331
           ++ +    S+
Sbjct: 320 YLEQYYDPSD 329

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 73/310 (23%), Positives = 132/310 (42%), Gaps = 44/310 (14%)
Query: 51  KLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKC 110
            L+ +G G  G+V       +    A+K ++         +   E +IL R   + I+  
Sbjct: 27  NLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI 86
Query: 111 HAVFY--TIEG-EICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQI 167
           + +    TIE  +  ++++ +    L+  L+  + LS D I    Y++L+GL+Y+H   +
Sbjct: 87  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANV 145
Query: 168 IHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYM 227
           +H D+KPSNLL+N   ++KI DFG++R+ +                       + T  Y 
Sbjct: 146 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY-----------VATRWYR 194
Query: 228 SPERVDSERWGGDYGFAGDVWSLGVVVLECLVG-------HY-----PLIGFGEKPDLMA 275
           +PE + + +    Y  + D+WS+G ++ E L         HY      ++G    P    
Sbjct: 195 APEIMLNSK---GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 251
Query: 276 LICAICFGER---LEMPETASPEFRRFVRSCLEK-----------DWRKRGTVEELLAYP 321
           L C I    R   L +P      + R   +   K           +  KR  VE+ LA+P
Sbjct: 252 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP 311
Query: 322 FVTKRSSSSN 331
           ++ +    S+
Sbjct: 312 YLEQYYDPSD 321

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 101/220 (45%), Gaps = 20/220 (9%)
Query: 46  ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQ 105
           + D   +  LG G  G V    ++ +    A+K+++   +         E  I K L+ +
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 106 FIVKCHAVFYTIEGEICFV-MEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG 164
            +VK +   +  EG I ++ +E+   G LFD +     + E       ++++ G+ YLHG
Sbjct: 65  NVVKFYG--HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACM-GT 223
           + I H DIKP NLL++ +  +KI+DFG++ +                   E  +  M GT
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR-------------ERLLNKMXGT 169
Query: 224 CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYP 263
             Y++PE +    +  +     DVWS G+V+   L G  P
Sbjct: 170 LPYVAPELLKRREFHAE---PVDVWSCGIVLTAMLAGELP 206

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 73/310 (23%), Positives = 132/310 (42%), Gaps = 44/310 (14%)
Query: 51  KLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKC 110
            L+ +G G  G+V       +    A+K ++         +   E +IL R   + I+  
Sbjct: 25  NLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI 84
Query: 111 HAVFY--TIEG-EICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQI 167
           + +    TIE  +  ++++ +    L+  L+  + LS D I    Y++L+GL+Y+H   +
Sbjct: 85  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANV 143
Query: 168 IHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYM 227
           +H D+KPSNLL+N   ++KI DFG++R+ +                       + T  Y 
Sbjct: 144 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY-----------VATRWYR 192
Query: 228 SPERVDSERWGGDYGFAGDVWSLGVVVLECLVG-------HY-----PLIGFGEKPDLMA 275
           +PE + + +    Y  + D+WS+G ++ E L         HY      ++G    P    
Sbjct: 193 APEIMLNSK---GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 249
Query: 276 LICAICFGER---LEMPETASPEFRRFVRSCLEK-----------DWRKRGTVEELLAYP 321
           L C I    R   L +P      + R   +   K           +  KR  VE+ LA+P
Sbjct: 250 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP 309
Query: 322 FVTKRSSSSN 331
           ++ +    S+
Sbjct: 310 YLEQYYDPSD 319

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 104/216 (48%), Gaps = 26/216 (12%)
Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH-EAEILKRLDSQFIV 108
           + L+ +G G  G V      K+    A+K L+    +II  +  + E  +LK +  + ++
Sbjct: 30  QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI 89
Query: 109 KCHAVFYTI----EGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG 164
               VF       E    +++ H+  G+  +++   +KL++D +  + Y++L+GL+Y+H 
Sbjct: 90  GLLDVFTPARSLEEFNDVYLVTHL-MGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 148
Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTC 224
             IIH D+KPSNL +N   E+KI DFG++R  +                 +     + T 
Sbjct: 149 ADIIHRDLKPSNLAVNEDXELKILDFGLARHTD-----------------DEMTGYVATR 191
Query: 225 AYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVG 260
            Y +PE +    W   Y    D+WS+G ++ E L G
Sbjct: 192 WYRAPEIM--LNWMH-YNQTVDIWSVGCIMAELLTG 224

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 101/220 (45%), Gaps = 20/220 (9%)
Query: 46  ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQ 105
           + D   +  LG G  G V    ++ +    A+K+++   +         E  I K L+ +
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 106 FIVKCHAVFYTIEGEICFV-MEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG 164
            +VK +   +  EG I ++ +E+   G LFD +     + E       ++++ G+ YLHG
Sbjct: 66  NVVKFYG--HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACM-GT 223
           + I H DIKP NLL++ +  +KI+DFG++ +                   E  +  M GT
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR-------------ERLLNKMCGT 170
Query: 224 CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYP 263
             Y++PE +    +  +     DVWS G+V+   L G  P
Sbjct: 171 LPYVAPELLKRREFHAE---PVDVWSCGIVLTAMLAGELP 207

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 101/220 (45%), Gaps = 20/220 (9%)
Query: 46  ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQ 105
           + D   +  LG G  G V    ++ +    A+K+++   +         E  I K L+ +
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 106 FIVKCHAVFYTIEGEICFV-MEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG 164
            +VK +   +  EG I ++ +E+   G LFD +     + E       ++++ G+ YLHG
Sbjct: 66  NVVKFYG--HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACM-GT 223
           + I H DIKP NLL++ +  +KI+DFG++ +                   E  +  M GT
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR-------------ERLLNKMCGT 170
Query: 224 CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYP 263
             Y++PE +    +  +     DVWS G+V+   L G  P
Sbjct: 171 LPYVAPELLKRREFHAE---PVDVWSCGIVLTAMLAGELP 207

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 101/220 (45%), Gaps = 20/220 (9%)
Query: 46  ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQ 105
           + D   +  LG G  G V    ++ +    A+K+++   +         E  I K L+ +
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 106 FIVKCHAVFYTIEGEICFV-MEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG 164
            +VK +   +  EG I ++ +E+   G LFD +     + E       ++++ G+ YLHG
Sbjct: 66  NVVKFYG--HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACM-GT 223
           + I H DIKP NLL++ +  +KI+DFG++ +                   E  +  M GT
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR-------------ERLLNKMCGT 170
Query: 224 CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYP 263
             Y++PE +    +  +     DVWS G+V+   L G  P
Sbjct: 171 LPYVAPELLKRREFHAE---PVDVWSCGIVLTAMLAGELP 207

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 98/219 (44%), Gaps = 18/219 (8%)
Query: 46  ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQ 105
           + D   +  LG G  G V    ++ +    A+K+++   +         E  I K L+ +
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 106 FIVKCHAVFYTIEGEICFV-MEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG 164
            +VK +   +  EG I ++ +E+   G LFD +     + E       ++++ G+ YLHG
Sbjct: 65  NVVKFYG--HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTC 224
           + I H DIKP NLL++ +  +KI+DFG++ +                          GT 
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN------------KMXGTL 170
Query: 225 AYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYP 263
            Y++PE +    +  +     DVWS G+V+   L G  P
Sbjct: 171 PYVAPELLKRREFHAE---PVDVWSCGIVLTAMLAGELP 206

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 101/220 (45%), Gaps = 20/220 (9%)
Query: 46  ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQ 105
           + D   +  LG G  G V    ++ +    A+K+++   +         E  I K L+ +
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 106 FIVKCHAVFYTIEGEICFV-MEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG 164
            +VK +   +  EG I ++ +E+   G LFD +     + E       ++++ G+ YLHG
Sbjct: 65  NVVKFYG--HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACM-GT 223
           + I H DIKP NLL++ +  +KI+DFG++ +                   E  +  M GT
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR-------------ERLLNKMCGT 169
Query: 224 CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYP 263
             Y++PE +    +  +     DVWS G+V+   L G  P
Sbjct: 170 LPYVAPELLKRREFHAE---PVDVWSCGIVLTAMLAGELP 206

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 73/310 (23%), Positives = 132/310 (42%), Gaps = 44/310 (14%)
Query: 51  KLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKC 110
            L+ +G G  G+V       +    A+K ++         +   E +IL R   + I+  
Sbjct: 32  NLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI 91
Query: 111 HAVFY--TIEG-EICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQI 167
           + +    TIE  +  ++++ +    L+  L+  + LS D I    Y++L+GL+Y+H   +
Sbjct: 92  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANV 150
Query: 168 IHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYM 227
           +H D+KPSNLL+N   ++KI DFG++R+ +                       + T  Y 
Sbjct: 151 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY-----------VATRWYR 199
Query: 228 SPERVDSERWGGDYGFAGDVWSLGVVVLECLVG-------HY-----PLIGFGEKPDLMA 275
           +PE + + +    Y  + D+WS+G ++ E L         HY      ++G    P    
Sbjct: 200 APEIMLNSK---GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 256
Query: 276 LICAICFGER---LEMPETASPEFRRFVRSCLEK-----------DWRKRGTVEELLAYP 321
           L C I    R   L +P      + R   +   K           +  KR  VE+ LA+P
Sbjct: 257 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP 316
Query: 322 FVTKRSSSSN 331
           ++ +    S+
Sbjct: 317 YLEQYYDPSD 326

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 73/310 (23%), Positives = 132/310 (42%), Gaps = 44/310 (14%)
Query: 51  KLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKC 110
            L+ +G G  G+V       +    A+K ++         +   E +IL R   + I+  
Sbjct: 33  NLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI 92
Query: 111 HAVFY--TIEG-EICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQI 167
           + +    TIE  +  ++++ +    L+  L+  + LS D I    Y++L+GL+Y+H   +
Sbjct: 93  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANV 151
Query: 168 IHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYM 227
           +H D+KPSNLL+N   ++KI DFG++R+ +                       + T  Y 
Sbjct: 152 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY-----------VATRWYR 200
Query: 228 SPERVDSERWGGDYGFAGDVWSLGVVVLECLVG-------HY-----PLIGFGEKPDLMA 275
           +PE + + +    Y  + D+WS+G ++ E L         HY      ++G    P    
Sbjct: 201 APEIMLNSK---GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 257
Query: 276 LICAICFGER---LEMPETASPEFRRFVRSCLEK-----------DWRKRGTVEELLAYP 321
           L C I    R   L +P      + R   +   K           +  KR  VE+ LA+P
Sbjct: 258 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP 317
Query: 322 FVTKRSSSSN 331
           ++ +    S+
Sbjct: 318 YLEQYYDPSD 327

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 73/310 (23%), Positives = 132/310 (42%), Gaps = 44/310 (14%)
Query: 51  KLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKC 110
            L+ +G G  G+V       +    A+K ++         +   E +IL R   + I+  
Sbjct: 24  NLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI 83
Query: 111 HAVFY--TIEG-EICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQI 167
           + +    TIE  +  ++++ +    L+  L+  + LS D I    Y++L+GL+Y+H   +
Sbjct: 84  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANV 142
Query: 168 IHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYM 227
           +H D+KPSNLL+N   ++KI DFG++R+ +                       + T  Y 
Sbjct: 143 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY-----------VATRWYR 191
Query: 228 SPERVDSERWGGDYGFAGDVWSLGVVVLECLVG-------HY-----PLIGFGEKPDLMA 275
           +PE + + +    Y  + D+WS+G ++ E L         HY      ++G    P    
Sbjct: 192 APEIMLNSK---GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 248
Query: 276 LICAICFGER---LEMPETASPEFRRFVRSCLEK-----------DWRKRGTVEELLAYP 321
           L C I    R   L +P      + R   +   K           +  KR  VE+ LA+P
Sbjct: 249 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP 308
Query: 322 FVTKRSSSSN 331
           ++ +    S+
Sbjct: 309 YLEQYYDPSD 318

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 73/310 (23%), Positives = 132/310 (42%), Gaps = 44/310 (14%)
Query: 51  KLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKC 110
            L+ +G G  G+V       +    A+K ++         +   E +IL R   + I+  
Sbjct: 31  NLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI 90
Query: 111 HAVFY--TIEG-EICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQI 167
           + +    TIE  +  ++++ +    L+  L+  + LS D I    Y++L+GL+Y+H   +
Sbjct: 91  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANV 149
Query: 168 IHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYM 227
           +H D+KPSNLL+N   ++KI DFG++R+ +                       + T  Y 
Sbjct: 150 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY-----------VATRWYR 198
Query: 228 SPERVDSERWGGDYGFAGDVWSLGVVVLECLVG-------HY-----PLIGFGEKPDLMA 275
           +PE + + +    Y  + D+WS+G ++ E L         HY      ++G    P    
Sbjct: 199 APEIMLNSK---GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 255
Query: 276 LICAICFGER---LEMPETASPEFRRFVRSCLEK-----------DWRKRGTVEELLAYP 321
           L C I    R   L +P      + R   +   K           +  KR  VE+ LA+P
Sbjct: 256 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP 315
Query: 322 FVTKRSSSSN 331
           ++ +    S+
Sbjct: 316 YLEQYYDPSD 325

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 73/310 (23%), Positives = 132/310 (42%), Gaps = 44/310 (14%)
Query: 51  KLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKC 110
            L+ +G G  G+V       +    A+K ++         +   E +IL R   + I+  
Sbjct: 27  NLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI 86
Query: 111 HAVFY--TIEG-EICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQI 167
           + +    TIE  +  ++++ +    L+  L+  + LS D I    Y++L+GL+Y+H   +
Sbjct: 87  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANV 145
Query: 168 IHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYM 227
           +H D+KPSNLL+N   ++KI DFG++R+ +                       + T  Y 
Sbjct: 146 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY-----------VATRWYR 194
Query: 228 SPERVDSERWGGDYGFAGDVWSLGVVVLECLVG-------HY-----PLIGFGEKPDLMA 275
           +PE + + +    Y  + D+WS+G ++ E L         HY      ++G    P    
Sbjct: 195 APEIMLNSK---GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 251
Query: 276 LICAICFGER---LEMPETASPEFRRFVRSCLEK-----------DWRKRGTVEELLAYP 321
           L C I    R   L +P      + R   +   K           +  KR  VE+ LA+P
Sbjct: 252 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP 311
Query: 322 FVTKRSSSSN 331
           ++ +    S+
Sbjct: 312 YLEQYYDPSD 321

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 101/220 (45%), Gaps = 20/220 (9%)
Query: 46  ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQ 105
           + D   +  LG G  G V    ++ +    A+K+++   +         E  I K L+ +
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 106 FIVKCHAVFYTIEGEICFV-MEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG 164
            +VK +   +  EG I ++ +E+   G LFD +     + E       ++++ G+ YLHG
Sbjct: 65  NVVKFYG--HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACM-GT 223
           + I H DIKP NLL++ +  +KI+DFG++ +                   E  +  M GT
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR-------------ERLLNKMCGT 169
Query: 224 CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYP 263
             Y++PE +    +  +     DVWS G+V+   L G  P
Sbjct: 170 LPYVAPELLKRREFHAE---PVDVWSCGIVLTAMLAGELP 206

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 101/220 (45%), Gaps = 20/220 (9%)
Query: 46  ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQ 105
           + D   +  LG G  G V    ++ +    A+K+++   +         E  I K L+ +
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 106 FIVKCHAVFYTIEGEICFV-MEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG 164
            +VK +   +  EG I ++ +E+   G LFD +     + E       ++++ G+ YLHG
Sbjct: 66  NVVKFYG--HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACM-GT 223
           + I H DIKP NLL++ +  +KI+DFG++ +                   E  +  M GT
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR-------------ERLLNKMCGT 170
Query: 224 CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYP 263
             Y++PE +    +  +     DVWS G+V+   L G  P
Sbjct: 171 LPYVAPELLKRREFHAE---PVDVWSCGIVLTAMLAGELP 207

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 104/216 (48%), Gaps = 26/216 (12%)
Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH-EAEILKRLDSQFIV 108
           + L+ +G G  G V      K+    A+K L+    +II  +  + E  +LK +  + ++
Sbjct: 25  QNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI 84
Query: 109 KCHAVFYTI----EGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG 164
               VF       E    +++ H+  G+  +++   +KL++D +  + Y++L+GL+Y+H 
Sbjct: 85  GLLDVFTPARSLEEFNDVYLVTHL-MGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTC 224
             IIH D+KPSNL +N   E+KI DFG++R  +                 +     + T 
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-----------------DEMTGYVATR 186
Query: 225 AYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVG 260
            Y +PE +    W   Y    D+WS+G ++ E L G
Sbjct: 187 WYRAPEIM--LNWMH-YNQTVDIWSVGCIMAELLTG 219

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 101/220 (45%), Gaps = 20/220 (9%)
Query: 46  ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQ 105
           + D   +  LG G  G V    ++ +    A+K+++   +         E  I K L+ +
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 106 FIVKCHAVFYTIEGEICFV-MEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG 164
            +VK +   +  EG I ++ +E+   G LFD +     + E       ++++ G+ YLHG
Sbjct: 65  NVVKFYG--HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACM-GT 223
           + I H DIKP NLL++ +  +KI+DFG++ +                   E  +  M GT
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR-------------ERLLNKMCGT 169
Query: 224 CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYP 263
             Y++PE +    +  +     DVWS G+V+   L G  P
Sbjct: 170 LPYVAPELLKRREFHAE---PVDVWSCGIVLTAMLAGELP 206

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 101/220 (45%), Gaps = 20/220 (9%)
Query: 46  ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQ 105
           + D   +  LG G  G V    ++ +    A+K+++   +         E  I K L+ +
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 106 FIVKCHAVFYTIEGEICFV-MEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG 164
            +VK +   +  EG I ++ +E+   G LFD +     + E       ++++ G+ YLHG
Sbjct: 65  NVVKFYG--HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACM-GT 223
           + I H DIKP NLL++ +  +KI+DFG++ +                   E  +  M GT
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR-------------ERLLNKMCGT 169
Query: 224 CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYP 263
             Y++PE +    +  +     DVWS G+V+   L G  P
Sbjct: 170 LPYVAPELLKRREFHAE---PVDVWSCGIVLTAMLAGELP 206

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 101/220 (45%), Gaps = 20/220 (9%)
Query: 46  ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQ 105
           + D   +  LG G  G V    ++ +    A+K+++   +         E  I K L+ +
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 106 FIVKCHAVFYTIEGEICFV-MEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG 164
            +VK +   +  EG I ++ +E+   G LFD +     + E       ++++ G+ YLHG
Sbjct: 65  NVVKFYG--HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACM-GT 223
           + I H DIKP NLL++ +  +KI+DFG++ +                   E  +  M GT
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR-------------ERLLNKMCGT 169
Query: 224 CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYP 263
             Y++PE +    +  +     DVWS G+V+   L G  P
Sbjct: 170 LPYVAPELLKRREFHAE---PVDVWSCGIVLTAMLAGELP 206

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 81/291 (27%), Positives = 122/291 (41%), Gaps = 53/291 (18%)
Query: 55  LGHGNGGIVY-----KVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVK 109
           LG G  G V+      +  ++   + A+K L   S +  R     EAE+L  L  Q IV+
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESA-RQDFQREAELLTMLQHQHIVR 107
Query: 110 CHAVFYTIEGE-ICFVMEHMERGSLFDSLRVR---KKL---SEDVISG---------VAY 153
              V    EG  +  V E+M  G L   LR      KL    EDV  G         VA 
Sbjct: 108 FFGV--CTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165
Query: 154 RVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXI 213
           +V  G+ YL G+  +H D+   N L+     VKI DFG+SR +  T              
Sbjct: 166 QVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYY----------- 214
Query: 214 GEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP-- 271
                  M    +M PE +   +    +    DVWS GVV+ E       +  +G++P  
Sbjct: 215 -RVGGRTMLPIRWMPPESILYRK----FTTESDVWSFGVVLWE-------IFTYGKQPWY 262
Query: 272 ---DLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA 319
              +  A+ C I  G  LE P    PE    +R C +++ ++R +++++ A
Sbjct: 263 QLSNTEAIDC-ITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHA 312

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 104/216 (48%), Gaps = 26/216 (12%)
Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH-EAEILKRLDSQFIV 108
           + L+ +G G  G V      K+    A+K L+    +II  +  + E  +LK +  + ++
Sbjct: 31  QNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI 90
Query: 109 KCHAVFYTI----EGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG 164
               VF       E    +++ H+  G+  +++   +KL++D +  + Y++L+GL+Y+H 
Sbjct: 91  GLLDVFTPARSLEEFNDVYLVTHL-MGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 149
Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTC 224
             IIH D+KPSNL +N   E+KI DFG++R  +                 +     + T 
Sbjct: 150 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-----------------DEMTGYVATR 192
Query: 225 AYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVG 260
            Y +PE +    W   Y    D+WS+G ++ E L G
Sbjct: 193 WYRAPEIM--LNWMH-YNQTVDIWSVGCIMAELLTG 225

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 75/310 (24%), Positives = 134/310 (43%), Gaps = 44/310 (14%)
Query: 51  KLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKC 110
            L+ +G G  G+V       +    A+K ++         +   E +IL R   + I+  
Sbjct: 31  NLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI 90
Query: 111 HAVFY--TIEG-EICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQI 167
           + +    TIE  +  ++++ +    L+  L+  + LS D I    Y++L+GL+Y+H   +
Sbjct: 91  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANV 149
Query: 168 IHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYM 227
           +H D+KPSNLL+N   ++KI DFG++R+ +                       + T  Y 
Sbjct: 150 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEX-----------VATRWYR 198
Query: 228 SPERVDSERWGGDYGFAGDVWSLGVVVLECLVG-------HY-----PLIGFGEKPDLMA 275
           +PE + + +    Y  + D+WS+G ++ E L         HY      ++G    P    
Sbjct: 199 APEIMLNSK---GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 255
Query: 276 LICAICFGER---LEMPETASPEFRRFVRSCLEK-----------DWRKRGTVEELLAYP 321
           L C I    R   L +P      + R   +   K           +  KR  VE+ LA+P
Sbjct: 256 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP 315
Query: 322 FVTKRSSSSN 331
           ++ +    S+
Sbjct: 316 YLEQYYDPSD 325

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 73/310 (23%), Positives = 132/310 (42%), Gaps = 44/310 (14%)
Query: 51  KLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKC 110
            L+ +G G  G+V       +    A+K ++         +   E +IL R   + I+  
Sbjct: 31  NLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI 90
Query: 111 HAVFY--TIEG-EICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQI 167
           + +    TIE  +  ++++ +    L+  L+  + LS D I    Y++L+GL+Y+H   +
Sbjct: 91  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKC-QHLSNDHICYFLYQILRGLKYIHSANV 149
Query: 168 IHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYM 227
           +H D+KPSNLL+N   ++KI DFG++R+ +                       + T  Y 
Sbjct: 150 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY-----------VATRWYR 198
Query: 228 SPERVDSERWGGDYGFAGDVWSLGVVVLECLVG-------HY-----PLIGFGEKPDLMA 275
           +PE + + +    Y  + D+WS+G ++ E L         HY      ++G    P    
Sbjct: 199 APEIMLNSK---GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 255
Query: 276 LICAICFGER---LEMPETASPEFRRFVRSCLEK-----------DWRKRGTVEELLAYP 321
           L C I    R   L +P      + R   +   K           +  KR  VE+ LA+P
Sbjct: 256 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP 315
Query: 322 FVTKRSSSSN 331
           ++ +    S+
Sbjct: 316 YLEQYYDPSD 325

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 75/310 (24%), Positives = 134/310 (43%), Gaps = 44/310 (14%)
Query: 51  KLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKC 110
            L+ +G G  G+V       +    A+K ++         +   E +IL R   + I+  
Sbjct: 32  NLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI 91
Query: 111 HAVFY--TIEG-EICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQI 167
           + +    TIE  +  ++++ +    L+  L+  + LS D I    Y++L+GL+Y+H   +
Sbjct: 92  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANV 150
Query: 168 IHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYM 227
           +H D+KPSNLL+N   ++KI DFG++R+ +                       + T  Y 
Sbjct: 151 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEX-----------VATRWYR 199
Query: 228 SPERVDSERWGGDYGFAGDVWSLGVVVLECLVG-------HY-----PLIGFGEKPDLMA 275
           +PE + + +    Y  + D+WS+G ++ E L         HY      ++G    P    
Sbjct: 200 APEIMLNSK---GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 256
Query: 276 LICAICFGER---LEMPETASPEFRRFVRSCLEK-----------DWRKRGTVEELLAYP 321
           L C I    R   L +P      + R   +   K           +  KR  VE+ LA+P
Sbjct: 257 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP 316
Query: 322 FVTKRSSSSN 331
           ++ +    S+
Sbjct: 317 YLEQYYDPSD 326

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 106/216 (49%), Gaps = 26/216 (12%)
Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH-EAEILKRLDSQFIV 108
           + L+ +G G  G V      K+    A+K L+    +II  +  + E  +LK +  + ++
Sbjct: 25  QNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI 84
Query: 109 KCHAVFYTI----EGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG 164
               VF       E    +++ H+  G+  +++   +KL++D +  + Y++L+GL+Y+H 
Sbjct: 85  GLLDVFTPARSLEEFNDVYLVTHL-MGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTC 224
             IIH D+KPSNL +N   E+KI DFG++R  ++                E A   + T 
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----------------EMA-GFVATR 186
Query: 225 AYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVG 260
            Y +PE +    W   Y    D+WS+G ++ E L G
Sbjct: 187 WYRAPEIM--LNWMH-YNQTVDIWSVGCIMAELLTG 219

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 101/220 (45%), Gaps = 20/220 (9%)
Query: 46  ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQ 105
           + D   +  LG G  G V    ++ +    A+K+++   +         E  I K L+ +
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 106 FIVKCHAVFYTIEGEICFV-MEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG 164
            +VK +   +  EG I ++ +E+   G LFD +     + E       ++++ G+ YLHG
Sbjct: 65  NVVKFYG--HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACM-GT 223
           + I H DIKP NLL++ +  +KI+DFG++ +                   E  +  M GT
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR-------------ERLLNKMCGT 169
Query: 224 CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYP 263
             Y++PE +    +  +     DVWS G+V+   L G  P
Sbjct: 170 LPYVAPELLKRREFHAE---PVDVWSCGIVLTAMLAGELP 206

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 104/216 (48%), Gaps = 26/216 (12%)
Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH-EAEILKRLDSQFIV 108
           + L+ +G G  G V      K+    A+K L+    +II  +  + E  +LK +  + ++
Sbjct: 21  QNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI 80
Query: 109 KCHAVFYTI----EGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG 164
               VF       E    +++ H+  G+  +++   +KL++D +  + Y++L+GL+Y+H 
Sbjct: 81  GLLDVFTPARSLEEFNDVYLVTHL-MGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 139
Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTC 224
             IIH D+KPSNL +N   E+KI DFG++R  +                 +     + T 
Sbjct: 140 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-----------------DEMTGYVATR 182
Query: 225 AYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVG 260
            Y +PE +    W   Y    D+WS+G ++ E L G
Sbjct: 183 WYRAPEIM--LNWMH-YNQTVDIWSVGCIMAELLTG 215

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 104/216 (48%), Gaps = 26/216 (12%)
Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH-EAEILKRLDSQFIV 108
           + L+ +G G  G V      K+    A+K L+    +II  +  + E  +LK +  + ++
Sbjct: 44  QNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI 103
Query: 109 KCHAVFYTI----EGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG 164
               VF       E    +++ H+  G+  +++   +KL++D +  + Y++L+GL+Y+H 
Sbjct: 104 GLLDVFTPARSLEEFNDVYLVTHL-MGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 162
Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTC 224
             IIH D+KPSNL +N   E+KI DFG++R  +                 +     + T 
Sbjct: 163 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-----------------DEMTGYVATR 205
Query: 225 AYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVG 260
            Y +PE +    W   Y    D+WS+G ++ E L G
Sbjct: 206 WYRAPEIM--LNWMH-YNQTVDIWSVGCIMAELLTG 238

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 102/218 (46%), Gaps = 24/218 (11%)
Query: 49  LKKLTVLGHGNGGIV----YKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDS 104
           LK L  LG GN G V    Y      +  + A+K L  ++   +R     E EILK L  
Sbjct: 13  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQH 71
Query: 105 QFIVKCHAVFYTI-EGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAY--RVLKGLQY 161
             IVK   V Y+     +  +ME++  GSL D L+  K+   D I  + Y  ++ KG++Y
Sbjct: 72  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI-DHIKLLQYTSQICKGMEY 130
Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACM 221
           L   + IH ++   N+L+  +  VKI DFG+++++ + +             GE+ I   
Sbjct: 131 LGTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEP-----GESPI--- 182
Query: 222 GTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV 259
               + +PE +   +    +  A DVWS GVV+ E   
Sbjct: 183 ---FWYAPESLTESK----FSVASDVWSFGVVLYELFT 213

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 81/291 (27%), Positives = 122/291 (41%), Gaps = 53/291 (18%)
Query: 55  LGHGNGGIVY-----KVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVK 109
           LG G  G V+      +  ++   + A+K L   S +  R     EAE+L  L  Q IV+
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESA-RQDFQREAELLTMLQHQHIVR 78
Query: 110 CHAVFYTIEGE-ICFVMEHMERGSLFDSLRVR---KKL---SEDVISG---------VAY 153
              V    EG  +  V E+M  G L   LR      KL    EDV  G         VA 
Sbjct: 79  FFGV--CTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 136
Query: 154 RVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXI 213
           +V  G+ YL G+  +H D+   N L+     VKI DFG+SR +  T              
Sbjct: 137 QVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYY----------- 185
Query: 214 GEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP-- 271
                  M    +M PE +   +    +    DVWS GVV+ E       +  +G++P  
Sbjct: 186 -RVGGRTMLPIRWMPPESILYRK----FTTESDVWSFGVVLWE-------IFTYGKQPWY 233
Query: 272 ---DLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA 319
              +  A+ C I  G  LE P    PE    +R C +++ ++R +++++ A
Sbjct: 234 QLSNTEAIDC-ITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHA 283

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 67/269 (24%), Positives = 117/269 (43%), Gaps = 29/269 (10%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVF 114
           LG G  G V+      +  + A+K L     T+       EA+++K+L  + +V+ +AV 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRV-AIKTLK--PGTMSPEAFLQEAQVMKKLRHEKLVQLYAV- 81
Query: 115 YTIEGEICFVMEHMERGSLFDSLR--VRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDI 172
              E  I  V+E+M +GSL D L+  + K L    +  +A ++  G+ Y+  M  +H D+
Sbjct: 82  -VSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDL 140
Query: 173 KPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERV 232
           + +N+L+      K+ADFG++R++E+                 A         + +PE  
Sbjct: 141 RAANILVGENLVCKVADFGLARLIEDNEYT-------------ARQGAKFPIKWTAPEAA 187
Query: 233 DSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICAICFGERLEMPET 291
                 G +    DVWS G+++ E    G  P  G   +     ++  +  G R+  P  
Sbjct: 188 LY----GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR----EVLDQVERGYRMPCPPE 239
Query: 292 ASPEFRRFVRSCLEKDWRKRGTVEELLAY 320
                   +  C  KD  +R T E L A+
Sbjct: 240 CPESLHDLMCQCWRKDPEERPTFEYLQAF 268

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 106/216 (49%), Gaps = 26/216 (12%)
Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH-EAEILKRLDSQFIV 108
           + L+ +G G  G V      K+    A+K L+    +II  +  + E  +LK +  + ++
Sbjct: 25  QNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI 84
Query: 109 KCHAVFYTI----EGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG 164
               VF       E    +++ H+  G+  +++   +KL++D +  + Y++L+GL+Y+H 
Sbjct: 85  GLLDVFTPARSLEEFNDVYLVTHL-MGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTC 224
             IIH D+KPSNL +N   E+KI DFG++R  ++                E A   + T 
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----------------EMA-GFVATR 186
Query: 225 AYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVG 260
            Y +PE +    W   Y    D+WS+G ++ E L G
Sbjct: 187 WYRAPEIM--LNWMH-YNQTVDIWSVGCIMAELLTG 219

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 99/229 (43%), Gaps = 33/229 (14%)
Query: 54  VLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAV 113
           +LG G    V++ RH+K+  ++A+KV N  S          E E+LK+L+ + IVK  A+
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 114 -FYTIEGEICFVMEHMERGSLFDSLRVRKK---LSEDVISGVAYRVLKGLQYLHGMQIIH 169
              T       +ME    GSL+  L        L E     V   V+ G+ +L    I+H
Sbjct: 76  EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVH 135
Query: 170 GDIKPSNLL----INGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCA 225
            +IKP N++     +G+   K+ DFG +R +E+                E  +   GT  
Sbjct: 136 RNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD---------------EQFVXLYGTEE 180
Query: 226 YMSPE-------RVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGF 267
           Y+ P+       R D ++    YG   D+WS+GV       G  P   F
Sbjct: 181 YLHPDMYERAVLRKDHQK---KYGATVDLWSIGVTFYHAATGSLPFRPF 226

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 104/216 (48%), Gaps = 26/216 (12%)
Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH-EAEILKRLDSQFIV 108
           + L+ +G G  G V      K+    A+K L+    +II  +  + E  +LK +  + ++
Sbjct: 45  QNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI 104
Query: 109 KCHAVFYTI----EGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG 164
               VF       E    +++ H+  G+  +++   +KL++D +  + Y++L+GL+Y+H 
Sbjct: 105 GLLDVFTPARSLEEFNDVYLVTHL-MGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 163
Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTC 224
             IIH D+KPSNL +N   E+KI DFG++R  +                 +     + T 
Sbjct: 164 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-----------------DEMTGYVATR 206
Query: 225 AYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVG 260
            Y +PE +    W   Y    D+WS+G ++ E L G
Sbjct: 207 WYRAPEIM--LNWMH-YNQTVDIWSVGCIMAELLTG 239

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 68/269 (25%), Positives = 118/269 (43%), Gaps = 29/269 (10%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVF 114
           LG G  G V+      +  + A+K L     T+       EA+++K+L  + +V+ +AV 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRV-AIKTLK--PGTMSPEAFLQEAQVMKKLRHEKLVQLYAV- 81
Query: 115 YTIEGEICFVMEHMERGSLFDSLR--VRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDI 172
              E  I  V+E+M +GSL D L+  + K L    +  +A ++  G+ Y+  M  +H D+
Sbjct: 82  -VSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDL 140
Query: 173 KPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERV 232
           + +N+L+      K+ADFG++R++E+                 A         + +PE  
Sbjct: 141 RAANILVGENLVCKVADFGLARLIEDNEXT-------------ARQGAKFPIKWTAPEAA 187
Query: 233 DSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICAICFGERLEMPET 291
                 G +    DVWS G+++ E    G  P  G   +     ++  +  G R+  P  
Sbjct: 188 LY----GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR----EVLDQVERGYRMPCPPE 239
Query: 292 ASPEFRRFVRSCLEKDWRKRGTVEELLAY 320
                   +  C  KD  +R T E L A+
Sbjct: 240 CPESLHDLMCQCWRKDPEERPTFEYLQAF 268

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 103/216 (47%), Gaps = 26/216 (12%)
Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH-EAEILKRLDSQFIV 108
           + L+ +G G  G V      K+    A+K L+    +II  +  + E  +LK +  + ++
Sbjct: 32  QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI 91
Query: 109 KCHAVFYTI----EGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG 164
               VF       E    +++ H+  G+  +++   +KL++D +  + Y++L+GL+Y+H 
Sbjct: 92  GLLDVFTPARSLEEFNDVYLVTHL-MGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 150
Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTC 224
             IIH D+KPSNL +N   E+KI DFG++R                    +     + T 
Sbjct: 151 ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----------------HTADEMTGYVATR 193
Query: 225 AYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVG 260
            Y +PE +    W   Y    D+WS+G ++ E L G
Sbjct: 194 WYRAPEIM--LNWMH-YNQTVDIWSVGCIMAELLTG 226

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 106/216 (49%), Gaps = 26/216 (12%)
Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH-EAEILKRLDSQFIV 108
           + L+ +G G  G V      K+    A+K L+    +II  +  + E  +LK +  + ++
Sbjct: 21  QNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI 80
Query: 109 KCHAVFYTI----EGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG 164
               VF       E    +++ H+  G+  +++   +KL++D +  + Y++L+GL+Y+H 
Sbjct: 81  GLLDVFTPARSLEEFNDVYLVTHL-MGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 139
Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTC 224
             IIH D+KPSNL +N   E+KI DFG++R  ++                E A   + T 
Sbjct: 140 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----------------EMA-GFVATR 182
Query: 225 AYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVG 260
            Y +PE +    W   Y    D+WS+G ++ E L G
Sbjct: 183 WYRAPEIM--LNWMH-YNQTVDIWSVGCIMAELLTG 215

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 81/291 (27%), Positives = 123/291 (42%), Gaps = 53/291 (18%)
Query: 55  LGHGNGGIVY-----KVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVK 109
           LG G  G V+      +  ++   + A+K L   S +  R     EAE+L  L  Q IV+
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESA-RQDFQREAELLTMLQHQHIVR 84
Query: 110 CHAVFYTIEGE-ICFVMEHMERGSLFDSLRVR---KKL---SEDVISG---------VAY 153
              V    EG  +  V E+M  G L   LR      KL    EDV  G         VA 
Sbjct: 85  FFGV--CTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 142
Query: 154 RVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXI 213
           +V  G+ YL G+  +H D+   N L+     VKI DFG+SR +  T              
Sbjct: 143 QVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYY----------- 191
Query: 214 GEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP-- 271
                  M    +M PE +   ++  +     DVWS GVV+ E       +  +G++P  
Sbjct: 192 -RVGGRTMLPIRWMPPESILYRKFTTE----SDVWSFGVVLWE-------IFTYGKQPWY 239
Query: 272 ---DLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA 319
              +  A+ C I  G  LE P    PE    +R C +++ ++R +++++ A
Sbjct: 240 QLSNTEAIDC-ITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHA 289

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 70/275 (25%), Positives = 115/275 (41%), Gaps = 26/275 (9%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVF 114
           +G GN G+   +R + +  + A+K +   ++  I      E    + L    IV+   V 
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIERGAA--IDENVQREIINHRSLRHPNIVRFKEVI 85
Query: 115 YTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKP 174
            T    +  +ME+   G L++ +    + SED       ++L G+ Y H MQI H D+K 
Sbjct: 86  LT-PTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKL 144
Query: 175 SNLLINGK--GEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERV 232
            N L++G     +KI DFG S+                  +     + +GT AY++PE +
Sbjct: 145 ENTLLDGSPAPRLKICDFGYSK---------------SSVLHSQPKSTVGTPAYIAPEVL 189
Query: 233 DSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPET- 291
             + + G      DVWS GV +   LVG YP     E  D    I  I    +  +P+  
Sbjct: 190 LRQEYDGK---IADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRI-LSVKYSIPDDI 245
Query: 292 -ASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTK 325
             SPE    +      D   R ++ E+  + +  K
Sbjct: 246 RISPECCHLISRIFVADPATRISIPEIKTHSWFLK 280

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 67/269 (24%), Positives = 116/269 (43%), Gaps = 29/269 (10%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVF 114
           LG G  G V+      +  + A+K L     T+       EA+++K+L  + +V+ +AV 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRV-AIKTLK--PGTMSPEAFLQEAQVMKKLRHEKLVQLYAV- 81
Query: 115 YTIEGEICFVMEHMERGSLFDSLR--VRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDI 172
              E  I  VME+M +G L D L+  + K L    +  +A ++  G+ Y+  M  +H D+
Sbjct: 82  -VSEEPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDL 140
Query: 173 KPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERV 232
           + +N+L+      K+ADFG++R++E+                 A         + +PE  
Sbjct: 141 RAANILVGENLVCKVADFGLARLIEDNEYT-------------ARQGAKFPIKWTAPEAA 187
Query: 233 DSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICAICFGERLEMPET 291
                 G +    DVWS G+++ E    G  P  G   +     ++  +  G R+  P  
Sbjct: 188 LY----GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR----EVLDQVERGYRMPCPPE 239
Query: 292 ASPEFRRFVRSCLEKDWRKRGTVEELLAY 320
                   +  C  KD  +R T E L A+
Sbjct: 240 CPESLHDLMCQCWRKDPEERPTFEYLQAF 268

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 104/216 (48%), Gaps = 26/216 (12%)
Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH-EAEILKRLDSQFIV 108
           + L+ +G G  G V      K+    A+K L+    +II  +  + E  +LK +  + ++
Sbjct: 45  QNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI 104
Query: 109 KCHAVFYTI----EGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG 164
               VF       E    +++ H+  G+  +++   +KL++D +  + Y++L+GL+Y+H 
Sbjct: 105 GLLDVFTPARSLEEFNDVYLVTHL-MGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 163
Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTC 224
             IIH D+KPSNL +N   E+KI DFG++R  +                 +     + T 
Sbjct: 164 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-----------------DEMXGXVATR 206
Query: 225 AYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVG 260
            Y +PE +    W   Y    D+WS+G ++ E L G
Sbjct: 207 WYRAPEIM--LNWMH-YNQTVDIWSVGCIMAELLTG 239

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 104/216 (48%), Gaps = 26/216 (12%)
Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH-EAEILKRLDSQFIV 108
           + L+ +G G  G V      K+    A+K L+    +II  +  + E  +LK +  + ++
Sbjct: 36  QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI 95
Query: 109 KCHAVFYTI----EGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG 164
               VF       E    +++ H+  G+  +++   +KL++D +  + Y++L+GL+Y+H 
Sbjct: 96  GLLDVFTPARSLEEFNDVYLVTHL-MGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 154
Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTC 224
             IIH D+KPSNL +N   E+KI DFG++R  +                 +     + T 
Sbjct: 155 ADIIHRDLKPSNLAVNEDXELKILDFGLARHTD-----------------DEMTGYVATR 197
Query: 225 AYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVG 260
            Y +PE +    W   Y    D+WS+G ++ E L G
Sbjct: 198 WYRAPEIM--LNWMH-YNQTVDIWSVGCIMAELLTG 230

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 73/292 (25%), Positives = 128/292 (43%), Gaps = 49/292 (16%)
Query: 54  VLGHGNGGIVYKVRHQKSNSIYALKVLNTTSST---IIRHQAAHEAEILKRLDSQFIVKC 110
           VLG G  G V ++ ++++   +ALK+L         +  H  A +   + R     IV  
Sbjct: 23  VLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVR-----IVDV 77
Query: 111 HAVFYTIEGEICFVMEHMERGSLFDSLRVR--KKLSEDVISGVAYRVLKGLQYLHGMQII 168
           +   Y     +  VME ++ G LF  ++ R  +  +E   S +   + + +QYLH + I 
Sbjct: 78  YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIA 137
Query: 169 HGDIKPSNLLINGK---GEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCA 225
           H D+KP NLL   K     +K+ DFG ++   ET                    C  T  
Sbjct: 138 HRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHNSLTE-----------PCY-TPY 182
Query: 226 YMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLI---GFGEKPDLMALICAICF 282
           Y++PE +  E+    Y  + D+WSLGV++   L G+ P     G    P +   I     
Sbjct: 183 YVAPEVLGPEK----YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI----- 233
Query: 283 GERLEMPETASPEF-------RRFVRSCLEKDWRKRGTVEELLAYPFVTKRS 327
             R+   E  +PE+       +  +R+ L+ +  +R T+ E + +P++ + +
Sbjct: 234 --RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 283

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 48/153 (31%), Positives = 80/153 (52%), Gaps = 19/153 (12%)
Query: 51  KLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKC 110
           KL  LG G    VYK + + ++++ ALK +           A  E  +LK L    IV  
Sbjct: 6   KLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTL 65
Query: 111 HAVFYTIEGEICFVMEHMER---------GSLFDSLRVRKKLSEDVISGVAYRVLKGLQY 161
           H + +T E  +  V E++++         G++ +   V+  L         +++L+GL Y
Sbjct: 66  HDIIHT-EKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFL---------FQLLRGLAY 115
Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSR 194
            H  +++H D+KP NLLIN +GE+K+ADFG++R
Sbjct: 116 CHRQKVLHRDLKPQNLLINERGELKLADFGLAR 148

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 103/216 (47%), Gaps = 26/216 (12%)
Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH-EAEILKRLDSQFIV 108
           + L+ +G G  G V      K+    A+K L+    +II  +  + E  +LK +  + ++
Sbjct: 32  QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI 91
Query: 109 KCHAVFYTI----EGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG 164
               VF       E    +++ H+  G+  +++   +KL++D +  + Y++L+GL+Y+H 
Sbjct: 92  GLLDVFTPARSLEEFNDVYLVTHL-MGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 150
Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTC 224
             IIH D+KPSNL +N   E+KI DFG++R                    +     + T 
Sbjct: 151 ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----------------HTADEMTGYVATR 193
Query: 225 AYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVG 260
            Y +PE +    W   Y    D+WS+G ++ E L G
Sbjct: 194 WYRAPEIM--LNWMH-YNQTVDIWSVGCIMAELLTG 226

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 103/216 (47%), Gaps = 26/216 (12%)
Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH-EAEILKRLDSQFIV 108
           + L+ +G G  G V      K+    A+K L+    +II  +  + E  +LK +  + ++
Sbjct: 32  QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI 91
Query: 109 KCHAVFYTI----EGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG 164
               VF       E    +++ H+  G+  +++   +KL++D +  + Y++L+GL+Y+H 
Sbjct: 92  GLLDVFTPARSLEEFNDVYLVTHL-MGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 150
Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTC 224
             IIH D+KPSNL +N   E+KI DFG++R                    +     + T 
Sbjct: 151 ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----------------HTADEMTGYVATR 193
Query: 225 AYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVG 260
            Y +PE +    W   Y    D+WS+G ++ E L G
Sbjct: 194 WYRAPEIM--LNWMH-YNQTVDIWSVGCIMAELLTG 226

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 104/216 (48%), Gaps = 26/216 (12%)
Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH-EAEILKRLDSQFIV 108
           + L+ +G G  G V      K+    A+K L+    +II  +  + E  +LK +  + ++
Sbjct: 25  QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI 84
Query: 109 KCHAVFYTI----EGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG 164
               VF       E    +++ H+  G+  +++   +KL++D +  + Y++L+GL+Y+H 
Sbjct: 85  GLLDVFTPARSLEEFNDVYLVTHL-MGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTC 224
             IIH D+KPSNL +N   E+KI DFG++R  +                 +     + T 
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-----------------DEMTGXVATR 186
Query: 225 AYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVG 260
            Y +PE +    W   Y    D+WS+G ++ E L G
Sbjct: 187 WYRAPEIM--LNWMH-YNQTVDIWSVGCIMAELLTG 219

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 104/216 (48%), Gaps = 26/216 (12%)
Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH-EAEILKRLDSQFIV 108
           + L+ +G G  G V      K+    A+K L+    +II  +  + E  +LK +  + ++
Sbjct: 37  QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLLKHMKHENVI 96
Query: 109 KCHAVFYTI----EGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG 164
               VF       E    +++ H+  G+  +++   +KL++D +  + Y++L+GL+Y+H 
Sbjct: 97  GLLDVFTPARSLEEFNDVYLVTHL-MGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 155
Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTC 224
             IIH D+KPSNL +N   E+KI DFG++R  +                 +     + T 
Sbjct: 156 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-----------------DEMTGYVATR 198
Query: 225 AYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVG 260
            Y +PE +    W   Y    D+WS+G ++ E L G
Sbjct: 199 WYRAPEIM--LNWMH-YNQTVDIWSVGCIMAELLTG 231

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 72/286 (25%), Positives = 132/286 (46%), Gaps = 36/286 (12%)
Query: 52  LTVLGHGNGGIVYKVRHQKSNSIYALKVLN---TTSSTIIRHQAAHEAEILKRLD--SQF 106
           L  +G G    V++V ++K   IYA+K +N     + T+  ++  +E   L +L   S  
Sbjct: 61  LKQIGSGGSSKVFQVLNEKK-QIYAIKYVNLEEADNQTLDSYR--NEIAYLNKLQQHSDK 117
Query: 107 IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAY--RVLKGLQYLHG 164
           I++ +   Y I  +  +++  ME G++  +  ++KK S D     +Y   +L+ +  +H 
Sbjct: 118 IIRLYD--YEITDQYIYMV--MECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 173
Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTC 224
             I+H D+KP+N LI   G +K+ DFG++  ++                     + +G  
Sbjct: 174 HGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKD------------SQVGAV 220
Query: 225 AYMSPERV---DSERWGGDYGFAG----DVWSLGVVVLECLVGHYPLIGFGEKPDLMALI 277
            YM PE +    S R  G          DVWSLG ++     G  P      +  +  L 
Sbjct: 221 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ--ISKLH 278
Query: 278 CAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV 323
             I     +E P+    + +  ++ CL++D ++R ++ ELLA+P+V
Sbjct: 279 AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 324

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 104/216 (48%), Gaps = 26/216 (12%)
Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH-EAEILKRLDSQFIV 108
           + L+ +G G  G V      K+    A+K L+    +II  +  + E  +LK +  + ++
Sbjct: 25  QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI 84
Query: 109 KCHAVFYTI----EGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG 164
               VF       E    +++ H+  G+  +++   +KL++D +  + Y++L+GL+Y+H 
Sbjct: 85  GLLDVFTPARSLEEFNDVYLVTHL-MGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTC 224
             IIH D+KPSNL +N   E+KI DFG++R  +                 +     + T 
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-----------------DEMTGYVATR 186
Query: 225 AYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVG 260
            Y +PE +    W   Y    D+WS+G ++ E L G
Sbjct: 187 WYRAPEIM--LNWMH-YNQTVDIWSVGCIMAELLTG 219

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 104/216 (48%), Gaps = 26/216 (12%)
Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH-EAEILKRLDSQFIV 108
           + L+ +G G  G V      K+    A+K L+    +II  +  + E  +LK +  + ++
Sbjct: 25  QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI 84
Query: 109 KCHAVFYTI----EGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG 164
               VF       E    +++ H+  G+  +++   +KL++D +  + Y++L+GL+Y+H 
Sbjct: 85  GLLDVFTPARSLEEFNDVYLVTHL-MGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTC 224
             IIH D+KPSNL +N   E+KI DFG++R  +                 +     + T 
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-----------------DEMTGYVATR 186
Query: 225 AYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVG 260
            Y +PE +    W   Y    D+WS+G ++ E L G
Sbjct: 187 WYRAPEIM--LNWMH-YNQTVDIWSVGCIMAELLTG 219

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 103/216 (47%), Gaps = 26/216 (12%)
Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH-EAEILKRLDSQFIV 108
           + L  +G G  G V      K+    A+K L+    +II  +  + E  +LK +  + ++
Sbjct: 35  QNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI 94
Query: 109 KCHAVFYTI----EGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG 164
               VF       E    +++ H+  G+  +++   +KL++D +  + Y++L+GL+Y+H 
Sbjct: 95  GLLDVFTPARSLEEFNDVYLVTHL-MGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 153
Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTC 224
             IIH D+KPSNL +N   E+KI DFG++R  +                 +     + T 
Sbjct: 154 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-----------------DEMTGYVATR 196
Query: 225 AYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVG 260
            Y +PE +    W   Y    D+WS+G ++ E L G
Sbjct: 197 WYRAPEIM--LNWMH-YNQTVDIWSVGCIMAELLTG 229

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 75/311 (24%), Positives = 133/311 (42%), Gaps = 46/311 (14%)
Query: 51  KLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKC 110
           +L  +G G  G+V         +  A+K ++         +   E +IL R   + ++  
Sbjct: 47  QLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVIGI 106
Query: 111 HAVF--YTIEG-EICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQI 167
             +    T+E     ++++ +    L+  L+  ++LS D I    Y++L+GL+Y+H   +
Sbjct: 107 RDILRASTLEAMRDVYIVQDLMETDLYKLLK-SQQLSNDHICYFLYQILRGLKYIHSANV 165
Query: 168 IHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYM 227
           +H D+KPSNLLIN   ++KI DFG++RI +                       + T  Y 
Sbjct: 166 LHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEX-----------VATRWYR 214
Query: 228 SPERVDSERWGGDYGFAGDVWSLGVVVLECLVG-------HY-----PLIGFGEKPDLMA 275
           +PE + + +    Y  + D+WS+G ++ E L         HY      ++G    P    
Sbjct: 215 APEIMLNSK---GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 271
Query: 276 LICAICFGERLEM---------------PETASPEFRRFVRSCLEKDWRKRGTVEELLAY 320
           L C I    R  +               P++ S       R  L  +  KR TVEE LA+
Sbjct: 272 LNCIINMKARNYLQSLPSKTKVAWAKLFPKSDSKALDLLDR-MLTFNPNKRITVEEALAH 330
Query: 321 PFVTKRSSSSN 331
           P++ +    ++
Sbjct: 331 PYLEQYYDPTD 341

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 104/216 (48%), Gaps = 26/216 (12%)
Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH-EAEILKRLDSQFIV 108
           + L+ +G G  G V      K+    A+K L+    +II  +  + E  +LK +  + ++
Sbjct: 25  QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI 84
Query: 109 KCHAVFYTI----EGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG 164
               VF       E    +++ H+  G+  +++   +KL++D +  + Y++L+GL+Y+H 
Sbjct: 85  GLLDVFTPARSLEEFNDVYLVTHL-MGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTC 224
             IIH D+KPSNL +N   E+KI DFG++R  +                 +     + T 
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-----------------DEMTGYVATR 186
Query: 225 AYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVG 260
            Y +PE +    W   Y    D+WS+G ++ E L G
Sbjct: 187 WYRAPEIM--LNWMH-YNQTVDIWSVGCIMAELLTG 219

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 103/216 (47%), Gaps = 26/216 (12%)
Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH-EAEILKRLDSQFIV 108
           + L+ +G G  G V      K+    A+K L+    +II  +  + E  +LK +  + ++
Sbjct: 21  QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI 80
Query: 109 KCHAVFYTI----EGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG 164
               VF       E    +++ H+    L + ++  +KL++D +  + Y++L+GL+Y+H 
Sbjct: 81  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHS 139
Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTC 224
             IIH D+KPSNL +N   E+KI DFG++R  +                 +     + T 
Sbjct: 140 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-----------------DEMTGYVATR 182
Query: 225 AYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVG 260
            Y +PE +    W   Y    D+WS+G ++ E L G
Sbjct: 183 WYRAPEIM--LNWMH-YNQTVDIWSVGCIMAELLTG 215

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 104/216 (48%), Gaps = 26/216 (12%)
Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH-EAEILKRLDSQFIV 108
           + L+ +G G  G V      K+    A+K L+    +II  +  + E  +LK +  + ++
Sbjct: 30  QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI 89
Query: 109 KCHAVFYTI----EGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG 164
               VF       E    +++ H+  G+  +++   +KL++D +  + Y++L+GL+Y+H 
Sbjct: 90  GLLDVFTPARSLEEFNDVYLVTHL-MGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 148
Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTC 224
             IIH D+KPSNL +N   E+KI DFG++R  +                 +     + T 
Sbjct: 149 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-----------------DEMTGYVATR 191
Query: 225 AYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVG 260
            Y +PE +    W   Y    D+WS+G ++ E L G
Sbjct: 192 WYRAPEIM--LNWMH-YNQTVDIWSVGCIMAELLTG 224

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 104/216 (48%), Gaps = 26/216 (12%)
Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH-EAEILKRLDSQFIV 108
           + L+ +G G  G V      K+    A+K L+    +II  +  + E  +LK +  + ++
Sbjct: 22  QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI 81
Query: 109 KCHAVFYTI----EGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG 164
               VF       E    +++ H+  G+  +++   +KL++D +  + Y++L+GL+Y+H 
Sbjct: 82  GLLDVFTPARSLEEFNDVYLVTHL-MGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 140
Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTC 224
             IIH D+KPSNL +N   E+KI DFG++R  +                 +     + T 
Sbjct: 141 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-----------------DEMTGYVATR 183
Query: 225 AYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVG 260
            Y +PE +    W   Y    D+WS+G ++ E L G
Sbjct: 184 WYRAPEIM--LNWMH-YNQTVDIWSVGCIMAELLTG 216

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 104/216 (48%), Gaps = 26/216 (12%)
Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH-EAEILKRLDSQFIV 108
           + L+ +G G  G V      K+    A+K L+    +II  +  + E  +LK +  + ++
Sbjct: 23  QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI 82
Query: 109 KCHAVFYTI----EGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG 164
               VF       E    +++ H+  G+  +++   +KL++D +  + Y++L+GL+Y+H 
Sbjct: 83  GLLDVFTPARSLEEFNDVYLVTHL-MGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 141
Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTC 224
             IIH D+KPSNL +N   E+KI DFG++R  +                 +     + T 
Sbjct: 142 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-----------------DEMTGYVATR 184
Query: 225 AYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVG 260
            Y +PE +    W   Y    D+WS+G ++ E L G
Sbjct: 185 WYRAPEIM--LNWMH-YNQTVDIWSVGCIMAELLTG 217

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 69/265 (26%), Positives = 115/265 (43%), Gaps = 37/265 (13%)
Query: 47  SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQF 106
           +D+     LG G  G VY    +K +   A+K L     T+   +   EA ++K +    
Sbjct: 32  TDITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLK--EDTMEVEEFLKEAAVMKEIKHPN 89
Query: 107 IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRV--RKKLSEDVISGVAYRVLKGLQYLHG 164
           +V+   V  T+E     V E+M  G+L D LR   R++++  V+  +A ++   ++YL  
Sbjct: 90  LVQLLGVC-TLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLEK 148
Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGT- 223
              IH D+   N L+     VK+ADFG+SR++                 G+   A  G  
Sbjct: 149 KNFIHRDLAARNCLVGENHVVKVADFGLSRLM----------------TGDTYTAHAGAK 192
Query: 224 --CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECL---VGHYPLIGFGEKPDLMALIC 278
               + +PE +        +    DVW+ GV++ E     +  YP I   +  DL+    
Sbjct: 193 FPIKWTAPESLAY----NTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYDLLEK-- 246
Query: 279 AICFGERLEMPETASPEFRRFVRSC 303
               G R+E PE   P+    +R+C
Sbjct: 247 ----GYRMEQPEGCPPKVYELMRAC 267

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 104/216 (48%), Gaps = 26/216 (12%)
Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH-EAEILKRLDSQFIV 108
           + L+ +G G  G V      K+    A+K L+    +II  +  + E  +LK +  + ++
Sbjct: 30  QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI 89
Query: 109 KCHAVFYTI----EGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG 164
               VF       E    +++ H+  G+  +++   +KL++D +  + Y++L+GL+Y+H 
Sbjct: 90  GLLDVFTPARSLEEFNDVYLVTHL-MGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 148
Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTC 224
             IIH D+KPSNL +N   E+KI DFG++R  +                 +     + T 
Sbjct: 149 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-----------------DEMTGYVATR 191
Query: 225 AYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVG 260
            Y +PE +    W   Y    D+WS+G ++ E L G
Sbjct: 192 WYRAPEIM--LNWMH-YNQTVDIWSVGCIMAELLTG 224

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 104/216 (48%), Gaps = 26/216 (12%)
Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH-EAEILKRLDSQFIV 108
           + L+ +G G  G V      K+    A+K L+    +II  +  + E  +LK +  + ++
Sbjct: 25  QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI 84
Query: 109 KCHAVFYTI----EGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG 164
               VF       E    +++ H+  G+  +++   +KL++D +  + Y++L+GL+Y+H 
Sbjct: 85  GLLDVFTPARSLEEFNDVYLVTHL-MGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTC 224
             IIH D+KPSNL +N   E+KI DFG++R  +                 +     + T 
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-----------------DEMTGYVATR 186
Query: 225 AYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVG 260
            Y +PE +    W   Y    D+WS+G ++ E L G
Sbjct: 187 WYRAPEIM--LNWMH-YNQTVDIWSVGCIMAELLTG 219

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 104/216 (48%), Gaps = 26/216 (12%)
Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH-EAEILKRLDSQFIV 108
           + L+ +G G  G V      K+    A+K L+    +II  +  + E  +LK +  + ++
Sbjct: 24  QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI 83
Query: 109 KCHAVFYTI----EGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG 164
               VF       E    +++ H+  G+  +++   +KL++D +  + Y++L+GL+Y+H 
Sbjct: 84  GLLDVFTPARSLEEFNDVYLVTHL-MGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 142
Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTC 224
             IIH D+KPSNL +N   E+KI DFG++R  +                 +     + T 
Sbjct: 143 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-----------------DEMTGYVATR 185
Query: 225 AYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVG 260
            Y +PE +    W   Y    D+WS+G ++ E L G
Sbjct: 186 WYRAPEIM--LNWMH-YNQTVDIWSVGCIMAELLTG 218

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 104/216 (48%), Gaps = 26/216 (12%)
Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH-EAEILKRLDSQFIV 108
           + L+ +G G  G V      K+    A+K L+    +II  +  + E  +LK +  + ++
Sbjct: 25  QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI 84
Query: 109 KCHAVFYTI----EGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG 164
               VF       E    +++ H+  G+  +++   +KL++D +  + Y++L+GL+Y+H 
Sbjct: 85  GLLDVFTPARSLEEFNDVYLVTHL-MGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTC 224
             IIH D+KPSNL +N   E+KI DFG++R  +                 +     + T 
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-----------------DEMTGYVATR 186
Query: 225 AYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVG 260
            Y +PE +    W   Y    D+WS+G ++ E L G
Sbjct: 187 WYRAPEIM--LNWMH-YNQTVDIWSVGCIMAELLTG 219

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 104/216 (48%), Gaps = 26/216 (12%)
Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH-EAEILKRLDSQFIV 108
           + L+ +G G  G V      K+    A+K L+    +II  +  + E  +LK +  + ++
Sbjct: 22  QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI 81
Query: 109 KCHAVFYTI----EGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG 164
               VF       E    +++ H+  G+  +++   +KL++D +  + Y++L+GL+Y+H 
Sbjct: 82  GLLDVFTPARSLEEFNDVYLVTHL-MGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 140
Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTC 224
             IIH D+KPSNL +N   E+KI DFG++R  +                 +     + T 
Sbjct: 141 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-----------------DEMTGYVATR 183
Query: 225 AYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVG 260
            Y +PE +    W   Y    D+WS+G ++ E L G
Sbjct: 184 WYRAPEIM--LNWMH-YNQTVDIWSVGCIMAELLTG 216

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 104/216 (48%), Gaps = 26/216 (12%)
Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH-EAEILKRLDSQFIV 108
           + L+ +G G  G V      K+    A+K L+    +II  +  + E  +LK +  + ++
Sbjct: 44  QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI 103
Query: 109 KCHAVFYTI----EGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG 164
               VF       E    +++ H+  G+  +++   +KL++D +  + Y++L+GL+Y+H 
Sbjct: 104 GLLDVFTPARSLEEFNDVYLVTHL-MGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 162
Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTC 224
             IIH D+KPSNL +N   E+KI DFG++R  +                 +     + T 
Sbjct: 163 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-----------------DEMTGYVATR 205
Query: 225 AYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVG 260
            Y +PE +    W   Y    D+WS+G ++ E L G
Sbjct: 206 WYRAPEIM--LNWMH-YNQTVDIWSVGCIMAELLTG 238

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 104/216 (48%), Gaps = 26/216 (12%)
Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH-EAEILKRLDSQFIV 108
           + L+ +G G  G V      K+    A+K L+    +II  +  + E  +LK +  + ++
Sbjct: 25  QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI 84
Query: 109 KCHAVFYTI----EGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG 164
               VF       E    +++ H+  G+  +++   +KL++D +  + Y++L+GL+Y+H 
Sbjct: 85  GLLDVFTPARSLEEFNDVYLVTHL-MGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTC 224
             IIH D+KPSNL +N   E+KI DFG++R  +                 +     + T 
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-----------------DEMTGYVATR 186
Query: 225 AYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVG 260
            Y +PE +    W   Y    D+WS+G ++ E L G
Sbjct: 187 WYRAPEIM--LNWMH-YNQTVDIWSVGCIMAELLTG 219

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 104/216 (48%), Gaps = 26/216 (12%)
Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH-EAEILKRLDSQFIV 108
           + L+ +G G  G V      K+    A+K L+    +II  +  + E  +LK +  + ++
Sbjct: 27  QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI 86
Query: 109 KCHAVFYTI----EGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG 164
               VF       E    +++ H+  G+  +++   +KL++D +  + Y++L+GL+Y+H 
Sbjct: 87  GLLDVFTPARSLEEFNDVYLVTHL-MGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 145
Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTC 224
             IIH D+KPSNL +N   E+KI DFG++R  +                 +     + T 
Sbjct: 146 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-----------------DEMTGYVATR 188
Query: 225 AYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVG 260
            Y +PE +    W   Y    D+WS+G ++ E L G
Sbjct: 189 WYRAPEIM--LNWMH-YNQTVDIWSVGCIMAELLTG 221

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 104/216 (48%), Gaps = 26/216 (12%)
Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH-EAEILKRLDSQFIV 108
           + L+ +G G  G V      K+    A+K L+    +II  +  + E  +LK +  + ++
Sbjct: 36  QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI 95
Query: 109 KCHAVFYTI----EGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG 164
               VF       E    +++ H+  G+  +++   +KL++D +  + Y++L+GL+Y+H 
Sbjct: 96  GLLDVFTPARSLEEFNDVYLVTHL-MGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 154
Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTC 224
             IIH D+KPSNL +N   E+KI DFG++R  +                 +     + T 
Sbjct: 155 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-----------------DEMTGYVATR 197
Query: 225 AYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVG 260
            Y +PE +    W   Y    D+WS+G ++ E L G
Sbjct: 198 WYRAPEIM--LNWMH-YNQTVDIWSVGCIMAELLTG 230

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 104/216 (48%), Gaps = 26/216 (12%)
Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH-EAEILKRLDSQFIV 108
           + L+ +G G  G V      K+    A+K L+    +II  +  + E  +LK +  + ++
Sbjct: 31  QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI 90
Query: 109 KCHAVFYTI----EGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG 164
               VF       E    +++ H+  G+  +++   +KL++D +  + Y++L+GL+Y+H 
Sbjct: 91  GLLDVFTPARSLEEFNDVYLVTHL-MGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 149
Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTC 224
             IIH D+KPSNL +N   E+KI DFG++R  +                 +     + T 
Sbjct: 150 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-----------------DEMTGYVATR 192
Query: 225 AYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVG 260
            Y +PE +    W   Y    D+WS+G ++ E L G
Sbjct: 193 WYRAPEIM--LNWMH-YNQTVDIWSVGCIMAELLTG 225

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 104/216 (48%), Gaps = 26/216 (12%)
Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH-EAEILKRLDSQFIV 108
           + L+ +G G  G V      K+    A+K L+    +II  +  + E  +LK +  + ++
Sbjct: 32  QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI 91
Query: 109 KCHAVFYTI----EGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG 164
               VF       E    +++ H+  G+  +++   +KL++D +  + Y++L+GL+Y+H 
Sbjct: 92  GLLDVFTPARSLEEFNDVYLVTHL-MGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 150
Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTC 224
             IIH D+KPSNL +N   E+KI DFG++R  +                 +     + T 
Sbjct: 151 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-----------------DEMTGYVATR 193
Query: 225 AYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVG 260
            Y +PE +    W   Y    D+WS+G ++ E L G
Sbjct: 194 WYRAPEIM--LNWMH-YNQTVDIWSVGCIMAELLTG 226

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 124/283 (43%), Gaps = 36/283 (12%)
Query: 47  SDLKKLTVLGHGNGGIVYK---VRHQKSNSI-YALKVLNTTSSTIIRHQAAHEAEILKRL 102
           ++L+K+ VLG G  G VYK   +   ++  I  A+KVL   +S     +   EA ++  +
Sbjct: 17  TELRKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGV 76
Query: 103 DSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRV-RKKLSEDVISGVAYRVLKGLQY 161
            S ++ +   +  T    +  V + M  G L D +R  R +L    +     ++ KG+ Y
Sbjct: 77  GSPYVSRLLGICLT--STVQLVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQIAKGMSY 134
Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRI--VEETRXXXXXXXXXXXXIGEAAIA 219
           L  ++++H D+   N+L+     VKI DFG++R+  ++ET              G+  I 
Sbjct: 135 LEDVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADG--------GKVPI- 185
Query: 220 CMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFG--EKPDLMAL 276
                 +M+ E +   R    +    DVWS GV V E +  G  P  G    E PDL+  
Sbjct: 186 -----KWMALESILRRR----FTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEK 236
Query: 277 ICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA 319
                 GERL  P   + +    +  C   D   R    EL++
Sbjct: 237 ------GERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVS 273

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 104/216 (48%), Gaps = 26/216 (12%)
Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH-EAEILKRLDSQFIV 108
           + L+ +G G  G V      K+    A+K L+    +II  +  + E  +LK +  + ++
Sbjct: 45  QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI 104
Query: 109 KCHAVFYTI----EGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG 164
               VF       E    +++ H+  G+  +++   +KL++D +  + Y++L+GL+Y+H 
Sbjct: 105 GLLDVFTPARSLEEFNDVYLVTHL-MGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 163
Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTC 224
             IIH D+KPSNL +N   E+KI DFG++R  +                 +     + T 
Sbjct: 164 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-----------------DEMTGYVATR 206
Query: 225 AYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVG 260
            Y +PE +    W   Y    D+WS+G ++ E L G
Sbjct: 207 WYRAPEIM--LNWMH-YNQTVDIWSVGCIMAELLTG 239

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 67/269 (24%), Positives = 116/269 (43%), Gaps = 29/269 (10%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVF 114
           LG G  G V+      +  + A+K L     T+       EA+++K+L  + +V+ +AV 
Sbjct: 17  LGQGCFGEVWMGTWNGTTRV-AIKTLK--PGTMSPEAFLQEAQVMKKLRHEKLVQLYAV- 72
Query: 115 YTIEGEICFVMEHMERGSLFDSLR--VRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDI 172
              E  I  V E+M +GSL D L+  + K L    +  +A ++  G+ Y+  M  +H D+
Sbjct: 73  -VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDL 131
Query: 173 KPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERV 232
           + +N+L+      K+ADFG++R++E+                 A         + +PE  
Sbjct: 132 RAANILVGENLVCKVADFGLARLIEDNEYT-------------ARQGAKFPIKWTAPEAA 178
Query: 233 DSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICAICFGERLEMPET 291
                 G +    DVWS G+++ E    G  P  G   +     ++  +  G R+  P  
Sbjct: 179 LY----GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR----EVLDQVERGYRMPCPPE 230
Query: 292 ASPEFRRFVRSCLEKDWRKRGTVEELLAY 320
                   +  C  KD  +R T E L A+
Sbjct: 231 CPESLHDLMCQCWRKDPEERPTFEYLQAF 259

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 104/216 (48%), Gaps = 26/216 (12%)
Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH-EAEILKRLDSQFIV 108
           + L+ +G G  G V      K+    A+K L+    +II  +  + E  +LK +  + ++
Sbjct: 25  QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI 84
Query: 109 KCHAVFYTI----EGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG 164
               VF       E    +++ H+  G+  +++   +KL++D +  + Y++L+GL+Y+H 
Sbjct: 85  GLLDVFTPARSLEEFNDVYLVTHL-MGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTC 224
             IIH D+KPSNL +N   E+KI DFG++R  +                 +     + T 
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-----------------DEMTGYVATR 186
Query: 225 AYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVG 260
            Y +PE +    W   Y    D+WS+G ++ E L G
Sbjct: 187 WYRAPEIM--LNWMH-YNQTVDIWSVGCIMAELLTG 219

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 104/216 (48%), Gaps = 26/216 (12%)
Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH-EAEILKRLDSQFIV 108
           + L+ +G G  G V      K+    A+K L+    +II  +  + E  +LK +  + ++
Sbjct: 27  QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI 86
Query: 109 KCHAVFYTI----EGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG 164
               VF       E    +++ H+  G+  +++   +KL++D +  + Y++L+GL+Y+H 
Sbjct: 87  GLLDVFTPARSLEEFNDVYLVTHL-MGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 145
Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTC 224
             IIH D+KPSNL +N   E+KI DFG++R  +                 +     + T 
Sbjct: 146 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-----------------DEMTGYVATR 188
Query: 225 AYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVG 260
            Y +PE +    W   Y    D+WS+G ++ E L G
Sbjct: 189 WYRAPEIM--LNWMH-YNQTVDIWSVGCIMAELLTG 221

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 67/269 (24%), Positives = 116/269 (43%), Gaps = 29/269 (10%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVF 114
           LG G  G V+      +  + A+K L     T+       EA+++K+L  + +V+ +AV 
Sbjct: 15  LGQGCFGEVWMGTWNGTTRV-AIKTLK--PGTMSPEAFLQEAQVMKKLRHEKLVQLYAV- 70
Query: 115 YTIEGEICFVMEHMERGSLFDSLR--VRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDI 172
              E  I  V E+M +GSL D L+  + K L    +  +A ++  G+ Y+  M  +H D+
Sbjct: 71  -VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDL 129
Query: 173 KPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERV 232
           + +N+L+      K+ADFG++R++E+                 A         + +PE  
Sbjct: 130 RAANILVGENLVCKVADFGLARLIEDNEYT-------------ARQGAKFPIKWTAPEAA 176
Query: 233 DSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICAICFGERLEMPET 291
                 G +    DVWS G+++ E    G  P  G   +     ++  +  G R+  P  
Sbjct: 177 LY----GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR----EVLDQVERGYRMPCPPE 228
Query: 292 ASPEFRRFVRSCLEKDWRKRGTVEELLAY 320
                   +  C  KD  +R T E L A+
Sbjct: 229 CPESLHDLMCQCWRKDPEERPTFEYLQAF 257

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 104/216 (48%), Gaps = 26/216 (12%)
Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH-EAEILKRLDSQFIV 108
           + L+ +G G  G V      K+    A+K L+    +II  +  + E  +LK +  + ++
Sbjct: 37  QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI 96
Query: 109 KCHAVFYTI----EGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG 164
               VF       E    +++ H+  G+  +++   +KL++D +  + Y++L+GL+Y+H 
Sbjct: 97  GLLDVFTPARSLEEFNDVYLVTHL-MGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 155
Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTC 224
             IIH D+KPSNL +N   E+KI DFG++R  +                 +     + T 
Sbjct: 156 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-----------------DEMTGYVATR 198
Query: 225 AYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVG 260
            Y +PE +    W   Y    D+WS+G ++ E L G
Sbjct: 199 WYRAPEIM--LNWMH-YNQTVDIWSVGCIMAELLTG 231

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 104/216 (48%), Gaps = 26/216 (12%)
Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH-EAEILKRLDSQFIV 108
           + L+ +G G  G V      K+    A+K L+    +II  +  + E  +LK +  + ++
Sbjct: 27  QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI 86
Query: 109 KCHAVFYTI----EGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG 164
               VF       E    +++ H+  G+  +++   +KL++D +  + Y++L+GL+Y+H 
Sbjct: 87  GLLDVFTPARSLEEFNDVYLVTHL-MGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 145
Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTC 224
             IIH D+KPSNL +N   E+KI DFG++R  +                 +     + T 
Sbjct: 146 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-----------------DEMTGYVATR 188
Query: 225 AYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVG 260
            Y +PE +    W   Y    D+WS+G ++ E L G
Sbjct: 189 WYRAPEIM--LNWMH-YNQTVDIWSVGCIMAELLTG 221

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 104/216 (48%), Gaps = 26/216 (12%)
Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH-EAEILKRLDSQFIV 108
           + L+ +G G  G V      K+    A+K L+    +II  +  + E  +LK +  + ++
Sbjct: 48  QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI 107
Query: 109 KCHAVFYTI----EGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG 164
               VF       E    +++ H+  G+  +++   +KL++D +  + Y++L+GL+Y+H 
Sbjct: 108 GLLDVFTPARSLEEFNDVYLVTHL-MGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 166
Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTC 224
             IIH D+KPSNL +N   E+KI DFG++R  +                 +     + T 
Sbjct: 167 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-----------------DEMTGYVATR 209
Query: 225 AYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVG 260
            Y +PE +    W   Y    D+WS+G ++ E L G
Sbjct: 210 WYRAPEIM--LNWMH-YNQTVDIWSVGCIMAELLTG 242

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 104/216 (48%), Gaps = 26/216 (12%)
Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH-EAEILKRLDSQFIV 108
           + L+ +G G  G V      K+    A+K L+    +II  +  + E  +LK +  + ++
Sbjct: 37  QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI 96
Query: 109 KCHAVFYTI----EGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG 164
               VF       E    +++ H+  G+  +++   +KL++D +  + Y++L+GL+Y+H 
Sbjct: 97  GLLDVFTPARSLEEFNDVYLVTHL-MGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 155
Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTC 224
             IIH D+KPSNL +N   E+KI DFG++R  +                 +     + T 
Sbjct: 156 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-----------------DEMTGYVATR 198
Query: 225 AYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVG 260
            Y +PE +    W   Y    D+WS+G ++ E L G
Sbjct: 199 WYRAPEIM--LNWMH-YNQTVDIWSVGCIMAELLTG 231

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 104/216 (48%), Gaps = 26/216 (12%)
Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH-EAEILKRLDSQFIV 108
           + L+ +G G  G V      K+    A+K L+    +II  +  + E  +LK +  + ++
Sbjct: 31  QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI 90
Query: 109 KCHAVFYTI----EGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG 164
               VF       E    +++ H+  G+  +++   +KL++D +  + Y++L+GL+Y+H 
Sbjct: 91  GLLDVFTPARSLEEFNDVYLVTHL-MGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 149
Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTC 224
             IIH D+KPSNL +N   E+KI DFG++R  +                 +     + T 
Sbjct: 150 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-----------------DEMTGYVATR 192
Query: 225 AYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVG 260
            Y +PE +    W   Y    D+WS+G ++ E L G
Sbjct: 193 WYRAPEIM--LNWMH-YNQTVDIWSVGCIMAELLTG 225

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 104/216 (48%), Gaps = 26/216 (12%)
Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH-EAEILKRLDSQFIV 108
           + L+ +G G  G V      K+    A+K L+    +II  +  + E  +LK +  + ++
Sbjct: 25  QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI 84
Query: 109 KCHAVFYTI----EGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG 164
               VF       E    +++ H+  G+  +++   +KL++D +  + Y++L+GL+Y+H 
Sbjct: 85  GLLDVFTPARSLEEFNDVYLVTHL-MGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTC 224
             IIH D+KPSNL +N   E+KI DFG++R  +                 +     + T 
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-----------------DEMTGYVATR 186
Query: 225 AYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVG 260
            Y +PE + +      Y    D+WS+G ++ E L G
Sbjct: 187 WYRAPEIMLN---AMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 79/325 (24%), Positives = 128/325 (39%), Gaps = 70/325 (21%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH----EAEILKRLDSQFIVKC 110
           +G G+ G+V      ++ +I A+K++N      I  +       E  ++K+L    I + 
Sbjct: 34  IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 111 HAVFYTIEGEICFVMEHMERGSLFDSLRV------------------------------- 139
           + V Y  E  IC VME    G L D L V                               
Sbjct: 94  YEV-YEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAING 152
Query: 140 -----RKKLS----EDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLI--NGKGEVKIA 188
                R+ L     E +IS +  ++   L YLH   I H DIKP N L   N   E+K+ 
Sbjct: 153 SIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLV 212
Query: 189 DFGVSRIVEETRXXXXXXXXXXXXIGE--AAIACMGTCAYMSPERVDSERWGGDYGFAGD 246
           DFG+S+   +               GE        GT  +++PE +++      YG   D
Sbjct: 213 DFGLSKEFYKLNN------------GEYYGMTTKAGTPYFVAPEVLNTT--NESYGPKCD 258
Query: 247 VWSLGVVVLECLVGHYPLIGFGEKPDLMALIC-AICFGERLEMP--ETASPEFRRFVRSC 303
            WS GV++   L+G  P  G  +   +  ++   +CF    E P     SP  R  + + 
Sbjct: 259 AWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCF----ENPNYNVLSPLARDLLSNL 314
Query: 304 LEKDWRKRGTVEELLAYPFVTKRSS 328
           L ++  +R      L +P++++ S 
Sbjct: 315 LNRNVDERFDAMRALQHPWISQFSD 339

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 71/310 (22%), Positives = 132/310 (42%), Gaps = 44/310 (14%)
Query: 51  KLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKC 110
            L+ +G G  G+V       +    A+K ++         +   E +IL R   + I+  
Sbjct: 27  NLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI 86
Query: 111 HAVFY--TIEG-EICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQI 167
           + +    TIE  +  ++++ +    L+  L+  + LS D I    Y++L+GL+Y+H   +
Sbjct: 87  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANV 145
Query: 168 IHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYM 227
           +H D+KPSNLL+N   ++KI DFG++R+ +                       + T  Y 
Sbjct: 146 LHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLT-----------EYVATRWYR 194
Query: 228 SPERVDSERWGGDYGFAGDVWSLGVVVLECLVG-------HY--------PLIGFGEKPD 272
           +PE + + +    Y  + D+WS+G ++ E L         HY         ++G   + D
Sbjct: 195 APEIMLNSK---GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 251
Query: 273 LMALICAICFGERLEMPETASPEFRRFVRSCLEK-----------DWRKRGTVEELLAYP 321
           L  +I        L +P      + R   +   K           +  KR  VE+ LA+P
Sbjct: 252 LNXIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP 311
Query: 322 FVTKRSSSSN 331
           ++ +    S+
Sbjct: 312 YLEQYYDPSD 321

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 72/310 (23%), Positives = 131/310 (42%), Gaps = 44/310 (14%)
Query: 51  KLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKC 110
            L+ +G G  G+V       +    A+K ++         +   E +IL     + I+  
Sbjct: 29  NLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGI 88
Query: 111 HAVFY--TIEG-EICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQI 167
           + +    TIE  +  ++++ +    L+  L+  + LS D I    Y++L+GL+Y+H   +
Sbjct: 89  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANV 147
Query: 168 IHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYM 227
           +H D+KPSNLL+N   ++KI DFG++R+ +                       + T  Y 
Sbjct: 148 LHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEY-----------VATRWYR 196
Query: 228 SPERVDSERWGGDYGFAGDVWSLGVVVLECLVG-------HY-----PLIGFGEKPDLMA 275
           +PE + + +    Y  + D+WS+G ++ E L         HY      ++G    P    
Sbjct: 197 APEIMLNSK---GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 253
Query: 276 LICAICFGER---LEMPETASPEFRRFVRSCLEK-----------DWRKRGTVEELLAYP 321
           L C I    R   L +P      + R   +   K           +  KR  VE+ LA+P
Sbjct: 254 LNCGINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP 313
Query: 322 FVTKRSSSSN 331
           ++ +    S+
Sbjct: 314 YLAQYYDPSD 323

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 67/269 (24%), Positives = 116/269 (43%), Gaps = 29/269 (10%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVF 114
           LG G  G V+      +  + A+K L     T+       EA+++K+L  + +V+ +AV 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRV-AIKTLK--PGTMSPEAFLQEAQVMKKLRHEKLVQLYAV- 81
Query: 115 YTIEGEICFVMEHMERGSLFDSLR--VRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDI 172
              E  I  V E+M +GSL D L+  + K L    +  +A ++  G+ Y+  M  +H D+
Sbjct: 82  -VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDL 140
Query: 173 KPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERV 232
           + +N+L+      K+ADFG++R++E+                 A         + +PE  
Sbjct: 141 RAANILVGENLVCKVADFGLARLIEDNEYT-------------ARQGAKFPIKWTAPEAA 187
Query: 233 DSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICAICFGERLEMPET 291
                 G +    DVWS G+++ E    G  P  G   +     ++  +  G R+  P  
Sbjct: 188 LY----GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR----EVLDQVERGYRMPCPPE 239
Query: 292 ASPEFRRFVRSCLEKDWRKRGTVEELLAY 320
                   +  C  KD  +R T E L A+
Sbjct: 240 CPESLHDLMCQCWRKDPEERPTFEYLQAF 268

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 71/310 (22%), Positives = 132/310 (42%), Gaps = 44/310 (14%)
Query: 51  KLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKC 110
            L+ +G G  G+V       +    A+K ++         +   E +IL R   + I+  
Sbjct: 27  NLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI 86
Query: 111 HAVFY--TIEG-EICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQI 167
           + +    TIE  +  ++++ +    L+  L+  + LS D I    Y++L+GL+Y+H   +
Sbjct: 87  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANV 145
Query: 168 IHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYM 227
           +H D+KPSNLL+N   ++KI DFG++R+ +                       + T  Y 
Sbjct: 146 LHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEY-----------VATRWYR 194
Query: 228 SPERVDSERWGGDYGFAGDVWSLGVVVLECLVG-------HY--------PLIGFGEKPD 272
           +PE + + +    Y  + D+WS+G ++ E L         HY         ++G   + D
Sbjct: 195 APEIMLNSK---GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 251
Query: 273 LMALICAICFGERLEMPETASPEFRRFVRSCLEK-----------DWRKRGTVEELLAYP 321
           L  +I        L +P      + R   +   K           +  KR  VE+ LA+P
Sbjct: 252 LNXIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP 311
Query: 322 FVTKRSSSSN 331
           ++ +    S+
Sbjct: 312 YLEQYYDPSD 321

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 104/216 (48%), Gaps = 26/216 (12%)
Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH-EAEILKRLDSQFIV 108
           + L+ +G G  G V      K+    A+K L+    +II  +  + E  +LK +  + ++
Sbjct: 48  QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI 107
Query: 109 KCHAVFYTI----EGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG 164
               VF       E    +++ H+  G+  +++   +KL++D +  + Y++L+GL+Y+H 
Sbjct: 108 GLLDVFTPARSLEEFNDVYLVTHL-MGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 166
Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTC 224
             IIH D+KPSNL +N   E+KI DFG++R  +                 +     + T 
Sbjct: 167 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-----------------DEMXGYVATR 209
Query: 225 AYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVG 260
            Y +PE +    W   Y    D+WS+G ++ E L G
Sbjct: 210 WYRAPEIM--LNWMH-YNQTVDIWSVGCIMAELLTG 242

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 74.3 bits (181), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 72/310 (23%), Positives = 132/310 (42%), Gaps = 44/310 (14%)
Query: 51  KLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKC 110
            L+ +G G  G+V       +    A++ ++         +   E +IL R   + I+  
Sbjct: 31  NLSYIGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENIIGI 90
Query: 111 HAVFY--TIEG-EICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQI 167
           + +    TIE  +  ++++ +    L+  L+  + LS D I    Y++L+GL+Y+H   +
Sbjct: 91  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANV 149
Query: 168 IHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYM 227
           +H D+KPSNLL+N   ++KI DFG++R+ +                       + T  Y 
Sbjct: 150 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY-----------VATRWYR 198
Query: 228 SPERVDSERWGGDYGFAGDVWSLGVVVLECLVG-------HY-----PLIGFGEKPDLMA 275
           +PE + + +    Y  + D+WS+G ++ E L         HY      ++G    P    
Sbjct: 199 APEIMLNSK---GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 255
Query: 276 LICAICFGER---LEMPETASPEFRRFVRSCLEK-----------DWRKRGTVEELLAYP 321
           L C I    R   L +P      + R   +   K           +  KR  VE+ LA+P
Sbjct: 256 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP 315
Query: 322 FVTKRSSSSN 331
           ++ +    S+
Sbjct: 316 YLEQYYDPSD 325

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 74.3 bits (181), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 77/294 (26%), Positives = 124/294 (42%), Gaps = 33/294 (11%)
Query: 41  PDVENISDLKKLTVLGHGNGGIVYKVRHQ----KSNSIYALKVLNTTSSTIIRHQAAHEA 96
           P +     LK ++ LG GN G V   R+      + ++ A+K L  +     R     E 
Sbjct: 17  PTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQR-DFQREI 75
Query: 97  EILKRLDSQFIVKCHAVFYTI-EGEICFVMEHMERGSLFDSL-RVRKKLSEDVISGVAYR 154
           +ILK L S FIVK   V Y      +  VME++  G L D L R R +L    +   + +
Sbjct: 76  QILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQ 135
Query: 155 VLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIG 214
           + KG++YL   + +H D+   N+L+  +  VKIADFG+++++   +             G
Sbjct: 136 ICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREP-----G 190
Query: 215 EAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLE----CLVGHYPLIGF--- 267
           ++ I       + +PE +        +    DVWS GVV+ E    C     P   F   
Sbjct: 191 QSPI------FWYAPESLSD----NIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRM 240
Query: 268 ----GEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEEL 317
                + P L  L+  +  G+RL  P     E    ++ C     + R +   L
Sbjct: 241 MGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSAL 294

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 102/216 (47%), Gaps = 26/216 (12%)
Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH-EAEILKRLDSQFIV 108
           + L+ +G G  G V      K+    A+K L+    +II  +  + E  +LK +  + ++
Sbjct: 21  QNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI 80
Query: 109 KCHAVFYTI----EGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG 164
               VF       E    +++ H+    L + ++   KL++D +  + Y++L+GL+Y+H 
Sbjct: 81  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-AKLTDDHVQFLIYQILRGLKYIHS 139
Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTC 224
             IIH D+KPSNL +N   E+KI DFG++R  +                 +     + T 
Sbjct: 140 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-----------------DEMTGYVATR 182
Query: 225 AYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVG 260
            Y +PE +    W   Y    D+WS+G ++ E L G
Sbjct: 183 WYRAPEIM--LNWMH-YNQTVDIWSVGCIMAELLTG 215

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 81/315 (25%), Positives = 128/315 (40%), Gaps = 56/315 (17%)
Query: 52  LTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCH 111
           L  LG G  G+V+       +   A+K +  T    ++H A  E +I++RLD   IVK  
Sbjct: 16  LKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKH-ALREIKIIRRLDHDNIVKVF 74
Query: 112 AVF-------------YTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKG 158
            +               T    +  V E+ME      ++  +  L E+      Y++L+G
Sbjct: 75  EILGPSGSQLTDDVGSLTELNSVYIVQEYMETD--LANVLEQGPLLEEHARLFMYQLLRG 132
Query: 159 LQYLHGMQIIHGDIKPSNLLINGKGEV-KIADFGVSRIVEETRXXXXXXXXXXXXIGEAA 217
           L+Y+H   ++H D+KP+NL IN +  V KI DFG++RI++               + E  
Sbjct: 133 LKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDP-------HYSHKGHLSEGL 185
Query: 218 IACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGE-------- 269
           +    T  Y SP  + S     +Y  A D+W+ G +  E L G     G  E        
Sbjct: 186 V----TKWYRSPRLLLSP---NNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLIL 238
Query: 270 -------KPDLMALICAICFGERLEMPETASP----------EFRRFVRSCLEKDWRKRG 312
                  + D   L+  I    R +M E   P          E   F+   L      R 
Sbjct: 239 ESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRL 298
Query: 313 TVEELLAYPFVTKRS 327
           T EE L++P+++  S
Sbjct: 299 TAEEALSHPYMSIYS 313

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 71/289 (24%), Positives = 123/289 (42%), Gaps = 44/289 (15%)
Query: 35  TSNPTSP---DVENI--SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIR 89
           +S P  P   D   I    LK    LG G  G V+   + K   + A+K +   S ++  
Sbjct: 165 SSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKV-AVKTMKPGSMSVEA 223
Query: 90  HQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVIS 149
             A  EA ++K L    +VK HAV    +  I  + E M +GSL D L+  +   + +  
Sbjct: 224 FLA--EANVMKTLQHDKLVKLHAV--VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPK 279
Query: 150 GVAY--RVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXX 207
            + +  ++ +G+ ++     IH D++ +N+L++     KIADFG++R             
Sbjct: 280 LIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLAR------------- 326
Query: 208 XXXXXIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIG 266
                     +       + +PE ++     G +    DVWS G++++E +  G  P  G
Sbjct: 327 ----------VGAKFPIKWTAPEAINF----GSFTIKSDVWSFGILLMEIVTYGRIPYPG 372
Query: 267 FGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVE 315
               P+   +I A+  G R+  PE    E    +  C +    +R T E
Sbjct: 373 MS-NPE---VIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFE 417

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/269 (24%), Positives = 116/269 (43%), Gaps = 29/269 (10%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVF 114
           LG G  G V+      +  + A+K L     T+       EA+++K+L  + +V+ +AV 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRV-AIKTLK--PGTMSPEAFLQEAQVMKKLRHEKLVQLYAV- 81
Query: 115 YTIEGEICFVMEHMERGSLFDSLR--VRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDI 172
              E  I  V E+M +GSL D L+  + K L    +  +A ++  G+ Y+  M  +H D+
Sbjct: 82  -VSEEPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDL 140
Query: 173 KPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERV 232
           + +N+L+      K+ADFG++R++E+                 A         + +PE  
Sbjct: 141 RAANILVGENLVCKVADFGLARLIEDNEYT-------------ARQGAKFPIKWTAPEAA 187
Query: 233 DSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICAICFGERLEMPET 291
                 G +    DVWS G+++ E    G  P  G   +     ++  +  G R+  P  
Sbjct: 188 LY----GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR----EVLDQVERGYRMPCPPE 239
Query: 292 ASPEFRRFVRSCLEKDWRKRGTVEELLAY 320
                   +  C  KD  +R T E L A+
Sbjct: 240 CPESLHDLMCQCWRKDPEERPTFEYLQAF 268

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 70/248 (28%), Positives = 111/248 (44%), Gaps = 35/248 (14%)
Query: 39  TSPDVENISDLKKL-TVLGHGNGGIVYKVRHQKSNSIYALKVLNTT----SSTIIRHQAA 93
           T+P   ++SD  +L  +LG G    V+  R  + +   A+KVL        S  +R +  
Sbjct: 5   TTP--SHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFR-- 60
Query: 94  HEAEILKRLDSQFIVKCHAVFYTIEGEIC------FVMEHMERGSLFDSLRVRKKLSEDV 147
            EA+    L+   IV   AV+ T E E         VME+++  +L D +     ++   
Sbjct: 61  REAQNAAALNHPAIV---AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKR 117
Query: 148 ISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXX 207
              V     + L + H   IIH D+KP+N++I+    VK+ DFG++R + ++        
Sbjct: 118 AIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTA 177
Query: 208 XXXXXIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGF 267
                      A +GT  Y+SPE+      G       DV+SLG V+ E L G  P    
Sbjct: 178 -----------AVIGTAQYLSPEQA----RGDSVDARSDVYSLGCVLYEVLTGEPPFT-- 220
Query: 268 GEKPDLMA 275
           G+ PD +A
Sbjct: 221 GDSPDSVA 228

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 103/218 (47%), Gaps = 24/218 (11%)
Query: 49  LKKLTVLGHGNGGIV----YKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDS 104
           LK L  LG GN G V    Y      +  + A+K L  ++   +R     E EILK L  
Sbjct: 15  LKFLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQH 73
Query: 105 QFIVKCHAVFYTI-EGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAY--RVLKGLQY 161
             IVK   V Y+     +  +ME +  GSL + L+  K+   D I  + Y  ++ KG++Y
Sbjct: 74  DNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERI-DHIKLLQYTSQICKGMEY 132
Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACM 221
           L   + IH D+   N+L+  +  VKI DFG+++++ + +             GE+ I   
Sbjct: 133 LGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEP-----GESPI--- 184
Query: 222 GTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV 259
               + +PE +   +    +  A DVWS GVV+ E   
Sbjct: 185 ---FWYAPESLTESK----FSVASDVWSFGVVLYELFT 215

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 70/283 (24%), Positives = 122/283 (43%), Gaps = 29/283 (10%)
Query: 45  NISDLKKLTVLGHGNGGIVYKVRHQ---KSNSIYALKVLNTTSSTIIRHQAAHEAEILKR 101
           ++S +K   V+G G  G V + R +   K  S  A+K L    +   R +   EA I+ +
Sbjct: 14  DVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQ 73
Query: 102 LDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQ 160
            +   I++   V  T    +  + E ME G+L   LR+   + +   + G+   +  G++
Sbjct: 74  FEHPNIIRLEGVV-TNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMR 132
Query: 161 YLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIAC 220
           YL  M  +H D+   N+L+N     K++DFG+SR +EE              I       
Sbjct: 133 YLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKI------- 185
Query: 221 MGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP--DL--MAL 276
                + +PE +   +    +  A D WS G+V+ E       ++ FGE+P  D+    +
Sbjct: 186 --PIRWTAPEAIAFRK----FTSASDAWSYGIVMWE-------VMSFGERPYWDMSNQDV 232
Query: 277 ICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA 319
           I AI    RL  P        + +  C +KD   R    ++++
Sbjct: 233 INAIEQDYRLPPPPDCPTSLHQLMLDCWQKDRNARPRFPQVVS 275

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 70/283 (24%), Positives = 122/283 (43%), Gaps = 29/283 (10%)
Query: 45  NISDLKKLTVLGHGNGGIVYKVRHQ---KSNSIYALKVLNTTSSTIIRHQAAHEAEILKR 101
           ++S +K   V+G G  G V + R +   K  S  A+K L    +   R +   EA I+ +
Sbjct: 12  DVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQ 71
Query: 102 LDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQ 160
            +   I++   V  T    +  + E ME G+L   LR+   + +   + G+   +  G++
Sbjct: 72  FEHPNIIRLEGVV-TNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMR 130
Query: 161 YLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIAC 220
           YL  M  +H D+   N+L+N     K++DFG+SR +EE              I       
Sbjct: 131 YLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKI------- 183
Query: 221 MGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP--DL--MAL 276
                + +PE +   +    +  A D WS G+V+ E       ++ FGE+P  D+    +
Sbjct: 184 --PIRWTAPEAIAFRK----FTSASDAWSYGIVMWE-------VMSFGERPYWDMSNQDV 230
Query: 277 ICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA 319
           I AI    RL  P        + +  C +KD   R    ++++
Sbjct: 231 INAIEQDYRLPPPPDCPTSLHQLMLDCWQKDRNARPRFPQVVS 273

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/269 (24%), Positives = 116/269 (43%), Gaps = 29/269 (10%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVF 114
           LG G  G V+      +  + A+K L     T+       EA+++K++  + +V+ +AV 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRV-AIKTLK--PGTMSPEAFLQEAQVMKKIRHEKLVQLYAV- 81
Query: 115 YTIEGEICFVMEHMERGSLFDSLR--VRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDI 172
              E  I  V E+M +GSL D L+  + K L    +  +A ++  G+ Y+  M  +H D+
Sbjct: 82  -VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDL 140
Query: 173 KPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERV 232
           + +N+L+      K+ADFG++R++E+                 A         + +PE  
Sbjct: 141 RAANILVGENLVCKVADFGLARLIEDNEYT-------------ARQGAKFPIKWTAPEAA 187
Query: 233 DSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICAICFGERLEMPET 291
                 G +    DVWS G+++ E    G  P  G   +     ++  +  G R+  P  
Sbjct: 188 LY----GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR----EVLDQVERGYRMPCPPE 239
Query: 292 ASPEFRRFVRSCLEKDWRKRGTVEELLAY 320
                   +  C  KD  +R T E L A+
Sbjct: 240 CPESLHDLMCQCWRKDPEERPTFEYLQAF 268

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 104/216 (48%), Gaps = 26/216 (12%)
Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH-EAEILKRLDSQFIV 108
           + L+ +G G  G V      K+    A+K L+    +II  +  + E  +LK +  + ++
Sbjct: 25  QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI 84
Query: 109 KCHAVFYTI----EGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG 164
               VF       E    +++ H+  G+  +++   +KL++D +  + Y++L+GL+Y+H 
Sbjct: 85  GLLDVFTPARSLEEFNDVYLVTHL-MGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTC 224
             IIH D+KPSNL +N   E+KI D+G++R  +                 +     + T 
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDYGLARHTD-----------------DEMTGYVATR 186
Query: 225 AYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVG 260
            Y +PE +    W   Y    D+WS+G ++ E L G
Sbjct: 187 WYRAPEIM--LNWMH-YNQTVDIWSVGCIMAELLTG 219

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 74/282 (26%), Positives = 118/282 (41%), Gaps = 34/282 (12%)
Query: 47  SDLKKLTVLGHGNGGIVYK---VRHQKSNSI-YALKVLNTTSSTIIRHQAAHEAEILKRL 102
           ++LK++ VLG G  G VYK   V   ++  I  A+K+LN T+      +   EA I+  +
Sbjct: 15  TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASM 74
Query: 103 DSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQY 161
           D   +V+   V   +   I  V + M  G L + +   K  +   ++     ++ KG+ Y
Sbjct: 75  DHPHLVRLLGV--CLSPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMY 132
Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACM 221
           L   +++H D+   N+L+     VKI DFG++R++E                G+  I  M
Sbjct: 133 LEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADG------GKMPIKWM 186
Query: 222 G-TCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFG--EKPDLMALI 277
              C +              +    DVWS GV + E +  G  P  G    E PDL+   
Sbjct: 187 ALECIHYR-----------KFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEK- 234
Query: 278 CAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA 319
                GERL  P   + +    +  C   D   R   +EL A
Sbjct: 235 -----GERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAA 271

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/269 (24%), Positives = 115/269 (42%), Gaps = 29/269 (10%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVF 114
           LG G  G V+      +  + A+K L     T+       EA+++K+L  + +V+ +AV 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRV-AIKTLK--PGTMSPEAFLQEAQVMKKLRHEKLVQLYAV- 81
Query: 115 YTIEGEICFVMEHMERGSLFDSLR--VRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDI 172
              E  I  V E+M +GSL D L+  + K L    +  +A ++  G+ Y+  M  +H D+
Sbjct: 82  -VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDL 140
Query: 173 KPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERV 232
             +N+L+      K+ADFG++R++E+                 A         + +PE  
Sbjct: 141 AAANILVGENLVCKVADFGLARLIEDNEYT-------------ARQGAKFPIKWTAPEAA 187
Query: 233 DSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICAICFGERLEMPET 291
                 G +    DVWS G+++ E    G  P  G   +     ++  +  G R+  P  
Sbjct: 188 LY----GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR----EVLDQVERGYRMPCPPE 239
Query: 292 ASPEFRRFVRSCLEKDWRKRGTVEELLAY 320
                   +  C  KD  +R T E L A+
Sbjct: 240 CPESLHDLMCQCWRKDPEERPTFEYLQAF 268

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 76/262 (29%), Positives = 113/262 (43%), Gaps = 43/262 (16%)
Query: 52  LTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCH 111
           L V+G G+ G V K    K +   ALK++          QAA E  IL+ L  Q      
Sbjct: 102 LKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKR--FHRQAAEEIRILEHLRKQDKDNTM 159
Query: 112 AVF-----YTIEGEICFVMEHMERGSLFDSLRVRK--KLSEDVISGVAYRVLKGLQYLHG 164
            V      +T    IC   E +   +L++ ++  K    S  ++   A+ +L+ L  LH 
Sbjct: 160 NVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHK 218
Query: 165 MQIIHGDIKPSNLLI--NGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMG 222
            +IIH D+KP N+L+   G+  +K+ DFG S   E  R                    + 
Sbjct: 219 NRIIHCDLKPENILLKQQGRSGIKVIDFG-SSCYEHQR----------------VYTXIQ 261
Query: 223 TCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICF 282
           +  Y +PE +     G  YG   D+WSLG ++ E L G YPL+   ++ D +A     C 
Sbjct: 262 SRFYRAPEVI----LGARYGMPIDMWSLGCILAELLTG-YPLLPGEDEGDQLA-----CM 311
Query: 283 GERLEMPET----ASPEFRRFV 300
            E L MP      AS   + FV
Sbjct: 312 IELLGMPSQKLLDASKRAKNFV 333

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 80/288 (27%), Positives = 124/288 (43%), Gaps = 38/288 (13%)
Query: 54  VLGHGNGGIVYKVRHQKSNSIYALKVLN----TTSSTIIRHQAAHEAEILKRLDSQFIVK 109
           V+G G   +V +  ++++   +A+K+++    T+S  +       EA I   L    IV+
Sbjct: 31  VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 110 CHAVFYTIEGEICFVMEHMERGSLFDSLRVRKK----LSEDVISGVAYRVLKGLQYLHGM 165
                Y+ +G +  V E M+   L   +  R       SE V S    ++L+ L+Y H  
Sbjct: 91  LLET-YSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN 149
Query: 166 QIIHGDIKPSNLLINGK---GEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMG 222
            IIH D+KP  +L+  K     VK+  FGV+  + E+              G  A   +G
Sbjct: 150 NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGES--------------GLVAGGRVG 195
Query: 223 TCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICF 282
           T  +M+PE V  E     YG   DVW  GV++   L G  P  G  E+     L   I  
Sbjct: 196 TPHFMAPEVVKRE----PYGKPVDVWGCGVILFILLSGCLPFYGTKER-----LFEGIIK 246
Query: 283 GERLEMPET---ASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRS 327
           G+    P      S   +  VR  L  D  +R TV E L +P++ +R 
Sbjct: 247 GKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERD 294

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 74/282 (26%), Positives = 118/282 (41%), Gaps = 34/282 (12%)
Query: 47  SDLKKLTVLGHGNGGIVYK---VRHQKSNSI-YALKVLNTTSSTIIRHQAAHEAEILKRL 102
           ++LK++ VLG G  G VYK   V   ++  I  A+K+LN T+      +   EA I+  +
Sbjct: 38  TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASM 97
Query: 103 DSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQY 161
           D   +V+   V   +   I  V + M  G L + +   K  +   ++     ++ KG+ Y
Sbjct: 98  DHPHLVRLLGV--CLSPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMY 155
Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACM 221
           L   +++H D+   N+L+     VKI DFG++R++E                G+  I  M
Sbjct: 156 LEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADG------GKMPIKWM 209
Query: 222 G-TCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFG--EKPDLMALI 277
              C +              +    DVWS GV + E +  G  P  G    E PDL+   
Sbjct: 210 ALECIHYR-----------KFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLE-- 256
Query: 278 CAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA 319
                GERL  P   + +    +  C   D   R   +EL A
Sbjct: 257 ----KGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAA 294

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 80/288 (27%), Positives = 124/288 (43%), Gaps = 38/288 (13%)
Query: 54  VLGHGNGGIVYKVRHQKSNSIYALKVLN----TTSSTIIRHQAAHEAEILKRLDSQFIVK 109
           V+G G   +V +  ++++   +A+K+++    T+S  +       EA I   L    IV+
Sbjct: 33  VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 92
Query: 110 CHAVFYTIEGEICFVMEHMERGSLFDSLRVRKK----LSEDVISGVAYRVLKGLQYLHGM 165
                Y+ +G +  V E M+   L   +  R       SE V S    ++L+ L+Y H  
Sbjct: 93  LLET-YSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN 151
Query: 166 QIIHGDIKPSNLLINGK---GEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMG 222
            IIH D+KP  +L+  K     VK+  FGV+  + E+              G  A   +G
Sbjct: 152 NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGES--------------GLVAGGRVG 197
Query: 223 TCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICF 282
           T  +M+PE V  E     YG   DVW  GV++   L G  P  G  E+     L   I  
Sbjct: 198 TPHFMAPEVVKRE----PYGKPVDVWGCGVILFILLSGCLPFYGTKER-----LFEGIIK 248
Query: 283 GERLEMPET---ASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRS 327
           G+    P      S   +  VR  L  D  +R TV E L +P++ +R 
Sbjct: 249 GKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERD 296

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 98/224 (43%), Gaps = 20/224 (8%)
Query: 52  LTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCH 111
           L  +G G  G+VYK ++    +    K+        I      E  ILK L    IVK +
Sbjct: 7   LEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLY 66
Query: 112 AVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVIS-GVAYRVLKGLQYLHGMQIIHG 170
            V +T +  +  V EH+++  L   L V +   E V +     ++L G+ Y H  +++H 
Sbjct: 67  DVIHT-KKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHR 124
Query: 171 DIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPE 230
           D+KP NLLIN +GE+KIADFG++R                    E       T  Y +P+
Sbjct: 125 DLKPQNLLINREGELKIADFGLAR---------AFGIPVRKYTHEVV-----TLWYRAPD 170
Query: 231 RVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLM 274
            +   +    Y    D+WS+G +  E + G     G  E   LM
Sbjct: 171 VLMGSK---KYSTTIDIWSVGCIFAEMVNGAPLFPGVSEADQLM 211

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 98/224 (43%), Gaps = 20/224 (8%)
Query: 52  LTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCH 111
           L  +G G  G+VYK ++    +    K+        I      E  ILK L    IVK +
Sbjct: 7   LEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLY 66
Query: 112 AVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVIS-GVAYRVLKGLQYLHGMQIIHG 170
            V +T +  +  V EH+++  L   L V +   E V +     ++L G+ Y H  +++H 
Sbjct: 67  DVIHT-KKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHR 124
Query: 171 DIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPE 230
           D+KP NLLIN +GE+KIADFG++R                    E       T  Y +P+
Sbjct: 125 DLKPQNLLINREGELKIADFGLAR---------AFGIPVRKYTHEVV-----TLWYRAPD 170
Query: 231 RVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLM 274
            +   +    Y    D+WS+G +  E + G     G  E   LM
Sbjct: 171 VLMGSK---KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLM 211

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 74/298 (24%), Positives = 125/298 (41%), Gaps = 39/298 (13%)
Query: 34  PTSNPTS----PDVENI--SDLKKLTVLGHGNGGIVYKVRHQKSN--SIYALKVLNTTSS 85
           PTS P +     D   I    L+    LG G  G V+      +   +I  LK  N +  
Sbjct: 166 PTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGNMSPE 225
Query: 86  TIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLR--VRKKL 143
             ++     EA+++K+L  + +V+ +AV    E  I  V E+M +GSL D L+  + K L
Sbjct: 226 AFLQ-----EAQVMKKLRHEKLVQLYAV--VSEEPIYIVTEYMSKGSLLDFLKGEMGKYL 278
Query: 144 SEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXX 203
               +  +A ++  G+ Y+  M  +H D++ +N+L+      K+ADFG+ R++E+     
Sbjct: 279 RLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLGRLIEDNEYT- 337
Query: 204 XXXXXXXXXIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHY 262
                       A         + +PE        G +    DVWS G+++ E    G  
Sbjct: 338 ------------ARQGAKFPIKWTAPEAALY----GRFTIKSDVWSFGILLTELTTKGRV 381
Query: 263 PLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY 320
           P  G   +     ++  +  G R+  P          +  C  KD  +R T E L A+
Sbjct: 382 PYPGMVNR----EVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAF 435

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 70/273 (25%), Positives = 123/273 (45%), Gaps = 30/273 (10%)
Query: 49  LKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIV 108
           +K +  LG G  G V+   +  S  + A+K L   + ++       EA ++K L    +V
Sbjct: 15  IKLVKRLGAGQFGEVWMGYYNNSTKV-AVKTLKPGTMSV--QAFLEEANLMKTLQHDKLV 71
Query: 109 KCHAVFYTIEGEICFVMEHMERGSLFDSLRVR---KKLSEDVISGVAYRVLKGLQYLHGM 165
           + +AV  T E  I  + E+M +GSL D L+     K L   +I   A ++ +G+ Y+   
Sbjct: 72  RLYAVV-TREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSA-QIAEGMAYIERK 129
Query: 166 QIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCA 225
             IH D++ +N+L++     KIADFG++R++E+                 A         
Sbjct: 130 NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT-------------AREGAKFPIK 176
Query: 226 YMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICAICFGE 284
           + +PE ++     G +    DVWS G+++ E +  G  P  G     D+M    A+  G 
Sbjct: 177 WTAPEAINF----GCFTIKSDVWSFGILLYEIVTYGKIPYPG-RTNADVMT---ALSQGY 228
Query: 285 RLEMPETASPEFRRFVRSCLEKDWRKRGTVEEL 317
           R+   E    E    ++ C ++   +R T + L
Sbjct: 229 RMPRVENCPDELYDIMKMCWKEKAEERPTFDYL 261

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 76/262 (29%), Positives = 113/262 (43%), Gaps = 43/262 (16%)
Query: 52  LTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCH 111
           L V+G G+ G V K    K +   ALK++          QAA E  IL+ L  Q      
Sbjct: 102 LKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKR--FHRQAAEEIRILEHLRKQDKDNTM 159
Query: 112 AVF-----YTIEGEICFVMEHMERGSLFDSLRVRK--KLSEDVISGVAYRVLKGLQYLHG 164
            V      +T    IC   E +   +L++ ++  K    S  ++   A+ +L+ L  LH 
Sbjct: 160 NVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHK 218
Query: 165 MQIIHGDIKPSNLLI--NGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMG 222
            +IIH D+KP N+L+   G+  +K+ DFG S   E  R                    + 
Sbjct: 219 NRIIHCDLKPENILLKQQGRSGIKVIDFG-SSCYEHQR----------------VYTXIQ 261
Query: 223 TCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICF 282
           +  Y +PE +     G  YG   D+WSLG ++ E L G YPL+   ++ D +A     C 
Sbjct: 262 SRFYRAPEVI----LGARYGMPIDMWSLGCILAELLTG-YPLLPGEDEGDQLA-----CM 311
Query: 283 GERLEMPET----ASPEFRRFV 300
            E L MP      AS   + FV
Sbjct: 312 IELLGMPSQKLLDASKRAKNFV 333

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 72/310 (23%), Positives = 131/310 (42%), Gaps = 44/310 (14%)
Query: 51  KLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKC 110
            L+ +G G  G+V       +    A+K ++         +   E +IL     + I+  
Sbjct: 29  NLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGI 88
Query: 111 HAVFY--TIEG-EICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQI 167
           + +    TIE  +  ++++ +    L+  L+  + LS D I    Y++L+GL+Y+H   +
Sbjct: 89  NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANV 147
Query: 168 IHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYM 227
           +H D+KPSNLL+N   ++KI DFG++R+ +                       + T  Y 
Sbjct: 148 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY-----------VATRWYR 196
Query: 228 SPERVDSERWGGDYGFAGDVWSLGVVVLECLVG-------HY-----PLIGFGEKPDLMA 275
           +PE + + +    Y  + D+WS+G ++ E L         HY      ++G    P    
Sbjct: 197 APEIMLNSK---GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 253
Query: 276 LICAICFGER---LEMPETASPEFRRFVRSCLEK-----------DWRKRGTVEELLAYP 321
           L C I    R   L +P      + R   +   K           +  KR  VE+ LA+P
Sbjct: 254 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP 313
Query: 322 FVTKRSSSSN 331
           ++ +    S+
Sbjct: 314 YLAQYYDPSD 323

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 100/220 (45%), Gaps = 20/220 (9%)
Query: 46  ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQ 105
           + D   +  LG G  G V    ++ +    A+K+++   +         E  I   L+ +
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHE 65
Query: 106 FIVKCHAVFYTIEGEICFV-MEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG 164
            +VK +   +  EG I ++ +E+   G LFD +     + E       ++++ G+ YLHG
Sbjct: 66  NVVKFYG--HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACM-GT 223
           + I H DIKP NLL++ +  +KI+DFG++ +                   E  +  M GT
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR-------------ERLLNKMCGT 170
Query: 224 CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYP 263
             Y++PE +    +  +     DVWS G+V+   L G  P
Sbjct: 171 LPYVAPELLKRREFHAE---PVDVWSCGIVLTAMLAGELP 207

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 98/224 (43%), Gaps = 20/224 (8%)
Query: 52  LTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCH 111
           L  +G G  G+VYK ++    +    K+        I      E  ILK L    IVK +
Sbjct: 7   LEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLY 66
Query: 112 AVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVIS-GVAYRVLKGLQYLHGMQIIHG 170
            V +T +  +  V EH+++  L   L V +   E V +     ++L G+ Y H  +++H 
Sbjct: 67  DVIHT-KKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHR 124
Query: 171 DIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPE 230
           D+KP NLLIN +GE+KIADFG++R                          + T  Y +P+
Sbjct: 125 DLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE--------------IVTLWYRAPD 170
Query: 231 RVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLM 274
            +   +    Y    D+WS+G +  E + G     G  E   LM
Sbjct: 171 VLMGSK---KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLM 211

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/273 (27%), Positives = 117/273 (42%), Gaps = 32/273 (11%)
Query: 54  VLGHGNGGIVYK---VRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKC 110
           +LG G  G VY+     H+      A+K      +   + +   EA I+K LD   IVK 
Sbjct: 31  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 90
Query: 111 HAVFYTIEGEICFV-MEHMERGSLFDSLRVRKKLSEDVISGVAY--RVLKGLQYLHGMQI 167
             +   IE E  ++ ME    G L   L  R K S  V++ V Y  ++ K + YL  +  
Sbjct: 91  IGI---IEEEPTWIIMELYPYGELGHYLE-RNKNSLKVLTLVLYSLQICKAMAYLESINC 146
Query: 168 IHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYM 227
           +H DI   N+L+     VK+ DFG+SR +E+                +A++  +    +M
Sbjct: 147 VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYY------------KASVTRLPI-KWM 193
Query: 228 SPERVDSERWGGDYGFAGDVWSLGVVVLECL-VGHYPLIGFGEKPDLMALICAICFGERL 286
           SPE ++  R    +  A DVW   V + E L  G  P     E  D++ ++     G+RL
Sbjct: 194 SPESINFRR----FTTASDVWMFAVCMWEILSFGKQPFFWL-ENKDVIGVLEK---GDRL 245
Query: 287 EMPETASPEFRRFVRSCLEKDWRKRGTVEELLA 319
             P+   P     +  C + D   R    EL+ 
Sbjct: 246 PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVC 278

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 73/296 (24%), Positives = 124/296 (41%), Gaps = 35/296 (11%)
Query: 34  PTSNPTS----PDVENI--SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTI 87
           PTS P +     D   I    L+    LG G  G V+      +  + A+K L     T+
Sbjct: 165 PTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLK--PGTM 221
Query: 88  IRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLR--VRKKLSE 145
                  EA+++K+L  + +V+ +AV    E  I  V E+M +GSL D L+    K L  
Sbjct: 222 SPEAFLQEAQVMKKLRHEKLVQLYAV--VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRL 279
Query: 146 DVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXX 205
             +  +A ++  G+ Y+  M  +H D++ +N+L+      K+ADFG++R++E+       
Sbjct: 280 PQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT--- 336
Query: 206 XXXXXXXIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPL 264
                     A         + +PE        G +    DVWS G+++ E    G  P 
Sbjct: 337 ----------ARQGAKFPIKWTAPEAALY----GRFTIKSDVWSFGILLTELTTKGRVPY 382
Query: 265 IGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY 320
            G   +     ++  +  G R+  P          +  C  K+  +R T E L A+
Sbjct: 383 PGMVNR----EVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAF 434

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/273 (27%), Positives = 117/273 (42%), Gaps = 32/273 (11%)
Query: 54  VLGHGNGGIVYK---VRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKC 110
           +LG G  G VY+     H+      A+K      +   + +   EA I+K LD   IVK 
Sbjct: 15  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 74
Query: 111 HAVFYTIEGEICFV-MEHMERGSLFDSLRVRKKLSEDVISGVAY--RVLKGLQYLHGMQI 167
             +   IE E  ++ ME    G L   L  R K S  V++ V Y  ++ K + YL  +  
Sbjct: 75  IGI---IEEEPTWIIMELYPYGELGHYLE-RNKNSLKVLTLVLYSLQICKAMAYLESINC 130
Query: 168 IHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYM 227
           +H DI   N+L+     VK+ DFG+SR +E+                +A++  +    +M
Sbjct: 131 VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYY------------KASVTRLPI-KWM 177
Query: 228 SPERVDSERWGGDYGFAGDVWSLGVVVLECL-VGHYPLIGFGEKPDLMALICAICFGERL 286
           SPE ++  R    +  A DVW   V + E L  G  P     E  D++ ++     G+RL
Sbjct: 178 SPESINFRR----FTTASDVWMFAVCMWEILSFGKQPFFWL-ENKDVIGVLEK---GDRL 229
Query: 287 EMPETASPEFRRFVRSCLEKDWRKRGTVEELLA 319
             P+   P     +  C + D   R    EL+ 
Sbjct: 230 PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVC 262

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 73/296 (24%), Positives = 124/296 (41%), Gaps = 35/296 (11%)
Query: 34  PTSNPTS----PDVENI--SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTI 87
           PTS P +     D   I    L+    LG G  G V+      +  + A+K L     T+
Sbjct: 165 PTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLK--PGTM 221
Query: 88  IRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLR--VRKKLSE 145
                  EA+++K+L  + +V+ +AV    E  I  V E+M +GSL D L+    K L  
Sbjct: 222 SPEAFLQEAQVMKKLRHEKLVQLYAV--VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRL 279
Query: 146 DVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXX 205
             +  +A ++  G+ Y+  M  +H D++ +N+L+      K+ADFG++R++E+       
Sbjct: 280 PQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT--- 336
Query: 206 XXXXXXXIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPL 264
                     A         + +PE        G +    DVWS G+++ E    G  P 
Sbjct: 337 ----------ARQGAKFPIKWTAPEAALY----GRFTIKSDVWSFGILLTELTTKGRVPY 382
Query: 265 IGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY 320
            G   +     ++  +  G R+  P          +  C  K+  +R T E L A+
Sbjct: 383 PGMVNR----EVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAF 434

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 69/239 (28%), Positives = 109/239 (45%), Gaps = 33/239 (13%)
Query: 39  TSPDVENISDLKKL-TVLGHGNGGIVYKVRHQKSNSIYALKVLNTT----SSTIIRHQAA 93
           T+P   ++SD  +L  +LG G    V+  R  + +   A+KVL        S  +R +  
Sbjct: 5   TTP--SHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFR-- 60
Query: 94  HEAEILKRLDSQFIVKCHAVFYTIEGEIC------FVMEHMERGSLFDSLRVRKKLSEDV 147
            EA+    L+   IV   AV+ T E E         VME+++  +L D +     ++   
Sbjct: 61  REAQNAAALNHPAIV---AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKR 117
Query: 148 ISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXX 207
              V     + L + H   IIH D+KP+N+LI+    VK+ DFG++R + ++        
Sbjct: 118 AIEVIADACQALNFSHQNGIIHRDVKPANILISATNAVKVVDFGIARAIADS-------- 169
Query: 208 XXXXXIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIG 266
                + + A A +GT  Y+SPE+      G       DV+SLG V+ E L G  P  G
Sbjct: 170 --GNSVXQTA-AVIGTAQYLSPEQA----RGDSVDARSDVYSLGCVLYEVLTGEPPFTG 221

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 71/272 (26%), Positives = 117/272 (43%), Gaps = 38/272 (13%)
Query: 54  VLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAV 113
           V+G G  G+V K + +  +   A+K + + S    R     E   L R++   IVK +  
Sbjct: 16  VVGRGAFGVVCKAKWRAKD--VAIKQIESESE---RKAFIVELRQLSRVNHPNIVKLYGA 70
Query: 114 FYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLK---GLQYLHGMQ---I 167
                  +C VME+ E GSL++ L   + L     +      L+   G+ YLH MQ   +
Sbjct: 71  CLN---PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKAL 127
Query: 168 IHGDIKPSNLLINGKGEV-KIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAY 226
           IH D+KP NLL+   G V KI DFG +  ++                        G+ A+
Sbjct: 128 IHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK-----------------GSAAW 170
Query: 227 MSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERL 286
           M+PE  +    G +Y    DV+S G+++ E +    P    G       ++ A+  G R 
Sbjct: 171 MAPEVFE----GSNYSEKCDVFSWGIILWEVITRRKPFDEIGGP--AFRIMWAVHNGTRP 224
Query: 287 EMPETASPEFRRFVRSCLEKDWRKRGTVEELL 318
            + +         +  C  KD  +R ++EE++
Sbjct: 225 PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIV 256

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/273 (27%), Positives = 117/273 (42%), Gaps = 32/273 (11%)
Query: 54  VLGHGNGGIVYK---VRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKC 110
           +LG G  G VY+     H+      A+K      +   + +   EA I+K LD   IVK 
Sbjct: 19  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 111 HAVFYTIEGEICFV-MEHMERGSLFDSLRVRKKLSEDVISGVAY--RVLKGLQYLHGMQI 167
             +   IE E  ++ ME    G L   L  R K S  V++ V Y  ++ K + YL  +  
Sbjct: 79  IGI---IEEEPTWIIMELYPYGELGHYLE-RNKNSLKVLTLVLYSLQICKAMAYLESINC 134
Query: 168 IHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYM 227
           +H DI   N+L+     VK+ DFG+SR +E+                +A++  +    +M
Sbjct: 135 VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYY------------KASVTRLPI-KWM 181
Query: 228 SPERVDSERWGGDYGFAGDVWSLGVVVLECL-VGHYPLIGFGEKPDLMALICAICFGERL 286
           SPE ++  R    +  A DVW   V + E L  G  P     E  D++ ++     G+RL
Sbjct: 182 SPESINFRR----FTTASDVWMFAVCMWEILSFGKQPFFWL-ENKDVIGVLEK---GDRL 233
Query: 287 EMPETASPEFRRFVRSCLEKDWRKRGTVEELLA 319
             P+   P     +  C + D   R    EL+ 
Sbjct: 234 PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVC 266

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/269 (24%), Positives = 116/269 (43%), Gaps = 29/269 (10%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVF 114
           LG G  G V+      +  + A+K L     T+       EA+++K+L  + +V+ +AV 
Sbjct: 16  LGQGCFGEVWMGTWNGTTRV-AIKTLK--PGTMSPEAFLQEAQVMKKLRHEKLVQLYAV- 71
Query: 115 YTIEGEICFVMEHMERGSLFDSLR--VRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDI 172
              E  I  V E+M +GSL D L+    K L    +  +A ++  G+ Y+  M  +H D+
Sbjct: 72  -VSEEPIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDL 130
Query: 173 KPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERV 232
           + +N+L+      K+ADFG++R++E+                 A         + +PE  
Sbjct: 131 RAANILVGENLVCKVADFGLARLIEDNEXT-------------ARQGAKFPIKWTAPEAA 177
Query: 233 DSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICAICFGERLEMPET 291
                 G +    DVWS G+++ E    G  P  G   +     ++  +  G R+  P  
Sbjct: 178 LY----GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR----EVLDQVERGYRMPCPPE 229
Query: 292 ASPEFRRFVRSCLEKDWRKRGTVEELLAY 320
                   +  C  K+  +R T E L A+
Sbjct: 230 CPESLHDLMCQCWRKEPEERPTFEYLQAF 258

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/241 (27%), Positives = 111/241 (46%), Gaps = 43/241 (17%)
Query: 34  PTSNPTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALK-VLNTTSSTIIRHQA 92
           P   P  P   + +D K   V+G+G+ G+VY+ +   S  + A+K VL        +   
Sbjct: 11  PGQGPDRPQEVSYTDTK---VIGNGSFGVVYQAKLCDSGELVAIKKVLQD------KRFK 61
Query: 93  AHEAEILKRLDSQFIVKCHAVFYTIEGE----------ICFVMEHMERGSLFDSLRVRKK 142
             E +I+++LD   IV+    FY+  GE          + +V E + R +   S R ++ 
Sbjct: 62  NRELQIMRKLDHCNIVRLRYFFYS-SGEKKDEVYLNLVLDYVPETVYRVARHYS-RAKQT 119
Query: 143 LSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEV-KIADFGVSRIVEETRX 201
           L    +    Y++ + L Y+H   I H DIKP NLL++    V K+ DFG ++ +     
Sbjct: 120 LPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--- 176
Query: 202 XXXXXXXXXXXIGEAAIACMGTCAYMSPERVDSERWGG-DYGFAGDVWSLGVVVLECLVG 260
                       GE  ++ + +  Y +PE +    +G  DY  + DVWS G V+ E L+G
Sbjct: 177 ------------GEPNVSXICSRYYRAPELI----FGATDYTSSIDVWSAGCVLAELLLG 220
Query: 261 H 261
Sbjct: 221 Q 221

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/241 (27%), Positives = 111/241 (46%), Gaps = 43/241 (17%)
Query: 34  PTSNPTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALK-VLNTTSSTIIRHQA 92
           P   P  P   + +D K   V+G+G+ G+VY+ +   S  + A+K VL        +   
Sbjct: 10  PGQGPDRPQEVSYTDTK---VIGNGSFGVVYQAKLCDSGELVAIKKVLQD------KRFK 60
Query: 93  AHEAEILKRLDSQFIVKCHAVFYTIEGE----------ICFVMEHMERGSLFDSLRVRKK 142
             E +I+++LD   IV+    FY+  GE          + +V E + R +   S R ++ 
Sbjct: 61  NRELQIMRKLDHCNIVRLRYFFYS-SGEKKDEVYLNLVLDYVPETVYRVARHYS-RAKQT 118
Query: 143 LSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEV-KIADFGVSRIVEETRX 201
           L    +    Y++ + L Y+H   I H DIKP NLL++    V K+ DFG ++ +     
Sbjct: 119 LPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--- 175
Query: 202 XXXXXXXXXXXIGEAAIACMGTCAYMSPERVDSERWGG-DYGFAGDVWSLGVVVLECLVG 260
                       GE  ++ + +  Y +PE +    +G  DY  + DVWS G V+ E L+G
Sbjct: 176 ------------GEPNVSXICSRYYRAPELI----FGATDYTSSIDVWSAGCVLAELLLG 219
Query: 261 H 261
Sbjct: 220 Q 220

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/241 (27%), Positives = 111/241 (46%), Gaps = 43/241 (17%)
Query: 34  PTSNPTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALK-VLNTTSSTIIRHQA 92
           P   P  P   + +D K   V+G+G+ G+VY+ +   S  + A+K VL        +   
Sbjct: 10  PGQGPDRPQEVSYTDTK---VIGNGSFGVVYQAKLCDSGELVAIKKVLQD------KRFK 60
Query: 93  AHEAEILKRLDSQFIVKCHAVFYTIEGE----------ICFVMEHMERGSLFDSLRVRKK 142
             E +I+++LD   IV+    FY+  GE          + +V E + R +   S R ++ 
Sbjct: 61  NRELQIMRKLDHCNIVRLRYFFYS-SGEKKDEVYLNLVLDYVPETVYRVARHYS-RAKQT 118
Query: 143 LSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEV-KIADFGVSRIVEETRX 201
           L    +    Y++ + L Y+H   I H DIKP NLL++    V K+ DFG ++ +     
Sbjct: 119 LPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--- 175
Query: 202 XXXXXXXXXXXIGEAAIACMGTCAYMSPERVDSERWGG-DYGFAGDVWSLGVVVLECLVG 260
                       GE  ++ + +  Y +PE +    +G  DY  + DVWS G V+ E L+G
Sbjct: 176 ------------GEPNVSXICSRYYRAPELI----FGATDYTSSIDVWSAGCVLAELLLG 219
Query: 261 H 261
Sbjct: 220 Q 220

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 68/267 (25%), Positives = 115/267 (43%), Gaps = 31/267 (11%)
Query: 47  SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQF 106
           S+L  +  +G G  G+V+ + +  +    A+K +   + +        EAE++ +L    
Sbjct: 10  SELTFVQEIGSGQFGLVH-LGYWLNKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPK 66
Query: 107 IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKL-SEDVISGVAYRVLKGLQYLHGM 165
           +V+ + V    +  IC V E ME G L D LR ++ L + + + G+   V +G+ YL   
Sbjct: 67  LVQLYGVCLE-QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 125
Query: 166 QIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCA 225
            +IH D+   N L+     +K++DFG++R V + +               ++        
Sbjct: 126 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-------------SSTGTKFPVK 172
Query: 226 YMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICAICFGE 284
           + SPE     R    Y    DVWS GV++ E    G  P     E      ++  I  G 
Sbjct: 173 WASPEVFSFSR----YSSKSDVWSFGVLMWEVFSEGKIPY----ENRSNSEVVEDISTGF 224
Query: 285 RLEMPETASPEFRRFVRSCLEKDWRKR 311
           RL  P  AS    + +  C    WR+R
Sbjct: 225 RLYKPRLASTHVYQIMNHC----WRER 247

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 97/219 (44%), Gaps = 32/219 (14%)
Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLN----TTSSTIIRHQAAHEAEILKRLDSQ 105
           +KL  LG G    VYK R + +N I A+K +     + +   I   A  E ++L+ L   
Sbjct: 13  EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 72
Query: 106 FIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKK-----LSEDVISGVAYRVLKGLQ 160
            I+     F   +  I  V + ME       L V  K     L+   I       L+GL+
Sbjct: 73  NIIGLLDAFGH-KSNISLVFDFMET-----DLEVIIKDNSLVLTPSHIKAYMLMTLQGLE 126
Query: 161 YLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIAC 220
           YLH   I+H D+KP+NLL++  G +K+ADFG+++                     A    
Sbjct: 127 YLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP--------------NRAYXHQ 172
Query: 221 MGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV 259
           + T  Y +PE +   R    YG   D+W++G ++ E L+
Sbjct: 173 VVTRWYRAPELLFGARM---YGVGVDMWAVGCILAELLL 208

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 71/272 (26%), Positives = 117/272 (43%), Gaps = 38/272 (13%)
Query: 54  VLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAV 113
           V+G G  G+V K + +  +   A+K + + S    R     E   L R++   IVK +  
Sbjct: 15  VVGRGAFGVVCKAKWRAKD--VAIKQIESESE---RKAFIVELRQLSRVNHPNIVKLYGA 69
Query: 114 FYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLK---GLQYLHGMQ---I 167
                  +C VME+ E GSL++ L   + L     +      L+   G+ YLH MQ   +
Sbjct: 70  CLN---PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKAL 126
Query: 168 IHGDIKPSNLLINGKGEV-KIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAY 226
           IH D+KP NLL+   G V KI DFG +  ++                        G+ A+
Sbjct: 127 IHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK-----------------GSAAW 169
Query: 227 MSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERL 286
           M+PE  +    G +Y    DV+S G+++ E +    P    G       ++ A+  G R 
Sbjct: 170 MAPEVFE----GSNYSEKCDVFSWGIILWEVITRRKPFDEIGGP--AFRIMWAVHNGTRP 223
Query: 287 EMPETASPEFRRFVRSCLEKDWRKRGTVEELL 318
            + +         +  C  KD  +R ++EE++
Sbjct: 224 PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIV 255

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 77/289 (26%), Positives = 124/289 (42%), Gaps = 35/289 (12%)
Query: 55  LGHGNGGIVYK--VRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHA 112
           LG GN G V +   R +K     A+KVL   +      +   EA+I+ +LD+ +IV+   
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 113 VFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVA---YRVLKGLQYLHGMQIIH 169
           V    + E   ++  M  G       V K+  E  +S VA   ++V  G++YL     +H
Sbjct: 78  V---CQAEALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKNFVH 133
Query: 170 GDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSP 229
            D+   N+L+  +   KI+DFG+S+ +                   A  A      + +P
Sbjct: 134 RDLAARNVLLVNRHYAKISDFGLSKALGADDSYYT-----------ARSAGKWPLKWYAP 182
Query: 230 ERVDSERWGGDYGFAGDVWSLGVVVLECL-VGHYPLIGFGEKPDLMALICAICFGERLEM 288
           E ++  +    +    DVWS GV + E L  G  P     + P++MA I     G+R+E 
Sbjct: 183 ECINFRK----FSSRSDVWSYGVTMWEALSYGQKPYKKM-KGPEVMAFIEQ---GKRMEC 234
Query: 289 PETASPEFRRFVRSCLEKDWRKRG---TVEELLAYPFVTKRSSSSNIEG 334
           P    PE    +  C    W  R    TVE+ +   +    S +S +EG
Sbjct: 235 PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY---SLASKVEG 280

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/269 (24%), Positives = 115/269 (42%), Gaps = 29/269 (10%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVF 114
           LG G  G V+      +  + A+K L     T+       EA+++K+L  + +V+ +AV 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRV-AIKTLK--PGTMSPEAFLQEAQVMKKLRHEKLVQLYAV- 81
Query: 115 YTIEGEICFVMEHMERGSLFDSLR--VRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDI 172
              E  I  V E+M +G L D L+  + K L    +  +A ++  G+ Y+  M  +H D+
Sbjct: 82  -VSEEPIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDL 140
Query: 173 KPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERV 232
           + +N+L+      K+ADFG++R++E+                 A         + +PE  
Sbjct: 141 RAANILVGENLVCKVADFGLARLIEDNEYT-------------ARQGAKFPIKWTAPEAA 187
Query: 233 DSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICAICFGERLEMPET 291
                 G +    DVWS G+++ E    G  P  G   +     ++  +  G R+  P  
Sbjct: 188 LY----GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR----EVLDQVERGYRMPCPPE 239
Query: 292 ASPEFRRFVRSCLEKDWRKRGTVEELLAY 320
                   +  C  KD  +R T E L A+
Sbjct: 240 CPESLHDLMCQCWRKDPEERPTFEYLQAF 268

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/241 (27%), Positives = 111/241 (46%), Gaps = 43/241 (17%)
Query: 34  PTSNPTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALK-VLNTTSSTIIRHQA 92
           P   P  P   + +D K   V+G+G+ G+VY+ +   S  + A+K VL        +   
Sbjct: 10  PGQGPDRPQEVSYTDTK---VIGNGSFGVVYQAKLCDSGELVAIKKVLQD------KRFK 60
Query: 93  AHEAEILKRLDSQFIVKCHAVFYTIEGE----------ICFVMEHMERGSLFDSLRVRKK 142
             E +I+++LD   IV+    FY+  GE          + +V E + R +   S R ++ 
Sbjct: 61  NRELQIMRKLDHCNIVRLRYFFYS-SGEKKDVVYLNLVLDYVPETVYRVARHYS-RAKQT 118
Query: 143 LSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEV-KIADFGVSRIVEETRX 201
           L    +    Y++ + L Y+H   I H DIKP NLL++    V K+ DFG ++ +     
Sbjct: 119 LPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--- 175
Query: 202 XXXXXXXXXXXIGEAAIACMGTCAYMSPERVDSERWGG-DYGFAGDVWSLGVVVLECLVG 260
                       GE  ++ + +  Y +PE +    +G  DY  + DVWS G V+ E L+G
Sbjct: 176 ------------GEPNVSXICSRYYRAPELI----FGATDYTSSIDVWSAGCVLAELLLG 219
Query: 261 H 261
Sbjct: 220 Q 220

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 80/306 (26%), Positives = 126/306 (41%), Gaps = 56/306 (18%)
Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVL-NTTSSTIIRHQAAHEAEILKRLDSQFIV 108
           + L  +G G  G V      ++ +  A+K L     S +   +A  E  +LK +  + ++
Sbjct: 28  RDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVI 87
Query: 109 KCHAVFYTIEG-----EICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLH 163
               VF   E      +   VM  M  G+    L   +KL ED I  + Y++LKGL+Y+H
Sbjct: 88  GLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIH 145
Query: 164 GMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGT 223
              IIH D+KP NL +N   E+KI DFG++R  +                       + T
Sbjct: 146 AAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD-----------------SEMXGXVVT 188
Query: 224 CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAIC-- 281
             Y +PE + +  W   Y    D+WS+G ++ E + G     G  +  D +  I  +   
Sbjct: 189 RWYRAPEVILN--WMR-YTQTVDIWSVGCIMAEMITGKTLFKG-SDHLDQLKEIMKVTGT 244
Query: 282 ----FGERLE----------MPE-----------TASPEFRRFVRSCLEKDWRKRGTVEE 316
               F +RL+          +PE            ASP     +   L  D  +R T  E
Sbjct: 245 PPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGE 304
Query: 317 LLAYPF 322
            LA+P+
Sbjct: 305 ALAHPY 310

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 113/242 (46%), Gaps = 45/242 (18%)
Query: 34  PTSNPTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQA- 92
           P   P  P   + +D K   V+G+G+ G+VY+ +   S  + A+K        +++ +A 
Sbjct: 10  PGQGPDRPQEVSYTDTK---VIGNGSFGVVYQAKLCDSGELVAIK-------KVLQGKAF 59
Query: 93  -AHEAEILKRLDSQFIVKCHAVFYTIEGE----------ICFVMEHMERGSLFDSLRVRK 141
              E +I+++LD   IV+    FY+  GE          + +V E + R +   S R ++
Sbjct: 60  KNRELQIMRKLDHCNIVRLRYFFYS-SGEKKDEVYLNLVLDYVPETVYRVARHYS-RAKQ 117
Query: 142 KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEV-KIADFGVSRIVEETR 200
            L    +    Y++ + L Y+H   I H DIKP NLL++    V K+ DFG ++ +    
Sbjct: 118 TLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-- 175
Query: 201 XXXXXXXXXXXXIGEAAIACMGTCAYMSPERVDSERWGG-DYGFAGDVWSLGVVVLECLV 259
                        GE  ++ + +  Y +PE +    +G  DY  + DVWS G V+ E L+
Sbjct: 176 -------------GEPNVSYICSRYYRAPELI----FGATDYTSSIDVWSAGCVLAELLL 218
Query: 260 GH 261
           G 
Sbjct: 219 GQ 220

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/241 (27%), Positives = 111/241 (46%), Gaps = 43/241 (17%)
Query: 34  PTSNPTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALK-VLNTTSSTIIRHQA 92
           P   P  P   + +D K   V+G+G+ G+VY+ +   S  + A+K VL        +   
Sbjct: 14  PGQGPDRPQEVSYTDTK---VIGNGSFGVVYQAKLCDSGELVAIKKVLQD------KRFK 64
Query: 93  AHEAEILKRLDSQFIVKCHAVFYTIEGE----------ICFVMEHMERGSLFDSLRVRKK 142
             E +I+++LD   IV+    FY+  GE          + +V E + R +   S R ++ 
Sbjct: 65  NRELQIMRKLDHCNIVRLRYFFYS-SGEKKDEVYLNLVLDYVPETVYRVARHYS-RAKQT 122
Query: 143 LSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEV-KIADFGVSRIVEETRX 201
           L    +    Y++ + L Y+H   I H DIKP NLL++    V K+ DFG ++ +     
Sbjct: 123 LPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--- 179
Query: 202 XXXXXXXXXXXIGEAAIACMGTCAYMSPERVDSERWGG-DYGFAGDVWSLGVVVLECLVG 260
                       GE  ++ + +  Y +PE +    +G  DY  + DVWS G V+ E L+G
Sbjct: 180 ------------GEPNVSXICSRYYRAPELI----FGATDYTSSIDVWSAGCVLAELLLG 223
Query: 261 H 261
Sbjct: 224 Q 224

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/269 (24%), Positives = 115/269 (42%), Gaps = 29/269 (10%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVF 114
           LG G  G V+      +  + A+K L     T+       EA+++K+L  + +V+ +AV 
Sbjct: 19  LGQGCFGEVWMGTWNGTTRV-AIKTLK--PGTMSPEAFLQEAQVMKKLRHEKLVQLYAV- 74
Query: 115 YTIEGEICFVMEHMERGSLFDSLR--VRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDI 172
              E  I  V E+M +GSL D L+    K L    +  +A ++  G+ Y+  M  +H D+
Sbjct: 75  -VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDL 133
Query: 173 KPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERV 232
           + +N+L+      K+ADFG++R++E+                 A         + +PE  
Sbjct: 134 RAANILVGENLVCKVADFGLARLIEDNEYT-------------ARQGAKFPIKWTAPEAA 180
Query: 233 DSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICAICFGERLEMPET 291
                 G +    DVWS G+++ E    G  P  G   +     ++  +  G R+  P  
Sbjct: 181 LY----GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR----EVLDQVERGYRMPCPPE 232
Query: 292 ASPEFRRFVRSCLEKDWRKRGTVEELLAY 320
                   +  C  K+  +R T E L A+
Sbjct: 233 CPESLHDLMCQCWRKEPEERPTFEYLQAF 261

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/241 (27%), Positives = 111/241 (46%), Gaps = 43/241 (17%)
Query: 34  PTSNPTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALK-VLNTTSSTIIRHQA 92
           P   P  P   + +D K   V+G+G+ G+VY+ +   S  + A+K VL        +   
Sbjct: 10  PGQGPDRPQEVSYTDTK---VIGNGSFGVVYQAKLCDSGELVAIKKVLQD------KRFK 60
Query: 93  AHEAEILKRLDSQFIVKCHAVFYTIEGE----------ICFVMEHMERGSLFDSLRVRKK 142
             E +I+++LD   IV+    FY+  GE          + +V E + R +   S R ++ 
Sbjct: 61  NRELQIMRKLDHCNIVRLRYFFYS-SGEKKDEVYLNLVLDYVPETVYRVARHYS-RAKQT 118
Query: 143 LSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEV-KIADFGVSRIVEETRX 201
           L    +    Y++ + L Y+H   I H DIKP NLL++    V K+ DFG ++ +     
Sbjct: 119 LPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--- 175
Query: 202 XXXXXXXXXXXIGEAAIACMGTCAYMSPERVDSERWGG-DYGFAGDVWSLGVVVLECLVG 260
                       GE  ++ + +  Y +PE +    +G  DY  + DVWS G V+ E L+G
Sbjct: 176 ------------GEPNVSYICSRYYRAPELI----FGATDYTSSIDVWSAGCVLAELLLG 219
Query: 261 H 261
Sbjct: 220 Q 220

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 71/283 (25%), Positives = 115/283 (40%), Gaps = 38/283 (13%)
Query: 47  SDLKKLTVLGHGNGGIVYK----VRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRL 102
           ++ KK+ VLG G  G VYK       +K     A+K L   +S     +   EA ++  +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 103 DSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQY 161
           D+  +  C  +   +   +  +M+ M  G L D +R  K  +    +     ++ KG+ Y
Sbjct: 77  DNPHV--CRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 134
Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIV--EETRXXXXXXXXXXXXIGEAAIA 219
           L   +++H D+   N+L+     VKI DFG ++++  EE               G+  I 
Sbjct: 135 LEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEG--------GKVPIK 186
Query: 220 CMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP----DLMA 275
            M   + +   R+        Y    DVWS GV V E       L+ FG KP        
Sbjct: 187 WMALESIL--HRI--------YTHQSDVWSYGVTVWE-------LMTFGSKPYDGIPASE 229
Query: 276 LICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELL 318
           +   +  GERL  P   + +    +R C   D   R    EL+
Sbjct: 230 ISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELI 272

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/241 (27%), Positives = 111/241 (46%), Gaps = 43/241 (17%)
Query: 34  PTSNPTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALK-VLNTTSSTIIRHQA 92
           P   P  P   + +D K   V+G+G+ G+VY+ +   S  + A+K VL        +   
Sbjct: 23  PGQGPDRPQEVSYTDTK---VIGNGSFGVVYQAKLCDSGELVAIKKVLQD------KRFK 73
Query: 93  AHEAEILKRLDSQFIVKCHAVFYTIEGE----------ICFVMEHMERGSLFDSLRVRKK 142
             E +I+++LD   IV+    FY+  GE          + +V E + R +   S R ++ 
Sbjct: 74  NRELQIMRKLDHCNIVRLRYFFYS-SGEKKDEVYLNLVLDYVPETVYRVARHYS-RAKQT 131
Query: 143 LSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEV-KIADFGVSRIVEETRX 201
           L    +    Y++ + L Y+H   I H DIKP NLL++    V K+ DFG ++ +     
Sbjct: 132 LPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--- 188
Query: 202 XXXXXXXXXXXIGEAAIACMGTCAYMSPERVDSERWGG-DYGFAGDVWSLGVVVLECLVG 260
                       GE  ++ + +  Y +PE +    +G  DY  + DVWS G V+ E L+G
Sbjct: 189 ------------GEPNVSYICSRYYRAPELI----FGATDYTSSIDVWSAGCVLAELLLG 232
Query: 261 H 261
Sbjct: 233 Q 233

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/241 (26%), Positives = 112/241 (46%), Gaps = 27/241 (11%)
Query: 42  DVENISDLKKLTV----LGHGNGGIVYK-VRHQKSNSIYALKVLNTTSSTIIRHQAAHEA 96
           +V N  D + ++V    +G G  G+VYK   +  + ++  L  +   ++  ++ Q   E 
Sbjct: 22  NVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEI 81
Query: 97  EILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRV---RKKLSEDVISGVAY 153
           +++ +   + +V+    F +   ++C V  +M  GSL D L        LS  +   +A 
Sbjct: 82  KVMAKCQHENLVELLG-FSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQ 140
Query: 154 RVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXI 213
               G+ +LH    IH DIK +N+L++     KI+DFG++R  E+               
Sbjct: 141 GAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSR------ 194
Query: 214 GEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDL 273
                  +GT AYM+PE +      G+     D++S GVV+LE + G  P +    +P L
Sbjct: 195 ------IVGTTAYMAPEAL-----RGEITPKSDIYSFGVVLLEIITG-LPAVDEHREPQL 242
Query: 274 M 274
           +
Sbjct: 243 L 243

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 113/242 (46%), Gaps = 45/242 (18%)
Query: 34  PTSNPTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQA- 92
           P   P  P   + +D K   V+G+G+ G+VY+ +   S  + A+K        +++ +A 
Sbjct: 10  PGQGPDRPQEVSYTDTK---VIGNGSFGVVYQAKLCDSGELVAIK-------KVLQGKAF 59
Query: 93  -AHEAEILKRLDSQFIVKCHAVFYTIEGE----------ICFVMEHMERGSLFDSLRVRK 141
              E +I+++LD   IV+    FY+  GE          + +V E + R +   S R ++
Sbjct: 60  KNRELQIMRKLDHCNIVRLRYFFYS-SGEKKDEVYLNLVLDYVPETVYRVARHYS-RAKQ 117
Query: 142 KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEV-KIADFGVSRIVEETR 200
            L    +    Y++ + L Y+H   I H DIKP NLL++    V K+ DFG ++ +    
Sbjct: 118 TLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-- 175
Query: 201 XXXXXXXXXXXXIGEAAIACMGTCAYMSPERVDSERWGG-DYGFAGDVWSLGVVVLECLV 259
                        GE  ++ + +  Y +PE +    +G  DY  + DVWS G V+ E L+
Sbjct: 176 -------------GEPNVSYICSRYYRAPELI----FGATDYTSSIDVWSAGCVLAELLL 218
Query: 260 GH 261
           G 
Sbjct: 219 GQ 220

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/241 (27%), Positives = 111/241 (46%), Gaps = 43/241 (17%)
Query: 34  PTSNPTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALK-VLNTTSSTIIRHQA 92
           P   P  P   + +D K   V+G+G+ G+VY+ +   S  + A+K VL        +   
Sbjct: 18  PGQGPDRPQEVSYTDTK---VIGNGSFGVVYQAKLCDSGELVAIKKVLQD------KRFK 68
Query: 93  AHEAEILKRLDSQFIVKCHAVFYTIEGE----------ICFVMEHMERGSLFDSLRVRKK 142
             E +I+++LD   IV+    FY+  GE          + +V E + R +   S R ++ 
Sbjct: 69  NRELQIMRKLDHCNIVRLRYFFYS-SGEKKDEVYLNLVLDYVPETVYRVARHYS-RAKQT 126
Query: 143 LSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEV-KIADFGVSRIVEETRX 201
           L    +    Y++ + L Y+H   I H DIKP NLL++    V K+ DFG ++ +     
Sbjct: 127 LPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--- 183
Query: 202 XXXXXXXXXXXIGEAAIACMGTCAYMSPERVDSERWGG-DYGFAGDVWSLGVVVLECLVG 260
                       GE  ++ + +  Y +PE +    +G  DY  + DVWS G V+ E L+G
Sbjct: 184 ------------GEPNVSXICSRYYRAPELI----FGATDYTSSIDVWSAGCVLAELLLG 227
Query: 261 H 261
Sbjct: 228 Q 228

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/241 (27%), Positives = 111/241 (46%), Gaps = 43/241 (17%)
Query: 34  PTSNPTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALK-VLNTTSSTIIRHQA 92
           P   P  P   + +D K   V+G+G+ G+VY+ +   S  + A+K VL        +   
Sbjct: 22  PGQGPDRPQEVSYTDTK---VIGNGSFGVVYQAKLCDSGELVAIKKVLQD------KRFK 72
Query: 93  AHEAEILKRLDSQFIVKCHAVFYTIEGE----------ICFVMEHMERGSLFDSLRVRKK 142
             E +I+++LD   IV+    FY+  GE          + +V E + R +   S R ++ 
Sbjct: 73  NRELQIMRKLDHCNIVRLRYFFYS-SGEKKDEVYLNLVLDYVPETVYRVARHYS-RAKQT 130
Query: 143 LSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEV-KIADFGVSRIVEETRX 201
           L    +    Y++ + L Y+H   I H DIKP NLL++    V K+ DFG ++ +     
Sbjct: 131 LPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--- 187
Query: 202 XXXXXXXXXXXIGEAAIACMGTCAYMSPERVDSERWGG-DYGFAGDVWSLGVVVLECLVG 260
                       GE  ++ + +  Y +PE +    +G  DY  + DVWS G V+ E L+G
Sbjct: 188 ------------GEPNVSXICSRYYRAPELI----FGATDYTSSIDVWSAGCVLAELLLG 231
Query: 261 H 261
Sbjct: 232 Q 232

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/241 (27%), Positives = 111/241 (46%), Gaps = 43/241 (17%)
Query: 34  PTSNPTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALK-VLNTTSSTIIRHQA 92
           P   P  P   + +D K   V+G+G+ G+VY+ +   S  + A+K VL        +   
Sbjct: 22  PGQGPDRPQEVSYTDTK---VIGNGSFGVVYQAKLCDSGELVAIKKVLQD------KRFK 72
Query: 93  AHEAEILKRLDSQFIVKCHAVFYTIEGE----------ICFVMEHMERGSLFDSLRVRKK 142
             E +I+++LD   IV+    FY+  GE          + +V E + R +   S R ++ 
Sbjct: 73  NRELQIMRKLDHCNIVRLRYFFYS-SGEKKDEVYLNLVLDYVPETVYRVARHYS-RAKQT 130
Query: 143 LSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEV-KIADFGVSRIVEETRX 201
           L    +    Y++ + L Y+H   I H DIKP NLL++    V K+ DFG ++ +     
Sbjct: 131 LPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--- 187
Query: 202 XXXXXXXXXXXIGEAAIACMGTCAYMSPERVDSERWGG-DYGFAGDVWSLGVVVLECLVG 260
                       GE  ++ + +  Y +PE +    +G  DY  + DVWS G V+ E L+G
Sbjct: 188 ------------GEPNVSXICSRYYRAPELI----FGATDYTSSIDVWSAGCVLAELLLG 231
Query: 261 H 261
Sbjct: 232 Q 232

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 68/267 (25%), Positives = 115/267 (43%), Gaps = 31/267 (11%)
Query: 47  SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQF 106
           S+L  +  +G G  G+V+ + +  +    A+K +   S +        EAE++ +L    
Sbjct: 27  SELTFVQEIGSGQFGLVH-LGYWLNKDKVAIKTIKEGSMS--EDDFIEEAEVMMKLSHPK 83
Query: 107 IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKL-SEDVISGVAYRVLKGLQYLHGM 165
           +V+ + V    +  IC V E ME G L D LR ++ L + + + G+   V +G+ YL   
Sbjct: 84  LVQLYGVCLE-QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 142
Query: 166 QIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCA 225
            +IH D+   N L+     +K++DFG++R V + +               ++        
Sbjct: 143 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-------------SSTGTKFPVK 189
Query: 226 YMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICAICFGE 284
           + SPE     R    Y    DVWS GV++ E    G  P     E      ++  I  G 
Sbjct: 190 WASPEVFSFSR----YSSKSDVWSFGVLMWEVFSEGKIPY----ENRSNSEVVEDISTGF 241
Query: 285 RLEMPETASPEFRRFVRSCLEKDWRKR 311
           RL  P  AS    + +  C    W++R
Sbjct: 242 RLYKPRLASTHVYQIMNHC----WKER 264

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 70/283 (24%), Positives = 120/283 (42%), Gaps = 31/283 (10%)
Query: 47  SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVL----NTTSSTIIRHQAAHEAEILKRL 102
           SDL    VLG G  G   KV H+++  +  +K L      T  T ++     E ++++ L
Sbjct: 10  SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLK-----EVKVMRCL 64
Query: 103 DSQFIVKCHAVFYTIEGEICFVMEHMERGSL---FDSLRVRKKLSEDVISGVAYRVLKGL 159
           +   ++K   V Y  +  + F+ E+++ G+L     S+  +   S+ V    A  +  G+
Sbjct: 65  EHPNVLKFIGVLYK-DKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRV--SFAKDIASGM 121
Query: 160 QYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIA 219
            YLH M IIH D+   N L+     V +ADFG++R++ + +              +    
Sbjct: 122 AYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYT 181
Query: 220 CMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIG-FGEKPDLMALIC 278
            +G   +M+PE ++    G  Y    DV+S G+V+ E       +IG     PD +    
Sbjct: 182 VVGNPYWMAPEMIN----GRSYDEKVDVFSFGIVLCE-------IIGRVNADPDYLPRTM 230
Query: 279 AICFGERLEM----PETASPEFRRFVRSCLEKDWRKRGTVEEL 317
                 R  +    P    P F      C + D  KR +  +L
Sbjct: 231 DFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKL 273

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 76/262 (29%), Positives = 112/262 (42%), Gaps = 43/262 (16%)
Query: 52  LTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCH 111
           L V+G G  G V K    K +   ALK++          QAA E  IL+ L  Q      
Sbjct: 102 LKVIGKGXFGQVVKAYDHKVHQHVALKMVRNEKR--FHRQAAEEIRILEHLRKQDKDNTM 159
Query: 112 AVF-----YTIEGEICFVMEHMERGSLFDSLRVRK--KLSEDVISGVAYRVLKGLQYLHG 164
            V      +T    IC   E +   +L++ ++  K    S  ++   A+ +L+ L  LH 
Sbjct: 160 NVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHK 218
Query: 165 MQIIHGDIKPSNLLI--NGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMG 222
            +IIH D+KP N+L+   G+  +K+ DFG S   E  R                    + 
Sbjct: 219 NRIIHCDLKPENILLKQQGRSGIKVIDFG-SSCYEHQR----------------VYXXIQ 261
Query: 223 TCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICF 282
           +  Y +PE +     G  YG   D+WSLG ++ E L G YPL+   ++ D +A     C 
Sbjct: 262 SRFYRAPEVI----LGARYGMPIDMWSLGCILAELLTG-YPLLPGEDEGDQLA-----CM 311
Query: 283 GERLEMPET----ASPEFRRFV 300
            E L MP      AS   + FV
Sbjct: 312 IELLGMPXQKLLDASKRAKNFV 333

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/241 (27%), Positives = 111/241 (46%), Gaps = 43/241 (17%)
Query: 34  PTSNPTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALK-VLNTTSSTIIRHQA 92
           P   P  P   + +D K   V+G+G+ G+VY+ +   S  + A+K VL        +   
Sbjct: 29  PGQGPDRPQEVSYTDTK---VIGNGSFGVVYQAKLCDSGELVAIKKVLQD------KRFK 79
Query: 93  AHEAEILKRLDSQFIVKCHAVFYTIEGE----------ICFVMEHMERGSLFDSLRVRKK 142
             E +I+++LD   IV+    FY+  GE          + +V E + R +   S R ++ 
Sbjct: 80  NRELQIMRKLDHCNIVRLRYFFYS-SGEKKDEVYLNLVLDYVPETVYRVARHYS-RAKQT 137
Query: 143 LSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEV-KIADFGVSRIVEETRX 201
           L    +    Y++ + L Y+H   I H DIKP NLL++    V K+ DFG ++ +     
Sbjct: 138 LPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--- 194
Query: 202 XXXXXXXXXXXIGEAAIACMGTCAYMSPERVDSERWGG-DYGFAGDVWSLGVVVLECLVG 260
                       GE  ++ + +  Y +PE +    +G  DY  + DVWS G V+ E L+G
Sbjct: 195 ------------GEPNVSXICSRYYRAPELI----FGATDYTSSIDVWSAGCVLAELLLG 238
Query: 261 H 261
Sbjct: 239 Q 239

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/241 (27%), Positives = 111/241 (46%), Gaps = 43/241 (17%)
Query: 34  PTSNPTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALK-VLNTTSSTIIRHQA 92
           P   P  P   + +D K   V+G+G+ G+VY+ +   S  + A+K VL        +   
Sbjct: 44  PGQGPDRPQEVSYTDTK---VIGNGSFGVVYQAKLCDSGELVAIKKVLQD------KRFK 94
Query: 93  AHEAEILKRLDSQFIVKCHAVFYTIEGE----------ICFVMEHMERGSLFDSLRVRKK 142
             E +I+++LD   IV+    FY+  GE          + +V E + R +   S R ++ 
Sbjct: 95  NRELQIMRKLDHCNIVRLRYFFYS-SGEKKDEVYLNLVLDYVPETVYRVARHYS-RAKQT 152
Query: 143 LSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEV-KIADFGVSRIVEETRX 201
           L    +    Y++ + L Y+H   I H DIKP NLL++    V K+ DFG ++ +     
Sbjct: 153 LPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--- 209
Query: 202 XXXXXXXXXXXIGEAAIACMGTCAYMSPERVDSERWGG-DYGFAGDVWSLGVVVLECLVG 260
                       GE  ++ + +  Y +PE +    +G  DY  + DVWS G V+ E L+G
Sbjct: 210 ------------GEPNVSXICSRYYRAPELI----FGATDYTSSIDVWSAGCVLAELLLG 253
Query: 261 H 261
Sbjct: 254 Q 254

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/242 (23%), Positives = 108/242 (44%), Gaps = 41/242 (16%)
Query: 46  ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQ 105
           ++D + +  LG G  G+V++ +++  +  YA+K +   +  + R +   E + L +L+  
Sbjct: 4   LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHP 63
Query: 106 FIVK-----------------CHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSE--- 145
            IV+                    V+  I+ ++C       + +L D +  R  + E   
Sbjct: 64  GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLC------RKENLKDWMNGRCTIEERER 117
Query: 146 DVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIV---EETRXX 202
            V   +  ++ + +++LH   ++H D+KPSN+       VK+ DFG+   +   EE +  
Sbjct: 118 SVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 177
Query: 203 XXXXXXXXXXIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHY 262
                      G+     +GT  YMSPE++     G  Y    D++SLG+++ E L   Y
Sbjct: 178 LTPMPAYARHTGQ-----VGTKLYMSPEQIH----GNSYSHKVDIFSLGLILFELL---Y 225
Query: 263 PL 264
           P 
Sbjct: 226 PF 227

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 103/216 (47%), Gaps = 26/216 (12%)
Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH-EAEILKRLDSQFIV 108
           + L+ +G G  G V      K+    A+K L+    +II  +  + E  +LK +  + ++
Sbjct: 25  QNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI 84
Query: 109 KCHAVFYTI----EGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG 164
               VF       E    +++ H+  G+  +++   +KL++D +  + Y++L+GL+Y+H 
Sbjct: 85  GLLDVFTPARSLEEFNDVYLVTHL-MGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTC 224
             IIH D+KPSNL +N   E+KI DF ++R  +                 +     + T 
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFYLARHTD-----------------DEMTGYVATR 186
Query: 225 AYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVG 260
            Y +PE +    W   Y    D+WS+G ++ E L G
Sbjct: 187 WYRAPEIM--LNWMH-YNQTVDIWSVGCIMAELLTG 219

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/267 (25%), Positives = 115/267 (43%), Gaps = 31/267 (11%)
Query: 47  SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQF 106
           S+L  +  +G G  G+V+ + +  +    A+K +   + +        EAE++ +L    
Sbjct: 7   SELTFVQEIGSGQFGLVH-LGYWLNKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPK 63
Query: 107 IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKL-SEDVISGVAYRVLKGLQYLHGM 165
           +V+ + V    +  IC V E ME G L D LR ++ L + + + G+   V +G+ YL   
Sbjct: 64  LVQLYGVCLE-QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 122
Query: 166 QIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCA 225
            +IH D+   N L+     +K++DFG++R V + +               ++        
Sbjct: 123 SVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-------------SSTGTKFPVK 169
Query: 226 YMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICAICFGE 284
           + SPE     R    Y    DVWS GV++ E    G  P     E      ++  I  G 
Sbjct: 170 WASPEVFSFSR----YSSKSDVWSFGVLMWEVFSEGKIPY----ENRSNSEVVEDISTGF 221
Query: 285 RLEMPETASPEFRRFVRSCLEKDWRKR 311
           RL  P  AS    + +  C    W++R
Sbjct: 222 RLYKPRLASTHVYQIMNHC----WKER 244

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 64/241 (26%), Positives = 113/241 (46%), Gaps = 27/241 (11%)
Query: 42  DVENISDLKKLTV----LGHGNGGIVYK-VRHQKSNSIYALKVLNTTSSTIIRHQAAHEA 96
           +V N  D + ++V    +G G  G+VYK   +  + ++  L  +   ++  ++ Q   E 
Sbjct: 22  NVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEI 81
Query: 97  EILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRV---RKKLSEDVISGVAY 153
           +++ +   + +V+    F +   ++C V  +M  GSL D L        LS  +   +A 
Sbjct: 82  KVMAKCQHENLVELLG-FSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQ 140
Query: 154 RVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXI 213
               G+ +LH    IH DIK +N+L++     KI+DFG++R  E+               
Sbjct: 141 GAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXR------ 194
Query: 214 GEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDL 273
                  +GT AYM+PE +      G+     D++S GVV+LE + G  P +    +P L
Sbjct: 195 ------IVGTTAYMAPEAL-----RGEITPKSDIYSFGVVLLEIITG-LPAVDEHREPQL 242
Query: 274 M 274
           +
Sbjct: 243 L 243

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 76/306 (24%), Positives = 133/306 (43%), Gaps = 38/306 (12%)
Query: 37  NPTSPDVENI----SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQA 92
           +P+SP+ +      +D+     LG G  G VY+   +K +   A+K L     T+   + 
Sbjct: 4   DPSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK--EDTMEVEEF 61
Query: 93  AHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRV--RKKLSEDVISG 150
             EA ++K +    +V+   V  T E     + E M  G+L D LR   R+++S  V+  
Sbjct: 62  LKEAAVMKEIKHPNLVQLLGVC-TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLY 120
Query: 151 VAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXX 210
           +A ++   ++YL     IH D+   N L+     VK+ADFG+SR++              
Sbjct: 121 MATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-------------- 166
Query: 211 XXIGEAAIACMGT---CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLE-CLVGHYPLIG 266
              G+   A  G      + +PE +   +    +    DVW+ GV++ E    G  P  G
Sbjct: 167 --TGDTYTAHAGAKFPIKWTAPESLAYNK----FSIKSDVWAFGVLLWEIATYGMSPYPG 220
Query: 267 FGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEEL-LAYPFVTK 325
                DL  +   +    R+E PE    +    +R+C + +   R +  E+  A+  + +
Sbjct: 221 I----DLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 276
Query: 326 RSSSSN 331
            SS S+
Sbjct: 277 ESSISD 282

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 67/241 (27%), Positives = 111/241 (46%), Gaps = 43/241 (17%)
Query: 34  PTSNPTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALK-VLNTTSSTIIRHQA 92
           P   P  P   + +D K   V+G+G+ G+VY+ +   S  + A+K VL        +   
Sbjct: 38  PGQGPDRPQEVSYTDTK---VIGNGSFGVVYQAKLCDSGELVAIKKVLQD------KRFK 88
Query: 93  AHEAEILKRLDSQFIVKCHAVFYTIEGE----------ICFVMEHMERGSLFDSLRVRKK 142
             E +I+++LD   IV+    FY+  GE          + +V E + R +   S R ++ 
Sbjct: 89  NRELQIMRKLDHCNIVRLRYFFYS-SGEKKDEVYLNLVLDYVPETVYRVARHYS-RAKQT 146
Query: 143 LSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEV-KIADFGVSRIVEETRX 201
           L    +    Y++ + L Y+H   I H DIKP NLL++    V K+ DFG ++ +     
Sbjct: 147 LPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--- 203
Query: 202 XXXXXXXXXXXIGEAAIACMGTCAYMSPERVDSERWGG-DYGFAGDVWSLGVVVLECLVG 260
                       GE  ++ + +  Y +PE +    +G  DY  + DVWS G V+ E L+G
Sbjct: 204 ------------GEPNVSYICSRYYRAPELI----FGATDYTSSIDVWSAGCVLAELLLG 247
Query: 261 H 261
Sbjct: 248 Q 248

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 66/269 (24%), Positives = 115/269 (42%), Gaps = 29/269 (10%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVF 114
           LG G  G V+      +  + A+K L     T+       EA+++K+L  + +V+ +AV 
Sbjct: 275 LGQGCFGEVWMGTWNGTTRV-AIKTLK--PGTMSPEAFLQEAQVMKKLRHEKLVQLYAV- 330
Query: 115 YTIEGEICFVMEHMERGSLFDSLR--VRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDI 172
              E  I  V E+M +GSL D L+    K L    +  +A ++  G+ Y+  M  +H D+
Sbjct: 331 -VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDL 389
Query: 173 KPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERV 232
           + +N+L+      K+ADFG++R++E+                 A         + +PE  
Sbjct: 390 RAANILVGENLVCKVADFGLARLIEDNEYT-------------ARQGAKFPIKWTAPEAA 436
Query: 233 DSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICAICFGERLEMPET 291
                 G +    DVWS G+++ E    G  P  G   +     ++  +  G R+  P  
Sbjct: 437 LY----GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR----EVLDQVERGYRMPCPPE 488
Query: 292 ASPEFRRFVRSCLEKDWRKRGTVEELLAY 320
                   +  C  K+  +R T E L A+
Sbjct: 489 CPESLHDLMCQCWRKEPEERPTFEYLQAF 517

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 73/296 (24%), Positives = 124/296 (41%), Gaps = 35/296 (11%)
Query: 34  PTSNPTS----PDVENI--SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTI 87
           PTS P +     D   I    L+    LG G  G V+      +  + A+K L     T+
Sbjct: 165 PTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLK--PGTM 221
Query: 88  IRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLR--VRKKLSE 145
                  EA+++K+L  + +V+ +AV    E  I  V E+M +GSL D L+    K L  
Sbjct: 222 SPEAFLQEAQVMKKLRHEKLVQLYAV--VSEEPIYIVGEYMSKGSLLDFLKGETGKYLRL 279
Query: 146 DVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXX 205
             +  +A ++  G+ Y+  M  +H D++ +N+L+      K+ADFG++R++E+       
Sbjct: 280 PQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT--- 336
Query: 206 XXXXXXXIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPL 264
                     A         + +PE        G +    DVWS G+++ E    G  P 
Sbjct: 337 ----------ARQGAKFPIKWTAPEAALY----GRFTIKSDVWSFGILLTELTTKGRVPY 382
Query: 265 IGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY 320
            G   +     ++  +  G R+  P          +  C  K+  +R T E L A+
Sbjct: 383 PGMVNR----EVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAF 434

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 70/270 (25%), Positives = 116/270 (42%), Gaps = 37/270 (13%)
Query: 47  SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQF 106
           S+L  +  +G G  G+V+ + +  +    A+K +   + +        EAE++ +L    
Sbjct: 8   SELTFVQEIGSGQFGLVH-LGYWLNKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPK 64
Query: 107 IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKL-SEDVISGVAYRVLKGLQYLHGM 165
           +V+ + V    +  IC V E ME G L D LR ++ L + + + G+   V +G+ YL   
Sbjct: 65  LVQLYGVCLE-QAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 123
Query: 166 QIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGT-- 223
            +IH D+   N L+     +K++DFG++R V                + +   +  GT  
Sbjct: 124 CVIHRDLAARNCLVGENQVIKVSDFGMTRFV----------------LDDQYTSSTGTKF 167
Query: 224 -CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICAIC 281
              + SPE     R    Y    DVWS GV++ E    G  P     E      ++  I 
Sbjct: 168 PVKWASPEVFSFSR----YSSKSDVWSFGVLMWEVFSEGKIPY----ENRSNSEVVEDIS 219
Query: 282 FGERLEMPETASPEFRRFVRSCLEKDWRKR 311
            G RL  P  AS    + +  C    WR+R
Sbjct: 220 TGFRLYKPRLASTHVYQIMNHC----WRER 245

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 73/277 (26%), Positives = 117/277 (42%), Gaps = 39/277 (14%)
Query: 54  VLGHGNGGIVYKVRHQ---KSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKC 110
           V+G G  G V   R +   K     A+K L    +   R     EA I+ + D   I+  
Sbjct: 29  VIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIHL 88
Query: 111 HAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVIS--GVAYRVLKGLQYLHGMQII 168
             V  T    +  V E+ME GSL D+   +      VI   G+   +  G++YL  M  +
Sbjct: 89  EGVV-TKSKPVMIVTEYMENGSL-DTFLKKNDGQFTVIQLVGMLRGISAGMKYLSDMGYV 146
Query: 169 HGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMG---TCA 225
           H D+   N+LIN     K++DFG+SR++E+                EAA    G      
Sbjct: 147 HRDLAARNILINSNLVCKVSDFGLSRVLEDD--------------PEAAYTTRGGKIPIR 192
Query: 226 YMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDL----MALICAIC 281
           + +PE +   +    +  A DVWS G+V+ E       ++ +GE+P        +I A+ 
Sbjct: 193 WTAPEAIAFRK----FTSASDVWSYGIVMWE-------VVSYGERPYWEMTNQDVIKAVE 241
Query: 282 FGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELL 318
            G RL  P        + +  C +K+   R   +E++
Sbjct: 242 EGYRLPSPMDCPAALYQLMLDCWQKERNSRPKFDEIV 278

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 106/239 (44%), Gaps = 33/239 (13%)
Query: 39  TSPDVENISDLKKL-TVLGHGNGGIVYKVRHQKSNSIYALKVLNTT----SSTIIRHQAA 93
           T+P   ++SD  +L  +LG G    V+  R  + +   A+KVL        S  +R +  
Sbjct: 5   TTP--SHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFR-- 60
Query: 94  HEAEILKRLDSQFIVKCHAVFYTIEGEIC------FVMEHMERGSLFDSLRVRKKLSEDV 147
            EA+    L+   IV   AV+ T E E         VME+++  +L D +     ++   
Sbjct: 61  REAQNAAALNHPAIV---AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKR 117
Query: 148 ISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXX 207
              V     + L + H   IIH D+KP+N++I+    VK+ DFG++R + ++        
Sbjct: 118 AIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTA 177
Query: 208 XXXXXIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIG 266
                      A +GT  Y+SPE+      G       DV+SLG V+ E L G  P  G
Sbjct: 178 -----------AVIGTAQYLSPEQA----RGDSVDARSDVYSLGCVLYEVLTGEPPFTG 221

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 67/241 (27%), Positives = 111/241 (46%), Gaps = 43/241 (17%)
Query: 34  PTSNPTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALK-VLNTTSSTIIRHQA 92
           P   P  P   + +D K   V+G+G+ G+VY+ +   S  + A+K VL        +   
Sbjct: 44  PGQGPDRPQEVSYTDTK---VIGNGSFGVVYQAKLCDSGELVAIKKVLQD------KRFK 94
Query: 93  AHEAEILKRLDSQFIVKCHAVFYTIEGE----------ICFVMEHMERGSLFDSLRVRKK 142
             E +I+++LD   IV+    FY+  GE          + +V E + R +   S R ++ 
Sbjct: 95  NRELQIMRKLDHCNIVRLRYFFYS-SGEKKDEVYLNLVLDYVPETVYRVARHYS-RAKQT 152
Query: 143 LSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEV-KIADFGVSRIVEETRX 201
           L    +    Y++ + L Y+H   I H DIKP NLL++    V K+ DFG ++ +     
Sbjct: 153 LPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--- 209
Query: 202 XXXXXXXXXXXIGEAAIACMGTCAYMSPERVDSERWGG-DYGFAGDVWSLGVVVLECLVG 260
                       GE  ++ + +  Y +PE +    +G  DY  + DVWS G V+ E L+G
Sbjct: 210 ------------GEPNVSYICSRYYRAPELI----FGATDYTSSIDVWSAGCVLAELLLG 253
Query: 261 H 261
Sbjct: 254 Q 254

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 67/241 (27%), Positives = 111/241 (46%), Gaps = 43/241 (17%)
Query: 34  PTSNPTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALK-VLNTTSSTIIRHQA 92
           P   P  P   + +D K   V+G+G+ G+VY+ +   S  + A+K VL        +   
Sbjct: 15  PGQGPDRPQEVSYTDTK---VIGNGSFGVVYQAKLCDSGELVAIKKVLQD------KRFK 65
Query: 93  AHEAEILKRLDSQFIVKCHAVFYTIEGE----------ICFVMEHMERGSLFDSLRVRKK 142
             E +I+++LD   IV+    FY+  GE          + +V E + R +   S R ++ 
Sbjct: 66  NRELQIMRKLDHCNIVRLRYFFYS-SGEKKDEVYLNLVLDYVPETVYRVARHYS-RAKQT 123
Query: 143 LSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEV-KIADFGVSRIVEETRX 201
           L    +    Y++ + L Y+H   I H DIKP NLL++    V K+ DFG ++ +     
Sbjct: 124 LPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--- 180
Query: 202 XXXXXXXXXXXIGEAAIACMGTCAYMSPERVDSERWGG-DYGFAGDVWSLGVVVLECLVG 260
                       GE  ++ + +  Y +PE +    +G  DY  + DVWS G V+ E L+G
Sbjct: 181 ------------GEPNVSYICSRYYRAPELI----FGATDYTSSIDVWSAGCVLAELLLG 224
Query: 261 H 261
Sbjct: 225 Q 225

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 108/229 (47%), Gaps = 43/229 (18%)
Query: 48  DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFI 107
           D K++ ++G G  G V+K +H+     Y +K +   +      +A  E + L +LD   I
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-----EKAEREVKALAKLDHVNI 66
Query: 108 VKCHAVFYTIEGE---------------ICFVMEHMERGSLFDSLRVRK--KLSEDVISG 150
           V  +  +   + +               +   ME  ++G+L   +  R+  KL + +   
Sbjct: 67  VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALE 126
Query: 151 VAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFG-VSRIVEETRXXXXXXXXX 209
           +  ++ KG+ Y+H  ++I+ D+KPSN+ +    +VKI DFG V+ +  + +         
Sbjct: 127 LFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRXR------ 180
Query: 210 XXXIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECL 258
                       GT  YMSPE++ S+    DYG   D+++LG+++ E L
Sbjct: 181 ----------SKGTLRYMSPEQISSQ----DYGKEVDLYALGLILAELL 215

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/241 (26%), Positives = 114/241 (47%), Gaps = 27/241 (11%)
Query: 42  DVENISDLKKLTV----LGHGNGGIVYK-VRHQKSNSIYALKVLNTTSSTIIRHQAAHEA 96
           +V N  D + ++V    +G G  G+VYK   +  + ++  L  +   ++  ++ Q   E 
Sbjct: 16  NVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEI 75
Query: 97  EILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRV---RKKLSEDVISGVAY 153
           +++ +   + +V+    F +   ++C V  +M  GSL D L        LS  +   +A 
Sbjct: 76  KVMAKCQHENLVELLG-FSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQ 134
Query: 154 RVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXI 213
               G+ +LH    IH DIK +N+L++     KI+DFG++R  E+               
Sbjct: 135 GAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXR------ 188
Query: 214 GEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDL 273
                  +GT AYM+PE +      G+     D++S GVV+LE + G  P +    +P L
Sbjct: 189 ------IVGTTAYMAPEAL-----RGEITPKSDIYSFGVVLLEIITG-LPAVDEHREPQL 236
Query: 274 M 274
           +
Sbjct: 237 L 237

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 67/241 (27%), Positives = 111/241 (46%), Gaps = 43/241 (17%)
Query: 34  PTSNPTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALK-VLNTTSSTIIRHQA 92
           P   P  P   + +D K   V+G+G+ G+VY+ +   S  + A+K VL        +   
Sbjct: 48  PGQGPDRPQEVSYTDTK---VIGNGSFGVVYQAKLCDSGELVAIKKVLQD------KRFK 98
Query: 93  AHEAEILKRLDSQFIVKCHAVFYTIEGE----------ICFVMEHMERGSLFDSLRVRKK 142
             E +I+++LD   IV+    FY+  GE          + +V E + R +   S R ++ 
Sbjct: 99  NRELQIMRKLDHCNIVRLRYFFYS-SGEKKDEVYLNLVLDYVPETVYRVARHYS-RAKQT 156
Query: 143 LSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEV-KIADFGVSRIVEETRX 201
           L    +    Y++ + L Y+H   I H DIKP NLL++    V K+ DFG ++ +     
Sbjct: 157 LPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--- 213
Query: 202 XXXXXXXXXXXIGEAAIACMGTCAYMSPERVDSERWGG-DYGFAGDVWSLGVVVLECLVG 260
                       GE  ++ + +  Y +PE +    +G  DY  + DVWS G V+ E L+G
Sbjct: 214 ------------GEPNVSYICSRYYRAPELI----FGATDYTSSIDVWSAGCVLAELLLG 257
Query: 261 H 261
Sbjct: 258 Q 258

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 79/304 (25%), Positives = 126/304 (41%), Gaps = 59/304 (19%)
Query: 53  TVLGHGNGGIVYKVRHQKSNSIYALKVLNTT-SSTIIRHQAAHEAEILKRLDSQFIVKCH 111
           T +G G  G V     ++S    A+K L+    S I   +A  E  +LK +  + ++   
Sbjct: 30  THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLL 89
Query: 112 AVFYTIEG-----EICFVMEHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQYLHGM 165
            VF          +   VM  M+     D  ++   K SE+ I  + Y++LKGL+Y+H  
Sbjct: 90  DVFTPASSLRNFYDFYLVMPFMQT----DLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSA 145
Query: 166 QIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCA 225
            ++H D+KP NL +N   E+KI DFG++R  +                       + T  
Sbjct: 146 GVVHRDLKPGNLAVNEDCELKILDFGLARHAD-----------------AEMTGYVVTRW 188
Query: 226 YMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAIC---- 281
           Y +PE + S  W   Y    D+WS+G ++ E L G     G  +  D +  I  +     
Sbjct: 189 YRAPEVILS--W-MHYNQTVDIWSVGCIMAEMLTGKTLFKG-KDYLDQLTQILKVTGVPG 244
Query: 282 --FGERLE----------MPET-----------ASPEFRRFVRSCLEKDWRKRGTVEELL 318
             F ++L           +P+T           ASP+    +   LE D  KR T  + L
Sbjct: 245 TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQAL 304
Query: 319 AYPF 322
            +PF
Sbjct: 305 THPF 308

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 67/241 (27%), Positives = 111/241 (46%), Gaps = 43/241 (17%)
Query: 34  PTSNPTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALK-VLNTTSSTIIRHQA 92
           P   P  P   + +D K   V+G+G+ G+VY+ +   S  + A+K VL        +   
Sbjct: 46  PGQGPDRPQEVSYTDTK---VIGNGSFGVVYQAKLCDSGELVAIKKVLQD------KRFK 96
Query: 93  AHEAEILKRLDSQFIVKCHAVFYTIEGE----------ICFVMEHMERGSLFDSLRVRKK 142
             E +I+++LD   IV+    FY+  GE          + +V E + R +   S R ++ 
Sbjct: 97  NRELQIMRKLDHCNIVRLRYFFYS-SGEKKDEVYLNLVLDYVPETVYRVARHYS-RAKQT 154
Query: 143 LSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEV-KIADFGVSRIVEETRX 201
           L    +    Y++ + L Y+H   I H DIKP NLL++    V K+ DFG ++ +     
Sbjct: 155 LPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--- 211
Query: 202 XXXXXXXXXXXIGEAAIACMGTCAYMSPERVDSERWGG-DYGFAGDVWSLGVVVLECLVG 260
                       GE  ++ + +  Y +PE +    +G  DY  + DVWS G V+ E L+G
Sbjct: 212 ------------GEPNVSYICSRYYRAPELI----FGATDYTSSIDVWSAGCVLAELLLG 255
Query: 261 H 261
Sbjct: 256 Q 256

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 67/241 (27%), Positives = 111/241 (46%), Gaps = 43/241 (17%)
Query: 34  PTSNPTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALK-VLNTTSSTIIRHQA 92
           P   P  P   + +D K   V+G+G+ G+VY+ +   S  + A+K VL        +   
Sbjct: 89  PGQGPDRPQEVSYTDTK---VIGNGSFGVVYQAKLCDSGELVAIKKVLQD------KRFK 139
Query: 93  AHEAEILKRLDSQFIVKCHAVFYTIEGE----------ICFVMEHMERGSLFDSLRVRKK 142
             E +I+++LD   IV+    FY+  GE          + +V E + R +   S R ++ 
Sbjct: 140 NRELQIMRKLDHCNIVRLRYFFYS-SGEKKDEVYLNLVLDYVPETVYRVARHYS-RAKQT 197
Query: 143 LSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEV-KIADFGVSRIVEETRX 201
           L    +    Y++ + L Y+H   I H DIKP NLL++    V K+ DFG ++ +     
Sbjct: 198 LPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--- 254
Query: 202 XXXXXXXXXXXIGEAAIACMGTCAYMSPERVDSERWGG-DYGFAGDVWSLGVVVLECLVG 260
                       GE  ++ + +  Y +PE +    +G  DY  + DVWS G V+ E L+G
Sbjct: 255 ------------GEPNVSYICSRYYRAPELI----FGATDYTSSIDVWSAGCVLAELLLG 298
Query: 261 H 261
Sbjct: 299 Q 299

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 65/269 (24%), Positives = 115/269 (42%), Gaps = 29/269 (10%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVF 114
           LG G  G V+      +  + A+K L     T+       EA+++K+L  + +V+ +AV 
Sbjct: 23  LGQGCFGEVWMGTWNGTTRV-AIKTLK--PGTMSPEAFLQEAQVMKKLRHEKLVQLYAV- 78
Query: 115 YTIEGEICFVMEHMERGSLFDSLR--VRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDI 172
              E  I  V E+M +GSL D L+    K L    +  ++ ++  G+ Y+  M  +H D+
Sbjct: 79  -VSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMNYVHRDL 137
Query: 173 KPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERV 232
           + +N+L+      K+ADFG++R++E+                 A         + +PE  
Sbjct: 138 RAANILVGENLVCKVADFGLARLIEDNEYT-------------ARQGAKFPIKWTAPEAA 184
Query: 233 DSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICAICFGERLEMPET 291
                 G +    DVWS G+++ E    G  P  G   +     ++  +  G R+  P  
Sbjct: 185 LY----GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR----EVLDQVERGYRMPCPPE 236
Query: 292 ASPEFRRFVRSCLEKDWRKRGTVEELLAY 320
                   +  C  K+  +R T E L A+
Sbjct: 237 CPESLHDLMCQCWRKEPEERPTFEYLQAF 265

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 65/269 (24%), Positives = 115/269 (42%), Gaps = 29/269 (10%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVF 114
           LG G  G V+      +  + A+K L     T+       EA+++K+L  + +V+ +AV 
Sbjct: 23  LGQGCFGEVWMGTWNGTTRV-AIKTLK--PGTMSPEAFLQEAQVMKKLRHEKLVQLYAV- 78
Query: 115 YTIEGEICFVMEHMERGSLFDSLR--VRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDI 172
              E  I  V E+M +GSL D L+    K L    +  ++ ++  G+ Y+  M  +H D+
Sbjct: 79  -VSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMNYVHRDL 137
Query: 173 KPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERV 232
           + +N+L+      K+ADFG++R++E+                 A         + +PE  
Sbjct: 138 RAANILVGENLVCKVADFGLARLIEDNEWT-------------ARQGAKFPIKWTAPEAA 184
Query: 233 DSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICAICFGERLEMPET 291
                 G +    DVWS G+++ E    G  P  G   +     ++  +  G R+  P  
Sbjct: 185 LY----GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR----EVLDQVERGYRMPCPPE 236
Query: 292 ASPEFRRFVRSCLEKDWRKRGTVEELLAY 320
                   +  C  K+  +R T E L A+
Sbjct: 237 CPESLHDLMCQCWRKEPEERPTFEYLQAF 265

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 71/291 (24%), Positives = 126/291 (43%), Gaps = 37/291 (12%)
Query: 37  NPTSPDVENI----SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQA 92
           +P+SP+ +      +D+     LG G  G VY+   +K +   A+K L     T+   + 
Sbjct: 4   DPSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK--EDTMEVEEF 61
Query: 93  AHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRV--RKKLSEDVISG 150
             EA ++K +    +V+   V  T E     ++E M  G+L D LR   R++++  V+  
Sbjct: 62  LKEAAVMKEIKHPNLVQLLGVC-TREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLY 120
Query: 151 VAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXX 210
           +A ++   ++YL     IH D+   N L+     VK+ADFG+SR++              
Sbjct: 121 MATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-------------- 166
Query: 211 XXIGEAAIACMGT---CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLE-CLVGHYPLIG 266
              G+   A  G      + +PE +   +    +    DVW+ GV++ E    G  P  G
Sbjct: 167 --TGDTYTAHAGAKFPIKWTAPESLAYNK----FSIKSDVWAFGVLLWEIATYGMSPYPG 220
Query: 267 FGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEEL 317
                DL  +   +    R+E PE    +    +R+C + +   R +  E+
Sbjct: 221 I----DLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 70/283 (24%), Positives = 115/283 (40%), Gaps = 38/283 (13%)
Query: 47  SDLKKLTVLGHGNGGIVYK----VRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRL 102
           ++ KK+ VLG G  G VYK       +K     A+K L   +S     +   EA ++  +
Sbjct: 25  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 84
Query: 103 DSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQY 161
           D+  +  C  +   +   +  + + M  G L D +R  K  +    +     ++ KG+ Y
Sbjct: 85  DNPHV--CRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 142
Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIV--EETRXXXXXXXXXXXXIGEAAIA 219
           L   +++H D+   N+L+     VKI DFG+++++  EE               G+  I 
Sbjct: 143 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG--------GKVPIK 194
Query: 220 CMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP----DLMA 275
            M   + +   R+        Y    DVWS GV V E       L+ FG KP        
Sbjct: 195 WMALESIL--HRI--------YTHQSDVWSYGVTVWE-------LMTFGSKPYDGIPASE 237
Query: 276 LICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELL 318
           +   +  GERL  P   + +    +R C   D   R    EL+
Sbjct: 238 ISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELI 280

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 76/291 (26%), Positives = 123/291 (42%), Gaps = 35/291 (12%)
Query: 55  LGHGNGGIVYK--VRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHA 112
           LG GN G V +   R +K     A+KVL   +      +   EA+I+ +LD+ +IV+   
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 113 VFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVA---YRVLKGLQYLHGMQIIH 169
           V    + E   ++  M  G       V K+  E  +S VA   ++V  G++YL     +H
Sbjct: 404 V---CQAEALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKNFVH 459
Query: 170 GDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSP 229
            ++   N+L+  +   KI+DFG+S+ +                   A  A      + +P
Sbjct: 460 RNLAARNVLLVNRHYAKISDFGLSKALGADDSYYT-----------ARSAGKWPLKWYAP 508
Query: 230 ERVDSERWGGDYGFAGDVWSLGVVVLECL-VGHYPLIGFGEKPDLMALICAICFGERLEM 288
           E ++  +    +    DVWS GV + E L  G  P     + P++MA I     G+R+E 
Sbjct: 509 ECINFRK----FSSRSDVWSYGVTMWEALSYGQKPYKKM-KGPEVMAFIEQ---GKRMEC 560
Query: 289 PETASPEFRRFVRSCLEKDWRKRG---TVEELL---AYPFVTKRSSSSNIE 333
           P    PE    +  C    W  R    TVE+ +    Y   +K    S +E
Sbjct: 561 PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGGSALE 611

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 103/216 (47%), Gaps = 26/216 (12%)
Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH-EAEILKRLDSQFIV 108
           + L+ +G G  G V      K+    A+K L+    +II  +  + E  +LK +  + ++
Sbjct: 25  QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI 84
Query: 109 KCHAVFYTI----EGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG 164
               VF       E    +++ H+  G+  +++   +KL++D +  + Y++L+GL+Y+H 
Sbjct: 85  GLLDVFTPARSLEEFNDVYLVTHL-MGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTC 224
             IIH D+KPSNL +N   E+KI  FG++R  +                 +     + T 
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILGFGLARHTD-----------------DEMTGYVATR 186
Query: 225 AYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVG 260
            Y +PE +    W   Y    D+WS+G ++ E L G
Sbjct: 187 WYRAPEIM--LNWMH-YNQTVDIWSVGCIMAELLTG 219

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 103/216 (47%), Gaps = 26/216 (12%)
Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH-EAEILKRLDSQFIV 108
           + L+ +G G  G V      K+    A+K L+    +II  +  + E  +LK +  + ++
Sbjct: 25  QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI 84
Query: 109 KCHAVFYTI----EGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG 164
               VF       E    +++ H+  G+  +++   +KL++D +  + Y++L+GL+Y+H 
Sbjct: 85  GLLDVFTPARSLEEFNDVYLVTHL-MGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTC 224
             IIH D+KPSNL +N   E+KI D G++R  +                 +     + T 
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDAGLARHTD-----------------DEMTGYVATR 186
Query: 225 AYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVG 260
            Y +PE +    W   Y    D+WS+G ++ E L G
Sbjct: 187 WYRAPEIM--LNWMH-YNQTVDIWSVGCIMAELLTG 219

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 67/267 (25%), Positives = 115/267 (43%), Gaps = 31/267 (11%)
Query: 47  SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQF 106
           S+L  +  +G G  G+V+ + +  +    A+K +   + +        EAE++ +L    
Sbjct: 7   SELTFVQEIGSGQFGLVH-LGYWLNKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPK 63
Query: 107 IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKL-SEDVISGVAYRVLKGLQYLHGM 165
           +V+ + V    +  IC V E ME G L D LR ++ L + + + G+   V +G+ YL   
Sbjct: 64  LVQLYGVCLE-QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 122
Query: 166 QIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCA 225
            +IH D+   N L+     +K++DFG++R V + +               ++        
Sbjct: 123 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-------------SSTGTKFPVK 169
Query: 226 YMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICAICFGE 284
           + SPE     R    Y    DVWS GV++ E    G  P     E      ++  I  G 
Sbjct: 170 WASPEVFSFSR----YSSKSDVWSFGVLMWEVFSEGKIPY----ENRSNSEVVEDISTGF 221
Query: 285 RLEMPETASPEFRRFVRSCLEKDWRKR 311
           RL  P  AS    + +  C    W++R
Sbjct: 222 RLYKPRLASTHVYQIMNHC----WKER 244

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 70/283 (24%), Positives = 115/283 (40%), Gaps = 38/283 (13%)
Query: 47  SDLKKLTVLGHGNGGIVYK----VRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRL 102
           ++ KK+ VLG G  G VYK       +K     A+K L   +S     +   EA ++  +
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 103 DSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQY 161
           D+  +  C  +   +   +  + + M  G L D +R  K  +    +     ++ KG+ Y
Sbjct: 78  DNPHV--CRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 135
Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIV--EETRXXXXXXXXXXXXIGEAAIA 219
           L   +++H D+   N+L+     VKI DFG+++++  EE               G+  I 
Sbjct: 136 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG--------GKVPIK 187
Query: 220 CMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP----DLMA 275
            M   + +   R+        Y    DVWS GV V E       L+ FG KP        
Sbjct: 188 WMALESIL--HRI--------YTHQSDVWSYGVTVWE-------LMTFGSKPYDGIPASE 230
Query: 276 LICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELL 318
           +   +  GERL  P   + +    +R C   D   R    EL+
Sbjct: 231 ISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELI 273

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 73/286 (25%), Positives = 124/286 (43%), Gaps = 37/286 (12%)
Query: 45  NISDLKKLTVLGHGNGGIVYKVRHQ---KSNSIYALKVLNTTSSTIIRHQAAHEAEILKR 101
           + S +K   V+G G  G V   R +   K +   A+K L    +   R     EA I+ +
Sbjct: 41  DASCIKIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQ 100
Query: 102 LDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQ 160
            D   +V    V  T    +  V+E ME G+L   LR    + +   + G+   +  G++
Sbjct: 101 FDHPNVVHLEGVV-TRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQLVGMLRGIAAGMR 159
Query: 161 YLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIAC 220
           YL  M  +H D+   N+L+N     K++DFG+SR++E+                EA    
Sbjct: 160 YLADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDD--------------PEAVYTT 205
Query: 221 MG---TCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP--DL-- 273
            G      + +PE +   +    +  A DVWS G+V+ E       ++ +GE+P  D+  
Sbjct: 206 TGGKIPVRWTAPEAIQYRK----FTSASDVWSYGIVMWE-------VMSYGERPYWDMSN 254
Query: 274 MALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA 319
             +I AI  G RL  P        + +  C +K+  +R   E+++ 
Sbjct: 255 QDVIKAIEEGYRLPAPMDCPAGLHQLMLDCWQKERAERPKFEQIVG 300

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 63/279 (22%), Positives = 122/279 (43%), Gaps = 39/279 (13%)
Query: 45  NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDS 104
           N+ +LK L  +G G  G V  +   + N + A+K +   ++         EA ++ +L  
Sbjct: 191 NMKELKLLQTIGKGEFGDVM-LGDYRGNKV-AVKCIKNDATA---QAFLAEASVMTQLRH 245
Query: 105 QFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKK--LSEDVISGVAYRVLKGLQYL 162
             +V+   V    +G +  V E+M +GSL D LR R +  L  D +   +  V + ++YL
Sbjct: 246 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 305
Query: 163 HGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMG 222
            G   +H D+   N+L++     K++DFG+++    T+             G+  +    
Sbjct: 306 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----------DTGKLPV---- 350
Query: 223 TCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP----DLMALIC 278
              + +PE +  ++    +    DVWS G+++ E       +  FG  P     L  ++ 
Sbjct: 351 --KWTAPEALREKK----FSTKSDVWSFGILLWE-------IYSFGRVPYPRIPLKDVVP 397
Query: 279 AICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEEL 317
            +  G +++ P+   P     +++C   D   R T  +L
Sbjct: 398 RVEKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQL 436

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 106/239 (44%), Gaps = 33/239 (13%)
Query: 39  TSPDVENISDLKKL-TVLGHGNGGIVYKVRHQKSNSIYALKVLNTT----SSTIIRHQAA 93
           T+P   ++SD  +L  +LG G    V+  R  + +   A+KVL        S  +R +  
Sbjct: 5   TTP--SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFR-- 60
Query: 94  HEAEILKRLDSQFIVKCHAVFYTIEGEIC------FVMEHMERGSLFDSLRVRKKLSEDV 147
            EA+    L+   IV   AV+ T E E         VME+++  +L D +     ++   
Sbjct: 61  REAQNAAALNHPAIV---AVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKR 117
Query: 148 ISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXX 207
              V     + L + H   IIH D+KP+N++I+    VK+ DFG++R + ++        
Sbjct: 118 AIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTA 177
Query: 208 XXXXXIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIG 266
                      A +GT  Y+SPE+      G       DV+SLG V+ E L G  P  G
Sbjct: 178 -----------AVIGTAQYLSPEQA----RGDSVDARSDVYSLGCVLYEVLTGEPPFTG 221

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 69/270 (25%), Positives = 116/270 (42%), Gaps = 37/270 (13%)
Query: 47  SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQF 106
           S+L  +  +G G  G+V+ + +  +    A+K +   + +        EAE++ +L    
Sbjct: 5   SELTFVQEIGSGQFGLVH-LGYWLNKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPK 61
Query: 107 IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKL-SEDVISGVAYRVLKGLQYLHGM 165
           +V+ + V    +  IC V E ME G L D LR ++ L + + + G+   V +G+ YL   
Sbjct: 62  LVQLYGVCLE-QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 120
Query: 166 QIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGT-- 223
            +IH D+   N L+     +K++DFG++R V                + +   +  GT  
Sbjct: 121 CVIHRDLAARNCLVGENQVIKVSDFGMTRFV----------------LDDQYTSSTGTKF 164
Query: 224 -CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICAIC 281
              + SPE     R    Y    DVWS GV++ E    G  P     E      ++  I 
Sbjct: 165 PVKWASPEVFSFSR----YSSKSDVWSFGVLMWEVFSEGKIPY----ENRSNSEVVEDIS 216
Query: 282 FGERLEMPETASPEFRRFVRSCLEKDWRKR 311
            G RL  P  AS    + +  C    W++R
Sbjct: 217 TGFRLYKPRLASTHVYQIMNHC----WKER 242

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 71/291 (24%), Positives = 125/291 (42%), Gaps = 37/291 (12%)
Query: 37  NPTSPDVENI----SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQA 92
           +P+SP+ +      +D+     LG G  G VY+   +K +   A+K L     T+   + 
Sbjct: 4   DPSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK--EDTMEVEEF 61
Query: 93  AHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRV--RKKLSEDVISG 150
             EA ++K +    +V+   V  T E     + E M  G+L D LR   R++++  V+  
Sbjct: 62  LKEAAVMKEIKHPNLVQLLGVC-TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLY 120
Query: 151 VAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXX 210
           +A ++   ++YL     IH D+   N L+     VK+ADFG+SR++              
Sbjct: 121 MATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-------------- 166
Query: 211 XXIGEAAIACMGT---CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLE-CLVGHYPLIG 266
              G+   A  G      + +PE +   +    +    DVW+ GV++ E    G  P  G
Sbjct: 167 --TGDTXTAHAGAKFPIKWTAPESLAYNK----FSIKSDVWAFGVLLWEIATYGMSPYPG 220
Query: 267 FGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEEL 317
                DL  +   +    R+E PE    +    +R+C + +   R +  E+
Sbjct: 221 I----DLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 72/278 (25%), Positives = 126/278 (45%), Gaps = 33/278 (11%)
Query: 44  ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLD 103
           E+I  +KKL   G G  G V+   +  S  + A+K L   + ++       EA ++K L 
Sbjct: 12  ESIKLVKKL---GAGQFGEVWMGYYNNSTKV-AVKTLKPGTMSV--QAFLEEANLMKTLQ 65
Query: 104 SQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVR---KKLSEDVISGVAYRVLKGLQ 160
              +V+ +AV  T E  I  + E M +GSL D L+     K L   +I   A ++ +G+ 
Sbjct: 66  HDKLVRLYAVV-TKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSA-QIAEGMA 123
Query: 161 YLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIAC 220
           Y+     IH D++ +N+L++     KIADFG++R++E+                 A    
Sbjct: 124 YIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT-------------AREGA 170
Query: 221 MGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICA 279
                + +PE ++     G +    +VWS G+++ E +  G  P  G     D+M+   A
Sbjct: 171 KFPIKWTAPEAINF----GCFTIKSNVWSFGILLYEIVTYGKIPYPG-RTNADVMS---A 222
Query: 280 ICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEEL 317
           +  G R+   E    E    ++ C ++   +R T + L
Sbjct: 223 LSQGYRMPRMENCPDELYDIMKMCWKEKAEERPTFDYL 260

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 77/305 (25%), Positives = 130/305 (42%), Gaps = 44/305 (14%)
Query: 45  NISDLKKLTVLGHGNGGIVYKVRHQ---KSNSIYALKVLNTTSSTIIRHQAAHEAEILKR 101
           + S +K   V+G G  G V   R +   K     A+K L    +   R     EA I+ +
Sbjct: 27  DASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQ 86
Query: 102 LDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQ 160
            D   I+    V    +  +  + E+ME GSL   LR    + +   + G+   +  G++
Sbjct: 87  FDHPNIIHLEGVVTKCK-PVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMK 145
Query: 161 YLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIAC 220
           YL  M  +H D+   N+L+N     K++DFG+SR++E+                EAA   
Sbjct: 146 YLSDMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDD--------------PEAAYTT 191
Query: 221 MG---TCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP--DL-- 273
            G      + +PE +   +    +  A DVWS G+V+ E       ++ +GE+P  D+  
Sbjct: 192 RGGKIPIRWTAPEAIAYRK----FTSASDVWSYGIVMWE-------VMSYGERPYWDMSN 240
Query: 274 MALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKR-------GTVEELLAYPFVTKR 326
             +I AI  G RL  P        + +  C +K+   R         +++L+  P   KR
Sbjct: 241 QDVIKAIEEGYRLPPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNMLDKLIRNPNSLKR 300
Query: 327 SSSSN 331
           + S +
Sbjct: 301 TGSES 305

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 75/306 (24%), Positives = 133/306 (43%), Gaps = 38/306 (12%)
Query: 37  NPTSPDVENI----SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQA 92
           +P+SP+ +      +D+     LG G  G VY+   +K +   A+K L     T+   + 
Sbjct: 4   DPSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK--EDTMEVEEF 61
Query: 93  AHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRV--RKKLSEDVISG 150
             EA ++K +    +V+   V  T E     + E M  G+L D LR   R++++  V+  
Sbjct: 62  LKEAAVMKEIKHPNLVQLLGVC-TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLY 120
Query: 151 VAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXX 210
           +A ++   ++YL     IH D+   N L+     VK+ADFG+SR++              
Sbjct: 121 MATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-------------- 166
Query: 211 XXIGEAAIACMGT---CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLE-CLVGHYPLIG 266
              G+   A  G      + +PE +   +    +    DVW+ GV++ E    G  P  G
Sbjct: 167 --TGDTYTAHAGAKFPIKWTAPESLAYNK----FSIKSDVWAFGVLLWEIATYGMSPYPG 220
Query: 267 FGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEEL-LAYPFVTK 325
                DL  +   +    R+E PE    +    +R+C + +   R +  E+  A+  + +
Sbjct: 221 I----DLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 276
Query: 326 RSSSSN 331
            SS S+
Sbjct: 277 ESSISD 282

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 103/216 (47%), Gaps = 26/216 (12%)
Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH-EAEILKRLDSQFIV 108
           + L+ +G G  G V      K+    A+K L+    +II  +  + E  +LK +  + ++
Sbjct: 25  QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI 84
Query: 109 KCHAVFYTI----EGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG 164
               VF       E    +++ H+  G+  +++   +KL++D +  + Y++L+GL+Y+H 
Sbjct: 85  GLLDVFTPARSLEEFNDVYLVTHL-MGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTC 224
             IIH D+KPSNL +N   E+KI D G++R  +                 +     + T 
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDRGLARHTD-----------------DEMTGYVATR 186
Query: 225 AYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVG 260
            Y +PE +    W   Y    D+WS+G ++ E L G
Sbjct: 187 WYRAPEIM--LNWMH-YNQTVDIWSVGCIMAELLTG 219

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 71/291 (24%), Positives = 125/291 (42%), Gaps = 37/291 (12%)
Query: 37  NPTSPDVENI----SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQA 92
           +P+SP+ +      +D+     LG G  G VY+   +K +   A+K L     T+   + 
Sbjct: 4   DPSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK--EDTMEVEEF 61
Query: 93  AHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRV--RKKLSEDVISG 150
             EA ++K +    +V+   V  T E     + E M  G+L D LR   R++++  V+  
Sbjct: 62  LKEAAVMKEIKHPNLVQLLGVC-TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLY 120
Query: 151 VAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXX 210
           +A ++   ++YL     IH D+   N L+     VK+ADFG+SR++              
Sbjct: 121 MATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-------------- 166
Query: 211 XXIGEAAIACMGT---CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLE-CLVGHYPLIG 266
              G+   A  G      + +PE +   +    +    DVW+ GV++ E    G  P  G
Sbjct: 167 --TGDTYTAHAGAKFPIKWTAPESLAYNK----FSIKSDVWAFGVLLWEIATYGMSPYPG 220
Query: 267 FGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEEL 317
                DL  +   +    R+E PE    +    +R+C + +   R +  E+
Sbjct: 221 I----DLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 70/283 (24%), Positives = 115/283 (40%), Gaps = 38/283 (13%)
Query: 47  SDLKKLTVLGHGNGGIVYK----VRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRL 102
           ++ KK+ VLG G  G VYK       +K     A+K L   +S     +   EA ++  +
Sbjct: 16  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 75
Query: 103 DSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQY 161
           D+  +  C  +   +   +  +M+ M  G L D +R  K  +    +     ++ KG+ Y
Sbjct: 76  DNPHV--CRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 133
Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIV--EETRXXXXXXXXXXXXIGEAAIA 219
           L   +++H D+   N+L+     VKI DFG+++++  EE               G+  I 
Sbjct: 134 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG--------GKVPIK 185
Query: 220 CMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP----DLMA 275
            M   + +   R+        Y    DVWS GV V E       L+ FG KP        
Sbjct: 186 WMALESIL--HRI--------YTHQSDVWSYGVTVWE-------LMTFGSKPYDGIPASE 228
Query: 276 LICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELL 318
           +   +  GERL  P   + +    +  C   D   R    EL+
Sbjct: 229 ISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 271

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 106/239 (44%), Gaps = 33/239 (13%)
Query: 39  TSPDVENISDLKKL-TVLGHGNGGIVYKVRHQKSNSIYALKVLNTT----SSTIIRHQAA 93
           T+P   ++SD  +L  +LG G    V+  R  + +   A+KVL        S  +R +  
Sbjct: 5   TTP--SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFR-- 60
Query: 94  HEAEILKRLDSQFIVKCHAVFYTIEGEIC------FVMEHMERGSLFDSLRVRKKLSEDV 147
            EA+    L+   IV   AV+ T E E         VME+++  +L D +     ++   
Sbjct: 61  REAQNAAALNHPAIV---AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKR 117
Query: 148 ISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXX 207
              V     + L + H   IIH D+KP+N++I+    VK+ DFG++R + ++        
Sbjct: 118 AIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTA 177
Query: 208 XXXXXIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIG 266
                      A +GT  Y+SPE+      G       DV+SLG V+ E L G  P  G
Sbjct: 178 -----------AVIGTAQYLSPEQA----RGDSVDARSDVYSLGCVLYEVLTGEPPFTG 221

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 70/283 (24%), Positives = 115/283 (40%), Gaps = 38/283 (13%)
Query: 47  SDLKKLTVLGHGNGGIVYK----VRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRL 102
           ++ KK+ VLG G  G VYK       +K     A+K L   +S     +   EA ++  +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 103 DSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQY 161
           D+  +  C  +   +   +  + + M  G L D +R  K  +    +     ++ KG+ Y
Sbjct: 75  DNPHV--CRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 132
Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIV--EETRXXXXXXXXXXXXIGEAAIA 219
           L   +++H D+   N+L+     VKI DFG+++++  EE               G+  I 
Sbjct: 133 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG--------GKVPIK 184
Query: 220 CMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP----DLMA 275
            M   + +   R+        Y    DVWS GV V E       L+ FG KP        
Sbjct: 185 WMALESIL--HRI--------YTHQSDVWSYGVTVWE-------LMTFGSKPYDGIPASE 227
Query: 276 LICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELL 318
           +   +  GERL  P   + +    +R C   D   R    EL+
Sbjct: 228 ISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELI 270

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 70/283 (24%), Positives = 115/283 (40%), Gaps = 38/283 (13%)
Query: 47  SDLKKLTVLGHGNGGIVYK----VRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRL 102
           ++ KK+ VLG G  G VYK       +K     A+K L   +S     +   EA ++  +
Sbjct: 16  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 75
Query: 103 DSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQY 161
           D+  +  C  +   +   +  +M+ M  G L D +R  K  +    +     ++ KG+ Y
Sbjct: 76  DNPHV--CRLLGICLTSTVQLIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 133
Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIV--EETRXXXXXXXXXXXXIGEAAIA 219
           L   +++H D+   N+L+     VKI DFG+++++  EE               G+  I 
Sbjct: 134 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG--------GKVPIK 185
Query: 220 CMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP----DLMA 275
            M   + +   R+        Y    DVWS GV V E       L+ FG KP        
Sbjct: 186 WMALESIL--HRI--------YTHQSDVWSYGVTVWE-------LMTFGSKPYDGIPASE 228
Query: 276 LICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELL 318
           +   +  GERL  P   + +    +  C   D   R    EL+
Sbjct: 229 ISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 271

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 70/283 (24%), Positives = 115/283 (40%), Gaps = 38/283 (13%)
Query: 47  SDLKKLTVLGHGNGGIVYK----VRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRL 102
           ++ KK+ VLG G  G VYK       +K     A+K L   +S     +   EA ++  +
Sbjct: 19  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 78
Query: 103 DSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQY 161
           D+  +  C  +   +   +  +M+ M  G L D +R  K  +    +     ++ KG+ Y
Sbjct: 79  DNPHV--CRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 136
Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIV--EETRXXXXXXXXXXXXIGEAAIA 219
           L   +++H D+   N+L+     VKI DFG+++++  EE               G+  I 
Sbjct: 137 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG--------GKVPIK 188
Query: 220 CMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP----DLMA 275
            M   + +   R+        Y    DVWS GV V E       L+ FG KP        
Sbjct: 189 WMALESIL--HRI--------YTHQSDVWSYGVTVWE-------LMTFGSKPYDGIPASE 231
Query: 276 LICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELL 318
           +   +  GERL  P   + +    +  C   D   R    EL+
Sbjct: 232 ISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 274

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 70/283 (24%), Positives = 115/283 (40%), Gaps = 38/283 (13%)
Query: 47  SDLKKLTVLGHGNGGIVYK----VRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRL 102
           ++ KK+ VLG G  G VYK       +K     A+K L   +S     +   EA ++  +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 103 DSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQY 161
           D+  +  C  +   +   +  +M+ M  G L D +R  K  +    +     ++ KG+ Y
Sbjct: 75  DNPHV--CRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 132
Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIV--EETRXXXXXXXXXXXXIGEAAIA 219
           L   +++H D+   N+L+     VKI DFG+++++  EE               G+  I 
Sbjct: 133 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG--------GKVPIK 184
Query: 220 CMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP----DLMA 275
            M   + +   R+        Y    DVWS GV V E       L+ FG KP        
Sbjct: 185 WMALESIL--HRI--------YTHQSDVWSYGVTVWE-------LMTFGSKPYDGIPASE 227
Query: 276 LICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELL 318
           +   +  GERL  P   + +    +  C   D   R    EL+
Sbjct: 228 ISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 270

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 70/283 (24%), Positives = 115/283 (40%), Gaps = 38/283 (13%)
Query: 47  SDLKKLTVLGHGNGGIVYK----VRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRL 102
           ++ KK+ VLG G  G VYK       +K     A+K L   +S     +   EA ++  +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 103 DSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQY 161
           D+  +  C  +   +   +  +M+ M  G L D +R  K  +    +     ++ KG+ Y
Sbjct: 77  DNPHV--CRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 134
Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIV--EETRXXXXXXXXXXXXIGEAAIA 219
           L   +++H D+   N+L+     VKI DFG+++++  EE               G+  I 
Sbjct: 135 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG--------GKVPIK 186
Query: 220 CMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP----DLMA 275
            M   + +   R+        Y    DVWS GV V E       L+ FG KP        
Sbjct: 187 WMALESIL--HRI--------YTHQSDVWSYGVTVWE-------LMTFGSKPYDGIPASE 229
Query: 276 LICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELL 318
           +   +  GERL  P   + +    +  C   D   R    EL+
Sbjct: 230 ISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 272

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 70/283 (24%), Positives = 115/283 (40%), Gaps = 38/283 (13%)
Query: 47  SDLKKLTVLGHGNGGIVYK----VRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRL 102
           ++ KK+ VLG G  G VYK       +K     A+K L   +S     +   EA ++  +
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 103 DSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQY 161
           D+  +  C  +   +   +  +M+ M  G L D +R  K  +    +     ++ KG+ Y
Sbjct: 78  DNPHV--CRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 135
Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIV--EETRXXXXXXXXXXXXIGEAAIA 219
           L   +++H D+   N+L+     VKI DFG+++++  EE               G+  I 
Sbjct: 136 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG--------GKVPIK 187
Query: 220 CMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP----DLMA 275
            M   + +   R+        Y    DVWS GV V E       L+ FG KP        
Sbjct: 188 WMALESIL--HRI--------YTHQSDVWSYGVTVWE-------LMTFGSKPYDGIPASE 230
Query: 276 LICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELL 318
           +   +  GERL  P   + +    +  C   D   R    EL+
Sbjct: 231 ISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 273

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 69/275 (25%), Positives = 116/275 (42%), Gaps = 29/275 (10%)
Query: 45  NISDLKKLTVLGHGNGGIVYKVRHQ---KSNSIYALKVLNTTSSTIIRHQAAHEAEILKR 101
           +IS +K   V+G G  G V     +   K     A+K L +  +   R     EA I+ +
Sbjct: 31  DISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQ 90
Query: 102 LDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQ 160
            D   ++    V  T    +  + E ME GSL   LR    + +   + G+   +  G++
Sbjct: 91  FDHPNVIHLEGVV-TKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMK 149
Query: 161 YLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIAC 220
           YL  M  +H D+   N+L+N     K++DFG+SR +E+                 +A+  
Sbjct: 150 YLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYT---------SALGG 200
Query: 221 MGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP--DL--MAL 276
                + +PE +   +    +  A DVWS G+V+ E       ++ +GE+P  D+    +
Sbjct: 201 KIPIRWTAPEAIQYRK----FTSASDVWSYGIVMWE-------VMSYGERPYWDMTNQDV 249
Query: 277 ICAICFGERLEMPETASPEFRRFVRSCLEKDWRKR 311
           I AI    RL  P        + +  C +KD   R
Sbjct: 250 INAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHR 284

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 103/216 (47%), Gaps = 26/216 (12%)
Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH-EAEILKRLDSQFIV 108
           + L+ +G G  G V      K+    A+K L+    +II  +  + E  +LK +  + ++
Sbjct: 25  QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI 84
Query: 109 KCHAVFYTI----EGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG 164
               VF       E    +++ H+  G+  +++   +KL++D +  + Y++L+GL+Y+H 
Sbjct: 85  GLLDVFTPARSLEEFNDVYLVTHL-MGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTC 224
             IIH D+KPSNL +N   E+KI D G++R  +                 +     + T 
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDGGLARHTD-----------------DEMTGYVATR 186
Query: 225 AYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVG 260
            Y +PE +    W   Y    D+WS+G ++ E L G
Sbjct: 187 WYRAPEIM--LNWMH-YNQTVDIWSVGCIMAELLTG 219

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 77/305 (25%), Positives = 130/305 (42%), Gaps = 44/305 (14%)
Query: 45  NISDLKKLTVLGHGNGGIVYKVRHQ---KSNSIYALKVLNTTSSTIIRHQAAHEAEILKR 101
           + S +K   V+G G  G V   R +   K     A+K L    +   R     EA I+ +
Sbjct: 6   DASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQ 65
Query: 102 LDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQ 160
            D   I+    V    +  +  + E+ME GSL   LR    + +   + G+   +  G++
Sbjct: 66  FDHPNIIHLEGVVTKCK-PVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMK 124
Query: 161 YLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIAC 220
           YL  M  +H D+   N+L+N     K++DFG+SR++E+                EAA   
Sbjct: 125 YLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDD--------------PEAAYTT 170
Query: 221 MG---TCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP--DL-- 273
            G      + +PE +   +    +  A DVWS G+V+ E       ++ +GE+P  D+  
Sbjct: 171 RGGKIPIRWTAPEAIAYRK----FTSASDVWSYGIVMWE-------VMSYGERPYWDMSN 219
Query: 274 MALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKR-------GTVEELLAYPFVTKR 326
             +I AI  G RL  P        + +  C +K+   R         +++L+  P   KR
Sbjct: 220 QDVIKAIEEGYRLPPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNMLDKLIRNPNSLKR 279
Query: 327 SSSSN 331
           + S +
Sbjct: 280 TGSES 284

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 74/284 (26%), Positives = 127/284 (44%), Gaps = 42/284 (14%)
Query: 44  ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLD 103
           E I+ LK+L   G G  G+V K+   K     A+K++   S +    +   EA+ + +L 
Sbjct: 8   EEITLLKEL---GSGQFGVV-KLGKWKGQYDVAVKMIKEGSMS--EDEFFQEAQTMMKLS 61
Query: 104 SQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKK-LSEDVISGVAYRVLKGLQYL 162
              +VK + V  + E  I  V E++  G L + LR   K L    +  + Y V +G+ +L
Sbjct: 62  HPKLVKFYGVC-SKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFL 120
Query: 163 HGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMG 222
              Q IH D+   N L++    VK++DFG++R V                + +  ++ +G
Sbjct: 121 ESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYV----------------LDDQYVSSVG 164
Query: 223 T---CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP-DLMA--- 275
           T     + +PE     +    Y    DVW+ G+++ E       +   G+ P DL     
Sbjct: 165 TKFPVKWSAPEVFHYFK----YSSKSDVWAFGILMWE-------VFSLGKMPYDLYTNSE 213
Query: 276 LICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA 319
           ++  +  G RL  P  AS    + + SC  +   KR T ++LL+
Sbjct: 214 VVLKVSQGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLS 257

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 77/305 (25%), Positives = 130/305 (42%), Gaps = 44/305 (14%)
Query: 45  NISDLKKLTVLGHGNGGIVYKVRHQ---KSNSIYALKVLNTTSSTIIRHQAAHEAEILKR 101
           + S +K   V+G G  G V   R +   K     A+K L    +   R     EA I+ +
Sbjct: 12  DASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQ 71
Query: 102 LDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQ 160
            D   I+    V    +  +  + E+ME GSL   LR    + +   + G+   +  G++
Sbjct: 72  FDHPNIIHLEGVVTKCK-PVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMK 130
Query: 161 YLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIAC 220
           YL  M  +H D+   N+L+N     K++DFG+SR++E+                EAA   
Sbjct: 131 YLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDD--------------PEAAYTT 176
Query: 221 MG---TCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP--DL-- 273
            G      + +PE +   +    +  A DVWS G+V+ E       ++ +GE+P  D+  
Sbjct: 177 RGGKIPIRWTAPEAIAYRK----FTSASDVWSYGIVMWE-------VMSYGERPYWDMSN 225
Query: 274 MALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKR-------GTVEELLAYPFVTKR 326
             +I AI  G RL  P        + +  C +K+   R         +++L+  P   KR
Sbjct: 226 QDVIKAIEEGYRLPPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNMLDKLIRNPNSLKR 285
Query: 327 SSSSN 331
           + S +
Sbjct: 286 TGSES 290

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 112/242 (46%), Gaps = 45/242 (18%)
Query: 34  PTSNPTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQA- 92
           P   P  P   + +D K   V+G+G+ G+VY+ +   S  + A+K        +++ +A 
Sbjct: 10  PGQGPDRPQEVSYTDTK---VIGNGSFGVVYQAKLCDSGELVAIK-------KVLQGKAF 59
Query: 93  -AHEAEILKRLDSQFIVKCHAVFYTIEGE----------ICFVMEHMERGSLFDSLRVRK 141
              E +I+++LD   IV+    FY+  GE          + +V   + R +   S R ++
Sbjct: 60  KNRELQIMRKLDHCNIVRLRYFFYS-SGEKKDEVYLNLVLDYVPATVYRVARHYS-RAKQ 117
Query: 142 KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEV-KIADFGVSRIVEETR 200
            L    +    Y++ + L Y+H   I H DIKP NLL++    V K+ DFG ++ +    
Sbjct: 118 TLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-- 175
Query: 201 XXXXXXXXXXXXIGEAAIACMGTCAYMSPERVDSERWGG-DYGFAGDVWSLGVVVLECLV 259
                        GE  ++ + +  Y +PE +    +G  DY  + DVWS G V+ E L+
Sbjct: 176 -------------GEPNVSXICSRYYRAPELI----FGATDYTSSIDVWSAGCVLAELLL 218
Query: 260 GH 261
           G 
Sbjct: 219 GQ 220

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/278 (23%), Positives = 117/278 (42%), Gaps = 38/278 (13%)
Query: 54  VLGHGNGGIVYK----VRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVK 109
           V+G G  G VYK        K     A+K L    +   R     EA I+ +     I++
Sbjct: 51  VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110
Query: 110 CHAVFYTIEGEICFVMEHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQYLHGMQII 168
              V    +  +  + E+ME G+L   LR +  + S   + G+   +  G++YL  M  +
Sbjct: 111 LEGVISKYK-PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYV 169
Query: 169 HGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMG---TCA 225
           H D+   N+L+N     K++DFG+SR++E+                EA     G      
Sbjct: 170 HRDLAARNILVNSNLVCKVSDFGLSRVLEDD--------------PEATYTTSGGKIPIR 215
Query: 226 YMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP----DLMALICAIC 281
           + +PE +   +    +  A DVWS G+V+ E +        +GE+P        ++ AI 
Sbjct: 216 WTAPEAISYRK----FTSASDVWSFGIVMWEVMT-------YGERPYWELSNHEVMKAIN 264
Query: 282 FGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA 319
            G RL  P        + +  C +++  +R    ++++
Sbjct: 265 DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS 302

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/259 (25%), Positives = 108/259 (41%), Gaps = 21/259 (8%)
Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVK 109
           +KL  +G G  G+VYK +  +   +   ++        I   A  E  +LK L    IV 
Sbjct: 24  QKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVS 83
Query: 110 CHAVFYTIEGEICFVMEHMERGSLFDSLRVRKK-LSEDVISGVAYRVLKGLQYLHGMQII 168
              V ++ E  +  V E ME+  L   L   K  L +  I    Y++L+G+ + H  +I+
Sbjct: 84  LIDVIHS-ERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRIL 141
Query: 169 HGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMS 228
           H D+KP NLLIN  G +K+ADFG++R                    E       T  Y +
Sbjct: 142 HRDLKPQNLLINSDGALKLADFGLAR---------AFGIPVRSYTHEVV-----TLWYRA 187
Query: 229 PERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEM 288
           P+ +   +    Y  + D+WS+G +  E + G     G  +   L  +   +      E 
Sbjct: 188 PDVLMGSK---KYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREW 244
Query: 289 PETAS-PEFRRFVRSCLEK 306
           P+    P +++      EK
Sbjct: 245 PQVQELPLWKQRTFQVFEK 263

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/242 (28%), Positives = 108/242 (44%), Gaps = 33/242 (13%)
Query: 36  SNPTSPDVENISDLKKL-TVLGHGNGGIVYKVRHQKSNSIYALKVLNTT----SSTIIRH 90
           S+ T+P   ++SD  +L  +LG G    V+  R  + +   A+KVL        S  +R 
Sbjct: 19  SHMTTP--SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRF 76
Query: 91  QAAHEAEILKRLDSQFIVKCHAVFYTIEGEIC------FVMEHMERGSLFDSLRVRKKLS 144
           +   EA+    L+   IV   AV+ T E E         VME+++  +L D +     ++
Sbjct: 77  R--REAQNAAALNHPAIV---AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMT 131
Query: 145 EDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXX 204
                 V     + L + H   IIH D+KP+N++I+    VK+ DFG++R + ++     
Sbjct: 132 PKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVT 191
Query: 205 XXXXXXXXIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPL 264
                         A +GT  Y+SPE+      G       DV+SLG V+ E L G  P 
Sbjct: 192 QTA-----------AVIGTAQYLSPEQA----RGDSVDARSDVYSLGCVLYEVLTGEPPF 236
Query: 265 IG 266
            G
Sbjct: 237 TG 238

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/259 (25%), Positives = 109/259 (42%), Gaps = 21/259 (8%)
Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVK 109
           +KL  +G G  G+VYK +  +   +   ++        I   A  E  +LK L    IV 
Sbjct: 24  QKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVS 83
Query: 110 CHAVFYTIEGEICFVMEHMERGSLFDSLRVRKK-LSEDVISGVAYRVLKGLQYLHGMQII 168
              V ++ E  +  V E ME+  L   L   K  L +  I    Y++L+G+ + H  +I+
Sbjct: 84  LIDVIHS-ERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRIL 141
Query: 169 HGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMS 228
           H D+KP NLLIN  G +K+ADFG++R                     +    + T  Y +
Sbjct: 142 HRDLKPQNLLINSDGALKLADFGLAR--------------AFGIPVRSYTHEVVTLWYRA 187
Query: 229 PERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEM 288
           P+ +   +    Y  + D+WS+G +  E + G     G  +   L  +   +      E 
Sbjct: 188 PDVLMGSK---KYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREW 244
Query: 289 PETAS-PEFRRFVRSCLEK 306
           P+    P +++      EK
Sbjct: 245 PQVQELPLWKQRTFQVFEK 263

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 78/304 (25%), Positives = 126/304 (41%), Gaps = 59/304 (19%)
Query: 53  TVLGHGNGGIVYKVRHQKSNSIYALKVLNTT-SSTIIRHQAAHEAEILKRLDSQFIVKCH 111
           T +G G  G V     ++S    A+K L+    S I   +A  E  +LK +  + ++   
Sbjct: 48  THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLL 107
Query: 112 AVFYTIEG-----EICFVMEHMERGSLFDSLRVR-KKLSEDVISGVAYRVLKGLQYLHGM 165
            VF          +   VM  M+     D  ++   + SE+ I  + Y++LKGL+Y+H  
Sbjct: 108 DVFTPASSLRNFYDFYLVMPFMQT----DLQKIMGMEFSEEKIQYLVYQMLKGLKYIHSA 163
Query: 166 QIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCA 225
            ++H D+KP NL +N   E+KI DFG++R  +                       + T  
Sbjct: 164 GVVHRDLKPGNLAVNEDCELKILDFGLARHAD-----------------AEMTGYVVTRW 206
Query: 226 YMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAIC---- 281
           Y +PE + S  W   Y    D+WS+G ++ E L G     G  +  D +  I  +     
Sbjct: 207 YRAPEVILS--W-MHYNQTVDIWSVGCIMAEMLTGKTLFKG-KDYLDQLTQILKVTGVPG 262
Query: 282 --FGERLE----------MPET-----------ASPEFRRFVRSCLEKDWRKRGTVEELL 318
             F ++L           +P+T           ASP+    +   LE D  KR T  + L
Sbjct: 263 TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQAL 322
Query: 319 AYPF 322
            +PF
Sbjct: 323 THPF 326

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 70/283 (24%), Positives = 114/283 (40%), Gaps = 38/283 (13%)
Query: 47  SDLKKLTVLGHGNGGIVYK----VRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRL 102
           ++ KK+ VLG G  G VYK       +K     A+K L   +S     +   EA ++  +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 103 DSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQY 161
           D+  +  C  +   +   +  + + M  G L D +R  K  +    +     ++ KG+ Y
Sbjct: 77  DNPHV--CRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 134
Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIV--EETRXXXXXXXXXXXXIGEAAIA 219
           L   +++H D+   N+L+     VKI DFG ++++  EE               G+  I 
Sbjct: 135 LEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEG--------GKVPIK 186
Query: 220 CMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP----DLMA 275
            M   + +   R+        Y    DVWS GV V E       L+ FG KP        
Sbjct: 187 WMALESIL--HRI--------YTHQSDVWSYGVTVWE-------LMTFGSKPYDGIPASE 229
Query: 276 LICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELL 318
           +   +  GERL  P   + +    +R C   D   R    EL+
Sbjct: 230 ISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELI 272

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 124/288 (43%), Gaps = 41/288 (14%)
Query: 54  VLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDS-QFIVKCHA 112
           VLG G  G V ++ ++++   +ALK L          +A  E E+  R      IV+   
Sbjct: 69  VLGLGINGKVLQIFNKRTQEKFALKXLQDCP------KARREVELHWRASQCPHIVRIVD 122
Query: 113 VFYTI-EGEICF--VMEHMERGSLFDSLRVR--KKLSEDVISGVAYRVLKGLQYLHGMQI 167
           V+  +  G  C   V E ++ G LF  ++ R  +  +E   S +   + + +QYLH + I
Sbjct: 123 VYENLYAGRKCLLIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGEAIQYLHSINI 182
Query: 168 IHGDIKPSNLLINGKGE---VKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTC 224
            H D+KP NLL   K     +K+ DFG ++   ET                    C  T 
Sbjct: 183 AHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSH-----------NSLTTPCY-TP 227
Query: 225 AYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLI---GFGEKPDLMALICAIC 281
            Y++PE +  E+    Y  + D WSLGV+    L G+ P     G    P     I    
Sbjct: 228 YYVAPEVLGPEK----YDKSCDXWSLGVIXYILLCGYPPFYSNHGLAISPGXKTRIRXGQ 283
Query: 282 FGERLEMPETA--SPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRS 327
           +      PE +  S E +  +R+ L+ +  +R T+ E   +P++ + +
Sbjct: 284 Y--EFPNPEWSEVSEEVKXLIRNLLKTEPTQRXTITEFXNHPWIXQST 329

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/277 (24%), Positives = 119/277 (42%), Gaps = 33/277 (11%)
Query: 48  DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFI 107
           DL  L  LG G  G+V   ++ K    Y + +      ++   +   EA+++  L  + +
Sbjct: 25  DLTFLKELGTGQFGVV---KYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKL 81
Query: 108 VKCHAVFYTIEGEICFVMEHMERGSLFDSLR-VRKKLSEDVISGVAYRVLKGLQYLHGMQ 166
           V+ + V  T +  I  + E+M  G L + LR +R +     +  +   V + ++YL   Q
Sbjct: 82  VQLYGVC-TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 140
Query: 167 IIHGDIKPSNLLINGKGEVKIADFGVSRIV---EETRXXXXXXXXXXXXIGEAAIACMGT 223
            +H D+   N L+N +G VK++DFG+SR V   EET                +++     
Sbjct: 141 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEET----------------SSVGSKFP 184
Query: 224 CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECL-VGHYPLIGFGEKPDLMALICAICF 282
             +  PE +   +    +    D+W+ GV++ E   +G  P   F            I  
Sbjct: 185 VRWSPPEVLMYSK----FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAE----HIAQ 236
Query: 283 GERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA 319
           G RL  P  AS +    + SC  +   +R T + LL+
Sbjct: 237 GLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLS 273

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 94/222 (42%), Gaps = 30/222 (13%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVF 114
           LG G  G V +  HQ +    A+K      S   R +   E +I+K+L+   +V    V 
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81
Query: 115 YTIEGEI-----CFVMEHMERGSLFDSLRVRKK---LSEDVISGVAYRVLKGLQYLHGMQ 166
             ++           ME+ E G L   L   +    L E  I  +   +   L+YLH  +
Sbjct: 82  DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR 141
Query: 167 IIHGDIKPSNLLINGKGEV---KIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGT 223
           IIH D+KP N+++    +    KI D G ++ +++               GE     +GT
Sbjct: 142 IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ---------------GELCTEFVGT 186
Query: 224 CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLI 265
             Y++PE ++ ++    Y    D WS G +  EC+ G  P +
Sbjct: 187 LQYLAPELLEQKK----YTVTVDYWSFGTLAFECITGFRPFL 224

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 94/222 (42%), Gaps = 30/222 (13%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVF 114
           LG G  G V +  HQ +    A+K      S   R +   E +I+K+L+   +V    V 
Sbjct: 23  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 82
Query: 115 YTIEGEI-----CFVMEHMERGSLFDSLRVRKK---LSEDVISGVAYRVLKGLQYLHGMQ 166
             ++           ME+ E G L   L   +    L E  I  +   +   L+YLH  +
Sbjct: 83  DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR 142
Query: 167 IIHGDIKPSNLLINGKGEV---KIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGT 223
           IIH D+KP N+++    +    KI D G ++ +++               GE     +GT
Sbjct: 143 IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ---------------GELCTEFVGT 187
Query: 224 CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLI 265
             Y++PE ++ ++    Y    D WS G +  EC+ G  P +
Sbjct: 188 LQYLAPELLEQKK----YTVTVDYWSFGTLAFECITGFRPFL 225

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 72/287 (25%), Positives = 117/287 (40%), Gaps = 32/287 (11%)
Query: 49  LKKLTVLGHGNGGIV----YKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDS 104
           LK++  LG G+ G V    Y      +    A+K L   S          E EIL+ L  
Sbjct: 23  LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYH 82
Query: 105 QFIVKCHAVFYTIEGE-ICFVMEHMERGSLFDSL-RVRKKLSEDVISGVAYRVLKGLQYL 162
           + IVK   +     G  I  +ME +  GSL + L + + K++       A ++ KG+ YL
Sbjct: 83  ENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYL 142
Query: 163 HGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMG 222
              Q +H D+   N+L+  + +VKI DFG+++ +E  +            +   A  C+ 
Sbjct: 143 GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLM 202
Query: 223 TCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLE----CLVGHYPLIGFGE-------KP 271
              +                 A DVWS GV + E    C     P+  F +       + 
Sbjct: 203 QSKFY---------------IASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQM 247
Query: 272 DLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELL 318
            +  L+  +  G+RL  P     E  + +R C E     R + + L+
Sbjct: 248 TVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLI 294

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 72/287 (25%), Positives = 117/287 (40%), Gaps = 32/287 (11%)
Query: 49  LKKLTVLGHGNGGIV----YKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDS 104
           LK++  LG G+ G V    Y      +    A+K L   S          E EIL+ L  
Sbjct: 11  LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYH 70
Query: 105 QFIVKCHAVFYTIEGE-ICFVMEHMERGSLFDSL-RVRKKLSEDVISGVAYRVLKGLQYL 162
           + IVK   +     G  I  +ME +  GSL + L + + K++       A ++ KG+ YL
Sbjct: 71  ENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYL 130
Query: 163 HGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMG 222
              Q +H D+   N+L+  + +VKI DFG+++ +E  +            +   A  C+ 
Sbjct: 131 GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLM 190
Query: 223 TCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLE----CLVGHYPLIGFGE-------KP 271
              +                 A DVWS GV + E    C     P+  F +       + 
Sbjct: 191 QSKFY---------------IASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQM 235
Query: 272 DLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELL 318
            +  L+  +  G+RL  P     E  + +R C E     R + + L+
Sbjct: 236 TVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLI 282

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/269 (22%), Positives = 118/269 (43%), Gaps = 19/269 (7%)
Query: 53  TVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHA 112
           T +G G+ G VYK +     ++  LKV++ T          +E  +L++     I+    
Sbjct: 42  TRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQF--QAFRNEVAVLRKTRHVNILLFMG 99
Query: 113 VFYTIEGEICFVMEHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQYLHGMQIIHGD 171
             Y  +  +  V +  E  SL+  L V++ K     +  +A +  +G+ YLH   IIH D
Sbjct: 100 --YMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRD 157
Query: 172 IKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPER 231
           +K +N+ ++    VKI DFG++ +  ++R              +      G+  +M+PE 
Sbjct: 158 MKSNNIFLHEGLTVKIGDFGLATV--KSRWSG----------SQQVEQPTGSVLWMAPEV 205
Query: 232 VDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPET 291
           +  +     + F  DV+S G+V+ E + G  P      +  ++ ++        L     
Sbjct: 206 IRMQD-NNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYK 264
Query: 292 ASPE-FRRFVRSCLEKDWRKRGTVEELLA 319
             P+  +R V  C++K   +R    ++L+
Sbjct: 265 NCPKAMKRLVADCVKKVKEERPLFPQILS 293

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/274 (23%), Positives = 117/274 (42%), Gaps = 27/274 (9%)
Query: 48  DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFI 107
           DL  L  LG G  G+V   ++ K    Y + +      ++   +   EA+++  L  + +
Sbjct: 9   DLTFLKELGTGQFGVV---KYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKL 65
Query: 108 VKCHAVFYTIEGEICFVMEHMERGSLFDSLR-VRKKLSEDVISGVAYRVLKGLQYLHGMQ 166
           V+ + V  T +  I  + E+M  G L + LR +R +     +  +   V + ++YL   Q
Sbjct: 66  VQLYGVC-TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 124
Query: 167 IIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAY 226
            +H D+   N L+N +G VK++DFG+SR V +                 +++       +
Sbjct: 125 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-------------SSVGSKFPVRW 171
Query: 227 MSPERVDSERWGGDYGFAGDVWSLGVVVLECL-VGHYPLIGFGEKPDLMALICAICFGER 285
             PE +   +    +    D+W+ GV++ E   +G  P   F            I  G R
Sbjct: 172 SPPEVLMYSK----FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAE----HIAQGLR 223
Query: 286 LEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA 319
           L  P  AS +    + SC  +   +R T + LL+
Sbjct: 224 LYRPHLASEKVYTIMYSCWHEKADERPTFKILLS 257

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/279 (22%), Positives = 122/279 (43%), Gaps = 39/279 (13%)
Query: 45  NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDS 104
           N+ +LK L  +G G  G V  +   + N + A+K +   ++         EA ++ +L  
Sbjct: 4   NMKELKLLQTIGKGEFGDVM-LGDYRGNKV-AVKCIKNDATA---QAFLAEASVMTQLRH 58
Query: 105 QFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKK--LSEDVISGVAYRVLKGLQYL 162
             +V+   V    +G +  V E+M +GSL D LR R +  L  D +   +  V + ++YL
Sbjct: 59  SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 118
Query: 163 HGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMG 222
            G   +H D+   N+L++     K++DFG+++    T+             G+  +    
Sbjct: 119 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----------DTGKLPV---- 163
Query: 223 TCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP----DLMALIC 278
              + +PE +  ++    +    DVWS G+++ E       +  FG  P     L  ++ 
Sbjct: 164 --KWTAPEALREKK----FSTKSDVWSFGILLWE-------IYSFGRVPYPRIPLKDVVP 210
Query: 279 AICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEEL 317
            +  G +++ P+   P     +++C   D   R +  +L
Sbjct: 211 RVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQL 249

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 75/305 (24%), Positives = 133/305 (43%), Gaps = 35/305 (11%)
Query: 34  PTSNPTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAA 93
           P+ N    ++E  +D+     LG G  G VY+   +K +   A+K L     T+   +  
Sbjct: 2   PSPNYDKWEMER-TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK--EDTMEVEEFL 58
Query: 94  HEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRV--RKKLSEDVISGV 151
            EA ++K +    +V+   V  T E     ++E M  G+L D LR   R++++  V+  +
Sbjct: 59  KEAAVMKEIKHPNLVQLLGVC-TREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYM 117
Query: 152 AYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXX 211
           A ++   ++YL     IH D+   N L+     VK+ADFG+SR++               
Sbjct: 118 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM--------------- 162
Query: 212 XIGEAAIACMGT---CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLE-CLVGHYPLIGF 267
             G+   A  G      + +PE +   +    +    DVW+ GV++ E    G  P  G 
Sbjct: 163 -TGDTXTAHAGAKFPIKWTAPESLAYNK----FSIKSDVWAFGVLLWEIATYGMSPYPGI 217
Query: 268 GEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEEL-LAYPFVTKR 326
               DL  +   +    R+E PE    +    +R+C + +   R +  E+  A+  + + 
Sbjct: 218 ----DLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 273
Query: 327 SSSSN 331
           SS S+
Sbjct: 274 SSISD 278

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 104/218 (47%), Gaps = 28/218 (12%)
Query: 49  LKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH-EAEILKRLDSQFI 107
           L+ L  +G G  G V      +     A+K L+    ++I  +  + E  +LK L  + +
Sbjct: 30  LQGLRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENV 89
Query: 108 VKCHAVFY---TIE--GEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYL 162
           +    VF    +IE   E+  V   M  G+  +++   + LS++ +  + Y++L+GL+Y+
Sbjct: 90  IGLLDVFTPATSIEDFSEVYLVTTLM--GADLNNIVKSQALSDEHVQFLVYQLLRGLKYI 147
Query: 163 HGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMG 222
           H   IIH D+KPSN+ +N   E++I DFG++R  +E                      + 
Sbjct: 148 HSAGIIHRDLKPSNVAVNEDSELRILDFGLARQADEE-----------------MTGYVA 190
Query: 223 TCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVG 260
           T  Y +PE + +  W   Y    D+WS+G ++ E L G
Sbjct: 191 TRWYRAPEIMLN--W-MHYNQTVDIWSVGCIMAELLQG 225

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 72/303 (23%), Positives = 124/303 (40%), Gaps = 44/303 (14%)
Query: 32  HFPTSNPTSPDVENIS-----------DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVL 80
           H+P      P +  +S           D+     LG G  G VY+   +K +   A+K L
Sbjct: 194 HYPAPKRNKPTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL 253
Query: 81  NTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRV- 139
                T+   +   EA ++K +    +V+   V  T E     + E M  G+L D LR  
Sbjct: 254 K--EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC-TREPPFYIITEFMTYGNLLDYLREC 310
Query: 140 -RKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEE 198
            R+++S  V+  +A ++   ++YL     IH ++   N L+     VK+ADFG+SR++  
Sbjct: 311 NRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLM-- 368
Query: 199 TRXXXXXXXXXXXXIGEAAIACMGT---CAYMSPERVDSERWGGDYGFAGDVWSLGVVVL 255
                          G+   A  G      + +PE +   +    +    DVW+ GV++ 
Sbjct: 369 --------------TGDTYTAHAGAKFPIKWTAPESLAYNK----FSIKSDVWAFGVLLW 410
Query: 256 E-CLVGHYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTV 314
           E    G  P  G     DL  +   +    R+E PE    +    +R+C + +   R + 
Sbjct: 411 EIATYGMSPYPGI----DLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSF 466
Query: 315 EEL 317
            E+
Sbjct: 467 AEI 469

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 75/285 (26%), Positives = 122/285 (42%), Gaps = 34/285 (11%)
Query: 53  TVLGHGNGGIVYKVRHQKSNSI--YALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKC 110
             +G G+ G V K+  QK   I   A K+       + R +   E EI+K LD   I++ 
Sbjct: 32  NTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFK--QEIEIMKSLDHPNIIRL 88
Query: 111 HAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHG 170
           +  F     +I  VME    G LF+ +  ++   E   + +   VL  + Y H + + H 
Sbjct: 89  YETFED-NTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHR 147
Query: 171 DIKPSNLLI---NGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYM 227
           D+KP N L    +    +K+ DFG++   +                G+     +GT  Y+
Sbjct: 148 DLKPENFLFLTDSPDSPLKLIDFGLAARFKP---------------GKMMRTKVGTPYYV 192
Query: 228 SPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALI--CAICFGER 285
           SP+ ++     G YG   D WS GV++   L G YP        ++M  I      F E+
Sbjct: 193 SPQVLE-----GLYGPECDEWSAGVMMYVLLCG-YPPFSAPTDXEVMLKIREGTFTFPEK 246
Query: 286 LEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSS 330
             +    SP+    +R  L K  ++R T  + L + +  K+ SSS
Sbjct: 247 DWL--NVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQLSSS 289

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 70/283 (24%), Positives = 114/283 (40%), Gaps = 38/283 (13%)
Query: 47  SDLKKLTVLGHGNGGIVYK----VRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRL 102
           ++ KK+ VLG G  G VYK       +K     A+K L   +S     +   EA ++  +
Sbjct: 19  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 78
Query: 103 DSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQY 161
           D+  +  C  +   +   +  +M+ M  G L D +R  K  +    +     ++ KG+ Y
Sbjct: 79  DNPHV--CRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 136
Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIV--EETRXXXXXXXXXXXXIGEAAIA 219
           L   +++H D+   N+L+     VKI DFG ++++  EE               G+  I 
Sbjct: 137 LEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEG--------GKVPIK 188
Query: 220 CMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP----DLMA 275
            M   + +   R+        Y    DVWS GV V E       L+ FG KP        
Sbjct: 189 WMALESIL--HRI--------YTHQSDVWSYGVTVWE-------LMTFGSKPYDGIPASE 231
Query: 276 LICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELL 318
           +   +  GERL  P   + +    +  C   D   R    EL+
Sbjct: 232 ISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 274

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/274 (23%), Positives = 117/274 (42%), Gaps = 27/274 (9%)
Query: 48  DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFI 107
           DL  L  LG G  G+V   ++ K    Y + +      ++   +   EA+++  L  + +
Sbjct: 25  DLTFLKELGTGQFGVV---KYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKL 81
Query: 108 VKCHAVFYTIEGEICFVMEHMERGSLFDSLR-VRKKLSEDVISGVAYRVLKGLQYLHGMQ 166
           V+ + V  T +  I  + E+M  G L + LR +R +     +  +   V + ++YL   Q
Sbjct: 82  VQLYGVC-TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 140
Query: 167 IIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAY 226
            +H D+   N L+N +G VK++DFG+SR V +                 +++       +
Sbjct: 141 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-------------SSVGSKFPVRW 187
Query: 227 MSPERVDSERWGGDYGFAGDVWSLGVVVLECL-VGHYPLIGFGEKPDLMALICAICFGER 285
             PE +   +    +    D+W+ GV++ E   +G  P   F            I  G R
Sbjct: 188 SPPEVLMYSK----FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAE----HIAQGLR 239
Query: 286 LEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA 319
           L  P  AS +    + SC  +   +R T + LL+
Sbjct: 240 LYRPHLASEKVYTIMYSCWHEKADERPTFKILLS 273

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 75/285 (26%), Positives = 122/285 (42%), Gaps = 34/285 (11%)
Query: 53  TVLGHGNGGIVYKVRHQKSNSI--YALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKC 110
             +G G+ G V K+  QK   I   A K+       + R +   E EI+K LD   I++ 
Sbjct: 15  NTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFK--QEIEIMKSLDHPNIIRL 71
Query: 111 HAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHG 170
           +  F     +I  VME    G LF+ +  ++   E   + +   VL  + Y H + + H 
Sbjct: 72  YETFED-NTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHR 130
Query: 171 DIKPSNLLI---NGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYM 227
           D+KP N L    +    +K+ DFG++   +                G+     +GT  Y+
Sbjct: 131 DLKPENFLFLTDSPDSPLKLIDFGLAARFKP---------------GKMMRTKVGTPYYV 175
Query: 228 SPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALI--CAICFGER 285
           SP+ ++     G YG   D WS GV++   L G YP        ++M  I      F E+
Sbjct: 176 SPQVLE-----GLYGPECDEWSAGVMMYVLLCG-YPPFSAPTDXEVMLKIREGTFTFPEK 229
Query: 286 LEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSS 330
             +    SP+    +R  L K  ++R T  + L + +  K+ SSS
Sbjct: 230 DWL--NVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQLSSS 272

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/274 (23%), Positives = 117/274 (42%), Gaps = 27/274 (9%)
Query: 48  DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFI 107
           DL  L  LG G  G+V   ++ K    Y + +      ++   +   EA+++  L  + +
Sbjct: 5   DLTFLKELGTGQFGVV---KYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKL 61
Query: 108 VKCHAVFYTIEGEICFVMEHMERGSLFDSLR-VRKKLSEDVISGVAYRVLKGLQYLHGMQ 166
           V+ + V  T +  I  + E+M  G L + LR +R +     +  +   V + ++YL   Q
Sbjct: 62  VQLYGVC-TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 120
Query: 167 IIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAY 226
            +H D+   N L+N +G VK++DFG+SR V +                 +++       +
Sbjct: 121 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-------------SSVGSKFPVRW 167
Query: 227 MSPERVDSERWGGDYGFAGDVWSLGVVVLECL-VGHYPLIGFGEKPDLMALICAICFGER 285
             PE +   ++        D+W+ GV++ E   +G  P   F            I  G R
Sbjct: 168 SPPEVLMYSKFSS----KSDIWAFGVLMWEIYSLGKMPYERFTNSETAE----HIAQGLR 219
Query: 286 LEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA 319
           L  P  AS +    + SC  +   +R T + LL+
Sbjct: 220 LYRPHLASEKVYTIMYSCWHEKADERPTFKILLS 253

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 69/281 (24%), Positives = 125/281 (44%), Gaps = 32/281 (11%)
Query: 55  LGHGNGGIVYK-VRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAV 113
           +G G+   VYK +  + +  +   ++ +   +   R +   EAE LK L    IV+ +  
Sbjct: 34  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYDS 93
Query: 114 F-YTIEGEICFVM--EHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQ--II 168
           +  T++G+ C V+  E    G+L   L+  K     V+     ++LKGLQ+LH     II
Sbjct: 94  WESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQILKGLQFLHTRTPPII 153
Query: 169 HGDIKPSNLLING-KGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYM 227
           H D+K  N+ I G  G VKI D G++ +                     A A +GT  + 
Sbjct: 154 HRDLKCDNIFITGPTGSVKIGDLGLATLKR----------------ASFAKAVIGTPEFX 197
Query: 228 SPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGER-L 286
           +PE  + +     Y  + DV++ G   LE     YP   + E  +   +   +  G +  
Sbjct: 198 APEXYEEK-----YDESVDVYAFGXCXLEXATSEYP---YSECQNAAQIYRRVTSGVKPA 249
Query: 287 EMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRS 327
              + A PE +  +  C+ ++  +R ++++LL + F  + +
Sbjct: 250 SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEET 290

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 73/292 (25%), Positives = 127/292 (43%), Gaps = 34/292 (11%)
Query: 47  SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQF 106
           +D+     LG G  G VY+   +K +   A+K L     T+   +   EA ++K +    
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK--EDTMEVEEFLKEAAVMKEIKHPN 70
Query: 107 IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRV--RKKLSEDVISGVAYRVLKGLQYLHG 164
           +V+   V  T E     ++E M  G+L D LR   R+++S  V+  +A ++   ++YL  
Sbjct: 71  LVQLLGVC-TREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 129
Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGT- 223
              IH D+   N L+     VK+ADFG+SR++                 G+   A  G  
Sbjct: 130 KNFIHRDLAARNCLVGENHLVKVADFGLSRLM----------------TGDTYTAHAGAK 173
Query: 224 --CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLE-CLVGHYPLIGFGEKPDLMALICAI 280
               + +PE +   +    +    DVW+ GV++ E    G  P  G     DL  +   +
Sbjct: 174 FPIKWTAPESLAYNK----FSIKSDVWAFGVLLWEIATYGMSPYPGI----DLSQVYELL 225
Query: 281 CFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEEL-LAYPFVTKRSSSSN 331
               R+E PE    +    +R+C + +   R +  E+  A+  + + SS S+
Sbjct: 226 EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISD 277

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/274 (23%), Positives = 117/274 (42%), Gaps = 27/274 (9%)
Query: 48  DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFI 107
           DL  L  LG G  G+V   ++ K    Y + +      ++   +   EA+++  L  + +
Sbjct: 10  DLTFLKELGTGQFGVV---KYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKL 66
Query: 108 VKCHAVFYTIEGEICFVMEHMERGSLFDSLR-VRKKLSEDVISGVAYRVLKGLQYLHGMQ 166
           V+ + V  T +  I  + E+M  G L + LR +R +     +  +   V + ++YL   Q
Sbjct: 67  VQLYGVC-TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 125
Query: 167 IIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAY 226
            +H D+   N L+N +G VK++DFG+SR V +                 +++       +
Sbjct: 126 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-------------SSVGSKFPVRW 172
Query: 227 MSPERVDSERWGGDYGFAGDVWSLGVVVLECL-VGHYPLIGFGEKPDLMALICAICFGER 285
             PE +   +    +    D+W+ GV++ E   +G  P   F            I  G R
Sbjct: 173 SPPEVLMYSK----FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAE----HIAQGLR 224
Query: 286 LEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA 319
           L  P  AS +    + SC  +   +R T + LL+
Sbjct: 225 LYRPHLASEKVYTIMYSCWHEKADERPTFKILLS 258

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/279 (22%), Positives = 122/279 (43%), Gaps = 39/279 (13%)
Query: 45  NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDS 104
           N+ +LK L  +G G  G V  +   + N + A+K +   ++         EA ++ +L  
Sbjct: 19  NMKELKLLQTIGKGEFGDVM-LGDYRGNKV-AVKCIKNDATA---QAFLAEASVMTQLRH 73
Query: 105 QFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKK--LSEDVISGVAYRVLKGLQYL 162
             +V+   V    +G +  V E+M +GSL D LR R +  L  D +   +  V + ++YL
Sbjct: 74  SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 133
Query: 163 HGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMG 222
            G   +H D+   N+L++     K++DFG+++    T+             G+  +    
Sbjct: 134 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----------DTGKLPV---- 178
Query: 223 TCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP----DLMALIC 278
              + +PE +  ++    +    DVWS G+++ E       +  FG  P     L  ++ 
Sbjct: 179 --KWTAPEALREKK----FSTKSDVWSFGILLWE-------IYSFGRVPYPRIPLKDVVP 225
Query: 279 AICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEEL 317
            +  G +++ P+   P     +++C   D   R +  +L
Sbjct: 226 RVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQL 264

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 70/283 (24%), Positives = 114/283 (40%), Gaps = 38/283 (13%)
Query: 47  SDLKKLTVLGHGNGGIVYK----VRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRL 102
           ++ KK+ VLG G  G VYK       +K     A+K L   +S     +   EA ++  +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 103 DSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQY 161
           D+  +  C  +   +   +  +M+ M  G L D +R  K  +    +     ++ KG+ Y
Sbjct: 77  DNPHV--CRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 134
Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIV--EETRXXXXXXXXXXXXIGEAAIA 219
           L   +++H D+   N+L+     VKI DFG ++++  EE               G+  I 
Sbjct: 135 LEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEG--------GKVPIK 186
Query: 220 CMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP----DLMA 275
            M   + +   R+        Y    DVWS GV V E       L+ FG KP        
Sbjct: 187 WMALESIL--HRI--------YTHQSDVWSYGVTVWE-------LMTFGSKPYDGIPASE 229
Query: 276 LICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELL 318
           +   +  GERL  P   + +    +  C   D   R    EL+
Sbjct: 230 ISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 272

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/274 (23%), Positives = 117/274 (42%), Gaps = 27/274 (9%)
Query: 48  DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFI 107
           DL  L  LG G  G+V   ++ K    Y + +      ++   +   EA+++  L  + +
Sbjct: 16  DLTFLKELGTGQFGVV---KYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKL 72
Query: 108 VKCHAVFYTIEGEICFVMEHMERGSLFDSLR-VRKKLSEDVISGVAYRVLKGLQYLHGMQ 166
           V+ + V  T +  I  + E+M  G L + LR +R +     +  +   V + ++YL   Q
Sbjct: 73  VQLYGVC-TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 131
Query: 167 IIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAY 226
            +H D+   N L+N +G VK++DFG+SR V +                 +++       +
Sbjct: 132 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-------------SSVGSKFPVRW 178
Query: 227 MSPERVDSERWGGDYGFAGDVWSLGVVVLECL-VGHYPLIGFGEKPDLMALICAICFGER 285
             PE +   +    +    D+W+ GV++ E   +G  P   F            I  G R
Sbjct: 179 SPPEVLMYSK----FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAE----HIAQGLR 230
Query: 286 LEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA 319
           L  P  AS +    + SC  +   +R T + LL+
Sbjct: 231 LYRPHLASEKVYTIMYSCWHEKADERPTFKILLS 264

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 73/292 (25%), Positives = 127/292 (43%), Gaps = 34/292 (11%)
Query: 47  SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQF 106
           +D+     LG G  G VY+   +K +   A+K L     T+   +   EA ++K +    
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK--EDTMEVEEFLKEAAVMKEIKHPN 70
Query: 107 IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRV--RKKLSEDVISGVAYRVLKGLQYLHG 164
           +V+   V  T E     ++E M  G+L D LR   R+++S  V+  +A ++   ++YL  
Sbjct: 71  LVQLLGVC-TREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 129
Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGT- 223
              IH D+   N L+     VK+ADFG+SR++                 G+   A  G  
Sbjct: 130 KNFIHRDLAARNCLVGENHLVKVADFGLSRLM----------------TGDTYTAHAGAK 173
Query: 224 --CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLE-CLVGHYPLIGFGEKPDLMALICAI 280
               + +PE +   +    +    DVW+ GV++ E    G  P  G     DL  +   +
Sbjct: 174 FPIKWTAPESLAYNK----FSIKSDVWAFGVLLWEIATYGMSPYPGI----DLSQVYELL 225
Query: 281 CFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEEL-LAYPFVTKRSSSSN 331
               R+E PE    +    +R+C + +   R +  E+  A+  + + SS S+
Sbjct: 226 EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISD 277

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/242 (24%), Positives = 107/242 (44%), Gaps = 56/242 (23%)
Query: 48  DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFI 107
           D K++ ++G G  G V+K +H+     Y ++ +   +      +A  E + L +LD   I
Sbjct: 13  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNN-----EKAEREVKALAKLDHVNI 67
Query: 108 VKCHAVF------------------YTIEGE----------ICFVMEHMERGSLFDSLRV 139
           V  +  +                  Y  E            +   ME  ++G+L   +  
Sbjct: 68  VHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEK 127
Query: 140 RK--KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFG-VSRIV 196
           R+  KL + +   +  ++ KG+ Y+H  ++IH D+KPSN+ +    +VKI DFG V+ + 
Sbjct: 128 RRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLK 187
Query: 197 EETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLE 256
            + +                     GT  YMSPE++ S+    DYG   D+++LG+++ E
Sbjct: 188 NDGKR----------------TRSKGTLRYMSPEQISSQ----DYGKEVDLYALGLILAE 227
Query: 257 CL 258
            L
Sbjct: 228 LL 229

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 69/279 (24%), Positives = 119/279 (42%), Gaps = 41/279 (14%)
Query: 54  VLGHGNGGIV----YKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVK 109
           ++G G+ G V     +V  Q+   + A+K L    +   R     EA I+ + D   I++
Sbjct: 56  IIGSGDSGEVCYGRLRVPGQRDVPV-AIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114
Query: 110 CHAVFYTIEGEICF-VMEHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQYLHGMQI 167
              V     G +   V E+ME GSL   LR    + +   + G+   V  G++YL  +  
Sbjct: 115 LEGV--VTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGY 172
Query: 168 IHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMG---TC 224
           +H D+   N+L++     K++DFG+SR++E+                +AA    G     
Sbjct: 173 VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD--------------PDAAXTTTGGKIPI 218
Query: 225 AYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMA----LICAI 280
            + +PE +        +  A DVWS GVV+ E L        +GE+P        +I ++
Sbjct: 219 RWTAPEAIAFR----TFSSASDVWSFGVVMWEVL-------AYGERPYWNMTNRDVISSV 267
Query: 281 CFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA 319
             G RL  P        + +  C  KD  +R    ++++
Sbjct: 268 EEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVS 306

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 69/279 (24%), Positives = 119/279 (42%), Gaps = 41/279 (14%)
Query: 54  VLGHGNGGIV----YKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVK 109
           ++G G+ G V     +V  Q+   + A+K L    +   R     EA I+ + D   I++
Sbjct: 56  IIGSGDSGEVCYGRLRVPGQRDVPV-AIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114
Query: 110 CHAVFYTIEGEICF-VMEHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQYLHGMQI 167
              V     G +   V E+ME GSL   LR    + +   + G+   V  G++YL  +  
Sbjct: 115 LEGV--VTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGY 172
Query: 168 IHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMG---TC 224
           +H D+   N+L++     K++DFG+SR++E+                +AA    G     
Sbjct: 173 VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD--------------PDAAYTTTGGKIPI 218
Query: 225 AYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMA----LICAI 280
            + +PE +        +  A DVWS GVV+ E L        +GE+P        +I ++
Sbjct: 219 RWTAPEAIAFR----TFSSASDVWSFGVVMWEVL-------AYGERPYWNMTNRDVISSV 267
Query: 281 CFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA 319
             G RL  P        + +  C  KD  +R    ++++
Sbjct: 268 EEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVS 306

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 73/292 (25%), Positives = 126/292 (43%), Gaps = 34/292 (11%)
Query: 47  SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQF 106
           +D+     LG G  G VY+   +K +   A+K L     T+   +   EA ++K +    
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK--EDTMEVEEFLKEAAVMKEIKHPN 70
Query: 107 IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRV--RKKLSEDVISGVAYRVLKGLQYLHG 164
           +V+   V  T E     + E M  G+L D LR   R+++S  V+  +A ++   ++YL  
Sbjct: 71  LVQLLGVC-TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 129
Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGT- 223
              IH D+   N L+     VK+ADFG+SR++                 G+   A  G  
Sbjct: 130 KNFIHRDLAARNCLVGENHLVKVADFGLSRLM----------------TGDTYTAHAGAK 173
Query: 224 --CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLE-CLVGHYPLIGFGEKPDLMALICAI 280
               + +PE +   +    +    DVW+ GV++ E    G  P  G     DL  +   +
Sbjct: 174 FPIKWTAPESLAYNK----FSIKSDVWAFGVLLWEIATYGMSPYPGI----DLSQVYELL 225
Query: 281 CFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEEL-LAYPFVTKRSSSSN 331
               R+E PE    +    +R+C + +   R +  E+  A+  + + SS S+
Sbjct: 226 EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISD 277

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 72/289 (24%), Positives = 122/289 (42%), Gaps = 53/289 (18%)
Query: 54  VLGHGNGGIVYKVR--HQKSNSIY---ALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIV 108
            LG G  G V K    H K  + Y   A+K+L   +S         E  +LK+++   ++
Sbjct: 30  TLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVI 89
Query: 109 KCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSE----------------------- 145
           K +    + +G +  ++E+ + GSL   LR  +K+                         
Sbjct: 90  KLYGAC-SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 146 --DVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXX 203
             D+IS  A+++ +G+QYL  M+++H D+   N+L+    ++KI+DFG+SR V E     
Sbjct: 149 MGDLIS-FAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXV 207
Query: 204 XXXXXXXXXIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECL-VGHY 262
                     G   +  M   +               Y    DVWS GV++ E + +G  
Sbjct: 208 KRSQ------GRIPVKWMAIESLFD----------HIYTTQSDVWSFGVLLWEIVTLGGN 251
Query: 263 PLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKR 311
           P  G   +     L   +  G R+E P+  S E  R +  C +++  KR
Sbjct: 252 PYPGIPPE----RLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKR 296

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 72/303 (23%), Positives = 124/303 (40%), Gaps = 44/303 (14%)
Query: 32  HFPTSNPTSPDVENIS-----------DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVL 80
           H+P      P V  +S           D+     LG G  G VY+   +K +   A+K L
Sbjct: 233 HYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL 292
Query: 81  NTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRV- 139
                T+   +   EA ++K +    +V+   V  T E     + E M  G+L D LR  
Sbjct: 293 K--EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC-TREPPFYIITEFMTYGNLLDYLREC 349
Query: 140 -RKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEE 198
            R++++  V+  +A ++   ++YL     IH ++   N L+     VK+ADFG+SR++  
Sbjct: 350 NRQEVNAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLM-- 407
Query: 199 TRXXXXXXXXXXXXIGEAAIACMGT---CAYMSPERVDSERWGGDYGFAGDVWSLGVVVL 255
                          G+   A  G      + +PE +   +    +    DVW+ GV++ 
Sbjct: 408 --------------TGDTYTAHAGAKFPIKWTAPESLAYNK----FSIKSDVWAFGVLLW 449
Query: 256 E-CLVGHYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTV 314
           E    G  P  G     DL  +   +    R+E PE    +    +R+C + +   R + 
Sbjct: 450 EIATYGMSPYPGI----DLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSF 505
Query: 315 EEL 317
            E+
Sbjct: 506 AEI 508

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 98/221 (44%), Gaps = 20/221 (9%)
Query: 54  VLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIR-HQAAHEAEILKRLDSQFIVKCHA 112
           ++G G+ G VY    + +N   A+K +N     +I   +   E  IL RL S +I++ H 
Sbjct: 35  LIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLHD 94
Query: 113 VFYTIE----GEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQII 168
           +    +     E+  V+E +    L    +    L+E  +  + Y +L G +++H   II
Sbjct: 95  LIIPEDLLKFDELYIVLE-IADSDLKKLFKTPIFLTEQHVKTILYNLLLGEKFIHESGII 153
Query: 169 HGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXX-----------XXXIGEAA 217
           H D+KP+N L+N    VKI DFG++R +   +                       + +  
Sbjct: 154 HRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDLEEKEENEEPGPHNKNLKKQL 213
Query: 218 IACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECL 258
            + + T  Y +PE +  +    +Y  + D+WS G +  E L
Sbjct: 214 TSHVVTRWYRAPELILLQE---NYTNSIDIWSTGCIFAELL 251

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 71/289 (24%), Positives = 121/289 (41%), Gaps = 53/289 (18%)
Query: 54  VLGHGNGGIVYKVR--HQKSNSIY---ALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIV 108
            LG G  G V K    H K  + Y   A+K+L   +S         E  +LK+++   ++
Sbjct: 30  TLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVI 89
Query: 109 KCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSE----------------------- 145
           K +    + +G +  ++E+ + GSL   LR  +K+                         
Sbjct: 90  KLYGAC-SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 146 --DVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXX 203
             D+IS  A+++ +G+QYL  M+++H D+   N+L+    ++KI+DFG+SR V E     
Sbjct: 149 MGDLIS-FAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYV 207
Query: 204 XXXXXXXXXIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECL-VGHY 262
                     G   +  M   +               Y    DVWS GV++ E + +G  
Sbjct: 208 KRSQ------GRIPVKWMAIESLFD----------HIYTTQSDVWSFGVLLWEIVTLGGN 251
Query: 263 PLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKR 311
           P  G   +     L   +  G R+E P+  S E  R +  C +++  KR
Sbjct: 252 PYPGIPPE----RLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKR 296

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 73/292 (25%), Positives = 126/292 (43%), Gaps = 34/292 (11%)
Query: 47  SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQF 106
           +D+     LG G  G VY+   +K +   A+K L     T+   +   EA ++K +    
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK--EDTMEVEEFLKEAAVMKEIKHPN 70
Query: 107 IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRV--RKKLSEDVISGVAYRVLKGLQYLHG 164
           +V+   V  T E     + E M  G+L D LR   R+++S  V+  +A ++   ++YL  
Sbjct: 71  LVQLLGVC-TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 129
Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGT- 223
              IH D+   N L+     VK+ADFG+SR++                 G+   A  G  
Sbjct: 130 KNFIHRDLAARNCLVGENHLVKVADFGLSRLM----------------TGDTYTAHAGAK 173
Query: 224 --CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLE-CLVGHYPLIGFGEKPDLMALICAI 280
               + +PE +   +    +    DVW+ GV++ E    G  P  G     DL  +   +
Sbjct: 174 FPIKWTAPESLAYNK----FSIKSDVWAFGVLLWEIATYGMSPYPGI----DLSQVYELL 225
Query: 281 CFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEEL-LAYPFVTKRSSSSN 331
               R+E PE    +    +R+C + +   R +  E+  A+  + + SS S+
Sbjct: 226 EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISD 277

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 69/283 (24%), Positives = 114/283 (40%), Gaps = 38/283 (13%)
Query: 47  SDLKKLTVLGHGNGGIVYK----VRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRL 102
           ++ KK+ VLG G  G VYK       +K     A+K L   +S     +   EA ++  +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 103 DSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQY 161
           D+  +  C  +   +   +  + + M  G L D +R  K  +    +     ++ KG+ Y
Sbjct: 75  DNPHV--CRLLGICLTSTVQLITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 132
Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIV--EETRXXXXXXXXXXXXIGEAAIA 219
           L   +++H D+   N+L+     VKI DFG+++++  EE               G+  I 
Sbjct: 133 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG--------GKVPIK 184
Query: 220 CMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP----DLMA 275
            M   + +   R+        Y    DVWS GV V E       L+ FG KP        
Sbjct: 185 WMALESIL--HRI--------YTHQSDVWSYGVTVWE-------LMTFGSKPYDGIPASE 227
Query: 276 LICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELL 318
           +   +  GERL  P   + +    +  C   D   R    EL+
Sbjct: 228 ISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 270

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 69/283 (24%), Positives = 114/283 (40%), Gaps = 38/283 (13%)
Query: 47  SDLKKLTVLGHGNGGIVYK----VRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRL 102
           ++ KK+ VLG G  G VYK       +K     A+K L   +S     +   EA ++  +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 103 DSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQY 161
           D+  +  C  +   +   +  + + M  G L D +R  K  +    +     ++ KG+ Y
Sbjct: 75  DNPHV--CRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 132
Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIV--EETRXXXXXXXXXXXXIGEAAIA 219
           L   +++H D+   N+L+     VKI DFG+++++  EE               G+  I 
Sbjct: 133 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG--------GKVPIK 184
Query: 220 CMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP----DLMA 275
            M   + +   R+        Y    DVWS GV V E       L+ FG KP        
Sbjct: 185 WMALESIL--HRI--------YTHQSDVWSYGVTVWE-------LMTFGSKPYDGIPASE 227
Query: 276 LICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELL 318
           +   +  GERL  P   + +    +  C   D   R    EL+
Sbjct: 228 ISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 270

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 69/283 (24%), Positives = 114/283 (40%), Gaps = 38/283 (13%)
Query: 47  SDLKKLTVLGHGNGGIVYK----VRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRL 102
           ++ KK+ VLG G  G VYK       +K     A+K L   +S     +   EA ++  +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 103 DSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQY 161
           D+  +  C  +   +   +  + + M  G L D +R  K  +    +     ++ KG+ Y
Sbjct: 77  DNPHV--CRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 134
Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIV--EETRXXXXXXXXXXXXIGEAAIA 219
           L   +++H D+   N+L+     VKI DFG+++++  EE               G+  I 
Sbjct: 135 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG--------GKVPIK 186
Query: 220 CMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP----DLMA 275
            M   + +   R+        Y    DVWS GV V E       L+ FG KP        
Sbjct: 187 WMALESIL--HRI--------YTHQSDVWSYGVTVWE-------LMTFGSKPYDGIPASE 229
Query: 276 LICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELL 318
           +   +  GERL  P   + +    +  C   D   R    EL+
Sbjct: 230 ISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 272

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 69/283 (24%), Positives = 114/283 (40%), Gaps = 38/283 (13%)
Query: 47  SDLKKLTVLGHGNGGIVYK----VRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRL 102
           ++ KK+ VLG G  G VYK       +K     A+K L   +S     +   EA ++  +
Sbjct: 21  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 80
Query: 103 DSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQY 161
           D+  +  C  +   +   +  + + M  G L D +R  K  +    +     ++ KG+ Y
Sbjct: 81  DNPHV--CRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 138
Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIV--EETRXXXXXXXXXXXXIGEAAIA 219
           L   +++H D+   N+L+     VKI DFG+++++  EE               G+  I 
Sbjct: 139 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG--------GKVPIK 190
Query: 220 CMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP----DLMA 275
            M   + +   R+        Y    DVWS GV V E       L+ FG KP        
Sbjct: 191 WMALESIL--HRI--------YTHQSDVWSYGVTVWE-------LMTFGSKPYDGIPASE 233
Query: 276 LICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELL 318
           +   +  GERL  P   + +    +  C   D   R    EL+
Sbjct: 234 ISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 276

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 69/283 (24%), Positives = 114/283 (40%), Gaps = 38/283 (13%)
Query: 47  SDLKKLTVLGHGNGGIVYK----VRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRL 102
           ++ KK+ VL  G  G VYK       +K     A+K L   +S     +   EA ++  +
Sbjct: 22  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 103 DSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQY 161
           D+  +  C  +   +   +  +M+ M  G L D +R  K  +    +     ++ KG+ Y
Sbjct: 82  DNPHV--CRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 139
Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIV--EETRXXXXXXXXXXXXIGEAAIA 219
           L   +++H D+   N+L+     VKI DFG+++++  EE               G+  I 
Sbjct: 140 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG--------GKVPIK 191
Query: 220 CMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP----DLMA 275
            M   + +   R+        Y    DVWS GV V E       L+ FG KP        
Sbjct: 192 WMALESIL--HRI--------YTHQSDVWSYGVTVWE-------LMTFGSKPYDGIPASE 234
Query: 276 LICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELL 318
           +   +  GERL  P   + +    +  C   D   R    EL+
Sbjct: 235 ISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 277

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 69/283 (24%), Positives = 114/283 (40%), Gaps = 38/283 (13%)
Query: 47  SDLKKLTVLGHGNGGIVYK----VRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRL 102
           ++ KK+ VLG G  G VYK       +K     A+K L   +S     +   EA ++  +
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 103 DSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQY 161
           D+  +  C  +   +   +  + + M  G L D +R  K  +    +     ++ KG+ Y
Sbjct: 78  DNPHV--CRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 135
Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIV--EETRXXXXXXXXXXXXIGEAAIA 219
           L   +++H D+   N+L+     VKI DFG+++++  EE               G+  I 
Sbjct: 136 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG--------GKVPIK 187
Query: 220 CMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP----DLMA 275
            M   + +   R+        Y    DVWS GV V E       L+ FG KP        
Sbjct: 188 WMALESIL--HRI--------YTHQSDVWSYGVTVWE-------LMTFGSKPYDGIPASE 230
Query: 276 LICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELL 318
           +   +  GERL  P   + +    +  C   D   R    EL+
Sbjct: 231 ISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 273

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 69/283 (24%), Positives = 114/283 (40%), Gaps = 38/283 (13%)
Query: 47  SDLKKLTVLGHGNGGIVYK----VRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRL 102
           ++ KK+ VLG G  G VYK       +K     A+K L   +S     +   EA ++  +
Sbjct: 40  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 99
Query: 103 DSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQY 161
           D+  +  C  +   +   +  + + M  G L D +R  K  +    +     ++ KG+ Y
Sbjct: 100 DNPHV--CRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 157
Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIV--EETRXXXXXXXXXXXXIGEAAIA 219
           L   +++H D+   N+L+     VKI DFG+++++  EE               G+  I 
Sbjct: 158 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG--------GKVPIK 209
Query: 220 CMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP----DLMA 275
            M   + +   R+        Y    DVWS GV V E       L+ FG KP        
Sbjct: 210 WMALESIL--HRI--------YTHQSDVWSYGVTVWE-------LMTFGSKPYDGIPASE 252
Query: 276 LICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELL 318
           +   +  GERL  P   + +    +  C   D   R    EL+
Sbjct: 253 ISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 295

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 71/290 (24%), Positives = 124/290 (42%), Gaps = 34/290 (11%)
Query: 34  PTSNPTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAA 93
           P+ N    ++E  +D+     LG G  G VY+   +K +   A+K L     T+   +  
Sbjct: 5   PSPNYDKWEMER-TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK--EDTMEVEEFL 61
Query: 94  HEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRV--RKKLSEDVISGV 151
            EA ++K +    +V+   V  T E     + E M  G+L D LR   R++++  V+  +
Sbjct: 62  KEAAVMKEIKHPNLVQLLGVC-TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYM 120
Query: 152 AYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXX 211
           A ++   ++YL     IH D+   N L+     VK+ADFG+SR++               
Sbjct: 121 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM--------------- 165
Query: 212 XIGEAAIACMGT---CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLE-CLVGHYPLIGF 267
             G+   A  G      + +PE +   +    +    DVW+ GV++ E    G  P  G 
Sbjct: 166 -TGDTYTAHAGAKFPIKWTAPESLAYNK----FSIKSDVWAFGVLLWEIATYGMSPYPGI 220
Query: 268 GEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEEL 317
               DL  +   +    R+E PE    +    +R+C + +   R +  E+
Sbjct: 221 ----DLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 266

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 104/218 (47%), Gaps = 28/218 (12%)
Query: 49  LKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH-EAEILKRLDSQFI 107
           L+ L  +G G  G V      +     A+K L+    ++I  +  + E  +LK L  + +
Sbjct: 30  LQGLRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENV 89
Query: 108 VKCHAVFY---TIE--GEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYL 162
           +    VF    +IE   E+  V   M  G+  +++   + LS++ +  + Y++L+GL+Y+
Sbjct: 90  IGLLDVFTPATSIEDFSEVYLVTTLM--GADLNNIVKCQALSDEHVQFLVYQLLRGLKYI 147
Query: 163 HGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMG 222
           H   IIH D+KPSN+ +N   E++I DFG++R  +E                      + 
Sbjct: 148 HSAGIIHRDLKPSNVAVNEDSELRILDFGLARQADEE-----------------MTGYVA 190
Query: 223 TCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVG 260
           T  Y +PE + +  W   Y    D+WS+G ++ E L G
Sbjct: 191 TRWYRAPEIMLN--W-MHYNQTVDIWSVGCIMAELLQG 225

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 69/283 (24%), Positives = 114/283 (40%), Gaps = 38/283 (13%)
Query: 47  SDLKKLTVLGHGNGGIVYK----VRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRL 102
           ++ KK+ VLG G  G VYK       +K     A+K L   +S     +   EA ++  +
Sbjct: 9   TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 103 DSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQY 161
           D+  +  C  +   +   +  + + M  G L D +R  K  +    +     ++ KG+ Y
Sbjct: 69  DNPHV--CRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 126
Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIV--EETRXXXXXXXXXXXXIGEAAIA 219
           L   +++H D+   N+L+     VKI DFG+++++  EE               G+  I 
Sbjct: 127 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG--------GKVPIK 178
Query: 220 CMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP----DLMA 275
            M   + +   R+        Y    DVWS GV V E       L+ FG KP        
Sbjct: 179 WMALESIL--HRI--------YTHQSDVWSYGVTVWE-------LMTFGSKPYDGIPASE 221
Query: 276 LICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELL 318
           +   +  GERL  P   + +    +  C   D   R    EL+
Sbjct: 222 ISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 264

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 69/283 (24%), Positives = 114/283 (40%), Gaps = 38/283 (13%)
Query: 47  SDLKKLTVLGHGNGGIVYK----VRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRL 102
           ++ KK+ VLG G  G VYK       +K     A+K L   +S     +   EA ++  +
Sbjct: 22  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 103 DSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQY 161
           D+  +  C  +   +   +  + + M  G L D +R  K  +    +     ++ KG+ Y
Sbjct: 82  DNPHV--CRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 139
Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIV--EETRXXXXXXXXXXXXIGEAAIA 219
           L   +++H D+   N+L+     VKI DFG+++++  EE               G+  I 
Sbjct: 140 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG--------GKVPIK 191
Query: 220 CMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP----DLMA 275
            M   + +   R+        Y    DVWS GV V E       L+ FG KP        
Sbjct: 192 WMALESIL--HRI--------YTHQSDVWSYGVTVWE-------LMTFGSKPYDGIPASE 234
Query: 276 LICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELL 318
           +   +  GERL  P   + +    +  C   D   R    EL+
Sbjct: 235 ISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 277

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 69/283 (24%), Positives = 114/283 (40%), Gaps = 38/283 (13%)
Query: 47  SDLKKLTVLGHGNGGIVYK----VRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRL 102
           ++ KK+ VLG G  G VYK       +K     A+K L   +S     +   EA ++  +
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 103 DSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQY 161
           D+  +  C  +   +   +  + + M  G L D +R  K  +    +     ++ KG+ Y
Sbjct: 78  DNPHV--CRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 135
Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIV--EETRXXXXXXXXXXXXIGEAAIA 219
           L   +++H D+   N+L+     VKI DFG+++++  EE               G+  I 
Sbjct: 136 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG--------GKVPIK 187
Query: 220 CMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP----DLMA 275
            M   + +   R+        Y    DVWS GV V E       L+ FG KP        
Sbjct: 188 WMALESIL--HRI--------YTHQSDVWSYGVTVWE-------LMTFGSKPYDGIPASE 230
Query: 276 LICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELL 318
           +   +  GERL  P   + +    +  C   D   R    EL+
Sbjct: 231 ISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 273

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 72/284 (25%), Positives = 115/284 (40%), Gaps = 49/284 (17%)
Query: 55  LGHGNGGIV-----YKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVK 109
           LG G  G V     Y +  ++   + A+K L   S    R     EAE+L  L  + IVK
Sbjct: 21  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNA-RKDFHREAELLTNLQHEHIVK 79
Query: 110 CHAVFYTIEGE-ICFVMEHMERGSLFDSLRVR-------------KKLSEDVISGVAYRV 155
            + V   +EG+ +  V E+M+ G L   LR                +L++  +  +A ++
Sbjct: 80  FYGV--CVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQI 137
Query: 156 LKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGE 215
             G+ YL     +H D+   N L+     VKI DFG+SR V  T                
Sbjct: 138 AAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYY------------R 185
Query: 216 AAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLM- 274
                M    +M PE +   ++  +     DVWSLGVV+ E       +  +G++P    
Sbjct: 186 VGGHTMLPIRWMPPESIMYRKFTTE----SDVWSLGVVLWE-------IFTYGKQPWYQL 234
Query: 275 ---ALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVE 315
               +I  I  G  L+ P T   E    +  C +++   R  ++
Sbjct: 235 SNNEVIECITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIK 278

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 72/289 (24%), Positives = 121/289 (41%), Gaps = 53/289 (18%)
Query: 54  VLGHGNGGIVYKVR--HQKSNSIY---ALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIV 108
            LG G  G V K    H K  + Y   A+K+L   +S         E  +LK+++   ++
Sbjct: 30  TLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVI 89
Query: 109 KCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSE----------------------- 145
           K +    + +G +  ++E+ + GSL   LR  +K+                         
Sbjct: 90  KLYGAC-SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 146 --DVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXX 203
             D+IS  A+++ +G+QYL  M ++H D+   N+L+    ++KI+DFG+SR V E     
Sbjct: 149 MGDLIS-FAWQISQGMQYLAEMSLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXV 207
Query: 204 XXXXXXXXXIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECL-VGHY 262
                     G   +  M   +               Y    DVWS GV++ E + +G  
Sbjct: 208 KRSQ------GRIPVKWMAIESLFD----------HIYTTQSDVWSFGVLLWEIVTLGGN 251
Query: 263 PLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKR 311
           P  G   +     L   +  G R+E P+  S E  R +  C +++  KR
Sbjct: 252 PYPGIPPE----RLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKR 296

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 72/292 (24%), Positives = 126/292 (43%), Gaps = 34/292 (11%)
Query: 47  SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQF 106
           +D+     LG G  G VY+   +K +   A+K L     T+   +   EA ++K +    
Sbjct: 15  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK--EDTMEVEEFLKEAAVMKEIKHPN 72
Query: 107 IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRV--RKKLSEDVISGVAYRVLKGLQYLHG 164
           +V+   V  T E     + E M  G+L D LR   R++++  V+  +A ++   ++YL  
Sbjct: 73  LVQLLGVC-TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 131
Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGT- 223
              IH D+   N L+     VK+ADFG+SR++                 G+   A  G  
Sbjct: 132 KNFIHRDLAARNCLVGENHLVKVADFGLSRLM----------------TGDTYTAPAGAK 175
Query: 224 --CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLE-CLVGHYPLIGFGEKPDLMALICAI 280
               + +PE +   +    +    DVW+ GV++ E    G  P  G     DL  +   +
Sbjct: 176 FPIKWTAPESLAYNK----FSIKSDVWAFGVLLWEIATYGMSPYPGI----DLSQVYELL 227
Query: 281 CFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEEL-LAYPFVTKRSSSSN 331
               R+E PE    +    +R+C + +   R +  E+  A+  + + SS S+
Sbjct: 228 EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISD 279

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 72/309 (23%), Positives = 135/309 (43%), Gaps = 43/309 (13%)
Query: 31  HHFPTSNPTSPDVENISDLKKLTV---LGHGNGGIVYK-----VRHQKSNSIYALKVLNT 82
            +F  ++   PD   ++  +K+T+   LG G+ G+VY+     V   +  +  A+K +N 
Sbjct: 29  EYFSAADVYVPDEWEVAR-EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNE 87
Query: 83  TSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFV-MEHMERGSLFDSLR-VR 140
            +S   R +  +EA ++K  +   +V+   V    +G+   V ME M RG L   LR +R
Sbjct: 88  AASMRERIEFLNEASVMKEFNCHHVVRLLGV--VSQGQPTLVIMELMTRGDLKSYLRSLR 145
Query: 141 KKLSEDVISG---------VAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFG 191
            ++  + +           +A  +  G+ YL+  + +H D+   N ++     VKI DFG
Sbjct: 146 PEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFG 205
Query: 192 VSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLG 251
           ++R + ET              G+  +       +MSPE +      G +    DVWS G
Sbjct: 206 MTRDIYETDYYRKG--------GKGLLP----VRWMSPESLKD----GVFTTYSDVWSFG 249
Query: 252 VVVLE-CLVGHYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRK 310
           VV+ E   +   P  G   +     ++  +  G  L+ P+         +R C + + + 
Sbjct: 250 VVLWEIATLAEQPYQGLSNE----QVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKM 305
Query: 311 RGTVEELLA 319
           R +  E+++
Sbjct: 306 RPSFLEIIS 314

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 72/292 (24%), Positives = 126/292 (43%), Gaps = 34/292 (11%)
Query: 47  SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQF 106
           +D+     LG G  G VY+   +K +   A+K L     T+   +   EA ++K +    
Sbjct: 14  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK--EDTMEVEEFLKEAAVMKEIKHPN 71
Query: 107 IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRV--RKKLSEDVISGVAYRVLKGLQYLHG 164
           +V+   V  T E     + E M  G+L D LR   R++++  V+  +A ++   ++YL  
Sbjct: 72  LVQLLGVC-TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 130
Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGT- 223
              IH D+   N L+     VK+ADFG+SR++                 G+   A  G  
Sbjct: 131 KNFIHRDLAARNCLVGENHLVKVADFGLSRLM----------------TGDTYTAPAGAK 174
Query: 224 --CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLE-CLVGHYPLIGFGEKPDLMALICAI 280
               + +PE +   +    +    DVW+ GV++ E    G  P  G     DL  +   +
Sbjct: 175 FPIKWTAPESLAYNK----FSIKSDVWAFGVLLWEIATYGMSPYPGI----DLSQVYELL 226
Query: 281 CFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEEL-LAYPFVTKRSSSSN 331
               R+E PE    +    +R+C + +   R +  E+  A+  + + SS S+
Sbjct: 227 EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISD 278

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 72/309 (23%), Positives = 135/309 (43%), Gaps = 43/309 (13%)
Query: 31  HHFPTSNPTSPDVENISDLKKLTV---LGHGNGGIVYK-----VRHQKSNSIYALKVLNT 82
            +F  ++   PD   ++  +K+T+   LG G+ G+VY+     V   +  +  A+K +N 
Sbjct: 7   EYFSAADVYVPDEWEVAR-EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNE 65
Query: 83  TSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFV-MEHMERGSLFDSLR-VR 140
            +S   R +  +EA ++K  +   +V+   V    +G+   V ME M RG L   LR +R
Sbjct: 66  AASMRERIEFLNEASVMKEFNCHHVVRLLGV--VSQGQPTLVIMELMTRGDLKSYLRSLR 123
Query: 141 KKLSEDVISG---------VAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFG 191
             ++ + +           +A  +  G+ YL+  + +H D+   N ++     VKI DFG
Sbjct: 124 PAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFG 183
Query: 192 VSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLG 251
           ++R + ET              G+  +       +MSPE +      G +    DVWS G
Sbjct: 184 MTRDIYETDYYRKG--------GKGLLP----VRWMSPESLKD----GVFTTYSDVWSFG 227
Query: 252 VVVLE-CLVGHYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRK 310
           VV+ E   +   P  G   +     ++  +  G  L+ P+         +R C + + + 
Sbjct: 228 VVLWEIATLAEQPYQGLSNE----QVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKM 283
Query: 311 RGTVEELLA 319
           R +  E+++
Sbjct: 284 RPSFLEIIS 292

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 67/281 (23%), Positives = 123/281 (43%), Gaps = 37/281 (13%)
Query: 55  LGHGNGGIVYK-----VRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVK 109
           LG G+ G+VY+     V   +  +  A+K +N  +S   R +  +EA ++K  +   +V+
Sbjct: 18  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 77
Query: 110 CHAVFYTIEGEICFVMEHMERGSLFDSLR-VRKKLSEDVISG---------VAYRVLKGL 159
              V    +  +  +ME M RG L   LR +R ++  + +           +A  +  G+
Sbjct: 78  LLGVVSQGQPTLV-IMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 136
Query: 160 QYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIA 219
            YL+  + +H D+   N ++     VKI DFG++R + ET              G+  + 
Sbjct: 137 AYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKG--------GKGLLP 188
Query: 220 CMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLE-CLVGHYPLIGFGEKPDLMALIC 278
                 +MSPE +      G +    DVWS GVV+ E   +   P  G   +     ++ 
Sbjct: 189 ----VRWMSPESLKD----GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE----QVLR 236
Query: 279 AICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA 319
            +  G  L+ P+         +R C + + + R +  E+++
Sbjct: 237 FVMEGGLLDKPDNCPDMLLELMRMCWQYNPKMRPSFLEIIS 277

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 69/263 (26%), Positives = 112/263 (42%), Gaps = 17/263 (6%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALK-VLNTTSSTIIRHQAAHEAEILKRLDS-QFIVKCHA 112
           LG G  GIV+K   +++  + A+K + +   ++    +   E  IL  L   + IV    
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLN 76
Query: 113 VFYTI-EGEICFVMEHMERGSLFDSLRVRKKLSEDVISG-VAYRVLKGLQYLHGMQIIHG 170
           V     + ++  V ++ME         +R  + E V    V Y+++K ++YLH   ++H 
Sbjct: 77  VLRADNDRDVYLVFDYMETDL---HAVIRANILEPVHKQYVVYQLIKVIKYLHSGGLLHR 133
Query: 171 DIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEA-------AIACMGT 223
           D+KPSN+L+N +  VK+ADFG+SR     R              E            + T
Sbjct: 134 DMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVAT 193
Query: 224 CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFG 283
             Y +PE +        Y    D+WSLG ++ E L G     G      L  +I  I F 
Sbjct: 194 RWYRAPEILLG---STKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFP 250
Query: 284 ERLEMPETASPEFRRFVRSCLEK 306
              ++    SP  +  + S  EK
Sbjct: 251 SNEDVESIQSPFAKTMIESLKEK 273

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 95/213 (44%), Gaps = 18/213 (8%)
Query: 52  LTVLGHGNGGIVYKVRHQKSNSIYALK-VLNTTSSTIIRHQAAHEAEILKRLDSQFIVKC 110
           +  +G+G  G+V   R + +    A+K + N         +   E +ILK      I+  
Sbjct: 60  IETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAI 119
Query: 111 HAVFYTI----EGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQ 166
             +        E +  +V+  +    L   +   + L+ + +    Y++L+GL+Y+H  Q
Sbjct: 120 KDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQ 179
Query: 167 IIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAY 226
           +IH D+KPSNLL+N   E+KI DFG++R +  +                     + T  Y
Sbjct: 180 VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEY----------VATRWY 229
Query: 227 MSPERVDSERWGGDYGFAGDVWSLGVVVLECLV 259
            +PE + S     +Y  A D+WS+G +  E L 
Sbjct: 230 RAPELMLSLH---EYTQAIDLWSVGCIFGEMLA 259

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 72/309 (23%), Positives = 135/309 (43%), Gaps = 43/309 (13%)
Query: 31  HHFPTSNPTSPDVENISDLKKLTV---LGHGNGGIVYK-----VRHQKSNSIYALKVLNT 82
            +F  ++   PD   ++  +K+T+   LG G+ G+VY+     V   +  +  A+K +N 
Sbjct: 7   EYFSAADVYVPDEWEVAR-EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNE 65
Query: 83  TSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFV-MEHMERGSLFDSLR-VR 140
            +S   R +  +EA ++K  +   +V+   V    +G+   V ME M RG L   LR +R
Sbjct: 66  AASMRERIEFLNEASVMKEFNCHHVVRLLGV--VSQGQPTLVIMELMTRGDLKSYLRSLR 123
Query: 141 KKLSEDVISG---------VAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFG 191
            ++  + +           +A  +  G+ YL+  + +H D+   N ++     VKI DFG
Sbjct: 124 PEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFG 183
Query: 192 VSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLG 251
           ++R + ET              G+  +       +MSPE +      G +    DVWS G
Sbjct: 184 MTRDIYETDYYRKG--------GKGLLP----VRWMSPESLKD----GVFTTYSDVWSFG 227
Query: 252 VVVLE-CLVGHYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRK 310
           VV+ E   +   P  G   +     ++  +  G  L+ P+         +R C + + + 
Sbjct: 228 VVLWEIATLAEQPYQGLSNE----QVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKM 283
Query: 311 RGTVEELLA 319
           R +  E+++
Sbjct: 284 RPSFLEIIS 292

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 95/212 (44%), Gaps = 18/212 (8%)
Query: 52  LTVLGHGNGGIVYKVRHQKSNSIYALK-VLNTTSSTIIRHQAAHEAEILKRLDSQFIVKC 110
           +  +G+G  G+V   R + +    A+K + N         +   E +ILK      I+  
Sbjct: 59  IETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAI 118
Query: 111 HAVFYTI----EGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQ 166
             +        E +  +V+  +    L   +   + L+ + +    Y++L+GL+Y+H  Q
Sbjct: 119 KDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQ 178
Query: 167 IIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAY 226
           +IH D+KPSNLL+N   E+KI DFG++R +  +                     + T  Y
Sbjct: 179 VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEY----------VATRWY 228
Query: 227 MSPERVDSERWGGDYGFAGDVWSLGVVVLECL 258
            +PE + S     +Y  A D+WS+G +  E L
Sbjct: 229 RAPELMLSLH---EYTQAIDLWSVGCIFGEML 257

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 74/297 (24%), Positives = 131/297 (44%), Gaps = 36/297 (12%)
Query: 41  PDVENISDLKKLT--VLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEI 98
           P    ++D  +L+  VLG G  G V +  H+++    ALK+L    S   R +  H  + 
Sbjct: 2   PKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLL--YDSPKARQEVDHHWQA 59
Query: 99  LKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVR--KKLSEDVISGVAYRVL 156
                   I+  +   +  +  +  +ME ME G LF  ++ R  +  +E   + +   + 
Sbjct: 60  SGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIG 119
Query: 157 KGLQYLHGMQIIHGDIKPSNLLINGKGE---VKIADFGVSRIVEETRXXXXXXXXXXXXI 213
             +Q+LH   I H D+KP NLL   K +   +K+ DFG ++  E T+             
Sbjct: 120 TAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK--ETTQ------------- 164
Query: 214 GEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPL---IGFGEK 270
             A      T  Y++PE +  E+    Y  + D+WSLGV++   L G  P     G    
Sbjct: 165 -NALQTPCYTPYYVAPEVLGPEK----YDKSCDMWSLGVIMYILLCGFPPFYSNTGQAIS 219
Query: 271 PDLMALICAICFGERLEMPETA--SPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTK 325
           P +   I    +G     PE +  S + ++ +R  L+ D  +R T+ + + +P++ +
Sbjct: 220 PGMKRRIRLGQYG--FPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQ 274

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 74/297 (24%), Positives = 131/297 (44%), Gaps = 36/297 (12%)
Query: 41  PDVENISDLKKLT--VLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEI 98
           P    ++D  +L+  VLG G  G V +  H+++    ALK+L    S   R +  H  + 
Sbjct: 21  PKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLL--YDSPKARQEVDHHWQA 78
Query: 99  LKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVR--KKLSEDVISGVAYRVL 156
                   I+  +   +  +  +  +ME ME G LF  ++ R  +  +E   + +   + 
Sbjct: 79  SGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIG 138
Query: 157 KGLQYLHGMQIIHGDIKPSNLLINGKGE---VKIADFGVSRIVEETRXXXXXXXXXXXXI 213
             +Q+LH   I H D+KP NLL   K +   +K+ DFG ++  E T+             
Sbjct: 139 TAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK--ETTQ------------- 183
Query: 214 GEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPL---IGFGEK 270
             A      T  Y++PE +  E+    Y  + D+WSLGV++   L G  P     G    
Sbjct: 184 -NALQTPCYTPYYVAPEVLGPEK----YDKSCDMWSLGVIMYILLCGFPPFYSNTGQAIS 238
Query: 271 PDLMALICAICFGERLEMPETA--SPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTK 325
           P +   I    +G     PE +  S + ++ +R  L+ D  +R T+ + + +P++ +
Sbjct: 239 PGMKRRIRLGQYG--FPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQ 293

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 104/218 (47%), Gaps = 28/218 (12%)
Query: 49  LKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH-EAEILKRLDSQFI 107
           L+ L  +G G  G V      +     A+K L+    ++I  +  + E  +LK L  + +
Sbjct: 22  LQGLRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENV 81
Query: 108 VKCHAVFY---TIE--GEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYL 162
           +    VF    +IE   E+  V   M  G+  +++   + LS++ +  + Y++L+GL+Y+
Sbjct: 82  IGLLDVFTPATSIEDFSEVYLVTTLM--GADLNNIVKCQALSDEHVQFLVYQLLRGLKYI 139
Query: 163 HGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMG 222
           H   IIH D+KPSN+ +N   E++I DFG++R  +E                      + 
Sbjct: 140 HSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADEE-----------------MTGYVA 182
Query: 223 TCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVG 260
           T  Y +PE + +  W   Y    D+WS+G ++ E L G
Sbjct: 183 TRWYRAPEIMLN--W-MHYNQTVDIWSVGCIMAELLQG 217

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 72/292 (24%), Positives = 126/292 (43%), Gaps = 34/292 (11%)
Query: 47  SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQF 106
           +D+     LG G  G VY+   +K +   A+K L     T+   +   EA ++K +    
Sbjct: 15  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK--EDTMEVEEFLKEAAVMKEIKHPN 72
Query: 107 IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRV--RKKLSEDVISGVAYRVLKGLQYLHG 164
           +V+   V  T E     + E M  G+L D LR   R++++  V+  +A ++   ++YL  
Sbjct: 73  LVQLLGVC-TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 131
Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGT- 223
              IH D+   N L+     VK+ADFG+SR++                 G+   A  G  
Sbjct: 132 KNFIHRDLAARNCLVGENHLVKVADFGLSRLM----------------TGDTYTAHAGAK 175
Query: 224 --CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLE-CLVGHYPLIGFGEKPDLMALICAI 280
               + +PE +   +    +    DVW+ GV++ E    G  P  G     DL  +   +
Sbjct: 176 FPIKWTAPESLAYNK----FSIKSDVWAFGVLLWEIATYGMSPYPGI----DLSQVYELL 227
Query: 281 CFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEEL-LAYPFVTKRSSSSN 331
               R+E PE    +    +R+C + +   R +  E+  A+  + + SS S+
Sbjct: 228 EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISD 279

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 69/282 (24%), Positives = 124/282 (43%), Gaps = 39/282 (13%)
Query: 55  LGHGNGGIVYK-----VRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVK 109
           LG G+ G+VY+     V   +  +  A+K +N  +S   R +  +EA ++K  +   +V+
Sbjct: 27  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 86
Query: 110 CHAVFYTIEGEICFV-MEHMERGSLFDSLR-VRKKLSEDVISG---------VAYRVLKG 158
              V    +G+   V ME M RG L   LR +R ++  + +           +A  +  G
Sbjct: 87  LLGV--VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADG 144
Query: 159 LQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAI 218
           + YL+  + +H D+   N ++     VKI DFG++R + ET              G+  +
Sbjct: 145 MAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKG--------GKGLL 196
Query: 219 ACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLE-CLVGHYPLIGFGEKPDLMALI 277
                  +MSPE +      G +    DVWS GVV+ E   +   P  G   +     ++
Sbjct: 197 P----VRWMSPESLKD----GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE----QVL 244
Query: 278 CAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA 319
             +  G  L+ P+         +R C + + + R +  E+++
Sbjct: 245 RFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 286

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 97/227 (42%), Gaps = 13/227 (5%)
Query: 44  ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLD 103
           E++  L++  VLG G    V    +  ++  YA+K++      I R +   E E+L +  
Sbjct: 11  EDVYQLQE-DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHI-RSRVFREVEMLYQCQ 68
Query: 104 SQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLH 163
               V     F+  E     V E M  GS+   +  R+  +E   S V   V   L +LH
Sbjct: 69  GHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLH 128
Query: 164 GMQIIHGDIKPSNLLI---NGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIAC 220
              I H D+KP N+L    N    VKI DFG+   ++                 E    C
Sbjct: 129 NKGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIK------LNGDCSPISTPELLTPC 182
Query: 221 MGTCAYMSPERVDS-ERWGGDYGFAGDVWSLGVVVLECLVGHYPLIG 266
            G+  YM+PE V++       Y    D+WSLGV++   L G+ P +G
Sbjct: 183 -GSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVG 228

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/279 (22%), Positives = 120/279 (43%), Gaps = 39/279 (13%)
Query: 45  NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDS 104
           N+ +LK L  +G G  G V  +   + N + A+K +   ++         EA ++ +L  
Sbjct: 10  NMKELKLLQTIGKGEFGDVM-LGDYRGNKV-AVKCIKNDATA---QAFLAEASVMTQLRH 64
Query: 105 QFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKK--LSEDVISGVAYRVLKGLQYL 162
             +V+   V    +G +  V E+M +GSL D LR R +  L  D +   +  V + ++YL
Sbjct: 65  SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 124
Query: 163 HGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMG 222
            G   +H D+   N+L++     K++DFG+++    T+             G+  +    
Sbjct: 125 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----------DTGKLPV---- 169
Query: 223 TCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP----DLMALIC 278
              + +PE +        +    DVWS G+++ E       +  FG  P     L  ++ 
Sbjct: 170 --KWTAPEALRE----AAFSTKSDVWSFGILLWE-------IYSFGRVPYPRIPLKDVVP 216
Query: 279 AICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEEL 317
            +  G +++ P+   P     +++C   D   R +  +L
Sbjct: 217 RVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQL 255

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/292 (22%), Positives = 118/292 (40%), Gaps = 70/292 (23%)
Query: 54  VLGHGNGGIVYKVRHQKSNSIYALKVLNTTSST---IIRHQAAHEAEILKRLDSQFIVKC 110
           VLG G  G V ++ ++++   +ALK+L         +  H  A +   + R     IV  
Sbjct: 25  VLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVR-----IVDV 79
Query: 111 HAVFYTIEGEICFVMEHMERGSLFDSLRVR--KKLSEDVISGVAYRVLKGLQYLHGMQII 168
           +   Y     +  VME ++ G LF  ++ R  +  +E   S +   + + +QYLH + I 
Sbjct: 80  YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIA 139
Query: 169 HGDIKPSNLLINGK---GEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCA 225
           H D+KP NLL   K     +K+ DFG ++                               
Sbjct: 140 HRDVKPENLLYTSKRPNAILKLTDFGFAK------------------------------- 168
Query: 226 YMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLI---GFGEKPDLMALICAICF 282
                    E  G  Y  + D+WSLGV++   L G+ P     G    P +   I     
Sbjct: 169 ---------ETTGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI----- 214
Query: 283 GERLEMPETASPEF-------RRFVRSCLEKDWRKRGTVEELLAYPFVTKRS 327
             R+   E  +PE+       +  +R+ L+ +  +R T+ E + +P++ + +
Sbjct: 215 --RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 264

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 108/233 (46%), Gaps = 35/233 (15%)
Query: 95  EAEILKRLDSQF--IVKCHAVFYTIEGEICFVMEHMER-GSLFDSLRVRKKLSEDVISGV 151
           E  +LK++ S F  +++    F   +     ++E ME    LFD +  R  L E++    
Sbjct: 61  EVVLLKKVSSGFSGVIRLLDWFERPDS-FVLILERMEPVQDLFDFITERGALQEELARSF 119
Query: 152 AYRVLKGLQYLHGMQIIHGDIKPSNLLIN-GKGEVKIADFGVSRIVEETRXXXXXXXXXX 210
            ++VL+ +++ H   ++H DIK  N+LI+  +GE+K+ DFG   ++++T           
Sbjct: 120 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----------- 168
Query: 211 XXIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEK 270
                      GT  Y  PE +   R+   +G +  VWSLG+++ + + G  P      +
Sbjct: 169 -----VYTDFDGTRVYSPPEWIRYHRY---HGRSAAVWSLGILLYDMVCGDIPF-----E 215
Query: 271 PDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV 323
            D   +   + F +R+      S E +  +R CL      R T EE+  +P++
Sbjct: 216 HDEEIIRGQVFFRQRV------SSECQHLIRWCLALRPSDRPTFEEIQNHPWM 262

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/254 (24%), Positives = 118/254 (46%), Gaps = 38/254 (14%)
Query: 54  VLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAV 113
           V+G+G+ G+V++ +  +S+ +   KVL        +     E +I++ +    +V   A 
Sbjct: 47  VIGNGSFGVVFQAKLVESDEVAIKKVLQD------KRFKNRELQIMRIVKHPNVVDLKAF 100
Query: 114 FYT-----IEGEICFVMEHMERGSLFDSLRVRKKLSED----VISGVAYRVLKGLQYLHG 164
           FY+      E  +  V+E++   +++ + R   KL +     +I    Y++L+ L Y+H 
Sbjct: 101 FYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS 159
Query: 165 MQIIHGDIKPSNLLINGK-GEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGT 223
           + I H DIKP NLL++   G +K+ DFG ++I+                 GE  ++ + +
Sbjct: 160 IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL---------------IAGEPNVSXICS 204
Query: 224 CAYMSPERVDSERWGG-DYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICF 282
             Y +PE +    +G  +Y    D+WS G V+ E + G  PL       D +  I  +  
Sbjct: 205 RYYRAPELI----FGATNYTTNIDIWSTGCVMAELMQGQ-PLFPGESGIDQLVEIIKVLG 259
Query: 283 GERLEMPETASPEF 296
               E  +T +P +
Sbjct: 260 TPSREQIKTMNPNY 273

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 72/292 (24%), Positives = 126/292 (43%), Gaps = 34/292 (11%)
Query: 47  SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQF 106
           +D+     LG G  G VY+   +K +   A+K L     T+   +   EA ++K +    
Sbjct: 15  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK--EDTMEVEEFLKEAAVMKEIKHPN 72
Query: 107 IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRV--RKKLSEDVISGVAYRVLKGLQYLHG 164
           +V+   V  T E     + E M  G+L D LR   R++++  V+  +A ++   ++YL  
Sbjct: 73  LVQLLGVC-TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 131
Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGT- 223
              IH D+   N L+     VK+ADFG+SR++                 G+   A  G  
Sbjct: 132 KNFIHRDLAARNCLVGENHLVKVADFGLSRLM----------------TGDTYTAHAGAK 175
Query: 224 --CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLE-CLVGHYPLIGFGEKPDLMALICAI 280
               + +PE +   +    +    DVW+ GV++ E    G  P  G     DL  +   +
Sbjct: 176 FPIKWTAPESLAYNK----FSIKSDVWAFGVLLWEIATYGMSPYPGI----DLSQVYELL 227
Query: 281 CFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEEL-LAYPFVTKRSSSSN 331
               R+E PE    +    +R+C + +   R +  E+  A+  + + SS S+
Sbjct: 228 EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISD 279

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 72/292 (24%), Positives = 126/292 (43%), Gaps = 34/292 (11%)
Query: 47  SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQF 106
           +D+     LG G  G VY+   +K +   A+K L     T+   +   EA ++K +    
Sbjct: 26  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK--EDTMEVEEFLKEAAVMKEIKHPN 83
Query: 107 IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRV--RKKLSEDVISGVAYRVLKGLQYLHG 164
           +V+   V  T E     + E M  G+L D LR   R++++  V+  +A ++   ++YL  
Sbjct: 84  LVQLLGVC-TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 142
Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGT- 223
              IH D+   N L+     VK+ADFG+SR++                 G+   A  G  
Sbjct: 143 KNFIHRDLAARNCLVGENHLVKVADFGLSRLM----------------TGDTYTAHAGAK 186
Query: 224 --CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLE-CLVGHYPLIGFGEKPDLMALICAI 280
               + +PE +   +    +    DVW+ GV++ E    G  P  G     DL  +   +
Sbjct: 187 FPIKWTAPESLAYNK----FSIKSDVWAFGVLLWEIATYGMSPYPGI----DLSQVYELL 238
Query: 281 CFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEEL-LAYPFVTKRSSSSN 331
               R+E PE    +    +R+C + +   R +  E+  A+  + + SS S+
Sbjct: 239 EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISD 290

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 72/294 (24%), Positives = 128/294 (43%), Gaps = 38/294 (12%)
Query: 47  SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQF 106
           +D+     LG G  G VY+   +K +   A+K L     T+   +   EA ++K +    
Sbjct: 11  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK--EDTMEVEEFLKEAAVMKEIKHPN 68
Query: 107 IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRV--RKKLSEDVISGVAYRVLKGLQYLHG 164
           +V+   V  T E     ++E M  G+L D LR   R+++S  V+  +A ++   ++YL  
Sbjct: 69  LVQLLGVC-TREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 127
Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGT- 223
              IH D+   N L+     VK+ADFG+SR++                 G+   A  G  
Sbjct: 128 KNFIHRDLAARNCLVGENHLVKVADFGLSRLM----------------TGDTXTAHAGAK 171
Query: 224 --CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECL---VGHYPLIGFGEKPDLMALIC 278
               + +PE +   +    +    DVW+ GV++ E     +  YP I   +  +L+    
Sbjct: 172 FPIKWTAPESLAYNK----FSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLEK-- 225
Query: 279 AICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEEL-LAYPFVTKRSSSSN 331
                 R+E PE    +    +R+C + +   R +  E+  A+  + + SS S+
Sbjct: 226 ----DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISD 275

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 68/275 (24%), Positives = 115/275 (41%), Gaps = 29/275 (10%)
Query: 45  NISDLKKLTVLGHGNGGIVYKVRHQ---KSNSIYALKVLNTTSSTIIRHQAAHEAEILKR 101
           +IS +K   V+G G  G V     +   K     A+K L +  +   R     EA I+ +
Sbjct: 5   DISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQ 64
Query: 102 LDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQ 160
            D   ++    V  T    +  + E ME GSL   LR    + +   + G+   +  G++
Sbjct: 65  FDHPNVIHLEGVV-TKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMK 123
Query: 161 YLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIAC 220
           YL  M  +H  +   N+L+N     K++DFG+SR +E+                 +A+  
Sbjct: 124 YLADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYT---------SALGG 174
Query: 221 MGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP--DL--MAL 276
                + +PE +   +    +  A DVWS G+V+ E       ++ +GE+P  D+    +
Sbjct: 175 KIPIRWTAPEAIQYRK----FTSASDVWSYGIVMWE-------VMSYGERPYWDMTNQDV 223
Query: 277 ICAICFGERLEMPETASPEFRRFVRSCLEKDWRKR 311
           I AI    RL  P        + +  C +KD   R
Sbjct: 224 INAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHR 258

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/274 (23%), Positives = 116/274 (42%), Gaps = 27/274 (9%)
Query: 48  DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFI 107
           DL  L  LG G  G+V   ++ K    Y + +      ++   +   EA+++  L  + +
Sbjct: 10  DLTFLKELGTGQFGVV---KYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKL 66
Query: 108 VKCHAVFYTIEGEICFVMEHMERGSLFDSLR-VRKKLSEDVISGVAYRVLKGLQYLHGMQ 166
           V+ + V  T +  I  + E+M  G L + LR +R +     +  +   V + ++YL   Q
Sbjct: 67  VQLYGVC-TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 125
Query: 167 IIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAY 226
            +H D+   N L+N +G VK++DFG+SR V +                 ++        +
Sbjct: 126 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-------------SSRGSKFPVRW 172
Query: 227 MSPERVDSERWGGDYGFAGDVWSLGVVVLECL-VGHYPLIGFGEKPDLMALICAICFGER 285
             PE +   +    +    D+W+ GV++ E   +G  P   F            I  G R
Sbjct: 173 SPPEVLMYSK----FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAE----HIAQGLR 224
Query: 286 LEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA 319
           L  P  AS +    + SC  +   +R T + LL+
Sbjct: 225 LYRPHLASEKVYTIMYSCWHEKADERPTFKILLS 258

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 68/277 (24%), Positives = 118/277 (42%), Gaps = 33/277 (11%)
Query: 47  SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQF 106
           +D+     LG G  G VY+   +K +   A+K L     T+   +   EA ++K +    
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK--EDTMEVEEFLKEAAVMKEIKHPN 70
Query: 107 IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRV--RKKLSEDVISGVAYRVLKGLQYLHG 164
           +V+   V  T E     + E M  G+L D LR   R++++  V+  +A ++   ++YL  
Sbjct: 71  LVQLLGVC-TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 129
Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGT- 223
              IH D+   N L+     VK+ADFG+SR++                 G+   A  G  
Sbjct: 130 KNFIHRDLAARNCLVGENHLVKVADFGLSRLM----------------TGDTYTAHAGAK 173
Query: 224 --CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLE-CLVGHYPLIGFGEKPDLMALICAI 280
               + +PE +   +    +    DVW+ GV++ E    G  P  G     DL  +   +
Sbjct: 174 FPIKWTAPESLAYNK----FSIKSDVWAFGVLLWEIATYGMSPYPGI----DLSQVYELL 225
Query: 281 CFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEEL 317
               R+E PE    +    +R+C + +   R +  E+
Sbjct: 226 EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 68/277 (24%), Positives = 118/277 (42%), Gaps = 33/277 (11%)
Query: 47  SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQF 106
           +D+     LG G  G VY+   +K +   A+K L     T+   +   EA ++K +    
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK--EDTMEVEEFLKEAAVMKEIKHPN 70
Query: 107 IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRV--RKKLSEDVISGVAYRVLKGLQYLHG 164
           +V+   V  T E     + E M  G+L D LR   R++++  V+  +A ++   ++YL  
Sbjct: 71  LVQLLGVC-TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 129
Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGT- 223
              IH D+   N L+     VK+ADFG+SR++                 G+   A  G  
Sbjct: 130 KNFIHRDLAARNCLVGENHLVKVADFGLSRLM----------------TGDTYTAHAGAK 173
Query: 224 --CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLE-CLVGHYPLIGFGEKPDLMALICAI 280
               + +PE +   +    +    DVW+ GV++ E    G  P  G     DL  +   +
Sbjct: 174 FPIKWTAPESLAYNK----FSIKSDVWAFGVLLWEIATYGMSPYPGI----DLSQVYELL 225
Query: 281 CFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEEL 317
               R+E PE    +    +R+C + +   R +  E+
Sbjct: 226 EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/282 (23%), Positives = 122/282 (43%), Gaps = 39/282 (13%)
Query: 55  LGHGNGGIVYK-----VRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVK 109
           LG G+ G+VY+     V   +  +  A+K +N  +S   R +  +EA ++K  +   +V+
Sbjct: 26  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 85
Query: 110 CHAVFYTIEGEICFV-MEHMERGSLFDSLR-VRKKLSEDVISG---------VAYRVLKG 158
              V    +G+   V ME M RG L   LR +R ++  + +           +A  +  G
Sbjct: 86  LLGV--VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADG 143
Query: 159 LQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAI 218
           + YL+  + +H D+   N ++     VKI DFG++R + ET              G+  +
Sbjct: 144 MAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG--------GKGLL 195
Query: 219 ACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLE-CLVGHYPLIGFGEKPDLMALI 277
                  +MSPE +      G +    DVWS GVV+ E   +   P  G   +     ++
Sbjct: 196 P----VRWMSPESLKD----GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE----QVL 243
Query: 278 CAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA 319
             +  G  L+ P+         +R C + + + R +  E+++
Sbjct: 244 RFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 285

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/282 (23%), Positives = 122/282 (43%), Gaps = 39/282 (13%)
Query: 55  LGHGNGGIVYK-----VRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVK 109
           LG G+ G+VY+     V   +  +  A+K +N  +S   R +  +EA ++K  +   +V+
Sbjct: 23  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 82
Query: 110 CHAVFYTIEGEICFV-MEHMERGSLFDSLR-VRKKLSEDVISG---------VAYRVLKG 158
              V    +G+   V ME M RG L   LR +R  ++ + +           +A  +  G
Sbjct: 83  LLGV--VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 140
Query: 159 LQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAI 218
           + YL+  + +H D+   N ++     VKI DFG++R + ET              G+  +
Sbjct: 141 MAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG--------GKGLL 192
Query: 219 ACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLE-CLVGHYPLIGFGEKPDLMALI 277
                  +MSPE +      G +    DVWS GVV+ E   +   P  G   +     ++
Sbjct: 193 P----VRWMSPESLKD----GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE----QVL 240
Query: 278 CAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA 319
             +  G  L+ P+         +R C + + + R +  E+++
Sbjct: 241 RFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 282

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 69/283 (24%), Positives = 113/283 (39%), Gaps = 38/283 (13%)
Query: 47  SDLKKLTVLGHGNGGIVYK----VRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRL 102
           ++ KK+ VLG G  G VYK       +K     A+K L   +S     +   EA ++  +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 103 DSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQY 161
           D+  +  C  +   +   +  + + M  G L D +R  K  +    +     ++ KG+ Y
Sbjct: 75  DNPHV--CRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 132
Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIV--EETRXXXXXXXXXXXXIGEAAIA 219
           L   +++H D+   N+L+     VKI DFG ++++  EE               G+  I 
Sbjct: 133 LEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEG--------GKVPIK 184
Query: 220 CMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP----DLMA 275
            M   + +   R+        Y    DVWS GV V E       L+ FG KP        
Sbjct: 185 WMALESIL--HRI--------YTHQSDVWSYGVTVWE-------LMTFGSKPYDGIPASE 227
Query: 276 LICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELL 318
           +   +  GERL  P   + +    +  C   D   R    EL+
Sbjct: 228 ISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 270

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/282 (23%), Positives = 122/282 (43%), Gaps = 39/282 (13%)
Query: 55  LGHGNGGIVYK-----VRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVK 109
           LG G+ G+VY+     V   +  +  A+K +N  +S   R +  +EA ++K  +   +V+
Sbjct: 26  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 85
Query: 110 CHAVFYTIEGEICFV-MEHMERGSLFDSLR-VRKKLSEDVISG---------VAYRVLKG 158
              V    +G+   V ME M RG L   LR +R ++  + +           +A  +  G
Sbjct: 86  LLGV--VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADG 143
Query: 159 LQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAI 218
           + YL+  + +H D+   N ++     VKI DFG++R + ET              G+  +
Sbjct: 144 MAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG--------GKGLL 195
Query: 219 ACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLE-CLVGHYPLIGFGEKPDLMALI 277
                  +MSPE +      G +    DVWS GVV+ E   +   P  G   +     ++
Sbjct: 196 P----VRWMSPESLKD----GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE----QVL 243
Query: 278 CAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA 319
             +  G  L+ P+         +R C + + + R +  E+++
Sbjct: 244 RFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 285

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/282 (23%), Positives = 122/282 (43%), Gaps = 39/282 (13%)
Query: 55  LGHGNGGIVYK-----VRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVK 109
           LG G+ G+VY+     V   +  +  A+K +N  +S   R +  +EA ++K  +   +V+
Sbjct: 20  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 79
Query: 110 CHAVFYTIEGEICFV-MEHMERGSLFDSLR-VRKKLSEDVISG---------VAYRVLKG 158
              V    +G+   V ME M RG L   LR +R ++  + +           +A  +  G
Sbjct: 80  LLGV--VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADG 137
Query: 159 LQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAI 218
           + YL+  + +H D+   N ++     VKI DFG++R + ET              G+  +
Sbjct: 138 MAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG--------GKGLL 189
Query: 219 ACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLE-CLVGHYPLIGFGEKPDLMALI 277
                  +MSPE +      G +    DVWS GVV+ E   +   P  G   +     ++
Sbjct: 190 P----VRWMSPESLKD----GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE----QVL 237
Query: 278 CAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA 319
             +  G  L+ P+         +R C + + + R +  E+++
Sbjct: 238 RFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 279

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 103/237 (43%), Gaps = 27/237 (11%)
Query: 95  EAEILKRLDSQFIVKCHAVFYTIEGEICF-VMEHMERG--SLFDSLRVRKKLSEDVISGV 151
           E ++L+RL  + +++   V Y  E +  + VME+   G   + DS+   K+       G 
Sbjct: 56  EIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVP-EKRFPVCQAHGY 114
Query: 152 AYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXX 211
             +++ GL+YLH   I+H DIKP NLL+   G +KI+  GV+  +               
Sbjct: 115 FCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHP------------F 162
Query: 212 XIGEAAIACMGTCAYMSPERVDSERWGGDY--GFAGDVWSLGVVVLECLVGHYPLIGFGE 269
              +      G+ A+  PE  +    G D   GF  D+WS GV +     G YP     E
Sbjct: 163 AADDTCRTSQGSPAFQPPEIAN----GLDTFSGFKVDIWSAGVTLYNITTGLYPF----E 214
Query: 270 KPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKR 326
             ++  L   I  G    +P    P     ++  LE +  KR ++ ++  + +  K+
Sbjct: 215 GDNIYKLFENIGKGS-YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKK 270

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/282 (23%), Positives = 122/282 (43%), Gaps = 39/282 (13%)
Query: 55  LGHGNGGIVYK-----VRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVK 109
           LG G+ G+VY+     V   +  +  A+K +N  +S   R +  +EA ++K  +   +V+
Sbjct: 27  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 86
Query: 110 CHAVFYTIEGEICFV-MEHMERGSLFDSLR-VRKKLSEDVISG---------VAYRVLKG 158
              V    +G+   V ME M RG L   LR +R ++  + +           +A  +  G
Sbjct: 87  LLGV--VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADG 144
Query: 159 LQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAI 218
           + YL+  + +H D+   N ++     VKI DFG++R + ET              G+  +
Sbjct: 145 MAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG--------GKGLL 196
Query: 219 ACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLE-CLVGHYPLIGFGEKPDLMALI 277
                  +MSPE +      G +    DVWS GVV+ E   +   P  G   +     ++
Sbjct: 197 P----VRWMSPESLKD----GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE----QVL 244
Query: 278 CAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA 319
             +  G  L+ P+         +R C + + + R +  E+++
Sbjct: 245 RFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 286

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 69/283 (24%), Positives = 113/283 (39%), Gaps = 38/283 (13%)
Query: 47  SDLKKLTVLGHGNGGIVYK----VRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRL 102
           ++ KK+ VLG G  G VYK       +K     A+K L   +S     +   EA ++  +
Sbjct: 22  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 103 DSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQY 161
           D+  +  C  +   +   +  + + M  G L D +R  K  +    +     ++ KG+ Y
Sbjct: 82  DNPHV--CRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 139
Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIV--EETRXXXXXXXXXXXXIGEAAIA 219
           L   +++H D+   N+L+     VKI DFG ++++  EE               G+  I 
Sbjct: 140 LEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEG--------GKVPIK 191
Query: 220 CMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP----DLMA 275
            M   + +   R+        Y    DVWS GV V E       L+ FG KP        
Sbjct: 192 WMALESIL--HRI--------YTHQSDVWSYGVTVWE-------LMTFGSKPYDGIPASE 234
Query: 276 LICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELL 318
           +   +  GERL  P   + +    +  C   D   R    EL+
Sbjct: 235 ISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 277

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/282 (23%), Positives = 122/282 (43%), Gaps = 39/282 (13%)
Query: 55  LGHGNGGIVYK-----VRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVK 109
           LG G+ G+VY+     V   +  +  A+K +N  +S   R +  +EA ++K  +   +V+
Sbjct: 24  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 83
Query: 110 CHAVFYTIEGEICFV-MEHMERGSLFDSLR-VRKKLSEDVISG---------VAYRVLKG 158
              V    +G+   V ME M RG L   LR +R ++  + +           +A  +  G
Sbjct: 84  LLGV--VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADG 141
Query: 159 LQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAI 218
           + YL+  + +H D+   N ++     VKI DFG++R + ET              G+  +
Sbjct: 142 MAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG--------GKGLL 193
Query: 219 ACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLE-CLVGHYPLIGFGEKPDLMALI 277
                  +MSPE +      G +    DVWS GVV+ E   +   P  G   +     ++
Sbjct: 194 P----VRWMSPESLKD----GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE----QVL 241
Query: 278 CAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA 319
             +  G  L+ P+         +R C + + + R +  E+++
Sbjct: 242 RFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 283

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 72/294 (24%), Positives = 127/294 (43%), Gaps = 38/294 (12%)
Query: 47  SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQF 106
           +D+     LG G  G VY+   +K +   A+K L     T+   +   EA ++K +    
Sbjct: 11  TDITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLK--EDTMEVEEFLKEAAVMKEIKHPN 68
Query: 107 IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRV--RKKLSEDVISGVAYRVLKGLQYLHG 164
           +V+   V  T E     + E M  G+L D LR   R+++S  V+  +A ++   ++YL  
Sbjct: 69  LVQLLGVC-TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 127
Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGT- 223
              IH D+   N L+     VK+ADFG+SR++                 G+   A  G  
Sbjct: 128 KNFIHRDLAARNCLVGENHLVKVADFGLSRLM----------------TGDTXTAHAGAK 171
Query: 224 --CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECL---VGHYPLIGFGEKPDLMALIC 278
               + +PE +   +    +    DVW+ GV++ E     +  YP I   +  +L+    
Sbjct: 172 FPIKWTAPESLAYNK----FSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLEK-- 225
Query: 279 AICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEEL-LAYPFVTKRSSSSN 331
                 R+E PE    +    +R+C + +   R +  E+  A+  + + SS S+
Sbjct: 226 ----DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISD 275

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 96/218 (44%), Gaps = 17/218 (7%)
Query: 54  VLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIR-HQAAHEAEILKRLDSQFIVKCHA 112
           ++G G+ G VY    + +    A+K +N     +I   +   E  IL RL S +I++ + 
Sbjct: 33  LIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYD 92
Query: 113 VFYTIE----GEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQII 168
           +    +     E+  V+E +    L    +    L+E+ I  + Y +L G  ++H   II
Sbjct: 93  LIIPDDLLKFDELYIVLE-IADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGII 151
Query: 169 HGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXX--------XXXIGEAAIAC 220
           H D+KP+N L+N    VK+ DFG++R +   +                    + +   + 
Sbjct: 152 HRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSH 211
Query: 221 MGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECL 258
           + T  Y +PE +       +Y  + D+WS G +  E L
Sbjct: 212 VVTRWYRAPELI---LLQENYTKSIDIWSTGCIFAELL 246

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 68/283 (24%), Positives = 114/283 (40%), Gaps = 38/283 (13%)
Query: 47  SDLKKLTVLGHGNGGIVYK----VRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRL 102
           ++ KK+ VLG G  G VYK       +K     A+K L   +S     +   EA ++  +
Sbjct: 12  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 71
Query: 103 DSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQY 161
           D+  +  C  +   +   +  + + M  G L D +R  K  +    +     ++ +G+ Y
Sbjct: 72  DNPHV--CRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAEGMNY 129
Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIV--EETRXXXXXXXXXXXXIGEAAIA 219
           L   +++H D+   N+L+     VKI DFG+++++  EE               G+  I 
Sbjct: 130 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG--------GKVPIK 181
Query: 220 CMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP----DLMA 275
            M   + +   R+        Y    DVWS GV V E       L+ FG KP        
Sbjct: 182 WMALESIL--HRI--------YTHQSDVWSYGVTVWE-------LMTFGSKPYDGIPASE 224
Query: 276 LICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELL 318
           +   +  GERL  P   + +    +  C   D   R    EL+
Sbjct: 225 ISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 267

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 75/297 (25%), Positives = 123/297 (41%), Gaps = 50/297 (16%)
Query: 54  VLGHGNGGIV-----YKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIV 108
           VLG G  G V     Y +     +   A+K+L   + +  R     E +++ +L S   +
Sbjct: 52  VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 111
Query: 109 KCHAVFYTIEGEICFVMEHMERGSLFDSLRV-RKKLSEDVIS------------------ 149
                  T+ G I  + E+   G L + LR  R+K SED I                   
Sbjct: 112 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 171
Query: 150 ----GVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSR-IVEETRXXXX 204
                 AY+V KG+++L     +H D+   N+L+     VKI DFG++R I+ ++     
Sbjct: 172 EDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVR 231
Query: 205 XXXXXXXXIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECL-VGHYP 263
                    G A +       +M+PE +    + G Y    DVWS G+++ E   +G  P
Sbjct: 232 ---------GNARLP----VKWMAPESL----FEGIYTIKSDVWSYGILLWEIFSLGVNP 274
Query: 264 LIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY 320
             G     +   LI     G +++ P  A+ E    ++SC   D RKR +   L ++
Sbjct: 275 YPGIPVDANFYKLIQN---GFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 328

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 68/283 (24%), Positives = 113/283 (39%), Gaps = 38/283 (13%)
Query: 47  SDLKKLTVLGHGNGGIVYK----VRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRL 102
           ++ KK+ VLG G  G VYK       +K     A+  L   +S     +   EA ++  +
Sbjct: 49  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASV 108
Query: 103 DSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQY 161
           D+  +  C  +   +   +  + + M  G L D +R  K  +    +     ++ KG+ Y
Sbjct: 109 DNPHV--CRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 166
Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIV--EETRXXXXXXXXXXXXIGEAAIA 219
           L   +++H D+   N+L+     VKI DFG+++++  EE               G+  I 
Sbjct: 167 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG--------GKVPIK 218
Query: 220 CMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP----DLMA 275
            M   + +   R+        Y    DVWS GV V E       L+ FG KP        
Sbjct: 219 WMALESIL--HRI--------YTHQSDVWSYGVTVWE-------LMTFGSKPYDGIPASE 261
Query: 276 LICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELL 318
           +   +  GERL  P   + +    +  C   D   R    EL+
Sbjct: 262 ISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 304

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 68/283 (24%), Positives = 113/283 (39%), Gaps = 38/283 (13%)
Query: 47  SDLKKLTVLGHGNGGIVYK----VRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRL 102
           ++ KK+ VL  G  G VYK       +K     A+K L   +S     +   EA ++  +
Sbjct: 15  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 103 DSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQY 161
           D+  +  C  +   +   +  + + M  G L D +R  K  +    +     ++ KG+ Y
Sbjct: 75  DNPHV--CRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 132
Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIV--EETRXXXXXXXXXXXXIGEAAIA 219
           L   +++H D+   N+L+     VKI DFG+++++  EE               G+  I 
Sbjct: 133 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG--------GKVPIK 184
Query: 220 CMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP----DLMA 275
            M   + +   R+        Y    DVWS GV V E       L+ FG KP        
Sbjct: 185 WMALESIL--HRI--------YTHQSDVWSYGVTVWE-------LMTFGSKPYDGIPASE 227
Query: 276 LICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELL 318
           +   +  GERL  P   + +    +  C   D   R    EL+
Sbjct: 228 ISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 270

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 105/232 (45%), Gaps = 33/232 (14%)
Query: 95  EAEILKRLDSQF--IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVA 152
           E  +LK++ S F  +++    F   +  +  +        LFD +  R  L E++     
Sbjct: 104 EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF 163
Query: 153 YRVLKGLQYLHGMQIIHGDIKPSNLLIN-GKGEVKIADFGVSRIVEETRXXXXXXXXXXX 211
           ++VL+ +++ H   ++H DIK  N+LI+  +GE+K+ DFG   ++++T            
Sbjct: 164 WQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT------------ 211
Query: 212 XIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP 271
                     GT  Y  PE +   R+   +G +  VWSLG+++ + + G  P      + 
Sbjct: 212 ----VYTDFDGTRVYSPPEWIRYHRY---HGRSAAVWSLGILLYDMVCGDIPF-----EH 259
Query: 272 DLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV 323
           D   +   + F +R+      S E +  +R CL      R T EE+  +P++
Sbjct: 260 DEEIIRGQVFFRQRV------SSECQHLIRWCLALRPSDRPTFEEIQNHPWM 305

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 88/211 (41%), Gaps = 28/211 (13%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTI-IRHQAAHEAEILKRLDS-------QF 106
           +G G  G VYK R   S    ALK +   +    +      E  +L+RL++       + 
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRL 71
Query: 107 IVKCHAVFYTIEGEICFVMEHMERG-SLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGM 165
           +  C       E ++  V EH+++    +        L  + I  +  + L+GL +LH  
Sbjct: 72  MDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN 131
Query: 166 QIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCA 225
            I+H D+KP N+L+   G VK+ADFG++RI                    A    + T  
Sbjct: 132 CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQM---------------ALFPVVVTLW 176
Query: 226 YMSPERVDSERWGGDYGFAGDVWSLGVVVLE 256
           Y +PE +        Y    D+WS+G +  E
Sbjct: 177 YRAPEVL----LQSTYATPVDMWSVGCIFAE 203

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 72/294 (24%), Positives = 127/294 (43%), Gaps = 38/294 (12%)
Query: 47  SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQF 106
           +D+     LG G  G VY+   +K +   A+K L     T+   +   EA ++K +    
Sbjct: 11  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK--EDTMEVEEFLKEAAVMKEIKHPN 68
Query: 107 IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRV--RKKLSEDVISGVAYRVLKGLQYLHG 164
           +V+   V  T E     + E M  G+L D LR   R+++S  V+  +A ++   ++YL  
Sbjct: 69  LVQLLGVC-TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 127
Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGT- 223
              IH D+   N L+     VK+ADFG+SR++                 G+   A  G  
Sbjct: 128 KNFIHRDLAARNCLVGENHLVKVADFGLSRLM----------------TGDTFTAHAGAK 171
Query: 224 --CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECL---VGHYPLIGFGEKPDLMALIC 278
               + +PE +   +    +    DVW+ GV++ E     +  YP I   +  +L+    
Sbjct: 172 FPIKWTAPESLAYNK----FSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLEK-- 225
Query: 279 AICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEEL-LAYPFVTKRSSSSN 331
                 R+E PE    +    +R+C + +   R +  E+  A+  + + SS S+
Sbjct: 226 ----DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISD 275

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 105/232 (45%), Gaps = 33/232 (14%)
Query: 95  EAEILKRLDSQF--IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVA 152
           E  +LK++ S F  +++    F   +  +  +        LFD +  R  L E++     
Sbjct: 89  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF 148
Query: 153 YRVLKGLQYLHGMQIIHGDIKPSNLLIN-GKGEVKIADFGVSRIVEETRXXXXXXXXXXX 211
           ++VL+ +++ H   ++H DIK  N+LI+  +GE+K+ DFG   ++++T            
Sbjct: 149 WQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT------------ 196
Query: 212 XIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP 271
                     GT  Y  PE +   R+   +G +  VWSLG+++ + + G  P      + 
Sbjct: 197 ----VYTDFDGTRVYSPPEWIRYHRY---HGRSAAVWSLGILLYDMVCGDIPF-----EH 244
Query: 272 DLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV 323
           D   +   + F +R+      S E +  +R CL      R T EE+  +P++
Sbjct: 245 DEEIIRGQVFFRQRV------SSECQHLIRWCLALRPSDRPTFEEIQNHPWM 290

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 68/283 (24%), Positives = 113/283 (39%), Gaps = 38/283 (13%)
Query: 47  SDLKKLTVLGHGNGGIVYK----VRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRL 102
           ++ KK+ VL  G  G VYK       +K     A+K L   +S     +   EA ++  +
Sbjct: 22  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 103 DSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQY 161
           D+  +  C  +   +   +  + + M  G L D +R  K  +    +     ++ KG+ Y
Sbjct: 82  DNPHV--CRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 139
Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIV--EETRXXXXXXXXXXXXIGEAAIA 219
           L   +++H D+   N+L+     VKI DFG+++++  EE               G+  I 
Sbjct: 140 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG--------GKVPIK 191
Query: 220 CMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP----DLMA 275
            M   + +   R+        Y    DVWS GV V E       L+ FG KP        
Sbjct: 192 WMALESIL--HRI--------YTHQSDVWSYGVTVWE-------LMTFGSKPYDGIPASE 234
Query: 276 LICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELL 318
           +   +  GERL  P   + +    +  C   D   R    EL+
Sbjct: 235 ISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 277

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 105/232 (45%), Gaps = 33/232 (14%)
Query: 95  EAEILKRLDSQF--IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVA 152
           E  +LK++ S F  +++    F   +  +  +        LFD +  R  L E++     
Sbjct: 104 EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF 163
Query: 153 YRVLKGLQYLHGMQIIHGDIKPSNLLIN-GKGEVKIADFGVSRIVEETRXXXXXXXXXXX 211
           ++VL+ +++ H   ++H DIK  N+LI+  +GE+K+ DFG   ++++T            
Sbjct: 164 WQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT------------ 211
Query: 212 XIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP 271
                     GT  Y  PE +   R+   +G +  VWSLG+++ + + G  P      + 
Sbjct: 212 ----VYTDFDGTRVYSPPEWIRYHRY---HGRSAAVWSLGILLYDMVCGDIPF-----EH 259
Query: 272 DLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV 323
           D   +   + F +R+      S E +  +R CL      R T EE+  +P++
Sbjct: 260 DEEIIRGQVFFRQRV------SSECQHLIRWCLALRPSDRPTFEEIQNHPWM 305

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 71/275 (25%), Positives = 108/275 (39%), Gaps = 37/275 (13%)
Query: 38  PTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAE 97
           P    V N  DL     +G GN G V+  R +  N++ A+K    T    ++ +   EA 
Sbjct: 105 PKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEAR 164
Query: 98  ILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVR-KKLSEDVISGVAYRVL 156
           ILK+     IV+   V  T +  I  VME ++ G     LR    +L    +  +     
Sbjct: 165 ILKQYSHPNIVRLIGVC-TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAA 223
Query: 157 KGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEA 216
            G++YL     IH D+   N L+  K  +KI+DFG+SR  EE                + 
Sbjct: 224 AGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSR--EE---------------ADG 266
Query: 217 AIACMG-----TCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECL---VGHYPLIGFG 268
             A  G        + +PE ++     G Y    DVWS G+++ E        YP +   
Sbjct: 267 VXAASGGLRQVPVKWTAPEALNY----GRYSSESDVWSFGILLWETFSLGASPYPNLSNQ 322
Query: 269 EKPDLMALICAICFGERLEMPETASPEFRRFVRSC 303
           +  + +        G RL  PE       R +  C
Sbjct: 323 QTREFVEK------GGRLPCPELCPDAVFRLMEQC 351

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 88/214 (41%), Gaps = 31/214 (14%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTI----IRHQAAHEAEILKRLDS------ 104
           +G G  G VYK R   S    ALK +   +       +      E  +L+RL++      
Sbjct: 17  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV 76
Query: 105 -QFIVKCHAVFYTIEGEICFVMEHMERG-SLFDSLRVRKKLSEDVISGVAYRVLKGLQYL 162
            + +  C       E ++  V EH+++    +        L  + I  +  + L+GL +L
Sbjct: 77  VRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFL 136
Query: 163 HGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMG 222
           H   I+H D+KP N+L+   G VK+ADFG++RI                    A    + 
Sbjct: 137 HANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQM---------------ALTPVVV 181
Query: 223 TCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLE 256
           T  Y +PE +        Y    D+WS+G +  E
Sbjct: 182 TLWYRAPEVL----LQSTYATPVDMWSVGCIFAE 211

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 67/282 (23%), Positives = 121/282 (42%), Gaps = 39/282 (13%)
Query: 55  LGHGNGGIVYK-----VRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVK 109
           LG G+ G+VY+     V   +  +  A+K +N  +S   R +  +EA ++K  +   +V+
Sbjct: 20  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 79
Query: 110 CHAVFYTIEGEICFV-MEHMERGSLFDSLR-VRKKLSEDVISG---------VAYRVLKG 158
              V    +G+   V ME M RG L   LR +R ++  + +           +A  +  G
Sbjct: 80  LLGV--VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADG 137
Query: 159 LQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAI 218
           + YL+  + +H D+   N  +     VKI DFG++R + ET              G+  +
Sbjct: 138 MAYLNANKFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKG--------GKGLL 189
Query: 219 ACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLE-CLVGHYPLIGFGEKPDLMALI 277
                  +MSPE +      G +    DVWS GVV+ E   +   P  G   +     ++
Sbjct: 190 P----VRWMSPESLKD----GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE----QVL 237
Query: 278 CAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA 319
             +  G  L+ P+         +R C + + + R +  E+++
Sbjct: 238 RFVMEGGLLDKPDNCPDMLLELMRMCWQYNPKMRPSFLEIIS 279

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 98/217 (45%), Gaps = 39/217 (17%)
Query: 55  LGHGNGGIVYKVRHQKSNSIY-ALKVLNTTS-------STI-----IRHQAAHEAEILKR 101
           +G G  G V+K R  K+   + ALK +   +       STI     +RH    E   + R
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 102 LDSQFIVKCHAVFYTIEGEICFVMEHMERG--SLFDSLRVRKKLSEDVISGVAYRVLKGL 159
           L   F V C       E ++  V EH+++   +  D +     +  + I  + +++L+GL
Sbjct: 79  L---FDV-CTVSRTDRETKLTLVFEHVDQDLTTYLDKVP-EPGVPTETIKDMMFQLLRGL 133
Query: 160 QYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIA 219
            +LH  +++H D+KP N+L+   G++K+ADFG++RI                    A  +
Sbjct: 134 DFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYS---------------FQMALTS 178
Query: 220 CMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLE 256
            + T  Y +PE +        Y    D+WS+G +  E
Sbjct: 179 VVVTLWYRAPEVL----LQSSYATPVDLWSVGCIFAE 211

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 71/275 (25%), Positives = 108/275 (39%), Gaps = 37/275 (13%)
Query: 38  PTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAE 97
           P    V N  DL     +G GN G V+  R +  N++ A+K    T    ++ +   EA 
Sbjct: 105 PKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEAR 164
Query: 98  ILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVR-KKLSEDVISGVAYRVL 156
           ILK+     IV+   V  T +  I  VME ++ G     LR    +L    +  +     
Sbjct: 165 ILKQYSHPNIVRLIGVC-TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAA 223
Query: 157 KGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEA 216
            G++YL     IH D+   N L+  K  +KI+DFG+SR  EE                + 
Sbjct: 224 AGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSR--EE---------------ADG 266
Query: 217 AIACMG-----TCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECL---VGHYPLIGFG 268
             A  G        + +PE ++     G Y    DVWS G+++ E        YP +   
Sbjct: 267 VYAASGGLRQVPVKWTAPEALNY----GRYSSESDVWSFGILLWETFSLGASPYPNLSNQ 322
Query: 269 EKPDLMALICAICFGERLEMPETASPEFRRFVRSC 303
           +  + +        G RL  PE       R +  C
Sbjct: 323 QTREFVEK------GGRLPCPELCPDAVFRLMEQC 351

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 105/232 (45%), Gaps = 33/232 (14%)
Query: 95  EAEILKRLDSQF--IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVA 152
           E  +LK++ S F  +++    F   +  +  +        LFD +  R  L E++     
Sbjct: 90  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF 149
Query: 153 YRVLKGLQYLHGMQIIHGDIKPSNLLIN-GKGEVKIADFGVSRIVEETRXXXXXXXXXXX 211
           ++VL+ +++ H   ++H DIK  N+LI+  +GE+K+ DFG   ++++T            
Sbjct: 150 WQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT------------ 197
Query: 212 XIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP 271
                     GT  Y  PE +   R+   +G +  VWSLG+++ + + G  P      + 
Sbjct: 198 ----VYTDFDGTRVYSPPEWIRYHRY---HGRSAAVWSLGILLYDMVCGDIPF-----EH 245
Query: 272 DLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV 323
           D   +   + F +R+      S E +  +R CL      R T EE+  +P++
Sbjct: 246 DEEIIGGQVFFRQRV------SSECQHLIRWCLALRPSDRPTFEEIQNHPWM 291

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 88/211 (41%), Gaps = 28/211 (13%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTI-IRHQAAHEAEILKRLDS-------QF 106
           +G G  G VYK R   S    ALK +   +    +      E  +L+RL++       + 
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRL 71
Query: 107 IVKCHAVFYTIEGEICFVMEHMERG-SLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGM 165
           +  C       E ++  V EH+++    +        L  + I  +  + L+GL +LH  
Sbjct: 72  MDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN 131
Query: 166 QIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCA 225
            I+H D+KP N+L+   G VK+ADFG++RI                    A    + T  
Sbjct: 132 CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQM---------------ALAPVVVTLW 176
Query: 226 YMSPERVDSERWGGDYGFAGDVWSLGVVVLE 256
           Y +PE +        Y    D+WS+G +  E
Sbjct: 177 YRAPEVL----LQSTYATPVDMWSVGCIFAE 203

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 68/300 (22%), Positives = 121/300 (40%), Gaps = 50/300 (16%)
Query: 31  HHFPTSNPTSPDVENIS-DLKKLTV----LGHGNGGIVYKVRHQKSNSIYALK---VLNT 82
           H  P ++P     + +  D K LT+    LG GN G V K  +Q    +  +    + N 
Sbjct: 4   HESPYADPEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNE 63
Query: 83  TSSTIIRHQAAHEAEILKRLDSQFIVK----CHAVFYTIEGEICFVMEHMERGSLFDSLR 138
            +   ++ +   EA ++++LD+ +IV+    C A  + +      VME  E G L   L+
Sbjct: 64  ANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWML------VMEMAELGPLNKYLQ 117
Query: 139 VRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEE 198
             + + +  I  + ++V  G++YL     +H D+   N+L+  +   KI+DFG+S+ +  
Sbjct: 118 QNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA 177
Query: 199 TRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECL 258
                         +   A  C+    + S                 DVWS GV++ E  
Sbjct: 178 DENYYKAQTHGKWPVKWYAPECINYYKFSS---------------KSDVWSFGVLMWEAF 222
Query: 259 VGHYPLIGFGEKP-------DLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKR 311
                   +G+KP       ++ A++     GER+  P     E    +  C   D   R
Sbjct: 223 -------SYGQKPYRGMKGSEVTAMLEK---GERMGCPAGCPREMYDLMNLCWTYDVENR 272

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 105/232 (45%), Gaps = 33/232 (14%)
Query: 95  EAEILKRLDSQF--IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVA 152
           E  +LK++ S F  +++    F   +  +  +        LFD +  R  L E++     
Sbjct: 76  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF 135
Query: 153 YRVLKGLQYLHGMQIIHGDIKPSNLLIN-GKGEVKIADFGVSRIVEETRXXXXXXXXXXX 211
           ++VL+ +++ H   ++H DIK  N+LI+  +GE+K+ DFG   ++++T            
Sbjct: 136 WQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT------------ 183
Query: 212 XIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP 271
                     GT  Y  PE +   R+   +G +  VWSLG+++ + + G  P      + 
Sbjct: 184 ----VYTDFDGTRVYSPPEWIRYHRY---HGRSAAVWSLGILLYDMVCGDIPF-----EH 231
Query: 272 DLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV 323
           D   +   + F +R+      S E +  +R CL      R T EE+  +P++
Sbjct: 232 DEEIIRGQVFFRQRV------SSECQHLIRWCLALRPSDRPTFEEIQNHPWM 277

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 105/232 (45%), Gaps = 33/232 (14%)
Query: 95  EAEILKRLDSQF--IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVA 152
           E  +LK++ S F  +++    F   +  +  +        LFD +  R  L E++     
Sbjct: 62  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF 121
Query: 153 YRVLKGLQYLHGMQIIHGDIKPSNLLIN-GKGEVKIADFGVSRIVEETRXXXXXXXXXXX 211
           ++VL+ +++ H   ++H DIK  N+LI+  +GE+K+ DFG   ++++T            
Sbjct: 122 WQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT------------ 169
Query: 212 XIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP 271
                     GT  Y  PE +   R+   +G +  VWSLG+++ + + G  P      + 
Sbjct: 170 ----VYTDFDGTRVYSPPEWIRYHRY---HGRSAAVWSLGILLYDMVCGDIPF-----EH 217
Query: 272 DLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV 323
           D   +   + F +R+      S E +  +R CL      R T EE+  +P++
Sbjct: 218 DEEIIRGQVFFRQRV------SSECQHLIRWCLALRPSDRPTFEEIQNHPWM 263

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 105/232 (45%), Gaps = 33/232 (14%)
Query: 95  EAEILKRLDSQF--IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVA 152
           E  +LK++ S F  +++    F   +  +  +        LFD +  R  L E++     
Sbjct: 57  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF 116
Query: 153 YRVLKGLQYLHGMQIIHGDIKPSNLLIN-GKGEVKIADFGVSRIVEETRXXXXXXXXXXX 211
           ++VL+ +++ H   ++H DIK  N+LI+  +GE+K+ DFG   ++++T            
Sbjct: 117 WQVLEAVRHCHNXGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT------------ 164
Query: 212 XIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP 271
                     GT  Y  PE +   R+   +G +  VWSLG+++ + + G  P      + 
Sbjct: 165 ----VYTDFDGTRVYSPPEWIRYHRY---HGRSAAVWSLGILLYDMVCGDIPF-----EH 212
Query: 272 DLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV 323
           D   +   + F +R+      S E +  +R CL      R T EE+  +P++
Sbjct: 213 DEEIIRGQVFFRQRV------SXECQHLIRWCLALRPSDRPTFEEIQNHPWM 258

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 105/232 (45%), Gaps = 33/232 (14%)
Query: 95  EAEILKRLDSQF--IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVA 152
           E  +LK++ S F  +++    F   +  +  +        LFD +  R  L E++     
Sbjct: 77  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF 136
Query: 153 YRVLKGLQYLHGMQIIHGDIKPSNLLIN-GKGEVKIADFGVSRIVEETRXXXXXXXXXXX 211
           ++VL+ +++ H   ++H DIK  N+LI+  +GE+K+ DFG   ++++T            
Sbjct: 137 WQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT------------ 184
Query: 212 XIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP 271
                     GT  Y  PE +   R+   +G +  VWSLG+++ + + G  P      + 
Sbjct: 185 ----VYTDFDGTRVYSPPEWIRYHRY---HGRSAAVWSLGILLYDMVCGDIPF-----EH 232
Query: 272 DLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV 323
           D   +   + F +R+      S E +  +R CL      R T EE+  +P++
Sbjct: 233 DEEIIRGQVFFRQRV------SSECQHLIRWCLALRPSDRPTFEEIQNHPWM 278

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 105/232 (45%), Gaps = 33/232 (14%)
Query: 95  EAEILKRLDSQF--IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVA 152
           E  +LK++ S F  +++    F   +  +  +        LFD +  R  L E++     
Sbjct: 90  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF 149
Query: 153 YRVLKGLQYLHGMQIIHGDIKPSNLLIN-GKGEVKIADFGVSRIVEETRXXXXXXXXXXX 211
           ++VL+ +++ H   ++H DIK  N+LI+  +GE+K+ DFG   ++++T            
Sbjct: 150 WQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT------------ 197
Query: 212 XIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP 271
                     GT  Y  PE +   R+   +G +  VWSLG+++ + + G  P      + 
Sbjct: 198 ----VYTDFDGTRVYSPPEWIRYHRY---HGRSAAVWSLGILLYDMVCGDIPF-----EH 245
Query: 272 DLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV 323
           D   +   + F +R+      S E +  +R CL      R T EE+  +P++
Sbjct: 246 DEEIIGGQVFFRQRV------SSECQHLIRWCLALRPSDRPTFEEIQNHPWM 291

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 105/232 (45%), Gaps = 33/232 (14%)
Query: 95  EAEILKRLDSQF--IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVA 152
           E  +LK++ S F  +++    F   +  +  +        LFD +  R  L E++     
Sbjct: 89  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF 148
Query: 153 YRVLKGLQYLHGMQIIHGDIKPSNLLIN-GKGEVKIADFGVSRIVEETRXXXXXXXXXXX 211
           ++VL+ +++ H   ++H DIK  N+LI+  +GE+K+ DFG   ++++T            
Sbjct: 149 WQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT------------ 196
Query: 212 XIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP 271
                     GT  Y  PE +   R+   +G +  VWSLG+++ + + G  P      + 
Sbjct: 197 ----VYTDFDGTRVYSPPEWIRYHRY---HGRSAAVWSLGILLYDMVCGDIPF-----EH 244
Query: 272 DLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV 323
           D   +   + F +R+      S E +  +R CL      R T EE+  +P++
Sbjct: 245 DEEIIGGQVFFRQRV------SSECQHLIRWCLALRPSDRPTFEEIQNHPWM 290

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 105/232 (45%), Gaps = 33/232 (14%)
Query: 95  EAEILKRLDSQF--IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVA 152
           E  +LK++ S F  +++    F   +  +  +        LFD +  R  L E++     
Sbjct: 109 EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF 168
Query: 153 YRVLKGLQYLHGMQIIHGDIKPSNLLIN-GKGEVKIADFGVSRIVEETRXXXXXXXXXXX 211
           ++VL+ +++ H   ++H DIK  N+LI+  +GE+K+ DFG   ++++T            
Sbjct: 169 WQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT------------ 216
Query: 212 XIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP 271
                     GT  Y  PE +   R+   +G +  VWSLG+++ + + G  P      + 
Sbjct: 217 ----VYTDFDGTRVYSPPEWIRYHRY---HGRSAAVWSLGILLYDMVCGDIPF-----EH 264
Query: 272 DLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV 323
           D   +   + F +R+      S E +  +R CL      R T EE+  +P++
Sbjct: 265 DEEIIRGQVFFRQRV------SXECQHLIRWCLALRPSDRPTFEEIQNHPWM 310

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 105/232 (45%), Gaps = 33/232 (14%)
Query: 95  EAEILKRLDSQF--IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVA 152
           E  +LK++ S F  +++    F   +  +  +        LFD +  R  L E++     
Sbjct: 96  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF 155
Query: 153 YRVLKGLQYLHGMQIIHGDIKPSNLLIN-GKGEVKIADFGVSRIVEETRXXXXXXXXXXX 211
           ++VL+ +++ H   ++H DIK  N+LI+  +GE+K+ DFG   ++++T            
Sbjct: 156 WQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT------------ 203
Query: 212 XIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP 271
                     GT  Y  PE +   R+   +G +  VWSLG+++ + + G  P      + 
Sbjct: 204 ----VYTDFDGTRVYSPPEWIRYHRY---HGRSAAVWSLGILLYDMVCGDIPF-----EH 251
Query: 272 DLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV 323
           D   +   + F +R+      S E +  +R CL      R T EE+  +P++
Sbjct: 252 DEEIIRGQVFFRQRV------SSECQHLIRWCLALRPSDRPTFEEIQNHPWM 297

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 105/232 (45%), Gaps = 33/232 (14%)
Query: 95  EAEILKRLDSQF--IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVA 152
           E  +LK++ S F  +++    F   +  +  +        LFD +  R  L E++     
Sbjct: 62  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF 121
Query: 153 YRVLKGLQYLHGMQIIHGDIKPSNLLIN-GKGEVKIADFGVSRIVEETRXXXXXXXXXXX 211
           ++VL+ +++ H   ++H DIK  N+LI+  +GE+K+ DFG   ++++T            
Sbjct: 122 WQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT------------ 169
Query: 212 XIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP 271
                     GT  Y  PE +   R+   +G +  VWSLG+++ + + G  P      + 
Sbjct: 170 ----VYTDFDGTRVYSPPEWIRYHRY---HGRSAAVWSLGILLYDMVCGDIPF-----EH 217
Query: 272 DLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV 323
           D   +   + F +R+      S E +  +R CL      R T EE+  +P++
Sbjct: 218 DEEIIRGQVFFRQRV------SSECQHLIRWCLALRPSDRPTFEEIQNHPWM 263

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 105/232 (45%), Gaps = 33/232 (14%)
Query: 95  EAEILKRLDSQF--IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVA 152
           E  +LK++ S F  +++    F   +  +  +        LFD +  R  L E++     
Sbjct: 89  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF 148
Query: 153 YRVLKGLQYLHGMQIIHGDIKPSNLLIN-GKGEVKIADFGVSRIVEETRXXXXXXXXXXX 211
           ++VL+ +++ H   ++H DIK  N+LI+  +GE+K+ DFG   ++++T            
Sbjct: 149 WQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT------------ 196
Query: 212 XIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP 271
                     GT  Y  PE +   R+   +G +  VWSLG+++ + + G  P      + 
Sbjct: 197 ----VYTDFDGTRVYSPPEWIRYHRY---HGRSAAVWSLGILLYDMVCGDIPF-----EH 244
Query: 272 DLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV 323
           D   +   + F +R+      S E +  +R CL      R T EE+  +P++
Sbjct: 245 DEEIIGGQVFFRQRV------SSECQHLIRWCLALRPSDRPTFEEIQNHPWM 290

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 105/232 (45%), Gaps = 33/232 (14%)
Query: 95  EAEILKRLDSQF--IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVA 152
           E  +LK++ S F  +++    F   +  +  +        LFD +  R  L E++     
Sbjct: 104 EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF 163
Query: 153 YRVLKGLQYLHGMQIIHGDIKPSNLLIN-GKGEVKIADFGVSRIVEETRXXXXXXXXXXX 211
           ++VL+ +++ H   ++H DIK  N+LI+  +GE+K+ DFG   ++++T            
Sbjct: 164 WQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT------------ 211
Query: 212 XIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP 271
                     GT  Y  PE +   R+   +G +  VWSLG+++ + + G  P      + 
Sbjct: 212 ----VYTDFDGTRVYSPPEWIRYHRY---HGRSAAVWSLGILLYDMVCGDIPF-----EH 259
Query: 272 DLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV 323
           D   +   + F +R+      S E +  +R CL      R T EE+  +P++
Sbjct: 260 DEEIIRGQVFFRQRV------SXECQHLIRWCLALRPSDRPTFEEIQNHPWM 305

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 105/232 (45%), Gaps = 33/232 (14%)
Query: 95  EAEILKRLDSQF--IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVA 152
           E  +LK++ S F  +++    F   +  +  +        LFD +  R  L E++     
Sbjct: 61  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF 120
Query: 153 YRVLKGLQYLHGMQIIHGDIKPSNLLIN-GKGEVKIADFGVSRIVEETRXXXXXXXXXXX 211
           ++VL+ +++ H   ++H DIK  N+LI+  +GE+K+ DFG   ++++T            
Sbjct: 121 WQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT------------ 168
Query: 212 XIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP 271
                     GT  Y  PE +   R+   +G +  VWSLG+++ + + G  P      + 
Sbjct: 169 ----VYTDFDGTRVYSPPEWIRYHRY---HGRSAAVWSLGILLYDMVCGDIPF-----EH 216
Query: 272 DLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV 323
           D   +   + F +R+      S E +  +R CL      R T EE+  +P++
Sbjct: 217 DEEIIRGQVFFRQRV------SSECQHLIRWCLALRPSDRPTFEEIQNHPWM 262

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 105/232 (45%), Gaps = 33/232 (14%)
Query: 95  EAEILKRLDSQF--IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVA 152
           E  +LK++ S F  +++    F   +  +  +        LFD +  R  L E++     
Sbjct: 62  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF 121
Query: 153 YRVLKGLQYLHGMQIIHGDIKPSNLLIN-GKGEVKIADFGVSRIVEETRXXXXXXXXXXX 211
           ++VL+ +++ H   ++H DIK  N+LI+  +GE+K+ DFG   ++++T            
Sbjct: 122 WQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT------------ 169
Query: 212 XIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP 271
                     GT  Y  PE +   R+   +G +  VWSLG+++ + + G  P      + 
Sbjct: 170 ----VYTDFDGTRVYSPPEWIRYHRY---HGRSAAVWSLGILLYDMVCGDIPF-----EH 217
Query: 272 DLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV 323
           D   +   + F +R+      S E +  +R CL      R T EE+  +P++
Sbjct: 218 DEEIIRGQVFFRQRV------SSECQHLIRWCLALRPSDRPTFEEIQNHPWM 263

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 105/232 (45%), Gaps = 33/232 (14%)
Query: 95  EAEILKRLDSQF--IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVA 152
           E  +LK++ S F  +++    F   +  +  +        LFD +  R  L E++     
Sbjct: 76  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF 135
Query: 153 YRVLKGLQYLHGMQIIHGDIKPSNLLIN-GKGEVKIADFGVSRIVEETRXXXXXXXXXXX 211
           ++VL+ +++ H   ++H DIK  N+LI+  +GE+K+ DFG   ++++T            
Sbjct: 136 WQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT------------ 183
Query: 212 XIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP 271
                     GT  Y  PE +   R+   +G +  VWSLG+++ + + G  P      + 
Sbjct: 184 ----VYTDFDGTRVYSPPEWIRYHRY---HGRSAAVWSLGILLYDMVCGDIPF-----EH 231
Query: 272 DLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV 323
           D   +   + F +R+      S E +  +R CL      R T EE+  +P++
Sbjct: 232 DEEIIRGQVFFRQRV------SXECQHLIRWCLALRPSDRPTFEEIQNHPWM 277

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 105/232 (45%), Gaps = 33/232 (14%)
Query: 95  EAEILKRLDSQF--IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVA 152
           E  +LK++ S F  +++    F   +  +  +        LFD +  R  L E++     
Sbjct: 60  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF 119
Query: 153 YRVLKGLQYLHGMQIIHGDIKPSNLLIN-GKGEVKIADFGVSRIVEETRXXXXXXXXXXX 211
           ++VL+ +++ H   ++H DIK  N+LI+  +GE+K+ DFG   ++++T            
Sbjct: 120 WQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT------------ 167
Query: 212 XIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP 271
                     GT  Y  PE +   R+   +G +  VWSLG+++ + + G  P      + 
Sbjct: 168 ----VYTDFDGTRVYSPPEWIRYHRY---HGRSAAVWSLGILLYDMVCGDIPF-----EH 215
Query: 272 DLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV 323
           D   +   + F +R+      S E +  +R CL      R T EE+  +P++
Sbjct: 216 DEEIIRGQVFFRQRV------SSECQHLIRWCLALRPSDRPTFEEIQNHPWM 261

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 71/291 (24%), Positives = 114/291 (39%), Gaps = 56/291 (19%)
Query: 55  LGHGNGGIV-----YKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVK 109
           LG G  G V     Y +   K   + A+K L    +   R     EAE+L  L  + IVK
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD-PTLAARKDFQREAELLTNLQHEHIVK 81
Query: 110 CHAVFYTIEGE---ICFVMEHMERGSLFDSLRVRKKLSEDVISG---------------- 150
               FY + G+   +  V E+M+ G L   LR     +  ++ G                
Sbjct: 82  ----FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 137
Query: 151 VAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXX 210
           +A ++  G+ YL     +H D+   N L+     VKI DFG+SR V  T           
Sbjct: 138 IASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYY-------- 189
Query: 211 XXIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEK 270
                     M    +M PE +   ++  +     DVWS GV++ E       +  +G++
Sbjct: 190 ----RVGGHTMLPIRWMPPESIMYRKFTTE----SDVWSFGVILWE-------IFTYGKQ 234
Query: 271 PDLM----ALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEEL 317
           P        +I  I  G  LE P     E    +  C +++ ++R  ++E+
Sbjct: 235 PWFQLSNTEVIECITQGRVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEI 285

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 105/232 (45%), Gaps = 33/232 (14%)
Query: 95  EAEILKRLDSQF--IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVA 152
           E  +LK++ S F  +++    F   +  +  +        LFD +  R  L E++     
Sbjct: 90  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF 149
Query: 153 YRVLKGLQYLHGMQIIHGDIKPSNLLIN-GKGEVKIADFGVSRIVEETRXXXXXXXXXXX 211
           ++VL+ +++ H   ++H DIK  N+LI+  +GE+K+ DFG   ++++T            
Sbjct: 150 WQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT------------ 197
Query: 212 XIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP 271
                     GT  Y  PE +   R+   +G +  VWSLG+++ + + G  P      + 
Sbjct: 198 ----VYTDFDGTRVYSPPEWIRYHRY---HGRSAAVWSLGILLYDMVCGDIPF-----EH 245
Query: 272 DLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV 323
           D   +   + F +R+      S E +  +R CL      R T EE+  +P++
Sbjct: 246 DEEIIGGQVFFRQRV------SXECQHLIRWCLALRPSDRPTFEEIQNHPWM 291

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 98/217 (45%), Gaps = 39/217 (17%)
Query: 55  LGHGNGGIVYKVRHQKSNSIY-ALKVLNTTS-------STI-----IRHQAAHEAEILKR 101
           +G G  G V+K R  K+   + ALK +   +       STI     +RH    E   + R
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 102 LDSQFIVKCHAVFYTIEGEICFVMEHMERG--SLFDSLRVRKKLSEDVISGVAYRVLKGL 159
           L   F V C       E ++  V EH+++   +  D +     +  + I  + +++L+GL
Sbjct: 79  L---FDV-CTVSRTDRETKLTLVFEHVDQDLTTYLDKVP-EPGVPTETIKDMMFQLLRGL 133
Query: 160 QYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIA 219
            +LH  +++H D+KP N+L+   G++K+ADFG++RI                    A  +
Sbjct: 134 DFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYS---------------FQMALTS 178
Query: 220 CMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLE 256
            + T  Y +PE +        Y    D+WS+G +  E
Sbjct: 179 VVVTLWYRAPEVL----LQSSYATPVDLWSVGCIFAE 211

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 105/232 (45%), Gaps = 33/232 (14%)
Query: 95  EAEILKRLDSQF--IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVA 152
           E  +LK++ S F  +++    F   +  +  +        LFD +  R  L E++     
Sbjct: 77  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF 136
Query: 153 YRVLKGLQYLHGMQIIHGDIKPSNLLIN-GKGEVKIADFGVSRIVEETRXXXXXXXXXXX 211
           ++VL+ +++ H   ++H DIK  N+LI+  +GE+K+ DFG   ++++T            
Sbjct: 137 WQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT------------ 184
Query: 212 XIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP 271
                     GT  Y  PE +   R+   +G +  VWSLG+++ + + G  P      + 
Sbjct: 185 ----VYTDFDGTRVYSPPEWIRYHRY---HGRSAAVWSLGILLYDMVCGDIPF-----EH 232
Query: 272 DLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV 323
           D   +   + F +R+      S E +  +R CL      R T EE+  +P++
Sbjct: 233 DEEIIRGQVFFRQRV------SXECQHLIRWCLALRPXDRPTFEEIQNHPWM 278

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 74/310 (23%), Positives = 124/310 (40%), Gaps = 42/310 (13%)
Query: 45  NISDLKKLT--VLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRL 102
              D+ KLT  +LG G    V      ++   YA+K++   +    R +   E E L + 
Sbjct: 9   KFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHS-RSRVFREVETLYQC 67
Query: 103 DSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYL 162
                +     F+  +     V E ++ GS+   ++ +K  +E   S V   V   L +L
Sbjct: 68  QGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFL 127
Query: 163 HGMQIIHGDIKPSNLLINGK---GEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIA 219
           H   I H D+KP N+L         VKI DF +   ++                 E    
Sbjct: 128 HTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMK------LNNSCTPITTPELTTP 181
Query: 220 CMGTCAYMSPERVDS-ERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGF---------GE 269
           C G+  YM+PE V+        Y    D+WSLGVV+   L G+ P +G          GE
Sbjct: 182 C-GSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGE 240
Query: 270 KPDLMALICAICFGE--------RLEMPETA----SPEFRRFVRSCLEKDWRKRGTVEEL 317
                  +C +C  +        + E P+      S E +  +   L +D ++R +  ++
Sbjct: 241 -------VCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQV 293
Query: 318 LAYPFVTKRS 327
           L +P+V  ++
Sbjct: 294 LQHPWVQGQA 303

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 105/232 (45%), Gaps = 33/232 (14%)
Query: 95  EAEILKRLDSQF--IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVA 152
           E  +LK++ S F  +++    F   +  +  +        LFD +  R  L E++     
Sbjct: 77  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF 136
Query: 153 YRVLKGLQYLHGMQIIHGDIKPSNLLIN-GKGEVKIADFGVSRIVEETRXXXXXXXXXXX 211
           ++VL+ +++ H   ++H DIK  N+LI+  +GE+K+ DFG   ++++T            
Sbjct: 137 WQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT------------ 184
Query: 212 XIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP 271
                     GT  Y  PE +   R+   +G +  VWSLG+++ + + G  P      + 
Sbjct: 185 ----VYTDFDGTRVYSPPEWIRYHRY---HGRSAAVWSLGILLYDMVCGDIPF-----EH 232
Query: 272 DLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV 323
           D   +   + F +R+      S E +  +R CL      R T EE+  +P++
Sbjct: 233 DEEIIRGQVFFRQRV------SXECQHLIRWCLALRPSDRPTFEEIQNHPWM 278

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 105/232 (45%), Gaps = 33/232 (14%)
Query: 95  EAEILKRLDSQF--IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVA 152
           E  +LK++ S F  +++    F   +  +  +        LFD +  R  L E++     
Sbjct: 90  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF 149
Query: 153 YRVLKGLQYLHGMQIIHGDIKPSNLLIN-GKGEVKIADFGVSRIVEETRXXXXXXXXXXX 211
           ++VL+ +++ H   ++H DIK  N+LI+  +GE+K+ DFG   ++++T            
Sbjct: 150 WQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT------------ 197
Query: 212 XIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP 271
                     GT  Y  PE +   R+   +G +  VWSLG+++ + + G  P      + 
Sbjct: 198 ----VYTDFDGTRVYSPPEWIRYHRY---HGRSAAVWSLGILLYDMVCGDIPF-----EH 245
Query: 272 DLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV 323
           D   +   + F +R+      S E +  +R CL      R T EE+  +P++
Sbjct: 246 DEEIIGGQVFFRQRV------SXECQHLIRWCLALRPSDRPTFEEIQNHPWM 291

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 105/232 (45%), Gaps = 33/232 (14%)
Query: 95  EAEILKRLDSQF--IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVA 152
           E  +LK++ S F  +++    F   +  +  +        LFD +  R  L E++     
Sbjct: 89  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF 148
Query: 153 YRVLKGLQYLHGMQIIHGDIKPSNLLIN-GKGEVKIADFGVSRIVEETRXXXXXXXXXXX 211
           ++VL+ +++ H   ++H DIK  N+LI+  +GE+K+ DFG   ++++T            
Sbjct: 149 WQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT------------ 196
Query: 212 XIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP 271
                     GT  Y  PE +   R+   +G +  VWSLG+++ + + G  P      + 
Sbjct: 197 ----VYTDFDGTRVYSPPEWIRYHRY---HGRSAAVWSLGILLYDMVCGDIPF-----EH 244
Query: 272 DLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV 323
           D   +   + F +R+      S E +  +R CL      R T EE+  +P++
Sbjct: 245 DEEIIGGQVFFRQRV------SXECQHLIRWCLALRPSDRPTFEEIQNHPWM 290

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 105/232 (45%), Gaps = 33/232 (14%)
Query: 95  EAEILKRLDSQF--IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVA 152
           E  +LK++ S F  +++    F   +  +  +        LFD +  R  L E++     
Sbjct: 57  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF 116
Query: 153 YRVLKGLQYLHGMQIIHGDIKPSNLLIN-GKGEVKIADFGVSRIVEETRXXXXXXXXXXX 211
           ++VL+ +++ H   ++H DIK  N+LI+  +GE+K+ DFG   ++++T            
Sbjct: 117 WQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT------------ 164
Query: 212 XIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP 271
                     GT  Y  PE +   R+   +G +  VWSLG+++ + + G  P      + 
Sbjct: 165 ----VYTDFDGTRVYSPPEWIRYHRY---HGRSAAVWSLGILLYDMVCGDIPF-----EH 212
Query: 272 DLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV 323
           D   +   + F +R+      S E +  +R CL      R T EE+  +P++
Sbjct: 213 DEEIIRGQVFFRQRV------SSECQHLIRWCLALRPSDRPTFEEIQNHPWM 258

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 96/217 (44%), Gaps = 39/217 (17%)
Query: 55  LGHGNGGIVYKVRHQKSNSIY-ALKVLNTTSS------------TIIRHQAAHEAEILKR 101
           +G G  G V+K R  K+   + ALK +   +              ++RH    E   + R
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 102 LDSQFIVKCHAVFYTIEGEICFVMEHMERG--SLFDSLRVRKKLSEDVISGVAYRVLKGL 159
           L   F V C       E ++  V EH+++   +  D +     +  + I  + +++L+GL
Sbjct: 79  L---FDV-CTVSRTDRETKLTLVFEHVDQDLTTYLDKVP-EPGVPTETIKDMMFQLLRGL 133
Query: 160 QYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIA 219
            +LH  +++H D+KP N+L+   G++K+ADFG++RI                    A  +
Sbjct: 134 DFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYS---------------FQMALTS 178
Query: 220 CMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLE 256
            + T  Y +PE +        Y    D+WS+G +  E
Sbjct: 179 VVVTLWYRAPEVL----LQSSYATPVDLWSVGCIFAE 211

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 88/213 (41%), Gaps = 32/213 (15%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALK---VLNTTSSTIIRHQAAHEAEILKRLDS------- 104
           +G G  G VYK R   S    ALK   V N      I      E  +L+RL++       
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPI--STVREVALLRRLEAFEHPNVV 69
Query: 105 QFIVKCHAVFYTIEGEICFVMEHMERG-SLFDSLRVRKKLSEDVISGVAYRVLKGLQYLH 163
           + +  C       E ++  V EH+++    +        L  + I  +  + L+GL +LH
Sbjct: 70  RLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLH 129
Query: 164 GMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGT 223
              I+H D+KP N+L+   G VK+ADFG++RI                    A    + T
Sbjct: 130 ANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQM---------------ALDPVVVT 174
Query: 224 CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLE 256
             Y +PE +        Y    D+WS+G +  E
Sbjct: 175 LWYRAPEVL----LQSTYATPVDMWSVGCIFAE 203

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 105/232 (45%), Gaps = 33/232 (14%)
Query: 95  EAEILKRLDSQF--IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVA 152
           E  +LK++ S F  +++    F   +  +  +        LFD +  R  L E++     
Sbjct: 84  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF 143
Query: 153 YRVLKGLQYLHGMQIIHGDIKPSNLLIN-GKGEVKIADFGVSRIVEETRXXXXXXXXXXX 211
           ++VL+ +++ H   ++H DIK  N+LI+  +GE+K+ DFG   ++++T            
Sbjct: 144 WQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT------------ 191
Query: 212 XIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP 271
                     GT  Y  PE +   R+   +G +  VWSLG+++ + + G  P      + 
Sbjct: 192 ----VYTDFDGTRVYSPPEWIRYHRY---HGRSAAVWSLGILLYDMVCGDIPF-----EH 239
Query: 272 DLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV 323
           D   +   + F +R+      S E +  +R CL      R T EE+  +P++
Sbjct: 240 DEEIIRGQVFFRQRV------SXECQHLIRWCLALRPSDRPTFEEIQNHPWM 285

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 105/232 (45%), Gaps = 33/232 (14%)
Query: 95  EAEILKRLDSQF--IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVA 152
           E  +LK++ S F  +++    F   +  +  +        LFD +  R  L E++     
Sbjct: 57  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF 116
Query: 153 YRVLKGLQYLHGMQIIHGDIKPSNLLIN-GKGEVKIADFGVSRIVEETRXXXXXXXXXXX 211
           ++VL+ +++ H   ++H DIK  N+LI+  +GE+K+ DFG   ++++T            
Sbjct: 117 WQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT------------ 164
Query: 212 XIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP 271
                     GT  Y  PE +   R+   +G +  VWSLG+++ + + G  P      + 
Sbjct: 165 ----VYTDFDGTRVYSPPEWIRYHRY---HGRSAAVWSLGILLYDMVCGDIPF-----EH 212
Query: 272 DLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV 323
           D   +   + F +R+      S E +  +R CL      R T EE+  +P++
Sbjct: 213 DEEIIGGQVFFRQRV------SSECQHLIRWCLALRPSDRPTFEEIQNHPWM 258

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 71/279 (25%), Positives = 113/279 (40%), Gaps = 32/279 (11%)
Query: 47  SDLKKLTVLGHGNGGIVYK-VRHQKSNSI---YALKVLNTTSSTIIRHQAAHEAEILKRL 102
           ++L+KL VLG G  G V+K V   +  SI     +KV+   S              +  L
Sbjct: 13  TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL 72
Query: 103 DSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRV-RKKLSEDVISGVAYRVLKGLQY 161
           D   IV+   +       +  V +++  GSL D +R  R  L   ++     ++ KG+ Y
Sbjct: 73  DHAHIVRLLGL--CPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYY 130
Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACM 221
           L    ++H ++   N+L+    +V++ADFGV+ ++                         
Sbjct: 131 LEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKT----------- 179
Query: 222 GTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIG--FGEKPDLMALIC 278
               +M+ E +      G Y    DVWS GV V E +  G  P  G    E PDL+    
Sbjct: 180 -PIKWMALESIHF----GKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE--- 231
Query: 279 AICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEEL 317
               GERL  P+  + +    +  C   D   R T +EL
Sbjct: 232 ---KGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKEL 267

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 96/227 (42%), Gaps = 13/227 (5%)
Query: 44  ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLD 103
           E++  L++  VLG G    V    +  ++  YA+K++      I R +   E E+L +  
Sbjct: 11  EDVYQLQE-DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHI-RSRVFREVEMLYQCQ 68
Query: 104 SQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLH 163
               V     F+  E     V E M  GS+   +  R+  +E   S V   V   L +LH
Sbjct: 69  GHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLH 128
Query: 164 GMQIIHGDIKPSNLLI---NGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIAC 220
              I H D+KP N+L    N    VKI DF +   ++                 E    C
Sbjct: 129 NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK------LNGDCSPISTPELLTPC 182
Query: 221 MGTCAYMSPERVDS-ERWGGDYGFAGDVWSLGVVVLECLVGHYPLIG 266
            G+  YM+PE V++       Y    D+WSLGV++   L G+ P +G
Sbjct: 183 -GSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVG 228

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 71/279 (25%), Positives = 113/279 (40%), Gaps = 32/279 (11%)
Query: 47  SDLKKLTVLGHGNGGIVYK-VRHQKSNSI---YALKVLNTTSSTIIRHQAAHEAEILKRL 102
           ++L+KL VLG G  G V+K V   +  SI     +KV+   S              +  L
Sbjct: 31  TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL 90
Query: 103 DSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRV-RKKLSEDVISGVAYRVLKGLQY 161
           D   IV+   +       +  V +++  GSL D +R  R  L   ++     ++ KG+ Y
Sbjct: 91  DHAHIVRLLGL--CPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYY 148
Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACM 221
           L    ++H ++   N+L+    +V++ADFGV+ ++                         
Sbjct: 149 LEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKT----------- 197
Query: 222 GTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIG--FGEKPDLMALIC 278
               +M+ E +      G Y    DVWS GV V E +  G  P  G    E PDL+    
Sbjct: 198 -PIKWMALESIHF----GKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE--- 249
Query: 279 AICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEEL 317
               GERL  P+  + +    +  C   D   R T +EL
Sbjct: 250 ---KGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKEL 285

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 65/282 (23%), Positives = 114/282 (40%), Gaps = 49/282 (17%)
Query: 48  DLKKLTV----LGHGNGGIVYKVRHQKSNSIYALK---VLNTTSSTIIRHQAAHEAEILK 100
           D K LT+    LG GN G V K  +Q    +  +    + N  +   ++ +   EA +++
Sbjct: 367 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQ 426
Query: 101 RLDSQFIVK----CHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVL 156
           +LD+ +IV+    C A  + +      VME  E G L   L+  + + +  I  + ++V 
Sbjct: 427 QLDNPYIVRMIGICEAESWML------VMEMAELGPLNKYLQQNRHVKDKNIIELVHQVS 480
Query: 157 KGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEA 216
            G++YL     +H D+   N+L+  +   KI+DFG+S+ +                +   
Sbjct: 481 MGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY 540
Query: 217 AIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP----- 271
           A  C+    + S                 DVWS GV++ E          +G+KP     
Sbjct: 541 APECINYYKFSS---------------KSDVWSFGVLMWEAF-------SYGQKPYRGMK 578
Query: 272 --DLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKR 311
             ++ A++     GER+  P     E    +  C   D   R
Sbjct: 579 GSEVTAMLEK---GERMGCPAGCPREMYDLMNLCWTYDVENR 617

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 65/282 (23%), Positives = 114/282 (40%), Gaps = 49/282 (17%)
Query: 48  DLKKLTV----LGHGNGGIVYKVRHQKSNSIYALK---VLNTTSSTIIRHQAAHEAEILK 100
           D K LT+    LG GN G V K  +Q    +  +    + N  +   ++ +   EA +++
Sbjct: 366 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQ 425
Query: 101 RLDSQFIVK----CHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVL 156
           +LD+ +IV+    C A  + +      VME  E G L   L+  + + +  I  + ++V 
Sbjct: 426 QLDNPYIVRMIGICEAESWML------VMEMAELGPLNKYLQQNRHVKDKNIIELVHQVS 479
Query: 157 KGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEA 216
            G++YL     +H D+   N+L+  +   KI+DFG+S+ +                +   
Sbjct: 480 MGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY 539
Query: 217 AIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP----- 271
           A  C+    + S                 DVWS GV++ E          +G+KP     
Sbjct: 540 APECINYYKFSS---------------KSDVWSFGVLMWEAF-------SYGQKPYRGMK 577
Query: 272 --DLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKR 311
             ++ A++     GER+  P     E    +  C   D   R
Sbjct: 578 GSEVTAMLEK---GERMGCPAGCPREMYDLMNLCWTYDVENR 616

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 102/223 (45%), Gaps = 23/223 (10%)
Query: 56  GHGNGGIVYK-VRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVF 114
           G G  G+VYK   +  + ++  L  +   ++  ++ Q   E ++  +   + +V+    F
Sbjct: 31  GEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVXAKCQHENLVELLG-F 89
Query: 115 YTIEGEICFVMEHMERGSLFDSLRV---RKKLSEDVISGVAYRVLKGLQYLHGMQIIHGD 171
            +   ++C V  +   GSL D L        LS      +A     G+ +LH    IH D
Sbjct: 90  SSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHXRCKIAQGAANGINFLHENHHIHRD 149
Query: 172 IKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPER 231
           IK +N+L++     KI+DFG++R  E+              +  + I  +GT AY +PE 
Sbjct: 150 IKSANILLDEAFTAKISDFGLARASEK----------FAQXVXXSRI--VGTTAYXAPEA 197
Query: 232 VDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLM 274
           +      G+     D++S GVV+LE + G  P +    +P L+
Sbjct: 198 LR-----GEITPKSDIYSFGVVLLEIITG-LPAVDEHREPQLL 234

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 76/298 (25%), Positives = 114/298 (38%), Gaps = 54/298 (18%)
Query: 37  NPTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSN--SIYALKVLNTTSSTIIRHQAAH 94
           +PT   V + +D+K   V+G GN G V K R +K       A+K +   +S       A 
Sbjct: 5   DPTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAG 64
Query: 95  EAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYR 154
           E E+L +L     +          G +   +E+   G+L D LR  + L  D    +A  
Sbjct: 65  ELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANS 124
Query: 155 ----------------VLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEE 198
                           V +G+ YL   Q IH D+   N+L+      KIADFG+SR  E 
Sbjct: 125 TASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQE- 183
Query: 199 TRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECL 258
                         +G   +  M          ++S  +   Y    DVWS GV++ E  
Sbjct: 184 --------VYVKKTMGRLPVRWMA---------IESLNYSV-YTTNSDVWSYGVLLWE-- 223
Query: 259 VGHYPLIGFGEKPDLMALICAICF-----GERLEMPETASPEFRRFVRSCLEKDWRKR 311
                ++  G  P    + CA  +     G RLE P     E    +R C    WR++
Sbjct: 224 -----IVSLGGTP-YCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQC----WREK 271

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/282 (23%), Positives = 114/282 (40%), Gaps = 49/282 (17%)
Query: 48  DLKKLTV----LGHGNGGIVYKVRHQKSNSIYALK---VLNTTSSTIIRHQAAHEAEILK 100
           D K LT+    LG GN G V K  +Q    +  +    + N  +   ++ +   EA +++
Sbjct: 24  DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQ 83
Query: 101 RLDSQFIVK----CHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVL 156
           +LD+ +IV+    C A  + +      VME  E G L   L+  + + +  I  + ++V 
Sbjct: 84  QLDNPYIVRMIGICEAESWML------VMEMAELGPLNKYLQQNRHVKDKNIIELVHQVS 137
Query: 157 KGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEA 216
            G++YL     +H D+   N+L+  +   KI+DFG+S+ +                +   
Sbjct: 138 MGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY 197
Query: 217 AIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP----- 271
           A  C+    + S                 DVWS GV++ E          +G+KP     
Sbjct: 198 APECINYYKFSS---------------KSDVWSFGVLMWEAF-------SYGQKPYRGMK 235
Query: 272 --DLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKR 311
             ++ A++     GER+  P     E    +  C   D   R
Sbjct: 236 GSEVTAMLEK---GERMGCPAGCPREMYDLMNLCWTYDVENR 274

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/282 (23%), Positives = 114/282 (40%), Gaps = 49/282 (17%)
Query: 48  DLKKLTV----LGHGNGGIVYKVRHQKSNSIYALK---VLNTTSSTIIRHQAAHEAEILK 100
           D K LT+    LG GN G V K  +Q    +  +    + N  +   ++ +   EA +++
Sbjct: 24  DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQ 83
Query: 101 RLDSQFIVK----CHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVL 156
           +LD+ +IV+    C A  + +      VME  E G L   L+  + + +  I  + ++V 
Sbjct: 84  QLDNPYIVRMIGICEAESWML------VMEMAELGPLNKYLQQNRHVKDKNIIELVHQVS 137
Query: 157 KGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEA 216
            G++YL     +H D+   N+L+  +   KI+DFG+S+ +                +   
Sbjct: 138 MGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY 197
Query: 217 AIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP----- 271
           A  C+    + S                 DVWS GV++ E          +G+KP     
Sbjct: 198 APECINYYKFSS---------------KSDVWSFGVLMWEAF-------SYGQKPYRGMK 235
Query: 272 --DLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKR 311
             ++ A++     GER+  P     E    +  C   D   R
Sbjct: 236 GSEVTAMLEK---GERMGCPAGCPREMYDLMNLCWTYDVENR 274

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 76/298 (25%), Positives = 115/298 (38%), Gaps = 54/298 (18%)
Query: 37  NPTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSN--SIYALKVLNTTSSTIIRHQAAH 94
           +PT   V + +D+K   V+G GN G V K R +K       A+K +   +S       A 
Sbjct: 15  DPTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAG 74
Query: 95  EAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYR 154
           E E+L +L     +          G +   +E+   G+L D LR  + L  D    +A  
Sbjct: 75  ELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANS 134
Query: 155 ----------------VLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEE 198
                           V +G+ YL   Q IH D+   N+L+      KIADFG+SR  E 
Sbjct: 135 TASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQE- 193
Query: 199 TRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECL 258
                         +G   +       +M+ E ++       Y    DVWS GV++ E  
Sbjct: 194 --------VYVKKTMGRLPV------RWMAIESLNYSV----YTTNSDVWSYGVLLWE-- 233
Query: 259 VGHYPLIGFGEKPDLMALICAICF-----GERLEMPETASPEFRRFVRSCLEKDWRKR 311
                ++  G  P    + CA  +     G RLE P     E    +R C    WR++
Sbjct: 234 -----IVSLGGTP-YCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQC----WREK 281

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 88/197 (44%), Gaps = 33/197 (16%)
Query: 94  HEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSL--FDS-LRVRKK-----LSE 145
           +E +I+  + +++ + C  +  T   E+  + E+ME  S+  FD    V  K     +  
Sbjct: 92  NELQIITDIKNEYCLTCEGII-TNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPI 150
Query: 146 DVISGVAYRVLKGLQYLHGMQ-IIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXX 204
            VI  +   VL    Y+H  + I H D+KPSN+L++  G VK++DFG S  +        
Sbjct: 151 QVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYM-------- 202
Query: 205 XXXXXXXXIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECL-VGHYP 263
                   + +      GT  +M PE   +E      G   D+WSLG+    CL V  Y 
Sbjct: 203 --------VDKKIKGSRGTYEFMPPEFFSNESSYN--GAKVDIWSLGI----CLYVMFYN 248
Query: 264 LIGFGEKPDLMALICAI 280
           ++ F  K  L+ L   I
Sbjct: 249 VVPFSLKISLVELFNNI 265

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/282 (23%), Positives = 114/282 (40%), Gaps = 49/282 (17%)
Query: 48  DLKKLTV----LGHGNGGIVYKVRHQKSNSIYALK---VLNTTSSTIIRHQAAHEAEILK 100
           D K LT+    LG GN G V K  +Q    +  +    + N  +   ++ +   EA +++
Sbjct: 8   DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQ 67
Query: 101 RLDSQFIVK----CHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVL 156
           +LD+ +IV+    C A  + +      VME  E G L   L+  + + +  I  + ++V 
Sbjct: 68  QLDNPYIVRMIGICEAESWML------VMEMAELGPLNKYLQQNRHVKDKNIIELVHQVS 121
Query: 157 KGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEA 216
            G++YL     +H D+   N+L+  +   KI+DFG+S+ +                +   
Sbjct: 122 MGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY 181
Query: 217 AIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP----- 271
           A  C+    + S                 DVWS GV++ E          +G+KP     
Sbjct: 182 APECINYYKFSS---------------KSDVWSFGVLMWEAF-------SYGQKPYRGMK 219
Query: 272 --DLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKR 311
             ++ A++     GER+  P     E    +  C   D   R
Sbjct: 220 GSEVTAMLEK---GERMGCPAGCPREMYDLMNLCWTYDVENR 258

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 68/288 (23%), Positives = 121/288 (42%), Gaps = 30/288 (10%)
Query: 47  SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAA---HEAEILKRLD 103
            D + L V+G G    V  V+ +++  +YA+K++N     + R + +    E ++L   D
Sbjct: 61  DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWD-MLKRGEVSCFREERDVLVNGD 119
Query: 104 SQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSL-RVRKKLSEDVISGVAYRVLKGLQYL 162
            ++I + H  F   E  +  VME+   G L   L +  +++  ++       ++  +  +
Sbjct: 120 RRWITQLHFAFQD-ENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSV 178
Query: 163 HGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMG 222
           H +  +H DIKP N+L++  G +++ADFG    +                    ++  +G
Sbjct: 179 HRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVR-------------SLVAVG 225
Query: 223 TCAYMSPE---RVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICA 279
           T  Y+SPE    V      G YG   D W+LGV   E   G  P            +   
Sbjct: 226 TPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKI--- 282
Query: 280 ICFGERLEMP---ETASPEFRRFVRS--CLEKDWRKRGTVEELLAYPF 322
           + + E L +P   E    E R F++   C  +    RG   +   +PF
Sbjct: 283 VHYKEHLSLPLVDEGVPEEARDFIQRLLCPPETRLGRGGAGDFRTHPF 330

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/282 (23%), Positives = 114/282 (40%), Gaps = 49/282 (17%)
Query: 48  DLKKLTV----LGHGNGGIVYKVRHQKSNSIYALK---VLNTTSSTIIRHQAAHEAEILK 100
           D K LT+    LG GN G V K  +Q    +  +    + N  +   ++ +   EA +++
Sbjct: 4   DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQ 63
Query: 101 RLDSQFIVK----CHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVL 156
           +LD+ +IV+    C A  + +      VME  E G L   L+  + + +  I  + ++V 
Sbjct: 64  QLDNPYIVRMIGICEAESWML------VMEMAELGPLNKYLQQNRHVKDKNIIELVHQVS 117
Query: 157 KGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEA 216
            G++YL     +H D+   N+L+  +   KI+DFG+S+ +                +   
Sbjct: 118 MGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY 177
Query: 217 AIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP----- 271
           A  C+    + S                 DVWS GV++ E          +G+KP     
Sbjct: 178 APECINYYKFSS---------------KSDVWSFGVLMWEAF-------SYGQKPYRGMK 215
Query: 272 --DLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKR 311
             ++ A++     GER+  P     E    +  C   D   R
Sbjct: 216 GSEVTAMLEK---GERMGCPAGCPREMYDLMNLCWTYDVENR 254

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/271 (23%), Positives = 111/271 (40%), Gaps = 25/271 (9%)
Query: 54  VLGHGNGGIVYKVRH--QKSNSIY-ALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKC 110
           V+G G+ G+VY   +  Q  N I  A+K L+  +          E  +++ L+   ++  
Sbjct: 28  VIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLAL 87
Query: 111 HAVFYTIEGEICFVMEHMERGSLFDSLRV--RKKLSEDVISGVAYRVLKGLQYLHGMQII 168
             +    EG    ++ +M  G L   +R   R    +D+IS    +V +G++YL   + +
Sbjct: 88  IGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLIS-FGLQVARGMEYLAEQKFV 146
Query: 169 HGDIKPSNLLINGKGEVKIADFGVSR-IVEETRXXXXXXXXXXXXIGEAAIACMGTCAYM 227
           H D+   N +++    VK+ADFG++R I++               +   A+  + T  + 
Sbjct: 147 HRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFT 206
Query: 228 SPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLE 287
           +                 DVWS GV++ E L    P     +  DL   +     G RL 
Sbjct: 207 T---------------KSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQ---GRRLP 248
Query: 288 MPETASPEFRRFVRSCLEKDWRKRGTVEELL 318
            PE       + ++ C E D   R T   L+
Sbjct: 249 QPEYCPDSLYQVMQQCWEADPAVRPTFRVLV 279

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/282 (23%), Positives = 114/282 (40%), Gaps = 49/282 (17%)
Query: 48  DLKKLTV----LGHGNGGIVYKVRHQKSNSIYALK---VLNTTSSTIIRHQAAHEAEILK 100
           D K LT+    LG GN G V K  +Q    +  +    + N  +   ++ +   EA +++
Sbjct: 14  DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQ 73
Query: 101 RLDSQFIVK----CHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVL 156
           +LD+ +IV+    C A  + +      VME  E G L   L+  + + +  I  + ++V 
Sbjct: 74  QLDNPYIVRMIGICEAESWML------VMEMAELGPLNKYLQQNRHVKDKNIIELVHQVS 127
Query: 157 KGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEA 216
            G++YL     +H D+   N+L+  +   KI+DFG+S+ +                +   
Sbjct: 128 MGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY 187
Query: 217 AIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP----- 271
           A  C+    + S                 DVWS GV++ E          +G+KP     
Sbjct: 188 APECINYYKFSS---------------KSDVWSFGVLMWEAF-------SYGQKPYRGMK 225
Query: 272 --DLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKR 311
             ++ A++     GER+  P     E    +  C   D   R
Sbjct: 226 GSEVTAMLEK---GERMGCPAGCPREMYDLMNLCWTYDVENR 264

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/282 (23%), Positives = 115/282 (40%), Gaps = 49/282 (17%)
Query: 48  DLKKLTV----LGHGNGGIVYKVRHQKSNSIYALK---VLNTTSSTIIRHQAAHEAEILK 100
           D K LT+    LG GN G V K  +Q    +  +    + N  +   ++ +   EA +++
Sbjct: 8   DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQ 67
Query: 101 RLDSQFIVK----CHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVL 156
           +LD+ +IV+    C A  + +      VME  E G L   L+  + + +  I  + ++V 
Sbjct: 68  QLDNPYIVRMIGICEAESWML------VMEMAELGPLNKYLQQNRHVKDKNIIELVHQVS 121
Query: 157 KGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEA 216
            G++YL     +H D+   N+L+  +   KI+DFG+S+ +                +   
Sbjct: 122 MGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWY 181
Query: 217 AIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP----- 271
           A  C+    + S                 DVWS GV++ E          +G+KP     
Sbjct: 182 APECINYYKFSS---------------KSDVWSFGVLMWEAF-------SYGQKPYRGMK 219
Query: 272 --DLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKR 311
             ++ A++     GER+  P     E    +  C   D   R
Sbjct: 220 GSEVTAMLEK---GERMGCPAGCPREMYDLMNLCWTYDVENR 258

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 73/305 (23%), Positives = 135/305 (44%), Gaps = 42/305 (13%)
Query: 33  FPTSNPTSPDVENISDLKKLTVL---GHGNGGIVYK-----VRHQKSNSIYALKVLNTTS 84
           FP+S    PD   +S  +K+T+L   G G+ G+VY+     +   ++ +  A+K +N ++
Sbjct: 2   FPSSV-FVPDEWEVSR-EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA 59
Query: 85  STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLS 144
           S   R +  +EA ++K      +V+   V    +  +  VME M  G L   LR  +  +
Sbjct: 60  SLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLV-VMELMAHGDLKSYLRSLRPEA 118
Query: 145 ED----------VISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSR 194
           E+           +  +A  +  G+ YL+  + +H D+   N ++     VKI DFG++R
Sbjct: 119 ENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTR 178
Query: 195 IVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVV 254
            + ET              G+  +       +M+PE +      G +  + D+WS GVV+
Sbjct: 179 DIXETDXXRKG--------GKGLLP----VRWMAPESLKD----GVFTTSSDMWSFGVVL 222
Query: 255 LECL-VGHYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGT 313
            E   +   P  G   +     ++  +  G  L+ P+         +R C + + + R T
Sbjct: 223 WEITSLAEQPYQGLSNE----QVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPT 278
Query: 314 VEELL 318
             E++
Sbjct: 279 FLEIV 283

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/282 (23%), Positives = 114/282 (40%), Gaps = 49/282 (17%)
Query: 48  DLKKLTV----LGHGNGGIVYKVRHQKSNSIYALK---VLNTTSSTIIRHQAAHEAEILK 100
           D K LT+    LG GN G V K  +Q    +  +    + N  +   ++ +   EA +++
Sbjct: 2   DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQ 61
Query: 101 RLDSQFIVK----CHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVL 156
           +LD+ +IV+    C A  + +      VME  E G L   L+  + + +  I  + ++V 
Sbjct: 62  QLDNPYIVRMIGICEAESWML------VMEMAELGPLNKYLQQNRHVKDKNIIELVHQVS 115
Query: 157 KGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEA 216
            G++YL     +H D+   N+L+  +   KI+DFG+S+ +                +   
Sbjct: 116 MGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY 175
Query: 217 AIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP----- 271
           A  C+    + S                 DVWS GV++ E          +G+KP     
Sbjct: 176 APECINYYKFSS---------------KSDVWSFGVLMWEAF-------SYGQKPYRGMK 213
Query: 272 --DLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKR 311
             ++ A++     GER+  P     E    +  C   D   R
Sbjct: 214 GSEVTAMLEK---GERMGCPAGCPREMYDLMNLCWTYDVENR 252

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/283 (23%), Positives = 123/283 (43%), Gaps = 37/283 (13%)
Query: 52  LTVLGHGNGGIVYK-----VRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQF 106
           L  LG G+ G+VY+     +   ++ +  A+K +N ++S   R +  +EA ++K      
Sbjct: 19  LRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHH 78
Query: 107 IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSED----------VISGVAYRVL 156
           +V+   V    +  +  VME M  G L   LR  +  +E+           +  +A  + 
Sbjct: 79  VVRLLGVVSKGQPTLV-VMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 137
Query: 157 KGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEA 216
            G+ YL+  + +H D+   N ++     VKI DFG++R + ET              G+ 
Sbjct: 138 DGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKG--------GKG 189
Query: 217 AIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECL-VGHYPLIGFGEKPDLMA 275
            +       +M+PE +      G +  + D+WS GVV+ E   +   P  G   +     
Sbjct: 190 LLP----VRWMAPESLKD----GVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE----Q 237
Query: 276 LICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELL 318
           ++  +  G  L+ P+         +R C + + + R T  E++
Sbjct: 238 VLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIV 280

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 71/305 (23%), Positives = 133/305 (43%), Gaps = 42/305 (13%)
Query: 33  FPTSNPTSPDVENISDLKKLTVL---GHGNGGIVYK-----VRHQKSNSIYALKVLNTTS 84
           FP+S    PD   +S  +K+T+L   G G+ G+VY+     +   ++ +  A+K +N ++
Sbjct: 2   FPSSV-FVPDEWEVSR-EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA 59
Query: 85  STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLS 144
           S   R +  +EA ++K      +V+   V    +  +  VME M  G L   LR  +  +
Sbjct: 60  SLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLV-VMELMAHGDLKSYLRSLRPEA 118
Query: 145 ED----------VISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSR 194
           E+           +  +A  +  G+ YL+  + +H D+   N ++     VKI DFG++R
Sbjct: 119 ENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTR 178
Query: 195 IVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVV 254
            + ET              G+  +       +M+PE +      G +  + D+WS GVV+
Sbjct: 179 DIYETAYYRKG--------GKGLLP----VRWMAPESLKD----GVFTTSSDMWSFGVVL 222
Query: 255 LECL-VGHYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGT 313
            E   +   P  G   +     ++  +  G  L+ P+         +R C + + + R T
Sbjct: 223 WEITSLAEQPYQGLSNE----QVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPT 278
Query: 314 VEELL 318
             E++
Sbjct: 279 FLEIV 283

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 71/305 (23%), Positives = 133/305 (43%), Gaps = 42/305 (13%)
Query: 33  FPTSNPTSPDVENISDLKKLTVL---GHGNGGIVYK-----VRHQKSNSIYALKVLNTTS 84
           FP+S    PD   +S  +K+T+L   G G+ G+VY+     +   ++ +  A+K +N ++
Sbjct: 2   FPSSV-FVPDEWEVSR-EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA 59
Query: 85  STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLS 144
           S   R +  +EA ++K      +V+   V    +  +  VME M  G L   LR  +  +
Sbjct: 60  SLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLV-VMELMAHGDLKSYLRSLRPEA 118
Query: 145 ED----------VISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSR 194
           E+           +  +A  +  G+ YL+  + +H D+   N ++     VKI DFG++R
Sbjct: 119 ENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTR 178
Query: 195 IVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVV 254
            + ET              G+  +       +M+PE +      G +  + D+WS GVV+
Sbjct: 179 DIYETDYYRKG--------GKGLLP----VRWMAPESLKD----GVFTTSSDMWSFGVVL 222
Query: 255 LECL-VGHYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGT 313
            E   +   P  G   +     ++  +  G  L+ P+         +R C + + + R T
Sbjct: 223 WEITSLAEQPYQGLSNE----QVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPT 278
Query: 314 VEELL 318
             E++
Sbjct: 279 FLEIV 283

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 68/278 (24%), Positives = 117/278 (42%), Gaps = 32/278 (11%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNT--TSSTIIRHQAAHEAEILKRLDSQFIVKCHA 112
           LG G  GIV++     S   Y  K +    T   +++     E  IL     + I+  H 
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKK----EISILNIARHRNILHLHE 68
Query: 113 VFYTIEGEICFVMEHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQYLHGMQIIHGD 171
            F ++E E+  + E +    +F+ +     +L+E  I    ++V + LQ+LH   I H D
Sbjct: 69  SFESME-ELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFD 127
Query: 172 IKPSNLLINGK--GEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSP 229
           I+P N++   +    +KI +FG +R ++                G+          Y +P
Sbjct: 128 IRPENIIYQTRRSSTIKIIEFGQARQLKP---------------GDNFRLLFTAPEYYAP 172
Query: 230 ERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICA-ICFGERLEM 288
           E    +        A D+WSLG +V   L G  P +    +  +  ++ A   F E  E 
Sbjct: 173 EVHQHDVVST----ATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDE--EA 226
Query: 289 PETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKR 326
            +  S E   FV   L K+ + R T  E L +P++ ++
Sbjct: 227 FKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 73/305 (23%), Positives = 134/305 (43%), Gaps = 42/305 (13%)
Query: 33  FPTSNPTSPDVENISDLKKLTVL---GHGNGGIVYK-----VRHQKSNSIYALKVLNTTS 84
           FP+S    PD   +S  +K+T+L   G G+ G+VY+     +   ++ +  A+K +N ++
Sbjct: 2   FPSSV-YVPDEWEVSR-EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA 59
Query: 85  STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLS 144
           S   R +  +EA ++K      +V+   V    +  +  VME M  G L   LR  +  +
Sbjct: 60  SLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLV-VMELMAHGDLKSYLRSLRPEA 118
Query: 145 ED----------VISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSR 194
           E+           +  +A  +  G+ YL+  + +H D+   N ++     VKI DFG++R
Sbjct: 119 ENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTR 178
Query: 195 IVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVV 254
            + ET              G+  +       +M+PE +      G +  + D+WS GVV+
Sbjct: 179 DIXETDXXRKG--------GKGLLP----VRWMAPESLKD----GVFTTSSDMWSFGVVL 222
Query: 255 LECL-VGHYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGT 313
            E   +   P  G   +     ++  +  G  L+ P+         +R C + +   R T
Sbjct: 223 WEITSLAEQPYQGLSNE----QVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPNMRPT 278
Query: 314 VEELL 318
             E++
Sbjct: 279 FLEIV 283

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 71/290 (24%), Positives = 113/290 (38%), Gaps = 51/290 (17%)
Query: 47  SDLKKLTVLGHGNGGIVYKVRHQ-----KSNSIYALKVLNTTSSTIIRHQAAHEAEILKR 101
           ++++ +  +G G  G V++ R       +  ++ A+K+L   +S  ++     EA ++  
Sbjct: 47  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 106
Query: 102 LDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRK-----KLSEDVISG------ 150
            D+  IVK   V   +   +C + E+M  G L + LR         LS   +S       
Sbjct: 107 FDNPNIVKLLGVC-AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 165
Query: 151 -------------VAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVE 197
                        +A +V  G+ YL   + +H D+   N L+     VKIADFG+SR + 
Sbjct: 166 PGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 225
Query: 198 ETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLEC 257
                           G  AI       +M PE +   R    Y    DVW+ GVV+ E 
Sbjct: 226 SADYYKAD--------GNDAI----PIRWMPPESIFYNR----YTTESDVWAYGVVLWEI 269
Query: 258 L-VGHYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEK 306
              G  P  G   +     +I  +  G  L  PE    E    +R C  K
Sbjct: 270 FSYGLQPYYGMAHE----EVIYYVRDGNILACPENCPLELYNLMRLCWSK 315

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 64/283 (22%), Positives = 121/283 (42%), Gaps = 37/283 (13%)
Query: 52  LTVLGHGNGGIVYK-----VRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQF 106
           L  LG G+ G+VY+     +   ++ +  A+K +N ++S   R +  +EA ++K      
Sbjct: 21  LRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHH 80
Query: 107 IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSED----------VISGVAYRVL 156
           +V+   V    +  +  VME M  G L   LR  +  +E+           +  +A  + 
Sbjct: 81  VVRLLGVVSKGQPTLV-VMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 139
Query: 157 KGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEA 216
            G+ YL+  + +H D+   N ++     VKI DFG++R + ET              G+ 
Sbjct: 140 DGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKG--------GKG 191
Query: 217 AIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECL-VGHYPLIGFGEKPDLMA 275
            +       +M+PE +      G +  + D+WS GVV+ E   +   P  G   +     
Sbjct: 192 LLP----VRWMAPESLKD----GVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE----Q 239
Query: 276 LICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELL 318
           ++  +  G  L+ P+         +R C + + + R T  E++
Sbjct: 240 VLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIV 282

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 75/298 (25%), Positives = 115/298 (38%), Gaps = 54/298 (18%)
Query: 37  NPTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSN--SIYALKVLNTTSSTIIRHQAAH 94
           +PT   V + +D+K   V+G GN G V K R +K       A+K +   +S       A 
Sbjct: 12  DPTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAG 71
Query: 95  EAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYR 154
           E E+L +L     +          G +   +E+   G+L D LR  + L  D    +A  
Sbjct: 72  ELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANS 131
Query: 155 ----------------VLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEE 198
                           V +G+ YL   Q IH ++   N+L+      KIADFG+SR  E 
Sbjct: 132 TASTLSSQQLLHFAADVARGMDYLSQKQFIHRNLAARNILVGENYVAKIADFGLSRGQE- 190
Query: 199 TRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECL 258
                         +G   +       +M+ E ++       Y    DVWS GV++ E  
Sbjct: 191 --------VYVKKTMGRLPV------RWMAIESLNYSV----YTTNSDVWSYGVLLWE-- 230
Query: 259 VGHYPLIGFGEKPDLMALICAICF-----GERLEMPETASPEFRRFVRSCLEKDWRKR 311
                ++  G  P    + CA  +     G RLE P     E    +R C    WR++
Sbjct: 231 -----IVSLGGTP-YCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQC----WREK 278

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 62/273 (22%), Positives = 109/273 (39%), Gaps = 27/273 (9%)
Query: 54  VLGHGNGGIVY--KVRHQKSNSIY-ALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKC 110
           V+G G+ G VY   +       I+ A+K LN  +      Q   E  I+K      ++  
Sbjct: 56  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 115
Query: 111 HAVFYTIEGEICFVMEHMERGSLFDSLR--VRKKLSEDVISGVAYRVLKGLQYLHGMQII 168
             +    EG    V+ +M+ G L + +R        +D+I G   +V KG++YL   + +
Sbjct: 116 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI-GFGLQVAKGMKYLASKKFV 174
Query: 169 HGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMS 228
           H D+   N +++ K  VK+ADFG++R + +                           +M+
Sbjct: 175 HRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSV----------HNKTGAKLPVKWMA 224
Query: 229 PERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICF--GERL 286
            E + +++    +    DVWS GV++ E +    P       PD+      +    G RL
Sbjct: 225 LESLQTQK----FTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITVYLLQGRRL 275
Query: 287 EMPETASPEFRRFVRSCLEKDWRKRGTVEELLA 319
             PE         +  C       R +  EL++
Sbjct: 276 LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 308

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 62/273 (22%), Positives = 109/273 (39%), Gaps = 27/273 (9%)
Query: 54  VLGHGNGGIVY--KVRHQKSNSIY-ALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKC 110
           V+G G+ G VY   +       I+ A+K LN  +      Q   E  I+K      ++  
Sbjct: 35  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 94
Query: 111 HAVFYTIEGEICFVMEHMERGSLFDSLR--VRKKLSEDVISGVAYRVLKGLQYLHGMQII 168
             +    EG    V+ +M+ G L + +R        +D+I G   +V KG++YL   + +
Sbjct: 95  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI-GFGLQVAKGMKYLASKKFV 153
Query: 169 HGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMS 228
           H D+   N +++ K  VK+ADFG++R + +                           +M+
Sbjct: 154 HRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSV----------HNKTGAKLPVKWMA 203
Query: 229 PERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICF--GERL 286
            E + +++    +    DVWS GV++ E +    P       PD+      +    G RL
Sbjct: 204 LESLQTQK----FTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITVYLLQGRRL 254
Query: 287 EMPETASPEFRRFVRSCLEKDWRKRGTVEELLA 319
             PE         +  C       R +  EL++
Sbjct: 255 LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 287

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 62/273 (22%), Positives = 109/273 (39%), Gaps = 27/273 (9%)
Query: 54  VLGHGNGGIVY--KVRHQKSNSIY-ALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKC 110
           V+G G+ G VY   +       I+ A+K LN  +      Q   E  I+K      ++  
Sbjct: 55  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 114
Query: 111 HAVFYTIEGEICFVMEHMERGSLFDSLR--VRKKLSEDVISGVAYRVLKGLQYLHGMQII 168
             +    EG    V+ +M+ G L + +R        +D+I G   +V KG++YL   + +
Sbjct: 115 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI-GFGLQVAKGMKYLASKKFV 173
Query: 169 HGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMS 228
           H D+   N +++ K  VK+ADFG++R + +                           +M+
Sbjct: 174 HRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSV----------HNKTGAKLPVKWMA 223
Query: 229 PERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICF--GERL 286
            E + +++    +    DVWS GV++ E +    P       PD+      +    G RL
Sbjct: 224 LESLQTQK----FTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITVYLLQGRRL 274
Query: 287 EMPETASPEFRRFVRSCLEKDWRKRGTVEELLA 319
             PE         +  C       R +  EL++
Sbjct: 275 LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 307

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 64/273 (23%), Positives = 111/273 (40%), Gaps = 27/273 (9%)
Query: 54  VLGHGNGGIVY--KVRHQKSNSIY-ALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKC 110
           V+G G+ G VY   +       I+ A+K LN  +      Q   E  I+K      ++  
Sbjct: 36  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 95
Query: 111 HAVFYTIEGEICFVMEHMERGSLFDSLR--VRKKLSEDVISGVAYRVLKGLQYLHGMQII 168
             +    EG    V+ +M+ G L + +R        +D+I G   +V KG++YL   + +
Sbjct: 96  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI-GFGLQVAKGMKYLASKKFV 154
Query: 169 HGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMS 228
           H D+   N +++ K  VK+ADFG++R + +                           +M+
Sbjct: 155 HRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSV----------HNKTGAKLPVKWMA 204
Query: 229 PERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICF--GERL 286
            E + +++    +    DVWS GV++ E +    P       PD+      +    G RL
Sbjct: 205 LESLQTQK----FTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITVYLLQGRRL 255
Query: 287 EMPETASPEFRRFVRSCLEKDWRKRGTVEELLA 319
             PE         +  C       R +  EL++
Sbjct: 256 LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 288

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 62/273 (22%), Positives = 109/273 (39%), Gaps = 27/273 (9%)
Query: 54  VLGHGNGGIVY--KVRHQKSNSIY-ALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKC 110
           V+G G+ G VY   +       I+ A+K LN  +      Q   E  I+K      ++  
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 111 HAVFYTIEGEICFVMEHMERGSLFDSLR--VRKKLSEDVISGVAYRVLKGLQYLHGMQII 168
             +    EG    V+ +M+ G L + +R        +D+I G   +V KG++YL   + +
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI-GFGLQVAKGMKYLASKKFV 155
Query: 169 HGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMS 228
           H D+   N +++ K  VK+ADFG++R + +                           +M+
Sbjct: 156 HRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSV----------HNKTGAKLPVKWMA 205
Query: 229 PERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICF--GERL 286
            E + +++    +    DVWS GV++ E +    P       PD+      +    G RL
Sbjct: 206 LESLQTQK----FTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITVYLLQGRRL 256
Query: 287 EMPETASPEFRRFVRSCLEKDWRKRGTVEELLA 319
             PE         +  C       R +  EL++
Sbjct: 257 LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 289

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 62/273 (22%), Positives = 109/273 (39%), Gaps = 27/273 (9%)
Query: 54  VLGHGNGGIVY--KVRHQKSNSIY-ALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKC 110
           V+G G+ G VY   +       I+ A+K LN  +      Q   E  I+K      ++  
Sbjct: 29  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 88
Query: 111 HAVFYTIEGEICFVMEHMERGSLFDSLR--VRKKLSEDVISGVAYRVLKGLQYLHGMQII 168
             +    EG    V+ +M+ G L + +R        +D+I G   +V KG++YL   + +
Sbjct: 89  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI-GFGLQVAKGMKYLASKKFV 147
Query: 169 HGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMS 228
           H D+   N +++ K  VK+ADFG++R + +                           +M+
Sbjct: 148 HRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSV----------HNKTGAKLPVKWMA 197
Query: 229 PERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICF--GERL 286
            E + +++    +    DVWS GV++ E +    P       PD+      +    G RL
Sbjct: 198 LESLQTQK----FTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITVYLLQGRRL 248
Query: 287 EMPETASPEFRRFVRSCLEKDWRKRGTVEELLA 319
             PE         +  C       R +  EL++
Sbjct: 249 LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 281

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 62/273 (22%), Positives = 109/273 (39%), Gaps = 27/273 (9%)
Query: 54  VLGHGNGGIVY--KVRHQKSNSIY-ALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKC 110
           V+G G+ G VY   +       I+ A+K LN  +      Q   E  I+K      ++  
Sbjct: 32  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 91
Query: 111 HAVFYTIEGEICFVMEHMERGSLFDSLR--VRKKLSEDVISGVAYRVLKGLQYLHGMQII 168
             +    EG    V+ +M+ G L + +R        +D+I G   +V KG++YL   + +
Sbjct: 92  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI-GFGLQVAKGMKYLASKKFV 150
Query: 169 HGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMS 228
           H D+   N +++ K  VK+ADFG++R + +                           +M+
Sbjct: 151 HRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSV----------HNKTGAKLPVKWMA 200
Query: 229 PERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICF--GERL 286
            E + +++    +    DVWS GV++ E +    P       PD+      +    G RL
Sbjct: 201 LESLQTQK----FTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITVYLLQGRRL 251
Query: 287 EMPETASPEFRRFVRSCLEKDWRKRGTVEELLA 319
             PE         +  C       R +  EL++
Sbjct: 252 LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 284

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 62/273 (22%), Positives = 109/273 (39%), Gaps = 27/273 (9%)
Query: 54  VLGHGNGGIVY--KVRHQKSNSIY-ALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKC 110
           V+G G+ G VY   +       I+ A+K LN  +      Q   E  I+K      ++  
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 111 HAVFYTIEGEICFVMEHMERGSLFDSLR--VRKKLSEDVISGVAYRVLKGLQYLHGMQII 168
             +    EG    V+ +M+ G L + +R        +D+I G   +V KG++YL   + +
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI-GFGLQVAKGMKYLASKKFV 155
Query: 169 HGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMS 228
           H D+   N +++ K  VK+ADFG++R + +                           +M+
Sbjct: 156 HRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSV----------HNKTGAKLPVKWMA 205
Query: 229 PERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICF--GERL 286
            E + +++    +    DVWS GV++ E +    P       PD+      +    G RL
Sbjct: 206 LESLQTQK----FTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITVYLLQGRRL 256
Query: 287 EMPETASPEFRRFVRSCLEKDWRKRGTVEELLA 319
             PE         +  C       R +  EL++
Sbjct: 257 LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 289

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 83/175 (47%), Gaps = 21/175 (12%)
Query: 145 EDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXX 204
           ED+IS  +++V +G+++L   + IH D+   N+L++    VKI DFG++R + +      
Sbjct: 199 EDLIS-YSFQVARGMEFLSSRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVR 257
Query: 205 XXXXXXXXIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECL-VGHYP 263
                    G+  +       +M+PE +    +   Y    DVWS GV++ E   +G  P
Sbjct: 258 K--------GDTRLP----LKWMAPESI----FDKIYSTKSDVWSYGVLLWEIFSLGGSP 301
Query: 264 LIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELL 318
             G     D  + +     G R+  PE ++PE  + +  C  +D ++R    EL+
Sbjct: 302 YPGVQMDEDFCSRLRE---GMRMRAPEYSTPEIYQIMLDCWHRDPKERPRFAELV 353

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 62/273 (22%), Positives = 109/273 (39%), Gaps = 27/273 (9%)
Query: 54  VLGHGNGGIVY--KVRHQKSNSIY-ALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKC 110
           V+G G+ G VY   +       I+ A+K LN  +      Q   E  I+K      ++  
Sbjct: 36  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 95
Query: 111 HAVFYTIEGEICFVMEHMERGSLFDSLR--VRKKLSEDVISGVAYRVLKGLQYLHGMQII 168
             +    EG    V+ +M+ G L + +R        +D+I G   +V KG++YL   + +
Sbjct: 96  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI-GFGLQVAKGMKYLASKKFV 154
Query: 169 HGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMS 228
           H D+   N +++ K  VK+ADFG++R + +                           +M+
Sbjct: 155 HRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSV----------HNKTGAKLPVKWMA 204
Query: 229 PERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICF--GERL 286
            E + +++    +    DVWS GV++ E +    P       PD+      +    G RL
Sbjct: 205 LESLQTQK----FTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITVYLLQGRRL 255
Query: 287 EMPETASPEFRRFVRSCLEKDWRKRGTVEELLA 319
             PE         +  C       R +  EL++
Sbjct: 256 LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 288

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 61/262 (23%), Positives = 105/262 (40%), Gaps = 38/262 (14%)
Query: 76  ALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFD 135
           A+K+L  ++    R     E ++L  L +   +       TI G    + E+   G L +
Sbjct: 57  AVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLN 116
Query: 136 SLRVRK------KLSEDVIS------------GVAYRVLKGLQYLHGMQIIHGDIKPSNL 177
            LR ++      K S  ++               +Y+V KG+ +L     IH D+   N+
Sbjct: 117 FLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNI 176
Query: 178 LINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERVDSERW 237
           L+      KI DFG++R ++                G A +       +M+PE +    +
Sbjct: 177 LLTHGRITKICDFGLARDIKNDSNYVVK--------GNARLP----VKWMAPESI----F 220
Query: 238 GGDYGFAGDVWSLGVVVLECL-VGHYPLIGFGEKPDLMALICAICFGERLEMPETASPEF 296
              Y F  DVWS G+ + E   +G  P  G         +I     G R+  PE A  E 
Sbjct: 221 NCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKE---GFRMLSPEHAPAEM 277
Query: 297 RRFVRSCLEKDWRKRGTVEELL 318
              +++C + D  KR T ++++
Sbjct: 278 YDIMKTCWDADPLKRPTFKQIV 299

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 62/273 (22%), Positives = 109/273 (39%), Gaps = 27/273 (9%)
Query: 54  VLGHGNGGIVY--KVRHQKSNSIY-ALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKC 110
           V+G G+ G VY   +       I+ A+K LN  +      Q   E  I+K      ++  
Sbjct: 34  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 93
Query: 111 HAVFYTIEGEICFVMEHMERGSLFDSLR--VRKKLSEDVISGVAYRVLKGLQYLHGMQII 168
             +    EG    V+ +M+ G L + +R        +D+I G   +V KG++YL   + +
Sbjct: 94  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI-GFGLQVAKGMKYLASKKFV 152
Query: 169 HGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMS 228
           H D+   N +++ K  VK+ADFG++R + +                           +M+
Sbjct: 153 HRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSV----------HNKTGAKLPVKWMA 202
Query: 229 PERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICF--GERL 286
            E + +++    +    DVWS GV++ E +    P       PD+      +    G RL
Sbjct: 203 LESLQTQK----FTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITVYLLQGRRL 253
Query: 287 EMPETASPEFRRFVRSCLEKDWRKRGTVEELLA 319
             PE         +  C       R +  EL++
Sbjct: 254 LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 286

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 61/262 (23%), Positives = 105/262 (40%), Gaps = 38/262 (14%)
Query: 76  ALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFD 135
           A+K+L  ++    R     E ++L  L +   +       TI G    + E+   G L +
Sbjct: 80  AVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLN 139
Query: 136 SLRVRK------KLSEDVIS------------GVAYRVLKGLQYLHGMQIIHGDIKPSNL 177
            LR ++      K S  ++               +Y+V KG+ +L     IH D+   N+
Sbjct: 140 FLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNI 199
Query: 178 LINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERVDSERW 237
           L+      KI DFG++R ++                G A +       +M+PE +    +
Sbjct: 200 LLTHGRITKICDFGLARDIKNDSNYVVK--------GNARLP----VKWMAPESI----F 243
Query: 238 GGDYGFAGDVWSLGVVVLECL-VGHYPLIGFGEKPDLMALICAICFGERLEMPETASPEF 296
              Y F  DVWS G+ + E   +G  P  G         +I     G R+  PE A  E 
Sbjct: 244 NCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKE---GFRMLSPEHAPAEM 300
Query: 297 RRFVRSCLEKDWRKRGTVEELL 318
              +++C + D  KR T ++++
Sbjct: 301 YDIMKTCWDADPLKRPTFKQIV 322

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 61/262 (23%), Positives = 105/262 (40%), Gaps = 38/262 (14%)
Query: 76  ALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFD 135
           A+K+L  ++    R     E ++L  L +   +       TI G    + E+   G L +
Sbjct: 80  AVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLN 139
Query: 136 SLRVRK------KLSEDVIS------------GVAYRVLKGLQYLHGMQIIHGDIKPSNL 177
            LR ++      K S  ++               +Y+V KG+ +L     IH D+   N+
Sbjct: 140 FLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNI 199
Query: 178 LINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERVDSERW 237
           L+      KI DFG++R ++                G A +       +M+PE +    +
Sbjct: 200 LLTHGRITKICDFGLARHIKNDSNYVVK--------GNARLP----VKWMAPESI----F 243
Query: 238 GGDYGFAGDVWSLGVVVLECL-VGHYPLIGFGEKPDLMALICAICFGERLEMPETASPEF 296
              Y F  DVWS G+ + E   +G  P  G         +I     G R+  PE A  E 
Sbjct: 244 NCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKE---GFRMLSPEHAPAEM 300
Query: 297 RRFVRSCLEKDWRKRGTVEELL 318
              +++C + D  KR T ++++
Sbjct: 301 YDIMKTCWDADPLKRPTFKQIV 322

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 61/262 (23%), Positives = 105/262 (40%), Gaps = 38/262 (14%)
Query: 76  ALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFD 135
           A+K+L  ++    R     E ++L  L +   +       TI G    + E+   G L +
Sbjct: 73  AVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLN 132
Query: 136 SLRVRK------KLSEDVIS------------GVAYRVLKGLQYLHGMQIIHGDIKPSNL 177
            LR ++      K S  ++               +Y+V KG+ +L     IH D+   N+
Sbjct: 133 FLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNI 192
Query: 178 LINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERVDSERW 237
           L+      KI DFG++R ++                G A +       +M+PE +    +
Sbjct: 193 LLTHGRITKICDFGLARDIKNDSNYVVK--------GNARLP----VKWMAPESI----F 236
Query: 238 GGDYGFAGDVWSLGVVVLECL-VGHYPLIGFGEKPDLMALICAICFGERLEMPETASPEF 296
              Y F  DVWS G+ + E   +G  P  G         +I     G R+  PE A  E 
Sbjct: 237 NCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKE---GFRMLSPEHAPAEM 293
Query: 297 RRFVRSCLEKDWRKRGTVEELL 318
              +++C + D  KR T ++++
Sbjct: 294 YDIMKTCWDADPLKRPTFKQIV 315

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 61/262 (23%), Positives = 105/262 (40%), Gaps = 38/262 (14%)
Query: 76  ALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFD 135
           A+K+L  ++    R     E ++L  L +   +       TI G    + E+   G L +
Sbjct: 75  AVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLN 134
Query: 136 SLRVRK------KLSEDVIS------------GVAYRVLKGLQYLHGMQIIHGDIKPSNL 177
            LR ++      K S  ++               +Y+V KG+ +L     IH D+   N+
Sbjct: 135 FLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNI 194
Query: 178 LINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERVDSERW 237
           L+      KI DFG++R ++                G A +       +M+PE +    +
Sbjct: 195 LLTHGRITKICDFGLARDIKNDSNYVVK--------GNARLP----VKWMAPESI----F 238
Query: 238 GGDYGFAGDVWSLGVVVLECL-VGHYPLIGFGEKPDLMALICAICFGERLEMPETASPEF 296
              Y F  DVWS G+ + E   +G  P  G         +I     G R+  PE A  E 
Sbjct: 239 NCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKE---GFRMLSPEHAPAEM 295
Query: 297 RRFVRSCLEKDWRKRGTVEELL 318
              +++C + D  KR T ++++
Sbjct: 296 YDIMKTCWDADPLKRPTFKQIV 317

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/260 (22%), Positives = 109/260 (41%), Gaps = 37/260 (14%)
Query: 76  ALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFD 135
           A+K+L + ++         E E++K +     +       T +G +  ++E+  +G+L +
Sbjct: 56  AVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE 115
Query: 136 SLRVRK----------------KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLI 179
            L+ R+                +LS   +   AY+V +G++YL   + IH D+   N+L+
Sbjct: 116 YLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV 175
Query: 180 NGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERVDSERWGG 239
                +KIADFG++R +                 G   +       +M+PE +    +  
Sbjct: 176 TEDNVMKIADFGLARDIHHIDYYKKTTN------GRLPV------KWMAPEAL----FDR 219
Query: 240 DYGFAGDVWSLGVVVLECL-VGHYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRR 298
            Y    DVWS GV++ E   +G  P  G      +  L   +  G R++ P   + E   
Sbjct: 220 IYTHQSDVWSFGVLLWEIFTLGGSPYPGVP----VEELFKLLKEGHRMDKPSNCTNELYM 275
Query: 299 FVRSCLEKDWRKRGTVEELL 318
            +R C      +R T ++L+
Sbjct: 276 MMRDCWHAVPSQRPTFKQLV 295

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/220 (23%), Positives = 94/220 (42%), Gaps = 37/220 (16%)
Query: 116 TIEGEICFVMEHMERGSLFDSLRVRK----------------KLSEDVISGVAYRVLKGL 159
           T +G +  ++E+  +G+L + L+ R+                +LS   +   AY+V +G+
Sbjct: 89  TQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGM 148
Query: 160 QYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIA 219
           +YL   + IH D+   N+L+     +KIADFG++R +                 G   + 
Sbjct: 149 EYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN------GRLPV- 201
Query: 220 CMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECL-VGHYPLIGFGEKPDLMALIC 278
                 +M+PE +    +   Y    DVWS GV++ E   +G  P  G      +  L  
Sbjct: 202 -----KWMAPEAL----FDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP----VEELFK 248
Query: 279 AICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELL 318
            +  G R++ P   + E    +R C      +R T ++L+
Sbjct: 249 LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLV 288

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/260 (22%), Positives = 109/260 (41%), Gaps = 37/260 (14%)
Query: 76  ALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFD 135
           A+K+L + ++         E E++K +     +       T +G +  ++E+  +G+L +
Sbjct: 53  AVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE 112
Query: 136 SLRVRK----------------KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLI 179
            L+ R+                +LS   +   AY+V +G++YL   + IH D+   N+L+
Sbjct: 113 YLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV 172
Query: 180 NGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERVDSERWGG 239
                +KIADFG++R +                 G   +       +M+PE +    +  
Sbjct: 173 TEDNVMKIADFGLARDIHHIDYYKKTTN------GRLPV------KWMAPEAL----FDR 216
Query: 240 DYGFAGDVWSLGVVVLECL-VGHYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRR 298
            Y    DVWS GV++ E   +G  P  G      +  L   +  G R++ P   + E   
Sbjct: 217 IYTHQSDVWSFGVLLWEIFTLGGSPYPGVP----VEELFKLLKEGHRMDKPSNCTNELYM 272
Query: 299 FVRSCLEKDWRKRGTVEELL 318
            +R C      +R T ++L+
Sbjct: 273 MMRDCWHAVPSQRPTFKQLV 292

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/260 (22%), Positives = 109/260 (41%), Gaps = 37/260 (14%)
Query: 76  ALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFD 135
           A+K+L + ++         E E++K +     +       T +G +  ++E+  +G+L +
Sbjct: 105 AVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE 164
Query: 136 SLRVRK----------------KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLI 179
            L+ R+                +LS   +   AY+V +G++YL   + IH D+   N+L+
Sbjct: 165 YLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV 224
Query: 180 NGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERVDSERWGG 239
                +KIADFG++R +                 G   +       +M+PE +    +  
Sbjct: 225 TEDNVMKIADFGLARDIHHIDYYKKTTN------GRLPV------KWMAPEAL----FDR 268
Query: 240 DYGFAGDVWSLGVVVLECL-VGHYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRR 298
            Y    DVWS GV++ E   +G  P  G      +  L   +  G R++ P   + E   
Sbjct: 269 IYTHQSDVWSFGVLLWEIFTLGGSPYPGV----PVEELFKLLKEGHRMDKPSNCTNELYM 324
Query: 299 FVRSCLEKDWRKRGTVEELL 318
            +R C      +R T ++L+
Sbjct: 325 MMRDCWHAVPSQRPTFKQLV 344

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/260 (22%), Positives = 109/260 (41%), Gaps = 37/260 (14%)
Query: 76  ALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFD 135
           A+K+L + ++         E E++K +     +       T +G +  ++E+  +G+L +
Sbjct: 64  AVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE 123
Query: 136 SLRVRK----------------KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLI 179
            L+ R+                +LS   +   AY+V +G++YL   + IH D+   N+L+
Sbjct: 124 YLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV 183
Query: 180 NGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERVDSERWGG 239
                +KIADFG++R +                 G   +       +M+PE +    +  
Sbjct: 184 TEDNVMKIADFGLARDIHHIDYYKKTTN------GRLPV------KWMAPEAL----FDR 227
Query: 240 DYGFAGDVWSLGVVVLECL-VGHYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRR 298
            Y    DVWS GV++ E   +G  P  G      +  L   +  G R++ P   + E   
Sbjct: 228 IYTHQSDVWSFGVLLWEIFTLGGSPYPGVP----VEELFKLLKEGHRMDKPSNCTNELYM 283
Query: 299 FVRSCLEKDWRKRGTVEELL 318
            +R C      +R T ++L+
Sbjct: 284 MMRDCWHAVPSQRPTFKQLV 303

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/260 (23%), Positives = 111/260 (42%), Gaps = 37/260 (14%)
Query: 76  ALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFD 135
           A+K+L + ++         E E++K +     +       T +G +  ++E+  +G+L +
Sbjct: 64  AVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE 123
Query: 136 SLRVRK----------------KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLI 179
            L+ R+                +LS   +   AY+V +G++YL   + IH D+   N+L+
Sbjct: 124 YLQARRPPGLEFSFNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV 183
Query: 180 NGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERVDSERWGG 239
                +KIADFG++R +                 G   +       +M+PE +    +  
Sbjct: 184 TEDNVMKIADFGLARDIHHIDXXKKTTN------GRLPV------KWMAPEAL----FDR 227
Query: 240 DYGFAGDVWSLGVVVLECL-VGHYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRR 298
            Y    DVWS GV++ E   +G  P  G      +  L   +  G R++ P   + E   
Sbjct: 228 IYTHQSDVWSFGVLLWEIFTLGGSPYPGVP----VEELFKLLKEGHRMDKPSNCTNELYM 283
Query: 299 FVRSCLEKDWRKRGTVEELL 318
            +R C      +R T ++L+
Sbjct: 284 MMRDCWHAVPSQRPTFKQLV 303

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/260 (22%), Positives = 109/260 (41%), Gaps = 37/260 (14%)
Query: 76  ALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFD 135
           A+K+L + ++         E E++K +     +       T +G +  ++E+  +G+L +
Sbjct: 64  AVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE 123
Query: 136 SLRVRK----------------KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLI 179
            L+ R+                +LS   +   AY+V +G++YL   + IH D+   N+L+
Sbjct: 124 YLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV 183
Query: 180 NGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERVDSERWGG 239
                +KIADFG++R +                 G   +       +M+PE +    +  
Sbjct: 184 TEDNVMKIADFGLARDIHHIDYYKKTTN------GRLPV------KWMAPEAL----FDR 227
Query: 240 DYGFAGDVWSLGVVVLECL-VGHYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRR 298
            Y    DVWS GV++ E   +G  P  G      +  L   +  G R++ P   + E   
Sbjct: 228 IYTHQSDVWSFGVLLWEIFTLGGSPYPGVP----VEELFKLLKEGHRMDKPSNCTNELYM 283
Query: 299 FVRSCLEKDWRKRGTVEELL 318
            +R C      +R T ++L+
Sbjct: 284 MMRDCWHAVPSQRPTFKQLV 303

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/220 (23%), Positives = 94/220 (42%), Gaps = 37/220 (16%)
Query: 116 TIEGEICFVMEHMERGSLFDSLRVRK----------------KLSEDVISGVAYRVLKGL 159
           T +G +  ++E+  +G+L + L+ R+                +LS   +   AY+V +G+
Sbjct: 97  TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGM 156
Query: 160 QYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIA 219
           +YL   + IH D+   N+L+     +KIADFG++R +                 G   + 
Sbjct: 157 EYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN------GRLPV- 209
Query: 220 CMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECL-VGHYPLIGFGEKPDLMALIC 278
                 +M+PE +    +   Y    DVWS GV++ E   +G  P  G      +  L  
Sbjct: 210 -----KWMAPEAL----FDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP----VEELFK 256
Query: 279 AICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELL 318
            +  G R++ P   + E    +R C      +R T ++L+
Sbjct: 257 LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLV 296

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 92/221 (41%), Gaps = 32/221 (14%)
Query: 55  LGHGNGGIVYKVRHQKSNSI--YALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHA 112
           +G G  G VYK + +       YALK +  T    I   A  E  +L+ L    ++    
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG---ISMSACREIALLRELKHPNVISLQK 85
Query: 113 VFYTIEGEICFVMEHMERGSLFDSLRVRK---------KLSEDVISGVAYRVLKGLQYLH 163
           VF +      +++       L+  ++  +         +L   ++  + Y++L G+ YLH
Sbjct: 86  VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 145
Query: 164 GMQIIHGDIKPSNLLING----KGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIA 219
              ++H D+KP+N+L+ G    +G VKIAD G +R+                        
Sbjct: 146 ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD-----------P 194
Query: 220 CMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVG 260
            + T  Y +PE +   R    Y  A D+W++G +  E L  
Sbjct: 195 VVVTFWYRAPELLLGAR---HYTKAIDIWAIGCIFAELLTS 232

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 70/305 (22%), Positives = 132/305 (43%), Gaps = 42/305 (13%)
Query: 33  FPTSNPTSPDVENISDLKKLTVL---GHGNGGIVYK-----VRHQKSNSIYALKVLNTTS 84
           FP+S    PD   +S  +K+T+L   G G+ G+VY+     +   ++ +  A+K +N ++
Sbjct: 2   FPSSV-YVPDEWEVSR-EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA 59
Query: 85  STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLS 144
           S   R +  +EA ++K      +V+   V    +  +  VME M  G L   LR  +  +
Sbjct: 60  SLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLV-VMELMAHGDLKSYLRSLRPEA 118
Query: 145 ED----------VISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSR 194
           E+           +  +A  +  G+ YL+  + +H ++   N ++     VKI DFG++R
Sbjct: 119 ENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMTR 178
Query: 195 IVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVV 254
            + ET              G+  +       +M+PE +      G +  + D+WS GVV+
Sbjct: 179 DIYETDYYRKG--------GKGLLP----VRWMAPESLKD----GVFTTSSDMWSFGVVL 222
Query: 255 LECL-VGHYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGT 313
            E   +   P  G   +     ++  +  G  L+ P+         +R C + +   R T
Sbjct: 223 WEITSLAEQPYQGLSNE----QVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPNMRPT 278
Query: 314 VEELL 318
             E++
Sbjct: 279 FLEIV 283

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 70/305 (22%), Positives = 132/305 (43%), Gaps = 42/305 (13%)
Query: 33  FPTSNPTSPDVENISDLKKLTVL---GHGNGGIVYK-----VRHQKSNSIYALKVLNTTS 84
           FP+S    PD   +S  +K+T+L   G G+ G+VY+     +   ++ +  A+K +N ++
Sbjct: 3   FPSSV-YVPDEWEVSR-EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA 60
Query: 85  STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLS 144
           S   R +  +EA ++K      +V+   V    +  +  VME M  G L   LR  +  +
Sbjct: 61  SLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLV-VMELMAHGDLKSYLRSLRPEA 119
Query: 145 ED----------VISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSR 194
           E+           +  +A  +  G+ YL+  + +H ++   N ++     VKI DFG++R
Sbjct: 120 ENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMTR 179
Query: 195 IVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVV 254
            + ET              G+  +       +M+PE +      G +  + D+WS GVV+
Sbjct: 180 DIYETDYYRKG--------GKGLLP----VRWMAPESLKD----GVFTTSSDMWSFGVVL 223
Query: 255 LECL-VGHYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGT 313
            E   +   P  G   +     ++  +  G  L+ P+         +R C + +   R T
Sbjct: 224 WEITSLAEQPYQGLSNE----QVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPNMRPT 279
Query: 314 VEELL 318
             E++
Sbjct: 280 FLEIV 284

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/253 (24%), Positives = 108/253 (42%), Gaps = 24/253 (9%)
Query: 27  RRRRHHF--PTSNPTSPDVE-NISDLKKLT-VLGHGNGGIVYKVRHQKSNSIYALK-VLN 81
           +R++HH   PT++   P  +  I D  ++  ++G G+ G V +   +    + A+K +L 
Sbjct: 29  QRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILR 88
Query: 82  TTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEI---CFVMEHMERGSLFDSLR 138
                I   +   E  IL RL+   +VK   +    + E     +V+  +         R
Sbjct: 89  VFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFR 148
Query: 139 VRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVE- 197
               L+E  I  + Y +L G++Y+H   I+H D+KP+N L+N    VK+ DFG++R V+ 
Sbjct: 149 TPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDY 208
Query: 198 ------------ETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERVDSERWGGDYGFAG 245
                                      +       + T  Y +PE +  +    +Y  A 
Sbjct: 209 PENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQE---NYTEAI 265
Query: 246 DVWSLGVVVLECL 258
           DVWS+G +  E L
Sbjct: 266 DVWSIGCIFAELL 278

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/260 (22%), Positives = 109/260 (41%), Gaps = 37/260 (14%)
Query: 76  ALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFD 135
           A+K+L + ++         E E++K +     +       T +G +  ++E+  +G+L +
Sbjct: 64  AVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE 123
Query: 136 SLRVRK----------------KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLI 179
            L+ R+                +LS   +   AY+V +G++YL   + IH D+   N+L+
Sbjct: 124 YLQAREPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV 183
Query: 180 NGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERVDSERWGG 239
                +KIADFG++R +                 G   +       +M+PE +    +  
Sbjct: 184 TEDNVMKIADFGLARDIHHIDYYKKTTN------GRLPV------KWMAPEAL----FDR 227
Query: 240 DYGFAGDVWSLGVVVLECL-VGHYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRR 298
            Y    DVWS GV++ E   +G  P  G      +  L   +  G R++ P   + E   
Sbjct: 228 IYTHQSDVWSFGVLLWEIFTLGGSPYPGVP----VEELFKLLKEGHRMDKPSNCTNELYM 283
Query: 299 FVRSCLEKDWRKRGTVEELL 318
            +R C      +R T ++L+
Sbjct: 284 MMRDCWHAVPSQRPTFKQLV 303

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/273 (22%), Positives = 109/273 (39%), Gaps = 27/273 (9%)
Query: 54  VLGHGNGGIVY--KVRHQKSNSIY-ALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKC 110
           V+G G+ G VY   +       I+ A+K LN  +      Q   E  I+K      ++  
Sbjct: 42  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 101
Query: 111 HAVFYTIEGEICFVMEHMERGSLFDSLR--VRKKLSEDVISGVAYRVLKGLQYLHGMQII 168
             +    EG    V+ +M+ G L + +R        +D+I G   +V KG+++L   + +
Sbjct: 102 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI-GFGLQVAKGMKFLASKKFV 160
Query: 169 HGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMS 228
           H D+   N +++ K  VK+ADFG++R + +                           +M+
Sbjct: 161 HRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV----------HNKTGAKLPVKWMA 210
Query: 229 PERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICF--GERL 286
            E + +++    +    DVWS GV++ E +    P       PD+      +    G RL
Sbjct: 211 LESLQTQK----FTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITVYLLQGRRL 261
Query: 287 EMPETASPEFRRFVRSCLEKDWRKRGTVEELLA 319
             PE         +  C       R +  EL++
Sbjct: 262 LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 294

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/273 (22%), Positives = 109/273 (39%), Gaps = 27/273 (9%)
Query: 54  VLGHGNGGIVY--KVRHQKSNSIY-ALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKC 110
           V+G G+ G VY   +       I+ A+K LN  +      Q   E  I+K      ++  
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 111 HAVFYTIEGEICFVMEHMERGSLFDSLR--VRKKLSEDVISGVAYRVLKGLQYLHGMQII 168
             +    EG    V+ +M+ G L + +R        +D+I G   +V KG+++L   + +
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI-GFGLQVAKGMKFLASKKFV 155
Query: 169 HGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMS 228
           H D+   N +++ K  VK+ADFG++R + +                           +M+
Sbjct: 156 HRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV----------HNKTGAKLPVKWMA 205
Query: 229 PERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICF--GERL 286
            E + +++    +    DVWS GV++ E +    P       PD+      +    G RL
Sbjct: 206 LESLQTQK----FTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITVYLLQGRRL 256
Query: 287 EMPETASPEFRRFVRSCLEKDWRKRGTVEELLA 319
             PE         +  C       R +  EL++
Sbjct: 257 LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 289

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/273 (22%), Positives = 109/273 (39%), Gaps = 27/273 (9%)
Query: 54  VLGHGNGGIVY--KVRHQKSNSIY-ALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKC 110
           V+G G+ G VY   +       I+ A+K LN  +      Q   E  I+K      ++  
Sbjct: 38  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 97
Query: 111 HAVFYTIEGEICFVMEHMERGSLFDSLR--VRKKLSEDVISGVAYRVLKGLQYLHGMQII 168
             +    EG    V+ +M+ G L + +R        +D+I G   +V KG+++L   + +
Sbjct: 98  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI-GFGLQVAKGMKFLASKKFV 156
Query: 169 HGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMS 228
           H D+   N +++ K  VK+ADFG++R + +                           +M+
Sbjct: 157 HRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV----------HNKTGAKLPVKWMA 206
Query: 229 PERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICF--GERL 286
            E + +++    +    DVWS GV++ E +    P       PD+      +    G RL
Sbjct: 207 LESLQTQK----FTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITVYLLQGRRL 257
Query: 287 EMPETASPEFRRFVRSCLEKDWRKRGTVEELLA 319
             PE         +  C       R +  EL++
Sbjct: 258 LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 290

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/273 (22%), Positives = 109/273 (39%), Gaps = 27/273 (9%)
Query: 54  VLGHGNGGIVY--KVRHQKSNSIY-ALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKC 110
           V+G G+ G VY   +       I+ A+K LN  +      Q   E  I+K      ++  
Sbjct: 35  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 94
Query: 111 HAVFYTIEGEICFVMEHMERGSLFDSLR--VRKKLSEDVISGVAYRVLKGLQYLHGMQII 168
             +    EG    V+ +M+ G L + +R        +D+I G   +V KG+++L   + +
Sbjct: 95  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI-GFGLQVAKGMKFLASKKFV 153
Query: 169 HGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMS 228
           H D+   N +++ K  VK+ADFG++R + +                           +M+
Sbjct: 154 HRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV----------HNKTGAKLPVKWMA 203
Query: 229 PERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICF--GERL 286
            E + +++    +    DVWS GV++ E +    P       PD+      +    G RL
Sbjct: 204 LESLQTQK----FTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITVYLLQGRRL 254
Query: 287 EMPETASPEFRRFVRSCLEKDWRKRGTVEELLA 319
             PE         +  C       R +  EL++
Sbjct: 255 LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 287

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/273 (22%), Positives = 109/273 (39%), Gaps = 27/273 (9%)
Query: 54  VLGHGNGGIVY--KVRHQKSNSIY-ALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKC 110
           V+G G+ G VY   +       I+ A+K LN  +      Q   E  I+K      ++  
Sbjct: 96  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 155
Query: 111 HAVFYTIEGEICFVMEHMERGSLFDSLR--VRKKLSEDVISGVAYRVLKGLQYLHGMQII 168
             +    EG    V+ +M+ G L + +R        +D+I G   +V KG+++L   + +
Sbjct: 156 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI-GFGLQVAKGMKFLASKKFV 214
Query: 169 HGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMS 228
           H D+   N +++ K  VK+ADFG++R + +                           +M+
Sbjct: 215 HRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKL----------PVKWMA 264
Query: 229 PERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICF--GERL 286
            E + +++    +    DVWS GV++ E +    P       PD+      +    G RL
Sbjct: 265 LESLQTQK----FTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITVYLLQGRRL 315
Query: 287 EMPETASPEFRRFVRSCLEKDWRKRGTVEELLA 319
             PE         +  C       R +  EL++
Sbjct: 316 LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 348

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/273 (22%), Positives = 109/273 (39%), Gaps = 27/273 (9%)
Query: 54  VLGHGNGGIVY--KVRHQKSNSIY-ALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKC 110
           V+G G+ G VY   +       I+ A+K LN  +      Q   E  I+K      ++  
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 111 HAVFYTIEGEICFVMEHMERGSLFDSLR--VRKKLSEDVISGVAYRVLKGLQYLHGMQII 168
             +    EG    V+ +M+ G L + +R        +D+I G   +V KG+++L   + +
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI-GFGLQVAKGMKFLASKKFV 155
Query: 169 HGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMS 228
           H D+   N +++ K  VK+ADFG++R + +                           +M+
Sbjct: 156 HRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV----------HNKTGAKLPVKWMA 205
Query: 229 PERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICF--GERL 286
            E + +++    +    DVWS GV++ E +    P       PD+      +    G RL
Sbjct: 206 LESLQTQK----FTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITVYLLQGRRL 256
Query: 287 EMPETASPEFRRFVRSCLEKDWRKRGTVEELLA 319
             PE         +  C       R +  EL++
Sbjct: 257 LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 289

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 67/264 (25%), Positives = 104/264 (39%), Gaps = 29/264 (10%)
Query: 48  DLKKLTVLGHGNGGIV----YKVRHQKSNSIYALKVL--NTTSSTIIRHQAAHEAEILKR 101
           DL+ L  LG G+ G+V    +     K+ S+ A+K L  +  S          E   +  
Sbjct: 9   DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSV-AVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 102 LDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQ 160
           LD + +++ + V  T   ++  V E    GSL D LR  +       +S  A +V +G+ 
Sbjct: 68  LDHRNLIRLYGVVLTPPMKM--VTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMG 125
Query: 161 YLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIAC 220
           YL   + IH D+   NLL+  +  VKI DFG+ R + +                      
Sbjct: 126 YLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF------- 178
Query: 221 MGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICA 279
               A+ +PE + +      +  A D W  GV + E    G  P IG      L  +   
Sbjct: 179 ----AWCAPESLKTRT----FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE 230
Query: 280 ICFGERLEMPETASPEFRRFVRSC 303
              GERL  PE    +    +  C
Sbjct: 231 ---GERLPRPEDCPQDIYNVMVQC 251

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 67/264 (25%), Positives = 103/264 (39%), Gaps = 29/264 (10%)
Query: 48  DLKKLTVLGHGNGGIV----YKVRHQKSNSIYALKVL--NTTSSTIIRHQAAHEAEILKR 101
           DL+ L  LG G+ G+V    +     K+ S+ A+K L  +  S          E   +  
Sbjct: 13  DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSV-AVKCLKPDVLSQPEAMDDFIREVNAMHS 71
Query: 102 LDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQ 160
           LD + +++ + V  T    +  V E    GSL D LR  +       +S  A +V +G+ 
Sbjct: 72  LDHRNLIRLYGVVLT--PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMG 129
Query: 161 YLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIAC 220
           YL   + IH D+   NLL+  +  VKI DFG+ R + +                      
Sbjct: 130 YLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF------- 182
Query: 221 MGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICA 279
               A+ +PE + +      +  A D W  GV + E    G  P IG      L  +   
Sbjct: 183 ----AWCAPESLKTRT----FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE 234
Query: 280 ICFGERLEMPETASPEFRRFVRSC 303
              GERL  PE    +    +  C
Sbjct: 235 ---GERLPRPEDCPQDIYNVMVQC 255

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 67/264 (25%), Positives = 103/264 (39%), Gaps = 29/264 (10%)
Query: 48  DLKKLTVLGHGNGGIV----YKVRHQKSNSIYALKVL--NTTSSTIIRHQAAHEAEILKR 101
           DL+ L  LG G+ G+V    +     K+ S+ A+K L  +  S          E   +  
Sbjct: 13  DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSV-AVKCLKPDVLSQPEAMDDFIREVNAMHS 71
Query: 102 LDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQ 160
           LD + +++ + V  T    +  V E    GSL D LR  +       +S  A +V +G+ 
Sbjct: 72  LDHRNLIRLYGVVLT--PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMG 129
Query: 161 YLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIAC 220
           YL   + IH D+   NLL+  +  VKI DFG+ R + +                      
Sbjct: 130 YLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF------- 182
Query: 221 MGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICA 279
               A+ +PE + +      +  A D W  GV + E    G  P IG      L  +   
Sbjct: 183 ----AWCAPESLKTRT----FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE 234
Query: 280 ICFGERLEMPETASPEFRRFVRSC 303
              GERL  PE    +    +  C
Sbjct: 235 ---GERLPRPEDCPQDIYNVMVQC 255

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 68/264 (25%), Positives = 104/264 (39%), Gaps = 29/264 (10%)
Query: 48  DLKKLTVLGHGNGGIV----YKVRHQKSNSIYALKVL--NTTSSTIIRHQAAHEAEILKR 101
           DL+ L  LG G+ G+V    +     K+ S+ A+K L  +  S          E   +  
Sbjct: 9   DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSV-AVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 102 LDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQ 160
           LD + +++ + V  T    +  V E    GSL D LR  +       +S  A +V +G+ 
Sbjct: 68  LDHRNLIRLYGVVLT--PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMG 125
Query: 161 YLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIAC 220
           YL   + IH D+   NLL+  +  VKI DFG+ R + +                      
Sbjct: 126 YLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPF------- 178
Query: 221 MGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICA 279
               A+ +PE + +      +  A D W  GV + E    G  P IG      L  +   
Sbjct: 179 ----AWCAPESLKTRT----FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE 230
Query: 280 ICFGERLEMPETASPEFRRFVRSC 303
              GERL  PE    +    +  C
Sbjct: 231 ---GERLPRPEDCPQDIYNVMVQC 251

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/273 (22%), Positives = 109/273 (39%), Gaps = 27/273 (9%)
Query: 54  VLGHGNGGIVY--KVRHQKSNSIY-ALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKC 110
           V+G G+ G VY   +       I+ A+K LN  +      Q   E  I+K      ++  
Sbjct: 38  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 97
Query: 111 HAVFYTIEGEICFVMEHMERGSLFDSLR--VRKKLSEDVISGVAYRVLKGLQYLHGMQII 168
             +    EG    V+ +M+ G L + +R        +D+I G   +V KG+++L   + +
Sbjct: 98  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI-GFGLQVAKGMKFLASKKFV 156
Query: 169 HGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMS 228
           H D+   N +++ K  VK+ADFG++R + +                           +M+
Sbjct: 157 HRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSV----------HNKTGAKLPVKWMA 206
Query: 229 PERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICF--GERL 286
            E + +++    +    DVWS GV++ E +    P       PD+      +    G RL
Sbjct: 207 LESLQTQK----FTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITVYLLQGRRL 257
Query: 287 EMPETASPEFRRFVRSCLEKDWRKRGTVEELLA 319
             PE         +  C       R +  EL++
Sbjct: 258 LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 290

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 67/264 (25%), Positives = 103/264 (39%), Gaps = 29/264 (10%)
Query: 48  DLKKLTVLGHGNGGIV----YKVRHQKSNSIYALKVL--NTTSSTIIRHQAAHEAEILKR 101
           DL+ L  LG G+ G+V    +     K+ S+ A+K L  +  S          E   +  
Sbjct: 19  DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSV-AVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 102 LDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQ 160
           LD + +++ + V  T    +  V E    GSL D LR  +       +S  A +V +G+ 
Sbjct: 78  LDHRNLIRLYGVVLT--PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMG 135
Query: 161 YLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIAC 220
           YL   + IH D+   NLL+  +  VKI DFG+ R + +                      
Sbjct: 136 YLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF------- 188
Query: 221 MGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICA 279
               A+ +PE + +      +  A D W  GV + E    G  P IG      L  +   
Sbjct: 189 ----AWCAPESLKTRT----FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE 240
Query: 280 ICFGERLEMPETASPEFRRFVRSC 303
              GERL  PE    +    +  C
Sbjct: 241 ---GERLPRPEDCPQDIYNVMVQC 261

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 67/264 (25%), Positives = 104/264 (39%), Gaps = 29/264 (10%)
Query: 48  DLKKLTVLGHGNGGIV----YKVRHQKSNSIYALKVL--NTTSSTIIRHQAAHEAEILKR 101
           DL+ L  LG G+ G+V    +     K+ S+ A+K L  +  S          E   +  
Sbjct: 9   DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSV-AVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 102 LDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQ 160
           LD + +++ + V  T   ++  V E    GSL D LR  +       +S  A +V +G+ 
Sbjct: 68  LDHRNLIRLYGVVLTPPMKM--VTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMG 125
Query: 161 YLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIAC 220
           YL   + IH D+   NLL+  +  VKI DFG+ R + +                      
Sbjct: 126 YLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF------- 178
Query: 221 MGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICA 279
               A+ +PE + +      +  A D W  GV + E    G  P IG      L  +   
Sbjct: 179 ----AWCAPESLKTRT----FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE 230
Query: 280 ICFGERLEMPETASPEFRRFVRSC 303
              GERL  PE    +    +  C
Sbjct: 231 ---GERLPRPEDCPQDIYNVMVQC 251

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/217 (23%), Positives = 96/217 (44%), Gaps = 36/217 (16%)
Query: 119 GEICFVMEHMERGSLFDSLRVR-------KKLSEDVIS-----GVAYRVLKGLQYLHGMQ 166
           G +  ++E  + G+L   LR +       K L +D ++       +++V KG+++L   +
Sbjct: 105 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQVAKGMEFLASRK 164
Query: 167 IIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAY 226
            IH D+   N+L++ K  VKI DFG++R + +               G+A +       +
Sbjct: 165 XIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRK--------GDARLP----LKW 212
Query: 227 MSPERVDSERWGGDYGFAGDVWSLGVVVLECL---VGHYPLIGFGEKPDLMALICAICFG 283
           M+PE +    +   Y    DVWS GV++ E        YP +   E+         +  G
Sbjct: 213 MAPETI----FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-----FXRRLKEG 263
Query: 284 ERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY 320
            R+  P+  +PE  + +  C   +  +R T  EL+ +
Sbjct: 264 TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 300

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 68/264 (25%), Positives = 104/264 (39%), Gaps = 29/264 (10%)
Query: 48  DLKKLTVLGHGNGGIV----YKVRHQKSNSIYALKVL--NTTSSTIIRHQAAHEAEILKR 101
           DL+ L  LG G+ G+V    +     K+ S+ A+K L  +  S          E   +  
Sbjct: 19  DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSV-AVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 102 LDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQ 160
           LD + +++ + V  T    +  V E    GSL D LR  +       +S  A +V +G+ 
Sbjct: 78  LDHRNLIRLYGVVLT--PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMG 135
Query: 161 YLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIAC 220
           YL   + IH D+   NLL+  +  VKI DFG+ R + +                      
Sbjct: 136 YLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPF------- 188
Query: 221 MGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICA 279
               A+ +PE + +      +  A D W  GV + E    G  P IG      L  +   
Sbjct: 189 ----AWCAPESLKTRT----FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE 240
Query: 280 ICFGERLEMPETASPEFRRFVRSC 303
              GERL  PE    +    +  C
Sbjct: 241 ---GERLPRPEDCPQDIYNVMVQC 261

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/222 (23%), Positives = 93/222 (41%), Gaps = 41/222 (18%)
Query: 116 TIEGEICFVMEHMERGSLFDSLRVRK----KLSEDV------------ISGVAYRVLKGL 159
           T +G +  ++E+  +G+L + LR R+    + S D+            +    Y++ +G+
Sbjct: 157 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGM 216
Query: 160 QYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIA 219
           +YL   + IH D+   N+L+     +KIADFG++R +                 G   + 
Sbjct: 217 EYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN------GRLPV- 269
Query: 220 CMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV---GHYPLIGFGEKPDLMAL 276
                 +M+PE +    +   Y    DVWS GV++ E        YP I   E      L
Sbjct: 270 -----KWMAPEAL----FDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE------L 314
Query: 277 ICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELL 318
              +  G R++ P   + E    +R C      +R T ++L+
Sbjct: 315 FKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLV 356

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 97/218 (44%), Gaps = 38/218 (17%)
Query: 119 GEICFVMEHMERGSLFDSLRVR-------KKLSEDVIS-----GVAYRVLKGLQYLHGMQ 166
           G +  ++E  + G+L   LR +       K L +D ++       +++V KG+++L   +
Sbjct: 105 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQVAKGMEFLASRK 164
Query: 167 IIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAY 226
            IH D+   N+L++ K  VKI DFG++R + +               G+A +       +
Sbjct: 165 XIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK--------GDARLP----LKW 212
Query: 227 MSPERVDSERWGGDYGFAGDVWSLGVVVLECL---VGHYPLIGFGEKPDLMALIC-AICF 282
           M+PE +    +   Y    DVWS GV++ E        YP +   E+       C  +  
Sbjct: 213 MAPETI----FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE------FCRRLKE 262
Query: 283 GERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY 320
           G R+  P+  +PE  + +  C   +  +R T  EL+ +
Sbjct: 263 GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 300

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 97/221 (43%), Gaps = 41/221 (18%)
Query: 119 GEICFVMEHMERGSLFDSLRVRK------KLSEDVISGV---------AYRVLKGLQYLH 163
           G +  ++E  + G+L   LR ++      K  ED+             +++V KG+++L 
Sbjct: 106 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICYSFQVAKGMEFLA 165
Query: 164 GMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGT 223
             + IH D+   N+L++ K  VKI DFG++R + +               G+A +     
Sbjct: 166 SRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRK--------GDARLP---- 213
Query: 224 CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECL---VGHYPLIGFGEKPDLMALIC-A 279
             +M+PE +    +   Y    DVWS GV++ E        YP +   E+       C  
Sbjct: 214 LKWMAPETI----FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE------FCRR 263
Query: 280 ICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY 320
           +  G R+  P+  +PE  + +  C   +  +R T  EL+ +
Sbjct: 264 LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 50/218 (22%), Positives = 90/218 (41%), Gaps = 31/218 (14%)
Query: 107 IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQ 166
           +++    F T EG +  +   +    LFD +  +  L E        +V+  +Q+ H   
Sbjct: 100 VIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRG 159
Query: 167 IIHGDIKPSNLLIN-GKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCA 225
           ++H DIK  N+LI+  +G  K+ DFG   ++ +                E      GT  
Sbjct: 160 VVHRDIKDENILIDLRRGCAKLIDFGSGALLHD----------------EPYTDFDGTRV 203
Query: 226 YMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGER 285
           Y  PE +   ++   +     VWSLG+++ + + G  P   F    +++           
Sbjct: 204 YSPPEWISRHQY---HALPATVWSLGILLYDMVCGDIP---FERDQEILE--------AE 249
Query: 286 LEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV 323
           L  P   SP+    +R CL      R ++EE+L  P++
Sbjct: 250 LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWM 287

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/262 (22%), Positives = 105/262 (40%), Gaps = 41/262 (15%)
Query: 76  ALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFD 135
           A+K+L   ++         E E++K +     +       T +G +  ++E+  +G+L +
Sbjct: 71  AVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLRE 130
Query: 136 SLRVRK----KLSEDV------------ISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLI 179
            LR R+    + S D+            +    Y++ +G++YL   + IH D+   N+L+
Sbjct: 131 YLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV 190
Query: 180 NGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERVDSERWGG 239
                +KIADFG++R +                 G   +  M   A    +RV       
Sbjct: 191 TENNVMKIADFGLARDINNIDYYKKTTN------GRLPVKWMAPEALF--DRV------- 235
Query: 240 DYGFAGDVWSLGVVVLECLV---GHYPLIGFGEKPDLMALICAICFGERLEMPETASPEF 296
            Y    DVWS GV++ E        YP I   E      L   +  G R++ P   + E 
Sbjct: 236 -YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE------LFKLLKEGHRMDKPANCTNEL 288
Query: 297 RRFVRSCLEKDWRKRGTVEELL 318
              +R C      +R T ++L+
Sbjct: 289 YMMMRDCWHAVPSQRPTFKQLV 310

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 74/300 (24%), Positives = 122/300 (40%), Gaps = 68/300 (22%)
Query: 54  VLGHGNGGIVYKVRHQKSNSIYALK-VLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHA 112
            LG G+ GIV +V   +S   +ALK VL        R++   E +I+K LD   I+K   
Sbjct: 14  TLGTGSFGIVCEVFDIESGKRFALKKVLQDP-----RYKN-RELDIMKVLDHVNIIKLVD 67
Query: 113 VFYTIEGE-------------------------------------ICFVMEHME---RGS 132
            FYT   E                                     +  +ME++       
Sbjct: 68  YFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKV 127
Query: 133 LFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGE-VKIADFG 191
           L   +R  + +  ++IS   Y++ + + ++H + I H DIKP NLL+N K   +K+ DFG
Sbjct: 128 LKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFG 187
Query: 192 VSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLG 251
            ++ +  +               E ++A + +  Y +PE +       +Y  + D+WS+G
Sbjct: 188 SAKKLIPS---------------EPSVAXICSRFYRAPELM---LGATEYTPSIDLWSIG 229
Query: 252 VVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLE-KDWRK 310
            V  E ++G  PL       D +  I  I      E     +P +       L+ KDWRK
Sbjct: 230 CVFGELILGK-PLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRK 288

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 91/222 (40%), Gaps = 41/222 (18%)
Query: 116 TIEGEICFVMEHMERGSLFDSLRVRK----KLSEDV------------ISGVAYRVLKGL 159
           T +G +  ++E+  +G+L + LR R+    + S D+            +    Y++ +G+
Sbjct: 111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGM 170
Query: 160 QYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIA 219
           +YL   + IH D+   N+L+     +KIADFG++R +                 G   + 
Sbjct: 171 EYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN------GRLPVK 224
Query: 220 CMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV---GHYPLIGFGEKPDLMAL 276
            M   A    +RV        Y    DVWS GV++ E        YP I   E      L
Sbjct: 225 WMAPEALF--DRV--------YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE------L 268
Query: 277 ICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELL 318
              +  G R++ P   + E    +R C      +R T ++L+
Sbjct: 269 FKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLV 310

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 45/173 (26%), Positives = 80/173 (46%), Gaps = 26/173 (15%)
Query: 152 AYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXX 211
           +++V KG+++L   + IH D+   N+L++ K  VKI DFG++R + +             
Sbjct: 154 SFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRK------ 207
Query: 212 XIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECL---VGHYPLIGFG 268
             G+A +       +M+PE +    +   Y    DVWS GV++ E        YP +   
Sbjct: 208 --GDARLP----LKWMAPETI----FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 257
Query: 269 EKPDLMALIC-AICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY 320
           E+       C  +  G R+  P+  +PE  + +  C   +  +R T  EL+ +
Sbjct: 258 EE------FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 93/222 (41%), Gaps = 41/222 (18%)
Query: 116 TIEGEICFVMEHMERGSLFDSLRVRK----KLSEDV------------ISGVAYRVLKGL 159
           T +G +  ++E+  +G+L + LR R+    + S D+            +    Y++ +G+
Sbjct: 111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGM 170
Query: 160 QYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIA 219
           +YL   + IH D+   N+L+     +KIADFG++R +                 G   + 
Sbjct: 171 EYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTN------GRLPVK 224
Query: 220 CMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV---GHYPLIGFGEKPDLMAL 276
            M   A    +RV        Y    DVWS GV++ E        YP I   E      L
Sbjct: 225 WMAPEALF--DRV--------YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE------L 268
Query: 277 ICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELL 318
              +  G R++ P   + E    +R C      +R T ++L+
Sbjct: 269 FKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLV 310

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 91/222 (40%), Gaps = 41/222 (18%)
Query: 116 TIEGEICFVMEHMERGSLFDSLRVRK----KLSEDV------------ISGVAYRVLKGL 159
           T +G +  ++E+  +G+L + LR R+    + S D+            +    Y++ +G+
Sbjct: 111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGM 170
Query: 160 QYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIA 219
           +YL   + IH D+   N+L+     +KIADFG++R +                 G   + 
Sbjct: 171 EYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTN------GRLPVK 224
Query: 220 CMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV---GHYPLIGFGEKPDLMAL 276
            M   A    +RV        Y    DVWS GV++ E        YP I   E      L
Sbjct: 225 WMAPEALF--DRV--------YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE------L 268
Query: 277 ICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELL 318
              +  G R++ P   + E    +R C      +R T ++L+
Sbjct: 269 FKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLV 310

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 52/222 (23%), Positives = 93/222 (41%), Gaps = 41/222 (18%)
Query: 116 TIEGEICFVMEHMERGSLFDSLRVRK----KLSEDV------------ISGVAYRVLKGL 159
           T +G +  ++E+  +G+L + LR R+    + S D+            +    Y++ +G+
Sbjct: 98  TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGM 157
Query: 160 QYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIA 219
           +YL   + IH D+   N+L+     +KIADFG++R +                 G   + 
Sbjct: 158 EYLASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTN------GRLPV- 210
Query: 220 CMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV---GHYPLIGFGEKPDLMAL 276
                 +M+PE +    +   Y    DVWS GV++ E        YP I   E      L
Sbjct: 211 -----KWMAPEAL----FDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE------L 255
Query: 277 ICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELL 318
              +  G R++ P   + E    +R C      +R T ++L+
Sbjct: 256 FKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLV 297

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 93/222 (41%), Gaps = 41/222 (18%)
Query: 116 TIEGEICFVMEHMERGSLFDSLRVRK----KLSEDV------------ISGVAYRVLKGL 159
           T +G +  ++E+  +G+L + LR R+    + S D+            +    Y++ +G+
Sbjct: 111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVSCTYQLARGM 170
Query: 160 QYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIA 219
           +YL   + IH D+   N+L+     +KIADFG++R +                 G   + 
Sbjct: 171 EYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTN------GRLPVK 224
Query: 220 CMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV---GHYPLIGFGEKPDLMAL 276
            M   A    +RV        Y    DVWS GV++ E        YP I   E      L
Sbjct: 225 WMAPEALF--DRV--------YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE------L 268
Query: 277 ICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELL 318
              +  G R++ P   + E    +R C      +R T ++L+
Sbjct: 269 FKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLV 310

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 52/222 (23%), Positives = 93/222 (41%), Gaps = 41/222 (18%)
Query: 116 TIEGEICFVMEHMERGSLFDSLRVRK----KLSEDV------------ISGVAYRVLKGL 159
           T +G +  ++E+  +G+L + LR R+    + S D+            +    Y++ +G+
Sbjct: 103 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGM 162
Query: 160 QYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIA 219
           +YL   + IH D+   N+L+     +KIADFG++R +                 G   + 
Sbjct: 163 EYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN------GRLPV- 215
Query: 220 CMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV---GHYPLIGFGEKPDLMAL 276
                 +M+PE +    +   Y    DVWS GV++ E        YP I   E      L
Sbjct: 216 -----KWMAPEAL----FDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE------L 260
Query: 277 ICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELL 318
              +  G R++ P   + E    +R C      +R T ++L+
Sbjct: 261 FKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLV 302

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 45/173 (26%), Positives = 80/173 (46%), Gaps = 26/173 (15%)
Query: 152 AYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXX 211
           +++V KG+++L   + IH D+   N+L++ K  VKI DFG++R + +             
Sbjct: 154 SFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRK------ 207
Query: 212 XIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECL---VGHYPLIGFG 268
             G+A +       +M+PE +    +   Y    DVWS GV++ E        YP +   
Sbjct: 208 --GDARLP----LKWMAPETI----FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 257
Query: 269 EKPDLMALIC-AICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY 320
           E+       C  +  G R+  P+  +PE  + +  C   +  +R T  EL+ +
Sbjct: 258 EE------FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 91/222 (40%), Gaps = 41/222 (18%)
Query: 116 TIEGEICFVMEHMERGSLFDSLRVRK----KLSEDV------------ISGVAYRVLKGL 159
           T +G +  ++E+  +G+L + LR R+    + S D+            +    Y++ +G+
Sbjct: 111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGM 170
Query: 160 QYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIA 219
           +YL   + IH D+   N+L+     +KIADFG++R +                 G   + 
Sbjct: 171 EYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN------GRLPVK 224
Query: 220 CMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV---GHYPLIGFGEKPDLMAL 276
            M   A    +RV        Y    DVWS GV++ E        YP I   E      L
Sbjct: 225 WMAPEALF--DRV--------YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE------L 268
Query: 277 ICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELL 318
              +  G R++ P   + E    +R C      +R T ++L+
Sbjct: 269 FKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLV 310

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 91/222 (40%), Gaps = 41/222 (18%)
Query: 116 TIEGEICFVMEHMERGSLFDSLRVRK----KLSEDV------------ISGVAYRVLKGL 159
           T +G +  ++E+  +G+L + LR R+    + S D+            +    Y++ +G+
Sbjct: 100 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGM 159
Query: 160 QYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIA 219
           +YL   + IH D+   N+L+     +KIADFG++R +                 G   + 
Sbjct: 160 EYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN------GRLPVK 213
Query: 220 CMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV---GHYPLIGFGEKPDLMAL 276
            M   A    +RV        Y    DVWS GV++ E        YP I   E      L
Sbjct: 214 WMAPEALF--DRV--------YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE------L 257
Query: 277 ICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELL 318
              +  G R++ P   + E    +R C      +R T ++L+
Sbjct: 258 FKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLV 299

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 45/173 (26%), Positives = 80/173 (46%), Gaps = 26/173 (15%)
Query: 152 AYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXX 211
           +++V KG+++L   + IH D+   N+L++ K  VKI DFG++R + +             
Sbjct: 145 SFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRK------ 198
Query: 212 XIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECL---VGHYPLIGFG 268
             G+A +       +M+PE +    +   Y    DVWS GV++ E        YP +   
Sbjct: 199 --GDARLP----LKWMAPETI----FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 248
Query: 269 EKPDLMALIC-AICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY 320
           E+       C  +  G R+  P+  +PE  + +  C   +  +R T  EL+ +
Sbjct: 249 EE------FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 295

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 45/173 (26%), Positives = 80/173 (46%), Gaps = 26/173 (15%)
Query: 152 AYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXX 211
           +++V KG+++L   + IH D+   N+L++ K  VKI DFG++R + +             
Sbjct: 145 SFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRK------ 198
Query: 212 XIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECL---VGHYPLIGFG 268
             G+A +       +M+PE +    +   Y    DVWS GV++ E        YP +   
Sbjct: 199 --GDARLP----LKWMAPETI----FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 248
Query: 269 EKPDLMALIC-AICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY 320
           E+       C  +  G R+  P+  +PE  + +  C   +  +R T  EL+ +
Sbjct: 249 EE------FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 295

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/173 (25%), Positives = 79/173 (45%), Gaps = 26/173 (15%)
Query: 152 AYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXX 211
           +++V KG+++L   + IH D+   N+L++ K  VKI DFG++R + +             
Sbjct: 145 SFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK------ 198
Query: 212 XIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECL---VGHYPLIGFG 268
             G+A +       +M+PE +    +   Y    DVWS GV++ E        YP +   
Sbjct: 199 --GDARLP----LKWMAPETI----FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 248
Query: 269 EKPDLMALIC-AICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY 320
           E+       C  +  G R+  P+  +PE  + +  C   +  +R T  EL+ +
Sbjct: 249 EE------FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 295

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/173 (26%), Positives = 80/173 (46%), Gaps = 26/173 (15%)
Query: 152 AYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXX 211
           +++V KG+++L   + IH D+   N+L++ K  VKI DFG++R + +             
Sbjct: 154 SFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRK------ 207
Query: 212 XIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECL---VGHYPLIGFG 268
             G+A +       +M+PE +    +   Y    DVWS GV++ E        YP +   
Sbjct: 208 --GDARLP----LKWMAPETI----FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 257
Query: 269 EKPDLMALIC-AICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY 320
           E+       C  +  G R+  P+  +PE  + +  C   +  +R T  EL+ +
Sbjct: 258 EE------FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/173 (25%), Positives = 79/173 (45%), Gaps = 26/173 (15%)
Query: 152 AYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXX 211
           +++V KG+++L   + IH D+   N+L++ K  VKI DFG++R + +             
Sbjct: 154 SFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK------ 207
Query: 212 XIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECL---VGHYPLIGFG 268
             G+A +       +M+PE +    +   Y    DVWS GV++ E        YP +   
Sbjct: 208 --GDARLP----LKWMAPETI----FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 257
Query: 269 EKPDLMALIC-AICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY 320
           E+       C  +  G R+  P+  +PE  + +  C   +  +R T  EL+ +
Sbjct: 258 EE------FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/173 (25%), Positives = 79/173 (45%), Gaps = 26/173 (15%)
Query: 152 AYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXX 211
           +++V KG+++L   + IH D+   N+L++ K  VKI DFG++R + +             
Sbjct: 145 SFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK------ 198
Query: 212 XIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECL---VGHYPLIGFG 268
             G+A +       +M+PE +    +   Y    DVWS GV++ E        YP +   
Sbjct: 199 --GDARLP----LKWMAPETI----FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 248
Query: 269 EKPDLMALIC-AICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY 320
           E+       C  +  G R+  P+  +PE  + +  C   +  +R T  EL+ +
Sbjct: 249 EE------FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 295

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/173 (25%), Positives = 79/173 (45%), Gaps = 26/173 (15%)
Query: 152 AYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXX 211
           +++V KG+++L   + IH D+   N+L++ K  VKI DFG++R + +             
Sbjct: 156 SFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK------ 209
Query: 212 XIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECL---VGHYPLIGFG 268
             G+A +       +M+PE +    +   Y    DVWS GV++ E        YP +   
Sbjct: 210 --GDARLP----LKWMAPETI----FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 259
Query: 269 EKPDLMALIC-AICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY 320
           E+       C  +  G R+  P+  +PE  + +  C   +  +R T  EL+ +
Sbjct: 260 EE------FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 306

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 97/217 (44%), Gaps = 28/217 (12%)
Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH-EAEILKRLDSQFIV 108
           + L  +G G  GIV            A+K L+         + A+ E  ++K ++ + I+
Sbjct: 27  QNLKPIGSGAQGIVVAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNII 86
Query: 109 KCHAVFYTIEG-----EICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLH 163
               VF   +      ++  VME M+      S  ++ +L  + +S + Y++L G+++LH
Sbjct: 87  GLLNVFTPQKSLEEFQDVYIVMELMDANL---SQVIQMELDHERMSYLLYQMLVGIKHLH 143
Query: 164 GMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGT 223
              IIH D+KPSN+++     +KI DFG++R    +                     + T
Sbjct: 144 SAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMT---------------PYVVT 188
Query: 224 CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVG 260
             Y +PE +     G  Y    D+WS+GV++ E + G
Sbjct: 189 RYYRAPEVI----LGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/173 (25%), Positives = 79/173 (45%), Gaps = 26/173 (15%)
Query: 152 AYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXX 211
           +++V KG+++L   + IH D+   N+L++ K  VKI DFG++R + +             
Sbjct: 204 SFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK------ 257
Query: 212 XIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECL---VGHYPLIGFG 268
             G+A +       +M+PE +    +   Y    DVWS GV++ E        YP +   
Sbjct: 258 --GDARLP----LKWMAPETI----FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 307
Query: 269 EKPDLMALIC-AICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY 320
           E+       C  +  G R+  P+  +PE  + +  C   +  +R T  EL+ +
Sbjct: 308 EE------FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 354

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/173 (25%), Positives = 79/173 (45%), Gaps = 26/173 (15%)
Query: 152 AYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXX 211
           +++V KG+++L   + IH D+   N+L++ K  VKI DFG++R + +             
Sbjct: 199 SFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK------ 252
Query: 212 XIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECL---VGHYPLIGFG 268
             G+A +       +M+PE +    +   Y    DVWS GV++ E        YP +   
Sbjct: 253 --GDARLP----LKWMAPETI----FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 302
Query: 269 EKPDLMALIC-AICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY 320
           E+       C  +  G R+  P+  +PE  + +  C   +  +R T  EL+ +
Sbjct: 303 EE------FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/173 (25%), Positives = 79/173 (45%), Gaps = 26/173 (15%)
Query: 152 AYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXX 211
           +++V KG+++L   + IH D+   N+L++ K  VKI DFG++R + +             
Sbjct: 191 SFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK------ 244
Query: 212 XIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECL---VGHYPLIGFG 268
             G+A +       +M+PE +    +   Y    DVWS GV++ E        YP +   
Sbjct: 245 --GDARLP----LKWMAPETI----FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 294
Query: 269 EKPDLMALIC-AICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY 320
           E+       C  +  G R+  P+  +PE  + +  C   +  +R T  EL+ +
Sbjct: 295 EE------FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/222 (23%), Positives = 91/222 (40%), Gaps = 41/222 (18%)
Query: 116 TIEGEICFVMEHMERGSLFDSLRVRK----KLSEDV------------ISGVAYRVLKGL 159
           T +G +  ++E+  +G+L + LR R+    + S D+            +    Y++ +G+
Sbjct: 111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGM 170
Query: 160 QYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIA 219
           +YL   + IH D+   N+L+     ++IADFG++R +                 G   + 
Sbjct: 171 EYLASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTN------GRLPVK 224
Query: 220 CMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV---GHYPLIGFGEKPDLMAL 276
            M   A    +RV        Y    DVWS GV++ E        YP I   E      L
Sbjct: 225 WMAPEALF--DRV--------YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE------L 268
Query: 277 ICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELL 318
              +  G R++ P   + E    +R C      +R T ++L+
Sbjct: 269 FKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLV 310

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/173 (25%), Positives = 79/173 (45%), Gaps = 26/173 (15%)
Query: 152 AYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXX 211
           +++V KG+++L   + IH D+   N+L++ K  VKI DFG++R + +             
Sbjct: 206 SFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK------ 259
Query: 212 XIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECL---VGHYPLIGFG 268
             G+A +       +M+PE +    +   Y    DVWS GV++ E        YP +   
Sbjct: 260 --GDARLP----LKWMAPETI----FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 309
Query: 269 EKPDLMALIC-AICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY 320
           E+       C  +  G R+  P+  +PE  + +  C   +  +R T  EL+ +
Sbjct: 310 EE------FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 356

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/173 (25%), Positives = 79/173 (45%), Gaps = 26/173 (15%)
Query: 152 AYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXX 211
           +++V KG+++L   + IH D+   N+L++ K  VKI DFG++R + +             
Sbjct: 197 SFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK------ 250
Query: 212 XIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECL---VGHYPLIGFG 268
             G+A +       +M+PE +    +   Y    DVWS GV++ E        YP +   
Sbjct: 251 --GDARLP----LKWMAPETI----FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 300
Query: 269 EKPDLMALIC-AICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY 320
           E+       C  +  G R+  P+  +PE  + +  C   +  +R T  EL+ +
Sbjct: 301 EE------FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 347

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/141 (27%), Positives = 69/141 (48%), Gaps = 22/141 (15%)
Query: 120 EICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLI 179
           ++  VME M+      S  ++ +L  + +S + Y++L G+++LH   IIH D+KPSN+++
Sbjct: 103 DVYIVMELMDANL---SQVIQMELDHERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVV 159
Query: 180 NGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERVDSERWGG 239
                +KI DFG++R    +                     + T  Y +PE +     G 
Sbjct: 160 KSDATLKILDFGLARTAGTSFMMT---------------PYVVTRYYRAPEVI----LGM 200
Query: 240 DYGFAGDVWSLGVVVLECLVG 260
            Y    D+WS+GV++ E + G
Sbjct: 201 GYKENVDIWSVGVIMGEMIKG 221

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/266 (22%), Positives = 109/266 (40%), Gaps = 26/266 (9%)
Query: 40  SPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTT-SSTIIRHQAAHEAEI 98
           +P   +I   +++T LG G  G VYK     +N   A+K +        +   A  E  +
Sbjct: 27  APSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSL 86
Query: 99  LKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKG 158
           LK L  + I++  +V +     +  + E+ E   L   +     +S  VI    Y+++ G
Sbjct: 87  LKELQHRNIIELKSVIHH-NHRLHLIFEYAE-NDLKKYMDKNPDVSMRVIKSFLYQLING 144
Query: 159 LQYLHGMQIIHGDIKPSNLLINGKGE-----VKIADFGVSRIVEETRXXXXXXXXXXXXI 213
           + + H  + +H D+KP NLL++         +KI DFG++R                  I
Sbjct: 145 VNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR-------------AFGIPI 191
Query: 214 GEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDL 273
            +     + T  Y  PE +   R    Y  + D+WS+  +  E L+      G  E   L
Sbjct: 192 RQFTHEII-TLWYRPPEILLGSR---HYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQL 247
Query: 274 MALICAICFGERLEMPE-TASPEFRR 298
             +   +   +    P  TA P++++
Sbjct: 248 FKIFEVLGLPDDTTWPGVTALPDWKQ 273

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 70/279 (25%), Positives = 119/279 (42%), Gaps = 51/279 (18%)
Query: 53  TVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQ------F 106
           +++G G+ G V K   +      A+K++    + +  +QA  E  +L+ ++        +
Sbjct: 60  SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFL--NQAQIEVRLLELMNKHDTEMKYY 117
Query: 107 IV--KCHAVFYTIEGEICFVMEHMERGSLFDSLRVR--KKLSEDVISGVAYRVLKGLQYL 162
           IV  K H +F      +C V E M   +L+D LR    + +S ++    A ++   L +L
Sbjct: 118 IVHLKRHFMF---RNHLCLVFE-MLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFL 173
Query: 163 HG--MQIIHGDIKPSNLLING--KGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAI 218
               + IIH D+KP N+L+    +  +KI DFG S                   +G+   
Sbjct: 174 ATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS-----------------CQLGQRIY 216
Query: 219 ACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALIC 278
             + +  Y SPE +     G  Y  A D+WSLG +++E   G  PL     + D M  I 
Sbjct: 217 QXIQSRFYRSPEVL----LGMPYDLAIDMWSLGCILVEMHTGE-PLFSGANEVDQMNKIV 271
Query: 279 AICFGERLEMPET----ASPEFRRFVRSCLEKDWRKRGT 313
                E L +P       +P+ R+F     +  W  + T
Sbjct: 272 -----EVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKT 305

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 72/285 (25%), Positives = 115/285 (40%), Gaps = 44/285 (15%)
Query: 52  LTVLGHGNGGIVYKVRHQKSNSIYALKVLN---TTSSTIIRH----QAAHEAEILKRLDS 104
           ++ LG G  G V+    ++ N    +K +          I      +   E  IL R++ 
Sbjct: 29  MSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEH 88
Query: 105 QFIVKCHAVFYTIEGEICFVMEHMERG-SLFDSLRVRKKLSEDVISGVAYRVLKGLQYLH 163
             I+K   +F   +G    VME    G  LF  +    +L E + S +  +++  + YL 
Sbjct: 89  ANIIKVLDIFEN-QGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLR 147
Query: 164 GMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGT 223
              IIH DIK  N++I     +K+ DFG +  +E                G+      GT
Sbjct: 148 LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLER---------------GKLFYTFCGT 192
Query: 224 CAYMSPERVDSERWGGDY-GFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAI-- 280
             Y +PE +     G  Y G   ++WSLGV +       Y L+ F E P      C +  
Sbjct: 193 IEYCAPEVL----MGNPYRGPELEMWSLGVTL-------YTLV-FEENP-----FCELEE 235
Query: 281 CFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTK 325
                +  P   S E    V   L+    +R T+E+L+  P+VT+
Sbjct: 236 TVEAAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQ 280

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 70/279 (25%), Positives = 119/279 (42%), Gaps = 51/279 (18%)
Query: 53  TVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQ------F 106
           +++G G+ G V K   +      A+K++    + +  +QA  E  +L+ ++        +
Sbjct: 41  SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFL--NQAQIEVRLLELMNKHDTEMKYY 98
Query: 107 IV--KCHAVFYTIEGEICFVMEHMERGSLFDSLRVR--KKLSEDVISGVAYRVLKGLQYL 162
           IV  K H +F      +C V E M   +L+D LR    + +S ++    A ++   L +L
Sbjct: 99  IVHLKRHFMF---RNHLCLVFE-MLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFL 154
Query: 163 HG--MQIIHGDIKPSNLLING--KGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAI 218
               + IIH D+KP N+L+    +  +KI DFG S                   +G+   
Sbjct: 155 ATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS-----------------CQLGQRIY 197
Query: 219 ACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALIC 278
             + +  Y SPE +     G  Y  A D+WSLG +++E   G  PL     + D M  I 
Sbjct: 198 QXIQSRFYRSPEVL----LGMPYDLAIDMWSLGCILVEMHTGE-PLFSGANEVDQMNKIV 252
Query: 279 AICFGERLEMPET----ASPEFRRFVRSCLEKDWRKRGT 313
                E L +P       +P+ R+F     +  W  + T
Sbjct: 253 -----EVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKT 286

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 70/279 (25%), Positives = 119/279 (42%), Gaps = 51/279 (18%)
Query: 53  TVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQ------F 106
           +++G G+ G V K   +      A+K++    + +  +QA  E  +L+ ++        +
Sbjct: 60  SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFL--NQAQIEVRLLELMNKHDTEMKYY 117
Query: 107 IV--KCHAVFYTIEGEICFVMEHMERGSLFDSLRVR--KKLSEDVISGVAYRVLKGLQYL 162
           IV  K H +F      +C V E M   +L+D LR    + +S ++    A ++   L +L
Sbjct: 118 IVHLKRHFMF---RNHLCLVFE-MLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFL 173
Query: 163 HG--MQIIHGDIKPSNLLING--KGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAI 218
               + IIH D+KP N+L+    +  +KI DFG S                   +G+   
Sbjct: 174 ATPELSIIHCDLKPENILLCNPKRXAIKIVDFGSS-----------------CQLGQRIY 216
Query: 219 ACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALIC 278
             + +  Y SPE +     G  Y  A D+WSLG +++E   G  PL     + D M  I 
Sbjct: 217 QXIQSRFYRSPEVL----LGMPYDLAIDMWSLGCILVEMHTGE-PLFSGANEVDQMNKIV 271
Query: 279 AICFGERLEMPET----ASPEFRRFVRSCLEKDWRKRGT 313
                E L +P       +P+ R+F     +  W  + T
Sbjct: 272 -----EVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKT 305

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 82/310 (26%), Positives = 128/310 (41%), Gaps = 54/310 (17%)
Query: 32  HFPTSNPT---SPDVENISDLKKLTV--------LGHGNGGIVYK-----VRHQKSNSIY 75
           +F  SNP    +    +ISDLK++          LGHG  G VY+     + +  S    
Sbjct: 19  YFQGSNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQV 78
Query: 76  ALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFV-MEHMERGSLF 134
           A+K L    S         EA I+ + + Q IV+C  V  +++    F+ ME M  G L 
Sbjct: 79  AVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGV--SLQSLPRFILMELMAGGDLK 136
Query: 135 DSLR-VRKKLSE-------DVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLIN--GKGE 184
             LR  R + S+       D++  VA  +  G QYL     IH DI   N L+   G G 
Sbjct: 137 SFLRETRPRPSQPSSLAMLDLLH-VARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGR 195
Query: 185 V-KIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERVDSERW-GGDYG 242
           V KI DFG++R                  I  A+    G CA +  + +  E +  G + 
Sbjct: 196 VAKIGDFGMAR-----------------DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFT 238
Query: 243 FAGDVWSLGVVVLECL-VGHYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVR 301
              D WS GV++ E   +G+ P      + +++  + +   G R++ P+       R + 
Sbjct: 239 SKTDTWSFGVLLWEIFSLGYMPYPSKSNQ-EVLEFVTS---GGRMDPPKNCPGPVYRIMT 294
Query: 302 SCLEKDWRKR 311
            C +     R
Sbjct: 295 QCWQHQPEDR 304

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/222 (23%), Positives = 90/222 (40%), Gaps = 41/222 (18%)
Query: 116 TIEGEICFVMEHMERGSLFDSLRVRK----KLSEDV------------ISGVAYRVLKGL 159
           T +G +  ++ +  +G+L + LR R+    + S D+            +    Y++ +G+
Sbjct: 111 TQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGM 170
Query: 160 QYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIA 219
           +YL   + IH D+   N+L+     +KIADFG++R +                 G   + 
Sbjct: 171 EYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN------GRLPVK 224
Query: 220 CMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV---GHYPLIGFGEKPDLMAL 276
            M   A    +RV        Y    DVWS GV++ E        YP I   E      L
Sbjct: 225 WMAPEALF--DRV--------YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE------L 268
Query: 277 ICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELL 318
              +  G R++ P   + E    +R C      +R T ++L+
Sbjct: 269 FKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLV 310

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 82/310 (26%), Positives = 129/310 (41%), Gaps = 54/310 (17%)
Query: 32  HFPTSNPT---SPDVENISDLKKLTV--------LGHGNGGIVYK-----VRHQKSNSIY 75
           +F  SNP    +    +ISDLK++          LGHG  G VY+     + +  S    
Sbjct: 19  YFQGSNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQV 78
Query: 76  ALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVM-EHMERGSLF 134
           A+K L    S         EA I+ +L+ Q IV+C  V  +++    F++ E M  G L 
Sbjct: 79  AVKTLPEVCSEQDELDFLMEALIISKLNHQNIVRCIGV--SLQSLPRFILLELMAGGDLK 136
Query: 135 DSLR-VRKKLSE-------DVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLIN--GKGE 184
             LR  R + S+       D++  VA  +  G QYL     IH DI   N L+   G G 
Sbjct: 137 SFLRETRPRPSQPSSLAMLDLLH-VARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGR 195
Query: 185 V-KIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERVDSERW-GGDYG 242
           V KI DFG++R                  I  A+    G CA +  + +  E +  G + 
Sbjct: 196 VAKIGDFGMAR-----------------DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFT 238
Query: 243 FAGDVWSLGVVVLECL-VGHYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVR 301
              D WS GV++ E   +G+ P      + +++  + +   G R++ P+       R + 
Sbjct: 239 SKTDTWSFGVLLWEIFSLGYMPYPSKSNQ-EVLEFVTS---GGRMDPPKNCPGPVYRIMT 294
Query: 302 SCLEKDWRKR 311
            C +     R
Sbjct: 295 QCWQHQPEDR 304

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 72/153 (47%), Gaps = 23/153 (15%)
Query: 113 VFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVL----KGLQYLHGMQII 168
           V+  I+ ++C       + +L D +  R  L ED   GV   +     + +++LH   ++
Sbjct: 134 VYLYIQMQLC------RKENLKDWMNRRCSL-EDREHGVCLHIFIQIAEAVEFLHSKGLM 186
Query: 169 HGDIKPSNLLINGKGEVKIADFGVSRIV---EETRXXXXXXXXXXXXIGEAAIACMGTCA 225
           H D+KPSN+       VK+ DFG+   +   EE +             G+     +GT  
Sbjct: 187 HRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQ-----VGTKL 241
Query: 226 YMSPERVDSERWGGDYGFAGDVWSLGVVVLECL 258
           YMSPE++     G +Y    D++SLG+++ E L
Sbjct: 242 YMSPEQIH----GNNYSHKVDIFSLGLILFELL 270

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 84/340 (24%), Positives = 138/340 (40%), Gaps = 56/340 (16%)
Query: 4   VRERRHQQALTLSLPATAANHQFRRRRHH--FPTSNPT---SPDVENISDLKKLTV---- 54
           V  R+HQ+   + +   +  ++  + R        NP    +    +ISDLK++      
Sbjct: 1   VYRRKHQELQAMQMELQSPEYKLSKLRTSTIMTDYNPNYSFAGKTSSISDLKEVPRKNIT 60
Query: 55  ----LGHGNGGIVYK-----VRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQ 105
               LGHG  G VY+     + +  S    A+K L    S         EA I+ + + Q
Sbjct: 61  LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 120
Query: 106 FIVKCHAVFYTIEGEICFVM-EHMERGSLFDSLR-VRKKLSE-------DVISGVAYRVL 156
            IV+C  V  +++    F++ E M  G L   LR  R + S+       D++  VA  + 
Sbjct: 121 NIVRCIGV--SLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH-VARDIA 177
Query: 157 KGLQYLHGMQIIHGDIKPSNLLIN--GKGEV-KIADFGVSRIVEETRXXXXXXXXXXXXI 213
            G QYL     IH DI   N L+   G G V KI DFG++R                  I
Sbjct: 178 CGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----------------DI 220
Query: 214 GEAAIACMGTCAYMSPERVDSERW-GGDYGFAGDVWSLGVVVLECL-VGHYPLIGFGEKP 271
             A+    G CA +  + +  E +  G +    D WS GV++ E   +G+ P      + 
Sbjct: 221 YRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ- 279
Query: 272 DLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKR 311
           +++  + +   G R++ P+       R +  C +     R
Sbjct: 280 EVLEFVTS---GGRMDPPKNCPGPVYRIMTQCWQHQPEDR 316

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/262 (22%), Positives = 104/262 (39%), Gaps = 41/262 (15%)
Query: 76  ALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFD 135
           A+K+L   ++         E E++K +     +       T +G +  ++ +  +G+L +
Sbjct: 71  AVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLRE 130
Query: 136 SLRVRK----KLSEDV------------ISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLI 179
            LR R+    + S D+            +    Y++ +G++YL   + IH D+   N+L+
Sbjct: 131 YLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV 190
Query: 180 NGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERVDSERWGG 239
                +KIADFG++R +                 G   +  M   A    +RV       
Sbjct: 191 TENNVMKIADFGLARDINNIDYYKKTTN------GRLPVKWMAPEALF--DRV------- 235
Query: 240 DYGFAGDVWSLGVVVLECLV---GHYPLIGFGEKPDLMALICAICFGERLEMPETASPEF 296
            Y    DVWS GV++ E        YP I   E      L   +  G R++ P   + E 
Sbjct: 236 -YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE------LFKLLKEGHRMDKPANCTNEL 288
Query: 297 RRFVRSCLEKDWRKRGTVEELL 318
              +R C      +R T ++L+
Sbjct: 289 YMMMRDCWHAVPSQRPTFKQLV 310

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 100/215 (46%), Gaps = 28/215 (13%)
Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH-EAEILKRLDSQFIV 108
           + L  +G G  GIV        +   A+K L+         + A+ E  ++K ++ + I+
Sbjct: 27  QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNII 86
Query: 109 KCHAVFY---TIE--GEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLH 163
               VF    T+E   ++  VME M+  +L   +++  +L  + +S + Y++L G+++LH
Sbjct: 87  SLLNVFTPQKTLEEFQDVYLVMELMD-ANLXQVIQM--ELDHERMSYLLYQMLXGIKHLH 143
Query: 164 GMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGT 223
              IIH D+KPSN+++     +KI DFG++R    +                     + T
Sbjct: 144 SAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMT---------------PYVVT 188
Query: 224 CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECL 258
             Y +PE +     G  Y    D+WS+G ++ E +
Sbjct: 189 RYYRAPEVI----LGMGYKENVDIWSVGCIMGEMV 219

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 38/141 (26%), Positives = 68/141 (48%), Gaps = 22/141 (15%)
Query: 120 EICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLI 179
           ++  VME M+      S  ++ +L  + +S + Y++L G+++LH   IIH D+KPSN+++
Sbjct: 103 DVYIVMELMDANL---SQVIQMELDHERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVV 159
Query: 180 NGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERVDSERWGG 239
                +KI DFG++R    +                     + T  Y +PE +     G 
Sbjct: 160 KSDATLKILDFGLARTAGTSFMMT---------------PYVVTRYYRAPEVI----LGM 200
Query: 240 DYGFAGDVWSLGVVVLECLVG 260
            Y    D+WS+G ++ E + G
Sbjct: 201 GYKENVDIWSVGCIMGEMIKG 221

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 59/257 (22%), Positives = 108/257 (42%), Gaps = 44/257 (17%)
Query: 45  NISDLKKLTVLGHGNGGIVYK------VRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEI 98
           ++S ++ +  LG    G VYK         +++ ++ A+K L   +   +R +  HEA +
Sbjct: 7   SLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAV-AIKTLKDKAEGPLREEFRHEAML 65
Query: 99  LKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSE------------- 145
             RL    +V C     T +  +  +  +   G L + L +R   S+             
Sbjct: 66  RARLQHPNVV-CLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSA 124
Query: 146 ----DVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRX 201
               D +  VA ++  G++YL    ++H D+   N+L+  K  VKI+D G+ R V     
Sbjct: 125 LEPPDFVHLVA-QIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREV----- 178
Query: 202 XXXXXXXXXXXIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECL-VG 260
                      +G + +       +M+PE +      G +    D+WS GVV+ E    G
Sbjct: 179 ---YAADYYKLLGNSLL----PIRWMAPEAIMY----GKFSIDSDIWSYGVVLWEVFSYG 227
Query: 261 HYPLIGFGEKPDLMALI 277
             P  G+  + D++ +I
Sbjct: 228 LQPYCGYSNQ-DVVEMI 243

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 72/285 (25%), Positives = 119/285 (41%), Gaps = 42/285 (14%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVF 114
           LG G    V  V        YALK +        R +A  EA++ +  +   I++  A  
Sbjct: 37  LGEGGFSYVDLVEGLHDGHFYALKRI-LCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 115 YTIEG---EICFVMEHMERGSLFDSL-RVRKK---LSEDVISGVAYRVLKGLQYLHGMQI 167
               G   E   ++   +RG+L++ + R++ K   L+ED I  +   + +GL+ +H    
Sbjct: 96  LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGY 155
Query: 168 IHGDIKPSNLLINGKGEVKIADFGVSRI----VEETRXXXXXXXXXXXXIGEAAIACMGT 223
            H D+KP+N+L+  +G+  + D G        VE +R               AA  C  T
Sbjct: 156 AHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDW-------AAQRC--T 206
Query: 224 CAYMSPER-------VDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMAL 276
            +Y +PE        V  ER         DVWSLG V+   + G  P     +K D +AL
Sbjct: 207 ISYRAPELFSVQSHCVIDER--------TDVWSLGCVLYAMMFGEGPYDMVFQKGDSVAL 258
Query: 277 ICAICFGERLEMPETA--SPEFRRFVRSCLEKDWRKRGTVEELLA 319
                   +L +P++   S    + + S +  D  +R  +  LL+
Sbjct: 259 AVQ----NQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLS 299

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 81/310 (26%), Positives = 128/310 (41%), Gaps = 54/310 (17%)
Query: 32  HFPTSNPT---SPDVENISDLKKLTV--------LGHGNGGIVYK-----VRHQKSNSIY 75
           +F  SNP    +    +ISDLK++          LGHG  G VY+     + +  S    
Sbjct: 19  YFQGSNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQV 78
Query: 76  ALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVM-EHMERGSLF 134
           A+K L    S         EA I+ + + Q IV+C  V  +++    F++ E M  G L 
Sbjct: 79  AVKTLPEVYSEQDELDFLMEALIISKFNHQNIVRCIGV--SLQSLPRFILLELMAGGDLK 136
Query: 135 DSLR-VRKKLSE-------DVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLIN--GKGE 184
             LR  R + S+       D++  VA  +  G QYL     IH DI   N L+   G G 
Sbjct: 137 SFLRETRPRPSQPSSLAMLDLLH-VARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGR 195
Query: 185 V-KIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERVDSERW-GGDYG 242
           V KI DFG++R                  I  A+    G CA +  + +  E +  G + 
Sbjct: 196 VAKIGDFGMAR-----------------DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFT 238
Query: 243 FAGDVWSLGVVVLECL-VGHYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVR 301
              D WS GV++ E   +G+ P      + +++  + +   G R++ P+       R + 
Sbjct: 239 SKTDTWSFGVLLWEIFSLGYMPYPSKSNQ-EVLEFVTS---GGRMDPPKNCPGPVYRIMT 294
Query: 302 SCLEKDWRKR 311
            C +     R
Sbjct: 295 QCWQHQPEDR 304

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 100/231 (43%), Gaps = 27/231 (11%)
Query: 45  NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLN-TTSSTIIRHQAAHEAEILKRLD 103
           ++ +LK L ++G G  G VYK          A+KV +       I  +  +   +++  +
Sbjct: 11  DLDNLKLLELIGRGRYGAVYK--GSLDERPVAVKVFSFANRQNFINEKNIYRVPLMEHDN 68
Query: 104 -SQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISG--VAYRVLKGLQ 160
            ++FIV    V      E   VME+   GSL   L +    + D +S   +A+ V +GL 
Sbjct: 69  IARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH---TSDWVSSCRLAHSVTRGLA 125
Query: 161 YLHGM---------QIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXX 211
           YLH            I H D+   N+L+   G   I+DFG+S  +   R           
Sbjct: 126 YLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEE---- 181
Query: 212 XIGEAAIACMGTCAYMSPERVDSERWGGDYGFA---GDVWSLGVVVLECLV 259
               AAI+ +GT  YM+PE ++      D   A    D+++LG++  E  +
Sbjct: 182 --DNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFM 230

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 99/233 (42%), Gaps = 28/233 (12%)
Query: 53  TVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHA 112
            +LG G  G VYK R     ++ A+K L          Q   E E++     + +++   
Sbjct: 44  NILGRGGFGKVYKGR-LADGTLVAVKRLKEERXQGGELQFQTEVEMISMAVHRNLLRLRG 102
Query: 113 VFYTIEGEICFVMEHMERGSLFDSLRVRKK----LSEDVISGVAYRVLKGLQYLHGM--- 165
            F     E   V  +M  GS+   LR R +    L       +A    +GL YLH     
Sbjct: 103 -FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDP 161
Query: 166 QIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCA 225
           +IIH D+K +N+L++ + E  + DFG++++++                     A  GT  
Sbjct: 162 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDX-------------HVXXAVRGTIG 208
Query: 226 YMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGH--YPLIGFGEKPDLMAL 276
           +++PE + +    G      DV+  GV++LE + G   + L       D+M L
Sbjct: 209 HIAPEYLST----GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL 257

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/257 (22%), Positives = 108/257 (42%), Gaps = 44/257 (17%)
Query: 45  NISDLKKLTVLGHGNGGIVYK------VRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEI 98
           ++S ++ +  LG    G VYK         +++ ++ A+K L   +   +R +  HEA +
Sbjct: 24  SLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAV-AIKTLKDKAEGPLREEFRHEAML 82
Query: 99  LKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSE------------- 145
             RL    +V C     T +  +  +  +   G L + L +R   S+             
Sbjct: 83  RARLQHPNVV-CLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSA 141
Query: 146 ----DVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRX 201
               D +  VA ++  G++YL    ++H D+   N+L+  K  VKI+D G+ R V     
Sbjct: 142 LEPPDFVHLVA-QIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREV----- 195
Query: 202 XXXXXXXXXXXIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECL-VG 260
                      +G + +       +M+PE +      G +    D+WS GVV+ E    G
Sbjct: 196 ---YAADYYKLLGNSLLP----IRWMAPEAIMY----GKFSIDSDIWSYGVVLWEVFSYG 244
Query: 261 HYPLIGFGEKPDLMALI 277
             P  G+  + D++ +I
Sbjct: 245 LQPYCGYSNQ-DVVEMI 260

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 78/294 (26%), Positives = 123/294 (41%), Gaps = 51/294 (17%)
Query: 45  NISDLKKLTV--------LGHGNGGIVYK-----VRHQKSNSIYALKVLNTTSSTIIRHQ 91
           +ISDLK++          LGHG  G VY+     + +  S    A+K L    S      
Sbjct: 21  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD 80
Query: 92  AAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVM-EHMERGSLFDSLR-VRKKLSE---- 145
              EA I+ +L+ Q IV+C  V  +++    F++ E M  G L   LR  R + S+    
Sbjct: 81  FLMEALIISKLNHQNIVRCIGV--SLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSL 138
Query: 146 ---DVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLIN--GKGEV-KIADFGVSRIVEET 199
              D++  VA  +  G QYL     IH DI   N L+   G G V KI DFG++R     
Sbjct: 139 AMLDLLH-VARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----- 192
Query: 200 RXXXXXXXXXXXXIGEAAIACMGTCAYMSPERVDSERW-GGDYGFAGDVWSLGVVVLECL 258
                        I  A+    G CA +  + +  E +  G +    D WS GV++ E  
Sbjct: 193 ------------DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 240
Query: 259 -VGHYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKR 311
            +G+ P      + +++  + +   G R++ P+       R +  C +     R
Sbjct: 241 SLGYMPYPSKSNQ-EVLEFVTS---GGRMDPPKNCPGPVYRIMTQCWQHQPEDR 290

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 95/221 (42%), Gaps = 17/221 (7%)
Query: 54  VLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDS--QFIVKCH 111
           VL  G    VY+ +   S   YALK L +      R     E   +K+L      +  C 
Sbjct: 35  VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNR-AIIQEVCFMKKLSGHPNIVQFCS 93
Query: 112 AVFYTIE----GEICFVM-EHMERGSLFDSLR---VRKKLSEDVISGVAYRVLKGLQYLH 163
           A     E    G+  F++   + +G L + L+    R  LS D +  + Y+  + +Q++H
Sbjct: 94  AASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH 153
Query: 164 GMQ--IIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACM 221
             +  IIH D+K  NLL++ +G +K+ DFG +  +  +             + E  I   
Sbjct: 154 RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTI--SHYPDYSWSAQRRALVEEEITRN 211
Query: 222 GTCAYMSPERVDSERWGGDYGFAGDVWSLGVVV-LECLVGH 261
            T  Y +PE +D        G   D+W+LG ++ L C   H
Sbjct: 212 TTPMYRTPEIIDLYS-NFPIGEKQDIWALGCILYLLCFRQH 251

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 78/294 (26%), Positives = 122/294 (41%), Gaps = 51/294 (17%)
Query: 45  NISDLKKLTV--------LGHGNGGIVYK-----VRHQKSNSIYALKVLNTTSSTIIRHQ 91
           +ISDLK++          LGHG  G VY+     + +  S    A+K L    S      
Sbjct: 20  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD 79
Query: 92  AAHEAEILKRLDSQFIVKCHAVFYTIEGEICFV-MEHMERGSLFDSLR-VRKKLSE---- 145
              EA I+ + + Q IV+C  V  +++    F+ ME M  G L   LR  R + S+    
Sbjct: 80  FLMEALIISKFNHQNIVRCIGV--SLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSL 137
Query: 146 ---DVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLIN--GKGEV-KIADFGVSRIVEET 199
              D++  VA  +  G QYL     IH DI   N L+   G G V KI DFG++R     
Sbjct: 138 AMLDLLH-VARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----- 191
Query: 200 RXXXXXXXXXXXXIGEAAIACMGTCAYMSPERVDSERW-GGDYGFAGDVWSLGVVVLECL 258
                        I  A+    G CA +  + +  E +  G +    D WS GV++ E  
Sbjct: 192 ------------DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 239
Query: 259 -VGHYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKR 311
            +G+ P      + +++  + +   G R++ P+       R +  C +     R
Sbjct: 240 SLGYMPYPSKSNQ-EVLEFVTS---GGRMDPPKNCPGPVYRIMTQCWQHQPEDR 289

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 38/141 (26%), Positives = 68/141 (48%), Gaps = 22/141 (15%)
Query: 120 EICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLI 179
           ++  VME M+      S  ++ +L  + +S + Y++L G+++LH   IIH D+KPSN+++
Sbjct: 103 DVYIVMELMDANL---SQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 159
Query: 180 NGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERVDSERWGG 239
                +KI DFG++R    +                     + T  Y +PE +     G 
Sbjct: 160 KSDATLKILDFGLARTAGTSFMMT---------------PYVVTRYYRAPEVI----LGM 200
Query: 240 DYGFAGDVWSLGVVVLECLVG 260
            Y    D+WS+G ++ E + G
Sbjct: 201 GYKENVDIWSVGCIMGEMIKG 221

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 38/141 (26%), Positives = 68/141 (48%), Gaps = 22/141 (15%)
Query: 120 EICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLI 179
           ++  VME M+      S  ++ +L  + +S + Y++L G+++LH   IIH D+KPSN+++
Sbjct: 103 DVYIVMELMDANL---SQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 159
Query: 180 NGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERVDSERWGG 239
                +KI DFG++R    +                     + T  Y +PE +     G 
Sbjct: 160 KSDATLKILDFGLARTAGTSFMMT---------------PYVVTRYYRAPEVI----LGM 200
Query: 240 DYGFAGDVWSLGVVVLECLVG 260
            Y    D+WS+G ++ E + G
Sbjct: 201 GYKENVDIWSVGCIMGEMIKG 221

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 100/215 (46%), Gaps = 28/215 (13%)
Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH-EAEILKRLDSQFIV 108
           + L  +G G  GIV        +   A+K L+         + A+ E  ++K ++ + I+
Sbjct: 20  QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 79
Query: 109 KCHAVFY---TIE--GEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLH 163
               VF    T+E   ++  VME M+  +L   +++  +L  + +S + Y++L G+++LH
Sbjct: 80  SLLNVFTPQKTLEEFQDVYLVMELMD-ANLXQVIQM--ELDHERMSYLLYQMLXGIKHLH 136
Query: 164 GMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGT 223
              IIH D+KPSN+++     +KI DFG++R    +                     + T
Sbjct: 137 SAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMT---------------PYVVT 181
Query: 224 CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECL 258
             Y +PE +     G  Y    D+WS+G ++ E +
Sbjct: 182 RYYRAPEVI----LGMGYKENVDIWSVGCIMGEMV 212

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 70/268 (26%), Positives = 117/268 (43%), Gaps = 31/268 (11%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVF 114
           LG G+ G V+++  +++    A+K +      + R   A E      L S  IV  +   
Sbjct: 101 LGRGSFGEVHRMEDKQTGFQCAVKKVRLE---VFR---AEELMACAGLTSPRIVPLYGAV 154
Query: 115 YTIEGE-ICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIK 173
              EG  +   ME +E GSL   ++ +  L ED       + L+GL+YLH  +I+HGD+K
Sbjct: 155 R--EGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDVK 212
Query: 174 PSNLLINGKGE-VKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIA---CMGTCAYMSP 229
             N+L++  G    + DFG +  ++               +G++ +      GT  +M+P
Sbjct: 213 ADNVLLSSDGSHAALCDFGHAVCLQPD------------GLGKSLLTGDYIPGTETHMAP 260
Query: 230 ERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMP 289
           E V     G       DVWS   ++L  L G +P   F   P  + L  A       E+P
Sbjct: 261 EVV----LGRSCDAKVDVWSSCCMMLHMLNGCHPWTQFFRGP--LCLKIASEPPPVREIP 314
Query: 290 ETASPEFRRFVRSCLEKDWRKRGTVEEL 317
            + +P   + ++  L K+   R +  EL
Sbjct: 315 PSCAPLTAQAIQEGLRKEPIHRVSAAEL 342

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 100/215 (46%), Gaps = 28/215 (13%)
Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH-EAEILKRLDSQFIV 108
           + L  +G G  GIV        +   A+K L+         + A+ E  ++K ++ + I+
Sbjct: 27  QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 86
Query: 109 KCHAVFY---TIE--GEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLH 163
               VF    T+E   ++  VME M+  +L   +++  +L  + +S + Y++L G+++LH
Sbjct: 87  SLLNVFTPQKTLEEFQDVYLVMELMD-ANLXQVIQM--ELDHERMSYLLYQMLXGIKHLH 143
Query: 164 GMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGT 223
              IIH D+KPSN+++     +KI DFG++R    +                     + T
Sbjct: 144 SAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMT---------------PYVVT 188
Query: 224 CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECL 258
             Y +PE +     G  Y    D+WS+G ++ E +
Sbjct: 189 RYYRAPEVI----LGMGYKENVDIWSVGCIMGEMV 219

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 81/206 (39%), Gaps = 20/206 (9%)
Query: 63  VYKVRHQKSNSIYALKVLNTT--SSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGE 120
           VY+        I ALK+ + T  S  + R +   EA    RL    +V  H  F  I+G+
Sbjct: 50  VYEAEDTVRERIVALKLXSETLSSDPVFRTRXQREARTAGRLQEPHVVPIHD-FGEIDGQ 108
Query: 121 ICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLIN 180
           +      +    L   LR +  L+      +  ++   L   H     H D+KP N+L++
Sbjct: 109 LYVDXRLINGVDLAAXLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVS 168
Query: 181 GKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERVDSERWGGD 240
                 + DFG++    + +            +G      +GT  Y +PER         
Sbjct: 169 ADDFAYLVDFGIASATTDEK---------LTQLGN----TVGTLYYXAPERFSESHA--- 212
Query: 241 YGFAGDVWSLGVVVLECLVGHYPLIG 266
             +  D+++L  V+ ECL G  P  G
Sbjct: 213 -TYRADIYALTCVLYECLTGSPPYQG 237

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 100/215 (46%), Gaps = 28/215 (13%)
Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH-EAEILKRLDSQFIV 108
           + L  +G G  GIV        +   A+K L+         + A+ E  ++K ++ + I+
Sbjct: 27  QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNII 86
Query: 109 KCHAVFY---TIE--GEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLH 163
               VF    T+E   ++  VME M+  +L   +++  +L  + +S + Y++L G+++LH
Sbjct: 87  SLLNVFTPQKTLEEFQDVYLVMELMD-ANLXQVIQM--ELDHERMSYLLYQMLCGIKHLH 143
Query: 164 GMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGT 223
              IIH D+KPSN+++     +KI DFG++R    +                     + T
Sbjct: 144 SAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMT---------------PYVVT 188
Query: 224 CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECL 258
             Y +PE +     G  Y    D+WS+G ++ E +
Sbjct: 189 RYYRAPEVI----LGMGYKENVDIWSVGCIMGEMV 219

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 59/128 (46%), Gaps = 31/128 (24%)
Query: 139 VRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEE 198
           ++ +L  + +S + Y++L G+++LH   IIH D+KPSN+++     +KI DFG++R    
Sbjct: 119 IQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-- 176
Query: 199 TRXXXXXXXXXXXXIGEAAIACMGTCAYMSPE------RVDSERWGGDYGFAGDVWSLGV 252
                                  GT   M+PE      R      G  Y    D+WS+G 
Sbjct: 177 -----------------------GTSFMMTPEVVTRYYRAPEVILGMGYKENVDIWSVGC 213
Query: 253 VVLECLVG 260
           ++ E + G
Sbjct: 214 IMGEMIKG 221

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 77/294 (26%), Positives = 122/294 (41%), Gaps = 51/294 (17%)
Query: 45  NISDLKKLTV--------LGHGNGGIVYK-----VRHQKSNSIYALKVLNTTSSTIIRHQ 91
           +ISDLK++          LGHG  G VY+     + +  S    A+K L    S      
Sbjct: 21  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD 80
Query: 92  AAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVM-EHMERGSLFDSLR-VRKKLSE---- 145
              EA I+ + + Q IV+C  V  +++    F++ E M  G L   LR  R + S+    
Sbjct: 81  FLMEALIISKFNHQNIVRCIGV--SLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSL 138
Query: 146 ---DVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLIN--GKGEV-KIADFGVSRIVEET 199
              D++  VA  +  G QYL     IH DI   N L+   G G V KI DFG++R     
Sbjct: 139 AMLDLLH-VARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----- 192
Query: 200 RXXXXXXXXXXXXIGEAAIACMGTCAYMSPERVDSERW-GGDYGFAGDVWSLGVVVLECL 258
                        I  A+    G CA +  + +  E +  G +    D WS GV++ E  
Sbjct: 193 ------------DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 240
Query: 259 -VGHYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKR 311
            +G+ P      + +++  + +   G R++ P+       R +  C +     R
Sbjct: 241 SLGYMPYPSKSNQ-EVLEFVTS---GGRMDPPKNCPGPVYRIMTQCWQHQPEDR 290

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 77/294 (26%), Positives = 122/294 (41%), Gaps = 51/294 (17%)
Query: 45  NISDLKKLTV--------LGHGNGGIVYK-----VRHQKSNSIYALKVLNTTSSTIIRHQ 91
           +ISDLK++          LGHG  G VY+     + +  S    A+K L    S      
Sbjct: 27  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD 86
Query: 92  AAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVM-EHMERGSLFDSLR-VRKKLSE---- 145
              EA I+ + + Q IV+C  V  +++    F++ E M  G L   LR  R + S+    
Sbjct: 87  FLMEALIISKFNHQNIVRCIGV--SLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSL 144
Query: 146 ---DVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLIN--GKGEV-KIADFGVSRIVEET 199
              D++  VA  +  G QYL     IH DI   N L+   G G V KI DFG++R     
Sbjct: 145 AMLDLLH-VARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----- 198
Query: 200 RXXXXXXXXXXXXIGEAAIACMGTCAYMSPERVDSERW-GGDYGFAGDVWSLGVVVLECL 258
                        I  A+    G CA +  + +  E +  G +    D WS GV++ E  
Sbjct: 199 ------------DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 246
Query: 259 -VGHYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKR 311
            +G+ P      + +++  + +   G R++ P+       R +  C +     R
Sbjct: 247 SLGYMPYPSKSNQ-EVLEFVTS---GGRMDPPKNCPGPVYRIMTQCWQHQPEDR 296

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 77/294 (26%), Positives = 122/294 (41%), Gaps = 51/294 (17%)
Query: 45  NISDLKKLTV--------LGHGNGGIVYK-----VRHQKSNSIYALKVLNTTSSTIIRHQ 91
           +ISDLK++          LGHG  G VY+     + +  S    A+K L    S      
Sbjct: 37  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD 96
Query: 92  AAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVM-EHMERGSLFDSLR-VRKKLSE---- 145
              EA I+ + + Q IV+C  V  +++    F++ E M  G L   LR  R + S+    
Sbjct: 97  FLMEALIISKFNHQNIVRCIGV--SLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSL 154
Query: 146 ---DVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLIN--GKGEV-KIADFGVSRIVEET 199
              D++  VA  +  G QYL     IH DI   N L+   G G V KI DFG++R     
Sbjct: 155 AMLDLLH-VARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----- 208
Query: 200 RXXXXXXXXXXXXIGEAAIACMGTCAYMSPERVDSERW-GGDYGFAGDVWSLGVVVLECL 258
                        I  A+    G CA +  + +  E +  G +    D WS GV++ E  
Sbjct: 209 ------------DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 256
Query: 259 -VGHYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKR 311
            +G+ P      + +++  + +   G R++ P+       R +  C +     R
Sbjct: 257 SLGYMPYPSKSNQ-EVLEFVTS---GGRMDPPKNCPGPVYRIMTQCWQHQPEDR 306

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 100/215 (46%), Gaps = 28/215 (13%)
Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH-EAEILKRLDSQFIV 108
           + L  +G G  GIV        +   A+K L+         + A+ E  ++K ++ + I+
Sbjct: 27  QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNII 86
Query: 109 KCHAVFY---TIE--GEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLH 163
               VF    T+E   ++  VME M+  +L   +++  +L  + +S + Y++L G+++LH
Sbjct: 87  SLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQM--ELDHERMSYLLYQMLCGIKHLH 143
Query: 164 GMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGT 223
              IIH D+KPSN+++     +KI DFG++R    +                     + T
Sbjct: 144 SAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMT---------------PYVVT 188
Query: 224 CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECL 258
             Y +PE +     G  Y    D+WS+G ++ E +
Sbjct: 189 RYYRAPEVI----LGMGYKENVDIWSVGCIMGEMV 219

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 77/294 (26%), Positives = 122/294 (41%), Gaps = 51/294 (17%)
Query: 45  NISDLKKLTV--------LGHGNGGIVYK-----VRHQKSNSIYALKVLNTTSSTIIRHQ 91
           +ISDLK++          LGHG  G VY+     + +  S    A+K L    S      
Sbjct: 20  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD 79
Query: 92  AAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVM-EHMERGSLFDSLR-VRKKLSE---- 145
              EA I+ + + Q IV+C  V  +++    F++ E M  G L   LR  R + S+    
Sbjct: 80  FLMEALIISKFNHQNIVRCIGV--SLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSL 137
Query: 146 ---DVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLIN--GKGEV-KIADFGVSRIVEET 199
              D++  VA  +  G QYL     IH DI   N L+   G G V KI DFG++R     
Sbjct: 138 AMLDLLH-VARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----- 191
Query: 200 RXXXXXXXXXXXXIGEAAIACMGTCAYMSPERVDSERW-GGDYGFAGDVWSLGVVVLECL 258
                        I  A+    G CA +  + +  E +  G +    D WS GV++ E  
Sbjct: 192 ------------DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 239
Query: 259 -VGHYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKR 311
            +G+ P      + +++  + +   G R++ P+       R +  C +     R
Sbjct: 240 SLGYMPYPSKSNQ-EVLEFVTS---GGRMDPPKNCPGPVYRIMTQCWQHQPEDR 289

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 70/268 (26%), Positives = 116/268 (43%), Gaps = 31/268 (11%)
Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVF 114
           LG G+ G V+++  +++    A+K +      + R   A E      L S  IV  +   
Sbjct: 82  LGRGSFGEVHRMEDKQTGFQCAVKKVRLE---VFR---AEELMACAGLTSPRIVPLYGAV 135
Query: 115 YTIEGE-ICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIK 173
              EG  +   ME +E GSL   ++ +  L ED       + L+GL+YLH  +I+HGD+K
Sbjct: 136 R--EGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDVK 193
Query: 174 PSNLLINGKGE-VKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIA---CMGTCAYMSP 229
             N+L++  G    + DFG +  ++               +G+  +      GT  +M+P
Sbjct: 194 ADNVLLSSDGSHAALCDFGHAVCLQPD------------GLGKDLLTGDYIPGTETHMAP 241
Query: 230 ERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMP 289
           E V     G       DVWS   ++L  L G +P   F   P  + L  A       E+P
Sbjct: 242 EVV----LGRSCDAKVDVWSSCCMMLHMLNGCHPWTQFFRGP--LCLKIASEPPPVREIP 295
Query: 290 ETASPEFRRFVRSCLEKDWRKRGTVEEL 317
            + +P   + ++  L K+   R +  EL
Sbjct: 296 PSCAPLTAQAIQEGLRKEPIHRVSAAEL 323

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 77/294 (26%), Positives = 122/294 (41%), Gaps = 51/294 (17%)
Query: 45  NISDLKKLTV--------LGHGNGGIVYK-----VRHQKSNSIYALKVLNTTSSTIIRHQ 91
           +ISDLK++          LGHG  G VY+     + +  S    A+K L    S      
Sbjct: 12  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD 71
Query: 92  AAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVM-EHMERGSLFDSLR-VRKKLSE---- 145
              EA I+ + + Q IV+C  V  +++    F++ E M  G L   LR  R + S+    
Sbjct: 72  FLMEALIISKFNHQNIVRCIGV--SLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSL 129
Query: 146 ---DVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLIN--GKGEV-KIADFGVSRIVEET 199
              D++  VA  +  G QYL     IH DI   N L+   G G V KI DFG++R     
Sbjct: 130 AMLDLLH-VARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----- 183
Query: 200 RXXXXXXXXXXXXIGEAAIACMGTCAYMSPERVDSERW-GGDYGFAGDVWSLGVVVLECL 258
                        I  A+    G CA +  + +  E +  G +    D WS GV++ E  
Sbjct: 184 ------------DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 231
Query: 259 -VGHYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKR 311
            +G+ P      + +++  + +   G R++ P+       R +  C +     R
Sbjct: 232 SLGYMPYPSKSNQ-EVLEFVTS---GGRMDPPKNCPGPVYRIMTQCWQHQPEDR 281

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 38/141 (26%), Positives = 68/141 (48%), Gaps = 22/141 (15%)
Query: 120 EICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLI 179
           ++  VME M+      S  ++ +L  + +S + Y++L G+++LH   IIH D+KPSN+++
Sbjct: 103 DVYIVMELMDANL---SQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 159
Query: 180 NGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERVDSERWGG 239
                +KI DFG++R    +                     + T  Y +PE +     G 
Sbjct: 160 KSDCTLKILDFGLARTAGTSFMMT---------------PYVVTRYYRAPEVI----LGM 200
Query: 240 DYGFAGDVWSLGVVVLECLVG 260
            Y    D+WS+G ++ E + G
Sbjct: 201 GYKENVDIWSVGCIMGEMIKG 221

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 77/294 (26%), Positives = 121/294 (41%), Gaps = 51/294 (17%)
Query: 45  NISDLKKLTV--------LGHGNGGIVYK-----VRHQKSNSIYALKVLNTTSSTIIRHQ 91
           +ISDLK++          LGHG  G VY+     + +  S    A+K L    S      
Sbjct: 38  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD 97
Query: 92  AAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVM-EHMERGSLFDSLR-VRKKLSE---- 145
              EA I+ + + Q IV+C  V  +++    F++ E M  G L   LR  R + S+    
Sbjct: 98  FLMEALIISKFNHQNIVRCIGV--SLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSL 155
Query: 146 ---DVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLIN--GKGEV-KIADFGVSRIVEET 199
              D++  VA  +  G QYL     IH DI   N L+   G G V KI DFG++R     
Sbjct: 156 AMLDLLH-VARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----- 209
Query: 200 RXXXXXXXXXXXXIGEAAIACMGTCAYMSPERVDSERW-GGDYGFAGDVWSLGVVVLECL 258
                        I  A     G CA +  + +  E +  G +    D WS GV++ E  
Sbjct: 210 ------------DIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 257
Query: 259 -VGHYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKR 311
            +G+ P      + +++  + +   G R++ P+       R +  C +     R
Sbjct: 258 SLGYMPYPSKSNQ-EVLEFVTS---GGRMDPPKNCPGPVYRIMTQCWQHQPEDR 307

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 77/294 (26%), Positives = 121/294 (41%), Gaps = 51/294 (17%)
Query: 45  NISDLKKLTV--------LGHGNGGIVYK-----VRHQKSNSIYALKVLNTTSSTIIRHQ 91
           +ISDLK++          LGHG  G VY+     + +  S    A+K L    S      
Sbjct: 61  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD 120
Query: 92  AAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVM-EHMERGSLFDSLR-VRKKLSE---- 145
              EA I+ + + Q IV+C  V  +++    F++ E M  G L   LR  R + S+    
Sbjct: 121 FLMEALIISKFNHQNIVRCIGV--SLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSL 178
Query: 146 ---DVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLIN--GKGEV-KIADFGVSRIVEET 199
              D++  VA  +  G QYL     IH DI   N L+   G G V KI DFG++R     
Sbjct: 179 AMLDLLH-VARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----- 232
Query: 200 RXXXXXXXXXXXXIGEAAIACMGTCAYMSPERVDSERW-GGDYGFAGDVWSLGVVVLECL 258
                        I  A     G CA +  + +  E +  G +    D WS GV++ E  
Sbjct: 233 ------------DIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 280
Query: 259 -VGHYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKR 311
            +G+ P      + +++  + +   G R++ P+       R +  C +     R
Sbjct: 281 SLGYMPYPSKSNQ-EVLEFVTS---GGRMDPPKNCPGPVYRIMTQCWQHQPEDR 330

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 101/221 (45%), Gaps = 36/221 (16%)
Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQ-----AAHEAEILKRLDS 104
           ++L  +G G  GIV        +++  + V     S   ++Q     A  E  +LK ++ 
Sbjct: 27  QQLKPIGSGAQGIVCAA----FDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNH 82
Query: 105 QFIVKCHAVFY---TIE--GEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGL 159
           + I+    VF    T+E   ++  VME M+  +L   + +  +L  + +S + Y++L G+
Sbjct: 83  KNIISLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIHM--ELDHERMSYLLYQMLCGI 139
Query: 160 QYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIA 219
           ++LH   IIH D+KPSN+++     +KI DFG++R                         
Sbjct: 140 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---------------TACTNFMMTP 184
Query: 220 CMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVG 260
            + T  Y +PE +     G  Y    D+WS+G ++ E + G
Sbjct: 185 YVVTRYYRAPEVI----LGMGYAANVDIWSVGCIMGELVKG 221

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 33/122 (27%), Positives = 61/122 (50%), Gaps = 19/122 (15%)
Query: 139 VRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEE 198
           ++ +L  + +S + Y++L G+++LH   IIH D+KPSN+++     +KI DFG++R    
Sbjct: 121 IQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 180
Query: 199 TRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECL 258
           +                  +  + T  Y +PE +     G  Y    D+WS+G ++ E +
Sbjct: 181 SFMM---------------VPFVVTRYYRAPEVI----LGMGYKENVDIWSVGCIMGEMI 221
Query: 259 VG 260
            G
Sbjct: 222 KG 223

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 80/151 (52%), Gaps = 9/151 (5%)
Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH-EAEILKRLDSQFIV 108
           + L  +G G  GIV        +   A+K L+         + A+ E  ++K ++ + I+
Sbjct: 26  QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 85
Query: 109 KCHAVFY---TIE--GEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLH 163
               VF    T+E   ++  VME M+  +L   +++  +L  + +S + Y++L G+++LH
Sbjct: 86  SLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQM--ELDHERMSYLLYQMLCGIKHLH 142
Query: 164 GMQIIHGDIKPSNLLINGKGEVKIADFGVSR 194
              IIH D+KPSN+++     +KI DFG++R
Sbjct: 143 SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 173

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 98/233 (42%), Gaps = 28/233 (12%)
Query: 53  TVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHA 112
            +LG G  G VYK R      + A+K L    +     Q   E E++     + +++   
Sbjct: 36  NILGRGGFGKVYKGR-LADGXLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 94
Query: 113 VFYTIEGEICFVMEHMERGSLFDSLRVRKK----LSEDVISGVAYRVLKGLQYLHGM--- 165
            F     E   V  +M  GS+   LR R +    L       +A    +GL YLH     
Sbjct: 95  -FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDP 153
Query: 166 QIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCA 225
           +IIH D+K +N+L++ + E  + DFG++++++                     A  G   
Sbjct: 154 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDX-------------HVXXAVRGXIG 200
Query: 226 YMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGH--YPLIGFGEKPDLMAL 276
           +++PE + +    G      DV+  GV++LE + G   + L       D+M L
Sbjct: 201 HIAPEYLST----GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL 249

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 80/151 (52%), Gaps = 9/151 (5%)
Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH-EAEILKRLDSQFIV 108
           + L  +G G  GIV        +   A+K L+         + A+ E  ++K ++ + I+
Sbjct: 27  QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 86
Query: 109 KCHAVFY---TIE--GEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLH 163
               VF    T+E   ++  VME M+  +L   +++  +L  + +S + Y++L G+++LH
Sbjct: 87  SLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQM--ELDHERMSYLLYQMLCGIKHLH 143
Query: 164 GMQIIHGDIKPSNLLINGKGEVKIADFGVSR 194
              IIH D+KPSN+++     +KI DFG++R
Sbjct: 144 SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 174

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 80/151 (52%), Gaps = 9/151 (5%)
Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH-EAEILKRLDSQFIV 108
           + L  +G G  GIV        +   A+K L+         + A+ E  ++K ++ + I+
Sbjct: 21  QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 80
Query: 109 KCHAVFY---TIE--GEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLH 163
               VF    T+E   ++  VME M+  +L   +++  +L  + +S + Y++L G+++LH
Sbjct: 81  SLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQM--ELDHERMSYLLYQMLCGIKHLH 137
Query: 164 GMQIIHGDIKPSNLLINGKGEVKIADFGVSR 194
              IIH D+KPSN+++     +KI DFG++R
Sbjct: 138 SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 168

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 80/151 (52%), Gaps = 9/151 (5%)
Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH-EAEILKRLDSQFIV 108
           + L  +G G  GIV        +   A+K L+         + A+ E  ++K ++ + I+
Sbjct: 21  QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 80
Query: 109 KCHAVFY---TIE--GEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLH 163
               VF    T+E   ++  VME M+  +L   +++  +L  + +S + Y++L G+++LH
Sbjct: 81  SLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQM--ELDHERMSYLLYQMLCGIKHLH 137
Query: 164 GMQIIHGDIKPSNLLINGKGEVKIADFGVSR 194
              IIH D+KPSN+++     +KI DFG++R
Sbjct: 138 SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 168

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 80/151 (52%), Gaps = 9/151 (5%)
Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH-EAEILKRLDSQFIV 108
           + L  +G G  GIV        +   A+K L+         + A+ E  ++K ++ + I+
Sbjct: 28  QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 87
Query: 109 KCHAVFY---TIE--GEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLH 163
               VF    T+E   ++  VME M+  +L   +++  +L  + +S + Y++L G+++LH
Sbjct: 88  SLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQM--ELDHERMSYLLYQMLCGIKHLH 144
Query: 164 GMQIIHGDIKPSNLLINGKGEVKIADFGVSR 194
              IIH D+KPSN+++     +KI DFG++R
Sbjct: 145 SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 175

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 80/151 (52%), Gaps = 9/151 (5%)
Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH-EAEILKRLDSQFIV 108
           + L  +G G  GIV        +   A+K L+         + A+ E  ++K ++ + I+
Sbjct: 65  QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 124
Query: 109 KCHAVFY---TIE--GEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLH 163
               VF    T+E   ++  VME M+  +L   +++  +L  + +S + Y++L G+++LH
Sbjct: 125 SLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQM--ELDHERMSYLLYQMLCGIKHLH 181
Query: 164 GMQIIHGDIKPSNLLINGKGEVKIADFGVSR 194
              IIH D+KPSN+++     +KI DFG++R
Sbjct: 182 SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 212

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 80/151 (52%), Gaps = 9/151 (5%)
Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH-EAEILKRLDSQFIV 108
           + L  +G G  GIV        +   A+K L+         + A+ E  ++K ++ + I+
Sbjct: 27  QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 86
Query: 109 KCHAVFY---TIE--GEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLH 163
               VF    T+E   ++  VME M+  +L   +++  +L  + +S + Y++L G+++LH
Sbjct: 87  SLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQM--ELDHERMSYLLYQMLCGIKHLH 143
Query: 164 GMQIIHGDIKPSNLLINGKGEVKIADFGVSR 194
              IIH D+KPSN+++     +KI DFG++R
Sbjct: 144 SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 174

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 80/151 (52%), Gaps = 9/151 (5%)
Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH-EAEILKRLDSQFIV 108
           + L  +G G  GIV        +   A+K L+         + A+ E  ++K ++ + I+
Sbjct: 20  QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 79
Query: 109 KCHAVFY---TIE--GEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLH 163
               VF    T+E   ++  VME M+  +L   +++  +L  + +S + Y++L G+++LH
Sbjct: 80  SLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQM--ELDHERMSYLLYQMLCGIKHLH 136
Query: 164 GMQIIHGDIKPSNLLINGKGEVKIADFGVSR 194
              IIH D+KPSN+++     +KI DFG++R
Sbjct: 137 SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 167

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 80/151 (52%), Gaps = 9/151 (5%)
Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH-EAEILKRLDSQFIV 108
           + L  +G G  GIV        +   A+K L+         + A+ E  ++K ++ + I+
Sbjct: 28  QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 87
Query: 109 KCHAVFY---TIE--GEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLH 163
               VF    T+E   ++  VME M+  +L   +++  +L  + +S + Y++L G+++LH
Sbjct: 88  SLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQM--ELDHERMSYLLYQMLCGIKHLH 144
Query: 164 GMQIIHGDIKPSNLLINGKGEVKIADFGVSR 194
              IIH D+KPSN+++     +KI DFG++R
Sbjct: 145 SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 175

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 101/221 (45%), Gaps = 36/221 (16%)
Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQ-----AAHEAEILKRLDS 104
           ++L  +G G  GIV        +++  + V     S   ++Q     A  E  +LK ++ 
Sbjct: 25  QQLKPIGSGAQGIVCAA----FDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNH 80
Query: 105 QFIVKCHAVFY---TIE--GEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGL 159
           + I+    VF    T+E   ++  VME M+  +L   + +  +L  + +S + Y++L G+
Sbjct: 81  KNIISLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIHM--ELDHERMSYLLYQMLCGI 137
Query: 160 QYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIA 219
           ++LH   IIH D+KPSN+++     +KI DFG++R                         
Sbjct: 138 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTASTNFMMT---------------P 182
Query: 220 CMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVG 260
            + T  Y +PE +     G  Y    D+WS+G ++ E + G
Sbjct: 183 YVVTRYYRAPEVI----LGMGYKENVDIWSVGCIMGELVKG 219

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 68/295 (23%), Positives = 117/295 (39%), Gaps = 44/295 (14%)
Query: 33  FPTSN-PTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVL-----NTTSST 86
           FP S  PT  D    ++++    +G G  G+V+K R  K  S+ A+K L        +  
Sbjct: 8   FPKSRLPTLAD----NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEM 63
Query: 87  IIRHQA-AHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRK-KLS 144
           I + Q    E  I+  L+   IVK + + +        VME +  G L+  L  +   + 
Sbjct: 64  IEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPR---MVMEFVPCGDLYHRLLDKAHPIK 120
Query: 145 EDVISGVAYRVLKGLQYLHGMQ--IIHGDIKPSNLLINGKGE-----VKIADFGVSRIVE 197
             V   +   +  G++Y+      I+H D++  N+ +    E      K+ADFG+S+   
Sbjct: 121 WSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ--- 177
Query: 198 ETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLEC 257
                             +    +G   +M+PE + +E     Y    D +S  +++   
Sbjct: 178 --------------QSVHSVSGLLGNFQWMAPETIGAEE--ESYTEKADTYSFAMILYTI 221
Query: 258 LVGHYPLIGFGE-KPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKR 311
           L G  P   +   K   + +I     G R  +PE   P  R  +  C   D +KR
Sbjct: 222 LTGEGPFDEYSYGKIKFINMIREE--GLRPTIPEDCPPRLRNVIELCWSGDPKKR 274

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 80/151 (52%), Gaps = 9/151 (5%)
Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH-EAEILKRLDSQFIV 108
           + L  +G G  GIV        +   A+K L+         + A+ E  ++K ++ + I+
Sbjct: 65  QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 124
Query: 109 KCHAVFY---TIE--GEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLH 163
               VF    T+E   ++  VME M+  +L   +++  +L  + +S + Y++L G+++LH
Sbjct: 125 SLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQM--ELDHERMSYLLYQMLCGIKHLH 181
Query: 164 GMQIIHGDIKPSNLLINGKGEVKIADFGVSR 194
              IIH D+KPSN+++     +KI DFG++R
Sbjct: 182 SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 212

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 65/315 (20%), Positives = 116/315 (36%), Gaps = 63/315 (20%)
Query: 45  NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLD- 103
           N  D + +  LG G    V++  +  +N    +K+L       I+     E +IL+ L  
Sbjct: 35  NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKNKIKR----EIKILENLRG 90
Query: 104 -SQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYL 162
               I     V   +      V EH+      D  ++ + L++  I    Y +LK L Y 
Sbjct: 91  GPNIITLADIVKDPVSRTPALVFEHVNNT---DFKQLYQTLTDYDIRFYMYEILKALDYC 147
Query: 163 HGMQIIHGDIKPSNLLINGKG-EVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACM 221
           H M I+H D+KP N++I+ +  ++++ D+G++                    G+     +
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP---------------GQEYNVRV 192
Query: 222 GTCAYMSPE-RVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAI 280
            +  +  PE  VD +     Y ++ D+WSLG ++   +    P     +  D +  I  +
Sbjct: 193 ASRYFKGPELLVDYQM----YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKV 248
Query: 281 CFGERL---------------------------------EMPETASPEFRRFVRSCLEKD 307
              E L                                 E     SPE   F+   L  D
Sbjct: 249 LGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYD 308
Query: 308 WRKRGTVEELLAYPF 322
            + R T  E + +P+
Sbjct: 309 HQSRLTAREAMEHPY 323

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 52/233 (22%), Positives = 94/233 (40%), Gaps = 51/233 (21%)
Query: 55  LGHGN-GGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRL-----DSQFIV 108
           LG G  G +V  + H +  S  ALK++        R  A  E  +LK++     +++F+ 
Sbjct: 27  LGEGTFGKVVECLDHARGKSQVALKIIRNVGK--YREAARLEINVLKKIKEKDKENKFLC 84
Query: 109 KCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDV--ISGVAYRVLKGLQYLHGMQ 166
              + ++   G +C   E + + + F+ L+        +  +  +AY++   L++LH  Q
Sbjct: 85  VLMSDWFNFHGHMCIAFELLGKNT-FEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ 143
Query: 167 IIHGDIKPSNLL-INGKGE------------------VKIADFGVSRIVEETRXXXXXXX 207
           + H D+KP N+L +N + E                  +++ADFG +    E         
Sbjct: 144 LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHH------- 196
Query: 208 XXXXXIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVG 260
                        + T  Y  PE +    W        DVWS+G ++ E   G
Sbjct: 197 ----------TTIVATRHYRPPEVILELGWAQ----PCDVWSIGCILFEYYRG 235

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 76/294 (25%), Positives = 122/294 (41%), Gaps = 51/294 (17%)
Query: 45  NISDLKKLTV--------LGHGNGGIVYK-----VRHQKSNSIYALKVLNTTSSTIIRHQ 91
           +ISDLK++          LGHG  G VY+     + +  S    A+K L    S      
Sbjct: 21  SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD 80
Query: 92  AAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVM-EHMERGSLFDSLR-VRKKLSE---- 145
              EA I+ + + Q IV+C  V  +++    F++ E M  G L   LR  R + S+    
Sbjct: 81  FLMEALIISKFNHQNIVRCIGV--SLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSL 138
Query: 146 ---DVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLIN--GKGEV-KIADFGVSRIVEET 199
              D++  VA  +  G QYL     IH DI   N L+   G G V KI DFG+++     
Sbjct: 139 AMLDLLH-VARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQ----- 192
Query: 200 RXXXXXXXXXXXXIGEAAIACMGTCAYMSPERVDSERW-GGDYGFAGDVWSLGVVVLECL 258
                        I  A+    G CA +  + +  E +  G +    D WS GV++ E  
Sbjct: 193 ------------DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 240
Query: 259 -VGHYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKR 311
            +G+ P      + +++  + +   G R++ P+       R +  C +     R
Sbjct: 241 SLGYMPYPSKSNQ-EVLEFVTS---GGRMDPPKNCPGPVYRIMTQCWQHQPEDR 290

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 43/171 (25%), Positives = 65/171 (38%), Gaps = 23/171 (13%)
Query: 121 ICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLIN 180
           +   M ++E  S  D L     LS   +      + K L+ +H   I+H D+KPSN L N
Sbjct: 95  VVIAMPYLEHESFLDIL---NSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYN 151
Query: 181 GK-GEVKIADFGVSRIVEETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERVDSERWGG 239
            +  +  + DFG+++   +T+              +        C+     R       G
Sbjct: 152 RRLKKYALVDFGLAQGTHDTKIELLKFVQSE---AQQERCSQNKCSICLSRRQQVAPRAG 208
Query: 240 DYGF--------------AGDVWSLGVVVLECLVGHYPLIGFGEKPDLMAL 276
             GF              A D+WS GV+ L  L G YP   +    DL AL
Sbjct: 209 TPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF--YKASDDLTAL 257

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 68/295 (23%), Positives = 116/295 (39%), Gaps = 44/295 (14%)
Query: 33  FPTSN-PTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVL-----NTTSST 86
           FP S  PT  D    ++++    +G G  G+V+K R  K  S+ A+K L        +  
Sbjct: 8   FPKSRLPTLAD----NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEM 63
Query: 87  IIRHQA-AHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRK-KLS 144
           I + Q    E  I+  L+   IVK + + +        VME +  G L+  L  +   + 
Sbjct: 64  IEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPR---MVMEFVPCGDLYHRLLDKAHPIK 120
Query: 145 EDVISGVAYRVLKGLQYLHGMQ--IIHGDIKPSNLLINGKGE-----VKIADFGVSRIVE 197
             V   +   +  G++Y+      I+H D++  N+ +    E      K+ADFG S+   
Sbjct: 121 WSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ--- 177
Query: 198 ETRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLEC 257
                             +    +G   +M+PE + +E     Y    D +S  +++   
Sbjct: 178 --------------QSVHSVSGLLGNFQWMAPETIGAEE--ESYTEKADTYSFAMILYTI 221
Query: 258 LVGHYPLIGFGE-KPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKR 311
           L G  P   +   K   + +I     G R  +PE   P  R  +  C   D +KR
Sbjct: 222 LTGEGPFDEYSYGKIKFINMIREE--GLRPTIPEDCPPRLRNVIELCWSGDPKKR 274

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 33/122 (27%), Positives = 60/122 (49%), Gaps = 19/122 (15%)
Query: 139 VRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEE 198
           ++ +L  + +S + Y++L G+++LH   IIH D+KPSN+++     +KI DFG++R    
Sbjct: 119 IQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 178
Query: 199 TRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECL 258
           +                     + T  Y +PE +     G  Y    D+WS+G ++ E +
Sbjct: 179 SFMMT---------------PYVVTRYYRAPEVI----LGMGYKENVDIWSVGCIMGEMI 219
Query: 259 VG 260
            G
Sbjct: 220 KG 221

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 33/122 (27%), Positives = 60/122 (49%), Gaps = 19/122 (15%)
Query: 139 VRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEE 198
           ++ +L  + +S + Y++L G+++LH   IIH D+KPSN+++     +KI DFG++R    
Sbjct: 119 IQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 178
Query: 199 TRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECL 258
           +                     + T  Y +PE +     G  Y    D+WS+G ++ E +
Sbjct: 179 SFMMT---------------PYVVTRYYRAPEVI----LGMGYKENVDIWSVGCIMGEMI 219
Query: 259 VG 260
            G
Sbjct: 220 KG 221

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 34/124 (27%), Positives = 56/124 (45%), Gaps = 31/124 (25%)
Query: 139 VRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEE 198
           ++ +L  + +S + Y++L G+++LH   IIH D+KPSN+++     +KI DFG++R    
Sbjct: 119 IQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-- 176
Query: 199 TRXXXXXXXXXXXXIGEAAIACMGTCAYMSPE------RVDSERWGGDYGFAGDVWSLGV 252
                                  GT   M PE      R      G  Y    D+WS+G 
Sbjct: 177 -----------------------GTSFMMEPEVVTRYYRAPEVILGMGYKENVDIWSVGC 213
Query: 253 VVLE 256
           ++ E
Sbjct: 214 IMGE 217

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 33/122 (27%), Positives = 59/122 (48%), Gaps = 19/122 (15%)
Query: 139 VRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEE 198
           ++ +L  + +S + Y++L G+++LH   IIH D+KPSN+++     +KI DFG++R    
Sbjct: 120 IQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 179
Query: 199 TRXXXXXXXXXXXXIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECL 258
           +                       T  Y +PE +     G  Y    D+WS+G ++ E +
Sbjct: 180 SFMMTPYVV---------------TRYYRAPEVI----LGMGYKENVDIWSVGCIMGEMI 220
Query: 259 VG 260
            G
Sbjct: 221 KG 222

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 52/233 (22%), Positives = 94/233 (40%), Gaps = 51/233 (21%)
Query: 55  LGHGN-GGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRL-----DSQFIV 108
           LG G  G +V  + H +  S  ALK++        R  A  E  +LK++     +++F+ 
Sbjct: 36  LGEGTFGKVVECLDHARGKSQVALKIIRNVGK--YREAARLEINVLKKIKEKDKENKFLC 93
Query: 109 KCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDV--ISGVAYRVLKGLQYLHGMQ 166
              + ++   G +C   E + + + F+ L+        +  +  +AY++   L++LH  Q
Sbjct: 94  VLMSDWFNFHGHMCIAFELLGKNT-FEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ 152
Query: 167 IIHGDIKPSNLL-INGKGE------------------VKIADFGVSRIVEETRXXXXXXX 207
           + H D+KP N+L +N + E                  +++ADFG +    E         
Sbjct: 153 LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHH------- 205
Query: 208 XXXXXIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVG 260
                        + T  Y  PE +    W        DVWS+G ++ E   G
Sbjct: 206 ----------TTIVATRHYRPPEVILELGWAQ----PCDVWSIGCILFEYYRG 244

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/233 (22%), Positives = 94/233 (40%), Gaps = 51/233 (21%)
Query: 55  LGHGN-GGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRL-----DSQFIV 108
           LG G  G +V  + H +  S  ALK++        R  A  E  +LK++     +++F+ 
Sbjct: 59  LGEGTFGKVVECLDHARGKSQVALKIIRNVGK--YREAARLEINVLKKIKEKDKENKFLC 116
Query: 109 KCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDV--ISGVAYRVLKGLQYLHGMQ 166
              + ++   G +C   E + + + F+ L+        +  +  +AY++   L++LH  Q
Sbjct: 117 VLMSDWFNFHGHMCIAFELLGKNT-FEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ 175
Query: 167 IIHGDIKPSNLL-INGKGE------------------VKIADFGVSRIVEETRXXXXXXX 207
           + H D+KP N+L +N + E                  +++ADFG +    E         
Sbjct: 176 LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHH------- 228
Query: 208 XXXXXIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVG 260
                        + T  Y  PE +    W        DVWS+G ++ E   G
Sbjct: 229 ----------TTIVATRHYRPPEVILELGWAQ----PCDVWSIGCILFEYYRG 267
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	337
3an0_A	340	Dual specificity mitogen-activated protein kinase;	7e-88
3fme_A	290	Dual specificity mitogen-activated protein kinase;	3e-87
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-86
3aln_A	327	Dual specificity mitogen-activated protein kinase;	7e-84
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	9e-84
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	9e-73
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	4e-70
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	5e-67
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	4e-66
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	6e-66
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	8e-66
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	3e-65
2a19_B	284	Interferon-induced, double-stranded RNA-activated	5e-65
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-64
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-64
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	2e-62
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	2e-62
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	7e-61
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	4e-60
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	1e-59
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	4e-59
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	4e-59
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	5e-59
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	2e-58
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	5e-58
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	5e-58
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	9e-58
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	3e-57
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	4e-57
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	7e-57
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	8e-57
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	8e-56
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	1e-55
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	2e-55
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-52
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	6e-51
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	1e-50
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	1e-50
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	4e-50
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-49
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	2e-49
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	3e-49
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	3e-49
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	1e-48
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	2e-48
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	3e-48
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	4e-48
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	6e-48
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	8e-48
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	2e-47
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	4e-47
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	4e-47
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	4e-47
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	5e-47
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	6e-47
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	7e-47
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-46
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-46
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	2e-46
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-46
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	2e-46
3bhy_A	283	Death-associated protein kinase 3; death associate	3e-46
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	3e-46
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	4e-46
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-45
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-45
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	1e-45
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	2e-45
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	3e-45
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	3e-45
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	4e-45
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	6e-45
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	6e-45
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	7e-45
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	9e-45
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-44
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-44
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	2e-44
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	3e-44
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	3e-44
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	4e-44
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	5e-44
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	5e-44
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	6e-44
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	7e-44
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	8e-44
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-43
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-43
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	2e-43
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	4e-43
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	5e-43
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	5e-43
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-42
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	4e-42
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	7e-42
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	1e-41
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	1e-41
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	1e-41
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	2e-41
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-41
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-41
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	3e-41
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	3e-41
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	5e-41
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	5e-41
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	8e-41
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	1e-40
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	3e-40
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	4e-40
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-39
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	2e-39
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	6e-39
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	6e-39
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	1e-38
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	2e-38
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-38
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-37
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	5e-37
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	1e-36
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	1e-36
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-36
3q4u_A	301	Activin receptor type-1; structural genomics conso	3e-36
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	6e-36
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	9e-36
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	9e-36
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	2e-35
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	2e-35
3soc_A	322	Activin receptor type-2A; structural genomics cons	4e-35
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-34
3niz_A	311	Rhodanese family protein; structural genomics, str	4e-32
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	4e-32
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-31
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-31
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	2e-31
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	2e-31
3o0g_A	292	Cell division protein kinase 5; kinase activator c	4e-31
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	7e-31
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	1e-30
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-30
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-30
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	3e-30
3ork_A	311	Serine/threonine protein kinase; structural genomi	3e-30
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	4e-30
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	5e-30
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	5e-30
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	9e-30
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	1e-29
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	1e-29
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	2e-29
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	2e-29
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	4e-29
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	4e-29
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	4e-29
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	6e-29
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	7e-29
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-28
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	1e-28
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-28
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	2e-28
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	3e-28
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	3e-28
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	3e-28
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	5e-28
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	6e-28
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	8e-28
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	9e-28
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	9e-28
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	1e-27
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	1e-27
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-27
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-27
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-27
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	2e-27
3rp9_A	458	Mitogen-activated protein kinase; structural genom	3e-27
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	4e-27
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	4e-27
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	4e-27
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	5e-27
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	6e-27
3pls_A	298	Macrophage-stimulating protein receptor; protein k	8e-27
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	9e-27
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	1e-26
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	2e-26
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	3e-26
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	5e-26
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	9e-26
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	2e-25
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	4e-25
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	7e-25
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	8e-25
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-24
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	1e-24
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	1e-24
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	3e-24
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	3e-24
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	4e-24
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	5e-24
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	7e-24
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-23
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-23
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	1e-23
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	1e-23
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	2e-23
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-23
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	2e-23
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	2e-23
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	3e-23
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	3e-23
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	4e-23
4aoj_A	329	High affinity nerve growth factor receptor; transf	4e-23
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	1e-22
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	2e-22
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	2e-22
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	3e-22
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	3e-22
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	4e-22
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	6e-22
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	1e-21
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-21
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	2e-21
3uqc_A	286	Probable conserved transmembrane protein; structur	7e-21
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	2e-20
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	4e-20
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	7e-20
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	3e-19
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	3e-19
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	5e-18
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	5e-15
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	7e-15
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	8e-15
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	8e-15
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	1e-14
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	4e-14
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	2e-13
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	2e-11
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	4e-07
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	4e-04

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  263 bits (674), Expect = 3e-87
 Identities = 82/288 (28%), Positives = 141/288 (48%), Gaps = 27/288 (9%)

Query: 45  NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRL-D 103
              DL+ +  LG G  G+V K+RH  S  I A+K +  T ++  + +   + +I  R  D
Sbjct: 5   KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVD 64

Query: 104 SQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLR----VRKKLSEDVISGVAYRVLKGL 159
             F V  +   +  EG++   ME M+  SL    +      + + ED++  +A  ++K L
Sbjct: 65  CPFTVTFYGALFR-EGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKAL 122

Query: 160 QYLHG-MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAI 218
           ++LH  + +IH D+KPSN+LIN  G+VK+ DFG+S  + +    +        + G    
Sbjct: 123 EHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDI-------DAG---- 171

Query: 219 ACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALIC 278
                  YM+PER++ E     Y    D+WSLG+ ++E  +  +P   +G        + 
Sbjct: 172 ----CKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWG---TPFQQLK 224

Query: 279 AICFGERLEMP-ETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTK 325
            +      ++P +  S EF  F   CL+K+ ++R T  EL+ +PF T 
Sbjct: 225 QVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  262 bits (671), Expect = 2e-86
 Identities = 77/286 (26%), Positives = 138/286 (48%), Gaps = 24/286 (8%)

Query: 45  NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRL-D 103
            I+DL+ L  +G G  G V+K+R +K+  + A+K +  + +     +   + +++ +  D
Sbjct: 23  EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHD 82

Query: 104 SQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLH 163
             +IV+C   F T   ++   ME M   +     R++  + E ++  +   ++K L YL 
Sbjct: 83  CPYIVQCFGTFIT-NTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLK 141

Query: 164 G-MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMG 222
               +IH D+KPSN+L++ +G++K+ DFG+S  + + +  +                  G
Sbjct: 142 EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRS---------------AG 186

Query: 223 TCAYMSPERVDSERW-GGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAIC 281
             AYM+PER+D       DY    DVWSLG+ ++E   G +P            ++  + 
Sbjct: 187 CAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCK---TDFEVLTKVL 243

Query: 282 FGE--RLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTK 325
             E   L      S +F+ FV+ CL KD RKR    +LL + F+ +
Sbjct: 244 QEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKR 289

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  255 bits (654), Expect = 7e-84
 Identities = 82/292 (28%), Positives = 133/292 (45%), Gaps = 31/292 (10%)

Query: 45  NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRL-D 103
              DLK L  +G G  G V K+ H+ S  I A+K + +T     + Q   + +++ R  D
Sbjct: 20  TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSD 79

Query: 104 SQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKK-----LSEDVISGVAYRVLKG 158
             +IV+ +   +  EG+    ME M   S     +         + E+++  +    +K 
Sbjct: 80  CPYIVQFYGALFR-EGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKA 137

Query: 159 LQYLHG-MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAA 217
           L +L   ++IIH DIKPSN+L++  G +K+ DFG+S  + ++            + G   
Sbjct: 138 LNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTR-------DAG--- 187

Query: 218 IACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALI 277
                   YM+PER+D       Y    DVWSLG+ + E   G +P   + +   +   +
Sbjct: 188 -----CRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFP---YPKWNSVFDQL 239

Query: 278 CAICFGE--RLEMPETA--SPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTK 325
             +  G+  +L   E    SP F  FV  CL KD  KR   +ELL +PF+  
Sbjct: 240 TQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILM 291

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  256 bits (656), Expect = 9e-84
 Identities = 96/321 (29%), Positives = 157/321 (48%), Gaps = 61/321 (19%)

Query: 45  NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDS 104
              D +K++ LG GNGG+V+KV H+ S  + A K+++      IR+Q   E ++L   +S
Sbjct: 31  KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 90

Query: 105 QFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG 164
            +IV  +  FY+ +GEI   MEHM+ GSL   L+   ++ E ++  V+  V+KGL YL  
Sbjct: 91  PYIVGFYGAFYS-DGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 149

Query: 165 -MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGT 223
             +I+H D+KPSN+L+N +GE+K+ DFGVS  + ++  N+                 +GT
Sbjct: 150 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF----------------VGT 193

Query: 224 CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPD----------- 272
            +YMSPER+     G  Y    D+WS+G+ ++E  VG YP+     K             
Sbjct: 194 RSYMSPERLQ----GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGD 249

Query: 273 ---------------------------LMALICAICFGERLEMPETA-SPEFRRFVRSCL 304
                                      +  L+  I      ++P    S EF+ FV  CL
Sbjct: 250 AAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCL 309

Query: 305 EKDWRKRGTVEELLAYPFVTK 325
            K+  +R  +++L+ + F+ +
Sbjct: 310 IKNPAERADLKQLMVHAFIKR 330

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  228 bits (582), Expect = 9e-73
 Identities = 75/303 (24%), Positives = 133/303 (43%), Gaps = 29/303 (9%)

Query: 30  RHHFPT---SNPTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-S 85
            HH  +       +   +++    +L  +G G+ G    V+  +    Y +K +N +  S
Sbjct: 4   HHHHSSGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMS 63

Query: 86  TIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKK--L 143
           +  R ++  E  +L  +    IV+    F    G +  VM++ E G LF  +  +K    
Sbjct: 64  SKEREESRREVAVLANMKHPNIVQYRESFEE-NGSLYIVMDYCEGGDLFKRINAQKGVLF 122

Query: 144 SEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNN 203
            ED I     ++   L+++H  +I+H DIK  N+ +   G V++ DFG++R++  T    
Sbjct: 123 QEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV--- 179

Query: 204 NHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYP 263
                      E A AC+GT  Y+SPE  +++     Y    D+W+LG V+ E     + 
Sbjct: 180 -----------ELARACIGTPYYLSPEICENKP----YNNKSDIWALGCVLYELCTLKHA 224

Query: 264 LIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV 323
              F E   +  L+  I  G    +    S + R  V    +++ R R +V  +L   F+
Sbjct: 225 ---F-EAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFI 280

Query: 324 TKR 326
            KR
Sbjct: 281 AKR 283

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  219 bits (561), Expect = 4e-70
 Identities = 76/312 (24%), Positives = 130/312 (41%), Gaps = 33/312 (10%)

Query: 34  PTSNPTSPDVEN-----ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--ST 86
           P   P      +     +++ +    +G G    VY+          ALK +        
Sbjct: 14  PQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDA 73

Query: 87  IIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKK---- 142
             R     E ++LK+L+   ++K +A F   + E+  V+E  + G L   ++  KK    
Sbjct: 74  KARADCIKEIDLLKQLNHPNVIKYYASFIE-DNELNIVLELADAGDLSRMIKHFKKQKRL 132

Query: 143 LSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNN 202
           + E  +     ++   L+++H  +++H DIKP+N+ I   G VK+ D G+ R        
Sbjct: 133 IPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT-- 190

Query: 203 NNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHY 262
                        AA + +GT  YMSPER+        Y F  D+WSLG ++ E      
Sbjct: 191 ------------TAAHSLVGTPYYMSPERIHENG----YNFKSDIWSLGCLLYEMAALQS 234

Query: 263 PLIGFGEKPDLMALICAICFGERLEMPETA-SPEFRRFVRSCLEKDWRKRGTVEELLAYP 321
           P   +G+K +L +L   I   +   +P    S E R+ V  C+  D  KR  V  +    
Sbjct: 235 PF--YGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVA 292

Query: 322 FVTKRSSSSNIE 333
                 ++S++E
Sbjct: 293 KRMHACTASSLE 304

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  210 bits (538), Expect = 5e-67
 Identities = 72/293 (24%), Positives = 118/293 (40%), Gaps = 33/293 (11%)

Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-STIIRHQAAHEAEILKRLDSQFIV 108
           + L  +G G+ G   K+R +    I   K L+  S +   +     E  +L+ L    IV
Sbjct: 9   EVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIV 68

Query: 109 KCHAVFY-TIEGEICFVMEHMERGSLFDSLRVRKK----LSEDVISGVAYRVLKGLQYLH 163
           + +          +  VME+ E G L   +    K    L E+ +  V  ++   L+  H
Sbjct: 69  RYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH 128

Query: 164 -----GMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAI 218
                G  ++H D+KP+N+ ++GK  VK+ DFG++RI+                    A 
Sbjct: 129 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT--------------SFAK 174

Query: 219 ACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALIC 278
             +GT  YMSPE+++       Y    D+WSLG ++ E      P   F        L  
Sbjct: 175 TFVGTPYYMSPEQMNRMS----YNEKSDIWSLGCLLYELCALMPPFTAF----SQKELAG 226

Query: 279 AICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSN 331
            I  G+   +P   S E    +   L      R +VEE+L  P + +     +
Sbjct: 227 KIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHHHHHH 279

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  209 bits (535), Expect = 4e-66
 Identities = 71/321 (22%), Positives = 132/321 (41%), Gaps = 31/321 (9%)

Query: 23  NHQFRRRRHHFPTSNPTSPDVE-NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLN 81
           +H          T N     +         L  +G G    V++V + +   IYA+K +N
Sbjct: 3   HHHHHSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVN 61

Query: 82  TTS-STIIRHQAAHEAEILKRLD--SQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLR 138
                        +E   L +L   S  I++ +    T +  I  VME      L   L+
Sbjct: 62  LEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT-DQYIYMVMECGN-IDLNSWLK 119

Query: 139 VRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEE 198
            +K +           +L+ +  +H   I+H D+KP+N LI   G +K+ DFG++  ++ 
Sbjct: 120 KKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 178

Query: 199 TRNNNNHNNNNNNNIGEAAIACMGTCAYMSPE-------RVDSERWGGDYGFAGDVWSLG 251
              +   ++             +GT  YM PE         ++ +         DVWSLG
Sbjct: 179 DTTSVVKDS------------QVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLG 226

Query: 252 VVVLECLVGHYPLIGFGEKPDLMALICAIC-FGERLEMPETASPEFRRFVRSCLEKDWRK 310
            ++     G  P   F +  + ++ + AI      +E P+    + +  ++ CL++D ++
Sbjct: 227 CILYYMTYGKTP---FQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQ 283

Query: 311 RGTVEELLAYPFVTKRSSSSN 331
           R ++ ELLA+P+V  ++   N
Sbjct: 284 RISIPELLAHPYVQIQTHPVN 304

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  209 bits (534), Expect = 6e-66
 Identities = 73/295 (24%), Positives = 112/295 (37%), Gaps = 31/295 (10%)

Query: 34  PTSNPTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLN-TTSSTIIRHQA 92
           P  +P+ P+       ++L+ LGHG+ G V+KVR ++   +YA+K           R + 
Sbjct: 44  PGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARK 103

Query: 93  AHEAEILKRL-DSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSL-RVRKKLSEDVISG 150
             E    +++      V+    +    G +    E     SL          L E  + G
Sbjct: 104 LAEVGSHEKVGQHPCCVRLEQAWEE-GGILYLQTELCG-PSLQQHCEAWGASLPEAQVWG 161

Query: 151 VAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNN 210
                L  L +LH   ++H D+KP+N+ +  +G  K+ DFG+   +              
Sbjct: 162 YLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA----------- 210

Query: 211 NNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEK 270
                A     G   YM+P     E   G YG A DV+SLG+ +LE         G    
Sbjct: 211 ----GAGEVQEGDPRYMAP-----ELLQGSYGTAADVFSLGLTILEVACNMELPHGGEGW 261

Query: 271 PDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTK 325
             L             E     S E R  +   LE D + R T E LLA P + +
Sbjct: 262 QQLRQGYL------PPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  208 bits (532), Expect = 8e-66
 Identities = 54/294 (18%), Positives = 118/294 (40%), Gaps = 26/294 (8%)

Query: 46  ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQ 105
           ++D + +  LG G  G+V++ +++  +  YA+K +   +  + R +   E + L +L+  
Sbjct: 4   LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHP 63

Query: 106 FIVKCHAVF-----------YTIEGEICFVMEHMERGSLFDSLRVRKKLS---EDVISGV 151
            IV+    +            + +  +   M+   + +L D +  R  +      V   +
Sbjct: 64  GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI 123

Query: 152 AYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNN 211
             ++ + +++LH   ++H D+KPSN+       VK+ DFG+   +++             
Sbjct: 124 FLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQD--EEEQTVLTPM 181

Query: 212 NIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP 271
                    +GT  YMSPE++        Y    D++SLG+++ E L   YP   F  + 
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNS----YSHKVDIFSLGLILFELL---YP---FSTQM 231

Query: 272 DLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTK 325
           + +  +  +   +   +     P     V+  L     +R     ++       
Sbjct: 232 ERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFED 285

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  207 bits (528), Expect = 3e-65
 Identities = 69/303 (22%), Positives = 133/303 (43%), Gaps = 21/303 (6%)

Query: 47  SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQF 106
           SD +++ VLG G  G V K R+   +  YA+K +  T           E  +L  L+ Q+
Sbjct: 6   SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK--LSTILSEVMLLASLNHQY 63

Query: 107 IVKCHAVF------------YTIEGEICFVMEHMERGSLFDSLRVRK-KLSEDVISGVAY 153
           +V+ +A +               +  +   ME+ E G+L+D +         D    +  
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123

Query: 154 RVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNI 213
           ++L+ L Y+H   IIH D+KP N+ I+    VKI DFG+++ V  + +    ++ N    
Sbjct: 124 QILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183

Query: 214 GEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDL 273
            +   + +GT  Y++ E V      G Y    D++SLG++  E +   YP     E+ ++
Sbjct: 184 SDNLTSAIGTAMYVATE-VLDGT--GHYNEKIDMYSLGIIFFEMI---YPFSTGMERVNI 237

Query: 274 MALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNIE 333
           +  + ++      +  +      ++ +R  ++ D  KR     LL   ++  +     I+
Sbjct: 238 LKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQDEVIK 297

Query: 334 GLI 336
             +
Sbjct: 298 EAL 300

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  205 bits (525), Expect = 5e-65
 Identities = 65/306 (21%), Positives = 124/306 (40%), Gaps = 50/306 (16%)

Query: 40  SPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEIL 99
           + D     D K++ ++G G  G V+K +H+     Y +K +          +A  E + L
Sbjct: 4   TVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN-----NEKAEREVKAL 58

Query: 100 KRLDSQFIVKCHAVF---------------YTIEGEICFVMEHMERGSLFDSLRVRKK-- 142
            +LD   IV  +  +                +    +   ME  ++G+L   +  R+   
Sbjct: 59  AKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK 118

Query: 143 LSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNN 202
           L + +   +  ++ KG+ Y+H  ++I+ D+KPSN+ +    +VKI DFG+   ++     
Sbjct: 119 LDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND--- 175

Query: 203 NNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHY 262
                      G+   +  GT  YMSPE++ S+     YG   D+++LG+++ E L    
Sbjct: 176 -----------GKRTRSK-GTLRYMSPEQISSQD----YGKEVDLYALGLILAELLHVCD 219

Query: 263 PLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPF 322
                 E       +          + +    + +  ++  L K    R    E+L    
Sbjct: 220 T---AFETSKFFTDLR------DGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLT 270

Query: 323 VTKRSS 328
           V K+S 
Sbjct: 271 VWKKSP 276

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  206 bits (526), Expect = 2e-64
 Identities = 68/298 (22%), Positives = 127/298 (42%), Gaps = 30/298 (10%)

Query: 45  NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-STIIRHQAAHEAEILKRLD 103
                  L  +G G    V++V + +   IYA+K +N             +E   L +L 
Sbjct: 7   KGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ 65

Query: 104 --SQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQY 161
             S  I++ +    T +  I  VME      L   L+ +K +           +L+ +  
Sbjct: 66  QHSDKIIRLYDYEIT-DQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHT 123

Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACM 221
           +H   I+H D+KP+N LI   G +K+ DFG++  ++    +   ++             +
Sbjct: 124 IHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDS------------QV 170

Query: 222 GTCAYMSPE-------RVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLM 274
           GT  YM PE         ++ +         DVWSLG ++     G  P   F +  + +
Sbjct: 171 GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP---FQQIINQI 227

Query: 275 ALICAIC-FGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSN 331
           + + AI      +E P+    + +  ++ CL++D ++R ++ ELLA+P+V  ++   N
Sbjct: 228 SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVN 285

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  207 bits (529), Expect = 2e-64
 Identities = 75/350 (21%), Positives = 142/350 (40%), Gaps = 45/350 (12%)

Query: 8   RHQQALTLSLPA-----TAANHQFRRRRHHFPTSNPTSPDVENISDLKKLTV-------- 54
            H    +  +P        A  +F R+    P       D  + S  + ++V        
Sbjct: 2   HHHHHSSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSIL 61

Query: 55  --LGHGNGGIVYKVRHQKSNSIYALKVLNTTS-STIIRHQAAHEAEILKRLD--SQFIVK 109
             +G G    V++V + +   IYA+K +N             +E   L +L   S  I++
Sbjct: 62  KQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 120

Query: 110 CHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIH 169
            +    T +  I  VME      L   L+ +K +           +L+ +  +H   I+H
Sbjct: 121 LYDYEIT-DQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVH 178

Query: 170 GDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSP 229
            D+KP+N LI   G +K+ DFG++  ++    +   ++             +G   YM P
Sbjct: 179 SDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDS------------QVGAVNYMPP 225

Query: 230 E-------RVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAIC- 281
           E         ++ +         DVWSLG ++     G  P   F +  + ++ + AI  
Sbjct: 226 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP---FQQIINQISKLHAIID 282

Query: 282 FGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSN 331
               +E P+    + +  ++ CL++D ++R ++ ELLA+P+V  ++   N
Sbjct: 283 PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVN 332

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  199 bits (509), Expect = 2e-62
 Identities = 92/301 (30%), Positives = 130/301 (43%), Gaps = 27/301 (8%)

Query: 35  TSNPTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH 94
            S+    D E   +     VLG G  GIVY  R   +    A+K +    S   +     
Sbjct: 11  ESDLLEYDYE-YDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQ-PLHE 68

Query: 95  EAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRK---KLSEDVISGV 151
           E  + K L  + IV+     ++  G I   ME +  GSL   LR +    K +E  I   
Sbjct: 69  EIALHKHLKHKNIVQYLG-SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFY 127

Query: 152 AYRVLKGLQYLHGMQIIHGDIKPSNLLINGK-GEVKIADFGVSRIVEETRNNNNHNNNNN 210
             ++L+GL+YLH  QI+H DIK  N+LIN   G +KI+DFG S+ +              
Sbjct: 128 TKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTE------ 181

Query: 211 NNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEK 270
                      GT  YM+PE +D    G  YG A D+WSLG  ++E   G  P    GE 
Sbjct: 182 --------TFTGTLQYMAPEIIDKGPRG--YGKAADIWSLGCTIIEMATGKPPFYELGEP 231

Query: 271 PDLMALICAICFGERL-EMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSS 329
               A +  +   +   E+PE+ S E + F+  C E D  KR    +LL   F+   S  
Sbjct: 232 ---QAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKK 288

Query: 330 S 330
            
Sbjct: 289 K 289

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  201 bits (512), Expect = 2e-62
 Identities = 61/298 (20%), Positives = 112/298 (37%), Gaps = 27/298 (9%)

Query: 36  SNPTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHE 95
                   E +  +     +G G+ G V++++ +++    A+K +       +      E
Sbjct: 47  KPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR------LEVFRVEE 100

Query: 96  AEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRV 155
                 L S  IV  +         +   ME +E GSL   ++    L ED       + 
Sbjct: 101 LVACAGLSSPRIVPLYG-AVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQA 159

Query: 156 LKGLQYLHGMQIIHGDIKPSNLLINGKG-EVKIADFGVSRIVEETRNNNNHNNNNNNNIG 214
           L+GL+YLH  +I+HGD+K  N+L++  G    + DFG +  ++      +    +     
Sbjct: 160 LEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDY---- 215

Query: 215 EAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLM 274
                  GT  +M+PE V  +          D+WS   ++L  L G +P   +       
Sbjct: 216 -----IPGTETHMAPEVVMGKP----CDAKVDIWSSCCMMLHMLNGCHPWTQYFR----G 262

Query: 275 ALICAI--CFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSS 330
            L   I        E+P + +P   + ++  L K+   R +  EL        +    
Sbjct: 263 PLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGG 320

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  196 bits (499), Expect = 7e-61
 Identities = 83/295 (28%), Positives = 144/295 (48%), Gaps = 32/295 (10%)

Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS----STIIRHQAAHEAEILKRLDSQ 105
           + +  LG G  G VYK +++++ ++ A KV+ T S       I      E EIL   D  
Sbjct: 22  EIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIV-----EIEILATCDHP 76

Query: 106 FIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKK-LSEDVISGVAYRVLKGLQYLHG 164
           +IVK    +Y  +G++  ++E    G++   +    + L+E  I  V  ++L+ L +LH 
Sbjct: 77  YIVKLLGAYY-HDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHS 135

Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTC 224
            +IIH D+K  N+L+  +G++++ADFGVS    +T    +              + +GT 
Sbjct: 136 KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRD--------------SFIGTP 181

Query: 225 AYMSPERVDSERW-GGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFG 283
            +M+PE V  E      Y +  D+WSLG+ ++E      P       P  M ++  I   
Sbjct: 182 YWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPH--HELNP--MRVLLKIAKS 237

Query: 284 E--RLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNIEGLI 336
           +   L  P   S EFR F++  L+K+   R +  +LL +PFV+  +S+  +  L+
Sbjct: 238 DPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNKALRELV 292

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  194 bits (495), Expect = 4e-60
 Identities = 96/292 (32%), Positives = 140/292 (47%), Gaps = 33/292 (11%)

Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFI 107
             L  LG G+ G VYK  H+++  I A+K +   S    II+     E  I+++ DS  +
Sbjct: 32  DVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIK-----EISIMQQCDSPHV 86

Query: 108 VKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKK-LSEDVISGVAYRVLKGLQYLHGMQ 166
           VK +  ++    ++  VME+   GS+ D +R+R K L+ED I+ +    LKGL+YLH M+
Sbjct: 87  VKYYGSYF-KNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR 145

Query: 167 IIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAY 226
            IH DIK  N+L+N +G  K+ADFGV+  + +T    N                +GT  +
Sbjct: 146 KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRN--------------TVIGTPFW 191

Query: 227 MSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGE-- 284
           M+PE +        Y    D+WSLG+  +E   G  P       P  M  I  I      
Sbjct: 192 MAPEVIQ----EIGYNCVADIWSLGITAIEMAEGKPPY--ADIHP--MRAIFMIPTNPPP 243

Query: 285 RLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNIEGLI 336
               PE  S  F  FV+ CL K   +R T  +LL +PFV      S +  LI
Sbjct: 244 TFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKGVSILRDLI 295

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  193 bits (492), Expect = 1e-59
 Identities = 63/306 (20%), Positives = 112/306 (36%), Gaps = 21/306 (6%)

Query: 28  RRRHHFPTSNPTSPDVE-----NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNT 82
              HH  +              +      +  LG G    V  V        YALK +  
Sbjct: 5   HHHHHHSSGRENLYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILC 64

Query: 83  TSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEG---EICFVMEHMERGSLFDSLRV 139
                 R +A  EA++ +  +   I++  A      G   E   ++   +RG+L++ +  
Sbjct: 65  HEQQD-REEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIER 123

Query: 140 RKK----LSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRI 195
            K     L+ED I  +   + +GL+ +H     H D+KP+N+L+  +G+  + D G    
Sbjct: 124 LKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183

Query: 196 VEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVL 255
                   +   +      +   A   T +Y +PE    +          DVWSLG V+ 
Sbjct: 184 A-----CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQS-HCVIDERTDVWSLGCVLY 237

Query: 256 ECLVGHYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVE 315
             + G  P     +K D +AL   +     +      S    + + S +  D  +R  + 
Sbjct: 238 AMMFGEGPYDMVFQKGDSVALA--VQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIP 295

Query: 316 ELLAYP 321
            LL+  
Sbjct: 296 LLLSQL 301

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  191 bits (488), Expect = 4e-59
 Identities = 76/315 (24%), Positives = 123/315 (39%), Gaps = 38/315 (12%)

Query: 35  TSNPTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH 94
             +   P   N  D +   V+G G   +V            A+K +N         +   
Sbjct: 3   EDSSALPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLK 62

Query: 95  EAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVR--------KKLSED 146
           E + + +     IV  +  F  ++ E+  VM+ +  GS+ D ++            L E 
Sbjct: 63  EIQAMSQCHHPNIVSYYTSFV-VKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDES 121

Query: 147 VISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHN 206
            I+ +   VL+GL+YLH    IH D+K  N+L+   G V+IADFGVS  +    +   + 
Sbjct: 122 TIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNK 181

Query: 207 NNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYP--- 263
                         +GT  +M+PE ++       Y F  D+WS G+  +E   G  P   
Sbjct: 182 VRK---------TFVGTPCWMAPEVMEQ---VRGYDFKADIWSFGITAIELATGAAPYHK 229

Query: 264 --------LIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVE 315
                   L    + P L   +      ++          FR+ +  CL+KD  KR T  
Sbjct: 230 YPPMKVLMLTLQNDPPSLETGVQDKEMLKKY------GKSFRKMISLCLQKDPEKRPTAA 283

Query: 316 ELLAYPFVTKRSSSS 330
           ELL + F  K  +  
Sbjct: 284 ELLRHKFFQKAKNKE 298

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  190 bits (486), Expect = 4e-59
 Identities = 80/284 (28%), Positives = 124/284 (43%), Gaps = 32/284 (11%)

Query: 46  ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIR----HQAAHEAEILKR 101
           + D +    LG G  G VY  R ++S  I ALKVL    + + +    HQ   E EI   
Sbjct: 8   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLF--KAQLEKAGVEHQLRREVEIQSH 65

Query: 102 LDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQY 161
           L    I++ +  F+     +  ++E+   G+++  L+   K  E   +     +   L Y
Sbjct: 66  LRHPNILRLYGYFHD-ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSY 124

Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACM 221
            H  ++IH DIKP NLL+   GE+KIADFG S     +R  +                C 
Sbjct: 125 CHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTD---------------LC- 168

Query: 222 GTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAIC 281
           GT  Y+ PE ++    G  +    D+WSLGV+  E LVG  P   F E          I 
Sbjct: 169 GTLDYLPPEMIE----GRMHDEKVDLWSLGVLCYEFLVGKPP---F-EANTYQETYKRIS 220

Query: 282 FGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTK 325
             E    P+  +   R  +   L+ +  +R  + E+L +P++T 
Sbjct: 221 RVE-FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 263

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  191 bits (486), Expect = 5e-59
 Identities = 73/287 (25%), Positives = 126/287 (43%), Gaps = 32/287 (11%)

Query: 49  LKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTI-IRHQAAHEAEILKRLDSQFI 107
           LK    +G G+   VYK    ++    A   L     T   R +   EAE+LK L    I
Sbjct: 28  LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 87

Query: 108 VKCHAVFYTI---EGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG 164
           V+ +  + +    +  I  V E M  G+L   L+  K +   V+     ++LKGLQ+LH 
Sbjct: 88  VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHT 147

Query: 165 MQ--IIHGDIKPSNLLINGK-GEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACM 221
               IIH D+K  N+ I G  G VKI D G++ +   +                   A +
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK----------------AVI 191

Query: 222 GTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAIC 281
           GT  +M+PE  + +     Y  + DV++ G+ +LE     YP   + E  +   +   + 
Sbjct: 192 GTPEFMAPEMYEEK-----YDESVDVYAFGMCMLEMATSEYP---YSECQNAAQIYRRVT 243

Query: 282 FGER-LEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRS 327
            G +     + A PE +  +  C+ ++  +R ++++LL + F  + +
Sbjct: 244 SGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEET 290

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  189 bits (482), Expect = 2e-58
 Identities = 82/296 (27%), Positives = 122/296 (41%), Gaps = 33/296 (11%)

Query: 35  TSNPTSPDVE-NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIR---- 89
           T+    P  +  I D      LG G  G VY  R +++  I ALKVL    S + +    
Sbjct: 1   TALAEMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLF--KSQLEKEGVE 58

Query: 90  HQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVIS 149
           HQ   E EI   L    I++ +  F+     I  ++E   RG L+  L+   +  E   +
Sbjct: 59  HQLRREIEIQSHLRHPNILRMYNYFHD-RKRIYLMLEFAPRGELYKELQKHGRFDEQRSA 117

Query: 150 GVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNN 209
                +   L Y H  ++IH DIKP NLL+  KGE+KIADFG S      R         
Sbjct: 118 TFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRT------ 171

Query: 210 NNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGE 269
                     C GT  Y+ PE ++    G  +    D+W  GV+  E LVG  P   F +
Sbjct: 172 ---------MC-GTLDYLPPEMIE----GKTHDEKVDLWCAGVLCYEFLVGMPP---F-D 213

Query: 270 KPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTK 325
            P        I   + L+ P   S   +  +   L     +R  ++ ++ +P+V  
Sbjct: 214 SPSHTETHRRIVNVD-LKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKA 268

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  188 bits (480), Expect = 5e-58
 Identities = 84/296 (28%), Positives = 129/296 (43%), Gaps = 35/296 (11%)

Query: 47  SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSST----IIRHQAAHEAEILKRL 102
               +   +G G  G VY      +    A++ +N         II      E  +++  
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN-----EILVMREN 74

Query: 103 DSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYL 162
            +  IV     +  +  E+  VME++  GSL D +     + E  I+ V    L+ L++L
Sbjct: 75  KNPNIVNYLDSYL-VGDELWVVMEYLAGGSLTDVVT-ETCMDEGQIAAVCRECLQALEFL 132

Query: 163 HGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMG 222
           H  Q+IH DIK  N+L+   G VK+ DFG    +   ++  +                +G
Sbjct: 133 HSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS--------------TMVG 178

Query: 223 TCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICF 282
           T  +M+PE V        YG   D+WSLG++ +E + G  P     E P L AL   I  
Sbjct: 179 TPYWMAPEVVT----RKAYGPKVDIWSLGIMAIEMIEGEPPY--LNENP-LRALY-LIAT 230

Query: 283 GE--RLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNIEGLI 336
                L+ PE  S  FR F+  CLE D  KRG+ +ELL + F+      S++  LI
Sbjct: 231 NGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAKPLSSLTPLI 286

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  189 bits (481), Expect = 5e-58
 Identities = 83/302 (27%), Positives = 142/302 (47%), Gaps = 38/302 (12%)

Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS---STIIRHQAAHEAEILKRL-DSQ 105
           + + ++G+G  G VYK RH K+  + A+KV++ T      I +     E  +LK+    +
Sbjct: 27  ELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQ-----EINMLKKYSHHR 81

Query: 106 FIVKCHAVFY-----TIEGEICFVMEHMERGSLFDSLRV--RKKLSEDVISGVAYRVLKG 158
            I   +  F       ++ ++  VME    GS+ D ++      L E+ I+ +   +L+G
Sbjct: 82  NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRG 141

Query: 159 LQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAI 218
           L +LH  ++IH DIK  N+L+    EVK+ DFGVS  ++ T    N              
Sbjct: 142 LSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRN-------------- 187

Query: 219 ACMGTCAYMSPERVDSERW-GGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALI 277
             +GT  +M+PE +  +      Y F  D+WSLG+  +E   G  PL      P  M  +
Sbjct: 188 TFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL--CDMHP--MRAL 243

Query: 278 CAICFGE--RLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNIEGL 335
             I      RL+  +  S +F+ F+ SCL K+  +R   E+L+ +PF+  + +   +   
Sbjct: 244 FLIPRNPAPRLK-SKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNERQVRIQ 302

Query: 336 II 337
           + 
Sbjct: 303 LK 304

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  190 bits (485), Expect = 9e-58
 Identities = 71/364 (19%), Positives = 123/364 (33%), Gaps = 72/364 (19%)

Query: 30  RHHFPTSNPTSPDVENISD----LKKLTVLGHGNG--GIVYKVRHQKSNSIYALKVLNTT 83
            HH    N     + +        + LTV+G G      V   R++ +     ++ +N  
Sbjct: 4   HHHHHMENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLE 63

Query: 84  SST------IIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSL 137
           + +      +       E  + K  +   IV   A F   + E+  V   M  GS  D +
Sbjct: 64  ACSNEMVTFLQG-----ELHVSKLFNHPNIVPYRATF-IADNELWVVTSFMAYGSAKDLI 117

Query: 138 RVRKK--LSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRI 195
                  ++E  I+ +   VLK L Y+H M  +H  +K S++LI+  G+V ++    +  
Sbjct: 118 CTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLS 177

Query: 196 VEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVL 255
           +                + +     +    ++SPE V  +   G Y    D++S+G+   
Sbjct: 178 MISH-------GQRQRVVHDFPKYSVKVLPWLSPE-VLQQNLQG-YDAKSDIYSVGITAC 228

Query: 256 ECLVGHYP-----------LIGFGEKPDL------------------------------M 274
           E   GH P               G  P L                               
Sbjct: 229 ELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTS 288

Query: 275 ALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV--TKRSSSSNI 332
               +           T SP F  FV  CL+++   R +   LL + F    KR +S  +
Sbjct: 289 TPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKRRASEAL 348

Query: 333 EGLI 336
             L+
Sbjct: 349 PELL 352

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  187 bits (477), Expect = 3e-57
 Identities = 77/308 (25%), Positives = 121/308 (39%), Gaps = 26/308 (8%)

Query: 20  TAANHQFRRRRHHFPTSNPTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKV 79
             A                   D  +     +   LG G     +++    +  ++A K+
Sbjct: 14  GVAAPGAPAAAPPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKI 73

Query: 80  LNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSL 137
           +  +       R + + E  I + L  Q +V  H  F      +  V+E   R SL +  
Sbjct: 74  VPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED-NDFVFVVLELCRRRSLLELH 132

Query: 138 RVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVE 197
           + RK L+E        +++ G QYLH  ++IH D+K  NL +N   EVKI DFG++  VE
Sbjct: 133 KRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192

Query: 198 ETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLEC 257
              +                  C GT  Y++PE +        + F  DVWS+G ++   
Sbjct: 193 --YDGERKKV-----------LC-GTPNYIAPEVLS----KKGHSFEVDVWSIGCIMYTL 234

Query: 258 LVGHYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEEL 317
           LVG  P   F E   L      I   E   +P+  +P     ++  L+ D   R T+ EL
Sbjct: 235 LVGKPP---F-ETSCLKETYLRIKKNE-YSIPKHINPVAASLIQKMLQTDPTARPTINEL 289

Query: 318 LAYPFVTK 325
           L   F T 
Sbjct: 290 LNDEFFTS 297

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  186 bits (474), Expect = 4e-57
 Identities = 77/283 (27%), Positives = 133/283 (46%), Gaps = 24/283 (8%)

Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVK 109
            KL  +G G+ G V+K    ++  + A+K+++   +         E  +L + DS ++ K
Sbjct: 25  TKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTK 84

Query: 110 CHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIH 169
            +  +   + ++  +ME++  GS  D L     L E  I+ +   +LKGL YLH  + IH
Sbjct: 85  YYGSYL-KDTKLWIIMEYLGGGSALDLLE-PGPLDETQIATILREILKGLDYLHSEKKIH 142

Query: 170 GDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSP 229
            DIK +N+L++  GEVK+ADFGV+  + +T+   N                +GT  +M+P
Sbjct: 143 RDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN--------------TFVGTPFWMAP 188

Query: 230 ERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMP 289
           E +        Y    D+WSLG+  +E   G  P       P  M ++  I       + 
Sbjct: 189 EVIK----QSAYDSKADIWSLGITAIELARGEPPH--SELHP--MKVLFLIPKNNPPTLE 240

Query: 290 ETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNI 332
              S   + FV +CL K+   R T +ELL + F+ + +  ++ 
Sbjct: 241 GNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTSY 283

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  186 bits (474), Expect = 7e-57
 Identities = 75/294 (25%), Positives = 135/294 (45%), Gaps = 35/294 (11%)

Query: 49  LKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSST----IIRHQAAHEAEILKRLDS 104
           L     +G G+ GIV   R + S    A+K+++         +       E  I++    
Sbjct: 47  LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFN-----EVVIMRDYQH 101

Query: 105 QFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG 164
             +V+ +  +  +  E+  +ME ++ G+L D +  + +L+E+ I+ V   VL+ L YLH 
Sbjct: 102 FNVVEMYKSYL-VGEELWVLMEFLQGGALTDIVS-QVRLNEEQIATVCEAVLQALAYLHA 159

Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTC 224
             +IH DIK  ++L+   G VK++DFG    + +                    + +GT 
Sbjct: 160 QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK--------------SLVGTP 205

Query: 225 AYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGE 284
            +M+PE +        Y    D+WSLG++V+E + G  P   F + P + A+   +    
Sbjct: 206 YWMAPEVIS----RSLYATEVDIWSLGIMVIEMVDGEPPY--FSDSP-VQAMK-RLRDSP 257

Query: 285 --RLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNIEGLI 336
             +L+     SP  R F+   L +D ++R T +ELL +PF+ +      +  LI
Sbjct: 258 PPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTGLPECLVPLI 311

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  185 bits (471), Expect = 8e-57
 Identities = 57/306 (18%), Positives = 109/306 (35%), Gaps = 54/306 (17%)

Query: 47  SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLN-TTSSTIIRHQAAHEAEILKRL-DS 104
           ++  +L  +G G  G V+K   +    IYA+K      + ++    A  E      L   
Sbjct: 11  TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQH 70

Query: 105 QFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKK----LSEDVISGVAYRVLKGLQ 160
             +V+  + +   +  +    E+   GSL D++    +      E  +  +  +V +GL+
Sbjct: 71  SHVVRYFSAWAE-DDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129

Query: 161 YLHGMQIIHGDIKPSNLLINGKGE-------------------VKIADFGVSRIVEETRN 201
           Y+H M ++H DIKPSN+ I+                        KI D G    +   + 
Sbjct: 130 YIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ- 188

Query: 202 NNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGH 261
                               G   +++ E +        +    D+++L + V+    G 
Sbjct: 189 -----------------VEEGDSRFLANEVLQENY---THLPKADIFALALTVVC-AAGA 227

Query: 262 YPLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYP 321
            PL      P        I  G    +P+  S EF   ++  +  D  +R +   L+ + 
Sbjct: 228 EPL------PRNGDQWHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHS 281

Query: 322 FVTKRS 327
            +   S
Sbjct: 282 VLLSAS 287

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  182 bits (465), Expect = 8e-56
 Identities = 76/290 (26%), Positives = 120/290 (41%), Gaps = 26/290 (8%)

Query: 38  PTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHE 95
               D  +     +   LG G     +++    +  ++A K++  +       R + + E
Sbjct: 6   EVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSME 65

Query: 96  AEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRV 155
             I + L  Q +V  H  F      +  V+E   R SL +  + RK L+E        ++
Sbjct: 66  ISIHRSLAHQHVVGFHGFFED-NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQI 124

Query: 156 LKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGE 215
           + G QYLH  ++IH D+K  NL +N   EVKI DFG++  VE   +              
Sbjct: 125 VLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE--YDGERKKV-------- 174

Query: 216 AAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMA 275
               C GT  Y++PE +        + F  DVWS+G ++   LVG  P   F E   L  
Sbjct: 175 ---LC-GTPNYIAPEVLS----KKGHSFEVDVWSIGCIMYTLLVGKPP---F-ETSCLKE 222

Query: 276 LICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTK 325
               I   E   +P+  +P     ++  L+ D   R T+ ELL   F T 
Sbjct: 223 TYLRIKKNE-YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTS 271

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  184 bits (468), Expect = 1e-55
 Identities = 89/292 (30%), Positives = 130/292 (44%), Gaps = 31/292 (10%)

Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKV--LNTTSSTIIRHQAAHEAEILKRLDSQFI 107
             L  +GHG+ G VY  R  +++ + A+K    +   S         E   L++L     
Sbjct: 57  SDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNT 116

Query: 108 VKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKK-LSEDVISGVAYRVLKGLQYLHGMQ 166
           ++    +   E     VME+   GS  D L V KK L E  I+ V +  L+GL YLH   
Sbjct: 117 IQYRGCYL-REHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN 174

Query: 167 IIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAY 226
           +IH D+K  N+L++  G VK+ DFG + I+     N                + +GT  +
Sbjct: 175 MIHRDVKAGNILLSEPGLVKLGDFGSASIM--APAN----------------SFVGTPYW 216

Query: 227 MSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGE-- 284
           M+PE + +   G  Y    DVWSLG+  +E      PL  F      M+ +  I   E  
Sbjct: 217 MAPEVILAMDEGQ-YDGKVDVWSLGITCIELAERKPPL--FNMNA--MSALYHIAQNESP 271

Query: 285 RLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNIEGLI 336
            L+     S  FR FV SCL+K  + R T E LL + FV +    + I  LI
Sbjct: 272 ALQSGHW-SEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLI 322

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  181 bits (461), Expect = 2e-55
 Identities = 72/293 (24%), Positives = 130/293 (44%), Gaps = 27/293 (9%)

Query: 44  ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKR 101
           E I D K   +LG G+   VY+     +    A+K+++  +     +  +  +E +I  +
Sbjct: 8   EKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQ 67

Query: 102 LDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVR-KKLSEDVISGVAYRVLKGLQ 160
           L    I++ +  F      +  V+E    G +   L+ R K  SE+      ++++ G+ 
Sbjct: 68  LKHPSILELYNYFED-SNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGML 126

Query: 161 YLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIAC 220
           YLH   I+H D+  SNLL+     +KIADFG++   +    +  H              C
Sbjct: 127 YLHSHGILHRDLTLSNLLLTRNMNIKIADFGLA--TQLKMPHEKHYT-----------LC 173

Query: 221 MGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAI 280
            GT  Y+SPE          +G   DVWSLG +    L+G  P   F +   +   +  +
Sbjct: 174 -GTPNYISPEIAT----RSAHGLESDVWSLGCMFYTLLIGRPP---F-DTDTVKNTLNKV 224

Query: 281 CFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNIE 333
              +  EMP   S E +  +   L ++   R ++  +L +PF+++ SS+ + +
Sbjct: 225 VLAD-YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNSSTKSKD 276

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  176 bits (447), Expect = 1e-52
 Identities = 70/352 (19%), Positives = 118/352 (33%), Gaps = 69/352 (19%)

Query: 18  PATAANHQFRRRRHHFPTSNPTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYAL 77
           P  +         +    +       + I+D + +  L  G    +        N  YAL
Sbjct: 2   PLGSMKDILSNYSNLIYLNKYVKEKDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYAL 59

Query: 78  KVLN----------------TTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEI 121
           K                     S         +E +I+  + +++ + C  +      E+
Sbjct: 60  KKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITN-YDEV 118

Query: 122 CFVMEHMERGSLFDSLRVRKKL--------SEDVISGVAYRVLKGLQYLHG-MQIIHGDI 172
             + E+ME  S+         L           VI  +   VL    Y+H    I H D+
Sbjct: 119 YIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDV 178

Query: 173 KPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERV 232
           KPSN+L++  G VK++DFG S  + + +                  +  GT  +M PE  
Sbjct: 179 KPSNILMDKNGRVKLSDFGESEYMVDKKIKG---------------SR-GTYEFMPPEFF 222

Query: 233 DSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPETA 292
            +E      G   D+WSLG+ +        P   F  K  L+ L   I     +E P   
Sbjct: 223 SNE--SSYNGAKVDIWSLGICLYVMFYNVVP---FSLKISLVELFNNIRTKN-IEYPLDR 276

Query: 293 -------------------SPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTK 325
                              S E   F++  L K+  +R T E+ L + ++  
Sbjct: 277 NHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLAD 328

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  173 bits (440), Expect = 6e-51
 Identities = 90/318 (28%), Positives = 138/318 (43%), Gaps = 37/318 (11%)

Query: 34  PTSNPTSPDVENISDLKKLT-VLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQA 92
            T +  S   + + D   ++  LG G  G V     +K+    A+++++     I   + 
Sbjct: 121 LTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSARE 180

Query: 93  AH-------EAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSE 145
           A        E EILK+L+   I+K    F     +   V+E ME G LFD +   K+L E
Sbjct: 181 ADPALNVETEIEILKKLNHPCIIKIKNFFDA--EDYYIVLELMEGGELFDKVVGNKRLKE 238

Query: 146 DVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGE---VKIADFGVSRIVEETRNN 202
                  Y++L  +QYLH   IIH D+KP N+L++ + E   +KI DFG S+I+ E    
Sbjct: 239 ATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE---- 294

Query: 203 NNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHY 262
                              GT  Y++PE + S    G Y  A D WSLGV++  CL G+ 
Sbjct: 295 -----------TSLMRTLCGTPTYLAPEVLVSVGTAG-YNRAVDCWSLGVILFICLSGYP 342

Query: 263 PLIGFGEKPDLMALICAICFGERLEMPE----TASPEFRRFVRSCLEKDWRKRGTVEELL 318
           P   F E    ++L   I  G+            S +    V+  L  D + R T EE L
Sbjct: 343 P---FSEHRTQVSLKDQITSGK-YNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEAL 398

Query: 319 AYPFVTKRSSSSNIEGLI 336
            +P++         + L+
Sbjct: 399 RHPWLQDEDMKRKFQDLL 416

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  171 bits (436), Expect = 1e-50
 Identities = 71/294 (24%), Positives = 123/294 (41%), Gaps = 27/294 (9%)

Query: 34  PTSNPTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTII-RHQA 92
           P     + DV N    + L  +G G+ G V  V+   +  +YA+K +N      + R++ 
Sbjct: 3   PPVFDENEDV-NFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMN--KQKCVERNEV 59

Query: 93  AH---EAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVIS 149
            +   E +I++ L+  F+V     F   E ++  V++ +  G L   L+      E+ + 
Sbjct: 60  RNVFKELQIMQGLEHPFLVNLWYSFQDEE-DMFMVVDLLLGGDLRYHLQQNVHFKEETVK 118

Query: 150 GVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNN 209
                ++  L YL   +IIH D+KP N+L++  G V I DF ++ ++             
Sbjct: 119 LFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET--------- 169

Query: 210 NNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGE 269
                +      GT  YM+PE   S +  G Y FA D WSLGV   E L G  P      
Sbjct: 170 -----QITTMA-GTKPYMAPEMFSSRKGAG-YSFAVDWWSLGVTAYELLRGRRPYHIRSS 222

Query: 270 KPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKR-GTVEELLAYPF 322
                 ++        +  P   S E    ++  LE +  +R   + ++  +P+
Sbjct: 223 T-SSKEIVHTFETTV-VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPY 274

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  169 bits (431), Expect = 1e-50
 Identities = 70/315 (22%), Positives = 115/315 (36%), Gaps = 51/315 (16%)

Query: 54  VLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAV 113
           +LG G    V++ RH+K+  ++A+KV N  S          E E+LK+L+ + IVK  A+
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75

Query: 114 FYTIEG-EICFVMEHMERGSLFDSLRVRKK---LSEDVISGVAYRVLKGLQYLHGMQIIH 169
                      +ME    GSL+  L        L E     V   V+ G+ +L    I+H
Sbjct: 76  EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVH 135

Query: 170 GDIKPSNLLI----NGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCA 225
            +IKP N++     +G+   K+ DFG +R +E+                E  ++  GT  
Sbjct: 136 RNIKPGNIMRVIGEDGQSVYKLTDFGAARELED---------------DEQFVSLYGTEE 180

Query: 226 YMSPE----RVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAIC 281
           Y+ P+     V  +     YG   D+WS+GV       G  P   F        ++  I 
Sbjct: 181 YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240

Query: 282 FGE------------------------RLEMPETASPEFRRFVRSCLEKDWRKRGTVEEL 317
            G+                           +           + + LE D  K    ++ 
Sbjct: 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQF 300

Query: 318 LAYPFVTKRSSSSNI 332
            A         +S+ 
Sbjct: 301 FAETSDILHRGNSHH 315

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  168 bits (427), Expect = 4e-50
 Identities = 61/277 (22%), Positives = 111/277 (40%), Gaps = 9/277 (3%)

Query: 45  NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDS 104
             SDL    VLG G  G   KV H+++  +  +K L        R     E ++++ L+ 
Sbjct: 8   RPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQR-TFLKEVKVMRCLEH 66

Query: 105 QFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQYLH 163
             ++K   V    +  + F+ E+++ G+L   ++    +         A  +  G+ YLH
Sbjct: 67  PNVLKFIGV-LYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH 125

Query: 164 GMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGT 223
            M IIH D+   N L+     V +ADFG++R++ + +       +      +     +G 
Sbjct: 126 SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGN 185

Query: 224 CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFG 283
             +M+PE ++       Y    DV+S G+V+ E +        +   P  M     +   
Sbjct: 186 PYWMAPEMINGRS----YDEKVDVFSFGIVLCEIIGRVNADPDYL--PRTMDFGLNVRGF 239

Query: 284 ERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY 320
                P    P F      C + D  KR +  +L  +
Sbjct: 240 LDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHW 276

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  170 bits (432), Expect = 1e-49
 Identities = 54/310 (17%), Positives = 106/310 (34%), Gaps = 33/310 (10%)

Query: 34  PTSNPTSPDVENISDLK--KLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQ 91
                    V  +  +      VLGHG  G +   R    N   A+K +     +     
Sbjct: 9   QDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFSFADR- 66

Query: 92  AAHEAEILKRLDS-QFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKK---LSEDV 147
              E ++L+  D    +++               +E     +L +   V +K        
Sbjct: 67  ---EVQLLRESDEHPNVIRYFCTEKD-RQFQYIAIELCA-ATLQE--YVEQKDFAHLGLE 119

Query: 148 ISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGE-----VKIADFGVSRIVEETRNN 202
              +  +   GL +LH + I+H D+KP N+LI+           I+DFG+ + +   R++
Sbjct: 120 PITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHS 179

Query: 203 NNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHY 262
            +  +              GT  +++PE +  +       +  D++S G V    +    
Sbjct: 180 FSRRSG-----------VPGTEGWIAPEMLSEDCKEN-PTYTVDIFSAGCVFYYVISEGS 227

Query: 263 PLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPF 322
              G   +     L+ A    + L   +      R  +   +  D +KR + + +L +PF
Sbjct: 228 HPFGKSLQRQANILLGACSL-DCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPF 286

Query: 323 VTKRSSSSNI 332
                     
Sbjct: 287 FWSLEKQLQF 296

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  168 bits (428), Expect = 2e-49
 Identities = 69/302 (22%), Positives = 112/302 (37%), Gaps = 51/302 (16%)

Query: 54  VLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAV 113
           +LG G    V++ RH+K+  ++A+KV N  S          E E+LK+L+ + IVK  A+
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75

Query: 114 FYTIEG-EICFVMEHMERGSLFDSLRVRKK---LSEDVISGVAYRVLKGLQYLHGMQIIH 169
                      +ME    GSL+  L        L E     V   V+ G+ +L    I+H
Sbjct: 76  EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVH 135

Query: 170 GDIKPSNLLI----NGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCA 225
            +IKP N++     +G+   K+ DFG +R +E+                E  ++  GT  
Sbjct: 136 RNIKPGNIMRVIGEDGQSVYKLTDFGAARELED---------------DEQFVSLYGTEE 180

Query: 226 YMSPE----RVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAIC 281
           Y+ P+     V  +     YG   D+WS+GV       G  P   F        ++  I 
Sbjct: 181 YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240

Query: 282 FGERLE------------------------MPETASPEFRRFVRSCLEKDWRKRGTVEEL 317
            G+                           +           + + LE D  K    ++ 
Sbjct: 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQF 300

Query: 318 LA 319
            A
Sbjct: 301 FA 302

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  167 bits (426), Expect = 3e-49
 Identities = 84/322 (26%), Positives = 139/322 (43%), Gaps = 37/322 (11%)

Query: 18  PATAANHQFRRRRHHFPTSNPTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYAL 77
            A+    Q   R   F  +   S    +  D+K+   LG G   +V +  H+ +   +A 
Sbjct: 4   MASMTGGQQMGRGSEFMMN--ASTKFSDNYDVKE--ELGKGAFSVVRRCVHKTTGLEFAA 59

Query: 78  KVLNTTSSTIIRHQAAH-EAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDS 136
           K++NT   +    Q    EA I ++L    IV+ H      E     V + +  G LF+ 
Sbjct: 60  KIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE-ESFHYLVFDLVTGGELFED 118

Query: 137 LRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGE---VKIADFGVS 193
           +  R+  SE   S    ++L+ + Y H   I+H ++KP NLL+  K +   VK+ADFG++
Sbjct: 119 IVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA 178

Query: 194 RIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVV 253
             V +                EA     GT  Y+SPE +        Y    D+W+ GV+
Sbjct: 179 IEVND---------------SEAWHGFAGTPGYLSPEVLK----KDPYSKPVDIWACGVI 219

Query: 254 VLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPE----TASPEFRRFVRSCLEKDWR 309
           +   LVG+ P   F ++     L   I  G   + P     T +PE +  + S L  + +
Sbjct: 220 LYILLVGYPP---FWDEDQ-HRLYAQIKAGA-YDYPSPEWDTVTPEAKSLIDSMLTVNPK 274

Query: 310 KRGTVEELLAYPFVTKRSSSSN 331
           KR T ++ L  P++  R   ++
Sbjct: 275 KRITADQALKVPWICNRERVAS 296

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  165 bits (420), Expect = 3e-49
 Identities = 80/300 (26%), Positives = 133/300 (44%), Gaps = 35/300 (11%)

Query: 40  SPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQA-AHEAEI 98
           S    +  D+K+   LG G   +V +  H+ +   +A K++NT   +    Q    EA I
Sbjct: 1   STKFSDNYDVKE--ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARI 58

Query: 99  LKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKG 158
            ++L    IV+ H      E     V + +  G LF+ +  R+  SE   S    ++L+ 
Sbjct: 59  CRKLQHPNIVRLHDSIQE-ESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILES 117

Query: 159 LQYLHGMQIIHGDIKPSNLLINGKGE---VKIADFGVSRIVEETRNNNNHNNNNNNNIGE 215
           + Y H   I+H ++KP NLL+  K +   VK+ADFG++  V +                E
Sbjct: 118 IAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND---------------SE 162

Query: 216 AAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMA 275
           A     GT  Y+SPE +        Y    D+W+ GV++   LVG+ P   F ++     
Sbjct: 163 AWHGFAGTPGYLSPEVLK----KDPYSKPVDIWACGVILYILLVGYPP---FWDEDQ-HR 214

Query: 276 LICAICFGERLEMPE----TASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSN 331
           L   I  G   + P     T +PE +  + S L  + +KR T ++ L  P++  R   ++
Sbjct: 215 LYAQIKAGA-YDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVAS 273

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  165 bits (419), Expect = 1e-48
 Identities = 64/297 (21%), Positives = 118/297 (39%), Gaps = 27/297 (9%)

Query: 54  VLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRL-DSQFIVKCHA 112
           VL  G    VY+ +   S   YALK L +      R     E   +K+L     IV+  +
Sbjct: 35  VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNR-AIIQEVCFMKKLSGHPNIVQFCS 93

Query: 113 VFYTI------EGEICFVMEHMERGSLFDSL---RVRKKLSEDVISGVAYRVLKGLQYLH 163
                            ++  + +G L + L     R  LS D +  + Y+  + +Q++H
Sbjct: 94  AASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH 153

Query: 164 GMQ--IIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACM 221
             +  IIH D+K  NLL++ +G +K+ DFG +  +  +   +   +     + E  I   
Sbjct: 154 RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTI--SHYPDYSWSAQRRALVEEEITRN 211

Query: 222 GTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAIC 281
            T  Y +PE +D        G   D+W+LG ++       +P   F +          I 
Sbjct: 212 TTPMYRTPEIIDLYS-NFPIGEKQDIWALGCILYLLCFRQHP---FED-----GAKLRIV 262

Query: 282 FGERLEMPETA--SPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNIEGLI 336
            G +  +P        F   +R+ L+ +  +R ++ E++        + + N +  I
Sbjct: 263 NG-KYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPKSPI 318

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  163 bits (416), Expect = 2e-48
 Identities = 77/315 (24%), Positives = 128/315 (40%), Gaps = 38/315 (12%)

Query: 35  TSNPTSPDVENISDLKKL----TVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTII-- 88
           T +   P   +     +      +LG G   +V +  H+ +   YA+K+++ T       
Sbjct: 1   TRDAALPGSHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSA 60

Query: 89  ------RHQAAHEAEILKRLDSQ-FIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRK 141
                 R     E +IL+++     I++    + T       V + M++G LFD L  + 
Sbjct: 61  EEVQELREATLKEVDILRKVSGHPNIIQLKDTYET-NTFFFLVFDLMKKGELFDYLTEKV 119

Query: 142 KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRN 201
            LSE     +   +L+ +  LH + I+H D+KP N+L++    +K+ DFG S  ++    
Sbjct: 120 TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP--- 176

Query: 202 NNNHNNNNNNNIGEAAIACMGTCAYMSPE--RVDSERWGGDYGFAGDVWSLGVVVLECLV 259
                       GE      GT +Y++PE            YG   D+WS GV++   L 
Sbjct: 177 ------------GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLA 224

Query: 260 GHYPLIGFGEKPDLMALICAICFGE-RLEMPE--TASPEFRRFVRSCLEKDWRKRGTVEE 316
           G  P   F  +   M ++  I  G  +   PE    S   +  V   L    +KR T EE
Sbjct: 225 GSPP---FWHRKQ-MLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEE 280

Query: 317 LLAYPFVTKRSSSSN 331
            LA+PF  +      
Sbjct: 281 ALAHPFFQQYVVEEV 295

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  164 bits (416), Expect = 3e-48
 Identities = 88/308 (28%), Positives = 133/308 (43%), Gaps = 37/308 (12%)

Query: 44  ENISDLKKLT-VLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH-------E 95
           + + D   ++  LG G  G V     +K+    A+K+++     I   + A        E
Sbjct: 6   KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 65

Query: 96  AEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRV 155
            EILK+L+   I+K    F     +   V+E ME G LFD +   K+L E       Y++
Sbjct: 66  IEILKKLNHPCIIKIKNFFDA--EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 123

Query: 156 LKGLQYLHGMQIIHGDIKPSNLLINGKGE---VKIADFGVSRIVEETRNNNNHNNNNNNN 212
           L  +QYLH   IIH D+KP N+L++ + E   +KI DFG S+I+ E              
Sbjct: 124 LLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE-------------- 169

Query: 213 IGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPD 272
                    GT  Y++PE V        Y  A D WSLGV++  CL G+ P   F E   
Sbjct: 170 -TSLMRTLCGTPTYLAPE-VLVSVGTAGYNRAVDCWSLGVILFICLSGYPP---FSEHRT 224

Query: 273 LMALICAICFGERLEMPE----TASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSS 328
            ++L   I  G+            S +    V+  L  D + R T EE L +P++     
Sbjct: 225 QVSLKDQITSGK-YNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDM 283

Query: 329 SSNIEGLI 336
               + L+
Sbjct: 284 KRKFQDLL 291

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  167 bits (426), Expect = 4e-48
 Identities = 81/331 (24%), Positives = 140/331 (42%), Gaps = 36/331 (10%)

Query: 8   RHQQALTLSLPATAANHQFRRRRHHFPTSNPTSPDVENISDLKKLTVLGHGNGGIVYKVR 67
            H    +            +     F TS      +  +    K   LG G  G V   R
Sbjct: 2   HHHHHHSSGRENLYFQGDLQATPGMFITSK--KGHLSEMYQRVK--KLGSGAYGEVLLCR 57

Query: 68  HQKSNSIYALKVLNTTSSTIIRHQA-AHEAEILKRLDSQFIVKCHAVFYTIEGEICFVME 126
            + ++   A+K++  TS +   +     E  +LK LD   I+K +  F   +     VME
Sbjct: 58  DKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFED-KRNYYLVME 116

Query: 127 HMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGE-- 184
             + G LFD +  R K +E   + +  +VL G+ YLH   I+H D+KP NLL+  K +  
Sbjct: 117 CYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDA 176

Query: 185 -VKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGF 243
            +KI DFG+S + E                 +     +GT  Y++PE +        Y  
Sbjct: 177 LIKIVDFGLSAVFEN---------------QKKMKERLGTAYYIAPEVLR-----KKYDE 216

Query: 244 AGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGE-RLEMPE--TASPEFRRFV 300
             DVWS+GV++   L G+ P  G  ++     ++  +  G+   + PE    S   +  +
Sbjct: 217 KCDVWSIGVILFILLAGYPPFGGQTDQ----EILRKVEKGKYTFDSPEWKNVSEGAKDLI 272

Query: 301 RSCLEKDWRKRGTVEELLAYPFVTKRSSSSN 331
           +  L+ D ++R + ++ L +P++ +  S   
Sbjct: 273 KQMLQFDSQRRISAQQALEHPWIKEMCSKKE 303

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  162 bits (412), Expect = 6e-48
 Identities = 68/274 (24%), Positives = 113/274 (41%), Gaps = 38/274 (13%)

Query: 45  NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDS 104
           +  +++   V+G G  G+V K + +      A+K + + S    R     E   L R++ 
Sbjct: 6   DYKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESES---ERKAFIVELRQLSRVNH 60

Query: 105 QFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRK---KLSEDVISGVAYRVLKGLQY 161
             IVK +         +C VME+ E GSL++ L   +     +         +  +G+ Y
Sbjct: 61  PNIVKLYGACLN---PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAY 117

Query: 162 LHGMQ---IIHGDIKPSNLLINGKGEV-KIADFGVSRIVEETRNNNNHNNNNNNNIGEAA 217
           LH MQ   +IH D+KP NLL+   G V KI DFG +  ++    NN              
Sbjct: 118 LHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNN-------------- 163

Query: 218 IACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALI 277
               G+ A+M+PE  +       Y    DV+S G+++ E +    P    G       ++
Sbjct: 164 ---KGSAAWMAPEVFEGSN----YSEKCDVFSWGIILWEVITRRKPFDEIGGPA--FRIM 214

Query: 278 CAICFGERLEMPETASPEFRRFVRSCLEKDWRKR 311
            A+  G R  + +         +  C  KD  +R
Sbjct: 215 WAVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQR 248

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  162 bits (412), Expect = 8e-48
 Identities = 82/314 (26%), Positives = 129/314 (41%), Gaps = 47/314 (14%)

Query: 29  RRHHFPTSNPTSPDVENI---------------SDLKKLTVLGHGNGGIVYKVRHQKSNS 73
             HH P S+   P  EN+                DL     +G G+ G V++       S
Sbjct: 4   HHHHHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWH--GS 61

Query: 74  IYALKVLNTTSSTIIRHQA-AHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGS 132
             A+K+L        R      E  I+KRL    IV       T    +  V E++ RGS
Sbjct: 62  DVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA-VTQPPNLSIVTEYLSRGS 120

Query: 133 LFDSLRV---RKKLSEDVISGVAYRVLKGLQYLHGM--QIIHGDIKPSNLLINGKGEVKI 187
           L+  L     R++L E     +AY V KG+ YLH     I+H ++K  NLL++ K  VK+
Sbjct: 121 LYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKV 180

Query: 188 ADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDV 247
            DFG+SR+   T                ++ +  GT  +M+PE +  E          DV
Sbjct: 181 CDFGLSRLKAST--------------FLSSKSAAGTPEWMAPEVLRDEP----SNEKSDV 222

Query: 248 WSLGVVVLECLVGHYPLIGFGEKPDLMALICAICF-GERLEMPETASPEFRRFVRSCLEK 306
           +S GV++ E      P        +   ++ A+ F  +RLE+P   +P+    +  C   
Sbjct: 223 YSFGVILWELATLQQPWGNL----NPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTN 278

Query: 307 DWRKRGTVEELLAY 320
           +  KR +   ++  
Sbjct: 279 EPWKRPSFATIMDL 292

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  161 bits (410), Expect = 2e-47
 Identities = 75/299 (25%), Positives = 123/299 (41%), Gaps = 34/299 (11%)

Query: 34  PTSNPTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRH-QA 92
               P  P  +   D K   +LG G+   V   R   ++  YA+K+L      II+  + 
Sbjct: 17  HAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILE--KRHIIKENKV 74

Query: 93  AH---EAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVIS 149
            +   E +++ RLD  F VK +  F   + ++ F + + + G L   +R      E    
Sbjct: 75  PYVTRERDVMSRLDHPFFVKLYFTFQD-DEKLYFGLSYAKNGELLKYIRKIGSFDETCTR 133

Query: 150 GVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNN 209
                ++  L+YLHG  IIH D+KP N+L+N    ++I DFG ++++         N+  
Sbjct: 134 FYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS-- 191

Query: 210 NNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGE 269
                       GT  Y+SPE +  +        + D+W+LG ++ + + G  P      
Sbjct: 192 ---------FV-GTAQYVSPELLTEK----SACKSSDLWALGCIIYQLVAGLPPF--RAG 235

Query: 270 KPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKR------GTVEELLAYPF 322
              L+     I   E  + PE   P+ R  V   L  D  KR           L A+PF
Sbjct: 236 NEYLI--FQKIIKLE-YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 291

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  164 bits (418), Expect = 4e-47
 Identities = 72/301 (23%), Positives = 125/301 (41%), Gaps = 37/301 (12%)

Query: 39  TSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTT--SSTIIRHQAAHEA 96
           ++    +    ++  VLG G+ G V   + + +    A+KV++         +     E 
Sbjct: 20  STAIFSDRYKGQR--VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREV 77

Query: 97  EILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVL 156
           ++LK+LD   I+K +  F   +G    V E    G LFD +  RK+ SE   + +  +VL
Sbjct: 78  QLLKQLDHPNIMKLYEFFED-KGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVL 136

Query: 157 KGLQYLHGMQIIHGDIKPSNLLINGKGE---VKIADFGVSRIVEETRNNNNHNNNNNNNI 213
            G+ Y+H  +I+H D+KP NLL+  K +   ++I DFG+S   E                
Sbjct: 137 SGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA--------------- 181

Query: 214 GEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDL 273
            +     +GT  Y++PE +      G Y    DVWS GV++   L G  P  G  E    
Sbjct: 182 SKKMKDKIGTAYYIAPEVLH-----GTYDEKCDVWSTGVILYILLSGCPPFNGANEY--- 233

Query: 274 MALICAICFGERLEMPE----TASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSS 329
             ++  +  G+            S   +  +R  L      R +  + L + ++   +  
Sbjct: 234 -DILKKVEKGK-YTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKE 291

Query: 330 S 330
            
Sbjct: 292 Q 292

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  164 bits (416), Expect = 4e-47
 Identities = 80/302 (26%), Positives = 128/302 (42%), Gaps = 34/302 (11%)

Query: 39  TSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH-EAE 97
           T         L +   LG G   +V +     +   YA  ++NT   +   HQ    EA 
Sbjct: 5   TCTRFTEEYQLFE--ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREAR 62

Query: 98  ILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLK 157
           I + L    IV+ H      EG    + + +  G LF+ +  R+  SE   S    ++L+
Sbjct: 63  ICRLLKHPNIVRLHDSISE-EGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILE 121

Query: 158 GLQYLHGMQIIHGDIKPSNLLINGKGE---VKIADFGVSRIVEETRNNNNHNNNNNNNIG 214
            + + H M ++H ++KP NLL+  K +   VK+ADFG++  VE                 
Sbjct: 122 AVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE----------GEQQAWF 171

Query: 215 EAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLM 274
             A    GT  Y+SPE +        YG   D+W+ GV++   LVG+ P        D  
Sbjct: 172 GFA----GTPGYLSPEVLR----KDPYGKPVDLWACGVILYILLVGYPPFWD----EDQH 219

Query: 275 ALICAICFGERLEMPE----TASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSS 330
            L   I  G   + P     T +PE +  +   L  +  KR T  E L +P+++ RS+ +
Sbjct: 220 RLYQQIKAG-AYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHRSTVA 278

Query: 331 NI 332
           + 
Sbjct: 279 SC 280

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  160 bits (408), Expect = 4e-47
 Identities = 77/304 (25%), Positives = 133/304 (43%), Gaps = 40/304 (13%)

Query: 42  DVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKV-----LNTTSSTIIRHQAAHEA 96
            VE+  D+ +   LG G   IV K R + +   YA K         +   + R +   E 
Sbjct: 9   KVEDFYDIGE--ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREV 66

Query: 97  EILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVL 156
            IL+++    ++  H V+     ++  ++E +  G LFD L  ++ LSE+  +    ++L
Sbjct: 67  SILRQVLHHNVITLHDVYEN-RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQIL 125

Query: 157 KGLQYLHGMQIIHGDIKPSNLLINGKGE----VKIADFGVSRIVEETRNNNNHNNNNNNN 212
            G+ YLH  +I H D+KP N+++  K      +K+ DFG++  +E+              
Sbjct: 126 DGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED-------------- 171

Query: 213 IGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPD 272
            G       GT  +++PE V+ E      G   D+WS+GV+    L G  P   F     
Sbjct: 172 -GVEFKNIFGTPEFVAPEIVNYEP----LGLEADMWSIGVITYILLSGASP---FLGDTK 223

Query: 273 LMALICAICFGERLEMPETA----SPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSS 328
               +  I      +  E      S   + F+R  L K+ RKR T++E L +P++T   +
Sbjct: 224 -QETLANITSVS-YDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDN 281

Query: 329 SSNI 332
              +
Sbjct: 282 QQAM 285

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  164 bits (418), Expect = 5e-47
 Identities = 81/309 (26%), Positives = 134/309 (43%), Gaps = 33/309 (10%)

Query: 31  HHFPTSNPTSPDVENISDLKKLT-VLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIR 89
           HH  +           ++   +  +LG G+ G V K + + +   YA+KV+N  S+    
Sbjct: 5   HHHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD 64

Query: 90  HQA-AHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVI 148
                 E E+LK+LD   I+K   +          V E    G LFD +  RK+ SE   
Sbjct: 65  TSTILREVELLKKLDHPNIMKLFEILED-SSSFYIVGELYTGGELFDEIIKRKRFSEHDA 123

Query: 149 SGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGE---VKIADFGVSRIVEETRNNNNH 205
           + +  +V  G+ Y+H   I+H D+KP N+L+  K +   +KI DFG+S   ++       
Sbjct: 124 ARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ------- 176

Query: 206 NNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLI 265
                          +GT  Y++PE +      G Y    DVWS GV++   L G  P  
Sbjct: 177 --------NTKMKDRIGTAYYIAPEVLR-----GTYDEKCDVWSAGVILYILLSGTPPFY 223

Query: 266 GFGEKPDLMALICAICFGE-RLEMPE--TASPEFRRFVRSCLEKDWRKRGTVEELLAYPF 322
           G  E      ++  +  G+   ++P+  T S + +  +R  L      R T  + L +P+
Sbjct: 224 GKNEY----DILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPW 279

Query: 323 VTKRSSSSN 331
           + K SS + 
Sbjct: 280 IQKYSSETP 288

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  159 bits (404), Expect = 6e-47
 Identities = 80/307 (26%), Positives = 129/307 (42%), Gaps = 35/307 (11%)

Query: 31  HHFPTSNPTSPDVENISDLKKLT-VLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-STII 88
           HH  +           ++   +  +LG G+ G V K + + +   YA+KV+N  S     
Sbjct: 5   HHHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD 64

Query: 89  RHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVI 148
                 E E+LK+LD   I+K   +          V E    G LFD +  RK+ SE   
Sbjct: 65  TSTILREVELLKKLDHPNIMKLFEILED-SSSFYIVGELYTGGELFDEIIKRKRFSEHDA 123

Query: 149 SGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGE---VKIADFGVSRIVEETRNNNNH 205
           + +  +V  G+ Y+H   I+H D+KP N+L+  K +   +KI DFG+S   ++       
Sbjct: 124 ARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ------- 176

Query: 206 NNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLI 265
                          +GT  Y++PE +      G Y    DVWS GV++   L G  P  
Sbjct: 177 --------NTKMKDRIGTAYYIAPEVLR-----GTYDEKCDVWSAGVILYILLSGTPP-- 221

Query: 266 GFGEKPDLMALICAICFGERLEMPE----TASPEFRRFVRSCLEKDWRKRGTVEELLAYP 321
            F  K +   ++  +  G+          T S + +  +R  L      R T  + L +P
Sbjct: 222 -FYGKNE-YDILKRVETGK-YAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHP 278

Query: 322 FVTKRSS 328
           ++ K SS
Sbjct: 279 WIQKYSS 285

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  161 bits (409), Expect = 7e-47
 Identities = 84/304 (27%), Positives = 139/304 (45%), Gaps = 40/304 (13%)

Query: 42  DVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAA-----HEA 96
            VE+  D+ +   LG G   IV K R + +   YA K +    S   R          E 
Sbjct: 9   KVEDFYDIGE--ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREV 66

Query: 97  EILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVL 156
            IL+++    I+  H V+     ++  ++E +  G LFD L  ++ LSE+  +    ++L
Sbjct: 67  SILRQVLHPNIITLHDVYEN-RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQIL 125

Query: 157 KGLQYLHGMQIIHGDIKPSNLLINGKGE----VKIADFGVSRIVEETRNNNNHNNNNNNN 212
            G+ YLH  +I H D+KP N+++  K      +K+ DFG++  +E+              
Sbjct: 126 DGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED-------------- 171

Query: 213 IGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGF-GE-K 270
            G       GT  +++PE V+ E      G   D+WS+GV+    L G  P   F G+ K
Sbjct: 172 -GVEFKNIFGTPEFVAPEIVNYEP----LGLEADMWSIGVITYILLSGASP---FLGDTK 223

Query: 271 PDLMALI--CAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSS 328
            + +A I   +  F E  E     S   + F+R  L K+ RKR T++E L +P++T   +
Sbjct: 224 QETLANITAVSYDFDE--EFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDT 281

Query: 329 SSNI 332
              +
Sbjct: 282 QQAM 285

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  160 bits (407), Expect = 1e-46
 Identities = 80/294 (27%), Positives = 126/294 (42%), Gaps = 42/294 (14%)

Query: 54  VLGHGNGGIVYKVRHQKSNSIYALKVLN----TTSSTIIRHQAAHEAEILKRLDSQFIVK 109
           V+G G   +V +  ++++   +A+K+++    T+S  +       EA I   L    IV+
Sbjct: 31  VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90

Query: 110 CHAVFYTIEGEICFVMEHMERGSLFDSLRVRKK----LSEDVISGVAYRVLKGLQYLHGM 165
               + + +G +  V E M+   L   +  R       SE V S    ++L+ L+Y H  
Sbjct: 91  LLETYSS-DGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN 149

Query: 166 QIIHGDIKPSNLLINGKGE---VKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMG 222
            IIH D+KP  +L+  K     VK+  FGV+  + E+              G  A   +G
Sbjct: 150 NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGES--------------GLVAGGRVG 195

Query: 223 TCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGF-GEKPDLMALICAIC 281
           T  +M+PE V  E     YG   DVW  GV++   L G  P   F G K  L   I    
Sbjct: 196 TPHFMAPEVVKREP----YGKPVDVWGCGVILFILLSGCLP---FYGTKERLFEGIIK-- 246

Query: 282 FGERLEMPE----TASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSN 331
            G+  +M        S   +  VR  L  D  +R TV E L +P++ +R   + 
Sbjct: 247 -GK-YKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAY 298

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  163 bits (415), Expect = 1e-46
 Identities = 79/307 (25%), Positives = 127/307 (41%), Gaps = 44/307 (14%)

Query: 44  ENISDLKKLT-VLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH-------- 94
             I +       LG G  G V   + +  +S  A+KV+  +     R+   +        
Sbjct: 32  GKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHE 91

Query: 95  ----EAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISG 150
               E  +LK LD   I+K   VF   +     V E  E G LF+ +  R K  E   + 
Sbjct: 92  EIYNEISLLKSLDHPNIIKLFDVFED-KKYFYLVTEFYEGGELFEQIINRHKFDECDAAN 150

Query: 151 VAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGE---VKIADFGVSRIVEETRNNNNHNN 207
           +  ++L G+ YLH   I+H DIKP N+L+  K     +KI DFG+S    +         
Sbjct: 151 IMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSK--------- 201

Query: 208 NNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGF 267
                        +GT  Y++PE +        Y    DVWS GV++   L G+ P  G 
Sbjct: 202 ------DYKLRDRLGTAYYIAPEVLK-----KKYNEKCDVWSCGVIMYILLCGYPPFGGQ 250

Query: 268 GEKPDLMALICAICFGE-RLEMPE--TASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVT 324
            ++     +I  +  G+   +  +    S E +  ++  L  D+ KR T EE L   ++ 
Sbjct: 251 NDQ----DIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIK 306

Query: 325 KRSSSSN 331
           K +++ N
Sbjct: 307 KYANNIN 313

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  159 bits (405), Expect = 2e-46
 Identities = 77/358 (21%), Positives = 128/358 (35%), Gaps = 68/358 (18%)

Query: 23  NHQFRRRRHHFPTSNPTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNT 82
           +H     R +      +  +++    LK    +G G+ G+V      ++ +I A+K++N 
Sbjct: 4   HHHHSSGRENLYFQGGSLLELQKKYHLKG--AIGQGSYGVVRVAIENQTRAIRAIKIMNK 61

Query: 83  T----SSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLR 138
                 +     +   E  ++K+L    I + + V+   E  IC VME    G L D L 
Sbjct: 62  NKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED-EQYICLVMELCHGGHLLDKLN 120

Query: 139 VRKK----------------------------------------LSEDVISGVAYRVLKG 158
           V                                             E +IS +  ++   
Sbjct: 121 VFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180

Query: 159 LQYLHGMQIIHGDIKPSNLLINGKGE--VKIADFGVSRIVEETRNNNNHNNNNNNNIGEA 216
           L YLH   I H DIKP N L +      +K+ DFG+S+              NN      
Sbjct: 181 LHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFY---------KLNNGEYYGM 231

Query: 217 AIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMAL 276
                GT  +++PE +        YG   D WS GV++   L+G  P   F    D    
Sbjct: 232 TTKA-GTPYFVAPEVL--NTTNESYGPKCDAWSAGVLLHLLLMGAVP---FPGVND-ADT 284

Query: 277 ICAICFGE-RLEMPE--TASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSN 331
           I  +   +   E P     SP  R  + + L ++  +R      L +P++++ S    
Sbjct: 285 ISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSDKIY 342

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  158 bits (401), Expect = 2e-46
 Identities = 90/302 (29%), Positives = 132/302 (43%), Gaps = 55/302 (18%)

Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH-------------------- 94
           +G G+ G+V    ++  N+ YA+KVL+     +IR                         
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLS--KKKLIRQAGFPRRPPPRGTRPAPGGCIQPRG 78

Query: 95  -------EAEILKRLDSQFIVKCHAVFYTI-EGEICFVMEHMERGSLFDSLRVRKKLSED 146
                  E  ILK+LD   +VK   V     E  +  V E + +G + +     K LSED
Sbjct: 79  PIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSED 137

Query: 147 VISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHN 206
                   ++KG++YLH  +IIH DIKPSNLL+   G +KIADFGVS   +         
Sbjct: 138 QARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKG-------- 189

Query: 207 NNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLI 265
                +    +    GT A+M+PE   SE      G A DVW++G V L C V G  P  
Sbjct: 190 -----SDALLSNTV-GTPAFMAPE-SLSETRKIFSGKALDVWAMG-VTLYCFVFGQCP-- 239

Query: 266 GFGEKPDLMALICAICFGERLEMPETA--SPEFRRFVRSCLEKDWRKRGTVEELLAYPFV 323
            F     +M L   I     LE P+    + + +  +   L+K+   R  V E+  +P+V
Sbjct: 240 -F-MDERIMCLHSKIKSQA-LEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWV 296

Query: 324 TK 325
           T+
Sbjct: 297 TR 298

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  158 bits (402), Expect = 2e-46
 Identities = 79/299 (26%), Positives = 130/299 (43%), Gaps = 36/299 (12%)

Query: 40  SPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEIL 99
           + ++       +  VLG G    V+ V+ + +  ++ALK +   S         +E  +L
Sbjct: 4   TTNIRKTFIFME--VLGSGAFSEVFLVKQRLTGKLFALKCIKK-SPAFRDSSLENEIAVL 60

Query: 100 KRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGL 159
           K++  + IV    ++ +       VM+ +  G LFD +  R   +E   S V  +VL  +
Sbjct: 61  KKIKHENIVTLEDIYES-TTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAV 119

Query: 160 QYLHGMQIIHGDIKPSNLLINGKGE---VKIADFGVSRIVEETRNNNNHNNNNNNNIGEA 216
           +YLH   I+H D+KP NLL     E   + I DFG+S++ +                G  
Sbjct: 120 KYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN---------------GIM 164

Query: 217 AIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMAL 276
           + AC GT  Y++PE +        Y  A D WS+GV+    L G+ P   F E+     L
Sbjct: 165 STAC-GTPGYVAPEVLA----QKPYSKAVDCWSIGVITYILLCGYPP---FYEE-TESKL 215

Query: 277 ICAICFGERLEMPE----TASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSN 331
              I  G   E         S   + F+   LEKD  +R T E+ L++P++   ++   
Sbjct: 216 FEKIKEGY-YEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNTALHR 273

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  157 bits (400), Expect = 3e-46
 Identities = 73/302 (24%), Positives = 129/302 (42%), Gaps = 40/302 (13%)

Query: 42  DVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAA-----HEA 96
            VE+  ++ +   LG G   IV K R + +   YA K +     +  R   +      E 
Sbjct: 2   MVEDHYEMGE--ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREV 59

Query: 97  EILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVL 156
            IL+ +    I+  H +F   + ++  ++E +  G LFD L  ++ L+ED  +    ++L
Sbjct: 60  NILREIRHPNIITLHDIFEN-KTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQIL 118

Query: 157 KGLQYLHGMQIIHGDIKPSNLLINGKGE----VKIADFGVSRIVEETRNNNNHNNNNNNN 212
            G+ YLH  +I H D+KP N+++  K      +K+ DFG++  +E               
Sbjct: 119 DGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA-------------- 164

Query: 213 IGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPD 272
            G       GT  +++PE V+ E      G   D+WS+GV+    L G  P   F  +  
Sbjct: 165 -GNEFKNIFGTPEFVAPEIVNYEP----LGLEADMWSIGVITYILLSGASP---FLGETK 216

Query: 273 LMALICAICFGERLEMPETA----SPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSS 328
               +  I      +  E      S   + F+R  L KD ++R T+ + L + ++     
Sbjct: 217 -QETLTNISAVN-YDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRR 274

Query: 329 SS 330
            +
Sbjct: 275 RN 276

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  157 bits (399), Expect = 3e-46
 Identities = 63/297 (21%), Positives = 112/297 (37%), Gaps = 40/297 (13%)

Query: 38  PTSPDVE-NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVL------NTTSSTIIRH 90
           P S       ++++    +G G  G+V+K R  K  S+ A+K L        T       
Sbjct: 9   PKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQ 68

Query: 91  QAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRK-KLSEDVIS 149
           +   E  I+  L+   IVK + +   +      VME +  G L+  L  +   +   V  
Sbjct: 69  EFQREVFIMSNLNHPNIVKLYGL---MHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKL 125

Query: 150 GVAYRVLKGLQYLHGM--QIIHGDIKPSNLLINGKGE-----VKIADFGVSRIVEETRNN 202
            +   +  G++Y+      I+H D++  N+ +    E      K+ADFG+S+    +   
Sbjct: 126 RLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS--- 182

Query: 203 NNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHY 262
                             +G   +M+PE + +E     Y    D +S  +++   L G  
Sbjct: 183 --------------VSGLLGNFQWMAPETIGAE--EESYTEKADTYSFAMILYTILTGEG 226

Query: 263 PLIGFGEKPDLMALICAICF-GERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELL 318
           P   +      +  I  I   G R  +PE   P  R  +  C   D +KR     ++
Sbjct: 227 PFDEY--SYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIV 281

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  157 bits (399), Expect = 4e-46
 Identities = 67/305 (21%), Positives = 125/305 (40%), Gaps = 37/305 (12%)

Query: 27  RRRRHHFPTSNPTSPDVENI--SDLKKLTVLGHGNGGIVYKVRHQKSNSIY----ALKVL 80
           ++  HH    +  + D   I    +     +G G+ G VYK         +    A+K+L
Sbjct: 2   KKGHHHHHHGSRDAADDWEIPDGQITVGQRIGSGSFGTVYK-------GKWHGDVAVKML 54

Query: 81  NTTSSTIIRHQA-AHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRV 139
           N T+ T  + QA  +E  +L++     I+       +   ++  V +  E  SL+  L  
Sbjct: 55  NVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY--STAPQLAIVTQWCEGSSLYHHLHA 112

Query: 140 RK-KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEE 198
            + K     +  +A +  +G+ YLH   IIH D+K +N+ ++    VKI DFG++     
Sbjct: 113 SETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR 172

Query: 199 TRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECL 258
              ++                  G+  +M+PE V   +    Y F  DV++ G+V+ E +
Sbjct: 173 WSGSHQFE------------QLSGSILWMAPE-VIRMQDSNPYSFQSDVYAFGIVLYELM 219

Query: 259 VGHYPLIGFGEKPDLMALICAICFGER----LEMPETASPEFRRFVRSCLEKDWRKRGTV 314
            G  P   +    +   +I  +  G       ++        +R +  CL+K   +R + 
Sbjct: 220 TGQLP---YSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSF 276

Query: 315 EELLA 319
             +LA
Sbjct: 277 PRILA 281

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  157 bits (398), Expect = 1e-45
 Identities = 73/323 (22%), Positives = 132/323 (40%), Gaps = 38/323 (11%)

Query: 23  NHQFRRRRHHFPTSNPTSPDVENISDLKKLT--VLGHGNGGIVYKVRHQKSNSIYALKVL 80
           +H          T N     +EN ++   LT   LG G   +V +   + +   YA K L
Sbjct: 3   HHHHHSSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFL 62

Query: 81  NTTS-STIIRHQAAHEAEILKRLDSQ-FIVKCHAVFYTIEGEICFVMEHMERGSLFDSL- 137
                    R +  HE  +L+   S   ++  H V+     EI  ++E+   G +F    
Sbjct: 63  KKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYEN-TSEIILILEYAAGGEIFSLCL 121

Query: 138 -RVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGE---VKIADFGVS 193
             + + +SE+ +  +  ++L+G+ YLH   I+H D+KP N+L++       +KI DFG+S
Sbjct: 122 PELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMS 181

Query: 194 RIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVV 253
           R +                        MGT  Y++PE ++ +        A D+W++G++
Sbjct: 182 RKIGH---------------ACELREIMGTPEYLAPEILNYDP----ITTATDMWNIGII 222

Query: 254 VLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPETA----SPEFRRFVRSCLEKDWR 309
               L    P   F  + +       I     ++  E      S     F++S L K+  
Sbjct: 223 AYMLLTHTSP---FVGEDN-QETYLNISQVN-VDYSEETFSSVSQLATDFIQSLLVKNPE 277

Query: 310 KRGTVEELLAYPFVTKRSSSSNI 332
           KR T E  L++ ++ +    +  
Sbjct: 278 KRPTAEICLSHSWLQQWDFENLF 300

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  157 bits (400), Expect = 1e-45
 Identities = 85/333 (25%), Positives = 136/333 (40%), Gaps = 37/333 (11%)

Query: 7   RRHQQALTLSLPATAANHQFRRRRHHFPTSNPTSPDVENISDLKKLTVLGHGNGGIVYKV 66
                    S+ A+AA         ++   +     + +  +++    LG G   IVY+ 
Sbjct: 16  ENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRD-ALSDFFEVES--ELGRGATSIVYRC 72

Query: 67  RHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVME 126
           + + +   YALKVL  T     +     E  +L RL    I+K   +F T   EI  V+E
Sbjct: 73  KQKGTQKPYALKVLKKTVD---KKIVRTEIGVLLRLSHPNIIKLKEIFET-PTEISLVLE 128

Query: 127 HMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGE-- 184
            +  G LFD +  +   SE   +    ++L+ + YLH   I+H D+KP NLL        
Sbjct: 129 LVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDA 188

Query: 185 -VKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGF 243
            +KIADFG+S+IVE                        GT  Y +PE +        YG 
Sbjct: 189 PLKIADFGLSKIVEH---------------QVLMKTVCGTPGYCAPEILRGCA----YGP 229

Query: 244 AGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPE----TASPEFRRF 299
             D+WS+G++    L G  P   F ++     +   I   E            S   +  
Sbjct: 230 EVDMWSVGIITYILLCGFEP---FYDERGDQFMFRRILNCE-YYFISPWWDEVSLNAKDL 285

Query: 300 VRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNI 332
           VR  +  D +KR T  + L +P+VT ++++   
Sbjct: 286 VRKLIVLDPKKRLTTFQALQHPWVTGKAANFVH 318

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  159 bits (403), Expect = 1e-45
 Identities = 84/307 (27%), Positives = 130/307 (42%), Gaps = 32/307 (10%)

Query: 25  QFRRRRHHFPTSNPTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS 84
            F  R     T N          D + + V+G G  G V  VRH+ +  +YA+K+L+   
Sbjct: 49  NFLSRYK--DTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSK-F 105

Query: 85  STIIRHQAAH---EAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRK 141
             I R  +A    E +I+   +S ++V+    F   +  +  VME+M  G L + +    
Sbjct: 106 EMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD-DRYLYMVMEYMPGGDLVNLMS-NY 163

Query: 142 KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRN 201
            + E         V+  L  +H M  IH D+KP N+L++  G +K+ADFG        + 
Sbjct: 164 DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCM-----KM 218

Query: 202 NNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGH 261
           N       +        A  GT  Y+SPE + S+   G YG   D WS+GV + E LVG 
Sbjct: 219 NKEGMVRCDT-------AV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270

Query: 262 YPLIGFGEKPDLMALICAICFG-ERLEMPETA--SPEFRRFVRSCLEKDWRKR---GTVE 315
            P   + +   L+     I      L  P+    S E +  + + L  D   R     VE
Sbjct: 271 TPF--YAD--SLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFL-TDREVRLGRNGVE 325

Query: 316 ELLAYPF 322
           E+  + F
Sbjct: 326 EIKRHLF 332

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  156 bits (397), Expect = 2e-45
 Identities = 68/301 (22%), Positives = 119/301 (39%), Gaps = 36/301 (11%)

Query: 42  DVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKR 101
           ++     + +   LG G  GIV++     S   Y  K +    +   +     E  IL  
Sbjct: 2   ELYEKYMIAE--DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD--QVLVKKEISILNI 57

Query: 102 LDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQ 160
              + I+  H  F +   E+  + E +    +F+ +     +L+E  I    ++V + LQ
Sbjct: 58  ARHRNILHLHESFES-MEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQ 116

Query: 161 YLHGMQIIHGDIKPSNLLINGKGE--VKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAI 218
           +LH   I H DI+P N++   +    +KI +FG +R ++                G+   
Sbjct: 117 FLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP---------------GDNFR 161

Query: 219 ACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGF-GE-KPDLMAL 276
                  Y +PE    +        A D+WSLG +V   L G  P   F  E    ++  
Sbjct: 162 LLFTAPEYYAPEVHQHD----VVSTATDMWSLGTLVYVLLSGINP---FLAETNQQIIEN 214

Query: 277 I--CAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNIEG 334
           I      F E  E  +  S E   FV   L K+ + R T  E L +P++ ++    + + 
Sbjct: 215 IMNAEYTFDE--EAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKV 272

Query: 335 L 335
           +
Sbjct: 273 I 273

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  155 bits (395), Expect = 3e-45
 Identities = 75/319 (23%), Positives = 129/319 (40%), Gaps = 35/319 (10%)

Query: 36  SNPTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHE 95
           ++  S   E++  L++  VLG G    V    +  ++  YA+K++       IR +   E
Sbjct: 3   TDSFSGRFEDVYQLQE-DVLGEGAHARVQTCINLITSQEYAVKIIEK-QPGHIRSRVFRE 60

Query: 96  AEILKRLDSQ-FIVKCHAVFYTIEGEICF--VMEHMERGSLFDSLRVRKKLSEDVISGVA 152
            E+L +      +++    F   E E  F  V E M  GS+   +  R+  +E   S V 
Sbjct: 61  VEMLYQCQGHRNVLELIEFF---EEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVV 117

Query: 153 YRVLKGLQYLHGMQIIHGDIKPSNLLINGKGE---VKIADFGVSRIVEETRNNNNHNNNN 209
             V   L +LH   I H D+KP N+L     +   VKI DF +   ++   + +  +   
Sbjct: 118 QDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPIST-- 175

Query: 210 NNNIGEAAIACMGTCAYMSPERVDSERWGGD-YGFAGDVWSLGVV-----------VLEC 257
                E    C G+  YM+PE V++       Y    D+WSLGV+           V  C
Sbjct: 176 ----PELLTPC-GSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRC 230

Query: 258 LVGHYPLIGFGEKPDLMALICAICFGERLEMPE----TASPEFRRFVRSCLEKDWRKRGT 313
                   G         L  +I  G+  E P+      S   +  +   L +D ++R +
Sbjct: 231 GSDCGWDRGEACPACQNMLFESIQEGK-YEFPDKDWAHISCAAKDLISKLLVRDAKQRLS 289

Query: 314 VEELLAYPFVTKRSSSSNI 332
             ++L +P+V   +  + +
Sbjct: 290 AAQVLQHPWVQGCAPENTL 308

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  157 bits (398), Expect = 3e-45
 Identities = 72/335 (21%), Positives = 134/335 (40%), Gaps = 38/335 (11%)

Query: 7   RRHQQALTLSLPATAANHQFRRRRHHFPTSNPTSPDVENISD---LKKLTVLGHGNGGIV 63
               +A  L+            +        P     +        K   V+G G   +V
Sbjct: 53  NLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKD--VIGRGVSSVV 110

Query: 64  YKVRHQKSNSIYALKVLNTTSSTI-------IRHQAAHEAEILKRLDSQ-FIVKCHAVFY 115
            +  H+ +   +A+K++  T+  +       +R     E  IL+++     I+     + 
Sbjct: 111 RRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYE 170

Query: 116 TIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPS 175
           +    +  V + M +G LFD L  +  LSE     +   +L+ + +LH   I+H D+KP 
Sbjct: 171 S-SSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPE 229

Query: 176 NLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPE--RVD 233
           N+L++   +++++DFG S  +E                GE      GT  Y++PE  +  
Sbjct: 230 NILLDDNMQIRLSDFGFSCHLEP---------------GEKLRELCGTPGYLAPEILKCS 274

Query: 234 SERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGE-RLEMPE-- 290
            +     YG   D+W+ GV++   L G  P   F  +   + ++  I  G+ +   PE  
Sbjct: 275 MDETHPGYGKEVDLWACGVILFTLLAGSPP---FWHRRQ-ILMLRMIMEGQYQFSSPEWD 330

Query: 291 TASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTK 325
             S   +  +   L+ D   R T E+ L +PF  +
Sbjct: 331 DRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  155 bits (395), Expect = 4e-45
 Identities = 77/307 (25%), Positives = 141/307 (45%), Gaps = 44/307 (14%)

Query: 41  PDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAA-----HE 95
            +V++  D  +   LG G   +V K R + +   YA K +    +   R   +      E
Sbjct: 7   ENVDDYYDTGE--ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE 64

Query: 96  AEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRV 155
             ILK +    ++  H V+   + ++  ++E +  G LFD L  ++ L+E+  +    ++
Sbjct: 65  VSILKEIQHPNVITLHEVYEN-KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 123

Query: 156 LKGLQYLHGMQIIHGDIKPSNLLINGKGE----VKIADFGVSRIVEETRNNNNHNNNNNN 211
           L G+ YLH +QI H D+KP N+++  +      +KI DFG++  ++              
Sbjct: 124 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF------------- 170

Query: 212 NIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVV--VLECLVGHYPLIGF-G 268
             G       GT  +++PE V+ E      G   D+WS+GV+  +L  L G  P   F G
Sbjct: 171 --GNEFKNIFGTPEFVAPEIVNYEP----LGLEADMWSIGVITYIL--LSGASP---FLG 219

Query: 269 E-KPDLMALI--CAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTK 325
           + K + +A +      F +      T S   + F+R  L KD +KR T+++ L +P++  
Sbjct: 220 DTKQETLANVSAVNYEFEDE-YFSNT-SALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 277

Query: 326 RSSSSNI 332
           + +   +
Sbjct: 278 KDTQQAL 284

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  157 bits (399), Expect = 6e-45
 Identities = 69/292 (23%), Positives = 119/292 (40%), Gaps = 34/292 (11%)

Query: 45  NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH---EAEILKR 101
              D + L V+G G    V  V+ +++  +YA+K++N     + R + +    E ++L  
Sbjct: 59  QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNK-WDMLKRGEVSCFREERDVLVN 117

Query: 102 LDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSL-RVRKKLSEDVISGVAYRVLKGLQ 160
            D ++I + H  F   E  +  VME+   G L   L +  +++  ++       ++  + 
Sbjct: 118 GDRRWITQLHFAFQD-ENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAID 176

Query: 161 YLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIAC 220
            +H +  +H DIKP N+L++  G +++ADFG        +   +    +         A 
Sbjct: 177 SVHRLGYVHRDIKPDNILLDRCGHIRLADFGSC-----LKLRADGTVRSLV-------AV 224

Query: 221 MGTCAYMSPE---RVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALI 277
            GT  Y+SPE    V      G YG   D W+LGV   E   G  P   + +        
Sbjct: 225 -GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPF--YAD--STAETY 279

Query: 278 CAICFG-ERLEMPETA---SPEFRRFVRSCLEKDWRKR---GTVEELLAYPF 322
             I    E L +P        E R F++  L      R   G   +   +PF
Sbjct: 280 GKIVHYKEHLSLPLVDEGVPEEARDFIQRLLCPP-ETRLGRGGAGDFRTHPF 330

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  155 bits (394), Expect = 6e-45
 Identities = 72/326 (22%), Positives = 129/326 (39%), Gaps = 42/326 (12%)

Query: 22  ANHQFRRRRHHFPTSNPTSPDVENISDLKKLT--VLGHGNGGIVYKVRHQKSNSIYALKV 79
           A+H                P    ++D  +L+  VLG G  G V +  H+++    ALK+
Sbjct: 2   AHHHHHHSSGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKL 61

Query: 80  LNTTSSTIIRHQAAHEAEILKRLDSQ-FIVKCHAVF---YTIEGEICFVMEHMERGSLFD 135
           L          +A  E +   +      IV    V+   +  +  +  +ME ME G LF 
Sbjct: 62  LYD------SPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFS 115

Query: 136 SL--RVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGE---VKIADF 190
            +  R  +  +E   + +   +   +Q+LH   I H D+KP NLL   K +   +K+ DF
Sbjct: 116 RIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDF 175

Query: 191 GVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSL 250
           G ++   +                     C  T  Y++PE +  E+    Y  + D+WSL
Sbjct: 176 GFAKETTQ---------------NALQTPC-YTPYYVAPEVLGPEK----YDKSCDMWSL 215

Query: 251 GVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPE----TASPEFRRFVRSCLEK 306
           GV++   L G  P      +     +   I  G+    P       S + ++ +R  L+ 
Sbjct: 216 GVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQ-YGFPNPEWSEVSEDAKQLIRLLLKT 274

Query: 307 DWRKRGTVEELLAYPFVTKRSSSSNI 332
           D  +R T+ + + +P++ +       
Sbjct: 275 DPTERLTITQFMNHPWINQSMVVPQT 300

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  156 bits (396), Expect = 7e-45
 Identities = 46/366 (12%), Positives = 95/366 (25%), Gaps = 71/366 (19%)

Query: 4   VRERRHQQALTLSLPATAANHQFRRRRHHFPTSNPT---SPDVENISDLKKLTVLGHGNG 60
           +  R  Q  +  +     +          + T  P    S   E    L + TVLG  + 
Sbjct: 27  LFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDP 86

Query: 61  GIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRL---------------- 102
               +   Q++   + + V   T    +    Q   E   L+ L                
Sbjct: 87  YAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFI 146

Query: 103 ---------DSQFIVKCHAVFYTIE-GEICFVMEHMER------GSLFDSLRVRKKLSED 146
                      + +++       +      F+   M+         L       K L   
Sbjct: 147 FPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHH 206

Query: 147 VISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHN 206
               +  +V++ L  LH   ++H  ++P +++++ +G V +  F                
Sbjct: 207 ARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGARVV----- 261

Query: 207 NNNNNNIGEAAIACMGTCAYMSPERVDSERW-------GGDYGFAGDVWSLGVVVLECLV 259
                           +  +  PE                   F+ D W+LG+V+     
Sbjct: 262 -------------SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWC 308

Query: 260 GHYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA 319
              P     +    +     I         +      R  +   L      R    + + 
Sbjct: 309 ADLP---ITK-DAALGGSEWI-----FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAME 359

Query: 320 YPFVTK 325
            P   +
Sbjct: 360 TPEYEQ 365

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  154 bits (392), Expect = 9e-45
 Identities = 58/333 (17%), Positives = 116/333 (34%), Gaps = 44/333 (13%)

Query: 19  ATAANHQFRRRRHHFPTSNPTSPDVE----NISDLKKLTVLGHGNGGIVYK------VRH 68
               N      R     ++ TS  ++        L+   ++G G  G VY       V  
Sbjct: 1   GPEMNLSLLSARSFPRKASQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHGEV-- 58

Query: 69  QKSNSIYALKVLNTTSSTIIRHQA-AHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEH 127
                  A+++++       + +A   E    ++   + +V            +  +   
Sbjct: 59  -------AIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGAC-MSPPHLAIITSL 110

Query: 128 MERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVK 186
            +  +L+  +R  K  L  +    +A  ++KG+ YLH   I+H D+K  N+  +  G+V 
Sbjct: 111 CKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVV 169

Query: 187 IADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPE-----RVDSERWGGDY 241
           I DFG+  I    +     +     N         G   +++PE       D+E     +
Sbjct: 170 ITDFGLFSISGVLQAGRREDKLRIQN---------GWLCHLAPEIIRQLSPDTEEDKLPF 220

Query: 242 GFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPE-TASPEFRRFV 300
               DV++LG +  E     +P           A+I  +  G +  + +     E    +
Sbjct: 221 SKHSDVFALGTIWYELHAREWPFKTQ----PAEAIIWQMGTGMKPNLSQIGMGKEISDIL 276

Query: 301 RSCLEKDWRKRGTVEELLAY--PFVTKRSSSSN 331
             C   +  +R T  +L+        +    S+
Sbjct: 277 LFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSH 309

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  155 bits (394), Expect = 1e-44
 Identities = 76/296 (25%), Positives = 139/296 (46%), Gaps = 39/296 (13%)

Query: 36  SNPTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRH-QAAH 94
             P+      +    ++  LG G+ G V  V+H++S + YA+K+L+     +++  Q  H
Sbjct: 31  ETPSQNTA-QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD--KQKVVKLKQIEH 87

Query: 95  ---EAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGV 151
              E  IL+ ++  F+VK    F      +  VME++  G +F  LR   + SE      
Sbjct: 88  TLNEKRILQAVNFPFLVKLEFSFKD-NSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFY 146

Query: 152 AYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNN 211
           A +++   +YLH + +I+ D+KP NLLI+ +G +++ DFG ++ V+              
Sbjct: 147 AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT--------- 197

Query: 212 NIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP 271
                   C GT   ++PE + S+     Y  A D W+LGV++ E   G+ P   F ++P
Sbjct: 198 -------LC-GTPEALAPEIILSK----GYNKAVDWWALGVLIYEMAAGYPPF--FADQP 243

Query: 272 DLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKR-----GTVEELLAYPF 322
             + +   I  G ++  P   S + +  +R+ L+ D  KR       V ++  + +
Sbjct: 244 --IQIYEKIVSG-KVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 296

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  152 bits (386), Expect = 2e-44
 Identities = 74/301 (24%), Positives = 122/301 (40%), Gaps = 36/301 (11%)

Query: 39  TSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEI 98
           T  D+     L+    +G G+ G V     + +    A K +       +  +   E EI
Sbjct: 3   TKGDINQYYTLEN--TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVD-RFKQEIEI 59

Query: 99  LKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKG 158
           +K LD   I++ +  F     +I  VME    G LF+ +  ++   E   + +   VL  
Sbjct: 60  MKSLDHPNIIRLYETFED-NTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSA 118

Query: 159 LQYLHGMQIIHGDIKPSNLLINGKGE---VKIADFGVSRIVEETRNNNNHNNNNNNNIGE 215
           + Y H + + H D+KP N L         +K+ DFG++   +                G+
Sbjct: 119 VAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP---------------GK 163

Query: 216 AAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMA 275
                +GT  Y+SP+ ++     G YG   D WS GV++   L G+ P   F    D   
Sbjct: 164 MMRTKVGTPYYVSPQVLE-----GLYGPECDEWSAGVMMYVLLCGYPP---FSAPTD-SE 214

Query: 276 LICAICFGERLEMPE----TASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSN 331
           ++  I  G     PE      SP+    +R  L K  ++R T  + L + +  K+ SSS 
Sbjct: 215 VMLKIREGT-FTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQLSSSP 273

Query: 332 I 332
            
Sbjct: 274 R 274

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  156 bits (396), Expect = 3e-44
 Identities = 74/301 (24%), Positives = 132/301 (43%), Gaps = 32/301 (10%)

Query: 34  PTSNPTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAA 93
           P ++       +  D + L V+G G  G V  V+ + ++ ++A+K+LN     + R + A
Sbjct: 61  PFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNK-WEMLKRAETA 119

Query: 94  H---EAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSL-RVRKKLSEDVIS 149
               E ++L   DS++I   H  F   +  +  VM++   G L   L +   +L E++  
Sbjct: 120 CFREERDVLVNGDSKWITTLHYAFQD-DNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMAR 178

Query: 150 GVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNN 209
                ++  +  +H +  +H DIKP N+L++  G +++ADFG                  
Sbjct: 179 FYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCL------------KLM 226

Query: 210 NNNIGEAAIACMGTCAYMSPERVDSERWG-GDYGFAGDVWSLGVVVLECLVGHYPLIGFG 268
            +   ++++A  GT  Y+SPE + +   G G YG   D WSLGV + E L G  P   + 
Sbjct: 227 EDGTVQSSVAV-GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPF--YA 283

Query: 269 EKPDLMALICAICFGE-RLEMPE---TASPEFRRFVRSCLEKDWRKR---GTVEELLAYP 321
           E   L+     I   + R + P      S   +  +R  +      R     +E+   +P
Sbjct: 284 E--SLVETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSR-EHRLGQNGIEDFKKHP 340

Query: 322 F 322
           F
Sbjct: 341 F 341

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  153 bits (389), Expect = 3e-44
 Identities = 71/302 (23%), Positives = 123/302 (40%), Gaps = 39/302 (12%)

Query: 45  NISDLKKLT----VLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILK 100
                  L      LG G+  I  K  H+KSN  +A+K+++       +     E   LK
Sbjct: 5   PFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK----EITALK 60

Query: 101 RLDSQ-FIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGL 159
             +    IVK H VF+  +     VME +  G LF+ ++ +K  SE   S +  +++  +
Sbjct: 61  LCEGHPNIVKLHEVFHD-QLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAV 119

Query: 160 QYLHGMQIIHGDIKPSNLLINGKGE---VKIADFGVSRIVEETRNNNNHNNNNNNNIGEA 216
            ++H + ++H D+KP NLL   + +   +KI DFG +R+             +N  +   
Sbjct: 120 SHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP----------DNQPLKTP 169

Query: 217 AIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIG---FGEKPDL 273
                 T  Y +PE ++       Y  + D+WSLGV++   L G  P             
Sbjct: 170 C----FTLHYAAPELLN----QNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSA 221

Query: 274 MALICAICFGERLEMPE----TASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSS 329
           + ++  I  G+            S E +  ++  L  D  KR  +  L    ++   S  
Sbjct: 222 VEIMKKIKKGD-FSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQL 280

Query: 330 SN 331
           S+
Sbjct: 281 SS 282

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  152 bits (385), Expect = 4e-44
 Identities = 75/305 (24%), Positives = 119/305 (39%), Gaps = 35/305 (11%)

Query: 31  HHFPTSNPTSPDVENISDLKKL-TVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIR 89
           HH  +          I DL      LG G  G V+ V  + S     +K +N   S +  
Sbjct: 5   HHHSSGRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPM 64

Query: 90  HQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFD----SLRVRKKLSE 145
            Q   E E+LK LD   I+K   VF      +  VME  E G L +    +    K LSE
Sbjct: 65  EQIEAEIEVLKSLDHPNIIKIFEVFED-YHNMYIVMETCEGGELLERIVSAQARGKALSE 123

Query: 146 DVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGE---VKIADFGVSRIVEETRNN 202
             ++ +  +++  L Y H   ++H D+KP N+L         +KI DFG++ + +     
Sbjct: 124 GYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS---- 179

Query: 203 NNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHY 262
                       E +    GT  YM+PE         D  F  D+WS GVV+   L G  
Sbjct: 180 -----------DEHSTNAAGTALYMAPEVFK-----RDVTFKCDIWSAGVVMYFLLTGCL 223

Query: 263 PLIGFGEKPDLMALI--CAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY 320
           P  G     ++          +          +P+    ++  L KD  +R +  ++L +
Sbjct: 224 PFTG-TSLEEVQQKATYKEPNYAVE---CRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH 279

Query: 321 PFVTK 325
            +  +
Sbjct: 280 EWFKQ 284

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  159 bits (403), Expect = 5e-44
 Identities = 67/315 (21%), Positives = 112/315 (35%), Gaps = 49/315 (15%)

Query: 38  PTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAE 97
             S   +     +    LG G  G V +  HQ +    A+K      S   R +   E +
Sbjct: 5   SPSLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQ 64

Query: 98  ILKRLDSQFIVKCHAVFYT-----IEGEICFVMEHMERGSLFDSLRVRKK---LSEDVIS 149
           I+K+L+   +V    V                ME+ E G L   L   +    L E  I 
Sbjct: 65  IMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIR 124

Query: 150 GVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGE---VKIADFGVSRIVEETRNNNNHN 206
            +   +   L+YLH  +IIH D+KP N+++    +    KI D G ++ +++        
Sbjct: 125 TLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL----- 179

Query: 207 NNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIG 266
                          GT  Y++PE ++ ++    Y    D WS G +  EC+ G  P + 
Sbjct: 180 ---------CTEFV-GTLQYLAPELLEQKK----YTVTVDYWSFGTLAFECITGFRPFLP 225

Query: 267 FGEKPDLMALI---------------CAICFGERLEMPETASP----EFRRFVRSCLEKD 307
             +       +                A+ F   L  P   S     +  R+++  L   
Sbjct: 226 NWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWH 285

Query: 308 WRKRGTVEELLAYPF 322
            R+RGT  +      
Sbjct: 286 QRQRGTDPQNPNVGC 300

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  153 bits (388), Expect = 5e-44
 Identities = 83/290 (28%), Positives = 131/290 (45%), Gaps = 41/290 (14%)

Query: 45  NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTII-RHQAAH---EAEILK 100
            ++D   L +LG G  G V  VR + +   YA+K+L      II + + AH   E+ +L+
Sbjct: 3   TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILR--KEVIIAKDEVAHTVTESRVLQ 60

Query: 101 RLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQ 160
                F+      F T    +CFVME+   G LF  L   +  +E+        ++  L+
Sbjct: 61  NTRHPFLTALKYAFQT-HDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALE 119

Query: 161 YLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIA- 219
           YLH   +++ DIK  NL+++  G +KI DFG+ +                  I + A   
Sbjct: 120 YLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCK----------------EGISDGATMK 163

Query: 220 --CMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALI 277
             C GT  Y++PE ++      DYG A D W LGVV+ E + G  P      +  L  LI
Sbjct: 164 TFC-GTPEYLAPEVLE----DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-RLFELI 217

Query: 278 CAICFGERLEMPETASPEFRRFVRSCLEKDWRKR-----GTVEELLAYPF 322
                 E +  P T SPE +  +   L+KD ++R        +E++ + F
Sbjct: 218 LM----EEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRF 263

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  154 bits (389), Expect = 6e-44
 Identities = 48/345 (13%), Positives = 86/345 (24%), Gaps = 59/345 (17%)

Query: 21  AANHQFRRRRHHFPTSNPT---SPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYAL 77
            A          +P +  T   S   +    LK +  L  G+  +V+ VR  +    +AL
Sbjct: 33  PAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFAL 92

Query: 78  KVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHAVF--------------------- 114
           KV    +  S     +         RL  +   +                          
Sbjct: 93  KVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLS 152

Query: 115 ----YTIEGEICFVMEHME------RGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG 164
                        +M            +L      R       +  +  ++++    L  
Sbjct: 153 PGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQS 212

Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTC 224
             ++HG   P NL I   G + + D      V                 G    A     
Sbjct: 213 KGLVHGHFTPDNLFIMPDGRLMLGDVSALWKV-----------------GTRGPASSVPV 255

Query: 225 AYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYP----LIGFGEKPDLMALICAI 280
            Y   E +++      +  A + W LG+ +        P      G        +L    
Sbjct: 256 TYAPREFLNAS--TATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPG 313

Query: 281 CFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTK 325
                           +  +   L  D R+R    E +  P   +
Sbjct: 314 TDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQ 358

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  154 bits (390), Expect = 7e-44
 Identities = 75/295 (25%), Positives = 136/295 (46%), Gaps = 31/295 (10%)

Query: 42  DVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKR 101
            V +  D+ +   LG G  G+V++   + +  ++  K +NT    + ++   +E  I+ +
Sbjct: 48  SVYDYYDILE--ELGSGAFGVVHRCVEKATGRVFVAKFINT-PYPLDKYTVKNEISIMNQ 104

Query: 102 LDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQ 160
           L    ++  H  F   + E+  ++E +  G LFD +     K+SE  +     +  +GL+
Sbjct: 105 LHHPKLINLHDAFED-KYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLK 163

Query: 161 YLHGMQIIHGDIKPSNLLINGKGE--VKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAI 218
           ++H   I+H DIKP N++   K    VKI DFG++  +                  E   
Sbjct: 164 HMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP---------------DEIVK 208

Query: 219 ACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALI- 277
               T  + +PE VD E      GF  D+W++GV+    L G  P  G  +  + +  + 
Sbjct: 209 VTTATAEFAAPEIVDREP----VGFYTDMWAIGVLGYVLLSGLSPFAGEDDL-ETLQNVK 263

Query: 278 -CAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSN 331
            C   F E  +   + SPE + F+++ L+K+ RKR TV + L +P++    S+  
Sbjct: 264 RCDWEFDE--DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLT 316

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  153 bits (389), Expect = 8e-44
 Identities = 71/298 (23%), Positives = 133/298 (44%), Gaps = 33/298 (11%)

Query: 42  DVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKR 101
            V +   + K  +LG G  G V+K     +    A K++ T      + +  +E  ++ +
Sbjct: 84  AVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKT-RGMKDKEEVKNEISVMNQ 142

Query: 102 LDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQ 160
           LD   +++ +  F + + +I  VME+++ G LFD +      L+E        ++ +G++
Sbjct: 143 LDHANLIQLYDAFES-KNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIR 201

Query: 161 YLHGMQIIHGDIKPSNLLINGKGE--VKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAI 218
           ++H M I+H D+KP N+L   +    +KI DFG++R  +                 E   
Sbjct: 202 HMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP---------------REKLK 246

Query: 219 ACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGF-GE-KPDLMAL 276
              GT  +++PE V+ +       F  D+WS+GV+    L G  P   F G+   + +  
Sbjct: 247 VNFGTPEFLAPEVVNYDF----VSFPTDMWSVGVIAYMLLSGLSP---FLGDNDAETLNN 299

Query: 277 I--CAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNI 332
           I  C     +  E  +  S E + F+   L K+   R +  E L +P+++     S +
Sbjct: 300 ILACRWDLED--EEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDHKLHSRL 355

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  156 bits (397), Expect = 1e-43
 Identities = 69/315 (21%), Positives = 134/315 (42%), Gaps = 35/315 (11%)

Query: 28  RRRHHFPTSNPTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTI 87
            ++++          V +  D+ +   LG G  G+V++V  + + + +A K + T     
Sbjct: 140 WKQYYPQPVEIKHDHVLDHYDIHE--ELGTGAFGVVHRVTERATGNNFAAKFVMT-PHES 196

Query: 88  IRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRK-KLSED 146
            +     E + +  L    +V  H  F   + E+  + E M  G LF+ +     K+SED
Sbjct: 197 DKETVRKEIQTMSVLRHPTLVNLHDAFED-DNEMVMIYEFMSGGELFEKVADEHNKMSED 255

Query: 147 VISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGE--VKIADFGVSRIVEETRNNNN 204
                  +V KGL ++H    +H D+KP N++   K    +K+ DFG++  ++       
Sbjct: 256 EAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP------ 309

Query: 205 HNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPL 264
                     ++     GT  + +PE  + +      G+  D+WS+GV+    L G  P 
Sbjct: 310 ---------KQSVKVTTGTAEFAAPEVAEGK----PVGYYTDMWSVGVLSYILLSGLSP- 355

Query: 265 IGFGEKPDLMALICAICFGERLEMPETA----SPEFRRFVRSCLEKDWRKRGTVEELLAY 320
             FG + D    +  +   +   M ++A    S + + F+R  L  D   R T+ + L +
Sbjct: 356 --FGGEND-DETLRNVKSCD-WNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 411

Query: 321 PFVTKRSSSSNIEGL 335
           P++T  ++      +
Sbjct: 412 PWLTPGNAPGRDSQI 426

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  151 bits (384), Expect = 2e-43
 Identities = 76/287 (26%), Positives = 129/287 (44%), Gaps = 38/287 (13%)

Query: 45  NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRH-QAAH---EAEILK 100
           ++ D + L  LG G+ G V+ +R + +   YA+KVL      ++R  Q  H   E  +L 
Sbjct: 4   SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLK--KEIVVRLKQVEHTNDERLMLS 61

Query: 101 RLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQ 160
            +   FI++    F     +I  +M+++E G LF  LR  ++    V    A  V   L+
Sbjct: 62  IVTHPFIIRMWGTFQD-AQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALE 120

Query: 161 YLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIAC 220
           YLH   II+ D+KP N+L++  G +KI DFG ++ V +                     C
Sbjct: 121 YLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT----------------LC 164

Query: 221 MGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAI 280
            GT  Y++PE V ++     Y  + D WS G+++ E L G+ P   F    + M     I
Sbjct: 165 -GTPDYIAPEVVSTK----PYNKSIDWWSFGILIYEMLAGYTP---F-YDSNTMKTYEKI 215

Query: 281 CFGERLEMPETASPEFRRFVRSCLEKDWRKR-----GTVEELLAYPF 322
              E L  P   + + +  +   + +D  +R        E++  +P+
Sbjct: 216 LNAE-LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPW 261

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  150 bits (382), Expect = 2e-43
 Identities = 68/280 (24%), Positives = 120/280 (42%), Gaps = 28/280 (10%)

Query: 54  VLGHGNGGIVYKVRHQKSNSIYALKVLNTT---SSTIIRHQAAHEAEILKRLDSQFIVKC 110
           +LG G+ G V +V   ++    A+K+L                 E ++L+RL  + +++ 
Sbjct: 12  LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71

Query: 111 HAVFYTI-EGEICFVMEHMERGS--LFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQI 167
             V Y   + ++  VME+   G   + DS+   K+       G   +++ GL+YLH   I
Sbjct: 72  VDVLYNEEKQKMYMVMEYCVCGMQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEYLHSQGI 130

Query: 168 IHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYM 227
           +H DIKP NLL+   G +KI+  GV+  +     +                +  G+ A+ 
Sbjct: 131 VHKDIKPGNLLLTTGGTLKISALGVAEALHPFAAD-----------DTCRTSQ-GSPAFQ 178

Query: 228 SPERVDSERWGGDY-GFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERL 286
            PE  +       + GF  D+WS GV +     G YP   F E  ++  L   I  G   
Sbjct: 179 PPEIANGLD---TFSGFKVDIWSAGVTLYNITTGLYP---F-EGDNIYKLFENIGKGS-Y 230

Query: 287 EMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKR 326
            +P    P     ++  LE +  KR ++ ++  + +  K+
Sbjct: 231 AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKK 270

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  148 bits (377), Expect = 4e-43
 Identities = 47/274 (17%), Positives = 96/274 (35%), Gaps = 33/274 (12%)

Query: 45  NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQA-AHEAEILKRLD 103
           +   L  LT L   + G ++K R Q   +   +KVL     +  + +    E   L+   
Sbjct: 8   DFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFS 65

Query: 104 SQFIVKCH-AVFYTIEGEICFVMEHMERGSLFDSLRVRK--KLSEDVISGVAYRVLKGLQ 160
              ++    A           +   M  GSL++ L       + +      A  + +G+ 
Sbjct: 66  HPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMA 125

Query: 161 YLHGMQ--IIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAI 218
           +LH ++  I    +   +++I+     +I+   V    +                     
Sbjct: 126 FLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGR----------------- 168

Query: 219 ACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALIC 278
             M   A+++PE +  +        + D+WS  V++ E +    P          M +  
Sbjct: 169 --MYAPAWVAPEALQKKPE-DTNRRSADMWSFAVLLWELVTREVPFADL----SNMEIGM 221

Query: 279 AICF-GERLEMPETASPEFRRFVRSCLEKDWRKR 311
            +   G R  +P   SP   + ++ C+ +D  KR
Sbjct: 222 KVALEGLRPTIPPGISPHVSKLMKICMNEDPAKR 255

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  150 bits (381), Expect = 5e-43
 Identities = 46/289 (15%), Positives = 96/289 (33%), Gaps = 26/289 (8%)

Query: 50  KKLTVLGHGN----------GGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEIL 99
           K L  L H                          +         SS       + +   +
Sbjct: 56  KALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRM 115

Query: 100 KRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAY---RVL 156
               ++  V         +  +   M+   + +L D +  R  L +       +   ++ 
Sbjct: 116 DPFSTKNTVGQLQPSSP-KVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIA 174

Query: 157 KGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEA 216
           + +++LH   ++H D+KPSN+       VK+ DFG+   +++                  
Sbjct: 175 EAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAY-ATH 233

Query: 217 AIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMAL 276
                GT  YMSPE++     G +Y    D++SLG+++ E L        F  + + + +
Sbjct: 234 TGQV-GTKLYMSPEQIH----GNNYSHKVDIFSLGLILFELLY------SFSTQMERVRI 282

Query: 277 ICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTK 325
           I  +   +   +     P+    V+  L     +R    +++       
Sbjct: 283 ITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFEN 331

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  150 bits (382), Expect = 5e-43
 Identities = 69/306 (22%), Positives = 128/306 (41%), Gaps = 41/306 (13%)

Query: 37  NPTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEA 96
           +  S    +  ++K+   +G G+  +  +  H+ +N  +A+K+++ +           E 
Sbjct: 14  HRNSIQFTDGYEVKE--DIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE-----EI 66

Query: 97  EILKRLDSQ-FIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRV 155
           EIL R      I+    V+      +  V E M+ G L D +  +K  SE   S V + +
Sbjct: 67  EILLRYGQHPNIITLKDVYDD-GKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTI 125

Query: 156 LKGLQYLHGMQIIHGDIKPSNLLINGKGE----VKIADFGVSRIVEETRNNNNHNNNNNN 211
            K ++YLH   ++H D+KPSN+L   +      ++I DFG ++ +             N 
Sbjct: 126 TKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA----------ENG 175

Query: 212 NIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP 271
            +         T  +++PE ++ +     Y  A D+WSLGV++   L G+ P   F   P
Sbjct: 176 LLMTPC----YTANFVAPEVLERQG----YDAACDIWSLGVLLYTMLTGYTP---FANGP 224

Query: 272 D--LMALICAICFGERLEMPE----TASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTK 325
           D     ++  I  G+   +      + S   +  V   L  D  +R T   +L +P++  
Sbjct: 225 DDTPEEILARIGSGK-FSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVH 283

Query: 326 RSSSSN 331
                 
Sbjct: 284 WDQLPQ 289

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  147 bits (374), Expect = 1e-42
 Identities = 61/281 (21%), Positives = 105/281 (37%), Gaps = 38/281 (13%)

Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVF 114
           LG G  G V    ++ +    A+K+++   +         E  I K L+ + +VK +   
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 115 YTIEGEICFVMEHMERGSLFDSLRVRKKLSEDV--------ISGVAYRVLKGLQYLHGMQ 166
                     +E+   G LFD +     + E          ++GV         YLHG+ 
Sbjct: 75  RE-GNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV--------VYLHGIG 125

Query: 167 IIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAY 226
           I H DIKP NLL++ +  +KI+DFG++ +          N             C GT  Y
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-----------MC-GTLPY 173

Query: 227 MSPERVDSERWGGDY-GFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGER 285
           ++PE +       ++     DVWS G+V+   L G  P   + +  D           + 
Sbjct: 174 VAPELLK----RREFHAEPVDVWSCGIVLTAMLAGELP---WDQPSDSCQEYSDWKEKKT 226

Query: 286 LEMPETA-SPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTK 325
              P           +   L ++   R T+ ++    +  K
Sbjct: 227 YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 267

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  146 bits (370), Expect = 4e-42
 Identities = 73/289 (25%), Positives = 113/289 (39%), Gaps = 43/289 (14%)

Query: 45  NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAA---HEAEILKR 101
           + ++L    ++G G  G VY+          A+K         I         EA++   
Sbjct: 5   DFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAM 62

Query: 102 LDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQY 161
           L    I+    V    E  +C VME    G L   L   K++  D++   A ++ +G+ Y
Sbjct: 63  LKHPNIIALRGV-CLKEPNLCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNY 120

Query: 162 LHGM---QIIHGDIKPSNLLINGKGE--------VKIADFGVSRIVEETRNNNNHNNNNN 210
           LH      IIH D+K SN+LI  K E        +KI DFG++R    T   +       
Sbjct: 121 LHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSA------ 174

Query: 211 NNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEK 270
                      G  A+M+PE + +      +    DVWS GV++ E L G  P  G    
Sbjct: 175 ----------AGAYAWMAPEVIRASM----FSKGSDVWSYGVLLWELLTGEVPFRGI--- 217

Query: 271 PDLMALICAICF-GERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELL 318
            D +A+   +      L +P T    F + +  C   D   R +   +L
Sbjct: 218 -DGLAVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNIL 265

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  147 bits (373), Expect = 7e-42
 Identities = 83/292 (28%), Positives = 136/292 (46%), Gaps = 43/292 (14%)

Query: 45  NISDLKKLTVLGHGNGGIVYKVRHQK---SNSIYALKVLNTTSSTIIRHQAAH---EAEI 98
           + S  + L VLG G+ G V+ V+      +  +YA+KVL    +T+          E +I
Sbjct: 22  DPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLK--KATLKVRDRVRTKMERDI 79

Query: 99  LKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKG 158
           L  ++  FIVK H  F T EG++  +++ +  G LF  L      +E+ +      +   
Sbjct: 80  LVEVNHPFIVKLHYAFQT-EGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALA 138

Query: 159 LQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAI 218
           L +LH + II+ D+KP N+L++ +G +K+ DFG+S+                 +I     
Sbjct: 139 LDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKE----------------SIDHEKK 182

Query: 219 A---CMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMA 275
           A   C GT  YM+PE V+       +  + D WS GV++ E L G  P  G   K + M 
Sbjct: 183 AYSFC-GTVEYMAPEVVN----RRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRK-ETMT 236

Query: 276 LICAICFGERLEMPETASPEFRRFVRSCLEKDWRKR-----GTVEELLAYPF 322
           +I       +L MP+  SPE +  +R   +++   R       VEE+  + F
Sbjct: 237 MILK----AKLGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSF 284

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  147 bits (373), Expect = 1e-41
 Identities = 89/332 (26%), Positives = 145/332 (43%), Gaps = 34/332 (10%)

Query: 6   ERRHQQALTLSLPATAANHQFRRRRHHFPTSNPTSPDVE-NISDLKKLTVLGHGNGGIVY 64
                 A   S        Q    +H   T+N T    +  I + + L VLG G  G V+
Sbjct: 12  GGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVF 71

Query: 65  KVRHQ---KSNSIYALKVLNTTSSTIIRH--QAAH---EAEILKRLDSQ-FIVKCHAVFY 115
            VR      +  +YA+KVL    +TI++      H   E ++L+ +    F+V  H  F 
Sbjct: 72  LVRKISGHDTGKLYAMKVLK--KATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ 129

Query: 116 TIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPS 175
           T E ++  +++++  G LF  L  R++ +E  +      ++  L++LH + II+ DIK  
Sbjct: 130 T-ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLE 188

Query: 176 NLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSE 235
           N+L++  G V + DFG+S+  E   +      +           C GT  YM+P+ V   
Sbjct: 189 NILLDSNGHVVLTDFGLSK--EFVADETERAYD----------FC-GTIEYMAPDIVRGG 235

Query: 236 RWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPETASPE 295
             G  +  A D WSLGV++ E L G  P    GEK     +   I   E    P+  S  
Sbjct: 236 DSG--HDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE-PPYPQEMSAL 292

Query: 296 FRRFVRSCLEKDWRKR-----GTVEELLAYPF 322
            +  ++  L KD +KR        +E+  + F
Sbjct: 293 AKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 324

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  153 bits (387), Expect = 1e-41
 Identities = 71/290 (24%), Positives = 129/290 (44%), Gaps = 36/290 (12%)

Query: 45  NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTII-RHQAAH---EAEILK 100
            ++D     ++G G  G VY  R   +  +YA+K L+     I  +        E  +L 
Sbjct: 187 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLD--KKRIKMKQGETLALNERIMLS 244

Query: 101 RLDSQ---FIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLK 157
            + +    FIV     F+T   ++ F+++ M  G L   L      SE  +   A  ++ 
Sbjct: 245 LVSTGDCPFIVCMSYAFHT-PDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIIL 303

Query: 158 GLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAA 217
           GL+++H   +++ D+KP+N+L++  G V+I+D G++    + + +               
Sbjct: 304 GLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH--------------- 348

Query: 218 IACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALI 277
            A +GT  YM+PE +     G  Y  + D +SLG ++ + L GH P      K D   + 
Sbjct: 349 -ASVGTHGYMAPEVLQK---GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK-DKHEID 403

Query: 278 CAICFGERLEMPETASPEFRRFVRSCLEKDWRKR-----GTVEELLAYPF 322
                   +E+P++ SPE R  +   L++D  +R        +E+   PF
Sbjct: 404 RMTLTMA-VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPF 452

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  149 bits (378), Expect = 1e-41
 Identities = 80/303 (26%), Positives = 130/303 (42%), Gaps = 40/303 (13%)

Query: 32  HFPTSNPTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQ 91
               S         +++ + L +LG G  G V  V+ + +   YA+K+L      + + +
Sbjct: 133 EMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKK-EVIVAKDE 191

Query: 92  AAH---EAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVI 148
            AH   E  +L+     F+      F T    +CFVME+   G LF  L   +  SED  
Sbjct: 192 VAHTLTENRVLQNSRHPFLTALKYSFQT-HDRLCFVMEYANGGELFFHLSRERVFSEDRA 250

Query: 149 SGVAYRVLKGLQYLHGMQ-IIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNN 207
                 ++  L YLH  + +++ D+K  NL+++  G +KI DFG+ +             
Sbjct: 251 RFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCK------------- 297

Query: 208 NNNNNIGEAAIA---CMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPL 264
                I + A     C GT  Y++PE ++      DYG A D W LGVV+ E + G  P 
Sbjct: 298 ---EGIKDGATMKTFC-GTPEYLAPEVLEDN----DYGRAVDWWGLGVVMYEMMCGRLPF 349

Query: 265 IGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKR-----GTVEELLA 319
                +  L  LI      E +  P T  PE +  +   L+KD ++R        +E++ 
Sbjct: 350 YNQDHE-KLFELILM----EEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404

Query: 320 YPF 322
           + F
Sbjct: 405 HRF 407

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  148 bits (376), Expect = 2e-41
 Identities = 62/314 (19%), Positives = 123/314 (39%), Gaps = 50/314 (15%)

Query: 42  DVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKR 101
            ++N+   +K  +LG+G+ G V   +        A+K +      I       E ++L  
Sbjct: 12  SLKNLVVSEK--ILGYGSSGTVVF-QGSFQGRPVAVKRMLIDFCDIALM----EIKLLTE 64

Query: 102 LDS-QFIVKCHAVFYTIEGEICFVMEHMERGSLFD-------SLRVRKKLSEDVISGVAY 153
            D    +++ +    T +  +   +E     +L D       S    K   E     +  
Sbjct: 65  SDDHPNVIRYYCSETT-DRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLR 122

Query: 154 RVLKGLQYLHGMQIIHGDIKPSNLLINGKGE-------------VKIADFGVSRIVEETR 200
           ++  G+ +LH ++IIH D+KP N+L++                 + I+DFG+ + ++  +
Sbjct: 123 QIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ 182

Query: 201 NNNNHNNNNNNNIGEAAIACMGTCAYMSPE---RVDSERWGGDYGFAGDVWSLGVVVLEC 257
           ++   N NN            GT  + +PE     ++ +       + D++S+G V    
Sbjct: 183 SSFRTNLNN---------PS-GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYI 232

Query: 258 LV-GHYPLIGFGEKPDLMALICAICF---GERLEMPETASPEFRRFVRSCLEKDWRKRGT 313
           L  G +P   FG+K    + I    F     +     +   E    +   ++ D  KR T
Sbjct: 233 LSKGKHP---FGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPT 289

Query: 314 VEELLAYPFVTKRS 327
             ++L +P    +S
Sbjct: 290 AMKVLRHPLFWPKS 303

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  146 bits (371), Expect = 2e-41
 Identities = 69/298 (23%), Positives = 121/298 (40%), Gaps = 38/298 (12%)

Query: 34  PTSNPTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTII-RHQA 92
               P+      I D     +LG G+ G V+    +K+N  +A+K L      ++     
Sbjct: 4   NKERPSLQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALK--KDVVLMDDDV 61

Query: 93  AH---EAEILKR-LDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVI 148
                E  +L    +  F+      F T +  + FVME++  G L   ++   K      
Sbjct: 62  ECTMVEKRVLSLAWEHPFLTHMFCTFQT-KENLFFVMEYLNGGDLMYHIQSCHKFDLSRA 120

Query: 149 SGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNN 208
           +  A  ++ GLQ+LH   I++ D+K  N+L++  G +KIADFG+ +              
Sbjct: 121 TFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKE------------- 167

Query: 209 NNNNIGEAAIA---CMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLI 265
              N+   A     C GT  Y++PE +  +     Y  + D WS GV++ E L+G  P  
Sbjct: 168 ---NMLGDAKTNTFC-GTPDYIAPEILLGQ----KYNHSVDWWSFGVLLYEMLIGQSPF- 218

Query: 266 GFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKR-GTVEELLAYPF 322
             G+  + +    +I        P     E +  +     ++  KR G   ++  +P 
Sbjct: 219 -HGQDEEEL--FHSIRMDN-PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPL 272

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  147 bits (373), Expect = 2e-41
 Identities = 44/309 (14%), Positives = 85/309 (27%), Gaps = 57/309 (18%)

Query: 49  LKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRL---D 103
           L + TVLG  +     +   Q++   + + V   T    +    Q   E   L+ L    
Sbjct: 80  LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139

Query: 104 SQFIVKCHAVFYTIE-----------------------GEICFVMEHMER------GSLF 134
           +Q   K H  F                               F+   M+         L 
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199

Query: 135 DSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSR 194
                 K L       +  +V++ L  LH   ++H  ++P +++++ +G V +  F    
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV 259

Query: 195 IVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWG-GDYGFAGDVWSLGVV 253
               +  +                         +   +   +       FA D W+LG+ 
Sbjct: 260 RDGASAVSPIG-------------RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA 306

Query: 254 VLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGT 313
           +        P     +    +     I F     +P       R  +   L      R  
Sbjct: 307 IYWIWCADLP---NTD-DAALGGSEWI-FRSCKNIP----QPVRALLEGFLRYPKEDRLL 357

Query: 314 VEELLAYPF 322
             + +  P 
Sbjct: 358 PLQAMETPE 366

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  150 bits (381), Expect = 3e-41
 Identities = 75/289 (25%), Positives = 126/289 (43%), Gaps = 34/289 (11%)

Query: 45  NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTII-RHQAAH---EAEILK 100
             +  ++  VLG G  G V   + + +  +YA K L      I  R   A    E +IL+
Sbjct: 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLE--KKRIKKRKGEAMALNEKQILE 239

Query: 101 RLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLR--VRKKLSEDVISGVAYRVLKG 158
           +++S+F+V     + T +  +C V+  M  G L   +    +    E      A  +  G
Sbjct: 240 KVNSRFVVSLAYAYET-KDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCG 298

Query: 159 LQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAI 218
           L+ LH  +I++ D+KP N+L++  G ++I+D G++  V E               G+   
Sbjct: 299 LEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE---------------GQTIK 343

Query: 219 ACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALIC 278
             +GT  YM+PE V +ER    Y F+ D W+LG ++ E + G  P     +K     +  
Sbjct: 344 GRVGTVGYMAPEVVKNER----YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVER 399

Query: 279 AICFGERLEMPETASPEFRRFVRSCLEKDWRKR-----GTVEELLAYPF 322
            +      E  E  SP+ R      L KD  +R     G+  E+  +P 
Sbjct: 400 LVKEVP-EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPL 447

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  145 bits (368), Expect = 3e-41
 Identities = 61/281 (21%), Positives = 105/281 (37%), Gaps = 38/281 (13%)

Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVF 114
           LG G  G V    ++ +    A+K+++   +         E  I K L+ + +VK +   
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 115 YTIEGEICFVMEHMERGSLFDSLRVRKKLSEDV--------ISGVAYRVLKGLQYLHGMQ 166
                     +E+   G LFD +     + E          ++GV         YLHG+ 
Sbjct: 75  RE-GNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV--------VYLHGIG 125

Query: 167 IIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAY 226
           I H DIKP NLL++ +  +KI+DFG++ +          N             C GT  Y
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-----------MC-GTLPY 173

Query: 227 MSPERVDSERWGGDY-GFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGER 285
           ++PE +       ++     DVWS G+V+   L G  P   + +  D           + 
Sbjct: 174 VAPELLK----RREFHAEPVDVWSCGIVLTAMLAGELP---WDQPSDSCQEYSDWKEKKT 226

Query: 286 LEMPETA-SPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTK 325
              P           +   L ++   R T+ ++    +  K
Sbjct: 227 YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 267

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  149 bits (378), Expect = 5e-41
 Identities = 75/291 (25%), Positives = 124/291 (42%), Gaps = 35/291 (12%)

Query: 45  NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTII-RHQAAH---EAEILK 100
                    VLG G  G V+  + + +  +YA K LN     +  R        E +IL 
Sbjct: 183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLN--KKRLKKRKGYQGAMVEKKILA 240

Query: 101 RLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLF----DSLRVRKKLSEDVISGVAYRVL 156
           ++ S+FIV     F T + ++C VM  M  G +     +         E        +++
Sbjct: 241 KVHSRFIVSLAYAFET-KTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIV 299

Query: 157 KGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEA 216
            GL++LH   II+ D+KP N+L++  G V+I+D G++  VE                 + 
Sbjct: 300 SGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLA--VELKAGQT-----------KT 346

Query: 217 AIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMAL 276
                GT  +M+PE +  E    +Y F+ D ++LGV + E +    P    GEK +   L
Sbjct: 347 KGYA-GTPGFMAPELLLGE----EYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKEL 401

Query: 277 ICAICFGERLEMPETASPEFRRFVRSCLEKDWRKR-----GTVEELLAYPF 322
              +     +  P+  SP  + F  + L+KD  KR     G+ + L  +P 
Sbjct: 402 KQRVLEQA-VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPL 451

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  145 bits (369), Expect = 5e-41
 Identities = 73/302 (24%), Positives = 124/302 (41%), Gaps = 42/302 (13%)

Query: 34  PTSNPTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTII-RHQA 92
              N  + D   ++D   L VLG G+ G V     + ++ +YA+K+L      +I     
Sbjct: 7   KFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILK--KDVVIQDDDV 64

Query: 93  AH---EAEILKRLDSQ-FIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVI 148
                E  +L       F+ + H+ F T    + FVME++  G L   ++   +  E   
Sbjct: 65  ECTMVEKRVLALPGKPPFLTQLHSCFQT-MDRLYFVMEYVNGGDLMYHIQQVGRFKEPHA 123

Query: 149 SGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNN 208
              A  +  GL +L    II+ D+K  N++++ +G +KIADFG+ +              
Sbjct: 124 VFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK-------------- 169

Query: 209 NNNNIGEAAIA---CMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLI 265
              NI +       C GT  Y++PE +  +     YG + D W+ GV++ E L G  P  
Sbjct: 170 --ENIWDGVTTKTFC-GTPDYIAPEIIAYQ----PYGKSVDWWAFGVLLYEMLAGQAPFE 222

Query: 266 GFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKR-----GTVEELLAY 320
           G  E  +L   I        +  P++ S E     +  + K   KR         ++  +
Sbjct: 223 GEDED-ELFQSIME----HNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277

Query: 321 PF 322
            F
Sbjct: 278 AF 279

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  146 bits (370), Expect = 8e-41
 Identities = 78/330 (23%), Positives = 137/330 (41%), Gaps = 41/330 (12%)

Query: 18  PATAANHQFRRRRHHFPTSNPTSPDVENISDLKKLT--VLGHGNGGIVYKVRHQKSNSIY 75
           P         ++   F   +        I D  K+T  VLG G  G V ++ ++++   +
Sbjct: 31  PPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKF 90

Query: 76  ALKVLNTTSSTIIRHQAAHEAEILKRLDSQ-FIVKCHAVF---YTIEGEICFVMEHMERG 131
           ALK+L          +A  E E+  R      IV+   V+   Y     +  VME ++ G
Sbjct: 91  ALKMLQD------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGG 144

Query: 132 SLFDSL--RVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGE---VK 186
            LF  +  R  +  +E   S +   + + +QYLH + I H D+KP NLL   K     +K
Sbjct: 145 ELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILK 204

Query: 187 IADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGD 246
           + DFG ++               +N++         T  Y++PE +  E+    Y  + D
Sbjct: 205 LTDFGFAKETTS-----------HNSLTTPC----YTPYYVAPEVLGPEK----YDKSCD 245

Query: 247 VWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPE----TASPEFRRFVRS 302
           +WSLGV++   L G+ P            +   I  G+  E P       S E +  +R+
Sbjct: 246 MWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ-YEFPNPEWSEVSEEVKMLIRN 304

Query: 303 CLEKDWRKRGTVEELLAYPFVTKRSSSSNI 332
            L+ +  +R T+ E + +P++ + +     
Sbjct: 305 LLKTEPTQRMTITEFMNHPWIMQSTKVPQT 334

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  144 bits (365), Expect = 1e-40
 Identities = 84/304 (27%), Positives = 133/304 (43%), Gaps = 45/304 (14%)

Query: 35  TSNPTSPDVENISDLKKLTVLGHGNGGIVYKVRHQ---KSNSIYALKVLNTTSSTIIRH- 90
           TS    P+       + L VLG G  G V++VR      +  I+A+KVL    + I+R+ 
Sbjct: 5   TSVNRGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLK--KAMIVRNA 62

Query: 91  -QAAH---EAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSED 146
              AH   E  IL+ +   FIV     F T  G++  ++E++  G LF  L       ED
Sbjct: 63  KDTAHTKAERNILEEVKHPFIVDLIYAFQT-GGKLYLILEYLSGGELFMQLEREGIFMED 121

Query: 147 VISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHN 206
                   +   L +LH   II+ D+KP N+++N +G VK+ DFG+ +            
Sbjct: 122 TACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKE----------- 170

Query: 207 NNNNNNIGEAAIA---CMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYP 263
                +I +  +    C GT  YM+PE +        +  A D WSLG ++ + L G  P
Sbjct: 171 -----SIHDGTVTHTFC-GTIEYMAPEILM----RSGHNRAVDWWSLGALMYDMLTGAPP 220

Query: 264 LIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKR-----GTVEELL 318
             G   K   +  I       +L +P   + E R  ++  L+++   R     G   E+ 
Sbjct: 221 FTGENRK-KTIDKILK----CKLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQ 275

Query: 319 AYPF 322
           A+PF
Sbjct: 276 AHPF 279

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  143 bits (363), Expect = 3e-40
 Identities = 75/301 (24%), Positives = 123/301 (40%), Gaps = 43/301 (14%)

Query: 36  SNPTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTII-RHQAAH 94
               S +   I + + + VLG G+ G V   R +++  +YA+KVL      I+       
Sbjct: 12  IGVNSSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLK--KDVILQDDDVEC 69

Query: 95  ---EAEILKRLDSQ-FIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISG 150
              E  IL    +  F+ +    F T    + FVME +  G L   ++  ++  E     
Sbjct: 70  TMTEKRILSLARNHPFLTQLFCCFQT-PDRLFFVMEFVNGGDLMFHIQKSRRFDEARARF 128

Query: 151 VAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNN 210
            A  ++  L +LH   II+ D+K  N+L++ +G  K+ADFG+ +                
Sbjct: 129 YAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKE--------------- 173

Query: 211 NNIGEAAIA---CMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGF 267
             I         C GT  Y++PE +        YG A D W++GV++ E L GH P    
Sbjct: 174 -GICNGVTTATFC-GTPDYIAPEILQEM----LYGPAVDWWAMGVLLYEMLCGHAPFEAE 227

Query: 268 GEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKR------GTVEELLAYP 321
            E  DL   I      + +  P     +    ++S + K+   R      G    +L +P
Sbjct: 228 NED-DLFEAILN----DEVVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHP 282

Query: 322 F 322
           F
Sbjct: 283 F 283

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  143 bits (363), Expect = 4e-40
 Identities = 78/298 (26%), Positives = 125/298 (41%), Gaps = 41/298 (13%)

Query: 37  NPTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTII-RHQAAH- 94
            P+S      SD   L V+G G+ G V   RH+     YA+KVL      I+ + +  H 
Sbjct: 28  GPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQ--KKAILKKKEEKHI 85

Query: 95  --EAEIL-KRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGV 151
             E  +L K +   F+V  H  F T   ++ FV++++  G LF  L+  +   E      
Sbjct: 86  MSERNVLLKNVKHPFLVGLHFSFQT-ADKLYFVLDYINGGELFYHLQRERCFLEPRARFY 144

Query: 152 AYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNN 211
           A  +   L YLH + I++ D+KP N+L++ +G + + DFG+ +                 
Sbjct: 145 AAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCK----------------E 188

Query: 212 NIGEAAIA---CMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFG 268
           NI   +     C GT  Y++PE +  +     Y    D W LG V+ E L G  P   + 
Sbjct: 189 NIEHNSTTSTFC-GTPEYLAPEVLHKQ----PYDRTVDWWCLGAVLYEMLYGLPPF--YS 241

Query: 269 EKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKR----GTVEELLAYPF 322
                M     I     L++    +   R  +   L+KD  KR        E+ ++ F
Sbjct: 242 RNTAEM--YDNILNKP-LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVF 296

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  140 bits (354), Expect = 1e-39
 Identities = 71/274 (25%), Positives = 118/274 (43%), Gaps = 28/274 (10%)

Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHA 112
           LG G  G V    HQ +    A+K+LN     S  +  +   E + LK      I+K + 
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78

Query: 113 VFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDI 172
           V  T   +   VME++  G LFD +    ++ E     +  ++L  + Y H   ++H D+
Sbjct: 79  VIST-PTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDL 137

Query: 173 KPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERV 232
           KP N+L++     KIADFG+S ++ +               GE      G+  Y +PE +
Sbjct: 138 KPENVLLDAHMNAKIADFGLSNMMSD---------------GEFLRTSCGSPNYAAPEVI 182

Query: 233 DSERWGGDY-GFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPET 291
                G  Y G   D+WS GV++   L G  P   F +   +  L   I  G    +PE 
Sbjct: 183 S----GRLYAGPEVDIWSCGVILYALLCGTLP---F-DDEHVPTLFKKIRGGV-FYIPEY 233

Query: 292 ASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTK 325
            +      +   L+ D  KR T++++  + +  +
Sbjct: 234 LNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQ 267

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  141 bits (358), Expect = 2e-39
 Identities = 75/313 (23%), Positives = 118/313 (37%), Gaps = 52/313 (16%)

Query: 30  RHHFPTSNPTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIR 89
           R    T     P + +      +  +G GN G+   +R + +  + A+K +       I 
Sbjct: 3   RAPVTTGPLDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIE--RGAAID 60

Query: 90  HQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDV-- 147
                E    + L    IV+   V  T    +  +ME+   G L++ +    + SED   
Sbjct: 61  ENVQREIINHRSLRHPNIVRFKEVILT-PTHLAIIMEYASGGELYERICNAGRFSEDEAR 119

Query: 148 ------ISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLI--NGKGEVKIADFGVSRIVEET 199
                 +SGV         Y H MQI H D+K  N L+  +    +KI DFG S+     
Sbjct: 120 FFFQQLLSGV--------SYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL- 170

Query: 200 RNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDY-GFAGDVWSLGVVVLECL 258
                              + +GT AY++PE +       +Y G   DVWS GV +   L
Sbjct: 171 --------------HSQPKSTVGTPAYIAPEVLL----RQEYDGKIADVWSCGVTLYVML 212

Query: 259 VGHYPLIGFGEKPDLMAL----ICAICFGERLEMPETA--SPEFRRFVRSCLEKDWRKRG 312
           VG YP   F E P+        I  I   +   +P+    SPE    +      D   R 
Sbjct: 213 VGAYP---F-EDPEEPRDYRKTIQRILSVK-YSIPDDIRISPECCHLISRIFVADPATRI 267

Query: 313 TVEELLAYPFVTK 325
           ++ E+  + +  K
Sbjct: 268 SIPEIKTHSWFLK 280

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  139 bits (353), Expect = 6e-39
 Identities = 73/281 (25%), Positives = 120/281 (42%), Gaps = 27/281 (9%)

Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLN-TTSSTIIRHQAAHEAEILKRLDSQFIVKCHAV 113
           +G GN   V   RH  +    A+K+++ T  +     +   E  I+K L+   IVK   V
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82

Query: 114 FYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIK 173
             T E  +  +ME+   G +FD L    ++ E        +++  +QY H  +I+H D+K
Sbjct: 83  IET-EKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLK 141

Query: 174 PSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVD 233
             NLL++    +KIADFG S                    G    A  G   Y +PE   
Sbjct: 142 AENLLLDADMNIKIADFGFSNEFTV---------------GGKLDAFCGAPPYAAPELFQ 186

Query: 234 SERWGGDY-GFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPETA 292
               G  Y G   DVWSLGV++   + G  P   F +  +L  L   +  G +  +P   
Sbjct: 187 ----GKKYDGPEVDVWSLGVILYTLVSGSLP---F-DGQNLKELRERVLRG-KYRIPFYM 237

Query: 293 SPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNIE 333
           S +    ++  L  +  KRGT+E+++   ++        ++
Sbjct: 238 STDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEEDELK 278

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  145 bits (366), Expect = 6e-39
 Identities = 75/330 (22%), Positives = 130/330 (39%), Gaps = 42/330 (12%)

Query: 6   ERRHQQALTLSLPATAANHQFRRRRHHFPTSNPTSPDVENISDLKKLTVLGHGNGGIVYK 65
           E   Q+     +       + +         N  + D   ++D   L VLG G+ G V  
Sbjct: 300 EELRQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVML 359

Query: 66  VRHQKSNSIYALKVLNTTSSTII-RHQAAH---EAEILKRLDSQ-FIVKCHAVFYTIEGE 120
              + ++ +YA+K+L      +I          E  +L       F+ + H+ F T    
Sbjct: 360 SERKGTDELYAVKILK--KDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT-MDR 416

Query: 121 ICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLIN 180
           + FVME++  G L   ++   +  E      A  +  GL +L    II+ D+K  N++++
Sbjct: 417 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLD 476

Query: 181 GKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIA---CMGTCAYMSPERVDSERW 237
            +G +KIADFG+ +                 NI +       C GT  Y++PE +  +  
Sbjct: 477 SEGHIKIADFGMCK----------------ENIWDGVTTKTFC-GTPDYIAPEIIAYQ-- 517

Query: 238 GGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPETASPEFR 297
              YG + D W+ GV++ E L G  P  G  E  +L   I        +  P++ S E  
Sbjct: 518 --PYGKSVDWWAFGVLLYEMLAGQAPFEGEDED-ELFQSIME----HNVAYPKSMSKEAV 570

Query: 298 RFVRSCLEKDWRKR-----GTVEELLAYPF 322
              +  + K   KR         ++  + F
Sbjct: 571 AICKGLMTKHPGKRLGCGPEGERDIKEHAF 600

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  139 bits (352), Expect = 1e-38
 Identities = 74/297 (24%), Positives = 133/297 (44%), Gaps = 44/297 (14%)

Query: 45  NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTII-RHQAAH---EAEILK 100
            + D   L V+G G+   V  VR +K++ IYA+KV+      +           E  + +
Sbjct: 7   GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVK--KELVNDDEDIDWVQTEKHVFE 64

Query: 101 RLDSQ-FIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGL 159
           +  +  F+V  H+ F T E  + FV+E++  G L   ++ ++KL E+     +  +   L
Sbjct: 65  QASNHPFLVGLHSCFQT-ESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLAL 123

Query: 160 QYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIA 219
            YLH   II+ D+K  N+L++ +G +K+ D+G+ +                  +      
Sbjct: 124 NYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK----------------EGLRPGDTT 167

Query: 220 ---CMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMA- 275
              C GT  Y++PE +  E    DYGF+ D W+LGV++ E + G  P    G   +    
Sbjct: 168 STFC-GTPNYIAPEILRGE----DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN 222

Query: 276 ----LICAICFGERLEMPETASPEFRRFVRSCLEKDWRKR------GTVEELLAYPF 322
               L   I   + + +P + S +    ++S L KD ++R          ++  +PF
Sbjct: 223 TEDYLFQVILEKQ-IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPF 278

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  139 bits (353), Expect = 2e-38
 Identities = 73/308 (23%), Positives = 135/308 (43%), Gaps = 44/308 (14%)

Query: 34  PTSNPTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTII-RHQA 92
              +  +     + D   L V+G G+   V  VR +K++ IYA++V+      +      
Sbjct: 39  TRESGKASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVK--KELVNDDEDI 96

Query: 93  AH---EAEILKRLDSQ-FIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVI 148
                E  + ++  +  F+V  H+ F T E  + FV+E++  G L   ++ ++KL E+  
Sbjct: 97  DWVQTEKHVFEQASNHPFLVGLHSCFQT-ESRLFFVIEYVNGGDLMFHMQRQRKLPEEHA 155

Query: 149 SGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNN 208
              +  +   L YLH   II+ D+K  N+L++ +G +K+ D+G+ +              
Sbjct: 156 RFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK-------------- 201

Query: 209 NNNNIGEAAIA---CMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLI 265
               +         C GT  Y++PE +  E    DYGF+ D W+LGV++ E + G  P  
Sbjct: 202 --EGLRPGDTTSTFC-GTPNYIAPEILRGE----DYGFSVDWWALGVLMFEMMAGRSPFD 254

Query: 266 GFGEKPDLMA-----LICAICFGERLEMPETASPEFRRFVRSCLEKDWRKR------GTV 314
             G   +        L   I   + + +P + S +    ++S L KD ++R         
Sbjct: 255 IVGSSDNPDQNTEDYLFQVILEKQ-IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGF 313

Query: 315 EELLAYPF 322
            ++  +PF
Sbjct: 314 ADIQGHPF 321

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  138 bits (350), Expect = 2e-38
 Identities = 48/291 (16%), Positives = 94/291 (32%), Gaps = 54/291 (18%)

Query: 54  VLGHGNGGIVYKVRH-----QKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIV 108
           +LG G    VY+         K+   + LKV    ++    +      E LK       +
Sbjct: 72  LLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKP-ANPWEFYIGTQLMERLKPSMQHMFM 130

Query: 109 KCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKK-----LSEDVISGVAYRVLKGLQYLH 163
           K ++     +     V E    G+L +++ + K      + + ++   A R+L  ++ +H
Sbjct: 131 KFYSAHLF-QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH 189

Query: 164 GMQIIHGDIKPSNLLING-----------KGEVKIADFGVSRIVEETRNNNNHNNNNNNN 212
             +IIHGDIKP N ++                + + D G S  ++               
Sbjct: 190 DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKG---------- 239

Query: 213 IGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPD 272
                 A   T  +   E +        + +  D + +   V   L G Y      +   
Sbjct: 240 --TIFTAKCETSGFQCVEMLS----NKPWNYQIDYFGVAATVYCMLFGTYM---KVKNEG 290

Query: 273 LMALICAI------------CFGERLEMPETASPEFRRFVRSCLEKDWRKR 311
                  +             F   L +P+         +R  L+K +++ 
Sbjct: 291 GECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH 341

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  134 bits (340), Expect = 5e-37
 Identities = 67/280 (23%), Positives = 107/280 (38%), Gaps = 40/280 (14%)

Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLN-------TTSSTIIRHQAAHEAEILKRLDSQFI 107
           LG G  G V+    ++ N    +K +                 +   E  IL R++   I
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 108 VKCHAVFYTIEGEICFVME-HMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQ 166
           +K   +F   +G    VME H     LF  +    +L E + S +  +++  + YL    
Sbjct: 92  IKVLDIFEN-QGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKD 150

Query: 167 IIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAY 226
           IIH DIK  N++I     +K+ DFG +  +E                G+      GT  Y
Sbjct: 151 IIHRDIKDENIVIAEDFTIKLIDFGSAAYLER---------------GKLFYTFCGTIEY 195

Query: 227 MSPERVDSERWGGDY-GFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGER 285
            +PE +     G  Y G   ++WSLGV +   +    P     E                
Sbjct: 196 CAPEVLM----GNPYRGPELEMWSLGVTLYTLVFEENPFCELEE----------TVEAA- 240

Query: 286 LEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTK 325
           +  P   S E    V   L+    +R T+E+L+  P+VT+
Sbjct: 241 IHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQ 280

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  136 bits (344), Expect = 1e-36
 Identities = 75/282 (26%), Positives = 122/282 (43%), Gaps = 44/282 (15%)

Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHA 112
           LG G  G V   +H+ +    A+K+LN     S  +  +   E + LK      I+K + 
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83

Query: 113 VFYTIEGEICFVMEHMERGSLFDSLRVRKKLSED--------VISGVAYRVLKGLQYLHG 164
           V  T   +I  VME++  G LFD +    +L E         ++SGV         Y H 
Sbjct: 84  VIST-PSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGV--------DYCHR 134

Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTC 224
             ++H D+KP N+L++     KIADFG+S ++ +               GE      G+ 
Sbjct: 135 HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD---------------GEFLRTSCGSP 179

Query: 225 AYMSPERVDSERWGGDY-GFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFG 283
            Y +PE +     G  Y G   D+WS GV++   L G  P   F +   +  L   IC G
Sbjct: 180 NYAAPEVIS----GRLYAGPEVDIWSSGVILYALLCGTLP---F-DDDHVPTLFKKICDG 231

Query: 284 ERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTK 325
                P+  +P     ++  L+ D  KR T++++  + +  +
Sbjct: 232 I-FYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQ 272

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  133 bits (337), Expect = 1e-36
 Identities = 77/274 (28%), Positives = 125/274 (45%), Gaps = 29/274 (10%)

Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTT--SSTIIRHQAAHEAEILKRLDSQFIVKCHA 112
           LG G+ G V    H K+    ALK ++      + +  +   E   LK L    I+K + 
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76

Query: 113 VFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDI 172
           V  T   +I  V+E+   G LFD +  +K+++ED       +++  ++Y H  +I+H D+
Sbjct: 77  VITT-PTDIVMVIEYAG-GELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDL 134

Query: 173 KPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERV 232
           KP NLL++    VKIADFG+S I+ +               G       G+  Y +PE +
Sbjct: 135 KPENLLLDDNLNVKIADFGLSNIMTD---------------GNFLKTSCGSPNYAAPEVI 179

Query: 233 DSERWGGDY-GFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPET 291
           +    G  Y G   DVWS G+V+   LVG  P   F +   +  L   +       MP+ 
Sbjct: 180 N----GKLYAGPEVDVWSCGIVLYVMLVGRLP---F-DDEFIPNLFKKVNSCV-YVMPDF 230

Query: 292 ASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTK 325
            SP  +  +R  +  D  +R T++E+   P+   
Sbjct: 231 LSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNV 264

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  132 bits (335), Expect = 2e-36
 Identities = 60/306 (19%), Positives = 107/306 (34%), Gaps = 49/306 (16%)

Query: 38  PTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAE 97
           P          +     +G G  G V++ + +      A+K+ ++            EAE
Sbjct: 33  PLLVQRTIARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSRE----ERSWFREAE 86

Query: 98  I--LKRLDSQFIVKCHAVFYTIEG---EICFVMEHMERGSLFDSLRVRKKLSEDVISGVA 152
           I     L  + I+   A      G   ++  V ++ E GSLFD L  R  ++ + +  +A
Sbjct: 87  IYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN-RYTVTVEGMIKLA 145

Query: 153 YRVLKGLQYLHG--------MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNN 204
                GL +LH           I H D+K  N+L+   G   IAD G++   +   +  +
Sbjct: 146 LSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTID 205

Query: 205 HNNNNNNNIGEAAIACMGTCAYMSPERVDSERWG--GDYGFAGDVWSLGVVVLECLVGHY 262
              N+           +GT  YM+PE +D        +     D++++G+V  E      
Sbjct: 206 IAPNHR----------VGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCS 255

Query: 263 PLIGF-----------GEKPDLMALICAICF-GERLEMPET-----ASPEFRRFVRSCLE 305
                              P +  +   +C    R  +P       A     + +R C  
Sbjct: 256 IGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWY 315

Query: 306 KDWRKR 311
            +   R
Sbjct: 316 ANGAAR 321

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  131 bits (332), Expect = 3e-36
 Identities = 60/303 (19%), Positives = 107/303 (35%), Gaps = 49/303 (16%)

Query: 48  DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEI--LKRLDSQ 105
           D+  L  +G G  G V++   Q      A+K+ ++            E E+     L  +
Sbjct: 9   DITLLECVGKGRYGEVWRGSWQ--GENVAVKIFSSRD----EKSWFRETELYNTVMLRHE 62

Query: 106 FIVKCHAVFYTIEG---EICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYL 162
            I+   A   T      ++  +  + E GSL+D L+    L       +   +  GL +L
Sbjct: 63  NILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQ-LTTLDTVSCLRIVLSIASGLAHL 121

Query: 163 HGMQ--------IIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIG 214
           H           I H D+K  N+L+   G+  IAD G++ +  ++ N  +  NN      
Sbjct: 122 HIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPR---- 177

Query: 215 EAAIACMGTCAYMSPERVDSE--RWGGDYGFAGDVWSLGVVVLECLVGHYPLIGF----- 267
                 +GT  YM+PE +D        D     D+W+ G+V+ E                
Sbjct: 178 ------VGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKP 231

Query: 268 ------GEKPDLMALICAICF-GERLEMPETAS-----PEFRRFVRSCLEKDWRKRGTVE 315
                    P    +   +C   +R  +P             + ++ C  ++   R T  
Sbjct: 232 PFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTAL 291

Query: 316 ELL 318
            + 
Sbjct: 292 RIK 294

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  131 bits (331), Expect = 6e-36
 Identities = 72/327 (22%), Positives = 123/327 (37%), Gaps = 42/327 (12%)

Query: 9   HQQALTLSLPATAANHQFRRRRHHFPTSNPTSPDVENISDLKKLTVLGHGNGGIVYKVRH 68
           H      S      +H       H     P        S  +   +LG G  G VY    
Sbjct: 5   HHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIR 64

Query: 69  QKSNSIYALKVLN-----TTSSTIIRHQAAHEAEILKRLDSQF--IVKCHAVFYTIEGEI 121
              N   A+K +               +   E  +LK++ S F  +++    F       
Sbjct: 65  VSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER-PDSF 123

Query: 122 CFVMEHME-RGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLIN 180
             ++E  E    LFD +  R  L E++     ++VL+ +++ H   ++H DIK  N+LI+
Sbjct: 124 VLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID 183

Query: 181 G-KGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGG 239
             +GE+K+ DFG   ++++                       GT  Y  PE +       
Sbjct: 184 LNRGELKLIDFGSGALLKD---------------TVYTDFD-GTRVYSPPEWI----RYH 223

Query: 240 DY-GFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRR 298
            Y G +  VWSLG+++ + + G  P   F    +       I  G+ +   +  S E + 
Sbjct: 224 RYHGRSAAVWSLGILLYDMVCGDIP---FEHDEE-------IIRGQ-VFFRQRVSSECQH 272

Query: 299 FVRSCLEKDWRKRGTVEELLAYPFVTK 325
            +R CL      R T EE+  +P++  
Sbjct: 273 LIRWCLALRPSDRPTFEEIQNHPWMQD 299

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  131 bits (331), Expect = 9e-36
 Identities = 60/304 (19%), Positives = 101/304 (33%), Gaps = 49/304 (16%)

Query: 47  SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEI--LKRLDS 104
             ++ +  +G G  G V+  + +      A+KV  TT           E EI     +  
Sbjct: 37  KQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE----EASWFRETEIYQTVLMRH 90

Query: 105 QFIVKCHAVFYTIEG---EICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQY 161
           + I+   A      G   ++  + ++ E GSL+D L+    L    +  +AY  + GL +
Sbjct: 91  ENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLK-STTLDAKSMLKLAYSSVSGLCH 149

Query: 162 LHGMQ--------IIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNI 213
           LH           I H D+K  N+L+   G   IAD G++       N  +   N     
Sbjct: 150 LHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTR--- 206

Query: 214 GEAAIACMGTCAYMSPE--RVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGF---- 267
                  +GT  YM PE       R         D++S G+++ E               
Sbjct: 207 -------VGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ 259

Query: 268 -------GEKPDLMALICAICF-GERLEMPETAS-----PEFRRFVRSCLEKDWRKRGTV 314
                     P    +   +C    R   P   S      +  + +  C   +   R T 
Sbjct: 260 LPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTA 319

Query: 315 EELL 318
             + 
Sbjct: 320 LRVK 323

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  129 bits (327), Expect = 2e-35
 Identities = 67/306 (21%), Positives = 120/306 (39%), Gaps = 60/306 (19%)

Query: 39  TSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEI 98
            +  +++     +  VLG G  G V ++ ++++   +ALK+L          +A  E E+
Sbjct: 12  KNAIIDDYKVTSQ--VLGLGINGKVLQIFNKRTQEKFALKMLQD------CPKARREVEL 63

Query: 99  LKRLDSQ-FIVKCHAVF---YTIEGEICFVMEHMERGSLFDSL--RVRKKLSEDVISGVA 152
             R      IV+   V+   Y     +  VME ++ G LF  +  R  +  +E   S + 
Sbjct: 64  HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIM 123

Query: 153 YRVLKGLQYLHGMQIIHGDIKPSNLLINGKGE---VKIADFGVSRIVEETRNNNNHNNNN 209
             + + +QYLH + I H D+KP NLL   K     +K+ DFG ++               
Sbjct: 124 KSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT------------ 171

Query: 210 NNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGE 269
                                       G  Y  + D+WSLGV++   L G+ P      
Sbjct: 172 ----------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG 203

Query: 270 KPDLMALICAICFGE-RLEMPE--TASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKR 326
                 +   I  G+     PE    S E +  +R+ L+ +  +R T+ E + +P++ + 
Sbjct: 204 LAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 263

Query: 327 SSSSNI 332
           +     
Sbjct: 264 TKVPQT 269

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  130 bits (328), Expect = 2e-35
 Identities = 67/305 (21%), Positives = 114/305 (37%), Gaps = 45/305 (14%)

Query: 34  PTSNPTSPDVEN-ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLN---TTSSTIIR 89
           PT  P   D E   ++ +   +LG G  G V+           A+KV+        + + 
Sbjct: 17  PTPPPGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLS 76

Query: 90  HQA--AHEAEILKRLDSQF----IVKCHAVFYTIEGEICFVMEHMERGS-LFDSLRVRKK 142
                  E  +L ++ +      +++    F T +     V+E       LFD +  +  
Sbjct: 77  DSVTCPLEVALLWKVGAGGGHPGVIRLLDWFET-QEGFMLVLERPLPAQDLFDYITEKGP 135

Query: 143 LSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGK-GEVKIADFGVSRIVEETRN 201
           L E        +V+  +Q+ H   ++H DIK  N+LI+ + G  K+ DFG   ++ +   
Sbjct: 136 LGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHD--- 192

Query: 202 NNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDY-GFAGDVWSLGVVVLECLVG 260
                               GT  Y  PE +        Y      VWSLG+++ + + G
Sbjct: 193 ------------EPYTDFD-GTRVYSPPEWIS----RHQYHALPATVWSLGILLYDMVCG 235

Query: 261 HYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY 320
             P   F    +       I   E L  P   SP+    +R CL      R ++EE+L  
Sbjct: 236 DIP---FERDQE-------ILEAE-LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284

Query: 321 PFVTK 325
           P++  
Sbjct: 285 PWMQT 289

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  129 bits (326), Expect = 4e-35
 Identities = 65/330 (19%), Positives = 120/330 (36%), Gaps = 59/330 (17%)

Query: 29  RRHHFPTSNPTSPD---VENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSS 85
             HH  +S               L+ L V   G  G V+K +    N   A+K+      
Sbjct: 3   HHHHHHSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD- 59

Query: 86  TIIRHQAAHEAEI--LKRLDSQFIVKCHAV---FYTIEGEICFVMEHMERGSLFDSLRVR 140
              +    +E E+  L  +  + I++         +++ ++  +    E+GSL D L+  
Sbjct: 60  ---KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK-A 115

Query: 141 KKLSEDVISGVAYRVLKGLQYLHGMQ----------IIHGDIKPSNLLINGKGEVKIADF 190
             +S + +  +A  + +GL YLH             I H DIK  N+L+       IADF
Sbjct: 116 NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADF 175

Query: 191 GVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSE-RWGGDYGFAGDVWS 249
           G++   E  ++  + +              +GT  YM+PE ++    +  D     D+++
Sbjct: 176 GLALKFEAGKSAGDTHGQ------------VGTRRYMAPEVLEGAINFQRDAFLRIDMYA 223

Query: 250 LGVVVLECLVGHYPLIG------------FGEKPDLMALICAICF-GERLEMPETASPE- 295
           +G+V+ E         G             G+ P L  +   +    +R  + +      
Sbjct: 224 MGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHA 283

Query: 296 ----FRRFVRSCLEKDWRKR---GTVEELL 318
                   +  C + D   R   G V E +
Sbjct: 284 GMAMLCETIEECWDHDAEARLSAGCVGERI 313

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  128 bits (322), Expect = 1e-34
 Identities = 68/306 (22%), Positives = 111/306 (36%), Gaps = 52/306 (16%)

Query: 45  NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEI--LKRL 102
           ++ +LK L ++G G  G VYK          A+KV +  +    R    +E  I  +  +
Sbjct: 11  DLDNLKLLELIGRGRYGAVYKGSLD--ERPVAVKVFSFAN----RQNFINEKNIYRVPLM 64

Query: 103 DS----QFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKG 158
           +     +FIV    V      E   VME+   GSL   L             +A+ V +G
Sbjct: 65  EHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS-LHTSDWVSSCRLAHSVTRG 123

Query: 159 LQYLHGM---------QIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNN 209
           L YLH            I H D+   N+L+   G   I+DFG+S  +   R       +N
Sbjct: 124 LAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDN 183

Query: 210 NNNIGEAAIACMGTCAYMSPERVDSE---RWGGDYGFAGDVWSLGVVVLECLVGHYPLIG 266
                    + +GT  YM+PE ++     R         D+++LG++  E  +    L  
Sbjct: 184 AAI------SEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFP 237

Query: 267 F--------------GEKPDLMALICAICF-GERLEMPET------ASPEFRRFVRSCLE 305
                          G  P    +   +    +R + PE       A    +  +  C +
Sbjct: 238 GESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWD 297

Query: 306 KDWRKR 311
           +D   R
Sbjct: 298 QDAEAR 303

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  121 bits (305), Expect = 4e-32
 Identities = 54/175 (30%), Positives = 82/175 (46%), Gaps = 17/175 (9%)

Query: 28  RRRHHFPTSNPTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--- 84
              HH  +          +   +KL  +G G  G+VYK +      I ALK +   +   
Sbjct: 2   HHHHHHSSGRENLYFQGLMEKYQKLEKVGEGTYGVVYKAKD-SQGRIVALKRIRLDAEDE 60

Query: 85  ---STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMER--GSLFDSLRV 139
              ST IR     E  +LK L    IV    V ++ E  +  V E ME+    + D  + 
Sbjct: 61  GIPSTAIR-----EISLLKELHHPNIVSLIDVIHS-ERCLTLVFEFMEKDLKKVLDENKT 114

Query: 140 RKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSR 194
              L +  I    Y++L+G+ + H  +I+H D+KP NLLIN  G +K+ADFG++R
Sbjct: 115 --GLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLAR 167

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  122 bits (308), Expect = 4e-32
 Identities = 78/360 (21%), Positives = 123/360 (34%), Gaps = 73/360 (20%)

Query: 3   LVRERRHQQALTLSLPATA---------ANHQFRRRRHHFPT------------------ 35
           LVRE + +Q   LS+              ++ +R     FP+                  
Sbjct: 36  LVRESQGKQEYVLSVLWDGLPRHFIIQSLDNLYRLEGEGFPSIPLLIDHLLSTQQPLTKK 95

Query: 36  -----SNPTSPDVENI--SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTII 88
                      D   +   DL     +G GN G V+  R +  N++ A+K    T    +
Sbjct: 96  SGVVLHRAVPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDL 155

Query: 89  RHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRK-KLSEDV 147
           + +   EA ILK+     IV+   V  T +  I  VME ++ G     LR    +L    
Sbjct: 156 KAKFLQEARILKQYSHPNIVRLIGVC-TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKT 214

Query: 148 ISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNN 207
           +  +      G++YL     IH D+   N L+  K  +KI+DFG+SR   +         
Sbjct: 215 LLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADG-------- 266

Query: 208 NNNNNIGEAAIACMGTCAY-----MSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHY 262
                      A  G          +PE ++  R    Y    DVWS G+++ E      
Sbjct: 267 ---------VYAASGGLRQVPVKWTAPEALNYGR----YSSESDVWSFGILLWE------ 307

Query: 263 PLIGFGEKP----DLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELL 318
                G  P            +  G RL  PE       R +  C   +  +R +   + 
Sbjct: 308 -TFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIY 366

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  120 bits (302), Expect = 1e-31
 Identities = 71/346 (20%), Positives = 122/346 (35%), Gaps = 91/346 (26%)

Query: 28  RRRHHFPTSNPTSPDV--ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS- 84
              HH    +  + ++  +++   + L ++G G+ G+V K R++ +  I A+K    +  
Sbjct: 4   HHHHHSSGVDLGTENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDD 63

Query: 85  -----STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMER--GSLFDSL 137
                   +R     E ++LK+L  + +V    V    +     V E ++       +  
Sbjct: 64  DKMVKKIAMR-----EIKLLKQLRHENLVNLLEVCKK-KKRWYLVFEFVDHTILDDLELF 117

Query: 138 RVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVE 197
                L   V+    ++++ G+ + H   IIH DIKP N+L++  G VK+ DFG +R   
Sbjct: 118 P--NGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFAR--- 172

Query: 198 ETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSE----RW---------GGDYGFA 244
                                         +P  V  +    RW            YG A
Sbjct: 173 ---------------------------TLAAPGEVYDDEVATRWYRAPELLVGDVKYGKA 205

Query: 245 GDVWSLGVVVLECLVGHYPLI-GFGEKPDLMALICAIC---------------FGERLEM 288
            DVW++G +V E +    PL  G  +  D +  I                       + +
Sbjct: 206 VDVWAIGCLVTE-MFMGEPLFPGDSDI-DQLYHIMMCLGNLIPRHQELFNKNPVFAGVRL 263

Query: 289 PE------------TASPEFRRFVRSCLEKDWRKRGTVEELLAYPF 322
           PE              S       + CL  D  KR    ELL + F
Sbjct: 264 PEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDF 309

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score =  118 bits (299), Expect = 2e-31
 Identities = 49/153 (32%), Positives = 84/153 (54%), Gaps = 15/153 (9%)

Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS------STIIRHQAAHEAEILKRLD 103
           +K+  +G G  G+VYK R++ +  + ALK +   +      ST IR     E  +LK L+
Sbjct: 6   QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-----EISLLKELN 60

Query: 104 SQFIVKCHAVFYTIEGEICFVMEHMER--GSLFDSLRVRKKLSEDVISGVAYRVLKGLQY 161
              IVK   V +T E ++  V E + +      D+  +   +   +I    +++L+GL +
Sbjct: 61  HPNIVKLLDVIHT-ENKLYLVFEFLHQDLKKFMDASALTG-IPLPLIKSYLFQLLQGLAF 118

Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSR 194
            H  +++H D+KP NLLIN +G +K+ADFG++R
Sbjct: 119 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 151

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  123 bits (311), Expect = 2e-31
 Identities = 53/275 (19%), Positives = 96/275 (34%), Gaps = 49/275 (17%)

Query: 54  VLGHGNGGIVYKVRHQK-SNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHA 112
            + HG  G +Y    +  +     LK L  +     +  A  E + L  +    IV    
Sbjct: 87  CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIV---Q 143

Query: 113 VFYTIEGEICF-------VMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGM 165
           +F  +E            VME++   SL       +KL           +L  L YLH +
Sbjct: 144 IFNFVEHTDRHGDPVGYIVMEYVGGQSLKR--SKGQKLPVAEAIAYLLEILPALSYLHSI 201

Query: 166 QIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCA 225
            +++ D+KP N+++  + ++K+ D G    +                         GT  
Sbjct: 202 GLVYNDLKPENIML-TEEQLKLIDLGAVSRINSFG------------------YLYGTPG 242

Query: 226 YMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGER 285
           + +PE V           A D++++G  +    +      G                 E 
Sbjct: 243 FQAPEIVR-----TGPTVATDIYTVGRTLAALTLDLPTRNGRYVDG----------LPED 287

Query: 286 LEMPETASPEFRRFVRSCLEKDWRKR-GTVEELLA 319
             + +T    + R +R  ++ D R+R  T EE+ A
Sbjct: 288 DPVLKT-YDSYGRLLRRAIDPDPRQRFTTAEEMSA 321

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  119 bits (300), Expect = 2e-31
 Identities = 67/288 (23%), Positives = 116/288 (40%), Gaps = 46/288 (15%)

Query: 47  SDLKKLTVLGHGNGGIVYK---VRHQKSNSIY-ALKVLNTTSSTIIRHQAAHEAEILKRL 102
           ++ KK+ VLG G  G VYK   +   +   I  A+K L   +S     +   EA ++  +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74

Query: 103 DSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQY 161
           D+  + +   +   +   +  + + M  G L D +R  K  +    +     ++ KG+ Y
Sbjct: 75  DNPHVCRLLGI--CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 132

Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACM 221
           L   +++H D+   N+L+     VKI DFG+++++                  E      
Sbjct: 133 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA---------------EEKEYHAE 177

Query: 222 GT---CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP------- 271
           G      +M+ E +        Y    DVWS GV V E       L+ FG KP       
Sbjct: 178 GGKVPIKWMALESILHRI----YTHQSDVWSYGVTVWE-------LMTFGSKPYDGIPAS 226

Query: 272 DLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA 319
           ++ +++     GERL  P   + +    +R C   D   R    EL+ 
Sbjct: 227 EISSILEK---GERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELII 271

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  118 bits (297), Expect = 4e-31
 Identities = 59/223 (26%), Positives = 104/223 (46%), Gaps = 33/223 (14%)

Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS------STIIRHQAAHEAEILKRLD 103
           +KL  +G G  G V+K ++++++ I ALK +          S+ +R     E  +LK L 
Sbjct: 5   EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-----EICLLKELK 59

Query: 104 SQFIVKCHAVFYTIEGEICFVMEHMER--GSLFDSLRVRKKLSEDVISGVAYRVLKGLQY 161
            + IV+ H V ++ + ++  V E  ++     FDS      L  +++    +++LKGL +
Sbjct: 60  HKNIVRLHDVLHS-DKKLTLVFEFCDQDLKKYFDSCNG--DLDPEIVKSFLFQLLKGLGF 116

Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACM 221
            H   ++H D+KP NLLIN  GE+K+A+FG++R         +                +
Sbjct: 117 CHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAE--------------V 162

Query: 222 GTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPL 264
            T  Y  P+ +   +    Y  + D+WS G +  E      PL
Sbjct: 163 VTLWYRPPDVLFGAK---LYSTSIDMWSAGCIFAELANAGRPL 202

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  121 bits (304), Expect = 7e-31
 Identities = 63/278 (22%), Positives = 115/278 (41%), Gaps = 33/278 (11%)

Query: 47  SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQF 106
           +D+     LG G  G VY+   +K +   A+K L   +      +   EA ++K +    
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPN 277

Query: 107 IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVR--KKLSEDVISGVAYRVLKGLQYLHG 164
           +V+   V  T E     + E M  G+L D LR    +++S  V+  +A ++   ++YL  
Sbjct: 278 LVQLLGVC-TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 336

Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTC 224
              IH ++   N L+     VK+ADFG+SR++               +   A        
Sbjct: 337 KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTG-------------DTYTAHAGAKFPI 383

Query: 225 AYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP----DLMALICAI 280
            + +PE +   +    +    DVW+ GV++ E       +  +G  P    DL  +   +
Sbjct: 384 KWTAPESLAYNK----FSIKSDVWAFGVLLWE-------IATYGMSPYPGIDLSQVYELL 432

Query: 281 CFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELL 318
               R+E PE    +    +R+C + +   R +  E+ 
Sbjct: 433 EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIH 470

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  116 bits (293), Expect = 1e-30
 Identities = 72/281 (25%), Positives = 120/281 (42%), Gaps = 51/281 (18%)

Query: 58  GNGG--IVYKVRHQKSNSIYALKVLNTT----SSTIIRHQAAHEAEILKRLDSQFIVKCH 111
           G GG   VY       N   A+K +         T+ R +   E     +L  Q IV   
Sbjct: 20  GGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFE--REVHNSSQLSHQNIV--- 74

Query: 112 AVF-YTIEGEICF-VMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIH 169
           ++     E +  + VME++E  +L + +     LS D       ++L G+++ H M+I+H
Sbjct: 75  SMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVH 134

Query: 170 GDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSP 229
            DIKP N+LI+    +KI DFG+++ + ET      +    N++       +GT  Y SP
Sbjct: 135 RDIKPQNILIDSNKTLKIFDFGIAKALSET------SLTQTNHV-------LGTVQYFSP 181

Query: 230 ERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGF-GEKPDLMALICAICFGERL-- 286
           E+      G       D++S+G+V+ E LVG  P   F GE    +A+       + +  
Sbjct: 182 EQAK----GEATDECTDIYSIGIVLYEMLVGEPP---FNGETAVSIAI-------KHIQD 227

Query: 287 EMPETAS-------PEFRRFVRSCLEKDWRKR-GTVEELLA 319
            +P   +             +    EKD   R  T++E+  
Sbjct: 228 SVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKD 268

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  116 bits (293), Expect = 2e-30
 Identities = 59/283 (20%), Positives = 101/283 (35%), Gaps = 51/283 (18%)

Query: 54  VLGHGNGGIVYKVRHQKSNSIYALKVLNTTSST----IIRHQAAHEAEILKRLDSQFIVK 109
           ++G G  G VY+        I ALK+++ T S+      R Q   EA    RL    +V 
Sbjct: 41  LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQ--REARTAGRLQEPHVV- 97

Query: 110 CHAVF-YTIEGEICF-VMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQI 167
              +  +       +  M  +    L   LR +  L+      +  ++   L   H    
Sbjct: 98  --PIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGA 155

Query: 168 IHGDIKPSNLLINGKGEVKIADFGVSRIVEE---TRNNNNHNNNNNNNIGEAAIACMGTC 224
            H D+KP N+L++      + DFG++    +   T+                    +GT 
Sbjct: 156 THRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLG----------------NTVGTL 199

Query: 225 AYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGE 284
            YM+PER           +  D+++L  V+ ECL G  P  G     D ++++       
Sbjct: 200 YYMAPERFS----ESHATYRADIYALTCVLYECLTGSPPYQG-----DQLSVM----GAH 246

Query: 285 RLEMPETAS-------PEFRRFVRSCLEKDWRKR-GTVEELLA 319
             +     S         F   +   + K+   R  T  +L A
Sbjct: 247 INQAIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA 289

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  116 bits (292), Expect = 2e-30
 Identities = 52/162 (32%), Positives = 87/162 (53%), Gaps = 16/162 (9%)

Query: 43  VENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-----STIIRHQAAHEAE 97
           + + S  K+L  LG+G    VYK  ++ +    ALK +   S     ST IR     E  
Sbjct: 1   MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIR-----EIS 55

Query: 98  ILKRLDSQFIVKCHAVFYTIEGEICFVMEHMER--GSLFDSLRVR---KKLSEDVISGVA 152
           ++K L  + IV+ + V +T E ++  V E M+       DS  V    + L  +++    
Sbjct: 56  LMKELKHENIVRLYDVIHT-ENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQ 114

Query: 153 YRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSR 194
           +++L+GL + H  +I+H D+KP NLLIN +G++K+ DFG++R
Sbjct: 115 WQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLAR 156

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  115 bits (291), Expect = 3e-30
 Identities = 52/153 (33%), Positives = 76/153 (49%), Gaps = 17/153 (11%)

Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS------STIIRHQAAHEAEILKRLD 103
             L  +G G  G+VYK ++      +ALK +          ST IR     E  ILK L 
Sbjct: 5   HGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIR-----EISILKELK 58

Query: 104 SQFIVKCHAVFYTIEGEICFVMEHMER--GSLFDSLRVRKKLSEDVISGVAYRVLKGLQY 161
              IVK + V +T +  +  V EH+++    L D       L          ++L G+ Y
Sbjct: 59  HSNIVKLYDVIHT-KKRLVLVFEHLDQDLKKLLDVCEG--GLESVTAKSFLLQLLNGIAY 115

Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSR 194
            H  +++H D+KP NLLIN +GE+KIADFG++R
Sbjct: 116 CHDRRVLHRDLKPQNLLINREGELKIADFGLAR 148

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  115 bits (291), Expect = 3e-30
 Identities = 75/284 (26%), Positives = 119/284 (41%), Gaps = 52/284 (18%)

Query: 58  GNGG--IVYKVRHQKSNSIYALKVLNTT----SSTIIRHQAAHEAEILKRLDSQFIVKCH 111
           G GG   V+  R  + +   A+KVL        S  +R +   EA+    L+   IV   
Sbjct: 21  GFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFR--REAQNAAALNHPAIV--- 75

Query: 112 AVF-----YTIEGEICF-VMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGM 165
           AV+      T  G + + VME+++  +L D +     ++      V     + L + H  
Sbjct: 76  AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQN 135

Query: 166 QIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCA 225
            IIH D+KP+N++I+    VK+ DFG++R + ++ N+                A +GT  
Sbjct: 136 GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTA-----------AVIGTAQ 184

Query: 226 YMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGF-GEKPDLMALICAICFGE 284
           Y+SPE+      G       DV+SLG V+ E L G  P   F G+ P  +A        +
Sbjct: 185 YLSPEQAR----GDSVDARSDVYSLGCVLYEVLTGEPP---FTGDSPVSVAY-------Q 230

Query: 285 RL-EMPETAS-------PEFRRFVRSCLEKDWRKR-GTVEELLA 319
            + E P   S        +    V   L K+   R  T  E+ A
Sbjct: 231 HVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRA 274

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  115 bits (291), Expect = 4e-30
 Identities = 67/321 (20%), Positives = 121/321 (37%), Gaps = 87/321 (27%)

Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS------STIIRHQAAHEAEILKRLD 103
           +K+  +G G+ G+V+K R++ +  I A+K    +          +R     E  +LK+L 
Sbjct: 6   EKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALR-----EIRMLKQLK 60

Query: 104 SQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKK-LSEDVISGVAYRVLKGLQYL 162
              +V    VF   +  +  V E+ +  ++   L   ++ + E ++  + ++ L+ + + 
Sbjct: 61  HPNLVNLLEVFRR-KRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFC 118

Query: 163 HGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMG 222
           H    IH D+KP N+LI     +K+ DFG +R                            
Sbjct: 119 HKHNCIHRDVKPENILITKHSVIKLCDFGFAR---------------------------- 150

Query: 223 TCAYMSPERVDSE----RW--------GG-DYGFAGDVWSLGVVVLECLVGHYPLI-GFG 268
                 P     +    RW        G   YG   DVW++G V  E L+   PL  G  
Sbjct: 151 --LLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAE-LLSGVPLWPGKS 207

Query: 269 EKPDLMALICAIC---------------FGERLEMPE------------TASPEFRRFVR 301
           +  D + LI                   +   +++P+              S      ++
Sbjct: 208 DV-DQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLK 266

Query: 302 SCLEKDWRKRGTVEELLAYPF 322
            CL  D  +R T E+LL +P+
Sbjct: 267 GCLHMDPTERLTCEQLLHHPY 287

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  116 bits (292), Expect = 5e-30
 Identities = 79/331 (23%), Positives = 132/331 (39%), Gaps = 68/331 (20%)

Query: 37  NPTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS------STIIRH 90
           +   P  + +S  +KL  +G G  G V+K RH+K+    ALK +   +       T +R 
Sbjct: 7   SVECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR- 65

Query: 91  QAAHEAEILKRLDSQFIVKCHAVFYT-------IEGEICFVMEHMER--GSLFDSLRVRK 141
               E +IL+ L  + +V    +  T        +G I  V +  E     L  ++ V  
Sbjct: 66  ----EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV-- 119

Query: 142 KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRN 201
           K +   I  V   +L GL Y+H  +I+H D+K +N+LI   G +K+ADFG++R     +N
Sbjct: 120 KFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKN 179

Query: 202 NNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGH 261
           +  +   N           + T  Y  PE +  ER   DYG   D+W  G ++ E     
Sbjct: 180 SQPNRYTN----------RVVTLWYRPPELLLGER---DYGPPIDLWGAGCIMAEMWTRS 226

Query: 262 YPLI-GFGEKPDLMALICAICFG---ERL-----EMPETASPEFRRFVRSCLEK------ 306
            P++ G  E    +ALI  +C G     +             E  +  +  ++       
Sbjct: 227 -PIMQGNTE-QHQLALISQLC-GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYV 283

Query: 307 ---------------DWRKRGTVEELLAYPF 322
                          D  +R   ++ L + F
Sbjct: 284 RDPYALDLIDKLLVLDPAQRIDSDDALNHDF 314

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  115 bits (290), Expect = 5e-30
 Identities = 57/249 (22%), Positives = 92/249 (36%), Gaps = 66/249 (26%)

Query: 45  NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVL---------NTTSSTIIRHQAAHE 95
             S  + +  +G G  G VYK R   S    ALK +              + +R     E
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVR-----E 61

Query: 96  AEILKRLDSQF---IVKCHAVFYT----IEGEICFVMEHMER--GSLFDSLRVRKKLSED 146
             +L+RL++     +V+   V  T     E ++  V EH+++   +  D       L  +
Sbjct: 62  VALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAP-PPGLPAE 120

Query: 147 VISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHN 206
            I  +  + L+GL +LH   I+H D+KP N+L+   G VK+ADFG++R            
Sbjct: 121 TIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLAR------------ 168

Query: 207 NNNNNNIGEAAIACMGTCAYMSPERVDSE---RW--------GGDYGFAGDVWSLGVVVL 255
                              Y     +       W           Y    D+WS+G +  
Sbjct: 169 ------------------IYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFA 210

Query: 256 ECLVGHYPL 264
           E +    PL
Sbjct: 211 E-MFRRKPL 218

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  115 bits (291), Expect = 9e-30
 Identities = 72/285 (25%), Positives = 119/285 (41%), Gaps = 37/285 (12%)

Query: 47  SDLKKLTVLGHGNGGIVYK---VRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLD 103
           +++    V+G G  G V         K     A+K L    +   R     EA I+ + D
Sbjct: 45  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 104

Query: 104 SQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQYL 162
              I++   V  T    +  V E+ME GSL   LR    + +   + G+   +  G++YL
Sbjct: 105 HPNIIRLEGVV-TKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL 163

Query: 163 HGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMG 222
             M  +H D+   N+LIN     K++DFG+ R++E+                EAA    G
Sbjct: 164 SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLED--------------DPEAAYTTRG 209

Query: 223 T---CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP----DLMA 275
                 + SPE +   +    +  A DVWS G+V+ E       ++ +GE+P        
Sbjct: 210 GKIPIRWTSPEAIAYRK----FTSASDVWSYGIVLWE-------VMSYGERPYWEMSNQD 258

Query: 276 LICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY 320
           +I A+  G RL  P        + +  C +KD   R   E++++ 
Sbjct: 259 VIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSI 303

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  115 bits (289), Expect = 1e-29
 Identities = 67/286 (23%), Positives = 121/286 (42%), Gaps = 38/286 (13%)

Query: 47  SDLKKLTVLGHGNGGIVYK----VRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRL 102
           S + +  V+G G  G VYK        K     A+K L    +   R     EA I+ + 
Sbjct: 44  SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 103

Query: 103 DSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQY 161
               I++   V  +    +  + E+ME G+L   LR +  + S   + G+   +  G++Y
Sbjct: 104 SHHNIIRLEGVI-SKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKY 162

Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACM 221
           L  M  +H D+   N+L+N     K++DFG+SR++E+                EA     
Sbjct: 163 LANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED--------------DPEATYTTS 208

Query: 222 GT---CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP----DLM 274
           G      + +PE +   +    +  A DVWS G+V+ E       ++ +GE+P       
Sbjct: 209 GGKIPIRWTAPEAISYRK----FTSASDVWSFGIVMWE-------VMTYGERPYWELSNH 257

Query: 275 ALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY 320
            ++ AI  G RL  P        + +  C +++  +R    ++++ 
Sbjct: 258 EVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSI 303

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  114 bits (287), Expect = 1e-29
 Identities = 68/285 (23%), Positives = 119/285 (41%), Gaps = 37/285 (12%)

Query: 47  SDLKKLTVLGHGNGGIVYK--VRHQKSNSIY-ALKVLNTTSSTIIRHQAAHEAEILKRLD 103
           S +    ++G G+ G V    +R      +  A+K L    +   R     EA I+ + D
Sbjct: 49  SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFD 108

Query: 104 SQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQYL 162
              I++   V  T       V E+ME GSL   LR    + +   + G+   V  G++YL
Sbjct: 109 HPNIIRLEGVV-TRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYL 167

Query: 163 HGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMG 222
             +  +H D+   N+L++     K++DFG+SR++E+                +AA    G
Sbjct: 168 SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP--------------DAAYTTTG 213

Query: 223 T---CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP----DLMA 275
                 + +PE +        +  A DVWS GVV+ E       ++ +GE+P        
Sbjct: 214 GKIPIRWTAPEAIAFRT----FSSASDVWSFGVVMWE-------VLAYGERPYWNMTNRD 262

Query: 276 LICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY 320
           +I ++  G RL  P        + +  C  KD  +R    ++++ 
Sbjct: 263 VISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSV 307

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  114 bits (287), Expect = 2e-29
 Identities = 48/152 (31%), Positives = 79/152 (51%), Gaps = 15/152 (9%)

Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNT-----TSSTIIRHQAAHEAEILKRLDS 104
            KL  LG G    VYK + + ++++ ALK +          T IR     E  +LK L  
Sbjct: 5   IKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR-----EVSLLKDLKH 59

Query: 105 QFIVKCHAVFYTIEGEICFVMEHMER--GSLFDSLRVRKKLSEDVISGVAYRVLKGLQYL 162
             IV  H + +T E  +  V E++++      D       ++   +    +++L+GL Y 
Sbjct: 60  ANIVTLHDIIHT-EKSLTLVFEYLDKDLKQYLDDCGN--IINMHNVKLFLFQLLRGLAYC 116

Query: 163 HGMQIIHGDIKPSNLLINGKGEVKIADFGVSR 194
           H  +++H D+KP NLLIN +GE+K+ADFG++R
Sbjct: 117 HRQKVLHRDLKPQNLLINERGELKLADFGLAR 148

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  113 bits (286), Expect = 2e-29
 Identities = 71/292 (24%), Positives = 114/292 (39%), Gaps = 42/292 (14%)

Query: 47  SDLKKLTVLGHGNGGIVYKVRHQKSNSIY----ALKVLNTTSSTIIRHQAAHEAEILKRL 102
             LKK+  LG G+ G V    +  +N       A+K L   +    R     E +IL+ L
Sbjct: 31  RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL 90

Query: 103 DSQFIVKCHAVFYTIEGE-ICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQY 161
             + I+K            +  VME++  GSL D L  R  +    +   A ++ +G+ Y
Sbjct: 91  YHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLP-RHSIGLAQLLLFAQQICEGMAY 149

Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACM 221
           LH    IH D+   N+L++    VKI DFG+++ V E                      +
Sbjct: 150 LHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE----------------YYRV 193

Query: 222 GTCA-----YMSPERVDSERWGGDYGFAGDVWSLGVVVLECL-VGHYPLIGFGEKPDLMA 275
                    + +PE +   +    + +A DVWS GV + E L           +  +L+ 
Sbjct: 194 REDGDSPVFWYAPECLKEYK----FYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIG 249

Query: 276 ----------LICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEEL 317
                     L   +  GERL  P+    E    +++C E +   R T E L
Sbjct: 250 IAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENL 301

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  112 bits (283), Expect = 4e-29
 Identities = 68/298 (22%), Positives = 110/298 (36%), Gaps = 52/298 (17%)

Query: 47  SDLKKLTVLGHGNGGIVYK----VRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRL 102
             LK++  LG G+ G V           +    A+K L   S          E EIL+ L
Sbjct: 21  RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL 80

Query: 103 DSQFIVKCHAVFYTIEGE-ICFVMEHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQ 160
             + IVK   +     G  I  +ME +  GSL + L   K K++       A ++ KG+ 
Sbjct: 81  YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMD 140

Query: 161 YLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIAC 220
           YL   Q +H D+   N+L+  + +VKI DFG+++ +E  +              E     
Sbjct: 141 YLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK--------------EYYTVK 186

Query: 221 MGT---CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALI 277
                   + +PE +   +    +  A DVWS GV + E       L+ + +       +
Sbjct: 187 DDRDSPVFWYAPECLMQSK----FYIASDVWSFGVTLHE-------LLTYCDSDSSPMAL 235

Query: 278 CAICF------------------GERLEMPETASPEFRRFVRSCLEKDWRKRGTVEEL 317
                                  G+RL  P     E  + +R C E     R + + L
Sbjct: 236 FLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNL 293

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  112 bits (282), Expect = 4e-29
 Identities = 72/289 (24%), Positives = 113/289 (39%), Gaps = 48/289 (16%)

Query: 47  SDLKKLTVLGHGNGGIVYK---VRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLD 103
             ++    +G G  G V++   +  +      A+K     +S  +R +   EA  +++ D
Sbjct: 15  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 74

Query: 104 SQFIVKCHAVFYTIEGE-ICFVMEHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQY 161
              IVK   V   I    +  +ME    G L   L+VRK  L    +   AY++   L Y
Sbjct: 75  HPHIVKLIGV---ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAY 131

Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACM 221
           L   + +H DI   N+L++    VK+ DFG+SR +E+                       
Sbjct: 132 LESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED----------------STYYKAS 175

Query: 222 GT---CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP------- 271
                  +M+PE ++  R    +  A DVW  GV + E       ++  G KP       
Sbjct: 176 KGKLPIKWMAPESINFRR----FTSASDVWMFGVCMWE-------ILMHGVKPFQGVKNN 224

Query: 272 DLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY 320
           D++  I     GERL MP    P     +  C   D  +R    EL A 
Sbjct: 225 DVIGRIEN---GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 270

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  113 bits (284), Expect = 4e-29
 Identities = 66/288 (22%), Positives = 115/288 (39%), Gaps = 46/288 (15%)

Query: 47  SDLKKLTVLGHGNGGIVYK---VRHQKSNSIY-ALKVLNTTSSTIIRHQAAHEAEILKRL 102
           ++ KK+ VLG G  G VYK   +   +   I  A+K L   +S     +   EA ++  +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74

Query: 103 DSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQY 161
           D+  + +   +   +   +  + + M  G L D +R  K  +    +     ++ KG+ Y
Sbjct: 75  DNPHVCRLLGI--CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 132

Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACM 221
           L   +++H D+   N+L+     VKI DFG+++++                  E      
Sbjct: 133 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA---------------EEKEYHAE 177

Query: 222 GT---CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP------- 271
           G      +M+ E +        Y    DVWS GV V E       L+ FG KP       
Sbjct: 178 GGKVPIKWMALESILHRI----YTHQSDVWSYGVTVWE-------LMTFGSKPYDGIPAS 226

Query: 272 DLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA 319
           ++ +++     GERL  P   + +    +  C   D   R    EL+ 
Sbjct: 227 EISSILEK---GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELII 271

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  113 bits (284), Expect = 6e-29
 Identities = 46/156 (29%), Positives = 73/156 (46%), Gaps = 19/156 (12%)

Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS---------STIIRHQAAHEAEILK 100
           +KL  LG G    VYK R + +N I A+K +              T +R     E ++L+
Sbjct: 13  EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALR-----EIKLLQ 67

Query: 101 RLDSQFIVKCHAVFYTIEGEICFVMEHMER--GSLFDSLRVRKKLSEDVISGVAYRVLKG 158
            L    I+     F   +  I  V + ME     +     +   L+   I       L+G
Sbjct: 68  ELSHPNIIGLLDAFGH-KSNISLVFDFMETDLEVIIKDNSL--VLTPSHIKAYMLMTLQG 124

Query: 159 LQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSR 194
           L+YLH   I+H D+KP+NLL++  G +K+ADFG+++
Sbjct: 125 LEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAK 160

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  112 bits (283), Expect = 7e-29
 Identities = 52/247 (21%), Positives = 97/247 (39%), Gaps = 64/247 (25%)

Query: 45  NISDLKKLTVLGHGNGGIVYKVRHQKS-NSIYALKVLNTTS------STIIRHQAAHEAE 97
                + +  +G G  G V+K R  K+     ALK +   +       + IR     E  
Sbjct: 9   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR-----EVA 63

Query: 98  ILKRLDSQF---IVK----CHAVFYTIEGEICFVMEHMER--GSLFDSLRVRKKLSEDVI 148
           +L+ L++     +V+    C       E ++  V EH+++   +  D +     +  + I
Sbjct: 64  VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVP-EPGVPTETI 122

Query: 149 SGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNN 208
             + +++L+GL +LH  +++H D+KP N+L+   G++K+ADFG++R              
Sbjct: 123 KDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR-------------- 168

Query: 209 NNNNIGEAAIACMGTCAYMSPERVDSE---RW--------GGDYGFAGDVWSLGVVVLEC 257
                            Y     + S     W           Y    D+WS+G +  E 
Sbjct: 169 ----------------IYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAE- 211

Query: 258 LVGHYPL 264
           +    PL
Sbjct: 212 MFRRKPL 218

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  112 bits (281), Expect = 1e-28
 Identities = 66/288 (22%), Positives = 116/288 (40%), Gaps = 46/288 (15%)

Query: 47  SDLKKLTVLGHGNGGIVYK---VRHQKSNSIY-ALKVLNTTSSTIIRHQAAHEAEILKRL 102
           ++L+KL VLG G  G V+K   +   +S  I   +KV+   S              +  L
Sbjct: 13  TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL 72

Query: 103 DSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQY 161
           D   IV+   +       +  V +++  GSL D +R  +  L   ++     ++ KG+ Y
Sbjct: 73  DHAHIVRLLGL--CPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYY 130

Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACM 221
           L    ++H ++   N+L+    +V++ADFGV+ ++                  +  +   
Sbjct: 131 LEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPP---------------DDKQLLYS 175

Query: 222 GT---CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP------- 271
                  +M+ E +   +    Y    DVWS GV V E       L+ FG +P       
Sbjct: 176 EAKTPIKWMALESIHFGK----YTHQSDVWSYGVTVWE-------LMTFGAEPYAGLRLA 224

Query: 272 DLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA 319
           ++  L+     GERL  P+  + +    +  C   D   R T +EL  
Sbjct: 225 EVPDLLEK---GERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELAN 269

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  111 bits (279), Expect = 1e-28
 Identities = 65/278 (23%), Positives = 116/278 (41%), Gaps = 45/278 (16%)

Query: 54  VLGHGNGGIVYK--VRHQKSNSIYALKVL-NTTSSTIIRHQAAHEAEILKRLDSQFIVKC 110
            LG GN G V K   + +K     A+K+L N  +   ++ +   EA ++++LD+ +IV+ 
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83

Query: 111 HAVFYTIEGE-ICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIH 169
             +    E E    VME  E G L   L+  + + +  I  + ++V  G++YL     +H
Sbjct: 84  IGI---CEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVH 140

Query: 170 GDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGT---CAY 226
            D+   N+L+  +   KI+DFG+S+ +    N                 A         +
Sbjct: 141 RDLAARNVLLVTQHYAKISDFGLSKALRADEN--------------YYKAQTHGKWPVKW 186

Query: 227 MSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP-------DLMALICA 279
            +PE ++  +    +    DVWS GV++ E          +G+KP       ++ A++  
Sbjct: 187 YAPECINYYK----FSSKSDVWSFGVLMWE-------AFSYGQKPYRGMKGSEVTAMLEK 235

Query: 280 ICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEEL 317
              GER+  P     E    +  C   D   R     +
Sbjct: 236 ---GERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAV 270

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  115 bits (289), Expect = 2e-28
 Identities = 74/303 (24%), Positives = 120/303 (39%), Gaps = 49/303 (16%)

Query: 34  PTSNPTSPDVE-NISDLKKLTVLGHGNGGIVYK--VRHQKSNSIY-ALKVLNTTSSTIIR 89
             + P++ D E     ++    +G G  G V++      ++ ++  A+K     +S  +R
Sbjct: 376 TYTMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVR 435

Query: 90  HQAAHEAEILKRLDSQFIVKCHAVFYTIEGE-ICFVMEHMERGSLFDSLRVRK-KLSEDV 147
            +   EA  +++ D   IVK   V   I    +  +ME    G L   L+VRK  L    
Sbjct: 436 EKFLQEALTMRQFDHPHIVKLIGV---ITENPVWIIMELCTLGELRSFLQVRKFSLDLAS 492

Query: 148 ISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNN 207
           +   AY++   L YL   + +H DI   N+L++    VK+ DFG+SR +E+         
Sbjct: 493 LILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED--------- 543

Query: 208 NNNNNIGEAAIACMGT---CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPL 264
                                +M+PE ++       +  A DVW  GV + E       +
Sbjct: 544 -------STYYKASKGKLPIKWMAPESINF----RRFTSASDVWMFGVCMWE-------I 585

Query: 265 IGFGEKP-------DLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEEL 317
           +  G KP       D++  I     GERL MP    P     +  C   D  +R    EL
Sbjct: 586 LMHGVKPFQGVKNNDVIGRIEN---GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTEL 642

Query: 318 LAY 320
            A 
Sbjct: 643 KAQ 645

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  109 bits (275), Expect = 2e-28
 Identities = 68/280 (24%), Positives = 115/280 (41%), Gaps = 39/280 (13%)

Query: 47  SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQF 106
           S+L  +  +G G  G+V+       + + A+K +   + +        EAE++ +L    
Sbjct: 8   SELTFVQEIGSGQFGLVHLGYWLNKDKV-AIKTIREGAMS--EEDFIEEAEVMMKLSHPK 64

Query: 107 IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQYLHGM 165
           +V+ + V    +  IC V E ME G L D LR ++   + + + G+   V +G+ YL   
Sbjct: 65  LVQLYGVC-LEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 123

Query: 166 QIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGT-- 223
            +IH D+   N L+     +K++DFG++R V +                +   +  GT  
Sbjct: 124 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD----------------DQYTSSTGTKF 167

Query: 224 -CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP----DLMALIC 278
              + SPE     R    Y    DVWS GV++ E       +   G+ P        ++ 
Sbjct: 168 PVKWASPEVFSFSR----YSSKSDVWSFGVLMWE-------VFSEGKIPYENRSNSEVVE 216

Query: 279 AICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELL 318
            I  G RL  P  AS    + +  C  +    R     LL
Sbjct: 217 DISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLL 256

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  110 bits (276), Expect = 3e-28
 Identities = 69/295 (23%), Positives = 115/295 (38%), Gaps = 46/295 (15%)

Query: 47  SDLKKLTVLGHGNGGIVYK----VRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRL 102
             LK L  LG GN G V           +  + A+K L  ++   +R     E EILK L
Sbjct: 10  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER-EIEILKSL 68

Query: 103 DSQFIVKCHAVFYTIEGE-ICFVMEHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQ 160
               IVK   V Y+     +  +ME++  GSL D L+  K ++    +     ++ KG++
Sbjct: 69  QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGME 128

Query: 161 YLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIAC 220
           YL   + IH D+   N+L+  +  VKI DFG+++++ + +              E     
Sbjct: 129 YLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK--------------EFFKVK 174

Query: 221 MGT---CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLE--------CLVGHYPLIGFGE 269
                   + +PE +   +    +  A DVWS GVV+ E               +   G 
Sbjct: 175 EPGESPIFWYAPESLTESK----FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGN 230

Query: 270 KP-------DLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEEL 317
                     L+ L+       RL  P+    E    +  C   +  +R +  +L
Sbjct: 231 DKQGQMIVFHLIELLKN---NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDL 282

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  110 bits (278), Expect = 3e-28
 Identities = 69/295 (23%), Positives = 114/295 (38%), Gaps = 46/295 (15%)

Query: 47  SDLKKLTVLGHGNGGIVYK----VRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRL 102
             LK L  LG GN G V           +  + A+K L  ++   +R     E EILK L
Sbjct: 41  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER-EIEILKSL 99

Query: 103 DSQFIVKCHAVFYTIEGE-ICFVMEHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQ 160
               IVK   V Y+     +  +ME++  GSL D L+  K ++    +     ++ KG++
Sbjct: 100 QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGME 159

Query: 161 YLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIAC 220
           YL   + IH D+   N+L+  +  VKI DFG+++++ +                E     
Sbjct: 160 YLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD--------------KEYYKVK 205

Query: 221 MGT---CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLE--------CLVGHYPLIGFGE 269
                   + +PE +   +    +  A DVWS GVV+ E               +   G 
Sbjct: 206 EPGESPIFWYAPESLTESK----FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGN 261

Query: 270 KP-------DLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEEL 317
                     L+ L+       RL  P+    E    +  C   +  +R +  +L
Sbjct: 262 DKQGQMIVFHLIELLKN---NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDL 313

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  110 bits (278), Expect = 3e-28
 Identities = 45/174 (25%), Positives = 76/174 (43%), Gaps = 22/174 (12%)

Query: 34  PTSNPTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS------STI 87
             S   +P   +I   +++T LG G  G VYK     +N   A+K +           T 
Sbjct: 21  SMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTA 80

Query: 88  IRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMER--GSLFDSLRVRKKLSE 145
           IR     E  +LK L  + I++  +V +     +  + E+ E       D       +S 
Sbjct: 81  IR-----EVSLLKELQHRNIIELKSVIHH-NHRLHLIFEYAENDLKKYMDK---NPDVSM 131

Query: 146 DVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLING-----KGEVKIADFGVSR 194
            VI    Y+++ G+ + H  + +H D+KP NLL++         +KI DFG++R
Sbjct: 132 RVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  109 bits (274), Expect = 5e-28
 Identities = 65/291 (22%), Positives = 110/291 (37%), Gaps = 47/291 (16%)

Query: 47  SDLKKLTVLGHGNGGIVYK--VRHQKSNSIY-ALKVL--NTTSSTIIRHQAAHEAEILKR 101
            DL+ L  LG G+ G+V +         ++  A+K L  +  S          E   +  
Sbjct: 18  KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77

Query: 102 LDSQFIVKCHAVFYTIEGE-ICFVMEHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGL 159
           LD + +++ + V   +    +  V E    GSL D LR  +       +S  A +V +G+
Sbjct: 78  LDHRNLIRLYGV---VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGM 134

Query: 160 QYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIA 219
            YL   + IH D+   NLL+  +  VKI DFG+ R + +  +                + 
Sbjct: 135 GYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDD--------------HYVM 180

Query: 220 CMGT---CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP----- 271
                   A+ +PE + +      +  A D W  GV + E       +  +G++P     
Sbjct: 181 QEHRKVPFAWCAPESLKTRT----FSHASDTWMFGVTLWE-------MFTYGQEPWIGLN 229

Query: 272 --DLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY 320
              ++  I     GERL  PE    +    +  C       R T   L  +
Sbjct: 230 GSQILHKIDKE--GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDF 278

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  109 bits (274), Expect = 6e-28
 Identities = 67/304 (22%), Positives = 118/304 (38%), Gaps = 59/304 (19%)

Query: 34  PTSNPTSPDVENI--SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQ 91
           P++         I   DL  L  LG G  G+V   + +    + A+K++   S +    +
Sbjct: 9   PSTAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGSMS--EDE 65

Query: 92  AAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRK-KLSEDVISG 150
              EA+++  L  + +V+ + V  T +  I  + E+M  G L + LR  + +     +  
Sbjct: 66  FIEEAKVMMNLSHEKLVQLYGVC-TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLE 124

Query: 151 VAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNN 210
           +   V + ++YL   Q +H D+   N L+N +G VK++DFG+SR V +            
Sbjct: 125 MCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD----------- 173

Query: 211 NNIGEAAIACMGTCAY------------MSPERVDSERWGGDYGFAGDVWSLGVVVLECL 258
                          Y              PE +   +    +    D+W+ GV++ E  
Sbjct: 174 --------------EYTSSVGSKFPVRWSPPEVLMYSK----FSSKSDIWAFGVLMWE-- 213

Query: 259 VGHYPLIGFGEKP----DLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTV 314
                +   G+ P            I  G RL  P  AS +    + SC  +   +R T 
Sbjct: 214 -----IYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTF 268

Query: 315 EELL 318
           + LL
Sbjct: 269 KILL 272

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  108 bits (272), Expect = 8e-28
 Identities = 67/282 (23%), Positives = 122/282 (43%), Gaps = 39/282 (13%)

Query: 47  SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQF 106
            ++  L  LG G  G+V   + +    + A+K++   S +    +   EA+ + +L    
Sbjct: 8   EEITLLKELGSGQFGVVKLGKWKGQYDV-AVKMIKEGSMS--EDEFFQEAQTMMKLSHPK 64

Query: 107 IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRV-RKKLSEDVISGVAYRVLKGLQYLHGM 165
           +VK + V  + E  I  V E++  G L + LR   K L    +  + Y V +G+ +L   
Sbjct: 65  LVKFYGVC-SKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESH 123

Query: 166 QIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGT-- 223
           Q IH D+   N L++    VK++DFG++R V +                +  ++ +GT  
Sbjct: 124 QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD----------------DQYVSSVGTKF 167

Query: 224 -CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP----DLMALIC 278
              + +PE     +    Y    DVW+ G+++ E       +   G+ P        ++ 
Sbjct: 168 PVKWSAPEVFHYFK----YSSKSDVWAFGILMWE-------VFSLGKMPYDLYTNSEVVL 216

Query: 279 AICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY 320
            +  G RL  P  AS    + + SC  +   KR T ++LL+ 
Sbjct: 217 KVSQGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSS 258

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  108 bits (273), Expect = 9e-28
 Identities = 72/289 (24%), Positives = 115/289 (39%), Gaps = 48/289 (16%)

Query: 47  SDLKKLTVLGHGNGGIVYK--VRHQKSNSIY-ALKVLNTTSSTIIRHQAAHEAEILKRLD 103
            D+    +LG G  G VY+    + K   I  A+K      +   + +   EA I+K LD
Sbjct: 12  EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD 71

Query: 104 SQFIVKCHAVFYTIEGE-ICFVMEHMERGSLFDSLRV-RKKLSEDVISGVAYRVLKGLQY 161
              IVK   +   IE E    +ME    G L   L   +  L    +   + ++ K + Y
Sbjct: 72  HPHIVKLIGI---IEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAY 128

Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACM 221
           L  +  +H DI   N+L+     VK+ DFG+SR +E+                E      
Sbjct: 129 LESINCVHRDIAVRNILVASPECVKLGDFGLSRYIED----------------EDYYKAS 172

Query: 222 GT---CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP------- 271
            T     +MSPE ++  R    +  A DVW   V + E       ++ FG++P       
Sbjct: 173 VTRLPIKWMSPESINFRR----FTTASDVWMFAVCMWE-------ILSFGKQPFFWLENK 221

Query: 272 DLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY 320
           D++ ++     G+RL  P+   P     +  C + D   R    EL+  
Sbjct: 222 DVIGVLEK---GDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS 267

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  108 bits (273), Expect = 9e-28
 Identities = 65/278 (23%), Positives = 118/278 (42%), Gaps = 33/278 (11%)

Query: 47  SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQF 106
           +D+     LG G  G VY+   +K +   A+K L   +      +   EA ++K +    
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPN 70

Query: 107 IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRV--RKKLSEDVISGVAYRVLKGLQYLHG 164
           +V+   V  T E     + E M  G+L D LR   R+++S  V+  +A ++   ++YL  
Sbjct: 71  LVQLLGVC-TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 129

Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTC 224
              IH D+   N L+     VK+ADFG+SR++         +    +   +  I      
Sbjct: 130 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-------DTYTAHAGAKFPI------ 176

Query: 225 AYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP----DLMALICAI 280
            + +PE +   +    +    DVW+ GV++ E       +  +G  P    DL  +   +
Sbjct: 177 KWTAPESLAYNK----FSIKSDVWAFGVLLWE-------IATYGMSPYPGIDLSQVYELL 225

Query: 281 CFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELL 318
               R+E PE    +    +R+C + +   R +  E+ 
Sbjct: 226 EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIH 263

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  108 bits (273), Expect = 1e-27
 Identities = 60/281 (21%), Positives = 112/281 (39%), Gaps = 29/281 (10%)

Query: 47  SDLKKLTVLGHGNGGIVYK---VRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLD 103
             +    V+G G+ G VY    + +       A+K LN  +      Q   E  I+K   
Sbjct: 25  LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS 84

Query: 104 SQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRV-RKKLSEDVISGVAYRVLKGLQYL 162
              ++    +    EG    V+ +M+ G L + +R      +   + G   +V KG++YL
Sbjct: 85  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL 144

Query: 163 HGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMG 222
              + +H D+   N +++ K  VK+ADFG++R + +      + + +N    +  +    
Sbjct: 145 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD----KEYYSVHNKTGAKLPV---- 196

Query: 223 TCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP----DLMALIC 278
              +M+ E + +      +    DVWS GV++ E       L+  G  P    +   +  
Sbjct: 197 --KWMALESLQT----QKFTTKSDVWSFGVLLWE-------LMTRGAPPYPDVNTFDITV 243

Query: 279 AICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA 319
            +  G RL  PE         +  C       R +  EL++
Sbjct: 244 YLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 284

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  111 bits (279), Expect = 1e-27
 Identities = 67/280 (23%), Positives = 117/280 (41%), Gaps = 35/280 (12%)

Query: 47  SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQF 106
             L+    LG G  G V+      +  + A+K L   + +        EA+++K+L  + 
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMS--PEAFLQEAQVMKKLRHEK 240

Query: 107 IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVR--KKLSEDVISGVAYRVLKGLQYLHG 164
           +V+ +AV    E  I  V E+M +GSL D L+    K L    +  +A ++  G+ Y+  
Sbjct: 241 LVQLYAV--VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 298

Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTC 224
           M  +H D++ +N+L+      K+ADFG++R++E+             N   A        
Sbjct: 299 MNYVHRDLRAANILVGENLVCKVADFGLARLIED-------------NEYTARQGAKFPI 345

Query: 225 AYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP----DLMALICAI 280
            + +PE     R    +    DVWS G+++ E       L   G  P        ++  +
Sbjct: 346 KWTAPEAALYGR----FTIKSDVWSFGILLTE-------LTTKGRVPYPGMVNREVLDQV 394

Query: 281 CFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY 320
             G R+  P          +  C  K+  +R T E L A+
Sbjct: 395 ERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAF 434

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  111 bits (280), Expect = 2e-27
 Identities = 67/280 (23%), Positives = 117/280 (41%), Gaps = 35/280 (12%)

Query: 47  SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQF 106
             L+    LG G  G V+      +  + A+K L   + +        EA+++K+L  + 
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMS--PEAFLQEAQVMKKLRHEK 323

Query: 107 IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVR--KKLSEDVISGVAYRVLKGLQYLHG 164
           +V+ +AV    E  I  V E+M +GSL D L+    K L    +  +A ++  G+ Y+  
Sbjct: 324 LVQLYAVV--SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 381

Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTC 224
           M  +H D++ +N+L+      K+ADFG++R++E+             N   A        
Sbjct: 382 MNYVHRDLRAANILVGENLVCKVADFGLARLIED-------------NEYTARQGAKFPI 428

Query: 225 AYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP----DLMALICAI 280
            + +PE     R    +    DVWS G+++ E       L   G  P        ++  +
Sbjct: 429 KWTAPEAALYGR----FTIKSDVWSFGILLTE-------LTTKGRVPYPGMVNREVLDQV 477

Query: 281 CFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY 320
             G R+  P          +  C  K+  +R T E L A+
Sbjct: 478 ERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAF 517

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  109 bits (275), Expect = 2e-27
 Identities = 66/336 (19%), Positives = 123/336 (36%), Gaps = 49/336 (14%)

Query: 7   RRHQQALTLSLPATAANHQFRRRRHHFPTSNPTSPDVENISD----------LKKLTVLG 56
              + + +L   A + N  F+         +  +P++               +    V+G
Sbjct: 39  SIEELSTSLYKKAGSENLYFQGANTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIG 98

Query: 57  HGNGGIVYK---VRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAV 113
            G+ G VY    + +       A+K LN  +      Q   E  I+K      ++    +
Sbjct: 99  RGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGI 158

Query: 114 FYTIEGEICFVMEHMERGSLFDSLRV-RKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDI 172
               EG    V+ +M+ G L + +R      +   + G   +V KG+++L   + +H D+
Sbjct: 159 CLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDL 218

Query: 173 KPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCA-----YM 227
              N +++ K  VK+ADFG++R + +                E       T A     +M
Sbjct: 219 AARNCMLDEKFTVKVADFGLARDMYDK---------------EFDSVHNKTGAKLPVKWM 263

Query: 228 SPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP----DLMALICAICFG 283
           + E + +      +    DVWS GV++ E       L+  G  P    +   +   +  G
Sbjct: 264 ALESLQT----QKFTTKSDVWSFGVLLWE-------LMTRGAPPYPDVNTFDITVYLLQG 312

Query: 284 ERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA 319
            RL  PE         +  C       R +  EL++
Sbjct: 313 RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 348

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  108 bits (273), Expect = 2e-27
 Identities = 74/315 (23%), Positives = 124/315 (39%), Gaps = 50/315 (15%)

Query: 30  RHHFPTSNP-TSPDVENI--SDLKKLTVLGHGNGGIVYK----VRHQKSNSIYALKVLNT 82
            HH   +      D        LK ++ LG GN G V           + ++ A+K L  
Sbjct: 3   HHHHHHAQLYACQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQH 62

Query: 83  TSSTIIRHQAA--HEAEILKRLDSQFIVKCHAVFYTIEGE-ICFVMEHMERGSLFDSLRV 139
           +       Q     E +ILK L S FIVK   V Y    + +  VME++  G L D L+ 
Sbjct: 63  SGPD---QQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQR 119

Query: 140 RK-KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEE 198
            + +L    +   + ++ KG++YL   + +H D+   N+L+  +  VKIADFG+++++  
Sbjct: 120 HRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPL 179

Query: 199 TRNNNNHNNNNNNNIGEAAIACMGTCA-----YMSPERVDSERWGGDYGFAGDVWSLGVV 253
            ++                   +         + +PE +        +    DVWS GVV
Sbjct: 180 DKD----------------YYVVREPGQSPIFWYAPESLSDNI----FSRQSDVWSFGVV 219

Query: 254 VLE--------CLVGHYPLIGFGEKPDLMA---LICAICFGERLEMPETASPEFRRFVRS 302
           + E        C      L   G + D+ A   L+  +  G+RL  P     E    ++ 
Sbjct: 220 LYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKL 279

Query: 303 CLEKDWRKRGTVEEL 317
           C     + R +   L
Sbjct: 280 CWAPSPQDRPSFSAL 294

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  107 bits (270), Expect = 2e-27
 Identities = 67/277 (24%), Positives = 119/277 (42%), Gaps = 39/277 (14%)

Query: 53  TVLGHGNGGIVYK-VRHQKSNSIY-ALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKC 110
             LG GN G V + V   +   I  A+KVL   +      +   EA+I+ +LD+ +IV+ 
Sbjct: 16  IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRL 75

Query: 111 HAVFYTIEGE-ICFVMEHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQYLHGMQII 168
             V    + E +  VME    G L   L  ++ ++    ++ + ++V  G++YL     +
Sbjct: 76  IGV---CQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFV 132

Query: 169 HGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMS 228
           H D+   N+L+  +   KI+DFG+S+ +             +++   A  A      + +
Sbjct: 133 HRDLAARNVLLVNRHYAKISDFGLSKALGA-----------DDSYYTARSAGKWPLKWYA 181

Query: 229 PERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP-------DLMALICAIC 281
           PE ++  +    +    DVWS GV + E        + +G+KP       ++MA I    
Sbjct: 182 PECINFRK----FSSRSDVWSYGVTMWE-------ALSYGQKPYKKMKGPEVMAFIEQ-- 228

Query: 282 FGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELL 318
            G+R+E P    PE    +  C    W  R     + 
Sbjct: 229 -GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVE 264

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  110 bits (276), Expect = 3e-27
 Identities = 62/262 (23%), Positives = 107/262 (40%), Gaps = 38/262 (14%)

Query: 19  ATAANHQFRRRRHHFPTSNPTSPDVENISDL------KKLTVLGHGNGGIVYKVRHQKSN 72
             + + Q  ++R    +S PT+      SD       +   ++G G+ G V +   +   
Sbjct: 19  TVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEK 78

Query: 73  SIYALKVLN------TTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGE----IC 122
            + A+K +            I+R     E  IL RL+   +VK   +    + E    + 
Sbjct: 79  RVVAIKKILRVFEDLIDCKRILR-----EIAILNRLNHDHVVKVLDIVIPKDVEKFDELY 133

Query: 123 FVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGK 182
            V+E  +        R    L+E  I  + Y +L G++Y+H   I+H D+KP+N L+N  
Sbjct: 134 VVLEIADS-DFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQD 192

Query: 183 GEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCA-------------YMSP 229
             VK+ DFG++R V+   N N+    +        +    T               Y +P
Sbjct: 193 CSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAP 252

Query: 230 ERVDSERWGGDYGFAGDVWSLG 251
           E +  +    +Y  A DVWS+G
Sbjct: 253 ELILLQE---NYTEAIDVWSIG 271

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  111 bits (278), Expect = 4e-27
 Identities = 66/276 (23%), Positives = 119/276 (43%), Gaps = 39/276 (14%)

Query: 53  TVLGHGNGGIVYK--VRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKC 110
             LG GN G V +   R +K     A+KVL   +      +   EA+I+ +LD+ +IV+ 
Sbjct: 342 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRL 401

Query: 111 HAVFYTIEGE-ICFVMEHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQYLHGMQII 168
             V    + E +  VME    G L   L  ++ ++    ++ + ++V  G++YL     +
Sbjct: 402 IGV---CQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFV 458

Query: 169 HGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMS 228
           H ++   N+L+  +   KI+DFG+S+ +             +++   A  A      + +
Sbjct: 459 HRNLAARNVLLVNRHYAKISDFGLSKALGA-----------DDSYYTARSAGKWPLKWYA 507

Query: 229 PERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP-------DLMALICAIC 281
           PE ++  +    +    DVWS GV + E        + +G+KP       ++MA I    
Sbjct: 508 PECINFRK----FSSRSDVWSYGVTMWE-------ALSYGQKPYKKMKGPEVMAFIEQ-- 554

Query: 282 FGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEEL 317
            G+R+E P    PE    +  C    W  R     +
Sbjct: 555 -GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTV 589

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  107 bits (270), Expect = 4e-27
 Identities = 76/328 (23%), Positives = 114/328 (34%), Gaps = 70/328 (21%)

Query: 31  HHFPTSNPT---------SPDVENI--SDLKKLTVLGHGNGGIVYK-----VRHQKSNSI 74
           HH    NP            D++ +   ++  +  LGHG  G VY+     + +  S   
Sbjct: 3   HHHHHHNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQ 62

Query: 75  YALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLF 134
            A+K L    S         EA I+ + + Q IV+C  V          +ME M  G L 
Sbjct: 63  VAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVS-LQSLPRFILMELMAGGDLK 121

Query: 135 DSLRVR-------KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGE--- 184
             LR           L+   +  VA  +  G QYL     IH DI   N L+   G    
Sbjct: 122 SFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRV 181

Query: 185 VKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAY-----MSPERVDSERWGG 239
            KI DFG++R                 +I  A+    G CA      M PE        G
Sbjct: 182 AKIGDFGMAR-----------------DIYRASYYRKGGCAMLPVKWMPPEAFME----G 220

Query: 240 DYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP-------DLMALICAICFGERLEMPETA 292
            +    D WS GV++ E       +   G  P       +++  + +   G R++ P+  
Sbjct: 221 IFTSKTDTWSFGVLLWE-------IFSLGYMPYPSKSNQEVLEFVTS---GGRMDPPKNC 270

Query: 293 SPEFRRFVRSCLEKDWRKRGTVEELLAY 320
                R +  C +     R     +L  
Sbjct: 271 PGPVYRIMTQCWQHQPEDRPNFAIILER 298

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  108 bits (272), Expect = 4e-27
 Identities = 65/348 (18%), Positives = 121/348 (34%), Gaps = 90/348 (25%)

Query: 52  LTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRL--------- 102
           +  LG G+   V+  +   +N+  A+K++      +    A  E ++L+R+         
Sbjct: 24  VRKLGWGHFSTVWLAKDMVNNTHVAMKIV--RGDKVYTEAAEDEIKLLQRVNDADNTKED 81

Query: 103 --DSQFIVKCHAVFYTIEGE---ICFVMEHMERGSLFDSLRVRK--KLSEDVISGVAYRV 155
              +  I+K    F         +  V E +   +L   ++  +   +    +  ++ ++
Sbjct: 82  SMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQL 140

Query: 156 LKGLQYLHGM-QIIHGDIKPSNLLIN------GKGEVKIADFGVSRIVEETRNNNNHNNN 208
           L GL Y+H    IIH DIKP N+L+          ++KIAD G +   +E   N+     
Sbjct: 141 LLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS----- 195

Query: 209 NNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHY-----P 263
                       + T  Y SPE +     G  +G   D+WS   ++ E + G +      
Sbjct: 196 ------------IQTREYRSPEVL----LGAPWGCGADIWSTACLIFELITGDFLFEPDE 239

Query: 264 LIGFGEKPDLMALICAIC-----------------FGERLE------------------- 287
              + +  D +A I  +                  F  R                     
Sbjct: 240 GHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEK 299

Query: 288 --MPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNIE 333
               +  + E   F+   L+ D RKR     L+ +P++        I 
Sbjct: 300 YKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIR 347

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  109 bits (275), Expect = 5e-27
 Identities = 69/303 (22%), Positives = 125/303 (41%), Gaps = 40/303 (13%)

Query: 27  RRRRHHFPTSNPTSPDVE-----NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLN 81
           ++      +S P  P  +         LK    LG G  G V+   + K   + A+K + 
Sbjct: 163 QKLSVPCMSSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKV-AVKTMK 221

Query: 82  TTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRK 141
             S +        EA ++K L    +VK HAV    +  I  + E M +GSL D L+  +
Sbjct: 222 PGSMS--VEAFLAEANVMKTLQHDKLVKLHAVV--TKEPIYIITEFMAKGSLLDFLKSDE 277

Query: 142 --KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEET 199
             K     +   + ++ +G+ ++     IH D++ +N+L++     KIADFG++R++E+ 
Sbjct: 278 GSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIED- 336

Query: 200 RNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV 259
                       N   A         + +PE ++       +    DVWS G++++E   
Sbjct: 337 ------------NEYTAREGAKFPIKWTAPEAINFGS----FTIKSDVWSFGILLME--- 377

Query: 260 GHYPLIGFGEKP----DLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVE 315
               ++ +G  P        +I A+  G R+  PE    E    +  C +    +R T E
Sbjct: 378 ----IVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFE 433

Query: 316 ELL 318
            + 
Sbjct: 434 YIQ 436

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  107 bits (270), Expect = 6e-27
 Identities = 79/308 (25%), Positives = 135/308 (43%), Gaps = 50/308 (16%)

Query: 52  LTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCH 111
            ++LG G  G+V    H+ +  I A+K +      +   +   E +ILK    + I+   
Sbjct: 16  KSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIF 75

Query: 112 AVFY--TIEG--EICFVMEHMERGSLFDSLRV--RKKLSEDVISGVAYRVLKGLQYLHGM 165
            +    + E   E+  + E M+     D  RV   + LS+D I    Y+ L+ ++ LHG 
Sbjct: 76  NIQRPDSFENFNEVYIIQELMQT----DLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGS 131

Query: 166 QIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGE--AAIACMGT 223
            +IH D+KPSNLLIN   ++K+ DFG++RI++E+  +N+      + + E  A      T
Sbjct: 132 NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVA------T 185

Query: 224 CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPL----------------IGF 267
             Y +PE + +      Y  A DVWS G ++ E  +   P+                IG 
Sbjct: 186 RWYRAPEVMLTSA---KYSRAMDVWSCGCILAELFLRR-PIFPGRDYRHQLLLIFGIIGT 241

Query: 268 GEKPDLMALIC---AICFGERLEMPE---------TASPEFRRFVRSCLEKDWRKRGTVE 315
               + +  I    A  + + L M             +P+    ++  L  D  KR T +
Sbjct: 242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAK 301

Query: 316 ELLAYPFV 323
           E L +P++
Sbjct: 302 EALEHPYL 309

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  106 bits (267), Expect = 8e-27
 Identities = 55/284 (19%), Positives = 111/284 (39%), Gaps = 35/284 (12%)

Query: 47  SDLKKLTVLGHGNGGIVYK---VRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLD 103
                  V+G G+ G+VY    +   ++    A+K L+  +          E  +++ L+
Sbjct: 21  VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLN 80

Query: 104 SQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRV-RKKLSEDVISGVAYRVLKGLQYL 162
              ++    +    EG    ++ +M  G L   +R  ++  +   +     +V +G++YL
Sbjct: 81  HPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYL 140

Query: 163 HGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMG 222
              + +H D+   N +++    VK+ADFG++R + +      + +   +      +    
Sbjct: 141 AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILD----REYYSVQQHRHARLPV---- 192

Query: 223 TCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP-------DLMA 275
              + + E + +      +    DVWS GV++ E       L+  G  P       DL  
Sbjct: 193 --KWTALESLQT----YRFTTKSDVWSFGVLLWE-------LLTRGAPPYRHIDPFDLTH 239

Query: 276 LICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA 319
            +     G RL  PE       + ++ C E D   R T   L+ 
Sbjct: 240 FLAQ---GRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVG 280

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  106 bits (267), Expect = 9e-27
 Identities = 65/304 (21%), Positives = 115/304 (37%), Gaps = 65/304 (21%)

Query: 47  SDLKKLTVLGHGNGGIVYK-----VRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKR 101
             +     LG G+ G+VY+     V   +  +  A+K +N  +S   R +  +EA ++K 
Sbjct: 25  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 84

Query: 102 LDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISG----------V 151
            +   +V+   V  +       +ME M RG L   LR  +    +              +
Sbjct: 85  FNCHHVVRLLGVV-SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQM 143

Query: 152 AYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEET---RNNNNHNNN 208
           A  +  G+ YL+  + +H D+   N ++     VKI DFG++R + ET   R        
Sbjct: 144 AGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR-------- 195

Query: 209 NNNNIGEAAIACMGTCAY-----MSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYP 263
                        G         MSPE +      G +    DVWS GVV+ E       
Sbjct: 196 ------------KGGKGLLPVRWMSPESLKD----GVFTTYSDVWSFGVVLWE------- 232

Query: 264 LIGFGEKP-------DLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEE 316
           +    E+P        ++  +     G  L+ P+         +R C + + + R +  E
Sbjct: 233 IATLAEQPYQGLSNEQVLRFVME---GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLE 289

Query: 317 LLAY 320
           +++ 
Sbjct: 290 IISS 293

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  105 bits (264), Expect = 1e-26
 Identities = 61/282 (21%), Positives = 121/282 (42%), Gaps = 43/282 (15%)

Query: 47  SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVL--NTTSSTIIRHQAAHEAEILKRLDS 104
            +LK L  +G G  G V    ++   +  A+K +  + T+   +      EA ++ +L  
Sbjct: 21  KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLA-----EASVMTQLRH 73

Query: 105 QFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVR--KKLSEDVISGVAYRVLKGLQYL 162
             +V+   V    +G +  V E+M +GSL D LR R    L  D +   +  V + ++YL
Sbjct: 74  SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 133

Query: 163 HGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMG 222
            G   +H D+   N+L++     K++DFG+++    T++            G+  +    
Sbjct: 134 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT-----------GKLPV---- 178

Query: 223 TCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP----DLMALIC 278
              + +PE +  ++    +    DVWS G+++ E       +  FG  P     L  ++ 
Sbjct: 179 --KWTAPEALREKK----FSTKSDVWSFGILLWE-------IYSFGRVPYPRIPLKDVVP 225

Query: 279 AICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY 320
            +  G +++ P+   P     +++C   D   R +  +L   
Sbjct: 226 RVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 267

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  106 bits (266), Expect = 2e-26
 Identities = 72/318 (22%), Positives = 113/318 (35%), Gaps = 61/318 (19%)

Query: 31  HHFPTSNPTSPDVENI--SDLKKLTVLGHGNGGIVYK-----VRHQKSNSIYALKVLNTT 83
           + F     +  D++ +   ++  +  LGHG  G VY+     + +  S    A+K L   
Sbjct: 53  YCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV 112

Query: 84  SSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRK-- 141
            S         EA I+ + + Q IV+C  V          ++E M  G L   LR  +  
Sbjct: 113 CSEQDELDFLMEALIISKFNHQNIVRCIGVS-LQSLPRFILLELMAGGDLKSFLRETRPR 171

Query: 142 -----KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGE---VKIADFGVS 193
                 L+   +  VA  +  G QYL     IH DI   N L+   G     KI DFG++
Sbjct: 172 PSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 231

Query: 194 RIVEETRNNNNHNNNNNNNIGEAAIACMGTCAY-----MSPERVDSERWGGDYGFAGDVW 248
           R                 +I  A     G CA      M PE        G +    D W
Sbjct: 232 R-----------------DIYRAGYYRKGGCAMLPVKWMPPEAFME----GIFTSKTDTW 270

Query: 249 SLGVVVLECLVGHYPLIGFGEKP-------DLMALICAICFGERLEMPETASPEFRRFVR 301
           S GV++ E       +   G  P       +++  + +   G R++ P+       R + 
Sbjct: 271 SFGVLLWE-------IFSLGYMPYPSKSNQEVLEFVTS---GGRMDPPKNCPGPVYRIMT 320

Query: 302 SCLEKDWRKRGTVEELLA 319
            C +     R     +L 
Sbjct: 321 QCWQHQPEDRPNFAIILE 338

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  105 bits (263), Expect = 3e-26
 Identities = 53/292 (18%), Positives = 105/292 (35%), Gaps = 52/292 (17%)

Query: 47  SDLKKLTVLGHGNGGIVYKVRHQKSNSIY-------ALKVLNTTSSTIIRHQAAHEAEIL 99
            DL     LG G    ++K   ++             LKVL+              A ++
Sbjct: 8   EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNY-SESFFEAASMM 66

Query: 100 KRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRV-RKKLSEDVISGVAYRVLKG 158
            +L  + +V  + V      E   V E ++ GSL   L+  +  ++      VA ++   
Sbjct: 67  SKLSHKHLVLNYGVC-VCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAA 125

Query: 159 LQYLHGMQIIHGDIKPSNLLINGKGE--------VKIADFGVSRIVEETRNNNNHNNNNN 210
           + +L    +IHG++   N+L+  + +        +K++D G+S  V              
Sbjct: 126 MHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP------------ 173

Query: 211 NNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEK 270
            +I +  I       ++ PE         +   A D WS G  + E       +   G+K
Sbjct: 174 KDILQERI------PWVPPE---CIENPKNLNLATDKWSFGTTLWE-------ICSGGDK 217

Query: 271 P----DLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELL 318
           P    D    +       +L  P+  + E    + +C++ +   R +   ++
Sbjct: 218 PLSALDSQRKLQFYEDRHQLPAPK--AAELANLINNCMDYEPDHRPSFRAII 267

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  103 bits (260), Expect = 5e-26
 Identities = 66/290 (22%), Positives = 121/290 (41%), Gaps = 59/290 (20%)

Query: 47  SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQF 106
             LK +  LG G  G V+   +     + A+K L   S +        EA ++K+L  Q 
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSMS--PDAFLAEANLMKQLQHQR 69

Query: 107 IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRK--KLSEDVISGVAYRVLKGLQYLHG 164
           +V+ +AV    +  I  + E+ME GSL D L+     KL+ + +  +A ++ +G+ ++  
Sbjct: 70  LVRLYAV--VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127

Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTC 224
              IH D++ +N+L++     KIADFG++R++E+                          
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN------------------------- 162

Query: 225 AY------------MSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP- 271
            Y             +PE ++       +    DVWS G+++ E       ++  G  P 
Sbjct: 163 EYTAREGAKFPIKWTAPEAINYGT----FTIKSDVWSFGILLTE-------IVTHGRIPY 211

Query: 272 ---DLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELL 318
                  +I  +  G R+  P+    E  + +R C ++    R T + L 
Sbjct: 212 PGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLR 261

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  105 bits (265), Expect = 9e-26
 Identities = 62/282 (21%), Positives = 119/282 (42%), Gaps = 43/282 (15%)

Query: 47  SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVL--NTTSSTIIRHQAAHEAEILKRLDS 104
            +LK L  +G G  G V         +  A+K +  + T+   +      EA ++ +L  
Sbjct: 193 KELKLLQTIGKGEFGDVML--GDYRGNKVAVKCIKNDATAQAFLA-----EASVMTQLRH 245

Query: 105 QFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRV--RKKLSEDVISGVAYRVLKGLQYL 162
             +V+   V    +G +  V E+M +GSL D LR   R  L  D +   +  V + ++YL
Sbjct: 246 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 305

Query: 163 HGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMG 222
            G   +H D+   N+L++     K++DFG+++    T++            G+  +    
Sbjct: 306 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT-----------GKLPV---- 350

Query: 223 TCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP----DLMALIC 278
              + +PE +  ++    +    DVWS G+++ E       +  FG  P     L  ++ 
Sbjct: 351 --KWTAPEALREKK----FSTKSDVWSFGILLWE-------IYSFGRVPYPRIPLKDVVP 397

Query: 279 AICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY 320
            +  G +++ P+   P     +++C   D   R T  +L   
Sbjct: 398 RVEKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQ 439

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  104 bits (262), Expect = 2e-25
 Identities = 69/312 (22%), Positives = 120/312 (38%), Gaps = 68/312 (21%)

Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVK 109
               V+G+G+ G+VY+ +   S  + A+K +        R     E +I+++LD   IV+
Sbjct: 57  TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-----ELQIMRKLDHCNIVR 111

Query: 110 CHAVFYTI-----EGEICFVMEHMERGSLFDSLRVRKK----LSEDVISGVAYRVLKGLQ 160
               FY+      E  +  V++++   +++   R   +    L    +    Y++ + L 
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 170

Query: 161 YLHGMQIIHGDIKPSNLLINGK-GEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIA 219
           Y+H   I H DIKP NLL++     +K+ DFG ++ +     N ++            I 
Sbjct: 171 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY------------IC 218

Query: 220 CMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGF-GEKP-DLMALI 277
              +  Y +PE +       DY  + DVWS G V+ E L+G  P+  F G+   D +  I
Sbjct: 219 ---SRYYRAPELIFGAT---DYTSSIDVWSAGCVLAELLLGQ-PI--FPGDSGVDQLVEI 269

Query: 278 CAIC---------------------------FGERLEMPETASPEFRRFVRSCLEKDWRK 310
             +                            + +         PE        LE     
Sbjct: 270 IKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVF--RPRTPPEAIALCSRLLEYTPTA 327

Query: 311 RGTVEELLAYPF 322
           R T  E  A+ F
Sbjct: 328 RLTPLEACAHSF 339

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  101 bits (254), Expect = 4e-25
 Identities = 59/310 (19%), Positives = 109/310 (35%), Gaps = 71/310 (22%)

Query: 47  SDLKKLTVLGHGNGGIVYK-----VRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKR 101
           S ++ +  LG    G VYK         +     A+K L   +   +R +  HEA +  R
Sbjct: 9   SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRAR 68

Query: 102 LDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVR----------------KKLSE 145
           L    +V    V  T +  +  +  +   G L + L +R                  L  
Sbjct: 69  LQHPNVVCLLGVV-TKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEP 127

Query: 146 DVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNH 205
                +  ++  G++YL    ++H D+   N+L+  K  VKI+D G+ R V         
Sbjct: 128 PDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAA------ 181

Query: 206 NNNNNNNIGEAAIACMGTCA-----YMSPERVDSERWGGDYGF---AGDVWSLGVVVLEC 257
                          +   +     +M+PE +        YG      D+WS GVV+ E 
Sbjct: 182 -----------DYYKLLGNSLLPIRWMAPEAI-------MYGKFSIDSDIWSYGVVLWE- 222

Query: 258 LVGHYPLIGFGEKP-------DLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRK 310
                 +  +G +P       D++ +I      + L  P+         +  C  +   +
Sbjct: 223 ------VFSYGLQPYCGYSNQDVVEMIRN---RQVLPCPDDCPAWVYALMIECWNEFPSR 273

Query: 311 RGTVEELLAY 320
           R   +++ + 
Sbjct: 274 RPRFKDIHSR 283

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  102 bits (256), Expect = 7e-25
 Identities = 72/309 (23%), Positives = 129/309 (41%), Gaps = 60/309 (19%)

Query: 52  LTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCH 111
           L+ +G G  G+V       +    A+K ++         +   E +IL R   + I+  +
Sbjct: 32  LSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 91

Query: 112 AVFY--TIEG--EICFVMEHMERGSLFDSLRVRK--KLSEDVISGVAYRVLKGLQYLHGM 165
            +    TIE   ++  V + ME     D  ++ K   LS D I    Y++L+GL+Y+H  
Sbjct: 92  DIIRAPTIEQMKDVYIVQDLMET----DLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 147

Query: 166 QIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACM---- 221
            ++H D+KPSNLL+N   ++KI DFG++R+ +   ++                  +    
Sbjct: 148 NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF---------------LTEYV 192

Query: 222 GTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPL----------------I 265
            T  Y +PE + + +    Y  + D+WS+G ++ E L    P+                +
Sbjct: 193 ATRWYRAPEIMLNSK---GYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGIL 248

Query: 266 GFGEKPDLMALIC--AICFGERLEMPE---------TASPEFRRFVRSCLEKDWRKRGTV 314
           G   + DL  +I   A  +   L              A  +    +   L  +  KR  V
Sbjct: 249 GSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEV 308

Query: 315 EELLAYPFV 323
           E+ LA+P++
Sbjct: 309 EQALAHPYL 317

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  101 bits (255), Expect = 8e-25
 Identities = 76/316 (24%), Positives = 122/316 (38%), Gaps = 79/316 (25%)

Query: 52  LTVLGHGNGGIVYKVRHQKSNSIYALK-VLNTTSSTIIRHQAAHEAEILKRLDSQFIVKC 110
            T +G G  G V     ++S    A+K +     S I   +A  E  +LK +  + ++  
Sbjct: 29  PTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGL 88

Query: 111 HAVFYTIEG-----EICFVMEHMERGSLFDSLRV-RKKLSEDVISGVAYRVLKGLQYLHG 164
             VF          +   VM  M+     D  ++   K SE+ I  + Y++LKGL+Y+H 
Sbjct: 89  LDVFTPASSLRNFYDFYLVMPFMQT----DLQKIMGLKFSEEKIQYLVYQMLKGLKYIHS 144

Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEE-------TRNNNNHNNNNNNNIGEAA 217
             ++H D+KP NL +N   E+KI DFG++R  +        TR                 
Sbjct: 145 AGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR----------------- 187

Query: 218 IACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGF-GEKP-DLMA 275
                   Y +PE + S      Y    D+WS+G ++ E L G   L  F G+   D + 
Sbjct: 188 -------WYRAPEVILSWM---HYNQTVDIWSVGCIMAEMLTGK-TL--FKGKDYLDQLT 234

Query: 276 LICAICFG--ERLEMPETASPEFRRFVRSC----------------------LEK----D 307
            I  +  G      + +      + +++S                       LEK    D
Sbjct: 235 QILKVT-GVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELD 293

Query: 308 WRKRGTVEELLAYPFV 323
             KR T  + L +PF 
Sbjct: 294 VDKRLTAAQALTHPFF 309

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  102 bits (255), Expect = 1e-24
 Identities = 55/225 (24%), Positives = 103/225 (45%), Gaps = 36/225 (16%)

Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVK 109
               V+G+G+ G+V++ +  +S+ + A+K +        R     E +I++ +    +V 
Sbjct: 43  TNCKVIGNGSFGVVFQAKLVESDEV-AIKKVLQDKRFKNR-----ELQIMRIVKHPNVVD 96

Query: 110 CHAVFYTI-----EGEICFVMEHMERGSLFDSLRVRKK----LSEDVISGVAYRVLKGLQ 160
             A FY+      E  +  V+E++   +++ + R   K    +   +I    Y++L+ L 
Sbjct: 97  LKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLA 155

Query: 161 YLHGMQIIHGDIKPSNLLING-KGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIA 219
           Y+H + I H DIKP NLL++   G +K+ DFG ++I+               N+      
Sbjct: 156 YIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE----------PNVSYIC-- 203

Query: 220 CMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPL 264
              +  Y +PE +       +Y    D+WS G V+ E + G  PL
Sbjct: 204 ---SRYYRAPELIFGAT---NYTTNIDIWSTGCVMAELMQGQ-PL 241

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  102 bits (256), Expect = 1e-24
 Identities = 58/235 (24%), Positives = 99/235 (42%), Gaps = 19/235 (8%)

Query: 52  LTVLGHGNGGIVYKVRHQKSNSIYALK-VLNTTSSTIIRHQAAHEAEILKRLDSQFIVKC 110
             ++G G+ G VY    + +    A+K V       I   +   E  IL RL S +I++ 
Sbjct: 31  KHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRL 90

Query: 111 HAVFY--TIEG--EICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQ 166
           + +     +    E+  V+E  +   L    +    L+E+ I  + Y +L G  ++H   
Sbjct: 91  YDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESG 149

Query: 167 IIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMG---- 222
           IIH D+KP+N L+N    VK+ DFG++R +   ++ N  N+   N         +     
Sbjct: 150 IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLT 209

Query: 223 ----TCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGF--GEKP 271
               T  Y +PE +  +    +Y  + D+WS G +  E L      I       P
Sbjct: 210 SHVVTRWYRAPELILLQE---NYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFP 261

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  101 bits (254), Expect = 1e-24
 Identities = 65/319 (20%), Positives = 121/319 (37%), Gaps = 69/319 (21%)

Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALK-VLNTTSSTIIRHQAAHEAEILKRLDSQFIV 108
           + L  +G G  GIV            A+K +     +     +A  E  ++K ++ + I+
Sbjct: 28  QNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 87

Query: 109 KCHAVF---YTIEG--EICFVMEHMERGSLFDSLRV-RKKLSEDVISGVAYRVLKGLQYL 162
               VF    ++E   ++  VME M+     +  +V + +L  + +S + Y++L G+++L
Sbjct: 88  GLLNVFTPQKSLEEFQDVYIVMELMD----ANLCQVIQMELDHERMSYLLYQMLCGIKHL 143

Query: 163 HGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMG 222
           H   IIH D+KPSN+++     +KI DFG++R    +     +               + 
Sbjct: 144 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY---------------VV 188

Query: 223 TCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPL------------------ 264
           T  Y +PE +        Y    D+WS+G ++ E + G   L                  
Sbjct: 189 TRYYRAPEVILGMG----YKENVDIWSVGCIMGEMIKGG-VLFPGTDHIDQWNKVIEQLG 243

Query: 265 --------------------IGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCL 304
                                          L   + F    E  +  + + R  +   L
Sbjct: 244 TPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKML 303

Query: 305 EKDWRKRGTVEELLAYPFV 323
             D  KR +V+E L +P++
Sbjct: 304 VIDASKRISVDEALQHPYI 322

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 99.6 bits (249), Expect = 3e-24
 Identities = 69/299 (23%), Positives = 116/299 (38%), Gaps = 45/299 (15%)

Query: 47  SDLKKLTVLGHGNGGIVYK-----VRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKR 101
           + L     LG G  G V +     +    +    A+K+L  ++    R     E ++L  
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 102 LDS-QFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGV--------- 151
           L +   IV       TI G    + E+   G L + LR ++       +           
Sbjct: 83  LGNHMNIVNLLGA-CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141

Query: 152 ---------AYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNN 202
                    +Y+V KG+ +L     IH D+   N+L+      KI DFG++R +      
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDI------ 195

Query: 203 NNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLE-CLVGH 261
              N++N    G A +       +M+PE + +      Y F  DVWS G+ + E   +G 
Sbjct: 196 --KNDSNYVVKGNARLPVK----WMAPESIFN----CVYTFESDVWSYGIFLWELFSLGS 245

Query: 262 YPLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY 320
            P  G         +I     G R+  PE A  E    +++C + D  KR T ++++  
Sbjct: 246 SPYPGMPVDSKFYKMIKE---GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 99.7 bits (249), Expect = 3e-24
 Identities = 54/300 (18%), Positives = 94/300 (31%), Gaps = 58/300 (19%)

Query: 47  SDLKKLTVLGHGNGGIVYK---VRHQKSNSIYALKVLNTTSSTIIRHQA-AHEAEILKRL 102
                  +LG G  G V +    +   S    A+K+L          +    EA  +K  
Sbjct: 23  QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF 82

Query: 103 DSQFIVKCHAV-----FYTIEGEICFVMEHMERGSLFDSLRVRK------KLSEDVISGV 151
           D   + K   V               ++  M+ G L   L   +       L    +   
Sbjct: 83  DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRF 142

Query: 152 AYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNN 211
              +  G++YL     IH D+   N ++     V +ADFG+SR +               
Sbjct: 143 MVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGD----------- 191

Query: 212 NIGEAAIACMGTCA-----YMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIG 266
                     G  +     +++ E +        Y    DVW+ GV + E       ++ 
Sbjct: 192 ------YYRQGCASKLPVKWLALESLAD----NLYTVHSDVWAFGVTMWE-------IMT 234

Query: 267 FGEKP-------DLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA 319
            G+ P       ++   +     G RL+ P     E    +  C   D ++R +   L  
Sbjct: 235 RGQTPYAGIENAEIYNYLIG---GNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRM 291

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  101 bits (253), Expect = 4e-24
 Identities = 62/317 (19%), Positives = 117/317 (36%), Gaps = 69/317 (21%)

Query: 52  LTVLGHGNGGIVYKVRHQKSNSIYALK-VLNTTSSTIIRHQAAHEAEILKRLDSQFIVKC 110
           L  +G G  GIV        +   A+K +     +     +A  E  ++K ++ + I+  
Sbjct: 67  LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 126

Query: 111 HAVFYTIEG-----EICFVMEHMERGSLFDSLRV-RKKLSEDVISGVAYRVLKGLQYLHG 164
             VF   +      ++  VME M+     +  +V + +L  + +S + Y++L G+++LH 
Sbjct: 127 LNVFTPQKTLEEFQDVYLVMELMDA----NLCQVIQMELDHERMSYLLYQMLCGIKHLHS 182

Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTC 224
             IIH D+KPSN+++     +KI DFG++R    +     +               + T 
Sbjct: 183 AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY---------------VVTR 227

Query: 225 AYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPL-------------------- 264
            Y +PE +        Y    D+WS+G ++ E +     L                    
Sbjct: 228 YYRAPEVILGMG----YKENVDIWSVGCIMGEMVRHK-ILFPGRDYIDQWNKVIEQLGTP 282

Query: 265 ------------------IGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEK 306
                                        L     F    E  +  + + R  +   L  
Sbjct: 283 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVI 342

Query: 307 DWRKRGTVEELLAYPFV 323
           D  KR +V++ L +P++
Sbjct: 343 DPAKRISVDDALQHPYI 359

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 99.3 bits (248), Expect = 5e-24
 Identities = 50/226 (22%), Positives = 94/226 (41%), Gaps = 32/226 (14%)

Query: 44  ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSST-IIRHQAAHEAEILKRL 102
            N  D + +  LG G    V++  +  +N    +K+L       I R     E +IL+ L
Sbjct: 33  GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKR-----EIKILENL 87

Query: 103 -DSQFIVKCHAVFYT-IEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQ 160
                I+    +    +      V EH+      D  ++ + L++  I    Y +LK L 
Sbjct: 88  RGGPNIITLADIVKDPVSRTPALVFEHVN---NTDFKQLYQTLTDYDIRFYMYEILKALD 144

Query: 161 YLHGMQIIHGDIKPSNLLINGK-GEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIA 219
           Y H M I+H D+KP N++I+ +  ++++ D+G++      +  N                
Sbjct: 145 YCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR-------------- 190

Query: 220 CMGTCAYMSPE-RVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPL 264
            + +  +  PE  VD +     Y ++ D+WSLG ++   +    P 
Sbjct: 191 -VASRYFKGPELLVDYQM----YDYSLDMWSLGCMLASMIFRKEPF 231

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 98.9 bits (247), Expect = 7e-24
 Identities = 66/348 (18%), Positives = 120/348 (34%), Gaps = 94/348 (27%)

Query: 28  RRRHHFPTSNPTSPDVENI------------SDLKKLTVLGHGNGGIVYK------VRHQ 69
              HH  + +P    V                 L     LG G  G V         + +
Sbjct: 4   SHHHHHHSQDPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDK 63

Query: 70  KSNSIY-ALKVLNTTSSTIIRHQAAHEAEILKRLDS-QFIVKCHAVFYTIEGEICFVMEH 127
              ++  A+K+L   ++         E E++K +   + I+       T +G +  ++E+
Sbjct: 64  PKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC-TQDGPLYVIVEY 122

Query: 128 MERGSLFDSLRVRKKLSEDVISGV----------------AYRVLKGLQYLHGMQIIHGD 171
             +G+L + LR R+    +    +                 Y++ +G++YL   + IH D
Sbjct: 123 ASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRD 182

Query: 172 IKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAY----- 226
           +   N+L+     +KIADFG++R +                             Y     
Sbjct: 183 LAARNVLVTENNVMKIADFGLARDINNIDY------------------------YKKTTN 218

Query: 227 -------MSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP-------D 272
                  M+PE +        Y    DVWS GV++ E       +   G  P       +
Sbjct: 219 GRLPVKWMAPEALFD----RVYTHQSDVWSFGVLMWE-------IFTLGGSPYPGIPVEE 267

Query: 273 LMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY 320
           L  L+     G R++ P   + E    +R C      +R T ++L+  
Sbjct: 268 LFKLLKE---GHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 99.9 bits (249), Expect = 1e-23
 Identities = 47/190 (24%), Positives = 87/190 (45%), Gaps = 29/190 (15%)

Query: 23  NHQFRRRRHHFPTSNPTSPDVENISDLKKLTVLGHGNGGIVYKVRHQ--KSNSIYALKVL 80
           ++ F+ +     +      D+      K    +G G  G VYK + +  K +  YALK +
Sbjct: 4   DYDFKVKL---SSERERVEDLFEYEGCK----VGRGTYGHVYKAKRKDGKDDKDYALKQI 56

Query: 81  NTT--SSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYT-IEGEICFVMEHMER--GSLFD 135
             T  S +  R     E  +L+ L    ++    VF +  + ++  + ++ E     +  
Sbjct: 57  EGTGISMSACR-----EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIK 111

Query: 136 SLRVRK------KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLING----KGEV 185
             R  K      +L   ++  + Y++L G+ YLH   ++H D+KP+N+L+ G    +G V
Sbjct: 112 FHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRV 171

Query: 186 KIADFGVSRI 195
           KIAD G +R+
Sbjct: 172 KIADMGFARL 181

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 98.1 bits (245), Expect = 1e-23
 Identities = 77/322 (23%), Positives = 123/322 (38%), Gaps = 78/322 (24%)

Query: 52  LTVLGHGNGGIVYKVRHQKSNSIYALKVL---NTTSST-IIRHQAAHEAEILKRLDSQFI 107
           L  LG G  G+V+       +   A+K +   +  S    +R     E +I++RLD   I
Sbjct: 16  LKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALR-----EIKIIRRLDHDNI 70

Query: 108 VKCHAVF-------------YTIEGEICFVMEHMERGSLFDSLRV--RKKLSEDVISGVA 152
           VK   +               T    +  V E+ME     D   V  +  L E+      
Sbjct: 71  VKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET----DLANVLEQGPLLEEHARLFM 126

Query: 153 YRVLKGLQYLHGMQIIHGDIKPSNLLINGKG-EVKIADFGVSRIVEETRNNNNHNNNNNN 211
           Y++L+GL+Y+H   ++H D+KP+NL IN +   +KI DFG++RI++   ++  H      
Sbjct: 127 YQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGH------ 180

Query: 212 NIGEAAIACM----GTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPL--- 264
                    +     T  Y SP  + S     +Y  A D+W+ G +  E L G   L   
Sbjct: 181 ---------LSEGLVTKWYRSPRLLLSPN---NYTKAIDMWAAGCIFAEMLTGK-TLFAG 227

Query: 265 -------------IGFGEKPDLMAL-------ICAICFGERLEMPE---TASPEFRRFVR 301
                        I    + D   L       I          + +     S E   F+ 
Sbjct: 228 AHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLE 287

Query: 302 SCLEKDWRKRGTVEELLAYPFV 323
             L      R T EE L++P++
Sbjct: 288 QILTFSPMDRLTAEEALSHPYM 309

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 98.1 bits (245), Expect = 1e-23
 Identities = 62/302 (20%), Positives = 112/302 (37%), Gaps = 52/302 (17%)

Query: 47  SDLKKLTVLGHGNGGIVYK-----VRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKR 101
             LK    LG G  G V +     +    +    A+K+L   ++         E +IL  
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86

Query: 102 LDS-QFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGV--------- 151
           +     +V          G +  ++E  + G+L   LR ++                   
Sbjct: 87  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146

Query: 152 -------AYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNN 204
                  +++V KG+++L   + IH D+   N+L++ K  VKI DFG++R + +  +   
Sbjct: 147 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY-- 204

Query: 205 HNNNNNNNIGEAAIACMGTCA-----YMSPERVDSERWGGDYGFAGDVWSLGVVVLE-CL 258
                               A     +M+PE +        Y    DVWS GV++ E   
Sbjct: 205 ---------------VRKGDARLPLKWMAPETIFD----RVYTIQSDVWSFGVLLWEIFS 245

Query: 259 VGHYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELL 318
           +G  P  G     +    +     G R+  P+  +PE  + +  C   +  +R T  EL+
Sbjct: 246 LGASPYPGVKIDEEFCRRLKE---GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELV 302

Query: 319 AY 320
            +
Sbjct: 303 EH 304

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 97.7 bits (244), Expect = 1e-23
 Identities = 70/313 (22%), Positives = 113/313 (36%), Gaps = 78/313 (24%)

Query: 47  SDLKKLTVLGHGNGGIVYK-----VRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKR 101
            D+     LG G  G V+      +   K   + A+K L   +    R     EAE+L  
Sbjct: 15  RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAA-RKDFQREAELLTN 73

Query: 102 LDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVR----------------KKLSE 145
           L  + IVK + V       +  V E+M+ G L   LR                   +L  
Sbjct: 74  LQHEHIVKFYGVC-GDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGL 132

Query: 146 DVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEET---RNN 202
             +  +A ++  G+ YL     +H D+   N L+     VKI DFG+SR V  T   R  
Sbjct: 133 SQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYR-- 190

Query: 203 NNHNNNNNNNIGEAAIACMGTCA-----YMSPERVDSERWGGDYGF---AGDVWSLGVVV 254
                             +G        +M PE +        Y       DVWS GV++
Sbjct: 191 ------------------VGGHTMLPIRWMPPESI-------MYRKFTTESDVWSFGVIL 225

Query: 255 LECLVGHYPLIGFGEKP-------DLMALICAICFGERLEMPETASPEFRRFVRSCLEKD 307
            E       +  +G++P       +++  I     G  LE P     E    +  C +++
Sbjct: 226 WE-------IFTYGKQPWFQLSNTEVIECITQ---GRVLERPRVCPKEVYDVMLGCWQRE 275

Query: 308 WRKRGTVEELLAY 320
            ++R  ++E+   
Sbjct: 276 PQQRLNIKEIYKI 288

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 99.0 bits (247), Expect = 2e-23
 Identities = 64/246 (26%), Positives = 106/246 (43%), Gaps = 50/246 (20%)

Query: 52  LTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRL------DSQ 105
           L V+G G+ G V K    K +   ALK++   +      QAA E  IL+ L      ++ 
Sbjct: 102 LKVIGKGSFGQVVKAYDHKVHQHVALKMVR--NEKRFHRQAAEEIRILEHLRKQDKDNTM 159

Query: 106 FIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRK--KLSEDVISGVAYRVLKGLQYLH 163
            ++     F      IC   E +   +L++ ++  K    S  ++   A+ +L+ L  LH
Sbjct: 160 NVIHMLENFT-FRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH 217

Query: 164 GMQIIHGDIKPSNLLIN--GKGEVKIADFGVSRIVEE-------TRNNNNHNNNNNNNIG 214
             +IIH D+KP N+L+   G+  +K+ DFG S    +       +R              
Sbjct: 218 KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSR-------------- 263

Query: 215 EAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLM 274
                      Y +PE +     G  YG   D+WSLG ++ E L G YPL+   ++ D +
Sbjct: 264 ----------FYRAPEVI----LGARYGMPIDMWSLGCILAELLTG-YPLLPGEDEGDQL 308

Query: 275 ALICAI 280
           A +  +
Sbjct: 309 ACMIEL 314

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 97.7 bits (244), Expect = 2e-23
 Identities = 76/331 (22%), Positives = 115/331 (34%), Gaps = 79/331 (23%)

Query: 30  RHHFPTSNPTSPDVENI-----SDLKKLTVLGHGNGGIVYK--VRHQKSNSIYALKVLNT 82
           +HH       +PD         +D+K   V+G GN G V K  ++        A+K +  
Sbjct: 3   KHHHHHHGKNNPDPTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE 62

Query: 83  TSSTIIRHQAAHEAEILKRLDSQF-IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRK 141
            +S       A E E+L +L     I+          G +   +E+   G+L D LR  +
Sbjct: 63  YASKDDHRDFAGELEVLCKLGHHPNIINLLGAC-EHRGYLYLAIEYAPHGNLLDFLRKSR 121

Query: 142 KLSEDVISGV----------------AYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEV 185
            L  D    +                A  V +G+ YL   Q IH D+   N+L+      
Sbjct: 122 VLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVA 181

Query: 186 KIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCA-----YMSPE----RVDSER 236
           KIADFG+SR  E                         T       +M+ E     V    
Sbjct: 182 KIADFGLSRGQEVYVK--------------------KTMGRLPVRWMAIESLNYSV---- 217

Query: 237 WGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP-------DLMALICAICFGERLEMP 289
               Y    DVWS GV++ E       ++  G  P       +L   +     G RLE P
Sbjct: 218 ----YTTNSDVWSYGVLLWE-------IVSLGGTPYCGMTCAELYEKLPQ---GYRLEKP 263

Query: 290 ETASPEFRRFVRSCLEKDWRKRGTVEELLAY 320
                E    +R C  +   +R +  ++L  
Sbjct: 264 LNCDDEVYDLMRQCWREKPYERPSFAQILVS 294

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 98.2 bits (245), Expect = 2e-23
 Identities = 66/348 (18%), Positives = 115/348 (33%), Gaps = 98/348 (28%)

Query: 52  LTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRL------DSQ 105
            +++G G+ G V K   +      A+K++   +     +QA  E  +L+ +         
Sbjct: 59  DSLIGKGSFGQVVKAYDRVEQEWVAIKIIK--NKKAFLNQAQIEVRLLELMNKHDTEMKY 116

Query: 106 FIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKK--LSEDVISGVAYRVLKGLQYLH 163
           +IV     F      +C V E +   +L+D LR      +S ++    A ++   L +L 
Sbjct: 117 YIVHLKRHFM-FRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLA 174

Query: 164 G--MQIIHGDIKPSNLLI--NGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIA 219
              + IIH D+KP N+L+    +  +KI DFG S      +                   
Sbjct: 175 TPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS-----CQLGQRIYQ------------ 217

Query: 220 CMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICA 279
            + +  Y SPE +     G  Y  A D+WSLG +++E   G  PL     + D M  I  
Sbjct: 218 YIQSRFYRSPEVL----LGMPYDLAIDMWSLGCILVEMHTG-EPLFSGANEVDQMNKIVE 272

Query: 280 IC-----------------------FGERLEMPETASPEFRR------------------ 298
           +                            L+  +    E++                   
Sbjct: 273 VLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPG 332

Query: 299 -------------------FVRSCLEKDWRKRGTVEELLAYPFVTKRS 327
                               +   L+ D + R      L + F  K +
Sbjct: 333 GRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTA 380

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 98.4 bits (245), Expect = 2e-23
 Identities = 70/358 (19%), Positives = 109/358 (30%), Gaps = 98/358 (27%)

Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDS--------QF 106
           LG G+   V+     +     A+KV+ +         A  E  +LK + +        + 
Sbjct: 45  LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHY--TETALDEIRLLKSVRNSDPNDPNREM 102

Query: 107 IVKCHAVFYTIEGE----ICFVMEHMERGSLFDSLRV--RKKLSEDVISGVAYRVLKGLQ 160
           +V+    F  I G     IC V E +    L   +     + L    +  +  +VL+GL 
Sbjct: 103 VVQLLDDF-KISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLD 160

Query: 161 YLHG-MQIIHGDIKPSNLLIN--------GKGEVKIADFGVSRIVEETRNNNNHNNNNNN 211
           YLH   +IIH DIKP N+L++           E        +     +  +       N 
Sbjct: 161 YLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNF 220

Query: 212 N---------------IGEAAIACMG---------TCAYMSPERVDSERWGGDYGFAGDV 247
                           I +   AC           T  Y S E +     G  Y    D+
Sbjct: 221 LVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVL----IGSGYNTPADI 276

Query: 248 WSLGVVVLECLVGHYPL-----IGFGEKPDLMALICAIC--------------------- 281
           WS   +  E   G Y         +    D +ALI  +                      
Sbjct: 277 WSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKK 336

Query: 282 -----------------FGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPF 322
                              E+ E  +  +  F  F+   LE    KR T  E L +P+
Sbjct: 337 GDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPW 394

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 98.2 bits (245), Expect = 3e-23
 Identities = 75/315 (23%), Positives = 122/315 (38%), Gaps = 76/315 (24%)

Query: 52  LTVLGHGNGGIVYKVRHQKSNSIYALK-VLNTTSSTIIRHQAAHEAEILKRLDSQFIVKC 110
           L  +G G  G V      ++ +  A+K +     S +   +A  E  +LK +  + ++  
Sbjct: 30  LQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGL 89

Query: 111 HAVFYTIEG-----EICFVMEHMERGSLFDSLRV--RKKLSEDVISGVAYRVLKGLQYLH 163
             VF   E      +   VM  M      D  ++   +KL ED I  + Y++LKGL+Y+H
Sbjct: 90  LDVFTPDETLDDFTDFYLVMPFMGT----DLGKLMKHEKLGEDRIQFLVYQMLKGLRYIH 145

Query: 164 GMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEE-------TRNNNNHNNNNNNNIGEA 216
              IIH D+KP NL +N   E+KI DFG++R  +        TR                
Sbjct: 146 AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTR---------------- 189

Query: 217 AIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMAL 276
                    Y +PE + +      Y    D+WS+G ++ E + G   L    +  D +  
Sbjct: 190 --------WYRAPEVILNWM---RYTQTVDIWSVGCIMAEMITGK-TLFKGSDHLDQLKE 237

Query: 277 ICAICFG--ERLEMPETASPEFRRFVRSC----------------------LEK----DW 308
           I  +  G      +    S E + +++                        LEK    D 
Sbjct: 238 IMKVT-GTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDA 296

Query: 309 RKRGTVEELLAYPFV 323
            +R T  E LA+P+ 
Sbjct: 297 EQRVTAGEALAHPYF 311

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 96.9 bits (242), Expect = 3e-23
 Identities = 66/319 (20%), Positives = 124/319 (38%), Gaps = 81/319 (25%)

Query: 47  SDLKKLTVLGHGNGGIVYK-----VRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKR 101
            +L     LG G  G V K     ++ +   +  A+K+L   +S         E  +LK+
Sbjct: 23  KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82

Query: 102 LDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGV---------- 151
           ++   ++K +    + +G +  ++E+ + GSL   LR  +K+    +             
Sbjct: 83  VNHPHVIKLYGAC-SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDH 141

Query: 152 --------------AYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVE 197
                         A+++ +G+QYL  M+++H D+   N+L+    ++KI+DFG+SR V 
Sbjct: 142 PDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVY 201

Query: 198 ETRNNNNHNNNNNNNIGEAAIACMGTCA-----YMSPE----RVDSERWGGDYGFAGDVW 248
           E  +                     +       +M+ E     +        Y    DVW
Sbjct: 202 EEDSY-----------------VKRSQGRIPVKWMAIESLFDHI--------YTTQSDVW 236

Query: 249 SLGVVVLECLVGHYPLIGFGEKP-------DLMALICAICFGERLEMPETASPEFRRFVR 301
           S GV++ E       ++  G  P        L  L+     G R+E P+  S E  R + 
Sbjct: 237 SFGVLLWE-------IVTLGGNPYPGIPPERLFNLLKT---GHRMERPDNCSEEMYRLML 286

Query: 302 SCLEKDWRKRGTVEELLAY 320
            C +++  KR    ++   
Sbjct: 287 QCWKQEPDKRPVFADISKD 305

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 97.4 bits (243), Expect = 4e-23
 Identities = 70/372 (18%), Positives = 129/372 (34%), Gaps = 98/372 (26%)

Query: 7   RRHQQALTLSLPATAANHQFRRRRHHFPTSNPTSPDVENISD---------------LKK 51
           RR       S  +  +N    R      +S   +P +  +S+               L  
Sbjct: 27  RRQVTVSAESSSSMNSNTPLVRITTR-LSSTADTPMLAGVSEYELPEDPKWEFPRDKLTL 85

Query: 52  LTVLGHGNGGIVYK------VRHQKSNSIY-ALKVLNTTSSTIIRHQAAHEAEILKRLDS 104
              LG G  G V         + +   ++  A+K+L   ++         E E++K +  
Sbjct: 86  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145

Query: 105 -QFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGV------------ 151
            + I+       T +G +  ++E+  +G+L + LR R+    +    +            
Sbjct: 146 HKNIINLLGAC-TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204

Query: 152 ----AYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNN 207
                Y++ +G++YL   + IH D+   N+L+     +KIADFG++R +           
Sbjct: 205 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDY------ 258

Query: 208 NNNNNIGEAAIACMGTCAY------------MSPERVDSERWGGDYGFAGDVWSLGVVVL 255
                             Y            M+PE +        Y    DVWS GV++ 
Sbjct: 259 ------------------YKKTTNGRLPVKWMAPEALFD----RVYTHQSDVWSFGVLMW 296

Query: 256 ECLVGHYPLIGFGEKP-------DLMALICAICFGERLEMPETASPEFRRFVRSCLEKDW 308
           E       +   G  P       +L  L+     G R++ P   + E    +R C     
Sbjct: 297 E-------IFTLGGSPYPGIPVEELFKLLKE---GHRMDKPANCTNELYMMMRDCWHAVP 346

Query: 309 RKRGTVEELLAY 320
            +R T ++L+  
Sbjct: 347 SQRPTFKQLVED 358

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 96.6 bits (241), Expect = 4e-23
 Identities = 74/306 (24%), Positives = 117/306 (38%), Gaps = 65/306 (21%)

Query: 47  SDLKKLTVLGHGNGGIVYK-----VRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKR 101
            D+     LG G  G V+      +  ++   + A+K L   S +  R     EAE+L  
Sbjct: 41  RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESA-RQDFQREAELLTM 99

Query: 102 LDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVR---------------KKLSED 146
           L  Q IV+   V  T    +  V E+M  G L   LR                   L   
Sbjct: 100 LQHQHIVRFFGVC-TEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLG 158

Query: 147 VISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHN 206
            +  VA +V  G+ YL G+  +H D+   N L+     VKI DFG+SR            
Sbjct: 159 QLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR------------ 206

Query: 207 NNNNNNIGEAAIACMGTCA-----YMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGH 261
                +I       +G        +M PE +        +    DVWS GVV+ E     
Sbjct: 207 -----DIYSTDYYRVGGRTMLPIRWMPPESILY----RKFTTESDVWSFGVVLWE----- 252

Query: 262 YPLIGFGEKP-------DLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTV 314
             +  +G++P       + +  I     G  LE P    PE    +R C +++ ++R ++
Sbjct: 253 --IFTYGKQPWYQLSNTEAIDCITQ---GRELERPRACPPEVYAIMRGCWQREPQQRHSI 307

Query: 315 EELLAY 320
           +++ A 
Sbjct: 308 KDVHAR 313

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 96.2 bits (240), Expect = 1e-22
 Identities = 80/344 (23%), Positives = 133/344 (38%), Gaps = 76/344 (22%)

Query: 23  NHQFRRRRHHFPTSNPTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALK-VLN 81
           +H   + R  F          E     + L+ +G G  G V      K+    A+K +  
Sbjct: 5   HHHHSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR 64

Query: 82  TTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEG-----EICFVMEHMERGSLFDS 136
              S I   +   E  +LK +  + ++    VF          ++  V   M    L + 
Sbjct: 65  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNI 123

Query: 137 LRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIV 196
           ++  +KL++D +  + Y++L+GL+Y+H   IIH D+KPSNL +N   E+KI DFG++R  
Sbjct: 124 VK-CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT 182

Query: 197 EE-------TRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWS 249
            +       TR                         Y +PE + +      Y    D+WS
Sbjct: 183 ADEMTGYVATR------------------------WYRAPEIMLNWM---HYNQTVDIWS 215

Query: 250 LGVVVLECLVGHYPLIGF-GEKP-DLMALICAICFG--ERLEMPETASPEFRRFVRSC-- 303
           +G ++ E L G   L  F G    D + LI  +  G      + + +S   R +++S   
Sbjct: 216 VGCIMAELLTGR-TL--FPGTDHIDQLKLILRLV-GTPGAELLKKISSESARNYIQSLTQ 271

Query: 304 --------------------LEK----DWRKRGTVEELLAYPFV 323
                               LEK    D  KR T  + LA+ + 
Sbjct: 272 MPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 315

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 95.4 bits (238), Expect = 2e-22
 Identities = 61/295 (20%), Positives = 116/295 (39%), Gaps = 41/295 (13%)

Query: 47  SDLKKLTVLGHGNGGIVYK-----VRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKR 101
           ++L+    LG G  G V +     +  + +    A+K+L +T+    +     E +I+  
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105

Query: 102 LDS-QFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKK--------------LSED 146
           L   + IV       T  G +  + E+   G L + LR + +               S  
Sbjct: 106 LGQHENIVNLLGAC-THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTR 164

Query: 147 VISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHN 206
            +   + +V +G+ +L     IH D+   N+L+      KI DFG++R +         N
Sbjct: 165 DLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDI--------MN 216

Query: 207 NNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECL-VGHYPLI 265
           ++N    G A +       +M+PE +        Y    DVWS G+++ E   +G  P  
Sbjct: 217 DSNYIVKGNARL----PVKWMAPESIFD----CVYTVQSDVWSYGILLWEIFSLGLNPYP 268

Query: 266 GFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY 320
           G         L+     G ++  P  A       +++C   +   R T +++ ++
Sbjct: 269 GILVNSKFYKLVKD---GYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF 320

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 96.0 bits (239), Expect = 2e-22
 Identities = 58/257 (22%), Positives = 101/257 (39%), Gaps = 67/257 (26%)

Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVK 109
                LG G+ GIV +V   +S   +ALK +        R     E +I+K LD   I+K
Sbjct: 10  SLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNR-----ELDIMKVLDHVNIIK 64

Query: 110 CHAVFYTI-------------------------------------EGEICFVMEHMERGS 132
               FYT                                         +  +ME++   +
Sbjct: 65  LVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DT 123

Query: 133 LFDSLRV----RKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGK-GEVKI 187
           L   L+      + +  ++IS   Y++ + + ++H + I H DIKP NLL+N K   +K+
Sbjct: 124 LHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKL 183

Query: 188 ADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDV 247
            DFG ++ +            +  ++         +  Y +PE +       +Y  + D+
Sbjct: 184 CDFGSAKKLIP----------SEPSVAYIC-----SRFYRAPELMLGAT---EYTPSIDL 225

Query: 248 WSLGVVVLECLVGHYPL 264
           WS+G V  E ++G  PL
Sbjct: 226 WSIGCVFGELILGK-PL 241

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 94.7 bits (236), Expect = 3e-22
 Identities = 69/358 (19%), Positives = 127/358 (35%), Gaps = 84/358 (23%)

Query: 12  ALTLS-LPATAANHQFRRRRHHFPTSNPTSPDVENI----SDLKKLTVLGHGNGGIVYK- 65
           A+TL+ LP+     +      +       +P + ++    ++++ +  +G G  G V++ 
Sbjct: 7   AVTLTTLPSELLLDRLHPNPMYQRMPLLLNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQA 66

Query: 66  ----VRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEI 121
               +   +  ++ A+K+L   +S  ++     EA ++   D+  IVK   V   +   +
Sbjct: 67  RAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC-AVGKPM 125

Query: 122 CFVMEHMERGSLFDSLRVRKKLSEDVISG------------------------VAYRVLK 157
           C + E+M  G L + LR     +   +S                         +A +V  
Sbjct: 126 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAA 185

Query: 158 GLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEET---RNNNNHNNNNNNNIG 214
           G+ YL   + +H D+   N L+     VKIADFG+SR +      +              
Sbjct: 186 GMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK-------------- 231

Query: 215 EAAIACMGTCAY-----MSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGE 269
                            M PE +        Y    DVW+ GVV+ E          +G 
Sbjct: 232 ------ADGNDAIPIRWMPPESIFY----NRYTTESDVWAYGVVLWEIFS-------YGL 274

Query: 270 KP-------DLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY 320
           +P       +++  +     G  L  PE    E    +R C  K    R +   +   
Sbjct: 275 QPYYGMAHEEVIYYVRD---GNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 93.9 bits (234), Expect = 3e-22
 Identities = 55/316 (17%), Positives = 102/316 (32%), Gaps = 63/316 (19%)

Query: 35  TSNPTSPDVENI----SDLKKLTVLGHGNGGIVYK---VRHQKSNSIYALKVLNTTSSTI 87
            S      +E++    + L    +LG G  G V +    +   ++   A+K +   +S+ 
Sbjct: 18  GSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQ 77

Query: 88  IRHQA-AHEAEILKRLDSQFIVKCHAVFYTIEGEICF-----VMEHMERGSLFDSLRVRK 141
              +    EA  +K      +++   V               ++  M+ G L   L   +
Sbjct: 78  REIEEFLSEAACMKDFSHPNVIRLLGVC-IEMSSQGIPKPMVILPFMKYGDLHTYLLYSR 136

Query: 142 ------KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRI 195
                  +    +      +  G++YL     +H D+   N ++     V +ADFG+S+ 
Sbjct: 137 LETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKK 196

Query: 196 VEETRNNNNHNNNNNNNIGEAAIACMGTCA-----YMSPERVDSERWGGDYGFAGDVWSL 250
           +                         G  A     +++ E +        Y    DVW+ 
Sbjct: 197 IYSG-----------------DYYRQGRIAKMPVKWIAIESLAD----RVYTSKSDVWAF 235

Query: 251 GVVVLECLVGHYPLIGFGEKP-------DLMALICAICFGERLEMPETASPEFRRFVRSC 303
           GV + E       +   G  P       ++   +     G RL+ PE    E    + SC
Sbjct: 236 GVTMWE-------IATRGMTPYPGVQNHEMYDYLLH---GHRLKQPEDCLDELYEIMYSC 285

Query: 304 LEKDWRKRGTVEELLA 319
              D   R T   L  
Sbjct: 286 WRTDPLDRPTFSVLRL 301

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 94.7 bits (236), Expect = 4e-22
 Identities = 65/314 (20%), Positives = 114/314 (36%), Gaps = 82/314 (26%)

Query: 47  SDLKKLTVLGHGNGGIVYK-----VRHQKSNSIY--ALKVLNTTSSTIIRHQAAHEAEIL 99
             L     LG G  G V       +   K N +   A+K+L + ++         E E++
Sbjct: 69  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 128

Query: 100 KRLDS-QFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGV------- 151
           K +   + I+       T +G +  ++E+  +G+L + L+ R+    +            
Sbjct: 129 KMIGKHKNIINLLGAC-TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 187

Query: 152 ---------AYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNN 202
                    AY+V +G++YL   + IH D+   N+L+     +KIADFG++R +      
Sbjct: 188 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY- 246

Query: 203 NNHNNNNNNNIGEAAIACMGTCAY------------MSPERVDSERWGGDYGFAGDVWSL 250
                                  Y            M+PE +        Y    DVWS 
Sbjct: 247 -----------------------YKKTTNGRLPVKWMAPEALFD----RIYTHQSDVWSF 279

Query: 251 GVVVLECLVGHYPLIGFGEKP-------DLMALICAICFGERLEMPETASPEFRRFVRSC 303
           GV++ E       +   G  P       +L  L+     G R++ P   + E    +R C
Sbjct: 280 GVLLWE-------IFTLGGSPYPGVPVEELFKLLKE---GHRMDKPSNCTNELYMMMRDC 329

Query: 304 LEKDWRKRGTVEEL 317
                 +R T ++L
Sbjct: 330 WHAVPSQRPTFKQL 343

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 94.4 bits (235), Expect = 6e-22
 Identities = 71/330 (21%), Positives = 122/330 (36%), Gaps = 69/330 (20%)

Query: 52  LTVLGHGNGGIVYKVRHQKSNSIYALK-VLNTTSSTIIRHQAAHEAEILKRLDS-QFIVK 109
           +  LG G  GIV+K   +++  + A+K + +   ++    +   E  IL  L   + IV 
Sbjct: 14  VKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVN 73

Query: 110 CHAVFYTIE-GEICFVMEHMERGSLFDSLRVRK--KLSEDVISGVAYRVLKGLQYLHGMQ 166
              V       ++  V ++ME     D   V +   L       V Y+++K ++YLH   
Sbjct: 74  LLNVLRADNDRDVYLVFDYMET----DLHAVIRANILEPVHKQYVVYQLIKVIKYLHSGG 129

Query: 167 IIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAY 226
           ++H D+KPSN+L+N +  VK+ADFG+SR     R   N+   + N   E           
Sbjct: 130 LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENF---DDDQPI 186

Query: 227 MSPERVDSERW---------GGDYGFAGDVWSLGVVVLECLVG----------------- 260
           ++ + V + RW            Y    D+WSLG ++ E L G                 
Sbjct: 187 LT-DYV-ATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERII 244

Query: 261 ---------------------------HYPLIGFGEKPDLMALICAICFGERLEMPETAS 293
                                          I    K D+      +    ++      +
Sbjct: 245 GVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLL--LKINPKADCN 302

Query: 294 PEFRRFVRSCLEKDWRKRGTVEELLAYPFV 323
            E    +   L+ +  KR +  + L +PFV
Sbjct: 303 EEALDLLDKLLQFNPNKRISANDALKHPFV 332

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 93.1 bits (232), Expect = 1e-21
 Identities = 71/316 (22%), Positives = 119/316 (37%), Gaps = 74/316 (23%)

Query: 47  SDLKKLTVLGHGNGGIVYK-----VRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKR 101
            +L+   VLG G  G V       +     +   A+K+L   + +  R     E +++ +
Sbjct: 45  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104

Query: 102 LDS-QFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVR-------------------- 140
           L S + IV       T+ G I  + E+   G L + LR +                    
Sbjct: 105 LGSHENIVNLLGAC-TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 163

Query: 141 ---KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVE 197
                L+ + +   AY+V KG+++L     +H D+   N+L+     VKI DFG++R + 
Sbjct: 164 EDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIM 223

Query: 198 ETRNNNNHNNNNNNNIGEAAIACMGTCAY------------MSPERVDSERWGGDYGFAG 245
              N                        Y            M+PE +      G Y    
Sbjct: 224 SDSN------------------------YVVRGNARLPVKWMAPESLFE----GIYTIKS 255

Query: 246 DVWSLGVVVLE-CLVGHYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCL 304
           DVWS G+++ E   +G  P  G     +   LI     G +++ P  A+ E    ++SC 
Sbjct: 256 DVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQN---GFKMDQPFYATEEIYIIMQSCW 312

Query: 305 EKDWRKRGTVEELLAY 320
             D RKR +   L ++
Sbjct: 313 AFDSRKRPSFPNLTSF 328

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 93.1 bits (232), Expect = 1e-21
 Identities = 49/247 (19%), Positives = 99/247 (40%), Gaps = 44/247 (17%)

Query: 34  PTSNPTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALK-VLNTTSSTI--IRH 90
                +  +++     +   + G G  G V   + + +    A+K V+         ++ 
Sbjct: 13  AADERSRKEMDRFQVER---MAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ- 68

Query: 91  QAAHEAEILKRLDSQFIVKCHAVFYTI----EGEICF--VMEHMERGSLFDSLR----VR 140
                 + L  L    IV+  + FYT+      +I    VME++   +L    R     +
Sbjct: 69  ----IMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQ 123

Query: 141 KKLSEDVISGVAYRVLKGLQYLH--GMQIIHGDIKPSNLLINGK-GEVKIADFGVSRIVE 197
                 +I    +++++ +  LH   + + H DIKP N+L+N   G +K+ DFG ++ + 
Sbjct: 124 VAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLS 183

Query: 198 ETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLEC 257
                      +  N+         +  Y +PE +   +    Y  A D+WS+G +  E 
Sbjct: 184 P----------SEPNVAYIC-----SRYYRAPELIFGNQ---HYTTAVDIWSVGCIFAEM 225

Query: 258 LVGHYPL 264
           ++G  P+
Sbjct: 226 MLGE-PI 231

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 92.4 bits (230), Expect = 2e-21
 Identities = 71/361 (19%), Positives = 115/361 (31%), Gaps = 122/361 (33%)

Query: 52  LTVLGHGNGGIVYKVR-HQKSNSIYALKVLNTTSSTIIR------HQAAHEAEILKRL-- 102
           +  LG G  G V +   H +  S  ALK        IIR        A  E  +LK++  
Sbjct: 24  VGNLGEGTFGKVVECLDHARGKSQVALK--------IIRNVGKYREAARLEINVLKKIKE 75

Query: 103 ----DSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKK--LSEDVISGVAYRVL 156
               +    V     F    G +C   E + + + F+ L+           +  +AY++ 
Sbjct: 76  KDKENKFLCVLMSDWFN-FHGHMCIAFELLGK-NTFEFLKENNFQPYPLPHVRHMAYQLC 133

Query: 157 KGLQYLHGMQIIHGDIKPSNLLIN-------------------GKGEVKIADFG------ 191
             L++LH  Q+ H D+KP N+L                         +++ADFG      
Sbjct: 134 HALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDH 193

Query: 192 --VSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWS 249
              + IV  TR    H                    Y  PE +        +    DVWS
Sbjct: 194 EHHTTIV-ATR----H--------------------YRPPEVI----LELGWAQPCDVWS 224

Query: 250 LGVVVLECLVGHYPLIGFGEKPDLMALICAIC-----------------FGERLEMPETA 292
           +G ++ E   G + L    E  + + ++  I                  +   L   E +
Sbjct: 225 IGCILFEYYRG-FTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENS 283

Query: 293 S-----------------------PEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSS 329
           S                        +    +R  LE D  +R T+ E L +PF    +  
Sbjct: 284 SDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPE 343

Query: 330 S 330
            
Sbjct: 344 E 344

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 89.8 bits (223), Expect = 7e-21
 Identities = 34/276 (12%), Positives = 64/276 (23%), Gaps = 58/276 (21%)

Query: 52  LTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSST--IIRHQAAHEAEILKRLDSQFIVK 109
           L   G       ++      +   AL  ++        +  +       L R+D   + +
Sbjct: 36  LIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95

Query: 110 CHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIH 169
              V          V E +  GSL +        S          +       H   +  
Sbjct: 96  VLDVV-HTRAGGLVVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAGVAL 152

Query: 170 GDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSP 229
               PS + ++  G+V +A                                      M  
Sbjct: 153 SIDHPSRVRVSIDGDVVLAYPA----------------------------------TMPD 178

Query: 230 ERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMP 289
                           D+  +G  +   LV  +PL   G +  L           +   P
Sbjct: 179 ANPQD-----------DIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDT--AGQPIEP 225

Query: 290 ETASP----EFRRFVRSCLEKD--WRKRGTVEELLA 319
                    +        ++ D   R   T+  L+ 
Sbjct: 226 ADIDRDIPFQISAVAARSVQGDGGIRSASTLLNLMQ 261

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 90.1 bits (224), Expect = 2e-20
 Identities = 69/337 (20%), Positives = 114/337 (33%), Gaps = 82/337 (24%)

Query: 52  LTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRL-----DSQF 106
           +  +G G  G V   +H  +   YA+KV+   +       A  EA+ILK++     ++  
Sbjct: 40  IRKMGDGTFGRVLLCQHIDNKKYYAVKVVR--NIKKYTRSAKIEADILKKIQNDDINNNN 97

Query: 107 IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKK--LSEDVISGVAYRVLKGLQYLHG 164
           IVK H  F      +C + E +   SL++ +          + I      +LK L YL  
Sbjct: 98  IVKYHGKFM-YYDHMCLIFEPLGP-SLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRK 155

Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAI------ 218
           M + H D+KP N+L++     K           +        +          I      
Sbjct: 156 MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKST--------GIKLIDFG 207

Query: 219 -ACMGTCA---------YMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFG 268
            A   +           Y +PE +        +  + D+WS G V+ E   G   L    
Sbjct: 208 CATFKSDYHGSIINTRQYRAPEVI----LNLGWDVSSDMWSFGCVLAELYTG-SLLFRTH 262

Query: 269 EKPDLMALICAIC----------------------FGERLEMPETAS------------- 293
           E  + +A++ +I                          +L  PE AS             
Sbjct: 263 EHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLP 322

Query: 294 -------PEFRRFVRSCLEKDWRKRGTVEELLAYPFV 323
                    F  F+ S L+ D   R +  ELL + F+
Sbjct: 323 LYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFL 359

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 88.4 bits (220), Expect = 4e-20
 Identities = 67/284 (23%), Positives = 107/284 (37%), Gaps = 71/284 (25%)

Query: 7   RRHQQALTLSLPATAANHQFRRRRHHFPTSNPTSPDVENISDLKKLT-------VLGHGN 59
            ++ +A      A ++++      +  P           + DL++ T       ++GHG 
Sbjct: 3   SKYSKATNSINDALSSSYLVPFESYRVP-----------LVDLEEATNNFDHKFLIGHGV 51

Query: 60  GGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH----EAEILKRLDSQFIVKCHAVFY 115
            G VYK    +  +  ALK     S      Q       E E L       +V    + +
Sbjct: 52  FGKVYK-GVLRDGAKVALKRRTPES-----SQGIEEFETEIETLSFCRHPHLVSL--IGF 103

Query: 116 TIEG-EICFVMEHMERGS----LFDSLRVRKKLS----EDVISGVAYRVLKGLQYLHGMQ 166
             E  E+  + ++ME G+    L+ S      +S     ++  G A    +GL YLH   
Sbjct: 104 CDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAA----RGLHYLHTRA 159

Query: 167 IIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAY 226
           IIH D+K  N+L++     KI DFG+S+   E   +  H           +    GT  Y
Sbjct: 160 IIHRDVKSINILLDENFVPKITDFGISKKGTEL--DQTH----------LSTVVKGTLGY 207

Query: 227 MSPERVDSERWGGDYGFAG------DVWSLGVVVLECLVGHYPL 264
           + PE          Y   G      DV+S GVV+ E L     +
Sbjct: 208 IDPE----------YFIKGRLTEKSDVYSFGVVLFEVLCARSAI 241

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 88.1 bits (219), Expect = 7e-20
 Identities = 59/318 (18%), Positives = 108/318 (33%), Gaps = 70/318 (22%)

Query: 52  LTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH----------EAEILKR 101
              +  G+ G V      +   + A+K +  T S                   E  +L  
Sbjct: 27  QRFISSGSYGAVCAGVDSEGIPV-AIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNH 85

Query: 102 LDSQFIVKCHAVFYTIE----GEICFVMEHMERGSLFDSLRVRKK-LSEDVISGVAYRVL 156
                I+    +F   E     ++  V E M    L   +  ++  +S   I    Y +L
Sbjct: 86  FHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHIL 144

Query: 157 KGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEA 216
            GL  LH   ++H D+ P N+L+    ++ I DF ++R      N  ++           
Sbjct: 145 LGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHY----------- 193

Query: 217 AIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGF-GEKP-DLM 274
               +    Y +PE V   +    +    D+WS G V+ E       L  F G    + +
Sbjct: 194 ----VTHRWYRAPELVMQFK---GFTKLVDMWSAGCVMAEMFNRK-AL--FRGSTFYNQL 243

Query: 275 ALICAICFG--ERLEMPETASPEFRRFVRSCL----EKDWR------------------- 309
             I  +  G  +  ++   +SP  R ++R+ L     + W                    
Sbjct: 244 NKIVEVV-GTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLE 302

Query: 310 ----KRGTVEELLAYPFV 323
               +R + E+ L +P+ 
Sbjct: 303 FNPQRRISTEQALRHPYF 320

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 86.2 bits (214), Expect = 3e-19
 Identities = 70/356 (19%), Positives = 120/356 (33%), Gaps = 122/356 (34%)

Query: 52  LTVLGHGNGGIVYKVR-HQKSNSIYALKVLNTTSSTIIR------HQAAHEAEILKRL-- 102
           +  LG G  G V +   H+      A+K        I++        A  E ++L+ L  
Sbjct: 19  VDTLGEGAFGKVVECIDHKAGGRHVAVK--------IVKNVDRYCEAARSEIQVLEHLNT 70

Query: 103 ----DSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKK--LSEDVISGVAYRVL 156
                +   V+    F    G IC V E +   S +D ++         D I  +AY++ 
Sbjct: 71  TDPNSTFRCVQMLEWFE-HHGHICIVFELLGL-STYDFIKENGFLPFRLDHIRKMAYQIC 128

Query: 157 KGLQYLHGMQIIHGDIKPSNLLIN-------------------GKGEVKIADFG------ 191
           K + +LH  ++ H D+KP N+L                        ++K+ DFG      
Sbjct: 129 KSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDD 188

Query: 192 --VSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWS 249
              S +V  TR    H                    Y +PE +        +    DVWS
Sbjct: 189 EHHSTLV-STR----H--------------------YRAPEVI----LALGWSQPCDVWS 219

Query: 250 LGVVVLECLVGHYPLIGFGEKPDLMALICAIC-----------------FGERLEMPETA 292
           +G +++E  +G + +    +  + +A++  I                    +RL+  E +
Sbjct: 220 IGCILIEYYLG-FTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHS 278

Query: 293 S-----------------------PEFRRFVRSCLEKDWRKRGTVEELLAYPFVTK 325
           S                             ++  LE D  KR T+ E L +PF   
Sbjct: 279 SAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDL 334

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 85.3 bits (212), Expect = 3e-19
 Identities = 57/225 (25%), Positives = 93/225 (41%), Gaps = 50/225 (22%)

Query: 54  VLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHE--AEI--LKRLDSQFIVK 109
            +G G  G+VYK     +N+  A+K L          +   +   EI  + +   + +V+
Sbjct: 38  KMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITT-EELKQQFDQEIKVMAKCQHENLVE 94

Query: 110 CHAVFYTIEG-EICFVMEHMERGSLFDSLRVRKKLSE-------DVISGVAYRVLKGLQY 161
                ++ +G ++C V  +M  GSL D L                +  G A     G+ +
Sbjct: 95  LLG--FSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAA----NGINF 148

Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACM 221
           LH    IH DIK +N+L++     KI+DFG++R  E+         +            +
Sbjct: 149 LHENHHIHRDIKSANILLDEAFTAKISDFGLARASEK--FAQTVMTS----------RIV 196

Query: 222 GTCAYMSPERVDSERWGGDYGFAG------DVWSLGVVVLECLVG 260
           GT AYM+PE              G      D++S GVV+LE + G
Sbjct: 197 GTTAYMAPE----------A-LRGEITPKSDIYSFGVVLLEIITG 230

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 82.6 bits (205), Expect = 5e-18
 Identities = 54/229 (23%), Positives = 95/229 (41%), Gaps = 48/229 (20%)

Query: 54  VLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAV 113
           +LG G  G VYK R     ++ A+K L    +     Q   E E++     + +++    
Sbjct: 37  ILGRGGFGKVYKGR-LADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG- 94

Query: 114 FYTIEG-EICFVMEHMERGS----LFDSLRVRKKLS----EDVISGVAYRVLKGLQYLH- 163
            + +   E   V  +M  GS    L +    +  L     + +  G A    +GL YLH 
Sbjct: 95  -FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSA----RGLAYLHD 149

Query: 164 --GMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACM 221
               +IIH D+K +N+L++ + E  + DFG++++++     + H             A  
Sbjct: 150 HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY---KDTH----------VTTAVR 196

Query: 222 GTCAYMSPERVDSERWGGDYGFAG------DVWSLGVVVLECLVGHYPL 264
           GT  +++PE          Y   G      DV+  GV++LE + G    
Sbjct: 197 GTIGHIAPE----------YLSTGKSSEKTDVFGYGVMLLELITGQRAF 235

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 74.0 bits (182), Expect = 5e-15
 Identities = 48/226 (21%), Positives = 89/226 (39%), Gaps = 43/226 (19%)

Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLD-SQFIVKCHAV 113
           +G GN G +   ++  +N   A+K+    S      Q   E    K+L     I + +  
Sbjct: 17  IGCGNFGELRLGKNLYTNEYVAIKLEPMKSR---APQLHLEYRFYKQLGSGDGIPQVY-- 71

Query: 114 FYTIEGEI-CFVMEHMERGSLFDSLRV-RKKLSEDVISGVAYRVLKGLQYLHGMQIIHGD 171
           ++   G+    V+E +   SL D   +  +  S   +  +A +++  ++Y+H   +I+ D
Sbjct: 72  YFGPCGKYNAMVLELLGP-SLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRD 130

Query: 172 IKPSNLLINGKGEVK------IADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCA 225
           +KP N LI G+   K      I DF +++   +     +     + ++        GT  
Sbjct: 131 VKPENFLI-GRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSL-------TGTAR 182

Query: 226 YMS--------PERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYP 263
           YMS          R D            D+ +LG + +  L G  P
Sbjct: 183 YMSINTHLGKEQSRRD------------DLEALGHMFMYFLRGSLP 216

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 73.8 bits (181), Expect = 7e-15
 Identities = 56/252 (22%), Positives = 103/252 (40%), Gaps = 24/252 (9%)

Query: 68  HQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEH 127
             K N     K           +  A   ++ +RLDS    +  A    +E +    +E 
Sbjct: 119 RSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 178

Query: 128 MERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKI 187
            E          +  L+ + +   +++V KG+++L   + IH D+   N+L++ K  VKI
Sbjct: 179 EEAPEDLY----KDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKI 234

Query: 188 ADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDV 247
            DFG++R +        + + +    G+A +       +M+PE +        Y    DV
Sbjct: 235 CDFGLARDI--------YKDPDYVRKGDARLPLK----WMAPETIFD----RVYTIQSDV 278

Query: 248 WSLGVVVLE-CLVGHYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEK 306
           WS GV++ E   +G  P  G     +    +     G R+  P+  +PE  + +  C   
Sbjct: 279 WSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE---GTRMRAPDYTTPEMYQTMLDCWHG 335

Query: 307 DWRKRGTVEELL 318
           +  +R T  EL+
Sbjct: 336 EPSQRPTFSELV 347

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 72.8 bits (179), Expect = 8e-15
 Identities = 54/224 (24%), Positives = 90/224 (40%), Gaps = 41/224 (18%)

Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLD-SQFIVKCHAV 113
           +G G+ G +Y      +    A+K+    +      Q   E++I K +     I      
Sbjct: 17  IGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIR-- 71

Query: 114 FYTIEGEI-CFVMEHMERGSLFDSLRV-RKKLSEDVISGVAYRVLKGLQYLHGMQIIHGD 171
           +   EG+    VME +   SL D      +K S   +  +A +++  ++Y+H    IH D
Sbjct: 72  WCGAEGDYNVMVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRD 130

Query: 172 IKPSNLLINGKGE----VKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYM 227
           +KP N L+ G G+    V I DFG+++   + R + +     N N+        GT  Y 
Sbjct: 131 VKPDNFLM-GLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNL-------TGTARYA 182

Query: 228 S--------PERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYP 263
           S          R D            D+ SLG V++   +G  P
Sbjct: 183 SINTHLGIEQSRRD------------DLESLGYVLMYFNLGSLP 214

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 72.8 bits (179), Expect = 8e-15
 Identities = 50/225 (22%), Positives = 86/225 (38%), Gaps = 41/225 (18%)

Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLD-SQFIVKCHAV 113
           +G G+ G++++  +  +N   A+K     S      Q   E    K L     I   +  
Sbjct: 18  IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD---APQLRDEYRTYKLLAGCTGIPNVY-- 72

Query: 114 FYTIEGEI-CFVMEHMERGSLFDSLRV-RKKLSEDVISGVAYRVLKGLQYLHGMQIIHGD 171
           ++  EG     V++ +   SL D L +  +K S   ++  A ++L  +Q +H   +++ D
Sbjct: 73  YFGQEGLHNVLVIDLLGP-SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRD 131

Query: 172 IKPSNLLINGKG-----EVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAY 226
           IKP N LI          + + DFG+ +   +     +       N+        GT  Y
Sbjct: 132 IKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNL-------SGTARY 184

Query: 227 MS--------PERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYP 263
           MS          R D            D+ +LG V +  L G  P
Sbjct: 185 MSINTHLGREQSRRD------------DLEALGHVFMYFLRGSLP 217

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 72.5 bits (178), Expect = 1e-14
 Identities = 50/260 (19%), Positives = 85/260 (32%), Gaps = 38/260 (14%)

Query: 27  RRRRHHFPTSNPTSPDVENISDLK-KLT-VLGHGNGGIVYKVRHQKSNSIYALKVLNTTS 84
               +      P    ++++   +  L   +G G  G++Y           A  V+    
Sbjct: 15  TENLYFQSMPFPEGKVLDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEY 74

Query: 85  STIIRHQAAHEAEILKRLDSQFI-----------------VKCHAVFYTIEGEICF-VME 126
                     E +  +R+  +                        +         F VME
Sbjct: 75  QE--NGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVME 132

Query: 127 HMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVK 186
            +    L           +  +  +  R+L  L+Y+H  + +HGDIK +NLL+  K   +
Sbjct: 133 RLGI-DLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQ 191

Query: 187 I--ADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACM-GTCAYMSPERVDSERWGGDYGF 243
           +  AD+G+S        N NH         E       GT  + S   +D+ + G     
Sbjct: 192 VYLADYGLSY---RYCPNGNH-----KQYQENPRKGHNGTIEFTS---LDAHK-GVALSR 239

Query: 244 AGDVWSLGVVVLECLVGHYP 263
             DV  LG  +L  L G  P
Sbjct: 240 RSDVEILGYCMLRWLCGKLP 259

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 72.0 bits (176), Expect = 4e-14
 Identities = 56/224 (25%), Positives = 97/224 (43%), Gaps = 41/224 (18%)

Query: 55  LGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRL-DSQFIVKCHAV 113
           +G G+ G +Y   + ++N   A+K+ N  +      Q  +E++I + L     I      
Sbjct: 15  IGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLLYESKIYRILQGGTGIPNVR-- 69

Query: 114 FYTIEGEI-CFVMEHMERGSLFDSLRV-RKKLSEDVISGVAYRVLKGLQYLHGMQIIHGD 171
           ++ +EG+    VM+ +   SL D      +KLS   +  +A +++  ++++H    +H D
Sbjct: 70  WFGVEGDYNVLVMDLLGP-SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRD 128

Query: 172 IKPSNLLINGKGE----VKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYM 227
           IKP N L+ G G     V I DFG+++   +T  + +     N N+        GT  Y 
Sbjct: 129 IKPDNFLM-GLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNL-------TGTARYA 180

Query: 228 S--------PERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYP 263
           S          R D            D+ SLG V++  L G  P
Sbjct: 181 SVNTHLGIEQSRRD------------DLESLGYVLMYFLRGSLP 212

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 69.0 bits (169), Expect = 2e-13
 Identities = 48/236 (20%), Positives = 92/236 (38%), Gaps = 45/236 (19%)

Query: 55  LGHGNGGIVYKVRHQKSNSI--------YALKV------LNTTSSTIIRHQAAHEAEILK 100
               N GI+Y+     + +         ++LK+      L    +   R     +    K
Sbjct: 50  QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109

Query: 101 RL---DSQFIVKCHAVFYTIEGEICF-VMEHMERGSLFDSLRV--RKKLSEDVISGVAYR 154
           +L       I  C   F   + +  F V+  + R SL  +L V  +  LSE  +  VA R
Sbjct: 110 KLYSTPLLAIPTCMG-FGVHQDKYRFLVLPSLGR-SLQSALDVSPKHVLSERSVLQVACR 167

Query: 155 VLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKI--ADFGVSRIVEETRNNNNH-----NN 207
           +L  L++LH  + +HG++   N+ ++ + + ++  A +G +        +  H      +
Sbjct: 168 LLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF---RYCPSGKHVAYVEGS 224

Query: 208 NNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYP 263
            + +          G   ++S   +D  + G       D+ SLG  +L+ L G  P
Sbjct: 225 RSPHE---------GDLEFIS---MDLHK-GCGPSRRSDLQSLGYCMLKWLYGFLP 267

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 62.9 bits (153), Expect = 2e-11
 Identities = 48/243 (19%), Positives = 84/243 (34%), Gaps = 59/243 (24%)

Query: 55  LGHGNGGIVYKVRHQKSNSI-----YALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVK 109
           +G G  G +Y      S S+       +KV  + +          E +  +R      ++
Sbjct: 43  IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNG-----PLFTELKFYQRAAKPEQIQ 97

Query: 110 -------------CHAVFYTIEGEI-----CFVMEHMERGSLFDSLRV-RKKLSEDVISG 150
                               +  +        +M+      L        K+ S   +  
Sbjct: 98  KWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS-DLQKIYEANAKRFSRKTVLQ 156

Query: 151 VAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGE--VKIADFGVSR--IVEET------R 200
           ++ R+L  L+Y+H  + +HGDIK SNLL+N K    V + D+G++     E         
Sbjct: 157 LSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAAD 216

Query: 201 NNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVG 260
               H+               GT  + S   +D+   G      GD+  LG  +++ L G
Sbjct: 217 PKRCHD---------------GTIEFTS---IDAHN-GVAPSRRGDLEILGYCMIQWLTG 257

Query: 261 HYP 263
           H P
Sbjct: 258 HLP 260

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 50.3 bits (119), Expect = 4e-07
 Identities = 29/252 (11%), Positives = 68/252 (26%), Gaps = 53/252 (21%)

Query: 45  NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIR-------HQAAHEAE 97
               L++   +G G  G V++      ++  A+K++      ++         +   E  
Sbjct: 18  PTEKLQRCEKIGEGVFGEVFQTIAD--HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEII 75

Query: 98  ILKR---LDSQFIVKCHAVFYTIEGEIC-------------------------------- 122
           I K    L  +   +                                             
Sbjct: 76  ISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDD 135

Query: 123 ---FVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLH-GMQIIHGDIKPSNLL 178
               V+E    G   + +R  K  S      + +++   L      ++  H D+   N+L
Sbjct: 136 QLFIVLEFEFGGIDLEQMR-TKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVL 194

Query: 179 INGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWG 238
           +      K+      +           +  +      + +   G   +      D + + 
Sbjct: 195 LKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTL---SRLERDGIVVFCDVSM-DEDLFT 250

Query: 239 GDYGFAGDVWSL 250
           GD  +  D++ L
Sbjct: 251 GDGDYQFDIYRL 262

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540

 Score = 41.2 bits (97), Expect = 4e-04
 Identities = 26/141 (18%), Positives = 52/141 (36%), Gaps = 19/141 (13%)

Query: 59  NGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIE 118
           +  ++ K R +K    Y  + L+     I + + A EA  L  +    I       + ++
Sbjct: 359 DFDVIIKERVKKG---YRDERLD---ENIRKSRTAREARYLALVKDFGI--PAPYIFDVD 410

Query: 119 G-EICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNL 177
                 +M ++      D +     ++  +   V          LH   +IH D+  SN 
Sbjct: 411 LDNKRIMMSYINGKLAKDVIEDNLDIAYKIGEIVGK--------LHKNDVIHNDLTTSNF 462

Query: 178 LINGKGEVKIADFGVSRIVEE 198
           + +    + I DFG+ +I   
Sbjct: 463 IFDKD--LYIIDFGLGKISNL 481

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	337
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.98
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.94
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.92
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.85
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.75
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.42
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.29
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.24
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.12
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.95
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.83
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.7
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.59
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.47
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.38
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.32
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	98.29
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.15
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.99
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.96
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.91
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.78
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.71
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.6
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.55
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.55
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.46
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.39
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.28
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.24
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	97.12
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.56
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.98
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	93.17
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	89.82
1cja_A	342	Protein (actin-fragmin kinase); transferase; HET:	80.12

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.8e-64  Score=439.23  Aligned_cols=266  Identities=27%  Similarity=0.416  Sum_probs=229.5

Q ss_pred             ccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCe
Q 019650           43 VENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGE  120 (337)
Q Consensus        43 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~  120 (337)
                      ....++|++++.||+|+||+||+|.+..+++.||+|++.+..  .....+.+.+|+.++++++||||+++++++.+ +..
T Consensus        28 ~~~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-~~~  106 (311)
T 4aw0_A           28 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD-DEK  106 (311)
T ss_dssp             CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSE
T ss_pred             CCCccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-CCE
Confidence            345678999999999999999999999999999999997542  22345678899999999999999999999877 789


Q ss_pred             EEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccc
Q 019650          121 ICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETR  200 (337)
Q Consensus       121 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~  200 (337)
                      +|+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||++.......
T Consensus       107 ~yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~  186 (311)
T 4aw0_A          107 LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES  186 (311)
T ss_dssp             EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred             EEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence            99999999999999999998999999999999999999999999999999999999999999999999999998764332


Q ss_pred             cCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHh
Q 019650          201 NNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAI  280 (337)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~  280 (337)
                      ..            ......+||+.|+|||++.    +..|+.++|||||||++|+|++|..||.+.+...    +....
T Consensus       187 ~~------------~~~~~~~GTp~YmAPEvl~----~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~----~~~~i  246 (311)
T 4aw0_A          187 KQ------------ARANSFVGTAQYVSPELLT----EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGL----IFAKI  246 (311)
T ss_dssp             TC------------CCBCCCCSCGGGCCHHHHH----HSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHH
T ss_pred             Cc------------ccccCcccCcccCCHHHHc----CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHH
Confidence            11            2334567999999999998    4578999999999999999999999997643322    22222


Q ss_pred             hccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHH------HhcCccccccCCCc
Q 019650          281 CFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEE------LLAYPFVTKRSSSS  330 (337)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e------il~hp~f~~~~~~~  330 (337)
                      ... ...+|..+++.+++||.+||..||.+|||++|      |++||||++.+|..
T Consensus       247 ~~~-~~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~  301 (311)
T 4aw0_A          247 IKL-EYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWEN  301 (311)
T ss_dssp             HHT-CCCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTT
T ss_pred             HcC-CCCCCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHH
Confidence            222 45677889999999999999999999999988      58999999987754

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=5.3e-63  Score=436.88  Aligned_cols=259  Identities=27%  Similarity=0.448  Sum_probs=220.8

Q ss_pred             CccccccccccccCcceEEEEEEEccCCceEEEEEeecCC-chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEE
Q 019650           45 NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICF  123 (337)
Q Consensus        45 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~l  123 (337)
                      +.++|++++.||+|+||+||+|.+..+++.||||+++... .....+.+.+|+.++++++||||+++++++.+ +..+|+
T Consensus        22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~-~~~~yi  100 (350)
T 4b9d_A           22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEE-NGSLYI  100 (350)
T ss_dssp             CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEE
T ss_pred             cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEE-CCEEEE
Confidence            4689999999999999999999999999999999997654 44456788999999999999999999999876 789999


Q ss_pred             EEeccCCCCchHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhcccc
Q 019650          124 VMEHMERGSLFDSLRVR--KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRN  201 (337)
Q Consensus       124 v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~  201 (337)
                      ||||++||+|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||++....... 
T Consensus       101 VmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-  179 (350)
T 4b9d_A          101 VMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV-  179 (350)
T ss_dssp             EEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH-
T ss_pred             EEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCc-
Confidence            99999999999999654  457999999999999999999999999999999999999999999999999998765432 


Q ss_pred             CCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhh
Q 019650          202 NNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAIC  281 (337)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~  281 (337)
                                   ......+||+.|+|||++.    +..|+.++|||||||++|||+||+.||.+...    ..++....
T Consensus       180 -------------~~~~~~~GT~~YmAPE~l~----~~~y~~~~DiwSlGvilyemltG~~PF~~~~~----~~~~~~i~  238 (350)
T 4b9d_A          180 -------------ELARACIGTPYYLSPEICE----NKPYNNKSDIWALGCVLYELCTLKHAFEAGSM----KNLVLKII  238 (350)
T ss_dssp             -------------HHHHHHHSCCTTCCHHHHT----TCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHH
T ss_pred             -------------ccccccCCCccccCHHHHC----CCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH----HHHHHHHH
Confidence                         2233457999999999998    55789999999999999999999999976432    33344444


Q ss_pred             ccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCcccccc
Q 019650          282 FGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKR  326 (337)
Q Consensus       282 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~  326 (337)
                      .+..+..+..++..+++||.+||..||++|||++|+|+||||++.
T Consensus       239 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~  283 (350)
T 4b9d_A          239 SGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKR  283 (350)
T ss_dssp             HTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHTT
T ss_pred             cCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhcC
Confidence            455566777889999999999999999999999999999999864

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.1e-62  Score=422.40  Aligned_cols=257  Identities=27%  Similarity=0.399  Sum_probs=207.1

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeE
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEI  121 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~  121 (337)
                      ..+++|++++.||+|+||+||+|.+..+++.||+|+++...  .....+.+.+|+.++++++||||+++++++.+ ...+
T Consensus        10 ~~ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-~~~~   88 (275)
T 3hyh_A           10 AHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKS-KDEI   88 (275)
T ss_dssp             ----CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEE
T ss_pred             CEeeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE-CCEE
Confidence            45789999999999999999999999999999999997653  23345678899999999999999999998876 7899


Q ss_pred             EEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhcccc
Q 019650          122 CFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRN  201 (337)
Q Consensus       122 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~  201 (337)
                      |+||||+ +|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||++....... 
T Consensus        89 ~ivmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~-  166 (275)
T 3hyh_A           89 IMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN-  166 (275)
T ss_dssp             EEEEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred             EEEEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCC-
Confidence            9999999 56999999988999999999999999999999999999999999999999999999999999997654332 


Q ss_pred             CCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCC-CccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHh
Q 019650          202 NNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDY-GFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAI  280 (337)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~-~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~  280 (337)
                                    .....+||+.|+|||++..    ..+ +.++|||||||++|+|+||+.||.+....    ......
T Consensus       167 --------------~~~~~~GT~~Y~APE~~~~----~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~----~~~~~i  224 (275)
T 3hyh_A          167 --------------FLKTSCGSPNYAAPEVISG----KLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP----VLFKNI  224 (275)
T ss_dssp             ----------------------CTTSCHHHHSS----SSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHH
T ss_pred             --------------ccCCeeECcccCChhhhcC----CCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHH----HHHHHH
Confidence                          2233579999999999984    344 67999999999999999999999653322    222222


Q ss_pred             hccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCcccccc
Q 019650          281 CFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKR  326 (337)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~  326 (337)
                      .. ....++..+++.+++||.+||+.||++|||++|+++||||+..
T Consensus       225 ~~-~~~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~~  269 (275)
T 3hyh_A          225 SN-GVYTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKVD  269 (275)
T ss_dssp             HH-TCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHTT
T ss_pred             Hc-CCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCcccccC
Confidence            22 2456778899999999999999999999999999999999854

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.5e-62  Score=433.24  Aligned_cols=265  Identities=29%  Similarity=0.433  Sum_probs=225.4

Q ss_pred             ccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 019650           46 ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVM  125 (337)
Q Consensus        46 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~  125 (337)
                      .+.|++++.||+|+||+||+|.+..+|+.||||+++.... ...+.+.+|+.++++++||||+++++++.+ +..+|+||
T Consensus        73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~-~~~~~ivm  150 (346)
T 4fih_A           73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ-QRRELLFNEVVIMRDYQHENVVEMYNSYLV-GDELWVVM  150 (346)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC-SSGGGGHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEEE
T ss_pred             hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCch-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-CCEEEEEE
Confidence            3579999999999999999999999999999999976532 234567889999999999999999999877 78999999


Q ss_pred             eccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCCC
Q 019650          126 EHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNH  205 (337)
Q Consensus       126 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~  205 (337)
                      ||++||+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||++.......     
T Consensus       151 Ey~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-----  224 (346)
T 4fih_A          151 EFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-----  224 (346)
T ss_dssp             CCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS-----
T ss_pred             eCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCC-----
Confidence            99999999999975 579999999999999999999999999999999999999999999999999998765432     


Q ss_pred             CCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhccCC
Q 019650          206 NNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGER  285 (337)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~  285 (337)
                               ......+||+.|+|||++.    +..|+.++|||||||++|||++|+.||.+.....    .+........
T Consensus       225 ---------~~~~~~~GTp~YmAPEvl~----~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~----~~~~i~~~~~  287 (346)
T 4fih_A          225 ---------PRRKSLVGTPYWMAPELIS----RLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK----AMKMIRDNLP  287 (346)
T ss_dssp             ---------CCBCCCCSCGGGCCHHHHT----TCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH----HHHHHHHSSC
T ss_pred             ---------CcccccccCcCcCCHHHHC----CCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH----HHHHHHcCCC
Confidence                     2233457999999999998    5578999999999999999999999997643322    2222222222


Q ss_pred             --CCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCCccccCc
Q 019650          286 --LEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNIEGL  335 (337)
Q Consensus       286 --~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~~~~~~~  335 (337)
                        ...+..+++.+++||.+||..||++|||++|+|+||||++....+.+.-+
T Consensus       288 ~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~~p~~l~pl  339 (346)
T 4fih_A          288 PRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPASIVPL  339 (346)
T ss_dssp             CCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCCGGGTGGG
T ss_pred             CCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCCCCcccCcc
Confidence              23345689999999999999999999999999999999988766655433

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.7e-62  Score=426.79  Aligned_cols=261  Identities=31%  Similarity=0.506  Sum_probs=216.4

Q ss_pred             CccccccccccccCcceEEEEEEEc---cCCceEEEEEeecCC-chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCe
Q 019650           45 NISDLKKLTVLGHGNGGIVYKVRHQ---KSNSIYALKVLNTTS-STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGE  120 (337)
Q Consensus        45 ~~~~y~~~~~lg~g~~~~v~~~~~~---~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~  120 (337)
                      ..++|++++.||+|+||+||+|.+.   .+++.||+|+++... .......+.+|+.++++++||||+++++++.+ +..
T Consensus        22 ~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-~~~  100 (304)
T 3ubd_A           22 DPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQT-EGK  100 (304)
T ss_dssp             CGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEE-TTE
T ss_pred             CccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE-CCE
Confidence            3478999999999999999999874   567899999997543 12223457789999999999999999999877 789


Q ss_pred             EEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccc
Q 019650          121 ICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETR  200 (337)
Q Consensus       121 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~  200 (337)
                      +|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||++.......
T Consensus       101 ~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~  180 (304)
T 3ubd_A          101 LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE  180 (304)
T ss_dssp             EEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-----
T ss_pred             EEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCCC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999998654332


Q ss_pred             cCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHh
Q 019650          201 NNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAI  280 (337)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~  280 (337)
                                    ......+||+.|+|||++.    +..|+.++|||||||++|+|+||+.||.+.+..+..    ...
T Consensus       181 --------------~~~~~~~GT~~YmAPE~~~----~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~----~~i  238 (304)
T 3ubd_A          181 --------------KKAYSFCGTVEYMAPEVVN----RRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETM----TMI  238 (304)
T ss_dssp             --------------CCCCSCCCCGGGCCHHHHH----TSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHH
T ss_pred             --------------ccccccccCcccCCHHHhc----cCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHH----HHH
Confidence                          2223457999999999998    557899999999999999999999999764333222    222


Q ss_pred             hccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCC-----HHHHhcCccccccCCC
Q 019650          281 CFGERLEMPETASPEFRRFVRSCLEKDWRKRGT-----VEELLAYPFVTKRSSS  329 (337)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s-----~~eil~hp~f~~~~~~  329 (337)
                      .. ....+|..+++.+++||.+||+.||++|||     ++|+++||||++.+|.
T Consensus       239 ~~-~~~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw~  291 (304)
T 3ubd_A          239 LK-AKLGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWN  291 (304)
T ss_dssp             HH-CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred             Hc-CCCCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCHH
Confidence            22 245677889999999999999999999998     5899999999987653

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=3.1e-61  Score=416.83  Aligned_cols=256  Identities=28%  Similarity=0.422  Sum_probs=215.5

Q ss_pred             ccc-ccccccccCcceEEEEEEEccCCceEEEEEeecCC-chHhHHHHHHHHHHHHhcCCCCceeeeeeEEee---CCeE
Q 019650           47 SDL-KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTI---EGEI  121 (337)
Q Consensus        47 ~~y-~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~---~~~~  121 (337)
                      ++| ++.+.||+|+||+||+|.+..++..||+|++.... .....+.+.+|+.++++++||||+++++++.+.   +..+
T Consensus        25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~  104 (290)
T 3fpq_A           25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI  104 (290)
T ss_dssp             SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEE
T ss_pred             CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEE
Confidence            444 67788999999999999999999999999997543 444567789999999999999999999988653   3468


Q ss_pred             EEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCCeEEcC-CCcEEEeeccCccchhc
Q 019650          122 CFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQ--IIHGDIKPSNLLING-KGEVKIADFGVSRIVEE  198 (337)
Q Consensus       122 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~--ivH~dl~~~Nili~~-~~~~~l~Dfg~~~~~~~  198 (337)
                      |+||||++||+|.+++...+.+++..++.++.||+.||+|||++|  |+||||||+|||++. ++++||+|||++.....
T Consensus       105 ~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~  184 (290)
T 3fpq_A          105 VLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  184 (290)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             EEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence            999999999999999999899999999999999999999999998  999999999999974 78999999999964322


Q ss_pred             cccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHH
Q 019650          199 TRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALIC  278 (337)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~  278 (337)
                                      ......+||+.|+|||++.     ..|+.++|||||||++|||+||+.||....+.....   .
T Consensus       185 ----------------~~~~~~~GTp~YmAPE~~~-----~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~---~  240 (290)
T 3fpq_A          185 ----------------SFAKAVIGTPEFMAPEMYE-----EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIY---R  240 (290)
T ss_dssp             ----------------TSBEESCSSCCCCCGGGGG-----TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHH---H
T ss_pred             ----------------CccCCcccCccccCHHHcC-----CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHH---H
Confidence                            2223457999999999986     258999999999999999999999997654433332   2


Q ss_pred             HhhccC-CCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCcccccc
Q 019650          279 AICFGE-RLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKR  326 (337)
Q Consensus       279 ~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~  326 (337)
                      ....+. +..++...++.+++||.+||..||++|||++|+|+||||++.
T Consensus       241 ~i~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~~  289 (290)
T 3fpq_A          241 RVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE  289 (290)
T ss_dssp             HHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred             HHHcCCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCC
Confidence            222222 234456678899999999999999999999999999999863

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=4.1e-61  Score=434.22  Aligned_cols=265  Identities=29%  Similarity=0.444  Sum_probs=226.5

Q ss_pred             ccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 019650           46 ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVM  125 (337)
Q Consensus        46 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~  125 (337)
                      .+.|++++.||+|+||+||+|.+..+|+.||||++...... ..+.+.+|+.++++++||||+++++++.+ +..+|+||
T Consensus       150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~-~~~~~~~Ei~il~~l~HpnIV~l~~~~~~-~~~~~iVm  227 (423)
T 4fie_A          150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ-RRELLFNEVVIMRDYQHENVVEMYNSYLV-GDELWVVM  227 (423)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCS-SGGGHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEEE
T ss_pred             hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchh-HHHHHHHHHHHHHhCCCCCCCceEEEEEE-CCEEEEEE
Confidence            35799999999999999999999999999999999765432 34567899999999999999999999877 78999999


Q ss_pred             eccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCCC
Q 019650          126 EHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNH  205 (337)
Q Consensus       126 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~  205 (337)
                      |||+||+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||++.......     
T Consensus       228 Ey~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~-----  301 (423)
T 4fie_A          228 EFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-----  301 (423)
T ss_dssp             ECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC-----
T ss_pred             eCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCC-----
Confidence            99999999999864 569999999999999999999999999999999999999999999999999998764432     


Q ss_pred             CCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhccC-
Q 019650          206 NNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGE-  284 (337)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~-  284 (337)
                               ......+||+.|||||++.    +..|+.++|||||||++|||++|+.||.+......    +..+.... 
T Consensus       302 ---------~~~~~~~GTp~YmAPEvl~----~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~----~~~i~~~~~  364 (423)
T 4fie_A          302 ---------PRRKSLVGTPYWMAPELIS----RLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA----MKMIRDNLP  364 (423)
T ss_dssp             ---------CCBCCCEECTTTCCHHHHT----TCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH----HHHHHHSCC
T ss_pred             ---------ccccccccCcCcCCHHHHC----CCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH----HHHHHcCCC
Confidence                     2233457999999999998    55789999999999999999999999976433222    22222222 


Q ss_pred             -CCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCCccccCc
Q 019650          285 -RLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNIEGL  335 (337)
Q Consensus       285 -~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~~~~~~~  335 (337)
                       ....+..+++.+++||.+||..||++|||++|+|+||||++....+.+.-+
T Consensus       365 ~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~~p~~l~pl  416 (423)
T 4fie_A          365 PRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPASIVPL  416 (423)
T ss_dssp             CCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCCGGGTGGG
T ss_pred             CCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCCCCCccccch
Confidence             233456789999999999999999999999999999999988776665443

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=4.1e-60  Score=416.61  Aligned_cols=264  Identities=24%  Similarity=0.292  Sum_probs=220.8

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEE
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICF  123 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~l  123 (337)
                      ...+.|++.++||+|+||+||+|.+..+++.||||+++.+..      ..+|+.++++++||||+++++++.+ ++.+|+
T Consensus        55 ~~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~------~~~E~~il~~l~HpnIV~l~~~~~~-~~~~~i  127 (336)
T 4g3f_A           55 EEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF------RVEELVACAGLSSPRIVPLYGAVRE-GPWVNI  127 (336)
T ss_dssp             BTTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC------CTHHHHTTTTCCCTTBCCEEEEEEE-TTEEEE
T ss_pred             cchhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh------HHHHHHHHHhCCCCCCCcEEEEEEE-CCEEEE
Confidence            456789999999999999999999999999999999986532      2469999999999999999999876 789999


Q ss_pred             EEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCC-cEEEeeccCccchhccccC
Q 019650          124 VMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKG-EVKIADFGVSRIVEETRNN  202 (337)
Q Consensus       124 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~-~~~l~Dfg~~~~~~~~~~~  202 (337)
                      ||||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.+| ++||+|||++.........
T Consensus       128 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~  207 (336)
T 4g3f_A          128 FMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG  207 (336)
T ss_dssp             EECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred             EEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence            999999999999999889999999999999999999999999999999999999999887 6999999999876543221


Q ss_pred             CCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhc
Q 019650          203 NNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICF  282 (337)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~  282 (337)
                      ...         ......+||+.|+|||++.    +..|+.++|||||||++|||+||+.||.+.........+...  .
T Consensus       208 ~~~---------~~~~~~~GT~~YmAPE~~~----~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~--~  272 (336)
T 4g3f_A          208 KSL---------LTGDYIPGTETHMAPEVVM----GKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASE--P  272 (336)
T ss_dssp             ---------------CCCCCCGGGCCHHHHT----TCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHS--C
T ss_pred             cce---------ecCCccccCccccCHHHHC----CCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcC--C
Confidence            110         1223457999999999998    567899999999999999999999999876555444443322  1


Q ss_pred             cCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHH-------------hcCccccccCCC
Q 019650          283 GERLEMPETASPEFRRFVRSCLEKDWRKRGTVEEL-------------LAYPFVTKRSSS  329 (337)
Q Consensus       283 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~ei-------------l~hp~f~~~~~~  329 (337)
                      .....+++.+++.+.++|.+||..||.+|||+.|+             |+|||+.+...+
T Consensus       273 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~P  332 (336)
T 4g3f_A          273 PPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKEP  332 (336)
T ss_dssp             CGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCCC
T ss_pred             CCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCCC
Confidence            11234677889999999999999999999999997             679999876543

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=3.4e-59  Score=407.37  Aligned_cols=272  Identities=19%  Similarity=0.330  Sum_probs=206.3

Q ss_pred             ccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCC------
Q 019650           46 ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEG------  119 (337)
Q Consensus        46 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~------  119 (337)
                      .++|++++.||+|+||+||+|.+..+++.||+|+++........+.+.+|+.++++++||||+++++++.+.+.      
T Consensus         4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~   83 (299)
T 4g31_A            4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP   83 (299)
T ss_dssp             HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred             chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence            46899999999999999999999999999999999877666677888999999999999999999999876432      


Q ss_pred             -----eEEEEEeccCCCCchHHhhhcCC---CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeecc
Q 019650          120 -----EICFVMEHMERGSLFDSLRVRKK---LSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFG  191 (337)
Q Consensus       120 -----~~~lv~e~~~~~~L~~~l~~~~~---l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg  191 (337)
                           ++|+||||++||+|.+++.....   .++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||
T Consensus        84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFG  163 (299)
T 4g31_A           84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFG  163 (299)
T ss_dssp             ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCC
T ss_pred             cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCc
Confidence                 47999999999999999986654   4567789999999999999999999999999999999999999999999


Q ss_pred             CccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCch
Q 019650          192 VSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP  271 (337)
Q Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~  271 (337)
                      ++...............  ..........+||+.|+|||++.    +..|+.++|||||||++|||++   ||..   ..
T Consensus       164 la~~~~~~~~~~~~~~~--~~~~~~~~~~~GT~~YmAPE~~~----~~~y~~~~DiwSlGvilyell~---Pf~~---~~  231 (299)
T 4g31_A          164 LVTAMDQDEEEQTVLTP--MPAYARHTGQVGTKLYMSPEQIH----GNSYSHKVDIFSLGLILFELLY---PFST---QM  231 (299)
T ss_dssp             CC----------------------------CCCTTSCHHHHT----TCCCCTHHHHHHHHHHHHHHHS---CCSS---HH
T ss_pred             cceecCCCccccccccc--cccccccCCcccCccccCHHHHc----CCCCCCHHHHHHHHHHHHHHcc---CCCC---cc
Confidence            99877553322111000  00002233457999999999998    5678999999999999999996   7743   22


Q ss_pred             hHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCC
Q 019650          272 DLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSS  329 (337)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~  329 (337)
                      .....+........+..+...++.+.+||.+||+.||.+|||++|+|+||||++.++.
T Consensus       232 ~~~~~~~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~~p  289 (299)
T 4g31_A          232 ERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFP  289 (299)
T ss_dssp             HHHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC---
T ss_pred             HHHHHHHHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCCCC
Confidence            2223333333332222233446778899999999999999999999999999987654

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=8.7e-58  Score=413.05  Aligned_cols=270  Identities=23%  Similarity=0.340  Sum_probs=219.8

Q ss_pred             cccccccccccCcceEEEEEEEccCCceEEEEEeecCC-chHhHHHHHHHHHHHHhcCCCCceeeeeeEEee-----CCe
Q 019650           47 SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTI-----EGE  120 (337)
Q Consensus        47 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~  120 (337)
                      ++|++++.||+|+||+||+|.+..+|+.||||+++... .....+.+.+|+.++++++||||+++++++...     ...
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            68999999999999999999999999999999997653 334456788999999999999999999987542     357


Q ss_pred             EEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccc
Q 019650          121 ICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETR  200 (337)
Q Consensus       121 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~  200 (337)
                      +|+||||++ |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus       134 ~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~  212 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSP  212 (398)
T ss_dssp             EEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC----
T ss_pred             EEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccCc
Confidence            899999996 5899999988999999999999999999999999999999999999999999999999999998764432


Q ss_pred             cCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHh
Q 019650          201 NNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAI  280 (337)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~  280 (337)
                      ....          ......+||+.|+|||++.+.   ..++.++||||+||++|||++|++||.+......+..+....
T Consensus       213 ~~~~----------~~~~~~~GT~~Y~APEv~~~~---~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~  279 (398)
T 4b99_A          213 AEHQ----------YFMTEYVATRWYRAPELMLSL---HEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVL  279 (398)
T ss_dssp             ---C----------CCCCSSCCCCTTCCHHHHTTC---SCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHH
T ss_pred             cccc----------cccccceeChHhcCHHHhcCC---CCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhc
Confidence            1111          233456799999999998742   357899999999999999999999998755444333333221


Q ss_pred             hccCC-------------------CC-------CCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCCc
Q 019650          281 CFGER-------------------LE-------MPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSS  330 (337)
Q Consensus       281 ~~~~~-------------------~~-------~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~~  330 (337)
                      .....                   ..       ..+..++.+.+||.+||..||.+|||++|+|+||||++.....
T Consensus       280 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~p~  355 (398)
T 4b99_A          280 GTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDPD  355 (398)
T ss_dssp             CCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCCGG
T ss_pred             CCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCCCc
Confidence            11100                   00       1135688999999999999999999999999999999865443

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=7.7e-57  Score=392.09  Aligned_cols=264  Identities=22%  Similarity=0.361  Sum_probs=212.4

Q ss_pred             CCCCccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCC-chHhHHHHHHHHHHHHhcCCCCceeeeeeEEee
Q 019650           39 TSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTI  117 (337)
Q Consensus        39 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~  117 (337)
                      ...|+...+++++.+.||+|+||+||+|.+.   ..||||+++... .....+.+.+|+.++++++||||+++++++.  
T Consensus        28 ~~~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~--  102 (307)
T 3omv_A           28 SYYWEIEASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT--  102 (307)
T ss_dssp             -CCCBCCTTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC--
T ss_pred             CcCcEEcHHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE--
Confidence            3456777899999999999999999999864   359999987543 4455678899999999999999999999763  


Q ss_pred             CCeEEEEEeccCCCCchHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccch
Q 019650          118 EGEICFVMEHMERGSLFDSLRVR-KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIV  196 (337)
Q Consensus       118 ~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~  196 (337)
                      ++.+++||||++||+|.+++... ..+++..+..++.|++.||+|||+++||||||||+|||++.++++||+|||++...
T Consensus       103 ~~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~  182 (307)
T 3omv_A          103 KDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVK  182 (307)
T ss_dssp             SSSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC-
T ss_pred             CCeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceec
Confidence            46789999999999999999754 57999999999999999999999999999999999999999999999999999765


Q ss_pred             hccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHH
Q 019650          197 EETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMAL  276 (337)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~  276 (337)
                      ......            ......+||+.|||||++.... +..|+.++|||||||++|||+||+.||.+..........
T Consensus       183 ~~~~~~------------~~~~~~~GT~~ymAPE~l~~~~-~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~  249 (307)
T 3omv_A          183 SRWSGS------------QQVEQPTGSVLWMAPEVIRMQD-NNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFM  249 (307)
T ss_dssp             -----------------------CCCCTTSCCHHHHHCCS-SCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHH
T ss_pred             ccCCcc------------eeecccccCCCccCHHHhhccC-CCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHH
Confidence            432211            2223446999999999997432 346899999999999999999999999776554444333


Q ss_pred             HHHhh-ccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          277 ICAIC-FGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       277 ~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                      ..... .......+..+++.+.+|+.+||+.||++|||+.+|+++
T Consensus       250 ~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~  294 (307)
T 3omv_A          250 VGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSS  294 (307)
T ss_dssp             HHTTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred             HhcCCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            33211 112234566789999999999999999999999987654

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.4e-57  Score=396.69  Aligned_cols=261  Identities=26%  Similarity=0.387  Sum_probs=219.0

Q ss_pred             cCccccccccccccCcceEEEEEEEc-----cCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeC
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQ-----KSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIE  118 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~  118 (337)
                      ...++|.+.+.||+|+||+||+|.+.     .++..||||+++... ....+.+.+|+.++++++||||+++++++.+ +
T Consensus        10 I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~-~   87 (299)
T 4asz_A           10 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNLQHEHIVKFYGVCVE-G   87 (299)
T ss_dssp             CCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-S
T ss_pred             cCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC-hHHHHHHHHHHHHHHhCCCCCCccEEEEEee-C
Confidence            44678999999999999999999874     467889999997653 4456788999999999999999999999876 6


Q ss_pred             CeEEEEEeccCCCCchHHhhhc-------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcE
Q 019650          119 GEICFVMEHMERGSLFDSLRVR-------------KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEV  185 (337)
Q Consensus       119 ~~~~lv~e~~~~~~L~~~l~~~-------------~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~  185 (337)
                      ..+++||||+++|+|.+++...             ..+++..+..++.|++.||+|||+++|+||||||+|||++.++++
T Consensus        88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~  167 (299)
T 4asz_A           88 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLV  167 (299)
T ss_dssp             SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCE
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcE
Confidence            7899999999999999999754             369999999999999999999999999999999999999999999


Q ss_pred             EEeeccCccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCC
Q 019650          186 KIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPL  264 (337)
Q Consensus       186 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf  264 (337)
                      ||+|||+++........            .......||+.|+|||++.    +..|+.++|||||||++|||+| |+.||
T Consensus       168 Ki~DFGla~~~~~~~~~------------~~~~~~~gt~~ymAPE~~~----~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf  231 (299)
T 4asz_A          168 KIGDFGMSRDVYSTDYY------------RVGGHTMLPIRWMPPESIM----YRKFTTESDVWSLGVVLWEIFTYGKQPW  231 (299)
T ss_dssp             EECCCSCHHHHTGGGCE------------EETTTEEECGGGCCHHHHH----HCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             EECCcccceecCCCCce------------eecCceecChhhcCHHHHc----CCCCCchhhHHHHHHHHHHHHcCCCCCC
Confidence            99999999876543211            1222345899999999998    4578999999999999999999 89999


Q ss_pred             CCCCCchhHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCC
Q 019650          265 IGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSS  328 (337)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~  328 (337)
                      .+...    .++......+..+..|..+++.+.+|+.+||+.||++|||+++|  ++|+++...
T Consensus       232 ~~~~~----~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~~~~  289 (299)
T 4asz_A          232 YQLSN----NEVIECITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQNLAK  289 (299)
T ss_dssp             TTSCH----HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHHHHHH
T ss_pred             CCCCH----HHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHHHHHh
Confidence            76543    23444455566777888999999999999999999999999999  457765443

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=9.1e-57  Score=393.12  Aligned_cols=257  Identities=22%  Similarity=0.349  Sum_probs=218.4

Q ss_pred             ccCccccccccccccCcceEEEEEEEc-----cCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEee
Q 019650           43 VENISDLKKLTVLGHGNGGIVYKVRHQ-----KSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTI  117 (337)
Q Consensus        43 ~~~~~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~  117 (337)
                      +...+++++.+.||+|+||+||+|...     .+++.||||+++........+.+.+|+.++++++||||+++++++.+ 
T Consensus        22 ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-  100 (308)
T 4gt4_A           22 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTK-  100 (308)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred             cCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEE-
Confidence            345788999999999999999999863     46788999999876655567889999999999999999999999876 


Q ss_pred             CCeEEEEEeccCCCCchHHhhhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcC
Q 019650          118 EGEICFVMEHMERGSLFDSLRVR----------------KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLING  181 (337)
Q Consensus       118 ~~~~~lv~e~~~~~~L~~~l~~~----------------~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~  181 (337)
                      ...+++||||+++|+|.++|...                ..+++..+..++.||+.||+|||+++||||||||+|||++.
T Consensus       101 ~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~  180 (308)
T 4gt4_A          101 DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYD  180 (308)
T ss_dssp             SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECC
Confidence            67899999999999999999642                35899999999999999999999999999999999999999


Q ss_pred             CCcEEEeeccCccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-C
Q 019650          182 KGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-G  260 (337)
Q Consensus       182 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g  260 (337)
                      ++++||+|||+++........            .......||+.|+|||++.    +..|+.++||||||+++|||+| |
T Consensus       181 ~~~~Ki~DFGlar~~~~~~~~------------~~~~~~~gt~~ymAPE~l~----~~~~s~ksDVwSfGvvl~El~t~g  244 (308)
T 4gt4_A          181 KLNVKISDLGLFREVYAADYY------------KLLGNSLLPIRWMAPEAIM----YGKFSIDSDIWSYGVVLWEVFSYG  244 (308)
T ss_dssp             GGCEEECCSCCBCGGGGGGCB------------CSSSSSCBCGGGCCHHHHH----HCCCCHHHHHHHHHHHHHHHHTTT
T ss_pred             CCCEEECCcccceeccCCCce------------eEecccccCCcccCHHHHh----CCCCCccchhhhHHHHHHHHHhCC
Confidence            999999999999876543221            1222346899999999998    4579999999999999999999 8


Q ss_pred             CCCCCCCCCchhHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          261 HYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       261 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                      ..||.+...    ..+......+...+.|..++..+.+|+.+||+.||++|||+++|+++
T Consensus       245 ~~Pf~~~~~----~~~~~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~  300 (308)
T 4gt4_A          245 LQPYCGYSN----QDVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR  300 (308)
T ss_dssp             CCTTTTCCH----HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCCCH----HHHHHHHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            999976543    23444455666777888999999999999999999999999999875

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=2.7e-56  Score=393.65  Aligned_cols=256  Identities=29%  Similarity=0.415  Sum_probs=211.0

Q ss_pred             ccCccccccccccccCcceEEEEEEEc-----cCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEee
Q 019650           43 VENISDLKKLTVLGHGNGGIVYKVRHQ-----KSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTI  117 (337)
Q Consensus        43 ~~~~~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~  117 (337)
                      ....++|.+.+.||+|+||+||+|.+.     .++..||||+++.. .....+.+.+|+.++++++||||+++++++.+ 
T Consensus        37 ~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~-  114 (329)
T 4aoj_A           37 HIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-SESARQDFQREAELLTMLQHQHIVRFFGVCTE-  114 (329)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-
T ss_pred             ccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-
Confidence            345678999999999999999999864     46788999999765 34456789999999999999999999999876 


Q ss_pred             CCeEEEEEeccCCCCchHHhhhc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCC
Q 019650          118 EGEICFVMEHMERGSLFDSLRVR---------------KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGK  182 (337)
Q Consensus       118 ~~~~~lv~e~~~~~~L~~~l~~~---------------~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~  182 (337)
                      ...+|+||||+++|+|.+++...               .++++.++..++.|++.||+|||+++|+||||||+|||++.+
T Consensus       115 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~  194 (329)
T 4aoj_A          115 GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQG  194 (329)
T ss_dssp             SSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETT
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCC
Confidence            67899999999999999999753               358999999999999999999999999999999999999999


Q ss_pred             CcEEEeeccCccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CC
Q 019650          183 GEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GH  261 (337)
Q Consensus       183 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~  261 (337)
                      +++||+|||+++........            ......+||+.|+|||++.    +..++.++|||||||++|||+| |+
T Consensus       195 ~~~Ki~DFGla~~~~~~~~~------------~~~~~~~gt~~ymAPE~~~----~~~~~~~sDvwS~Gvvl~Ellt~G~  258 (329)
T 4aoj_A          195 LVVKIGDFGMSRDIYSTDYY------------RVGGRTMLPIRWMPPESIL----YRKFTTESDVWSFGVVLWEIFTYGK  258 (329)
T ss_dssp             TEEEECCCC----------------------------CCCCGGGCCHHHHT----TCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred             CcEEEcccccceeccCCCcc------------eecCcccccccccChhhhc----CCCCCccccccchHHHHHHHHcCCC
Confidence            99999999999866433211            1223346899999999998    5688999999999999999999 89


Q ss_pred             CCCCCCCCchhHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          262 YPLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       262 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                      .||......    +.+.....+..+..|..+++.+.+|+.+||+.||++|||++||+++
T Consensus       259 ~Pf~~~~~~----~~~~~i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~  313 (329)
T 4aoj_A          259 QPWYQLSNT----EAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR  313 (329)
T ss_dssp             CTTCSSCHH----HHHHHHHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred             CCCCCCCHH----HHHHHHHcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            999765432    3334445566777888999999999999999999999999999875

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.6e-56  Score=421.90  Aligned_cols=265  Identities=26%  Similarity=0.436  Sum_probs=223.2

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCceEEEEEeecCC-----chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeC
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-----STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIE  118 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~  118 (337)
                      .++++|++++.||+|+||+||+|.+..+|+.||+|++++..     ..........++.+++.++||||+++++++.+ .
T Consensus       186 ~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~-~  264 (689)
T 3v5w_A          186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT-P  264 (689)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC-S
T ss_pred             CchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEE-C
Confidence            45799999999999999999999999999999999996532     11112222334666777899999999999877 7


Q ss_pred             CeEEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhc
Q 019650          119 GEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEE  198 (337)
Q Consensus       119 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~  198 (337)
                      ..+|+||||++||+|.+++...+.+++..++.++.||+.||.|||++|||||||||+|||++.+|++||+|||++.....
T Consensus       265 ~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~  344 (689)
T 3v5w_A          265 DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK  344 (689)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCC
Confidence            89999999999999999999999999999999999999999999999999999999999999999999999999986643


Q ss_pred             cccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHH
Q 019650          199 TRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALIC  278 (337)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~  278 (337)
                      .                .....+||+.|+|||++..   +..|+.++|+|||||++|+|++|..||.+..... ...+..
T Consensus       345 ~----------------~~~t~~GTp~YmAPEvl~~---~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~-~~~i~~  404 (689)
T 3v5w_A          345 K----------------KPHASVGTHGYMAPEVLQK---GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-KHEIDR  404 (689)
T ss_dssp             C----------------CCCSCCSCGGGCCHHHHST---TCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCC-HHHHHH
T ss_pred             C----------------CCCCccCCcCccCHHHHhC---CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHH
Confidence            2                2234579999999999963   2468999999999999999999999997543322 222222


Q ss_pred             HhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCC-----HHHHhcCccccccCCCc
Q 019650          279 AICFGERLEMPETASPEFRRFVRSCLEKDWRKRGT-----VEELLAYPFVTKRSSSS  330 (337)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s-----~~eil~hp~f~~~~~~~  330 (337)
                       ........+|..+++.+++||.+||..||.+|++     ++||++||||++.+|..
T Consensus       405 -~i~~~~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~~  460 (689)
T 3v5w_A          405 -MTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQM  460 (689)
T ss_dssp             -HHHHCCCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHHH
T ss_pred             -hhcCCCCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHHH
Confidence             2233456778889999999999999999999998     79999999999987653

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=3.2e-56  Score=396.31  Aligned_cols=260  Identities=24%  Similarity=0.328  Sum_probs=222.3

Q ss_pred             CccCccccccccccccCcceEEEEEEEccC-----CceEEEEEeecCCchHhHHHHHHHHHHHHhcCC-CCceeeeeeEE
Q 019650           42 DVENISDLKKLTVLGHGNGGIVYKVRHQKS-----NSIYALKVLNTTSSTIIRHQAAHEAEILKRLDS-QFIVKCHAVFY  115 (337)
Q Consensus        42 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~-~~i~~~~~~~~  115 (337)
                      |+...++|++.+.||+|+||+||+|.+..+     ++.||+|.++........+.+.+|+.++.++.| |||+++++++.
T Consensus        59 wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~  138 (353)
T 4ase_A           59 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT  138 (353)
T ss_dssp             HBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEE
Confidence            456678999999999999999999997643     367999999877666667788999999999977 89999999987


Q ss_pred             eeCCeEEEEEeccCCCCchHHhhhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEE
Q 019650          116 TIEGEICFVMEHMERGSLFDSLRVR----------------KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLI  179 (337)
Q Consensus       116 ~~~~~~~lv~e~~~~~~L~~~l~~~----------------~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili  179 (337)
                      +.+..+++||||+++|+|.++|...                ..+++..+..++.||+.||.|||+++||||||||+|||+
T Consensus       139 ~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl  218 (353)
T 4ase_A          139 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL  218 (353)
T ss_dssp             CTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred             ecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceee
Confidence            7566789999999999999999753                248999999999999999999999999999999999999


Q ss_pred             cCCCcEEEeeccCccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh
Q 019650          180 NGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV  259 (337)
Q Consensus       180 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t  259 (337)
                      +.++.+||+|||+++........            .......||+.|||||++.    +..|+.++|||||||++|||+|
T Consensus       219 ~~~~~vKi~DFGlar~~~~~~~~------------~~~~~~~gt~~ymAPE~l~----~~~y~~ksDVwS~Gv~l~El~t  282 (353)
T 4ase_A          219 SEKNVVKICDFGLARDIYKDPDY------------VRKGDARLPLKWMAPETIF----DRVYTIQSDVWSFGVLLWEIFS  282 (353)
T ss_dssp             CGGGCEEECCCGGGSCTTTCTTS------------EEETTEEECGGGCCHHHHH----HCCCCHHHHHHHHHHHHHHHTT
T ss_pred             CCCCCEEECcchhhhhcccCCCc------------eeeccccccccccCHHHHh----cCCCCCcccEeehHHHHHHHHh
Confidence            99999999999999866433211            2233446899999999998    4589999999999999999998


Q ss_pred             -CCCCCCCCCCchhHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          260 -GHYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       260 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                       |+.||.+..........   ...+..+..|..+++.+.+++.+||+.||++|||+++|++|
T Consensus       283 ~G~~Pf~~~~~~~~~~~~---i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~  341 (353)
T 4ase_A          283 LGASPYPGVKIDEEFCRR---LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  341 (353)
T ss_dssp             TSCCSSTTCCCSHHHHHH---HHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCCCCCHHHHHHHH---HHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence             99999876555444333   34456777888899999999999999999999999999998

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=3.6e-55  Score=391.86  Aligned_cols=271  Identities=25%  Similarity=0.296  Sum_probs=210.0

Q ss_pred             ccccccccccccCcceEEEEEEEc---cCCceEEEEEeecCCchHhHHHHHHHHHHHHhc-CCCCceeeeeeEEeeCCeE
Q 019650           46 ISDLKKLTVLGHGNGGIVYKVRHQ---KSNSIYALKVLNTTSSTIIRHQAAHEAEILKRL-DSQFIVKCHAVFYTIEGEI  121 (337)
Q Consensus        46 ~~~y~~~~~lg~g~~~~v~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~  121 (337)
                      .++|++.+.||+|+||+||+|.++   .+++.||+|.+.....   ..++.+|+.+++.+ +||||+++++++.+ ..++
T Consensus        20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~---~~~~~~E~~~l~~~~~h~nIv~l~~~~~~-~~~~   95 (361)
T 4f9c_A           20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH---PIRIAAELQCLTVAGGQDNVMGVKYCFRK-NDHV   95 (361)
T ss_dssp             GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC---HHHHHHHHHHHHHTCSBTTBCCCSEEEEE-TTEE
T ss_pred             cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC---HHHHHHHHHHHHHhcCCCCCceEEEEEEE-CCEE
Confidence            467999999999999999999875   4678999999876543   34567899999988 69999999998876 7899


Q ss_pred             EEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCC-CcEEEeeccCccchhccc
Q 019650          122 CFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGK-GEVKIADFGVSRIVEETR  200 (337)
Q Consensus       122 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~-~~~~l~Dfg~~~~~~~~~  200 (337)
                      |+||||++||+|.+++.   .+++.+++.++.||+.||+|||++||+||||||+|||++.+ +++||+|||++....+..
T Consensus        96 ~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~  172 (361)
T 4f9c_A           96 VIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTK  172 (361)
T ss_dssp             EEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCS
T ss_pred             EEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcc
Confidence            99999999999999994   69999999999999999999999999999999999999877 799999999997654432


Q ss_pred             cCCCCCCC--------------CCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCC
Q 019650          201 NNNNHNNN--------------NNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIG  266 (337)
Q Consensus       201 ~~~~~~~~--------------~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~  266 (337)
                      ........              ............+||+.|+|||++...   ..|+.++||||+||++|+|++|+.||..
T Consensus       173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~---~~y~~~~DiWSlG~il~ell~G~~Pf~~  249 (361)
T 4f9c_A          173 IELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKC---PNQTTAIDMWSAGVIFLSLLSGRYPFYK  249 (361)
T ss_dssp             CGGGGGC--------------------------CCCCGGGCCHHHHTTC---SCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred             ccccccccccccccccccccccccccccccccccccCccccCHHHHcCC---CCCCCccchhhhHHHHHHHHHCCCCCCC
Confidence            11100000              000011223455799999999999742   3588999999999999999999999976


Q ss_pred             CCCchhHHHHHHHhhc--------------------------------------------------cCCCCCCCCCCHHH
Q 019650          267 FGEKPDLMALICAICF--------------------------------------------------GERLEMPETASPEF  296 (337)
Q Consensus       267 ~~~~~~~~~~~~~~~~--------------------------------------------------~~~~~~~~~~~~~~  296 (337)
                      ..+..+....+.....                                                  .........+++.+
T Consensus       250 ~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a  329 (361)
T 4f9c_A          250 ASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEA  329 (361)
T ss_dssp             CSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHH
T ss_pred             CCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHH
Confidence            5443322222111100                                                  00011234578899


Q ss_pred             HHHHHHHhhcCcCCCCCHHHHhcCcccccc
Q 019650          297 RRFVRSCLEKDWRKRGTVEELLAYPFVTKR  326 (337)
Q Consensus       297 ~~li~~~l~~~p~~R~s~~eil~hp~f~~~  326 (337)
                      .+||.+||..||++|+|++|+|+||||++.
T Consensus       330 ~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i  359 (361)
T 4f9c_A          330 YDLLDKLLDLNPASRITAEEALLHPFFKDM  359 (361)
T ss_dssp             HHHHHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred             HHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence            999999999999999999999999999874

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=1.4e-54  Score=410.02  Aligned_cols=265  Identities=25%  Similarity=0.395  Sum_probs=224.0

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEE
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICF  123 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~l  123 (337)
                      ...++|++++.||+|+||+||+|.+..+|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.+ ...+|+
T Consensus       154 ~il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-~~~~~i  231 (573)
T 3uto_A          154 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH-ESDKETVRKEIQTMSVLRHPTLVNLHDAFED-DNEMVM  231 (573)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEC-SSEEEE
T ss_pred             cCccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc-hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEE-CCEEEE
Confidence            34589999999999999999999999999999999997654 3345678899999999999999999999876 789999


Q ss_pred             EEeccCCCCchHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCC--CcEEEeeccCccchhccc
Q 019650          124 VMEHMERGSLFDSLRV-RKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGK--GEVKIADFGVSRIVEETR  200 (337)
Q Consensus       124 v~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~--~~~~l~Dfg~~~~~~~~~  200 (337)
                      ||||++||+|.+++.. .+.+++.+++.++.||+.||.|||++||+||||||+|||++.+  +++||+|||++..+... 
T Consensus       232 v~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~-  310 (573)
T 3uto_A          232 IYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-  310 (573)
T ss_dssp             EEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT-
T ss_pred             EEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCC-
Confidence            9999999999999964 4679999999999999999999999999999999999999854  79999999999876433 


Q ss_pred             cCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHh
Q 019650          201 NNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAI  280 (337)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~  280 (337)
                                    ......+||+.|+|||++.    +..|+.++|||||||++|+|++|..||.+....+....+ ...
T Consensus       311 --------------~~~~~~~GT~~y~APEv~~----~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i-~~~  371 (573)
T 3uto_A          311 --------------QSVKVTTGTAEFAAPEVAE----GKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNV-KSC  371 (573)
T ss_dssp             --------------SEEEEECSSGGGCCHHHHT----TCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH-HTT
T ss_pred             --------------CceeeeEECccccCHHHhC----CCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH-HhC
Confidence                          2233457999999999998    557899999999999999999999999765433322222 111


Q ss_pred             hccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCCc
Q 019650          281 CFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSS  330 (337)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~~  330 (337)
                      ........+..+++.+++||.+||..||.+|||++|+|+||||+...+..
T Consensus       372 ~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~~  421 (573)
T 3uto_A          372 DWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPG  421 (573)
T ss_dssp             CCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCTT
T ss_pred             CCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCCCC
Confidence            11222233457899999999999999999999999999999999876543

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.2e-52  Score=372.56  Aligned_cols=265  Identities=28%  Similarity=0.416  Sum_probs=226.4

Q ss_pred             ccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCC-chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeE
Q 019650           43 VENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEI  121 (337)
Q Consensus        43 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~  121 (337)
                      ....++|++++.||+|+||.||+|.+..+++.||+|++.... .....+.+.+|+.+++.++|+||+++++++.+ ....
T Consensus        11 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-~~~~   89 (328)
T 3fe3_A           11 QPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIET-EKTL   89 (328)
T ss_dssp             CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEE
T ss_pred             CCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-CCEE
Confidence            456789999999999999999999999999999999997653 34456778899999999999999999998866 7889


Q ss_pred             EEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhcccc
Q 019650          122 CFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRN  201 (337)
Q Consensus       122 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~  201 (337)
                      ++||||++|++|.+++...+.+++..++.++.|++.||+|||++|++||||||+||+++.+++++|+|||++......  
T Consensus        90 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~--  167 (328)
T 3fe3_A           90 YLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG--  167 (328)
T ss_dssp             EEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS--
T ss_pred             EEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCC--
Confidence            999999999999999998889999999999999999999999999999999999999999999999999998765432  


Q ss_pred             CCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCC-CccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHh
Q 019650          202 NNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDY-GFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAI  280 (337)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~-~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~  280 (337)
                                   ......+|++.|+|||.+..    ..+ +.++||||||+++|+|++|..||.+.....    .....
T Consensus       168 -------------~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~----~~~~i  226 (328)
T 3fe3_A          168 -------------GKLDAFCGAPPYAAPELFQG----KKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE----LRERV  226 (328)
T ss_dssp             -------------CGGGTTSSSGGGCCHHHHHT----CCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHH
T ss_pred             -------------CccccccCCcceeCcccccC----CCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHH----HHHHH
Confidence                         12233469999999999984    344 579999999999999999999997643222    22222


Q ss_pred             hccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCCccc
Q 019650          281 CFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNI  332 (337)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~~~~  332 (337)
                      ..+ ....+...+..+.+++.+||..||.+|||++|+++||||+.......+
T Consensus       227 ~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~~~~~  277 (328)
T 3fe3_A          227 LRG-KYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEEDEL  277 (328)
T ss_dssp             HHC-CCCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTCTTCCC
T ss_pred             HhC-CCCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCCccccc
Confidence            222 445667789999999999999999999999999999999987655443

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=3.4e-52  Score=370.66  Aligned_cols=261  Identities=28%  Similarity=0.474  Sum_probs=223.7

Q ss_pred             CccccccccccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEE
Q 019650           45 NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEIC  122 (337)
Q Consensus        45 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~  122 (337)
                      ..++|++++.||+|+||+||+|.+..+++.||+|+++...  .......+.+|..+++.++||||+++++.+.+ ...+|
T Consensus         3 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~~   81 (337)
T 1o6l_A            3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT-HDRLC   81 (337)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC-SSEEE
T ss_pred             ChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEe-CCEEE
Confidence            4789999999999999999999999999999999997542  22234567889999999999999999998876 68899


Q ss_pred             EEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccC
Q 019650          123 FVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNN  202 (337)
Q Consensus       123 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~  202 (337)
                      +||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.+++++|+|||++.......  
T Consensus        82 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~--  159 (337)
T 1o6l_A           82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--  159 (337)
T ss_dssp             EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT--
T ss_pred             EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCC--
Confidence            999999999999999988899999999999999999999999999999999999999999999999999987543221  


Q ss_pred             CCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhc
Q 019650          203 NNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICF  282 (337)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~  282 (337)
                                  ......+||+.|+|||++.    +..++.++|+||||+++|+|++|..||........    ......
T Consensus       160 ------------~~~~~~~gt~~y~aPE~~~----~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~----~~~i~~  219 (337)
T 1o6l_A          160 ------------ATMKTFCGTPEYLAPEVLE----DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL----FELILM  219 (337)
T ss_dssp             ------------CCBCCCEECGGGCCGGGGS----SSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHH
T ss_pred             ------------CcccccccChhhCChhhhc----CCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHH----HHHHHc
Confidence                        2223446899999999998    45789999999999999999999999976432222    222222


Q ss_pred             cCCCCCCCCCCHHHHHHHHHHhhcCcCCCC-----CHHHHhcCccccccCCC
Q 019650          283 GERLEMPETASPEFRRFVRSCLEKDWRKRG-----TVEELLAYPFVTKRSSS  329 (337)
Q Consensus       283 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~-----s~~eil~hp~f~~~~~~  329 (337)
                       ....++..++..+.++|.+||..||.+||     +++++++||||++..|.
T Consensus       220 -~~~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~~  270 (337)
T 1o6l_A          220 -EEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQ  270 (337)
T ss_dssp             -CCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred             -CCCCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCHH
Confidence             24556778899999999999999999999     99999999999987654

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=3.1e-52  Score=373.21  Aligned_cols=263  Identities=26%  Similarity=0.377  Sum_probs=218.8

Q ss_pred             ccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHHhc-CCCCceeeeeeEEeeCC
Q 019650           43 VENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRL-DSQFIVKCHAVFYTIEG  119 (337)
Q Consensus        43 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~  119 (337)
                      ....++|++++.||+|+||+||+|.+..+++.||+|+++...  .......+.+|..++..+ +||||+++++++.+ ..
T Consensus        19 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~-~~   97 (353)
T 3txo_A           19 RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQT-PD   97 (353)
T ss_dssp             ----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-SS
T ss_pred             CCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEe-CC
Confidence            355789999999999999999999999999999999997542  223445677899999988 79999999998876 68


Q ss_pred             eEEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhcc
Q 019650          120 EICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEET  199 (337)
Q Consensus       120 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~  199 (337)
                      .+|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.+++++|+|||++......
T Consensus        98 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~  177 (353)
T 3txo_A           98 RLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN  177 (353)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-
T ss_pred             EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccC
Confidence            89999999999999999998899999999999999999999999999999999999999999999999999998753322


Q ss_pred             ccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHH
Q 019650          200 RNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICA  279 (337)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~  279 (337)
                      .              ......+||+.|+|||++.    +..++.++||||||+++|+|++|..||...........+   
T Consensus       178 ~--------------~~~~~~~gt~~y~aPE~~~----~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i---  236 (353)
T 3txo_A          178 G--------------VTTATFCGTPDYIAPEILQ----EMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAI---  236 (353)
T ss_dssp             ----------------------CCGGGCCHHHHH----HHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---
T ss_pred             C--------------ccccccCCCcCeEChhhcC----CCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHH---
Confidence            1              2233456999999999998    446889999999999999999999999765433222222   


Q ss_pred             hhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCH------HHHhcCccccccCCC
Q 019650          280 ICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTV------EELLAYPFVTKRSSS  329 (337)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~------~eil~hp~f~~~~~~  329 (337)
                       .. ....++..++..+.++|.+||..||.+||++      +++++||||++..|.
T Consensus       237 -~~-~~~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~  290 (353)
T 3txo_A          237 -LN-DEVVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWA  290 (353)
T ss_dssp             -HH-CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHH
T ss_pred             -Hc-CCCCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCHH
Confidence             22 2455677789999999999999999999998      899999999987654

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-51  Score=363.89  Aligned_cols=260  Identities=26%  Similarity=0.439  Sum_probs=223.8

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeE
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEI  121 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~  121 (337)
                      ...++|++++.||.|+||+||+|.+..+++.||+|+++...  .....+.+.+|..+++.++||||+++++.+.+ ...+
T Consensus         3 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~-~~~~   81 (318)
T 1fot_A            3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD-AQQI   81 (318)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC-SSEE
T ss_pred             CChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEe-CCEE
Confidence            35789999999999999999999999999999999997542  11234567789999999999999999998876 6889


Q ss_pred             EEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhcccc
Q 019650          122 CFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRN  201 (337)
Q Consensus       122 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~  201 (337)
                      |+||||++|++|.+++.....+++..++.++.||+.||.|||++||+||||||+||+++.+++++|+|||++......  
T Consensus        82 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~--  159 (318)
T 1fot_A           82 FMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--  159 (318)
T ss_dssp             EEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred             EEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCc--
Confidence            999999999999999998889999999999999999999999999999999999999999999999999999765321  


Q ss_pred             CCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhh
Q 019650          202 NNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAIC  281 (337)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~  281 (337)
                                     ....+||+.|+|||++.    +..++.++|+||||+++|+|++|..||...........+    .
T Consensus       160 ---------------~~~~~gt~~y~aPE~~~----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i----~  216 (318)
T 1fot_A          160 ---------------TYTLCGTPDYIAPEVVS----TKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI----L  216 (318)
T ss_dssp             ---------------BCCCCSCTTTCCHHHHT----TCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH----H
T ss_pred             ---------------cccccCCccccCHhHhc----CCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH----H
Confidence                           12346899999999998    457889999999999999999999999764332222222    2


Q ss_pred             ccCCCCCCCCCCHHHHHHHHHHhhcCcCCCC-----CHHHHhcCccccccCCCc
Q 019650          282 FGERLEMPETASPEFRRFVRSCLEKDWRKRG-----TVEELLAYPFVTKRSSSS  330 (337)
Q Consensus       282 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~-----s~~eil~hp~f~~~~~~~  330 (337)
                      . ....++...+..+.++|.+||..||.+||     +++++++||||++..|..
T Consensus       217 ~-~~~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~~~  269 (318)
T 1fot_A          217 N-AELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEK  269 (318)
T ss_dssp             H-CCCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHH
T ss_pred             h-CCCCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCCHHH
Confidence            2 24556778899999999999999999999     999999999999876543

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=4.6e-51  Score=357.85  Aligned_cols=265  Identities=28%  Similarity=0.460  Sum_probs=223.3

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEE
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICF  123 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~l  123 (337)
                      ...++|++.+.||+|+||+||+|.+..+++.||+|++...... ..+.+.+|+.++++++||||+++++.+.. ....++
T Consensus        17 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~l   94 (297)
T 3fxz_A           17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLV-GDELWV   94 (297)
T ss_dssp             CGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCS-CHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEE
T ss_pred             ChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccccc-HHHHHHHHHHHHhcCCCCCCCeEeEEEEE-CCEEEE
Confidence            4568999999999999999999999999999999998755322 34667889999999999999999998876 788999


Q ss_pred             EEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCC
Q 019650          124 VMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNN  203 (337)
Q Consensus       124 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~  203 (337)
                      ||||++|++|.+++... .+++..+..++.|++.||.|||++|++||||||+||+++.+++++|+|||++.......   
T Consensus        95 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---  170 (297)
T 3fxz_A           95 VMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ---  170 (297)
T ss_dssp             EEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT---
T ss_pred             EEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc---
Confidence            99999999999999754 69999999999999999999999999999999999999999999999999987654332   


Q ss_pred             CCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhcc
Q 019650          204 NHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFG  283 (337)
Q Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~  283 (337)
                                 .......|++.|+|||.+.    +..++.++||||||+++|+|++|..||.............  ....
T Consensus       171 -----------~~~~~~~gt~~y~aPE~~~----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~--~~~~  233 (297)
T 3fxz_A          171 -----------SKRSTMVGTPYWMAPEVVT----RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA--TNGT  233 (297)
T ss_dssp             -----------CCBCCCCSCGGGCCHHHHH----CSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH--HHCS
T ss_pred             -----------cccCCccCCcCccChhhhc----CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--hCCC
Confidence                       1222346899999999998    4578999999999999999999999997643332222222  1222


Q ss_pred             CCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCCcc
Q 019650          284 ERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSN  331 (337)
Q Consensus       284 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~~~  331 (337)
                      .....+..++..+.++|.+||+.||.+|||++++++||||+.....+.
T Consensus       234 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~~~  281 (297)
T 3fxz_A          234 PELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAKPLSS  281 (297)
T ss_dssp             CCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCCGGG
T ss_pred             CCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhcccCcccc
Confidence            233445678999999999999999999999999999999998765443

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.4e-51  Score=373.28  Aligned_cols=268  Identities=26%  Similarity=0.460  Sum_probs=223.2

Q ss_pred             ccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHHhc-CCCCceeeeeeEEeeCC
Q 019650           43 VENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRL-DSQFIVKCHAVFYTIEG  119 (337)
Q Consensus        43 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~  119 (337)
                      ....++|++++.||+|+||+||+|.+..+++.||+|+++...  .....+.+.+|..++.++ +||||+++++++.+ ..
T Consensus        48 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~-~~  126 (396)
T 4dc2_A           48 SLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT-ES  126 (396)
T ss_dssp             -CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEEC-SS
T ss_pred             CCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEE-CC
Confidence            456789999999999999999999999999999999997643  223344567888888877 89999999998876 78


Q ss_pred             eEEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhcc
Q 019650          120 EICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEET  199 (337)
Q Consensus       120 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~  199 (337)
                      .+|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+++++|+|||++......
T Consensus       127 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~  206 (396)
T 4dc2_A          127 RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP  206 (396)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             EEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccC
Confidence            89999999999999999998889999999999999999999999999999999999999999999999999998753222


Q ss_pred             ccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCch----hHHH
Q 019650          200 RNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP----DLMA  275 (337)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~----~~~~  275 (337)
                      .              ......+||+.|+|||++.    +..++.++|+||||+++|+|++|..||.......    ....
T Consensus       207 ~--------------~~~~~~~gt~~Y~aPE~l~----~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~  268 (396)
T 4dc2_A          207 G--------------DTTSTFCGTPNYIAPEILR----GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTED  268 (396)
T ss_dssp             T--------------CCBCCCCBCGGGCCHHHHT----TCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHH
T ss_pred             C--------------CccccccCCcccCCchhhc----CCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHH
Confidence            1              2233457999999999998    5578999999999999999999999996432211    1112


Q ss_pred             HHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCH------HHHhcCccccccCCC
Q 019650          276 LICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTV------EELLAYPFVTKRSSS  329 (337)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~------~eil~hp~f~~~~~~  329 (337)
                      .+..........++..++..+.+||.+||+.||.+||++      +++++||||++..|.
T Consensus       269 ~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w~  328 (396)
T 4dc2_A          269 YLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWD  328 (396)
T ss_dssp             HHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCHH
T ss_pred             HHHHHHhccccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCHH
Confidence            222222334567778899999999999999999999985      899999999987654

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=1e-51  Score=368.55  Aligned_cols=263  Identities=25%  Similarity=0.386  Sum_probs=221.7

Q ss_pred             ccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHHhc-CCCCceeeeeeEEeeCC
Q 019650           43 VENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRL-DSQFIVKCHAVFYTIEG  119 (337)
Q Consensus        43 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~  119 (337)
                      ....++|++.+.||+|+||+||+|.+..+++.||+|+++...  ..........|..++..+ +||||+++++++.+ ..
T Consensus        13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~-~~   91 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT-KE   91 (345)
T ss_dssp             ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC-SS
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEe-CC
Confidence            456789999999999999999999999999999999997642  122345567788888876 99999999998876 68


Q ss_pred             eEEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhcc
Q 019650          120 EICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEET  199 (337)
Q Consensus       120 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~  199 (337)
                      .+|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.+++++|+|||++......
T Consensus        92 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  171 (345)
T 1xjd_A           92 NLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG  171 (345)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccC
Confidence            89999999999999999998889999999999999999999999999999999999999999999999999998754321


Q ss_pred             ccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHH
Q 019650          200 RNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICA  279 (337)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~  279 (337)
                      .              ......+||+.|+|||++.    +..++.++|+||||+++|+|++|..||.+......    ...
T Consensus       172 ~--------------~~~~~~~gt~~y~aPE~~~----~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~----~~~  229 (345)
T 1xjd_A          172 D--------------AKTNTFCGTPDYIAPEILL----GQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL----FHS  229 (345)
T ss_dssp             T--------------CCBCCCCSCGGGCCHHHHT----TCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHH
T ss_pred             C--------------CcccCCCCCcccCChhhhc----CCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHH----HHH
Confidence            1              1223456999999999998    45789999999999999999999999976433222    222


Q ss_pred             hhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHH-HHhcCccccccCCC
Q 019650          280 ICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVE-ELLAYPFVTKRSSS  329 (337)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~-eil~hp~f~~~~~~  329 (337)
                      ... ....++..++..+.++|.+||..||.+||++. ++++||||++..|.
T Consensus       230 i~~-~~~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~w~  279 (345)
T 1xjd_A          230 IRM-DNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWE  279 (345)
T ss_dssp             HHH-CCCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCHH
T ss_pred             HHh-CCCCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCCHH
Confidence            222 24556777899999999999999999999998 99999999987654

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=7e-51  Score=363.63  Aligned_cols=267  Identities=27%  Similarity=0.463  Sum_probs=224.0

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHHhc-CCCCceeeeeeEEeeCCe
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRL-DSQFIVKCHAVFYTIEGE  120 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~  120 (337)
                      ...++|++++.||+|+||+||+|.+..+++.||+|++....  .....+.+.+|..+++++ +||||+++++++.+ ...
T Consensus         6 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~-~~~   84 (345)
T 3a8x_A            6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT-ESR   84 (345)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-SSE
T ss_pred             CchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEe-CCE
Confidence            45789999999999999999999999999999999997653  334456678899999887 89999999998876 789


Q ss_pred             EEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccc
Q 019650          121 ICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETR  200 (337)
Q Consensus       121 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~  200 (337)
                      +|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.+++++|+|||++.......
T Consensus        85 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~  164 (345)
T 3a8x_A           85 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG  164 (345)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCCC
Confidence            99999999999999999988899999999999999999999999999999999999999999999999999987532221


Q ss_pred             cCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCch----hHHHH
Q 019650          201 NNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP----DLMAL  276 (337)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~----~~~~~  276 (337)
                                    ......+||+.|+|||++.    +..++.++|+||||+++|+|++|..||.......    .....
T Consensus       165 --------------~~~~~~~gt~~y~aPE~~~----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~  226 (345)
T 3a8x_A          165 --------------DTTSTFCGTPNYIAPEILR----GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDY  226 (345)
T ss_dssp             --------------CCBCCCCSCGGGCCHHHHT----TCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHH
T ss_pred             --------------CcccccCCCccccCccccC----CCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHH
Confidence                          2223446999999999998    4578899999999999999999999996532211    11111


Q ss_pred             HHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCH------HHHhcCccccccCCC
Q 019650          277 ICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTV------EELLAYPFVTKRSSS  329 (337)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~------~eil~hp~f~~~~~~  329 (337)
                      ...........++..++..+.++|.+||..||.+||++      +++++||||++..|.
T Consensus       227 ~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w~  285 (345)
T 3a8x_A          227 LFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWD  285 (345)
T ss_dssp             HHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCHH
T ss_pred             HHHHHHcCCCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCHH
Confidence            11222233556778889999999999999999999995      899999999987653

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=2.6e-51  Score=368.21  Aligned_cols=263  Identities=29%  Similarity=0.465  Sum_probs=220.8

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCch-----HhHHHHHHHHHHHHhcCCCCceeeeeeEEeeC
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSST-----IIRHQAAHEAEILKRLDSQFIVKCHAVFYTIE  118 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~  118 (337)
                      ...++|++.+.||.|+||+||+|.+..++..||+|++......     ...+.+.+|+.++++++||||+++++++.+ .
T Consensus         9 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~   87 (361)
T 2yab_A            9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYEN-R   87 (361)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-S
T ss_pred             ChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEe-C
Confidence            4467899999999999999999999999999999999765422     134678899999999999999999998866 6


Q ss_pred             CeEEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCC----cEEEeeccCcc
Q 019650          119 GEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKG----EVKIADFGVSR  194 (337)
Q Consensus       119 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~----~~~l~Dfg~~~  194 (337)
                      ..+++||||++|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||+++.++    +++|+|||++.
T Consensus        88 ~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~  167 (361)
T 2yab_A           88 TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH  167 (361)
T ss_dssp             SEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCE
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCce
Confidence            88999999999999999999888999999999999999999999999999999999999998776    79999999998


Q ss_pred             chhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHH
Q 019650          195 IVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLM  274 (337)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~  274 (337)
                      ......               .....+||+.|+|||++.    +..++.++||||||+++|+|++|..||.+........
T Consensus       168 ~~~~~~---------------~~~~~~gt~~y~aPE~~~----~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~  228 (361)
T 2yab_A          168 EIEDGV---------------EFKNIFGTPEFVAPEIVN----YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA  228 (361)
T ss_dssp             ECCTTC---------------CCCCCCSCGGGCCHHHHT----TCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHH
T ss_pred             EcCCCC---------------ccccCCCCccEECchHHc----CCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            764421               122346999999999998    4578999999999999999999999997643322222


Q ss_pred             HHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccC
Q 019650          275 ALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRS  327 (337)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~  327 (337)
                      . +...........+..++..+++||.+||..||.+|||++++|+||||++..
T Consensus       229 ~-i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~  280 (361)
T 2yab_A          229 N-ITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD  280 (361)
T ss_dssp             H-HHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSS
T ss_pred             H-HHhcCCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCCc
Confidence            2 111111112222356789999999999999999999999999999999654

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=5.6e-51  Score=368.17  Aligned_cols=269  Identities=25%  Similarity=0.435  Sum_probs=228.1

Q ss_pred             CccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCC
Q 019650           42 DVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEG  119 (337)
Q Consensus        42 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~  119 (337)
                      .....++|++++.||.|+||.||+|.+..+++.||+|++....  .......+.+|+.+++.++||||+++++++.+ ..
T Consensus        10 ~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-~~   88 (384)
T 4fr4_A           10 EDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQD-EE   88 (384)
T ss_dssp             CCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SS
T ss_pred             CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe-CC
Confidence            3456799999999999999999999999999999999987542  22334677889999999999999999998876 68


Q ss_pred             eEEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhcc
Q 019650          120 EICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEET  199 (337)
Q Consensus       120 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~  199 (337)
                      .+|+||||+.||+|.+++.....+++..++.++.||+.||.|||++||+||||||+||+++.+++++|+|||++......
T Consensus        89 ~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  168 (384)
T 4fr4_A           89 DMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE  168 (384)
T ss_dssp             EEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence            89999999999999999998889999999999999999999999999999999999999999999999999999765432


Q ss_pred             ccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHH
Q 019650          200 RNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICA  279 (337)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~  279 (337)
                                     ......+||+.|+|||++.... +..++.++||||||+++|+|++|..||........ ......
T Consensus       169 ---------------~~~~~~~gt~~Y~aPE~~~~~~-~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~-~~~~~~  231 (384)
T 4fr4_A          169 ---------------TQITTMAGTKPYMAPEMFSSRK-GAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSS-KEIVHT  231 (384)
T ss_dssp             ---------------CCBCCCCSCGGGCCGGGTCCCS-SCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCH-HHHHHH
T ss_pred             ---------------CceeccCCCccccCCeeeccCC-CCCCCccceeechHHHHHHHHhCCCCCCCCCCccH-HHHHHH
Confidence                           2223446999999999997432 34688999999999999999999999975433222 222222


Q ss_pred             hhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCC-HHHHhcCccccccCCC
Q 019650          280 ICFGERLEMPETASPEFRRFVRSCLEKDWRKRGT-VEELLAYPFVTKRSSS  329 (337)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s-~~eil~hp~f~~~~~~  329 (337)
                       .......++..++..+.+||.+||..||.+||+ ++++++||||++..|.
T Consensus       232 -~~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w~  281 (384)
T 4fr4_A          232 -FETTVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINWD  281 (384)
T ss_dssp             -HHHCCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCHH
T ss_pred             -HhhcccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCCHH
Confidence             223355667788999999999999999999998 9999999999987764

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=5.5e-51  Score=364.90  Aligned_cols=260  Identities=27%  Similarity=0.445  Sum_probs=224.5

Q ss_pred             ccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCe
Q 019650           43 VENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGE  120 (337)
Q Consensus        43 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~  120 (337)
                      ....++|++++.||+|+||+||+|.+..+++.||+|++....  .....+.+.+|+.+++.++||||+++++.+.+ ...
T Consensus        37 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~  115 (350)
T 1rdq_E           37 TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD-NSN  115 (350)
T ss_dssp             CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSE
T ss_pred             CCCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc-CCE
Confidence            356799999999999999999999999999999999986543  12234667889999999999999999998876 688


Q ss_pred             EEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccc
Q 019650          121 ICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETR  200 (337)
Q Consensus       121 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~  200 (337)
                      +|+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.+++++|+|||++...... 
T Consensus       116 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~-  194 (350)
T 1rdq_E          116 LYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-  194 (350)
T ss_dssp             EEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred             EEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC-
Confidence            9999999999999999998889999999999999999999999999999999999999999999999999999865322 


Q ss_pred             cCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHh
Q 019650          201 NNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAI  280 (337)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~  280 (337)
                                      ....+||+.|+|||++.    +..++.++|+||||+++|+|++|..||.......    .....
T Consensus       195 ----------------~~~~~gt~~y~aPE~~~----~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~----~~~~i  250 (350)
T 1rdq_E          195 ----------------TWTLCGTPEALAPEIIL----SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ----IYEKI  250 (350)
T ss_dssp             ----------------BCCCEECGGGCCHHHHT----TCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHH
T ss_pred             ----------------cccccCCccccCHHHhc----CCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHH----HHHHH
Confidence                            12336899999999998    4578899999999999999999999997643322    22222


Q ss_pred             hccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCC-----HHHHhcCccccccCCC
Q 019650          281 CFGERLEMPETASPEFRRFVRSCLEKDWRKRGT-----VEELLAYPFVTKRSSS  329 (337)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s-----~~eil~hp~f~~~~~~  329 (337)
                      ..+ ...++..++..+.++|.+||..||.+||+     ++++++||||++.+|.
T Consensus       251 ~~~-~~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w~  303 (350)
T 1rdq_E          251 VSG-KVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWI  303 (350)
T ss_dssp             HHC-CCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHH
T ss_pred             HcC-CCCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCHH
Confidence            222 45667788999999999999999999998     9999999999987654

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=1.2e-50  Score=364.51  Aligned_cols=267  Identities=26%  Similarity=0.366  Sum_probs=213.8

Q ss_pred             CCCCccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeC
Q 019650           39 TSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIE  118 (337)
Q Consensus        39 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~  118 (337)
                      ..+.....++|++++.||+|+||+||++.+..+++.||+|++.....  ..+.+.+|+.+++.++|+||+++++++.+ .
T Consensus        12 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~   88 (361)
T 3uc3_A           12 DMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA--IDENVQREIINHRSLRHPNIVRFKEVILT-P   88 (361)
T ss_dssp             CCCCCCCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT--SCHHHHHHHHHHHHCCCTTBCCEEEEEEC-S
T ss_pred             CccCCCCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc--ccHHHHHHHHHHHhCCCCCCCcEEEEEee-C
Confidence            33455667899999999999999999999999999999999976432  23567789999999999999999999876 6


Q ss_pred             CeEEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCc--EEEeeccCccch
Q 019650          119 GEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGE--VKIADFGVSRIV  196 (337)
Q Consensus       119 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~--~~l~Dfg~~~~~  196 (337)
                      ...++||||+++++|.+++...+.+++..++.++.||+.||+|||++|++||||||+||+++.++.  ++|+|||++...
T Consensus        89 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~  168 (361)
T 3uc3_A           89 THLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS  168 (361)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC---
T ss_pred             CEEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccc
Confidence            889999999999999999988889999999999999999999999999999999999999987765  999999998743


Q ss_pred             hccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCc-cccHHHHHHHHHHHHhCCCCCCCCCCchhHHH
Q 019650          197 EETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGF-AGDVWSLGVVVLECLVGHYPLIGFGEKPDLMA  275 (337)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~-~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~  275 (337)
                      ...               .......||+.|+|||++..    ..++. ++||||||+++|+|++|+.||...........
T Consensus       169 ~~~---------------~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~  229 (361)
T 3uc3_A          169 VLH---------------SQPKSTVGTPAYIAPEVLLR----QEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRK  229 (361)
T ss_dssp             ---------------------------CTTSCHHHHHC----SSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHH
T ss_pred             ccc---------------CCCCCCcCCCCcCChhhhcC----CCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHH
Confidence            322               11223358999999999984    35544 48999999999999999999987655555555


Q ss_pred             HHHHhhccC-CCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccC
Q 019650          276 LICAICFGE-RLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRS  327 (337)
Q Consensus       276 ~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~  327 (337)
                      ......... .......++..+.+||.+||..||.+|||++++++||||.+..
T Consensus       230 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~  282 (361)
T 3uc3_A          230 TIQRILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNL  282 (361)
T ss_dssp             HHHHHHTTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTTC
T ss_pred             HHHHHhcCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcCC
Confidence            444433322 2222335789999999999999999999999999999997653

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=1.9e-50  Score=371.59  Aligned_cols=264  Identities=28%  Similarity=0.390  Sum_probs=220.4

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCceEEEEEeecCC-chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEE
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEIC  122 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~  122 (337)
                      ...++|++.+.||+|+||+||+|.+..+++.+|+|++.... .....+.+.+|+.++++++||||+++++++.+ ....+
T Consensus         8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~~   86 (444)
T 3soa_A            8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISE-EGHHY   86 (444)
T ss_dssp             HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEEC-SSEEE
T ss_pred             cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEE-CCEEE
Confidence            44689999999999999999999999999999999997654 33445678899999999999999999998866 78999


Q ss_pred             EEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEc---CCCcEEEeeccCccchhcc
Q 019650          123 FVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLIN---GKGEVKIADFGVSRIVEET  199 (337)
Q Consensus       123 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~---~~~~~~l~Dfg~~~~~~~~  199 (337)
                      +||||++||+|.+.+...+.+++..+..++.||+.||.|||++||+||||||+||+++   .++.++|+|||++......
T Consensus        87 lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~  166 (444)
T 3soa_A           87 LIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE  166 (444)
T ss_dssp             EEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTT
T ss_pred             EEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCC
Confidence            9999999999999999889999999999999999999999999999999999999998   4578999999999765433


Q ss_pred             ccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHH
Q 019650          200 RNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICA  279 (337)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~  279 (337)
                      .              .......||+.|+|||++.    +..++.++||||||+++|+|++|..||.+...... ......
T Consensus       167 ~--------------~~~~~~~gt~~Y~APE~l~----~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~-~~~i~~  227 (444)
T 3soa_A          167 Q--------------QAWFGFAGTPGYLSPEVLR----KDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRL-YQQIKA  227 (444)
T ss_dssp             C--------------CBCCCSCSCGGGCCHHHHT----TCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHH
T ss_pred             C--------------ceeecccCCcccCCHHHhc----CCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHH-HHHHHh
Confidence            2              1122346999999999998    45788999999999999999999999976433222 222222


Q ss_pred             hhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccC
Q 019650          280 ICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRS  327 (337)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~  327 (337)
                      .....+......+++.+.+||.+||..||.+|||++|+|+||||++..
T Consensus       228 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~~  275 (444)
T 3soa_A          228 GAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHRS  275 (444)
T ss_dssp             TCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHHH
T ss_pred             CCCCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccCCc
Confidence            222222233357799999999999999999999999999999998653

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=8.8e-51  Score=360.15  Aligned_cols=266  Identities=22%  Similarity=0.268  Sum_probs=219.0

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEE
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICF  123 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~l  123 (337)
                      ...++|++++.||+|+||+||+|.+..+++.||+|++.........+.+.+|+.+++.++|+||+++++++.+ +...++
T Consensus         4 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~~~~~l   82 (323)
T 3tki_A            4 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE-GNIQYL   82 (323)
T ss_dssp             TTTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEE
T ss_pred             cHhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEec-CCeEEE
Confidence            4578999999999999999999999999999999999766544445677899999999999999999998766 788999


Q ss_pred             EEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCC
Q 019650          124 VMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNN  203 (337)
Q Consensus       124 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~  203 (337)
                      ||||+++++|.+++.....+++..++.++.||+.||.|||+.|++||||||+||+++.++.++|+|||++......... 
T Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-  161 (323)
T 3tki_A           83 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE-  161 (323)
T ss_dssp             EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE-
T ss_pred             EEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcc-
Confidence            9999999999999998888999999999999999999999999999999999999999999999999999765432211 


Q ss_pred             CCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhcc
Q 019650          204 NHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFG  283 (337)
Q Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~  283 (337)
                                 .......|++.|+|||++...   ..++.++||||||+++|+|++|..||..............  ...
T Consensus       162 -----------~~~~~~~gt~~y~aPE~~~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~--~~~  225 (323)
T 3tki_A          162 -----------RLLNKMCGTLPYVAPELLKRR---EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK--EKK  225 (323)
T ss_dssp             -----------CCBCSCCSCGGGSCHHHHHCS---SBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHH--TTC
T ss_pred             -----------cccCCCccCcCccCcHHhccC---CCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh--ccc
Confidence                       112234689999999999742   2247789999999999999999999976544333222221  122


Q ss_pred             CCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccC
Q 019650          284 ERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRS  327 (337)
Q Consensus       284 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~  327 (337)
                      ........++..+.+||.+||..||.+|||++|+++||||++..
T Consensus       226 ~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~  269 (323)
T 3tki_A          226 TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL  269 (323)
T ss_dssp             TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred             ccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhcccc
Confidence            22233356789999999999999999999999999999998754

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.1e-50  Score=360.30  Aligned_cols=264  Identities=28%  Similarity=0.415  Sum_probs=214.2

Q ss_pred             CccCccccccccccccCcceEEEEEEEc---cCCceEEEEEeecCC---chHhHHHHHHHHHHHHhcCCCCceeeeeeEE
Q 019650           42 DVENISDLKKLTVLGHGNGGIVYKVRHQ---KSNSIYALKVLNTTS---STIIRHQAAHEAEILKRLDSQFIVKCHAVFY  115 (337)
Q Consensus        42 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~---~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~  115 (337)
                      .....++|++.+.||+|+||+||+|.+.   .+++.||+|+++...   .......+.+|+.++++++|+||+++++++.
T Consensus        12 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~   91 (327)
T 3a62_A           12 EKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQ   91 (327)
T ss_dssp             -CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEE
T ss_pred             CCCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEE
Confidence            3456789999999999999999999985   688999999997653   2223455678999999999999999999887


Q ss_pred             eeCCeEEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccc
Q 019650          116 TIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRI  195 (337)
Q Consensus       116 ~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~  195 (337)
                      . ...+|+||||++|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||+++.+++++|+|||++..
T Consensus        92 ~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~  170 (327)
T 3a62_A           92 T-GGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKE  170 (327)
T ss_dssp             C-SSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred             c-CCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence            6 688999999999999999999888999999999999999999999999999999999999999999999999999875


Q ss_pred             hhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHH
Q 019650          196 VEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMA  275 (337)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~  275 (337)
                      .....              .......|++.|+|||.+.    +..++.++||||||+++|+|++|..||...........
T Consensus       171 ~~~~~--------------~~~~~~~gt~~y~aPE~~~----~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~  232 (327)
T 3a62_A          171 SIHDG--------------TVTHTFCGTIEYMAPEILM----RSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDK  232 (327)
T ss_dssp             ----------------------CTTSSCCTTSCHHHHT----TSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred             cccCC--------------ccccccCCCcCccCHhhCc----CCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence            43322              1222346899999999998    45788999999999999999999999976433322222


Q ss_pred             HHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCC-----CHHHHhcCccccccCCC
Q 019650          276 LICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRG-----TVEELLAYPFVTKRSSS  329 (337)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~-----s~~eil~hp~f~~~~~~  329 (337)
                      +.    . ....++..++..+.++|.+||..||.+||     +++++++||||++..+.
T Consensus       233 i~----~-~~~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~~  286 (327)
T 3a62_A          233 IL----K-CKLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWE  286 (327)
T ss_dssp             HH----H-TCCCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCHH
T ss_pred             HH----h-CCCCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCHH
Confidence            22    1 24456677899999999999999999999     89999999999987654

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=2.1e-50  Score=352.88  Aligned_cols=263  Identities=25%  Similarity=0.391  Sum_probs=213.9

Q ss_pred             ccccccccccccCcceEEEEEEEccCCceEEEEEeecCC-chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 019650           46 ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFV  124 (337)
Q Consensus        46 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv  124 (337)
                      +++|++++.||+|+||+||+|.+..+++.||+|++.... .......+.+|+.++++++|+||+++++++.+ +...++|
T Consensus         1 l~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv   79 (292)
T 3o0g_A            1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS-DKKLTLV   79 (292)
T ss_dssp             CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-TTEEEEE
T ss_pred             CCCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEe-CCEEEEE
Confidence            368999999999999999999999999999999997654 33345677899999999999999999998876 7899999


Q ss_pred             EeccCCCCchHHhh-hcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCC
Q 019650          125 MEHMERGSLFDSLR-VRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNN  203 (337)
Q Consensus       125 ~e~~~~~~L~~~l~-~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~  203 (337)
                      |||+++ +|.+.+. ..+.+++..++.++.|++.||+|||++|++||||||+||+++.+++++|+|||.+.......   
T Consensus        80 ~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~---  155 (292)
T 3o0g_A           80 FEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV---  155 (292)
T ss_dssp             EECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC---
T ss_pred             EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcc---
Confidence            999986 5655554 46789999999999999999999999999999999999999999999999999997664322   


Q ss_pred             CCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhcc
Q 019650          204 NHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFG  283 (337)
Q Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~  283 (337)
                                 .......+|+.|+|||.+...   ..++.++||||||+++|+|++|..||............+......
T Consensus       156 -----------~~~~~~~~t~~y~aPE~~~~~---~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~  221 (292)
T 3o0g_A          156 -----------RCYSAEVVTLWYRPPDVLFGA---KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGT  221 (292)
T ss_dssp             -----------SCCCSCCSCGGGCCHHHHTTC---SCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCC
T ss_pred             -----------ccccCCccccCCcChHHHcCC---CCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCC
Confidence                       122233589999999999742   347999999999999999999888865444433333333222111


Q ss_pred             CC-------------------------CCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccC
Q 019650          284 ER-------------------------LEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRS  327 (337)
Q Consensus       284 ~~-------------------------~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~  327 (337)
                      ..                         ....+..+..+.+||.+||+.||++|||++|+|+||||++..
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  290 (292)
T 3o0g_A          222 PTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC  290 (292)
T ss_dssp             CCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred             CChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCC
Confidence            10                         112235688999999999999999999999999999999754

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=8.6e-51  Score=366.20  Aligned_cols=264  Identities=27%  Similarity=0.407  Sum_probs=215.9

Q ss_pred             ccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCc--hHhHHHHHHHHHH-HHhcCCCCceeeeeeEEeeCC
Q 019650           43 VENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSS--TIIRHQAAHEAEI-LKRLDSQFIVKCHAVFYTIEG  119 (337)
Q Consensus        43 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~-~~~l~~~~i~~~~~~~~~~~~  119 (337)
                      ....++|++++.||+|+||+||+|.+..++..||+|+++....  ......+..|..+ ++.++|+||+++++.+.+ ..
T Consensus        34 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~-~~  112 (373)
T 2r5t_A           34 HAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT-AD  112 (373)
T ss_dssp             TCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEEC-SS
T ss_pred             CCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEe-CC
Confidence            4567899999999999999999999999999999999976531  2223444556655 467899999999998877 68


Q ss_pred             eEEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhcc
Q 019650          120 EICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEET  199 (337)
Q Consensus       120 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~  199 (337)
                      .+|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.+|+++|+|||++......
T Consensus       113 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~  192 (373)
T 2r5t_A          113 KLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH  192 (373)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred             EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence            99999999999999999998889999999999999999999999999999999999999999999999999998754322


Q ss_pred             ccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHH
Q 019650          200 RNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICA  279 (337)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~  279 (337)
                      .              ......+||+.|+|||++.    +..++.++|+||||+++|+|++|..||...........+   
T Consensus       193 ~--------------~~~~~~~gt~~y~aPE~~~----~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i---  251 (373)
T 2r5t_A          193 N--------------STTSTFCGTPEYLAPEVLH----KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNI---  251 (373)
T ss_dssp             C--------------CCCCSBSCCCCCCCHHHHT----TCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHH---
T ss_pred             C--------------CccccccCCccccCHHHhC----CCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHH---
Confidence            1              2223456999999999998    457899999999999999999999999764332222222   


Q ss_pred             hhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCH----HHHhcCccccccCCCc
Q 019650          280 ICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTV----EELLAYPFVTKRSSSS  330 (337)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~----~eil~hp~f~~~~~~~  330 (337)
                       .. ....++..++..+.++|.+||..||.+||++    +++++||||++..|..
T Consensus       252 -~~-~~~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w~~  304 (373)
T 2r5t_A          252 -LN-KPLQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWDD  304 (373)
T ss_dssp             -HH-SCCCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCHHH
T ss_pred             -Hh-cccCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCHHH
Confidence             22 2455677889999999999999999999986    6999999999877643

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=5.2e-51  Score=365.14  Aligned_cols=262  Identities=25%  Similarity=0.358  Sum_probs=221.4

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHHhc-CCCCceeeeeeEEeeCCe
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRL-DSQFIVKCHAVFYTIEGE  120 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~  120 (337)
                      ...++|++++.||+|+||+||+|.+..+++.||+|+++...  .....+.+..|..++..+ .|++|+++++.+.+ ...
T Consensus        17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~-~~~   95 (353)
T 2i0e_A           17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT-MDR   95 (353)
T ss_dssp             --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEEC-SSE
T ss_pred             CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEc-CCE
Confidence            55789999999999999999999999999999999997642  122345667888888887 89999999998876 688


Q ss_pred             EEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccc
Q 019650          121 ICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETR  200 (337)
Q Consensus       121 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~  200 (337)
                      +|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.+++++|+|||++.......
T Consensus        96 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~  175 (353)
T 2i0e_A           96 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG  175 (353)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred             EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccCC
Confidence            99999999999999999988899999999999999999999999999999999999999999999999999987532211


Q ss_pred             cCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHh
Q 019650          201 NNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAI  280 (337)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~  280 (337)
                                    ......+||+.|+|||++.    +..++.++|+||||+++|+|++|..||.+.........+    
T Consensus       176 --------------~~~~~~~gt~~y~aPE~~~----~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i----  233 (353)
T 2i0e_A          176 --------------VTTKTFCGTPDYIAPEIIA----YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI----  233 (353)
T ss_dssp             --------------CCBCCCCSCGGGCCHHHHT----TCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH----
T ss_pred             --------------cccccccCCccccChhhhc----CCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHH----
Confidence                          2233456999999999998    457899999999999999999999999764332222222    


Q ss_pred             hccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCC-----HHHHhcCccccccCCC
Q 019650          281 CFGERLEMPETASPEFRRFVRSCLEKDWRKRGT-----VEELLAYPFVTKRSSS  329 (337)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s-----~~eil~hp~f~~~~~~  329 (337)
                      .. ....++..++..+.+||.+||..||.+||+     ++++++||||++..|.
T Consensus       234 ~~-~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~  286 (353)
T 2i0e_A          234 ME-HNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWE  286 (353)
T ss_dssp             HH-CCCCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCHH
T ss_pred             Hh-CCCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCHH
Confidence            22 245667788999999999999999999994     6999999999987654

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.4e-50  Score=357.86  Aligned_cols=264  Identities=27%  Similarity=0.462  Sum_probs=220.9

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCch-----HhHHHHHHHHHHHHhcCCCCceeeeeeEEeeC
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSST-----IIRHQAAHEAEILKRLDSQFIVKCHAVFYTIE  118 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~  118 (337)
                      ...++|++.+.||+|+||+||+|.+..++..||+|++......     ...+.+.+|+.++++++||||+++++++.. .
T Consensus         8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~   86 (326)
T 2y0a_A            8 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN-K   86 (326)
T ss_dssp             CHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-S
T ss_pred             CcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEe-C
Confidence            4457899999999999999999999999999999999765422     235678899999999999999999998866 7


Q ss_pred             CeEEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCC----cEEEeeccCcc
Q 019650          119 GEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKG----EVKIADFGVSR  194 (337)
Q Consensus       119 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~----~~~l~Dfg~~~  194 (337)
                      ...++||||+++++|.+++.....+++..++.++.||+.||.|||++|++|+||||+||+++.++    .++|+|||++.
T Consensus        87 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~  166 (326)
T 2y0a_A           87 TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH  166 (326)
T ss_dssp             SEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred             CEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence            88999999999999999999888999999999999999999999999999999999999998877    89999999998


Q ss_pred             chhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHH
Q 019650          195 IVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLM  274 (337)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~  274 (337)
                      ......               ......|++.|+|||++.    +..++.++||||||+++|+|++|..||.+........
T Consensus       167 ~~~~~~---------------~~~~~~gt~~y~aPE~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  227 (326)
T 2y0a_A          167 KIDFGN---------------EFKNIFGTPEFVAPEIVN----YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA  227 (326)
T ss_dssp             ECCTTS---------------CCCCCCSCTTTCCHHHHT----TCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHH
T ss_pred             ECCCCC---------------ccccccCCcCcCCceeec----CCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHH
Confidence            764321               112235899999999998    4578999999999999999999999997643322222


Q ss_pred             HHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCC
Q 019650          275 ALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSS  328 (337)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~  328 (337)
                      .. ...........+...+..+.++|.+||..||.+|||++++|+||||++..+
T Consensus       228 ~~-~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~  280 (326)
T 2y0a_A          228 NV-SAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDT  280 (326)
T ss_dssp             HH-HHTCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCCSH
T ss_pred             HH-HhcCCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCCcc
Confidence            22 111111111223567899999999999999999999999999999987654

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=3.6e-50  Score=361.44  Aligned_cols=262  Identities=29%  Similarity=0.414  Sum_probs=219.0

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCceEEEEEeecCC-chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEE
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEIC  122 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~  122 (337)
                      ...++|++.+.||.|+||+||+|.+..++..||+|++.... .....+.+.+|+.++++++||||+++++++.+ ....+
T Consensus        26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-~~~~~  104 (362)
T 2bdw_A           26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE-ESFHY  104 (362)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEE
T ss_pred             CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-CCEEE
Confidence            44578999999999999999999999999999999997654 33455678899999999999999999998876 78899


Q ss_pred             EEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCC---cEEEeeccCccchhcc
Q 019650          123 FVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKG---EVKIADFGVSRIVEET  199 (337)
Q Consensus       123 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~---~~~l~Dfg~~~~~~~~  199 (337)
                      +||||++|++|.+++.....+++..+..++.||+.||.|||++||+||||||+||+++.++   .++|+|||++......
T Consensus       105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~  184 (362)
T 2bdw_A          105 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS  184 (362)
T ss_dssp             EEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC
T ss_pred             EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCC
Confidence            9999999999999998888899999999999999999999999999999999999998654   5999999999766432


Q ss_pred             ccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHH
Q 019650          200 RNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICA  279 (337)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~  279 (337)
                      .               ......||+.|+|||++.    +..++.++||||||+++|+|++|..||....... .......
T Consensus       185 ~---------------~~~~~~gt~~y~aPE~~~----~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~-~~~~i~~  244 (362)
T 2bdw_A          185 E---------------AWHGFAGTPGYLSPEVLK----KDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR-LYAQIKA  244 (362)
T ss_dssp             C---------------SCCCSCSCTTTCCHHHHT----TCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHH
T ss_pred             c---------------ccccCCCCccccCHHHHc----cCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHh
Confidence            1               112346899999999998    4578999999999999999999999997643322 2222212


Q ss_pred             hhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCcccccc
Q 019650          280 ICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKR  326 (337)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~  326 (337)
                      .....+......++..+.+||.+||..||.+|||++++|+||||++.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~  291 (362)
T 2bdw_A          245 GAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR  291 (362)
T ss_dssp             TCCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred             CCCCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCCC
Confidence            11111122224578999999999999999999999999999999864

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=5.8e-50  Score=353.14  Aligned_cols=266  Identities=26%  Similarity=0.375  Sum_probs=216.9

Q ss_pred             ccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCc-hHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeE
Q 019650           43 VENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSS-TIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEI  121 (337)
Q Consensus        43 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~  121 (337)
                      ....++|++++.||+|+||+||+|.+. +++.||+|++..... ......+.+|+.++++++|+||+++++++.+ +...
T Consensus        17 q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~   94 (311)
T 3niz_A           17 QGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHS-ERCL   94 (311)
T ss_dssp             ECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECC-SSCE
T ss_pred             cchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEcc-CCEE
Confidence            466799999999999999999999985 588999999875532 2234677899999999999999999998766 6889


Q ss_pred             EEEEeccCCCCchHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccc
Q 019650          122 CFVMEHMERGSLFDSLRVR-KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETR  200 (337)
Q Consensus       122 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~  200 (337)
                      ++||||+++ +|.+++... ..+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++.......
T Consensus        95 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~  173 (311)
T 3niz_A           95 TLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPV  173 (311)
T ss_dssp             EEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred             EEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence            999999986 888887654 459999999999999999999999999999999999999999999999999998764322


Q ss_pred             cCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHh
Q 019650          201 NNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAI  280 (337)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~  280 (337)
                                    .......+++.|+|||.+...   ..++.++||||||+++|+|++|+.||.+..............
T Consensus       174 --------------~~~~~~~~t~~y~aPE~~~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~  236 (311)
T 3niz_A          174 --------------RSYTHEVVTLWYRAPDVLMGS---KKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSIL  236 (311)
T ss_dssp             --------------C---CCCCCCTTCCHHHHTTC---CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHH
T ss_pred             --------------ccccCCcccCCcCCHHHhcCC---CCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHH
Confidence                          112223589999999998742   467899999999999999999999998776665555544432


Q ss_pred             hccCCCC-------------------------CCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCC
Q 019650          281 CFGERLE-------------------------MPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSS  328 (337)
Q Consensus       281 ~~~~~~~-------------------------~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~  328 (337)
                      .......                         ..+..++.+.+||.+||..||.+|||++|+|+||||++...
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  309 (311)
T 3niz_A          237 GTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLDP  309 (311)
T ss_dssp             CCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSCT
T ss_pred             CCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCCc
Confidence            2221111                         12346788999999999999999999999999999998753

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=4.4e-51  Score=357.74  Aligned_cols=260  Identities=21%  Similarity=0.237  Sum_probs=195.2

Q ss_pred             ccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCC---eEE
Q 019650           46 ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEG---EIC  122 (337)
Q Consensus        46 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~---~~~  122 (337)
                      .++|.+.+.||+|+||+||+|.+  +|+.||||+++.....  ......|+..+.+++||||+++++++.+.+.   .+|
T Consensus         2 ar~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~--~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~   77 (303)
T 3hmm_A            2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREER--SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW   77 (303)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHH--HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred             CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchh--hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEE
Confidence            46799999999999999999987  5889999999754322  2223446666678899999999999887543   589


Q ss_pred             EEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CceeccCCCCCeEEcCCCcEEEeeccCcc
Q 019650          123 FVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGM--------QIIHGDIKPSNLLINGKGEVKIADFGVSR  194 (337)
Q Consensus       123 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~--------~ivH~dl~~~Nili~~~~~~~l~Dfg~~~  194 (337)
                      +||||+++|+|.+++.. ..++++.+..++.|++.||+|||++        +|+||||||+|||++.++++||+|||++.
T Consensus        78 lV~Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~  156 (303)
T 3hmm_A           78 LVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  156 (303)
T ss_dssp             EEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             EEecCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence            99999999999999975 4699999999999999999999987        99999999999999999999999999997


Q ss_pred             chhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccC--CCCCCccccHHHHHHHHHHHHhCCCCCCCCCC---
Q 019650          195 IVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERW--GGDYGFAGDVWSLGVVVLECLVGHYPLIGFGE---  269 (337)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~---  269 (337)
                      ..........          ......+||+.|+|||++.....  ...++.++|||||||++|||+||..||.....   
T Consensus       157 ~~~~~~~~~~----------~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~  226 (303)
T 3hmm_A          157 RHDSATDTID----------IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL  226 (303)
T ss_dssp             EEETTTTEES----------CC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCC
T ss_pred             cccCCCCcee----------eecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccc
Confidence            7644321110          12223469999999999974310  11367799999999999999999776532211   


Q ss_pred             -------ch-hHHHHHHHhh-ccCCCCCCCC-----CCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          270 -------KP-DLMALICAIC-FGERLEMPET-----ASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       270 -------~~-~~~~~~~~~~-~~~~~~~~~~-----~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                             .. .......... ...++.+|..     .+..+.+|+.+||+.||++|||+.||++.
T Consensus       227 p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  291 (303)
T 3hmm_A          227 PYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             TTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             cchhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence                   11 1112222211 2223333322     23468899999999999999999999874

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=3.2e-50  Score=355.82  Aligned_cols=266  Identities=25%  Similarity=0.382  Sum_probs=204.5

Q ss_pred             CccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 019650           45 NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFV  124 (337)
Q Consensus        45 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv  124 (337)
                      ..++|++++.||+|+||+||+|.+..+++.||+|++.........+.+.+|+.++++++|+||+++++++.. +...++|
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv   81 (317)
T 2pmi_A            3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHT-ENKLTLV   81 (317)
T ss_dssp             ----------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECC-TTEEEEE
T ss_pred             cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEE-CCeEEEE
Confidence            357899999999999999999999999999999999876544455678889999999999999999998766 6889999


Q ss_pred             EeccCCCCchHHhhhc------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhc
Q 019650          125 MEHMERGSLFDSLRVR------KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEE  198 (337)
Q Consensus       125 ~e~~~~~~L~~~l~~~------~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~  198 (337)
                      |||+++ +|.+++...      ..+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||++.....
T Consensus        82 ~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  160 (317)
T 2pmi_A           82 FEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGI  160 (317)
T ss_dssp             EECCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTS
T ss_pred             EEecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCC
Confidence            999985 999998754      3589999999999999999999999999999999999999999999999999987643


Q ss_pred             cccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHH
Q 019650          199 TRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALIC  278 (337)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~  278 (337)
                      ..              .......+++.|+|||.+...   ..++.++||||||+++|+|++|..||.+............
T Consensus       161 ~~--------------~~~~~~~~t~~y~aPE~~~~~---~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~  223 (317)
T 2pmi_A          161 PV--------------NTFSSEVVTLWYRAPDVLMGS---RTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFD  223 (317)
T ss_dssp             CC--------------CCCCCCCSCCTTCCHHHHTTC---CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred             Cc--------------ccCCCCcccccccCchHhhCC---CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence            22              111233589999999999732   3678999999999999999999999976544433333322


Q ss_pred             HhhccC-----------------------------CCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCC
Q 019650          279 AICFGE-----------------------------RLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSS  329 (337)
Q Consensus       279 ~~~~~~-----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~  329 (337)
                      ......                             ........+..+.+||.+||..||++|||++|+|+||||++....
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~  303 (317)
T 2pmi_A          224 IMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHH  303 (317)
T ss_dssp             HHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC-
T ss_pred             HhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccch
Confidence            211100                             001123568899999999999999999999999999999987654

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=2.1e-50  Score=358.83  Aligned_cols=271  Identities=24%  Similarity=0.353  Sum_probs=212.5

Q ss_pred             CCCccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCc-hHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeC
Q 019650           40 SPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSS-TIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIE  118 (337)
Q Consensus        40 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~  118 (337)
                      .+.....++|++++.||+|+||+||+|.+..+++.||+|++..... ....+.+.+|+.++++++|+||+++++++.+ +
T Consensus        27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~  105 (329)
T 3gbz_A           27 APSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHH-N  105 (329)
T ss_dssp             -----CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEE-T
T ss_pred             CCcccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEec-C
Confidence            3446778999999999999999999999999999999999976542 2234566789999999999999999998876 7


Q ss_pred             CeEEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEc-----CCCcEEEeeccCc
Q 019650          119 GEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLIN-----GKGEVKIADFGVS  193 (337)
Q Consensus       119 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~-----~~~~~~l~Dfg~~  193 (337)
                      ...++||||+++ +|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++     .++.++|+|||++
T Consensus       106 ~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a  184 (329)
T 3gbz_A          106 HRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA  184 (329)
T ss_dssp             TEEEEEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred             CEEEEEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence            899999999975 9999999888999999999999999999999999999999999999994     4456999999999


Q ss_pred             cchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhH
Q 019650          194 RIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDL  273 (337)
Q Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~  273 (337)
                      .......              .......+++.|+|||++...   ..++.++||||||+++|+|++|..||.........
T Consensus       185 ~~~~~~~--------------~~~~~~~~t~~y~aPE~~~~~---~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~  247 (329)
T 3gbz_A          185 RAFGIPI--------------RQFTHEIITLWYRPPEILLGS---RHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQL  247 (329)
T ss_dssp             HHHC-------------------------CCTTCCHHHHTTC---CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred             cccCCcc--------------cccCCCcCCccccCHHHhcCC---CCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHH
Confidence            8764332              112223579999999999742   35799999999999999999999999775544444


Q ss_pred             HHHHHHhhccCCCCCC-------------------------CCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCC
Q 019650          274 MALICAICFGERLEMP-------------------------ETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSS  328 (337)
Q Consensus       274 ~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~  328 (337)
                      ..............++                         ..+++.+.+||.+||+.||.+|||++|+|+||||++..+
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  327 (329)
T 3gbz_A          248 FKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDF  327 (329)
T ss_dssp             HHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCS
T ss_pred             HHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCC
Confidence            4443332211111110                         115789999999999999999999999999999998765


Q ss_pred             C
Q 019650          329 S  329 (337)
Q Consensus       329 ~  329 (337)
                      .
T Consensus       328 ~  328 (329)
T 3gbz_A          328 D  328 (329)
T ss_dssp             C
T ss_pred             C
Confidence            3

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=9.3e-50  Score=362.65  Aligned_cols=279  Identities=22%  Similarity=0.301  Sum_probs=221.8

Q ss_pred             CCccCccccccccccccC--cceEEEEEEEccCCceEEEEEeecCC-chHhHHHHHHHHHHHHhcCCCCceeeeeeEEee
Q 019650           41 PDVENISDLKKLTVLGHG--NGGIVYKVRHQKSNSIYALKVLNTTS-STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTI  117 (337)
Q Consensus        41 ~~~~~~~~y~~~~~lg~g--~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~  117 (337)
                      ......++|++++.||.|  +||+||+|.+..+++.||+|++.... .....+.+.+|+.++++++|+||+++++++.+ 
T Consensus        19 ~~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-   97 (389)
T 3gni_B           19 SFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIA-   97 (389)
T ss_dssp             CCCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-
T ss_pred             cccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEE-
Confidence            345678999999999999  99999999999999999999997653 33455677889999999999999999999876 


Q ss_pred             CCeEEEEEeccCCCCchHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccc
Q 019650          118 EGEICFVMEHMERGSLFDSLRVR--KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRI  195 (337)
Q Consensus       118 ~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~  195 (337)
                      ....++||||+++++|.+++...  ..+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||.+..
T Consensus        98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~  177 (389)
T 3gni_B           98 DNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLS  177 (389)
T ss_dssp             TTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred             CCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEccccccee
Confidence            78999999999999999999865  6799999999999999999999999999999999999999999999999998876


Q ss_pred             hhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHH
Q 019650          196 VEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMA  275 (337)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~  275 (337)
                      ............       ......+|++.|+|||++...  ...++.++||||||+++|+|++|+.||.+.........
T Consensus       178 ~~~~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~--~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~  248 (389)
T 3gni_B          178 MISHGQRQRVVH-------DFPKYSVKVLPWLSPEVLQQN--LQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLE  248 (389)
T ss_dssp             CEETTEECSCBC-------CCCTTCTTTGGGSCHHHHSTT--SSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHH
T ss_pred             eccccccccccc-------cccccccccccccCHHHHhcc--CCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence            543321111100       112233689999999999842  14688999999999999999999999977554443322


Q ss_pred             HHHHhhc-----------------------------------------cCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCH
Q 019650          276 LICAICF-----------------------------------------GERLEMPETASPEFRRFVRSCLEKDWRKRGTV  314 (337)
Q Consensus       276 ~~~~~~~-----------------------------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~  314 (337)
                      .......                                         ......+..+++.+.+||.+||+.||++|||+
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta  328 (389)
T 3gni_B          249 KLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSA  328 (389)
T ss_dssp             C--------------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCH
T ss_pred             HhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCH
Confidence            2211000                                         00112345578899999999999999999999


Q ss_pred             HHHhcCccccccCCC
Q 019650          315 EELLAYPFVTKRSSS  329 (337)
Q Consensus       315 ~eil~hp~f~~~~~~  329 (337)
                      +|+|+||||++..+.
T Consensus       329 ~ell~hp~f~~~~~~  343 (389)
T 3gni_B          329 STLLNHSFFKQIKRR  343 (389)
T ss_dssp             HHHTTSGGGGGC---
T ss_pred             HHHhcCHHHHHHhhc
Confidence            999999999987643

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=8.4e-51  Score=375.79  Aligned_cols=264  Identities=27%  Similarity=0.449  Sum_probs=216.1

Q ss_pred             ccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCe
Q 019650           43 VENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGE  120 (337)
Q Consensus        43 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~  120 (337)
                      ....++|++++.||+|+||.||+|.+..+++.||+|++....  .......+.+|+.+++.++|+||+++++++.+ ...
T Consensus       144 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~-~~~  222 (446)
T 4ejn_A          144 RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT-HDR  222 (446)
T ss_dssp             CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEE-TTE
T ss_pred             CCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEee-CCE
Confidence            345789999999999999999999999999999999997542  22334566789999999999999999998876 788


Q ss_pred             EEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCeEEcCCCcEEEeeccCccchhcc
Q 019650          121 ICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG-MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEET  199 (337)
Q Consensus       121 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~-~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~  199 (337)
                      +++||||+++++|.+++.....+++..+..++.||+.||+|||+ .||+||||||+|||++.+++++|+|||++......
T Consensus       223 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  302 (446)
T 4ejn_A          223 LCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD  302 (446)
T ss_dssp             EEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred             EEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCC
Confidence            99999999999999999988899999999999999999999998 99999999999999999999999999998754322


Q ss_pred             ccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHH
Q 019650          200 RNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICA  279 (337)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~  279 (337)
                      .              ......+||+.|+|||++.    +..++.++||||||+++|+|++|+.||............   
T Consensus       303 ~--------------~~~~~~~gt~~y~aPE~~~----~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i---  361 (446)
T 4ejn_A          303 G--------------ATMKTFCGTPEYLAPEVLE----DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI---  361 (446)
T ss_dssp             ------------------CCSSSCGGGCCHHHHH----TSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---
T ss_pred             C--------------cccccccCCccccCHhhcC----CCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHH---
Confidence            1              2223346999999999998    567899999999999999999999999764332222221   


Q ss_pred             hhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCC-----CHHHHhcCccccccCCCc
Q 019650          280 ICFGERLEMPETASPEFRRFVRSCLEKDWRKRG-----TVEELLAYPFVTKRSSSS  330 (337)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~-----s~~eil~hp~f~~~~~~~  330 (337)
                       . .....++..+++.+.+||.+||+.||.+||     |++++++||||++..+..
T Consensus       362 -~-~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~~~  415 (446)
T 4ejn_A          362 -L-MEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQH  415 (446)
T ss_dssp             -H-HCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHH
T ss_pred             -H-hCCCCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCHHH
Confidence             1 234556778899999999999999999999     999999999999876644

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=4e-50  Score=359.59  Aligned_cols=262  Identities=31%  Similarity=0.424  Sum_probs=207.2

Q ss_pred             CccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 019650           45 NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFV  124 (337)
Q Consensus        45 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv  124 (337)
                      ..++|++.+.||+|+||+||+|.+..+++.||+|++....   ..+.+.+|+.++++++|+||+++++++.+ ....++|
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv  126 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV---DKKIVRTEIGVLLRLSHPNIIKLKEIFET-PTEISLV  126 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-------------CHHHHHCCCTTBCCEEEEEEC-SSEEEEE
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch---hHHHHHHHHHHHHhCCCCCCcceeeeEec-CCeEEEE
Confidence            3467999999999999999999999999999999997653   23567789999999999999999998876 6889999


Q ss_pred             EeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcC---CCcEEEeeccCccchhcccc
Q 019650          125 MEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLING---KGEVKIADFGVSRIVEETRN  201 (337)
Q Consensus       125 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~---~~~~~l~Dfg~~~~~~~~~~  201 (337)
                      |||+++++|.+++...+.+++..++.++.||+.||.|||+.|++||||||+||+++.   ++.++|+|||++....... 
T Consensus       127 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~-  205 (349)
T 2w4o_A          127 LELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV-  205 (349)
T ss_dssp             ECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC----------
T ss_pred             EEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCccc-
Confidence            999999999999998888999999999999999999999999999999999999975   7899999999987654321 


Q ss_pred             CCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhh
Q 019650          202 NNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAIC  281 (337)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~  281 (337)
                                    ......|++.|+|||++.    +..++.++||||||+++|+|++|..||.................
T Consensus       206 --------------~~~~~~gt~~y~aPE~~~----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~  267 (349)
T 2w4o_A          206 --------------LMKTVCGTPGYCAPEILR----GCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCE  267 (349)
T ss_dssp             ---------------------CGGGSCHHHHT----TCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTC
T ss_pred             --------------ccccccCCCCccCHHHhc----CCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCC
Confidence                          112335899999999998    45789999999999999999999999976544433333222222


Q ss_pred             ccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCC
Q 019650          282 FGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSS  329 (337)
Q Consensus       282 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~  329 (337)
                      ..........++..+.++|.+||..||++|||+.++|+||||++....
T Consensus       268 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~  315 (349)
T 2w4o_A          268 YYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAAN  315 (349)
T ss_dssp             CCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTTCC
T ss_pred             CccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCccc
Confidence            222223345679999999999999999999999999999999987643

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2e-50  Score=357.52  Aligned_cols=260  Identities=24%  Similarity=0.325  Sum_probs=217.6

Q ss_pred             CccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 019650           45 NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFV  124 (337)
Q Consensus        45 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv  124 (337)
                      ..++|++.+.||+|+||+||+|.+..++..+|+|++....  .....+.+|+.+++.++||||+++++++.+ ....++|
T Consensus         3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~~~~~lv   79 (321)
T 1tki_A            3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG--TDQVLVKKEISILNIARHRNILHLHESFES-MEELVMI   79 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT--HHHHHHHHHHHHHHHSCCTTBCCEEEEEEE-TTEEEEE
T ss_pred             hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc--ccHHHHHHHHHHHHhCCCCCCCeEeEEEec-CCEEEEE
Confidence            3579999999999999999999999999999999987543  334567899999999999999999998876 7899999


Q ss_pred             EeccCCCCchHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcC--CCcEEEeeccCccchhcccc
Q 019650          125 MEHMERGSLFDSLRVR-KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLING--KGEVKIADFGVSRIVEETRN  201 (337)
Q Consensus       125 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~--~~~~~l~Dfg~~~~~~~~~~  201 (337)
                      |||++|++|.+++... ..+++..++.++.|++.||.|||++|++||||||+||+++.  ++.++|+|||++......  
T Consensus        80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~--  157 (321)
T 1tki_A           80 FEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG--  157 (321)
T ss_dssp             ECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT--
T ss_pred             EEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC--
Confidence            9999999999999765 47999999999999999999999999999999999999987  789999999999776432  


Q ss_pred             CCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhh
Q 019650          202 NNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAIC  281 (337)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~  281 (337)
                                   .......+++.|+|||++.    +..++.++||||||+++|+|++|..||............... .
T Consensus       158 -------------~~~~~~~gt~~y~aPE~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~-~  219 (321)
T 1tki_A          158 -------------DNFRLLFTAPEYYAPEVHQ----HDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNA-E  219 (321)
T ss_dssp             -------------CEEEEEESCGGGSCHHHHT----TCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT-C
T ss_pred             -------------CccccccCChhhcCcHHhc----CCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcC-C
Confidence                         1222346899999999998    446789999999999999999999999764433222222211 1


Q ss_pred             ccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccC
Q 019650          282 FGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRS  327 (337)
Q Consensus       282 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~  327 (337)
                      ..........++..+.++|.+||..||.+|||+.|+|+||||++..
T Consensus       220 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  265 (321)
T 1tki_A          220 YTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKI  265 (321)
T ss_dssp             CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred             CCCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccCc
Confidence            1111112246799999999999999999999999999999998764

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=4.7e-51  Score=363.02  Aligned_cols=258  Identities=29%  Similarity=0.393  Sum_probs=217.9

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeE
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEI  121 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~  121 (337)
                      ..+++|.+.+.||+|+||+||+|.+..+++.||+|++....  .......+.+|+.+++.++||||+++++++.+ ....
T Consensus         6 ~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-~~~~   84 (336)
T 3h4j_B            6 RHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITT-PTDI   84 (336)
T ss_dssp             SEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEE
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-CCEE
Confidence            45789999999999999999999999999999999987542  11223567889999999999999999998876 6889


Q ss_pred             EEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhcccc
Q 019650          122 CFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRN  201 (337)
Q Consensus       122 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~  201 (337)
                      ++||||+ +|+|.+++...+.+++..++.++.||+.||.|||+.|++||||||+||+++.+++++|+|||++....... 
T Consensus        85 ~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~-  162 (336)
T 3h4j_B           85 VMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN-  162 (336)
T ss_dssp             EEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB-
T ss_pred             EEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCc-
Confidence            9999999 67999999888899999999999999999999999999999999999999999999999999987654332 


Q ss_pred             CCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCC-CccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHh
Q 019650          202 NNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDY-GFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAI  280 (337)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~-~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~  280 (337)
                                    .....+|++.|+|||.+..    ..+ +.++||||||+++|+|++|..||..........     .
T Consensus       163 --------------~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~-----~  219 (336)
T 3h4j_B          163 --------------FLKTSCGSPNYAAPEVING----KLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK-----K  219 (336)
T ss_dssp             --------------TTCCCTTSTTTSCGGGSCC----SGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBC-----C
T ss_pred             --------------ccccccCCcCcCCHHHHcC----CCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHH-----H
Confidence                          1223368999999999984    343 789999999999999999999996543222111     1


Q ss_pred             hccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccC
Q 019650          281 CFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRS  327 (337)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~  327 (337)
                      ........+..+++.+.++|.+||..||.+|||++|+++||||+...
T Consensus       220 i~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~  266 (336)
T 3h4j_B          220 VNSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVNL  266 (336)
T ss_dssp             CCSSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTTC
T ss_pred             HHcCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccCC
Confidence            11223445677899999999999999999999999999999998653

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.9e-50  Score=370.52  Aligned_cols=272  Identities=24%  Similarity=0.361  Sum_probs=222.8

Q ss_pred             CccccccccccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEE
Q 019650           45 NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEIC  122 (337)
Q Consensus        45 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~  122 (337)
                      ..++|+++++||+|+||+||+|.+..+++.||+|+++...  .......+.+|..++..++|+||+++++.+.+ ...+|
T Consensus        72 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~-~~~~~  150 (437)
T 4aw2_A           72 HREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD-DNNLY  150 (437)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC-SSEEE
T ss_pred             ChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-CCEEE
Confidence            4579999999999999999999999999999999997532  11122336789999999999999999998876 78899


Q ss_pred             EEEeccCCCCchHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhcccc
Q 019650          123 FVMEHMERGSLFDSLRV-RKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRN  201 (337)
Q Consensus       123 lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~  201 (337)
                      +||||++||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||++........
T Consensus       151 lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~  230 (437)
T 4aw2_A          151 LVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT  230 (437)
T ss_dssp             EEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC
T ss_pred             EEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCC
Confidence            99999999999999986 57899999999999999999999999999999999999999999999999999976543221


Q ss_pred             CCCCCCCCCCccccccccccCCCCCcCCccccccc-CCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHh
Q 019650          202 NNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSER-WGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAI  280 (337)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~  280 (337)
                                   ......+||+.|+|||++.... .+..++.++||||||+++|||++|+.||.+....+....++...
T Consensus       231 -------------~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~  297 (437)
T 4aw2_A          231 -------------VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK  297 (437)
T ss_dssp             -------------EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH
T ss_pred             -------------cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcc
Confidence                         1222346999999999986210 02357889999999999999999999997654444433333222


Q ss_pred             hccCCCCCCCCCCHHHHHHHHHHhhcCcCC--CCCHHHHhcCccccccCCCc
Q 019650          281 CFGERLEMPETASPEFRRFVRSCLEKDWRK--RGTVEELLAYPFVTKRSSSS  330 (337)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~--R~s~~eil~hp~f~~~~~~~  330 (337)
                      .....+.....+++.+++||.+||..+|++  |++++|+++||||++.+|..
T Consensus       298 ~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~  349 (437)
T 4aw2_A          298 ERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDN  349 (437)
T ss_dssp             HHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTT
T ss_pred             ccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHHH
Confidence            222233333568999999999999988888  99999999999999987653

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=6.9e-50  Score=350.63  Aligned_cols=265  Identities=31%  Similarity=0.418  Sum_probs=210.3

Q ss_pred             CCccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCch-------------------------HhHHHHHHH
Q 019650           41 PDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSST-------------------------IIRHQAAHE   95 (337)
Q Consensus        41 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~-------------------------~~~~~~~~e   95 (337)
                      ......++|++.+.||+|+||+||+|.+..+++.||+|++......                         ...+.+.+|
T Consensus         7 ~~~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E   86 (298)
T 2zv2_A            7 GDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQE   86 (298)
T ss_dssp             ---CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHH
T ss_pred             CCceeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHH
Confidence            3456679999999999999999999999999999999999764311                         123567889


Q ss_pred             HHHHHhcCCCCceeeeeeEEee-CCeEEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCC
Q 019650           96 AEILKRLDSQFIVKCHAVFYTI-EGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKP  174 (337)
Q Consensus        96 ~~~~~~l~~~~i~~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~  174 (337)
                      +.++++++|+||+++++++.+. ....++||||+++++|.+++. ...+++..++.++.||+.||+|||++|++|+||||
T Consensus        87 ~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp  165 (298)
T 2zv2_A           87 IAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKP  165 (298)
T ss_dssp             HHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG
T ss_pred             HHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCH
Confidence            9999999999999999988763 467899999999999988764 45799999999999999999999999999999999


Q ss_pred             CCeEEcCCCcEEEeeccCccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHH
Q 019650          175 SNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVV  254 (337)
Q Consensus       175 ~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il  254 (337)
                      +||+++.+++++|+|||++.......              .......|++.|+|||.+.... ...++.++||||||+++
T Consensus       166 ~Nil~~~~~~~kl~Dfg~~~~~~~~~--------------~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~Di~slG~~l  230 (298)
T 2zv2_A          166 SNLLVGEDGHIKIADFGVSNEFKGSD--------------ALLSNTVGTPAFMAPESLSETR-KIFSGKALDVWAMGVTL  230 (298)
T ss_dssp             GGEEECTTSCEEECCCTTCEECSSSS--------------CEECCCCSCGGGCCGGGCCTTC-CCEESHHHHHHHHHHHH
T ss_pred             HHEEECCCCCEEEecCCCcccccccc--------------ccccCCcCCccccChhhhccCC-CCCCCchhhhHhHHHHH
Confidence            99999999999999999987654321              1122346899999999997431 01137789999999999


Q ss_pred             HHHHhCCCCCCCCCCchhHHHHHHHhhcc-CCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccc
Q 019650          255 LECLVGHYPLIGFGEKPDLMALICAICFG-ERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTK  325 (337)
Q Consensus       255 ~~l~tg~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~  325 (337)
                      |+|++|..||.......    ........ ........+++.+.++|.+||+.||++|||++|+++||||+.
T Consensus       231 ~~l~~g~~pf~~~~~~~----~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~~  298 (298)
T 2zv2_A          231 YCFVFGQCPFMDERIMC----LHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR  298 (298)
T ss_dssp             HHHHHSSCSSCCSSHHH----HHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHHC
T ss_pred             HHHHHCCCCCCCccHHH----HHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCccccC
Confidence            99999999996542211    11111111 122223567899999999999999999999999999999963

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=2.9e-49  Score=344.17  Aligned_cols=267  Identities=28%  Similarity=0.409  Sum_probs=223.8

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCceEEEEEeecCC-chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEE
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEIC  122 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~  122 (337)
                      ...++|++.+.||.|+||+||+|.+..++..||+|++.... .....+.+.+|+.++++++|+||+++++++.. ....+
T Consensus         3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   81 (284)
T 3kk8_A            3 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE-ESFHY   81 (284)
T ss_dssp             TTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEE
T ss_pred             hhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEc-CCEEE
Confidence            34689999999999999999999999999999999997653 34455678899999999999999999998866 68899


Q ss_pred             EEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCc---EEEeeccCccchhcc
Q 019650          123 FVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGE---VKIADFGVSRIVEET  199 (337)
Q Consensus       123 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~---~~l~Dfg~~~~~~~~  199 (337)
                      +||||+++++|.+.+.....+++..+..++.|++.||.|||+.|++|+||||+||+++.++.   ++|+|||.+......
T Consensus        82 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~  161 (284)
T 3kk8_A           82 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS  161 (284)
T ss_dssp             EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS
T ss_pred             EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC
Confidence            99999999999999988889999999999999999999999999999999999999987655   999999999765433


Q ss_pred             ccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHH
Q 019650          200 RNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICA  279 (337)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~  279 (337)
                      .               ......+++.|+|||.+.    +..++.++||||||+++|+|++|..||....... .......
T Consensus       162 ~---------------~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-~~~~~~~  221 (284)
T 3kk8_A          162 E---------------AWHGFAGTPGYLSPEVLK----KDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR-LYAQIKA  221 (284)
T ss_dssp             C---------------BCCCSCSCGGGCCHHHHT----TCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHH
T ss_pred             c---------------cccCCCCCcCCcCchhhc----CCCCCcccchHHHHHHHHHHHHCCCCCCCCchhH-HHHHHHh
Confidence            2               112335899999999998    4578899999999999999999999997643322 2222222


Q ss_pred             hhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCCcc
Q 019650          280 ICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSN  331 (337)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~~~  331 (337)
                      .....+......+++.+.+++.+||+.||++|||++++|+||||++..+...
T Consensus       222 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~~  273 (284)
T 3kk8_A          222 GAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVAS  273 (284)
T ss_dssp             TCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCCGGG
T ss_pred             ccccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCChhHHh
Confidence            2222223333567899999999999999999999999999999998876543

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.3e-49  Score=346.67  Aligned_cols=259  Identities=27%  Similarity=0.381  Sum_probs=211.9

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEE
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICF  123 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~l  123 (337)
                      ...++|.+.+.||+|+||+||+|.+..++..+|+|++.........+.+.+|+.++++++|+||+++++++.+ ....++
T Consensus        19 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~l   97 (285)
T 3is5_A           19 TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFED-YHNMYI   97 (285)
T ss_dssp             CHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSEEEE
T ss_pred             ChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheec-CCeEEE
Confidence            4568999999999999999999999999999999999876555556788899999999999999999998866 688999


Q ss_pred             EEeccCCCCchHHhhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEE---cCCCcEEEeeccCccch
Q 019650          124 VMEHMERGSLFDSLRVR----KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLI---NGKGEVKIADFGVSRIV  196 (337)
Q Consensus       124 v~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili---~~~~~~~l~Dfg~~~~~  196 (337)
                      ||||+++++|.+++...    ..+++..++.++.|++.||.|||+.|++|+||||+||++   +.++.++|+|||++...
T Consensus        98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~  177 (285)
T 3is5_A           98 VMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF  177 (285)
T ss_dssp             EECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred             EEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence            99999999999988543    679999999999999999999999999999999999999   44578999999999765


Q ss_pred             hccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHH
Q 019650          197 EETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMAL  276 (337)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~  276 (337)
                      ....               ......+++.|+|||.+.     ..++.++||||||+++|+|++|..||........ ...
T Consensus       178 ~~~~---------------~~~~~~~t~~y~aPE~~~-----~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~-~~~  236 (285)
T 3is5_A          178 KSDE---------------HSTNAAGTALYMAPEVFK-----RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEV-QQK  236 (285)
T ss_dssp             ------------------------CTTGGGCCHHHHT-----TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHH
T ss_pred             CCcc---------------cCcCcccccCcCChHHhc-----cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHH-Hhh
Confidence            4322               122335899999999986     3578999999999999999999999976432221 111


Q ss_pred             HHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccc
Q 019650          277 ICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTK  325 (337)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~  325 (337)
                      ... ............++.+.+++.+||+.||++|||++|+|+||||++
T Consensus       237 ~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~  284 (285)
T 3is5_A          237 ATY-KEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ  284 (285)
T ss_dssp             HHH-CCCCCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred             hcc-CCcccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence            111 111111222346899999999999999999999999999999986

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=2.7e-50  Score=366.72  Aligned_cols=270  Identities=26%  Similarity=0.360  Sum_probs=220.6

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeE
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEI  121 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~  121 (337)
                      ...++|++++.||+|+||+||+|.+..+++.||+|++....  .......+.+|..+++.++||||+++++++.+ ...+
T Consensus        66 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-~~~~  144 (410)
T 3v8s_A           66 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD-DRYL  144 (410)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC-SSEE
T ss_pred             cCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE-CCEE
Confidence            45689999999999999999999999999999999986532  11122346789999999999999999998876 7889


Q ss_pred             EEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhcccc
Q 019650          122 CFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRN  201 (337)
Q Consensus       122 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~  201 (337)
                      |+||||++||+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||+++.+++++|+|||++........
T Consensus       145 ~lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~  223 (410)
T 3v8s_A          145 YMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM  223 (410)
T ss_dssp             EEEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSE
T ss_pred             EEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCCc
Confidence            999999999999999975 4699999999999999999999999999999999999999999999999999976543221


Q ss_pred             CCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhh
Q 019650          202 NNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAIC  281 (337)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~  281 (337)
                                   ......+||+.|+|||++........++.++||||||+++|+|++|..||.+.........+.... 
T Consensus       224 -------------~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~-  289 (410)
T 3v8s_A          224 -------------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHK-  289 (410)
T ss_dssp             -------------EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH-
T ss_pred             -------------ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhcc-
Confidence                         122345799999999999854212237889999999999999999999997654333333332211 


Q ss_pred             ccCCCCCCCCCCHHHHHHHHHHhhcCcCC--CCCHHHHhcCccccccCCC
Q 019650          282 FGERLEMPETASPEFRRFVRSCLEKDWRK--RGTVEELLAYPFVTKRSSS  329 (337)
Q Consensus       282 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~--R~s~~eil~hp~f~~~~~~  329 (337)
                      ..........++..+++||.+||..+|.+  |++++||++||||++..|.
T Consensus       290 ~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~  339 (410)
T 3v8s_A          290 NSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWA  339 (410)
T ss_dssp             HHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCC
T ss_pred             ccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCHH
Confidence            11122223468999999999999999988  9999999999999998664

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=8.4e-50  Score=348.39  Aligned_cols=261  Identities=26%  Similarity=0.389  Sum_probs=211.5

Q ss_pred             ccccccccccccCcceEEEEEEEccCCceEEEEEeecCCc-hHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 019650           46 ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSS-TIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFV  124 (337)
Q Consensus        46 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv  124 (337)
                      +++|++++.||+|+||+||+|.+ .+++.||+|++..... ....+.+.+|+.++++++|+||+++++++.+ ....++|
T Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv   78 (288)
T 1ob3_A            1 MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT-KKRLVLV   78 (288)
T ss_dssp             CCSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC-SSCEEEE
T ss_pred             CccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEcc-CCeEEEE
Confidence            36899999999999999999998 6788999999976542 2234667889999999999999999998876 6889999


Q ss_pred             EeccCCCCchHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCC
Q 019650          125 MEHMERGSLFDSLRVR-KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNN  203 (337)
Q Consensus       125 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~  203 (337)
                      |||+++ +|.+++... +.+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++.......   
T Consensus        79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---  154 (288)
T 1ob3_A           79 FEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV---  154 (288)
T ss_dssp             EECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred             EEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCccc---
Confidence            999976 999988754 679999999999999999999999999999999999999999999999999987664321   


Q ss_pred             CCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhcc
Q 019650          204 NHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFG  283 (337)
Q Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~  283 (337)
                                 .......+++.|+|||++...   ..++.++||||||+++|+|++|..||...................
T Consensus       155 -----------~~~~~~~~t~~y~aPE~~~~~---~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  220 (288)
T 1ob3_A          155 -----------RKYTHEIVTLWYRAPDVLMGS---KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTP  220 (288)
T ss_dssp             ------------------CCCTTCCHHHHTTC---CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             -----------cccccccccccccCchheeCC---CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCC
Confidence                       111223589999999999732   357899999999999999999999997755444333333321111


Q ss_pred             CCC------------------------CCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCcccccc
Q 019650          284 ERL------------------------EMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKR  326 (337)
Q Consensus       284 ~~~------------------------~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~  326 (337)
                      ...                        .....++..+.++|.+||..||++|||++++|+||||++.
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  287 (288)
T 1ob3_A          221 NSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN  287 (288)
T ss_dssp             CTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred             ChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence            000                        1124578899999999999999999999999999999864

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=4.8e-50  Score=359.47  Aligned_cols=263  Identities=28%  Similarity=0.374  Sum_probs=215.3

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCceEEEEEeecCC----chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCC
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS----STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEG  119 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~  119 (337)
                      ...++|++.+.||+|+||+||+|.+..+++.||+|++....    .....+.+.+|+.+++.++||||+++++++.+ ..
T Consensus        21 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~~   99 (351)
T 3c0i_A           21 LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSS-DG   99 (351)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TT
T ss_pred             ccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEe-CC
Confidence            34578999999999999999999999999999999986432    11235678899999999999999999998876 78


Q ss_pred             eEEEEEeccCCCCchHHhhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCc---EEEeeccC
Q 019650          120 EICFVMEHMERGSLFDSLRVR----KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGE---VKIADFGV  192 (337)
Q Consensus       120 ~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~---~~l~Dfg~  192 (337)
                      .+|+||||++|++|.+++...    ..+++..++.++.||+.||.|||++||+||||||+||+++.++.   ++|+|||+
T Consensus       100 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~  179 (351)
T 3c0i_A          100 MLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGV  179 (351)
T ss_dssp             EEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred             EEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcc
Confidence            999999999999998888643    35899999999999999999999999999999999999987654   99999999


Q ss_pred             ccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchh
Q 019650          193 SRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPD  272 (337)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~  272 (337)
                      +.......              ......+||+.|+|||++.    +..++.++||||||+++|+|++|..||...  ...
T Consensus       180 a~~~~~~~--------------~~~~~~~gt~~y~aPE~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~--~~~  239 (351)
T 3c0i_A          180 AIQLGESG--------------LVAGGRVGTPHFMAPEVVK----REPYGKPVDVWGCGVILFILLSGCLPFYGT--KER  239 (351)
T ss_dssp             CEECCTTS--------------CBCCCCCSCGGGCCHHHHT----TCCBCTHHHHHHHHHHHHHHHHSSCSSCSS--HHH
T ss_pred             eeEecCCC--------------eeecCCcCCcCccCHHHHc----CCCCCchHhhHHHHHHHHHHHHCCCCCCCc--HHH
Confidence            97765432              1122346899999999998    457889999999999999999999999753  222


Q ss_pred             HHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccC
Q 019650          273 LMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRS  327 (337)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~  327 (337)
                      ...................++..+.++|.+||..||.+|||+.++|+||||++..
T Consensus       240 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~  294 (351)
T 3c0i_A          240 LFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERD  294 (351)
T ss_dssp             HHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTHH
T ss_pred             HHHHHHcCCCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCCc
Confidence            2222221111111112246789999999999999999999999999999998754

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.8e-50  Score=366.01  Aligned_cols=272  Identities=23%  Similarity=0.344  Sum_probs=220.8

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeE
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEI  121 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~  121 (337)
                      ...++|++++.||+|+||+||+|.+..+++.||+|+++...  .....+.+.+|..++..++|++|+++++.+.+ ...+
T Consensus        58 ~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~-~~~~  136 (412)
T 2vd5_A           58 LQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD-ENYL  136 (412)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC-SSEE
T ss_pred             CChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee-CCEE
Confidence            45689999999999999999999999999999999997532  12223446789999999999999999998876 6889


Q ss_pred             EEEEeccCCCCchHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccc
Q 019650          122 CFVMEHMERGSLFDSLRVR-KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETR  200 (337)
Q Consensus       122 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~  200 (337)
                      |+||||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.+++++|+|||++.......
T Consensus       137 ~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~  216 (412)
T 2vd5_A          137 YLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADG  216 (412)
T ss_dssp             EEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred             EEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCC
Confidence            9999999999999999875 479999999999999999999999999999999999999999999999999997654322


Q ss_pred             cCCCCCCCCCCccccccccccCCCCCcCCccccccc---CCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHH
Q 019650          201 NNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSER---WGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALI  277 (337)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~  277 (337)
                      .             ......+||+.|+|||++....   .+..++.++|+||||+++|||++|+.||...........+.
T Consensus       217 ~-------------~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~  283 (412)
T 2vd5_A          217 T-------------VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIV  283 (412)
T ss_dssp             C-------------EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred             c-------------cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            1             1122346999999999997310   02357889999999999999999999997654433333333


Q ss_pred             HHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCC---CCHHHHhcCccccccCCCc
Q 019650          278 CAICFGERLEMPETASPEFRRFVRSCLEKDWRKR---GTVEELLAYPFVTKRSSSS  330 (337)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R---~s~~eil~hp~f~~~~~~~  330 (337)
                      ........+..+..++..+++||.+||. +|.+|   ++++++++||||++..|..
T Consensus       284 ~~~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~  338 (412)
T 2vd5_A          284 HYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDG  338 (412)
T ss_dssp             THHHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCSTT
T ss_pred             hcccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHHH
Confidence            2211222233345789999999999999 99998   5999999999999987754

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.3e-49  Score=350.98  Aligned_cols=270  Identities=24%  Similarity=0.401  Sum_probs=214.9

Q ss_pred             ccccccccccccCcceEEEEEEEccCCceEEEEEeecCC-chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 019650           46 ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFV  124 (337)
Q Consensus        46 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv  124 (337)
                      .++|++++.||+|++|+||+|.+..+++.||+|++.... .....+.+.+|+.++++++|+||+++++++.. ....++|
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv   80 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRR-KRRLHLV   80 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeec-CCeEEEE
Confidence            478999999999999999999999999999999986654 33345667889999999999999999998876 7889999


Q ss_pred             EeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCC
Q 019650          125 MEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNN  204 (337)
Q Consensus       125 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~  204 (337)
                      |||+++++|.+++.....+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||.+.......    
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~----  156 (311)
T 4agu_A           81 FEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS----  156 (311)
T ss_dssp             EECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred             EEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc----
Confidence            9999999999999888889999999999999999999999999999999999999999999999999997764322    


Q ss_pred             CCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhcc-
Q 019650          205 HNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFG-  283 (337)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~-  283 (337)
                                .......+++.|+|||.+...   ..++.++||||||+++|+|++|..||.+................. 
T Consensus       157 ----------~~~~~~~~~~~y~aPE~~~~~---~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  223 (311)
T 4agu_A          157 ----------DYYDDEVATRWYRSPELLVGD---TQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLI  223 (311)
T ss_dssp             -------------------GGGCCHHHHHTC---SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCC
T ss_pred             ----------cccCCCcCCccccChHHHhcC---CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccc
Confidence                      111233589999999999742   467899999999999999999999997754443333322211100 


Q ss_pred             ---------------CCCC----------CCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCCcccc
Q 019650          284 ---------------ERLE----------MPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNIE  333 (337)
Q Consensus       284 ---------------~~~~----------~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~~~~~  333 (337)
                                     ....          ..+.++..+.+++.+||+.||.+|||++++|+||||++......+.
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~  298 (311)
T 4agu_A          224 PRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIEDLA  298 (311)
T ss_dssp             HHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC------
T ss_pred             cccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCHHHHH
Confidence                           0000          0135688899999999999999999999999999999987655443

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1.1e-49  Score=345.98  Aligned_cols=259  Identities=30%  Similarity=0.440  Sum_probs=219.0

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeE
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEI  121 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~  121 (337)
                      ...++|++.+.||.|++|+||+|.+..++..||+|++....  .......+.+|+.++++++|+||+++++++.+ ....
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~   84 (279)
T 3fdn_A            6 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD-ATRV   84 (279)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEE
T ss_pred             eecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEec-CCEE
Confidence            46789999999999999999999999999999999986543  12234567889999999999999999998866 6889


Q ss_pred             EEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhcccc
Q 019650          122 CFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRN  201 (337)
Q Consensus       122 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~  201 (337)
                      ++||||+++++|.+++.....+++..+..++.||+.||.|||+.|++|+||+|+||+++.+++++|+|||++....... 
T Consensus        85 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~-  163 (279)
T 3fdn_A           85 YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-  163 (279)
T ss_dssp             EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC-----
T ss_pred             EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCccc-
Confidence            9999999999999999988899999999999999999999999999999999999999999999999999885543321 


Q ss_pred             CCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhh
Q 019650          202 NNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAIC  281 (337)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~  281 (337)
                                     .....+++.|+|||.+.    +..++.++||||||+++|+|++|..||............     
T Consensus       164 ---------------~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~-----  219 (279)
T 3fdn_A          164 ---------------RTDLCGTLDYLPPEMIE----GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI-----  219 (279)
T ss_dssp             -------------------CCCCTTCCHHHHT----TCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH-----
T ss_pred             ---------------ccccCCCCCccCHhHhc----cCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHH-----
Confidence                           12235899999999998    457788999999999999999999999754322222111     


Q ss_pred             ccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCC
Q 019650          282 FGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSS  328 (337)
Q Consensus       282 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~  328 (337)
                      ......++...+..+.++|.+||+.||.+|||++++++||||++...
T Consensus       220 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~~  266 (279)
T 3fdn_A          220 SRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSS  266 (279)
T ss_dssp             HHTCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHCS
T ss_pred             HhCCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCcc
Confidence            12244566778999999999999999999999999999999987653

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=2.4e-49  Score=348.80  Aligned_cols=265  Identities=25%  Similarity=0.360  Sum_probs=208.3

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCc----hHhHHHHHHHHHHHHhc---CCCCceeeeeeEEe
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSS----TIIRHQAAHEAEILKRL---DSQFIVKCHAVFYT  116 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~e~~~~~~l---~~~~i~~~~~~~~~  116 (337)
                      ...++|++.+.||+|+||+||+|.+..+++.||+|++.....    ......+.+|+.+++++   +|+||+++++++..
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~   85 (308)
T 3g33_A            6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT   85 (308)
T ss_dssp             ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred             ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence            346799999999999999999999999999999999874321    11123445566666655   59999999999877


Q ss_pred             eCC----eEEEEEeccCCCCchHHhhhcCC--CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeec
Q 019650          117 IEG----EICFVMEHMERGSLFDSLRVRKK--LSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADF  190 (337)
Q Consensus       117 ~~~----~~~lv~e~~~~~~L~~~l~~~~~--l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Df  190 (337)
                      ...    ..+++||++.+ +|.+++.....  +++..++.++.||+.||+|||++|++||||||+||+++.+++++|+||
T Consensus        86 ~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Df  164 (308)
T 3g33_A           86 SRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADF  164 (308)
T ss_dssp             CCSSSEEEEEEEEECCCC-BHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSC
T ss_pred             cCCCCceeEEEEehhhhc-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeC
Confidence            433    58999999975 99999987654  999999999999999999999999999999999999999999999999


Q ss_pred             cCccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCc
Q 019650          191 GVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEK  270 (337)
Q Consensus       191 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~  270 (337)
                      |.+......               .......+|+.|+|||++.    +..++.++||||||+++|+|++|..||.+....
T Consensus       165 g~a~~~~~~---------------~~~~~~~gt~~y~aPE~~~----~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~  225 (308)
T 3g33_A          165 GLARIYSYQ---------------MALTPVVVTLWYRAPEVLL----QSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA  225 (308)
T ss_dssp             SCTTTSTTC---------------CCSGGGGCCCSSCCHHHHH----TSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHH
T ss_pred             ccccccCCC---------------cccCCccccccccCchHHc----CCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            999765432               1223346899999999998    457899999999999999999999999775554


Q ss_pred             hhHHHHHHHhhccCCCC----------------------CCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCC
Q 019650          271 PDLMALICAICFGERLE----------------------MPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSS  328 (337)
Q Consensus       271 ~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~  328 (337)
                      .................                      ..+.+++.+.++|.+||+.||++|||++|+|+||||++...
T Consensus       226 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~~  305 (308)
T 3g33_A          226 DQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDEG  305 (308)
T ss_dssp             HHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC-----
T ss_pred             HHHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCCC
Confidence            44444433322111111                      11356889999999999999999999999999999998764

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=2e-49  Score=355.64  Aligned_cols=281  Identities=28%  Similarity=0.380  Sum_probs=224.5

Q ss_pred             CCCCccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCC-chHhHHHHHHHHHHHHhcCCCCceeeeeeEEee
Q 019650           39 TSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTI  117 (337)
Q Consensus        39 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~  117 (337)
                      ..+.....++|++++.||+|+||+||+|.+..+++.||+|++.... .......+.+|+.++++++|+||+++++++...
T Consensus         9 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   88 (351)
T 3mi9_A            9 ECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTK   88 (351)
T ss_dssp             CCTTSCBGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC
T ss_pred             cccccccccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecc
Confidence            3455677899999999999999999999999999999999986554 222345677899999999999999999988764


Q ss_pred             -------CCeEEEEEeccCCCCchHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEee
Q 019650          118 -------EGEICFVMEHMERGSLFDSLRV-RKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIAD  189 (337)
Q Consensus       118 -------~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~D  189 (337)
                             ....++||||+++ +|.+.+.. ...+++..++.++.||+.||+|||++|++||||||+||+++.++.++|+|
T Consensus        89 ~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~D  167 (351)
T 3mi9_A           89 ASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLAD  167 (351)
T ss_dssp             --------CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECC
T ss_pred             ccccccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEcc
Confidence                   3468999999976 77777754 36799999999999999999999999999999999999999999999999


Q ss_pred             ccCccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCC
Q 019650          190 FGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGE  269 (337)
Q Consensus       190 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~  269 (337)
                      ||++...........          .......+++.|+|||++...   ..++.++||||||+++|+|++|..||.+...
T Consensus       168 fg~a~~~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~---~~~~~~~DiwslG~il~ell~g~~pf~~~~~  234 (351)
T 3mi9_A          168 FGLARAFSLAKNSQP----------NRYTNRVVTLWYRPPELLLGE---RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE  234 (351)
T ss_dssp             CTTCEECCCCSSSSC----------CCCCSSCSCGGGCCHHHHTTC---CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             chhcccccccccccc----------cccCCcccccCccCchhhcCC---CCCCcHhHHHHHHHHHHHHHhCCCCCCCCCh
Confidence            999987653322111          122334689999999998742   3578999999999999999999999976543


Q ss_pred             chhHHHHHHHhhccCCCCCCCC----------------------------CCHHHHHHHHHHhhcCcCCCCCHHHHhcCc
Q 019650          270 KPDLMALICAICFGERLEMPET----------------------------ASPEFRRFVRSCLEKDWRKRGTVEELLAYP  321 (337)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~li~~~l~~~p~~R~s~~eil~hp  321 (337)
                      .... ..+............+.                            .++.+.+||.+||..||.+|||++|+|+||
T Consensus       235 ~~~~-~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp  313 (351)
T 3mi9_A          235 QHQL-ALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD  313 (351)
T ss_dssp             HHHH-HHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred             HHHH-HHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCC
Confidence            3333 33333333222222211                            266799999999999999999999999999


Q ss_pred             cccccCCCccccC
Q 019650          322 FVTKRSSSSNIEG  334 (337)
Q Consensus       322 ~f~~~~~~~~~~~  334 (337)
                      ||++....+.++.
T Consensus       314 ~f~~~~~~~~~~~  326 (351)
T 3mi9_A          314 FFWSDPMPSDLKG  326 (351)
T ss_dssp             GGGSSSCCCCSHH
T ss_pred             CcCCCCCcccccc
Confidence            9998887776543

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=4.2e-49  Score=356.87  Aligned_cols=263  Identities=26%  Similarity=0.426  Sum_probs=219.8

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEE
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICF  123 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~l  123 (337)
                      ...++|++++.||+|+||+||+|.+..+++.||+|++..... .....+.+|+.++++++|+||+++++++.+ ....++
T Consensus        48 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-~~~~~l  125 (387)
T 1kob_A           48 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP-LDKYTVKNEISIMNQLHHPKLINLHDAFED-KYEMVL  125 (387)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH-HHHHHHHHHHHHHTTCCSTTBCCEEEEEEC-SSEEEE
T ss_pred             ccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccch-hhHHHHHHHHHHHHhCCCcCCCeEEEEEEe-CCEEEE
Confidence            446899999999999999999999999999999999976543 344577899999999999999999998876 788999


Q ss_pred             EEeccCCCCchHHhhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcC--CCcEEEeeccCccchhccc
Q 019650          124 VMEHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLING--KGEVKIADFGVSRIVEETR  200 (337)
Q Consensus       124 v~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~--~~~~~l~Dfg~~~~~~~~~  200 (337)
                      ||||++|++|.+++.... .+++..++.++.||+.||.|||++|++||||||+||+++.  ++.++|+|||++.......
T Consensus       126 v~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~  205 (387)
T 1kob_A          126 ILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE  205 (387)
T ss_dssp             EEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred             EEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCc
Confidence            999999999999997553 7999999999999999999999999999999999999974  4689999999998764321


Q ss_pred             cCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHh
Q 019650          201 NNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAI  280 (337)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~  280 (337)
                                     ......||+.|+|||++.    +..++.++||||||+++|+|++|..||.+........ .....
T Consensus       206 ---------------~~~~~~gt~~y~aPE~~~----~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~-~i~~~  265 (387)
T 1kob_A          206 ---------------IVKVTTATAEFAAPEIVD----REPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQ-NVKRC  265 (387)
T ss_dssp             ---------------CEEEECSSGGGCCHHHHT----TCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHH-HHHHC
T ss_pred             ---------------ceeeeccCCCccCchhcc----CCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHH-HHHhC
Confidence                           122335899999999998    4578899999999999999999999997643322222 22221


Q ss_pred             hccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCC
Q 019650          281 CFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSS  328 (337)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~  328 (337)
                      ...........++..+.++|.+||..||.+|||++++|+||||++...
T Consensus       266 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  313 (387)
T 1kob_A          266 DWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHS  313 (387)
T ss_dssp             CCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCCT
T ss_pred             CCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCCcc
Confidence            222233344567999999999999999999999999999999987653

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=1.1e-49  Score=368.89  Aligned_cols=261  Identities=26%  Similarity=0.379  Sum_probs=222.0

Q ss_pred             ccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCe
Q 019650           43 VENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGE  120 (337)
Q Consensus        43 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~  120 (337)
                      ....++|.+++.||.|+||+||+|.+..+++.||+|++....  .......+.+|+.+++.++||||+++++++.+ ...
T Consensus        12 ~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~-~~~   90 (476)
T 2y94_A           12 RVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIST-PSD   90 (476)
T ss_dssp             CCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSE
T ss_pred             CceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-CCE
Confidence            456789999999999999999999999999999999997542  11234678899999999999999999998876 688


Q ss_pred             EEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccc
Q 019650          121 ICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETR  200 (337)
Q Consensus       121 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~  200 (337)
                      .++||||++|++|.+++...+.+++..++.++.||+.||.|||++|++||||||+||+++.+++++|+|||++.......
T Consensus        91 ~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~  170 (476)
T 2y94_A           91 IFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE  170 (476)
T ss_dssp             EEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC
T ss_pred             EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhccccc
Confidence            99999999999999999988899999999999999999999999999999999999999999999999999997654321


Q ss_pred             cCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHh
Q 019650          201 NNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAI  280 (337)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~  280 (337)
                                     .....+|++.|+|||.+...   ...+.++||||||+++|+|++|..||.........    ...
T Consensus       171 ---------------~~~~~~gt~~y~aPE~~~~~---~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~----~~i  228 (476)
T 2y94_A          171 ---------------FLRTSCGSPNYAAPEVISGR---LYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLF----KKI  228 (476)
T ss_dssp             ---------------CBCCCCSCSTTCCHHHHTTC---CBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHH----HHH
T ss_pred             ---------------cccccCCCcCeEChhhccCC---CCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHH----HHH
Confidence                           12233689999999999842   12368999999999999999999999764433222    222


Q ss_pred             hccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccC
Q 019650          281 CFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRS  327 (337)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~  327 (337)
                      ..+ ....+..++..+.++|.+||..||.+|||++++++||||++..
T Consensus       229 ~~~-~~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~~  274 (476)
T 2y94_A          229 CDG-IFYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQDL  274 (476)
T ss_dssp             HTT-CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTTC
T ss_pred             hcC-CcCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhcC
Confidence            222 3455667899999999999999999999999999999998753

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=2.2e-49  Score=357.59  Aligned_cols=259  Identities=25%  Similarity=0.395  Sum_probs=209.5

Q ss_pred             ccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEec
Q 019650           48 DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEH  127 (337)
Q Consensus        48 ~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~e~  127 (337)
                      .+...+.||+|+||+||+|.+..++..||+|+++.... ...+.+.+|+.++++++|+||+++++++.+ ....++||||
T Consensus        90 ~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~~~~~lv~E~  167 (373)
T 2x4f_A           90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM-KDKEEVKNEISVMNQLDHANLIQLYDAFES-KNDIVLVMEY  167 (373)
T ss_dssp             EEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEEEEEC
T ss_pred             eeecceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEE-CCEEEEEEeC
Confidence            34447789999999999999999999999999987543 345678899999999999999999998876 6889999999


Q ss_pred             cCCCCchHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEE--cCCCcEEEeeccCccchhccccCCC
Q 019650          128 MERGSLFDSLRVR-KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLI--NGKGEVKIADFGVSRIVEETRNNNN  204 (337)
Q Consensus       128 ~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili--~~~~~~~l~Dfg~~~~~~~~~~~~~  204 (337)
                      +++++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+||++  +.++.++|+|||++.......    
T Consensus       168 ~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~----  243 (373)
T 2x4f_A          168 VDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE----  243 (373)
T ss_dssp             CTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC----
T ss_pred             CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc----
Confidence            9999999988654 579999999999999999999999999999999999999  556789999999998764332    


Q ss_pred             CCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhccC
Q 019650          205 HNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGE  284 (337)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~  284 (337)
                                 ......|++.|+|||++.    +..++.++||||||+++|+|++|..||...........+... ....
T Consensus       244 -----------~~~~~~gt~~y~aPE~~~----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~-~~~~  307 (373)
T 2x4f_A          244 -----------KLKVNFGTPEFLAPEVVN----YDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILAC-RWDL  307 (373)
T ss_dssp             -----------BCCCCCSSCTTCCHHHHT----TCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT-CCCS
T ss_pred             -----------ccccccCCCcEeChhhcc----CCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-cCCC
Confidence                       112235899999999997    457889999999999999999999999765443333332221 1111


Q ss_pred             CCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCC
Q 019650          285 RLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSS  328 (337)
Q Consensus       285 ~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~  328 (337)
                      .......+++.+.+||.+||..||.+|||++++|+||||++...
T Consensus       308 ~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~~~  351 (373)
T 2x4f_A          308 EDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDHKL  351 (373)
T ss_dssp             CSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCHHH
T ss_pred             ChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCCch
Confidence            12223567899999999999999999999999999999987643

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=2.4e-50  Score=369.48  Aligned_cols=269  Identities=30%  Similarity=0.406  Sum_probs=213.9

Q ss_pred             ccccccccccccCcceEEEEEEEccCCceEEEEEeecCC-------chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeC
Q 019650           46 ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-------STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIE  118 (337)
Q Consensus        46 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~  118 (337)
                      .++|.+.+.||+|+||+||+|.+..+++.||+|++....       .......+.+|+.++++++||||+++++++.  .
T Consensus       134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~--~  211 (419)
T 3i6u_A          134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD--A  211 (419)
T ss_dssp             HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE--S
T ss_pred             hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe--c
Confidence            578999999999999999999999999999999987542       1112234678999999999999999999863  4


Q ss_pred             CeEEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCC---cEEEeeccCccc
Q 019650          119 GEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKG---EVKIADFGVSRI  195 (337)
Q Consensus       119 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~---~~~l~Dfg~~~~  195 (337)
                      ...++||||+++++|.+++...+.+++..++.++.|++.||+|||++|++||||||+||+++.++   .++|+|||++..
T Consensus       212 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~  291 (419)
T 3i6u_A          212 EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI  291 (419)
T ss_dssp             SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTS
T ss_pred             CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeeccccee
Confidence            67899999999999999999888999999999999999999999999999999999999997654   599999999987


Q ss_pred             hhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHH
Q 019650          196 VEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMA  275 (337)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~  275 (337)
                      .....               ......||+.|+|||++.... ...++.++||||||+++|+|++|..||...........
T Consensus       292 ~~~~~---------------~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~  355 (419)
T 3i6u_A          292 LGETS---------------LMRTLCGTPTYLAPEVLVSVG-TAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKD  355 (419)
T ss_dssp             CC--------------------------CTTCCTTTTC-----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHH
T ss_pred             cCCCc---------------cccccCCCCCccCceeeecCC-CCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHH
Confidence            64321               122346899999999986321 24678899999999999999999999976554444444


Q ss_pred             HHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCCccc
Q 019650          276 LICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNI  332 (337)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~~~~  332 (337)
                      ..........+.....++..+.++|.+||..||.+|||++++|+||||++.......
T Consensus       356 ~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~~~~~  412 (419)
T 3i6u_A          356 QITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKF  412 (419)
T ss_dssp             HHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCHHHHHHH
T ss_pred             HHhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCChhHHHHH
Confidence            433322222222335678999999999999999999999999999999987654443

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.5e-49  Score=373.19  Aligned_cols=265  Identities=26%  Similarity=0.387  Sum_probs=224.0

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeE
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEI  121 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~  121 (337)
                      ...++|++.+.||.|+||.||+|.+..+++.||+|++....  .......+.+|+.++++++|+||+++++++.+ ...+
T Consensus       181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~-~~~l  259 (576)
T 2acx_A          181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET-KDAL  259 (576)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEE
T ss_pred             ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEee-CCEE
Confidence            45688999999999999999999999999999999996542  12234567789999999999999999998876 6899


Q ss_pred             EEEEeccCCCCchHHhhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhcc
Q 019650          122 CFVMEHMERGSLFDSLRVRK--KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEET  199 (337)
Q Consensus       122 ~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~  199 (337)
                      |+||||++||+|.+++...+  .+++..++.++.||+.||.|||++||+||||||+||+++.+++++|+|||++......
T Consensus       260 ~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~  339 (576)
T 2acx_A          260 CLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG  339 (576)
T ss_dssp             EEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence            99999999999999997654  4999999999999999999999999999999999999999999999999999765432


Q ss_pred             ccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHH
Q 019650          200 RNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICA  279 (337)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~  279 (337)
                      .               .....+||+.|+|||++.    +..++.++||||||+++|+|++|..||...........+...
T Consensus       340 ~---------------~~~~~~GT~~Y~APEvl~----~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~  400 (576)
T 2acx_A          340 Q---------------TIKGRVGTVGYMAPEVVK----NERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERL  400 (576)
T ss_dssp             C---------------CEECCCSCGGGCCHHHHT----TCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHH
T ss_pred             c---------------cccccCCCccccCHHHHc----CCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHH
Confidence            1               122346999999999998    456889999999999999999999999775443222223222


Q ss_pred             hhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCC-----CHHHHhcCccccccCCC
Q 019650          280 ICFGERLEMPETASPEFRRFVRSCLEKDWRKRG-----TVEELLAYPFVTKRSSS  329 (337)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~-----s~~eil~hp~f~~~~~~  329 (337)
                      . ......++..++..+.+||.+||..||.+||     +++|+++||||++..|.
T Consensus       401 i-~~~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w~  454 (576)
T 2acx_A          401 V-KEVPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFK  454 (576)
T ss_dssp             H-HHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCHH
T ss_pred             h-hcccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCHH
Confidence            2 2335566778899999999999999999999     89999999999986543

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=4.2e-49  Score=351.29  Aligned_cols=263  Identities=27%  Similarity=0.392  Sum_probs=224.4

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeE
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEI  121 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~  121 (337)
                      ...++|.+.+.||+|+||.||++.+..+++.+|+|++....  .....+.+.+|+.+++.++|+||+++++++.+ ....
T Consensus        38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~  116 (335)
T 2owb_A           38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED-NDFV  116 (335)
T ss_dssp             TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSEE
T ss_pred             ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-CCeE
Confidence            45689999999999999999999999999999999987543  33456778899999999999999999998876 6889


Q ss_pred             EEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhcccc
Q 019650          122 CFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRN  201 (337)
Q Consensus       122 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~  201 (337)
                      ++||||+++++|.+++.....+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++....... 
T Consensus       117 ~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~-  195 (335)
T 2owb_A          117 FVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG-  195 (335)
T ss_dssp             EEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT-
T ss_pred             EEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCc-
Confidence            9999999999999999888899999999999999999999999999999999999999999999999999997664322 


Q ss_pred             CCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhh
Q 019650          202 NNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAIC  281 (337)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~  281 (337)
                                   .......+++.|+|||.+.    +..++.++||||||+++|+|++|..||............    .
T Consensus       196 -------------~~~~~~~gt~~y~aPE~~~----~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~----~  254 (335)
T 2owb_A          196 -------------ERKKVLCGTPNYIAPEVLS----KKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI----K  254 (335)
T ss_dssp             -------------CCBCCCCSCCSSCCHHHHH----TSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH----H
T ss_pred             -------------ccccccCCCccccCHHHhc----cCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHH----h
Confidence                         1122335899999999998    457789999999999999999999999654332222211    1


Q ss_pred             ccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCCc
Q 019650          282 FGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSS  330 (337)
Q Consensus       282 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~~  330 (337)
                      . .....+..++..+.++|.+||+.||.+|||++++++||||++.....
T Consensus       255 ~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~~~~  302 (335)
T 2owb_A          255 K-NEYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPA  302 (335)
T ss_dssp             H-TCCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCCS
T ss_pred             c-CCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCCccc
Confidence            1 23455677899999999999999999999999999999999876543

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=4.6e-49  Score=341.42  Aligned_cols=268  Identities=22%  Similarity=0.271  Sum_probs=222.4

Q ss_pred             CccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 019650           45 NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFV  124 (337)
Q Consensus        45 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv  124 (337)
                      ..++|++.+.||+|++|+||+|.+..+++.||+|++.........+.+.+|+.+++.++|+||+++++++.+ +...++|
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv   83 (276)
T 2yex_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE-GNIQYLF   83 (276)
T ss_dssp             HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-TTEEEEE
T ss_pred             eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEc-CCEEEEE
Confidence            468999999999999999999999999999999999766544556778899999999999999999998876 7889999


Q ss_pred             EeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCC
Q 019650          125 MEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNN  204 (337)
Q Consensus       125 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~  204 (337)
                      |||+++++|.+++.....+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+.........  
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~--  161 (276)
T 2yex_A           84 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE--  161 (276)
T ss_dssp             EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE--
T ss_pred             EEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcch--
Confidence            999999999999988888999999999999999999999999999999999999999999999999998765432211  


Q ss_pred             CCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhccC
Q 019650          205 HNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGE  284 (337)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~  284 (337)
                                .......+++.|+|||.+...   ..++.++|+||||+++|+|++|..||...............  ...
T Consensus       162 ----------~~~~~~~~~~~y~aPE~~~~~---~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~  226 (276)
T 2yex_A          162 ----------RLLNKMCGTLPYVAPELLKRR---EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE--KKT  226 (276)
T ss_dssp             ----------CCBCCCCSCGGGCCGGGGTCS---SBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHT--TCT
T ss_pred             ----------hcccCCccccCccChHHHhcC---CCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhh--ccc
Confidence                      112233589999999999842   22467899999999999999999999765443322222211  111


Q ss_pred             CCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCCc
Q 019650          285 RLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSS  330 (337)
Q Consensus       285 ~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~~  330 (337)
                      .......++..+.++|.+||..||.+|||++++++||||++.....
T Consensus       227 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~  272 (276)
T 2yex_A          227 YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKG  272 (276)
T ss_dssp             TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC--
T ss_pred             ccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccChhhcc
Confidence            2222346789999999999999999999999999999999876543

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.3e-49  Score=353.02  Aligned_cols=261  Identities=27%  Similarity=0.425  Sum_probs=198.5

Q ss_pred             ccccccc---cccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcC-CCCceeeeeeEEeeCCeE
Q 019650           46 ISDLKKL---TVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLD-SQFIVKCHAVFYTIEGEI  121 (337)
Q Consensus        46 ~~~y~~~---~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~  121 (337)
                      .++|.+.   +.||+|+||+||+|.+..+++.||+|++...    ......+|+.+++.+. |+||+++++++.+ ....
T Consensus         7 ~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~-~~~~   81 (325)
T 3kn6_A            7 YQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR----MEANTQKEITALKLCEGHPNIVKLHEVFHD-QLHT   81 (325)
T ss_dssp             HHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG----GHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-SSEE
T ss_pred             hhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEc-CCEE
Confidence            4566664   7899999999999999999999999999754    3456678999999997 9999999998876 7889


Q ss_pred             EEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCC---cEEEeeccCccchhc
Q 019650          122 CFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKG---EVKIADFGVSRIVEE  198 (337)
Q Consensus       122 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~---~~~l~Dfg~~~~~~~  198 (337)
                      |+||||++|++|.+++...+.+++..++.++.||+.||.|||++|++||||||+||+++.++   .++|+|||++.....
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~  161 (325)
T 3kn6_A           82 FLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP  161 (325)
T ss_dssp             EEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC
T ss_pred             EEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCC
Confidence            99999999999999999888999999999999999999999999999999999999998765   899999999976543


Q ss_pred             cccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCc---hhHHH
Q 019650          199 TRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEK---PDLMA  275 (337)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~---~~~~~  275 (337)
                      ..              .......+++.|+|||.+.    +..++.++||||||+++|+|++|..||......   .....
T Consensus       162 ~~--------------~~~~~~~~t~~y~aPE~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~  223 (325)
T 3kn6_A          162 DN--------------QPLKTPCFTLHYAAPELLN----QNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVE  223 (325)
T ss_dssp             ----------------------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHH
T ss_pred             CC--------------CcccccCCCcCccCHHHhc----CCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHH
Confidence            32              1122335799999999998    557899999999999999999999999764321   11222


Q ss_pred             HHHHhhccCCCCCC----CCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCCc
Q 019650          276 LICAICFGERLEMP----ETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSS  330 (337)
Q Consensus       276 ~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~~  330 (337)
                      .......+. ..++    ..+++.+.+||.+||..||.+|||++++++||||++....+
T Consensus       224 ~~~~i~~~~-~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~~~  281 (325)
T 3kn6_A          224 IMKKIKKGD-FSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLS  281 (325)
T ss_dssp             HHHHHTTTC-CCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCCCC
T ss_pred             HHHHHHcCC-CCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCccCC
Confidence            333333222 1222    35789999999999999999999999999999999865443

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=1.3e-49  Score=354.99  Aligned_cols=259  Identities=25%  Similarity=0.398  Sum_probs=213.8

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhc-CCCCceeeeeeEEeeCCeEE
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRL-DSQFIVKCHAVFYTIEGEIC  122 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~~  122 (337)
                      ...++|++.+.||.|+||+||+|.+..+++.||+|++......     ..+|+.++.++ +||||+++++++.+ ....|
T Consensus        19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-----~~~E~~~l~~~~~hp~iv~~~~~~~~-~~~~~   92 (342)
T 2qr7_A           19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD-----PTEEIEILLRYGQHPNIITLKDVYDD-GKYVY   92 (342)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC-----CHHHHHHHHHHTTSTTBCCEEEEEEC-SSEEE
T ss_pred             CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC-----hHHHHHHHHHhcCCCCcCeEEEEEEc-CCEEE
Confidence            4568999999999999999999999999999999999765422     24577788777 79999999998866 78899


Q ss_pred             EEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCC-C---cEEEeeccCccchhc
Q 019650          123 FVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGK-G---EVKIADFGVSRIVEE  198 (337)
Q Consensus       123 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~-~---~~~l~Dfg~~~~~~~  198 (337)
                      +||||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+||++..+ +   .++|+|||++.....
T Consensus        93 lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~  172 (342)
T 2qr7_A           93 VVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA  172 (342)
T ss_dssp             EEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBC
T ss_pred             EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcC
Confidence            999999999999999988899999999999999999999999999999999999998543 3   599999999986543


Q ss_pred             cccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHH
Q 019650          199 TRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALIC  278 (337)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~  278 (337)
                      ..              ......++|+.|+|||++..    ..++.++||||||+++|+|++|..||...... .......
T Consensus       173 ~~--------------~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-~~~~~~~  233 (342)
T 2qr7_A          173 EN--------------GLLMTPCYTANFVAPEVLER----QGYDAACDIWSLGVLLYTMLTGYTPFANGPDD-TPEEILA  233 (342)
T ss_dssp             TT--------------CCBCCSSCCSSCCCHHHHHH----HHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTS-CHHHHHH
T ss_pred             CC--------------CceeccCCCccccCHHHhcC----CCCCCccCeeeHhHHHHHHhcCCCCCCCCCcC-CHHHHHH
Confidence            32              12223468999999999983    45788999999999999999999999754221 2222222


Q ss_pred             HhhccC---CCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccC
Q 019650          279 AICFGE---RLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRS  327 (337)
Q Consensus       279 ~~~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~  327 (337)
                      ....+.   ....+..+++.+.+||.+||..||++|||++++++||||.++.
T Consensus       234 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~  285 (342)
T 2qr7_A          234 RIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWD  285 (342)
T ss_dssp             HHHHCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTGG
T ss_pred             HHccCCcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCcc
Confidence            222222   2223467899999999999999999999999999999997754

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=6.1e-50  Score=355.06  Aligned_cols=265  Identities=25%  Similarity=0.355  Sum_probs=209.3

Q ss_pred             ccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 019650           46 ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVM  125 (337)
Q Consensus        46 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~  125 (337)
                      +++|++++.||+|+||+||+|.+..+++.||+|++...........+.+|+.++++++|+||+++++++.. ....++||
T Consensus         1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~   79 (324)
T 3mtl_A            1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHT-EKSLTLVF   79 (324)
T ss_dssp             CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEEC-SSCEEEEE
T ss_pred             CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEee-CCEEEEEe
Confidence            36899999999999999999999999999999999765433333344579999999999999999998866 68899999


Q ss_pred             eccCCCCchHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCC
Q 019650          126 EHMERGSLFDSLRVR-KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNN  204 (337)
Q Consensus       126 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~  204 (337)
                      ||+++ +|.+++... ..+++..++.++.||+.||.|||+.|++||||||+||+++.++.++|+|||.+.......    
T Consensus        80 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~----  154 (324)
T 3mtl_A           80 EYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT----  154 (324)
T ss_dssp             ECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC--------
T ss_pred             ccccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCc----
Confidence            99975 899988765 459999999999999999999999999999999999999999999999999987654322    


Q ss_pred             CCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhccC
Q 019650          205 HNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGE  284 (337)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~  284 (337)
                                .......+++.|+|||.+...   ..++.++||||||+++|+|++|..||.+..................
T Consensus       155 ----------~~~~~~~~t~~y~aPE~~~~~---~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~  221 (324)
T 3mtl_A          155 ----------KTYDNEVVTLWYRPPDILLGS---TDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPT  221 (324)
T ss_dssp             ------------------CGGGCCHHHHTTC---CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             ----------cccccccCcccccChhhhcCC---CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence                      112233579999999998742   4678999999999999999999999977544433333332211111


Q ss_pred             CCC-------------------------CCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCC
Q 019650          285 RLE-------------------------MPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSS  329 (337)
Q Consensus       285 ~~~-------------------------~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~  329 (337)
                      ...                         ..+.+++.+.+||.+||+.||.+|||++|+|+||||.+....
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  291 (324)
T 3mtl_A          222 EETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGER  291 (324)
T ss_dssp             TTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCST
T ss_pred             hHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccc
Confidence            111                         113467899999999999999999999999999999987643

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1.9e-49  Score=370.61  Aligned_cols=268  Identities=29%  Similarity=0.419  Sum_probs=220.9

Q ss_pred             CCccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCC-chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCC
Q 019650           41 PDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEG  119 (337)
Q Consensus        41 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~  119 (337)
                      ......++|.+++.||+|+||+||+|.+..+++.||+|++.... .......+.+|+.++++++||||+++++++.+ ..
T Consensus        16 ~~g~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~   94 (486)
T 3mwu_A           16 FQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED-SS   94 (486)
T ss_dssp             TCCHHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SS
T ss_pred             ccCChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEc-CC
Confidence            33456789999999999999999999999999999999986432 12235677899999999999999999998876 78


Q ss_pred             eEEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEc---CCCcEEEeeccCccch
Q 019650          120 EICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLIN---GKGEVKIADFGVSRIV  196 (337)
Q Consensus       120 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~---~~~~~~l~Dfg~~~~~  196 (337)
                      ..++||||+.+++|.+.+...+.+++..++.++.||+.||.|||++||+||||||+||+++   .++.++|+|||++...
T Consensus        95 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~  174 (486)
T 3mwu_A           95 SFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF  174 (486)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred             EEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence            8999999999999999998888999999999999999999999999999999999999995   4567999999998765


Q ss_pred             hccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHH
Q 019650          197 EETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMAL  276 (337)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~  276 (337)
                      ....               .....+||+.|+|||++.     ..++.++||||||+++|+|++|..||.+........ .
T Consensus       175 ~~~~---------------~~~~~~gt~~y~aPE~~~-----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~-~  233 (486)
T 3mwu_A          175 QQNT---------------KMKDRIGTAYYIAPEVLR-----GTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILK-R  233 (486)
T ss_dssp             CCC-------------------CCTTGGGGCCGGGGG-----SCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-H
T ss_pred             CCCC---------------ccCCCcCCCCCCCHHHhC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-H
Confidence            4321               222346899999999987     258899999999999999999999997654332222 2


Q ss_pred             HHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCCc
Q 019650          277 ICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSS  330 (337)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~~  330 (337)
                      +...........+..+++.++++|.+||..||.+|||+.++|+||||++.....
T Consensus       234 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~~~  287 (486)
T 3mwu_A          234 VETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSET  287 (486)
T ss_dssp             HHHTCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCCCC
T ss_pred             HHhCCCCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCcccC
Confidence            222111122223356789999999999999999999999999999999876543

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=3.7e-49  Score=369.60  Aligned_cols=266  Identities=27%  Similarity=0.401  Sum_probs=224.2

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCc--hHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeE
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSS--TIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEI  121 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~  121 (337)
                      ...++|.+++.||+|+||+||+|.+..+++.||+|++.....  ......+.+|..++++++|+||+++++.+.+ ...+
T Consensus       182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~-~~~l  260 (543)
T 3c4z_A          182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFET-KTDL  260 (543)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEE
T ss_pred             CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEee-CCEE
Confidence            456899999999999999999999999999999999975431  1234567889999999999999999998876 6889


Q ss_pred             EEEEeccCCCCchHHhhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchh
Q 019650          122 CFVMEHMERGSLFDSLRVR----KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVE  197 (337)
Q Consensus       122 ~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~  197 (337)
                      |+||||++||+|.+++...    ..+++..++.++.||+.||.|||++||+||||||+||+++.+|+++|+|||++....
T Consensus       261 ~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~  340 (543)
T 3c4z_A          261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK  340 (543)
T ss_dssp             EEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence            9999999999999999753    369999999999999999999999999999999999999999999999999998754


Q ss_pred             ccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHH
Q 019650          198 ETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALI  277 (337)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~  277 (337)
                      ...              ......+||+.|+|||++.    +..++.++|+||||+++|+|++|..||.............
T Consensus       341 ~~~--------------~~~~~~~GT~~Y~APE~l~----~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~  402 (543)
T 3c4z_A          341 AGQ--------------TKTKGYAGTPGFMAPELLL----GEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK  402 (543)
T ss_dssp             TTC--------------CCBCCCCSCTTTSCHHHHT----TCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHH
T ss_pred             CCC--------------cccccccCCccccChhhhc----CCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHH
Confidence            332              1122346999999999998    4578999999999999999999999997754433333333


Q ss_pred             HHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCC-----HHHHhcCccccccCCC
Q 019650          278 CAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGT-----VEELLAYPFVTKRSSS  329 (337)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s-----~~eil~hp~f~~~~~~  329 (337)
                      .... .....++..++..+.++|.+||..||.+||+     ++++++||||++..|.
T Consensus       403 ~~i~-~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w~  458 (543)
T 3c4z_A          403 QRVL-EQAVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWR  458 (543)
T ss_dssp             HHHH-HCCCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCHH
T ss_pred             HHHh-hcccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCHH
Confidence            3322 2345667888999999999999999999996     5899999999986643

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=2.5e-49  Score=350.65  Aligned_cols=264  Identities=28%  Similarity=0.460  Sum_probs=220.5

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCch-----HhHHHHHHHHHHHHhcCCCCceeeeeeEEeeC
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSST-----IIRHQAAHEAEILKRLDSQFIVKCHAVFYTIE  118 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~  118 (337)
                      ...++|++.+.||.|+||+||+|.+..++..||+|++......     ...+.+.+|+.++++++|+||+++++++.+ .
T Consensus         9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~   87 (321)
T 2a2a_A            9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYEN-R   87 (321)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-S
T ss_pred             hhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEec-C
Confidence            4467899999999999999999999999999999999765422     135678899999999999999999998866 6


Q ss_pred             CeEEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCC----cEEEeeccCcc
Q 019650          119 GEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKG----EVKIADFGVSR  194 (337)
Q Consensus       119 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~----~~~l~Dfg~~~  194 (337)
                      ...++||||+++++|.+++.....+++..++.++.|++.||.|||+.|++|+||||+||+++.++    +++|+|||++.
T Consensus        88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~  167 (321)
T 2a2a_A           88 TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH  167 (321)
T ss_dssp             SEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCE
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccce
Confidence            88999999999999999999888899999999999999999999999999999999999999887    79999999997


Q ss_pred             chhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHH
Q 019650          195 IVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLM  274 (337)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~  274 (337)
                      .......               .....|++.|+|||.+.    +..++.++||||||+++|+|++|..||..........
T Consensus       168 ~~~~~~~---------------~~~~~gt~~y~aPE~~~----~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~  228 (321)
T 2a2a_A          168 EIEDGVE---------------FKNIFGTPEFVAPEIVN----YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA  228 (321)
T ss_dssp             ECCTTCC---------------CCCCCSCGGGCCHHHHT----TCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHH
T ss_pred             ecCcccc---------------ccccCCCCCccCccccc----CCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence            6644221               12235899999999998    4578999999999999999999999997643322222


Q ss_pred             HHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCC
Q 019650          275 ALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSS  328 (337)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~  328 (337)
                       .............+...+..+.++|.+||..||.+|||++++++||||++..+
T Consensus       229 -~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~~  281 (321)
T 2a2a_A          229 -NITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDN  281 (321)
T ss_dssp             -HHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSSH
T ss_pred             -HHHhcccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCCCc
Confidence             11111111111223567899999999999999999999999999999987653

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=4.8e-49  Score=348.78  Aligned_cols=262  Identities=27%  Similarity=0.416  Sum_probs=218.9

Q ss_pred             cccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEe
Q 019650           47 SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVME  126 (337)
Q Consensus        47 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~e  126 (337)
                      ..|...+.||+|+||+||+|.+..+++.||+|++..... ...+.+.+|+.++++++|+||+++++.+.. ....++|||
T Consensus        45 ~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e  122 (321)
T 2c30_A           45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ-QRRELLFNEVVIMRDYQHFNVVEMYKSYLV-GEELWVLME  122 (321)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-CSHHHHHHHHHHHTTCCCTTBCCEEEEEEE-TTEEEEEEC
T ss_pred             hhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch-hHHHHHHHHHHHHHhCCCCCcceEEEEEEE-CCEEEEEEe
Confidence            357888899999999999999998999999999976542 245667899999999999999999998876 688999999


Q ss_pred             ccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCCCC
Q 019650          127 HMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHN  206 (337)
Q Consensus       127 ~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~  206 (337)
                      |+++++|.+++.. ..+++..+..++.|++.||.|||+.|++||||||+||+++.+++++|+|||++.......      
T Consensus       123 ~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~------  195 (321)
T 2c30_A          123 FLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV------  195 (321)
T ss_dssp             CCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS------
T ss_pred             cCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCc------
Confidence            9999999999874 469999999999999999999999999999999999999999999999999987664322      


Q ss_pred             CCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhccCCC
Q 019650          207 NNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERL  286 (337)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~  286 (337)
                              .......||+.|+|||.+.    +..++.++||||||+++|+|++|..||.......    ..........+
T Consensus       196 --------~~~~~~~gt~~y~aPE~~~----~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~----~~~~~~~~~~~  259 (321)
T 2c30_A          196 --------PKRKSLVGTPYWMAPEVIS----RSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQ----AMKRLRDSPPP  259 (321)
T ss_dssp             --------CCBCCCCSCGGGCCHHHHT----TCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH----HHHHHHHSSCC
T ss_pred             --------cccccccCCccccCHhhhc----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHhcCCCC
Confidence                    1122346899999999998    4578899999999999999999999997543322    22222222222


Q ss_pred             --CCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCCcccc
Q 019650          287 --EMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNIE  333 (337)
Q Consensus       287 --~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~~~~~  333 (337)
                        .....++..+.+++.+||..||.+|||++++++||||.+....+++.
T Consensus       260 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~~~~~~  308 (321)
T 2c30_A          260 KLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTGLPECLV  308 (321)
T ss_dssp             CCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGCCCGGGGH
T ss_pred             CcCccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccCCCcccch
Confidence              22345688999999999999999999999999999999877665543

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=3.6e-49  Score=343.65  Aligned_cols=261  Identities=29%  Similarity=0.410  Sum_probs=222.4

Q ss_pred             ccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCe
Q 019650           43 VENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGE  120 (337)
Q Consensus        43 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~  120 (337)
                      ....++|++.+.||+|++|+||+|.+..++..||+|++....  .....+.+.+|+.++++++|+||+++++++.+ ...
T Consensus        10 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~   88 (284)
T 2vgo_A           10 KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHD-RKR   88 (284)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSE
T ss_pred             chhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEc-CCE
Confidence            356789999999999999999999999999999999986542  12234667889999999999999999998876 688


Q ss_pred             EEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccc
Q 019650          121 ICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETR  200 (337)
Q Consensus       121 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~  200 (337)
                      .++||||+++++|.+++...+.+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        89 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~  168 (284)
T 2vgo_A           89 IYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR  168 (284)
T ss_dssp             EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC
T ss_pred             EEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCcccc
Confidence            99999999999999999988899999999999999999999999999999999999999999999999999886543321


Q ss_pred             cCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHh
Q 019650          201 NNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAI  280 (337)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~  280 (337)
                                      .....+++.|+|||.+.    +..++.++|+||||+++|+|++|..||............    
T Consensus       169 ----------------~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~----  224 (284)
T 2vgo_A          169 ----------------RRTMCGTLDYLPPEMIE----GKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRI----  224 (284)
T ss_dssp             ----------------BCCCCSCGGGCCHHHHT----TCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH----
T ss_pred             ----------------cccccCCCCcCCHHHhc----cCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHH----
Confidence                            11235899999999998    457789999999999999999999999764332222111    


Q ss_pred             hccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCC
Q 019650          281 CFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSS  329 (337)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~  329 (337)
                       ......++..++..+.++|.+||+.||.+|||++++++||||++....
T Consensus       225 -~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~~~  272 (284)
T 2vgo_A          225 -VNVDLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSRR  272 (284)
T ss_dssp             -HTTCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHCCC
T ss_pred             -hccccCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhccc
Confidence             123445667789999999999999999999999999999999976643

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=9.2e-49  Score=342.77  Aligned_cols=263  Identities=27%  Similarity=0.396  Sum_probs=224.3

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeE
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEI  121 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~  121 (337)
                      ...++|.+.+.||+|+||+||+|.+..+++.+|+|++....  .....+.+.+|+.+++.++|+||+++++++.+ ....
T Consensus        12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~   90 (294)
T 2rku_A           12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED-NDFV   90 (294)
T ss_dssp             TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSEE
T ss_pred             CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeecc-CCEE
Confidence            55689999999999999999999999999999999987643  33456778889999999999999999998866 6889


Q ss_pred             EEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhcccc
Q 019650          122 CFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRN  201 (337)
Q Consensus       122 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~  201 (337)
                      ++||||+++++|.+++.....+++..++.++.|++.||.|||++|++|+||+|+||+++.+++++|+|||.+....... 
T Consensus        91 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~-  169 (294)
T 2rku_A           91 FVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG-  169 (294)
T ss_dssp             EEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT-
T ss_pred             EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCc-
Confidence            9999999999999999888899999999999999999999999999999999999999999999999999987654322 


Q ss_pred             CCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhh
Q 019650          202 NNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAIC  281 (337)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~  281 (337)
                                   .......+++.|+|||.+.    +..++.++|+||||+++|+|++|..||..........    ...
T Consensus       170 -------------~~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~----~~~  228 (294)
T 2rku_A          170 -------------ERKKVLCGTPNYIAPEVLS----KKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYL----RIK  228 (294)
T ss_dssp             -------------CCBCCCCSCCSSCCHHHHT----TSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH----HHH
T ss_pred             -------------cccccccCCCCcCCcchhc----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH----HHh
Confidence                         1122335899999999998    4567889999999999999999999996543322221    111


Q ss_pred             ccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCCc
Q 019650          282 FGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSS  330 (337)
Q Consensus       282 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~~  330 (337)
                       ......+..++..+.+++.+||+.||++|||++++++||||++.....
T Consensus       229 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~~~  276 (294)
T 2rku_A          229 -KNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPA  276 (294)
T ss_dssp             -TTCCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCCS
T ss_pred             -hccCCCccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCCcCC
Confidence             223456677899999999999999999999999999999998775443

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=5.8e-49  Score=341.06  Aligned_cols=259  Identities=25%  Similarity=0.355  Sum_probs=219.0

Q ss_pred             CccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 019650           45 NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFV  124 (337)
Q Consensus        45 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv  124 (337)
                      ..++|++.+.||+|+||+||+|.+..++..+|+|.+..... ...+.+.+|+.++++++|+||+++++++.+ ....++|
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv   84 (277)
T 3f3z_A            7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV-EDVDRFKQEIEIMKSLDHPNIIRLYETFED-NTDIYLV   84 (277)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-SCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSEEEEE
T ss_pred             hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc-chHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCeEEEE
Confidence            45789999999999999999999999999999999876432 235678899999999999999999998876 7889999


Q ss_pred             EeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEE---cCCCcEEEeeccCccchhcccc
Q 019650          125 MEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLI---NGKGEVKIADFGVSRIVEETRN  201 (337)
Q Consensus       125 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili---~~~~~~~l~Dfg~~~~~~~~~~  201 (337)
                      |||+++++|.+++.....+++..++.++.|++.||.|||++|++|+||||+||++   +.++.++|+|||.+....... 
T Consensus        85 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~-  163 (277)
T 3f3z_A           85 MELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK-  163 (277)
T ss_dssp             EECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS-
T ss_pred             EeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc-
Confidence            9999999999999988899999999999999999999999999999999999999   778899999999987654332 


Q ss_pred             CCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhh
Q 019650          202 NNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAIC  281 (337)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~  281 (337)
                                    ......+++.|+|||.+.     ..++.++||||||+++|+|++|..||............    .
T Consensus       164 --------------~~~~~~~t~~y~aPE~~~-----~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~----~  220 (277)
T 3f3z_A          164 --------------MMRTKVGTPYYVSPQVLE-----GLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKI----R  220 (277)
T ss_dssp             --------------CBCCCCSCTTTCCHHHHT-----TCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH----H
T ss_pred             --------------chhccCCCCCccChHHhc-----ccCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHH----H
Confidence                          112335899999999986     24888999999999999999999999764433222222    1


Q ss_pred             ccCCCCCC----CCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCCc
Q 019650          282 FGERLEMP----ETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSS  330 (337)
Q Consensus       282 ~~~~~~~~----~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~~  330 (337)
                      .. ....+    ..+++.+.++|.+||+.||.+|||+.++|+||||++...++
T Consensus       221 ~~-~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~~~  272 (277)
T 3f3z_A          221 EG-TFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQLSSS  272 (277)
T ss_dssp             HC-CCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHHCCS
T ss_pred             hC-CCCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcccccc
Confidence            12 12222    26789999999999999999999999999999999876444

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=6.3e-49  Score=357.86  Aligned_cols=260  Identities=26%  Similarity=0.393  Sum_probs=205.2

Q ss_pred             cCccccccc-cccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHH-HhcCCCCceeeeeeEEee---C
Q 019650           44 ENISDLKKL-TVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEIL-KRLDSQFIVKCHAVFYTI---E  118 (337)
Q Consensus        44 ~~~~~y~~~-~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~-~~l~~~~i~~~~~~~~~~---~  118 (337)
                      ...++|.+. +.||.|+||+||+|.+..+++.||+|++...      ..+.+|+.++ +..+|+||+++++++...   .
T Consensus        58 ~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~  131 (400)
T 1nxk_A           58 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGR  131 (400)
T ss_dssp             CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred             cccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCC
Confidence            345778887 6899999999999999999999999999643      3455677776 445899999999987642   3


Q ss_pred             CeEEEEEeccCCCCchHHhhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcC---CCcEEEeeccCc
Q 019650          119 GEICFVMEHMERGSLFDSLRVRK--KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLING---KGEVKIADFGVS  193 (337)
Q Consensus       119 ~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~---~~~~~l~Dfg~~  193 (337)
                      ..+|+||||++||+|.+++...+  .+++..++.++.||+.||.|||++||+||||||+||+++.   ++.++|+|||++
T Consensus       132 ~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a  211 (400)
T 1nxk_A          132 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA  211 (400)
T ss_dssp             EEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred             cEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccc
Confidence            56899999999999999998653  5999999999999999999999999999999999999987   788999999999


Q ss_pred             cchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchh-
Q 019650          194 RIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPD-  272 (337)
Q Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~-  272 (337)
                      .......               .....+||+.|+|||++.    +..++.++||||||+++|+|++|..||........ 
T Consensus       212 ~~~~~~~---------------~~~~~~gt~~y~aPE~~~----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~  272 (400)
T 1nxk_A          212 KETTSHN---------------SLTTPCYTPYYVAPEVLG----PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS  272 (400)
T ss_dssp             EECC--------------------------CTTCCGGGSC----CCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSC
T ss_pred             cccCCCC---------------ccccCCCCCCccCHhhcC----CCCCCCcccHHHHHHHHHHHHhCCCCCCCCcccccc
Confidence            7654321               112346899999999997    45789999999999999999999999976543221 


Q ss_pred             --HHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCC
Q 019650          273 --LMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSS  328 (337)
Q Consensus       273 --~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~  328 (337)
                        ...................++..+.+||.+||..||.+|||++++++||||.+...
T Consensus       273 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~  330 (400)
T 1nxk_A          273 PGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK  330 (400)
T ss_dssp             CSHHHHHHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTTT
T ss_pred             HHHHHHHHcCcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCCC
Confidence              12222221111112223567999999999999999999999999999999987553

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=8.6e-49  Score=352.69  Aligned_cols=265  Identities=36%  Similarity=0.629  Sum_probs=223.3

Q ss_pred             ccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEE
Q 019650           43 VENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEIC  122 (337)
Q Consensus        43 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~  122 (337)
                      ....++|++++.||.|+||+||+|.+..++..||+|++.........+.+.+|+.++++++|+||+++++++.. +...+
T Consensus        29 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~  107 (360)
T 3eqc_A           29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-DGEIS  107 (360)
T ss_dssp             CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE-TTEEE
T ss_pred             ccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEE-CCEEE
Confidence            45578999999999999999999999999999999999877666667888999999999999999999998876 78899


Q ss_pred             EEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCCeEEcCCCcEEEeeccCccchhcccc
Q 019650          123 FVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGM-QIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRN  201 (337)
Q Consensus       123 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~-~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~  201 (337)
                      +||||+++++|.+++...+.+++..+..++.|++.||.|||+. |++|+||||+||+++.+++++|+|||++....... 
T Consensus       108 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  186 (360)
T 3eqc_A          108 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-  186 (360)
T ss_dssp             EEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC-
T ss_pred             EEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCccccccc-
Confidence            9999999999999999888999999999999999999999996 99999999999999999999999999987664432 


Q ss_pred             CCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhH--------
Q 019650          202 NNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDL--------  273 (337)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~--------  273 (337)
                                     .....|++.|+|||++.    +..++.++||||||+++|+|++|..||.........        
T Consensus       187 ---------------~~~~~gt~~y~aPE~~~----~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  247 (360)
T 3eqc_A          187 ---------------ANSFVGTRSYMSPERLQ----GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVE  247 (360)
T ss_dssp             -------------------CCCCTTCCHHHHT----TCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC----
T ss_pred             ---------------ccCCCCCCCeECHHHHc----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccccc
Confidence                           11235899999999998    557899999999999999999999999754322110        


Q ss_pred             ------------------------------HHHHHHhhccCCCCC-CCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCcc
Q 019650          274 ------------------------------MALICAICFGERLEM-PETASPEFRRFVRSCLEKDWRKRGTVEELLAYPF  322 (337)
Q Consensus       274 ------------------------------~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~  322 (337)
                                                    ............... ...++..+.+||.+||+.||.+|||++++|+|||
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~  327 (360)
T 3eqc_A          248 GDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF  327 (360)
T ss_dssp             --------------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHH
T ss_pred             ccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChH
Confidence                                          111111222222222 2346889999999999999999999999999999


Q ss_pred             ccccCC
Q 019650          323 VTKRSS  328 (337)
Q Consensus       323 f~~~~~  328 (337)
                      |++...
T Consensus       328 ~~~~~~  333 (360)
T 3eqc_A          328 IKRSDA  333 (360)
T ss_dssp             HHHHHH
T ss_pred             hhcchH
Confidence            987653

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=3.3e-49  Score=342.79  Aligned_cols=261  Identities=28%  Similarity=0.414  Sum_probs=198.3

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeE
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEI  121 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~  121 (337)
                      ...++|++.+.||+|+||+||+|.+..+++.||+|++....  .....+.+.+|+.++++++|+||+++++.+.+ ....
T Consensus         8 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~   86 (278)
T 3cok_A            8 EKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFED-SNYV   86 (278)
T ss_dssp             SSGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEEC-SSEE
T ss_pred             cccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEcc-CCeE
Confidence            45789999999999999999999999999999999986542  11234678889999999999999999998866 6889


Q ss_pred             EEEEeccCCCCchHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccc
Q 019650          122 CFVMEHMERGSLFDSLRVR-KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETR  200 (337)
Q Consensus       122 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~  200 (337)
                      ++||||+++++|.+++... ..+++..++.++.|++.||.|||++|++|+||+|+||+++.+++++|+|||.+.......
T Consensus        87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~  166 (278)
T 3cok_A           87 YLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH  166 (278)
T ss_dssp             EEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred             EEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence            9999999999999999865 679999999999999999999999999999999999999999999999999987664322


Q ss_pred             cCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHh
Q 019650          201 NNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAI  280 (337)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~  280 (337)
                                    .......+++.|+|||.+.    +..++.++|+||||+++|+|++|+.||............    
T Consensus       167 --------------~~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~----  224 (278)
T 3cok_A          167 --------------EKHYTLCGTPNYISPEIAT----RSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKV----  224 (278)
T ss_dssp             -------------------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----C----
T ss_pred             --------------CcceeccCCCCcCCcchhc----CCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHH----
Confidence                          1112235899999999998    456788999999999999999999999764433221111    


Q ss_pred             hccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCC
Q 019650          281 CFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSS  328 (337)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~  328 (337)
                       .......+..++..+.++|.+||+.||.+|||++++++||||++...
T Consensus       225 -~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~  271 (278)
T 3cok_A          225 -VLADYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNSS  271 (278)
T ss_dssp             -CSSCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC----
T ss_pred             -hhcccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCCCC
Confidence             12233456678999999999999999999999999999999987653

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=1.7e-48  Score=361.74  Aligned_cols=283  Identities=25%  Similarity=0.323  Sum_probs=204.7

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCceEEEEEeecCC-chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeC----
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIE----  118 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~----  118 (337)
                      ...++|++++.||.|+||+||+|.+..+++.||+|++.... .....+.+.+|+.++++++|+||+++++++....    
T Consensus        50 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  129 (458)
T 3rp9_A           50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKF  129 (458)
T ss_dssp             CSCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred             ccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccC
Confidence            34589999999999999999999999999999999986543 3445677889999999999999999999875432    


Q ss_pred             CeEEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhc
Q 019650          119 GEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEE  198 (337)
Q Consensus       119 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~  198 (337)
                      ..+|+|||++. ++|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.+++++|+|||++.....
T Consensus       130 ~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~  208 (458)
T 3rp9_A          130 DELYVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDY  208 (458)
T ss_dssp             CCEEEEECCCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTS
T ss_pred             ceEEEEEeccc-cchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccC
Confidence            56899999985 59999999888899999999999999999999999999999999999999999999999999987654


Q ss_pred             cccCCCCCCC-------------CCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh------
Q 019650          199 TRNNNNHNNN-------------NNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV------  259 (337)
Q Consensus       199 ~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t------  259 (337)
                      ..........             ............+||+.|+|||++..   +..++.++|||||||++|||++      
T Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~---~~~~~~~~DiwSlG~il~elltg~~~~~  285 (458)
T 3rp9_A          209 PENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILL---QENYTEAIDVWSIGCIFAELLNMIKENV  285 (458)
T ss_dssp             CTTCCCCCC---------------------------CCCTTCCHHHHTT---CCCCCTHHHHHHHHHHHHHHHTTSTTTC
T ss_pred             ccccccccccCccccccccccccccccccccccCCcccccccChHHhhC---CCCCCcHhHHHHHHHHHHHHHHhccccc
Confidence            3211110000             00000122345578999999998753   3468999999999999999998      


Q ss_pred             -----CCCCCCCCCCc-------------------hhHHHHHHHhhccC---------------------------CCCC
Q 019650          260 -----GHYPLIGFGEK-------------------PDLMALICAICFGE---------------------------RLEM  288 (337)
Q Consensus       260 -----g~~pf~~~~~~-------------------~~~~~~~~~~~~~~---------------------------~~~~  288 (337)
                           |.++|.+....                   .+....+.......                           ....
T Consensus       286 ~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  365 (458)
T 3rp9_A          286 AYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAER  365 (458)
T ss_dssp             SSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGG
T ss_pred             cccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHH
Confidence                 66666543210                   00111111000000                           0011


Q ss_pred             CCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCCc
Q 019650          289 PETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSS  330 (337)
Q Consensus       289 ~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~~  330 (337)
                      .+..+..+.+||.+||..||.+|||++|+|+||||++..+..
T Consensus       366 ~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~~  407 (458)
T 3rp9_A          366 FPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAE  407 (458)
T ss_dssp             STTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCGG
T ss_pred             CCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCCc
Confidence            245689999999999999999999999999999999886543

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=7.1e-49  Score=340.28  Aligned_cols=264  Identities=25%  Similarity=0.333  Sum_probs=214.4

Q ss_pred             CccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCC
Q 019650           42 DVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEG  119 (337)
Q Consensus        42 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~  119 (337)
                      .....++|.+.+.||.|++|.||+|.+..+++.||+|++....  .....+.+.+|+.+++.++|+||+++++.+.. ..
T Consensus         6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~   84 (276)
T 2h6d_A            6 GRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIST-PT   84 (276)
T ss_dssp             -CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SS
T ss_pred             CcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEec-CC
Confidence            3456789999999999999999999999999999999987542  22234577889999999999999999998766 68


Q ss_pred             eEEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhcc
Q 019650          120 EICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEET  199 (337)
Q Consensus       120 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~  199 (337)
                      ..++||||+++++|.+++.....+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+......
T Consensus        85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~  164 (276)
T 2h6d_A           85 DFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG  164 (276)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred             eEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence            89999999999999999998889999999999999999999999999999999999999999999999999998765432


Q ss_pred             ccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHH
Q 019650          200 RNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICA  279 (337)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~  279 (337)
                      .               ......+++.|+|||.+...   ...+.++|+||||+++|+|++|..||.......    ....
T Consensus       165 ~---------------~~~~~~~~~~y~aPE~~~~~---~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~~  222 (276)
T 2h6d_A          165 E---------------FLRTSCGSPNYAAPEVISGR---LYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT----LFKK  222 (276)
T ss_dssp             ---------------------------CCTGGGTTS---CCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHH
T ss_pred             c---------------ceecccCCccccCHHHHcCC---CCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH----HHHH
Confidence            1               11223588999999999842   123689999999999999999999996543222    2222


Q ss_pred             hhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCC
Q 019650          280 ICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSS  329 (337)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~  329 (337)
                      ... .....+...+..+.++|.+||+.||.+|||++++++||||++...+
T Consensus       223 ~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~~  271 (276)
T 2h6d_A          223 IRG-GVFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQDLPS  271 (276)
T ss_dssp             HHH-CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTTCCG
T ss_pred             hhc-CcccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccCchh
Confidence            222 2344567789999999999999999999999999999999886543

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=5.7e-49  Score=349.86  Aligned_cols=267  Identities=25%  Similarity=0.397  Sum_probs=216.9

Q ss_pred             ccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCC-chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeE
Q 019650           43 VENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEI  121 (337)
Q Consensus        43 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~  121 (337)
                      ....++|++++.||.|+||+||+|.+..+++.||+|++.... .....+.+.+|+.++++++|+||+++++++.+ ....
T Consensus        21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~   99 (331)
T 4aaa_A           21 FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKK-KKRW   99 (331)
T ss_dssp             CBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEE
T ss_pred             hhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeec-CCEE
Confidence            456899999999999999999999999999999999986654 33445667789999999999999999998876 7889


Q ss_pred             EEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhcccc
Q 019650          122 CFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRN  201 (337)
Q Consensus       122 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~  201 (337)
                      ++||||+++++|.+++.....+++..+..++.||+.||.|||+.|++||||||+||+++.++.++|+|||.+....... 
T Consensus       100 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  178 (331)
T 4aaa_A          100 YLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-  178 (331)
T ss_dssp             EEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred             EEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCc-
Confidence            9999999998998888877889999999999999999999999999999999999999999999999999997664432 


Q ss_pred             CCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhh
Q 019650          202 NNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAIC  281 (337)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~  281 (337)
                                   .......+++.|+|||.+...   ..++.++||||||+++|+|++|..||.................
T Consensus       179 -------------~~~~~~~~t~~y~aPE~~~~~---~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  242 (331)
T 4aaa_A          179 -------------EVYDDEVATRWYRAPELLVGD---VKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLG  242 (331)
T ss_dssp             ------------------CCCCCTTCCHHHHTTC---TTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred             -------------cccCCCcCCccccCcccccCC---CCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Confidence                         111223589999999999742   3678999999999999999999999977544433333322111


Q ss_pred             cc--------------CCCC------------CCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccC
Q 019650          282 FG--------------ERLE------------MPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRS  327 (337)
Q Consensus       282 ~~--------------~~~~------------~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~  327 (337)
                      ..              ....            ..+.+++.+.+||.+||..||.+|||++|+|+||||+...
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  314 (331)
T 4aaa_A          243 NLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDG  314 (331)
T ss_dssp             SCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGGG
T ss_pred             CCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccCC
Confidence            00              0000            1135688999999999999999999999999999998754

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=2.6e-48  Score=339.30  Aligned_cols=260  Identities=27%  Similarity=0.390  Sum_probs=216.7

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCceEEEEEeecCC-chHhHHHHHHHHHHHHhcCCCCceeeeeeEEee---CC
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTI---EG  119 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~---~~  119 (337)
                      .....|++.+.||+|+||+||+|.+..++..||+|++.... .....+.+.+|+.++++++|+||+++++++...   ..
T Consensus        23 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  102 (290)
T 1t4h_A           23 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK  102 (290)
T ss_dssp             TTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCE
T ss_pred             cCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCc
Confidence            34457899999999999999999999999999999987643 344567788999999999999999999987653   34


Q ss_pred             eEEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCCeEEc-CCCcEEEeeccCccch
Q 019650          120 EICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQ--IIHGDIKPSNLLIN-GKGEVKIADFGVSRIV  196 (337)
Q Consensus       120 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~--ivH~dl~~~Nili~-~~~~~~l~Dfg~~~~~  196 (337)
                      .+++||||+++++|.+++...+.+++..++.++.||+.||.|||+.|  ++|+||||+||+++ .++.++|+|||++...
T Consensus       103 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~  182 (290)
T 1t4h_A          103 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK  182 (290)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred             eEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccc
Confidence            68999999999999999998889999999999999999999999999  99999999999998 7889999999998654


Q ss_pred             hccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHH
Q 019650          197 EETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMAL  276 (337)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~  276 (337)
                      ...                ......+++.|+|||.+.     ..++.++||||||+++|+|++|..||............
T Consensus       183 ~~~----------------~~~~~~~t~~y~aPE~~~-----~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~  241 (290)
T 1t4h_A          183 RAS----------------FAKAVIGTPEFMAPEMYE-----EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR  241 (290)
T ss_dssp             CTT----------------SBEESCSSCCCCCGGGGG-----TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHH
T ss_pred             ccc----------------ccccccCCcCcCCHHHHh-----ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHH
Confidence            322                122335899999999886     35889999999999999999999999765444333222


Q ss_pred             HHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCcccccc
Q 019650          277 ICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKR  326 (337)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~  326 (337)
                      ..  ........+...++.+.++|.+||..||.+|||++++++||||++.
T Consensus       242 ~~--~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~~  289 (290)
T 1t4h_A          242 VT--SGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE  289 (290)
T ss_dssp             HT--TTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred             Hh--ccCCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCcccccC
Confidence            21  1222333455667899999999999999999999999999999864

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=3.7e-49  Score=380.49  Aligned_cols=263  Identities=25%  Similarity=0.363  Sum_probs=222.9

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHHhc-CCCCceeeeeeEEeeCCe
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRL-DSQFIVKCHAVFYTIEGE  120 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~  120 (337)
                      ...++|++++.||+|+||+||+|.+..+++.||+|+++...  .......+..|..++..+ .|++|+.+++.+.+ ...
T Consensus       338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~-~~~  416 (674)
T 3pfq_A          338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT-MDR  416 (674)
T ss_dssp             --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBC-SSE
T ss_pred             ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEe-CCE
Confidence            45689999999999999999999999999999999997542  222345667788888887 78999999998765 688


Q ss_pred             EEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccc
Q 019650          121 ICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETR  200 (337)
Q Consensus       121 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~  200 (337)
                      +|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+++++|+|||++.......
T Consensus       417 ~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~  496 (674)
T 3pfq_A          417 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG  496 (674)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTT
T ss_pred             EEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccCC
Confidence            99999999999999999988899999999999999999999999999999999999999999999999999987533221


Q ss_pred             cCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHh
Q 019650          201 NNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAI  280 (337)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~  280 (337)
                                    ......+||+.|+|||++.    +..++.++||||||+++|||++|..||.+....+..    ..+
T Consensus       497 --------------~~~~~~~GT~~Y~APE~l~----~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~----~~i  554 (674)
T 3pfq_A          497 --------------VTTKTFCGTPDYIAPEIIA----YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF----QSI  554 (674)
T ss_dssp             --------------CCBCCCCSCSSSCCHHHHT----CCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHH
T ss_pred             --------------cccccccCCCcccCHhhhc----CCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHH----HHH
Confidence                          2233457999999999998    557899999999999999999999999764333222    222


Q ss_pred             hccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCH-----HHHhcCccccccCCCc
Q 019650          281 CFGERLEMPETASPEFRRFVRSCLEKDWRKRGTV-----EELLAYPFVTKRSSSS  330 (337)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~-----~eil~hp~f~~~~~~~  330 (337)
                      . .....++..++..+.+||.+||..||.+|+++     ++|++||||++.+|..
T Consensus       555 ~-~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~~  608 (674)
T 3pfq_A          555 M-EHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEK  608 (674)
T ss_dssp             H-SSCCCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHHH
T ss_pred             H-hCCCCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCHHH
Confidence            2 23566778899999999999999999999997     9999999999877643

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1e-48  Score=367.15  Aligned_cols=264  Identities=28%  Similarity=0.413  Sum_probs=217.3

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCch------------HhHHHHHHHHHHHHhcCCCCceeee
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSST------------IIRHQAAHEAEILKRLDSQFIVKCH  111 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~------------~~~~~~~~e~~~~~~l~~~~i~~~~  111 (337)
                      ...++|.+++.||+|+||+||+|.+..++..||+|++......            ...+.+.+|+.++++++||||++++
T Consensus        33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~  112 (504)
T 3q5i_A           33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF  112 (504)
T ss_dssp             CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence            4568999999999999999999999999999999999764311            2356788999999999999999999


Q ss_pred             eeEEeeCCeEEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCC---cEEEe
Q 019650          112 AVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKG---EVKIA  188 (337)
Q Consensus       112 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~---~~~l~  188 (337)
                      +++.+ ....++||||++||+|.+++.....+++..++.++.||+.||+|||++||+||||||+||+++.++   .++|+
T Consensus       113 ~~~~~-~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~  191 (504)
T 3q5i_A          113 DVFED-KKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIV  191 (504)
T ss_dssp             EEEEC-SSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEEC
T ss_pred             EEEEc-CCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEE
Confidence            99876 788999999999999999998888999999999999999999999999999999999999998776   69999


Q ss_pred             eccCccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Q 019650          189 DFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFG  268 (337)
Q Consensus       189 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~  268 (337)
                      |||++.......               .....+|++.|+|||++.     ..++.++||||||+++|+|++|..||.+..
T Consensus       192 Dfg~a~~~~~~~---------------~~~~~~gt~~y~aPE~~~-----~~~~~~~DiwslG~il~~ll~g~~pf~~~~  251 (504)
T 3q5i_A          192 DFGLSSFFSKDY---------------KLRDRLGTAYYIAPEVLK-----KKYNEKCDVWSCGVIMYILLCGYPPFGGQN  251 (504)
T ss_dssp             CCTTCEECCTTS---------------CBCCCCSCTTTCCHHHHT-----TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             ECCCCEEcCCCC---------------ccccccCCcCCCCHHHhc-----cCCCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            999997664331               122336899999999986     358899999999999999999999997644


Q ss_pred             CchhHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCC
Q 019650          269 EKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSS  329 (337)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~  329 (337)
                      ...... .+...........+..+++.+.+||.+||..||.+|||++++|+||||++....
T Consensus       252 ~~~~~~-~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~  311 (504)
T 3q5i_A          252 DQDIIK-KVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANN  311 (504)
T ss_dssp             HHHHHH-HHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCCC
T ss_pred             HHHHHH-HHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchhc
Confidence            332222 222211111111225679999999999999999999999999999999887644

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=6.4e-49  Score=364.04  Aligned_cols=262  Identities=24%  Similarity=0.362  Sum_probs=208.3

Q ss_pred             CccccccccccccCcceEEEEEEEccCCceEEEEEeecCC-chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeC-----
Q 019650           45 NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIE-----  118 (337)
Q Consensus        45 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~-----  118 (337)
                      ..++|++++.||.|+||+||+|.+..+++.||+|++.... .....+.+.+|+.+++.++|+||+++++++....     
T Consensus        60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~  139 (464)
T 3ttj_A           60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF  139 (464)
T ss_dssp             EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred             ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence            3589999999999999999999999999999999997643 3445667889999999999999999999986532     


Q ss_pred             CeEEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhc
Q 019650          119 GEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEE  198 (337)
Q Consensus       119 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~  198 (337)
                      ..+|+||||+++ +|.+.+.  ..+++..++.++.||+.||+|||++||+||||||+||+++.+++++|+|||++.....
T Consensus       140 ~~~~lv~E~~~~-~l~~~~~--~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  216 (464)
T 3ttj_A          140 QDVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  216 (464)
T ss_dssp             CEEEEEEECCSE-EHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----
T ss_pred             CeEEEEEeCCCC-CHHHHHh--hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCC
Confidence            467999999976 5777765  3599999999999999999999999999999999999999999999999999976543


Q ss_pred             cccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHH
Q 019650          199 TRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALIC  278 (337)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~  278 (337)
                      ..               .....+||+.|+|||++.    +..++.++||||||+++|+|++|+.||.+.+.......+..
T Consensus       217 ~~---------------~~~~~~gt~~y~aPE~~~----~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~  277 (464)
T 3ttj_A          217 SF---------------MMTPYVVTRYYRAPEVIL----GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE  277 (464)
T ss_dssp             CC---------------CC----CCCTTCCHHHHT----TCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             Cc---------------ccCCCcccccccCHHHHc----CCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            21               222346899999999998    45789999999999999999999999977554433333332


Q ss_pred             Hhhcc-----------------CCCCC---------CCC-----------CCHHHHHHHHHHhhcCcCCCCCHHHHhcCc
Q 019650          279 AICFG-----------------ERLEM---------PET-----------ASPEFRRFVRSCLEKDWRKRGTVEELLAYP  321 (337)
Q Consensus       279 ~~~~~-----------------~~~~~---------~~~-----------~~~~~~~li~~~l~~~p~~R~s~~eil~hp  321 (337)
                      .....                 ..+..         +..           .+..+.+||.+||..||++|||++|+|+||
T Consensus       278 ~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp  357 (464)
T 3ttj_A          278 QLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP  357 (464)
T ss_dssp             HHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTST
T ss_pred             hcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcCh
Confidence            21110                 00000         000           045689999999999999999999999999


Q ss_pred             cccccCC
Q 019650          322 FVTKRSS  328 (337)
Q Consensus       322 ~f~~~~~  328 (337)
                      ||+....
T Consensus       358 ~~~~~~~  364 (464)
T 3ttj_A          358 YINVWYD  364 (464)
T ss_dssp             TTGGGCC
T ss_pred             hhhhccC
Confidence            9987543

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=5.6e-49  Score=349.65  Aligned_cols=269  Identities=19%  Similarity=0.347  Sum_probs=211.8

Q ss_pred             CccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCC-----
Q 019650           45 NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEG-----  119 (337)
Q Consensus        45 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~-----  119 (337)
                      ..++|++.+.||+|+||+||+|.+..+++.||+|++.........+.+.+|+.++++++||||+++++++.+...     
T Consensus         4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~   83 (332)
T 3qd2_B            4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE   83 (332)
T ss_dssp             HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred             hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence            367899999999999999999999999999999999876655667888999999999999999999998865322     


Q ss_pred             ---------------------------------------------------eEEEEEeccCCCCchHHhhhcC---CCCH
Q 019650          120 ---------------------------------------------------EICFVMEHMERGSLFDSLRVRK---KLSE  145 (337)
Q Consensus       120 ---------------------------------------------------~~~lv~e~~~~~~L~~~l~~~~---~l~~  145 (337)
                                                                         ..++||||+++++|.+++....   ..++
T Consensus        84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~  163 (332)
T 3qd2_B           84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH  163 (332)
T ss_dssp             HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred             hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence                                                               3899999999999999998654   3566


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCCCCCCCCCccccccccccCCCC
Q 019650          146 DVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCA  225 (337)
Q Consensus       146 ~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  225 (337)
                      ..++.++.||+.||+|||++|++||||||+||+++.++.++|+|||++...............  ...........||+.
T Consensus       164 ~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~--~~~~~~~~~~~gt~~  241 (332)
T 3qd2_B          164 GVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP--MPAYATHTGQVGTKL  241 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC----------------CCCSCC-CGG
T ss_pred             HHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhcccccc--ccccccccccCCCcC
Confidence            779999999999999999999999999999999999999999999999877543221110000  000012233468999


Q ss_pred             CcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhh
Q 019650          226 YMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLE  305 (337)
Q Consensus       226 y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  305 (337)
                      |+|||.+.    +..++.++||||||+++|+|++|..|+      ...............+......++.+.++|.+||+
T Consensus       242 y~aPE~~~----~~~~~~~~Di~slG~il~el~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  311 (332)
T 3qd2_B          242 YMSPEQIH----GNNYSHKVDIFSLGLILFELLYSFSTQ------MERVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLS  311 (332)
T ss_dssp             GSCHHHHH----CCCCCTHHHHHHHHHHHHHHHSCCCCH------HHHHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHC
T ss_pred             ccChHHhc----CCCCcchhhHHHHHHHHHHHHHcCCCh------hHHHHHHHHhhccCCCcccccCChhHHHHHHHHcc
Confidence            99999998    457899999999999999999987654      12222222222222222223456788999999999


Q ss_pred             cCcCCCCCHHHHhcCccccc
Q 019650          306 KDWRKRGTVEELLAYPFVTK  325 (337)
Q Consensus       306 ~~p~~R~s~~eil~hp~f~~  325 (337)
                      .||.+|||++++|+||||++
T Consensus       312 ~~p~~Rps~~~~l~~~~f~~  331 (332)
T 3qd2_B          312 PSPTERPEATDIIENAIFEN  331 (332)
T ss_dssp             SSGGGSCCHHHHHHSTTCCC
T ss_pred             CCCCcCCCHHHHhhchhhhc
Confidence            99999999999999999986

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=2.5e-48  Score=341.69  Aligned_cols=262  Identities=27%  Similarity=0.412  Sum_probs=217.0

Q ss_pred             ccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEE
Q 019650           43 VENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEIC  122 (337)
Q Consensus        43 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~  122 (337)
                      ....++|.+.+.||.|+||+||+|.+..+++.||+|++..... ...+.+.+|+.++++++|+||+++++++.+ ....+
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   82 (304)
T 2jam_A            5 TNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA-FRDSSLENEIAVLKKIKHENIVTLEDIYES-TTHYY   82 (304)
T ss_dssp             -CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-------HHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEE
T ss_pred             cchhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc-cchHHHHHHHHHHHhCCCCCeeehhhhccc-CCEEE
Confidence            3456899999999999999999999999999999999986532 234567889999999999999999998766 68899


Q ss_pred             EEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEE---cCCCcEEEeeccCccchhcc
Q 019650          123 FVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLI---NGKGEVKIADFGVSRIVEET  199 (337)
Q Consensus       123 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili---~~~~~~~l~Dfg~~~~~~~~  199 (337)
                      +||||+++++|.+++...+.+++..+..++.|++.||.|||+.|++|+||+|+||++   +.++.++|+|||.+......
T Consensus        83 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~  162 (304)
T 2jam_A           83 LVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG  162 (304)
T ss_dssp             EEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB
T ss_pred             EEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC
Confidence            999999999999999888899999999999999999999999999999999999999   67789999999998653221


Q ss_pred             ccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHH
Q 019650          200 RNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICA  279 (337)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~  279 (337)
                                      ......+++.|+|||.+.    +..++.++||||||+++|+|++|..||....... .......
T Consensus       163 ----------------~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~i~~  221 (304)
T 2jam_A          163 ----------------IMSTACGTPGYVAPEVLA----QKPYSKAVDCWSIGVITYILLCGYPPFYEETESK-LFEKIKE  221 (304)
T ss_dssp             ----------------TTHHHHSCCCBCCTTTBS----SCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHH
T ss_pred             ----------------ccccccCCCCccChHHhc----cCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHc
Confidence                            112235899999999998    4578999999999999999999999997643322 2222222


Q ss_pred             hhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccC
Q 019650          280 ICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRS  327 (337)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~  327 (337)
                      .........+..++..+.++|.+||..||.+|||++++++||||++..
T Consensus       222 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  269 (304)
T 2jam_A          222 GYYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNT  269 (304)
T ss_dssp             CCCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred             CCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCCC
Confidence            111222334467899999999999999999999999999999998754

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=4.6e-48  Score=341.06  Aligned_cols=256  Identities=27%  Similarity=0.356  Sum_probs=204.7

Q ss_pred             CccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCC-chHhHHHHHHHHHHHHhc-CCCCceeeeeeEEeeCC
Q 019650           42 DVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-STIIRHQAAHEAEILKRL-DSQFIVKCHAVFYTIEG  119 (337)
Q Consensus        42 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~  119 (337)
                      .....++|++.+.||+|+||+||+|.+..+++.||+|++.... ..........|+..+.++ .|+||+++++++.+ +.
T Consensus        52 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~-~~  130 (311)
T 3p1a_A           52 ESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEE-GG  130 (311)
T ss_dssp             SCHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TT
T ss_pred             cchhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEe-CC
Confidence            3344489999999999999999999999999999999986543 222333444555555554 99999999998866 78


Q ss_pred             eEEEEEeccCCCCchHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhc
Q 019650          120 EICFVMEHMERGSLFDSLRVR-KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEE  198 (337)
Q Consensus       120 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~  198 (337)
                      ..++||||+ +++|.+++... ..+++..++.++.||+.||+|||+.||+|+||||+||+++.+++++|+|||++.....
T Consensus       131 ~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~  209 (311)
T 3p1a_A          131 ILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT  209 (311)
T ss_dssp             EEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred             EEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence            999999999 56998888754 4699999999999999999999999999999999999999999999999999876543


Q ss_pred             cccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHH
Q 019650          199 TRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALIC  278 (337)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~  278 (337)
                      ..               ......||+.|+|||++.    + .++.++||||||+++|+|++|..|+..   .......  
T Consensus       210 ~~---------------~~~~~~gt~~y~aPE~~~----~-~~~~~~DiwslG~il~el~~g~~~~~~---~~~~~~~--  264 (311)
T 3p1a_A          210 AG---------------AGEVQEGDPRYMAPELLQ----G-SYGTAADVFSLGLTILEVACNMELPHG---GEGWQQL--  264 (311)
T ss_dssp             --------------------CCCCCGGGCCGGGGG----T-CCSTHHHHHHHHHHHHHHHHTCCCCSS---HHHHHHH--
T ss_pred             CC---------------CCcccCCCccccCHhHhc----C-CCCchhhHHHHHHHHHHHHhCCCCCCC---ccHHHHH--
Confidence            32               112235899999999987    2 688999999999999999999766533   1121111  


Q ss_pred             HhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccc
Q 019650          279 AICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTK  325 (337)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~  325 (337)
                       ........++..+++.+.++|.+||+.||++|||++++|+||||++
T Consensus       265 -~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~  310 (311)
T 3p1a_A          265 -RQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ  310 (311)
T ss_dssp             -TTTCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred             -hccCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence             1111122334567999999999999999999999999999999986

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=7.5e-49  Score=356.52  Aligned_cols=281  Identities=26%  Similarity=0.358  Sum_probs=210.0

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCceEEEEEeecCC-chHhHHHHHHHHHHHHhcC-CCCceeeeeeEEeeC-Ce
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-STIIRHQAAHEAEILKRLD-SQFIVKCHAVFYTIE-GE  120 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~-~~  120 (337)
                      ...++|++++.||.|+||+||+|.+..+++.||+|++.... .......+.+|+.+++++. |+||+++++++...+ ..
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~   85 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD   85 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence            34689999999999999999999999999999999986542 3445667788999999997 999999999987533 36


Q ss_pred             EEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccc
Q 019650          121 ICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETR  200 (337)
Q Consensus       121 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~  200 (337)
                      +|+||||+++ +|.+++.. ..+++..+..++.||+.||+|||+.||+||||||+||+++.++.++|+|||++.......
T Consensus        86 ~~lv~e~~~~-~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  163 (388)
T 3oz6_A           86 VYLVFDYMET-DLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIR  163 (388)
T ss_dssp             EEEEEECCSE-EHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCC
T ss_pred             EEEEecccCc-CHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccccc
Confidence            8999999975 89998875 579999999999999999999999999999999999999999999999999998664321


Q ss_pred             cCCCCC-------CCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhH
Q 019650          201 NNNNHN-------NNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDL  273 (337)
Q Consensus       201 ~~~~~~-------~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~  273 (337)
                      ......       ..............+||+.|+|||++...   ..++.++|||||||++|+|++|+.||.+.......
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~  240 (388)
T 3oz6_A          164 RVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGS---TKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQL  240 (388)
T ss_dssp             CCCCCGGGCCC---------------CCCGGGGCCHHHHTTC---CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred             cccccccccccccccccccccccccCCcccCCcCCHHHhcCC---CCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            110000       00000001233445799999999999742   46899999999999999999999999876544433


Q ss_pred             HHHHHHhhccCC------------------------------------------CCCCCCCCHHHHHHHHHHhhcCcCCC
Q 019650          274 MALICAICFGER------------------------------------------LEMPETASPEFRRFVRSCLEKDWRKR  311 (337)
Q Consensus       274 ~~~~~~~~~~~~------------------------------------------~~~~~~~~~~~~~li~~~l~~~p~~R  311 (337)
                      ..+.........                                          ...+...++.+.+|+.+||..||++|
T Consensus       241 ~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R  320 (388)
T 3oz6_A          241 ERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKR  320 (388)
T ss_dssp             HHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGS
T ss_pred             HHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccC
Confidence            333321110000                                          01122568899999999999999999


Q ss_pred             CCHHHHhcCccccccCCC
Q 019650          312 GTVEELLAYPFVTKRSSS  329 (337)
Q Consensus       312 ~s~~eil~hp~f~~~~~~  329 (337)
                      ||++|+|+||||+.....
T Consensus       321 ~t~~e~l~Hp~~~~~~~~  338 (388)
T 3oz6_A          321 ISANDALKHPFVSIFHNP  338 (388)
T ss_dssp             CCHHHHTTSTTTTTTCCG
T ss_pred             CCHHHHhCCHHHHHhcCC
Confidence            999999999999876543

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=1.3e-48  Score=345.22  Aligned_cols=278  Identities=25%  Similarity=0.362  Sum_probs=210.4

Q ss_pred             Cccccccc-cccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhc-CCCCceeeeeeEEeeCCeEE
Q 019650           45 NISDLKKL-TVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRL-DSQFIVKCHAVFYTIEGEIC  122 (337)
Q Consensus        45 ~~~~y~~~-~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~~  122 (337)
                      ..++|.+. +.||+|+||+||+|.+..+++.||+|++.... ......+.+|+.++.++ +|+||+++++++.+ ....+
T Consensus        10 ~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~-~~~~~   87 (316)
T 2ac3_A           10 FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP-GHIRSRVFREVEMLYQCQGHRNVLELIEFFEE-EDRFY   87 (316)
T ss_dssp             TTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS-SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-TTEEE
T ss_pred             cceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc-chhHHHHHHHHHHHHHhcCCCCeeeEEEEEee-CCEEE
Confidence            45789885 78999999999999999999999999997653 23456778899999884 79999999998876 78999


Q ss_pred             EEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCc---EEEeeccCccchhcc
Q 019650          123 FVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGE---VKIADFGVSRIVEET  199 (337)
Q Consensus       123 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~---~~l~Dfg~~~~~~~~  199 (337)
                      +||||+++++|.+++.....+++..++.++.||+.||+|||++|++||||||+||+++.++.   ++|+|||++......
T Consensus        88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~  167 (316)
T 2ac3_A           88 LVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN  167 (316)
T ss_dssp             EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----
T ss_pred             EEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccC
Confidence            99999999999999998889999999999999999999999999999999999999988765   999999998765432


Q ss_pred             ccCCCCCCCCCCccccccccccCCCCCcCCcccccccC-CCCCCccccHHHHHHHHHHHHhCCCCCCCCCCch-------
Q 019650          200 RNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERW-GGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP-------  271 (337)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~-------  271 (337)
                      .......       ........|++.|+|||.+..... ...++.++||||||+++|+|++|..||.......       
T Consensus       168 ~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~  240 (316)
T 2ac3_A          168 GDCSPIS-------TPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGE  240 (316)
T ss_dssp             ---------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----
T ss_pred             Ccccccc-------ccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccc
Confidence            2111000       011223458999999999873100 1347889999999999999999999997653321       


Q ss_pred             ----hHHHHHHHhhccCCCCCC----CCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCCccc
Q 019650          272 ----DLMALICAICFGERLEMP----ETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNI  332 (337)
Q Consensus       272 ----~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~~~~  332 (337)
                          ............ ...++    ..++..+.+||.+||..||.+|||++++|+||||++......+
T Consensus       241 ~~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~~~~~  308 (316)
T 2ac3_A          241 ACPACQNMLFESIQEG-KYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTL  308 (316)
T ss_dssp             CCHHHHHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC--------
T ss_pred             cchhHHHHHHHHHhcc-CcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCCCcccC
Confidence                011122222222 22222    3578999999999999999999999999999999987655443

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=2.7e-48  Score=349.92  Aligned_cols=269  Identities=24%  Similarity=0.378  Sum_probs=221.2

Q ss_pred             ccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeC----CeE
Q 019650           46 ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIE----GEI  121 (337)
Q Consensus        46 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~----~~~  121 (337)
                      .++|++++.||+|+||+||+|.+..++..||+|++.........+.+.+|+.++++++|+||+++++++....    ...
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            4699999999999999999999999999999999987666666678889999999999999999999886532    468


Q ss_pred             EEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhcccc
Q 019650          122 CFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRN  201 (337)
Q Consensus       122 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~  201 (337)
                      ++|||++.+ +|.+++.. ..+++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||.+........
T Consensus       106 ~iv~e~~~~-~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~  183 (364)
T 3qyz_A          106 YIVQDLMET-DLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD  183 (364)
T ss_dssp             EEEEECCSE-EHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGC
T ss_pred             EEEEcccCc-CHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCCC
Confidence            999999975 99998875 5699999999999999999999999999999999999999999999999999987654332


Q ss_pred             CCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhh
Q 019650          202 NNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAIC  281 (337)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~  281 (337)
                      ..           .......||+.|+|||++..   +..++.++||||||+++|+|++|+.||.+...............
T Consensus       184 ~~-----------~~~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~  249 (364)
T 3qyz_A          184 HT-----------GFLTEYVATRWYRAPEIMLN---SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG  249 (364)
T ss_dssp             BC-----------CTTCCCCSCGGGCCHHHHHT---BCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHC
T ss_pred             cc-----------ccccccccccCCCCCHHhcC---CCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhC
Confidence            11           11223468999999998764   24578999999999999999999999987655444443332111


Q ss_pred             ccC---------------------C-----CCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCCc
Q 019650          282 FGE---------------------R-----LEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSS  330 (337)
Q Consensus       282 ~~~---------------------~-----~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~~  330 (337)
                      ...                     .     ....+..+..+.+||.+||+.||.+|||++++|+||||++....+
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~~  324 (364)
T 3qyz_A          250 SPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPS  324 (364)
T ss_dssp             SCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCCGG
T ss_pred             CCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccCcc
Confidence            100                     0     001245688999999999999999999999999999999875443

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.7e-49  Score=348.61  Aligned_cols=281  Identities=27%  Similarity=0.416  Sum_probs=195.9

Q ss_pred             CCCCCCccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEe
Q 019650           37 NPTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYT  116 (337)
Q Consensus        37 ~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~  116 (337)
                      ++..|+....++|++.+.||+|++|+||+|.+..+++.||+|++.........+.+.+|+.++++++|+||+++++++..
T Consensus         5 s~~~p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   84 (303)
T 2vwi_A            5 SSALPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVV   84 (303)
T ss_dssp             --------CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEES
T ss_pred             ccccccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEee
Confidence            34456677789999999999999999999999889999999998765544556677889999999999999999998876


Q ss_pred             eCCeEEEEEeccCCCCchHHhhh--------cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEe
Q 019650          117 IEGEICFVMEHMERGSLFDSLRV--------RKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIA  188 (337)
Q Consensus       117 ~~~~~~lv~e~~~~~~L~~~l~~--------~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~  188 (337)
                       ....++||||+++++|.+++..        ...+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+
T Consensus        85 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~  163 (303)
T 2vwi_A           85 -KDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIA  163 (303)
T ss_dssp             -SSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEEC
T ss_pred             -cCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEE
Confidence             6789999999999999999974        3569999999999999999999999999999999999999999999999


Q ss_pred             eccCccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Q 019650          189 DFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFG  268 (337)
Q Consensus       189 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~  268 (337)
                      |||.+...........         ........+++.|+|||.+...   ..++.++||||||+++|+|++|..||....
T Consensus       164 dfg~~~~~~~~~~~~~---------~~~~~~~~~~~~y~aPE~~~~~---~~~~~~~Di~slG~il~~l~~g~~pf~~~~  231 (303)
T 2vwi_A          164 DFGVSAFLATGGDITR---------NKVRKTFVGTPCWMAPEVMEQV---RGYDFKADIWSFGITAIELATGAAPYHKYP  231 (303)
T ss_dssp             CCHHHHHCC------------------------CCCTTCCHHHHHHH---HCCCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred             eccchheeccCCCccc---------hhhhcccCCCccccCHHHhccc---cCCCchhhHHHHHHHHHHHHhCCCCCccCc
Confidence            9999876543321110         0122334689999999998742   357889999999999999999999997654


Q ss_pred             CchhHHHHHHHhhcc-----CCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCCc
Q 019650          269 EKPDLMALICAICFG-----ERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSS  330 (337)
Q Consensus       269 ~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~~  330 (337)
                      ...............     ........++..+.+++.+||+.||.+|||++++++||||++.....
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~  298 (303)
T 2vwi_A          232 PMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNKE  298 (303)
T ss_dssp             GGGHHHHHHTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC-------
T ss_pred             hhhHHHHHhccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCCCc
Confidence            433322221110000     01123356788999999999999999999999999999999877554

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-48  Score=350.21  Aligned_cols=269  Identities=29%  Similarity=0.446  Sum_probs=221.5

Q ss_pred             ccCccccccccccccCcceEEEEEEEc---cCCceEEEEEeecCC---chHhHHHHHHHHHHHHhc-CCCCceeeeeeEE
Q 019650           43 VENISDLKKLTVLGHGNGGIVYKVRHQ---KSNSIYALKVLNTTS---STIIRHQAAHEAEILKRL-DSQFIVKCHAVFY  115 (337)
Q Consensus        43 ~~~~~~y~~~~~lg~g~~~~v~~~~~~---~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~  115 (337)
                      ....++|++++.||+|+||+||+|.+.   .+++.||+|+++...   .....+.+.+|+.+++++ .|+||+++++.+.
T Consensus        50 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~  129 (355)
T 1vzo_A           50 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ  129 (355)
T ss_dssp             CCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE
T ss_pred             cccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEe
Confidence            345689999999999999999999984   588999999986532   112334556799999999 6999999999886


Q ss_pred             eeCCeEEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccc
Q 019650          116 TIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRI  195 (337)
Q Consensus       116 ~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~  195 (337)
                      . ....++||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+||+++.+++++|+|||++..
T Consensus       130 ~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~  208 (355)
T 1vzo_A          130 T-ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE  208 (355)
T ss_dssp             E-TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred             e-CceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence            6 788999999999999999999888999999999999999999999999999999999999999999999999999876


Q ss_pred             hhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHH
Q 019650          196 VEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMA  275 (337)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~  275 (337)
                      ......             .......||+.|+|||++...  ...++.++||||||+++|+|++|..||...........
T Consensus       209 ~~~~~~-------------~~~~~~~gt~~y~aPE~~~~~--~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~  273 (355)
T 1vzo_A          209 FVADET-------------ERAYDFCGTIEYMAPDIVRGG--DSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAE  273 (355)
T ss_dssp             CCGGGG-------------GGGCGGGSCCTTCCHHHHTTC--C---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHH
T ss_pred             cccCCC-------------CcccCcccCcCccChhhhcCC--CCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHH
Confidence            543221             122234689999999999843  23578899999999999999999999976544433333


Q ss_pred             HHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCC-----CHHHHhcCccccccCC
Q 019650          276 LICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRG-----TVEELLAYPFVTKRSS  328 (337)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~-----s~~eil~hp~f~~~~~  328 (337)
                      ...... ...+.++..++..+.+||.+||..||.+||     |++++++||||++..+
T Consensus       274 ~~~~~~-~~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~  330 (355)
T 1vzo_A          274 ISRRIL-KSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINW  330 (355)
T ss_dssp             HHHHHH-HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCH
T ss_pred             HHHHHh-ccCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCCh
Confidence            333322 234566778899999999999999999999     9999999999998654

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=4.3e-48  Score=339.97  Aligned_cols=262  Identities=28%  Similarity=0.463  Sum_probs=224.3

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEE
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICF  123 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~l  123 (337)
                      ...+.|++++.||+|+||+||+|.+..+++.||+|++.........+.+.+|+.++++++|+||+++++.+.. ....++
T Consensus        19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~l   97 (303)
T 3a7i_A           19 DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-DTKLWI   97 (303)
T ss_dssp             CGGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEE
T ss_pred             ChHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec-CCeEEE
Confidence            4457799999999999999999999999999999999876655566788999999999999999999998876 788999


Q ss_pred             EEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCC
Q 019650          124 VMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNN  203 (337)
Q Consensus       124 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~  203 (337)
                      ||||+++++|.+++.. ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+........  
T Consensus        98 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~--  174 (303)
T 3a7i_A           98 IMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--  174 (303)
T ss_dssp             EEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC--
T ss_pred             EEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCcccc--
Confidence            9999999999999874 5799999999999999999999999999999999999999999999999999977644321  


Q ss_pred             CCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhcc
Q 019650          204 NHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFG  283 (337)
Q Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~  283 (337)
                                  ......+++.|+|||.+.    +..++.++||||||+++|+|++|..||.......    ........
T Consensus       175 ------------~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~~~~~  234 (303)
T 3a7i_A          175 ------------KRNTFVGTPFWMAPEVIK----QSAYDSKADIWSLGITAIELARGEPPHSELHPMK----VLFLIPKN  234 (303)
T ss_dssp             ------------CBCCCCSCGGGCCHHHHT----TCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH----HHHHHHHS
T ss_pred             ------------ccCccCCCcCccCHHHHh----cCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHH----HHHHhhcC
Confidence                        112335899999999998    4578889999999999999999999996543222    22223334


Q ss_pred             CCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCC
Q 019650          284 ERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSS  329 (337)
Q Consensus       284 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~  329 (337)
                      .....+..++..+.+++.+||..||.+|||++++++||||.+....
T Consensus       235 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~  280 (303)
T 3a7i_A          235 NPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKK  280 (303)
T ss_dssp             CCCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHHCCC
T ss_pred             CCCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcCCCc
Confidence            4556667889999999999999999999999999999999765543

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=6.4e-49  Score=349.87  Aligned_cols=252  Identities=26%  Similarity=0.391  Sum_probs=214.9

Q ss_pred             CccccccccccccCcceEEEEEEEccCCceEEEEEeecCCc-------hHhHHHHHHHHHHHHhcCCCCceeeeeeEEee
Q 019650           45 NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSS-------TIIRHQAAHEAEILKRLDSQFIVKCHAVFYTI  117 (337)
Q Consensus        45 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~  117 (337)
                      ..++|++.+.||+|+||+||+|.+..+++.||+|++.....       ......+.+|+.++++++|+||+++++++.. 
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~-  100 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN-  100 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC-
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee-
Confidence            35799999999999999999999999999999999976531       1123456679999999999999999998866 


Q ss_pred             CCeEEEEEeccCCC-CchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccch
Q 019650          118 EGEICFVMEHMERG-SLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIV  196 (337)
Q Consensus       118 ~~~~~lv~e~~~~~-~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~  196 (337)
                      ....++|||++.+| +|.+++...+.+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||++...
T Consensus       101 ~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~  180 (335)
T 3dls_A          101 QGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL  180 (335)
T ss_dssp             SSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             CCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceEC
Confidence            78899999998766 99999998889999999999999999999999999999999999999999999999999999766


Q ss_pred             hccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCC-CccccHHHHHHHHHHHHhCCCCCCCCCCchhHHH
Q 019650          197 EETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDY-GFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMA  275 (337)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~-~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~  275 (337)
                      ....               ......||+.|+|||.+..    ..+ +.++||||||+++|+|++|..||.....      
T Consensus       181 ~~~~---------------~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------  235 (335)
T 3dls_A          181 ERGK---------------LFYTFCGTIEYCAPEVLMG----NPYRGPELEMWSLGVTLYTLVFEENPFCELEE------  235 (335)
T ss_dssp             CTTC---------------CBCEECSCGGGCCHHHHTT----CCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------
T ss_pred             CCCC---------------ceeccCCCccccChhhhcC----CCCCCCcccchhHHHHHHHHHhCCCchhhHHH------
Confidence            4332               1223458999999999984    344 7899999999999999999999964221      


Q ss_pred             HHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccC
Q 019650          276 LICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRS  327 (337)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~  327 (337)
                           ........+..++..+.++|.+||+.||.+|||++++++||||++..
T Consensus       236 -----~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~  282 (335)
T 3dls_A          236 -----TVEAAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPV  282 (335)
T ss_dssp             -----GTTTCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCCC
T ss_pred             -----HHhhccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCCc
Confidence                 11223344566899999999999999999999999999999998754

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=8.3e-49  Score=347.49  Aligned_cols=266  Identities=31%  Similarity=0.411  Sum_probs=215.8

Q ss_pred             CccccccccccccCcceEEEEEEEccCCceEEEEEeecCCc-------hHhHHHHHHHHHHHHhcCCCCceeeeeeEEee
Q 019650           45 NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSS-------TIIRHQAAHEAEILKRLDSQFIVKCHAVFYTI  117 (337)
Q Consensus        45 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~  117 (337)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++.....       ......+.+|+.++++++|+||+++++++.. 
T Consensus         8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-   86 (322)
T 2ycf_A            8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-   86 (322)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES-
T ss_pred             hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC-
Confidence            45799999999999999999999999999999999865421       1223457789999999999999999998754 


Q ss_pred             CCeEEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCc---EEEeeccCcc
Q 019650          118 EGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGE---VKIADFGVSR  194 (337)
Q Consensus       118 ~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~---~~l~Dfg~~~  194 (337)
                       ...++||||+++++|.+++.....+++..++.++.||+.||.|||++|++|+||||+||+++.++.   ++|+|||++.
T Consensus        87 -~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~  165 (322)
T 2ycf_A           87 -EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK  165 (322)
T ss_dssp             -SSEEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCE
T ss_pred             -CceEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccce
Confidence             458999999999999999998889999999999999999999999999999999999999987664   9999999987


Q ss_pred             chhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHH
Q 019650          195 IVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLM  274 (337)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~  274 (337)
                      .....               .......|++.|+|||.+.... ...++.++||||||+++|+|++|..||..........
T Consensus       166 ~~~~~---------------~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~  229 (322)
T 2ycf_A          166 ILGET---------------SLMRTLCGTPTYLAPEVLVSVG-TAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK  229 (322)
T ss_dssp             ECCCC---------------HHHHHHHSCCTTCCHHHHHHTT-TTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHH
T ss_pred             ecccc---------------cccccccCCcCccCchhhccCC-CCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHH
Confidence            65432               1122335899999999985321 3467899999999999999999999997655444443


Q ss_pred             HHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCC
Q 019650          275 ALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSS  328 (337)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~  328 (337)
                      ...........+..+..++..+.++|.+||..||.+|||++++|+||||++...
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~~~  283 (322)
T 2ycf_A          230 DQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDM  283 (322)
T ss_dssp             HHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCHHH
T ss_pred             HHHHhCccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCHHH
Confidence            333332222222223567899999999999999999999999999999987654

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=2e-48  Score=364.26  Aligned_cols=260  Identities=29%  Similarity=0.420  Sum_probs=213.5

Q ss_pred             CccccccccccccCcceEEEEEEEccCCceEEEEEeecCC-chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEE
Q 019650           45 NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICF  123 (337)
Q Consensus        45 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~l  123 (337)
                      ..++|++++.||+|+||+||+|.+..++..||+|++.... .......+.+|+.+++.++||||+++++++.+ ....++
T Consensus        35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~l  113 (494)
T 3lij_A           35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFED-KRNYYL  113 (494)
T ss_dssp             HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEE
T ss_pred             hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-CCEEEE
Confidence            4568999999999999999999999999999999997653 22335678899999999999999999998876 788999


Q ss_pred             EEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCC---CcEEEeeccCccchhccc
Q 019650          124 VMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGK---GEVKIADFGVSRIVEETR  200 (337)
Q Consensus       124 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~---~~~~l~Dfg~~~~~~~~~  200 (337)
                      ||||+++|+|.+++.....+++..++.++.||+.||.|||++||+||||||+||+++..   +.++|+|||++.......
T Consensus       114 v~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~  193 (494)
T 3lij_A          114 VMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK  193 (494)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB
T ss_pred             EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc
Confidence            99999999999999888899999999999999999999999999999999999999764   459999999987664332


Q ss_pred             cCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHh
Q 019650          201 NNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAI  280 (337)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~  280 (337)
                                     .....+||+.|+|||++.     ..++.++||||||+++|+|++|..||.+....... ......
T Consensus       194 ---------------~~~~~~gt~~y~aPE~l~-----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~~i~~~  252 (494)
T 3lij_A          194 ---------------KMKERLGTAYYIAPEVLR-----KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEIL-RKVEKG  252 (494)
T ss_dssp             ---------------CBCCCCSCTTTCCHHHHT-----TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-HHHHHT
T ss_pred             ---------------cccccCCCcCeeCHHHHc-----ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHhC
Confidence                           122346999999999986     35889999999999999999999999765433222 222221


Q ss_pred             hccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCcccccc
Q 019650          281 CFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKR  326 (337)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~  326 (337)
                      ...........++..+.++|.+||..||.+|||++++|+||||++.
T Consensus       253 ~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~  298 (494)
T 3lij_A          253 KYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM  298 (494)
T ss_dssp             CCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred             CCCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence            1122222235679999999999999999999999999999999875

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.7e-48  Score=349.12  Aligned_cols=264  Identities=28%  Similarity=0.381  Sum_probs=210.6

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCceEEEEEeecCC-chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeC----
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIE----  118 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~----  118 (337)
                      ...++|++++.||.|+||+||+|.+..+++.||+|++.... .....+.+.+|+.++++++|+||+++++++....    
T Consensus        22 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~  101 (367)
T 1cm8_A           22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD  101 (367)
T ss_dssp             CCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred             eecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCcccc
Confidence            34578999999999999999999999999999999986543 3445677889999999999999999999886632    


Q ss_pred             -CeEEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchh
Q 019650          119 -GEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVE  197 (337)
Q Consensus       119 -~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~  197 (337)
                       ..+|+||||+ +++|.+++.. ..+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++....
T Consensus       102 ~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  179 (367)
T 1cm8_A          102 FTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD  179 (367)
T ss_dssp             CCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             CceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccccc
Confidence             3469999999 7799999875 579999999999999999999999999999999999999999999999999997653


Q ss_pred             ccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHH
Q 019650          198 ETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALI  277 (337)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~  277 (337)
                      ..                 ....++|+.|+|||++...   ..++.++|||||||++|+|++|+.||.+.........+.
T Consensus       180 ~~-----------------~~~~~~t~~y~aPE~~~~~---~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~  239 (367)
T 1cm8_A          180 SE-----------------MTGYVVTRWYRAPEVILNW---MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIM  239 (367)
T ss_dssp             SS-----------------CCSSCSCGGGCCTHHHHTT---TCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             cc-----------------cCcCcCCCCcCCHHHHhCC---CCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            21                 1223589999999998742   468999999999999999999999997654433333322


Q ss_pred             HHhhc--------------------------cCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCC
Q 019650          278 CAICF--------------------------GERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSS  329 (337)
Q Consensus       278 ~~~~~--------------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~  329 (337)
                      .....                          ..........++.+.+|+.+||..||.+|||++++|+||||++....
T Consensus       240 ~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~  317 (367)
T 1cm8_A          240 KVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT  317 (367)
T ss_dssp             HHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC--
T ss_pred             HhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCC
Confidence            21100                          00012234668999999999999999999999999999999986543

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=5.8e-49  Score=351.70  Aligned_cols=270  Identities=26%  Similarity=0.392  Sum_probs=214.8

Q ss_pred             CccccccccccccCcceEEEEEEEccCCceEEEEEeecCC----chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCe
Q 019650           45 NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS----STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGE  120 (337)
Q Consensus        45 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~  120 (337)
                      ..++|++.+.||+|+||+||+|.+..++..||+|++....    .....+.+.+|+.++++++||||+++++++.+ ...
T Consensus        24 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~  102 (345)
T 3hko_A           24 LQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED-EQY  102 (345)
T ss_dssp             HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSE
T ss_pred             hhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc-CCe
Confidence            3479999999999999999999999999999999986532    23345778899999999999999999998866 788


Q ss_pred             EEEEEeccCCCCchHHhhhc----------------------------------------CCCCHHHHHHHHHHHHHHHH
Q 019650          121 ICFVMEHMERGSLFDSLRVR----------------------------------------KKLSEDVISGVAYRVLKGLQ  160 (337)
Q Consensus       121 ~~lv~e~~~~~~L~~~l~~~----------------------------------------~~l~~~~~~~i~~~l~~~l~  160 (337)
                      .++||||++|++|.+++...                                        ..+++..++.++.||+.||+
T Consensus       103 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~  182 (345)
T 3hko_A          103 ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALH  182 (345)
T ss_dssp             EEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHH
Confidence            99999999999999998521                                        12367889999999999999


Q ss_pred             HHHhCCceeccCCCCCeEEcCCC--cEEEeeccCccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCC
Q 019650          161 YLHGMQIIHGDIKPSNLLINGKG--EVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWG  238 (337)
Q Consensus       161 ~LH~~~ivH~dl~~~Nili~~~~--~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  238 (337)
                      |||+.|++||||||+||+++.++  .++|+|||++...........          .......|++.|+|||.+...  +
T Consensus       183 ~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~--~  250 (345)
T 3hko_A          183 YLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEY----------YGMTTKAGTPYFVAPEVLNTT--N  250 (345)
T ss_dssp             HHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC------------------CCCGGGCCHHHHTCS--S
T ss_pred             HHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCcccc----------ccccccCCCccccCchhhccC--C
Confidence            99999999999999999998776  899999999987644221111          112234589999999999743  3


Q ss_pred             CCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHh
Q 019650          239 GDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELL  318 (337)
Q Consensus       239 ~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil  318 (337)
                      ..++.++||||||+++|+|++|..||................. .........++..+.++|.+||+.||.+|||+.++|
T Consensus       251 ~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l  329 (345)
T 3hko_A          251 ESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKL-CFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRAL  329 (345)
T ss_dssp             SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-CTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHH
T ss_pred             CCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhccc-ccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHh
Confidence            5788999999999999999999999976544433333322211 111111224689999999999999999999999999


Q ss_pred             cCccccccCC
Q 019650          319 AYPFVTKRSS  328 (337)
Q Consensus       319 ~hp~f~~~~~  328 (337)
                      +||||++...
T Consensus       330 ~hp~~~~~~~  339 (345)
T 3hko_A          330 QHPWISQFSD  339 (345)
T ss_dssp             HSHHHHTTSS
T ss_pred             cChhhccChH
Confidence            9999998653

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=5.1e-48  Score=341.12  Aligned_cols=267  Identities=32%  Similarity=0.500  Sum_probs=216.7

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEE
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICF  123 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~l  123 (337)
                      ...++|++.+.||.|+||+||+|.+..+++.||+|++....   ..+.+.+|+.++++++|+||+++++.+.. ....++
T Consensus        26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~l  101 (314)
T 3com_A           26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES---DLQEIIKEISIMQQCDSPHVVKYYGSYFK-NTDLWI  101 (314)
T ss_dssp             ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS---CCHHHHHHHHHHHTCCCTTBCCEEEEEEE-TTEEEE
T ss_pred             cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH---HHHHHHHHHHHHHhCCCCCCccEEEEEEe-CCEEEE
Confidence            44678999999999999999999999999999999997653   24567889999999999999999998876 788999


Q ss_pred             EEeccCCCCchHHhh-hcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccC
Q 019650          124 VMEHMERGSLFDSLR-VRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNN  202 (337)
Q Consensus       124 v~e~~~~~~L~~~l~-~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~  202 (337)
                      ||||+++++|.+++. ....+++..++.++.|++.||.|||+.|++|+||+|+||+++.+++++|+|||.+.......  
T Consensus       102 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~--  179 (314)
T 3com_A          102 VMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM--  179 (314)
T ss_dssp             EEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB--
T ss_pred             EeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc--
Confidence            999999999999997 45679999999999999999999999999999999999999999999999999997664332  


Q ss_pred             CCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhc
Q 019650          203 NNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICF  282 (337)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~  282 (337)
                                  .......+++.|+|||.+.    +..++.++||||||+++|+|++|..||............  ....
T Consensus       180 ------------~~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~--~~~~  241 (314)
T 3com_A          180 ------------AKRNTVIGTPFWMAPEVIQ----EIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMI--PTNP  241 (314)
T ss_dssp             ------------SCBCCCCSCGGGCCHHHHS----SSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH--HHSC
T ss_pred             ------------cccCccCCCCCccChhhcC----CCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHH--hcCC
Confidence                        1112335899999999998    457889999999999999999999999764332221111  1111


Q ss_pred             cCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCCccccC
Q 019650          283 GERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNIEG  334 (337)
Q Consensus       283 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~~~~~~  334 (337)
                      ......+..++..+.++|.+||..||.+|||++++++||||++....+.+..
T Consensus       242 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~~~~~~~~  293 (314)
T 3com_A          242 PPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKGVSILRD  293 (314)
T ss_dssp             CCCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCCCGGGGHH
T ss_pred             CcccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCCcchHHHH
Confidence            1122234557899999999999999999999999999999999887665543

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=2.5e-48  Score=347.59  Aligned_cols=263  Identities=30%  Similarity=0.420  Sum_probs=218.4

Q ss_pred             ccccccccccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEE
Q 019650           46 ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICF  123 (337)
Q Consensus        46 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~l  123 (337)
                      .+.|++++.||+|+||+||+|.+..+++.||+|++....  .....+.+.+|+.++++++|+||+++++++.. +...++
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~l  131 (348)
T 1u5q_A           53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-EHTAWL  131 (348)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEE
T ss_pred             hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-CCeEEE
Confidence            467999999999999999999999999999999997643  33445678899999999999999999998876 789999


Q ss_pred             EEeccCCCCchHHhh-hcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccC
Q 019650          124 VMEHMERGSLFDSLR-VRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNN  202 (337)
Q Consensus       124 v~e~~~~~~L~~~l~-~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~  202 (337)
                      ||||+.| +|.+++. ....+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++......   
T Consensus       132 v~e~~~g-~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~---  207 (348)
T 1u5q_A          132 VMEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---  207 (348)
T ss_dssp             EEECCSE-EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---
T ss_pred             EEecCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC---
Confidence            9999975 8888875 4567999999999999999999999999999999999999999999999999998765322   


Q ss_pred             CCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhc
Q 019650          203 NNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICF  282 (337)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~  282 (337)
                                     ....|++.|+|||++.... +..++.++||||||+++|+|++|..||............   ...
T Consensus       208 ---------------~~~~gt~~y~aPE~~~~~~-~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~---~~~  268 (348)
T 1u5q_A          208 ---------------NSFVGTPYWMAPEVILAMD-EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI---AQN  268 (348)
T ss_dssp             ---------------CCCCSCGGGCCHHHHHTTS-SCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH---HHS
T ss_pred             ---------------CcccCCcceeCHhhhcccc-CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH---Hhc
Confidence                           1235899999999985321 346888999999999999999999999764433222222   222


Q ss_pred             cCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCCccc
Q 019650          283 GERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNI  332 (337)
Q Consensus       283 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~~~~  332 (337)
                      ..+...+...++.+.++|.+||+.||.+|||++++++||||.+......+
T Consensus       269 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~~~~~~  318 (348)
T 1u5q_A          269 ESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVI  318 (348)
T ss_dssp             CCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCCCTTHH
T ss_pred             CCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhccCCcchh
Confidence            22333345678999999999999999999999999999999887655443

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=1.3e-48  Score=339.84  Aligned_cols=263  Identities=27%  Similarity=0.461  Sum_probs=216.9

Q ss_pred             ccccccccccccCcceEEEEEEEccCCceEEEEEeecCCch-----HhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCe
Q 019650           46 ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSST-----IIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGE  120 (337)
Q Consensus        46 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~  120 (337)
                      .++|++.+.||.|+||+||+|.+..+++.||+|++......     ...+.+.+|+.++++++|+||+++++++.. ...
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~   82 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFEN-KTD   82 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSE
T ss_pred             hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecC-CCe
Confidence            46899999999999999999999999999999998765321     235778899999999999999999998876 688


Q ss_pred             EEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCC----cEEEeeccCccch
Q 019650          121 ICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKG----EVKIADFGVSRIV  196 (337)
Q Consensus       121 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~----~~~l~Dfg~~~~~  196 (337)
                      .++||||+++++|.+++.....+++..++.++.|++.||.|||++|++|+||+|+||+++.++    .++|+|||.+...
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~  162 (283)
T 3bhy_A           83 VVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI  162 (283)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred             EEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceec
Confidence            999999999999999998888999999999999999999999999999999999999998877    8999999998766


Q ss_pred             hccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHH
Q 019650          197 EETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMAL  276 (337)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~  276 (337)
                      .....               .....+++.|+|||.+.    +..++.++|+||||+++|+|++|..||......... ..
T Consensus       163 ~~~~~---------------~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~~  222 (283)
T 3bhy_A          163 EAGNE---------------FKNIFGTPEFVAPEIVN----YEPLGLEADMWSIGVITYILLSGASPFLGETKQETL-TN  222 (283)
T ss_dssp             C-----------------------CCCGGGCCHHHHT----TCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-HH
T ss_pred             cCCCc---------------ccccCCCcCccCcceec----CCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHH-HH
Confidence            43221               12235899999999998    457889999999999999999999999764332221 11


Q ss_pred             HHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCC
Q 019650          277 ICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSS  329 (337)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~  329 (337)
                      ............+...+..+.+++.+||..||.+|||+.++++||||++..+.
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~  275 (283)
T 3bhy_A          223 ISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRR  275 (283)
T ss_dssp             HHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHC
T ss_pred             hHhcccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHH
Confidence            11111111112235678999999999999999999999999999999986543

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=4.2e-48  Score=343.66  Aligned_cols=264  Identities=25%  Similarity=0.373  Sum_probs=217.1

Q ss_pred             ccccccc-cccccCcceEEEEEEEccCCceEEEEEeecCC-chHhHHHHHHHHHHHHhcC-CCCceeeeeeEEeeCCeEE
Q 019650           46 ISDLKKL-TVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-STIIRHQAAHEAEILKRLD-SQFIVKCHAVFYTIEGEIC  122 (337)
Q Consensus        46 ~~~y~~~-~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~~  122 (337)
                      .++|.+. +.||+|+||+||+|.+..+++.||+|++.... .......+.+|+.+++.+. |+||+++++++.. ....+
T Consensus        27 ~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~-~~~~~  105 (327)
T 3lm5_A           27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYEN-TSEII  105 (327)
T ss_dssp             HHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-SSEEE
T ss_pred             hhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEe-CCeEE
Confidence            3577777 89999999999999999999999999987643 2233567788999999995 5999999998866 78899


Q ss_pred             EEEeccCCCCchHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcC---CCcEEEeeccCccchh
Q 019650          123 FVMEHMERGSLFDSLRVR--KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLING---KGEVKIADFGVSRIVE  197 (337)
Q Consensus       123 lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~---~~~~~l~Dfg~~~~~~  197 (337)
                      +||||+++++|.+++...  ..+++..++.++.||+.||+|||++|++||||||+||+++.   ++.++|+|||++....
T Consensus       106 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~  185 (327)
T 3lm5_A          106 LILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG  185 (327)
T ss_dssp             EEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC-
T ss_pred             EEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccC
Confidence            999999999999999643  67999999999999999999999999999999999999987   7899999999998764


Q ss_pred             ccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHH
Q 019650          198 ETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALI  277 (337)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~  277 (337)
                      ...               ......+++.|+|||.+.    +..++.++||||||+++|+|++|..||........ ....
T Consensus       186 ~~~---------------~~~~~~gt~~y~aPE~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~i  245 (327)
T 3lm5_A          186 HAC---------------ELREIMGTPEYLAPEILN----YDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQET-YLNI  245 (327)
T ss_dssp             -----------------------CCCGGGCCHHHHT----TCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHH
T ss_pred             Ccc---------------ccccccCCcCccCCeeec----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH-HHHH
Confidence            332               112335899999999998    45789999999999999999999999976443322 2222


Q ss_pred             HHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCCc
Q 019650          278 CAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSS  330 (337)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~~  330 (337)
                      ..............++..+.++|.+||..||.+|||++++|+||||++..+..
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~~  298 (327)
T 3lm5_A          246 SQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFEN  298 (327)
T ss_dssp             HHTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTTC
T ss_pred             HhcccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccccccc
Confidence            23333334444567899999999999999999999999999999999876543

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.8e-48  Score=346.63  Aligned_cols=268  Identities=25%  Similarity=0.359  Sum_probs=211.0

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCch----HhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCC
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSST----IIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEG  119 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~  119 (337)
                      ...++|++.+.||.|+||+||+|.+..+++.||+|++......    .....+.+|+.++++++|+||+++++++.. ..
T Consensus         7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~   85 (346)
T 1ua2_A            7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH-KS   85 (346)
T ss_dssp             ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC-TT
T ss_pred             HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEee-CC
Confidence            4468999999999999999999999999999999998754321    123457789999999999999999998866 67


Q ss_pred             eEEEEEeccCCCCchHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhc
Q 019650          120 EICFVMEHMERGSLFDSLRVR-KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEE  198 (337)
Q Consensus       120 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~  198 (337)
                      ..++||||+++ +|.+++... ..+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++.....
T Consensus        86 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  164 (346)
T 1ua2_A           86 NISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGS  164 (346)
T ss_dssp             CCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTS
T ss_pred             ceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccC
Confidence            89999999986 888888754 4689999999999999999999999999999999999999999999999999987643


Q ss_pred             cccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHH
Q 019650          199 TRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALIC  278 (337)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~  278 (337)
                      ..              .......+|+.|+|||.+...   ..++.++||||||+++|+|++|..||.+............
T Consensus       165 ~~--------------~~~~~~~~t~~y~aPE~~~~~---~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~  227 (346)
T 1ua2_A          165 PN--------------RAYTHQVVTRWYRAPELLFGA---RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFE  227 (346)
T ss_dssp             CC--------------CCCCCSCCCCTTCCHHHHTTC---SCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             Cc--------------ccCCcccccccccCchHhhCC---CCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHH
Confidence            32              112233589999999999732   3578999999999999999999999976554444444333


Q ss_pred             HhhccCCCCC-----------------------CCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCCc
Q 019650          279 AICFGERLEM-----------------------PETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSS  330 (337)
Q Consensus       279 ~~~~~~~~~~-----------------------~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~~  330 (337)
                      .........+                       ....+..+.++|.+||..||.+|||++|+|+||||++.....
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~~~  302 (346)
T 1ua2_A          228 TLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPT  302 (346)
T ss_dssp             HHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCC
T ss_pred             HcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCCCC
Confidence            3221111110                       134578999999999999999999999999999999865443

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=6.4e-48  Score=354.91  Aligned_cols=284  Identities=25%  Similarity=0.333  Sum_probs=213.6

Q ss_pred             ccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCC-chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeC---
Q 019650           43 VENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIE---  118 (337)
Q Consensus        43 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~---  118 (337)
                      ....++|++++.||+|+||+||+|.+..+++.||+|++.... .....+.+.+|+.++++++|+||+++++++....   
T Consensus        22 ~~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  101 (432)
T 3n9x_A           22 VHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLK  101 (432)
T ss_dssp             CCCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTT
T ss_pred             ceecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCc
Confidence            345689999999999999999999999999999999997643 3445677889999999999999999999886643   


Q ss_pred             -CeEEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchh
Q 019650          119 -GEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVE  197 (337)
Q Consensus       119 -~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~  197 (337)
                       ..+|+|||++.+ +|.+++.....+++..++.++.||+.||+|||+.||+||||||+||+++.++.++|+|||++....
T Consensus       102 ~~~~~lv~e~~~~-~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~  180 (432)
T 3n9x_A          102 FDELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTIN  180 (432)
T ss_dssp             CCCEEEEEECCSE-EHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC-
T ss_pred             CCeEEEEEecCCc-CHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccccc
Confidence             578999999965 999999988889999999999999999999999999999999999999999999999999998765


Q ss_pred             ccccCCCCCC--------CCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCC-------
Q 019650          198 ETRNNNNHNN--------NNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHY-------  262 (337)
Q Consensus       198 ~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~-------  262 (337)
                      ..........        .............+||+.|+|||++..   +..++.++|||||||++|+|++|..       
T Consensus       181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~---~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~  257 (432)
T 3n9x_A          181 SEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILL---QENYTKSIDIWSTGCIFAELLNMLQSHINDPT  257 (432)
T ss_dssp             ------------------------------CCCCCTTCCHHHHTT---CSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGG
T ss_pred             ccccccccccccccccccccccchhccccCCCCCccccCHHHHhc---CCCCCcccccchHHHHHHHHHhcccccccccc
Confidence            4321100000        000000022345578999999998753   3468999999999999999998443       


Q ss_pred             ----CCCCCCCc----------------hhHHHHHHHhhcc--------------------CCCC-------CCCCCCHH
Q 019650          263 ----PLIGFGEK----------------PDLMALICAICFG--------------------ERLE-------MPETASPE  295 (337)
Q Consensus       263 ----pf~~~~~~----------------~~~~~~~~~~~~~--------------------~~~~-------~~~~~~~~  295 (337)
                          +|.+....                .+....+......                    ....       ..+..++.
T Consensus       258 ~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  337 (432)
T 3n9x_A          258 NRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDD  337 (432)
T ss_dssp             GCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHH
T ss_pred             cccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHH
Confidence                33332110                0000000000000                    0000       11457899


Q ss_pred             HHHHHHHHhhcCcCCCCCHHHHhcCccccccCCCc
Q 019650          296 FRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSS  330 (337)
Q Consensus       296 ~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~~  330 (337)
                      +.+||.+||..||.+|||++|+|+||||++..+..
T Consensus       338 ~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~  372 (432)
T 3n9x_A          338 GINLLESMLKFNPNKRITIDQALDHPYLKDVRKKK  372 (432)
T ss_dssp             HHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCTT
T ss_pred             HHHHHHHHhcCCcccCCCHHHHhcChhhhhccCcc
Confidence            99999999999999999999999999999876543

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=8.6e-49  Score=366.10  Aligned_cols=263  Identities=28%  Similarity=0.390  Sum_probs=220.6

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeE
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEI  121 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~  121 (337)
                      ...++|++.+.||+|+||+||+|.+..+++.||+|++....  .....+.+.+|+.++++++||||+++++++.+ ....
T Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~  101 (484)
T 3nyv_A           23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFED-KGYF  101 (484)
T ss_dssp             CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEE
T ss_pred             cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEe-CCEE
Confidence            45689999999999999999999999999999999986543  23346778899999999999999999998876 7889


Q ss_pred             EEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEE---cCCCcEEEeeccCccchhc
Q 019650          122 CFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLI---NGKGEVKIADFGVSRIVEE  198 (337)
Q Consensus       122 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili---~~~~~~~l~Dfg~~~~~~~  198 (337)
                      ++||||+.+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||++   +.++.++|+|||++.....
T Consensus       102 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~  181 (484)
T 3nyv_A          102 YLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA  181 (484)
T ss_dssp             EEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCC
T ss_pred             EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccc
Confidence            9999999999999999988899999999999999999999999999999999999999   4668999999999876543


Q ss_pred             cccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHH
Q 019650          199 TRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALIC  278 (337)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~  278 (337)
                      .               ......+||+.|+|||++.    + .++.++||||||+++|+|++|..||.+.........+ .
T Consensus       182 ~---------------~~~~~~~gt~~y~aPE~~~----~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i-~  240 (484)
T 3nyv_A          182 S---------------KKMKDKIGTAYYIAPEVLH----G-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKV-E  240 (484)
T ss_dssp             C---------------CSHHHHTTGGGTCCHHHHH----T-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-H
T ss_pred             c---------------cccccCCCCccccCceeec----C-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHH-H
Confidence            2               1222345899999999987    2 5889999999999999999999999765433222222 2


Q ss_pred             HhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCC
Q 019650          279 AICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSS  328 (337)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~  328 (337)
                      ..........+..+++.+++||.+||..||.+|||++++|+||||++...
T Consensus       241 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~  290 (484)
T 3nyv_A          241 KGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTK  290 (484)
T ss_dssp             HCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC
T ss_pred             cCCCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhccccc
Confidence            21111122223467899999999999999999999999999999997654

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=4.4e-48  Score=337.60  Aligned_cols=266  Identities=30%  Similarity=0.481  Sum_probs=205.0

Q ss_pred             ccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHH-HHHHHHHHHHhcCCCCceeeeeeEEeeCCeE
Q 019650           43 VENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRH-QAAHEAEILKRLDSQFIVKCHAVFYTIEGEI  121 (337)
Q Consensus        43 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~-~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~  121 (337)
                      ....++|++.+.||+|+||+||+|.+..+++.||+|++.......... .+..+...++.++|+||+++++++.+ ....
T Consensus         3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~-~~~~   81 (290)
T 3fme_A            3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFR-EGDV   81 (290)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSSE
T ss_pred             cccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeec-cCCE
Confidence            355789999999999999999999999999999999997664333333 34445555788899999999998876 6889


Q ss_pred             EEEEeccCCCCchHHhhh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCCeEEcCCCcEEEeeccCccch
Q 019650          122 CFVMEHMERGSLFDSLRV----RKKLSEDVISGVAYRVLKGLQYLHGM-QIIHGDIKPSNLLINGKGEVKIADFGVSRIV  196 (337)
Q Consensus       122 ~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~~-~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~  196 (337)
                      ++||||+++ +|.+++..    ...+++..++.++.|++.||+|||++ |++||||||+||+++.+++++|+|||.+...
T Consensus        82 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  160 (290)
T 3fme_A           82 WICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL  160 (290)
T ss_dssp             EEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred             EEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence            999999975 88777653    46899999999999999999999998 9999999999999999999999999999776


Q ss_pred             hccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHH
Q 019650          197 EETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMAL  276 (337)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~  276 (337)
                      .....               .....+++.|+|||.+.....+..++.++||||||+++|+|++|..||.......  ...
T Consensus       161 ~~~~~---------------~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~  223 (290)
T 3fme_A          161 VDDVA---------------KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPF--QQL  223 (290)
T ss_dssp             ------------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHH--HHH
T ss_pred             ccccc---------------ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchH--HHH
Confidence            54321               1122589999999997432224578999999999999999999999997543322  222


Q ss_pred             HHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccC
Q 019650          277 ICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRS  327 (337)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~  327 (337)
                      ...............++..+.+++.+||+.||.+|||++++++||||+...
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~~  274 (290)
T 3fme_A          224 KQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHE  274 (290)
T ss_dssp             HHHHHSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred             HHHhccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccCc
Confidence            222333333333456799999999999999999999999999999998754

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.2e-47  Score=336.15  Aligned_cols=269  Identities=26%  Similarity=0.388  Sum_probs=218.8

Q ss_pred             ccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCc--------hHhHHHHHHHHHHHHhcC-CCCceeeeee
Q 019650           43 VENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSS--------TIIRHQAAHEAEILKRLD-SQFIVKCHAV  113 (337)
Q Consensus        43 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~e~~~~~~l~-~~~i~~~~~~  113 (337)
                      ....++|++.+.||.|++|.||+|.+..+++.||+|++.....        ....+.+.+|+.+++++. |+||++++++
T Consensus        13 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~   92 (298)
T 1phk_A           13 HGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDT   92 (298)
T ss_dssp             --CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred             cchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeee
Confidence            4557899999999999999999999999999999999976531        233456778999999995 9999999998


Q ss_pred             EEeeCCeEEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCc
Q 019650          114 FYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVS  193 (337)
Q Consensus       114 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~  193 (337)
                      +.. ....++||||+++++|.+++.....+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||.+
T Consensus        93 ~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~  171 (298)
T 1phk_A           93 YET-NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFS  171 (298)
T ss_dssp             EEC-SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred             ecc-CCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccch
Confidence            765 7889999999999999999998889999999999999999999999999999999999999999999999999998


Q ss_pred             cchhccccCCCCCCCCCCccccccccccCCCCCcCCccccccc--CCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCch
Q 019650          194 RIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSER--WGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP  271 (337)
Q Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~  271 (337)
                      .......               ......+++.|+|||.+....  ....++.++||||||+++|+|++|..||.......
T Consensus       172 ~~~~~~~---------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~  236 (298)
T 1phk_A          172 CQLDPGE---------------KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML  236 (298)
T ss_dssp             EECCTTC---------------CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred             hhcCCCc---------------ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHH
Confidence            7654321               112235899999999985211  02457889999999999999999999997643322


Q ss_pred             hHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCC
Q 019650          272 DLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSS  328 (337)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~  328 (337)
                      .. .................++..+.+++.+||+.||.+|||++++++||||++...
T Consensus       237 ~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  292 (298)
T 1phk_A          237 ML-RMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVV  292 (298)
T ss_dssp             HH-HHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC-
T ss_pred             HH-HHHhcCCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhccc
Confidence            22 222111111111222457899999999999999999999999999999997653

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=6.9e-48  Score=344.53  Aligned_cols=265  Identities=25%  Similarity=0.389  Sum_probs=213.4

Q ss_pred             CccccccccccccCcceEEEEEEEccCCceEEEEEeecCC-chHhHHHHHHHHHHHHhcCC--CCceeeeeeEEeeCCeE
Q 019650           45 NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-STIIRHQAAHEAEILKRLDS--QFIVKCHAVFYTIEGEI  121 (337)
Q Consensus        45 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~~--~~i~~~~~~~~~~~~~~  121 (337)
                      .-++|++++.||+|+||+||++.+ .++..||+|++.... .....+.+.+|+.+++++.|  +||+++++++.. ....
T Consensus         7 ~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~-~~~~   84 (343)
T 3dbq_A            7 KGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT-DQYI   84 (343)
T ss_dssp             SSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-SSEE
T ss_pred             ecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEee-CCEE
Confidence            457899999999999999999988 468889999997654 34455778899999999987  899999998776 7889


Q ss_pred             EEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhcccc
Q 019650          122 CFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRN  201 (337)
Q Consensus       122 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~  201 (337)
                      ++|||+ .+++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||+++ ++.++|+|||++........
T Consensus        85 ~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~  162 (343)
T 3dbq_A           85 YMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT  162 (343)
T ss_dssp             EEEECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-----
T ss_pred             EEEEeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCcccc
Confidence            999995 4679999999888999999999999999999999999999999999999997 67899999999987644321


Q ss_pred             CCCCCCCCCCccccccccccCCCCCcCCccccccc-------CCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHH
Q 019650          202 NNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSER-------WGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLM  274 (337)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-------~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~  274 (337)
                      .            .......||+.|+|||++....       ....++.++||||||+++|+|++|..||....+.  ..
T Consensus       163 ~------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~  228 (343)
T 3dbq_A          163 S------------VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ--IS  228 (343)
T ss_dssp             -------------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH--HH
T ss_pred             c------------ccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH--HH
Confidence            1            1122346899999999986310       0146888999999999999999999999754332  22


Q ss_pred             HHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccC
Q 019650          275 ALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRS  327 (337)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~  327 (337)
                      .............++...+..+.+++.+||..||.+|||+.++|+||||+...
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  281 (343)
T 3dbq_A          229 KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT  281 (343)
T ss_dssp             HHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred             HHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccC
Confidence            22233333445566777788999999999999999999999999999998654

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1e-47  Score=334.65  Aligned_cols=255  Identities=21%  Similarity=0.304  Sum_probs=212.2

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCceEEEEEeecCC-chHhHHHHHHHHHHHHhc-CCCCceeeeeeEEeeCCeE
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-STIIRHQAAHEAEILKRL-DSQFIVKCHAVFYTIEGEI  121 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~  121 (337)
                      ...++|++.+.||+|+||+||+|.+..+++.||+|++.... .......+.+|+..+..+ +||||+++++++.+ ....
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~-~~~~   86 (289)
T 1x8b_A            8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAE-DDHM   86 (289)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEE-TTEE
T ss_pred             cccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeec-CCeE
Confidence            34589999999999999999999999999999999997653 233456777899999999 99999999998876 7899


Q ss_pred             EEEEeccCCCCchHHhhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCC---------------
Q 019650          122 CFVMEHMERGSLFDSLRVR----KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGK---------------  182 (337)
Q Consensus       122 ~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~---------------  182 (337)
                      ++||||+++++|.+++...    ..+++..++.++.||+.||.|||++|++|+||||+||+++.+               
T Consensus        87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~  166 (289)
T 1x8b_A           87 LIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDW  166 (289)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-----------------
T ss_pred             EEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence            9999999999999999765    679999999999999999999999999999999999999844               


Q ss_pred             ----CcEEEeeccCccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHH
Q 019650          183 ----GEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECL  258 (337)
Q Consensus       183 ----~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~  258 (337)
                          ..++|+|||.+.......                  ...+++.|+|||.+...   ..++.++||||||+++|+|+
T Consensus       167 ~~~~~~~kl~Dfg~~~~~~~~~------------------~~~gt~~y~aPE~~~~~---~~~~~~~Di~slG~il~~l~  225 (289)
T 1x8b_A          167 ASNKVMFKIGDLGHVTRISSPQ------------------VEEGDSRFLANEVLQEN---YTHLPKADIFALALTVVCAA  225 (289)
T ss_dssp             ---CCCEEECCCTTCEETTCSC------------------CCCCCGGGCCHHHHTTC---CTTHHHHHHHHHHHHHHHHT
T ss_pred             cCCceEEEEcccccccccCCcc------------------ccCCCccccChhHhcCC---CCCCchhhHHHHHHHHHHHh
Confidence                479999999987764322                  12489999999999742   25667999999999999999


Q ss_pred             hCCCCCCCCCCchhHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccC
Q 019650          259 VGHYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRS  327 (337)
Q Consensus       259 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~  327 (337)
                      +|..++...   ..    ......+..+..+..+++.+.++|.+||+.||.+|||++++++||||++..
T Consensus       226 ~~~~~~~~~---~~----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  287 (289)
T 1x8b_A          226 GAEPLPRNG---DQ----WHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSAS  287 (289)
T ss_dssp             TCCCCCSSS---HH----HHHHHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC----
T ss_pred             cCCCCCcch---hH----HHHHHcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhhc
Confidence            998776331   22    222333445566778899999999999999999999999999999999764

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=6.8e-48  Score=347.21  Aligned_cols=262  Identities=24%  Similarity=0.406  Sum_probs=214.6

Q ss_pred             cccccccccccCcceEEEEEEEccCCceEEEEEeecCCc-------hHhHHHHHHHHHHHHhc-CCCCceeeeeeEEeeC
Q 019650           47 SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSS-------TIIRHQAAHEAEILKRL-DSQFIVKCHAVFYTIE  118 (337)
Q Consensus        47 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~  118 (337)
                      ++|.+.+.||.|++|+||+|.+..+|+.||+|++.....       ....+.+.+|+.+++++ +|+||+++++++.. .
T Consensus        94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-~  172 (365)
T 2y7j_A           94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES-S  172 (365)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEB-S
T ss_pred             hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEee-C
Confidence            679999999999999999999998999999999876531       12345677899999999 89999999998766 7


Q ss_pred             CeEEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhc
Q 019650          119 GEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEE  198 (337)
Q Consensus       119 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~  198 (337)
                      ...++||||++|++|.+++.....+++..+..++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++.....
T Consensus       173 ~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~  252 (365)
T 2y7j_A          173 SFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP  252 (365)
T ss_dssp             SEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred             CEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCC
Confidence            88999999999999999999888999999999999999999999999999999999999999999999999999877643


Q ss_pred             cccCCCCCCCCCCccccccccccCCCCCcCCcccccccC--CCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHH
Q 019650          199 TRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERW--GGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMAL  276 (337)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~  276 (337)
                      ..               ......|++.|+|||++.....  ...++.++||||||+++|+|++|..||.......... .
T Consensus       253 ~~---------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~-~  316 (365)
T 2y7j_A          253 GE---------------KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLR-M  316 (365)
T ss_dssp             TC---------------CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-H
T ss_pred             Cc---------------ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHH-H
Confidence            32               1123468999999999863210  2357889999999999999999999996543222211 1


Q ss_pred             HHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccc
Q 019650          277 ICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTK  325 (337)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~  325 (337)
                      ............+...+..+.++|.+||..||.+|||++++|+||||+.
T Consensus       317 i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r  365 (365)
T 2y7j_A          317 IMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER  365 (365)
T ss_dssp             HHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             HHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence            1111111111112467889999999999999999999999999999973

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=3e-48  Score=340.73  Aligned_cols=273  Identities=29%  Similarity=0.439  Sum_probs=218.3

Q ss_pred             ccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEE
Q 019650           43 VENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEIC  122 (337)
Q Consensus        43 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~  122 (337)
                      ....++|++.+.||.|+||+||+|.+..++..||+|++.... ....+.+.+|+.+++.++|+||+++++++.. ....+
T Consensus        15 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   92 (302)
T 2j7t_A           15 LDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS-EEELEDYIVEIEILATCDHPYIVKLLGAYYH-DGKLW   92 (302)
T ss_dssp             SCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-----CCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-C-CEE
T ss_pred             cCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC-HHHHHHHHHHHHHHhcCCCCCEeeeeeeeee-CCeEE
Confidence            456789999999999999999999999999999999987543 3345678889999999999999999998876 67899


Q ss_pred             EEEeccCCCCchHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhcccc
Q 019650          123 FVMEHMERGSLFDSLRV-RKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRN  201 (337)
Q Consensus       123 lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~  201 (337)
                      +||||+++++|.+++.. ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....... 
T Consensus        93 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  171 (302)
T 2j7t_A           93 IMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL-  171 (302)
T ss_dssp             EEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH-
T ss_pred             EEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccccc-
Confidence            99999999999998875 4679999999999999999999999999999999999999999999999999876543322 


Q ss_pred             CCCCCCCCCCccccccccccCCCCCcCCccccccc-CCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHh
Q 019650          202 NNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSER-WGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAI  280 (337)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~  280 (337)
                                   .......+++.|+|||.+.... .+..++.++||||||+++|+|++|..||..............  
T Consensus       172 -------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--  236 (302)
T 2j7t_A          172 -------------QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK--  236 (302)
T ss_dssp             -------------HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH--
T ss_pred             -------------cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhc--
Confidence                         1112235899999999984210 034678899999999999999999999976443222222111  


Q ss_pred             hccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCCcccc
Q 019650          281 CFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNIE  333 (337)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~~~~~  333 (337)
                      ........+..++..+.++|.+||+.||.+|||++++++||||++......+.
T Consensus       237 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~~~  289 (302)
T 2j7t_A          237 SDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNKALR  289 (302)
T ss_dssp             SCCCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCCCCHHHH
T ss_pred             cCCcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhccchhHH
Confidence            11111223456788999999999999999999999999999999877655443

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=5.6e-48  Score=347.39  Aligned_cols=258  Identities=25%  Similarity=0.380  Sum_probs=210.5

Q ss_pred             CCccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcC-----CCCceeeeeeEE
Q 019650           41 PDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLD-----SQFIVKCHAVFY  115 (337)
Q Consensus        41 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-----~~~i~~~~~~~~  115 (337)
                      +.....++|++++.||+|+||+||+|.+..+++.||+|++...  .........|+.+++.+.     |+||+++++.+.
T Consensus        29 ~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~  106 (360)
T 3llt_A           29 KGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI--KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFM  106 (360)
T ss_dssp             TTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC--HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEE
T ss_pred             cceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc--hhhhhhhHHHHHHHHHhcccCCCCCCeecccceee
Confidence            3345568999999999999999999999999999999998743  334556677999999986     999999999887


Q ss_pred             eeCCeEEEEEeccCCCCchHHhhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcC------------
Q 019650          116 TIEGEICFVMEHMERGSLFDSLRVRK--KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLING------------  181 (337)
Q Consensus       116 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~------------  181 (337)
                      . ....++|||++ +++|.+++....  .+++..++.++.||+.||+|||++||+||||||+||+++.            
T Consensus       107 ~-~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~  184 (360)
T 3llt_A          107 Y-YDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRR  184 (360)
T ss_dssp             E-TTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEEC
T ss_pred             E-CCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhc
Confidence            7 68899999999 889999998654  5999999999999999999999999999999999999975            


Q ss_pred             -------------CCcEEEeeccCccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHH
Q 019650          182 -------------KGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVW  248 (337)
Q Consensus       182 -------------~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Diw  248 (337)
                                   ++.++|+|||++.......                 ....||+.|+|||++.    +..++.++|||
T Consensus       185 ~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----------------~~~~gt~~y~aPE~~~----~~~~~~~~Diw  243 (360)
T 3llt_A          185 VTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-----------------GSIINTRQYRAPEVIL----NLGWDVSSDMW  243 (360)
T ss_dssp             TTTCCEEEEEEESCCCEEECCCTTCEETTSCC-----------------CSCCSCGGGCCHHHHT----TCCCCTTHHHH
T ss_pred             ccccccccccccCCCCEEEEeccCceecCCCC-----------------cCccCcccccCcHHHc----CCCCCCccchH
Confidence                         7899999999997643321                 2335899999999998    55789999999


Q ss_pred             HHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhccCCC----------------------CCC-----------------
Q 019650          249 SLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERL----------------------EMP-----------------  289 (337)
Q Consensus       249 slG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~----------------------~~~-----------------  289 (337)
                      |||+++|+|++|+.||........... +.......+.                      .++                 
T Consensus       244 slG~il~ell~g~~pf~~~~~~~~~~~-~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~  322 (360)
T 3llt_A          244 SFGCVLAELYTGSLLFRTHEHMEHLAM-MESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLP  322 (360)
T ss_dssp             HHHHHHHHHHHSSCSCCCSSHHHHHHH-HHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCC
T ss_pred             HHHHHHHHHHHCCCCCCCCcHHHHHHH-HHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhccc
Confidence            999999999999999976543322222 2221111000                      001                 


Q ss_pred             ---CCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCcccc
Q 019650          290 ---ETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVT  324 (337)
Q Consensus       290 ---~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~  324 (337)
                         ...++.+.+||.+||+.||.+|||++|+|+||||+
T Consensus       323 ~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~  360 (360)
T 3llt_A          323 LYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE  360 (360)
T ss_dssp             HHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred             ccccchHHHHHHHHHHHhcCChhhCCCHHHHhcCcccC
Confidence               11236788999999999999999999999999996

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=6.3e-48  Score=334.82  Aligned_cols=263  Identities=27%  Similarity=0.415  Sum_probs=220.7

Q ss_pred             CccccccccccccCcceEEEEEEEccCCceEEEEEeecCC-chHhHHHHHHHHHHHHhcCCCCceeeeeeEEe-eCCeEE
Q 019650           45 NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-STIIRHQAAHEAEILKRLDSQFIVKCHAVFYT-IEGEIC  122 (337)
Q Consensus        45 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-~~~~~~  122 (337)
                      ..++|++.+.||+|+||+||+|.+..+++.||+|++.... .....+.+.+|+.++++++|+||+++++.+.. .....+
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   83 (279)
T 2w5a_A            4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY   83 (279)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred             chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence            4689999999999999999999999999999999997654 34456778899999999999999999998764 346789


Q ss_pred             EEEeccCCCCchHHhhhcC----CCCHHHHHHHHHHHHHHHHHHHhCC-----ceeccCCCCCeEEcCCCcEEEeeccCc
Q 019650          123 FVMEHMERGSLFDSLRVRK----KLSEDVISGVAYRVLKGLQYLHGMQ-----IIHGDIKPSNLLINGKGEVKIADFGVS  193 (337)
Q Consensus       123 lv~e~~~~~~L~~~l~~~~----~l~~~~~~~i~~~l~~~l~~LH~~~-----ivH~dl~~~Nili~~~~~~~l~Dfg~~  193 (337)
                      +||||+++++|.+++....    .+++..++.++.|++.||.|||+.|     ++|+||+|+||+++.+++++|+|||.+
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~  163 (279)
T 2w5a_A           84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA  163 (279)
T ss_dssp             EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHH
T ss_pred             EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchh
Confidence            9999999999999997543    4999999999999999999999999     999999999999999999999999998


Q ss_pred             cchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhH
Q 019650          194 RIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDL  273 (337)
Q Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~  273 (337)
                      .......              .......+++.|+|||.+.    +..++.++||||||+++|+|++|..||.....    
T Consensus       164 ~~~~~~~--------------~~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----  221 (279)
T 2w5a_A          164 RILNHDT--------------SFAKTFVGTPYYMSPEQMN----RMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ----  221 (279)
T ss_dssp             HHC---C--------------HHHHHHHSCCTTCCHHHHH----CC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH----
T ss_pred             eeecccc--------------ccccccCCCccccChHHhc----cCCCCchhhHHHHHHHHHHHHHCCCCCcccCH----
Confidence            7654321              1122335899999999998    45788999999999999999999999976432    


Q ss_pred             HHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCC
Q 019650          274 MALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSS  329 (337)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~  329 (337)
                      .........+.....+..++..+.++|.+||+.||.+|||++++++|+|+.....+
T Consensus       222 ~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~~  277 (279)
T 2w5a_A          222 KELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHHHH  277 (279)
T ss_dssp             HHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGGSC
T ss_pred             HHHHHHHhhcccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhccc
Confidence            22233333444556677889999999999999999999999999999999887643

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=3.7e-47  Score=337.91  Aligned_cols=260  Identities=22%  Similarity=0.346  Sum_probs=212.0

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcC-CCCceeeeeeEEee-CCeE
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLD-SQFIVKCHAVFYTI-EGEI  121 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~-~~~~  121 (337)
                      ...++|++.+.||+|+||+||+|.+..+++.||+|++....    .+.+.+|+.+++++. |+||+++++++... ....
T Consensus        33 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~  108 (330)
T 3nsz_A           33 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTP  108 (330)
T ss_dssp             EEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCE
T ss_pred             cCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc----hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCce
Confidence            45689999999999999999999999999999999987543    456788999999997 99999999988763 4568


Q ss_pred             EEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCC-cEEEeeccCccchhccc
Q 019650          122 CFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKG-EVKIADFGVSRIVEETR  200 (337)
Q Consensus       122 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~-~~~l~Dfg~~~~~~~~~  200 (337)
                      ++||||+++++|.+++.   .+++..++.++.||+.||+|||++|++||||||+||+++.++ .++|+|||++.......
T Consensus       109 ~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~  185 (330)
T 3nsz_A          109 ALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ  185 (330)
T ss_dssp             EEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred             EEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC
Confidence            99999999999999985   599999999999999999999999999999999999999776 89999999997654332


Q ss_pred             cCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHh
Q 019650          201 NNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAI  280 (337)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~  280 (337)
                      .               .....++..|+|||.+...   ..++.++||||||+++|+|++|..||................
T Consensus       186 ~---------------~~~~~~~~~y~aPE~~~~~---~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~  247 (330)
T 3nsz_A          186 E---------------YNVRVASRYFKGPELLVDY---QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKV  247 (330)
T ss_dssp             C---------------CCSCCSCGGGCCHHHHTTC---CCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHH
T ss_pred             c---------------cccccccccccChhhhcCC---CcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHh
Confidence            1               1223588999999999742   468999999999999999999999996544332222111111


Q ss_pred             hcc---------------------------------CCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccC
Q 019650          281 CFG---------------------------------ERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRS  327 (337)
Q Consensus       281 ~~~---------------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~  327 (337)
                      ...                                 .....+..++..+.+||.+||+.||.+|||++|+|+||||++..
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~  327 (330)
T 3nsz_A          248 LGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV  327 (330)
T ss_dssp             HCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred             cCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhc
Confidence            000                                 00011223689999999999999999999999999999999865


Q ss_pred             C
Q 019650          328 S  328 (337)
Q Consensus       328 ~  328 (337)
                      +
T Consensus       328 ~  328 (330)
T 3nsz_A          328 K  328 (330)
T ss_dssp             -
T ss_pred             c
Confidence            4

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=6.3e-48  Score=337.51  Aligned_cols=264  Identities=25%  Similarity=0.300  Sum_probs=211.0

Q ss_pred             CCccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeC
Q 019650           41 PDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIE  118 (337)
Q Consensus        41 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~  118 (337)
                      ......++|++++.||+|+||+||+|.+..++..||+|++....  .....+.+.+|+.++++++||||+++++++.+ +
T Consensus         5 ~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-~   83 (294)
T 4eqm_A            5 IGKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEE-D   83 (294)
T ss_dssp             CSSCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEEC-S
T ss_pred             hhhHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeee-C
Confidence            34455689999999999999999999999999999999986543  34456778899999999999999999998765 7


Q ss_pred             CeEEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhc
Q 019650          119 GEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEE  198 (337)
Q Consensus       119 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~  198 (337)
                      ...++||||++|++|.+++...+++++..++.++.|++.||+|||++|++||||||+||+++.+++++|+|||++.....
T Consensus        84 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  163 (294)
T 4eqm_A           84 DCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSE  163 (294)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred             CeEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence            88999999999999999999888999999999999999999999999999999999999999999999999999976643


Q ss_pred             cccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHH
Q 019650          199 TRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALIC  278 (337)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~  278 (337)
                      ...             .......|++.|+|||.+.    +..++.++||||||+++|+|++|+.||..............
T Consensus       164 ~~~-------------~~~~~~~gt~~y~aPE~~~----~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~  226 (294)
T 4eqm_A          164 TSL-------------TQTNHVLGTVQYFSPEQAK----GEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQ  226 (294)
T ss_dssp             ------------------------CCSSCCHHHHH----TCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHS
T ss_pred             ccc-------------cccCccccCccccCHhHhc----CCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhh
Confidence            221             1122345899999999998    45788999999999999999999999976433222222211


Q ss_pred             HhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCcc
Q 019650          279 AICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPF  322 (337)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~  322 (337)
                      ..........+..+++.+.++|.+||+.||.+||+..+.+.+.+
T Consensus       227 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l  270 (294)
T 4eqm_A          227 DSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDL  270 (294)
T ss_dssp             SCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHH
T ss_pred             ccCCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHH
Confidence            11111112245678999999999999999999995555555444

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1.1e-47  Score=338.07  Aligned_cols=264  Identities=27%  Similarity=0.371  Sum_probs=209.4

Q ss_pred             CccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCC-chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCe
Q 019650           42 DVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGE  120 (337)
Q Consensus        42 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~  120 (337)
                      .....++|++.+.||+|+||+||+|.+  ++..||+|++.... .....+.+.+|+.++++++|+||+++++++.. ...
T Consensus        32 ~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~  108 (309)
T 3p86_A           32 MDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQ-PPN  108 (309)
T ss_dssp             CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-TTC
T ss_pred             ccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-CCc
Confidence            345578999999999999999999977  57889999987654 34455678899999999999999999998866 678


Q ss_pred             EEEEEeccCCCCchHHhhhcCC---CCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCCeEEcCCCcEEEeeccCccc
Q 019650          121 ICFVMEHMERGSLFDSLRVRKK---LSEDVISGVAYRVLKGLQYLHGMQ--IIHGDIKPSNLLINGKGEVKIADFGVSRI  195 (337)
Q Consensus       121 ~~lv~e~~~~~~L~~~l~~~~~---l~~~~~~~i~~~l~~~l~~LH~~~--ivH~dl~~~Nili~~~~~~~l~Dfg~~~~  195 (337)
                      .++||||+++++|.+++.....   +++..++.++.|++.||+|||+.|  ++||||||+||+++.++.++|+|||++..
T Consensus       109 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~  188 (309)
T 3p86_A          109 LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL  188 (309)
T ss_dssp             CEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC----
T ss_pred             eEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCcc
Confidence            9999999999999999986543   999999999999999999999999  99999999999999999999999999875


Q ss_pred             hhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHH
Q 019650          196 VEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMA  275 (337)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~  275 (337)
                      .....              .......|++.|+|||++.    +..++.++||||||+++|+|++|..||.......... 
T Consensus       189 ~~~~~--------------~~~~~~~gt~~y~aPE~~~----~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~-  249 (309)
T 3p86_A          189 KASTF--------------LSSKSAAGTPEWMAPEVLR----DEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVA-  249 (309)
T ss_dssp             ---------------------------CCTTSCHHHHT----TCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHH-
T ss_pred             ccccc--------------cccccCCCCccccChhhhc----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-
Confidence            44321              1122345899999999998    4578899999999999999999999997643322211 


Q ss_pred             HHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhc--CccccccCCC
Q 019650          276 LICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA--YPFVTKRSSS  329 (337)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~--hp~f~~~~~~  329 (337)
                        ...........+..++..+.++|.+||+.||.+|||++++++  .+++++...+
T Consensus       250 --~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~  303 (309)
T 3p86_A          250 --AVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPP  303 (309)
T ss_dssp             --HHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-----
T ss_pred             --HHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCC
Confidence              112234456677888999999999999999999999999998  5666655433

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1.3e-48  Score=344.60  Aligned_cols=269  Identities=23%  Similarity=0.267  Sum_probs=213.7

Q ss_pred             ccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCC-
Q 019650           43 VENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEG-  119 (337)
Q Consensus        43 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~-  119 (337)
                      ....++|++.+.||.|+||+||+|.+..+++.||+|++....  .......+.+|+.++++++|+||+++++.+..... 
T Consensus         8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   87 (311)
T 3ork_A            8 SHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPA   87 (311)
T ss_dssp             SEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETT
T ss_pred             ceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCC
Confidence            345689999999999999999999999999999999997653  33445678899999999999999999998876433 


Q ss_pred             --eEEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchh
Q 019650          120 --EICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVE  197 (337)
Q Consensus       120 --~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~  197 (337)
                        ..|+||||++|++|.+++...+.+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++....
T Consensus        88 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~  167 (311)
T 3ork_A           88 GPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA  167 (311)
T ss_dssp             EEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC----
T ss_pred             CcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccccc
Confidence              359999999999999999988899999999999999999999999999999999999999999999999999998765


Q ss_pred             ccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHH
Q 019650          198 ETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALI  277 (337)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~  277 (337)
                      ......           .......|++.|+|||++.    +..++.++||||||+++|+|++|+.||.............
T Consensus       168 ~~~~~~-----------~~~~~~~gt~~y~aPE~~~----~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~  232 (311)
T 3ork_A          168 DSGNSV-----------TQTAAVIGTAQYLSPEQAR----GDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV  232 (311)
T ss_dssp             -------------------------CCTTCCHHHHH----TCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             cccccc-----------ccccccCcCcccCCHHHhc----CCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHh
Confidence            432111           1222346899999999998    5578999999999999999999999997643322222221


Q ss_pred             HHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccC
Q 019650          278 CAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRS  327 (337)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~  327 (337)
                      .. ...........++..+.++|.+||+.||.+||+..+++.|+|++-..
T Consensus       233 ~~-~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~  281 (311)
T 3ork_A          233 RE-DPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN  281 (311)
T ss_dssp             HC-CCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred             cC-CCCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhc
Confidence            11 11111112356789999999999999999999999999999997543

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=4.6e-48  Score=342.25  Aligned_cols=263  Identities=25%  Similarity=0.376  Sum_probs=215.4

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeC-CeEE
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIE-GEIC  122 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~-~~~~  122 (337)
                      ..-++|++.+.||+|+||+||+|.+..+++.||+|++.........+.+.+|+.++++++|+||+++++++.... ...+
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   85 (319)
T 4euu_A            6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV   85 (319)
T ss_dssp             CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred             CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEE
Confidence            446799999999999999999999999999999999976554445667789999999999999999999887643 3789


Q ss_pred             EEEeccCCCCchHHhhhcCC---CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEE----cCCCcEEEeeccCccc
Q 019650          123 FVMEHMERGSLFDSLRVRKK---LSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLI----NGKGEVKIADFGVSRI  195 (337)
Q Consensus       123 lv~e~~~~~~L~~~l~~~~~---l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili----~~~~~~~l~Dfg~~~~  195 (337)
                      +||||+++++|.+++.....   +++..++.++.||+.||+|||+.|++|+||||+||++    +.++.++|+|||++..
T Consensus        86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~  165 (319)
T 4euu_A           86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE  165 (319)
T ss_dssp             EEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred             EEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence            99999999999999986543   9999999999999999999999999999999999999    7777899999999987


Q ss_pred             hhccccCCCCCCCCCCccccccccccCCCCCcCCcccccc----cCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCch
Q 019650          196 VEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSE----RWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP  271 (337)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~  271 (337)
                      .....               ......+++.|+|||.+...    ..+..++.++||||||+++|+|++|..||.......
T Consensus       166 ~~~~~---------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~  230 (319)
T 4euu_A          166 LEDDE---------------QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR  230 (319)
T ss_dssp             CCTTC---------------CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGG
T ss_pred             cCCCC---------------ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccc
Confidence            64432               11233589999999998521    002467889999999999999999999997655555


Q ss_pred             hHHHHHHHhhccCCCC------------------------CCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCc
Q 019650          272 DLMALICAICFGERLE------------------------MPETASPEFRRFVRSCLEKDWRKRGTVEELLAYP  321 (337)
Q Consensus       272 ~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp  321 (337)
                      .....+.....+.+..                        .....+..+.+++.+||+.||++|||++|+|+||
T Consensus       231 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~  304 (319)
T 4euu_A          231 RNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET  304 (319)
T ss_dssp             GCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred             hhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence            4445554444333211                        1122346789999999999999999999999997

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=2.4e-47  Score=346.45  Aligned_cols=264  Identities=25%  Similarity=0.388  Sum_probs=212.3

Q ss_pred             ccccccccccccCcceEEEEEEEccCCceEEEEEeecCC-chHhHHHHHHHHHHHHhcC--CCCceeeeeeEEeeCCeEE
Q 019650           46 ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-STIIRHQAAHEAEILKRLD--SQFIVKCHAVFYTIEGEIC  122 (337)
Q Consensus        46 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~--~~~i~~~~~~~~~~~~~~~  122 (337)
                      .++|++++.||+|+||+||+|.+.. +..||+|++.... .....+.+.+|+.+++++.  |+||+++++++.. ...++
T Consensus        55 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~-~~~~~  132 (390)
T 2zmd_A           55 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT-DQYIY  132 (390)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-SSEEE
T ss_pred             CCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEec-CCEEE
Confidence            4579999999999999999999865 8899999997654 3445677889999999997  4999999998776 67899


Q ss_pred             EEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccC
Q 019650          123 FVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNN  202 (337)
Q Consensus       123 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~  202 (337)
                      +||| +.+++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++ ++.++|+|||++.........
T Consensus       133 lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~  210 (390)
T 2zmd_A          133 MVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS  210 (390)
T ss_dssp             EEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC------
T ss_pred             EEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCcc
Confidence            9999 45779999999888999999999999999999999999999999999999995 589999999999876433211


Q ss_pred             CCCCCCCCCccccccccccCCCCCcCCcccccccC-------CCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHH
Q 019650          203 NNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERW-------GGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMA  275 (337)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-------~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~  275 (337)
                                  ......+||+.|+|||++.....       ...++.++||||||+++|+|++|..||....+..  ..
T Consensus       211 ------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~--~~  276 (390)
T 2zmd_A          211 ------------VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI--SK  276 (390)
T ss_dssp             ---------------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH--HH
T ss_pred             ------------ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH--HH
Confidence                        11223469999999999874210       1368899999999999999999999997643322  22


Q ss_pred             HHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccC
Q 019650          276 LICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRS  327 (337)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~  327 (337)
                      ............++...+..+.+||.+||..||.+|||+.++|+||||+...
T Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~  328 (390)
T 2zmd_A          277 LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT  328 (390)
T ss_dssp             HHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred             HHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccC
Confidence            2222223334455666788999999999999999999999999999998654

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=5.2e-48  Score=338.99  Aligned_cols=279  Identities=24%  Similarity=0.403  Sum_probs=210.8

Q ss_pred             ccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEee--------
Q 019650           46 ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTI--------  117 (337)
Q Consensus        46 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--------  117 (337)
                      .++|++++.||+|+||+||+|.+..+++.||+|++...  ....+.+.+|+.++++++|+||+++++.+.+.        
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT--EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT   82 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc--HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence            57899999999999999999999999999999999653  34457788999999999999999999987652        


Q ss_pred             ----CCeEEEEEeccCCCCchHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccC
Q 019650          118 ----EGEICFVMEHMERGSLFDSLRVR-KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGV  192 (337)
Q Consensus       118 ----~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~  192 (337)
                          ....++||||+++++|.+++... ..+++..++.++.|++.||+|||++|++|+||+|+||+++.++.++|+|||.
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~  162 (303)
T 1zy4_A           83 AVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGL  162 (303)
T ss_dssp             ---CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred             ccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCcc
Confidence                34689999999999999999754 4688999999999999999999999999999999999999999999999999


Q ss_pred             ccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchh
Q 019650          193 SRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPD  272 (337)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~  272 (337)
                      +............................+++.|+|||.+...   ..++.++||||||+++|+|++   ||....+...
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~  236 (303)
T 1zy4_A          163 AKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGT---GHYNEKIDMYSLGIIFFEMIY---PFSTGMERVN  236 (303)
T ss_dssp             CSCTTC-------------------------CTTSCHHHHTSC---SCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred             hhhcccccchhccccccccccccccccCCCcccccCcccccCC---CCCcchhhHHHHHHHHHHHHh---ccCCchhHHH
Confidence            9876533211100000000000222344689999999999732   368899999999999999998   5532212122


Q ss_pred             HHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCCccc
Q 019650          273 LMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNI  332 (337)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~~~~  332 (337)
                      ............+..++...+..+.++|.+||+.||.+|||++++++||||+.......+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~~  296 (303)
T 1zy4_A          237 ILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQDEVI  296 (303)
T ss_dssp             HHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCCCHHHHH
T ss_pred             HHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCCChHHHH
Confidence            222222222222334455667889999999999999999999999999999987655443

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=2.8e-47  Score=343.72  Aligned_cols=257  Identities=24%  Similarity=0.376  Sum_probs=216.7

Q ss_pred             ccCccccccccccccCcceEEEEEEEc-------cCCceEEEEEeecCCchHhHHHHHHHHHHHHhc-CCCCceeeeeeE
Q 019650           43 VENISDLKKLTVLGHGNGGIVYKVRHQ-------KSNSIYALKVLNTTSSTIIRHQAAHEAEILKRL-DSQFIVKCHAVF  114 (337)
Q Consensus        43 ~~~~~~y~~~~~lg~g~~~~v~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~  114 (337)
                      ....++|++.+.||+|+||+||+|.+.       .++..||+|+++........+.+.+|+.+++++ +||||+++++++
T Consensus        77 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~  156 (370)
T 2psq_A           77 EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC  156 (370)
T ss_dssp             BCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred             cccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence            455689999999999999999999874       345679999998776666677889999999999 899999999987


Q ss_pred             EeeCCeEEEEEeccCCCCchHHhhhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeE
Q 019650          115 YTIEGEICFVMEHMERGSLFDSLRVRK----------------KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLL  178 (337)
Q Consensus       115 ~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nil  178 (337)
                      .. ...+|+||||+++|+|.+++....                .+++..+..++.||+.||.|||++||+||||||+||+
T Consensus       157 ~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIl  235 (370)
T 2psq_A          157 TQ-DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL  235 (370)
T ss_dssp             CS-SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEE
T ss_pred             cc-CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEE
Confidence            66 678999999999999999997643                4789999999999999999999999999999999999


Q ss_pred             EcCCCcEEEeeccCccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHH
Q 019650          179 INGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECL  258 (337)
Q Consensus       179 i~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~  258 (337)
                      ++.++.++|+|||++.........            .......+++.|+|||++.    +..++.++||||||+++|+|+
T Consensus       236 l~~~~~~kl~DFG~a~~~~~~~~~------------~~~~~~~~t~~y~aPE~~~----~~~~~~~~DvwslG~il~ell  299 (370)
T 2psq_A          236 VTENNVMKIADFGLARDINNIDYY------------KKTTNGRLPVKWMAPEALF----DRVYTHQSDVWSFGVLMWEIF  299 (370)
T ss_dssp             ECTTCCEEECCCSSCEETTCCCTT------------CTTTTTTSCGGGCCHHHHH----TCCCCHHHHHHHHHHHHHHHH
T ss_pred             ECCCCCEEEccccCCcccCcccce------------ecccCCCcccceECHhHhc----CCCCCcHHHHHHHHHHHHHHH
Confidence            999999999999999866443211            1112234678999999998    557899999999999999999


Q ss_pred             h-CCCCCCCCCCchhHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          259 V-GHYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       259 t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                      + |..||.......    .......+.....+..++..+.++|.+||..||.+|||+++++++
T Consensus       300 t~g~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~  358 (370)
T 2psq_A          300 TLGGSPYPGIPVEE----LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  358 (370)
T ss_dssp             TTSCCSSTTCCGGG----HHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCCCCCCCCCCHHH----HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            9 999997654332    222333445566777889999999999999999999999999875

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.5e-47  Score=339.66  Aligned_cols=259  Identities=25%  Similarity=0.384  Sum_probs=215.7

Q ss_pred             CccCccccccccccccCcceEEEEEEEccCCc---eEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeC
Q 019650           42 DVENISDLKKLTVLGHGNGGIVYKVRHQKSNS---IYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIE  118 (337)
Q Consensus        42 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~  118 (337)
                      .....++|++.+.||+|+||+||+|.+..++.   .||+|+++........+.+.+|+.++++++|+||+++++++.+ .
T Consensus        44 ~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~  122 (325)
T 3kul_A           44 REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTR-G  122 (325)
T ss_dssp             CBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG-G
T ss_pred             cccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe-C
Confidence            34567899999999999999999999975554   4999999876666667788999999999999999999998765 6


Q ss_pred             CeEEEEEeccCCCCchHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchh
Q 019650          119 GEICFVMEHMERGSLFDSLRVR-KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVE  197 (337)
Q Consensus       119 ~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~  197 (337)
                      ...++||||+++++|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++....
T Consensus       123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  202 (325)
T 3kul_A          123 RLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE  202 (325)
T ss_dssp             GCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred             CccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence            7889999999999999999654 579999999999999999999999999999999999999999999999999998765


Q ss_pred             ccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCchhHHHH
Q 019650          198 ETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMAL  276 (337)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~~~~~~~~~~~  276 (337)
                      ......           .......+++.|+|||++.    +..++.++||||||+++|+|++ |..||......    ..
T Consensus       203 ~~~~~~-----------~~~~~~~~t~~y~aPE~~~----~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~----~~  263 (325)
T 3kul_A          203 DDPDAA-----------YTTTGGKIPIRWTAPEAIA----FRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR----DV  263 (325)
T ss_dssp             ----CC-----------EECC---CCGGGSCHHHHH----HCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH----HH
T ss_pred             cCccce-----------eeccCCCCcccccCHhHhc----CCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH----HH
Confidence            432111           1112224677899999998    4578899999999999999999 99999664332    23


Q ss_pred             HHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          277 ICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                      ............+..++..+.+++.+||..||.+|||++++++.
T Consensus       264 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  307 (325)
T 3kul_A          264 ISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSV  307 (325)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHcCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            33334445566677889999999999999999999999999874

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1.4e-47  Score=337.72  Aligned_cols=269  Identities=23%  Similarity=0.327  Sum_probs=213.0

Q ss_pred             ccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEE
Q 019650           43 VENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEIC  122 (337)
Q Consensus        43 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~  122 (337)
                      ....++|.+.+.||+|+||+||+|.+..++..||+|.+... .....+.+.+|+.++++++|+||+++++++.+ +...+
T Consensus         6 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~   83 (310)
T 3s95_A            6 IFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF-DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYK-DKRLN   83 (310)
T ss_dssp             EECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-TTEEE
T ss_pred             eeChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCcCcccEEEEEec-CCeeE
Confidence            45678999999999999999999999999999999998654 44566788899999999999999999999876 78899


Q ss_pred             EEEeccCCCCchHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhcccc
Q 019650          123 FVMEHMERGSLFDSLRV-RKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRN  201 (337)
Q Consensus       123 lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~  201 (337)
                      +||||+++++|.+++.. ...+++..+..++.|++.||+|||++|++|+||||+||+++.+++++|+|||.+........
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  163 (310)
T 3s95_A           84 FITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT  163 (310)
T ss_dssp             EEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred             EEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence            99999999999999986 56799999999999999999999999999999999999999999999999999987654332


Q ss_pred             CCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhh
Q 019650          202 NNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAIC  281 (337)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~  281 (337)
                      ....................||+.|+|||++.    +..++.++||||||+++|+|++|..||...............  
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~--  237 (310)
T 3s95_A          164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMIN----GRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVR--  237 (310)
T ss_dssp             ----------------CCCCSCGGGCCHHHHT----TCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHH--
T ss_pred             cccccccccccccccccccCCCcceeCHHHhc----CCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhh--
Confidence            21111000011112223457999999999998    567899999999999999999999998653322110000000  


Q ss_pred             ccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhc
Q 019650          282 FGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA  319 (337)
Q Consensus       282 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~  319 (337)
                      .......+..+++.+.+++.+||+.||++|||++++++
T Consensus       238 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~  275 (310)
T 3s95_A          238 GFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH  275 (310)
T ss_dssp             HHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            00112235677889999999999999999999999987

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=9.8e-48  Score=346.11  Aligned_cols=265  Identities=26%  Similarity=0.365  Sum_probs=200.5

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCceEEEEEeecCC-chHhHHHHHHHHHHHHhcCCCCceeeeeeEEee-----
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTI-----  117 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----  117 (337)
                      ...++|++++.||.|+||+||+|.+..+++.||+|++.... .....+.+.+|+.+++.++|+||+++++++...     
T Consensus        26 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~  105 (367)
T 2fst_X           26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE  105 (367)
T ss_dssp             EEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGG
T ss_pred             CCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCcccc
Confidence            34589999999999999999999999999999999986543 344567788999999999999999999987652     


Q ss_pred             CCeEEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchh
Q 019650          118 EGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVE  197 (337)
Q Consensus       118 ~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~  197 (337)
                      ....+++++++ +++|.+++.. ..+++..++.++.||+.||.|||+.|++||||||+||+++.++.++|+|||++....
T Consensus       106 ~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~  183 (367)
T 2fst_X          106 FNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTA  183 (367)
T ss_dssp             CCCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC--------
T ss_pred             CCeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccccccc
Confidence            25679999999 6799999875 679999999999999999999999999999999999999999999999999987654


Q ss_pred             ccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHH
Q 019650          198 ETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALI  277 (337)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~  277 (337)
                      ..                 ....++|+.|+|||.+...   ..++.++||||||+++|+|++|+.||.+.........+.
T Consensus       184 ~~-----------------~~~~~~t~~y~aPE~~~~~---~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~  243 (367)
T 2fst_X          184 DE-----------------MTGYVATRWYRAPEIMLNW---MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL  243 (367)
T ss_dssp             ------------------------CCCTTCCHHHHTTC---CSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             cc-----------------CCCcCcCcCccChHHHcCC---cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            32                 1223589999999998742   468899999999999999999999997754433333322


Q ss_pred             HHhhcc------------------CCC--------CCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCCc
Q 019650          278 CAICFG------------------ERL--------EMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSS  330 (337)
Q Consensus       278 ~~~~~~------------------~~~--------~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~~  330 (337)
                      ......                  ...        ......+..+.+||.+||..||.+|||++++|+||||++.....
T Consensus       244 ~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~  322 (367)
T 2fst_X          244 RLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD  322 (367)
T ss_dssp             HHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCGG
T ss_pred             HHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCCC
Confidence            211100                  000        01134678899999999999999999999999999999865443

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=5.8e-47  Score=339.80  Aligned_cols=279  Identities=26%  Similarity=0.399  Sum_probs=218.3

Q ss_pred             ccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEee----C
Q 019650           43 VENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTI----E  118 (337)
Q Consensus        43 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~----~  118 (337)
                      ....++|.+.+.||+|+||+||+|.+..+++.||+|++...........+.+|+.++++++|+||+++++++...    .
T Consensus         7 ~~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   86 (353)
T 2b9h_A            7 YNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENF   86 (353)
T ss_dssp             CCSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTC
T ss_pred             cccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCcc
Confidence            345689999999999999999999999999999999997665555667788999999999999999999976542    2


Q ss_pred             CeEEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhc
Q 019650          119 GEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEE  198 (337)
Q Consensus       119 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~  198 (337)
                      ...++||||+.+ +|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.....
T Consensus        87 ~~~~lv~e~~~~-~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  164 (353)
T 2b9h_A           87 NEVYIIQELMQT-DLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDE  164 (353)
T ss_dssp             CCEEEEECCCSE-EHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred             ceEEEEEeccCc-cHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccccccccc
Confidence            678999999975 89998875 5799999999999999999999999999999999999999999999999999987654


Q ss_pred             cccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHH
Q 019650          199 TRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALIC  278 (337)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~  278 (337)
                      .........    ..........|++.|+|||++..   +..++.++||||||+++|+|++|..||.+............
T Consensus       165 ~~~~~~~~~----~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~  237 (353)
T 2b9h_A          165 SAADNSEPT----GQQSGMVEFVATRWYRAPEVMLT---SAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFG  237 (353)
T ss_dssp             -------------------CCCCCCGGGCCHHHHHS---CCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred             ccccccCcc----ccccchhhccccccccCCeeecc---CCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHH
Confidence            322111000    00011223468999999998863   24688999999999999999999999976543322222221


Q ss_pred             HhhccC-------------------CC--------CCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCCc
Q 019650          279 AICFGE-------------------RL--------EMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSS  330 (337)
Q Consensus       279 ~~~~~~-------------------~~--------~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~~  330 (337)
                      ......                   ..        ...+.++..+.++|.+||..||++|||++++|+||||++.....
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~  316 (353)
T 2b9h_A          238 IIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPN  316 (353)
T ss_dssp             HHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTT
T ss_pred             HhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCcc
Confidence            110000                   00        01246788999999999999999999999999999999876543

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=5e-47  Score=348.41  Aligned_cols=263  Identities=29%  Similarity=0.440  Sum_probs=210.3

Q ss_pred             ccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhc------CCCCceeeeeeEEe
Q 019650           43 VENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRL------DSQFIVKCHAVFYT  116 (337)
Q Consensus        43 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l------~~~~i~~~~~~~~~  116 (337)
                      ....++|++++.||.|+||+||+|.+..+++.||+|++...  ......+.+|+.+++.+      .|+||+.+++.+..
T Consensus        93 ~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~  170 (429)
T 3kvw_A           93 DHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE--KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF  170 (429)
T ss_dssp             CEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE
T ss_pred             CcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc--cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc
Confidence            44567899999999999999999999999999999999754  33445667788888887      56799999998876


Q ss_pred             eCCeEEEEEeccCCCCchHHhhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCc--EEEeeccC
Q 019650          117 IEGEICFVMEHMERGSLFDSLRVRK--KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGE--VKIADFGV  192 (337)
Q Consensus       117 ~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~--~~l~Dfg~  192 (337)
                       ...+++|||++. ++|.+++....  .+++..++.++.||+.||+|||++||+||||||+|||++.++.  ++|+|||+
T Consensus       171 -~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~  248 (429)
T 3kvw_A          171 -RNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGS  248 (429)
T ss_dssp             -TTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred             -CCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeeccc
Confidence             789999999996 59999997654  4999999999999999999999999999999999999999887  99999999


Q ss_pred             ccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchh
Q 019650          193 SRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPD  272 (337)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~  272 (337)
                      +......                 ....++++.|+|||++.    +..++.++||||||+++|+|++|..||.+......
T Consensus       249 a~~~~~~-----------------~~~~~gt~~y~aPE~~~----~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~  307 (429)
T 3kvw_A          249 SCYEHQR-----------------VYTYIQSRFYRAPEVIL----GARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQ  307 (429)
T ss_dssp             CEETTCC-----------------CCSSCSCGGGCCHHHHH----TBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             ceecCCc-----------------ccccCCCCCccChHHHh----CCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHH
Confidence            8654322                 12236899999999998    45789999999999999999999999977554443


Q ss_pred             HHHHHHHhhccCC------------------C------------------------------------CCCCCCCHHHHH
Q 019650          273 LMALICAICFGER------------------L------------------------------------EMPETASPEFRR  298 (337)
Q Consensus       273 ~~~~~~~~~~~~~------------------~------------------------------------~~~~~~~~~~~~  298 (337)
                      .............                  +                                    .+....++.+.+
T Consensus       308 l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~d  387 (429)
T 3kvw_A          308 LACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLD  387 (429)
T ss_dssp             HHHHHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHH
T ss_pred             HHHHHHHcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHH
Confidence            3333322110000                  0                                    011223678999


Q ss_pred             HHHHHhhcCcCCCCCHHHHhcCccccccCCCc
Q 019650          299 FVRSCLEKDWRKRGTVEELLAYPFVTKRSSSS  330 (337)
Q Consensus       299 li~~~l~~~p~~R~s~~eil~hp~f~~~~~~~  330 (337)
                      ||.+||.+||++|||++|+|+||||++.....
T Consensus       388 li~~~L~~dP~~Rpta~e~L~Hpw~~~~~~~~  419 (429)
T 3kvw_A          388 FLKQCLEWDPAVRMTPGQALRHPWLRRRLPKP  419 (429)
T ss_dssp             HHHHHTCSSTTTSCCHHHHHTSTTTC------
T ss_pred             HHHHHCCCChhhCCCHHHHhCChhhccCCCCC
Confidence            99999999999999999999999999876443

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.7e-47  Score=347.05  Aligned_cols=260  Identities=26%  Similarity=0.371  Sum_probs=208.9

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEee------
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTI------  117 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~------  117 (337)
                      ...++|++++.||+|+||+||+|.+..+++.||+|++......     ..+|+.+++.++|+||+++++++...      
T Consensus         4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~-----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~   78 (383)
T 3eb0_A            4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY-----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK   78 (383)
T ss_dssp             --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS-----CCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred             cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch-----HHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence            4467999999999999999999999999999999998755322     23699999999999999999988553      


Q ss_pred             -------------------------------CCeEEEEEeccCCCCchHHhh----hcCCCCHHHHHHHHHHHHHHHHHH
Q 019650          118 -------------------------------EGEICFVMEHMERGSLFDSLR----VRKKLSEDVISGVAYRVLKGLQYL  162 (337)
Q Consensus       118 -------------------------------~~~~~lv~e~~~~~~L~~~l~----~~~~l~~~~~~~i~~~l~~~l~~L  162 (337)
                                                     ...+++||||+++ +|.+.+.    ....+++..++.++.||+.||+||
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L  157 (383)
T 3eb0_A           79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI  157 (383)
T ss_dssp             -------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence                                           2348899999985 7776664    456899999999999999999999


Q ss_pred             HhCCceeccCCCCCeEEc-CCCcEEEeeccCccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCC
Q 019650          163 HGMQIIHGDIKPSNLLIN-GKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDY  241 (337)
Q Consensus       163 H~~~ivH~dl~~~Nili~-~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~  241 (337)
                      |++||+||||||+||+++ .++.++|+|||++.......               ......+++.|+|||.+...   ..+
T Consensus       158 H~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---------------~~~~~~~t~~y~aPE~~~~~---~~~  219 (383)
T 3eb0_A          158 HSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---------------PSVAYICSRFYRAPELMLGA---TEY  219 (383)
T ss_dssp             HTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---------------CCCCCCCCSSCCCHHHHTTC---SSC
T ss_pred             HHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---------------CCcCcccCCCccCHHHhcCC---CCC
Confidence            999999999999999997 57899999999998664332               12233589999999998742   358


Q ss_pred             CccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhccC------------------------CCCCCCCCCHHHH
Q 019650          242 GFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGE------------------------RLEMPETASPEFR  297 (337)
Q Consensus       242 ~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~~~  297 (337)
                      +.++||||||+++|+|++|+.||.+....+.............                        ...++...+..+.
T Consensus       220 ~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (383)
T 3eb0_A          220 TPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAI  299 (383)
T ss_dssp             CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHH
T ss_pred             CcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHH
Confidence            9999999999999999999999987554444443332211000                        0013455788999


Q ss_pred             HHHHHHhhcCcCCCCCHHHHhcCccccccC
Q 019650          298 RFVRSCLEKDWRKRGTVEELLAYPFVTKRS  327 (337)
Q Consensus       298 ~li~~~l~~~p~~R~s~~eil~hp~f~~~~  327 (337)
                      +||.+||..||.+|||+.|+|+||||++..
T Consensus       300 ~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  329 (383)
T 3eb0_A          300 DLLEQILRYEPDLRINPYEAMAHPFFDHLR  329 (383)
T ss_dssp             HHHHHHCCSSGGGSCCHHHHHTSGGGHHHH
T ss_pred             HHHHHHccCChhhCCCHHHHhcCHHHHHHH
Confidence            999999999999999999999999998653

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.3e-47  Score=346.29  Aligned_cols=263  Identities=25%  Similarity=0.366  Sum_probs=205.0

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCceEEEEEeecCC-chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeC----
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIE----  118 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~----  118 (337)
                      ...++|++++.||+|+||+||+|.+..+++.||+|++.... .....+.+.+|+.+++.++|+||+++++++....    
T Consensus        22 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~  101 (371)
T 2xrw_A           22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE  101 (371)
T ss_dssp             EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTT
T ss_pred             chhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccc
Confidence            34689999999999999999999999999999999997643 3445567889999999999999999999887633    


Q ss_pred             -CeEEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchh
Q 019650          119 -GEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVE  197 (337)
Q Consensus       119 -~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~  197 (337)
                       ...++||||+++ +|.+.+.  ..+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++....
T Consensus       102 ~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~  178 (371)
T 2xrw_A          102 FQDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  178 (371)
T ss_dssp             CCEEEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC-----
T ss_pred             ccceEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccccc
Confidence             278999999975 7888885  569999999999999999999999999999999999999999999999999997654


Q ss_pred             ccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHH
Q 019650          198 ETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALI  277 (337)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~  277 (337)
                      ...               ......+++.|+|||++.    +..++.++||||||+++|+|++|..||.+...........
T Consensus       179 ~~~---------------~~~~~~gt~~y~aPE~~~----~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~  239 (371)
T 2xrw_A          179 TSF---------------MMTPYVVTRYYRAPEVIL----GMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVI  239 (371)
T ss_dssp             --------------------------CTTCCHHHHT----TCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             ccc---------------ccCCceecCCccCHHHhc----CCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            321               112336899999999998    4578899999999999999999999997654333222222


Q ss_pred             HHhhcc-----------------CCCCC--------------CC------CCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          278 CAICFG-----------------ERLEM--------------PE------TASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       278 ~~~~~~-----------------~~~~~--------------~~------~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                      ......                 ..+.+              +.      ..+..+.+||.+||..||.+|||++|+|+|
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  319 (371)
T 2xrw_A          240 EQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  319 (371)
T ss_dssp             C-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             HHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence            110000                 00000              00      014678999999999999999999999999


Q ss_pred             ccccccCC
Q 019650          321 PFVTKRSS  328 (337)
Q Consensus       321 p~f~~~~~  328 (337)
                      |||+....
T Consensus       320 p~~~~~~~  327 (371)
T 2xrw_A          320 PYINVWYD  327 (371)
T ss_dssp             HHHHTTCC
T ss_pred             cchhhhcC
Confidence            99987554

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=1.2e-47  Score=344.94  Aligned_cols=260  Identities=24%  Similarity=0.347  Sum_probs=219.5

Q ss_pred             CccCccccccccccccCcceEEEEEE-----EccCCceEEEEEeecCCchHhHHHHHHHHHHHHhc-CCCCceeeeeeEE
Q 019650           42 DVENISDLKKLTVLGHGNGGIVYKVR-----HQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRL-DSQFIVKCHAVFY  115 (337)
Q Consensus        42 ~~~~~~~y~~~~~lg~g~~~~v~~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~  115 (337)
                      +....++|++.+.||+|+||.||+|.     +..+++.||+|+++........+.+.+|+.++.++ .|+||+++++++.
T Consensus        17 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~   96 (359)
T 3vhe_A           17 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT   96 (359)
T ss_dssp             HBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeee
Confidence            34567899999999999999999999     45667899999998766666667889999999999 7899999999987


Q ss_pred             eeCCeEEEEEeccCCCCchHHhhhcCC-----------------------------------------------------
Q 019650          116 TIEGEICFVMEHMERGSLFDSLRVRKK-----------------------------------------------------  142 (337)
Q Consensus       116 ~~~~~~~lv~e~~~~~~L~~~l~~~~~-----------------------------------------------------  142 (337)
                      +.+...++||||+++|+|.+++.....                                                     
T Consensus        97 ~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  176 (359)
T 3vhe_A           97 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDV  176 (359)
T ss_dssp             STTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------------
T ss_pred             cCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchh
Confidence            755668999999999999999976432                                                     


Q ss_pred             -------------CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCCCCCCC
Q 019650          143 -------------LSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNN  209 (337)
Q Consensus       143 -------------l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~  209 (337)
                                   +++..++.++.||+.||+|||++|++||||||+||+++.++.++|+|||++.........       
T Consensus       177 ~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-------  249 (359)
T 3vhe_A          177 EEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY-------  249 (359)
T ss_dssp             -------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTC-------
T ss_pred             hhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccc-------
Confidence                         899999999999999999999999999999999999999999999999999765432211       


Q ss_pred             CCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHhhccCCCCC
Q 019650          210 NNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICAICFGERLEM  288 (337)
Q Consensus       210 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  288 (337)
                           .......+++.|+|||++.    +..++.++||||||+++|+|++ |..||.............   ........
T Consensus       250 -----~~~~~~~~t~~y~aPE~~~----~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~---~~~~~~~~  317 (359)
T 3vhe_A          250 -----VRKGDARLPLKWMAPETIF----DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL---KEGTRMRA  317 (359)
T ss_dssp             -----EEC--CEECGGGCCHHHHH----HCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHH---HHTCCCCC
T ss_pred             -----hhccccCCCceeEChhhhc----CCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHH---HcCCCCCC
Confidence                 1222345788999999998    4578999999999999999998 999997765554443333   33445566


Q ss_pred             CCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          289 PETASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       289 ~~~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                      +..+++.+.+++.+||+.||.+|||++++++|
T Consensus       318 ~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  349 (359)
T 3vhe_A          318 PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  349 (359)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence            77789999999999999999999999999986

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-46  Score=334.34  Aligned_cols=267  Identities=29%  Similarity=0.477  Sum_probs=212.7

Q ss_pred             ccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhc-CCCCceeeeeeEEee----
Q 019650           43 VENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRL-DSQFIVKCHAVFYTI----  117 (337)
Q Consensus        43 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~----  117 (337)
                      ....++|++.+.||.|+||+||+|.+..+++.||+|++.....  ..+.+.+|+.+++++ +|+||+++++.+...    
T Consensus        20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~   97 (326)
T 2x7f_A           20 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD--EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG   97 (326)
T ss_dssp             CCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS--TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--C
T ss_pred             cCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc--cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcc
Confidence            3557899999999999999999999999999999999976532  346778899999999 899999999998764    


Q ss_pred             -CCeEEEEEeccCCCCchHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCcc
Q 019650          118 -EGEICFVMEHMERGSLFDSLRVR--KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSR  194 (337)
Q Consensus       118 -~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~  194 (337)
                       ....++||||+++++|.+++...  ..+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.
T Consensus        98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~  177 (326)
T 2x7f_A           98 MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA  177 (326)
T ss_dssp             CCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC
T ss_pred             ccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCce
Confidence             35789999999999999999764  579999999999999999999999999999999999999999999999999987


Q ss_pred             chhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccC-CCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhH
Q 019650          195 IVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERW-GGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDL  273 (337)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~  273 (337)
                      ......              .......+++.|+|||.+..... +..++.++||||||+++|+|++|..||.........
T Consensus       178 ~~~~~~--------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~  243 (326)
T 2x7f_A          178 QLDRTV--------------GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL  243 (326)
T ss_dssp             ---------------------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHH
T ss_pred             ecCcCc--------------cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHH
Confidence            654321              11123358999999999863211 246788999999999999999999999654332222


Q ss_pred             HHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCC
Q 019650          274 MALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSS  328 (337)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~  328 (337)
                      .   ..............++..+.++|.+||..||.+|||++++++||||++...
T Consensus       244 ~---~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~  295 (326)
T 2x7f_A          244 F---LIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPN  295 (326)
T ss_dssp             H---HHHHSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCTT
T ss_pred             H---HhhcCccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCcc
Confidence            1   111222222334567899999999999999999999999999999987653

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.5e-47  Score=343.82  Aligned_cols=264  Identities=25%  Similarity=0.320  Sum_probs=219.2

Q ss_pred             ccCccccccccccccCcceEEEEEE-----EccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEee
Q 019650           43 VENISDLKKLTVLGHGNGGIVYKVR-----HQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTI  117 (337)
Q Consensus        43 ~~~~~~y~~~~~lg~g~~~~v~~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~  117 (337)
                      ....++|++++.||+|+||+||+|.     +..++..||+|++...........+.+|+.++++++|+||+++++++.. 
T Consensus        67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-  145 (367)
T 3l9p_A           67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ-  145 (367)
T ss_dssp             BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred             hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec-
Confidence            3456899999999999999999999     4457788999999766556666778899999999999999999998866 


Q ss_pred             CCeEEEEEeccCCCCchHHhhhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCC---cEEE
Q 019650          118 EGEICFVMEHMERGSLFDSLRVRK-------KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKG---EVKI  187 (337)
Q Consensus       118 ~~~~~lv~e~~~~~~L~~~l~~~~-------~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~---~~~l  187 (337)
                      ....++||||+++|+|.+++....       .+++..++.++.||+.||+|||++||+||||||+||+++.++   .++|
T Consensus       146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL  225 (367)
T 3l9p_A          146 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI  225 (367)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEE
Confidence            677899999999999999997653       589999999999999999999999999999999999999555   5999


Q ss_pred             eeccCccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCC
Q 019650          188 ADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIG  266 (337)
Q Consensus       188 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~  266 (337)
                      +|||++.........            .......+++.|+|||++.    +..++.++||||||+++|+|++ |..||..
T Consensus       226 ~DFG~a~~~~~~~~~------------~~~~~~~~t~~y~aPE~~~----~~~~~~~~DvwslG~il~ellt~g~~pf~~  289 (367)
T 3l9p_A          226 GDFGMARDIYRAGYY------------RKGGCAMLPVKWMPPEAFM----EGIFTSKTDTWSFGVLLWEIFSLGYMPYPS  289 (367)
T ss_dssp             CCCHHHHHHHHHSSC------------TTCCGGGSCGGGCCHHHHH----HCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             CCCcccccccccccc------------ccCCCcCCcccEECHHHhc----CCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            999999866543221            1122335789999999998    4578999999999999999998 9999965


Q ss_pred             CCCchhHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccC
Q 019650          267 FGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRS  327 (337)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~  327 (337)
                      ...    .........+.....+..++..+.+|+.+||+.||.+|||+++++++.++....
T Consensus       290 ~~~----~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~  346 (367)
T 3l9p_A          290 KSN----QEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD  346 (367)
T ss_dssp             CCH----HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             CCH----HHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence            432    233344445555666778899999999999999999999999999998765443

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.1e-46  Score=329.67  Aligned_cols=267  Identities=33%  Similarity=0.487  Sum_probs=215.6

Q ss_pred             ccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEE
Q 019650           43 VENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEIC  122 (337)
Q Consensus        43 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~  122 (337)
                      ....++|.....||.|+||+||+|.+..++..||+|.+.... ....+.+.+|+.+++.++|+||+++++++.. ....+
T Consensus        18 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~   95 (295)
T 2clq_A           18 DYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD-SRYSQPLHEEIALHKHLKHKNIVQYLGSFSE-NGFIK   95 (295)
T ss_dssp             EECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC-C---HHHHHHHHHHHTCCCTTBCCEEEEEEE-TTEEE
T ss_pred             cccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc-hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEe-CCcEE
Confidence            344566667779999999999999999999999999997654 3345678899999999999999999998876 68899


Q ss_pred             EEEeccCCCCchHHhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcC-CCcEEEeeccCccchhc
Q 019650          123 FVMEHMERGSLFDSLRVR---KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLING-KGEVKIADFGVSRIVEE  198 (337)
Q Consensus       123 lv~e~~~~~~L~~~l~~~---~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~-~~~~~l~Dfg~~~~~~~  198 (337)
                      +||||+++++|.+++...   ..+++..+..++.|++.||.|||+.|++|+||+|+||+++. ++.++|+|||.+.....
T Consensus        96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~  175 (295)
T 2clq_A           96 IFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG  175 (295)
T ss_dssp             EEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC
T ss_pred             EEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCC
Confidence            999999999999999764   24678999999999999999999999999999999999987 78999999999876543


Q ss_pred             cccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHH
Q 019650          199 TRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALIC  278 (337)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~  278 (337)
                      ..              .......+++.|+|||.+...  ...++.++||||||+++|+|++|..||........  ....
T Consensus       176 ~~--------------~~~~~~~~~~~y~aPE~~~~~--~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~  237 (295)
T 2clq_A          176 IN--------------PCTETFTGTLQYMAPEIIDKG--PRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA--AMFK  237 (295)
T ss_dssp             -------------------CCCCCCGGGCCHHHHHHG--GGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH--HHHH
T ss_pred             CC--------------CcccccCCCccccChhhhcCC--CCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhH--HHHh
Confidence            21              112233589999999999743  12478899999999999999999999965433222  1222


Q ss_pred             HhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCC
Q 019650          279 AICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSS  329 (337)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~  329 (337)
                      .......+..+..++..+.++|.+||..||.+|||++++++||||+.....
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~  288 (295)
T 2clq_A          238 VGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKK  288 (295)
T ss_dssp             HHHHCCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC----
T ss_pred             hccccccccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhcccc
Confidence            223344556677889999999999999999999999999999999876644

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=3.7e-47  Score=331.50  Aligned_cols=263  Identities=30%  Similarity=0.446  Sum_probs=216.6

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCceEEEEEeecCC-chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEE
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEIC  122 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~  122 (337)
                      ...++|++.+.||+|++|+||+|.+..+++.||+|++.... .....+.+.+|+.++++++|+||+++++++.. ....+
T Consensus        19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   97 (287)
T 2wei_A           19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED-SSSFY   97 (287)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSEEE
T ss_pred             HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeC-CCeEE
Confidence            44579999999999999999999999999999999986543 22345678899999999999999999998866 68899


Q ss_pred             EEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCC---CcEEEeeccCccchhcc
Q 019650          123 FVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGK---GEVKIADFGVSRIVEET  199 (337)
Q Consensus       123 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~---~~~~l~Dfg~~~~~~~~  199 (337)
                      +|||++++++|.+++.....+++..++.++.||+.||.|||++|++|+||+|+||+++.+   +.++|+|||.+......
T Consensus        98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~  177 (287)
T 2wei_A           98 IVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN  177 (287)
T ss_dssp             EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC
T ss_pred             EEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCC
Confidence            999999999999999888899999999999999999999999999999999999999764   47999999998765432


Q ss_pred             ccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHH
Q 019650          200 RNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICA  279 (337)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~  279 (337)
                      .               ......+++.|+|||.+.     ..++.++|+||||+++|+|++|..||....... .......
T Consensus       178 ~---------------~~~~~~~~~~y~aPE~~~-----~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~  236 (287)
T 2wei_A          178 T---------------KMKDRIGTAYYIAPEVLR-----GTYDEKCDVWSAGVILYILLSGTPPFYGKNEYD-ILKRVET  236 (287)
T ss_dssp             S---------------SCSCHHHHHTTCCHHHHT-----TCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHH
T ss_pred             C---------------ccccccCcccccChHHhc-----CCCCCchhhHhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHc
Confidence            1               111224788999999987     247899999999999999999999997643322 2222222


Q ss_pred             hhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCC
Q 019650          280 ICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSS  328 (337)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~  328 (337)
                      ............++..+.++|.+||..||.+|||++++|+||||++...
T Consensus       237 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~  285 (287)
T 2wei_A          237 GKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS  285 (287)
T ss_dssp             CCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHHCC
T ss_pred             CCCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhcccc
Confidence            1111111222567899999999999999999999999999999987653

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=5.1e-47  Score=333.34  Aligned_cols=266  Identities=25%  Similarity=0.390  Sum_probs=214.6

Q ss_pred             CccccccccccccCcceEEEEEEEccCCceEEEEEeecCCc---hHhHHHHHHHHHHHHhcCCCCceeeeeeEEee-CCe
Q 019650           45 NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSS---TIIRHQAAHEAEILKRLDSQFIVKCHAVFYTI-EGE  120 (337)
Q Consensus        45 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-~~~  120 (337)
                      ..++|.+.+.||.|+||.||+|.+..++..||+|++.....   ......+.+|+.++++++|+||+++++++... ...
T Consensus         3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (305)
T 2wtk_C            3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK   82 (305)
T ss_dssp             --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred             cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence            35799999999999999999999999999999999875421   23456788999999999999999999987532 457


Q ss_pred             EEEEEeccCCCCchHHhhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhc
Q 019650          121 ICFVMEHMERGSLFDSLRV--RKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEE  198 (337)
Q Consensus       121 ~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~  198 (337)
                      .++||||++++ |.+++..  ...+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||.+.....
T Consensus        83 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~  161 (305)
T 2wtk_C           83 MYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHP  161 (305)
T ss_dssp             EEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred             EEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCc
Confidence            89999999875 7777764  35699999999999999999999999999999999999999999999999999976643


Q ss_pred             cccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHH
Q 019650          199 TRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALIC  278 (337)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~  278 (337)
                      ....            .......+++.|+|||.+...  ...++.++||||||+++|+|++|..||......    ....
T Consensus       162 ~~~~------------~~~~~~~~~~~y~aPE~~~~~--~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~  223 (305)
T 2wtk_C          162 FAAD------------DTCRTSQGSPAFQPPEIANGL--DTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY----KLFE  223 (305)
T ss_dssp             TCSS------------CEECCCCSCGGGCCHHHHTCC--SCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH----HHHH
T ss_pred             cccc------------cccccCCCCCCCcChhhccCc--ccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH----HHHH
Confidence            2111            122234589999999999743  123477999999999999999999999754322    2222


Q ss_pred             HhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCCc
Q 019650          279 AICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSS  330 (337)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~~  330 (337)
                      .... .....+..++..+.++|.+||..||.+|||++++++||||++.....
T Consensus       224 ~i~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~  274 (305)
T 2wtk_C          224 NIGK-GSYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPA  274 (305)
T ss_dssp             HHHH-CCCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC-
T ss_pred             HHhc-CCCCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCCCc
Confidence            2222 23456677899999999999999999999999999999999876543

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=6.1e-47  Score=341.85  Aligned_cols=261  Identities=28%  Similarity=0.394  Sum_probs=210.3

Q ss_pred             ccccccccccccCcceEEEEEEEccCCceEEEEEeecCC-chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCC-----
Q 019650           46 ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEG-----  119 (337)
Q Consensus        46 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~-----  119 (337)
                      .++|.+.+.||.|+||+||+|.+..+++.||+|++.... .....+.+.+|+.+++.++|+||+++++++...+.     
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            479999999999999999999999999999999997643 34456778899999999999999999998876332     


Q ss_pred             eEEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhcc
Q 019650          120 EICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEET  199 (337)
Q Consensus       120 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~  199 (337)
                      ..++||||+.+ +|.+++.  ..+++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||.+......
T Consensus       121 ~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~  197 (371)
T 4exu_A          121 DFYLVMPFMQT-DLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE  197 (371)
T ss_dssp             CCEEEEECCCE-EHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC------
T ss_pred             eEEEEEccccc-cHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccccccC
Confidence            23999999974 8888874  45999999999999999999999999999999999999999999999999999765432


Q ss_pred             ccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHH
Q 019650          200 RNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICA  279 (337)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~  279 (337)
                      .                 ....+++.|+|||.+...   ..++.++||||||+++|+|++|..||.+.............
T Consensus       198 ~-----------------~~~~~t~~y~aPE~~~~~---~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~  257 (371)
T 4exu_A          198 M-----------------TGYVVTRWYRAPEVILSW---MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKV  257 (371)
T ss_dssp             -------------------CTTCCCTTSCHHHHSCC---SCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred             c-----------------CCcccCccccCHHHhcCC---CCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence            1                 223589999999999742   47889999999999999999999999765433333332221


Q ss_pred             hhcc-----------------------CC---CCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCC
Q 019650          280 ICFG-----------------------ER---LEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSS  329 (337)
Q Consensus       280 ~~~~-----------------------~~---~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~  329 (337)
                      ....                       ..   ...++..++.+.+||.+||+.||++|||++++|+||||++....
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~  333 (371)
T 4exu_A          258 TGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDP  333 (371)
T ss_dssp             HCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCG
T ss_pred             hCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCCc
Confidence            1000                       00   01124568999999999999999999999999999999976543

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1.9e-48  Score=352.47  Aligned_cols=256  Identities=16%  Similarity=0.182  Sum_probs=201.9

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHH---HHHHhcCCCCceeee-------
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEA---EILKRLDSQFIVKCH-------  111 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~---~~~~~l~~~~i~~~~-------  111 (337)
                      ...++|++.+.||+|+||+||+|.+..+++.||+|++....  .....+.+.+|+   ..+++++||||++++       
T Consensus        70 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~  149 (377)
T 3byv_A           70 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF  149 (377)
T ss_dssp             CCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCS
T ss_pred             CCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhh
Confidence            34589999999999999999999998899999999997542  333457788899   556666899999988       


Q ss_pred             eeEEeeCC----------------eEEEEEeccCCCCchHHhhhcCCCCH-------HHHHHHHHHHHHHHHHHHhCCce
Q 019650          112 AVFYTIEG----------------EICFVMEHMERGSLFDSLRVRKKLSE-------DVISGVAYRVLKGLQYLHGMQII  168 (337)
Q Consensus       112 ~~~~~~~~----------------~~~lv~e~~~~~~L~~~l~~~~~l~~-------~~~~~i~~~l~~~l~~LH~~~iv  168 (337)
                      +++...+.                ..|++|||+ +|+|.+++...+.+++       ..++.++.||+.||+|||++||+
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iv  228 (377)
T 3byv_A          150 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLV  228 (377)
T ss_dssp             EEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             hhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCee
Confidence            54433211                378999999 5699999987665555       88888999999999999999999


Q ss_pred             eccCCCCCeEEcCCCcEEEeeccCccchhccccCCCCCCCCCCccccccccccCCCCCcCCccccccc-------CCCCC
Q 019650          169 HGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSER-------WGGDY  241 (337)
Q Consensus       169 H~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-------~~~~~  241 (337)
                      ||||||+|||++.+++++|+|||++......                 .....| +.|+|||++....       ....+
T Consensus       229 HrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----------------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~  290 (377)
T 3byv_A          229 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAR-----------------VVSSVS-RGFEPPELEARRATISYHRDRRTLM  290 (377)
T ss_dssp             CSCCCGGGEEECTTCCEEECCGGGCEETTCE-----------------EECCCC-TTCCCHHHHHHHTSTHHHHCCEEEC
T ss_pred             cCCCCHHHEEEcCCCCEEEEechhheecCCc-----------------ccCCCC-cCccChhhhcccccccccccccccC
Confidence            9999999999999999999999998854321                 223357 9999999998420       00168


Q ss_pred             CccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCc
Q 019650          242 GFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYP  321 (337)
Q Consensus       242 ~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp  321 (337)
                      +.++||||||+++|+|++|+.||..........         .....+..+++.+.++|.+||+.||.+|||+.++++||
T Consensus       291 ~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~---------~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp  361 (377)
T 3byv_A          291 TFSFDAWALGLVIYWIWCADLPITKDAALGGSE---------WIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETP  361 (377)
T ss_dssp             CHHHHHHHHHHHHHHHHHSSCCC------CCSG---------GGGSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSH
T ss_pred             ChhhhHHHHHHHHHHHHHCCCCCcccccccchh---------hhhhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhCh
Confidence            999999999999999999999996543222111         11122356799999999999999999999999999999


Q ss_pred             cccccC
Q 019650          322 FVTKRS  327 (337)
Q Consensus       322 ~f~~~~  327 (337)
                      ||++..
T Consensus       362 ~f~~~~  367 (377)
T 3byv_A          362 EYEQLR  367 (377)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            998754

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=9.4e-47  Score=345.79  Aligned_cols=262  Identities=24%  Similarity=0.368  Sum_probs=209.4

Q ss_pred             ccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeC----
Q 019650           43 VENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIE----  118 (337)
Q Consensus        43 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~----  118 (337)
                      .....+|++.+.||+|+||+||+|.+..+++.||+|++.....     ...+|+.++++++|+||+++++++....    
T Consensus        50 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~  124 (420)
T 1j1b_A           50 RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKD  124 (420)
T ss_dssp             CCEEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTT
T ss_pred             CcccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-----hHHHHHHHHHHcCCCCccceeeEEeccCCCCc
Confidence            3445689999999999999999999999999999999875432     2236999999999999999999886532    


Q ss_pred             -CeEEEEEeccCCCCchHHhh----hcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCC-CcEEEeeccC
Q 019650          119 -GEICFVMEHMERGSLFDSLR----VRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGK-GEVKIADFGV  192 (337)
Q Consensus       119 -~~~~lv~e~~~~~~L~~~l~----~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~-~~~~l~Dfg~  192 (337)
                       .++++||||+++ +|.+.+.    ....+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+
T Consensus       125 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~  203 (420)
T 1j1b_A          125 EVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGS  203 (420)
T ss_dssp             EEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             ceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchh
Confidence             246799999976 6666654    34679999999999999999999999999999999999999965 5789999999


Q ss_pred             ccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchh
Q 019650          193 SRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPD  272 (337)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~  272 (337)
                      +.......               .....++++.|+|||++...   ..++.++|||||||++|||++|+.||.+......
T Consensus       204 a~~~~~~~---------------~~~~~~~t~~y~aPE~~~~~---~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~  265 (420)
T 1j1b_A          204 AKQLVRGE---------------PNVSYICSRYYRAPELIFGA---TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ  265 (420)
T ss_dssp             CEECCTTC---------------CCCSCCSCTTSCCHHHHTTC---SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             hhhcccCC---------------CceeeeeCCCcCCHHHHcCC---CCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            98654321               11233689999999999732   3689999999999999999999999987554444


Q ss_pred             HHHHHHHhhcc------------CCCC------------CCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCC
Q 019650          273 LMALICAICFG------------ERLE------------MPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSS  328 (337)
Q Consensus       273 ~~~~~~~~~~~------------~~~~------------~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~  328 (337)
                      +..++......            ....            ++...+..+.+||.+||..||.+|||+.|+++||||++...
T Consensus       266 l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  345 (420)
T 1j1b_A          266 LVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD  345 (420)
T ss_dssp             HHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred             HHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccccc
Confidence            43333221100            0001            23456889999999999999999999999999999987643

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=6.1e-47  Score=338.98  Aligned_cols=260  Identities=25%  Similarity=0.384  Sum_probs=215.6

Q ss_pred             ccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchH----------------hHHHHHHHHHHHHhcCCCC
Q 019650           43 VENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTI----------------IRHQAAHEAEILKRLDSQF  106 (337)
Q Consensus        43 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~----------------~~~~~~~e~~~~~~l~~~~  106 (337)
                      ....++|++.+.||+|+||.||+|.+  +++.||+|++.......                ..+.+.+|+.++++++|+|
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~  104 (348)
T 2pml_X           27 DKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEY  104 (348)
T ss_dssp             CEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTT
T ss_pred             ccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCC
Confidence            34568999999999999999999998  89999999986542111                1177889999999999999


Q ss_pred             ceeeeeeEEeeCCeEEEEEeccCCCCchHH------hhh--cCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCe
Q 019650          107 IVKCHAVFYTIEGEICFVMEHMERGSLFDS------LRV--RKKLSEDVISGVAYRVLKGLQYLHG-MQIIHGDIKPSNL  177 (337)
Q Consensus       107 i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~------l~~--~~~l~~~~~~~i~~~l~~~l~~LH~-~~ivH~dl~~~Ni  177 (337)
                      |+++++++.+ ....++||||+++++|.++      +..  ...+++..++.++.|++.||.|||+ .|++|+||+|+||
T Consensus       105 i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Ni  183 (348)
T 2pml_X          105 CLTCEGIITN-YDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNI  183 (348)
T ss_dssp             BCCCSEEEES-SSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGE
T ss_pred             cceEEEEEee-CCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhE
Confidence            9999998876 6889999999999999999      665  5679999999999999999999999 9999999999999


Q ss_pred             EEcCCCcEEEeeccCccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCc-cccHHHHHHHHHH
Q 019650          178 LINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGF-AGDVWSLGVVVLE  256 (337)
Q Consensus       178 li~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~-~~DiwslG~il~~  256 (337)
                      +++.+++++|+|||.+.......                .....+++.|+|||.+...   ..++. ++||||||+++|+
T Consensus       184 l~~~~~~~kl~dfg~~~~~~~~~----------------~~~~~~~~~y~aPE~~~~~---~~~~~~~~Di~slG~il~~  244 (348)
T 2pml_X          184 LMDKNGRVKLSDFGESEYMVDKK----------------IKGSRGTYEFMPPEFFSNE---SSYNGAKVDIWSLGICLYV  244 (348)
T ss_dssp             EECTTSCEEECCCTTCEECBTTE----------------ECSSCSCGGGCCGGGGSSC---CCEEHHHHHHHHHHHHHHH
T ss_pred             EEcCCCcEEEecccccccccccc----------------ccCCCCCcCccCchhhcCC---CCCCcchhhHHHHHHHHHH
Confidence            99999999999999997754321                1123589999999999842   14555 9999999999999


Q ss_pred             HHhCCCCCCCCCCchhHHHHHHHhhccCCCCCC-------------------CCCCHHHHHHHHHHhhcCcCCCCCHHHH
Q 019650          257 CLVGHYPLIGFGEKPDLMALICAICFGERLEMP-------------------ETASPEFRRFVRSCLEKDWRKRGTVEEL  317 (337)
Q Consensus       257 l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~li~~~l~~~p~~R~s~~ei  317 (337)
                      |++|..||.............   ... ...++                   ..++..+.++|.+||..||.+|||++++
T Consensus       245 l~~g~~pf~~~~~~~~~~~~i---~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~  320 (348)
T 2pml_X          245 MFYNVVPFSLKISLVELFNNI---RTK-NIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDA  320 (348)
T ss_dssp             HHHSSCSSCCSSCSHHHHHHH---TSC-CCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred             HHhCCCCCCCCCcHHHHHHHH---hcc-CcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHH
Confidence            999999997655433332222   212 22233                   5678999999999999999999999999


Q ss_pred             hcCccccccCC
Q 019650          318 LAYPFVTKRSS  328 (337)
Q Consensus       318 l~hp~f~~~~~  328 (337)
                      ++||||++...
T Consensus       321 l~hp~f~~~~~  331 (348)
T 2pml_X          321 LKHEWLADTNI  331 (348)
T ss_dssp             HTSGGGTTCCH
T ss_pred             hcCccccCCCH
Confidence            99999998653

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1.5e-46  Score=333.46  Aligned_cols=266  Identities=23%  Similarity=0.369  Sum_probs=212.4

Q ss_pred             cCccccccccccccCcceEEEEEEEc-cCCceEEEEEeecCCch-HhHHHHHHHHHHHHhc---CCCCceeeeeeEEe--
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQ-KSNSIYALKVLNTTSST-IIRHQAAHEAEILKRL---DSQFIVKCHAVFYT--  116 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~~~~l---~~~~i~~~~~~~~~--  116 (337)
                      ...++|++.+.||+|+||+||+|.+. .+++.||+|++...... .....+.+|+.+++.+   +|+||+++++++..  
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~   87 (326)
T 1blx_A            8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR   87 (326)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred             CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence            34589999999999999999999995 67889999998654321 1123345566666655   89999999998762  


Q ss_pred             --eCCeEEEEEeccCCCCchHHhhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccC
Q 019650          117 --IEGEICFVMEHMERGSLFDSLRVRK--KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGV  192 (337)
Q Consensus       117 --~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~  192 (337)
                        .....++||||++ ++|.+++....  .+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||.
T Consensus        88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~  166 (326)
T 1blx_A           88 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL  166 (326)
T ss_dssp             CSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred             cCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcc
Confidence              2457899999997 59999997653  499999999999999999999999999999999999999999999999999


Q ss_pred             ccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchh
Q 019650          193 SRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPD  272 (337)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~  272 (337)
                      +.......               ......+++.|+|||.+.    +..++.++||||||+++|+|++|..||.+......
T Consensus       167 ~~~~~~~~---------------~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~  227 (326)
T 1blx_A          167 ARIYSFQM---------------ALTSVVVTLWYRAPEVLL----QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ  227 (326)
T ss_dssp             CCCCCGGG---------------GGCCCCCCCTTCCHHHHT----TCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred             cccccCCC---------------CccccccccceeCHHHHh----cCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHH
Confidence            87654322               122335899999999998    45789999999999999999999999976554443


Q ss_pred             HHHHHHHhhccC----------------------CCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCC
Q 019650          273 LMALICAICFGE----------------------RLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSS  329 (337)
Q Consensus       273 ~~~~~~~~~~~~----------------------~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~  329 (337)
                      ............                      ...+...++..+.++|.+||..||.+|||++++++||||++..+.
T Consensus       228 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~  306 (326)
T 1blx_A          228 LGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERC  306 (326)
T ss_dssp             HHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred             HHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccchh
Confidence            333332211110                      012335678999999999999999999999999999999987643

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=6.4e-47  Score=340.70  Aligned_cols=270  Identities=20%  Similarity=0.262  Sum_probs=209.5

Q ss_pred             CccccccccccccCcceEEEEEEEccCCceEEEEEeecCCc----------hHhHHHHHHHHHHHHhcCCCCceeeeeeE
Q 019650           45 NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSS----------TIIRHQAAHEAEILKRLDSQFIVKCHAVF  114 (337)
Q Consensus        45 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~----------~~~~~~~~~e~~~~~~l~~~~i~~~~~~~  114 (337)
                      ..++|++.+.||.|+||.||+|.+.. +..||+|++.....          ....+.+.+|+.++++++|+||+++++++
T Consensus        20 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   98 (362)
T 3pg1_A           20 MQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIF   98 (362)
T ss_dssp             TTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred             hccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeE
Confidence            35789999999999999999998854 88999999855321          22347788999999999999999999988


Q ss_pred             EeeC----CeEEEEEeccCCCCchHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEee
Q 019650          115 YTIE----GEICFVMEHMERGSLFDSLRVR-KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIAD  189 (337)
Q Consensus       115 ~~~~----~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~D  189 (337)
                      ....    ...++||||+.| +|.+++... ..+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|
T Consensus        99 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~D  177 (362)
T 3pg1_A           99 VHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICD  177 (362)
T ss_dssp             EECCTTTCCEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred             EeccCCCcceEEEEEccCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEe
Confidence            6533    368999999975 888887644 4799999999999999999999999999999999999999999999999


Q ss_pred             ccCccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCC
Q 019650          190 FGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGE  269 (337)
Q Consensus       190 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~  269 (337)
                      ||.+.......               ......+++.|+|||.+...   ..++.++||||||+++|+|++|+.||.+...
T Consensus       178 fg~~~~~~~~~---------------~~~~~~~t~~y~aPE~~~~~---~~~~~~~DiwslG~il~~l~~g~~pf~~~~~  239 (362)
T 3pg1_A          178 FNLAREDTADA---------------NKTHYVTHRWYRAPELVMQF---KGFTKLVDMWSAGCVMAEMFNRKALFRGSTF  239 (362)
T ss_dssp             TTC------------------------------CGGGCCHHHHTTC---TTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             cCccccccccc---------------ccceecccceecCcHHhcCC---CCCCcHhHHHhHHHHHHHHHhCCCCCCCCCH
Confidence            99997544322               11223588999999998742   4688999999999999999999999976544


Q ss_pred             chhHHHHHHHhhcc-------------------CCC--------CCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCcc
Q 019650          270 KPDLMALICAICFG-------------------ERL--------EMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPF  322 (337)
Q Consensus       270 ~~~~~~~~~~~~~~-------------------~~~--------~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~  322 (337)
                      ..............                   ...        ...+..++.+.+||.+||+.||.+|||++++|+|||
T Consensus       240 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~  319 (362)
T 3pg1_A          240 YNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPY  319 (362)
T ss_dssp             HHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred             HHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCch
Confidence            33333332211100                   000        112356788999999999999999999999999999


Q ss_pred             ccccCCCccccC
Q 019650          323 VTKRSSSSNIEG  334 (337)
Q Consensus       323 f~~~~~~~~~~~  334 (337)
                      |++......+..
T Consensus       320 f~~~~~~~~~~~  331 (362)
T 3pg1_A          320 FESLFDPLDLTE  331 (362)
T ss_dssp             GTTTCCGGGGTT
T ss_pred             hhhccCcccccc
Confidence            999876655543

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=9.5e-48  Score=347.25  Aligned_cols=264  Identities=16%  Similarity=0.108  Sum_probs=195.5

Q ss_pred             CccccccccccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHHhc--CCCCceeee-------ee
Q 019650           45 NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRL--DSQFIVKCH-------AV  113 (337)
Q Consensus        45 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l--~~~~i~~~~-------~~  113 (337)
                      ...+|++.+.||.|+||+||+|.+..+++.||+|++....  .....+.+.+|+.+++.+  +|||+++++       ++
T Consensus        60 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~  139 (371)
T 3q60_A           60 GERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDA  139 (371)
T ss_dssp             CEEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEE
T ss_pred             CceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehh
Confidence            3567999999999999999999999999999999998765  334555667775544444  699988755       33


Q ss_pred             EEeeC----------------CeEEEEEeccCCCCchHHhhhc-CCCCHHHH------HHHHHHHHHHHHHHHhCCceec
Q 019650          114 FYTIE----------------GEICFVMEHMERGSLFDSLRVR-KKLSEDVI------SGVAYRVLKGLQYLHGMQIIHG  170 (337)
Q Consensus       114 ~~~~~----------------~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~------~~i~~~l~~~l~~LH~~~ivH~  170 (337)
                      +...+                ..+|+||||++ ++|.+++... ..+++..+      ..++.||+.||+|||++||+||
T Consensus       140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHr  218 (371)
T 3q60_A          140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHG  218 (371)
T ss_dssp             EEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred             eecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccC
Confidence            33211                34899999998 6999999864 34555555      6777999999999999999999


Q ss_pred             cCCCCCeEEcCCCcEEEeeccCccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHH
Q 019650          171 DIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSL  250 (337)
Q Consensus       171 dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Diwsl  250 (337)
                      ||||+|||++.+++++|+|||++.......                 ....+++.|+|||++...  ...++.++|||||
T Consensus       219 Dikp~NIll~~~~~~kL~DFG~a~~~~~~~-----------------~~~~~t~~y~aPE~~~~~--~~~~~~~~DiwSl  279 (371)
T 3q60_A          219 HFTPDNLFIMPDGRLMLGDVSALWKVGTRG-----------------PASSVPVTYAPREFLNAS--TATFTHALNAWQL  279 (371)
T ss_dssp             TCSGGGEEECTTSCEEECCGGGEEETTCEE-----------------EGGGSCGGGCCHHHHTCS--EEECCHHHHHHHH
T ss_pred             cCCHHHEEECCCCCEEEEecceeeecCCCc-----------------cCccCCcCCcChhhccCC--CCCcCccccHHHH
Confidence            999999999999999999999998664322                 122467999999999732  1478999999999


Q ss_pred             HHHHHHHHhCCCCCCCCCCchhH--HHH--HHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCcccccc
Q 019650          251 GVVVLECLVGHYPLIGFGEKPDL--MAL--ICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKR  326 (337)
Q Consensus       251 G~il~~l~tg~~pf~~~~~~~~~--~~~--~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~  326 (337)
                      |+++|+|++|+.||.........  ...  ............+..+++.+.+||.+||+.||++|||++++|+||||++.
T Consensus       280 G~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  359 (371)
T 3q60_A          280 GLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQL  359 (371)
T ss_dssp             HHHHHHHHHSSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHH
T ss_pred             HHHHHHHHhCCCCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHH
Confidence            99999999999999765322100  000  00000011112234779999999999999999999999999999999976


Q ss_pred             CC
Q 019650          327 SS  328 (337)
Q Consensus       327 ~~  328 (337)
                      .+
T Consensus       360 ~~  361 (371)
T 3q60_A          360 QN  361 (371)
T ss_dssp             HH
T ss_pred             HH
Confidence            54

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=3.6e-47  Score=344.00  Aligned_cols=258  Identities=26%  Similarity=0.357  Sum_probs=217.6

Q ss_pred             CCccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCe
Q 019650           41 PDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGE  120 (337)
Q Consensus        41 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~  120 (337)
                      .+....++|++.+.||+|+||+||+|.+..++..||+|+++........+.+.+|+.++++++||||+++++++.. ...
T Consensus       108 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~  186 (377)
T 3cbl_A          108 KWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ-KQP  186 (377)
T ss_dssp             TTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECS-SSS
T ss_pred             ccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEec-CCC
Confidence            4566778999999999999999999999989999999999866555556678899999999999999999998865 678


Q ss_pred             EEEEEeccCCCCchHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhcc
Q 019650          121 ICFVMEHMERGSLFDSLRVR-KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEET  199 (337)
Q Consensus       121 ~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~  199 (337)
                      .++||||+++|+|.+++... ..+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++......
T Consensus       187 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~  266 (377)
T 3cbl_A          187 IYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADG  266 (377)
T ss_dssp             CEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred             cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence            89999999999999999865 46999999999999999999999999999999999999999999999999998765432


Q ss_pred             ccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHH
Q 019650          200 RNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALIC  278 (337)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~  278 (337)
                      ....            ......+++.|+|||.+.    +..++.++||||||+++|||++ |..||......    ....
T Consensus       267 ~~~~------------~~~~~~~~~~y~aPE~~~----~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~----~~~~  326 (377)
T 3cbl_A          267 VYAA------------SGGLRQVPVKWTAPEALN----YGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ----QTRE  326 (377)
T ss_dssp             EEEC------------CSSCCEEEGGGSCHHHHH----HCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH----HHHH
T ss_pred             ceee------------cCCCCCCCcCcCCHhHhc----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH----HHHH
Confidence            1110            001112467899999998    3468889999999999999998 99999765332    2233


Q ss_pred             HhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhc
Q 019650          279 AICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA  319 (337)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~  319 (337)
                      ....+.....+..++..+.+++.+||+.||++|||++++++
T Consensus       327 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  367 (377)
T 3cbl_A          327 FVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ  367 (377)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            33445566677888999999999999999999999999986

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=1.2e-46  Score=338.65  Aligned_cols=266  Identities=21%  Similarity=0.318  Sum_probs=201.5

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCC----
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEG----  119 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~----  119 (337)
                      ...++|++.+.||.|+||+||+|.+..++..||+|++.....  ......+++..+..++|+||+++++++.....    
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~   97 (360)
T 3e3p_A           20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR--FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRR   97 (360)
T ss_dssp             HHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT--CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTT
T ss_pred             hhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc--ccHHHHHHHHHHHhcCCCCcccHHHhhhcccccccc
Confidence            557899999999999999999999999999999999865432  23445668888889999999999999876432    


Q ss_pred             --eEEEEEeccCCCCchHHh----hhcCCCCHHHHHHHHHHHHHHHHHHH--hCCceeccCCCCCeEEcC-CCcEEEeec
Q 019650          120 --EICFVMEHMERGSLFDSL----RVRKKLSEDVISGVAYRVLKGLQYLH--GMQIIHGDIKPSNLLING-KGEVKIADF  190 (337)
Q Consensus       120 --~~~lv~e~~~~~~L~~~l----~~~~~l~~~~~~~i~~~l~~~l~~LH--~~~ivH~dl~~~Nili~~-~~~~~l~Df  190 (337)
                        ..++||||+++ +|.+.+    .....+++..++.++.|++.||.|||  +.||+||||||+||+++. ++.++|+||
T Consensus        98 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Df  176 (360)
T 3e3p_A           98 DIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDF  176 (360)
T ss_dssp             CEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCC
T ss_pred             ceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeC
Confidence              27899999986 555444    35567999999999999999999999  999999999999999997 899999999


Q ss_pred             cCccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCc
Q 019650          191 GVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEK  270 (337)
Q Consensus       191 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~  270 (337)
                      |++.......               ......+++.|+|||++...   ..++.++||||||+++|+|++|..||......
T Consensus       177 g~a~~~~~~~---------------~~~~~~gt~~y~aPE~~~~~---~~~~~~~Di~slG~il~ell~g~~pf~~~~~~  238 (360)
T 3e3p_A          177 GSAKKLSPSE---------------PNVAYICSRYYRAPELIFGN---QHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA  238 (360)
T ss_dssp             TTCBCCCTTS---------------CCCSTTSCGGGCCHHHHTTC---SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred             CCceecCCCC---------------CcccccCCcceeCHHHHcCC---CCCCcHHHHHHHHHHHHHHHhCCCCcCCCChH
Confidence            9998665432               11233589999999998632   35799999999999999999999999775444


Q ss_pred             hhHHHHHHHhhccC---------------------------CCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccc
Q 019650          271 PDLMALICAICFGE---------------------------RLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV  323 (337)
Q Consensus       271 ~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f  323 (337)
                      ..............                           ........+..+.+||.+||+.||.+|||+.|+|+||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f  318 (360)
T 3e3p_A          239 GQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYF  318 (360)
T ss_dssp             HHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGG
T ss_pred             HHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccc
Confidence            33333332111000                           011222356789999999999999999999999999999


Q ss_pred             cccCCCc
Q 019650          324 TKRSSSS  330 (337)
Q Consensus       324 ~~~~~~~  330 (337)
                      ++.....
T Consensus       319 ~~~~~~~  325 (360)
T 3e3p_A          319 DELHDPA  325 (360)
T ss_dssp             GGGGCTT
T ss_pred             cccCCcc
Confidence            9876543

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.3e-46  Score=342.04  Aligned_cols=265  Identities=23%  Similarity=0.389  Sum_probs=194.6

Q ss_pred             cccccc-ccccccCcceEEEEEEEc--cCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEe-eCCeE
Q 019650           46 ISDLKK-LTVLGHGNGGIVYKVRHQ--KSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYT-IEGEI  121 (337)
Q Consensus        46 ~~~y~~-~~~lg~g~~~~v~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-~~~~~  121 (337)
                      .+.|.+ .++||+|+||+||+|.+.  .+++.||+|++.....   ...+.+|+.++++++|+||+++++++.. .....
T Consensus        19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   95 (405)
T 3rgf_A           19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI---SMSACREIALLRELKHPNVISLQKVFLSHADRKV   95 (405)
T ss_dssp             HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC---CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEE
T ss_pred             hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC---CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeE
Confidence            456777 458999999999999965  5788999999975432   3457789999999999999999999865 35678


Q ss_pred             EEEEeccCCCCchHHhhhcC---------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEE----cCCCcEEEe
Q 019650          122 CFVMEHMERGSLFDSLRVRK---------KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLI----NGKGEVKIA  188 (337)
Q Consensus       122 ~lv~e~~~~~~L~~~l~~~~---------~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili----~~~~~~~l~  188 (337)
                      ++||||+.+ +|.+++....         .+++..++.++.||+.||+|||++||+||||||+||++    +.++.++|+
T Consensus        96 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~  174 (405)
T 3rgf_A           96 WLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIA  174 (405)
T ss_dssp             EEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred             EEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEE
Confidence            999999975 8888886322         49999999999999999999999999999999999999    667899999


Q ss_pred             eccCccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Q 019650          189 DFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFG  268 (337)
Q Consensus       189 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~  268 (337)
                      |||++..........           ......+||+.|+|||++...   ..++.++|||||||++|+|++|..||....
T Consensus       175 Dfg~a~~~~~~~~~~-----------~~~~~~~gt~~y~aPE~~~~~---~~~~~~~DiwSlG~il~ell~g~~pf~~~~  240 (405)
T 3rgf_A          175 DMGFARLFNSPLKPL-----------ADLDPVVVTFWYRAPELLLGA---RHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  240 (405)
T ss_dssp             CTTCCC---------------------------CCCTTCCHHHHTTC---CSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred             ECCCceecCCCCccc-----------ccCCCceecCcccCchhhcCC---CcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence            999998765322110           122234689999999999842   358999999999999999999999996543


Q ss_pred             Cc---------hhHHHHHHHhhccCCC---------------------------------CCCCCCCHHHHHHHHHHhhc
Q 019650          269 EK---------PDLMALICAICFGERL---------------------------------EMPETASPEFRRFVRSCLEK  306 (337)
Q Consensus       269 ~~---------~~~~~~~~~~~~~~~~---------------------------------~~~~~~~~~~~~li~~~l~~  306 (337)
                      ..         ..+..+..........                                 ......+..+.+||.+||..
T Consensus       241 ~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~  320 (405)
T 3rgf_A          241 EDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTM  320 (405)
T ss_dssp             ------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCS
T ss_pred             ccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccC
Confidence            32         1122221111100000                                 00112267899999999999


Q ss_pred             CcCCCCCHHHHhcCccccccCC
Q 019650          307 DWRKRGTVEELLAYPFVTKRSS  328 (337)
Q Consensus       307 ~p~~R~s~~eil~hp~f~~~~~  328 (337)
                      ||.+|||++|+|+||||++...
T Consensus       321 dP~~R~ta~e~L~hp~f~~~~~  342 (405)
T 3rgf_A          321 DPIKRITSEQAMQDPYFLEDPL  342 (405)
T ss_dssp             SGGGSCCHHHHHTSGGGTSSSC
T ss_pred             CcccCCCHHHHhcChhhccCCC
Confidence            9999999999999999987653

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=2.9e-46  Score=332.95  Aligned_cols=260  Identities=24%  Similarity=0.352  Sum_probs=209.8

Q ss_pred             ccCccccccccccccCcceEEEEEEE-ccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCC------ceeeeeeEE
Q 019650           43 VENISDLKKLTVLGHGNGGIVYKVRH-QKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQF------IVKCHAVFY  115 (337)
Q Consensus        43 ~~~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~------i~~~~~~~~  115 (337)
                      ....++|++.+.||.|+||+||+|.+ ..+++.||+|++...  ....+.+.+|+.+++.++|++      ++++++.+.
T Consensus        10 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~   87 (339)
T 1z57_A           10 DVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV--DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFE   87 (339)
T ss_dssp             CEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS--HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEE
T ss_pred             CCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC--CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccc
Confidence            34457999999999999999999998 568899999998753  334566788999998886654      899999876


Q ss_pred             eeCCeEEEEEeccCCCCchHHhhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcC------------
Q 019650          116 TIEGEICFVMEHMERGSLFDSLRVRK--KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLING------------  181 (337)
Q Consensus       116 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~------------  181 (337)
                      . ....++||||+ +++|.+++...+  .+++..++.++.||+.||+|||++|++||||||+||+++.            
T Consensus        88 ~-~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~  165 (339)
T 1z57_A           88 H-HGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIK  165 (339)
T ss_dssp             E-TTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----
T ss_pred             c-CCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccc
Confidence            6 78999999999 779999998665  6899999999999999999999999999999999999987            


Q ss_pred             -------CCcEEEeeccCccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHH
Q 019650          182 -------KGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVV  254 (337)
Q Consensus       182 -------~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il  254 (337)
                             ++.++|+|||.+......                 .....+++.|+|||.+.    +..++.++||||||+++
T Consensus       166 ~~~~~~~~~~~kl~Dfg~~~~~~~~-----------------~~~~~gt~~y~aPE~~~----~~~~~~~~Di~slG~il  224 (339)
T 1z57_A          166 RDERTLINPDIKVVDFGSATYDDEH-----------------HSTLVSTRHYRAPEVIL----ALGWSQPCDVWSIGCIL  224 (339)
T ss_dssp             CEEEEESCCCEEECCCSSCEETTSC-----------------CCSSCSCGGGCCHHHHT----TSCCCTHHHHHHHHHHH
T ss_pred             cccccccCCCceEeeCcccccCccc-----------------cccccCCccccChHHhh----CCCCCcchhhHHHHHHH
Confidence                   668999999998764322                 12235899999999998    45789999999999999


Q ss_pred             HHHHhCCCCCCCCCCchhHHHHHHHhhccCC----------------------------------------CCCCCCCCH
Q 019650          255 LECLVGHYPLIGFGEKPDLMALICAICFGER----------------------------------------LEMPETASP  294 (337)
Q Consensus       255 ~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~----------------------------------------~~~~~~~~~  294 (337)
                      |+|++|..||........ ...+.......+                                        .......++
T Consensus       225 ~el~~g~~pf~~~~~~~~-~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (339)
T 1z57_A          225 IEYYLGFTVFPTHDSKEH-LAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHE  303 (339)
T ss_dssp             HHHHHSSCSCCCSCHHHH-HHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHH
T ss_pred             HHHHhCCCCCCCCChHHH-HHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHH
Confidence            999999999976543322 222222111100                                        001122346


Q ss_pred             HHHHHHHHHhhcCcCCCCCHHHHhcCccccccCC
Q 019650          295 EFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSS  328 (337)
Q Consensus       295 ~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~  328 (337)
                      .+.+||.+||+.||.+|||++|+++||||++...
T Consensus       304 ~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  337 (339)
T 1z57_A          304 RLFDLIQKMLEYDPAKRITLREALKHPFFDLLKK  337 (339)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHTTSGGGGGGGC
T ss_pred             HHHHHHHHHhCcCcccccCHHHHhcCHHHHHHhc
Confidence            7899999999999999999999999999997653

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.5e-46  Score=336.93  Aligned_cols=259  Identities=24%  Similarity=0.358  Sum_probs=218.9

Q ss_pred             CCccCccccccccccccCcceEEEEEEEcc-------CCceEEEEEeecCCchHhHHHHHHHHHHHHhc-CCCCceeeee
Q 019650           41 PDVENISDLKKLTVLGHGNGGIVYKVRHQK-------SNSIYALKVLNTTSSTIIRHQAAHEAEILKRL-DSQFIVKCHA  112 (337)
Q Consensus        41 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~  112 (337)
                      .+....++|.+.+.||+|+||+||+|.+..       .+..||+|++...........+.+|+.+++++ +|+||+++++
T Consensus        63 ~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~  142 (382)
T 3tt0_A           63 RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLG  142 (382)
T ss_dssp             TTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             ccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhhee
Confidence            345667899999999999999999999753       33579999998776666678889999999999 9999999999


Q ss_pred             eEEeeCCeEEEEEeccCCCCchHHhhhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCC
Q 019650          113 VFYTIEGEICFVMEHMERGSLFDSLRVRK----------------KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSN  176 (337)
Q Consensus       113 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~N  176 (337)
                      ++.. ....++||||+++++|.+++....                .+++..++.++.||+.||+|||+.|++||||||+|
T Consensus       143 ~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N  221 (382)
T 3tt0_A          143 ACTQ-DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN  221 (382)
T ss_dssp             EECS-SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred             eecc-CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcce
Confidence            8866 678999999999999999998653                48999999999999999999999999999999999


Q ss_pred             eEEcCCCcEEEeeccCccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHH
Q 019650          177 LLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLE  256 (337)
Q Consensus       177 ili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~  256 (337)
                      |+++.++.++|+|||++.........            .......+++.|+|||++.    +..++.++||||||+++|+
T Consensus       222 Ill~~~~~~kL~DFG~a~~~~~~~~~------------~~~~~~~~t~~y~aPE~~~----~~~~~~~~DiwslG~il~e  285 (382)
T 3tt0_A          222 VLVTEDNVMKIADFGLARDIHHIDYY------------KKTTNGRLPVKWMAPEALF----DRIYTHQSDVWSFGVLLWE  285 (382)
T ss_dssp             EEECTTCCEEECSCSCCCCSSCCCTT------------CCCTTCCCGGGGSCHHHHH----SCCCCHHHHHHHHHHHHHH
T ss_pred             EEEcCCCcEEEcccCccccccccccc------------ccccCCCCCcceeCHHHhc----CCCCCchhHHHHHHHHHHH
Confidence            99999999999999999766432211            1112234688999999998    5678999999999999999


Q ss_pred             HHh-CCCCCCCCCCchhHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          257 CLV-GHYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       257 l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                      |++ |..||.....    .........+.....+..++..+.+++.+||+.||++|||+++++++
T Consensus       286 llt~g~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  346 (382)
T 3tt0_A          286 IFTLGGSPYPGVPV----EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  346 (382)
T ss_dssp             HHTTSCCSSTTCCH----HHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHhCCCCCCCCCCH----HHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            999 9999965432    23334444555666778889999999999999999999999999986

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=4.2e-46  Score=334.27  Aligned_cols=262  Identities=28%  Similarity=0.381  Sum_probs=211.7

Q ss_pred             CccccccccccccCcceEEEEEEEccCCceEEEEEeecCC-chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCC----
Q 019650           45 NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEG----  119 (337)
Q Consensus        45 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~----  119 (337)
                      ..++|.+.+.||.|+||+||+|.+..+++.||+|++.... .....+.+.+|+.++++++|+||+++++++.....    
T Consensus        22 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  101 (353)
T 3coi_A           22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF  101 (353)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred             cCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence            3578999999999999999999999999999999997643 34456778899999999999999999998876332    


Q ss_pred             -eEEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhc
Q 019650          120 -EICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEE  198 (337)
Q Consensus       120 -~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~  198 (337)
                       ..++||||+.+ +|.+++.  ..+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||.+.....
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  178 (353)
T 3coi_A          102 YDFYLVMPFMQT-DLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA  178 (353)
T ss_dssp             CCCEEEEECCSE-EGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC---
T ss_pred             eeEEEEeccccC-CHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCC
Confidence             35999999974 8988885  4599999999999999999999999999999999999999999999999999876532


Q ss_pred             cccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHH
Q 019650          199 TRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALIC  278 (337)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~  278 (337)
                      ..                 ....+++.|+|||.+...   ..++.++||||||+++|+|++|..||.+............
T Consensus       179 ~~-----------------~~~~~t~~y~aPE~~~~~---~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~  238 (353)
T 3coi_A          179 EM-----------------TGYVVTRWYRAPEVILSW---MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILK  238 (353)
T ss_dssp             ----------------------CCSBCCSCHHHHSCC---SCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHH
T ss_pred             Cc-----------------cccccCcCcCCHHHHhCc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            21                 123589999999998742   4688999999999999999999999976543332222221


Q ss_pred             Hhh-----------------------cc---CCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCC
Q 019650          279 AIC-----------------------FG---ERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSS  329 (337)
Q Consensus       279 ~~~-----------------------~~---~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~  329 (337)
                      ...                       ..   .........+..+.++|.+||..||++|||++++|+||||+.....
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~  315 (353)
T 3coi_A          239 VTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDP  315 (353)
T ss_dssp             HHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCG
T ss_pred             HhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccCc
Confidence            100                       00   0112234678999999999999999999999999999999876543

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=9.4e-47  Score=333.62  Aligned_cols=272  Identities=28%  Similarity=0.373  Sum_probs=209.8

Q ss_pred             CccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEe-----
Q 019650           42 DVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYT-----  116 (337)
Q Consensus        42 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----  116 (337)
                      .....++|++++.||.|++|+||+|.+..+++.||+|++.... ....+.+.+|+.++++++|+||+++++++..     
T Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (320)
T 2i6l_A            6 GFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD-PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQL   84 (320)
T ss_dssp             CEEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBC
T ss_pred             cCccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC-hHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccc
Confidence            3455689999999999999999999999999999999987653 3456778899999999999999999987642     


Q ss_pred             --------eCCeEEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEc-CCCcEEE
Q 019650          117 --------IEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLIN-GKGEVKI  187 (337)
Q Consensus       117 --------~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~-~~~~~~l  187 (337)
                              .....++||||+++ +|.+++.. +.+++..++.++.|++.||+|||++|++|+||||+||+++ .++.++|
T Consensus        85 ~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl  162 (320)
T 2i6l_A           85 TDDVGSLTELNSVYIVQEYMET-DLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKI  162 (320)
T ss_dssp             CC----CCSCSEEEEEEECCSE-EHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEE
T ss_pred             ccccccccccCceeEEeeccCC-CHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEE
Confidence                    23678999999974 99999874 5699999999999999999999999999999999999997 4679999


Q ss_pred             eeccCccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Q 019650          188 ADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGF  267 (337)
Q Consensus       188 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~  267 (337)
                      +|||.+..........           .......++..|+|||.+..   ...++.++||||||+++|+|++|+.||...
T Consensus       163 ~Dfg~~~~~~~~~~~~-----------~~~~~~~~~~~y~aPE~~~~---~~~~~~~~Di~slG~il~el~~g~~pf~~~  228 (320)
T 2i6l_A          163 GDFGLARIMDPHYSHK-----------GHLSEGLVTKWYRSPRLLLS---PNNYTKAIDMWAAGCIFAEMLTGKTLFAGA  228 (320)
T ss_dssp             CCCTTCBCC-------------------CCCGGGSCCTTCCHHHHHC---TTCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ccCccccccCCCcccc-----------cccccccccccccCcHHhcC---cccCCchhhhHhHHHHHHHHHhCCCCCCCC
Confidence            9999998764321111           11223357899999999864   246889999999999999999999999765


Q ss_pred             CCchhHHHHHHHhhc---------------------cCC----CCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCcc
Q 019650          268 GEKPDLMALICAICF---------------------GER----LEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPF  322 (337)
Q Consensus       268 ~~~~~~~~~~~~~~~---------------------~~~----~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~  322 (337)
                      ...............                     ...    ......++..+.++|.+||+.||.+|||++++|+|||
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~  308 (320)
T 2i6l_A          229 HELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPY  308 (320)
T ss_dssp             SHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHH
T ss_pred             CHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcc
Confidence            443332222211000                     000    0122457899999999999999999999999999999


Q ss_pred             ccccCCCc
Q 019650          323 VTKRSSSS  330 (337)
Q Consensus       323 f~~~~~~~  330 (337)
                      |+....+.
T Consensus       309 ~~~~~~p~  316 (320)
T 2i6l_A          309 MSIYSFPM  316 (320)
T ss_dssp             HHTTCC--
T ss_pred             cccccCcc
Confidence            99876543

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=1.2e-46  Score=333.80  Aligned_cols=266  Identities=21%  Similarity=0.317  Sum_probs=198.5

Q ss_pred             ccCccccccccccccCcceEEEEEEEccCCc---eEEEEEeecCC-chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeC
Q 019650           43 VENISDLKKLTVLGHGNGGIVYKVRHQKSNS---IYALKVLNTTS-STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIE  118 (337)
Q Consensus        43 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~---~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~  118 (337)
                      ....++|++.+.||+|+||+||+|.+..++.   .||+|++.... .....+.+.+|+.++++++|+||+++++++....
T Consensus        19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   98 (323)
T 3qup_A           19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSR   98 (323)
T ss_dssp             BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred             ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence            4556899999999999999999999876664   79999987653 3345677889999999999999999999887632


Q ss_pred             Ce-----EEEEEeccCCCCchHHhhhcC------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEE
Q 019650          119 GE-----ICFVMEHMERGSLFDSLRVRK------KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKI  187 (337)
Q Consensus       119 ~~-----~~lv~e~~~~~~L~~~l~~~~------~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l  187 (337)
                      ..     .++||||+++++|.+++....      .+++..++.++.||+.||+|||++|++||||||+||+++.++.++|
T Consensus        99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl  178 (323)
T 3qup_A           99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCV  178 (323)
T ss_dssp             ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEE
T ss_pred             cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEE
Confidence            21     389999999999999996543      5999999999999999999999999999999999999999999999


Q ss_pred             eeccCccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCC
Q 019650          188 ADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIG  266 (337)
Q Consensus       188 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~  266 (337)
                      +|||++.........            .......+++.|+|||.+.    +..++.++||||||+++|+|++ |..||..
T Consensus       179 ~Dfg~a~~~~~~~~~------------~~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~il~ell~~g~~p~~~  242 (323)
T 3qup_A          179 ADFGLSRKIYSGDYY------------RQGCASKLPVKWLALESLA----DNLYTVHSDVWAFGVTMWEIMTRGQTPYAG  242 (323)
T ss_dssp             CCCCC-----------------------------CCGGGCCHHHHH----HCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred             eeccccccccccccc------------cccccccCcccccCchhhc----CCCCCCccchhhHHHHHHHHHhCCCCCccc
Confidence            999999876443211            1111223678899999998    4578999999999999999999 9999976


Q ss_pred             CCCchhHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCC-------HHHHhcCccccccCC
Q 019650          267 FGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGT-------VEELLAYPFVTKRSS  328 (337)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s-------~~eil~hp~f~~~~~  328 (337)
                      .......    ...........+..++..+.+++.+||+.||.+|||       ++++++|||+.+...
T Consensus       243 ~~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~  307 (323)
T 3qup_A          243 IENAEIY----NYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQ  307 (323)
T ss_dssp             CCGGGHH----HHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--------
T ss_pred             cChHHHH----HHHhcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCC
Confidence            5444322    223334455667788999999999999999999999       889999999988653

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=2.8e-46  Score=328.17  Aligned_cols=267  Identities=25%  Similarity=0.341  Sum_probs=217.0

Q ss_pred             CCCCCccCccccccccccccCcceEEEEEE----EccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeee
Q 019650           38 PTSPDVENISDLKKLTVLGHGNGGIVYKVR----HQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAV  113 (337)
Q Consensus        38 ~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~  113 (337)
                      ...+.....++|++++.||+|+||.||+|.    +..+++.||+|++.........+.+.+|+.++++++|+||++++++
T Consensus        12 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~   91 (302)
T 4e5w_A           12 EVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGI   91 (302)
T ss_dssp             CCCTTBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ecChhhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeE
Confidence            344455667889999999999999999998    5678999999999876555556788899999999999999999998


Q ss_pred             EEeeC-CeEEEEEeccCCCCchHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeecc
Q 019650          114 FYTIE-GEICFVMEHMERGSLFDSLRV-RKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFG  191 (337)
Q Consensus       114 ~~~~~-~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg  191 (337)
                      +...+ ...++||||+++++|.+++.. ...+++..++.++.|++.||+|||++|++|+||||+||+++.+++++|+|||
T Consensus        92 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg  171 (302)
T 4e5w_A           92 CTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFG  171 (302)
T ss_dssp             EEC---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCT
T ss_pred             EecCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECccc
Confidence            87632 568999999999999999954 4579999999999999999999999999999999999999999999999999


Q ss_pred             CccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCC----
Q 019650          192 VSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGF----  267 (337)
Q Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~----  267 (337)
                      ++..........           .......++..|+|||.+.    +..++.++||||||+++|+|++|..|+...    
T Consensus       172 ~~~~~~~~~~~~-----------~~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~  236 (302)
T 4e5w_A          172 LTKAIETDKEYY-----------TVKDDRDSPVFWYAPECLM----QSKFYIASDVWSFGVTLHELLTYCDSDSSPMALF  236 (302)
T ss_dssp             TCEECCTTCCEE-----------ECCCCTTCCGGGCCHHHHH----HCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH
T ss_pred             ccccccCCCcce-----------eccCCCCCCccccCCeeec----CCCCCcchhHHHHHHHHHHHHHccCCCcchhhHH
Confidence            998765432110           1122335788899999998    446788999999999999999999876321    


Q ss_pred             -------CCchhHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhc
Q 019650          268 -------GEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA  319 (337)
Q Consensus       268 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~  319 (337)
                             .....................+..+++.+.+++.+||+.||.+|||++++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  295 (302)
T 4e5w_A          237 LKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE  295 (302)
T ss_dssp             HHHHCSCCGGGHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             hhccCCcccccCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence                   1222334444555556666777889999999999999999999999999986

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=3.1e-46  Score=322.55  Aligned_cols=255  Identities=26%  Similarity=0.408  Sum_probs=214.0

Q ss_pred             CCccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCe
Q 019650           41 PDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGE  120 (337)
Q Consensus        41 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~  120 (337)
                      .+....++|++.+.||+|+||+||+|.+. ++..||+|++......  .+.+.+|+.++++++|+||+++++++.+ ...
T Consensus         4 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~   79 (269)
T 4hcu_A            4 KWVIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGVCLE-QAP   79 (269)
T ss_dssp             -CBCCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBC--HHHHHHHHHHHHTCCCTTBCCEEEEECS-SSS
T ss_pred             cEEeChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccC--HHHHHHHHHHHHhCCCCCEeeEEEEEec-CCc
Confidence            45667789999999999999999999986 5677999999765432  3568899999999999999999998766 678


Q ss_pred             EEEEEeccCCCCchHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhcc
Q 019650          121 ICFVMEHMERGSLFDSLRVR-KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEET  199 (337)
Q Consensus       121 ~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~  199 (337)
                      .++||||+++++|.+++... ..+++..++.++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++......
T Consensus        80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  159 (269)
T 4hcu_A           80 ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD  159 (269)
T ss_dssp             EEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred             eEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecccccccccccc
Confidence            99999999999999999654 56899999999999999999999999999999999999999999999999999766443


Q ss_pred             ccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHH
Q 019650          200 RNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALIC  278 (337)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~  278 (337)
                      ...             ......+++.|+|||.+.    +..++.++|+||||+++|+|++ |..||......    ....
T Consensus       160 ~~~-------------~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~----~~~~  218 (269)
T 4hcu_A          160 QYT-------------SSTGTKFPVKWASPEVFS----FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS----EVVE  218 (269)
T ss_dssp             HHH-------------STTSTTCCGGGCCHHHHH----HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH----HHHH
T ss_pred             ccc-------------cccCcccccccCCHHHhc----CCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH----HHHH
Confidence            211             111224677899999998    4578999999999999999999 99999654332    2333


Q ss_pred             HhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          279 AICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                      ..........+...+..+.+++.+||+.||.+|||++++++|
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  260 (269)
T 4hcu_A          219 DISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ  260 (269)
T ss_dssp             HHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHhcCccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            334445556667789999999999999999999999999986

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=1.9e-46  Score=341.13  Aligned_cols=261  Identities=23%  Similarity=0.384  Sum_probs=206.6

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCC----
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEG----  119 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~----  119 (337)
                      ....+|++.+.||.|+||+||+|.+..++. +|+|.+......     ..+|+.+++.++|+||+++++++.....    
T Consensus        37 ~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~-----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~  110 (394)
T 4e7w_A           37 QREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF-----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDE  110 (394)
T ss_dssp             EEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS-----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSC
T ss_pred             cccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch-----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCc
Confidence            345789999999999999999999977765 778777544321     2369999999999999999999876433    


Q ss_pred             -eEEEEEeccCCCCchHHhh----hcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEc-CCCcEEEeeccCc
Q 019650          120 -EICFVMEHMERGSLFDSLR----VRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLIN-GKGEVKIADFGVS  193 (337)
Q Consensus       120 -~~~lv~e~~~~~~L~~~l~----~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~-~~~~~~l~Dfg~~  193 (337)
                       .+++||||+++ ++.+.+.    ....+++..++.++.||+.||+|||++||+||||||+||+++ .++.++|+|||++
T Consensus       111 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a  189 (394)
T 4e7w_A          111 VFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSA  189 (394)
T ss_dssp             EEEEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             eEEEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCc
Confidence             37899999987 4444333    356799999999999999999999999999999999999999 7899999999999


Q ss_pred             cchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhH
Q 019650          194 RIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDL  273 (337)
Q Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~  273 (337)
                      .......               ......+++.|+|||.+...   ..++.++||||||+++|+|++|+.||.+.......
T Consensus       190 ~~~~~~~---------------~~~~~~~t~~y~aPE~~~~~---~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l  251 (394)
T 4e7w_A          190 KILIAGE---------------PNVSYICSRYYRAPELIFGA---TNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQL  251 (394)
T ss_dssp             EECCTTC---------------CCCSSCSCGGGCCHHHHTTC---SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred             ccccCCC---------------CCcccccCcCccCHHHHcCC---CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            7764322               12233589999999999742   35899999999999999999999999875544444


Q ss_pred             HHHHHHhhcc------------CCC------------CCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCC
Q 019650          274 MALICAICFG------------ERL------------EMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSS  329 (337)
Q Consensus       274 ~~~~~~~~~~------------~~~------------~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~  329 (337)
                      ..........            ...            .++...+..+.+||.+||..||.+|||+.++++||||++..+.
T Consensus       252 ~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  331 (394)
T 4e7w_A          252 VEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTG  331 (394)
T ss_dssp             HHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSS
T ss_pred             HHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhccc
Confidence            3333221100            000            1234578899999999999999999999999999999986543

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=2.2e-46  Score=334.67  Aligned_cols=257  Identities=26%  Similarity=0.362  Sum_probs=217.5

Q ss_pred             ccCccccccccccccCcceEEEEEEEc-----cCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEee
Q 019650           43 VENISDLKKLTVLGHGNGGIVYKVRHQ-----KSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTI  117 (337)
Q Consensus        43 ~~~~~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~  117 (337)
                      ....++|++.+.||+|+||.||+|.+.     .+++.||+|+++........+.+.+|+.++++++|+||+++++++.+ 
T Consensus        43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-  121 (343)
T 1luf_A           43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV-  121 (343)
T ss_dssp             BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-
T ss_pred             EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc-
Confidence            456789999999999999999999987     35588999999876666667788999999999999999999998866 


Q ss_pred             CCeEEEEEeccCCCCchHHhhhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCC
Q 019650          118 EGEICFVMEHMERGSLFDSLRVR------------------------KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIK  173 (337)
Q Consensus       118 ~~~~~lv~e~~~~~~L~~~l~~~------------------------~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~  173 (337)
                      ....++||||+++++|.+++...                        ..+++..++.++.||+.||.|||++|++|||||
T Consensus       122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlk  201 (343)
T 1luf_A          122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLA  201 (343)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred             CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence            67899999999999999999763                        568999999999999999999999999999999


Q ss_pred             CCCeEEcCCCcEEEeeccCccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHH
Q 019650          174 PSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVV  253 (337)
Q Consensus       174 ~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~i  253 (337)
                      |+||+++.++.++|+|||++.........            .......+++.|+|||.+.    +..++.++||||||++
T Consensus       202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~------------~~~~~~~~t~~y~aPE~~~----~~~~~~~~Di~slG~i  265 (343)
T 1luf_A          202 TRNCLVGENMVVKIADFGLSRNIYSADYY------------KADGNDAIPIRWMPPESIF----YNRYTTESDVWAYGVV  265 (343)
T ss_dssp             GGGEEECGGGCEEECCCSCHHHHTGGGCB------------C----CCBCGGGCCHHHHH----HCCCCHHHHHHHHHHH
T ss_pred             cceEEECCCCeEEEeecCCCcccccCccc------------cccCCCcccceecChhhhc----cCCcCcccccHHHHHH
Confidence            99999999999999999999876543211            1112234788999999998    4578999999999999


Q ss_pred             HHHHHh-CCCCCCCCCCchhHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          254 VLECLV-GHYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       254 l~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                      +|+|++ |..||.....    .........+.....+..++..+.+++.+||+.||.+|||+.+++++
T Consensus       266 l~el~t~g~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~  329 (343)
T 1luf_A          266 LWEIFSYGLQPYYGMAH----EEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI  329 (343)
T ss_dssp             HHHHHTTTCCTTTTSCH----HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHhcCCCcCCCCCh----HHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence            999999 9999976432    22333344455556677889999999999999999999999999875

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=5.3e-46  Score=323.41  Aligned_cols=257  Identities=25%  Similarity=0.379  Sum_probs=212.8

Q ss_pred             CCCccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCC
Q 019650           40 SPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEG  119 (337)
Q Consensus        40 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~  119 (337)
                      ..+....++|++++.||.|+||+||++.+. ++..||+|++......  .+.+.+|+.++++++|+||+++++++.+ ..
T Consensus        17 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~   92 (283)
T 3gen_A           17 GSWEIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCTK-QR   92 (283)
T ss_dssp             CTTBCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBC--HHHHHHHHHHHHTCCCTTBCCEEEEECS-SS
T ss_pred             CCccCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCC--HHHHHHHHHHHhcCCCCCEeeEEEEEec-CC
Confidence            345677889999999999999999999875 6678999999765432  3668899999999999999999998765 67


Q ss_pred             eEEEEEeccCCCCchHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhc
Q 019650          120 EICFVMEHMERGSLFDSLRV-RKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEE  198 (337)
Q Consensus       120 ~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~  198 (337)
                      ..++||||+++++|.+++.. ...+++..++.++.|++.||+|||++|++|+||||+||+++.+++++|+|||.+.....
T Consensus        93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  172 (283)
T 3gen_A           93 PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD  172 (283)
T ss_dssp             SEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred             CeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccc
Confidence            89999999999999999976 56799999999999999999999999999999999999999999999999999976644


Q ss_pred             cccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCchhHHHHH
Q 019650          199 TRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALI  277 (337)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~  277 (337)
                      ....             ......+++.|+|||.+.    +..++.++|+||||+++|+|++ |..||......    ...
T Consensus       173 ~~~~-------------~~~~~~~~~~y~aPE~~~----~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~----~~~  231 (283)
T 3gen_A          173 DEYT-------------SSVGSKFPVRWSPPEVLM----YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS----ETA  231 (283)
T ss_dssp             HHHH-------------STTSTTSCGGGCCHHHHH----HCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH----HHH
T ss_pred             cccc-------------cccCCccCcccCCHHHhc----cCCCCchhhHHHHHHHHHHHHhCCCCCccccChh----HHH
Confidence            3211             111223678899999998    4578999999999999999998 99999764432    223


Q ss_pred             HHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCc
Q 019650          278 CAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYP  321 (337)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp  321 (337)
                      ...........+...++.+.+++.+||+.||.+|||++++++|-
T Consensus       232 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L  275 (283)
T 3gen_A          232 EHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNI  275 (283)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred             HHHhcccCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHH
Confidence            33334445556677899999999999999999999999999863

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1.4e-46  Score=334.94  Aligned_cols=263  Identities=24%  Similarity=0.342  Sum_probs=188.3

Q ss_pred             CCccCcccccccc-ccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEee--
Q 019650           41 PDVENISDLKKLT-VLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTI--  117 (337)
Q Consensus        41 ~~~~~~~~y~~~~-~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--  117 (337)
                      ......++|.+.+ .||.|+||+||+|.+..+++.||+|++....     .........++.++|+||+++++++...  
T Consensus        22 ~~~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~   96 (336)
T 3fhr_A           22 KKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-----KARQEVDHHWQASGGPHIVCILDVYENMHH   96 (336)
T ss_dssp             BCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-----HHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred             CCccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-----HHHHHHHHHHHhcCCCChHHHHHHHhhccC
Confidence            3345678999965 6999999999999999999999999987532     1112233346677999999999987652  


Q ss_pred             -CCeEEEEEeccCCCCchHHhhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCC---CcEEEeecc
Q 019650          118 -EGEICFVMEHMERGSLFDSLRVRK--KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGK---GEVKIADFG  191 (337)
Q Consensus       118 -~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~---~~~~l~Dfg  191 (337)
                       +...++||||++|++|.+++....  .+++..++.++.||+.||.|||++|++||||||+||+++.+   +.++|+|||
T Consensus        97 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg  176 (336)
T 3fhr_A           97 GKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFG  176 (336)
T ss_dssp             TEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             CCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccc
Confidence             245899999999999999998654  69999999999999999999999999999999999999764   459999999


Q ss_pred             CccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCch
Q 019650          192 VSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP  271 (337)
Q Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~  271 (337)
                      ++.......                .....+++.|+|||.+.    +..++.++||||||+++|+|++|..||.......
T Consensus       177 ~~~~~~~~~----------------~~~~~~t~~y~aPE~~~----~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~  236 (336)
T 3fhr_A          177 FAKETTQNA----------------LQTPCYTPYYVAPEVLG----PEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQA  236 (336)
T ss_dssp             TCEEC------------------------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred             cceeccccc----------------cccCCCCcCccChhhhC----CCCCCchhhHHHHHHHHHHHHHCCCCCCCccchh
Confidence            997654321                11235799999999997    4567889999999999999999999996644332


Q ss_pred             hHHHHHHH---hhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCC
Q 019650          272 DLMALICA---ICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSS  328 (337)
Q Consensus       272 ~~~~~~~~---~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~  328 (337)
                      ........   ............++..+.+||.+||..||.+|||++++|+||||++...
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  296 (336)
T 3fhr_A          237 ISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMV  296 (336)
T ss_dssp             --------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGGG
T ss_pred             hhhhHHHhhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccccc
Confidence            21111111   1111122233567999999999999999999999999999999987653

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=1.6e-46  Score=341.90  Aligned_cols=260  Identities=27%  Similarity=0.366  Sum_probs=207.0

Q ss_pred             CccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcC--------CCCceeeeee
Q 019650           42 DVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLD--------SQFIVKCHAV  113 (337)
Q Consensus        42 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~--------~~~i~~~~~~  113 (337)
                      .....++|++.+.||+|+||+||+|.+..+++.||+|++...  ....+.+.+|+.+++++.        |+||+++++.
T Consensus        32 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~  109 (397)
T 1wak_A           32 GDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA--EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDD  109 (397)
T ss_dssp             TCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEE
T ss_pred             hhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC--CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecc
Confidence            334458999999999999999999999999999999999754  344567788999999985        7789999998


Q ss_pred             EEee---CCeEEEEEeccCCCCchHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCCeEEcCCC----
Q 019650          114 FYTI---EGEICFVMEHMERGSLFDSLRVR--KKLSEDVISGVAYRVLKGLQYLHGM-QIIHGDIKPSNLLINGKG----  183 (337)
Q Consensus       114 ~~~~---~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~-~ivH~dl~~~Nili~~~~----  183 (337)
                      +...   ....++||||+ +++|.+++...  ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++    
T Consensus       110 ~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~  188 (397)
T 1wak_A          110 FKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIR  188 (397)
T ss_dssp             EEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHH
T ss_pred             eeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhh
Confidence            8732   35789999999 55777776543  5699999999999999999999998 999999999999998775    


Q ss_pred             ---------------------------------------------cEEEeeccCccchhccccCCCCCCCCCCccccccc
Q 019650          184 ---------------------------------------------EVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAI  218 (337)
Q Consensus       184 ---------------------------------------------~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~  218 (337)
                                                                   .++|+|||.+.......                 .
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~-----------------~  251 (397)
T 1wak_A          189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF-----------------T  251 (397)
T ss_dssp             HHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCS-----------------C
T ss_pred             hhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccC-----------------c
Confidence                                                         79999999997764321                 1


Q ss_pred             cccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCch-----hHHHHHHHhhccC---------
Q 019650          219 ACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP-----DLMALICAICFGE---------  284 (337)
Q Consensus       219 ~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~-----~~~~~~~~~~~~~---------  284 (337)
                      ..+||+.|+|||++.    +..++.++||||||+++|+|++|..||.......     .....+.......         
T Consensus       252 ~~~gt~~y~aPE~~~----~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~  327 (397)
T 1wak_A          252 EDIQTRQYRSLEVLI----GSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGK  327 (397)
T ss_dssp             SCCSCGGGCCHHHHH----TSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCT
T ss_pred             cCCCCCcccCChhhc----CCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhccc
Confidence            225899999999998    4578999999999999999999999997654321     1111111111110         


Q ss_pred             -----------------------------CCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccc
Q 019650          285 -----------------------------RLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTK  325 (337)
Q Consensus       285 -----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~  325 (337)
                                                   ....+...+..+.+||.+||+.||++|||++|+|+||||++
T Consensus       328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~  397 (397)
T 1wak_A          328 YSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS  397 (397)
T ss_dssp             TGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred             ccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence                                         00112223467899999999999999999999999999974

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=7.1e-47  Score=335.79  Aligned_cols=266  Identities=30%  Similarity=0.488  Sum_probs=195.9

Q ss_pred             CccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHH-HHHhcCCCCceeeeeeEEeeCCe
Q 019650           42 DVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAE-ILKRLDSQFIVKCHAVFYTIEGE  120 (337)
Q Consensus        42 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~-~~~~l~~~~i~~~~~~~~~~~~~  120 (337)
                      +....++|++++.||+|+||.||+|.+..+++.||+|++...........+..|+. +++.++|+||+++++++.. ...
T Consensus        17 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~-~~~   95 (327)
T 3aln_A           17 WDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFR-EGD   95 (327)
T ss_dssp             ECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEEC-SSE
T ss_pred             cccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEe-CCc
Confidence            44567899999999999999999999999999999999987655545555666665 6777899999999998876 688


Q ss_pred             EEEEEeccCCCCchHHhhh-----cCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCCeEEcCCCcEEEeeccCcc
Q 019650          121 ICFVMEHMERGSLFDSLRV-----RKKLSEDVISGVAYRVLKGLQYLHGM-QIIHGDIKPSNLLINGKGEVKIADFGVSR  194 (337)
Q Consensus       121 ~~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~i~~~l~~~l~~LH~~-~ivH~dl~~~Nili~~~~~~~l~Dfg~~~  194 (337)
                      .++||||+++ +|.+++..     ...+++..+..++.|++.||.|||+. |++|+||||+||+++.++.++|+|||++.
T Consensus        96 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~  174 (327)
T 3aln_A           96 CWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISG  174 (327)
T ss_dssp             EEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSC
T ss_pred             eEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCce
Confidence            9999999986 88888763     56799999999999999999999998 99999999999999999999999999997


Q ss_pred             chhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHH
Q 019650          195 IVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLM  274 (337)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~  274 (337)
                      .......               .....|++.|+|||.+.....+..++.++||||||+++|+|++|..||.......   
T Consensus       175 ~~~~~~~---------------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---  236 (327)
T 3aln_A          175 QLVDSIA---------------KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF---  236 (327)
T ss_dssp             C---------------------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------
T ss_pred             ecccccc---------------cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH---
Confidence            6643321               1122589999999999532214568899999999999999999999996533211   


Q ss_pred             HHHHHhhccCCCCC----CCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccC
Q 019650          275 ALICAICFGERLEM----PETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRS  327 (337)
Q Consensus       275 ~~~~~~~~~~~~~~----~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~  327 (337)
                      ........+..+.+    ...++..+.+++.+||..||.+|||++++++||||.+..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~  293 (327)
T 3aln_A          237 DQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYE  293 (327)
T ss_dssp             ---CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred             HHHHHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhH
Confidence            11111222222222    235789999999999999999999999999999998754

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=2.8e-46  Score=327.14  Aligned_cols=263  Identities=26%  Similarity=0.383  Sum_probs=211.2

Q ss_pred             CCccCccccccccccccCcceEEEEEE----EccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEe
Q 019650           41 PDVENISDLKKLTVLGHGNGGIVYKVR----HQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYT  116 (337)
Q Consensus        41 ~~~~~~~~y~~~~~lg~g~~~~v~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~  116 (337)
                      +.....++|++++.||+|+||+||+|.    +..+++.||+|++.... ....+.+.+|+.++++++|+||+++++++..
T Consensus         4 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   82 (295)
T 3ugc_A            4 PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEILKSLQHDNIVKYKGVCYS   82 (295)
T ss_dssp             --CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECH
T ss_pred             cCcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            445668999999999999999999998    56788999999997653 4455678899999999999999999998765


Q ss_pred             e-CCeEEEEEeccCCCCchHHhhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCcc
Q 019650          117 I-EGEICFVMEHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSR  194 (337)
Q Consensus       117 ~-~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~  194 (337)
                      . ....++||||+++++|.+++...+ .+++..+..++.|++.||+|||+.|++|+||||+||+++.+++++|+|||++.
T Consensus        83 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~  162 (295)
T 3ugc_A           83 AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK  162 (295)
T ss_dssp             HHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred             CCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccc
Confidence            3 256899999999999999998654 59999999999999999999999999999999999999999999999999998


Q ss_pred             chhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCC-----
Q 019650          195 IVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGE-----  269 (337)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~-----  269 (337)
                      .........           .......++..|+|||.+.    +..++.++||||||+++|+|++|..||.....     
T Consensus       163 ~~~~~~~~~-----------~~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~  227 (295)
T 3ugc_A          163 VLPQDKEFF-----------KVKEPGESPIFWYAPESLT----ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRM  227 (295)
T ss_dssp             ------------------------CTTCGGGGCCHHHHH----HCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHH
T ss_pred             cccCCccee-----------eeccCCCCccceeCcHHhc----CCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhh
Confidence            765432111           1112234677899999998    45789999999999999999999988754211     


Q ss_pred             -------chhHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhc
Q 019650          270 -------KPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA  319 (337)
Q Consensus       270 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~  319 (337)
                             ...................+..+++.+.+++.+||+.||.+|||++++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~  284 (295)
T 3ugc_A          228 IGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  284 (295)
T ss_dssp             HCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             hcCccccchhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                   11112333344455566677888999999999999999999999999986

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.3e-46  Score=334.72  Aligned_cols=260  Identities=26%  Similarity=0.363  Sum_probs=215.2

Q ss_pred             CccCccccccccccccCcceEEEEEEEc-----cCCceEEEEEeecCCchHhHHHHHHHHHHHHhc-CCCCceeeeeeEE
Q 019650           42 DVENISDLKKLTVLGHGNGGIVYKVRHQ-----KSNSIYALKVLNTTSSTIIRHQAAHEAEILKRL-DSQFIVKCHAVFY  115 (337)
Q Consensus        42 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~  115 (337)
                      +....++|.+.+.||.|+||+||+|.+.     .++..||+|++.........+.+.+|+.+++++ +||||+++++++.
T Consensus        40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  119 (344)
T 1rjb_A           40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT  119 (344)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence            4566789999999999999999999973     466789999998665555567888999999999 9999999999886


Q ss_pred             eeCCeEEEEEeccCCCCchHHhhhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccC
Q 019650          116 TIEGEICFVMEHMERGSLFDSLRVRK-----------------------KLSEDVISGVAYRVLKGLQYLHGMQIIHGDI  172 (337)
Q Consensus       116 ~~~~~~~lv~e~~~~~~L~~~l~~~~-----------------------~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl  172 (337)
                      . ....++||||+++++|.+++....                       .+++..++.++.||+.||.|||++|++||||
T Consensus       120 ~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Di  198 (344)
T 1rjb_A          120 L-SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDL  198 (344)
T ss_dssp             S-SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred             e-CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Confidence            6 678999999999999999997643                       3799999999999999999999999999999


Q ss_pred             CCCCeEEcCCCcEEEeeccCccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHH
Q 019650          173 KPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGV  252 (337)
Q Consensus       173 ~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~  252 (337)
                      ||+||+++.++.++|+|||++.........            .......+++.|+|||.+.    +..++.++||||||+
T Consensus       199 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~------------~~~~~~~~t~~y~aPE~~~----~~~~~~~~Di~slG~  262 (344)
T 1rjb_A          199 AARNVLVTHGKVVKICDFGLARDIMSDSNY------------VVRGNARLPVKWMAPESLF----EGIYTIKSDVWSYGI  262 (344)
T ss_dssp             SGGGEEEETTTEEEECCCGGGSCGGGCTTS------------EEETTEEECGGGCCHHHHH----HCCCCHHHHHHHHHH
T ss_pred             ChhhEEEcCCCcEEeCCCccCcccccCccc------------eeccCccCccCccCHHHhc----cCCCChhHhHHHHHH
Confidence            999999999999999999999876543211            1222334688999999998    457899999999999


Q ss_pred             HHHHHHh-CCCCCCCCCCchhHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCc
Q 019650          253 VVLECLV-GHYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYP  321 (337)
Q Consensus       253 il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp  321 (337)
                      ++|+|+| |..||.............   ........+...+..+.+++.+||..||.+|||+.++++|.
T Consensus       263 il~el~t~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l  329 (344)
T 1rjb_A          263 LLWEIFSLGVNPYPGIPVDANFYKLI---QNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL  329 (344)
T ss_dssp             HHHHHTTTSCCSSTTCCCSHHHHHHH---HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHHcCCCCCcccCCcHHHHHHHH---hcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence            9999998 999998765554444333   23344556677899999999999999999999999999875

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=5.7e-46  Score=327.95  Aligned_cols=269  Identities=25%  Similarity=0.376  Sum_probs=212.8

Q ss_pred             ccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCC-chHhHHHHHHHHHHHHhcC--CCCceeeeeeEEeeCC
Q 019650           43 VENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-STIIRHQAAHEAEILKRLD--SQFIVKCHAVFYTIEG  119 (337)
Q Consensus        43 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~--~~~i~~~~~~~~~~~~  119 (337)
                      ....++|++++.||+|+||.||++.+. +++.||+|++.... .....+.+.+|+.+++++.  |+||+++++.+.. ..
T Consensus        24 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~-~~  101 (313)
T 3cek_A           24 SVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT-DQ  101 (313)
T ss_dssp             EETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC-SS
T ss_pred             eeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeec-CC
Confidence            344578999999999999999999885 58889999997653 3445677889999999997  4999999998776 68


Q ss_pred             eEEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhcc
Q 019650          120 EICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEET  199 (337)
Q Consensus       120 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~  199 (337)
                      ..+++||+ .+++|.+++.....+++..++.++.|++.||.|||++|++|+||||+||+++ ++.++|+|||++......
T Consensus       102 ~~~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~~  179 (313)
T 3cek_A          102 YIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD  179 (313)
T ss_dssp             EEEEEECC-CSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC----
T ss_pred             EEEEEEec-CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccccccccCc
Confidence            89999994 5679999999888999999999999999999999999999999999999996 489999999999876443


Q ss_pred             ccCCCCCCCCCCccccccccccCCCCCcCCcccccccC-------CCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchh
Q 019650          200 RNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERW-------GGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPD  272 (337)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-------~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~  272 (337)
                      ...            .......+++.|+|||.+.....       ...++.++||||||+++|+|++|..||....... 
T Consensus       180 ~~~------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-  246 (313)
T 3cek_A          180 TTS------------VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-  246 (313)
T ss_dssp             ----------------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH-
T ss_pred             ccc------------ccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH-
Confidence            211            11123358999999999874210       1367889999999999999999999997644322 


Q ss_pred             HHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCC
Q 019650          273 LMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSS  329 (337)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~  329 (337)
                       ..............++...+..+.++|.+||+.||.+|||++++++||||+.....
T Consensus       247 -~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~  302 (313)
T 3cek_A          247 -SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP  302 (313)
T ss_dssp             -HHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC---
T ss_pred             -HHHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCCCc
Confidence             22222233334445667778999999999999999999999999999999976543

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=2.1e-46  Score=330.72  Aligned_cols=258  Identities=26%  Similarity=0.369  Sum_probs=217.0

Q ss_pred             CccCccccccccccccCcceEEEEEEEc-----cCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEe
Q 019650           42 DVENISDLKKLTVLGHGNGGIVYKVRHQ-----KSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYT  116 (337)
Q Consensus        42 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~  116 (337)
                      +....++|.+.+.||.|+||.||+|.+.     .++..||+|++.........+.+.+|+.++++++||||+++++++.+
T Consensus        18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   97 (314)
T 2ivs_A           18 WEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ   97 (314)
T ss_dssp             TBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred             cccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEec
Confidence            4556789999999999999999999983     45588999999876666667788899999999999999999998766


Q ss_pred             eCCeEEEEEeccCCCCchHHhhhcCC------------------------CCHHHHHHHHHHHHHHHHHHHhCCceeccC
Q 019650          117 IEGEICFVMEHMERGSLFDSLRVRKK------------------------LSEDVISGVAYRVLKGLQYLHGMQIIHGDI  172 (337)
Q Consensus       117 ~~~~~~lv~e~~~~~~L~~~l~~~~~------------------------l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl  172 (337)
                       ....++||||+++++|.+++.....                        +++..++.++.||+.||.|||++|++|+||
T Consensus        98 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~di  176 (314)
T 2ivs_A           98 -DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDL  176 (314)
T ss_dssp             -SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred             -CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCccccc
Confidence             6789999999999999999986543                        899999999999999999999999999999


Q ss_pred             CCCCeEEcCCCcEEEeeccCccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHH
Q 019650          173 KPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGV  252 (337)
Q Consensus       173 ~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~  252 (337)
                      ||+||+++.++.++|+|||++.........            .......+++.|+|||.+.    +..++.++||||||+
T Consensus       177 kp~NIli~~~~~~kl~Dfg~~~~~~~~~~~------------~~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~  240 (314)
T 2ivs_A          177 AARNILVAEGRKMKISDFGLSRDVYEEDSY------------VKRSQGRIPVKWMAIESLF----DHIYTTQSDVWSFGV  240 (314)
T ss_dssp             SGGGEEEETTTEEEECCCTTCEECTTTSCE------------ECSSCCCSCGGGCCHHHHH----HCEECHHHHHHHHHH
T ss_pred             chheEEEcCCCCEEEccccccccccccccc------------eeccCCCCcccccChhhhc----CCCcCchhhHHHHHH
Confidence            999999999999999999998766432211            1112234678899999998    456889999999999


Q ss_pred             HHHHHHh-CCCCCCCCCCchhHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          253 VVLECLV-GHYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       253 il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                      ++|+|++ |..||....... .   ............+..+++.+.+++.+||+.||.+|||+++++++
T Consensus       241 il~el~t~g~~p~~~~~~~~-~---~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~  305 (314)
T 2ivs_A          241 LLWEIVTLGGNPYPGIPPER-L---FNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD  305 (314)
T ss_dssp             HHHHHHTTSCCSSTTCCGGG-H---HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHhCCCCCCCCCCHHH-H---HHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            9999999 999997654332 2   22233344556677889999999999999999999999999875

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=1.6e-46  Score=333.45  Aligned_cols=264  Identities=25%  Similarity=0.313  Sum_probs=214.5

Q ss_pred             ccCccccccccccccCcceEEEEEE-----EccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEee
Q 019650           43 VENISDLKKLTVLGHGNGGIVYKVR-----HQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTI  117 (337)
Q Consensus        43 ~~~~~~y~~~~~lg~g~~~~v~~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~  117 (337)
                      ....++|++.+.||.|+||+||+|.     +..++..||+|++...........+.+|+.++++++|+||+++++++.. 
T Consensus        26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-  104 (327)
T 2yfx_A           26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ-  104 (327)
T ss_dssp             BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred             cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC-
Confidence            4567899999999999999999999     4567889999999766556666788899999999999999999998876 


Q ss_pred             CCeEEEEEeccCCCCchHHhhhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCC---CcEEE
Q 019650          118 EGEICFVMEHMERGSLFDSLRVRK-------KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGK---GEVKI  187 (337)
Q Consensus       118 ~~~~~lv~e~~~~~~L~~~l~~~~-------~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~---~~~~l  187 (337)
                      ....++||||+++++|.+++....       .+++..++.++.|++.||.|||+.|++||||||+||+++.+   ..++|
T Consensus       105 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl  184 (327)
T 2yfx_A          105 SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI  184 (327)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEE
Confidence            677899999999999999998653       48999999999999999999999999999999999999844   46999


Q ss_pred             eeccCccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCC
Q 019650          188 ADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIG  266 (337)
Q Consensus       188 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~  266 (337)
                      +|||.+.........            .......+++.|+|||.+.    +..++.++||||||+++|+|++ |..||..
T Consensus       185 ~Dfg~~~~~~~~~~~------------~~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~il~ellt~g~~p~~~  248 (327)
T 2yfx_A          185 GDFGMARDIYRASYY------------RKGGCAMLPVKWMPPEAFM----EGIFTSKTDTWSFGVLLWEIFSLGYMPYPS  248 (327)
T ss_dssp             CCCHHHHHHHC------------------CCGGGSCGGGCCHHHHH----HCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             Ccccccccccccccc------------ccCCCcCCCcceeCHhHhc----CCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Confidence            999998766443211            1112335788999999997    4578999999999999999998 9999965


Q ss_pred             CCCchhHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccC
Q 019650          267 FGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRS  327 (337)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~  327 (337)
                      ...    .........+.....+..++..+.++|.+||+.||.+|||+.++++++|+....
T Consensus       249 ~~~----~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~  305 (327)
T 2yfx_A          249 KSN----QEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD  305 (327)
T ss_dssp             CCH----HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             cCH----HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence            432    223333444455666778899999999999999999999999999998875443

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=3.4e-46  Score=324.37  Aligned_cols=256  Identities=28%  Similarity=0.387  Sum_probs=205.7

Q ss_pred             CccCccccccccccccCcceEEEEEEEcc---CCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeC
Q 019650           42 DVENISDLKKLTVLGHGNGGIVYKVRHQK---SNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIE  118 (337)
Q Consensus        42 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~  118 (337)
                      .....++|++.+.||+|+||+||+|.+..   .+..||+|++.........+.+.+|+.++++++||||+++++++.  +
T Consensus        10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~   87 (281)
T 1mp8_A           10 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT--E   87 (281)
T ss_dssp             CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC--S
T ss_pred             eEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc--c
Confidence            45667899999999999999999999864   345699999877666666778889999999999999999999863  5


Q ss_pred             CeEEEEEeccCCCCchHHhhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchh
Q 019650          119 GEICFVMEHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVE  197 (337)
Q Consensus       119 ~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~  197 (337)
                      ...++||||+++++|.+++.... .+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++....
T Consensus        88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  167 (281)
T 1mp8_A           88 NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME  167 (281)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred             CccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccC
Confidence            67899999999999999998654 69999999999999999999999999999999999999999999999999998764


Q ss_pred             ccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCchhHHHH
Q 019650          198 ETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMAL  276 (337)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~~~~~~~~~~~  276 (337)
                      .....             ......+++.|+|||.+.    +..++.++||||||+++|+|++ |..||.........   
T Consensus       168 ~~~~~-------------~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~---  227 (281)
T 1mp8_A          168 DSTYY-------------KASKGKLPIKWMAPESIN----FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI---  227 (281)
T ss_dssp             ------------------------CCGGGCCHHHHH----HCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH---
T ss_pred             ccccc-------------ccccCCCcccccChhhcc----cCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHH---
Confidence            43211             111224678899999998    4578899999999999999997 99999765443322   


Q ss_pred             HHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          277 ICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                       ...........+..++..+.+++.+||+.||.+|||+.+++++
T Consensus       228 -~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  270 (281)
T 1mp8_A          228 -GRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  270 (281)
T ss_dssp             -HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -HHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence             2233344556777889999999999999999999999999874

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=8.3e-46  Score=335.78  Aligned_cols=261  Identities=25%  Similarity=0.385  Sum_probs=207.0

Q ss_pred             CccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcC-CC-----CceeeeeeEE
Q 019650           42 DVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLD-SQ-----FIVKCHAVFY  115 (337)
Q Consensus        42 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-~~-----~i~~~~~~~~  115 (337)
                      .....++|++.+.||+|+||+||+|.+..+++.||+|+++..  ......+..|+.+++.+. |+     +++.+++.+.
T Consensus        49 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~  126 (382)
T 2vx3_A           49 GEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK--KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM  126 (382)
T ss_dssp             TCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS--HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEE
T ss_pred             CCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc--HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeec
Confidence            345568999999999999999999999999999999999753  334566677888888875 44     4888999877


Q ss_pred             eeCCeEEEEEeccCCCCchHHhhhc--CCCCHHHHHHHHHHHHHHHHHHH--hCCceeccCCCCCeEEc--CCCcEEEee
Q 019650          116 TIEGEICFVMEHMERGSLFDSLRVR--KKLSEDVISGVAYRVLKGLQYLH--GMQIIHGDIKPSNLLIN--GKGEVKIAD  189 (337)
Q Consensus       116 ~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH--~~~ivH~dl~~~Nili~--~~~~~~l~D  189 (337)
                      . ....|+|||++.+ +|.+++...  ..+++..++.++.|++.||.|||  +.||+||||||+||+++  .++.++|+|
T Consensus       127 ~-~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~D  204 (382)
T 2vx3_A          127 F-RNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVD  204 (382)
T ss_dssp             E-TTEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECC
T ss_pred             c-CCceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEe
Confidence            6 7899999999965 999999765  46999999999999999999999  57999999999999995  467899999


Q ss_pred             ccCccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCC
Q 019650          190 FGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGE  269 (337)
Q Consensus       190 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~  269 (337)
                      ||++.......                 ....+++.|+|||++.    +..++.++||||||+++|+|++|+.||.+...
T Consensus       205 FG~a~~~~~~~-----------------~~~~~t~~y~aPE~~~----~~~~~~~~DiwSlG~il~elltg~~pf~~~~~  263 (382)
T 2vx3_A          205 FGSSCQLGQRI-----------------YQYIQSRFYRSPEVLL----GMPYDLAIDMWSLGCILVEMHTGEPLFSGANE  263 (382)
T ss_dssp             CTTCEETTCCC-----------------CSSCSCGGGCCHHHHT----TCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             ccCceeccccc-----------------ccccCCccccChHHHc----CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            99997764321                 1235899999999998    45789999999999999999999999987544


Q ss_pred             chhHHHHHHHhhccCC----------------C--------------CC-CCC---------------------------
Q 019650          270 KPDLMALICAICFGER----------------L--------------EM-PET---------------------------  291 (337)
Q Consensus       270 ~~~~~~~~~~~~~~~~----------------~--------------~~-~~~---------------------------  291 (337)
                      ................                +              .+ ++.                           
T Consensus       264 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  343 (382)
T 2vx3_A          264 VDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTV  343 (382)
T ss_dssp             HHHHHHHHHHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCH
T ss_pred             HHHHHHHHHHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccc
Confidence            4433333322110000                0              00 000                           


Q ss_pred             -CCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccC
Q 019650          292 -ASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRS  327 (337)
Q Consensus       292 -~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~  327 (337)
                       ....+.+||.+||..||.+|||++|+|+||||++..
T Consensus       344 ~~~~~~~dli~~mL~~dP~~Rpta~e~L~hp~f~~~~  380 (382)
T 2vx3_A          344 ADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTA  380 (382)
T ss_dssp             HHHHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGCC--
T ss_pred             hhhHHHHHHHHHhcCCChhhCCCHHHHhcCcccccCC
Confidence             013789999999999999999999999999998764

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=7.1e-46  Score=327.14  Aligned_cols=259  Identities=25%  Similarity=0.362  Sum_probs=218.0

Q ss_pred             CccCccccccccccccCcceEEEEEEE-----ccCCceEEEEEeecCCchHhHHHHHHHHHHHHhc-CCCCceeeeeeEE
Q 019650           42 DVENISDLKKLTVLGHGNGGIVYKVRH-----QKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRL-DSQFIVKCHAVFY  115 (337)
Q Consensus        42 ~~~~~~~y~~~~~lg~g~~~~v~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~  115 (337)
                      +....++|++.+.||+|+||+||+|.+     ..++..||+|++.........+.+.+|+.+++++ +|+||+++++++.
T Consensus        18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   97 (313)
T 1t46_A           18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT   97 (313)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEe
Confidence            345568999999999999999999985     4577899999998766555667888999999999 9999999999886


Q ss_pred             eeCCeEEEEEeccCCCCchHHhhhcC------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCe
Q 019650          116 TIEGEICFVMEHMERGSLFDSLRVRK------------------KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNL  177 (337)
Q Consensus       116 ~~~~~~~lv~e~~~~~~L~~~l~~~~------------------~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Ni  177 (337)
                      . ....++||||+++++|.+++....                  .+++..++.++.||+.||.|||++|++|+||||+||
T Consensus        98 ~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Ni  176 (313)
T 1t46_A           98 I-GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNI  176 (313)
T ss_dssp             S-SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred             c-CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceE
Confidence            6 678899999999999999997654                  489999999999999999999999999999999999


Q ss_pred             EEcCCCcEEEeeccCccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHH
Q 019650          178 LINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLEC  257 (337)
Q Consensus       178 li~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l  257 (337)
                      +++.++.++|+|||.+.........            .......+++.|+|||.+.    +..++.++||||||+++|+|
T Consensus       177 l~~~~~~~kl~Dfg~~~~~~~~~~~------------~~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~il~el  240 (313)
T 1t46_A          177 LLTHGRITKICDFGLARDIKNDSNY------------VVKGNARLPVKWMAPESIF----NCVYTFESDVWSYGIFLWEL  240 (313)
T ss_dssp             EEETTTEEEECCCGGGSCTTSCTTS------------EECSSSEECGGGCCHHHHH----HCCCCHHHHHHHHHHHHHHH
T ss_pred             EEcCCCCEEEccccccccccccccc------------eeccCCCCcceeeChHHhc----CCCCChHHHHHHHHHHHHHH
Confidence            9999999999999998876543211            1122234678899999998    45789999999999999999


Q ss_pred             Hh-CCCCCCCCCCchhHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          258 LV-GHYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       258 ~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                      ++ |..||...............   ......+...+..+.+++.+||+.||.+|||+++++++
T Consensus       241 lt~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  301 (313)
T 1t46_A          241 FSLGSSPYPGMPVDSKFYKMIKE---GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL  301 (313)
T ss_dssp             HTTTCCSSTTCCSSHHHHHHHHH---TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HhCCCCCCCcccchhHHHHHhcc---CCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            99 99999776555444443332   33444566789999999999999999999999999975

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=7.8e-46  Score=319.84  Aligned_cols=253  Identities=25%  Similarity=0.375  Sum_probs=212.2

Q ss_pred             ccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEE
Q 019650           43 VENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEIC  122 (337)
Q Consensus        43 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~  122 (337)
                      ....++|++.+.||+|+||+||+|.+. ++..||+|++.....  ..+.+.+|+.++++++|+||+++++++.. ....+
T Consensus         4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~   79 (268)
T 3sxs_A            4 ELKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSM--SEDEFFQEAQTMMKLSHPKLVKFYGVCSK-EYPIY   79 (268)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTB--CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSSEE
T ss_pred             EechhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCC--cHHHHHHHHHHHHhCCCCCEeeEEEEEcc-CCceE
Confidence            456789999999999999999999775 566799999976543  24668899999999999999999998765 67899


Q ss_pred             EEEeccCCCCchHHhhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhcccc
Q 019650          123 FVMEHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRN  201 (337)
Q Consensus       123 lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~  201 (337)
                      +||||+++++|.+++...+ .+++..++.++.|++.||+|||+.|++|+||||+||+++.++.++|+|||.+........
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  159 (268)
T 3sxs_A           80 IVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY  159 (268)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE
T ss_pred             EEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhhh
Confidence            9999999999999998654 599999999999999999999999999999999999999999999999999876543321


Q ss_pred             CCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHh
Q 019650          202 NNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICAI  280 (337)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~  280 (337)
                                   .......+++.|+|||.+.    +..++.++||||||+++|+|++ |..||......    ......
T Consensus       160 -------------~~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~----~~~~~~  218 (268)
T 3sxs_A          160 -------------VSSVGTKFPVKWSAPEVFH----YFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS----EVVLKV  218 (268)
T ss_dssp             -------------EECCSCCCCGGGCCHHHHH----HSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH----HHHHHH
T ss_pred             -------------hcccCCCcCcccCCHHHHh----ccCCchhhhhHHHHHHHHHHHcCCCCCccccChH----HHHHHH
Confidence                         1112234677899999998    4467889999999999999999 99999654332    223333


Q ss_pred             hccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          281 CFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                      ........+...++.+.+++.+||+.||.+|||+++++++
T Consensus       219 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (268)
T 3sxs_A          219 SQGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSS  258 (268)
T ss_dssp             HTTCCCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HcCCCCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            4444555667789999999999999999999999999986

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=2.9e-45  Score=322.95  Aligned_cols=257  Identities=26%  Similarity=0.427  Sum_probs=202.4

Q ss_pred             ccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCe
Q 019650           43 VENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGE  120 (337)
Q Consensus        43 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~  120 (337)
                      ....++|++.+.||+|+||.||+|.+..+++.||+|++....  .......+.+|+.++++++|+||+++++.+.. ...
T Consensus        28 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~  106 (310)
T 2wqm_A           28 YNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE-DNE  106 (310)
T ss_dssp             TSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-TTE
T ss_pred             cccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc-CCc
Confidence            456789999999999999999999999999999999997532  34456778899999999999999999998877 789


Q ss_pred             EEEEEeccCCCCchHHhhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccch
Q 019650          121 ICFVMEHMERGSLFDSLRV----RKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIV  196 (337)
Q Consensus       121 ~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~  196 (337)
                      .++||||+++++|.+++..    ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++...
T Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~  186 (310)
T 2wqm_A          107 LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF  186 (310)
T ss_dssp             EEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC------
T ss_pred             EEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence            9999999999999999864    456899999999999999999999999999999999999999999999999998765


Q ss_pred             hccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHH
Q 019650          197 EETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMAL  276 (337)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~  276 (337)
                      ....              .......+++.|+|||.+.    +..++.++||||||+++|+|++|..||......  ....
T Consensus       187 ~~~~--------------~~~~~~~~~~~y~aPE~~~----~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~  246 (310)
T 2wqm_A          187 SSKT--------------TAAHSLVGTPYYMSPERIH----ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN--LYSL  246 (310)
T ss_dssp             --------------------------CCSSCCHHHHT----TCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC--HHHH
T ss_pred             cCCC--------------ccccccCCCeeEeChHHhC----CCCCCchhhHHHHHHHHHHHHhCCCCCcccchh--HHHH
Confidence            4332              1112335899999999998    457889999999999999999999999654322  2222


Q ss_pred             HHHhhccCCCC-CCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          277 ICAICFGERLE-MPETASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       277 ~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                      .........+. ....++..+.+++.+||+.||.+|||+++++++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~  291 (310)
T 2wqm_A          247 CKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDV  291 (310)
T ss_dssp             HHHHHTTCSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHhhcccCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            22222222222 235678999999999999999999999999874

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=3.3e-46  Score=329.70  Aligned_cols=260  Identities=24%  Similarity=0.349  Sum_probs=218.5

Q ss_pred             ccCccccccccccccCcceEEEEEEE-----ccCCceEEEEEeecCCchHhHHHHHHHHHHHHhc-CCCCceeeeeeEEe
Q 019650           43 VENISDLKKLTVLGHGNGGIVYKVRH-----QKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRL-DSQFIVKCHAVFYT  116 (337)
Q Consensus        43 ~~~~~~y~~~~~lg~g~~~~v~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~  116 (337)
                      ....++|++.+.||.|+||+||+|.+     ..+++.||+|++...........+.+|+.++.++ .|+||+++++.+..
T Consensus        23 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  102 (316)
T 2xir_A           23 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK  102 (316)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred             ecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEec
Confidence            45568999999999999999999985     3567899999998776666667788999999999 78999999999877


Q ss_pred             eCCeEEEEEeccCCCCchHHhhhcCC----------------CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEc
Q 019650          117 IEGEICFVMEHMERGSLFDSLRVRKK----------------LSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLIN  180 (337)
Q Consensus       117 ~~~~~~lv~e~~~~~~L~~~l~~~~~----------------l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~  180 (337)
                      .+...++||||+++++|.+++.....                +++..++.++.|++.||.|||+.|++|+||||+||+++
T Consensus       103 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~  182 (316)
T 2xir_A          103 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS  182 (316)
T ss_dssp             TTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred             CCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEEC
Confidence            55669999999999999999986543                89999999999999999999999999999999999999


Q ss_pred             CCCcEEEeeccCccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-
Q 019650          181 GKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-  259 (337)
Q Consensus       181 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-  259 (337)
                      .+++++|+|||.+.........            .......+++.|+|||.+.    +..++.++||||||+++|+|++ 
T Consensus       183 ~~~~~kl~Dfg~~~~~~~~~~~------------~~~~~~~~t~~y~aPE~~~----~~~~~~~~Di~slG~il~~l~t~  246 (316)
T 2xir_A          183 EKNVVKICDFGLARDIYKDPDY------------VRKGDARLPLKWMAPETIF----DRVYTIQSDVWSFGVLLWEIFSL  246 (316)
T ss_dssp             GGGCEEECCCGGGSCTTTCTTS------------EEETTEEECGGGCCHHHHH----HCCCCHHHHHHHHHHHHHHHHTT
T ss_pred             CCCCEEECCCccccccccCccc------------eeccCCCcceeecCchhhc----cccccchhHHHHHHHHHHHHHhC
Confidence            9999999999999765432211            1222335788999999998    4578999999999999999998 


Q ss_pred             CCCCCCCCCCchhHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCc
Q 019650          260 GHYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYP  321 (337)
Q Consensus       260 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp  321 (337)
                      |..||.............   ..+.....+...+..+.+++.+||+.||.+|||++++++|.
T Consensus       247 g~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L  305 (316)
T 2xir_A          247 GASPYPGVKIDEEFCRRL---KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL  305 (316)
T ss_dssp             SCCSSTTCCCSHHHHHHH---HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             CCCCCcccchhHHHHHHh---ccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence            999997765544433332   33444556677899999999999999999999999999873

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1e-45  Score=327.48  Aligned_cols=266  Identities=24%  Similarity=0.356  Sum_probs=220.9

Q ss_pred             CCccCccccccccccccCcceEEEEEEEc-----cCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEE
Q 019650           41 PDVENISDLKKLTVLGHGNGGIVYKVRHQ-----KSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFY  115 (337)
Q Consensus        41 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~  115 (337)
                      .+....++|++.+.||+|+||+||+|.+.     .++..||+|++...........+.+|+.++++++|+||+++++++.
T Consensus        19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   98 (322)
T 1p4o_A           19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS   98 (322)
T ss_dssp             TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred             hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEc
Confidence            34566789999999999999999999876     4678899999987665556677889999999999999999999876


Q ss_pred             eeCCeEEEEEeccCCCCchHHhhhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcE
Q 019650          116 TIEGEICFVMEHMERGSLFDSLRVR----------KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEV  185 (337)
Q Consensus       116 ~~~~~~~lv~e~~~~~~L~~~l~~~----------~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~  185 (337)
                      + ....++||||+++++|.+++...          ..+++..++.++.||+.||.|||++|++||||||+||+++.++.+
T Consensus        99 ~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~  177 (322)
T 1p4o_A           99 Q-GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV  177 (322)
T ss_dssp             S-SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCE
T ss_pred             c-CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeE
Confidence            5 67889999999999999999753          356999999999999999999999999999999999999999999


Q ss_pred             EEeeccCccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCC
Q 019650          186 KIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPL  264 (337)
Q Consensus       186 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf  264 (337)
                      +|+|||++.........            .......+++.|+|||.+.    +..++.++||||||+++|+|++ |..||
T Consensus       178 kl~Dfg~~~~~~~~~~~------------~~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~il~el~~~g~~p~  241 (322)
T 1p4o_A          178 KIGDFGMTRDIYETDYY------------RKGGKGLLPVRWMSPESLK----DGVFTTYSDVWSFGVVLWEIATLAEQPY  241 (322)
T ss_dssp             EECCTTCCCGGGGGGCE------------EGGGSSEECGGGCCHHHHH----HCCCCHHHHHHHHHHHHHHHHHTSCCTT
T ss_pred             EECcCcccccccccccc------------ccccCCCCCCCccChhhhc----cCCCCchhhHHHHHHHHHHHHhcCCCcc
Confidence            99999999766443211            1122334688999999998    4578999999999999999999 89999


Q ss_pred             CCCCCchhHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC------ccccccC
Q 019650          265 IGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY------PFVTKRS  327 (337)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~h------p~f~~~~  327 (337)
                      ......    ..............+..++..+.+++.+||+.||.+|||+.+++++      |+|+...
T Consensus       242 ~~~~~~----~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~~~~~  306 (322)
T 1p4o_A          242 QGLSNE----QVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVS  306 (322)
T ss_dssp             TTSCHH----HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHHC
T ss_pred             ccCCHH----HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCCcccc
Confidence            654322    2333333444556677889999999999999999999999999987      6665543

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=1.3e-46  Score=333.03  Aligned_cols=257  Identities=25%  Similarity=0.373  Sum_probs=213.9

Q ss_pred             CccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCch-----HhHHHHHHHHHHHHhcC--CCCceeeeeeE
Q 019650           42 DVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSST-----IIRHQAAHEAEILKRLD--SQFIVKCHAVF  114 (337)
Q Consensus        42 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~e~~~~~~l~--~~~i~~~~~~~  114 (337)
                      .....++|++.+.||+|+||+||+|.+..+++.||+|++......     .....+.+|+.+++++.  |+|++++++.+
T Consensus        38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~  117 (320)
T 3a99_A           38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF  117 (320)
T ss_dssp             --CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred             cCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence            345578999999999999999999999999999999999764311     12234567899999996  59999999988


Q ss_pred             EeeCCeEEEEEeccCC-CCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEc-CCCcEEEeeccC
Q 019650          115 YTIEGEICFVMEHMER-GSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLIN-GKGEVKIADFGV  192 (337)
Q Consensus       115 ~~~~~~~~lv~e~~~~-~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~-~~~~~~l~Dfg~  192 (337)
                      .. ....++|||++.+ ++|.+++...+.+++..++.++.||+.||.|||+.|++||||||+||+++ .++.++|+|||+
T Consensus       118 ~~-~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~  196 (320)
T 3a99_A          118 ER-PDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGS  196 (320)
T ss_dssp             EC-SSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTT
T ss_pred             ec-CCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCcc
Confidence            76 6889999999976 79999999888999999999999999999999999999999999999999 678999999999


Q ss_pred             ccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchh
Q 019650          193 SRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPD  272 (337)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~  272 (337)
                      +.......                .....+++.|+|||.+...   ..++.++||||||+++|+|++|..||...   . 
T Consensus       197 ~~~~~~~~----------------~~~~~gt~~y~aPE~~~~~---~~~~~~~Di~slG~il~el~~g~~pf~~~---~-  253 (320)
T 3a99_A          197 GALLKDTV----------------YTDFDGTRVYSPPEWIRYH---RYHGRSAAVWSLGILLYDMVCGDIPFEHD---E-  253 (320)
T ss_dssp             CEECCSSC----------------BCCCCSCGGGSCHHHHHHS---CBCHHHHHHHHHHHHHHHHHHSSCSCCSH---H-
T ss_pred             cccccccc----------------ccCCCCCccCCChHHhccC---CCCCccchHHhHHHHHHHHHHCCCCCCCh---h-
Confidence            87664321                1123589999999999743   23467899999999999999999999542   1 


Q ss_pred             HHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCC
Q 019650          273 LMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSS  329 (337)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~  329 (337)
                        ...     ......+..+++.+.++|.+||..||.+|||++++++||||++....
T Consensus       254 --~~~-----~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~~  303 (320)
T 3a99_A          254 --EII-----RGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLP  303 (320)
T ss_dssp             --HHH-----HCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCCH
T ss_pred             --hhh-----cccccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCccCc
Confidence              111     12344566789999999999999999999999999999999987654

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=1.4e-45  Score=328.33  Aligned_cols=258  Identities=24%  Similarity=0.371  Sum_probs=214.9

Q ss_pred             CccCccccccccccccCcceEEEEEEEc-------cCCceEEEEEeecCCchHhHHHHHHHHHHHHhc-CCCCceeeeee
Q 019650           42 DVENISDLKKLTVLGHGNGGIVYKVRHQ-------KSNSIYALKVLNTTSSTIIRHQAAHEAEILKRL-DSQFIVKCHAV  113 (337)
Q Consensus        42 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~  113 (337)
                      +....++|++.+.||+|+||+||+|.+.       .++..||+|++.........+.+.+|+.+++++ +|+||++++++
T Consensus        30 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~  109 (334)
T 2pvf_A           30 WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGA  109 (334)
T ss_dssp             TBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEE
Confidence            4556789999999999999999999975       456789999998776666677888999999999 99999999998


Q ss_pred             EEeeCCeEEEEEeccCCCCchHHhhhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCe
Q 019650          114 FYTIEGEICFVMEHMERGSLFDSLRVRK----------------KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNL  177 (337)
Q Consensus       114 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Ni  177 (337)
                      +.. ....++||||+++++|.+++....                .+++..++.++.||+.||.|||+.|++|+||||+||
T Consensus       110 ~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI  188 (334)
T 2pvf_A          110 CTQ-DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV  188 (334)
T ss_dssp             ECS-SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred             Ecc-CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceE
Confidence            766 678999999999999999998654                389999999999999999999999999999999999


Q ss_pred             EEcCCCcEEEeeccCccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHH
Q 019650          178 LINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLEC  257 (337)
Q Consensus       178 li~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l  257 (337)
                      +++.++.++|+|||++.........            .......+++.|+|||++.    +..++.++||||||+++|+|
T Consensus       189 ll~~~~~~kL~Dfg~~~~~~~~~~~------------~~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~il~el  252 (334)
T 2pvf_A          189 LVTENNVMKIADFGLARDINNIDYY------------KKTTNGRLPVKWMAPEALF----DRVYTHQSDVWSFGVLMWEI  252 (334)
T ss_dssp             EECTTCCEEECCCTTCEECTTTSSE------------ECCSCCCCCGGGCCHHHHH----HCEECHHHHHHHHHHHHHHH
T ss_pred             EEcCCCCEEEccccccccccccccc------------cccCCCCcccceeChHHhc----CCCcChHHHHHHHHHHHHHH
Confidence            9999999999999999766432211            1112224678899999997    44688999999999999999


Q ss_pred             Hh-CCCCCCCCCCchhHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          258 LV-GHYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       258 ~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                      ++ |..||......    ..............+..++..+.+++.+||+.||.+|||+++++++
T Consensus       253 lt~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  312 (334)
T 2pvf_A          253 FTLGGSPYPGIPVE----ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  312 (334)
T ss_dssp             HTTSCCSSTTCCHH----HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HhCCCCCcCcCCHH----HHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            99 99999764322    2233333444556677889999999999999999999999999875

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=5.4e-46  Score=335.58  Aligned_cols=257  Identities=26%  Similarity=0.397  Sum_probs=203.3

Q ss_pred             ccCccccccccccccCcceEEEEEEEc---cCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCC
Q 019650           43 VENISDLKKLTVLGHGNGGIVYKVRHQ---KSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEG  119 (337)
Q Consensus        43 ~~~~~~y~~~~~lg~g~~~~v~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~  119 (337)
                      ....++|++.+.||+|+||+||+|.+.   .++..||+|+++........+.+.+|+.++++++|+||+++++++.+ ..
T Consensus        41 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~  119 (373)
T 2qol_A           41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK-SK  119 (373)
T ss_dssp             BCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SS
T ss_pred             hcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee-CC
Confidence            345679999999999999999999886   56778999999876666667788999999999999999999998766 67


Q ss_pred             eEEEEEeccCCCCchHHhhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhc
Q 019650          120 EICFVMEHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEE  198 (337)
Q Consensus       120 ~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~  198 (337)
                      ..++||||+++++|.+++...+ .+++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||++.....
T Consensus       120 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  199 (373)
T 2qol_A          120 PVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLED  199 (373)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             ceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCcccccccc
Confidence            8999999999999999997654 699999999999999999999999999999999999999999999999999987654


Q ss_pred             cccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCchhHHHHH
Q 019650          199 TRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALI  277 (337)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~  277 (337)
                      .....           .......+++.|+|||++.    +..++.++||||||+++|+|++ |+.||......    ...
T Consensus       200 ~~~~~-----------~~~~~~~~~~~y~aPE~~~----~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~----~~~  260 (373)
T 2qol_A          200 DPEAA-----------YTTRGGKIPIRWTSPEAIA----YRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ----DVI  260 (373)
T ss_dssp             -------------------------CTTSCHHHHH----HCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH----HHH
T ss_pred             CCccc-----------eeccCCCcCCCccChhhhc----cCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH----HHH
Confidence            32111           1111223577899999998    4578999999999999999998 99999764332    222


Q ss_pred             HHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhc
Q 019650          278 CAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA  319 (337)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~  319 (337)
                      ...........+..++..+.+++.+||+.||.+|||++++++
T Consensus       261 ~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~  302 (373)
T 2qol_A          261 KAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS  302 (373)
T ss_dssp             HHHHTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence            333334445556678999999999999999999999999887

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=3.6e-46  Score=331.23  Aligned_cols=256  Identities=24%  Similarity=0.389  Sum_probs=206.1

Q ss_pred             ccCccccccccccccCcceEEEEEEEccCCce----EEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeC
Q 019650           43 VENISDLKKLTVLGHGNGGIVYKVRHQKSNSI----YALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIE  118 (337)
Q Consensus        43 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~----vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~  118 (337)
                      ....++|++.+.||+|+||+||+|.+..++..    ||+|.+.........+.+.+|+.++++++|+||+++++++.+  
T Consensus        11 ~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--   88 (327)
T 3poz_A           11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT--   88 (327)
T ss_dssp             ECCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEES--
T ss_pred             hcCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec--
Confidence            45578999999999999999999998777654    578877655555566788899999999999999999998865  


Q ss_pred             CeEEEEEeccCCCCchHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchh
Q 019650          119 GEICFVMEHMERGSLFDSLRV-RKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVE  197 (337)
Q Consensus       119 ~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~  197 (337)
                      ...+++++++.+|+|.+++.. ...+++..++.++.||+.||.|||++|++||||||+||+++.+++++|+|||++....
T Consensus        89 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~  168 (327)
T 3poz_A           89 STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             SSEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred             CCeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence            458899999999999999976 4579999999999999999999999999999999999999999999999999998765


Q ss_pred             ccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCchhHHHH
Q 019650          198 ETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMAL  276 (337)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~~~~~~~~~~~  276 (337)
                      .....            .......+++.|+|||.+.    +..++.++||||||+++|+|++ |..||....... ..  
T Consensus       169 ~~~~~------------~~~~~~~~t~~y~aPE~~~----~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-~~--  229 (327)
T 3poz_A          169 AEEKE------------YHAEGGKVPIKWMALESIL----HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-IS--  229 (327)
T ss_dssp             TTCC-------------------CCCGGGSCHHHHH----HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-HH--
T ss_pred             CCccc------------ccccCCCccccccChHHhc----cCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH-HH--
Confidence            43211            1112234688999999998    4578999999999999999999 999997654332 22  


Q ss_pred             HHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          277 ICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                       ...........+...+..+.+++.+||+.||.+|||+.+++++
T Consensus       230 -~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  272 (327)
T 3poz_A          230 -SILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             -HHHHTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred             -HHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence             2233344556677789999999999999999999999999976

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=2.7e-45  Score=338.97  Aligned_cols=249  Identities=24%  Similarity=0.391  Sum_probs=212.6

Q ss_pred             CCccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCe
Q 019650           41 PDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGE  120 (337)
Q Consensus        41 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~  120 (337)
                      .+....++|++.+.||+|+||+||+|.+.  ++.||+|+++...   ..+.+.+|+.++++++|+||+++++++......
T Consensus       187 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  261 (450)
T 1k9a_A          187 GWALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG  261 (450)
T ss_dssp             TCBCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT---TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSC
T ss_pred             ccccChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch---HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCc
Confidence            35567789999999999999999999875  6789999997653   456788999999999999999999998775568


Q ss_pred             EEEEEeccCCCCchHHhhhcCC--CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhc
Q 019650          121 ICFVMEHMERGSLFDSLRVRKK--LSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEE  198 (337)
Q Consensus       121 ~~lv~e~~~~~~L~~~l~~~~~--l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~  198 (337)
                      .++||||+++|+|.+++...+.  +++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++.....
T Consensus       262 ~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  341 (450)
T 1k9a_A          262 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  341 (450)
T ss_dssp             EEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             eEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccc
Confidence            9999999999999999986543  79999999999999999999999999999999999999999999999999875432


Q ss_pred             cccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCchhHHHHH
Q 019650          199 TRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALI  277 (337)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~  277 (337)
                      ..                 ....+++.|+|||.+.    +..++.++||||||+++|+|++ |..||......+..    
T Consensus       342 ~~-----------------~~~~~~~~y~aPE~~~----~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~----  396 (450)
T 1k9a_A          342 TQ-----------------DTGKLPVKWTAPEALR----EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV----  396 (450)
T ss_dssp             ----------------------CCCTTTSCHHHHH----SSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHH----
T ss_pred             cc-----------------cCCCCCcceeCHHHhc----CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH----
Confidence            11                 1113688999999998    4578999999999999999998 99999776544332    


Q ss_pred             HHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhc
Q 019650          278 CAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA  319 (337)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~  319 (337)
                      .....+.....+..++..+.++|.+||+.||.+|||++++++
T Consensus       397 ~~i~~~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~  438 (450)
T 1k9a_A          397 PRVEKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE  438 (450)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            233345566778889999999999999999999999999976

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=4.1e-45  Score=318.46  Aligned_cols=254  Identities=23%  Similarity=0.348  Sum_probs=210.1

Q ss_pred             ccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHh------HHHHHHHHHHHHhcCCCCceeeeeeEEe
Q 019650           43 VENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTII------RHQAAHEAEILKRLDSQFIVKCHAVFYT  116 (337)
Q Consensus        43 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~------~~~~~~e~~~~~~l~~~~i~~~~~~~~~  116 (337)
                      ....++|++.+.||.|+||+||+|.+..+++.||+|++........      .+.+.+|+.++++++|+||+++++++.+
T Consensus        15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   94 (287)
T 4f0f_A           15 TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN   94 (287)
T ss_dssp             BCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETT
T ss_pred             hhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecC
Confidence            3556899999999999999999999999999999999865432211      1678899999999999999999998744


Q ss_pred             eCCeEEEEEeccCCCCchHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCCeEEcCCCc-----EEEe
Q 019650          117 IEGEICFVMEHMERGSLFDSLRVR-KKLSEDVISGVAYRVLKGLQYLHGMQ--IIHGDIKPSNLLINGKGE-----VKIA  188 (337)
Q Consensus       117 ~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~--ivH~dl~~~Nili~~~~~-----~~l~  188 (337)
                         ..++||||+++++|.+++... ..+++..++.++.|++.||+|||++|  ++|+||||+||+++.++.     ++|+
T Consensus        95 ---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~  171 (287)
T 4f0f_A           95 ---PPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVA  171 (287)
T ss_dssp             ---TTEEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred             ---CCeEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeC
Confidence               237999999999998888644 57999999999999999999999999  999999999999988776     9999


Q ss_pred             eccCccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Q 019650          189 DFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFG  268 (337)
Q Consensus       189 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~  268 (337)
                      |||++......                 .....+++.|+|||.+...  +..++.++||||||+++|+|++|+.||....
T Consensus       172 Dfg~~~~~~~~-----------------~~~~~g~~~y~aPE~~~~~--~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~  232 (287)
T 4f0f_A          172 DFGLSQQSVHS-----------------VSGLLGNFQWMAPETIGAE--EESYTEKADTYSFAMILYTILTGEGPFDEYS  232 (287)
T ss_dssp             CCTTCBCCSSC-----------------EECCCCCCTTSCGGGSSCS--SCEECHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred             CCCcccccccc-----------------ccccCCCccccCchhhccC--CCCcCchhhHHHHHHHHHHHHcCCCCCcccc
Confidence            99998744321                 2233589999999999533  3467889999999999999999999997654


Q ss_pred             CchhHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhc
Q 019650          269 EKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA  319 (337)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~  319 (337)
                      .... ...............+..+++.+.+++.+||+.||.+|||++++++
T Consensus       233 ~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  282 (287)
T 4f0f_A          233 YGKI-KFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK  282 (287)
T ss_dssp             CCHH-HHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccHH-HHHHHHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            4332 2222223344556677888999999999999999999999999986

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.4e-45  Score=323.43  Aligned_cols=258  Identities=22%  Similarity=0.328  Sum_probs=202.6

Q ss_pred             CccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCC
Q 019650           42 DVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEG  119 (337)
Q Consensus        42 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~  119 (337)
                      .....++|++.+.||.|+||+||+|.+..+++.||+|++....  .....+.+.+|+.++++++|+||+++++++.. +.
T Consensus        29 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-~~  107 (309)
T 2h34_A           29 EGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEI-DG  107 (309)
T ss_dssp             -----CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-TT
T ss_pred             CCcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEee-CC
Confidence            3456799999999999999999999999999999999987543  23345778899999999999999999998876 78


Q ss_pred             eEEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhcc
Q 019650          120 EICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEET  199 (337)
Q Consensus       120 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~  199 (337)
                      ..+++|||+++++|.+++...+.+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus       108 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  187 (309)
T 2h34_A          108 QLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDE  187 (309)
T ss_dssp             EEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred             eEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence            99999999999999999998889999999999999999999999999999999999999999999999999998766443


Q ss_pred             ccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHH
Q 019650          200 RNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICA  279 (337)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~  279 (337)
                      ..             .......+++.|+|||.+.    +..++.++||||||+++|+|++|..||.....  ........
T Consensus       188 ~~-------------~~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~~~~~  248 (309)
T 2h34_A          188 KL-------------TQLGNTVGTLYYMAPERFS----ESHATYRADIYALTCVLYECLTGSPPYQGDQL--SVMGAHIN  248 (309)
T ss_dssp             ----------------------CCGGGCCGGGTC----C----CCCHHHHHHHHHHHHHHSSCSSCSCHH--HHHHHHHH
T ss_pred             cc-------------ccccccCCCcCccCHHHHc----CCCCCchHhHHHHHHHHHHHHHCCCCCCCchH--HHHHHHhc
Confidence            21             1112335899999999998    45788899999999999999999999965322  11111111


Q ss_pred             hhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCC-CHHHHhc
Q 019650          280 ICFGERLEMPETASPEFRRFVRSCLEKDWRKRG-TVEELLA  319 (337)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~-s~~eil~  319 (337)
                      .........+..++..+.++|.+||+.||.+|| |++++++
T Consensus       249 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~  289 (309)
T 2h34_A          249 QAIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA  289 (309)
T ss_dssp             SCCCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred             cCCCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence            111122244567899999999999999999999 8888876

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1e-45  Score=328.31  Aligned_cols=254  Identities=29%  Similarity=0.376  Sum_probs=211.1

Q ss_pred             ccCccccccccccccCcceEEEEEEEccCCceE--EEEEeecCCchHhHHHHHHHHHHHHhc-CCCCceeeeeeEEeeCC
Q 019650           43 VENISDLKKLTVLGHGNGGIVYKVRHQKSNSIY--ALKVLNTTSSTIIRHQAAHEAEILKRL-DSQFIVKCHAVFYTIEG  119 (337)
Q Consensus        43 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v--aiK~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~  119 (337)
                      ....++|++.+.||+|+||.||+|.+..++..+  ++|.+.........+.+.+|+.+++++ +|+||+++++++.+ ..
T Consensus        21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-~~   99 (327)
T 1fvr_A           21 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-RG   99 (327)
T ss_dssp             BCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE-TT
T ss_pred             cccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeee-CC
Confidence            455789999999999999999999998888765  999987655555566788999999999 99999999998866 78


Q ss_pred             eEEEEEeccCCCCchHHhhhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCC
Q 019650          120 EICFVMEHMERGSLFDSLRVRK----------------KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKG  183 (337)
Q Consensus       120 ~~~lv~e~~~~~~L~~~l~~~~----------------~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~  183 (337)
                      ..++||||+++++|.+++...+                .+++..++.++.||+.||.|||++|++||||||+||+++.++
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~  179 (327)
T 1fvr_A          100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY  179 (327)
T ss_dssp             EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred             ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCC
Confidence            8999999999999999997654                699999999999999999999999999999999999999999


Q ss_pred             cEEEeeccCccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCC
Q 019650          184 EVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHY  262 (337)
Q Consensus       184 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~  262 (337)
                      .++|+|||++.......               ......+++.|+|||.+.    +..++.++||||||+++|+|++ |..
T Consensus       180 ~~kL~Dfg~~~~~~~~~---------------~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~il~ellt~g~~  240 (327)
T 1fvr_A          180 VAKIADFGLSRGQEVYV---------------KKTMGRLPVRWMAIESLN----YSVYTTNSDVWSYGVLLWEIVSLGGT  240 (327)
T ss_dssp             CEEECCTTCEESSCEEC---------------CC----CCTTTCCHHHHH----HCEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred             eEEEcccCcCccccccc---------------cccCCCCCccccChhhhc----cccCCchhcchHHHHHHHHHHcCCCC
Confidence            99999999987443221               111224678999999997    4467899999999999999998 999


Q ss_pred             CCCCCCCchhHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          263 PLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       263 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                      ||.....    .........+.....+..++..+.++|.+||..||.+|||+++++++
T Consensus       241 pf~~~~~----~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  294 (327)
T 1fvr_A          241 PYCGMTC----AELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  294 (327)
T ss_dssp             TTTTCCH----HHHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCcH----HHHHHHhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            9965432    23334444455556677889999999999999999999999999986

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=3.2e-45  Score=323.68  Aligned_cols=265  Identities=29%  Similarity=0.538  Sum_probs=197.5

Q ss_pred             ccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhH-HHHHHHHHHHHhcCCCCceeeeeeEEeeCCeE
Q 019650           43 VENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIR-HQAAHEAEILKRLDSQFIVKCHAVFYTIEGEI  121 (337)
Q Consensus        43 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~  121 (337)
                      ....++|++++.||.|+||+||+|.+..+++.||+|++......... +.+..+..+++.++|+||+++++++.. ....
T Consensus        21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~-~~~~   99 (318)
T 2dyl_A           21 QAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFIT-NTDV   99 (318)
T ss_dssp             ECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-SSEE
T ss_pred             hhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEec-CCcE
Confidence            45678999999999999999999999999999999999876544333 334445556888899999999998876 6889


Q ss_pred             EEEEeccCCCCchHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCCeEEcCCCcEEEeeccCccchhcc
Q 019650          122 CFVMEHMERGSLFDSLRV-RKKLSEDVISGVAYRVLKGLQYLHGM-QIIHGDIKPSNLLINGKGEVKIADFGVSRIVEET  199 (337)
Q Consensus       122 ~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~-~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~  199 (337)
                      ++||||+ ++.+..+... ...+++..++.++.|++.||.|||+. |++|+||+|+||+++.+++++|+|||.+......
T Consensus       100 ~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  178 (318)
T 2dyl_A          100 FIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD  178 (318)
T ss_dssp             EEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred             EEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence            9999999 4455555543 46799999999999999999999995 9999999999999999999999999998765432


Q ss_pred             ccCCCCCCCCCCccccccccccCCCCCcCCccccccc-CCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHH
Q 019650          200 RNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSER-WGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALIC  278 (337)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~  278 (337)
                      ..               .....+++.|+|||.+.... .+..++.++||||||+++|+|++|..||...........   
T Consensus       179 ~~---------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~---  240 (318)
T 2dyl_A          179 KA---------------KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLT---  240 (318)
T ss_dssp             -----------------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHH---
T ss_pred             cc---------------ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHH---
Confidence            21               12235899999999995321 034678899999999999999999999976443332222   


Q ss_pred             HhhccCCCCCC--CCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccC
Q 019650          279 AICFGERLEMP--ETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRS  327 (337)
Q Consensus       279 ~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~  327 (337)
                      ..........+  ..++..+.++|.+||+.||.+|||++++++||||++..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  291 (318)
T 2dyl_A          241 KVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYE  291 (318)
T ss_dssp             HHHHSCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHH
T ss_pred             HHhccCCCCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhcc
Confidence            22222233332  35789999999999999999999999999999998754

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.4e-45  Score=328.17  Aligned_cols=259  Identities=22%  Similarity=0.309  Sum_probs=216.9

Q ss_pred             CccCccccccccccccCcceEEEEEEEccCCc-----eEEEEEeecCCchHhHHHHHHHHHHHHhc-CCCCceeeeeeEE
Q 019650           42 DVENISDLKKLTVLGHGNGGIVYKVRHQKSNS-----IYALKVLNTTSSTIIRHQAAHEAEILKRL-DSQFIVKCHAVFY  115 (337)
Q Consensus        42 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~  115 (337)
                      +....++|.+.+.||.|+||+||+|.+..++.     .||+|.+.........+.+.+|+.+++++ +|+||+++++++.
T Consensus        41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~  120 (333)
T 2i1m_A           41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT  120 (333)
T ss_dssp             GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence            45567899999999999999999999876554     79999998776666677888999999999 8999999999876


Q ss_pred             eeCCeEEEEEeccCCCCchHHhhhc--------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcC
Q 019650          116 TIEGEICFVMEHMERGSLFDSLRVR--------------KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLING  181 (337)
Q Consensus       116 ~~~~~~~lv~e~~~~~~L~~~l~~~--------------~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~  181 (337)
                      . ....++||||+++++|.+++...              ..+++..++.++.|++.||.|||+.|++||||||+||+++.
T Consensus       121 ~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~  199 (333)
T 2i1m_A          121 H-GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTN  199 (333)
T ss_dssp             S-SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEG
T ss_pred             c-CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECC
Confidence            6 67899999999999999999753              35799999999999999999999999999999999999999


Q ss_pred             CCcEEEeeccCccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-C
Q 019650          182 KGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-G  260 (337)
Q Consensus       182 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g  260 (337)
                      ++.++|+|||++.........            .......+++.|+|||.+.    +..++.++||||||+++|+|++ |
T Consensus       200 ~~~~kl~Dfg~~~~~~~~~~~------------~~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~il~el~t~g  263 (333)
T 2i1m_A          200 GHVAKIGDFGLARDIMNDSNY------------IVKGNARLPVKWMAPESIF----DCVYTVQSDVWSYGILLWEIFSLG  263 (333)
T ss_dssp             GGEEEBCCCGGGCCGGGCTTS------------EECSSCEECGGGSCHHHHH----HCCCCHHHHHHHHHHHHHHHTTTS
T ss_pred             CCeEEECccccccccccccce------------eecCCCCCCccccCHHHhc----cCCCChHHHHHHHHHHHHHHHcCC
Confidence            999999999999866443211            1122234678999999998    4578999999999999999999 9


Q ss_pred             CCCCCCCCCchhHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          261 HYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       261 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                      ..||...............   ......+...+..+.+++.+||+.||.+|||+++++++
T Consensus       264 ~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  320 (333)
T 2i1m_A          264 LNPYPGILVNSKFYKLVKD---GYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF  320 (333)
T ss_dssp             CCSSTTCCSSHHHHHHHHH---TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCcccchhHHHHHHHhc---CCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence            9999776555444433332   33445566779999999999999999999999999874

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=6.8e-46  Score=335.23  Aligned_cols=263  Identities=23%  Similarity=0.368  Sum_probs=207.8

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcC-----------CCCceeeee
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLD-----------SQFIVKCHA  112 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-----------~~~i~~~~~  112 (337)
                      ...++|++.+.||+|+||+||+|.+..+++.||+|++...  ....+.+.+|+.+++++.           |+||+++++
T Consensus        16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~   93 (373)
T 1q8y_A           16 YKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD--KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD   93 (373)
T ss_dssp             ETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred             ccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC--ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHH
Confidence            4567999999999999999999999999999999998743  334566778999888876           789999999


Q ss_pred             eEEeeCC---eEEEEEeccCCCCchHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCCeEEcC-----
Q 019650          113 VFYTIEG---EICFVMEHMERGSLFDSLRVR--KKLSEDVISGVAYRVLKGLQYLHGM-QIIHGDIKPSNLLING-----  181 (337)
Q Consensus       113 ~~~~~~~---~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~-~ivH~dl~~~Nili~~-----  181 (337)
                      .+...+.   ..+++||++ +++|.+++...  ..+++..+..++.||+.||+|||++ ||+||||||+||+++.     
T Consensus        94 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~  172 (373)
T 1q8y_A           94 HFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPE  172 (373)
T ss_dssp             EEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTT
T ss_pred             HhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCc
Confidence            8876432   689999999 77999999763  4599999999999999999999998 9999999999999953     


Q ss_pred             -CCcEEEeeccCccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhC
Q 019650          182 -KGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVG  260 (337)
Q Consensus       182 -~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg  260 (337)
                       .+.++|+|||++.......                 ....+|+.|+|||++.    +..++.++||||||+++|+|++|
T Consensus       173 ~~~~~kl~Dfg~a~~~~~~~-----------------~~~~~t~~y~aPE~~~----~~~~~~~~Di~slG~il~el~~g  231 (373)
T 1q8y_A          173 NLIQIKIADLGNACWYDEHY-----------------TNSIQTREYRSPEVLL----GAPWGCGADIWSTACLIFELITG  231 (373)
T ss_dssp             TEEEEEECCCTTCEETTBCC-----------------CSCCSCGGGCCHHHHH----TCCCCTHHHHHHHHHHHHHHHHS
T ss_pred             CcceEEEcccccccccCCCC-----------------CCCCCCccccCcHHHh----CCCCCchHhHHHHHHHHHHHHhC
Confidence             3479999999997664321                 1225899999999998    45789999999999999999999


Q ss_pred             CCCCCCCCCc------hhHHHHHHHhhc-------------------------------------cCCCCCCCCCCHHHH
Q 019650          261 HYPLIGFGEK------PDLMALICAICF-------------------------------------GERLEMPETASPEFR  297 (337)
Q Consensus       261 ~~pf~~~~~~------~~~~~~~~~~~~-------------------------------------~~~~~~~~~~~~~~~  297 (337)
                      ..||......      ............                                     .....++...+..+.
T Consensus       232 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (373)
T 1q8y_A          232 DFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEIS  311 (373)
T ss_dssp             SCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHH
T ss_pred             CCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHH
Confidence            9999754321      111111111000                                     001122334467899


Q ss_pred             HHHHHHhhcCcCCCCCHHHHhcCccccccCCCc
Q 019650          298 RFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSS  330 (337)
Q Consensus       298 ~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~~  330 (337)
                      +||.+||+.||++|||++|+|+||||++.....
T Consensus       312 ~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~  344 (373)
T 1q8y_A          312 DFLSPMLQLDPRKRADAGGLVNHPWLKDTLGME  344 (373)
T ss_dssp             HHHGGGGCSSTTTCBCHHHHHTCGGGTTCTTCT
T ss_pred             HHHHHHhccCccccCCHHHHhhChhhhcccCcc
Confidence            999999999999999999999999999875443

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.3e-45  Score=321.80  Aligned_cols=257  Identities=24%  Similarity=0.348  Sum_probs=217.5

Q ss_pred             CCCccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCC
Q 019650           40 SPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEG  119 (337)
Q Consensus        40 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~  119 (337)
                      ..+....++|++.+.||+|++|+||+|.+..++..||+|++....  ...+.+.+|+.++++++|+||+++++++.+ ..
T Consensus         6 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~   82 (288)
T 3kfa_A            6 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-EP   82 (288)
T ss_dssp             CTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS--THHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred             hcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEcc-CC
Confidence            456677899999999999999999999999999999999997643  345678899999999999999999998765 67


Q ss_pred             eEEEEEeccCCCCchHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchh
Q 019650          120 EICFVMEHMERGSLFDSLRVR--KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVE  197 (337)
Q Consensus       120 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~  197 (337)
                      ..++||||+++++|.+++...  ..+++..++.++.|++.||+|||++|++|+||||+||+++.++.++|+|||.+....
T Consensus        83 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~  162 (288)
T 3kfa_A           83 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT  162 (288)
T ss_dssp             SEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSC
T ss_pred             CEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceecc
Confidence            899999999999999999864  459999999999999999999999999999999999999999999999999987654


Q ss_pred             ccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCchhHHHH
Q 019650          198 ETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMAL  276 (337)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~~~~~~~~~~~  276 (337)
                      ....             .......+++.|+|||.+.    +..++.++||||||+++|+|++ |..||....... ..  
T Consensus       163 ~~~~-------------~~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~-~~--  222 (288)
T 3kfa_A          163 GDTY-------------TAHAGAKFPIKWTAPESLA----YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-VY--  222 (288)
T ss_dssp             SSSS-------------EEETTEEECGGGCCHHHHH----HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-HH--
T ss_pred             CCcc-------------ccccCCccccCcCChhhhc----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-HH--
Confidence            3221             1222234678899999998    4578999999999999999999 999997654332 22  


Q ss_pred             HHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          277 ICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                       ...........+..+++.+.+++.+||..||.+|||++++++.
T Consensus       223 -~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~  265 (288)
T 3kfa_A          223 -ELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQA  265 (288)
T ss_dssp             -HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -HHHhccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHH
Confidence             2223344556677889999999999999999999999999873

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=3e-45  Score=320.88  Aligned_cols=262  Identities=20%  Similarity=0.186  Sum_probs=210.9

Q ss_pred             ccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhc-CCCCceeeeeeEEeeCCeE
Q 019650           43 VENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRL-DSQFIVKCHAVFYTIEGEI  121 (337)
Q Consensus        43 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~  121 (337)
                      ....++|++.+.||+|++|+||+|.+..+++.||+|++.....   .+.+.+|+.+++.+ .|++++.+++.+.. ....
T Consensus         6 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~e~~~~~~l~~~~~i~~~~~~~~~-~~~~   81 (298)
T 1csn_A            6 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD---APQLRDEYRTYKLLAGCTGIPNVYYFGQE-GLHN   81 (298)
T ss_dssp             CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT---SCCHHHHHHHHHHTTTCTTCCCEEEEEEE-TTEE
T ss_pred             cccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc---cHHHHHHHHHHHHHhcCCCCCeEEeecCC-Ccee
Confidence            3456789999999999999999999999999999999875432   24567799999999 78999999998765 7889


Q ss_pred             EEEEeccCCCCchHHhhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCc-----EEEeeccCccc
Q 019650          122 CFVMEHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGE-----VKIADFGVSRI  195 (337)
Q Consensus       122 ~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~-----~~l~Dfg~~~~  195 (337)
                      ++||||+ +++|.+++...+ .+++..+..++.|++.||.|||++|++||||||+||+++.++.     ++|+|||++..
T Consensus        82 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~  160 (298)
T 1csn_A           82 VLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  160 (298)
T ss_dssp             EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             EEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence            9999999 889999998654 6999999999999999999999999999999999999987765     99999999987


Q ss_pred             hhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHH-
Q 019650          196 VEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLM-  274 (337)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~-  274 (337)
                      ...........       ........|++.|+|||.+.    +..++.++||||||+++|+|++|+.||.......... 
T Consensus       161 ~~~~~~~~~~~-------~~~~~~~~gt~~y~aPE~~~----~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~  229 (298)
T 1csn_A          161 YRDPVTKQHIP-------YREKKNLSGTARYMSINTHL----GREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQK  229 (298)
T ss_dssp             SBCTTTCCBCC-------CCCCCCCCSCTTTCCHHHHT----TCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHH
T ss_pred             ccccccccccc-------ccCccCCCCCcccCCchhhc----CCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHH
Confidence            75433211100       01223446899999999998    4578999999999999999999999997754332221 


Q ss_pred             --HHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          275 --ALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       275 --~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                        .................+++.+.+++.+||+.||++|||++++++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~  277 (298)
T 1csn_A          230 YERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL  277 (298)
T ss_dssp             HHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred             HHHHHhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence              1111212222223345679999999999999999999999998764

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=1.4e-45  Score=332.11  Aligned_cols=263  Identities=19%  Similarity=0.241  Sum_probs=203.6

Q ss_pred             CccccccccccccCcceEEEEEEEccC-----CceEEEEEeecCCchHh----------HHHHHHHHHHHHhcCCCCcee
Q 019650           45 NISDLKKLTVLGHGNGGIVYKVRHQKS-----NSIYALKVLNTTSSTII----------RHQAAHEAEILKRLDSQFIVK  109 (337)
Q Consensus        45 ~~~~y~~~~~lg~g~~~~v~~~~~~~~-----~~~vaiK~~~~~~~~~~----------~~~~~~e~~~~~~l~~~~i~~  109 (337)
                      ..++|++.+.||+|+||+||+|.+..+     ++.||+|++........          ......|+..+..++|+||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            345999999999999999999998754     57899999876542211          112234555667778999999


Q ss_pred             eeeeEEeeC---CeEEEEEeccCCCCchHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEc--CCC
Q 019650          110 CHAVFYTIE---GEICFVMEHMERGSLFDSLRVR-KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLIN--GKG  183 (337)
Q Consensus       110 ~~~~~~~~~---~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~--~~~  183 (337)
                      +++++....   ...++||||+ |++|.+++... ..+++..++.++.||+.||+|||++||+||||||+||+++  .++
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~  191 (364)
T 3op5_A          113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPD  191 (364)
T ss_dssp             EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTT
T ss_pred             EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCC
Confidence            999887642   4589999999 88999999865 6799999999999999999999999999999999999999  789


Q ss_pred             cEEEeeccCccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCC
Q 019650          184 EVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYP  263 (337)
Q Consensus       184 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~p  263 (337)
                      .++|+|||++..............       .......||+.|+|||++.    +..++.++||||||+++|+|++|+.|
T Consensus       192 ~~kl~DFG~a~~~~~~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~----~~~~~~~~Di~slG~~l~el~~g~~P  260 (364)
T 3op5_A          192 QVYLVDYGLAYRYCPEGVHKAYAA-------DPKRCHDGTIEFTSIDAHN----GVAPSRRGDLEILGYCMIQWLTGHLP  260 (364)
T ss_dssp             CEEECCCTTCEESSGGGCCCCSSC-------CSSCCCCCCTTTCCHHHHT----TCCCCHHHHHHHHHHHHHHHHHSCCT
T ss_pred             eEEEEECCcceecccCCccccccc-------CcccccCCCCCccCHHHhC----CCCCCchhhHHHHHHHHHHHHhCCCC
Confidence            999999999987765432221110       1223446999999999998    55789999999999999999999999


Q ss_pred             CCCCCCchhHHHHHHHhhccCCC------CCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhc
Q 019650          264 LIGFGEKPDLMALICAICFGERL------EMPETASPEFRRFVRSCLEKDWRKRGTVEELLA  319 (337)
Q Consensus       264 f~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~  319 (337)
                      |.+....................      ......+..+.+++..||..||.+||+++++++
T Consensus       261 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~  322 (364)
T 3op5_A          261 WEDNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD  322 (364)
T ss_dssp             TGGGTTCHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             ccccccCHHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence            97644433332222211111100      112567899999999999999999999999876

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.4e-46  Score=330.16  Aligned_cols=255  Identities=23%  Similarity=0.375  Sum_probs=203.9

Q ss_pred             ccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCch-----HhHHHHHHHHHHHHhc----CCCCceeeeee
Q 019650           43 VENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSST-----IIRHQAAHEAEILKRL----DSQFIVKCHAV  113 (337)
Q Consensus        43 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~e~~~~~~l----~~~~i~~~~~~  113 (337)
                      ....++|++.+.||+|+||.||+|.+..+++.||+|++......     .....+.+|+.++.++    +|+||++++++
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~  106 (312)
T 2iwi_A           27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW  106 (312)
T ss_dssp             ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred             hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence            34567899999999999999999999999999999999655321     1223345688999988    89999999998


Q ss_pred             EEeeCCeEEEEEec-cCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEc-CCCcEEEeecc
Q 019650          114 FYTIEGEICFVMEH-MERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLIN-GKGEVKIADFG  191 (337)
Q Consensus       114 ~~~~~~~~~lv~e~-~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~-~~~~~~l~Dfg  191 (337)
                      +.. ....++|||+ +.+++|.+++.....+++..++.++.||+.||.|||+.|++||||+|+||+++ .++.++|+|||
T Consensus       107 ~~~-~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg  185 (312)
T 2iwi_A          107 FET-QEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFG  185 (312)
T ss_dssp             C------CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCS
T ss_pred             Eec-CCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcc
Confidence            766 5778899999 78889999999888899999999999999999999999999999999999999 78999999999


Q ss_pred             CccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCch
Q 019650          192 VSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP  271 (337)
Q Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~  271 (337)
                      .+.......                .....++..|+|||++...   ...+.++||||||+++|+|++|+.||...   .
T Consensus       186 ~~~~~~~~~----------------~~~~~~~~~y~aPE~~~~~---~~~~~~~Di~slG~il~~l~~g~~pf~~~---~  243 (312)
T 2iwi_A          186 SGALLHDEP----------------YTDFDGTRVYSPPEWISRH---QYHALPATVWSLGILLYDMVCGDIPFERD---Q  243 (312)
T ss_dssp             SCEECCSSC----------------BCCCCSCTTTSCHHHHHHS---CBCHHHHHHHHHHHHHHHHHHSSCSCCSH---H
T ss_pred             hhhhcccCc----------------ccccCCcccccCceeeecC---CCCCccchHHHHHHHHHHHHHCCCCCCCh---H
Confidence            987764322                1123489999999998743   22345899999999999999999999532   1


Q ss_pred             hHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCC
Q 019650          272 DLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSS  328 (337)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~  328 (337)
                         ...     .....++..++..+.++|.+||+.||++|||++++++||||++...
T Consensus       244 ---~~~-----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~  292 (312)
T 2iwi_A          244 ---EIL-----EAELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAE  292 (312)
T ss_dssp             ---HHH-----HTCCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC---
T ss_pred             ---HHh-----hhccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCchh
Confidence               111     1244566778999999999999999999999999999999998654

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2e-45  Score=320.56  Aligned_cols=258  Identities=25%  Similarity=0.371  Sum_probs=216.0

Q ss_pred             ccCcccccccc-ccccCcceEEEEEEEc--cCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCC
Q 019650           43 VENISDLKKLT-VLGHGNGGIVYKVRHQ--KSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEG  119 (337)
Q Consensus        43 ~~~~~~y~~~~-~lg~g~~~~v~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~  119 (337)
                      ....++|.+.+ .||+|+||+||+|.+.  .++..||+|+++........+.+.+|+.++++++|+||+++++++ . ..
T Consensus         5 ~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~-~~   82 (287)
T 1u59_A            5 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-Q-AE   82 (287)
T ss_dssp             BCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-E-SS
T ss_pred             cccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-c-CC
Confidence            34567888887 9999999999999864  567889999998776666778889999999999999999999987 3 56


Q ss_pred             eEEEEEeccCCCCchHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhc
Q 019650          120 EICFVMEHMERGSLFDSLRVR-KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEE  198 (337)
Q Consensus       120 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~  198 (337)
                      ..++|||++++++|.+++... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus        83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~  162 (287)
T 1u59_A           83 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA  162 (287)
T ss_dssp             SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred             CcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence            799999999999999999644 5699999999999999999999999999999999999999999999999999987643


Q ss_pred             cccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCchhHHHHH
Q 019650          199 TRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALI  277 (337)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~  277 (337)
                      .....           .......+++.|+|||.+.    +..++.++||||||+++|+|++ |..||.......    ..
T Consensus       163 ~~~~~-----------~~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~----~~  223 (287)
T 1u59_A          163 DDSYY-----------TARSAGKWPLKWYAPECIN----FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE----VM  223 (287)
T ss_dssp             CSCEE-----------CCCCSSCCCGGGCCHHHHH----HCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH----HH
T ss_pred             Cccee-----------eccccccccccccCHHHhc----cCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH----HH
Confidence            32111           1112224688999999997    4468889999999999999998 999997654432    23


Q ss_pred             HHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCc
Q 019650          278 CAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYP  321 (337)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp  321 (337)
                      .....+.....+..+++.+.++|.+||+.||.+|||+.+++++.
T Consensus       224 ~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l  267 (287)
T 1u59_A          224 AFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM  267 (287)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred             HHHhcCCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence            33344555667788999999999999999999999999999874

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=4.4e-46  Score=330.41  Aligned_cols=256  Identities=25%  Similarity=0.352  Sum_probs=211.0

Q ss_pred             ccCccccccccccccCcceEEEEEEEccCCce----EEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeC
Q 019650           43 VENISDLKKLTVLGHGNGGIVYKVRHQKSNSI----YALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIE  118 (337)
Q Consensus        43 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~----vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~  118 (337)
                      ....++|++++.||+|+||+||+|.+..++..    |++|.+...........+.+|+.++++++|+||+++++++.  +
T Consensus         9 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~   86 (325)
T 3kex_A            9 IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP--G   86 (325)
T ss_dssp             BCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC--B
T ss_pred             hcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc--C
Confidence            45568999999999999999999999877765    77787755443334455678999999999999999999764  4


Q ss_pred             CeEEEEEeccCCCCchHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchh
Q 019650          119 GEICFVMEHMERGSLFDSLRVR-KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVE  197 (337)
Q Consensus       119 ~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~  197 (337)
                      ...++||||+.+++|.+++... +.+++..+..++.||+.||.|||++|++||||||+||+++.+++++|+|||++....
T Consensus        87 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  166 (325)
T 3kex_A           87 SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLP  166 (325)
T ss_dssp             SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred             CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccC
Confidence            6789999999999999999764 579999999999999999999999999999999999999999999999999998764


Q ss_pred             ccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCchhHHHH
Q 019650          198 ETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMAL  276 (337)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~~~~~~~~~~~  276 (337)
                      .....            .......++..|+|||++.    +..++.++||||||+++|+|++ |..||........    
T Consensus       167 ~~~~~------------~~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~----  226 (325)
T 3kex_A          167 PDDKQ------------LLYSEAKTPIKWMALESIH----FGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEV----  226 (325)
T ss_dssp             CCTTC------------CC-----CCTTTSCHHHHH----HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHH----
T ss_pred             ccccc------------ccccCCCCcccccChHHhc----cCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHH----
Confidence            43211            1122335788999999998    4578999999999999999999 9999976544322    


Q ss_pred             HHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          277 ICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                      ............+..++..+.+++.+||..||.+|||+++++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~  270 (325)
T 3kex_A          227 PDLLEKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANE  270 (325)
T ss_dssp             HHHHHTTCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred             HHHHHcCCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            22233444556667788899999999999999999999999886

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.9e-45  Score=318.60  Aligned_cols=258  Identities=21%  Similarity=0.309  Sum_probs=211.5

Q ss_pred             ccccccccccccCcceEEEEEEEccCCc---eEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEE
Q 019650           46 ISDLKKLTVLGHGNGGIVYKVRHQKSNS---IYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEIC  122 (337)
Q Consensus        46 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~  122 (337)
                      .-.|.+.+.||+|+||+||+|.+..++.   .+|+|++.........+.+.+|+.++++++|+||+++++++.+.+...+
T Consensus        20 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   99 (298)
T 3pls_A           20 RVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPH   99 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred             ceEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcE
Confidence            3467778999999999999999754443   7999999876666667788899999999999999999999877555569


Q ss_pred             EEEeccCCCCchHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhcccc
Q 019650          123 FVMEHMERGSLFDSLRV-RKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRN  201 (337)
Q Consensus       123 lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~  201 (337)
                      ++|||+.+++|.+++.. ...+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++........
T Consensus       100 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~  179 (298)
T 3pls_A          100 VLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREY  179 (298)
T ss_dssp             EEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGG
T ss_pred             EEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcc
Confidence            99999999999999976 45789999999999999999999999999999999999999999999999999986654332


Q ss_pred             CCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhh
Q 019650          202 NNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAIC  281 (337)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~  281 (337)
                      ...          .......+++.|+|||.+.    +..++.++||||||+++|+|++|..|+....+.......   ..
T Consensus       180 ~~~----------~~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~---~~  242 (298)
T 3pls_A          180 YSV----------QQHRHARLPVKWTALESLQ----TYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHF---LA  242 (298)
T ss_dssp             GCS----------CCSSCTTCGGGGSCHHHHT----TCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHH---HH
T ss_pred             ccc----------ccCcCCCCCccccChhhhc----cCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHH---hh
Confidence            111          1122335788999999998    557899999999999999999965555443333333333   33


Q ss_pred             ccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          282 FGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       282 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                      .......+..++..+.+++.+||+.||.+|||++++++.
T Consensus       243 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  281 (298)
T 3pls_A          243 QGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGE  281 (298)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            344555667789999999999999999999999999874

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1.9e-45  Score=326.98  Aligned_cols=258  Identities=20%  Similarity=0.221  Sum_probs=207.0

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhc-CCCCceeeeeeEEeeCCeEE
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRL-DSQFIVKCHAVFYTIEGEIC  122 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~~  122 (337)
                      ...++|++.+.||.|+||+||+|.+..+++.||+|++.....   .+.+.+|+.+++++ +|+||+++++++.. +...+
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-~~~~~   81 (330)
T 2izr_A            6 MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR---APQLHLEYRFYKQLGSGDGIPQVYYFGPC-GKYNA   81 (330)
T ss_dssp             EETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS---SCCHHHHHHHHHHHCSCTTSCCEEEEEEE-TTEEE
T ss_pred             EEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc---hHHHHHHHHHHHHhhCCCCCCEEEEEEec-CCccE
Confidence            345789999999999999999999999999999999875532   23567899999999 99999999998776 78899


Q ss_pred             EEEeccCCCCchHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCc-----EEEeeccCccch
Q 019650          123 FVMEHMERGSLFDSLRV-RKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGE-----VKIADFGVSRIV  196 (337)
Q Consensus       123 lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~-----~~l~Dfg~~~~~  196 (337)
                      +||||+ +++|.+++.. ...+++..++.++.|++.||+|||+.||+||||||+||+++.++.     ++|+|||++...
T Consensus        82 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~  160 (330)
T 2izr_A           82 MVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY  160 (330)
T ss_dssp             EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred             EEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence            999999 8899999986 468999999999999999999999999999999999999998887     999999999876


Q ss_pred             hccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHH
Q 019650          197 EETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMAL  276 (337)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~  276 (337)
                      ..........       ........||+.|+|||.+.    +..++.++||||||+++|+|++|..||......... ..
T Consensus       161 ~~~~~~~~~~-------~~~~~~~~gt~~y~aPE~~~----~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~-~~  228 (330)
T 2izr_A          161 IDPETKKHIP-------YREHKSLTGTARYMSINTHL----GKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLK-ER  228 (330)
T ss_dssp             BCTTTCCBCC-------CCCCCCCCSCTTTCCHHHHT----TCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHH-HH
T ss_pred             ecCCCCcccc-------ccccCCcCCCccccChHHHc----CCCCCchhHHHHHHHHHHHHhcCCCCccccccccHH-HH
Confidence            5432211100       01223456999999999998    557899999999999999999999999875433221 11


Q ss_pred             HHHh---hccCCC-CCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhc
Q 019650          277 ICAI---CFGERL-EMPETASPEFRRFVRSCLEKDWRKRGTVEELLA  319 (337)
Q Consensus       277 ~~~~---~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~  319 (337)
                      ....   ...... ......+ .+.+++..||+.||.+||+++++++
T Consensus       229 ~~~i~~~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~  274 (330)
T 2izr_A          229 YQKIGDTKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK  274 (330)
T ss_dssp             HHHHHHHHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             HHHHHhhhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            1111   111111 1122344 9999999999999999999998876

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=4.5e-45  Score=327.46  Aligned_cols=260  Identities=23%  Similarity=0.328  Sum_probs=206.5

Q ss_pred             ccCccccccccccccCcceEEEEEEEccCC-ceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCC------ceeeeeeEE
Q 019650           43 VENISDLKKLTVLGHGNGGIVYKVRHQKSN-SIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQF------IVKCHAVFY  115 (337)
Q Consensus        43 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~-~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~------i~~~~~~~~  115 (337)
                      ....++|++.+.||+|+||+||+|.+..++ ..||+|+++..  ....+.+.+|+.+++++.|++      ++.+.+.+.
T Consensus        15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~   92 (355)
T 2eu9_A           15 DWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV--GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFN   92 (355)
T ss_dssp             CEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEE
T ss_pred             ceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc--ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeee
Confidence            344589999999999999999999998766 68999998753  334566778999999987655      788888766


Q ss_pred             eeCCeEEEEEeccCCCCchHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEE--------------
Q 019650          116 TIEGEICFVMEHMERGSLFDSLRVR--KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLI--------------  179 (337)
Q Consensus       116 ~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili--------------  179 (337)
                      . ....++||||+ +++|.+++...  ..+++..++.++.||+.||+|||++||+||||||+||++              
T Consensus        93 ~-~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~  170 (355)
T 2eu9_A           93 F-HGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKS  170 (355)
T ss_dssp             E-TTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred             e-CCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccccc
Confidence            5 78999999999 55787777654  369999999999999999999999999999999999999              


Q ss_pred             -----cCCCcEEEeeccCccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHH
Q 019650          180 -----NGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVV  254 (337)
Q Consensus       180 -----~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il  254 (337)
                           +.++.++|+|||++.......                 ....||+.|+|||++.    +..++.++||||||+++
T Consensus       171 ~~~~~~~~~~~kl~Dfg~~~~~~~~~-----------------~~~~gt~~y~aPE~~~----~~~~~~~~Di~slG~il  229 (355)
T 2eu9_A          171 CEEKSVKNTSIRVADFGSATFDHEHH-----------------TTIVATRHYRPPEVIL----ELGWAQPCDVWSIGCIL  229 (355)
T ss_dssp             CCEEEESCCCEEECCCTTCEETTSCC-----------------CSSCSCGGGCCHHHHT----TCCCCTHHHHHHHHHHH
T ss_pred             ccccccCCCcEEEeecCccccccccc-----------------cCCcCCCcccCCeeee----cCCCCCccchHHHHHHH
Confidence                 567899999999987643221                 2235899999999998    45789999999999999


Q ss_pred             HHHHhCCCCCCCCCCchhHHHHHHHhhccCCC----------------------------------------CCCCCCCH
Q 019650          255 LECLVGHYPLIGFGEKPDLMALICAICFGERL----------------------------------------EMPETASP  294 (337)
Q Consensus       255 ~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~----------------------------------------~~~~~~~~  294 (337)
                      |+|++|..||.......... .+.......+.                                        ......+.
T Consensus       230 ~el~~g~~pf~~~~~~~~~~-~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (355)
T 2eu9_A          230 FEYYRGFTLFQTHENREHLV-MMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHV  308 (355)
T ss_dssp             HHHHHSSCSCCCSSHHHHHH-HHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHH
T ss_pred             HHHHhCCCCCCCCCHHHHHH-HHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHH
Confidence            99999999997654333222 22221111000                                        00111235


Q ss_pred             HHHHHHHHHhhcCcCCCCCHHHHhcCccccccCC
Q 019650          295 EFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSS  328 (337)
Q Consensus       295 ~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~  328 (337)
                      .+.+||.+||+.||.+|||++++|+||||++...
T Consensus       309 ~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~  342 (355)
T 2eu9_A          309 QLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTP  342 (355)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHTTSGGGGGCCH
T ss_pred             HHHHHHHHHhcCChhhCcCHHHHhcChhhcCCCh
Confidence            7889999999999999999999999999998653

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=8.1e-45  Score=317.87  Aligned_cols=262  Identities=19%  Similarity=0.211  Sum_probs=211.5

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEE
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICF  123 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~l  123 (337)
                      ...++|++.+.||+|+||+||+|.+..+++.||+|++......   +.+.+|+.+++.+.|+++++.+..+.......++
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l   82 (296)
T 3uzp_A            6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH---PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM   82 (296)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC---CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred             eeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch---hHHHHHHHHHHHhhcCCCCCccccccCCCCceEE
Confidence            3457999999999999999999999999999999998765422   4577899999999999988888877777888999


Q ss_pred             EEeccCCCCchHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEc---CCCcEEEeeccCccchhcc
Q 019650          124 VMEHMERGSLFDSLRV-RKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLIN---GKGEVKIADFGVSRIVEET  199 (337)
Q Consensus       124 v~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~---~~~~~~l~Dfg~~~~~~~~  199 (337)
                      ||||+ +++|.+++.. ...+++..++.++.|++.||+|||++|++||||||+||+++   .++.++|+|||.+......
T Consensus        83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~  161 (296)
T 3uzp_A           83 VMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  161 (296)
T ss_dssp             EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             EEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence            99999 8899999974 46799999999999999999999999999999999999994   7889999999999876544


Q ss_pred             ccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCc---hhHHHH
Q 019650          200 RNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEK---PDLMAL  276 (337)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~---~~~~~~  276 (337)
                      .......       ........|++.|+|||.+.    +..++.++||||||+++|+|++|+.||......   ......
T Consensus       162 ~~~~~~~-------~~~~~~~~gt~~y~aPE~~~----~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~  230 (296)
T 3uzp_A          162 RTHQHIP-------YRENKNLTGTARYASINTHL----GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI  230 (296)
T ss_dssp             TTCCBCC-------CCCSCCCCSCTTTCCHHHHT----TCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHH
T ss_pred             ccccccc-------cccccccccccccCChhhhc----CCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhh
Confidence            3211100       01223446899999999998    457899999999999999999999999764322   222222


Q ss_pred             HHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          277 ICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                      ............+..+++.+.+++.+||+.||++|||++++++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  274 (296)
T 3uzp_A          231 SEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQL  274 (296)
T ss_dssp             HHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHH
T ss_pred             cccccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHH
Confidence            22222222222345678999999999999999999999998873

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=5.2e-45  Score=316.92  Aligned_cols=256  Identities=26%  Similarity=0.345  Sum_probs=210.9

Q ss_pred             CccCccccccccccccCcceEEEEEEEcc---CCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeC
Q 019650           42 DVENISDLKKLTVLGHGNGGIVYKVRHQK---SNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIE  118 (337)
Q Consensus        42 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~  118 (337)
                      .....++|++.+.||+|+||+||+|.+..   ++..||+|++.........+.+.+|+.++++++|+||+++++++.  .
T Consensus         7 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~   84 (281)
T 3cc6_A            7 YGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIE--E   84 (281)
T ss_dssp             CSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEEC--S
T ss_pred             ceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEc--C
Confidence            34567899999999999999999998753   344699999987765666788899999999999999999999864  3


Q ss_pred             CeEEEEEeccCCCCchHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchh
Q 019650          119 GEICFVMEHMERGSLFDSLRVR-KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVE  197 (337)
Q Consensus       119 ~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~  197 (337)
                      ...++||||+++++|.+++... ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||.+....
T Consensus        85 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  164 (281)
T 3cc6_A           85 EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIE  164 (281)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred             CCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcccc
Confidence            5678999999999999999765 459999999999999999999999999999999999999999999999999987764


Q ss_pred             ccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCchhHHHH
Q 019650          198 ETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMAL  276 (337)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~~~~~~~~~~~  276 (337)
                      .....             ......+++.|+|||.+.    +..++.++||||||+++|+|++ |+.||......... ..
T Consensus       165 ~~~~~-------------~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~-~~  226 (281)
T 3cc6_A          165 DEDYY-------------KASVTRLPIKWMSPESIN----FRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVI-GV  226 (281)
T ss_dssp             ---------------------CCCCCGGGCCHHHHH----HCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHH-HH
T ss_pred             ccccc-------------ccccCCCCcceeCchhhc----cCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHH-HH
Confidence            43211             111224678999999997    4578899999999999999998 99999765443322 22


Q ss_pred             HHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          277 ICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                         .........+..+++.+.+++.+||..||.+|||+.+++++
T Consensus       227 ---~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~  267 (281)
T 3cc6_A          227 ---LEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS  267 (281)
T ss_dssp             ---HHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---HhcCCCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence               22334455667789999999999999999999999999875

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.8e-45  Score=324.24  Aligned_cols=258  Identities=24%  Similarity=0.388  Sum_probs=208.1

Q ss_pred             ccCccccccccccccCcceEEEEEEEccCC----ceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeC
Q 019650           43 VENISDLKKLTVLGHGNGGIVYKVRHQKSN----SIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIE  118 (337)
Q Consensus        43 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~  118 (337)
                      ....++|++.+.||+|+||+||+|.+..++    ..||+|++...........+.+|+.++++++|+||+++++++.. .
T Consensus        40 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~  118 (333)
T 1mqb_A           40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK-Y  118 (333)
T ss_dssp             BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-S
T ss_pred             cCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec-C
Confidence            445678999999999999999999986543    45999999876656566778899999999999999999998765 6


Q ss_pred             CeEEEEEeccCCCCchHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchh
Q 019650          119 GEICFVMEHMERGSLFDSLRVR-KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVE  197 (337)
Q Consensus       119 ~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~  197 (337)
                      ...++||||+++++|.+++... ..+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||.+....
T Consensus       119 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~  198 (333)
T 1mqb_A          119 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE  198 (333)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             CCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence            7899999999999999999764 679999999999999999999999999999999999999999999999999998765


Q ss_pred             ccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCchhHHHH
Q 019650          198 ETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMAL  276 (337)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~~~~~~~~~~~  276 (337)
                      ......           .......+++.|+|||.+.    +..++.++||||||+++|+|++ |..||......    ..
T Consensus       199 ~~~~~~-----------~~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~----~~  259 (333)
T 1mqb_A          199 DDPEAT-----------YTTSGGKIPIRWTAPEAIS----YRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH----EV  259 (333)
T ss_dssp             -----------------------CCCGGGSCHHHHH----SCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH----HH
T ss_pred             cccccc-----------cccCCCCccccccCchhcc----cCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH----HH
Confidence            432111           1111223678899999998    4578999999999999999999 99999654332    23


Q ss_pred             HHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          277 ICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                      ......+.....+..++..+.+++.+||+.||.+|||+.+++++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  303 (333)
T 1mqb_A          260 MKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSI  303 (333)
T ss_dssp             HHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             HHHHHCCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            33333444555667789999999999999999999999999875

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=1.2e-45  Score=322.10  Aligned_cols=249  Identities=20%  Similarity=0.294  Sum_probs=206.5

Q ss_pred             cCccccccccccccCcceEEEEEEEccCC-------ceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEe
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSN-------SIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYT  116 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~-------~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~  116 (337)
                      ...++|++.+.||+|+||+||+|.+..++       ..||+|++.... ....+.+.+|+.++++++|+||+++++++..
T Consensus         5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   83 (289)
T 4fvq_A            5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH-RNYSESFFEAASMMSKLSHKHLVLNYGVCVC   83 (289)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG-GGGHHHHHHHHHHHHTSCCTTBCCEEEEECC
T ss_pred             echhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEe
Confidence            45689999999999999999999998776       469999986543 3455778899999999999999999998876


Q ss_pred             eCCeEEEEEeccCCCCchHHhhhcCC-CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCc--------EEE
Q 019650          117 IEGEICFVMEHMERGSLFDSLRVRKK-LSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGE--------VKI  187 (337)
Q Consensus       117 ~~~~~~lv~e~~~~~~L~~~l~~~~~-l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~--------~~l  187 (337)
                       ....++||||+++++|.+++...+. +++..++.++.||+.||.|||++|++||||||+||+++.++.        ++|
T Consensus        84 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl  162 (289)
T 4fvq_A           84 -GDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKL  162 (289)
T ss_dssp             -TTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred             -CCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeee
Confidence             6788999999999999999987654 999999999999999999999999999999999999998887        999


Q ss_pred             eeccCccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Q 019650          188 ADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGF  267 (337)
Q Consensus       188 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~  267 (337)
                      +|||.+.......                  ...+++.|+|||.+...   ..++.++||||||+++|+|++|..|+...
T Consensus       163 ~Dfg~~~~~~~~~------------------~~~~~~~y~aPE~~~~~---~~~~~~~DiwslG~il~el~~g~~~~~~~  221 (289)
T 4fvq_A          163 SDPGISITVLPKD------------------ILQERIPWVPPECIENP---KNLNLATDKWSFGTTLWEICSGGDKPLSA  221 (289)
T ss_dssp             CCCCSCTTTSCHH------------------HHHHTTTTSCHHHHHCG---GGCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             ccCcccccccCcc------------------ccCCcCcccCHHHhCCC---CCCCchhHHHHHHHHHHHHHcCCCCCccc
Confidence            9999986553321                  12368899999999842   46899999999999999999955454333


Q ss_pred             CCchhHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          268 GEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                      .+.........     .....+...+..+.+++.+||+.||.+|||+++++++
T Consensus       222 ~~~~~~~~~~~-----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  269 (289)
T 4fvq_A          222 LDSQRKLQFYE-----DRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD  269 (289)
T ss_dssp             SCHHHHHHHHH-----TTCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             cchHHHHHHhh-----ccCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            33322222221     2445556678899999999999999999999999986

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=6.1e-45  Score=319.09  Aligned_cols=259  Identities=22%  Similarity=0.305  Sum_probs=211.3

Q ss_pred             cCccccccccccccCcceEEEEEEEccC---CceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCe
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKS---NSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGE  120 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~  120 (337)
                      ....+|++.+.||+|+||+||+|.+..+   ...+|+|.+.........+.+.+|+.++++++|+||+++++++...+..
T Consensus        22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  101 (298)
T 3f66_A           22 PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS  101 (298)
T ss_dssp             GGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSC
T ss_pred             ccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCc
Confidence            3456899999999999999999997533   3458999988766666678889999999999999999999987776778


Q ss_pred             EEEEEeccCCCCchHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhcc
Q 019650          121 ICFVMEHMERGSLFDSLRV-RKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEET  199 (337)
Q Consensus       121 ~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~  199 (337)
                      .++||||+++++|.+++.. ...+++..++.++.|++.||+|||++|++||||||+||+++.++.++|+|||.+......
T Consensus       102 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~  181 (298)
T 3f66_A          102 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK  181 (298)
T ss_dssp             CEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCG
T ss_pred             eEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECccccccccccc
Confidence            8999999999999999975 456899999999999999999999999999999999999999999999999999876543


Q ss_pred             ccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHH
Q 019650          200 RNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALIC  278 (337)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~  278 (337)
                      .....          .......+++.|+|||.+.    +..++.++|+||||+++|+|++ +.+||.........    .
T Consensus       182 ~~~~~----------~~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~----~  243 (298)
T 3f66_A          182 EYYSV----------HNKTGAKLPVKWMALESLQ----TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT----V  243 (298)
T ss_dssp             GGCBC---------------CCBCGGGSCHHHHH----HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHH----H
T ss_pred             chhcc----------ccccCCCCCccccChHHhc----CCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHH----H
Confidence            32111          1222335788999999998    4578999999999999999999 66666554333322    2


Q ss_pred             HhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          279 AICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                      ..........+..+++.+.+++.+||+.||.+|||++++++.
T Consensus       244 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~  285 (298)
T 3f66_A          244 YLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  285 (298)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHhcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            222344455567789999999999999999999999999873

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=4.3e-45  Score=314.90  Aligned_cols=254  Identities=26%  Similarity=0.406  Sum_probs=212.9

Q ss_pred             CccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeE
Q 019650           42 DVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEI  121 (337)
Q Consensus        42 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~  121 (337)
                      +....++|++.+.||+|++|+||+|.+. ++..||+|++......  .+.+.+|+.++++++|+||+++++++.+ ....
T Consensus         3 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~   78 (267)
T 3t9t_A            3 WVIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGVCLE-QAPI   78 (267)
T ss_dssp             CBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBC--HHHHHHHHHHHHTCCCTTBCCEEEEECS-SSSC
T ss_pred             eEEchhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCC--HHHHHHHHHHHHhCCCCCEeeEEEEEcc-CCCe
Confidence            4556789999999999999999999986 6678999999765432  3678899999999999999999998866 6789


Q ss_pred             EEEEeccCCCCchHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccc
Q 019650          122 CFVMEHMERGSLFDSLRVR-KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETR  200 (337)
Q Consensus       122 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~  200 (337)
                      +++|||+++++|.+++... ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        79 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~  158 (267)
T 3t9t_A           79 CLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ  158 (267)
T ss_dssp             EEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred             EEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccccc
Confidence            9999999999999999765 568999999999999999999999999999999999999999999999999987654322


Q ss_pred             cCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHH
Q 019650          201 NNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICA  279 (337)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~  279 (337)
                      .             .......++..|+|||.+.    +..++.++|+||||+++|+|++ |..||......    .....
T Consensus       159 ~-------------~~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~----~~~~~  217 (267)
T 3t9t_A          159 Y-------------TSSTGTKFPVKWASPEVFS----FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS----EVVED  217 (267)
T ss_dssp             H-------------HSTTSTTCCGGGCCHHHHH----HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH----HHHHH
T ss_pred             c-------------cccccccccccccChhhhc----CCCccchhchhhhHHHHHHHhccCCCCCCCCCHH----HHHHH
Confidence            1             1111224678899999998    4578899999999999999999 89999654322    23333


Q ss_pred             hhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          280 ICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                      ...+.....+...+..+.+++.+||+.||.+|||+++++++
T Consensus       218 i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (267)
T 3t9t_A          218 ISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ  258 (267)
T ss_dssp             HHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HhcCCcCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            34444555667789999999999999999999999999875

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=2.9e-45  Score=320.10  Aligned_cols=256  Identities=24%  Similarity=0.373  Sum_probs=211.2

Q ss_pred             ccCcccccccc-ccccCcceEEEEEEE--ccCCceEEEEEeecCC-chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeC
Q 019650           43 VENISDLKKLT-VLGHGNGGIVYKVRH--QKSNSIYALKVLNTTS-STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIE  118 (337)
Q Consensus        43 ~~~~~~y~~~~-~lg~g~~~~v~~~~~--~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~  118 (337)
                      ....++|.+.+ .||.|+||+||+|.+  ..+++.||+|++.... .....+.+.+|+.+++.++|+||+++++++ . .
T Consensus        12 ~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~-~   89 (291)
T 1xbb_A           12 YLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-E-A   89 (291)
T ss_dssp             BCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-E-S
T ss_pred             eecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-C-C
Confidence            34567999998 999999999999954  5677899999997653 233467788999999999999999999987 3 5


Q ss_pred             CeEEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhc
Q 019650          119 GEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEE  198 (337)
Q Consensus       119 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~  198 (337)
                      ...++||||+++++|.+++...+.+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.....
T Consensus        90 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  169 (291)
T 1xbb_A           90 ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA  169 (291)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred             CCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeecc
Confidence            78899999999999999999888899999999999999999999999999999999999999999999999999876643


Q ss_pred             cccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCchhHHHHH
Q 019650          199 TRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALI  277 (337)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~  277 (337)
                      .....           .......+++.|+|||.+.    +..++.++||||||+++|+|++ |..||......    ...
T Consensus       170 ~~~~~-----------~~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~----~~~  230 (291)
T 1xbb_A          170 DENYY-----------KAQTHGKWPVKWYAPECIN----YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS----EVT  230 (291)
T ss_dssp             TCSEE-----------EC----CCCGGGCCHHHHH----HCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH----HHH
T ss_pred             CCCcc-----------cccccCCCCceeeChHHhc----cCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH----HHH
Confidence            32111           1111223678899999997    3467889999999999999999 99999764332    233


Q ss_pred             HHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhc
Q 019650          278 CAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA  319 (337)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~  319 (337)
                      .....+.....+..++..+.+++.+||+.||.+|||+.++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  272 (291)
T 1xbb_A          231 AMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL  272 (291)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            334445566677888999999999999999999999999986

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=2.2e-45  Score=324.99  Aligned_cols=261  Identities=26%  Similarity=0.361  Sum_probs=212.3

Q ss_pred             ccCccccccccccccCcceEEEEEEE----ccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEee-
Q 019650           43 VENISDLKKLTVLGHGNGGIVYKVRH----QKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTI-  117 (337)
Q Consensus        43 ~~~~~~y~~~~~lg~g~~~~v~~~~~----~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-  117 (337)
                      ...-+.|++++.||+|+||+||++..    ..+++.||+|++.........+.+.+|+.++++++|+||+++++++.+. 
T Consensus        27 ~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  106 (318)
T 3lxp_A           27 VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAG  106 (318)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             eecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCC
Confidence            33334459999999999999988754    4578999999998776666677889999999999999999999998774 


Q ss_pred             CCeEEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchh
Q 019650          118 EGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVE  197 (337)
Q Consensus       118 ~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~  197 (337)
                      ...+++||||+++++|.+++... .+++..++.++.||+.||+|||+.|++|+||||+||+++.++.++|+|||.+....
T Consensus       107 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  185 (318)
T 3lxp_A          107 AASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  185 (318)
T ss_dssp             TTEEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred             CceEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccccccc
Confidence            35789999999999999999754 49999999999999999999999999999999999999999999999999998764


Q ss_pred             ccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCC--------
Q 019650          198 ETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGE--------  269 (337)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~--------  269 (337)
                      ......           .......++..|+|||.+.    +..++.++||||||+++|+|++|..||.....        
T Consensus       186 ~~~~~~-----------~~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~  250 (318)
T 3lxp_A          186 EGHEYY-----------RVREDGDSPVFWYAPECLK----EYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGI  250 (318)
T ss_dssp             TTCSEE-----------EC---CCCCGGGCCHHHHH----HCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCS
T ss_pred             cccccc-----------ccccCCCCCceeeChHHhc----CCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcc
Confidence            432110           1122334788899999998    44678899999999999999999999854211        


Q ss_pred             ---chhHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhc
Q 019650          270 ---KPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA  319 (337)
Q Consensus       270 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~  319 (337)
                         ...................+..++..+.++|.+||+.||.+|||++++++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  303 (318)
T 3lxp_A          251 AQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP  303 (318)
T ss_dssp             CCHHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cccchhHHHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence               11122233344455566677888999999999999999999999999986

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=6.8e-46  Score=337.81  Aligned_cols=262  Identities=26%  Similarity=0.377  Sum_probs=211.1

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeC-CeEE
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIE-GEIC  122 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~-~~~~  122 (337)
                      ..-++|++.+.||+|+||+||+|.+..+++.||+|++.........+.+.+|+.++++++|+||+++++++.... ...+
T Consensus         6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~   85 (396)
T 4eut_A            6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV   85 (396)
T ss_dssp             CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred             CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeE
Confidence            446799999999999999999999999999999999976554445667788999999999999999999887643 3789


Q ss_pred             EEEeccCCCCchHHhhhcCC---CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEE----cCCCcEEEeeccCccc
Q 019650          123 FVMEHMERGSLFDSLRVRKK---LSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLI----NGKGEVKIADFGVSRI  195 (337)
Q Consensus       123 lv~e~~~~~~L~~~l~~~~~---l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili----~~~~~~~l~Dfg~~~~  195 (337)
                      +||||+++++|.+++.....   +++..++.++.||+.||+|||+.||+||||||+||++    +.++.++|+|||++..
T Consensus        86 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~  165 (396)
T 4eut_A           86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE  165 (396)
T ss_dssp             EEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred             EEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence            99999999999999976443   9999999999999999999999999999999999999    6677899999999987


Q ss_pred             hhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccC----CCCCCccccHHHHHHHHHHHHhCCCCCCCCCCch
Q 019650          196 VEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERW----GGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP  271 (337)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~----~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~  271 (337)
                      ......               .....|++.|+|||.+.....    +..++.++||||||+++|+|++|..||.......
T Consensus       166 ~~~~~~---------------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~  230 (396)
T 4eut_A          166 LEDDEQ---------------FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR  230 (396)
T ss_dssp             CCCGGG---------------SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTT
T ss_pred             ccCCCc---------------cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCccc
Confidence            654321               123358999999999863100    0256779999999999999999999997654444


Q ss_pred             hHHHHHHHhhccCCCC------------------------CCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          272 DLMALICAICFGERLE------------------------MPETASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       272 ~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                      .....+.....+.+..                        +...++..+.+++.+||+.||++|||+++++++
T Consensus       231 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~  303 (396)
T 4eut_A          231 RNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE  303 (396)
T ss_dssp             TCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred             chHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence            4444444443333221                        112234578999999999999999999998653

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=6.4e-45  Score=317.63  Aligned_cols=266  Identities=22%  Similarity=0.380  Sum_probs=203.0

Q ss_pred             CCCCCCccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCC-chHhHHHHHHHHHHHHhcCCCCceeeeeeEE
Q 019650           37 NPTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-STIIRHQAAHEAEILKRLDSQFIVKCHAVFY  115 (337)
Q Consensus        37 ~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~  115 (337)
                      ....+++...++|++.+.||+|+||+||+|.+.   ..+|+|+++... .....+.+.+|+.++++++|+||+++++.. 
T Consensus        14 ~~~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-   89 (289)
T 3og7_A           14 DAADDWEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-   89 (289)
T ss_dssp             ----CCBCCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-
T ss_pred             CCCCCCccCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-
Confidence            334455677789999999999999999999764   359999987654 344567788999999999999999999953 


Q ss_pred             eeCCeEEEEEeccCCCCchHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCcc
Q 019650          116 TIEGEICFVMEHMERGSLFDSLRV-RKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSR  194 (337)
Q Consensus       116 ~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~  194 (337)
                      . ....++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.
T Consensus        90 ~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~  168 (289)
T 3og7_A           90 T-APQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLAT  168 (289)
T ss_dssp             C-SSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC---
T ss_pred             c-CCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceecc
Confidence            3 5678999999999999999964 4579999999999999999999999999999999999999999999999999987


Q ss_pred             chhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHH
Q 019650          195 IVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLM  274 (337)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~  274 (337)
                      ........            .......|++.|+|||.+.... +..++.++||||||+++|+|++|+.||..........
T Consensus       169 ~~~~~~~~------------~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~  235 (289)
T 3og7_A          169 EKSRWSGS------------HQFEQLSGSILWMAPEVIRMQD-SNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII  235 (289)
T ss_dssp             ---------------------------CCCTTCCHHHHC-----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHH
T ss_pred             cccccccc------------ccccccCCCccccCchhhcccC-CCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHH
Confidence            65432111            1122335899999999986332 3467889999999999999999999998766655554


Q ss_pred             HHHHHhhccC-CCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          275 ALICAICFGE-RLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       275 ~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                      .......... .......+++.+.+++.+||+.||.+|||++++++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~  282 (289)
T 3og7_A          236 EMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAE  282 (289)
T ss_dssp             HHHHHTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHhcccccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence            4443322221 123345778999999999999999999999999863

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.5e-45  Score=325.69  Aligned_cols=256  Identities=25%  Similarity=0.395  Sum_probs=206.7

Q ss_pred             ccCccccccccccccCcceEEEEEEEccCCceE----EEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeC
Q 019650           43 VENISDLKKLTVLGHGNGGIVYKVRHQKSNSIY----ALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIE  118 (337)
Q Consensus        43 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v----aiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~  118 (337)
                      ....++|++++.||+|+||+||+|.+..++..+    ++|.+.........+.+.+|+.++++++|+||+++++++..  
T Consensus        11 ~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--   88 (327)
T 3lzb_A           11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT--   88 (327)
T ss_dssp             ECCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEES--
T ss_pred             ccCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEec--
Confidence            355689999999999999999999998777654    67776555445566788899999999999999999998865  


Q ss_pred             CeEEEEEeccCCCCchHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchh
Q 019650          119 GEICFVMEHMERGSLFDSLRVR-KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVE  197 (337)
Q Consensus       119 ~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~  197 (337)
                      ...+++++++.+++|.+++... ..+++..++.++.||+.||.|||++|++||||||+||+++.+++++|+|||++....
T Consensus        89 ~~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~  168 (327)
T 3lzb_A           89 STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             SSEEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred             CCceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence            4588999999999999999764 579999999999999999999999999999999999999999999999999998764


Q ss_pred             ccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCchhHHHH
Q 019650          198 ETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMAL  276 (337)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~~~~~~~~~~~  276 (337)
                      .....            .......+++.|+|||.+.    +..++.++||||||+++|+|++ |..||....... ..  
T Consensus       169 ~~~~~------------~~~~~~~~t~~y~aPE~~~----~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~-~~--  229 (327)
T 3lzb_A          169 AEEKE------------YHAEGGKVPIKWMALESIL----HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-IS--  229 (327)
T ss_dssp             -----------------------CCCGGGSCHHHHH----HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-HH--
T ss_pred             Ccccc------------ccccCCCccccccCHHHHc----CCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH-HH--
Confidence            43211            1112234678899999998    4578999999999999999999 999997654433 22  


Q ss_pred             HHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          277 ICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                       ...........+..++..+.+++.+||..||.+|||++++++.
T Consensus       230 -~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  272 (327)
T 3lzb_A          230 -SILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             -HHHHTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -HHHHcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence             2233344556677789999999999999999999999999874

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=4.2e-45  Score=341.38  Aligned_cols=257  Identities=24%  Similarity=0.340  Sum_probs=217.6

Q ss_pred             CCCccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCC
Q 019650           40 SPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEG  119 (337)
Q Consensus        40 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~  119 (337)
                      ..+....++|++.+.||+|+||+||+|.+..++..||+|+++....  ..+.+.+|+.++++++|+||+++++++.. ..
T Consensus       213 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~  289 (495)
T 1opk_A          213 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCTR-EP  289 (495)
T ss_dssp             SCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred             cccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc--chHHHHHHHHHHHhcCCCCEeeEEEEEec-CC
Confidence            3456677899999999999999999999998899999999976542  35678899999999999999999998866 67


Q ss_pred             eEEEEEeccCCCCchHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchh
Q 019650          120 EICFVMEHMERGSLFDSLRVR--KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVE  197 (337)
Q Consensus       120 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~  197 (337)
                      ..++||||+++|+|.+++...  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus       290 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  369 (495)
T 1opk_A          290 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMT  369 (495)
T ss_dssp             SCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCT
T ss_pred             cEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceecc
Confidence            899999999999999999753  458999999999999999999999999999999999999999999999999998764


Q ss_pred             ccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCchhHHHH
Q 019650          198 ETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMAL  276 (337)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~~~~~~~~~~~  276 (337)
                      ....             .......++..|+|||.+.    +..++.++||||||+++|+|++ |..||.......    .
T Consensus       370 ~~~~-------------~~~~~~~~~~~y~aPE~~~----~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~----~  428 (495)
T 1opk_A          370 GDTY-------------TAHAGAKFPIKWTAPESLA----YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----V  428 (495)
T ss_dssp             TCCE-------------ECCTTCCCCGGGCCHHHHH----HCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG----H
T ss_pred             CCce-------------eecCCCcCCcceeCHhHHh----cCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH----H
Confidence            3211             1112223678899999998    4468899999999999999999 999997654332    2


Q ss_pred             HHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          277 ICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                      ............+..++..+.+||.+||+.||.+|||++++++.
T Consensus       429 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~  472 (495)
T 1opk_A          429 YELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQA  472 (495)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHcCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            22333455566778889999999999999999999999999873

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=2.8e-45  Score=327.84  Aligned_cols=264  Identities=19%  Similarity=0.190  Sum_probs=203.3

Q ss_pred             CccccccccccccCcceEEEEEEEcc---CCceEEEEEeecCCchH----------hHHHHHHHHHHHHhcCCCCceeee
Q 019650           45 NISDLKKLTVLGHGNGGIVYKVRHQK---SNSIYALKVLNTTSSTI----------IRHQAAHEAEILKRLDSQFIVKCH  111 (337)
Q Consensus        45 ~~~~y~~~~~lg~g~~~~v~~~~~~~---~~~~vaiK~~~~~~~~~----------~~~~~~~e~~~~~~l~~~~i~~~~  111 (337)
                      ..++|++.+.||+|+||+||+|.+..   ++..+|+|++.......          ....+.+|+..++.++|+||++++
T Consensus        35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~  114 (345)
T 2v62_A           35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFY  114 (345)
T ss_dssp             TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEE
T ss_pred             cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceee
Confidence            34789999999999999999999986   78899999987654221          122355788889999999999999


Q ss_pred             eeEEee---CCeEEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCC--cEE
Q 019650          112 AVFYTI---EGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKG--EVK  186 (337)
Q Consensus       112 ~~~~~~---~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~--~~~  186 (337)
                      +++...   ....++||||+ +++|.+++...+.+++..++.++.||+.||+|||++|++||||||+||+++.++  .++
T Consensus       115 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~k  193 (345)
T 2v62_A          115 GSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVY  193 (345)
T ss_dssp             EEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEE
T ss_pred             cccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEE
Confidence            988763   46789999999 889999999888999999999999999999999999999999999999999887  999


Q ss_pred             EeeccCccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCC
Q 019650          187 IADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIG  266 (337)
Q Consensus       187 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~  266 (337)
                      |+|||++.............       ........|++.|+|||++.    +..++.++||||||+++|+|++|..||..
T Consensus       194 L~Dfg~a~~~~~~~~~~~~~-------~~~~~~~~gt~~y~aPE~~~----~~~~~~~~Di~slG~il~ell~g~~pf~~  262 (345)
T 2v62_A          194 LADYGLSYRYCPNGNHKQYQ-------ENPRKGHNGTIEFTSLDAHK----GVALSRRSDVEILGYCMLRWLCGKLPWEQ  262 (345)
T ss_dssp             ECCCTTCEESSGGGCCCCCC-------CCGGGCSCSCTTTCCHHHHH----TCCCCHHHHHHHHHHHHHHHHHSSCTTGG
T ss_pred             EEeCCCceecccccccccch-------hccccccCCCccccCHHHhc----CCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            99999998775443221110       02223456899999999998    45789999999999999999999999954


Q ss_pred             CCCchhHHHHHH-HhhccCCC-----CCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          267 FGEKPDLMALIC-AICFGERL-----EMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       267 ~~~~~~~~~~~~-~~~~~~~~-----~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                      ............ ......+.     .....++..+.+++.+||..||++|||++++++.
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  322 (345)
T 2v62_A          263 NLKDPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI  322 (345)
T ss_dssp             GTTCHHHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred             cccccHHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence            333322222221 21111111     0112678999999999999999999999998874

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=6.7e-45  Score=314.42  Aligned_cols=250  Identities=27%  Similarity=0.453  Sum_probs=199.2

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCc---hHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCe
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSS---TIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGE  120 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~  120 (337)
                      ...++|++.+.||+|+||+||+|.+.  +..||+|++.....   ....+.+.+|+.+++.++|+||+++++++.. ...
T Consensus         4 ~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~   80 (271)
T 3dtc_A            4 IDFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLK-EPN   80 (271)
T ss_dssp             CCTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECC-C--
T ss_pred             cchhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec-CCc
Confidence            45689999999999999999999875  78899999875432   2234678889999999999999999998866 678


Q ss_pred             EEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCCCCeEEcC--------CCcEEEee
Q 019650          121 ICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQ---IIHGDIKPSNLLING--------KGEVKIAD  189 (337)
Q Consensus       121 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~---ivH~dl~~~Nili~~--------~~~~~l~D  189 (337)
                      .++||||+++++|.+++. ...+++..++.++.|++.||+|||++|   ++||||||+||+++.        ++.++|+|
T Consensus        81 ~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D  159 (271)
T 3dtc_A           81 LCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD  159 (271)
T ss_dssp             CEEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred             eEEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence            899999999999999986 457999999999999999999999999   899999999999986        67899999


Q ss_pred             ccCccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCC
Q 019650          190 FGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGE  269 (337)
Q Consensus       190 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~  269 (337)
                      ||.+........                ....+++.|+|||.+.    +..++.++||||||+++|+|++|..||.....
T Consensus       160 fg~~~~~~~~~~----------------~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~  219 (271)
T 3dtc_A          160 FGLAREWHRTTK----------------MSAAGAYAWMAPEVIR----ASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG  219 (271)
T ss_dssp             CCC-----------------------------CCGGGSCHHHHH----HCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCH
T ss_pred             CCcccccccccc----------------cCCCCccceeCHHHhc----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence            999976543221                1235899999999998    45789999999999999999999999976433


Q ss_pred             chhHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          270 KPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                      ...   .............+..+++.+.+++.+||+.||.+|||+++++++
T Consensus       220 ~~~---~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  267 (271)
T 3dtc_A          220 LAV---AYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ  267 (271)
T ss_dssp             HHH---HHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHH---HHhhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence            222   222223334455667889999999999999999999999999875

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1.2e-44  Score=316.71  Aligned_cols=261  Identities=20%  Similarity=0.214  Sum_probs=206.8

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEE
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICF  123 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~l  123 (337)
                      ...++|++.+.||+|+||+||+|.+..+++.||+|++.....   .+.+.+|+.+++.+.|++++..+..+.......++
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l   82 (296)
T 4hgt_A            6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM   82 (296)
T ss_dssp             -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred             ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc---chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEE
Confidence            345799999999999999999999999999999998765432   23467799999999999999888888777888999


Q ss_pred             EEeccCCCCchHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEE---cCCCcEEEeeccCccchhcc
Q 019650          124 VMEHMERGSLFDSLRV-RKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLI---NGKGEVKIADFGVSRIVEET  199 (337)
Q Consensus       124 v~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili---~~~~~~~l~Dfg~~~~~~~~  199 (337)
                      ||||+ +++|.+++.. ...+++..++.++.||+.||.|||++|++||||||+||++   +.++.++|+|||++......
T Consensus        83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~  161 (296)
T 4hgt_A           83 VMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  161 (296)
T ss_dssp             EEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             EEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCc
Confidence            99999 8899999974 4679999999999999999999999999999999999999   78899999999999876543


Q ss_pred             ccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCch---hHHHH
Q 019650          200 RNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP---DLMAL  276 (337)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~---~~~~~  276 (337)
                      .......       ........+++.|+|||.+.    +..++.++||||||+++|+|++|+.||.......   .....
T Consensus       162 ~~~~~~~-------~~~~~~~~gt~~y~aPE~~~----~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~  230 (296)
T 4hgt_A          162 RTHQHIP-------YRENKNLTGTARYASINTHL----GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI  230 (296)
T ss_dssp             TTCCBCC-------CCCSCCCCSCGGGCCHHHHT----TCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHH
T ss_pred             ccCccCC-------CCcccccCCCccccchHHhc----CCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhh
Confidence            3211100       01222446899999999998    4578999999999999999999999997654332   22222


Q ss_pred             HHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhc
Q 019650          277 ICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA  319 (337)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~  319 (337)
                      ...............+++.+.+++.+||+.||++|||++++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  273 (296)
T 4hgt_A          231 SEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             HHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             hcccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence            2222222222233567899999999999999999999999887

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=3e-45  Score=317.87  Aligned_cols=248  Identities=24%  Similarity=0.408  Sum_probs=203.8

Q ss_pred             CccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeE
Q 019650           42 DVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEI  121 (337)
Q Consensus        42 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~  121 (337)
                      +....++|++.+.||+|++|+||++.+.  +..||+|+++...   ..+.+.+|+.++++++|+||+++++.+.+.....
T Consensus        16 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   90 (278)
T 1byg_A           16 WALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL   90 (278)
T ss_dssp             CBCCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CC
T ss_pred             ccCChhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh---HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCce
Confidence            3566799999999999999999999874  7889999987543   3467888999999999999999999877655678


Q ss_pred             EEEEeccCCCCchHHhhhcCC--CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhcc
Q 019650          122 CFVMEHMERGSLFDSLRVRKK--LSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEET  199 (337)
Q Consensus       122 ~lv~e~~~~~~L~~~l~~~~~--l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~  199 (337)
                      ++||||+++++|.+++.....  +++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++......
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  170 (278)
T 1byg_A           91 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  170 (278)
T ss_dssp             EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred             EEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccccccccc
Confidence            999999999999999976543  899999999999999999999999999999999999999999999999998765432


Q ss_pred             ccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHH
Q 019650          200 RNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALIC  278 (337)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~  278 (337)
                      ..                 ...+++.|+|||.+.    +..++.++||||||+++|+|++ |..||.......    ...
T Consensus       171 ~~-----------------~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~----~~~  225 (278)
T 1byg_A          171 QD-----------------TGKLPVKWTAPEALR----EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD----VVP  225 (278)
T ss_dssp             ----------------------CCTTTSCHHHHH----HCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG----HHH
T ss_pred             cc-----------------CCCccccccCHHHhC----CCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH----HHH
Confidence            11                 123688999999998    4578899999999999999998 999997654332    222


Q ss_pred             HhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhc
Q 019650          279 AICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA  319 (337)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~  319 (337)
                      ....+.....+..+++.+.+++.+||+.||.+|||++++++
T Consensus       226 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  266 (278)
T 1byg_A          226 RVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE  266 (278)
T ss_dssp             HHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHhcCCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence            33344456667788999999999999999999999999986

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1.2e-44  Score=335.23  Aligned_cols=254  Identities=26%  Similarity=0.419  Sum_probs=213.3

Q ss_pred             CCCccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCC
Q 019650           40 SPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEG  119 (337)
Q Consensus        40 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~  119 (337)
                      ..+....++|++.+.||+|+||+||+|.+. ++..||+|+++...  ...+.+.+|+.++++++|+||+++++++.  ..
T Consensus       181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~l~~~~~--~~  255 (454)
T 1qcf_A          181 DAWEIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS--MSVEAFLAEANVMKTLQHDKLVKLHAVVT--KE  255 (454)
T ss_dssp             TCSBCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS--BCHHHHHHHHHHHTTCCCTTBCCEEEEEC--SS
T ss_pred             cceeechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC--ccHHHHHHHHHHHhhCCCCCEeeEEEEEe--CC
Confidence            345667789999999999999999999985 46789999997654  23577889999999999999999999864  56


Q ss_pred             eEEEEEeccCCCCchHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchh
Q 019650          120 EICFVMEHMERGSLFDSLRVR--KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVE  197 (337)
Q Consensus       120 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~  197 (337)
                      ..++||||+++|+|.+++...  ..+++..+..++.||+.||+|||++|++||||||+|||++.++.+||+|||++....
T Consensus       256 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~  335 (454)
T 1qcf_A          256 PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIE  335 (454)
T ss_dssp             SCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBC
T ss_pred             ccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcC
Confidence            789999999999999999754  378999999999999999999999999999999999999999999999999998764


Q ss_pred             ccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCchhHHHH
Q 019650          198 ETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMAL  276 (337)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~~~~~~~~~~~  276 (337)
                      .....             ......+++.|+|||.+.    +..++.++||||||+++|||++ |+.||.+....+    .
T Consensus       336 ~~~~~-------------~~~~~~~~~~y~aPE~~~----~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~----~  394 (454)
T 1qcf_A          336 DNEYT-------------AREGAKFPIKWTAPEAIN----FGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE----V  394 (454)
T ss_dssp             CHHHH-------------TTCSSSSCGGGSCHHHHH----HCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH----H
T ss_pred             CCcee-------------ccCCCcccccccCHHHhc----cCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHH----H
Confidence            32211             111223678899999998    4578999999999999999999 999997654332    2


Q ss_pred             HHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhc
Q 019650          277 ICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA  319 (337)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~  319 (337)
                      ......+.....+..+++.+.++|.+||+.||.+|||+++|++
T Consensus       395 ~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~  437 (454)
T 1qcf_A          395 IRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQS  437 (454)
T ss_dssp             HHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence            3333344556667788999999999999999999999999986

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.8e-45  Score=330.00  Aligned_cols=256  Identities=18%  Similarity=0.268  Sum_probs=205.1

Q ss_pred             ccccccccccccCcceEEEEEEEcc--------CCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCcee--------
Q 019650           46 ISDLKKLTVLGHGNGGIVYKVRHQK--------SNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVK--------  109 (337)
Q Consensus        46 ~~~y~~~~~lg~g~~~~v~~~~~~~--------~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~--------  109 (337)
                      .++|++.+.||.|+||+||+|.+..        .++.||+|++...      +.+.+|+.++++++|+||++        
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~  114 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD------GRLFNEQNFFQRAAKPLQVNKWKKLYST  114 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT------STHHHHHHHHHHHCCHHHHHHHHHHTTC
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc------chHHHHHHHHHHhcccchhhhhhhhccC
Confidence            4799999999999999999999987        4889999998754      35678999999999999887        


Q ss_pred             -------eeeeEEeeCCeEEEEEeccCCCCchHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEc
Q 019650          110 -------CHAVFYTIEGEICFVMEHMERGSLFDSLRVR--KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLIN  180 (337)
Q Consensus       110 -------~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~  180 (337)
                             +++.+...+...++||||+ +++|.+++...  ..+++..++.++.||+.||.|||++|++||||||+||+++
T Consensus       115 ~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~  193 (352)
T 2jii_A          115 PLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVD  193 (352)
T ss_dssp             TTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEE
T ss_pred             CccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEc
Confidence                   5666655567899999999 88999999876  7899999999999999999999999999999999999999


Q ss_pred             CCC--cEEEeeccCccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHH
Q 019650          181 GKG--EVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECL  258 (337)
Q Consensus       181 ~~~--~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~  258 (337)
                      .++  .++|+|||++..............       .......|++.|+|||.+.    +..++.++||||||+++|+|+
T Consensus       194 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~----~~~~~~~~Di~slG~il~el~  262 (352)
T 2jii_A          194 PEDQSQVTLAGYGFAFRYCPSGKHVAYVE-------GSRSPHEGDLEFISMDLHK----GCGPSRRSDLQSLGYCMLKWL  262 (352)
T ss_dssp             TTEEEEEEECCGGGCBCSSGGGCCCCCCT-------TSSCTTCSCTTTCCHHHHT----TCCCCHHHHHHHHHHHHHHHH
T ss_pred             CCCCceEEEecCcceeeccCCCccccccc-------cccccccCCccccCHHHHc----cCCCCchhhHHHHHHHHHHHH
Confidence            998  999999999987765432211100       1223346899999999998    457899999999999999999


Q ss_pred             hCCCCCCCCCCch-hHHHHHHHhhccCCCCCC------CCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          259 VGHYPLIGFGEKP-DLMALICAICFGERLEMP------ETASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       259 tg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~------~~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                      +|+.||....... ......... ......+.      ..++..+.+++.+||..||.+|||++++++.
T Consensus       263 ~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  330 (352)
T 2jii_A          263 YGFLPWTNCLPNTEDIMKQKQKF-VDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNN  330 (352)
T ss_dssp             HSCCTTGGGTTCHHHHHHHHHHH-HHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred             hCCCCcccCCcCHHHHHHHHHhc-cCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHH
Confidence            9999997654222 222222222 22222222      2468999999999999999999999999764

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=3e-45  Score=324.47  Aligned_cols=261  Identities=24%  Similarity=0.287  Sum_probs=207.6

Q ss_pred             ccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEE
Q 019650           43 VENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEIC  122 (337)
Q Consensus        43 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~  122 (337)
                      ....++|.+.+.||+|+||+||+|.+ .++..||+|++..... ...+.+.+|+.+++.++|+||+++++++.+ ....+
T Consensus        35 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~  111 (321)
T 2qkw_B           35 EEATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPESS-QGIEEFETEIETLSFCRHPHLVSLIGFCDE-RNEMI  111 (321)
T ss_dssp             CCCCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCCS-SHHHHHHHHHHGGGSCCCTTBCCEEEECCC-TTCCE
T ss_pred             HHHHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccCh-HHHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CCeEE
Confidence            45678999999999999999999996 4688999999876543 345678899999999999999999998765 67899


Q ss_pred             EEEeccCCCCchHHhhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhc
Q 019650          123 FVMEHMERGSLFDSLRVRK----KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEE  198 (337)
Q Consensus       123 lv~e~~~~~~L~~~l~~~~----~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~  198 (337)
                      +||||+++++|.+++....    .+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++.....
T Consensus       112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  191 (321)
T 2qkw_B          112 LIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTE  191 (321)
T ss_dssp             EEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSS
T ss_pred             EEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            9999999999999997543    589999999999999999999999999999999999999999999999999876432


Q ss_pred             cccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhH--HHH
Q 019650          199 TRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDL--MAL  276 (337)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~--~~~  276 (337)
                      ....            .......|++.|+|||.+.    +..++.++||||||+++|+|++|+.||.........  ...
T Consensus       192 ~~~~------------~~~~~~~gt~~y~aPE~~~----~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~  255 (321)
T 2qkw_B          192 LDQT------------HLSTVVKGTLGYIDPEYFI----KGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEW  255 (321)
T ss_dssp             SSCC------------CCBCCCEEETTTCCHHHHH----HCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHH
T ss_pred             cccc------------ccccccCCCccccCHHHhc----CCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHH
Confidence            2111            1122335799999999998    446889999999999999999999999754332211  111


Q ss_pred             H-HHhhccC-----CC----CCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCcc
Q 019650          277 I-CAICFGE-----RL----EMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPF  322 (337)
Q Consensus       277 ~-~~~~~~~-----~~----~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~  322 (337)
                      . .......     ..    ..+...+..+.+++.+||+.||++|||+++++++..
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~  311 (321)
T 2qkw_B          256 AVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE  311 (321)
T ss_dssp             THHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             hhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence            0 0110110     01    112233567999999999999999999999998753

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=6.2e-45  Score=323.27  Aligned_cols=262  Identities=26%  Similarity=0.384  Sum_probs=217.0

Q ss_pred             ccCccccccccccccCcceEEEEEE----EccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEe-e
Q 019650           43 VENISDLKKLTVLGHGNGGIVYKVR----HQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYT-I  117 (337)
Q Consensus        43 ~~~~~~y~~~~~lg~g~~~~v~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-~  117 (337)
                      ....++|++++.||+|+||+||+|.    +..++..||+|++.... ....+.+.+|+.++++++|+||+++++++.. .
T Consensus        19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   97 (327)
T 3lxl_A           19 IFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG-PDQQRDFQREIQILKALHSDFIVKYRGVSYGPG   97 (327)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             hhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC-HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCC
Confidence            4556899999999999999999998    46788999999997653 3445678899999999999999999998774 2


Q ss_pred             CCeEEEEEeccCCCCchHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccch
Q 019650          118 EGEICFVMEHMERGSLFDSLRVR-KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIV  196 (337)
Q Consensus       118 ~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~  196 (337)
                      ....++||||+++++|.+++... ..+++..++.++.|++.||+|||+.|++|+||||+||+++.+++++|+|||.+...
T Consensus        98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~  177 (327)
T 3lxl_A           98 RQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLL  177 (327)
T ss_dssp             SCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred             CceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceec
Confidence            46789999999999999999863 56999999999999999999999999999999999999999999999999999876


Q ss_pred             hccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCC-------
Q 019650          197 EETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGE-------  269 (337)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~-------  269 (337)
                      .......           .......+++.|+|||.+.    +..++.++||||||+++|+|++|..||.....       
T Consensus       178 ~~~~~~~-----------~~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~  242 (327)
T 3lxl_A          178 PLDKDYY-----------VVREPGQSPIFWYAPESLS----DNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMG  242 (327)
T ss_dssp             CTTCSEE-----------ECSSCCCSCGGGSCHHHHH----HCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC
T ss_pred             ccCCccc-----------eeeccCCccccccCHHHhc----cCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcc
Confidence            4322111           1122335788899999998    44678899999999999999999999854211       


Q ss_pred             ----chhHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          270 ----KPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       270 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                          ...................+..+++.+.+++.+||+.||.+|||+++++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  297 (327)
T 3lxl_A          243 CERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ  297 (327)
T ss_dssp             ----CCHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cccccccHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                112233444455555666778889999999999999999999999999765

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.9e-45  Score=329.74  Aligned_cols=256  Identities=22%  Similarity=0.312  Sum_probs=202.6

Q ss_pred             cccccccccccCcceEEEEEEEccC---CceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEE
Q 019650           47 SDLKKLTVLGHGNGGIVYKVRHQKS---NSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICF  123 (337)
Q Consensus        47 ~~y~~~~~lg~g~~~~v~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~l  123 (337)
                      ..|.+.+.||+|+||+||+|.+..+   +..||+|.++........+.+.+|+.++++++||||+++++++...+...++
T Consensus        89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l  168 (373)
T 3c1x_A           89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  168 (373)
T ss_dssp             EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred             ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence            4688899999999999999997543   2468999987665556678889999999999999999999987765678899


Q ss_pred             EEeccCCCCchHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccC
Q 019650          124 VMEHMERGSLFDSLRVR-KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNN  202 (337)
Q Consensus       124 v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~  202 (337)
                      ||||+++++|.+++... ..+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++.........
T Consensus       169 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~  248 (373)
T 3c1x_A          169 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD  248 (373)
T ss_dssp             EEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------------
T ss_pred             EEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccccccc
Confidence            99999999999999754 45899999999999999999999999999999999999999999999999999866433211


Q ss_pred             CCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHhh
Q 019650          203 NNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICAIC  281 (337)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~  281 (337)
                      ..          .......+++.|+|||.+.    +..++.++||||||+++|+|++ |.+||..........    ...
T Consensus       249 ~~----------~~~~~~~~~~~y~aPE~~~----~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~----~~~  310 (373)
T 3c1x_A          249 SV----------HNKTGAKLPVKWMALESLQ----TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV----YLL  310 (373)
T ss_dssp             -------------------CCGGGSCHHHHH----HCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHH----HHH
T ss_pred             cc----------cccCCCCCcccccChHHhc----CCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHH----HHH
Confidence            10          1112234678999999998    4578999999999999999999 778886654433222    223


Q ss_pred             ccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          282 FGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       282 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                      .+.....+..++..+.+++.+||+.||.+|||+++++++
T Consensus       311 ~~~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~  349 (373)
T 3c1x_A          311 QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  349 (373)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            344555667789999999999999999999999999875

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=6.8e-45  Score=314.17  Aligned_cols=254  Identities=19%  Similarity=0.281  Sum_probs=211.0

Q ss_pred             CccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCC-chHhHHHHHHHHHHHHhcCCCCceeeeeeEEee-CC
Q 019650           42 DVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTI-EG  119 (337)
Q Consensus        42 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-~~  119 (337)
                      .....++|++.+.||+|+||+||+|.+.  +..||+|++.... .....+.+.+|+.++++++|+||+++++++.+. ..
T Consensus         5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   82 (271)
T 3kmu_A            5 SGIDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAP   82 (271)
T ss_dssp             CCCCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSS
T ss_pred             CCCCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCC
Confidence            3466899999999999999999999985  7889999997654 344556788999999999999999999988663 26


Q ss_pred             eEEEEEeccCCCCchHHhhhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCCeEEcCCCcEEEeeccCccc
Q 019650          120 EICFVMEHMERGSLFDSLRVRK--KLSEDVISGVAYRVLKGLQYLHGMQ--IIHGDIKPSNLLINGKGEVKIADFGVSRI  195 (337)
Q Consensus       120 ~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~~--ivH~dl~~~Nili~~~~~~~l~Dfg~~~~  195 (337)
                      ..++||||+++++|.+++....  .+++..++.++.|++.||+|||++|  ++|+||||+||+++.++.++++|||+...
T Consensus        83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~  162 (271)
T 3kmu_A           83 HPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFS  162 (271)
T ss_dssp             SCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCT
T ss_pred             CeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceee
Confidence            7899999999999999998765  4899999999999999999999999  99999999999999999999998887654


Q ss_pred             hhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHH
Q 019650          196 VEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMA  275 (337)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~  275 (337)
                      ....                   ...+++.|+|||.+.... ...++.++||||||+++|+|++|..||........   
T Consensus       163 ~~~~-------------------~~~~t~~y~aPE~~~~~~-~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~---  219 (271)
T 3kmu_A          163 FQSP-------------------GRMYAPAWVAPEALQKKP-EDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI---  219 (271)
T ss_dssp             TSCT-------------------TCBSCGGGSCHHHHHSCG-GGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHH---
T ss_pred             eccc-------------------CccCCccccChhhhccCC-CCCCCchhhHHHHHHHHHHHHhCCCCccccChHHH---
Confidence            3221                   124899999999998432 12334489999999999999999999976433222   


Q ss_pred             HHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          276 LICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                      ..........+..+..++..+.+++.+||+.||.+|||++++++.
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  264 (271)
T 3kmu_A          220 GMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPI  264 (271)
T ss_dssp             HHHHHHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            222233445566778889999999999999999999999999863

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=8.2e-45  Score=315.89  Aligned_cols=254  Identities=25%  Similarity=0.391  Sum_probs=209.5

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEe-------
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYT-------  116 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-------  116 (337)
                      ...++|++.+.||+|+||.||+|.+..+++.||+|++....     +.+.+|+.++++++|+||+++++++..       
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (284)
T 2a19_B            8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPET   82 (284)
T ss_dssp             HHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---
T ss_pred             hhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccc
Confidence            34579999999999999999999999899999999997654     245679999999999999999998753       


Q ss_pred             --------eCCeEEEEEeccCCCCchHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEE
Q 019650          117 --------IEGEICFVMEHMERGSLFDSLRVR--KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVK  186 (337)
Q Consensus       117 --------~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~  186 (337)
                              ....+++||||+++++|.+++...  ..+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++
T Consensus        83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~k  162 (284)
T 2a19_B           83 SSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVK  162 (284)
T ss_dssp             ------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEE
T ss_pred             ccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEE
Confidence                    134579999999999999999754  5799999999999999999999999999999999999999999999


Q ss_pred             EeeccCccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCC
Q 019650          187 IADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIG  266 (337)
Q Consensus       187 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~  266 (337)
                      |+|||.+........               .....+++.|+|||.+.    +..++.++||||||+++|+|++|..|+..
T Consensus       163 l~Dfg~~~~~~~~~~---------------~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~il~~l~~~~~~~~~  223 (284)
T 2a19_B          163 IGDFGLVTSLKNDGK---------------RTRSKGTLRYMSPEQIS----SQDYGKEVDLYALGLILAELLHVCDTAFE  223 (284)
T ss_dssp             ECCCTTCEESSCCSC---------------CCCCCSCCTTSCHHHHH----CSCCCTHHHHHHHHHHHHHHHSCCSSHHH
T ss_pred             ECcchhheecccccc---------------ccccCCcccccChhhhc----cCCCcchhhhHHHHHHHHHHHhcCCcchh
Confidence            999999877654321               11235899999999998    45789999999999999999999988732


Q ss_pred             CCCchhHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCCc
Q 019650          267 FGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSS  330 (337)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~~  330 (337)
                            .........   ....+...+..+.++|.+||..||.+|||+.+++++++.-......
T Consensus       224 ------~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~  278 (284)
T 2a19_B          224 ------TSKFFTDLR---DGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEK  278 (284)
T ss_dssp             ------HHHHHHHHH---TTCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC----
T ss_pred             ------HHHHHHHhh---cccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCc
Confidence                  111111111   2234566789999999999999999999999999998776655443

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.4e-44  Score=318.96  Aligned_cols=259  Identities=21%  Similarity=0.275  Sum_probs=204.3

Q ss_pred             CccCccccccccccccCcceEEEEEEEcc---CCceEEEEEeecCC-chHhHHHHHHHHHHHHhcCCCCceeeeeeEEee
Q 019650           42 DVENISDLKKLTVLGHGNGGIVYKVRHQK---SNSIYALKVLNTTS-STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTI  117 (337)
Q Consensus        42 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~---~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~  117 (337)
                      .....++|.+.+.||+|+||+||+|.+..   ++..||+|++.... .....+.+.+|+.++++++|+||+++++++.+.
T Consensus        29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  108 (313)
T 3brb_A           29 VVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEM  108 (313)
T ss_dssp             TBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-
T ss_pred             cccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeec
Confidence            34566899999999999999999998764   55689999987653 344557788999999999999999999988764


Q ss_pred             CC----eEEEEEeccCCCCchHHhh------hcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEE
Q 019650          118 EG----EICFVMEHMERGSLFDSLR------VRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKI  187 (337)
Q Consensus       118 ~~----~~~lv~e~~~~~~L~~~l~------~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l  187 (337)
                      ..    ..++||||+++++|.+++.      ....+++..++.++.||+.||.|||++|++||||||+||+++.++.++|
T Consensus       109 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl  188 (313)
T 3brb_A          109 SSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCV  188 (313)
T ss_dssp             ------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEE
T ss_pred             cccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEE
Confidence            32    4599999999999999984      3356999999999999999999999999999999999999999999999


Q ss_pred             eeccCccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCC
Q 019650          188 ADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIG  266 (337)
Q Consensus       188 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~  266 (337)
                      +|||.+.........            .......+++.|+|||.+.    +..++.++||||||+++|+|++ |..||..
T Consensus       189 ~Dfg~~~~~~~~~~~------------~~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~il~el~~~g~~p~~~  252 (313)
T 3brb_A          189 ADFGLSKKIYSGDYY------------RQGRIAKMPVKWIAIESLA----DRVYTSKSDVWAFGVTMWEIATRGMTPYPG  252 (313)
T ss_dssp             CSCSCC----------------------------CCGGGSCHHHHH----SSCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             eecCcceeccccccc------------CcccccCCCccccCchhhc----CCCccchhhhHHHHHHHHHHHhcCCCCCcc
Confidence            999998776443211            1111224678999999998    5578999999999999999999 8899976


Q ss_pred             CCCchhHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          267 FGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                      .......    .....+.....+..++..+.+++.+||..||.+|||+.+++++
T Consensus       253 ~~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  302 (313)
T 3brb_A          253 VQNHEMY----DYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ  302 (313)
T ss_dssp             CCGGGHH----HHHHTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             CCHHHHH----HHHHcCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            5443322    2233344566677889999999999999999999999999875

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.3e-44  Score=315.82  Aligned_cols=246  Identities=27%  Similarity=0.451  Sum_probs=202.5

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEE
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICF  123 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~l  123 (337)
                      ...++|++.+.||+|+||+||+|.+.  ++.||+|++....   ..+.+.+|+.++++++|+||+++++.+.   ...++
T Consensus         5 i~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~---~~~~l   76 (307)
T 2eva_A            5 IDYKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESES---ERKAFIVELRQLSRVNHPNIVKLYGACL---NPVCL   76 (307)
T ss_dssp             CCGGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSSTT---HHHHHHHHHHHHHHCCCTTBCCEEEBCT---TTTEE
T ss_pred             CCHhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecChh---HHHHHHHHHHHHhcCCCCCcCeEEEEEc---CCcEE
Confidence            45789999999999999999999875  6789999986442   4567889999999999999999999764   45789


Q ss_pred             EEeccCCCCchHHhhhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCceeccCCCCCeEEcCCCc-EEEeeccCccch
Q 019650          124 VMEHMERGSLFDSLRVRK---KLSEDVISGVAYRVLKGLQYLHG---MQIIHGDIKPSNLLINGKGE-VKIADFGVSRIV  196 (337)
Q Consensus       124 v~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~~l~~~l~~LH~---~~ivH~dl~~~Nili~~~~~-~~l~Dfg~~~~~  196 (337)
                      ||||+++++|.+++....   .++...++.++.|++.||+|||+   +|++||||||+||+++.++. ++|+|||.+...
T Consensus        77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~  156 (307)
T 2eva_A           77 VMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI  156 (307)
T ss_dssp             EEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----
T ss_pred             EEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccc
Confidence            999999999999998654   47899999999999999999999   89999999999999998886 799999998755


Q ss_pred             hccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHH
Q 019650          197 EETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMAL  276 (337)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~  276 (337)
                      ....                 ....|++.|+|||.+.    +..++.++||||||+++|+|++|+.||.......  ...
T Consensus       157 ~~~~-----------------~~~~gt~~y~aPE~~~----~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~~  213 (307)
T 2eva_A          157 QTHM-----------------TNNKGSAAWMAPEVFE----GSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA--FRI  213 (307)
T ss_dssp             -------------------------CCTTSSCHHHHT----CCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSH--HHH
T ss_pred             cccc-----------------ccCCCCCceEChhhhC----CCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccH--HHH
Confidence            3321                 1224899999999998    4578999999999999999999999997644332  233


Q ss_pred             HHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          277 ICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                      .........+..+..++..+.+++.+||+.||.+|||+++++++
T Consensus       214 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  257 (307)
T 2eva_A          214 MWAVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKI  257 (307)
T ss_dssp             HHHHHTTCCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHhcCCCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence            33344455666677889999999999999999999999999884

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=7.5e-45  Score=322.04  Aligned_cols=261  Identities=22%  Similarity=0.252  Sum_probs=201.9

Q ss_pred             ccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCC---
Q 019650           43 VENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEG---  119 (337)
Q Consensus        43 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~---  119 (337)
                      ....++|++.+.||+|+||+||+|.+.  ++.||+|++....  ........|+.++++++|+||+++++++.....   
T Consensus        20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   95 (322)
T 3soc_A           20 YFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD--KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDV   95 (322)
T ss_dssp             EETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred             ccchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc--hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCc
Confidence            355689999999999999999999875  7899999997543  233445568888999999999999999877532   


Q ss_pred             eEEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhC----------CceeccCCCCCeEEcCCCcEEEee
Q 019650          120 EICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGM----------QIIHGDIKPSNLLINGKGEVKIAD  189 (337)
Q Consensus       120 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~----------~ivH~dl~~~Nili~~~~~~~l~D  189 (337)
                      .+++||||+++|+|.+++.. ..+++..++.++.|++.||+|||+.          |++||||||+||+++.++.++|+|
T Consensus        96 ~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~D  174 (322)
T 3soc_A           96 DLWLITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIAD  174 (322)
T ss_dssp             EEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECC
T ss_pred             eEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEcc
Confidence            47999999999999999975 4599999999999999999999999          999999999999999999999999


Q ss_pred             ccCccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccC-CCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Q 019650          190 FGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERW-GGDYGFAGDVWSLGVVVLECLVGHYPLIGFG  268 (337)
Q Consensus       190 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~~~~~DiwslG~il~~l~tg~~pf~~~~  268 (337)
                      ||++.........            .......||+.|+|||++..... ...++.++||||||+++|+|++|+.||.+..
T Consensus       175 Fg~a~~~~~~~~~------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~  242 (322)
T 3soc_A          175 FGLALKFEAGKSA------------GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV  242 (322)
T ss_dssp             CTTCEEECTTSCC------------CCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCC
T ss_pred             CCcccccccccCc------------cccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCc
Confidence            9999776543211            11223468999999999974210 1245668899999999999999999997643


Q ss_pred             Cch------------hHHHHHHHhhccC-CCCCCC-----CCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          269 EKP------------DLMALICAICFGE-RLEMPE-----TASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       269 ~~~------------~~~~~~~~~~~~~-~~~~~~-----~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                      +..            ............. .+..+.     ..+..+.++|.+||+.||++|||++++++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  312 (322)
T 3soc_A          243 DEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGER  312 (322)
T ss_dssp             CCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             chhccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            211            1111111111111 111111     113459999999999999999999999863

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=4e-44  Score=310.93  Aligned_cols=253  Identities=27%  Similarity=0.418  Sum_probs=210.9

Q ss_pred             CCccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCe
Q 019650           41 PDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGE  120 (337)
Q Consensus        41 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~  120 (337)
                      .+....++|++++.||+|+||+||+|.+. ++..||+|.+.....  ..+.+.+|+.++++++|+||+++++++.  ...
T Consensus         7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~   81 (279)
T 1qpc_A            7 EWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM--SPDAFLAEANLMKQLQHQRLVRLYAVVT--QEP   81 (279)
T ss_dssp             TTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEEC--SSS
T ss_pred             hcccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcc--cHHHHHHHHHHHHhCCCcCcceEEEEEc--CCC
Confidence            34566789999999999999999999975 567899999876542  3467889999999999999999999764  456


Q ss_pred             EEEEEeccCCCCchHHhhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhc
Q 019650          121 ICFVMEHMERGSLFDSLRVRK--KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEE  198 (337)
Q Consensus       121 ~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~  198 (337)
                      .++||||+++++|.+++....  .+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||.+.....
T Consensus        82 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  161 (279)
T 1qpc_A           82 IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED  161 (279)
T ss_dssp             CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             cEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccC
Confidence            899999999999999997543  799999999999999999999999999999999999999999999999999987643


Q ss_pred             cccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCchhHHHHH
Q 019650          199 TRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALI  277 (337)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~  277 (337)
                      ...             .......++..|+|||.+.    +..++.++||||||+++|+|++ |..||......    ...
T Consensus       162 ~~~-------------~~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~----~~~  220 (279)
T 1qpc_A          162 NEY-------------TAREGAKFPIKWTAPEAIN----YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP----EVI  220 (279)
T ss_dssp             SCE-------------ECCTTCCCCTTTSCHHHHH----HCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH----HHH
T ss_pred             ccc-------------ccccCCCCccCccChhhhc----cCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH----HHH
Confidence            321             1111224678899999997    4467889999999999999999 99999764332    223


Q ss_pred             HHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhc
Q 019650          278 CAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA  319 (337)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~  319 (337)
                      ...........+..++..+.+++.+||+.||.+|||++++++
T Consensus       221 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  262 (279)
T 1qpc_A          221 QNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS  262 (279)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHhcccCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            333344455666788999999999999999999999999987

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=1.6e-44  Score=316.75  Aligned_cols=259  Identities=22%  Similarity=0.315  Sum_probs=199.3

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHh--cCCCCceeeeeeEEee---C
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKR--LDSQFIVKCHAVFYTI---E  118 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~--l~~~~i~~~~~~~~~~---~  118 (337)
                      ...++|++.+.||+|+||+||+|.+  +++.||+|++....    ...+..|.+++..  ++|+||+++++.+...   .
T Consensus         5 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~----~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~   78 (301)
T 3q4u_A            5 TVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD----EKSWFRETELYNTVMLRHENILGFIASDMTSRHSS   78 (301)
T ss_dssp             CCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG----HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTE
T ss_pred             cccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc----chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCC
Confidence            4568999999999999999999987  58899999986542    3344556666666  8999999999987653   2


Q ss_pred             CeEEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHH--------hCCceeccCCCCCeEEcCCCcEEEeec
Q 019650          119 GEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLH--------GMQIIHGDIKPSNLLINGKGEVKIADF  190 (337)
Q Consensus       119 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH--------~~~ivH~dl~~~Nili~~~~~~~l~Df  190 (337)
                      ...++||||+++|+|.++++. ..+++..++.++.|++.||+|||        +.|++||||||+||+++.+++++|+||
T Consensus        79 ~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  157 (301)
T 3q4u_A           79 TQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADL  157 (301)
T ss_dssp             EEEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred             ceeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeC
Confidence            458999999999999999964 57999999999999999999999        999999999999999999999999999


Q ss_pred             cCccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCC--CCCccccHHHHHHHHHHHHhC--------
Q 019650          191 GVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGG--DYGFAGDVWSLGVVVLECLVG--------  260 (337)
Q Consensus       191 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~--~~~~~~DiwslG~il~~l~tg--------  260 (337)
                      |++...........          .......||+.|+|||.+.......  .++.++||||||+++|+|++|        
T Consensus       158 g~a~~~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~  227 (301)
T 3q4u_A          158 GLAVMHSQSTNQLD----------VGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVE  227 (301)
T ss_dssp             TTCEEEETTTTEEE----------CCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCC
T ss_pred             CCeeeccccccccc----------ccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccc
Confidence            99876544321110          1112336899999999998431111  345789999999999999999        


Q ss_pred             --CCCCCCCCCchhHHHHHHHhh--ccCCCCCCC-----CCCHHHHHHHHHHhhcCcCCCCCHHHHhc
Q 019650          261 --HYPLIGFGEKPDLMALICAIC--FGERLEMPE-----TASPEFRRFVRSCLEKDWRKRGTVEELLA  319 (337)
Q Consensus       261 --~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~-----~~~~~~~~li~~~l~~~p~~R~s~~eil~  319 (337)
                        ..||.................  ....+..+.     ..+..+.+++.+||+.||.+|||++++++
T Consensus       228 ~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  295 (301)
T 3q4u_A          228 DYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK  295 (301)
T ss_dssp             CCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             cccccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence              888866433322222222211  122222221     23467999999999999999999999986

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=3.8e-44  Score=331.51  Aligned_cols=260  Identities=25%  Similarity=0.394  Sum_probs=211.7

Q ss_pred             CCCccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCC
Q 019650           40 SPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEG  119 (337)
Q Consensus        40 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~  119 (337)
                      ..+....++|++.+.||+|+||+||+|.+.. +..||+|+++....  ..+.+.+|+.++++++|+||+++++++.+  .
T Consensus       177 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~  251 (452)
T 1fmk_A          177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVSE--E  251 (452)
T ss_dssp             TCSBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECS--S
T ss_pred             cccccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCC--CHHHHHHHHHHHHhCCCCCEeeEEEEEcC--C
Confidence            3456677899999999999999999999864 45799999976542  34678899999999999999999998643  6


Q ss_pred             eEEEEEeccCCCCchHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchh
Q 019650          120 EICFVMEHMERGSLFDSLRVR--KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVE  197 (337)
Q Consensus       120 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~  197 (337)
                      ..++||||+++|+|.+++...  ..+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++....
T Consensus       252 ~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  331 (452)
T 1fmk_A          252 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE  331 (452)
T ss_dssp             SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred             ceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecC
Confidence            789999999999999999743  569999999999999999999999999999999999999999999999999998764


Q ss_pred             ccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCchhHHHH
Q 019650          198 ETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMAL  276 (337)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~~~~~~~~~~~  276 (337)
                      ....             .......++..|+|||.+.    +..++.++||||||+++|+|++ |..||.+....    ..
T Consensus       332 ~~~~-------------~~~~~~~~~~~y~aPE~~~----~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~----~~  390 (452)
T 1fmk_A          332 DNEY-------------TARQGAKFPIKWTAPEAAL----YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR----EV  390 (452)
T ss_dssp             ------------------------CCGGGSCHHHHH----HCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH----HH
T ss_pred             CCce-------------ecccCCcccccccCHhHHh----cCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH----HH
Confidence            3221             1111224678899999998    4578999999999999999999 99999765332    23


Q ss_pred             HHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC--ccccc
Q 019650          277 ICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY--PFVTK  325 (337)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~h--p~f~~  325 (337)
                      ......+.....+..+++.+.++|.+||+.||++|||++++++.  .++..
T Consensus       391 ~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~  441 (452)
T 1fmk_A          391 LDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  441 (452)
T ss_dssp             HHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             HHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence            33344555666778889999999999999999999999999873  45544

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=7.7e-45  Score=322.50  Aligned_cols=260  Identities=23%  Similarity=0.323  Sum_probs=204.3

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEE
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICF  123 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~l  123 (337)
                      ...++|++.+.||+|+||+||+|.+ .+++.||+|++...........+.+|+.+++.++|+||+++++++.. ....++
T Consensus        27 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~l  104 (326)
T 3uim_A           27 VASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMT-PTERLL  104 (326)
T ss_dssp             TTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECC-SSCCEE
T ss_pred             HHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEec-CCceEE
Confidence            4567999999999999999999975 46889999999766544344467889999999999999999998876 678899


Q ss_pred             EEeccCCCCchHHhhhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCCCCeEEcCCCcEEEeeccCccch
Q 019650          124 VMEHMERGSLFDSLRVRK----KLSEDVISGVAYRVLKGLQYLHGM---QIIHGDIKPSNLLINGKGEVKIADFGVSRIV  196 (337)
Q Consensus       124 v~e~~~~~~L~~~l~~~~----~l~~~~~~~i~~~l~~~l~~LH~~---~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~  196 (337)
                      ||||+++++|.+++....    .+++..+..++.|++.||+|||+.   |++||||||+||+++.++.++|+|||++...
T Consensus       105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~  184 (326)
T 3uim_A          105 VYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM  184 (326)
T ss_dssp             EEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred             EEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCcccccc
Confidence            999999999999997543    499999999999999999999999   9999999999999999999999999999866


Q ss_pred             hccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCC----CCCchh
Q 019650          197 EETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIG----FGEKPD  272 (337)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~----~~~~~~  272 (337)
                      .....             .......|++.|+|||.+.    +..++.++||||||+++|+|++|..||..    ......
T Consensus       185 ~~~~~-------------~~~~~~~gt~~y~aPE~~~----~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~  247 (326)
T 3uim_A          185 DYKDT-------------HVTTAVRGTIGHIAPEYLS----TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM  247 (326)
T ss_dssp             CSSSS-------------CEECCCCSCGGGCCHHHHH----HSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSB
T ss_pred             Ccccc-------------cccccccCCcCccCHHHhc----cCCCCccccchhHHHHHHHHHhCCCcccccccccccchh
Confidence            43221             1222335899999999997    44678999999999999999999999942    111111


Q ss_pred             HHHHHHHhhccCCC----------CCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCcc
Q 019650          273 LMALICAICFGERL----------EMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPF  322 (337)
Q Consensus       273 ~~~~~~~~~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~  322 (337)
                      ..............          ..+...+..+.+++.+||+.||.+|||++++++|..
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~  307 (326)
T 3uim_A          248 LLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE  307 (326)
T ss_dssp             HHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred             HHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence            11111111111110          111122367999999999999999999999999853

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=2.9e-44  Score=314.99  Aligned_cols=242  Identities=27%  Similarity=0.430  Sum_probs=193.6

Q ss_pred             CccCccccccc-cccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHH-HhcCCCCceeeeeeEEe---
Q 019650           42 DVENISDLKKL-TVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEIL-KRLDSQFIVKCHAVFYT---  116 (337)
Q Consensus        42 ~~~~~~~y~~~-~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~-~~l~~~~i~~~~~~~~~---  116 (337)
                      .....++|.+. +.||.|+||.||+|.+..+++.||+|++...      ....+|+.++ +.++|+||+++++++..   
T Consensus        12 ~~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~   85 (299)
T 3m2w_A           12 KNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYA   85 (299)
T ss_dssp             CSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred             ccccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc------HHHHHHHHHHHHhccCCCchhHHhhhhhhcC
Confidence            34567889988 7899999999999999999999999998643      3456677777 66699999999998765   


Q ss_pred             eCCeEEEEEeccCCCCchHHhhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcC---CCcEEEeecc
Q 019650          117 IEGEICFVMEHMERGSLFDSLRVRK--KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLING---KGEVKIADFG  191 (337)
Q Consensus       117 ~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~---~~~~~l~Dfg  191 (337)
                      .....++||||+++++|.+++....  .+++..++.++.|++.||+|||++|++|+||||+||+++.   ++.++|+|||
T Consensus        86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg  165 (299)
T 3m2w_A           86 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG  165 (299)
T ss_dssp             TEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred             CCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccc
Confidence            1456899999999999999998654  6999999999999999999999999999999999999998   7889999999


Q ss_pred             CccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCch
Q 019650          192 VSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP  271 (337)
Q Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~  271 (337)
                      ++....                                        +..++.++||||||+++|+|++|..||.......
T Consensus       166 ~a~~~~----------------------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~  205 (299)
T 3m2w_A          166 FAKETT----------------------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA  205 (299)
T ss_dssp             TCEECT----------------------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-----
T ss_pred             cccccc----------------------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchh
Confidence            886432                                        1246678999999999999999999996543221


Q ss_pred             hHHHHHHHhhccCCCCCC----CCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCCc
Q 019650          272 DLMALICAICFGERLEMP----ETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSS  330 (337)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~~  330 (337)
                      ...... ..........+    ..++..+.+++.+||+.||.+|||++++++||||++.....
T Consensus       206 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~~~  267 (299)
T 3m2w_A          206 ISPGMK-TRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVP  267 (299)
T ss_dssp             --CCSC-CSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGGSC
T ss_pred             hhHHHH-HHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccccCC
Confidence            100000 00001111122    45789999999999999999999999999999998876443

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=9.8e-44  Score=339.70  Aligned_cols=252  Identities=25%  Similarity=0.386  Sum_probs=206.9

Q ss_pred             ccccccc-ccccCcceEEEEEEEc--cCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEE
Q 019650           47 SDLKKLT-VLGHGNGGIVYKVRHQ--KSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICF  123 (337)
Q Consensus        47 ~~y~~~~-~lg~g~~~~v~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~l  123 (337)
                      +++.+.+ .||+|+||+||+|.+.  .++..||+|+++........+.+.+|+.++++++|+||+++++++..  ..+++
T Consensus       335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~--~~~~l  412 (613)
T 2ozo_A          335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA--EALML  412 (613)
T ss_dssp             TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES--SSEEE
T ss_pred             cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc--CCeEE
Confidence            4555555 8999999999999875  45667999999876555567788999999999999999999998754  56999


Q ss_pred             EEeccCCCCchHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccC
Q 019650          124 VMEHMERGSLFDSLRVR-KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNN  202 (337)
Q Consensus       124 v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~  202 (337)
                      ||||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++.........
T Consensus       413 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~  492 (613)
T 2ozo_A          413 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSY  492 (613)
T ss_dssp             EEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-----
T ss_pred             EEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCce
Confidence            99999999999999754 56999999999999999999999999999999999999999999999999999876432211


Q ss_pred             CCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHhh
Q 019650          203 NNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICAIC  281 (337)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~  281 (337)
                      .           .......+++.|+|||++.    +..++.++||||||+++|||++ |+.||......+    ......
T Consensus       493 ~-----------~~~~~~~~~~~y~APE~~~----~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~----~~~~i~  553 (613)
T 2ozo_A          493 Y-----------TARSAGKWPLKWYAPECIN----FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE----VMAFIE  553 (613)
T ss_dssp             --------------------CCTTSCHHHHH----HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH----HHHHHH
T ss_pred             e-----------eeccCCCCccceeCHhhhc----CCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH----HHHHHH
Confidence            1           1111223568999999998    4578999999999999999998 999997754433    333444


Q ss_pred             ccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhc
Q 019650          282 FGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA  319 (337)
Q Consensus       282 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~  319 (337)
                      .+.....+..++..+.++|.+||+.||.+|||++++++
T Consensus       554 ~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~  591 (613)
T 2ozo_A          554 QGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQ  591 (613)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred             cCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            56667778889999999999999999999999999854

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=4.6e-44  Score=316.21  Aligned_cols=269  Identities=22%  Similarity=0.256  Sum_probs=207.5

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEee---CCe
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTI---EGE  120 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~---~~~  120 (337)
                      ...++|++.+.||+|+||.||++.+..+++.||+|++.... ....+.+.+|+.+++.++|+||+++++++...   ...
T Consensus        26 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  104 (317)
T 2buj_A           26 IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE-QQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHE  104 (317)
T ss_dssp             ETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS-HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEE
T ss_pred             ECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC-HHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCce
Confidence            34579999999999999999999999999999999987643 34567788999999999999999999988742   247


Q ss_pred             EEEEEeccCCCCchHHhhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccch
Q 019650          121 ICFVMEHMERGSLFDSLRV----RKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIV  196 (337)
Q Consensus       121 ~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~  196 (337)
                      .++||||+.+++|.+++..    ...+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||.+...
T Consensus       105 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~  184 (317)
T 2buj_A          105 AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQA  184 (317)
T ss_dssp             EEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred             eEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence            8999999999999999975    467999999999999999999999999999999999999999999999999987765


Q ss_pred             hccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHH
Q 019650          197 EETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMAL  276 (337)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~  276 (337)
                      ..........     ..........|++.|+|||.+.... ...++.++||||||+++|+|++|+.||..........  
T Consensus       185 ~~~~~~~~~~-----~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~--  256 (317)
T 2buj_A          185 CIHVEGSRQA-----LTLQDWAAQRCTISYRAPELFSVQS-HCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSV--  256 (317)
T ss_dssp             CEEEESHHHH-----HHHHHHHHHHSCGGGCCGGGSSCCS-EEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCH--
T ss_pred             cccccccccc-----ccccccccccCCcccCCHhHhccCC-CcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchh--
Confidence            3221100000     0000111234789999999987431 1236889999999999999999999984311111111  


Q ss_pred             HHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCc
Q 019650          277 ICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYP  321 (337)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp  321 (337)
                      ............+..++..+.++|.+||+.||.+|||+++++++-
T Consensus       257 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L  301 (317)
T 2buj_A          257 ALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQL  301 (317)
T ss_dssp             HHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             hHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHh
Confidence            111112223334456789999999999999999999999999874

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=1.1e-43  Score=340.12  Aligned_cols=246  Identities=25%  Similarity=0.397  Sum_probs=204.3

Q ss_pred             cccccCcceEEEEEEE--ccCCceEEEEEeecCC-chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEeccC
Q 019650           53 TVLGHGNGGIVYKVRH--QKSNSIYALKVLNTTS-STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHME  129 (337)
Q Consensus        53 ~~lg~g~~~~v~~~~~--~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~  129 (337)
                      +.||+|+||+||+|.+  ..+++.||+|+++... .....+.+.+|+.++++++|+||+++++++.  ....++||||++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~--~~~~~lv~E~~~  452 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE--AESWMLVMEMAE  452 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE--SSSEEEEEECCT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe--cCCEEEEEEccC
Confidence            4799999999999965  4567889999997653 2334678899999999999999999999874  456899999999


Q ss_pred             CCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCCCCCCC
Q 019650          130 RGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNN  209 (337)
Q Consensus       130 ~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~  209 (337)
                      +|+|.+++.....+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++..........      
T Consensus       453 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~------  526 (635)
T 4fl3_A          453 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY------  526 (635)
T ss_dssp             TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----------
T ss_pred             CCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc------
Confidence            99999999988899999999999999999999999999999999999999999999999999998765432111      


Q ss_pred             CCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHhhccCCCCC
Q 019650          210 NNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICAICFGERLEM  288 (337)
Q Consensus       210 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  288 (337)
                           .......+++.|+|||++.    +..++.++||||||+++|+|++ |+.||.+....    ........+.....
T Consensus       527 -----~~~~~~~~t~~y~APE~~~----~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~----~~~~~i~~~~~~~~  593 (635)
T 4fl3_A          527 -----KAQTHGKWPVKWYAPECIN----YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS----EVTAMLEKGERMGC  593 (635)
T ss_dssp             -------------CGGGSCHHHHH----HCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH----HHHHHHHTTCCCCC
T ss_pred             -----ccccCCCCceeeeChhhhc----CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH----HHHHHHHcCCCCCC
Confidence                 1112224678899999998    4578999999999999999998 99999764332    33344445566777


Q ss_pred             CCCCCHHHHHHHHHHhhcCcCCCCCHHHHhc
Q 019650          289 PETASPEFRRFVRSCLEKDWRKRGTVEELLA  319 (337)
Q Consensus       289 ~~~~~~~~~~li~~~l~~~p~~R~s~~eil~  319 (337)
                      +..++..+.++|.+||+.||++|||++++++
T Consensus       594 p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~  624 (635)
T 4fl3_A          594 PAGCPREMYDLMNLCWTYDVENRPGFAAVEL  624 (635)
T ss_dssp             CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence            8889999999999999999999999999986

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=1.2e-45  Score=350.14  Aligned_cols=265  Identities=24%  Similarity=0.327  Sum_probs=207.1

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEe-----eC
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYT-----IE  118 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~  118 (337)
                      ...++|++.+.||.|+||+||+|.+..+++.||+|++.........+.+.+|+.++++++||||+++++++..     .+
T Consensus        11 ~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~   90 (676)
T 3qa8_A           11 QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPN   90 (676)
T ss_dssp             ------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTT
T ss_pred             CCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCC
Confidence            4468999999999999999999999999999999999876666667788999999999999999999987543     14


Q ss_pred             CeEEEEEeccCCCCchHHhhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCc---EEEeeccC
Q 019650          119 GEICFVMEHMERGSLFDSLRVRK---KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGE---VKIADFGV  192 (337)
Q Consensus       119 ~~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~---~~l~Dfg~  192 (337)
                      ...++||||++|++|.+++....   .+++..++.++.|++.||+|||+.|++||||+|+||+++.++.   ++|+|||.
T Consensus        91 ~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~  170 (676)
T 3qa8_A           91 DLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGY  170 (676)
T ss_dssp             SSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred             CeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccc
Confidence            56799999999999999998644   6899999999999999999999999999999999999997764   99999999


Q ss_pred             ccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchh
Q 019650          193 SRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPD  272 (337)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~  272 (337)
                      +.......               ......+++.|+|||.+.    +..++.++||||||+++|+|++|..||........
T Consensus       171 a~~~~~~~---------------~~~~~~gt~~Y~APE~l~----~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~  231 (676)
T 3qa8_A          171 AKELDQGE---------------LCTEFVGTLQYLAPELLE----QKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQ  231 (676)
T ss_dssp             CCBTTSCC---------------CCCCCCSCCTTCSSCSSC----CSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHH
T ss_pred             cccccccc---------------ccccccCCcccCChHHhc----cCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhh
Confidence            98764432               112346899999999998    56789999999999999999999999965311110


Q ss_pred             HH-----HHHHHhh----------ccC----CCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccC
Q 019650          273 LM-----ALICAIC----------FGE----RLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRS  327 (337)
Q Consensus       273 ~~-----~~~~~~~----------~~~----~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~  327 (337)
                      ..     .......          ...    +......++..+.++|.+||..||.+|||++++++||||+...
T Consensus       232 ~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~  305 (676)
T 3qa8_A          232 WHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALD  305 (676)
T ss_dssp             SSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHH
T ss_pred             hhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHH
Confidence            00     0000000          000    0112223567899999999999999999999999999998754

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=6.5e-44  Score=316.59  Aligned_cols=261  Identities=25%  Similarity=0.378  Sum_probs=211.0

Q ss_pred             ccCccccccccccccCcceEEEEEE----EccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeC
Q 019650           43 VENISDLKKLTVLGHGNGGIVYKVR----HQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIE  118 (337)
Q Consensus        43 ~~~~~~y~~~~~lg~g~~~~v~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~  118 (337)
                      ....++|++++.||+|+||.||+|.    +..+++.||+|++.... ....+.+.+|+.++++++|+||+++++++...+
T Consensus        37 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  115 (326)
T 2w1i_A           37 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG  115 (326)
T ss_dssp             CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC-SHHHHHHHHHHHHHHTCCCTTBCCEEEEECC--
T ss_pred             ccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecC
Confidence            4557889999999999999999998    45688999999997653 345667889999999999999999999876533


Q ss_pred             -CeEEEEEeccCCCCchHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccch
Q 019650          119 -GEICFVMEHMERGSLFDSLRVR-KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIV  196 (337)
Q Consensus       119 -~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~  196 (337)
                       ...++||||+++++|.+++... ..+++..++.++.|++.||.+||+.|++|+||||+||+++.++.++|+|||++...
T Consensus       116 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~  195 (326)
T 2w1i_A          116 RRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVL  195 (326)
T ss_dssp             --CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             CCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhhc
Confidence             3689999999999999999865 46999999999999999999999999999999999999999999999999999876


Q ss_pred             hccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCC--------
Q 019650          197 EETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFG--------  268 (337)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~--------  268 (337)
                      .......           .......++..|+|||.+.    +..++.++||||||+++|+|++|..||....        
T Consensus       196 ~~~~~~~-----------~~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~  260 (326)
T 2w1i_A          196 PQDKEYY-----------KVKEPGESPIFWYAPESLT----ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIG  260 (326)
T ss_dssp             CSSCSEE-----------ECSSCCSCCGGGCCHHHHH----HCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHC
T ss_pred             ccccccc-----------ccccCCCCceeEECchhhc----CCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhc
Confidence            5432110           1112234677899999998    3467889999999999999999998875321        


Q ss_pred             --C--chhHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhc
Q 019650          269 --E--KPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA  319 (337)
Q Consensus       269 --~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~  319 (337)
                        .  ...................+..++..+.++|.+||+.||++|||++++++
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~  315 (326)
T 2w1i_A          261 NDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  315 (326)
T ss_dssp             TTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             cccchhhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence              0  01111222333344455667788999999999999999999999999986

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=2.2e-44  Score=331.38  Aligned_cols=261  Identities=20%  Similarity=0.238  Sum_probs=191.5

Q ss_pred             cccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhc-CCCCceeeeeeEEeeCCeEEEEE
Q 019650           47 SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRL-DSQFIVKCHAVFYTIEGEICFVM  125 (337)
Q Consensus        47 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~~lv~  125 (337)
                      +.|.+.+.||+|+||+||.+. ..+++.||+|++....    .+.+.+|+.+++++ +||||+++++.+.+ ....++||
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~----~~~~~~E~~~l~~l~~HpnIv~~~~~~~~-~~~~~lv~   88 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDF----CDIALMEIKLLTESDDHPNVIRYYCSETT-DRFLYIAL   88 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGG----HHHHHHHHHHHHHHTTSTTBCCEEEEEEC-SSEEEEEE
T ss_pred             heeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHH----HHHHHHHHHHHHhccCCCCcCeEEEEEec-CCeEEEEE
Confidence            455667899999999998753 4678999999987542    34567899999876 89999999998765 68899999


Q ss_pred             eccCCCCchHHhhhcCCC-------CHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCC-------------CcE
Q 019650          126 EHMERGSLFDSLRVRKKL-------SEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGK-------------GEV  185 (337)
Q Consensus       126 e~~~~~~L~~~l~~~~~l-------~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~-------------~~~  185 (337)
                      ||+. |+|.+++......       ++..++.++.||+.||+|||++||+||||||+||+++.+             +++
T Consensus        89 E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~  167 (434)
T 2rio_A           89 ELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRI  167 (434)
T ss_dssp             CCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred             ecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEE
Confidence            9996 5999999865432       233457899999999999999999999999999999754             489


Q ss_pred             EEeeccCccchhccccCCCCCCCCCCccccccccccCCCCCcCCccccccc---CCCCCCccccHHHHHHHHHHHHh-CC
Q 019650          186 KIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSER---WGGDYGFAGDVWSLGVVVLECLV-GH  261 (337)
Q Consensus       186 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~~~~~DiwslG~il~~l~t-g~  261 (337)
                      +|+|||++...........          .......||+.|+|||++....   ....++.++||||||+++|+|++ |.
T Consensus       168 kL~DFG~a~~~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~  237 (434)
T 2rio_A          168 LISDFGLCKKLDSGQSSFR----------TNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGK  237 (434)
T ss_dssp             EECCCTTCEECCC------------------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSC
T ss_pred             EEcccccceecCCCCccce----------eeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCC
Confidence            9999999987654321110          1122346899999999997421   02468999999999999999999 99


Q ss_pred             CCCCCCCCchhHHHHHHHhhccCCCCC--CCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCcccccc
Q 019650          262 YPLIGFGEKPDLMALICAICFGERLEM--PETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKR  326 (337)
Q Consensus       262 ~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~  326 (337)
                      .||.......  ...............  ...++..+.++|.+||+.||.+|||+.++++||||.+.
T Consensus       238 ~Pf~~~~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~~  302 (434)
T 2rio_A          238 HPFGDKYSRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPK  302 (434)
T ss_dssp             CTTCSTTTHH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSCH
T ss_pred             CCCCCchhhH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCCc
Confidence            9996543322  222211111111110  11234789999999999999999999999999999754

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=2.8e-43  Score=326.67  Aligned_cols=260  Identities=21%  Similarity=0.243  Sum_probs=208.1

Q ss_pred             CccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 019650           45 NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFV  124 (337)
Q Consensus        45 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv  124 (337)
                      ..++|++++.||.|+||.||+|.+..+++.||||++......   ..+.+|+.+++.+.|++.+..+..+.......++|
T Consensus         5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lv   81 (483)
T 3sv0_A            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLV   81 (483)
T ss_dssp             ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS---CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEE
T ss_pred             cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc---HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEE
Confidence            357899999999999999999999999999999998765432   34678999999999877666666666667889999


Q ss_pred             EeccCCCCchHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEE---cCCCcEEEeeccCccchhccc
Q 019650          125 MEHMERGSLFDSLRV-RKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLI---NGKGEVKIADFGVSRIVEETR  200 (337)
Q Consensus       125 ~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili---~~~~~~~l~Dfg~~~~~~~~~  200 (337)
                      |||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+   +.++.++|+|||++.......
T Consensus        82 me~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~  160 (483)
T 3sv0_A           82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS  160 (483)
T ss_dssp             EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred             EECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCc
Confidence            9999 8899999975 4679999999999999999999999999999999999999   578899999999998765433


Q ss_pred             cCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHH---HHH
Q 019650          201 NNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLM---ALI  277 (337)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~---~~~  277 (337)
                      ......       ........|++.|+|||.+.    +..++.++||||||+++|+|++|+.||..........   ...
T Consensus       161 ~~~~~~-------~~~~~~~~gt~~Y~aPE~~~----~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~  229 (483)
T 3sv0_A          161 THQHIP-------YRENKNLTGTARYASVNTHL----GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS  229 (483)
T ss_dssp             TCCBCC-------CCCCCCCCSCTTTCCHHHHT----TCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHH
T ss_pred             cccccc-------cccccccCCCccccCHHHhc----CCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHh
Confidence            211100       01222446999999999998    5578999999999999999999999998754432221   122


Q ss_pred             HHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhc
Q 019650          278 CAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA  319 (337)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~  319 (337)
                      ..............++..+.+++..||+.+|.+||++++|++
T Consensus       230 ~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~  271 (483)
T 3sv0_A          230 EKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR  271 (483)
T ss_dssp             HHHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             hccccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            221112222233567899999999999999999999998765

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=7.5e-44  Score=327.17  Aligned_cols=261  Identities=19%  Similarity=0.251  Sum_probs=194.0

Q ss_pred             ccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhc-CCCCceeeeeeEEeeCCeEEEE
Q 019650           46 ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRL-DSQFIVKCHAVFYTIEGEICFV  124 (337)
Q Consensus        46 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~~lv  124 (337)
                      ..+|.+.+.||.|+||+|+.. ...+++.||||++......    .+.+|+.+++++ +||||+++++.+.+ ....|+|
T Consensus        23 ~~~y~~~~~LG~G~~G~V~~~-~~~~~~~vAvK~~~~~~~~----~~~~E~~~l~~l~~HpnIv~l~~~~~~-~~~~~lv   96 (432)
T 3p23_A           23 KISFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILPECFS----FADREVQLLRESDEHPNVIRYFCTEKD-RQFQYIA   96 (432)
T ss_dssp             TEEEEEEEEEEECGGGCEEEE-EESSSSEEEEEEECTTTEE----ECHHHHHHHHHSCCCTTBCCEEEEEEE-TTEEEEE
T ss_pred             cEEEecCCeeecCcCEEEEEE-EEeCCeEEEEEEECHHHHH----HHHHHHHHHHhccCCCCcCeEEEEEec-CCEEEEE
Confidence            457999999999999997643 3467889999998754322    245799999999 89999999998766 7889999


Q ss_pred             EeccCCCCchHHhhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcC---C--CcEEEeeccCccchhc
Q 019650          125 MEHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLING---K--GEVKIADFGVSRIVEE  198 (337)
Q Consensus       125 ~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~---~--~~~~l~Dfg~~~~~~~  198 (337)
                      ||++.| +|.+++.... ...+..+..++.||+.||.|||++||+||||||+||+++.   +  .+++|+|||++.....
T Consensus        97 ~E~~~g-~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~  175 (432)
T 3p23_A           97 IELCAA-TLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV  175 (432)
T ss_dssp             EECCSE-EHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred             EECCCC-CHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence            999965 9999997553 4566677899999999999999999999999999999953   2  3688999999987654


Q ss_pred             cccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCchhHHHHH
Q 019650          199 TRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALI  277 (337)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~  277 (337)
                      .....           .......||+.|+|||++.... +..++.++||||||+++|+|++ |..||......  .....
T Consensus       176 ~~~~~-----------~~~~~~~gt~~y~APE~l~~~~-~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~--~~~~~  241 (432)
T 3p23_A          176 GRHSF-----------SRRSGVPGTEGWIAPEMLSEDC-KENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR--QANIL  241 (432)
T ss_dssp             ---------------------CCSCTTSCCGGGTSCC----CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH--HHHHH
T ss_pred             CCcce-----------eeccccCCCcCccChhhhhccc-ccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH--HHHHH
Confidence            32111           1222346899999999997431 2356789999999999999999 99998543222  11111


Q ss_pred             HHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccC
Q 019650          278 CAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRS  327 (337)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~  327 (337)
                      ...............+..+.+||.+||+.||.+|||++++++||||.+..
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~~  291 (432)
T 3p23_A          242 LGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLE  291 (432)
T ss_dssp             TTCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCHH
T ss_pred             hccCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccChH
Confidence            11111111111222345689999999999999999999999999998644

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=2.2e-43  Score=317.94  Aligned_cols=258  Identities=18%  Similarity=0.226  Sum_probs=200.7

Q ss_pred             CCCCCccCccccccccccccCcceEEEEEE-----EccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcC---CCCcee
Q 019650           38 PTSPDVENISDLKKLTVLGHGNGGIVYKVR-----HQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLD---SQFIVK  109 (337)
Q Consensus        38 ~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~---~~~i~~  109 (337)
                      +........++|.+.+.||+|+||+||+|.     +..+++.||+|++....    ...+..|..+++.+.   |++++.
T Consensus        56 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~e~~~~~~l~~~~~~~iv~  131 (365)
T 3e7e_A           56 PKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN----PWEFYIGTQLMERLKPSMQHMFMK  131 (365)
T ss_dssp             SSCEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC----HHHHHHHHHHHHHSCGGGGGGBCC
T ss_pred             cceeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC----hhHHHHHHHHHHHhhhhhhhhhhh
Confidence            333344556889999999999999999994     66789999999997653    345667777777776   899999


Q ss_pred             eeeeEEeeCCeEEEEEeccCCCCchHHhhh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcC---
Q 019650          110 CHAVFYTIEGEICFVMEHMERGSLFDSLRV-----RKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLING---  181 (337)
Q Consensus       110 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~---  181 (337)
                      +++.+.. ....++||||+++|+|.+++..     ...+++..++.++.||+.||+|||++||+||||||+|||++.   
T Consensus       132 ~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~  210 (365)
T 3e7e_A          132 FYSAHLF-QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFL  210 (365)
T ss_dssp             EEEEEEC-SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGT
T ss_pred             hheeeec-CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEeccccc
Confidence            9998876 6889999999999999999973     457999999999999999999999999999999999999998   


Q ss_pred             --------CCcEEEeeccCccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHH
Q 019650          182 --------KGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVV  253 (337)
Q Consensus       182 --------~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~i  253 (337)
                              ++.++|+|||++.........            ......+||+.|+|||++.    +..++.++||||||++
T Consensus       211 ~~~~~~~~~~~~kl~DFG~a~~~~~~~~~------------~~~~~~~gt~~y~aPE~~~----~~~~~~~~DiwslG~i  274 (365)
T 3e7e_A          211 EQDDEDDLSAGLALIDLGQSIDMKLFPKG------------TIFTAKCETSGFQCVEMLS----NKPWNYQIDYFGVAAT  274 (365)
T ss_dssp             CC------CTTEEECCCTTCEEGGGSCTT------------EEECCSSCTTSCCCHHHHT----TCCBSTHHHHHHHHHH
T ss_pred             CccccccccCCEEEeeCchhhhhhccCCC------------ceeeeecCCCCCCChHHhc----CCCCCccccHHHHHHH
Confidence                    899999999999765422110            2333456999999999998    4578999999999999


Q ss_pred             HHHHHhCCCCCCCCCCchhHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCC-HHHHhc--Cccccc
Q 019650          254 VLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGT-VEELLA--YPFVTK  325 (337)
Q Consensus       254 l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s-~~eil~--hp~f~~  325 (337)
                      +|+|++|+.||.........        .. ........++.+.+++..||+.+|.+|++ ++++.+  ..|+.+
T Consensus       275 l~elltg~~pf~~~~~~~~~--------~~-~~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~  340 (365)
T 3e7e_A          275 VYCMLFGTYMKVKNEGGECK--------PE-GLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ  340 (365)
T ss_dssp             HHHHHHSSCCCEEEETTEEE--------EC-SCCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             HHHHHhCCCccccCCCCcee--------ec-hhccccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence            99999999999543221100        00 00011123678999999999999999965 444433  345544

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=1.1e-43  Score=334.73  Aligned_cols=260  Identities=25%  Similarity=0.395  Sum_probs=215.8

Q ss_pred             CCCccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCC
Q 019650           40 SPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEG  119 (337)
Q Consensus        40 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~  119 (337)
                      ..+....++|++.+.||+|+||+||+|.+.. +..||+|+++....  ..+.+.+|+.++++++|+||+++++++.+  .
T Consensus       260 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~  334 (535)
T 2h8h_A          260 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVSE--E  334 (535)
T ss_dssp             TCSBCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECS--S
T ss_pred             cceecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCC--CHHHHHHHHHHHHhCCCCCEeeEEEEEee--c
Confidence            3456677899999999999999999999864 45799999976542  34678899999999999999999998643  6


Q ss_pred             eEEEEEeccCCCCchHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchh
Q 019650          120 EICFVMEHMERGSLFDSLRVR--KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVE  197 (337)
Q Consensus       120 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~  197 (337)
                      ..++||||+++|+|.+++...  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++....
T Consensus       335 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  414 (535)
T 2h8h_A          335 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE  414 (535)
T ss_dssp             SCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCC
T ss_pred             cceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecC
Confidence            789999999999999999743  569999999999999999999999999999999999999999999999999997664


Q ss_pred             ccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCchhHHHH
Q 019650          198 ETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMAL  276 (337)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~~~~~~~~~~~  276 (337)
                      .....             ......++..|+|||.+.    +..++.++||||||+++|||++ |..||.+....    ..
T Consensus       415 ~~~~~-------------~~~~~~~~~~y~aPE~~~----~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~----~~  473 (535)
T 2h8h_A          415 DNEYT-------------ARQGAKFPIKWTAPEAAL----YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR----EV  473 (535)
T ss_dssp             CHHHH-------------TTCSTTSCGGGSCHHHHH----HCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH----HH
T ss_pred             CCcee-------------cccCCcCcccccCHHHhc----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH----HH
Confidence            32211             111223678899999998    4578999999999999999999 99999765332    23


Q ss_pred             HHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC--ccccc
Q 019650          277 ICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY--PFVTK  325 (337)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~h--p~f~~  325 (337)
                      ......+.....+..++..+.+||.+||+.||++|||+++|++.  .+|..
T Consensus       474 ~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~  524 (535)
T 2h8h_A          474 LDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  524 (535)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred             HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence            33344455666777889999999999999999999999999874  45543

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=4.7e-44  Score=312.26  Aligned_cols=258  Identities=26%  Similarity=0.381  Sum_probs=200.3

Q ss_pred             ccCccccccccccccCcceEEEEEEEcc-CCc--eEEEEEeecCC--chHhHHHHHHHHHHHHhcCCCCceeeeeeEEee
Q 019650           43 VENISDLKKLTVLGHGNGGIVYKVRHQK-SNS--IYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTI  117 (337)
Q Consensus        43 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~-~~~--~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~  117 (337)
                      ....++|++.+.||.|+||+||+|.+.. ++.  .||+|+++...  .....+.+.+|+.++++++|+||+++++++.. 
T Consensus        14 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-   92 (291)
T 1u46_A           14 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-   92 (291)
T ss_dssp             ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred             ccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcc-
Confidence            3456899999999999999999998643 333  68999987543  33456778899999999999999999998765 


Q ss_pred             CCeEEEEEeccCCCCchHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccch
Q 019650          118 EGEICFVMEHMERGSLFDSLRVR-KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIV  196 (337)
Q Consensus       118 ~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~  196 (337)
                       ...++|||++++++|.+++... ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++...
T Consensus        93 -~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~  171 (291)
T 1u46_A           93 -PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL  171 (291)
T ss_dssp             -SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             -CCceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccc
Confidence             4488999999999999999764 57999999999999999999999999999999999999999999999999998776


Q ss_pred             hccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCchhHHH
Q 019650          197 EETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMA  275 (337)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~~~~~~~~~~  275 (337)
                      .......           .......++..|+|||.+.    +..++.++||||||+++|+|++ |..||...........
T Consensus       172 ~~~~~~~-----------~~~~~~~~~~~y~aPE~~~----~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~  236 (291)
T 1u46_A          172 PQNDDHY-----------VMQEHRKVPFAWCAPESLK----TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHK  236 (291)
T ss_dssp             CC-CCEE-----------EC-----CCGGGCCHHHHH----HCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH
T ss_pred             cccccch-----------hhhccCCCCceeeCchhhc----CCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHH
Confidence            4332110           1112234678899999998    3467889999999999999999 9999976533222211


Q ss_pred             HHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          276 LICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                         ..........+..++..+.+++.+||..||.+|||+.+++++
T Consensus       237 ---~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  278 (291)
T 1u46_A          237 ---IDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDF  278 (291)
T ss_dssp             ---HHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---HHccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence               122233445566789999999999999999999999999973

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=2.3e-43  Score=314.11  Aligned_cols=267  Identities=23%  Similarity=0.302  Sum_probs=192.1

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcC-CCCceeeeeeEEe------
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLD-SQFIVKCHAVFYT------  116 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~------  116 (337)
                      ....+|++.+.||.|+||+||+|.+..+++.||+|++.... ......+.+|+.+++++. |+||+++++.+..      
T Consensus        25 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~  103 (337)
T 3ll6_A           25 LGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE-EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESD  103 (337)
T ss_dssp             ETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS-HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTST
T ss_pred             ccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc-hHHHHHHHHHHHHHHHhccCCChhhccccccccccccc
Confidence            34469999999999999999999999999999999986653 345567788999999996 9999999998852      


Q ss_pred             -eCCeEEEEEeccCCCCchHHhhh---cCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCCeEEcCCCcEEEeec
Q 019650          117 -IEGEICFVMEHMERGSLFDSLRV---RKKLSEDVISGVAYRVLKGLQYLHGMQ--IIHGDIKPSNLLINGKGEVKIADF  190 (337)
Q Consensus       117 -~~~~~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~i~~~l~~~l~~LH~~~--ivH~dl~~~Nili~~~~~~~l~Df  190 (337)
                       .....+++|||+. |+|.+++..   .+.+++..++.++.||+.||+|||+.|  ++|+||||+||+++.+++++|+||
T Consensus       104 ~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Df  182 (337)
T 3ll6_A          104 TGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDF  182 (337)
T ss_dssp             TSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred             cCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecC
Confidence             2345899999996 599998864   457999999999999999999999999  999999999999999999999999


Q ss_pred             cCccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCc
Q 019650          191 GVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEK  270 (337)
Q Consensus       191 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~  270 (337)
                      |++..............  ............+++.|+|||.+.... +..++.++||||||+++|+|++|+.||......
T Consensus       183 g~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~  259 (337)
T 3ll6_A          183 GSATTISHYPDYSWSAQ--RRALVEEEITRNTTPMYRTPEIIDLYS-NFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL  259 (337)
T ss_dssp             TTCBCCSSCC---------------------------------CCT-TSCSSHHHHHHHHHHHHHHHHHSSCCC------
T ss_pred             ccceeccccCccccccc--ccccchhhccccCCCCcCChhhhhccc-cCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH
Confidence            99987654322110000  000001122345899999999984221 457889999999999999999999999653221


Q ss_pred             hhHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCcc
Q 019650          271 PDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPF  322 (337)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~  322 (337)
                      .    ..   ............+..+.+++.+||+.||.+|||+++++++..
T Consensus       260 ~----~~---~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  304 (337)
T 3ll6_A          260 R----IV---NGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ  304 (337)
T ss_dssp             -------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred             H----hh---cCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            1    11   112223334566788999999999999999999999999853

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=2.9e-43  Score=309.72  Aligned_cols=254  Identities=25%  Similarity=0.358  Sum_probs=202.7

Q ss_pred             cccccccccccCcceEEEEEEEccCCceEEEEEeecCC---chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEE
Q 019650           47 SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS---STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICF  123 (337)
Q Consensus        47 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~l  123 (337)
                      ..|...+.||+|+||+||+|.+  ++..||+|++....   .....+.+.+|+.++++++|+||+++++++.. ....++
T Consensus        31 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~l  107 (307)
T 2nru_A           31 PISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSD-GDDLCL  107 (307)
T ss_dssp             BTTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSSCEE
T ss_pred             cccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEec-CCceEE
Confidence            4455668999999999999986  57789999986532   23456778899999999999999999998766 678999


Q ss_pred             EEeccCCCCchHHhhh---cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccc
Q 019650          124 VMEHMERGSLFDSLRV---RKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETR  200 (337)
Q Consensus       124 v~e~~~~~~L~~~l~~---~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~  200 (337)
                      ||||+++++|.+++..   ...+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||.+.......
T Consensus       108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~  187 (307)
T 2nru_A          108 VYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFA  187 (307)
T ss_dssp             EEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCS
T ss_pred             EEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeeccccccccccc
Confidence            9999999999999863   3469999999999999999999999999999999999999999999999999987654321


Q ss_pred             cCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHh
Q 019650          201 NNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAI  280 (337)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~  280 (337)
                      ..            .......|++.|+|||.+..     .++.++||||||+++|+|++|..||................
T Consensus       188 ~~------------~~~~~~~g~~~y~aPE~~~~-----~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~  250 (307)
T 2nru_A          188 QT------------VMTSRIVGTTAYMAPEALRG-----EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEI  250 (307)
T ss_dssp             SC------------EECSSCCSCGGGCCHHHHTT-----EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHH
T ss_pred             cc------------ccccccCCCcCcCChHHhcC-----CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHh
Confidence            11            12223468999999999862     47889999999999999999999997654443322222221


Q ss_pred             hcc----------CCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          281 CFG----------ERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       281 ~~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                      ...          .....+...+..+.+++.+||+.||.+|||+++++++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~  300 (307)
T 2nru_A          251 EDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL  300 (307)
T ss_dssp             HTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             hhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            111          1111222335679999999999999999999999874

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.5e-43  Score=311.34  Aligned_cols=256  Identities=22%  Similarity=0.298  Sum_probs=194.6

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHh--cCCCCceeeeeeEEeeC---
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKR--LDSQFIVKCHAVFYTIE---  118 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~--l~~~~i~~~~~~~~~~~---  118 (337)
                      ...++|++.+.||+|+||+||+|.+.  +..||+|++....    ......|.+++..  ++|+||+++++.+....   
T Consensus        34 ~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~  107 (337)
T 3mdy_A           34 TIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE----EASWFRETEIYQTVLMRHENILGFIAADIKGTGSW  107 (337)
T ss_dssp             THHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGG
T ss_pred             ccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc----cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCC
Confidence            44589999999999999999999875  8899999986542    2233344444444  49999999999887732   


Q ss_pred             CeEEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CceeccCCCCCeEEcCCCcEEEeec
Q 019650          119 GEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGM--------QIIHGDIKPSNLLINGKGEVKIADF  190 (337)
Q Consensus       119 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~--------~ivH~dl~~~Nili~~~~~~~l~Df  190 (337)
                      ...++||||+++++|.+++.. ..+++..++.++.|++.||+|||+.        |++||||||+||+++.++.++|+||
T Consensus       108 ~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Df  186 (337)
T 3mdy_A          108 TQLYLITDYHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADL  186 (337)
T ss_dssp             CEEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCC
T ss_pred             CceEEEEeccCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeC
Confidence            678999999999999999965 4699999999999999999999999        9999999999999999999999999


Q ss_pred             cCccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCc------cccHHHHHHHHHHHHhC----
Q 019650          191 GVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGF------AGDVWSLGVVVLECLVG----  260 (337)
Q Consensus       191 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~------~~DiwslG~il~~l~tg----  260 (337)
                      |++...........          .......||+.|+|||++...    .+..      ++||||||+++|+|++|    
T Consensus       187 g~a~~~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~----~~~~~~~~~~~~DiwslG~il~el~tg~~~~  252 (337)
T 3mdy_A          187 GLAVKFISDTNEVD----------IPPNTRVGTKRYMPPEVLDES----LNRNHFQSYIMADMYSFGLILWEVARRCVSG  252 (337)
T ss_dssp             TTCEECC-------------------CCSSCSCGGGCCHHHHTTC----CCTTCTHHHHHHHHHHHHHHHHHHHTTBCBT
T ss_pred             CCceeecccccccc----------CCCCCCccCcceeChhhcccc----cCCccccCccccchHHHHHHHHHHHhccCcc
Confidence            99976644322111          111234689999999999843    3333      39999999999999999    


Q ss_pred             ------CCCCCCCCCchhHHHHHHHhh--ccCCCCCCC-----CCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          261 ------HYPLIGFGEKPDLMALICAIC--FGERLEMPE-----TASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       261 ------~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~-----~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                            ..||.................  ....+.++.     .++..+.+++.+||+.||.+|||+++++++
T Consensus       253 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  325 (337)
T 3mdy_A          253 GIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT  325 (337)
T ss_dssp             TBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             cccccccccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence                  777755433222222222111  111222222     345679999999999999999999999986

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=8.8e-43  Score=335.17  Aligned_cols=255  Identities=29%  Similarity=0.400  Sum_probs=211.4

Q ss_pred             ccCccccccccccccCcceEEEEEEEcc---CCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCC
Q 019650           43 VENISDLKKLTVLGHGNGGIVYKVRHQK---SNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEG  119 (337)
Q Consensus        43 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~  119 (337)
                      ....++|++.+.||+|+||+||+|.+..   .+..||+|.+.........+.+.+|+.++++++||||+++++++.  ++
T Consensus       386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~--~~  463 (656)
T 2j0j_A          386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT--EN  463 (656)
T ss_dssp             BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC--SS
T ss_pred             ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe--cC
Confidence            3445789999999999999999999864   346799999877666666678899999999999999999999863  46


Q ss_pred             eEEEEEeccCCCCchHHhhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhc
Q 019650          120 EICFVMEHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEE  198 (337)
Q Consensus       120 ~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~  198 (337)
                      ..++||||+++|+|.+++...+ .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.....
T Consensus       464 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~  543 (656)
T 2j0j_A          464 PVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  543 (656)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC
T ss_pred             ceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecCC
Confidence            7899999999999999998654 689999999999999999999999999999999999999999999999999987643


Q ss_pred             cccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCchhHHHHH
Q 019650          199 TRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALI  277 (337)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~  277 (337)
                      ...             .......+++.|+|||.+.    +..++.++||||||+++|+|++ |..||.+....    ...
T Consensus       544 ~~~-------------~~~~~~~~t~~y~aPE~~~----~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~----~~~  602 (656)
T 2j0j_A          544 STY-------------YKASKGKLPIKWMAPESIN----FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN----DVI  602 (656)
T ss_dssp             -----------------------CCGGGCCHHHHH----HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH----HHH
T ss_pred             Ccc-------------eeccCCCCCcceeCHHHhc----CCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH----HHH
Confidence            321             1111224678999999997    4578999999999999999997 99999764332    233


Q ss_pred             HHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          278 CAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                      .....+.....+..++..+.+++.+||..||.+|||+.++++.
T Consensus       603 ~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~  645 (656)
T 2j0j_A          603 GRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  645 (656)
T ss_dssp             HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHcCCCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            3344455666778889999999999999999999999999864

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=5.1e-43  Score=312.00  Aligned_cols=273  Identities=23%  Similarity=0.289  Sum_probs=196.3

Q ss_pred             ccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHH--HHHHHHHhcCCCCceeeeeeEEee---
Q 019650           43 VENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAA--HEAEILKRLDSQFIVKCHAVFYTI---  117 (337)
Q Consensus        43 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~--~e~~~~~~l~~~~i~~~~~~~~~~---  117 (337)
                      ....++|++++.||+|+||+||+|.+  +++.||+|++.....    ..+.  .++..+..++|+||+++++.+...   
T Consensus         9 ~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~----~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~   82 (336)
T 3g2f_A            9 SLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANR----QNFINEKNIYRVPLMEHDNIARFIVGDERVTAD   82 (336)
T ss_dssp             CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGH----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTT
T ss_pred             CcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccch----hhHHHHHHHHHHHhccCcchhhheecccccccC
Confidence            45689999999999999999999976  578999999975432    2233  344445568999999999755432   


Q ss_pred             -CCeEEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhC---------CceeccCCCCCeEEcCCCcEEE
Q 019650          118 -EGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGM---------QIIHGDIKPSNLLINGKGEVKI  187 (337)
Q Consensus       118 -~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~---------~ivH~dl~~~Nili~~~~~~~l  187 (337)
                       ...+++||||+++|+|.+++... ..++..+..++.||+.||+|||+.         |++||||||+||+++.++.++|
T Consensus        83 ~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL  161 (336)
T 3g2f_A           83 GRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVI  161 (336)
T ss_dssp             SCEEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEE
T ss_pred             CCceEEEEEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEE
Confidence             23578999999999999999754 458999999999999999999999         9999999999999999999999


Q ss_pred             eeccCccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccC---CCCCCccccHHHHHHHHHHHHhCCCCC
Q 019650          188 ADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERW---GGDYGFAGDVWSLGVVVLECLVGHYPL  264 (337)
Q Consensus       188 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~~~~~DiwslG~il~~l~tg~~pf  264 (337)
                      +|||++.............      .........||+.|+|||++.....   ...++.++||||||+++|+|++|..||
T Consensus       162 ~DFG~a~~~~~~~~~~~~~------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~  235 (336)
T 3g2f_A          162 SDFGLSMRLTGNRLVRPGE------EDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL  235 (336)
T ss_dssp             CCCTTCEECSSSSCC---------------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGG
T ss_pred             eeccceeecccccccCccc------cccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcC
Confidence            9999998765432111100      0022234468999999999974210   024567899999999999999997776


Q ss_pred             CCCCCchh--------------HHHHHH-HhhccCCCCCCCCC------CHHHHHHHHHHhhcCcCCCCCHHHHh-----
Q 019650          265 IGFGEKPD--------------LMALIC-AICFGERLEMPETA------SPEFRRFVRSCLEKDWRKRGTVEELL-----  318 (337)
Q Consensus       265 ~~~~~~~~--------------~~~~~~-~~~~~~~~~~~~~~------~~~~~~li~~~l~~~p~~R~s~~eil-----  318 (337)
                      ........              ...... .......+.++...      +..+.++|.+||+.||++|||+++++     
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~  315 (336)
T 3g2f_A          236 FPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAE  315 (336)
T ss_dssp             STTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred             CCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHH
Confidence            43222110              011111 11122233333332      34799999999999999999999994     


Q ss_pred             -cCccccccCC
Q 019650          319 -AYPFVTKRSS  328 (337)
Q Consensus       319 -~hp~f~~~~~  328 (337)
                       -++|-++...
T Consensus       316 ll~~~~~~~~~  326 (336)
T 3g2f_A          316 LMMIWERNKSV  326 (336)
T ss_dssp             HHHCCCC----
T ss_pred             HHHHHHhcccC
Confidence             4677776654

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=3.2e-43  Score=311.03  Aligned_cols=262  Identities=18%  Similarity=0.263  Sum_probs=202.6

Q ss_pred             CCccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCC-chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCC
Q 019650           41 PDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEG  119 (337)
Q Consensus        41 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~  119 (337)
                      .+....++|++.+.||.|+||+||+|.+..   .+|+|+++... .....+.+.+|+.++++++|+||+++++++.. ..
T Consensus        27 ~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~  102 (319)
T 2y4i_B           27 EWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS-PP  102 (319)
T ss_dssp             GSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEEC-SS
T ss_pred             cccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEec-CC
Confidence            445667899999999999999999998853   48999987543 22233456679999999999999999998876 67


Q ss_pred             eEEEEEeccCCCCchHHhhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhc
Q 019650          120 EICFVMEHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEE  198 (337)
Q Consensus       120 ~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~  198 (337)
                      ..+++|||+++++|.+++...+ .+++..++.++.||+.||+|||++|++|+||||+||+++ ++.++|+|||++.....
T Consensus       103 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~  181 (319)
T 2y4i_B          103 HLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGV  181 (319)
T ss_dssp             CEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC----
T ss_pred             ceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCcccccc
Confidence            8999999999999999998654 699999999999999999999999999999999999998 67999999999876532


Q ss_pred             cccCCCCCCCCCCccccccccccCCCCCcCCcccccccC-----CCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhH
Q 019650          199 TRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERW-----GGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDL  273 (337)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-----~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~  273 (337)
                      .......         .......|++.|+|||.+.....     ...++.++||||||+++|+|++|..||.......  
T Consensus       182 ~~~~~~~---------~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--  250 (319)
T 2y4i_B          182 LQAGRRE---------DKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA--  250 (319)
T ss_dssp             ------C---------CSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHH--
T ss_pred             ccccccc---------cccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--
Confidence            2111100         12223358899999999974210     2357889999999999999999999997543322  


Q ss_pred             HHHHHHhhccCCCCC-CCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          274 MALICAICFGERLEM-PETASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       274 ~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                        .......+..+.. ...++..+.+++.+||..||.+|||++++++.
T Consensus       251 --~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~  296 (319)
T 2y4i_B          251 --IIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDM  296 (319)
T ss_dssp             --HHHHHHTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHH
T ss_pred             --HHHHhccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence              2222222223322 33578899999999999999999999999874

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=3.4e-42  Score=307.36  Aligned_cols=259  Identities=22%  Similarity=0.283  Sum_probs=200.9

Q ss_pred             CccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHh--cCCCCceeeeeeEEeeC---C
Q 019650           45 NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKR--LDSQFIVKCHAVFYTIE---G  119 (337)
Q Consensus        45 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~--l~~~~i~~~~~~~~~~~---~  119 (337)
                      ..++|++.+.||+|+||+||+|.+  +++.||+|++...    ....+.+|.+++..  ++|+||+++++++....   .
T Consensus        40 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~  113 (342)
T 1b6c_B           40 IARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT  113 (342)
T ss_dssp             HHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred             ccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence            347999999999999999999987  4889999998654    23456678888887  79999999999987743   2


Q ss_pred             eEEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHH--------hCCceeccCCCCCeEEcCCCcEEEeecc
Q 019650          120 EICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLH--------GMQIIHGDIKPSNLLINGKGEVKIADFG  191 (337)
Q Consensus       120 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH--------~~~ivH~dl~~~Nili~~~~~~~l~Dfg  191 (337)
                      ..++||||+++++|.+++.. ..+++..++.++.|++.||.|||        +.|++|+||||+||+++.+++++|+|||
T Consensus       114 ~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg  192 (342)
T 1b6c_B          114 QLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG  192 (342)
T ss_dssp             CEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCT
T ss_pred             eeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECC
Confidence            78999999999999999975 46999999999999999999999        8999999999999999999999999999


Q ss_pred             CccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCC--CCCccccHHHHHHHHHHHHhC---------
Q 019650          192 VSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGG--DYGFAGDVWSLGVVVLECLVG---------  260 (337)
Q Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~--~~~~~~DiwslG~il~~l~tg---------  260 (337)
                      ++...........          .......+++.|+|||.+.......  .++.++||||||+++|+|++|         
T Consensus       193 ~~~~~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~  262 (342)
T 1b6c_B          193 LAVRHDSATDTID----------IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED  262 (342)
T ss_dssp             TCEEEETTTTEEE----------ECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCC
T ss_pred             Cceeccccccccc----------cccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccc
Confidence            9976644321100          1122346899999999997431111  223689999999999999999         


Q ss_pred             -CCCCCCCCCchh-HHHHHHHhh-ccCCCCCCC-----CCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          261 -HYPLIGFGEKPD-LMALICAIC-FGERLEMPE-----TASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       261 -~~pf~~~~~~~~-~~~~~~~~~-~~~~~~~~~-----~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                       ..||........ ......... ....+.++.     ..+..+.+++.+||+.||++|||++++++|
T Consensus       263 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~  330 (342)
T 1b6c_B          263 YQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  330 (342)
T ss_dssp             CCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             cccCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence             788866433221 222222221 112222222     223579999999999999999999999986

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.3e-42  Score=317.67  Aligned_cols=254  Identities=17%  Similarity=0.162  Sum_probs=194.1

Q ss_pred             CccccccccccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHHhcCC-CCc---------eeeee
Q 019650           45 NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDS-QFI---------VKCHA  112 (337)
Q Consensus        45 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~~-~~i---------~~~~~  112 (337)
                      ....|+..+.||+|+||+||+|.+..+++.||||++....  .....+.+.+|+.+++.+.| .+.         +....
T Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~  155 (413)
T 3dzo_A           76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD  155 (413)
T ss_dssp             CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred             CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence            4467999999999999999999999999999999987443  22335678889999998877 211         11111


Q ss_pred             e------------EEe----eCCeEEEEEeccCCCCchHHhhh-------cCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q 019650          113 V------------FYT----IEGEICFVMEHMERGSLFDSLRV-------RKKLSEDVISGVAYRVLKGLQYLHGMQIIH  169 (337)
Q Consensus       113 ~------------~~~----~~~~~~lv~e~~~~~~L~~~l~~-------~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH  169 (337)
                      .            +..    ....++++|+.. +++|.+++..       ...+++..+..++.||+.||+|||++||+|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiH  234 (413)
T 3dzo_A          156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVH  234 (413)
T ss_dssp             EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence            1            111    013467888877 4699988841       235778899999999999999999999999


Q ss_pred             ccCCCCCeEEcCCCcEEEeeccCccchhccccCCCCCCCCCCccccccccccCCCCCcCCccccccc------CCCCCCc
Q 019650          170 GDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSER------WGGDYGF  243 (337)
Q Consensus       170 ~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~------~~~~~~~  243 (337)
                      |||||+|||++.++.+||+|||++......                 ....+| +.|+|||++....      .+..++.
T Consensus       235 rDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----------------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~  296 (413)
T 3dzo_A          235 TYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----------------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTF  296 (413)
T ss_dssp             SCCCGGGEEECTTCCEEECCGGGCEETTEE-----------------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECH
T ss_pred             CCcccceEEEecCCeEEEEeccceeecCCc-----------------cccCCC-CceeCchhhhccccccccccCcCCCc
Confidence            999999999999999999999998765443                 122347 9999999993210      1446788


Q ss_pred             cccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccc
Q 019650          244 AGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV  323 (337)
Q Consensus       244 ~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f  323 (337)
                      ++||||||+++|+|++|+.||..........         ........+++.+.+||.+||+.||++|||+.++++||||
T Consensus       297 ~~DvwSlGvil~elltg~~Pf~~~~~~~~~~---------~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~  367 (413)
T 3dzo_A          297 AFDTWTLGLAIYWIWCADLPNTDDAALGGSE---------WIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEY  367 (413)
T ss_dssp             HHHHHHHHHHHHHHHHSSCCCCTTGGGSCSG---------GGGSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHH
T ss_pred             hhhHHHHHHHHHHHHHCCCCCCCcchhhhHH---------HHHhhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHH
Confidence            9999999999999999999996543221111         0112224678999999999999999999999999999999


Q ss_pred             ccc
Q 019650          324 TKR  326 (337)
Q Consensus       324 ~~~  326 (337)
                      ++.
T Consensus       368 ~~~  370 (413)
T 3dzo_A          368 EQL  370 (413)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            865

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.1e-41  Score=296.51  Aligned_cols=228  Identities=15%  Similarity=0.114  Sum_probs=185.4

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCc--hHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeE
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSS--TIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEI  121 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~  121 (337)
                      ...++|++.+.||+|+||+||+|.+..+++.||+|++.....  ....+.+.+|+..+.+++|+||+++++++.+ ....
T Consensus        28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-~~~~  106 (286)
T 3uqc_A           28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHT-RAGG  106 (286)
T ss_dssp             ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-TTEE
T ss_pred             EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEE-CCcE
Confidence            344789999999999999999999999999999999976542  4455778899999999999999999998876 6889


Q ss_pred             EEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhcccc
Q 019650          122 CFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRN  201 (337)
Q Consensus       122 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~  201 (337)
                      |+||||++|++|.+++...  ....++..++.|++.||.|||++||+||||||+||+++.++.++|++++.         
T Consensus       107 ~lv~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~~---------  175 (286)
T 3uqc_A          107 LVVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPAT---------  175 (286)
T ss_dssp             EEEEECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCCC---------
T ss_pred             EEEEEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEeccc---------
Confidence            9999999999999999643  46667899999999999999999999999999999999999999984432         


Q ss_pred             CCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhh
Q 019650          202 NNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAIC  281 (337)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~  281 (337)
                                               ++           .++.++||||||+++|+|++|+.||.................
T Consensus       176 -------------------------~~-----------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~  219 (286)
T 3uqc_A          176 -------------------------MP-----------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTA  219 (286)
T ss_dssp             -------------------------CT-----------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTT
T ss_pred             -------------------------cC-----------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhc
Confidence                                     22           357789999999999999999999976443221100000000


Q ss_pred             ccC--CCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          282 FGE--RLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       282 ~~~--~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                      ...  .......++..+.++|.+||+.||++| |++++++.
T Consensus       220 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~  259 (286)
T 3uqc_A          220 GQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNL  259 (286)
T ss_dssp             SCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred             cCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHH
Confidence            000  012235678999999999999999999 99999874

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=4.6e-42  Score=305.96  Aligned_cols=246  Identities=16%  Similarity=0.172  Sum_probs=191.0

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCceEEEEEeecCC-------chHhHHHHHHHHHHHHhcC---------CCCc
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-------STIIRHQAAHEAEILKRLD---------SQFI  107 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~e~~~~~~l~---------~~~i  107 (337)
                      ...++|++.+.||+|+||+||+|.+  +++.||+|++....       .....+.+.+|+.++++++         |+||
T Consensus        17 ~~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~ni   94 (336)
T 2vuw_A           17 LPTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGF   94 (336)
T ss_dssp             SCHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCB
T ss_pred             cccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCch
Confidence            3468999999999999999999988  67999999997653       2223467788999998886         7777


Q ss_pred             eeeeeeEEe-----------------------------eCCeEEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHH
Q 019650          108 VKCHAVFYT-----------------------------IEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKG  158 (337)
Q Consensus       108 ~~~~~~~~~-----------------------------~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~  158 (337)
                      +.+.+++..                             ....+|+||||+++|++.+.+.. ..+++..++.++.||+.|
T Consensus        95 v~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~a  173 (336)
T 2vuw_A           95 IGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTAS  173 (336)
T ss_dssp             CCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHH
T ss_pred             hhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHH
Confidence            776665432                             15789999999999977777654 678999999999999999


Q ss_pred             HHHHH-hCCceeccCCCCCeEEcCCC--------------------cEEEeeccCccchhccccCCCCCCCCCCcccccc
Q 019650          159 LQYLH-GMQIIHGDIKPSNLLINGKG--------------------EVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAA  217 (337)
Q Consensus       159 l~~LH-~~~ivH~dl~~~Nili~~~~--------------------~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~  217 (337)
                      |+||| ++||+||||||+|||++.++                    .+||+|||++......                  
T Consensus       174 L~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------------------  235 (336)
T 2vuw_A          174 LAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------------------  235 (336)
T ss_dssp             HHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------------------
T ss_pred             HHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------------------
Confidence            99999 99999999999999999887                    8999999999866432                  


Q ss_pred             ccccCCCCCcCCcccccccCCCCCCccccHHHHHHH-HHHHHhCCCCCCCCCCchhHHHHHHHhhcc--CCCC----CCC
Q 019650          218 IACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVV-VLECLVGHYPLIGFGEKPDLMALICAICFG--ERLE----MPE  290 (337)
Q Consensus       218 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~i-l~~l~tg~~pf~~~~~~~~~~~~~~~~~~~--~~~~----~~~  290 (337)
                       ..+||+.|+|||++.+    .. +.++||||||++ .+++++|..||...   .............  ....    .+.
T Consensus       236 -~~~gt~~y~aPE~~~g----~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (336)
T 2vuw_A          236 -IVVFCDVSMDEDLFTG----DG-DYQFDIYRLMKKENNNRWGEYHPYSNV---LWLHYLTDKMLKQMTFKTKCNTPAMK  306 (336)
T ss_dssp             -EEECCCCTTCSGGGCC----CS-SHHHHHHHHHHHHHTTCTTSCCTHHHH---HHHHHHHHHHHHTCCCSSCCCSHHHH
T ss_pred             -cEEEeecccChhhhcC----CC-ccceehhhhhCCCCcccccccCCCcch---hhhhHHHHhhhhhhccCcccchhhhh
Confidence             1258999999999983    23 789999998776 77888899888321   0001111111111  0111    122


Q ss_pred             CCCHHHHHHHHHHhhcCcCCCCCHHHHh-cCcccc
Q 019650          291 TASPEFRRFVRSCLEKDWRKRGTVEELL-AYPFVT  324 (337)
Q Consensus       291 ~~~~~~~~li~~~l~~~p~~R~s~~eil-~hp~f~  324 (337)
                      .+++.+.+||.+||..|     |++|+| +||||+
T Consensus       307 ~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~  336 (336)
T 2vuw_A          307 QIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK  336 (336)
T ss_dssp             HHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred             hcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence            45788999999999976     999999 999995

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.6e-41  Score=328.91  Aligned_cols=244  Identities=20%  Similarity=0.224  Sum_probs=199.7

Q ss_pred             cCccccccccccccCcceEEEEEEEcc-CCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCe--
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQK-SNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGE--  120 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~--  120 (337)
                      ...++|++.+.||.|+||+||+|.+.. +++.||+|++...........+.+|+.++++++||||+++++++...+..  
T Consensus        77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~  156 (681)
T 2pzi_A           77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGD  156 (681)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSC
T ss_pred             EeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCC
Confidence            334899999999999999999999975 78999999987665555667788999999999999999999998774432  


Q ss_pred             --EEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhc
Q 019650          121 --ICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEE  198 (337)
Q Consensus       121 --~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~  198 (337)
                        .|+||||++|++|.+++..  .+++..++.++.||+.+|.|||++||+||||||+||+++.+ .++|+|||++.....
T Consensus       157 ~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~  233 (681)
T 2pzi_A          157 PVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS  233 (681)
T ss_dssp             EEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETTC
T ss_pred             ceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhccc
Confidence              7999999999999998864  79999999999999999999999999999999999999875 999999999976543


Q ss_pred             cccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHH
Q 019650          199 TRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALIC  278 (337)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~  278 (337)
                      .                  ....||+.|+|||++..     .++.++||||||+++|+|++|..||........      
T Consensus       234 ~------------------~~~~gt~~y~aPE~~~~-----~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~------  284 (681)
T 2pzi_A          234 F------------------GYLYGTPGFQAPEIVRT-----GPTVATDIYTVGRTLAALTLDLPTRNGRYVDGL------  284 (681)
T ss_dssp             C------------------SCCCCCTTTSCTTHHHH-----CSCHHHHHHHHHHHHHHHHSCCCEETTEECSSC------
T ss_pred             C------------------CccCCCccccCHHHHcC-----CCCCceehhhhHHHHHHHHhCCCCCcccccccc------
Confidence            2                  12358999999999873     348899999999999999999988754211100      


Q ss_pred             HhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCcccc
Q 019650          279 AICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVT  324 (337)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~  324 (337)
                           .........++.+.++|.+||+.||.+||+..+.+.|+|+.
T Consensus       285 -----~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~  325 (681)
T 2pzi_A          285 -----PEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG  325 (681)
T ss_dssp             -----CTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             -----cccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence                 00000011357899999999999999999999999888774

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.98  E-value=8.3e-34  Score=268.19  Aligned_cols=184  Identities=16%  Similarity=0.110  Sum_probs=132.2

Q ss_pred             cccCcceEEEEEEEccCCceEEEEEeecCC---------chHhHHHHHHHHHHHHhc-CCCCceeeeeeEEeeCCeEEEE
Q 019650           55 LGHGNGGIVYKVRHQKSNSIYALKVLNTTS---------STIIRHQAAHEAEILKRL-DSQFIVKCHAVFYTIEGEICFV  124 (337)
Q Consensus        55 lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~---------~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~~lv  124 (337)
                      .+.|+.|....+.....|+.+++|++....         .+...+++.+|+++++++ .|+||+++++++.+ +...|||
T Consensus       242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed-~~~~yLV  320 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGEN-AQSGWLV  320 (569)
T ss_dssp             -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEEC-SSEEEEE
T ss_pred             cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEE-CCEEEEE
Confidence            456666666666666678899999997642         234456788999999999 78999999998766 7899999


Q ss_pred             EeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCC
Q 019650          125 MEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNN  204 (337)
Q Consensus       125 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~  204 (337)
                      |||++|++|.+++...+++++.   .|+.||+.||+|+|++|||||||||+|||++.+|++||+|||+++......    
T Consensus       321 MEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~----  393 (569)
T 4azs_A          321 MEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC----  393 (569)
T ss_dssp             EECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC-------
T ss_pred             EecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCC----
Confidence            9999999999999988888875   478999999999999999999999999999999999999999997664432    


Q ss_pred             CCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCC
Q 019650          205 HNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGH  261 (337)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~  261 (337)
                                ......+||+.|+|||++.+     .+..++|+|++|++++++.++.
T Consensus       394 ----------~~~~t~vGTp~YmAPE~l~g-----~~~~~~d~~s~g~~~~~l~~~~  435 (569)
T 4azs_A          394 ----------SWPTNLVQSFFVFVNELFAE-----NKSWNGFWRSAPVHPFNLPQPW  435 (569)
T ss_dssp             ----------CCSHHHHHHHHHHHHHHC----------------------CCCCTTH
T ss_pred             ----------ccccCceechhhccHHHhCC-----CCCCcccccccccchhhhcccc
Confidence                      22334579999999999973     4567899999999988765543

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.94  E-value=2e-27  Score=223.45  Aligned_cols=193  Identities=16%  Similarity=0.128  Sum_probs=141.7

Q ss_pred             ccccccccCcceEEEEEEEccCCceEEEEEeecCC-------chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEE
Q 019650           50 KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-------STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEIC  122 (337)
Q Consensus        50 ~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~  122 (337)
                      ...+.||+|+||+||+|.  ..+..+++|......       .....+.+.+|+.++++++|+||+++...... ....|
T Consensus       339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~-~~~~~  415 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVD-LDNKR  415 (540)
T ss_dssp             ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEE-TTTTE
T ss_pred             CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEe-CCccE
Confidence            446799999999999994  456788898864432       11224557899999999999999955444444 56679


Q ss_pred             EEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccC
Q 019650          123 FVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNN  202 (337)
Q Consensus       123 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~  202 (337)
                      +||||++|++|.+++..        +..++.|++.+|.|||++||+||||||+||+++.  +++|+|||++.........
T Consensus       416 lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~  485 (540)
T 3en9_A          416 IMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDK  485 (540)
T ss_dssp             EEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHH
T ss_pred             EEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCcccc
Confidence            99999999999999975        6789999999999999999999999999999998  9999999999876543210


Q ss_pred             CCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCC
Q 019650          203 NNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPL  264 (337)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf  264 (337)
                      ...       .........||+.|+|||++...  -..|+..+|+|+..+-..+-...+.+|
T Consensus       486 ~~~-------~~~~~~~~~GT~~y~APEv~~~~--~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          486 AVD-------LIVFKKAVLSTHHEKFDEIWERF--LEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHH-------HHHHHHHHHHHCGGGHHHHHHHH--HHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             ccc-------hhhhhhhhcCCCCcCCHHHHHHH--HHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            000       00012345689999999999842  135677889999988888877766555

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.92  E-value=3e-25  Score=191.97  Aligned_cols=128  Identities=20%  Similarity=0.303  Sum_probs=106.7

Q ss_pred             cccccCcceEEEEEEEccCCceEEEEEeecCCch-----------------HhHHHHHHHHHHHHhcCCCCceeeeeeEE
Q 019650           53 TVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSST-----------------IIRHQAAHEAEILKRLDSQFIVKCHAVFY  115 (337)
Q Consensus        53 ~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~-----------------~~~~~~~~e~~~~~~l~~~~i~~~~~~~~  115 (337)
                      +.||.|+||.||+|.+ .+++.||+|+++.....                 .....+.+|+.+++++.  | +++.+.+.
T Consensus        96 ~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~~  171 (282)
T 1zar_A           96 KLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVYA  171 (282)
T ss_dssp             EEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEEE
T ss_pred             CEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEEe
Confidence            9999999999999999 88999999999653211                 13456789999999999  4 66666543


Q ss_pred             eeCCeEEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCcc
Q 019650          116 TIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSR  194 (337)
Q Consensus       116 ~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~  194 (337)
                      .  +..++||||++|++|.+ +..      .....++.|++.||.|||++|++||||||+||+++ ++.++|+|||++.
T Consensus       172 ~--~~~~lvmE~~~g~~L~~-l~~------~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG~a~  240 (282)
T 1zar_A          172 W--EGNAVLMELIDAKELYR-VRV------ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQSV  240 (282)
T ss_dssp             E--ETTEEEEECCCCEEGGG-CCC------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCTTCE
T ss_pred             c--cceEEEEEecCCCcHHH-cch------hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECCCCe
Confidence            3  45689999999999988 421      23457999999999999999999999999999999 9999999999986

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.85  E-value=2.3e-21  Score=165.54  Aligned_cols=141  Identities=17%  Similarity=0.170  Sum_probs=108.0

Q ss_pred             ccccccccccCcceEEEEEEEccCCce--EEEEEeecCCch-----------------------HhHHHHHHHHHHHHhc
Q 019650           48 DLKKLTVLGHGNGGIVYKVRHQKSNSI--YALKVLNTTSST-----------------------IIRHQAAHEAEILKRL  102 (337)
Q Consensus        48 ~y~~~~~lg~g~~~~v~~~~~~~~~~~--vaiK~~~~~~~~-----------------------~~~~~~~~e~~~~~~l  102 (337)
                      -|.+.+.||.|+||.||+|.+..+|..  ||+|+++.....                       .....+.+|+.++.++
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            367889999999999999998778888  999997543211                       1123577899999999


Q ss_pred             CCCCceeeeeeEEeeCCeEEEEEeccCC-C----CchHHhhhcCCCCHHHHHHHHHHHHHHHHHHH-hCCceeccCCCCC
Q 019650          103 DSQFIVKCHAVFYTIEGEICFVMEHMER-G----SLFDSLRVRKKLSEDVISGVAYRVLKGLQYLH-GMQIIHGDIKPSN  176 (337)
Q Consensus       103 ~~~~i~~~~~~~~~~~~~~~lv~e~~~~-~----~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH-~~~ivH~dl~~~N  176 (337)
                      .|+++.....+. .  ...++||||+.+ |    +|.+....   .++..+..++.|++.+|.+|| +.|++||||||+|
T Consensus       128 ~~~~i~~p~~~~-~--~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~N  201 (258)
T 1zth_A          128 KEAGVSVPQPYT-Y--MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYN  201 (258)
T ss_dssp             HHTTCCCCCEEE-E--ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTS
T ss_pred             HhCCCCCCeEEE-c--CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHH
Confidence            887652221111 1  245799999942 3    56655432   235577899999999999999 9999999999999


Q ss_pred             eEEcCCCcEEEeeccCccch
Q 019650          177 LLINGKGEVKIADFGVSRIV  196 (337)
Q Consensus       177 ili~~~~~~~l~Dfg~~~~~  196 (337)
                      ||++.  .++|+|||++...
T Consensus       202 ILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          202 IMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             EEESS--SEEECCCTTCEET
T ss_pred             EEEcC--cEEEEECcccccC
Confidence            99998  9999999999754

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.75  E-value=2.2e-18  Score=153.18  Aligned_cols=138  Identities=16%  Similarity=0.092  Sum_probs=100.8

Q ss_pred             cccccccccCcceEEEEEEEccCCceEEEEEeecCCc-----------------hH----hHHHHHHHHHHHHhcCCCCc
Q 019650           49 LKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSS-----------------TI----IRHQAAHEAEILKRLDSQFI  107 (337)
Q Consensus        49 y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-----------------~~----~~~~~~~e~~~~~~l~~~~i  107 (337)
                      |.+++.||.|++|.||+|.+. +|+.||+|+++....                 ..    ..-....|...+.++.+.++
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            889999999999999999884 688999999754210                 00    00112356777777755444


Q ss_pred             eeeeeeEEeeCCeEEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCC----
Q 019650          108 VKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKG----  183 (337)
Q Consensus       108 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~----  183 (337)
                      ....- +.. .. .++||||++|++|.++..      ......++.||+.+|.+||+.|+|||||||.|||+++++    
T Consensus       176 ~vp~p-~~~-~~-~~LVME~i~G~~L~~l~~------~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d  246 (397)
T 4gyi_A          176 PVPEP-IAQ-SR-HTIVMSLVDALPMRQVSS------VPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAED  246 (397)
T ss_dssp             SCCCE-EEE-ET-TEEEEECCSCEEGGGCCC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSC
T ss_pred             CCCee-eec-cC-ceEEEEecCCccHhhhcc------cHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCccc
Confidence            32222 212 12 369999999888876543      123467889999999999999999999999999998776    


Q ss_pred             ------cEEEeeccCccch
Q 019650          184 ------EVKIADFGVSRIV  196 (337)
Q Consensus       184 ------~~~l~Dfg~~~~~  196 (337)
                            .+.|+||+-+...
T Consensus       247 ~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          247 PSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             TTSEEEEEEECCCTTCEET
T ss_pred             ccccccceEEEEeCCcccC
Confidence                  3899999977654

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.42  E-value=7.1e-13  Score=113.10  Aligned_cols=140  Identities=16%  Similarity=0.164  Sum_probs=108.1

Q ss_pred             ccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcC-CCCceeeeeeEEeeCCeEEEE
Q 019650           46 ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLD-SQFIVKCHAVFYTIEGEICFV  124 (337)
Q Consensus        46 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~~lv  124 (337)
                      ++.|++...++.|+.+.||++...  +..+++|+...... .....+.+|+.+++.+. +..+.+++..... .+..|+|
T Consensus        13 l~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~-~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~-~~~~~lv   88 (263)
T 3tm0_A           13 IEKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYK-GTTYDVEREKDMMLWLEGKLPVPKVLHFERH-DGWSNLL   88 (263)
T ss_dssp             HTTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGT-TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE-TTEEEEE
T ss_pred             hccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccC-CCHHHHHHHHHHHHHHhcCCCCCeEEEEEec-CCceEEE
Confidence            467889999999999999999754  57899999864211 11235778999998885 5566777776654 6788999


Q ss_pred             EeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------
Q 019650          125 MEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG----------------------------------------  164 (337)
Q Consensus       125 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~----------------------------------------  164 (337)
                      ||+++|.+|.+.+.     +......++.+++.+|+.||+                                        
T Consensus        89 ~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (263)
T 3tm0_A           89 MSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP  163 (263)
T ss_dssp             EECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCS
T ss_pred             EEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccccc
Confidence            99999988877632     122345788899999999998                                        


Q ss_pred             -------------------CCceeccCCCCCeEEcCCCcEEEeeccCcc
Q 019650          165 -------------------MQIIHGDIKPSNLLINGKGEVKIADFGVSR  194 (337)
Q Consensus       165 -------------------~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~  194 (337)
                                         ..++|||+++.||+++.++.+.|+||+.+.
T Consensus       164 ~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             SSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             CCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                               448999999999999876556799999775

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.29  E-value=2.1e-11  Score=103.56  Aligned_cols=135  Identities=13%  Similarity=0.146  Sum_probs=96.4

Q ss_pred             cccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCc--eeeeeeEEeeCCeEEEE
Q 019650           47 SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFI--VKCHAVFYTIEGEICFV  124 (337)
Q Consensus        47 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i--~~~~~~~~~~~~~~~lv  124 (337)
                      ..+.+....+.|..+.||++.. .+|..+++|+....    ....+.+|+.+++.+.+.++  .+++..... .+..++|
T Consensus        20 ~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~-~~~~~~v   93 (264)
T 1nd4_A           20 FGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG----ALNELQDEAARLSWLATTGVPCAAVLDVVTE-AGRDWLL   93 (264)
T ss_dssp             TTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEEC-SSCEEEE
T ss_pred             CCCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc----cchhhhHHHHHHHHHHhCCCCCCeEEEeccC-CCCCEEE
Confidence            4455544445677799999964 45677999997643    12446678888888865454  446665544 5678999


Q ss_pred             EeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------
Q 019650          125 MEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQ--------------------------------------  166 (337)
Q Consensus       125 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~--------------------------------------  166 (337)
                      ||+++|.+|.  ..   ..+   ...++.+++..|+.||+..                                      
T Consensus        94 ~e~i~G~~l~--~~---~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (264)
T 1nd4_A           94 LGEVPGQDLL--SS---HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL  165 (264)
T ss_dssp             EECCSSEETT--TS---CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred             EEecCCcccC--cC---cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCc
Confidence            9999998874  21   122   2356777888888888653                                      


Q ss_pred             --------------------ceeccCCCCCeEEcCCCcEEEeeccCccc
Q 019650          167 --------------------IIHGDIKPSNLLINGKGEVKIADFGVSRI  195 (337)
Q Consensus       167 --------------------ivH~dl~~~Nili~~~~~~~l~Dfg~~~~  195 (337)
                                          ++|||++|.||+++.++.+.|+||+.+..
T Consensus       166 ~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          166 APAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             cHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                                99999999999998766667999998753

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.24  E-value=4.3e-11  Score=106.79  Aligned_cols=141  Identities=16%  Similarity=0.273  Sum_probs=102.7

Q ss_pred             cccccccCcceEEEEEEEccCCceEEEEEee--cCCchHhHHHHHHHHHHHHhcCC--CCceeeeeeEEeeC--CeEEEE
Q 019650           51 KLTVLGHGNGGIVYKVRHQKSNSIYALKVLN--TTSSTIIRHQAAHEAEILKRLDS--QFIVKCHAVFYTIE--GEICFV  124 (337)
Q Consensus        51 ~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~--~~~~~~~~~~~~~e~~~~~~l~~--~~i~~~~~~~~~~~--~~~~lv  124 (337)
                      ..+.++.|.++.+|++...  +..+++|+..  ..........+.+|..+++.+..  ..+.+++..+.+..  +..|+|
T Consensus        42 ~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v  119 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI  119 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred             eEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence            4667899999999998764  3578888775  33211224567789999999975  34566666554321  347899


Q ss_pred             EeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------
Q 019650          125 MEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG----------------------------------------  164 (337)
Q Consensus       125 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~----------------------------------------  164 (337)
                      ||+++|.++.+..  ...++......++.+++.+|+.||.                                        
T Consensus       120 me~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  197 (359)
T 3dxp_A          120 MEFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAM  197 (359)
T ss_dssp             EECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHH
T ss_pred             EEecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHH
Confidence            9999998775422  2357888899999999999999997                                        


Q ss_pred             ------------------CCceeccCCCCCeEEcCCCc--EEEeeccCccc
Q 019650          165 ------------------MQIIHGDIKPSNLLINGKGE--VKIADFGVSRI  195 (337)
Q Consensus       165 ------------------~~ivH~dl~~~Nili~~~~~--~~l~Dfg~~~~  195 (337)
                                        ..++|||+++.||+++.++.  +.|+||+.+..
T Consensus       198 ~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          198 DSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                              35899999999999997753  68999998764

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.12  E-value=2.6e-11  Score=105.73  Aligned_cols=135  Identities=21%  Similarity=0.238  Sum_probs=97.2

Q ss_pred             ccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCC-CCc--eeeeeeEEeeC--CeEEEEEe
Q 019650           52 LTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDS-QFI--VKCHAVFYTIE--GEICFVME  126 (337)
Q Consensus        52 ~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~-~~i--~~~~~~~~~~~--~~~~lv~e  126 (337)
                      ++.++.|....||++.     ..+++|+....   .....+.+|..+++.+.. ..+  ..++.......  ...|+||+
T Consensus        25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~---~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~   96 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS---RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFT   96 (304)
T ss_dssp             CCEEEECSSEEEEEST-----TSEEEEEESSH---HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEE
T ss_pred             eEecCCCCcceEEEEC-----CEEEEEecCCc---chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEc
Confidence            3458999999999863     45889986432   345677889999988843 332  22332211111  13478999


Q ss_pred             ccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------------
Q 019650          127 HMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG------------------------------------------  164 (337)
Q Consensus       127 ~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~------------------------------------------  164 (337)
                      +++|.+|.+...  ..++.++...++.+++..++.||+                                          
T Consensus        97 ~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  174 (304)
T 3sg8_A           97 KIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD  174 (304)
T ss_dssp             CCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred             ccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence            999988875433  467888888899999999999986                                          


Q ss_pred             ----------------CCceeccCCCCCeEEcC--CCcEEEeeccCccch
Q 019650          165 ----------------MQIIHGDIKPSNLLING--KGEVKIADFGVSRIV  196 (337)
Q Consensus       165 ----------------~~ivH~dl~~~Nili~~--~~~~~l~Dfg~~~~~  196 (337)
                                      ..++|||+++.||+++.  +..+.++||+.+..-
T Consensus       175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~  224 (304)
T 3sg8_A          175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAIS  224 (304)
T ss_dssp             HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEE
T ss_pred             HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccC
Confidence                            13699999999999998  456889999987653

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.83  E-value=7.2e-08  Score=83.86  Aligned_cols=134  Identities=21%  Similarity=0.242  Sum_probs=94.4

Q ss_pred             ccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCC---CceeeeeeEEeeCCeEEEEEecc
Q 019650           52 LTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQ---FIVKCHAVFYTIEGEICFVMEHM  128 (337)
Q Consensus        52 ~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~---~i~~~~~~~~~~~~~~~lv~e~~  128 (337)
                      .+.++.|....||++     +..+++|+..   .......+.+|..+++.+.+.   .+..++.......+..+++|+++
T Consensus        24 v~~l~~G~~n~v~~v-----g~~~VlR~~~---~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i   95 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----NGDWVFRFPK---SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKV   95 (306)
T ss_dssp             EEEEEECSSEEEEEE-----TTTEEEEEES---SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECC
T ss_pred             eeecCCCcceeEEEE-----CCEEEEEecC---CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEecc
Confidence            345788999999998     4568889853   223456788999999999753   24444444433345678999999


Q ss_pred             CCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhC-------------------------------------------
Q 019650          129 ERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGM-------------------------------------------  165 (337)
Q Consensus       129 ~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~-------------------------------------------  165 (337)
                      +|.++.+..-  ..++......++.++...|+.||+.                                           
T Consensus        96 ~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~  173 (306)
T 3tdw_A           96 QGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT  173 (306)
T ss_dssp             CSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred             CCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence            9988876321  2445566666666666666666642                                           


Q ss_pred             -----------------CceeccCCCCCeEEcC---CCc-EEEeeccCccc
Q 019650          166 -----------------QIIHGDIKPSNLLING---KGE-VKIADFGVSRI  195 (337)
Q Consensus       166 -----------------~ivH~dl~~~Nili~~---~~~-~~l~Dfg~~~~  195 (337)
                                       .++|||+++.||+++.   ++. +.|+||+.+..
T Consensus       174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                             3489999999999987   455 58999998764

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.70  E-value=2.7e-07  Score=78.54  Aligned_cols=133  Identities=17%  Similarity=0.212  Sum_probs=93.5

Q ss_pred             ccccCcce-EEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCC-CCceeeeeeEEeeCCeEEEEEeccCCC
Q 019650           54 VLGHGNGG-IVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDS-QFIVKCHAVFYTIEGEICFVMEHMERG  131 (337)
Q Consensus        54 ~lg~g~~~-~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~-~~i~~~~~~~~~~~~~~~lv~e~~~~~  131 (337)
                      .+..|..+ .||+......+..+++|+....    ....+..|...++.+.. -.+.+++....+ ....++||++++|.
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~-~~~~~lvme~l~G~  105 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS----VANDVTDEMVRLNWLTAFMPLPTIKHFIRT-PDDAWLLTTAIPGK  105 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETH----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEE-TTEEEEEEECCCSE
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCC----CHhHHHHHHHHHHHhccCCCcCeEEEEEEE-CCeEEEEEEeeCCc
Confidence            34445444 7899887777788999986532    34567789988888843 335556665544 67889999999998


Q ss_pred             CchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhC----------------------------------------------
Q 019650          132 SLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGM----------------------------------------------  165 (337)
Q Consensus       132 ~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~----------------------------------------------  165 (337)
                      ++.+.....    ......+..++...|+.||..                                              
T Consensus       106 ~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  181 (272)
T 4gkh_A          106 TAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK  181 (272)
T ss_dssp             EHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred             cccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence            877665421    123345566666666666641                                              


Q ss_pred             ------------CceeccCCCCCeEEcCCCcEEEeeccCccc
Q 019650          166 ------------QIIHGDIKPSNLLINGKGEVKIADFGVSRI  195 (337)
Q Consensus       166 ------------~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~  195 (337)
                                  .++|||+++.||+++.++.+-|+||+.+..
T Consensus       182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                        178999999999999777778999998753

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.47  E-value=6.7e-07  Score=80.66  Aligned_cols=78  Identities=18%  Similarity=0.210  Sum_probs=48.6

Q ss_pred             cccccccCcceEEEEEEEccCCceEEEEEeecCCc------hHhHHHHHHHHHHHHhcCC--CCce-eeeeeEEeeCCeE
Q 019650           51 KLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSS------TIIRHQAAHEAEILKRLDS--QFIV-KCHAVFYTIEGEI  121 (337)
Q Consensus        51 ~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~e~~~~~~l~~--~~i~-~~~~~~~~~~~~~  121 (337)
                      ..+.||.|..+.||++....++..+++|.......      ....+++..|..+++.+..  +..+ .++..  + ....
T Consensus        34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d-~~~~  110 (397)
T 2olc_A           34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--D-TEMA  110 (397)
T ss_dssp             EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--E-TTTT
T ss_pred             EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--c-CCcc
Confidence            35678999999999997665677899998643211      1123455678888887743  3344 34432  2 3445


Q ss_pred             EEEEeccCCC
Q 019650          122 CFVMEHMERG  131 (337)
Q Consensus       122 ~lv~e~~~~~  131 (337)
                      ++|||+++|.
T Consensus       111 ~lvmE~l~g~  120 (397)
T 2olc_A          111 VTVMEDLSHL  120 (397)
T ss_dssp             EEEECCCTTS
T ss_pred             EEEEEeCCCc
Confidence            7999999764

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.32  E-value=3.5e-06  Score=74.67  Aligned_cols=86  Identities=12%  Similarity=0.093  Sum_probs=53.0

Q ss_pred             cccccc-ccCcceEEEEEEEc--c----CCceEEEEEeecCCc--hHhHHHHHHHHHHHHhcCC---CCceeeeeeEEee
Q 019650           50 KKLTVL-GHGNGGIVYKVRHQ--K----SNSIYALKVLNTTSS--TIIRHQAAHEAEILKRLDS---QFIVKCHAVFYTI  117 (337)
Q Consensus        50 ~~~~~l-g~g~~~~v~~~~~~--~----~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~~---~~i~~~~~~~~~~  117 (337)
                      ...+.| +.|....+|++...  .    ++..+++|+......  ......+.+|..+++.+..   ..+.+++....+.
T Consensus        23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~  102 (357)
T 3ats_A           23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG  102 (357)
T ss_dssp             EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred             EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence            345677 88999999998653  1    156788998653220  0012345667777777743   3455566654331


Q ss_pred             C--CeEEEEEeccCCCCchH
Q 019650          118 E--GEICFVMEHMERGSLFD  135 (337)
Q Consensus       118 ~--~~~~lv~e~~~~~~L~~  135 (337)
                      .  +..++|||+++|.++.+
T Consensus       103 ~~~g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          103 DVLGTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             TTTSSCEEEEECCCCBCCCB
T ss_pred             CccCCceEEEEecCCCChhh
Confidence            1  34689999999876653

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=98.29  E-value=8.5e-06  Score=65.68  Aligned_cols=134  Identities=15%  Similarity=0.151  Sum_probs=91.2

Q ss_pred             CchHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCCCCCCC
Q 019650          132 SLFDSLRV-RKKLSEDVISGVAYRVLKGLQYLHG-MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNN  209 (337)
Q Consensus       132 ~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~-~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~  209 (337)
                      +|.+.|.. +.+++++++|.++.|.+.+|..+-. ..-...=+.|..|++..+|++.+.+ ..+.               
T Consensus        34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~---------------   97 (229)
T 2yle_A           34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD---------------   97 (229)
T ss_dssp             EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------------
T ss_pred             cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc---------------
Confidence            78888874 5689999999999999999887621 2212334456889999999888775 1111               


Q ss_pred             CCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhccCCCCCC
Q 019650          210 NNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMP  289 (337)
Q Consensus       210 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  289 (337)
                                 .....+.|||...     ...+.+.=|||||+++|.-+-...|-                      .-+
T Consensus        98 -----------~~~~~~~~pe~~~-----~~~te~~~IysLG~tLY~ALDygL~e----------------------~eE  139 (229)
T 2yle_A           98 -----------AGEPPPVAGKLGY-----SQCMETEVIESLGIIIYKALDYGLKE----------------------NEE  139 (229)
T ss_dssp             --------------------CCSS-----SSSCHHHHHHHHHHHHHHHHTTTCCT----------------------TEE
T ss_pred             -----------ccccCCCChhhcc-----ccchHHHHHHHHHHHHHHHhhcCCCc----------------------ccc
Confidence                       0223466887764     24566788999999999998865542                      113


Q ss_pred             CCCCHHHHHHHHHHhhc-------------------------CcCCCCCHHHHhc
Q 019650          290 ETASPEFRRFVRSCLEK-------------------------DWRKRGTVEELLA  319 (337)
Q Consensus       290 ~~~~~~~~~li~~~l~~-------------------------~p~~R~s~~eil~  319 (337)
                      ..+++.+.+||..|.+-                         .+..|+++++|++
T Consensus       140 ~eLS~~LE~LL~~Mt~~~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~  194 (229)
T 2yle_A          140 RELSPPLEQLIDHMANTVEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMK  194 (229)
T ss_dssp             ECCCHHHHHHHHHHTTCCC--------------------CCSCCCCCCSHHHHHH
T ss_pred             hhhCHHHHHHHHHHHhcccccccccccccccccccccccccccccCcCCHHHHHH
Confidence            45689999999999766                         2457889998885

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.15  E-value=4e-05  Score=67.23  Aligned_cols=30  Identities=17%  Similarity=0.296  Sum_probs=27.4

Q ss_pred             CCceeccCCCCCeEEcCCCcEEEeeccCcc
Q 019650          165 MQIIHGDIKPSNLLINGKGEVKIADFGVSR  194 (337)
Q Consensus       165 ~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~  194 (337)
                      .+++|||+++.||+++.++.+.++||+.+.
T Consensus       222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            579999999999999888899999999774

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.99  E-value=0.00011  Score=63.66  Aligned_cols=76  Identities=14%  Similarity=0.141  Sum_probs=55.9

Q ss_pred             cccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcC---CCCceeeeeeEEeeCCeEEEEEec
Q 019650           51 KLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLD---SQFIVKCHAVFYTIEGEICFVMEH  127 (337)
Q Consensus        51 ~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~---~~~i~~~~~~~~~~~~~~~lv~e~  127 (337)
                      -.+.|+.|....+|++..  ++..+++|+....    ....+..|...++.+.   ...+++++..... ....++|||+
T Consensus        40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~-~g~~~lvme~  112 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERS----YRSMFRAEADQLALLAKTNSINVPLVYGIGNS-QGHSFLLLEA  112 (312)
T ss_dssp             EEEEECCSSSSEEEEEES--SSCEEEEEEEEGG----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEEC-SSEEEEEEEC
T ss_pred             eeEEeCCccceeeeEEEE--CCCeEEEEeCCcc----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeec-CCceEEEEEe
Confidence            356789999999999975  3567889987643    2456778888888773   3456666665443 5678999999


Q ss_pred             cCCCCc
Q 019650          128 MERGSL  133 (337)
Q Consensus       128 ~~~~~L  133 (337)
                      ++|..+
T Consensus       113 l~G~~~  118 (312)
T 3jr1_A          113 LNKSKN  118 (312)
T ss_dssp             CCCCCC
T ss_pred             ccCCCC
Confidence            998765

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.96  E-value=2.6e-05  Score=67.35  Aligned_cols=72  Identities=11%  Similarity=0.052  Sum_probs=44.1

Q ss_pred             ccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCce-eeeeeEEeeCCeEEEEEecc-C
Q 019650           52 LTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIV-KCHAVFYTIEGEICFVMEHM-E  129 (337)
Q Consensus        52 ~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~-~~~~~~~~~~~~~~lv~e~~-~  129 (337)
                      .+.|+.|....+|++      ..+++|+.......  .-...+|..+++.+...++. +++..  . ...-+++++|+ +
T Consensus        23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~--~~~r~~E~~~l~~l~~~g~~P~~~~~--~-~~~~~~v~e~i~~   91 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEE--YINRANEAVAAREAAKAGVSPEVLHV--D-PATGVMVTRYIAG   91 (301)
T ss_dssp             CEEEESCSSEEEEEE------TTEEEEEECC------CCCHHHHHHHHHHHHHTTSSCCEEEE--C-TTTCCEEEECCTT
T ss_pred             eeEcCCcccccccee------eeEEEECCCCCccc--eeCHHHHHHHHHHHHHcCCCCceEEE--E-CCCCEEEEeecCC
Confidence            678999999999998      45889987653211  11124577777766544444 34432  2 23346899999 6


Q ss_pred             CCCch
Q 019650          130 RGSLF  134 (337)
Q Consensus       130 ~~~L~  134 (337)
                      |.++.
T Consensus        92 g~~l~   96 (301)
T 3dxq_A           92 AQTMS   96 (301)
T ss_dssp             CEECC
T ss_pred             CccCC
Confidence            65553

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.91  E-value=5.3e-05  Score=68.70  Aligned_cols=33  Identities=18%  Similarity=0.364  Sum_probs=28.3

Q ss_pred             HhCCceeccCCCCCeEEcCCCcEEEeeccCccch
Q 019650          163 HGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIV  196 (337)
Q Consensus       163 H~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~  196 (337)
                      +...++|||+++.||+++.++ +.++||+.+..-
T Consensus       230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G  262 (420)
T 2pyw_A          230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG  262 (420)
T ss_dssp             BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred             CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence            356799999999999998776 999999987653

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.78  E-value=5.7e-05  Score=65.74  Aligned_cols=140  Identities=14%  Similarity=0.179  Sum_probs=76.2

Q ss_pred             cccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCc--eeeeee-----EEeeCCeEEE
Q 019650           51 KLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFI--VKCHAV-----FYTIEGEICF  123 (337)
Q Consensus        51 ~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i--~~~~~~-----~~~~~~~~~l  123 (337)
                      -.+.|+.|....+|++... ++ .+++|+......   ...+..|..++..+...++  ..++..     +....+..++
T Consensus        26 ~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~~~---~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~  100 (322)
T 2ppq_A           26 SYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRVE---KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAA  100 (322)
T ss_dssp             EEEEECC---EEEEEEEES-SC-CEEEEEECC------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEE
T ss_pred             EeeccCCCcccceEEEEeC-Cc-cEEEEEeCCCCC---HHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEE
Confidence            4567788988999999764 33 588998875311   2234456666666532222  222211     1112456789


Q ss_pred             EEeccCCCCchH----H----------hhhc-C----C----CC---HHHHHH------------HHHHHHHHHHHHHh-
Q 019650          124 VMEHMERGSLFD----S----------LRVR-K----K----LS---EDVISG------------VAYRVLKGLQYLHG-  164 (337)
Q Consensus       124 v~e~~~~~~L~~----~----------l~~~-~----~----l~---~~~~~~------------i~~~l~~~l~~LH~-  164 (337)
                      ++++++|..+..    .          ++.. .    +    ..   +.....            +-..+...+..+.. 
T Consensus       101 l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~  180 (322)
T 2ppq_A          101 LISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAH  180 (322)
T ss_dssp             EEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHH
T ss_pred             EEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhh
Confidence            999998865421    0          1110 0    0    01   111000            00113344555542 


Q ss_pred             ------CCceeccCCCCCeEEcCCCcEEEeeccCccc
Q 019650          165 ------MQIIHGDIKPSNLLINGKGEVKIADFGVSRI  195 (337)
Q Consensus       165 ------~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~  195 (337)
                            .+++|+|+++.||+++.++.+.++||+.+..
T Consensus       181 ~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          181 WPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             CCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             CcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence                  3699999999999998775568999997754

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.71  E-value=0.00013  Score=64.99  Aligned_cols=137  Identities=12%  Similarity=0.141  Sum_probs=80.6

Q ss_pred             ccccccCcceEEEEEEEcc-------CCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCcee-eeeeEEeeCCeEEE
Q 019650           52 LTVLGHGNGGIVYKVRHQK-------SNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVK-CHAVFYTIEGEICF  123 (337)
Q Consensus        52 ~~~lg~g~~~~v~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~-~~~~~~~~~~~~~l  123 (337)
                      ++.+..|-...+|++....       ++..+++|+.-...  .....+.+|..+++.+...++.+ +++.+   .+  .+
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~--~~~~~~~rE~~vl~~L~~~gv~P~ll~~~---~~--g~  127 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL--QGVDSLVLESVMFAILAERSLGPQLYGVF---PE--GR  127 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-----CCHHHHHHHHHHHHHHHHTTSSCCEEEEE---TT--EE
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc--chHHHHHHHHHHHHHHHhcCCCCeEEEEc---CC--cc
Confidence            4567888899999998642       34789999863321  12345568988888885544443 44432   22  28


Q ss_pred             EEeccCCCCchHH--------------h---hhc-----CCCC--HHHHHHHHHHHHH-------------------HHH
Q 019650          124 VMEHMERGSLFDS--------------L---RVR-----KKLS--EDVISGVAYRVLK-------------------GLQ  160 (337)
Q Consensus       124 v~e~~~~~~L~~~--------------l---~~~-----~~l~--~~~~~~i~~~l~~-------------------~l~  160 (337)
                      ||||++|.+|..-              |   +..     ....  ...+..++.++-.                   .+.
T Consensus       128 v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~  207 (379)
T 3feg_A          128 LEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMG  207 (379)
T ss_dssp             EEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHH
T ss_pred             EEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHH
Confidence            9999998655311              0   000     0111  3455555544322                   122


Q ss_pred             HH----Hh----CCceeccCCCCCeEEcCC----CcEEEeeccCccc
Q 019650          161 YL----HG----MQIIHGDIKPSNLLINGK----GEVKIADFGVSRI  195 (337)
Q Consensus       161 ~L----H~----~~ivH~dl~~~Nili~~~----~~~~l~Dfg~~~~  195 (337)
                      .|    ..    ..++|+|+.+.||+++.+    +.+.++||..+..
T Consensus       208 ~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          208 NLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            22    22    258999999999999876    6899999998864

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.60  E-value=0.0006  Score=58.28  Aligned_cols=82  Identities=17%  Similarity=0.154  Sum_probs=53.3

Q ss_pred             ccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEec
Q 019650           48 DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEH  127 (337)
Q Consensus        48 ~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~e~  127 (337)
                      +..-++.+|.|..+.||++... +|+.+++|+..... ......+..|...++.+....-+++-.++.. + .-++|||+
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~-~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~-~-~~~lv~e~   91 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDA-PALDGLFRAEALGLDWLGRSFGSPVPQVAGW-D-DRTLAMEW   91 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTC-CCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE-E-TTEEEEEC
T ss_pred             CeEEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCC-cchhhHHHHHHHHHHHHHhhCCCCcceEEec-c-CceEEEEe
Confidence            3455678999999999999864 67789999865432 2223456789999988854322222222222 1 23689999


Q ss_pred             cCCCCc
Q 019650          128 MERGSL  133 (337)
Q Consensus       128 ~~~~~L  133 (337)
                      ++++..
T Consensus        92 l~~~~~   97 (288)
T 3f7w_A           92 VDERPP   97 (288)
T ss_dssp             CCCCCC
T ss_pred             ecccCC
Confidence            987654

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.55  E-value=0.00029  Score=64.01  Aligned_cols=75  Identities=16%  Similarity=0.262  Sum_probs=49.0

Q ss_pred             cccccccCcceEEEEEEEcc-------CCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCc-eeeeeeEEeeCCeEE
Q 019650           51 KLTVLGHGNGGIVYKVRHQK-------SNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFI-VKCHAVFYTIEGEIC  122 (337)
Q Consensus        51 ~~~~lg~g~~~~v~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i-~~~~~~~~~~~~~~~  122 (337)
                      .++.|+.|....+|++....       ++..+++|+......   .+.+.+|..+++.+...++ .++++.+   .+  .
T Consensus        77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~---~~~li~E~~~l~~L~~~g~~P~l~~~~---~~--g  148 (429)
T 1nw1_A           77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET---ESHLVAESVIFTLLSERHLGPKLYGIF---SG--G  148 (429)
T ss_dssp             EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC---HHHHHHHHHHHHHHHHTTSSSCEEEEE---TT--E
T ss_pred             EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc---HHHHHHHHHHHHHHHhCCCCCcEEEEe---CC--C
Confidence            35678899999999998653       257899998843211   1344568888887754445 3455533   22  3


Q ss_pred             EEEeccCCCCc
Q 019650          123 FVMEHMERGSL  133 (337)
Q Consensus       123 lv~e~~~~~~L  133 (337)
                      +|++|++|.+|
T Consensus       149 ~v~e~l~G~~l  159 (429)
T 1nw1_A          149 RLEEYIPSRPL  159 (429)
T ss_dssp             EEECCCCEEEC
T ss_pred             EEEEEeCCccc
Confidence            89999987444

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.55  E-value=0.00018  Score=62.88  Aligned_cols=32  Identities=28%  Similarity=0.438  Sum_probs=27.5

Q ss_pred             CCceeccCCCCCeEEcCC----CcEEEeeccCccch
Q 019650          165 MQIIHGDIKPSNLLINGK----GEVKIADFGVSRIV  196 (337)
Q Consensus       165 ~~ivH~dl~~~Nili~~~----~~~~l~Dfg~~~~~  196 (337)
                      ..++|||+.+.||+++.+    +.+.++||+.+..-
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            479999999999999875    68999999987653

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.46  E-value=0.00097  Score=58.01  Aligned_cols=137  Identities=14%  Similarity=0.158  Sum_probs=75.9

Q ss_pred             cccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCC--ceeeeee----EEeeCCeEEEEEe
Q 019650           53 TVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQF--IVKCHAV----FYTIEGEICFVME  126 (337)
Q Consensus        53 ~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~--i~~~~~~----~~~~~~~~~lv~e  126 (337)
                      ..++ |....||++... +|+.+++|+......  ....+..|..+++.+...+  ++.++..    .....+..+++|+
T Consensus        32 ~~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~~--~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~  107 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDE-DRRRFVVKFYRPERW--TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFP  107 (328)
T ss_dssp             EEEC-CSSSEEEEECCT-TCCCEEEEEECTTTS--CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEE
T ss_pred             Eeec-CcccceEEEEcC-CCCEEEEEEcCCCCC--CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEE
Confidence            3456 788899988653 455799999864321  2344556777777664322  3333332    1112456688999


Q ss_pred             ccCCCCch----HH----------hhh----c-----CCCCHHHH----------------------HHHHHHHHHHHHH
Q 019650          127 HMERGSLF----DS----------LRV----R-----KKLSEDVI----------------------SGVAYRVLKGLQY  161 (337)
Q Consensus       127 ~~~~~~L~----~~----------l~~----~-----~~l~~~~~----------------------~~i~~~l~~~l~~  161 (337)
                      +++|.++.    +.          ++.    .     ...+....                      ...+..++..+..
T Consensus       108 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~  187 (328)
T 1zyl_A          108 SVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTA  187 (328)
T ss_dssp             CCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHH
T ss_pred             ecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHH
Confidence            99875432    00          010    0     01111110                      1111122222222


Q ss_pred             H----HhCCceeccCCCCCeEEcCCCcEEEeeccCccc
Q 019650          162 L----HGMQIIHGDIKPSNLLINGKGEVKIADFGVSRI  195 (337)
Q Consensus       162 L----H~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~  195 (337)
                      +    ....++|||+++.||+++ + .+.++||+.+..
T Consensus       188 ~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          188 HWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             HCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             HhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence            2    234589999999999999 4 899999987653

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.39  E-value=0.00082  Score=59.64  Aligned_cols=75  Identities=13%  Similarity=0.169  Sum_probs=43.6

Q ss_pred             ccccccCcceEEEEEEEcc--------CCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCce-eeeeeEEeeCCeEE
Q 019650           52 LTVLGHGNGGIVYKVRHQK--------SNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIV-KCHAVFYTIEGEIC  122 (337)
Q Consensus        52 ~~~lg~g~~~~v~~~~~~~--------~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~-~~~~~~~~~~~~~~  122 (337)
                      ...++.|....+|++....        .+..+++|+.......  ......|..+++.+...+++ +++...   .+  +
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~--~~~~~~E~~~l~~L~~~g~~P~~~~~~---~~--~  110 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE--LYNTISEFEVYKTMSKYKIAPQLLNTF---NG--G  110 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG--TSCHHHHHHHHHHHHHTTSSCCEEEEE---TT--E
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc--eecHHHHHHHHHHHHhcCCCCceEEec---CC--c
Confidence            4577888899999998653        1267889987543221  11234577777777544443 454432   22  5


Q ss_pred             EEEeccCCCCc
Q 019650          123 FVMEHMERGSL  133 (337)
Q Consensus       123 lv~e~~~~~~L  133 (337)
                      +||+|++|.++
T Consensus       111 ~v~e~i~G~~l  121 (369)
T 3c5i_A          111 RIEEWLYGDPL  121 (369)
T ss_dssp             EEEECCCSEEC
T ss_pred             EEEEEecCCcC
Confidence            89999987544

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.28  E-value=0.0017  Score=59.23  Aligned_cols=75  Identities=20%  Similarity=0.277  Sum_probs=47.6

Q ss_pred             ccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCce-eeeeeEEeeCCeEEEEEeccCC
Q 019650           52 LTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIV-KCHAVFYTIEGEICFVMEHMER  130 (337)
Q Consensus        52 ~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~-~~~~~~~~~~~~~~lv~e~~~~  130 (337)
                      ++.|+.|-...+|++.....+..+++|+....... .. ...+|..+++.+...++. ++++.+   .+  .+||+|++|
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~i-dR~~E~~vl~~L~~~gl~P~ll~~~---~~--G~v~e~I~G  185 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-II-NREREKKISCILYNKNIAKKIYVFF---TN--GRIEEFMDG  185 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CS-CHHHHHHHHHHHTTSSSBCCEEEEE---TT--EEEEECCCS
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hc-CHHHHHHHHHHHHhcCCCCCEEEEe---CC--eEEEEeeCC
Confidence            45678898999999987644578999987543211 11 124688888888766664 455543   22  259999987


Q ss_pred             CCc
Q 019650          131 GSL  133 (337)
Q Consensus       131 ~~L  133 (337)
                      .+|
T Consensus       186 ~~l  188 (458)
T 2qg7_A          186 YAL  188 (458)
T ss_dssp             EEC
T ss_pred             ccC
Confidence            554

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.24  E-value=0.0043  Score=54.29  Aligned_cols=32  Identities=22%  Similarity=0.447  Sum_probs=28.0

Q ss_pred             CCceeccCCCCCeEEcCCCcEEEeeccCccch
Q 019650          165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIV  196 (337)
Q Consensus       165 ~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~  196 (337)
                      ..++|||+.+.||+++.++.+.++||+.+..-
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~  237 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA  237 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence            46999999999999998888999999877543

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.56  E-value=0.0056  Score=55.23  Aligned_cols=76  Identities=12%  Similarity=0.118  Sum_probs=47.9

Q ss_pred             cccccccCcceEEEEEEEccC-------CceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCce-eeeeeEEeeCCeEE
Q 019650           51 KLTVLGHGNGGIVYKVRHQKS-------NSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIV-KCHAVFYTIEGEIC  122 (337)
Q Consensus        51 ~~~~lg~g~~~~v~~~~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~-~~~~~~~~~~~~~~  122 (337)
                      -++.+..|-...+|++.....       +..+++++..... .. .-...+|..+++.+...++. ++++.+   .+  +
T Consensus        74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~-~idR~~E~~~l~~L~~~gi~P~l~~~~---~~--~  146 (424)
T 3mes_A           74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GK-FYDSKVELDVFRYLSNINIAPNIIADF---PE--G  146 (424)
T ss_dssp             EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--C-CCCHHHHHHHHHHHHHTTSSCCEEEEE---TT--E
T ss_pred             EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-ch-hcCHHHHHHHHHHHHhcCCCCCEEEEc---CC--C
Confidence            355678899999999987521       5779999875432 11 11234677777777544444 344322   22  6


Q ss_pred             EEEeccCCCCc
Q 019650          123 FVMEHMERGSL  133 (337)
Q Consensus       123 lv~e~~~~~~L  133 (337)
                      +||+|++|.+|
T Consensus       147 ~I~efI~G~~l  157 (424)
T 3mes_A          147 RIEEFIDGEPL  157 (424)
T ss_dssp             EEEECCCSEEC
T ss_pred             EEEEEeCCccC
Confidence            89999998654

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=95.98  E-value=0.025  Score=50.63  Aligned_cols=30  Identities=27%  Similarity=0.397  Sum_probs=25.2

Q ss_pred             ceeccCCCCCeEEc------CCCcEEEeeccCccch
Q 019650          167 IIHGDIKPSNLLIN------GKGEVKIADFGVSRIV  196 (337)
Q Consensus       167 ivH~dl~~~Nili~------~~~~~~l~Dfg~~~~~  196 (337)
                      ++|+|+.+.||++.      ++..+.++||..+..-
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~n  281 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSYN  281 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccCC
Confidence            67999999999993      4567999999988643

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=93.17  E-value=0.32  Score=39.08  Aligned_cols=85  Identities=9%  Similarity=0.088  Sum_probs=61.2

Q ss_pred             cCCCCceeeeeeEEeeCCeEEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcC
Q 019650          102 LDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLING  181 (337)
Q Consensus       102 l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~  181 (337)
                      ..+|++++. .+..+ +..+.+.++.-+.+.=+..+   ...+....+.++..|+....++  ..-+|--++|+|++++.
T Consensus        42 ~~~~~Fl~~-~I~e~-eD~v~~~y~~~~~~~~f~~i---k~~~~~eKlr~l~ni~~l~~~~--~~r~tf~L~P~NL~f~~  114 (215)
T 4ann_A           42 QHSPYFIDA-ELTEL-RDSFQIHYDINDNHTPFDNI---KSFTKNEKLRYLLNIKNLEEVN--RTRYTFVLAPDELFFTR  114 (215)
T ss_dssp             SCCTTBCCE-EEEEC-SSEEEEEECCCTTSEEGGGG---GGSCHHHHHHHHHHGGGGGGGG--GSSEECCCSGGGEEECT
T ss_pred             ccCCcccce-EEEEc-ccEEEEEEEcCcccCCHHHH---HhcCHHHHHHHHHHHHHHHHHh--cCceEEEEecceEEEcC
Confidence            467888877 33333 56677777665433222223   4688899999999999887444  33478999999999999


Q ss_pred             CCcEEEeeccCc
Q 019650          182 KGEVKIADFGVS  193 (337)
Q Consensus       182 ~~~~~l~Dfg~~  193 (337)
                      ++.+++.-.|..
T Consensus       115 ~~~p~i~~RGik  126 (215)
T 4ann_A          115 DGLPIAKTRGLQ  126 (215)
T ss_dssp             TSCEEESCCEET
T ss_pred             CCCEEEEEccCc
Confidence            999999977754

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=89.82  E-value=1  Score=36.26  Aligned_cols=84  Identities=17%  Similarity=0.059  Sum_probs=60.1

Q ss_pred             cCCCCceeeeeeEEeeCCeEEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHH-HHHhCCceeccCCCCCeEEc
Q 019650          102 LDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQ-YLHGMQIIHGDIKPSNLLIN  180 (337)
Q Consensus       102 l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~-~LH~~~ivH~dl~~~Nili~  180 (337)
                      ..||++ +.-- . ..+..+.+.++.-+++.=+..+   ...+..+.+.++..|+.... ++  ..-+|--++|+|++++
T Consensus        47 ~~~~~f-~~~I-~-~~eD~~~i~y~~~~~~~~f~~i---~~~~~~eKlrll~nl~~L~~~~~--~~r~tf~l~P~NL~f~  118 (219)
T 4ano_A           47 EVDPCI-VRDI-D-VSEDEVKVVIKPPSSFLTFAAI---RKTTLLSRIRAAIHLVSKVKHHS--ARRLIFIVCPENLMFN  118 (219)
T ss_dssp             GSCSSS-EEEE-E-ECSSEEEEEEECCTTCEEHHHH---HTSCHHHHHHHHHHHHHHHSSCC--SSSEECCCCGGGEEEC
T ss_pred             ccCCCC-CeEE-E-EeCCEEEEEEEcCcccCcHHHH---HhcCHHHHHHHHHHHHHHHHHhh--hCceeEEEeCceEEEe
Confidence            367777 3322 2 3356777777776554333344   47889999999888888765 33  4558899999999999


Q ss_pred             CCCcEEEeeccCc
Q 019650          181 GKGEVKIADFGVS  193 (337)
Q Consensus       181 ~~~~~~l~Dfg~~  193 (337)
                      .++.+++.-.|.-
T Consensus       119 ~~~~p~i~hRGi~  131 (219)
T 4ano_A          119 RALEPFFLHVGVK  131 (219)
T ss_dssp             TTCCEEESCCEET
T ss_pred             CCCcEEEEEcCCc
Confidence            9999999977754

>1cja_A Protein (actin-fragmin kinase); transferase; HET: AMP; 2.90A {Physarum polycephalum} SCOP: d.144.1.3

Probab=80.12  E-value=24  Score=30.30  Aligned_cols=137  Identities=12%  Similarity=0.114  Sum_probs=72.1

Q ss_pred             ccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEE------------
Q 019650           48 DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFY------------  115 (337)
Q Consensus        48 ~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~------------  115 (337)
                      +++.++....|..|.++...   ++..+++|-.    .....+.+-.++...-.+.-|+..-+.....            
T Consensus        70 ~v~~I~~s~~Gstgvff~~t---d~~~~VVK~s----~~l~~E~l~s~LA~~LGlpiP~~Riv~~~~~E~~e~~~~L~~~  142 (342)
T 1cja_A           70 QFKGIERSEKGTEGLFFVET---ESGVFIVKRS----TNIESETFCSLLCMRLGLHAPKVRVVSSNSEEGTNMLECLAAI  142 (342)
T ss_dssp             GEEEEEECCSTTSCEEEEEE---SSCEEEEECC----TTHHHHHHHHHHHHHHTCCCCCEEEEESSSHHHHHHHHHHHHH
T ss_pred             CeeEEEeccCCCCCeEEEEe---CCCEEEEeCc----HHHHHHHHHHHHHHHhCCCCCCeeEEeeCcHHHHHHHHHHHHh
Confidence            36666666777655544444   3667889943    2333444445555555566665433322100            


Q ss_pred             e---------eCCeEEEEEeccCCCCchHHhhh--cCCCCHHHHHHHHHHHH--HHHHHHHhCC----ce-eccCCCCCe
Q 019650          116 T---------IEGEICFVMEHMERGSLFDSLRV--RKKLSEDVISGVAYRVL--KGLQYLHGMQ----II-HGDIKPSNL  177 (337)
Q Consensus       116 ~---------~~~~~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~i~~~l~--~~l~~LH~~~----iv-H~dl~~~Ni  177 (337)
                      +         .....+++|+|.+|..|.+.-..  ...+..+.    +.++.  -++..+..++    .+ +..-.++||
T Consensus       143 ~~~~~~l~~l~~~~~~l~meyv~G~~L~e~~~~~~~~~f~~~~----~k~LG~Ii~FDi~InN~DR~Pl~W~n~GN~~NI  218 (342)
T 1cja_A          143 DKSFRVITTLANQANILLMELVRGITLNKLTTTSAPEVLTKST----MQQLGSLMALDVIVNNSDRLPIAWTNEGNLDNI  218 (342)
T ss_dssp             CSSSCHHHHHTTCSEEEEEECCCEEESTTCCSSSHHHHSCHHH----HHHHHHHHHHHHHHTCCSSSCSSSCSCCCGGGE
T ss_pred             hhhhHHHHHhhcccceehhhhcCCCccccchhhhhhhhcCHHH----HHhhchhheehhhhcCCccCcccccCCCChhhe
Confidence            0         01245699999987666543211  11133333    33332  2333333321    11 123588999


Q ss_pred             EEcCCC-cEEEeeccCccc
Q 019650          178 LINGKG-EVKIADFGVSRI  195 (337)
Q Consensus       178 li~~~~-~~~l~Dfg~~~~  195 (337)
                      +++.++ .+.++|-+.+..
T Consensus       219 L~~~~n~~~~~IDhn~af~  237 (342)
T 1cja_A          219 MLSERGATVVPIDSKIIPL  237 (342)
T ss_dssp             EEESBTTCEEECSCCCCCC
T ss_pred             EEeCCCCeEEEEcCCcccc
Confidence            997765 588999887754

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	337
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	1e-70
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	5e-70
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	8e-70
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	7e-69
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	8e-67
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	6e-66
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	1e-64
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	7e-64
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	1e-63
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	5e-63
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	8e-63
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	5e-62
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	3e-61
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	2e-60
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	3e-60
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	3e-58
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	3e-58
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	6e-58
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	7e-57
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	7e-56
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	8e-56
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-55
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	2e-55
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	3e-55
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	5e-55
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	5e-55
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	1e-54
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	1e-54
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	1e-54
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	1e-54
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	2e-54
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	4e-54
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-53
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	4e-53
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	4e-52
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	4e-52
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-51
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	6e-51
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	7e-51
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	1e-50
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-50
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	2e-50
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	3e-50
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	5e-50
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	7e-50
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	3e-49
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-48
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	3e-48
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	5e-48
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	2e-47
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	6e-47
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	7e-47
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	9e-47
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	1e-46
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	6e-45
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	2e-44
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	8e-44
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	6e-43
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	2e-42
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	6e-42
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	4e-40
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	1e-32
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	1e-17
d2pula1	392	d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {	0.003

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  218 bits (557), Expect = 1e-70
 Identities = 79/285 (27%), Positives = 120/285 (42%), Gaps = 28/285 (9%)

Query: 46  ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTT--SSTIIRHQAAHEAEILKRLD 103
           + D +    LG G  G VY  R ++S  I ALKVL         + HQ   E EI   L 
Sbjct: 5   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 64

Query: 104 SQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLH 163
              I++ +  F+     +  ++E+   G+++  L+   K  E   +     +   L Y H
Sbjct: 65  HPNILRLYGYFHD-ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 123

Query: 164 GMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGT 223
             ++IH DIKP NLL+   GE+KIADFG S     +R                     GT
Sbjct: 124 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTL----------------CGT 167

Query: 224 CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFG 283
             Y+ PE ++    G  +    D+WSLGV+  E LVG  P                I   
Sbjct: 168 LDYLPPEMIE----GRMHDEKVDLWSLGVLCYEFLVGKPPFEA----NTYQETYKRISRV 219

Query: 284 ERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSS 328
           E    P+  +   R  +   L+ +  +R  + E+L +P++T  SS
Sbjct: 220 E-FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSS 263

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  219 bits (558), Expect = 5e-70
 Identities = 98/326 (30%), Positives = 158/326 (48%), Gaps = 62/326 (19%)

Query: 48  DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFI 107
           D +K++ LG GNGG+V+KV H+ S  + A K+++      IR+Q   E ++L   +S +I
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66

Query: 108 VKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQ- 166
           V  +  FY+ +GEI   MEHM+ GSL   L+   ++ E ++  V+  V+KGL YL     
Sbjct: 67  VGFYGAFYS-DGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 125

Query: 167 IIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAY 226
           I+H D+KPSN+L+N +GE+K+ DFGVS  + ++  N+                 +GT +Y
Sbjct: 126 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS----------------FVGTRSY 169

Query: 227 MSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERL 286
           MSPER+     G  Y    D+WS+G+ ++E  VG YP+     K   +   C +      
Sbjct: 170 MSPERLQ----GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAE 225

Query: 287 EMPETA---------------------------------------SPEFRRFVRSCLEKD 307
             P                                          S EF+ FV  CL K+
Sbjct: 226 TPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKN 285

Query: 308 WRKRGTVEELLAYPFVTKRSSSSNIE 333
             +R  +++L+ + F+ KRS +  ++
Sbjct: 286 PAERADLKQLMVHAFI-KRSDAEEVD 310

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  218 bits (556), Expect = 8e-70
 Identities = 80/290 (27%), Positives = 126/290 (43%), Gaps = 27/290 (9%)

Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFI 107
             L  +GHG+ G VY  R  +++ + A+K ++ +   S         E   L++L     
Sbjct: 18  SDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNT 77

Query: 108 VKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQI 167
           ++    +   E     VME+    +       +K L E  I+ V +  L+GL YLH   +
Sbjct: 78  IQYRGCYLR-EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNM 136

Query: 168 IHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYM 227
           IH D+K  N+L++  G VK+ DFG + I+    +                   +GT  +M
Sbjct: 137 IHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS------------------FVGTPYWM 178

Query: 228 SPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLE 287
           +PE + +   G  Y    DVWSLG+  +E      PL       + M+ +  I   E   
Sbjct: 179 APEVILAMDEGQ-YDGKVDVWSLGITCIELAERKPPLFN----MNAMSALYHIAQNESPA 233

Query: 288 M-PETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNIEGLI 336
           +     S  FR FV SCL+K  + R T E LL + FV +    + I  LI
Sbjct: 234 LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLI 283

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  215 bits (548), Expect = 7e-69
 Identities = 88/289 (30%), Positives = 135/289 (46%), Gaps = 25/289 (8%)

Query: 45  NISDL-KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLD 103
           N  D  + +  LG G  G VYK ++++++ + A KV++T S   +      E +IL   D
Sbjct: 9   NPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELE-DYMVEIDILASCD 67

Query: 104 SQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSL-RVRKKLSEDVISGVAYRVLKGLQYL 162
              IVK    FY  E  +  ++E    G++   +  + + L+E  I  V  + L  L YL
Sbjct: 68  HPNIVKLLDAFYY-ENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYL 126

Query: 163 HGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMG 222
           H  +IIH D+K  N+L    G++K+ADFGVS     T    +                +G
Sbjct: 127 HDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--------------FIG 172

Query: 223 TCAYMSPERVDSERW-GGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAIC 281
           T  +M+PE V  E      Y +  DVWSLG+ ++E      P        + M ++  I 
Sbjct: 173 TPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL----NPMRVLLKIA 228

Query: 282 FGE--RLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSS 328
             E   L  P   S  F+ F++ CLEK+   R T  +LL +PFVT  S+
Sbjct: 229 KSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSN 277

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  209 bits (532), Expect = 8e-67
 Identities = 59/280 (21%), Positives = 106/280 (37%), Gaps = 18/280 (6%)

Query: 46  ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQ 105
           + D   +  LG G  G V    ++ +    A+K+++   +         E  I K L+ +
Sbjct: 4   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 63

Query: 106 FIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGM 165
            +VK +             +E+   G LFD +     + E       ++++ G+ YLHG+
Sbjct: 64  NVVKFYGHRR-EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 122

Query: 166 QIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCA 225
            I H DIKP NLL++ +  +KI+DFG++ +          N               GT  
Sbjct: 123 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK------------MCGTLP 170

Query: 226 YMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGER 285
           Y++PE +   +    +    DVWS G+V+   L G  P                      
Sbjct: 171 YVAPELL---KRREFHAEPVDVWSCGIVLTAMLAGELPW--DQPSDSCQEYSDWKEKKTY 225

Query: 286 LEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTK 325
           L   +         +   L ++   R T+ ++    +  K
Sbjct: 226 LNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 265

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  206 bits (526), Expect = 6e-66
 Identities = 74/287 (25%), Positives = 120/287 (41%), Gaps = 33/287 (11%)

Query: 48  DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSST-IIRHQAAHEAEILKRLDSQF 106
           D + L  +G G+ G   K+R +    I   K L+  S T   +     E  +L+ L    
Sbjct: 5   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64

Query: 107 IVKCHAVFY-TIEGEICFVMEHMERGSLFDSL----RVRKKLSEDVISGVAYRVLKGLQY 161
           IV+ +          +  VME+ E G L   +    + R+ L E+ +  V  ++   L+ 
Sbjct: 65  IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124

Query: 162 LH-----GMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEA 216
            H     G  ++H D+KP+N+ ++GK  VK+ DFG++RI+    +               
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAK------------ 172

Query: 217 AIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMAL 276
             A +GT  YMSPE+++       Y    D+WSLG ++ E      P   F        L
Sbjct: 173 --AFVGTPYYMSPEQMN----RMSYNEKSDIWSLGCLLYELCALMPPFTAF----SQKEL 222

Query: 277 ICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV 323
              I  G+   +P   S E    +   L      R +VEE+L  P +
Sbjct: 223 AGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  204 bits (519), Expect = 1e-64
 Identities = 76/287 (26%), Positives = 125/287 (43%), Gaps = 23/287 (8%)

Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVK 109
            +   +G G  G VY      +    A++ +N       +    +E  +++   +  IV 
Sbjct: 23  TRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK-KELIINEILVMRENKNPNIVN 81

Query: 110 CHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIH 169
               +     E+  VME++  GSL D +     + E  I+ V    L+ L++LH  Q+IH
Sbjct: 82  YLDSYLV-GDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQVIH 139

Query: 170 GDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSP 229
            DIK  N+L+   G VK+ DFG    +   ++  +                +GT  +M+P
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--------------MVGTPYWMAP 185

Query: 230 ERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMP 289
           E V        YG   D+WSLG++ +E + G  P +       L  +         L+ P
Sbjct: 186 EVV----TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT--NGTPELQNP 239

Query: 290 ETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNIEGLI 336
           E  S  FR F+  CL+ D  KRG+ +ELL + F+      S++  LI
Sbjct: 240 EKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLTPLI 286

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  204 bits (519), Expect = 7e-64
 Identities = 71/296 (23%), Positives = 132/296 (44%), Gaps = 26/296 (8%)

Query: 38  PTSPDVENISDL-KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEA 96
           P      ++ D    L  LG G  G+V++   + +  ++  K +NT    + ++   +E 
Sbjct: 19  PVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINT-PYPLDKYTVKNEI 77

Query: 97  EILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRK-KLSEDVISGVAYRV 155
            I+ +L    ++  H  F   + E+  ++E +  G LFD +     K+SE  +     + 
Sbjct: 78  SIMNQLHHPKLINLHDAFED-KYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQA 136

Query: 156 LKGLQYLHGMQIIHGDIKPSNLLI--NGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNI 213
            +GL+++H   I+H DIKP N++        VKI DFG++  +                 
Sbjct: 137 CEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP--------------- 181

Query: 214 GEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDL 273
            E       T  + +PE VD        GF  D+W++GV+    L G  P  G  +  + 
Sbjct: 182 DEIVKVTTATAEFAAPEIVD----REPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL-ET 236

Query: 274 MALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSS 329
           +  +    +    +   + SPE + F+++ L+K+ RKR TV + L +P++    S+
Sbjct: 237 LQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSN 292

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  203 bits (518), Expect = 1e-63
 Identities = 69/304 (22%), Positives = 130/304 (42%), Gaps = 28/304 (9%)

Query: 26  FRRRRHHFPTSNPTSPDVENISD-LKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS 84
           F   + ++P   P     +++ D       LG G  G+V++V  + + + +A K + T  
Sbjct: 6   FDIWKQYYP--QPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH 63

Query: 85  STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSL-RVRKKL 143
            +  +     E + +  L    +V  H  F   + E+  + E M  G LF+ +     K+
Sbjct: 64  ESD-KETVRKEIQTMSVLRHPTLVNLHDAFED-DNEMVMIYEFMSGGELFEKVADEHNKM 121

Query: 144 SEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGK--GEVKIADFGVSRIVEETRN 201
           SED       +V KGL ++H    +H D+KP N++   K   E+K+ DFG++  ++  ++
Sbjct: 122 SEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 181

Query: 202 NNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGH 261
                               GT  + +PE  +    G   G+  D+WS+GV+    L G 
Sbjct: 182 VKV---------------TTGTAEFAAPEVAE----GKPVGYYTDMWSVGVLSYILLSGL 222

Query: 262 YPLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYP 321
            P  G  +  + +  + +  +          S + + F+R  L  D   R T+ + L +P
Sbjct: 223 SPFGGENDD-ETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHP 281

Query: 322 FVTK 325
           ++T 
Sbjct: 282 WLTP 285

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  200 bits (510), Expect = 5e-63
 Identities = 69/291 (23%), Positives = 127/291 (43%), Gaps = 25/291 (8%)

Query: 44  ENISDL-KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRL 102
           E+I D+     VLG G    V     +++  + A+K +   +         +E  +L ++
Sbjct: 5   EDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKI 64

Query: 103 DSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYL 162
               IV    ++ +  G +  +M+ +  G LFD +  +   +E   S + ++VL  ++YL
Sbjct: 65  KHPNIVALDDIYES-GGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYL 123

Query: 163 HGMQIIHGDIKPSNLLI---NGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIA 219
           H + I+H D+KP NLL    +   ++ I+DFG+S++ +     +                
Sbjct: 124 HDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLST--------------- 168

Query: 220 CMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICA 279
             GT  Y++PE +        Y  A D WS+GV+    L G+ P     +   L   I  
Sbjct: 169 ACGTPGYVAPEVL----AQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND-AKLFEQILK 223

Query: 280 ICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSS 330
             +       +  S   + F+R  +EKD  KR T E+ L +P++   ++  
Sbjct: 224 AEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALD 274

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (506), Expect = 8e-63
 Identities = 73/282 (25%), Positives = 123/282 (43%), Gaps = 32/282 (11%)

Query: 49  LKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSST-IIRHQAAHEAEILKRLDSQFI 107
           LK    +G G+   VYK    ++    A   L     T   R +   EAE+LK L    I
Sbjct: 11  LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70

Query: 108 VKCHAVFYTI---EGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLH- 163
           V+ +  + +    +  I  V E M  G+L   L+  K +   V+     ++LKGLQ+LH 
Sbjct: 71  VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHT 130

Query: 164 -GMQIIHGDIKPSNLLINGK-GEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACM 221
               IIH D+K  N+ I G  G VKI D G++ +   +                   A +
Sbjct: 131 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK----------------AVI 174

Query: 222 GTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAIC 281
           GT  +M+PE  +       Y  + DV++ G+ +LE     YP   + E  +   +   + 
Sbjct: 175 GTPEFMAPEMYE-----EKYDESVDVYAFGMCMLEMATSEYP---YSECQNAAQIYRRVT 226

Query: 282 FGER-LEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPF 322
            G +     + A PE +  +  C+ ++  +R ++++LL + F
Sbjct: 227 SGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAF 268

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (502), Expect = 5e-62
 Identities = 69/278 (24%), Positives = 115/278 (41%), Gaps = 24/278 (8%)

Query: 48  DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLN--TTSSTIIRHQAAHEAEILKRLDSQ 105
           D K   +LG G+   V   R   ++  YA+K+L                E +++ RLD  
Sbjct: 9   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68

Query: 106 FIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGM 165
           F VK +  F   + ++ F + + + G L   +R      E         ++  L+YLHG 
Sbjct: 69  FFVKLYFTFQD-DEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 127

Query: 166 QIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCA 225
            IIH D+KP N+L+N    ++I DFG ++++         N+             +GT  
Sbjct: 128 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS------------FVGTAQ 175

Query: 226 YMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGER 285
           Y+SPE +           + D+W+LG ++ + + G  P        +   +   I   E 
Sbjct: 176 YVSPELLT----EKSACKSSDLWALGCIIYQLVAGLPPFRA----GNEYLIFQKIIKLE- 226

Query: 286 LEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV 323
            + PE   P+ R  V   L  D  KR   EE+  Y  +
Sbjct: 227 YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPL 264

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  194 bits (495), Expect = 3e-61
 Identities = 68/289 (23%), Positives = 125/289 (43%), Gaps = 28/289 (9%)

Query: 48  DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTI--------IRHQAAHEAEIL 99
           + +   +LG G   +V +  H+ +   YA+K+++ T            +R     E +IL
Sbjct: 4   NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63

Query: 100 KRLDSQ-FIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKG 158
           +++     I++    + T       V + M++G LFD L  +  LSE     +   +L+ 
Sbjct: 64  RKVSGHPNIIQLKDTYET-NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 122

Query: 159 LQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAI 218
           +  LH + I+H D+KP N+L++    +K+ DFG S  ++                     
Sbjct: 123 ICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE-------------- 168

Query: 219 ACMGTCAYMSPERVDSERWGGD--YGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMAL 276
              GT +Y++PE ++         YG   D+WS GV++   L G  P     ++  ++ +
Sbjct: 169 -VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH-RKQMLMLRM 226

Query: 277 ICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTK 325
           I +  +       +  S   +  V   L    +KR T EE LA+PF  +
Sbjct: 227 IMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (490), Expect = 2e-60
 Identities = 59/276 (21%), Positives = 117/276 (42%), Gaps = 21/276 (7%)

Query: 47  SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSST-IIRHQAAHEAEILKRLDSQ 105
             +     +G G+ G VYK +        A+K+LN T+ T        +E  +L++    
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 64

Query: 106 FIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQYLHG 164
            I+      Y+   ++  V +  E  SL+  L + + K     +  +A +  +G+ YLH 
Sbjct: 65  NILLFMG--YSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 122

Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTC 224
             IIH D+K +N+ ++    VKI DFG++ +      ++                  G+ 
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ------------LSGSI 170

Query: 225 AYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALIC-AICFG 283
            +M+PE +  +     Y F  DV++ G+V+ E + G  P      +  ++ ++       
Sbjct: 171 LWMAPEVIRMQDKNP-YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSP 229

Query: 284 ERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA 319
           +  ++        +R +  CL+K   +R    ++LA
Sbjct: 230 DLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILA 265

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (487), Expect = 3e-60
 Identities = 57/276 (20%), Positives = 114/276 (41%), Gaps = 31/276 (11%)

Query: 45  NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDS 104
           N+ +LK L  +G G  G V    ++   +  A+K +   ++         EA ++ +L  
Sbjct: 5   NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDAT---AQAFLAEASVMTQLRH 59

Query: 105 QFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKK--LSEDVISGVAYRVLKGLQYL 162
             +V+   V    +G +  V E+M +GSL D LR R +  L  D +   +  V + ++YL
Sbjct: 60  SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 119

Query: 163 HGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMG 222
            G   +H D+   N+L++     K++DFG+++    T++                     
Sbjct: 120 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT-----------------GKL 162

Query: 223 TCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICF 282
              + +PE +        +    DVWS G+++ E             +  L  ++  +  
Sbjct: 163 PVKWTAPEALR----EKKFSTKSDVWSFGILLWEIYSFGRV---PYPRIPLKDVVPRVEK 215

Query: 283 GERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELL 318
           G +++ P+   P     +++C   D   R +  +L 
Sbjct: 216 GYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLR 251

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (479), Expect = 3e-58
 Identities = 64/276 (23%), Positives = 108/276 (39%), Gaps = 26/276 (9%)

Query: 54  VLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAV 113
            LG G  GIV++     S   Y  K +    +   +     E  IL     + I+  H  
Sbjct: 12  DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD--QVLVKKEISILNIARHRNILHLHES 69

Query: 114 FYTIEGEICFVMEHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQYLHGMQIIHGDI 172
           F +   E+  + E +    +F+ +     +L+E  I    ++V + LQ+LH   I H DI
Sbjct: 70  FES-MEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDI 128

Query: 173 KPSNLLI--NGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPE 230
           +P N++        +KI +FG +R ++   N                        Y +PE
Sbjct: 129 RPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---------------LFTAPEYYAPE 173

Query: 231 RVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPE 290
                        A D+WSLG +V   L G  P +    +  ++  I    +    E  +
Sbjct: 174 ----VHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ-QIIENIMNAEYTFDEEAFK 228

Query: 291 TASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKR 326
             S E   FV   L K+ + R T  E L +P++ ++
Sbjct: 229 EISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (477), Expect = 3e-58
 Identities = 75/293 (25%), Positives = 134/293 (45%), Gaps = 31/293 (10%)

Query: 44  ENISDL-KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSST-----IIRHQAAHEAE 97
           EN+ D       LG G   +V K R + +   YA K +    +      + R     E  
Sbjct: 6   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 65

Query: 98  ILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLK 157
           ILK +    ++  H V+   + ++  ++E +  G LFD L  ++ L+E+  +    ++L 
Sbjct: 66  ILKEIQHPNVITLHEVYEN-KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN 124

Query: 158 GLQYLHGMQIIHGDIKPSNLLINGKGE----VKIADFGVSRIVEETRNNNNHNNNNNNNI 213
           G+ YLH +QI H D+KP N+++  +      +KI DFG++  ++                
Sbjct: 125 GVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF--------------- 169

Query: 214 GEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDL 273
           G       GT  +++PE V+        G   D+WS+GV+    L G  P +G   K + 
Sbjct: 170 GNEFKNIFGTPEFVAPEIVN----YEPLGLEADMWSIGVITYILLSGASPFLG-DTKQET 224

Query: 274 MALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKR 326
           +A + A+ +    E     S   + F+R  L KD +KR T+++ L +P++  +
Sbjct: 225 LANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 277

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  189 bits (480), Expect = 6e-58
 Identities = 68/287 (23%), Positives = 126/287 (43%), Gaps = 32/287 (11%)

Query: 46  ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSST-----IIRHQAAHEAEILK 100
           ++D     ++G G  G VY  R   +  +YA+K L+           +         ++ 
Sbjct: 3   MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVS 62

Query: 101 RLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQ 160
             D  FIV     F+T   ++ F+++ M  G L   L      SE  +   A  ++ GL+
Sbjct: 63  TGDCPFIVCMSYAFHT-PDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLE 121

Query: 161 YLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIAC 220
           ++H   +++ D+KP+N+L++  G V+I+D G++    + + +                  
Sbjct: 122 HMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----------------S 165

Query: 221 MGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAI 280
           +GT  YM+PE +   + G  Y  + D +SLG ++ + L GH P      K      I  +
Sbjct: 166 VGTHGYMAPEVL---QKGVAYDSSADWFSLGCMLFKLLRGHSPF--RQHKTKDKHEIDRM 220

Query: 281 CFGERLEMPETASPEFRRFVRSCLEKDWRKR-----GTVEELLAYPF 322
                +E+P++ SPE R  +   L++D  +R        +E+   PF
Sbjct: 221 TLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPF 267

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (470), Expect = 7e-57
 Identities = 67/281 (23%), Positives = 113/281 (40%), Gaps = 28/281 (9%)

Query: 46  ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLN---TTSSTIIRHQAAHEAEILKRL 102
           I D     +LG G+ G V+    +K+N  +A+K L          +      +  +    
Sbjct: 1   IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 60

Query: 103 DSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYL 162
           +  F+      F T +  + FVME++  G L   ++   K      +  A  ++ GLQ+L
Sbjct: 61  EHPFLTHMFCTFQT-KENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFL 119

Query: 163 HGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMG 222
           H   I++ D+K  N+L++  G +KIADFG+ +         N                 G
Sbjct: 120 HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--------------FCG 165

Query: 223 TCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICF 282
           T  Y++PE +     G  Y  + D WS GV++ E L+G  P  G     D   L  +I  
Sbjct: 166 TPDYIAPEIL----LGQKYNHSVDWWSFGVLLYEMLIGQSPFHG----QDEEELFHSIRM 217

Query: 283 GERLEMPETASPEFRRFVRSCLEKDWRKR-GTVEELLAYPF 322
                 P     E +  +     ++  KR G   ++  +P 
Sbjct: 218 D-NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPL 257

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (459), Expect = 7e-56
 Identities = 63/275 (22%), Positives = 123/275 (44%), Gaps = 27/275 (9%)

Query: 47  SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQF 106
             LK +  LG G  G V+   +   ++  A+K L     ++       EA ++K+L  Q 
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLK--QGSMSPDAFLAEANLMKQLQHQR 69

Query: 107 IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRK--KLSEDVISGVAYRVLKGLQYLHG 164
           +V+ +AV    +  I  + E+ME GSL D L+     KL+ + +  +A ++ +G+ ++  
Sbjct: 70  LVRLYAVV--TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127

Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTC 224
              IH D++ +N+L++     KIADFG++R++E+                          
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG-------------AKFPI 174

Query: 225 AYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGE 284
            + +PE ++     G +    DVWS G+++ E +            P+++  +     G 
Sbjct: 175 KWTAPEAIN----YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER---GY 227

Query: 285 RLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA 319
           R+  P+    E  + +R C ++    R T + L +
Sbjct: 228 RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS 262

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (457), Expect = 8e-56
 Identities = 64/277 (23%), Positives = 115/277 (41%), Gaps = 27/277 (9%)

Query: 45  NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDS 104
           +  DL  L  LG G  G+V   +  +     A+K++     ++   +   EA+++  L  
Sbjct: 2   DPKDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIK--EGSMSEDEFIEEAKVMMNLSH 58

Query: 105 QFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRV-RKKLSEDVISGVAYRVLKGLQYLH 163
           + +V+ + V    +  I  + E+M  G L + LR  R +     +  +   V + ++YL 
Sbjct: 59  EKLVQLYGVCTK-QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE 117

Query: 164 GMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGT 223
             Q +H D+   N L+N +G VK++DFG+SR V +    ++                   
Sbjct: 118 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG-------------SKFP 164

Query: 224 CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECL-VGHYPLIGFGEKPDLMALICAICF 282
             +  PE +        +    D+W+ GV++ E   +G  P   F            I  
Sbjct: 165 VRWSPPEVL----MYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF----TNSETAEHIAQ 216

Query: 283 GERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA 319
           G RL  P  AS +    + SC  +   +R T + LL+
Sbjct: 217 GLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLS 253

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (458), Expect = 1e-55
 Identities = 65/291 (22%), Positives = 115/291 (39%), Gaps = 29/291 (9%)

Query: 34  PTSNPTSPDVENI--SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQ 91
           P +   + D   I    L+    LG G  G V+        +  A+K L     T+    
Sbjct: 2   PQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTW-NGTTRVAIKTLK--PGTMSPEA 58

Query: 92  AAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVR--KKLSEDVIS 149
              EA+++K+L  + +V+ +AV       I  V E+M +GSL D L+    K L    + 
Sbjct: 59  FLQEAQVMKKLRHEKLVQLYAVVSE--EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLV 116

Query: 150 GVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNN 209
            +A ++  G+ Y+  M  +H D++ +N+L+      K+ADFG++R++E+           
Sbjct: 117 DMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG--- 173

Query: 210 NNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGE 269
                           + +PE        G +    DVWS G+++ E             
Sbjct: 174 ----------AKFPIKWTAPEAA----LYGRFTIKSDVWSFGILLTELTTKGRV---PYP 216

Query: 270 KPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY 320
                 ++  +  G R+  P          +  C  K+  +R T E L A+
Sbjct: 217 GMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAF 267

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (456), Expect = 2e-55
 Identities = 65/275 (23%), Positives = 111/275 (40%), Gaps = 25/275 (9%)

Query: 45  NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDS 104
           + S+L  +  +G G  G+V+      +    A+K +      +       EAE++ +L  
Sbjct: 3   DPSELTFVQEIGSGQFGLVHLGYW-LNKDKVAIKTIR--EGAMSEEDFIEEAEVMMKLSH 59

Query: 105 QFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKL-SEDVISGVAYRVLKGLQYLH 163
             +V+ + V    +  IC V E ME G L D LR ++ L + + + G+   V +G+ YL 
Sbjct: 60  PKLVQLYGVCLE-QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 118

Query: 164 GMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGT 223
              +IH D+   N L+     +K++DFG++R V + +  ++                   
Sbjct: 119 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG-------------TKFP 165

Query: 224 CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFG 283
             + SPE          Y    DVWS GV++ E            E      ++  I  G
Sbjct: 166 VKWASPEVF----SFSRYSSKSDVWSFGVLMWEVFSEGKI---PYENRSNSEVVEDISTG 218

Query: 284 ERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELL 318
            RL  P  AS    + +  C ++    R     LL
Sbjct: 219 FRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLL 253

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (456), Expect = 3e-55
 Identities = 71/296 (23%), Positives = 124/296 (41%), Gaps = 35/296 (11%)

Query: 46  ISDLKKLTVLGHGNGGIVYKVRHQKSNS--IYALKVLNTTSSTIIRHQAAHEAEILKRLD 103
           I+D++    LG GN G V +  ++        A+KVL   +      +   EA+I+ +LD
Sbjct: 12  IADIE----LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD 67

Query: 104 SQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLR-VRKKLSEDVISGVAYRVLKGLQYL 162
           + +IV+   V       +  VME    G L   L   R+++    ++ + ++V  G++YL
Sbjct: 68  NPYIVRLIGVCQAEA--LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL 125

Query: 163 HGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMG 222
                +H D+   N+L+  +   KI+DFG+S+ +    +     +           A   
Sbjct: 126 EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS-----------AGKW 174

Query: 223 TCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECL-VGHYPLIGFGEKPDLMALICAIC 281
              + +PE ++       +    DVWS GV + E L  G  P            ++  I 
Sbjct: 175 PLKWYAPECIN----FRKFSSRSDVWSYGVTMWEALSYGQKPYKKM----KGPEVMAFIE 226

Query: 282 FGERLEMPETASPEFRRFVRSCLEKDWRKR---GTVEELLAYPFVTKRSSSSNIEG 334
            G+R+E P    PE    +  C    W  R    TVE+ +   +    S +S +EG
Sbjct: 227 QGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY---SLASKVEG 279

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (454), Expect = 5e-55
 Identities = 66/280 (23%), Positives = 111/280 (39%), Gaps = 29/280 (10%)

Query: 48  DLKKLTV----LGHGNGGIVYKVRHQ--KSNSIYALKVL-NTTSSTIIRHQAAHEAEILK 100
           D K LT+    LG GN G V K  +Q  K     A+K+L N  +   ++ +   EA +++
Sbjct: 4   DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQ 63

Query: 101 RLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQ 160
           +LD+ +IV+   +          VME  E G L   L+  + + +  I  + ++V  G++
Sbjct: 64  QLDNPYIVRMIGICEA--ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMK 121

Query: 161 YLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIAC 220
           YL     +H D+   N+L+  +   KI+DFG+S+ +    N                   
Sbjct: 122 YLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT-----------HG 170

Query: 221 MGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECL-VGHYPLIGFGEKPDLMALICA 279
                + +PE +        +    DVWS GV++ E    G  P  G         +   
Sbjct: 171 KWPVKWYAPECI----NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM----KGSEVTAM 222

Query: 280 ICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA 319
           +  GER+  P     E    +  C   D   R     +  
Sbjct: 223 LEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 262

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (457), Expect = 5e-55
 Identities = 77/322 (23%), Positives = 123/322 (38%), Gaps = 50/322 (15%)

Query: 40  SPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSST-IIRHQAAHEAEI 98
            P  + +S  +KL  +G G  G V+K RH+K+    ALK +   +        A  E +I
Sbjct: 3   CPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKI 62

Query: 99  LKRLDSQFIVKCHAVFYT-------IEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGV 151
           L+ L  + +V    +  T        +G I  V +  E         V  K +   I  V
Sbjct: 63  LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRV 122

Query: 152 AYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNN 211
              +L GL Y+H  +I+H D+K +N+LI   G +K+ADFG++R     +N+  +   N  
Sbjct: 123 MQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTN-- 180

Query: 212 NIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP 271
                    + T  Y  PE +  ER   DYG   D+W  G ++ E       + G  E+ 
Sbjct: 181 --------RVVTLWYRPPELLLGER---DYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ- 228

Query: 272 DLMALICAICFGERLEM----------------------------PETASPEFRRFVRSC 303
             +ALI  +C     E+                                 P     +   
Sbjct: 229 HQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKL 288

Query: 304 LEKDWRKRGTVEELLAYPFVTK 325
           L  D  +R   ++ L + F   
Sbjct: 289 LVLDPAQRIDSDDALNHDFFWS 310

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (456), Expect = 1e-54
 Identities = 67/291 (23%), Positives = 122/291 (41%), Gaps = 37/291 (12%)

Query: 54  VLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRL-DSQFIVKCHA 112
           VLG G  G V ++ ++++   +ALK+L          +A  E E+  R      IV+   
Sbjct: 19  VLGLGINGKVLQIFNKRTQEKFALKMLQD------CPKARREVELHWRASQCPHIVRIVD 72

Query: 113 VFYTI---EGEICFVMEHMERGSLFDSLRVR--KKLSEDVISGVAYRVLKGLQYLHGMQI 167
           V+  +      +  VME ++ G LF  ++ R  +  +E   S +   + + +QYLH + I
Sbjct: 73  VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINI 132

Query: 168 IHGDIKPSNLLIN---GKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTC 224
            H D+KP NLL         +K+ DFG ++      +                     T 
Sbjct: 133 AHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT---------------PCYTP 177

Query: 225 AYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGE 284
            Y++PE +  E+    Y  + D+WSLGV++   L G+ P            +   I  G+
Sbjct: 178 YYVAPEVLGPEK----YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ 233

Query: 285 ---RLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNI 332
                      S E +  +R+ L+ +  +R T+ E + +P++ + +     
Sbjct: 234 YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQT 284

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  178 bits (453), Expect = 1e-54
 Identities = 65/279 (23%), Positives = 113/279 (40%), Gaps = 23/279 (8%)

Query: 45  NISDLKKLTVLGHGNGGIVYKVRHQKSNS---IYALKVLNTTSSTIIRHQAAHEAEILKR 101
           +IS +K   V+G G  G V     +         A+K L +  +   R     EA I+ +
Sbjct: 24  DISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQ 83

Query: 102 LDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVR-KKLSEDVISGVAYRVLKGLQ 160
            D   ++    V       +  + E ME GSL   LR    + +   + G+   +  G++
Sbjct: 84  FDHPNVIHLEGVVTK-STPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMK 142

Query: 161 YLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIAC 220
           YL  M  +H D+   N+L+N     K++DFG+SR +E+  ++  +          +A+  
Sbjct: 143 YLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYT---------SALGG 193

Query: 221 MGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECL-VGHYPLIGFGEKPDLMALICA 279
                + +PE +        +  A DVWS G+V+ E +  G  P            +I A
Sbjct: 194 KIPIRWTAPEAIQ----YRKFTSASDVWSYGIVMWEVMSYGERPYWDM----TNQDVINA 245

Query: 280 ICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELL 318
           I    RL  P        + +  C +KD   R    +++
Sbjct: 246 IEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIV 284

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  178 bits (452), Expect = 1e-54
 Identities = 67/305 (21%), Positives = 121/305 (39%), Gaps = 31/305 (10%)

Query: 37  NPTSPDVE----NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQA 92
           +P+SP+ +      +D+     LG G  G VY+   +K +   A+K L     T+   + 
Sbjct: 3   DPSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK--EDTMEVEEF 60

Query: 93  AHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSL--RVRKKLSEDVISG 150
             EA ++K +    +V+   V    E     + E M  G+L D L    R+++S  V+  
Sbjct: 61  LKEAAVMKEIKHPNLVQLLGVCTR-EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLY 119

Query: 151 VAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNN 210
           +A ++   ++YL     IH D+   N L+     VK+ADFG+SR++       +      
Sbjct: 120 MATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG---- 175

Query: 211 NNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEK 270
                          + +PE +        +    DVW+ GV++ E              
Sbjct: 176 ---------AKFPIKWTAPESL----AYNKFSIKSDVWAFGVLLWEIATYGMS---PYPG 219

Query: 271 PDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY--PFVTKRSS 328
            DL  +   +    R+E PE    +    +R+C + +   R +  E+         + S 
Sbjct: 220 IDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSI 279

Query: 329 SSNIE 333
           S  +E
Sbjct: 280 SDEVE 284

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (456), Expect = 1e-54
 Identities = 77/285 (27%), Positives = 121/285 (42%), Gaps = 31/285 (10%)

Query: 45  NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLN--TTSSTIIRHQAAHEAEILKRL 102
            ++D   L +LG G  G V  VR + +   YA+K+L      +         E+ +L+  
Sbjct: 3   TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62

Query: 103 DSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYL 162
              F+      F T    +CFVME+   G LF  L   +  +E+        ++  L+YL
Sbjct: 63  RHPFLTALKYAFQT-HDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 121

Query: 163 HGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMG 222
           H   +++ DIK  NL+++  G +KI DFG+ +                   G       G
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--------------GATMKTFCG 167

Query: 223 TCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICF 282
           T  Y++PE +       DYG A D W LGVV+ E + G  P        D   L   I  
Sbjct: 168 TPEYLAPEVL----EDNDYGRAVDWWGLGVVMYEMMCGRLPFYN----QDHERLFELILM 219

Query: 283 GERLEMPETASPEFRRFVRSCLEKDWRKR-----GTVEELLAYPF 322
            E +  P T SPE +  +   L+KD ++R        +E++ + F
Sbjct: 220 EE-IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRF 263

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  178 bits (453), Expect = 2e-54
 Identities = 71/284 (25%), Positives = 119/284 (41%), Gaps = 34/284 (11%)

Query: 46  ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLN--TTSSTIIRHQAAHEAEILKRLD 103
           + D + L  LG G+ G V+ +R + +   YA+KVL                E  +L  + 
Sbjct: 3   LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT 62

Query: 104 SQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLH 163
             FI++    F     +I  +M+++E G LF  LR  ++    V    A  V   L+YLH
Sbjct: 63  HPFIIRMWGTFQD-AQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH 121

Query: 164 GMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGT 223
              II+ D+KP N+L++  G +KI DFG ++ V +                       GT
Sbjct: 122 SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT-----------------LCGT 164

Query: 224 CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFG 283
             Y++PE V        Y  + D WS G+++ E L G+ P        + M     I   
Sbjct: 165 PDYIAPEVV----STKPYNKSIDWWSFGILIYEMLAGYTPFYD----SNTMKTYEKILNA 216

Query: 284 ERLEMPETASPEFRRFVRSCLEKDWRKR-----GTVEELLAYPF 322
           E L  P   + + +  +   + +D  +R        E++  +P+
Sbjct: 217 E-LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPW 259

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (449), Expect = 4e-54
 Identities = 71/303 (23%), Positives = 117/303 (38%), Gaps = 45/303 (14%)

Query: 51  KLTVLGHGNGGIVYKVRHQKSNSIYALKVLN----TTSSTIIRHQAAHEAEILKRLDSQF 106
           KL  LG G    VYK R + +N I A+K +     + +   I   A  E ++L+ L    
Sbjct: 2   KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPN 61

Query: 107 IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQ 166
           I+     F   +  I  V + ME             L+   I       L+GL+YLH   
Sbjct: 62  IIGLLDAFGH-KSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 120

Query: 167 IIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAY 226
           I+H D+KP+NLL++  G +K+ADFG+++          H               + T  Y
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTH--------------QVVTRWY 166

Query: 227 MSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEK---------------- 270
            +PE +   R    YG   D+W++G ++ E L+    L G  +                 
Sbjct: 167 RAPELLFGARM---YGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEE 223

Query: 271 --PDLMALICAICFGERLEMP-----ETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV 323
             PD+ +L   + F     +P       A  +    ++     +   R T  + L   + 
Sbjct: 224 QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYF 283

Query: 324 TKR 326
           + R
Sbjct: 284 SNR 286

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (447), Expect = 2e-53
 Identities = 57/278 (20%), Positives = 102/278 (36%), Gaps = 26/278 (9%)

Query: 47  SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKV----LNTTSSTIIRHQAAHEAEILKRL 102
           ++ KK+ VLG G  G VYK           + V    L   +S     +   EA ++  +
Sbjct: 9   TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68

Query: 103 DSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKL-SEDVISGVAYRVLKGLQY 161
           D+  + +   +   +   +  + + M  G L D +R  K       +     ++ KG+ Y
Sbjct: 69  DNPHVCRLLGIC--LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 126

Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACM 221
           L   +++H D+   N+L+     VKI DFG+++++       +                 
Sbjct: 127 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG------------GK 174

Query: 222 GTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAIC 281
               +M+ E +        Y    DVWS GV V E +          +      +   + 
Sbjct: 175 VPIKWMALESI----LHRIYTHQSDVWSYGVTVWELMTFGSK---PYDGIPASEISSILE 227

Query: 282 FGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA 319
            GERL  P   + +    +  C   D   R    EL+ 
Sbjct: 228 KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELII 265

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (446), Expect = 4e-53
 Identities = 65/306 (21%), Positives = 121/306 (39%), Gaps = 46/306 (15%)

Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVK 109
             L+ +G G  G+V       +    A+K ++         +   E +IL R   + I+ 
Sbjct: 11  TNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIG 70

Query: 110 CHAVFYT---IEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQ 166
            + +       + +  +++ H+    L+  L+  + LS D I    Y++L+GL+Y+H   
Sbjct: 71  INDIIRAPTIEQMKDVYLVTHLMGADLYKLLK-TQHLSNDHICYFLYQILRGLKYIHSAN 129

Query: 167 IIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAY 226
           ++H D+KPSNLL+N   ++KI DFG++R+ +   ++                  + T  Y
Sbjct: 130 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE-----------YVATRWY 178

Query: 227 MSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERL 286
            +PE +        Y  + D+WS+G ++ E L       G     D +  I  I      
Sbjct: 179 RAPEIM---LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL-DQLNHILGILGSPSQ 234

Query: 287 EM---------------------------PETASPEFRRFVRSCLEKDWRKRGTVEELLA 319
           E                               A  +    +   L  +  KR  VE+ LA
Sbjct: 235 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294

Query: 320 YPFVTK 325
           +P++ +
Sbjct: 295 HPYLEQ 300

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  172 bits (436), Expect = 4e-52
 Identities = 68/312 (21%), Positives = 111/312 (35%), Gaps = 50/312 (16%)

Query: 37  NPTSPDVE-NISDLKKLTVLGHGNGGIVYKVRH-----QKSNSIYALKVLNTTSSTIIRH 90
           NP    +E   ++++ +  +G G  G V++ R       +  ++ A+K+L   +S  ++ 
Sbjct: 2   NPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQA 61

Query: 91  QAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLR------------ 138
               EA ++   D+  IVK   V       +C + E+M  G L + LR            
Sbjct: 62  DFQREAALMAEFDNPNIVKLLGVCAV-GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSH 120

Query: 139 ------------VRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVK 186
                           LS      +A +V  G+ YL   + +H D+   N L+     VK
Sbjct: 121 SDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVK 180

Query: 187 IADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGD 246
           IADFG+SR +          N                  +M PE +    +   Y    D
Sbjct: 181 IADFGLSRNIYSADYYKADGN------------DAIPIRWMPPESI----FYNRYTTESD 224

Query: 247 VWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEK 306
           VW+ GVV+ E                   +I  +  G  L  PE    E    +R C  K
Sbjct: 225 VWAYGVVLWEIFSYGLQ---PYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSK 281

Query: 307 DWRKRGTVEELL 318
               R +   + 
Sbjct: 282 LPADRPSFCSIH 293

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  171 bits (434), Expect = 4e-52
 Identities = 65/276 (23%), Positives = 106/276 (38%), Gaps = 22/276 (7%)

Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSST--IIRHQAAHEAEILKRLDSQFI 107
           +   +LG G    V+  R  + +   A+KVL    +       +   EA+    L+   I
Sbjct: 10  ELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAI 69

Query: 108 VKCHAVFYT---IEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG 164
           V  +               VME+++  +L D +     ++      V     + L + H 
Sbjct: 70  VAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQ 129

Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTC 224
             IIH D+KP+N++I+    VK+ DFG++R + ++ N+                A +GT 
Sbjct: 130 NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTA-----------AVIGTA 178

Query: 225 AYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGE 284
            Y+SPE+      G       DV+SLG V+ E L G  P  G      +           
Sbjct: 179 QYLSPEQA----RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP-VSVAYQHVREDPIP 233

Query: 285 RLEMPETASPEFRRFVRSCLEKDWRKR-GTVEELLA 319
                E  S +    V   L K+   R  T  E+ A
Sbjct: 234 PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRA 269

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (430), Expect = 2e-51
 Identities = 65/277 (23%), Positives = 106/277 (38%), Gaps = 26/277 (9%)

Query: 47  SDLKKLTVLGHGNGGIVYKVRHQKSNS---IYALKVLNTTSSTIIRHQAAHEAEILKRLD 103
             ++    +G G  G V++  +    +     A+K     +S  +R +   EA  +++ D
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66

Query: 104 SQFIVKCHAVFYTIEGEICFVMEHMERGSLFD-SLRVRKKLSEDVISGVAYRVLKGLQYL 162
              IVK   V    E  +  +ME    G L       +  L    +   AY++   L YL
Sbjct: 67  HPHIVKLIGVIT--ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL 124

Query: 163 HGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMG 222
              + +H DI   N+L++    VK+ DFG+SR +E++                       
Sbjct: 125 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK-------------GKL 171

Query: 223 TCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICF 282
              +M+PE ++       +  A DVW  GV + E L+         +      +I  I  
Sbjct: 172 PIKWMAPESIN----FRRFTSASDVWMFGVCMWEILMHGVK---PFQGVKNNDVIGRIEN 224

Query: 283 GERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA 319
           GERL MP    P     +  C   D  +R    EL A
Sbjct: 225 GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 261

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (430), Expect = 6e-51
 Identities = 84/314 (26%), Positives = 137/314 (43%), Gaps = 30/314 (9%)

Query: 25  QFRRRRHHFPTSNPTS-PDVENISDLKKLTVLGHGNGGIVYKVRH---QKSNSIYALKVL 80
           Q    +H   T+N T   +   I + + L VLG G  G V+ VR      +  +YA+KVL
Sbjct: 1   QLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVL 60

Query: 81  N---TTSSTIIRHQAAHEAEILKRLD-SQFIVKCHAVFYTIEGEICFVMEHMERGSLFDS 136
                            E ++L+ +  S F+V  H  F T E ++  +++++  G LF  
Sbjct: 61  KKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT-ETKLHLILDYINGGELFTH 119

Query: 137 LRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIV 196
           L  R++ +E  +      ++  L++LH + II+ DIK  N+L++  G V + DFG+S+  
Sbjct: 120 LSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 179

Query: 197 EETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLE 256
                   ++               GT  YM+P+ V     G  +  A D WSLGV++ E
Sbjct: 180 VADETERAYD-------------FCGTIEYMAPDIVRGGDSG--HDKAVDWWSLGVLMYE 224

Query: 257 CLVGHYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKR----- 311
            L G  P    GEK +  A I           P+  S   +  ++  L KD +KR     
Sbjct: 225 LLTGASPFTVDGEK-NSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGP 283

Query: 312 GTVEELLAYPFVTK 325
              +E+  + F  K
Sbjct: 284 RDADEIKEHLFFQK 297

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (430), Expect = 7e-51
 Identities = 70/306 (22%), Positives = 119/306 (38%), Gaps = 50/306 (16%)

Query: 45  NISDLKKLTVLGHGNGGIVYKVRHQKSNSI-----YALKVLNTTSSTIIRHQAAHEAEIL 99
              +L+   VLG G  G V        +        A+K+L   + +  R     E +++
Sbjct: 35  PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMM 94

Query: 100 KRLDS-QFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKK---------------- 142
            +L S + IV          G I  + E+   G L + LR +++                
Sbjct: 95  TQLGSHENIVNLLGACTL-SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 153

Query: 143 -------LSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRI 195
                  L+ + +   AY+V KG+++L     +H D+   N+L+     VKI DFG++R 
Sbjct: 154 EEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARD 213

Query: 196 VEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVL 255
           +    N     N                  +M+PE +      G Y    DVWS G+++ 
Sbjct: 214 IMSDSNYVVRGN------------ARLPVKWMAPESLF----EGIYTIKSDVWSYGILLW 257

Query: 256 ECL-VGHYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTV 314
           E   +G  P  G     +   LI     G +++ P  A+ E    ++SC   D RKR + 
Sbjct: 258 EIFSLGVNPYPGIPVDANFYKLIQN---GFKMDQPFYATEEIYIIMQSCWAFDSRKRPSF 314

Query: 315 EELLAY 320
             L ++
Sbjct: 315 PNLTSF 320

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (424), Expect = 1e-50
 Identities = 59/278 (21%), Positives = 112/278 (40%), Gaps = 24/278 (8%)

Query: 47  SDLKKLTVLGHGNGGIVYKVRHQKSNS----IYALKVLNTTSSTIIRHQAAHEAEILKRL 102
           S + +  V+G G  G VYK   + S+       A+K L    +   R     EA I+ + 
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66

Query: 103 DSQFIVKCHAVFYTIEGEICFVMEHMERGSLFD-SLRVRKKLSEDVISGVAYRVLKGLQY 161
               I++   V       +  + E+ME G+L         + S   + G+   +  G++Y
Sbjct: 67  SHHNIIRLEGVISK-YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKY 125

Query: 162 LHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACM 221
           L  M  +H D+   N+L+N     K++DFG+SR++E+        +              
Sbjct: 126 LANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS-----------GGK 174

Query: 222 GTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAIC 281
               + +PE +   ++      A DVWS G+V+ E +           +     ++ AI 
Sbjct: 175 IPIRWTAPEAISYRKF----TSASDVWSFGIVMWEVMTYGER---PYWELSNHEVMKAIN 227

Query: 282 FGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA 319
            G RL  P        + +  C +++  +R    ++++
Sbjct: 228 DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (426), Expect = 2e-50
 Identities = 72/301 (23%), Positives = 109/301 (36%), Gaps = 42/301 (13%)

Query: 38  PTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIY--ALKVLNTTSSTIIRHQAAHE 95
           PT   V + +D+K   V+G GN G V K R +K       A+K +   +S       A E
Sbjct: 1   PTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGE 60

Query: 96  AEILKRL-DSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVR-------------- 140
            E+L +L     I+          G +   +E+   G+L D LR                
Sbjct: 61  LEVLCKLGHHPNIINLLGAC-EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANS 119

Query: 141 --KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEE 198
               LS   +   A  V +G+ YL   Q IH D+   N+L+      KIADFG+SR  E 
Sbjct: 120 TASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV 179

Query: 199 TRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECL 258
                                      +M+ E ++   +        DVWS GV++ E +
Sbjct: 180 YVKKTM---------------GRLPVRWMAIESLNYSVYTT----NSDVWSYGVLLWEIV 220

Query: 259 VGHYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELL 318
                            L   +  G RLE P     E    +R C  +   +R +  ++L
Sbjct: 221 SLGGT---PYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQIL 277

Query: 319 A 319
            
Sbjct: 278 V 278

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (425), Expect = 2e-50
 Identities = 57/270 (21%), Positives = 107/270 (39%), Gaps = 21/270 (7%)

Query: 54  VLGHGNGGIVYKVRHQKSNS---IYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKC 110
           V+G G+ G VY      ++      A+K LN  +      Q   E  I+K      ++  
Sbjct: 34  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 93

Query: 111 HAVFYTIEGEICFVMEHMERGSLFD-SLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIH 169
             +    EG    V+ +M+ G L +         +   + G   +V KG+++L   + +H
Sbjct: 94  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVH 153

Query: 170 GDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSP 229
            D+   N +++ K  VK+ADFG++R + +   ++ HN                   +M+ 
Sbjct: 154 RDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKT----------GAKLPVKWMAL 203

Query: 230 ERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMP 289
           E + ++++        DVWS GV++ E +    P        +   +   +  G RL  P
Sbjct: 204 ESLQTQKF----TTKSDVWSFGVLLWELMTRGAP---PYPDVNTFDITVYLLQGRRLLQP 256

Query: 290 ETASPEFRRFVRSCLEKDWRKRGTVEELLA 319
           E         +  C       R +  EL++
Sbjct: 257 EYCPDPLYEVMLKCWHPKAEMRPSFSELVS 286

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (422), Expect = 3e-50
 Identities = 65/279 (23%), Positives = 120/279 (43%), Gaps = 40/279 (14%)

Query: 54  VLGHGNGGIVYKVRHQKSNSIYALKVLNTTSST-----IIRHQAAHEAEILKRLDSQF-- 106
           +LG G  G VY       N   A+K +     +         +   E  +LK++ S F  
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 107 IVKCHAVFYTIEGEICFVMEHME-RGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGM 165
           +++    F         ++E  E    LFD +  R  L E++     ++VL+ +++ H  
Sbjct: 71  VIRLLDWFER-PDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 129

Query: 166 QIIHGDIKPSNLLING-KGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTC 224
            ++H DIK  N+LI+  +GE+K+ DFG   ++++T   +                  GT 
Sbjct: 130 GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD----------------FDGTR 173

Query: 225 AYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGE 284
            Y  PE +   R+   +G +  VWSLG+++ + + G  P   F    +++          
Sbjct: 174 VYSPPEWIRYHRY---HGRSAAVWSLGILLYDMVCGDIP---FEHDEEIIR--------G 219

Query: 285 RLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV 323
           ++   +  S E +  +R CL      R T EE+  +P++
Sbjct: 220 QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 258

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (421), Expect = 5e-50
 Identities = 64/302 (21%), Positives = 124/302 (41%), Gaps = 44/302 (14%)

Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLN-TTSSTIIRHQAAHEAEILKRLDSQFIV 108
           +KL  +G G  G V+K ++++++ I ALK +        +   A  E  +LK L  + IV
Sbjct: 5   EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIV 64

Query: 109 KCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQII 168
           + H V ++ + ++  V E  ++            L  +++    +++LKGL + H   ++
Sbjct: 65  RLHDVLHS-DKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVL 123

Query: 169 HGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMS 228
           H D+KP NLLIN  GE+K+A+FG++R         +                + T  Y  
Sbjct: 124 HRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA--------------EVVTLWYRP 169

Query: 229 PERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICF------ 282
           P+ +   +    Y  + D+WS G +  E      PL    +  D +  I  +        
Sbjct: 170 PDVLFGAKL---YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQ 226

Query: 283 -------------------GERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV 323
                                 + +    +   R  +++ L+ +  +R + EE L +P+ 
Sbjct: 227 WPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF 286

Query: 324 TK 325
           + 
Sbjct: 287 SD 288

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (419), Expect = 7e-50
 Identities = 61/280 (21%), Positives = 100/280 (35%), Gaps = 25/280 (8%)

Query: 45  NISDLKKLTVLGHGNGGIVYKVRHQKSNS---IYALKVLN--TTSSTIIRHQAAHEAEIL 99
              DL+ L  LG G+ G+V +      +      A+K L     S          E   +
Sbjct: 6   GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAM 65

Query: 100 KRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFD-SLRVRKKLSEDVISGVAYRVLKG 158
             LD + +++ + V   +   +  V E    GSL D   + +       +S  A +V +G
Sbjct: 66  HSLDHRNLIRLYGVV--LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 123

Query: 159 LQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAI 218
           + YL   + IH D+   NLL+  +  VKI DFG+ R + +  ++     +          
Sbjct: 124 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEH---------- 173

Query: 219 ACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALIC 278
                 A+ +PE +        +  A D W  GV + E                ++  I 
Sbjct: 174 -RKVPFAWCAPESLK----TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID 228

Query: 279 AICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELL 318
               GERL  PE    +    +  C       R T   L 
Sbjct: 229 KE--GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALR 266

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  166 bits (421), Expect = 3e-49
 Identities = 70/290 (24%), Positives = 130/290 (44%), Gaps = 34/290 (11%)

Query: 40  SPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIR--HQAAHEAE 97
           S +   +    ++  LG G+ G V  V+H++S + YA+K+L+      ++      +E  
Sbjct: 34  SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR 93

Query: 98  ILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLK 157
           IL+ ++  F+VK    F      +  VME++  G +F  LR   + SE      A +++ 
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNS-NLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL 152

Query: 158 GLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAA 217
             +YLH + +I+ D+KP NLLI+ +G +++ DFG ++ V+                    
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT--------------- 197

Query: 218 IACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALI 277
               GT   ++PE +        Y  A D W+LGV++ E   G+ P          + + 
Sbjct: 198 --LCGTPEALAPEII----LSKGYNKAVDWWALGVLIYEMAAGYPPFFA----DQPIQIY 247

Query: 278 CAICFGERLEMPETASPEFRRFVRSCLEKDWRKR-----GTVEELLAYPF 322
             I  G+ +  P   S + +  +R+ L+ D  KR       V ++  + +
Sbjct: 248 EKIVSGK-VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 296

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (411), Expect = 2e-48
 Identities = 61/288 (21%), Positives = 113/288 (39%), Gaps = 35/288 (12%)

Query: 47  SDLKKLTVLGHGNGGIVYKVRHQ-----KSNSIYALKVLNTTSSTIIRHQAAHEAEILKR 101
             +     LG G+ G+VY+   +     +  +  A+K +N  +S   R +  +EA ++K 
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79

Query: 102 LDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKK----------LSEDVISGV 151
            +   +V+   V  +       +ME M RG L   LR  +            S   +  +
Sbjct: 80  FNCHHVVRLLGVV-SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQM 138

Query: 152 AYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNN 211
           A  +  G+ YL+  + +H D+   N ++     VKI DFG++R + ET            
Sbjct: 139 AGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK---- 194

Query: 212 NIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP 271
                    +    +MSPE +      G +    DVWS GVV+ E            +  
Sbjct: 195 --------GLLPVRWMSPESL----KDGVFTTYSDVWSFGVVLWEIATLAEQ---PYQGL 239

Query: 272 DLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA 319
               ++  +  G  L+ P+         +R C + + + R +  E+++
Sbjct: 240 SNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (413), Expect = 3e-48
 Identities = 68/322 (21%), Positives = 116/322 (36%), Gaps = 58/322 (18%)

Query: 35  TSNPTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAH 94
            +    PD           V+G+G+ G+VY+ +   S  + A+K +        R     
Sbjct: 8   ATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----- 62

Query: 95  EAEILKRLDSQFIVKCHAVFYTIEGE-----ICFVMEHMERG---SLFDSLRVRKKLSED 146
           E +I+++LD   IV+    FY+   +     +  V++++            R ++ L   
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 122

Query: 147 VISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGE-VKIADFGVSRIVEETRNNNNH 205
            +    Y++ + L Y+H   I H DIKP NLL++     +K+ DFG ++ +         
Sbjct: 123 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR------- 175

Query: 206 NNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLI 265
                   GE  ++ + +  Y +PE +        Y  + DVWS G V+ E L+G     
Sbjct: 176 --------GEPNVSYICSRYYRAPELIFGATD---YTSSIDVWSAGCVLAELLLGQPIFP 224

Query: 266 GFGEKPDLMALICAICFGERLEM-------------------------PETASPEFRRFV 300
           G     D +  I  +      E                               PE     
Sbjct: 225 GDSGV-DQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALC 283

Query: 301 RSCLEKDWRKRGTVEELLAYPF 322
              LE     R T  E  A+ F
Sbjct: 284 SRLLEYTPTARLTPLEACAHSF 305

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (408), Expect = 5e-48
 Identities = 73/303 (24%), Positives = 124/303 (40%), Gaps = 44/303 (14%)

Query: 46  ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSST-IIRHQAAHEAEILKRLDS 104
           + + +K+  +G G  G+VYK R++ +  + ALK +   + T  +   A  E  +LK L+ 
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60

Query: 105 QFIVKCHAVFYTIEGEICFVMEHMERGSL-FDSLRVRKKLSEDVISGVAYRVLKGLQYLH 163
             IVK   V +T E ++  V E + +    F        +   +I    +++L+GL + H
Sbjct: 61  PNIVKLLDVIHT-ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119

Query: 164 GMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGT 223
             +++H D+KP NLLIN +G +K+ADFG++R          H               + T
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH--------------EVVT 165

Query: 224 CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFG 283
             Y +PE +        Y  A D+WSLG +  E +       G  E   L  +   +   
Sbjct: 166 LWYRAPEIL---LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTP 222

Query: 284 ERLEMPE------------------------TASPEFRRFVRSCLEKDWRKRGTVEELLA 319
           + +  P                             + R  +   L  D  KR + +  LA
Sbjct: 223 DEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282

Query: 320 YPF 322
           +PF
Sbjct: 283 HPF 285

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (405), Expect = 2e-47
 Identities = 68/310 (21%), Positives = 112/310 (36%), Gaps = 44/310 (14%)

Query: 34  PTSNPTSPDVE-NISDLKKLTVLGHGNGGIVYKVR-----HQKSNSIYALKVLNTTSSTI 87
           PT  P     E   + L     LG G  G V +          +    A+K+L  ++   
Sbjct: 9   PTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT 68

Query: 88  IRHQAAHEAEILKRL-DSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRK----- 141
            R     E ++L  L +   IV          G    + E+   G L + LR ++     
Sbjct: 69  EREALMSELKVLSYLGNHMNIVNLLGACTI-GGPTLVITEYCCYGDLLNFLRRKRDSFIC 127

Query: 142 -------------KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIA 188
                         L  + +   +Y+V KG+ +L     IH D+   N+L+      KI 
Sbjct: 128 SKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKIC 187

Query: 189 DFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVW 248
           DFG++R ++   N     N                  +M+PE +    +   Y F  DVW
Sbjct: 188 DFGLARDIKNDSNYVVKGN------------ARLPVKWMAPESI----FNCVYTFESDVW 231

Query: 249 SLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDW 308
           S G+ + E          +   P        I  G R+  PE A  E    +++C + D 
Sbjct: 232 SYGIFLWELFSLGSS--PYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADP 289

Query: 309 RKRGTVEELL 318
            KR T ++++
Sbjct: 290 LKRPTFKQIV 299

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  159 bits (403), Expect = 6e-47
 Identities = 60/315 (19%), Positives = 111/315 (35%), Gaps = 61/315 (19%)

Query: 44  ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRL- 102
            N  D + +  LG G    V++  +  +N    +K+L        + +   E +IL+ L 
Sbjct: 32  GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK----KKKIKREIKILENLR 87

Query: 103 DSQFIVKCHAVFYTIEGE-ICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQY 161
               I+    +           V EH+          + + L++  I    Y +LK L Y
Sbjct: 88  GGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ---LYQTLTDYDIRFYMYEILKALDY 144

Query: 162 LHGMQIIHGDIKPSNLLINGKG-EVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIAC 220
            H M I+H D+KP N++I+ +  ++++ D+G++      +  N                 
Sbjct: 145 CHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNV---------------R 189

Query: 221 MGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAI 280
           + +  +  PE          Y ++ D+WSLG ++   +    P     +  D +  I  +
Sbjct: 190 VASRYFKGPE---LLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKV 246

Query: 281 CFGERL---------------------------------EMPETASPEFRRFVRSCLEKD 307
              E L                                 E     SPE   F+   L  D
Sbjct: 247 LGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYD 306

Query: 308 WRKRGTVEELLAYPF 322
            + R T  E + +P+
Sbjct: 307 HQSRLTAREAMEHPY 321

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (400), Expect = 7e-47
 Identities = 61/295 (20%), Positives = 112/295 (37%), Gaps = 42/295 (14%)

Query: 47  SDLKKLTVLGHGNGGIVYKVRHQKSN-------SIYALKVLNTTSSTIIRHQAAHEAEIL 99
             L     LG G  G V        +       +  A+K+L + ++         E E++
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72

Query: 100 KRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRK----------------KL 143
           K +     +       T +G +  ++E+  +G+L + L+ R+                +L
Sbjct: 73  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132

Query: 144 SEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNN 203
           S   +   AY+V +G++YL   + IH D+   N+L+     +KIADFG++R +       
Sbjct: 133 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 192

Query: 204 NHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYP 263
              N                  +M+PE +    +   Y    DVWS GV++ E       
Sbjct: 193 KTTN------------GRLPVKWMAPEAL----FDRIYTHQSDVWSFGVLLWEIFTLGGS 236

Query: 264 LIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELL 318
                    +  L   +  G R++ P   + E    +R C      +R T ++L+
Sbjct: 237 ---PYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLV 288

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  158 bits (400), Expect = 9e-47
 Identities = 51/293 (17%), Positives = 99/293 (33%), Gaps = 25/293 (8%)

Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVK 109
           +    +G G+ G +Y      +    A+K+    +      Q   E++I K +     + 
Sbjct: 10  RLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIP 66

Query: 110 CHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIH 169
                         VME +            +K S   +  +A +++  ++Y+H    IH
Sbjct: 67  TIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIH 126

Query: 170 GDIKPSNLLINGKG---EVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAY 226
            D+KP N L+        V I DFG+++   + R + +     N N+        GT  Y
Sbjct: 127 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNL-------TGTARY 179

Query: 227 MSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGE-- 284
            S         G +     D+ SLG V++   +G        +          I   +  
Sbjct: 180 ASINTHL----GIEQSRRDDLESLGYVLMYFNLGS-LPWQGLKAATKRQKYERISEKKMS 234

Query: 285 --RLEMPETASPEFRRFVRSCLEKDWRKR---GTVEELLAYPFVTKRSSSSNI 332
                + +    EF  ++  C    +  +     + +L    F  +  S   +
Sbjct: 235 TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYV 287

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  157 bits (397), Expect = 1e-46
 Identities = 68/302 (22%), Positives = 110/302 (36%), Gaps = 46/302 (15%)

Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLN-TTSSTIIRHQAAHEAEILKRLDSQFIV 108
             L  +G G  G+VYK ++      +ALK +        I      E  ILK L    IV
Sbjct: 5   HGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIV 63

Query: 109 KCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQII 168
           K + V +T +  +  V EH+++            L          ++L G+ Y H  +++
Sbjct: 64  KLYDVIHT-KKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVL 122

Query: 169 HGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMS 228
           H D+KP NLLIN +GE+KIADFG++R          H               + T  Y +
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH--------------EIVTLWYRA 168

Query: 229 PERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLE- 287
           P+          Y    D+WS+G +  E + G     G  E  D +  I  I      + 
Sbjct: 169 PD---VLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA-DQLMRIFRILGTPNSKN 224

Query: 288 ------------------------MPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV 323
                                     +         +   L+ D  +R T ++ L + + 
Sbjct: 225 WPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284

Query: 324 TK 325
            +
Sbjct: 285 KE 286

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (390), Expect = 6e-45
 Identities = 75/309 (24%), Positives = 118/309 (38%), Gaps = 56/309 (18%)

Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLN-TTSSTIIRHQAAHEAEILKRLDSQFIV 108
           + L  +G G  G V      ++ +  A+K L     S +   +A  E  +LK +  + ++
Sbjct: 21  RDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVI 80

Query: 109 KCHAVFYTIE-----GEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLH 163
               VF   E      +   VM  M  G+    L   +KL ED I  + Y++LKGL+Y+H
Sbjct: 81  GLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIH 138

Query: 164 GMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGT 223
              IIH D+KP NL +N   E+KI DFG++R  +                       + T
Sbjct: 139 AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTG-----------------YVVT 181

Query: 224 CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFG 283
             Y +PE + +      Y    D+WS+G ++ E + G     G     D +  I  +   
Sbjct: 182 RWYRAPEVILN---WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL-DQLKEIMKVTGT 237

Query: 284 ERLEMPE---------------------------TASPEFRRFVRSCLEKDWRKRGTVEE 316
              E  +                            ASP     +   L  D  +R T  E
Sbjct: 238 PPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGE 297

Query: 317 LLAYPFVTK 325
            LA+P+   
Sbjct: 298 ALAHPYFES 306

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  152 bits (384), Expect = 2e-44
 Identities = 50/277 (18%), Positives = 92/277 (33%), Gaps = 24/277 (8%)

Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVK 109
           K    +G G+ G++++  +  +N   A+K     S      Q   E    K L     + 
Sbjct: 8   KVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD---APQLRDEYRTYKLLAGCTGIP 64

Query: 110 CHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIH 169
               F         V++ +            +K S   ++  A ++L  +Q +H   +++
Sbjct: 65  NVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVY 124

Query: 170 GDIKPSNLLIN-----GKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTC 224
            DIKP N LI          + + DFG+ +   +     +       N+        GT 
Sbjct: 125 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNL-------SGTA 177

Query: 225 AYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGE 284
            YMS         G +     D+ +LG V +  L G  P  G             I   +
Sbjct: 178 RYMSINTH----LGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA-ATNKQKYERIGEKK 232

Query: 285 RL----EMPETASPEFRRFVRSCLEKDWRKRGTVEEL 317
           +     E+      EF +++       +      + L
Sbjct: 233 QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYL 269

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (380), Expect = 8e-44
 Identities = 59/294 (20%), Positives = 110/294 (37%), Gaps = 40/294 (13%)

Query: 47  SDLKKLTVLGHGNGGIVYKVRHQKSNS-----IYALKVLNTTSSTIIRHQAAHEAEILKR 101
             LK    LG G  G V +      +        A+K+L   ++         E +IL  
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 102 LDSQF-IVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKK----------------LS 144
           +     +V          G +  ++E  + G+L   LR ++                 L+
Sbjct: 73  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 145 EDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNN 204
            + +   +++V KG+++L   + IH D+   N+L++ K  VKI DFG++R + +  +   
Sbjct: 133 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 192

Query: 205 HNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPL 264
             +                  +M+PE +        Y    DVWS GV++ E        
Sbjct: 193 KGD------------ARLPLKWMAPETIF----DRVYTIQSDVWSFGVLLWEIFSLGASP 236

Query: 265 IGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELL 318
             +            +  G R+  P+  +PE  + +  C   +  +R T  EL+
Sbjct: 237 --YPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELV 288

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (374), Expect = 6e-43
 Identities = 60/305 (19%), Positives = 118/305 (38%), Gaps = 51/305 (16%)

Query: 50  KKLTVLGHGNGGIVYKVRHQKS-NSIYALKVLNTTSST-IIRHQAAHEAEILKRLDS--- 104
           + +  +G G  G V+K R  K+     ALK +   +    +      E  +L+ L++   
Sbjct: 10  ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEH 69

Query: 105 QFIVKCHAVFYTI----EGEICFVMEHMERGSLFDSLRVRKK-LSEDVISGVAYRVLKGL 159
             +V+   V        E ++  V EH+++       +V +  +  + I  + +++L+GL
Sbjct: 70  PNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGL 129

Query: 160 QYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIA 219
            +LH  +++H D+KP N+L+   G++K+ADFG++RI        +               
Sbjct: 130 DFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS--------------- 174

Query: 220 CMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICA 279
            + T  Y +PE +        Y    D+WS+G +  E         G  +   L  ++  
Sbjct: 175 VVVTLWYRAPEVL----LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDV 230

Query: 280 ICFGERLEMPE----------------------TASPEFRRFVRSCLEKDWRKRGTVEEL 317
           I      + P                             +  +  CL  +  KR +    
Sbjct: 231 IGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290

Query: 318 LAYPF 322
           L++P+
Sbjct: 291 LSHPY 295

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (373), Expect = 2e-42
 Identities = 71/308 (23%), Positives = 127/308 (41%), Gaps = 54/308 (17%)

Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTII-RHQAAHEAEILKRLDSQFIV 108
           + L+ +G G  G V      K+    A+K L+    +II   +   E  +LK +  + ++
Sbjct: 21  QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI 80

Query: 109 KCHAVFYT----IEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG 164
               VF       E    +++ H+  G+  +++   +KL++D +  + Y++L+GL+Y+H 
Sbjct: 81  GLLDVFTPARSLEEFNDVYLVTHL-MGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 139

Query: 165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTC 224
             IIH D+KPSNL +N   E+KI DFG++R  ++                      + T 
Sbjct: 140 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG-----------------YVATR 182

Query: 225 AYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGE 284
            Y +PE + +      Y    D+WS+G ++ E L G     G     D + LI  +    
Sbjct: 183 WYRAPEIMLNWMH---YNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVGTP 238

Query: 285 RLEMPET---------------------------ASPEFRRFVRSCLEKDWRKRGTVEEL 317
             E+ +                            A+P     +   L  D  KR T  + 
Sbjct: 239 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 298

Query: 318 LAYPFVTK 325
           LA+ +  +
Sbjct: 299 LAHAYFAQ 306

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (367), Expect = 6e-42
 Identities = 58/295 (19%), Positives = 107/295 (36%), Gaps = 45/295 (15%)

Query: 54  VLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAV 113
            +G G  G V++ +        A+K+ ++        +A  E      L  + I+   A 
Sbjct: 10  SIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREA--EIYQTVMLRHENILGFIAA 65

Query: 114 FYTIEG---EICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLH------- 163
                G   ++  V ++ E GSLFD L  R  ++ + +  +A     GL +LH       
Sbjct: 66  DNKDNGTWTQLWLVSDYHEHGSLFDYLN-RYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 124

Query: 164 -GMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMG 222
               I H D+K  N+L+   G   IAD G++   +   +  +   N+           +G
Sbjct: 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNH----------RVG 174

Query: 223 TCAYMSPERVDSERW--GGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEK---------- 270
           T  YM+PE +D        +     D++++G+V  E            +           
Sbjct: 175 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234

Query: 271 -PDLMALICAICFGE-RLEMPET-----ASPEFRRFVRSCLEKDWRKRGTVEELL 318
            P +  +   +C  + R  +P       A     + +R C   +   R T   + 
Sbjct: 235 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 289

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (358), Expect = 4e-40
 Identities = 64/328 (19%), Positives = 121/328 (36%), Gaps = 67/328 (20%)

Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLN-TTSSTIIRHQAAHEAEILKRLDSQFIV 108
           + L  +G G  GIV        +   A+K L+    +     +A  E  ++K ++ + I+
Sbjct: 20  QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 79

Query: 109 KCHAVFYT-----IEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLH 163
               VF          ++  VME M+         ++ +L  + +S + Y++L G+++LH
Sbjct: 80  SLLNVFTPQKTLEEFQDVYLVMELMDANLCQV---IQMELDHERMSYLLYQMLCGIKHLH 136

Query: 164 GMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGT 223
              IIH D+KPSN+++     +KI DFG++R    +     +               + T
Sbjct: 137 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY---------------VVT 181

Query: 224 CAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAIC-- 281
             Y +PE +     G  Y    D+WS+G ++ E +       G     D    +      
Sbjct: 182 RYYRAPEVI----LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI-DQWNKVIEQLGT 236

Query: 282 ------------------------------------FGERLEMPETASPEFRRFVRSCLE 305
                                               F    E  +  + + R  +   L 
Sbjct: 237 PCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLV 296

Query: 306 KDWRKRGTVEELLAYPFVTKRSSSSNIE 333
            D  KR +V++ L +P++      + +E
Sbjct: 297 IDPAKRISVDDALQHPYINVWYDPAEVE 324

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  122 bits (307), Expect = 1e-32
 Identities = 64/349 (18%), Positives = 117/349 (33%), Gaps = 88/349 (25%)

Query: 50  KKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLD------ 103
             +  LG G+   V+  +   +N+  A+K++      +    A  E ++L+R++      
Sbjct: 16  ILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVR--GDKVYTEAAEDEIKLLQRVNDADNTK 73

Query: 104 -----SQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKK----LSEDVISGVAYR 154
                +  I+K    F         V+   E         ++K     +    +  ++ +
Sbjct: 74  EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133

Query: 155 VLKGLQYLHGMQ-IIHGDIKPSNLLINGKG------EVKIADFGVSRIVEETRNNNNHNN 207
           +L GL Y+H    IIH DIKP N+L+          ++KIAD G +   +E   N     
Sbjct: 134 LLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTN----- 188

Query: 208 NNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGF 267
                        + T  Y SPE +     G  +G   D+WS   ++ E + G +     
Sbjct: 189 ------------SIQTREYRSPEVL----LGAPWGCGADIWSTACLIFELITGDFLFEPD 232

Query: 268 GEKP-----DLMALICAIC--------------------------------------FGE 284
                    D +A I  +                                         E
Sbjct: 233 EGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTE 292

Query: 285 RLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNIE 333
           + +  +  + E   F+   L+ D RKR     L+ +P++        I 
Sbjct: 293 KYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIR 341

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 77.5 bits (190), Expect = 1e-17
 Identities = 32/220 (14%), Positives = 66/220 (30%), Gaps = 52/220 (23%)

Query: 54  VLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-----------------STIIRHQAAHEA 96
           ++G G    V+     +      +K                       S +    A +E 
Sbjct: 7   LMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 97  EILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVL 156
             L++L    + K +A           +ME ++            ++  +    V   +L
Sbjct: 66  RALQKLQGLAVPKVYAWE-----GNAVLMELIDAK-------ELYRVRVENPDEVLDMIL 113

Query: 157 KGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEA 216
           + +   +   I+HGD+   N+L++ +G + I DF  S                   I E 
Sbjct: 114 EEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQSV---------EVGEEGWREILER 163

Query: 217 AIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLE 256
            +  +               +   Y    D+ S    +L+
Sbjct: 164 DVRNI------------ITYFSRTYRTEKDINSAIDRILQ 191

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} Length = 392

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

 Score = 37.1 bits (85), Expect = 0.003
 Identities = 23/136 (16%), Positives = 42/136 (30%), Gaps = 8/136 (5%)

Query: 46  ISDLKKLTV--LGHGNGGIVYKVRHQKSNSIYALK------VLNTTSSTIIRHQAAHEAE 97
                 LT   +G GN   V+ +  Q+ +    +K       +   S  +   +A  E+ 
Sbjct: 23  FPSKSTLTCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESS 82

Query: 98  ILKRLDSQFIVKCHAVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLK 157
            L R           VFY+       VME +    +     +  +    +   +   + K
Sbjct: 83  ALIRQGEHVPHLVPRVFYSDTEMAVTVMEDLSHLKIARKGLIEGENYPHLSQHIGEFLGK 142

Query: 158 GLQYLHGMQIIHGDIK 173
            L Y     +     K
Sbjct: 143 TLFYSSDYALEPKVKK 158

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	337
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.91
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.55
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.37
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.26
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.4
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.3
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	97.25
d1cjaa_	342	Actin-fragmin kinase, catalytic domain {Physarum p	81.09

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-62  Score=417.32  Aligned_cols=264  Identities=22%  Similarity=0.289  Sum_probs=220.4

Q ss_pred             CccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 019650           45 NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFV  124 (337)
Q Consensus        45 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv  124 (337)
                      ..++|++++.||+|+||+||+|.+..+++.||+|++.........+.+.+|+.++++++||||+++++++.+ ++.+|+|
T Consensus         3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~-~~~~~iv   81 (271)
T d1nvra_           3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE-GNIQYLF   81 (271)
T ss_dssp             TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEE-TTEEEEE
T ss_pred             CCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CceeEEE
Confidence            367899999999999999999999999999999999876544455678899999999999999999999877 7899999


Q ss_pred             EeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCC
Q 019650          125 MEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNN  204 (337)
Q Consensus       125 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~  204 (337)
                      |||++||+|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.++++||+|||++.........  
T Consensus        82 mEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~--  159 (271)
T d1nvra_          82 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE--  159 (271)
T ss_dssp             EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE--
T ss_pred             EeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCcc--
Confidence            999999999999998889999999999999999999999999999999999999999999999999999876543211  


Q ss_pred             CCCCCCCccccccccccCCCCCcCCcccccccCCCCC-CccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhcc
Q 019650          205 HNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDY-GFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFG  283 (337)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~-~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~  283 (337)
                                ......+||+.|+|||++..    ..+ +.++|||||||++|+|++|+.||....+........  ....
T Consensus       160 ----------~~~~~~~GT~~Y~APE~~~~----~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~--~~~~  223 (271)
T d1nvra_         160 ----------RLLNKMCGTLPYVAPELLKR----REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW--KEKK  223 (271)
T ss_dssp             ----------CCBCCCCSCGGGSCTHHHHC----SSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHH--HTTC
T ss_pred             ----------ccccceeeCcCccCHhHhcC----CCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHH--hcCC
Confidence                      22234579999999999984    344 678999999999999999999997654433332222  2222


Q ss_pred             CCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccC
Q 019650          284 ERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRS  327 (337)
Q Consensus       284 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~  327 (337)
                      ........+++.+.+||.+||+.||++|||++|+|+||||++.-
T Consensus       224 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~l  267 (271)
T d1nvra_         224 TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL  267 (271)
T ss_dssp             TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred             CCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCcCC
Confidence            23333456799999999999999999999999999999998643

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.8e-62  Score=414.55  Aligned_cols=256  Identities=29%  Similarity=0.440  Sum_probs=222.2

Q ss_pred             CccccccccccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEE
Q 019650           45 NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEIC  122 (337)
Q Consensus        45 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~  122 (337)
                      .+++|++++.||+|+||+||+|.+..+++.||+|++....  .....+.+.+|+.++++++||||+++++++.+ +..+|
T Consensus         4 ~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-~~~~~   82 (263)
T d2j4za1           4 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD-ATRVY   82 (263)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSEEE
T ss_pred             chhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEE-CCEEE
Confidence            3689999999999999999999999999999999986542  22345677899999999999999999999876 78899


Q ss_pred             EEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccC
Q 019650          123 FVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNN  202 (337)
Q Consensus       123 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~  202 (337)
                      +||||+++|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||++......   
T Consensus        83 ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~---  159 (263)
T d2j4za1          83 LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS---  159 (263)
T ss_dssp             EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC---
T ss_pred             EEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCC---
Confidence            99999999999999998899999999999999999999999999999999999999999999999999999755332   


Q ss_pred             CCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhc
Q 019650          203 NNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICF  282 (337)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~  282 (337)
                                   ......||+.|+|||++.    +..++.++|||||||++|+|++|+.||.+.....    ...... 
T Consensus       160 -------------~~~~~~Gt~~Y~APE~~~----~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~----~~~~i~-  217 (263)
T d2j4za1         160 -------------RRTTLCGTLDYLPPEMIE----GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE----TYKRIS-  217 (263)
T ss_dssp             -------------CCEETTEEGGGCCHHHHT----TCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH----HHHHHH-
T ss_pred             -------------cccccCCCCcccCHHHHc----CCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH----HHHHHH-
Confidence                         122346999999999998    5578999999999999999999999996543222    222222 


Q ss_pred             cCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCcccccc
Q 019650          283 GERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKR  326 (337)
Q Consensus       283 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~  326 (337)
                      .....+|..+++.+++||.+||+.||++|||++|+|+||||++.
T Consensus       218 ~~~~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~~  261 (263)
T d2j4za1         218 RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITAN  261 (263)
T ss_dssp             TTCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHHH
T ss_pred             cCCCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCCc
Confidence            23456778889999999999999999999999999999999864

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-60  Score=413.79  Aligned_cols=265  Identities=28%  Similarity=0.457  Sum_probs=224.2

Q ss_pred             ccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 019650           46 ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVM  125 (337)
Q Consensus        46 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~  125 (337)
                      .++|++++.||+|+||+||+|.+..+|+.||+|+++.... ...+.+.+|+.++++++||||+++++++.+ .+.+|+||
T Consensus        19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-~~~~~ivm   96 (293)
T d1yhwa1          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLV-GDELWVVM   96 (293)
T ss_dssp             TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEEE
T ss_pred             ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccC-hHHHHHHHHHHHHHhCCCCCEeeEeEEEEE-CCEEEEEE
Confidence            3589999999999999999999999999999999976532 235678899999999999999999999877 78999999


Q ss_pred             eccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCCC
Q 019650          126 EHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNH  205 (337)
Q Consensus       126 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~  205 (337)
                      ||++||+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||++.......     
T Consensus        97 Ey~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~-----  170 (293)
T d1yhwa1          97 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-----  170 (293)
T ss_dssp             ECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-----
T ss_pred             EecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecccc-----
Confidence            99999999998765 569999999999999999999999999999999999999999999999999998764332     


Q ss_pred             CCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhccCC
Q 019650          206 NNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGER  285 (337)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~  285 (337)
                               ......+||+.|+|||++.    +..++.++|||||||++|+|++|+.||.+............  .....
T Consensus       171 ---------~~~~~~~gt~~Y~aPE~~~----~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~--~~~~~  235 (293)
T d1yhwa1         171 ---------SKRSTMVGTPYWMAPEVVT----RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT--NGTPE  235 (293)
T ss_dssp             ---------CCBCCCCSCGGGCCHHHHS----SSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH--HCSCC
T ss_pred             ---------ccccccccCCCccChhhhc----CCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHh--CCCCC
Confidence                     2223446999999999998    55789999999999999999999999976443332222221  12223


Q ss_pred             CCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCCcccc
Q 019650          286 LEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNIE  333 (337)
Q Consensus       286 ~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~~~~~  333 (337)
                      ...+..+++.+++||.+||+.||.+|||++|+|+||||+.....+.+.
T Consensus       236 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~~~~~~~l~  283 (293)
T d1yhwa1         236 LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLT  283 (293)
T ss_dssp             CSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGGCCCGGGGH
T ss_pred             CCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCCCCCcCC
Confidence            345567899999999999999999999999999999998766555443

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-60  Score=410.84  Aligned_cols=263  Identities=27%  Similarity=0.418  Sum_probs=223.0

Q ss_pred             CccccccccccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEE
Q 019650           45 NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEIC  122 (337)
Q Consensus        45 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~  122 (337)
                      ..++|++++.||+|+||+||+|.+..+++.||+|++....  .....+.+.+|+.++++++||||+++++++.+ +..+|
T Consensus         6 ~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-~~~~~   84 (288)
T d1uu3a_           6 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD-DEKLY   84 (288)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEEC-SSEEE
T ss_pred             CCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEE-CCEEE
Confidence            3578999999999999999999999999999999987542  22345678899999999999999999998876 78899


Q ss_pred             EEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccC
Q 019650          123 FVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNN  202 (337)
Q Consensus       123 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~  202 (337)
                      +||||++||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+||+++.+++++|+|||++.........
T Consensus        85 ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~  164 (288)
T d1uu3a_          85 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ  164 (288)
T ss_dssp             EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred             EEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCcc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999876433211


Q ss_pred             CCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhc
Q 019650          203 NNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICF  282 (337)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~  282 (337)
                                  ......+||+.|+|||++.    +..++.++|||||||++|+|++|..||.+.....    .......
T Consensus       165 ------------~~~~~~~GT~~Y~APE~~~----~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~----~~~~i~~  224 (288)
T d1uu3a_         165 ------------ARANSFVGTAQYVSPELLT----EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL----IFQKIIK  224 (288)
T ss_dssp             -----------------CCCCGGGCCHHHHH----TCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHT
T ss_pred             ------------cccccccCCccccCceeec----cCCCCcccceehhhHHHHHHhhCCCCCCCcCHHH----HHHHHHc
Confidence                        2223446999999999998    5578999999999999999999999997643222    2222222


Q ss_pred             cCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHH------HhcCccccccCCC
Q 019650          283 GERLEMPETASPEFRRFVRSCLEKDWRKRGTVEE------LLAYPFVTKRSSS  329 (337)
Q Consensus       283 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~e------il~hp~f~~~~~~  329 (337)
                       ....++..+++.+++||.+||+.||++|||++|      +++||||++..|.
T Consensus       225 -~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~  276 (288)
T d1uu3a_         225 -LEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWE  276 (288)
T ss_dssp             -TCCCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCT
T ss_pred             -CCCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHH
Confidence             245677889999999999999999999999988      5889999988764

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.3e-59  Score=410.00  Aligned_cols=262  Identities=25%  Similarity=0.386  Sum_probs=206.0

Q ss_pred             CccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 019650           45 NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFV  124 (337)
Q Consensus        45 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv  124 (337)
                      ..+.|++.+.||+|+||+||+|.+..+++.||+|++...........+.+|+.++++++||||+++++++.+ +..+|+|
T Consensus         7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~~~~lv   85 (307)
T d1a06a_           7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYES-GGHLYLI   85 (307)
T ss_dssp             GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEEC-SSEEEEE
T ss_pred             CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-CCEEEEE
Confidence            346799999999999999999999999999999999876544445667899999999999999999998876 7889999


Q ss_pred             EeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEc---CCCcEEEeeccCccchhcccc
Q 019650          125 MEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLIN---GKGEVKIADFGVSRIVEETRN  201 (337)
Q Consensus       125 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~---~~~~~~l~Dfg~~~~~~~~~~  201 (337)
                      |||++||+|.+++...+.+++..+..++.||+.||+|||++||+||||||+||++.   .++.+||+|||++....... 
T Consensus        86 mE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~-  164 (307)
T d1a06a_          86 MQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS-  164 (307)
T ss_dssp             ECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-----------
T ss_pred             EeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCC-
Confidence            99999999999999888999999999999999999999999999999999999995   46899999999997654432 


Q ss_pred             CCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhh
Q 019650          202 NNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAIC  281 (337)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~  281 (337)
                                    .....+||+.|+|||++.    +..++.++|||||||++|+|++|+.||.+....... .......
T Consensus       165 --------------~~~~~~GT~~y~APE~~~----~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~-~~i~~~~  225 (307)
T d1a06a_         165 --------------VLSTACGTPGYVAPEVLA----QKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLF-EQILKAE  225 (307)
T ss_dssp             ----------------------CTTSCHHHHT----TCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-HHHHTTC
T ss_pred             --------------eeeeeeeCccccCcHHHc----CCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHH-HHHhccC
Confidence                          223346999999999998    557899999999999999999999999764332222 2222212


Q ss_pred             ccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccC
Q 019650          282 FGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRS  327 (337)
Q Consensus       282 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~  327 (337)
                      .......+..+++.+.+||.+||..||++|||++|+|+||||++..
T Consensus       226 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~  271 (307)
T d1a06a_         226 YEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDT  271 (307)
T ss_dssp             CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSSC
T ss_pred             CCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence            2222334467899999999999999999999999999999998644

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-59  Score=405.14  Aligned_cols=264  Identities=32%  Similarity=0.446  Sum_probs=222.3

Q ss_pred             ccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 019650           46 ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVM  125 (337)
Q Consensus        46 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~  125 (337)
                      .+.|++++.||+|+||+||+|.+..++..||+|++.... ....+.+.+|+.++++++||||+++++++.+ .+.+++||
T Consensus        11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-~~~~~lvm   88 (288)
T d2jfla1          11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS-EEELEDYMVEIDILASCDHPNIVKLLDAFYY-ENNLWILI   88 (288)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS-SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEEE
T ss_pred             ccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEee-CCeEEEEE
Confidence            467999999999999999999999999999999997654 3345678899999999999999999999877 78999999


Q ss_pred             eccCCCCchHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCC
Q 019650          126 EHMERGSLFDSLRV-RKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNN  204 (337)
Q Consensus       126 e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~  204 (337)
                      ||++||+|.+++.+ ...+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||++.......    
T Consensus        89 Ey~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~----  164 (288)
T d2jfla1          89 EFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI----  164 (288)
T ss_dssp             ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH----
T ss_pred             ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCc----
Confidence            99999999999765 4579999999999999999999999999999999999999999999999999987664432    


Q ss_pred             CCCCCCCccccccccccCCCCCcCCcccccccC-CCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhcc
Q 019650          205 HNNNNNNNIGEAAIACMGTCAYMSPERVDSERW-GGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFG  283 (337)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~  283 (337)
                                .......||+.|+|||++..... +..|+.++|||||||++|+|++|+.||.+....+........  ..
T Consensus       165 ----------~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~--~~  232 (288)
T d2jfla1         165 ----------QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKS--EP  232 (288)
T ss_dssp             ----------HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHS--CC
T ss_pred             ----------ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC--CC
Confidence                      12223469999999999854321 356889999999999999999999999776554443333221  11


Q ss_pred             CCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccC
Q 019650          284 ERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRS  327 (337)
Q Consensus       284 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~  327 (337)
                      .....+..+++.+++||.+||+.||++|||++|+|+||||+...
T Consensus       233 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~~~  276 (288)
T d2jfla1         233 PTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDS  276 (288)
T ss_dssp             CCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCCCC
T ss_pred             CCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence            12334567899999999999999999999999999999998654

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-59  Score=402.47  Aligned_cols=256  Identities=29%  Similarity=0.435  Sum_probs=210.9

Q ss_pred             ccccccccccccCcceEEEEEEEccCCceEEEEEeecCC-chHhHHHHHHHHHHHHhcCCCCceeeeeeEEee-CCeEEE
Q 019650           46 ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTI-EGEICF  123 (337)
Q Consensus        46 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-~~~~~l  123 (337)
                      .++|++++.||+|+||+||+|.+..+++.||+|.+.... .+...+.+.+|+.++++++||||+++++++.+. ...+|+
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i   82 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   82 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred             chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence            578999999999999999999999999999999997654 445567788999999999999999999988753 456899


Q ss_pred             EEeccCCCCchHHhhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC-----ceeccCCCCCeEEcCCCcEEEeeccCcc
Q 019650          124 VMEHMERGSLFDSLRV----RKKLSEDVISGVAYRVLKGLQYLHGMQ-----IIHGDIKPSNLLINGKGEVKIADFGVSR  194 (337)
Q Consensus       124 v~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~~~-----ivH~dl~~~Nili~~~~~~~l~Dfg~~~  194 (337)
                      ||||++||+|.+++..    ...+++..++.++.||+.||.|||++|     |+||||||+|||++.++++||+|||++.
T Consensus        83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~  162 (269)
T d2java1          83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  162 (269)
T ss_dssp             EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred             EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence            9999999999999864    357999999999999999999999876     9999999999999999999999999998


Q ss_pred             chhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHH
Q 019650          195 IVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLM  274 (337)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~  274 (337)
                      ......              ......+||+.|+|||++.    +..++.++||||||+++|+|+||+.||.+...    .
T Consensus       163 ~~~~~~--------------~~~~~~~gt~~Y~APE~l~----~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~----~  220 (269)
T d2java1         163 ILNHDT--------------SFAKAFVGTPYYMSPEQMN----RMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ----K  220 (269)
T ss_dssp             HC-------------------------CCCSCCCHHHHT----TCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH----H
T ss_pred             ecccCC--------------CccccCCCCcccCCHHHHc----CCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH----H
Confidence            765432              1223346899999999998    45789999999999999999999999975432    2


Q ss_pred             HHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccc
Q 019650          275 ALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV  323 (337)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f  323 (337)
                      ........+.....+..+++.+.+||.+||+.||.+|||++|+|+|||+
T Consensus       221 ~~~~~i~~~~~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         221 ELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             HHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             HHHHHHHcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence            3333444455566778899999999999999999999999999999996

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-59  Score=413.72  Aligned_cols=262  Identities=37%  Similarity=0.651  Sum_probs=221.8

Q ss_pred             CccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 019650           45 NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFV  124 (337)
Q Consensus        45 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv  124 (337)
                      ..++|++++.||+|+||+||+|.+..+++.||+|+++........+.+.+|+.++++++||||+++++++.+ ...+|+|
T Consensus         4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~~~~iV   82 (322)
T d1s9ja_           4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-DGEISIC   82 (322)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEEC-SSEEEEE
T ss_pred             CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-CCEEEEE
Confidence            467999999999999999999999999999999999876666667788999999999999999999999877 7889999


Q ss_pred             EeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCC
Q 019650          125 MEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG-MQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNN  203 (337)
Q Consensus       125 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~-~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~  203 (337)
                      |||++||+|.+++.+.+.+++..++.++.||+.||.|||+ +||+||||||+|||++.++++||+|||++.......   
T Consensus        83 mEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~---  159 (322)
T d1s9ja_          83 MEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---  159 (322)
T ss_dssp             EECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT---
T ss_pred             EEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCCc---
Confidence            9999999999999988899999999999999999999997 599999999999999999999999999998765432   


Q ss_pred             CCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHH--------
Q 019650          204 NHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMA--------  275 (337)
Q Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~--------  275 (337)
                                   ....+||+.|+|||++.    +..|+.++||||+||++|||++|+.||.+.........        
T Consensus       160 -------------~~~~~GT~~Y~APEvl~----~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~  222 (322)
T d1s9ja_         160 -------------ANSFVGTRSYMSPERLQ----GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGD  222 (322)
T ss_dssp             -------------C---CCSSCCCCHHHHH----CSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------
T ss_pred             -------------cccccCCccccCchHHc----CCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCC
Confidence                         12347999999999998    56789999999999999999999999976443221110        


Q ss_pred             ------------------------------HHHHhhccCCCCCC-CCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCcccc
Q 019650          276 ------------------------------LICAICFGERLEMP-ETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVT  324 (337)
Q Consensus       276 ------------------------------~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~  324 (337)
                                                    .........++..+ ...+..+.+||.+||..||.+|||++|+|+||||+
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~  302 (322)
T d1s9ja_         223 AAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIK  302 (322)
T ss_dssp             -----------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred             cccCCcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhC
Confidence                                          11111111112222 23578999999999999999999999999999998


Q ss_pred             ccC
Q 019650          325 KRS  327 (337)
Q Consensus       325 ~~~  327 (337)
                      +..
T Consensus       303 ~~~  305 (322)
T d1s9ja_         303 RSD  305 (322)
T ss_dssp             HHH
T ss_pred             cCC
Confidence            754

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-59  Score=398.28  Aligned_cols=252  Identities=28%  Similarity=0.425  Sum_probs=213.7

Q ss_pred             cccccccccCcceEEEEEEEccCCceEEEEEeecCC-chHhHHHHHHHHHHHHhcCCCCceeeeeeEEee---CCeEEEE
Q 019650           49 LKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTI---EGEICFV  124 (337)
Q Consensus        49 y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~---~~~~~lv  124 (337)
                      |++.+.||+|+||+||+|.+..++..||+|.+.... .....+.+.+|++++++++||||+++++++.+.   +..+|+|
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv   90 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV   90 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence            367778999999999999999999999999987653 444567788999999999999999999988653   3468999


Q ss_pred             EeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCCeEEc-CCCcEEEeeccCccchhcccc
Q 019650          125 MEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQ--IIHGDIKPSNLLIN-GKGEVKIADFGVSRIVEETRN  201 (337)
Q Consensus       125 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~--ivH~dl~~~Nili~-~~~~~~l~Dfg~~~~~~~~~~  201 (337)
                      |||+++|+|.+++.+...+++..++.++.||+.||+|||++|  |+||||||+|||++ +++.+||+|||++.....   
T Consensus        91 mE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~---  167 (270)
T d1t4ha_          91 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA---  167 (270)
T ss_dssp             EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT---
T ss_pred             EeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC---
Confidence            999999999999998899999999999999999999999998  99999999999996 478999999999975432   


Q ss_pred             CCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhh
Q 019650          202 NNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAIC  281 (337)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~  281 (337)
                                   ......+||+.|+|||++.     ..++.++|||||||++|+|++|+.||....+......   ...
T Consensus       168 -------------~~~~~~~GT~~Y~aPE~~~-----~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~---~i~  226 (270)
T d1t4ha_         168 -------------SFAKAVIGTPEFMAPEMYE-----EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYR---RVT  226 (270)
T ss_dssp             -------------TSBEESCSSCCCCCGGGGG-----TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHH---HHT
T ss_pred             -------------CccCCcccCccccCHHHhC-----CCCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHH---HHH
Confidence                         1223446999999999986     2589999999999999999999999976544333322   222


Q ss_pred             cc-CCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCcccc
Q 019650          282 FG-ERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVT  324 (337)
Q Consensus       282 ~~-~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~  324 (337)
                      .+ .+..++...++.+.++|.+||+.||++|||++|+|+||||+
T Consensus       227 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         227 SGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             TTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             cCCCCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence            22 22344566789999999999999999999999999999996

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-59  Score=410.70  Aligned_cols=260  Identities=29%  Similarity=0.478  Sum_probs=226.1

Q ss_pred             CccccccccccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEE
Q 019650           45 NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEIC  122 (337)
Q Consensus        45 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~  122 (337)
                      ++++|++++.||+|+||+||+|.+..+++.||+|+++...  .....+.+.+|+.++++++||||+++++++.+ ...+|
T Consensus         3 ~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-~~~~~   81 (337)
T d1o6la_           3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT-HDRLC   81 (337)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC-SSEEE
T ss_pred             chHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecc-ccccc
Confidence            5789999999999999999999999999999999997543  22345678899999999999999999999877 78999


Q ss_pred             EEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccC
Q 019650          123 FVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNN  202 (337)
Q Consensus       123 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~  202 (337)
                      +||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||++.......  
T Consensus        82 iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~--  159 (337)
T d1o6la_          82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--  159 (337)
T ss_dssp             EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT--
T ss_pred             cceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCC--
Confidence            999999999999999999999999999999999999999999999999999999999999999999999997654322  


Q ss_pred             CCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhc
Q 019650          203 NNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICF  282 (337)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~  282 (337)
                                  ......+||+.|+|||++.    +..|+.++|||||||++|+|++|+.||.+.....    +..... 
T Consensus       160 ------------~~~~~~~GT~~Y~aPE~~~----~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~----~~~~i~-  218 (337)
T d1o6la_         160 ------------ATMKTFCGTPEYLAPEVLE----DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER----LFELIL-  218 (337)
T ss_dssp             ------------CCBCCCEECGGGCCGGGGS----SSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHH-
T ss_pred             ------------cccccceeCHHHhhhhhcc----CCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH----HHHHHh-
Confidence                        2233457999999999998    5578999999999999999999999997643322    222222 


Q ss_pred             cCCCCCCCCCCHHHHHHHHHHhhcCcCCCCC-----HHHHhcCccccccCC
Q 019650          283 GERLEMPETASPEFRRFVRSCLEKDWRKRGT-----VEELLAYPFVTKRSS  328 (337)
Q Consensus       283 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s-----~~eil~hp~f~~~~~  328 (337)
                      .....+|..+++.+++||.+||+.||.+|++     ++++++||||++..+
T Consensus       219 ~~~~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~  269 (337)
T d1o6la_         219 MEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW  269 (337)
T ss_dssp             HCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred             cCCCCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccCCH
Confidence            2356778889999999999999999999994     899999999988654

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.5e-59  Score=408.29  Aligned_cols=262  Identities=29%  Similarity=0.393  Sum_probs=222.0

Q ss_pred             cccccccccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 019650           47 SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFV  124 (337)
Q Consensus        47 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv  124 (337)
                      +.|++++.||+|+||+||+|.+..+++.||+|+++...  .....+.+.+|+.++++++||||+++++++.+ ...+|+|
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-~~~~~iv   93 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-EHTAWLV   93 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-TTEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEE-CCEEEEE
Confidence            46999999999999999999999999999999997654  34455678899999999999999999999877 7899999


Q ss_pred             EeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCC
Q 019650          125 MEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNN  204 (337)
Q Consensus       125 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~  204 (337)
                      |||+.+|+|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||++......     
T Consensus        94 ~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~-----  168 (309)
T d1u5ra_          94 MEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-----  168 (309)
T ss_dssp             EECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-----
T ss_pred             EEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCCC-----
Confidence            999999999888888889999999999999999999999999999999999999999999999999999765332     


Q ss_pred             CCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhccC
Q 019650          205 HNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGE  284 (337)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~  284 (337)
                                   ....||+.|+|||++.... ...|+.++|||||||++|+|++|..||.+..........   .....
T Consensus       169 -------------~~~~GT~~Y~APE~~~~~~-~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i---~~~~~  231 (309)
T d1u5ra_         169 -------------NSFVGTPYWMAPEVILAMD-EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI---AQNES  231 (309)
T ss_dssp             -------------CCCCSCGGGCCHHHHTTTT-SCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH---HHSCC
T ss_pred             -------------CccccCccccCHHHHhccC-CCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHH---HhCCC
Confidence                         1235999999999996432 246889999999999999999999999764433222222   22222


Q ss_pred             CCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCCcc
Q 019650          285 RLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSN  331 (337)
Q Consensus       285 ~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~~~  331 (337)
                      +...+..+++.+.+||.+||+.||.+|||++|+|+||||.+....+.
T Consensus       232 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~~~~~~  278 (309)
T d1u5ra_         232 PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTV  278 (309)
T ss_dssp             CCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCCCTTH
T ss_pred             CCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcCCCCchh
Confidence            23334567999999999999999999999999999999987665543

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.8e-58  Score=404.29  Aligned_cols=258  Identities=27%  Similarity=0.445  Sum_probs=224.5

Q ss_pred             CccccccccccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEE
Q 019650           45 NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEIC  122 (337)
Q Consensus        45 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~  122 (337)
                      ++++|++++.||+|+||+||+|.+..+|+.||+|+++...  .....+.+.+|+.++++++||||+++++++.+ ...+|
T Consensus         2 sl~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-~~~~~   80 (316)
T d1fota_           2 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD-AQQIF   80 (316)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC-SSEEE
T ss_pred             chhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEee-CCeee
Confidence            4689999999999999999999999999999999997542  22345678899999999999999999999876 78999


Q ss_pred             EEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccC
Q 019650          123 FVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNN  202 (337)
Q Consensus       123 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~  202 (337)
                      +||||++||+|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||++.......  
T Consensus        81 ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~--  158 (316)
T d1fota_          81 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT--  158 (316)
T ss_dssp             EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB--
T ss_pred             eEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEecccc--
Confidence            999999999999999999999999999999999999999999999999999999999999999999999998764321  


Q ss_pred             CCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhc
Q 019650          203 NNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICF  282 (337)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~  282 (337)
                                     ...+||+.|+|||++.    +..|+.++|||||||++|+|++|+.||.+....+.    ......
T Consensus       159 ---------------~~~~Gt~~Y~APE~l~----~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~----~~~i~~  215 (316)
T d1fota_         159 ---------------YTLCGTPDYIAPEVVS----TKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT----YEKILN  215 (316)
T ss_dssp             ---------------CCCCSCTTTCCHHHHT----TCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH----HHHHHH
T ss_pred             ---------------ccccCcccccCHHHHc----CCCCCchhhccccchhHHHHHhCCCCCCCcCHHHH----HHHHHc
Confidence                           2346999999999998    45788999999999999999999999976433222    222222


Q ss_pred             cCCCCCCCCCCHHHHHHHHHHhhcCcCCCC-----CHHHHhcCccccccCCC
Q 019650          283 GERLEMPETASPEFRRFVRSCLEKDWRKRG-----TVEELLAYPFVTKRSSS  329 (337)
Q Consensus       283 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~-----s~~eil~hp~f~~~~~~  329 (337)
                      + ...++..+++.+.+++.+||..||.+|+     |++++++||||++..|.
T Consensus       216 ~-~~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~~  266 (316)
T d1fota_         216 A-ELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWE  266 (316)
T ss_dssp             C-CCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHH
T ss_pred             C-CCCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccCCHH
Confidence            2 4566778899999999999999999996     99999999999987543

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-58  Score=402.09  Aligned_cols=267  Identities=26%  Similarity=0.459  Sum_probs=219.3

Q ss_pred             ccccccccccccCcceEEEEEEEccCCceEEEEEeecCC-----chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCe
Q 019650           46 ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-----STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGE  120 (337)
Q Consensus        46 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~  120 (337)
                      -++|++++.||+|+||+||+|.+..+|+.||+|+++...     .....+.+.+|+.++++++||||+++++++.+ ...
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-~~~   87 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN-KTD   87 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-CCE
Confidence            367999999999999999999999999999999997543     22245778899999999999999999999876 789


Q ss_pred             EEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCC----cEEEeeccCccch
Q 019650          121 ICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKG----EVKIADFGVSRIV  196 (337)
Q Consensus       121 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~----~~~l~Dfg~~~~~  196 (337)
                      +|+||||++||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+||+++.++    ++|++|||++...
T Consensus        88 ~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~  167 (293)
T d1jksa_          88 VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI  167 (293)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred             EEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhc
Confidence            999999999999999999888999999999999999999999999999999999999998776    5999999999876


Q ss_pred             hccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHH
Q 019650          197 EETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMAL  276 (337)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~  276 (337)
                      ....               ......+++.|+|||++.    +..++.++|||||||++|+|++|+.||.+....+.....
T Consensus       168 ~~~~---------------~~~~~~~t~~y~APE~~~----~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i  228 (293)
T d1jksa_         168 DFGN---------------EFKNIFGTPEFVAPEIVN----YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV  228 (293)
T ss_dssp             TTSC---------------BCSCCCCCGGGCCHHHHT----TCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             CCCc---------------cccccCCCCcccCHHHHc----CCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence            5432               122335899999999998    457899999999999999999999999764333222222


Q ss_pred             HHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCCcccc
Q 019650          277 ICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNIE  333 (337)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~~~~~  333 (337)
                       ...........+..++..+++||.+||+.||++|||++|+|+||||++..+...+.
T Consensus       229 -~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~~~l~  284 (293)
T d1jksa_         229 -SAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALS  284 (293)
T ss_dssp             -HTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC--------
T ss_pred             -HhcCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCChhHhhc
Confidence             11111112223357899999999999999999999999999999999877655443

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=8.1e-58  Score=405.22  Aligned_cols=264  Identities=25%  Similarity=0.393  Sum_probs=222.0

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEE
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICF  123 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~l  123 (337)
                      ...++|++++.||+|+||+||+|.+..+|+.||+|++.... ....+.+.+|+.++++++||||+++++++.+ ++.+|+
T Consensus        23 ~il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-~~~~~i  100 (350)
T d1koaa2          23 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH-ESDKETVRKEIQTMSVLRHPTLVNLHDAFED-DNEMVM  100 (350)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS-HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEE-TTEEEE
T ss_pred             CCccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc-hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEE-CCEEEE
Confidence            35789999999999999999999999999999999997654 3345778899999999999999999998876 789999


Q ss_pred             EEeccCCCCchHHhh-hcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcC--CCcEEEeeccCccchhccc
Q 019650          124 VMEHMERGSLFDSLR-VRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLING--KGEVKIADFGVSRIVEETR  200 (337)
Q Consensus       124 v~e~~~~~~L~~~l~-~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~--~~~~~l~Dfg~~~~~~~~~  200 (337)
                      ||||++||+|.+++. ..+.+++..++.++.||+.||.|||++||+||||||+|||++.  ++.+||+|||++...... 
T Consensus       101 vmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~-  179 (350)
T d1koaa2         101 IYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-  179 (350)
T ss_dssp             EECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT-
T ss_pred             EEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccc-
Confidence            999999999999985 4567999999999999999999999999999999999999964  578999999999876433 


Q ss_pred             cCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHh
Q 019650          201 NNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAI  280 (337)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~  280 (337)
                                    .......||+.|+|||++.    +..++.++|||||||++|+|++|+.||.+....+....+ ...
T Consensus       180 --------------~~~~~~~gT~~Y~aPEv~~----~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i-~~~  240 (350)
T d1koaa2         180 --------------QSVKVTTGTAEFAAPEVAE----GKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNV-KSC  240 (350)
T ss_dssp             --------------SCEEEECSCTTTCCHHHHH----TCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-HHT
T ss_pred             --------------cccceecCcccccCHHHHc----CCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHH-HhC
Confidence                          2223346899999999998    557889999999999999999999999764333222222 221


Q ss_pred             hccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCC
Q 019650          281 CFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSS  329 (337)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~  329 (337)
                      ...........+++.+++||.+||..||++|||++|+|+||||++....
T Consensus       241 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~~  289 (350)
T d1koaa2         241 DWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAP  289 (350)
T ss_dssp             CCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTCC
T ss_pred             CCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCCC
Confidence            1222223335679999999999999999999999999999999976543

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1e-57  Score=404.90  Aligned_cols=262  Identities=26%  Similarity=0.429  Sum_probs=221.7

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEE
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICF  123 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~l  123 (337)
                      ...++|++++.||+|+||+||+|.+..+++.||+|+++.... .....+.+|+.++++++||||+++++++.+ +..+|+
T Consensus        26 ~~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-~~~~~i  103 (352)
T d1koba_          26 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP-LDKYTVKNEISIMNQLHHPKLINLHDAFED-KYEMVL  103 (352)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH-HHHHHHHHHHHHHTTCCSTTBCCEEEEEEC-SSEEEE
T ss_pred             CcccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcch-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-CCEEEE
Confidence            345789999999999999999999999999999999986543 345677899999999999999999998876 789999


Q ss_pred             EEeccCCCCchHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEc--CCCcEEEeeccCccchhccc
Q 019650          124 VMEHMERGSLFDSLRVR-KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLIN--GKGEVKIADFGVSRIVEETR  200 (337)
Q Consensus       124 v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~--~~~~~~l~Dfg~~~~~~~~~  200 (337)
                      ||||++||+|.+++... .++++.+++.++.||+.||.|||++||+||||||+|||++  .++++||+|||++...... 
T Consensus       104 vmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~-  182 (352)
T d1koba_         104 ILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-  182 (352)
T ss_dssp             EEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT-
T ss_pred             EEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCC-
Confidence            99999999999887654 4699999999999999999999999999999999999997  5689999999999876543 


Q ss_pred             cCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHh
Q 019650          201 NNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAI  280 (337)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~  280 (337)
                                    .......|++.|+|||++.    +..++.++|||||||++|+|+||..||.+......... +...
T Consensus       183 --------------~~~~~~~gt~~y~aPE~~~----~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~-i~~~  243 (352)
T d1koba_         183 --------------EIVKVTTATAEFAAPEIVD----REPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQN-VKRC  243 (352)
T ss_dssp             --------------SCEEEECSSGGGCCHHHHT----TCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHH-HHHC
T ss_pred             --------------CceeeccCcccccCHHHHc----CCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHhC
Confidence                          2223346899999999998    55789999999999999999999999976443332222 2222


Q ss_pred             hccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccC
Q 019650          281 CFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRS  327 (337)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~  327 (337)
                      ....+...+..+++.+.+||.+||..||.+|||++|+|+||||++.+
T Consensus       244 ~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~  290 (352)
T d1koba_         244 DWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH  290 (352)
T ss_dssp             CCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred             CCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCc
Confidence            22223344567899999999999999999999999999999998765

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.4e-57  Score=403.98  Aligned_cols=258  Identities=26%  Similarity=0.441  Sum_probs=223.5

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeE
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEI  121 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~  121 (337)
                      ..+++|++++.||+|+||+||+|.+..+|+.||+|++....  .....+.+.+|+.+++.++||||+++++++.+ ....
T Consensus        38 ~~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-~~~~  116 (350)
T d1rdqe_          38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD-NSNL  116 (350)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEE
T ss_pred             CCccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccc-cccc
Confidence            34689999999999999999999999999999999986542  22345678899999999999999999998876 7889


Q ss_pred             EEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhcccc
Q 019650          122 CFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRN  201 (337)
Q Consensus       122 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~  201 (337)
                      ++||||+.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||++....... 
T Consensus       117 ~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~-  195 (350)
T d1rdqe_         117 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-  195 (350)
T ss_dssp             EEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB-
T ss_pred             ccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeeccccc-
Confidence            9999999999999999988999999999999999999999999999999999999999999999999999998764321 


Q ss_pred             CCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhh
Q 019650          202 NNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAIC  281 (337)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~  281 (337)
                                      ....||+.|+|||++.    +..++.++|||||||++|+|+||+.||.+.....    ......
T Consensus       196 ----------------~~~~Gt~~Y~APE~~~----~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~----~~~~i~  251 (350)
T d1rdqe_         196 ----------------WTLCGTPEALAPEIIL----SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ----IYEKIV  251 (350)
T ss_dssp             ----------------CCCEECGGGCCHHHHT----TCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHH
T ss_pred             ----------------ccccCccccCCHHHHc----CCCCCccccccchhHHHHHHHhCCCCCCCcCHHH----HHHHHh
Confidence                            2336999999999998    5578899999999999999999999997643222    222222


Q ss_pred             ccCCCCCCCCCCHHHHHHHHHHhhcCcCCCC-----CHHHHhcCccccccCC
Q 019650          282 FGERLEMPETASPEFRRFVRSCLEKDWRKRG-----TVEELLAYPFVTKRSS  328 (337)
Q Consensus       282 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~-----s~~eil~hp~f~~~~~  328 (337)
                      . ....++..+++.+.++|.+||..||.+|+     |++++++||||++..+
T Consensus       252 ~-~~~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~  302 (350)
T d1rdqe_         252 S-GKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW  302 (350)
T ss_dssp             H-CCCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCH
T ss_pred             c-CCCCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCCH
Confidence            2 24566778899999999999999999994     9999999999998754

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=2.2e-57  Score=404.78  Aligned_cols=262  Identities=26%  Similarity=0.454  Sum_probs=220.3

Q ss_pred             CccccccccccccCcceEEEEEEEccCCceEEEEEeecCC-----chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCC
Q 019650           45 NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-----STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEG  119 (337)
Q Consensus        45 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~  119 (337)
                      ++++|++++.||+|+||+||+|.+..+|+.||+|++....     ..........++.+++.++||||+++++++.+ ..
T Consensus         2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~-~~   80 (364)
T d1omwa3           2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT-PD   80 (364)
T ss_dssp             CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC-SS
T ss_pred             CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEE-CC
Confidence            5789999999999999999999999999999999986432     11112222345677777899999999998876 68


Q ss_pred             eEEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhcc
Q 019650          120 EICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEET  199 (337)
Q Consensus       120 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~  199 (337)
                      .+|+||||++||+|.+++.....+++..++.++.||+.||.|||++|++||||||+|||++.+|.+||+|||++......
T Consensus        81 ~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~  160 (364)
T d1omwa3          81 KLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK  160 (364)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS
T ss_pred             EEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCC
Confidence            89999999999999999999999999999999999999999999999999999999999999999999999999866443


Q ss_pred             ccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHH
Q 019650          200 RNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICA  279 (337)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~  279 (337)
                      .                .....||+.|+|||++..   +..|+.++|||||||++|+|+||+.||....... ... ...
T Consensus       161 ~----------------~~~~~GT~~y~APE~~~~---~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~-~~~-~~~  219 (364)
T d1omwa3         161 K----------------PHASVGTHGYMAPEVLQK---GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-KHE-IDR  219 (364)
T ss_dssp             C----------------CCSCCSCGGGCCHHHHST---TCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSC-HHH-HHH
T ss_pred             c----------------ccccccccccchhHHhhc---CCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHH-HHH-HHH
Confidence            2                123369999999999974   3468899999999999999999999997644332 222 223


Q ss_pred             hhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCC-----HHHHhcCccccccCC
Q 019650          280 ICFGERLEMPETASPEFRRFVRSCLEKDWRKRGT-----VEELLAYPFVTKRSS  328 (337)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s-----~~eil~hp~f~~~~~  328 (337)
                      .........+..+++.+.+||.+||..||.+|||     ++++++||||++..|
T Consensus       220 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~  273 (364)
T d1omwa3         220 MTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDW  273 (364)
T ss_dssp             HSSSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCH
T ss_pred             hcccCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCCH
Confidence            3344456667789999999999999999999999     799999999998654

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-57  Score=397.96  Aligned_cols=258  Identities=26%  Similarity=0.415  Sum_probs=219.4

Q ss_pred             ccccccccccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHH-hcCCCCceeeeeeEEeeCCeEE
Q 019650           46 ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILK-RLDSQFIVKCHAVFYTIEGEIC  122 (337)
Q Consensus        46 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~-~l~~~~i~~~~~~~~~~~~~~~  122 (337)
                      +++|++++.||+|+||+||+|.+..+++.||+|+++...  .....+.+..|..++. .++||||+++++++.+ +..+|
T Consensus         1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~-~~~~y   79 (320)
T d1xjda_           1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT-KENLF   79 (320)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC-SSEEE
T ss_pred             CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEcc-CCcee
Confidence            478999999999999999999999999999999997542  1223345556666654 6899999999999877 78899


Q ss_pred             EEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccC
Q 019650          123 FVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNN  202 (337)
Q Consensus       123 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~  202 (337)
                      +||||++||+|.+++.....+++..++.++.||+.||.|||++|++||||||+|||++.+++++|+|||.+.......  
T Consensus        80 ivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~--  157 (320)
T d1xjda_          80 FVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD--  157 (320)
T ss_dssp             EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT--
T ss_pred             EEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhccccc--
Confidence            999999999999999999999999999999999999999999999999999999999999999999999997654332  


Q ss_pred             CCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhc
Q 019650          203 NNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICF  282 (337)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~  282 (337)
                                  .......||+.|+|||++.    +..++.++|||||||++|+|++|+.||.+.....    +......
T Consensus       158 ------------~~~~~~~gt~~y~aPE~~~----~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~----~~~~i~~  217 (320)
T d1xjda_         158 ------------AKTNTFCGTPDYIAPEILL----GQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE----LFHSIRM  217 (320)
T ss_dssp             ------------CCBCCCCSCGGGCCHHHHT----TCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHH
T ss_pred             ------------ccccccCCCCCcCCHHHHc----CCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH----HHHHHHc
Confidence                        2222346999999999998    5678999999999999999999999997643322    2222222


Q ss_pred             cCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHH-HHhcCccccccC
Q 019650          283 GERLEMPETASPEFRRFVRSCLEKDWRKRGTVE-ELLAYPFVTKRS  327 (337)
Q Consensus       283 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~-eil~hp~f~~~~  327 (337)
                       ..+.++..+++.+.+||.+||..||.+|||++ ++++||||++..
T Consensus       218 -~~~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~~  262 (320)
T d1xjda_         218 -DNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN  262 (320)
T ss_dssp             -CCCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCC
T ss_pred             -CCCCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccCC
Confidence             24567788899999999999999999999996 899999998754

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=8.2e-57  Score=386.60  Aligned_cols=263  Identities=26%  Similarity=0.406  Sum_probs=220.4

Q ss_pred             ccccccccccccCcceEEEEEEEccCCceEEEEEeecCCc--------hHhHHHHHHHHHHHHhcC-CCCceeeeeeEEe
Q 019650           46 ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSS--------TIIRHQAAHEAEILKRLD-SQFIVKCHAVFYT  116 (337)
Q Consensus        46 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~  116 (337)
                      .++|++.+.||+|+||+||+|.+..+++.||+|++.....        ....+.+.+|+.++++++ ||||+++++++.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            4789999999999999999999999999999999976531        223456788999999997 9999999999876


Q ss_pred             eCCeEEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccch
Q 019650          117 IEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIV  196 (337)
Q Consensus       117 ~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~  196 (337)
                       +..+|+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++...
T Consensus        82 -~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~  160 (277)
T d1phka_          82 -NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL  160 (277)
T ss_dssp             -SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             -CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEc
Confidence             7899999999999999999998899999999999999999999999999999999999999999999999999999876


Q ss_pred             hccccCCCCCCCCCCccccccccccCCCCCcCCcccccccC--CCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHH
Q 019650          197 EETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERW--GGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLM  274 (337)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~  274 (337)
                      ....               .....+||+.|+|||.+.....  ...++.++||||+|+++|+|++|+.||.+........
T Consensus       161 ~~~~---------------~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~  225 (277)
T d1phka_         161 DPGE---------------KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLR  225 (277)
T ss_dssp             CTTC---------------CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred             cCCC---------------ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHH
Confidence            5432               1223468999999999864321  2356889999999999999999999997654332222


Q ss_pred             HHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccc
Q 019650          275 ALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTK  325 (337)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~  325 (337)
                      ... .............+++.+++|+.+||+.||.+|||++|+|+||||++
T Consensus       226 ~i~-~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~  275 (277)
T d1phka_         226 MIM-SGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ  275 (277)
T ss_dssp             HHH-HTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred             HHH-hCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence            222 21112222334478999999999999999999999999999999975

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-56  Score=393.04  Aligned_cols=259  Identities=24%  Similarity=0.339  Sum_probs=217.3

Q ss_pred             CccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 019650           45 NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFV  124 (337)
Q Consensus        45 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv  124 (337)
                      ..++|++++.||+|+||+||+|.+..+++.||+|+++....  ....+.+|+.++++++||||+++++++.+ +..+|+|
T Consensus         3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~--~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-~~~~~lv   79 (321)
T d1tkia_           3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT--DQVLVKKEISILNIARHRNILHLHESFES-MEELVMI   79 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH--HHHHHHHHHHHHHHSCCTTBCCEEEEEEE-TTEEEEE
T ss_pred             CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc--cHHHHHHHHHHHHhCCCCCCCeEEEEEEE-CCEEEEE
Confidence            46889999999999999999999999999999999976542  34567799999999999999999998876 7899999


Q ss_pred             EeccCCCCchHHhhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCC--CcEEEeeccCccchhcccc
Q 019650          125 MEHMERGSLFDSLRVRK-KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGK--GEVKIADFGVSRIVEETRN  201 (337)
Q Consensus       125 ~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~--~~~~l~Dfg~~~~~~~~~~  201 (337)
                      |||++||+|.+++...+ .+++.+++.++.||+.||.|||++||+||||||+||+++.+  ++++|+|||++......  
T Consensus        80 mE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~--  157 (321)
T d1tkia_          80 FEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG--  157 (321)
T ss_dssp             ECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT--
T ss_pred             EecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccC--
Confidence            99999999999998665 79999999999999999999999999999999999999854  48999999998765432  


Q ss_pred             CCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhh
Q 019650          202 NNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAIC  281 (337)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~  281 (337)
                                   .......+++.|+|||.+.    +..++.++|||||||++|+|++|..||...........+... .
T Consensus       158 -------------~~~~~~~~t~~y~ape~~~----~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~-~  219 (321)
T d1tkia_         158 -------------DNFRLLFTAPEYYAPEVHQ----HDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNA-E  219 (321)
T ss_dssp             -------------CEEEEEESCGGGSCHHHHT----TCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT-C
T ss_pred             -------------Ccccccccccccccchhcc----CCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-C
Confidence                         2223346899999999998    457889999999999999999999999765433322222211 1


Q ss_pred             ccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCcccccc
Q 019650          282 FGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKR  326 (337)
Q Consensus       282 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~  326 (337)
                      ...+...+..+++.+++||.+||..||.+|||++|+|+||||++.
T Consensus       220 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~  264 (321)
T d1tkia_         220 YTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred             CCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence            111112234679999999999999999999999999999999764

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-56  Score=388.26  Aligned_cols=262  Identities=25%  Similarity=0.354  Sum_probs=211.5

Q ss_pred             cccccccCcceEEEEEEEccCCceEEEEEeecCCch----HhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEe
Q 019650           51 KLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSST----IIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVME  126 (337)
Q Consensus        51 ~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~e  126 (337)
                      .+++||+|+||+||+|.+..+++.||+|+++.....    ...+.+.+|+.++++++||||+++++++.. +.++|+|||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~-~~~~~ivmE   80 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH-KSNISLVFD   80 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC-TTCCEEEEE
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCceeehhh
Confidence            568999999999999999999999999998654322    223467889999999999999999998876 788999999


Q ss_pred             ccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCCCC
Q 019650          127 HMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHN  206 (337)
Q Consensus       127 ~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~  206 (337)
                      |+.++++..+......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......      
T Consensus        81 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~------  154 (299)
T d1ua2a_          81 FMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN------  154 (299)
T ss_dssp             CCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC------
T ss_pred             hhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCc------
Confidence            99988887777777889999999999999999999999999999999999999999999999999997665432      


Q ss_pred             CCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhccCCC
Q 019650          207 NNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERL  286 (337)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~  286 (337)
                              ......+||+.|+|||++..   +..++.++|||||||++|+|++|..||.+..+.+....+..........
T Consensus       155 --------~~~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~  223 (299)
T d1ua2a_         155 --------RAYTHQVVTRWYRAPELLFG---ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEE  223 (299)
T ss_dssp             --------CCCCCSCCCCTTCCHHHHTT---CSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             --------ccccceecChhhccHHHHcc---CCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChh
Confidence                    12223468999999999874   2467999999999999999999999997654444333333221111000


Q ss_pred             C-----------------------CCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCCc
Q 019650          287 E-----------------------MPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSS  330 (337)
Q Consensus       287 ~-----------------------~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~~  330 (337)
                      .                       .....++.+.+||.+||..||++|||++|+|+||||++.-...
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p~  290 (299)
T d1ua2a_         224 QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPT  290 (299)
T ss_dssp             TSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCC
T ss_pred             hccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCCCC
Confidence            0                       0124678999999999999999999999999999999765433

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=7.3e-56  Score=383.00  Aligned_cols=259  Identities=23%  Similarity=0.300  Sum_probs=219.7

Q ss_pred             CCCCCccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEee
Q 019650           38 PTSPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTI  117 (337)
Q Consensus        38 ~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~  117 (337)
                      ....|+...++|++.+.||+|+||+||+|.+..+++.||+|+++.+..  ..+.+.+|+.++++++||||+++++++.+ 
T Consensus         8 ~~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~--~~~~~~~E~~il~~l~HpnIv~~~~~~~~-   84 (287)
T d1opja_           8 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCTR-   84 (287)
T ss_dssp             TCCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS--CHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred             CCcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc--hHHHHHHHHHHHHhCCCCCEecCCccEee-
Confidence            344567778999999999999999999999999999999999876543  35678899999999999999999998876 


Q ss_pred             CCeEEEEEeccCCCCchHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccc
Q 019650          118 EGEICFVMEHMERGSLFDSLRVR--KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRI  195 (337)
Q Consensus       118 ~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~  195 (337)
                      ++..++||||+++|+|.+++...  ..+++..+..++.||+.||.|||++||+||||||+|||++.++++||+|||++..
T Consensus        85 ~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~  164 (287)
T d1opja_          85 EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL  164 (287)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTT
T ss_pred             CCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceee
Confidence            68899999999999999999654  5789999999999999999999999999999999999999999999999999986


Q ss_pred             hhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHH
Q 019650          196 VEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMA  275 (337)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~  275 (337)
                      ......             .......|++.|+|||++.    +..++.++||||||+++|||++|..||....+...   
T Consensus       165 ~~~~~~-------------~~~~~~~g~~~y~aPE~~~----~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~---  224 (287)
T d1opja_         165 MTGDTY-------------TAHAGAKFPIKWTAPESLA----YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---  224 (287)
T ss_dssp             CCSSSS-------------EEETTEEECGGGCCHHHHH----HCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---
T ss_pred             cCCCCc-------------eeeccccccccccChHHHc----CCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHH---
Confidence            543221             1122334788999999998    45789999999999999999997767654333333   


Q ss_pred             HHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhc
Q 019650          276 LICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA  319 (337)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~  319 (337)
                      .......+..+..+..+++.+.+||.+||+.||++|||++++++
T Consensus       225 ~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~  268 (287)
T d1opja_         225 VYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  268 (287)
T ss_dssp             HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHhcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence            33334445667778889999999999999999999999999976

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-55  Score=381.62  Aligned_cols=269  Identities=26%  Similarity=0.410  Sum_probs=214.9

Q ss_pred             ccccccccccccCcceEEEEEEEccCCceEEEEEeecCC-chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 019650           46 ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFV  124 (337)
Q Consensus        46 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv  124 (337)
                      .++|++++.||+|+||+||+|.+..+++.||+|+++... .....+.+.+|+.++++++||||+++++.+.+ +..+|+|
T Consensus         1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~-~~~~~iv   79 (298)
T d1gz8a_           1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT-ENKLYLV   79 (298)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEE-TTEEEEE
T ss_pred             CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccc-ccceeEE
Confidence            478999999999999999999999999999999996553 22345678899999999999999999999877 7899999


Q ss_pred             EeccCCCCchHHhh--hcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccC
Q 019650          125 MEHMERGSLFDSLR--VRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNN  202 (337)
Q Consensus       125 ~e~~~~~~L~~~l~--~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~  202 (337)
                      |||+.+ .+.+++.  ....+++..++.++.||+.||.|||++|||||||||+|||++.+++++|+|||.+.......  
T Consensus        80 ~e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~--  156 (298)
T d1gz8a_          80 FEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV--  156 (298)
T ss_dssp             EECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS--
T ss_pred             EeecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCc--
Confidence            999976 4444443  34579999999999999999999999999999999999999999999999999998765432  


Q ss_pred             CCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhc
Q 019650          203 NNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICF  282 (337)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~  282 (337)
                                  .......|++.|+|||.+...   ..++.++|+||||+++|+|++|+.||.+................
T Consensus       157 ------------~~~~~~~gt~~y~apE~~~~~---~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~  221 (298)
T d1gz8a_         157 ------------RTYTHEVVTLWYRAPEILLGC---KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT  221 (298)
T ss_dssp             ------------BCTTCCBCCCTTCCHHHHTTC---SSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             ------------ccceeecccceeeehhhhccc---cCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCC
Confidence                        223334699999999998743   34578999999999999999999999765443333333222111


Q ss_pred             cCCCC------------------------CCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCCccccCc
Q 019650          283 GERLE------------------------MPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSSNIEGL  335 (337)
Q Consensus       283 ~~~~~------------------------~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~~~~~~~  335 (337)
                      .....                        .....+..+.+|+.+||..||++|||++|+|+||||++...+  +++|
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p--~p~~  296 (298)
T d1gz8a_         222 PDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP--VPHL  296 (298)
T ss_dssp             CCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC--CCCC
T ss_pred             CchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC--CCCC
Confidence            10000                        112457889999999999999999999999999999877543  4444

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-55  Score=388.82  Aligned_cols=259  Identities=27%  Similarity=0.446  Sum_probs=210.0

Q ss_pred             cCcccccccc-ccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHh-cCCCCceeeeeeEEee---C
Q 019650           44 ENISDLKKLT-VLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKR-LDSQFIVKCHAVFYTI---E  118 (337)
Q Consensus        44 ~~~~~y~~~~-~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~-l~~~~i~~~~~~~~~~---~  118 (337)
                      ..+++|.+++ .||+|+||+||+|.+..+++.||+|+++..      ..+.+|+.++.+ .+||||+++++++.+.   +
T Consensus         8 ~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~   81 (335)
T d2ozaa1           8 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGR   81 (335)
T ss_dssp             CGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred             CcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCC
Confidence            3478999875 599999999999999999999999998643      446678888655 4899999999988652   3


Q ss_pred             CeEEEEEeccCCCCchHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcC---CCcEEEeeccCc
Q 019650          119 GEICFVMEHMERGSLFDSLRVR--KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLING---KGEVKIADFGVS  193 (337)
Q Consensus       119 ~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~---~~~~~l~Dfg~~  193 (337)
                      ..+|+||||++||+|.+++...  ..+++.+++.++.||+.||+|||++||+||||||+||+++.   ++.+||+|||++
T Consensus        82 ~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a  161 (335)
T d2ozaa1          82 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA  161 (335)
T ss_dssp             EEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             CEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccccccccccccccccccee
Confidence            5689999999999999999764  46999999999999999999999999999999999999975   457999999999


Q ss_pred             cchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhH
Q 019650          194 RIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDL  273 (337)
Q Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~  273 (337)
                      ........               ....+||+.|+|||++.    +..|+.++|||||||++|+|+||+.||.+.......
T Consensus       162 ~~~~~~~~---------------~~~~~gt~~y~aPE~~~----~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~  222 (335)
T d2ozaa1         162 KETTSHNS---------------LTTPCYTPYYVAPEVLG----PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS  222 (335)
T ss_dssp             EECCCCCC---------------CCCCSCCCSSCCCCCCC----GGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC---
T ss_pred             eeccCCCc---------------cccccCCcccCCcHHHc----CCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHH
Confidence            87654321               22336999999999998    457899999999999999999999999765444333


Q ss_pred             HHHHHHhhccCCCCCC----CCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCC
Q 019650          274 MALICAICFGERLEMP----ETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSS  328 (337)
Q Consensus       274 ~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~  328 (337)
                      .......... ...++    ..+++.+.+||.+||..||++|||++|+|+||||++...
T Consensus       223 ~~~~~~i~~~-~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~  280 (335)
T d2ozaa1         223 PGMKTRIRMG-QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK  280 (335)
T ss_dssp             -----CCCSC-SSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTTS
T ss_pred             HHHHHHHhcC-CCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCCC
Confidence            3333222222 22222    246889999999999999999999999999999976543

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-55  Score=376.73  Aligned_cols=262  Identities=22%  Similarity=0.362  Sum_probs=212.2

Q ss_pred             CccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCC-chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCe
Q 019650           42 DVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGE  120 (337)
Q Consensus        42 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~  120 (337)
                      |+...++|++.+.||+|+||+||+|...   ..||||+++... .....+.+.+|+.++++++||||+++++++.  ++.
T Consensus         3 wei~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~--~~~   77 (276)
T d1uwha_           3 WEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST--APQ   77 (276)
T ss_dssp             CBCCTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC--SSS
T ss_pred             cccccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe--ccE
Confidence            4566789999999999999999999754   359999987543 3445678889999999999999999999653  567


Q ss_pred             EEEEEeccCCCCchHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhcc
Q 019650          121 ICFVMEHMERGSLFDSLRVR-KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEET  199 (337)
Q Consensus       121 ~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~  199 (337)
                      +++||||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++++||+|||++......
T Consensus        78 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~  157 (276)
T d1uwha_          78 LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW  157 (276)
T ss_dssp             CEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred             EEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence            89999999999999999654 56999999999999999999999999999999999999999999999999999766432


Q ss_pred             ccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHH
Q 019650          200 RNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICA  279 (337)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~  279 (337)
                      ...            .......||+.|+|||++.... ...++.++||||||+++|||+||+.||.+.............
T Consensus       158 ~~~------------~~~~~~~gt~~y~APE~l~~~~-~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~  224 (276)
T d1uwha_         158 SGS------------HQFEQLSGSILWMAPEVIRMQD-KNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGR  224 (276)
T ss_dssp             --------------------CCCCGGGCCHHHHTTCS-SCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHH
T ss_pred             CCc------------ccccccccCcccCCHHHHhccc-CCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhc
Confidence            211            1223346899999999997542 246899999999999999999999999876655544444433


Q ss_pred             hhc-cCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCc
Q 019650          280 ICF-GERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYP  321 (337)
Q Consensus       280 ~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp  321 (337)
                      ... ......+..+++.+.+|+.+||+.||++|||+++|+++-
T Consensus       225 ~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~L  267 (276)
T d1uwha_         225 GYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASI  267 (276)
T ss_dssp             TSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             CCCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence            221 122345667899999999999999999999999999873

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.3e-54  Score=377.41  Aligned_cols=263  Identities=25%  Similarity=0.396  Sum_probs=209.2

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCc---eEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCe
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNS---IYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGE  120 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~  120 (337)
                      ...++|++.+.||+|+||+||+|.+..+++   .||+|.+.........+.+.+|+.++++++||||+++++++.+ ...
T Consensus        23 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~-~~~  101 (299)
T d1jpaa_          23 IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTK-STP  101 (299)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSS
T ss_pred             hChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEee-CCE
Confidence            446889999999999999999999876554   5889988776666667789999999999999999999998866 678


Q ss_pred             EEEEEeccCCCCchHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhcc
Q 019650          121 ICFVMEHMERGSLFDSLRVR-KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEET  199 (337)
Q Consensus       121 ~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~  199 (337)
                      +++||||+++|+|.+++... +.+++.++..++.||+.||.|||++|++||||||+|||++.++++||+|||++......
T Consensus       102 ~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~  181 (299)
T d1jpaa_         102 VMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD  181 (299)
T ss_dssp             CEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred             EEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccCC
Confidence            99999999999999988764 57999999999999999999999999999999999999999999999999999876543


Q ss_pred             ccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHH
Q 019650          200 RNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALIC  278 (337)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~  278 (337)
                      ......         .......+|+.|+|||.+.    +..++.++|||||||++|||+| |+.||.+....    .+..
T Consensus       182 ~~~~~~---------~~~~~~~~t~~y~aPE~~~----~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~----~~~~  244 (299)
T d1jpaa_         182 TSDPTY---------TSALGGKIPIRWTAPEAIQ----YRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ----DVIN  244 (299)
T ss_dssp             -----------------------CGGGSCHHHHH----SCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH----HHHH
T ss_pred             CCccee---------eecccccCCccccCHHHHh----cCCCCcccccccchHHHHHHHhCCCCCCCCCCHH----HHHH
Confidence            322111         1122235789999999998    5578999999999999999998 89999764332    3344


Q ss_pred             HhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC--cccc
Q 019650          279 AICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY--PFVT  324 (337)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~h--p~f~  324 (337)
                      ....+..+..+..+++.+.+|+.+||+.||++|||+++|+++  .+++
T Consensus       245 ~i~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~  292 (299)
T d1jpaa_         245 AIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR  292 (299)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             HHHcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence            445566677788899999999999999999999999999876  4444

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8e-55  Score=383.41  Aligned_cols=259  Identities=26%  Similarity=0.366  Sum_probs=215.8

Q ss_pred             CccCccccccccccccCcceEEEEEEEccCCc-----eEEEEEeecCCchHhHHHHHHHHHHHHhc-CCCCceeeeeeEE
Q 019650           42 DVENISDLKKLTVLGHGNGGIVYKVRHQKSNS-----IYALKVLNTTSSTIIRHQAAHEAEILKRL-DSQFIVKCHAVFY  115 (337)
Q Consensus        42 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~  115 (337)
                      |+...++|++++.||+|+||+||+|.+..+++     .||+|.+...........+.+|+.++.++ +||||+++++++.
T Consensus        32 wei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~  111 (325)
T d1rjba_          32 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT  111 (325)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEe
Confidence            45567899999999999999999999865443     69999987665555667788999999998 8999999999887


Q ss_pred             eeCCeEEEEEeccCCCCchHHhhhc-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccC
Q 019650          116 TIEGEICFVMEHMERGSLFDSLRVR-----------------------KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDI  172 (337)
Q Consensus       116 ~~~~~~~lv~e~~~~~~L~~~l~~~-----------------------~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl  172 (337)
                      + ...+++||||+++|+|.+++...                       ..+++..++.++.|++.||+|||++||+||||
T Consensus       112 ~-~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDl  190 (325)
T d1rjba_         112 L-SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDL  190 (325)
T ss_dssp             S-SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred             e-CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence            6 67899999999999999999754                       24899999999999999999999999999999


Q ss_pred             CCCCeEEcCCCcEEEeeccCccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHH
Q 019650          173 KPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGV  252 (337)
Q Consensus       173 ~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~  252 (337)
                      ||+||+++.++++||+|||++.........            .......||+.|+|||++.    +..++.++|||||||
T Consensus       191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~~------------~~~~~~~gt~~y~aPE~l~----~~~~~~~~DiwS~Gv  254 (325)
T d1rjba_         191 AARNVLVTHGKVVKICDFGLARDIMSDSNY------------VVRGNARLPVKWMAPESLF----EGIYTIKSDVWSYGI  254 (325)
T ss_dssp             SGGGEEEETTTEEEECCCGGGSCGGGCTTS------------EEETTEEECGGGCCHHHHH----HCCCCHHHHHHHHHH
T ss_pred             chhccccccCCeEEEeeccccccccCCCce------------eeeccccCCCccCChHHHc----CCCCCcceeccchhH
Confidence            999999999999999999999776543211            1223345799999999998    457899999999999


Q ss_pred             HHHHHHh-CCCCCCCCCCchhHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          253 VVLECLV-GHYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       253 il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                      ++|||+| |..||.+...........   ..+..+..|..+++.+++||.+||+.||++|||++||++|
T Consensus       255 il~emlt~g~~Pf~~~~~~~~~~~~~---~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  320 (325)
T d1rjba_         255 LLWEIFSLGVNPYPGIPVDANFYKLI---QNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  320 (325)
T ss_dssp             HHHHHTTTSCCSSTTCCCSHHHHHHH---HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHhCCCCCCCCCCHHHHHHHHH---hcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            9999998 899998766555444443   3445667778899999999999999999999999999986

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-55  Score=379.11  Aligned_cols=253  Identities=25%  Similarity=0.380  Sum_probs=211.8

Q ss_pred             ccccccccccccCcceEEEEEEEccCCceEEEEEeecCCch-----HhHHHHHHHHHHHHhcC--CCCceeeeeeEEeeC
Q 019650           46 ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSST-----IIRHQAAHEAEILKRLD--SQFIVKCHAVFYTIE  118 (337)
Q Consensus        46 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~e~~~~~~l~--~~~i~~~~~~~~~~~  118 (337)
                      .++|++.+.||+|+||+||+|.+..+++.||+|++......     ....++.+|+.++++++  ||||+++++++.+ .
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~-~   81 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER-P   81 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC-S
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEee-C
Confidence            46899999999999999999999999999999998754211     11233567999999986  8999999998876 6


Q ss_pred             CeEEEEEeccCC-CCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCC-CcEEEeeccCccch
Q 019650          119 GEICFVMEHMER-GSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGK-GEVKIADFGVSRIV  196 (337)
Q Consensus       119 ~~~~lv~e~~~~-~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~-~~~~l~Dfg~~~~~  196 (337)
                      ...++|||++.+ +++.+++.....+++..++.++.||+.||.|||++||+||||||+||+++.+ +.++|+|||++...
T Consensus        82 ~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~  161 (273)
T d1xwsa_          82 DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL  161 (273)
T ss_dssp             SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             CeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceec
Confidence            889999999976 5788888888899999999999999999999999999999999999999865 79999999999765


Q ss_pred             hccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHH
Q 019650          197 EETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMAL  276 (337)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~  276 (337)
                      ...                ......||+.|+|||++...   ..++.++|||||||++|+|++|+.||...   .   ..
T Consensus       162 ~~~----------------~~~~~~GT~~y~aPE~~~~~---~~~~~~~DiwSlGvilyell~g~~Pf~~~---~---~i  216 (273)
T d1xwsa_         162 KDT----------------VYTDFDGTRVYSPPEWIRYH---RYHGRSAAVWSLGILLYDMVCGDIPFEHD---E---EI  216 (273)
T ss_dssp             CSS----------------CBCCCCSCGGGSCHHHHHHS---CBCHHHHHHHHHHHHHHHHHHSSCSCCSH---H---HH
T ss_pred             ccc----------------cccccccCCCcCCHHHHcCC---CCCCcccccccceeeehhHhhCCCCCCCc---h---HH
Confidence            332                12234699999999999843   23467899999999999999999999541   1   11


Q ss_pred             HHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCC
Q 019650          277 ICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSS  329 (337)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~  329 (337)
                      .     .....++..+++.+.+||.+||..||++|||++|+|+||||++...+
T Consensus       217 ~-----~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~~p  264 (273)
T d1xwsa_         217 I-----RGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLP  264 (273)
T ss_dssp             H-----HCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCCH
T ss_pred             h-----hcccCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCCCC
Confidence            1     12445667889999999999999999999999999999999986543

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-55  Score=375.84  Aligned_cols=260  Identities=25%  Similarity=0.387  Sum_probs=219.5

Q ss_pred             cCccccccccc-cccCcceEEEEEEEc--cCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCe
Q 019650           44 ENISDLKKLTV-LGHGNGGIVYKVRHQ--KSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGE  120 (337)
Q Consensus        44 ~~~~~y~~~~~-lg~g~~~~v~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~  120 (337)
                      ...++|.+.+. ||+|+||+||+|.+.  .++..||||+++........+.+.+|+.++++++||||+++++++.  .+.
T Consensus         5 l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~   82 (285)
T d1u59a_           5 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ--AEA   82 (285)
T ss_dssp             CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE--SSS
T ss_pred             ecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeec--cCe
Confidence            34577888885 999999999999875  3455799999987766667788999999999999999999999874  356


Q ss_pred             EEEEEeccCCCCchHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhcc
Q 019650          121 ICFVMEHMERGSLFDSLRV-RKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEET  199 (337)
Q Consensus       121 ~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~  199 (337)
                      +|+||||+++|+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++......
T Consensus        83 ~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~  162 (285)
T d1u59a_          83 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD  162 (285)
T ss_dssp             EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred             EEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccccc
Confidence            8999999999999999864 467999999999999999999999999999999999999999999999999999877543


Q ss_pred             ccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHH
Q 019650          200 RNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALIC  278 (337)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~  278 (337)
                      ....           .......||+.|+|||++.    +..++.++||||||+++|||+| |+.||.+....    ++..
T Consensus       163 ~~~~-----------~~~~~~~gt~~y~aPE~~~----~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~----~~~~  223 (285)
T d1u59a_         163 DSYY-----------TARSAGKWPLKWYAPECIN----FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP----EVMA  223 (285)
T ss_dssp             SCEE-----------CCCCSSCCCGGGCCHHHHH----HCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH----HHHH
T ss_pred             cccc-----------ccccccccCccccChHHHh----CCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH----HHHH
Confidence            2111           1122335889999999998    4578999999999999999998 89999765433    2344


Q ss_pred             HhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHH---hcCcccc
Q 019650          279 AICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEEL---LAYPFVT  324 (337)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~ei---l~hp~f~  324 (337)
                      ....+..+..|..+++.+.+||.+||+.||++|||+.+|   |+|+|+.
T Consensus       224 ~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~  272 (285)
T d1u59a_         224 FIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  272 (285)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHcCCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence            455667778888999999999999999999999999888   6688875

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.9e-54  Score=375.01  Aligned_cols=261  Identities=25%  Similarity=0.358  Sum_probs=214.0

Q ss_pred             ccccccccccccCcceEEEEEEEccCCceEEEEEeecCC-chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 019650           46 ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFV  124 (337)
Q Consensus        46 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv  124 (337)
                      .++|++++.||+|+||+||+|.+. +++.||+|+++... .....+.+.+|+.++++++||||+++++.+.. .+..+++
T Consensus         1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-~~~~~i~   78 (286)
T d1ob3a_           1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT-KKRLVLV   78 (286)
T ss_dssp             CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC-SSCEEEE
T ss_pred             CCCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeeccc-CCceeEE
Confidence            378999999999999999999985 77899999997654 23345778899999999999999999998876 7889999


Q ss_pred             EeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCC
Q 019650          125 MEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNN  204 (337)
Q Consensus       125 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~  204 (337)
                      |+++.++.+..+....+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+|++|||.+.......    
T Consensus        79 ~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~----  154 (286)
T d1ob3a_          79 FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV----  154 (286)
T ss_dssp             EECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred             EEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCc----
Confidence            9999887777777778889999999999999999999999999999999999999999999999999998765432    


Q ss_pred             CCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhccC
Q 019650          205 HNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGE  284 (337)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~  284 (337)
                                .......+++.|+|||.+...   ..++.++|+||||+++|+|++|+.||.+..+...............
T Consensus       155 ----------~~~~~~~~~~~y~~pE~~~~~---~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~  221 (286)
T d1ob3a_         155 ----------RKYTHEIVTLWYRAPDVLMGS---KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPN  221 (286)
T ss_dssp             -----------------CCCTTCCHHHHTTC---CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             ----------cccceecccchhhhHHHHhCC---CCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCC
Confidence                      122233589999999999743   3578999999999999999999999976544433333322111100


Q ss_pred             C------------------------CCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccc
Q 019650          285 R------------------------LEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTK  325 (337)
Q Consensus       285 ~------------------------~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~  325 (337)
                      .                        .......++.+.+||.+||..||++|||++|+|+||||++
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         222 SKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (286)
T ss_dssp             TTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             hhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence            0                        1123456889999999999999999999999999999985

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-54  Score=377.64  Aligned_cols=279  Identities=27%  Similarity=0.352  Sum_probs=218.7

Q ss_pred             CCCccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCC-chHhHHHHHHHHHHHHhcCCCCceeeeeeEEee-
Q 019650           40 SPDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTI-  117 (337)
Q Consensus        40 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-  117 (337)
                      +++...+++|++++.||+|+||+||+|.+..+++.||||++.... .+.....+.+|+.++++++|+|++++++++... 
T Consensus         3 ~~~~~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~   82 (318)
T d3blha1           3 CPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKA   82 (318)
T ss_dssp             CTTSCBGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--
T ss_pred             CCCCCccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccc
Confidence            456777999999999999999999999999999999999986553 333456778999999999999999999987553 


Q ss_pred             ------CCeEEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeecc
Q 019650          118 ------EGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFG  191 (337)
Q Consensus       118 ------~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg  191 (337)
                            +..++++||++.++.+.........+++..++.++.|++.||.|||++||+||||||+|||++.++.++++|||
T Consensus        83 ~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg  162 (318)
T d3blha1          83 SPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFG  162 (318)
T ss_dssp             --------CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCT
T ss_pred             ccccccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecc
Confidence                  24589999999887766666666789999999999999999999999999999999999999999999999999


Q ss_pred             CccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCch
Q 019650          192 VSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKP  271 (337)
Q Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~  271 (337)
                      ++...........          ......+||+.|+|||.+...   ..++.++|||||||++|+|++|+.||.+..+..
T Consensus       163 ~~~~~~~~~~~~~----------~~~~~~~gT~~Y~aPE~~~~~---~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~  229 (318)
T d3blha1         163 LARAFSLAKNSQP----------NRYTNRVVTLWYRPPELLLGE---RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH  229 (318)
T ss_dssp             TCEECCC-----C----------CCCCSCCSCGGGCCHHHHTTC---SSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             eeeeccccccccc----------ccccceecCHHHhhHHHHcCC---CCCCcHHHcccCCceeeeHhhCCCCCCCCCHHH
Confidence            9976654322111          122234689999999998743   368899999999999999999999997654333


Q ss_pred             hHHHHHHHhhccCCCCCCC----------------------------CCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccc
Q 019650          272 DLMALICAICFGERLEMPE----------------------------TASPEFRRFVRSCLEKDWRKRGTVEELLAYPFV  323 (337)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f  323 (337)
                      ... .+.............                            ..++.+.+||.+||..||++|||++|+|+||||
T Consensus       230 ~~~-~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff  308 (318)
T d3blha1         230 QLA-LISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF  308 (318)
T ss_dssp             HHH-HHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred             HHH-HHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhh
Confidence            322 222222222221111                            125678899999999999999999999999999


Q ss_pred             cccCCCccc
Q 019650          324 TKRSSSSNI  332 (337)
Q Consensus       324 ~~~~~~~~~  332 (337)
                      ++.-.++.|
T Consensus       309 ~~~p~p~~~  317 (318)
T d3blha1         309 WSDPMPSDL  317 (318)
T ss_dssp             SSSSCCCCC
T ss_pred             ccCCCCCCC
Confidence            986655544

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-54  Score=371.44  Aligned_cols=260  Identities=26%  Similarity=0.372  Sum_probs=217.0

Q ss_pred             CCccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCe
Q 019650           41 PDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGE  120 (337)
Q Consensus        41 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~  120 (337)
                      .|+...++|++.+.||+|+||+||+|.+. ++..||||+++....  ..+.+.+|+.++++++||||+++++++.  ++.
T Consensus         7 ~wei~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~--~~~   81 (272)
T d1qpca_           7 EWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM--SPDAFLAEANLMKQLQHQRLVRLYAVVT--QEP   81 (272)
T ss_dssp             TTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEEC--SSS
T ss_pred             CeecCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcC--CHHHHHHHHHHHHhCCCCCEeEEEeeec--cCC
Confidence            45566789999999999999999999975 567899999976542  3467899999999999999999999763  466


Q ss_pred             EEEEEeccCCCCchHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhc
Q 019650          121 ICFVMEHMERGSLFDSLRVR--KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEE  198 (337)
Q Consensus       121 ~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~  198 (337)
                      .++||||+++|+|.+++...  ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus        82 ~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~  161 (272)
T d1qpca_          82 IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED  161 (272)
T ss_dssp             CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             eEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccC
Confidence            79999999999999987643  3699999999999999999999999999999999999999999999999999987654


Q ss_pred             cccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHH
Q 019650          199 TRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALIC  278 (337)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~  278 (337)
                      ...             .......+++.|+|||++.    +..++.++||||||+++|||+||..|+.......   ....
T Consensus       162 ~~~-------------~~~~~~~gt~~y~APE~~~----~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~---~~~~  221 (272)
T d1qpca_         162 NEY-------------TAREGAKFPIKWTAPEAIN----YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP---EVIQ  221 (272)
T ss_dssp             SCE-------------ECCTTCCCCTTTSCHHHHH----HCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHH
T ss_pred             Ccc-------------ccccccCCcccccChHHHh----CCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHH---HHHH
Confidence            321             1122335889999999998    4478899999999999999999655554333332   3334


Q ss_pred             HhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhc--Cccccc
Q 019650          279 AICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA--YPFVTK  325 (337)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~--hp~f~~  325 (337)
                      ....+..+..+..+++.+.+|+.+||+.||++|||++++++  ++||..
T Consensus       222 ~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts  270 (272)
T d1qpca_         222 NLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (272)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHhcCCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence            44556667778889999999999999999999999999999  788864

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-54  Score=373.64  Aligned_cols=251  Identities=25%  Similarity=0.398  Sum_probs=208.4

Q ss_pred             cccccCcceEEEEEEEc--cCCceEEEEEeecCC-chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEeccC
Q 019650           53 TVLGHGNGGIVYKVRHQ--KSNSIYALKVLNTTS-STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHME  129 (337)
Q Consensus        53 ~~lg~g~~~~v~~~~~~--~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~  129 (337)
                      +.||+|+||+||+|.+.  .+++.||+|+++... .....+.+.+|+.++++++||||+++++++.  ....++||||++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~--~~~~~lvmE~~~   90 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE--AESWMLVMEMAE   90 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE--SSSEEEEEECCT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEec--cCCEEEEEEcCC
Confidence            46999999999999864  456789999996543 3345677899999999999999999999874  356789999999


Q ss_pred             CCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCCCCCCC
Q 019650          130 RGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNN  209 (337)
Q Consensus       130 ~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~  209 (337)
                      +|+|.+++.....+++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||++..........      
T Consensus        91 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~------  164 (277)
T d1xbba_          91 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY------  164 (277)
T ss_dssp             TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE------
T ss_pred             CCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccccc------
Confidence            99999999988999999999999999999999999999999999999999999999999999998664332111      


Q ss_pred             CCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHhhccCCCCC
Q 019650          210 NNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICAICFGERLEM  288 (337)
Q Consensus       210 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  288 (337)
                           .......||+.|+|||.+.    +..++.++||||||+++|||+| |+.||.+...    .++......+..+..
T Consensus       165 -----~~~~~~~gt~~y~APE~l~----~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~----~~~~~~i~~~~~~~~  231 (277)
T d1xbba_         165 -----KAQTHGKWPVKWYAPECIN----YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG----SEVTAMLEKGERMGC  231 (277)
T ss_dssp             -----EC----CCCGGGCCHHHHH----HCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH----HHHHHHHHTTCCCCC
T ss_pred             -----ccccccCCCceecCchhhc----CCCCCchhhhccchhhhhHHhhCCCCCCCCCCH----HHHHHHHHcCCCCCC
Confidence                 1222345899999999998    4578899999999999999998 8999976432    233444555677788


Q ss_pred             CCCCCHHHHHHHHHHhhcCcCCCCCHHHH---hcCcccc
Q 019650          289 PETASPEFRRFVRSCLEKDWRKRGTVEEL---LAYPFVT  324 (337)
Q Consensus       289 ~~~~~~~~~~li~~~l~~~p~~R~s~~ei---l~hp~f~  324 (337)
                      +..+++.+.+||.+||+.||++|||+++|   |+|+|+.
T Consensus       232 p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~  270 (277)
T d1xbba_         232 PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD  270 (277)
T ss_dssp             CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             CcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence            88999999999999999999999999998   4566654

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-54  Score=375.16  Aligned_cols=265  Identities=22%  Similarity=0.360  Sum_probs=210.1

Q ss_pred             CccccccccccccCcceEEEEEEEccC-CceEEEEEeecCCc-hHhHHHHHHHHHHHHhc---CCCCceeeeeeEEee--
Q 019650           45 NISDLKKLTVLGHGNGGIVYKVRHQKS-NSIYALKVLNTTSS-TIIRHQAAHEAEILKRL---DSQFIVKCHAVFYTI--  117 (337)
Q Consensus        45 ~~~~y~~~~~lg~g~~~~v~~~~~~~~-~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l---~~~~i~~~~~~~~~~--  117 (337)
                      ..++|++++.||+|+||+||+|.+..+ ++.||+|+++.... ......+.+|+.+++.+   +||||+++++++...  
T Consensus         5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~   84 (305)
T d1blxa_           5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   84 (305)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence            458999999999999999999999755 66799999865432 22223345666666555   899999999988643  


Q ss_pred             --CCeEEEEEeccCCCCchHHhh-hcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCcc
Q 019650          118 --EGEICFVMEHMERGSLFDSLR-VRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSR  194 (337)
Q Consensus       118 --~~~~~lv~e~~~~~~L~~~l~-~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~  194 (337)
                        ...++++||+++++.+..... ....+++..++.++.|++.||+|||++||+||||||+|||++.++.++|+|||.+.
T Consensus        85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~  164 (305)
T d1blxa_          85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR  164 (305)
T ss_dssp             SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred             ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhh
Confidence              246899999998876654443 34579999999999999999999999999999999999999999999999999987


Q ss_pred             chhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHH
Q 019650          195 IVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLM  274 (337)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~  274 (337)
                      ......               ......||+.|+|||++.    +..|+.++|||||||++|||++|+.||.+........
T Consensus       165 ~~~~~~---------------~~~~~~gT~~Y~APE~~~----~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~  225 (305)
T d1blxa_         165 IYSFQM---------------ALTSVVVTLWYRAPEVLL----QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLG  225 (305)
T ss_dssp             CCCGGG---------------GGCCCCCCCTTCCHHHHT----TCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred             hhcccc---------------cCCCcccChhhcCcchhc----CCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHH
Confidence            654332               223446999999999998    5688999999999999999999999997654444333


Q ss_pred             HHHHHhhccC----------------------CCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCC
Q 019650          275 ALICAICFGE----------------------RLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSS  328 (337)
Q Consensus       275 ~~~~~~~~~~----------------------~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~  328 (337)
                      ..........                      ...++..+++.+.+||.+||..||++|||++|+|+||||++.++
T Consensus       226 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~  301 (305)
T d1blxa_         226 KILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER  301 (305)
T ss_dssp             HHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred             HHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchh
Confidence            3332211110                      01234567889999999999999999999999999999998764

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-53  Score=364.72  Aligned_cols=251  Identities=25%  Similarity=0.408  Sum_probs=203.0

Q ss_pred             CccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 019650           45 NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFV  124 (337)
Q Consensus        45 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv  124 (337)
                      ..++|++++.||+|+||+||+|.+. ++..||||+++....  ..+.+.+|+.++++++||||+++++++.+ .+..++|
T Consensus         3 dp~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~~lv   78 (263)
T d1sm2a_           3 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM--SEEDFIEEAEVMMKLSHPKLVQLYGVCLE-QAPICLV   78 (263)
T ss_dssp             CCSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSSCEEE
T ss_pred             ChHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcC--cHHHHHHHHHHHHhcCCCCcccccceecc-CCceEEE
Confidence            3578999999999999999999985 567899999876432  34678899999999999999999998876 6789999


Q ss_pred             EeccCCCCchHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCC
Q 019650          125 MEHMERGSLFDSLRVR-KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNN  203 (337)
Q Consensus       125 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~  203 (337)
                      |||+++|+|.+++... ..++++.+..++.|++.||.|||+++|+||||||+||+++.++++||+|||++........  
T Consensus        79 ~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~--  156 (263)
T d1sm2a_          79 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY--  156 (263)
T ss_dssp             EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred             EEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCc--
Confidence            9999999999998654 5689999999999999999999999999999999999999999999999999977654321  


Q ss_pred             CCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhC-CCCCCCCCCchhHHHHHHHhhc
Q 019650          204 NHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVG-HYPLIGFGEKPDLMALICAICF  282 (337)
Q Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg-~~pf~~~~~~~~~~~~~~~~~~  282 (337)
                                 .......||+.|+|||++.    +..++.++||||||+++|||+|+ .+||.. ...   .........
T Consensus       157 -----------~~~~~~~gt~~y~aPE~l~----~~~~~~k~DVwS~Gvil~el~t~~~~~~~~-~~~---~~~~~~i~~  217 (263)
T d1sm2a_         157 -----------TSSTGTKFPVKWASPEVFS----FSRYSSKSDVWSFGVLMWEVFSEGKIPYEN-RSN---SEVVEDIST  217 (263)
T ss_dssp             -------------------CTTSCCHHHHT----TCCCCHHHHHHHHHHHHHHHHTTSCCTTCS-CCH---HHHHHHHHH
T ss_pred             -----------eeecceecCcccCChHHhc----CCCCCchhhhcchHHHHHHHHHCCCCCCCC-CCH---HHHHHHHHh
Confidence                       1122335899999999998    55789999999999999999995 555543 222   233334445


Q ss_pred             cCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          283 GERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       283 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                      +.....|...++.+.+++.+||+.||++|||+++|++|
T Consensus       218 ~~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~  255 (263)
T d1sm2a_         218 GFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ  255 (263)
T ss_dssp             TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCCCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence            56667778889999999999999999999999999986

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.1e-53  Score=368.46  Aligned_cols=263  Identities=24%  Similarity=0.274  Sum_probs=207.8

Q ss_pred             ccccccccccccCcceEEEEEEEccCCceEEEEEeecCC--chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCC---e
Q 019650           46 ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEG---E  120 (337)
Q Consensus        46 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~---~  120 (337)
                      .++|++.+.||+|+||+||+|.+..+++.||+|+++...  .......+.+|+.++++++||||+++++++.....   .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            467999999999999999999999999999999997653  34456678899999999999999999999877443   4


Q ss_pred             EEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccc
Q 019650          121 ICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETR  200 (337)
Q Consensus       121 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~  200 (337)
                      +|+||||++|++|.+++...+.+++.+++.++.||+.||+|||++||+||||||+||+++.++..+++|||.+.......
T Consensus        86 ~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~  165 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG  165 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC---
T ss_pred             EEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhcccc
Confidence            89999999999999999988999999999999999999999999999999999999999999999999999886654332


Q ss_pred             cCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHh
Q 019650          201 NNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAI  280 (337)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~  280 (337)
                      ...           ......+||+.|+|||++.    +..++.++||||||+++|+|+||+.||.+....+........ 
T Consensus       166 ~~~-----------~~~~~~~Gt~~Y~aPE~~~----~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~-  229 (277)
T d1o6ya_         166 NSV-----------TQTAAVIGTAQYLSPEQAR----GDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRE-  229 (277)
T ss_dssp             ------------------------TTCCHHHHT----TCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHC-
T ss_pred             ccc-----------cccccccCcccccCHHHHc----CCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhc-
Confidence            111           2233446999999999998    557899999999999999999999999764333222222211 


Q ss_pred             hccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCcccc
Q 019650          281 CFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVT  324 (337)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~  324 (337)
                      ...........+++.+.++|.+||..||++||+..+.|.|+|.+
T Consensus       230 ~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r  273 (277)
T d1o6ya_         230 DPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR  273 (277)
T ss_dssp             CCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             CCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence            11112234567899999999999999999999444444456553

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-53  Score=360.54  Aligned_cols=250  Identities=26%  Similarity=0.397  Sum_probs=214.8

Q ss_pred             ccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEE
Q 019650           46 ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVM  125 (337)
Q Consensus        46 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~  125 (337)
                      .++|++.++||+|+||+||+|.+. ++..||+|+++....  ..+.+.+|+.++++++||||+++++++.+ ++.+++||
T Consensus         3 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~-~~~~~iv~   78 (258)
T d1k2pa_           3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM--SEDEFIEEAKVMMNLSHEKLVQLYGVCTK-QRPIFIIT   78 (258)
T ss_dssp             CCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS--CHHHHHHHHHHHHTCCCTTBCCEEEEECC-SSSEEEEE
T ss_pred             hHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcC--CHHHHHHHHHHHHhcCCCceeeEEEEEee-CCceEEEE
Confidence            478999999999999999999984 778899999986543  34678899999999999999999998866 68899999


Q ss_pred             eccCCCCchHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCC
Q 019650          126 EHMERGSLFDSLRV-RKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNN  204 (337)
Q Consensus       126 e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~  204 (337)
                      ||+++|+|.+++.. ...+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++.........  
T Consensus        79 Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~--  156 (258)
T d1k2pa_          79 EYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT--  156 (258)
T ss_dssp             ECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC--
T ss_pred             EccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCce--
Confidence            99999999998654 467999999999999999999999999999999999999999999999999999765443211  


Q ss_pred             CCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHHhhcc
Q 019650          205 HNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICAICFG  283 (337)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~~~~~  283 (337)
                                 ......+|+.|+|||.+.    +..++.++||||||+++|||+| |+.||......    .+......+
T Consensus       157 -----------~~~~~~~t~~y~aPE~~~----~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~----~~~~~i~~~  217 (258)
T d1k2pa_         157 -----------SSVGSKFPVRWSPPEVLM----YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS----ETAEHIAQG  217 (258)
T ss_dssp             -----------CCCCSCCCGGGCCHHHHH----HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH----HHHHHHHTT
T ss_pred             -----------eecccCCCCCcCCcHHhc----CCCCCcceeecccchhhHhHHhcCCCCCCCCCHH----HHHHHHHhC
Confidence                       112235899999999998    4578999999999999999998 89999765432    334444556


Q ss_pred             CCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          284 ERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       284 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                      .....|...+..+.+||.+||+.||++|||+++|++|
T Consensus       218 ~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  254 (258)
T d1k2pa_         218 LRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSN  254 (258)
T ss_dssp             CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence            6777788899999999999999999999999999987

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-53  Score=373.22  Aligned_cols=266  Identities=29%  Similarity=0.455  Sum_probs=223.2

Q ss_pred             CccccccccccccCcceEEEEEEEc---cCCceEEEEEeecCC---chHhHHHHHHHHHHHHhcCC-CCceeeeeeEEee
Q 019650           45 NISDLKKLTVLGHGNGGIVYKVRHQ---KSNSIYALKVLNTTS---STIIRHQAAHEAEILKRLDS-QFIVKCHAVFYTI  117 (337)
Q Consensus        45 ~~~~y~~~~~lg~g~~~~v~~~~~~---~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~~~~l~~-~~i~~~~~~~~~~  117 (337)
                      .+++|++++.||+|+||+||+|.+.   .+|+.||+|+++...   .....+.+.+|+.++++++| +||+++++.+.+ 
T Consensus        22 ~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~-  100 (322)
T d1vzoa_          22 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT-  100 (322)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE-
T ss_pred             chhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc-
Confidence            5799999999999999999999874   478999999986532   22334567789999999977 799999998766 


Q ss_pred             CCeEEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchh
Q 019650          118 EGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVE  197 (337)
Q Consensus       118 ~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~  197 (337)
                      ....+++|||+.+++|.+++...+.+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||++....
T Consensus       101 ~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~  180 (322)
T d1vzoa_         101 ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV  180 (322)
T ss_dssp             TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred             CCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhc
Confidence            78999999999999999999999999999999999999999999999999999999999999999999999999987654


Q ss_pred             ccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHH
Q 019650          198 ETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALI  277 (337)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~  277 (337)
                      ....             .......|++.|+|||.+...  ...++.++|||||||++|+|++|+.||...........+.
T Consensus       181 ~~~~-------------~~~~~~~g~~~~~~pe~~~~~--~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~  245 (322)
T d1vzoa_         181 ADET-------------ERAYDFCGTIEYMAPDIVRGG--DSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS  245 (322)
T ss_dssp             GGGG-------------GGGCGGGSCCTTCCHHHHTTC--C---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHH
T ss_pred             cccc-------------ccccccccccccchhHHhhcC--CcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            3321             222334689999999999754  2357889999999999999999999998765555544444


Q ss_pred             HHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCC-----CHHHHhcCccccccC
Q 019650          278 CAICFGERLEMPETASPEFRRFVRSCLEKDWRKRG-----TVEELLAYPFVTKRS  327 (337)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~-----s~~eil~hp~f~~~~  327 (337)
                      .... ...+..+..+++.+.+|+.+||..||.+||     |++|+++||||++..
T Consensus       246 ~~~~-~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~  299 (322)
T d1vzoa_         246 RRIL-KSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN  299 (322)
T ss_dssp             HHHH-HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred             Hhcc-cCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCC
Confidence            4333 335566778899999999999999999999     489999999999865

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-52  Score=364.39  Aligned_cols=264  Identities=25%  Similarity=0.364  Sum_probs=220.9

Q ss_pred             ccccccccccccCcceEEEEEEEccCCceEEEEEeecCC-chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEE
Q 019650           46 ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFV  124 (337)
Q Consensus        46 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv  124 (337)
                      .++|++++.||+|+||+||+|.+..+++.||+|+++... .......+.+|+.++++++|+||+++++.+.+ ....+++
T Consensus         1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~-~~~~~iv   79 (292)
T d1unla_           1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS-DKKLTLV   79 (292)
T ss_dssp             CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEEE
T ss_pred             CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccccc-ccceeEE
Confidence            368999999999999999999999999999999997654 33456788899999999999999999998876 6889999


Q ss_pred             EeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCC
Q 019650          125 MEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNN  204 (337)
Q Consensus       125 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~  204 (337)
                      ++++.+++|..++...+.+++..++.++.|++.||+|||++||+||||||+|||++.+++++|+|||.+.......    
T Consensus        80 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~----  155 (292)
T d1unla_          80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV----  155 (292)
T ss_dssp             EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC----
T ss_pred             eeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCC----
Confidence            9999999999998888899999999999999999999999999999999999999999999999999998765432    


Q ss_pred             CCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhccC
Q 019650          205 HNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGE  284 (337)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~  284 (337)
                                .......+++.|+|||.+...   ..++.++|||||||++|+|++|..||....+.......+.......
T Consensus       156 ----------~~~~~~~~~~~~~~pe~~~~~---~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~  222 (292)
T d1unla_         156 ----------RCYSAEVVTLWYRPPDVLFGA---KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTP  222 (292)
T ss_dssp             ----------SCCCSCCSCGGGCCHHHHTTC---SCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             ----------ccceeeccccchhhhhHhccC---CCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCC
Confidence                      122233578889999998743   3468899999999999999999999866555444433333222211


Q ss_pred             -------------------------CCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccC
Q 019650          285 -------------------------RLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRS  327 (337)
Q Consensus       285 -------------------------~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~  327 (337)
                                               ........++.+.+|+.+||..||.+|||++|+|+||||++..
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~  290 (292)
T d1unla_         223 TEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC  290 (292)
T ss_dssp             CTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCS
T ss_pred             ChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCC
Confidence                                     1112345678999999999999999999999999999998643

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-52  Score=362.23  Aligned_cols=257  Identities=24%  Similarity=0.343  Sum_probs=208.4

Q ss_pred             cCccccccccccccCcceEEEEEEEccCC----ceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCC
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSN----SIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEG  119 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~  119 (337)
                      ...++|++.++||+|+||+||+|.+..++    ..||||+++..........+.+|+.++++++||||+++++++.+ ..
T Consensus         4 i~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~-~~   82 (283)
T d1mqba_           4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK-YK   82 (283)
T ss_dssp             CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SS
T ss_pred             CCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEec-CC
Confidence            34568999999999999999999986544    46999999877666667788999999999999999999998876 67


Q ss_pred             eEEEEEeccCCCCchHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhc
Q 019650          120 EICFVMEHMERGSLFDSLRVR-KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEE  198 (337)
Q Consensus       120 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~  198 (337)
                      ..++||||+.++++.+++... ..+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||++.....
T Consensus        83 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~  162 (283)
T d1mqba_          83 PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  162 (283)
T ss_dssp             SEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred             ceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccC
Confidence            899999999999998887654 6799999999999999999999999999999999999999999999999999987654


Q ss_pred             cccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHH
Q 019650          199 TRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALIC  278 (337)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~  278 (337)
                      .....           .......||+.|+|||++.    +..++.++||||||+++|||+++..|+......   .....
T Consensus       163 ~~~~~-----------~~~~~~~gt~~Y~APE~l~----~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~---~~~~~  224 (283)
T d1mqba_         163 DPEAT-----------YTTSGGKIPIRWTAPEAIS----YRKFTSASDVWSFGIVMWEVMTYGERPYWELSN---HEVMK  224 (283)
T ss_dssp             ----------------------CCCGGGSCHHHHH----SCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHH
T ss_pred             CCccc-----------eEeccCCCCccccCHHHHc----cCCCCCcccccccHHHHHHHHhCCCCccccCCH---HHHHH
Confidence            32211           1122335789999999998    568899999999999999999966665443332   23444


Q ss_pred             HhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhc
Q 019650          279 AICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA  319 (337)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~  319 (337)
                      ....+..+..+..++..+.+||.+||+.||++|||+.+|++
T Consensus       225 ~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~  265 (283)
T d1mqba_         225 AINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS  265 (283)
T ss_dssp             HHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             HHhccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence            45556677778889999999999999999999999999987

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-52  Score=373.03  Aligned_cols=262  Identities=27%  Similarity=0.379  Sum_probs=207.9

Q ss_pred             CccccccccccccCcceEEEEEEEccCCceEEEEEeecCC-chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeC-----
Q 019650           45 NISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIE-----  118 (337)
Q Consensus        45 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~-----  118 (337)
                      ..++|++++.||+|+||+||+|.+..+++.||+|+++... .....+.+.+|+.++++++||||+++++++...+     
T Consensus        16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~   95 (346)
T d1cm8a_          16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF   95 (346)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence            4579999999999999999999999999999999997543 4455677889999999999999999999987643     


Q ss_pred             CeEEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhc
Q 019650          119 GEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEE  198 (337)
Q Consensus       119 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~  198 (337)
                      ..+|+||||+ +.+|..++. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.++++|||++.....
T Consensus        96 ~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~  173 (346)
T d1cm8a_          96 TDFYLVMPFM-GTDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS  173 (346)
T ss_dssp             CCCEEEEECC-SEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             ceEEEEEecc-cccHHHHHH-hccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccCC
Confidence            2579999999 446666654 56799999999999999999999999999999999999999999999999999976543


Q ss_pred             cccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHH
Q 019650          199 TRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALIC  278 (337)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~  278 (337)
                      ..                 ....+++.|+|||.+...   ..++.++||||+||++|+|++|+.||.+............
T Consensus       174 ~~-----------------~~~~~t~~y~aPE~~~~~---~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~  233 (346)
T d1cm8a_         174 EM-----------------TGYVVTRWYRAPEVILNW---MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMK  233 (346)
T ss_dssp             SC-----------------CSSCSCGGGCCTHHHHTT---TCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             cc-----------------ccccccccccCHHHHcCC---CCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHh
Confidence            21                 233689999999998742   3568899999999999999999999976543332222221


Q ss_pred             Hhhc--------------------------cCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCC
Q 019650          279 AICF--------------------------GERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSS  328 (337)
Q Consensus       279 ~~~~--------------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~  328 (337)
                      ....                          ..........++.+.+||.+||..||++|||++|+|+||||++...
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~  309 (346)
T d1cm8a_         234 VTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD  309 (346)
T ss_dssp             HHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred             ccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCC
Confidence            1000                          0011123467899999999999999999999999999999997653

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-52  Score=371.83  Aligned_cols=269  Identities=24%  Similarity=0.371  Sum_probs=213.0

Q ss_pred             ccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeC----CeE
Q 019650           46 ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIE----GEI  121 (337)
Q Consensus        46 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~----~~~  121 (337)
                      .++|++++.||+|+||+||+|.+..+++.||||++.........+.+.+|+.++++++|||++++++++....    ..+
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            3679999999999999999999999999999999987666666778889999999999999999999886532    235


Q ss_pred             EEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhcccc
Q 019650          122 CFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRN  201 (337)
Q Consensus       122 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~  201 (337)
                      |+++ ++.+|+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus        87 ~l~~-~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~  164 (345)
T d1pmea_          87 YLVT-HLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD  164 (345)
T ss_dssp             EEEE-ECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGC
T ss_pred             EEEE-eecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCc
Confidence            5555 5558899999975 4699999999999999999999999999999999999999999999999999987654432


Q ss_pred             CCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhh
Q 019650          202 NNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAIC  281 (337)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~  281 (337)
                      ..           ......+|++.|+|||.+..   +..++.++||||+|+++|+|++|+.||.+...............
T Consensus       165 ~~-----------~~~~~~~gt~~y~aPE~l~~---~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~  230 (345)
T d1pmea_         165 HT-----------GFLTEYVATRWYRAPEIMLN---SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG  230 (345)
T ss_dssp             BC-----------CTTCCCCSCGGGCCGGGTTT---BCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred             cc-----------eeeccccccceechHHHhhc---CCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhcc
Confidence            21           12233468999999999864   34678899999999999999999999976443322222211110


Q ss_pred             cc-------------------CCC-------CCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCCc
Q 019650          282 FG-------------------ERL-------EMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSSS  330 (337)
Q Consensus       282 ~~-------------------~~~-------~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~~  330 (337)
                      ..                   ...       ...+..+..+.+|+.+||..||.+|||++|+|+||||+......
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~~  305 (345)
T d1pmea_         231 SPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPS  305 (345)
T ss_dssp             SCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCGG
T ss_pred             CCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCCc
Confidence            00                   000       11245678999999999999999999999999999999766543

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-52  Score=361.87  Aligned_cols=263  Identities=24%  Similarity=0.335  Sum_probs=214.4

Q ss_pred             CCccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCe
Q 019650           41 PDVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGE  120 (337)
Q Consensus        41 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~  120 (337)
                      .|+.+.++|++.+.||+|+||+||+|.+..+ ..||||+++....  ..+.+.+|+.++++++|+||+++++++.  +..
T Consensus        11 ~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~g~~~--~~~   85 (285)
T d1fmka3          11 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVS--EEP   85 (285)
T ss_dssp             CSBCCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEEC--SSS
T ss_pred             ceEcCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccC--CHHHHHHHHHHHHhcccCCEeEEEEEEe--cCC
Confidence            3556679999999999999999999998755 5699999976543  3467899999999999999999999874  456


Q ss_pred             EEEEEeccCCCCchHHhhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhc
Q 019650          121 ICFVMEHMERGSLFDSLRV--RKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEE  198 (337)
Q Consensus       121 ~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~  198 (337)
                      .++||||+++|+|.+++..  .+.+++..+..++.||+.||+|||++|++||||||+|||++.++++||+|||++.....
T Consensus        86 ~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~  165 (285)
T d1fmka3          86 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED  165 (285)
T ss_dssp             CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred             eEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccC
Confidence            7899999999999988864  35799999999999999999999999999999999999999999999999999987644


Q ss_pred             cccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHH
Q 019650          199 TRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALIC  278 (337)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~  278 (337)
                      ...             .......+++.|+|||++.    +..++.++||||||+++|||++|..|+........   ...
T Consensus       166 ~~~-------------~~~~~~~gt~~y~aPE~~~----~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~---~~~  225 (285)
T d1fmka3         166 NEY-------------TARQGAKFPIKWTAPEAAL----YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---VLD  225 (285)
T ss_dssp             -----------------------CCGGGSCHHHHH----HCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHH
T ss_pred             CCc-------------eeeccccccccccChHHHh----CCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHH---HHH
Confidence            321             1112235899999999998    45789999999999999999996666544333322   333


Q ss_pred             HhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhc--CccccccCC
Q 019650          279 AICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA--YPFVTKRSS  328 (337)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~--hp~f~~~~~  328 (337)
                      ....+.....+..+++.+.++|.+||+.||++|||+++|++  ++||++...
T Consensus       226 ~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p  277 (285)
T d1fmka3         226 QVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP  277 (285)
T ss_dssp             HHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred             HHHhcCCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCC
Confidence            34445566778889999999999999999999999999998  889987654

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-52  Score=372.03  Aligned_cols=263  Identities=25%  Similarity=0.350  Sum_probs=208.6

Q ss_pred             CccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEee----
Q 019650           42 DVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTI----  117 (337)
Q Consensus        42 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~----  117 (337)
                      .....-+|+.+++||+|+||+||+|.+..+++.||||++......     ..+|+.++++++|+||+++++++...    
T Consensus        15 ~~~~~~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~   89 (350)
T d1q5ka_          15 DRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-----KNRELQIMRKLDHCNIVRLRYFFYSSGEKK   89 (350)
T ss_dssp             CCCEEEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS-----CCHHHHHHHHCCCTTBCCEEEEEEEC--CC
T ss_pred             CCcccCCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH-----HHHHHHHHHhcCCCCCCcEEEEEEecCccC
Confidence            334455899999999999999999999999999999999765422     23699999999999999999998653    


Q ss_pred             -CCeEEEEEeccCCCCchHH---hhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCC-cEEEeeccC
Q 019650          118 -EGEICFVMEHMERGSLFDS---LRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKG-EVKIADFGV  192 (337)
Q Consensus       118 -~~~~~lv~e~~~~~~L~~~---l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~-~~~l~Dfg~  192 (337)
                       ..++++||||++++.+..+   ......+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+
T Consensus        90 ~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~  169 (350)
T d1q5ka_          90 DEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGS  169 (350)
T ss_dssp             SCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTT
T ss_pred             CceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccc
Confidence             2357999999987533332   23456799999999999999999999999999999999999999775 899999999


Q ss_pred             ccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchh
Q 019650          193 SRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPD  272 (337)
Q Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~  272 (337)
                      +.......               .....+|++.|+|||.+...   ..++.++||||+||++|||++|+.||........
T Consensus       170 a~~~~~~~---------------~~~~~~gt~~y~aPE~~~~~---~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~  231 (350)
T d1q5ka_         170 AKQLVRGE---------------PNVSYICSRYYRAPELIFGA---TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ  231 (350)
T ss_dssp             CEECCTTS---------------CCCSCCSCTTSCCHHHHTTC---SSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH
T ss_pred             hhhccCCc---------------ccccccccccccChHHhhcc---cCCCcceeecccceEEEehhhCCCCCCCCCHHHH
Confidence            87664332               22234689999999988742   4689999999999999999999999976544333


Q ss_pred             HHHHHHHhhc------------cCCC------------CCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccC
Q 019650          273 LMALICAICF------------GERL------------EMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRS  327 (337)
Q Consensus       273 ~~~~~~~~~~------------~~~~------------~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~  327 (337)
                      ..........            ....            ......++.+.+||.+||..||.+|||++|+|+||||++..
T Consensus       232 l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~  310 (350)
T d1q5ka_         232 LVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR  310 (350)
T ss_dssp             HHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred             HHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence            3332221100            0000            11234688999999999999999999999999999998754

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.4e-53  Score=361.96  Aligned_cols=256  Identities=28%  Similarity=0.384  Sum_probs=207.8

Q ss_pred             CccCccccccccccccCcceEEEEEEEccC---CceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeC
Q 019650           42 DVENISDLKKLTVLGHGNGGIVYKVRHQKS---NSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIE  118 (337)
Q Consensus        42 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~  118 (337)
                      |+...++|++++.||+|+||+||+|.+..+   +..||+|.++........+.+.+|+.++++++||||+++++++.  +
T Consensus         2 ~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~--~   79 (273)
T d1mp8a_           2 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT--E   79 (273)
T ss_dssp             CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC--S
T ss_pred             CCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe--c
Confidence            345568999999999999999999998643   45688999877666667788999999999999999999999874  4


Q ss_pred             CeEEEEEeccCCCCchHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchh
Q 019650          119 GEICFVMEHMERGSLFDSLRV-RKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVE  197 (337)
Q Consensus       119 ~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~  197 (337)
                      +.+++||||+++|+|.+++.. ...+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++....
T Consensus        80 ~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~  159 (273)
T d1mp8a_          80 NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME  159 (273)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred             CeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheecc
Confidence            678999999999999998764 4579999999999999999999999999999999999999999999999999997764


Q ss_pred             ccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCchhHHHH
Q 019650          198 ETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMAL  276 (337)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~~~~~~~~~~~  276 (337)
                      ....             .......||+.|+|||.+.    +..++.++||||||+++|||++ |.+||......+    .
T Consensus       160 ~~~~-------------~~~~~~~gt~~y~apE~l~----~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~----~  218 (273)
T d1mp8a_         160 DSTY-------------YKASKGKLPIKWMAPESIN----FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND----V  218 (273)
T ss_dssp             ------------------------CCGGGCCHHHHH----HCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG----H
T ss_pred             CCcc-------------eeccceecCcccchhhHhc----cCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH----H
Confidence            3321             1122335789999999998    4578999999999999999998 899997654433    2


Q ss_pred             HHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          277 ICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                      ......+...+.++.+++.+.+||.+||+.||++|||+++|++|
T Consensus       219 ~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~  262 (273)
T d1mp8a_         219 IGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  262 (273)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            33344566677888999999999999999999999999999986

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=8.1e-52  Score=365.40  Aligned_cols=260  Identities=22%  Similarity=0.344  Sum_probs=212.0

Q ss_pred             cCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcC-CCCceeeeeeEEee-CCeE
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLD-SQFIVKCHAVFYTI-EGEI  121 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~-~~~~  121 (337)
                      ...++|++++.||+|+||+||+|.+..+++.||+|+++...    .+.+.+|+.+++++. |+||+++++++... ...+
T Consensus        32 ~~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~  107 (328)
T d3bqca1          32 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTP  107 (328)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSE
T ss_pred             CCCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCce
Confidence            35689999999999999999999999999999999987543    456788999999995 99999999988653 3569


Q ss_pred             EEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCC-cEEEeeccCccchhccc
Q 019650          122 CFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKG-EVKIADFGVSRIVEETR  200 (337)
Q Consensus       122 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~-~~~l~Dfg~~~~~~~~~  200 (337)
                      ++||||+++++|.++.   +.+++..++.++.||+.||.|||++||+||||||+|||++.++ .++|+|||++.......
T Consensus       108 ~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~  184 (328)
T d3bqca1         108 ALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ  184 (328)
T ss_dssp             EEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC
T ss_pred             eEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCCC
Confidence            9999999999988775   4799999999999999999999999999999999999998765 69999999998765432


Q ss_pred             cCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHh
Q 019650          201 NNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAI  280 (337)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~  280 (337)
                                     .....++|+.|+|||.+...   ..++.++|+||+|+++|++++|..||....+.......+...
T Consensus       185 ---------------~~~~~~~t~~y~aPE~~~~~---~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~  246 (328)
T d3bqca1         185 ---------------EYNVRVASRYFKGPELLVDY---QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKV  246 (328)
T ss_dssp             ---------------CCCSCCSCGGGCCHHHHTTC---CCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHH
T ss_pred             ---------------cccccccCccccCcccccCC---CCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHH
Confidence                           12233589999999998743   357899999999999999999999997655443322222111


Q ss_pred             hcc---------------------------------CCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccC
Q 019650          281 CFG---------------------------------ERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRS  327 (337)
Q Consensus       281 ~~~---------------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~  327 (337)
                      ...                                 ........+++.+.+||.+||..||.+|||++|+|+||||++..
T Consensus       247 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~  326 (328)
T d3bqca1         247 LGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV  326 (328)
T ss_dssp             HCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSC
T ss_pred             HCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence            100                                 00011134678899999999999999999999999999999865


Q ss_pred             C
Q 019650          328 S  328 (337)
Q Consensus       328 ~  328 (337)
                      +
T Consensus       327 ~  327 (328)
T d3bqca1         327 K  327 (328)
T ss_dssp             C
T ss_pred             C
Confidence            4

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-52  Score=365.12  Aligned_cols=259  Identities=24%  Similarity=0.327  Sum_probs=207.4

Q ss_pred             ccCccccccccccccCcceEEEEEEEcc-----CCceEEEEEeecCCchHhHHHHHHHHHHHHhc-CCCCceeeeeeEEe
Q 019650           43 VENISDLKKLTVLGHGNGGIVYKVRHQK-----SNSIYALKVLNTTSSTIIRHQAAHEAEILKRL-DSQFIVKCHAVFYT  116 (337)
Q Consensus        43 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~  116 (337)
                      +...++|++++.||+|+||+||+|.+..     +++.||+|+++........+.+.+|...+.++ .|+||+.+++.+.+
T Consensus         9 ei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~   88 (299)
T d1ywna1           9 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK   88 (299)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeecc
Confidence            3456899999999999999999999753     44689999998766666667777888888777 67899999998877


Q ss_pred             eCCeEEEEEeccCCCCchHHhhhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEc
Q 019650          117 IEGEICFVMEHMERGSLFDSLRVR----------------KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLIN  180 (337)
Q Consensus       117 ~~~~~~lv~e~~~~~~L~~~l~~~----------------~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~  180 (337)
                      .+..+++||||+++|+|.+++...                ..+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus        89 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~  168 (299)
T d1ywna1          89 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS  168 (299)
T ss_dssp             TTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC
T ss_pred             CCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeEC
Confidence            667799999999999999999643                2488999999999999999999999999999999999999


Q ss_pred             CCCcEEEeeccCccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhC
Q 019650          181 GKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVG  260 (337)
Q Consensus       181 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg  260 (337)
                      .++++||+|||++.........            .......||+.|+|||.+.    +..++.++||||||+++|||+|+
T Consensus       169 ~~~~~Kl~DFGla~~~~~~~~~------------~~~~~~~gt~~y~APE~l~----~~~~~~~sDiwS~Gvil~ellt~  232 (299)
T d1ywna1         169 EKNVVKICDFGLARDIYKDPDY------------VRKGDARLPLKWMAPETIF----DRVYTIQSDVWSFGVLLWEIFSL  232 (299)
T ss_dssp             GGGCEEECC------CCSCTTS------------CCTTSCCCGGGGCCHHHHH----HCCCCHHHHHHHHHHHHHHHHTT
T ss_pred             CCCcEEEccCcchhhccccccc------------cccCceeeCccccchhHhh----cCCCCcccceeehHHHHHHHHhC
Confidence            9999999999999765433211            1223346899999999998    45789999999999999999986


Q ss_pred             -CCCCCCCCCchhHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          261 -HYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       261 -~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                       ..||............   ...+..+..+..+++.+.+++.+||+.||++|||++|+++|
T Consensus       233 ~~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~  290 (299)
T d1ywna1         233 GASPYPGVKIDEEFCRR---LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  290 (299)
T ss_dssp             SCCSSTTCCCSHHHHHH---HHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHH---HhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence             5678665554443333   34456677788899999999999999999999999999987

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-52  Score=357.55  Aligned_cols=249  Identities=24%  Similarity=0.401  Sum_probs=207.3

Q ss_pred             CccCccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeE
Q 019650           42 DVENISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEI  121 (337)
Q Consensus        42 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~  121 (337)
                      |+.+.++|++++.||+|+||.||+|.++  +..||+|+++.+.   ..+.+.+|+.++++++||||+++++++.+..+.+
T Consensus         2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~---~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~   76 (262)
T d1byga_           2 WALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL   76 (262)
T ss_dssp             CBCCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CC
T ss_pred             CccCHHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcHH---HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcE
Confidence            6678899999999999999999999884  6789999997543   3467889999999999999999999887655678


Q ss_pred             EEEEeccCCCCchHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhcc
Q 019650          122 CFVMEHMERGSLFDSLRVR--KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEET  199 (337)
Q Consensus       122 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~  199 (337)
                      ++||||+++|+|.+++...  ..+++..++.++.||+.||.|||+.+++||||||+||+++.++.++++|||++......
T Consensus        77 ~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~  156 (262)
T d1byga_          77 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  156 (262)
T ss_dssp             EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred             EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCC
Confidence            9999999999999999654  35899999999999999999999999999999999999999999999999999765432


Q ss_pred             ccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHH
Q 019650          200 RNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALIC  278 (337)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~  278 (337)
                      ..                 ...++..|+|||.+.    +..++.++||||||+++|||+| |++||......    ....
T Consensus       157 ~~-----------------~~~~~~~y~aPE~l~----~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~----~~~~  211 (262)
T d1byga_         157 QD-----------------TGKLPVKWTAPEALR----EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK----DVVP  211 (262)
T ss_dssp             ----------------------CCTTTSCHHHHH----HCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG----GHHH
T ss_pred             Cc-----------------cccccccCCChHHHh----CCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH----HHHH
Confidence            21                 124788999999998    4578999999999999999998 78887654332    2333


Q ss_pred             HhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          279 AICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                      ....+..+..+...++.+.+||.+||..||.+|||+.+++++
T Consensus       212 ~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~  253 (262)
T d1byga_         212 RVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ  253 (262)
T ss_dssp             HHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHcCCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence            345567778888899999999999999999999999999885

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-52  Score=366.02  Aligned_cols=254  Identities=24%  Similarity=0.382  Sum_probs=208.1

Q ss_pred             ccccccccccccCcceEEEEEEEccCCc----eEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeE
Q 019650           46 ISDLKKLTVLGHGNGGIVYKVRHQKSNS----IYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEI  121 (337)
Q Consensus        46 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~  121 (337)
                      .++|++++.||+|+||+||+|.+..+++    +||+|.++........+.+.+|+.++++++||||+++++++.+  ...
T Consensus         8 ~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~--~~~   85 (317)
T d1xkka_           8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT--STV   85 (317)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES--SSE
T ss_pred             HHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec--CCe
Confidence            4679999999999999999999987765    5888888765555567788999999999999999999998865  567


Q ss_pred             EEEEeccCCCCchHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccc
Q 019650          122 CFVMEHMERGSLFDSLRVR-KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETR  200 (337)
Q Consensus       122 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~  200 (337)
                      +++++++.+++|.+++... ..+++..++.++.||+.||+|||++||+||||||+||+++.++++||+|||++.......
T Consensus        86 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~  165 (317)
T d1xkka_          86 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE  165 (317)
T ss_dssp             EEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTC
T ss_pred             eEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceeccccc
Confidence            8889999999999888654 679999999999999999999999999999999999999999999999999998765432


Q ss_pred             cCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCchhHHHHHHH
Q 019650          201 NNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALICA  279 (337)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~~  279 (337)
                      ..            .......||+.|+|||.+.    +..++.++||||||+++|||+| |..||.+....+ .   ...
T Consensus       166 ~~------------~~~~~~~gt~~y~APE~l~----~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~-~---~~~  225 (317)
T d1xkka_         166 KE------------YHAEGGKVPIKWMALESIL----HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-I---SSI  225 (317)
T ss_dssp             C--------------------CCTTTSCHHHHH----HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG-H---HHH
T ss_pred             cc------------ccccccccCccccChHHHh----cCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH-H---HHH
Confidence            11            1122335899999999998    4578999999999999999999 788887654332 2   233


Q ss_pred             hhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCc
Q 019650          280 ICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAYP  321 (337)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp  321 (337)
                      ...+..+..+..+++.+.+|+.+||..||.+|||+.+|++|.
T Consensus       226 i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l  267 (317)
T d1xkka_         226 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEF  267 (317)
T ss_dssp             HHHTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHcCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHH
Confidence            344566677788999999999999999999999999999884

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-51  Score=355.17  Aligned_cols=257  Identities=25%  Similarity=0.368  Sum_probs=214.9

Q ss_pred             CccCccccccccccccCcceEEEEEEEccCC-------ceEEEEEeecCCchHhHHHHHHHHHHHHhc-CCCCceeeeee
Q 019650           42 DVENISDLKKLTVLGHGNGGIVYKVRHQKSN-------SIYALKVLNTTSSTIIRHQAAHEAEILKRL-DSQFIVKCHAV  113 (337)
Q Consensus        42 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~-------~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~  113 (337)
                      |....++|++++.||+|+||.||+|.+..++       ..||+|+++..........+.+|...+.++ +||||++++++
T Consensus         8 ~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~   87 (299)
T d1fgka_           8 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA   87 (299)
T ss_dssp             TBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             CcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccc
Confidence            5667899999999999999999999976544       469999998877666677888899999888 89999999999


Q ss_pred             EEeeCCeEEEEEeccCCCCchHHhhhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCe
Q 019650          114 FYTIEGEICFVMEHMERGSLFDSLRVRK----------------KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNL  177 (337)
Q Consensus       114 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Ni  177 (337)
                      +.+ +...++||||+++|+|.+++....                .+++.+++.++.||+.||.|||+.||+||||||+||
T Consensus        88 ~~~-~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~Ni  166 (299)
T d1fgka_          88 CTQ-DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNV  166 (299)
T ss_dssp             ECS-SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred             ccc-CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccce
Confidence            876 678999999999999999997543                489999999999999999999999999999999999


Q ss_pred             EEcCCCcEEEeeccCccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHH
Q 019650          178 LINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLEC  257 (337)
Q Consensus       178 li~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l  257 (337)
                      |++.++.+||+|||.+..........            ......+++.|+|||.+.    +..|+.++||||||+++|||
T Consensus       167 Ll~~~~~~kl~dfg~~~~~~~~~~~~------------~~~~~~~~~~y~aPE~l~----~~~y~~k~DiwS~Gvvl~el  230 (299)
T d1fgka_         167 LVTEDNVMKIADFGLARDIHHIDYYK------------KTTNGRLPVKWMAPEALF----DRIYTHQSDVWSFGVLLWEI  230 (299)
T ss_dssp             EECTTCCEEECSTTCCCCGGGCCTTC------------CCTTSCCGGGGSCHHHHH----HCCCCHHHHHHHHHHHHHHH
T ss_pred             eecCCCCeEeccchhhcccccccccc------------ccccCCCChhhhhhhHhc----CCCCCchhhhHHhHHHHHHh
Confidence            99999999999999998776543221            223345889999999998    45889999999999999999


Q ss_pred             Hh-CCCCCCCCCCchhHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhc
Q 019650          258 LV-GHYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA  319 (337)
Q Consensus       258 ~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~  319 (337)
                      ++ |..||.....    .........+..+..+..+++.+.+||.+||+.||++|||+.||++
T Consensus       231 l~~g~~p~~~~~~----~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~  289 (299)
T d1fgka_         231 FTLGGSPYPGVPV----EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  289 (299)
T ss_dssp             HTTSCCSSTTCCH----HHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccCCCCCCCCCCH----HHHHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence            98 7888865332    2334445566777888889999999999999999999999999987

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-51  Score=359.58  Aligned_cols=254  Identities=29%  Similarity=0.361  Sum_probs=211.9

Q ss_pred             ccCccccccccccccCcceEEEEEEEccCCce--EEEEEeecCCchHhHHHHHHHHHHHHhc-CCCCceeeeeeEEeeCC
Q 019650           43 VENISDLKKLTVLGHGNGGIVYKVRHQKSNSI--YALKVLNTTSSTIIRHQAAHEAEILKRL-DSQFIVKCHAVFYTIEG  119 (337)
Q Consensus        43 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~--vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~  119 (337)
                      ..+.++|++.+.||+|+||+||+|.+..++..  ||||.++........+.+.+|+.+++++ +||||+++++++.+ ++
T Consensus         6 ~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~-~~   84 (309)
T d1fvra_           6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-RG   84 (309)
T ss_dssp             BCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE-TT
T ss_pred             ccCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEec-CC
Confidence            34678999999999999999999999887764  6778776555555566789999999999 79999999999876 78


Q ss_pred             eEEEEEeccCCCCchHHhhhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCC
Q 019650          120 EICFVMEHMERGSLFDSLRVR----------------KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKG  183 (337)
Q Consensus       120 ~~~lv~e~~~~~~L~~~l~~~----------------~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~  183 (337)
                      .+++||||+++|+|.+++...                ..+++..+..++.||+.||.|||+.|++||||||+|||++.++
T Consensus        85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~  164 (309)
T d1fvra_          85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY  164 (309)
T ss_dssp             EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred             eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCC
Confidence            999999999999999999643                4689999999999999999999999999999999999999999


Q ss_pred             cEEEeeccCccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCC-C
Q 019650          184 EVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGH-Y  262 (337)
Q Consensus       184 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~-~  262 (337)
                      .+||+|||++........               .....+|..|+|||.+.    +..++.++||||||+++|||++|. +
T Consensus       165 ~~kl~DfG~a~~~~~~~~---------------~~~~~gt~~y~aPE~l~----~~~~~~~sDvwSfGvil~ell~~~~~  225 (309)
T d1fvra_         165 VAKIADFGLSRGQEVYVK---------------KTMGRLPVRWMAIESLN----YSVYTTNSDVWSYGVLLWEIVSLGGT  225 (309)
T ss_dssp             CEEECCTTCEESSCEECC---------------C----CCTTTCCHHHHH----HCEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred             ceEEcccccccccccccc---------------ccceecCCcccchHHhc----cCCCCccceeehhHHHHHHHHhcCCC
Confidence            999999999976544321               12335899999999998    457899999999999999999965 5


Q ss_pred             CCCCCCCchhHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          263 PLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       263 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                      ||.+.    ....+......+..+..+..+++.+.+||.+||+.||++|||+++|+++
T Consensus       226 p~~~~----~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  279 (309)
T d1fvra_         226 PYCGM----TCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  279 (309)
T ss_dssp             TTTTC----CHHHHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCC----CHHHHHHHHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            66543    2333444555667778888899999999999999999999999999987

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3e-51  Score=356.98  Aligned_cols=255  Identities=26%  Similarity=0.361  Sum_probs=215.4

Q ss_pred             cCccccccccccccCcceEEEEEEEc-----cCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeC
Q 019650           44 ENISDLKKLTVLGHGNGGIVYKVRHQ-----KSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIE  118 (337)
Q Consensus        44 ~~~~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~  118 (337)
                      ...++|++.+.||+|+||+||+|...     .++..||||+++........+.+.+|+.++++++|+||+++++++.. .
T Consensus        10 ~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~-~   88 (301)
T d1lufa_          10 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV-G   88 (301)
T ss_dssp             CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-S
T ss_pred             CCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeecc-C
Confidence            34678999999999999999999875     35678999999877666667889999999999999999999998876 6


Q ss_pred             CeEEEEEeccCCCCchHHhhhcC------------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCC
Q 019650          119 GEICFVMEHMERGSLFDSLRVRK------------------------KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKP  174 (337)
Q Consensus       119 ~~~~lv~e~~~~~~L~~~l~~~~------------------------~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~  174 (337)
                      ...+++|||+++|+|.+++....                        .+++..+..++.|++.||+|||++|++||||||
T Consensus        89 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp  168 (301)
T d1lufa_          89 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLAT  168 (301)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred             CceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcc
Confidence            88999999999999999996432                        488999999999999999999999999999999


Q ss_pred             CCeEEcCCCcEEEeeccCccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHH
Q 019650          175 SNLLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVV  254 (337)
Q Consensus       175 ~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il  254 (337)
                      +|||++.++++||+|||++.........            .......+++.|+|||.+.    +..++.++||||||+++
T Consensus       169 ~NILld~~~~~Kl~DFGls~~~~~~~~~------------~~~~~~~~~~~y~aPE~~~----~~~~t~ksDVwS~Gvvl  232 (301)
T d1lufa_         169 RNCLVGENMVVKIADFGLSRNIYSADYY------------KADGNDAIPIRWMPPESIF----YNRYTTESDVWAYGVVL  232 (301)
T ss_dssp             GGEEECGGGCEEECCCSCHHHHTGGGCB------------C----CCBCGGGCCHHHHH----HCCCCHHHHHHHHHHHH
T ss_pred             cceEECCCCcEEEccchhheeccCCccc------------cccCCCCcCcCcCCHHHHc----cCCCChhhhhccchhhH
Confidence            9999999999999999999866543221            1222345889999999998    55789999999999999


Q ss_pred             HHHHhCC-CCCCCCCCchhHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhc
Q 019650          255 LECLVGH-YPLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA  319 (337)
Q Consensus       255 ~~l~tg~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~  319 (337)
                      |||++|. +||......    +.......+..+..+..+++.+.+|+.+||+.||++|||+.||++
T Consensus       233 ~ell~~~~~p~~~~~~~----e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~  294 (301)
T d1lufa_         233 WEIFSYGLQPYYGMAHE----EVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR  294 (301)
T ss_dssp             HHHHTTTCCTTTTSCHH----HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHccCCCCCCCCCHH----HHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            9999985 567554332    333444556667778889999999999999999999999999965

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-51  Score=367.64  Aligned_cols=262  Identities=24%  Similarity=0.335  Sum_probs=202.7

Q ss_pred             ccccccccccccCcceEEEEEEEccCCceEEEEEeecCC-chHhHHHHHHHHHHHHhcCCCCceeeeeeEEee-----CC
Q 019650           46 ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTI-----EG  119 (337)
Q Consensus        46 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~  119 (337)
                      .++|+++++||+|+||+||+|.+..+|+.||+|++.... .....+.+.+|+.++++++||||+++++++...     ..
T Consensus        16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~   95 (355)
T d2b1pa1          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ   95 (355)
T ss_dssp             ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence            478999999999999999999999999999999997653 344556788999999999999999999998643     36


Q ss_pred             eEEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhcc
Q 019650          120 EICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEET  199 (337)
Q Consensus       120 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~  199 (337)
                      .+|+||||+.+ ++.+.+.  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++++|||.+......
T Consensus        96 ~~~iv~Ey~~~-~l~~~~~--~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~  172 (355)
T d2b1pa1          96 DVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS  172 (355)
T ss_dssp             EEEEEEECCSE-EHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred             eeEEEEeccch-HHHHhhh--cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhccccc
Confidence            78999999976 4555553  57999999999999999999999999999999999999999999999999988766543


Q ss_pred             ccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHH
Q 019650          200 RNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICA  279 (337)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~  279 (337)
                      .               .....++|+.|+|||++.    +..++.++||||+||++|+|++|+.||.+.+...........
T Consensus       173 ~---------------~~~~~~~t~~y~aPE~l~----~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~  233 (355)
T d2b1pa1         173 F---------------MMTPYVVTRYYRAPEVIL----GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ  233 (355)
T ss_dssp             -----------------------CCTTCCHHHHT----TCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred             c---------------ccccccccccccChhhhc----CCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHh
Confidence            2               222335899999999998    567899999999999999999999999765433333222221


Q ss_pred             hhc------------------cCCCC-------------C------CCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCcc
Q 019650          280 ICF------------------GERLE-------------M------PETASPEFRRFVRSCLEKDWRKRGTVEELLAYPF  322 (337)
Q Consensus       280 ~~~------------------~~~~~-------------~------~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~  322 (337)
                      ...                  .....             .      ....++.+.+||.+||..||++|||++|+|+|||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw  313 (355)
T d2b1pa1         234 LGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPY  313 (355)
T ss_dssp             HCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTT
T ss_pred             ccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcc
Confidence            111                  00000             0      0112457899999999999999999999999999


Q ss_pred             ccccCCC
Q 019650          323 VTKRSSS  329 (337)
Q Consensus       323 f~~~~~~  329 (337)
                      |+.....
T Consensus       314 ~~~~~~~  320 (355)
T d2b1pa1         314 INVWYDP  320 (355)
T ss_dssp             TGGGCCH
T ss_pred             cCCCCCc
Confidence            9986543

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-51  Score=365.60  Aligned_cols=263  Identities=26%  Similarity=0.369  Sum_probs=209.4

Q ss_pred             ccccccccccccCcceEEEEEEEccCCceEEEEEeecCC-chHhHHHHHHHHHHHHhcCCCCceeeeeeEEee----CCe
Q 019650           46 ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTS-STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTI----EGE  120 (337)
Q Consensus        46 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~----~~~  120 (337)
                      .++|++++.||+|+||+||+|.+..+++.||||+++... .....+.+.+|+.++++++|+|++++++++...    ...
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            478999999999999999999999999999999997654 344556788999999999999999999987642    123


Q ss_pred             EEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccc
Q 019650          121 ICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETR  200 (337)
Q Consensus       121 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~  200 (337)
                      .+++++++.||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+||+++.++.++++|||.+.......
T Consensus        97 ~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~~~  175 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM  175 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTGGG
T ss_pred             eEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCccc
Confidence            4556667778899999864 569999999999999999999999999999999999999999999999999987654322


Q ss_pred             cCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHh
Q 019650          201 NNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAI  280 (337)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~  280 (337)
                                       ....|++.|+|||.+...   ..++.++||||||+++|+|++|+.||.+.+............
T Consensus       176 -----------------~~~~g~~~y~apE~~~~~---~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~  235 (348)
T d2gfsa1         176 -----------------TGYVATRWYRAPEIMLNW---MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV  235 (348)
T ss_dssp             -----------------SSSCHHHHTSCHHHHTTC---SCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred             -----------------ccccccccccCchhhcCC---ccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence                             233588999999987742   356889999999999999999999997654433333222211


Q ss_pred             hccC------------------CCC--------CCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcCccccccCCC
Q 019650          281 CFGE------------------RLE--------MPETASPEFRRFVRSCLEKDWRKRGTVEELLAYPFVTKRSSS  329 (337)
Q Consensus       281 ~~~~------------------~~~--------~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~hp~f~~~~~~  329 (337)
                      ....                  ...        .....++.+.+||.+||..||.+|||++|+|+||||++....
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~  310 (348)
T d2gfsa1         236 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP  310 (348)
T ss_dssp             CCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCT
T ss_pred             CCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCC
Confidence            1000                  000        113568899999999999999999999999999999976543

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-50  Score=354.11  Aligned_cols=263  Identities=24%  Similarity=0.351  Sum_probs=222.1

Q ss_pred             CccCccccccccccccCcceEEEEEEEcc-----CCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEe
Q 019650           42 DVENISDLKKLTVLGHGNGGIVYKVRHQK-----SNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYT  116 (337)
Q Consensus        42 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~  116 (337)
                      |+...++|++++.||+|+||+||+|.+..     ++..||||+++..........+.+|+.++++++|+||+++++++..
T Consensus        15 ~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~   94 (308)
T d1p4oa_          15 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ   94 (308)
T ss_dssp             TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred             eeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec
Confidence            56667999999999999999999998852     3578999999876666666778999999999999999999998865


Q ss_pred             eCCeEEEEEeccCCCCchHHhhhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEE
Q 019650          117 IEGEICFVMEHMERGSLFDSLRVR----------KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVK  186 (337)
Q Consensus       117 ~~~~~~lv~e~~~~~~L~~~l~~~----------~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~  186 (337)
                       +...++||||+++|+|.+++...          ..+++..+..++.|++.||.|||+++|+||||||+|||++.++++|
T Consensus        95 -~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~K  173 (308)
T d1p4oa_          95 -GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVK  173 (308)
T ss_dssp             -SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEE
T ss_pred             -CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEE
Confidence             67899999999999999998643          2478999999999999999999999999999999999999999999


Q ss_pred             EeeccCccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhC-CCCCC
Q 019650          187 IADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVG-HYPLI  265 (337)
Q Consensus       187 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg-~~pf~  265 (337)
                      |+|||++.........            .......+++.|+|||.+.    +..++.++||||||+++|||+|| ..||.
T Consensus       174 l~DFGla~~~~~~~~~------------~~~~~~~~t~~y~aPe~l~----~~~~~~~~Dv~S~G~il~El~t~~~~p~~  237 (308)
T d1p4oa_         174 IGDFGMTRDIYETDYY------------RKGGKGLLPVRWMSPESLK----DGVFTTYSDVWSFGVVLWEIATLAEQPYQ  237 (308)
T ss_dssp             ECCTTCCCGGGGGGCE------------EGGGSSEECGGGCCHHHHH----HCCCCHHHHHHHHHHHHHHHHHTSCCTTT
T ss_pred             EeecccceeccCCcce------------eeccceecccccCCHHHHc----cCCCCcccccccHHHHHHHHHhCCCCCCC
Confidence            9999999876544321            2223345899999999998    56789999999999999999997 57775


Q ss_pred             CCCCchhHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhc------Cccccc
Q 019650          266 GFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA------YPFVTK  325 (337)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~------hp~f~~  325 (337)
                      +....    +.......+..+..+..++..+.++|.+||+.||++|||+++|++      +|+|++
T Consensus       238 ~~~~~----~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~  299 (308)
T d1p4oa_         238 GLSNE----QVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE  299 (308)
T ss_dssp             TSCHH----HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHH
T ss_pred             CCCHH----HHHHHHHhCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCcC
Confidence            54332    233344456667778889999999999999999999999999998      788765

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-51  Score=352.10  Aligned_cols=255  Identities=27%  Similarity=0.384  Sum_probs=200.7

Q ss_pred             CccccccccccccCcceEEEEEEEcc-CC--ceEEEEEeecCC--chHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCC
Q 019650           45 NISDLKKLTVLGHGNGGIVYKVRHQK-SN--SIYALKVLNTTS--STIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEG  119 (337)
Q Consensus        45 ~~~~y~~~~~lg~g~~~~v~~~~~~~-~~--~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~  119 (337)
                      ..++|++++.||+|+||+||+|.... ++  ..||+|+++...  .....+.+.+|+.++++++||||+++++++.+  +
T Consensus         6 ~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~--~   83 (273)
T d1u46a_           6 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT--P   83 (273)
T ss_dssp             CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--S
T ss_pred             chHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee--c
Confidence            35789999999999999999998653 22  468999987643  33456778999999999999999999998853  5


Q ss_pred             eEEEEEeccCCCCchHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhc
Q 019650          120 EICFVMEHMERGSLFDSLRV-RKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEE  198 (337)
Q Consensus       120 ~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~  198 (337)
                      ..++||||++++++.+++.. .+.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus        84 ~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~  163 (273)
T d1u46a_          84 PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ  163 (273)
T ss_dssp             SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred             chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhccc
Confidence            77899999999999988764 45799999999999999999999999999999999999999999999999999987654


Q ss_pred             cccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHh-CCCCCCCCCCchhHHHHH
Q 019650          199 TRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLV-GHYPLIGFGEKPDLMALI  277 (337)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~t-g~~pf~~~~~~~~~~~~~  277 (337)
                      .....           .......++..|+|||.+.    +..++.++||||||+++|||+| |..||.+....+..... 
T Consensus       164 ~~~~~-----------~~~~~~~~~~~~~aPE~~~----~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i-  227 (273)
T d1u46a_         164 NDDHY-----------VMQEHRKVPFAWCAPESLK----TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI-  227 (273)
T ss_dssp             -CCEE-----------EC-----CCGGGCCHHHHH----HCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH-
T ss_pred             CCCcc-----------eecCccccCcccCCHHHHh----CCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHH-
Confidence            32211           1122334788999999998    4578899999999999999998 89999765433322222 


Q ss_pred             HHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhc
Q 019650          278 CAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA  319 (337)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~  319 (337)
                        ...+..++.+..+++.+.+||.+||+.||++|||+++|++
T Consensus       228 --~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~  267 (273)
T d1u46a_         228 --DKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD  267 (273)
T ss_dssp             --HTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --HhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence              2344556667888999999999999999999999999974

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-50  Score=352.70  Aligned_cols=259  Identities=25%  Similarity=0.354  Sum_probs=219.3

Q ss_pred             CCccCccccccccccccCcceEEEEEEEc-----cCCceEEEEEeecCCchHhHHHHHHHHHHHHhc-CCCCceeeeeeE
Q 019650           41 PDVENISDLKKLTVLGHGNGGIVYKVRHQ-----KSNSIYALKVLNTTSSTIIRHQAAHEAEILKRL-DSQFIVKCHAVF  114 (337)
Q Consensus        41 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~  114 (337)
                      .|+...++|++.+.||+|+||.||+|.+.     .+++.||+|+++..........+.+|+.+++++ +||||+++++++
T Consensus        17 ~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~   96 (311)
T d1t46a_          17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC   96 (311)
T ss_dssp             GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence            35566789999999999999999999863     566789999998777666777888999999999 699999999998


Q ss_pred             EeeCCeEEEEEeccCCCCchHHhhhcC------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCC
Q 019650          115 YTIEGEICFVMEHMERGSLFDSLRVRK------------------KLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSN  176 (337)
Q Consensus       115 ~~~~~~~~lv~e~~~~~~L~~~l~~~~------------------~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~N  176 (337)
                      .+ ....+++|||+++|+|.+++....                  .+++..+..++.||+.||+|||++|++||||||+|
T Consensus        97 ~~-~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~N  175 (311)
T d1t46a_          97 TI-GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN  175 (311)
T ss_dssp             CS-SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             ee-CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccc
Confidence            66 677999999999999999997543                  58999999999999999999999999999999999


Q ss_pred             eEEcCCCcEEEeeccCccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHH
Q 019650          177 LLINGKGEVKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLE  256 (337)
Q Consensus       177 ili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~  256 (337)
                      |+++.++.++++|||.+.........            .......||+.|+|||.+.    +..++.++||||||+++||
T Consensus       176 Il~~~~~~~ki~DfG~~~~~~~~~~~------------~~~~~~~gt~~y~aPE~~~----~~~~~~~~DIwS~G~~l~e  239 (311)
T d1t46a_         176 ILLTHGRITKICDFGLARDIKNDSNY------------VVKGNARLPVKWMAPESIF----NCVYTFESDVWSYGIFLWE  239 (311)
T ss_dssp             EEEETTTEEEECCCGGGSCTTSCTTS------------EECSSSEECGGGCCHHHHH----HCCCCHHHHHHHHHHHHHH
T ss_pred             ccccccCcccccccchheeccCCCcc------------eEeeecccChHHcCHHHhc----CCCCCCcccccchHHHHHH
Confidence            99999999999999999876543211            2233446899999999998    4578999999999999999


Q ss_pred             HHh-CCCCCCCCCCchhHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhc
Q 019650          257 CLV-GHYPLIGFGEKPDLMALICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA  319 (337)
Q Consensus       257 l~t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~  319 (337)
                      |+| |.+||......+.......   .+..+..+...++.+.+||.+||+.||.+|||+++|++
T Consensus       240 llt~g~p~~~~~~~~~~~~~~i~---~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~  300 (311)
T d1t46a_         240 LFSLGSSPYPGMPVDSKFYKMIK---EGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (311)
T ss_dssp             HHTTTCCSSTTCCSSHHHHHHHH---HTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHhCCCCCCCCCCHHHHHHHHHh---cCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            999 6666665555444444433   35566667788999999999999999999999999986

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-50  Score=349.83  Aligned_cols=252  Identities=22%  Similarity=0.312  Sum_probs=210.1

Q ss_pred             ccccccCcceEEEEEEEccC---CceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEecc
Q 019650           52 LTVLGHGNGGIVYKVRHQKS---NSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVMEHM  128 (337)
Q Consensus        52 ~~~lg~g~~~~v~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~e~~  128 (337)
                      .++||+|+||+||+|.+..+   ...||||.++........+.+.+|+.++++++||||+++++++.+.++..++||||+
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            57899999999999998643   336899999866666677889999999999999999999999877677899999999


Q ss_pred             CCCCchHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeeccCccchhccccCCCCCC
Q 019650          129 ERGSLFDSLRVR-KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFGVSRIVEETRNNNNHNN  207 (337)
Q Consensus       129 ~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~  207 (337)
                      ++++|.+++... ...++..+..++.|++.||.|||+.+|+||||||+|||++.++.+||+|||++...........   
T Consensus       112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~---  188 (311)
T d1r0pa_         112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV---  188 (311)
T ss_dssp             TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT---
T ss_pred             ecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccccc---
Confidence            999999988744 4578889999999999999999999999999999999999999999999999987754432221   


Q ss_pred             CCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHHHhhccCCCC
Q 019650          208 NNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALICAICFGERLE  287 (337)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~  287 (337)
                             .......||+.|+|||.+.    +..++.++||||||+++|||+||..||.......   ........+..+.
T Consensus       189 -------~~~~~~~gt~~y~aPE~~~----~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~---~~~~~i~~g~~~~  254 (311)
T d1r0pa_         189 -------HNKTGAKLPVKWMALESLQ----TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF---DITVYLLQGRRLL  254 (311)
T ss_dssp             -------TCTTCSSCCGGGSCHHHHH----HCCCCHHHHHHHHHHHHHHHHTTSCCSCC---------CHHHHHTTCCCC
T ss_pred             -------eecccccccccccChHHHh----cCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH---HHHHHHHcCCCCC
Confidence                   1222345899999999998    4578999999999999999999887875533322   2333344566777


Q ss_pred             CCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          288 MPETASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       288 ~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                      .+..+++.+.+||.+||+.||++|||+.||++|
T Consensus       255 ~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~  287 (311)
T d1r0pa_         255 QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  287 (311)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            788889999999999999999999999999998

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.8e-49  Score=343.09  Aligned_cols=266  Identities=20%  Similarity=0.217  Sum_probs=208.3

Q ss_pred             cccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCCeEEEEEe
Q 019650           47 SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEGEICFVME  126 (337)
Q Consensus        47 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~lv~e  126 (337)
                      ++|++++.||+|+||+||+|.+..+++.||||++......   +.+..|+++++.+.|++++..+..+.......++|||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme   83 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH---PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   83 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS---CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC---HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence            5799999999999999999999999999999998765422   3467899999999998888777777776888999999


Q ss_pred             ccCCCCchHHhh-hcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcC---CCcEEEeeccCccchhccccC
Q 019650          127 HMERGSLFDSLR-VRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLING---KGEVKIADFGVSRIVEETRNN  202 (337)
Q Consensus       127 ~~~~~~L~~~l~-~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~---~~~~~l~Dfg~~~~~~~~~~~  202 (337)
                      |+.+ +|.+.+. ....+++..+..++.|++.||+|||++||+||||||+||+++.   +..++++|||++.........
T Consensus        84 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~  162 (299)
T d1ckia_          84 LLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH  162 (299)
T ss_dssp             CCCC-BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTC
T ss_pred             EcCC-chhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccccc
Confidence            9954 6666654 4568999999999999999999999999999999999999864   457999999999887654322


Q ss_pred             CCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHHHHH---H
Q 019650          203 NNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMALIC---A  279 (337)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~~~~---~  279 (337)
                      ....       ........||+.|+|||.+.    +..++.++||||||+++|||++|..||..............   .
T Consensus       163 ~~~~-------~~~~~~~~gt~~y~aPE~~~----~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~  231 (299)
T d1ckia_         163 QHIP-------YRENKNLTGTARYASINTHL----GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK  231 (299)
T ss_dssp             CBCC-------CCBCCSCCCCSSSCCHHHHT----TBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHH
T ss_pred             ccee-------ccccCCcCCCccccCHHHHh----CCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcc
Confidence            1110       02333457999999999998    56789999999999999999999999976544433322221   1


Q ss_pred             hhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHH---HHhcCccccccC
Q 019650          280 ICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVE---ELLAYPFVTKRS  327 (337)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~---eil~hp~f~~~~  327 (337)
                      ............+++.+.+++.+||+.+|++||+++   ++|+|+|.++..
T Consensus       232 ~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~  282 (299)
T d1ckia_         232 KMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF  282 (299)
T ss_dssp             HHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTC
T ss_pred             cCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCC
Confidence            111222233467899999999999999999999987   457788776543

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=6.3e-47  Score=328.18  Aligned_cols=258  Identities=20%  Similarity=0.205  Sum_probs=205.9

Q ss_pred             ccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCC-CCceeeeeeEEeeCCeEEEE
Q 019650           46 ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDS-QFIVKCHAVFYTIEGEICFV  124 (337)
Q Consensus        46 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~-~~i~~~~~~~~~~~~~~~lv  124 (337)
                      .++|++++.||+|+||+||+|.+..+++.||+|++......   ..+.+|++.++.+.| ++++.+++.+.+ +...++|
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~e~~~~~~l~~~~~i~~~~~~~~~-~~~~~~v   79 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA---PQLRDEYRTYKLLAGCTGIPNVYYFGQE-GLHNVLV   79 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS---CCHHHHHHHHHHTTTCTTCCCEEEEEEE-TTEEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc---HHHHHHHHHHHHhcCCCCCCEEEEEeec-CCccEEE
Confidence            36899999999999999999999999999999998665422   345678888899876 788888887655 7889999


Q ss_pred             EeccCCCCchHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcC-----CCcEEEeeccCccchhc
Q 019650          125 MEHMERGSLFDSLRVR-KKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLING-----KGEVKIADFGVSRIVEE  198 (337)
Q Consensus       125 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~-----~~~~~l~Dfg~~~~~~~  198 (337)
                      ||++ +++|.+++... ..++..++..++.|++.||.|||++||+||||||+||+++.     ++.++|+|||++.....
T Consensus        80 me~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~  158 (293)
T d1csna_          80 IDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD  158 (293)
T ss_dssp             EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred             EEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEccc
Confidence            9999 67999998765 47999999999999999999999999999999999999964     56899999999988754


Q ss_pred             cccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCCchhHHH---
Q 019650          199 TRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEKPDLMA---  275 (337)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~~~~~~---  275 (337)
                      .........       ......+||+.|+|||++.    +..++.++||||||+++|+|++|..||.+.........   
T Consensus       159 ~~~~~~~~~-------~~~~~~~GT~~y~aPE~~~----~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~  227 (293)
T d1csna_         159 PVTKQHIPY-------REKKNLSGTARYMSINTHL----GREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYER  227 (293)
T ss_dssp             TTTCCBCCC-------CCCCCCCSCTTTCCHHHHT----TCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHH
T ss_pred             Cccccceee-------cccCceEEchhhcCHHHhc----CCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHH
Confidence            332211110       2233457999999999998    56789999999999999999999999976544332222   


Q ss_pred             HHHHhhccCCCCCCCCCCHHHHHHHHHHhhcCcCCCCCHHHHhc
Q 019650          276 LICAICFGERLEMPETASPEFRRFVRSCLEKDWRKRGTVEELLA  319 (337)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~eil~  319 (337)
                      ................+++.+.+++..|++.+|++||+++.+.+
T Consensus       228 i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~  271 (293)
T d1csna_         228 IGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  271 (293)
T ss_dssp             HHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             HHhccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence            22222222222344667899999999999999999999777654

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-47  Score=331.69  Aligned_cols=260  Identities=22%  Similarity=0.241  Sum_probs=194.4

Q ss_pred             ccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEEeeCC---eEE
Q 019650           46 ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFYTIEG---EIC  122 (337)
Q Consensus        46 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~---~~~  122 (337)
                      ..+|.+.+.||+|+||+||+|+.  +|+.||||+++....  .....+.|+..+.+++||||+++++++.+.+.   .++
T Consensus         2 ~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~--~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~   77 (303)
T d1vjya_           2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE--RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW   77 (303)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGH--HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred             CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch--hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEE
Confidence            46889999999999999999986  578999999865432  22223345556667899999999999887543   589


Q ss_pred             EEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHh--------CCceeccCCCCCeEEcCCCcEEEeeccCcc
Q 019650          123 FVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG--------MQIIHGDIKPSNLLINGKGEVKIADFGVSR  194 (337)
Q Consensus       123 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~--------~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~  194 (337)
                      +||||+++|+|.+++.+. ++++..+..++.|++.+|+|||+        .||+||||||+|||++.++++||+|||++.
T Consensus        78 lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~  156 (303)
T d1vjya_          78 LVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  156 (303)
T ss_dssp             EEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             EEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence            999999999999999764 69999999999999999999996        599999999999999999999999999998


Q ss_pred             chhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccC--CCCCCccccHHHHHHHHHHHHhCCCCCCCCCCc--
Q 019650          195 IVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERW--GGDYGFAGDVWSLGVVVLECLVGHYPLIGFGEK--  270 (337)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~~~~~DiwslG~il~~l~tg~~pf~~~~~~--  270 (337)
                      ..........          ......+||+.|+|||++.....  ...++.++||||||+++|||+||..||......  
T Consensus       157 ~~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~  226 (303)
T d1vjya_         157 RHDSATDTID----------IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL  226 (303)
T ss_dssp             EEETTTTEEC----------C----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCC
T ss_pred             cccCCCccee----------ccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCccccccc
Confidence            7654321111          12234469999999999874311  012567899999999999999998776432211  


Q ss_pred             ---------hhHHHHHHHhh-ccCCCCCCCC-----CCHHHHHHHHHHhhcCcCCCCCHHHHhcC
Q 019650          271 ---------PDLMALICAIC-FGERLEMPET-----ASPEFRRFVRSCLEKDWRKRGTVEELLAY  320 (337)
Q Consensus       271 ---------~~~~~~~~~~~-~~~~~~~~~~-----~~~~~~~li~~~l~~~p~~R~s~~eil~h  320 (337)
                               ........... ...++.++..     ....+.+++.+||+.||.+|||+.||+++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~  291 (303)
T d1vjya_         227 PYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             TTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             chhhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence                     11111111111 1222222222     12358999999999999999999999874

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=9.7e-45  Score=324.34  Aligned_cols=260  Identities=24%  Similarity=0.376  Sum_probs=194.6

Q ss_pred             cccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcC-----------CCCceeeeeeEE
Q 019650           47 SDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLD-----------SQFIVKCHAVFY  115 (337)
Q Consensus        47 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-----------~~~i~~~~~~~~  115 (337)
                      ++|+++++||+|+||+||+|.+..+|+.||||+++...  ...+.+.+|+.+++.+.           |+||+++++++.
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~--~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~   90 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK--VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   90 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc--cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEee
Confidence            57999999999999999999999999999999997543  33456778888888775           578999988876


Q ss_pred             eeC-CeEEEEEeccCCCCchHHh---hhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCeEEcCCC------c
Q 019650          116 TIE-GEICFVMEHMERGSLFDSL---RVRKKLSEDVISGVAYRVLKGLQYLHG-MQIIHGDIKPSNLLINGKG------E  184 (337)
Q Consensus       116 ~~~-~~~~lv~e~~~~~~L~~~l---~~~~~l~~~~~~~i~~~l~~~l~~LH~-~~ivH~dl~~~Nili~~~~------~  184 (337)
                      ... ...++++.++..+......   .....+++..++.++.||+.||.|||+ .||+||||||+|||++.++      .
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~  170 (362)
T d1q8ya_          91 HKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQ  170 (362)
T ss_dssp             EEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEE
T ss_pred             eccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccce
Confidence            533 4556666666544332222   234678999999999999999999997 8999999999999998665      3


Q ss_pred             EEEeeccCccchhccccCCCCCCCCCCccccccccccCCCCCcCCcccccccCCCCCCccccHHHHHHHHHHHHhCCCCC
Q 019650          185 VKIADFGVSRIVEETRNNNNHNNNNNNNIGEAAIACMGTCAYMSPERVDSERWGGDYGFAGDVWSLGVVVLECLVGHYPL  264 (337)
Q Consensus       185 ~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~DiwslG~il~~l~tg~~pf  264 (337)
                      ++++|||.+......                 ....+|++.|+|||++.    +..++.++|+||+|+++++|++|+.||
T Consensus       171 ~kl~dfg~s~~~~~~-----------------~~~~~gt~~y~aPE~~~----~~~~~~~~DiwSlG~il~el~~g~~pF  229 (362)
T d1q8ya_         171 IKIADLGNACWYDEH-----------------YTNSIQTREYRSPEVLL----GAPWGCGADIWSTACLIFELITGDFLF  229 (362)
T ss_dssp             EEECCCTTCEETTBC-----------------CCSCCSCGGGCCHHHHH----TCCCCTHHHHHHHHHHHHHHHHSSCCC
T ss_pred             eeEeecccccccccc-----------------cccccccccccChhhcc----ccCCCccccccchHHHHHHHHHCCCCC
Confidence            999999998755432                 12346999999999998    457899999999999999999999999


Q ss_pred             CCCCCch-----hHHHHHHHhhcc--------------------------------------CCCCCCCCCCHHHHHHHH
Q 019650          265 IGFGEKP-----DLMALICAICFG--------------------------------------ERLEMPETASPEFRRFVR  301 (337)
Q Consensus       265 ~~~~~~~-----~~~~~~~~~~~~--------------------------------------~~~~~~~~~~~~~~~li~  301 (337)
                      .......     +...........                                      .....+...++.+.+||.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~  309 (362)
T d1q8ya_         230 EPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLS  309 (362)
T ss_dssp             ---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHG
T ss_pred             CCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHH
Confidence            6532211     001100000000                                      001111233567999999


Q ss_pred             HHhhcCcCCCCCHHHHhcCccccccCCC
Q 019650          302 SCLEKDWRKRGTVEELLAYPFVTKRSSS  329 (337)
Q Consensus       302 ~~l~~~p~~R~s~~eil~hp~f~~~~~~  329 (337)
                      +||..||.+|||++|+|+||||++.-..
T Consensus       310 ~mL~~dP~~Rpta~e~L~Hp~f~~~~~~  337 (362)
T d1q8ya_         310 PMLQLDPRKRADAGGLVNHPWLKDTLGM  337 (362)
T ss_dssp             GGGCSSTTTCBCHHHHHTCGGGTTCTTC
T ss_pred             HHCCCChhHCcCHHHHhcCcccCCCCCc
Confidence            9999999999999999999999965433

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.91  E-value=4.9e-25  Score=177.87  Aligned_cols=135  Identities=19%  Similarity=0.228  Sum_probs=105.7

Q ss_pred             cccccccccCcceEEEEEEEccCCceEEEEEeecCCc-----------------hHhHHHHHHHHHHHHhcCCCCceeee
Q 019650           49 LKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSS-----------------TIIRHQAAHEAEILKRLDSQFIVKCH  111 (337)
Q Consensus        49 y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-----------------~~~~~~~~~e~~~~~~l~~~~i~~~~  111 (337)
                      +.++++||+|+||+||+|.+. +|+.||+|+++....                 .........|...+.++.|.+++..+
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~   80 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY   80 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred             chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence            467889999999999999884 688999998753211                 11223345688889999999988877


Q ss_pred             eeEEeeCCeEEEEEeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCeEEcCCCcEEEeecc
Q 019650          112 AVFYTIEGEICFVMEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHGMQIIHGDIKPSNLLINGKGEVKIADFG  191 (337)
Q Consensus       112 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~~ivH~dl~~~Nili~~~~~~~l~Dfg  191 (337)
                      +..   .  .+++||++++..+.+       ++...+..++.|++.+|+|||++||+||||||+|||++++ .++|+|||
T Consensus        81 ~~~---~--~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG  147 (191)
T d1zara2          81 AWE---G--NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFP  147 (191)
T ss_dssp             EEE---T--TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCT
T ss_pred             Eec---C--CEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECC
Confidence            642   2  269999998754432       4455567899999999999999999999999999999965 58999999


Q ss_pred             Cccchh
Q 019650          192 VSRIVE  197 (337)
Q Consensus       192 ~~~~~~  197 (337)
                      .+....
T Consensus       148 ~a~~~~  153 (191)
T d1zara2         148 QSVEVG  153 (191)
T ss_dssp             TCEETT
T ss_pred             CcccCC
Confidence            987653

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.55  E-value=1.8e-07  Score=77.27  Aligned_cols=141  Identities=15%  Similarity=0.135  Sum_probs=89.5

Q ss_pred             ccccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCC-CCceeeeeeEEeeCCeEEEE
Q 019650           46 ISDLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDS-QFIVKCHAVFYTIEGEICFV  124 (337)
Q Consensus        46 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~-~~i~~~~~~~~~~~~~~~lv  124 (337)
                      +..|.+.+..+.++.+.||++..  ++..+++|+...... .....+.+|...+..+.. -.+..++.... ..+..++|
T Consensus        13 ~~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~-~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~-~~~~~~lv   88 (263)
T d1j7la_          13 IEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYK-GTTYDVEREKDMMLWLEGKLPVPKVLHFER-HDGWSNLL   88 (263)
T ss_dssp             HTTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGT-TSTTCHHHHHHHHHHHTTTSCCCCEEEEEE-ETTEEEEE
T ss_pred             hhceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCcc-cchhhHHHHHHHHHHHhccCCCCcEEEEEe-cCCceEEE
Confidence            34666677666666789999853  455678888754321 123345667777776643 22445555443 36788999


Q ss_pred             EeccCCCCchHHhhhcCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------
Q 019650          125 MEHMERGSLFDSLRVRKKLSEDVISGVAYRVLKGLQYLHG----------------------------------------  164 (337)
Q Consensus       125 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~----------------------------------------  164 (337)
                      |++++|.++.+.....     .....++.++...++.||+                                        
T Consensus        89 ~~~l~G~~~~~~~~~~-----~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (263)
T d1j7la_          89 MSEADGVLCSEEYEDE-----QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP  163 (263)
T ss_dssp             EECCSSEEHHHHTTTC-----SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCS
T ss_pred             EEeccccccccccccc-----ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccccccc
Confidence            9999987765443211     1122233444444444442                                        


Q ss_pred             -------------------CCceeccCCCCCeEEcCCCcEEEeeccCccc
Q 019650          165 -------------------MQIIHGDIKPSNLLINGKGEVKIADFGVSRI  195 (337)
Q Consensus       165 -------------------~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~  195 (337)
                                         ..++|||+.|.||++++++.+.|+||+.+..
T Consensus       164 ~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             CSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             chHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                               1278999999999999776677999998753

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.37  E-value=8.7e-07  Score=77.58  Aligned_cols=79  Identities=18%  Similarity=0.187  Sum_probs=47.3

Q ss_pred             ccccccCcceEEEEEEEccCCceEEEEEeecC------CchHhHHHHHHHHHHHHhcC-C-CC-ceeeeeeEEeeCCeEE
Q 019650           52 LTVLGHGNGGIVYKVRHQKSNSIYALKVLNTT------SSTIIRHQAAHEAEILKRLD-S-QF-IVKCHAVFYTIEGEIC  122 (337)
Q Consensus        52 ~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~------~~~~~~~~~~~e~~~~~~l~-~-~~-i~~~~~~~~~~~~~~~  122 (337)
                      .+.||.|....||++.+..+++.+++|.-...      ......++...|...++.+. + |. +++++..  + ...-+
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d-~~~~~  107 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--D-TEMAV  107 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--E-TTTTE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--c-CCCCE
Confidence            44689999999999998877888999974321      11223344556777777662 2 33 3334432  3 34456


Q ss_pred             EEEeccCCCCc
Q 019650          123 FVMEHMERGSL  133 (337)
Q Consensus       123 lv~e~~~~~~L  133 (337)
                      +|||++++..+
T Consensus       108 lvmE~L~~~~~  118 (392)
T d2pula1         108 TVMEDLSHLKI  118 (392)
T ss_dssp             EEECCCTTSEE
T ss_pred             EEEeccCCccc
Confidence            89999976543

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.26  E-value=1.7e-06  Score=70.78  Aligned_cols=75  Identities=13%  Similarity=0.139  Sum_probs=47.6

Q ss_pred             ccccCc-ceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCC--ceeeeeeEEeeCCeEEEEEeccCC
Q 019650           54 VLGHGN-GGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQF--IVKCHAVFYTIEGEICFVMEHMER  130 (337)
Q Consensus        54 ~lg~g~-~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~--i~~~~~~~~~~~~~~~lv~e~~~~  130 (337)
                      .+..|. .+.||+... .++..+++|......    ...+..|...++.+...+  +.+++....+ .+..++||++++|
T Consensus        17 ~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~----~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~-~~~~~~v~~~i~G   90 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA----LNELQDEAARLSWLATTGVPCAAVLDVVTE-AGRDWLLLGEVPG   90 (255)
T ss_dssp             ECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT----TSCHHHHHHHHHHHHTTTCCBCCEEEEEEC-SSCEEEEEECCSS
T ss_pred             EcCCcccCCeEEEEEe-CCCCEEEEEeCCccC----HhHHHHHHHHHHHHHhcCCCCCceeeeccc-ccceEEEEEeeec
Confidence            344444 468899876 456668889865443    223556777777664433  4445655443 5678999999988


Q ss_pred             CCch
Q 019650          131 GSLF  134 (337)
Q Consensus       131 ~~L~  134 (337)
                      .++.
T Consensus        91 ~~~~   94 (255)
T d1nd4a_          91 QDLL   94 (255)
T ss_dssp             EETT
T ss_pred             cccc
Confidence            6653

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.40  E-value=0.00041  Score=58.37  Aligned_cols=131  Identities=13%  Similarity=0.159  Sum_probs=72.9

Q ss_pred             ceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCce-----ee-eeeEEeeCCeEEEEEeccCCCCc
Q 019650           60 GGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIV-----KC-HAVFYTIEGEICFVMEHMERGSL  133 (337)
Q Consensus        60 ~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~-----~~-~~~~~~~~~~~~lv~e~~~~~~L  133 (337)
                      .-.||++.. .+|..+++|+.+....  ..+++..|...+..|...++.     .. -+.....+...+.++++++|..+
T Consensus        35 EN~vy~v~~-~dg~~~VlK~~rp~~~--s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~  111 (325)
T d1zyla1          35 ENRVYQFQD-EDRRRFVVKFYRPERW--TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQF  111 (325)
T ss_dssp             SSEEEEECC-TTCCCEEEEEECTTTS--CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEEC
T ss_pred             cceeEEEEc-CCCCEEEEEEeCCCCC--CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCC
Confidence            468999976 4677899999875431  234566677777776432221     11 11122235667889999876433


Q ss_pred             h-----H------Hh---h----hc-----C-------------------CCCHH---HHHHHHHHHHHHHHHHH----h
Q 019650          134 F-----D------SL---R----VR-----K-------------------KLSED---VISGVAYRVLKGLQYLH----G  164 (337)
Q Consensus       134 ~-----~------~l---~----~~-----~-------------------~l~~~---~~~~i~~~l~~~l~~LH----~  164 (337)
                      .     .      .+   .    ..     .                   .++..   .....+.++...+..+-    .
T Consensus       112 ~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p  191 (325)
T d1zyla1         112 EADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFT  191 (325)
T ss_dssp             CSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSC
T ss_pred             CCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCC
Confidence            1     0      00   0    00     0                   11111   22222333333333221    1


Q ss_pred             CCceeccCCCCCeEEcCCCcEEEeeccCccc
Q 019650          165 MQIIHGDIKPSNLLINGKGEVKIADFGVSRI  195 (337)
Q Consensus       165 ~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~  195 (337)
                      .++||||+.+.||+++. + ..++||+.+..
T Consensus       192 ~~liHgDlh~~NvL~~~-~-~~~IDFdd~~~  220 (325)
T d1zyla1         192 VLRLHGDCHAGNILWRD-G-PMFVDLDDARN  220 (325)
T ss_dssp             CEECCSSCSGGGEEESS-S-EEECCCTTCCE
T ss_pred             ceeecCCCCcccEEEeC-C-ceEEechhccc
Confidence            36899999999999974 3 45899998753

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.30  E-value=0.00051  Score=59.49  Aligned_cols=74  Identities=16%  Similarity=0.235  Sum_probs=48.9

Q ss_pred             ccccccCcceEEEEEEEcc-------CCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCce-eeeeeEEeeCCeEEE
Q 019650           52 LTVLGHGNGGIVYKVRHQK-------SNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIV-KCHAVFYTIEGEICF  123 (337)
Q Consensus        52 ~~~lg~g~~~~v~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~-~~~~~~~~~~~~~~l  123 (337)
                      ++.|+.|-.-.+|++....       ..+.|++++.-.....   -...+|..+++.+...++. ++++.+.   +  ++
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~---idr~~E~~i~~~ls~~gl~Pkll~~~~---~--g~  118 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETE---SHLVAESVIFTLLSERHLGPKLYGIFS---G--GR  118 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCH---HHHHHHHHHHHHHHHTTSSSCEEEEET---T--EE
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchh---hHHHHHHHHHHHHHhCCCCCeEEEEcC---C--ce
Confidence            4578899999999998753       2356778876532222   2345688888887555555 4555432   2  58


Q ss_pred             EEeccCCCCc
Q 019650          124 VMEHMERGSL  133 (337)
Q Consensus       124 v~e~~~~~~L  133 (337)
                      |++|++|.+|
T Consensus       119 I~efi~g~~l  128 (395)
T d1nw1a_         119 LEEYIPSRPL  128 (395)
T ss_dssp             EECCCCEEEC
T ss_pred             EEEEeccccC
Confidence            9999987554

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=97.25  E-value=0.0009  Score=55.87  Aligned_cols=143  Identities=12%  Similarity=0.138  Sum_probs=73.7

Q ss_pred             ccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCce-----eee--eeEEeeCCe
Q 019650           48 DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIV-----KCH--AVFYTIEGE  120 (337)
Q Consensus        48 ~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~-----~~~--~~~~~~~~~  120 (337)
                      +..-.+.|..|-.-+.|++...+ | .+++|++.....   .+.+..|..++..+...++.     ...  ..+......
T Consensus        19 ~~~~~~~i~~G~~N~ny~v~t~~-g-~yVLri~~~~~~---~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~   93 (316)
T d2ppqa1          19 SLTSYKGIAEGVENSNFLLHTTK-D-PLILTLYEKRVE---KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGR   93 (316)
T ss_dssp             CEEEEEEECC---EEEEEEEESS-C-CEEEEEECC------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTE
T ss_pred             CceEeecCCCCcccCeEEEEECC-C-cEEEEEcCCCCC---HHHHHHHHHHHHhhhhccccccccceecCCCcceeeecc
Confidence            34445567788888999997653 3 488999865422   23344466666665332221     110  001111344


Q ss_pred             EEEEEeccCCCCchHH--------------hhhc----C-----------------------CCCHHHHHHHHHHHHHHH
Q 019650          121 ICFVMEHMERGSLFDS--------------LRVR----K-----------------------KLSEDVISGVAYRVLKGL  159 (337)
Q Consensus       121 ~~lv~e~~~~~~L~~~--------------l~~~----~-----------------------~l~~~~~~~i~~~l~~~l  159 (337)
                      .+.++.+..|......              +...    .                       ..........+..+...+
T Consensus        94 ~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  173 (316)
T d2ppqa1          94 PAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYL  173 (316)
T ss_dssp             EEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHH
T ss_pred             cceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhh
Confidence            5566666655433110              0000    0                       001111222233333333


Q ss_pred             HHHH----hCCceeccCCCCCeEEcCCCcEEEeeccCccc
Q 019650          160 QYLH----GMQIIHGDIKPSNLLINGKGEVKIADFGVSRI  195 (337)
Q Consensus       160 ~~LH----~~~ivH~dl~~~Nili~~~~~~~l~Dfg~~~~  195 (337)
                      ....    ..|+||+|+.+.|++++.+...-++||+.+..
T Consensus       174 ~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         174 AAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             HHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence            3333    24799999999999999887779999998864

>d1cjaa_ d.144.1.3 (A:) Actin-fragmin kinase, catalytic domain {Physarum polycephalum [TaxId: 5791]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Actin-fragmin kinase, catalytic domain
domain: Actin-fragmin kinase, catalytic domain
species: Physarum polycephalum [TaxId: 5791]

Probab=81.09  E-value=3.7  Score=32.87  Aligned_cols=136  Identities=12%  Similarity=0.109  Sum_probs=71.7

Q ss_pred             ccccccccccCcceEEEEEEEccCCceEEEEEeecCCchHhHHHHHHHHHHHHhcCCCCceeeeeeEE------------
Q 019650           48 DLKKLTVLGHGNGGIVYKVRHQKSNSIYALKVLNTTSSTIIRHQAAHEAEILKRLDSQFIVKCHAVFY------------  115 (337)
Q Consensus        48 ~y~~~~~lg~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~------------  115 (337)
                      +++-++.=-.|+.| |+-+..  ++..+++|.-    .....+.+-.++.....++-|...-+...-.            
T Consensus        70 ~~K~i~~s~~Gs~G-v~FV~~--e~gaiVlK~s----~tta~E~y~~eLAr~LGvpvPqmRvI~~~~~E~~~~~~~~l~~  142 (342)
T d1cjaa_          70 QFKGIERSEKGTEG-LFFVET--ESGVFIVKRS----TNIESETFCSLLCMRLGLHAPKVRVVSSNSEEGTNMLECLAAI  142 (342)
T ss_dssp             GEEEEEECCSTTSC-EEEEEE--SSCEEEEECC----TTHHHHHHHHHHHHHHTCCCCCEEEEESSSHHHHHHHHHHHHH
T ss_pred             hhhceEEeecCCce-EEEEEc--CCceEEEecC----CchHHHHHHHHHHHHhCCCCCceEEecCCCHHHHHHHHHHhcC
Confidence            44333333344444 444433  2345777752    2344566667777777788887766541100            


Q ss_pred             ---------eeCCeEEEEEeccCCCCchHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CceeccC-CCCCeEEc
Q 019650          116 ---------TIEGEICFVMEHMERGSLFDSLRVR--KKLSEDVISGVAYRVLKGLQYLHGM---QIIHGDI-KPSNLLIN  180 (337)
Q Consensus       116 ---------~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~---~ivH~dl-~~~Nili~  180 (337)
                               ......+++|||.+|.+|.+.-...  ..+..+.+..+.+ |+..=.+++..   .+.+++- .+.|+++.
T Consensus       143 ~e~d~~I~sel~~A~~liMeYvpG~~l~e~~~~~a~~~fs~~~l~~LGk-IiaFDifInN~DR~PL~Wrn~GN~~Niml~  221 (342)
T d1cjaa_         143 DKSFRVITTLANQANILLMELVRGITLNKLTTTSAPEVLTKSTMQQLGS-LMALDVIVNNSDRLPIAWTNEGNLDNIMLS  221 (342)
T ss_dssp             CSSSCHHHHHTTCSEEEEEECCCEEESTTCCSSSHHHHSCHHHHHHHHH-HHHHHHHHTCCSSSCSSSCSCCCGGGEEEE
T ss_pred             CChhHHHHHHHhcccceeeeccCCccccccccccchhhhcHHHHHHhhh-HHHHHHHHcCCccccccccCCCCccceEEe
Confidence                     0012467899999987775543211  1234444333222 12112245533   3455522 78899998


Q ss_pred             CCC-cEEEeecc
Q 019650          181 GKG-EVKIADFG  191 (337)
Q Consensus       181 ~~~-~~~l~Dfg  191 (337)
                      .++ .+..+|=+
T Consensus       222 ~n~~~~~~IDs~  233 (342)
T d1cjaa_         222 ERGATVVPIDSK  233 (342)
T ss_dssp             SBTTCEEECSCC
T ss_pred             cCCcEEEEecCC
Confidence            776 67777733